,X1,Cmpds,Name,Formula,AllNames,AllReactions,AllPath,AllEnzyme,AllModule,AllBrite,AllDB,OtherCmpds,C,H,O,N,P,S,Cl,I,Br,F,Se,B,Mo,Fe,Co,Mg,Ni,As,PosForm,NegForm,NeutalMass,PosMZ,NegMZ1,1,cpd:C00022,Pyruvate;,C3H4O3,Pyruvate; Pyruvic acid; 2-Oxopropanoate; 2-Oxopropanoic acid; Pyroracemic acid,R00006 R00008 R00014 R00195 R00196 R00197 R00198 R00199; R00200 R00203 R00205 R00206 R00207 R00208 R00209 R00210; R00211 R00212 R00213 R00214 R00215 R00216 R00217 R00218; R00219 R00220 R00221 R00223 R00224 R00226 R00237 R00258; R00297 R00324 R00325 R00344 R00350 R00353 R00368 R00369; R00396 R00398 R00400 R00409 R00430 R00452 R00453 R00470; R00471 R00532 R00543 R00562 R00572 R00576 R00585 R00659; R00666 R00673 R00692 R00703 R00704 R00724 R00728 R00750; R00782 R00906 R00907 R00930 R00985 R00986 R01012 R01031; R01032 R01064 R01085 R01138 R01147 R01148 R01196 R01215; R01261 R01286 R01302 R01335 R01344 R01355 R01447 R01576; R01584 R01645 R01647 R01683 R01699 R01712 R01782 R01784; R01811 R01858 R01874 R02050 R02261 R02271 R02293 R02320; R02408 R02628 R02721 R02754 R02953 R02970 R03001 R03037; R03050 R03081 R03105 R03106 R03145 R03277 R03465 R03502; R03528 R03732 R03796 R03854 R04152 R04187 R04672 R04861; R04941 R05136 R05298 R05538 R05544 R05553 R05605 R05636; R05648 R05652 R05861 R06602 R06603 R06913 R06923 R06934; R07399 R07633 R07634 R07685 R07692 R07713 R08166 R08170; R08197 R08200 R08253 R08570 R08648 R08654 R08660 R08667; R08686 R08698 R08714 R09048 R09088 R09238 R09254 R09366; R10147 R10178 R10180 R10283 R10487 R10527 R10539 R10542; R10550 R10552 R10583 R10597 R10616 R10674 R10691 R10866; R10992 R11023 R11038 R11099 R11141 R11213 R11257 R11352; R11463,"Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Pentose phosphate pathway; Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Alanine, aspartate and glutamate metabolism; Glycine, serine and threonine metabolism; Monobactam biosynthesis; Cysteine and methionine metabolism; Valine, leucine and isoleucine biosynthesis; Arginine and proline metabolism; Tyrosine metabolism; Phenylalanine metabolism; Benzoate degradation; Taurine and hypotaurine metabolism; Phosphonate and phosphinate metabolism; D-Alanine metabolism; Pyruvate metabolism; Dioxin degradation; Xylene degradation; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; C5-Branched dibasic acid metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Carbon fixation pathways in prokaryotes; Thiamine metabolism; Nicotinate and nicotinamide metabolism; Pantothenate and CoA biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Degradation of aromatic compounds; Biosynthesis of amino acids; Vancomycin resistance; Phosphotransferase system (PTS); HIF-1 signaling pathway; AMPK signaling pathway; Insulin secretion; Glucagon signaling pathway; Type II diabetes mellitus; Insulin resistance; Central carbon metabolism in cancer",1.1.1.27; 1.1.1.28; 1.1.1.38; 1.1.1.39; 1.1.1.40; 1.1.1.83; 1.1.2.3; 1.1.2.4; 1.1.2.5; 1.1.99.6; 1.1.99.7; 1.2.1.22; 1.2.1.23; 1.2.1.49; 1.2.1.51; 1.2.3.3; 1.2.3.6; 1.2.3.15; 1.2.4.1; 1.2.5.1; 1.2.7.1; 1.2.7.11; 1.2.7.-; 1.4.1.1; 1.4.1.17; 1.4.3.3; 1.4.3.19; 1.5.1.11; 1.5.1.16; 1.5.1.17; 1.5.1.22; 1.5.1.23; 1.5.1.24; 1.5.1.26; 1.5.1.28; 1.8.1.4; 1.14.11.43; 1.14.11.44; 2.1.3.1; 2.2.1.6; 2.2.1.7; 2.2.1.12; 2.3.1.12; 2.3.1.54; 2.3.1.182; 2.6.1.2; 2.6.1.12; 2.6.1.15; 2.6.1.18; 2.6.1.21; 2.6.1.30; 2.6.1.37; 2.6.1.40; 2.6.1.41; 2.6.1.43; 2.6.1.44; 2.6.1.46; 2.6.1.47; 2.6.1.51; 2.6.1.56; 2.6.1.58; 2.6.1.66; 2.6.1.71; 2.6.1.77; 2.6.1.84; 2.6.1.96; 2.6.1.99; 2.6.1.108; 2.6.1.-; 2.6.3.1; 2.7.1.40; 2.7.1.121; 2.7.3.9; 2.7.9.1; 2.7.9.2; 2.8.1.2; 3.1.3.60; 3.3.2.1; 3.3.2.13; 3.3.2.15; 3.5.99.10; 3.7.1.5; 3.7.1.6; 3.7.1.20; 3.7.1.23; 3.7.1.-; 3.11.1.3; 4.1.1.1; 4.1.1.3; 4.1.1.64; 4.1.1.78; 4.1.1.-; 4.1.2.14; 4.1.2.18; 4.1.2.20; 4.1.2.21; 4.1.2.23; 4.1.2.28; 4.1.2.34; 4.1.2.45; 4.1.2.51; 4.1.2.52; 4.1.2.53; 4.1.2.54; 4.1.2.55; 4.1.2.58; 4.1.2.-; 4.1.3.3; 4.1.3.16; 4.1.3.17; 4.1.3.22; 4.1.3.25; 4.1.3.27; 4.1.3.30; 4.1.3.32; 4.1.3.38; 4.1.3.39; 4.1.3.40; 4.1.3.42; 4.1.3.43; 4.1.3.44; 4.1.3.45; 4.1.3.46; 4.1.99.1; 4.1.99.2; 4.2.1.-; 4.2.99.20; 4.2.99.21; 4.3.1.10; 4.3.1.13; 4.3.1.15; 4.3.1.17; 4.3.1.18; 4.3.1.19; 4.3.3.7; 4.4.1.1; 4.4.1.6; 4.4.1.8; 4.4.1.13; 4.4.1.15; 4.4.1.24; 4.4.1.25; 4.4.1.28; 4.4.1.-; 4.5.1.2; 6.4.1.1,"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate; Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P; C5 isoprenoid biosynthesis, non-mevalonate pathway; CAM (Crassulacean acid metabolism), light; C4-dicarboxylic acid cycle, NAD - malic enzyme type; C4-dicarboxylic acid cycle, NADP - malic enzyme type; Reductive citrate cycle (Arnon-Buchanan cycle); Pyruvate oxidation, pyruvate => acetyl-CoA; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; Dicarboxylate-hydroxybutyrate cycle; 3-Hydroxypropionate bi-cycle; Isoleucine biosynthesis, pyruvate => 2-oxobutanoate; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00022  Pyruvate; 2-Oxopropanoate,CAS: 127-17-3; PubChem: 3324; ChEBI: 15361 32816; ChEMBL: CHEMBL1162144; LIPIDMAPS: LMFA01060077; LipidBank: DFA0385; KNApSAcK: C00001200; PDB-CCD: PYR; 3DMET: B00006; NIKKAJI: J2.015J,cpd:C00022; cpd:C00222; cpd:C00957; cpd:C02055; cpd:C02853; cpd:C12069; cpd:C18618; cpd:C20363,3,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O3,C3H3O3,88.01604399,89.02386902,87.008218962,2,cpd:C00024,Acetyl-CoA;,C23H38N7O17P3S,Acetyl-CoA; Acetyl coenzyme A,R00209 R00210 R00211 R00212 R00227 R00228 R00229 R00230; R00233 R00235 R00236 R00237 R00238 R00259 R00271 R00351; R00352 R00353 R00354 R00371 R00391 R00393 R00399 R00454; R00472 R00473 R00487 R00586 R00627 R00693 R00705 R00706; R00742 R00743 R00829 R00927 R00928 R00998 R01023 R01089; R01154 R01160 R01177 R01179 R01196 R01204 R01213 R01323; R01359 R01360 R01556 R01624 R01776 R01806 R01807 R01808; R01850 R01889 R01978 R02058 R02152 R02191 R02232 R02387; R02396 R02481 R02569 R02616 R02772 R02837 R02911 R02955; R03017 R03056 R03064 R03065 R03153 R03168 R03230 R03437; R03455 R03552 R03621 R03668 R03760 R03767 R03778 R03858; R03884 R03903 R03910 R03991 R04000 R04024 R04057 R04192; R04316 R04348 R04364 R04386 R04466 R04484 R04723 R04742; R04747 R04950 R05063 R05188 R05190 R05332 R05336 R05351; R05506 R05508 R05509 R05537 R05586 R05672 R05773 R05870; R05876 R06251 R06307 R06311 R06510 R06635 R06735 R06736; R06978 R06997 R07249 R07252 R07253 R07399 R07815 R07832; R07833 R07891 R07895 R07899 R07937 R07953 R08036 R08091; R08095 R08213 R08248 R08250 R08331 R08332 R08386 R08433; R08530 R08531 R08532 R08619 R08623 R08627 R08631 R08640; R08644 R08680 R08767 R08870 R08871 R08938 R09096 R09317; R09524 R09527 R09622 R09631 R09839 R09842 R09873 R10099; R10100 R10142 R10174 R10200 R10219 R10243 R10253 R10254; R10343 R10473 R10474 R10500 R10514 R10564 R10600 R10614; R10674 R10707 R10745 R10746 R10866 R10893 R11124 R11125; R11182 R11412 R11479,"Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Fatty acid biosynthesis; Fatty acid elongation; Fatty acid degradation; Synthesis and degradation of ketone bodies; Aflatoxin biosynthesis; Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Lysine biosynthesis; Lysine degradation; Phenylalanine metabolism; Benzoate degradation; Tryptophan metabolism; beta-Alanine metabolism; Taurine and hypotaurine metabolism; Glutathione metabolism; Inositol phosphate metabolism; Pyruvate metabolism; Dioxin degradation; Xylene degradation; Chloroalkane and chloroalkene degradation; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Ethylbenzene degradation; Butanoate metabolism; Methane metabolism; Carbon fixation pathways in prokaryotes; Terpenoid backbone biosynthesis; Biosynthesis of type II polyketide backbone; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism; Degradation of aromatic compounds; HIF-1 signaling pathway; AMPK signaling pathway; Cholinergic synapse; Glucagon signaling pathway; Insulin resistance; Bile secretion; Central carbon metabolism in cancer",1.1.1.-; 1.2.1.10; 1.2.1.18; 1.2.1.27; 1.2.1.51; 1.2.3.6; 1.2.4.1; 1.2.7.1; 1.2.7.4; 1.2.7.11; 1.2.7.-; 1.8.1.4; 2.1.1.258; 2.1.3.1; 2.3.1.1; 2.3.1.2; 2.3.1.3; 2.3.1.4; 2.3.1.5; 2.3.1.6; 2.3.1.7; 2.3.1.8; 2.3.1.9; 2.3.1.10; 2.3.1.11; 2.3.1.12; 2.3.1.16; 2.3.1.17; 2.3.1.18; 2.3.1.27; 2.3.1.28; 2.3.1.29; 2.3.1.30; 2.3.1.31; 2.3.1.33; 2.3.1.34; 2.3.1.36; 2.3.1.38; 2.3.1.44; 2.3.1.45; 2.3.1.48; 2.3.1.53; 2.3.1.54; 2.3.1.57; 2.3.1.59; 2.3.1.60; 2.3.1.66; 2.3.1.67; 2.3.1.69; 2.3.1.78; 2.3.1.79; 2.3.1.80; 2.3.1.81; 2.3.1.82; 2.3.1.84; 2.3.1.85; 2.3.1.86; 2.3.1.87; 2.3.1.88; 2.3.1.89; 2.3.1.102; 2.3.1.105; 2.3.1.107; 2.3.1.108; 2.3.1.118; 2.3.1.128; 2.3.1.136; 2.3.1.150; 2.3.1.155; 2.3.1.157; 2.3.1.160; 2.3.1.162; 2.3.1.163; 2.3.1.165; 2.3.1.167; 2.3.1.169; 2.3.1.174; 2.3.1.175; 2.3.1.178; 2.3.1.180; 2.3.1.182; 2.3.1.183; 2.3.1.185; 2.3.1.186; 2.3.1.189; 2.3.1.190; 2.3.1.194; 2.3.1.195; 2.3.1.197; 2.3.1.201; 2.3.1.202; 2.3.1.203; 2.3.1.205; 2.3.1.209; 2.3.1.210; 2.3.1.223; 2.3.1.224; 2.3.1.227; 2.3.1.236; 2.3.1.237; 2.3.1.245; 2.3.1.247; 2.3.1.-; 2.3.3.1; 2.3.3.3; 2.3.3.6; 2.3.3.8; 2.3.3.9; 2.3.3.10; 2.3.3.13; 2.3.3.14; 2.3.3.16; 2.3.3.17; 2.3.3.-; 2.3.-.-; 2.6.1.33; 2.8.3.1; 2.8.3.3; 2.8.3.8; 2.8.3.10; 2.8.3.11; 2.8.3.12; 2.8.3.14; 2.8.3.18; 2.8.3.19; 2.8.3.-; 3.1.2.1; 4.1.1.9; 4.1.2.41; 4.1.3.4; 4.1.3.24; 4.1.3.25; 4.1.3.34; 4.1.3.35; 4.1.3.46; 4.1.3.-; 6.2.1.1; 6.2.1.13; 6.4.1.2,"Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate; Glyoxylate cycle; Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA; Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Fatty acid biosynthesis, initiation; Fatty acid biosynthesis, elongation, mitochondria; Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone; C5 isoprenoid biosynthesis, mevalonate pathway; Reductive citrate cycle (Arnon-Buchanan cycle); Pyruvate oxidation, pyruvate => acetyl-CoA; Methanogenesis, acetate => methane; Ethylmalonyl pathway; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway); Acetyl-CoA pathway, CO2 => acetyl-CoA; Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate; Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA; Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Methylaspartate cycle",NA,CAS: 72-89-9; PubChem: 3326; ChEBI: 15351; LIPIDMAPS: LMFA07050029; KNApSAcK: C00007259; PDB-CCD: ACO; 3DMET: B04621; NIKKAJI: J192.549K,cpd:C00024; cpd:C02843,23,38,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C23H39O17N7P3S1,C23H37O17N7P3S1,809.125775,810.1336,808.11794993,3,cpd:C00031,D-Glucose;,C6H12O6,D-Glucose; Grape sugar; Dextrose; Glucose; D-Glucopyranose,R00010 R00015 R00028 R00049 R00063 R00299 R00300 R00301; R00302 R00303 R00304 R00305 R00306 R00307 R00308 R00327; R00337 R00503 R00534 R00550 R00725 R00801 R00837 R00838; R00839 R00850 R00874 R00952 R00953 R00960 R01006 R01100; R01101 R01139 R01444 R01460 R01498 R01555 R01718 R01790; R01791 R02185 R02558 R02595 R02727 R02738 R02887 R02985; R03075 R03323 R03527 R03604 R03703 R03801 R03802 R03820; R04006 R04094 R04194 R04333 R04409 R04410 R04411 R04498; R04503 R04949 R04998 R05061 R05140 R05141 R05142 R05196; R05804 R05979 R05980 R05981 R06040 R06053 R06056 R06058; R06059 R06067 R06069 R06079 R06087 R06091 R06103 R06104; R06105 R06106 R06107 R06108 R06109 R06112 R06113 R06114; R06115 R06135 R06204 R06620 R07147 R07264 R08404 R08514; R08819 R08823 R08946 R09039 R09723 R09941 R09943 R10411; R10494 R10525 R10530 R10580 R10581 R11215 R11306,"Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Galactose metabolism; Starch and sucrose metabolism; Amino sugar and nucleotide sugar metabolism; Streptomycin biosynthesis; Neomycin, kanamycin and gentamicin biosynthesis; Indole alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; ABC transporters; Two-component system; Phosphotransferase system (PTS); HIF-1 signaling pathway; FoxO signaling pathway; Meiosis - yeast; AMPK signaling pathway; Taste transduction; Insulin signaling pathway; Insulin secretion; Prolactin signaling pathway; Glucagon signaling pathway; Type II diabetes mellitus; Insulin resistance; Non-alcoholic fatty liver disease (NAFLD); AGE-RAGE signaling pathway in diabetic complications; Carbohydrate digestion and absorption; Bile secretion; Mineral absorption; Biofilm formation - Vibrio cholerae; Central carbon metabolism in cancer",1.1.1.118; 1.1.1.119; 1.1.1.121; 1.1.1.359; 1.1.1.360; 1.1.3.10; 1.1.5.2; 1.1.5.9; 1.1.99.28; 1.1.99.35; 2.3.1.72; 2.3.1.90; 2.3.1.91; 2.3.1.92; 2.3.1.103; 2.3.1.143; 2.3.1.152; 2.3.1.-; 2.4.1.8; 2.4.1.9; 2.4.1.10; 2.4.1.20; 2.4.1.22; 2.4.1.25; 2.4.1.31; 2.4.1.64; 2.4.1.99; 2.4.1.230; 2.4.1.245; 2.4.1.279; 2.4.1.281; 2.7.1.1; 2.7.1.2; 2.7.1.41; 2.7.1.42; 2.7.1.61; 2.7.1.62; 2.7.1.63; 2.7.1.142; 2.7.1.147; 2.7.1.199; 3.1.1.33; 3.1.3.9; 3.1.3.10; 3.1.3.58; 3.1.4.48; 3.1.6.3; 3.2.1.3; 3.2.1.10; 3.2.1.20; 3.2.1.21; 3.2.1.22; 3.2.1.23; 3.2.1.26; 3.2.1.28; 3.2.1.39; 3.2.1.42; 3.2.1.45; 3.2.1.48; 3.2.1.58; 3.2.1.62; 3.2.1.74; 3.2.1.84; 3.2.1.86; 3.2.1.93; 3.2.1.104; 3.2.1.105; 3.2.1.106; 3.2.1.107; 3.2.1.108; 3.2.1.117; 3.2.1.118; 3.2.1.122; 3.2.1.125; 3.2.1.126; 3.2.1.147; 3.2.1.175; 3.2.1.186; 3.2.1.188; 3.2.1.189; 3.2.1.-; 4.2.99.22; 4.2.99.23; 5.3.1.5,NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00031  D-Glucose; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05C IRRIGATING SOLUTIONS;     B05CX Other irrigating solutions;      B05CX01 Glucose;       D00009  Glucose (JP17);  V VARIOUS;   V04 DIAGNOSTIC AGENTS;    V04C OTHER DIAGNOSTIC AGENTS;     V04CA Tests for diabetes;      V04CA02 Glucose;       D00009  Glucose (JP17);   V06 GENERAL NUTRIENTS;    V06D OTHER NUTRIENTS;     V06DC Carbohydrates;      V06DC01 Glucose;       D00009  Glucose (JP17); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   32  Nutrients, tonics;    323  Saccharide preparations;     3231  Glucoses;      D00009  Glucose (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Glucose;     D00009  Glucose (JP17); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00009  [001540] Glucose;  Buffering agent;   D00009  [001540] Glucose;  Sweetening agent;   D00009  [001540] Glucose;  Flavoring substance;   D00009  [001540] Glucose;  Bonding agent;   D00009  [001540] Glucose;  Coating agent;   D00009  [001540] Glucose;  Tonicity agent;   D00009  [001540] Glucose;  Diluting agent;   D00009  [001540] Glucose;   D00009  [999999] Glucose solution;  Soothing agent;   D00009  [001540] Glucose;  Solubilizer;   D00009  [001540] Glucose;  Solubilization agent;   D00009  [001540] Glucose;  Solvent;   D00009  [001540] Glucose; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00009  Glucose;   D00009  Glucose injection; Major components of natural products [BR:br08323];  Crude drugs;   Honey; Honey, purified;    C00031  D-Glucose; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   964  Saccharide preparations and blood substitutes;    9641  Dextrose and preparations;     C00031  D-Glucose",CAS: 50-99-7 2280-44-6; PubChem: 3333; ChEBI: 4167; ChEMBL: CHEMBL1222250 CHEMBL1614854 CHEMBL423707 CHEMBL98182; KNApSAcK: C00042470; PDB-CCD: BGC GLC; 3DMET: B04623; NIKKAJI: J4.109B,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.05556314,4,cpd:C00033,Acetate;,C2H4O2,Acetate; Acetic acid; Ethanoic acid,R00227 R00229 R00235 R00315 R00316 R00317 R00318 R00319; R00320 R00321 R00322 R00324 R00325 R00326 R00327 R00338; R00362 R00393 R00458 R00488 R00628 R00651 R00669 R00710; R00711 R00743 R00897 R00909 R00928 R01019 R01026 R01156; R01179 R01200 R01241 R01287 R01308 R01323 R01359 R01426; R01649 R01810 R01987 R02026 R02059 R02276 R02333 R02733; R02942 R02955 R03062 R03131 R03132 R03133 R03134 R03145; R03153 R03217 R03482 R03601 R03884 R04000 R04043 R04056; R04057 R04091 R04141 R04146 R04174 R04397 R04449 R04450; R04452 R04490 R04525 R04587 R04727 R04769 R04859 R04945; R05138 R05168 R05219 R05336 R05508 R05509 R05677 R05880; R05917 R06241 R06893 R07183 R07300 R07301 R07342 R07513; R07832 R08090 R08206 R08517 R08518 R08600 R08601 R08874; R08876 R08895 R08901 R08944 R09107 R09475 R09483 R09651; R09721 R09801 R09931 R10248 R10249 R10289 R10305 R10343; R10398 R10401 R10461 R10553 R10600 R10614 R10705 R10839; R10840 R11116 R11283,Glycolysis / Gluconeogenesis; Taurine and hypotaurine metabolism; Phosphonate and phosphinate metabolism; Glycosaminoglycan biosynthesis - heparan sulfate / heparin; Pyruvate metabolism; Propanoate metabolism; C5-Branched dibasic acid metabolism; Methane metabolism; Carbon fixation pathways in prokaryotes; Zeatin biosynthesis; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Degradation of aromatic compounds; Cholinergic synapse; Carbohydrate digestion and absorption; Protein digestion and absorption,1.1.1.318; 1.1.1.319; 1.2.1.3; 1.2.1.4; 1.2.1.5; 1.2.1.-; 1.2.5.1; 1.2.5.2; 1.2.99.6; 1.13.11.50; 1.13.12.4; 1.14.13.54; 1.14.14.32; 2.1.1.152; 2.3.1.187; 2.5.1.47; 2.5.1.48; 2.5.1.49; 2.5.1.50; 2.5.1.51; 2.5.1.52; 2.5.1.53; 2.5.1.65; 2.5.1.118; 2.5.1.119; 2.5.1.134; 2.6.99.3; 2.7.2.1; 2.7.2.12; 2.7.2.15; 2.8.3.1; 2.8.3.3; 2.8.3.8; 2.8.3.10; 2.8.3.11; 2.8.3.12; 2.8.3.14; 2.8.3.18; 2.8.3.19; 2.8.3.-; 3.1.1.2; 3.1.1.6; 3.1.1.7; 3.1.1.8; 3.1.1.33; 3.1.1.41; 3.1.1.47; 3.1.1.53; 3.1.1.54; 3.1.1.55; 3.1.1.56; 3.1.1.58; 3.1.1.66; 3.1.1.71; 3.1.1.80; 3.1.1.94; 3.1.1.-; 3.1.2.1; 3.1.2.16; 3.5.1.4; 3.5.1.14; 3.5.1.15; 3.5.1.16; 3.5.1.17; 3.5.1.21; 3.5.1.25; 3.5.1.29; 3.5.1.33; 3.5.1.41; 3.5.1.47; 3.5.1.48; 3.5.1.51; 3.5.1.62; 3.5.1.63; 3.5.1.66; 3.5.1.76; 3.5.1.85; 3.5.1.89; 3.5.1.103; 3.5.1.104; 3.5.1.108; 3.5.1.112; 3.5.1.113; 3.5.1.114; 3.5.1.-; 3.6.1.7; 3.6.1.20; 3.7.1.1; 3.7.1.6; 3.7.1.-; 3.11.1.2; 4.1.1.88; 4.1.1.89; 4.1.3.4; 4.1.3.6; 4.1.3.22; 4.1.3.26; 6.2.1.1; 6.2.1.13; 6.2.1.22; 6.2.1.35,"Methanogenesis, acetate => methane; Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Monocarboxylic acids;     C00033  Acetate; Ethanoate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C00033  Acetic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;    G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;     G01AD Organic acids;      G01AD02 Acetic acid;       D00010  Acetic acid, glacial (USP);  S SENSORY ORGANS;   S02 OTOLOGICALS;    S02A ANTIINFECTIVES;     S02AA Antiinfectives;      S02AA10 Acetic acid;       D00010  Acetic acid, glacial (USP); USP drug classification [BR:br08302];  Antibacterials;   Antibacterials, Other;    Acetic acid;     D00010  Acetic acid, glacial (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    264  Analgesics, anti-itchings, astringents, anti-inflammatory agents;     2649  Others;      D00010  Acetic acid, glacial (USP); Acetic acid (JP17/NF); Glacial acetic acid (JP17);    266  Emollients;     2661  Organic acids;      D00010  Acetic acid, glacial (USP); Acetic acid (JP17/NF); Glacial acetic acid (JP17);  7  Agents not mainly for therapeutic purpose;   71  Dispensing medicines;    714  Flavorings, deodorants, coloring agents;     7149  Others;      D00010  Acetic acid, glacial (USP); Acetic acid (JP17/NF); Glacial acetic acid (JP17);    719  Miscellaneous;     7190  Miscellaneous;      D00010  Acetic acid, glacial (USP); Acetic acid (JP17/NF); Glacial acetic acid (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Acetic acid;     D00010  Acetic acid, glacial (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00010  [001258] Acetic acid;   D00010  [001259] Glacial acetic acid;  Buffering agent;   D00010  [001258] Acetic acid;   D00010  [001259] Glacial acetic acid;  Flavoring substance;   D00010  [001258] Acetic acid;   D00010  [001259] Glacial acetic acid;  pH regulator;   D00010  [001258] Acetic acid;   D00010  [001259] Glacial acetic acid;  Solubilization agent;   D00010  [001259] Glacial acetic acid;  Solvent;   D00010  [001258] Acetic acid;   D00010  [001259] Glacial acetic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00010  Acetic acid;   D00010  Glacial acetic acid",CAS: 64-19-7; PubChem: 3335; ChEBI: 15366 30089; ChEMBL: CHEMBL539; LIPIDMAPS: LMFA01010002; LipidBank: DFA0002; KNApSAcK: C00001176; PDB-CCD: ACT ACY; 3DMET: B00009; NIKKAJI: J2.355H,cpd:C00012; cpd:C00017; cpd:C00033; cpd:C00045; cpd:C00098; cpd:C00151; cpd:C00266; cpd:C00405; cpd:C02086; cpd:C05167; cpd:C05234; cpd:C13301; cpd:C13400; cpd:C14860; cpd:C18091; cpd:C18372; cpd:C18568; cpd:C18723; cpd:C18940,2,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H5O2,C2H3O2,60.02112937,61.0289544,59.013304345,5,cpd:C00036,Oxaloacetate;,C4H4O5,Oxaloacetate; Oxalacetic acid; Oxaloacetic acid; 2-Oxobutanedioic acid; 2-Oxosuccinic acid; keto-Oxaloacetate,R00217 R00338 R00339 R00340 R00341 R00342 R00343 R00344; R00345 R00346 R00347 R00348 R00350 R00351 R00352 R00353; R00354 R00355 R00357 R00359 R00360 R00361 R00362 R00363; R00373 R00400 R00431 R00477 R00493 R00695 R00726 R00930; R00931 R01144 R01257 R01447 R01713 R01731 R03735 R05053; R05758 R07164 R07165 R09683,"Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Alanine, aspartate and glutamate metabolism; Benzoate degradation; Pyruvate metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Two-component system; Glucagon signaling pathway; Proximal tubule bicarbonate reclamation; Central carbon metabolism in cancer",1.1.1.37; 1.1.1.38; 1.1.1.40; 1.1.1.82; 1.1.1.299; 1.1.5.4; 1.1.99.7; 1.4.1.21; 1.4.3.1; 1.4.3.2; 1.4.3.15; 1.4.3.16; 2.1.3.1; 2.3.3.1; 2.3.3.2; 2.3.3.3; 2.3.3.5; 2.3.3.8; 2.3.3.16; 2.6.1.1; 2.6.1.12; 2.6.1.21; 2.6.1.31; 2.6.1.35; 2.6.1.57; 2.6.1.70; 2.6.1.78; 2.6.1.-; 3.1.1.44; 3.5.1.3; 3.7.1.1; 4.1.1.3; 4.1.1.31; 4.1.1.32; 4.1.1.38; 4.1.1.49; 4.1.3.6; 4.1.3.13; 4.1.3.17; 4.1.3.34; 4.2.1.32; 4.2.1.81; 4.3.1.16; 4.3.1.20; 4.3.1.27; 5.3.2.2; 6.4.1.1,"Gluconeogenesis, oxaloacetate => fructose-6P; Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate; Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; Glyoxylate cycle; CAM (Crassulacean acid metabolism), dark; C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type; C4-dicarboxylic acid cycle, NAD - malic enzyme type; C4-dicarboxylic acid cycle, NADP - malic enzyme type; Reductive citrate cycle (Arnon-Buchanan cycle); Formaldehyde assimilation, serine pathway; Dicarboxylate-hydroxybutyrate cycle; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Methylaspartate cycle",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00036  Oxaloacetate; 2-Oxosuccinate,CAS: 328-42-7; PubChem: 3338; ChEBI: 16452 30744; LIPIDMAPS: LMFA01170120; KNApSAcK: C00001197; PDB-CCD: OAA; 3DMET: B00010; NIKKAJI: J5.675H,cpd:C00036; cpd:C03548; cpd:C03981; cpd:C20341,4,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H5O5,C4H3O5,132.0058732,133.0136983,130.99804826,6,cpd:C00068,Thiamin diphosphate;,C12H19N4O7P2S,Thiamin diphosphate; Thiamine diphosphate; Thiamin pyrophosphate; TPP; ThPP,R00014 R00615 R00616 R00617 R00618 R00619 R00621 R00755; R03050 R03270 R03316 R04672 R04673 R06861 R06862 R06863; R07599 R07600 R07601 R07602 R07603 R07604 R10996 R10997; R11319,"Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Valine, leucine and isoleucine degradation; Pyruvate metabolism; Propanoate metabolism; Thiamine metabolism; Metabolic pathways; Vitamin digestion and absorption",1.2.4.1; 1.2.4.2; 1.2.4.4; 2.2.1.1; 2.2.1.3; 2.2.1.6; 2.7.4.3; 2.7.4.15; 2.7.4.16; 2.7.6.2; 3.6.1.15; 3.6.1.28; 3.6.1.-; 4.1.1.1,"Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00068  TPP,PubChem: 3368; ChEBI: 9532; ChEMBL: CHEMBL1236376; KNApSAcK: C00019627; PDB-CCD: TDP TPP; 3DMET: B01146; NIKKAJI: J184.400H J232.214E,cpd:C00068,12,19,7,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H20O7N4P2S1,C12H18O7N4P2S1,425.0449691,426.0527942,424.03714417,7,cpd:C00074,Phosphoenolpyruvate;,C3H5O6P,Phosphoenolpyruvate; Phosphoenolpyruvic acid; PEP,R00199 R00200 R00206 R00208 R00341 R00345 R00346 R00430; R00431 R00572 R00658 R00659 R00660 R00661 R00724 R00726; R01012 R01138 R01804 R01826 R01858 R02320 R02628 R02769; R03254 R03460 R04435 R06591 R07476 R09760 R09841 R10304; R11439,"Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Phenylalanine, tyrosine and tryptophan biosynthesis; Phosphonate and phosphinate metabolism; Pyruvate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Phosphotransferase system (PTS); Glucagon signaling pathway; Proximal tubule bicarbonate reclamation; Central carbon metabolism in cancer",2.5.1.7; 2.5.1.19; 2.5.1.54; 2.5.1.55; 2.5.1.56; 2.5.1.57; 2.5.1.95; 2.5.1.97; 2.5.1.101; 2.5.1.132; 2.7.1.40; 2.7.1.121; 2.7.3.9; 2.7.9.1; 2.7.9.2; 3.1.3.60; 4.1.1.31; 4.1.1.32; 4.1.1.38; 4.1.1.49; 4.2.1.11; 4.4.1.19; 5.4.2.9,"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate; CAM (Crassulacean acid metabolism), dark; CAM (Crassulacean acid metabolism), light; C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type; C4-dicarboxylic acid cycle, NAD - malic enzyme type; C4-dicarboxylic acid cycle, NADP - malic enzyme type; Reductive citrate cycle (Arnon-Buchanan cycle); Formaldehyde assimilation, serine pathway; Coenzyme M biosynthesis; Dicarboxylate-hydroxybutyrate cycle",NA,CAS: 138-08-9; PubChem: 3374; ChEBI: 18021 44897; ChEMBL: CHEMBL1235228; KNApSAcK: C00000798; PDB-CCD: PEP; 3DMET: B00019; NIKKAJI: J9.706C,cpd:C00074; cpd:C02798; cpd:C16849,3,5,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H6O6P1,C3H4O6P1,167.9823749,168.9901999,166.97454988,8,cpd:C00084,Acetaldehyde;,C2H4O,Acetaldehyde; Ethanal,R00025 R00224 R00228 R00326 R00710 R00711 R00746 R00747; R00748 R00749 R00750 R00751 R00753 R00754 R00755 R00799; R01019 R01066 R01410 R02345 R03723 R05198 R05380 R05381; R05382 R05565 R05567 R05811 R06171 R06973 R07247 R07772; R08195 R08196 R09127 R09156 R09479 R09524 R09552 R09959; R10285 R10936,Glycolysis / Gluconeogenesis; Phenylalanine metabolism; Benzoate degradation; Phosphonate and phosphinate metabolism; Glycerophospholipid metabolism; Pyruvate metabolism; Dioxin degradation; Xylene degradation; Chloroalkane and chloroalkene degradation; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Degradation of aromatic compounds,1.1.1.1; 1.1.1.2; 1.1.1.71; 1.1.2.7; 1.1.2.8; 1.1.5.5; 1.1.99.36; 1.2.1.3; 1.2.1.4; 1.2.1.5; 1.2.1.10; 1.2.1.-; 1.2.5.2; 1.2.99.6; 1.7.3.1; 1.13.12.16; 1.13.12.-; 1.14.15.-; 1.14.99.39; 2.1.1.-; 2.2.1.4; 2.2.1.8; 2.3.1.190; 3.7.1.12; 3.11.1.1; 4.1.1.1; 4.1.1.-; 4.1.2.4; 4.1.2.5; 4.1.2.33; 4.1.2.36; 4.1.2.42; 4.1.2.48; 4.1.2.49; 4.1.2.50; 4.1.3.39; 4.2.1.112; 4.2.1.155; 4.2.3.2; 4.3.1.7; 4.3.3.-; 4.3.99.4,"Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C00084  Acetaldehyde,CAS: 75-07-0; PubChem: 3384; ChEBI: 15343; ChEMBL: CHEMBL170365; KNApSAcK: C00007392; PDB-CCD: ACE; 3DMET: B01155; NIKKAJI: J2.388D,cpd:C00084; cpd:C00980; cpd:C01857; cpd:C02998; cpd:C06548; cpd:C11317; cpd:C11623; cpd:C11624; cpd:C11625; cpd:C18675; cpd:C19158; cpd:C20305,2,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H5O1,C2H3O1,44.02621475,45.03403978,43.018389729,9,cpd:C00103,D-Glucose 1-phosphate;,C6H13O9P,D-Glucose 1-phosphate; alpha-D-Glucose 1-phosphate; Cori ester; D-Glucose alpha-1-phosphate,R00287 R00289 R00304 R00550 R00803 R00947 R00948 R00949; R00951 R00952 R00953 R00954 R00955 R00956 R00957 R00959; R00960 R01233 R01660 R01821 R02111 R02328 R02888 R03116; R04180 R05512 R06018 R06022 R06034 R06050 R06056 R06058; R06061 R06185 R07265 R08514 R08515 R08639 R09752 R10832; R10987 R11128 R11530,Glycolysis / Gluconeogenesis; Pentose and glucuronate interconversions; Galactose metabolism; Starch and sucrose metabolism; Amino sugar and nucleotide sugar metabolism; Streptomycin biosynthesis; Polyketide sugar unit biosynthesis; Acarbose and validamycin biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Glucagon signaling pathway,2.4.1.1; 2.4.1.7; 2.4.1.20; 2.4.1.30; 2.4.1.31; 2.4.1.49; 2.4.1.97; 2.4.1.139; 2.4.1.231; 2.4.1.321; 2.4.1.329; 2.4.1.333; 2.4.1.342; 2.7.1.10; 2.7.1.41; 2.7.1.42; 2.7.1.62; 2.7.1.106; 2.7.7.9; 2.7.7.12; 2.7.7.24; 2.7.7.27; 2.7.7.33; 2.7.7.34; 2.7.7.36; 2.7.7.64; 2.7.7.78; 3.1.3.10; 3.1.4.51; 3.6.1.8; 3.6.1.9; 3.6.1.21; 3.6.1.45; 3.6.1.-; 5.4.2.2; 5.4.2.5,"Ascorbate biosynthesis, animals, glucose-1P => ascorbate; Nucleotide sugar biosynthesis, glucose => UDP-glucose; Trehalose biosynthesis, D-glucose 1P => trehalose; Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P; dTDP-L-rhamnose biosynthesis",NA,CAS: 59-56-3; PubChem: 3403; ChEBI: 29042; KNApSAcK: C00007482; PDB-CCD: G1P; 3DMET: B04634; NIKKAJI: J40.065C,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.02189410,10,cpd:C00111,Glycerone phosphate;,C3H7O6P,Glycerone phosphate; Dihydroxyacetone phosphate; 3-Hydroxy-2-oxopropyl phosphate,R00842 R00844 R00846 R00848 R00849 R01010 R01011 R01012; R01013 R01014 R01015 R01016 R01068 R01069 R01070 R01785; R01829 R02262 R02263 R02568 R04292 R05378 R05679 R05680; R08650 R08657 R10673 R10760 R11182,Glycolysis / Gluconeogenesis; Pentose and glucuronate interconversions; Fructose and mannose metabolism; Galactose metabolism; Glycerolipid metabolism; Inositol phosphate metabolism; Glycerophospholipid metabolism; Propanoate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Nicotinate and nicotinamide metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids,1.1.1.8; 1.1.1.94; 1.1.1.261; 1.1.3.21; 1.1.5.3; 2.3.1.42; 2.3.1.245; 2.5.1.72; 2.7.1.29; 2.7.1.121; 3.1.3.1; 3.1.3.2; 4.1.2.2; 4.1.2.13; 4.1.2.17; 4.1.2.19; 4.1.2.29; 4.1.2.40; 4.1.2.56; 4.1.2.57; 4.2.3.3; 5.3.1.1,"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Formaldehyde assimilation, xylulose monophosphate pathway; Formaldehyde assimilation, ribulose monophosphate pathway",NA,CAS: 57-04-5; PubChem: 3411; ChEBI: 16108; ChEMBL: CHEMBL1161998; KNApSAcK: C00007560; PDB-CCD: 13P; 3DMET: B00029; NIKKAJI: J213.543D,cpd:C00111; cpd:C00118; cpd:C00661; cpd:C05217; cpd:C12935; cpd:C19156,3,7,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O6P1,C3H6O6P1,169.9980249,171.00585,168.990199911,11,cpd:C00118,D-Glyceraldehyde 3-phosphate;,C3H7O6P,D-Glyceraldehyde 3-phosphate; (2R)-2-Hydroxy-3-(phosphonooxy)-propanal; Glyceraldehyde 3-phosphate,R00845 R01015 R01058 R01059 R01061 R01063 R01064 R01066; R01067 R01068 R01069 R01070 R01440 R01621 R01641 R01827; R01830 R02340 R02721 R02722 R05465 R05605 R05636 R06861; R07159 R07456 R08575 R10049 R10088 R10089 R10349 R10860; R10935,"Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Fructose and mannose metabolism; Galactose metabolism; Clavulanic acid biosynthesis; Inositol phosphate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Thiamine metabolism; Vitamin B6 metabolism; Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids",1.1.1.177; 1.2.1.9; 1.2.1.12; 1.2.1.13; 1.2.1.59; 1.2.1.90; 1.2.7.6; 2.2.1.1; 2.2.1.2; 2.2.1.3; 2.2.1.7; 2.2.1.11; 2.5.1.66; 2.7.1.28; 4.1.2.4; 4.1.2.8; 4.1.2.9; 4.1.2.13; 4.1.2.14; 4.1.2.21; 4.1.2.40; 4.1.2.55; 4.2.1.20; 4.2.3.153; 4.3.3.6; 5.3.1.1,"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate; D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P; C5 isoprenoid biosynthesis, non-mevalonate pathway; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P; Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P; D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P; Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate",NA,CAS: 591-57-1; PubChem: 3418; ChEBI: 29052; KNApSAcK: C00007564; PDB-CCD: G3H; 3DMET: B01163; NIKKAJI: J228.059K,cpd:C00111; cpd:C00118; cpd:C00661; cpd:C05217; cpd:C12935; cpd:C19156,3,7,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O6P1,C3H6O6P1,169.9980249,171.00585,168.990199912,12,cpd:C00186,(S)-Lactate;,C3H6O3,(S)-Lactate; L-Lactate; L-Lactic acid,R00196 R00319 R00703 R00753 R01446 R01447 R01449 R01450; R05508 R10691 R11074,Glycolysis / Gluconeogenesis; Fructose and mannose metabolism; Pyruvate metabolism; Propanoate metabolism; Styrene degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; cAMP signaling pathway; HIF-1 signaling pathway; Glucagon signaling pathway; Central carbon metabolism in cancer,1.1.1.27; 1.1.2.3; 1.1.99.7; 1.2.1.22; 1.13.12.4; 2.8.3.1; 3.7.1.-; 4.1.1.101; 4.1.2.36; 5.1.2.1,NA,Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Hydroxycarboxylic acids;     C00186  L-Lactate; (S)-2-Hydroxypropanoate; Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: other receptors;    Lactate;     G protein-coupled receptor 81;      C00186  (S)-Lactate,CAS: 79-33-4; PubChem: 3486; ChEBI: 16651 422; ChEMBL: CHEMBL330546; LipidBank: DFA0268; KNApSAcK: C00001191; PDB-CCD: 2OP; 3DMET: B01180; NIKKAJI: J9.134K,cpd:C00184; cpd:C00186; cpd:C00256; cpd:C00577; cpd:C01013; cpd:C01432; cpd:C02154; cpd:C02426; cpd:C03726; cpd:C05823; cpd:C10899; cpd:C12677; cpd:C19286; cpd:C19296,3,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O3,C3H5O3,90.03169405,91.03951908,89.0238690213,13,cpd:C00197,3-Phospho-D-glycerate;,C3H7O7P,3-Phospho-D-glycerate; D-Glycerate 3-phosphate; 3-Phospho-(R)-glycerate; 3-Phosphoglycerate,R00024 R01058 R01511 R01512 R01513 R01514 R01515 R01516; R01517 R01518 R01660 R02188 R03140 R05768 R07159 R08887; R09100 R09663 R10860,"Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Glycine, serine and threonine metabolism; Glycerolipid metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Glucagon signaling pathway; Central carbon metabolism in cancer",1.1.1.95; 1.2.1.9; 1.2.1.90; 1.2.7.6; 2.4.1.217; 2.4.1.266; 2.7.1.31; 2.7.1.106; 2.7.2.3; 2.7.2.10; 2.7.4.17; 3.1.3.38; 3.6.1.7; 4.1.1.39; 5.4.2.11; 5.4.2.12,"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Serine biosynthesis, glycerate-3P => serine; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; Photorespiration; D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,PubChem: 3497; ChEBI: 17794; ChEMBL: CHEMBL1160563; KNApSAcK: C00019551; PDB-CCD: 3PG; 3DMET: B01185; NIKKAJI: J40.061K,cpd:C00197; cpd:C00597; cpd:C00631,3,7,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O7P1,C3H6O7P1,185.9929396,187.0007646,184.985114514,14,cpd:C00221,beta-D-Glucose,C6H12O6,beta-D-Glucose,R00026 R01520 R01521 R01522 R01600 R01602 R02187 R03256; R04783 R06077 R06092 R06110 R06144 R09086 R09568 R10035; R10039 R10040 R10236,Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism,1.1.1.47; 1.1.3.4; 1.1.3.5; 2.3.1.213; 2.7.1.1; 2.7.1.2; 2.7.1.63; 2.7.1.147; 3.1.6.3; 3.2.1.21; 3.2.1.23; 3.2.1.85; 4.3.3.5; 5.1.3.3,NA,NA,CAS: 492-61-5; PubChem: 3521; ChEBI: 15903; ChEMBL: CHEMBL1222250 CHEMBL1614854; PDB-CCD: BGC; 3DMET: B01193; NIKKAJI: J44.213E,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.055563115,15,cpd:C00236,3-Phospho-D-glyceroyl phosphate;,C3H8O10P2,"3-Phospho-D-glyceroyl phosphate; 1,3-Bisphospho-D-glycerate; (R)-2-Hydroxy-3-(phosphonooxy)-1-monoanhydride with phosphoric propanoic acid; D-Glycerate 1,3-diphosphate",R01061 R01063 R01512 R01515 R01517 R01660 R01662 R02188,Glycolysis / Gluconeogenesis; Carbon fixation in photosynthetic organisms; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids,1.2.1.12; 1.2.1.13; 1.2.1.59; 2.7.1.106; 2.7.2.3; 2.7.2.10; 2.7.4.17; 3.6.1.7; 5.4.2.4,"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P",NA,CAS: 38168-82-0; PubChem: 3535; ChEBI: 16001; KNApSAcK: C00019552; PDB-CCD: X15; 3DMET: B01197; NIKKAJI: J40.060B,cpd:C00236; cpd:C01159; cpd:C03339,3,8,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O10P2,C3H7O10P2,265.9592705,266.9670955,264.951445416,16,cpd:C00267,alpha-D-Glucose,C6H12O6,alpha-D-Glucose,R00802 R00878 R00947 R01602 R01678 R01718 R01786 R01787; R01788 R02109 R02189 R03115 R06078 R06080 R06084 R06088; R06098 R06158 R06199 R07265 R09085,"Glycolysis / Gluconeogenesis; Fructose and mannose metabolism; Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Proximal tubule bicarbonate reclamation",1.1.1.21; 2.4.1.231; 2.7.1.1; 2.7.1.2; 2.7.1.63; 2.7.1.147; 3.1.3.9; 3.1.3.10; 3.1.6.3; 3.2.1.3; 3.2.1.10; 3.2.1.20; 3.2.1.23; 3.2.1.26; 3.2.1.33; 3.2.1.48; 3.2.1.58; 3.2.1.108; 5.1.3.3; 5.3.1.5,"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Nucleotide sugar biosynthesis, glucose => UDP-glucose",NA,CAS: 492-62-6; PubChem: 3565; ChEBI: 17925; ChEMBL: CHEMBL1222250 CHEMBL423707 CHEMBL98182; KNApSAcK: C00001122; PDB-CCD: GLC; 3DMET: B01203; NIKKAJI: J44.217H,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.055563117,17,cpd:C00469,Ethanol;,C2H6O,Ethanol; Ethyl alcohol; Methylcarbinol,R00746 R00754 R02359 R02682 R04410 R05198 R09127 R09479; R09552,Glycolysis / Gluconeogenesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Inflammatory mediator regulation of TRP channels; Alcoholism,1.1.1.1; 1.1.1.2; 1.1.1.71; 1.1.2.7; 1.1.2.8; 1.1.5.5; 1.1.99.36; 2.3.1.152; 2.8.1.2; 3.1.1.67; 3.5.1.75,NA,"Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C00469  Ethanol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D08 ANTISEPTICS AND DISINFECTANTS;    D08A ANTISEPTICS AND DISINFECTANTS;     D08AX Other antiseptics and disinfectants;      D08AX08 Ethanol;       D00068  Alcohol (USP);  V VARIOUS;   V03 ALL OTHER THERAPEUTIC PRODUCTS;    V03A ALL OTHER THERAPEUTIC PRODUCTS;     V03AB Antidotes;      V03AB16 Ethanol;       D00068  Alcohol (USP);     V03AZ Nerve depressants;      V03AZ01 Ethanol;       D00068  Alcohol (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    261  Antimicrobial agents;     2615  Alcohols;      D00068  Alcohol (USP); Anhydrous ethanol (JP17);  4  Agents affecting cellular function;   42  Antineoplastics;    429  Miscellaneous;     4291  Other Antitumors;      D00068  Alcohol (USP); Anhydrous ethanol (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   54 Disinfectants (incl. special bandages);    D00068  Alcohol (USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Ethanol;     D00068  Alcohol (USP);  Third-class OTC drugs;   Inorganic and organic chemicals;    Ethanol;     D00068  Alcohol (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00068  [001075] Ethanol;  Solubilizing agent;   D00068  [001075] Ethanol;   D00068  [001076] Anhydrous ethanol;  Base;   D00068  [001075] Ethanol;  Flavoring substance;   D00068  [001075] Ethanol;   D00068  [001076] Anhydrous ethanol;  Suspending agent;   D00068  [001075] Ethanol;  Antifoaming agent;   D00068  [001075] Ethanol;  Favoring agent, Fragrance;   D00068  [001075] Ethanol;  Emulsion;   D00068  [001075] Ethanol;  Tenacious agent;   D00068  [001076] Anhydrous ethanol;  Dispersant;   D00068  [001075] Ethanol;  Antiseptic agent;   D00068  [001075] Ethanol;  Preserving agent;   D00068  [001075] Ethanol;  Solubilizer;   D00068  [001075] Ethanol;   D00068  [001076] Anhydrous ethanol;  Solubilization agent;   D00068  [001075] Ethanol;   D00068  [001076] Anhydrous ethanol;  Solvent;   D00068  [001075] Ethanol;   D00068  [110749] 55vol% Ethanol;   D00068  [109570] 70vol% Ethanol;   D00068  [110566] Ethanol 50;   D00068  [001076] Anhydrous ethanol;  Fluidizer;   D00068  [001076] Anhydrous ethanol; Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2D6;    Ethanol;     D00068  Alcohol (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00068  Anhydrous ethanol",CAS: 64-17-5; PubChem: 3752; ChEBI: 16236; ChEMBL: CHEMBL545; KNApSAcK: C00019560; PDB-CCD: EOH; 3DMET: B01253; NIKKAJI: J1.930E,cpd:C00469; cpd:C00928; cpd:C02297; cpd:C07447; cpd:C11143; cpd:C11144; cpd:C14704; cpd:C16363,2,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H7O1,C2H5O1,46.04186481,47.04968985,45.0340397818,18,cpd:C00631,2-Phospho-D-glycerate;,C3H7O7P,2-Phospho-D-glycerate; D-Glycerate 2-phosphate; 2-Phospho-(R)-glycerate,R00658 R01518 R01748 R02664 R08572 R09532,"Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Glycine, serine and threonine metabolism; Glycerolipid metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Glucagon signaling pathway; Central carbon metabolism in cancer",2.7.1.165; 2.7.2.-; 3.1.3.20; 3.1.3.80; 4.2.1.11; 5.4.2.11; 5.4.2.12,"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Glycolysis, core module involving three-carbon compounds; Gluconeogenesis, oxaloacetate => fructose-6P; Formaldehyde assimilation, serine pathway",NA,PubChem: 3904; ChEBI: 17835; KNApSAcK: C00000123; PDB-CCD: 2PG; 3DMET: B01295; NIKKAJI: J71.811D,cpd:C00197; cpd:C00597; cpd:C00631,3,7,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O7P1,C3H6O7P1,185.9929396,187.0007646,184.985114519,19,cpd:C00668,alpha-D-Glucose 6-phosphate,C6H13O9P,alpha-D-Glucose 6-phosphate,R00959 R01786 R01788 R02189 R02737 R02738 R02739 R02740; R06102 R06226 R09085,"Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; AMPK signaling pathway; Glucagon signaling pathway",2.4.1.15; 2.7.1.1; 2.7.1.2; 2.7.1.63; 2.7.1.147; 2.7.1.199; 3.1.3.9; 3.2.1.26; 5.1.3.15; 5.3.1.9; 5.4.2.2; 5.4.2.5,"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Pentose phosphate pathway (Pentose phosphate cycle); Ascorbate biosynthesis, plants, glucose-6P => ascorbate; Nucleotide sugar biosynthesis, glucose => UDP-glucose",NA,PubChem: 3937; ChEBI: 17665; PDB-CCD: G6P; 3DMET: B01304; NIKKAJI: J40.066A,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.02189420,20,cpd:C01159,"2,3-Bisphospho-D-glycerate;",C3H8O10P2,"2,3-Bisphospho-D-glycerate; 2,3-Disphospho-D-glycerate; D-Greenwald ester; DPG",R01516 R01662 R02664 R03298 R09532,Glycolysis / Gluconeogenesis; Metabolic pathways,2.7.2.-; 3.1.3.80; 4.6.1.-; 5.4.2.4; 5.4.2.11,NA,NA,PubChem: 4387; ChEBI: 17720; PDB-CCD: DG2; 3DMET: B01397; NIKKAJI: J2.731.659J,cpd:C00236; cpd:C01159; cpd:C03339,3,8,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O10P2,C3H7O10P2,265.9592705,266.9670955,264.951445421,21,cpd:C01172,beta-D-Glucose 6-phosphate,C6H13O9P,beta-D-Glucose 6-phosphate,R01600 R02187 R02728 R02736 R02739 R03321 R05133 R05134; R09086 R10907,Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; AMPK signaling pathway; Glucagon signaling pathway,1.1.1.49; 1.1.1.363; 1.1.1.388; 2.7.1.1; 2.7.1.2; 2.7.1.63; 2.7.1.147; 3.2.1.86; 5.1.3.15; 5.3.1.9; 5.4.2.6,"Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P; Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate",NA,PubChem: 4399; ChEBI: 17719; ChEMBL: CHEMBL257975; PDB-CCD: BG6; 3DMET: B01400; NIKKAJI: J396.144C,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.02189422,22,cpd:C01451,Salicin;,C13H18O7,Salicin; Salicoside,R03558 R04394,Glycolysis / Gluconeogenesis; Biosynthesis of phenylpropanoids; Phosphotransferase system (PTS); Taste transduction,2.4.1.172; 2.7.1.-,NA,Major components of natural products [BR:br08323];  Medicinal herbs;   Willow;    C01451  Salicin,CAS: 138-52-3; PubChem: 4628; ChEBI: 17814; ChEMBL: CHEMBL462997; KNApSAcK: C00002672; PDB-CCD: SA0; 3DMET: B01452; NIKKAJI: J5.634K,cpd:C01451; cpd:C16964; cpd:C17599,13,18,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H19O7,C13H17O7,286.1052529,287.1130779,285.097427923,23,cpd:C05125,2-(alpha-Hydroxyethyl)thiamine diphosphate;,C14H23N4O8P2S,2-(alpha-Hydroxyethyl)thiamine diphosphate; 2-Hydroxyethyl-ThPP,R00014 R00755 R03050 R03270 R04672 R04673,Glycolysis / Gluconeogenesis; Citrate cycle (TCA cycle); Pyruvate metabolism; Metabolic pathways,1.2.4.1; 2.2.1.6; 4.1.1.1,NA,NA,PubChem: 7546; ChEBI: 978; 3DMET: B04982; NIKKAJI: J683.157E,cpd:C05125,14,23,8,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C14H24O8N4P2S1,C14H22O8N4P2S1,469.0711839,470.0790089,468.063358924,24,cpd:C05345,beta-D-Fructose 6-phosphate,C6H13O9P,beta-D-Fructose 6-phosphate,R00867 R01819 R01827 R01830 R02073 R02703 R02731 R02732; R02740 R03321 R03920 R04779 R04780 R05607 R09031 R09084; R09780 R10987,"Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids",1.1.1.17; 1.1.1.140; 2.2.1.1; 2.2.1.2; 2.4.1.329; 2.7.1.1; 2.7.1.4; 2.7.1.11; 2.7.1.90; 2.7.1.105; 2.7.1.146; 3.1.3.11; 3.1.3.46; 5.1.3.-; 5.3.1.8; 5.3.1.9; 5.3.1.27,"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Gluconeogenesis, oxaloacetate => fructose-6P; Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; Ascorbate biosynthesis, plants, glucose-6P => ascorbate; Pentose phosphate pathway, archaea, fructose 6P => ribose 5P",NA,PubChem: 7723; ChEBI: 16084; ChEMBL: CHEMBL604196; KNApSAcK: C00019548; PDB-CCD: F6P; 3DMET: B01846; NIKKAJI: J879.002G,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.02189425,25,cpd:C05378,"beta-D-Fructose 1,6-bisphosphate",C6H14O12P2,"beta-D-Fructose 1,6-bisphosphate",R01070 R02071 R02073 R04779 R04780 R09084,Glycolysis / Gluconeogenesis; Pentose phosphate pathway; Fructose and mannose metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids,2.7.1.11; 2.7.1.56; 2.7.1.90; 2.7.1.146; 3.1.3.11; 4.1.2.13,"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate; Gluconeogenesis, oxaloacetate => fructose-6P",NA,PubChem: 7752; ChEBI: 28013; ChEMBL: CHEMBL97893; PDB-CCD: FBP; 3DMET: B01851; NIKKAJI: J322.162H,cpd:C00354; cpd:C00665; cpd:C01220; cpd:C01231; cpd:C03693; cpd:C03785; cpd:C04062; cpd:C04063; cpd:C04064; cpd:C05378,6,14,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O12P2,C6H13O12P2,339.9960499,341.0038749,338.988224926,26,cpd:C06186,Arbutin;,C12H16O7,Arbutin; Ursin; Uvasol; Hydroquinone-O-beta-D-glucopyranoside,R05132 R05769,Glycolysis / Gluconeogenesis; Phosphotransferase system (PTS),2.4.1.218; 2.7.1.-,NA,Target-based classification of compounds [BR:br08010];  Enzymes;   Oxidoreductases;    tyrosinase;     C06186  Arbutin; Major components of natural products [BR:br08323];  Crude drugs;   Bearberry leaf;    C06186  Arbutin;   Uva ursi fluidextract;    C06186  Arbutin;  Medicinal herbs;   Bearberry;    C06186  Arbutin,CAS: 497-76-7; PubChem: 8437; ChEBI: 18305; ChEMBL: CHEMBL232202; KNApSAcK: C00002638; 3DMET: B01987; NIKKAJI: J6.104B,cpd:C03003; cpd:C05995; cpd:C06186; cpd:C12079,12,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H17O7,C12H15O7,272.0896029,273.0974279,271.081777827,27,cpd:C06187,Arbutin 6-phosphate;,C12H17O10P,Arbutin 6-phosphate; Arbutin-6P,R05132 R05133,Glycolysis / Gluconeogenesis; Phosphotransferase system (PTS),2.7.1.-; 3.2.1.86,NA,NA,PubChem: 8438; ChEBI: 2807; 3DMET: B01988; NIKKAJI: J2.761.841C,cpd:C06187,12,17,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H18O10P1,C12H16O10P1,352.0559337,353.0637588,351.048108728,28,cpd:C06188,Salicin 6-phosphate;,C13H19O10P,Salicin 6-phosphate; Salicin-6P,R04394 R05134,Glycolysis / Gluconeogenesis; Phosphotransferase system (PTS),2.7.1.-; 3.2.1.86,NA,NA,PubChem: 8439; ChEBI: 9003; PDB-CCD: P53; 3DMET: B01989; NIKKAJI: J2.761.856A,cpd:C06188; cpd:C06436,13,19,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H20O10P1,C13H18O10P1,366.0715838,367.0794088,365.063758829,32,cpd:C00026,2-Oxoglutarate;,C5H6O5,2-Oxoglutarate; Oxoglutaric acid; 2-Ketoglutaric acid; alpha-Ketoglutaric acid,R00021 R00093 R00114 R00243 R00248 R00250 R00258 R00264; R00265 R00267 R00268 R00269 R00270 R00271 R00272 R00279; R00298 R00355 R00372 R00457 R00474 R00563 R00621 R00667; R00668 R00684 R00694 R00709 R00715 R00716 R00734 R00895; R00896 R00908 R01090 R01148 R01155 R01161 R01197 R01214; R01252 R01339 R01412 R01580 R01582 R01587 R01648 R01684; R01700 R01879 R01939 R01956 R02077 R02160 R02199 R02274; R02283 R02397 R02433 R02444 R02445 R02486 R02619 R02700; R02772 R02773 R03008 R03009 R03053 R03063 R03120 R03126; R03207 R03218 R03219 R03225 R03243 R03248 R03266 R03376; R03451 R03534 R03590 R03640 R03698 R03737 R03806 R03807; R03809 R03812 R03859 R03952 R04028 R04029 R04051 R04073; R04171 R04173 R04188 R04217 R04234 R04269 R04276 R04338; R04438 R04467 R04475 R04529 R05036 R05037 R05039 R05052; R05085 R05097 R05126 R05127 R05228 R05229 R05301 R05302; R05320 R05419 R05466 R05468 R05469 R05493 R05507 R05722; R05723 R05839 R05857 R06322 R06323 R06335 R06336 R06337; R06338 R06423 R06426 R06539 R06540 R06551 R06586 R06631; R06634 R06977 R07184 R07185 R07186 R07187 R07275 R07276; R07277 R07329 R07366 R07367 R07368 R07396 R07613 R07659; R07993 R07996 R07997 R08050 R08081 R08082 R08165 R08198; R08201 R08213 R08254 R08549 R08610 R08611 R08897 R08903; R08931 R08972 R09363 R09402 R09510 R09511 R09572 R09778; R09784 R09785 R09824 R09825 R10056 R10064 R10081 R10086; R10094 R10141 R10143 R10144 R10145 R10157 R10210 R10312; R10413 R10415 R10445 R10446 R10460 R10487 R10522 R10527; R10539 R10542 R10575 R10698 R10723 R10724 R10735 R10740; R10741 R10742 R10845 R10920 R10932 R10991 R11030 R11053; R11118 R11210 R11269 R11270 R11285 R11291 R11297 R11298; R11299 R11337 R11340 R11345 R11395 R11409 R11475 R11549,"Citrate cycle (TCA cycle); Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Arginine biosynthesis; Alanine, aspartate and glutamate metabolism; Lysine biosynthesis; Histidine metabolism; Furfural degradation; Taurine and hypotaurine metabolism; D-Glutamine and D-glutamate metabolism; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; C5-Branched dibasic acid metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; HIF-1 signaling pathway; GABAergic synapse; Glucagon signaling pathway; Proximal tubule bicarbonate reclamation; Bile secretion; Central carbon metabolism in cancer",1.1.1.41; 1.1.1.42; 1.1.1.95; 1.1.1.286; 1.1.1.399; 1.1.99.2; 1.1.99.24; 1.1.99.39; 1.2.1.3; 1.2.1.26; 1.2.1.52; 1.2.4.2; 1.2.7.3; 1.2.7.11; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.13; 1.4.1.14; 1.4.3.7; 1.4.3.11; 1.4.3.15; 1.4.7.1; 1.5.1.7; 1.5.1.8; 1.5.1.19; 1.8.1.4; 1.13.12.19; 1.14.11.1; 1.14.11.2; 1.14.11.3; 1.14.11.4; 1.14.11.6; 1.14.11.7; 1.14.11.8; 1.14.11.9; 1.14.11.10; 1.14.11.11; 1.14.11.12; 1.14.11.13; 1.14.11.14; 1.14.11.15; 1.14.11.16; 1.14.11.17; 1.14.11.18; 1.14.11.19; 1.14.11.20; 1.14.11.21; 1.14.11.22; 1.14.11.23; 1.14.11.24; 1.14.11.25; 1.14.11.26; 1.14.11.27; 1.14.11.28; 1.14.11.31; 1.14.11.32; 1.14.11.34; 1.14.11.35; 1.14.11.36; 1.14.11.37; 1.14.11.38; 1.14.11.39; 1.14.11.40; 1.14.11.41; 1.14.11.42; 1.14.11.43; 1.14.11.44; 1.14.11.45; 1.14.11.46; 1.14.11.48; 1.14.11.49; 1.14.11.50; 1.14.11.51; 1.14.11.52; 1.14.11.-; 1.14.20.1; 1.14.20.2; 1.14.20.3; 1.14.20.-; 2.2.1.5; 2.2.1.9; 2.3.1.61; 2.3.3.4; 2.3.3.14; 2.6.1.1; 2.6.1.2; 2.6.1.3; 2.6.1.4; 2.6.1.5; 2.6.1.6; 2.6.1.7; 2.6.1.8; 2.6.1.9; 2.6.1.11; 2.6.1.13; 2.6.1.17; 2.6.1.19; 2.6.1.21; 2.6.1.22; 2.6.1.23; 2.6.1.24; 2.6.1.26; 2.6.1.27; 2.6.1.29; 2.6.1.33; 2.6.1.34; 2.6.1.36; 2.6.1.38; 2.6.1.39; 2.6.1.40; 2.6.1.42; 2.6.1.44; 2.6.1.48; 2.6.1.49; 2.6.1.52; 2.6.1.54; 2.6.1.55; 2.6.1.57; 2.6.1.59; 2.6.1.65; 2.6.1.67; 2.6.1.72; 2.6.1.74; 2.6.1.75; 2.6.1.76; 2.6.1.79; 2.6.1.80; 2.6.1.81; 2.6.1.82; 2.6.1.83; 2.6.1.87; 2.6.1.89; 2.6.1.90; 2.6.1.92; 2.6.1.93; 2.6.1.94; 2.6.1.95; 2.6.1.98; 2.6.1.102; 2.6.1.103; 2.6.1.104; 2.6.1.106; 2.6.1.107; 2.6.1.109; 2.6.1.110; 2.6.1.-; 3.5.1.3; 3.5.1.36; 3.5.1.111; 4.1.1.71; 4.2.1.168; 6.4.1.7,"Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate; Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Reductive citrate cycle (Arnon-Buchanan cycle); Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; Photorespiration; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Methylaspartate cycle",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00026  2-Oxoglutarate,CAS: 328-50-7; PubChem: 3328; ChEBI: 16810 30915; ChEMBL: CHEMBL1686; KNApSAcK: C00000769; PDB-CCD: AKG; 3DMET: B00008; NIKKAJI: J11.847H,cpd:C00026; cpd:C00165; cpd:C00641; cpd:C02715; cpd:C03716; cpd:C03957; cpd:C05406; cpd:C06030; cpd:C06316; cpd:C06380; cpd:C06437; cpd:C12248,5,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O5,C5H5O5,146.0215233,147.0293483,145.013698330,33,cpd:C00042,Succinate;,C4H6O4,Succinate; Succinic acid; Butanedionic acid; Ethylenesuccinic acid,R00402 R00405 R00406 R00407 R00408 R00409 R00410 R00411; R00412 R00432 R00479 R00499 R00713 R00714 R00727 R00999; R01252 R01288 R01412 R01559 R01780 R01867 R01879 R02084; R02160 R02164 R02397 R02407 R02444 R02445 R02486 R02508; R02603 R02734 R02990 R03008 R03009 R03126 R03154 R03218; R03219 R03260 R03376 R03451 R03590 R03640 R03698 R03737; R03806 R03807 R03809 R03812 R04073 R04276 R04946 R05036; R05037 R05039 R05097 R05126 R05127 R05228 R05229 R05301; R05302 R05320 R05419 R05466 R05468 R05469 R05493 R05588; R05722 R05723 R05857 R06322 R06323 R06335 R06336 R06337; R06338 R06539 R06540 R06551 R06855 R06904 R07184 R07185; R07186 R07187 R07329 R07366 R07367 R07368 R07993 R07996; R07997 R08050 R08081 R08082 R08610 R08611 R08972 R09363; R09402 R09510 R09511 R09572 R09785 R10056 R10081 R10143; R10144 R10145 R10157 R10312 R10343 R10413 R10415 R10445; R10446 R10487 R10522 R10527 R10539 R10542 R10640 R10641; R10660 R10723 R10724 R10735 R10740 R10741 R10742 R10904; R10920 R11030 R11053 R11210 R11340 R11345 R11549,"Citrate cycle (TCA cycle); Oxidative phosphorylation; Alanine, aspartate and glutamate metabolism; Tyrosine metabolism; Phenylalanine metabolism; Chlorocyclohexane and chlorobenzene degradation; Pyruvate metabolism; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Nicotinate and nicotinamide metabolism; Sulfur metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Degradation of aromatic compounds; Two-component system; cAMP signaling pathway; GABAergic synapse; Glucagon signaling pathway; Central carbon metabolism in cancer",1.2.1.16; 1.2.1.24; 1.2.1.79; 1.3.1.6; 1.3.4.1; 1.3.5.1; 1.3.5.4; 1.3.98.1; 1.3.99.-; 1.14.11.1; 1.14.11.2; 1.14.11.3; 1.14.11.4; 1.14.11.6; 1.14.11.7; 1.14.11.8; 1.14.11.9; 1.14.11.10; 1.14.11.11; 1.14.11.12; 1.14.11.13; 1.14.11.14; 1.14.11.15; 1.14.11.16; 1.14.11.17; 1.14.11.18; 1.14.11.19; 1.14.11.20; 1.14.11.21; 1.14.11.22; 1.14.11.23; 1.14.11.24; 1.14.11.25; 1.14.11.26; 1.14.11.27; 1.14.11.28; 1.14.11.31; 1.14.11.32; 1.14.11.34; 1.14.11.35; 1.14.11.36; 1.14.11.37; 1.14.11.38; 1.14.11.39; 1.14.11.40; 1.14.11.41; 1.14.11.42; 1.14.11.43; 1.14.11.44; 1.14.11.45; 1.14.11.46; 1.14.11.48; 1.14.11.49; 1.14.11.50; 1.14.11.51; 1.14.11.52; 1.14.11.-; 1.14.20.1; 1.14.20.2; 1.14.20.3; 1.14.20.-; 2.5.1.48; 2.5.1.-; 2.8.3.2; 2.8.3.5; 2.8.3.6; 2.8.3.13; 2.8.3.15; 2.8.3.18; 2.8.3.20; 2.8.3.22; 2.8.3.-; 3.1.2.3; 3.1.2.13; 3.5.1.18; 3.5.1.96; 3.7.1.14; 4.1.3.1; 4.1.3.30; 6.2.1.4; 6.2.1.5,"Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; GABA (gamma-Aminobutyrate) shunt; Succinate dehydrogenase (ubiquinone); Succinate dehydrogenase, prokaryotes; Fumarate reductase, prokaryotes; Reductive citrate cycle (Arnon-Buchanan cycle); Dicarboxylate-hydroxybutyrate cycle; 3-Hydroxypropionate bi-cycle; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Dicarboxylic acids;     C00042  Succinate; Pharmaceutical additives [BR:br08316];  Flavoring substance;   C00042  [106962] Succinate;  pH regulator;   C00042  [106962] Succinate,CAS: 110-15-6; PubChem: 3344; ChEBI: 15741; ChEMBL: CHEMBL576; LIPIDMAPS: LMFA01170043; KNApSAcK: C00001205; PDB-CCD: SIN; 3DMET: B00012; NIKKAJI: J2.879G,cpd:C00042; cpd:C02170; cpd:C03201; cpd:C07598; cpd:C10900; cpd:C11117; cpd:C14872; cpd:C15607; cpd:C19414; cpd:C20231,4,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O4,C4H5O4,118.0266087,119.0344337,117.018783631,34,cpd:C00091,Succinyl-CoA;,C25H40N7O19P3S,Succinyl-CoA; Succinyl coenzyme A,R00265 R00405 R00406 R00407 R00410 R00432 R00727 R00829; R00830 R00832 R00833 R01197 R01559 R01777 R01780 R02084; R02407 R02570 R02990 R03154 R04365 R05587 R05588 R06904; R06908 R08549 R09280 R10343 R10640 R10641 R10904,"Citrate cycle (TCA cycle); Valine, leucine and isoleucine degradation; Phenylalanine metabolism; Benzoate degradation; Toluene degradation; Naphthalene degradation; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Degradation of aromatic compounds",1.2.1.52; 1.2.1.76; 1.2.4.2; 1.2.7.3; 1.2.7.11; 1.8.1.4; 2.3.1.16; 2.3.1.37; 2.3.1.46; 2.3.1.61; 2.3.1.109; 2.3.1.117; 2.3.1.174; 2.3.1.-; 2.8.3.2; 2.8.3.5; 2.8.3.6; 2.8.3.13; 2.8.3.15; 2.8.3.18; 2.8.3.20; 2.8.3.22; 2.8.3.-; 3.1.2.3; 5.4.99.2; 6.2.1.4; 6.2.1.5,"Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; Reductive citrate cycle (Arnon-Buchanan cycle); Ethylmalonyl pathway; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA",NA,CAS: 604-98-8; PubChem: 3391; ChEBI: 15380; KNApSAcK: C00019546; PDB-CCD: SCA; 3DMET: B04629; NIKKAJI: J252.493G,cpd:C00091; cpd:C00683; cpd:C01213; cpd:C02557,25,40,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O19N7P3S1,C25H39O19N7P3S1,867.1312543,868.1390793,866.123429232,35,cpd:C00122,Fumarate;,C4H4O4,Fumarate; Fumaric acid; trans-Butenedioic acid,R00402 R00408 R00412 R00490 R01082 R01083 R01085 R01086; R01087 R01336 R01364 R01867 R02164 R04559 R05598 R06789; R06903 R10660 R10940,"Citrate cycle (TCA cycle); Oxidative phosphorylation; Arginine biosynthesis; Alanine, aspartate and glutamate metabolism; Tyrosine metabolism; Phenylalanine metabolism; Pyruvate metabolism; Styrene degradation; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Nicotinate and nicotinamide metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Degradation of aromatic compounds; Two-component system; Glucagon signaling pathway; Pathways in cancer; Renal cell carcinoma; Central carbon metabolism in cancer",1.3.1.6; 1.3.4.1; 1.3.5.1; 1.3.5.4; 1.3.98.1; 1.3.99.-; 3.7.1.2; 3.7.1.5; 3.7.1.14; 3.7.1.20; 4.1.99.11; 4.1.99.-; 4.2.1.2; 4.2.99.12; 4.3.1.1; 4.3.2.1; 4.3.2.2; 5.2.1.1; 6.3.2.46,"Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; Urea cycle; Tyrosine degradation, tyrosine => homogentisate; Succinate dehydrogenase (ubiquinone); Succinate dehydrogenase, prokaryotes; Fumarate reductase, prokaryotes; Reductive citrate cycle (Arnon-Buchanan cycle); Dicarboxylate-hydroxybutyrate cycle; 3-Hydroxypropionate bi-cycle; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Nicotinate degradation, nicotinate => fumarate",Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D05 ANTIPSORIATICS;    D05A ANTIPSORIATICS FOR TOPICAL USE;     D05AX Other antipsoriatics for topical use;      D05AX01 Fumaric acid;       D02308  Fumaric acid (NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D02308  [102419] Fumaric acid;  Lubricating agent;   D02308  [102419] Fumaric acid;  Flavoring substance;   D02308  [102419] Fumaric acid;  Bonding agent;   D02308  [102419] Fumaric acid,CAS: 110-17-8; PubChem: 3422; ChEBI: 18012 29806; ChEMBL: CHEMBL503160; KNApSAcK: C00001183 C00033849; PDB-CCD: FUM; 3DMET: B00033; NIKKAJI: J2.880K,cpd:C00122; cpd:C01384; cpd:C02150; cpd:C07780; cpd:C07783; cpd:C12574; cpd:C12896; cpd:C13424; cpd:C13540; cpd:C14029; cpd:C18572,4,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H5O4,C4H3O4,116.0109586,117.0187836,115.003133633,36,cpd:C00149,(S)-Malate;,C4H6O5,(S)-Malate; L-Malate; L-Apple acid; L-Malic acid; L-2-Hydroxybutanedioic acid; Malate; Malic acid,R00214 R00216 R00342 R00343 R00360 R00361 R00406 R00472; R01082 R01256 R01257 R01447 R03323 R10612 R11074,"Citrate cycle (TCA cycle); Pyruvate metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Two-component system; Taste transduction; Glucagon signaling pathway; Proximal tubule bicarbonate reclamation; Pathways in cancer; Renal cell carcinoma; Central carbon metabolism in cancer",1.1.1.37; 1.1.1.38; 1.1.1.39; 1.1.1.40; 1.1.1.82; 1.1.1.299; 1.1.5.4; 1.1.99.7; 2.3.1.92; 2.3.3.9; 2.8.3.22; 3.1.2.30; 4.1.1.101; 4.2.1.2; 6.2.1.9,"Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate; Glyoxylate cycle; CAM (Crassulacean acid metabolism), dark; CAM (Crassulacean acid metabolism), light; C4-dicarboxylic acid cycle, NAD - malic enzyme type; C4-dicarboxylic acid cycle, NADP - malic enzyme type; Reductive citrate cycle (Arnon-Buchanan cycle); Formaldehyde assimilation, serine pathway; Ethylmalonyl pathway; Dicarboxylate-hydroxybutyrate cycle; 3-Hydroxypropionate bi-cycle; Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate; Methylaspartate cycle",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Hydroxycarboxylic acids;     C00149  Malate; (S)-2-Hydroxybutanediate,CAS: 97-67-6; PubChem: 3449; ChEBI: 15589 30797; ChEMBL: CHEMBL1234046; KNApSAcK: C00001192; PDB-CCD: LMR; 3DMET: B00042; NIKKAJI: J74.430A,cpd:C00149; cpd:C00497; cpd:C00711; cpd:C03064; cpd:C14873,4,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O5,C4H5O5,134.0215233,135.0293483,133.013698334,37,cpd:C00158,Citrate;,C6H8O7,"Citrate; Citric acid; 2-Hydroxy-1,2,3-propanetricarboxylic acid; 2-Hydroxytricarballylic acid",R00351 R00352 R00362 R01322 R01323 R01324 R01325 R10090; R10677,"Citrate cycle (TCA cycle); Alanine, aspartate and glutamate metabolism; Glyoxylate and dicarboxylate metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Two-component system; Taste transduction; Glucagon signaling pathway; Central carbon metabolism in cancer",2.3.3.1; 2.3.3.3; 2.3.3.8; 2.3.3.16; 2.8.3.10; 4.1.3.6; 4.2.1.3; 6.2.1.18; 6.3.1.17; 6.3.2.38,"Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate; Glyoxylate cycle; Reductive citrate cycle (Arnon-Buchanan cycle); Methylaspartate cycle","Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Tricarboxylic acids;     C00158  Citrate; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A09 DIGESTIVES, INCL. ENZYMES;    A09A DIGESTIVES, INCL. ENZYMES;     A09AB Acid preparations;      A09AB04 Citric acid;       D00037  Citric acid, anhydrous (USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Anhydrous citric acid;     D00037  Citric acid, anhydrous (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00037  [001216] Anhydrous citric acid;  Solubilizing agent;   D00037  [001216] Anhydrous citric acid;  Buffering agent;   D00037  [001216] Anhydrous citric acid;  Flavoring substance;   D00037  [001216] Anhydrous citric acid;  Coating agent;   D00037  [001216] Anhydrous citric acid;  Bloating agent;   D00037  [001216] Anhydrous citric acid;  pH regulator;   D00037  [001216] Anhydrous citric acid;  Diluting agent;   D00037  [001216] Anhydrous citric acid;  Disintegrant;   D00037  [001216] Anhydrous citric acid;  Disintegrating adjuvant;   D00037  [001216] Anhydrous citric acid;  Solubilization agent;   D00037  [001216] Anhydrous citric acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00037  Anhydrous citric acid",CAS: 77-92-9; PubChem: 3458; ChEBI: 16947 30769; ChEMBL: CHEMBL1261; KNApSAcK: C00007619; PDB-CCD: CIT FLC; 3DMET: B00046; NIKKAJI: J2.824J,cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095,6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O7,C6H7O7,192.0270026,193.0348276,191.019177635,38,cpd:C00311,Isocitrate;,C6H8O7,"Isocitrate; Isocitric acid; 1-Hydroxytricarballylic acid; 1-Hydroxypropane-1,2,3-tricarboxylic acid",R00267 R00479 R00709 R01324 R01899 R01900 R01946,"Citrate cycle (TCA cycle); Glyoxylate and dicarboxylate metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Glucagon signaling pathway; Central carbon metabolism in cancer",1.1.1.41; 1.1.1.42; 1.1.1.286; 2.3.1.126; 4.1.3.1; 4.2.1.3,"Citrate cycle (TCA cycle, Krebs cycle); Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate; Glyoxylate cycle; Reductive citrate cycle (Arnon-Buchanan cycle); Methylaspartate cycle",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Tricarboxylic acids;     C00311  Isocitrate,CAS: 320-77-4; PubChem: 3605; ChEBI: 16087 30887; ChEMBL: CHEMBL539669; 3DMET: B04664; NIKKAJI: J95.796H,cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095,6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O7,C6H7O7,192.0270026,193.0348276,191.019177636,39,cpd:C00417,cis-Aconitate;,C6H6O6,cis-Aconitate; cis-Aconitic acid,R01325 R01900 R02243 R02244,"Citrate cycle (TCA cycle); Glyoxylate and dicarboxylate metabolism; C5-Branched dibasic acid metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism",4.1.1.6; 4.2.1.3; 5.3.3.7,Glyoxylate cycle; Reductive citrate cycle (Arnon-Buchanan cycle); Methylaspartate cycle,Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Tricarboxylic acids;     C00417  cis-Aconitate,CAS: 585-84-2; PubChem: 3707; ChEBI: 16383 32805; ChEMBL: CHEMBL347285; KNApSAcK: C00001177; 3DMET: B00107; NIKKAJI: J37.488A,cpd:C00417; cpd:C02341; cpd:C03360; cpd:C05422,6,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O6,C6H5O6,174.0164379,175.0242629,173.008612937,40,cpd:C05379,Oxalosuccinate;,C6H6O7,Oxalosuccinate; Oxalosuccinic acid,R00268 R01899 R08201,Citrate cycle (TCA cycle); Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism,1.1.1.42; 6.4.1.7,Methylaspartate cycle,NA,CAS: 1948-82-9; PubChem: 7753; ChEBI: 7815; 3DMET: B05012; NIKKAJI: J13.032J,cpd:C05379; cpd:C06675; cpd:C06676,6,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O7,C6H5O7,190.0113525,191.0191776,189.003527538,41,cpd:C05381,3-Carboxy-1-hydroxypropyl-ThPP;,C16H25N4O10P2S,3-Carboxy-1-hydroxypropyl-ThPP; Succinate semialdehyde-thiamin diphosphate,R00621 R03316,Citrate cycle (TCA cycle),1.2.4.2,NA,NA,PubChem: 7755; ChEBI: 1463; NIKKAJI: J2.755.812G,cpd:C05381,16,25,10,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O10N4P2S1,C16H24O10N4P2S1,527.0766632,528.0844882,526.068838239,43,cpd:C00117,D-Ribose 5-phosphate;,C5H11O8P,D-Ribose 5-phosphate; Ribose 5-phosphate,R00182 R00510 R01049 R01050 R01051 R01052 R01053 R01054; R01055 R01056 R01057 R01128 R01270 R01641 R02171 R02345; R06590 R06863 R10088 R10089 R10973 R11553,Pentose phosphate pathway; Purine metabolism; Phosphonate and phosphinate metabolism; Carbon fixation in photosynthetic organisms; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Thyroid hormone synthesis,2.2.1.1; 2.2.1.4; 2.7.1.15; 2.7.1.18; 2.7.6.1; 2.7.7.35; 2.7.7.96; 3.1.4.57; 3.2.2.4; 3.2.2.10; 3.2.2.12; 3.2.2.14; 3.6.1.13; 3.6.1.21; 3.6.1.53; 3.6.1.-; 4.2.1.70; 4.3.3.6; 5.3.1.6; 5.4.2.2; 5.4.2.7; 6.3.4.7,"Pentose phosphate pathway (Pentose phosphate cycle); PRPP biosynthesis, ribose 5P => PRPP; Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P; Pentose phosphate pathway, archaea, fructose 6P => ribose 5P",NA,CAS: 4300-28-1; PubChem: 3417; ChEBI: 17797 52742; ChEMBL: CHEMBL573025 CHEMBL605020; KNApSAcK: C00007473; PDB-CCD: HSX RP5; 3DMET: B04635; NIKKAJI: J205.693C,cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814,5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O8P1,C5H10O8P1,230.0191543,231.0269793,229.011329340,44,cpd:C00119,5-Phospho-alpha-D-ribose 1-diphosphate;,C5H13O14P3,5-Phospho-alpha-D-ribose 1-diphosphate; 5-Phosphoribosyl diphosphate; 5-Phosphoribosyl 1-pyrophosphate; PRPP,R00190 R00966 R01049 R01071 R01072 R01073 R01132 R01229; R01271 R01724 R01870 R02142 R03348 R04068 R04346 R04378; R06836 R08231 R08237 R08238 R08245 R08898 R10095 R10337; R11102 R11280,"Pentose phosphate pathway; Purine metabolism; Pyrimidine metabolism; Histidine metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Antifolate resistance",2.4.2.7; 2.4.2.8; 2.4.2.9; 2.4.2.10; 2.4.2.12; 2.4.2.14; 2.4.2.17; 2.4.2.18; 2.4.2.19; 2.4.2.20; 2.4.2.22; 2.4.2.45; 2.4.2.49; 2.4.2.54; 2.4.2.-; 2.7.4.23; 2.7.6.1; 6.3.4.8; 6.3.4.21,"PRPP biosynthesis, ribose 5P => PRPP; Histidine biosynthesis, PRPP => histidine; Inosine monophosphate biosynthesis, PRPP + glutamine => IMP; Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP",NA,PubChem: 3419; ChEBI: 17111; ChEMBL: CHEMBL606077; KNApSAcK: C00007296; PDB-CCD: PRP; 3DMET: B01164; NIKKAJI: J40.073D,cpd:C00119; cpd:C02884,5,13,14,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H14O14P3,C5H12O14P3,389.9518161,390.9596411,388.943991141,45,cpd:C00121,D-Ribose,C5H10O5,D-Ribose,R01051 R01079 R01080 R01081 R01245 R01273 R01677 R01770; R02137 R02143 R02172 R02341 R03885 R07918 R08072 R08073; R08074 R08080 R10046,Pentose phosphate pathway; ABC transporters; Bacterial chemotaxis,1.1.1.115; 2.7.1.15; 3.2.2.1; 3.2.2.2; 3.2.2.3; 3.2.2.7; 3.2.2.8; 3.2.2.13; 3.2.2.25; 5.3.1.20,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00121  D-Ribose,CAS: 50-69-1; PubChem: 3421; ChEBI: 47013; ChEMBL: CHEMBL444125 CHEMBL606078; KNApSAcK: C00034198; PDB-CCD: BDR RIB; 3DMET: B04636; NIKKAJI: J60.867J,cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382,5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O5,C5H9O5,150.0528234,151.0606485,149.044998442,46,cpd:C00198,"D-Glucono-1,5-lactone;",C6H10O6,"D-Glucono-1,5-lactone; Gluconic lactone; Gluconic acid lactone; 1,5-Gluconolactone; delta-Gluconolactone; D-Gluconolactone; Gluconolactone",R00300 R00305 R00874 R01519 R01520 R01521 R01522 R03861; R06620 R07147 R10411,Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism,1.1.1.47; 1.1.1.118; 1.1.1.119; 1.1.1.121; 1.1.1.359; 1.1.1.360; 1.1.3.4; 1.1.3.5; 1.1.5.2; 1.1.5.9; 1.1.99.28; 1.1.99.35; 2.3.1.132; 3.1.1.17,NA,Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D04332  [102518] Glucono-delta-lactone;  Flavoring substance;   D04332  [102518] Glucono-delta-lactone;  Adhesive;   D04332  [102518] Glucono-delta-lactone;  Tenacious agent;   D04332  [102518] Glucono-delta-lactone;  pH regulator;   D04332  [102518] Glucono-delta-lactone,CAS: 90-80-2; PubChem: 3498; ChEBI: 16217; ChEMBL: CHEMBL1200829; PDB-CCD: LGC; 3DMET: B01186; NIKKAJI: J1.174F,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.03991343,47,cpd:C00199,D-Ribulose 5-phosphate,C5H11O8P,D-Ribulose 5-phosphate,R01056 R01523 R01524 R01525 R01526 R01528 R01529 R01530; R05338 R07281 R07456 R10221,Pentose phosphate pathway; Pentose and glucuronate interconversions; Lipopolysaccharide biosynthesis; Methane metabolism; Carbon fixation in photosynthetic organisms; Riboflavin metabolism; Vitamin B6 metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids,1.1.1.44; 1.1.1.137; 1.1.1.343; 1.1.1.351; 2.7.1.16; 2.7.1.19; 2.7.1.47; 4.1.2.43; 4.1.99.12; 4.3.3.6; 5.1.3.1; 5.3.1.6; 5.3.1.13,"Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P; Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; CMP-KDO biosynthesis; Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P; Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P; Pentose phosphate pathway, archaea, fructose 6P => ribose 5P",NA,CAS: 551-85-9; PubChem: 3499; ChEBI: 17363; PDB-CCD: 5RP; 3DMET: B01187; NIKKAJI: J275.266B,cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814,5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O8P1,C5H10O8P1,230.0191543,231.0269793,229.011329344,48,cpd:C00204,2-Dehydro-3-deoxy-D-gluconate;,C6H10O6,2-Dehydro-3-deoxy-D-gluconate; 2-Keto-3-deoxy-D-gluconate,R01538 R01540 R01541 R01542 R01543 R01544 R05606 R08570; R10775,Pentose phosphate pathway; Pentose and glucuronate interconversions; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.1.1.125; 1.1.1.126; 1.1.1.127; 2.7.1.45; 2.7.1.178; 4.1.2.51; 4.1.2.55; 4.2.1.7; 4.2.1.8; 4.2.1.39; 4.2.1.140; 4.3.1.9,"D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,CAS: 17510-99-5; PubChem: 3504; ChEBI: 17032; PDB-CCD: KDG; 3DMET: B04648,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.03991345,49,cpd:C00231,D-Xylulose 5-phosphate,C5H11O8P,D-Xylulose 5-phosphate,R01067 R01440 R01529 R01621 R01639 R01641 R01830 R05850; R06861 R09544,Pentose phosphate pathway; Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Thyroid hormone synthesis,1.1.1.301; 2.2.1.1; 2.2.1.3; 2.7.1.17; 4.1.2.9; 5.1.3.1; 5.1.3.4,"Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; Glucuronate pathway (uronate pathway); Ascorbate degradation, ascorbate => D-xylulose-5P",NA,PubChem: 3530; ChEBI: 16332; KNApSAcK: C00019693; PDB-CCD: 5SP; 3DMET: B01195; NIKKAJI: J652.282C,cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814,5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O8P1,C5H10O8P1,230.0191543,231.0269793,229.011329346,50,cpd:C00257,D-Gluconic acid;,C6H12O7,D-Gluconic acid; D-Gluconate; D-gluco-Hexonic acid,R01519 R01538 R01737 R01738 R01739 R01740 R01741 R01742; R10832,Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism,1.1.1.69; 1.1.1.215; 1.1.99.3; 2.4.1.321; 2.7.1.12; 3.1.1.17; 4.2.1.39; 4.2.1.140,"Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C00257  D-Gluconic acid; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Calcium gluconate;     C00257  D-Gluconic acid; Pharmaceutical additives [BR:br08316];  pH regulator;   C00257  [102517] Gluconic acid,CAS: 526-95-4; PubChem: 3556; ChEBI: 18391 33198; ChEMBL: CHEMBL464345; KNApSAcK: C00007303 C00034850; PDB-CCD: GCO; 3DMET: B04655; NIKKAJI: J3.286G,cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930,6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O7,C6H11O7,196.0583027,197.0661278,195.050477747,51,cpd:C00258,D-Glycerate;,C3H6O4,D-Glycerate; Glycerate; (R)-Glycerate; Glyceric acid,R01388 R01392 R01511 R01514 R01745 R01747 R01748 R01749; R01750 R01751 R01752 R08571 R08572 R09645 R09665 R09666; R10324 R10615,"Pentose phosphate pathway; Glycine, serine and threonine metabolism; Glycerolipid metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism",1.1.1.26; 1.1.1.29; 1.1.1.60; 1.1.1.79; 1.1.1.81; 1.1.1.92; 1.2.1.3; 1.2.1.89; 1.2.7.5; 1.2.99.8; 2.4.1.268; 2.4.1.269; 2.7.1.31; 2.7.1.165; 3.1.3.20; 3.1.3.38; 3.2.1.170; 4.1.1.73,"Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; Formaldehyde assimilation, serine pathway; Photorespiration",NA,CAS: 473-81-4; PubChem: 3557; ChEBI: 16659 32398; KNApSAcK: C00001185; PDB-CCD: DGY; 3DMET: B00076; NIKKAJI: J5.966H,cpd:C00258; cpd:C00603; cpd:C02766; cpd:C13034,3,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O4,C3H5O4,106.0266087,107.0344337,105.018783648,52,cpd:C00279,D-Erythrose 4-phosphate,C4H9O7P,D-Erythrose 4-phosphate,R00761 R01067 R01825 R01826 R01827 R01829 R01830 R08575; R09083 R11333,"Pentose phosphate pathway; Phenylalanine, tyrosine and tryptophan biosynthesis; Carbon fixation in photosynthetic organisms; Vitamin B6 metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids",1.2.1.72; 1.13.11.79; 2.2.1.1; 2.2.1.2; 2.5.1.54; 4.1.2.13; 4.1.2.22; 5.3.1.34,"Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate; Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P",NA,CAS: 585-18-2; PubChem: 3574; ChEBI: 48153; ChEMBL: CHEMBL1232448; KNApSAcK: C00007472; PDB-CCD: E4P; 3DMET: B04660; NIKKAJI: J39.057G,cpd:C00279; cpd:C03109; cpd:C03394; cpd:C03604; cpd:C21285; cpd:C21286,4,9,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O7P1,C4H8O7P1,200.0085896,201.0164147,199.000764649,53,cpd:C00345,6-Phospho-D-gluconate,C6H13O10P,6-Phospho-D-gluconate,R01528 R01737 R02032 R02034 R02035 R02036 R10221,Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism,1.1.1.43; 1.1.1.44; 1.1.1.343; 1.1.1.351; 2.7.1.12; 3.1.1.31; 4.2.1.12,"Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P; Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate",NA,PubChem: 3638; ChEBI: 48928; ChEMBL: CHEMBL1230513; KNApSAcK: C00007481; PDB-CCD: 6PG; 3DMET: B01221; NIKKAJI: J1.343.743B,cpd:C00345; cpd:C04234,6,13,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O10P1,C6H12O10P1,276.0246336,277.0324586,275.016808650,54,cpd:C00577,D-Glyceraldehyde,C3H6O3,D-Glyceraldehyde,R01036 R01041 R01059 R01752 R02568 R08570 R08571 R10050; R10324 R10615 R10616,Pentose phosphate pathway; Fructose and mannose metabolism; Galactose metabolism; Glycerolipid metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.1.1.2; 1.1.1.21; 1.1.1.72; 1.1.1.372; 1.2.1.3; 1.2.1.89; 1.2.7.5; 1.2.99.8; 2.2.1.11; 2.7.1.28; 4.1.2.13; 4.1.2.51; 4.1.2.55,"Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate",Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00577  D-Glyceraldehyde,CAS: 453-17-8 367-47-5; PubChem: 3856; ChEBI: 17378; PDB-CCD: 3GR; 3DMET: B00137; NIKKAJI: J5.790H J9.119G,cpd:C00184; cpd:C00186; cpd:C00256; cpd:C00577; cpd:C01013; cpd:C01432; cpd:C02154; cpd:C02426; cpd:C03726; cpd:C05823; cpd:C10899; cpd:C12677; cpd:C19286; cpd:C19296,3,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O3,C3H5O3,90.03169405,91.03951908,89.0238690251,55,cpd:C00620,alpha-D-Ribose 1-phosphate;,C5H11O8P,alpha-D-Ribose 1-phosphate; Ribose 1-phosphate; D-Ribose 1-phosphate,R01057 R01561 R01863 R01876 R01885 R02147 R02294 R02295; R02296 R02297 R02298 R02646 R06837 R08229 R08368 R11535,Pentose phosphate pathway; Purine metabolism,2.4.2.1; 2.4.2.2; 2.4.2.3; 2.4.2.15; 2.4.2.16; 2.4.2.-; 2.7.1.212; 3.6.1.21; 5.4.2.2; 5.4.2.7,NA,NA,PubChem: 3894; ChEBI: 16300; ChEMBL: CHEMBL603367; PDB-CCD: R1P; 3DMET: B04706; NIKKAJI: J292.493E,cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814,5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O8P1,C5H10O8P1,230.0191543,231.0269793,229.011329352,56,cpd:C00672,2-Deoxy-D-ribose 1-phosphate;,C5H11O7P,2-Deoxy-D-ribose 1-phosphate; 2-Deoxy-alpha-D-ribose 1-phosphate,R01570 R01969 R02484 R02557 R02748 R02749 R08230 R10244,Pentose phosphate pathway; Pyrimidine metabolism,2.4.2.1; 2.4.2.2; 2.4.2.3; 2.4.2.4; 5.4.2.7,NA,NA,CAS: 17210-42-3; PubChem: 3941; ChEBI: 11563 28542; 3DMET: B04713; NIKKAJI: J1.011.725I,cpd:C00653; cpd:C00672; cpd:C00673; cpd:C02270; cpd:C04111; cpd:C11437; cpd:C16637,5,11,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O7P1,C5H10O7P1,214.0242397,215.0320647,213.016414753,57,cpd:C00673,2-Deoxy-D-ribose 5-phosphate,C5H11O7P,2-Deoxy-D-ribose 5-phosphate,R01066 R02749 R02750,Pentose phosphate pathway,2.7.1.15; 4.1.2.4; 5.4.2.7,NA,NA,PubChem: 3942; ChEBI: 16132 55513; PDB-CCD: AAB ORP; 3DMET: B04714; NIKKAJI: J993.340I,cpd:C00653; cpd:C00672; cpd:C00673; cpd:C02270; cpd:C04111; cpd:C11437; cpd:C16637,5,11,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O7P1,C5H10O7P1,214.0242397,215.0320647,213.016414754,58,cpd:C01151,"D-Ribose 1,5-bisphosphate;",C5H12O11P2,"D-Ribose 1,5-bisphosphate; Ribose 1,5-bisphosphate; alpha-D-Ribose 1,5-bisphosphate",R01050 R06836 R06837 R10205 R10555 R10836 R10837 R10838; R11535,Pentose phosphate pathway; Phosphonate and phosphinate metabolism,2.4.2.57; 2.7.1.18; 2.7.1.212; 2.7.4.23; 3.1.4.55; 5.3.1.29,NA,NA,PubChem: 4380; ChEBI: 17994 68819; PDB-CCD: RI2; 3DMET: B01393; NIKKAJI: J531.560C,cpd:C01095; cpd:C01151; cpd:C01182; cpd:C20986,5,12,11,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O11P2,C5H11O11P2,309.9854852,310.9933102,308.977660255,59,cpd:C01218,6-Phospho-2-dehydro-D-gluconate;,C6H11O10P,6-Phospho-2-dehydro-D-gluconate; 2-Dehydro-D-gluconate 6-phosphate,R02032 R02034 R02658,Pentose phosphate pathway; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.43; 2.7.1.13,NA,NA,PubChem: 4440; ChEBI: 2229; 3DMET: B04785; NIKKAJI: J2.731.896G,cpd:C01218; cpd:C04037; cpd:C05385; cpd:C14899,6,11,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O10P1,C6H10O10P1,274.0089835,275.0168086,273.001158556,60,cpd:C01236,"D-Glucono-1,5-lactone 6-phosphate;",C6H11O9P,"D-Glucono-1,5-lactone 6-phosphate; 6-Phospho-D-glucono-1,5-lactone",R00835 R02035 R02736 R09550 R10520 R10907,Pentose phosphate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism,1.1.1.49; 1.1.1.363; 1.1.1.388; 1.1.98.2; 3.1.1.31,"Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P; Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate",NA,PubChem: 4457; ChEBI: 16938; 3DMET: B01420; NIKKAJI: J40.067J,cpd:C01236; cpd:C01286; cpd:C04442; cpd:C06893; cpd:C20668,6,11,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O9P1,C6H10O9P1,258.0140689,259.021894,257.006243957,61,cpd:C01801,Deoxyribose;,C5H10O4,Deoxyribose; 2-Deoxy-D-erythro-pentose; Thyminose; 2-Deoxy-D-ribose,R02750,Pentose phosphate pathway,2.7.1.15,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Deoxy sugars;     C01801  Deoxyribose,CAS: 533-67-5; PubChem: 4927; ChEBI: 28816; KNApSAcK: C00001115; PDB-CCD: 2DR; 3DMET: B01499; NIKKAJI: J6.332K,cpd:C01801; cpd:C02783; cpd:C04039; cpd:C04272; cpd:C06257; cpd:C08347; cpd:C11497,5,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O4,C5H9O4,134.0579088,135.0657338,133.050083858,62,cpd:C03752,2-Amino-2-deoxy-D-gluconate;,C6H13NO6,2-Amino-2-deoxy-D-gluconate; D-Glucosaminate; D-Glucosaminic acid; Glucosaminate,R01544 R01962 R04299 R10407 R10773,Pentose phosphate pathway; Microbial metabolism in diverse environments; Phosphotransferase system (PTS),1.1.3.-; 2.7.1.203; 4.3.1.9,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C03752  D-Glucosaminic acid,CAS: 3646-68-2; PubChem: 6511; ChEBI: 17784; 3DMET: B04912; NIKKAJI: J205.566J,cpd:C02264; cpd:C03752,6,13,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O6N1,C6H12O6N1,195.0742871,196.0821122,194.066462159,63,cpd:C04442,2-Dehydro-3-deoxy-6-phospho-D-gluconate;,C6H11O9P,2-Dehydro-3-deoxy-6-phospho-D-gluconate; 6-Phospho-2-dehydro-3-deoxy-D-gluconate; 2-Keto-3-deoxy-6-phosphogluconate; 2-Dehydro-3-deoxy-D-gluconate 6-phosphate,R01541 R02036 R05605 R10408,Pentose phosphate pathway; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,2.7.1.45; 2.7.1.178; 4.1.2.14; 4.1.2.55; 4.2.1.12; 4.3.1.29,"Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate; D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P; D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,PubChem: 7071; ChEBI: 15925; KNApSAcK: C00019434; 3DMET: B04941; NIKKAJI: J40.082C,cpd:C01236; cpd:C01286; cpd:C04442; cpd:C06893; cpd:C20668,6,11,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O9P1,C6H10O9P1,258.0140689,259.021894,257.006243960,64,cpd:C05382,Sedoheptulose 7-phosphate;,C7H15O10P,Sedoheptulose 7-phosphate; D-Sedoheptulose 7-phosphate; D-altro-Heptulose 7-phosphate; altro-Heptulose 7-phosphate,R01641 R01827 R01843 R01844 R01845 R05645 R06590 R06863; R08575 R09768 R09769 R11326 R11327,Pentose phosphate pathway; Lipopolysaccharide biosynthesis; Carbon fixation in photosynthetic organisms; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids,2.2.1.1; 2.2.1.2; 2.7.1.11; 2.7.1.14; 3.1.3.11; 3.1.3.37; 4.2.3.154; 4.2.3.155; 5.3.1.28,"Pentose phosphate pathway (Pentose phosphate cycle); Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P; ADP-L-glycero-D-manno-heptose biosynthesis; Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P",NA,PubChem: 7756; ChEBI: 15721; KNApSAcK: C00019575; PDB-CCD: I22; 3DMET: B05013; NIKKAJI: J604.570G,cpd:C05382; cpd:C06222; cpd:C07836; cpd:C07838; cpd:C19878; cpd:C19880; cpd:C19882; cpd:C20956,7,15,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O10P1,C7H14O10P1,290.0402837,291.0481087,289.032458661,65,cpd:C06019,D-arabino-Hex-3-ulose 6-phosphate;,C6H13O9P,D-arabino-Hex-3-ulose 6-phosphate; D-arabino-3-Hexulose 6-phosphate; D-arabino-6-Phospho-hex-3-ulose,R05338 R05339 R09780,Pentose phosphate pathway; Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Biosynthesis of amino acids,4.1.2.43; 5.3.1.27,"Formaldehyde assimilation, ribulose monophosphate pathway; Pentose phosphate pathway, archaea, fructose 6P => ribose 5P",NA,PubChem: 8291; ChEBI: 27973; 3DMET: B01952; NIKKAJI: J2.760.897C,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.02189462,66,cpd:C06473,2-Keto-D-gluconic acid;,C6H10O7,2-Keto-D-gluconic acid; 2-Dehydro-D-gluconate; 2-Dehydro-D-gluconic acid; alpha-D-arabino-2-Hexulosonic acid,R01739 R01741 R01742 R02658 R02659 R05823 R07153,Pentose phosphate pathway; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.215; 1.1.1.274; 1.1.99.3; 1.1.99.4; 2.7.1.13,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C06473  2-Keto-D-gluconic acid,CAS: 669-90-9; PubChem: 8705; ChEBI: 27469; 3DMET: B05206; NIKKAJI: J117.707I,cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059,6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O7,C6H9O7,194.0426527,195.0504777,193.034827663,67,cpd:C20589,D-Glucosaminate-6-phosphate;,C6H14NO9P,D-Glucosaminate-6-phosphate; 2-Amino-2-deoxy-D-gluconate 6-phosphate,R10407 R10408,Pentose phosphate pathway; Microbial metabolism in diverse environments; Phosphotransferase system (PTS),2.7.1.203; 4.3.1.29,NA,NA,PubChem: 172232326,cpd:C20589,6,14,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O9N1P1,C6H13O9N1P1,275.040618,276.0484431,274.03279364,68,cpd:C00029,UDP-glucose;,C15H24N2O17P2,UDP-glucose; UDPglucose; UDP-D-glucose; Uridine diphosphate glucose; UDP-alpha-D-glucose,R00286 R00287 R00289 R00291 R00292 R00293 R00766 R00806; R00836 R00955 R01005 R01240 R01304 R01497 R01722 R01912; R01994 R01995 R02113 R02118 R02158 R02179 R02256 R02380; R02388 R02594 R02689 R02709 R02716 R02737 R02889 R02897; R02932 R02951 R03094 R03118 R03190 R03213 R03267 R03297; R03526 R03547 R03548 R03558 R03565 R03573 R03574 R03588; R03594 R03605 R03625 R03680 R03681 R03686 R03710 R03797; R03996 R04005 R04041 R04071 R04108 R04127 R04179 R04296; R04359 R04377 R04491 R04577 R04579 R04948 R05083 R05164; R05324 R05325 R05769 R05775 R05882 R06047 R06048 R06534; R06535 R06536 R06546 R06547 R06594 R06611 R06795 R06803; R06804 R06805 R06810 R06812 R06813 R06819 R07260 R07266; R07332 R07333 R07338 R07339 R07340 R07426 R07574 R07575; R07718 R07720 R07729 R07740 R07753 R07874 R07875 R07877; R07878 R07879 R07911 R07912 R07913 R07914 R07923 R08006; R08007 R08013 R08021 R08075 R08076 R08128 R08164 R08369; R08533 R08534 R08661 R08668 R08687 R08813 R08814 R08816; R08822 R08830 R08839 R08859 R09641 R09757 R09758 R09759; R09804 R09857 R10037 R10063 R10096 R10262 R10263 R10264; R10265 R10293 R10294 R10295 R10434 R10594 R10607 R10638; R10639 R10807 R10834 R10835 R10850 R10988 R10989 R10990; R11241 R11271 R11272 R11306,"Pentose and glucuronate interconversions; Galactose metabolism; Ascorbate and aldarate metabolism; Pyrimidine metabolism; Starch and sucrose metabolism; Amino sugar and nucleotide sugar metabolism; Neomycin, kanamycin and gentamicin biosynthesis; Glycerolipid metabolism; Zeatin biosynthesis; Biosynthesis of ansamycins; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of antibiotics",1.1.1.22; 1.1.1.-; 2.4.1.11; 2.4.1.12; 2.4.1.13; 2.4.1.14; 2.4.1.15; 2.4.1.34; 2.4.1.35; 2.4.1.52; 2.4.1.53; 2.4.1.58; 2.4.1.63; 2.4.1.66; 2.4.1.71; 2.4.1.73; 2.4.1.78; 2.4.1.80; 2.4.1.81; 2.4.1.85; 2.4.1.91; 2.4.1.103; 2.4.1.104; 2.4.1.105; 2.4.1.106; 2.4.1.111; 2.4.1.114; 2.4.1.115; 2.4.1.116; 2.4.1.117; 2.4.1.118; 2.4.1.120; 2.4.1.121; 2.4.1.126; 2.4.1.127; 2.4.1.128; 2.4.1.136; 2.4.1.158; 2.4.1.160; 2.4.1.170; 2.4.1.171; 2.4.1.172; 2.4.1.173; 2.4.1.176; 2.4.1.177; 2.4.1.178; 2.4.1.181; 2.4.1.183; 2.4.1.185; 2.4.1.186; 2.4.1.188; 2.4.1.192; 2.4.1.193; 2.4.1.194; 2.4.1.195; 2.4.1.196; 2.4.1.202; 2.4.1.203; 2.4.1.208; 2.4.1.209; 2.4.1.210; 2.4.1.215; 2.4.1.218; 2.4.1.219; 2.4.1.220; 2.4.1.237; 2.4.1.238; 2.4.1.239; 2.4.1.240; 2.4.1.242; 2.4.1.245; 2.4.1.249; 2.4.1.263; 2.4.1.271; 2.4.1.276; 2.4.1.284; 2.4.1.286; 2.4.1.295; 2.4.1.296; 2.4.1.297; 2.4.1.298; 2.4.1.301; 2.4.1.305; 2.4.1.310; 2.4.1.314; 2.4.1.315; 2.4.1.323; 2.4.1.324; 2.4.1.330; 2.4.1.336; 2.4.1.337; 2.4.1.338; 2.4.1.-; 2.7.7.9; 2.7.7.12; 2.7.7.64; 2.7.8.19; 2.7.8.31; 3.6.1.8; 3.6.1.9; 3.6.1.45; 3.13.1.1; 4.2.1.76; 5.1.3.2,"Glucuronate pathway (uronate pathway); Ascorbate biosynthesis, animals, glucose-1P => ascorbate; Nucleotide sugar biosynthesis, glucose => UDP-glucose; Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00029  UDP-glucose,CAS: 133-89-1; PubChem: 3331; ChEBI: 18066 46229; ChEMBL: CHEMBL1742482 CHEMBL375951; KNApSAcK: C00001514; PDB-CCD: UPG; 3DMET: B04622; NIKKAJI: J9.610E,cpd:C00029; cpd:C00052; cpd:C03733,15,24,17,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O17N2P2,C15H23O17N2P2,566.0550213,567.0628463,565.047196365,69,cpd:C00116,Glycerol;,C3H8O3,"Glycerol; Glycerin; 1,2,3-Trihydroxypropane; 1,2,3-Propanetriol",R00841 R00847 R00850 R01034 R01036 R01039 R01041 R01043; R01044 R01045 R01047 R01104 R01350 R01351 R01352 R02591; R03331 R03616 R07293 R07298 R07390 R08372 R08658 R10563; R11127,Pentose and glucuronate interconversions; Galactose metabolism; Glycerolipid metabolism; Metabolic pathways; ABC transporters; Retrograde endocannabinoid signaling; Regulation of lipolysis in adipocytes,1.1.1.2; 1.1.1.6; 1.1.1.21; 1.1.1.72; 1.1.1.156; 1.1.1.372; 1.1.99.22; 2.4.1.332; 2.7.1.30; 2.7.1.79; 2.7.1.142; 2.7.8.-; 3.1.1.23; 3.1.1.34; 3.1.1.79; 3.1.3.19; 3.1.3.21; 3.1.4.38; 3.1.4.43; 3.2.1.22; 3.2.1.-; 4.2.1.30,"Acylglycerol degradation; D-Galacturonate degradation (fungi), D-galacturonate => glycerol","Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar alcohols;     C00116  Glycerol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A06 DRUGS FOR CONSTIPATION;    A06A DRUGS FOR CONSTIPATION;     A06AG Enemas;      A06AG04 Glycerol;       D00028  Glycerin (JP17/USP);     A06AX Other drugs for constipation;      A06AX01 Glycerol;       D00028  Glycerin (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   23  Digestive organ agents;    235  Purgatives, clysters;     2357  Glycerins;      D00028  Glycerin (JP17/USP); Concentrated glycerin (JP17); Glycerin, concentrated (JAN); Glycerol (INN);  7  Agents not mainly for therapeutic purpose;   71  Dispensing medicines;    713  Solvents;     7139  Others;      D00028  Glycerin (JP17/USP); Concentrated glycerin (JP17); Glycerin, concentrated (JAN); Glycerol (INN);    719  Miscellaneous;     7190  Miscellaneous;      D00028  Glycerin (JP17/USP); Concentrated glycerin (JP17); Glycerin, concentrated (JAN); Glycerol (INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for digestive organs;   18 Enema;    D00028  Glycerin (JP17/USP);  Agents for integumentary system;   55 Chilblain and chap remedies;    D00028  Glycerin (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Glycerin;     D00028  Glycerin (JP17/USP);  Third-class OTC drugs;   Inorganic and organic chemicals;    Glycerin;     D00028  Glycerin (JP17/USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Plasticizer;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Lubricating agent;   D00028  [001223] Glycerin;  Solubilizing agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Sweetening agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Base;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Flavoring substance;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Bonding agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Suspending agent;   D00028  [001223] Glycerin;  Coating agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Film;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Wetting agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Wetting adjuster;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Sugarcoated agent;   D00028  [001223] Glycerin;  Tonicity agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Flexibilizer;   D00028  [001223] Glycerin;  Emulsion;   D00028  [001223] Glycerin;  Adhesive;   D00028  [001223] Glycerin;  Adhesion-enhancing agent;   D00028  [001223] Glycerin;  Tenacious agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Diluting agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Dispersant;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Disintegrating adjuvant;   D00028  [001223] Glycerin;  Dampproof agent;   D00028  [001223] Glycerin;  Preserving agent;   D00028  [001223] Glycerin;  Solubilizer;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Solubilization agent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Solvent;   D00028  [001223] Glycerin;   D00028  [001224] Concentrated glycerin;  Fluidizer;   D00028  [001224] Concentrated glycerin; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00028  Glycerin;   D00028  Concentrated glycerin; Gastrointestinal agents [br08371.html];  Cathartic agent, antidiarrheal agent, intestinal regulator;   D00028; Animal drugs in Japan [BR:br08331];  93  Agents affecting digestive organs;   937  Clysters;    9371  Glycerine and preparations;     C00116  Glycerine",CAS: 56-81-5; PubChem: 3416; ChEBI: 17754; ChEMBL: CHEMBL692; KNApSAcK: C00001163; PDB-CCD: GOL; 3DMET: B00032; NIKKAJI: J1.916J,cpd:C00116; cpd:C03920; cpd:C10922; cpd:C19239,3,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O3,C3H7O3,92.04734412,93.05516915,91.0395190866,70,cpd:C00167,UDP-glucuronate;,C15H22N2O18P2,UDP-glucuronate; UDPglucuronate; UDP-D-glucuronate; UDP-alpha-D-glucuronate,R00286 R01381 R01383 R01384 R01385 R01386 R01387 R02358; R02389 R02478 R02502 R02902 R03091 R03589 R04352 R04353; R04354 R04607 R04683 R05327 R06827 R06828 R07106 R07335; R07336 R07658 R07932 R08259 R08261 R08262 R08263 R08615; R08817 R08824 R09426 R09427 R09428 R09529 R09635 R09636; R09732,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways,1.1.1.22; 1.1.1.305; 2.4.1.17; 2.4.1.135; 2.4.1.189; 2.4.1.190; 2.4.1.191; 2.4.1.212; 2.4.1.225; 2.4.1.226; 2.4.1.253; 2.4.1.254; 2.4.1.262; 2.4.1.264; 2.4.1.-; 2.7.7.44; 2.7.7.64; 4.1.1.35; 5.1.3.6; 5.1.3.12,"Glucuronate pathway (uronate pathway); Ascorbate biosynthesis, animals, glucose-1P => ascorbate; Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N",NA,PubChem: 3467; ChEBI: 17200; ChEMBL: CHEMBL228057; KNApSAcK: C00007238; PDB-CCD: UGA; 3DMET: B01177; NIKKAJI: J247.699A,cpd:C00167; cpd:C00617; cpd:C02330,15,22,18,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O18N2P2,C15H21O18N2P2,580.0342859,581.0421109,579.026460867,71,cpd:C00181,D-Xylose;,C5H10O5,D-Xylose; Wood sugar,R01429 R01430 R01431 R01432 R01433 R04937 R06203 R09477,Pentose and glucuronate interconversions; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; ABC transporters,1.1.1.21; 1.1.1.121; 1.1.1.175; 1.1.1.179; 1.1.1.307; 3.2.1.37; 3.2.1.-; 5.3.1.5,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00181  D-Xylose; Pharmaceutical additives [BR:br08316];  Flavoring substance;   D06346  [101651] D-Xylose,CAS: 58-86-6; PubChem: 3481; ChEBI: 15936 53455; ChEMBL: CHEMBL502135; KNApSAcK: C00007290 C00034344; PDB-CCD: XYP XYS; 3DMET: B04643; NIKKAJI: J2.806A,cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382,5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O5,C5H9O5,150.0528234,151.0606485,149.044998468,72,cpd:C00191,D-Glucuronate;,C6H10O7,D-Glucuronate; Glucuronic acid; Glucuronate,R01184 R01476 R01478 R01480 R01481 R01482 R01483 R01484; R04512 R04979 R06143 R07818 R08127 R08260 R08615 R09447; R09533 R10134 R10830 R10842,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Inositol phosphate metabolism; Metabolic pathways,1.1.1.2; 1.1.1.19; 1.1.1.203; 1.13.99.1; 1.-.-.-; 2.4.1.17; 2.7.1.43; 3.1.1.19; 3.1.1.93; 3.2.1.31; 3.2.1.56; 3.2.1.139; 3.2.1.167; 5.3.1.12,"Glucuronate pathway (uronate pathway); D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P; Ascorbate biosynthesis, animals, glucose-1P => ascorbate",Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C00191  D-Glucuronic acid; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Sodium glucuronate hydrate;     C00191  D-Glucuronate,CAS: 6556-12-3; PubChem: 3491; ChEBI: 15748 4178 47952; ChEMBL: CHEMBL1159524 CHEMBL496672; KNApSAcK: C00001123; PDB-CCD: BDP GCU; 3DMET: B04646; NIKKAJI: J82.112H,cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059,6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O7,C6H9O7,194.0426527,195.0504777,193.034827669,73,cpd:C00259,L-Arabinose;,C5H10O5,L-Arabinose; L-Arabinopyranose,R01754 R01757 R01758 R01759 R01760 R01761 R01762 R04938; R10787,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; ABC transporters,1.1.1.21; 1.1.1.46; 1.1.1.376; 2.7.1.46; 3.2.1.55; 3.2.1.88; 3.2.1.-; 5.3.1.4,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00259  L-Arabinose,CAS: 147-81-9; PubChem: 3558; ChEBI: 17535; ChEMBL: CHEMBL1357418 CHEMBL505348; KNApSAcK: C00041349; PDB-CCD: ARA ARB; 3DMET: B04656; NIKKAJI: J231.471A,cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382,5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O5,C5H9O5,150.0528234,151.0606485,149.044998470,74,cpd:C00266,Glycolaldehyde;,C2H4O2,Glycolaldehyde; Hydroxyacetaldehyde,R01333 R01393 R01469 R01781 R01782 R01784 R01785 R03504; R05840 R11037 R11501 R11503,Pentose and glucuronate interconversions; Glyoxylate and dicarboxylate metabolism; Vitamin B6 metabolism; Folate biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.77; 1.2.1.21; 1.4.3.8; 1.11.1.14; 1.11.1.16; 1.13.11.81; 4.1.1.40; 4.1.2.18; 4.1.2.19; 4.1.2.25; 4.1.2.28,NA,NA,CAS: 141-46-8; PubChem: 3564; ChEBI: 17071; KNApSAcK: C00007457; 3DMET: B00079; NIKKAJI: J2.537B,cpd:C00012; cpd:C00017; cpd:C00033; cpd:C00045; cpd:C00098; cpd:C00151; cpd:C00266; cpd:C00405; cpd:C02086; cpd:C05167; cpd:C05234; cpd:C13301; cpd:C13400; cpd:C14860; cpd:C18091; cpd:C18372; cpd:C18568; cpd:C18723; cpd:C18940,2,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H5O2,C2H3O2,60.02112937,61.0289544,59.0133043471,75,cpd:C00309,D-Ribulose;,C5H10O5,D-Ribulose; D-erythro-2-Pentulose; D-Arabinoketose; D-Arabinulose; D-Riboketose,R01081 R01526 R01577 R01892 R01895 R07134 R07144,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.56; 1.1.1.250; 1.1.1.287; 1.1.2.2; 2.7.1.16; 2.7.1.47; 5.3.1.3; 5.3.1.20,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00309  D-Ribulose,CAS: 488-84-6; PubChem: 3603; ChEBI: 17173; ChEMBL: CHEMBL1341376; KNApSAcK: C00001131; 3DMET: B04662; NIKKAJI: J6.034H,cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382,5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O5,C5H9O5,150.0528234,151.0606485,149.044998472,76,cpd:C00310,D-Xylulose;,C5H10O5,D-Xylulose; D-threo-Pentulose; D-Lyxulose,R01432 R01639 R01896 R01898 R05604 R07143,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.9; 1.1.1.11; 1.1.1.14; 1.1.1.287; 2.7.1.17; 5.3.1.5; 5.3.1.15,Glucuronate pathway (uronate pathway),Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00310  D-Xylulose,CAS: 551-84-8; PubChem: 3604; ChEBI: 17140; KNApSAcK: C00019684; PDB-CCD: XLF; 3DMET: B04663; NIKKAJI: J14.195J,cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382,5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O5,C5H9O5,150.0528234,151.0606485,149.044998473,77,cpd:C00312,L-Xylulose;,C5H10O5,L-Xylulose; L-threo-Pentulose; L-Lyxulose,R01901 R01902 R01903 R01904 R01905 R01906 R05831,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.10; 1.1.1.12; 1.1.1.15; 2.7.1.5; 2.7.1.53; 4.1.1.34; 5.3.1.-,Glucuronate pathway (uronate pathway),Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00312  L-Xylulose,CAS: 527-50-4; PubChem: 3606; ChEBI: 17399; 3DMET: B04665; NIKKAJI: J13.211J,cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382,5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O5,C5H9O5,150.0528234,151.0606485,149.044998474,78,cpd:C00333,D-Galacturonate;,C6H10O7,D-Galacturonate; D-Galacturonic acid,R01980 R01981 R01982 R01983 R01984 R04320 R06201 R07413; R07676 R10565 R10841,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; ABC transporters,1.1.1.203; 1.1.1.365; 1.1.1.-; 2.7.1.44; 3.2.1.15; 3.2.1.67; 5.3.1.12,"Pectin degradation; D-Galacturonate degradation (fungi), D-galacturonate => glycerol; D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P",Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C00333  D-Galacturonic acid,CAS: 685-73-4; PubChem: 3627; ChEBI: 12952 4153; KNApSAcK: C00001120; PDB-CCD: ADA GTR; 3DMET: B04672; NIKKAJI: J82.118G,cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059,6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O7,C6H9O7,194.0426527,195.0504777,193.034827675,79,cpd:C00379,Xylitol,C5H12O5,Xylitol,R01431 R01896 R01904 R02136 R05831 R07152 R09477,Pentose and glucuronate interconversions; Metabolic pathways; ABC transporters,1.1.1.9; 1.1.1.10; 1.1.1.14; 1.1.1.15; 1.1.1.21; 1.1.1.307; 1.1.3.41; 2.7.1.122,Glucuronate pathway (uronate pathway),"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar alcohols;     C00379  Xylitol; Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   32  Nutrients, tonics;    323  Saccharide preparations;     3234  Xylitols;      D00061  Xylitol (JP17/NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00061  [004200] Xylitol;  Sweetening agent;   D00061  [004200] Xylitol;  Flavoring substance;   D00061  [004200] Xylitol;  Tonicity agent;   D00061  [004200] Xylitol;  Diluting agent;   D00061  [004200] Xylitol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00061  Xylitol;   D00061  Xylitol injection; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   964  Saccharide preparations and blood substitutes;    9643  Xylitol and preparations;     C00379  Xylitol",CAS: 87-99-0; PubChem: 3669; ChEBI: 17151; ChEMBL: CHEMBL1865120 CHEMBL96783; PDB-CCD: XYL; 3DMET: B04675; NIKKAJI: J3.905E,cpd:C00379; cpd:C00474; cpd:C00532; cpd:C01569; cpd:C01904; cpd:C13734; cpd:C17942,5,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O5,C5H11O5,152.0684735,153.0762985,151.060648576,80,cpd:C00433,"2,5-Dioxopentanoate;",C5H6O4,"2,5-Dioxopentanoate; 2-Oxoglutarate semialdehyde",R00264 R02278 R02279 R02280 R09186 R09253,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Arginine and proline metabolism; Metabolic pathways,1.2.1.3; 1.2.1.26; 3.5.4.22; 4.2.1.41; 4.2.1.43; 4.2.1.141,NA,NA,PubChem: 3722; ChEBI: 17415; PDB-CCD: DO4; 3DMET: B00112; NIKKAJI: J2.593.782A,cpd:C00337; cpd:C00433; cpd:C00490; cpd:C01732; cpd:C02132; cpd:C02214; cpd:C02226; cpd:C02800; cpd:C02871; cpd:C03306; cpd:C03703; cpd:C10600; cpd:C20756; cpd:C20757,5,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O4,C5H5O4,130.0266087,131.0344337,129.018783677,82,cpd:C00474,Ribitol;,C5H12O5,Ribitol; Adonitol,R01732 R01892 R01895,Pentose and glucuronate interconversions; Riboflavin metabolism; Metabolic pathways,1.1.1.56; 1.1.2.2; 3.5.99.1,NA,NA,CAS: 488-81-3; PubChem: 3757; ChEBI: 15963; ChEMBL: CHEMBL1865120; KNApSAcK: C00001171; PDB-CCD: RB0; 3DMET: B04685; NIKKAJI: J6.033J,cpd:C00379; cpd:C00474; cpd:C00532; cpd:C01569; cpd:C01904; cpd:C13734; cpd:C17942,5,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O5,C5H11O5,152.0684735,153.0762985,151.060648578,83,cpd:C00476,D-Lyxose,C5H10O5,D-Lyxose,R01898,Pentose and glucuronate interconversions,5.3.1.15,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00476  D-Lyxose,CAS: 1114-34-7; PubChem: 3759; ChEBI: 16789 82838; ChEMBL: CHEMBL1159661; PDB-CCD: LDY; 3DMET: B04686; NIKKAJI: J82.119E,cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382,5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O5,C5H9O5,150.0528234,151.0606485,149.044998479,84,cpd:C00502,D-Xylonate,C5H10O6,D-Xylonate,R02427 R02428 R02429,Pentose and glucuronate interconversions,3.1.1.68; 4.2.1.82,NA,NA,CAS: 526-91-0; PubChem: 3785; ChEBI: 48093; 3DMET: B04688; NIKKAJI: J387.172J,cpd:C00502; cpd:C00545; cpd:C00608; cpd:C00675; cpd:C00676; cpd:C00878; cpd:C01685; cpd:C03607; cpd:C05411; cpd:C05412; cpd:C15646,5,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O6,C5H9O6,166.047738,167.0555631,165.03991380,85,cpd:C00508,L-Ribulose;,C5H10O5,L-Ribulose; L-erythro-Pentulose; L-Arabinoketose; L-Arabinulose; L-Riboketose,R01761 R02439 R02441,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.13; 2.7.1.16; 5.3.1.4,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00508  L-Ribulose,CAS: 2042-27-5; PubChem: 3791; ChEBI: 16880; KNApSAcK: C00019634; PDB-CCD: 34V RUU; 3DMET: B04690; NIKKAJI: J14.173I,cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382,5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O5,C5H9O5,150.0528234,151.0606485,149.044998481,86,cpd:C00514,D-Mannonate,C6H12O7,D-Mannonate,R02454 R02455 R02456 R05606,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.57; 1.1.1.131; 4.2.1.8,"D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P",NA,CAS: 642-99-9; PubChem: 3797; ChEBI: 17767 33076; ChEMBL: CHEMBL1231941; PDB-CCD: CS2; 3DMET: B04694; NIKKAJI: J13.218G,cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930,6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O7,C6H11O7,196.0583027,197.0661278,195.050477782,87,cpd:C00532,L-Arabitol;,C5H12O5,L-Arabitol; L-Arabinol; L-Arabinitol; L-Lyxitol,R01758 R01759 R01903 R02441,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.12; 1.1.1.13; 1.1.1.21,NA,NA,CAS: 7643-75-6; PubChem: 3814; ChEBI: 18403; PDB-CCD: SST; 3DMET: B01282; NIKKAJI: J8.955I,cpd:C00379; cpd:C00474; cpd:C00532; cpd:C01569; cpd:C01904; cpd:C13734; cpd:C17942,5,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O5,C5H11O5,152.0684735,153.0762985,151.060648583,88,cpd:C00558,D-Tagaturonate;,C6H10O7,D-Tagaturonate; D-Tagaturonic acid,R01983 R02555,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.58; 5.3.1.12,"D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P",Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C00558  D-Tagaturonic acid,PubChem: 3838; ChEBI: 17886; 3DMET: B04700; NIKKAJI: J1.367.593G,cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059,6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O7,C6H9O7,194.0426527,195.0504777,193.034827684,89,cpd:C00618,3-Dehydro-L-gulonate,C6H10O7,3-Dehydro-L-gulonate,R01905 R02637 R02639 R02640 R07127,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways,1.1.1.45; 1.1.1.130; 2.7.1.53; 4.1.1.34,Glucuronate pathway (uronate pathway),NA,PubChem: 3892; ChEBI: 16142; 3DMET: B01294; NIKKAJI: J2.729.793E,cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059,6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O7,C6H9O7,194.0426527,195.0504777,193.034827685,91,cpd:C00789,CDP-ribitol;,C14H25N3O15P2,CDP-ribitol; CDP-L-ribitol; CDP 5-ester with D-ribitol,R02921 R04083 R06235,Pentose and glucuronate interconversions; Mannose type O-glycan biosynthesis; Metabolic pathways,2.7.7.40; 2.7.8.14,NA,NA,CAS: 3506-17-0; PubChem: 4047; ChEBI: 16022; 3DMET: B04723; NIKKAJI: J2.620.993E,cpd:C00789,14,25,15,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H26O15N3P2,C14H24O15N3P2,537.0760911,538.0839161,536.068266186,92,cpd:C00800,L-Gulonate;,C6H12O7,L-Gulonate; L-Gulonic acid; Gulonate; Gulonic acid,R01481 R02640 R02933 R10848,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways,1.1.1.2; 1.1.1.19; 1.1.1.45; 1.1.1.380; 3.1.1.17; 3.1.1.25,"Glucuronate pathway (uronate pathway); Ascorbate biosynthesis, animals, glucose-1P => ascorbate",NA,CAS: 526-97-6; PubChem: 4058; ChEBI: 13115 16154; PDB-CCD: 2UF; 3DMET: B04727; NIKKAJI: J2.356.740G,cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930,6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O7,C6H11O7,196.0583027,197.0661278,195.050477787,93,cpd:C00817,D-Altronate,C6H12O7,D-Altronate,R01540 R02555,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.58; 4.2.1.7,"D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P",NA,PubChem: 4075; ChEBI: 17360 46644; 3DMET: B01337; NIKKAJI: J2.730.724H,cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930,6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O7,C6H11O7,196.0583027,197.0661278,195.050477788,94,cpd:C00905,D-Fructuronate;,C6H10O7,D-Fructuronate; D-Fructuronic acid,R01482 R02454 R10848,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.57; 1.1.1.380; 5.3.1.12,"D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P",Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C00905  D-Fructuronic acid,PubChem: 4160; ChEBI: 4126; 3DMET: B04749; NIKKAJI: J2.372.985G,cpd:C00191; cpd:C00333; cpd:C00558; cpd:C00618; cpd:C00905; cpd:C01062; cpd:C02024; cpd:C03342; cpd:C06472; cpd:C06473; cpd:C06477; cpd:C08348; cpd:C08350; cpd:C13086; cpd:C15673; cpd:C16245; cpd:C21034; cpd:C21037; cpd:C21047; cpd:C21059,6,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O7,C6H9O7,194.0426527,195.0504777,193.034827689,95,cpd:C01068,D-Ribitol 5-phosphate;,C5H13O8P,D-Ribitol 5-phosphate; Ribitol 5-phosphate; L-Ribitol 1-phosphate,R01524 R01525 R02921,Pentose and glucuronate interconversions; Mannose type O-glycan biosynthesis; Metabolic pathways,1.1.1.137; 2.7.7.40,NA,NA,PubChem: 4307; ChEBI: 16246; 3DMET: B04762; NIKKAJI: J1.612.794I,cpd:C01068; cpd:C02895; cpd:C03509; cpd:C19674,5,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H14O8P1,C5H12O8P1,232.0348044,233.0426294,231.026979390,96,cpd:C01101,L-Ribulose 5-phosphate,C5H11O8P,L-Ribulose 5-phosphate,R02439 R03244 R05850,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways; Microbial metabolism in diverse environments,2.7.1.16; 5.1.3.4; 5.1.3.22; 5.-.-.-,"Ascorbate degradation, ascorbate => D-xylulose-5P",NA,CAS: 2922-69-2; PubChem: 4335; ChEBI: 17666; ChEMBL: CHEMBL1233359; KNApSAcK: C00019543; PDB-CCD: HMS; 3DMET: B01379; NIKKAJI: J974.176C,cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814,5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O8P1,C5H10O8P1,230.0191543,231.0269793,229.011329391,97,cpd:C01508,L-Lyxose,C5H10O5,L-Lyxose,R01906,Pentose and glucuronate interconversions,5.3.1.-,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C01508  L-Lyxose,CAS: 1949-78-6; PubChem: 4676; ChEBI: 28480 62321; 3DMET: B04799; NIKKAJI: J14.174G,cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382,5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O5,C5H9O5,150.0528234,151.0606485,149.044998492,98,cpd:C01904,D-Arabitol;,C5H12O5,D-Arabitol; D-Arabinitol; D-Arabinol; D-Lyxitol,R05604 R07134 R07143 R07144,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.11; 1.1.1.250; 1.1.1.287,NA,NA,CAS: 488-82-4; PubChem: 5013; ChEBI: 18333; KNApSAcK: C00001156; 3DMET: B04821; NIKKAJI: J12.591A,cpd:C00379; cpd:C00474; cpd:C00532; cpd:C01569; cpd:C01904; cpd:C13734; cpd:C17942,5,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O5,C5H11O5,152.0684735,153.0762985,151.060648593,99,cpd:C02266,D-Xylonolactone;,C5H8O5,"D-Xylonolactone; D-Xylono-1,5-lactone",R01429 R01430 R02427,Pentose and glucuronate interconversions,1.1.1.121; 1.1.1.175; 1.1.1.179; 3.1.1.68,NA,NA,PubChem: 5327; ChEBI: 15867; 3DMET: B01553; NIKKAJI: J2.735.715F,cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031,5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O5,C5H7O5,148.0371734,149.0449984,147.029348394,100,cpd:C02273,Digalacturonate;,C12H18O13,Digalacturonate; Digalacturonic acid,R02360 R07413,Pentose and glucuronate interconversions; Metabolic pathways; ABC transporters,3.2.1.15; 3.2.1.67,Pectin degradation,NA,CAS: 5894-59-7; PubChem: 5333; ChEBI: 28737 33809; PDB-CCD: AD0; 3DMET: B04846; NIKKAJI: J506.523B,cpd:C00470; cpd:C02273; cpd:C04354,12,18,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H19O13,C12H17O13,370.0747406,371.0825657,369.066915695,101,cpd:C02426,L-Glyceraldehyde;,C3H6O3,"L-Glyceraldehyde; L-2,3-Dihydroxypropionaldehyde; L-2,3-Dihydroxypropanal; L-Glycerose; L-Aldotriose",R10550 R10563,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.372; 4.1.2.54,"D-Galacturonate degradation (fungi), D-galacturonate => glycerol",Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C02426  L-Glyceraldehyde,CAS: 497-09-6; PubChem: 5454; ChEBI: 27975; PDB-CCD: GXV; 3DMET: B01571; NIKKAJI: J9.120K,cpd:C00184; cpd:C00186; cpd:C00256; cpd:C00577; cpd:C01013; cpd:C01432; cpd:C02154; cpd:C02426; cpd:C03726; cpd:C05823; cpd:C10899; cpd:C12677; cpd:C19286; cpd:C19296,3,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O3,C3H5O3,90.03169405,91.03951908,89.0238690296,103,cpd:C03291,L-Xylulose 5-phosphate,C5H11O8P,L-Xylulose 5-phosphate,R01901 R03244 R07125,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways; Microbial metabolism in diverse environments,2.7.1.53; 4.1.1.85; 5.1.3.22; 5.-.-.-,"Ascorbate degradation, ascorbate => D-xylulose-5P",NA,PubChem: 6148; ChEBI: 16593; 3DMET: B04887; NIKKAJI: J652.281E,cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814,5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O8P1,C5H10O8P1,230.0191543,231.0269793,229.011329397,104,cpd:C03826,2-Dehydro-3-deoxy-D-xylonate;,C5H8O5,"2-Dehydro-3-deoxy-D-xylonate; 2-Dehydro-3-deoxy-D-arabinonate; 2-Dehydro-3-deoxy-D-pentonate; (4S)-4,5-Dihydroxy-2-oxopentanoate",R01782 R02429 R03032 R04375 R09186,Pentose and glucuronate interconversions,1.1.1.-; 4.1.2.28; 4.2.1.5; 4.2.1.82; 4.2.1.141,NA,NA,PubChem: 6569; ChEBI: 1060; NIKKAJI: J1.965.898H,cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031,5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O5,C5H7O5,148.0371734,149.0449984,147.029348398,105,cpd:C04053,5-Dehydro-4-deoxy-D-glucuronate;,C6H8O6,5-Dehydro-4-deoxy-D-glucuronate; 4-Deoxy-L-threo-5-hexosulose uronate,R04382 R04383 R06249 R09831 R10867,Pentose and glucuronate interconversions,3.2.1.179; 3.2.1.180; 4.2.2.6; 5.3.1.17,NA,NA,PubChem: 6754; ChEBI: 17117 17782; PDB-CCD: D54; 3DMET: B04924; NIKKAJI: J2.745.978A,cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364,6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O6,C6H7O6,176.032088,177.039913,175.024262999,106,cpd:C04349,"(4S)-4,6-Dihydroxy-2,5-dioxohexanoate;",C6H8O6,"(4S)-4,6-Dihydroxy-2,5-dioxohexanoate; 3-Deoxy-D-glycero-2,5-hexodiulosonate; 2,5-Diketo-3-deoxy-D-gluconate",R01542 R04383 R11035,Pentose and glucuronate interconversions,1.1.1.125; 1.1.1.127; 1.1.1.389; 5.3.1.17,NA,NA,PubChem: 6998; ChEBI: 15623; 3DMET: B00703; NIKKAJI: J2.369.069A,cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364,6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O6,C6H7O6,176.032088,177.039913,175.0242629100,107,cpd:C04575,"(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate;",C6H8O7,"(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate; 2,3-Diketo-L-gulonate",R02637 R02639 R04515 R04784 R04785,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism,1.1.1.130; 3.1.1.17; 4.1.1.-,NA,NA,PubChem: 7176; ChEBI: 15622; LIPIDMAPS: LMFA01060195; 3DMET: B01760; NIKKAJI: J156.563J,cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095,6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O7,C6H7O7,192.0270026,193.0348276,191.0191776101,108,cpd:C05385,D-Glucuronate 1-phosphate;,C6H11O10P,D-Glucuronate 1-phosphate; 1-Phospho-alpha-D-glucuronate,R01381 R01476,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.7.1.43; 2.7.7.44; 2.7.7.64,Glucuronate pathway (uronate pathway),NA,PubChem: 7759; ChEBI: 16787 28547; 3DMET: B05014; NIKKAJI: J294.575D,cpd:C01218; cpd:C04037; cpd:C05385; cpd:C14899,6,11,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O10P1,C6H10O10P1,274.0089835,275.0168086,273.0011585102,109,cpd:C05411,L-Xylonate;,C5H10O6,L-Xylonate; L-Xylonic acid,R04515,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism,4.1.1.-,NA,NA,PubChem: 7777; ChEBI: 48092; 3DMET: B05019; NIKKAJI: J2.367.490D,cpd:C00502; cpd:C00545; cpd:C00608; cpd:C00675; cpd:C00676; cpd:C00878; cpd:C01685; cpd:C03607; cpd:C05411; cpd:C05412; cpd:C15646,5,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O6,C5H9O6,166.047738,167.0555631,165.039913103,110,cpd:C05412,L-Lyxonate;,C5H10O6,L-Lyxonate; L-Lyxonic acid,R04784,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism,4.1.1.-,NA,NA,PubChem: 7778; ChEBI: 6268; 3DMET: B05020; NIKKAJI: J237.995C,cpd:C00502; cpd:C00545; cpd:C00608; cpd:C00675; cpd:C00676; cpd:C00878; cpd:C01685; cpd:C03607; cpd:C05411; cpd:C05412; cpd:C15646,5,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O6,C5H9O6,166.047738,167.0555631,165.039913104,111,cpd:C06118,4-(4-Deoxy-alpha-D-gluc-4-enuronosyl)-D-galacturonate;,C12H16O12,4-(4-Deoxy-alpha-D-gluc-4-enuronosyl)-D-galacturonate; 4-(4-Deoxy-alpha-D-galact-4-enuronosyl)-D-galacturonate; Unsaturated digalacturonate,R02361 R04382,Pentose and glucuronate interconversions,4.2.2.2; 4.2.2.6; 4.2.2.9,NA,NA,PubChem: 8378; ChEBI: 27450; PDB-CCD: UNF; 3DMET: B01975; NIKKAJI: J2.761.155I,cpd:C03893; cpd:C04733; cpd:C06118,12,16,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H17O12,C12H15O12,352.064176,353.072001,351.0563509105,112,cpd:C06441,L-Xylulose 1-phosphate,C5H11O8P,L-Xylulose 1-phosphate,R01785 R01902,Pentose and glucuronate interconversions,2.7.1.5; 4.1.2.19,NA,NA,PubChem: 8675; ChEBI: 28566; 3DMET: B05194; NIKKAJI: J2.765.415K,cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814,5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O8P1,C5H10O8P1,230.0191543,231.0269793,229.0113293106,113,cpd:C14899,3-Dehydro-L-gulonate 6-phosphate,C6H11O10P,3-Dehydro-L-gulonate 6-phosphate,R07125 R07127 R07677,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways; Microbial metabolism in diverse environments,2.7.1.53; 3.1.1.-; 4.1.1.85,"Ascorbate degradation, ascorbate => D-xylulose-5P",NA,PubChem: 17395897; ChEBI: 49039; NIKKAJI: J2.790.402E,cpd:C01218; cpd:C04037; cpd:C05385; cpd:C14899,6,11,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O10P1,C6H10O10P1,274.0089835,275.0168086,273.0011585107,114,cpd:C15930,L-Galactonate;,C6H12O7,L-Galactonate; L-Galactonic acid,R07676 R07680 R10532 R10565,Pentose and glucuronate interconversions; Ascorbate and aldarate metabolism; Metabolic pathways,1.1.1.365; 1.1.1.-; 3.1.1.-; 4.2.1.146,"D-Galacturonate degradation (fungi), D-galacturonate => glycerol",NA,PubChem: 47205248; ChEBI: 37425; PDB-CCD: 2Q2; NIKKAJI: J351.183I,cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930,6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O7,C6H11O7,196.0583027,197.0661278,195.0504777108,115,cpd:C20680,2-Dehydro-3-deoxy-L-galactonate;,C6H10O6,2-Dehydro-3-deoxy-L-galactonate; 2-Keto-3-deoxy-L-galactonate; L-threo-3-Deoxy-hexulosonate,R10532 R10550 R10900 R11035,Pentose and glucuronate interconversions; Metabolic pathways,1.1.1.389; 4.1.2.54; 4.2.1.146; 5.5.1.25,"D-Galacturonate degradation (fungi), D-galacturonate => glycerol",NA,PubChem: 172232400,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.039913109,116,cpd:C00095,D-Fructose;,C6H12O6,D-Fructose; Levulose; Fruit sugar; D-arabino-Hexulose,R00307 R00760 R00801 R00803 R00806 R00865 R00866 R00867; R00868 R00870 R00872 R00873 R00874 R00875 R00876 R00877; R00878 R00879 R01140 R01823 R02120 R02410 R03232 R03635; R03921 R06034 R06036 R06052 R06066 R06087 R06100 R06101; R06208 R08406 R08407 R08548 R08651 R08676 R10817,Fructose and mannose metabolism; Galactose metabolism; Starch and sucrose metabolism; Metabolic pathways; Microbial metabolism in diverse environments; ABC transporters; Phosphotransferase system (PTS); Taste transduction; Insulin resistance; Carbohydrate digestion and absorption,1.1.1.11; 1.1.1.14; 1.1.1.15; 1.1.1.67; 1.1.1.124; 1.1.1.138; 1.1.2.2; 1.1.99.11; 1.1.99.28; 2.4.1.4; 2.4.1.5; 2.4.1.7; 2.4.1.13; 2.4.1.125; 2.7.1.1; 2.7.1.3; 2.7.1.4; 2.7.1.61; 2.7.1.202; 3.1.3.68; 3.1.3.-; 3.2.1.10; 3.2.1.20; 3.2.1.26; 3.2.1.48; 3.2.1.80; 5.1.3.30; 5.1.3.31; 5.3.1.5; 5.3.1.7,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00095  D-Fructose; Fruit sugar; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   964  Saccharide preparations and blood substitutes;    9642  Fructose and preparations;     C00095  D-Fructose,CAS: 57-48-7; PubChem: 3395; ChEBI: 15824 37721; ChEMBL: CHEMBL604608; KNApSAcK: C00033848; PDB-CCD: FRU; 3DMET: B04631; NIKKAJI: J4.580B,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631110,117,cpd:C00096,GDP-mannose;,C16H25N5O16P2,GDP-mannose; GDP-D-mannose; GDP-alpha-D-mannose,R00880 R00881 R00883 R00885 R00887 R00888 R00889 R00890; R01009 R03768 R03769 R03829 R03924 R04082 R04331 R04502; R05002 R05768 R07257 R07672 R08858 R08947 R09666 R09667; R09733 R09734,Fructose and mannose metabolism; Ascorbate and aldarate metabolism; N-Glycan biosynthesis; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.132; 2.4.1.32; 2.4.1.48; 2.4.1.54; 2.4.1.83; 2.4.1.110; 2.4.1.132; 2.4.1.142; 2.4.1.217; 2.4.1.246; 2.4.1.251; 2.4.1.252; 2.4.1.269; 2.4.1.270; 2.4.1.-; 2.7.7.13; 2.7.7.22; 2.7.8.9; 3.6.1.21; 3.6.1.-; 4.2.1.47; 5.1.3.18,"Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,CAS: 3123-67-9; PubChem: 3396; ChEBI: 15820; KNApSAcK: C00007246; PDB-CCD: GDD; 3DMET: B01158; NIKKAJI: J247.698C,cpd:C00096; cpd:C00394; cpd:C01581; cpd:C02280; cpd:C15925,16,25,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O16N5P2,C16H24O16N5P2,605.0771537,606.0849788,604.0693287111,118,cpd:C00159,D-Mannose;,C6H12O6,D-Mannose; Mannose; Seminose; Carubinose,R00877 R01326 R01327 R01328 R01329 R01330 R01331 R01332; R02630 R05698 R05816 R05982 R05984 R06142 R06149 R06150; R06151 R06207 R06722 R07135 R08405 R08613 R08614 R08717; R08718 R10809 R11398,Fructose and mannose metabolism; Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; ABC transporters; Phosphotransferase system (PTS); Lysosome,1.1.1.255; 1.1.3.40; 2.4.1.339; 2.7.1.1; 2.7.1.7; 2.7.1.61; 2.7.1.191; 3.1.4.49; 3.2.1.22; 3.2.1.24; 3.2.1.25; 3.2.1.77; 3.2.1.78; 3.2.1.113; 3.2.1.114; 3.2.1.137; 3.2.1.163; 5.3.1.7,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00159  D-Mannose,CAS: 3458-28-4 31103-86-3; PubChem: 3459; ChEBI: 4208; ChEMBL: CHEMBL469448 CHEMBL98182; PDB-CCD: BMA MAN; 3DMET: B04642; NIKKAJI: J82.111J,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631112,119,cpd:C00247,L-Sorbose;,C6H12O6,L-Sorbose; L-xylo-Hexulose,R01694 R01695 R01696 R01697 R02925 R04076 R07145 R07346; R09551,Fructose and mannose metabolism,1.1.1.14; 1.1.1.123; 1.1.1.289; 1.1.3.11; 1.1.99.12; 1.1.99.21; 1.1.99.32; 2.7.1.206,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00247  L-Sorbose,CAS: 87-79-6; PubChem: 3546; ChEBI: 48649; PDB-CCD: SOE; 3DMET: B04653; NIKKAJI: J4.280C,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631113,120,cpd:C00275,D-Mannose 6-phosphate,C6H13O9P,D-Mannose 6-phosphate,R00772 R01326 R01327 R01330 R01817 R01818 R01819 R02630; R08405 R09645 R11439,Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Phosphotransferase system (PTS); Lysosome,1.1.1.224; 2.5.1.132; 2.7.1.1; 2.7.1.7; 2.7.1.61; 2.7.1.191; 3.2.1.170; 5.3.1.8; 5.4.2.8,"Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,PubChem: 3572; ChEBI: 17369 48066; ChEMBL: CHEMBL402001; PDB-CCD: M6D M6P; 3DMET: B01204; NIKKAJI: J817.412A,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894114,121,cpd:C00325,GDP-L-fucose;,C16H25N5O15P2,GDP-L-fucose; GDP-beta-L-fucose,R01951 R03519 R04081 R04553 R04646 R05106 R05692 R07060; R10439,Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways,1.1.1.271; 2.4.1.65; 2.4.1.69; 2.4.1.152; 2.4.1.308; 2.7.7.30,NA,NA,PubChem: 3619; ChEBI: 13332 17009; ChEMBL: CHEMBL1229250; PDB-CCD: GFB; 3DMET: B04668; NIKKAJI: J272.491J,cpd:C00325; cpd:C00498; cpd:C02977; cpd:C03117; cpd:C05386; cpd:C06192,16,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O15N5P2,C16H24O15N5P2,589.0822391,590.0900642,588.0744141115,122,cpd:C00392,Mannitol;,C6H14O6,Mannitol; D-Mannitol,R00865 R00868 R00870 R02167 R02704 R05698 R07135,Fructose and mannose metabolism; ABC transporters; Phosphotransferase system (PTS),1.1.1.11; 1.1.1.67; 1.1.1.138; 1.1.1.255; 1.1.2.2; 1.1.3.40; 2.7.1.197; 3.1.3.22,NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar alcohols;     C00392  Mannitol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A06 DRUGS FOR CONSTIPATION;    A06A DRUGS FOR CONSTIPATION;     A06AD Osmotically acting laxatives;      A06AD16 Mannitol;       D00062  Mannitol (USP);  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05B I.V. SOLUTIONS;     B05BC Solutions producing osmotic diuresis;      B05BC01 Mannitol;       D00062  Mannitol (USP);    B05C IRRIGATING SOLUTIONS;     B05CX Other irrigating solutions;      B05CX04 Mannitol;       D00062  Mannitol (USP);  R RESPIRATORY SYSTEM;   R05 COUGH AND COLD PREPARATIONS;    R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;     R05CB Mucolytics;      R05CB16 Mannitol;       D00062  Mannitol (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   21  Cardiovascular agents;    219  Miscellaneous;     2190  Miscellaneous;      D00062  Mannitol (USP); D-Mannitol (JP17); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00062  [009007] D-Mannitol;  Solubilizing agent;   D00062  [009007] D-Mannitol;  Sweetening agent;   D00062  [009007] D-Mannitol;  Base;   D00062  [009007] D-Mannitol;  Flavoring substance;   D00062  [009007] D-Mannitol;  Bonding agent;   D00062  [009007] D-Mannitol;  Suspending agent;   D00062  [009007] D-Mannitol;  Coating agent;   D00062  [009007] D-Mannitol;  Sugarcoated agent;   D00062  [009007] D-Mannitol;  Tonicity agent;   D00062  [009007] D-Mannitol;  Diluting agent;   D00062  [009007] D-Mannitol;  Disintegrant;   D00062  [009007] D-Mannitol;  Solubilization agent;   D00062  [009007] D-Mannitol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00062  D-Mannitol;   D00062  D-Mannitol injection; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00062",CAS: 69-65-8; PubChem: 3682; ChEBI: 16899; ChEMBL: CHEMBL689; KNApSAcK: C00001165; PDB-CCD: MTL; 3DMET: B04676; NIKKAJI: J2.369H,cpd:C00392; cpd:C00794; cpd:C01489; cpd:C01507; cpd:C01697; cpd:C01722; cpd:C06862,6,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O6,C6H13O6,182.0790382,183.0868632,181.0712131116,123,cpd:C00424,(S)-Lactaldehyde;,C3H6O2,(S)-Lactaldehyde; L-Lactaldehyde; L-2-Hydroxypropionaldehyde,R01446 R02257 R02258 R02259 R02260 R02261 R02262 R02263; R10715,Fructose and mannose metabolism; Pyruvate metabolism; Propanoate metabolism; Microbial metabolism in diverse environments,1.1.1.6; 1.1.1.55; 1.1.1.77; 1.1.1.283; 1.2.1.22; 1.2.1.49; 4.1.2.17; 4.1.2.19; 4.1.2.53,NA,NA,CAS: 3913-64-2; PubChem: 3714; ChEBI: 18041; KNApSAcK: C00019649; 3DMET: B01242; NIKKAJI: J2.715D,cpd:C00163; cpd:C00424; cpd:C00937; cpd:C00969; cpd:C01021; cpd:C02634; cpd:C02635; cpd:C02638; cpd:C02718; cpd:C02749; cpd:C02882; cpd:C03148; cpd:C03173; cpd:C04080; cpd:C05235; cpd:C05726; cpd:C05999; cpd:C06682; cpd:C08057; cpd:C10920; cpd:C16632; cpd:C17266; cpd:C17530,3,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O2,C3H5O2,74.03677943,75.04460446,73.0289544117,124,cpd:C00507,L-Rhamnose;,C6H12O5,L-Rhamnose; 6-Deoxy-L-mannose; L-Mannomethylose; L-Rhamnopyranose,R02436 R02437 R02438 R09632 R10098 R10581 R10582 R10788; R10995,Fructose and mannose metabolism; Microbial metabolism in diverse environments,1.1.1.377; 1.1.1.378; 2.4.1.247; 2.4.1.282; 3.2.1.66; 3.2.1.189; 3.2.1.190; 5.3.1.14,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Deoxy sugars;     C00507  L-Rhamnose,CAS: 3615-41-6 73-34-7; PubChem: 3790; ChEBI: 62345 62346; PDB-CCD: RAM RM4; 3DMET: B04689; NIKKAJI: J8.185J,cpd:C00507; cpd:C00586; cpd:C00861; cpd:C01018; cpd:C01019; cpd:C01684; cpd:C01721; cpd:C02095; cpd:C02338; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02781; cpd:C04384; cpd:C07326; cpd:C08258; cpd:C08259; cpd:C08352; cpd:C16538; cpd:C17949; cpd:C20835; cpd:C20836; cpd:C21033; cpd:C21058,6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O5,C6H11O5,164.0684735,165.0762985,163.0606485118,125,cpd:C00636,D-Mannose 1-phosphate;,C6H13O9P,D-Mannose 1-phosphate; alpha-D-Mannose 1-phosphate,R00881 R00883 R00885 R01818 R02677 R09943 R10811 R10829; R11397 R11398 R11429,Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Biosynthesis of enediyne antibiotics; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.4.1.281; 2.4.1.319; 2.4.1.320; 2.4.1.339; 2.4.1.340; 2.7.7.13; 2.7.7.22; 3.6.1.21; 3.6.1.-; 5.4.2.8,"Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,PubChem: 3909; ChEBI: 18205 35374; ChEMBL: CHEMBL291890; KNApSAcK: C00007389; PDB-CCD: M1P; 3DMET: B01296; NIKKAJI: J313.724D,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894119,126,cpd:C00644,D-Mannitol 1-phosphate,C6H15O9P,D-Mannitol 1-phosphate,R00758 R01817 R02167 R02703 R02704,Fructose and mannose metabolism; Phosphotransferase system (PTS),1.1.1.17; 1.1.1.224; 2.7.1.197; 3.1.3.22,NA,NA,CAS: 15806-48-1; PubChem: 3917; ChEBI: 16298; ChEMBL: CHEMBL1161480; KNApSAcK: C00019638; 3DMET: B04709; NIKKAJI: J923.291E,cpd:C00644; cpd:C01096; cpd:C02810; cpd:C06311,6,15,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H16O9P1,C6H14O9P1,262.0453691,263.0531941,261.037544120,127,cpd:C00665,"beta-D-Fructose 2,6-bisphosphate;",C6H14O12P2,"beta-D-Fructose 2,6-bisphosphate; D-Fructose 2,6-bisphosphate",R00763 R02730 R02731 R02732,Fructose and mannose metabolism; AMPK signaling pathway; Glucagon signaling pathway; Central carbon metabolism in cancer,2.7.1.105; 3.1.3.46; 3.1.3.54,NA,NA,PubChem: 3934; ChEBI: 28602; PDB-CCD: FDP; 3DMET: B01302; NIKKAJI: J470.690K,cpd:C00354; cpd:C00665; cpd:C01220; cpd:C01231; cpd:C03693; cpd:C03785; cpd:C04062; cpd:C04063; cpd:C04064; cpd:C05378,6,14,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O12P2,C6H13O12P2,339.9960499,341.0038749,338.9882249121,128,cpd:C00794,D-Sorbitol;,C6H14O6,D-Sorbitol; D-Glucitol; L-Gulitol; Sorbitol,R00874 R00875 R01697 R01787 R02865 R02866 R02867 R02868; R02925 R02926 R05820 R07346,Fructose and mannose metabolism; Galactose metabolism; Metabolic pathways; ABC transporters; Phosphotransferase system (PTS),1.1.1.14; 1.1.1.15; 1.1.1.21; 1.1.1.289; 1.1.99.21; 1.1.99.28; 2.7.1.1; 2.7.1.198; 3.1.3.50; 3.2.1.22,NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar alcohols;     C00794  Sorbitol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A06 DRUGS FOR CONSTIPATION;    A06A DRUGS FOR CONSTIPATION;     A06AD Osmotically acting laxatives;      A06AD18 Sorbitol;       D00096  D-Sorbitol (JP17);     A06AG Enemas;      A06AG07 Sorbitol;       D00096  D-Sorbitol (JP17);  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05C IRRIGATING SOLUTIONS;     B05CX Other irrigating solutions;      B05CX02 Sorbitol;       D00096  D-Sorbitol (JP17);  V VARIOUS;   V04 DIAGNOSTIC AGENTS;    V04C OTHER DIAGNOSTIC AGENTS;     V04CC Tests for bile duct patency;      V04CC01 Sorbitol;       D00096  D-Sorbitol (JP17); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   25  Urogenital and anal organ agents;    251  Urinary organ agents;     2519  Others;      D00096  D-Sorbitol (JP17); Sorbitol (NF);  7  Agents not mainly for therapeutic purpose;   79  Other agents not mainly for therapeutic purpose;    799  Miscellaneous;     7990  Miscellaneous;      D00096  D-Sorbitol (JP17); Sorbitol (NF); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    D-Sorbitol;     D00096  D-Sorbitol (JP17); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Plasticizer;   D00096  [002244] D-Sorbitol;  Sweetening agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Base;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Flavoring substance;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Bonding agent;   D00096  [002244] D-Sorbitol;  Suspending agent;   D00096  [002244] D-Sorbitol;  Coating agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Film;   D00096  [002244] D-Sorbitol;  Wetting agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Tonicity agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Emulsion;   D00096  [002244] D-Sorbitol;  Tenacious agent;   D00096  [002245] D-Sorbitol solution;  Diluting agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution;  Dispersant;   D00096  [002244] D-Sorbitol;  Preserving agent;   D00096  [002244] D-Sorbitol;  Solubilization agent;   D00096  [002244] D-Sorbitol;   D00096  [002245] D-Sorbitol solution; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00096  D-Sorbitol;   D00096  D-Sorbitol solution; Gastrointestinal agents [br08371.html];  Cathartic agent, antidiarrheal agent, intestinal regulator;   D00096",CAS: 50-70-4; PubChem: 4052; ChEBI: 17924; ChEMBL: CHEMBL1682; KNApSAcK: C00001173; PDB-CCD: SOR; 3DMET: B04724; NIKKAJI: J2.299C,cpd:C00392; cpd:C00794; cpd:C01489; cpd:C01507; cpd:C01697; cpd:C01722; cpd:C06862,6,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O6,C6H13O6,182.0790382,183.0868632,181.0712131122,129,cpd:C00861,L-Rhamnulose;,C6H12O5,L-Rhamnulose; 6-Deoxy-L-fructose,R02437 R03014,Fructose and mannose metabolism; Microbial metabolism in diverse environments,2.7.1.5; 5.3.1.14,NA,NA,PubChem: 4118; ChEBI: 17897; KNApSAcK: C00019652; 3DMET: B01346; NIKKAJI: J1.739.241G,cpd:C00507; cpd:C00586; cpd:C00861; cpd:C01018; cpd:C01019; cpd:C01684; cpd:C01721; cpd:C02095; cpd:C02338; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02781; cpd:C04384; cpd:C07326; cpd:C08258; cpd:C08259; cpd:C08352; cpd:C16538; cpd:C17949; cpd:C20835; cpd:C20836; cpd:C21033; cpd:C21058,6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O5,C6H11O5,164.0684735,165.0762985,163.0606485123,130,cpd:C00976,GDP-D-mannuronate;,C16H23N5O17P2,GDP-D-mannuronate; GDP-D-mannuronic acid,R00880 R03129 R08692,Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism,1.1.1.132; 2.4.1.33,NA,NA,PubChem: 4225; ChEBI: 85507; PDB-CCD: GDX; 3DMET: B04752; NIKKAJI: J2.731.034F,cpd:C00976,16,23,17,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H24O17N5P2,C16H22O17N5P2,619.0564183,620.0642433,618.0485933124,131,cpd:C01019,6-Deoxy-L-galactose;,C6H12O5,6-Deoxy-L-galactose; L-Fucose,R03161 R03162 R03163 R04270 R06118 R08926,Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Two-component system; Quorum sensing,1.1.1.122; 2.7.1.52; 3.2.1.51; 3.2.1.63; 5.3.1.3; 5.3.1.25,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Deoxy sugars;     C01019  L-Fucose,CAS: 2438-80-4; PubChem: 4264; ChEBI: 2181; ChEMBL: CHEMBL469449; KNApSAcK: C00035100; PDB-CCD: FUC FUL; 3DMET: B04756; NIKKAJI: J92.797J,cpd:C00507; cpd:C00586; cpd:C00861; cpd:C01018; cpd:C01019; cpd:C01684; cpd:C01721; cpd:C02095; cpd:C02338; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02781; cpd:C04384; cpd:C07326; cpd:C08258; cpd:C08259; cpd:C08352; cpd:C16538; cpd:C17949; cpd:C20835; cpd:C20836; cpd:C21033; cpd:C21058,6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O5,C6H11O5,164.0684735,165.0762985,163.0606485125,132,cpd:C01094,D-Fructose 1-phosphate,C6H13O9P,D-Fructose 1-phosphate,R00866 R02071 R02568 R03232 R08407 R08548 R10050,"Fructose and mannose metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Phosphotransferase system (PTS)",2.2.1.11; 2.7.1.3; 2.7.1.56; 2.7.1.61; 2.7.1.202; 3.1.3.68; 4.1.2.13,NA,NA,CAS: 15978-08-2; PubChem: 4329; ChEBI: 18105 37515; ChEMBL: CHEMBL605021; KNApSAcK: C00019676; PDB-CCD: F1X; 3DMET: B04765; NIKKAJI: J219.923H,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894126,133,cpd:C01096,Sorbitol 6-phosphate;,C6H15O9P,Sorbitol 6-phosphate; D-Sorbitol 6-phosphate; D-Glucitol 6-phosphate,R00834 R02865 R02866 R02867 R02868 R03234 R05607 R05820; R07133,Fructose and mannose metabolism; Phosphotransferase system (PTS),1.1.1.140; 1.1.1.200; 1.1.1.-; 2.7.1.1; 2.7.1.198; 3.1.3.50,NA,NA,CAS: 20479-58-7; PubChem: 4331; ChEBI: 17044; PDB-CCD: S6P; 3DMET: B04766; NIKKAJI: J728.846H,cpd:C00644; cpd:C01096; cpd:C02810; cpd:C06311,6,15,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H16O9P1,C6H14O9P1,262.0453691,263.0531941,261.037544127,134,cpd:C01099,L-Fuculose 1-phosphate,C6H13O8P,L-Fuculose 1-phosphate,R02262 R03241,Fructose and mannose metabolism; Microbial metabolism in diverse environments,2.7.1.51; 4.1.2.17,NA,NA,PubChem: 4333; ChEBI: 16647 6220; KNApSAcK: C00019651; 3DMET: B01377; NIKKAJI: J1.419.302B,cpd:C01099; cpd:C01131; cpd:C02985; cpd:C06369,6,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O8P1,C6H12O8P1,244.0348044,245.0426294,243.0269793128,135,cpd:C01131,L-Rhamnulose 1-phosphate,C6H13O8P,L-Rhamnulose 1-phosphate,R02263 R03014,Fructose and mannose metabolism; Microbial metabolism in diverse environments,2.7.1.5; 4.1.2.19,NA,NA,CAS: 444-09-7; PubChem: 4362; ChEBI: 17892; KNApSAcK: C00019653; 3DMET: B01389; NIKKAJI: J2.731.617D,cpd:C01099; cpd:C01131; cpd:C02985; cpd:C06369,6,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O8P1,C6H12O8P1,244.0348044,245.0426294,243.0269793129,136,cpd:C01222,GDP-4-dehydro-6-deoxy-D-mannose;,C16H23N5O15P2,GDP-4-dehydro-6-deoxy-D-mannose; GDP-4-dehydro-6-deoxy-D-talose; GDP-4-oxo-6-deoxy-D-mannose; GDP-4-dehydro-D-rhamnose; GDP-4-keto-6-deoxy-D-mannose; GDP-4-dehydro-alpha-D-rhamnose; GDP-4-dehydro-6-deoxy-alpha-D-mannose,R00888 R03396 R03397 R03398 R03399 R05692 R07059 R10460; R11409,Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways,1.1.1.135; 1.1.1.187; 1.1.1.271; 1.1.1.281; 2.6.1.102; 4.2.1.47; 4.2.1.168,NA,NA,PubChem: 4444; ChEBI: 16955; KNApSAcK: C00007244; 3DMET: B01413; NIKKAJI: J945.361J,cpd:C01222; cpd:C05344; cpd:C14830,16,23,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H24O15N5P2,C16H22O15N5P2,587.0665891,588.0744141,586.058764130,137,cpd:C01487,D-Allose,C6H12O6,D-Allose,R03576,Fructose and mannose metabolism; Microbial metabolism in diverse environments; ABC transporters,2.7.1.55,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C01487  D-Allose,CAS: 2595-97-3; PubChem: 4657; ChEBI: 4093; ChEMBL: CHEMBL1222152; PDB-CCD: AFD ALL; 3DMET: B04798; NIKKAJI: J14.386C,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631131,138,cpd:C01720,L-Fuconate,C6H12O6,L-Fuconate,R03688 R10689,Fructose and mannose metabolism; Microbial metabolism in diverse environments,3.1.1.-; 4.2.1.68,NA,NA,CAS: 26372-13-4; PubChem: 4857; ChEBI: 17291 21291; PDB-CCD: LFC; NIKKAJI: J1.694.210C,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631132,139,cpd:C01721,L-Fuculose;,C6H12O5,L-Fuculose; 6-Deoxy-L-tagatose,R03163 R03241,Fructose and mannose metabolism; Microbial metabolism in diverse environments,2.7.1.51; 5.3.1.3; 5.3.1.25,NA,NA,PubChem: 4858; ChEBI: 17617; KNApSAcK: C00019650; PDB-CCD: CVU; 3DMET: B01487; NIKKAJI: J37.412A,cpd:C00507; cpd:C00586; cpd:C00861; cpd:C01018; cpd:C01019; cpd:C01684; cpd:C01721; cpd:C02095; cpd:C02338; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02781; cpd:C04384; cpd:C07326; cpd:C08258; cpd:C08259; cpd:C08352; cpd:C16538; cpd:C17949; cpd:C20835; cpd:C20836; cpd:C21033; cpd:C21058,6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O5,C6H11O5,164.0684735,165.0762985,163.0606485133,141,cpd:C01934,L-Rhamnonate;,C6H12O6,L-Rhamnonate; 6-Deoxy-L-mannonic acid,R03772 R03774,Fructose and mannose metabolism; Microbial metabolism in diverse environments,3.1.1.65; 4.2.1.90,NA,NA,CAS: 6422-34-0; PubChem: 5039; ChEBI: 17357 21376; 3DMET: B04824; NIKKAJI: J13.859B,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631134,142,cpd:C02431,L-Rhamnofuranose,C6H12O5,L-Rhamnofuranose,R02438 R03942,Fructose and mannose metabolism; Microbial metabolism in diverse environments,1.1.1.173,NA,NA,PubChem: 5458; ChEBI: 16935; 3DMET: B04851; NIKKAJI: J2.367.210C,cpd:C00507; cpd:C00586; cpd:C00861; cpd:C01018; cpd:C01019; cpd:C01684; cpd:C01721; cpd:C02095; cpd:C02338; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02781; cpd:C04384; cpd:C07326; cpd:C08258; cpd:C08259; cpd:C08352; cpd:C16538; cpd:C17949; cpd:C20835; cpd:C20836; cpd:C21033; cpd:C21058,6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O5,C6H11O5,164.0684735,165.0762985,163.0606485135,144,cpd:C02888,Sorbose 1-phosphate;,C6H13O9P,Sorbose 1-phosphate; L-Sorbose 1P; L-xylo-Hexulose 1-phosphate; L-Sorbose 1-phosphate,R03234 R04076,Fructose and mannose metabolism; Phosphotransferase system (PTS),1.1.1.-; 2.7.1.206,NA,NA,PubChem: 5819; ChEBI: 38342; KNApSAcK: C00019630; 3DMET: B01609; NIKKAJI: J2.743.651J,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894136,145,cpd:C02962,D-Allose 6-phosphate,C6H13O9P,D-Allose 6-phosphate,R03576 R09030,Fructose and mannose metabolism; Microbial metabolism in diverse environments,2.7.1.55; 5.3.1.6,NA,NA,PubChem: 5878; ChEBI: 17942; PDB-CCD: A6P; NIKKAJI: J2.740.279H,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894137,146,cpd:C02977,GDP-6-deoxy-D-talose;,C16H25N5O15P2,GDP-6-deoxy-D-talose; GDP-6-deoxy-alpha-D-talose,R03396 R03398,Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism,1.1.1.135; 1.1.1.187,NA,NA,PubChem: 5888; ChEBI: 16097; ChEMBL: CHEMBL1208550 CHEMBL609921; 3DMET: B04871; NIKKAJI: J1.849.863D,cpd:C00325; cpd:C00498; cpd:C02977; cpd:C03117; cpd:C05386; cpd:C06192,16,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O15N5P2,C16H24O15N5P2,589.0822391,590.0900642,588.0744141138,147,cpd:C02985,L-Fucose 1-phosphate;,C6H13O8P,L-Fucose 1-phosphate; 6-Deoxy-L-galactose 1-phosphate; beta-L-Fucose 1-phosphate,R01951 R03161,Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.7.1.52; 2.7.7.30,NA,NA,PubChem: 5894; ChEBI: 12387 28319; 3DMET: B04872; NIKKAJI: J840.342B,cpd:C01099; cpd:C01131; cpd:C02985; cpd:C06369,6,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O8P1,C6H12O8P1,244.0348044,245.0426294,243.0269793139,148,cpd:C02991,"L-Rhamnono-1,4-lactone;",C6H10O5,"L-Rhamnono-1,4-lactone; L-Rhamno-1,4-lactone",R03772 R03942 R10788 R10995,Fructose and mannose metabolism; Microbial metabolism in diverse environments,1.1.1.173; 1.1.1.377; 1.1.1.378; 3.1.1.65,NA,NA,PubChem: 5900; ChEBI: 17937; 3DMET: B01616; NIKKAJI: J1.153.839H,cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335,6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5,C6H9O5,162.0528234,163.0606485,161.0449984140,149,cpd:C03117,GDP-6-deoxy-D-mannose;,C16H25N5O15P2,GDP-6-deoxy-D-mannose; GDP-D-rhamnose; GDP-6-deoxy-alpha-D-mannose; GDP-alpha-D-rhamnose,R03397 R03399,Fructose and mannose metabolism; Amino sugar and nucleotide sugar metabolism,1.1.1.187; 1.1.1.281,NA,NA,PubChem: 6011; ChEBI: 17661; ChEMBL: CHEMBL609921; PDB-CCD: GDR; 3DMET: B01633; NIKKAJI: J1.485.223I,cpd:C00325; cpd:C00498; cpd:C02977; cpd:C03117; cpd:C05386; cpd:C06192,16,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O15N5P2,C16H24O15N5P2,589.0822391,590.0900642,588.0744141141,150,cpd:C03267,beta-D-Fructose 2-phosphate;,C6H13O9P,beta-D-Fructose 2-phosphate; beta-D-Fructofuranose 2-phosphate,R00872 R02730,Fructose and mannose metabolism,3.1.3.54; 3.1.3.-,NA,NA,PubChem: 6130; ChEBI: 12350; 3DMET: B01644; NIKKAJI: J2.741.446J,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894142,151,cpd:C03827,2-Dehydro-3-deoxy-L-fuconate,C6H10O5,2-Dehydro-3-deoxy-L-fuconate,R03688 R10690,Fructose and mannose metabolism; Microbial metabolism in diverse environments,1.1.1.-; 4.2.1.68,NA,NA,PubChem: 6570; ChEBI: 16950; NIKKAJI: J2.751.180E,cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335,6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5,C6H9O5,162.0528234,163.0606485,161.0449984143,152,cpd:C03979,2-Dehydro-3-deoxy-L-rhamnonate,C6H10O5,2-Dehydro-3-deoxy-L-rhamnonate,R02261 R03774 R11339,Fructose and mannose metabolism; Microbial metabolism in diverse environments,1.1.1.401; 4.1.2.53; 4.2.1.90,NA,NA,PubChem: 6696; ChEBI: 18078; 3DMET: B04919; NIKKAJI: J2.745.065B,cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335,6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5,C6H9O5,162.0528234,163.0606485,161.0449984144,155,cpd:C06192,ADP-mannose;,C16H25N5O15P2,ADP-mannose; APD-D-mannose,R02677,Fructose and mannose metabolism,3.6.1.21,NA,NA,PubChem: 8442; ChEBI: 28845; 3DMET: B01990; NIKKAJI: J811.607E,cpd:C00325; cpd:C00498; cpd:C02977; cpd:C03117; cpd:C05386; cpd:C06192,16,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O15N5P2,C16H24O15N5P2,589.0822391,590.0900642,588.0744141145,156,cpd:C11516,2-(alpha-D-Mannosyl)-3-phosphoglycerate,C9H17O12P,2-(alpha-D-Mannosyl)-3-phosphoglycerate,R05768 R05790,Fructose and mannose metabolism,2.4.1.217; 3.1.3.70,NA,NA,PubChem: 13686; ChEBI: 16351; NIKKAJI: J2.774.854F,cpd:C11516; cpd:C16699; cpd:C19791; cpd:C21383,9,17,12,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H18O12P1,C9H16O12P1,348.045763,349.053588,347.0379379146,157,cpd:C11544,2-O-(alpha-D-Mannosyl)-D-glycerate;,C9H16O9,2-O-(alpha-D-Mannosyl)-D-glycerate; alpha-Mannosylglycerate; 2-O-(alpha-D-Mannopyranosyl)-D-glycerate,R05790 R09666 R11169,Fructose and mannose metabolism; Phosphotransferase system (PTS),2.4.1.269; 2.7.1.195; 3.1.3.70,NA,NA,PubChem: 13711; ChEBI: 15847; PDB-CCD: 2M8; NIKKAJI: J2.662.226C,cpd:C11544; cpd:C19792; cpd:C20934,9,16,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O9,C9H15O9,268.0794321,269.0872571,267.0716071147,158,cpd:C18028,"L-Fucono-1,5-lactone",C6H10O5,"L-Fucono-1,5-lactone",R08926 R10689,Fructose and mannose metabolism; Microbial metabolism in diverse environments,1.1.1.122; 3.1.1.-,NA,NA,PubChem: 96024248; ChEBI: 81457,cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335,6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5,C6H9O5,162.0528234,163.0606485,161.0449984148,159,cpd:C18096,D-Allulose 6-phosphate,C6H13O9P,D-Allulose 6-phosphate,R09030 R09031,Fructose and mannose metabolism; Microbial metabolism in diverse environments,5.1.3.-; 5.3.1.6,NA,NA,PubChem: 96024313; ChEBI: 81499; NIKKAJI: J2.640.215H,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894149,160,cpd:C20781,"2,4-Diketo-3-deoxy-L-fuconate;",C6H8O5,"2,4-Diketo-3-deoxy-L-fuconate; 2,4-Diketo-3-deoxy-L-rhamnonate; 2,4-Didehydro-3-deoxy-L-rhamnonate",R10690 R10691 R11339,Fructose and mannose metabolism; Microbial metabolism in diverse environments,1.1.1.401; 1.1.1.-; 3.7.1.-,NA,NA,PubChem: 254741248,cpd:C00322; cpd:C00846; cpd:C04287; cpd:C04305; cpd:C04361; cpd:C06379; cpd:C06891; cpd:C16159; cpd:C19128; cpd:C20781,6,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O5,C6H7O5,160.0371734,161.0449984,159.0293483150,161,cpd:C00052,UDP-alpha-D-galactose;,C15H24N2O17P2,UDP-alpha-D-galactose; UDP-D-galactose; UDP-galactose; UDP-D-galactopyranose; UDP-alpha-D-galactopyranose,R00291 R00501 R00502 R00503 R00504 R00505 R00506 R00809; R00853 R00854 R00955 R01192 R01205 R01500 R01535 R01928; R01997 R02691 R02791 R03354 R03380 R03486 R03679 R03981; R04016 R04322 R04334 R04431 R04469 R04495 R04531 R04548; R04610 R04631 R04644 R05080 R05107 R05110 R05111 R06808; R09753 R09755 R10240 R10432 R10433 R10436 R10440 R10804; R10865,Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways,1.1.1.-; 2.4.1.22; 2.4.1.23; 2.4.1.37; 2.4.1.38; 2.4.1.44; 2.4.1.46; 2.4.1.47; 2.4.1.50; 2.4.1.62; 2.4.1.74; 2.4.1.86; 2.4.1.87; 2.4.1.90; 2.4.1.96; 2.4.1.122; 2.4.1.123; 2.4.1.137; 2.4.1.156; 2.4.1.167; 2.4.1.179; 2.4.1.205; 2.4.1.228; 2.4.1.234; 2.4.1.241; 2.4.1.272; 2.4.1.274; 2.4.1.275; 2.4.1.294; 2.4.1.303; 2.4.1.304; 2.4.1.309; 2.4.1.-; 2.7.7.10; 2.7.7.12; 2.7.7.64; 2.7.8.6; 2.7.8.18; 5.1.3.2; 5.4.99.9,"Nucleotide sugar biosynthesis, galactose => UDP-galactose; Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P",NA,CAS: 2956-16-3; PubChem: 3354; ChEBI: 18307 67119; ChEMBL: CHEMBL1742482 CHEMBL439009; KNApSAcK: C00007390; PDB-CCD: GDU; 3DMET: B04625; NIKKAJI: J247.696G,cpd:C00029; cpd:C00052; cpd:C03733,15,24,17,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O17N2P2,C15H23O17N2P2,566.0550213,567.0628463,565.0471963151,162,cpd:C00089,Sucrose;,C12H22O11,Sucrose; Cane sugar; Saccharose; 1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside,R00015 R00039 R00801 R00802 R00803 R00805 R00806 R00807; R00808 R00809 R00810 R00811 R01103 R01823 R02120 R02411; R04194 R05140 R07256 R08616 R08676,Galactose metabolism; Starch and sucrose metabolism; Metabolic pathways; ABC transporters; Phosphotransferase system (PTS); Taste transduction; Carbohydrate digestion and absorption,1.1.99.13; 2.4.1.4; 2.4.1.5; 2.4.1.7; 2.4.1.9; 2.4.1.10; 2.4.1.13; 2.4.1.82; 2.4.1.99; 2.4.1.125; 2.4.1.166; 2.4.1.167; 2.7.1.211; 3.1.3.24; 3.2.1.10; 3.2.1.20; 3.2.1.22; 3.2.1.26; 3.2.1.48; 5.4.99.11,NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Oligosaccharides;    Disaccharides;     C00089  Sucrose; Cane sugar; Therapeutic category of drugs in Japan [BR:br08301];  7  Agents not mainly for therapeutic purpose;   71  Dispensing medicines;    714  Flavorings, deodorants, coloring agents;     7149  Others;      D00025  Sucrose (JP17/NF); White soft sugar (JP17); Sugar, compressible (NF); Sugar, confectioner's (NF); Sugar spheres (NF); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    White soft sugar;     D00025  Sucrose (JP17/NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Lubricating agent;   D00025  [500313] White soft sugar;  Sweetening agent;   D00025  [110635] Liquid sugar;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Base;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Flavoring substance;   D00025  [110635] Liquid sugar;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;   D00025  [109287] Powdered sucrose;  Bonding agent;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Brightening agent;   D00025  [001480] Sucrose;  Coating agent;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;   D00025  [109287] Powdered sucrose;  Sugarcoated agent;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Diluting agent;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;   D00025  [109287] Powdered sucrose;  Disintegrant;   D00025  [001480] Sucrose;   D00025  [500313] White soft sugar;  Dampproof agent;   D00025  [001480] Sucrose;  Antiseptic agent;   D00025  [500313] White soft sugar;  Solubilizer;   D00025  [500313] White soft sugar;  Solubilization agent;   D00025  [500313] White soft sugar; Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Metabotropic glutamate receptor family;    Chemoreception;     taste receptor type 1;      Sucrose;       D00025  Sucrose (JP17/NF); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00025  White soft sugar;   D00025  Sucrose",CAS: 57-50-1; PubChem: 3389; ChEBI: 17992; ChEMBL: CHEMBL253582; KNApSAcK: C00001151; PDB-CCD: SUC; 3DMET: B01156; NIKKAJI: J4.581K,cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336,12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O11,C12H21O11,342.1162115,343.1240366,341.1083865152,163,cpd:C00124,D-Galactose;,C6H12O6,D-Galactose; D-Galactopyranose,R01093 R01094 R01095 R01096 R01097 R01098 R01099 R01100; R01101 R01103 R01104 R01105 R01194 R01329 R01678 R02926; R03355 R03617 R03618 R03634 R04019 R04470 R04633 R05112; R05549 R05961 R05994 R06010 R06070 R06091 R06093 R06094; R06096 R06098 R06099 R06114 R06136 R06142 R06152 R06202; R07807 R08544 R10619 R10622 R11171,Galactose metabolism; Metabolic pathways; Bacterial chemotaxis; Phosphotransferase system (PTS); Carbohydrate digestion and absorption; Mineral absorption,1.1.1.21; 1.1.1.48; 1.1.1.120; 1.1.1.121; 1.1.1.359; 1.1.1.360; 1.1.3.9; 2.7.1.204; 3.1.3.94; 3.2.1.22; 3.2.1.23; 3.2.1.46; 3.2.1.47; 3.2.1.62; 3.2.1.108; 5.1.3.3,"Nucleotide sugar biosynthesis, galactose => UDP-galactose; Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P",Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C00124  D-Galactose,CAS: 59-23-4 10257-28-0; PubChem: 3424; ChEBI: 4139; ChEMBL: CHEMBL195923 CHEMBL300520; KNApSAcK: C00019681; PDB-CCD: GAL GLA; 3DMET: B04637; NIKKAJI: J4.597G,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631153,164,cpd:C00137,myo-Inositol;,C6H12O6,myo-Inositol; D-myo-Inositol; 1D-myo-Inositol; L-myo-Inositol; 1L-myo-Inositol; meso-Inositol; Inositol; Dambose; Cyclohexitol; Meat sugar; Bios I,R01183 R01184 R01185 R01186 R01187 R01188 R01189 R01190; R01192 R01193 R01194 R01802 R02411 R03418 R04333 R06042; R06071 R06093 R06214 R07279 R07343,Galactose metabolism; Ascorbate and aldarate metabolism; Streptomycin biosynthesis; Inositol phosphate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; ABC transporters; Phosphatidylinositol signaling system,1.1.1.18; 1.13.99.1; 2.1.1.39; 2.1.1.40; 2.1.1.129; 2.3.1.72; 2.4.1.67; 2.4.1.82; 2.4.1.123; 2.7.1.64; 2.7.8.11; 3.1.3.25; 3.1.4.44; 3.2.1.22,"Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol",Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar alcohols;     C00137  myo-Inositol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA07 Inositol;       D08079  Inositol (NF); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Inositol;     D08079  Inositol (NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D08079  [001062] Inositol;  Diluting agent;   D08079  [001062] Inositol;  Soothing agent;   D08079  [001062] Inositol,CAS: 87-89-8; PubChem: 3437; ChEBI: 17268; ChEMBL: CHEMBL1222251; KNApSAcK: C00001164; PDB-CCD: INS; 3DMET: B00038; NIKKAJI: J4.282J,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631154,165,cpd:C00243,Lactose;,C12H22O11,Lactose; 1-beta-D-Galactopyranosyl-4-D-glucopyranose; beta-D-Gal-(1->4)-D-Glc; Milk sugar,R00503 R01100 R01678 R01680 R04393 R05166,Galactose metabolism; Metabolic pathways; ABC transporters; Phosphotransferase system (PTS); Carbohydrate digestion and absorption,1.1.99.13; 2.4.1.22; 2.7.1.207; 3.2.1.23; 3.2.1.108; 3.2.1.140,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Oligosaccharides;    Disaccharides;     C00243  Lactose; Milk sugar; Pharmaceutical additives [BR:br08316];  Diluting agent;   D00046  [107790] Anhydrous lactose; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00046  Anhydrous lactose,CAS: 63-42-3; PubChem: 3542; ChEBI: 17716; ChEMBL: CHEMBL417016; KNApSAcK: C00001136; PDB-CCD: LAT LBT; 3DMET: B01199; NIKKAJI: J353.435I,cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336,12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O11,C12H21O11,342.1162115,343.1240366,341.1083865155,166,cpd:C00446,alpha-D-Galactose 1-phosphate;,C6H13O9P,alpha-D-Galactose 1-phosphate; alpha-D-Galactopyranose 1-phosphate,R00502 R00955 R01092 R02329 R05326 R06057 R09632 R10622,Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.4.1.211; 2.4.1.247; 2.7.1.6; 2.7.7.10; 2.7.7.12; 2.7.7.32; 2.7.7.64; 3.1.3.94,"Nucleotide sugar biosynthesis, galactose => UDP-galactose; Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P",NA,CAS: 2255-14-3; PubChem: 3734; ChEBI: 17973; ChEMBL: CHEMBL1159526; KNApSAcK: C00007391; PDB-CCD: GL1; 3DMET: B01244; NIKKAJI: J92.787B,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894156,167,cpd:C00492,Raffinose;,C18H32O16,Raffinose; Melitose; Melitriose; Gossypose; 6G-alpha-D-galactosylsucrose,R00039 R01103 R02410 R02411 R03418 R03634 R08616,Galactose metabolism; ABC transporters,2.4.1.67; 2.4.1.82; 2.4.1.166; 3.2.1.22; 3.2.1.26,NA,NA,CAS: 512-69-6; PubChem: 3775; ChEBI: 16634; ChEMBL: CHEMBL175500 CHEMBL603717; KNApSAcK: C00001145; PDB-CCD: RAF; 3DMET: B01266; NIKKAJI: J9.760H,cpd:C00492; cpd:C00713; cpd:C00883; cpd:C01835; cpd:C02160; cpd:C03367; cpd:C03661; cpd:C03848; cpd:C05404; cpd:C06219; cpd:C08239; cpd:C08243; cpd:C08251; cpd:C21454,18,32,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O16,C18H31O16,504.1690349,505.17686,503.1612099157,168,cpd:C00795,D-Tagatose;,C6H12O6,D-Tagatose; lyxo-Hexulose,R02927 R02928 R10818,Galactose metabolism,1.1.1.16; 2.7.1.101; 5.1.3.31,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00795  D-Tagatose,CAS: 87-81-0; PubChem: 4053; ChEBI: 4249; PDB-CCD: T6T; 3DMET: B04725; NIKKAJI: J9.874D,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631158,169,cpd:C00880,D-Galactonate;,C6H12O7,D-Galactonate; D-Galactonic acid,R01098 R03033 R03034 R10604,Galactose metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.1.3.9; 3.1.1.25; 4.2.1.6; 4.2.1.140,"Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,CAS: 576-36-3; PubChem: 4136; ChEBI: 12931 16534; 3DMET: B04742; NIKKAJI: J82.117I,cpd:C00257; cpd:C00514; cpd:C00770; cpd:C00800; cpd:C00817; cpd:C00880; cpd:C03215; cpd:C04475; cpd:C08038; cpd:C15930,6,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O7,C6H11O7,196.0583027,197.0661278,195.0504777159,170,cpd:C00984,alpha-D-Galactose,C6H12O6,alpha-D-Galactose,R01092 R10619,Galactose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.7.1.6; 5.1.3.3,"Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P",Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  V VARIOUS;   V04 DIAGNOSTIC AGENTS;    V04C OTHER DIAGNOSTIC AGENTS;     V04CE Tests for liver functional capacity;      V04CE01 Galactose;       D04291  Galactose (NF); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Galactose;     D04291  Galactose (NF),CAS: 3646-73-9; PubChem: 4231; ChEBI: 28061; ChEMBL: CHEMBL195923; KNApSAcK: C00001119; PDB-CCD: GLA; NIKKAJI: J292.885J,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631160,171,cpd:C01097,D-Tagatose 6-phosphate,C6H13O9P,D-Tagatose 6-phosphate,R02927 R03236 R03237 R03238 R03239 R03240 R05571 R08365,Galactose metabolism; Metabolic pathways,1.1.1.251; 2.7.1.11; 2.7.1.56; 2.7.1.101; 2.7.1.144; 5.3.1.26; 5.3.1.-,NA,NA,PubChem: 4332; ChEBI: 4251; PDB-CCD: TA6; 3DMET: B04767; NIKKAJI: J2.731.241A,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894161,172,cpd:C01113,D-Galactose 6-phosphate;,C6H13O9P,D-Galactose 6-phosphate; 6-Phospho-D-galactose,R03240 R03255 R03256 R06110 R11171,Galactose metabolism; Metabolic pathways; Phosphotransferase system (PTS),2.7.1.204; 3.2.1.85; 5.3.1.26,NA,NA,PubChem: 4345; ChEBI: 17733 4141; ChEMBL: CHEMBL1159525; PDB-CCD: BGP; 3DMET: B04769; NIKKAJI: J2.731.379E,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894162,173,cpd:C01132,N-Acetyl-D-galactosamine;,C8H15NO6,N-Acetyl-D-galactosamine; N-Acetyl-D-chondrosamine; 2-Acetamido-2-deoxy-D-galactose,R03492 R04183 R04184 R04586 R05963 R05966 R06001 R06004; R08366 R08967,Galactose metabolism; Phosphotransferase system (PTS),2.7.1.157; 2.7.1.162; 2.7.1.-; 3.2.1.49; 3.2.1.52,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Amino sugars;     C01132  N-Acetyl-D-galactosamine,CAS: 14215-68-0 1811-31-0; PubChem: 4363; ChEBI: 28037; ChEMBL: CHEMBL39064 CHEMBL469447; PDB-CCD: A2G NGA; 3DMET: B04773; NIKKAJI: J199.634G J382.936G,cpd:C00140; cpd:C00645; cpd:C01132; cpd:C02711; cpd:C03136; cpd:C03878; cpd:C05021; cpd:C20328; cpd:C21036; cpd:C21039; cpd:C21049; cpd:C21052; cpd:C21061,8,15,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O6N1,C8H14O6N1,221.0899372,222.0977622,220.0821122163,174,cpd:C01216,2-Dehydro-3-deoxy-D-galactonate,C6H10O6,2-Dehydro-3-deoxy-D-galactonate,R03033 R03387 R10616,Galactose metabolism; Metabolic pathways; Microbial metabolism in diverse environments,2.7.1.58; 2.7.1.178; 4.1.2.51; 4.1.2.55; 4.2.1.6; 4.2.1.140,"Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate; D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,PubChem: 4438; ChEBI: 17028; 3DMET: B04784; NIKKAJI: J913.056J,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.039913164,175,cpd:C01235,alpha-D-Galactosyl-(1->3)-1D-myo-inositol;,C12H22O11,alpha-D-Galactosyl-(1->3)-1D-myo-inositol; O-alpha-D-Galactosyl-(1->3)-1D-myo-inositol; 3-O-alpha-D-Galactosyl-1D-myo-inositol; 1-alpha-D-Galactosyl-myo-inositol; Galactinol,R01192 R01194 R02411 R03418,Galactose metabolism,2.4.1.67; 2.4.1.82; 2.4.1.123; 3.2.1.22,NA,NA,PubChem: 4456; ChEBI: 17505; 3DMET: B01419; NIKKAJI: J475.283J,cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336,12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O11,C12H21O11,342.1162115,343.1240366,341.1083865165,176,cpd:C01286,2-Dehydro-3-deoxy-6-phospho-D-galactonate;,C6H11O9P,2-Dehydro-3-deoxy-6-phospho-D-galactonate; 2-Dehydro-3-deoxy-D-galactonate 6-phosphate,R01064 R03387,Galactose metabolism; Metabolic pathways,2.7.1.58; 2.7.1.178; 4.1.2.21; 4.1.2.55,"D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P; Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P",NA,PubChem: 4505; ChEBI: 17860; PDB-CCD: KDP; 3DMET: B04789; NIKKAJI: J1.013.608C,cpd:C01236; cpd:C01286; cpd:C04442; cpd:C06893; cpd:C20668,6,11,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O9P1,C6H10O9P1,258.0140689,259.021894,257.0062439166,177,cpd:C01613,Stachyose,C24H42O21,Stachyose,R03418 R03634 R03635,Galactose metabolism,2.4.1.67; 3.2.1.22; 3.2.1.26,NA,NA,CAS: 10094-58-3 470-55-3; PubChem: 4765; ChEBI: 17164; ChEMBL: CHEMBL1625803; KNApSAcK: C00001150; 3DMET: B01470; NIKKAJI: J5.938B,cpd:C00182; cpd:C01613; cpd:C02013; cpd:C02052; cpd:C03989; cpd:C04861; cpd:C08242; cpd:C08248,24,42,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H43O21,C24H41O21,666.2218584,667.2296834,665.2140333167,178,cpd:C01697,Galactitol;,C6H14O6,Galactitol; Dulcitol; Dulcose,R01093 R01095 R02928 R05570,Galactose metabolism; Metabolic pathways; Phosphotransferase system (PTS),1.1.1.16; 1.1.1.21; 2.7.1.200,NA,NA,CAS: 608-66-2; PubChem: 4837; ChEBI: 16813; ChEMBL: CHEMBL1773904; KNApSAcK: C00001160; 3DMET: B04809; NIKKAJI: J7.011D,cpd:C00392; cpd:C00794; cpd:C01489; cpd:C01507; cpd:C01697; cpd:C01722; cpd:C06862,6,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O6,C6H13O6,182.0790382,183.0868632,181.0712131168,179,cpd:C02262,D-Galactosamine;,C6H13NO5,D-Galactosamine; D-Chondrosamine; 2-Amino-2-deoxy-D-galactose,R08367,Galactose metabolism; Phosphotransferase system (PTS),2.7.1.-,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Amino sugars;     C02262  D-Galactosamine,CAS: 7535-00-4; PubChem: 5324; ChEBI: 60312; PDB-CCD: 1GN X6X; 3DMET: B04845; NIKKAJI: J16.141A,cpd:C00329; cpd:C01214; cpd:C02262; cpd:C03570; cpd:C06763; cpd:C08349; cpd:C12212; cpd:C17578; cpd:C21035; cpd:C21038; cpd:C21048; cpd:C21051; cpd:C21060,6,13,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O5N1,C6H12O5N1,179.0793725,180.0871976,178.0715475169,180,cpd:C02669,"D-Galactono-1,5-lactone",C6H10O6,"D-Galactono-1,5-lactone",R01096 R08544 R10604,Galactose metabolism,1.1.1.48; 1.1.1.120; 1.1.1.121; 1.1.1.359; 1.1.1.360,NA,NA,CAS: 15892-28-1; PubChem: 5640; ChEBI: 15945; PDB-CCD: 149; NIKKAJI: J426.673K,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.039913170,181,cpd:C03383,"D-Galactono-1,4-lactone;",C6H10O6,"D-Galactono-1,4-lactone; gamma-D-Galactonolactone",R01094 R01097 R03034,Galactose metabolism; Metabolic pathways,1.1.1.48; 1.1.1.120; 3.1.1.25,NA,NA,CAS: 2782-07-2; PubChem: 6218; ChEBI: 15895; ChEMBL: CHEMBL466882; 3DMET: B01654; NIKKAJI: J208.533J,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.039913171,182,cpd:C03733,UDP-alpha-D-galactofuranose;,C15H24N2O17P2,"UDP-alpha-D-galactofuranose; UDP-alpha-D-galacto-1,4-furanose; UDP-D-galacto-1,4-furanose",R00505,Galactose metabolism; Amino sugar and nucleotide sugar metabolism,5.4.99.9,NA,NA,PubChem: 6496; ChEBI: 67118; NIKKAJI: J794.314H,cpd:C00029; cpd:C00052; cpd:C03733,15,24,17,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O17N2P2,C15H23O17N2P2,566.0550213,567.0628463,565.0471963172,183,cpd:C03785,"D-Tagatose 1,6-bisphosphate",C6H14O12P2,"D-Tagatose 1,6-bisphosphate",R01069 R03236 R03237 R03238 R03239,Galactose metabolism; Metabolic pathways,2.7.1.11; 2.7.1.56; 2.7.1.144; 4.1.2.40,NA,NA,PubChem: 6535; ChEBI: 4250; 3DMET: B04913; NIKKAJI: J2.748.254F,cpd:C00354; cpd:C00665; cpd:C01220; cpd:C01231; cpd:C03693; cpd:C03785; cpd:C04062; cpd:C04063; cpd:C04064; cpd:C05378,6,14,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O12P2,C6H13O12P2,339.9960499,341.0038749,338.9882249173,184,cpd:C05396,Lactose 6'-phosphate,C12H23O14P,Lactose 6'-phosphate,R03256 R04393,Galactose metabolism; Metabolic pathways; Phosphotransferase system (PTS),2.7.1.207; 3.2.1.23; 3.2.1.85,NA,NA,PubChem: 7765; ChEBI: 28339; 3DMET: B05015; NIKKAJI: J2.755.851H,cpd:C00689; cpd:C02591; cpd:C02995; cpd:C04534; cpd:C05396; cpd:C16687; cpd:C16688; cpd:C18050; cpd:C20237,12,23,14,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O14P1,C12H22O14P1,422.0825424,423.0903674,421.0747174174,185,cpd:C05399,Melibiitol;,C12H24O11,Melibiitol; 6-O-alpha-D-Galactosyl-D-glucitol,R02926,Galactose metabolism,3.2.1.22,NA,NA,PubChem: 7766; ChEBI: 27527; 3DMET: B01853; NIKKAJI: J15.208K,cpd:C05399; cpd:C08254; cpd:C13542,12,24,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H25O11,C12H23O11,344.1318616,345.1396866,343.1240366175,186,cpd:C05400,Epimelibiose;,C12H22O11,Epimelibiose; 6-O-(alpha-D-Galactopyranosyl)-D-mannopyranose,R01329,Galactose metabolism,3.2.1.22,NA,NA,CAS: 17296-19-4; PubChem: 7767; ChEBI: 4808; 3DMET: B01854; NIKKAJI: J92.817H,cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336,12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O11,C12H21O11,342.1162115,343.1240366,341.1083865176,187,cpd:C05401,3-beta-D-Galactosyl-sn-glycerol;,C9H18O8,3-beta-D-Galactosyl-sn-glycerol; Galactosylglycerol,R01104 R03467 R03616 R04471,Galactose metabolism; Glycerolipid metabolism,3.1.1.26; 3.2.1.22; 3.2.1.-,NA,NA,PubChem: 7768; ChEBI: 15754; ChEMBL: CHEMBL446492; PDB-CCD: RGG; 3DMET: B05016; NIKKAJI: J362.297E,cpd:C03492; cpd:C05401; cpd:C11546; cpd:C18910,9,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H19O8,C9H17O8,254.1001675,255.1079926,253.0923425177,188,cpd:C05402,Melibiose;,C12H22O11,Melibiose; 6-O-(alpha-D-Galactopyranosyl)-D-glucopyranose; D-Gal-alpha1->6D-Glucose,R01101 R02410 R05549,Galactose metabolism; ABC transporters,3.2.1.22; 3.2.1.26,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Oligosaccharides;    Disaccharides;     C05402  Melibiose,CAS: 585-99-9; PubChem: 7769; ChEBI: 28053; ChEMBL: CHEMBL1159652 CHEMBL136400 CHEMBL417686; KNApSAcK: C00001142; PDB-CCD: MLB; 3DMET: B05017; NIKKAJI: J6.735K,cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336,12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O11,C12H21O11,342.1162115,343.1240366,341.1083865178,189,cpd:C05404,D-Gal alpha 1->6D-Gal alpha 1->6D-Glucose;,C18H32O16,D-Gal alpha 1->6D-Gal alpha 1->6D-Glucose; D-Gal-alpha1->6D-Gal-alpha1->6D-Glucose; Manninotriose,R03635 R05549,Galactose metabolism,3.2.1.22; 3.2.1.26,NA,NA,CAS: 13382-86-0; PubChem: 7771; ChEBI: 27387 31005; 3DMET: B05018; NIKKAJI: J396.387J,cpd:C00492; cpd:C00713; cpd:C00883; cpd:C01835; cpd:C02160; cpd:C03367; cpd:C03661; cpd:C03848; cpd:C05404; cpd:C06219; cpd:C08239; cpd:C08243; cpd:C08251; cpd:C21454,18,32,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O16,C18H31O16,504.1690349,505.17686,503.1612099179,191,cpd:C06311,Galactitol 1-phosphate;,C6H15O9P,Galactitol 1-phosphate; L-Galactitol 1-phosphate; D-Galactitol 6-phosphate,R05147 R05570 R05571,Galactose metabolism; Metabolic pathways; Phosphotransferase system (PTS),1.1.1.251; 2.7.1.200,NA,NA,PubChem: 8547; ChEBI: 28663; 3DMET: B02007; NIKKAJI: J439.912I,cpd:C00644; cpd:C01096; cpd:C02810; cpd:C06311,6,15,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H16O9P1,C6H14O9P1,262.0453691,263.0531941,261.037544180,192,cpd:C06376,N-Acetyl-D-galactosamine 6-phosphate,C8H16NO9P,N-Acetyl-D-galactosamine 6-phosphate,R05168 R08366,Galactose metabolism; Phosphotransferase system (PTS),2.7.1.-; 3.5.1.25,NA,NA,PubChem: 8612; ChEBI: 18207; 3DMET: B05186; NIKKAJI: J2.761.994K,cpd:C00357; cpd:C04256; cpd:C04257; cpd:C04501; cpd:C06376; cpd:C18055; cpd:C18060,8,16,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O9N1P1,C8H15O9N1P1,301.0562681,302.0640931,300.0484431181,193,cpd:C06377,D-Galactosamine 6-phosphate,C6H14NO8P,D-Galactosamine 6-phosphate,R05168 R08365 R08367,Galactose metabolism; Phosphotransferase system (PTS),2.7.1.-; 3.5.1.25; 5.3.1.-,NA,NA,PubChem: 8613; ChEBI: 18232; 3DMET: B05187; NIKKAJI: J2.381.964C,cpd:C00352; cpd:C01283; cpd:C03783; cpd:C06156; cpd:C06377; cpd:C12213; cpd:C12214,6,14,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O8N1P1,C6H13O8N1P1,259.0457034,260.0535284,258.0378784182,194,cpd:C00072,Ascorbate;,C6H8O6,Ascorbate; Ascorbic acid; L-Ascorbate; L-Ascorbic acid; Vitamin C,R00068 R00095 R00640 R00643 R00644 R00645 R00646 R00647; R01108 R02535 R03147 R03186 R03912 R07178 R07179 R07214; R07671 R07679 R08358 R09540 R09739 R10053 R10055,Ascorbate and aldarate metabolism; Glutathione metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Phosphotransferase system (PTS); HIF-1 signaling pathway; Vitamin digestion and absorption,1.1.3.8; 1.3.2.3; 1.3.3.12; 1.6.5.4; 1.8.5.1; 1.10.2.1; 1.10.3.3; 1.11.1.11; 1.14.17.1; 1.14.17.3; 1.14.17.4; 1.14.-.-; 1.16.5.1; 1.23.5.1; 2.7.1.194,"Ascorbate biosynthesis, plants, glucose-6P => ascorbate; Ascorbate biosynthesis, animals, glucose-1P => ascorbate; Ascorbate degradation, ascorbate => D-xylulose-5P","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Water-soluble vitamins;     C00072  Ascorbic acid (Vitamin C); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS;     A11GA Ascorbic acid (vitamin C), plain;      A11GA01 Ascorbic acid (vit C);       D00018  Ascorbic acid (JP17/USP/INN);  G GENITO URINARY SYSTEM AND SEX HORMONES;   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;    G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;     G01AD Organic acids;      G01AD03 Ascorbic acid;       D00018  Ascorbic acid (JP17/USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01X OTHER OPHTHALMOLOGICALS;     S01XA Other ophthalmologicals;      S01XA15 Ascorbic acid;       D00018  Ascorbic acid (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    314  Vitamin C preparations;     3140  Vitamin C preparations;      D00018  Ascorbic acid (JP17/USP/INN); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   38 Vitamin C based drugs;    D00018  Ascorbic acid (JP17/USP/INN);   41 Vitamin EC based drugs;    D00018  Ascorbic acid (JP17/USP/INN);   43 Vitamin containing supplements;    D00018  Ascorbic acid (JP17/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Ascorbic acid;     D00018  Ascorbic acid (JP17/USP/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00018  [001008] Ascorbic acid;  Buffering agent;   D00018  [001008] Ascorbic acid;  Flavoring substance;   D00018  [001008] Ascorbic acid;  Antioxidant agent;   D00018  [001008] Ascorbic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00018  Ascorbic acid;   D00018  Ascorbic acid powder;   D00018  Ascorbic acid injection; Major components of natural products [BR:br08323];  Medicinal herbs;   Cranberry;    C00072  Ascorbate;   Rose hip;    C00072  Ascorbate; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   962  Vitamin preparations;    9624  Vitamin C and preparations;     C00072  Ascorbate",CAS: 50-81-7; PubChem: 3372; ChEBI: 29073 38290; ChEMBL: CHEMBL196; KNApSAcK: C00001179; PDB-CCD: ASC; 3DMET: B01147; NIKKAJI: J2.301I,cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364,6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O6,C6H7O6,176.032088,177.039913,175.0242629183,195,cpd:C00545,L-Arabinonate,C5H10O6,L-Arabinonate,R02522 R02526,Ascorbate and aldarate metabolism; Metabolic pathways,3.1.1.15; 4.2.1.25,NA,NA,CAS: 608-53-7; PubChem: 3826; ChEBI: 16501 33510; 3DMET: B04698; NIKKAJI: J7.010F,cpd:C00502; cpd:C00545; cpd:C00608; cpd:C00675; cpd:C00676; cpd:C00878; cpd:C01685; cpd:C03607; cpd:C05411; cpd:C05412; cpd:C15646,5,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O6,C5H9O6,166.047738,167.0555631,165.039913184,196,cpd:C00679,5-Dehydro-4-deoxy-D-glucarate;,C6H8O7,"5-Dehydro-4-deoxy-D-glucarate; (2R,3S)-2,3-Dihydroxy-5-oxohexanedioate",R02279 R02752 R02754 R05608 R10847 R11075 R11083,Ascorbate and aldarate metabolism; Metabolic pathways,4.1.2.20; 4.2.1.40; 4.2.1.41; 4.2.1.42; 4.2.1.156; 5.5.1.27,NA,NA,PubChem: 3948; ChEBI: 16369 42819; PDB-CCD: GLR; 3DMET: B01308; NIKKAJI: J913.057H,cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095,6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O7,C6H7O7,192.0270026,193.0348276,191.0191776185,197,cpd:C00684,2-Dehydro-3-deoxy-L-arabinonate;,C5H8O5,2-Dehydro-3-deoxy-L-arabinonate; 2-Dehydro-3-deoxy-L-pentonate,R01784 R02278 R02522,Ascorbate and aldarate metabolism; Metabolic pathways,4.1.2.18; 4.2.1.25; 4.2.1.43,NA,NA,PubChem: 3953; ChEBI: 17647; 3DMET: B01310; NIKKAJI: J1.965.899F,cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031,5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O5,C5H7O5,148.0371734,149.0449984,147.0293483186,198,cpd:C00818,D-Glucarate;,C6H10O8,D-Glucarate; D-Glucaric acid; L-Gularic acid; D-Saccharic acid; D-Glucosaccharic acid; Glucaric acid; Glucarate,R02752 R02899 R02957 R02998 R08056 R09447,Ascorbate and aldarate metabolism; Metabolic pathways,1.2.1.3; 2.3.1.98; 2.3.1.131; 4.2.1.40,NA,NA,CAS: 87-73-0; PubChem: 4076; ChEBI: 16002 30612; LIPIDMAPS: LMFA01170108; KNApSAcK: C00034205; PDB-CCD: GKR; 3DMET: B04731; NIKKAJI: J9.318A,cpd:C00818; cpd:C00879; cpd:C21064; cpd:C21088; cpd:C21180,6,10,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O8,C6H9O8,210.0375673,211.0453923,209.0297422187,199,cpd:C00879,D-Galactarate;,C6H10O8,D-Galactarate; D-Mucic acid; D-Galactaric acid; Galactaric acid; Galactarate; Mucic acid,R01981 R03727 R05608 R11077,Ascorbate and aldarate metabolism,2.3.1.130; 4.2.1.42; 4.2.1.158,NA,NA,CAS: 526-99-8; PubChem: 4135; ChEBI: 30852; LIPIDMAPS: LMFA01170107; PDB-CCD: GAE; 3DMET: B04741; NIKKAJI: J6.665F,cpd:C00818; cpd:C00879; cpd:C21064; cpd:C21088; cpd:C21180,6,10,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O8,C6H9O8,210.0375673,211.0453923,209.0297422188,200,cpd:C01040,"L-Gulono-1,4-lactone;",C6H10O6,"L-Gulono-1,4-lactone; L-Gulono-gamma-lactone; gamma-Gulonolactone; L-Gulonic acid gamma-lactone; L-Gulonolactone",R02933 R03183 R03184 R10053,Ascorbate and aldarate metabolism; Metabolic pathways,1.1.1.20; 1.1.3.8; 3.1.1.17; 3.1.1.25,"Ascorbate biosynthesis, animals, glucose-1P => ascorbate",NA,CAS: 1128-23-0; PubChem: 4282; ChEBI: 17587; ChEMBL: CHEMBL509311; 3DMET: B01369; NIKKAJI: J208.558E,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.039913189,201,cpd:C01041,Monodehydroascorbate;,C6H7O6,Monodehydroascorbate; Monodehydroascorbate radical; Ascorbate radical; Semidehydroascorbic acid,R00095 R00645 R03147 R03185 R03186 R09540 R09739,Ascorbate and aldarate metabolism; Metabolic pathways,1.6.5.4; 1.10.2.1; 1.11.1.11; 1.14.-.-; 1.16.5.1,NA,NA,PubChem: 4283; ChEBI: 16504,cpd:C01041; cpd:C04662; cpd:C04810; cpd:C20954,6,7,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O6,C6H6O6,175.0242629,176.032088,174.0164379190,202,cpd:C01114,"L-Arabinono-1,4-lactone;",C5H8O5,"L-Arabinono-1,4-lactone; L-Arabonolactone",R01757 R02526 R10787,Ascorbate and aldarate metabolism; Metabolic pathways,1.1.1.46; 1.1.1.376; 3.1.1.15,NA,NA,CAS: 51532-86-6; PubChem: 4346; ChEBI: 17100; 3DMET: B01385; NIKKAJI: J1.782.210A,cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031,5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O5,C5H7O5,148.0371734,149.0449984,147.0293483191,203,cpd:C01115,"L-Galactono-1,4-lactone",C6H10O6,"L-Galactono-1,4-lactone",R00640 R00643 R03257 R07675 R07680,Ascorbate and aldarate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.122; 1.1.1.316; 1.3.2.3; 1.3.3.12; 3.1.1.-,"Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,CAS: 1668-08-2; PubChem: 4347; ChEBI: 17464; KNApSAcK: C00007388; 3DMET: B04770; NIKKAJI: J630.331E,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.039913192,204,cpd:C01146,2-Hydroxy-3-oxopropanoate;,C3H4O4,2-Hydroxy-3-oxopropanoate; Tartronate semialdehyde,R00013 R01394 R01745 R01747 R02754 R03127 R03277,Ascorbate and aldarate metabolism; Glyoxylate and dicarboxylate metabolism; Metabolic pathways,1.1.1.60; 4.1.1.47; 4.1.1.54; 4.1.2.20; 5.3.1.22,NA,NA,CAS: 2480-77-5; PubChem: 4376; ChEBI: 16992; 3DMET: B04777; NIKKAJI: J1.397.673B,cpd:C00168; cpd:C00383; cpd:C00802; cpd:C01146,3,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O4,C3H3O4,104.0109586,105.0187836,103.0031336193,205,cpd:C01620,Threonate;,C4H8O5,"Threonate; L-Threonate; (2R,3S)-2,3,4-Trihydroxybutanoic acid",R00646 R03733,Ascorbate and aldarate metabolism,1.1.1.129,NA,NA,CAS: 7306-96-9; PubChem: 4772; ChEBI: 15908 49060; LipidBank: DFA0363; PDB-CCD: LTH; 3DMET: B04806; NIKKAJI: J660.315G,cpd:C01620,4,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O5,C4H7O5,136.0371734,137.0449984,135.0293483194,206,cpd:C01825,L-Galactose,C6H12O6,L-Galactose,R07674 R07675,Ascorbate and aldarate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.122; 1.1.1.316; 3.1.3.93,"Ascorbate biosynthesis, plants, glucose-6P => ascorbate",Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C01825  L-Galactose,CAS: 15572-79-9; PubChem: 4948; ChEBI: 42905; PDB-CCD: GIV GXL; 3DMET: B01504; NIKKAJI: J92.789I,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631195,207,cpd:C02280,GDP-L-galactose,C16H25N5O16P2,GDP-L-galactose,R00889 R07673 R07678,Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.7.7.69; 5.1.3.18; 5.1.3.-,"Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,PubChem: 5337; ChEBI: 18038 42660; KNApSAcK: C00007455; PDB-CCD: GDC; 3DMET: B01556; NIKKAJI: J969.615F,cpd:C00096; cpd:C00394; cpd:C01581; cpd:C02280; cpd:C15925,16,25,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O16N5P2,C16H24O16N5P2,605.0771537,606.0849788,604.0693287196,208,cpd:C02670,D-Glucuronolactone;,C6H8O6,"D-Glucuronolactone; Glucurone; D-Glucurono-3,6-lactone; D-Glucurone",R01483 R02957 R03183,Ascorbate and aldarate metabolism; Metabolic pathways,1.1.1.20; 1.2.1.3; 3.1.1.19,NA,Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Glucuronolactone;     D01800  Glucuronolactone (JAN),CAS: 32449-92-6; PubChem: 5641; ChEBI: 18268; 3DMET: B04859; NIKKAJI: J3.805I,cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364,6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O6,C6H7O6,176.032088,177.039913,175.0242629197,209,cpd:C03064,3-Dehydro-L-threonate,C4H6O5,3-Dehydro-L-threonate,R03733,Ascorbate and aldarate metabolism,1.1.1.129,NA,NA,PubChem: 5964; ChEBI: 16943; 3DMET: B01627; NIKKAJI: J2.740.512F,cpd:C00149; cpd:C00497; cpd:C00711; cpd:C03064; cpd:C14873,4,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O5,C4H5O5,134.0215233,135.0293483,133.0136983198,210,cpd:C03289,L-xylo-Hexulonolactone;,C6H8O6,"L-xylo-Hexulonolactone; L-xylo-Hex-2-ulono-1,4-lactone",R00647 R03184,Ascorbate and aldarate metabolism; Metabolic pathways,1.1.3.8,"Ascorbate biosynthesis, animals, glucose-1P => ascorbate",NA,PubChem: 6146; ChEBI: 73681; 3DMET: B01647; NIKKAJI: J2.741.521K,cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364,6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O6,C6H7O6,176.032088,177.039913,175.0242629199,211,cpd:C03921,2-Dehydro-3-deoxy-D-glucarate,C6H8O7,2-Dehydro-3-deoxy-D-glucarate,R03277 R08056,Ascorbate and aldarate metabolism,4.1.2.20; 4.2.1.40,NA,NA,PubChem: 6650; ChEBI: 17305; 3DMET: B01700; NIKKAJI: J790.293J,cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095,6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O7,C6H7O7,192.0270026,193.0348276,191.0191776200,212,cpd:C05422,Dehydroascorbate;,C6H6O6,Dehydroascorbate; Dehydroascorbic acid; L-Dehydroascorbate; L-Dehydroascorbic acid,R00068 R00644 R01108 R02535 R03185 R03186 R03912 R04785; R07178 R07179 R07214 R07679 R08358 R10055,Ascorbate and aldarate metabolism; Glutathione metabolism; Metabolic pathways,1.3.2.3; 1.8.5.1; 1.10.3.3; 1.11.1.11; 1.14.17.1; 1.14.17.3; 1.14.17.4; 1.23.5.1; 3.1.1.17,NA,NA,CAS: 490-83-5; PubChem: 7786; ChEBI: 27956; KNApSAcK: C00007380; 3DMET: B01855; NIKKAJI: J12.580F,cpd:C00417; cpd:C02341; cpd:C03360; cpd:C05422,6,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O6,C6H5O6,174.0164379,175.0242629,173.0086129201,213,cpd:C15923,L-Gulose,C6H12O6,L-Gulose,NA,Ascorbate and aldarate metabolism,NA,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Aldoses;     C15923  L-Gulose,CAS: 6027-89-0; PubChem: 47205241; ChEBI: 37704; ChEMBL: CHEMBL103010; PDB-CCD: GUP; NIKKAJI: J227.238E,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.0555631202,214,cpd:C15924,L-Gulose 1-phosphate,C6H13O9P,L-Gulose 1-phosphate,NA,Ascorbate and aldarate metabolism,NA,NA,NA,PubChem: 47205242; ChEBI: 80181; NIKKAJI: J2.796.906B,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894203,215,cpd:C15925,GDP-L-gulose,C16H25N5O16P2,GDP-L-gulose,R07672 R07673,Ascorbate and aldarate metabolism; Amino sugar and nucleotide sugar metabolism,5.1.3.18; 5.1.3.-,NA,NA,PubChem: 47205243; ChEBI: 80182; PDB-CCD: GKE; NIKKAJI: J2.221.020C,cpd:C00096; cpd:C00394; cpd:C01581; cpd:C02280; cpd:C15925,16,25,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O16N5P2,C16H24O16N5P2,605.0771537,606.0849788,604.0693287204,216,cpd:C15926,beta-L-Galactose 1-phosphate;,C6H13O9P,beta-L-Galactose 1-phosphate; L-Galactose 1-phosphate,R07674 R07678,Ascorbate and aldarate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.7.7.69; 3.1.3.93,"Ascorbate biosynthesis, plants, glucose-6P => ascorbate",NA,PubChem: 47205244; ChEBI: 53072; NIKKAJI: J2.796.938K,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.021894205,217,cpd:C16186,L-Ascorbate 6-phosphate,C6H9O9P,L-Ascorbate 6-phosphate,R07671 R07677,Ascorbate and aldarate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Phosphotransferase system (PTS),2.7.1.194; 3.1.1.-,"Ascorbate degradation, ascorbate => D-xylulose-5P",NA,PubChem: 47205494; ChEBI: 80368; NIKKAJI: J1.517.171E,cpd:C16186; cpd:C18341,6,9,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O9P1,C6H8O9P1,255.9984189,257.0062439,254.9905938206,218,cpd:C20889,"D-Galactaro-1,5-lactone",C6H8O7,"D-Galactaro-1,5-lactone",R10841 R10846,Ascorbate and aldarate metabolism,1.1.1.203; 5.4.1.4,NA,NA,PubChem: 254741352; PDB-CCD: 15L,cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095,6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O7,C6H7O7,192.0270026,193.0348276,191.0191776207,219,cpd:C20896,"D-Galactaro-1,4-lactone",C6H8O7,"D-Galactaro-1,4-lactone",R10846 R10847,Ascorbate and aldarate metabolism,5.4.1.4; 5.5.1.27,NA,NA,PubChem: 254741359; ChEBI: 85532,cpd:C00158; cpd:C00311; cpd:C00451; cpd:C00679; cpd:C02579; cpd:C02780; cpd:C03600; cpd:C03921; cpd:C04575; cpd:C04617; cpd:C08161; cpd:C12649; cpd:C13494; cpd:C13660; cpd:C20889; cpd:C20890; cpd:C20896; cpd:C21091; cpd:C21095,6,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O7,C6H7O7,192.0270026,193.0348276,191.0191776208,220,cpd:C00083,Malonyl-CoA;,C24H38N7O19P3S,Malonyl-CoA; Malonyl coenzyme A,R00233 R00353 R00740 R00742 R00743 R00744 R00989 R01613; R01614 R01626 R02224 R02447 R02482 R02505 R04050 R04356; R04386 R04618 R04709 R05188 R05190 R05331 R06448 R06453; R06458 R06459 R06480 R06481 R06482 R06483 R06510 R06568; R06625 R06635 R06637 R06641 R06643 R06644 R06645 R06796; R06797 R06799 R06800 R06801 R06817 R06821 R07250 R07251; R07253 R07255 R07719 R07721 R07731 R07741 R07754 R07757; R07758 R07884 R07885 R07886 R07910 R07938 R07987 R07988; R07989 R08796 R08797 R08805 R08806 R09090 R09195 R09258; R09419 R09527 R09621 R10171 R10173 R10233 R10234 R10238; R10239 R10485 R10590 R10825 R10960 R10965 R10967 R11124; R11125 R11412 R11435 R11445 R11516,"Fatty acid biosynthesis; Fatty acid elongation; Tetracycline biosynthesis; Aflatoxin biosynthesis; Carbapenem biosynthesis; Phenylalanine metabolism; beta-Alanine metabolism; Biosynthesis of 12-, 14- and 16-membered macrolides; Pyruvate metabolism; Propanoate metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of vancomycin group antibiotics; Biosynthesis of type II polyketide backbone; Biosynthesis of enediyne antibiotics; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism; AMPK signaling pathway; Adipocytokine signaling pathway; Glucagon signaling pathway; Insulin resistance",1.2.1.75; 2.1.3.1; 2.3.1.39; 2.3.1.74; 2.3.1.85; 2.3.1.86; 2.3.1.95; 2.3.1.112; 2.3.1.113; 2.3.1.114; 2.3.1.115; 2.3.1.116; 2.3.1.146; 2.3.1.151; 2.3.1.156; 2.3.1.159; 2.3.1.161; 2.3.1.165; 2.3.1.170; 2.3.1.171; 2.3.1.172; 2.3.1.177; 2.3.1.194; 2.3.1.199; 2.3.1.206; 2.3.1.208; 2.3.1.211; 2.3.1.212; 2.3.1.214; 2.3.1.216; 2.3.1.218; 2.3.1.220; 2.3.1.221; 2.3.1.226; 2.3.1.230; 2.3.1.233; 2.3.1.235; 2.3.1.236; 2.3.1.237; 2.3.1.239; 2.3.1.240; 2.3.1.244; 2.3.1.246; 2.3.1.253; 2.3.1.260; 2.3.1.-; 2.8.3.3; 4.1.1.9; 6.3.5.-; 6.4.1.2,"Fatty acid biosynthesis, initiation; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Fatty acid biosynthesis, elongation, endoplasmic reticulum; Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate; Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin; Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin; Pikromycin/methymycin/neomethymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin/neomethymycin; Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide; 9-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 9-membered enediyne core; 10-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 10-membered enediyne core; 3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA; Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA; Calicheamicin biosynthesis, calicheamicinone => calicheamicin; Calicheamicin orsellinate moiety biosynthesis, malonyl-CoA => orsellinate-ACP => 5-iodo-2,3-dimethoxyorsellinate-ACP",NA,CAS: 524-14-1; PubChem: 3383; ChEBI: 15531; LIPIDMAPS: LMFA07050031; KNApSAcK: C00007260; PDB-CCD: MLC; 3DMET: B04627; NIKKAJI: J203.864A,cpd:C00083,24,38,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C24H39O19N7P3S1,C24H37O19N7P3S1,853.1156042,854.1234292,852.1077792209,221,cpd:C00154,Palmitoyl-CoA;,C37H66N7O17P3S,Palmitoyl-CoA; Hexadecanoyl-CoA,R01274 R01277 R01278 R01279 R01280 R01281 R01282 R01923; R01952 R02138 R02367 R02375 R04021 R04022 R05918 R07758; R08381 R10484 R10700 R11011 R11012,Fatty acid biosynthesis; Fatty acid elongation; Fatty acid degradation; Glycosylphosphatidylinositol (GPI)-anchor biosynthesis; Sphingolipid metabolism; Biosynthesis of unsaturated fatty acids; Biosynthesis of plant hormones; Metabolic pathways; Fatty acid metabolism; Sphingolipid signaling pathway,1.2.1.42; 1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.8.9; 1.3.99.-; 1.14.19.32; 2.3.1.21; 2.3.1.50; 2.3.1.76; 2.3.1.86; 2.3.1.96; 2.3.1.100; 2.3.1.123; 2.3.1.139; 2.3.1.142; 2.3.1.199; 2.3.1.225; 2.3.1.-; 2.3.-.-; 3.1.2.2; 3.1.2.22; 6.2.1.3,"beta-Oxidation, acyl-CoA synthesis; beta-Oxidation; Ceramide biosynthesis; Sphingosine biosynthesis",Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C00154  Hexadecanoyl-CoA,CAS: 1763-10-6; PubChem: 3454; ChEBI: 15525; LIPIDMAPS: LMFA07050002; KNApSAcK: C00007462; PDB-CCD: PKZ; 3DMET: B04641; NIKKAJI: J207.891K,cpd:C00154; cpd:C07296,37,66,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C37H67O17N7P3S1,C37H65O17N7P3S1,1005.344876,1006.352701,1004.337051210,223,cpd:C00249,Hexadecanoic acid;,C16H32O2,Hexadecanoic acid; Hexadecanoate; Hexadecylic acid; Palmitic acid; Palmitate; Cetylic acid,R01274 R01280 R01703 R01704 R01705 R01706 R02368 R03049; R08602 R09451,"Fatty acid biosynthesis; Fatty acid elongation; Fatty acid degradation; Cutin, suberine and wax biosynthesis; Biosynthesis of unsaturated fatty acids; Biosynthesis of plant secondary metabolites; Metabolic pathways; Fatty acid metabolism",1.2.1.48; 1.11.1.3; 1.14.-.-; 2.3.1.85; 3.1.1.63; 3.1.1.-; 3.1.2.2; 3.1.2.14; 3.1.2.22; 6.2.1.3,"beta-Oxidation, acyl-CoA synthesis",Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C00249  Palmitic acid (16:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C00249  Hexadecanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C00249  Palmitic acid; Pharmaceutical additives [BR:br08316];  Tenacious agent;   D05341  [104981] Palmitic acid; Major components of natural products [BR:br08323];  Crude drugs;   Burdock fruit;    C00249  Hexadecanoic acid;   Hemp fruit;    C00249  Hexadecanoic acid;  Medicinal herbs;   Hemp;    C00249  Hexadecanoic acid,CAS: 57-10-3; PubChem: 3548; ChEBI: 15756; ChEMBL: CHEMBL82293; LIPIDMAPS: LMFA01010001; LipidBank: DFA0016; KNApSAcK: C00001233 C00030479; PDB-CCD: PLM; 3DMET: B00071; NIKKAJI: J1.378A,cpd:C00249,16,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H33O2,C16H31O2,256.2402303,257.2480553,255.2324052211,224,cpd:C00712,(9Z)-Octadecenoic acid;,C18H34O2,(9Z)-Octadecenoic acid; (Z)-Octadec-9-enoic acid; Oleate; Oleic acid,R02813 R02814 R08176 R09452 R09462 R09537 R10576,"Fatty acid biosynthesis; Cutin, suberine and wax biosynthesis; Biosynthesis of unsaturated fatty acids; Biosynthesis of plant secondary metabolites; Longevity regulating pathway - worm",1.11.2.3; 1.13.11.77; 1.14.-.-; 3.1.2.2; 3.1.2.14; 3.5.1.99; 4.2.1.53,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C00712  Oleic acid (18:1;9); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Monounsaturated fatty acids;      C00712  (Z)-Octadec-9-enoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Unsaturated fatty acids;     C00712  Oleic acid; Pharmaceutical additives [BR:br08316];  Base;   D02315  [002062] Oleic acid;   D02315  [531108] Purified oleic acid;  Suspending agent;   D02315  [002062] Oleic acid;  Dispersant;   D02315  [002062] Oleic acid;   D02315  [531108] Purified oleic acid;  Solvent;   D02315  [002062] Oleic acid;   D02315  [531108] Purified oleic acid; Major components of natural products [BR:br08323];  Medicinal herbs;   Neem;    C00712  (9Z)-Octadecenoic acid,CAS: 112-80-1; PubChem: 3978; ChEBI: 16196; ChEMBL: CHEMBL8659; LIPIDMAPS: LMFA01030002; LipidBank: DFA0111; KNApSAcK: C00001232; PDB-CCD: OLA; 3DMET: B00158; NIKKAJI: J2.460K,cpd:C00712; cpd:C01712; cpd:C08363; cpd:C08367; cpd:C12103,18,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H35O2,C18H33O2,282.2558803,283.2637054,281.2480553212,227,cpd:C01530,Octadecanoic acid;,C18H36O2,Octadecanoic acid; Stearate; Stearic acid,R08163 R08174,Fatty acid biosynthesis; Biosynthesis of unsaturated fatty acids; Biosynthesis of plant secondary metabolites; Phototransduction - fly,3.1.2.2; 3.1.2.14,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C01530  Stearic acid (18:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C01530  Octadecanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C01530  Stearic acid; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Stearic acid;     D00119  Stearic acid (JP17/NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00119  [002220] Stearic acid;  Lubricating agent;   D00119  [002220] Stearic acid;  Base;   D00119  [002220] Stearic acid;  Flavoring substance;   D00119  [002220] Stearic acid;  Bonding agent;   D00119  [002220] Stearic acid;  Brightening agent;   D00119  [002220] Stearic acid;  Coating agent;   D00119  [002220] Stearic acid;  Sugarcoated agent;   D00119  [002220] Stearic acid;  Emulsion;   D00119  [002220] Stearic acid;  Diluting agent;   D00119  [002220] Stearic acid;  Dispersant;   D00119  [002220] Stearic acid;  Disintegrating adjuvant;   D00119  [002220] Stearic acid;  Dampproof agent;   D00119  [002220] Stearic acid;  Fluidizer;   D00119  [002220] Stearic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00119  Stearic acid,CAS: 57-11-4; PubChem: 4692; ChEBI: 25629 28842; ChEMBL: CHEMBL46403; LIPIDMAPS: LMFA01010018; LipidBank: DFA0018; KNApSAcK: C00001238 C00032087; PDB-CCD: STE; 3DMET: B01462; NIKKAJI: J1.379J,cpd:C01530; cpd:C20356,18,36,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H37O2,C18H35O2,284.2715304,285.2793554,283.2637054213,228,cpd:C01571,Decanoic acid;,C10H20O2,Decanoic acid; Decanoate; Decylic acid; n-Capric acid,R08158,Fatty acid biosynthesis; Metabolic pathways,3.1.2.21,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C01571  Capric acid (10:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C01571  Decanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C01571  Capric acid; Pharmaceutical additives [BR:br08316];  Solubilization agent;   C01571  [511014] Capric acid,CAS: 334-48-5; PubChem: 4728; ChEBI: 27689 30813; ChEMBL: CHEMBL107498; LIPIDMAPS: LMFA01010010; LipidBank: DFA0010; KNApSAcK: C00001213; PDB-CCD: DKA; 3DMET: B01466; NIKKAJI: J2.575E,cpd:C01571; cpd:C02904; cpd:C05546; cpd:C06404; cpd:C12289; cpd:C12292; cpd:C21365,10,20,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H21O2,C10H19O2,172.1463299,173.1541549,171.1385049214,229,cpd:C02679,Dodecanoic acid;,C12H24O2,Dodecanoic acid; Dodecanoate; Dodecylcarboxylate; Lauric acid,R04014 R11054,Fatty acid biosynthesis; Metabolic pathways,1.14.13.206; 3.1.2.14; 3.1.2.21,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C02679  Lauric acid (12:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C02679  Dodecanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C02679  Lauric acid,CAS: 143-07-7; PubChem: 5649; ChEBI: 18262 30805; ChEMBL: CHEMBL108766; LIPIDMAPS: LMFA01010012; LipidBank: DFA0012; KNApSAcK: C00001221; PDB-CCD: DAO; 3DMET: B00483; NIKKAJI: J2.548H,cpd:C02679,12,24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H25O2,C12H23O2,200.17763,201.185455,199.169805215,261,cpd:C06423,Octanoic acid;,C8H16O2,Octanoic acid; Caprylic acid; Octylic acid,R08157 R08509,Fatty acid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from terpenoid and polyketide; Metabolic pathways,3.1.2.21,NA,Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Monocarboxylic acids;     C06423  Caprylate; Octanoate;  Lipids;   Fatty acids;    Saturated fatty acids;     C06423  Caprylic acid (8:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C06423  Octanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C06423  Octanoic acid,CAS: 124-07-2; PubChem: 8658; ChEBI: 28837; ChEMBL: CHEMBL324846; LIPIDMAPS: LMFA01010008; LipidBank: DFA0008; KNApSAcK: C00001231; PDB-CCD: OCA; 3DMET: B02018; NIKKAJI: J2.013C,cpd:C02147; cpd:C06423; cpd:C07185,8,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O2,C8H15O2,144.1150298,145.1228548,143.1072047216,262,cpd:C06424,Tetradecanoic acid;,C14H28O2,Tetradecanoic acid; Tetradecanoate; Myristic acid,R08159,Fatty acid biosynthesis; Metabolic pathways,3.1.2.14,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C06424  Myristic acid (14:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C06424  Tetradecanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C06424  Myristic acid; Pharmaceutical additives [BR:br08316];  Base;   C06424  [104368] Myristic acid,CAS: 544-63-8; PubChem: 8659; ChEBI: 28875 30807; ChEMBL: CHEMBL111077; LIPIDMAPS: LMFA01010014; LipidBank: DFA0014; KNApSAcK: C00001228; PDB-CCD: MYR; 3DMET: B02019; NIKKAJI: J4.411C,cpd:C06424,14,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H29O2,C14H27O2,228.2089301,229.2167552,227.2011051217,263,cpd:C08362,(9Z)-Hexadecenoic acid;,C16H30O2,(9Z)-Hexadecenoic acid; Palmitoleic acid; cis-9-Hexadecenoic acid; (9Z)-Hexadec-9-enoate,R08162 R11202,Fatty acid biosynthesis,3.1.1.98; 3.1.2.14,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C08362  Palmitoleic acid (16:1;9); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Monounsaturated fatty acids;      C08362  (Z)-Hexadec-9-enoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Unsaturated fatty acids;     C08362  Palmitoleic acid,CAS: 373-49-9; PubChem: 10558; ChEBI: 28716; ChEMBL: CHEMBL453509; LIPIDMAPS: LMFA01030056; LipidBank: DFA0095; KNApSAcK: C00001234 C00029354; PDB-CCD: PAM; 3DMET: B02171; NIKKAJI: J12.503B,cpd:C08362,16,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H31O2,C16H29O2,254.2245802,255.2324052,253.2167552218,270,cpd:C00136,Butanoyl-CoA;,C25H42N7O17P3S,Butanoyl-CoA; Butyryl-CoA,R01171 R01172 R01173 R01174 R01175 R01176 R01177 R01179; R01180 R01181 R01365 R06637 R06645 R08924 R09738 R09958,Fatty acid elongation; Fatty acid degradation; Lysine degradation; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; Biosynthesis of type II polyketide backbone; Metabolic pathways; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism,1.2.1.10; 1.2.1.57; 1.2.1.87; 1.3.1.44; 1.3.1.86; 1.3.3.6; 1.3.8.1; 1.3.8.7; 1.3.99.-; 2.3.1.9; 2.3.1.16; 2.3.1.19; 2.3.1.-; 2.3.3.7; 2.8.3.8; 2.8.3.9; 4.1.1.94; 5.4.99.13; 6.2.1.2; 6.4.1.3,NA,NA,PubChem: 3436; ChEBI: 15517; ChEMBL: CHEMBL1949894; PDB-CCD: BCO; 3DMET: B04638; NIKKAJI: J363.721B,cpd:C00136; cpd:C00630,25,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H43O17N7P3S1,C25H41O17N7P3S1,837.1570751,838.1649001,836.1492501219,277,cpd:C01832,Lauroyl-CoA;,C33H58N7O17P3S,Lauroyl-CoA; Lauroyl coenzyme A; Dodecanoyl-CoA,R03735 R03856 R03857 R03858 R03859,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 2.3.1.16; 2.3.3.2; 2.3.3.4,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C01832  Dodecanoyl-CoA,CAS: 6244-92-4; PubChem: 4951; ChEBI: 15521; ChEMBL: CHEMBL1949898; LIPIDMAPS: LMFA07050005; PDB-CCD: DCC; 3DMET: B04816; NIKKAJI: J710.292E,cpd:C01832,33,58,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C33H59O17N7P3S1,C33H57O17N7P3S1,949.2822756,950.2901006,948.2744506220,278,cpd:C01944,Octanoyl-CoA,C29H50N7O17P3S,Octanoyl-CoA,R03776 R03777 R03778 R03779 R10172,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 2.3.1.16; 2.3.1.137; 2.3.1.207,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C01944  Octanoyl-CoA,CAS: 1264-52-4; PubChem: 5048; ChEBI: 15533; ChEMBL: CHEMBL1949896; PDB-CCD: CO8; 3DMET: B04826; NIKKAJI: J358.061J,cpd:C01944,29,50,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H51O17N7P3S1,C29H49O17N7P3S1,893.2196753,894.2275004,892.2118503221,279,cpd:C02593,Tetradecanoyl-CoA;,C35H62N7O17P3S,Tetradecanoyl-CoA; Myristoyl-CoA,R03989 R03990 R03991 R03992 R05321 R05322 R07216 R07217,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.8.9; 1.3.99.-; 2.3.1.16; 2.3.1.97; 2.3.1.155,beta-Oxidation,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C02593  Tetradecanoyl-CoA,PubChem: 5585; ChEBI: 15532; ChEMBL: CHEMBL1949899; LIPIDMAPS: LMFA07050008; 3DMET: B04857; NIKKAJI: J589.553G,cpd:C02593,35,62,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C35H63O17N7P3S1,C35H61O17N7P3S1,977.3135757,978.3214008,976.3057507222,281,cpd:C03221,2-trans-Dodecenoyl-CoA;,C33H56N7O17P3S,2-trans-Dodecenoyl-CoA; (2E)-Dodec-2-enoyl-CoA; (2E)-Dodecenoyl-CoA,R03856 R03857 R04100 R04170,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 4.2.1.17; 4.2.1.74; 5.3.3.8,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C03221  (2E)-Dodecenoyl-CoA,PubChem: 6094; ChEBI: 15471; LIPIDMAPS: LMFA07050010; 3DMET: B04884; NIKKAJI: J2.741.386B,cpd:C02944; cpd:C03221,33,56,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C33H57O17N7P3S1,C33H55O17N7P3S1,947.2666255,948.2744506,946.2588005223,282,cpd:C05258,(S)-3-Hydroxyhexadecanoyl-CoA,C37H66N7O18P3S,(S)-3-Hydroxyhexadecanoyl-CoA,R04737 R04738,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74,beta-Oxidation,NA,PubChem: 7645; ChEBI: 27402; 3DMET: B04987; NIKKAJI: J2.755.077K,cpd:C05258,37,66,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C37H67O18N7P3S1,C37H65O18N7P3S1,1021.33979,1022.347616,1020.331965224,283,cpd:C05259,3-Oxopalmitoyl-CoA;,C37H64N7O18P3S,3-Oxopalmitoyl-CoA; 3-Ketopalmitoyl-CoA; 3-Oxohexadecanoyl-CoA,R03991 R04737,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 2.3.1.16; 2.3.1.155,beta-Oxidation,NA,PubChem: 7646; ChEBI: 15491; 3DMET: B04988; NIKKAJI: J2.755.078I,cpd:C05259,37,64,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C37H65O18N7P3S1,C37H63O18N7P3S1,1019.32414,1020.331965,1018.316315225,284,cpd:C05260,(S)-3-Hydroxytetradecanoyl-CoA,C35H62N7O18P3S,(S)-3-Hydroxytetradecanoyl-CoA,R04739 R04740,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74,NA,NA,PubChem: 7647; ChEBI: 27466; 3DMET: B04989; NIKKAJI: J2.755.089D,cpd:C05260,35,62,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C35H63O18N7P3S1,C35H61O18N7P3S1,993.3084904,994.3163154,992.3006653226,285,cpd:C05261,3-Oxotetradecanoyl-CoA,C35H60N7O18P3S,3-Oxotetradecanoyl-CoA,R03858 R04739,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 2.3.1.16,NA,NA,PubChem: 7648; ChEBI: 28726; NIKKAJI: J2.755.090H,cpd:C05261,35,60,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C35H61O18N7P3S1,C35H59O18N7P3S1,991.2928403,992.3006653,990.2850153227,286,cpd:C05262,(S)-3-Hydroxydodecanoyl-CoA,C33H58N7O18P3S,(S)-3-Hydroxydodecanoyl-CoA,R04170 R04741,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05262  (S)-3-Hydroxydodecanoyl-CoA,PubChem: 7649; ChEBI: 27668; LIPIDMAPS: LMFA07050012; 3DMET: B04990; NIKKAJI: J2.755.091F,cpd:C05262,33,58,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C33H59O18N7P3S1,C33H57O18N7P3S1,965.2771902,966.2850153,964.2693652228,287,cpd:C05263,3-Oxododecanoyl-CoA,C33H56N7O18P3S,3-Oxododecanoyl-CoA,R04741 R04742,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 2.3.1.16,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05263  3-Oxododecanoyl-CoA,PubChem: 7650; ChEBI: 27868; LIPIDMAPS: LMFA07050013; 3DMET: B04991; NIKKAJI: J2.755.092D,cpd:C05263,33,56,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C33H57O18N7P3S1,C33H55O18N7P3S1,963.2615402,964.2693652,962.2537151229,288,cpd:C05264,(S)-Hydroxydecanoyl-CoA;,C31H54N7O18P3S,(S)-Hydroxydecanoyl-CoA; (S)-3-Hydroxydecanoyl-CoA,R04743 R04744,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05264  (S)-3-Hydroxydecanoyl-CoA,PubChem: 7651; ChEBI: 28325; LIPIDMAPS: LMFA07050014; PDB-CCD: HSC; 3DMET: B04992; NIKKAJI: J2.755.093B,cpd:C05264,31,54,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H55O18N7P3S1,C31H53O18N7P3S1,937.2458901,938.2537151,936.2380651230,289,cpd:C05265,3-Oxodecanoyl-CoA,C31H52N7O18P3S,3-Oxodecanoyl-CoA,R03778 R04743,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 2.3.1.16,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05265  3-Oxodecanoyl-CoA,PubChem: 7652; ChEBI: 28528; PDB-CCD: ZOZ; 3DMET: B04993; NIKKAJI: J2.755.094K,cpd:C05265; cpd:C11947,31,52,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H53O18N7P3S1,C31H51O18N7P3S1,935.23024,936.2380651,934.222415231,290,cpd:C05266,(S)-3-Hydroxyoctanoyl-CoA;,C29H50N7O18P3S,(S)-3-Hydroxyoctanoyl-CoA; (S)-3-Hydroxycapryloyl-CoA; (S)-Hydroxyoctanoyl-CoA,R04745 R04746,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74; 5.1.2.3,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05266  (S)-3-Hydroxyoctanoyl-CoA,PubChem: 7653; ChEBI: 28632; LIPIDMAPS: LMFA07050015; 3DMET: B04994; NIKKAJI: J915.535J,cpd:C05266; cpd:C05278,29,50,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H51O18N7P3S1,C29H49O18N7P3S1,909.21459,910.222415,908.2067649232,291,cpd:C05267,3-Oxooctanoyl-CoA,C29H48N7O18P3S,3-Oxooctanoyl-CoA,R04745 R04747,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 2.3.1.16,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05267  3-Oxooctanoyl-CoA,PubChem: 7654; ChEBI: 28264; LIPIDMAPS: LMFA07050016; 3DMET: B04995; NIKKAJI: J2.755.103C,cpd:C04316; cpd:C05267,29,48,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H49O18N7P3S1,C29H47O18N7P3S1,907.1989399,908.2067649,906.1911149233,292,cpd:C05268,(S)-Hydroxyhexanoyl-CoA;,C27H46N7O18P3S,(S)-Hydroxyhexanoyl-CoA; (S)-3-Hydroxyhexanoyl-CoA,R04748 R04749,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 4.2.1.17; 4.2.1.74,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05268  (S)-3-Hydroxyhexanoyl-CoA,PubChem: 7655; ChEBI: 28276; LIPIDMAPS: LMFA07050017; PDB-CCD: 3H9; 3DMET: B04996; NIKKAJI: J2.755.104A,cpd:C05268; cpd:C21089,27,46,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O18N7P3S1,C27H45O18N7P3S1,881.1832898,882.1911149,880.1754648234,293,cpd:C05269,3-Oxohexanoyl-CoA;,C27H44N7O18P3S,3-Oxohexanoyl-CoA; 3-Ketohexanoyl-CoA,R01177 R04748,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.1.1.35; 1.1.1.211; 2.3.1.9; 2.3.1.16,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05269  3-Oxohexanoyl-CoA,CAS: 19774-86-8; PubChem: 7656; ChEBI: 27648; LIPIDMAPS: LMFA07050018; 3DMET: B04997; NIKKAJI: J2.755.105J,cpd:C05269,27,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O18N7P3S1,C27H43O18N7P3S1,879.1676398,880.1754648,878.1598147235,294,cpd:C05270,Hexanoyl-CoA,C27H46N7O17P3S,Hexanoyl-CoA,R04747 R04751 R06985 R08796 R08797 R10171,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.1; 1.3.8.7; 1.3.8.8; 1.3.99.-; 2.3.1.16; 2.3.1.206,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05270  Hexanoyl-CoA,PubChem: 7657; ChEBI: 27540; ChEMBL: CHEMBL1949895; LIPIDMAPS: LMFA07050001; PDB-CCD: HXC; 3DMET: B04998; NIKKAJI: J358.059H,cpd:C05270; cpd:C21400,27,46,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O17N7P3S1,C27H45O17N7P3S1,865.1883752,866.1962002,864.1805502236,295,cpd:C05271,trans-Hex-2-enoyl-CoA;,C27H44N7O17P3S,trans-Hex-2-enoyl-CoA; (2E)-Hexenoyl-CoA,R04749 R04751 R06985,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.1; 1.3.8.7; 1.3.8.8; 1.3.99.-; 4.2.1.17; 4.2.1.74,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05271  (2E)-Hexenoyl-CoA,PubChem: 7658; ChEBI: 28706; LIPIDMAPS: LMFA07050019; PDB-CCD: TC6; 3DMET: B04999; NIKKAJI: J2.755.178E,cpd:C05271; cpd:C21090,27,44,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O17N7P3S1,C27H43O17N7P3S1,863.1727252,864.1805502,862.1649001237,296,cpd:C05272,trans-Hexadec-2-enoyl-CoA;,C37H64N7O17P3S,trans-Hexadec-2-enoyl-CoA; trans-2-Hexadecenoyl-CoA; (2E)-Hexadecenoyl-CoA,R01278 R01279 R01282 R04738,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.8.9; 1.3.99.-; 4.2.1.17; 4.2.1.74,beta-Oxidation,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05272  (2E)-Hexadecenoyl-CoA,PubChem: 7659; ChEBI: 28935; LIPIDMAPS: LMFA07050020; 3DMET: B05000; NIKKAJI: J2.755.187D,cpd:C05272; cpd:C20996; cpd:C20997; cpd:C20998; cpd:C21072,37,64,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C37H65O17N7P3S1,C37H63O17N7P3S1,1003.329226,1004.337051,1002.321401238,297,cpd:C05273,trans-Tetradec-2-enoyl-CoA;,C35H60N7O17P3S,trans-Tetradec-2-enoyl-CoA; (2E)-Tetradecenoyl-CoA,R03989 R03990 R04740,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.8.9; 1.3.99.-; 4.2.1.17; 4.2.1.74,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05273  (2E)-Tetradecenoyl-CoA,PubChem: 7660; ChEBI: 27721; LIPIDMAPS: LMFA07050021; 3DMET: B05001; NIKKAJI: J2.755.213G,cpd:C05273; cpd:C06736; cpd:C06737,35,60,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C35H61O17N7P3S1,C35H59O17N7P3S1,975.2979257,976.3057507,974.2901006239,298,cpd:C05274,Decanoyl-CoA,C31H54N7O17P3S,Decanoyl-CoA,R04742 R04753 R04754,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 2.3.1.16,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05274  Decanoyl-CoA,PubChem: 7661; ChEBI: 28493; ChEMBL: CHEMBL1949897; LIPIDMAPS: LMFA07050022; PDB-CCD: MFK; 3DMET: B05002; NIKKAJI: J362.551F,cpd:C05274,31,54,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H55O17N7P3S1,C31H53O17N7P3S1,921.2509755,922.2588005,920.2431504240,299,cpd:C05275,trans-Dec-2-enoyl-CoA;,C31H52N7O17P3S,trans-Dec-2-enoyl-CoA; (2E)-Decenoyl-CoA,R04744 R04753 R04754,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 4.2.1.17; 4.2.1.74,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05275  (2E)-Decenoyl-CoA,PubChem: 7662; ChEBI: 10723; LIPIDMAPS: LMFA07050023; 3DMET: B05003; NIKKAJI: J2.755.219F,cpd:C05275; cpd:C16464,31,52,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H53O17N7P3S1,C31H51O17N7P3S1,919.2353254,920.2431504,918.2275004241,300,cpd:C05276,trans-Oct-2-enoyl-CoA;,C29H48N7O17P3S,trans-Oct-2-enoyl-CoA; (2E)-Octenoyl-CoA,R03776 R03777 R04746,Fatty acid elongation; Fatty acid degradation; Metabolic pathways; Fatty acid metabolism,1.3.1.8; 1.3.1.38; 1.3.3.6; 1.3.8.7; 1.3.8.8; 1.3.99.-; 4.2.1.17; 4.2.1.74,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C05276  (2E)-Octenoyl-CoA,PubChem: 7663; ChEBI: 27537; LIPIDMAPS: LMFA07050024; 3DMET: B05004; NIKKAJI: J2.755.239K,cpd:C05276,29,48,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H49O17N7P3S1,C29H47O17N7P3S1,891.2040253,892.2118503,890.1962002242,305,cpd:C00010,CoA;,C21H36N7O16P3S,CoA; Coenzyme A; CoA-SH,R00091 R00130 R00209 R00210 R00211 R00212 R00227 R00228; R00229 R00230 R00235 R00236 R00238 R00259 R00265 R00271; R00351 R00352 R00371 R00383 R00389 R00390 R00391 R00394; R00395 R00399 R00405 R00407 R00432 R00454 R00468 R00472; R00487 R00521 R00577 R00586 R00627 R00664 R00693 R00705; R00706 R00727 R00740 R00829 R00830 R00832 R00851 R00918; R00920 R00921 R00922 R00925 R00926 R00927 R00931 R00932; R00935 R00982 R00989 R00998 R01013 R01023 R01075 R01089; R01111 R01154 R01160 R01172 R01173 R01174 R01176 R01177; R01180 R01196 R01197 R01199 R01204 R01210 R01213 R01256; R01274 R01277 R01280 R01281 R01300 R01301 R01318 R01319; R01322 R01357 R01358 R01368 R01422 R01461 R01496 R01556; R01558 R01598 R01613 R01614 R01615 R01616 R01617 R01624; R01625 R01626 R01651 R01776 R01777 R01798 R01806 R01807; R01808 R01850 R01889 R01923 R01933 R01941 R01943 R01944; R01945 R01946 R01952 R01978 R01999 R02058 R02081 R02082; R02083 R02138 R02152 R02191 R02193 R02194 R02195 R02220; R02221 R02224 R02241 R02242 R02251 R02255 R02366 R02367; R02375 R02385 R02387 R02396 R02402 R02404 R02405 R02406; R02416 R02447 R02450 R02452 R02453 R02481 R02482 R02505; R02506 R02539 R02543 R02569 R02570 R02571 R02576 R02616; R02617 R02620 R02662 R02694 R02699 R02760 R02764 R02772; R02794 R02837 R02899 R02911 R02986 R03017 R03040 R03056; R03064 R03065 R03109 R03157 R03158 R03168 R03171 R03174; R03209 R03210 R03230 R03352 R03374 R03381 R03383 R03437; R03438 R03455 R03552 R03621 R03631 R03668 R03695 R03718; R03719 R03720 R03727 R03735 R03755 R03756 R03760 R03762; R03767 R03778 R03779 R03838 R03858 R03859 R03861 R03903; R03910 R03932 R03965 R03974 R03991 R03992 R03994 R04021; R04022 R04024 R04030 R04050 R04097 R04150 R04157 R04192; R04205 R04211 R04254 R04316 R04348 R04356 R04361 R04363; R04364 R04365 R04413 R04466 R04480 R04484 R04507 R04546; R04580 R04618 R04709 R04723 R04742 R04747 R04776 R04777; R04811 R04868 R04950 R05063 R05064 R05129 R05163 R05188; R05189 R05190 R05330 R05331 R05332 R05351 R05451 R05452; R05455 R05506 R05537 R05546 R05586 R05587 R05620 R05672; R05714 R05744 R05841 R05870 R05876 R05918 R06251 R06307; R06310 R06311 R06361 R06367 R06368 R06396 R06409 R06410; R06414 R06415 R06448 R06453 R06458 R06459 R06480 R06481; R06482 R06483 R06510 R06515 R06517 R06527 R06544 R06545; R06568 R06569 R06583 R06624 R06625 R06635 R06637 R06641; R06643 R06644 R06645 R06731 R06735 R06736 R06796 R06797; R06799 R06800 R06801 R06806 R06817 R06821 R06872 R06908; R06944 R06978 R06987 R06997 R07160 R07161 R07175 R07249; R07250 R07251 R07252 R07253 R07255 R07262 R07294 R07296; R07382 R07399 R07416 R07432 R07433 R07719 R07721 R07731; R07741 R07754 R07757 R07758 R07815 R07828 R07833 R07873; R07876 R07880 R07881 R07882 R07883 R07884 R07885 R07886; R07887 R07891 R07895 R07899 R07902 R07910 R07926 R07927; R07928 R07929 R07930 R07931 R07937 R07938 R07944 R07953; R07987 R07988 R07989 R08036 R08088 R08091 R08095 R08097; R08117 R08171 R08172 R08174 R08175 R08176 R08177 R08178; R08179 R08180 R08181 R08182 R08183 R08184 R08185 R08186; R08187 R08188 R08189 R08190 R08191 R08192 R08213 R08248; R08250 R08273 R08331 R08332 R08381 R08386 R08423 R08430; R08432 R08433 R08530 R08531 R08532 R08549 R08566 R08567; R08619 R08623 R08627 R08631 R08640 R08644 R08680 R08712; R08713 R08733 R08738 R08743 R08744 R08745 R08767 R08796; R08797 R08805 R08806 R08807 R08808 R08809 R08810 R08870; R08871 R08938 R08983 R09034 R09035 R09036 R09037 R09096; R09097 R09106 R09255 R09256 R09257 R09258 R09279 R09280; R09286 R09317 R09419 R09450 R09470 R09524 R09527 R09528; R09557 R09589 R09621 R09622 R09631 R09643 R09839 R09840; R09842 R09854 R09873 R10003 R10099 R10100 R10104 R10142; R10171 R10172 R10173 R10174 R10200 R10210 R10219 R10233; R10234 R10237 R10238 R10239 R10243 R10253 R10254 R10278; R10473 R10474 R10484 R10485 R10500 R10514 R10516 R10526; R10529 R10589 R10590 R10612 R10681 R10700 R10707 R10745; R10746 R10747 R10758 R10769 R10770 R10771 R10820 R10825; R10866 R10893 R10936 R10947 R10960 R10965 R10967 R10998; R11124 R11125 R11182 R11199 R11200 R11201 R11370 R11390; R11412 R11435 R11445 R11450 R11451 R11479 R11516 R11542; R11550,Fatty acid degradation; Carbapenem biosynthesis; Pantothenate and CoA biosynthesis; Metabolic pathways; Biosynthesis of antibiotics; Cholinergic synapse; Fat digestion and absorption; Vitamin digestion and absorption,1.1.1.34; 1.1.1.88; 1.1.1.-; 1.2.1.10; 1.2.1.17; 1.2.1.18; 1.2.1.25; 1.2.1.27; 1.2.1.42; 1.2.1.44; 1.2.1.50; 1.2.1.51; 1.2.1.52; 1.2.1.57; 1.2.1.58; 1.2.1.75; 1.2.1.76; 1.2.1.81; 1.2.1.84; 1.2.1.87; 1.2.1.-; 1.2.3.6; 1.2.4.1; 1.2.4.2; 1.2.7.1; 1.2.7.3; 1.2.7.4; 1.2.7.7; 1.2.7.8; 1.2.7.11; 1.2.7.-; 1.8.1.4; 1.8.1.10; 1.8.1.14; 1.8.4.3; 1.13.11.80; 2.1.1.258; 2.3.1.1; 2.3.1.2; 2.3.1.3; 2.3.1.4; 2.3.1.5; 2.3.1.6; 2.3.1.7; 2.3.1.8; 2.3.1.9; 2.3.1.10; 2.3.1.11; 2.3.1.12; 2.3.1.13; 2.3.1.14; 2.3.1.15; 2.3.1.16; 2.3.1.17; 2.3.1.18; 2.3.1.19; 2.3.1.20; 2.3.1.21; 2.3.1.22; 2.3.1.23; 2.3.1.24; 2.3.1.25; 2.3.1.26; 2.3.1.27; 2.3.1.28; 2.3.1.29; 2.3.1.30; 2.3.1.31; 2.3.1.33; 2.3.1.34; 2.3.1.36; 2.3.1.37; 2.3.1.38; 2.3.1.39; 2.3.1.42; 2.3.1.44; 2.3.1.45; 2.3.1.46; 2.3.1.47; 2.3.1.48; 2.3.1.50; 2.3.1.51; 2.3.1.52; 2.3.1.53; 2.3.1.54; 2.3.1.57; 2.3.1.58; 2.3.1.59; 2.3.1.60; 2.3.1.61; 2.3.1.62; 2.3.1.63; 2.3.1.64; 2.3.1.65; 2.3.1.66; 2.3.1.67; 2.3.1.68; 2.3.1.69; 2.3.1.71; 2.3.1.74; 2.3.1.75; 2.3.1.76; 2.3.1.78; 2.3.1.79; 2.3.1.80; 2.3.1.81; 2.3.1.82; 2.3.1.84; 2.3.1.85; 2.3.1.86; 2.3.1.87; 2.3.1.88; 2.3.1.89; 2.3.1.93; 2.3.1.94; 2.3.1.95; 2.3.1.96; 2.3.1.97; 2.3.1.99; 2.3.1.100; 2.3.1.102; 2.3.1.105; 2.3.1.106; 2.3.1.107; 2.3.1.108; 2.3.1.109; 2.3.1.110; 2.3.1.111; 2.3.1.112; 2.3.1.113; 2.3.1.114; 2.3.1.115; 2.3.1.116; 2.3.1.117; 2.3.1.118; 2.3.1.121; 2.3.1.123; 2.3.1.125; 2.3.1.126; 2.3.1.127; 2.3.1.128; 2.3.1.130; 2.3.1.131; 2.3.1.132; 2.3.1.133; 2.3.1.136; 2.3.1.137; 2.3.1.138; 2.3.1.139; 2.3.1.140; 2.3.1.142; 2.3.1.144; 2.3.1.145; 2.3.1.146; 2.3.1.150; 2.3.1.151; 2.3.1.153; 2.3.1.155; 2.3.1.156; 2.3.1.157; 2.3.1.159; 2.3.1.160; 2.3.1.161; 2.3.1.162; 2.3.1.163; 2.3.1.164; 2.3.1.165; 2.3.1.166; 2.3.1.167; 2.3.1.168; 2.3.1.169; 2.3.1.170; 2.3.1.171; 2.3.1.172; 2.3.1.173; 2.3.1.174; 2.3.1.175; 2.3.1.176; 2.3.1.177; 2.3.1.178; 2.3.1.180; 2.3.1.182; 2.3.1.183; 2.3.1.185; 2.3.1.186; 2.3.1.188; 2.3.1.189; 2.3.1.190; 2.3.1.192; 2.3.1.194; 2.3.1.195; 2.3.1.196; 2.3.1.197; 2.3.1.198; 2.3.1.199; 2.3.1.201; 2.3.1.202; 2.3.1.203; 2.3.1.205; 2.3.1.206; 2.3.1.207; 2.3.1.208; 2.3.1.209; 2.3.1.210; 2.3.1.211; 2.3.1.212; 2.3.1.214; 2.3.1.215; 2.3.1.216; 2.3.1.217; 2.3.1.218; 2.3.1.219; 2.3.1.220; 2.3.1.221; 2.3.1.222; 2.3.1.223; 2.3.1.224; 2.3.1.225; 2.3.1.226; 2.3.1.227; 2.3.1.228; 2.3.1.229; 2.3.1.230; 2.3.1.232; 2.3.1.233; 2.3.1.235; 2.3.1.236; 2.3.1.237; 2.3.1.239; 2.3.1.240; 2.3.1.244; 2.3.1.245; 2.3.1.246; 2.3.1.248; 2.3.1.249; 2.3.1.250; 2.3.1.252; 2.3.1.253; 2.3.1.260; 2.3.1.-; 2.3.2.-; 2.3.3.1; 2.3.3.2; 2.3.3.3; 2.3.3.4; 2.3.3.5; 2.3.3.6; 2.3.3.7; 2.3.3.8; 2.3.3.9; 2.3.3.10; 2.3.3.11; 2.3.3.12; 2.3.3.13; 2.3.3.14; 2.3.3.16; 2.3.3.17; 2.3.3.-; 2.3.-.-; 2.6.1.33; 2.7.1.24; 2.7.8.7; 2.7.8.-; 2.8.3.-; 3.1.2.1; 3.1.2.2; 3.1.2.3; 3.1.2.4; 3.1.2.5; 3.1.2.10; 3.1.2.11; 3.1.2.17; 3.1.2.18; 3.1.2.19; 3.1.2.20; 3.1.2.22; 3.1.2.23; 3.1.2.25; 3.1.2.27; 3.1.2.28; 3.1.2.29; 3.1.2.30; 3.1.2.32; 3.1.2.-; 3.2.1.-; 3.6.1.-; 4.1.3.36; 4.1.3.-; 4.2.1.155; 4.4.1.26; 6.2.1.1; 6.2.1.2; 6.2.1.3; 6.2.1.4; 6.2.1.5; 6.2.1.6; 6.2.1.7; 6.2.1.8; 6.2.1.9; 6.2.1.10; 6.2.1.11; 6.2.1.12; 6.2.1.13; 6.2.1.14; 6.2.1.15; 6.2.1.16; 6.2.1.17; 6.2.1.18; 6.2.1.23; 6.2.1.24; 6.2.1.25; 6.2.1.26; 6.2.1.27; 6.2.1.28; 6.2.1.30; 6.2.1.31; 6.2.1.32; 6.2.1.33; 6.2.1.34; 6.2.1.36; 6.2.1.37; 6.2.1.38; 6.2.1.40; 6.2.1.41; 6.2.1.42; 6.2.1.43; 6.2.1.44; 6.2.1.-,"Coenzyme A biosynthesis, pantothenate => CoA",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00010  CoA,CAS: 85-61-0; PubChem: 3312; ChEBI: 15346; ChEMBL: CHEMBL1213327 CHEMBL1623949; KNApSAcK: C00007258; PDB-CCD: COA; 3DMET: B04618; NIKKAJI: J192.630F,cpd:C00010,21,36,16,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C21H37O16N7P3S1,C21H35O16N7P3S1,767.1152103,768.1230353,766.1073852243,308,cpd:C00332,Acetoacetyl-CoA;,C25H40N7O18P3S,Acetoacetyl-CoA; Acetoacetyl coenzyme A; 3-Acetoacetyl-CoA,R00238 R00410 R01357 R01358 R01359 R01365 R01975 R01976; R01977 R01978 R05129 R05576 R09527,"Fatty acid degradation; Synthesis and degradation of ketone bodies; Valine, leucine and isoleucine degradation; Lysine degradation; Benzoate degradation; Tryptophan metabolism; Pyruvate metabolism; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Terpenoid backbone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism",1.1.1.35; 1.1.1.36; 1.1.1.157; 2.3.1.9; 2.3.1.194; 2.3.3.10; 2.8.3.5; 2.8.3.8; 2.8.3.9; 3.1.2.11; 6.2.1.16,"Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone; C5 isoprenoid biosynthesis, mevalonate pathway; Ethylmalonyl pathway; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle",NA,CAS: 1420-36-6; PubChem: 3626; ChEBI: 15345; LIPIDMAPS: LMFA07050030; KNApSAcK: C00007269; PDB-CCD: CAA; 3DMET: B04671; NIKKAJI: J298.605A,cpd:C00332,25,40,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O18N7P3S1,C25H39O18N7P3S1,851.1363396,852.1441647,850.1285146244,309,cpd:C00489,Glutarate;,C5H8O4,"Glutarate; Glutaric acid; Pentanedioic acid; 1,3-Propanedicarboxylic acid",R02401 R02402 R07402 R10982,Fatty acid degradation; Lysine degradation,1.2.1.20; 1.2.1.-; 3.5.1.93; 6.2.1.6,NA,Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Dicarboxylic acids;     C00489  Glutarate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0117 Dicarboxylic acids;     C00489  Pentanedioic acid,CAS: 110-94-1; PubChem: 3772; ChEBI: 17859; ChEMBL: CHEMBL1162495; KNApSAcK: C00001184; PDB-CCD: GUA; 3DMET: B01263; NIKKAJI: J40.077G,cpd:C00489; cpd:C00707; cpd:C00900; cpd:C02352; cpd:C02674; cpd:C03409; cpd:C03589; cpd:C04106; cpd:C04181; cpd:C06010; cpd:C08298; cpd:C11838; cpd:C18061; cpd:C19483; cpd:C19885; cpd:C20232; cpd:C20846; cpd:C21177,5,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O4,C5H7O4,132.0422587,133.0500838,131.0344337245,310,cpd:C00517,Hexadecanal;,C16H32O,Hexadecanal; Palmitaldehyde,R01277 R01704 R02462 R02463 R02464,Fatty acid degradation,1.1.1.164; 1.1.1.192; 1.2.1.42; 1.2.1.48; 1.3.1.27; 4.1.2.27,NA,NA,CAS: 629-80-1; PubChem: 3800; ChEBI: 17600; ChEMBL: CHEMBL1235338; LIPIDMAPS: LMFA06000088; LipidBank: DLD0088; KNApSAcK: C00007542; 3DMET: B00119; NIKKAJI: J1.704C,cpd:C00517; cpd:C14499,16,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H33O1,C16H31O1,240.2453157,241.2531407,239.2374906246,311,cpd:C00527,Glutaryl-CoA,C26H42N7O19P3S,Glutaryl-CoA,R01933 R02402 R02487 R02488 R02571 R05579 R05586 R10074,Fatty acid degradation; Lysine degradation; Benzoate degradation; Tryptophan metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics,1.2.4.2; 1.3.8.6; 1.3.99.32; 1.8.1.4; 2.3.1.16; 2.3.1.61; 6.2.1.6,"Lysine degradation, lysine => saccharopine => acetoacetyl-CoA",NA,CAS: 3131-84-8; PubChem: 3810; ChEBI: 15524; PDB-CCD: GRA; 3DMET: B04695; NIKKAJI: J1.748.735C,cpd:C00527; cpd:C18026; cpd:C18324; cpd:C20238,26,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H43O19N7P3S1,C26H41O19N7P3S1,881.1469043,882.1547294,880.1390793247,312,cpd:C00823,1-Hexadecanol;,C16H34O,1-Hexadecanol; Hexadecanol; Cetyl alcohol; Palmityl alcohol; 16-Hexadecanol,R02462,Fatty acid degradation,1.1.1.164; 1.1.1.192,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA05 Fatty alcohols;    C00823  1-Hexadecanol; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00099  [002229] Cetanol;  Surfactant;   D00099  [002229] Cetanol;  Lubricating agent;   D00099  [002229] Cetanol;  Base;   D00099  [002229] Cetanol;  Bonding agent;   D00099  [002229] Cetanol;  Suspending agent;   D00099  [002229] Cetanol;  Brightening agent;   D00099  [002229] Cetanol;  Coating agent;   D00099  [002229] Cetanol;  Emulsion;   D00099  [002229] Cetanol;  Tenacious agent;   D00099  [002229] Cetanol;  Diluting agent;   D00099  [002229] Cetanol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00099  Cetanol,CAS: 36653-82-4; PubChem: 4081; ChEBI: 16125; ChEMBL: CHEMBL706; LIPIDMAPS: LMFA05000061; PDB-CCD: PL3; 3DMET: B00182; NIKKAJI: J3.499A,cpd:C00823,16,34,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H35O1,C16H33O1,242.2609657,243.2687907,241.2531407248,313,cpd:C00877,Crotonoyl-CoA;,C25H40N7O17P3S,Crotonoyl-CoA; Crotonyl-CoA; 2-Butenoyl-CoA; trans-But-2-enoyl-CoA; But-2-enoyl-CoA; (E)-But-2-enoyl-CoA,R01171 R01175 R02487 R02488 R03026 R03027 R03028 R03030; R03031 R05595 R07829 R09291 R09738 R10782,Fatty acid degradation; Lysine degradation; Benzoate degradation; Tryptophan metabolism; Aminobenzoate degradation; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism,1.3.1.44; 1.3.1.85; 1.3.1.86; 1.3.3.6; 1.3.8.1; 1.3.8.6; 1.3.8.7; 1.3.99.-; 4.1.1.70; 4.2.1.17; 4.2.1.55; 4.2.1.120; 4.3.1.14; 5.3.3.3; 5.5.1.-,"Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Ethylmalonyl pathway; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle",NA,CAS: 992-67-6; PubChem: 4133; ChEBI: 15473 36926; 3DMET: B04740; NIKKAJI: J1.040.164J J298.590J J808.602H,cpd:C00877; cpd:C02331; cpd:C03460; cpd:C16268,25,40,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O17N7P3S1,C25H39O17N7P3S1,835.141425,836.1492501,834.1336249,314,cpd:C01144,(S)-3-Hydroxybutanoyl-CoA;,C25H42N7O18P3S,(S)-3-Hydroxybutanoyl-CoA; (S)-3-Hydroxybutyryl-CoA,R01975 R01976 R03026 R03276 R07833 R11334,Fatty acid degradation; Lysine degradation; Benzoate degradation; Tryptophan metabolism; Aminobenzoate degradation; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Fatty acid metabolism,1.1.1.35; 1.1.1.157; 2.3.1.-; 4.2.1.17; 5.1.2.3; 5.3.3.20,"Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle",NA,PubChem: 4375; ChEBI: 15453; PDB-CCD: 3HC; 3DMET: B04776; NIKKAJI: J2.731.656E,cpd:C01144; cpd:C03561; cpd:C04047; cpd:C05116; cpd:C06000; cpd:C11062; cpd:C21287,25,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H43O18N7P3S1,C25H41O18N7P3S1,853.1519897,854.1598147,852.1441647250,316,cpd:C02990,L-Palmitoylcarnitine,C23H45NO4,L-Palmitoylcarnitine,R01923,Fatty acid degradation; Fatty acid metabolism,2.3.1.21,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0707 Fatty acyl carnitines;     C02990  L-Palmitoylcarnitine,CAS: 2364-67-2; PubChem: 5899; ChEBI: 17490; ChEMBL: CHEMBL1398676; LIPIDMAPS: LMFA07070004; 3DMET: B00524; NIKKAJI: J410.749G,cpd:C02990,23,45,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H46O4N1,C23H44O4N1,399.3348589,400.342684,398.3270339251,318,cpd:C03561,(R)-3-Hydroxybutanoyl-CoA;,C25H42N7O18P3S,(R)-3-Hydroxybutanoyl-CoA; (3R)-3-Hydroxybutanoyl-CoA,R01977 R03027 R03276 R04254,Fatty acid degradation; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; Microbial metabolism in diverse environments; Carbon metabolism,1.1.1.36; 2.3.1.-; 4.2.1.55; 5.1.2.3,Ethylmalonyl pathway,NA,PubChem: 6354; ChEBI: 15452; 3DMET: B04902; NIKKAJI: J2.742.980G,cpd:C01144; cpd:C03561; cpd:C04047; cpd:C05116; cpd:C06000; cpd:C11062; cpd:C21287,25,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H43O18N7P3S1,C25H41O18N7P3S1,853.1519897,854.1598147,852.1441647252,320,cpd:C05279,"trans,cis-Lauro-2,6-dienoyl-CoA",C33H54N7O17P3S,"trans,cis-Lauro-2,6-dienoyl-CoA",R04756,Fatty acid degradation,5.3.3.8,NA,NA,PubChem: 7666; ChEBI: 28387; 3DMET: B05005; NIKKAJI: J2.755.267F,cpd:C05279; cpd:C05280,33,54,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C33H55O17N7P3S1,C33H53O17N7P3S1,945.2509755,946.2588005,944.2431504253,321,cpd:C05280,"cis,cis-3,6-Dodecadienoyl-CoA",C33H54N7O17P3S,"cis,cis-3,6-Dodecadienoyl-CoA",R04756,Fatty acid degradation,5.3.3.8,NA,NA,PubChem: 7667; ChEBI: 28002; 3DMET: B05006; NIKKAJI: J2.755.268D,cpd:C05279; cpd:C05280,33,54,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C33H55O17N7P3S1,C33H53O17N7P3S1,945.2509755,946.2588005,944.2431504254,323,cpd:C00164,Acetoacetate;,C4H6O3,Acetoacetate; 3-Oxobutanoic acid; beta-Ketobutyric acid; Acetoacetic acid,R00410 R01357 R01358 R01359 R01360 R01361 R01364 R01365; R01366 R01367 R03225 R05713 R05735 R10564,"Synthesis and degradation of ketone bodies; Valine, leucine and isoleucine degradation; Lysine degradation; Tyrosine metabolism; Propanoate metabolism; Styrene degradation; Butanoate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Two-component system",1.1.1.30; 1.1.99.24; 1.8.1.5; 2.3.1.247; 2.8.3.5; 2.8.3.8; 2.8.3.9; 3.1.2.11; 3.7.1.2; 4.1.1.4; 4.1.3.4; 4.2.1.27; 6.2.1.16; 6.4.1.6,"Leucine degradation, leucine => acetoacetate + acetyl-CoA; Tyrosine degradation, tyrosine => homogentisate; Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    3-Oxocarboxylic acids;     C00164  Acetoacetate; 3-Oxobutanoate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C00164  3-Oxobutanoic acid,CAS: 541-50-4; PubChem: 3464; ChEBI: 13705 15344; LIPIDMAPS: LMFA01060003; LipidBank: DFA0387; KNApSAcK: C00007458; PDB-CCD: AAE; 3DMET: B00047; NIKKAJI: J4.508J,cpd:C00107; cpd:C00109; cpd:C00164; cpd:C00211; cpd:C00232; cpd:C00349; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C01551; cpd:C02189; cpd:C02348; cpd:C02350; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C02847; cpd:C03011; cpd:C03135; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06002; cpd:C06395; cpd:C06396; cpd:C06805; cpd:C16116; cpd:C18904; cpd:C20254; cpd:C21030; cpd:C21172,4,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O3,C4H5O3,102.0316941,103.0395191,101.023869255,324,cpd:C00207,Acetone;,C3H6O,Acetone; Dimethyl ketone; 2-Propanone,R01366 R01550 R01553 R03796 R05564 R05568 R05735 R08207; R08543 R09002 R09487 R10703 R10704,Synthesis and degradation of ketone bodies; Propanoate metabolism; Metabolic pathways,1.1.1.80; 1.1.1.-; 1.14.13.102; 1.14.13.115; 1.14.13.226; 1.14.15.-; 2.6.3.1; 4.1.1.4; 4.1.2.46; 4.1.99.16; 4.2.3.22; 6.4.1.6,"Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone",Pharmaceutical additives [BR:br08316];  Solubilizing agent;   D02311  [001018] Acetone;  Solubilizer;   D02311  [001018] Acetone;  Solubilization agent;   D02311  [001018] Acetone;  Solvent;   D02311  [001018] Acetone,CAS: 67-64-1; PubChem: 3507; ChEBI: 15347; ChEMBL: CHEMBL14253; LIPIDMAPS: LMFA12000057; KNApSAcK: C00048304 C00048954; PDB-CCD: ACN; 3DMET: B00058; NIKKAJI: J2.365E,cpd:C00207; cpd:C00479; cpd:C02001; cpd:C08389; cpd:C11119; cpd:C11506; cpd:C11507; cpd:C14399; cpd:C15508; cpd:C19175; cpd:C19224; cpd:C19282,3,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O1,C3H5O1,58.04186481,59.04968985,57.03403978256,325,cpd:C00356,(S)-3-Hydroxy-3-methylglutaryl-CoA;,C27H44N7O20P3S,(S)-3-Hydroxy-3-methylglutaryl-CoA; Hydroxymethylglutaryl-CoA; Hydroxymethylglutaroyl coenzyme A; HMG-CoA; 3-Hydroxy-3-methylglutaryl-CoA,R01360 R01978 R02081 R02082 R02083 R02084 R02085,"Synthesis and degradation of ketone bodies; Valine, leucine and isoleucine degradation; Butanoate metabolism; Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; HMG-CoA reductase inhibitors",1.1.1.34; 1.1.1.88; 2.3.3.10; 2.8.3.13; 3.1.2.5; 4.1.3.4; 4.2.1.18,"Leucine degradation, leucine => acetoacetate + acetyl-CoA; Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone; C5 isoprenoid biosynthesis, mevalonate pathway",NA,CAS: 1553-55-5; PubChem: 3649; ChEBI: 15467; ChEMBL: CHEMBL1794644; KNApSAcK: C00007270; PDB-CCD: HMG; 3DMET: B04674,cpd:C00356; cpd:C14145,27,44,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O20N7P3S1,C27H43O20N7P3S1,911.157469,912.165294,910.149644257,326,cpd:C01089,(R)-3-Hydroxybutanoate;,C4H8O3,(R)-3-Hydroxybutanoate; (R)-3-Hydroxybutanoic acid; (R)-3-Hydroxybutyric acid; D-beta-Hydroxybutyric acid,R00048 R01361,Synthesis and degradation of ketone bodies; Butanoate metabolism; Metabolic pathways; cAMP signaling pathway,1.1.1.30; 3.1.1.22,"Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Hydroxycarboxylic acids;     C01089  (R)-3-Hydroxybutanoate,CAS: 625-72-9; PubChem: 4324; ChEBI: 10983 17066; ChEMBL: CHEMBL1162484; LIPIDMAPS: LMFA01050005 LMFA01050243; LipidBank: DFA0271; PDB-CCD: 3HR; 3DMET: B00239; NIKKAJI: J5.217E,cpd:C00152; cpd:C00989; cpd:C01043; cpd:C01089; cpd:C01188; cpd:C01905; cpd:C01991; cpd:C02037; cpd:C02642; cpd:C03197; cpd:C03804; cpd:C05984; cpd:C06001; cpd:C14601; cpd:C15533; cpd:C16438; cpd:C19258; cpd:C19301; cpd:C21297,4,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O3,C4H7O3,104.0473441,105.0551691,103.0395191258,330,cpd:C08281,Docosanoic acid;,C22H44O2,Docosanoic acid; Docosanoate; Behenic acid,R08184 R09454,"Cutin, suberine and wax biosynthesis; Biosynthesis of unsaturated fatty acids",1.14.-.-; 3.1.2.-,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C08281  Behenic acid (22:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C08281  Docosanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C08281  Behenic acid; Pharmaceutical additives [BR:br08316];  Base;   C08281  [122107] Behenic acid,CAS: 112-85-6; PubChem: 10479; ChEBI: 23858 28941; ChEMBL: CHEMBL1173474; LIPIDMAPS: LMFA01010022; LipidBank: DFA0022; KNApSAcK: C00001211; 3DMET: B02157; NIKKAJI: J2.461I,cpd:C08281,22,44,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H45O2,C22H43O2,340.3341307,341.3419557,339.3263056259,331,cpd:C08285,"10,16-Dihydroxyhexadecanoic acid;",C16H32O4,"10,16-Dihydroxyhexadecanoic acid; Hexadecanoic acid, 10,16-dihydroxy-",R09460,"Cutin, suberine and wax biosynthesis",1.14.-.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0105 Hydroxy fatty acids;     C08285  10,16-Dihydroxyhexadecanoic acid",CAS: 3233-90-7; PubChem: 10483; ChEBI: 692; LIPIDMAPS: LMFA01050341; KNApSAcK: C00007440; 3DMET: B05260; NIKKAJI: J1.900.757J,cpd:C08285,16,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H33O4,C16H31O4,288.2300595,289.2378845,287.2222345260,332,cpd:C18217,16-Feruloyloxypalmitate;,C26H40O6,16-Feruloyloxypalmitate; 16-Feruloyloxypalmitic acid,R09106,"Cutin, suberine and wax biosynthesis",2.3.1.188,NA,NA,PubChem: 103061399; ChEBI: 55330; NIKKAJI: J1.135.019D,cpd:C18217,26,40,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H41O6,C26H39O6,448.282489,449.290314,447.274664261,333,cpd:C18218,16-Hydroxypalmitate;,C16H32O3,16-Hydroxypalmitate; 16-Hydroxypalmitic acid,R09106 R09448 R09451 R09460,"Cutin, suberine and wax biosynthesis; Metabolic pathways",1.1.-.-; 1.14.-.-; 2.3.1.188,NA,NA,PubChem: 103061400; ChEBI: 55328; LIPIDMAPS: LMFA01050051; KNApSAcK: C00007430 C00034997; PDB-CCD: 16Y; NIKKAJI: J11.795A,cpd:C18218,16,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H33O3,C16H31O3,272.2351449,273.2429699,271.2273199262,334,cpd:C19418,"cis-9,10-Epoxystearic acid",C18H34O3,"cis-9,10-Epoxystearic acid",R09453 R09462 R09465,"Cutin, suberine and wax biosynthesis",1.11.2.3; 1.14.-.-; 3.3.2.-,NA,"Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C19418  cis-9,10-Epoxystearic acid",CAS: 2443-39-2; PubChem: 124490090; ChEBI: 82464; ChEMBL: CHEMBL27918,cpd:C00869; cpd:C08365; cpd:C13791; cpd:C19418; cpd:C19616,18,34,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H35O3,C18H33O3,298.250795,299.25862,297.2429699263,335,cpd:C19614,16-Oxopalmitate,C16H30O3,16-Oxopalmitate,R09448 R09457,"Cutin, suberine and wax biosynthesis; Metabolic pathways",1.1.-.-; 1.2.-.-,NA,NA,PubChem: 124490282,cpd:C19614,16,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H31O3,C16H29O3,270.2194948,271.2273199,269.2116698264,336,cpd:C19615,Hexadecanedioate,C16H30O4,Hexadecanedioate,R09457,"Cutin, suberine and wax biosynthesis; Metabolic pathways",1.2.-.-,NA,NA,PubChem: 135626103; ChEBI: 73722; LIPIDMAPS: LMFA01170022; KNApSAcK: C00007429,cpd:C14987; cpd:C19615,16,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H31O4,C16H29O4,286.2144094,287.2222345,285.2065844265,337,cpd:C19616,18-Hydroxyoleate,C18H34O3,18-Hydroxyoleate,R09452 R09455 R09463,"Cutin, suberine and wax biosynthesis",1.1.-.-; 1.11.2.3; 1.14.-.-,NA,NA,PubChem: 135626104; ChEBI: 78424 79312; LIPIDMAPS: LMFA02000181; KNApSAcK: C00007439,cpd:C00869; cpd:C08365; cpd:C13791; cpd:C19418; cpd:C19616,18,34,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H35O3,C18H33O3,298.250795,299.25862,297.2429699266,338,cpd:C19617,18-Oxooleate,C18H32O3,18-Oxooleate,R09455 R09458,"Cutin, suberine and wax biosynthesis",1.1.-.-; 1.2.-.-,NA,NA,PubChem: 135626105; ChEBI: 133357,cpd:C08318; cpd:C08368; cpd:C14762; cpd:C14767; cpd:C14825; cpd:C14826; cpd:C19617,18,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O3,C18H31O3,296.2351449,297.2429699,295.2273199267,339,cpd:C19618,"Octadec-9-ene-1,18-dioic-acid",C18H32O4,"Octadec-9-ene-1,18-dioic-acid",R09458,"Cutin, suberine and wax biosynthesis",1.2.-.-,NA,NA,PubChem: 135626106; LIPIDMAPS: LMFA01170055,cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703,18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O4,C18H31O4,312.2300595,313.2378845,311.2222345268,340,cpd:C19620,"9,10-Epoxy-18-hydroxystearate",C18H34O4,"9,10-Epoxy-18-hydroxystearate",R09453 R09463 R09464,"Cutin, suberine and wax biosynthesis",1.11.2.3; 1.14.-.-; 3.3.2.-,NA,NA,PubChem: 135626108; ChEBI: 133381; KNApSAcK: C00034432,cpd:C07355; cpd:C14828; cpd:C14829; cpd:C19620; cpd:C20702,18,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H35O4,C18H33O4,314.2457096,315.2535346,313.2378845269,341,cpd:C19621,"9,10,18-Trihydroxystearate",C18H36O5,"9,10,18-Trihydroxystearate",R09461 R09464,"Cutin, suberine and wax biosynthesis",1.14.-.-; 3.3.2.-,NA,NA,PubChem: 135626109; ChEBI: 133325; LIPIDMAPS: LMFA02000147; KNApSAcK: C00034431,cpd:C16566; cpd:C17989; cpd:C17993; cpd:C19621,18,36,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H37O5,C18H35O5,332.2562743,333.2640993,331.2484492270,342,cpd:C19622,"9,10-Dihydroxystearate",C18H36O4,"9,10-Dihydroxystearate",R09461 R09465,"Cutin, suberine and wax biosynthesis",1.14.-.-; 3.3.2.-,NA,NA,PubChem: 135626110; LIPIDMAPS: LMFA02000142,cpd:C08314; cpd:C15988; cpd:C19622,18,36,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H37O4,C18H35O4,316.2613596,317.2691847,315.2535346271,343,cpd:C19623,22-Hydroxydocosanoate,C22H44O3,22-Hydroxydocosanoate,R09454 R09456,"Cutin, suberine and wax biosynthesis",1.1.-.-; 1.14.-.-,NA,NA,PubChem: 135626111; ChEBI: 76322; LIPIDMAPS: LMFA01050079; KNApSAcK: C00035005,cpd:C03049; cpd:C19623,22,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H45O3,C22H43O3,356.3290453,357.3368703,355.3212202272,344,cpd:C19624,22-Oxodocosanoate,C22H42O3,22-Oxodocosanoate,R09456 R09459,"Cutin, suberine and wax biosynthesis",1.1.-.-; 1.2.-.-,NA,NA,PubChem: 135626112; ChEBI: 76318,cpd:C19624,22,42,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H43O3,C22H41O3,354.3133952,355.3212202,353.3055702273,345,cpd:C19625,Docosanedioate,C22H42O4,Docosanedioate,R09459,"Cutin, suberine and wax biosynthesis",1.2.-.-,NA,NA,PubChem: 135626113; ChEBI: 76319; LIPIDMAPS: LMFA01170037,cpd:C14240; cpd:C19625,22,42,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H43O4,C22H41O4,370.3083098,371.3161349,369.3004848274,346,cpd:C00187,Cholesterol;,C27H46O,Cholesterol; Cholest-5-en-3beta-ol,R01451 R01452 R01453 R01454 R01456 R01457 R01459 R01460; R01461 R01462 R01463 R02692 R02723 R02724 R07207 R07218; R08505 R08941 R08977 R09920 R11007 R11008,Steroid biosynthesis; Primary bile acid biosynthesis; Steroid hormone biosynthesis; Insect hormone biosynthesis; Steroid degradation; Biosynthesis of alkaloids derived from terpenoid and polyketide; Metabolic pathways; Microbial metabolism in diverse environments; Ovarian steroidogenesis; Aldosterone synthesis and secretion; Fat digestion and absorption; Bile secretion; Vitamin digestion and absorption; Pathways in cancer; Basal cell carcinoma,1.1.1.145; 1.1.3.6; 1.3.1.21; 1.3.1.72; 1.14.13.-; 1.14.14.23; 1.14.14.25; 1.14.15.6; 1.14.15.15; 1.14.19.21; 1.14.99.38; 2.3.1.26; 2.3.1.73; 2.8.2.2; 2.8.2.14; 3.1.1.13; 3.1.6.2; 3.2.1.104; 5.3.3.1,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol; Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate; Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone",Compounds with biological roles [BR:br08001];  Steroids;   27-Carbon atoms;    Cholestane derivatives;     C00187  Cholesterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C00187  Cholesterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Cholestane;     C00187  Cholesterol; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00187  Cholesterol; Pharmaceutical additives [BR:br08316];  Surfactant;   D00040  [001255] Cholesterol;  Base;   D00040  [001255] Cholesterol;  Diluting agent;   D00040  [001255] Cholesterol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00040  Cholesterol,CAS: 57-88-5; PubChem: 3487; ChEBI: 16113; ChEMBL: CHEMBL112570 CHEMBL1867358; LIPIDMAPS: LMST01010001; LipidBank: SST0005 SST9061; KNApSAcK: C00003648; PDB-CCD: CLR; 3DMET: B01181; NIKKAJI: J2.804E,cpd:C00187; cpd:C01189; cpd:C03091; cpd:C03238; cpd:C03845; cpd:C05417; cpd:C05423; cpd:C15337; cpd:C19663,27,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O1,C27H45O1,386.3548661,387.3626911,385.3470411275,347,cpd:C00448,"trans,trans-Farnesyl diphosphate;",C15H28O7P2,"trans,trans-Farnesyl diphosphate; Farnesyl diphosphate; Farnesyl pyrophosphate; 2-trans,6-trans-Farnesyl diphosphate; (2E,6E)-Farnesyl diphosphate",R00702 R02003 R02061 R02303 R02305 R02306 R02307 R02310; R02311 R05555 R05556 R06223 R06447 R06523 R07411 R07630; R07647 R07648 R07649 R07652 R07830 R08144 R08370 R08373; R08374 R08540 R08541 R08542 R08543 R08545 R08546 R08691; R08695 R08696 R08697 R08746 R09064 R09065 R09140 R09245; R09247 R09248 R09249 R09525 R09526 R09558 R09574 R09606; R09614 R09615 R09616 R09617 R09618 R09619 R09620 R09623; R09624 R09626 R09627 R09628 R09629 R09630 R09788 R09789; R09844 R09850 R09886 R09887 R09888 R09889 R09890 R09891; R09892 R09893 R09894 R09895 R09896 R09897 R09898 R09900; R09901 R09902 R09976 R10004 R10005 R10006 R10007 R10008; R10271 R10272 R10273 R10274 R10275 R10493 R10584 R10598; R10599 R10726 R10732 R10733 R10734,Steroid biosynthesis; Terpenoid backbone biosynthesis; Carotenoid biosynthesis; Sesquiterpenoid and triterpenoid biosynthesis; Insect hormone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.5.1.10; 2.5.1.21; 2.5.1.29; 2.5.1.30; 2.5.1.31; 2.5.1.58; 2.5.1.83; 2.5.1.87; 2.5.1.90; 2.5.1.91; 2.5.1.96; 2.5.1.103; 2.5.1.-; 2.7.4.18; 3.1.3.-; 3.1.7.6; 3.1.7.7; 4.1.99.16; 4.2.3.6; 4.2.3.7; 4.2.3.9; 4.2.3.13; 4.2.3.21; 4.2.3.22; 4.2.3.23; 4.2.3.24; 4.2.3.37; 4.2.3.38; 4.2.3.39; 4.2.3.40; 4.2.3.46; 4.2.3.47; 4.2.3.48; 4.2.3.49; 4.2.3.55; 4.2.3.56; 4.2.3.57; 4.2.3.58; 4.2.3.59; 4.2.3.60; 4.2.3.61; 4.2.3.63; 4.2.3.64; 4.2.3.65; 4.2.3.66; 4.2.3.67; 4.2.3.68; 4.2.3.69; 4.2.3.70; 4.2.3.71; 4.2.3.72; 4.2.3.73; 4.2.3.74; 4.2.3.75; 4.2.3.76; 4.2.3.77; 4.2.3.78; 4.2.3.79; 4.2.3.80; 4.2.3.81; 4.2.3.82; 4.2.3.83; 4.2.3.84; 4.2.3.85; 4.2.3.86; 4.2.3.87; 4.2.3.88; 4.2.3.89; 4.2.3.90; 4.2.3.91; 4.2.3.92; 4.2.3.93; 4.2.3.94; 4.2.3.95; 4.2.3.96; 4.2.3.97; 4.2.3.98; 4.2.3.100; 4.2.3.101; 4.2.3.102; 4.2.3.104; 4.2.3.123; 4.2.3.125; 4.2.3.126; 4.2.3.127; 4.2.3.128; 4.2.3.129; 4.2.3.133; 4.2.3.135; 4.2.3.136; 4.2.3.137; 4.2.3.138; 4.2.3.139; 4.2.3.143; 5.5.1.-,"C10-C20 isoprenoid biosynthesis, bacteria; C10-C20 isoprenoid biosynthesis, archaea; C10-C20 isoprenoid biosynthesis, plants; C10-C20 isoprenoid biosynthesis, non-plant eukaryotes; Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone","Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010301 Acyclic farnesane sesquiterpenoids;      C00448  trans,trans-Farnesyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Farnesenes;     C00448  Farnesyl diphosphate",CAS: 372-97-4; PubChem: 3736; ChEBI: 17407; ChEMBL: CHEMBL69330; LIPIDMAPS: LMPR0103010002; LipidBank: IIP0005; KNApSAcK: C00000907 C00007268; PDB-CCD: FPP; 3DMET: B01245; NIKKAJI: J348.314B,cpd:C00448; cpd:C06111; cpd:C16826; cpd:C19760; cpd:C19853,15,28,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H29O7P2,C15H27O7P2,382.1310272,383.1388523,381.1232022276,348,cpd:C00751,Squalene;,C30H50,Squalene; Spinacene; Supraene,R02872 R02873 R02874 R02875 R02876 R06223 R07322 R07323; R08535 R09712 R10167 R10169 R11401,Steroid biosynthesis; Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.3.1.96; 1.14.14.17; 1.17.8.1; 2.1.1.262; 2.5.1.21; 4.2.1.123; 4.2.1.129; 5.4.99.17; 5.4.99.37,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010601 Acyclic triterpenoids;      C00751  Squalene; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Liner triterpenes;     C00751  Squalene; Pharmaceutical additives [BR:br08316];  Base;   C00751  [508064] Squalene;  Flexibilizer;   C00751  [508064] Squalene;  Emulsion;   C00751  [508064] Squalene;  Solubilizer;   C00751  [508064] Squalene;  Solvent;   C00751  [508064] Squalene,CAS: 111-02-4; PubChem: 4013; ChEBI: 15440; ChEMBL: CHEMBL458402; LIPIDMAPS: LMPR0106010002; LipidBank: SST0122; KNApSAcK: C00003755; PDB-CCD: SQL; 3DMET: B00166; NIKKAJI: J5.103I,cpd:C00751; cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C03685; cpd:C04930; cpd:C04934; cpd:C06310; cpd:C08615; cpd:C08616; cpd:C08618; cpd:C08622; cpd:C08624; cpd:C08625; cpd:C08626; cpd:C08628; cpd:C08634; cpd:C08636; cpd:C08637; cpd:C08789; cpd:C08931; cpd:C08980; cpd:C11523; cpd:C15274; cpd:C16783; cpd:C16958; cpd:C16973; cpd:C17419; cpd:C17421; cpd:C17459; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19732; cpd:C19733; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19834; cpd:C19835; cpd:C19918; cpd:C19942; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C20432; cpd:C20945; cpd:C21116,30,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51,C30H49,410.3912516,411.3990766,409.3834266277,349,cpd:C01054,"(S)-2,3-Epoxysqualene;",C30H50O,"(S)-2,3-Epoxysqualene; Squalene 2,3-epoxide; Squalene 2,3-oxide; (S)-Squalene-2,3-epoxide; 2,3-Oxidosqualene; (3S)-2,3-Epoxy-2,3-dihydrosqualene",R02116 R02873 R02874 R03199 R03200 R03201 R06466 R06469; R06471 R08376 R08378 R09476 R09688 R09689 R09700 R09701; R09709 R09710 R09711 R09713 R09743 R09906 R09907 R09908; R09909 R09910 R09911 R09912 R09913 R09914 R09915 R09916; R09917,Steroid biosynthesis; Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.14.14.17; 4.2.1.124; 4.2.1.125; 4.2.1.128; 5.4.99.7; 5.4.99.8; 5.4.99.31; 5.4.99.32; 5.4.99.33; 5.4.99.34; 5.4.99.35; 5.4.99.36; 5.4.99.38; 5.4.99.39; 5.4.99.40; 5.4.99.41; 5.4.99.46; 5.4.99.47; 5.4.99.48; 5.4.99.49; 5.4.99.50; 5.4.99.51; 5.4.99.52; 5.4.99.53; 5.4.99.54; 5.4.99.55; 5.4.99.56; 5.4.99.57,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol","Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010601 Acyclic triterpenoids;      C01054  (S)-2,3-Epoxysqualene; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Liner triterpenes;     C01054  (S)-2,3-Epoxysqualene",PubChem: 4295; ChEBI: 15441; LIPIDMAPS: LMPR0106010010; KNApSAcK: C00007282; PDB-CCD: 2TX; 3DMET: B01371; NIKKAJI: J39.259F,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.3783412278,350,cpd:C01164,7-Dehydrocholesterol;,C27H44O,"7-Dehydrocholesterol; Provitamin D3; Cholesta-5,7-dien-3beta-ol",R01451 R01456 R03311 R07215 R07507 R08132 R11007 R11008,Steroid biosynthesis; Insect hormone biosynthesis; Metabolic pathways,1.3.1.21; 1.3.1.72; 1.14.19.20; 1.14.19.21,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol; Cholecalciferol biosynthesis",Compounds with biological roles [BR:br08001];  Steroids;   27-Carbon atoms;    Cholestane derivatives;     C01164  7-Dehydrocholesterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST03 Secosteroids;    ST0302 Vitamin D3 and derivatives;     C01164  Provitamin D3,CAS: 434-16-2; PubChem: 4391; ChEBI: 17759; ChEMBL: CHEMBL1797131; LIPIDMAPS: LMST01010069; LipidBank: SST0007; KNApSAcK: C00023747; 3DMET: B01398; NIKKAJI: J60.101B,cpd:C00599; cpd:C01164; cpd:C01802; cpd:C05104; cpd:C05437; cpd:C05439; cpd:C05443; cpd:C07711,27,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O1,C27H43O1,384.339216,385.3470411,383.331391279,351,cpd:C01189,Lathosterol;,C27H46O,Lathosterol; 5alpha-Cholest-7-en-3beta-ol,R03353 R04328 R05703 R07215,Steroid biosynthesis; Metabolic pathways,1.1.1.170; 1.1.1.270; 1.3.1.72; 1.14.13.72; 1.14.19.20; 5.3.3.5,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C01189  Lathosterol,CAS: 80-99-9; PubChem: 4415; ChEBI: 17168; LIPIDMAPS: LMST01010089; LipidBank: SST9096; KNApSAcK: C00023744; 3DMET: B01406; NIKKAJI: J9.827B,cpd:C00187; cpd:C01189; cpd:C03091; cpd:C03238; cpd:C03845; cpd:C05417; cpd:C05423; cpd:C15337; cpd:C19663,27,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O1,C27H45O1,386.3548661,387.3626911,385.3470411280,352,cpd:C01561,Calcidiol;,C27H44O2,"Calcidiol; 25-Hydroxyvitamin D3; Calcifediol; Calcifediol anhydrous; (3S,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-3,25-diol",R03610 R03611 R09516 R11458 R11459,Steroid biosynthesis; Metabolic pathways; Tuberculosis,1.14.14.24; 1.14.15.16; 1.14.15.18; 1.14.15.22,Cholecalciferol biosynthesis,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST03 Secosteroids;    ST0302 Vitamin D3 and derivatives;     C01561  Calcidiol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;     A11CC Vitamin D and analogues;      A11CC06 Calcifediol;       C01561  Calcidiol",CAS: 19356-17-3; PubChem: 4719; ChEBI: 17933; ChEMBL: CHEMBL1040 CHEMBL15596 CHEMBL1599212; LIPIDMAPS: LMST03020246; LipidBank: VVD0273; KNApSAcK: C00040805; PDB-CCD: VDY; 3DMET: B04804; NIKKAJI: J9.697K,cpd:C01561; cpd:C05455; cpd:C15632; cpd:C19662; cpd:C20143; cpd:C21303,27,44,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O2,C27H43O2,400.3341307,401.3419557,399.3263056281,353,cpd:C01673,Calcitriol;,C27H44O3,"Calcitriol; 1alpha,25-Dihydroxyvitamin D3; (1S,3R,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-1,3,25-triol",R03610 R09515 R11459,Steroid biosynthesis; Metabolic pathways; Endocrine and other factor-regulated calcium reabsorption; Mineral absorption; Tuberculosis,1.14.15.16; 1.14.15.18; 1.14.15.22,Cholecalciferol biosynthesis,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Others;     C01673  Calcitriol (Vitamin D); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;     A11CC Vitamin D and analogues;      A11CC04 Calcitriol;       D00129  Calcitriol (JAN/USP/INN);  D DERMATOLOGICALS;   D05 ANTIPSORIATICS;    D05A ANTIPSORIATICS FOR TOPICAL USE;     D05AX Other antipsoriatics for topical use;      D05AX03 Calcitriol;       D00129  Calcitriol (JAN/USP/INN); USP drug classification [BR:br08302];  Dermatological Agents;   Calcitriol;    D00129  Calcitriol (JAN/USP/INN);  Metabolic Bone Disease Agents;   Calcitriol;    D00129  Calcitriol (JAN/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    311  Vitamins A and D preparations;     3112  Synthetic vitamin D preparations;      D00129  Calcitriol (JAN/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Vitamin D3 like receptor;     vitamin D receptor;      Calcitriol;       D00129  Calcitriol (JAN/USP/INN); Osteoporosis drugs [br08368.html];  D00129; Rx-to-OTC switch list in Japan [br08314.html];  D00129",CAS: 32222-06-3; PubChem: 4817; ChEBI: 17823; ChEMBL: CHEMBL267223 CHEMBL297508 CHEMBL298498 CHEMBL55542 CHEMBL846; LIPIDMAPS: LMST03020258; PDB-CCD: VDX; 3DMET: B01476; NIKKAJI: J17.427K,cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650,27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O3,C27H43O3,416.3290453,417.3368703,415.3212202282,354,cpd:C01694,Ergosterol;,C28H44O,Ergosterol; Provitamin D2,R03675 R03677 R05641,Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.3.1.71; 4.2.1.62,Ergocalciferol biosynthesis,Compounds with biological roles [BR:br08001];  Steroids;   28-Carbon atoms;    Ergostane derivatives;     C01694  Ergosterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C01694  Ergosterol;   ST03 Secosteroids;    ST0301 Vitamin D2 and derivatives;     C01694  Ergosterol; Major components of natural products [BR:br08323];  Crude drugs;   Polyporus sclerotium;    C01694  Ergosterol,CAS: 57-87-4; PubChem: 4835; ChEBI: 16933; ChEMBL: CHEMBL1232562; LIPIDMAPS: LMST01030093; LipidBank: SST0012 SST9075 VVD0358; KNApSAcK: C00003652 C00023755; PDB-CCD: ERG; 3DMET: B01480; NIKKAJI: J209.317K,cpd:C01694; cpd:C05441; cpd:C08823; cpd:C15778; cpd:C15780; cpd:C15816; cpd:C19653,28,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O1,C28H43O1,396.339216,397.3470411,395.331391283,355,cpd:C01724,Lanosterol;,C30H50O,"Lanosterol; 4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol",R03199 R03689 R05640,Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.3.1.72; 1.14.13.70; 5.4.99.7,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C01724  Lanosterol,CAS: 79-63-0; PubChem: 4861; ChEBI: 16521; ChEMBL: CHEMBL225111; LIPIDMAPS: LMST01010017; LipidBank: SST9081; KNApSAcK: C00003657; PDB-CCD: LAN; 3DMET: B01488; NIKKAJI: J4.237D,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.3783412284,356,cpd:C01753,beta-Sitosterol;,C29H50O,beta-Sitosterol; Sitosterol,R07488 R07489,Steroid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,1.3.1.-; 1.14.19.41,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C01753  Sitosterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Stigmastane;     C01753  beta-Sitosterol,CAS: 83-46-5; PubChem: 4886; ChEBI: 27693; ChEMBL: CHEMBL1875388 CHEMBL221542; LIPIDMAPS: LMST01040129; LipidBank: SST0017; KNApSAcK: C00003672 C00023770; 3DMET: B01493; NIKKAJI: J4.633G,cpd:C01753; cpd:C04530; cpd:C08839; cpd:C15915; cpd:C19654,29,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H51O1,C29H49O1,414.3861662,415.3939913,413.3783412285,357,cpd:C01789,Campesterol,C28H48O,Campesterol,R07427 R07445 R07493,Steroid biosynthesis; Brassinosteroid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.-; 1.14.13.-,"Castasterone biosynthesis, campesterol => castasterone",Compounds with biological roles [BR:br08001];  Steroids;   28-Carbon atoms;    Campestane derivatives;     C01789  Campesterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C01789  Campesterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Ergostane;     C01789  Campesterol,CAS: 474-62-4; PubChem: 4917; ChEBI: 28623; ChEMBL: CHEMBL1836653 CHEMBL520535; LIPIDMAPS: LMST01030097; LipidBank: SST0036 SST9062; KNApSAcK: C00003647; 3DMET: B01498; NIKKAJI: J5.962E,cpd:C01789; cpd:C05110; cpd:C05111; cpd:C08825; cpd:C08833; cpd:C15784; cpd:C15786; cpd:C19652; cpd:C21106,28,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O1,C28H47O1,400.3705162,401.3783412,399.3626911286,358,cpd:C01802,Desmosterol;,C27H44O,"Desmosterol; 24-Dehydrocholesterol; Cholesta-5,24-dien-3beta-ol",R01457 R03723 R03724 R03725 R04763,Steroid biosynthesis; Metabolic pathways,1.3.1.72; 4.1.2.33,NA,Compounds with biological roles [BR:br08001];  Steroids;   27-Carbon atoms;    Cholestane derivatives;     C01802  Desmosterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C01802  Desmosterol,CAS: 313-04-2; PubChem: 4928; ChEBI: 17737; ChEMBL: CHEMBL455876; LIPIDMAPS: LMST01010016 LMST01010090; LipidBank: SST0008 SST9090; KNApSAcK: C00023743; 3DMET: B01500; NIKKAJI: J5.659F,cpd:C00599; cpd:C01164; cpd:C01802; cpd:C05104; cpd:C05437; cpd:C05439; cpd:C05443; cpd:C07711,27,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O1,C27H43O1,384.339216,385.3470411,383.331391287,359,cpd:C01902,Cycloartenol;,C30H50O,"Cycloartenol; 9beta,19-Cyclo-24-lanosten-3beta-ol",R03200 R03765 R05760 R07481,Steroid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites,2.1.1.41; 2.1.1.142; 5.4.99.8,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0110 Cycloartanols and derivatives;     C01902  Cycloartenol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Cycloartane;     C01902  Cycloartenol,CAS: 469-38-5; PubChem: 5012; ChEBI: 17030; ChEMBL: CHEMBL2007217 CHEMBL225815 CHEMBL393145; LIPIDMAPS: LMST01100008; LipidBank: SST9083; KNApSAcK: C00003650; 3DMET: B01514; NIKKAJI: J11.335B,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.3783412288,360,cpd:C01943,Obtusifoliol;,C30H50O,"Obtusifoliol; 4alpha,14alpha-Dimethyl-5alpha-ergosta-8,24(28)-dien-3beta-ol; 4alpha,14alpha-Dimethyl-24-methylene-5alpha-cholesta-8-en-3beta-ol",R03775 R05731,Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.70; 5.5.1.9,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C01943  Obtusifoliol,CAS: 16910-32-0; PubChem: 5047; ChEBI: 17791; ChEMBL: CHEMBL1978954 CHEMBL481434; LIPIDMAPS: LMST01030101; LipidBank: SST9079; KNApSAcK: C00007368; 3DMET: B01520; NIKKAJI: J69.979I,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.3783412289,361,cpd:C02141,Cycloeucalenol,C30H50O,Cycloeucalenol,R03775 R07482,Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.72; 5.5.1.9,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0110 Cycloartanols and derivatives;     C02141  Cycloeucalenol,CAS: 469-39-6; PubChem: 5220; ChEBI: 16653; ChEMBL: CHEMBL225634; LIPIDMAPS: LMST01100011; LipidBank: SST9080; KNApSAcK: C00007367; 3DMET: B01539; NIKKAJI: J11.336K,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.3783412290,363,cpd:C03428,Presqualene diphosphate,C30H52O7P2,Presqualene diphosphate,R00702 R02872 R09793 R10194 R11410,Steroid biosynthesis; Carotenoid biosynthesis; Sesquiterpenoid and triterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.3.1.96; 1.3.1.97; 2.5.1.21; 2.5.1.96; 2.5.1.103; 4.2.3.156,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010601 Acyclic triterpenoids;      C03428  Presqualene diphosphate,PubChem: 6255; ChEBI: 15442; LIPIDMAPS: LMPR0106010003; PDB-CCD: PS7; 3DMET: B01658; NIKKAJI: J816.761C,cpd:C01230; cpd:C03428; cpd:C17434,30,52,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H53O7P2,C30H51O7P2,586.318828,587.326653,585.311003291,364,cpd:C03845,5alpha-Cholest-8-en-3beta-ol;,C27H46O,5alpha-Cholest-8-en-3beta-ol; Zymostenol; Cholestenol,R03353 R07498,Steroid biosynthesis; Metabolic pathways,1.3.1.72; 5.3.3.5,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol",NA,CAS: 566-97-2; PubChem: 6582; ChEBI: 16608; LIPIDMAPS: LMST01010096; KNApSAcK: C00033775; 3DMET: B01693; NIKKAJI: J488.411F,cpd:C00187; cpd:C01189; cpd:C03091; cpd:C03238; cpd:C03845; cpd:C05417; cpd:C05423; cpd:C15337; cpd:C19663,27,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O1,C27H45O1,386.3548661,387.3626911,385.3470411292,365,cpd:C04525,Fecosterol;,C28H46O,Fecosterol; 24-Methylene-5alpha-cholest-8-en-3beta-ol,R04427 R07497,Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,2.1.1.41,Ergocalciferol biosynthesis,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C04525  24-Methylene-5alpha-cholest-8-en-3beta-ol;    ST0103 Ergosterols and C24-methyl derivatives;     C04525  Fecosterol,CAS: 516-86-9; PubChem: 7136; ChEBI: 17038; LIPIDMAPS: LMST01030095; KNApSAcK: C00023751; 3DMET: B01753; NIKKAJI: J16.117I,cpd:C04453; cpd:C04525; cpd:C05103; cpd:C06957; cpd:C08813; cpd:C15777; cpd:C15781; cpd:C15785; cpd:C18192,28,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O1,C28H45O1,398.3548661,399.3626911,397.3470411293,366,cpd:C05103,4alpha-Methylzymosterol,C28H46O,4alpha-Methylzymosterol,R07495 R07496,Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.1.1.270,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05103  4alpha-Methylzymosterol,PubChem: 7531; ChEBI: 1949; LIPIDMAPS: LMST01010202; KNApSAcK: C00023768; 3DMET: B04976; NIKKAJI: J669.213C,cpd:C04453; cpd:C04525; cpd:C05103; cpd:C06957; cpd:C08813; cpd:C15777; cpd:C15781; cpd:C15785; cpd:C18192,28,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O1,C28H45O1,398.3548661,399.3626911,397.3470411294,367,cpd:C05107,7-Dehydrodesmosterol;,C27H42O,"7-Dehydrodesmosterol; Cholesta-5,7,24-triene-3beta-ol",R03724 R04667 R07507,Steroid biosynthesis; Metabolic pathways,1.3.1.72,NA,NA,CAS: 1715-86-2; PubChem: 7533; ChEBI: 27910; LIPIDMAPS: LMST01010121; 3DMET: B01809; NIKKAJI: J2.754.720F,cpd:C05107; cpd:C15357,27,42,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O1,C27H41O1,382.323566,383.331391,381.3157409295,368,cpd:C05108,14-Demethyllanosterol;,C29H48O,"14-Demethyllanosterol; 4,4-Dimethyl-5alpha-cholesta-8,24-dien-3beta-ol; 4,4-Dimethyl-8,24-cholestadienol",R05639 R07499 R07509,Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.3.1.70; 1.3.1.72; 1.14.13.72,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05108  14-Demethyllanosterol,CAS: 7448-02-4; PubChem: 7534; ChEBI: 18364; LIPIDMAPS: LMST01010176; KNApSAcK: C00023776; 3DMET: B04978; NIKKAJI: J14.903I,cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193,29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H49O1,C29H47O1,412.3705162,413.3783412,411.3626911296,369,cpd:C05109,"24,25-Dihydrolanosterol",C30H52O,"24,25-Dihydrolanosterol",R03689 R04670,Steroid biosynthesis,1.3.1.72,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05109  24,25-Dihydrolanosterol",CAS: 79-62-9; PubChem: 7535; ChEBI: 28113; ChEMBL: CHEMBL132906; LIPIDMAPS: LMST01010087; KNApSAcK: C00023781; 3DMET: B01810; NIKKAJI: J40.430F,cpd:C05109; cpd:C06083; cpd:C06309; cpd:C17123,30,52,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H53O1,C30H51O1,428.4018163,429.4096413,427.3939913297,370,cpd:C05437,Zymosterol;,C27H44O,"Zymosterol; Delta8,24-Cholestadien-3beta-ol; 5alpha-Cholesta-8,24-dien-3beta-ol",R03765 R04427 R04804 R07496 R07498,Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.3.1.72; 2.1.1.41; 5.3.3.5,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol; Ergocalciferol biosynthesis",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05437  Zymosterol,CAS: 128-33-6; PubChem: 7800; ChEBI: 18252; LIPIDMAPS: LMST01010066; LipidBank: SST9103; KNApSAcK: C00023749; 3DMET: B01856; NIKKAJI: J10.048J,cpd:C00599; cpd:C01164; cpd:C01802; cpd:C05104; cpd:C05437; cpd:C05439; cpd:C05443; cpd:C07711,27,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O1,C27H43O1,384.339216,385.3470411,383.331391298,371,cpd:C05439,"5alpha-Cholesta-7,24-dien-3beta-ol",C27H44O,"5alpha-Cholesta-7,24-dien-3beta-ol",R04667 R04804 R05703,Steroid biosynthesis; Metabolic pathways,1.3.1.72; 5.3.3.5,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05439  5alpha-Cholesta-7,24-dien-3beta-ol",CAS: 651-54-7; PubChem: 7801; ChEBI: 16290; LIPIDMAPS: LMST01010206; 3DMET: B05022; NIKKAJI: J530.073H,cpd:C00599; cpd:C01164; cpd:C01802; cpd:C05104; cpd:C05437; cpd:C05439; cpd:C05443; cpd:C07711,27,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O1,C27H43O1,384.339216,385.3470411,383.331391299,372,cpd:C05440,"Ergosta-5,7,22,24(28)-tetraen-3beta-ol;",C28H42O,"Ergosta-5,7,22,24(28)-tetraen-3beta-ol; Ergosta-5,7,22,24(24(1))-tetraen-3beta-ol; 5,7,22,24(28)-Ergostatetraenol",R04763 R05641 R07506,Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.3.1.71; 1.14.19.41,Ergocalciferol biosynthesis,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C05440  Ergosta-5,7,22,24(28)-tetraen-3beta-ol;   ST03 Secosteroids;    ST0301 Vitamin D2 and derivatives;     C05440  Ergosta-5,7,22,24(28)-tetraen-3beta-ol",PubChem: 7802; ChEBI: 18249; LIPIDMAPS: LMST01031015; KNApSAcK: C00023764; 3DMET: B05023; NIKKAJI: J492.623D,cpd:C05440,28,42,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H43O1,C28H41O1,394.323566,395.331391,393.3157409300,373,cpd:C05441,Vitamin D2;,C28H44O,Vitamin D2; Ergocalciferol,R03677,Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,NA,Ergocalciferol biosynthesis,"Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Fat-soluble vitamins;     C05441  Ergocalciferol (Vitamin D2); Lipids [BR:br08002];  ST  Sterol Lipids;   ST03 Secosteroids;    ST0301 Vitamin D2 and derivatives;     C05441  Vitamin D2; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;     A11CC Vitamin D and analogues;      A11CC01 Ergocalciferol;       D00187  Ergocalciferol (JP17/USP); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   39 Vitamin AD based drugs;    D00187  Ergocalciferol (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Ergocalciferol or Cholecalciferol;     D00187  Ergocalciferol (JP17/USP);  Third-class OTC drugs;   Inorganic and organic chemicals;    Ergocalciferol;     D00187  Ergocalciferol (JP17/USP); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Vitamin D3 like receptor;     vitamin D receptor;      Ergocalciferol;       D00187  Ergocalciferol (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00187  Ergocalciferol",CAS: 50-14-6; PubChem: 7803; ChEBI: 28934; ChEMBL: CHEMBL1436587 CHEMBL1536 CHEMBL50241; LIPIDMAPS: LMST03010000 LMST03010001; LipidBank: VVD0351; PDB-CCD: D2V; 3DMET: B01857; NIKKAJI: J1.907K,cpd:C01694; cpd:C05441; cpd:C08823; cpd:C15778; cpd:C15780; cpd:C15816; cpd:C19653,28,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O1,C28H43O1,396.339216,397.3470411,395.331391301,374,cpd:C05442,Stigmasterol,C29H48O,Stigmasterol,R07489,Steroid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,1.14.19.41,NA,Compounds with biological roles [BR:br08001];  Steroids;   29-Carbon atoms;    Stigmastane derivatives;     C05442  Stigmasterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C05442  Stigmasterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Stigmastane;     C05442  Stigmasterol; Major components of natural products [BR:br08323];  Medicinal herbs;   Pumpkin seed;    C05442  Stigmasterol,CAS: 83-48-7; PubChem: 7804; ChEBI: 28824; ChEMBL: CHEMBL186373 CHEMBL400247 CHEMBL66943; LIPIDMAPS: LMST01040123; LipidBank: SST9068; KNApSAcK: C00003674 C00023774; 3DMET: B01858; NIKKAJI: J4.635C,cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193,29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H49O1,C29H47O1,412.3705162,413.3783412,411.3626911302,375,cpd:C05443,Vitamin D3;,C27H44O,Vitamin D3; Cholecalciferol; Calciol,R03311 R03611 R11458,Steroid biosynthesis; Metabolic pathways; Vitamin digestion and absorption; Rheumatoid arthritis,1.14.14.24; 1.14.15.22,Cholecalciferol biosynthesis,"Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Fat-soluble vitamins;     C05443  Cholecalciferol (Vitamin D3); Lipids [BR:br08002];  ST  Sterol Lipids;   ST03 Secosteroids;    ST0302 Vitamin D3 and derivatives;     C05443  Vitamin D3; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;     A11CC Vitamin D and analogues;      A11CC05 Colecalciferol;       D00188  Cholecalciferol (JP17/USP); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   33 Vitamin D based drugs;    D00188  Cholecalciferol (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Ergocalciferol or Cholecalciferol;     D00188  Cholecalciferol (JP17/USP);  Third-class OTC drugs;   Inorganic and organic chemicals;    Ergocalciferol;     D00188  Cholecalciferol (JP17/USP); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Vitamin D3 like receptor;     vitamin D receptor;      Colecalciferol;       D00188  Cholecalciferol (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00188  Cholecalciferol; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   962  Vitamin preparations;    9621  Vitamin A, D and preparations;     C05443  Vitamin D3",CAS: 67-97-0; PubChem: 7805; ChEBI: 28940; ChEMBL: CHEMBL1042 CHEMBL1365250 CHEMBL432780; LIPIDMAPS: LMST03020000 LMST03020001; LipidBank: VVD0237; KNApSAcK: C00041217; 3DMET: B01859; NIKKAJI: J2.367A,cpd:C00599; cpd:C01164; cpd:C01802; cpd:C05104; cpd:C05437; cpd:C05439; cpd:C05443; cpd:C07711,27,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O1,C27H43O1,384.339216,385.3470411,383.331391303,376,cpd:C07712,Secalciferol;,C27H44O3,"Secalciferol; 24(R),25-Dihydroxyvitamin D3; (24R),25-Dihydroxyvitamin D3; (3S,5Z,7E,24R)-9,10-Secocholesta-5,7,10-triene-3,24,25-triol",R09516 R11324,Steroid biosynthesis; Metabolic pathways,1.14.15.16; 1.14.15.18,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST03 Secosteroids;    ST0302 Vitamin D3 and derivatives;     C07712  Secalciferol,CAS: 55721-11-4; PubChem: 9914; ChEBI: 28818; LIPIDMAPS: LMST03020273; LipidBank: VVD0300; 3DMET: B05256; NIKKAJI: J458.721I,cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650,27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O3,C27H43O3,416.3290453,417.3368703,415.3212202304,377,cpd:C08813,Brassicasterol,C28H46O,Brassicasterol,R11097,Steroid biosynthesis; Metabolic pathways,1.14.19.41,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C08813  Brassicasterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Ergostane;     C08813  Brassicasterol,CAS: 474-67-9; PubChem: 11006; ChEBI: 3168; LIPIDMAPS: LMST01030098; KNApSAcK: C00003646; 3DMET: B02432; NIKKAJI: J12.044H,cpd:C04453; cpd:C04525; cpd:C05103; cpd:C06957; cpd:C08813; cpd:C15777; cpd:C15781; cpd:C15785; cpd:C18192,28,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O1,C28H45O1,398.3548661,399.3626911,397.3470411305,378,cpd:C08821,Isofucosterol;,C29H48O,Isofucosterol; Delta5-Avenasterol,R07487 R07488,Steroid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.21; 1.3.1.-,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C08821  Isofucosterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Stigmastane;     C08821  Isofucosterol,CAS: 481-14-1; PubChem: 11014; ChEBI: 28604; ChEMBL: CHEMBL1836654; LIPIDMAPS: LMST01040145; LipidBank: SST9070; KNApSAcK: C00003656; 3DMET: B02437; NIKKAJI: J12.392G,cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193,29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H49O1,C29H47O1,412.3705162,413.3783412,411.3626911306,379,cpd:C08830,24-Methylenecycloartanol;,C31H52O,"24-Methylenecycloartanol; 9,19-Cyclolanostan-3-o1, 24-methylene-, (3beta)-",R07481 R07482,Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.72; 2.1.1.41,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0110 Cycloartanols and derivatives;     C08830  24-Methylenecycloartanol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Cycloartane;     C08830  24-Methylenecycloartanol,CAS: 1449-09-8; PubChem: 11023; ChEBI: 1307; ChEMBL: CHEMBL376350; KNApSAcK: C00003661; 3DMET: B02440; NIKKAJI: J113.713A,cpd:C08830; cpd:C11513; cpd:C16916; cpd:C17534,31,52,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H53O1,C31H51O1,440.4018163,441.4096413,439.3939913307,380,cpd:C11455,"4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol",C29H46O,"4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol",R05639 R05640,Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.3.1.70; 1.14.13.70,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C11455  4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol",CAS: 64284-64-6; PubChem: 13626; ChEBI: 17813; ChEMBL: CHEMBL10850; LIPIDMAPS: LMST01010149; 3DMET: B04267; NIKKAJI: J1.007.648J,cpd:C11455; cpd:C11508; cpd:C15783,29,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H47O1,C29H45O1,410.3548661,411.3626911,409.3470411308,381,cpd:C11508,"4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol;",C29H46O,"4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol; Delta8,14 -Sterol",R05731 R07483,Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.70; 1.14.13.70,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C11508  4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol",PubChem: 13678; ChEBI: 30109; LIPIDMAPS: LMST01031020; KNApSAcK: C00007523; 3DMET: B04269; NIKKAJI: J2.774.817A,cpd:C11455; cpd:C11508; cpd:C15783,29,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H47O1,C29H45O1,410.3548661,411.3626911,409.3470411309,382,cpd:C11522,24-Methylenelophenol;,C29H48O,"24-Methylenelophenol; 4-alpha-Methyl-5-alpha-ergosta-7,24-dien-3-beta-ol",R05776 R07484 R07490,Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.72; 2.1.1.143; 5.3.3.5,NA,NA,PubChem: 13690; ChEBI: 29107; LIPIDMAPS: LMST01030100; LipidBank: SST9077; KNApSAcK: C00007320; 3DMET: B05533; NIKKAJI: J14.185B,cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193,29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H49O1,C29H47O1,412.3705162,413.3783412,411.3626911310,383,cpd:C11523,24-Ethylidenelophenol;,C30H50O,"24-Ethylidenelophenol; alpha1-Sitosterol; 4-alpha-Methyl-5-alpha-stigmasta-7,Z-24-dien-3-beta-ol; (Z)-24-Ethylidenelophenol",R05776 R07485,Steroid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.72; 2.1.1.143,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C11523  24-Ethylidene lophenol;     C11523  24-Ethylidene lophenol,CAS: 474-40-8; PubChem: 13691; ChEMBL: CHEMBL1394708; LIPIDMAPS: LMST01040144; LipidBank: SST0116; KNApSAcK: C00007321; 3DMET: B05534; NIKKAJI: J12.662D,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.3783412311,384,cpd:C15776,4alpha-Methylfecosterol,C29H48O,4alpha-Methylfecosterol,R07483 R07484,Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.70; 5.3.3.5,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15776  4alpha-Methylfecosterol,CAS: 17757-07-2; PubChem: 47205102; ChEBI: 80094; LIPIDMAPS: LMST01031019; KNApSAcK: C00007524; NIKKAJI: J126.773F,cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193,29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H49O1,C29H47O1,412.3705162,413.3783412,411.3626911312,385,cpd:C15777,Episterol,C28H46O,Episterol,R07490 R07491 R07497 R07505,Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.14.13.72; 1.14.19.20,Ergocalciferol biosynthesis,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15777  Episterol,CAS: 474-68-0; PubChem: 47205103; ChEBI: 50586; LIPIDMAPS: LMST01030115; KNApSAcK: C00007272; NIKKAJI: J12.013H,cpd:C04453; cpd:C04525; cpd:C05103; cpd:C06957; cpd:C08813; cpd:C15777; cpd:C15781; cpd:C15785; cpd:C18192,28,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O1,C28H45O1,398.3548661,399.3626911,397.3470411313,386,cpd:C15778,"5,7,24(28)-Ergostatrienol;",C28H44O,"5,7,24(28)-Ergostatrienol; Ergosta-5,7,24(28)-trien-3beta-ol",R07505 R07506,Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.14.19.20; 1.14.19.41,Ergocalciferol biosynthesis,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15778  5,7,24(28)-Ergostatrienol",PubChem: 47205104; ChEBI: 80095; NIKKAJI: J527.837F,cpd:C01694; cpd:C05441; cpd:C08823; cpd:C15778; cpd:C15780; cpd:C15816; cpd:C19653,28,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O1,C28H43O1,396.339216,397.3470411,395.331391314,387,cpd:C15780,5-Dehydroepisterol,C28H44O,5-Dehydroepisterol,R07491 R07492,Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.21; 1.14.19.20,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15780  5-Dehydroepisterol,PubChem: 47205105; ChEBI: 52972; LIPIDMAPS: LMST01030135; KNApSAcK: C00007261; NIKKAJI: J527.837F,cpd:C01694; cpd:C05441; cpd:C08823; cpd:C15778; cpd:C15780; cpd:C15816; cpd:C19653,28,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O1,C28H43O1,396.339216,397.3470411,395.331391315,388,cpd:C15781,24-Methylenecholesterol,C28H46O,24-Methylenecholesterol,R03725 R07492 R07493 R11096,Steroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.21; 1.3.1.-,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15781  24-Methylenecholesterol,CAS: 474-63-5; PubChem: 47205106; ChEBI: 19812; ChEMBL: CHEMBL477971; LIPIDMAPS: LMST01030099; KNApSAcK: C00007271; NIKKAJI: J12.062F,cpd:C04453; cpd:C04525; cpd:C05103; cpd:C06957; cpd:C08813; cpd:C15777; cpd:C15781; cpd:C15785; cpd:C18192,28,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O1,C28H45O1,398.3548661,399.3626911,397.3470411316,389,cpd:C15782,Delta7-Avenasterol;,C29H48O,Delta7-Avenasterol; 7-Dehydroavenasterol,R07485 R07486,Steroid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.72; 1.14.19.20,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C15782  delta7-Avenasterol,PubChem: 47205107; ChEBI: 80096; LIPIDMAPS: LMST01040154; KNApSAcK: C00007322; NIKKAJI: J387.516D,cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193,29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H49O1,C29H47O1,412.3705162,413.3783412,411.3626911317,390,cpd:C15783,5-Dehydroavenasterol,C29H46O,5-Dehydroavenasterol,R07486 R07487,Steroid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.21; 1.14.19.20,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C15783  5-Dehydroavenasterol,PubChem: 47205108; ChEBI: 80097; LIPIDMAPS: LMST01040155; KNApSAcK: C00007527; NIKKAJI: J707.020I,cpd:C11455; cpd:C11508; cpd:C15783,29,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H47O1,C29H45O1,410.3548661,411.3626911,409.3470411318,391,cpd:C15808,4alpha-Methylzymosterol-4-carboxylate;,C29H46O3,"4alpha-Methylzymosterol-4-carboxylate; 4alpha-Carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol",R07494 R07509,Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.1.1.170; 1.14.13.72,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol",NA,PubChem: 47205133; ChEBI: 50591; LIPIDMAPS: LMST01010150; PDB-CCD: 4D8; NIKKAJI: J1.817.123F,cpd:C14607; cpd:C15622; cpd:C15808,29,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H47O3,C29H45O3,442.3446953,443.3525204,441.3368703319,392,cpd:C15816,3-Keto-4-methylzymosterol,C28H44O,3-Keto-4-methylzymosterol,R07494 R07495,Steroid biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.1.1.170; 1.1.1.270,"Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol",NA,PubChem: 47205141; ChEBI: 50593; LIPIDMAPS: LMST01010167; NIKKAJI: J1.817.124D,cpd:C01694; cpd:C05441; cpd:C08823; cpd:C15778; cpd:C15780; cpd:C15816; cpd:C19653,28,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O1,C28H43O1,396.339216,397.3470411,395.331391320,393,cpd:C15915,"4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol",C29H50O,"4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol",R07499,Steroid biosynthesis,1.3.1.72,NA,NA,PubChem: 47205233; ChEBI: 87044; LIPIDMAPS: LMST01010225; NIKKAJI: J2.796.893G,cpd:C01753; cpd:C04530; cpd:C08839; cpd:C15915; cpd:C19654,29,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H51O1,C29H49O1,414.3861662,415.3939913,413.3783412321,394,cpd:C18231,Calcitetrol;,C27H44O4,"Calcitetrol; 1alpha,24R,25-Trihydroxyvitamin D3; (1S,3R,5Z,7E,24R,25)-9,10-Secocholesta-5,7,10(19)-triene-1,3,24,25-tetrol",R09515 R11324,Steroid biosynthesis; Metabolic pathways,1.14.15.16; 1.14.15.18,NA,NA,PubChem: 103061413; ChEBI: 47799; ChEMBL: CHEMBL55281,cpd:C08899; cpd:C16494; cpd:C17003; cpd:C17335; cpd:C18231,27,44,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O4,C27H43O4,432.3239599,433.3317849,431.3161349322,395,cpd:C21106,24-epi-Campesterol,C28H48O,24-epi-Campesterol,R11096 R11097,Steroid biosynthesis; Metabolic pathways,1.3.1.-; 1.14.19.41,NA,NA,PubChem: 312642075,cpd:C01789; cpd:C05110; cpd:C05111; cpd:C08825; cpd:C08833; cpd:C15784; cpd:C15786; cpd:C19652; cpd:C21106,28,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O1,C28H47O1,400.3705162,401.3783412,399.3626911323,396,cpd:C00037,Glycine;,C2H5NO2,Glycine; Aminoacetic acid; Gly,R00364 R00365 R00366 R00367 R00368 R00369 R00371 R00372; R00373 R00374 R00395 R00478 R00497 R00565 R00588 R00610; R00611 R00652 R00751 R00775 R00830 R00899 R00945 R01221; R01424 R01723 R01766 R01957 R02452 R02551 R02729 R03121; R03284 R03425 R03579 R03654 R03718 R03956 R03975 R04144; R04486 R04777 R04951 R05055 R05704 R05835 R05841 R06171; R07226 R07463 R08195 R08196 R08252 R08701 R08744 R09099; R09717 R09718 R10060 R10062 R10179 R10685 R10722 R10908; R10994,"Primary bile acid biosynthesis; Purine metabolism; Glycine, serine and threonine metabolism; Lysine degradation; Phosphonate and phosphinate metabolism; Cyanoamino acid metabolism; Glutathione metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Thiamine metabolism; Porphyrin and chlorophyll metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Vancomycin resistance; ABC transporters; Biofilm formation - Escherichia coli; Neuroactive ligand-receptor interaction; Synaptic vesicle cycle; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer",1.4.1.1; 1.4.1.10; 1.4.2.1; 1.4.3.3; 1.4.3.19; 1.4.4.2; 1.4.99.5; 1.5.1.22; 1.5.3.1; 1.5.8.3; 1.8.1.4; 1.13.11.78; 1.21.4.2; 2.1.1.20; 2.1.1.156; 2.1.1.162; 2.1.2.1; 2.1.2.4; 2.1.2.10; 2.1.4.1; 2.3.1.13; 2.3.1.29; 2.3.1.37; 2.3.1.65; 2.3.1.71; 2.3.1.192; 2.3.1.-; 2.3.2.15; 2.3.2.-; 2.6.1.4; 2.6.1.35; 2.6.1.44; 2.6.1.45; 2.6.1.60; 2.6.1.63; 2.6.1.73; 2.6.1.96; 2.6.1.-; 3.4.11.1; 3.4.11.2; 3.4.11.23; 3.4.13.-; 3.5.1.24; 3.5.1.32; 3.5.1.58; 3.5.1.71; 3.5.3.2; 4.1.2.5; 4.1.2.26; 4.1.2.42; 4.1.2.48; 4.1.2.49; 4.1.2.-; 4.1.3.14; 4.1.3.41; 6.1.1.14; 6.3.2.3; 6.3.4.13,"Formaldehyde assimilation, serine pathway; Photorespiration",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00037  Glycine (Gly);  Hormones and transmitters;   Neurotransmitters;    Amino acids;     C00037  Glycine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05C IRRIGATING SOLUTIONS;     B05CX Other irrigating solutions;      B05CX03 Glycine;       D00011  Glycine (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Glycine;     D00011  Glycine (JP17/USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00011  [102546] Glycine;  Buffering agent;   D00011  [102546] Glycine;  Sweetening agent;   D00011  [102546] Glycine;  Base;   D00011  [102546] Glycine;  Flavoring substance;   D00011  [102546] Glycine;  Suspending agent;   D00011  [102546] Glycine;  pH regulator;   D00011  [102546] Glycine;  Diluting agent;   D00011  [102546] Glycine;  Solubilization agent;   D00011  [102546] Glycine; Target-based classification of drugs [BR:br08310];  Ion channels;   Cys-loop superfamily;    Glycine;     glycine receptor;      Glycine;       D00011  Glycine (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00011  Glycine,CAS: 56-40-6; PubChem: 3339; ChEBI: 15428; ChEMBL: CHEMBL773; KNApSAcK: C00001361; PDB-CCD: GLY; 3DMET: B01136; NIKKAJI: J1.163K,cpd:C00037; cpd:C01837; cpd:C02038; cpd:C02471; cpd:C06808; cpd:C19445,2,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H6O2N1,C2H4O2N1,75.0320284,76.03985344,74.02420337324,397,cpd:C00245,Taurine;,C2H7NO3S,Taurine; 2-Aminoethanesulfonic acid; Aminoethylsulfonic acid,R01681 R01682 R01683 R01684 R01685 R01686 R01687 R02797; R03720 R03977 R04487 R05320 R05652 R07167 R08745,Primary bile acid biosynthesis; Taurine and hypotaurine metabolism; Sulfur metabolism; Metabolic pathways; ABC transporters; Neuroactive ligand-receptor interaction,1.4.2.-; 1.4.99.2; 1.5.1.23; 1.8.1.3; 1.14.11.17; 2.1.4.1; 2.3.1.65; 2.3.2.2; 2.6.1.55; 2.6.1.77; 3.5.1.24; 3.5.1.74; 4.1.1.15; 4.1.1.29,NA,Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    391  Liver disease agents;     3919  Others;      D00047  Taurine (JP17/USP/INN); Aminoethylsulfonic acid (JAN); Classification of Japanese OTC drugs [BR:br08313];  Agents for ophthalmologic use;   62 General eye drops;    D00047  Taurine (JP17/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Aminoethylsulfonic acid; Taurine;     D00047  Taurine (JP17/USP/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00047  [002019] Taurine;  Buffering agent;   D00047  [002019] Taurine;  Flavoring substance;   D00047  [002019] Taurine;  Bonding agent;   D00047  [002019] Taurine;  Tonicity agent;   D00047  [002019] Taurine;  Diluting agent;   D00047  [002019] Taurine;  Antiseptic agent;   D00047  [002019] Taurine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00047  Taurine; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   967  Agents for liver disease and antidotes;    9674  Taurine and preparations;     C00245  Aminoethylsulfonic acid,CAS: 107-35-7; PubChem: 3544; ChEBI: 15891; ChEMBL: CHEMBL239243; KNApSAcK: C00048188; PDB-CCD: TAU; 3DMET: B00069; NIKKAJI: J5.056C,cpd:C00245,2,7,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C2H8O3N1S1,C2H6O3N1S1,125.0146643,126.0224893,124.0068392325,398,cpd:C00695,Cholic acid;,C24H40O5,"Cholic acid; Cholate; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanate; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid",R02792 R02793 R02794 R02797 R02798 R05835 R07220 R07295; R07296 R11539,Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Metabolic pathways; Bile secretion,1.1.1.159; 1.1.1.176; 2.8.3.25; 3.1.2.27; 3.5.1.24; 6.2.1.7,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate; Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate","Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C00695  Cholic acid; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C00695  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A05 BILE AND LIVER THERAPY;    A05A BILE THERAPY;     A05AA Bile acid preparations;      A05AA03 Cholic acid;       D10699  Cholic acid (USAN); Gastrointestinal agents [br08371.html];  Other gastrointestinal agents;   D10699; New drug approvals in the USA [br08319.html];  New Molecular Entity and New Therapeutic Biological Product Approvals;   D10699; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D10699; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D10699; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D10699; Pharmacogenomic biomarkers in FDA drug labels [br08341.html];  Polymorphisms and germline mutations;   D10699; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Cholic acid;     C00695  Cholic acid",CAS: 81-25-4; PubChem: 3963; ChEBI: 16359; ChEMBL: CHEMBL205596; LIPIDMAPS: LMST04010001; LipidBank: BBA0084; PDB-CCD: CHD; 3DMET: B01314; NIKKAJI: J8.604E,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494326,399,cpd:C01301,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al",C27H46O4,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al",R03506 R03507 R08759 R08761,Primary bile acid biosynthesis; Metabolic pathways,1.14.15.15,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C01301  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al",CAS: 3836-01-9; PubChem: 4519; ChEBI: 16466; LIPIDMAPS: LMST04030164; LipidBank: BBA0425; 3DMET: B04791; NIKKAJI: J2.732.427D,cpd:C01301; cpd:C04554; cpd:C18043,27,46,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O4,C27H45O4,434.33961,435.347435,433.3317849327,400,cpd:C01794,Choloyl-CoA;,C45H74N7O20P3S,"Choloyl-CoA; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanoyl-CoA; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-one-CoA",R02794 R03718 R03719 R03720 R07295 R07296 R11539,Primary bile acid biosynthesis; Metabolic pathways,2.3.1.65; 2.3.1.176; 2.8.3.25; 3.1.2.27; 6.2.1.7,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate; Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate",NA,PubChem: 4921; ChEBI: 15519; 3DMET: B04814; NIKKAJI: J614.038F,cpd:C01794,45,74,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H75O20N7P3S1,C45H73O20N7P3S1,1157.39222,1158.400045,1156.384395328,401,cpd:C01921,Glycocholate;,C26H43NO6,"Glycocholate; Glycocholic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine",R03718 R05835,Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Metabolic pathways; Bile secretion,2.3.1.65; 3.5.1.24,"Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate","Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C01921  Glycocholate; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0402 C26 bile acids, alcohols, and derivatives;     C01921  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine;   ST05 Steroid conjugates;    ST0503 Glycine conjugates;     C01921  Glycocholate",CAS: 475-31-0; PubChem: 5027; ChEBI: 17687 29746; ChEMBL: CHEMBL1354821 CHEMBL411070; LIPIDMAPS: LMST05030001; KNApSAcK: C00030410; PDB-CCD: GCH; 3DMET: B04823; NIKKAJI: J12.411G,cpd:C01921,26,43,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H44O6N1,C26H42O6N1,465.3090381,466.3168631,464.3012131329,402,cpd:C02528,Chenodeoxycholate;,C24H40O4,"Chenodeoxycholate; Chenodeoxycholic acid; 3alpha,7alpha-Dihydroxy-5beta-cholanic acid; Chenodiol",R03974 R03975 R03977 R03978 R08743,Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Metabolic pathways; Bile secretion,3.1.2.27; 3.5.1.24; 3.5.1.74; 6.2.1.7,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C02528  Chenodeoxycholate; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C02528  3alpha,7alpha-Dihydroxy-5beta-cholanic acid; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Thyroid hormone like receptors;    Liver X receptor like receptor;     farnesoid X receptor;      C02528  Chenodeoxycholate; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A05 BILE AND LIVER THERAPY;    A05A BILE THERAPY;     A05AA Bile acid preparations;      A05AA01 Chenodeoxycholic acid;       D00163  Chenodiol (USAN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   23  Digestive organ agents;    236  Cholagogues;     2362  Bile acids;      D00163  Chenodiol (USAN); Chenodeoxycholic acid (JP17/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00163  Chenodeoxycholic acid; Gastrointestinal agents [br08371.html];  Other gastrointestinal agents;   D00163; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00163",CAS: 474-25-9; PubChem: 5536; ChEBI: 16755; ChEMBL: CHEMBL240597 CHEMBL73390; LIPIDMAPS: LMST04010032; LipidBank: BBA0032; PDB-CCD: JN3; 3DMET: B01586; NIKKAJI: J2.053B,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347330,403,cpd:C03594,7alpha-Hydroxycholesterol;,C27H46O2,"7alpha-Hydroxycholesterol; Cholest-5-ene-3beta,7alpha-diol",R01463 R04263 R04264,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.181; 1.14.14.23,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C03594  7alpha-Hydroxycholesterol,CAS: 566-26-7; PubChem: 6385; ChEBI: 17500; ChEMBL: CHEMBL497207; LIPIDMAPS: LMST01010013; LipidBank: SST9032; PDB-CCD: 5JK; 3DMET: B01674,cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992,27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O2,C27H45O2,402.3497807,403.3576058,401.3419557331,404,cpd:C04554,"3alpha,7alpha-Dihydroxy-5beta-cholestanate;",C27H46O4,"3alpha,7alpha-Dihydroxy-5beta-cholestanate; 3alpha,7alpha-Dihydroxy-5beta-cholestanoate",R04506 R04507 R08738 R08760,Primary bile acid biosynthesis; Metabolic pathways,1.2.1.3; 1.14.15.15; 6.2.1.7; 6.2.1.28,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C04554  3alpha,7alpha-Dihydroxy-5beta-cholestanoic acid",PubChem: 7159; ChEBI: 16577; LIPIDMAPS: LMST04030066; LipidBank: BBA0386; 3DMET: B04947; NIKKAJI: J82.699E,cpd:C01301; cpd:C04554; cpd:C18043,27,46,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O4,C27H45O4,434.33961,435.347435,433.3317849332,405,cpd:C04722,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoate;",C27H46O5,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoate; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oate; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanate",R03506 R04580 R08733 R08761 R11142,Primary bile acid biosynthesis; Metabolic pathways,1.14.15.15; 6.2.1.7,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C04722  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoic acid",CAS: 547-98-8; PubChem: 7294; ChEBI: 18402 85674; LIPIDMAPS: LMST04030001; LipidBank: BBA0396; 3DMET: B04957; NIKKAJI: J40.090D,cpd:C04722,27,46,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O5,C27H45O5,450.3345246,451.3423496,449.3266995333,406,cpd:C05122,Taurocholate;,C26H45NO7S,Taurocholate; Taurocholic acid; Cholyltaurine,R02797 R03720,Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Taurine and hypotaurine metabolism; Metabolic pathways; Bile secretion,2.3.1.65; 3.5.1.24,"Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate","Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C05122  Taurocholate; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0402 C26 bile acids, alcohols, and derivatives;     C05122  Taurocholic acid;   ST05 Steroid conjugates;    ST0504 Taurine conjugates;     C05122  Taurocholate",CAS: 81-24-3; PubChem: 7544; ChEBI: 28865; LIPIDMAPS: LMST05040001; PDB-CCD: TCH; 3DMET: B04981; NIKKAJI: J8.603G,cpd:C05122; cpd:C15516,26,45,7,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H46O7N1S1,C26H44O7N1S1,515.291674,516.299499,514.2838489334,407,cpd:C05337,Chenodeoxycholoyl-CoA;,C45H74N7O19P3S,"Chenodeoxycholoyl-CoA; 3alpha,7alpha-Dihydroxy-5beta-cholanoyl-CoA",R03974 R04546 R04811 R08743 R08744 R08745,Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Metabolic pathways,2.3.1.65; 2.3.1.176; 3.1.2.27; 6.2.1.7,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 7715; ChEBI: 28701; 3DMET: B05010; NIKKAJI: J1.665.314D,cpd:C05337; cpd:C15560; cpd:C17689,45,74,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H75O19N7P3S1,C45H73O19N7P3S1,1141.397305,1142.40513,1140.38948335,408,cpd:C05444,"3alpha,7alpha,26-Trihydroxy-5beta-cholestane;",C27H48O3,"3alpha,7alpha,26-Trihydroxy-5beta-cholestane; 5beta-Cholestane-3alpha,7alpha,26-triol",R04805 R04806 R08758,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.1; 1.14.15.15,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05444  3alpha,7alpha,26-Trihydroxy-5beta-cholestane",PubChem: 7806; ChEBI: 28540; LIPIDMAPS: LMST04030020; LipidBank: BBA0328 SST9002; 3DMET: B05024; NIKKAJI: J676.110K,cpd:C05425; cpd:C05444; cpd:C05454,27,48,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H49O3,C27H47O3,420.3603454,421.3681704,419.3525204336,409,cpd:C05445,"3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al",C27H46O3,"3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al",R04506 R04805 R08758 R08760,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.1; 1.2.1.3; 1.14.15.15,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05445  3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al",PubChem: 7807; ChEBI: 27428; LIPIDMAPS: LMST04030162; 3DMET: B05025; NIKKAJI: J2.755.883F,cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520,27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O3,C27H45O3,418.3446953,419.3525204,417.3368703337,410,cpd:C05446,"3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane;",C27H48O4,"3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane; 5beta-Cholestane-3alpha,7alpha,12alpha,26-tetraol; 5beta-Cholestane-3alpha,7alpha,12alpha,26-tetrol",R03507 R04807 R04808 R08759,Primary bile acid biosynthesis; Metabolic pathways,1.14.15.15,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05446  3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane",CAS: 862-53-3; PubChem: 7808; ChEBI: 17278; LIPIDMAPS: LMST04030014; LipidBank: BBA0316; 3DMET: B05026; NIKKAJI: J1.513.287F,cpd:C05446,27,48,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H49O4,C27H47O4,436.35526,437.3630851,435.347435338,411,cpd:C05447,"3alpha,7alpha-Dihydroxy-5beta-cholest-24-enoyl-CoA",C48H78N7O19P3S,"3alpha,7alpha-Dihydroxy-5beta-cholest-24-enoyl-CoA",R04547 R04809 R08740,Primary bile acid biosynthesis; Metabolic pathways,1.3.99.-; 1.17.99.3; 4.2.1.107,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 7809; ChEBI: 27393; LIPIDMAPS: LMST01010220; 3DMET: B05027; NIKKAJI: J2.755.897F,cpd:C05447,48,78,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C48H79O19N7P3S1,C48H77O19N7P3S1,1181.428605,1182.436431,1180.42078339,412,cpd:C05448,"3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoA",C48H80N7O20P3S,"3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoA",R04809 R04810,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.35; 4.2.1.107,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 7810; ChEBI: 27403; 3DMET: B05028; NIKKAJI: J2.755.940I,cpd:C04760; cpd:C05448; cpd:C15613; cpd:C17343,48,80,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C48H81O20N7P3S1,C48H79O20N7P3S1,1199.43917,1200.446995,1198.431345340,413,cpd:C05449,"3alpha,7alpha-Dihydroxy-5beta-24-oxocholestanoyl-CoA",C48H78N7O20P3S,"3alpha,7alpha-Dihydroxy-5beta-24-oxocholestanoyl-CoA",R04810 R04811,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.35; 2.3.1.176,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 7811; ChEBI: 28533; LIPIDMAPS: LMST01010219; 3DMET: B05029; NIKKAJI: J2.755.941G,cpd:C05449; cpd:C05460,48,78,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C48H79O20N7P3S1,C48H77O20N7P3S1,1197.42352,1198.431345,1196.415695341,414,cpd:C05450,"3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA;",C48H80N7O21P3S,"3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA; 3alpha,7alpha,12alpha,24zeta-Tetrahydroxy-5beta-cholestanoyl-CoA",R04812 R04813,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.35; 4.2.1.107,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 7812; ChEBI: 27458; LIPIDMAPS: LMST01010215; 3DMET: B05030; NIKKAJI: J2.755.944A,cpd:C05450; cpd:C15614,48,80,21,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C48H81O21N7P3S1,C48H79O21N7P3S1,1215.434085,1216.44191,1214.42626342,415,cpd:C05451,7alpha-Hydroxy-5beta-cholestan-3-one;,C27H46O2,7alpha-Hydroxy-5beta-cholestan-3-one; 5beta-Cholestan-7alpha-ol-3-one,R04817 R04818 R04819,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.50; 1.3.1.3,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05451  7alpha-Hydroxy-5beta-cholestan-3-one",PubChem: 7813; ChEBI: 2290; LIPIDMAPS: LMST04030112; LipidBank: BBA0438; 3DMET: B05031; NIKKAJI: J2.755.945J,cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992,27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O2,C27H45O2,402.3497807,403.3576058,401.3419557343,416,cpd:C05452,"3alpha,7alpha-Dihydroxy-5beta-cholestane;",C27H48O2,"3alpha,7alpha-Dihydroxy-5beta-cholestane; 5beta-Cholestane-3alpha,7alpha-diol",R04806 R04818 R04819 R07204,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.50; 1.14.13.96; 1.14.15.15,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05452  3alpha,7alpha-Dihydroxy-5beta-cholestane",PubChem: 7814; ChEBI: 28047; LIPIDMAPS: LMST04030109; LipidBank: BBA0435; 3DMET: B05032; NIKKAJI: J608.249A,cpd:C05424; cpd:C05452; cpd:C10818,27,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H49O2,C27H47O2,404.3654308,405.3732558,403.3576058344,417,cpd:C05453,"7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one;",C27H46O3,"7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one; 5beta-Cholesten-7alpha,12alpha-diol-3-one",R04823 R04824 R04825,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.50; 1.3.1.3,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 7815; ChEBI: 2288; LIPIDMAPS: LMST04030113; LipidBank: BBA0439; 3DMET: B05033; NIKKAJI: J2.755.946H,cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520,27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O3,C27H45O3,418.3446953,419.3525204,417.3368703345,418,cpd:C05454,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane;",C27H48O3,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane; 5beta-Cholestane-3alpha,7alpha,12alpha-triol; 3alpha,7alpha,12alpha-Trihydroxycoprostane",R04807 R04824 R04825 R07204 R11142,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.50; 1.14.13.96; 1.14.15.15,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate","Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0403 C27 bile acids, alcohols, and derivatives;     C05454  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane",CAS: 547-96-6; PubChem: 7816; ChEBI: 16496; LIPIDMAPS: LMST04030035; LipidBank: BBA0347 SST9020; 3DMET: B01860; NIKKAJI: J40.089K,cpd:C05425; cpd:C05444; cpd:C05454,27,48,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H49O3,C27H47O3,420.3603454,421.3681704,419.3525204346,419,cpd:C05455,7alpha-Hydroxycholest-4-en-3-one,C27H44O2,7alpha-Hydroxycholest-4-en-3-one,R04263 R04264 R04817 R04826,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.181; 1.3.1.3; 1.14.18.8,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05455  7alpha-Hydroxycholest-4-en-3-one,CAS: 3862-25-7; PubChem: 7817; ChEBI: 17899; LIPIDMAPS: LMST04030123; LipidBank: BBA0449; 3DMET: B05034; NIKKAJI: J602.383E,cpd:C01561; cpd:C05455; cpd:C15632; cpd:C19662; cpd:C20143; cpd:C21303,27,44,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O2,C27H43O2,400.3341307,401.3419557,399.3263056347,420,cpd:C05460,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA",C48H78N7O20P3S,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA",R04592 R04813 R08735,Primary bile acid biosynthesis; Metabolic pathways,1.3.99.-; 1.17.99.3; 4.2.1.107,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 7820; ChEBI: 27505; LIPIDMAPS: LMST01010217; 3DMET: B05037; NIKKAJI: J2.755.972G,cpd:C05449; cpd:C05460,48,78,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C48H79O20N7P3S1,C48H77O20N7P3S1,1197.42352,1198.431345,1196.415695348,421,cpd:C05465,Taurochenodeoxycholate;,C26H45NO6S,Taurochenodeoxycholate; Taurochenodeoxycholic acid; Chenodeoxycholoyltaurine,R03977 R07205 R08745,Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Bile secretion,1.14.13.97; 2.3.1.65; 3.5.1.24; 3.5.1.74,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0402 C26 bile acids, alcohols, and derivatives;     C05465  Taurochenodeoxycholic acid;   ST05 Steroid conjugates;    ST0504 Taurine conjugates;     C05465  Taurochenodeoxycholate",CAS: 516-35-8; PubChem: 7825; ChEBI: 16525 9407; ChEMBL: CHEMBL185878 CHEMBL55965 CHEMBL73668; LIPIDMAPS: LMST05040005; PDB-CCD: TUD; 3DMET: B05042; NIKKAJI: J13.987D,cpd:C05463; cpd:C05465; cpd:C16868,26,45,6,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H46O6N1S1,C26H44O6N1S1,499.2967593,500.3045844,498.2889343349,422,cpd:C05466,Glycochenodeoxycholate;,C26H43NO5,Glycochenodeoxycholate; Glycochenodeoxycholic acid; Chenodeoxyglycocholate,R03975 R07289 R08744,Primary bile acid biosynthesis; Secondary bile acid biosynthesis; Bile secretion,2.3.1.65; 2.8.2.34; 3.5.1.24,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0402 C26 bile acids, alcohols, and derivatives;     C05466  Glycochenodeoxycholic acid",CAS: 640-79-9; PubChem: 7826; ChEBI: 36274; ChEMBL: CHEMBL1552 CHEMBL55736 CHEMBL75793; LIPIDMAPS: LMST05030008; PDB-CCD: CHO; 3DMET: B05043; NIKKAJI: J22.601G,cpd:C05464; cpd:C05466,26,43,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H44O5N1,C26H42O5N1,449.3141235,450.3219485,448.3062985350,423,cpd:C05467,"3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA;",C48H78N7O21P3S,"3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA; 3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholestanoyl-CoA",R03719 R04812,Primary bile acid biosynthesis; Metabolic pathways,1.1.1.35; 2.3.1.176,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 7827; ChEBI: 27379; LIPIDMAPS: LMST01010216; 3DMET: B05044; NIKKAJI: J2.755.975A,cpd:C05467,48,78,21,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C48H79O21N7P3S1,C48H77O21N7P3S1,1213.418435,1214.42626,1212.41061351,424,cpd:C05468,5beta-Cyprinolsulfate,C27H48O8S,5beta-Cyprinolsulfate,R04808,Primary bile acid biosynthesis,NA,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST05 Steroid conjugates;    ST0502 Sulfates;     C05468  5beta-Cyprinolsulfate,PubChem: 7828; ChEBI: 2149; LIPIDMAPS: LMST05020004; 3DMET: B05045; NIKKAJI: J2.755.981F,cpd:C05468,27,48,8,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H49O8S1,C27H47O8S1,532.3069897,533.3148147,531.2991646352,425,cpd:C06341,"7alpha,27-Dihydroxycholesterol;",C27H46O3,"7alpha,27-Dihydroxycholesterol; Cholest-5-ene-3beta,7alpha,26-triol; Cholest-5-ene-3beta,7alpha,27-triol",R07372 R08724,Primary bile acid biosynthesis,1.1.1.181; 1.14.14.23; 1.14.14.29,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C06341  7-alpha,27-Dihydroxycholesterol",CAS: 4725-24-0; PubChem: 8577; ChEBI: 18431; LIPIDMAPS: LMST04030081; 3DMET: B05185; NIKKAJI: J575.886F,cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520,27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O3,C27H45O3,418.3446953,419.3525204,417.3368703353,426,cpd:C13550,Cerebrosterol;,C27H46O2,"Cerebrosterol; 24-Hydroxycholesterol; Cholest-5-ene-3,24-diol; (24S)-24-Hydroxycholesterol; (24S)-Cholest-5-ene-3beta,24-diol",R07207 R07208,Primary bile acid biosynthesis,1.14.14.25; 1.14.14.26,NA,Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Thyroid hormone like receptors;    Liver X receptor like receptor;     liver X receptor alpha;      C13550  Cerebrosterol;     liver X receptor beta;      C13550  Cerebrosterol Agonist,CAS: 474-73-7; PubChem: 7846926; ChEBI: 34310; ChEMBL: CHEMBL171804; LIPIDMAPS: LMST01010019; LipidBank: SST0080; NIKKAJI: J637.349F,cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992,27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O2,C27H45O2,402.3497807,403.3576058,401.3419557354,427,cpd:C15518,"(24S)-Cholest-5-ene-3beta,7alpha,24-triol;",C27H46O3,"(24S)-Cholest-5-ene-3beta,7alpha,24-triol; 5-Cholesten-3beta,7alpha,24(S)-triol",R07208 R08721,Primary bile acid biosynthesis,1.1.1.181; 1.14.14.26,NA,NA,PubChem: 17396510; ChEBI: 37640; LIPIDMAPS: LMST04030168; NIKKAJI: J1.343.556A,cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520,27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O3,C27H45O3,418.3446953,419.3525204,417.3368703355,428,cpd:C15519,25-Hydroxycholesterol;,C27H46O2,"25-Hydroxycholesterol; Cholest-5-ene-3beta,25-diol",R07209 R07218,Primary bile acid biosynthesis,1.14.14.29; 1.14.99.38,NA,NA,CAS: 2140-46-7; PubChem: 17396511; ChEBI: 42977; ChEMBL: CHEMBL169046; LIPIDMAPS: LMST01010018; LipidBank: SST0081 SST9041; PDB-CCD: HC3; NIKKAJI: J80.397I,cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992,27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O2,C27H45O2,402.3497807,403.3576058,401.3419557356,429,cpd:C15520,"Cholest-5-ene-3beta,7alpha,25-triol;",C27H46O3,"Cholest-5-ene-3beta,7alpha,25-triol; 7alpha,25-Dihydroxycholesterol; 5-Cholesten-3beta,7alpha,25-triol; 3beta,7alpha,25-Trihydroxycholest-5-ene",R07209 R08723,Primary bile acid biosynthesis,1.1.1.181; 1.14.14.29,NA,NA,PubChem: 17396512; ChEBI: 37623; LIPIDMAPS: LMST04030166; NIKKAJI: J652.922D,cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520,27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O3,C27H45O3,418.3446953,419.3525204,417.3368703357,430,cpd:C15610,"Cholest-5-ene-3beta,26-diol;",C27H46O2,"Cholest-5-ene-3beta,26-diol; Cholest-5-ene-3beta,27-diol; 26-Hydroxycholesterol; 27-Hydroxycholesterol",R07372 R08505 R08506 R08507 R08508 R08726,Primary bile acid biosynthesis; Biosynthesis of alkaloids derived from terpenoid and polyketide,1.14.14.23; 1.14.14.29; 1.14.15.15,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C15610  27-Hydroxycholesterol; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Thyroid hormone like receptors;    Liver X receptor like receptor;     liver X receptor alpha;      C15610  Cholest-5-ene-3beta,26-diol;     liver X receptor beta;      C15610  Cholest-5-ene-3beta,26-diol",CAS: 13095-61-9; PubChem: 17396601; ChEBI: 17703; ChEMBL: CHEMBL162044 CHEMBL353882; LIPIDMAPS: LMST01010057; NIKKAJI: J533.768B,cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992,27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O2,C27H45O2,402.3497807,403.3576058,401.3419557358,431,cpd:C15613,"(25R)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA",C48H80N7O20P3S,"(25R)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA",R07374 R08733 R08734,Primary bile acid biosynthesis; Metabolic pathways,1.17.99.3; 5.1.99.4; 6.2.1.7,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 17396604; ChEBI: 37642; NIKKAJI: J2.795.088D,cpd:C04760; cpd:C05448; cpd:C15613; cpd:C17343,48,80,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C48H81O20N7P3S1,C48H79O20N7P3S1,1199.43917,1200.446995,1198.431345359,432,cpd:C17331,"7alpha,24-Dihydroxy-4-cholesten-3-one",C27H44O3,"7alpha,24-Dihydroxy-4-cholesten-3-one",R08721,Primary bile acid biosynthesis,1.1.1.181,NA,NA,PubChem: 96023693; ChEBI: 48701; LIPIDMAPS: LMST04030170; NIKKAJI: J2.806.270B,cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650,27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O3,C27H43O3,416.3290453,417.3368703,415.3212202360,433,cpd:C17332,"7alpha,25-Dihydroxy-4-cholesten-3-one",C27H44O3,"7alpha,25-Dihydroxy-4-cholesten-3-one",R08723,Primary bile acid biosynthesis,1.1.1.181,NA,NA,PubChem: 96023694; ChEBI: 81013; LIPIDMAPS: LMST04030107; NIKKAJI: J674.519I,cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650,27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O3,C27H43O3,416.3290453,417.3368703,415.3212202361,434,cpd:C17333,3beta-Hydroxy-5-cholestenoate;,C27H44O3,3beta-Hydroxy-5-cholestenoate; 3beta-Hydroxycholest-5-en-27-oic acid,R08726 R08727,Primary bile acid biosynthesis,1.14.14.29,NA,NA,CAS: 6561-58-6; PubChem: 96023695; ChEBI: 81014; NIKKAJI: J676.103H,cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650,27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O3,C27H43O3,416.3290453,417.3368703,415.3212202362,435,cpd:C17335,"3beta,7alpha-Dihydroxy-5-cholestenoate;",C27H44O4,"3beta,7alpha-Dihydroxy-5-cholestenoate; 3beta,7alpha-Dihydroxy-5-cholesten-26-oic acid",R08727 R08728,Primary bile acid biosynthesis,1.1.1.181; 1.14.14.29,NA,NA,CAS: 115538-84-6; PubChem: 96023696; ChEBI: 81015; NIKKAJI: J676.104F,cpd:C08899; cpd:C16494; cpd:C17003; cpd:C17335; cpd:C18231,27,44,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O4,C27H43O4,432.3239599,433.3317849,431.3161349363,436,cpd:C17336,"7alpha,26-Dihydroxy-4-cholesten-3-one",C27H44O3,"7alpha,26-Dihydroxy-4-cholesten-3-one",R08724 R08725,Primary bile acid biosynthesis,1.1.1.181,NA,NA,CAS: 4675-38-1; PubChem: 96023697; ChEBI: 48825; LIPIDMAPS: LMST04030157; NIKKAJI: J676.106B,cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650,27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O3,C27H43O3,416.3290453,417.3368703,415.3212202364,437,cpd:C17337,7alpha-Hydroxy-3-oxo-4-cholestenoate,C27H42O4,7alpha-Hydroxy-3-oxo-4-cholestenoate,R08725 R08728,Primary bile acid biosynthesis,1.1.1.181,NA,NA,CAS: 115538-85-7; PubChem: 96023698; NIKKAJI: J676.107K,cpd:C04715; cpd:C08891; cpd:C08902; cpd:C08909; cpd:C16498; cpd:C17337; cpd:C17891,27,42,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O4,C27H41O4,430.3083098,431.3161349,429.3004848365,438,cpd:C17339,"4-Cholesten-7alpha,12alpha-diol-3-one;",C27H44O3,"4-Cholesten-7alpha,12alpha-diol-3-one; 7alpha,12alpha-Dihydroxy-4-cholesten-3-one",R04823 R04826 R04827,Primary bile acid biosynthesis; Metabolic pathways,1.3.1.3; 1.3.99.5; 1.14.18.8,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,CAS: 1254-03-1; PubChem: 96023699; ChEBI: 28477; LIPIDMAPS: LMST04030114; NIKKAJI: J1.513.288D,cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650,27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O3,C27H43O3,416.3290453,417.3368703,415.3212202366,439,cpd:C17343,"(25S)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA",C48H80N7O20P3S,"(25S)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA",R08734 R08735,Primary bile acid biosynthesis; Metabolic pathways,1.17.99.3; 5.1.99.4,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 96023700; ChEBI: 81017; NIKKAJI: J2.806.271K,cpd:C04760; cpd:C05448; cpd:C15613; cpd:C17343,48,80,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C48H81O20N7P3S1,C48H79O20N7P3S1,1199.43917,1200.446995,1198.431345367,440,cpd:C17345,"(25R)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA",C48H80N7O19P3S,"(25R)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA",R08738 R08739,Primary bile acid biosynthesis; Metabolic pathways,5.1.99.4; 6.2.1.7,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 96023701; ChEBI: 81018; NIKKAJI: J2.806.273G,cpd:C04644; cpd:C17345; cpd:C17346,48,80,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C48H81O19N7P3S1,C48H79O19N7P3S1,1183.444256,1184.452081,1182.436431368,441,cpd:C17346,"(25S)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA",C48H80N7O19P3S,"(25S)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA",R08739 R08740,Primary bile acid biosynthesis; Metabolic pathways,1.17.99.3; 5.1.99.4,"Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate",NA,PubChem: 96023702; ChEBI: 81019; NIKKAJI: J2.806.274E,cpd:C04644; cpd:C17345; cpd:C17346,48,80,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C48H81O19N7P3S1,C48H79O19N7P3S1,1183.444256,1184.452081,1182.436431369,442,cpd:C03990,Lithocholic acid;,C24H40O3,Lithocholic acid; Lithocholate; 3alpha-Hydroxy-5beta-cholanate; 3alpha-Hydroxy-5beta-cholanic acid,R03978 R04139 R07203 R07206 R11145 R11539,Secondary bile acid biosynthesis; Bile secretion,1.1.1.52; 1.1.1.392; 1.14.13.94; 1.14.13.97; 2.8.3.25,NA,"Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C03990  Lithocholic acid; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C03990  3alpha-Hydroxy-5beta-cholanic acid",CAS: 434-13-9; PubChem: 6705; ChEBI: 16325; ChEMBL: CHEMBL137446 CHEMBL1478 CHEMBL160837 CHEMBL1997202 CHEMBL369963; LIPIDMAPS: LMST04010003; LipidBank: BBA0003; PDB-CCD: 4OA; 3DMET: B01708; NIKKAJI: J1.532F,cpd:C03990; cpd:C17658,24,40,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O3,C24H39O3,376.2977451,377.3055702,375.2899201370,443,cpd:C04483,Deoxycholic acid;,C24H40O4,"Deoxycholic acid; Deoxycholate; 3alpha,12alpha-Dihydroxy-5beta-cholanate; 3alpha,12alpha-Dihydroxy-5beta-cholanic acid",R04486 R04487 R05836 R07220 R07295,Secondary bile acid biosynthesis; Bile secretion,2.8.3.25; 3.5.1.24,NA,"Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C04483  Deoxycholic acid; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C04483  3alpha,12alpha-Dihydroxy-5beta-cholanic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D11 OTHER DERMATOLOGICAL PREPARATIONS;    D11A OTHER DERMATOLOGICAL PREPARATIONS;     D11AX Other dermatologicals;      D11AX24 Deoxycholic acid;       D10781  Deoxycholic acid (USAN/INN); New drug approvals in the USA [br08319.html];  New Molecular Entity and New Therapeutic Biological Product Approvals;   D10781; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D10781",CAS: 83-44-3; PubChem: 7102; ChEBI: 28834; ChEMBL: CHEMBL1253841 CHEMBL134680 CHEMBL406393; LIPIDMAPS: LMST04010040; LipidBank: BBA0040; KNApSAcK: C00030117; PDB-CCD: DXC; 3DMET: B04945; NIKKAJI: J3.873C,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347371,444,cpd:C07880,Ursodiol;,C24H40O4,"Ursodiol; Ursodeoxycholic acid; Ursodeoxycholate; 3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid",NA,Secondary bile acid biosynthesis,NA,NA,"Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C07880  Ursodiol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C07880  Ursodeoxycholic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A05 BILE AND LIVER THERAPY;    A05A BILE THERAPY;     A05AA Bile acid preparations;      A05AA02 Ursodeoxycholic acid;       D00734  Ursodiol (USP); USP drug classification [BR:br08302];  Gastrointestinal Agents;   Gastrointestinal Agents, Other;    Ursodiol;     D00734  Ursodiol (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   23  Digestive organ agents;    236  Cholagogues;     2362  Bile acids;      D00734  Ursodiol (USP); Ursodeoxycholic acid (JP17/INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for digestive organs;   11 Stomachics;    D00734  Ursodiol (USP);   13 Digestives;    D00734  Ursodiol (USP);   14 Two or more combinations from antacids, stomachics, digestives, and intestinal regulators;    D00734  Ursodiol (USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Ursodeoxycholic acid;     D00734  Ursodiol (USP); Pharmaceutical additives [BR:br08316];  Solubilizer;   D00734  [001070] Ursodeoxycholic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00734  Ursodeoxycholic acid;   D00734  Ursodeoxycholic acid tablets;   D00734  Ursodeoxycholic acid granules; Gastrointestinal agents [br08371.html];  Other gastrointestinal agents;   D00734; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00734; Animal drugs in Japan [BR:br08331];  93  Agents affecting digestive organs;   935  Cholagogues;    9351  Bile acid, derivatives preparations;     C07880  Ursodeoxycholic acid",CAS: 128-13-2; PubChem: 10082; ChEBI: 9907; ChEMBL: CHEMBL118093 CHEMBL1551 CHEMBL163550 CHEMBL311521 CHEMBL73390; LIPIDMAPS: LMST04010033; LipidBank: BBA0033; KNApSAcK: C00032464; 3DMET: B02140; NIKKAJI: J2.520H,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347372,445,cpd:C15515,Murideoxycholic acid;,C24H40O4,"Murideoxycholic acid; Murideoxycholate; 6beta-Hydroxylithocholate; 3alpha,6beta-Dihydroxy-5beta-cholanic acid",R07203,Secondary bile acid biosynthesis,1.14.13.94,NA,Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C15515  Murideoxycholate,PubChem: 17396507; ChEBI: 52030; ChEMBL: CHEMBL272620 CHEMBL345642; LIPIDMAPS: LMST04010025; LipidBank: BBA0025; NIKKAJI: J472.757F,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347373,446,cpd:C15517,Hyodeoxycholate;,C24H40O4,"Hyodeoxycholate; Hyodesoxycholic acid; 6alpha-Hydroxylithocholate; Iodeoxycholic acid; 3alpha,6alpha-Dihydroxy-5beta-cholanic acid",R07206,Secondary bile acid biosynthesis,1.14.13.97,NA,Compounds with biological roles [BR:br08001];  Steroids;   24-Carbon atoms;    Cholane derivatives;     C15517  Hyodeoxycholate,CAS: 83-49-8; PubChem: 17396509; ChEBI: 52023; ChEMBL: CHEMBL135587 CHEMBL272621 CHEMBL74719; LIPIDMAPS: LMST04010024; LipidBank: BBA0024; KNApSAcK: C00030498; NIKKAJI: J4.636A,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347374,447,cpd:C17644,Ursocholate;,C24H40O5,"Ursocholate; Ursocholic acid; 3alpha,7beta,12alpha-Trihydroxy-5beta-cholan-24-oic acid; 3alpha,7beta,12alpha-Trihydroxy-5beta-cholanic acid; 7beta-Hydroxyisocholic acid; 7-Epicholic acid",NA,Secondary bile acid biosynthesis,NA,NA,NA,CAS: 2955-27-3; PubChem: 96023988; ChEBI: 81240; ChEMBL: CHEMBL1254416; LIPIDMAPS: LMST04010088; NIKKAJI: J363.683F,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494375,448,cpd:C17646,12-Epideoxycholic acid;,C24H40O4,12-Epideoxycholic acid; 12-Epideoxycholate,NA,Secondary bile acid biosynthesis,NA,NA,NA,PubChem: 96023990; ChEBI: 81242; ChEMBL: CHEMBL157202 CHEMBL410872; LIPIDMAPS: LMST04010041; NIKKAJI: J39.832B,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347376,449,cpd:C17647,alpha-Muricholate;,C24H40O5,"alpha-Muricholate; alpha-Muricholic acid; 5beta-Cholanic acid-3alpha,6beta,7alpha-triol; 3alpha,6beta,7alpha-Trihydroxy-5beta-cholan-24-oic acid",NA,Secondary bile acid biosynthesis,NA,NA,NA,CAS: 2393-58-0; PubChem: 96023991; ChEBI: 134116 81243; ChEMBL: CHEMBL1997972; LIPIDMAPS: LMST04010066; NIKKAJI: J367.449E,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494377,450,cpd:C17649,Hyocholate;,C24H40O5,"Hyocholate; Hyocholic acid; Iocholic acid; gamma-Muricholate; alpha-Hyocholic acid; 3alpha,6alpha,7alpha-Trihydroxy-5beta-cholan-24-oic acid; 6alpha-Hydroxychenodeoxycholic acid",NA,Secondary bile acid biosynthesis,NA,NA,NA,CAS: 547-75-1; PubChem: 96023992; ChEBI: 81244; ChEMBL: CHEMBL156391 CHEMBL1908063 CHEMBL1997972 CHEMBL360867; LIPIDMAPS: LMST04010064; NIKKAJI: J15.782A,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494378,451,cpd:C17650,Vulpecholate;,C24H40O5,"Vulpecholate; Vulpecholic acid; 1alpha,3alpha,7alpha-Trihydroxy-5beta-cholan-24-oic acid",NA,Secondary bile acid biosynthesis,NA,NA,NA,CAS: 107368-95-6; PubChem: 96023993; ChEBI: 81245; LIPIDMAPS: LMST04010057,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494379,452,cpd:C17651,alpha-Phocaecholic acid;,C24H40O6,"alpha-Phocaecholic acid; 3alpha,7alpha,12alpha,23R-Tetrahydroxycholanic acid",NA,Secondary bile acid biosynthesis,NA,NA,NA,CAS: 6879-45-4; PubChem: 96023994; ChEBI: 81246; LIPIDMAPS: LMST04010254,cpd:C17651,24,40,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O6,C24H39O6,424.282489,425.290314,423.274664380,453,cpd:C17654,beta-Phocaecholate;,C24H40O5,beta-Phocaecholate; beta-Phocaecholic acid; (23R)-Hydroxychenodeoxycholate,NA,Secondary bile acid biosynthesis,NA,NA,NA,CAS: 105369-89-9; PubChem: 96023997; ChEBI: 81249; ChEMBL: CHEMBL186681; LIPIDMAPS: LMST04010102; NIKKAJI: J91.793A,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494381,454,cpd:C17657,Bitocholate;,C24H40O5,Bitocholate; Bitocholic acid,NA,Secondary bile acid biosynthesis,NA,NA,NA,PubChem: 96024000; ChEBI: 81252; LIPIDMAPS: LMST04010113,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494382,455,cpd:C17658,Isolithocholate;,C24H40O3,Isolithocholate; Isolithocholic acid; beta-Lithocholic acid; beta-Lithocholanic acid; 3-Epilithocholic acid; 3beta-Hydroxy-5beta-cholan-24-oic acid; 3beta-Hydroxy-5beta-cholan-24-oic acid,R11144 R11146,Secondary bile acid biosynthesis,1.1.1.391; 1.1.1.393,NA,NA,CAS: 1534-35-6; PubChem: 96024001; ChEBI: 81253; ChEMBL: CHEMBL1997202 CHEMBL318229 CHEMBL349105; LIPIDMAPS: LMST04010004; NIKKAJI: J363.671B,cpd:C03990; cpd:C17658,24,40,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O3,C24H39O3,376.2977451,377.3055702,375.2899201383,456,cpd:C17660,Isochenodeoxycholate;,C24H40O4,"Isochenodeoxycholate; Isochenodeoxycholic acid; 3beta,7alpha-Dihydroxy-5beta-cholanic acid",NA,Secondary bile acid biosynthesis,NA,NA,NA,CAS: 566-24-5; PubChem: 96024003; ChEBI: 88102; LIPIDMAPS: LMST04010034; NIKKAJI: J21.478G,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347384,457,cpd:C17662,Isoursodeoxycholate;,C24H40O4,"Isoursodeoxycholate; Isoursodeoxycholic acid; 3beta,7beta-Dihydroxy-5beta-cholanoic acid; 3beta,7beta-Dihydroxy-5beta-cholan-24-oic acid",NA,Secondary bile acid biosynthesis,NA,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C17662  Isoursodeoxycholate",CAS: 78919-26-3; PubChem: 96024005; ChEBI: 43419; LIPIDMAPS: LMST04010035; PDB-CCD: IU5; NIKKAJI: J21.479E,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347385,458,cpd:C17664,Allochenodeoxycholate;,C24H40O4,"Allochenodeoxycholate; Allochenodeoxycholic acid; 3alpha,7alpha-Dihydroxy-5alpha-cholanoic acid",NA,Secondary bile acid biosynthesis,NA,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C17664  Allochenodeoxycholate",PubChem: 96024007; ChEBI: 81258; ChEMBL: CHEMBL73390; LIPIDMAPS: LMST04010036; NIKKAJI: J14.876H,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347386,459,cpd:C17667,Avicholate;,C24H40O5,Avicholate; Avicholic acid,NA,Secondary bile acid biosynthesis,NA,NA,NA,PubChem: 96024010; ChEBI: 81261; LIPIDMAPS: LMST04010107; NIKKAJI: J1.772.832F,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494387,460,cpd:C17668,Haemulcholate;,C24H40O5,"Haemulcholate; Hemulcholic acid; 3alpha,7alpha,22-Trihydroxy-5beta-cholan-24-oic acid",NA,Secondary bile acid biosynthesis,NA,NA,NA,CAS: 14959-83-2; PubChem: 96024011; ChEBI: 81262; LIPIDMAPS: LMST04010101,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494388,461,cpd:C17687,Allodeoxycholate;,C24H40O4,"Allodeoxycholate; 5alpha-Deoxycholic acid; 3alpha,12alpha-Dihydroxy-5alpha-cholanoic acid",NA,Secondary bile acid biosynthesis,NA,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C17687  Allodeoxycholate",PubChem: 96024028; ChEBI: 81276; ChEMBL: CHEMBL1253841; LIPIDMAPS: LMST04010044; NIKKAJI: J15.089D,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347389,462,cpd:C17689,Ursodeoxycholoyl-CoA;,C45H74N7O19P3S,"Ursodeoxycholoyl-CoA; 3alpha,7beta-Dihydroxy-5beta-cholanoyl-CoA",NA,Secondary bile acid biosynthesis,NA,NA,NA,PubChem: 96024029; ChEBI: 81277,cpd:C05337; cpd:C15560; cpd:C17689,45,74,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H75O19N7P3S1,C45H73O19N7P3S1,1141.397305,1142.40513,1140.38948390,463,cpd:C17726,beta-Muricholate;,C24H40O5,"beta-Muricholate; beta-Muricholic acid; 3alpha,6beta,7beta-Trihydroxy-5beta-cholan-24-oic acid; 5beta-Cholanic acid-3alpha,6beta,7beta-triol",NA,Secondary bile acid biosynthesis,NA,NA,NA,CAS: 2393-59-1; PubChem: 96024056; ChEBI: 134119 81298; ChEMBL: CHEMBL1997972; LIPIDMAPS: LMST04010067; NIKKAJI: J367.450I,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494391,464,cpd:C17727,omega-Muricholate;,C24H40O5,omega-Muricholate; omega-Muricholic acid,NA,Secondary bile acid biosynthesis,NA,NA,NA,PubChem: 96024057; ChEBI: 81299; ChEMBL: CHEMBL159119 CHEMBL1997972; LIPIDMAPS: LMST04010065; NIKKAJI: J472.758D,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494392,465,cpd:C17737,Allocholic acid;,C24H40O5,"Allocholic acid; Allocholate; 3alpha,7alpha,12alpha-Trihydroxy-5alpha-cholanoic acid",NA,Secondary bile acid biosynthesis,NA,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0401 C24 bile acids, alcohols, and derivatives;     C17737  Allocholic acid",CAS: 2464-18-8; PubChem: 96024066; ChEBI: 81308; LIPIDMAPS: LMST04010092; NIKKAJI: J14.831H,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494393,466,cpd:C20865,"3beta,12alpha-Dihydroxy-5beta-cholanoate;",C24H40O4,"3beta,12alpha-Dihydroxy-5beta-cholanoate; 3beta,12alpha-Dihydroxy-5beta-cholanoic acid",NA,Secondary bile acid biosynthesis,NA,NA,NA,CAS: 570-63-8; PubChem: 254741331,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347394,467,cpd:C20866,Alloavicholate;,C24H40O5,"Alloavicholate; Alloavicholic acid; 3alpha,7alpha,16alpha-Trihydroxy-5alpha-cholan-24-oic acid",NA,Secondary bile acid biosynthesis,NA,NA,NA,PubChem: 254741332,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494395,468,cpd:C20867,Avideoxycholate;,C24H40O4,"Avideoxycholate; Avideoxycholic acid; 3alpha,16alpha-Dihydroxy-5beta-cholan-24-oic acid",NA,Secondary bile acid biosynthesis,NA,NA,NA,PubChem: 254741333,cpd:C02528; cpd:C04483; cpd:C07880; cpd:C15515; cpd:C15517; cpd:C17646; cpd:C17660; cpd:C17661; cpd:C17662; cpd:C17664; cpd:C17687; cpd:C20865; cpd:C20867,24,40,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O4,C24H39O4,392.2926598,393.3004848,391.2848347396,469,cpd:C20868,Cygnocholate;,C24H40O5,"Cygnocholate; Cygnocholic acid; 3alpha,7alpha,15alpha-Trihydroxy-5beta-cholan-24-oic acid",NA,Secondary bile acid biosynthesis,NA,NA,NA,PubChem: 254741334,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.2797494397,470,cpd:C00082,L-Tyrosine;,C9H11NO3,L-Tyrosine; (S)-3-(p-Hydroxyphenyl)alanine; (S)-2-Amino-3-(p-hydroxyphenyl)propionic acid; Tyrosine,R00031 R00728 R00729 R00730 R00731 R00732 R00733 R00734; R00735 R00736 R00737 R00739 R01795 R01815 R02078 R02918; R03539 R04730 R05671 R06626 R06751 R07211 R07212 R08825; R09254 R09521 R09830 R10059 R10246 R10671 R10964 R10968; R11366,"Ubiquinone and other terpenoid-quinone biosynthesis; Puromycin biosynthesis; Monobactam biosynthesis; Tyrosine metabolism; Phenylalanine metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Novobiocin biosynthesis; Cyanoamino acid metabolism; Methane metabolism; Thiamine metabolism; Phenylpropanoid biosynthesis; Isoquinoline alkaloid biosynthesis; Betalain biosynthesis; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of vancomycin group antibiotics; Biosynthesis of enediyne antibiotics; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Dopaminergic synapse; Melanogenesis; Prolactin signaling pathway; Protein digestion and absorption; Parkinson's disease; Cocaine addiction; Amphetamine addiction; Alcoholism; Central carbon metabolism in cancer",1.3.1.43; 1.3.1.78; 1.3.1.79; 1.4.1.20; 1.4.3.2; 1.10.3.1; 1.11.1.8; 1.14.14.36; 1.14.16.1; 1.14.16.2; 1.14.18.1; 1.21.1.1; 2.1.1.304; 2.5.1.122; 2.6.1.1; 2.6.1.5; 2.6.1.9; 2.6.1.57; 2.6.1.58; 2.6.1.103; 4.1.1.25; 4.1.1.28; 4.1.99.2; 4.1.99.19; 4.3.1.23; 4.3.1.25; 5.4.3.6; 6.1.1.1; 6.3.2.24; 6.3.2.25,"Tyrosine biosynthesis, chorismate => tyrosine; Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol; Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine; Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline; Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine; Tyrosine degradation, tyrosine => homogentisate; Cyanogenic glycoside biosynthesis, tyrosine => dhurrin; C-1027 beta-amino acid moiety biosynthesis, tyrosine => 3-chloro-4,5-dihydroxy-beta-phenylalanyl-PCP; Maduropeptin beta-hydroxy acid moiety biosynthesis, tyrosine => 3-(2-chloro-3-hydroxy-4-methoxyphenyl)-3-hydroxypropanoyl-PCP",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00082  Tyrosine (Tyr); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00022  L-Tyrosine,CAS: 60-18-4; PubChem: 3382; ChEBI: 17895; ChEMBL: CHEMBL925; KNApSAcK: C00001397; PDB-CCD: TYR; 3DMET: B01154; NIKKAJI: J9.173A,cpd:C00082; cpd:C01536; cpd:C03290; cpd:C04368; cpd:C06420; cpd:C14322; cpd:C19579; cpd:C19712; cpd:C20807; cpd:C21308,9,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O3N1,C9H10O3N1,181.0738932,182.0817182,180.0660682398,471,cpd:C00156,4-Hydroxybenzoate;,C7H6O3,4-Hydroxybenzoate; Hydroxybenzoic acid; 4-Hydroxybenzoic acid; Hydroxybenzenecarboxylic acid,R01238 R01293 R01294 R01295 R01296 R01297 R01298 R01299; R01300 R01301 R01302 R01303 R01304 R01305 R01306 R01307; R01308 R05000 R05603 R05615 R05616 R06889 R07273 R09039; R09040 R09105 R11102,Ubiquinone and other terpenoid-quinone biosynthesis; Phenylalanine metabolism; Benzoate degradation; Bisphenol degradation; Toluene degradation; Aminobenzoate degradation; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Degradation of aromatic compounds; Benzoic acid family,1.2.1.7; 1.2.1.28; 1.2.1.64; 1.2.1.96; 1.13.11.41; 1.13.-.-; 1.14.13.2; 1.14.13.12; 1.14.13.33; 1.14.13.64; 1.14.99.15; 1.14.99.-; 2.4.1.194; 2.4.2.54; 2.5.1.39; 2.5.1.93; 3.1.1.-; 3.1.2.23; 3.2.1.-; 3.8.1.6; 4.1.1.61; 4.1.3.40; 6.2.1.27; 6.4.1.-,"Ubiquinone biosynthesis, prokaryotes, chorismate => ubiquinone; Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate => ubiquinone",NA,CAS: 99-96-7; PubChem: 3456; ChEBI: 17879 30763; ChEMBL: CHEMBL441343; KNApSAcK: C00000856; PDB-CCD: PHB; 3DMET: B00045; NIKKAJI: J43.201F,cpd:C00156; cpd:C00587; cpd:C00805; cpd:C05585; cpd:C08055; cpd:C10832; cpd:C12114; cpd:C14015; cpd:C16700; cpd:C17098; cpd:C18316; cpd:C20248,7,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O3,C7H5O3,138.0316941,139.0395191,137.023869399,472,cpd:C00223,p-Coumaroyl-CoA;,C30H42N7O18P3S,p-Coumaroyl-CoA; 4-Coumaroyl-CoA; 4-Hydroxycinnamoyl-CoA,R01613 R01614 R01615 R01616 R01617 R02416 R06544 R06545; R06568 R06806 R07432 R07436 R07880 R07882 R07883 R07927; R07929 R08767 R08796 R08805 R08807 R08809 R08815 R08983; R09256 R10233 R10234 R10237 R10529 R11200,"Ubiquinone and other terpenoid-quinone biosynthesis; Arginine and proline metabolism; Phenylalanine metabolism; Phenylpropanoid biosynthesis; Flavonoid biosynthesis; Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites; Degradation of aromatic compounds",1.2.1.44; 1.14.13.11; 1.14.13.-; 2.3.1.64; 2.3.1.74; 2.3.1.95; 2.3.1.133; 2.3.1.153; 2.3.1.170; 2.3.1.173; 2.3.1.211; 2.3.1.212; 2.3.1.215; 2.3.1.218; 2.3.1.219; 2.3.1.229; 2.3.1.249; 2.3.1.-; 6.2.1.12,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol; Flavanone biosynthesis, phenylalanine => naringenin; Capsaicin biosynthesis, L-Phenylalanine => Capsaicin",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Paracoumaryl alcohol derivatives;     C00223  p-Coumaroyl-CoA,CAS: 119785-99-8; PubChem: 3523; ChEBI: 15499; ChEMBL: CHEMBL250086; KNApSAcK: C00007280; PDB-CCD: WCA; 3DMET: B04651; NIKKAJI: J796.717I,cpd:C00223; cpd:C07118,30,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H43O18N7P3S1,C30H41O18N7P3S1,913.1519897,914.1598147,912.1441647400,473,cpd:C00251,Chorismate;,C10H10O6,"Chorismate; Chorismic acid; (3R,4R)-3-[(1-Carboxyethenyl)oxy]-4-hydroxycyclohexa-1,5-diene-1-carboxylate",R00985 R00986 R01302 R01714 R01715 R01716 R01717 R05552; R06603 R08956 R10583 R10597 R10666,"Ubiquinone and other terpenoid-quinone biosynthesis; Phenylalanine, tyrosine and tryptophan biosynthesis; Folate biosynthesis; Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of enediyne antibiotics; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",2.6.1.85; 2.6.1.86; 3.3.2.13; 4.1.3.27; 4.1.3.40; 4.1.3.45; 4.2.1.151; 4.2.3.5; 5.4.4.2; 5.4.99.5,"Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate; Tryptophan biosynthesis, chorismate => tryptophan; Phenylalanine biosynthesis, chorismate => phenylalanine; Tyrosine biosynthesis, chorismate => tyrosine; Menaquinone biosynthesis, chorismate => menaquinone; Ubiquinone biosynthesis, prokaryotes, chorismate => ubiquinone; C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA",NA,CAS: 617-12-9; PubChem: 3550; ChEBI: 17333; KNApSAcK: C00000733; PDB-CCD: ISJ; 3DMET: B01200; NIKKAJI: J7.035A,cpd:C00251; cpd:C00254; cpd:C00885; cpd:C03721; cpd:C11631,10,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O6,C10H9O6,226.047738,227.0555631,225.039913401,474,cpd:C00341,Geranyl diphosphate,C10H20O7P2,Geranyl diphosphate,R01658 R02003 R02004 R02006 R02007 R02009 R02010 R02011; R02013 R05765 R05766 R06120 R06421 R07631 R07632 R08393; R08394 R08395 R08396 R08397 R08398 R08399 R08528 R09040; R09250 R09940 R09961 R09962 R09963 R09964 R09965 R09966; R09968 R09969 R09970 R09971 R09972 R09974 R09975 R10176; R10509 R10969 R11086 R11087 R11551,Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Monoterpenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.1.1.255; 2.5.1.1; 2.5.1.10; 2.5.1.68; 2.5.1.84; 2.5.1.93; 2.5.1.102; 2.5.1.123; 2.5.1.124; 2.5.1.125; 3.1.7.3; 3.1.7.11; 3.6.1.68; 4.2.3.10; 4.2.3.11; 4.2.3.15; 4.2.3.16; 4.2.3.20; 4.2.3.25; 4.2.3.26; 4.2.3.105; 4.2.3.106; 4.2.3.107; 4.2.3.108; 4.2.3.109; 4.2.3.110; 4.2.3.111; 4.2.3.112; 4.2.3.113; 4.2.3.114; 4.2.3.115; 4.2.3.116; 4.2.3.117; 4.2.3.119; 4.2.3.120; 4.2.3.121; 4.2.3.122; 4.2.3.-; 5.5.1.8; 5.5.1.22,"C10-C20 isoprenoid biosynthesis, bacteria; C10-C20 isoprenoid biosynthesis, archaea; C10-C20 isoprenoid biosynthesis, plants; C10-C20 isoprenoid biosynthesis, non-plant eukaryotes",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C00341  Geranyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C00341  Geranyl diphosphate,PubChem: 3634; ChEBI: 17211; ChEMBL: CHEMBL41342; LIPIDMAPS: LMPR0102010001; LipidBank: IIP0003; KNApSAcK: C00000846; PDB-CCD: GPP; 3DMET: B00091; NIKKAJI: J1.452.575K J39.583H,cpd:C00341; cpd:C02569; cpd:C03190; cpd:C05308; cpd:C18051; cpd:C18052; cpd:C20664,10,20,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H21O7P2,C10H19O7P2,314.068427,315.076252,313.0606019402,475,cpd:C00353,Geranylgeranyl diphosphate;,C20H36O7P2,"Geranylgeranyl diphosphate; Geranylgeranyl pyrophosphate; all-trans-Geranylgeranyl diphosphate; all-trans-Geranylgeranyl pyrophosphate; (2E,6E,10E)-3,7,11,15-Tetramethylhexadeca-2,6,10,14-tetraen-1-yl diphosphate",R02061 R02063 R02064 R02065 R02068 R04158 R04520 R06298; R06305 R06312 R06321 R07475 R07916 R08754 R08992 R08993; R09123 R09246 R09251 R09685 R09714 R09715 R09730 R09874; R09967 R10177 R10349 R10533 R10708 R10763 R10896 R10897; R10898 R10899 R11514 R11517,Ubiquinone and other terpenoid-quinone biosynthesis; Indole diterpene alkaloid biosynthesis; Terpenoid backbone biosynthesis; Diterpenoid biosynthesis; Carotenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.3.1.83; 1.3.1.-; 2.5.1.29; 2.5.1.32; 2.5.1.41; 2.5.1.42; 2.5.1.81; 2.5.1.82; 2.5.1.85; 2.5.1.89; 2.5.1.99; 2.5.1.116; 2.5.1.133; 3.1.7.5; 3.1.7.10; 4.2.1.133; 4.2.3.8; 4.2.3.17; 4.2.3.41; 4.2.3.43; 4.2.3.144; 4.2.3.146; 4.2.3.148; 4.2.3.149; 4.2.3.150; 4.2.3.151; 5.5.1.12; 5.5.1.13; 5.5.1.14; 5.5.1.15; 5.5.1.16,"beta-Carotene biosynthesis, GGAP => beta-carotene; Tocopherol/tocotorienol biosynthesis; C10-C20 isoprenoid biosynthesis, bacteria; C10-C20 isoprenoid biosynthesis, archaea; C10-C20 isoprenoid biosynthesis, plants; C10-C20 isoprenoid biosynthesis, non-plant eukaryotes; Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline; Terpentecin biosynthesis, GGAP => terpentecin",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010401 Acyclic diterpenoids;      C00353  Geranylgeranyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Linear diterpenes;     C00353  Geranylgeranyl diphosphate,CAS: 6699-20-3; PubChem: 3646; ChEBI: 48861; ChEMBL: CHEMBL1229266; LipidBank: IIP0006; KNApSAcK: C00000908; PDB-CCD: GRG; 3DMET: B01223; NIKKAJI: J39.582J,cpd:C00353; cpd:C05859; cpd:C06089; cpd:C11356; cpd:C11901; cpd:C11902; cpd:C19815; cpd:C19836,20,36,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H37O7P2,C20H35O7P2,450.1936275,451.2014525,449.1858025403,477,cpd:C00423,trans-Cinnamate;,C9H8O2,trans-Cinnamate; trans-Cinnamic acid; (E)-Cinnamate; (2E)-3-Phenylprop-2-enoate,R00697 R01426 R02252 R02253 R02254 R02255 R02256 R06745; R06781 R06783 R07796 R08422 R08423 R11070,Ubiquinone and other terpenoid-quinone biosynthesis; Phenylalanine metabolism; Phenylpropanoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.31; 1.14.12.19; 1.14.13.11; 1.14.13.14; 2.4.1.177; 2.8.3.17; 4.1.1.102; 4.3.1.24; 4.3.1.25; 6.2.1.12,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol; Flavanone biosynthesis, phenylalanine => naringenin; Capsaicin biosynthesis, L-Phenylalanine => Capsaicin; Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C00423  trans-Cinnamate,CAS: 140-10-3; PubChem: 3713; ChEBI: 15669 35697; ChEMBL: CHEMBL27246; KNApSAcK: C00000170 C00029961; PDB-CCD: TCA; 3DMET: B00108; NIKKAJI: J2.024I,cpd:C00423; cpd:C02274; cpd:C04050; cpd:C05608; cpd:C07720; cpd:C07728; cpd:C07899; cpd:C10438; cpd:C14438; cpd:C17268,9,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O2,C9H7O2,148.0524295,149.0602545,147.0446045404,478,cpd:C00544,Homogentisate;,C8H8O4,"Homogentisate; Homogentisic acid; 2,5-Dihydroxyphenylacetic acid; 2,5-Dihydroxyphenylacetate",R02514 R02515 R02516 R02517 R02518 R02519 R02520 R02521; R05450 R07500 R08782 R10708,Ubiquinone and other terpenoid-quinone biosynthesis; Tyrosine metabolism; Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.13.11.5; 1.13.11.27; 1.13.12.-; 1.14.13.18; 1.14.13.63; 1.14.13.-; 2.5.1.115; 2.5.1.116; 2.5.1.117; 4.1.1.-,"Tyrosine degradation, tyrosine => homogentisate",Major components of natural products [BR:br08323];  Crude drugs;   Pinellia tuber;    C00544  Homogentisate,CAS: 451-13-8; PubChem: 3825; ChEBI: 16169 44747; KNApSAcK: C00007309; PDB-CCD: OMD; 3DMET: B00126; NIKKAJI: J5.750I,cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272,8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O4,C8H7O4,168.0422587,169.0500838,167.0344337405,479,cpd:C00811,4-Coumarate;,C9H8O3,4-Coumarate; p-Coumaric acid; trans-4-Hydroxycinnamate; trans-p-Hydroxycinnamate; 4-Hydroxycinnamic acid; 4-Hydroxycinnamate,R00737 R01308 R01616 R02253 R02950 R02951 R02952 R07826; R08023 R08534 R08766,Ubiquinone and other terpenoid-quinone biosynthesis; Tyrosine metabolism; Phenylalanine metabolism; Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites; Degradation of aromatic compounds,1.14.13.11; 1.14.13.-; 1.14.18.1; 2.4.1.126; 4.1.1.102; 4.2.1.-; 4.3.1.23; 4.3.1.25; 6.2.1.12,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol; Flavanone biosynthesis, phenylalanine => naringenin; Capsaicin biosynthesis, L-Phenylalanine => Capsaicin",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Paracoumaryl alcohol derivatives;     C00811  4-Coumarate,CAS: 7400-08-0 501-98-4; PubChem: 4069; ChEBI: 32374; ChEMBL: CHEMBL66879; KNApSAcK: C00000152 C00000580 C00026316; PDB-CCD: HC4; 3DMET: B01335; NIKKAJI: J6.196D J8.929J,cpd:C00166; cpd:C00811; cpd:C01772; cpd:C02763; cpd:C05838; cpd:C06738; cpd:C07114; cpd:C10945; cpd:C11020; cpd:C12463; cpd:C12621; cpd:C20685; cpd:C20687; cpd:C20939; cpd:C21345,9,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O3,C9H7O3,164.0473441,165.0551691,163.0395191406,481,cpd:C00885,Isochorismate;,C10H10O6,Isochorismate; Isochorismic acid,R01717 R03037 R06602 R08165,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of phenylpropanoids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.2.1.9; 3.3.2.1; 4.2.99.21; 5.4.4.2,"Menaquinone biosynthesis, chorismate => menaquinone",NA,CAS: 22642-82-6; PubChem: 4141; ChEBI: 17582 29780; KNApSAcK: C00000734; PDB-CCD: ISC; 3DMET: B01348; NIKKAJI: J389.211E,cpd:C00251; cpd:C00254; cpd:C00885; cpd:C03721; cpd:C11631,10,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O6,C10H9O6,226.047738,227.0555631,225.039913407,482,cpd:C01179,3-(4-Hydroxyphenyl)pyruvate;,C9H8O4,3-(4-Hydroxyphenyl)pyruvate; 4-Hydroxyphenylpyruvate; p-Hydroxyphenylpyruvic acid,R00042 R00729 R00734 R01728 R01730 R02521 R03336 R03337; R03338 R03339 R03341 R03342 R05778 R06626 R06632 R06757; R09254 R09396 R09830,"Ubiquinone and other terpenoid-quinone biosynthesis; Monobactam biosynthesis; Tyrosine metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Novobiocin biosynthesis; Methane metabolism; Isoquinoline alkaloid biosynthesis; Biosynthesis of vancomycin group antibiotics; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.222; 1.1.1.237; 1.2.3.13; 1.3.1.12; 1.3.1.13; 1.4.1.20; 1.4.3.2; 1.13.11.27; 1.13.11.46; 2.5.1.77; 2.5.1.111; 2.6.1.1; 2.6.1.5; 2.6.1.9; 2.6.1.57; 2.6.1.58; 2.6.1.103; 4.1.1.80; 5.3.2.1,"Tyrosine biosynthesis, chorismate => tyrosine; Tyrosine degradation, tyrosine => homogentisate; F420 biosynthesis",NA,CAS: 156-39-8; PubChem: 4406; ChEBI: 15999 36242; ChEMBL: CHEMBL607712; KNApSAcK: C00007512; PDB-CCD: ENO; 3DMET: B00254; NIKKAJI: J101.877I,cpd:C01179; cpd:C01197; cpd:C01405; cpd:C01481; cpd:C04367; cpd:C05350; cpd:C12467; cpd:C12623; cpd:C13400; cpd:C17086; cpd:C18819; cpd:C21346,9,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O4,C9H7O4,180.0422587,181.0500838,179.0344337408,483,cpd:C01230,all-trans-Hexaprenyl diphosphate,C30H52O7P2,all-trans-Hexaprenyl diphosphate,R05612 R05613 R05616 R09245 R09246,Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.39; 2.5.1.82; 2.5.1.83; 2.5.1.-,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Others;    Polyterpenoids;     C01230  all-trans-Hexaprenyl diphosphate,PubChem: 4452; ChEBI: 17528; LIPIDMAPS: LMPR03030005; 3DMET: B01417,cpd:C01230; cpd:C03428; cpd:C17434,30,52,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H53O7P2,C30H51O7P2,586.318828,587.326653,585.311003409,484,cpd:C01967,Ubiquinone-9;,C54H82O4,Ubiquinone-9; Ubiquinone-45; Coenzyme Q(9),R07235,Ubiquinone and other terpenoid-quinone biosynthesis,2.1.1.64,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0201 Ubiquinones;     C01967  Ubiquinone-9,CAS: 303-97-9; PubChem: 5068; ChEBI: 18160; LIPIDMAPS: LMPR02010004; LipidBank: VCQ0002; KNApSAcK: C00007442; 3DMET: B01523; NIKKAJI: J11.404I,cpd:C01967,54,82,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C54H83O4,C54H81O4,794.6213111,795.6291362,793.6134861410,485,cpd:C02059,Phylloquinone;,C31H46O2,"Phylloquinone; Vitamin K1; Phytonadione; 2-Methyl-3-phytyl-1,4-naphthoquinone",R03510 R03511 R03816 R06859 R10728,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Vitamin digestion and absorption,1.6.5.2; 1.14.13.194; 1.14.99.20; 1.17.4.4; 2.1.1.163,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Fat-soluble vitamins;     C02059  Phylloquinone (Vitamin K1); Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0203 Vitamin K;     C02059  Phylloquinone (Vitamin K1); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B02 ANTIHEMORRHAGICS;    B02B VITAMIN K AND OTHER HEMOSTATICS;     B02BA Vitamin K;      B02BA01 Phytomenadione;       D00148  Phytonadione (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    316  Vitamin K preparations;     3160  Vitamin K preparations;      D00148  Phytonadione (JP17/USP); Phytomenadione (INN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Phytonadione;     D00148  Phytonadione (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Phylloquinone;     C02059  Phylloquinone; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00148  Phytonadione,CAS: 84-80-0; PubChem: 5148; ChEBI: 18067; ChEMBL: CHEMBL520156; LIPIDMAPS: LMPR02030028; LipidBank: VVK0001; KNApSAcK: C00002868; 3DMET: B04836; NIKKAJI: J3.883K,cpd:C02059,31,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H47O2,C31H45O2,450.3497807,451.3576058,449.3419557411,486,cpd:C02477,alpha-Tocopherol;,C29H50O2,alpha-Tocopherol; Vitamin E,R07236 R07508,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Vitamin digestion and absorption,2.1.1.95,Tocopherol/tocotorienol biosynthesis,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Fat-soluble vitamins;     C02477  alpha-Tocopherol (Vitamin E); Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C02477  alpha-Tocopherol; Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   34 Vitamin E based drugs;    C02477  alpha-Tocopherol; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Tocopherol;     C02477  alpha-Tocopherol; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   C02477  [001439] Tocopherol;  Antioxidant agent;   C02477  [001439] Tocopherol,CAS: 59-02-9; PubChem: 5492; ChEBI: 18145; ChEMBL: CHEMBL47; LIPIDMAPS: LMPR02020000 LMPR02020001; LipidBank: VVE0002 VVE0003; KNApSAcK: C00007366; PDB-CCD: VIV; 3DMET: B01577; NIKKAJI: J24.260H,cpd:C02477; cpd:C04814,29,50,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H51O2,C29H49O2,430.3810809,431.3889059,429.3732558412,487,cpd:C02483,gamma-Tocopherol,C28H48O2,gamma-Tocopherol,R07236 R07502,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.1.1.95; 5.5.1.24,Tocopherol/tocotorienol biosynthesis,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C02483  gamma-Tocopherol,CAS: 54-28-4; PubChem: 5496; ChEBI: 18185; LIPIDMAPS: LMPR02020060 LMPR02020065; LipidBank: VVE0006; KNApSAcK: C00029470; 3DMET: B01578; NIKKAJI: J213.540J,cpd:C02483; cpd:C14152; cpd:C15789; cpd:C15795; cpd:C15797; cpd:C15883,28,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O2,C28H47O2,416.3654308,417.3732558,415.3576058413,488,cpd:C02730,2-Succinylbenzoate;,C11H10O5,2-Succinylbenzoate; o-Succinylbenzoate; Succinylbenzoate,R04030 R04031 R05454,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.1.113; 6.2.1.26,"Menaquinone biosynthesis, chorismate => menaquinone",NA,PubChem: 5692; ChEBI: 18325 44788; KNApSAcK: C00000743; PDB-CCD: OSB; 3DMET: B00493; NIKKAJI: J387.833C,cpd:C02730; cpd:C09271; cpd:C10496; cpd:C12264; cpd:C14106; cpd:C14107; cpd:C17479; cpd:C17480,11,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O5,C11H9O5,222.0528234,223.0606485,221.0449984414,489,cpd:C02949,4-Hydroxybenzoyl-CoA,C28H40N7O18P3S,4-Hydroxybenzoyl-CoA,R01300 R01301 R04101 R05316 R08118 R08767,Ubiquinone and other terpenoid-quinone biosynthesis; Benzoate degradation; Fluorobenzoate degradation; Aminobenzoate degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.7.9; 3.1.2.23; 3.8.1.7; 6.2.1.27,NA,NA,PubChem: 5868; ChEBI: 15500; PDB-CCD: BCA; NIKKAJI: J727.498J,cpd:C02949; cpd:C05195; cpd:C19684; cpd:C20394,28,40,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H41O18N7P3S1,C28H39O18N7P3S1,887.1363396,888.1441647,886.1285146415,490,cpd:C03160,2-Succinylbenzoyl-CoA;,C32H44N7O20P3S,2-Succinylbenzoyl-CoA; o-Succinylbenzoyl-CoA; Succinylbenzoyl-CoA; 4-(2-Carboxyphenyl)-4-oxobutanoyl-CoA,R04030 R04150 R05455 R07263,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,4.1.3.36; 6.2.1.26,"Menaquinone biosynthesis, chorismate => menaquinone",NA,PubChem: 6045; ChEBI: 15509; 3DMET: B04881; NIKKAJI: J1.968.559D,cpd:C03160; cpd:C09820,32,44,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H45O20N7P3S1,C32H43O20N7P3S1,971.157469,972.165294,970.149644416,491,cpd:C03313,Phylloquinol;,C31H48O2,Phylloquinol; Vitamin K1 hydroquinone; Phytonadiol,R03816 R04994 R05144,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.6.5.2; 2.1.1.329; 4.1.1.90,NA,NA,CAS: 572-96-3; PubChem: 6166; ChEBI: 28433; LIPIDMAPS: LMPR02030030; NIKKAJI: J188.437I,cpd:C03313; cpd:C07373,31,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H49O2,C31H47O2,452.3654308,453.3732558,451.3576058417,492,cpd:C03657,"1,4-Dihydroxy-2-naphthoate;",C11H8O4,"1,4-Dihydroxy-2-naphthoate; 1,4-Dihydroxy-2-naphthoic acid",R04150 R05617 R06858 R07262 R10757,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.5.1.74; 2.5.1.-; 3.1.2.28; 4.1.3.36,"Menaquinone biosynthesis, chorismate => menaquinone",NA,CAS: 31519-22-9; PubChem: 6435; ChEBI: 18094; ChEMBL: CHEMBL1232286; KNApSAcK: C00000736; PDB-CCD: DNA; 3DMET: B00613; NIKKAJI: J27.838F,cpd:C03657; cpd:C06986; cpd:C10335; cpd:C13429; cpd:C14093; cpd:C17018,11,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O4,C11H7O4,204.0422587,205.0500838,203.0344337418,493,cpd:C03672,3-(4-Hydroxyphenyl)lactate;,C9H10O4,3-(4-Hydroxyphenyl)lactate; 4-Hydroxyphenyllactate; p-Hydroxyphenyllactate; 2-Hydroxy-3-(4-hydroxyphenyl)propanoate,R03336 R03338 R08766,Ubiquinone and other terpenoid-quinone biosynthesis; Tyrosine metabolism; Biosynthesis of secondary metabolites,1.1.1.222; 1.1.1.237; 4.2.1.-,NA,NA,PubChem: 6448; ChEBI: 17385 36659; ChEMBL: CHEMBL1162489; 3DMET: B04909; NIKKAJI: J70.493H,cpd:C02333; cpd:C03672; cpd:C03964; cpd:C04044; cpd:C05582; cpd:C05583; cpd:C06663; cpd:C10447; cpd:C10680; cpd:C12622; cpd:C20953; cpd:C21085,9,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O4,C9H9O4,182.0579088,183.0657338,181.0500838419,494,cpd:C03885,3-Nonaprenyl-4-hydroxybenzoate;,C52H78O3,3-Nonaprenyl-4-hydroxybenzoate; Nonaprenyl-4-hydroxybenzoate,R07273,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.39,NA,NA,PubChem: 6618; ChEBI: 18162 84501; NIKKAJI: J2.744.423G,cpd:C03885,52,78,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C52H79O3,C52H77O3,750.5950964,751.6029214,749.5872713420,495,cpd:C03993,4-(beta-D-Glucosyloxy)benzoate;,C13H16O8,4-(beta-D-Glucosyloxy)benzoate; 4-Hydroxybenzoate-O-glucoside,R01304 R09039,Ubiquinone and other terpenoid-quinone biosynthesis,2.4.1.194; 3.2.1.-,NA,NA,PubChem: 6706; ChEBI: 11935 16741; NIKKAJI: J589.936B,cpd:C03993; cpd:C11755; cpd:C14295; cpd:C20691,13,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H17O8,C13H15O8,300.0845175,301.0923425,299.0766924421,496,cpd:C04145,all-trans-Nonaprenyl diphosphate;,C45H76O7P2,all-trans-Nonaprenyl diphosphate; Solanesyl pyrophosphate; Solanesyl diphosphate,R07267 R07273 R08747 R08782 R09250 R09251,Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.39; 2.5.1.84; 2.5.1.85; 2.5.1.117; 2.5.1.-,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Others;    Polyterpenoids;     C04145  all-trans-Nonaprenyl diphosphate,PubChem: 6830; ChEBI: 18144; LIPIDMAPS: LMPR03030007; KNApSAcK: C00007289; 3DMET: B01720; NIKKAJI: J435.278E,cpd:C04145; cpd:C17438,45,76,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C45H77O7P2,C45H75O7P2,790.5066288,791.5144538,789.4988038422,497,cpd:C04146,all-trans-Octaprenyl diphosphate;,C40H68O7P2,all-trans-Octaprenyl diphosphate; Farnesylfarnesylgeraniol,R05611 R05615 R05617 R07267 R09248,Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.39; 2.5.1.74; 2.5.1.84; 2.5.1.85; 2.5.1.90; 2.5.1.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C04146  all-trans-Octaprenyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Others;    Polyterpenoids;     C04146  all-trans-Octaprenyl diphosphate,PubChem: 6831; ChEBI: 16275; LIPIDMAPS: LMPR01070226; PDB-CCD: OTP; 3DMET: B01721; NIKKAJI: J2.167.537G,cpd:C03427; cpd:C04146; cpd:C17437,40,68,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H69O7P2,C40H67O7P2,722.4440285,723.4518536,721.4362035423,498,cpd:C05200,"3-Hexaprenyl-4,5-dihydroxybenzoate",C37H54O4,"3-Hexaprenyl-4,5-dihydroxybenzoate",R04711 R06865,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.1.1.114,NA,NA,PubChem: 7605; ChEBI: 18081; LIPIDMAPS: LMPR02010043; 3DMET: B00760; NIKKAJI: J2.754.909H,cpd:C05200,37,54,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H55O4,C37H53O4,562.4022102,563.4100353,561.3943852424,499,cpd:C05313,3-Hexaprenyl-4-hydroxy-5-methoxybenzoate,C38H56O4,3-Hexaprenyl-4-hydroxy-5-methoxybenzoate,R04711 R06866,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.1.1.114,NA,NA,PubChem: 7695; ChEBI: 16835; LIPIDMAPS: LMPR02010044; 3DMET: B00764; NIKKAJI: J2.755.454G,cpd:C05313; cpd:C05805,38,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C38H57O4,C38H55O4,576.4178603,577.4256853,575.4100353425,500,cpd:C05427,Phytyl diphosphate,C20H42O7P2,Phytyl diphosphate,R02063 R04795 R06284 R06858 R07500 R08756 R09067,Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.83; 1.3.1.-; 2.5.1.62; 2.5.1.115; 2.5.1.-,Tocopherol/tocotorienol biosynthesis,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010401 Acyclic diterpenoids;      C05427  Phytyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Linear diterpenes;     C05427  Phytyl diphosphate,PubChem: 7791; ChEBI: 75837; LIPIDMAPS: LMPR0104010008 LMPR0104010017; LipidBank: IIP0039; KNApSAcK: C00007255; 3DMET: B05021; NIKKAJI: J841.050J,cpd:C05427,20,42,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H43O7P2,C20H41O7P2,456.2405777,457.2484027,455.2327527426,501,cpd:C05802,2-Hexaprenyl-6-methoxyphenol,C37H56O2,2-Hexaprenyl-6-methoxyphenol,R04981 R04982 R06866,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.1.1.-,NA,NA,PubChem: 8097; ChEBI: 1109; LIPIDMAPS: LMPR02010042; 3DMET: B00844; NIKKAJI: J2.759.730K,cpd:C05802,37,56,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H57O2,C37H55O2,532.428031,533.4358561,531.420206427,502,cpd:C05803,"2-Hexaprenyl-6-methoxy-1,4-benzoquinone",C37H54O3,"2-Hexaprenyl-6-methoxy-1,4-benzoquinone",R04982 R04983,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.1.1.201,NA,NA,PubChem: 8098; ChEBI: 27752; 3DMET: B00845; NIKKAJI: J2.759.731I,cpd:C05803; cpd:C13425,37,54,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H55O3,C37H53O3,546.4072956,547.4151206,545.3994706428,503,cpd:C05804,"2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone",C38H56O3,"2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone",R04983 R04984,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.1.1.201,NA,NA,PubChem: 8099; ChEBI: 28711; 3DMET: B00846; NIKKAJI: J93.211F,cpd:C05804,38,56,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C38H57O3,C38H55O3,560.4229457,561.4307707,559.4151206429,504,cpd:C05805,"2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone",C38H56O4,"2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone",R02175 R04984,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.1.1.64,NA,NA,PubChem: 8100; ChEBI: 28753; 3DMET: B00847; NIKKAJI: J2.068.755J,cpd:C05313; cpd:C05805,38,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C38H57O4,C38H55O4,576.4178603,577.4256853,575.4100353430,506,cpd:C05809,3-Octaprenyl-4-hydroxybenzoate;,C47H70O3,3-Octaprenyl-4-hydroxybenzoate; 4-Hydroxy-3-octaprenylbenzoate,R04986 R05615,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.39; 4.1.1.98,NA,NA,PubChem: 8104; ChEBI: 50116; 3DMET: B00848; NIKKAJI: J2.759.756D,cpd:C05809; cpd:C05813,47,70,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C47H71O3,C47H69O3,682.5324961,683.5403211,681.5246711431,507,cpd:C05810,2-Octaprenylphenol,C46H70O,2-Octaprenylphenol,R04986 R04987,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 4.1.1.98,NA,NA,CAS: 42187-47-3; PubChem: 8105; ChEBI: 40407; PDB-CCD: 8PP; 3DMET: B00849; NIKKAJI: J2.759.758K,cpd:C05810,46,70,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H71O1,C46H69O1,638.5426669,639.5504919,637.5348418432,508,cpd:C05811,2-Octaprenyl-6-hydroxyphenol;,C46H70O2,2-Octaprenyl-6-hydroxyphenol; 3-Octaprenylcatechol,R04987 R04988,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.1.1.222,NA,NA,PubChem: 8106; ChEBI: 1233; 3DMET: B00850; NIKKAJI: J2.759.759I,cpd:C05811,46,70,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H71O2,C46H69O2,654.5375815,655.5454065,653.5297565433,509,cpd:C05812,2-Octaprenyl-6-methoxyphenol,C47H72O2,2-Octaprenyl-6-methoxyphenol,R04988 R04989,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.1.1.222,NA,NA,PubChem: 8107; ChEBI: 1235; 3DMET: B00851; NIKKAJI: J2.759.762I,cpd:C05812,47,72,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C47H73O2,C47H71O2,668.5532316,669.5610566,667.5454065434,510,cpd:C05813,"2-Octaprenyl-6-methoxy-1,4-benzoquinone",C47H70O3,"2-Octaprenyl-6-methoxy-1,4-benzoquinone",R04989 R04990,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.1.1.201,NA,NA,PubChem: 8108; ChEBI: 28423; 3DMET: B00852; NIKKAJI: J2.759.805F,cpd:C05809; cpd:C05813,47,70,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C47H71O3,C47H69O3,682.5324961,683.5403211,681.5246711435,511,cpd:C05814,"2-Octaprenyl-3-methyl-6-methoxy-1,4-benzoquinone",C48H72O3,"2-Octaprenyl-3-methyl-6-methoxy-1,4-benzoquinone",R04990 R06146,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.1.1.201,NA,NA,PubChem: 8109; ChEBI: 28636; 3DMET: B00853; NIKKAJI: J28.579J,cpd:C05814,48,72,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C48H73O3,C48H71O3,696.5481462,697.5559712,695.5403211436,512,cpd:C05815,"2-Octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone",C48H72O4,"2-Octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone",R05614 R06146,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.1.1.64,NA,NA,PubChem: 8110; ChEBI: 27688; 3DMET: B00854; NIKKAJI: J2.759.807B,cpd:C05815,48,72,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C48H73O4,C48H71O4,712.5430608,713.5508858,711.5352358437,513,cpd:C05817,"(1R,6R)-6-Hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate;",C11H12O6,"(1R,6R)-6-Hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate; (1R,6R)-2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate; SHCHC",R04031 R08166,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.1.113; 4.2.99.20,"Menaquinone biosynthesis, chorismate => menaquinone",NA,PubChem: 8112; ChEBI: 39564; PDB-CCD: 164; 3DMET: B05119; NIKKAJI: J2.759.808K,cpd:C05817; cpd:C08566,11,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O6,C11H11O6,240.0633881,241.0712131,239.0555631438,518,cpd:C05849,Vitamin K1 epoxide;,C31H46O3,"Vitamin K1 epoxide; (2,3-Epoxyphytyl)menaquinone; 2,3-Epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone; 2,3-Epoxyphylloquinone; 1a,7a-Dihydro-1a-methyl-7a-(3,7,11,15-tetramethyl-2-hexadecenyl)-naphth[2,3-b]oxirene-2,7-dione; Phylloquinone oxide; Phylloquinone epoxide; Phylloquinone-2,3-epoxide; Vitamin K1 2,3-epoxide; Vitamin K1 oxide",R03510 R03511 R03512 R05144 R05830,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.99.20; 1.17.4.4; 1.17.4.5; 4.1.1.90,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0203 Vitamin K;     C05849  Vitamin K epoxide,CAS: 25486-55-9; PubChem: 8142; ChEBI: 28371; ChEMBL: CHEMBL299632; 3DMET: B05123; NIKKAJI: J16.897A,cpd:C05849; cpd:C20806,31,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H47O3,C31H45O3,466.3446953,467.3525204,465.3368703439,519,cpd:C06986,Spirodilactone,C11H8O4,Spirodilactone,R05454 R05455,Ubiquinone and other terpenoid-quinone biosynthesis,NA,NA,NA,PubChem: 9200; ChEBI: 9239; 3DMET: B05236; NIKKAJI: J1.968.558F,cpd:C03657; cpd:C06986; cpd:C10335; cpd:C13429; cpd:C14093; cpd:C17018,11,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O4,C11H7O4,204.0422587,205.0500838,203.0344337440,520,cpd:C10793,Geranylhydroquinone,C16H22O2,Geranylhydroquinone,R09041 R09042 R09045,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.116,NA,NA,CAS: 10457-66-6; PubChem: 12976; ChEBI: 24233; ChEMBL: CHEMBL459815; KNApSAcK: C00002650; 3DMET: B04127; NIKKAJI: J40.428D,cpd:C10793; cpd:C18947,16,22,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H23O2,C16H21O2,246.1619799,247.169805,245.1541549441,521,cpd:C13309,"2-Phytyl-1,4-naphthoquinone;",C30H44O2,"2-Phytyl-1,4-naphthoquinone; Demethylphylloquinone",R06858 R06859 R11061,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.6.5.12; 2.1.1.163; 2.5.1.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0203 Vitamin K;     C13309  2-Demethylphylloquinone,PubChem: 586053; ChEBI: 31087; 3DMET: B05649; NIKKAJI: J1.722.871D,cpd:C13309,30,44,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H45O2,C30H43O2,436.3341307,437.3419557,435.3263056442,522,cpd:C13425,3-Hexaprenyl-4-hydroxybenzoate;,C37H54O3,3-Hexaprenyl-4-hydroxybenzoate; 3-Hexaprenyl-4-hydroxybenzoic acid,R05616 R06865,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.39,NA,NA,PubChem: 586167; ChEBI: 31116; LIPIDMAPS: LMPR02010045; 3DMET: B04571; NIKKAJI: J669.042D,cpd:C05803; cpd:C13425,37,54,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H55O3,C37H53O3,546.4072956,547.4151206,545.3994706443,523,cpd:C14151,delta-Tocopherol,C27H46O2,delta-Tocopherol,R07503 R07504,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.1.1.95; 5.5.1.24,Tocopherol/tocotorienol biosynthesis,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14151  delta-Tocopherol; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   C14151  [109575] d-delta-Tocopherol;  Antioxidant agent;   C14151  [109575] d-delta-Tocopherol,CAS: 119-13-1; PubChem: 7846963; ChEBI: 47772; ChEMBL: CHEMBL1451395; LIPIDMAPS: LMPR02020061 LMPR02020066; LipidBank: VVE0007; KNApSAcK: C00007363; NIKKAJI: J5.309K,cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992,27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O2,C27H45O2,402.3497807,403.3576058,401.3419557444,524,cpd:C14152,beta-Tocopherol,C28H48O2,beta-Tocopherol,R07504 R07508,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.1.1.95,Tocopherol/tocotorienol biosynthesis,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14152  beta-Tocopherol,CAS: 148-03-8; PubChem: 7846964; ChEBI: 47771; LipidBank: VVE0005; KNApSAcK: C00007364; NIKKAJI: J1.604.281A,cpd:C02483; cpd:C14152; cpd:C15789; cpd:C15795; cpd:C15797; cpd:C15883,28,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O2,C28H47O2,416.3654308,417.3732558,415.3576058445,525,cpd:C14153,alpha-Tocotrienol,C29H44O2,alpha-Tocotrienol,R10491,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.1.1.95,Tocopherol/tocotorienol biosynthesis,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14153  alpha-Tocotrienol,CAS: 1721-51-3; PubChem: 7846965; ChEBI: 33270; ChEMBL: CHEMBL120276; LIPIDMAPS: LMPR02020054; LipidBank: VVE0018; KNApSAcK: C00035044; NIKKAJI: J152.078D,cpd:C14153; cpd:C14287,29,44,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H45O2,C29H43O2,424.3341307,425.3419557,423.3263056446,526,cpd:C14154,beta-Tocotrienol,C28H42O2,beta-Tocotrienol,R10492,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.1.1.95,Tocopherol/tocotorienol biosynthesis,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14154  beta-Tocotrienol,CAS: 490-23-3; PubChem: 7846966; ChEBI: 33275; LIPIDMAPS: LMPR02020055; LipidBank: VVE0019; KNApSAcK: C00035060; NIKKAJI: J37.066E,cpd:C07773; cpd:C14154; cpd:C14155; cpd:C20738,28,42,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H43O2,C28H41O2,410.3184806,411.3263056,409.3106556447,527,cpd:C14155,gamma-Tocotrienol,C28H42O2,gamma-Tocotrienol,R10491 R10624,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.1.1.95; 5.5.1.24,Tocopherol/tocotorienol biosynthesis,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14155  gamma-Tocotrienol,PubChem: 7846967; ChEBI: 33277; ChEMBL: CHEMBL120697; LIPIDMAPS: LMPR02020057; LipidBank: VVE0020; KNApSAcK: C00035101; NIKKAJI: J13.903C,cpd:C07773; cpd:C14154; cpd:C14155; cpd:C20738,28,42,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H43O2,C28H41O2,410.3184806,411.3263056,409.3106556448,528,cpd:C14156,delta-Tocotrienol,C27H40O2,delta-Tocotrienol,R10492 R10623,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.1.1.95; 5.5.1.24,Tocopherol/tocotorienol biosynthesis,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0202 Vitamin E;     C14156  delta-Tocotrienol,CAS: 25612-59-3; PubChem: 7846968; ChEBI: 33276; ChEMBL: CHEMBL121305; LIPIDMAPS: LMPR02020056; LipidBank: VVE0021; KNApSAcK: C00035077; NIKKAJI: J17.358D,cpd:C14156; cpd:C20737,27,40,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H41O2,C27H39O2,396.3028305,397.3106556,395.2950055449,529,cpd:C15547,"1,4-Dihydroxy-2-naphthoyl-CoA",C32H42N7O19P3S,"1,4-Dihydroxy-2-naphthoyl-CoA",R07262 R07263,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,3.1.2.28; 4.1.3.36,"Menaquinone biosynthesis, chorismate => menaquinone",NA,PubChem: 17396539; ChEBI: 52668; NIKKAJI: J1.968.560H,cpd:C15547,32,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H43O19N7P3S1,C32H41O19N7P3S1,953.1469043,954.1547294,952.1390793450,530,cpd:C15882,2-Methyl-6-phytylquinol;,C27H46O2,"2-Methyl-6-phytylquinol; 2-Methyl-6-phytyl-1,4-hydroquinone; 2-Methyl-6-phytylbenzene-1,4-diol; 2-Methyl-6-phytyl-1,4-benzoquinol",R07500 R07501 R07503,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.1.1.295; 2.5.1.115; 5.5.1.24,Tocopherol/tocotorienol biosynthesis,NA,PubChem: 47205202; ChEBI: 75406 75920; KNApSAcK: C00007590; NIKKAJI: J1.989.063E,cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992,27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O2,C27H45O2,402.3497807,403.3576058,401.3419557451,531,cpd:C15883,"2,3-Dimethyl-5-phytylquinol;",C28H48O2,"2,3-Dimethyl-5-phytylquinol; 2,3-Dimethyl-5-phytyl-1,4-hydroquinone; 2,3-Dimethyl-6-phytylbenzene-1,4-diol",R07501 R07502,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.1.1.295; 5.5.1.24,Tocopherol/tocotorienol biosynthesis,NA,PubChem: 47205203; ChEBI: 75407; KNApSAcK: C00007591; NIKKAJI: J1.039.810J,cpd:C02483; cpd:C14152; cpd:C15789; cpd:C15795; cpd:C15797; cpd:C15883,28,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O2,C28H47O2,416.3654308,417.3732558,415.3576058452,532,cpd:C16519,2-Succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate;,C14H16O9,2-Succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate; 5-Enolpyruvoyl-6-hydroxy-2-succinylcyclohex-3-ene-1-carboxylate,R08165 R08166,Ubiquinone and other terpenoid-quinone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.2.1.9; 4.2.99.20,"Menaquinone biosynthesis, chorismate => menaquinone",NA,PubChem: 51090848; ChEBI: 50271; NIKKAJI: J2.532.457I,cpd:C09919; cpd:C16519,14,16,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H17O9,C14H15O9,328.0794321,329.0872571,327.0716071453,533,cpd:C16695,Plastoquinol-9;,C53H82O2,Plastoquinol-9; Plastoquinol A,R08409 R10709,Ubiquinone and other terpenoid-quinone biosynthesis,1.10.9.1; 2.1.1.295,NA,NA,PubChem: 51091017; ChEBI: 28026; NIKKAJI: J1.914.166G,cpd:C16695,53,82,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C53H83O2,C53H81O2,750.6314819,751.6393069,749.6236568454,534,cpd:C16999,Futalosine,C19H18N4O7,Futalosine,R08587 R10695,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,3.2.2.26; 3.5.4.40,NA,NA,PubChem: 96023485; ChEBI: 51310; NIKKAJI: J1.114.779H,cpd:C16999,19,18,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H19O7N4,C19H17O7N4,414.1175489,415.125374,413.1097239455,535,cpd:C17010,Dehypoxanthine futalosine,C14H16O7,Dehypoxanthine futalosine,R08587 R08588 R10668,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.21.98.1; 3.2.2.26; 3.2.2.30,NA,NA,PubChem: 96023493; ChEBI: 51312; NIKKAJI: J2.695.784B,cpd:C08564; cpd:C17010,14,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H17O7,C14H15O7,296.0896029,297.0974279,295.0817778456,536,cpd:C17017,Cyclic dehypoxanthine futalosine,C14H14O7,Cyclic dehypoxanthine futalosine,R08588 R08589,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.-.-; 1.21.98.1,NA,NA,PubChem: 96023498; ChEBI: 64252; NIKKAJI: J2.695.783D,cpd:C17017,14,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H15O7,C14H13O7,294.0739528,295.0817778,293.0661278457,537,cpd:C17018,"1,4-Dihydroxy-6-naphthoate",C11H8O4,"1,4-Dihydroxy-6-naphthoate",R08589 R08596,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.-.-,NA,NA,PubChem: 96023499; ChEBI: 64254 64284; NIKKAJI: J2.695.785K,cpd:C03657; cpd:C06986; cpd:C10335; cpd:C13429; cpd:C14093; cpd:C17018,11,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O4,C11H7O4,204.0422587,205.0500838,203.0344337458,538,cpd:C17412,Shikonin,C16H16O5,Shikonin,R09044,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Others;   Naphthoquinones;    alpha-Naphthoquinones;     C17412  Shikonin; Major components of natural products [BR:br08323];  Crude drugs;   Lithospermum root;    C17412  Shikonin,CAS: 517-89-5; PubChem: 96023762; ChEBI: 81068; ChEMBL: CHEMBL9470; KNApSAcK: C00000859; NIKKAJI: J13.981E,cpd:C09471; cpd:C10292; cpd:C12435; cpd:C16187; cpd:C17412,16,16,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O5,C16H15O5,288.0997736,289.1075986,287.0919486459,539,cpd:C17432,all-trans-Decaprenyl diphosphate,C50H84O7P2,all-trans-Decaprenyl diphosphate,R08747 R09249,Ubiquinone and other terpenoid-quinone biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.91; 2.5.1.-,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Others;    Polyterpenoids;     C17432  all-trans-Decaprenyl diphosphate,PubChem: 96023782; ChEBI: 61011,cpd:C04509; cpd:C17432; cpd:C18321,50,84,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C50H85O7P2,C50H83O7P2,858.569229,859.5770541,857.561404460,547,cpd:C17568,Ubiquinone-6;,C39H58O4,Ubiquinone-6; Coenzyme Q6,R02175,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.1.1.64,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0201 Ubiquinones;     C17568  Ubiquinone-6,CAS: 1065-31-2; PubChem: 96023913; ChEBI: 52971; LIPIDMAPS: LMPR02010002; NIKKAJI: J14.035J,cpd:C17568,39,58,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C39H59O4,C39H57O4,590.4335103,591.4413354,589.4256853461,548,cpd:C17569,Ubiquinone-8;,C49H74O4,Ubiquinone-8; Coenzyme Q8,R05614,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.1.1.64,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0201 Ubiquinones;     C17569  Ubiquinone-8,CAS: 2394-68-5; PubChem: 96023914; ChEBI: 61683; LIPIDMAPS: LMPR02010005; PDB-CCD: UQ8; NIKKAJI: J34.208D,cpd:C17569,49,74,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C49H75O4,C49H73O4,726.5587109,727.5665359,725.5508858462,549,cpd:C17570,"2-Methyl-6-solanyl-1,4-benzoquinol;",C52H80O2,"2-Methyl-6-solanyl-1,4-benzoquinol; 2-Methyl-6-nonaprenyl-benzene-1,4-diol; 2-Methyl-6-all-trans-nonaprenylbenzene-1,4-diol; 2-Methyl-6-solanesylbenzene-1,4-diol; MSBQ",R08782 R10709,Ubiquinone and other terpenoid-quinone biosynthesis,2.1.1.295; 2.5.1.117,NA,NA,PubChem: 96023915; ChEBI: 81191,cpd:C17570,52,80,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C52H81O2,C52H79O2,736.6158318,737.6236568,735.6080068463,550,cpd:C18131,Geranyl-hydroxybenzoate,C17H22O3,Geranyl-hydroxybenzoate,R09040 R09041,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.93,NA,NA,PubChem: 96024348; ChEBI: 61122; ChEMBL: CHEMBL482787; KNApSAcK: C00000852; NIKKAJI: J796.688A J909.752J,cpd:C09171; cpd:C14660; cpd:C18131,17,22,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H23O3,C17H21O3,274.1568946,275.1647196,273.1490695464,551,cpd:C18132,3''-Hydroxy-geranylhydroquinone,C16H22O3,3''-Hydroxy-geranylhydroquinone,R09042 R09043,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,1.14.13.116,NA,NA,PubChem: 96024349; ChEBI: 61158; NIKKAJI: J1.266.490G,cpd:C09170; cpd:C13235; cpd:C18132; cpd:C18497; cpd:C19051,16,22,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H23O3,C16H21O3,262.1568946,263.1647196,261.1490695465,552,cpd:C18133,Deoxyshikonin,C16H16O4,Deoxyshikonin,R09043 R09044,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 96024350; ChEBI: 81530; ChEMBL: CHEMBL486627; NIKKAJI: J19.312G,cpd:C04547; cpd:C08109; cpd:C09014; cpd:C09644; cpd:C10340; cpd:C10372; cpd:C10540; cpd:C13705; cpd:C16225; cpd:C18133; cpd:C18417; cpd:C18420,16,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O4,C16H15O4,272.104859,273.112684,271.097034466,553,cpd:C18134,Dihydroechinofuran,C16H18O3,Dihydroechinofuran,R09046,Ubiquinone and other terpenoid-quinone biosynthesis,NA,NA,NA,PubChem: 96024351; ChEBI: 81531; NIKKAJI: J460.241B,cpd:C06687; cpd:C09936; cpd:C10271; cpd:C10610; cpd:C11697; cpd:C11819; cpd:C18134; cpd:C19076,16,18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H19O3,C16H17O3,258.1255944,259.1334195,257.1177694467,554,cpd:C18135,Dihydroshikonofuran,C16H20O3,Dihydroshikonofuran,R09045 R09046,Ubiquinone and other terpenoid-quinone biosynthesis,NA,NA,NA,PubChem: 96024352; ChEBI: 81532,cpd:C09695; cpd:C11494; cpd:C11495; cpd:C17744; cpd:C18135,16,20,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H21O3,C16H19O3,260.1412445,261.1490695,259.1334195468,556,cpd:C20737,"6-Geranylgeranyl-2-methylbenzene-1,4-diol",C27H40O2,"6-Geranylgeranyl-2-methylbenzene-1,4-diol",R10623 R10708 R10710,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.1.1.295; 2.5.1.116; 5.5.1.24,Tocopherol/tocotorienol biosynthesis,NA,PubChem: 254741205,cpd:C14156; cpd:C20737,27,40,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H41O2,C27H39O2,396.3028305,397.3106556,395.2950055469,557,cpd:C20738,"6-Geranylgeranyl-2,3-dimethylbenzene-1,4-diol",C28H42O2,"6-Geranylgeranyl-2,3-dimethylbenzene-1,4-diol",R10624 R10710,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.1.1.295; 5.5.1.24,Tocopherol/tocotorienol biosynthesis,NA,PubChem: 254741206,cpd:C07773; cpd:C14154; cpd:C14155; cpd:C20738,28,42,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H43O2,C28H41O2,410.3184806,411.3263056,409.3106556470,558,cpd:C20772,3-[(1-Carboxyvinyl)oxy]benzoate;,C10H8O5,3-[(1-Carboxyvinyl)oxy]benzoate; 3-[(1-Carboxyethenyl)oxy]benzoic acid,R10666 R10667,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.120; 4.2.1.151,NA,NA,PubChem: 254741239,cpd:C05155; cpd:C09265; cpd:C16196; cpd:C20772,10,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O5,C10H7O5,208.0371734,209.0449984,207.0293483471,559,cpd:C20773,6-Amino-6-deoxyfutalosine,C19H19N5O6,6-Amino-6-deoxyfutalosine,R10667 R10668 R10695,Ubiquinone and other terpenoid-quinone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.120; 3.2.2.30; 3.5.4.40,NA,NA,PubChem: 254741240,cpd:C20773,19,19,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H20O6N5,C19H18O6N5,413.1335334,414.1413584,412.1257083472,560,cpd:C00280,Androstenedione;,C19H26O2,"Androstenedione; Androst-4-ene-3,17-dione; 4-Androstene-3,17-dione",R01833 R01834 R01835 R01836 R01837 R01838 R01840 R01842; R02725 R08205 R08206 R08518 R09884 R09919 R09955 R10242; R10515,Steroid hormone biosynthesis; Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments; Endocrine resistance; Ovarian steroidogenesis; Prolactin signaling pathway; Pathways in cancer; Prostate cancer,1.1.1.51; 1.1.1.64; 1.1.1.145; 1.1.1.239; 1.3.1.3; 1.3.1.22; 1.3.99.4; 1.3.99.5; 1.14.13.54; 1.14.14.1; 1.14.14.14; 1.14.14.32; 1.14.15.4; 1.14.99.12; 5.3.3.1,"C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone","Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C00280  Androstenedione;  Hormones and transmitters;   Steroid hormones;    Androgens;     C00280  Androstenedione; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C00280  Androst-4-ene-3,17-dione; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Androstane;     C00280  Androstenedione; Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Triterpenoids (C30) and related compounds;    Sterols and steroids;     D00051  Androstenedione (JAN)",CAS: 63-05-8; PubChem: 3575; ChEBI: 16422; ChEMBL: CHEMBL274826; LIPIDMAPS: LMST02020007; LipidBank: SST0028; KNApSAcK: C00003644; PDB-CCD: ASD; 3DMET: B01205; NIKKAJI: J38.388K,cpd:C00280; cpd:C14483; cpd:C14502; cpd:C15293; cpd:C15315; cpd:C20217; cpd:C20252,19,26,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H27O2,C19H25O2,286.1932801,287.2011051,285.185455473,561,cpd:C00410,Progesterone;,C21H30O2,"Progesterone; 4-Pregnene-3,20-dione",R02207 R02208 R02209 R02210 R02211 R02212 R02213 R02214; R02215 R02216 R02218 R02219 R09587,"Steroid hormone biosynthesis; Metabolic pathways; Oocyte meiosis; Ovarian steroidogenesis; Progesterone-mediated oocyte maturation; Prolactin signaling pathway; Aldosterone synthesis and secretion; Pathways in cancer; Prostate cancer; Breast cancer; Glucocorticoid and meneralocorticoid receptor agonists/antagonists; Progesterone, androgen and estrogen receptor agonists/antagonists",1.1.1.145; 1.1.1.149; 1.3.1.3; 1.3.1.22; 1.3.99.6; 1.14.13.54; 1.14.14.16; 1.14.14.19; 1.14.15.4; 1.14.15.8; 1.14.99.4; 1.14.99.14; 5.3.3.1,"Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone; C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone; C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C00410  Progesterone;  Hormones and transmitters;   Steroid hormones;    Progestagens;     C00410  Progesterone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03D PROGESTOGENS;     G03DA Pregnen (4) derivatives;      G03DA04 Progesterone;       D00066  Progesterone (JP17/USP/INN); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers);   Progestins;    Progesterone;     D00066  Progesterone (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    247  Estrogen and progesterone preparations;     2477  Progesterones;      D00066  Progesterone (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     progesterone receptor;      Progesterone;       D00066  Progesterone (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2C19;    Progesterone;     D00066  Progesterone (JP17/USP/INN);   CYP3A4;    Progesterone;     D00066  Progesterone (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00066  Progesterone;   D00066  Progesterone injection; Endocrine and hormonal agents [br08373.html];  Hormone related agents;   D00066;  Other gynecological agents;   D00066; Animal drugs in Japan [BR:br08331];  94  Agents for breeding;   941  Hormone preparations (except posterior-pituitary hormone and preparations);    9415  Luteinizing hormone and preparations;     C00410  Progesterone",CAS: 57-83-0; PubChem: 3700; ChEBI: 17026; ChEMBL: CHEMBL103; LIPIDMAPS: LMST02030159; KNApSAcK: C00034649; PDB-CCD: STR; 3DMET: B01238; NIKKAJI: J2.329I,cpd:C00410; cpd:C06392; cpd:C06972; cpd:C07578; cpd:C08998; cpd:C14661; cpd:C15158; cpd:C15260; cpd:C15342; cpd:C15402; cpd:C15468,21,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O2,C21H29O2,314.2245802,315.2324052,313.2167552474,562,cpd:C00468,Estrone;,C18H22O2,"Estrone; 3-Hydroxy-1,3,5(10)-estratrien-17-one",R02347 R02349 R02350 R02351 R02352 R02353 R02354 R02355; R02356 R02358 R03980 R10515,"Steroid hormone biosynthesis; Metabolic pathways; Ovarian steroidogenesis; Prolactin signaling pathway; Progesterone, androgen and estrogen receptor agonists/antagonists",1.1.1.51; 1.1.1.62; 1.1.1.148; 1.14.13.-; 1.14.14.1; 1.14.14.14; 2.4.1.17; 2.8.2.4; 2.8.2.15; 3.1.6.1,"C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone","Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C00468  Estrone;  Hormones and transmitters;   Steroid hormones;    Estrogens;     C00468  Estrone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C00468  Estrone; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Estrane;     C00468  Estrone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03C ESTROGENS;     G03CA Natural and semisynthetic estrogens, plain;      G03CA07 Estrone;       D00067  Estrone (JAN/USP/INN);     G03CC Estrogens, combinations with other drugs;      G03CC04 Estrone;       D00067  Estrone (JAN/USP/INN); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers);   Estrogens;    Estrone;     D00067  Estrone (JAN/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    Estrogen receptor;     estrogen receptor 1;      Estrone;       D00067  Estrone (JAN/USP/INN);     estrogen receptor 2;      Estrone;       D00067  Estrone (JAN/USP/INN); Cytochrome P450 interactions [BR:br08309];  Transporter inhibitors;   ABCG2;    Estrone;     D00067  Estrone (JAN/USP/INN); Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Triterpenoids (C30) and related compounds;    Sterols and steroids;     D00067  Estrone (JAN/USP/INN)",CAS: 53-16-7; PubChem: 3751; ChEBI: 17263; ChEMBL: CHEMBL1405; LIPIDMAPS: LMST02010004; LipidBank: SST0015 SST0067; KNApSAcK: C00003663; PDB-CCD: J3Z; 3DMET: B01252; NIKKAJI: J9.114F,cpd:C00468; cpd:C13101; cpd:C14261; cpd:C14485; cpd:C14590; cpd:C15215; cpd:C18422; cpd:C20436,18,22,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H23O2,C18H21O2,270.1619799,271.169805,269.1541549475,563,cpd:C00523,Androsterone;,C19H30O2,Androsterone; 3alpha-Hydroxy-5alpha-androstan-17-one,R02476 R02477 R02478,Steroid hormone biosynthesis,1.1.1.50; 1.1.1.209; 1.1.1.213; 2.4.1.17,NA,Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C00523  Androsterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C00523  3alpha-Hydroxy-5alpha-androstan-17-one,CAS: 53-41-8; PubChem: 3806; ChEBI: 16032; ChEMBL: CHEMBL41708 CHEMBL87285; LIPIDMAPS: LMST02020001; PDB-CCD: AOI; 3DMET: B01279; NIKKAJI: J4.145I,cpd:C00523; cpd:C01986; cpd:C03917; cpd:C04295; cpd:C04373; cpd:C05293; cpd:C07635; cpd:C14210; cpd:C14631; cpd:C14932; cpd:C15326; cpd:C15442,19,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H31O2,C19H29O2,290.2245802,291.2324052,289.2167552476,564,cpd:C00535,Testosterone;,C19H28O2,Testosterone; 17beta-Hydroxy-4-androsten-3-one,R01836 R01838 R02497 R02498 R02499 R02501 R02502 R02503; R10511 R11349,"Steroid hormone biosynthesis; Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments; Endocrine resistance; Ovarian steroidogenesis; Pathways in cancer; Prostate cancer; Progesterone, androgen and estrogen receptor agonists/antagonists",1.1.1.51; 1.1.1.64; 1.1.1.145; 1.1.1.239; 1.3.1.3; 1.3.1.22; 1.14.14.1; 1.14.14.14; 1.14.15.19; 2.4.1.17; 5.3.3.1,NA,"Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C00535  Testosterone;  Hormones and transmitters;   Steroid hormones;    Androgens;     C00535  Testosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C00535  17beta-Hydroxy-4-androsten-3-one; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Androstane;     C00535  Testosterone; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     androgen receptor;      C00535  Testosterone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03B ANDROGENS;     G03BA 3-oxoandrosten (4) derivatives;      G03BA03 Testosterone;       D00075  Testosterone (JAN/USP); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers);   Androgens;    Testosterone;     D00075  Testosterone (JAN/USP); Classification of Japanese OTC drugs [BR:br08313];  Agents for  urogenital organs and anus;   31 Other drugs for  urogenital organs and anus;    D00075  Testosterone (JAN/USP);  Agents for integumentary system;   61 Other agents for integumentary system;    D00075  Testosterone (JAN/USP); Risk category of Japanese OTC drugs [BR:br08312];  First-class OTC drugs;   Inorganic and organic chemicals;    Testosterone;     D00075  Testosterone (JAN/USP); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     androgen receptor;      Testosterone;       D00075  Testosterone (JAN/USP); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Testosterone;     D00075  Testosterone (JAN/USP);   CYP3A5;    Testosterone;     D00075  Testosterone (JAN/USP);   CYP3A7;    Testosterone;     D00075  Testosterone (JAN/USP);  Transporter inhibitors;   SLC22A2;    Testosterone;     D00075  Testosterone (JAN/USP); Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Triterpenoids (C30) and related compounds;    Sterols and steroids;     D00075  Testosterone (JAN/USP); Endocrine and hormonal agents [br08373.html];  Hormone related agents;   D00075",CAS: 58-22-0; PubChem: 3817; ChEBI: 17347; ChEMBL: CHEMBL386630 CHEMBL67934; LIPIDMAPS: LMST02020002; KNApSAcK: C00003675; PDB-CCD: TES; 3DMET: B01283; NIKKAJI: J4.590J,cpd:C00535; cpd:C00674; cpd:C01227; cpd:C03772; cpd:C14491; cpd:C14682; cpd:C15258; cpd:C15335; cpd:C15377; cpd:C15395,19,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O2,C19H27O2,288.2089301,289.2167552,287.2011051477,565,cpd:C00674,"5alpha-Androstane-3,17-dione;",C19H28O2,"5alpha-Androstane-3,17-dione; Androstanedione",R01834 R02476 R02477 R09956 R10242,Steroid hormone biosynthesis; Steroid degradation; Microbial metabolism in diverse environments,1.1.1.50; 1.1.1.51; 1.1.1.209; 1.1.1.213; 1.3.1.22; 1.3.99.5,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C00674  5alpha-Androstane-3,17-dione",CAS: 846-46-8; PubChem: 3943; ChEBI: 15994; ChEMBL: CHEMBL1253; LIPIDMAPS: LMST02020085; PDB-CCD: 5SD; 3DMET: B04715; NIKKAJI: J38.549B,cpd:C00535; cpd:C00674; cpd:C01227; cpd:C03772; cpd:C14491; cpd:C14682; cpd:C15258; cpd:C15335; cpd:C15377; cpd:C15395,19,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O2,C19H27O2,288.2089301,289.2167552,287.2011051478,566,cpd:C00735,Cortisol;,C21H30O5,"Cortisol; Hydrocortisone; 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione; Kendall's compound F; Reichstein's substance M",R02834 R02836 R02837 R02838 R02839 R02840 R02841 R02843; R08995,Steroid hormone biosynthesis; Metabolic pathways; Neuroactive ligand-receptor interaction; Aldosterone-regulated sodium reabsorption; Bile secretion; Pathways in cancer; Prostate cancer; Glucocorticoid and meneralocorticoid receptor agonists/antagonists,1.1.1.145; 1.1.1.146; 1.1.1.-; 1.3.1.3; 1.14.14.16; 1.14.15.4; 2.3.1.27; 2.8.2.18; 5.3.3.1,"C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C00735  Cortisol;  Hormones and transmitters;   Steroid hormones;    Glucocorticoids;     C00735  Cortisol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C00735  Cortisol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A01 STOMATOLOGICAL PREPARATIONS;    A01A STOMATOLOGICAL PREPARATIONS;     A01AC Corticosteroids for local oral treatment;      A01AC03 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);   A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;    A07E INTESTINAL ANTIINFLAMMATORY AGENTS;     A07EA Corticosteroids acting locally;      A07EA02 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);  C CARDIOVASCULAR SYSTEM;   C05 VASOPROTECTIVES;    C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;     C05AA Corticosteroids;      C05AA01 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);  D DERMATOLOGICALS;   D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS;    D07A CORTICOSTEROIDS, PLAIN;     D07AA Corticosteroids, weak (group I);      D07AA02 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);    D07X CORTICOSTEROIDS, OTHER COMBINATIONS;     D07XA Corticosteroids, weak, other combinations;      D07XA01 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);  H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;   H02 CORTICOSTEROIDS FOR SYSTEMIC USE;    H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;     H02AB Glucocorticoids;      H02AB09 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01B ANTIINFLAMMATORY AGENTS;     S01BA Corticosteroids, plain;      S01BA02 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);    S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;     S01CB Corticosteroids/antiinfectives/mydriatics in combination;      S01CB03 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN);   S02 OTOLOGICALS;    S02B CORTICOSTEROIDS;     S02BA Corticosteroids;      S02BA01 Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal);   Hydrocortisone;    D00088  Hydrocortisone (JP17/USP/INN);   Hydrocortisone;    D00088  Hydrocortisone (JP17/USP/INN);   Hydrocortisone;    D00088  Hydrocortisone (JP17/USP/INN);  Inflammatory Bowel Disease Agents;   Glucocorticoids;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    245  Adrenal hormone preparations;     2452  Cortisones;      D00088  Hydrocortisone (JP17/USP/INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches);    D00088  Hydrocortisone (JP17/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN);  Second-class OTC drugs;   Inorganic and organic chemicals;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     glucocorticoid receptor;      Hydrocortisone;       D00088  Hydrocortisone (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN);   CYP3A5;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN);   CYP3A7;    Hydrocortisone;     D00088  Hydrocortisone (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00088  Hydrocortisone; Endocrine and hormonal agents [br08373.html];  Hormone related agents;   D00088; Dermatological agents [br08370.html];  Topical steroids;   D00088; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00088; Rx-to-OTC switch list in the USA [br08315.html];  D00088",CAS: 50-23-7; PubChem: 3998; ChEBI: 17650; ChEMBL: CHEMBL1092578 CHEMBL196519 CHEMBL389621; LIPIDMAPS: LMST02030001; LipidBank: SST0244; PDB-CCD: HCY; 3DMET: B01319; NIKKAJI: J1.908I,cpd:C00735; cpd:C01124; cpd:C03588; cpd:C05469; cpd:C05473; cpd:C08837; cpd:C10695; cpd:C14127; cpd:C15034,21,30,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O5,C21H29O5,362.2093241,363.2171491,361.201499479,567,cpd:C00762,Cortisone;,C21H28O5,"Cortisone; 17alpha,21-Dihydroxy-4-pregnene-3,11,20-trione; Kendall's compound E; Reichstein's substance Fa",R02834 R02836 R02892 R02893,Steroid hormone biosynthesis; Metabolic pathways; Aldosterone-regulated sodium reabsorption; Pathways in cancer; Prostate cancer; Glucocorticoid and meneralocorticoid receptor agonists/antagonists,1.1.1.146; 1.1.1.-; 1.3.1.3; 1.3.1.22,"C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C00762  Cortisone;  Hormones and transmitters;   Steroid hormones;    Glucocorticoids;     C00762  Cortisone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C00762  Cortisone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;   H02 CORTICOSTEROIDS FOR SYSTEMIC USE;    H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;     H02AB Glucocorticoids;      H02AB10 Cortisone;       D07749  Cortisone (INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01B ANTIINFLAMMATORY AGENTS;     S01BA Corticosteroids, plain;      S01BA03 Cortisone;       D07749  Cortisone (INN); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal);   Cortisone;    D07749  Cortisone (INN);  Inflammatory Bowel Disease Agents;   Glucocorticoids;    Cortisone;     D07749  Cortisone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     glucocorticoid receptor;      Cortisone;       D07749  Cortisone (INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Cortisone;     D07749  Cortisone (INN);   CYP3A5;    Cortisone;     D07749  Cortisone (INN)",CAS: 53-06-5; PubChem: 4024; ChEBI: 16962; ChEMBL: CHEMBL1499 CHEMBL536; LIPIDMAPS: LMST02030090; LipidBank: SST0042; 3DMET: B01327; NIKKAJI: J4.139D,cpd:C00762; cpd:C01780; cpd:C07178; cpd:C07369; cpd:C09846; cpd:C10723; cpd:C18039,21,28,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H29O5,C21H27O5,360.193674,361.201499,359.185849480,568,cpd:C00951,Estradiol-17beta;,C18H24O2,Estradiol-17beta; Estradiol; beta-Estradiol,R00535 R02352 R02353 R03086 R03087 R03088 R03089 R03090; R03091 R10511,"Steroid hormone biosynthesis; Metabolic pathways; Endocrine resistance; Ovarian steroidogenesis; Estrogen signaling pathway; Prolactin signaling pathway; Endocrine and other factor-regulated calcium reabsorption; Pathways in cancer; Prostate cancer; Breast cancer; Progesterone, androgen and estrogen receptor agonists/antagonists",1.1.1.51; 1.1.1.62; 1.14.14.1; 1.14.14.14; 1.14.99.11; 2.4.1.17; 2.8.2.15,NA,"Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C00951  Estradiol-17beta;  Hormones and transmitters;   Steroid hormones;    Estrogens;     C00951  Estradiol-17beta; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C00951  Estradiol-17beta; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Estrogen like receptors;    Estrogen receptor;     estrogen receptor 1, 2;      C00951  Estradiol-17beta; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03C ESTROGENS;     G03CA Natural and semisynthetic estrogens, plain;      G03CA03 Estradiol;       D00105  Estradiol (JAN/USP/INN); USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers);   Estrogens;    Estradiol;     D00105  Estradiol (JAN/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    247  Estrogen and progesterone preparations;     2473  Estradiols;      D00105  Estradiol (JAN/USP/INN); Classification of Japanese OTC drugs [BR:br08313];  Drugs for women;   51 Other drugs for women;    D00105  Estradiol (JAN/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Estradiol;     D00105  Estradiol (JAN/USP/INN);  Second-class OTC drugs;   Inorganic and organic chemicals;    Estradiol;     D00105  Estradiol (JAN/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    Estrogen receptor;     estrogen receptor 1;      Estradiol;       D00105  Estradiol (JAN/USP/INN);     estrogen receptor 2;      Estradiol;       D00105  Estradiol (JAN/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP1A2;    Estradiol;     D00105  Estradiol (JAN/USP/INN);   CYP1B1;    Estradiol;     D00105  Estradiol (JAN/USP/INN);   CYP3A4;    Estradiol;     D00105  Estradiol (JAN/USP/INN); Osteoporosis drugs [br08368.html];  D00105; Endocrine and hormonal agents [br08373.html];  Hormone related agents;   D00105",CAS: 50-28-2; PubChem: 4202; ChEBI: 16469; ChEMBL: CHEMBL135; LIPIDMAPS: LMST02010001; LipidBank: SST0013 SST0064; PDB-CCD: EST; 3DMET: B01357; NIKKAJI: J4.100I,cpd:C00951; cpd:C02537; cpd:C14500; cpd:C15129; cpd:C15261,18,24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H25O2,C18H23O2,272.17763,273.185455,271.169805481,569,cpd:C01124,18-Hydroxycorticosterone,C21H30O5,18-Hydroxycorticosterone,R03262 R03263,Steroid hormone biosynthesis; Metabolic pathways; Aldosterone synthesis and secretion,1.14.15.4; 1.14.15.5,"C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone","Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Mineralocorticoids;     C01124  18-Hydroxycorticosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C01124  18-Hydroxycorticosterone",CAS: 561-65-9; PubChem: 4355; ChEBI: 16485; LIPIDMAPS: LMST02030091; 3DMET: B04772; NIKKAJI: J188.422K,cpd:C00735; cpd:C01124; cpd:C03588; cpd:C05469; cpd:C05473; cpd:C08837; cpd:C10695; cpd:C14127; cpd:C15034,21,30,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O5,C21H29O5,362.2093241,363.2171491,361.201499482,570,cpd:C01176,17alpha-Hydroxyprogesterone;,C21H30O3,"17alpha-Hydroxyprogesterone; 17alpha-Hydroxy-4-pregnene-3,20-dione; Pregn-4-ene-3,20-dione-17-ol; 17alpha-Hydroxy-progesterone",R02211 R03325 R03326 R03327 R03329 R08206 R08518,Steroid hormone biosynthesis; Metabolic pathways; Ovarian steroidogenesis,1.1.1.145; 1.1.1.149; 1.14.13.54; 1.14.14.16; 1.14.14.19; 1.14.14.32; 1.14.15.4; 5.3.3.1,"C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone",Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Progestagens;     C01176  17alpha-Hydroxyprogesterone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03D PROGESTOGENS;     G03DA Pregnen (4) derivatives;      G03DA03 Hydroxyprogesterone;       D08052  Hydroxyprogesterone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     progesterone receptor;      Hydroxyprogesterone;       D08052  Hydroxyprogesterone (INN),CAS: 68-96-2; PubChem: 4403; ChEBI: 17252; ChEMBL: CHEMBL1062; LIPIDMAPS: LMST02030161; PDB-CCD: 3QZ; 3DMET: B01402; NIKKAJI: J4.862C,cpd:C01176; cpd:C03027; cpd:C03205; cpd:C03747; cpd:C03748; cpd:C04108; cpd:C05498; cpd:C10838; cpd:C14654; cpd:C14881; cpd:C14984; cpd:C14995; cpd:C15132; cpd:C15154; cpd:C15364; cpd:C15409; cpd:C16780; cpd:C19726; cpd:C20218,21,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O3,C21H29O3,330.2194948,331.2273199,329.2116698483,571,cpd:C01227,Dehydroepiandrosterone;,C19H28O2,Dehydroepiandrosterone; 3beta-Hydroxyandrost-5-en-17-one; Dehydroisoandrosterone; DHA; DHEA,R01837 R03404 R03405 R03406 R03407 R03408 R08517 R08961; R09957,Steroid hormone biosynthesis; Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments; Ovarian steroidogenesis; Pathways in cancer; Prostate cancer,1.1.1.51; 1.1.1.145; 1.14.13.-; 1.14.14.1; 1.14.14.23; 1.14.14.32; 2.8.2.2; 3.1.6.2; 5.3.3.1,"C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone",Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C01227  Dehydroepiandrosterone;  Hormones and transmitters;   Steroid hormones;    Androgens;     C01227  Dehydroepiandrosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C01227  3beta-Hydroxyandrost-5-en-17-one; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A14 ANABOLIC AGENTS FOR SYSTEMIC USE;    A14A ANABOLIC STEROIDS;     A14AA Androstan derivatives;      A14AA07 Prasterone;       D08409  Prasterone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     androgen receptor;      Prasterone;       D08409  Prasterone (INN),CAS: 53-43-0; PubChem: 4449; ChEBI: 28689; ChEMBL: CHEMBL309821 CHEMBL363554 CHEMBL90593; LIPIDMAPS: LMST02020021; LipidBank: SST0185; PDB-CCD: AND; 3DMET: B01415; NIKKAJI: J4.147E,cpd:C00535; cpd:C00674; cpd:C01227; cpd:C03772; cpd:C14491; cpd:C14682; cpd:C15258; cpd:C15335; cpd:C15377; cpd:C15395,19,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O2,C19H27O2,288.2089301,289.2167552,287.2011051484,572,cpd:C01780,Aldosterone;,C21H28O5,"Aldosterone; 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al",R03263 R03713 R03714 R08949 R08953,Steroid hormone biosynthesis; Metabolic pathways; Aldosterone synthesis and secretion; Aldosterone-regulated sodium reabsorption; Glucocorticoid and meneralocorticoid receptor agonists/antagonists,1.3.1.3; 1.14.15.4; 1.14.15.5,"C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C01780  Aldosterone;  Hormones and transmitters;   Steroid hormones;    Mineralocorticoids;     C01780  Aldosterone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;   H02 CORTICOSTEROIDS FOR SYSTEMIC USE;    H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;     H02AA Mineralocorticoids;      H02AA01 Aldosterone;       D10528  Aldosterone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     mineralocorticoid receptor;      Aldosterone;       D10528  Aldosterone (INN)",CAS: 52-39-1; PubChem: 4910; ChEBI: 27584; ChEMBL: CHEMBL273453; LIPIDMAPS: LMST02030026; PDB-CCD: AS4; 3DMET: B01497; NIKKAJI: J4.130K,cpd:C00762; cpd:C01780; cpd:C07178; cpd:C07369; cpd:C09846; cpd:C10723; cpd:C18039,21,28,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H29O5,C21H27O5,360.193674,361.201499,359.185849485,573,cpd:C01953,Pregnenolone;,C21H32O2,Pregnenolone; 5-Pregnen-3beta-ol-20-one; 3beta-Hydroxypregn-5-en-20-one,R02216 R02724 R03783 R03784 R03933 R08942 R08943 R08978,Steroid hormone biosynthesis; Metabolic pathways; Ovarian steroidogenesis; Aldosterone synthesis and secretion,1.1.1.145; 1.14.14.16; 1.14.14.19; 1.14.14.29; 1.14.15.6; 2.8.2.2; 2.8.2.14; 3.1.6.2; 5.3.3.1,"Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone; C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone",Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C01953  Pregnenolone;  Hormones and transmitters;   Steroid hormones;    Progestagens;     C01953  Pregnenolone; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived by amination reactions;    Steroidal alkaloids;     D00143  Pregnenolone (JAN/INN),CAS: 145-13-1; PubChem: 5056; ChEBI: 16581; ChEMBL: CHEMBL253363 CHEMBL77462; LIPIDMAPS: LMST02030088; KNApSAcK: C00047082 C00049664; PDB-CCD: PLO; 3DMET: B04827; NIKKAJI: J11.381F,cpd:C01953; cpd:C03681; cpd:C04042; cpd:C05479; cpd:C10839; cpd:C14475; cpd:C14477; cpd:C14962; cpd:C15012; cpd:C15108; cpd:C15156; cpd:C15199; cpd:C15334; cpd:C15339; cpd:C20219,21,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O2,C21H31O2,316.2402303,317.2480553,315.2324052486,574,cpd:C02140,Corticosterone;,C21H30O4,"Corticosterone; 11beta,21-Dihydroxy-4-pregnene-3,20-dione; Kendall's compound B; Reichstein's substance H",R03262 R03847 R03848 R03849 R03850 R03851,Steroid hormone biosynthesis; Metabolic pathways; Regulation of lipolysis in adipocytes; Aldosterone synthesis and secretion; Prion diseases,1.1.1.146; 1.1.1.-; 1.3.1.3; 1.14.14.16; 1.14.15.4; 1.14.15.5,"C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C02140  Corticosterone;  Hormones and transmitters;   Steroid hormones;    Mineralocorticoids;     C02140  Corticosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C02140  Corticosterone",CAS: 50-22-6; PubChem: 5219; ChEBI: 16827; ChEMBL: CHEMBL110739 CHEMBL1513569; LIPIDMAPS: LMST02030186; LipidBank: SST0168; PDB-CCD: C0R; 3DMET: B01538; NIKKAJI: J5.239F,cpd:C02140; cpd:C02942; cpd:C05477; cpd:C05488; cpd:C05497; cpd:C06391; cpd:C15002; cpd:C15015; cpd:C15304; cpd:C15363; cpd:C15365,21,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O4,C21H29O4,346.2144094,347.2222345,345.2065844487,575,cpd:C02373,4-Methylpentanal;,C6H12O,4-Methylpentanal; Isocaproaldehyde; Isohexanal,R02724 R03933 R04676,Steroid hormone biosynthesis,1.14.15.6,NA,NA,CAS: 1119-16-0; PubChem: 5415; ChEBI: 17998; PDB-CCD: MOP; 3DMET: B00433; NIKKAJI: J49.658H,cpd:C00854; cpd:C01952; cpd:C02373; cpd:C02837; cpd:C02893; cpd:C05328; cpd:C08492; cpd:C19263; cpd:C19350; cpd:C19543; cpd:C19809; cpd:C21098,6,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O1,C6H11O1,100.088815,101.09664,99.08098997488,576,cpd:C02537,Estradiol-17alpha;,C18H24O2,Estradiol-17alpha; 17alpha-Estradiol,R02347 R02349,Steroid hormone biosynthesis,1.1.1.148,NA,Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C02537  Estradiol-17alpha; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C02537  Estradiol-17alpha,CAS: 57-91-0; PubChem: 5544; ChEBI: 17160; ChEMBL: CHEMBL286452; LIPIDMAPS: LMST02010029; 3DMET: B01587; NIKKAJI: J4.586A,cpd:C00951; cpd:C02537; cpd:C14500; cpd:C15129; cpd:C15261,18,24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H25O2,C18H23O2,272.17763,273.185455,271.169805489,577,cpd:C02538,Estrone 3-sulfate,C18H22O5S,Estrone 3-sulfate,R02350 R03980,Steroid hormone biosynthesis; Bile secretion,2.8.2.4; 2.8.2.15; 3.1.6.1,NA,Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Estrogens;     C02538  Estrone 3-sulfate; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C02538  Estrone 3-sulfate;   ST05 Steroid conjugates;    ST0502 Sulfates;     C02538  Estrone 3-sulfate,CAS: 481-97-0; PubChem: 5545; ChEBI: 17474; ChEMBL: CHEMBL494753; LIPIDMAPS: LMST02010043; 3DMET: B04855; NIKKAJI: J5.782G,cpd:C02538,18,22,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C18H23O5S1,C18H21O5S1,350.118795,351.12662,349.1109699490,578,cpd:C03205,11-Deoxycorticosterone;,C21H30O3,"11-Deoxycorticosterone; Deoxycorticosterone; Cortexone; 21-Hydroxy-4-pregnene-3,20-dione; Desoxycortone; DOC",R02213 R03851 R04163 R04165 R08949 R08954,Steroid hormone biosynthesis; Metabolic pathways; Aldosterone synthesis and secretion,1.1.1.145; 1.3.1.22; 1.14.14.16; 1.14.15.4; 5.3.1.21; 5.3.3.1,"C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone","Compounds with biological roles [BR:br08001];  Steroids;   21-Carbon atoms;    Pregnane derivatives;     C03205  11-Deoxycorticosterone;  Hormones and transmitters;   Steroid hormones;    Mineralocorticoids;     C03205  11-Deoxycorticosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C03205  11-Deoxycorticosterone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;   H02 CORTICOSTEROIDS FOR SYSTEMIC USE;    H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;     H02AA Mineralocorticoids;      H02AA03 Desoxycortone;       D07792  Desoxycortone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     mineralocorticoid receptor;      Desoxycortone;       D07792  Desoxycortone (INN)",CAS: 64-85-7; PubChem: 6081; ChEBI: 16973; ChEMBL: CHEMBL1498; LIPIDMAPS: LMST02030087; LipidBank: SST0186; PDB-CCD: 1CA; 3DMET: B01638; NIKKAJI: J1.407I,cpd:C01176; cpd:C03027; cpd:C03205; cpd:C03747; cpd:C03748; cpd:C04108; cpd:C05498; cpd:C10838; cpd:C14654; cpd:C14881; cpd:C14984; cpd:C14995; cpd:C15132; cpd:C15154; cpd:C15364; cpd:C15409; cpd:C16780; cpd:C19726; cpd:C20218,21,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O3,C21H29O3,330.2194948,331.2273199,329.2116698491,579,cpd:C03681,"5alpha-Pregnane-3,20-dione;",C21H32O2,"5alpha-Pregnane-3,20-dione; 5alpha-Dihydroprogesterone",R02208 R07138 R08957 R08958,Steroid hormone biosynthesis,1.1.1.149; 1.1.1.213; 1.1.1.278; 1.3.1.22,NA,NA,CAS: 566-65-4; PubChem: 6456; ChEBI: 28952; ChEMBL: CHEMBL407717 CHEMBL40910; LIPIDMAPS: LMST02030170; 3DMET: B01685; NIKKAJI: J6.519F,cpd:C01953; cpd:C03681; cpd:C04042; cpd:C05479; cpd:C10839; cpd:C14475; cpd:C14477; cpd:C14962; cpd:C15012; cpd:C15108; cpd:C15156; cpd:C15199; cpd:C15334; cpd:C15339; cpd:C20219,21,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O2,C21H31O2,316.2402303,317.2480553,315.2324052492,580,cpd:C03747,11alpha-Hydroxyprogesterone,C21H30O3,11alpha-Hydroxyprogesterone,R02214,Steroid hormone biosynthesis,1.14.99.14,NA,NA,CAS: 80-75-1; PubChem: 6508; ChEBI: 16076; ChEMBL: CHEMBL1563246 CHEMBL1908051; LIPIDMAPS: LMST02030184; 3DMET: B04911; NIKKAJI: J121.148J,cpd:C01176; cpd:C03027; cpd:C03205; cpd:C03747; cpd:C03748; cpd:C04108; cpd:C05498; cpd:C10838; cpd:C14654; cpd:C14881; cpd:C14984; cpd:C14995; cpd:C15132; cpd:C15154; cpd:C15364; cpd:C15409; cpd:C16780; cpd:C19726; cpd:C20218,21,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O3,C21H29O3,330.2194948,331.2273199,329.2116698493,581,cpd:C03772,"5beta-Androstane-3,17-dione",C19H28O2,"5beta-Androstane-3,17-dione",R01835 R04309 R04310,Steroid hormone biosynthesis,1.1.1.50; 1.1.1.152; 1.3.1.3,NA,"Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C03772  5beta-Androstane-3,17-dione; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C03772  5beta-Androstane-3,17-dione",CAS: 1229-12-5; PubChem: 6526; ChEBI: 16985; ChEMBL: CHEMBL1230988; LIPIDMAPS: LMST02020058; PDB-CCD: ANO; 3DMET: B01689; NIKKAJI: J38.550F,cpd:C00535; cpd:C00674; cpd:C01227; cpd:C03772; cpd:C14491; cpd:C14682; cpd:C15258; cpd:C15335; cpd:C15377; cpd:C15395,19,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O2,C19H27O2,288.2089301,289.2167552,287.2011051494,582,cpd:C03852,"Androstan-3alpha,17beta-diol;",C19H32O2,"Androstan-3alpha,17beta-diol; 5alpha-Androstan-3alpha,17beta-diol",R04330 R08963,Steroid hormone biosynthesis,1.1.1.50; 1.1.1.53,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C03852  Androstan-3alpha,17beta-diol",PubChem: 6589; ChEBI: 18011; ChEMBL: CHEMBL410494; 3DMET: B04916; NIKKAJI: J58.218B,cpd:C01090; cpd:C02159; cpd:C03050; cpd:C03051; cpd:C03176; cpd:C03852; cpd:C07632; cpd:C10800; cpd:C12525; cpd:C14960; cpd:C14975; cpd:C15288,19,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H33O2,C19H31O2,292.2402303,293.2480553,291.2324052495,583,cpd:C03917,Dihydrotestosterone;,C19H30O2,Dihydrotestosterone; 17beta-Hydroxyandrostan-3-one; Androstanolone; 17beta-Hydroxy-5alpha-androstan-3-one,R02497 R04330 R04344 R08963,Steroid hormone biosynthesis; Pathways in cancer; Prostate cancer,1.1.1.50; 1.1.1.53; 1.1.1.210; 1.3.1.22,NA,Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C03917  Dihydrotestosterone;  Hormones and transmitters;   Steroid hormones;    Androgens;     C03917  Dihydrotestosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C03917  17beta-Hydroxy-5alpha-androstan-3-one; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A14 ANABOLIC AGENTS FOR SYSTEMIC USE;    A14A ANABOLIC STEROIDS;     A14AA Androstan derivatives;      A14AA01 Androstanolone;       D07456  Androstanolone (INN);  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03B ANDROGENS;     G03BB 5-androstanon (3) derivatives;      G03BB02 Androstanolone;       D07456  Androstanolone (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     androgen receptor;      Androstanolone;       D07456  Androstanolone (INN),CAS: 521-18-6; PubChem: 6646; ChEBI: 16330; ChEMBL: CHEMBL27769 CHEMBL358627; LIPIDMAPS: LMST02020042 LMST02020107; LipidBank: SST0297; PDB-CCD: DHT; 3DMET: B01699; NIKKAJI: J39.503J,cpd:C00523; cpd:C01986; cpd:C03917; cpd:C04295; cpd:C04373; cpd:C05293; cpd:C07635; cpd:C14210; cpd:C14631; cpd:C14932; cpd:C15326; cpd:C15442,19,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H31O2,C19H29O2,290.2245802,291.2324052,289.2167552496,584,cpd:C03935,6beta-Hydroxy-17beta-estradiol;,C18H24O3,6beta-Hydroxy-17beta-estradiol; 6beta-Hydroxyestradiol-17beta,R03086,Steroid hormone biosynthesis,1.14.99.11,NA,Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C03935  6beta-Hydroxyestradiol-17beta; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C03935  6beta-Hydroxyestradiol-17beta,PubChem: 6661; ChEBI: 16784; ChEMBL: CHEMBL390714; LIPIDMAPS: LMST02010031; 3DMET: B01701; NIKKAJI: J824.125B,cpd:C03935; cpd:C05141; cpd:C05301; cpd:C14209; cpd:C15385; cpd:C18415,18,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H25O3,C18H23O3,288.1725446,289.1803697,287.1647196497,585,cpd:C04042,20alpha-Hydroxy-4-pregnen-3-one;,C21H32O2,20alpha-Hydroxy-4-pregnen-3-one; 20alpha-Hydroxypregn-4-en-3-one; 20alpha-Hydroxyprogesterone; (S)-20-Hydroxypregn-4-en-3-one,R02207 R02209,Steroid hormone biosynthesis,1.1.1.149,NA,NA,CAS: 145-14-2; PubChem: 6743; ChEBI: 28453; ChEMBL: CHEMBL137320 CHEMBL1583424; LIPIDMAPS: LMST02030169; 3DMET: B04922; NIKKAJI: J6.126C,cpd:C01953; cpd:C03681; cpd:C04042; cpd:C05479; cpd:C10839; cpd:C14475; cpd:C14477; cpd:C14962; cpd:C15012; cpd:C15108; cpd:C15156; cpd:C15199; cpd:C15334; cpd:C15339; cpd:C20219,21,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O2,C21H31O2,316.2402303,317.2480553,315.2324052498,586,cpd:C04295,Androstenediol;,C19H30O2,"Androstenediol; Androst-5-ene-3beta,17beta-diol; 3beta,17beta-Dihydroxyandrost-5-ene; 3beta,17beta-Dihydroxy-5-androstene",R02499 R03406 R03407,Steroid hormone biosynthesis; Ovarian steroidogenesis,1.1.1.51; 1.1.1.145; 5.3.3.1,NA,"Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C04295  Androstenediol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C04295  3beta,17beta-Dihydroxyandrost-5-ene",CAS: 521-17-5; PubChem: 6955; ChEBI: 2710; ChEMBL: CHEMBL317104 CHEMBL440283 CHEMBL77135; LIPIDMAPS: LMST02020005; PDB-CCD: B81; 3DMET: B01731; NIKKAJI: J6.611G,cpd:C00523; cpd:C01986; cpd:C03917; cpd:C04295; cpd:C04373; cpd:C05293; cpd:C07635; cpd:C14210; cpd:C14631; cpd:C14932; cpd:C15326; cpd:C15442,19,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H31O2,C19H29O2,290.2245802,291.2324052,289.2167552499,587,cpd:C04373,Etiocholanolone;,C19H30O2,Etiocholanolone; 3alpha-Hydroxy-5beta-androstan-17-one; Etiocholan-3alpha-ol-17-one; 3alpha-Hydroxyetiocholan-17-one,R04309 R04310 R04352,Steroid hormone biosynthesis,1.1.1.50; 1.1.1.152; 2.4.1.17,NA,Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C04373  Etiocholanolone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C04373  3alpha-Hydroxy-5beta-androstan-17-one,CAS: 53-42-9; PubChem: 7015; ChEBI: 28195; ChEMBL: CHEMBL1257060 CHEMBL1405827 CHEMBL289067 CHEMBL85799; LIPIDMAPS: LMST02020059; PDB-CCD: AE2; 3DMET: B01736; NIKKAJI: J4.146G,cpd:C00523; cpd:C01986; cpd:C03917; cpd:C04295; cpd:C04373; cpd:C05293; cpd:C07635; cpd:C14210; cpd:C14631; cpd:C14932; cpd:C15326; cpd:C15442,19,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H31O2,C19H29O2,290.2245802,291.2324052,289.2167552500,588,cpd:C04518,"17alpha,20alpha-Dihydroxypregn-4-en-3-one",C21H32O3,"17alpha,20alpha-Dihydroxypregn-4-en-3-one",R03325,Steroid hormone biosynthesis,1.1.1.149,NA,NA,CAS: 652-69-7; PubChem: 7131; ChEBI: 16418; LIPIDMAPS: LMST02030183; 3DMET: B01751; NIKKAJI: J396.241E,cpd:C04518; cpd:C05138; cpd:C05485; cpd:C06390; cpd:C07393; cpd:C08005; cpd:C13803; cpd:C15011; cpd:C15022; cpd:C15355; cpd:C15384; cpd:C15401; cpd:C15405; cpd:C18038; cpd:C18040,21,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O3,C21H31O3,332.2351449,333.2429699,331.2273199501,589,cpd:C04555,Dehydroepiandrosterone sulfate;,C19H28O5S,Dehydroepiandrosterone sulfate; 3beta-Hydroxyandrost-5-en-17-one 3-sulfate; DHEA sulfate,R03404 R03405,Steroid hormone biosynthesis; Bile secretion,2.8.2.2; 3.1.6.2,NA,Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Androgens;     C04555  Dehydroepiandrosterone sulfate; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C04555  3beta-Hydroxyandrost-5-en-17-one 3-sulfate;   ST05 Steroid conjugates;    ST0502 Sulfates;     C04555  3beta-Hydroxyandrost-5-en-17-one 3-sulfate,CAS: 651-48-9; PubChem: 7160; ChEBI: 16814; ChEMBL: CHEMBL259898; LIPIDMAPS: LMST05020010; 3DMET: B01756; NIKKAJI: J412.303D,cpd:C04555,19,28,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O5S1,C19H27O5S1,368.1657452,369.1735702,367.1579201502,590,cpd:C04676,Testololactone;,C19H26O3,"Testololactone; 3-Oxo-13,17-secoandrost-4-ene-17,13alpha-lactone",R01833 R03641 R08205,Steroid hormone biosynthesis,1.14.13.54; 1.14.99.12; 3.1.1.37,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C04676  3-Oxo-13,17-secoandrost-4-ene-17,13alpha-lactone",CAS: 4416-57-3; PubChem: 7257; ChEBI: 18084; LIPIDMAPS: LMST02020061; 3DMET: B01773; NIKKAJI: J39.509I,cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693,19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H27O3,C19H25O3,302.1881947,303.1960197,301.1803697503,591,cpd:C05138,17alpha-Hydroxypregnenolone,C21H32O3,17alpha-Hydroxypregnenolone,R03327 R03783 R04675 R04676 R08517,Steroid hormone biosynthesis; Metabolic pathways; Ovarian steroidogenesis,1.1.1.145; 1.14.14.16; 1.14.14.19; 1.14.14.32; 1.14.15.6; 5.3.3.1,"C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone",Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Progestagens;     C05138  17alpha-Hydroxypregnenolone,CAS: 387-79-1; PubChem: 7557; ChEBI: 28750; ChEMBL: CHEMBL408706; LIPIDMAPS: LMST02030089; PDB-CCD: LZZ; 3DMET: B04983; NIKKAJI: J22.718H,cpd:C04518; cpd:C05138; cpd:C05485; cpd:C06390; cpd:C07393; cpd:C08005; cpd:C13803; cpd:C15011; cpd:C15022; cpd:C15355; cpd:C15384; cpd:C15401; cpd:C15405; cpd:C18038; cpd:C18040,21,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O3,C21H31O3,332.2351449,333.2429699,331.2273199504,592,cpd:C05139,16alpha-Hydroxydehydroepiandrosterone;,C19H28O3,"16alpha-Hydroxydehydroepiandrosterone; 5-Androstene-3beta,16alpha-diol-17-one",R03408 R04678,Steroid hormone biosynthesis,1.1.1.145; 1.14.13.-; 1.14.14.1; 5.3.3.1,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05139  16alpha-Hydroxydehydroepiandrosterone,CAS: 1232-73-1; PubChem: 7558; ChEBI: 27771; LIPIDMAPS: LMST02020064; 3DMET: B01812; NIKKAJI: J14.213A,cpd:C05139; cpd:C05291; cpd:C05294; cpd:C14497; cpd:C14552; cpd:C14600; cpd:C14627; cpd:C14649; cpd:C14671; cpd:C14912; cpd:C15144; cpd:C15286; cpd:C15306; cpd:C15332; cpd:C15416; cpd:C18045; cpd:C18075; cpd:C21296,19,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O3,C19H27O3,304.2038448,305.2116698,303.1960197505,593,cpd:C05140,"16alpha-Hydroxyandrost-4-ene-3,17-dione;",C19H26O3,"16alpha-Hydroxyandrost-4-ene-3,17-dione; 4-Androsten-16alpha-ol-3,17-dione",R04678,Steroid hormone biosynthesis,1.1.1.145; 5.3.3.1,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05140  16alpha-Hydroxyandrost-4-ene-3,17-dione",CAS: 63-02-5; PubChem: 7559; ChEBI: 27582; ChEMBL: CHEMBL143789 CHEMBL1908014; LIPIDMAPS: LMST02020065; 3DMET: B01813; NIKKAJI: J337.168I,cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693,19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H27O3,C19H25O3,302.1881947,303.1960197,301.1803697506,594,cpd:C05141,Estriol;,C18H24O3,"Estriol; 1,3,5(10)-Estratriene-3,16-alpha,17beta-triol",R03089 R04681 R04682 R04683,"Steroid hormone biosynthesis; Metabolic pathways; Progesterone, androgen and estrogen receptor agonists/antagonists",1.1.1.62; 1.14.14.1; 2.4.1.17,NA,"Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C05141  Estriol;  Hormones and transmitters;   Steroid hormones;    Estrogens;     C05141  Estriol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05141  Estriol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;    G03C ESTROGENS;     G03CA Natural and semisynthetic estrogens, plain;      G03CA04 Estriol;       D00185  Estriol (JP17/USP);     G03CC Estrogens, combinations with other drugs;      G03CC06 Estriol;       D00185  Estriol (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    247  Estrogen and progesterone preparations;     2475  Estriols;      D00185  Estriol (JP17/USP);   25  Urogenital and anal organ agents;    252  Genital organ agents;     2529  Others;      D00185  Estriol (JP17/USP); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    Estrogen receptor;     estrogen receptor 1;      Estriol;       D00185  Estriol (JP17/USP);     estrogen receptor 2;      Estriol;       D00185  Estriol (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00185  Estriol;   D00185  Estriol tablets;   D00185  Estriol injection (aqueous suspension); Osteoporosis drugs [br08368.html];  D00185; Endocrine and hormonal agents [br08373.html];  Hormone related agents;   D00185; Animal drugs in Japan [BR:br08331];  94  Agents for breeding;   941  Hormone preparations (except posterior-pituitary hormone and preparations);    9414  Follicle stimulating hormone and preparations;     C05141  Estriol",CAS: 50-27-1; PubChem: 7560; ChEBI: 27974; ChEMBL: CHEMBL193482; LIPIDMAPS: LMST02010003; LipidBank: SST0014; PDB-CCD: ESL; 3DMET: B01814; NIKKAJI: J4.099A,cpd:C03935; cpd:C05141; cpd:C05301; cpd:C14209; cpd:C15385; cpd:C18415,18,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H25O3,C18H23O3,288.1725446,289.1803697,287.1647196507,595,cpd:C05284,"11beta-Hydroxyandrost-4-ene-3,17-dione;",C19H26O3,"11beta-Hydroxyandrost-4-ene-3,17-dione; Androst-4-ene-3,17-dione-11beta-ol; 4-Androsten-11beta-ol-3,17-dione",R02725 R04758 R08945 R08980 R08995,Steroid hormone biosynthesis,1.1.1.62; 1.1.1.146; 1.1.1.-; 1.14.15.4,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05284  11beta-Hydroxyandrost-4-ene-3,17-dione",CAS: 382-44-5; PubChem: 7671; ChEBI: 27967; ChEMBL: CHEMBL347785; LIPIDMAPS: LMST02020066; 3DMET: B01832; NIKKAJI: J104.102I,cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693,19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H27O3,C19H25O3,302.1881947,303.1960197,301.1803697508,596,cpd:C05285,Adrenosterone,C19H24O3,Adrenosterone,R04758,Steroid hormone biosynthesis,1.1.1.146; 1.1.1.-,NA,Compounds with biological roles [BR:br08001];  Steroids;   19-Carbon atoms;    Androstane derivatives;     C05285  Adrenosterone,CAS: 382-45-6; PubChem: 7672; ChEBI: 2495; ChEMBL: CHEMBL485683; LipidBank: SST0128; 3DMET: B01833; NIKKAJI: J5.714B,cpd:C02197; cpd:C05285; cpd:C05297; cpd:C05299; cpd:C06494; cpd:C07063; cpd:C13326; cpd:C13676; cpd:C14587; cpd:C14909; cpd:C15150; cpd:C15200; cpd:C15295; cpd:C15386; cpd:C15406; cpd:C16991; cpd:C17567; cpd:C17850; cpd:C17851; cpd:C18510; cpd:C19944; cpd:C19982,19,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O3,C19H23O3,300.1725446,301.1803697,299.1647196509,597,cpd:C05290,"19-Hydroxyandrost-4-ene-3,17-dione;",C19H26O3,"19-Hydroxyandrost-4-ene-3,17-dione; 19-Hydroxyandrostenedione",R01840 R04759,Steroid hormone biosynthesis; Metabolic pathways,1.14.14.14,"C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone","Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05290  19-Hydroxyandrost-4-ene-3,17-dione",CAS: 510-64-5; PubChem: 7675; ChEBI: 27576; ChEMBL: CHEMBL1385863; LIPIDMAPS: LMST02020067; 3DMET: B01834; NIKKAJI: J117.011B,cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693,19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H27O3,C19H25O3,302.1881947,303.1960197,301.1803697510,598,cpd:C05291,7alpha-Hydroxytestosterone,C19H28O3,7alpha-Hydroxytestosterone,R02503 R04760,Steroid hormone biosynthesis,1.14.14.1,NA,Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Androgens;     C05291  7alpha-Hydroxytestosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05291  7alpha-Hydroxytestosterone,CAS: 62-83-9; PubChem: 7676; ChEBI: 2295; LIPIDMAPS: LMST02020068; 3DMET: B05007; NIKKAJI: J239.114G,cpd:C05139; cpd:C05291; cpd:C05294; cpd:C14497; cpd:C14552; cpd:C14600; cpd:C14627; cpd:C14649; cpd:C14671; cpd:C14912; cpd:C15144; cpd:C15286; cpd:C15306; cpd:C15332; cpd:C15416; cpd:C18045; cpd:C18075; cpd:C21296,19,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O3,C19H27O3,304.2038448,305.2116698,303.1960197511,599,cpd:C05293,5beta-Dihydrotestosterone,C19H30O2,5beta-Dihydrotestosterone,R02498,Steroid hormone biosynthesis,1.3.1.3,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05293  5beta-Dihydrotestosterone,CAS: 571-22-2; PubChem: 7677; ChEBI: 2150; ChEMBL: CHEMBL1872046 CHEMBL373357; LIPIDMAPS: LMST02020069; PDB-CCD: BDT; 3DMET: B01835; NIKKAJI: J16.844K,cpd:C00523; cpd:C01986; cpd:C03917; cpd:C04295; cpd:C04373; cpd:C05293; cpd:C07635; cpd:C14210; cpd:C14631; cpd:C14932; cpd:C15326; cpd:C15442,19,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H31O2,C19H29O2,290.2245802,291.2324052,289.2167552512,600,cpd:C05294,19-Hydroxytestosterone;,C19H28O3,"19-Hydroxytestosterone; 17beta,19-Dihydroxyandrost-4-en-3-one",R02501 R04761,Steroid hormone biosynthesis; Metabolic pathways,1.14.14.14,NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Androgens;     C05294  19-Hydroxytestosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05294  17beta,19-Dihydroxyandrost-4-en-3-one",PubChem: 7678; ChEBI: 798; LIPIDMAPS: LMST02020070; 3DMET: B01836; NIKKAJI: J426.714A,cpd:C05139; cpd:C05291; cpd:C05294; cpd:C14497; cpd:C14552; cpd:C14600; cpd:C14627; cpd:C14649; cpd:C14671; cpd:C14912; cpd:C15144; cpd:C15286; cpd:C15306; cpd:C15332; cpd:C15416; cpd:C18045; cpd:C18075; cpd:C21296,19,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O3,C19H27O3,304.2038448,305.2116698,303.1960197513,601,cpd:C05295,19-Oxotestosterone,C19H26O3,19-Oxotestosterone,R03087 R04761,Steroid hormone biosynthesis; Metabolic pathways,1.14.14.14,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05295  19-Oxotestosterone,PubChem: 7679; ChEBI: 75308; NIKKAJI: J1.968.925E,cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693,19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H27O3,C19H25O3,302.1881947,303.1960197,301.1803697514,602,cpd:C05296,"7alpha-Hydroxyandrost-4-ene-3,17-dione;",C19H26O3,"7alpha-Hydroxyandrost-4-ene-3,17-dione; 7alpha-Hydroxyandrostenedione",R01842 R04760,Steroid hormone biosynthesis,1.14.14.1,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05296  7alpha-Hydroxyandrost-4-ene-3,17-dione",PubChem: 7680; ChEBI: 27768; LIPIDMAPS: LMST02020071; 3DMET: B01837; NIKKAJI: J337.164F,cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693,19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H27O3,C19H25O3,302.1881947,303.1960197,301.1803697515,603,cpd:C05297,"19-Oxoandrost-4-ene-3,17-dione;",C19H24O3,"19-Oxoandrost-4-ene-3,17-dione; 19-Oxoandrostenedione",R02351 R04759,Steroid hormone biosynthesis; Metabolic pathways,1.14.14.14,"C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone","Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C05297  19-Oxoandrost-4-ene-3,17-dione",PubChem: 7681; ChEBI: 799; ChEMBL: CHEMBL1545651; LIPIDMAPS: LMST02020083; 3DMET: B05008; NIKKAJI: J101.998H,cpd:C02197; cpd:C05285; cpd:C05297; cpd:C05299; cpd:C06494; cpd:C07063; cpd:C13326; cpd:C13676; cpd:C14587; cpd:C14909; cpd:C15150; cpd:C15200; cpd:C15295; cpd:C15386; cpd:C15406; cpd:C16991; cpd:C17567; cpd:C17850; cpd:C17851; cpd:C18510; cpd:C19944; cpd:C19982,19,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O3,C19H23O3,300.1725446,301.1803697,299.1647196516,604,cpd:C05298,2-Hydroxyestrone,C18H22O3,2-Hydroxyestrone,R02354 R02355 R04762,Steroid hormone biosynthesis,1.14.14.1; 2.1.1.6,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05298  2-Hydroxyestrone,CAS: 362-06-1; PubChem: 7682; ChEBI: 1156; ChEMBL: CHEMBL1627343; LIPIDMAPS: LMST02010032; 3DMET: B01838; NIKKAJI: J108.087C,cpd:C05298; cpd:C05300; cpd:C06490; cpd:C07621; cpd:C14383; cpd:C14496; cpd:C18506,18,22,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H23O3,C18H21O3,286.1568946,287.1647196,285.1490695517,605,cpd:C05299,2-Methoxyestrone,C19H24O3,2-Methoxyestrone,R00536 R04353 R04762,Steroid hormone biosynthesis,2.1.1.6; 2.4.1.17; 2.8.2.15,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05299  2-Methoxyestrone,CAS: 362-08-3; PubChem: 7683; ChEBI: 1189; ChEMBL: CHEMBL425194; LIPIDMAPS: LMST02010033; 3DMET: B01839; NIKKAJI: J101.999F,cpd:C02197; cpd:C05285; cpd:C05297; cpd:C05299; cpd:C06494; cpd:C07063; cpd:C13326; cpd:C13676; cpd:C14587; cpd:C14909; cpd:C15150; cpd:C15200; cpd:C15295; cpd:C15386; cpd:C15406; cpd:C16991; cpd:C17567; cpd:C17850; cpd:C17851; cpd:C18510; cpd:C19944; cpd:C19982,19,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O3,C19H23O3,300.1725446,301.1803697,299.1647196518,606,cpd:C05300,16alpha-Hydroxyestrone,C18H22O3,16alpha-Hydroxyestrone,R02356 R04681 R04682,Steroid hormone biosynthesis; Metabolic pathways,1.1.1.62; 1.14.13.-; 1.14.14.1,NA,Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Estrogens;     C05300  16alpha-Hydroxyestrone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05300  16alpha-Hydroxyestrone,CAS: 566-76-7; PubChem: 7684; ChEBI: 776; LIPIDMAPS: LMST02010041; PDB-CCD: J2Z; 3DMET: B01840; NIKKAJI: J130.683I,cpd:C05298; cpd:C05300; cpd:C06490; cpd:C07621; cpd:C14383; cpd:C14496; cpd:C18506,18,22,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H23O3,C18H21O3,286.1568946,287.1647196,285.1490695519,607,cpd:C05301,2-Hydroxyestradiol;,C18H24O3,2-Hydroxyestradiol; 2-Hydroxyestradiol-17beta; 2-OH-Estradiol,R03088 R03090 R04764,Steroid hormone biosynthesis; Ovarian steroidogenesis,1.14.14.1; 2.1.1.6,NA,Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C05301  2-Hydroxyestradiol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05301  2-Hydroxyestradiol-17beta,CAS: 362-05-0; PubChem: 7685; ChEBI: 28744; ChEMBL: CHEMBL467987; LIPIDMAPS: LMST02010027; PDB-CCD: ECS; NIKKAJI: J108.138A,cpd:C03935; cpd:C05141; cpd:C05301; cpd:C14209; cpd:C15385; cpd:C18415,18,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H25O3,C18H23O3,288.1725446,289.1803697,287.1647196520,608,cpd:C05302,2-Methoxy-17beta-estradiol;,C19H26O3,2-Methoxy-17beta-estradiol; 2-Methoxyestradiol-17beta,R00537 R04354 R04764,Steroid hormone biosynthesis,2.1.1.6; 2.4.1.17; 2.8.2.15,NA,Compounds with biological roles [BR:br08001];  Steroids;   18-Carbon atoms;    Estrane derivatives;     C05302  2-Methoxyestradiol-17beta; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05302  2-Methoxyestradiol-17beta,CAS: 362-07-2; PubChem: 7686; ChEBI: 28955; ChEMBL: CHEMBL1627340 CHEMBL299613; LIPIDMAPS: LMST02010035; PDB-CCD: ESM; 3DMET: B01841; NIKKAJI: J104.105C,cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693,19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H27O3,C19H25O3,302.1881947,303.1960197,301.1803697521,609,cpd:C05469,"17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione;",C21H30O5,"17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione; 5beta-Pregnane-17alpha,21-diol-3,11,20-trione; 4,5beta-Dihydrocortisone",R02893 R04829 R04830,Steroid hormone biosynthesis,1.1.1.50; 1.3.1.3,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05469  4,5beta-Dihydrocortisone",CAS: 68-54-2; PubChem: 7829; ChEBI: 18093; LIPIDMAPS: LMST02030095; 3DMET: B01861; NIKKAJI: J789.264K,cpd:C00735; cpd:C01124; cpd:C03588; cpd:C05469; cpd:C05473; cpd:C08837; cpd:C10695; cpd:C14127; cpd:C15034,21,30,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O5,C21H29O5,362.2093241,363.2171491,361.201499522,610,cpd:C05470,Tetrahydrocortisone;,C21H32O5,Tetrahydrocortisone; Urocortisone,R04829 R04830 R04831,Steroid hormone biosynthesis,1.1.1.50; 1.1.1.53,NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Glucocorticoids;     C05470  Tetrahydrocortisone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05470  Urocortisone",CAS: 53-05-4; PubChem: 7830; ChEBI: 9901; ChEMBL: CHEMBL1908043; LIPIDMAPS: LMST02030098; 3DMET: B05046; NIKKAJI: J4.138F,cpd:C05470; cpd:C05471; cpd:C05474; cpd:C05489; cpd:C18044,21,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O5,C21H31O5,364.2249741,365.2327992,363.2171491523,611,cpd:C05471,"11beta,17alpha,21-Trihydroxy-5beta-pregnane-3,20-dione;",C21H32O5,"11beta,17alpha,21-Trihydroxy-5beta-pregnane-3,20-dione; 5beta-Pregnane-11beta,17alpha,21-triol-3,20-dione",R02841 R04832 R04833,Steroid hormone biosynthesis,1.1.1.50; 1.3.1.3,NA,NA,CAS: 1482-50-4; PubChem: 7831; ChEBI: 732; LIPIDMAPS: LMST02030204; LipidBank: SST0243; 3DMET: B01862; NIKKAJI: J39.546C,cpd:C05470; cpd:C05471; cpd:C05474; cpd:C05489; cpd:C18044,21,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O5,C21H31O5,364.2249741,365.2327992,363.2171491524,612,cpd:C05472,Urocortisol;,C21H34O5,"Urocortisol; Tetrahydrocortisol; 5beta-Pregnane-3alpha,11beta,17alpha,21-tetrol-20-one",R04832 R04833 R04834,Steroid hormone biosynthesis,1.1.1.50; 1.1.1.53,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05472  Urocortisol",CAS: 53-02-1; PubChem: 7832; ChEBI: 28320; ChEMBL: CHEMBL1908047; LIPIDMAPS: LMST02030143; 3DMET: B05047; NIKKAJI: J39.547A,cpd:C05472; cpd:C05481,21,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H35O5,C21H33O5,366.2406242,367.2484492,365.2327992525,613,cpd:C05473,"11beta,21-Dihydroxy-3,20-oxo-5beta-pregnan-18-al",C21H30O5,"11beta,21-Dihydroxy-3,20-oxo-5beta-pregnan-18-al",R03713 R03714 R04835 R04836,Steroid hormone biosynthesis,1.1.1.50; 1.3.1.3,NA,NA,PubChem: 7833; ChEBI: 86389; LIPIDMAPS: LMST02030187; 3DMET: B05048; NIKKAJI: J2.755.992A,cpd:C00735; cpd:C01124; cpd:C03588; cpd:C05469; cpd:C05473; cpd:C08837; cpd:C10695; cpd:C14127; cpd:C15034,21,30,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O5,C21H29O5,362.2093241,363.2171491,361.201499526,614,cpd:C05474,"3alpha,11beta,21-Trihydroxy-20-oxo-5beta-pregnan-18-al",C21H32O5,"3alpha,11beta,21-Trihydroxy-20-oxo-5beta-pregnan-18-al",R04835 R04836,Steroid hormone biosynthesis,1.1.1.50,NA,NA,PubChem: 7834; ChEBI: 1684; LIPIDMAPS: LMST02030197; 3DMET: B05049; NIKKAJI: J2.755.993J,cpd:C05470; cpd:C05471; cpd:C05474; cpd:C05489; cpd:C18044,21,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O5,C21H31O5,364.2249741,365.2327992,363.2171491527,615,cpd:C05475,"11beta,21-Dihydroxy-5beta-pregnane-3,20-dione;",C21H32O4,"11beta,21-Dihydroxy-5beta-pregnane-3,20-dione; 5beta-Pregnane-11beta,21-diol-3,20-dione",R03850 R04837 R04838,Steroid hormone biosynthesis,1.1.1.50; 1.3.1.3,NA,NA,CAS: 566-01-8; PubChem: 7835; ChEBI: 86381; LIPIDMAPS: LMST02030188; 3DMET: B05050; NIKKAJI: J401.582G,cpd:C05475; cpd:C05478; cpd:C05487; cpd:C14598; cpd:C15685,21,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O4,C21H31O4,348.2300595,349.2378845,347.2222345528,616,cpd:C05476,Tetrahydrocorticosterone,C21H34O4,Tetrahydrocorticosterone,R04837 R04838 R04840,Steroid hormone biosynthesis,1.1.1.50; 1.1.1.146; 1.1.1.-,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05476  Tetrahydrocorticosterone",CAS: 68-42-8; PubChem: 7836; ChEBI: 9481; LIPIDMAPS: LMST02030100; 3DMET: B01863; NIKKAJI: J4.858E,cpd:C05476; cpd:C05483; cpd:C14594; cpd:C15368; cpd:C15403; cpd:C17496,21,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H35O4,C21H33O4,350.2457096,351.2535346,349.2378845529,617,cpd:C05477,"21-Hydroxy-5beta-pregnane-3,11,20-trione",C21H30O4,"21-Hydroxy-5beta-pregnane-3,11,20-trione",R04842 R04843 R08994,Steroid hormone biosynthesis,1.1.1.50,NA,NA,PubChem: 7837; ChEBI: 1298; LIPIDMAPS: LMST02030196; 3DMET: B05051; NIKKAJI: J2.755.994H,cpd:C02140; cpd:C02942; cpd:C05477; cpd:C05488; cpd:C05497; cpd:C06391; cpd:C15002; cpd:C15015; cpd:C15304; cpd:C15363; cpd:C15365,21,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O4,C21H29O4,346.2144094,347.2222345,345.2065844530,618,cpd:C05478,"3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione;",C21H32O4,"3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione; 5beta-Pregnane-3alpha,21-diol-11,20-dione",R04840 R04842 R04843 R04844,Steroid hormone biosynthesis,1.1.1.50; 1.1.1.53; 1.1.1.146; 1.1.1.-,NA,NA,CAS: 566-03-0; PubChem: 7838; ChEBI: 1690; LIPIDMAPS: LMST02030199; 3DMET: B05052; NIKKAJI: J188.431J,cpd:C05475; cpd:C05478; cpd:C05487; cpd:C14598; cpd:C15685,21,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O4,C21H31O4,348.2300595,349.2378845,347.2222345531,619,cpd:C05479,"5beta-Pregnane-3,20-dione",C21H32O2,"5beta-Pregnane-3,20-dione",R02215 R02219 R04845 R04846 R06166,Steroid hormone biosynthesis; Metabolic pathways,1.1.1.50; 1.1.1.277; 1.3.1.3; 1.3.99.6,NA,NA,CAS: 128-23-4; PubChem: 7839; ChEBI: 30154; ChEMBL: CHEMBL486954; LIPIDMAPS: LMST02030146; LipidBank: SST0097; PDB-CCD: CI2; 3DMET: B05053; NIKKAJI: J6.569B,cpd:C01953; cpd:C03681; cpd:C04042; cpd:C05479; cpd:C10839; cpd:C14475; cpd:C14477; cpd:C14962; cpd:C15012; cpd:C15108; cpd:C15156; cpd:C15199; cpd:C15334; cpd:C15339; cpd:C20219,21,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O2,C21H31O2,316.2402303,317.2480553,315.2324052532,620,cpd:C05480,Pregnanolone;,C21H34O2,Pregnanolone; 3alpha-Hydroxy-5beta-pregnan-20-one,R04845 R04846 R04847,Steroid hormone biosynthesis; Metabolic pathways,1.1.1.50; 1.1.1.53,NA,NA,CAS: 128-20-1; PubChem: 7840; ChEBI: 1712; ChEMBL: CHEMBL210952; LIPIDMAPS: LMST02030175; LipidBank: SST0098; 3DMET: B05054; NIKKAJI: J6.567F,cpd:C05480; cpd:C10770; cpd:C11825; cpd:C13712; cpd:C15099; cpd:C15264; cpd:C15484; cpd:C18041,21,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H35O2,C21H33O2,318.2558803,319.2637054,317.2480553533,621,cpd:C05481,Cortolone,C21H34O5,Cortolone,R04831,Steroid hormone biosynthesis,1.1.1.53,NA,NA,CAS: 516-42-7; PubChem: 7841; ChEBI: 3899; ChEMBL: CHEMBL1908042; 3DMET: B05055; NIKKAJI: J6.310J,cpd:C05472; cpd:C05481,21,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H35O5,C21H33O5,366.2406242,367.2484492,365.2327992534,622,cpd:C05482,Cortol,C21H36O5,Cortol,R04834,Steroid hormone biosynthesis,1.1.1.53,NA,NA,CAS: 516-38-1; PubChem: 7842; ChEBI: 3898; ChEMBL: CHEMBL1908046; 3DMET: B05056; NIKKAJI: J6.307J,cpd:C05482; cpd:C06872; cpd:C11717,21,36,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H37O5,C21H35O5,368.2562743,369.2640993,367.2484492535,623,cpd:C05483,"3alpha,20alpha,21-Trihydroxy-5beta-pregnan-11-one",C21H34O4,"3alpha,20alpha,21-Trihydroxy-5beta-pregnan-11-one",R04844,Steroid hormone biosynthesis,1.1.1.53,NA,NA,PubChem: 7843; ChEBI: 1689; 3DMET: B05057; NIKKAJI: J2.755.996D,cpd:C05476; cpd:C05483; cpd:C14594; cpd:C15368; cpd:C15403; cpd:C17496,21,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H35O4,C21H33O4,350.2457096,351.2535346,349.2378845536,624,cpd:C05484,Pregnanediol;,C21H36O2,"Pregnanediol; 5beta-Pregnane-3alpha,20alpha-diol; Pregnandiol; Diol",R04847,Steroid hormone biosynthesis; Metabolic pathways,1.1.1.53,NA,NA,CAS: 80-92-2; PubChem: 7844; ChEBI: 8387; ChEMBL: CHEMBL269897; LIPIDMAPS: LMST02030202; 3DMET: B05058; NIKKAJI: J4.884D,cpd:C05484; cpd:C10809; cpd:C14878; cpd:C14982; cpd:C15047; cpd:C15198; cpd:C18042,21,36,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H37O2,C21H35O2,320.2715304,321.2793554,319.2637054537,625,cpd:C05485,21-Hydroxypregnenolone,C21H32O3,21-Hydroxypregnenolone,R03784 R04163,Steroid hormone biosynthesis,1.1.1.145; 1.14.14.16; 5.3.3.1,NA,NA,CAS: 1164-98-3; PubChem: 7845; ChEBI: 28043; ChEMBL: CHEMBL1908012; LIPIDMAPS: LMST02030167; 3DMET: B05059; NIKKAJI: J924.614B,cpd:C04518; cpd:C05138; cpd:C05485; cpd:C06390; cpd:C07393; cpd:C08005; cpd:C13803; cpd:C15011; cpd:C15022; cpd:C15355; cpd:C15384; cpd:C15401; cpd:C15405; cpd:C18038; cpd:C18040,21,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O3,C21H31O3,332.2351449,333.2429699,331.2273199538,626,cpd:C05487,"17alpha,21-Dihydroxypregnenolone",C21H32O4,"17alpha,21-Dihydroxypregnenolone",R04675 R04849 R04850,Steroid hormone biosynthesis,1.1.1.145; 1.14.14.16; 1.14.15.4; 5.3.3.1,NA,NA,CAS: 1167-48-2; PubChem: 7846; ChEBI: 27832; LIPIDMAPS: LMST02030141; 3DMET: B05060; NIKKAJI: J2.756.013J,cpd:C05475; cpd:C05478; cpd:C05487; cpd:C14598; cpd:C15685,21,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O4,C21H31O4,348.2300595,349.2378845,347.2222345539,627,cpd:C05488,11-Deoxycortisol;,C21H30O4,11-Deoxycortisol; Cortodoxone,R02843 R03326 R04849,Steroid hormone biosynthesis; Metabolic pathways,1.1.1.145; 1.14.14.16; 1.14.15.4; 5.3.3.1,"C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone","Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Glucocorticoids;     C05488  11-Deoxycortisol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05488  11-Deoxycortisol; Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     glucocorticoid receptor;      Cortodoxone;       D03595  Cortodoxone (USAN)",CAS: 152-58-9; PubChem: 7847; ChEBI: 28324; ChEMBL: CHEMBL253144; LIPIDMAPS: LMST02030086; 3DMET: B01864; NIKKAJI: J5.867J,cpd:C02140; cpd:C02942; cpd:C05477; cpd:C05488; cpd:C05497; cpd:C06391; cpd:C15002; cpd:C15015; cpd:C15304; cpd:C15363; cpd:C15365,21,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O4,C21H29O4,346.2144094,347.2222345,345.2065844540,628,cpd:C05489,"11beta,17alpha,21-Trihydroxypregnenolone",C21H32O5,"11beta,17alpha,21-Trihydroxypregnenolone",R02840 R04850,Steroid hormone biosynthesis,1.1.1.145; 1.14.15.4; 5.3.3.1,NA,NA,PubChem: 7848; ChEBI: 27783; LIPIDMAPS: LMST02030166; 3DMET: B05061; NIKKAJI: J2.756.014H,cpd:C05470; cpd:C05471; cpd:C05474; cpd:C05489; cpd:C18044,21,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O5,C21H31O5,364.2249741,365.2327992,363.2171491541,629,cpd:C05490,11-Dehydrocorticosterone,C21H28O4,11-Dehydrocorticosterone,R03847 R03848 R08994,Steroid hormone biosynthesis,1.1.1.146; 1.1.1.-,NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Mineralocorticoids;     C05490  11-Dehydrocorticosterone; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05490  11-Dehydrocorticosterone",CAS: 72-23-1; PubChem: 7849; ChEBI: 78600; LIPIDMAPS: LMST02030192; 3DMET: B05062; NIKKAJI: J5.250G,cpd:C05490; cpd:C14478; cpd:C15135; cpd:C15208,21,28,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H29O4,C21H27O4,344.1987594,345.2065844,343.1909343542,630,cpd:C05497,21-Deoxycortisol;,C21H30O4,"21-Deoxycortisol; 4-Pregnene-11beta,17alpha-diol-3,20-dione; 11beta,17alpha-Dihydroxyprogesterone",R02838 R03329 R04852,Steroid hormone biosynthesis,1.14.14.16; 1.14.14.19; 1.14.15.4,NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Steroid hormones;    Glucocorticoids;     C05497  21-Deoxycortisol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;     C05497  21-Deoxycortisol",CAS: 641-77-0; PubChem: 7850; ChEBI: 28697; ChEMBL: CHEMBL1527439; LIPIDMAPS: LMST02030195; 3DMET: B05063; NIKKAJI: J205.915K,cpd:C02140; cpd:C02942; cpd:C05477; cpd:C05488; cpd:C05497; cpd:C06391; cpd:C15002; cpd:C15015; cpd:C15304; cpd:C15363; cpd:C15365,21,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O4,C21H29O4,346.2144094,347.2222345,345.2065844543,631,cpd:C05498,11beta-Hydroxyprogesterone,C21H30O3,11beta-Hydroxyprogesterone,R02218 R03849 R04852,Steroid hormone biosynthesis,1.14.14.16; 1.14.14.19; 1.14.15.4,NA,NA,CAS: 600-57-7; PubChem: 7851; ChEBI: 28247; ChEMBL: CHEMBL345682; LIPIDMAPS: LMST02030168; 3DMET: B05064; NIKKAJI: J66.993H,cpd:C01176; cpd:C03027; cpd:C03205; cpd:C03747; cpd:C03748; cpd:C04108; cpd:C05498; cpd:C10838; cpd:C14654; cpd:C14881; cpd:C14984; cpd:C14995; cpd:C15132; cpd:C15154; cpd:C15364; cpd:C15409; cpd:C16780; cpd:C19726; cpd:C20218,21,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O3,C21H29O3,330.2194948,331.2273199,329.2116698544,632,cpd:C05499,"17alpha,20alpha-Dihydroxycholesterol",C27H46O3,"17alpha,20alpha-Dihydroxycholesterol",R04676 R04853,Steroid hormone biosynthesis,1.14.14.19; 1.14.15.6,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05499  17alpha,20alpha-Dihydroxycholesterol",PubChem: 7852; ChEBI: 783; LIPIDMAPS: LMST04030176; 3DMET: B05065; NIKKAJI: J2.756.020B,cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520,27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O3,C27H45O3,418.3446953,419.3525204,417.3368703545,633,cpd:C05500,20alpha-Hydroxycholesterol;,C27H46O2,20alpha-Hydroxycholesterol; 20-Hydroxycholesterol,R01454 R04853 R04854,Steroid hormone biosynthesis; Metabolic pathways,1.14.14.19; 1.14.15.6,"Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05500  20alpha-Hydroxycholesterol,CAS: 516-72-3; PubChem: 7853; ChEBI: 1296; ChEMBL: CHEMBL173898; LIPIDMAPS: LMST01010201; PDB-CCD: HCD; 3DMET: B01865; NIKKAJI: J631.217I,cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992,27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O2,C27H45O2,402.3497807,403.3576058,401.3419557546,634,cpd:C05501,"20alpha,22beta-Dihydroxycholesterol;",C27H46O3,"20alpha,22beta-Dihydroxycholesterol; (22R)-20alpha,22-Dihydroxycholesterol",R03933 R04854 R04855,Steroid hormone biosynthesis; Metabolic pathways,1.14.15.6,"Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone","Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05501  20alpha,22beta-Dihydroxycholesterol",PubChem: 7854; ChEBI: 1294; ChEMBL: CHEMBL560194; LIPIDMAPS: LMST01010200; PDB-CCD: 2DC; 3DMET: B05066; NIKKAJI: J401.177E,cpd:C05445; cpd:C05453; cpd:C05458; cpd:C05499; cpd:C05501; cpd:C06341; cpd:C15518; cpd:C15520,27,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O3,C27H45O3,418.3446953,419.3525204,417.3368703547,635,cpd:C05502,22(R)-Hydroxycholesterol;,C27H46O2,22(R)-Hydroxycholesterol; (22R)-22-Hydroxycholesterol; 22beta-Hydroxycholesterol,R02723 R04855,Steroid hormone biosynthesis; Metabolic pathways,1.14.15.6,"Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C05502  22beta-Hydroxycholesterol; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Thyroid hormone like receptors;    Liver X receptor like receptor;     liver X receptor alpha;      C05502  22(R)-Hydroxycholesterol;     liver X receptor beta;      C05502 22beta-Hydroxycholesterol,CAS: 17954-98-2; PubChem: 7855; ChEBI: 67237; ChEMBL: CHEMBL422904 CHEMBL59549; LIPIDMAPS: LMST01010086; LipidBank: SST9039; PDB-CCD: HC9; 3DMET: B01866; NIKKAJI: J14.202F,cpd:C03594; cpd:C05418; cpd:C05451; cpd:C05500; cpd:C05502; cpd:C10821; cpd:C13550; cpd:C14151; cpd:C15519; cpd:C15610; cpd:C15882; cpd:C15992,27,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O2,C27H45O2,402.3497807,403.3576058,401.3419557548,636,cpd:C05503,Estradiol-17beta 3-glucuronide;,C24H32O8,Estradiol-17beta 3-glucuronide; 17beta-Estradiol 3-(beta-D-glucuronide),R03091,Steroid hormone biosynthesis; Bile secretion,2.4.1.17,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05503  17beta-Estradiol 3-(beta-D-glucuronide);   ST05 Steroid conjugates;    ST0501 Glucuronides;     C05503  17beta-Estradiol 3-(beta-D-glucuronide),PubChem: 7856; ChEBI: 36489; LIPIDMAPS: LMST05010007; 3DMET: B01867; NIKKAJI: J506.208J,cpd:C04300; cpd:C05503; cpd:C09121; cpd:C11237,24,32,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H33O8,C24H31O8,448.209718,449.217543,447.201893549,637,cpd:C05504,16-Glucuronide-estriol;,C24H32O9,"16-Glucuronide-estriol; 16alpha,17beta-Estriol 16-(beta-D-glucuronide)",R04683,Steroid hormone biosynthesis,2.4.1.17,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C05504  16alpha,17beta-Estriol 16-(beta-D-glucuronide);   ST05 Steroid conjugates;    ST0501 Glucuronides;     C05504  16alpha,17beta-Estriol 16-(beta-D-glucuronide)",CAS: 1852-50-2; PubChem: 7857; ChEBI: 766; LIPIDMAPS: LMST05010008; 3DMET: B01868; NIKKAJI: J459.851B,cpd:C05504; cpd:C11288; cpd:C11346; cpd:C16859,24,32,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H33O9,C24H31O9,464.2046326,465.2124576,463.1968076550,638,cpd:C08357,Estradiol-17beta 3-sulfate,C18H24O5S,Estradiol-17beta 3-sulfate,R00535,Steroid hormone biosynthesis; Bile secretion,2.8.2.15,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C08357  Estradiol-17beta 3-sulfate;   ST05 Steroid conjugates;    ST0502 Sulfates;     C08357  Estradiol-17beta 3-sulfate,PubChem: 10554; ChEBI: 4866; ChEMBL: CHEMBL1628111; LIPIDMAPS: LMST05020005; 3DMET: B02168; NIKKAJI: J464.382H,cpd:C08357,18,24,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C18H25O5S1,C18H23O5S1,352.134445,353.1422701,351.12662551,639,cpd:C08358,2-Methoxyestrone 3-sulfate,C19H24O6S,2-Methoxyestrone 3-sulfate,R00536,Steroid hormone biosynthesis,2.8.2.15,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C08358  2-Methoxyestrone 3-sulfate;   ST05 Steroid conjugates;    ST0502 Sulfates;     C08358  2-Methoxyestrone 3-sulfate,PubChem: 10555; ChEBI: 1191; LIPIDMAPS: LMST05020006; 3DMET: B02169; NIKKAJI: J2.765.944F,cpd:C08358,19,24,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O6S1,C19H23O6S1,380.1293597,381.1371847,379.1215346552,640,cpd:C08359,2-Methoxyestradiol-17beta 3-sulfate,C19H26O6S,2-Methoxyestradiol-17beta 3-sulfate,R00537,Steroid hormone biosynthesis,2.8.2.15,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C08359  2-Methoxyestradiol-17beta 3-sulfate;   ST05 Steroid conjugates;    ST0502 Sulfates;     C08359  2-Methoxyestradiol-17beta 3-sulfate,PubChem: 10556; ChEBI: 1188; LIPIDMAPS: LMST05020007; 3DMET: B02170; NIKKAJI: J2.765.948I,cpd:C08359,19,26,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C19H27O6S1,C19H25O6S1,382.1450097,383.1528348,381.1371847553,641,cpd:C11131,2-Methoxy-estradiol-17beta 3-glucuronide,C25H34O9,2-Methoxy-estradiol-17beta 3-glucuronide,R04354,Steroid hormone biosynthesis,2.4.1.17,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C11131  2-Methoxy-estradiol-17beta 3-glucuronide;   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11131  2-Methoxy-estradiol-17beta 3-glucuronide,PubChem: 13313; ChEBI: 36491; LIPIDMAPS: LMST05010009; 3DMET: B04205; NIKKAJI: J506.208J,cpd:C08746; cpd:C08755; cpd:C08783; cpd:C11131,25,34,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H35O9,C25H33O9,478.2202827,479.2281077,477.2124576554,642,cpd:C11132,2-Methoxyestrone 3-glucuronide,C25H32O9,2-Methoxyestrone 3-glucuronide,R04353,Steroid hormone biosynthesis,2.4.1.17,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C11132  2-Methoxyestrone 3-glucuronide;   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11132  2-Methoxyestrone 3-glucuronide,CAS: 25577-70-2; PubChem: 13314; ChEBI: 37450; LIPIDMAPS: LMST05010010; 3DMET: B04206; NIKKAJI: J2.773.451K,cpd:C11132,25,32,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H33O9,C25H31O9,476.2046326,477.2124576,475.1968076555,643,cpd:C11133,Estrone glucuronide;,C24H30O8,Estrone glucuronide; Estrone 3-glucuronide; Estrone beta-D-glucuronide,R02358,Steroid hormone biosynthesis,2.4.1.17,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0201 C18 steroids (estrogens) and derivatives;     C11133  Estrone 3-glucuronide;   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11133  Estrone 3-glucuronide,CAS: 2479-90-5; PubChem: 13315; ChEBI: 28919; LIPIDMAPS: LMST05010011; PDB-CCD: E3G; 3DMET: B04207; NIKKAJI: J468.255F,cpd:C10894; cpd:C11133,24,30,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H31O8,C24H29O8,446.1940679,447.201893,445.1862429556,644,cpd:C11134,Testosterone glucuronide;,C25H36O8,Testosterone glucuronide; Testosterone 17beta-(beta-D-glucuronide),R02502,Steroid hormone biosynthesis,2.4.1.17,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C11134  Testosterone 17beta-(beta-D-glucuronide);   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11134  Testosterone glucuronide,CAS: 1180-25-2; PubChem: 13316; ChEBI: 28835; LIPIDMAPS: LMST05010012; 3DMET: B04208; NIKKAJI: J752.948A,cpd:C11134,25,36,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H37O8,C25H35O8,464.2410181,465.2488431,463.2331931557,645,cpd:C11135,Androsterone glucuronide;,C25H38O8,Androsterone glucuronide; Androsterone 3-glucuronide,R02478,Steroid hormone biosynthesis,2.4.1.17,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C11135  Androsterone 3-glucuronide;   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11135  Androsterone 3-glucuronide,CAS: 1852-43-3; PubChem: 13317; ChEBI: 28832; LIPIDMAPS: LMST05010013; 3DMET: B04209; NIKKAJI: J448.218B,cpd:C11135; cpd:C11136,25,38,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H39O8,C25H37O8,466.2566682,467.2644932,465.2488431558,646,cpd:C11136,Etiocholan-3alpha-ol-17-one 3-glucuronide,C25H38O8,Etiocholan-3alpha-ol-17-one 3-glucuronide,R04352,Steroid hormone biosynthesis,2.4.1.17,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST05 Steroid conjugates;    ST0501 Glucuronides;     C11136  Etiocholan-3alpha-ol-17-one 3-glucuronide,CAS: 3602-09-3; PubChem: 13318; ChEBI: 37451; LIPIDMAPS: LMST05010014; 3DMET: B04210; NIKKAJI: J1.437.459K,cpd:C11135; cpd:C11136,25,38,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H39O8,C25H37O8,466.2566682,467.2644932,465.2488431559,647,cpd:C13712,Allopregnanolone;,C21H34O2,Allopregnanolone; 3alpha-Hydroxy-5alpha-pregnan-20-one; 3alpha-OH DHP,R08957 R08959,Steroid hormone biosynthesis,1.1.1.149; 1.1.1.213,NA,NA,CAS: 516-54-1; PubChem: 586301; ChEMBL: CHEMBL207538 CHEMBL38856 CHEMBL435035; LIPIDMAPS: LMST02030130 LMST02030156; NIKKAJI: J6.315K,cpd:C05480; cpd:C10770; cpd:C11825; cpd:C13712; cpd:C15099; cpd:C15264; cpd:C15484; cpd:C18041,21,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H35O2,C21H33O2,318.2558803,319.2637054,317.2480553560,648,cpd:C13713,Allotetrahydrodeoxycorticosterone;,C21H34O3,"Allotetrahydrodeoxycorticosterone; 5alpha-THDOC; 3alpha,21-Dihydroxy-5alpha-pregnan-20-one",R08955,Steroid hormone biosynthesis,1.1.1.213,NA,NA,CAS: 567-02-2; PubChem: 586302; ChEBI: 34461; ChEMBL: CHEMBL1256760 CHEMBL288464 CHEMBL76857; LIPIDMAPS: LMST05030013; NIKKAJI: J188.433F,cpd:C13713; cpd:C14608; cpd:C14609; cpd:C14978; cpd:C15137; cpd:C15139; cpd:C15391,21,34,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H35O3,C21H33O3,334.250795,335.25862,333.2429699561,649,cpd:C18038,7alpha-Hydroxypregnenolone;,C21H32O3,"7alpha-Hydroxypregnenolone; 3beta,7alpha-Dihydroxy-5-pregnen-20-one",R08943,Steroid hormone biosynthesis,1.14.14.29,NA,NA,PubChem: 96024258; ChEBI: 81467; NIKKAJI: J704.244B,cpd:C04518; cpd:C05138; cpd:C05485; cpd:C06390; cpd:C07393; cpd:C08005; cpd:C13803; cpd:C15011; cpd:C15022; cpd:C15355; cpd:C15384; cpd:C15401; cpd:C15405; cpd:C18038; cpd:C18040,21,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O3,C21H31O3,332.2351449,333.2429699,331.2273199562,650,cpd:C18039,Aldosterone hemiacetal;,C21H28O5,"Aldosterone hemiacetal; 11beta,18-Epoxy-18,21-dihydroxypregn-4-ene-3,20-dione",R08953,Steroid hormone biosynthesis,NA,NA,NA,CAS: 6251-69-0; PubChem: 96024259; ChEBI: 30834; LIPIDMAPS: LMST02030145,cpd:C00762; cpd:C01780; cpd:C07178; cpd:C07369; cpd:C09846; cpd:C10723; cpd:C18039,21,28,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H29O5,C21H27O5,360.193674,361.201499,359.185849563,651,cpd:C18040,5alpha-Dihydrodeoxycorticosterone;,C21H32O3,"5alpha-Dihydrodeoxycorticosterone; 5alpha-Pregnan-21-ol-3,20-dione; Allopregnane-21-ol-3,20-dione",R08954 R08955,Steroid hormone biosynthesis,1.1.1.213; 1.3.1.22,NA,NA,CAS: 298-36-2; PubChem: 96024260; ChEBI: 81468; ChEMBL: CHEMBL40713; NIKKAJI: J322.211J,cpd:C04518; cpd:C05138; cpd:C05485; cpd:C06390; cpd:C07393; cpd:C08005; cpd:C13803; cpd:C15011; cpd:C15022; cpd:C15355; cpd:C15384; cpd:C15401; cpd:C15405; cpd:C18038; cpd:C18040,21,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O3,C21H31O3,332.2351449,333.2429699,331.2273199564,652,cpd:C18041,5alpha-Pregnan-20alpha-ol-3-one;,C21H34O2,5alpha-Pregnan-20alpha-ol-3-one; Allopregnan-20alpha-ol-3-one,R08958 R08960,Steroid hormone biosynthesis,1.1.1.149; 1.1.1.213,NA,NA,CAS: 516-59-6; PubChem: 96024261; ChEBI: 81469,cpd:C05480; cpd:C10770; cpd:C11825; cpd:C13712; cpd:C15099; cpd:C15264; cpd:C15484; cpd:C18041,21,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H35O2,C21H33O2,318.2558803,319.2637054,317.2480553565,653,cpd:C18042,"5alpha-Pregnane-3alpha,20alpha-diol;",C21H36O2,"5alpha-Pregnane-3alpha,20alpha-diol; Allopregnane-3alpha,20alpha-diol",R08959 R08960,Steroid hormone biosynthesis,1.1.1.149; 1.1.1.213,NA,NA,CAS: 566-58-5; PubChem: 96024262; ChEBI: 81470; ChEMBL: CHEMBL1790205,cpd:C05484; cpd:C10809; cpd:C14878; cpd:C14982; cpd:C15047; cpd:C15198; cpd:C18042,21,36,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H37O2,C21H35O2,320.2715304,321.2793554,319.2637054566,654,cpd:C18043,Cholesterol sulfate;,C27H46O4S,Cholesterol sulfate; Cholest-5-en-3beta-ol sulfate,R08941 R08977,Steroid hormone biosynthesis,2.8.2.2; 2.8.2.14; 3.1.6.2,NA,NA,CAS: 1256-86-6; PubChem: 96024263; ChEBI: 41321; LIPIDMAPS: LMST05020016; PDB-CCD: C3S; NIKKAJI: J324.075D,cpd:C18043,27,46,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O4S1,C27H45O4S1,466.3116811,467.3195062,465.3038561567,655,cpd:C18044,3beta-Hydroxypregn-5-en-20-one sulfate;,C21H32O5S,3beta-Hydroxypregn-5-en-20-one sulfate; Pregnenolone sulfate,R08942 R08978,Steroid hormone biosynthesis,2.8.2.2; 2.8.2.14; 3.1.6.2,NA,NA,CAS: 1247-64-9; PubChem: 96024264; ChEBI: 35420; ChEMBL: CHEMBL1179605 CHEMBL1330831; LIPIDMAPS: LMST05020014; NIKKAJI: J468.821J,cpd:C18044,21,32,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O5S1,C21H31O5S1,396.1970453,397.2048703,395.1892203568,656,cpd:C18045,7alpha-Hydroxydehydroepiandrosterone;,C19H28O3,"7alpha-Hydroxydehydroepiandrosterone; 7alpha-OH-DHEA; 3beta,7alpha-Dihydroxy-5-androstene-17-one",R08961,Steroid hormone biosynthesis,1.14.14.23,NA,NA,CAS: 53-00-9; PubChem: 96024265; ChEBI: 81471; ChEMBL: CHEMBL1079392; LIPIDMAPS: LMST02020101; NIKKAJI: J575.713D,cpd:C05139; cpd:C05291; cpd:C05294; cpd:C14497; cpd:C14552; cpd:C14600; cpd:C14627; cpd:C14649; cpd:C14671; cpd:C14912; cpd:C15144; cpd:C15286; cpd:C15306; cpd:C15332; cpd:C15416; cpd:C18045; cpd:C18075; cpd:C21296,19,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O3,C19H27O3,304.2038448,305.2116698,303.1960197569,657,cpd:C18075,"11beta,17beta-Dihydroxy-4-androsten-3-one;",C19H28O3,"11beta,17beta-Dihydroxy-4-androsten-3-one; 11beta-Hydroxytestosterone",R08945 R08980,Steroid hormone biosynthesis,1.1.1.62,NA,NA,CAS: 1816-85-9; PubChem: 96024292; ChEBI: 81481; ChEMBL: CHEMBL486718; NIKKAJI: J337.158A,cpd:C05139; cpd:C05291; cpd:C05294; cpd:C14497; cpd:C14552; cpd:C14600; cpd:C14627; cpd:C14649; cpd:C14671; cpd:C14912; cpd:C15144; cpd:C15286; cpd:C15306; cpd:C15332; cpd:C15416; cpd:C18045; cpd:C18075; cpd:C21296,19,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O3,C19H27O3,304.2038448,305.2116698,303.1960197570,659,cpd:C00002,ATP;,C10H16N5O13P3,ATP; Adenosine 5'-triphosphate,R00002 R00076 R00085 R00086 R00087 R00088 R00089 R00104; R00105 R00124 R00126 R00127 R00128 R00129 R00130 R00137; R00139 R00140 R00141 R00149 R00150 R00156 R00158 R00161; R00162 R00174 R00177 R00184 R00185 R00189 R00199 R00200; R00206 R00229 R00235 R00239 R00241 R00251 R00253 R00257; R00283 R00299 R00315 R00316 R00330 R00331 R00332 R00334; R00341 R00344 R00352 R00381 R00389 R00390 R00405 R00429; R00435 R00436 R00480 R00482 R00483 R00497 R00509 R00512; R00513 R00518 R00529 R00549 R00554 R00570 R00571 R00573; R00575 R00578 R00616 R00617 R00619 R00686 R00722 R00735; R00742 R00756 R00760 R00774 R00847 R00866 R00867 R00894; R00910 R00912 R00920 R00925 R00942 R00943 R00948 R00949; R00964 R00982 R01011 R01021 R01049 R01050 R01051 R01053; R01059 R01071 R01074 R01075 R01092 R01121 R01131 R01137; R01150 R01164 R01176 R01201 R01228 R01230 R01231 R01256; R01280 R01300 R01322 R01326 R01353 R01354 R01357 R01395; R01406 R01407 R01417 R01422 R01441 R01468 R01476 R01490; R01492 R01495 R01504 R01512 R01514 R01523 R01526 R01541; R01547 R01558 R01567 R01573 R01585 R01598 R01600 R01616; R01618 R01639 R01654 R01665 R01666 R01688 R01723 R01724; R01737 R01754 R01771 R01786 R01843 R01844 R01857 R01859; R01881 R01888 R01901 R01902 R01909 R01917 R01926 R01943; R01954 R01961 R01967 R01980 R01991 R02014 R02071 R02089; R02090 R02093 R02094 R02098 R02099 R02134 R02136 R02184; R02194 R02221 R02225 R02226 R02227 R02237 R02238 R02240; R02245 R02255 R02301 R02303 R02324 R02326 R02331 R02402; R02404 R02412 R02430 R02439 R02451 R02473 R02493 R02539; R02575 R02584 R02625 R02626 R02649 R02650 R02658 R02664; R02699 R02705 R02711 R02718 R02732 R02741 R02750 R02757; R02758 R02783 R02786 R02788 R02794 R02848 R02865 R02884; R02903 R02918 R02927 R02929 R02971 R02976 R02980 R02986; R03005 R03014 R03018 R03035 R03038 R03095 R03098 R03150; R03157 R03161 R03182 R03187 R03193 R03209 R03236 R03241; R03245 R03258 R03272 R03274 R03286 R03298 R03315 R03347; R03361 R03362 R03383 R03384 R03387 R03395 R03428 R03429; R03433 R03449 R03469 R03471 R03473 R03478 R03479 R03494; R03503 R03516 R03530 R03576 R03595 R03607 R03613 R03631; R03632 R03646 R03647 R03648 R03650 R03651 R03652 R03654; R03655 R03656 R03657 R03658 R03659 R03660 R03661 R03662; R03663 R03664 R03665 R03691 R03744 R03754 R03766 R03770; R03780 R03785 R03819 R03822 R03840 R03876 R03877 R03905; R03920 R03932 R03939 R03944 R04002 R04023 R04030 R04036; R04068 R04126 R04138 R04143 R04144 R04157 R04208 R04212; R04230 R04235 R04241 R04267 R04274 R04275 R04358 R04369; R04385 R04388 R04391 R04401 R04403 R04448 R04449 R04463; R04504 R04507 R04509 R04545 R04555 R04562 R04563 R04573; R04580 R04582 R04589 R04591 R04604 R04617 R04657 R04730; R04771 R04773 R04779 R04870 R04928 R04929 R05030 R05185; R05186 R05193 R05197 R05202 R05220 R05221 R05224 R05225; R05227 R05451 R05452 R05453 R05467 R05496 R05537 R05577; R05578 R05620 R05625 R05626 R05634 R05644 R05646 R05661; R05668 R05735 R05744 R05795 R05799 R05800 R05801 R05802; R05803 R05806 R05815 R06176 R06282 R06367 R06368 R06396; R06409 R06410 R06515 R06529 R06531 R06583 R06588 R06731; R06746 R06751 R06777 R06778 R06836 R06944 R06974 R06975; R06976 R07127 R07268 R07279 R07302 R07325 R07404 R07414; R07416 R07459 R07640 R07641 R07642 R07643 R07644 R07646; R07770 R07828 R07887 R08051 R08088 R08117 R08124 R08154; R08201 R08217 R08218 R08223 R08232 R08233 R08241 R08242; R08244 R08323 R08352 R08353 R08354 R08355 R08572 R08576; R08578 R08700 R08733 R08738 R08743 R08844 R08855 R08872; R08905 R08906 R08924 R08962 R08964 R08967 R08968 R09047; R09053 R09060 R09087 R09195 R09279 R09286 R09378 R09379; R09382 R09386 R09401 R09475 R09588 R09589 R09590 R09591; R09592 R09593 R09594 R09595 R09596 R09597 R09598 R09599; R09640 R09675 R09726 R09729 R09767 R09770 R09775 R09776; R09879 R09880 R09945 R09946 R09978 R10003 R10011 R10065; R10090 R10091 R10093 R10185 R10288 R10342 R10453 R10462; R10463 R10470 R10495 R10496 R10531 R10541 R10548 R10556; R10561 R10657 R10661 R10677 R10678 R10679 R10693 R10758; R10767 R10768 R10769 R10770 R10771 R10772 R10779 R10780; R10820 R10821 R10880 R10892 R10901 R10902 R10909 R10910; R10929 R10930 R10940 R10941 R10942 R10943 R10944 R10948; R10951 R10953 R10970 R10993 R10994 R11024 R11039 R11064; R11084 R11085 R11090 R11143 R11183 R11184 R11185 R11207; R11234 R11279 R11367 R11370 R11392 R11400 R11406 R11460; R11461 R11515 R11531 R11536 R11537 R11538 R11553 R11554,Oxidative phosphorylation; Photosynthesis; Purine metabolism; Puromycin biosynthesis; Zeatin biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Bacterial secretion system; Calcium signaling pathway; HIF-1 signaling pathway; Neuroactive ligand-receptor interaction; Lysosome; Platelet activation; NOD-like receptor signaling pathway; Synaptic vesicle cycle; Taste transduction; Inflammatory mediator regulation of TRP channels; Insulin secretion; Prolactin signaling pathway; Renin secretion; Type II diabetes mellitus; Parkinson's disease; Pertussis; Hypertrophic cardiomyopathy (HCM),1.2.1.30; 1.2.1.31; 1.3.7.7; 1.3.7.8; 1.3.7.14; 1.3.7.15; 1.13.12.7; 1.17.4.2; 1.18.6.1; 1.19.6.1; 1.-.-.-; 2.1.2.-; 2.3.3.8; 2.4.2.17; 2.4.2.52; 2.5.1.6; 2.5.1.17; 2.5.1.112; 2.7.1.1; 2.7.1.2; 2.7.1.3; 2.7.1.4; 2.7.1.5; 2.7.1.6; 2.7.1.7; 2.7.1.8; 2.7.1.10; 2.7.1.11; 2.7.1.12; 2.7.1.13; 2.7.1.14; 2.7.1.15; 2.7.1.16; 2.7.1.17; 2.7.1.18; 2.7.1.19; 2.7.1.20; 2.7.1.21; 2.7.1.22; 2.7.1.23; 2.7.1.24; 2.7.1.25; 2.7.1.26; 2.7.1.27; 2.7.1.28; 2.7.1.29; 2.7.1.30; 2.7.1.31; 2.7.1.32; 2.7.1.33; 2.7.1.34; 2.7.1.35; 2.7.1.36; 2.7.1.39; 2.7.1.40; 2.7.1.43; 2.7.1.44; 2.7.1.45; 2.7.1.46; 2.7.1.47; 2.7.1.48; 2.7.1.49; 2.7.1.50; 2.7.1.51; 2.7.1.52; 2.7.1.53; 2.7.1.54; 2.7.1.55; 2.7.1.56; 2.7.1.58; 2.7.1.59; 2.7.1.60; 2.7.1.64; 2.7.1.65; 2.7.1.66; 2.7.1.67; 2.7.1.68; 2.7.1.71; 2.7.1.72; 2.7.1.73; 2.7.1.74; 2.7.1.76; 2.7.1.78; 2.7.1.82; 2.7.1.83; 2.7.1.84; 2.7.1.85; 2.7.1.86; 2.7.1.87; 2.7.1.88; 2.7.1.89; 2.7.1.91; 2.7.1.92; 2.7.1.93; 2.7.1.94; 2.7.1.95; 2.7.1.100; 2.7.1.101; 2.7.1.102; 2.7.1.103; 2.7.1.105; 2.7.1.107; 2.7.1.113; 2.7.1.119; 2.7.1.122; 2.7.1.127; 2.7.1.130; 2.7.1.134; 2.7.1.136; 2.7.1.137; 2.7.1.138; 2.7.1.140; 2.7.1.144; 2.7.1.145; 2.7.1.148; 2.7.1.149; 2.7.1.150; 2.7.1.151; 2.7.1.153; 2.7.1.154; 2.7.1.156; 2.7.1.157; 2.7.1.158; 2.7.1.159; 2.7.1.162; 2.7.1.163; 2.7.1.164; 2.7.1.165; 2.7.1.166; 2.7.1.167; 2.7.1.168; 2.7.1.169; 2.7.1.170; 2.7.1.173; 2.7.1.175; 2.7.1.176; 2.7.1.177; 2.7.1.178; 2.7.1.179; 2.7.1.181; 2.7.1.183; 2.7.1.184; 2.7.1.185; 2.7.1.186; 2.7.1.187; 2.7.1.188; 2.7.1.189; 2.7.1.209; 2.7.1.210; 2.7.1.213; 2.7.1.214; 2.7.1.215; 2.7.1.-; 2.7.2.1; 2.7.2.2; 2.7.2.3; 2.7.2.4; 2.7.2.6; 2.7.2.7; 2.7.2.8; 2.7.2.11; 2.7.2.13; 2.7.2.14; 2.7.2.15; 2.7.2.-; 2.7.3.1; 2.7.3.2; 2.7.3.3; 2.7.3.4; 2.7.3.5; 2.7.3.6; 2.7.3.7; 2.7.3.8; 2.7.3.10; 2.7.4.1; 2.7.4.2; 2.7.4.3; 2.7.4.4; 2.7.4.6; 2.7.4.7; 2.7.4.8; 2.7.4.9; 2.7.4.11; 2.7.4.12; 2.7.4.13; 2.7.4.14; 2.7.4.15; 2.7.4.16; 2.7.4.18; 2.7.4.19; 2.7.4.21; 2.7.4.22; 2.7.4.23; 2.7.4.24; 2.7.4.25; 2.7.4.26; 2.7.4.31; 2.7.4.-; 2.7.6.1; 2.7.6.2; 2.7.6.3; 2.7.6.4; 2.7.6.5; 2.7.7.1; 2.7.7.2; 2.7.7.3; 2.7.7.4; 2.7.7.6; 2.7.7.18; 2.7.7.19; 2.7.7.27; 2.7.7.42; 2.7.7.46; 2.7.7.47; 2.7.7.48; 2.7.7.53; 2.7.7.58; 2.7.7.70; 2.7.7.72; 2.7.7.73; 2.7.7.75; 2.7.7.80; 2.7.7.84; 2.7.7.85; 2.7.7.86; 2.7.7.87; 2.7.7.94; 2.7.7.96; 2.7.7.97; 2.7.8.37; 2.7.9.1; 2.7.9.2; 2.7.9.3; 2.7.9.-; 2.7.10.1; 2.7.10.2; 2.7.11.1; 2.7.11.2; 2.7.11.3; 2.7.11.4; 2.7.11.5; 2.7.11.6; 2.7.11.7; 2.7.11.8; 2.7.11.9; 2.7.11.10; 2.7.11.11; 2.7.11.12; 2.7.11.13; 2.7.11.14; 2.7.11.15; 2.7.11.17; 2.7.11.18; 2.7.11.19; 2.7.11.21; 2.7.11.22; 2.7.11.23; 2.7.11.24; 2.7.11.25; 2.7.11.26; 2.7.11.27; 2.7.11.28; 2.7.11.29; 2.7.11.30; 2.7.11.31; 2.7.12.1; 2.7.12.2; 2.7.13.1; 2.7.13.2; 2.7.14.1; 2.8.1.13; 3.5.2.9; 3.5.2.14; 3.5.4.17; 3.5.4.18; 3.6.1.3; 3.6.1.5; 3.6.1.8; 3.6.1.9; 3.6.1.14; 3.6.1.15; 3.6.1.17; 3.6.1.61; 3.6.3.1; 3.6.3.2; 3.6.3.3; 3.6.3.4; 3.6.3.5; 3.6.3.6; 3.6.3.7; 3.6.3.8; 3.6.3.9; 3.6.3.10; 3.6.3.11; 3.6.3.12; 3.6.3.14; 3.6.3.15; 3.6.3.16; 3.6.3.17; 3.6.3.18; 3.6.3.19; 3.6.3.20; 3.6.3.21; 3.6.3.22; 3.6.3.23; 3.6.3.24; 3.6.3.25; 3.6.3.26; 3.6.3.27; 3.6.3.28; 3.6.3.29; 3.6.3.30; 3.6.3.31; 3.6.3.32; 3.6.3.33; 3.6.3.34; 3.6.3.35; 3.6.3.36; 3.6.3.37; 3.6.3.38; 3.6.3.39; 3.6.3.40; 3.6.3.41; 3.6.3.42; 3.6.3.43; 3.6.3.44; 3.6.3.46; 3.6.3.47; 3.6.3.48; 3.6.3.49; 3.6.3.50; 3.6.3.51; 3.6.3.52; 3.6.3.53; 3.6.3.54; 3.6.3.55; 3.6.4.1; 3.6.4.2; 3.6.4.3; 3.6.4.4; 3.6.4.5; 3.6.4.6; 3.6.4.7; 3.6.4.8; 3.6.4.9; 3.6.4.10; 3.6.4.11; 3.6.4.12; 3.6.4.13; 4.1.1.33; 4.1.1.49; 4.1.1.99; 4.2.1.93; 4.6.1.1; 4.6.1.-; 5.1.1.11; 6.1.1.1; 6.1.1.2; 6.1.1.3; 6.1.1.4; 6.1.1.5; 6.1.1.6; 6.1.1.7; 6.1.1.9; 6.1.1.10; 6.1.1.11; 6.1.1.12; 6.1.1.13; 6.1.1.14; 6.1.1.15; 6.1.1.16; 6.1.1.17; 6.1.1.18; 6.1.1.19; 6.1.1.20; 6.1.1.21; 6.1.1.22; 6.1.1.23; 6.1.1.24; 6.1.1.26; 6.1.1.27; 6.1.2.1; 6.1.2.2; 6.2.1.1; 6.2.1.2; 6.2.1.3; 6.2.1.5; 6.2.1.6; 6.2.1.7; 6.2.1.8; 6.2.1.9; 6.2.1.11; 6.2.1.12; 6.2.1.13; 6.2.1.14; 6.2.1.15; 6.2.1.16; 6.2.1.17; 6.2.1.18; 6.2.1.19; 6.2.1.20; 6.2.1.22; 6.2.1.23; 6.2.1.24; 6.2.1.25; 6.2.1.26; 6.2.1.27; 6.2.1.28; 6.2.1.30; 6.2.1.31; 6.2.1.32; 6.2.1.33; 6.2.1.34; 6.2.1.35; 6.2.1.36; 6.2.1.37; 6.2.1.38; 6.2.1.39; 6.2.1.40; 6.2.1.41; 6.2.1.42; 6.2.1.43; 6.2.1.44; 6.2.1.46; 6.2.1.-; 6.3.1.1; 6.3.1.2; 6.3.1.4; 6.3.1.5; 6.3.1.6; 6.3.1.7; 6.3.1.8; 6.3.1.9; 6.3.1.10; 6.3.1.11; 6.3.1.12; 6.3.1.13; 6.3.1.14; 6.3.1.15; 6.3.1.17; 6.3.1.18; 6.3.1.19; 6.3.1.20; 6.3.2.1; 6.3.2.2; 6.3.2.3; 6.3.2.4; 6.3.2.5; 6.3.2.6; 6.3.2.7; 6.3.2.8; 6.3.2.9; 6.3.2.10; 6.3.2.11; 6.3.2.12; 6.3.2.13; 6.3.2.14; 6.3.2.16; 6.3.2.17; 6.3.2.18; 6.3.2.20; 6.3.2.23; 6.3.2.24; 6.3.2.25; 6.3.2.26; 6.3.2.29; 6.3.2.30; 6.3.2.32; 6.3.2.33; 6.3.2.35; 6.3.2.36; 6.3.2.37; 6.3.2.38; 6.3.2.39; 6.3.2.40; 6.3.2.41; 6.3.2.42; 6.3.2.43; 6.3.2.44; 6.3.2.45; 6.3.2.46; 6.3.2.47; 6.3.2.48; 6.3.2.49; 6.3.2.-; 6.3.3.1; 6.3.3.2; 6.3.3.3; 6.3.3.4; 6.3.3.5; 6.3.3.6; 6.3.4.2; 6.3.4.3; 6.3.4.5; 6.3.4.6; 6.3.4.7; 6.3.4.8; 6.3.4.9; 6.3.4.10; 6.3.4.11; 6.3.4.12; 6.3.4.13; 6.3.4.14; 6.3.4.15; 6.3.4.16; 6.3.4.17; 6.3.4.18; 6.3.4.19; 6.3.4.20; 6.3.4.21; 6.3.4.22; 6.3.4.23; 6.3.4.24; 6.3.5.1; 6.3.5.2; 6.3.5.3; 6.3.5.4; 6.3.5.5; 6.3.5.6; 6.3.5.7; 6.3.5.9; 6.3.5.10; 6.3.5.11; 6.3.5.-; 6.4.1.1; 6.4.1.2; 6.4.1.3; 6.4.1.4; 6.4.1.5; 6.4.1.6; 6.4.1.7; 6.4.1.8; 6.5.1.1; 6.5.1.3; 6.5.1.4; 6.5.1.6; 6.5.1.7; 6.6.1.1; 6.6.1.2,"Adenine ribonucleotide biosynthesis, IMP => ADP,ATP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00002  ATP;  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00002  ATP; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01E OTHER CARDIAC PREPARATIONS;     C01EB Other cardiac preparations;      C01EB10 Adenosine;       D08646  Triphosadenine (DCF); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Adenosinetriphosphoric acid;     D08646  Triphosadenine (DCF),CAS: 56-65-5; PubChem: 3304; ChEBI: 15422; ChEMBL: CHEMBL14249 CHEMBL605638; KNApSAcK: C00001491; PDB-CCD: ATP; 3DMET: B01125; NIKKAJI: J10.680A,cpd:C00002; cpd:C00286; cpd:C01806; cpd:C19969,10,16,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O13N5P3,C10H15O13N5P3,506.9957466,508.0035716,505.9879216571,660,cpd:C00003,NAD+;,C21H28N7O14P2,NAD+; NAD; Nicotinamide adenine dinucleotide; DPN; Diphosphopyridine nucleotide; Nadide; beta-NAD+,R00023 R00090 R00091 R00092 R00093 R00094 R00095 R00097; R00099 R00100 R00101 R00102 R00103 R00104 R00112 R00118; R00137 R00143 R00145 R00189 R00203 R00209 R00214 R00215; R00228 R00243 R00245 R00257 R00281 R00286 R00300 R00342; R00365 R00368 R00382 R00384 R00396 R00398 R00402 R00421; R00445 R00446 R00501 R00519 R00538 R00555 R00562 R00581; R00604 R00605 R00623 R00624 R00631 R00675 R00688 R00700; R00703 R00704 R00705 R00707 R00709 R00710 R00713 R00715; R00717 R00732 R00754 R00758 R00787 R00794 R00812 R00813; R00818 R00823 R00842 R00868 R00875 R00880 R00892 R00904; R00906 R00922 R00935 R00936 R00937 R00977 R00994 R01000; R01033 R01034 R01036 R01061 R01088 R01093 R01094 R01130; R01142 R01158 R01163 R01171 R01172 R01183 R01202 R01210; R01211 R01218 R01221 R01246 R01248 R01258 R01277 R01293; R01296 R01297 R01308 R01333 R01337 R01361 R01370 R01388; R01403 R01414 R01419 R01426 R01429 R01434 R01446 R01451; R01465 R01486 R01487 R01505 R01513 R01520 R01524 R01542; R01574 R01604 R01608 R01629 R01633 R01636 R01644 R01651; R01681 R01683 R01689 R01698 R01704 R01707 R01728 R01735; R01738 R01745 R01749 R01752 R01757 R01758 R01763 R01768; R01773 R01778 R01781 R01793 R01825 R01836 R01837 R01869; R01872 R01895 R01896 R01903 R01921 R01932 R01933 R01934; R01937 R01971 R01975 R01981 R01998 R02000 R02032 R02039; R02047 R02081 R02103 R02123 R02124 R02163 R02196 R02201; R02207 R02216 R02229 R02235 R02246 R02252 R02257 R02258; R02313 R02343 R02344 R02347 R02352 R02354 R02377 R02383; R02391 R02395 R02401 R02434 R02441 R02450 R02454 R02455; R02462 R02471 R02476 R02492 R02499 R02514 R02515 R02527; R02531 R02536 R02544 R02545 R02549 R02553 R02555 R02559; R02561 R02565 R02580 R02589 R02611 R02618 R02637 R02640; R02651 R02655 R02678 R02679 R02683 R02695 R02698 R02703; R02762 R02766 R02792 R02819 R02823 R02830 R02834 R02840; R02847 R02855 R02878 R02896 R02928 R02935 R02940 R02941; R02944 R02945 R02946 R02957 R02964 R02968 R02969 R02988; R02993 R02994 R03012 R03021 R03022 R03023 R03043 R03048; R03080 R03082 R03088 R03102 R03104 R03119 R03171 R03176; R03177 R03191 R03198 R03226 R03251 R03261 R03278 R03279; R03283 R03290 R03291 R03299 R03300 R03306 R03317 R03327; R03336 R03337 R03349 R03369 R03373 R03381 R03385 R03391; R03396 R03397 R03406 R03431 R03439 R03447 R03475 R03476; R03497 R03506 R03543 R03544 R03559 R03577 R03582 R03584; R03591 R03614 R03630 R03637 R03643 R03707 R03709 R03732; R03733 R03745 R03759 R03761 R03763 R03787 R03790 R03792; R03815 R03816 R03826 R03847 R03863 R03869 R03882 R03886; R03889 R03913 R03942 R03945 R03947 R03963 R03964 R03998; R04046 R04049 R04065 R04066 R04074 R04088 R04102 R04115; R04123 R04130 R04139 R04142 R04151 R04163 R04176 R04185; R04198 R04200 R04203 R04210 R04228 R04236 R04263 R04278; R04304 R04307 R04309 R04330 R04339 R04366 R04375 R04412; R04418 R04426 R04429 R04444 R04483 R04501 R04506 R04517; R04524 R04556 R04598 R04600 R04678 R04681 R04687 R04724; R04737 R04739 R04741 R04743 R04745 R04748 R04805 R04810; R04812 R04818 R04824 R04829 R04831 R04832 R04834 R04835; R04837 R04842 R04844 R04845 R04847 R04849 R04862 R04876; R04880 R04882 R04888 R04891 R04903 R04916 R04955 R04958; R04961 R04966 R04969 R04996 R05049 R05050 R05051 R05066; R05119 R05147 R05148 R05154 R05156 R05157 R05158 R05217; R05232 R05233 R05234 R05235 R05236 R05239 R05240 R05241; R05243 R05247 R05261 R05263 R05266 R05271 R05272 R05273; R05274 R05275 R05281 R05282 R05283 R05286 R05288 R05290; R05292 R05294 R05305 R05307 R05309 R05310 R05311 R05312; R05313 R05314 R05315 R05321 R05322 R05347 R05348 R05349; R05351 R05352 R05353 R05354 R05355 R05395 R05397 R05399; R05414 R05417 R05418 R05422 R05423 R05425 R05426 R05428; R05429 R05430 R05431 R05434 R05435 R05437 R05439 R05440; R05442 R05443 R05444 R05448 R05450 R05487 R05515 R05537; R05571 R05575 R05581 R05582 R05604 R05607 R05621 R05632; R05643 R05649 R05653 R05654 R05655 R05665 R05668 R05678; R05679 R05681 R05683 R05685 R05689 R05690 R05693 R05699; R05700 R05705 R05715 R05724 R05729 R05730 R05733 R05734; R05746 R05812 R05831 R05837 R05843 R05875 R06117 R06180; R06289 R06357 R06366 R06376 R06377 R06378 R06379 R06382; R06383 R06384 R06385 R06398 R06399 R06406 R06407 R06408; R06413 R06438 R06594 R06621 R06782 R06783 R06784 R06785; R06786 R06787 R06831 R06832 R06847 R06848 R06856 R06857; R06883 R06884 R06888 R06891 R06894 R06909 R06910 R06914; R06915 R06916 R06917 R06918 R06919 R06926 R06927 R06928; R06930 R06931 R06935 R06936 R06937 R06939 R06941 R06945; R06954 R06980 R06983 R07058 R07104 R07105 R07133 R07134; R07135 R07136 R07141 R07145 R07148 R07156 R07164 R07168; R07171 R07188 R07194 R07326 R07345 R07349 R07351 R07354; R07358 R07410 R07417 R07428 R07441 R07477 R07478 R07530; R07558 R07559 R07561 R07562 R07568 R07569 R07570 R07572; R07618 R07658 R07665 R07667 R07675 R07703 R07704 R07705; R07706 R07709 R07765 R07781 R07799 R07851 R07890 R07894; R07898 R07936 R07952 R07954 R07955 R07957 R07959 R07961; R07963 R07965 R07967 R07969 R07971 R07973 R07975 R07985; R08017 R08018 R08042 R08043 R08044 R08045 R08046 R08047; R08086 R08087 R08094 R08096 R08100 R08101 R08103 R08104; R08105 R08108 R08109 R08110 R08111 R08112 R08113 R08140; R08141 R08146 R08198 R08214 R08215 R08240 R08281 R08282; R08306 R08307 R08310 R08382 R08385 R08536 R08544 R08549; R08550 R08557 R08569 R08590 R08621 R08625 R08629 R08636; R08642 R08646 R08709 R08721 R08723 R08724 R08728 R08764; R08767 R08846 R08892 R08914 R08916 R08918 R08919 R08926; R08945 R09055 R09069 R09078 R09097 R09129 R09130 R09132; R09137 R09141 R09148 R09151 R09152 R09159 R09160 R09162; R09165 R09183 R09201 R09204 R09209 R09213 R09219 R09223; R09224 R09227 R09228 R09230 R09231 R09232 R09233 R09235; R09236 R09288 R09312 R09375 R09385 R09388 R09447 R09472; R09477 R09478 R09484 R09498 R09508 R09513 R09514 R09524; R09544 R09545 R09561 R09567 R09586 R09662 R09747 R09748; R09750 R09783 R09786 R09805 R09830 R09859 R09860 R09920; R09922 R09923 R09924 R09925 R09951 R09953 R09956 R09957; R09981 R09984 R09986 R09988 R10012 R10021 R10042 R10043; R10048 R10052 R10054 R10057 R10106 R10107 R10108 R10113; R10125 R10126 R10128 R10129 R10131 R10140 R10146 R10156; R10161 R10163 R10189 R10190 R10217 R10218 R10221 R10222; R10301 R10308 R10310 R10311 R10325 R10332 R10412 R10419; R10420 R10422 R10428 R10459 R10467 R10502 R10504 R10505; R10517 R10519 R10520 R10565 R10592 R10629 R10633 R10634; R10635 R10685 R10690 R10702 R10703 R10715 R10717 R10718; R10719 R10783 R10785 R10790 R10798 R10800 R10841 R10842; R10848 R10860 R10861 R10907 R10916 R10917 R10918 R10981; R10985 R10986 R10995 R11007 R11026 R11031 R11035 R11036; R11056 R11067 R11091 R11092 R11093 R11121 R11144 R11147; R11149 R11150 R11151 R11153 R11155 R11156 R11158 R11197; R11231 R11243 R11265 R11290 R11336 R11337 R11338 R11339; R11342 R11346 R11347 R11350 R11355 R11356 R11357 R11373; R11374 R11382 R11384 R11424 R11448 R11471 R11472 R11504; R11505 R11578,Oxidative phosphorylation; Thiamine metabolism; Nicotinate and nicotinamide metabolism; Metabolic pathways; AMPK signaling pathway; Longevity regulating pathway; Longevity regulating pathway - worm; Aldosterone synthesis and secretion; Vitamin digestion and absorption,1.1.1.1; 1.1.1.3; 1.1.1.4; 1.1.1.6; 1.1.1.7; 1.1.1.8; 1.1.1.9; 1.1.1.11; 1.1.1.12; 1.1.1.13; 1.1.1.14; 1.1.1.15; 1.1.1.16; 1.1.1.17; 1.1.1.18; 1.1.1.21; 1.1.1.22; 1.1.1.23; 1.1.1.24; 1.1.1.26; 1.1.1.27; 1.1.1.28; 1.1.1.29; 1.1.1.30; 1.1.1.31; 1.1.1.32; 1.1.1.35; 1.1.1.37; 1.1.1.38; 1.1.1.39; 1.1.1.41; 1.1.1.43; 1.1.1.45; 1.1.1.46; 1.1.1.47; 1.1.1.48; 1.1.1.50; 1.1.1.51; 1.1.1.52; 1.1.1.53; 1.1.1.56; 1.1.1.57; 1.1.1.58; 1.1.1.59; 1.1.1.60; 1.1.1.61; 1.1.1.62; 1.1.1.66; 1.1.1.67; 1.1.1.69; 1.1.1.71; 1.1.1.72; 1.1.1.73; 1.1.1.75; 1.1.1.76; 1.1.1.77; 1.1.1.78; 1.1.1.79; 1.1.1.81; 1.1.1.83; 1.1.1.84; 1.1.1.85; 1.1.1.87; 1.1.1.88; 1.1.1.90; 1.1.1.92; 1.1.1.93; 1.1.1.94; 1.1.1.95; 1.1.1.96; 1.1.1.98; 1.1.1.99; 1.1.1.103; 1.1.1.104; 1.1.1.105; 1.1.1.106; 1.1.1.107; 1.1.1.108; 1.1.1.110; 1.1.1.111; 1.1.1.112; 1.1.1.114; 1.1.1.116; 1.1.1.117; 1.1.1.118; 1.1.1.121; 1.1.1.122; 1.1.1.125; 1.1.1.127; 1.1.1.129; 1.1.1.130; 1.1.1.131; 1.1.1.132; 1.1.1.135; 1.1.1.136; 1.1.1.137; 1.1.1.140; 1.1.1.141; 1.1.1.143; 1.1.1.144; 1.1.1.145; 1.1.1.147; 1.1.1.148; 1.1.1.149; 1.1.1.150; 1.1.1.152; 1.1.1.154; 1.1.1.157; 1.1.1.159; 1.1.1.163; 1.1.1.164; 1.1.1.165; 1.1.1.166; 1.1.1.167; 1.1.1.170; 1.1.1.172; 1.1.1.173; 1.1.1.174; 1.1.1.175; 1.1.1.178; 1.1.1.181; 1.1.1.185; 1.1.1.186; 1.1.1.187; 1.1.1.190; 1.1.1.192; 1.1.1.196; 1.1.1.198; 1.1.1.199; 1.1.1.202; 1.1.1.203; 1.1.1.205; 1.1.1.209; 1.1.1.211; 1.1.1.212; 1.1.1.213; 1.1.1.218; 1.1.1.221; 1.1.1.222; 1.1.1.223; 1.1.1.226; 1.1.1.227; 1.1.1.228; 1.1.1.232; 1.1.1.233; 1.1.1.237; 1.1.1.239; 1.1.1.240; 1.1.1.241; 1.1.1.244; 1.1.1.245; 1.1.1.250; 1.1.1.251; 1.1.1.254; 1.1.1.255; 1.1.1.256; 1.1.1.257; 1.1.1.258; 1.1.1.259; 1.1.1.260; 1.1.1.261; 1.1.1.262; 1.1.1.264; 1.1.1.265; 1.1.1.268; 1.1.1.269; 1.1.1.275; 1.1.1.281; 1.1.1.282; 1.1.1.284; 1.1.1.285; 1.1.1.286; 1.1.1.288; 1.1.1.290; 1.1.1.291; 1.1.1.294; 1.1.1.295; 1.1.1.296; 1.1.1.297; 1.1.1.299; 1.1.1.301; 1.1.1.302; 1.1.1.303; 1.1.1.304; 1.1.1.305; 1.1.1.306; 1.1.1.307; 1.1.1.308; 1.1.1.309; 1.1.1.310; 1.1.1.311; 1.1.1.312; 1.1.1.315; 1.1.1.316; 1.1.1.322; 1.1.1.323; 1.1.1.326; 1.1.1.327; 1.1.1.328; 1.1.1.329; 1.1.1.331; 1.1.1.332; 1.1.1.333; 1.1.1.335; 1.1.1.336; 1.1.1.337; 1.1.1.339; 1.1.1.340; 1.1.1.343; 1.1.1.344; 1.1.1.345; 1.1.1.347; 1.1.1.350; 1.1.1.351; 1.1.1.352; 1.1.1.354; 1.1.1.356; 1.1.1.357; 1.1.1.359; 1.1.1.361; 1.1.1.363; 1.1.1.364; 1.1.1.366; 1.1.1.368; 1.1.1.369; 1.1.1.370; 1.1.1.373; 1.1.1.374; 1.1.1.375; 1.1.1.376; 1.1.1.378; 1.1.1.379; 1.1.1.380; 1.1.1.382; 1.1.1.383; 1.1.1.385; 1.1.1.386; 1.1.1.387; 1.1.1.388; 1.1.1.389; 1.1.1.390; 1.1.1.391; 1.1.1.394; 1.1.1.396; 1.1.1.397; 1.1.1.399; 1.1.1.400; 1.1.1.401; 1.1.1.403; 1.1.1.-; 1.1.-.-; 1.2.1.2; 1.2.1.3; 1.2.1.5; 1.2.1.8; 1.2.1.10; 1.2.1.12; 1.2.1.15; 1.2.1.16; 1.2.1.18; 1.2.1.19; 1.2.1.20; 1.2.1.21; 1.2.1.22; 1.2.1.23; 1.2.1.24; 1.2.1.25; 1.2.1.27; 1.2.1.28; 1.2.1.29; 1.2.1.31; 1.2.1.32; 1.2.1.33; 1.2.1.36; 1.2.1.39; 1.2.1.42; 1.2.1.46; 1.2.1.47; 1.2.1.48; 1.2.1.53; 1.2.1.54; 1.2.1.57; 1.2.1.58; 1.2.1.59; 1.2.1.60; 1.2.1.61; 1.2.1.62; 1.2.1.64; 1.2.1.65; 1.2.1.67; 1.2.1.68; 1.2.1.69; 1.2.1.71; 1.2.1.72; 1.2.1.73; 1.2.1.74; 1.2.1.78; 1.2.1.80; 1.2.1.82; 1.2.1.85; 1.2.1.86; 1.2.1.87; 1.2.1.88; 1.2.1.90; 1.2.1.92; 1.2.1.98; 1.2.1.-; 1.2.3.9; 1.2.4.1; 1.2.4.2; 1.2.4.-; 1.3.1.1; 1.3.1.5; 1.3.1.6; 1.3.1.7; 1.3.1.9; 1.3.1.11; 1.3.1.12; 1.3.1.14; 1.3.1.18; 1.3.1.19; 1.3.1.21; 1.3.1.24; 1.3.1.25; 1.3.1.28; 1.3.1.29; 1.3.1.31; 1.3.1.32; 1.3.1.41; 1.3.1.43; 1.3.1.44; 1.3.1.47; 1.3.1.48; 1.3.1.49; 1.3.1.53; 1.3.1.56; 1.3.1.58; 1.3.1.60; 1.3.1.62; 1.3.1.64; 1.3.1.65; 1.3.1.66; 1.3.1.67; 1.3.1.68; 1.3.1.74; 1.3.1.76; 1.3.1.77; 1.3.1.79; 1.3.1.87; 1.3.1.95; 1.3.1.98; 1.3.1.101; 1.3.1.105; 1.3.1.106; 1.3.1.107; 1.3.1.-; 1.4.1.1; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.5; 1.4.1.7; 1.4.1.8; 1.4.1.9; 1.4.1.10; 1.4.1.11; 1.4.1.12; 1.4.1.14; 1.4.1.15; 1.4.1.18; 1.4.1.19; 1.4.1.20; 1.4.1.21; 1.4.1.23; 1.4.1.24; 1.4.1.-; 1.4.4.2; 1.5.1.1; 1.5.1.2; 1.5.1.3; 1.5.1.7; 1.5.1.9; 1.5.1.11; 1.5.1.15; 1.5.1.17; 1.5.1.18; 1.5.1.20; 1.5.1.22; 1.5.1.23; 1.5.1.25; 1.5.1.26; 1.5.1.28; 1.5.1.34; 1.5.1.36; 1.5.1.37; 1.5.1.39; 1.5.1.41; 1.5.1.42; 1.5.1.44; 1.5.1.45; 1.5.1.47; 1.5.1.49; 1.5.1.-; 1.6.1.1; 1.6.1.2; 1.6.1.3; 1.6.2.2; 1.6.2.6; 1.6.3.1; 1.6.3.2; 1.6.3.3; 1.6.3.4; 1.6.3.5; 1.6.5.2; 1.6.5.3; 1.6.5.4; 1.6.5.7; 1.6.5.8; 1.6.5.9; 1.6.5.11; 1.6.5.-; 1.6.6.9; 1.6.99.3; 1.7.1.1; 1.7.1.2; 1.7.1.4; 1.7.1.5; 1.7.1.9; 1.7.1.10; 1.7.1.12; 1.7.1.14; 1.7.1.15; 1.7.1.-; 1.7.99.1; 1.8.1.3; 1.8.1.4; 1.8.1.6; 1.8.1.7; 1.8.1.8; 1.8.1.11; 1.8.1.15; 1.8.1.16; 1.8.1.17; 1.8.1.18; 1.11.1.1; 1.12.1.2; 1.12.1.4; 1.12.1.5; 1.13.11.29; 1.13.11.30; 1.13.11.-; 1.13.12.17; 1.13.12.-; 1.14.12.1; 1.14.12.3; 1.14.12.4; 1.14.12.7; 1.14.12.8; 1.14.12.9; 1.14.12.10; 1.14.12.11; 1.14.12.12; 1.14.12.13; 1.14.12.14; 1.14.12.15; 1.14.12.16; 1.14.12.17; 1.14.12.18; 1.14.12.19; 1.14.12.22; 1.14.12.23; 1.14.12.24; 1.14.12.25; 1.14.12.-; 1.14.13.1; 1.14.13.4; 1.14.13.5; 1.14.13.6; 1.14.13.10; 1.14.13.18; 1.14.13.19; 1.14.13.24; 1.14.13.25; 1.14.13.27; 1.14.13.29; 1.14.13.33; 1.14.13.40; 1.14.13.44; 1.14.13.61; 1.14.13.62; 1.14.13.63; 1.14.13.64; 1.14.13.69; 1.14.13.72; 1.14.13.82; 1.14.13.83; 1.14.13.107; 1.14.13.111; 1.14.13.113; 1.14.13.114; 1.14.13.127; 1.14.13.128; 1.14.13.129; 1.14.13.130; 1.14.13.131; 1.14.13.135; 1.14.13.141; 1.14.13.142; 1.14.13.151; 1.14.13.162; 1.14.13.163; 1.14.13.165; 1.14.13.172; 1.14.13.178; 1.14.13.179; 1.14.13.182; 1.14.13.196; 1.14.13.209; 1.14.13.210; 1.14.13.211; 1.14.13.212; 1.14.13.215; 1.14.13.216; 1.14.13.217; 1.14.13.218; 1.14.13.220; 1.14.13.222; 1.14.13.223; 1.14.13.224; 1.14.13.227; 1.14.13.230; 1.14.13.-; 1.14.14.1; 1.14.14.9; 1.14.15.3; 1.14.18.1; 1.14.19.21; 1.14.99.2; 1.14.-.-; 1.16.1.2; 1.16.1.3; 1.16.1.4; 1.16.1.7; 1.17.1.1; 1.17.1.4; 1.17.1.8; 1.18.1.1; 1.18.1.3; 1.18.1.4; 1.18.1.5; 1.20.1.1; 1.-.-.-; 2.1.2.10; 2.3.1.12; 2.3.1.61; 2.3.1.190; 2.3.1.-; 2.4.2.30; 2.4.2.31; 2.4.2.36; 2.4.2.37; 2.5.1.46; 2.7.1.23; 2.7.7.1; 2.7.7.18; 3.1.3.-; 3.2.2.5; 3.2.2.6; 3.5.1.-; 3.6.1.9; 3.6.1.22; 4.3.1.22; 5.3.3.1; 6.3.1.5; 6.3.5.1; 6.5.1.2; 6.5.1.6,"NAD biosynthesis, aspartate => NAD; NADH:ubiquinone oxidoreductase, mitochondria; NADH:quinone oxidoreductase, prokaryotes; NAD(P)H:quinone oxidoreductase, chloroplasts and cyanobacteria",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00003  NAD; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA01 Nicotinamide;       D00002  Nadide (JAN/USAN/INN),CAS: 53-84-9; PubChem: 3305; ChEBI: 15846; ChEMBL: CHEMBL1454168; KNApSAcK: C00007256; PDB-CCD: NAD NAJ; 3DMET: B01126; NIKKAJI: J136.554A,cpd:C00003,21,28,14,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H29O14N7P2,C21H27O14N7P2,664.1169476,665.1247726,663.1091226572,661,cpd:C00004,NADH;,C21H29N7O14P2,NADH; DPNH; Reduced nicotinamide adenine dinucleotide,R00023 R00090 R00091 R00092 R00093 R00094 R00095 R00097; R00099 R00100 R00101 R00105 R00112 R00129 R00143 R00145; R00203 R00209 R00214 R00215 R00228 R00243 R00245 R00281; R00286 R00300 R00342 R00365 R00368 R00384 R00396 R00398; R00402 R00421 R00445 R00446 R00501 R00519 R00538 R00562; R00581 R00604 R00605 R00623 R00624 R00631 R00675 R00688; R00700 R00703 R00704 R00705 R00707 R00709 R00710 R00713; R00715 R00717 R00732 R00754 R00758 R00787 R00794 R00812; R00813 R00818 R00823 R00842 R00868 R00875 R00880 R00892; R00904 R00906 R00922 R00935 R00936 R00937 R00977 R00994; R01000 R01033 R01034 R01036 R01061 R01088 R01093 R01094; R01130 R01142 R01158 R01163 R01171 R01172 R01183 R01202; R01210 R01211 R01218 R01221 R01246 R01248 R01258 R01277; R01293 R01296 R01297 R01308 R01333 R01337 R01361 R01370; R01388 R01403 R01414 R01419 R01426 R01429 R01434 R01446; R01451 R01465 R01486 R01487 R01505 R01513 R01520 R01524; R01542 R01574 R01604 R01608 R01629 R01633 R01636 R01644; R01651 R01681 R01683 R01689 R01698 R01704 R01707 R01728; R01735 R01738 R01745 R01749 R01752 R01757 R01758 R01763; R01768 R01773 R01778 R01781 R01793 R01825 R01836 R01837; R01869 R01872 R01895 R01896 R01903 R01921 R01932 R01933; R01934 R01937 R01971 R01975 R01981 R01998 R02000 R02032; R02039 R02047 R02081 R02103 R02123 R02124 R02163 R02196; R02201 R02207 R02216 R02229 R02235 R02246 R02252 R02257; R02258 R02313 R02343 R02344 R02347 R02352 R02354 R02377; R02383 R02391 R02395 R02401 R02434 R02441 R02450 R02454; R02455 R02462 R02471 R02476 R02492 R02499 R02514 R02515; R02527 R02531 R02536 R02544 R02545 R02549 R02553 R02555; R02559 R02561 R02565 R02580 R02589 R02611 R02618 R02637; R02640 R02651 R02655 R02678 R02679 R02683 R02695 R02698; R02703 R02762 R02766 R02792 R02819 R02823 R02830 R02834; R02840 R02847 R02855 R02878 R02896 R02928 R02935 R02940; R02941 R02944 R02945 R02946 R02957 R02964 R02968 R02969; R02988 R02993 R02994 R03012 R03021 R03022 R03023 R03043; R03048 R03080 R03082 R03088 R03102 R03104 R03119 R03171; R03176 R03177 R03191 R03198 R03226 R03251 R03261 R03278; R03279 R03283 R03290 R03291 R03299 R03300 R03306 R03317; R03327 R03336 R03337 R03349 R03369 R03373 R03381 R03385; R03391 R03396 R03397 R03406 R03431 R03439 R03475 R03476; R03497 R03506 R03543 R03544 R03559 R03577 R03582 R03584; R03591 R03614 R03630 R03637 R03643 R03707 R03709 R03732; R03733 R03745 R03759 R03761 R03763 R03787 R03790 R03792; R03815 R03816 R03826 R03847 R03863 R03869 R03882 R03886; R03889 R03913 R03942 R03945 R03947 R03963 R03964 R03998; R04046 R04049 R04065 R04066 R04088 R04102 R04115 R04123; R04130 R04139 R04142 R04151 R04163 R04185 R04198 R04200; R04203 R04210 R04228 R04236 R04263 R04278 R04304 R04307; R04309 R04330 R04339 R04366 R04375 R04412 R04418 R04426; R04429 R04444 R04483 R04501 R04506 R04517 R04524 R04556; R04598 R04600 R04678 R04681 R04687 R04724 R04737 R04739; R04741 R04743 R04745 R04748 R04805 R04810 R04812 R04818; R04824 R04829 R04831 R04832 R04834 R04835 R04837 R04842; R04844 R04845 R04847 R04849 R04862 R04876 R04880 R04882; R04888 R04891 R04903 R04916 R04955 R04958 R04961 R04966; R04969 R04996 R05049 R05050 R05051 R05066 R05119 R05147; R05148 R05154 R05156 R05157 R05158 R05217 R05232 R05233; R05234 R05235 R05236 R05239 R05240 R05241 R05243 R05247; R05261 R05263 R05266 R05271 R05272 R05273 R05274 R05275; R05281 R05282 R05283 R05286 R05288 R05290 R05292 R05294; R05305 R05307 R05309 R05310 R05311 R05312 R05313 R05314; R05315 R05321 R05322 R05347 R05348 R05349 R05351 R05352; R05353 R05354 R05355 R05395 R05397 R05399 R05414 R05417; R05418 R05422 R05423 R05425 R05426 R05428 R05429 R05430; R05431 R05434 R05435 R05437 R05439 R05440 R05442 R05443; R05444 R05448 R05450 R05487 R05515 R05537 R05571 R05575; R05581 R05582 R05604 R05607 R05621 R05632 R05643 R05649; R05653 R05654 R05655 R05665 R05668 R05678 R05679 R05681; R05683 R05685 R05689 R05690 R05693 R05699 R05700 R05705; R05715 R05724 R05729 R05730 R05733 R05734 R05746 R05812; R05831 R05837 R05843 R05875 R06117 R06180 R06289 R06357; R06366 R06376 R06377 R06378 R06379 R06382 R06383 R06384; R06385 R06398 R06399 R06406 R06407 R06408 R06413 R06438; R06594 R06621 R06782 R06783 R06784 R06785 R06786 R06787; R06831 R06832 R06847 R06848 R06856 R06857 R06883 R06884; R06888 R06891 R06894 R06909 R06910 R06914 R06915 R06916; R06917 R06918 R06919 R06926 R06927 R06928 R06930 R06931; R06935 R06936 R06937 R06939 R06941 R06945 R06954 R06980; R06983 R07058 R07104 R07105 R07133 R07134 R07135 R07136; R07141 R07145 R07148 R07156 R07164 R07168 R07171 R07188; R07194 R07326 R07345 R07349 R07351 R07354 R07358 R07410; R07417 R07428 R07441 R07477 R07478 R07530 R07558 R07559; R07561 R07562 R07568 R07569 R07570 R07572 R07618 R07658; R07665 R07667 R07675 R07703 R07704 R07705 R07706 R07709; R07765 R07781 R07799 R07851 R07890 R07894 R07898 R07936; R07952 R07954 R07955 R07957 R07959 R07961 R07963 R07965; R07967 R07969 R07971 R07973 R07975 R07985 R08017 R08018; R08042 R08043 R08044 R08045 R08046 R08047 R08086 R08087; R08094 R08096 R08100 R08101 R08103 R08104 R08105 R08108; R08109 R08110 R08111 R08112 R08113 R08140 R08141 R08146; R08198 R08214 R08215 R08240 R08281 R08282 R08306 R08307; R08310 R08382 R08385 R08536 R08544 R08549 R08550 R08557; R08569 R08590 R08621 R08625 R08629 R08636 R08642 R08646; R08709 R08721 R08723 R08724 R08728 R08764 R08767 R08846; R08892 R08914 R08916 R08918 R08919 R08926 R08945 R09055; R09069 R09078 R09097 R09129 R09130 R09132 R09137 R09141; R09148 R09151 R09152 R09159 R09160 R09162 R09165 R09183; R09201 R09204 R09209 R09213 R09219 R09223 R09224 R09227; R09228 R09230 R09231 R09232 R09233 R09235 R09236 R09288; R09312 R09375 R09385 R09388 R09447 R09472 R09477 R09478; R09484 R09498 R09508 R09513 R09514 R09524 R09544 R09545; R09561 R09567 R09586 R09662 R09747 R09748 R09750 R09783; R09786 R09805 R09830 R09859 R09860 R09920 R09922 R09923; R09924 R09925 R09951 R09953 R09956 R09957 R09981 R09984; R09986 R09988 R10012 R10021 R10042 R10043 R10048 R10052; R10054 R10057 R10106 R10107 R10108 R10113 R10125 R10126; R10128 R10129 R10131 R10140 R10146 R10156 R10161 R10163; R10189 R10190 R10217 R10218 R10221 R10222 R10267 R10301; R10308 R10310 R10311 R10325 R10332 R10412 R10419 R10420; R10422 R10428 R10459 R10467 R10502 R10504 R10505 R10517; R10519 R10520 R10565 R10592 R10690 R10702 R10703 R10715; R10717 R10718 R10719 R10783 R10785 R10790 R10798 R10800; R10841 R10842 R10848 R10860 R10861 R10907 R10916 R10917; R10918 R10981 R10985 R10986 R10995 R11007 R11026 R11031; R11035 R11036 R11056 R11067 R11091 R11092 R11093 R11104; R11121 R11144 R11147 R11149 R11150 R11151 R11153 R11155; R11156 R11158 R11197 R11231 R11243 R11265 R11290 R11336; R11337 R11338 R11339 R11342 R11346 R11347 R11350 R11355; R11356 R11357 R11373 R11374 R11382 R11384 R11424 R11448; R11471 R11472 R11578,Oxidative phosphorylation; Metabolic pathways; Calcium signaling pathway; Aldosterone synthesis and secretion,1.1.1.1; 1.1.1.3; 1.1.1.4; 1.1.1.6; 1.1.1.7; 1.1.1.8; 1.1.1.9; 1.1.1.11; 1.1.1.12; 1.1.1.13; 1.1.1.14; 1.1.1.15; 1.1.1.16; 1.1.1.17; 1.1.1.18; 1.1.1.21; 1.1.1.22; 1.1.1.23; 1.1.1.24; 1.1.1.26; 1.1.1.27; 1.1.1.28; 1.1.1.29; 1.1.1.30; 1.1.1.31; 1.1.1.32; 1.1.1.35; 1.1.1.37; 1.1.1.38; 1.1.1.39; 1.1.1.41; 1.1.1.43; 1.1.1.45; 1.1.1.46; 1.1.1.47; 1.1.1.48; 1.1.1.50; 1.1.1.51; 1.1.1.52; 1.1.1.53; 1.1.1.56; 1.1.1.57; 1.1.1.58; 1.1.1.59; 1.1.1.60; 1.1.1.61; 1.1.1.62; 1.1.1.66; 1.1.1.67; 1.1.1.69; 1.1.1.71; 1.1.1.72; 1.1.1.73; 1.1.1.75; 1.1.1.76; 1.1.1.77; 1.1.1.78; 1.1.1.79; 1.1.1.81; 1.1.1.83; 1.1.1.84; 1.1.1.85; 1.1.1.87; 1.1.1.88; 1.1.1.90; 1.1.1.92; 1.1.1.93; 1.1.1.94; 1.1.1.95; 1.1.1.96; 1.1.1.98; 1.1.1.99; 1.1.1.103; 1.1.1.104; 1.1.1.105; 1.1.1.106; 1.1.1.107; 1.1.1.108; 1.1.1.110; 1.1.1.111; 1.1.1.112; 1.1.1.114; 1.1.1.116; 1.1.1.117; 1.1.1.118; 1.1.1.121; 1.1.1.122; 1.1.1.125; 1.1.1.127; 1.1.1.129; 1.1.1.130; 1.1.1.131; 1.1.1.132; 1.1.1.135; 1.1.1.136; 1.1.1.137; 1.1.1.140; 1.1.1.141; 1.1.1.143; 1.1.1.144; 1.1.1.145; 1.1.1.147; 1.1.1.148; 1.1.1.149; 1.1.1.150; 1.1.1.152; 1.1.1.154; 1.1.1.157; 1.1.1.159; 1.1.1.163; 1.1.1.164; 1.1.1.165; 1.1.1.166; 1.1.1.167; 1.1.1.170; 1.1.1.172; 1.1.1.173; 1.1.1.174; 1.1.1.175; 1.1.1.178; 1.1.1.181; 1.1.1.185; 1.1.1.186; 1.1.1.187; 1.1.1.190; 1.1.1.192; 1.1.1.196; 1.1.1.198; 1.1.1.199; 1.1.1.202; 1.1.1.203; 1.1.1.205; 1.1.1.209; 1.1.1.211; 1.1.1.212; 1.1.1.213; 1.1.1.218; 1.1.1.221; 1.1.1.222; 1.1.1.223; 1.1.1.226; 1.1.1.227; 1.1.1.228; 1.1.1.232; 1.1.1.233; 1.1.1.237; 1.1.1.239; 1.1.1.240; 1.1.1.241; 1.1.1.244; 1.1.1.245; 1.1.1.250; 1.1.1.251; 1.1.1.254; 1.1.1.255; 1.1.1.256; 1.1.1.257; 1.1.1.258; 1.1.1.259; 1.1.1.260; 1.1.1.261; 1.1.1.262; 1.1.1.264; 1.1.1.265; 1.1.1.268; 1.1.1.269; 1.1.1.275; 1.1.1.281; 1.1.1.282; 1.1.1.284; 1.1.1.285; 1.1.1.286; 1.1.1.288; 1.1.1.290; 1.1.1.291; 1.1.1.294; 1.1.1.295; 1.1.1.296; 1.1.1.297; 1.1.1.299; 1.1.1.301; 1.1.1.302; 1.1.1.303; 1.1.1.304; 1.1.1.305; 1.1.1.306; 1.1.1.307; 1.1.1.308; 1.1.1.309; 1.1.1.310; 1.1.1.311; 1.1.1.312; 1.1.1.315; 1.1.1.316; 1.1.1.322; 1.1.1.323; 1.1.1.326; 1.1.1.327; 1.1.1.328; 1.1.1.329; 1.1.1.331; 1.1.1.332; 1.1.1.333; 1.1.1.335; 1.1.1.336; 1.1.1.337; 1.1.1.339; 1.1.1.340; 1.1.1.343; 1.1.1.344; 1.1.1.345; 1.1.1.347; 1.1.1.350; 1.1.1.351; 1.1.1.352; 1.1.1.354; 1.1.1.356; 1.1.1.357; 1.1.1.359; 1.1.1.361; 1.1.1.363; 1.1.1.364; 1.1.1.366; 1.1.1.368; 1.1.1.369; 1.1.1.370; 1.1.1.373; 1.1.1.374; 1.1.1.375; 1.1.1.376; 1.1.1.378; 1.1.1.379; 1.1.1.380; 1.1.1.382; 1.1.1.383; 1.1.1.385; 1.1.1.386; 1.1.1.387; 1.1.1.388; 1.1.1.389; 1.1.1.390; 1.1.1.391; 1.1.1.394; 1.1.1.396; 1.1.1.397; 1.1.1.399; 1.1.1.400; 1.1.1.401; 1.1.1.403; 1.1.1.-; 1.1.-.-; 1.2.1.2; 1.2.1.3; 1.2.1.5; 1.2.1.8; 1.2.1.10; 1.2.1.12; 1.2.1.15; 1.2.1.16; 1.2.1.18; 1.2.1.19; 1.2.1.20; 1.2.1.21; 1.2.1.22; 1.2.1.23; 1.2.1.24; 1.2.1.25; 1.2.1.27; 1.2.1.28; 1.2.1.29; 1.2.1.31; 1.2.1.32; 1.2.1.33; 1.2.1.36; 1.2.1.39; 1.2.1.42; 1.2.1.46; 1.2.1.47; 1.2.1.48; 1.2.1.53; 1.2.1.54; 1.2.1.57; 1.2.1.58; 1.2.1.59; 1.2.1.60; 1.2.1.61; 1.2.1.62; 1.2.1.64; 1.2.1.65; 1.2.1.67; 1.2.1.68; 1.2.1.69; 1.2.1.71; 1.2.1.72; 1.2.1.73; 1.2.1.74; 1.2.1.78; 1.2.1.80; 1.2.1.82; 1.2.1.85; 1.2.1.86; 1.2.1.87; 1.2.1.88; 1.2.1.90; 1.2.1.92; 1.2.1.98; 1.2.1.-; 1.2.3.9; 1.2.4.1; 1.2.4.2; 1.2.4.-; 1.3.1.1; 1.3.1.5; 1.3.1.6; 1.3.1.7; 1.3.1.9; 1.3.1.11; 1.3.1.12; 1.3.1.14; 1.3.1.18; 1.3.1.19; 1.3.1.21; 1.3.1.24; 1.3.1.25; 1.3.1.28; 1.3.1.29; 1.3.1.31; 1.3.1.32; 1.3.1.41; 1.3.1.43; 1.3.1.44; 1.3.1.47; 1.3.1.48; 1.3.1.49; 1.3.1.53; 1.3.1.56; 1.3.1.58; 1.3.1.60; 1.3.1.62; 1.3.1.64; 1.3.1.65; 1.3.1.66; 1.3.1.67; 1.3.1.68; 1.3.1.74; 1.3.1.76; 1.3.1.77; 1.3.1.79; 1.3.1.87; 1.3.1.95; 1.3.1.98; 1.3.1.101; 1.3.1.105; 1.3.1.106; 1.3.1.107; 1.3.1.-; 1.4.1.1; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.5; 1.4.1.7; 1.4.1.8; 1.4.1.9; 1.4.1.10; 1.4.1.11; 1.4.1.12; 1.4.1.14; 1.4.1.15; 1.4.1.18; 1.4.1.19; 1.4.1.20; 1.4.1.21; 1.4.1.23; 1.4.1.24; 1.4.1.-; 1.4.4.2; 1.5.1.1; 1.5.1.2; 1.5.1.3; 1.5.1.7; 1.5.1.9; 1.5.1.11; 1.5.1.15; 1.5.1.17; 1.5.1.18; 1.5.1.20; 1.5.1.22; 1.5.1.23; 1.5.1.25; 1.5.1.26; 1.5.1.28; 1.5.1.34; 1.5.1.36; 1.5.1.37; 1.5.1.39; 1.5.1.41; 1.5.1.42; 1.5.1.44; 1.5.1.45; 1.5.1.47; 1.5.1.49; 1.5.1.-; 1.6.1.1; 1.6.1.2; 1.6.1.3; 1.6.2.2; 1.6.2.6; 1.6.3.1; 1.6.3.2; 1.6.3.3; 1.6.3.4; 1.6.5.2; 1.6.5.3; 1.6.5.4; 1.6.5.7; 1.6.5.8; 1.6.5.9; 1.6.5.11; 1.6.5.-; 1.6.6.9; 1.6.99.3; 1.7.1.1; 1.7.1.2; 1.7.1.4; 1.7.1.5; 1.7.1.9; 1.7.1.10; 1.7.1.12; 1.7.1.14; 1.7.1.15; 1.7.1.-; 1.7.99.1; 1.8.1.3; 1.8.1.4; 1.8.1.6; 1.8.1.7; 1.8.1.8; 1.8.1.11; 1.8.1.15; 1.8.1.16; 1.8.1.17; 1.8.1.18; 1.11.1.1; 1.12.1.2; 1.12.1.4; 1.12.1.5; 1.13.11.29; 1.13.11.30; 1.13.11.-; 1.13.12.17; 1.13.12.-; 1.14.12.1; 1.14.12.3; 1.14.12.4; 1.14.12.7; 1.14.12.8; 1.14.12.9; 1.14.12.10; 1.14.12.11; 1.14.12.12; 1.14.12.13; 1.14.12.14; 1.14.12.15; 1.14.12.16; 1.14.12.17; 1.14.12.18; 1.14.12.19; 1.14.12.22; 1.14.12.23; 1.14.12.24; 1.14.12.25; 1.14.12.-; 1.14.13.1; 1.14.13.4; 1.14.13.5; 1.14.13.6; 1.14.13.10; 1.14.13.18; 1.14.13.19; 1.14.13.24; 1.14.13.25; 1.14.13.27; 1.14.13.29; 1.14.13.33; 1.14.13.40; 1.14.13.44; 1.14.13.61; 1.14.13.62; 1.14.13.63; 1.14.13.64; 1.14.13.69; 1.14.13.72; 1.14.13.82; 1.14.13.83; 1.14.13.107; 1.14.13.111; 1.14.13.113; 1.14.13.114; 1.14.13.127; 1.14.13.128; 1.14.13.129; 1.14.13.130; 1.14.13.131; 1.14.13.135; 1.14.13.141; 1.14.13.142; 1.14.13.151; 1.14.13.162; 1.14.13.163; 1.14.13.165; 1.14.13.172; 1.14.13.178; 1.14.13.179; 1.14.13.182; 1.14.13.196; 1.14.13.209; 1.14.13.210; 1.14.13.211; 1.14.13.212; 1.14.13.215; 1.14.13.216; 1.14.13.217; 1.14.13.218; 1.14.13.220; 1.14.13.222; 1.14.13.223; 1.14.13.224; 1.14.13.227; 1.14.13.230; 1.14.13.-; 1.14.14.1; 1.14.14.9; 1.14.15.3; 1.14.18.1; 1.14.19.21; 1.14.99.2; 1.14.-.-; 1.16.1.2; 1.16.1.3; 1.16.1.4; 1.16.1.7; 1.17.1.1; 1.17.1.4; 1.17.1.8; 1.18.1.1; 1.18.1.3; 1.18.1.4; 1.18.1.5; 1.20.1.1; 1.-.-.-; 2.1.2.10; 2.3.1.12; 2.3.1.61; 2.3.1.190; 2.3.1.-; 2.5.1.46; 2.7.1.86; 3.6.1.22; 4.2.1.93; 4.2.1.136; 4.3.1.22; 5.3.3.1,"NADH:ubiquinone oxidoreductase, mitochondria; NADH:quinone oxidoreductase, prokaryotes; NAD(P)H:quinone oxidoreductase, chloroplasts and cyanobacteria",NA,CAS: 58-68-4; PubChem: 3306; ChEBI: 16908; KNApSAcK: C00019343; PDB-CCD: NAI; 3DMET: B01127; NIKKAJI: J213.546I,cpd:C00004; cpd:C20744; cpd:C21423; cpd:C21424,21,29,14,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H30O14N7P2,C21H28O14N7P2,665.1247726,666.1325977,664.1169476573,663,cpd:C00008,ADP;,C10H15N5O10P2,ADP; Adenosine 5'-diphosphate,R00002 R00076 R00086 R00104 R00105 R00122 R00123 R00124; R00125 R00126 R00127 R00129 R00130 R00139 R00140 R00141; R00149 R00150 R00156 R00157 R00158 R00162 R00174 R00185; R00187 R00200 R00229 R00239 R00241 R00251 R00253 R00283; R00299 R00315 R00330 R00331 R00332 R00333 R00334 R00341; R00344 R00352 R00405 R00437 R00480 R00482 R00497 R00509; R00512 R00513 R00518 R00530 R00549 R00554 R00570 R00571; R00573 R00575 R00616 R00617 R00722 R00742 R00756 R00760; R00774 R00847 R00866 R00867 R00894 R00910 R00912 R00920; R00942 R00943 R00949 R00964 R01011 R01021 R01050 R01051; R01052 R01053 R01059 R01092 R01121 R01131 R01137 R01150; R01164 R01201 R01228 R01256 R01322 R01326 R01353 R01395; R01417 R01441 R01468 R01476 R01495 R01512 R01514 R01523; R01526 R01541 R01547 R01567 R01568 R01573 R01585 R01600; R01639 R01654 R01665 R01666 R01688 R01724 R01737 R01754; R01771 R01786 R01843 R01844 R01857 R01859 R01881 R01888; R01901 R01902 R01909 R01917 R01926 R01961 R01967 R01980; R01991 R02017 R02071 R02089 R02090 R02093 R02094 R02098; R02099 R02134 R02136 R02184 R02225 R02227 R02237 R02238; R02240 R02245 R02301 R02303 R02324 R02326 R02331 R02402; R02404 R02412 R02420 R02421 R02430 R02439 R02451 R02493; R02575 R02584 R02625 R02626 R02649 R02650 R02658 R02664; R02705 R02732 R02741 R02750 R02757 R02758 R02783 R02786; R02788 R02848 R02865 R02884 R02903 R02927 R02929 R02971; R02976 R02980 R03014 R03018 R03095 R03142 R03150 R03157; R03161 R03182 R03187 R03193 R03236 R03241 R03245 R03272; R03274 R03286 R03298 R03315 R03347 R03361 R03362 R03384; R03387 R03395 R03428 R03429 R03433 R03449 R03469 R03471; R03474 R03478 R03479 R03494 R03516 R03530 R03576 R03607; R03632 R03691 R03744 R03754 R03766 R03770 R03780 R03785; R03819 R03822 R03840 R03877 R03905 R03920 R03939 R03944; R04002 R04023 R04068 R04126 R04138 R04143 R04144 R04208; R04212 R04235 R04241 R04267 R04275 R04358 R04369 R04385; R04388 R04391 R04401 R04403 R04448 R04463 R04504 R04509; R04545 R04555 R04573 R04589 R04591 R04617 R04657 R04730; R04779 R04928 R05030 R05185 R05186 R05197 R05202 R05221; R05224 R05225 R05227 R05328 R05453 R05496 R05626 R05634; R05646 R05661 R05795 R05799 R05800 R05801 R05802 R05803; R05804 R05805 R05806 R05815 R06282 R06367 R06396 R06529; R06531 R06588 R06836 R06974 R06975 R06976 R07127 R07279; R07302 R07404 R07414 R07641 R07642 R07828 R08052 R08124; R08154 R08201 R08217 R08223 R08232 R08233 R08241 R08242; R08323 R08352 R08353 R08354 R08355 R08515 R08572 R08676; R08844 R08855 R08905 R08906 R08924 R08946 R08962 R08964; R08967 R08968 R09053 R09060 R09084 R09085 R09086 R09087; R09378 R09401 R09588 R09590 R09592 R09593 R09594 R09595; R09596 R09598 R09599 R09640 R09665 R09729 R09767 R09770; R09775 R09776 R09880 R09945 R09946 R09978 R10065 R10093; R10267 R10268 R10288 R10470 R10531 R10548 R10561 R10657; R10677 R10678 R10679 R10693 R10758 R10772 R10779 R10780; R10821 R10822 R10892 R10901 R10902 R10929 R10930 R10941; R10942 R10943 R10944 R10948 R10951 R10953 R10970 R10993; R10994 R11024 R11039 R11064 R11085 R11090 R11183 R11184; R11185 R11207 R11234 R11319 R11400 R11406 R11460 R11461; R11530 R11531 R11535 R11536,Oxidative phosphorylation; Photosynthesis; Purine metabolism; Zeatin biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; FoxO signaling pathway; Neuroactive ligand-receptor interaction; Lysosome; AMPK signaling pathway; Platelet activation; Taste transduction; Renin secretion; Parkinson's disease,1.3.7.7; 1.3.7.8; 1.3.7.14; 1.3.7.15; 1.17.4.1; 1.18.6.1; 1.19.6.1; 2.1.2.-; 2.3.3.8; 2.4.1.13; 2.4.1.21; 2.4.1.113; 2.4.1.213; 2.4.1.242; 2.4.1.245; 2.4.1.268; 2.4.1.342; 2.5.1.112; 2.7.1.1; 2.7.1.2; 2.7.1.3; 2.7.1.4; 2.7.1.5; 2.7.1.6; 2.7.1.7; 2.7.1.8; 2.7.1.10; 2.7.1.11; 2.7.1.12; 2.7.1.13; 2.7.1.14; 2.7.1.15; 2.7.1.16; 2.7.1.17; 2.7.1.18; 2.7.1.19; 2.7.1.20; 2.7.1.21; 2.7.1.22; 2.7.1.23; 2.7.1.24; 2.7.1.25; 2.7.1.26; 2.7.1.27; 2.7.1.28; 2.7.1.29; 2.7.1.30; 2.7.1.31; 2.7.1.32; 2.7.1.33; 2.7.1.34; 2.7.1.35; 2.7.1.36; 2.7.1.39; 2.7.1.40; 2.7.1.43; 2.7.1.44; 2.7.1.45; 2.7.1.46; 2.7.1.47; 2.7.1.48; 2.7.1.49; 2.7.1.50; 2.7.1.51; 2.7.1.52; 2.7.1.53; 2.7.1.54; 2.7.1.55; 2.7.1.56; 2.7.1.58; 2.7.1.59; 2.7.1.60; 2.7.1.64; 2.7.1.65; 2.7.1.66; 2.7.1.67; 2.7.1.68; 2.7.1.71; 2.7.1.72; 2.7.1.73; 2.7.1.74; 2.7.1.76; 2.7.1.78; 2.7.1.82; 2.7.1.83; 2.7.1.84; 2.7.1.85; 2.7.1.86; 2.7.1.87; 2.7.1.88; 2.7.1.89; 2.7.1.91; 2.7.1.92; 2.7.1.93; 2.7.1.94; 2.7.1.95; 2.7.1.100; 2.7.1.101; 2.7.1.102; 2.7.1.103; 2.7.1.105; 2.7.1.107; 2.7.1.113; 2.7.1.118; 2.7.1.119; 2.7.1.122; 2.7.1.127; 2.7.1.130; 2.7.1.134; 2.7.1.136; 2.7.1.137; 2.7.1.138; 2.7.1.140; 2.7.1.144; 2.7.1.145; 2.7.1.146; 2.7.1.147; 2.7.1.148; 2.7.1.149; 2.7.1.150; 2.7.1.151; 2.7.1.153; 2.7.1.154; 2.7.1.156; 2.7.1.157; 2.7.1.158; 2.7.1.159; 2.7.1.162; 2.7.1.163; 2.7.1.164; 2.7.1.165; 2.7.1.166; 2.7.1.167; 2.7.1.168; 2.7.1.169; 2.7.1.170; 2.7.1.173; 2.7.1.175; 2.7.1.176; 2.7.1.177; 2.7.1.178; 2.7.1.179; 2.7.1.181; 2.7.1.183; 2.7.1.184; 2.7.1.185; 2.7.1.186; 2.7.1.187; 2.7.1.188; 2.7.1.189; 2.7.1.209; 2.7.1.210; 2.7.1.212; 2.7.1.213; 2.7.1.214; 2.7.1.215; 2.7.1.-; 2.7.2.1; 2.7.2.2; 2.7.2.3; 2.7.2.4; 2.7.2.6; 2.7.2.7; 2.7.2.8; 2.7.2.11; 2.7.2.13; 2.7.2.14; 2.7.2.15; 2.7.2.-; 2.7.3.1; 2.7.3.2; 2.7.3.3; 2.7.3.4; 2.7.3.5; 2.7.3.6; 2.7.3.7; 2.7.3.8; 2.7.3.10; 2.7.4.1; 2.7.4.2; 2.7.4.3; 2.7.4.4; 2.7.4.6; 2.7.4.7; 2.7.4.8; 2.7.4.9; 2.7.4.10; 2.7.4.11; 2.7.4.12; 2.7.4.13; 2.7.4.14; 2.7.4.15; 2.7.4.16; 2.7.4.18; 2.7.4.19; 2.7.4.21; 2.7.4.22; 2.7.4.23; 2.7.4.24; 2.7.4.25; 2.7.4.26; 2.7.4.31; 2.7.4.-; 2.7.7.5; 2.7.7.8; 2.7.7.35; 2.7.7.36; 2.7.7.53; 2.7.7.89; 2.7.10.1; 2.7.10.2; 2.7.11.1; 2.7.11.2; 2.7.11.3; 2.7.11.4; 2.7.11.5; 2.7.11.6; 2.7.11.7; 2.7.11.8; 2.7.11.9; 2.7.11.10; 2.7.11.11; 2.7.11.12; 2.7.11.13; 2.7.11.14; 2.7.11.15; 2.7.11.17; 2.7.11.18; 2.7.11.19; 2.7.11.21; 2.7.11.22; 2.7.11.23; 2.7.11.24; 2.7.11.25; 2.7.11.26; 2.7.11.27; 2.7.11.28; 2.7.11.29; 2.7.11.30; 2.7.11.31; 2.7.12.1; 2.7.12.2; 2.7.13.1; 2.7.13.2; 2.7.14.1; 3.5.2.9; 3.5.2.14; 3.5.4.7; 3.5.4.17; 3.6.1.3; 3.6.1.5; 3.6.1.8; 3.6.1.15; 3.6.1.29; 3.6.1.41; 3.6.1.61; 3.6.3.1; 3.6.3.2; 3.6.3.3; 3.6.3.4; 3.6.3.5; 3.6.3.6; 3.6.3.7; 3.6.3.8; 3.6.3.9; 3.6.3.10; 3.6.3.11; 3.6.3.12; 3.6.3.14; 3.6.3.15; 3.6.3.16; 3.6.3.17; 3.6.3.18; 3.6.3.19; 3.6.3.20; 3.6.3.21; 3.6.3.22; 3.6.3.23; 3.6.3.24; 3.6.3.25; 3.6.3.26; 3.6.3.27; 3.6.3.28; 3.6.3.29; 3.6.3.30; 3.6.3.31; 3.6.3.32; 3.6.3.33; 3.6.3.34; 3.6.3.35; 3.6.3.36; 3.6.3.37; 3.6.3.38; 3.6.3.39; 3.6.3.40; 3.6.3.41; 3.6.3.42; 3.6.3.43; 3.6.3.44; 3.6.3.46; 3.6.3.47; 3.6.3.48; 3.6.3.49; 3.6.3.50; 3.6.3.51; 3.6.3.52; 3.6.3.53; 3.6.3.54; 3.6.3.55; 3.6.4.1; 3.6.4.2; 3.6.4.3; 3.6.4.4; 3.6.4.5; 3.6.4.6; 3.6.4.7; 3.6.4.8; 3.6.4.9; 3.6.4.10; 3.6.4.11; 3.6.4.12; 3.6.4.13; 4.1.1.33; 4.1.1.49; 4.1.1.99; 4.2.1.93; 4.2.1.136; 4.6.1.-; 6.1.2.1; 6.2.1.5; 6.2.1.6; 6.2.1.9; 6.2.1.13; 6.2.1.18; 6.2.1.39; 6.2.1.-; 6.3.1.2; 6.3.1.4; 6.3.1.6; 6.3.1.8; 6.3.1.9; 6.3.1.10; 6.3.1.11; 6.3.1.12; 6.3.1.17; 6.3.1.18; 6.3.1.19; 6.3.2.2; 6.3.2.3; 6.3.2.4; 6.3.2.6; 6.3.2.7; 6.3.2.8; 6.3.2.9; 6.3.2.10; 6.3.2.11; 6.3.2.12; 6.3.2.13; 6.3.2.16; 6.3.2.17; 6.3.2.18; 6.3.2.20; 6.3.2.23; 6.3.2.25; 6.3.2.29; 6.3.2.30; 6.3.2.32; 6.3.2.33; 6.3.2.35; 6.3.2.37; 6.3.2.41; 6.3.2.42; 6.3.2.43; 6.3.2.44; 6.3.2.45; 6.3.2.47; 6.3.2.48; 6.3.2.49; 6.3.2.-; 6.3.3.1; 6.3.3.2; 6.3.3.3; 6.3.3.5; 6.3.4.2; 6.3.4.3; 6.3.4.6; 6.3.4.7; 6.3.4.8; 6.3.4.12; 6.3.4.13; 6.3.4.14; 6.3.4.16; 6.3.4.17; 6.3.4.18; 6.3.4.20; 6.3.4.21; 6.3.4.23; 6.3.4.24; 6.3.5.3; 6.3.5.5; 6.3.5.6; 6.3.5.7; 6.3.5.9; 6.3.5.10; 6.3.5.11; 6.3.5.-; 6.4.1.1; 6.4.1.2; 6.4.1.3; 6.4.1.4; 6.4.1.5; 6.4.1.7; 6.4.1.8; 6.5.1.7; 6.6.1.1; 6.6.1.2,"Adenine ribonucleotide biosynthesis, IMP => ADP,ATP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00008  ADP,CAS: 58-64-0; PubChem: 3310; ChEBI: 16761; ChEMBL: CHEMBL14830; KNApSAcK: C00019353; PDB-CCD: ADP; 3DMET: B01130; NIKKAJI: J10.683F,cpd:C00008; cpd:C00054; cpd:C00361; cpd:C03850,10,15,10,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O10N5P2,C10H14O10N5P2,427.0294157,428.0372407,426.0215907574,666,cpd:C00061,FMN;,C17H21N4O9P,FMN; Riboflavin-5-phosphate; Flavin mononucleotide,R00025 R00160 R00161 R00548 R00549 R00550 R05218 R05705; R05706 R07210 R07664 R08574 R08908 R09313 R09314 R09559; R09798 R09819 R09936 R09937 R10203 R10206 R10551 R11161; R11162 R11163 R11164 R11404 R11454 R11455 R11456 R11457,Oxidative phosphorylation; Riboflavin metabolism; Biosynthesis of type II polyketide products; Metabolic pathways; Biosynthesis of secondary metabolites; Vitamin digestion and absorption,1.1.99.31; 1.3.99.24; 1.5.1.36; 1.5.1.38; 1.5.1.39; 1.5.1.41; 1.5.1.42; 1.5.1.-; 1.13.12.16; 1.14.14.3; 1.14.14.5; 1.14.14.10; 1.14.14.12; 1.14.14.13; 1.14.14.21; 1.14.14.22; 1.14.14.30; 1.14.14.33; 1.14.14.34; 1.14.14.35; 1.14.14.-; 1.14.99.46; 1.16.8.1; 2.7.1.26; 2.7.1.42; 2.7.1.161; 2.7.7.2; 3.1.3.2; 3.1.3.102; 3.6.1.9; 3.6.1.18,"Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00061  FMN,CAS: 146-17-8; PubChem: 3361; ChEBI: 17621; ChEMBL: CHEMBL1201794; KNApSAcK: C00019686; PDB-CCD: FMN; 3DMET: B04626; NIKKAJI: J30.175B,cpd:C00061,17,21,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H22O9N4P1,C17H20O9N4P1,456.1046153,457.1124403,455.0967902575,671,cpd:C00005,NADPH;,C21H30N7O17P3,NADPH; TPNH; Reduced nicotinamide adenine dinucleotide phosphate,R00105 R00106 R00107 R00108 R00109 R00111 R00112 R00113; R00114 R00115 R00134 R00146 R00205 R00210 R00216 R00248; R00264 R00265 R00267 R00282 R00301 R00343 R00385 R00387; R00448 R00452 R00465 R00468 R00557 R00558 R00563 R00625; R00634 R00666 R00676 R00706 R00708 R00711 R00714 R00716; R00733 R00740 R00744 R00746 R00789 R00796 R00814 R00815; R00825 R00828 R00834 R00835 R00844 R00845 R00858 R00870; R00871 R00900 R00918 R00919 R00939 R00940 R00941 R00978; R00980 R01039 R01041 R01058 R01063 R01079 R01095 R01096; R01097 R01134 R01143 R01173 R01195 R01212 R01220 R01224; R01249 R01251 R01260 R01278 R01294 R01295 R01298 R01299; R01338 R01371 R01392 R01404 R01415 R01420 R01430 R01431; R01452 R01453 R01456 R01457 R01463 R01481 R01488 R01490; R01521 R01525 R01528 R01543 R01550 R01575 R01584 R01607; R01615 R01628 R01630 R01694 R01708 R01720 R01730 R01739; R01740 R01747 R01750 R01759 R01775 R01779 R01787 R01794; R01812 R01813 R01817 R01835 R01838 R01866 R01899 R01904; R01938 R01941 R01960 R01976 R01977 R01986 R02002 R02016; R02034 R02063 R02082 R02177 R02178 R02193 R02203 R02208; R02209 R02210 R02219 R02220 R02224 R02231 R02236 R02247; R02253 R02254 R02259 R02260 R02291 R02315 R02339 R02349; R02353 R02355 R02356 R02364 R02393 R02413 R02417 R02442; R02449 R02456 R02463 R02468 R02469 R02470 R02472 R02477; R02497 R02498 R02506 R02516 R02517 R02518 R02528 R02537; R02548 R02554 R02562 R02566 R02577 R02581 R02593 R02600; R02609 R02610 R02620 R02639 R02680 R02684 R02697 R02736; R02742 R02755 R02756 R02767 R02776 R02777 R02793 R02799; R02800 R02807 R02820 R02829 R02832 R02836 R02841 R02856; R02872 R02874 R02892 R02893 R02906 R02915 R02936 R02954; R02975 R02978 R02983 R02989 R02995 R02999 R03006 R03044; R03051 R03054 R03089 R03090 R03103 R03114 R03123 R03124; R03155 R03183 R03192 R03203 R03227 R03234 R03264 R03281; R03292 R03293 R03302 R03313 R03322 R03325 R03338 R03339; R03344 R03357 R03386 R03388 R03392 R03398 R03399 R03401; R03407 R03408 R03440 R03443 R03452 R03458 R03463 R03495; R03498 R03520 R03545 R03555 R03556 R03557 R03560 R03562; R03566 R03568 R03572 R03581 R03583 R03585 R03586 R03592; R03596 R03608 R03611 R03615 R03636 R03638 R03639 R03667; R03689 R03712 R03713 R03716 R03728 R03753 R03764 R03776; R03821 R03827 R03834 R03842 R03845 R03848 R03850 R03856; R03860 R03864 R03866 R03879 R03883 R03900 R03914 R03918; R03930 R03962 R03982 R03989 R03997 R03999 R04047 R04059; R04060 R04099 R04105 R04106 R04109 R04136 R04186 R04199; R04201 R04229 R04256 R04264 R04265 R04279 R04285 R04303; R04310 R04319 R04328 R04340 R04342 R04344 R04360 R04370; R04387 R04390 R04400 R04419 R04430 R04439 R04440 R04445; R04453 R04518 R04523 R04533 R04534 R04536 R04543 R04552; R04557 R04566 R04570 R04599 R04601 R04623 R04670 R04675; R04682 R04688 R04690 R04694 R04695 R04696 R04697 R04699; R04700 R04702 R04708 R04725 R04753 R04758 R04789 R04790; R04817 R04819 R04823 R04825 R04830 R04833 R04836 R04838; R04840 R04843 R04846 R04853 R04883 R04889 R04892 R04901; R04902 R04910 R04917 R04919 R04940 R04953 R04956 R04959; R04962 R04964 R04967 R04970 R04980 R04984 R04987 R04989; R05038 R05068 R05099 R05102 R05124 R05150 R05182 R05188; R05189 R05190 R05210 R05215 R05231 R05244 R05249 R05250; R05258 R05262 R05264 R05270 R05276 R05289 R05291 R05293; R05308 R05350 R05396 R05400 R05401 R05432 R05433 R05436; R05438 R05441 R05462 R05463 R05471 R05521 R05522 R05526; R05576 R05622 R05623 R05639 R05640 R05641 R05663 R05664; R05680 R05682 R05684 R05686 R05687 R05688 R05691 R05692; R05694 R05701 R05702 R05703 R05706 R05707 R05711 R05713; R05714 R05716 R05725 R05727 R05731 R05732 R05736 R05737; R05738 R05741 R05823 R05827 R05828 R05832 R05833 R05847; R05848 R05855 R05866 R05874 R05877 R05878 R05879 R06119; R06126 R06146 R06166 R06223 R06265 R06266 R06267 R06272; R06286 R06290 R06291 R06292 R06293 R06294 R06295 R06296; R06297 R06308 R06309 R06351 R06354 R06386 R06387 R06388; R06389 R06400 R06417 R06419 R06420 R06434 R06436 R06448; R06449 R06453 R06454 R06458 R06459 R06462 R06463 R06464; R06465 R06467 R06468 R06470 R06472 R06473 R06474 R06475; R06480 R06481 R06482 R06483 R06532 R06533 R06537 R06538; R06541 R06542 R06543 R06560 R06561 R06562 R06563 R06568; R06569 R06570 R06571 R06572 R06573 R06582 R06606 R06607; R06610 R06613 R06615 R06622 R06629 R06642 R06677 R06682; R06683 R06688 R06689 R06690 R06691 R06692 R06704 R06734; R06792 R06846 R06851 R06890 R06892 R06896 R06985 R07000; R07001 R07015 R07016 R07020 R07021 R07022 R07041 R07046; R07048 R07050 R07051 R07052 R07054 R07055 R07056 R07060; R07066 R07068 R07075 R07079 R07080 R07081 R07085 R07087; R07088 R07089 R07090 R07098 R07099 R07107 R07112 R07137; R07138 R07140 R07142 R07143 R07144 R07147 R07149 R07150; R07162 R07165 R07169 R07172 R07175 R07181 R07191 R07192; R07193 R07195 R07196 R07197 R07198 R07201 R07202 R07203; R07204 R07205 R07206 R07207 R07208 R07216 R07217 R07241; R07251 R07253 R07328 R07346 R07350 R07352 R07355 R07356; R07357 R07359 R07369 R07370 R07371 R07373 R07403 R07407; R07418 R07421 R07422 R07423 R07429 R07430 R07437 R07440; R07442 R07445 R07447 R07452 R07453 R07454 R07470 R07474; R07483 R07488 R07489 R07493 R07494 R07495 R07498 R07499; R07506 R07507 R07509 R07605 R07666 R07676 R07710 R07711; R07714 R07715 R07727 R07728 R07737 R07739 R07745 R07746; R07747 R07748 R07751 R07752 R07759 R07761 R07763 R07776; R07777 R07778 R07779 R07786 R07787 R07791 R07792 R07836; R07837 R07939 R07956 R07958 R07960 R07962 R07964 R07966; R07968 R07970 R07972 R07974 R07976 R07998 R07999 R08002; R08014 R08015 R08016 R08019 R08032 R08059 R08083 R08084; R08085 R08148 R08160 R08168 R08194 R08203 R08204 R08205; R08206 R08207 R08208 R08226 R08266 R08267 R08270 R08271; R08274 R08275 R08283 R08285 R08294 R08303 R08304 R08312; R08313 R08325 R08326 R08327 R08356 R08357 R08379 R08380; R08383 R08390 R08391 R08392 R08442 R08492 R08494 R08499; R08510 R08539 R08551 R08558 R08561 R08562 R08563 R08573; R08604 R08607 R08651 R08652 R08653 R08655 R08659 R08663; R08664 R08665 R08666 R08670 R08672 R08673 R08674 R08675; R08684 R08685 R08705 R08710 R08711 R08725 R08726 R08727; R08754 R08755 R08756 R08768 R08775 R08784 R08790 R08815; R08838 R08851 R08852 R08853 R08854 R08861 R08878 R08879; R08880 R08912 R08913 R08915 R08917 R08922 R08923 R08925; R08935 R08943 R08954 R08955 R08957 R08958 R08959 R08960; R08961 R08963 R08980 R09002 R09042 R09070 R09079 R09080; R09122 R09131 R09133 R09138 R09190 R09193 R09194 R09198; R09234 R09240 R09241 R09242 R09243 R09262 R09263 R09264; R09275 R09280 R09281 R09289 R09291 R09306 R09309 R09329; R09353 R09372 R09376 R09389 R09390 R09393 R09403 R09404; R09405 R09406 R09407 R09408 R09416 R09418 R09420 R09421; R09423 R09424 R09425 R09441 R09442 R09446 R09449 R09451; R09452 R09453 R09454 R09460 R09461 R09470 R09485 R09512; R09520 R09521 R09522 R09541 R09546 R09547 R09548 R09549; R09554 R09555 R09557 R09573 R09575 R09576 R09577 R09578; R09579 R09580 R09583 R09584 R09602 R09738 R09749 R09756; R09777 R09806 R09812 R09813 R09814 R09815 R09816 R09817; R09818 R09820 R09838 R09861 R09862 R09863 R09864 R09865; R09866 R09867 R09868 R09921 R09926 R09927 R09928 R09929; R09930 R09931 R09932 R09933 R09934 R09935 R09954 R09985; R09987 R09989 R09990 R10023 R10024 R10025 R10026 R10027; R10028 R10031 R10032 R10036 R10038 R10044 R10045 R10058; R10059 R10066 R10067 R10068 R10069 R10072 R10073 R10075; R10076 R10077 R10080 R10104 R10105 R10114 R10116 R10118; R10120 R10122 R10127 R10130 R10132 R10154 R10155 R10159; R10181 R10194 R10225 R10226 R10227 R10228 R10229 R10242; R10248 R10249 R10258 R10260 R10268 R10288 R10289 R10309; R10313 R10314 R10315 R10316 R10317 R10318 R10319 R10320; R10321 R10323 R10326 R10350 R10351 R10356 R10357 R10358; R10359 R10361 R10362 R10366 R10367 R10368 R10371 R10373; R10376 R10379 R10381 R10399 R10400 R10414 R10416 R10417; R10418 R10421 R10423 R10429 R10438 R10476 R10477 R10478; R10479 R10512 R10518 R10528 R10540 R10549 R10562 R10563; R10573 R10591 R10593 R10615 R10626 R10627 R10628 R10637; R10656 R10662 R10663 R10664 R10665 R10670 R10671 R10672; R10692 R10694 R10704 R10725 R10727 R10728 R10730 R10786; R10787 R10788 R10789 R10791 R10793 R10794 R10795 R10799; R10801 R10826 R10828 R10851 R10852 R10862 R10875 R10877; R10878 R10879 R10882 R10919 R10921 R10922 R10923 R10924; R10925 R10931 R10954 R10982 R10984 R10999 R11000 R11008; R11019 R11032 R11051 R11054 R11061 R11096 R11097 R11107; R11124 R11125 R11132 R11134 R11135 R11145 R11146 R11152; R11157 R11195 R11198 R11211 R11212 R11222 R11226 R11232; R11266 R11276 R11277 R11341 R11358 R11359 R11360 R11361; R11383 R11385 R11405 R11425 R11426 R11427 R11435 R11445; R11446 R11447 R11449 R11450 R11451 R11474 R11477 R11485; R11500 R11518 R11525 R11526,Photosynthesis; Glutathione metabolism; Metabolic pathways; Thyroid hormone synthesis; Aldosterone synthesis and secretion,1.1.1.1; 1.1.1.2; 1.1.1.3; 1.1.1.10; 1.1.1.19; 1.1.1.20; 1.1.1.21; 1.1.1.25; 1.1.1.33; 1.1.1.34; 1.1.1.36; 1.1.1.40; 1.1.1.42; 1.1.1.43; 1.1.1.44; 1.1.1.47; 1.1.1.48; 1.1.1.49; 1.1.1.50; 1.1.1.51; 1.1.1.54; 1.1.1.55; 1.1.1.60; 1.1.1.62; 1.1.1.64; 1.1.1.65; 1.1.1.69; 1.1.1.71; 1.1.1.72; 1.1.1.79; 1.1.1.80; 1.1.1.81; 1.1.1.82; 1.1.1.86; 1.1.1.91; 1.1.1.92; 1.1.1.94; 1.1.1.97; 1.1.1.100; 1.1.1.101; 1.1.1.102; 1.1.1.104; 1.1.1.111; 1.1.1.112; 1.1.1.113; 1.1.1.115; 1.1.1.117; 1.1.1.119; 1.1.1.120; 1.1.1.123; 1.1.1.124; 1.1.1.126; 1.1.1.130; 1.1.1.131; 1.1.1.133; 1.1.1.134; 1.1.1.135; 1.1.1.137; 1.1.1.138; 1.1.1.142; 1.1.1.145; 1.1.1.146; 1.1.1.147; 1.1.1.148; 1.1.1.149; 1.1.1.151; 1.1.1.153; 1.1.1.154; 1.1.1.156; 1.1.1.157; 1.1.1.160; 1.1.1.162; 1.1.1.168; 1.1.1.169; 1.1.1.170; 1.1.1.176; 1.1.1.177; 1.1.1.179; 1.1.1.181; 1.1.1.183; 1.1.1.184; 1.1.1.185; 1.1.1.186; 1.1.1.187; 1.1.1.188; 1.1.1.189; 1.1.1.191; 1.1.1.193; 1.1.1.194; 1.1.1.195; 1.1.1.196; 1.1.1.197; 1.1.1.200; 1.1.1.201; 1.1.1.206; 1.1.1.207; 1.1.1.208; 1.1.1.209; 1.1.1.210; 1.1.1.213; 1.1.1.214; 1.1.1.215; 1.1.1.216; 1.1.1.217; 1.1.1.218; 1.1.1.219; 1.1.1.220; 1.1.1.222; 1.1.1.224; 1.1.1.225; 1.1.1.229; 1.1.1.230; 1.1.1.231; 1.1.1.232; 1.1.1.234; 1.1.1.235; 1.1.1.236; 1.1.1.237; 1.1.1.238; 1.1.1.243; 1.1.1.247; 1.1.1.248; 1.1.1.252; 1.1.1.256; 1.1.1.261; 1.1.1.263; 1.1.1.264; 1.1.1.265; 1.1.1.266; 1.1.1.267; 1.1.1.270; 1.1.1.271; 1.1.1.272; 1.1.1.273; 1.1.1.274; 1.1.1.276; 1.1.1.277; 1.1.1.278; 1.1.1.279; 1.1.1.280; 1.1.1.281; 1.1.1.282; 1.1.1.283; 1.1.1.284; 1.1.1.285; 1.1.1.287; 1.1.1.289; 1.1.1.292; 1.1.1.294; 1.1.1.295; 1.1.1.298; 1.1.1.299; 1.1.1.300; 1.1.1.302; 1.1.1.307; 1.1.1.312; 1.1.1.313; 1.1.1.314; 1.1.1.317; 1.1.1.318; 1.1.1.319; 1.1.1.320; 1.1.1.321; 1.1.1.322; 1.1.1.323; 1.1.1.324; 1.1.1.325; 1.1.1.328; 1.1.1.329; 1.1.1.330; 1.1.1.334; 1.1.1.338; 1.1.1.341; 1.1.1.342; 1.1.1.344; 1.1.1.346; 1.1.1.348; 1.1.1.349; 1.1.1.351; 1.1.1.353; 1.1.1.355; 1.1.1.356; 1.1.1.357; 1.1.1.358; 1.1.1.359; 1.1.1.360; 1.1.1.362; 1.1.1.363; 1.1.1.364; 1.1.1.365; 1.1.1.367; 1.1.1.371; 1.1.1.372; 1.1.1.375; 1.1.1.376; 1.1.1.377; 1.1.1.378; 1.1.1.381; 1.1.1.383; 1.1.1.384; 1.1.1.386; 1.1.1.392; 1.1.1.393; 1.1.1.402; 1.1.1.-; 1.2.1.3; 1.2.1.4; 1.2.1.5; 1.2.1.7; 1.2.1.8; 1.2.1.9; 1.2.1.11; 1.2.1.13; 1.2.1.15; 1.2.1.16; 1.2.1.17; 1.2.1.18; 1.2.1.26; 1.2.1.28; 1.2.1.30; 1.2.1.31; 1.2.1.38; 1.2.1.41; 1.2.1.43; 1.2.1.44; 1.2.1.49; 1.2.1.50; 1.2.1.51; 1.2.1.52; 1.2.1.57; 1.2.1.59; 1.2.1.63; 1.2.1.68; 1.2.1.70; 1.2.1.75; 1.2.1.76; 1.2.1.77; 1.2.1.79; 1.2.1.80; 1.2.1.81; 1.2.1.83; 1.2.1.84; 1.2.1.88; 1.2.1.89; 1.2.1.90; 1.2.1.91; 1.2.1.92; 1.2.1.96; 1.2.1.-; 1.3.1.2; 1.3.1.3; 1.3.1.5; 1.3.1.8; 1.3.1.10; 1.3.1.13; 1.3.1.15; 1.3.1.16; 1.3.1.17; 1.3.1.20; 1.3.1.21; 1.3.1.22; 1.3.1.24; 1.3.1.27; 1.3.1.32; 1.3.1.33; 1.3.1.34; 1.3.1.36; 1.3.1.37; 1.3.1.38; 1.3.1.39; 1.3.1.40; 1.3.1.42; 1.3.1.45; 1.3.1.46; 1.3.1.47; 1.3.1.48; 1.3.1.51; 1.3.1.54; 1.3.1.57; 1.3.1.67; 1.3.1.69; 1.3.1.70; 1.3.1.71; 1.3.1.72; 1.3.1.73; 1.3.1.74; 1.3.1.75; 1.3.1.77; 1.3.1.78; 1.3.1.79; 1.3.1.81; 1.3.1.82; 1.3.1.83; 1.3.1.84; 1.3.1.85; 1.3.1.86; 1.3.1.92; 1.3.1.93; 1.3.1.96; 1.3.1.97; 1.3.1.98; 1.3.1.101; 1.3.1.102; 1.3.1.103; 1.3.1.104; 1.3.1.105; 1.3.1.107; 1.3.1.111; 1.3.1.112; 1.3.1.-; 1.3.3.9; 1.3.99.6; 1.4.1.1; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.5; 1.4.1.7; 1.4.1.8; 1.4.1.9; 1.4.1.10; 1.4.1.12; 1.4.1.13; 1.4.1.15; 1.4.1.16; 1.4.1.17; 1.4.1.19; 1.4.1.20; 1.4.1.21; 1.4.1.-; 1.5.1.1; 1.5.1.2; 1.5.1.3; 1.5.1.5; 1.5.1.6; 1.5.1.8; 1.5.1.10; 1.5.1.16; 1.5.1.19; 1.5.1.20; 1.5.1.21; 1.5.1.24; 1.5.1.25; 1.5.1.27; 1.5.1.30; 1.5.1.31; 1.5.1.32; 1.5.1.33; 1.5.1.34; 1.5.1.38; 1.5.1.39; 1.5.1.40; 1.5.1.41; 1.5.1.43; 1.5.1.45; 1.5.1.46; 1.5.1.47; 1.5.1.48; 1.5.1.49; 1.5.1.50; 1.5.1.-; 1.6.1.1; 1.6.1.2; 1.6.1.3; 1.6.2.4; 1.6.2.5; 1.6.2.6; 1.6.3.1; 1.6.3.2; 1.6.5.2; 1.6.5.5; 1.6.5.6; 1.6.5.10; 1.6.5.12; 1.6.99.1; 1.7.1.2; 1.7.1.3; 1.7.1.4; 1.7.1.6; 1.7.1.7; 1.7.1.9; 1.7.1.11; 1.7.1.12; 1.7.1.13; 1.7.1.14; 1.7.1.-; 1.8.1.2; 1.8.1.5; 1.8.1.7; 1.8.1.8; 1.8.1.9; 1.8.1.10; 1.8.1.12; 1.8.1.13; 1.8.1.14; 1.8.1.15; 1.8.1.18; 1.8.1.19; 1.10.1.1; 1.11.1.2; 1.12.1.3; 1.12.1.5; 1.13.11.29; 1.13.11.30; 1.13.11.-; 1.13.12.-; 1.14.12.1; 1.14.12.4; 1.14.12.5; 1.14.12.10; 1.14.12.17; 1.14.12.18; 1.14.12.22; 1.14.12.-; 1.14.13.2; 1.14.13.7; 1.14.13.8; 1.14.13.9; 1.14.13.11; 1.14.13.12; 1.14.13.14; 1.14.13.16; 1.14.13.18; 1.14.13.19; 1.14.13.20; 1.14.13.21; 1.14.13.22; 1.14.13.23; 1.14.13.25; 1.14.13.27; 1.14.13.28; 1.14.13.30; 1.14.13.31; 1.14.13.32; 1.14.13.33; 1.14.13.34; 1.14.13.35; 1.14.13.36; 1.14.13.37; 1.14.13.38; 1.14.13.39; 1.14.13.40; 1.14.13.43; 1.14.13.46; 1.14.13.47; 1.14.13.48; 1.14.13.49; 1.14.13.50; 1.14.13.51; 1.14.13.52; 1.14.13.53; 1.14.13.54; 1.14.13.55; 1.14.13.56; 1.14.13.57; 1.14.13.58; 1.14.13.59; 1.14.13.63; 1.14.13.64; 1.14.13.66; 1.14.13.67; 1.14.13.70; 1.14.13.71; 1.14.13.72; 1.14.13.73; 1.14.13.74; 1.14.13.75; 1.14.13.76; 1.14.13.77; 1.14.13.78; 1.14.13.79; 1.14.13.80; 1.14.13.81; 1.14.13.84; 1.14.13.85; 1.14.13.87; 1.14.13.88; 1.14.13.89; 1.14.13.91; 1.14.13.92; 1.14.13.93; 1.14.13.94; 1.14.13.96; 1.14.13.97; 1.14.13.101; 1.14.13.102; 1.14.13.103; 1.14.13.104; 1.14.13.105; 1.14.13.106; 1.14.13.107; 1.14.13.108; 1.14.13.109; 1.14.13.110; 1.14.13.112; 1.14.13.115; 1.14.13.116; 1.14.13.117; 1.14.13.118; 1.14.13.119; 1.14.13.120; 1.14.13.121; 1.14.13.122; 1.14.13.123; 1.14.13.124; 1.14.13.125; 1.14.13.128; 1.14.13.133; 1.14.13.134; 1.14.13.135; 1.14.13.136; 1.14.13.137; 1.14.13.138; 1.14.13.139; 1.14.13.140; 1.14.13.143; 1.14.13.144; 1.14.13.145; 1.14.13.146; 1.14.13.147; 1.14.13.148; 1.14.13.149; 1.14.13.150; 1.14.13.153; 1.14.13.154; 1.14.13.156; 1.14.13.157; 1.14.13.158; 1.14.13.160; 1.14.13.161; 1.14.13.165; 1.14.13.167; 1.14.13.168; 1.14.13.170; 1.14.13.171; 1.14.13.172; 1.14.13.173; 1.14.13.174; 1.14.13.175; 1.14.13.176; 1.14.13.177; 1.14.13.178; 1.14.13.179; 1.14.13.180; 1.14.13.181; 1.14.13.183; 1.14.13.184; 1.14.13.185; 1.14.13.186; 1.14.13.187; 1.14.13.188; 1.14.13.189; 1.14.13.190; 1.14.13.194; 1.14.13.195; 1.14.13.196; 1.14.13.197; 1.14.13.198; 1.14.13.199; 1.14.13.200; 1.14.13.201; 1.14.13.202; 1.14.13.203; 1.14.13.204; 1.14.13.206; 1.14.13.208; 1.14.13.210; 1.14.13.211; 1.14.13.213; 1.14.13.214; 1.14.13.216; 1.14.13.217; 1.14.13.219; 1.14.13.221; 1.14.13.222; 1.14.13.224; 1.14.13.225; 1.14.13.226; 1.14.13.228; 1.14.13.229; 1.14.13.231; 1.14.13.232; 1.14.13.233; 1.14.13.234; 1.14.13.-; 1.14.14.1; 1.14.14.16; 1.14.14.17; 1.14.14.19; 1.14.14.23; 1.14.14.24; 1.14.14.25; 1.14.14.26; 1.14.14.29; 1.14.14.36; 1.14.15.3; 1.14.16.-; 1.14.19.21; 1.14.19.41; 1.14.19.48; 1.14.21.1; 1.14.21.2; 1.14.21.3; 1.14.21.4; 1.14.21.5; 1.14.21.7; 1.14.21.8; 1.14.21.9; 1.14.21.10; 1.14.21.11; 1.14.21.12; 1.14.21.-; 1.14.99.2; 1.14.99.34; 1.14.-.-; 1.16.1.1; 1.16.1.5; 1.16.1.6; 1.16.1.8; 1.16.1.9; 1.17.1.1; 1.17.1.3; 1.17.1.5; 1.17.1.8; 1.18.1.2; 1.18.1.4; 1.18.1.6; 1.19.1.1; 1.21.1.1; 1.21.1.2; 1.23.1.1; 1.23.1.2; 1.23.1.3; 1.23.1.4; 1.23.1.-; 1.-.-.-; 2.1.1.147; 2.1.1.148; 2.3.1.85; 2.3.1.86; 2.3.1.94; 2.3.1.111; 2.3.1.161; 2.3.1.165; 2.3.1.170; 2.3.1.236; 2.3.1.237; 2.3.1.239; 2.3.1.240; 2.3.1.244; 2.3.1.252; 2.3.1.-; 2.5.1.21; 2.7.1.86; 4.1.1.-; 4.1.99.5; 4.2.1.93; 4.2.1.136; 4.2.1.-; 5.3.3.1,NA,NA,CAS: 2646-71-1; PubChem: 3307; ChEBI: 16474; ChEMBL: CHEMBL1163090 CHEMBL1594246 CHEMBL407009; PDB-CCD: NDP; 3DMET: B01128; NIKKAJI: J208.978E,cpd:C00005; cpd:C20745,21,30,17,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O17N7P3,C21H29O17N7P3,745.0911035,746.0989286,744.0832785576,672,cpd:C00006,NADP+;,C21H29N7O17P3,NADP+; NADP; Nicotinamide adenine dinucleotide phosphate; beta-Nicotinamide adenine dinucleotide phosphate; TPN; Triphosphopyridine nucleotide; beta-NADP+,R00104 R00106 R00107 R00108 R00109 R00111 R00112 R00113; R00114 R00115 R00118 R00119 R00134 R00146 R00205 R00210; R00216 R00248 R00264 R00265 R00267 R00282 R00301 R00343; R00385 R00387 R00448 R00452 R00465 R00468 R00557 R00558; R00563 R00625 R00634 R00666 R00676 R00706 R00708 R00711; R00714 R00716 R00733 R00740 R00744 R00746 R00789 R00796; R00814 R00815 R00825 R00828 R00834 R00835 R00844 R00845; R00858 R00870 R00871 R00900 R00918 R00919 R00939 R00940; R00941 R00978 R00980 R01039 R01041 R01058 R01063 R01079; R01095 R01096 R01097 R01134 R01143 R01173 R01195 R01212; R01220 R01224 R01249 R01251 R01260 R01278 R01294 R01295; R01298 R01299 R01338 R01371 R01392 R01404 R01415 R01420; R01430 R01431 R01452 R01453 R01456 R01457 R01463 R01481; R01488 R01490 R01521 R01525 R01528 R01543 R01550 R01575; R01584 R01607 R01615 R01628 R01630 R01694 R01708 R01720; R01730 R01739 R01740 R01747 R01750 R01759 R01775 R01779; R01787 R01794 R01812 R01813 R01817 R01835 R01838 R01866; R01899 R01904 R01938 R01941 R01960 R01976 R01977 R01986; R02002 R02016 R02034 R02063 R02082 R02177 R02178 R02193; R02203 R02208 R02209 R02210 R02219 R02220 R02224 R02231; R02236 R02247 R02253 R02254 R02259 R02260 R02291 R02315; R02339 R02349 R02353 R02355 R02356 R02364 R02393 R02413; R02417 R02442 R02449 R02456 R02463 R02468 R02469 R02470; R02472 R02477 R02497 R02498 R02506 R02516 R02517 R02518; R02528 R02537 R02548 R02554 R02562 R02566 R02577 R02581; R02593 R02600 R02609 R02610 R02620 R02639 R02680 R02684; R02697 R02736 R02742 R02755 R02756 R02767 R02776 R02777; R02793 R02799 R02800 R02807 R02820 R02829 R02832 R02836; R02841 R02856 R02872 R02874 R02892 R02893 R02906 R02915; R02936 R02954 R02975 R02978 R02983 R02989 R02995 R02999; R03006 R03044 R03051 R03054 R03089 R03090 R03103 R03114; R03123 R03124 R03155 R03183 R03192 R03203 R03227 R03234; R03264 R03281 R03292 R03293 R03302 R03313 R03322 R03325; R03338 R03339 R03344 R03357 R03386 R03388 R03392 R03398; R03399 R03401 R03407 R03408 R03440 R03443 R03452 R03458; R03463 R03495 R03498 R03520 R03545 R03555 R03556 R03557; R03560 R03562 R03566 R03568 R03572 R03581 R03583 R03585; R03586 R03592 R03596 R03608 R03611 R03615 R03636 R03638; R03639 R03667 R03689 R03712 R03713 R03716 R03728 R03753; R03764 R03776 R03821 R03827 R03834 R03842 R03845 R03848; R03850 R03856 R03860 R03864 R03866 R03879 R03883 R03900; R03914 R03918 R03930 R03962 R03982 R03989 R03997 R03999; R04047 R04059 R04060 R04099 R04105 R04106 R04109 R04136; R04186 R04199 R04201 R04229 R04256 R04264 R04265 R04279; R04285 R04303 R04310 R04319 R04328 R04340 R04342 R04344; R04360 R04370 R04387 R04390 R04400 R04419 R04430 R04439; R04440 R04445 R04453 R04518 R04523 R04533 R04534 R04536; R04543 R04552 R04557 R04566 R04570 R04599 R04601 R04623; R04670 R04675 R04682 R04688 R04690 R04694 R04695 R04696; R04697 R04699 R04700 R04702 R04708 R04725 R04753 R04758; R04789 R04790 R04817 R04819 R04823 R04825 R04830 R04833; R04836 R04838 R04840 R04843 R04846 R04853 R04883 R04889; R04892 R04901 R04902 R04910 R04917 R04919 R04940 R04953; R04956 R04959 R04962 R04964 R04967 R04970 R04980 R04984; R04987 R04989 R05038 R05068 R05099 R05102 R05124 R05150; R05182 R05188 R05189 R05190 R05210 R05215 R05231 R05244; R05249 R05250 R05258 R05262 R05264 R05270 R05276 R05289; R05291 R05293 R05308 R05350 R05396 R05400 R05401 R05432; R05433 R05436 R05438 R05441 R05462 R05463 R05471 R05521; R05522 R05526 R05576 R05622 R05623 R05639 R05640 R05641; R05663 R05664 R05680 R05682 R05684 R05686 R05687 R05688; R05691 R05692 R05694 R05701 R05702 R05703 R05706 R05707; R05711 R05713 R05714 R05716 R05725 R05727 R05731 R05732; R05736 R05737 R05738 R05741 R05823 R05827 R05828 R05832; R05833 R05847 R05848 R05855 R05866 R05874 R05877 R05878; R05879 R06119 R06126 R06146 R06166 R06223 R06265 R06266; R06267 R06272 R06286 R06290 R06291 R06292 R06293 R06294; R06295 R06296 R06297 R06308 R06309 R06351 R06354 R06386; R06387 R06388 R06389 R06400 R06417 R06419 R06420 R06434; R06436 R06448 R06449 R06453 R06454 R06458 R06459 R06462; R06463 R06464 R06465 R06467 R06468 R06470 R06472 R06473; R06474 R06475 R06480 R06481 R06482 R06483 R06532 R06533; R06537 R06538 R06541 R06542 R06543 R06560 R06561 R06562; R06563 R06568 R06569 R06570 R06571 R06572 R06573 R06582; R06606 R06607 R06610 R06613 R06615 R06622 R06629 R06642; R06677 R06682 R06683 R06688 R06689 R06690 R06691 R06692; R06704 R06734 R06792 R06846 R06851 R06890 R06892 R06896; R06985 R07000 R07001 R07015 R07016 R07020 R07021 R07022; R07041 R07046 R07048 R07050 R07051 R07052 R07054 R07055; R07056 R07060 R07066 R07068 R07075 R07079 R07080 R07081; R07085 R07087 R07088 R07089 R07090 R07098 R07099 R07107; R07112 R07137 R07138 R07140 R07142 R07143 R07144 R07147; R07149 R07150 R07162 R07165 R07169 R07172 R07175 R07181; R07191 R07192 R07193 R07195 R07196 R07197 R07198 R07201; R07202 R07203 R07204 R07205 R07206 R07207 R07208 R07216; R07217 R07241 R07251 R07253 R07328 R07346 R07350 R07352; R07355 R07356 R07357 R07359 R07369 R07370 R07371 R07373; R07403 R07407 R07418 R07421 R07422 R07423 R07429 R07430; R07437 R07440 R07442 R07445 R07447 R07452 R07453 R07454; R07470 R07474 R07483 R07488 R07489 R07493 R07494 R07495; R07498 R07499 R07506 R07507 R07509 R07605 R07666 R07676; R07710 R07711 R07714 R07715 R07727 R07728 R07737 R07739; R07745 R07746 R07747 R07748 R07751 R07752 R07759 R07761; R07763 R07776 R07777 R07778 R07779 R07786 R07787 R07791; R07792 R07836 R07837 R07939 R07956 R07958 R07960 R07962; R07964 R07966 R07968 R07970 R07972 R07974 R07976 R07998; R07999 R08002 R08014 R08015 R08016 R08019 R08032 R08059; R08083 R08084 R08085 R08148 R08160 R08168 R08194 R08203; R08204 R08205 R08206 R08207 R08208 R08226 R08266 R08267; R08270 R08271 R08274 R08275 R08283 R08285 R08294 R08303; R08304 R08312 R08313 R08325 R08326 R08327 R08356 R08357; R08379 R08380 R08383 R08390 R08391 R08392 R08442 R08492; R08494 R08499 R08510 R08539 R08551 R08558 R08561 R08562; R08563 R08573 R08604 R08607 R08651 R08652 R08653 R08655; R08659 R08663 R08664 R08665 R08666 R08670 R08672 R08673; R08674 R08675 R08684 R08685 R08705 R08710 R08711 R08725; R08726 R08727 R08754 R08755 R08756 R08768 R08775 R08784; R08790 R08815 R08838 R08851 R08852 R08853 R08854 R08861; R08878 R08879 R08880 R08912 R08913 R08915 R08917 R08922; R08923 R08925 R08935 R08943 R08954 R08955 R08957 R08958; R08959 R08960 R08961 R08963 R08980 R09002 R09042 R09070; R09079 R09080 R09122 R09131 R09133 R09138 R09190 R09193; R09194 R09198 R09234 R09240 R09241 R09242 R09243 R09262; R09263 R09264 R09275 R09280 R09281 R09289 R09291 R09306; R09309 R09329 R09353 R09372 R09376 R09389 R09390 R09393; R09403 R09404 R09405 R09406 R09407 R09408 R09416 R09418; R09420 R09421 R09423 R09424 R09425 R09441 R09442 R09446; R09449 R09451 R09452 R09453 R09454 R09460 R09461 R09470; R09485 R09512 R09520 R09521 R09522 R09541 R09546 R09547; R09548 R09549 R09554 R09555 R09557 R09573 R09575 R09576; R09577 R09578 R09579 R09580 R09583 R09584 R09602 R09738; R09749 R09756 R09777 R09806 R09812 R09813 R09814 R09815; R09816 R09817 R09818 R09820 R09838 R09861 R09862 R09863; R09864 R09865 R09866 R09867 R09868 R09921 R09926 R09927; R09928 R09929 R09930 R09931 R09932 R09933 R09934 R09935; R09954 R09985 R09987 R09989 R09990 R10023 R10024 R10025; R10026 R10027 R10028 R10031 R10032 R10036 R10038 R10044; R10045 R10058 R10059 R10066 R10067 R10068 R10069 R10072; R10073 R10075 R10076 R10077 R10080 R10104 R10105 R10114; R10116 R10118 R10120 R10122 R10127 R10130 R10132 R10154; R10155 R10159 R10181 R10194 R10225 R10226 R10227 R10228; R10229 R10242 R10248 R10249 R10258 R10260 R10289 R10309; R10313 R10314 R10315 R10316 R10317 R10318 R10319 R10320; R10321 R10323 R10326 R10350 R10351 R10356 R10357 R10358; R10359 R10361 R10362 R10366 R10367 R10368 R10371 R10373; R10376 R10379 R10381 R10399 R10400 R10414 R10416 R10417; R10418 R10421 R10423 R10429 R10438 R10476 R10477 R10478; R10479 R10512 R10518 R10528 R10540 R10549 R10562 R10563; R10573 R10591 R10593 R10615 R10626 R10627 R10628 R10631; R10636 R10637 R10656 R10662 R10663 R10664 R10665 R10670; R10671 R10672 R10692 R10694 R10704 R10725 R10727 R10728; R10730 R10786 R10787 R10788 R10789 R10791 R10793 R10794; R10795 R10799 R10801 R10826 R10828 R10851 R10852 R10862; R10875 R10877 R10878 R10879 R10882 R10919 R10921 R10922; R10923 R10924 R10925 R10931 R10954 R10982 R10984 R10999; R11000 R11008 R11019 R11032 R11051 R11054 R11061 R11096; R11097 R11107 R11124 R11125 R11132 R11134 R11135 R11145; R11146 R11152 R11157 R11195 R11198 R11211 R11212 R11222; R11226 R11232 R11266 R11276 R11277 R11341 R11358 R11359; R11360 R11361 R11383 R11385 R11405 R11425 R11426 R11427; R11435 R11445 R11446 R11447 R11449 R11450 R11451 R11474; R11477 R11485 R11500 R11518 R11525 R11526,Photosynthesis; Glutathione metabolism; Nicotinate and nicotinamide metabolism; Metabolic pathways; Thyroid hormone synthesis; Aldosterone synthesis and secretion,1.1.1.1; 1.1.1.2; 1.1.1.3; 1.1.1.10; 1.1.1.19; 1.1.1.20; 1.1.1.21; 1.1.1.25; 1.1.1.33; 1.1.1.34; 1.1.1.36; 1.1.1.40; 1.1.1.42; 1.1.1.43; 1.1.1.44; 1.1.1.47; 1.1.1.48; 1.1.1.49; 1.1.1.50; 1.1.1.51; 1.1.1.54; 1.1.1.55; 1.1.1.60; 1.1.1.62; 1.1.1.64; 1.1.1.65; 1.1.1.69; 1.1.1.71; 1.1.1.72; 1.1.1.79; 1.1.1.80; 1.1.1.81; 1.1.1.82; 1.1.1.86; 1.1.1.91; 1.1.1.92; 1.1.1.94; 1.1.1.97; 1.1.1.100; 1.1.1.101; 1.1.1.102; 1.1.1.104; 1.1.1.111; 1.1.1.112; 1.1.1.113; 1.1.1.115; 1.1.1.117; 1.1.1.119; 1.1.1.120; 1.1.1.123; 1.1.1.124; 1.1.1.126; 1.1.1.130; 1.1.1.131; 1.1.1.133; 1.1.1.134; 1.1.1.135; 1.1.1.137; 1.1.1.138; 1.1.1.142; 1.1.1.145; 1.1.1.146; 1.1.1.147; 1.1.1.148; 1.1.1.149; 1.1.1.151; 1.1.1.153; 1.1.1.154; 1.1.1.156; 1.1.1.157; 1.1.1.160; 1.1.1.162; 1.1.1.168; 1.1.1.169; 1.1.1.170; 1.1.1.176; 1.1.1.177; 1.1.1.179; 1.1.1.181; 1.1.1.183; 1.1.1.184; 1.1.1.185; 1.1.1.186; 1.1.1.187; 1.1.1.188; 1.1.1.189; 1.1.1.191; 1.1.1.193; 1.1.1.194; 1.1.1.195; 1.1.1.196; 1.1.1.197; 1.1.1.200; 1.1.1.201; 1.1.1.206; 1.1.1.207; 1.1.1.208; 1.1.1.209; 1.1.1.210; 1.1.1.213; 1.1.1.214; 1.1.1.215; 1.1.1.216; 1.1.1.217; 1.1.1.218; 1.1.1.219; 1.1.1.220; 1.1.1.222; 1.1.1.224; 1.1.1.225; 1.1.1.229; 1.1.1.230; 1.1.1.231; 1.1.1.232; 1.1.1.234; 1.1.1.235; 1.1.1.236; 1.1.1.237; 1.1.1.238; 1.1.1.243; 1.1.1.247; 1.1.1.248; 1.1.1.252; 1.1.1.256; 1.1.1.261; 1.1.1.263; 1.1.1.264; 1.1.1.265; 1.1.1.266; 1.1.1.267; 1.1.1.270; 1.1.1.271; 1.1.1.272; 1.1.1.273; 1.1.1.274; 1.1.1.276; 1.1.1.277; 1.1.1.278; 1.1.1.279; 1.1.1.280; 1.1.1.281; 1.1.1.282; 1.1.1.283; 1.1.1.284; 1.1.1.285; 1.1.1.287; 1.1.1.289; 1.1.1.292; 1.1.1.294; 1.1.1.295; 1.1.1.298; 1.1.1.299; 1.1.1.300; 1.1.1.302; 1.1.1.307; 1.1.1.312; 1.1.1.313; 1.1.1.314; 1.1.1.317; 1.1.1.318; 1.1.1.319; 1.1.1.320; 1.1.1.321; 1.1.1.322; 1.1.1.323; 1.1.1.324; 1.1.1.325; 1.1.1.328; 1.1.1.329; 1.1.1.330; 1.1.1.334; 1.1.1.338; 1.1.1.341; 1.1.1.342; 1.1.1.344; 1.1.1.346; 1.1.1.348; 1.1.1.349; 1.1.1.351; 1.1.1.353; 1.1.1.355; 1.1.1.356; 1.1.1.357; 1.1.1.358; 1.1.1.359; 1.1.1.360; 1.1.1.362; 1.1.1.363; 1.1.1.364; 1.1.1.365; 1.1.1.367; 1.1.1.371; 1.1.1.372; 1.1.1.375; 1.1.1.376; 1.1.1.377; 1.1.1.378; 1.1.1.381; 1.1.1.383; 1.1.1.384; 1.1.1.386; 1.1.1.392; 1.1.1.393; 1.1.1.402; 1.1.1.-; 1.2.1.3; 1.2.1.4; 1.2.1.5; 1.2.1.7; 1.2.1.8; 1.2.1.9; 1.2.1.11; 1.2.1.13; 1.2.1.15; 1.2.1.16; 1.2.1.17; 1.2.1.18; 1.2.1.26; 1.2.1.28; 1.2.1.30; 1.2.1.31; 1.2.1.38; 1.2.1.41; 1.2.1.43; 1.2.1.44; 1.2.1.49; 1.2.1.50; 1.2.1.51; 1.2.1.52; 1.2.1.57; 1.2.1.59; 1.2.1.63; 1.2.1.68; 1.2.1.70; 1.2.1.75; 1.2.1.76; 1.2.1.77; 1.2.1.79; 1.2.1.80; 1.2.1.81; 1.2.1.83; 1.2.1.84; 1.2.1.88; 1.2.1.89; 1.2.1.90; 1.2.1.91; 1.2.1.92; 1.2.1.96; 1.2.1.-; 1.3.1.2; 1.3.1.3; 1.3.1.5; 1.3.1.8; 1.3.1.10; 1.3.1.13; 1.3.1.15; 1.3.1.16; 1.3.1.17; 1.3.1.20; 1.3.1.21; 1.3.1.22; 1.3.1.24; 1.3.1.27; 1.3.1.32; 1.3.1.33; 1.3.1.34; 1.3.1.36; 1.3.1.37; 1.3.1.38; 1.3.1.39; 1.3.1.40; 1.3.1.42; 1.3.1.45; 1.3.1.46; 1.3.1.47; 1.3.1.48; 1.3.1.51; 1.3.1.54; 1.3.1.57; 1.3.1.67; 1.3.1.69; 1.3.1.70; 1.3.1.71; 1.3.1.72; 1.3.1.73; 1.3.1.74; 1.3.1.75; 1.3.1.77; 1.3.1.78; 1.3.1.79; 1.3.1.81; 1.3.1.82; 1.3.1.83; 1.3.1.84; 1.3.1.85; 1.3.1.86; 1.3.1.92; 1.3.1.93; 1.3.1.96; 1.3.1.97; 1.3.1.98; 1.3.1.101; 1.3.1.102; 1.3.1.103; 1.3.1.104; 1.3.1.105; 1.3.1.107; 1.3.1.111; 1.3.1.112; 1.3.1.-; 1.3.3.9; 1.3.99.6; 1.4.1.1; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.5; 1.4.1.7; 1.4.1.8; 1.4.1.9; 1.4.1.10; 1.4.1.12; 1.4.1.13; 1.4.1.15; 1.4.1.16; 1.4.1.17; 1.4.1.19; 1.4.1.20; 1.4.1.21; 1.4.1.-; 1.5.1.1; 1.5.1.2; 1.5.1.3; 1.5.1.5; 1.5.1.6; 1.5.1.8; 1.5.1.10; 1.5.1.16; 1.5.1.19; 1.5.1.20; 1.5.1.21; 1.5.1.24; 1.5.1.25; 1.5.1.27; 1.5.1.30; 1.5.1.31; 1.5.1.32; 1.5.1.33; 1.5.1.34; 1.5.1.38; 1.5.1.39; 1.5.1.40; 1.5.1.41; 1.5.1.43; 1.5.1.45; 1.5.1.46; 1.5.1.47; 1.5.1.48; 1.5.1.49; 1.5.1.50; 1.5.1.-; 1.6.1.1; 1.6.1.2; 1.6.1.3; 1.6.2.4; 1.6.2.5; 1.6.2.6; 1.6.3.1; 1.6.3.2; 1.6.3.5; 1.6.5.2; 1.6.5.5; 1.6.5.6; 1.6.5.10; 1.6.5.12; 1.6.99.1; 1.7.1.2; 1.7.1.3; 1.7.1.4; 1.7.1.6; 1.7.1.7; 1.7.1.9; 1.7.1.11; 1.7.1.12; 1.7.1.13; 1.7.1.14; 1.7.1.-; 1.8.1.2; 1.8.1.5; 1.8.1.7; 1.8.1.8; 1.8.1.9; 1.8.1.10; 1.8.1.12; 1.8.1.13; 1.8.1.14; 1.8.1.15; 1.8.1.18; 1.8.1.19; 1.10.1.1; 1.11.1.2; 1.12.1.3; 1.12.1.5; 1.13.11.29; 1.13.11.30; 1.13.11.-; 1.13.12.-; 1.14.12.1; 1.14.12.4; 1.14.12.5; 1.14.12.10; 1.14.12.17; 1.14.12.18; 1.14.12.22; 1.14.12.-; 1.14.13.2; 1.14.13.7; 1.14.13.8; 1.14.13.9; 1.14.13.11; 1.14.13.12; 1.14.13.14; 1.14.13.16; 1.14.13.18; 1.14.13.19; 1.14.13.20; 1.14.13.21; 1.14.13.22; 1.14.13.23; 1.14.13.25; 1.14.13.27; 1.14.13.28; 1.14.13.30; 1.14.13.31; 1.14.13.32; 1.14.13.33; 1.14.13.34; 1.14.13.35; 1.14.13.36; 1.14.13.37; 1.14.13.38; 1.14.13.39; 1.14.13.40; 1.14.13.43; 1.14.13.46; 1.14.13.47; 1.14.13.48; 1.14.13.49; 1.14.13.50; 1.14.13.51; 1.14.13.52; 1.14.13.53; 1.14.13.54; 1.14.13.55; 1.14.13.56; 1.14.13.57; 1.14.13.58; 1.14.13.59; 1.14.13.63; 1.14.13.64; 1.14.13.66; 1.14.13.67; 1.14.13.70; 1.14.13.71; 1.14.13.72; 1.14.13.73; 1.14.13.74; 1.14.13.75; 1.14.13.76; 1.14.13.77; 1.14.13.78; 1.14.13.79; 1.14.13.80; 1.14.13.81; 1.14.13.84; 1.14.13.85; 1.14.13.87; 1.14.13.88; 1.14.13.89; 1.14.13.91; 1.14.13.92; 1.14.13.93; 1.14.13.94; 1.14.13.96; 1.14.13.97; 1.14.13.101; 1.14.13.102; 1.14.13.103; 1.14.13.104; 1.14.13.105; 1.14.13.106; 1.14.13.107; 1.14.13.108; 1.14.13.109; 1.14.13.110; 1.14.13.112; 1.14.13.115; 1.14.13.116; 1.14.13.117; 1.14.13.118; 1.14.13.119; 1.14.13.120; 1.14.13.121; 1.14.13.122; 1.14.13.123; 1.14.13.124; 1.14.13.125; 1.14.13.128; 1.14.13.133; 1.14.13.134; 1.14.13.135; 1.14.13.136; 1.14.13.137; 1.14.13.138; 1.14.13.139; 1.14.13.140; 1.14.13.143; 1.14.13.144; 1.14.13.145; 1.14.13.146; 1.14.13.147; 1.14.13.148; 1.14.13.149; 1.14.13.150; 1.14.13.153; 1.14.13.154; 1.14.13.156; 1.14.13.157; 1.14.13.158; 1.14.13.160; 1.14.13.161; 1.14.13.165; 1.14.13.167; 1.14.13.168; 1.14.13.170; 1.14.13.171; 1.14.13.172; 1.14.13.173; 1.14.13.174; 1.14.13.175; 1.14.13.176; 1.14.13.177; 1.14.13.178; 1.14.13.179; 1.14.13.180; 1.14.13.181; 1.14.13.183; 1.14.13.184; 1.14.13.185; 1.14.13.186; 1.14.13.187; 1.14.13.188; 1.14.13.189; 1.14.13.190; 1.14.13.194; 1.14.13.195; 1.14.13.196; 1.14.13.197; 1.14.13.198; 1.14.13.199; 1.14.13.200; 1.14.13.201; 1.14.13.202; 1.14.13.203; 1.14.13.204; 1.14.13.206; 1.14.13.208; 1.14.13.210; 1.14.13.211; 1.14.13.213; 1.14.13.214; 1.14.13.216; 1.14.13.217; 1.14.13.219; 1.14.13.221; 1.14.13.222; 1.14.13.224; 1.14.13.225; 1.14.13.226; 1.14.13.228; 1.14.13.229; 1.14.13.231; 1.14.13.232; 1.14.13.233; 1.14.13.234; 1.14.13.-; 1.14.14.1; 1.14.14.16; 1.14.14.17; 1.14.14.19; 1.14.14.23; 1.14.14.24; 1.14.14.25; 1.14.14.26; 1.14.14.29; 1.14.14.36; 1.14.15.3; 1.14.16.-; 1.14.19.21; 1.14.19.41; 1.14.19.48; 1.14.21.1; 1.14.21.2; 1.14.21.3; 1.14.21.4; 1.14.21.5; 1.14.21.7; 1.14.21.8; 1.14.21.9; 1.14.21.10; 1.14.21.11; 1.14.21.12; 1.14.21.-; 1.14.99.2; 1.14.99.34; 1.14.-.-; 1.16.1.1; 1.16.1.5; 1.16.1.6; 1.16.1.8; 1.16.1.9; 1.17.1.1; 1.17.1.3; 1.17.1.5; 1.17.1.8; 1.18.1.2; 1.18.1.4; 1.18.1.6; 1.19.1.1; 1.21.1.1; 1.21.1.2; 1.23.1.1; 1.23.1.2; 1.23.1.3; 1.23.1.4; 1.23.1.-; 1.-.-.-; 2.1.1.147; 2.1.1.148; 2.3.1.85; 2.3.1.86; 2.3.1.94; 2.3.1.111; 2.3.1.161; 2.3.1.165; 2.3.1.170; 2.3.1.236; 2.3.1.237; 2.3.1.239; 2.3.1.240; 2.3.1.244; 2.3.1.252; 2.3.1.-; 2.4.99.20; 2.5.1.21; 2.7.1.23; 3.1.3.-; 4.1.1.-; 4.1.99.5; 4.2.1.-; 5.3.3.1,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00006  NADP,CAS: 53-59-8; PubChem: 3308; ChEBI: 18009; ChEMBL: CHEMBL1623886 CHEMBL295069; PDB-CCD: NAP; 3DMET: B01129; NIKKAJI: J247.824B,cpd:C00006,21,29,17,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H30O17N7P3,C21H28O17N7P3,744.0832785,745.0911035,743.0754535577,675,cpd:C02185,Plastoquinol-1,C13H18O2,Plastoquinol-1,NA,Photosynthesis; Metabolic pathways,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0201 Ubiquinones;     C02185  Plastoquinol-1,PubChem: 5256; ChEBI: 16323; LIPIDMAPS: LMPR02010037; 3DMET: B04841; NIKKAJI: J2.735.622B,cpd:C01588; cpd:C02185; cpd:C07122; cpd:C11200; cpd:C18326; cpd:C18718; cpd:C19256; cpd:C19442,13,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H19O2,C13H17O2,206.1306798,207.1385049,205.1228548578,678,cpd:C00025,L-Glutamate;,C5H9NO4,L-Glutamate; L-Glutamic acid; L-Glutaminic acid; Glutamate,R00021 R00093 R00114 R00239 R00241 R00243 R00245 R00248; R00250 R00251 R00253 R00254 R00256 R00257 R00258 R00259; R00260 R00261 R00262 R00263 R00355 R00372 R00411 R00457; R00494 R00525 R00573 R00575 R00578 R00609 R00667 R00668; R00684 R00694 R00707 R00708 R00734 R00768 R00894 R00895; R00908 R00942 R00986 R01072 R01090 R01155 R01161 R01214; R01231 R01339 R01585 R01586 R01648 R01654 R01684 R01716; R01939 R01956 R02040 R02077 R02199 R02237 R02274 R02282; R02283 R02285 R02287 R02313 R02315 R02433 R02619 R02700; R02772 R02773 R02929 R02930 R03053 R03120 R03189 R03207; R03243 R03248 R03266 R03651 R03905 R03916 R03952 R03970; R03971 R04028 R04029 R04051 R04171 R04173 R04188 R04212; R04217 R04234 R04241 R04242 R04269 R04338 R04438 R04463; R04467 R04475 R04529 R04558 R04776 R05052 R05085 R05197; R05207 R05224 R05225 R05507 R05578 R05815 R06423 R06426; R06586 R06631 R06634 R06977 R07275 R07276 R07277 R07396; R07414 R07419 R07456 R07613 R07643 R07659 R08244 R08855; R08897 R08903 R08905 R08906 R08931 R08956 R09195 R09399; R09400 R09401 R09495 R09594 R09598 R09599 R09778 R09824; R09825 R09875 R10064 R10086 R10089 R10094 R10141 R10153; R10460 R10677 R10678 R10679 R10687 R10688 R10693 R10698; R10772 R10845 R10902 R10929 R10932 R10991 R10993 R11021; R11118 R11269 R11270 R11285 R11291 R11297 R11298 R11299; R11395 R11409 R11475 R11515 R11561,"Arginine biosynthesis; Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Carbapenem biosynthesis; Histidine metabolism; Taurine and hypotaurine metabolism; D-Glutamine and D-glutamate metabolism; Glutathione metabolism; Neomycin, kanamycin and gentamicin biosynthesis; Glyoxylate and dicarboxylate metabolism; Butanoate metabolism; C5-Branched dibasic acid metabolism; Porphyrin and chlorophyll metabolism; Nitrogen metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; Two-component system; FoxO signaling pathway; Phospholipase D signaling pathway; Neuroactive ligand-receptor interaction; Gap junction; Circadian entrainment; Long-term potentiation; Synaptic vesicle cycle; Retrograde endocannabinoid signaling; Glutamatergic synapse; GABAergic synapse; Long-term depression; Taste transduction; Proximal tubule bicarbonate reclamation; Protein digestion and absorption; Amyotrophic lateral sclerosis (ALS); Huntington's disease; Cocaine addiction; Amphetamine addiction; Nicotine addiction; Alcoholism; Central carbon metabolism in cancer",1.2.1.88; 1.4.1.2; 1.4.1.3; 1.4.1.4; 1.4.1.13; 1.4.1.14; 1.4.3.11; 1.4.7.1; 1.5.1.9; 1.5.1.10; 1.5.3.18; 1.5.99.5; 2.1.1.21; 2.1.2.5; 2.3.1.1; 2.3.1.14; 2.3.1.35; 2.3.2.2; 2.3.2.-; 2.4.2.14; 2.4.2.-; 2.6.1.1; 2.6.1.2; 2.6.1.3; 2.6.1.4; 2.6.1.5; 2.6.1.6; 2.6.1.7; 2.6.1.8; 2.6.1.9; 2.6.1.11; 2.6.1.13; 2.6.1.16; 2.6.1.17; 2.6.1.19; 2.6.1.22; 2.6.1.23; 2.6.1.24; 2.6.1.26; 2.6.1.27; 2.6.1.29; 2.6.1.33; 2.6.1.34; 2.6.1.36; 2.6.1.38; 2.6.1.39; 2.6.1.40; 2.6.1.42; 2.6.1.44; 2.6.1.48; 2.6.1.49; 2.6.1.52; 2.6.1.55; 2.6.1.57; 2.6.1.59; 2.6.1.65; 2.6.1.67; 2.6.1.72; 2.6.1.75; 2.6.1.76; 2.6.1.79; 2.6.1.80; 2.6.1.81; 2.6.1.82; 2.6.1.83; 2.6.1.85; 2.6.1.86; 2.6.1.87; 2.6.1.89; 2.6.1.90; 2.6.1.92; 2.6.1.93; 2.6.1.94; 2.6.1.95; 2.6.1.98; 2.6.1.102; 2.6.1.103; 2.6.1.104; 2.6.1.106; 2.6.1.107; 2.6.1.109; 2.6.1.110; 2.6.1.-; 2.7.2.11; 2.7.2.13; 3.4.17.21; 3.4.19.9; 3.4.19.13; 3.4.19.14; 3.5.1.2; 3.5.1.38; 3.5.1.55; 3.5.1.65; 3.5.1.68; 3.5.1.87; 3.5.1.94; 3.5.1.96; 3.5.1.118; 3.5.1.123; 3.5.2.9; 3.5.3.8; 4.1.1.15; 4.1.3.27; 4.1.3.-; 4.2.1.168; 4.3.3.6; 5.1.1.3; 5.4.3.9; 5.4.99.1; 6.1.1.17; 6.1.1.24; 6.2.1.39; 6.3.1.2; 6.3.1.6; 6.3.1.11; 6.3.1.17; 6.3.1.18; 6.3.2.2; 6.3.2.12; 6.3.2.17; 6.3.2.18; 6.3.2.31; 6.3.2.32; 6.3.2.33; 6.3.2.34; 6.3.2.41; 6.3.2.42; 6.3.2.-; 6.3.4.2; 6.3.4.12; 6.3.4.24; 6.3.5.1; 6.3.5.2; 6.3.5.3; 6.3.5.4; 6.3.5.5; 6.3.5.6; 6.3.5.7; 6.3.5.9; 6.3.5.10; 6.3.5.11; 6.3.5.-,"Proline biosynthesis, glutamate => proline; GABA (gamma-Aminobutyrate) shunt; Ornithine biosynthesis, glutamate => ornithine; Histidine degradation, histidine => N-formiminoglutamate => glutamate; Glutathione biosynthesis, glutamate => glutathione; Heme biosynthesis, glutamate => protoheme/siroheme; Photorespiration; Methylaspartate cycle; Ornithine biosynthesis, mediated by LysW, glutamate => ornithine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00025  Glutamic acid (Glu);  Hormones and transmitters;   Neurotransmitters;    Amino acids;     C00025  Glutamate; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Glutamic acid;     D00007  Glutamic acid (USP); Pharmaceutical additives [BR:br08316];  Buffering agent;   D00007  [003613] L-Glutamic acid;  Flavoring substance;   D00007  [003613] L-Glutamic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00007  L-Glutamic acid,CAS: 56-86-0; PubChem: 3327; ChEBI: 16015; ChEMBL: CHEMBL575060; KNApSAcK: C00001358; PDB-CCD: GGL GLU; 3DMET: B00007; NIKKAJI: J9.171E,cpd:C00025; cpd:C00217; cpd:C00302; cpd:C00979; cpd:C03618; cpd:C03727; cpd:C03790; cpd:C05574; cpd:C05938; cpd:C05941; cpd:C12269,5,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O4N1,C5H8O4N1,147.0531578,148.0609828,146.0453327579,679,cpd:C00049,L-Aspartate;,C4H7NO4,L-Aspartate; L-Aspartic acid; 2-Aminosuccinic acid; L-Asp,R00355 R00357 R00373 R00397 R00400 R00480 R00481 R00482; R00483 R00484 R00485 R00486 R00487 R00488 R00489 R00490; R00491 R00493 R00526 R00546 R00578 R00695 R00777 R01135; R01397 R01713 R01731 R01954 R03421 R03647 R04591 R05577; R07164 R07165 R07407 R07410 R08478 R09592 R09805,"Arginine biosynthesis; Alanine, aspartate and glutamate metabolism; Glycine, serine and threonine metabolism; Monobactam biosynthesis; Cysteine and methionine metabolism; Lysine biosynthesis; Histidine metabolism; beta-Alanine metabolism; Cyanoamino acid metabolism; Carbon fixation in photosynthetic organisms; Nicotinate and nicotinamide metabolism; Pantothenate and CoA biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; Two-component system; Bacterial chemotaxis; Neuroactive ligand-receptor interaction; Protein digestion and absorption; Central carbon metabolism in cancer",1.2.1.-; 1.4.1.21; 1.4.3.2; 1.4.3.16; 2.1.3.2; 2.3.1.17; 2.6.1.1; 2.6.1.12; 2.6.1.31; 2.6.1.35; 2.6.1.57; 2.6.1.70; 2.6.1.78; 2.6.1.-; 2.7.2.4; 3.5.1.1; 3.5.1.7; 3.5.1.8; 3.5.1.15; 3.5.1.26; 3.5.1.38; 3.5.3.14; 3.5.5.4; 4.1.1.11; 4.1.1.12; 4.1.1.15; 4.3.1.1; 5.1.1.13; 6.1.1.12; 6.1.1.23; 6.3.1.1; 6.3.1.4; 6.3.2.6; 6.3.2.29; 6.3.4.4; 6.3.4.5; 6.3.5.4,"Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Methionine biosynthesis, apartate => homoserine => methionine; Threonine biosynthesis, aspartate => homoserine => threonine; Urea cycle; Ectoine biosynthesis, aspartate => ectoine; NAD biosynthesis, aspartate => NAD; Pantothenate biosynthesis, valine/L-aspartate => pantothenate; C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type; C4-dicarboxylic acid cycle, NAD - malic enzyme type; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00049  Aspartic acid (Asp);  Hormones and transmitters;   Neurotransmitters;    Amino acids;     C00049  Aspartate; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Aspartic acid;     D00013  Aspartic acid (USP/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00013  [003608] L-Aspartic acid;  Solubilizing agent;   D00013  [003608] L-Aspartic acid;  Flavoring substance;   D00013  [003608] L-Aspartic acid;  Diluting agent;   D00013  [003608] L-Aspartic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00013  L-Aspartic acid,CAS: 56-84-8; PubChem: 3351; ChEBI: 17053; ChEMBL: CHEMBL274323; KNApSAcK: C00001342; PDB-CCD: ASP IAS; 3DMET: B00015; NIKKAJI: J9.169C,cpd:C00049; cpd:C00402; cpd:C16433; cpd:C19710; cpd:C19911,4,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H8O4N1,C4H6O4N1,133.0375077,134.0453327,132.0296827580,680,cpd:C00062,L-Arginine;,C6H14N4O2,L-Arginine; (S)-2-Amino-5-guanidinovaleric acid; L-Arg,R00551 R00552 R00554 R00557 R00558 R00559 R00562 R00563; R00565 R00566 R00567 R00735 R00832 R00912 R01086 R01686; R01886 R01989 R03477 R03646 R05465 R05547 R08197 R09363; R09593 R09785 R10081 R10106 R10107 R10880 R11031 R11032; R11033 R11085,"Arginine biosynthesis; Monobactam biosynthesis; Arginine and proline metabolism; Clavulanic acid biosynthesis; D-Arginine and D-ornithine metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption; Amyotrophic lateral sclerosis (ALS); Salmonella infection; Chagas disease (American trypanosomiasis); Amoebiasis; Central carbon metabolism in cancer",1.4.1.-; 1.5.1.11; 1.5.1.19; 1.13.12.1; 1.14.11.34; 1.14.11.41; 1.14.13.39; 1.14.13.165; 2.1.4.1; 2.1.4.2; 2.3.1.109; 2.5.1.66; 2.6.1.84; 2.7.3.3; 3.2.2.19; 3.5.3.1; 3.5.3.6; 4.1.1.19; 4.3.2.1; 5.1.1.9; 6.1.1.19; 6.3.2.11; 6.3.2.24; 6.3.2.30; 6.3.2.48,"Urea cycle; Creatine pathway; Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine; Polyamine biosynthesis, arginine => ornithine => putrescine; Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate; Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A; Cycloserine biosynthesis, arginine/serine => cycloserine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00062  Arginine (Arg); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Arginine;     D02982  Arginine (USP/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D02982  [003610] L-Arginine;  Solubilizing agent;   D02982  [003610] L-Arginine;  Buffering agent;   D02982  [003610] L-Arginine;  Solubilization agent;   D02982  [003610] L-Arginine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D02982  L-Arginine,CAS: 74-79-3; PubChem: 3362; ChEBI: 16467; ChEMBL: CHEMBL1485; KNApSAcK: C00001340; PDB-CCD: ARG GND; 3DMET: B01143; NIKKAJI: J9.182K,cpd:C00062; cpd:C00792; cpd:C02385,6,14,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O2N4,C6H13O2N4,174.1116757,175.1195007,173.1038507581,681,cpd:C00064,L-Glutamine;,C5H10N2O3,L-Glutamine; L-2-Aminoglutaramic acid,R00021 R00093 R00114 R00253 R00256 R00257 R00573 R00575; R00576 R00577 R00578 R00579 R00768 R00986 R01072 R01149; R01231 R01375 R01716 R02576 R02781 R02895 R03652 R03905; R04011 R04212 R04463 R04558 R05224 R05225 R05815 R07456; R08244 R08855 R08890 R08891 R08956 R09195 R09598 R09599; R10089 R11515,"Arginine biosynthesis; Purine metabolism; Pyrimidine metabolism; Alanine, aspartate and glutamate metabolism; D-Glutamine and D-glutamate metabolism; Glyoxylate and dicarboxylate metabolism; Nitrogen metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of amino acids; ABC transporters; Two-component system; Glutamatergic synapse; GABAergic synapse; Proximal tubule bicarbonate reclamation; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer",1.4.1.13; 1.4.1.14; 1.4.7.1; 2.3.1.14; 2.3.1.68; 2.3.2.1; 2.3.2.14; 2.4.2.14; 2.4.2.-; 2.6.1.15; 2.6.1.16; 2.6.1.50; 2.6.1.64; 2.6.1.85; 2.6.1.86; 2.6.1.100; 2.6.1.101; 3.5.1.2; 3.5.1.38; 4.1.3.27; 4.1.3.-; 4.3.3.6; 5.1.1.10; 6.1.1.18; 6.3.1.2; 6.3.4.2; 6.3.5.1; 6.3.5.2; 6.3.5.3; 6.3.5.4; 6.3.5.5; 6.3.5.6; 6.3.5.7; 6.3.5.9; 6.3.5.10; 6.3.5.11; 6.3.5.-,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP; Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00064  Glutamine (Gln); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;    A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;     A16AA Amino acids and derivatives;      A16AA03 Glutamine;       D00015  Glutamine (USP); USP drug classification [BR:br08302];  Gastrointestinal Agents;   Gastrointestinal Agents, Other;    Glutamine;     D00015  Glutamine (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   23  Digestive organ agents;    232  Peptic ulcer agents;     2322  Glutamines;      D00015  Glutamine (USP); L-Glutamine (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Glutamine;     D00015  Glutamine (USP); Pharmaceutical additives [BR:br08316];  Diluting agent;   D00015  [003612] L-Glutamine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00015  L-Glutamine; Gastrointestinal agents [br08371.html];  Antiulcer agent;   D00015; New drug approvals in the USA [br08319.html];  New Molecular Entity and New Therapeutic Biological Product Approvals;   D00015; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D00015; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00015",CAS: 56-85-9; PubChem: 3364; ChEBI: 18050; ChEMBL: CHEMBL930; KNApSAcK: C00001359; PDB-CCD: GLN; 3DMET: B00017; NIKKAJI: J9.170G,cpd:C00064; cpd:C00303; cpd:C00819; cpd:C01419; cpd:C05100; cpd:C16673; cpd:C21029,5,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O3N2,C5H9O3N2,146.0691422,147.0769672,145.0613172582,682,cpd:C00077,L-Ornithine;,C5H12N2O2,"L-Ornithine; (S)-2,5-Diaminovaleric acid; (S)-2,5-Diaminopentanoic acid; (S)-2,5-Diaminopentanoate",R00551 R00565 R00664 R00665 R00666 R00667 R00668 R00669; R00670 R00671 R00672 R01343 R01398 R01686 R01989 R02282; R03477 R05547 R10466 R10789 R10790 R10933,"Arginine biosynthesis; Arginine and proline metabolism; D-Arginine and D-ornithine metabolism; Glutathione metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters",1.5.1.24; 1.14.13.195; 1.14.13.196; 2.1.3.3; 2.1.4.1; 2.1.4.2; 2.3.1.35; 2.3.1.127; 2.6.1.13; 3.5.1.14; 3.5.1.16; 3.5.1.20; 3.5.3.1; 3.5.3.25; 4.1.1.17; 4.3.1.12; 5.1.1.9; 5.1.1.10; 5.1.1.12,"Ornithine biosynthesis, glutamate => ornithine; Urea cycle; Polyamine biosynthesis, arginine => ornithine => putrescine; Ornithine biosynthesis, mediated by LysW, glutamate => ornithine; Cycloserine biosynthesis, arginine/serine => cycloserine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00077  L-Ornithine,CAS: 70-26-8; PubChem: 3377; ChEBI: 15729; ChEMBL: CHEMBL446143; KNApSAcK: C00001384; PDB-CCD: ORN; 3DMET: B00020; NIKKAJI: J9.177D,cpd:C00077; cpd:C00515; cpd:C01602; cpd:C03943; cpd:C11320; cpd:C16550; cpd:C16555,5,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O2N2,C5H11O2N2,132.0898776,133.0977027,131.0820526583,683,cpd:C00086,Urea;,CH4N2O,Urea; Carbamide,R00131 R00551 R00774 R00775 R00776 R00777 R00778 R00913; R01157 R01418 R01566 R01589 R01990 R02422 R02458 R03250; R03870 R05357 R07629 R10347 R10778,Arginine biosynthesis; Purine metabolism; Pyrimidine metabolism; Arginine and proline metabolism; Biotin metabolism; Atrazine degradation; Metabolic pathways; Microbial metabolism in diverse environments; ABC transporters; Epithelial cell signaling in Helicobacter pylori infection,3.5.1.5; 3.5.1.84; 3.5.1.95; 3.5.2.1; 3.5.3.1; 3.5.3.2; 3.5.3.3; 3.5.3.4; 3.5.3.7; 3.5.3.10; 3.5.3.11; 3.5.3.14; 3.5.3.16; 3.5.3.17; 3.5.3.20; 3.5.3.22; 3.5.3.24; 4.2.1.69; 4.3.2.3; 6.3.4.6,"Urea cycle; Purine degradation, xanthine => urea",Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05B I.V. SOLUTIONS;     B05BC Solutions producing osmotic diuresis;      B05BC02 Carbamide;       D00023  Urea (JP17/USP);  D DERMATOLOGICALS;   D02 EMOLLIENTS AND PROTECTIVES;    D02A EMOLLIENTS AND PROTECTIVES;     D02AE Carbamide products;      D02AE01 Carbamide;       D00023  Urea (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    266  Emollients;     2669  Others;      D00023  Urea (JP17/USP); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   59 Skin emollient (incl. pus extrusion);    D00023  Urea (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Urea;     D00023  Urea (JP17/USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00023  [002286] Urea;  Wetting agent;   D00023  [002286] Urea;  Wetting adjuster;   D00023  [002286] Urea;  Tenacious agent;   D00023  [002286] Urea;  Diluting agent;   D00023  [120238] Purified urea;  Solubilization agent;   D00023  [002286] Urea; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00023  Urea; Dermatological agents [br08370.html];  Non-steroidal topical agent;   D00023,CAS: 57-13-6; PubChem: 3386; ChEBI: 16199; ChEMBL: CHEMBL985; KNApSAcK: C00007314; PDB-CCD: URE; 3DMET: B00021; NIKKAJI: J2.322A,cpd:C00086; cpd:C19568; cpd:C20306,1,4,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H5O1N2,C1H3O1N2,60.03236276,61.04018779,59.02453773584,684,cpd:C00169,Carbamoyl phosphate,CH4NO5P,Carbamoyl phosphate,R00149 R00150 R00575 R01395 R01396 R01397 R01398 R01399; R01400 R02937 R04281 R05230 R06772 R07245 R07641 R08937; R09853 R09858 R10541 R10767 R10768 R11279,"Arginine biosynthesis; Purine metabolism; Pyrimidine metabolism; Alanine, aspartate and glutamate metabolism; Nitrogen metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Biosynthesis of amino acids",2.1.3.2; 2.1.3.3; 2.1.3.5; 2.1.3.6; 2.1.3.7; 2.1.3.8; 2.1.3.9; 2.1.3.11; 2.1.3.12; 2.1.3.-; 2.7.2.2; 6.1.2.2; 6.3.4.16; 6.3.5.5,"Urea cycle; Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP",NA,CAS: 590-55-6; PubChem: 3469; ChEBI: 17672; ChEMBL: CHEMBL369105; KNApSAcK: C00007513; PDB-CCD: CP; 3DMET: B00050; NIKKAJI: J39.574I,cpd:C00169,1,4,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H5O5N1P1,C1H3O5N1P1,140.9827092,141.9905343,139.9748842585,685,cpd:C00327,L-Citrulline;,C6H13N3O3,L-Citrulline; 2-Amino-5-ureidovaleric acid; Citrulline,R00111 R00552 R00557 R00665 R01398 R01954 R02513 R09107; R10106 R10108,Arginine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids,1.14.13.39; 1.14.13.165; 2.1.3.3; 3.5.1.16; 3.5.1.20; 3.5.3.6; 3.5.3.18; 6.3.4.5,Urea cycle,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00327  L-Citrulline,CAS: 372-75-8; PubChem: 3621; ChEBI: 16349; ChEMBL: CHEMBL444814; KNApSAcK: C00001348; PDB-CCD: CIR; 3DMET: B01217; NIKKAJI: J5.711H,cpd:C00327,6,13,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O3N3,C6H12O3N3,175.0956913,176.1035163,174.0878663586,686,cpd:C00437,N-Acetylornithine;,C7H14N2O3,N-Acetylornithine; N2-Acetyl-L-ornithine,R00669 R02282 R02283 R07245,Arginine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids,2.1.3.9; 2.3.1.35; 2.6.1.11; 3.5.1.14; 3.5.1.16,"Ornithine biosynthesis, glutamate => ornithine",NA,CAS: 6205-08-9; PubChem: 3726; ChEBI: 16543; PDB-CCD: AOR; 3DMET: B00114; NIKKAJI: J37.495D,cpd:C00437; cpd:C01047,7,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O3N2,C7H13O3N2,174.1004423,175.1082674,173.0926173587,687,cpd:C00624,N-Acetyl-L-glutamate;,C7H11NO5,N-Acetyl-L-glutamate; N-Acetyl-L-glutamic acid,R00259 R02282 R02649,Arginine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids,2.3.1.1; 2.3.1.35; 2.7.2.8,"Ornithine biosynthesis, glutamate => ornithine",NA,CAS: 1188-37-0; PubChem: 3897; ChEBI: 17533 44337; ChEMBL: CHEMBL1234751; PDB-CCD: NLG; 3DMET: B00147; NIKKAJI: J37.497K,cpd:C00624; cpd:C03871; cpd:C12109,7,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O5N1,C7H10O5N1,189.0637225,190.0715475,188.0558974588,688,cpd:C01010,Urea-1-carboxylate;,C2H4N2O3,Urea-1-carboxylate; Allophanate; Allophanic acid,R00005 R00774 R05563,Arginine biosynthesis; Atrazine degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.5.1.54; 3.5.1.84; 6.3.4.6,NA,NA,CAS: 625-78-5; PubChem: 4255; ChEBI: 15832 9889; 3DMET: B00219; NIKKAJI: J38.544A,cpd:C01010,2,4,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H5O3N2,C2H3O3N2,104.022192,105.030017,103.014367589,689,cpd:C01250,N-Acetyl-L-glutamate 5-semialdehyde;,C7H11NO4,N-Acetyl-L-glutamate 5-semialdehyde; 2-Acetamido-5-oxopentanoate,R02283 R03443,Arginine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids,1.2.1.38; 2.6.1.11,"Ornithine biosynthesis, glutamate => ornithine",NA,PubChem: 4470; ChEBI: 16319 29123; 3DMET: B00264; NIKKAJI: J37.498I,cpd:C01250; cpd:C12121; cpd:C17366; cpd:C21248,7,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O4N1,C7H10O4N1,173.0688078,174.0766329,172.0609828590,690,cpd:C03406,N-(L-Arginino)succinate;,C10H18N4O6,N-(L-Arginino)succinate; 2-(Nomega-L-Arginino)succinate; L-Argininosuccinate; L-Argininosuccinic acid; L-Arginosuccinic acid,R01086 R01954,"Arginine biosynthesis; Alanine, aspartate and glutamate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",4.3.2.1; 6.3.4.5,Urea cycle,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C03406  L-Argininosuccinate,CAS: 2387-71-5; PubChem: 6235; ChEBI: 15682; KNApSAcK: C00019688; 3DMET: B04894; NIKKAJI: J37.380J,cpd:C03406,10,18,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O6N4,C10H17O6N4,290.1226343,291.1304593,289.1148093591,691,cpd:C04133,N-Acetyl-L-glutamate 5-phosphate;,C7H12NO8P,N-Acetyl-L-glutamate 5-phosphate; N-Acetyl-L-glutamyl 5-phosphate,R02649 R03443,Arginine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids,1.2.1.38; 2.7.2.8,"Ornithine biosynthesis, glutamate => ornithine",NA,PubChem: 6819; ChEBI: 16878; PDB-CCD: X2W; 3DMET: B00683; NIKKAJI: J37.496B,cpd:C00350; cpd:C04133,7,12,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O8N1P1,C7H11O8N1P1,269.0300533,270.0378784,268.0222283592,692,cpd:C15532,N-Acetyl-L-citrulline,C8H15N3O4,N-Acetyl-L-citrulline,R07245 R09107,Arginine biosynthesis; Metabolic pathways,2.1.3.9; 3.5.1.16,NA,NA,PubChem: 17396524; ChEBI: 49002; PDB-CCD: OLN; NIKKAJI: J2.794.851K,cpd:C15532,8,15,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O4N3,C8H14O4N3,217.106256,218.114081,216.0984309593,697,cpd:C00020,AMP;,C10H14N5O7P,AMP; Adenosine 5'-monophosphate; Adenylic acid; Adenylate; 5'-AMP; 5'-Adenylic acid; 5'-Adenosine monophosphate; Adenosine 5'-phosphate,R00085 R00087 R00103 R00122 R00127 R00157 R00160 R00181; R00182 R00183 R00184 R00185 R00187 R00188 R00189 R00190; R00191 R00199 R00206 R00235 R00236 R00257 R00322 R00333; R00381 R00382 R00389 R00390 R00429 R00436 R00483 R00531; R00542 R00578 R00619 R00686 R00735 R00860 R00925 R00926; R00951 R00982 R01049 R01054 R01075 R01083 R01176 R01230; R01231 R01280 R01300 R01357 R01406 R01407 R01422 R01423; R01490 R01558 R01568 R01571 R01598 R01616 R01723 R01885; R01943 R01954 R02194 R02221 R02255 R02473 R02539 R02677; R02699 R02711 R02718 R02794 R02918 R02986 R03004 R03036; R03038 R03209 R03258 R03383 R03503 R03570 R03595 R03613; R03631 R03646 R03647 R03648 R03650 R03651 R03652 R03654; R03655 R03656 R03657 R03658 R03659 R03660 R03661 R03662; R03663 R03664 R03665 R03762 R03876 R03932 R04030 R04036; R04038 R04157 R04230 R04274 R04449 R04507 R04562 R04563; R04580 R04582 R04604 R04773 R04863 R04870 R04927 R05145; R05193 R05451 R05452 R05467 R05537 R05577 R05578 R05620; R05625 R05717 R05735 R05804 R05805 R06368 R06409 R06410; R06515 R06583 R06731 R06746 R06751 R06777 R06778 R06944; R07176 R07325 R07416 R07461 R07636 R07640 R07644 R07646; R07771 R07887 R08088 R08117 R08218 R08244 R08553 R08576; R08578 R08700 R08733 R08738 R08743 R08872 R09084 R09085; R09086 R09195 R09279 R09286 R09379 R09475 R09589 R09591; R09597 R09735 R09881 R09882 R10003 R10090 R10091 R10267; R10268 R10453 R10495 R10496 R10543 R10544 R10556 R10613; R10648 R10661 R10711 R10767 R10768 R10769 R10770 R10771; R10820 R10822 R10836 R10880 R10940 R11084 R11104 R11143; R11279 R11319 R11367 R11370 R11392 R11515 R11535,Purine metabolism; Zeatin biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Antifolate resistance; cGMP-PKG signaling pathway; cAMP signaling pathway; FoxO signaling pathway; mTOR signaling pathway; PI3K-Akt signaling pathway; AMPK signaling pathway; Longevity regulating pathway; Olfactory transduction; Taste transduction; Regulation of lipolysis in adipocytes; Renin secretion; Aldosterone synthesis and secretion; Parkinson's disease; Morphine addiction,1.2.1.30; 1.2.1.31; 1.8.4.9; 1.8.4.10; 1.8.99.2; 1.13.12.7; 2.3.1.234; 2.4.2.7; 2.4.2.8; 2.4.2.57; 2.5.1.27; 2.7.1.20; 2.7.1.74; 2.7.1.114; 2.7.1.118; 2.7.1.146; 2.7.1.147; 2.7.1.180; 2.7.1.212; 2.7.4.3; 2.7.4.10; 2.7.6.1; 2.7.6.2; 2.7.6.3; 2.7.6.4; 2.7.6.5; 2.7.9.1; 2.7.9.2; 2.7.9.3; 2.7.9.-; 2.8.1.11; 2.8.1.13; 2.8.1.-; 2.10.1.1; 3.1.3.5; 3.1.3.7; 3.1.3.97; 3.1.4.17; 3.1.4.53; 3.2.2.4; 3.5.4.6; 3.5.4.17; 3.6.1.5; 3.6.1.8; 3.6.1.9; 3.6.1.13; 3.6.1.17; 3.6.1.18; 3.6.1.20; 3.6.1.21; 3.6.1.22; 3.6.1.29; 3.6.1.53; 3.6.1.60; 3.6.1.61; 3.6.1.-; 3.6.2.1; 4.2.1.136; 4.3.2.2; 4.6.1.15; 5.1.1.11; 6.1.1.1; 6.1.1.2; 6.1.1.3; 6.1.1.4; 6.1.1.5; 6.1.1.6; 6.1.1.7; 6.1.1.9; 6.1.1.10; 6.1.1.11; 6.1.1.12; 6.1.1.13; 6.1.1.14; 6.1.1.15; 6.1.1.16; 6.1.1.17; 6.1.1.18; 6.1.1.19; 6.1.1.20; 6.1.1.21; 6.1.1.22; 6.1.1.23; 6.1.1.24; 6.1.1.26; 6.1.1.27; 6.1.2.2; 6.2.1.1; 6.2.1.2; 6.2.1.3; 6.2.1.7; 6.2.1.8; 6.2.1.11; 6.2.1.12; 6.2.1.14; 6.2.1.15; 6.2.1.16; 6.2.1.17; 6.2.1.19; 6.2.1.20; 6.2.1.22; 6.2.1.23; 6.2.1.24; 6.2.1.25; 6.2.1.26; 6.2.1.27; 6.2.1.28; 6.2.1.30; 6.2.1.31; 6.2.1.32; 6.2.1.33; 6.2.1.35; 6.2.1.36; 6.2.1.37; 6.2.1.38; 6.2.1.40; 6.2.1.41; 6.2.1.42; 6.2.1.43; 6.2.1.44; 6.2.1.46; 6.2.1.-; 6.3.1.1; 6.3.1.5; 6.3.1.7; 6.3.1.13; 6.3.1.14; 6.3.1.15; 6.3.1.20; 6.3.2.1; 6.3.2.5; 6.3.2.14; 6.3.2.18; 6.3.2.24; 6.3.2.26; 6.3.2.36; 6.3.2.38; 6.3.2.39; 6.3.2.40; 6.3.2.46; 6.3.3.4; 6.3.3.6; 6.3.4.5; 6.3.4.9; 6.3.4.10; 6.3.4.11; 6.3.4.15; 6.3.4.19; 6.3.4.22; 6.3.5.1; 6.3.5.2; 6.3.5.4; 6.3.5.-; 6.4.1.6; 6.5.1.1; 6.5.1.2; 6.5.1.3; 6.5.1.4; 6.5.1.6; 6.5.1.7,"Adenine ribonucleotide biosynthesis, IMP => ADP,ATP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00020  AMP; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01E OTHER CARDIAC PREPARATIONS;     C01EB Other cardiac preparations;      C01EB10 Adenosine;       D02769  Adenosine phosphate (USAN/INN),CAS: 61-19-8; PubChem: 3322; ChEBI: 16027; ChEMBL: CHEMBL603764 CHEMBL752; KNApSAcK: C00019347; PDB-CCD: A AMP AP7; 3DMET: B01133; NIKKAJI: J4.814C,cpd:C00020; cpd:C00362; cpd:C00946; cpd:C01367; cpd:C04378; cpd:C11475; cpd:C16619; cpd:C17324; cpd:C19970; cpd:C20459; cpd:C20648,10,14,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O7N5P1,C10H13O7N5P1,347.0630848,348.0709098,346.0552598594,698,cpd:C00035,GDP;,C10H15N5O11P2,GDP; Guanosine 5'-diphosphate; Guanosine diphosphate,R00328 R00330 R00332 R00335 R00336 R00337 R00394 R00430; R00431 R00432 R00439 R00517 R00883 R00887 R00890 R00968; R01009 R01135 R01517 R02019 R02168 R02405 R02890 R03129; R03378 R03519 R03768 R03769 R03829 R04081 R04082 R04331; R04502 R04553 R04646 R05002 R05106 R05768 R06558 R07257; R07678 R08692 R08858 R08947 R09399 R09400 R09666 R09667; R09733 R09734 R09752 R10439 R11203 R11229 R11497,Purine metabolism; Metabolic pathways; RNA transport; Ras signaling pathway; Rap1 signaling pathway; Endocytosis,1.17.4.1; 2.4.1.29; 2.4.1.32; 2.4.1.33; 2.4.1.36; 2.4.1.48; 2.4.1.54; 2.4.1.65; 2.4.1.69; 2.4.1.83; 2.4.1.110; 2.4.1.132; 2.4.1.142; 2.4.1.152; 2.4.1.217; 2.4.1.246; 2.4.1.251; 2.4.1.252; 2.4.1.269; 2.4.1.270; 2.4.1.308; 2.4.1.-; 2.5.1.135; 2.7.1.40; 2.7.1.48; 2.7.1.81; 2.7.1.156; 2.7.1.190; 2.7.2.10; 2.7.4.6; 2.7.4.8; 2.7.7.8; 2.7.7.22; 2.7.7.69; 2.7.7.78; 2.7.7.88; 3.1.7.2; 3.2.1.42; 3.6.1.5; 3.6.1.6; 3.6.1.42; 3.6.5.1; 3.6.5.2; 3.6.5.3; 3.6.5.4; 3.6.5.5; 3.6.5.6; 4.1.1.32; 6.2.1.4; 6.2.1.10; 6.3.2.31; 6.3.2.34; 6.3.4.4,"Guanine ribonucleotide biosynthesis IMP => GDP,GTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00035  GDP,CAS: 146-91-8; PubChem: 3337; ChEBI: 17552; ChEMBL: CHEMBL384759; PDB-CCD: GDP; 3DMET: B01135; NIKKAJI: J40.056D,cpd:C00035; cpd:C20176,10,15,11,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O11N5P2,C10H14O11N5P2,443.0243303,444.0321553,442.0165053595,700,cpd:C00044,GTP;,C10H16N5O14P3,GTP; Guanosine 5'-triphosphate,R00012 R00330 R00335 R00394 R00424 R00425 R00426 R00428; R00429 R00430 R00431 R00432 R00434 R00441 R00517 R00885; R00954 R00968 R01135 R01232 R01517 R01951 R02020 R02405; R03318 R03378 R03828 R05222 R06558 R07306 R08057 R09394; R09397 R09399 R09400 R09772 R10348 R10462 R10537 R10823; R11229 R11402,Purine metabolism; Riboflavin metabolism; Folate biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biofilm formation - Pseudomonas aeruginosa; RNA transport; Ras signaling pathway; Rap1 signaling pathway; Sulfur relay system; Endocytosis; Biofilm formation - Vibrio cholerae,1.17.4.2; 2.7.1.40; 2.7.1.48; 2.7.1.81; 2.7.1.156; 2.7.1.190; 2.7.2.10; 2.7.4.6; 2.7.6.5; 2.7.7.6; 2.7.7.13; 2.7.7.28; 2.7.7.30; 2.7.7.34; 2.7.7.45; 2.7.7.48; 2.7.7.50; 2.7.7.62; 2.7.7.65; 2.7.7.68; 2.7.7.71; 2.7.7.86; 2.7.7.91; 3.5.4.16; 3.5.4.25; 3.5.4.29; 3.5.4.39; 3.6.1.5; 3.6.1.8; 3.6.1.17; 3.6.1.-; 3.6.5.1; 3.6.5.2; 3.6.5.3; 3.6.5.4; 3.6.5.5; 3.6.5.6; 4.1.1.32; 4.1.99.22; 4.6.1.1; 4.6.1.2; 6.2.1.4; 6.2.1.10; 6.3.2.31; 6.3.2.34; 6.3.4.4; 6.5.1.5; 6.5.1.7,"Guanine ribonucleotide biosynthesis IMP => GDP,GTP; Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD; Tetrahydrofolate biosynthesis, GTP => THF",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00044  GTP,CAS: 86-01-1; PubChem: 3346; ChEBI: 15996; ChEMBL: CHEMBL1233147; KNApSAcK: C00007223; PDB-CCD: GTP; 3DMET: B01137; NIKKAJI: J40.055F,cpd:C00044; cpd:C19967; cpd:C21310,10,16,14,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O14N5P3,C10H15O14N5P3,522.9906612,523.9984862,521.9828362596,702,cpd:C00048,Glyoxylate;,C2H2O3,Glyoxylate; Glyoxalate; Glyoxylic acid,R00013 R00364 R00365 R00366 R00369 R00372 R00373 R00465; R00466 R00468 R00469 R00470 R00471 R00472 R00473 R00474; R00475 R00476 R00477 R00478 R00479 R00588 R00652 R00717; R00776 R00932 R00934 R01180 R01957 R03040 R03121 R03874; R05418 R05419 R05493 R05862 R05863 R07982 R08702 R09144; R09151 R09717 R09718 R09798 R10179 R10245 R10283 R10908; R11351 R11454 R11455 R11456 R11486,"Purine metabolism; Caffeine metabolism; Glycine, serine and threonine metabolism; Arginine and proline metabolism; Chloroalkane and chloroalkene degradation; Glyoxylate and dicarboxylate metabolism; C5-Branched dibasic acid metabolism; Methane metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism",1.1.1.26; 1.1.1.29; 1.1.1.79; 1.1.3.15; 1.1.99.14; 1.2.1.17; 1.2.3.5; 1.2.3.15; 1.4.1.1; 1.4.1.10; 1.4.2.1; 1.4.3.3; 1.4.3.19; 1.5.3.23; 1.5.3.-; 1.14.11.-; 1.14.12.11; 1.14.13.-; 1.14.14.10; 1.14.14.33; 2.2.1.5; 2.3.3.7; 2.3.3.9; 2.3.3.11; 2.3.3.12; 2.6.1.4; 2.6.1.35; 2.6.1.44; 2.6.1.45; 2.6.1.60; 2.6.1.63; 2.6.1.73; 2.6.1.96; 2.6.1.-; 3.5.1.116; 4.1.1.47; 4.1.3.1; 4.1.3.13; 4.1.3.14; 4.1.3.16; 4.1.3.24; 4.1.3.41; 4.1.3.42; 4.3.2.3; 4.3.2.5,"Glyoxylate cycle; Formaldehyde assimilation, serine pathway; Ethylmalonyl pathway; 3-Hydroxypropionate bi-cycle; Photorespiration; Methylaspartate cycle",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00048  Glyoxylate; Oxoacetate,CAS: 298-12-4; PubChem: 3350; ChEBI: 16891; ChEMBL: CHEMBL1162545; KNApSAcK: C00001186; PDB-CCD: GLV; 3DMET: B00014; NIKKAJI: J38.150K,cpd:C00048; cpd:C05718,2,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H3O3,C2H1O3,74.00039392,75.00821896,72.99256889597,703,cpd:C00053,3'-Phosphoadenylyl sulfate;,C10H15N5O13P2S,3'-Phosphoadenylyl sulfate; 3'-Phosphoadenosine 5'-phosphosulfate; 3'-Phospho-5'-adenylyl sulfate; PAPS,R00507 R00508 R00509 R00535 R00536 R00537 R00629 R01027; R01236 R01242 R01861 R02021 R02122 R02159 R02180 R02181; R02350 R02586 R02632 R02633 R02809 R02839 R03138 R03214; R03289 R03405 R03553 R03700 R03946 R03987 R04017 R04213; R04476 R04643 R05105 R05798 R06122 R06279 R06809 R07287; R07288 R07289 R07797 R07798 R08167 R08662 R08669 R08671; R08688 R08699 R08977 R08978 R09444 R10655 R10751 R10805; R10868 R10869 R10873 R10971,Purine metabolism; Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate; Glycosaminoglycan biosynthesis - heparan sulfate / heparin; Sulfur metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.8.4.8; 2.7.1.25; 2.8.2.1; 2.8.2.2; 2.8.2.3; 2.8.2.4; 2.8.2.5; 2.8.2.6; 2.8.2.7; 2.8.2.8; 2.8.2.9; 2.8.2.10; 2.8.2.11; 2.8.2.13; 2.8.2.14; 2.8.2.15; 2.8.2.16; 2.8.2.17; 2.8.2.18; 2.8.2.19; 2.8.2.20; 2.8.2.21; 2.8.2.23; 2.8.2.24; 2.8.2.25; 2.8.2.26; 2.8.2.27; 2.8.2.28; 2.8.2.29; 2.8.2.30; 2.8.2.31; 2.8.2.32; 2.8.2.33; 2.8.2.34; 2.8.2.35; 2.8.2.36; 2.8.2.37; 2.8.2.-; 3.1.3.7; 3.6.2.2,"Assimilatory sulfate reduction, sulfate => H2S",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00053  PAPS,CAS: 482-67-7; PubChem: 3355; ChEBI: 17980; KNApSAcK: C00007446; PDB-CCD: PPS; 3DMET: B01139; NIKKAJI: J372.802A,cpd:C00053; cpd:C03568,10,15,13,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O13N5P2S1,C10H14O13N5P2S1,506.9862307,507.9940558,505.9784057598,704,cpd:C00054,"Adenosine 3',5'-bisphosphate;",C10H15N5O10P2,"Adenosine 3',5'-bisphosphate; PAP; 3'-Phosphoadenylate; Phosphoadenosine phosphate",R00188 R00507 R00535 R00536 R00537 R00629 R01027 R01236; R01242 R01625 R01861 R02021 R02122 R02159 R02180 R02181; R02350 R02586 R02632 R02633 R02809 R02839 R03138 R03214; R03289 R03405 R03553 R03700 R03946 R03987 R04017 R04213; R04476 R04643 R04940 R05105 R05798 R06122 R06279 R06809; R07287 R07288 R07289 R07797 R07798 R08167 R08662 R08669; R08671 R08688 R08699 R08977 R08978 R09444 R10655 R10747; R10751 R10805 R10868 R10869 R10873 R10971,Purine metabolism; Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate; Glycosaminoglycan biosynthesis - heparan sulfate / heparin; Pantothenate and CoA biosynthesis; Sulfur metabolism,1.8.4.8; 2.7.8.7; 2.7.8.-; 2.8.2.1; 2.8.2.2; 2.8.2.3; 2.8.2.4; 2.8.2.5; 2.8.2.6; 2.8.2.7; 2.8.2.8; 2.8.2.9; 2.8.2.10; 2.8.2.11; 2.8.2.13; 2.8.2.14; 2.8.2.15; 2.8.2.16; 2.8.2.17; 2.8.2.18; 2.8.2.19; 2.8.2.20; 2.8.2.21; 2.8.2.23; 2.8.2.24; 2.8.2.25; 2.8.2.26; 2.8.2.27; 2.8.2.28; 2.8.2.29; 2.8.2.30; 2.8.2.31; 2.8.2.32; 2.8.2.33; 2.8.2.34; 2.8.2.35; 2.8.2.36; 2.8.2.37; 2.8.2.-; 3.1.3.7; 3.1.3.97; 3.6.1.-; 3.6.2.2,NA,NA,CAS: 1053-73-2; PubChem: 3356; ChEBI: 17985; ChEMBL: CHEMBL574817; KNApSAcK: C00019352; PDB-CCD: A3P; 3DMET: B01140; NIKKAJI: J14.396K,cpd:C00008; cpd:C00054; cpd:C00361; cpd:C03850,10,15,10,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O10N5P2,C10H14O10N5P2,427.0294157,428.0372407,426.0215907599,706,cpd:C00081,ITP;,C10H15N4O14P3,ITP; Inosine 5'-triphosphate; Inosine triphosphate; Inosine tripolyphosphate,R00088 R00719 R00720 R00722 R00723 R00724 R00725 R00726; R00727 R00770 R00876 R00962 R00970 R01327 R01964 R02406; R02849 R02867 R03239,Purine metabolism,2.7.1.1; 2.7.1.11; 2.7.1.40; 2.7.1.48; 2.7.4.6; 3.5.4.17; 3.5.4.18; 3.6.1.5; 3.6.1.8; 3.6.1.14; 3.6.1.-; 4.1.1.32; 6.2.1.4,NA,NA,CAS: 132-06-9; PubChem: 3381; ChEBI: 16039; ChEMBL: CHEMBL1233686; PDB-CCD: ITT; 3DMET: B01153; NIKKAJI: J38.562J,cpd:C00081; cpd:C01348,10,15,14,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O14N4P3,C10H14O14N4P3,507.9797622,508.9875872,506.9719371600,707,cpd:C00104,IDP;,C10H14N4O11P2,IDP; Inosine 5'-diphosphate; Inosine diphosphate,R00123 R00719 R00722 R00724 R00725 R00726 R00727 R00770; R00876 R00961 R00962 R00970 R01327 R01964 R02406 R02849; R02867 R03239,Purine metabolism,2.7.1.1; 2.7.1.11; 2.7.1.40; 2.7.1.48; 2.7.4.6; 3.5.4.7; 3.5.4.17; 3.6.1.5; 3.6.1.6; 3.6.1.64; 4.1.1.32; 6.2.1.4,NA,NA,CAS: 86-04-4; PubChem: 3404; ChEBI: 17808; PDB-CCD: IDP; 3DMET: B01160; NIKKAJI: J38.561A,cpd:C00104; cpd:C01347,10,14,11,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O11N4P2,C10H13O11N4P2,428.0134313,429.0212563,427.0056062601,708,cpd:C00130,IMP;,C10H13N4O8P,IMP; Inosinic acid; Inosine monophosphate; Inosine 5'-monophosphate; Inosine 5'-phosphate; 5'-Inosinate; 5'-Inosinic acid; 5'-Inosine monophosphate; 5'-IMP,R00181 R00720 R00961 R01126 R01127 R01128 R01130 R01131; R01132 R01134 R01135 R01690,Purine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Antifolate resistance; Taste transduction,1.1.1.205; 1.7.1.7; 2.1.2.3; 2.4.2.8; 2.7.1.73; 3.1.3.5; 3.1.3.99; 3.2.2.12; 3.5.4.6; 3.5.4.10; 3.5.4.17; 3.6.1.5; 3.6.1.6; 3.6.1.8; 3.6.1.20; 3.6.1.64; 3.6.1.-; 6.3.4.4,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP; Adenine ribonucleotide biosynthesis, IMP => ADP,ATP; Guanine ribonucleotide biosynthesis IMP => GDP,GTP",NA,CAS: 131-99-7; PubChem: 3430; ChEBI: 17202; ChEMBL: CHEMBL1207374 CHEMBL603339; KNApSAcK: C00007224; PDB-CCD: IMP; 3DMET: B01168; NIKKAJI: J9.493E,cpd:C00130; cpd:C16618; cpd:C20451; cpd:C20458,10,13,8,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O8N4P1,C10H12O8N4P1,348.0471004,349.0549254,347.0392754602,709,cpd:C00131,dATP;,C10H16N5O12P3,dATP; 2'-Deoxyadenosine 5'-triphosphate; Deoxyadenosine 5'-triphosphate; Deoxyadenosine triphosphate,R00375 R01137 R01138 R01139 R01140 R01330 R01548 R01549; R01965 R02014 R02850 R02868 R03904,Purine metabolism; Metabolic pathways,1.17.4.2; 2.6.99.1; 2.7.1.1; 2.7.1.40; 2.7.1.48; 2.7.4.6; 2.7.7.7,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00131  dATP,CAS: 1927-31-7; PubChem: 3431; ChEBI: 16284; ChEMBL: CHEMBL335538; PDB-CCD: DTP; 3DMET: B01169; NIKKAJI: J90.479A,cpd:C00131; cpd:C13742,10,16,12,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O12N5P3,C10H15O12N5P3,491.000832,492.008657,489.9930069603,710,cpd:C00144,GMP;,C10H14N5O8P,GMP; Guanosine 5'-phosphate; Guanosine monophosphate; Guanosine 5'-monophosphate; Guanylic acid,R00328 R00332 R00426 R00881 R01134 R01227 R01228 R01229; R01230 R01231 R01232 R01233 R01234 R03924 R05223 R09398; R10537 R10823 R11174,Purine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Antifolate resistance; cGMP-PKG signaling pathway; Olfactory transduction; Taste transduction; Phototransduction,1.7.1.7; 2.4.2.7; 2.4.2.8; 2.4.2.22; 2.7.1.73; 2.7.4.8; 2.7.8.9; 2.7.8.26; 2.7.8.28; 3.1.3.5; 3.1.4.17; 3.1.4.35; 3.6.1.5; 3.6.1.6; 3.6.1.8; 3.6.1.17; 3.6.1.21; 3.6.1.42; 3.6.1.-; 6.3.5.2; 6.5.1.5; 6.5.1.7,"Guanine ribonucleotide biosynthesis IMP => GDP,GTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00144  GMP,CAS: 85-32-5; PubChem: 3444; ChEBI: 17345; ChEMBL: CHEMBL281820 CHEMBL283807; KNApSAcK: C00019635; PDB-CCD: 5GP G; 3DMET: B01172; NIKKAJI: J10.615A,cpd:C00144; cpd:C01977; cpd:C06193; cpd:C18239; cpd:C19968,10,14,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O8N5P1,C10H13O8N5P1,363.0579994,364.0658245,362.0501744604,711,cpd:C00147,Adenine;,C5H5N5,Adenine; 6-Aminopurine,R00182 R00190 R00194 R01244 R01245 R01401 R01402 R01561; R02557 R05708 R09675 R10185 R10668 R10836 R11113,Purine metabolism; Zeatin biosynthesis; Metabolic pathways,1.5.99.12; 2.4.2.1; 2.4.2.7; 2.4.2.8; 2.4.2.28; 2.4.2.52; 2.4.2.57; 2.7.8.37; 3.2.2.1; 3.2.2.4; 3.2.2.7; 3.2.2.8; 3.2.2.9; 3.2.2.16; 3.2.2.30; 3.5.4.2,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Bases;    Purines;     C00147  Adenine (Ade); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   41  Cellular function activating agents;    419  Miscellaneous;     4191  Adenines;      D00034  Adenine (JAN/USP),CAS: 73-24-5; PubChem: 3447; ChEBI: 16708; ChEMBL: CHEMBL226345; KNApSAcK: C00001490; PDB-CCD: ADE; 3DMET: B00041; NIKKAJI: J5.257D,cpd:C00147; cpd:C00242; cpd:C07648; cpd:C20155,5,5,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H6N5,C5H4N5,135.0544952,136.0623202,134.0466702605,712,cpd:C00206,dADP;,C10H15N5O9P2,dADP; 2'-Deoxyadenosine 5'-diphosphate,R01137 R01138 R01139 R01140 R01330 R01547 R01548 R01549; R01965 R02017 R02850 R02868,Purine metabolism; Metabolic pathways,1.17.4.1; 2.7.1.1; 2.7.1.40; 2.7.1.48; 2.7.4.3; 2.7.4.6; 2.7.4.11,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00206  dADP,CAS: 2793-06-8; PubChem: 3506; ChEBI: 16174; PDB-CCD: DAT; 3DMET: B01188; NIKKAJI: J247.700I,cpd:C00206; cpd:C13743,10,15,9,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O9N5P2,C10H14O9N5P2,411.0345011,412.0423261,410.026676606,713,cpd:C00212,Adenosine,C10H13N5O4,Adenosine,R00183 R00185 R00192 R01245 R01560 R01561 R01562 R01571; R04936 R05695 R05696,Purine metabolism; Metabolic pathways; cGMP-PKG signaling pathway; cAMP signaling pathway; Sphingolipid signaling pathway; Neuroactive ligand-receptor interaction; Vascular smooth muscle contraction; Regulation of lipolysis in adipocytes; Renin secretion; Parkinson's disease; Morphine addiction; Alcoholism,1.1.3.39; 2.4.2.1; 2.7.1.20; 2.7.1.74; 2.7.1.114; 3.1.3.5; 3.1.3.6; 3.2.2.1; 3.2.2.7; 3.2.2.8; 3.3.1.1; 3.5.4.4,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Ribonucleosides;     C00212  Adenosine (A); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01E OTHER CARDIAC PREPARATIONS;     C01EB Other cardiac preparations;      C01EB10 Adenosine;       D00045  Adenosine (JAN/USP); Therapeutic category of drugs in Japan [BR:br08301];  7  Agents not mainly for therapeutic purpose;   79  Other agents not mainly for therapeutic purpose;    799  Miscellaneous;     7990  Miscellaneous;      D00045  Adenosine (JAN/USP); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adenosine;     adenosine A1 receptor;      Adenosine;       D00045  Adenosine (JAN/USP);     adenosine A2a receptor;      Adenosine;       D00045  Adenosine (JAN/USP);     adenosine A2b receptor;      Adenosine;       D00045  Adenosine (JAN/USP);     adenosine A3 receptor;      Adenosine;       D00045  Adenosine (JAN/USP); New drug approvals in Japan [br08318.html];  Drugs with new active ingredients;   D00045,CAS: 58-61-7; PubChem: 3512; ChEBI: 16335; ChEMBL: CHEMBL477; KNApSAcK: C00007444; PDB-CCD: ADN; 3DMET: B01189; NIKKAJI: J4.501B,cpd:C00212; cpd:C00330; cpd:C07195; cpd:C07210,10,13,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O4N5,C10H12O4N5,267.0967539,268.104579,266.0889289607,714,cpd:C00224,Adenylyl sulfate;,C10H14N5O10PS,Adenylyl sulfate; Adenosine 5'-phosphosulfate; APS; 5'-Adenylyl sulfate,R00508 R00509 R00529 R00530 R00531 R00860 R01618 R01619; R05717 R07176 R08553,Purine metabolism; Monobactam biosynthesis; Sulfur metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics,1.8.4.9; 1.8.4.10; 1.8.99.2; 2.7.1.25; 2.7.7.4; 2.7.7.5; 2.7.7.51; 2.7.7.53; 3.1.3.7; 3.6.2.1,"Assimilatory sulfate reduction, sulfate => H2S; Dissimilatory sulfate reduction, sulfate => H2S",NA,CAS: 485-84-7; PubChem: 3524; ChEBI: 17709; ChEMBL: CHEMBL572546; KNApSAcK: C00007445; PDB-CCD: ADX; 3DMET: B01194; NIKKAJI: J37.502K,cpd:C00224,10,14,10,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O10N5P1S1,C10H13O10N5P1S1,427.0198998,428.0277249,426.0120748608,715,cpd:C00242,Guanine;,C5H5N5O,Guanine; 2-Amino-6-hydroxypurine,R01229 R01676 R01677 R01969 R02147 R03789 R10209,Purine metabolism; Metabolic pathways,2.4.2.1; 2.4.2.4; 2.4.2.7; 2.4.2.8; 2.4.2.15; 2.4.2.22; 2.4.2.29; 3.2.2.1; 3.2.2.8; 3.5.4.3,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Bases;    Purines;     C00242  Guanine (Gua),CAS: 73-40-5; PubChem: 3541; ChEBI: 16235; ChEMBL: CHEMBL219568; KNApSAcK: C00001501; PDB-CCD: GUN; 3DMET: B00067; NIKKAJI: J9.344K,cpd:C00242,5,5,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H6O1N5,C5H4O1N5,151.0494098,152.0572348,150.0415848609,716,cpd:C00262,Hypoxanthine;,C5H4N4O,Hypoxanthine; Purine-6-ol,R01128 R01132 R01244 R01768 R01769 R01770 R01863 R02748; R08587 R09668,Purine metabolism; Metabolic pathways,1.17.1.4; 1.17.3.2; 2.4.2.1; 2.4.2.4; 2.4.2.8; 2.4.2.15; 2.4.2.44; 3.2.2.1; 3.2.2.2; 3.2.2.8; 3.2.2.12; 3.2.2.26; 3.5.4.2,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C00262  Hypoxanthine,CAS: 68-94-0; PubChem: 3560; ChEBI: 17368; ChEMBL: CHEMBL1427; KNApSAcK: C00001502; PDB-CCD: HPA; 3DMET: B00078; NIKKAJI: J1.934H,cpd:C00262,5,4,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H5O1N4,C5H3O1N4,136.0385108,137.0463358,135.0306857610,717,cpd:C00286,dGTP;,C10H16N5O13P3,dGTP; 2'-Deoxyguanosine 5'-triphosphate; Deoxyguanosine 5'-triphosphate; Deoxyguanosine triphosphate,R00376 R01855 R01856 R01857 R01858 R01880 R02020 R02091; R07278,Purine metabolism; Metabolic pathways,1.17.4.2; 2.6.99.1; 2.7.1.40; 2.7.1.48; 2.7.4.6; 2.7.7.7; 3.1.5.1; 3.6.1.-,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00286  dGTP,CAS: 2564-35-4; PubChem: 3581; ChEBI: 16497; ChEMBL: CHEMBL477486; KNApSAcK: C00019346; PDB-CCD: DGT; 3DMET: B01207; NIKKAJI: J192.065K,cpd:C00002; cpd:C00286; cpd:C01806; cpd:C19969,10,16,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O13N5P3,C10H15O13N5P3,506.9957466,508.0035716,505.9879216611,718,cpd:C00294,Inosine,C10H12N4O5,Inosine,R00055 R01126 R01131 R01560 R01770 R01863 R05821,Purine metabolism; Metabolic pathways,1.1.3.28; 2.4.2.1; 2.4.2.15; 2.7.1.73; 3.1.3.5; 3.1.3.99; 3.2.2.1; 3.2.2.2; 3.2.2.8; 3.5.4.4,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;    D06B CHEMOTHERAPEUTICS FOR TOPICAL USE;     D06BB Antivirals;      D06BB05 Inosine;       D00054  Inosine (JAN/INN);  G GENITO URINARY SYSTEM AND SEX HORMONES;   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;    G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;     G01AX Other antiinfectives and antiseptics;      G01AX02 Inosine;       D00054  Inosine (JAN/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01X OTHER OPHTHALMOLOGICALS;     S01XA Other ophthalmologicals;      S01XA10 Inosine;       D00054  Inosine (JAN/INN)",CAS: 58-63-9; PubChem: 3588; ChEBI: 17596; ChEMBL: CHEMBL1556; KNApSAcK: C00019692; PDB-CCD: NOS; 3DMET: B01208; NIKKAJI: J1.388I,cpd:C00294; cpd:C07771,10,12,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O5N4,C10H11O5N4,268.0807695,269.0885945,267.0729445612,719,cpd:C00301,ADP-ribose;,C15H23N5O14P2,ADP-ribose; ADP-D-ribose; Adenosine diphosphate ribose,R00102 R01052 R01054 R01885 R01886 R03446 R07626 R10630; R11553,Purine metabolism,2.7.7.35; 2.7.7.96; 3.2.2.5; 3.2.2.6; 3.2.2.19; 3.2.2.24; 3.5.1.-; 3.6.1.13; 3.6.1.21; 3.6.1.53; 3.6.1.-,NA,NA,PubChem: 3595; ChEBI: 16960; ChEMBL: CHEMBL1161865; PDB-CCD: APR; 3DMET: B01211; NIKKAJI: J17.074G,cpd:C00301; cpd:C01882; cpd:C02741,15,23,14,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H24O14N5P2,C15H22O14N5P2,559.0716744,560.0794995,558.0638494613,720,cpd:C00330,Deoxyguanosine;,C10H13N5O4,Deoxyguanosine; 2'-Deoxyguanosine,R01856 R01967 R01968 R01969,Purine metabolism; Metabolic pathways,2.4.2.1; 2.4.2.4; 2.7.1.113; 3.1.3.5; 3.1.3.89; 3.1.5.1,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Deoxyribonucleosides;     C00330  Deoxyguanosine (dG),CAS: 961-07-9; PubChem: 3624; ChEBI: 17172; ChEMBL: CHEMBL1415372 CHEMBL68908; PDB-CCD: GNG; 3DMET: B01219; NIKKAJI: J13.863K,cpd:C00212; cpd:C00330; cpd:C07195; cpd:C07210,10,13,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O4N5,C10H12O4N5,267.0967539,268.104579,266.0889289614,721,cpd:C00360,dAMP;,C10H14N5O6P,dAMP; 2'-Deoxyadenosine 5'-phosphate; 2'-Deoxyadenosine 5'-monophosphate; Deoxyadenylic acid; Deoxyadenosine monophosphate,R01547 R02088 R02089,Purine metabolism; Metabolic pathways,2.7.1.76; 2.7.4.3; 2.7.4.11; 3.1.3.5; 3.1.3.89,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00360  dAMP,CAS: 653-63-4; PubChem: 3651; ChEBI: 17713; ChEMBL: CHEMBL1206239; PDB-CCD: D5M DA; 3DMET: B01226; NIKKAJI: J205.943F,cpd:C00360; cpd:C00821; cpd:C05924,10,14,6,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O6N5P1,C10H13O6N5P1,331.0681702,332.0759952,330.0603452615,722,cpd:C00361,dGDP;,C10H15N5O10P2,dGDP; 2'-Deoxyguanosine 5'-diphosphate,R01857 R01858 R01880 R02019 R02090 R02091,Purine metabolism; Metabolic pathways,1.17.4.1; 2.7.1.40; 2.7.1.48; 2.7.4.6; 2.7.4.8; 2.7.4.12,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00361  dGDP,PubChem: 3652; ChEBI: 28862; PDB-CCD: DGI; 3DMET: B01227; NIKKAJI: J366.498H,cpd:C00008; cpd:C00054; cpd:C00361; cpd:C03850,10,15,10,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O10N5P2,C10H14O10N5P2,427.0294157,428.0372407,426.0215907616,723,cpd:C00362,dGMP;,C10H14N5O7P,dGMP; 2'-Deoxyguanosine 5'-monophosphate; 2'-Deoxyguanosine 5'-phosphate; Deoxyguanylic acid; Deoxyguanosine monophosphate,R01855 R01967 R01968 R02090,Purine metabolism; Metabolic pathways,2.7.1.113; 2.7.4.8; 2.7.4.12; 3.1.3.5; 3.1.3.89; 3.6.1.-,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00362  dGMP,CAS: 902-04-5; PubChem: 3653; ChEBI: 16192; ChEMBL: CHEMBL477487; KNApSAcK: C00019356; PDB-CCD: DG DGP; 3DMET: B01228; NIKKAJI: J195.198J,cpd:C00020; cpd:C00362; cpd:C00946; cpd:C01367; cpd:C04378; cpd:C11475; cpd:C16619; cpd:C17324; cpd:C19970; cpd:C20459; cpd:C20648,10,14,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O7N5P1,C10H13O7N5P1,347.0630848,348.0709098,346.0552598617,724,cpd:C00366,Urate;,C5H4N4O3,Urate; Uric acid,R02103 R02106 R02107 R02646 R09514 R09876 R10920,Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Bile secretion,1.7.3.3; 1.14.11.48; 1.14.13.113; 1.17.1.4; 1.17.3.2; 2.4.2.16; 3.5.4.32,"Purine degradation, xanthine => urea",NA,CAS: 69-93-2; PubChem: 3657; ChEBI: 17775; ChEMBL: CHEMBL792; KNApSAcK: C00007301; PDB-CCD: 8HX URC; 3DMET: B00094; NIKKAJI: J2.372H,cpd:C00366,5,4,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H5O3N4,C5H3O3N4,168.02834,169.036165,167.020515618,725,cpd:C00385,Xanthine,C5H4N4O2,Xanthine,R01676 R01768 R01769 R02103 R02107 R02141 R02142 R02143; R02297 R07965 R07966 R07967 R07968 R07969 R07970 R08410; R10920,Purine metabolism; Caffeine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,1.14.11.48; 1.14.13.128; 1.14.13.178; 1.14.13.179; 1.17.1.4; 1.17.3.2; 2.4.2.1; 2.4.2.8; 2.4.2.22; 2.4.2.-; 3.2.2.1; 3.5.2.-; 3.5.4.3,"Purine degradation, xanthine => urea",Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C00385  Xanthine,CAS: 69-89-6; PubChem: 3675; ChEBI: 17712 48517; ChEMBL: CHEMBL1424; KNApSAcK: C00019660; PDB-CCD: XAN; 3DMET: B00099; NIKKAJI: J2.371J,cpd:C00385; cpd:C07599; cpd:C16613,5,4,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H5O2N4,C5H3O2N4,152.0334254,153.0412504,151.0256004619,726,cpd:C00387,Guanosine,C10H13N5O5,Guanosine,R01227 R01228 R01677 R02145 R02147 R02148,Purine metabolism; Metabolic pathways,2.4.2.1; 2.4.2.15; 2.7.1.73; 3.1.3.5; 3.1.3.6; 3.2.2.1; 3.2.2.8; 3.5.4.15,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Ribonucleosides;     C00387  Guanosine (G),CAS: 118-00-3; PubChem: 3677; ChEBI: 16750; ChEMBL: CHEMBL375655; KNApSAcK: C00019679; PDB-CCD: GMP; 3DMET: B01233; NIKKAJI: J10.076E,cpd:C00387; cpd:C08432,10,13,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O5N5,C10H12O5N5,283.0916685,284.0994936,282.0838435620,727,cpd:C00499,Allantoate;,C4H8N4O4,Allantoate; Allantoic acid,R02422 R02423 R02425,Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments,3.5.2.5; 3.5.3.4; 3.5.3.9,"Purine degradation, xanthine => urea",NA,CAS: 99-16-1; PubChem: 3782; ChEBI: 17536 30837; KNApSAcK: C00007470; PDB-CCD: 1AL; 3DMET: B01270; NIKKAJI: J11.619J,cpd:C00499,4,8,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O4N4,C4H7O4N4,176.0545548,177.0623798,175.0467297621,728,cpd:C00559,Deoxyadenosine;,C10H13N5O3,Deoxyadenosine; 2'-Deoxyadenosine,R02088 R02089 R02556 R02557,Purine metabolism; Metabolic pathways,2.4.2.1; 2.7.1.76; 3.1.3.5; 3.1.3.89; 3.5.4.4,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Deoxyribonucleosides;     C00559  Deoxyadenosine (dA),CAS: 958-09-8; PubChem: 3839; ChEBI: 17256; ChEMBL: CHEMBL449329; KNApSAcK: C00019281; PDB-CCD: 3D1; 3DMET: B01287; NIKKAJI: J80.042B,cpd:C00559; cpd:C05198; cpd:C08431,10,13,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O3N5,C10H12O3N5,251.1018393,252.1096643,250.0940143622,729,cpd:C00575,"3',5'-Cyclic AMP;",C10H12N5O6P,"3',5'-Cyclic AMP; Cyclic adenylic acid; Cyclic AMP; Adenosine 3',5'-phosphate; Adenosine 3',5'-cyclic phosphate; cAMP",R00089 R00191,Purine metabolism; Endocrine resistance; Biofilm formation - Pseudomonas aeruginosa; Biofilm formation - Escherichia coli; MAPK signaling pathway; Ras signaling pathway; Rap1 signaling pathway; Calcium signaling pathway; cGMP-PKG signaling pathway; cAMP signaling pathway; Chemokine signaling pathway; Phospholipase D signaling pathway; Cell cycle - yeast; Meiosis - yeast; Oocyte meiosis; Longevity regulating pathway; Longevity regulating pathway - multiple species; Adrenergic signaling in cardiomyocytes; Vascular smooth muscle contraction; Hedgehog signaling pathway; Apelin signaling pathway; Gap junction; Platelet activation; Leukocyte transendothelial migration; Circadian rhythm; Circadian entrainment; Long-term potentiation; Retrograde endocannabinoid signaling; Glutamatergic synapse; Cholinergic synapse; Serotonergic synapse; GABAergic synapse; Dopaminergic synapse; Olfactory transduction; Taste transduction; Inflammatory mediator regulation of TRP channels; Insulin signaling pathway; Insulin secretion; GnRH signaling pathway; Ovarian steroidogenesis; Progesterone-mediated oocyte maturation; Estrogen signaling pathway; Melanogenesis; Thyroid hormone synthesis; Thyroid hormone signaling pathway; Oxytocin signaling pathway; Glucagon signaling pathway; Regulation of lipolysis in adipocytes; Renin secretion; Aldosterone synthesis and secretion; Aldosterone-regulated sodium reabsorption; Endocrine and other factor-regulated calcium reabsorption; Vasopressin-regulated water reabsorption; Salivary secretion; Gastric acid secretion; Pancreatic secretion; Bile secretion; Parkinson's disease; Prion diseases; Cocaine addiction; Amphetamine addiction; Morphine addiction; Alcoholism; Vibrio cholerae infection; Biofilm formation - Vibrio cholerae; Pertussis; Chagas disease (American trypanosomiasis); Amoebiasis; HTLV-I infection; Pathways in cancer; Dilated cardiomyopathy,3.1.4.17; 3.1.4.53; 4.6.1.1,NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    3',5'-Cyclic nuclcleotides;     C00575  3',5'-Cyclic AMP",CAS: 60-92-4; PubChem: 3854; ChEBI: 17489; ChEMBL: CHEMBL316966; KNApSAcK: C00001497; PDB-CCD: CMP; 3DMET: B01289; NIKKAJI: J4.811I,cpd:C00575; cpd:C00895; cpd:C02353; cpd:C02507; cpd:C20935,10,12,6,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O6N5P1,C10H11O6N5P1,329.0525201,330.0603452,328.0446951623,730,cpd:C00603,(-)-Ureidoglycolate;,C3H6N2O4,(-)-Ureidoglycolate; (S)-Ureidoglycolate,R00469 R00776 R02422 R02935 R02936 R05554,Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.154; 1.1.1.350; 3.5.1.116; 3.5.3.4; 3.5.3.26; 4.3.2.3,NA,NA,PubChem: 3878; ChEBI: 15412; KNApSAcK: C00007466; PDB-CCD: UGC; 3DMET: B01292; NIKKAJI: J1.344.912K,cpd:C00603; cpd:C02766,3,6,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O4N2,C3H5O4N2,134.0327567,135.0405817,133.0249316624,731,cpd:C00655,Xanthosine 5'-phosphate;,C10H13N4O9P,Xanthosine 5'-phosphate; Xanthylic acid; XMP; (9-D-Ribosylxanthine)-5'-phosphate,R01130 R01230 R01231 R02142 R02719 R02720 R02805,Purine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.205; 2.4.2.8; 2.4.2.22; 3.1.3.5; 3.6.1.17; 3.6.1.66; 3.6.1.-; 6.3.5.2,"Guanine ribonucleotide biosynthesis IMP => GDP,GTP",Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C00655  Xanthosine 5'-phosphate,CAS: 523-98-8; PubChem: 3925; ChEBI: 15652; ChEMBL: CHEMBL1206243; KNApSAcK: C00007396; PDB-CCD: XMP; 3DMET: B01300; NIKKAJI: J29.066A,cpd:C00655,10,13,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O9N4P1,C10H12O9N4P1,364.042015,365.04984,363.03419625,732,cpd:C00700,XTP;,C10H15N4O15P3,XTP; Xanthosine 5'-triphosphate,R02720 R02805,Purine metabolism,3.6.1.17; 3.6.1.66; 3.6.1.-,NA,NA,CAS: 6253-56-1; PubChem: 3968; ChEBI: 10049; 3DMET: B01316; NIKKAJI: J276.384B,cpd:C00700,10,15,15,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O15N4P3,C10H14O15N4P3,523.9746768,524.9825018,522.9668518626,733,cpd:C00802,Oxalureate;,C3H4N2O4,Oxalureate; Oxaluric acid; Monooxalylurea; Oxalurate,R02935 R02936 R02937 R10908,Purine metabolism; Microbial metabolism in diverse environments,1.1.1.154; 1.1.1.350; 2.1.3.5; 2.6.1.-,NA,NA,CAS: 585-05-7; PubChem: 4060; ChEBI: 16582; KNApSAcK: C00007463; 3DMET: B01334; NIKKAJI: J2.677H,cpd:C00802,3,4,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O4N2,C3H3O4N2,132.0171066,133.0249316,131.0092816627,734,cpd:C00942,"3',5'-Cyclic GMP;",C10H12N5O7P,"3',5'-Cyclic GMP; Guanosine 3',5'-cyclic monophosphate; Guanosine 3',5'-cyclic phosphate; Cyclic GMP; cGMP",R00434 R01234,Purine metabolism; cGMP-PKG signaling pathway; Vascular smooth muscle contraction; Gap junction; Platelet activation; Circadian entrainment; Long-term depression; Olfactory transduction; Phototransduction; Oxytocin signaling pathway; Regulation of lipolysis in adipocytes; Renin secretion; Aldosterone synthesis and secretion; Salivary secretion; Bile secretion,3.1.4.17; 3.1.4.35; 4.6.1.1; 4.6.1.2,NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    3',5'-Cyclic nuclcleotides;     C00942  3',5'-Cyclic GMP",CAS: 7665-99-8; PubChem: 4194; ChEBI: 16356; ChEMBL: CHEMBL395336 CHEMBL68554; KNApSAcK: C00019673; PDB-CCD: 35G PCG; 3DMET: B01354; NIKKAJI: J8.958C,cpd:C00942; cpd:C01445; cpd:C06194; cpd:C07025; cpd:C18344,10,12,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O7N5P1,C10H11O7N5P1,345.0474347,346.0552598,344.0396097628,735,cpd:C01228,"Guanosine 3',5'-bis(diphosphate);",C10H17N5O17P4,"Guanosine 3',5'-bis(diphosphate); Guanosine 3'-diphosphate 5'-diphosphate; Guanosine 5'-diphosphate,3'-diphosphate",R00336 R03409,Purine metabolism; Biofilm formation - Escherichia coli,3.1.7.2; 3.6.1.11; 3.6.1.40,NA,NA,PubChem: 4450; ChEBI: 17633; PDB-CCD: G4P; 3DMET: B01416; NIKKAJI: J40.058K,cpd:C01228,10,17,17,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O17N5P4,C10H16O17N5P4,602.9569921,603.9648171,601.9491671629,736,cpd:C01260,"P1,P4-Bis(5'-adenosyl)tetraphosphate;",C20H28N10O19P4,"P1,P4-Bis(5'-adenosyl)tetraphosphate; AppppA",R00125 R00126 R00184 R01618,Purine metabolism,2.7.7.53; 3.6.1.17; 3.6.1.41; 3.6.1.61,NA,NA,PubChem: 4479; ChEBI: 17422; ChEMBL: CHEMBL339385; PDB-CCD: B4P; 3DMET: B01424; NIKKAJI: J313.703A,cpd:C01260; cpd:C20935,20,28,19,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O19N10P4,C20H27O19N10P4,836.0482667,837.0560917,835.0404417630,737,cpd:C01261,"P1,P4-Bis(5'-guanosyl) tetraphosphate;",C20H28N10O21P4,"P1,P4-Bis(5'-guanosyl) tetraphosphate; GppppG; Bis(5'-guanosyl) tetraphosphate",R00012 R01232,Purine metabolism,2.7.7.45; 3.6.1.17,NA,NA,PubChem: 4480; ChEBI: 15883; ChEMBL: CHEMBL448348; 3DMET: B01425; NIKKAJI: J398.256D,cpd:C01261,20,28,21,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O21N10P4,C20H27O21N10P4,868.038096,869.045921,867.0302709631,738,cpd:C01344,dIDP;,C10H14N4O10P2,dIDP; 2'-Deoxyinosine-5'-diphosphate; 2'-Deoxyinosine 5'-diphosphate,R03530 R10235,Purine metabolism,2.7.4.6; 3.6.1.64,NA,NA,PubChem: 4549; ChEBI: 28823; 3DMET: B01439; NIKKAJI: J2.732.433I,cpd:C01344; cpd:C16616,10,14,10,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O10N4P2,C10H13O10N4P2,412.0185167,413.0263417,411.0106916632,739,cpd:C01345,dITP;,C10H15N4O13P3,dITP; 2'-Deoxyinosine-5'-triphosphate; 2'-Deoxyinosine 5'-triphosphate,R03530 R03531,Purine metabolism,2.7.4.6; 3.6.1.66; 3.6.1.-,NA,NA,PubChem: 4550; ChEBI: 28807; 3DMET: B01440; NIKKAJI: J322.120B,cpd:C01345; cpd:C16617,10,15,13,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O13N4P3,C10H14O13N4P3,491.9848476,492.9926726,490.9770225633,740,cpd:C01367,3'-AMP;,C10H14N5O7P,3'-AMP; 3'-Adenylic acid; 3'-Adenosine monophosphate; Adenosine-3'-monophosphate; Adenosine 3'-phosphate; AMP 3'-phosphate,R01562 R03537,Purine metabolism,3.1.3.6; 3.1.4.16,NA,NA,CAS: 84-21-9; PubChem: 4566; ChEBI: 28931; ChEMBL: CHEMBL576739; KNApSAcK: C00019350; PDB-CCD: 3AM; 3DMET: B01442; NIKKAJI: J36.734F,cpd:C00020; cpd:C00362; cpd:C00946; cpd:C01367; cpd:C04378; cpd:C11475; cpd:C16619; cpd:C17324; cpd:C19970; cpd:C20459; cpd:C20648,10,14,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O7N5P1,C10H13O7N5P1,347.0630848,348.0709098,346.0552598634,741,cpd:C01762,Xanthosine,C10H12N4O6,Xanthosine,R02143 R02145 R02297 R02719 R07917,Purine metabolism; Caffeine metabolism; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites,2.1.1.158; 2.4.2.1; 2.4.2.-; 3.1.3.5; 3.2.2.1; 3.5.4.15,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C01762  Xanthosine,CAS: 146-80-5; PubChem: 4895; ChEBI: 18107; ChEMBL: CHEMBL402439 CHEMBL605888; KNApSAcK: C00007222; PDB-CCD: 4UO; 3DMET: B01495; NIKKAJI: J9.367J,cpd:C01762,10,12,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O6N4,C10H11O6N4,284.0756841,285.0835092,283.0678591635,742,cpd:C02091,(S)-Ureidoglycine,C3H7N3O3,(S)-Ureidoglycine,R02423 R05554 R10908,Purine metabolism; Microbial metabolism in diverse environments,2.6.1.-; 3.5.3.9; 3.5.3.26,NA,NA,PubChem: 5176; ChEBI: 16282 59945; KNApSAcK: C00007467; PDB-CCD: UGY; 3DMET: B00388; NIKKAJI: J2.735.485H,cpd:C02091; cpd:C06382,3,7,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O3N3,C3H6O3N3,133.0487411,134.0565661,132.0409161636,743,cpd:C02348,(R)(-)-Allantoin;,C4H6N4O3,(R)(-)-Allantoin; (R)-Allantoin,R03925 R06063 R06605,Purine metabolism; Microbial metabolism in diverse environments,5.1.99.3,NA,NA,PubChem: 5396; ChEBI: 15677; 3DMET: B01563; NIKKAJI: J732.397B,cpd:C01551; cpd:C02348; cpd:C02350; cpd:C06805,4,6,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O3N4,C4H5O3N4,158.0439901,159.0518151,157.036165637,744,cpd:C02350,(S)-Allantoin;,C4H6N4O3,(S)-Allantoin; (S)(+)-Allantoin,R02425 R03925 R06064 R06604,Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments,3.5.2.5; 4.1.1.97; 5.1.99.3,"Purine degradation, xanthine => urea",NA,PubChem: 5397; ChEBI: 15678; ChEMBL: CHEMBL1230080; PDB-CCD: 3AL; 3DMET: B00428; NIKKAJI: J732.396D,cpd:C01551; cpd:C02348; cpd:C02350; cpd:C06805,4,6,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O3N4,C4H5O3N4,158.0439901,159.0518151,157.036165638,745,cpd:C02353,"2',3'-Cyclic AMP",C10H12N5O6P,"2',3'-Cyclic AMP",R03537,Purine metabolism,3.1.4.16,NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    2',3'-Cyclic nucleotides;     C02353  2',3'-Cyclic AMP",PubChem: 5400; ChEBI: 27844; PDB-CCD: ACK; 3DMET: B01564; NIKKAJI: J205.905C,cpd:C00575; cpd:C00895; cpd:C02353; cpd:C02507; cpd:C20935,10,12,6,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O6N5P1,C10H11O6N5P1,329.0525201,330.0603452,328.0446951639,746,cpd:C02718,N-Formiminoglycine;,C3H6N2O2,N-Formiminoglycine; Formiminoglycine; N-Formimidoylglycine,R02729 R04026,Purine metabolism,2.1.2.4; 3.5.2.-,NA,NA,CAS: 2140-03-6; PubChem: 5681; ChEBI: 18415; 3DMET: B00489; NIKKAJI: J2.359.626A,cpd:C02718; cpd:C06682; cpd:C08057,3,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O2N2,C3H5O2N2,102.0429274,103.0507525,101.0351024640,747,cpd:C03090,5-Phosphoribosylamine;,C5H12NO7P,5-Phosphoribosylamine; 5-Phospho-beta-D-ribosylamine; 5-Phospho-D-ribosylamine; 5-Phosphoribosyl-1-amine,R01053 R01072 R04144,"Purine metabolism; Alanine, aspartate and glutamate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics",2.4.2.14; 6.3.4.7; 6.3.4.13,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,PubChem: 5988; ChEBI: 37737; KNApSAcK: C00007377; PDB-CCD: GRF; 3DMET: B01631; NIKKAJI: J40.074B,cpd:C03090,5,12,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O7N1P1,C5H11O7N1P1,229.0351387,230.0429638,228.0273137641,748,cpd:C03373,Aminoimidazole ribotide;,C8H14N3O7P,Aminoimidazole ribotide; AIR; 1-(5'-Phosphoribosyl)-5-aminoimidazole; 5'-Phosphoribosyl-5-aminoimidazole; 1-(5-Phospho-D-ribosyl)-5-aminoimidazole; 5-Amino-1-(5-phospho-D-ribosyl)imidazole,R03472 R04208 R04209 R07404,Purine metabolism; Thiamine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,4.1.1.21; 4.1.99.17; 6.3.3.1; 6.3.4.18,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP; Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P",NA,CAS: 25635-88-5; PubChem: 6208; ChEBI: 28843; KNApSAcK: C00019655; PDB-CCD: AIR; 3DMET: B01653; NIKKAJI: J17.002J,cpd:C03373,8,14,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O7N3P1,C8H13O7N3P1,295.0569368,296.0647618,294.0491118642,749,cpd:C03483,Adenosine tetraphosphate;,C10H17N5O16P4,Adenosine tetraphosphate; Adenosine 5'-tetraphosphate,R00128 R09882,Purine metabolism,3.6.1.14; 3.6.1.60,NA,NA,PubChem: 6295; ChEBI: 18334; PDB-CCD: AQP; 3DMET: B01663,cpd:C03483,10,17,16,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O16N5P4,C10H16O16N5P4,586.9620775,587.9699025,585.9542524643,750,cpd:C03614,Inosine 5'-tetraphosphate,C10H16N4O17P4,Inosine 5'-tetraphosphate,R00723,Purine metabolism,3.6.1.14,NA,NA,PubChem: 6400; ChEBI: 28505; 3DMET: B01675; NIKKAJI: J952.101A,cpd:C03614,10,16,17,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O17N4P4,C10H15O17N4P4,587.9460931,588.9539181,586.938268644,751,cpd:C03794,"N6-(1,2-Dicarboxyethyl)-AMP;",C14H18N5O11P,"N6-(1,2-Dicarboxyethyl)-AMP; N6-(1,2-Dicarboxyethyl)AMP; Adenylosuccinate; Adenylosuccinic acid",R01083 R01135,"Purine metabolism; Alanine, aspartate and glutamate metabolism; Metabolic pathways",4.3.2.2; 6.3.4.4,"Adenine ribonucleotide biosynthesis, IMP => ADP,ATP",NA,CAS: 19046-78-7; PubChem: 6543; ChEBI: 15919; KNApSAcK: C00007229; PDB-CCD: 2SA; 3DMET: B04914; NIKKAJI: J37.503I,cpd:C03794,14,18,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H19O11N5P1,C14H17O11N5P1,463.0740434,464.0818684,462.0662184645,752,cpd:C03838,5'-Phosphoribosylglycinamide;,C7H15N2O8P,5'-Phosphoribosylglycinamide; GAR; N1-(5-Phospho-D-ribosyl)glycinamide; Glycinamide ribonucleotide,R04144 R04325 R04326 R06974,Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.1.2.2; 2.1.2.-; 6.3.4.13,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,CAS: 10074-18-7; PubChem: 6578; ChEBI: 18349; KNApSAcK: C00007395; PDB-CCD: GAR; 3DMET: B04915; NIKKAJI: J372.863C,cpd:C03838,7,15,8,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O8N2P1,C7H14O8N2P1,286.0566024,287.0644275,285.0487774646,753,cpd:C04051,5-Amino-4-imidazolecarboxyamide,C4H6N4O,5-Amino-4-imidazolecarboxyamide,R04378,Purine metabolism,2.4.2.7,NA,NA,PubChem: 6752; ChEBI: 2030; ChEMBL: CHEMBL1610; PDB-CCD: 5AC; 3DMET: B00671; NIKKAJI: J37.792I,cpd:C04051,4,6,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O1N4,C4H5O1N4,126.0541608,127.0619859,125.0463358647,754,cpd:C04376,5'-Phosphoribosyl-N-formylglycinamide;,C8H15N2O9P,5'-Phosphoribosyl-N-formylglycinamide; N-Formyl-GAR; N-Formylglycinamide ribonucleotide; N2-Formyl-N1-(5-phospho-D-ribosyl)glycinamide,R04325 R04326 R04463 R06974,Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.1.2.2; 2.1.2.-; 6.3.5.3,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,CAS: 349-34-8; PubChem: 7017; ChEBI: 18272 42411; KNApSAcK: C00019642; PDB-CCD: FGR; 3DMET: B04939; NIKKAJI: J40.075K,cpd:C04376,8,15,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O9N2P1,C8H14O9N2P1,314.0515171,315.0593421,313.043692648,755,cpd:C04392,"P1,P4-Bis(5'-xanthosyl) tetraphosphate;",C20H26N8O23P4,"P1,P4-Bis(5'-xanthosyl) tetraphosphate; XppppX",R02805,Purine metabolism,3.6.1.17,NA,NA,PubChem: 7032; ChEBI: 28400; 3DMET: B01739; NIKKAJI: J2.750.452C,cpd:C04392,20,26,23,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H27O23N8P4,C20H25O23N8P4,870.0061271,871.0139521,868.9983021649,756,cpd:C04494,Guanosine 3'-diphosphate 5'-triphosphate;,C10H18N5O20P5,"Guanosine 3'-diphosphate 5'-triphosphate; Guanosine 5'-triphosphate,3'-diphosphate",R00429 R03409,Purine metabolism; Biofilm formation - Escherichia coli,2.7.6.5; 3.6.1.11; 3.6.1.40,NA,NA,CAS: 38918-96-6; PubChem: 7111; ChEBI: 16690; PDB-CCD: 0O2; 3DMET: B01748; NIKKAJI: J40.057B,cpd:C04494,10,18,20,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O20N5P5,C10H17O20N5P5,682.923323,683.931148,681.915498650,757,cpd:C04640,2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine;,C8H16N3O8P,2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine; 1-(5'-Phosphoribosyl)-N-formylglycinamidine; 5'-Phosphoribosyl-N-formylglycinamidine; 5'-Phosphoribosylformylglycinamidine; 2-(Formamido)-N1-(5-phospho-D-ribosyl)acetamidine,R04208 R04463,Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,6.3.3.1; 6.3.5.3,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,PubChem: 7229; ChEBI: 18413; 3DMET: B01768; NIKKAJI: J2.752.466D,cpd:C04640,8,16,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O8N3P1,C8H15O8N3P1,313.0675015,314.0753265,312.0596765651,758,cpd:C04677,1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide;,C9H15N4O8P,1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide; 5'-Phosphoribosyl-5-amino-4-imidazolecarboxamide; 5'-Phospho-ribosyl-5-amino-4-imidazole carboxamide; AICAR; 5-Aminoimidazole-4-carboxamide ribotide; 5-Phosphoribosyl-4-carbamoyl-5-aminoimidazole; 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide,R04378 R04558 R04559 R04560 R06975,Purine metabolism; Histidine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; AMPK signaling pathway,2.1.2.3; 2.4.2.7; 2.4.2.-; 4.1.3.-; 4.3.2.2; 6.3.4.23,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,CAS: 3031-94-5; PubChem: 7258; ChEBI: 18406; ChEMBL: CHEMBL483849; KNApSAcK: C00007383; PDB-CCD: AMZ; 3DMET: B01774; NIKKAJI: J7.665A,cpd:C04677,9,15,8,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16O8N4P1,C9H14O8N4P1,338.0627505,339.0705755,337.0549254652,759,cpd:C04734,1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide;,C10H15N4O9P,1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide; 5'-Phosphoribosyl-5-formamido-4-imidazolecarboxamide; 5-Formamido-1-(5-phosphoribosyl)imidazole-4-carboxamide; 5-Formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide; FAICAR,R01127 R04560 R06975,Purine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.1.2.3; 3.5.4.10; 6.3.4.23,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,PubChem: 7305; ChEBI: 18381; ChEMBL: CHEMBL521310; PDB-CCD: FAI; 3DMET: B01781; NIKKAJI: J602.393B,cpd:C04734,10,15,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O9N4P1,C10H14O9N4P1,366.0576651,367.0654901,365.04984653,760,cpd:C04751,1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate;,C9H14N3O9P,1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate; 1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxylate; 1-(5'-Phosphoribosyl)-5-amino-4-carboxyimidazole; 5'-Phosphoribosyl-5-amino-4-imidazolecarboxylate; 1-(5'-Phosphoribosyl)-4-carboxy-5-aminoimidazole; 5'-Phosphoribosyl-4-carboxy-5-aminoimidazole; 5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate,R04209 R04591 R07405,Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,4.1.1.21; 5.4.99.18; 6.3.2.6,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,PubChem: 7321; ChEBI: 28413; PDB-CCD: C2R; 3DMET: B01784; NIKKAJI: J38.129B,cpd:C04751; cpd:C15667,9,14,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O9N3P1,C9H13O9N3P1,339.046766,340.0545911,338.038941654,761,cpd:C04823,1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole;,C13H19N4O12P,1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole; 1-(5'-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole; 5'-Phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole; (S)-2-[5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido]succinate; SAICAR,R04559 R04591,Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,4.3.2.2; 6.3.2.6,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,CAS: 3031-95-6; PubChem: 7384; ChEBI: 18319; 3DMET: B04963; NIKKAJI: J7.666J,cpd:C04823,13,19,12,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H20O12N4P1,C13H18O12N4P1,454.0737091,455.0815341,453.065884655,762,cpd:C05239,5-Aminoimidazole;,C3H5N3,5-Aminoimidazole; Aminoimidazole; 4-Aminoimidazole,R04731 R04732,Purine metabolism,3.5.4.8; 4.1.1.-,NA,NA,CAS: 4919-03-3; PubChem: 7633; ChEBI: 16607; 3DMET: B00762; NIKKAJI: J507.002C,cpd:C05239; cpd:C07455,3,5,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H6N3,C3H4N3,83.04834717,84.05617221,82.04052214656,763,cpd:C05512,Deoxyinosine,C10H12N4O4,Deoxyinosine,R02556 R02748,Purine metabolism; Metabolic pathways,2.4.2.1; 2.4.2.4; 3.5.4.4,NA,NA,CAS: 890-38-0; PubChem: 7859; ChEBI: 28997; ChEMBL: CHEMBL1229971; PDB-CCD: 2ND; 3DMET: B01869; NIKKAJI: J128.131C,cpd:C00343; cpd:C01736; cpd:C05512; cpd:C15586; cpd:C21102,10,12,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O4N4,C10H11O4N4,252.0858549,253.0936799,251.0780299657,764,cpd:C05513,Urate-3-ribonucleoside;,C10H12N4O7,Urate-3-ribonucleoside; Uric acid ribonucleoside,R02646,Purine metabolism,2.4.2.16,NA,NA,PubChem: 7860; ChEBI: 50547; NIKKAJI: J2.328.067A,cpd:C05513,10,12,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O7N4,C10H11O7N4,300.0705987,301.0784238,299.0627737658,765,cpd:C05515,5-Ureido-4-imidazole carboxylate;,C5H6N4O3,5-Ureido-4-imidazole carboxylate; 4-Ureido-5-imidazolecarboxylic acid,R02141 R04857,Purine metabolism,3.5.2.-; 3.5.3.-,NA,NA,PubChem: 7861; ChEBI: 27580; 3DMET: B00782; NIKKAJI: J805.606D,cpd:C05515,5,6,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O3N4,C5H5O3N4,170.0439901,171.0518151,169.036165659,766,cpd:C05516,5-Amino-4-imidazole carboxylate;,C4H5N3O2,5-Amino-4-imidazole carboxylate; 4-Amino-5-imidazolecarboxylic acid,R04732 R04857,Purine metabolism,3.5.3.-; 4.1.1.-,NA,NA,PubChem: 7862; ChEBI: 28280; 3DMET: B00783; NIKKAJI: J2.361.602E,cpd:C05516; cpd:C16621,4,5,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H6O2N3,C4H4O2N3,127.0381764,128.0460014,126.0303514660,767,cpd:C05993,Acetyl adenylate;,C12H16N5O8P,Acetyl adenylate; 5'-Acetylphosphoadenosine,R00236 R00316 R00322,Purine metabolism; Pyruvate metabolism,3.6.1.20; 6.2.1.1,NA,NA,CAS: 13015-87-7; PubChem: 8267; ChEBI: 37666; PDB-CCD: 6R9; 3DMET: B01944; NIKKAJI: J227.896K,cpd:C05993,12,16,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H17O8N5P1,C12H15O8N5P1,389.0736495,390.0814745,388.0658245661,768,cpd:C06193,Guanosine 3'-phosphate;,C10H14N5O8P,Guanosine 3'-phosphate; 3'-GMP; 3'-Guanylic acid; Guo-3'-P; Gp,R02148 R05135,Purine metabolism,3.1.3.6; 3.1.4.16,NA,NA,CAS: 117-68-0; PubChem: 8443; ChEBI: 28072; PDB-CCD: 3GP; 3DMET: B01991; NIKKAJI: J10.077C,cpd:C00144; cpd:C01977; cpd:C06193; cpd:C18239; cpd:C19968,10,14,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O8N5P1,C10H13O8N5P1,363.0579994,364.0658245,362.0501744662,769,cpd:C06194,"2',3'-Cyclic GMP",C10H12N5O7P,"2',3'-Cyclic GMP",R05135,Purine metabolism,3.1.4.16,NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    2',3'-Cyclic nucleotides;     C06194  2',3'-Cyclic GMP",PubChem: 8444; ChEBI: 28181; 3DMET: B01992; NIKKAJI: J205.906A,cpd:C00942; cpd:C01445; cpd:C06194; cpd:C07025; cpd:C18344,10,12,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O7N5P1,C10H11O7N5P1,345.0474347,346.0552598,344.0396097663,770,cpd:C06195,Imidazolone;,C3H4N2O,Imidazolone; 4-Imidazolone; Imidazol-4-one,R04026 R04731,Purine metabolism,3.5.2.-; 3.5.4.8,NA,NA,PubChem: 8445; ChEBI: 28470 51023; 3DMET: B00917; NIKKAJI: J776.713G,cpd:C06195; cpd:C20382,3,4,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O1N2,C3H3O1N2,84.03236276,85.04018779,83.02453773664,771,cpd:C06196,2'-Deoxyinosine 5'-phosphate;,C10H13N4O7P,2'-Deoxyinosine 5'-phosphate; dIMP,R03531 R10235,Purine metabolism,3.6.1.64; 3.6.1.66; 3.6.1.-,NA,NA,PubChem: 8446; ChEBI: 28806; PDB-CCD: DI; NIKKAJI: J205.494I,cpd:C04646; cpd:C05325; cpd:C06196,10,13,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O7N4P1,C10H12O7N4P1,332.0521858,333.0600108,331.0443607665,772,cpd:C06197,"P1,P3-Bis(5'-adenosyl) triphosphate;",C20H27N10O16P3,"P1,P3-Bis(5'-adenosyl) triphosphate; ApppA; Adenosine 5'-triphosphate 5'-adenosine",R00187,Purine metabolism,3.6.1.29,NA,NA,CAS: 5959-90-0; PubChem: 8447; ChEBI: 27775; ChEMBL: CHEMBL407938; PDB-CCD: BA3; 3DMET: B01993; NIKKAJI: J398.258K,cpd:C04307; cpd:C06197,20,27,16,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H28O16N10P3,C20H26O16N10P3,756.0819358,757.0897609,755.0741108666,773,cpd:C06433,5'-Benzoylphosphoadenosine,C17H18N5O8P,5'-Benzoylphosphoadenosine,R01423,Purine metabolism,3.6.1.20,NA,NA,PubChem: 8667; ChEBI: 1955; PDB-CCD: OOB; 3DMET: B02024; NIKKAJI: J396.565A,cpd:C06433,17,18,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H19O8N5P1,C17H17O8N5P1,451.0892996,452.0971246,450.0814745667,774,cpd:C06435,5'-Butyrylphosphoinosine;,C14H19N4O9P,5'-Butyrylphosphoinosine; Inosine 5'-phosphobutyrate,R01690,Purine metabolism,3.6.1.20,NA,NA,PubChem: 8669; ChEBI: 1956; 3DMET: B02025; NIKKAJI: J2.767.314G,cpd:C06435,14,19,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H20O9N4P1,C14H18O9N4P1,418.0889652,419.0967902,417.0811402668,775,cpd:C11821,5-Hydroxyisourate,C5H4N4O4,5-Hydroxyisourate,R02106 R06063 R06064 R06601 R09514,Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.7.3.3; 1.14.13.113; 3.5.2.17,"Purine degradation, xanthine => urea",NA,PubChem: 13985; ChEBI: 18072; KNApSAcK: C00007531; 3DMET: B05546; NIKKAJI: J861.998K,cpd:C11821,5,4,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H5O4N4,C5H3O4N4,184.0232546,185.0310797,183.0154296669,776,cpd:C12248,"5-Hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate;",C5H6N4O5,"5-Hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate; 2-Oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline",R06601 R06604 R06605,Purine metabolism; Metabolic pathways; Microbial metabolism in diverse environments,3.5.2.17; 4.1.1.97,"Purine degradation, xanthine => urea",NA,PubChem: 14393; ChEBI: 31132; KNApSAcK: C00007532; 3DMET: B05622; NIKKAJI: J861.997B,cpd:C12248,5,6,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O5N4,C5H5O5N4,202.0338193,203.0416443,201.0259943670,777,cpd:C15667,5-Carboxyamino-1-(5-phospho-D-ribosyl)imidazole,C9H14N3O9P,5-Carboxyamino-1-(5-phospho-D-ribosyl)imidazole,R07404 R07405,Purine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,5.4.99.18; 6.3.4.18,"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",NA,PubChem: 47204994; ChEBI: 48000; NIKKAJI: J2.795.736F,cpd:C04751; cpd:C15667,9,14,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O9N3P1,C9H13O9N3P1,339.046766,340.0545911,338.038941671,778,cpd:C01610,Puromycin,C22H29N7O5,Puromycin,R03633 R05677,Puromycin biosynthesis; Biosynthesis of antibiotics,2.1.1.38,NA,Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    Others;     Aminonucleoside;      Puromycin;       D05653  Puromycin (USAN),CAS: 53-79-2; PubChem: 4763; ChEBI: 17939; ChEMBL: CHEMBL2009976 CHEMBL469912; KNApSAcK: C00001507; PDB-CCD: PUY; 3DMET: B01469; NIKKAJI: J2.310H,cpd:C01610; cpd:C11618,22,29,5,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H30O5N7,C22H28O5N7,471.2230171,472.2308421,470.215192672,779,cpd:C07024,3'-Keto-3'-deoxy-ATP,C10H14N5O13P3,3'-Keto-3'-deoxy-ATP,R05668 R05669,Puromycin biosynthesis; Biosynthesis of antibiotics,1.-.-.-; 3.-.-.-,NA,NA,PubChem: 9236; ChEBI: 27782; 3DMET: B02104; NIKKAJI: J1.012.248A,cpd:C07024,10,14,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O13N5P3,C10H13O13N5P3,504.9800965,505.9879216,503.9722715673,780,cpd:C07025,3'-Keto-3'-deoxy-AMP,C10H12N5O7P,3'-Keto-3'-deoxy-AMP,R05669 R05670,Puromycin biosynthesis; Biosynthesis of antibiotics,2.-.-.-; 3.-.-.-,NA,NA,PubChem: 9237; ChEBI: 28722; 3DMET: B02105; NIKKAJI: J2.764.870C,cpd:C00942; cpd:C01445; cpd:C06194; cpd:C07025; cpd:C18344,10,12,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O7N5P1,C10H11O7N5P1,345.0474347,346.0552598,344.0396097674,781,cpd:C07026,3'-Amino-3'-deoxy-AMP,C10H15N6O6P,3'-Amino-3'-deoxy-AMP,R05670 R05671,Puromycin biosynthesis; Biosynthesis of antibiotics,2.-.-.-,NA,NA,PubChem: 9238; ChEBI: 27488; PDB-CCD: 8AN; 3DMET: B05237; NIKKAJI: J1.219.758F,cpd:C01655; cpd:C03851; cpd:C07026,10,15,6,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O6N6P1,C10H14O6N6P1,346.0790692,347.0868943,345.0712442675,782,cpd:C07027,"N6,N6,O-Tridemethylpuromycin-5'-phosphate",C19H24N7O8P,"N6,N6,O-Tridemethylpuromycin-5'-phosphate",R05671 R05672,Puromycin biosynthesis; Biosynthesis of antibiotics,2.3.-.-,NA,NA,PubChem: 9239; ChEBI: 27830; 3DMET: B05238; NIKKAJI: J2.764.875D,cpd:C07027,19,24,8,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O8N7P1,C19H23O8N7P1,509.1423978,510.1502228,508.1345727676,783,cpd:C07028,"N-Acetyl-N6,N6,O-tridemethylpuromycin-5'-phosphate",C21H26N7O9P,"N-Acetyl-N6,N6,O-tridemethylpuromycin-5'-phosphate",R05672 R05673,Puromycin biosynthesis; Biosynthesis of antibiotics,2.3.-.-; 2.-.-.-,NA,NA,PubChem: 9240; ChEBI: 28337; 3DMET: B05239; NIKKAJI: J2.764.876B,cpd:C07028,21,26,9,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H27O9N7P1,C21H25O9N7P1,551.1529624,552.1607875,550.1451374677,784,cpd:C07029,"N-Acetyl-N6,O-didemethylpuromycin-5'-phosphate",C22H28N7O9P,"N-Acetyl-N6,O-didemethylpuromycin-5'-phosphate",R05673 R05674,Puromycin biosynthesis; Biosynthesis of antibiotics,2.-.-.-,NA,NA,PubChem: 9241; ChEBI: 28060; 3DMET: B05240; NIKKAJI: J2.764.877K,cpd:C07029,22,28,9,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H29O9N7P1,C22H27O9N7P1,565.1686125,566.1764375,564.1607875678,785,cpd:C07030,N-Acetyl-O-demethylpuromycin-5'-phosphate,C23H30N7O9P,N-Acetyl-O-demethylpuromycin-5'-phosphate,R05674 R05675,Puromycin biosynthesis; Biosynthesis of antibiotics,2.-.-.-,NA,NA,PubChem: 9242; ChEBI: 27883; 3DMET: B05241; NIKKAJI: J2.764.879G,cpd:C07030,23,30,9,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H31O9N7P1,C23H29O9N7P1,579.1842626,580.1920876,578.1764375679,786,cpd:C07031,N-Acetyl-O-demethylpuromycin,C23H29N7O6,N-Acetyl-O-demethylpuromycin,R05675 R05676,Puromycin biosynthesis; Biosynthesis of antibiotics,2.1.1.38,NA,NA,PubChem: 9243; ChEBI: 28682; 3DMET: B05242; NIKKAJI: J2.764.882G,cpd:C07031,23,29,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H30O6N7,C23H28O6N7,499.2179317,500.2257567,498.2101067680,787,cpd:C07032,N-Acetylpuromycin,C24H31N7O6,N-Acetylpuromycin,R05676 R05677,Puromycin biosynthesis; Biosynthesis of antibiotics,2.1.1.38,NA,NA,PubChem: 9244; ChEBI: 28588; 3DMET: B05243; NIKKAJI: J2.764.883E,cpd:C07032,24,31,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H32O6N7,C24H30O6N7,513.2335817,514.2414068,512.2257567681,788,cpd:C07130,Theophylline;,C7H8N4O2,"Theophylline; 1,3-Dimethylxanthine",R07971 R07972 R07973 R07974 R07975 R07976 R08410,Caffeine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,1.13.12.-; 1.14.13.178; 1.14.13.179,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C07130  Theophylline; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07130  Theophylline; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  R RESPIRATORY SYSTEM;   R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;    R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;     R03DA Xanthines;      R03DA04 Theophylline;       D00371  Theophylline (JP17); USP drug classification [BR:br08302];  Respiratory Tract/Pulmonary Agents;   Phosphodiesterase Inhibitors, Airways Disease;    Theophylline;     D00371  Theophylline (JP17); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   22  Respiratory organ agents;    225  Bronchodilators;     2251  Xanthines;      D00371  Theophylline (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for respiratory organs;   26 Antitussives and expectorants;    D00371  Theophylline (JP17); Risk category of Japanese OTC drugs [BR:br08312];  First-class OTC drugs;   Inorganic and organic chemicals;    Theophylline;     D00371  Theophylline (JP17); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adenosine;     adenosine A1 receptor;      Theophylline;       D00371  Theophylline (JP17);     adenosine A2a receptor;      Theophylline;       D00371  Theophylline (JP17);  Enzymes;   Hydrolases;    phosphodiesterase (PDE);     Theophylline;      D00371  Theophylline (JP17); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP1A2;    Theophylline;     D00371  Theophylline (JP17); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00371  Theophylline; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Others;    Purine alkaloids;     D00371  Theophylline (JP15); Respiratory agents [br08372.html];  Bronchodilator;   D00371",CAS: 58-55-9; PubChem: 9340; ChEBI: 28177; ChEMBL: CHEMBL190; KNApSAcK: C00001510; PDB-CCD: TEP; 3DMET: B02107; NIKKAJI: J2.333G,cpd:C00615; cpd:C06409; cpd:C06410; cpd:C07130; cpd:C07480; cpd:C13747; cpd:C19601; cpd:C20663,7,8,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O2N4,C7H7O2N4,180.0647255,181.0725505,179.0569005682,789,cpd:C07480,Theobromine;,C7H8N4O2,"Theobromine; 3,7-Dimethylxanthine",R07919 R07920 R07955 R07956 R07961 R07962 R07963 R07964; R07978,Caffeine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,1.13.12.-; 1.14.13.178; 1.14.13.179; 1.17.3.2; 2.1.1.159; 2.1.1.160,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C07480  Theobromine; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07480  Theobromine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C03 DIURETICS;    C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES;     C03BD Xanthine derivatives;      C03BD01 Theobromine;       C07480  Theobromine;  R RESPIRATORY SYSTEM;   R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;    R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;     R03DA Xanthines;      R03DA07 Theobromine;       C07480  Theobromine; Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Theobromine;     C07480  Theobromine",CAS: 83-67-0; PubChem: 9683; ChEBI: 28946; ChEMBL: CHEMBL1114; KNApSAcK: C00001509; PDB-CCD: 37T; 3DMET: B02123; NIKKAJI: J3.874A,cpd:C00615; cpd:C06409; cpd:C06410; cpd:C07130; cpd:C07480; cpd:C13747; cpd:C19601; cpd:C20663,7,8,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O2N4,C7H7O2N4,180.0647255,181.0725505,179.0569005683,790,cpd:C07481,Caffeine;,C8H10N4O2,"Caffeine; 1,3,7-Trimethylxanthine",R07920 R07921 R07939 R07954 R07955 R07956 R07971 R07972; R07980,Caffeine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,1.13.12.-; 1.14.13.178; 1.14.13.179; 1.14.14.1; 1.17.5.2; 1.17.5.-; 2.1.1.160,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C07481  Caffeine; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07481  Caffeine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N06 PSYCHOANALEPTICS;    N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS;     N06BC Xanthine derivatives;      N06BC01 Caffeine;       D00528  Caffeine (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   21  Cardiovascular agents;    211  Cardiotonics;     2115  Caffeines;      D00528  Caffeine (USP); Anhydrous caffeine (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for nervous and sensory systems;   05 Alertness drug;    D00528  Caffeine (USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Anhydrous caffeine;     D00528  Caffeine (USP); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adenosine;     adenosine A1 receptor;      Caffeine;       D00528  Caffeine (USP);     adenosine A2a receptor;      Caffeine;       D00528  Caffeine (USP);     adenosine A2b receptor;      Caffeine;       D00528  Caffeine (USP);  Enzymes;   Hydrolases;    phosphodiesterase (PDE);     Caffeine;      D00528  Caffeine (USP); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP1A2;    Caffeine;     D00528  Caffeine (USP);  CYP substrates;   CYP1A2;    Caffeine;     D00528  Caffeine (USP);   CYP3A4;    Caffeine;     D00528  Caffeine (USP);   CYP3A5;    Caffeine;     D00528  Caffeine (USP);   CYP3A7;    Caffeine;     D00528  Caffeine (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00528  Anhydrous caffeine; Major components of natural products [BR:br08323];  Medicinal herbs;   Guarana;    C07481  Caffeine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Others;    Purine alkaloids;     D00528  Anhydrous caffeine (JP15); Caffeine (USP); Rx-to-OTC switch list in the USA [br08315.html];  D00528",CAS: 58-08-2; PubChem: 9684; ChEBI: 27732; ChEMBL: CHEMBL113; KNApSAcK: C00001492; PDB-CCD: CFF; 3DMET: B02124; NIKKAJI: J2.330B,cpd:C04087; cpd:C07481; cpd:C13403,8,10,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O2N4,C8H9O2N4,194.0803756,195.0882006,193.0725505684,791,cpd:C13747,"1,7-Dimethylxanthine;",C7H8N4O2,"1,7-Dimethylxanthine; Paraxanthine",R07921 R07922 R07939 R07940 R07943 R07945 R07954 R07957; R07958 R07959 R07960 R07977,Caffeine metabolism; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,1.13.12.-; 1.14.13.178; 1.14.13.179; 1.14.13.-; 1.14.14.1; 1.17.3.2; 2.1.1.160; 2.3.1.5,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C13747  1,7-Dimethylxanthine; Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: other receptors;    Adenosine;     adenosine A1 receptor;      C13747  1,7-Dimethylxanthine;     adenosine A2a receptor;      C13747  1,7-Dimethylxanthine;     adenosine A2b receptor;      C13747  1,7-Dimethylxanthine",CAS: 611-59-6; PubChem: 586336; ChEBI: 25858; ChEMBL: CHEMBL1158; KNApSAcK: C00039930; 3DMET: B04575; NIKKAJI: J2.991B,cpd:C00615; cpd:C06409; cpd:C06410; cpd:C07130; cpd:C07480; cpd:C13747; cpd:C19601; cpd:C20663,7,8,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O2N4,C7H7O2N4,180.0647255,181.0725505,179.0569005685,792,cpd:C16352,7-Methylxanthosine,C11H15N4O6,7-Methylxanthosine,R07917 R07918,Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.1.1.158; 3.2.2.25,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16352  7-Methylxanthosine,PubChem: 47205660; ChEBI: 49310; NIKKAJI: J466.510D,cpd:C16352,11,15,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H16O6N4,C11H14O6N4,299.0991592,300.1069843,298.0913342686,793,cpd:C16353,7-Methylxanthine,C6H6N4O2,7-Methylxanthine,R07918 R07919 R07922 R07957 R07958 R07961 R07962 R07965; R07966 R07979,Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,1.14.13.128; 1.14.13.178; 1.14.13.179; 1.17.3.2; 2.1.1.159; 2.1.1.160; 3.2.2.25,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16353  7-Methylxanthine,CAS: 552-62-5; PubChem: 47205661; ChEBI: 48991; ChEMBL: CHEMBL321248; KNApSAcK: C00007326; NIKKAJI: J1.614D,cpd:C16353; cpd:C16357; cpd:C16358,6,6,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O2N4,C6H5O2N4,166.0490755,167.0569005,165.0412504687,794,cpd:C16355,7-Methyluric acid,C6H6N4O3,7-Methyluric acid,R07979,Caffeine metabolism,1.17.3.2,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16355  7-Methyluric acid,CAS: 612-37-3; PubChem: 47205663; ChEBI: 80470; ChEMBL: CHEMBL34869; NIKKAJI: J252.499F,cpd:C16355; cpd:C16359; cpd:C19268,6,6,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O3N4,C6H5O3N4,182.0439901,183.0518151,181.036165688,795,cpd:C16356,"1,7-Dimethyluric acid",C7H8N4O3,"1,7-Dimethyluric acid",R07945 R07977,Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.-; 1.14.14.1; 1.17.3.2,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16356  1,7-Dimethyluric acid",CAS: 33868-03-0; PubChem: 47205664; ChEBI: 68449; ChEMBL: CHEMBL794; NIKKAJI: J308.550C,cpd:C16356; cpd:C16360,7,8,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O3N4,C7H7O3N4,196.0596401,197.0674652,195.0518151689,796,cpd:C16357,3-Methylxanthine,C6H6N4O2,3-Methylxanthine,R07963 R07964 R07967 R07968 R07973 R07974,Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,1.13.12.-; 1.14.13.178; 1.14.13.179,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16357  3-Methylxanthine,CAS: 1076-22-8; PubChem: 47205665; ChEBI: 62207 62208; ChEMBL: CHEMBL619; KNApSAcK: C00043196; NIKKAJI: J3.360J,cpd:C16353; cpd:C16357; cpd:C16358,6,6,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O2N4,C6H5O2N4,166.0490755,167.0569005,165.0412504690,797,cpd:C16358,1-Methylxanthine,C6H6N4O2,1-Methylxanthine,R07942 R07943 R07959 R07960 R07969 R07970 R07975 R07976,Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,1.13.12.-; 1.14.13.178; 1.14.13.179; 1.14.14.1; 1.17.3.2,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16358  1-Methylxanthine,CAS: 6136-37-4; PubChem: 47205666; ChEBI: 68444; ChEMBL: CHEMBL1250; NIKKAJI: J2.241A,cpd:C16353; cpd:C16357; cpd:C16358,6,6,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O2N4,C6H5O2N4,166.0490755,167.0569005,165.0412504691,798,cpd:C16359,1-Methyluric acid,C6H6N4O3,1-Methyluric acid,R07942,Caffeine metabolism,1.17.3.2,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16359  1-Methyluric acid,CAS: 708-79-2; PubChem: 47205667; ChEBI: 68441; ChEMBL: CHEMBL793; NIKKAJI: J94.928K,cpd:C16355; cpd:C16359; cpd:C19268,6,6,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O3N4,C6H5O3N4,182.0439901,183.0518151,181.036165692,799,cpd:C16360,"3,7-Dimethyluric acid",C7H8N4O3,"3,7-Dimethyluric acid",R07978,Caffeine metabolism,1.17.3.2,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16360  3,7-Dimethyluric acid",CAS: 13087-49-5; PubChem: 47205668; ChEBI: 68531; ChEMBL: CHEMBL430928; NIKKAJI: J367.208E,cpd:C16356; cpd:C16360,7,8,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O3N4,C7H7O3N4,196.0596401,197.0674652,195.0518151693,800,cpd:C16361,"1,3,7-Trimethyluric acid;",C8H10N4O3,"1,3,7-Trimethyluric acid; 1,3,7-Trimethylurate",R07980 R07981 R11153,Caffeine metabolism; Microbial metabolism in diverse environments,1.7.3.3; 1.14.13.212; 1.17.5.2; 1.17.5.-,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Others;    Purine alkaloids;     C16361  1,3,7-Trimethyluric acid",CAS: 5415-44-1; PubChem: 47205669; ChEBI: 691622; ChEMBL: CHEMBL1767; NIKKAJI: J2.233K,cpd:C16361,8,10,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O3N4,C8H9O3N4,210.0752902,211.0831152,209.0674652694,801,cpd:C16362,"3,6,8-Trimethylallantoin",C7H12N4O3,"3,6,8-Trimethylallantoin",R07981 R07982,Caffeine metabolism; Microbial metabolism in diverse environments,1.7.3.3,NA,NA,CAS: 42794-72-9; PubChem: 47205670; ChEBI: 80471; NIKKAJI: J2.802.445B,cpd:C03022; cpd:C16362; cpd:C19092,7,12,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O3N4,C7H11O3N4,200.0909403,201.0987653,199.0831152695,802,cpd:C16363,N-Methylurea;,C2H6N2O,N-Methylurea; Methylurea,R07982,Caffeine metabolism; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 598-50-5; PubChem: 47205671; ChEBI: 44383; PDB-CCD: NMU; NIKKAJI: J2.718I,cpd:C02297; cpd:C07447; cpd:C14704; cpd:C16363,2,6,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H7O1N2,C2H5O1N2,74.04801282,75.05583785,73.04018779696,803,cpd:C16364,"N,N'-Dimethylurea;",C3H8N2O,"N,N'-Dimethylurea; 1,3-Dimethylurea",R07982,Caffeine metabolism; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 96-31-1; PubChem: 47205672; ChEBI: 80472; PDB-CCD: MMU; NIKKAJI: J4.720A,cpd:C16364; cpd:C19281; cpd:C19779,3,8,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O1N2,C3H7O1N2,88.06366289,89.07148792,87.05583785697,804,cpd:C16365,5-Acetylamino-6-formylamino-3-methyluracil;,C8H10N4O4,5-Acetylamino-6-formylamino-3-methyluracil; AFMU,R07940 R07941,Caffeine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.3.1.5,NA,NA,CAS: 85438-96-6; PubChem: 47205673; ChEBI: 32643; NIKKAJI: J425.388D,cpd:C16365; cpd:C21144,8,10,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O4N4,C8H9O4N4,226.0702048,227.0780299,225.0623798698,805,cpd:C16366,5-Acetylamino-6-amino-3-methyluracil;,C7H10N4O3,5-Acetylamino-6-amino-3-methyluracil; AAMU,R07941,Caffeine metabolism,NA,NA,NA,CAS: 19893-78-8; PubChem: 47205674; ChEBI: 80473; ChEMBL: CHEMBL1899490; NIKKAJI: J128.135F,cpd:C16366; cpd:C18498,7,10,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O3N4,C7H9O3N4,198.0752902,199.0831152,197.0674652699,806,cpd:C00015,UDP;,C9H14N2O12P2,UDP; Uridine 5'-diphosphate,R00155 R00156 R00157 R00158 R00159 R00292 R00414 R00417; R00438 R00503 R00506 R00516 R00659 R00766 R00769 R00806; R00809 R00836 R00853 R00854 R00967 R01005 R01008 R01192; R01205 R01240 R01304 R01383 R01472 R01474 R01497 R01500; R01722 R01912 R01928 R01994 R01995 R01996 R01997 R02018; R02113 R02118 R02119 R02158 R02179 R02183 R02256 R02335; R02358 R02380 R02388 R02389 R02478 R02502 R02594 R02654; R02689 R02691 R02707 R02709 R02716 R02717 R02737 R02789; R02790 R02791 R02889 R02897 R02902 R02932 R02951 R03078; R03079 R03091 R03094 R03118 R03190 R03213 R03238 R03267; R03268 R03297 R03354 R03380 R03486 R03490 R03513 R03514; R03526 R03547 R03548 R03558 R03565 R03573 R03574 R03588; R03589 R03594 R03605 R03625 R03679 R03680 R03681 R03686; R03710 R03797 R03880 R03928 R03981 R03996 R04005 R04016; R04041 R04071 R04108 R04127 R04182 R04296 R04322 R04334; R04335 R04343 R04352 R04353 R04354 R04359 R04377 R04423; R04431 R04451 R04469 R04477 R04491 R04493 R04494 R04495; R04526 R04531 R04548 R04575 R04577 R04579 R04584 R04603; R04606 R04607 R04610 R04615 R04619 R04631 R04636 R04642; R04644 R04645 R04653 R04654 R04659 R04662 R04665 R04683; R04900 R04948 R05032 R05080 R05083 R05107 R05108 R05109; R05110 R05111 R05164 R05191 R05324 R05325 R05327 R05566; R05631 R05662 R05769 R05882 R06047 R06048 R06534 R06535; R06536 R06546 R06547 R06611 R06795 R06802 R06803 R06804; R06805 R06808 R06810 R06811 R06812 R06813 R06814 R06818; R06819 R06820 R06826 R06827 R06828 R06829 R06867 R07106; R07258 R07259 R07260 R07266 R07332 R07333 R07334 R07335; R07336 R07337 R07338 R07339 R07340 R07397 R07426 R07574; R07575 R07661 R07718 R07720 R07729 R07740 R07753 R07874; R07875 R07877 R07878 R07879 R07903 R07911 R07912 R07913; R07914 R07923 R07932 R08006 R08007 R08013 R08021 R08022; R08075 R08076 R08128 R08164 R08259 R08261 R08262 R08263; R08369 R08533 R08534 R08615 R08661 R08668 R08687 R08813; R08814 R08816 R08817 R08822 R08824 R08830 R08839 R08859; R08894 R08900 R09426 R09427 R09428 R09529 R09634 R09635; R09636 R09676 R09677 R09732 R09753 R09754 R09755 R09757; R09758 R09759 R09802 R09803 R09804 R09834 R09857 R10037; R10063 R10096 R10187 R10188 R10240 R10256 R10257 R10262; R10263 R10264 R10265 R10290 R10291 R10292 R10293 R10294; R10295 R10424 R10425 R10426 R10427 R10432 R10433 R10434; R10435 R10436 R10440 R10594 R10596 R10607 R10609 R10620; R10638 R10639 R10804 R10807 R10834 R10835 R10850 R10865; R10988 R10989 R10990 R11115 R11224 R11241 R11271 R11272; R11278 R11282 R11289 R11306,Pyrimidine metabolism; Zeatin biosynthesis; Metabolic pathways; Neuroactive ligand-receptor interaction,1.17.4.1; 2.4.1.11; 2.4.1.12; 2.4.1.13; 2.4.1.14; 2.4.1.15; 2.4.1.16; 2.4.1.17; 2.4.1.22; 2.4.1.23; 2.4.1.34; 2.4.1.35; 2.4.1.37; 2.4.1.38; 2.4.1.39; 2.4.1.40; 2.4.1.41; 2.4.1.43; 2.4.1.44; 2.4.1.46; 2.4.1.47; 2.4.1.50; 2.4.1.52; 2.4.1.53; 2.4.1.56; 2.4.1.58; 2.4.1.62; 2.4.1.63; 2.4.1.66; 2.4.1.70; 2.4.1.71; 2.4.1.73; 2.4.1.74; 2.4.1.78; 2.4.1.79; 2.4.1.80; 2.4.1.81; 2.4.1.85; 2.4.1.86; 2.4.1.87; 2.4.1.88; 2.4.1.90; 2.4.1.91; 2.4.1.92; 2.4.1.94; 2.4.1.96; 2.4.1.102; 2.4.1.103; 2.4.1.104; 2.4.1.105; 2.4.1.106; 2.4.1.111; 2.4.1.114; 2.4.1.115; 2.4.1.116; 2.4.1.117; 2.4.1.118; 2.4.1.120; 2.4.1.121; 2.4.1.122; 2.4.1.123; 2.4.1.126; 2.4.1.127; 2.4.1.128; 2.4.1.135; 2.4.1.136; 2.4.1.137; 2.4.1.138; 2.4.1.141; 2.4.1.143; 2.4.1.144; 2.4.1.145; 2.4.1.146; 2.4.1.147; 2.4.1.148; 2.4.1.149; 2.4.1.150; 2.4.1.153; 2.4.1.155; 2.4.1.156; 2.4.1.158; 2.4.1.159; 2.4.1.160; 2.4.1.164; 2.4.1.165; 2.4.1.167; 2.4.1.170; 2.4.1.171; 2.4.1.172; 2.4.1.173; 2.4.1.175; 2.4.1.176; 2.4.1.177; 2.4.1.178; 2.4.1.179; 2.4.1.180; 2.4.1.181; 2.4.1.182; 2.4.1.183; 2.4.1.185; 2.4.1.186; 2.4.1.187; 2.4.1.188; 2.4.1.189; 2.4.1.190; 2.4.1.191; 2.4.1.192; 2.4.1.193; 2.4.1.194; 2.4.1.195; 2.4.1.196; 2.4.1.198; 2.4.1.201; 2.4.1.202; 2.4.1.203; 2.4.1.205; 2.4.1.206; 2.4.1.208; 2.4.1.209; 2.4.1.210; 2.4.1.212; 2.4.1.215; 2.4.1.218; 2.4.1.219; 2.4.1.220; 2.4.1.223; 2.4.1.224; 2.4.1.225; 2.4.1.226; 2.4.1.227; 2.4.1.228; 2.4.1.234; 2.4.1.236; 2.4.1.237; 2.4.1.238; 2.4.1.239; 2.4.1.240; 2.4.1.241; 2.4.1.242; 2.4.1.245; 2.4.1.249; 2.4.1.250; 2.4.1.253; 2.4.1.254; 2.4.1.255; 2.4.1.262; 2.4.1.263; 2.4.1.264; 2.4.1.271; 2.4.1.272; 2.4.1.273; 2.4.1.274; 2.4.1.275; 2.4.1.276; 2.4.1.283; 2.4.1.284; 2.4.1.285; 2.4.1.286; 2.4.1.290; 2.4.1.294; 2.4.1.295; 2.4.1.296; 2.4.1.297; 2.4.1.298; 2.4.1.301; 2.4.1.303; 2.4.1.304; 2.4.1.305; 2.4.1.306; 2.4.1.309; 2.4.1.310; 2.4.1.312; 2.4.1.313; 2.4.1.314; 2.4.1.315; 2.4.1.323; 2.4.1.324; 2.4.1.330; 2.4.1.335; 2.4.1.336; 2.4.1.337; 2.4.1.338; 2.4.1.-; 2.4.2.24; 2.4.2.25; 2.4.2.32; 2.4.2.34; 2.4.2.35; 2.4.2.40; 2.4.2.50; 2.4.2.51; 2.4.2.53; 2.4.2.56; 2.4.2.-; 2.7.1.11; 2.7.1.40; 2.7.1.48; 2.7.4.4; 2.7.4.6; 2.7.4.10; 2.7.4.14; 2.7.4.22; 2.7.7.8; 3.2.1.183; 3.2.1.184; 3.2.1.-; 3.6.1.5; 3.6.1.6; 3.6.1.39; 3.6.1.57; 5.1.3.14,"Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00015  UDP,CAS: 58-98-0; PubChem: 3317; ChEBI: 17659; ChEMBL: CHEMBL130266 CHEMBL605272; KNApSAcK: C00007313; PDB-CCD: UDP; 3DMET: B01132; NIKKAJI: J4.595K,cpd:C00015,9,14,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O12N2P2,C9H13O12N2P2,404.0021979,405.0100229,402.9943729700,807,cpd:C00055,CMP;,C9H14N3O8P,CMP; Cytidine-5'-monophosphate; Cytidylic acid,R00510 R00511 R00512 R00513 R00514 R00515 R00516 R00517; R00855 R00962 R01321 R01503 R01548 R01797 R01800 R01801; R01802 R01891 R01929 R02030 R02057 R02091 R02096 R02371; R02372 R02563 R02598 R03110 R03468 R03488 R03489 R04042; R04083 R04231 R04321 R04532 R04564 R04583 R04590 R04596; R04630 R04632 R04635 R04647 R04648 R04649 R04656 R04658; R04660 R04661 R04920 R04921 R04922 R05074 R05113 R05114; R05116 R05580 R05637 R05794 R06285 R06364 R07384 R07389; R08887 R09538 R09670 R09763 R09764 R09765 R09766 R10255; R10441 R10464 R10837 R11558,Pyrimidine metabolism; Metabolic pathways,2.4.2.57; 2.4.99.1; 2.4.99.2; 2.4.99.4; 2.4.99.5; 2.4.99.6; 2.4.99.7; 2.4.99.8; 2.4.99.9; 2.4.99.10; 2.4.99.12; 2.4.99.13; 2.4.99.14; 2.4.99.15; 2.4.99.-; 2.7.1.48; 2.7.1.213; 2.7.4.14; 2.7.4.25; 2.7.8.1; 2.7.8.2; 2.7.8.3; 2.7.8.4; 2.7.8.5; 2.7.8.8; 2.7.8.10; 2.7.8.11; 2.7.8.12; 2.7.8.14; 2.7.8.22; 2.7.8.24; 2.7.8.34; 2.7.8.38; 2.7.8.39; 2.7.8.41; 2.7.8.44; 2.7.8.-; 3.1.3.5; 3.1.3.91; 3.1.4.40; 3.2.2.10; 3.6.1.5; 3.6.1.8; 3.6.1.9; 3.6.1.16; 3.6.1.26; 3.6.1.53; 3.6.1.65; 4.6.1.12; 6.3.2.5,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00055  CMP,CAS: 63-37-6; PubChem: 3357; ChEBI: 17361; ChEMBL: CHEMBL307679; PDB-CCD: C C5P; 3DMET: B01141; NIKKAJI: J60.869F,cpd:C00055; cpd:C03104; cpd:C05822; cpd:C17325; cpd:C19722,9,14,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O8N3P1,C9H13O8N3P1,323.0518514,324.0596765,322.0440264701,808,cpd:C00063,CTP;,C9H16N3O14P3,CTP; Cytidine 5'-triphosphate; Cytidine triphosphate,R00442 R00515 R00568 R00569 R00570 R00571 R00572 R00573; R00574 R00767 R00856 R00956 R01018 R01117 R01799 R01890; R02022 R02038 R02590 R02599 R02921 R03237 R03351 R03375; R04215 R04231 R04247 R05633 R08574 R08867 R08966 R09382; R09383 R09384 R09669 R09843 R09849 R09850 R09944 R10182; R10659 R11396 R11441,Pyrimidine metabolism; Mannose type O-glycan biosynthesis; Metabolic pathways,1.17.4.2; 2.7.1.11; 2.7.1.40; 2.7.1.108; 2.7.1.161; 2.7.1.174; 2.7.1.182; 2.7.1.-; 2.7.4.6; 2.7.7.6; 2.7.7.14; 2.7.7.15; 2.7.7.33; 2.7.7.38; 2.7.7.39; 2.7.7.40; 2.7.7.41; 2.7.7.43; 2.7.7.48; 2.7.7.57; 2.7.7.60; 2.7.7.67; 2.7.7.72; 2.7.7.74; 2.7.7.81; 2.7.7.82; 2.7.7.90; 2.7.7.92; 2.7.7.93; 3.5.4.13; 3.6.1.5; 3.6.1.8; 3.6.1.9; 3.6.1.65; 4.6.1.6; 6.3.2.5; 6.3.4.2,"Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP; Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00063  CTP;  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00063  CTP,CAS: 65-47-4; PubChem: 3363; ChEBI: 17677; ChEMBL: CHEMBL223533; KNApSAcK: C00019639; PDB-CCD: CTP; 3DMET: B01144; NIKKAJI: J213.552C,cpd:C00063,9,16,14,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O14N3P3,C9H15O14N3P3,482.9845132,483.9923382,481.9766882702,809,cpd:C00075,UTP;,C9H15N2O15P3,UTP; Uridine 5'-triphosphate; Uridine triphosphate,R00156 R00157 R00159 R00289 R00416 R00443 R00502 R00516; R00568 R00571 R00573 R00659 R00662 R00769 R00967 R00969; R01381 R01471 R02023 R02634 R03077 R03238 R04733 R08845; R10183 R11025,Pyrimidine metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction,1.17.4.2; 2.7.1.11; 2.7.1.40; 2.7.1.48; 2.7.4.6; 2.7.4.10; 2.7.7.6; 2.7.7.9; 2.7.7.10; 2.7.7.11; 2.7.7.23; 2.7.7.44; 2.7.7.48; 2.7.7.52; 2.7.7.59; 2.7.7.64; 2.7.7.83; 2.7.7.-; 3.5.4.13; 3.6.1.5; 3.6.1.8; 3.6.1.9; 3.6.1.17; 3.6.1.39; 6.3.4.2,"Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00075  UTP,CAS: 63-39-8; PubChem: 3375; ChEBI: 15713; ChEMBL: CHEMBL336296 CHEMBL605653; PDB-CCD: UTP; 3DMET: B01149; NIKKAJI: J4.827E,cpd:C00075,9,15,15,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16O15N2P3,C9H14O15N2P3,483.9685288,484.9763538,482.9607037703,810,cpd:C00099,beta-Alanine;,C3H7NO2,beta-Alanine; 3-Aminopropionic acid; 3-Aminopropanoate,R00489 R00904 R00905 R00906 R00907 R00908 R00909 R00910; R00911 R00912 R00913 R00914 R00915 R00916 R00917 R01164; R01166 R02473 R02474 R02741 R03286 R03288 R03935 R09379; R09648 R10821,Pyrimidine metabolism; beta-Alanine metabolism; Propanoate metabolism; Pantothenate and CoA biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Neuroactive ligand-receptor interaction; Protein digestion and absorption,1.2.1.3; 1.2.1.5; 1.2.1.19; 1.5.1.26; 2.6.1.18; 2.6.1.19; 2.6.1.55; 2.8.3.-; 3.4.13.4; 3.4.13.5; 3.4.13.18; 3.4.13.20; 3.5.1.6; 3.5.1.21; 3.5.1.22; 3.5.1.100; 3.5.3.17; 4.1.1.11; 4.1.1.15; 6.3.2.1; 6.3.2.11; 6.3.2.23; 6.3.2.36; 6.3.2.44,"Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate; Pantothenate biosynthesis, valine/L-aspartate => pantothenate",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00099  beta-Alanine;   Amines;    Biogenic amines;     C00099  beta-Alanine,CAS: 107-95-9; PubChem: 3399; ChEBI: 16958; ChEMBL: CHEMBL297569; KNApSAcK: C00001333; PDB-CCD: BAL; 3DMET: B00025; NIKKAJI: J4.070C,cpd:C00041; cpd:C00097; cpd:C00099; cpd:C00133; cpd:C00213; cpd:C00736; cpd:C00793; cpd:C01401; cpd:C01537; cpd:C01962; cpd:C02116; cpd:C05688; cpd:C11488,3,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O2N1,C3H6O2N1,89.04767847,90.0555035,88.03985344704,811,cpd:C00105,UMP;,C9H13N2O9P,UMP; Uridylic acid; Uridine monophosphate; Uridine 5'-monophosphate; 5'Uridylic acid,R00155 R00158 R00287 R00504 R00662 R00963 R00964 R00965; R00966 R00967 R00968 R00969 R00970 R01007 R01535 R01549; R01880 R02097 R02327 R02332 R03986 R04179 R04291 R04549; R05629 R05630 R05969 R08856 R09641 R09642 R10137 R10184; R10465 R10838 R11053,Pyrimidine metabolism; Peptidoglycan biosynthesis; Metabolic pathways,1.14.11.49; 2.4.2.9; 2.4.2.57; 2.7.1.48; 2.7.1.213; 2.7.4.4; 2.7.4.14; 2.7.4.22; 2.7.8.6; 2.7.8.13; 2.7.8.15; 2.7.8.17; 2.7.8.18; 2.7.8.19; 2.7.8.31; 2.7.8.32; 2.7.8.33; 2.7.8.35; 2.7.8.36; 2.7.8.40; 3.1.3.5; 3.6.1.5; 3.6.1.6; 3.6.1.8; 3.6.1.9; 3.6.1.17; 3.6.1.45; 3.6.1.54; 4.1.1.23,"Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP; Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00105  UMP,CAS: 58-97-9; PubChem: 3405; ChEBI: 16695; ChEMBL: CHEMBL214393; KNApSAcK: C00007311; PDB-CCD: U U5P; 3DMET: B01161; NIKKAJI: J4.594B,cpd:C00105; cpd:C00868; cpd:C01168; cpd:C01368; cpd:C01764; cpd:C02764; cpd:C03031,9,13,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O9N2P1,C9H12O9N2P1,324.035867,325.043692,323.028042705,812,cpd:C00106,Uracil,C4H4N2O2,Uracil,R00966 R00973 R00974 R00975 R00976 R00977 R00978 R01055; R01080 R01876 R02484 R02486 R03131 R09936 R10838,Pyrimidine metabolism; beta-Alanine metabolism; Pantothenate and CoA biosynthesis; Metabolic pathways,1.3.1.1; 1.3.1.2; 1.3.3.7; 1.14.11.10; 1.14.99.46; 1.17.99.4; 2.4.2.1; 2.4.2.2; 2.4.2.3; 2.4.2.4; 2.4.2.9; 2.4.2.57; 2.5.1.53; 3.2.2.3; 3.5.4.1; 4.1.1.66; 4.2.1.70,"Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",Compounds with biological roles [BR:br08001];  Nucleic acids;   Bases;    Pyrimidines;     C00106  Uracil (Ura),CAS: 66-22-8; PubChem: 3406; ChEBI: 17568; ChEMBL: CHEMBL566; KNApSAcK: C00001513; PDB-CCD: URA; 3DMET: B00026; NIKKAJI: J4.842I,cpd:C00106; cpd:C16734; cpd:C18474,4,4,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H5O2N2,C4H3O2N2,112.0272774,113.0351024,111.0194523706,813,cpd:C00112,CDP;,C9H15N3O11P2,CDP; Cytidine 5'-diphosphate; Cytidine diphosphate,R00440 R00512 R00514 R00569 R00570 R00572 R00767 R01018; R02024 R03237 R04581 R08574 R09849 R09850 R09944 R10659,Pyrimidine metabolism; Metabolic pathways,1.17.4.1; 2.4.1.60; 2.7.1.11; 2.7.1.40; 2.7.1.108; 2.7.1.161; 2.7.1.174; 2.7.1.182; 2.7.1.-; 2.7.4.6; 2.7.4.14; 2.7.4.25; 2.7.7.8; 3.6.1.5,"Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP; Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Ribonucleotides;     C00112  CDP,CAS: 63-38-7; PubChem: 3412; ChEBI: 17239; ChEMBL: CHEMBL425252 CHEMBL610634; PDB-CCD: CDP; 3DMET: B01162; NIKKAJI: J150.290E,cpd:C00112,9,15,11,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16O11N3P2,C9H14O11N3P2,403.0181823,404.0260073,402.0103573707,814,cpd:C00178,Thymine;,C5H6N2O2,Thymine; 5-Methyluracil,R01411 R01412 R01413 R01414 R01415 R01570 R02806 R09937; R11026,Pyrimidine metabolism; Metabolic pathways,1.3.1.1; 1.3.1.2; 1.14.11.6; 1.14.99.46; 1.17.99.4; 2.4.2.2; 2.4.2.4; 2.4.2.6; 3.5.4.1,"Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",Compounds with biological roles [BR:br08001];  Nucleic acids;   Bases;    Pyrimidines;     C00178  Thymine (Thy),CAS: 65-71-4; PubChem: 3478; ChEBI: 17821; ChEMBL: CHEMBL993; KNApSAcK: C00001511; PDB-CCD: TDR; 3DMET: B00051; NIKKAJI: J2.357D,cpd:C00178; cpd:C02835,5,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O2N2,C5H5O2N2,126.0429274,127.0507525,125.0351024708,815,cpd:C00214,Thymidine;,C10H14N2O5,Thymidine; Deoxythymidine,R01567 R01568 R01569 R01570 R01571 R02806,Pyrimidine metabolism; Metabolic pathways,2.4.2.2; 2.4.2.4; 2.4.2.6; 2.7.1.21; 2.7.1.114; 2.7.1.118; 3.1.3.5; 3.1.3.35; 3.1.3.89,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Deoxyribonucleosides;     C00214  Deoxythymidine (dT),CAS: 50-89-5; PubChem: 3514; ChEBI: 17748; ChEMBL: CHEMBL52609; KNApSAcK: C00019698; PDB-CCD: THM; 3DMET: B01191; NIKKAJI: J4.548I,cpd:C00214; cpd:C19431,10,14,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O5N2,C10H13O5N2,242.0902716,243.0980966,241.0824465709,816,cpd:C00222,3-Oxopropanoate;,C3H4O3,3-Oxopropanoate; Malonate semialdehyde,R00705 R00706 R00740 R00907 R00908 R01604 R01607 R01608; R01609 R01611 R05371 R05372 R05378 R06973 R09289 R09983; R10947,Pyrimidine metabolism; beta-Alanine metabolism; Inositol phosphate metabolism; Chloroalkane and chloroalkene degradation; Propanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.1.1.59; 1.1.1.298; 1.1.1.-; 1.2.1.15; 1.2.1.18; 1.2.1.27; 1.2.1.75; 1.7.3.5; 2.6.1.18; 2.6.1.19; 2.6.1.55; 3.5.1.-; 3.8.1.-; 4.1.1.-; 4.1.2.29; 4.2.1.27; 4.2.1.155,"Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    3-Oxocarboxylic acids;     C00222  3-Oxopropanoate,PubChem: 3522; ChEBI: 17960 33190; 3DMET: B00062; NIKKAJI: J7.174I,cpd:C00022; cpd:C00222; cpd:C00957; cpd:C02055; cpd:C02853; cpd:C12069; cpd:C18618; cpd:C20363,3,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O3,C3H3O3,88.01604399,89.02386902,87.00821896710,817,cpd:C00239,dCMP;,C9H14N3O7P,dCMP; Deoxycytidylic acid; Deoxycytidine monophosphate; Deoxycytidylate; 2'-Deoxycytidine 5'-monophosphate,R01663 R01664 R01665 R01666 R01667 R01668 R01669 R01670; R02321,Pyrimidine metabolism; Metabolic pathways,2.1.1.54; 2.1.2.8; 2.7.1.74; 2.7.1.213; 2.7.4.14; 2.7.4.25; 3.1.3.5; 3.1.3.89; 3.5.4.12; 3.6.1.12; 3.6.1.65,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00239  dCMP,CAS: 1032-65-1; PubChem: 3538; ChEBI: 15918; ChEMBL: CHEMBL374699; PDB-CCD: DC DCM DNR; 3DMET: B01198; NIKKAJI: J14.407J,cpd:C00239; cpd:C00856,9,14,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O7N3P1,C9H13O7N3P1,307.0569368,308.0647618,306.0491118711,818,cpd:C00295,Orotate;,C5H4N2O4,Orotate; Orotic acid; Uracil-6-carboxylic acid,R01866 R01867 R01868 R01869 R01870,Pyrimidine metabolism; Metabolic pathways,1.3.1.14; 1.3.1.15; 1.3.5.2; 1.3.98.1; 2.4.2.10,"Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP",Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Orotic acid;     D00055  Orotic acid (JAN),CAS: 65-86-1; PubChem: 3589; ChEBI: 16742; ChEMBL: CHEMBL1235017; KNApSAcK: C00007300 C00019689; PDB-CCD: ORO; 3DMET: B00083; NIKKAJI: J2.359K,cpd:C00295; cpd:C03030,5,4,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H5O4N2,C5H3O4N2,156.0171066,157.0249316,155.0092816712,819,cpd:C00299,Uridine,C9H12N2O6,Uridine,R00963 R00964 R00967 R00968 R00970 R01080 R01549 R01876; R01877 R01878 R01879 R01880 R02097 R02327 R02332,Pyrimidine metabolism; Metabolic pathways,1.14.11.3; 2.4.2.2; 2.4.2.3; 2.7.1.48; 2.7.1.213; 3.1.3.5; 3.1.3.6; 3.2.2.3; 3.5.4.5,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Ribonucleosides;     C00299  Uridine (U),CAS: 58-96-8; PubChem: 3593; ChEBI: 16704; ChEMBL: CHEMBL100259; KNApSAcK: C00019674; PDB-CCD: URI; 3DMET: B01210; NIKKAJI: J4.593D,cpd:C00299; cpd:C02067; cpd:C16745,9,12,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13O6N2,C9H11O6N2,244.0695361,245.0773611,243.0617111713,820,cpd:C00337,(S)-Dihydroorotate;,C5H6N2O4,"(S)-Dihydroorotate; (S)-4,5-Dihydroorotate; L-Dihydroorotate; L-Dihydroorotic acid; Dihydro-L-orotic acid",R01866 R01867 R01868 R01869 R01993,Pyrimidine metabolism; Metabolic pathways,1.3.1.14; 1.3.1.15; 1.3.5.2; 1.3.98.1; 3.5.2.3,"Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP",NA,CAS: 5988-19-2; PubChem: 3630; ChEBI: 17025; KNApSAcK: C00007302; PDB-CCD: DOR; 3DMET: B01220; NIKKAJI: J236.345C,cpd:C00337; cpd:C02871; cpd:C03306; cpd:C03703; cpd:C10600; cpd:C20756; cpd:C20757,5,6,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O4N2,C5H5O4N2,158.0327567,159.0405817,157.0249316714,823,cpd:C00363,dTDP;,C10H16N2O11P2,dTDP; Deoxythymidine 5'-diphosphate,R02092 R02093 R02094 R02095 R02096 R02097 R04222 R05530; R05531 R06443 R06450 R06451 R06452 R06455 R06457 R06460; R06461 R06484 R06485 R06486 R06487 R06488 R06489 R06490; R06491 R06492 R06493 R06494 R06495 R06496 R06497 R06498; R06499 R06506 R06659 R06660 R06662 R06664 R06666 R06667; R06668 R06684 R06716 R06717 R06718 R06767 R06770 R06773; R08857 R09331 R09332 R09345 R09351 R09352 R10175 R10303; R10595 R10833 R10874 R10876 R10955 R11122 R11417 R11418; R11420 R11421 R11422 R11423,Pyrimidine metabolism; Metabolic pathways,2.4.1.277; 2.4.1.278; 2.4.1.289; 2.4.1.302; 2.4.1.311; 2.4.1.316; 2.4.1.317; 2.4.1.318; 2.4.1.322; 2.4.1.325; 2.4.1.326; 2.4.1.327; 2.4.1.328; 2.4.1.331; 2.4.1.-; 2.4.2.27; 2.4.2.-; 2.4.-.-; 2.7.1.48; 2.7.4.6; 2.7.4.9; 2.7.4.12; 3.6.1.5; 3.6.1.39,"Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00363  dTDP,CAS: 491-97-4; PubChem: 3654; ChEBI: 18075; ChEMBL: CHEMBL259724; KNApSAcK: C00019696; PDB-CCD: TYD; 3DMET: B01229; NIKKAJI: J247.693B,cpd:C00363,10,16,11,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O11N2P2,C10H15O11N2P2,402.0229333,403.0307584,401.0151083715,824,cpd:C00364,dTMP;,C10H15N2O8P,dTMP; Thymidine 5'-phosphate; Deoxythymidine 5'-phosphate; Thymidylic acid; 5'-Thymidylic acid; Thymidine monophosphate; Deoxythymidylic acid; Thymidylate,R01567 R01568 R01569 R01571 R02092 R02094 R02101 R06613; R11323,Pyrimidine metabolism; Metabolic pathways; Antifolate resistance,2.1.1.45; 2.1.1.148; 2.7.1.21; 2.7.1.114; 2.7.1.118; 2.7.4.9; 2.7.4.12; 3.1.3.5; 3.1.3.35; 3.1.3.89; 3.6.1.5; 3.6.1.9,"Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00364  dTMP,CAS: 365-07-1; PubChem: 3655; ChEBI: 17013; ChEMBL: CHEMBL394429; KNApSAcK: C00019637; PDB-CCD: DT TMP; 3DMET: B01230; NIKKAJI: J150.344H,cpd:C00364,10,15,8,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O8N2P1,C10H14O8N2P1,322.0566024,323.0644275,321.0487774716,825,cpd:C00365,dUMP;,C9H13N2O8P,dUMP; Deoxyuridylic acid; Deoxyuridine monophosphate; Deoxyuridine 5'-phosphate; 2'-Deoxyuridine 5'-phosphate,R01663 R02098 R02099 R02100 R02101 R02102 R06613 R07307,Pyrimidine metabolism; Metabolic pathways; Antifolate resistance,2.1.1.45; 2.1.1.148; 2.7.1.21; 2.7.4.4; 2.7.4.9; 3.1.3.5; 3.1.3.89; 3.5.4.12; 3.5.4.30; 3.6.1.23; 3.6.1.-,"Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00365  dUMP,CAS: 964-26-1; PubChem: 3656; ChEBI: 17622; ChEMBL: CHEMBL211312; KNApSAcK: C00019282; PDB-CCD: DU UMP; 3DMET: B01231; NIKKAJI: J298.569A,cpd:C00365; cpd:C17322,9,13,8,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O8N2P1,C9H12O8N2P1,308.0409524,309.0487774,307.0331274717,826,cpd:C00380,Cytosine,C4H5N3O,Cytosine,R00510 R00974 R02137 R02296 R10837,Pyrimidine metabolism; Metabolic pathways,2.4.2.2; 2.4.2.57; 3.2.2.8; 3.2.2.10; 3.5.4.1,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Bases;    Pyrimidines;     C00380  Cytosine (Cyt),CAS: 71-30-7; PubChem: 3670; ChEBI: 16040; ChEMBL: CHEMBL15913; KNApSAcK: C00001498; PDB-CCD: CYT; 3DMET: B00097; NIKKAJI: J9.343B,cpd:C00380,4,5,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H6O1N3,C4H4O1N3,111.0432618,112.0510868,110.0354368718,827,cpd:C00383,Malonate;,C3H4O4,Malonate; Malonic acid; Propanedioic acid,R00743 R01604 R01607 R07629 R08944 R09483,Pyrimidine metabolism; beta-Alanine metabolism,1.2.1.15; 2.3.1.187; 2.8.3.3; 3.5.1.95; 4.1.1.88; 4.1.1.89,NA,Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Dicarboxylic acids;     C00383  Malonate; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   C00383  [120347] Malonate,CAS: 141-82-2; PubChem: 3673; ChEBI: 15792 30794; ChEMBL: CHEMBL7942; LIPIDMAPS: LMFA01170041; KNApSAcK: C00001193; PDB-CCD: MLA MLI; 3DMET: B00098; NIKKAJI: J2.541K,cpd:C00168; cpd:C00383; cpd:C00802; cpd:C01146,3,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O4,C3H3O4,104.0109586,105.0187836,103.0031336719,828,cpd:C00429,"5,6-Dihydrouracil;",C4H6N2O2,"5,6-Dihydrouracil; Dihydro-2,4(1H,3H)-pyrimidinedione; Dihydrouracile; Dihydrouracil; 5,6-Dihydro-2,4-dihydroxypyrimidine; Hydrouracil; 2,4-Dioxotetrahydropyrimidine",R00975 R00977 R00978 R02269 R04346,Pyrimidine metabolism; beta-Alanine metabolism; Pantothenate and CoA biosynthesis; Metabolic pathways,1.3.1.1; 1.3.1.2; 1.3.3.7; 2.4.2.20; 3.5.2.2,"Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",NA,CAS: 504-07-4; PubChem: 3718; ChEBI: 15901; PDB-CCD: DUC; 3DMET: B00109; NIKKAJI: J11.667J,cpd:C00429; cpd:C02065; cpd:C02248; cpd:C02512; cpd:C02565; cpd:C02743; cpd:C02777; cpd:C08311; cpd:C13695; cpd:C15811; cpd:C15812; cpd:C21440,4,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O2N2,C4H5O2N2,114.0429274,115.0507525,113.0351024720,829,cpd:C00438,N-Carbamoyl-L-aspartate,C5H8N2O5,N-Carbamoyl-L-aspartate,R00484 R01397 R01993 R02284,"Pyrimidine metabolism; Alanine, aspartate and glutamate metabolism; Metabolic pathways",2.1.3.2; 3.5.1.7; 3.5.2.3; 3.5.2.4,"Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP",NA,PubChem: 3727; ChEBI: 15859; KNApSAcK: C00007265; PDB-CCD: NCD; 3DMET: B00115; NIKKAJI: J39.568D,cpd:C00438; cpd:C04209,5,8,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O5N2,C5H7O5N2,176.0433214,177.0511464,175.0354963721,830,cpd:C00458,dCTP;,C9H16N3O13P3,dCTP; Deoxycytidine 5'-triphosphate; Deoxycytidine triphosphate; 2'-Deoxycytidine 5'-triphosphate,R00377 R01668 R02022 R02325 R02326 R02327 R02371 R07307,Pyrimidine metabolism; Metabolic pathways,1.17.4.2; 2.7.1.48; 2.7.4.6; 2.7.7.7; 3.5.4.13; 3.5.4.30; 3.6.1.12; 3.6.1.65,"Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00458  dCTP,CAS: 2056-98-6; PubChem: 3742; ChEBI: 16311; ChEMBL: CHEMBL560403; PDB-CCD: DCP; 3DMET: B01248; NIKKAJI: J247.702E,cpd:C00458,9,16,13,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O13N3P3,C9H15O13N3P3,466.9895986,467.9974236,465.9817735722,831,cpd:C00459,dTTP;,C10H17N2O14P3,dTTP; Deoxythymidine triphosphate; Deoxythymidine 5'-triphosphate; TTP,R00378 R02093 R02095 R02096 R02097 R02328 R02329 R11323,Pyrimidine metabolism; Metabolic pathways,2.7.1.48; 2.7.4.6; 2.7.7.7; 2.7.7.24; 2.7.7.32; 3.6.1.5; 3.6.1.9; 3.6.1.39,"Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00459  dTTP,PubChem: 3743; ChEBI: 18077; ChEMBL: CHEMBL363559; PDB-CCD: TTP; 3DMET: B01249; NIKKAJI: J193.870C,cpd:C00459,10,17,14,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O14N2P3,C10H16O14N2P3,481.9892642,482.9970893,480.9814392723,832,cpd:C00460,dUTP;,C9H15N2O14P3,dUTP; 2'-Deoxyuridine 5'-triphosphate,R02023 R02100 R02325 R02330 R02331 R02332 R02372,Pyrimidine metabolism; Metabolic pathways,1.17.4.2; 2.7.1.48; 2.7.4.6; 3.5.4.13; 3.6.1.23; 3.6.1.39; 3.6.1.-,"Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00460  dUTP,PubChem: 3744; ChEBI: 17625; ChEMBL: CHEMBL374361; KNApSAcK: C00019636; PDB-CCD: DUT; 3DMET: B01250; NIKKAJI: J315.490D,cpd:C00460,9,15,14,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16O14N2P3,C9H14O14N2P3,467.9736142,468.9814392,466.9657891724,833,cpd:C00475,Cytidine,C9H13N3O5,Cytidine,R00511 R00513 R00516 R00517 R00962 R01548 R01878 R02091; R02096 R02137 R02296 R02370 R02371 R02372,Pyrimidine metabolism; Metabolic pathways,2.4.2.2; 2.7.1.48; 2.7.1.213; 3.1.3.5; 3.1.3.6; 3.1.3.91; 3.2.2.8; 3.5.4.5,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Ribonucleosides;     C00475  Cytidine (C),CAS: 65-46-3; PubChem: 3758; ChEBI: 17562; ChEMBL: CHEMBL136152 CHEMBL95606; KNApSAcK: C00042440; PDB-CCD: CTN; 3DMET: B01256; NIKKAJI: J4.837B,cpd:C00475; cpd:C02961; cpd:C05711,9,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O5N3,C9H12O5N3,243.0855205,244.0933456,242.0776955725,834,cpd:C00526,Deoxyuridine;,C9H12N2O5,Deoxyuridine; 2-Deoxyuridine; 2'-Deoxyuridine,R01879 R02099 R02102 R02484 R02485 R02486,Pyrimidine metabolism,1.14.11.3; 1.14.11.10; 2.4.2.1; 2.4.2.2; 2.4.2.3; 2.4.2.4; 2.7.1.21; 3.1.3.5; 3.1.3.89; 3.5.4.5,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Deoxyribonucleosides;     C00526  Deoxyuridine (dU),CAS: 951-78-0; PubChem: 3809; ChEBI: 16450; ChEMBL: CHEMBL353955; KNApSAcK: C00019697; PDB-CCD: DUR; 3DMET: B01281; NIKKAJI: J7.186B,cpd:C00526,9,12,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13O5N2,C9H11O5N2,228.0746215,229.0824465,227.0667965726,835,cpd:C00705,dCDP;,C9H15N3O10P2,dCDP; 2'-Deoxycytidine diphosphate; 2'-Deoxycytidine 5'-diphosphate,R01665 R01667 R02024 R02326 R02327 R02371,Pyrimidine metabolism; Metabolic pathways,1.17.4.1; 2.7.1.48; 2.7.4.6; 2.7.4.14; 2.7.4.25; 3.6.1.12,"Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP",Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C00705  dCDP,CAS: 800-73-7; PubChem: 3972; ChEBI: 28846; PDB-CCD: YYY; 3DMET: B01317; NIKKAJI: J247.701G,cpd:C00705,9,15,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16O10N3P2,C9H14O10N3P2,387.0232677,388.0310927,386.0154427727,836,cpd:C00813,Barbiturate;,C4H4N2O3,Barbiturate; Barbituric acid; Malonylurea,R00976 R02139,Pyrimidine metabolism,1.17.99.4; 3.5.2.1,NA,NA,CAS: 67-52-7; PubChem: 4071; ChEBI: 16294 29745; ChEMBL: CHEMBL574699; PDB-CCD: BR8; 3DMET: B01336; NIKKAJI: J348D,cpd:C00813; cpd:C11116,4,4,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H5O3N2,C4H3O3N2,128.022192,129.030017,127.014367728,837,cpd:C00881,Deoxycytidine;,C9H13N3O4,Deoxycytidine; 2'-Deoxycytidine,R01664 R01666 R02321 R02485,Pyrimidine metabolism,2.7.1.74; 2.7.1.213; 3.1.3.5; 3.1.3.89; 3.5.4.5,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleosides;    Deoxyribonucleosides;     C00881  Deoxycytidine (dC),CAS: 951-77-9; PubChem: 4137; ChEBI: 15698; ChEMBL: CHEMBL66115; PDB-CCD: DCZ; 3DMET: B01347; NIKKAJI: J14.406A,cpd:C00881,9,13,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O4N3,C9H12O4N3,227.0906059,228.0984309,226.0827809729,838,cpd:C01013,3-Hydroxypropanoate;,C3H6O3,3-Hydroxypropanoate; 3-Hydroxypropanoic acid; 3-Hydroxypropionate; 3-Hydroxypropionic acid; Hydracrylic acid,R01608 R03157 R03158 R09286 R09289,Pyrimidine metabolism; beta-Alanine metabolism; Propanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.1.1.59; 1.1.1.298; 1.1.1.-; 3.1.2.4; 6.2.1.36; 6.2.1.-,"Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Hydroxycarboxylic acids;     C01013  3-Hydroxypropanoate,CAS: 503-66-2; PubChem: 4258; ChEBI: 16510 33404; ChEMBL: CHEMBL1205969; LipidBank: DFA0269; PDB-CCD: 3OH; 3DMET: B00221; NIKKAJI: J6.213H,cpd:C00184; cpd:C00186; cpd:C00256; cpd:C00577; cpd:C01013; cpd:C01432; cpd:C02154; cpd:C02426; cpd:C03726; cpd:C05823; cpd:C10899; cpd:C12677; cpd:C19286; cpd:C19296,3,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O3,C3H5O3,90.03169405,91.03951908,89.02386902730,839,cpd:C01103,Orotidine 5'-phosphate;,C10H13N2O11P,Orotidine 5'-phosphate; Orotidylic acid,R00965 R01870,Pyrimidine metabolism; Metabolic pathways,2.4.2.10; 4.1.1.23,"Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP",NA,CAS: 2149-82-8; PubChem: 4337; ChEBI: 15842; ChEMBL: CHEMBL1207358 CHEMBL610606; PDB-CCD: OMP; 3DMET: B01381; NIKKAJI: J13.801K,cpd:C01103,10,13,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O11N2P1,C10H12O11N2P1,368.0256962,369.0335213,367.0178712731,840,cpd:C01168,Pseudouridine 5'-phosphate,C9H13N2O9P,Pseudouridine 5'-phosphate,R01055 R03315 R11180,Pyrimidine metabolism,2.7.1.83; 3.1.3.96; 4.2.1.70,NA,NA,CAS: 1157-60-4; PubChem: 4395; ChEBI: 18116; PDB-CCD: PSU; 3DMET: B01399; NIKKAJI: J2.731.765K,cpd:C00105; cpd:C00868; cpd:C01168; cpd:C01368; cpd:C01764; cpd:C02764; cpd:C03031,9,13,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O9N2P1,C9H12O9N2P1,324.035867,325.043692,323.028042732,841,cpd:C01205,(R)-3-Amino-2-methylpropanoate;,C4H9NO2,(R)-3-Amino-2-methylpropanoate; (R)-3-Aminoisobutyrate; D-3-Aminoisobutanoate; (R)-beta-Aminoisobutyrate,R02050 R04666,"Pyrimidine metabolism; Valine, leucine and isoleucine degradation; Metabolic pathways",2.6.1.40; 3.5.1.6,"Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",NA,PubChem: 4429; ChEBI: 16320; LIPIDMAPS: LMFA01100049; NIKKAJI: J36.420G,cpd:C00155; cpd:C00334; cpd:C01026; cpd:C01205; cpd:C02261; cpd:C02356; cpd:C02721; cpd:C03284; cpd:C03665; cpd:C05145; cpd:C05330; cpd:C05689; cpd:C05698; cpd:C11109; cpd:C11735; cpd:C19514,4,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O2N1,C4H8O2N1,103.0633285,104.0711536,102.0555035733,842,cpd:C01346,dUDP;,C9H14N2O11P2,dUDP; 2'-Deoxyuridine 5'-diphosphate,R02018 R02098 R02330 R02331 R02332 R02372,Pyrimidine metabolism; Metabolic pathways,1.17.4.1; 2.7.1.48; 2.7.4.4; 2.7.4.6; 2.7.4.9; 3.6.1.39,NA,Compounds with biological roles [BR:br08001];  Nucleic acids;   Nucleotides;    Deoxyribonucleotides;     C01346  dUDP,CAS: 4208-67-7; PubChem: 4551; ChEBI: 28850; ChEMBL: CHEMBL9519; PDB-CCD: DUD; 3DMET: B01441; NIKKAJI: J699.272B,cpd:C01346,9,14,11,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O11N2P2,C9H13O11N2P2,388.0072833,389.0151083,386.9994582734,843,cpd:C01368,3'-UMP;,C9H13N2O9P,3'-UMP; Uridine 3'-monophosphate; Uridine 3'-phosphate,R01877 R03538,Pyrimidine metabolism,3.1.3.6; 3.1.4.16,NA,NA,CAS: 35170-03-7; PubChem: 4567; ChEBI: 28895; ChEMBL: CHEMBL460741; PDB-CCD: U3P; 3DMET: B01443; NIKKAJI: J150.311A,cpd:C00105; cpd:C00868; cpd:C01168; cpd:C01368; cpd:C01764; cpd:C02764; cpd:C03031,9,13,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O9N2P1,C9H12O9N2P1,324.035867,325.043692,323.028042735,844,cpd:C01563,Carbamate;,CH3NO2,Carbamate; Carbamic acid; Aminoformic acid,R01395 R03546 R07316 R09947 R09949 R09980 R10949,Pyrimidine metabolism; Nitrogen metabolism,2.7.2.2; 3.5.1.110; 4.2.1.104; 6.3.5.5,NA,NA,CAS: 463-77-4 302-11-4; PubChem: 4721; ChEBI: 28616; ChEMBL: CHEMBL125278; PDB-CCD: OUT; 3DMET: B00320; NIKKAJI: J39.572B,cpd:C01563; cpd:C19275,1,3,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H4O2N1,C1H2O2N1,61.01637834,62.02420337,60.00855331736,845,cpd:C02067,Pseudouridine,C9H12N2O6,Pseudouridine,R03315 R11180,Pyrimidine metabolism,2.7.1.83; 3.1.3.96,NA,NA,CAS: 1445-07-4; PubChem: 5155; ChEBI: 17802; ChEMBL: CHEMBL603512; KNApSAcK: C00001508; 3DMET: B01529; NIKKAJI: J20.385H,cpd:C00299; cpd:C02067; cpd:C16745,9,12,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13O6N2,C9H11O6N2,244.0695361,245.0773611,243.0617111737,846,cpd:C02170,Methylmalonate;,C4H6O4,Methylmalonate; Methylmalonic acid,R02764 R03383 R03869 R03870 R03871 R03872 R10778,"Pyrimidine metabolism; Valine, leucine and isoleucine degradation; Propanoate metabolism",1.2.1.3; 1.2.3.1; 3.1.2.17; 3.5.1.95; 3.5.2.1; 6.2.1.-,NA,NA,CAS: 516-05-2; PubChem: 5245; ChEBI: 17453 30860; ChEMBL: CHEMBL1232416; LIPIDMAPS: LMFA01170118; PDB-CCD: DXX; 3DMET: B00395; NIKKAJI: J6.302I,cpd:C00042; cpd:C02170; cpd:C03201; cpd:C07598; cpd:C10900; cpd:C11117; cpd:C14872; cpd:C15607; cpd:C19414; cpd:C20231,4,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O4,C4H5O4,118.0266087,119.0344337,117.0187836738,847,cpd:C02354,"2',3'-Cyclic CMP",C9H12N3O7P,"2',3'-Cyclic CMP",R03929,Pyrimidine metabolism,3.1.4.16,NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    2',3'-Cyclic nucleotides;     C02354  2',3'-Cyclic CMP",PubChem: 5401; ChEBI: 27652; 3DMET: B01565; NIKKAJI: J32.847B,cpd:C00941; cpd:C02072; cpd:C02354,9,12,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13O7N3P1,C9H11O7N3P1,305.0412867,306.0491118,304.0334617739,848,cpd:C02355,"2',3'-Cyclic UMP",C9H11N2O8P,"2',3'-Cyclic UMP",R03538,Pyrimidine metabolism,3.1.4.16,NA,"Compounds with biological roles [BR:br08001];  Nucleic acids;   Cyclic nucleotides;    2',3'-Cyclic nucleotides;     C02355  2',3'-Cyclic UMP",PubChem: 5402; ChEBI: 28637; 3DMET: B01566; NIKKAJI: J380.961G,cpd:C00549; cpd:C02355,9,11,8,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O8N2P1,C9H10O8N2P1,306.0253023,307.0331274,305.0174773740,849,cpd:C02376,5-Methylcytosine,C5H7N3O,5-Methylcytosine,R01411,Pyrimidine metabolism,3.5.4.1,NA,NA,CAS: 554-01-8; PubChem: 5418; ChEBI: 27551; PDB-CCD: 17E; 3DMET: B00435; NIKKAJI: J9.416A,cpd:C02376,5,7,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8O1N3,C5H6O1N3,125.0589119,126.0667369,124.0510868741,850,cpd:C02642,3-Ureidopropionate;,C4H8N2O3,3-Ureidopropionate; 3-Ureidopropanoate; beta-Ureidopropionic acid; N-Carbamoyl-beta-alanine,R00905 R02269,Pyrimidine metabolism; beta-Alanine metabolism; Pantothenate and CoA biosynthesis; Metabolic pathways,3.5.1.6; 3.5.2.2,"Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",NA,CAS: 462-88-4; PubChem: 5621; ChEBI: 18261; ChEMBL: CHEMBL20962; PDB-CCD: URP; 3DMET: B00472; NIKKAJI: J39.569B,cpd:C00152; cpd:C01043; cpd:C01905; cpd:C02037; cpd:C02642; cpd:C16438; cpd:C19258; cpd:C19301,4,8,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O3N2,C4H7O3N2,132.0534921,133.0613172,131.0456671742,851,cpd:C03997,5-Hydroxymethyldeoxycytidylate;,C10H16N3O8P,5-Hydroxymethyldeoxycytidylate; 5-Hydroxymethyldeoxycytidylic acid; 2'-Deoxy-5-hydroxymethylcytidine 5'-phosphate,R00140 R01669,Pyrimidine metabolism,2.1.2.8; 2.7.4.12,NA,NA,CAS: 13009-95-5; PubChem: 6710; ChEBI: 16952; PDB-CCD: 5HC; 3DMET: B01709; NIKKAJI: J2.745.326K,cpd:C03997; cpd:C04155; cpd:C11478; cpd:C21031,10,16,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O8N3P1,C10H15O8N3P1,337.0675015,338.0753265,336.0596765743,852,cpd:C05281,5-Methylbarbiturate;,C5H6N2O3,5-Methylbarbiturate; 5-Methylbarbituric acid,R01413 R03870 R10777,Pyrimidine metabolism,1.17.99.4; 3.5.2.1,NA,NA,CAS: 2417-22-3; PubChem: 7668; ChEBI: 28492; NIKKAJI: J497.987G,cpd:C02144; cpd:C03088; cpd:C05133; cpd:C05281,5,6,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O3N2,C5H5O3N2,142.0378421,143.0456671,141.030017744,853,cpd:C05822,3'-CMP;,C9H14N3O8P,3'-CMP; Cytidine 3'-phosphate,R02370 R03929,Pyrimidine metabolism,3.1.3.6; 3.1.4.16,NA,NA,CAS: 84-52-6; PubChem: 8117; ChEBI: 53013; ChEMBL: CHEMBL258728; PDB-CCD: C3P; 3DMET: B01898; NIKKAJI: J60.869F,cpd:C00055; cpd:C03104; cpd:C05822; cpd:C17325; cpd:C19722,9,14,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O8N3P1,C9H13O8N3P1,323.0518514,324.0596765,322.0440264745,854,cpd:C06198,"P1,P4-Bis(5'-uridyl) tetraphosphate;",C18H26N4O23P4,"P1,P4-Bis(5'-uridyl) tetraphosphate; UppppU",R00969,Pyrimidine metabolism,3.6.1.17,NA,NA,PubChem: 8448; ChEBI: 27791; ChEMBL: CHEMBL221326; 3DMET: B01994; NIKKAJI: J1.474.025B,cpd:C06198,18,26,23,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H27O23N4P4,C18H25O23N4P4,789.9938311,791.0016561,788.9860061746,855,cpd:C11038,2'-Deoxy-5-hydroxymethylcytidine-5'-diphosphate,C10H17N3O11P2,2'-Deoxy-5-hydroxymethylcytidine-5'-diphosphate,R00139 R00140,Pyrimidine metabolism,2.7.4.6; 2.7.4.12,NA,NA,PubChem: 13221; ChEBI: 835; 3DMET: B04201; NIKKAJI: J2.787.088K,cpd:C11038,10,17,11,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O11N3P2,C10H16O11N3P2,417.0338324,418.0416574,416.0260073747,856,cpd:C11039,2'-Deoxy-5-hydroxymethylcytidine-5'-triphosphate,C10H18N3O14P3,2'-Deoxy-5-hydroxymethylcytidine-5'-triphosphate,R00139 R11029,Pyrimidine metabolism,2.7.4.6; 2.7.7.7,NA,NA,PubChem: 13222; ChEBI: 836; 3DMET: B04202; NIKKAJI: J1.301.486H,cpd:C11039,10,18,14,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O14N3P3,C10H17O14N3P3,497.0001633,498.0079883,495.9923382748,857,cpd:C15607,3-Oxo-3-ureidopropanoate;,C4H6N2O4,3-Oxo-3-ureidopropanoate; Malonuric acid,R02139 R07629,Pyrimidine metabolism,3.5.1.95; 3.5.2.1,NA,NA,PubChem: 47204992; ChEBI: 49049; NIKKAJI: J657.734B,cpd:C11117; cpd:C15607; cpd:C20231,4,6,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O4N2,C4H5O4N2,146.0327567,147.0405817,145.0249316749,858,cpd:C20231,(Z)-3-Ureidoacrylate peracid;,C4H6N2O4,(Z)-3-Ureidoacrylate peracid; Ureidoperacrylic acid,R09936 R09947 R09948 R09981,Pyrimidine metabolism; Metabolic pathways,1.14.99.46; 3.5.1.110,NA,NA,PubChem: 163311974,cpd:C11117; cpd:C15607; cpd:C20231,4,6,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O4N2,C4H5O4N2,146.0327567,147.0405817,145.0249316750,859,cpd:C20249,(Z)-3-Peroxyaminoacrylate,C3H5NO3,(Z)-3-Peroxyaminoacrylate,R09947 R09948 R09982,Pyrimidine metabolism; Metabolic pathways,3.5.1.110,NA,NA,PubChem: 163311992,cpd:C02193; cpd:C11822; cpd:C20249,3,5,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H6O3N1,C3H4O3N1,103.026943,104.0347681,102.019118751,860,cpd:C20253,Aminoacrylate;,C3H5NO2,Aminoacrylate; (Z)-3-Aminoacrylate,R09980 R09982 R09983,Pyrimidine metabolism; Metabolic pathways,3.5.1.110; 3.5.1.-,NA,NA,PubChem: 163311996,cpd:C02218; cpd:C04313; cpd:C06695; cpd:C20253; cpd:C20904,3,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H6O2N1,C3H4O2N1,87.0320284,88.03985344,86.02420337752,861,cpd:C20254,Ureidoacrylate;,C4H6N2O3,Ureidoacrylate; (Z)-3-Ureidoacrylate,R09980 R09981,Pyrimidine metabolism,3.5.1.110,NA,NA,PubChem: 163311997,cpd:C00107; cpd:C00211; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C02189; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06395; cpd:C06396; cpd:C16116; cpd:C20254; cpd:C21172,4,6,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O3N2,C4H5O3N2,130.0378421,131.0456671,129.030017753,862,cpd:C20846,3-Oxo-3-ureidoisobutyrate,C5H8N2O4,3-Oxo-3-ureidoisobutyrate,R10777 R10778,Pyrimidine metabolism,3.5.1.95; 3.5.2.1,NA,NA,PubChem: 254741312,cpd:C03409; cpd:C08298; cpd:C19483; cpd:C20232; cpd:C20846,5,8,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O4N2,C5H7O4N2,160.0484067,161.0562318,159.0405817754,863,cpd:C21028,"(R)-5,6-Dihydrothymine;",C5H8N2O2,"(R)-5,6-Dihydrothymine; (5R)-Dihydrothymine",R01415 R03055 R11026,Pyrimidine metabolism; Metabolic pathways,1.3.1.1; 1.3.1.2; 3.5.2.2,"Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",NA,CAS: 86387-01-1; PubChem: 254816253,cpd:C00906; cpd:C03800; cpd:C05715; cpd:C05717; cpd:C21028,5,8,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O2N2,C5H7O2N2,128.0585775,129.0664025,127.0507525755,864,cpd:C21029,(R)-3-Ureidoisobutyrate;,C5H10N2O3,(R)-3-Ureidoisobutyrate; (R)-N-Carbamyl-beta-aminoisobutyrate,R03055 R04666,Pyrimidine metabolism; Metabolic pathways,3.5.1.6; 3.5.2.2,"Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate",NA,PubChem: 254816254,cpd:C00064; cpd:C00303; cpd:C00819; cpd:C01419; cpd:C05100; cpd:C16673; cpd:C21029,5,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O3N2,C5H9O3N2,146.0691422,147.0769672,145.0613172756,866,cpd:C00041,L-Alanine;,C3H7NO2,L-Alanine; L-2-Aminopropionic acid; L-alpha-Alanine,R00258 R00369 R00396 R00397 R00398 R00400 R00401 R00453; R00576 R00585 R00692 R00863 R00907 R00987 R01215 R01261; R01712 R02050 R02271 R02293 R02668 R02970 R03001 R03038; R03193 R03210 R03502 R03599 R03854 R03936 R04112 R04152; R04187 R05652 R07460 R08197 R08714 R08872 R09048 R09254; R10124 R10178 R10180 R10992 R11038 R11064 R11528,"Alanine, aspartate and glutamate metabolism; Cysteine and methionine metabolism; Taurine and hypotaurine metabolism; Selenocompound metabolism; D-Alanine metabolism; Carbon fixation in photosynthetic organisms; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Biosynthesis of amino acids; Vancomycin resistance; ABC transporters; Sulfur relay system; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer",1.4.1.1; 1.5.1.17; 2.3.1.47; 2.6.1.2; 2.6.1.12; 2.6.1.15; 2.6.1.18; 2.6.1.30; 2.6.1.37; 2.6.1.40; 2.6.1.41; 2.6.1.43; 2.6.1.44; 2.6.1.46; 2.6.1.47; 2.6.1.51; 2.6.1.56; 2.6.1.58; 2.6.1.66; 2.6.1.71; 2.6.1.77; 2.6.1.84; 2.6.1.96; 2.6.1.99; 2.6.1.108; 2.6.1.-; 2.8.1.7; 3.5.1.28; 3.7.1.3; 4.1.1.12; 4.1.1.64; 4.4.1.16; 5.1.1.1; 6.1.1.7; 6.3.2.8; 6.3.2.49,"C4-dicarboxylic acid cycle, NAD - malic enzyme type",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00041  Alanine (Ala); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Alanine;     D00012  Alanine (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00012  [003609] L-Alanine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00012  L-Alanine,CAS: 56-41-7; PubChem: 3343; ChEBI: 16977; ChEMBL: CHEMBL279597; KNApSAcK: C00001332; PDB-CCD: ALA; 3DMET: B00011; NIKKAJI: J9.168E,cpd:C00041; cpd:C00097; cpd:C00099; cpd:C00133; cpd:C00213; cpd:C00736; cpd:C00793; cpd:C01401; cpd:C01537; cpd:C01962; cpd:C02116; cpd:C05688; cpd:C11488,3,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O2N1,C3H6O2N1,89.04767847,90.0555035,88.03985344757,867,cpd:C00152,L-Asparagine;,C4H8N2O3,L-Asparagine; 2-Aminosuccinamic acid,R00482 R00483 R00485 R00578 R01266 R01267 R01346 R01485; R03648 R10446,"Alanine, aspartate and glutamate metabolism; Cyanoamino acid metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer",1.14.11.39; 2.3.2.7; 2.6.1.14; 3.2.2.11; 3.5.1.1; 3.5.1.38; 3.5.5.4; 4.2.1.65; 6.1.1.22; 6.3.1.1; 6.3.1.4; 6.3.5.4,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00152  Asparagine (Asn),CAS: 70-47-3; PubChem: 3452; ChEBI: 17196; ChEMBL: CHEMBL58832; KNApSAcK: C00001341 C00034027; PDB-CCD: 41Q ASN; 3DMET: B00043; NIKKAJI: J9.178B,cpd:C00152; cpd:C01043; cpd:C01905; cpd:C02037; cpd:C02642; cpd:C16438; cpd:C19258; cpd:C19301,4,8,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O3N2,C4H7O3N2,132.0534921,133.0613172,131.0456671758,868,cpd:C00232,Succinate semialdehyde;,C4H6O3,Succinate semialdehyde; Succinic semialdehyde; 4-Oxobutanoate,R00272 R00713 R00714 R01644 R01645 R01647 R01648 R01649; R01650 R08461 R09280 R09281 R09472 R10101 R10178 R10179,"Alanine, aspartate and glutamate metabolism; Tyrosine metabolism; Butanoate metabolism; Carbon fixation pathways in prokaryotes; Vitamin B6 metabolism; Nicotinate and nicotinamide metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Quorum sensing",1.1.1.61; 1.1.1.-; 1.2.1.16; 1.2.1.24; 1.2.1.76; 1.2.1.79; 1.5.3.21; 1.14.13.163; 2.6.1.19; 2.6.1.96; 3.5.1.29; 4.1.1.71; 4.1.2.52,"GABA (gamma-Aminobutyrate) shunt; Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle; Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde; Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    4-Oxocarboxylic acid;     C00232  Succinate semialdehyde; 4-Oxobutanoate,CAS: 692-29-5; PubChem: 3531; ChEBI: 16265; LIPIDMAPS: LMFA06000118; KNApSAcK: C00019682; PDB-CCD: SSN; 3DMET: B00065; NIKKAJI: J61.361D,cpd:C00107; cpd:C00109; cpd:C00164; cpd:C00211; cpd:C00232; cpd:C00349; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C01551; cpd:C02189; cpd:C02348; cpd:C02350; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C02847; cpd:C03011; cpd:C03135; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06002; cpd:C06395; cpd:C06396; cpd:C06805; cpd:C16116; cpd:C18904; cpd:C20254; cpd:C21030; cpd:C21172,4,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O3,C4H5O3,102.0316941,103.0395191,101.023869759,869,cpd:C00334,4-Aminobutanoate;,C4H9NO2,4-Aminobutanoate; 4-Aminobutanoic acid; 4-Aminobutyrate; 4-Aminobutyric acid; gamma-Aminobutyric acid; GABA,R00261 R01648 R01986 R01987 R01989 R01990 R01991 R01992; R02549 R07419 R08461 R10102 R10178 R10179,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; beta-Alanine metabolism; Butanoate metabolism; Nicotinate and nicotinamide metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Quorum sensing; cAMP signaling pathway; Neuroactive ligand-receptor interaction; Synaptic vesicle cycle; Retrograde endocannabinoid signaling; GABAergic synapse; Taste transduction; Estrogen signaling pathway; Morphine addiction; Nicotine addiction",1.2.1.3; 1.2.1.19; 1.2.1.-; 1.5.3.19; 2.1.4.1; 2.6.1.19; 2.6.1.96; 3.4.13.18; 3.4.13.20; 3.5.1.63; 3.5.1.94; 3.5.3.7; 4.1.1.15; 6.3.2.11,"GABA (gamma-Aminobutyrate) shunt; GABA biosynthesis, eukaryotes, putrescine => GABA; GABA biosynthesis, prokaryotes, putrescine => GABA",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00334  gamma-Aminobutyric acid;   Amines;    Biogenic amines;     C00334  gamma-Aminobutyric acid (GABA);  Hormones and transmitters;   Neurotransmitters;    Amino acids;     C00334  GABA; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0110 Amino fatty acids;     C00334  4-Aminobutanoic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N03 ANTIEPILEPTICS;    N03A ANTIEPILEPTICS;     N03AG Fatty acid derivatives;      N03AG03 Aminobutyric acid;       D00058  gamma-Aminobutyric acid (JAN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   21  Cardiovascular agents;    219  Miscellaneous;     2190  Miscellaneous;      D00058  gamma-Aminobutyric acid (JAN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Metabotropic glutamate receptor family;    GABA;     GABAB-receptor;      Aminobutyric acid;       D00058  gamma-Aminobutyric acid (JAN);  Ion channels;   Cys-loop superfamily;    GABA-A;     GABAA-receptor (benzodiazepine binding site);      Aminobutyric acid;       D00058  gamma-Aminobutyric acid (JAN); Neurological agents [br08367.html];  Antiepileptic agents;   D00058,CAS: 56-12-2; PubChem: 3628; ChEBI: 16865 30566; ChEMBL: CHEMBL96; LIPIDMAPS: LMFA01100039; KNApSAcK: C00001337; PDB-CCD: ABU; 3DMET: B00090; NIKKAJI: J1.375G,cpd:C00155; cpd:C00334; cpd:C01026; cpd:C01205; cpd:C02261; cpd:C02356; cpd:C02721; cpd:C03284; cpd:C03665; cpd:C05145; cpd:C05330; cpd:C05689; cpd:C05698; cpd:C11109; cpd:C11735; cpd:C19514,4,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O2N1,C4H8O2N1,103.0633285,104.0711536,102.0555035760,870,cpd:C00352,D-Glucosamine 6-phosphate;,C6H14NO8P,D-Glucosamine 6-phosphate; D-Glucosamine phosphate,R00765 R00768 R01961 R01964 R01965 R02058 R02059 R02060; R02631,"Alanine, aspartate and glutamate metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of antibiotics; Phosphotransferase system (PTS); Insulin resistance",2.3.1.4; 2.6.1.16; 2.7.1.1; 2.7.1.8; 2.7.1.-; 3.5.1.25; 3.5.99.6; 5.4.2.10,NA,NA,CAS: 3616-42-0; PubChem: 3645; ChEBI: 15873 47987; KNApSAcK: C00019580; PDB-CCD: 4R1 GLP; 3DMET: B01222; NIKKAJI: J79.822C,cpd:C00352; cpd:C01283; cpd:C03783; cpd:C06156; cpd:C06377; cpd:C12213; cpd:C12214,6,14,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O8N1P1,C6H13O8N1P1,259.0457034,260.0535284,258.0378784761,871,cpd:C00402,D-Aspartate;,C4H7NO4,D-Aspartate; D-Aspartic acid,R00359 R00491 R02182 R05053 R09590,"Alanine, aspartate and glutamate metabolism",1.4.3.1; 1.4.3.15; 2.6.1.21; 3.5.1.83; 5.1.1.13; 6.3.1.12,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00402  D-Aspartic acid,CAS: 1783-96-6; PubChem: 3692; ChEBI: 17364; ChEMBL: CHEMBL29757; PDB-CCD: DAS; 3DMET: B01235; NIKKAJI: J9.205C,cpd:C00049; cpd:C00402; cpd:C16433; cpd:C19710; cpd:C19911,4,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H8O4N1,C4H6O4N1,133.0375077,134.0453327,132.0296827762,872,cpd:C00940,2-Oxoglutaramate;,C5H7NO4,2-Oxoglutaramate; 2-Oxoglutaramic acid; alpha-Ketoglutaramate; 2-Ketoglutaramate,R00269 R00576 R01375 R02781 R08890 R08891,"Alanine, aspartate and glutamate metabolism",2.6.1.15; 2.6.1.50; 2.6.1.64; 2.6.1.100; 2.6.1.101; 3.5.1.3; 3.5.1.111,NA,NA,CAS: 18465-19-5; PubChem: 4192; ChEBI: 16769 30882; 3DMET: B00205; NIKKAJI: J39.559E,cpd:C00940; cpd:C05572,5,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8O4N1,C5H6O4N1,145.0375077,146.0453327,144.0296827763,873,cpd:C01042,N-Acetyl-L-aspartate;,C6H9NO5,N-Acetyl-L-aspartate; N-Acetyl-L-aspartic acid,R00487 R00488 R10678 R10679 R10687,"Alanine, aspartate and glutamate metabolism; Metabolic pathways",2.3.1.17; 3.4.17.21; 3.5.1.15; 6.3.2.41; 6.3.2.42,NA,NA,CAS: 997-55-7; PubChem: 4284; ChEBI: 16953 21547; ChEMBL: CHEMBL1162494; 3DMET: B00227; NIKKAJI: J62.824G,cpd:C01042; cpd:C01045; cpd:C05520,6,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O5N1,C6H8O5N1,175.0480724,176.0558974,174.0402474764,874,cpd:C02362,2-Oxosuccinamate;,C4H5NO4,2-Oxosuccinamate; 2-Oxosuccinamic acid; gamma-Aminooxaloacetate; Oxaloacetamide,R00348 R01346,"Alanine, aspartate and glutamate metabolism",2.6.1.14; 3.5.1.3,NA,NA,PubChem: 5407; ChEBI: 16327; 3DMET: B01568; NIKKAJI: J2.362.002B,cpd:C02362; cpd:C05840; cpd:C13058,4,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H6O4N1,C4H4O4N1,131.0218576,132.0296827,130.0140326765,875,cpd:C03912,(S)-1-Pyrroline-5-carboxylate;,C5H7NO2,(S)-1-Pyrroline-5-carboxylate; L-1-Pyrroline-5-carboxylate; 1-Pyrroline-5-carboxylate,R00707 R00708 R01248 R01251 R01253 R03314 R09785 R10082; R10485 R10507,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Carbapenem biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",1.2.1.88; 1.5.1.2; 1.5.5.2; 1.5.-.-; 1.14.11.34; 2.3.1.226,"Proline biosynthesis, glutamate => proline; Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate",NA,PubChem: 6642; ChEBI: 17388 371; KNApSAcK: C00007606; 3DMET: B01698; NIKKAJI: J654.872E,cpd:C03564; cpd:C03912; cpd:C04322; cpd:C04445; cpd:C07275; cpd:C20317,5,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8O2N1,C5H6O2N1,113.0476785,114.0555035,112.0398534766,876,cpd:C12270,N-Acetylaspartylglutamate;,C11H16N2O8,N-Acetylaspartylglutamate; NAAG; Isospaglumic acid; N-Acetyl-L-aspartyl-L-glutamate,R10678 R10687 R10688 R10693,"Alanine, aspartate and glutamate metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction",3.4.17.21; 6.3.2.41; 6.3.2.42,NA,NA,CAS: 3106-85-2; PubChem: 14415; ChEBI: 73688; ChEMBL: CHEMBL376326 CHEMBL94282; NIKKAJI: J22.752H,cpd:C12270,11,16,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H17O8N2,C11H15O8N2,304.0906655,305.0984905,303.0828404767,877,cpd:C20775,beta-Citryl-L-glutamate;,C11H15NO10,beta-Citryl-L-glutamate; beta-Citrylglutamate,R10677,"Alanine, aspartate and glutamate metabolism; Metabolic pathways",6.3.1.17,NA,NA,PubChem: 254741242; PDB-CCD: BC8,cpd:C20775,11,15,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H16O10N1,C11H14O10N1,321.0695957,322.0774207,320.0617707768,878,cpd:C20776,N-Acetylaspartylglutamylglutamate;,C16H23N3O11,N-Acetylaspartylglutamylglutamate; N-Acetyl-L-aspartyl-L-glutamyl-L-glutamate; NAAG2,R10679 R10688 R10693,"Alanine, aspartate and glutamate metabolism; Metabolic pathways",3.4.17.21; 6.3.2.42,NA,NA,PubChem: 254741243,cpd:C20776,16,23,11,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H24O11N3,C16H22O11N3,433.1332586,434.1410836,432.1254335769,879,cpd:C02811,Anhydrotetracycline,C22H22N2O7,Anhydrotetracycline,R04060 R09191 R11521,Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.38; 2.1.1.335,"Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline",Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C02811  Anhydrotetracycline,PubChem: 5761; ChEBI: 17146; ChEMBL: CHEMBL1214599; PDB-CCD: TDC; 3DMET: B01603; NIKKAJI: J114.616E,cpd:C02811,22,22,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H23O7N2,C22H21O7N2,426.1427011,427.1505261,425.134876770,880,cpd:C03206,"5a,11a-Dehydrotetracycline;",C22H22N2O8,"5a,11a-Dehydrotetracycline; 12-Dehydrotetracycline",R04060 R05459 R09198,Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.3.98.4; 1.14.13.38; 1.14.13.234,"Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline",Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C03206  12-Dehydrotetracycline,PubChem: 6082; ChEBI: 15808; 3DMET: B01639; NIKKAJI: J2.741.332C,cpd:C03206; cpd:C07654; cpd:C08029,22,22,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H23O8N2,C22H21O8N2,442.1376157,443.1454407,441.1297906771,881,cpd:C06570,Tetracycline,C22H24N2O8,Tetracycline,R05459 R11449 R11478,Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics; Bile secretion,1.3.98.4; 1.14.13.231; 1.14.19.49,"Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline",Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Tetracyclines;     C06570  Tetracycline; Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C06570  Tetracycline; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A01 STOMATOLOGICAL PREPARATIONS;    A01A STOMATOLOGICAL PREPARATIONS;     A01AB Antiinfectives and antiseptics for local oral treatment;      A01AB13 Tetracycline;       D00201  Tetracycline (JAN/USP/INN);  D DERMATOLOGICALS;   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;    D06A ANTIBIOTICS FOR TOPICAL USE;     D06AA Tetracycline and derivatives;      D06AA04 Tetracycline;       D00201  Tetracycline (JAN/USP/INN);  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01A TETRACYCLINES;     J01AA Tetracyclines;      J01AA07 Tetracycline;       D00201  Tetracycline (JAN/USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA09 Tetracycline;       D00201  Tetracycline (JAN/USP/INN);   S02 OTOLOGICALS;    S02A ANTIINFECTIVES;     S02AA Antiinfectives;      S02AA08 Tetracycline;       D00201  Tetracycline (JAN/USP/INN);   S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;    S03A ANTIINFECTIVES;     S03AA Antiinfectives;      S03AA02 Tetracycline;       D00201  Tetracycline (JAN/USP/INN); USP drug classification [BR:br08302];  Antibacterials;   Tetracyclines;    Tetracycline;     D00201  Tetracycline (JAN/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Tetracycline;     D00201  Tetracycline (JAN/USP/INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Tetracyclines;      Tetracycline;       D00201  Tetracycline (JAN/USP/INN),CAS: 60-54-8; PubChem: 8799; ChEBI: 27902; ChEMBL: CHEMBL1440 CHEMBL1485984 CHEMBL198; PDB-CCD: TAC; 3DMET: B02074; NIKKAJI: J209.316B,cpd:C06570; cpd:C06973,22,24,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H25O8N2,C22H23O8N2,444.1532657,445.1610908,443.1454407772,882,cpd:C06571,Chlortetracycline;,C22H23ClN2O8,Chlortetracycline; 7-Chlorotetracycline; Aureomycin,R09194 R11478 R11526,Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.231; 1.14.19.49,"Chlortetracycline biosynthesis, pretetramide => chlortetracycline",Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Tetracyclines;     C06571  Chlortetracycline; Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C06571  Chlortetracycline; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A01 STOMATOLOGICAL PREPARATIONS;    A01A STOMATOLOGICAL PREPARATIONS;     A01AB Antiinfectives and antiseptics for local oral treatment;      A01AB21 Chlortetracycline;       D07689  Chlortetracycline (INN);  D DERMATOLOGICALS;   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;    D06A ANTIBIOTICS FOR TOPICAL USE;     D06AA Tetracycline and derivatives;      D06AA02 Chlortetracycline;       D07689  Chlortetracycline (INN);  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01A TETRACYCLINES;     J01AA Tetracyclines;      J01AA03 Chlortetracycline;       D07689  Chlortetracycline (INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA02 Chlortetracycline;       D07689  Chlortetracycline (INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Tetracyclines;      Chlortetracycline;       D07689  Chlortetracycline (INN),CAS: 57-62-5; PubChem: 8800; ChEBI: 27644; LIPIDMAPS: LMPK07000004; PDB-CCD: CTC; NIKKAJI: J4.583G,cpd:C06571,22,23,8,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C22H24O8N2Cl1,C22H22O8N2Cl1,478.1142934,479.1221184,477.1064684773,883,cpd:C06624,Oxytetracycline;,C22H24N2O9,Oxytetracycline; Oxytetracycline anhydrous,R09192 R11525,Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.3.98.4; 1.14.13.231,"Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline","Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C06624  Oxytetracycline; Pesticides [BR:br08007];  Pesticides;   Fungicides;    Antibiotic fungicides;     C06624  Oxytetracycline; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;    D06A ANTIBIOTICS FOR TOPICAL USE;     D06AA Tetracycline and derivatives;      D06AA03 Oxytetracycline;       C06624  Oxytetracycline;  G GENITO URINARY SYSTEM AND SEX HORMONES;   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;    G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;     G01AA Antibiotics;      G01AA07 Oxytetracycline;       C06624  Oxytetracycline;  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01A TETRACYCLINES;     J01AA Tetracyclines;      J01AA06 Oxytetracycline;       C06624  Oxytetracycline;  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA04 Oxytetracycline;       C06624  Oxytetracycline; Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Tetracyclines;      Oxytetracycline;       C06624  Oxytetracycline",CAS: 79-57-2; PubChem: 8850; ChEBI: 27701; ChEMBL: CHEMBL1517; LIPIDMAPS: LMPK07000005; PDB-CCD: OTC; 3DMET: B02077; NIKKAJI: J3.847D,cpd:C06624; cpd:C13055; cpd:C21391,22,24,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H25O9N2,C22H23O9N2,460.1481804,461.1560054,459.1403553774,884,cpd:C06627,4-Keto-anhydrotetracycline;,C20H15NO8,"4-Keto-anhydrotetracycline; 4-Ketoanhydrotetracycline; 4-Keto-ATC; 4-Dedimethylamino-4-oxo-anhydrotetracycline; 4-De(dimethylamino)-4-oxoanhydrotetracycline; (4aR,12aS)-3,10,11,12a-Tetrahydroxy-6-methyl-1,4,12-trioxo-4a,5-dihydrotetracene-2-carboxamide",R05456 R05462 R09190 R09197,Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.232; 1.14.13.233; 1.14.14.-,"Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline",Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C06627  4-Dedimethylamino-4-oxo-anhydrotetracycline,PubChem: 8853; ChEBI: 28408; LIPIDMAPS: LMPK07000007; 3DMET: B05217; NIKKAJI: J2.762.510J,cpd:C06627,20,15,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H16O8N1,C20H14O8N1,397.0797664,398.0875915,396.0719414775,885,cpd:C06628,4-Hydroxy-6-methylpretetramide;,C20H15NO7,"4-Hydroxy-6-methylpretetramide; 1,3,4,10,11,12-Hexahydroxy-6-methyltetracene-2-carboxamide",R05462 R05463,Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.232; 1.14.13.233,"Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline",NA,PubChem: 8854; ChEBI: 28464; 3DMET: B01003; NIKKAJI: J147.317D,cpd:C06628,20,15,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H16O7N1,C20H14O7N1,381.0848518,382.0926769,380.0770268776,886,cpd:C06629,6-Methylpretetramide;,C20H15NO6,"6-Methylpretetramide; 1,3,10,11,12-Pentahydroxy-6-methyltetracene-2-carboxamide",R05463 R09189 R09190,Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.232; 1.14.13.233; 2.1.1.-,"Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline",NA,PubChem: 8855; ChEBI: 27879; 3DMET: B01004; NIKKAJI: J2.622.010F,cpd:C06629,20,15,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H16O6N1,C20H14O6N1,365.0899372,366.0977622,364.0821122777,887,cpd:C06654,4-Amino-anhydrotetracycline;,C20H18N2O7,4-Amino-anhydrotetracycline; 4-Amino-ATC; 4-Dedimethyl-6-dehydro-anhydrotetracycline; 4-Amino-4-de(dimethylamino)anhydrotetracycline,R09191 R09197 R11520,Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.335,"Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline",Lipids [BR:br08002];  PK  Polyketides;   PK07 Linear tetracyclines;    C06654  4-Dedimethyl-6-dehydro-anhydrotetracycline,PubChem: 8879; ChEBI: 28461; LIPIDMAPS: LMPK07000008; 3DMET: B05221; NIKKAJI: J2.763.320J,cpd:C06654,20,18,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O7N2,C20H17O7N2,398.1114009,399.119226,397.1035759778,892,cpd:C18295,Pretetramid;,C19H13NO6,Pretetramid; Pretetramide,R09189 R09196,Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.-,"Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline; Chlortetracycline biosynthesis, pretetramide => chlortetracycline",NA,PubChem: 103061477; ChEBI: 81646,cpd:C18295,19,13,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H14O6N1,C19H12O6N1,351.0742871,352.0821122,350.0664621779,893,cpd:C18296,"5a,11a-Dehydrooxytetracycline",C22H22N2O9,"5a,11a-Dehydrooxytetracycline",R09192 R09198,Tetracycline biosynthesis; Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.3.98.4; 1.14.13.234,"Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline",NA,PubChem: 103061478; ChEBI: 134368,cpd:C18296,22,22,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H23O9N2,C22H21O9N2,458.1325303,459.1403553,457.1247053780,894,cpd:C21391,11a-Hydroxytetracycline,C22H24N2O9,11a-Hydroxytetracycline,R11449,Tetracycline biosynthesis; Biosynthesis of antibiotics,1.14.13.231,NA,NA,PubChem: 328082934,cpd:C06624; cpd:C13055; cpd:C21391,22,24,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H25O9N2,C22H23O9N2,460.1481804,461.1560054,459.1403553781,896,cpd:C21438,11a-Hydroxyoxytetracycline,C22H24N2O10,11a-Hydroxyoxytetracycline,R11525,Tetracycline biosynthesis; Biosynthesis of antibiotics,1.14.13.231,NA,NA,PubChem: 329728061,cpd:C21438,22,24,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H25O10N2,C22H23O10N2,476.143095,477.15092,475.1352699782,897,cpd:C21439,11a-Hydroxy-7-chlortetracycline,C22H23ClN2O9,11a-Hydroxy-7-chlortetracycline,R11526,Tetracycline biosynthesis; Biosynthesis of antibiotics,1.14.13.231,NA,NA,PubChem: 329728062,cpd:C21439,22,23,9,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C22H24O9N2Cl1,C22H22O9N2Cl1,494.109208,495.117033,493.101383783,898,cpd:C00961,Sterigmatocystin,C18H12O6,Sterigmatocystin,R03111 R03112,Aflatoxin biosynthesis,2.1.1.109; 2.1.1.110,NA,Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C00961  Sterigmatocystin; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C00961  Sterigmatocystin; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Others;     C00961  Sterigmatocystin,CAS: 10048-13-2; PubChem: 4212; ChEBI: 18227; ChEMBL: CHEMBL524291; LIPIDMAPS: LMPK10000001; KNApSAcK: C00000563; 3DMET: B01360; NIKKAJI: J9.276B,cpd:C00961,18,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H13O6,C18H11O6,324.0633881,325.0712131,323.0555631784,899,cpd:C03683,6-Demethylsterigmatocystin,C17H10O6,6-Demethylsterigmatocystin,R03112 R10481,Aflatoxin biosynthesis,2.1.1.109,NA,Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C03683  6-Demethylsterigmatocystin,PubChem: 6458; ChEBI: 18236; LIPIDMAPS: LMPK10000002; 3DMET: B00622; NIKKAJI: J75.542G,cpd:C03683,17,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H11O6,C17H9O6,310.047738,311.0555631,309.039913785,900,cpd:C03686,O-Methylsterigmatocystin;,C19H14O6,O-Methylsterigmatocystin; 8-O-Methylsterigmatocystin,R03111 R10319 R10483,Aflatoxin biosynthesis,1.14.13.175; 2.1.1.110,NA,Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C03686  7-O-Methylsterigmatocystin,CAS: 17878-69-2; PubChem: 6461; ChEBI: 18171; LIPIDMAPS: LMPK10000003; KNApSAcK: C00023634; 3DMET: B00623; NIKKAJI: J86.123E,cpd:C03686; cpd:C12402; cpd:C18294; cpd:C19979,19,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H15O6,C19H13O6,338.0790382,339.0868632,337.0712131786,901,cpd:C03944,Dihydro-O-methylsterigmatocystin;,C19H16O6,Dihydro-O-methylsterigmatocystin; DHOMST; Dihydromethylsterigmatocystin; 8-O-Methyldihydrosterigmatocystin,R10307 R10320 R10482,Aflatoxin biosynthesis,1.14.13.175; 2.1.1.110,NA,Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C03944  Dihydromethylsterigmatocystin,PubChem: 6668; ChEBI: 4572; LIPIDMAPS: LMPK10000004; 3DMET: B01703; NIKKAJI: J2.744.788K,cpd:C03944; cpd:C10090; cpd:C17473,19,16,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H17O6,C19H15O6,340.0946882,341.1025133,339.0868632787,902,cpd:C06800,Aflatoxin B1,C17H12O6,Aflatoxin B1,R09404 R09405 R09407 R09408 R10319,Aflatoxin biosynthesis; Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.175; 1.14.13.-; 1.14.14.1,NA,Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C06800  Aflatoxin B1; Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C06800  Aflatoxin B1; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Aflatoxins;     C06800  Aflatoxin B1,CAS: 1162-65-8; PubChem: 9019; ChEBI: 2504; LIPIDMAPS: LMPK10000006; KNApSAcK: C00000546; 3DMET: B05231; NIKKAJI: J5.139J,cpd:C02007; cpd:C06800; cpd:C10201; cpd:C20444,17,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O6,C17H11O6,312.0633881,313.0712131,311.0555631788,903,cpd:C16753,Aflatoxin B2,C17H14O6,Aflatoxin B2,R10320,Aflatoxin biosynthesis,1.14.13.175,NA,Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C16753  Aflatoxin B2; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Aflatoxins;     C16753  Aflatoxin B2,CAS: 7220-81-7; PubChem: 96023277; ChEBI: 48209; KNApSAcK: C00023617; NIKKAJI: J37.504G,cpd:C10407; cpd:C10471; cpd:C10516; cpd:C15100; cpd:C16418; cpd:C16753; cpd:C17784; cpd:C17785; cpd:C19584,17,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H15O6,C17H13O6,314.0790382,315.0868632,313.0712131789,904,cpd:C16754,Aflatoxin G2,C17H14O7,Aflatoxin G2,R10482,Aflatoxin biosynthesis,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C16754  Aflatoxin G2; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Aflatoxins;     C16754  Aflatoxin G2,CAS: 7241-98-7; PubChem: 96023278; ChEBI: 80705; KNApSAcK: C00023619; NIKKAJI: J9.341F,cpd:C01265; cpd:C03036; cpd:C03040; cpd:C10033; cpd:C10193; cpd:C10424; cpd:C12478; cpd:C13702; cpd:C16754; cpd:C17670,17,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H15O7,C17H13O7,330.0739528,331.0817778,329.0661278790,905,cpd:C16755,Aflatoxin G1,C17H12O7,Aflatoxin G1,R10483,Aflatoxin biosynthesis,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C16755  Aflatoxin G1; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Aflatoxins;     C16755  Aflatoxin G1,CAS: 1165-39-5; PubChem: 96023279; ChEBI: 80706; KNApSAcK: C00023618; NIKKAJI: J9.339D,cpd:C10198; cpd:C16755; cpd:C16756; cpd:C19585; cpd:C19586; cpd:C19595,17,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O7,C17H11O7,328.0583027,329.0661278,327.0504777791,906,cpd:C20444,Dihydrodemethylsterigmatocystin;,C17H12O6,Dihydrodemethylsterigmatocystin; DHDMST,R10403 R10480,Aflatoxin biosynthesis,2.1.1.109,NA,NA,PubChem: 163312181,cpd:C02007; cpd:C06800; cpd:C10201; cpd:C20444,17,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O6,C17H11O6,312.0633881,313.0712131,311.0555631792,907,cpd:C20445,Dihydrosterigmatocystin;,C18H14O6,Dihydrosterigmatocystin; DHST,R10307 R10403,Aflatoxin biosynthesis,2.1.1.109; 2.1.1.110,NA,NA,PubChem: 163312182,cpd:C10074; cpd:C17471; cpd:C20445,18,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H15O6,C18H13O6,326.0790382,327.0868632,325.0712131793,908,cpd:C20452,Norsolorinic acid;,C20H18O7,"Norsolorinic acid; Norsolorinate; 2-Hexanoyl-1,3,6,8-tetrahydroxy-9,10-anthraquinone",R10224 R10309,Aflatoxin biosynthesis,1.1.1.349; 1.13.12.20,NA,NA,CAS: 10254-99-6; PubChem: 163312189,cpd:C06654; cpd:C10887; cpd:C20452,20,18,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O7,C20H17O7,370.1052529,371.1130779,369.0974279794,909,cpd:C20453,Norsolorinic acid anthrone;,C20H20O6,"Norsolorinic acid anthrone; Noranthrone; 2-Hexanoyl-1,3,6,8-tetrahydroxyanthracen-9(10H)-one",R10224 R10239,Aflatoxin biosynthesis,1.13.12.20; 2.3.1.221,NA,NA,PubChem: 163312190,cpd:C01590; cpd:C09166; cpd:C10549; cpd:C17855; cpd:C18024; cpd:C20453; cpd:C21191,20,20,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H21O6,C20H19O6,356.1259884,357.1338134,355.1181633795,910,cpd:C20499,(1'S)-Averantin;,C20H20O7,"(1'S)-Averantin; 1,3,6,8-Tetrahydroxy-[(1S)-2-hydroxyhexyl]-9,10-anthraquinone",R10309 R10317 R10318,Aflatoxin biosynthesis,1.1.1.349; 1.14.13.174,NA,NA,PubChem: 172232248,cpd:C10186; cpd:C10190; cpd:C10883; cpd:C20499,20,20,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H21O7,C20H19O7,372.120903,373.128728,371.1130779796,911,cpd:C20500,"(1'S,5'S)-5'-Hydroxyaverantin;",C20H20O8,"(1'S,5'S)-5'-Hydroxyaverantin; (1'S,5'S)-Hydroxyaverantin",R10310 R10317,Aflatoxin biosynthesis,1.1.1.352; 1.14.13.174,NA,NA,PubChem: 172232249,cpd:C20500; cpd:C20501,20,20,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H21O8,C20H19O8,388.1158176,389.1236426,387.1079926797,912,cpd:C20501,"(1'S,5'R)-5'-Hydroxyaverantin;",C20H20O8,"(1'S,5'R)-5'-Hydroxyaverantin; (1'S,5'R)-Hydroxyaverantin",R10311 R10318,Aflatoxin biosynthesis,1.1.1.352; 1.14.13.174,NA,NA,PubChem: 172232250,cpd:C20500; cpd:C20501,20,20,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H21O8,C20H19O8,388.1158176,389.1236426,387.1079926798,913,cpd:C20502,5'-Oxoaverantin;,C20H18O8,"5'-Oxoaverantin; 1,3,6,8-Tetrahydroxy-2-[(1S)-1-hydroxy-5-oxohexyl]anthracene-9,10-dione",R10310 R10311 R10475,Aflatoxin biosynthesis,1.1.1.352; 4.2.1.142,NA,NA,PubChem: 172232251,cpd:C03503; cpd:C09922; cpd:C09924; cpd:C10446; cpd:C17958; cpd:C20502; cpd:C20504,20,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O8,C20H17O8,386.1001675,387.1079926,385.0923425799,914,cpd:C20503,1'-Hydroxyversicolorone;,C20H16O8,1'-Hydroxyversicolorone; Hydroxyversicolorone,R09756 R10476 R10477,Aflatoxin biosynthesis,1.1.1.353,NA,NA,CAS: 111975-78-1; PubChem: 172232252,cpd:C12366; cpd:C18709; cpd:C20503,20,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O8,C20H15O8,384.0845175,385.0923425,383.0766924800,915,cpd:C20504,Versicolorone,C20H18O8,Versicolorone,R09756 R10478,Aflatoxin biosynthesis,1.1.1.353,NA,NA,PubChem: 172232253,cpd:C03503; cpd:C09922; cpd:C09924; cpd:C10446; cpd:C17958; cpd:C20502; cpd:C20504,20,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O8,C20H17O8,386.1001675,387.1079926,385.0923425801,916,cpd:C20505,Versiconal hemiacetal acetate,C20H16O9,Versiconal hemiacetal acetate,R10399 R10401 R10477,Aflatoxin biosynthesis,1.1.1.353; 3.1.1.94,NA,NA,PubChem: 172232254,cpd:C12382; cpd:C20505,20,16,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O9,C20H15O9,400.0794321,401.0872571,399.0716071802,917,cpd:C20506,Versiconol acetate,C20H18O9,Versiconol acetate,R10398 R10399 R10478,Aflatoxin biosynthesis,1.1.1.353; 3.1.1.94,NA,NA,CAS: 70979-72-5; PubChem: 172232255,cpd:C04719; cpd:C10349; cpd:C20506,20,18,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O9,C20H17O9,402.0950822,403.1029072,401.0872571803,918,cpd:C20507,Versiconal,C18H14O8,Versiconal,R10400 R10401 R10402,Aflatoxin biosynthesis,1.1.1.353; 3.1.1.94; 4.2.1.143,NA,NA,PubChem: 172232256,cpd:C20507,18,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H15O8,C18H13O8,358.0688674,359.0766924,357.0610424804,919,cpd:C20508,Versiconol,C18H16O8,Versiconol,R10398 R10400,Aflatoxin biosynthesis,1.1.1.353; 3.1.1.94,NA,NA,CAS: 22268-13-9; PubChem: 172232257,cpd:C01850; cpd:C04552; cpd:C08105; cpd:C08539; cpd:C09764; cpd:C09982; cpd:C10031; cpd:C10115; cpd:C10116; cpd:C10191; cpd:C17753; cpd:C17787; cpd:C17957; cpd:C20508,18,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H17O8,C18H15O8,360.0845175,361.0923425,359.0766924805,920,cpd:C20574,"(1'S,5'S)-Averufin",C20H16O7,"(1'S,5'S)-Averufin",R10475 R10476,Aflatoxin biosynthesis,4.2.1.142,NA,NA,PubChem: 172232311,cpd:C10194; cpd:C12401; cpd:C18629; cpd:C20574,20,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O7,C20H15O7,368.0896029,369.0974279,367.0817778806,921,cpd:C20575,Versicolorin B,C18H12O7,Versicolorin B,R10402 R10479 R10480,Aflatoxin biosynthesis,4.2.1.143,NA,NA,CAS: 4331-22-0; PubChem: 172232312,cpd:C20575,18,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H13O7,C18H11O7,340.0583027,341.0661278,339.0504777807,922,cpd:C20583,Versicolorin A,C18H10O7,Versicolorin A,R10479 R10481,Aflatoxin biosynthesis,NA,NA,NA,CAS: 6807-96-1; PubChem: 172232320,cpd:C20583,18,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H11O7,C18H9O7,338.0426527,339.0504777,337.0348276808,923,cpd:C00065,L-Serine;,C3H7NO3,L-Serine; L-2-Amino-3-hydroxypropionic acid; L-3-Hydroxy-alanine; Serine,R00220 R00581 R00582 R00584 R00585 R00586 R00588 R00589; R00590 R00674 R00891 R00945 R01281 R01289 R01290 R01800; R02378 R02563 R02722 R02817 R03662 R03923 R04350 R04942; R06126 R07376 R07377 R07644 R08218 R09099 R10255 R10441; R10880 R10984 R10985 R10986,"Glycine, serine and threonine metabolism; Monobactam biosynthesis; Cysteine and methionine metabolism; Cyanoamino acid metabolism; Sphingolipid metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Sulfur metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Vancomycin resistance; ABC transporters; Sphingolipid signaling pathway; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer",1.1.1.276; 1.1.1.387; 1.4.1.7; 2.1.2.1; 2.3.1.30; 2.3.1.50; 2.6.1.45; 2.6.1.51; 2.7.1.80; 2.7.8.4; 2.7.8.8; 2.7.8.29; 2.7.8.38; 2.8.1.4; 3.1.3.3; 3.1.4.13; 3.5.1.61; 4.2.1.20; 4.2.1.22; 4.2.1.50; 4.2.1.122; 4.3.1.17; 4.3.1.19; 5.1.1.10; 5.1.1.18; 6.1.1.11; 6.3.2.14,"Serine biosynthesis, glycerate-3P => serine; Cysteine biosynthesis, serine => cysteine; Methionine degradation; Ceramide biosynthesis; Cysteine biosynthesis, homocysteine + serine => cysteine; Formaldehyde assimilation, serine pathway; Photorespiration; Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A; Cycloserine biosynthesis, arginine/serine => cycloserine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00065  Serine (Ser); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00016  L-Serine,CAS: 56-45-1; PubChem: 3365; ChEBI: 17115; ChEMBL: CHEMBL11298; KNApSAcK: C00001393; PDB-CCD: SER; 3DMET: B01145; NIKKAJI: J1.195I,cpd:C00065; cpd:C00716; cpd:C00740,3,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O3N1,C3H6O3N1,105.0425931,106.0504181,104.0347681809,924,cpd:C00078,L-Tryptophan;,C11H12N2O2,L-Tryptophan; Tryptophan; (S)-alpha-Amino-beta-(3-indolyl)-propionic acid,R00673 R00674 R00675 R00676 R00677 R00678 R00679 R00681; R00682 R00683 R00684 R00685 R01376 R01657 R01814 R02722; R03664 R05317 R07213 R08160 R08547 R09570 R09583 R09638; R10180 R10661 R11119 R11328,"Glycine, serine and threonine metabolism; Tryptophan metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Staurosporine biosynthesis; Indole alkaloid biosynthesis; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Serotonergic synapse; Protein digestion and absorption; Mineral absorption; African trypanosomiasis; Central carbon metabolism in cancer",1.3.3.10; 1.4.1.19; 1.4.3.2; 1.4.3.-; 1.13.11.11; 1.13.11.52; 1.13.12.3; 1.13.99.3; 1.14.13.125; 1.14.16.4; 1.14.19.9; 2.1.1.106; 2.5.1.34; 2.5.1.80; 2.6.1.27; 2.6.1.28; 2.6.1.99; 3.5.1.57; 4.1.1.28; 4.1.99.1; 4.2.1.20; 4.2.1.122; 4.3.1.31; 6.1.1.2,"Tryptophan biosynthesis, chorismate => tryptophan; Melatonin biosynthesis, tryptophan => serotonin => melatonin; Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate; Glucosinolate biosynthesis, tryptophan => glucobrassicin; Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A; Rebeccamycin biosynthesis, tryptophan => rebeccamycin; Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin; Staurosporine biosynthesis, tryptophan => staurosporine; Violacein biosynthesis, tryptophan => violacein",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00078  Tryptophan (Trp); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N06 PSYCHOANALEPTICS;    N06A ANTIDEPRESSANTS;     N06AX Other antidepressants;      N06AX02 Tryptophan;       D00020  Tryptophan (USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Tryptophan;     D00020  Tryptophan (USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00020  L-Tryptophan,CAS: 73-22-3; PubChem: 3378; ChEBI: 16828; ChEMBL: CHEMBL54976; KNApSAcK: C00001396; PDB-CCD: TRP; 3DMET: B01150; NIKKAJI: J9.181B,cpd:C00078; cpd:C00525; cpd:C00806; cpd:C07839; cpd:C10743; cpd:C10968; cpd:C14916,11,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O2N2,C11H11O2N2,204.0898776,205.0977027,203.0820526810,925,cpd:C00097,L-Cysteine;,C3H7NO2S,L-Cysteine; L-2-Amino-3-mercaptopropionic acid,R00782 R00891 R00892 R00893 R00894 R00895 R00896 R00897; R00899 R00900 R00901 R00903 R01001 R01113 R02409 R02508; R02743 R03217 R03260 R03524 R03650 R03923 R04230 R04231; R04859 R04870 R07274 R07360 R07460 R08168 R08608 R08632; R08653 R08659 R08666 R08685 R08848 R09562 R09591 R10409; R10670 R10672 R10736 R11014 R11015 R11524 R11528,"Glycine, serine and threonine metabolism; Cysteine and methionine metabolism; Penicillin and cephalosporin biosynthesis; Carbapenem biosynthesis; Taurine and hypotaurine metabolism; Cyanoamino acid metabolism; Glutathione metabolism; Thiamine metabolism; Pantothenate and CoA biosynthesis; Sulfur metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Sulfur relay system; Protein digestion and absorption; Central carbon metabolism in cancer",1.8.1.6; 1.8.1.9; 1.8.1.10; 1.8.3.5; 1.8.3.6; 1.8.4.3; 1.8.4.4; 1.13.11.20; 1.14.99.51; 1.14.99.52; 1.14.-.-; 2.3.2.4; 2.5.1.47; 2.5.1.48; 2.5.1.49; 2.5.1.65; 2.6.1.1; 2.6.1.3; 2.8.1.4; 2.8.1.7; 3.4.11.1; 3.4.11.2; 3.4.11.23; 3.4.13.-; 3.4.17.-; 4.2.1.22; 4.4.1.1; 4.4.1.8; 4.4.1.9; 4.4.1.10; 4.4.1.28; 5.1.1.10; 6.1.1.16; 6.3.1.13; 6.3.2.2; 6.3.2.5; 6.3.2.26,"Cysteine biosynthesis, serine => cysteine; Cysteine biosynthesis, homocysteine + serine => cysteine; Cysteine biosynthesis, methionine => cysteine; Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin; Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00097  Cysteine (Cys); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    399  Miscellaneous;     3999  Others;      D00026  L-Cysteine (JP17); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   45 Protein and amino acid based drugs;    D00026  L-Cysteine (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Cysteine;     D00026  L-Cysteine (JP17); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00026  [003614] L-Cysteine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00026  L-Cysteine,CAS: 52-90-4; PubChem: 3397; ChEBI: 17561; ChEMBL: CHEMBL863; KNApSAcK: C00001351; PDB-CCD: CYS; 3DMET: B01159; NIKKAJI: J9.167G,cpd:C00097; cpd:C00736; cpd:C00793,3,7,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O2N1S1,C3H6O2N1S1,121.0197496,122.0275747,120.0119246811,926,cpd:C00101,Tetrahydrofolate;,C19H23N7O6,"Tetrahydrofolate; 5,6,7,8-Tetrahydrofolate; Tetrahydrofolic acid; THF; (6S)-Tetrahydrofolate; (6S)-Tetrahydrofolic acid; (6S)-THFA",R00936 R00937 R00939 R00940 R00941 R00942 R00943 R00944; R00945 R00946 R01221 R01225 R01226 R01669 R02287 R02289; R02573 R02729 R02912 R03189 R03704 R03940 R04125 R04242; R04325 R04326 R04560 R06613 R07660 R08701 R09093 R09270; R09271 R10136 R10243 R10333,"Glycine, serine and threonine metabolism; One carbon pool by folate; Methane metabolism; Carbon fixation pathways in prokaryotes; Folate biosynthesis; Aminoacyl-tRNA biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Antifolate resistance",1.4.4.2; 1.5.1.3; 1.5.1.6; 1.8.1.4; 2.1.1.13; 2.1.1.19; 2.1.1.74; 2.1.1.148; 2.1.1.258; 2.1.1.269; 2.1.1.-; 2.1.2.1; 2.1.2.2; 2.1.2.3; 2.1.2.4; 2.1.2.5; 2.1.2.7; 2.1.2.8; 2.1.2.9; 2.1.2.10; 2.1.2.11; 2.1.2.13; 2.3.1.169; 3.4.19.9; 3.5.1.10; 6.3.2.17; 6.3.4.3,"Tetrahydrofolate biosynthesis, GTP => THF; C1-unit interconversion, prokaryotes; C1-unit interconversion, eukaryotes; Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway)",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00101  THF,CAS: 135-16-0; PubChem: 3401; ChEBI: 15635 20506; KNApSAcK: C00007249; PDB-CCD: THG; 3DMET: B04633; NIKKAJI: J184.393A,cpd:C00101,19,23,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H24O6N7,C19H22O6N7,445.1709815,446.1788065,444.1631565812,927,cpd:C00109,2-Oxobutanoate;,C4H6O3,2-Oxobutanoate; 2-Ketobutyric acid; 2-Oxobutyric acid; 2-Oxobutyrate; 2-Oxobutanoic acid; alpha-Ketobutyric acid; alpha-Ketobutyrate,R00654 R00993 R00994 R00995 R00996 R00997 R00998 R00999; R01000 R01001 R01199 R01283 R04673 R04770 R04930 R05840; R06987 R08637 R08648 R10991 R10992 R10996 R11098,"Glycine, serine and threonine metabolism; Cysteine and methionine metabolism; Valine, leucine and isoleucine biosynthesis; Propanoate metabolism; C5-Branched dibasic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.27; 1.1.1.85; 1.2.3.-; 1.2.4.4; 1.2.7.1; 2.2.1.6; 2.3.1.54; 2.3.3.6; 2.5.1.48; 2.6.1.42; 2.6.1.44; 3.5.99.7; 3.5.99.10; 4.1.1.3; 4.3.1.19; 4.4.1.1; 4.4.1.2; 4.4.1.11,"Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, pyruvate => 2-oxobutanoate; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00109  2-Oxobutanoate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C00109  2-Oxobutanoic acid,CAS: 600-18-0; PubChem: 3409; ChEBI: 16763 30831; ChEMBL: CHEMBL171246; LIPIDMAPS: LMFA01060002; LipidBank: DFA0386; KNApSAcK: C00019675; PDB-CCD: 2KT; 3DMET: B00028; NIKKAJI: J2.726J,cpd:C00107; cpd:C00109; cpd:C00164; cpd:C00211; cpd:C00232; cpd:C00349; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C01551; cpd:C02189; cpd:C02348; cpd:C02350; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C02847; cpd:C03011; cpd:C03135; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06002; cpd:C06395; cpd:C06396; cpd:C06805; cpd:C16116; cpd:C18904; cpd:C20254; cpd:C21030; cpd:C21172,4,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O3,C4H5O3,102.0316941,103.0395191,101.023869813,928,cpd:C00114,Choline;,C5H14NO,Choline; Bilineurine,R01021 R01022 R01023 R01025 R01026 R01027 R01028 R01029; R01030 R01310 R02381 R02542 R03075 R05739 R05794 R06871; R07377 R07386 R07409 R08212 R08557 R08558 R10285,"Glycine, serine and threonine metabolism; Glycerophospholipid metabolism; Metabolic pathways; ABC transporters; Cholinergic synapse; Bile secretion; Choline metabolism in cancer",1.1.1.1; 1.1.3.17; 1.1.99.1; 1.14.15.7; 2.3.1.6; 2.3.1.91; 2.6.-.-; 2.7.1.32; 2.7.8.24; 2.8.2.6; 3.1.1.7; 3.1.1.8; 3.1.1.49; 3.1.3.75; 3.1.4.2; 3.1.4.4; 3.1.4.41; 3.1.4.46; 3.1.6.6; 4.3.99.4,"Phosphatidylcholine (PC) biosynthesis, choline => PC; Betaine biosynthesis, choline => betaine",Pesticides [BR:br08007];  Pesticides;   Plant growth regulators;    Others;     C00114  Choline; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Choline;     C00114  Choline,CAS: 62-49-7; PubChem: 3414; ChEBI: 15354; ChEMBL: CHEMBL920; KNApSAcK: C00007298; PDB-CCD: CHT; 3DMET: B00031; NIKKAJI: J4.822D,cpd:C00114,5,14,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H15O1N1,C5H13O1N1,104.1075391,105.1153641,103.099714814,929,cpd:C00143,"5,10-Methylenetetrahydrofolate;",C20H23N7O6,"5,10-Methylenetetrahydrofolate; (6R)-5,10-Methylenetetrahydrofolate; 5,10-Methylene-THF",R00945 R01217 R01218 R01220 R01221 R01224 R01225 R01226; R01669 R01670 R02101 R03704 R04125 R06613 R07168 R09093,"Glycine, serine and threonine metabolism; One carbon pool by folate; Methane metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Antifolate resistance",1.4.4.2; 1.5.1.5; 1.5.1.15; 1.5.1.20; 1.5.7.1; 1.8.1.4; 2.1.1.45; 2.1.1.54; 2.1.1.74; 2.1.1.148; 2.1.2.1; 2.1.2.7; 2.1.2.8; 2.1.2.10; 2.1.2.11,"C1-unit interconversion, prokaryotes; C1-unit interconversion, eukaryotes; Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway)",NA,CAS: 3432-99-3; PubChem: 3443; ChEBI: 1989; KNApSAcK: C00007250; PDB-CCD: MEF MHF; 3DMET: B04640; NIKKAJI: J356.347B,cpd:C00143,20,23,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H24O6N7,C20H22O6N7,457.1709815,458.1788065,456.1631565815,930,cpd:C00168,Hydroxypyruvate;,C3H4O4,Hydroxypyruvate; Hydroxypyruvic acid; 3-Hydroxypyruvate; 3-Hydroxypyruvic acid,R00581 R00585 R00588 R01388 R01390 R01392 R01393 R01394,"Glycine, serine and threonine metabolism; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism",1.1.1.26; 1.1.1.29; 1.1.1.79; 1.1.1.81; 1.4.1.7; 2.6.1.45; 2.6.1.51; 4.1.1.40; 5.3.1.22,"Formaldehyde assimilation, serine pathway; Photorespiration",NA,CAS: 1113-60-6; PubChem: 3468; ChEBI: 17180 30841; KNApSAcK: C00007563; PDB-CCD: 3PY; 3DMET: B00049; NIKKAJI: J515.825G,cpd:C00168; cpd:C00383; cpd:C00802; cpd:C01146,3,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O4,C3H3O4,104.0109586,105.0187836,103.0031336816,931,cpd:C00188,L-Threonine;,C4H9NO3,L-Threonine; 2-Amino-3-hydroxybutyric acid,R00751 R00996 R01465 R01466 R01467 R03663 R06531 R07247; R08323 R10463 R10888 R10891 R10892,"Glycine, serine and threonine metabolism; Monobactam biosynthesis; Valine, leucine and isoleucine biosynthesis; Porphyrin and chlorophyll metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption; Mineral absorption",1.1.1.103; 2.2.1.8; 2.7.1.177; 2.7.7.87; 3.4.-.-; 4.1.2.5; 4.1.2.48; 4.2.3.1; 4.3.1.19; 5.1.1.6; 6.1.1.3; 6.3.2.-,"Threonine biosynthesis, aspartate => homoserine => threonine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00188  Threonine (Thr); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Threonine;     D00041  Threonine (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00041  L-Threonine,CAS: 72-19-5; PubChem: 3488; ChEBI: 16857; ChEMBL: CHEMBL291747; KNApSAcK: C00001394; PDB-CCD: THR; 3DMET: B01182; NIKKAJI: J21.883I,cpd:C00188; cpd:C00263; cpd:C00820; cpd:C02115; cpd:C03678; cpd:C05519; cpd:C11108; cpd:C12317; cpd:C18905,4,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O3N1,C4H8O3N1,119.0582432,120.0660682,118.0504181817,932,cpd:C00213,Sarcosine;,C3H7NO2,Sarcosine; N-Methylglycine,R00367 R00610 R00611 R01563 R01564 R01565 R01566 R05862; R07227 R07243 R10061,"Glycine, serine and threonine metabolism; Arginine and proline metabolism; Metabolic pathways",1.4.3.19; 1.5.3.1; 1.5.3.10; 1.5.8.3; 1.5.8.4; 1.21.4.3; 2.1.1.20; 2.1.1.156; 2.1.1.157; 2.1.1.162; 3.5.1.59; 3.5.3.3,NA,NA,CAS: 107-97-1; PubChem: 3513; ChEBI: 15611; ChEMBL: CHEMBL304383; PDB-CCD: SAR; 3DMET: B01190; NIKKAJI: J5.067I,cpd:C00041; cpd:C00097; cpd:C00099; cpd:C00133; cpd:C00213; cpd:C00736; cpd:C00793; cpd:C01401; cpd:C01537; cpd:C01962; cpd:C02116; cpd:C05688; cpd:C11488,3,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O2N1,C3H6O2N1,89.04767847,90.0555035,88.03985344818,933,cpd:C00263,L-Homoserine;,C4H9NO3,L-Homoserine; 2-Amino-4-hydroxybutyric acid,R00175 R01771 R01773 R01775 R01776 R01777,"Glycine, serine and threonine metabolism; Cysteine and methionine metabolism; Lysine biosynthesis; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids",1.1.1.3; 2.3.1.31; 2.3.1.46; 2.7.1.39; 3.3.1.2,"Methionine biosynthesis, apartate => homoserine => methionine; Threonine biosynthesis, aspartate => homoserine => threonine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00263  L-Homoserine,CAS: 672-15-1; PubChem: 3561; ChEBI: 15699; ChEMBL: CHEMBL11722; KNApSAcK: C00001366; PDB-CCD: HSE; 3DMET: B01202; NIKKAJI: J9.199E,cpd:C00188; cpd:C00263; cpd:C00820; cpd:C02115; cpd:C03678; cpd:C05519; cpd:C11108; cpd:C12317; cpd:C18905,4,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O3N1,C4H8O3N1,119.0582432,120.0660682,118.0504181819,934,cpd:C00300,Creatine;,C4H9N3O2,Creatine; alpha-Methylguanidino acetic acid; Methylglycocyamine,R01566 R01881 R01882 R01883 R01884,"Glycine, serine and threonine metabolism; Arginine and proline metabolism; Metabolic pathways",2.1.1.2; 2.7.3.2; 3.5.2.10; 3.5.3.3; 3.9.1.1,Creatine pathway,NA,CAS: 57-00-1; PubChem: 3594; ChEBI: 16919; ChEMBL: CHEMBL283800; PDB-CCD: CRN; 3DMET: B00084; NIKKAJI: J9.321A,cpd:C00300; cpd:C03065,4,9,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O2N3,C4H8O2N3,131.0694765,132.0773016,130.0616515820,935,cpd:C00430,5-Aminolevulinate;,C5H9NO3,5-Aminolevulinate; 5-Amino-4-oxopentanoate; 5-Amino-4-oxovaleric acid,R00036 R00830 R02271 R02272,"Glycine, serine and threonine metabolism; Porphyrin and chlorophyll metabolism; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; ABC transporters",2.3.1.37; 2.6.1.43; 4.2.1.24; 5.4.3.8,"Heme biosynthesis, glutamate => protoheme/siroheme",Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01X OTHER ANTINEOPLASTIC AGENTS;     L01XD Sensitizers used in photodynamic/radiation therapy;      L01XD04 Aminolevulinic acid;       D07567  Aminolevulinic acid,CAS: 106-60-5; PubChem: 3719; ChEBI: 17549; ChEMBL: CHEMBL601; LIPIDMAPS: LMFA01100055; KNApSAcK: C00007378; 3DMET: B00110; NIKKAJI: J38.537I,cpd:C00430; cpd:C01015; cpd:C01073; cpd:C01110; cpd:C01157; cpd:C01165; cpd:C03341; cpd:C03440; cpd:C03651; cpd:C03741; cpd:C05147; cpd:C06809; cpd:C12876; cpd:C19706,5,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O3N1,C5H8O3N1,131.0582432,132.0660682,130.0504181821,936,cpd:C00441,L-Aspartate 4-semialdehyde;,C4H7NO3,L-Aspartate 4-semialdehyde; Aspartate beta-semialdehyde; L-Aspartic 4-semialdehyde,R01773 R01775 R02291 R02293 R06977 R08568 R08650 R09079; R09080 R09805 R10147 R10673,"Glycine, serine and threonine metabolism; Monobactam biosynthesis; Cysteine and methionine metabolism; Lysine biosynthesis; Arginine and proline metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.3; 1.2.1.11; 1.2.1.-; 1.5.1.43; 2.2.1.10; 2.6.1.46; 2.6.1.76; 4.1.2.56; 4.3.3.7,"Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Methionine biosynthesis, apartate => homoserine => methionine; Threonine biosynthesis, aspartate => homoserine => threonine; Ectoine biosynthesis, aspartate => ectoine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,PubChem: 3730; ChEBI: 13086 18051; ChEMBL: CHEMBL404100; KNApSAcK: C00007469; 3DMET: B00117; NIKKAJI: J457.019G,cpd:C00441; cpd:C03214; cpd:C03508; cpd:C20250,4,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H8O3N1,C4H6O3N1,117.0425931,118.0504181,116.0347681822,937,cpd:C00546,Methylglyoxal;,C3H4O2,Methylglyoxal; Pyruvaldehyde; Pyruvic aldehyde; 2-Ketopropionaldehyde; 2-Oxopropanal,R00203 R00205 R01016 R02260 R02527 R02528 R02529 R02530; R02531 R07183 R09796 R10049 R10050 R10715 R10718 R11352,"Glycine, serine and threonine metabolism; Pyruvate metabolism; Propanoate metabolism; Microbial metabolism in diverse environments",1.1.1.6; 1.1.1.21; 1.1.1.78; 1.1.1.79; 1.1.1.283; 1.1.1.-; 1.2.1.22; 1.2.1.23; 1.2.1.49; 1.2.3.15; 1.4.3.4; 1.4.3.21; 1.13.11.50; 2.2.1.11; 4.2.1.130; 4.2.3.3; 4.4.1.5,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00546  Methylglyoxal,CAS: 78-98-8; PubChem: 3827; ChEBI: 17158; ChEMBL: CHEMBL170721; KNApSAcK: C00007562; 3DMET: B00127; NIKKAJI: J1.489C,cpd:C00511; cpd:C00546; cpd:C01271; cpd:C03129; cpd:C05146; cpd:C05197; cpd:C08734; cpd:C18600; cpd:C19246; cpd:C19297; cpd:C19440; cpd:C19501; cpd:C21430,3,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O2,C3H3O2,72.02112937,73.0289544,71.01330434823,938,cpd:C00576,Betaine aldehyde,C5H12NO,Betaine aldehyde,R01022 R01025 R02565 R02566 R07409 R08211 R08557 R08558,"Glycine, serine and threonine metabolism; Metabolic pathways",1.1.1.1; 1.1.3.17; 1.1.99.1; 1.2.1.8; 1.14.15.7,"Betaine biosynthesis, choline => betaine",NA,CAS: 7418-61-3; PubChem: 3855; ChEBI: 15710; ChEMBL: CHEMBL1231491; PDB-CCD: BTL; 3DMET: B00136; NIKKAJI: J413.989E,cpd:C00576,5,12,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O1N1,C5H11O1N1,102.091889,103.099714,101.084064824,939,cpd:C00581,Guanidinoacetate;,C3H7N3O2,Guanidinoacetate; Guanidinoacetic acid; Glycocyamine; N-Amidinoglycine; Guanidoacetic acid,R00565 R00775 R01883 R02575,"Glycine, serine and threonine metabolism; Arginine and proline metabolism; Metabolic pathways",2.1.1.2; 2.1.4.1; 2.7.3.1; 3.5.3.2,Creatine pathway,NA,CAS: 352-97-6; PubChem: 3860; ChEBI: 16344; ChEMBL: CHEMBL281593; PDB-CCD: NMG; 3DMET: B00139; NIKKAJI: J4.504G,cpd:C00581; cpd:C19178,3,7,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O2N3,C3H6O2N3,117.0538265,118.0616515,116.0460014825,940,cpd:C00719,Betaine;,C5H11NO2,"Betaine; Trimethylaminoacetate; Glycine betaine; N,N,N-Trimethylglycine; Trimethylammonioacetate",R02565 R02566 R02821 R07228 R07244 R08211 R08212 R10061; R10062,"Glycine, serine and threonine metabolism; Metabolic pathways; ABC transporters",1.1.3.17; 1.2.1.8; 1.21.4.4; 2.1.1.5; 2.1.1.157; 2.1.1.161; 2.1.1.162,"Betaine biosynthesis, choline => betaine","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;    A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;     A16AA Amino acids and derivatives;      A16AA06 Betaine;       D07523  Betaine (JAN); USP drug classification [BR:br08302];  Enzyme Replacement/Modifiers;   Betaine;    D07523  Betaine (JAN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    399  Miscellaneous;     3999  Others;      D07523  Betaine (JAN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Betaine;     D07523  Betaine (JAN); New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D07523; New drug approvals in Japan [br08318.html];  Drugs with new active ingredients;   D07523; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D07523; Major components of natural products [BR:br08323];  Crude drugs;   Lycium fruit;    C00719  Betaine",CAS: 107-43-7; PubChem: 3985; ChEBI: 17750; ChEMBL: CHEMBL95889; KNApSAcK: C00007291; PDB-CCD: BET; 3DMET: B01318; NIKKAJI: J5.058J,cpd:C00073; cpd:C00183; cpd:C00431; cpd:C00719; cpd:C00855; cpd:C01733; cpd:C01799; cpd:C01826; cpd:C03571; cpd:C05335; cpd:C06417; cpd:C07418; cpd:C07457; cpd:C15987; cpd:C16436,5,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O2N1,C5H10O2N1,117.0789786,118.0868036,116.0711536826,941,cpd:C00740,D-Serine,C3H7NO3,D-Serine,R00221 R00589 R02853 R02854 R09595,"Glycine, serine and threonine metabolism; Metabolic pathways; Vancomycin resistance; Taste transduction",3.1.3.3; 4.3.1.18; 5.1.1.10; 5.1.1.18; 6.3.2.35,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00740  D-Serine,CAS: 312-84-5; PubChem: 4003; ChEBI: 16523; ChEMBL: CHEMBL285123; PDB-CCD: DSN; 3DMET: B00163; NIKKAJI: J1.196G,cpd:C00065; cpd:C00716; cpd:C00740,3,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O3N1,C3H6O3N1,105.0425931,106.0504181,104.0347681827,942,cpd:C00986,"1,3-Diaminopropane;",C3H10N2,"1,3-Diaminopropane; Trimethylenediamine; 1,3-Propanediamine; Propane-1,3-diamine",R01914 R01915 R01919 R03139 R03271 R05329 R07479 R07650; R09075 R09080,"Glycine, serine and threonine metabolism; Arginine and proline metabolism; beta-Alanine metabolism; Microbial metabolism in diverse environments",1.4.3.21; 1.4.3.22; 1.5.1.43; 1.5.3.14; 1.5.3.15; 1.5.99.6; 2.5.1.23; 2.5.1.44; 2.5.1.45; 2.5.1.46; 4.1.1.86,NA,NA,CAS: 109-76-2; PubChem: 4233; ChEBI: 15725; ChEMBL: CHEMBL174324; KNApSAcK: C00007404; PDB-CCD: 13D; 3DMET: B00214; NIKKAJI: J1.969K,cpd:C00986,3,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H11N2,C3H9N2,74.08439833,75.09222336,73.0765733828,943,cpd:C01005,O-Phospho-L-serine;,C3H8NO6P,O-Phospho-L-serine; L-O-Phosphoserine; 3-Phosphoserine; Dexfosfoserine,R00582 R00584 R04173 R07274 R08576 R09530 R10610,"Glycine, serine and threonine metabolism; Cysteine and methionine metabolism; Methane metabolism; Aminoacyl-tRNA biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids",2.5.1.65; 2.5.1.76; 2.5.1.113; 2.6.1.52; 2.7.1.80; 3.1.3.3; 6.1.1.27,"Serine biosynthesis, glycerate-3P => serine",NA,CAS: 407-41-0; PubChem: 4251; ChEBI: 15811; ChEMBL: CHEMBL284377; KNApSAcK: C00007287; PDB-CCD: SEP; 3DMET: B01366; NIKKAJI: J136.545B,cpd:C01005; cpd:C02532,3,8,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O6N1P1,C3H7O6N1P1,185.008924,186.016749,184.0010989829,944,cpd:C01026,"N,N-Dimethylglycine;",C4H9NO2,"N,N-Dimethylglycine; Dimethylglycine",R01564 R01565 R02821 R07243 R07244 R10060,"Glycine, serine and threonine metabolism; Metabolic pathways",1.5.3.10; 1.5.8.4; 2.1.1.5; 2.1.1.156; 2.1.1.157; 2.1.1.161; 2.1.1.162,NA,NA,CAS: 1118-68-9; PubChem: 4271; ChEBI: 17724; PDB-CCD: DMG; 3DMET: B00224; NIKKAJI: J135.420E,cpd:C00155; cpd:C00334; cpd:C01026; cpd:C01205; cpd:C02261; cpd:C02356; cpd:C02721; cpd:C03284; cpd:C03665; cpd:C05145; cpd:C05330; cpd:C05689; cpd:C05698; cpd:C11109; cpd:C11735; cpd:C19514,4,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O2N1,C4H8O2N1,103.0633285,104.0711536,102.0555035830,945,cpd:C01102,O-Phospho-L-homoserine,C4H10NO6P,O-Phospho-L-homoserine,R01466 R01771,"Glycine, serine and threonine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of amino acids",2.7.1.39; 4.2.3.1,"Threonine biosynthesis, aspartate => homoserine => threonine",NA,PubChem: 4336; ChEBI: 15961; KNApSAcK: C00007385; 3DMET: B01380; NIKKAJI: J2.731.281K,cpd:C01102; cpd:C05702; cpd:C12147; cpd:C12215,4,10,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O6N1P1,C4H9O6N1P1,199.024574,200.0323991,198.016749831,947,cpd:C01726,D-Lombricine,C6H15N4O6P,D-Lombricine,R02854 R03691,"Glycine, serine and threonine metabolism",2.7.3.5,NA,NA,PubChem: 4863; ChEBI: 32969; 3DMET: B01489; NIKKAJI: J2.733.996D,cpd:C01726; cpd:C14177,6,15,6,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H16O6N4P1,C6H14O6N4P1,270.0729212,271.0807462,269.0650962832,948,cpd:C01888,Aminoacetone;,C3H7NO,Aminoacetone; 1-Amino-2-propanone,R02529 R03758 R03759 R10852,"Glycine, serine and threonine metabolism",1.1.1.75; 1.1.1.381; 1.4.3.4; 1.4.3.21,NA,NA,CAS: 298-08-8; PubChem: 5001; ChEBI: 17906; 3DMET: B00367; NIKKAJI: J38.126H,cpd:C01888; cpd:C01995; cpd:C03134; cpd:C05665,3,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O1N1,C3H6O1N1,73.05276385,74.06058888,72.04493882833,950,cpd:C02291,L-Cystathionine,C7H14N2O4S,L-Cystathionine,R01001 R01286 R01290 R03217 R03260 R08632 R10305,"Glycine, serine and threonine metabolism; Cysteine and methionine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",2.5.1.48; 2.5.1.134; 4.2.1.22; 4.4.1.1; 4.4.1.8,"Methionine biosynthesis, apartate => homoserine => methionine; Methionine degradation; Cysteine biosynthesis, homocysteine + serine => cysteine; Cysteine biosynthesis, methionine => cysteine",NA,CAS: 56-88-2; PubChem: 5347; ChEBI: 17482; KNApSAcK: C00007498; 3DMET: B01559; NIKKAJI: J4.574H,cpd:C00542; cpd:C02291; cpd:C18646; cpd:C18906,7,14,4,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O4N2S1,C7H13O4N2S1,222.0674281,223.0752531,221.0596031834,952,cpd:C02855,N-Phospho-D-lombricine,C6H16N4O9P2,N-Phospho-D-lombricine,R03691,"Glycine, serine and threonine metabolism",2.7.3.5,NA,NA,PubChem: 5793; ChEBI: 35265; 3DMET: B01606; NIKKAJI: J2.740.230E,cpd:C02855; cpd:C14178,6,16,9,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H17O9N4P2,C6H15O9N4P2,350.0392521,351.0470771,349.0314271835,954,cpd:C03082,4-Phospho-L-aspartate;,C4H8NO7P,4-Phospho-L-aspartate; L-4-Aspartyl phosphate,R00480 R02291,"Glycine, serine and threonine metabolism; Monobactam biosynthesis; Cysteine and methionine metabolism; Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.2.1.11; 2.7.2.4,"Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Methionine biosynthesis, apartate => homoserine => methionine; Threonine biosynthesis, aspartate => homoserine => threonine; Ectoine biosynthesis, aspartate => ectoine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,CAS: 22138-53-0; PubChem: 5980; ChEBI: 15836; KNApSAcK: C00007471; PDB-CCD: PHD; 3DMET: B01629; NIKKAJI: J37.493H,cpd:C03082; cpd:C07335,4,8,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O7N1P1,C4H7O7N1P1,213.0038386,214.0116636,211.9960136836,955,cpd:C03194,(R)-1-Aminopropan-2-ol;,C3H9NO,(R)-1-Aminopropan-2-ol; (R)-1-Amino-2-propanol,R03759 R05226 R07302,"Glycine, serine and threonine metabolism; Porphyrin and chlorophyll metabolism",1.1.1.75; 3.5.1.90; 6.3.1.10,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C03194  Aminopropanol,CAS: 2799-16-8; PubChem: 6071; ChEBI: 15675; PDB-CCD: FOP; 3DMET: B00555; NIKKAJI: J9.255J,cpd:C01104; cpd:C03194; cpd:C05771,3,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H10O1N1,C3H8O1N1,75.06841391,76.07623895,74.06058888837,956,cpd:C03232,3-Phosphonooxypyruvate;,C3H5O7P,3-Phosphonooxypyruvate; 3-Phosphonooxypyruvic acid; 3-Phosphohydroxypyruvate; 3-Phosphohydroxypyruvic acid,R01513 R04173,"Glycine, serine and threonine metabolism; Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids",1.1.1.95; 2.6.1.52,"Serine biosynthesis, glycerate-3P => serine",NA,PubChem: 6103; ChEBI: 18110 30933; KNApSAcK: C00019657; PDB-CCD: HPV; 3DMET: B00565; NIKKAJI: J2.180.747H,cpd:C03232,3,5,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H6O7P1,C3H4O7P1,183.9772895,184.9851145,182.9694645838,957,cpd:C03283,"L-2,4-Diaminobutanoate;",C4H10N2O2,"L-2,4-Diaminobutanoate; alpha,gamma-Diaminobutyrate; L-2,4-Diaminobutyrate",R02293 R06977 R06978 R07650 R09801,"Glycine, serine and threonine metabolism; Metabolic pathways; Microbial metabolism in diverse environments; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",2.3.1.178; 2.6.1.46; 2.6.1.76; 3.5.1.-; 4.1.1.86,"Ectoine biosynthesis, aspartate => ectoine",NA,CAS: 1758-80-1; PubChem: 6142; ChEBI: 48950; ChEMBL: CHEMBL321357; KNApSAcK: C00001353 C00034868; PDB-CCD: DAB; 3DMET: B00574; NIKKAJI: J80.310C,cpd:C03283; cpd:C08291,4,10,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O2N2,C4H9O2N2,118.0742276,119.0820526,117.0664025839,958,cpd:C03508,L-2-Amino-3-oxobutanoic acid;,C4H7NO3,L-2-Amino-3-oxobutanoic acid; L-2-Amino-3-oxobutanoate; L-2-Amino-acetoacetate; (S)-2-Amino-3-oxobutanoic acid,R00371 R01465 R03758 R10851,"Glycine, serine and threonine metabolism",1.1.1.103; 1.1.1.381; 2.3.1.29,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C03508  L-2-Amino-3-oxobutanoic acid,PubChem: 6318; ChEBI: 16944 40673; LIPIDMAPS: LMFA01060172; PDB-CCD: AKB; 3DMET: B00594; NIKKAJI: J2.359.951A,cpd:C00441; cpd:C03214; cpd:C03508; cpd:C20250,4,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H8O3N1,C4H6O3N1,117.0425931,118.0504181,116.0347681840,959,cpd:C05519,L-Allothreonine;,C4H9NO3,L-Allothreonine; L-allo-Threonine,R06171 R10851 R10852,"Glycine, serine and threonine metabolism; Metabolic pathways",1.1.1.381; 4.1.2.48; 4.1.2.49,NA,NA,CAS: 28954-12-3; PubChem: 7864; ChEBI: 28718; ChEMBL: CHEMBL1734340 CHEMBL59238; PDB-CCD: ALO; 3DMET: B01870; NIKKAJI: J1.327G,cpd:C00188; cpd:C00263; cpd:C00820; cpd:C02115; cpd:C03678; cpd:C05519; cpd:C11108; cpd:C12317; cpd:C18905,4,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O3N1,C4H8O3N1,119.0582432,120.0660682,118.0504181841,960,cpd:C06231,Ectoine;,C6H10N2O2,Ectoine; L-Ectoine,R06979 R08050 R09800,"Glycine, serine and threonine metabolism; Metabolic pathways; Microbial metabolism in diverse environments",1.14.11.-; 4.2.1.108,"Ectoine biosynthesis, aspartate => ectoine",NA,CAS: 96702-03-3; PubChem: 8474; ChEBI: 27592; PDB-CCD: 4CS; 3DMET: B05179; NIKKAJI: J648.947H,cpd:C03023; cpd:C05205; cpd:C06231; cpd:C21377,6,10,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O2N2,C6H9O2N2,142.0742276,143.0820526,141.0664025842,961,cpd:C06442,N(gamma)-Acetyldiaminobutyrate;,C6H12N2O3,"N(gamma)-Acetyldiaminobutyrate; N4-Acetyl-L-2,4-diaminobutyrate; N4-Acetyl-L-2,4-diaminobutanoate",R06978 R06979,"Glycine, serine and threonine metabolism; Metabolic pathways; Microbial metabolism in diverse environments",2.3.1.178; 4.2.1.108,"Ectoine biosynthesis, aspartate => ectoine",NA,PubChem: 8676; ChEBI: 7351; 3DMET: B02029; NIKKAJI: J80.071F,cpd:C00993; cpd:C03153; cpd:C03922; cpd:C06442; cpd:C10996; cpd:C19929,6,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O3N2,C6H11O3N2,160.0847923,161.0926173,159.0769672843,962,cpd:C16432,5-Hydroxyectoine,C6H10N2O3,5-Hydroxyectoine,R08050,"Glycine, serine and threonine metabolism; Microbial metabolism in diverse environments",1.14.11.-,NA,NA,PubChem: 47205729; ChEBI: 49432; PDB-CCD: 6CS; NIKKAJI: J2.662.228J,cpd:C01109; cpd:C03625; cpd:C03895; cpd:C15653; cpd:C16432; cpd:C21378,6,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O3N2,C6H9O3N2,158.0691422,159.0769672,157.0613172844,963,cpd:C19929,"N-alpha-Acetyl-L-2,4-diaminobutyrate",C6H12N2O3,"N-alpha-Acetyl-L-2,4-diaminobutyrate",R09800 R09801,"Glycine, serine and threonine metabolism; Metabolic pathways",3.5.1.-,NA,NA,PubChem: 135626395,cpd:C00993; cpd:C03153; cpd:C03922; cpd:C06442; cpd:C10996; cpd:C19929,6,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O3N2,C6H11O3N2,160.0847923,161.0926173,159.0769672845,964,cpd:C00019,S-Adenosyl-L-methionine;,C15H22N6O5S,S-Adenosyl-L-methionine; S-Adenosylmethionine; AdoMet; SAM,R00075 R00175 R00177 R00178 R00179 R00180 R00367 R00380; R00594 R00595 R00596 R00597 R00598 R00599 R00600 R00601; R00649 R00650 R00683 R00827 R00984 R01078 R01153 R01159; R01169 R01188 R01189 R01190 R01235 R01239 R01269 R01320; R01349 R01721 R01883 R01942 R01972 R01973 R02037 R02056; R02144 R02155 R02157 R02174 R02175 R02379 R02384 R02533; R02534 R02572 R02623 R02627 R02667 R02671 R02808 R02858; R02859 R02862 R02882 R02910 R02917 R02920 R02931 R02961; R02982 R03003 R03019 R03072 R03111 R03112 R03130 R03194; R03229 R03231 R03304 R03366 R03410 R03411 R03424 R03456; R03472 R03554 R03571 R03587 R03623 R03633 R03701 R03721; R03725 R03726 R03731 R03746 R03788 R03805 R03832 R03835; R03875 R03922 R03934 R03938 R03943 R03948 R03950 R03955; R04013 R04033 R04062 R04077 R04145 R04169 R04190 R04237; R04301 R04332 R04396 R04398 R04421 R04427 R04436 R04481; R04496 R04505 R04691 R04692 R04705 R04707 R04710 R04711; R04713 R04714 R04715 R04716 R04717 R04718 R04719 R04762; R04763 R04764 R04772 R04858 R04866 R04867 R04881 R04887; R04905 R04931 R04981 R04983 R04988 R04990 R04993 R04994; R05035 R05122 R05123 R05149 R05162 R05179 R05180 R05181; R05182 R05211 R05212 R05213 R05214 R05216 R05219 R05303; R05323 R05520 R05532 R05614 R05673 R05674 R05676 R05754; R05755 R05756 R05757 R05759 R05760 R05763 R05764 R05776; R05808 R05809 R05810 R05811 R05813 R05834 R05881 R05885; R06268 R06269 R06270 R06427 R06439 R06456 R06476 R06477; R06478 R06479 R06564 R06574 R06575 R06576 R06577 R06578; R06627 R06675 R06680 R06687 R06693 R06703 R06713 R06715; R06719 R06767 R06771 R06774 R06778 R06794 R06807 R06815; R06816 R06824 R06859 R06868 R06869 R06895 R06998 R07232; R07233 R07234 R07235 R07236 R07237 R07238 R07239 R07240; R07241 R07242 R07243 R07244 R07251 R07330 R07375 R07481; R07501 R07504 R07521 R07524 R07527 R07529 R07533 R07535; R07722 R07724 R07750 R07767 R07768 R07773 R07774 R07775; R07917 R07919 R07920 R07921 R07922 R08147 R08151 R08236; R08239 R08246 R08410 R08437 R08441 R08446 R08449 R08455; R08465 R08467 R08468 R08469 R08479 R08537 R08538 R08547; R08583 R08588 R08769 R08771 R08774 R08781 R08787 R08788; R08789 R08791 R08794 R08803 R08804 R08862 R08873 R08875; R08893 R08932 R08933 R08939 R08940 R08973 R08987 R09063; R09072 R09073 R09177 R09189 R09191 R09200 R09369 R09370; R09371 R09394 R09396 R09523 R09543 R09569 R09611 R09612; R09613 R09637 R09639 R09678 R09679 R09736 R09737 R09791; R09792 R09821 R09822 R09823 R09856 R09870 R09871 R09872; R09939 R09940 R10060 R10061 R10062 R10166 R10167 R10168; R10169 R10195 R10196 R10197 R10198 R10199 R10204 R10246; R10250 R10251 R10252 R10306 R10307 R10403 R10404 R10431; R10447 R10448 R10449 R10450 R10451 R10452 R10454 R10455; R10472 R10491 R10492 R10495 R10497 R10498 R10523 R10524; R10526 R10529 R10552 R10586 R10587 R10588 R10605 R10606; R10611 R10645 R10646 R10647 R10649 R10650 R10651 R10652; R10653 R10654 R10658 R10667 R10680 R10709 R10710 R10716; R10806 R10812 R10824 R10881 R10956 R10957 R10958 R10959; R10962 R10963 R10964 R11020 R11041 R11045 R11112 R11165; R11191 R11192 R11193 R11216 R11217 R11218 R11219 R11220; R11221 R11230 R11274 R11275 R11292 R11293 R11294 R11371; R11413 R11416 R11445 R11452 R11453 R11469 R11476 R11484; R11494 R11507 R11508 R11509 R11520 R11521 R11533 R11534; R11545 R11546,Monobactam biosynthesis; Cysteine and methionine metabolism; Arginine and proline metabolism; Zeatin biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids; Sulfur relay system,1.1.99.38; 1.3.98.3; 1.16.1.8; 1.17.98.2; 1.21.98.1; 1.21.98.3; 1.97.1.4; 2.1.1.1; 2.1.1.2; 2.1.1.4; 2.1.1.6; 2.1.1.7; 2.1.1.8; 2.1.1.9; 2.1.1.10; 2.1.1.11; 2.1.1.12; 2.1.1.15; 2.1.1.16; 2.1.1.17; 2.1.1.18; 2.1.1.20; 2.1.1.22; 2.1.1.25; 2.1.1.26; 2.1.1.27; 2.1.1.28; 2.1.1.33; 2.1.1.34; 2.1.1.35; 2.1.1.37; 2.1.1.38; 2.1.1.39; 2.1.1.40; 2.1.1.41; 2.1.1.42; 2.1.1.43; 2.1.1.44; 2.1.1.47; 2.1.1.49; 2.1.1.50; 2.1.1.53; 2.1.1.55; 2.1.1.56; 2.1.1.57; 2.1.1.59; 2.1.1.60; 2.1.1.61; 2.1.1.62; 2.1.1.64; 2.1.1.65; 2.1.1.67; 2.1.1.68; 2.1.1.69; 2.1.1.70; 2.1.1.71; 2.1.1.72; 2.1.1.75; 2.1.1.76; 2.1.1.77; 2.1.1.78; 2.1.1.79; 2.1.1.80; 2.1.1.82; 2.1.1.83; 2.1.1.84; 2.1.1.85; 2.1.1.87; 2.1.1.88; 2.1.1.89; 2.1.1.91; 2.1.1.94; 2.1.1.95; 2.1.1.96; 2.1.1.97; 2.1.1.98; 2.1.1.99; 2.1.1.100; 2.1.1.101; 2.1.1.102; 2.1.1.103; 2.1.1.104; 2.1.1.105; 2.1.1.106; 2.1.1.107; 2.1.1.108; 2.1.1.109; 2.1.1.110; 2.1.1.111; 2.1.1.112; 2.1.1.113; 2.1.1.114; 2.1.1.115; 2.1.1.116; 2.1.1.117; 2.1.1.118; 2.1.1.119; 2.1.1.120; 2.1.1.121; 2.1.1.122; 2.1.1.123; 2.1.1.127; 2.1.1.128; 2.1.1.129; 2.1.1.130; 2.1.1.131; 2.1.1.132; 2.1.1.133; 2.1.1.136; 2.1.1.137; 2.1.1.139; 2.1.1.140; 2.1.1.141; 2.1.1.142; 2.1.1.143; 2.1.1.144; 2.1.1.145; 2.1.1.146; 2.1.1.147; 2.1.1.150; 2.1.1.151; 2.1.1.152; 2.1.1.153; 2.1.1.154; 2.1.1.155; 2.1.1.156; 2.1.1.157; 2.1.1.158; 2.1.1.159; 2.1.1.160; 2.1.1.161; 2.1.1.162; 2.1.1.163; 2.1.1.164; 2.1.1.165; 2.1.1.169; 2.1.1.171; 2.1.1.172; 2.1.1.173; 2.1.1.174; 2.1.1.175; 2.1.1.181; 2.1.1.182; 2.1.1.183; 2.1.1.184; 2.1.1.187; 2.1.1.188; 2.1.1.195; 2.1.1.196; 2.1.1.197; 2.1.1.201; 2.1.1.202; 2.1.1.203; 2.1.1.204; 2.1.1.210; 2.1.1.212; 2.1.1.222; 2.1.1.228; 2.1.1.231; 2.1.1.232; 2.1.1.234; 2.1.1.235; 2.1.1.236; 2.1.1.237; 2.1.1.238; 2.1.1.239; 2.1.1.240; 2.1.1.241; 2.1.1.243; 2.1.1.254; 2.1.1.255; 2.1.1.261; 2.1.1.262; 2.1.1.263; 2.1.1.267; 2.1.1.270; 2.1.1.271; 2.1.1.273; 2.1.1.274; 2.1.1.275; 2.1.1.276; 2.1.1.277; 2.1.1.278; 2.1.1.279; 2.1.1.281; 2.1.1.282; 2.1.1.283; 2.1.1.284; 2.1.1.285; 2.1.1.286; 2.1.1.287; 2.1.1.288; 2.1.1.289; 2.1.1.290; 2.1.1.291; 2.1.1.292; 2.1.1.293; 2.1.1.294; 2.1.1.295; 2.1.1.296; 2.1.1.297; 2.1.1.298; 2.1.1.300; 2.1.1.302; 2.1.1.303; 2.1.1.304; 2.1.1.305; 2.1.1.306; 2.1.1.307; 2.1.1.308; 2.1.1.314; 2.1.1.315; 2.1.1.316; 2.1.1.317; 2.1.1.319; 2.1.1.320; 2.1.1.321; 2.1.1.322; 2.1.1.323; 2.1.1.324; 2.1.1.325; 2.1.1.326; 2.1.1.327; 2.1.1.328; 2.1.1.329; 2.1.1.330; 2.1.1.331; 2.1.1.332; 2.1.1.333; 2.1.1.334; 2.1.1.335; 2.1.1.336; 2.1.1.-; 2.3.1.161; 2.3.1.184; 2.3.1.228; 2.3.1.229; 2.3.1.231; 2.3.1.244; 2.5.1.4; 2.5.1.6; 2.5.1.24; 2.5.1.25; 2.5.1.38; 2.5.1.43; 2.5.1.63; 2.5.1.77; 2.5.1.94; 2.5.1.108; 2.5.1.114; 2.5.1.120; 2.6.1.62; 2.8.1.6; 2.8.1.8; 2.8.4.3; 2.8.4.4; 2.8.4.5; 2.-.-.-; 3.3.1.2; 4.1.1.50; 4.1.3.44; 4.1.99.17; 4.1.99.19; 4.1.99.22; 4.3.1.30; 4.4.1.14; 4.7.1.1; 6.3.2.40,"Methionine salvage pathway; Methionine degradation; Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine; Ethylene biosynthesis, methionine => ethylene; Cysteine biosynthesis, methionine => cysteine",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00019  SAM,CAS: 29908-03-0; PubChem: 3321; ChEBI: 15414 67040; ChEMBL: CHEMBL1088977 CHEMBL1235831 CHEMBL224120; KNApSAcK: C00007347; PDB-CCD: SAM; 3DMET: B04620; NIKKAJI: J23.293I,cpd:C00019,15,22,5,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O5N6S1,C15H21O5N6S1,398.137239,399.145064,397.129414846,965,cpd:C00927,Isonocardicin A;,C23H24N4O9,Isonocardicin A; 1-Azetidineacetic acid,R03072 R03073,Monobactam biosynthesis; Biosynthesis of antibiotics,2.5.1.38; 5.1.1.14,"Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",NA,PubChem: 4180; ChEBI: 16483; NIKKAJI: J2.731.006K,cpd:C00927; cpd:C01941; cpd:C17350,23,24,9,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H25O9N4,C23H23O9N4,500.1543284,501.1621534,499.1465033847,966,cpd:C01739,Nocardicin E,C19H17N3O7,Nocardicin E,R03072 R10903,Monobactam biosynthesis; Biosynthesis of antibiotics,2.5.1.38,"Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",NA,CAS: 63555-59-9; PubChem: 4874; ChEBI: 29091; NIKKAJI: J19.574J,cpd:C01739; cpd:C17354,19,17,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H18O7N3,C19H16O7N3,399.1066499,400.1144749,398.0988249848,967,cpd:C01941,Nocardicin A,C23H24N4O9,Nocardicin A,R03073 R10882,Monobactam biosynthesis; Biosynthesis of antibiotics; Cephalosporins - parenteral agents,1.14.13.-; 5.1.1.14,"Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",Compounds with biological roles [BR:br08001];  Antibiotics;   beta-Lactams;    Monobactams;     C01941  Nocardicin A,CAS: 39391-39-4; PubChem: 5045; ChEBI: 17711; KNApSAcK: C00018088; NIKKAJI: J17.397E,cpd:C00927; cpd:C01941; cpd:C17350,23,24,9,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H25O9N4,C23H23O9N4,500.1543284,501.1621534,499.1465033849,968,cpd:C03198,(S)-4-Hydroxymandelate;,C8H8O4,(S)-4-Hydroxymandelate; (S)-2-Hydroxy-2-(4-hydroxyphenyl)acetate; L-4-Hydroxymandelate; L-p-Hydroxymandelate,R02673 R03794 R04160 R04161 R06632 R06633,Monobactam biosynthesis; Aminobenzoate degradation; Biosynthesis of vancomycin group antibiotics; Microbial metabolism in diverse environments; Biosynthesis of antibiotics,1.1.3.19; 1.1.3.46; 1.1.99.31; 1.13.11.46; 1.14.16.6; 5.1.2.2,NA,NA,PubChem: 6075; ChEBI: 17210 32802; PDB-CCD: HHH; 3DMET: B00557; NIKKAJI: J74.174D,cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272,8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O4,C8H7O4,168.0422587,169.0500838,167.0344337850,969,cpd:C03590,4-Hydroxyphenylglyoxylate;,C8H6O4,4-Hydroxyphenylglyoxylate; 4-Hydroxybenzoylformate; 4-Hydroxyphenylglyoxylic acid; 2-(4-Hydroxyphenyl)-2-oxoacetate,R02672 R04160 R04234 R06626 R06633,Monobactam biosynthesis; Aminobenzoate degradation; Biosynthesis of vancomycin group antibiotics; Microbial metabolism in diverse environments; Biosynthesis of antibiotics,1.1.3.46; 1.1.99.31; 2.6.1.72; 2.6.1.103; 4.1.1.7,NA,NA,CAS: 15573-67-8; PubChem: 6381; ChEBI: 28719; ChEMBL: CHEMBL129918; 3DMET: B00609; NIKKAJI: J410.258D,cpd:C01606; cpd:C03590; cpd:C06337; cpd:C14096; cpd:C14100; cpd:C19240,8,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O4,C8H5O4,166.0266087,167.0344337,165.0187836851,970,cpd:C03972,"2,3,4,5-Tetrahydrodipicolinate;",C7H9NO4,"2,3,4,5-Tetrahydrodipicolinate; Delta1-Piperidine-2,6-dicarboxylate; L-2,3,4,5-Tetrahydrodipicolinate; (S)-2,3,4,5-Tetrahydropyridine-2,6-dicarboxylate",R04198 R04199 R04336 R04364 R04365 R07613,Monobactam biosynthesis; Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids,1.17.1.8; 2.3.1.89; 2.3.1.117; 2.3.1.-; 2.6.1.83,"Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,PubChem: 6692; ChEBI: 16845 864; KNApSAcK: C00007502; 3DMET: B01707; NIKKAJI: J603.133A,cpd:C03972; cpd:C12108; cpd:C17356; cpd:C21249,7,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O4N1,C7H8O4N1,171.0531578,172.0609828,170.0453327852,971,cpd:C05539,N-Acetyl-L-2-amino-6-oxopimelate;,C9H13NO6,N-Acetyl-L-2-amino-6-oxopimelate; L-2-Acetamido-6-oxoheptanedioate; L-2-Acetamido-6-oxopimelate,R04364 R04467 R10884,Monobactam biosynthesis; Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids,2.3.1.89; 2.3.1.-; 2.6.1.-,"Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine",NA,PubChem: 7878; ChEBI: 17355; 3DMET: B00788; NIKKAJI: J788.070G,cpd:C05539; cpd:C05932,9,13,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O6N1,C9H12O6N1,231.0742871,232.0821122,230.0664621853,972,cpd:C12323,L-4-Hydroxyphenylglycine,C8H9NO3,L-4-Hydroxyphenylglycine,R06626 R10880,Monobactam biosynthesis; Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,2.6.1.103,"Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",Target-based classification of drugs [BR:br08310];  Enzymes;   Transferases;    carnitine palmitoyltransferase (CPT) 1;     Oxfenicine;      D05292  Oxfenicine (USAN/INN),CAS: 32462-30-9; PubChem: 582713; ChEBI: 31755; PDB-CCD: D4P; 3DMET: B04451; NIKKAJI: J17.730J,cpd:C00250; cpd:C03493; cpd:C03986; cpd:C05831; cpd:C06051; cpd:C12323; cpd:C14170; cpd:C14171; cpd:C20821,8,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O3N1,C8H8O3N1,167.0582432,168.0660682,166.0504181854,973,cpd:C16842,SQ 26180,C6H10N2O6S,SQ 26180,NA,Monobactam biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96023366; ChEBI: 80766; ChEMBL: CHEMBL1205337; NIKKAJI: J39.232D,cpd:C16842,6,10,6,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6N2S1,C6H9O6N2S1,238.0259572,239.0337823,237.0181322855,974,cpd:C17351,Nocardicin C,C23H26N4O8,Nocardicin C,R10882 R10883,Monobactam biosynthesis; Biosynthesis of antibiotics,1.14.13.-; 5.1.1.14,"Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",NA,CAS: 59511-12-5; PubChem: 96023704; ChEBI: 81021; NIKKAJI: J12.900C,cpd:C17351; cpd:C17352,23,26,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H27O8N4,C23H25O8N4,486.1750638,487.1828888,485.1672388856,975,cpd:C17352,Isonocardicin C,C23H26N4O8,Isonocardicin C,R10881 R10883,Monobactam biosynthesis; Biosynthesis of antibiotics,2.5.1.38; 5.1.1.14,"Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",NA,PubChem: 96023705; ChEBI: 81022; NIKKAJI: J2.806.282F,cpd:C17351; cpd:C17352,23,26,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H27O8N4,C23H25O8N4,486.1750638,487.1828888,485.1672388857,976,cpd:C17355,Nocardicin G,C19H19N3O6,Nocardicin G,R10880 R10881 R10903,Monobactam biosynthesis; Biosynthesis of antibiotics,2.5.1.38,"Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A",NA,CAS: 65309-11-7; PubChem: 96023708; ChEBI: 81024; NIKKAJI: J19.575H,cpd:C17355,19,19,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H20O6N3,C19H18O6N3,385.1273853,386.1352104,384.1195603858,977,cpd:C20258,"(2S,4S)-4-Hydroxy-2,3,4,5-tetrahydrodipicolinate;",C7H9NO5,"(2S,4S)-4-Hydroxy-2,3,4,5-tetrahydrodipicolinate; (2S,4S)-4-Hydroxy-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate; HTPA",R04198 R04199 R10147,Monobactam biosynthesis; Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids,1.17.1.8; 4.3.3.7,"Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,PubChem: 163311998; ChEMBL: CHEMBL1668237,cpd:C01215; cpd:C20258,7,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O5N1,C7H8O5N1,187.0480724,188.0558974,186.0402474859,978,cpd:C20911,C20911;,C10H13NO8,C20911; Tabtoxin biosynthesis intermediate 1,R10884 R10885,Monobactam biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 254741374,cpd:C11107; cpd:C20911,10,13,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O8N1,C10H12O8N1,275.0641164,276.0719414,274.0562913860,979,cpd:C20912,C20912;,C10H16N2O7,C20912; Tabtoxin biosynthesis intermediate 2,R10885 R10886,Monobactam biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 254741375,cpd:C01425; cpd:C05282; cpd:C20912,10,16,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O7N2,C10H15O7N2,276.0957509,277.1035759,275.0879258861,980,cpd:C20913,C20913;,C8H14N2O6,C20913; Tabtoxin biosynthesis intermediate 3,R10886 R10887,Monobactam biosynthesis; Biosynthesis of antibiotics,4.1.1.-,NA,NA,PubChem: 254741376,cpd:C20913; cpd:C21396,8,14,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O6N2,C8H13O6N2,234.0851862,235.0930112,233.0773611862,981,cpd:C20914,C20914;,C7H14N2O4,C20914; Tabtoxin biosynthesis intermediate 4,R10887 R10888,Monobactam biosynthesis; Biosynthesis of antibiotics,4.1.1.-,NA,NA,PubChem: 254741377,cpd:C00542; cpd:C00666; cpd:C00680; cpd:C02291; cpd:C05699; cpd:C08275; cpd:C18646; cpd:C18906; cpd:C20914,7,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O4N2,C7H13O4N2,190.0953569,191.103182,189.0875319863,982,cpd:C20915,C20915;,C11H21N3O6,C20915; Tabtoxin biosynthesis intermediate 5,R10888 R10889,Monobactam biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 254741378,cpd:C20915,11,21,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H22O6N3,C11H20O6N3,291.1430354,292.1508604,290.1352104864,983,cpd:C20916,C20916;,C11H19N3O5,C20916; Tabtoxin biosynthesis intermediate 6,R10889 R10890,Monobactam biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 254741379,cpd:C20916,11,19,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H20O5N3,C11H18O5N3,273.1324707,274.1402958,272.1246457865,984,cpd:C20917,Tabtoxin;,C11H19N3O6,Tabtoxin; beta-Tabtoxin,R10890 R10891 R10892 R10895,Monobactam biosynthesis; Biosynthesis of antibiotics,3.4.-.-; 6.3.2.-,NA,NA,PubChem: 254741380,cpd:C04544; cpd:C11347; cpd:C20917; cpd:C20919; cpd:C21016,11,19,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H20O6N3,C11H18O6N3,289.1273853,290.1352104,288.1195603866,985,cpd:C20918,Tabtoxinine-beta-lactam,C7H12N2O4,Tabtoxinine-beta-lactam,R10891 R10892 R10893 R10894,Monobactam biosynthesis; Biosynthesis of antibiotics,2.3.1.-; 3.4.-.-; 6.3.2.-,NA,NA,PubChem: 254741381,cpd:C11490; cpd:C20918; cpd:C20920,7,12,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O4N2,C7H11O4N2,188.0797069,189.0875319,187.0718818867,986,cpd:C20919,Isotabtoxin;,C11H19N3O6,Isotabtoxin; delta-Tabtoxin,R10895,Monobactam biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 254741382,cpd:C04544; cpd:C11347; cpd:C20917; cpd:C20919; cpd:C21016,11,19,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H20O6N3,C11H18O6N3,289.1273853,290.1352104,288.1195603868,987,cpd:C20920,Tabtoxinine-delta-lactam,C7H12N2O4,Tabtoxinine-delta-lactam,R10894,Monobactam biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 254741383,cpd:C11490; cpd:C20918; cpd:C20920,7,12,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O4N2,C7H11O4N2,188.0797069,189.0875319,187.0718818869,988,cpd:C20921,N1-Acetyl-tabtoxinine-beta-lactam,C9H14N2O5,N1-Acetyl-tabtoxinine-beta-lactam,R10893,Monobactam biosynthesis; Biosynthesis of antibiotics,2.3.1.-,NA,NA,PubChem: 254741384,cpd:C20921,9,14,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O5N2,C9H13O5N2,230.0902716,231.0980966,229.0824465870,989,cpd:C20927,Sulfazecin;,C12H20N4O9S,Sulfazecin; SQ 26445,NA,Monobactam biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,CAS: 77912-79-9; PubChem: 254741390,cpd:C20927,12,20,9,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H21O9N4S1,C12H19O9N4S1,396.0950994,397.1029244,395.0872744871,990,cpd:C20928,MM 42842,C13H22N4O9S,MM 42842,NA,Monobactam biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,CAS: 113784-28-4; PubChem: 254741391,cpd:C20928,13,22,9,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C13H23O9N4S1,C13H21O9N4S1,410.1107495,411.1185745,409.1029244872,992,cpd:C00021,S-Adenosyl-L-homocysteine;,C14H20N6O5S,S-Adenosyl-L-homocysteine; S-Adenosylhomocysteine,R00192 R00193 R00194 R00367 R00380 R00594 R00595 R00596; R00597 R00598 R00599 R00600 R00601 R00649 R00650 R00683; R00827 R00984 R01153 R01159 R01169 R01188 R01189 R01190; R01235 R01239 R01269 R01320 R01349 R01721 R01883 R01942; R01972 R01973 R02037 R02056 R02144 R02155 R02157 R02174; R02175 R02379 R02384 R02533 R02534 R02572 R02623 R02627; R02667 R02671 R02808 R02858 R02859 R02862 R02882 R02910; R02917 R02920 R02931 R02961 R02982 R03003 R03111 R03112; R03130 R03194 R03229 R03304 R03366 R03410 R03411 R03424; R03456 R03554 R03571 R03587 R03623 R03633 R03701 R03721; R03725 R03731 R03746 R03788 R03805 R03832 R03835 R03875; R03922 R03934 R03938 R03943 R03948 R03950 R03955 R04013; R04033 R04062 R04077 R04145 R04169 R04190 R04237 R04301; R04332 R04396 R04398 R04421 R04427 R04436 R04481 R04496; R04505 R04691 R04692 R04705 R04707 R04711 R04713 R04714; R04715 R04716 R04717 R04718 R04719 R04762 R04763 R04764; R04772 R04858 R04866 R04867 R04881 R04887 R04905 R04931; R04981 R04983 R04988 R04990 R04993 R04994 R05035 R05122; R05123 R05149 R05162 R05179 R05180 R05181 R05182 R05211; R05212 R05213 R05214 R05216 R05219 R05303 R05323 R05520; R05532 R05614 R05673 R05674 R05676 R05754 R05755 R05756; R05757 R05759 R05760 R05763 R05764 R05776 R05808 R05809; R05810 R05811 R05813 R05834 R05881 R05885 R06427 R06439; R06456 R06476 R06477 R06478 R06479 R06564 R06574 R06575; R06576 R06577 R06578 R06627 R06675 R06680 R06687 R06693; R06703 R06713 R06715 R06719 R06767 R06771 R06774 R06778; R06794 R06807 R06815 R06816 R06824 R06859 R06868 R06869; R06998 R07232 R07233 R07234 R07235 R07236 R07237 R07238; R07239 R07240 R07241 R07242 R07243 R07244 R07251 R07330; R07375 R07481 R07501 R07504 R07521 R07524 R07527 R07529; R07533 R07535 R07722 R07724 R07750 R07773 R07774 R07775; R07917 R07919 R07920 R07921 R07922 R08147 R08151 R08236; R08239 R08246 R08410 R08437 R08441 R08446 R08449 R08455; R08465 R08467 R08468 R08469 R08479 R08537 R08538 R08547; R08769 R08771 R08774 R08781 R08787 R08788 R08789 R08791; R08794 R08803 R08804 R08932 R08933 R08973 R08987 R09063; R09073 R09177 R09189 R09191 R09200 R09369 R09370 R09371; R09523 R09543 R09569 R09611 R09612 R09613 R09678 R09679; R09736 R09737 R09791 R09792 R09821 R09822 R09823 R09856; R09870 R09871 R09872 R09939 R09940 R10060 R10061 R10062; R10166 R10167 R10168 R10169 R10195 R10196 R10197 R10198; R10199 R10250 R10251 R10252 R10306 R10307 R10403 R10404; R10431 R10447 R10448 R10449 R10450 R10451 R10452 R10454; R10472 R10491 R10492 R10495 R10497 R10498 R10523 R10524; R10586 R10587 R10588 R10605 R10606 R10645 R10647 R10649; R10651 R10652 R10654 R10658 R10680 R10709 R10710 R10716; R10806 R10812 R10824 R10956 R10957 R10958 R10959 R10962; R10963 R10964 R11020 R11041 R11045 R11165 R11191 R11192; R11193 R11216 R11217 R11218 R11219 R11220 R11221 R11230; R11292 R11371 R11413 R11416 R11445 R11452 R11453 R11469; R11476 R11507 R11508 R11509 R11520 R11521 R11533 R11534; R11545 R11546,Cysteine and methionine metabolism; Metabolic pathways; Biosynthesis of amino acids,1.16.1.8; 2.1.1.1; 2.1.1.2; 2.1.1.4; 2.1.1.6; 2.1.1.7; 2.1.1.8; 2.1.1.9; 2.1.1.10; 2.1.1.11; 2.1.1.12; 2.1.1.15; 2.1.1.16; 2.1.1.17; 2.1.1.18; 2.1.1.20; 2.1.1.22; 2.1.1.25; 2.1.1.26; 2.1.1.27; 2.1.1.28; 2.1.1.33; 2.1.1.34; 2.1.1.35; 2.1.1.37; 2.1.1.38; 2.1.1.39; 2.1.1.40; 2.1.1.41; 2.1.1.42; 2.1.1.43; 2.1.1.44; 2.1.1.47; 2.1.1.49; 2.1.1.50; 2.1.1.53; 2.1.1.55; 2.1.1.56; 2.1.1.57; 2.1.1.59; 2.1.1.60; 2.1.1.61; 2.1.1.62; 2.1.1.64; 2.1.1.65; 2.1.1.67; 2.1.1.68; 2.1.1.69; 2.1.1.70; 2.1.1.71; 2.1.1.72; 2.1.1.75; 2.1.1.76; 2.1.1.77; 2.1.1.78; 2.1.1.79; 2.1.1.80; 2.1.1.82; 2.1.1.83; 2.1.1.84; 2.1.1.85; 2.1.1.87; 2.1.1.88; 2.1.1.89; 2.1.1.91; 2.1.1.94; 2.1.1.95; 2.1.1.96; 2.1.1.97; 2.1.1.98; 2.1.1.99; 2.1.1.100; 2.1.1.101; 2.1.1.102; 2.1.1.103; 2.1.1.104; 2.1.1.105; 2.1.1.106; 2.1.1.107; 2.1.1.108; 2.1.1.109; 2.1.1.110; 2.1.1.111; 2.1.1.112; 2.1.1.113; 2.1.1.114; 2.1.1.115; 2.1.1.116; 2.1.1.117; 2.1.1.118; 2.1.1.119; 2.1.1.120; 2.1.1.121; 2.1.1.122; 2.1.1.123; 2.1.1.127; 2.1.1.128; 2.1.1.129; 2.1.1.130; 2.1.1.131; 2.1.1.132; 2.1.1.133; 2.1.1.136; 2.1.1.137; 2.1.1.139; 2.1.1.140; 2.1.1.141; 2.1.1.142; 2.1.1.143; 2.1.1.144; 2.1.1.145; 2.1.1.146; 2.1.1.147; 2.1.1.150; 2.1.1.151; 2.1.1.152; 2.1.1.153; 2.1.1.154; 2.1.1.155; 2.1.1.156; 2.1.1.157; 2.1.1.158; 2.1.1.159; 2.1.1.160; 2.1.1.161; 2.1.1.162; 2.1.1.163; 2.1.1.164; 2.1.1.165; 2.1.1.169; 2.1.1.171; 2.1.1.172; 2.1.1.173; 2.1.1.174; 2.1.1.175; 2.1.1.181; 2.1.1.182; 2.1.1.183; 2.1.1.184; 2.1.1.187; 2.1.1.188; 2.1.1.195; 2.1.1.196; 2.1.1.197; 2.1.1.201; 2.1.1.202; 2.1.1.203; 2.1.1.204; 2.1.1.210; 2.1.1.212; 2.1.1.222; 2.1.1.228; 2.1.1.231; 2.1.1.232; 2.1.1.234; 2.1.1.235; 2.1.1.236; 2.1.1.237; 2.1.1.238; 2.1.1.239; 2.1.1.240; 2.1.1.241; 2.1.1.243; 2.1.1.254; 2.1.1.255; 2.1.1.261; 2.1.1.262; 2.1.1.263; 2.1.1.267; 2.1.1.270; 2.1.1.271; 2.1.1.273; 2.1.1.274; 2.1.1.275; 2.1.1.276; 2.1.1.277; 2.1.1.278; 2.1.1.279; 2.1.1.281; 2.1.1.282; 2.1.1.283; 2.1.1.284; 2.1.1.285; 2.1.1.286; 2.1.1.287; 2.1.1.288; 2.1.1.289; 2.1.1.290; 2.1.1.291; 2.1.1.292; 2.1.1.293; 2.1.1.294; 2.1.1.295; 2.1.1.296; 2.1.1.297; 2.1.1.298; 2.1.1.300; 2.1.1.302; 2.1.1.303; 2.1.1.304; 2.1.1.305; 2.1.1.306; 2.1.1.307; 2.1.1.314; 2.1.1.315; 2.1.1.316; 2.1.1.317; 2.1.1.319; 2.1.1.320; 2.1.1.321; 2.1.1.322; 2.1.1.323; 2.1.1.324; 2.1.1.325; 2.1.1.327; 2.1.1.328; 2.1.1.329; 2.1.1.330; 2.1.1.331; 2.1.1.332; 2.1.1.333; 2.1.1.334; 2.1.1.335; 2.1.1.336; 2.1.1.-; 2.3.1.161; 2.3.1.231; 2.3.1.244; 2.8.4.3; 2.8.4.4; 2.8.4.5; 2.-.-.-; 3.2.2.9; 3.3.1.1; 3.5.4.28; 6.3.2.40,"Methionine degradation; Cysteine biosynthesis, methionine => cysteine",NA,CAS: 979-92-0; PubChem: 3323; ChEBI: 16680; ChEMBL: CHEMBL142828 CHEMBL418052; KNApSAcK: C00007230; PDB-CCD: SAH SAO; 3DMET: B01134; NIKKAJI: J14.397I,cpd:C00021,14,20,5,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C14H21O5N6S1,C14H19O5N6S1,384.1215889,385.129414,383.1137639873,993,cpd:C00051,Glutathione;,C10H17N3O6S,Glutathione; 5-L-Glutamyl-L-cysteinylglycine; N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine; gamma-L-Glutamyl-L-cysteinyl-glycine; GSH; Reduced glutathione,R00094 R00115 R00120 R00274 R00494 R00497 R00499 R00527; R00547 R00900 R01108 R01109 R01110 R01111 R01113 R01262; R01292 R01736 R01875 R01917 R01918 R02530 R02824 R03059; R03082 R03167 R03522 R03822 R03915 R03956 R03984 R04039; R04090 R04860 R05267 R05269 R05402 R05403 R05714 R05717; R05748 R06982 R07002 R07003 R07004 R07023 R07024 R07025; R07026 R07034 R07035 R07069 R07070 R07083 R07084 R07091; R07092 R07093 R07094 R07100 R07113 R07116 R07124 R08280; R08350 R08351 R08352 R08353 R08354 R08355 R08511 R08512; R08677 R08678 R09338 R09367 R09368 R09409 R11411,Cysteine and methionine metabolism; Glutathione metabolism; Metabolic pathways; ABC transporters; Thyroid hormone synthesis; Bile secretion,1.5.4.1; 1.8.1.7; 1.8.1.9; 1.8.1.10; 1.8.3.3; 1.8.4.1; 1.8.4.2; 1.8.4.3; 1.8.4.4; 1.8.4.7; 1.8.4.9; 1.8.5.1; 1.11.1.9; 1.11.1.12; 1.13.11.18; 1.20.4.2; 2.3.2.2; 2.3.2.15; 2.5.1.18; 2.5.1.-; 2.8.1.3; 3.1.2.6; 3.1.2.7; 3.1.2.12; 3.1.2.13; 3.4.19.13; 3.5.1.78; 3.5.1.-; 4.4.1.5; 4.4.1.20; 4.4.1.22; 4.4.1.34; 6.3.1.8; 6.3.1.9; 6.3.2.3,"Glutathione biosynthesis, glutamate => glutathione",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00051  Glutathione; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  V VARIOUS;   V03 ALL OTHER THERAPEUTIC PRODUCTS;    V03A ALL OTHER THERAPEUTIC PRODUCTS;     V03AB Antidotes;      V03AB32 Glutathione;       D00014  Glutathione (JP17); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   13  Agents affecting sensory organs;    131  Ophthalmic agents;     1319  Others;      D00014  Glutathione (JP17);  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    392  Antidotes;     3922  Glutathiones;      D00014  Glutathione (JP17); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00014  Glutathione; Endocrine and hormonal agents [br08373.html];  Other gynecological agents;   D00014; Dermatological agents [br08370.html];  Non-steroidal injection;   D00014; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   967  Agents for liver disease and antidotes;    9676  Other amino acid and preparations;     C00051  Glutathione,CAS: 70-18-8; PubChem: 3353; ChEBI: 16856; ChEMBL: CHEMBL1514919 CHEMBL1543 CHEMBL31464; KNApSAcK: C00001518; PDB-CCD: GSH; 3DMET: B01138; NIKKAJI: J10.686K,cpd:C00051; cpd:C02755; cpd:C18871,10,17,6,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O6N3S1,C10H16O6N3S1,307.0838065,308.0916315,306.0759814874,994,cpd:C00073,L-Methionine;,C5H11NO2S,L-Methionine; Methionine; L-2-Amino-4methylthiobutyric acid,R00177 R00648 R00649 R00650 R00651 R00652 R00653 R00654; R00655 R00656 R00657 R00946 R01078 R02025 R02821 R03472; R03659 R04153 R04405 R04710 R06268 R06269 R06270 R06895; R07396 R07606 R07608 R07767 R07768 R08583 R08588 R08618; R08635 R08862 R08873 R08875 R08893 R09373 R09394 R09396; R09637 R09639 R10204 R10246 R10430 R10552 R10645 R10646; R10649 R10650 R10652 R10653 R10667 R11063 R11112 R11274; R11275 R11293 R11294 R11484,Cysteine and methionine metabolism; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; Antifolate resistance; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer,1.1.99.38; 1.3.98.3; 1.4.3.2; 1.8.4.11; 1.8.4.13; 1.8.4.14; 1.17.98.2; 1.21.98.1; 1.21.98.3; 1.97.1.4; 2.1.1.3; 2.1.1.5; 2.1.1.10; 2.1.1.12; 2.1.1.13; 2.1.1.14; 2.1.1.280; 2.1.1.308; 2.1.1.326; 2.1.1.-; 2.5.1.6; 2.5.1.49; 2.5.1.63; 2.5.1.77; 2.5.1.94; 2.5.1.120; 2.6.1.5; 2.6.1.57; 2.6.1.73; 2.6.1.88; 2.6.1.-; 2.8.1.6; 2.8.1.8; 2.8.4.3; 2.8.4.4; 2.8.4.5; 3.4.13.12; 3.5.1.31; 4.1.1.57; 4.1.3.44; 4.1.99.17; 4.1.99.19; 4.1.99.22; 4.3.1.30; 4.4.1.11; 4.7.1.1; 5.1.1.2; 6.1.1.10,"Methionine biosynthesis, apartate => homoserine => methionine; Methionine salvage pathway; Methionine degradation; Ethylene biosynthesis, methionine => ethylene; Cysteine biosynthesis, methionine => cysteine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00073  Methionine (Met); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  V VARIOUS;   V03 ALL OTHER THERAPEUTIC PRODUCTS;    V03A ALL OTHER THERAPEUTIC PRODUCTS;     V03AB Antidotes;      V03AB26 Methionine;       D00019  Methionine (USP); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    392  Antidotes;     3929  Others;      D00019  Methionine (USP); L-Methionine (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Methionine;     D00019  Methionine (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00019  [001621] L-Methionine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00019  L-Methionine,CAS: 63-68-3; PubChem: 3373; ChEBI: 16643; ChEMBL: CHEMBL42336; KNApSAcK: C00001379; PDB-CCD: MET; 3DMET: B01148; NIKKAJI: J9.174J,cpd:C00073; cpd:C00855; cpd:C01733; cpd:C07418,5,11,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O2N1S1,C5H10O2N1S1,149.0510498,150.0588748,148.0432247875,996,cpd:C00155,L-Homocysteine;,C4H9NO2S,L-Homocysteine; L-2-Amino-4-mercaptobutyric acid; Homocysteine,R00192 R00650 R00946 R01283 R01286 R01287 R01288 R01289; R01290 R01291 R01292 R02026 R02821 R04153 R04405 R08633; R10305 R11063,Cysteine and methionine metabolism; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids; Antifolate resistance; NOD-like receptor signaling pathway,1.8.4.1; 2.1.1.3; 2.1.1.5; 2.1.1.10; 2.1.1.13; 2.1.1.14; 2.5.1.48; 2.5.1.49; 2.5.1.134; 2.5.1.-; 3.3.1.1; 4.2.1.22; 4.4.1.2; 4.4.1.8; 4.4.1.21,"Methionine biosynthesis, apartate => homoserine => methionine; Methionine degradation; Cysteine biosynthesis, homocysteine + serine => cysteine; Cysteine biosynthesis, methionine => cysteine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00155  L-Homocysteine,CAS: 6027-13-0; PubChem: 3455; ChEBI: 17588; ChEMBL: CHEMBL469662; KNApSAcK: C00001365; PDB-CCD: HCS; 3DMET: B01174; NIKKAJI: J228C,cpd:C00155; cpd:C05330,4,9,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O2N1S1,C4H8O2N1S1,135.0353997,136.0432247,134.0275747876,997,cpd:C00170,5'-Methylthioadenosine;,C11H15N5O3S,5'-Methylthioadenosine; Methylthioadenosine; S-Methyl-5'-thioadenosine; 5-Methylthioadenosine; 5'-Deoxy-5'-(methylthio)adenosine; Thiomethyladenosine; MTA,R00075 R00175 R00179 R00180 R01401 R01402 R01920 R02869; R03019 R03072 R03271 R03726 R08359 R08939 R08940 R09072; R09531 R09660 R10338 R10455 R10526 R10529 R10611 R10881; R11088 R11089 R11154 R11159 R11160,Cysteine and methionine metabolism; Zeatin biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways,2.3.1.184; 2.3.1.228; 2.3.1.229; 2.4.2.28; 2.5.1.4; 2.5.1.16; 2.5.1.22; 2.5.1.23; 2.5.1.24; 2.5.1.25; 2.5.1.38; 2.5.1.43; 2.5.1.79; 2.5.1.104; 2.5.1.108; 2.5.1.114; 2.5.1.126; 2.5.1.127; 2.5.1.128; 3.2.2.9; 3.2.2.16; 3.3.1.2; 3.5.4.31; 4.4.1.14,Methionine salvage pathway,NA,CAS: 2457-80-9; PubChem: 3470; ChEBI: 17509; ChEMBL: CHEMBL277041 CHEMBL603295; PDB-CCD: MTA; 3DMET: B01178; NIKKAJI: J22.737D,cpd:C00170,11,15,3,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H16O3N5S1,C11H14O3N5S1,297.0895605,298.0973856,296.0817355877,1000,cpd:C00409,Methanethiol;,CH4S,Methanethiol; Methylmercaptan,R00651 R00654 R01851 R08635 R09786 R09997 R10001 R10936; R10946 R11546,Cysteine and methionine metabolism; Sulfur metabolism,1.8.3.4; 1.14.13.131; 2.1.1.251; 2.1.1.334; 2.5.1.49; 4.2.1.155; 4.4.1.11,NA,NA,CAS: 74-93-1; PubChem: 3699; ChEBI: 16007; KNApSAcK: C00001258; PDB-CCD: MEE; 3DMET: B00105; NIKKAJI: J1.432J,cpd:C00409; cpd:C02704; cpd:C08087; cpd:C08091; cpd:C11145; cpd:C12560; cpd:C13167; cpd:C13168; cpd:C13524; cpd:C14053; cpd:C14054; cpd:C14055; cpd:C14415; cpd:C18361; cpd:C19432; cpd:C21398,1,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C1H5S1,C1H3S1,48.0033713,49.01119634,46.99554627878,1001,cpd:C00491,L-Cystine;,C6H12N2O4S2,L-Cystine; L-Dicysteine; L-alpha-Diamino-beta-dithiolactic acid,R00892 R01113 R02408 R02409,Cysteine and methionine metabolism; ABC transporters; Protein digestion and absorption,1.8.1.6; 1.8.4.3; 1.8.4.4; 4.4.1.1; 4.4.1.8,NA,Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Cystine;     D03636  Cystine (USAN/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D03636  [103758] L-Cystine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D03636  L-Cystine,CAS: 56-89-3; PubChem: 3774; ChEBI: 16283; ChEMBL: CHEMBL590540; KNApSAcK: C00001352; 3DMET: B01265; NIKKAJI: J9.172C,cpd:C00491; cpd:C01420,6,12,4,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O4N2S2,C6H11O4N2S2,240.0238492,241.0316743,239.0160242879,1002,cpd:C00506,L-Cysteate;,C3H7NO5S,L-Cysteate; L-Cysteic acid; 3-Sulfoalanine; 2-Amino-3-sulfopropionic acid,R00901 R01682 R02433 R02434 R07634 R08699 R09530,Cysteine and methionine metabolism; Taurine and hypotaurine metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction,2.5.1.76; 2.6.1.1; 4.1.1.15; 4.1.1.29; 4.4.1.10; 4.4.1.25,NA,NA,CAS: 13100-82-8; PubChem: 3789; ChEBI: 17285; PDB-CCD: OCS; 3DMET: B01274; NIKKAJI: J8.084E,cpd:C00506,3,7,5,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O5N1S1,C3H6O5N1S1,169.0044935,170.0123185,167.9966685880,1003,cpd:C00606,3-Sulfino-L-alanine;,C3H7NO4S,3-Sulfino-L-alanine; L-Cysteinesulfinic acid; 3-Sulphino-L-alanine; 3-Sulfinoalanine,R00863 R00893 R02434 R02466 R02618 R02619,Cysteine and methionine metabolism; Taurine and hypotaurine metabolism; Metabolic pathways,1.4.1.-; 1.13.11.20; 2.6.1.1; 4.1.1.12; 4.1.1.15; 4.1.1.29,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00606  3-Sulfino-L-alanine,CAS: 1115-65-7; PubChem: 3881; ChEBI: 16345; ChEMBL: CHEMBL1160508; PDB-CCD: CSD; 3DMET: B01293; NIKKAJI: J36.785K,cpd:C00606,3,7,4,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O4N1S1,C3H6O4N1S1,153.0095789,154.0174039,152.0017539881,1004,cpd:C00793,D-Cysteine;,C3H7NO2S,D-Cysteine; D-Amino-3-mercaptopropionic acid,R00903 R01874,Cysteine and methionine metabolism,4.4.1.15; 5.1.1.10,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00793  D-Cysteine,CAS: 921-01-7; PubChem: 4051; ChEBI: 16375; ChEMBL: CHEMBL171281; KNApSAcK: C00007323; PDB-CCD: DCY; 3DMET: B01332; NIKKAJI: J9.202I,cpd:C00097; cpd:C00736; cpd:C00793,3,7,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O2N1S1,C3H6O2N1S1,121.0197496,122.0275747,120.0119246882,1005,cpd:C00957,Mercaptopyruvate;,C3H4O3S,Mercaptopyruvate; 3-Mercaptopyruvic acid; 3-Mercaptopyruvate,R00895 R00896 R03104 R03105 R03106,Cysteine and methionine metabolism; Metabolic pathways,1.1.1.27; 2.6.1.1; 2.6.1.3; 2.8.1.2,NA,NA,CAS: 2464-23-5; PubChem: 4208; ChEBI: 16208; KNApSAcK: C00007464; 3DMET: B00208; NIKKAJI: J72.997C,cpd:C00957; cpd:C18618,3,4,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O3S1,C3H3O3S1,119.9881152,120.9959402,118.9802901883,1006,cpd:C00979,O-Acetyl-L-serine;,C5H9NO4,O-Acetyl-L-serine; O3-Acetyl-L-serine,R00586 R00897 R03131 R03132 R03133 R03134 R03601 R04091; R04859 R10305 R10461 R10839 R10840,Cysteine and methionine metabolism; Zeatin biosynthesis; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Biosynthesis of amino acids; Sulfur relay system,2.3.1.30; 2.5.1.47; 2.5.1.49; 2.5.1.50; 2.5.1.51; 2.5.1.52; 2.5.1.53; 2.5.1.65; 2.5.1.118; 2.5.1.119; 2.5.1.134; 2.6.99.3,"Cysteine biosynthesis, serine => cysteine; Cycloserine biosynthesis, arginine/serine => cycloserine",NA,CAS: 5147-00-2; PubChem: 4228; ChEBI: 17981; KNApSAcK: C00007459; PDB-CCD: OAS; 3DMET: B00213; NIKKAJI: J37.500D,cpd:C00025; cpd:C00217; cpd:C00302; cpd:C00979; cpd:C03618; cpd:C03727; cpd:C03790; cpd:C05574; cpd:C05938; cpd:C05941; cpd:C12269,5,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O4N1,C5H8O4N1,147.0531578,148.0609828,146.0453327884,1007,cpd:C01077,O-Acetyl-L-homoserine;,C6H11NO4,O-Acetyl-L-homoserine; O-Acetylhomoserine,R00651 R01287 R01776 R02026 R03217 R04945,Cysteine and methionine metabolism; Metabolic pathways; Biosynthesis of antibiotics,2.3.1.31; 2.5.1.48; 2.5.1.49,NA,NA,CAS: 7540-67-2; PubChem: 4315; ChEBI: 16288; KNApSAcK: C00019570; 3DMET: B01374; NIKKAJI: J37.499G,cpd:C00734; cpd:C00956; cpd:C01046; cpd:C01077; cpd:C02207; cpd:C03210; cpd:C05016; cpd:C06234; cpd:C17581; cpd:C19694,6,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O4N1,C6H10O4N1,161.0688078,162.0766329,160.0609828885,1008,cpd:C01118,O-Succinyl-L-homoserine;,C8H13NO6,O-Succinyl-L-homoserine; O4-Succinyl-L-homoserine; O-Succinylhomoserine,R00999 R01288 R01777 R02508 R03260 R04946,Cysteine and methionine metabolism; Sulfur metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids,2.3.1.46; 2.5.1.48; 2.5.1.-,"Methionine biosynthesis, apartate => homoserine => methionine",NA,CAS: 1492-23-5; PubChem: 4349; ChEBI: 16160; KNApSAcK: C00019621; 3DMET: B01386; NIKKAJI: J1.770.210F,cpd:C01118; cpd:C03776,8,13,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H14O6N1,C8H12O6N1,219.0742871,220.0821122,218.0664621886,1009,cpd:C01137,S-Adenosylmethioninamine;,C14H23N6O3S,S-Adenosylmethioninamine; (5-Deoxy-5-adenosyl)(3-aminopropyl)methylsulfonium; (5-Deoxy-5-adenosyl)(3-aminopropyl)methylsulfonium cation; S-Adenosyl-(5')-3-methylthiopropylamine; S-Adenosyl 3-(methylthio)propylamine; Decarboxy-AdoMet,R00178 R01920 R02869 R03271 R08359 R09531 R10338 R11088; R11089 R11154 R11159 R11160,Cysteine and methionine metabolism; Arginine and proline metabolism; Metabolic pathways,2.5.1.16; 2.5.1.22; 2.5.1.23; 2.5.1.79; 2.5.1.104; 2.5.1.126; 2.5.1.127; 2.5.1.128; 4.1.1.50,"Methionine salvage pathway; Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine",Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C01137  S-Adenosylmethioninamine,PubChem: 4368; ChEBI: 15625; 3DMET: B04775; NIKKAJI: J39.567F,cpd:C01137,14,23,3,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C14H24O3N6S1,C14H22O3N6S1,355.1552348,356.1630598,354.1474098887,1010,cpd:C01180,4-Methylthio-2-oxobutanoic acid;,C5H8O3S,4-Methylthio-2-oxobutanoic acid; 4-Methylthio-2-oxobutanoate; 2-Keto-4-methylthiobutyric acid; 2-Oxo-4-methylthiobutanoate; 2-Oxo-4-methylthiobutanoic acid,R00648 R00652 R03001 R07364 R07396 R08618 R08619 R09373,Cysteine and methionine metabolism; Glucosinolate biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.4.3.2; 1.13.11.54; 2.3.3.17; 2.6.1.5; 2.6.1.41; 2.6.1.57; 2.6.1.73; 2.6.1.88; 2.6.1.-,Methionine salvage pathway,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C01180  2-Oxo-4-methylthiobutanoic acid,CAS: 583-92-6; PubChem: 4407; ChEBI: 16723 33574; LIPIDMAPS: LMFA01060170; KNApSAcK: C00007474; PDB-CCD: KMT; 3DMET: B00255; NIKKAJI: J39.561G,cpd:C01180; cpd:C05727; cpd:C18006,5,8,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O3S1,C5H7O3S1,148.0194153,149.0272403,147.0115903888,1011,cpd:C01234,1-Aminocyclopropane-1-carboxylate;,C4H7NO2,1-Aminocyclopropane-1-carboxylate; 1-Aminocyclopropane-1-carboxylic acid,R00179 R00997 R07214,Cysteine and methionine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.17.4; 3.5.99.7; 4.4.1.14,"Ethylene biosynthesis, methionine => ethylene",NA,CAS: 22059-21-8; PubChem: 4455; ChEBI: 18053 30526; ChEMBL: CHEMBL265325; KNApSAcK: C00007566; PDB-CCD: 1AC; 3DMET: B00262; NIKKAJI: J83.133F,cpd:C01234; cpd:C02926; cpd:C07509; cpd:C08267; cpd:C11106; cpd:C17234; cpd:C19456; cpd:C19777; cpd:C20905,4,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H8O2N1,C4H6O2N1,101.0476785,102.0555035,100.0398534889,1012,cpd:C01817,L-Homocystine;,C8H16N2O4S2,L-Homocystine; Homocystine,R01292,Cysteine and methionine metabolism,1.8.4.1,NA,NA,CAS: 626-72-2; PubChem: 4941; ChEBI: 17485; ChEMBL: CHEMBL212056; 3DMET: B01502; NIKKAJI: J5.770C,cpd:C01817; cpd:C20788,8,16,4,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O4N2S2,C8H15O4N2S2,268.0551494,269.0629744,267.0473243890,1013,cpd:C01962,Thiocysteine;,C3H7NO2S2,Thiocysteine; S-Mercapto-L-cysteine,R02408,Cysteine and methionine metabolism,4.4.1.1; 4.4.1.8,NA,NA,CAS: 5652-32-4; PubChem: 5063; ChEBI: 28839; PDB-CCD: CSS; 3DMET: B00374; NIKKAJI: J2.365.199H,cpd:C01962,3,7,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O2N1S2,C3H6O2N1S2,152.9918208,153.9996459,151.9839958891,1014,cpd:C02218,Dehydroalanine;,C3H5NO2,Dehydroalanine; 2-Aminoacrylate; 2-Aminoprop-2-enoate,R00590 R03208 R03901 R03953 R08698 R08699 R11100,Cysteine and methionine metabolism,1.11.1.8; 4.3.1.17; 4.4.1.4,NA,NA,CAS: 1948-56-7; PubChem: 5284; ChEBI: 17123; PDB-CCD: DHA; 3DMET: B00405; NIKKAJI: J80.352I,cpd:C02218; cpd:C04313; cpd:C06695; cpd:C20253; cpd:C20904,3,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H6O2N1,C3H4O2N1,87.0320284,88.03985344,86.02420337892,1015,cpd:C02356,(S)-2-Aminobutanoate;,C4H9NO2,(S)-2-Aminobutanoate; (S)-2-Aminobutanoic acid; (S)-2-Aminobutyric acid,R10991 R10992 R10993,Cysteine and methionine metabolism; Metabolic pathways,2.6.1.42; 2.6.1.44; 6.3.2.2,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0110 Amino fatty acids;     C02356  (S)-2-Aminobutanoic acid,PubChem: 5403; ChEBI: 28340 35619 74359; ChEMBL: CHEMBL1230782; LIPIDMAPS: LMFA01100034; PDB-CCD: ABA UNK; 3DMET: B01567; NIKKAJI: J7.749F,cpd:C00155; cpd:C00334; cpd:C01026; cpd:C01205; cpd:C02261; cpd:C02356; cpd:C02721; cpd:C03284; cpd:C03665; cpd:C05145; cpd:C05330; cpd:C05689; cpd:C05698; cpd:C11109; cpd:C11735; cpd:C19514,4,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O2N1,C4H8O2N1,103.0633285,104.0711536,102.0555035893,1016,cpd:C02989,L-Methionine S-oxide,C5H11NO3S,L-Methionine S-oxide,R02025,Cysteine and methionine metabolism,1.8.4.13; 1.8.4.14,NA,NA,CAS: 3226-65-1; PubChem: 5898; ChEBI: 17016; ChEMBL: CHEMBL445753; PDB-CCD: MHO SME; 3DMET: B04873; NIKKAJI: J231.856C,cpd:C02989; cpd:C15998; cpd:C15999,5,11,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O3N1S1,C5H10O3N1S1,165.0459644,166.0537894,164.0381394894,1017,cpd:C03089,5-Methylthio-D-ribose;,C6H12O4S,5-Methylthio-D-ribose; S-Methyl-5-thio-D-ribose,R01401 R04143,Cysteine and methionine metabolism; Biosynthesis of plant secondary metabolites; Metabolic pathways,2.7.1.100; 3.2.2.9; 3.2.2.16,Methionine salvage pathway,NA,PubChem: 5987; ChEBI: 78440; PDB-CCD: SR1; 3DMET: B01630; NIKKAJI: J1.615.621C,cpd:C03089,6,12,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O4S1,C6H11O4S1,180.04563,181.0534551,179.037805895,1018,cpd:C03145,N-Formylmethionine;,C6H11NO3S,N-Formylmethionine; N-Formyl-L-methionine,R00653,Cysteine and methionine metabolism,3.5.1.31,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C03145  N-Formylmethionine,CAS: 4289-98-9; PubChem: 6033; ChEBI: 16552; PDB-CCD: FME; 3DMET: B01634; NIKKAJI: J208.507K,cpd:C03145; cpd:C08265; cpd:C08295,6,11,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O3N1S1,C6H10O3N1S1,177.0459644,178.0537894,176.0381394896,1019,cpd:C03539,S-Ribosyl-L-homocysteine;,C9H17NO6S,S-Ribosyl-L-homocysteine; S-D-Ribosyl-L-homocysteine; Ribose-5-S-homocysteine; S-Ribosylhomocysteine; S-(5-Deoxy-D-ribos-5-yl)-L-homocysteine,R00194 R01291,Cysteine and methionine metabolism; Metabolic pathways; Biosynthesis of amino acids,3.2.2.9; 4.4.1.21,"Cysteine biosynthesis, methionine => cysteine",NA,PubChem: 6343; ChEMBL: CHEMBL593446; PDB-CCD: 2WP RHC; 3DMET: B01667; NIKKAJI: J1.589.202A,cpd:C03539,9,17,6,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C9H18O6N1S1,C9H16O6N1S1,267.0776584,268.0854835,266.0698334897,1020,cpd:C04188,S-Methyl-5-thio-D-ribose 1-phosphate;,C6H13O7PS,S-Methyl-5-thio-D-ribose 1-phosphate; S-Methyl-5-thio-alpha-D-ribose 1-phosphate; S-Methyl-5-thio-5-deoxy-D-ribose 1-phosphate,R01402 R04143 R04420 R09668,Cysteine and methionine metabolism; Biosynthesis of plant secondary metabolites; Metabolic pathways,2.4.2.28; 2.4.2.44; 2.7.1.100; 5.3.1.23,Methionine salvage pathway,NA,PubChem: 6864; ChEBI: 27859; 3DMET: B01722; NIKKAJI: J2.401.247F,cpd:C04188; cpd:C04582,6,13,7,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O7P1S1,C6H12O7P1S1,260.0119609,261.019786,259.0041359898,1021,cpd:C04582,S-Methyl-5-thio-D-ribulose 1-phosphate,C6H13O7PS,S-Methyl-5-thio-D-ribulose 1-phosphate,R04420 R07392,Cysteine and methionine metabolism; Metabolic pathways,4.2.1.109; 5.3.1.23,Methionine salvage pathway,NA,PubChem: 7183; ChEBI: 28096; PDB-CCD: MRU; 3DMET: B04948; NIKKAJI: J2.752.046D,cpd:C04188; cpd:C04582,6,13,7,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O7P1S1,C6H12O7P1S1,260.0119609,261.019786,259.0041359899,1022,cpd:C05526,S-Glutathionyl-L-cysteine,C13H22N4O8S2,S-Glutathionyl-L-cysteine,R00900 R04860,Cysteine and methionine metabolism,1.8.1.9; 1.8.1.10; 1.8.4.3,NA,NA,PubChem: 7869; ChEBI: 21264 8959; NIKKAJI: J2.756.162D,cpd:C05526,13,22,8,4,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C13H23O8N4S2,C13H21O8N4S2,426.087906,427.0957311,425.080081900,1023,cpd:C05527,3-Sulfinylpyruvate;,C3H4O5S,3-Sulfinylpyruvate; 3-Sulfinopyruvate,R02618 R02619 R04861,Cysteine and methionine metabolism; Metabolic pathways,1.4.1.-; 2.6.1.1,NA,NA,PubChem: 7870; ChEBI: 1665; 3DMET: B00785; NIKKAJI: J2.365.114I,cpd:C05527; cpd:C20929,3,4,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O5S1,C3H3O5S1,151.9779444,152.9857694,150.9701194901,1024,cpd:C05528,3-Sulfopyruvate;,C3H4O6S,3-Sulfopyruvate; 3-Sulfopyruvic acid,R02433 R05693 R05694 R05774 R07136 R07137 R08590,Cysteine and methionine metabolism; Methane metabolism; Microbial metabolism in diverse environments,1.1.1.37; 1.1.1.310; 1.1.1.337; 1.1.1.338; 2.6.1.1; 4.1.1.79,Coenzyme M biosynthesis,NA,PubChem: 7871; ChEBI: 16894; KNApSAcK: C00000764; PDB-CCD: SPV; 3DMET: B00786; NIKKAJI: J1.837.369F,cpd:C05528,3,4,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O6S1,C3H3O6S1,167.972859,168.9806841,166.965034902,1025,cpd:C05823,3-Mercaptolactate;,C3H6O3S,3-Mercaptolactate; L-3-Mercaptolactate; (R)-3-Mercaptolactate,R03104,Cysteine and methionine metabolism,1.1.1.27,NA,NA,PubChem: 8118; ChEBI: 28580; 3DMET: B05120; NIKKAJI: J397.550I,cpd:C03726; cpd:C05823; cpd:C19296,3,6,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O3S1,C3H5O3S1,122.0037652,123.0115903,120.9959402903,1026,cpd:C05824,S-Sulfo-L-cysteine,C3H7NO5S2,S-Sulfo-L-cysteine,R02409 R03132 R04860 R10409,Cysteine and methionine metabolism; Biosynthesis of amino acids,1.8.4.3; 2.5.1.47,NA,NA,CAS: 1637-71-4; PubChem: 8119; ChEBI: 27891; ChEMBL: CHEMBL457665; PDB-CCD: CSU; 3DMET: B01899; NIKKAJI: J832.997D,cpd:C05824,3,7,5,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O5N1S2,C3H6O5N1S2,200.9765647,201.9843897,199.9687396904,1027,cpd:C06547,Ethylene,C2H4,Ethylene,R05444 R05496 R05498 R07214 R09784,Cysteine and methionine metabolism; Chloroalkane and chloroalkene degradation; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Plant hormone signal transduction; Chemical carcinogenesis,1.13.12.19; 1.14.13.69; 1.14.17.4; 1.18.6.1; 1.97.1.-,"Ethylene biosynthesis, methionine => ethylene",Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C06547  Ethylene,CAS: 74-85-1; PubChem: 8777; ChEBI: 18153; ChEMBL: CHEMBL117822; KNApSAcK: C00000175; 3DMET: B00966; NIKKAJI: J1.939I,cpd:C00012; cpd:C00017; cpd:C00033; cpd:C00045; cpd:C00084; cpd:C00098; cpd:C00151; cpd:C00160; cpd:C00266; cpd:C00405; cpd:C00593; cpd:C00980; cpd:C01010; cpd:C01857; cpd:C02086; cpd:C02896; cpd:C02903; cpd:C02998; cpd:C03129; cpd:C05167; cpd:C05234; cpd:C05710; cpd:C06547; cpd:C06548; cpd:C06752; cpd:C07165; cpd:C08382; cpd:C11088; cpd:C11261; cpd:C11317; cpd:C11623; cpd:C11624; cpd:C11625; cpd:C13301; cpd:C13400; cpd:C13724; cpd:C14179; cpd:C14860; cpd:C18091; cpd:C18247; cpd:C18372; cpd:C18424; cpd:C18568; cpd:C18675; cpd:C18723; cpd:C18940; cpd:C19158; cpd:C19419; cpd:C19503; cpd:C20305; cpd:C20794,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H5,C2H3,28.03130013,29.03912516,27.0234751905,1028,cpd:C08276,3-(Methylthio)propanoate;,C4H8O2S,3-(Methylthio)propanoate; 3-(Methylthio)propionic acid; 3-Methylthiopropionate,R07363 R10333 R10820,Cysteine and methionine metabolism; Sulfur metabolism; Metabolic pathways,1.13.11.53; 2.1.1.269; 6.2.1.44,NA,NA,CAS: 646-01-5; PubChem: 10474; ChEBI: 1438; ChEMBL: CHEMBL116212; LIPIDMAPS: LMFA01130006; KNApSAcK: C00001194; 3DMET: B02154; NIKKAJI: J22.485E,cpd:C08276,4,8,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O2S1,C4H7O2S1,120.0245007,121.0323257,119.0166756906,1031,cpd:C11499,(S)-3-Sulfolactate;,C3H6O6S,(S)-3-Sulfolactate; (2S)-3-Sulfolactate,R05693 R05694,Cysteine and methionine metabolism,1.1.1.310,NA,NA,PubChem: 13669; ChEBI: 16712 61289; NIKKAJI: J2.774.742F,cpd:C02543; cpd:C02914; cpd:C11499; cpd:C11537; cpd:C16069; cpd:C17205,3,6,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O6S1,C3H5O6S1,169.9885091,170.9963341,168.9806841907,1032,cpd:C11537,(2R)-3-Sulfolactate;,C3H6O6S,(2R)-3-Sulfolactate; (R)-3-Sulfolactate,R05789 R07136 R07137 R09545,Cysteine and methionine metabolism; Methane metabolism; Microbial metabolism in diverse environments,1.1.1.37; 1.1.1.308; 1.1.1.337; 1.1.1.338; 3.1.3.71,Coenzyme M biosynthesis,NA,PubChem: 13704; ChEBI: 48291; PDB-CCD: 3SL; NIKKAJI: J2.774.884H,cpd:C02543; cpd:C02914; cpd:C11499; cpd:C11537; cpd:C16069; cpd:C17205,3,6,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O6S1,C3H5O6S1,169.9885091,170.9963341,168.9806841908,1033,cpd:C15606,"1,2-Dihydroxy-5-(methylthio)pent-1-en-3-one",C6H10O3S,"1,2-Dihydroxy-5-(methylthio)pent-1-en-3-one",R07363 R07364 R07394 R07395,Cysteine and methionine metabolism; Metabolic pathways,1.13.11.53; 1.13.11.54; 3.1.3.77; 3.1.3.87,Methionine salvage pathway,NA,PubChem: 17396598; ChEBI: 49252; NIKKAJI: J1.779.751D,cpd:C03895; cpd:C05535; cpd:C15606; cpd:C15653; cpd:C17211; cpd:C21378,6,10,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O3S1,C6H9O3S1,162.0350654,163.0428904,161.0272403909,1034,cpd:C15650,"2,3-Diketo-5-methylthiopentyl-1-phosphate;",C6H11O6PS,"2,3-Diketo-5-methylthiopentyl-1-phosphate; 5-(Methylthio)-2,3-dioxopentyl phosphate",R07392 R07393 R07395,Cysteine and methionine metabolism; Metabolic pathways,3.1.3.77; 4.2.1.109; 5.3.2.5,Methionine salvage pathway,NA,PubChem: 17396640; ChEBI: 50604; NIKKAJI: J2.178.133I,cpd:C15650; cpd:C15651,6,11,6,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O6P1S1,C6H10O6P1S1,242.0013962,243.0092213,240.9935712910,1035,cpd:C15651,2-Hydroxy-3-keto-5-methylthiopentenyl-1-phosphate;,C6H11O6PS,2-Hydroxy-3-keto-5-methylthiopentenyl-1-phosphate; 2-Hydroxy-5-(methylthio)-3-oxopent-1-enyl phosphate,R07393 R07394,Cysteine and methionine metabolism; Metabolic pathways,3.1.3.77; 3.1.3.87; 5.3.2.5,Methionine salvage pathway,NA,PubChem: 17396641; ChEBI: 50605; NIKKAJI: J1.971.656B,cpd:C15650; cpd:C15651,6,11,6,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O6P1S1,C6H10O6P1S1,242.0013962,243.0092213,240.9935712911,1037,cpd:C19787,5'-S-Methyl-5'-thioinosine;,C11H14N4O4S,5'-S-Methyl-5'-thioinosine; 5'-Deoxy-5'-methylthioinosine; S-Methyl-5'-thioinosine,R09660 R09668,Cysteine and methionine metabolism; Metabolic pathways,2.4.2.44; 3.5.4.31,NA,NA,CAS: 17298-58-7; PubChem: 135626254,cpd:C19787,11,14,4,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O4N4S1,C11H13O4N4S1,298.0735761,299.0814012,297.0657511912,1038,cpd:C21015,gamma-L-Glutamyl-L-2-aminobutyrate,C9H16N2O5,gamma-L-Glutamyl-L-2-aminobutyrate,R10993 R10994,Cysteine and methionine metabolism; Metabolic pathways,6.3.2.2; 6.3.2.3,NA,NA,PubChem: 254741469,cpd:C01410; cpd:C03415; cpd:C04390; cpd:C05695; cpd:C15767; cpd:C21015,9,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O5N2,C9H15O5N2,232.1059216,233.1137467,231.0980966913,1039,cpd:C21016,Ophthalmate;,C11H19N3O6,Ophthalmate; gamma-L-Glutamyl-L-2-aminobutyrylglycine,R10994,Cysteine and methionine metabolism; Metabolic pathways,6.3.2.3,NA,NA,PubChem: 254741470,cpd:C04544; cpd:C11347; cpd:C20917; cpd:C20919; cpd:C21016,11,19,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H20O6N3,C11H18O6N3,289.1273853,290.1352104,288.1195603914,1040,cpd:C00100,Propanoyl-CoA;,C24H40N7O17P3S,Propanoyl-CoA; Propionyl-CoA; Propionyl coenzyme A,R00918 R00919 R00920 R00921 R00922 R00923 R00924 R00925; R00926 R00927 R00928 R00930 R00931 R00932 R00934 R00935; R01199 R01449 R01859 R03719 R04432 R04546 R04811 R05330; R05373 R06414 R06644 R06987 R09097 R10161 R10974 R10998,"Valine, leucine and isoleucine degradation; beta-Alanine metabolism; Biosynthesis of 12-, 14- and 16-membered macrolides; Xylene degradation; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; C5-Branched dibasic acid metabolism; Carbon fixation pathways in prokaryotes; Biosynthesis of type II polyketide backbone; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; Degradation of aromatic compounds",1.2.1.27; 1.2.1.87; 1.2.7.1; 1.3.1.84; 1.3.1.95; 1.3.1.-; 1.3.8.7; 2.1.3.1; 2.3.1.8; 2.3.1.9; 2.3.1.16; 2.3.1.54; 2.3.1.94; 2.3.1.168; 2.3.1.176; 2.3.1.222; 2.3.1.-; 2.3.3.5; 2.3.3.11; 2.8.3.1; 3.13.1.4; 4.1.1.9; 4.1.1.41; 4.1.3.24; 6.2.1.1; 6.2.1.13; 6.2.1.17; 6.4.1.3,"Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA; Ethylmalonyl pathway; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA; Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA; Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B",NA,CAS: 317-66-8; PubChem: 3400; ChEBI: 15539; PDB-CCD: 1VU; 3DMET: B04632; NIKKAJI: J1.695.704F,cpd:C00100,24,40,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O17N7P3S1,C24H39O17N7P3S1,823.141425,824.1492501,822.1336915,1041,cpd:C00123,L-Leucine;,C6H13NO2,L-Leucine; 2-Amino-4-methylvaleric acid; (2S)-alpha-2-Amino-4-methylvaleric acid; (2S)-alpha-Leucine,R01088 R01089 R01090 R01091 R02552 R03657 R08411 R08664; R10944,"Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; mTOR signaling pathway; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer",1.4.1.9; 1.14.13.-; 2.3.1.66; 2.6.1.6; 2.6.1.42; 2.6.1.67; 3.5.1.64; 5.4.3.7; 6.1.1.4; 6.3.2.47,"Leucine degradation, leucine => acetoacetate + acetyl-CoA",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00123  Leucine (Leu); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Leucine;     D00030  Leucine (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00030  [003619] L-Leucine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00030  L-Leucine,CAS: 61-90-5; PubChem: 3423; ChEBI: 15603; ChEMBL: CHEMBL291962; KNApSAcK: C00001377; PDB-CCD: LEU; 3DMET: B00034; NIKKAJI: J1.167C,cpd:C00123; cpd:C00407; cpd:C01570; cpd:C01777; cpd:C01933; cpd:C02378; cpd:C02486; cpd:C06418; cpd:C08263; cpd:C11227; cpd:C16434; cpd:C16439; cpd:C16647; cpd:C17213; cpd:C20988; cpd:C21092; cpd:C21096,6,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O2N1,C6H12O2N1,131.0946287,132.1024537,130.0868036916,1042,cpd:C00141,3-Methyl-2-oxobutanoic acid;,C5H8O3,3-Methyl-2-oxobutanoic acid; 3-Methyl-2-oxobutyric acid; 3-Methyl-2-oxobutanoate; 2-Oxo-3-methylbutanoate; 2-Oxoisovalerate; 2-Oxoisopentanoate; alpha-Ketovaline; 2-Ketovaline; 2-Keto-3-methylbutyric acid,R01209 R01210 R01211 R01212 R01213 R01214 R01215 R01216; R01226 R01434 R01701 R02200 R04441 R07160 R07599,"Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Pantothenate and CoA biosynthesis; Glucosinolate biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.84; 1.2.1.25; 1.2.4.4; 1.2.7.7; 1.4.1.8; 1.4.1.9; 1.4.1.23; 2.1.2.11; 2.3.3.13; 2.6.1.6; 2.6.1.32; 2.6.1.42; 2.6.1.66; 4.1.2.12; 4.2.1.9,"Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Pantothenate biosynthesis, valine/L-aspartate => pantothenate; Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00141  2-Oxoisovalerate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C00141  3-Methyl-2-oxobutanoic acid,CAS: 759-05-7; PubChem: 3441; ChEBI: 11851 16530; ChEMBL: CHEMBL146554; LIPIDMAPS: LMFA01020274; LipidBank: DFA0388; KNApSAcK: C00007623; PDB-CCD: KIV; 3DMET: B00039; NIKKAJI: J39.558G,cpd:C00141; cpd:C01180; cpd:C02233; cpd:C02707; cpd:C03273; cpd:C05727; cpd:C06255; cpd:C07764; cpd:C18006; cpd:C19485; cpd:C19803,5,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O3,C5H7O3,116.0473441,117.0551691,115.0395191917,1043,cpd:C00183,L-Valine;,C5H11NO2,L-Valine; 2-Amino-3-methylbutyric acid,R01212 R01214 R01215 R01434 R01437 R02200 R03665 R04870; R08663 R10031 R10941 R10942,"Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Penicillin and cephalosporin biosynthesis; Cyanoamino acid metabolism; Pantothenate and CoA biosynthesis; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer",1.4.1.8; 1.4.1.9; 1.4.1.23; 1.14.13.117; 1.14.13.118; 2.6.1.6; 2.6.1.32; 2.6.1.42; 2.6.1.66; 4.1.1.14; 6.1.1.9; 6.3.2.26; 6.3.2.47,"Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Pantothenate biosynthesis, valine/L-aspartate => pantothenate; Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin; Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00183  Valine (Val); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Valine;     D00039  Valine (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00039  L-Valine,CAS: 72-18-4; PubChem: 3483; ChEBI: 16414; ChEMBL: CHEMBL43068; KNApSAcK: C00001398; PDB-CCD: VAL; 3DMET: B00054; NIKKAJI: J9.179K,cpd:C00073; cpd:C00183; cpd:C00431; cpd:C00719; cpd:C00855; cpd:C01733; cpd:C01799; cpd:C01826; cpd:C03571; cpd:C05335; cpd:C06417; cpd:C07418; cpd:C07457; cpd:C15987; cpd:C16436,5,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O2N1,C5H10O2N1,117.0789786,118.0868036,116.0711536918,1044,cpd:C00233,4-Methyl-2-oxopentanoate;,C6H10O3,4-Methyl-2-oxopentanoate; 2-Oxoisocaproate,R01088 R01090 R01651 R01652 R01702 R07601 R08566 R10052,"Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Glucosinolate biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.85; 1.2.1.25; 1.2.4.4; 1.2.7.7; 1.4.1.9; 2.6.1.6; 2.6.1.42; 2.6.1.67,"Leucine degradation, leucine => acetoacetate + acetyl-CoA; Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00233  2-Oxoisocaproate,CAS: 816-66-0; PubChem: 3532; ChEBI: 17865 48430; ChEMBL: CHEMBL445647; KNApSAcK: C00019677; PDB-CCD: COI; 3DMET: B00066; NIKKAJI: J39.557I,cpd:C00233; cpd:C00671; cpd:C00902; cpd:C01012; cpd:C01109; cpd:C02122; cpd:C02129; cpd:C03241; cpd:C03465; cpd:C03467; cpd:C03500; cpd:C03625; cpd:C03895; cpd:C05535; cpd:C06008; cpd:C06102; cpd:C12314; cpd:C14530; cpd:C15606; cpd:C15653; cpd:C16432; cpd:C17211; cpd:C21378,6,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O3,C6H9O3,130.0629942,131.0708192,129.0551691919,1045,cpd:C00349,2-Methyl-3-oxopropanoate;,C4H6O3,2-Methyl-3-oxopropanoate; 3-Oxo-2-methylpropanoate; Methylmalonate semialdehyde,R00922 R02047 R02050,"Valine, leucine and isoleucine degradation",1.1.1.31; 1.2.1.27; 2.6.1.40,NA,NA,PubChem: 3642; ChEBI: 16256; LIPIDMAPS: LMFA01060193; NIKKAJI: J707.628B,cpd:C00107; cpd:C00109; cpd:C00164; cpd:C00211; cpd:C00232; cpd:C00349; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C01551; cpd:C02189; cpd:C02348; cpd:C02350; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C02847; cpd:C03011; cpd:C03135; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06002; cpd:C06395; cpd:C06396; cpd:C06805; cpd:C16116; cpd:C18904; cpd:C20254; cpd:C21030; cpd:C21172,4,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O3,C4H5O3,102.0316941,103.0395191,101.023869920,1046,cpd:C00407,L-Isoleucine;,C6H13NO2,L-Isoleucine; 2-Amino-3-methylvaleric acid,R02196 R02197 R02199 R02200 R03656 R06726 R09344 R09403; R10027 R10723 R10943 R11078,"Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Cyanoamino acid metabolism; Tropane, piperidine and pyridine alkaloid biosynthesis; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer",1.4.1.9; 1.4.3.2; 1.14.11.45; 1.14.13.117; 1.14.13.118; 2.6.1.32; 2.6.1.42; 5.1.1.21; 6.1.1.5; 6.3.2.47,"Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00407  Isoleucine (Ile); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Isoleucine;     D00065  Isoleucine (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00065  L-Isoleucine,CAS: 73-32-5; PubChem: 3697; ChEBI: 17191; ChEMBL: CHEMBL1233584 CHEMBL1869615; LIPIDMAPS: LMFA01100047; KNApSAcK: C00001374; PDB-CCD: ILE; 3DMET: B01236; NIKKAJI: J2.818E,cpd:C00123; cpd:C00407; cpd:C01570; cpd:C01777; cpd:C01933; cpd:C02378; cpd:C02486; cpd:C06418; cpd:C08263; cpd:C11227; cpd:C16434; cpd:C16439; cpd:C16647; cpd:C17213; cpd:C20988; cpd:C21092; cpd:C21096,6,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O2N1,C6H12O2N1,131.0946287,132.1024537,130.0868036921,1047,cpd:C00630,2-Methylpropanoyl-CoA;,C25H42N7O17P3S,2-Methylpropanoyl-CoA; 2-Methylpropionyl-CoA; Isobutyryl-CoA,R01181 R01210 R02661 R02662 R02663 R06482 R06483 R07160; R09090 R09854,"Valine, leucine and isoleucine degradation; Phenylalanine metabolism; Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics",1.2.1.25; 1.2.7.7; 1.3.8.1; 1.3.8.7; 1.3.99.12; 1.3.99.-; 2.3.1.168; 5.4.99.13,"Capsaicin biosynthesis, L-Phenylalanine => Capsaicin; Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 3903; ChEBI: 15479; PDB-CCD: CO6; 3DMET: B04708; NIKKAJI: J721.070A,cpd:C00136; cpd:C00630,25,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H43O17N7P3S1,C25H41O17N7P3S1,837.1570751,838.1649001,836.1492501922,1048,cpd:C00671,(S)-3-Methyl-2-oxopentanoic acid;,C6H10O3,(S)-3-Methyl-2-oxopentanoic acid; (S)-3-Methyl-2-oxopentanoate; (3S)-3-Methyl-2-oxopentanoic acid; (3S)-3-Methyl-2-oxopentanoate,R02196 R02197 R02199 R02200 R03171 R03894 R04225 R05070; R07603 R08567,"Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis; Glucosinolate biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.2.1.25; 1.2.4.4; 1.2.7.7; 1.4.1.9; 1.4.3.2; 2.6.1.32; 2.6.1.42; 4.1.1.72; 4.2.1.9,"Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00671  (S)-3-Methyl-2-oxopentanoic acid; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C00671  (S)-3-Methyl-2-oxopentanoic acid,PubChem: 3940; ChEBI: 15614 35146; LIPIDMAPS: LMFA01020275; PDB-CCD: 1QQ; 3DMET: B01307; NIKKAJI: J264.814H,cpd:C00233; cpd:C00671; cpd:C00902; cpd:C01012; cpd:C01109; cpd:C02122; cpd:C02129; cpd:C03241; cpd:C03465; cpd:C03467; cpd:C03500; cpd:C03625; cpd:C03895; cpd:C05535; cpd:C06008; cpd:C06102; cpd:C12314; cpd:C14530; cpd:C15606; cpd:C15653; cpd:C16432; cpd:C17211; cpd:C21378,6,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O3,C6H9O3,130.0629942,131.0708192,129.0551691923,1049,cpd:C00683,(S)-Methylmalonyl-CoA;,C25H40N7O19P3S,(S)-Methylmalonyl-CoA; (S)-Methylmalonyl-coenzyme A; (2S)-Methylmalonyl-CoA; D-Methylmalonyl-CoA,R00918 R00923 R00930 R01859 R02764 R02765 R06458 R06459,"Valine, leucine and isoleucine degradation; Biosynthesis of 12-, 14- and 16-membered macrolides; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism",2.1.3.1; 2.3.1.94; 2.3.1.239; 2.3.1.240; 3.1.2.17; 4.1.1.41; 5.1.99.1; 6.4.1.3,"Ethylmalonyl pathway; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA; Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B; Pikromycin/methymycin/neomethymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin/neomethymycin",NA,PubChem: 3952; ChEBI: 15466; 3DMET: B04716; NIKKAJI: J921.435F,cpd:C00091; cpd:C00683; cpd:C01213; cpd:C02557,25,40,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O19N7P3S1,C25H39O19N7P3S1,867.1312543,868.1390793,866.1234292924,1050,cpd:C01213,(R)-Methylmalonyl-CoA;,C25H40N7O19P3S,(R)-Methylmalonyl-CoA; L-Methylmalonyl-CoA,R00833 R02765 R03381 R03383,"Valine, leucine and isoleucine degradation; Glyoxylate and dicarboxylate metabolism; Propanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism",1.2.1.-; 5.1.99.1; 5.4.99.2; 6.2.1.-,"Ethylmalonyl pathway; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle; Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA",NA,PubChem: 4435; ChEBI: 15465; PDB-CCD: MCA; 3DMET: B04783; NIKKAJI: J890.616E,cpd:C00091; cpd:C00683; cpd:C01213; cpd:C02557,25,40,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O19N7P3S1,C25H39O19N7P3S1,867.1312543,868.1390793,866.1234292925,1051,cpd:C02939,3-Methylbutanoyl-CoA;,C26H44N7O17P3S,3-Methylbutanoyl-CoA; Isovaleryl-CoA,R01651 R04095 R04096 R04097 R04098 R05331 R08566 R10526,"Valine, leucine and isoleucine degradation; Metabolic pathways",1.2.1.25; 1.2.7.7; 1.3.8.4; 1.3.8.7; 2.3.1.156; 2.3.1.168; 2.3.1.228,"Leucine degradation, leucine => acetoacetate + acetyl-CoA",NA,PubChem: 5858; ChEBI: 15487; PDB-CCD: IVC; 3DMET: B04869; NIKKAJI: J675.058C,cpd:C00888; cpd:C01033; cpd:C02939; cpd:C15980,26,44,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H45O17N7P3S1,C26H43O17N7P3S1,851.1727252,852.1805502,850.1649001926,1052,cpd:C03069,3-Methylcrotonyl-CoA;,C26H42N7O17P3S,3-Methylcrotonyl-CoA; 3-Methylbut-2-enoyl-CoA; 3-Methylcrotonoyl-CoA; Dimethylacryloyl-CoA,R04095 R04096 R04137 R04138 R08095,"Valine, leucine and isoleucine degradation; Geraniol degradation; Metabolic pathways",1.3.8.4; 1.3.8.7; 2.3.1.16; 4.2.1.17; 6.4.1.4,"Leucine degradation, leucine => acetoacetate + acetyl-CoA",NA,PubChem: 5969; ChEBI: 15486; 3DMET: B04879; NIKKAJI: J1.710.034C,cpd:C02451; cpd:C03069; cpd:C03345; cpd:C03466,26,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H43O17N7P3S1,C26H41O17N7P3S1,849.1570751,850.1649001,848.1492501927,1053,cpd:C03231,3-Methylglutaconyl-CoA;,C27H42N7O19P3S,3-Methylglutaconyl-CoA; trans-3-Methylglutaconyl-CoA; (E)-3-Methylglutaconyl-1-CoA,R02085 R04138,"Valine, leucine and isoleucine degradation; Metabolic pathways",4.2.1.18; 6.4.1.4,"Leucine degradation, leucine => acetoacetate + acetyl-CoA",NA,PubChem: 6102; ChEBI: 15488; 3DMET: B04886; NIKKAJI: J2.741.395A,cpd:C03231; cpd:C14144; cpd:C19682,27,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O19N7P3S1,C27H41O19N7P3S1,893.1469043,894.1547294,892.1390793928,1054,cpd:C03284,L-3-Aminoisobutanoate;,C4H9NO2,L-3-Aminoisobutanoate; (S)-3-Aminoisobutyrate; L-3-Aminoisobutyrate; (S)-3-Aminoisobutanoate; (S)-3-Amino-2-methylpropanoate; (S)-beta-Aminoisobutyrate,R04187 R04188,"Valine, leucine and isoleucine degradation",2.6.1.18; 2.6.1.22,NA,NA,PubChem: 6143; ChEBI: 18188 33094; LIPIDMAPS: LMFA01100050; PDB-CCD: 62H BIB; 3DMET: B01645; NIKKAJI: J52.799H,cpd:C00155; cpd:C00334; cpd:C01026; cpd:C01205; cpd:C02261; cpd:C02356; cpd:C02721; cpd:C03284; cpd:C03665; cpd:C05145; cpd:C05330; cpd:C05689; cpd:C05698; cpd:C11109; cpd:C11735; cpd:C19514,4,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O2N1,C4H8O2N1,103.0633285,104.0711536,102.0555035929,1055,cpd:C03344,2-Methylacetoacetyl-CoA;,C26H42N7O18P3S,2-Methylacetoacetyl-CoA; 2-Methyl-3-acetoacetyl-CoA,R00927 R04203,"Valine, leucine and isoleucine degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics",1.1.1.35; 1.1.1.178; 2.3.1.9; 2.3.1.16,NA,NA,PubChem: 6187; ChEBI: 15476; 3DMET: B04890; NIKKAJI: J2.741.588A,cpd:C03344,26,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H43O18N7P3S1,C26H41O18N7P3S1,865.1519897,866.1598147,864.1441647930,1056,cpd:C03345,2-Methylbut-2-enoyl-CoA;,C26H42N7O17P3S,2-Methylbut-2-enoyl-CoA; trans-2-Methylbut-2-enoyl-CoA; Tiglyl-CoA; (E)-2-Methylcrotonoyl-CoA; Methylcrotonoyl-CoA; Methylcrotonyl-CoA; Tigloyl-CoA; 2-Methylcrotanoyl-CoA,R03169 R03172 R03173 R04204 R04205,"Valine, leucine and isoleucine degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics",1.3.8.1; 1.3.8.5; 1.3.8.7; 1.3.99.12; 2.3.1.93; 4.2.1.17,NA,NA,PubChem: 6188; ChEBI: 15478; 3DMET: B04891,cpd:C02451; cpd:C03069; cpd:C03345; cpd:C03466,26,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H43O17N7P3S1,C26H41O17N7P3S1,849.1570751,850.1649001,848.1492501931,1057,cpd:C03460,2-Methylprop-2-enoyl-CoA;,C25H40N7O17P3S,2-Methylprop-2-enoyl-CoA; Methacrylyl-CoA; Methylacrylyl-CoA,R02661 R04224,"Valine, leucine and isoleucine degradation; Metabolic pathways",1.3.8.1; 1.3.8.7; 1.3.99.12; 1.3.99.-; 4.2.1.17,NA,NA,PubChem: 6280; ChEBI: 27754; PDB-CCD: 2MC; 3DMET: B04898; NIKKAJI: J2.076.063J,cpd:C00877; cpd:C02331; cpd:C03460; cpd:C16268,25,40,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O17N7P3S1,C25H39O17N7P3S1,835.141425,836.1492501,834.1336932,1058,cpd:C04405,"(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA;",C26H44N7O18P3S,"(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA; (S)-3-Hydroxy-2-methylbutyryl-CoA",R04203 R04204,"Valine, leucine and isoleucine degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics",1.1.1.35; 1.1.1.178; 4.2.1.17,NA,NA,PubChem: 7041; ChEBI: 15449; PDB-CCD: T1G; 3DMET: B04940; NIKKAJI: J2.750.522H,cpd:C03237; cpd:C04405; cpd:C05998,26,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H45O18N7P3S1,C26H43O18N7P3S1,867.1676398,868.1754648,866.1598147933,1059,cpd:C05998,3-Hydroxyisovaleryl-CoA;,C26H44N7O18P3S,3-Hydroxyisovaleryl-CoA; 3-Hydroxyisovaleryl coenzyme A,R04137 R10759,"Valine, leucine and isoleucine degradation",4.2.1.17,NA,NA,PubChem: 8272; ChEBI: 28291; 3DMET: B05143; NIKKAJI: J2.760.860D,cpd:C03237; cpd:C04405; cpd:C05998,26,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H45O18N7P3S1,C26H43O18N7P3S1,867.1676398,868.1754648,866.1598147934,1060,cpd:C06000,(S)-3-Hydroxyisobutyryl-CoA,C25H42N7O18P3S,(S)-3-Hydroxyisobutyryl-CoA,R04224 R05064,"Valine, leucine and isoleucine degradation; Metabolic pathways",3.1.2.4; 4.2.1.17,NA,NA,PubChem: 8274; ChEBI: 28259; 3DMET: B05145; NIKKAJI: J2.760.861B,cpd:C01144; cpd:C03561; cpd:C04047; cpd:C05116; cpd:C06000; cpd:C11062; cpd:C21287,25,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H43O18N7P3S1,C25H41O18N7P3S1,853.1519897,854.1598147,852.1441647935,1061,cpd:C06001,(S)-3-Hydroxyisobutyrate,C4H8O3,(S)-3-Hydroxyisobutyrate,R05064 R05066,"Valine, leucine and isoleucine degradation; Metabolic pathways",1.1.1.31; 1.1.1.35; 3.1.2.4,NA,NA,PubChem: 8275; ChEBI: 37373 62638; 3DMET: B01946; NIKKAJI: J61.903E,cpd:C00152; cpd:C00989; cpd:C01043; cpd:C01089; cpd:C01188; cpd:C01905; cpd:C01991; cpd:C02037; cpd:C02642; cpd:C03197; cpd:C03804; cpd:C05984; cpd:C06001; cpd:C14601; cpd:C15533; cpd:C16438; cpd:C19258; cpd:C19301; cpd:C21297,4,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O3,C4H7O3,104.0473441,105.0551691,103.0395191936,1062,cpd:C06002,(S)-Methylmalonate semialdehyde,C4H6O3,(S)-Methylmalonate semialdehyde,R00935 R03381 R03869 R03871 R03872 R04187 R04188 R05066; R09238 R11028,"Valine, leucine and isoleucine degradation; Nitrotoluene degradation; Propanoate metabolism; Metabolic pathways; Microbial metabolism in diverse environments",1.1.1.31; 1.1.1.35; 1.2.1.3; 1.2.1.27; 1.2.1.-; 1.2.3.1; 2.6.1.18; 2.6.1.22; 3.7.1.-,NA,NA,PubChem: 8276; ChEBI: 27821; LIPIDMAPS: LMFA01060190; 3DMET: B01947; NIKKAJI: J2.359.609A,cpd:C00107; cpd:C00109; cpd:C00164; cpd:C00211; cpd:C00232; cpd:C00349; cpd:C00403; cpd:C00839; cpd:C01003; cpd:C01139; cpd:C01141; cpd:C01256; cpd:C01551; cpd:C02189; cpd:C02348; cpd:C02350; cpd:C02601; cpd:C02705; cpd:C02706; cpd:C02847; cpd:C03011; cpd:C03135; cpd:C03788; cpd:C04125; cpd:C04128; cpd:C04632; cpd:C04726; cpd:C06002; cpd:C06395; cpd:C06396; cpd:C06805; cpd:C16116; cpd:C18904; cpd:C20254; cpd:C21030; cpd:C21172,4,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O3,C4H5O3,102.0316941,103.0395191,101.023869937,1063,cpd:C15974,3-Methyl-1-hydroxybutyl-ThPP;,C17H29N4O8P2S,3-Methyl-1-hydroxybutyl-ThPP; 3-Methyl-1-hydroxybutyl-TPP,R07601 R07602,"Valine, leucine and isoleucine degradation",1.2.4.4,NA,NA,PubChem: 47205287; ChEBI: 80220; NIKKAJI: J2.799.840B,cpd:C15974; cpd:C15978,17,29,8,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C17H30O8N4P2S1,C17H28O8N4P2S1,511.1181341,512.1259591,510.110309938,1065,cpd:C15976,2-Methyl-1-hydroxypropyl-ThPP;,C16H27N4O8P2S,2-Methyl-1-hydroxypropyl-ThPP; 2-Methyl-1-hydroxypropyl-TPP,R07599 R07600,"Valine, leucine and isoleucine degradation",1.2.4.4,NA,NA,PubChem: 47205289; ChEBI: 48522; NIKKAJI: J2.799.841K,cpd:C15976,16,27,8,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O8N4P2S1,C16H26O8N4P2S1,497.102484,498.110309,496.094659939,1067,cpd:C15978,2-Methyl-1-hydroxybutyl-ThPP;,C17H29N4O8P2S,2-Methyl-1-hydroxybutyl-ThPP; 2-Methyl-1-hydroxybutyl-TPP,R07603 R07604,"Valine, leucine and isoleucine degradation",1.2.4.4,NA,NA,PubChem: 47205291; ChEBI: 80223; NIKKAJI: J2.799.847J,cpd:C15974; cpd:C15978,17,29,8,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C17H30O8N4P2S1,C17H28O8N4P2S1,511.1181341,512.1259591,510.110309940,1069,cpd:C15980,(S)-2-Methylbutanoyl-CoA,C26H44N7O17P3S,(S)-2-Methylbutanoyl-CoA,R03171 R03172 R03174 R03175 R08567,"Valine, leucine and isoleucine degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics",1.2.1.25; 1.2.7.7; 1.3.8.1; 1.3.8.7; 1.3.99.12; 2.3.1.168,NA,NA,PubChem: 47205293; ChEBI: 90222; NIKKAJI: J971.426J,cpd:C00888; cpd:C01033; cpd:C02939; cpd:C15980,26,44,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H45O17N7P3S1,C26H43O17N7P3S1,851.1727252,852.1805502,850.1649001941,1070,cpd:C20827,3-Hydroxyisovalerate;,C5H10O3,3-Hydroxyisovalerate; 3-Hydroxy-3-methylbutyrate,R10759,"Valine, leucine and isoleucine degradation",NA,NA,NA,PubChem: 254741293,cpd:C00064; cpd:C00303; cpd:C00819; cpd:C01419; cpd:C02804; cpd:C05100; cpd:C16673; cpd:C20827; cpd:C21029,5,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O3,C5H9O3,118.0629942,119.0708192,117.0551691942,1071,cpd:C01291,3-(4-Methylpent-3-en-1-yl)pent-2-enedioyl-CoA;,C32H50N7O19P3S,3-(4-Methylpent-3-en-1-yl)pent-2-enedioyl-CoA; Isohexenyl-glutaconyl-CoA,R03493 R03494,Geraniol degradation,4.2.1.57; 6.4.1.5,NA,NA,PubChem: 4510; ChEBI: 15480; NIKKAJI: J2.732.417G,cpd:C01291,32,50,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H51O19N7P3S1,C32H49O19N7P3S1,961.2095046,962.2173296,960.2016796943,1072,cpd:C01499,Geranial;,C10H16O,Geranial; trans-Citral,R03581 R08086 R08099 R08398 R10308,Geraniol degradation; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.1.1.183; 1.1.1.347; 1.2.1.86,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C01499  Geranial; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C01499  Geranial; Major components of natural products [BR:br08323];  Medicinal herbs;   Lemon grass;    C01499  Geranial,CAS: 141-27-5 5392-40-5; PubChem: 4668; ChEBI: 16980; ChEMBL: CHEMBL1080997; LIPIDMAPS: LMPR0102010003; KNApSAcK: C00003035 C00035822; 3DMET: B00306; NIKKAJI: J2.026E J3.073B,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.1122901944,1073,cpd:C01500,Geraniol,C10H18O,Geraniol,R03581 R08396 R08501 R08502 R08785 R09708 R10308 R11552,Geraniol degradation; Monoterpenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.1.1.183; 1.1.1.347; 1.14.13.152; 3.1.7.3; 3.1.7.11; 5.4.4.4,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C01500  Geraniol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C01500  Geraniol; Pharmaceutical additives [BR:br08316];  Base;   C01500  [102490] Geraniol;  Algefacient;   C01500  [102490] Geraniol;  Favoring agent, Fragrance;   C01500  [102490] Geraniol;  Solubilization agent;   C01500  [102490] Geraniol; Major components of natural products [BR:br08323];  Essential oils;   Palmarosa oil (India);    C01500  Geraniol",CAS: 106-24-1; PubChem: 4669; ChEBI: 17447; ChEMBL: CHEMBL25719; LipidBank: IIP0004; KNApSAcK: C00000845; PDB-CCD: 64Z; 3DMET: B00307; NIKKAJI: J3.240I,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.1279402945,1074,cpd:C01920,Geranoyl-CoA;,C31H50N7O17P3S,Geranoyl-CoA; cis-Geranyl-CoA,R03494 R08089 R08098,Geraniol degradation,1.3.99.-; 5.2.1.-; 6.4.1.5,NA,NA,PubChem: 5026; ChEBI: 15523; NIKKAJI: J2.609.446A,cpd:C01920; cpd:C11945; cpd:C11946; cpd:C16465,31,50,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H51O17N7P3S1,C31H49O17N7P3S1,917.2196753,918.2275004,916.2118503946,1075,cpd:C04675,3-Hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl-CoA;,C32H52N7O20P3S,3-Hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl-CoA; 3-Hydroxy-3-isohexeneylglutaryl-CoA,R03493 R08090,Geraniol degradation,4.1.3.4; 4.1.3.26; 4.2.1.57,NA,NA,PubChem: 7256; ChEBI: 15483; NIKKAJI: J2.752.858I,cpd:C04675,32,52,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H53O20N7P3S1,C32H51O20N7P3S1,979.2200693,980.2278943,978.2122442947,1076,cpd:C09847,cis-Citral;,C10H16O,cis-Citral; Neral,R08083 R08099 R08394,Geraniol degradation; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,1.1.1.183,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C09847  Neral; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C09847  cis-Citral; Major components of natural products [BR:br08323];  Medicinal herbs;   Lemon grass;    C09847  cis-Citral,CAS: 106-26-3; PubChem: 12034; ChEBI: 29020; LIPIDMAPS: LMPR0102010006; KNApSAcK: C00003036; 3DMET: B03319; NIKKAJI: J3.242E,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.1122901948,1077,cpd:C09848,(R)-(+)-Citronellal,C10H18O,(R)-(+)-Citronellal,R08084 R08087 R08399 R10125,Geraniol degradation; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,1.1.1.183; 1.1.1.-; 1.2.1.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C09848  (R)-(+)-Citronellal; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C09848  (R)-(+)-Citronellal,CAS: 2385-77-5; PubChem: 12035; ChEBI: 299; ChEMBL: CHEMBL1081721; LIPIDMAPS: LMPR0102010007; KNApSAcK: C00003037; 3DMET: B03320; NIKKAJI: J3.239E J43.580E,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.1279402949,1078,cpd:C09849,beta-Citronellol;,C10H20O,beta-Citronellol; (R)-(+)-Citronellol,R08084 R08397 R10125,Geraniol degradation; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,1.1.1.183; 1.1.1.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C09849  beta-Citronellol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C09849  beta-Citronellol; Major components of natural products [BR:br08323];  Essential oils;   Rose oil;    C09849  beta-Citronellol;   Geranium oil;    C09849  beta-Citronellol,CAS: 106-22-9 1117-61-9; PubChem: 12036; ChEBI: 10360; ChEMBL: CHEMBL1907993; LIPIDMAPS: LMPR0102010008; KNApSAcK: C00000844 C00003038; 3DMET: B03321; NIKKAJI: J3.238G J67.959C,cpd:C00400; cpd:C00553; cpd:C09849; cpd:C11386; cpd:C12307,10,20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H21O1,C10H19O1,156.1514153,157.1592403,155.1435902950,1079,cpd:C09871,Nerol;,C10H18O,"Nerol; (Z)-3,7-Dimethylocta-2,6-dien-1-ol",R08083 R08393,Geraniol degradation; Biosynthesis of terpenoids and steroids,1.1.1.183,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C09871  Nerol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C09871  Nerol,CAS: 106-25-2; PubChem: 12057; ChEBI: 29452; ChEMBL: CHEMBL452683; LIPIDMAPS: LMPR0102010010; KNApSAcK: C00000855; 3DMET: B03338; NIKKAJI: J3.241G,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.1279402951,1080,cpd:C11384,(S)-(-)-Citronellal;,C10H18O,"(S)-(-)-Citronellal; (S)-3,7-Dimethyloct-6-enal",R08085 R08096 R10126,Geraniol degradation,1.1.1.183; 1.1.1.-; 1.2.1.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C11384  (S)-(-)-Citronellal; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C11384  (S)-(-)-Citronellal,CAS: 5949-05-3; PubChem: 13558; ChEBI: 368; LIPIDMAPS: LMPR0102010011; KNApSAcK: C00010309; 3DMET: B04233; NIKKAJI: J66.806K,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.1279402952,1081,cpd:C11386,(-)-Citronellol,C10H20O,(-)-Citronellol,R08085 R10126,Geraniol degradation,1.1.1.183; 1.1.1.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C11386  (-)-Citronellol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C11386  (-)-Citronellol; Major components of natural products [BR:br08323];  Essential oils;   Rose oil;    C11386  (-)-Citronellol;   Geranium oil;    C11386  (-)-Citronellol,CAS: 7540-51-4; PubChem: 13560; ChEBI: 88; ChEMBL: CHEMBL1907995; LIPIDMAPS: LMPR0102010012; KNApSAcK: C00000844; 3DMET: B04234; NIKKAJI: J67.958E,cpd:C00400; cpd:C00553; cpd:C09849; cpd:C11386; cpd:C12307,10,20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H21O1,C10H19O1,156.1514153,157.1592403,155.1435902953,1082,cpd:C16461,Geranic acid;,C10H16O2,"Geranic acid; 3,7-Dimethylocta-2,6-dienoate; Geranate",R08086 R08097,Geraniol degradation; Biosynthesis of antibiotics,1.2.1.86; 2.8.3.-,NA,NA,CAS: 459-80-3; PubChem: 47205757; ChEBI: 67264; ChEMBL: CHEMBL170190; LIPIDMAPS: LMFA01030784; PDB-CCD: 58X; NIKKAJI: J400F,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.1072047954,1083,cpd:C16462,Citronellate;,C10H18O2,"Citronellate; Citronellic acid; 3,7-Dimethyl-6-octenoic acid",R08087 R08088 R08096,Geraniol degradation,1.2.1.-; 6.2.1.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16462  3,7-Dimethyl-6-octenoic acid",CAS: 502-47-6; PubChem: 47205758; ChEBI: 80507; LIPIDMAPS: LMFA01020104; NIKKAJI: J11.776E,cpd:C03092; cpd:C04433; cpd:C06185; cpd:C07276; cpd:C07640; cpd:C09790; cpd:C16255; cpd:C16462; cpd:C17621; cpd:C18020; cpd:C18027; cpd:C18066; cpd:C18202; cpd:C19082; cpd:C20326; cpd:C21139,10,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O2,C10H17O2,170.1306798,171.1385049,169.1228548955,1084,cpd:C16464,Citronellyl-CoA,C31H52N7O17P3S,Citronellyl-CoA,R08088 R08089,Geraniol degradation,1.3.99.-; 6.2.1.-,NA,NA,PubChem: 47205760; ChEBI: 80508; NIKKAJI: J2.802.630G,cpd:C05275; cpd:C16464,31,52,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H53O17N7P3S1,C31H51O17N7P3S1,919.2353254,920.2431504,918.2275004956,1085,cpd:C16465,trans-Geranyl-CoA,C31H50N7O17P3S,trans-Geranyl-CoA,R08097 R08098,Geraniol degradation,2.8.3.-; 5.2.1.-,NA,NA,PubChem: 47205761; ChEBI: 80509; NIKKAJI: J2.802.631E,cpd:C01920; cpd:C11945; cpd:C11946; cpd:C16465,31,50,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H51O17N7P3S1,C31H49O17N7P3S1,917.2196753,918.2275004,916.2118503957,1086,cpd:C16466,7-Methyl-3-oxo-6-octenoyl-CoA,C30H48N7O18P3S,7-Methyl-3-oxo-6-octenoyl-CoA,R08090 R08091,Geraniol degradation,2.3.1.16; 4.1.3.4; 4.1.3.26,NA,NA,PubChem: 47205762; ChEBI: 52043; NIKKAJI: J2.802.632C,cpd:C16466,30,48,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H49O18N7P3S1,C30H47O18N7P3S1,919.1989399,920.2067649,918.1911149958,1087,cpd:C16468,"(2E)-5-Methylhexa-2,4-dienoyl-CoA",C28H44N7O17P3S,"(2E)-5-Methylhexa-2,4-dienoyl-CoA",R08092 R08093,Geraniol degradation,1.3.99.-; 4.2.1.17,NA,NA,PubChem: 47205764; ChEBI: 80511; NIKKAJI: J2.802.633A,cpd:C09811; cpd:C16468,28,44,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O17N7P3S1,C28H43O17N7P3S1,875.1727252,876.1805502,874.1649001959,1088,cpd:C16469,3-Hydroxy-5-methylhex-4-enoyl-CoA,C28H46N7O18P3S,3-Hydroxy-5-methylhex-4-enoyl-CoA,R08093 R08094,Geraniol degradation,1.1.1.35; 4.2.1.17,NA,NA,PubChem: 47205765; ChEBI: 80512; NIKKAJI: J2.802.634J,cpd:C09812; cpd:C16469,28,46,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O18N7P3S1,C28H45O18N7P3S1,893.1832898,894.1911149,892.1754648960,1089,cpd:C16470,5-Methylhex-4-enoyl-CoA,C28H46N7O17P3S,5-Methylhex-4-enoyl-CoA,R08091 R08092,Geraniol degradation,1.3.99.-; 2.3.1.16,NA,NA,PubChem: 47205766; ChEBI: 80513; NIKKAJI: J2.802.635H,cpd:C09823; cpd:C11949; cpd:C16470,28,46,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O17N7P3S1,C28H45O17N7P3S1,877.1883752,878.1962002,876.1805502961,1090,cpd:C16471,5-Methyl-3-oxo-4-hexenoyl-CoA,C28H44N7O18P3S,5-Methyl-3-oxo-4-hexenoyl-CoA,R08094 R08095,Geraniol degradation,1.1.1.35; 2.3.1.16,NA,NA,PubChem: 47205767; ChEBI: 80514; NIKKAJI: J2.802.636F,cpd:C06749; cpd:C09813; cpd:C16471,28,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O18N7P3S1,C28H43O18N7P3S1,891.1676398,892.1754648,890.1598147962,1091,cpd:C02226,2-Methylmaleate;,C5H6O4,2-Methylmaleate; Citraconate; Citraconic acid; Methylmaleic acid,R03896 R03897 R03898,"Valine, leucine and isoleucine biosynthesis; C5-Branched dibasic acid metabolism; Metabolic pathways; 2-Oxocarboxylic acid metabolism",4.2.1.35,"Isoleucine biosynthesis, pyruvate => 2-oxobutanoate",NA,CAS: 498-23-7; PubChem: 5291; ChEBI: 17626 30719; LIPIDMAPS: LMFA01170099; PDB-CCD: CIZ; 3DMET: B00408; NIKKAJI: J6.106I,cpd:C00337; cpd:C00433; cpd:C00490; cpd:C01732; cpd:C02132; cpd:C02214; cpd:C02226; cpd:C02800; cpd:C02871; cpd:C03306; cpd:C03703; cpd:C10600; cpd:C20756; cpd:C20757,5,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O4,C5H5O4,130.0266087,131.0344337,129.0187836963,1092,cpd:C02504,alpha-Isopropylmalate;,C7H12O5,alpha-Isopropylmalate; (2S)-2-Isopropylmalate; (2S)-2-Hydroxy-2-isopropylsuccinic acid; 2-Isopropylmalic acid; 3-Carboxy-3-hydroxy-4-methylpentanoate; 3-Carboxy-3-hydroxyisocaproate,R01213 R03968 R10170,"Valine, leucine and isoleucine biosynthesis; Pyruvate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",2.3.3.13; 4.2.1.33,"Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate",NA,PubChem: 5516; ChEBI: 1178 35128; LIPIDMAPS: LMFA01170083; KNApSAcK: C00019690; PDB-CCD: VPM; 3DMET: B01581; NIKKAJI: J319.987H,cpd:C02123; cpd:C02504; cpd:C03328; cpd:C04411; cpd:C05994; cpd:C17210; cpd:C17212; cpd:C21371,7,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O5,C7H11O5,176.0684735,177.0762985,175.0606485964,1093,cpd:C02612,(R)-2-Methylmalate;,C5H8O5,(R)-2-Methylmalate; (R)-2-Methylmalic acid; (R)-Citramalate; (R)-Citramalic acid; (R)-alpha-Hydroxypyrotartaric acid; D-Citramalate; D-Citramalic acid; D-alpha-Hydroxypyrotartaric acid; (2R)-2-Hydroxy-2-methylbutanedioate,R03896 R03995 R07399 R10640,"Valine, leucine and isoleucine biosynthesis; C5-Branched dibasic acid metabolism; Metabolic pathways; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",2.3.1.182; 2.8.3.20; 4.2.1.35,"Isoleucine biosynthesis, pyruvate => 2-oxobutanoate",NA,PubChem: 5597; ChEBI: 15586 30934; 3DMET: B00465; NIKKAJI: J73.970G,cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031,5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O5,C5H7O5,148.0371734,149.0449984,147.0293483965,1094,cpd:C02631,2-Isopropylmaleate;,C7H10O4,2-Isopropylmaleate; beta-Isopropylmaleate,R03968 R04001,"Valine, leucine and isoleucine biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism",4.2.1.33,NA,NA,PubChem: 5611; ChEBI: 17275; 3DMET: B00468; NIKKAJI: J867.346B,cpd:C02631; cpd:C04142; cpd:C04670; cpd:C04815; cpd:C05126; cpd:C13672; cpd:C21468,7,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O4,C7H9O4,158.0579088,159.0657338,157.0500838966,1095,cpd:C04181,3-Hydroxy-3-methyl-2-oxobutanoic acid;,C5H8O4,3-Hydroxy-3-methyl-2-oxobutanoic acid; 3-Hydroxy-3-methyl-2-oxobutanoate; 2-Oxo-3-hydroxyisovalerate,R03052 R04440 R05071,"Valine, leucine and isoleucine biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism",1.1.1.86; 5.4.99.3,"Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine",Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C04181  3-Hydroxy-3-methyl-2-oxobutanoic acid,PubChem: 6858; ChEBI: 11812 17667; LIPIDMAPS: LMFA01020277; 3DMET: B00686; NIKKAJI: J2.362.068E,cpd:C00489; cpd:C00707; cpd:C00900; cpd:C02352; cpd:C02674; cpd:C03409; cpd:C03589; cpd:C04106; cpd:C04181; cpd:C06010; cpd:C08298; cpd:C11838; cpd:C18061; cpd:C19483; cpd:C19885; cpd:C20232; cpd:C20846; cpd:C21177,5,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O4,C5H7O4,132.0422587,133.0500838,131.0344337967,1096,cpd:C04236,(2S)-2-Isopropyl-3-oxosuccinate;,C7H10O5,(2S)-2-Isopropyl-3-oxosuccinate; 3-Carboxy-4-methyl-2-oxopentanoate; 2-Oxo-4-methyl-3-carboxypentanoate,R01652 R04426,"Valine, leucine and isoleucine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism",1.1.1.85,NA,NA,PubChem: 6905; ChEBI: 1467; 3DMET: B01725; NIKKAJI: J2.747.832H,cpd:C00493; cpd:C04236; cpd:C16588; cpd:C17696; cpd:C18307; cpd:C18312; cpd:C20961; cpd:C21281,7,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O5,C7H9O5,174.0528234,175.0606485,173.0449984968,1097,cpd:C04272,"(R)-2,3-Dihydroxy-3-methylbutanoate;",C5H10O4,"(R)-2,3-Dihydroxy-3-methylbutanoate; (R)-2,3-Dihydroxy-isovalerate; (R)-2,3-Dihydroxy-isovaleric acid; (2R)-2,3-Dihydroxy-3-methylbutanoate",R04439 R04440 R04441 R10916,"Valine, leucine and isoleucine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.86; 1.1.1.382; 1.1.1.383; 4.2.1.9,"Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine",NA,PubChem: 6935; ChEBI: 15684 49072; 3DMET: B01729; NIKKAJI: J57.649B,cpd:C01801; cpd:C02783; cpd:C04039; cpd:C04272; cpd:C06257; cpd:C08347; cpd:C11497,5,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O4,C5H9O4,134.0579088,135.0657338,133.0500838969,1098,cpd:C04411,"(2R,3S)-3-Isopropylmalate;",C7H12O5,"(2R,3S)-3-Isopropylmalate; 3-Isopropylmalate; 3-Carboxy-2-hydroxy-4-methylpentanoate; 2-D-threo-Hydroxy-3-carboxy-isocaproate",R04001 R04426 R10052 R10170,"Valine, leucine and isoleucine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.85; 4.2.1.33,"Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate",NA,PubChem: 7045; ChEBI: 35121 43468; ChEMBL: CHEMBL376564; KNApSAcK: C00019691; PDB-CCD: IPM; 3DMET: B01741; NIKKAJI: J1.641.400J,cpd:C02123; cpd:C02504; cpd:C03328; cpd:C04411; cpd:C05994; cpd:C17210; cpd:C17212; cpd:C21371,7,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O5,C7H11O5,176.0684735,177.0762985,175.0606485970,1099,cpd:C06006,(S)-2-Aceto-2-hydroxybutanoate;,C6H10O4,(S)-2-Aceto-2-hydroxybutanoate; (S)-2-Hydroxy-2-ethyl-3-oxobutanoate,R04673 R05069 R08648,"Valine, leucine and isoleucine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.86; 2.2.1.6; 5.4.99.3,"Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine",NA,PubChem: 8279; ChEBI: 27681 49256; LIPIDMAPS: LMFA01050383; 3DMET: B01948; NIKKAJI: J372.593F,cpd:C00439; cpd:C00659; cpd:C00772; cpd:C00966; cpd:C01053; cpd:C04237; cpd:C04327; cpd:C04556; cpd:C06006; cpd:C06104; cpd:C06762; cpd:C13811; cpd:C14463; cpd:C16272; cpd:C16674; cpd:C18379; cpd:C18384; cpd:C18719; cpd:C21465,6,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O4,C6H9O4,146.0579088,147.0657338,145.0500838971,1100,cpd:C06007,"(R)-2,3-Dihydroxy-3-methylpentanoate;",C6H12O4,"(R)-2,3-Dihydroxy-3-methylpentanoate; (R)-2,3-Dihydroxy-3-methylvalerate; (2R,3R)-2,3-Dihydroxy-3-methylpentanoate",R05068 R05070,"Valine, leucine and isoleucine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.86; 4.2.1.9,"Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine",NA,PubChem: 8280; ChEBI: 27512 49258; PDB-CCD: DMV; 3DMET: B05146; NIKKAJI: J2.760.883C,cpd:C00418; cpd:C00491; cpd:C00522; cpd:C01100; cpd:C01420; cpd:C02104; cpd:C03089; cpd:C03348; cpd:C04104; cpd:C05704; cpd:C06007; cpd:C06471; cpd:C13522; cpd:C14445; cpd:C18988; cpd:C19719; cpd:C21045; cpd:C21054; cpd:C21055; cpd:C21062; cpd:C21397,6,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O4,C6H11O4,148.0735589,149.0813839,147.0657338972,1101,cpd:C06010,(S)-2-Acetolactate;,C5H8O4,(S)-2-Acetolactate; (S)-2-Hydroxy-2-methyl-3-oxobutanoate; (2S)-2-Hydroxy-2-methyl-3-oxobutanoate,R00226 R02948 R04439 R04672 R05071 R10506 R10916,"Valine, leucine and isoleucine biosynthesis; Butanoate metabolism; C5-Branched dibasic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.86; 1.1.1.382; 1.1.1.383; 2.2.1.6; 4.1.1.5; 5.4.99.3,"Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine",NA,PubChem: 8282; ChEBI: 18409; PDB-CCD: X2X; 3DMET: B01949; NIKKAJI: J2.362.063D,cpd:C00489; cpd:C00707; cpd:C00900; cpd:C02352; cpd:C02674; cpd:C03409; cpd:C03589; cpd:C04106; cpd:C04181; cpd:C06010; cpd:C08298; cpd:C11838; cpd:C18061; cpd:C19483; cpd:C19885; cpd:C20232; cpd:C20846; cpd:C21177,5,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O4,C5H7O4,132.0422587,133.0500838,131.0344337973,1102,cpd:C06032,D-erythro-3-Methylmalate;,C5H8O5,"D-erythro-3-Methylmalate; (2R,3S)-3-Methylmalate",R00994 R03898,"Valine, leucine and isoleucine biosynthesis; C5-Branched dibasic acid metabolism; Metabolic pathways; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.85; 4.2.1.35,"Isoleucine biosynthesis, pyruvate => 2-oxobutanoate",NA,PubChem: 8304; ChEBI: 27394; ChEMBL: CHEMBL226414; 3DMET: B01955; NIKKAJI: J883.007J,cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031,5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O5,C5H7O5,148.0371734,149.0449984,147.0293483974,1103,cpd:C14463,(R)-3-Hydroxy-3-methyl-2-oxopentanoate,C6H10O4,(R)-3-Hydroxy-3-methyl-2-oxopentanoate,R05068 R05069,"Valine, leucine and isoleucine biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism",1.1.1.86; 5.4.99.3,"Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine; Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine",NA,PubChem: 17395463; ChEBI: 34008 49257; NIKKAJI: J2.788.388E,cpd:C00439; cpd:C00659; cpd:C00772; cpd:C00966; cpd:C01053; cpd:C04237; cpd:C04327; cpd:C04556; cpd:C06006; cpd:C06104; cpd:C06762; cpd:C13811; cpd:C14463; cpd:C16272; cpd:C16674; cpd:C18379; cpd:C18384; cpd:C18719; cpd:C21465,6,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O4,C6H9O4,146.0579088,147.0657338,145.0500838975,1104,cpd:C00047,L-Lysine;,C6H14N2O2,"L-Lysine; Lysine acid; 2,6-Diaminohexanoic acid",R00445 R00446 R00447 R00448 R00449 R00451 R00452 R00453; R00454 R00457 R00458 R00459 R00460 R00461 R00462 R00463; R00545 R00612 R00715 R00716 R00910 R00911 R01077 R01396; R01620 R02786 R03095 R03658 R07598 R07646 R08125 R09597; R09779 R10010 R10011 R10054 R10277 R10699 R11190,"Lysine biosynthesis; Lysine degradation; Biotin metabolism; Tropane, piperidine and pyridine alkaloid biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption",1.4.1.15; 1.4.1.18; 1.4.3.14; 1.4.3.20; 1.5.1.7; 1.5.1.8; 1.5.1.16; 1.5.3.4; 1.13.12.2; 1.14.13.59; 2.1.3.8; 2.3.1.32; 2.3.1.-; 2.6.1.36; 2.6.1.71; 2.6.1.105; 3.4.13.4; 3.4.14.13; 3.5.1.12; 3.5.1.17; 3.5.1.-; 3.5.2.11; 3.5.-.-; 4.1.1.18; 4.1.1.20; 4.3.1.28; 5.1.1.5; 5.1.1.9; 5.4.3.2; 5.4.99.58; 6.1.1.6; 6.3.2.7; 6.3.2.11; 6.3.2.20; 6.3.4.19,"Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine; Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00047  Lysine (Lys); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05X I.V. SOLUTION ADDITIVES;     B05XB Amino acids;      B05XB03 Lysine;       D02304  Lysine (USAN/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Lysine;     D02304  Lysine (USAN/INN),CAS: 56-87-1; PubChem: 3349; ChEBI: 18019; ChEMBL: CHEMBL8085; KNApSAcK: C00001378; PDB-CCD: LYS; 3DMET: B00013; NIKKAJI: J9.176F,cpd:C00047; cpd:C00739; cpd:C01142; cpd:C01186; cpd:C05161; cpd:C16440; cpd:C20277,6,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O2N2,C6H13O2N2,146.1055277,147.1133527,145.0977027976,1105,cpd:C00322,2-Oxoadipate;,C6H8O5,2-Oxoadipate; 2-Oxoadipic acid,R01932 R01933 R01934 R01936 R01937 R01938 R01939 R01940; R08331,Lysine biosynthesis; Lysine degradation; Tryptophan metabolism; Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids,1.1.1.87; 1.1.1.172; 1.1.1.286; 1.2.4.2; 1.5.1.-; 1.8.1.4; 2.3.1.61; 2.3.3.-; 2.6.1.39,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C00322  2-Oxoadipate,CAS: 3184-35-8; PubChem: 3616; ChEBI: 15753; LIPIDMAPS: LMFA01170121; KNApSAcK: C00000770; PDB-CCD: OOG; 3DMET: B00088; NIKKAJI: J39.063A,cpd:C00322; cpd:C00846; cpd:C04287; cpd:C04305; cpd:C04361; cpd:C06379; cpd:C06891; cpd:C16159; cpd:C19128; cpd:C20781,6,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O5,C6H7O5,160.0371734,161.0449984,159.0293483977,1106,cpd:C00449,"N6-(L-1,3-Dicarboxypropyl)-L-lysine;",C11H20N2O6,"N6-(L-1,3-Dicarboxypropyl)-L-lysine; Saccharopine; L-Saccharopine; N-[(S)-5-Amino-5-carboxypentyl]-L-glutamic acid",R00715 R00716 R02313 R02315 R09495,Lysine biosynthesis; Lysine degradation; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids,1.5.1.7; 1.5.1.8; 1.5.1.9; 1.5.1.10; 1.5.3.18,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine degradation, lysine => saccharopine => acetoacetyl-CoA",NA,CAS: 997-68-2; PubChem: 3737; ChEBI: 16927; KNApSAcK: C00007227; PDB-CCD: SHR; 3DMET: B01246; NIKKAJI: J7.215J,cpd:C00449,11,20,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H21O6N2,C11H19O6N2,276.1321364,277.1399614,275.1243113978,1107,cpd:C00666,"LL-2,6-Diaminoheptanedioate;",C7H14N2O4,"LL-2,6-Diaminoheptanedioate; LL-2,6-Diaminopimelate; LL-2,6-Diaminopimelic acid",R02733 R02734 R02735 R07613,Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids,2.6.1.83; 3.5.1.18; 3.5.1.47; 5.1.1.7,"Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,PubChem: 3935; ChEBI: 16026 47031; LIPIDMAPS: LMFA01170102; KNApSAcK: C00007596; 3DMET: B01303; NIKKAJI: J81.742B,cpd:C00542; cpd:C00666; cpd:C00680; cpd:C02291; cpd:C05699; cpd:C08275; cpd:C18646; cpd:C18906; cpd:C20914,7,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O4N2,C7H13O4N2,190.0953569,191.103182,189.0875319979,1108,cpd:C00680,"meso-2,6-Diaminoheptanedioate;",C7H14N2O4,"meso-2,6-Diaminoheptanedioate; meso-2,6-Diaminopimelate; meso-2,6-Diaminopimelic acid; meso-Diaminoheptanedioate",R00451 R02735 R02755 R02788,Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Biosynthesis of amino acids,1.4.1.16; 4.1.1.20; 5.1.1.7; 6.3.2.13,"Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine; Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine; Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine",NA,PubChem: 3949; ChEBI: 16488 30308; ChEMBL: CHEMBL415306; KNApSAcK: C00007595; PDB-CCD: 6CL API; 3DMET: B01309; NIKKAJI: J407.120D,cpd:C00542; cpd:C00666; cpd:C00680; cpd:C02291; cpd:C05699; cpd:C08275; cpd:C18646; cpd:C18906; cpd:C20914,7,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O4N2,C7H13O4N2,190.0953569,191.103182,189.0875319980,1109,cpd:C00956,L-2-Aminoadipate;,C6H11NO4,L-2-Aminoadipate; L-alpha-Aminoadipate; L-alpha-Aminoadipic acid; L-2-Aminoadipic acid; L-2-Aminohexanedioate,R01939 R03098 R03102 R03103 R04868 R04870 R06361 R09775; R11231 R11232,Lysine biosynthesis; Lysine degradation; Penicillin and cephalosporin biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids,1.2.1.31; 2.3.1.164; 2.6.1.39; 6.3.2.26; 6.3.2.43,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine; Lysine degradation, lysine => saccharopine => acetoacetyl-CoA; Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin; Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",NA,CAS: 542-32-5; PubChem: 4207; ChEBI: 37023; ChEMBL: CHEMBL88804; KNApSAcK: C00007393; PDB-CCD: UN1; 3DMET: B01358; NIKKAJI: J38.125J,cpd:C00734; cpd:C00956; cpd:C01046; cpd:C01077; cpd:C02207; cpd:C03210; cpd:C05016; cpd:C06234; cpd:C17581; cpd:C19694,6,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O4N1,C6H10O4N1,161.0688078,162.0766329,160.0609828981,1110,cpd:C01251,"(R)-2-Hydroxybutane-1,2,4-tricarboxylate;",C7H10O7,"(R)-2-Hydroxybutane-1,2,4-tricarboxylate; Homocitrate; Homocitric acid; 3-Hydroxy-3-carboxyadipic acid; (R)-2-Hydroxy-1,2,4-butanetricarboxylic acid",R00271 R03444 R09720,Lysine biosynthesis; Pyruvate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids,2.3.3.14; 4.2.1.114; 4.2.1.-,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,PubChem: 4471; ChEBI: 17852 36457 52222; PDB-CCD: HCA; 3DMET: B01423; NIKKAJI: J593.429J,cpd:C01251; cpd:C02225; cpd:C04593; cpd:C05662,7,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O7,C7H9O7,206.0426527,207.0504777,205.0348276982,1111,cpd:C03871,L-2-Amino-6-oxoheptanedioate;,C7H11NO5,L-2-Amino-6-oxoheptanedioate; L-2-Amino-6-oxopimelate,R02755 R04336,Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids,1.4.1.16,"Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine",NA,PubChem: 6605; ChEBI: 28245; PDB-CCD: 26P; 3DMET: B00648; NIKKAJI: J1.813.077G,cpd:C00624; cpd:C03871; cpd:C12109,7,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O5N1,C7H10O5N1,189.0637225,190.0715475,188.0558974983,1112,cpd:C04002,"(Z)-But-1-ene-1,2,4-tricarboxylate;",C7H8O6,"(Z)-But-1-ene-1,2,4-tricarboxylate; Homo-cis-aconitate; cis-Homoaconitate; (Z)-1,2,4-But-1-enetricarboxylic acid",R03444 R04371,Lysine biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids,4.2.1.36; 4.2.1.114; 4.2.1.-,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,PubChem: 6715; ChEBI: 17516; 3DMET: B00663; NIKKAJI: J181.759K,cpd:C04002; cpd:C04225; cpd:C06246; cpd:C11514; cpd:C11515; cpd:C16579; cpd:C21250,7,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O6,C7H7O6,188.032088,189.039913,187.0242629984,1113,cpd:C04076,L-2-Aminoadipate 6-semialdehyde;,C6H11NO3,L-2-Aminoadipate 6-semialdehyde; 2-Aminoadipate 6-semialdehyde; L-Allysine; Allysine; (S)-2-Amino-6-oxohexanoate,R00446 R00453 R00457 R02313 R02315 R02317 R03102 R03103; R04390 R07598 R09495 R10270 R10699,"Lysine biosynthesis; Lysine degradation; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",1.2.1.31; 1.4.1.18; 1.4.3.20; 1.5.1.9; 1.5.1.10; 1.5.3.18; 2.6.1.36; 2.6.1.71; 2.6.1.105; 4.2.3.134,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine degradation, lysine => saccharopine => acetoacetyl-CoA",NA,PubChem: 6771; ChEBI: 17917; 3DMET: B00675; NIKKAJI: J1.136.598A,cpd:C02946; cpd:C03145; cpd:C03239; cpd:C03656; cpd:C04076; cpd:C05706; cpd:C05825; cpd:C06023; cpd:C08265; cpd:C08295,6,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O3N1,C6H10O3N1,145.0738932,146.0817182,144.0660682985,1114,cpd:C04390,"N6-Acetyl-LL-2,6-diaminoheptanedioate;",C9H16N2O5,"N6-Acetyl-LL-2,6-diaminoheptanedioate; N2-Acetyl-LL-2,6-diaminoheptanedioate; N6-Acetyl-LL-2,6-diaminopimelate; N2-Acetyl-LL-2,6-diaminopimelate; N6-Acetyl-L-2,6-diaminoheptanedioate; N6-Acetyl-L-2,6-diaminopimelate; N-Acetyl-LL-2,6-diaminoheptanedioate",R02733 R04467,Lysine biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids,2.6.1.-; 3.5.1.47,"Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine",NA,PubChem: 7030; ChEBI: 18317 49004; 3DMET: B01738; NIKKAJI: J2.358.308I,cpd:C01410; cpd:C03415; cpd:C04390; cpd:C05695; cpd:C15767; cpd:C21015,9,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O5N2,C9H15O5N2,232.1059216,233.1137467,231.0980966986,1115,cpd:C04421,"N-Succinyl-LL-2,6-diaminoheptanedioate;",C11H18N2O7,"N-Succinyl-LL-2,6-diaminoheptanedioate; N-Succinyl-LL-2,6-diaminopimelate; N-Succinyl-L-2,6-diaminoheptanedioate; N-Succinyl-L-2,6-diaminopimelate",R02734 R04475,Lysine biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of amino acids,2.6.1.17; 3.5.1.18,"Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine",NA,PubChem: 7053; ChEBI: 17279; KNApSAcK: C00007597; 3DMET: B01743; NIKKAJI: J978.287G,cpd:C04421,11,18,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H19O7N2,C11H17O7N2,290.1114009,291.119226,289.1035759987,1116,cpd:C04462,N-Succinyl-2-L-amino-6-oxoheptanedioate;,C11H15NO8,N-Succinyl-2-L-amino-6-oxoheptanedioate; N-Succinyl-L-2-amino-6-oxoheptanedioate; N-Succinyl-L-2-amino-6-oxopimelate; N-Succinyl-2-amino-6-oxo-L-pimelic acid; N-Succinyl-epsilon-keto-L-aminopimelic acid; (S)-2-(Succinylamino)-6-oxoheptanedioate,R04365 R04475,Lysine biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of amino acids,2.3.1.117; 2.6.1.17,"Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine",NA,PubChem: 7087; ChEBI: 15685 35266; ChEMBL: CHEMBL175209; KNApSAcK: C00007598; 3DMET: B00719; NIKKAJI: J788.069C,cpd:C04462; cpd:C05537,11,15,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H16O8N1,C11H14O8N1,289.0797664,290.0875915,288.0719414988,1117,cpd:C04877,"UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminopimelate;",C35H55N7O26P2,"UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminopimelate; UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate; UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate; UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-diaminopimelate; UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-diamino-heptanedioate",R02788 R04617 R10901,Lysine biosynthesis; Peptidoglycan biosynthesis,6.3.2.10; 6.3.2.13; 6.3.2.45,NA,NA,PubChem: 7429; ChEBI: 84805; 3DMET: B04971; NIKKAJI: J2.757.188C,cpd:C04877; cpd:C20886,35,55,26,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H56O26N7P2,C35H54O26N7P2,1051.267199,1052.275024,1050.259374989,1118,cpd:C04882,UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-6-carboxy-L-lysyl-D-alanyl-D-alanine;,C41H65N9O28P2,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-6-carboxy-L-lysyl-D-alanyl-D-alanine; UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine; UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-6-carboxy-L-lysyl-D-alanyl-D-alanine",R04617 R05630 R08850,Lysine biosynthesis; Peptidoglycan biosynthesis,2.7.8.13; 3.4.17.8; 6.3.2.10,NA,NA,PubChem: 7434; ChEBI: 18199; 3DMET: B04972; NIKKAJI: J2.754.729J,cpd:C04882,41,65,28,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H66O28N9P2,C41H64O28N9P2,1193.341426,1194.349252,1192.333601990,1120,cpd:C05560,L-2-Aminoadipate adenylate;,C16H23N6O10P,L-2-Aminoadipate adenylate; 5-Adenylyl-2-aminoadipate; alpha-Aminoadipoyl-C6-AMP,R03098 R04863,Lysine biosynthesis,1.2.1.31,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine",NA,PubChem: 7891; ChEBI: 20536 6163; 3DMET: B01874; NIKKAJI: J2.756.232I,cpd:C05560,16,23,10,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H24O10N6P1,C16H22O10N6P1,490.121328,491.129153,489.1135029991,1121,cpd:C05662,Homoisocitrate;,C7H10O7,"Homoisocitrate; 3-Carboxy-2-hydroxyadipate; (-)-1-Hydroxy-1,2,4-butanetricarboxylate; (1R,2S)-1-Hydroxybutane-1,2,4-tricarboxylate; (-)-threo-Homoisocitrate",R01934 R04371 R04862 R09720,Lysine biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids,1.1.1.87; 1.1.1.286; 4.2.1.36; 4.2.1.114,"Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine; Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate; 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,PubChem: 7972; ChEBI: 15404 30903 30904; ChEMBL: CHEMBL375897; PDB-CCD: 48Y; 3DMET: B01881; NIKKAJI: J2.204.427C,cpd:C01251; cpd:C02225; cpd:C04593; cpd:C05662,7,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O7,C7H9O7,206.0426527,207.0504777,205.0348276992,1122,cpd:C16138,L-Pyrrolysine;,C12H21N3O3,L-Pyrrolysine; Pyrrolysine,R08578 R10013,Lysine biosynthesis; Aminoacyl-tRNA biosynthesis; Microbial metabolism in diverse environments; Protein digestion and absorption,6.1.1.26,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C16138  Pyrrolysine (Pyl),CAS: 448235-52-7; PubChem: 47205448; ChEBI: 21860; PDB-CCD: PYL; NIKKAJI: J1.888.988I,cpd:C16138,12,21,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H22O3N3,C12H20O3N3,255.1582915,256.1661166,254.1504665993,1127,cpd:C20277,"(2R,3R)-3-Methylornithine;",C6H14N2O2,"(2R,3R)-3-Methylornithine; (3R)-3-Methyl-D-ornithine",R10010 R10011,Lysine biosynthesis; Microbial metabolism in diverse environments,5.4.99.58,NA,NA,PubChem: 163312017; PDB-CCD: MD0,cpd:C00047; cpd:C00739; cpd:C01142; cpd:C01186; cpd:C05161; cpd:C16440; cpd:C20277,6,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O2N2,C6H13O2N2,146.1055277,147.1133527,145.0977027994,1128,cpd:C20278,"(2R,3R)-3-Methylornithinyl-N6-lysine",C12H26N4O3,"(2R,3R)-3-Methylornithinyl-N6-lysine",R10011 R10012,Lysine biosynthesis; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 163312018,cpd:C20278,12,26,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H27O3N4,C12H25O3N4,274.2004907,275.2083157,273.1926657995,1129,cpd:C20279,"(2R,3R)-3-Methylglutamyl-5-semialdehyde-N6-lysine",C12H23N3O4,"(2R,3R)-3-Methylglutamyl-5-semialdehyde-N6-lysine",R10012 R10013,Lysine biosynthesis; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 163312019,cpd:C20279,12,23,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O4N3,C12H22O4N3,273.1688562,274.1766813,272.1610312996,1130,cpd:C00408,L-Pipecolate;,C6H11NO2,L-Pipecolate; Pipecolinic acid; Pipecolic acid; 2-Piperidinecarboxylic acid; (S)-Piperidine-2-carboxylic acid,R00459 R02201 R02203 R02204 R02205 R02206 R08414 R08415; R09680 R10277,"Lysine degradation; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",1.5.1.1; 1.5.1.21; 1.5.3.7; 1.5.99.3; 3.5.1.101; 4.3.1.28,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C00408  L-Pipecolate,CAS: 3105-95-1; PubChem: 3698; ChEBI: 30633 30913; ChEMBL: CHEMBL322883; KNApSAcK: C00000210 C00001387; PDB-CCD: YCP; 3DMET: B01237; NIKKAJI: J215.717I,cpd:C00408; cpd:C03969; cpd:C05936; cpd:C07500; cpd:C13696; cpd:C16759; cpd:C20204,6,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O2N1,C6H10O2N1,129.0789786,130.0868036,128.0711536997,1131,cpd:C00431,5-Aminopentanoate;,C5H11NO2,5-Aminopentanoate; 5-Aminopentanoic acid; 5-Aminovaleric acid,R02273 R02274 R02276 R02825,Lysine degradation; Arginine and proline metabolism,1.4.1.12; 1.21.4.1; 2.6.1.48; 3.5.1.30; 3.5.1.63,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0110 Amino fatty acids;     C00431  5-Aminopentanoic acid,CAS: 660-88-8; PubChem: 3720; ChEBI: 15887; ChEMBL: CHEMBL284116; LIPIDMAPS: LMFA01100040; PDB-CCD: DAV; 3DMET: B00111; NIKKAJI: J38.132B,cpd:C00073; cpd:C00183; cpd:C00431; cpd:C00719; cpd:C00855; cpd:C01733; cpd:C01799; cpd:C01826; cpd:C03571; cpd:C05335; cpd:C06417; cpd:C07418; cpd:C07457; cpd:C15987; cpd:C16436,5,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O2N1,C5H10O2N1,117.0789786,118.0868036,116.0711536998,1132,cpd:C00450,"(S)-2,3,4,5-Tetrahydropyridine-2-carboxylate;",C6H9NO2,"(S)-2,3,4,5-Tetrahydropyridine-2-carboxylate; Delta1-Piperideine-6-L-carboxylate",R02204 R02205 R02206 R02317 R08414 R10054 R11231 R11232,"Lysine degradation; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",1.2.1.31; 1.4.1.18; 1.5.3.7; 1.5.99.3,NA,NA,PubChem: 3738; ChEBI: 49014 58769; 3DMET: B04684; NIKKAJI: J762.515D,cpd:C00450; cpd:C04092; cpd:C08268; cpd:C08292; cpd:C10149; cpd:C13694,6,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O2N1,C6H8O2N1,127.0633285,128.0711536,126.0555035999,1133,cpd:C00487,Carnitine;,C7H16NO3,Carnitine; gamma-Trimethyl-hydroxybutyrobetaine; 3-Hydroxy-4-trimethylammoniobutanoate,R02395 R02396 R02397 R02398,Lysine degradation; ABC transporters,1.1.1.108; 1.14.11.1; 2.3.1.7; 4.1.1.42,NA,Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Carnitine;     C00487  Carnitine,CAS: 406-76-8; PubChem: 3770; ChEBI: 17126 3424; ChEMBL: CHEMBL1620698; 3DMET: B04687; NIKKAJI: J334.275A,cpd:C00487,7,16,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H17O3N1,C7H15O3N1,162.1130184,163.1208434,161.10519331000,1134,cpd:C00739,D-Lysine;,C6H14N2O2,"D-Lysine; D-2,6-Diaminohexanoic acid",R00460 R02851 R02852 R09596,Lysine degradation,2.6.1.21; 5.1.1.5; 5.1.1.9; 5.4.3.4; 6.3.2.37,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00739  D-Lysine,CAS: 923-27-3; PubChem: 4002; ChEBI: 16855; ChEMBL: CHEMBL319497; PDB-CCD: DLY; 3DMET: B01320; NIKKAJI: J9.203G,cpd:C00047; cpd:C00739; cpd:C01142; cpd:C01186; cpd:C05161; cpd:C16440; cpd:C20277,6,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O2N2,C6H13O2N2,146.1055277,147.1133527,145.09770271001,1135,cpd:C00990,5-Aminopentanamide,C5H12N2O,5-Aminopentanamide,R00449 R02273,Lysine degradation,1.13.12.2; 3.5.1.30,NA,NA,PubChem: 4236; ChEBI: 18120; 3DMET: B00217; NIKKAJI: J38.134I,cpd:C00990,5,12,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O1N2,C5H11O1N2,116.094963,117.102788,115.0871381002,1136,cpd:C01028,N6-Hydroxy-L-lysine,C6H14N2O3,N6-Hydroxy-L-lysine,R00448 R03168,Lysine degradation; Microbial metabolism in diverse environments,1.14.13.59; 2.3.1.102,NA,NA,PubChem: 4272; ChEBI: 16570; 3DMET: B01367; NIKKAJI: J35.840A,cpd:C01028; cpd:C02627; cpd:C16741; cpd:C16742; cpd:C21041,6,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O3N2,C6H13O3N2,162.1004423,163.1082674,161.09261731003,1137,cpd:C01142,"(3S)-3,6-Diaminohexanoate;",C6H14N2O2,"(3S)-3,6-Diaminohexanoate; L-beta-Lysine",R00461 R03275,Lysine degradation,5.4.3.2; 5.4.3.3,NA,NA,PubChem: 4373; ChEBI: 15613; PDB-CCD: KBE; 3DMET: B01391; NIKKAJI: J79.639E,cpd:C00047; cpd:C00739; cpd:C01142; cpd:C01186; cpd:C05161; cpd:C16440; cpd:C20277,6,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O2N2,C6H13O2N2,146.1055277,147.1133527,145.09770271004,1138,cpd:C01149,4-Trimethylammoniobutanal,C7H16NO,4-Trimethylammoniobutanal,R03283 R03284,Lysine degradation,1.2.1.3; 1.2.1.47; 4.1.2.-,NA,NA,PubChem: 4378; ChEBI: 18020; PDB-CCD: 2ZO; 3DMET: B00247; NIKKAJI: J2.362.000F,cpd:C01149,7,16,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H17O1N1,C7H15O1N1,130.1231891,131.1310142,129.11536411005,1139,cpd:C01181,4-Trimethylammoniobutanoate;,C7H16NO2,4-Trimethylammoniobutanoate; Butyro-betaine; gamma-Butyrobetaine,R02397 R03283 R10644,Lysine degradation; ABC transporters,1.2.1.3; 1.2.1.47; 1.14.11.1; 2.8.3.21,NA,NA,PubChem: 4408; ChEBI: 1941; PDB-CCD: NM2; 3DMET: B00256; NIKKAJI: J38.536K,cpd:C01181; cpd:C01996; cpd:C08201,7,16,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H17O2N1,C7H15O2N1,146.1181038,147.1259288,145.11027871006,1140,cpd:C01186,"(3S,5S)-3,5-Diaminohexanoate;",C6H14N2O2,"(3S,5S)-3,5-Diaminohexanoate; L-erythro-3,5-Diaminohexanoate; (3S,5S)-3,5-Diaminocaproate; L-erythro-3,5-Diaminocaproate",R03275 R03349,Lysine degradation,1.4.1.11; 5.4.3.3,NA,NA,PubChem: 4412; ChEBI: 15616; 3DMET: B01405; NIKKAJI: J2.364.557B,cpd:C00047; cpd:C00739; cpd:C01142; cpd:C01186; cpd:C05161; cpd:C16440; cpd:C20277,6,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O2N2,C6H13O2N2,146.1055277,147.1133527,145.09770271007,1142,cpd:C01259,"3-Hydroxy-N6,N6,N6-trimethyl-L-lysine",C9H21N2O3,"3-Hydroxy-N6,N6,N6-trimethyl-L-lysine",R03284 R03451,Lysine degradation,1.14.11.8; 4.1.2.-,NA,NA,PubChem: 4478; ChEBI: 15786; 3DMET: B04788; NIKKAJI: J2.732.026K,cpd:C01259,9,21,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H22O3N2,C9H20O3N2,205.1552175,206.1630426,204.14739251008,1143,cpd:C01672,Cadaverine;,C5H14N2,"Cadaverine; 1,5-Pentanediamine; 1,5-Diaminopentane; Pentamethylenediamine",R00462 R03666 R06740 R08359 R08418 R08419 R08421 R09048,"Lysine degradation; Glutathione metabolism; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Protein digestion and absorption",1.4.3.21; 2.5.1.16; 4.1.1.18,NA,NA,CAS: 462-94-2; PubChem: 4816; ChEBI: 18127; ChEMBL: CHEMBL119296; KNApSAcK: C00001403; PDB-CCD: N2P; 3DMET: B00334; NIKKAJI: J5.771A,cpd:C01672; cpd:C02723; cpd:C07651,5,14,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H15N2,C5H13N2,102.1156985,103.1235235,101.10787341009,1145,cpd:C02727,N6-Acetyl-L-lysine,C8H16N2O3,N6-Acetyl-L-lysine,R00454 R00458 R01620 R04029,Lysine degradation,2.3.1.32; 2.3.1.-; 2.6.1.65; 3.5.1.17,NA,NA,CAS: 692-04-6; PubChem: 5689; ChEBI: 17752; ChEMBL: CHEMBL1230958; PDB-CCD: ALY; 3DMET: B01598; NIKKAJI: J206.006J,cpd:C02155; cpd:C02727; cpd:C03846; cpd:C12989; cpd:C17242,8,16,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O3N2,C8H15O3N2,188.1160924,189.1239174,187.10826741010,1146,cpd:C03087,5-Acetamidopentanoate,C7H13NO3,5-Acetamidopentanoate,R02276 R04142,Lysine degradation,1.2.4.-; 3.5.1.63,NA,NA,PubChem: 5985; ChEBI: 2024; 3DMET: B00539; NIKKAJI: J2.366.333C,cpd:C02712; cpd:C03087; cpd:C08269; cpd:C10151; cpd:C10850,7,13,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O3N1,C7H12O3N1,159.0895433,160.0973683,158.08171821011,1147,cpd:C03239,6-Amino-2-oxohexanoate;,C6H11NO3,6-Amino-2-oxohexanoate; 2-Oxo-6-aminocaproate,R00447 R02851 R04174 R04175,"Lysine degradation; Tropane, piperidine and pyridine alkaloid biosynthesis; Metabolic pathways",1.4.3.14; 2.6.1.21; 3.5.1.17,NA,NA,PubChem: 6109; ChEBI: 17534; 3DMET: B00567; NIKKAJI: J39.064J,cpd:C02946; cpd:C03145; cpd:C03239; cpd:C03656; cpd:C04076; cpd:C05706; cpd:C05825; cpd:C06023; cpd:C08265; cpd:C08295,6,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O3N1,C6H10O3N1,145.0738932,146.0817182,144.06606821012,1148,cpd:C03273,5-Oxopentanoate;,C5H8O3,5-Oxopentanoate; Glutarate semialdehyde,R02274 R02401 R10981 R10982,Lysine degradation,1.1.1.-; 1.2.1.20; 1.2.1.-; 2.6.1.48,NA,NA,PubChem: 6134; ChEBI: 16120 39153; LIPIDMAPS: LMFA01060161; 3DMET: B00572; NIKKAJI: J135.882K,cpd:C00141; cpd:C01180; cpd:C02233; cpd:C02707; cpd:C03273; cpd:C05727; cpd:C06255; cpd:C07764; cpd:C18006; cpd:C19485; cpd:C19803,5,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O3,C5H7O3,116.0473441,117.0551691,115.03951911013,1149,cpd:C03366,5-Phosphonooxy-L-lysine;,C6H15N2O6P,5-Phosphonooxy-L-lysine; O-Phosphohydroxy-L-lysine; (5R)-5-Phosphonooxy-L-lysine,R03378 R10270,Lysine degradation; Metabolic pathways,2.7.1.81; 4.2.3.134,NA,NA,PubChem: 6203; ChEBI: 16752; 3DMET: B04892; NIKKAJI: J2.741.593H,cpd:C03366; cpd:C03828; cpd:C03980; cpd:C16743,6,15,6,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H16O6N2P1,C6H14O6N2P1,242.0667732,243.0745982,241.05894821014,1150,cpd:C03656,(S)-5-Amino-3-oxohexanoic acid;,C6H11NO3,(S)-5-Amino-3-oxohexanoic acid; (S)-5-Amino-3-oxohexanoate,R03349 R10564,Lysine degradation,1.4.1.11; 2.3.1.247,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C03656  (5S)-5-Amino-3-oxohexanoic acid,PubChem: 6434; ChEBI: 27713; LIPIDMAPS: LMFA01060173; PDB-CCD: KMH; 3DMET: B01681; NIKKAJI: J2.363.874F,cpd:C02946; cpd:C03145; cpd:C03239; cpd:C03656; cpd:C04076; cpd:C05706; cpd:C05825; cpd:C06023; cpd:C08265; cpd:C08295,6,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O3N1,C6H10O3N1,145.0738932,146.0817182,144.06606821015,1151,cpd:C03793,"N6,N6,N6-Trimethyl-L-lysine",C9H20N2O2,"N6,N6,N6-Trimethyl-L-lysine",R03451 R04313,Lysine degradation,1.14.11.8; 3.4.-.-,NA,NA,PubChem: 6542; ChEBI: 17311; ChEMBL: CHEMBL1234168; PDB-CCD: M3L; 3DMET: B01691; NIKKAJI: J839.325G,cpd:C01037; cpd:C03793; cpd:C18885,9,20,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H21O2N2,C9H19O2N2,188.1524779,189.1603029,187.14465291016,1152,cpd:C03955,N6-Acetyl-N6-hydroxy-L-lysine;,C8H16N2O4,N6-Acetyl-N6-hydroxy-L-lysine; N6-Acetyl-N6-hydroxylysine,R03168 R10090 R10091,Lysine degradation; Microbial metabolism in diverse environments,2.3.1.102; 6.3.2.38; 6.3.2.39,NA,NA,CAS: 88492-29-9; PubChem: 6676; ChEBI: 17374; 3DMET: B00657; NIKKAJI: J609.684K,cpd:C01817; cpd:C03955; cpd:C04210; cpd:C05707; cpd:C20788,8,16,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O4N2,C8H15O4N2,204.111007,205.118832,203.1031821017,1153,cpd:C04020,D-Lysopine;,C9H18N2O4,D-Lysopine; N2-(D-1-Carboxyethyl)-L-lysine; Lysopine,R00452,Lysine degradation,1.5.1.16,NA,NA,CAS: 34522-31-1; PubChem: 6726; ChEBI: 17213; KNApSAcK: C00001544; 3DMET: B01711; NIKKAJI: J345.985C,cpd:C04020,9,18,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H19O4N2,C9H17O4N2,218.1266571,219.1344821,217.1188321018,1154,cpd:C04092,Delta1-Piperideine-2-carboxylate;,C6H9NO2,"Delta1-Piperideine-2-carboxylate; 1,2-Didehydropiperidine-2-carboxylate; 1-Piperideine-2-carboxylate",R00445 R02201 R02203 R04175,"Lysine degradation; Tropane, piperidine and pyridine alkaloid biosynthesis; Metabolic pathways",1.4.1.15; 1.5.1.1; 1.5.1.21,NA,NA,PubChem: 6784; ChEBI: 30912; ChEMBL: CHEMBL308149; 3DMET: B00677; NIKKAJI: J395.124C,cpd:C00450; cpd:C04092; cpd:C08268; cpd:C08292; cpd:C10149; cpd:C13694,6,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O2N1,C6H8O2N1,127.0633285,128.0711536,126.05550351019,1156,cpd:C05161,"2,5-Diaminohexanoate",C6H14N2O2,"2,5-Diaminohexanoate",R02852 R04687 R04688,Lysine degradation,1.4.1.12; 5.4.3.4,NA,NA,PubChem: 7577; ChEBI: 16926; 3DMET: B04985; NIKKAJI: J2.364.555F,cpd:C00047; cpd:C00739; cpd:C01142; cpd:C01186; cpd:C05161; cpd:C16440; cpd:C20277,6,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O2N2,C6H13O2N2,146.1055277,147.1133527,145.09770271020,1157,cpd:C05231,L-3-Aminobutyryl-CoA;,C25H43N8O17P3S,L-3-Aminobutyryl-CoA; L-3-Aminobutanoyl-CoA,R03030 R10564,Lysine degradation,2.3.1.247; 4.3.1.14,NA,NA,PubChem: 7627; ChEBI: 15512; NIKKAJI: J2.755.065G,cpd:C02801; cpd:C05117; cpd:C05231,25,43,17,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H44O17N8P3S1,C25H42O17N8P3S1,852.1679741,853.1757992,851.16014911021,1161,cpd:C05548,6-Acetamido-2-oxohexanoate;,C8H13NO4,6-Acetamido-2-oxohexanoate; 2-Oxo-6-acetamidocaproate,R04029 R04142 R04174,Lysine degradation,1.2.4.-; 2.6.1.65; 3.5.1.17,NA,NA,PubChem: 7884; ChEBI: 28376; 3DMET: B00789; NIKKAJI: J2.368.593K,cpd:C03682; cpd:C05548; cpd:C11842; cpd:C12988; cpd:C21195,8,13,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H14O4N1,C8H12O4N1,187.0844579,188.0922829,186.07663291022,1162,cpd:C05554,Aerobactin,C22H36N4O13,Aerobactin,R10091,Lysine degradation; Microbial metabolism in diverse environments,6.3.2.39,NA,NA,CAS: 26198-65-2; PubChem: 7887; ChEBI: 18157; 3DMET: B01872; NIKKAJI: J93.384H,cpd:C05554,22,36,13,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H37O13N4,C22H35O13N4,564.2278872,565.2357123,563.22006221023,1163,cpd:C05825,2-Amino-5-oxohexanoate,C6H11NO3,2-Amino-5-oxohexanoate,R04687 R04688,Lysine degradation,1.4.1.12,NA,NA,PubChem: 8120; ChEBI: 1010 19450; 3DMET: B00855; NIKKAJI: J137.029D,cpd:C02946; cpd:C03145; cpd:C03239; cpd:C03656; cpd:C04076; cpd:C05706; cpd:C05825; cpd:C06023; cpd:C08265; cpd:C08295,6,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O3N1,C6H10O3N1,145.0738932,146.0817182,144.06606821024,1165,cpd:C06181,Piperideine;,C5H9N,Piperideine; 1-Piperideine,R03666 R05128 R05129 R05130 R06741 R08422 R08423 R09052,"Lysine degradation; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C06181  Piperideine,PubChem: 8432; ChEBI: 47858; 3DMET: B00915; NIKKAJI: J102.014E,cpd:C00025; cpd:C00148; cpd:C00217; cpd:C00302; cpd:C00430; cpd:C00763; cpd:C00979; cpd:C01015; cpd:C01073; cpd:C01110; cpd:C01157; cpd:C01165; cpd:C03066; cpd:C03079; cpd:C03341; cpd:C03440; cpd:C03618; cpd:C03651; cpd:C03727; cpd:C03741; cpd:C03790; cpd:C03901; cpd:C05147; cpd:C05574; cpd:C05938; cpd:C05941; cpd:C05947; cpd:C06181; cpd:C06809; cpd:C11118; cpd:C12269; cpd:C12876; cpd:C16435; cpd:C18170; cpd:C18796; cpd:C19706; cpd:C20808,5,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10N1,C5H8N1,83.07349929,84.08132433,82.065674261025,1166,cpd:C16741,L-Hydroxylysine;,C6H14N2O3,L-Hydroxylysine; 5-Hydroxy-L-lysine; L-erythro-5-Hydroxylysine; (5R)-5-Hydroxy-L-lysine,R03378,Lysine degradation; Metabolic pathways,2.7.1.81,NA,NA,CAS: 1190-94-9 28902-93-4; PubChem: 96023265; ChEBI: 18040; ChEMBL: CHEMBL457104; PDB-CCD: LYZ; NIKKAJI: J38.540I,cpd:C01028; cpd:C02627; cpd:C16741; cpd:C16742; cpd:C21041,6,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O3N2,C6H13O3N2,162.1004423,163.1082674,161.09261731026,1167,cpd:C20333,N2-Citryl-N6-acetyl-N6-hydroxy-L-lysine;,C14H22N2O10,N2-Citryl-N6-acetyl-N6-hydroxy-L-lysine; N2-Citryl-N6-acetyl-N6-hydroxylysine,R10090 R10091,Lysine degradation; Microbial metabolism in diverse environments,6.3.2.38; 6.3.2.39,NA,NA,PubChem: 163312071,cpd:C20333,14,22,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H23O10N2,C14H21O10N2,378.1274449,379.1352699,377.11961991027,1169,cpd:C00916,Cephalosporin C,C16H21N3O8S,Cephalosporin C,R03062 R03063 R03064 R07400,Penicillin and cephalosporin biosynthesis; Metabolic pathways; Biosynthesis of antibiotics; Cephalosporins - parenteral agents; Cephalosporins - oral agents,1.4.3.3; 2.3.1.175; 2.6.1.74; 3.1.1.41,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   beta-Lactams;    Cephems;     C00916  Cephalosporin C,CAS: 61-24-5; PubChem: 4170; ChEBI: 15776; ChEMBL: CHEMBL482858; PDB-CCD: CSC; 3DMET: B01351; NIKKAJI: J4.815A,cpd:C00916,16,21,8,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C16H22O8N3S1,C16H20O8N3S1,415.1049358,416.1127609,414.09711081028,1170,cpd:C02954,6-Aminopenicillanate;,C8H12N2O3S,6-Aminopenicillanate; 6-Aminopenicillanic acid,R02170 R04103,Penicillin and cephalosporin biosynthesis; Biosynthesis of antibiotics; Penicillins; Cephalosporins - parenteral agents,3.5.1.11,NA,NA,CAS: 551-16-6; PubChem: 5872; ChEBI: 16705 30938; ChEMBL: CHEMBL1373667; PDB-CCD: X1E; 3DMET: B01615; NIKKAJI: J14.224G J38.373B,cpd:C02954; cpd:C20384,8,12,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O3N2S1,C8H11O3N2S1,216.0568634,217.0646885,215.04903841029,1171,cpd:C03112,Deacetylcephalosporin C,C14H19N3O7S,Deacetylcephalosporin C,R03062 R03064 R05228 R05229 R05230,Penicillin and cephalosporin biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.14.11.26; 2.1.3.7; 2.3.1.175; 3.1.1.41,"Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",NA,CAS: 1476-46-6; PubChem: 6007; ChEBI: 18065; 3DMET: B01632; NIKKAJI: J91.970E,cpd:C03112,14,19,7,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C14H20O7N3S1,C14H18O7N3S1,373.0943711,374.1021962,372.08654611030,1172,cpd:C04712,(7R)-7-(5-Carboxy-5-oxopentanoyl)aminocephalosporinate,C16H18N2O9S,(7R)-7-(5-Carboxy-5-oxopentanoyl)aminocephalosporinate,R03063 R07400 R07401,Penicillin and cephalosporin biosynthesis; Biosynthesis of antibiotics,1.4.3.3; 2.6.1.74,NA,NA,PubChem: 7284; ChEBI: 15838; 3DMET: B01777; NIKKAJI: J431.585E,cpd:C04712,16,18,9,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C16H19O9N2S1,C16H17O9N2S1,414.0733013,415.0811264,413.06547631031,1173,cpd:C05556,delta-(L-2-Aminoadipyl)-L-cysteinyl-D-valine;,C14H25N3O6S,delta-(L-2-Aminoadipyl)-L-cysteinyl-D-valine; N-[L-5-Amino-5-carboxypentanoyl]-L-cysteinyl-D-valine; L-delta-(alpha-Aminoadipoyl)-L-cysteinyl-D-valine; ACV,R04870 R04872,Penicillin and cephalosporin biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.21.3.1; 6.3.2.26,"Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin; Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",NA,PubChem: 7889; ChEBI: 28496; ChEMBL: CHEMBL60683 CHEMBL70421; PDB-CCD: ACV; 3DMET: B05070; NIKKAJI: J1.270.234E,cpd:C05556,14,25,6,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C14H26O6N3S1,C14H24O6N3S1,363.1464067,364.1542317,362.13858171032,1174,cpd:C05557,Isopenicillin N,C14H21N3O6S,Isopenicillin N,R04147 R04868 R04872 R06361,Penicillin and cephalosporin biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.21.3.1; 2.3.1.164; 5.1.1.17,"Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin; Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",NA,PubChem: 7890; ChEBI: 18165; KNApSAcK: C00000778; PDB-CCD: IP1; 3DMET: B01873; NIKKAJI: J480.698K,cpd:C05557; cpd:C06564,14,21,6,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C14H22O6N3S1,C14H20O6N3S1,359.1151066,360.1229316,358.10728151033,1175,cpd:C06564,Penicillin N;,C14H21N3O6S,Penicillin N; Adicillin,R04147 R05228 R05301,Penicillin and cephalosporin biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.14.20.1; 5.1.1.17,"Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",NA,CAS: 525-94-0; PubChem: 8793; ChEBI: 18203; ChEMBL: CHEMBL41048; KNApSAcK: C00000780; 3DMET: B02069; NIKKAJI: J9.767E,cpd:C05557; cpd:C06564,14,21,6,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C14H22O6N3S1,C14H20O6N3S1,359.1151066,360.1229316,358.10728151034,1176,cpd:C06565,Deacetoxycephalosporin C;,C14H19N3O6S,Deacetoxycephalosporin C; DAOC,R05229 R05301,Penicillin and cephalosporin biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,1.14.11.26; 1.14.20.1,"Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",NA,CAS: 26924-74-3; PubChem: 8794; ChEBI: 18229; PDB-CCD: P1C; 3DMET: B02070; NIKKAJI: J92.761I,cpd:C06565,14,19,6,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C14H20O6N3S1,C14H18O6N3S1,357.0994565,358.1072815,356.09163151035,1177,cpd:C06566,Cephamycin C,C16H22N4O9S,Cephamycin C,R05303,Penicillin and cephalosporin biosynthesis; Biosynthesis of antibiotics; Cephalosporins - parenteral agents,NA,"Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",Compounds with biological roles [BR:br08001];  Antibiotics;   beta-Lactams;    Cephems;     C06566  Cephamycin C,CAS: 38429-35-5; PubChem: 8795; ChEBI: 3543; 3DMET: B02071; NIKKAJI: J17.435A,cpd:C06566,16,22,9,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C16H23O9N4S1,C16H21O9N4S1,446.1107495,447.1185745,445.10292441036,1179,cpd:C06568,O-Carbamoyl-deacetylcephalosporin C,C15H20N4O8S,O-Carbamoyl-deacetylcephalosporin C,R05230 R05302,Penicillin and cephalosporin biosynthesis; Biosynthesis of antibiotics,2.1.3.7,"Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",NA,PubChem: 8797; ChEBI: 7678; 3DMET: B02072; NIKKAJI: J2.762.442A,cpd:C06568,15,20,8,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O8N4S1,C15H19O8N4S1,416.1001848,417.1080098,415.09235981037,1180,cpd:C06569,7a-Hydroxy-O-carbamoyl-deacetylcephalosporin C,C15H20N4O9S,7a-Hydroxy-O-carbamoyl-deacetylcephalosporin C,R05302 R05303,Penicillin and cephalosporin biosynthesis; Biosynthesis of antibiotics,NA,"Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C",NA,PubChem: 8798; ChEBI: 2286; 3DMET: B02073; NIKKAJI: J2.762.444H,cpd:C06569,15,20,9,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O9N4S1,C15H19O9N4S1,432.0950994,433.1029244,431.08727441038,1181,cpd:C07756,7-Aminocephalosporanic acid;,C10H12N2O5S,7-Aminocephalosporanic acid; 7-Aminocephalosporinic acid; 7-ACA; (7R)-7-Aminocephalosporanate,R07402,Penicillin and cephalosporin biosynthesis; Biosynthesis of antibiotics,3.5.1.93,NA,NA,CAS: 957-68-6; PubChem: 9958; ChEBI: 2255; ChEMBL: CHEMBL1615585; PDB-CCD: 4KR; 3DMET: B02139; NIKKAJI: J7.191I,cpd:C07756,10,12,5,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O5N2S1,C10H11O5N2S1,272.0466927,273.0545177,271.03886761039,1182,cpd:C15666,(7R)-7-(4-Carboxybutanamido)cephalosporanate;,C15H18N2O8S,(7R)-7-(4-Carboxybutanamido)cephalosporanate; 7-Glutarylaminocephalosporanate,R07401 R07402,Penicillin and cephalosporin biosynthesis; Biosynthesis of antibiotics,3.5.1.93,NA,NA,PubChem: 17396655; ChEBI: 41425; PDB-CCD: CEN; NIKKAJI: J431.584G,cpd:C15666,15,18,8,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H19O8N2S1,C15H17O8N2S1,386.0783867,387.0862118,385.07056171040,1184,cpd:C00134,Putrescine;,C4H12N2,"Putrescine; 1,4-Butanediamine; 1,4-Diaminobutane; Tetramethylenediamine; Butane-1,4-diamine",R00018 R00670 R01151 R01152 R01153 R01154 R01155 R01156; R01157 R01399 R01919 R01920 R01944 R07414 R08714 R09074; R09077 R09079 R09256 R09257 R10064,"Arginine and proline metabolism; Glutathione metabolism; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; ABC transporters; Protein digestion and absorption",1.4.3.10; 1.4.3.22; 1.5.1.43; 1.5.3.13; 1.5.3.17; 2.1.1.53; 2.1.3.6; 2.3.1.57; 2.3.1.138; 2.3.1.-; 2.5.1.16; 2.5.1.44; 2.5.1.45; 2.6.1.29; 2.6.1.82; 2.6.1.-; 3.5.1.53; 3.5.1.62; 3.5.3.11; 4.1.1.17; 6.3.1.11,"Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine; Polyamine biosynthesis, arginine => ornithine => putrescine; GABA biosynthesis, eukaryotes, putrescine => GABA; GABA biosynthesis, prokaryotes, putrescine => GABA",Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C00134  Putrescine,CAS: 110-60-1; PubChem: 3434; ChEBI: 17148; ChEMBL: CHEMBL46257; KNApSAcK: C00001428; PDB-CCD: PUT; 3DMET: B00037; NIKKAJI: J1.979H,cpd:C00134; cpd:C18980; cpd:C19227,4,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H13N2,C4H11N2,88.1000484,89.10787343,87.092223361041,1185,cpd:C00148,L-Proline;,C5H9NO2,L-Proline; 2-Pyrrolidinecarboxylic acid,R00135 R00671 R01246 R01248 R01249 R01251 R01252 R01253; R01255 R03661 R06746 R09572 R09650 R10507 R10661,Arginine and proline metabolism; Carbapenem biosynthesis; Novobiocin biosynthesis; Staurosporine biosynthesis; Aminoacyl-tRNA biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer,1.5.1.1; 1.5.1.2; 1.5.1.21; 1.5.1.49; 1.5.5.2; 1.5.-.-; 1.14.11.2; 1.14.11.28; 3.4.11.5; 3.5.1.101; 4.3.1.12; 5.1.1.4; 6.1.1.15,"Proline biosynthesis, glutamate => proline; Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00148  Proline (Pro); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00035  L-Proline,CAS: 147-85-3; PubChem: 3448; ChEBI: 17203; ChEMBL: CHEMBL54922; KNApSAcK: C00001388; PDB-CCD: PRO; 3DMET: B01173; NIKKAJI: J9.117K,cpd:C00148; cpd:C00763; cpd:C03901; cpd:C16435; cpd:C18170,5,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O2N1,C5H8O2N1,115.0633285,116.0711536,114.05550351042,1186,cpd:C00179,Agmatine;,C5H14N4,Agmatine; (4-Aminobutyl) guanidine,R00566 R01157 R01416 R01417 R01418 R01425 R01617 R09255; R10338 R10496,Arginine and proline metabolism; Metabolic pathways,2.3.1.64; 2.5.1.104; 2.7.3.10; 3.5.1.40; 3.5.3.11; 3.5.3.12; 3.5.3.20; 4.1.1.19; 6.3.4.22,"Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine",Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Others;    Amines;     C00179  Agmatine; Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: amine receptors;    Adrenaline;     alpha2a-adrenergic receptor;      C00179  Agmatine;     alpha2b-adrenergic receptor;      C00179  Agmatine;     alpha2c-adrenergic receptor;      C00179  Agmatine,CAS: 306-60-5; PubChem: 3479; ChEBI: 17431; ChEMBL: CHEMBL58343; KNApSAcK: C00001400; PDB-CCD: AG2; 3DMET: B00052; NIKKAJI: J11.608D,cpd:C00179,5,14,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H15N4,C5H13N4,130.1218465,131.1296715,129.11402141043,1187,cpd:C00315,Spermidine;,C7H19N3,"Spermidine; N-(3-Aminopropyl)-1,4-butane-diamine",R01914 R01915 R01917 R01918 R01919 R01920 R02869 R03899; R05329 R07300 R07477 R08983 R09076 R09077 R09081 R09531; R10347 R11154 R11159 R11199 R11200,Arginine and proline metabolism; beta-Alanine metabolism; Glutathione metabolism; Phenylpropanoid biosynthesis; Metabolic pathways; ABC transporters; Bile secretion,1.5.3.13; 1.5.3.14; 1.5.3.16; 1.5.3.17; 1.5.99.6; 2.3.1.248; 2.3.1.249; 2.5.1.16; 2.5.1.22; 2.5.1.44; 2.5.1.45; 2.5.1.46; 2.5.1.79; 2.5.1.128; 3.5.1.48; 3.5.1.78; 3.5.1.-; 3.5.3.24; 4.1.1.96; 6.3.1.8; 6.3.1.9,"Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine",NA,CAS: 124-20-9; PubChem: 3609; ChEBI: 16610; ChEMBL: CHEMBL19612; KNApSAcK: C00001431; PDB-CCD: SPD; 3DMET: B01214; NIKKAJI: J10.054D,cpd:C00315,7,19,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H20N3,C7H18N3,145.1578976,146.1657227,144.15007261044,1188,cpd:C00436,N-Carbamoylputrescine,C5H13N3O,N-Carbamoylputrescine,R01152 R01399 R01416,Arginine and proline metabolism; Metabolic pathways,2.1.3.6; 3.5.1.53; 3.5.3.12,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Others;    Amines;     C00436  N-Carbamoylputrescine,CAS: 6851-51-0; PubChem: 3725; ChEBI: 17902; KNApSAcK: C00001404; 3DMET: B00113; NIKKAJI: J492.784B,cpd:C00436; cpd:C17146,5,13,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H14O1N3,C5H12O1N3,131.1058621,132.1136871,130.0980371045,1190,cpd:C00555,4-Aminobutyraldehyde;,C4H9NO,4-Aminobutyraldehyde; 4-Aminobutanal,R01151 R01155 R01914 R01915 R01986 R02549 R07408 R08714,Arginine and proline metabolism; beta-Alanine metabolism; Metabolic pathways,1.2.1.3; 1.2.1.19; 1.2.1.-; 1.4.3.10; 1.4.3.22; 1.5.3.14; 1.5.99.6; 2.6.1.29; 2.6.1.82; 2.6.1.-,NA,NA,PubChem: 3835; ChEBI: 17769; KNApSAcK: C00019656; 3DMET: B00129; NIKKAJI: J38.531J,cpd:C00555; cpd:C03219; cpd:C03537; cpd:C14452; cpd:C19332; cpd:C20315; cpd:C20339; cpd:C21404,4,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O1N1,C4H8O1N1,87.06841391,88.07623895,86.060588881046,1191,cpd:C00750,Spermine;,C10H26N4,"Spermine; N,N'-Bis(3-aminopropyl)-1,4-butanediamine",R02869 R08352 R09076,Arginine and proline metabolism; beta-Alanine metabolism; Glutathione metabolism; Metabolic pathways; Bile secretion,1.5.3.16; 1.5.3.17; 2.5.1.16; 2.5.1.22; 6.3.1.9,NA,NA,CAS: 71-44-3; PubChem: 4012; ChEBI: 15746; ChEMBL: CHEMBL23194; KNApSAcK: C00001432; PDB-CCD: SPK SPM; 3DMET: B01325; NIKKAJI: J5.246I,cpd:C00750; cpd:C19669; cpd:C21009,10,26,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H27N4,C10H25N4,202.2157469,203.2235719,201.20792181047,1192,cpd:C00763,D-Proline,C5H9NO2,D-Proline,R01255 R02825 R02894 R02895 R09496,Arginine and proline metabolism; Metabolic pathways,1.4.1.12; 1.4.3.3; 1.5.99.13; 1.21.4.1; 5.1.1.4,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00763  D-Proline,CAS: 344-25-2; PubChem: 4025; ChEBI: 16313; ChEMBL: CHEMBL80257; PDB-CCD: DPR; 3DMET: B01328; NIKKAJI: J9.118I,cpd:C00148; cpd:C00763; cpd:C03901; cpd:C16435; cpd:C18170,5,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O2N1,C5H8O2N1,115.0633285,116.0711536,114.05550351048,1193,cpd:C00791,Creatinine;,C4H7N3O,Creatinine; 1-Methylglycocyamidine,R01884 R02922 R07420,Arginine and proline metabolism; Metabolic pathways,3.5.2.10; 3.5.4.1; 3.5.4.21,Creatine pathway,Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D03600  [101592] Creatinine;  Buffering agent;   D03600  [101592] Creatinine;  Soothing agent;   D03600  [101592] Creatinine; Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   SLC22A2;    Creatinine;     D03600  Creatinine (NF),CAS: 60-27-5; PubChem: 4049; ChEBI: 16737; ChEMBL: CHEMBL65567; 3DMET: B00175; NIKKAJI: J1.397H,cpd:C00791; cpd:C19280,4,7,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H8O1N3,C4H6O1N3,113.0589119,114.0667369,112.05108681049,1194,cpd:C00884,Homocarnosine;,C10H16N4O3,Homocarnosine; L-Homocarnosine; gamma-Aminobutyryl histidine; N-(4-Amino-1-oxobutyryl)histidine,R01991 R01992,Arginine and proline metabolism,3.4.13.18; 3.4.13.20; 6.3.2.11,NA,NA,CAS: 3650-73-5; PubChem: 4140; ChEBI: 85981; ChEMBL: CHEMBL243618; 3DMET: B04744; NIKKAJI: J14.557B,cpd:C00884; cpd:C01262; cpd:C04138,10,16,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O3N4,C10H15O3N4,240.1222404,241.1300654,239.11441541050,1195,cpd:C01035,4-Guanidinobutanoate;,C5H11N3O2,4-Guanidinobutanoate; 4-Guanidinobutyric acid,R01989 R01990 R03177 R03180,Arginine and proline metabolism; Metabolic pathways,1.2.1.54; 2.1.4.1; 3.5.1.4; 3.5.3.7,NA,NA,PubChem: 4278; ChEBI: 15728; ChEMBL: CHEMBL21157; PDB-CCD: ALG; 3DMET: B00225; NIKKAJI: J196.182I,cpd:C01035,5,11,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O2N3,C5H10O2N3,145.0851266,146.0929516,144.07730161051,1196,cpd:C01043,N-Carbamoylsarcosine,C4H8N2O3,N-Carbamoylsarcosine,R01563 R03187,Arginine and proline metabolism; Metabolic pathways,3.5.1.59; 3.5.2.14,NA,NA,PubChem: 4285; ChEBI: 15737; PDB-CCD: CMS; 3DMET: B00228,cpd:C00152; cpd:C01043; cpd:C01905; cpd:C02037; cpd:C02642; cpd:C16438; cpd:C19258; cpd:C19301,4,8,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O3N2,C4H7O3N2,132.0534921,133.0613172,131.04566711052,1197,cpd:C01110,5-Amino-2-oxopentanoic acid;,C5H9NO3,5-Amino-2-oxopentanoic acid; 5-Amino-2-oxopentanoate; 2-Oxo-5-amino-pentanoate; 2-Oxo-5-aminopentanoate; alpha-Keto-delta-aminopentanoate; 2-Oxo-5-aminovalerate,R02457 R02459 R03248 R03249 R03250,Arginine and proline metabolism; D-Arginine and D-ornithine metabolism; Metabolic pathways,1.4.3.3; 2.6.1.8; 2.6.1.21,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C01110  5-Amino-2-oxopentanoic acid,PubChem: 4342; ChEBI: 17572 49268; LIPIDMAPS: LMFA01060169; 3DMET: B00241; NIKKAJI: J315.454H,cpd:C00430; cpd:C01015; cpd:C01073; cpd:C01110; cpd:C01157; cpd:C01165; cpd:C03341; cpd:C03440; cpd:C03651; cpd:C03741; cpd:C05147; cpd:C06809; cpd:C12876; cpd:C19706,5,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O3N1,C5H8O3N1,131.0582432,132.0660682,130.05041811053,1198,cpd:C01157,Hydroxyproline;,C5H9NO3,Hydroxyproline; L-Hydroxyproline; trans-4-Hydroxy-L-proline,R01252 R03290 R03291 R03292 R03293 R03295 R03296,Arginine and proline metabolism; Metabolic pathways,1.1.1.104; 1.5.1.2; 1.5.-.-; 1.14.11.2; 5.1.1.8,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C01157  Hydroxyproline,CAS: 51-35-4; PubChem: 4385; ChEBI: 18095; ChEMBL: CHEMBL352418; KNApSAcK: C00001370; PDB-CCD: HYP; 3DMET: B01395; NIKKAJI: J148.015D,cpd:C00430; cpd:C01015; cpd:C01073; cpd:C01110; cpd:C01157; cpd:C01165; cpd:C03341; cpd:C03440; cpd:C03651; cpd:C03741; cpd:C05147; cpd:C06809; cpd:C12876; cpd:C19706,5,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O3N1,C5H8O3N1,131.0582432,132.0660682,130.05041811054,1199,cpd:C01165,L-Glutamate 5-semialdehyde;,C5H9NO3,L-Glutamate 5-semialdehyde; L-Glutamate gamma-semialdehyde,R00245 R00667 R01343 R03313 R03314,Arginine and proline metabolism; Carbapenem biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids,1.2.1.41; 1.2.1.88; 2.6.1.13,"Proline biosynthesis, glutamate => proline",NA,PubChem: 4392; ChEBI: 17232; KNApSAcK: C00007475; 3DMET: B00252; NIKKAJI: J40.076I,cpd:C00430; cpd:C01015; cpd:C01073; cpd:C01110; cpd:C01157; cpd:C01165; cpd:C03341; cpd:C03440; cpd:C03651; cpd:C03741; cpd:C05147; cpd:C06809; cpd:C12876; cpd:C19706,5,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O3N1,C5H8O3N1,131.0582432,132.0660682,130.05041811055,1200,cpd:C01682,Nopaline;,C11H20N4O6,"Nopaline; D-Nopaline; N2-(D-1,3-Dicarboxypropyl)-L-arginine; N-[(1S)-4-Carbamimidamido-1-carboxybutyl]-D-glutamic acid",R00563,Arginine and proline metabolism; ABC transporters,1.5.1.19,NA,NA,CAS: 22350-70-5; PubChem: 4824; ChEBI: 17249; KNApSAcK: C00001548; PDB-CCD: 2W2; 3DMET: B04808; NIKKAJI: J15.868B,cpd:C01682,11,20,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H21O6N4,C11H19O6N4,304.1382844,305.1461094,303.13045931056,1201,cpd:C01877,4-Oxoproline;,C5H7NO3,4-Oxoproline; 4-Oxo-L-proline,R03290 R03292,Arginine and proline metabolism,1.1.1.104,NA,NA,CAS: 4347-18-6; PubChem: 4991; ChEBI: 16821; PDB-CCD: DPL; 3DMET: B04819; NIKKAJI: J205.723I,cpd:C01877; cpd:C01879; cpd:C02237; cpd:C03541; cpd:C03801; cpd:C04281; cpd:C04282; cpd:C05723; cpd:C05929,5,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8O3N1,C5H6O3N1,129.0425931,130.0504181,128.03476811057,1202,cpd:C02305,Phosphocreatine;,C4H10N3O5P,Phosphocreatine; N-Phosphocreatine; Creatine phosphate,R01881 R01882 R07420,Arginine and proline metabolism; Metabolic pathways,2.7.3.2; 3.9.1.1,Creatine pathway,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01E OTHER CARDIAC PREPARATIONS;     C01EB Other cardiac preparations;      C01EB06 Fosfocreatine;       C02305  Phosphocreatine,CAS: 67-07-2; PubChem: 5359; ChEBI: 17287; ChEMBL: CHEMBL1204644; 3DMET: B00422; NIKKAJI: J4.848H,cpd:C02305,4,10,5,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O5N3P1,C4H9O5N3P1,211.0358074,212.0436325,210.02798241058,1203,cpd:C02565,N-Methylhydantoin;,C4H6N2O2,"N-Methylhydantoin; N-Methylimidazolidine-2,4-dione",R02922 R03187,Arginine and proline metabolism; Metabolic pathways,3.5.2.14; 3.5.4.1; 3.5.4.21,NA,NA,PubChem: 5563; ChEBI: 16354; 3DMET: B00461; NIKKAJI: J100.995H,cpd:C00429; cpd:C02065; cpd:C02248; cpd:C02512; cpd:C02565; cpd:C02743; cpd:C02777; cpd:C08311; cpd:C13695; cpd:C15811; cpd:C15812; cpd:C21440,4,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O2N2,C4H5O2N2,114.0429274,115.0507525,113.03510241059,1204,cpd:C02647,4-Guanidinobutanal,C5H11N3O,4-Guanidinobutanal,R03177 R03178,Arginine and proline metabolism; Metabolic pathways,1.2.1.54; 4.1.1.75,NA,NA,PubChem: 5624; ChEBI: 16671; 3DMET: B00474; NIKKAJI: J1.191.009B,cpd:C02647; cpd:C19778; cpd:C19782,5,11,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O1N3,C5H10O1N3,129.090212,130.098037,128.0823871060,1205,cpd:C02714,N-Acetylputrescine,C6H14N2O,N-Acetylputrescine,R01154 R01156 R04025,Arginine and proline metabolism; Metabolic pathways,1.4.3.4; 2.3.1.57; 3.5.1.62,"GABA biosynthesis, eukaryotes, putrescine => GABA",NA,CAS: 5699-41-2; PubChem: 5677; ChEBI: 17768; ChEMBL: CHEMBL81241; 3DMET: B01596; NIKKAJI: J367.698F,cpd:C02714; cpd:C19279,6,14,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O1N2,C6H13O1N2,130.1106131,131.1184381,129.1027881061,1206,cpd:C02946,4-Acetamidobutanoate;,C6H11NO3,4-Acetamidobutanoate; N4-Acetylaminobutanoate,R01987 R05050,Arginine and proline metabolism; Metabolic pathways,1.2.1.3; 3.5.1.63,"GABA biosynthesis, eukaryotes, putrescine => GABA",NA,PubChem: 5865; ChEBI: 11951 17645; 3DMET: B00519; NIKKAJI: J35.110E,cpd:C02946; cpd:C03145; cpd:C03239; cpd:C03656; cpd:C04076; cpd:C05706; cpd:C05825; cpd:C06023; cpd:C08265; cpd:C08295,6,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O3N1,C6H10O3N1,145.0738932,146.0817182,144.06606821062,1207,cpd:C03078,4-Guanidinobutanamide,C5H12N4O,4-Guanidinobutanamide,R00559 R03180,Arginine and proline metabolism,1.13.12.1; 3.5.1.4,NA,NA,PubChem: 5976; ChEBI: 18062; 3DMET: B00537; NIKKAJI: J9.619I,cpd:C03078,5,12,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O1N4,C5H11O1N4,144.101111,145.1089361,143.0932861063,1208,cpd:C03166,Phosphoguanidinoacetate;,C3H8N3O5P,Phosphoguanidinoacetate; Guanidinoacetate phosphate,R02575,Arginine and proline metabolism,2.7.3.1,NA,NA,PubChem: 6049; ChEBI: 16034; ChEMBL: CHEMBL1206371; 3DMET: B00551; NIKKAJI: J2.740.866D,cpd:C03166,3,8,5,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O5N3P1,C3H7O5N3P1,197.0201574,198.0279824,196.01233231064,1209,cpd:C03287,L-Glutamyl 5-phosphate;,C5H10NO7P,L-Glutamyl 5-phosphate; L-Glutamate 5-phosphate,R00239 R03313,Arginine and proline metabolism; Carbapenem biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids,1.2.1.41; 2.7.2.11,"Proline biosynthesis, glutamate => proline",NA,PubChem: 6144; ChEBI: 17798; 3DMET: B01646; NIKKAJI: J40.070J,cpd:C03287; cpd:C03734; cpd:C05765,5,10,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O7N1P1,C5H9O7N1P1,227.0194887,228.0273137,226.01166361065,1210,cpd:C03296,N2-Succinyl-L-arginine;,C10H18N4O5,N2-Succinyl-L-arginine; (2S)-2-(3-Carboxypropanoylamino)-5-(diaminomethylideneamino)pentanoic acid,R00832 R04189,Arginine and proline metabolism; Metabolic pathways,2.3.1.109; 3.5.3.23,NA,NA,PubChem: 6152; ChEBI: 17705; PDB-CCD: SUG; 3DMET: B00575; NIKKAJI: J2.741.529F,cpd:C03296; cpd:C19689,10,18,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O5N4,C10H17O5N4,274.1277197,275.1355447,273.11989471066,1211,cpd:C03375,Norspermidine;,C6H17N3,"Norspermidine; Bis(3-aminopropyl)amine; 3,3'-Iminobispropylamine",R03271 R09082 R11088,Arginine and proline metabolism,2.5.1.23; 2.5.1.126; 4.1.1.96,NA,NA,CAS: 56-18-8; PubChem: 6210; ChEBI: 16841; ChEMBL: CHEMBL28743; PDB-CCD: NSD; 3DMET: B00581; NIKKAJI: J9.891D,cpd:C03375,6,17,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H18N3,C6H16N3,131.1422476,132.1500726,130.13442251067,1212,cpd:C03415,N2-Succinyl-L-ornithine;,C9H16N2O5,N2-Succinyl-L-ornithine; (2S)-5-Amino-2-(3-carboxypropanoylamino)pentanoic acid,R04189 R04217 R08937,Arginine and proline metabolism; Metabolic pathways,2.1.3.11; 2.6.1.81; 3.5.3.23,NA,NA,PubChem: 6244; ChEBI: 27574; PDB-CCD: SUO; 3DMET: B00582; NIKKAJI: J2.742.381G,cpd:C01410; cpd:C03415; cpd:C04390; cpd:C05695; cpd:C15767; cpd:C21015,9,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O5N2,C9H15O5N2,232.1059216,233.1137467,231.09809661068,1213,cpd:C03440,cis-4-Hydroxy-D-proline,C5H9NO3,cis-4-Hydroxy-D-proline,R03296 R04221 R11428,Arginine and proline metabolism,1.4.3.3; 1.5.99.-; 5.1.1.8,NA,NA,CAS: 2584-71-6; PubChem: 6264; ChEBI: 16231; ChEMBL: CHEMBL1229563; 3DMET: B01659; NIKKAJI: J192.095B,cpd:C00430; cpd:C01015; cpd:C01073; cpd:C01110; cpd:C01157; cpd:C01165; cpd:C03341; cpd:C03440; cpd:C03651; cpd:C03741; cpd:C05147; cpd:C06809; cpd:C12876; cpd:C19706,5,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O3N1,C5H8O3N1,131.0582432,132.0660682,130.05041811069,1214,cpd:C03564,1-Pyrroline-2-carboxylate;,C5H7NO2,1-Pyrroline-2-carboxylate; 1-Pyrroline-2-carboxylic acid; Delta1-Pyrroline 2-carboxylate; 1-Pyrroline 2-carboxylate,R01246 R01249 R02894 R03249 R04374 R09496,Arginine and proline metabolism; D-Arginine and D-ornithine metabolism,1.4.3.3; 1.5.1.1; 1.5.1.21; 1.5.1.49; 1.5.99.13; 4.2.1.77,NA,NA,CAS: 2139-03-9; PubChem: 6356; ChEBI: 17425 36761; ChEMBL: CHEMBL18591; PDB-CCD: 2PC; 3DMET: B00599; NIKKAJI: J626.050K,cpd:C03564; cpd:C03912; cpd:C04322; cpd:C04445; cpd:C07275; cpd:C20317,5,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8O2N1,C5H6O2N1,113.0476785,114.0555035,112.03985341070,1215,cpd:C03771,5-Guanidino-2-oxopentanoate;,C6H11N3O3,5-Guanidino-2-oxopentanoate; 5-Guanidino-2-oxo-pentanoate; 2-Oxo-5-guanidinopentanoate; 2-Oxo-5-guanidino-pentanoate; 2-Oxoarginine,R02923 R02924 R03178 R03250 R08197 R09939 R11017 R11018; R11031 R11032,Arginine and proline metabolism; D-Arginine and D-ornithine metabolism; Metabolic pathways,1.4.1.-; 1.4.3.3; 1.4.99.6; 2.1.1.243; 2.6.1.21; 2.6.1.84; 4.1.1.75,NA,NA,CAS: 3715-10-4; PubChem: 6525; ChEBI: 18253 28116; 3DMET: B00640; NIKKAJI: J616.728D,cpd:C03771,6,11,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O3N3,C6H10O3N3,173.0800412,174.0878663,172.07221621071,1216,cpd:C04137,D-Octopine;,C9H18N4O4,"D-Octopine; N2-(D-1-Carboxyethyl)-L-arginine; N2-(1-Carboxyethyl)-L-arginine; Arginine, N2-(1-carboxyethyl)-, L-; D-(+)-Octopine; L-Arginine, N2-(1-carboxyethyl)-, (R)-; L-Arginine, N2-[(1R)-1-carboxyethyl]-; Octopine",R00562,Arginine and proline metabolism; ABC transporters,1.5.1.11,NA,NA,CAS: 34522-32-2; PubChem: 6823; ChEBI: 15805; KNApSAcK: C00001549; 3DMET: B04929; NIKKAJI: J18.376H,cpd:C04137; cpd:C06655,9,18,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H19O4N4,C9H17O4N4,246.1328051,247.1406301,245.124981072,1217,cpd:C04281,L-1-Pyrroline-3-hydroxy-5-carboxylate;,C5H7NO3,"L-1-Pyrroline-3-hydroxy-5-carboxylate; 3-Hydroxy-L-1-pyrroline-5-carboxylate; (3R,5S)-1-Pyrroline-3-hydroxy-5-carboxylate",R03291 R03293 R03295 R04443 R04444 R04445,Arginine and proline metabolism; Metabolic pathways,1.2.1.88; 1.5.1.2; 1.5.-.-,NA,NA,PubChem: 6943; ChEBI: 27391 6151; 3DMET: B04933; NIKKAJI: J2.749.619I,cpd:C01877; cpd:C01879; cpd:C02237; cpd:C03541; cpd:C03801; cpd:C04281; cpd:C04282; cpd:C05723; cpd:C05929,5,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8O3N1,C5H6O3N1,129.0425931,130.0504181,128.03476811073,1218,cpd:C04282,1-Pyrroline-4-hydroxy-2-carboxylate,C5H7NO3,1-Pyrroline-4-hydroxy-2-carboxylate,R02280 R04221 R04446 R04447 R11428,Arginine and proline metabolism,1.4.3.3; 1.5.99.-; 3.5.4.22,NA,NA,PubChem: 6944; ChEBI: 16352; 3DMET: B04934; NIKKAJI: J2.361.836B,cpd:C01877; cpd:C01879; cpd:C02237; cpd:C03541; cpd:C03801; cpd:C04281; cpd:C04282; cpd:C05723; cpd:C05929,5,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8O3N1,C5H6O3N1,129.0425931,130.0504181,128.03476811074,1219,cpd:C04498,p-Coumaroylagmatine;,C14H20N4O2,p-Coumaroylagmatine; N-(4-Guanidinobutyl)-4-hydroxycinnamide; N-(4-Guanidinobutyl)-4-hydroxycinnamamide,R01617,Arginine and proline metabolism,2.3.1.64,NA,NA,PubChem: 7113; ChEBI: 32818; ChEMBL: CHEMBL568603; KNApSAcK: C00028060; 3DMET: B00725; NIKKAJI: J817.815A,cpd:C04498,14,20,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H21O2N4,C14H19O2N4,276.1586259,277.1664509,275.15080091075,1220,cpd:C05147,trans-3-Hydroxy-L-proline;,C5H9NO3,trans-3-Hydroxy-L-proline; trans-L-3-Hydroxyproline,R04374,Arginine and proline metabolism,4.2.1.77,NA,NA,PubChem: 7565; ChEBI: 16889; ChEMBL: CHEMBL1233466; PDB-CCD: HY3; NIKKAJI: J191.774I,cpd:C00430; cpd:C01015; cpd:C01073; cpd:C01110; cpd:C01157; cpd:C01165; cpd:C03341; cpd:C03440; cpd:C03651; cpd:C03741; cpd:C05147; cpd:C06809; cpd:C12876; cpd:C19706,5,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O3N1,C5H8O3N1,131.0582432,132.0660682,130.05041811076,1221,cpd:C05931,N-Succinyl-L-glutamate;,C9H13NO7,N-Succinyl-L-glutamate; (2S)-2-(3-Carboxypropanoylamino)pentanedioic acid,R00411 R05049,Arginine and proline metabolism; Metabolic pathways,1.2.1.71; 3.5.1.96,NA,NA,PubChem: 8219; ChEBI: 48957; 3DMET: B00877; NIKKAJI: J347.295G,cpd:C05931; cpd:C18168,9,13,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O7N1,C9H12O7N1,247.0692018,248.0770268,246.06137671077,1222,cpd:C05932,N-Succinyl-L-glutamate 5-semialdehyde;,C9H13NO6,N-Succinyl-L-glutamate 5-semialdehyde; (2S)-2-(3-Carboxypropanoylamino)-5-oxopentanoic acid,R04217 R05049,Arginine and proline metabolism; Metabolic pathways,1.2.1.71; 2.6.1.81,NA,NA,PubChem: 8220; ChEBI: 27657; 3DMET: B00878; NIKKAJI: J2.760.759D,cpd:C05539; cpd:C05932,9,13,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O6N1,C9H12O6N1,231.0742871,232.0821122,230.06646211078,1223,cpd:C05933,N(omega)-Hydroxyarginine;,C6H14N4O3,N(omega)-Hydroxyarginine; N(omega)-Hydroxy-L-arginine,R00111 R00558 R10107 R10108 R10466 R11033,Arginine and proline metabolism; Biosynthesis of antibiotics,1.14.13.39; 1.14.13.165; 3.5.3.25,"Cycloserine biosynthesis, arginine/serine => cycloserine",NA,CAS: 53054-07-2; PubChem: 8221; ChEBI: 7101; ChEMBL: CHEMBL260629; PDB-CCD: HAR; 3DMET: B05141; NIKKAJI: J390.553E,cpd:C05933; cpd:C08284; cpd:C18473; cpd:C20330,6,14,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O3N4,C6H13O3N4,190.1065903,191.1144154,189.09876531079,1224,cpd:C05936,N4-Acetylaminobutanal;,C6H11NO2,N4-Acetylaminobutanal; 4-Acetamidobutanal,R04025 R05050 R09075,Arginine and proline metabolism; Metabolic pathways,1.2.1.3; 1.4.3.4; 1.5.3.15,"GABA biosynthesis, eukaryotes, putrescine => GABA",NA,PubChem: 8223; ChEBI: 7386; 3DMET: B00880; NIKKAJI: J763.548F,cpd:C00408; cpd:C03969; cpd:C05936; cpd:C07500; cpd:C13696; cpd:C16759; cpd:C20204,6,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O2N1,C6H10O2N1,129.0789786,130.0868036,128.07115361080,1225,cpd:C05938,L-4-Hydroxyglutamate semialdehyde,C5H9NO4,L-4-Hydroxyglutamate semialdehyde,R04443 R05051,Arginine and proline metabolism,1.2.1.88,NA,NA,PubChem: 8224; ChEBI: 27809; 3DMET: B01917; NIKKAJI: J2.760.771C,cpd:C00025; cpd:C00217; cpd:C00302; cpd:C00979; cpd:C03618; cpd:C03727; cpd:C03790; cpd:C05574; cpd:C05938; cpd:C05941; cpd:C12269,5,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O4N1,C5H8O4N1,147.0531578,148.0609828,146.04533271081,1226,cpd:C05939,Linatine;,C10H17N3O5,Linatine; N-(gamma-L-Glutamyl)amino-D-proline,R02895,Arginine and proline metabolism,NA,NA,NA,CAS: 10139-06-7; PubChem: 8225; ChEBI: 28004; 3DMET: B01918; NIKKAJI: J8.984B,cpd:C05939,10,17,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O5N3,C10H16O5N3,259.1168207,260.1246457,258.10899561082,1227,cpd:C05941,2-Oxo-4-hydroxy-5-aminovalerate,C5H9NO4,2-Oxo-4-hydroxy-5-aminovalerate,R04446 R09253,Arginine and proline metabolism,NA,NA,NA,PubChem: 8226; ChEBI: 1241; 3DMET: B01919; NIKKAJI: J2.364.584J,cpd:C00025; cpd:C00217; cpd:C00302; cpd:C00979; cpd:C03618; cpd:C03727; cpd:C03790; cpd:C05574; cpd:C05938; cpd:C05941; cpd:C12269,5,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O4N1,C5H8O4N1,147.0531578,148.0609828,146.04533271083,1228,cpd:C05942,Pyrrole-2-carboxylate,C5H5NO2,Pyrrole-2-carboxylate,R04447 R09586 R09794 R09795,Arginine and proline metabolism,1.14.13.130; 4.1.1.93,NA,NA,PubChem: 8227; ChEBI: 36751; ChEMBL: CHEMBL509027; KNApSAcK: C00043859; PDB-CCD: PYC; 3DMET: B00881; NIKKAJI: J1.713B,cpd:C01059; cpd:C02932; cpd:C03056; cpd:C03927; cpd:C05942,5,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H6O2N1,C5H4O2N1,111.0320284,112.0398534,110.02420341084,1229,cpd:C05945,L-Arginine phosphate;,C6H15N4O5P,L-Arginine phosphate; N5-[Imino(phosphonoamino)methyl]L-ornithine; omega-N-Phosphoarginine; Arginine phosphate; L-Arginine-NG-phosphoric acid; Phosphoarginine A; N-Phospho-L-arginine; N(omega)-Phospho-L-arginine; Phosphoarginine,R00554,Arginine and proline metabolism,2.7.3.3,NA,NA,CAS: 1189-11-3; PubChem: 8229; ChEBI: 18412; PDB-CCD: RPI; 3DMET: B01920; NIKKAJI: J20.415C,cpd:C05945,6,15,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H16O5N4P1,C6H14O5N4P1,254.0780066,255.0858316,253.07018161085,1230,cpd:C05946,(4R)-4-Hydroxy-2-oxoglutarate;,C5H6O6,(4R)-4-Hydroxy-2-oxoglutarate; (R)-2-Hydroxy-4-oxopentanedioate; D-4-Hydroxy-2-oxoglutarate,R00471 R05052 R05053,Arginine and proline metabolism; Metabolic pathways,2.6.1.1; 2.6.1.21; 2.6.1.23; 4.1.3.16,NA,NA,PubChem: 8230; ChEBI: 4083 62213; 3DMET: B01921; NIKKAJI: J465.641E,cpd:C01127; cpd:C05946; cpd:C20485,5,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O6,C5H5O6,162.0164379,163.0242629,161.00861291086,1231,cpd:C05947,L-erythro-4-Hydroxyglutamate,C5H9NO5,L-erythro-4-Hydroxyglutamate,R04444 R04445 R05051 R05052 R05053,Arginine and proline metabolism; Metabolic pathways,1.2.1.88; 2.6.1.1; 2.6.1.21; 2.6.1.23,NA,NA,PubChem: 8231; ChEBI: 21285 6331; ChEMBL: CHEMBL371946; 3DMET: B01922; NIKKAJI: J83.286C,cpd:C03066; cpd:C03079; cpd:C05947,5,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O5N1,C5H8O5N1,163.0480724,164.0558974,162.04024741087,1232,cpd:C10497,Feruloylputrescine;,C14H20N2O3,Feruloylputrescine; Subaphyllin,R09257,Arginine and proline metabolism,2.3.1.-,NA,NA,CAS: 501-13-3; PubChem: 12680; ChEBI: 9299; KNApSAcK: C00002780; 3DMET: B03901; NIKKAJI: J11.793E,cpd:C10497,14,20,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H21O3N2,C14H19O3N2,264.1473925,265.1552175,263.13956751088,1233,cpd:C15699,gamma-L-Glutamylputrescine,C9H19N3O3,gamma-L-Glutamylputrescine,R07414 R07415,Arginine and proline metabolism; Metabolic pathways,1.4.3.-; 6.3.1.11,"GABA biosynthesis, prokaryotes, putrescine => GABA",NA,PubChem: 47205025; ChEBI: 48005; NIKKAJI: J624.987F,cpd:C05341; cpd:C15699,9,19,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H20O3N3,C9H18O3N3,217.1426415,218.1504665,216.13481651089,1234,cpd:C15700,gamma-Glutamyl-gamma-aminobutyraldehyde,C9H16N2O4,gamma-Glutamyl-gamma-aminobutyraldehyde,R07415 R07417 R07418,Arginine and proline metabolism; Metabolic pathways,1.2.1.-; 1.4.3.-,"GABA biosynthesis, prokaryotes, putrescine => GABA",NA,PubChem: 47205026; ChEBI: 61521; NIKKAJI: J2.795.757I,cpd:C15700,9,16,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O4N2,C9H15O4N2,216.111007,217.118832,215.1031821090,1235,cpd:C15767,4-(L-gamma-Glutamylamino)butanoate;,C9H16N2O5,4-(L-gamma-Glutamylamino)butanoate; 4-(gamma-L-Glutamylamino)butanoate; gamma-Glutamyl-gamma-aminobutyrate; 4-(Glutamylamino)butanoate; gamma-Glutamyl-GABA,R07417 R07418 R07419,Arginine and proline metabolism; Metabolic pathways,1.2.1.-; 3.5.1.94,"GABA biosynthesis, prokaryotes, putrescine => GABA",NA,PubChem: 47205093; ChEBI: 49260; NIKKAJI: J2.796.144D,cpd:C01410; cpd:C03415; cpd:C04390; cpd:C05695; cpd:C15767; cpd:C21015,9,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O5N2,C9H15O5N2,232.1059216,233.1137467,231.09809661091,1236,cpd:C18172,Carboxyspermidine;,C8H19N3O2,Carboxyspermidine; 2-Amino-4-[(4-aminobutyl)amino]-butanoic acid,R09079 R09081,Arginine and proline metabolism; Metabolic pathways,1.5.1.43; 4.1.1.96,NA,NA,PubChem: 96024388; ChEBI: 66868,cpd:C18172,8,19,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H20O2N3,C8H18O2N3,189.1477269,190.1555519,188.13990181092,1237,cpd:C18174,Carboxynorspermidine,C7H17N3O2,Carboxynorspermidine,R09080 R09082,Arginine and proline metabolism,1.5.1.43; 4.1.1.96,NA,NA,PubChem: 96024390; ChEBI: 67204,cpd:C18174,7,17,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H18O2N3,C7H16O2N3,175.1320768,176.1399018,174.12425181093,1238,cpd:C18325,Feruloylagmatine,C15H22N4O3,Feruloylagmatine,R09255,Arginine and proline metabolism,2.3.1.64,NA,NA,PubChem: 103061506; ChEBI: 75544,cpd:C01670; cpd:C18325,15,22,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O3N4,C15H21O3N4,306.1691906,307.1770156,305.16136561094,1239,cpd:C18326,p-Coumaroylputrescine,C13H18N2O2,p-Coumaroylputrescine,R09256,Arginine and proline metabolism,2.3.1.-,NA,NA,CAS: 34136-53-3; PubChem: 103061507; ChEBI: 70431; ChEMBL: CHEMBL373847,cpd:C07122; cpd:C11200; cpd:C18326; cpd:C19256; cpd:C19442,13,18,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H19O2N2,C13H17O2N2,234.1368278,235.1446529,233.12900281095,1240,cpd:C06655,L-N2-(2-Carboxyethyl)arginine;,C9H18N4O4,L-N2-(2-Carboxyethyl)arginine; N2-(2-Carboxyethyl)-L-arginine,R05465 R05467,Clavulanic acid biosynthesis; Biosynthesis of antibiotics,2.5.1.66; 6.3.3.4,"Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate",NA,PubChem: 8880; ChEBI: 15427; PDB-CCD: CMA; 3DMET: B05222; NIKKAJI: J976.696K,cpd:C04137; cpd:C06655,9,18,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H19O4N4,C9H17O4N4,246.1328051,247.1406301,245.124981096,1241,cpd:C06656,Deoxyguanidinoproclavaminic acid;,C9H16N4O3,Deoxyguanidinoproclavaminic acid; Deoxyguanidinoproclavaminate; Deoxyamidinoproclavaminate,R05466 R05467,Clavulanic acid biosynthesis; Biosynthesis of antibiotics,1.14.11.21; 6.3.3.4,"Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate",NA,PubChem: 8881; ChEBI: 15426; PDB-CCD: PCX; 3DMET: B01019; NIKKAJI: J648.549I,cpd:C06656,9,16,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O3N4,C9H15O3N4,228.1222404,229.1300654,227.11441541097,1242,cpd:C06657,Guanidinoproclavaminic acid;,C9H16N4O4,Guanidinoproclavaminic acid; Guanidinoproclavaminate; Amidinoproclavaminate,R05357 R05466,Clavulanic acid biosynthesis; Biosynthesis of antibiotics,1.14.11.21; 3.5.3.22,"Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate",NA,PubChem: 8882; ChEBI: 32963; 3DMET: B02080; NIKKAJI: J1.049.138J,cpd:C06657,9,16,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O4N4,C9H15O4N4,244.117155,245.12498,243.109331098,1243,cpd:C06658,Proclavaminic acid;,C8H14N2O4,Proclavaminic acid; Proclavaminate,R05357 R05468,Clavulanic acid biosynthesis; Biosynthesis of antibiotics,1.14.11.21; 3.5.3.22,"Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate",NA,CAS: 112240-59-2; PubChem: 8883; ChEBI: 15425; PDB-CCD: PCV; 3DMET: B02081; NIKKAJI: J370.816K,cpd:C04504; cpd:C06658; cpd:C08271,8,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O4N2,C8H13O4N2,202.0953569,203.103182,201.08753191099,1244,cpd:C06659,Dihydroclavaminic acid;,C8H12N2O4,Dihydroclavaminic acid; Dihydroclavaminate,R05468 R05469,Clavulanic acid biosynthesis; Biosynthesis of antibiotics,1.14.11.21,"Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate",NA,PubChem: 8884; ChEBI: 15424; 3DMET: B02082; NIKKAJI: J2.374.459G,cpd:C02471; cpd:C02755; cpd:C06659; cpd:C17360,8,12,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O4N2,C8H11O4N2,200.0797069,201.0875319,199.07188181100,1245,cpd:C06660,Clavaminic acid;,C8H10N2O4,Clavaminic acid; Clavaminate,R05469 R05470,Clavulanic acid biosynthesis; Biosynthesis of antibiotics,1.14.11.21,"Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate",NA,PubChem: 8885; ChEBI: 15423; 3DMET: B02083; NIKKAJI: J1.206.329F,cpd:C04771; cpd:C06660; cpd:C18350,8,10,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O4N2,C8H9O4N2,198.0640568,199.0718818,197.05623181101,1246,cpd:C06661,Clavulanate-9-aldehyde,C8H7NO5,Clavulanate-9-aldehyde,R05470 R05471,Clavulanic acid biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 8886; ChEBI: 27819; 3DMET: B02084; NIKKAJI: J1.018.184D J2.373.851A,cpd:C04604; cpd:C06661; cpd:C15771,8,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O5N1,C8H6O5N1,197.0324223,198.0402474,196.02459731102,1247,cpd:C06662,Clavulanic acid;,C8H9NO5,Clavulanic acid; Clavulanate,R05471,Clavulanic acid biosynthesis; Biosynthesis of antibiotics; Penicillins,NA,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   beta-Lactams;    Clavams;     C06662  Clavulanic acid; Antiinfectives [BR:br08307];  Antibacterials;   Cell wall biosynthesis inhibitor;    Beta-lactamase inhibitor;     Clavam;      Clavulanic acid;       D07711  Clavulanic acid (INN),CAS: 58001-44-8; PubChem: 8887; ChEBI: 48947; ChEMBL: CHEMBL777; KNApSAcK: C00018091; PDB-CCD: J01; 3DMET: B02085; NIKKAJI: J14.640D,cpd:C06662; cpd:C11833,8,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O5N1,C8H8O5N1,199.0480724,200.0558974,198.04024741103,1248,cpd:C00831,Pantetheine;,C11H22N2O4S,Pantetheine; (R)-Pantetheine,R02971 R02972 R02973 R10748 R10749,Carbapenem biosynthesis; Pantothenate and CoA biosynthesis; Biosynthesis of antibiotics,2.7.1.33; 2.7.1.34; 3.1.3.-; 3.5.1.92; 4.1.1.30,NA,NA,CAS: 496-65-1; PubChem: 4089; ChEBI: 16753; PDB-CCD: PNY; 3DMET: B00185; NIKKAJI: J15.187D,cpd:C00831,11,22,4,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H23O4N2S1,C11H21O4N2S1,278.1300284,279.1378534,277.12220331104,1249,cpd:C01134,Pantetheine 4'-phosphate;,C11H23N2O7PS,Pantetheine 4'-phosphate; 4'-Phosphopantetheine; Phosphopantetheine; D-Pantetheine 4'-phosphate,R01623 R02971 R03035 R03036 R03269 R04588 R10747 R10748,Carbapenem biosynthesis; Pantothenate and CoA biosynthesis; Metabolic pathways; Biosynthesis of antibiotics,2.3.1.49; 2.7.1.33; 2.7.1.34; 2.7.7.3; 3.1.3.-; 3.1.4.14; 3.6.1.9; 3.6.1.-; 4.1.1.36,"Coenzyme A biosynthesis, pantothenate => CoA",NA,PubChem: 4365; ChEBI: 16858 4222; PDB-CCD: PNS; 3DMET: B04774; NIKKAJI: J1.112.929C,cpd:C01134,11,23,7,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H24O7N2P1S1,C11H22O7N2P1S1,358.0963593,359.1041843,357.08853421105,1250,cpd:C06664,Thienamycin,C11H16N2O4S,Thienamycin,R10740 R10744 R10745,Carbapenem biosynthesis; Biosynthesis of antibiotics,1.14.20.-; 2.3.1.-,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   beta-Lactams;    Carbapenems;     C06664  Thienamycin,CAS: 59995-64-1; PubChem: 8889; ChEBI: 9542; ChEMBL: CHEMBL278773; KNApSAcK: C00018212; NIKKAJI: J20.130H,cpd:C06664,11,16,4,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H17O4N2S1,C11H15O4N2S1,272.0830782,273.0909032,271.07525311106,1251,cpd:C06669,(5R)-Carbapen-2-em-3-carboxylate;,C7H7NO3,(5R)-Carbapen-2-em-3-carboxylate; 1-Carbapen-2-em-3-carboxylic acid; (5R)-Carbapenem-3-carboxylic acid; (5R)-Carbapenem-3-carboxylate; (5R)-7-Oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate,R10415 R10736,Carbapenem biosynthesis; Biosynthesis of antibiotics,1.14.20.3; 1.14.20.-,"Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate",NA,PubChem: 8894; ChEBI: 615; ChEMBL: CHEMBL1240705; NIKKAJI: J1.466.424F,cpd:C00632; cpd:C01270; cpd:C02518; cpd:C06669; cpd:C07555; cpd:C11343; cpd:C12107; cpd:C12115; cpd:C14520; cpd:C16235; cpd:C19270,7,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O3N1,C7H6O3N1,153.0425931,154.0504181,152.03476811107,1252,cpd:C11755,Epithienamycin E;,C13H16N2O8S2,Epithienamycin E; MM13902,R10741 R10742,Carbapenem biosynthesis; Biosynthesis of antibiotics,1.14.20.-,NA,NA,CAS: 79057-46-8; PubChem: 13919; ChEBI: 91030; KNApSAcK: C00018092; NIKKAJI: J23.015D,cpd:C11755,13,16,8,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C13H17O8N2S2,C13H15O8N2S2,392.0348078,393.0426329,391.02698281108,1253,cpd:C17366,"(2S,5S)-trans-Carboxymethylproline;",C7H11NO4,"(2S,5S)-trans-Carboxymethylproline; (2S,5S)-5-Carboxymethylproline",R10485 R10556,Carbapenem biosynthesis; Biosynthesis of antibiotics,2.3.1.226; 6.3.3.6,"Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate",NA,PubChem: 96023719; ChEBI: 45757; PDB-CCD: SSC; NIKKAJI: J1.466.422J,cpd:C01250; cpd:C12121; cpd:C17366; cpd:C21248,7,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O4N1,C7H10O4N1,173.0688078,174.0766329,172.06098281109,1254,cpd:C17367,"(3S,5S)-Carbapenam-3-carboxylic acid;",C7H9NO3,"(3S,5S)-Carbapenam-3-carboxylic acid; (3S,5S)-Carbapenam-3-carboxylate",R10415 R10556,Carbapenem biosynthesis; Biosynthesis of antibiotics,1.14.20.3; 1.14.20.-; 6.3.3.6,"Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate",NA,PubChem: 96023720; ChEBI: 73939 73978; PDB-CCD: 2TQ; NIKKAJI: J1.466.421A,cpd:C17367; cpd:C19830; cpd:C19831,7,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O3N1,C7H8O3N1,155.0582432,156.0660682,154.05041811110,1255,cpd:C17368,8-Dehydroxythienamycin;,C11H16N2O3S,8-Dehydroxythienamycin; 8-Deshydroxythienamycin; Deshydroxythienamycin; NS-5,R10743 R10744,Carbapenem biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,CAS: 74806-75-0; PubChem: 96023721; ChEBI: 81035; NIKKAJI: J392.426B,cpd:C17368; cpd:C20823,11,16,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H17O3N2S1,C11H15O3N2S1,256.0881636,257.0959886,255.08033851111,1256,cpd:C17369,Northienamycin,C10H14N2O4S,Northienamycin,R10756,Carbapenem biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,CAS: 77550-86-8; PubChem: 96023722; ChEBI: 81036; KNApSAcK: C00018525; NIKKAJI: J2.806.285K,cpd:C17369,10,14,4,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O4N2S1,C10H13O4N2S1,258.0674281,259.0752531,257.05960311112,1257,cpd:C17373,OA-6129 B1,C20H31N3O8S,OA-6129 B1,R10750 R10751,Carbapenem biosynthesis; Biosynthesis of antibiotics,2.8.2.-,NA,NA,CAS: 82510-13-2; PubChem: 96023726; ChEBI: 81040; KNApSAcK: C00018450; NIKKAJI: J2.806.286I,cpd:C17373; cpd:C17374,20,31,8,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H32O8N3S1,C20H30O8N3S1,473.1831861,474.1910112,472.17536111113,1258,cpd:C17374,OA-6129 B2,C20H31N3O8S,OA-6129 B2,R10735 R10750,Carbapenem biosynthesis; Biosynthesis of antibiotics,1.14.20.-,NA,NA,CAS: 82475-10-3; PubChem: 96023727; ChEBI: 81041; KNApSAcK: C00018451; NIKKAJI: J2.806.287G,cpd:C17373; cpd:C17374,20,31,8,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H32O8N3S1,C20H30O8N3S1,473.1831861,474.1910112,472.17536111114,1259,cpd:C17377,N-Acetylthienamycin,C13H18N2O5S,N-Acetylthienamycin,R10745,Carbapenem biosynthesis; Biosynthesis of antibiotics,2.3.1.-,NA,NA,PubChem: 96023730; ChEBI: 81044; ChEMBL: CHEMBL346183 CHEMBL82073; KNApSAcK: C00018325; NIKKAJI: J133.884F,cpd:C17372; cpd:C17377; cpd:C17397,13,18,5,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C13H19O5N2S1,C13H17O5N2S1,314.0936429,315.1014679,313.08581781115,1260,cpd:C17399,Epithienamycin F,C13H18N2O8S2,Epithienamycin F,R10741 R10746,Carbapenem biosynthesis; Biosynthesis of antibiotics,1.14.20.-; 2.3.1.-,NA,NA,CAS: 79057-45-7; PubChem: 96023752; ChEBI: 81061; ChEMBL: CHEMBL1205319; KNApSAcK: C00018220; NIKKAJI: J2.806.288E,cpd:C17399,13,18,8,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C13H19O8N2S2,C13H17O8N2S2,394.0504579,395.0582829,393.04263291116,1261,cpd:C20813,OA-6129 A,C20H31N3O7S,OA-6129 A,R10735 R10749,Carbapenem biosynthesis; Biosynthesis of antibiotics,1.14.20.-,NA,NA,CAS: 82475-11-4; PubChem: 254741279,cpd:C20813,20,31,7,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H32O7N3S1,C20H30O7N3S1,457.1882715,458.1960966,456.18044651117,1262,cpd:C20814,OA-6129 C,C20H31N3O11S2,OA-6129 C,R10751 R10752,Carbapenem biosynthesis; Biosynthesis of antibiotics,2.8.2.-; 3.5.1.-,NA,NA,CAS: 82475-09-0; PubChem: 254741280,cpd:C20814,20,31,11,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C20H32O11N3S2,C20H30O11N3S2,553.1400012,554.1478262,552.13217611118,1263,cpd:C20815,MM 4550,C13H16N2O9S2,MM 4550,R10742,Carbapenem biosynthesis; Biosynthesis of antibiotics,1.14.20.-,NA,NA,PubChem: 254741281,cpd:C20815,13,16,9,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C13H17O9N2S2,C13H15O9N2S2,408.0297224,409.0375475,407.02189741119,1264,cpd:C20816,Deacetylepithienamycin F;,C11H16N2O7S2,Deacetylepithienamycin F; Deacetyl MM 17880; NA 26975,R10746 R10752,Carbapenem biosynthesis; Biosynthesis of antibiotics,2.3.1.-; 3.5.1.-,NA,NA,PubChem: 254741282,cpd:C20816,11,16,7,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C11H17O7N2S2,C11H15O7N2S2,352.0398932,353.0477182,351.03206821120,1265,cpd:C20817,C20817;,C9H14N2O3S,C20817; Carbapenem biosynthesis intermediate 1,R10736 R10737,Carbapenem biosynthesis; Biosynthesis of antibiotics,2.1.1.-,NA,NA,PubChem: 254741283,cpd:C20817,9,14,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O3N2S1,C9H13O3N2S1,230.0725135,231.0803385,229.06468851121,1266,cpd:C20818,C20818;,C10H16N2O3S,C20818; Carbapenem biosynthesis intermediate 2,R10737 R10738 R10753,Carbapenem biosynthesis; Biosynthesis of antibiotics,2.1.1.-,NA,NA,PubChem: 254741284,cpd:C00120; cpd:C20818,10,16,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O3N2S1,C10H15O3N2S1,244.0881636,245.0959886,243.08033851122,1267,cpd:C20819,C20819;,C11H18N2O3S,C20819; Carbapenem biosynthesis intermediate 5,R10738 R10739 R10743 R10755,Carbapenem biosynthesis; Biosynthesis of antibiotics,2.1.1.-,NA,NA,PubChem: 254741285,cpd:C20819,11,18,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H19O3N2S1,C11H17O3N2S1,258.1038136,259.1116387,257.09598861123,1268,cpd:C20820,"2,3-Dihydrothienamycin",C11H18N2O4S,"2,3-Dihydrothienamycin",R10739 R10740,Carbapenem biosynthesis; Biosynthesis of antibiotics,1.14.20.-,NA,NA,PubChem: 254741286,cpd:C20820,11,18,4,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H19O4N2S1,C11H17O4N2S1,274.0987282,275.1065533,273.09090321124,1269,cpd:C20821,C20821;,C8H9NO3,C20821; Carbapenem biosynthesis intermediate 6,R10749,Carbapenem biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 254741287,cpd:C00250; cpd:C03493; cpd:C03986; cpd:C05831; cpd:C06051; cpd:C12323; cpd:C14170; cpd:C14171; cpd:C20821,8,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O3N1,C8H8O3N1,167.0582432,168.0660682,166.05041811125,1270,cpd:C20822,C20822;,C10H14N2O3S,C20822; Carbapenem biosynthesis intermediate 3,R10753 R10754 R10756,Carbapenem biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 254741288,cpd:C20822,10,14,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O3N2S1,C10H13O3N2S1,242.0725135,243.0803385,241.06468851126,1271,cpd:C20823,C20823;,C11H16N2O3S,C20823; Carbapenem biosynthesis intermediate 4,R10754 R10755,Carbapenem biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 254741289,cpd:C17368; cpd:C20823,11,16,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H17O3N2S1,C11H15O3N2S1,256.0881636,257.0959886,255.08033851127,1272,cpd:C00135,L-Histidine;,C6H9N3O2,L-Histidine; (S)-alpha-Amino-1H-imidazole-4-propionic acid,R01158 R01159 R01160 R01161 R01163 R01164 R01166 R01167; R01168 R01169 R01991 R01992 R03655 R08412 R08413 R10523; R10686 R11015,Histidine metabolism; beta-Alanine metabolism; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption; Central carbon metabolism in cancer,1.1.1.23; 1.14.99.52; 2.1.1.44; 2.1.1.-; 2.3.1.33; 2.6.1.38; 3.4.13.18; 3.4.13.20; 4.1.1.22; 4.1.1.28; 4.3.1.3; 6.1.1.21; 6.3.2.11,"Histidine biosynthesis, PRPP => histidine; Histidine degradation, histidine => N-formiminoglutamate => glutamate",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00135  Histidine (His); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Histidine;     D00032  Histidine (USP/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00032  [003617] L-Histidine;  Buffering agent;   D00032  [003617] L-Histidine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00032  L-Histidine;   D00032  L-Histidine hydrochloride hydrate,CAS: 71-00-1; PubChem: 3435; ChEBI: 15971; ChEMBL: CHEMBL17962; KNApSAcK: C00001363; PDB-CCD: HIS; 3DMET: B01171; NIKKAJI: J4.881J,cpd:C00135; cpd:C00768; cpd:C01162; cpd:C06419,6,9,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O2N3,C6H8O2N3,155.0694765,156.0773016,154.06165151128,1273,cpd:C00386,Carnosine;,C9H14N4O3,Carnosine; Nalpha-(beta-alanyl)-L-histidine,R01164 R01166 R02144,Histidine metabolism; beta-Alanine metabolism; Metabolic pathways,2.1.1.22; 3.4.13.18; 3.4.13.20; 6.3.2.11,NA,Compounds with biological roles [BR:br08001];  Peptides;   Peptides;    Dipeptides;     C00386  Carnosine,CAS: 305-84-0; PubChem: 3676; ChEBI: 15727; ChEMBL: CHEMBL242948; 3DMET: B00100; NIKKAJI: J5.496H,cpd:C00386,9,14,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O3N4,C9H13O3N4,226.1065903,227.1144154,225.09876531129,1274,cpd:C00388,Histamine;,C5H9N3,Histamine; 1H-Imidazole-4-ethanamine; 2-(4-Imidazolyl)ethylamine,R01167 R02150 R02152 R02155 R07643,Histidine metabolism; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Neuroactive ligand-receptor interaction; Fc epsilon RI signaling pathway; Synaptic vesicle cycle; Inflammatory mediator regulation of TRP channels; Gastric acid secretion; Protein digestion and absorption; Asthma; Histamine H2/H3 receptor agonists/antagonists,1.4.3.22; 2.1.1.8; 2.3.1.-; 4.1.1.22; 4.1.1.28; 6.3.2.18,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C00388  Histamine;  Hormones and transmitters;   Other hormones;    Histamine;     C00388  Histamine;   Neurotransmitters;    Biogenic amines;     C00388  Histamine; Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Histamine;     H1-receptor;      Histamine;       D08040  Histamine (DCF);     H2-receptor;      Histamine;       D08040  Histamine (DCF);     H3-receptor;      Histamine;       D08040  Histamine (DCF);     H4-receptor;      Histamine;       D08040  Histamine (DCF),CAS: 51-45-6; PubChem: 3678; ChEBI: 18295; ChEMBL: CHEMBL90; KNApSAcK: C00001414; PDB-CCD: HSM; 3DMET: B00101; NIKKAJI: J4.117C,cpd:C00388; cpd:C03139; cpd:C06873,5,9,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10N3,C5H8N3,111.0796473,112.0874723,110.07182231130,1275,cpd:C00439,N-Formimino-L-glutamate;,C6H10N2O4,N-Formimino-L-glutamate; N-Formimidoyl-L-glutamate,R02285 R02286 R02287 R02288,Histidine metabolism; Metabolic pathways,2.1.2.5; 3.5.2.7; 3.5.3.8; 3.5.3.13,"Histidine degradation, histidine => N-formiminoglutamate => glutamate",NA,PubChem: 3728; ChEBI: 18327 7274; PDB-CCD: NIG; 3DMET: B00116; NIKKAJI: J193.205E,cpd:C00439; cpd:C16674,6,10,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O4N2,C6H9O4N2,174.0640568,175.0718818,173.05623181131,1276,cpd:C00785,Urocanate;,C6H6N2O2,Urocanate; Urocanic acid,R01168 R02914 R10330,Histidine metabolism; Metabolic pathways,1.3.99.33; 4.2.1.49; 4.3.1.3,"Histidine degradation, histidine => N-formiminoglutamate => glutamate",NA,CAS: 104-98-3; PubChem: 4043; ChEBI: 27247 30817; ChEMBL: CHEMBL1236602; PDB-CCD: URO; 3DMET: B01329; NIKKAJI: J5.039C,cpd:C00785; cpd:C02126; cpd:C05571; cpd:C19345,6,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O2N2,C6H5O2N2,138.0429274,139.0507525,137.03510241132,1277,cpd:C00860,L-Histidinol,C6H11N3O,L-Histidinol,R01158 R03012 R03013,Histidine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids,1.1.1.23; 3.1.3.15,"Histidine biosynthesis, PRPP => histidine",NA,CAS: 4836-52-6; PubChem: 4117; ChEBI: 16255; ChEMBL: CHEMBL278081; KNApSAcK: C00007479; PDB-CCD: HSO; 3DMET: B01345; NIKKAJI: J80.912H,cpd:C00860,6,11,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O1N3,C6H10O1N3,141.090212,142.098037,140.0823871133,1278,cpd:C01044,N-Formyl-L-aspartate,C5H7NO5,N-Formyl-L-aspartate,R00526 R03188,Histidine metabolism,3.5.1.8; 3.5.1.15; 3.5.3.5,NA,NA,CAS: 19427-28-2; PubChem: 4286; ChEBI: 48429; 3DMET: B00229; NIKKAJI: J242.809A,cpd:C01044,5,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8O5N1,C5H6O5N1,161.0324223,162.0402474,160.02459731134,1279,cpd:C01045,N-Formyl-L-glutamate,C6H9NO5,N-Formyl-L-glutamate,R00525 R02286 R03189,Histidine metabolism,2.1.2.5; 3.5.1.68; 3.5.3.13,NA,NA,PubChem: 4287; ChEBI: 48309; 3DMET: B00230; NIKKAJI: J195.329J,cpd:C01042; cpd:C01045; cpd:C05520,6,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O5N1,C6H8O5N1,175.0480724,176.0558974,174.04024741135,1280,cpd:C01100,L-Histidinol phosphate,C6H12N3O4P,L-Histidinol phosphate,R03013 R03243,Histidine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids,2.6.1.9; 3.1.3.15,"Histidine biosynthesis, PRPP => histidine",NA,CAS: 25679-93-0; PubChem: 4334; ChEBI: 16996; KNApSAcK: C00007480; PDB-CCD: HSA; 3DMET: B01378; NIKKAJI: J540.521A,cpd:C01100,6,12,4,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O4N3P1,C6H11O4N3P1,221.0565429,222.0643679,220.04871781136,1281,cpd:C01152,N(pi)-Methyl-L-histidine;,C7H11N3O2,N(pi)-Methyl-L-histidine; N-pros-Methyl-L-histidine; 3-Methylhistidine; 1-Methylhistidine,R01159 R03286 R03288,Histidine metabolism,2.1.1.-; 3.4.13.5; 3.4.13.20; 6.3.2.11,NA,NA,CAS: 368-16-1; PubChem: 4381; ChEBI: 27596; PDB-CCD: MHS; 3DMET: B01394; NIKKAJI: J111.364J,cpd:C01152; cpd:C03298,7,11,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O2N3,C7H10O2N3,169.0851266,170.0929516,168.07730161137,1282,cpd:C01262,beta-Alanyl-N(pi)-methyl-L-histidine;,C10H16N4O3,beta-Alanyl-N(pi)-methyl-L-histidine; Anserine,R02144 R03286 R03288,Histidine metabolism; beta-Alanine metabolism; Metabolic pathways,2.1.1.22; 3.4.13.5; 3.4.13.20; 6.3.2.11,NA,Compounds with biological roles [BR:br08001];  Peptides;   Peptides;    Dipeptides;     C01262  Anserine,CAS: 584-85-0; PubChem: 4481; ChEBI: 18323; ChEMBL: CHEMBL448301; 3DMET: B01426; NIKKAJI: J28.566H,cpd:C00884; cpd:C01262; cpd:C04138,10,16,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O3N4,C10H15O3N4,240.1222404,241.1300654,239.11441541138,1283,cpd:C01267,3-(Imidazol-4-yl)-2-oxopropyl phosphate;,C6H9N2O5P,3-(Imidazol-4-yl)-2-oxopropyl phosphate; Imidazole-acetol phosphate,R03243 R03457,Histidine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids,2.6.1.9; 4.2.1.19,"Histidine biosynthesis, PRPP => histidine",NA,PubChem: 4486; ChEBI: 16426; KNApSAcK: C00007308; 3DMET: B00269; NIKKAJI: J670.555C,cpd:C01267,6,9,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O5N2P1,C6H8O5N2P1,220.0249084,221.0327334,219.01708341139,1284,cpd:C01929,L-Histidinal,C6H9N3O,L-Histidinal,R01163 R03012,Histidine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.23,"Histidine biosynthesis, PRPP => histidine",NA,PubChem: 5035; ChEBI: 27676; ChEMBL: CHEMBL307302; KNApSAcK: C00007495; PDB-CCD: HSV; 3DMET: B01518; NIKKAJI: J36.234D,cpd:C01279; cpd:C01929,6,9,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O1N3,C6H8O1N3,139.0745619,140.082387,138.06673691140,1285,cpd:C02739,1-(5-Phospho-D-ribosyl)-ATP;,C15H25N5O20P4,1-(5-Phospho-D-ribosyl)-ATP; Phosphoribosyl-ATP; N1-(5-Phospho-D-ribosyl)-ATP; 1-(5-Phosphoribosyl)-ATP; 1-(5-Phospho-beta-D-ribosyl)-ATP,R01071 R04035,Histidine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids,2.4.2.17; 3.6.1.31,"Histidine biosynthesis, PRPP => histidine",NA,PubChem: 5699; ChEBI: 73200; 3DMET: B04862; NIKKAJI: J608.031F,cpd:C02739,15,25,20,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O20N5P4,C15H24O20N5P4,719.0043362,720.0121612,717.99651121141,1286,cpd:C02741,Phosphoribosyl-AMP;,C15H23N5O14P2,Phosphoribosyl-AMP; N1-(5-Phospho-D-ribosyl)-AMP; 1-(5-Phosphoribosyl)-AMP; 1-(5-Phospho-beta-D-ribosyl)-AMP,R04035 R04037,Histidine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids,3.5.4.19; 3.6.1.31,"Histidine biosynthesis, PRPP => histidine",NA,PubChem: 5701; ChEBI: 18374; 3DMET: B04863,cpd:C00301; cpd:C01882; cpd:C02741,15,23,14,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H24O14N5P2,C15H22O14N5P2,559.0716744,560.0794995,558.06384941142,1287,cpd:C02835,Imidazole-4-acetate;,C5H6N2O2,Imidazole-4-acetate; Imidazoleacetic acid; 4-Imidazoleacetate,R04065 R04066 R04068,Histidine metabolism,1.2.1.3; 1.14.13.5; 6.3.4.8,NA,NA,CAS: 645-65-8; PubChem: 5778; ChEBI: 16974; ChEMBL: CHEMBL784; 3DMET: B00507; NIKKAJI: J38.564F,cpd:C00178; cpd:C02835,5,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O2N2,C5H5O2N2,126.0429274,127.0507525,125.03510241143,1288,cpd:C03277,Imidazol-5-yl-pyruvate;,C6H6N2O3,Imidazol-5-yl-pyruvate; 3-(Imidazol-5-yl)pyruvate; Imidazole pyruvate; Imidazole pyruvic acid,R01161 R04185 R04186 R04874 R04876,Histidine metabolism,1.1.1.111; 2.6.1.38,NA,NA,PubChem: 6136; ChEBI: 17406; 3DMET: B00573; NIKKAJI: J467.750A,cpd:C03277; cpd:C03762; cpd:C19321; cpd:C19322; cpd:C19323,6,6,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O3N2,C6H5O3N2,154.0378421,155.0456671,153.0300171144,1289,cpd:C03409,N-Formimino-L-aspartate;,C5H8N2O4,N-Formimino-L-aspartate; N-Formimidoyl-L-aspartate,R03188 R04214,Histidine metabolism,3.5.2.-; 3.5.3.5,NA,NA,PubChem: 6238; ChEBI: 48427; PDB-CCD: NFQ; 3DMET: B01655; NIKKAJI: J2.742.121K,cpd:C03409; cpd:C08298; cpd:C19483; cpd:C20232; cpd:C20846,5,8,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O4N2,C5H7O4N2,160.0484067,161.0562318,159.04058171145,1290,cpd:C03680,4-Imidazolone-5-propanoate;,C6H8N2O3,"4-Imidazolone-5-propanoate; 4-Imidazolone-5-propionic acid; 4,5-Dihydro-4-oxo-5-imidazolepropanoate",R00069 R02288 R02914 R04282 R04283,Histidine metabolism; Metabolic pathways,1.14.13.-; 1.17.3.2; 3.5.2.7; 4.2.1.49,"Histidine degradation, histidine => N-formiminoglutamate => glutamate",NA,PubChem: 6455; ChEBI: 27384; 3DMET: B00620; NIKKAJI: J38.565D,cpd:C03680; cpd:C03817; cpd:C04397; cpd:C04398; cpd:C05568; cpd:C19481; cpd:C20385,6,8,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O3N2,C6H7O3N2,156.0534921,157.0613172,155.04566711146,1291,cpd:C04437,1-(5-Phosphoribosyl)imidazole-4-acetate,C10H15N2O9P,1-(5-Phosphoribosyl)imidazole-4-acetate,R04068 R04479,Histidine metabolism,6.3.4.8,NA,NA,PubChem: 7068; ChEBI: 16805; 3DMET: B01744; NIKKAJI: J2.098.321C,cpd:C03446; cpd:C04437,10,15,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O9N2P1,C10H14O9N2P1,338.0515171,339.0593421,337.0436921147,1292,cpd:C04666,D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate;,C6H11N2O6P,D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate; D-erythro-Imidazole-glycerol 3-phosphate; D-erythro-Imidazole-glycerol phosphate,R03457 R04558,Histidine metabolism; Biosynthesis of alkaloids derived from histidine and purine; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids,2.4.2.-; 4.1.3.-; 4.2.1.19,"Histidine biosynthesis, PRPP => histidine",NA,PubChem: 7249; ChEBI: 17805; KNApSAcK: C00007478; PDB-CCD: IYP; 3DMET: B01771; NIKKAJI: J721.046I,cpd:C04666,6,11,6,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O6N2P1,C6H10O6N2P1,238.0354731,239.0432981,237.0276481148,1293,cpd:C04896,5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide;,C15H25N5O15P2,5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide; N-(5'-Phospho-D-ribosylformimino)-5-amino-1-(5''-phospho-D-ribosyl)-4-imidazolecarboxamide; N-(5'-Phosphoribosylformimino)-5-amino-1-(5''-phosphoribosyl)-4-imidazolecarboxamide; Phosphoribosyl-formimino-AICAR-phosphate; 1-(5-Phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino]imidazole-4-carboxamide; 1-(5-Phospho-beta-D-ribosyl)-5-[(5-phospho-beta-D-ribosylamino)methylideneamino]imidazole-4-carboxamide,R04037 R04640,Histidine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids,3.5.4.19; 5.3.1.16,"Histidine biosynthesis, PRPP => histidine",NA,PubChem: 7447; ChEBI: 18302; PDB-CCD: GUO; 3DMET: B01802; NIKKAJI: J574.865H,cpd:C04896; cpd:C04916,15,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O15N5P2,C15H24O15N5P2,577.0822391,578.0900642,576.07441411149,1294,cpd:C04916,N-(5'-Phospho-D-1'-ribulosylformimino)-5-amino-1-(5''-phospho-D-ribosyl)-4-imidazolecarboxamide;,C15H25N5O15P2,N-(5'-Phospho-D-1'-ribulosylformimino)-5-amino-1-(5''-phospho-D-ribosyl)-4-imidazolecarboxamide; 5-[(5-Phospho-1-deoxyribulos-1-ylamino)methylideneamino]-1-(5-phosphoribosyl)imidazole-4-carboxamide; Phosphoribulosyl-formimino-AICAR-phosphate; 5-[(5-Phospho-1-deoxy-D-ribulos-1-ylamino)methylideneamino]-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide,R04558 R04640,Histidine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids,2.4.2.-; 4.1.3.-; 5.3.1.16,"Histidine biosynthesis, PRPP => histidine",NA,PubChem: 7464; ChEBI: 27735; PDB-CCD: 2ER; 3DMET: B01804; NIKKAJI: J2.760.456K,cpd:C04896; cpd:C04916,15,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O15N5P2,C15H24O15N5P2,577.0822391,578.0900642,576.07441411150,1295,cpd:C05127,N-Methylhistamine;,C6H11N3,N-Methylhistamine; 1-Methylhistamine; 1-Methyl-4-(2-aminoethyl)imidazole; Ntau-Methylhistamine,R02155 R04674,Histidine metabolism,1.4.3.4; 1.4.3.22; 2.1.1.8,NA,NA,CAS: 501-75-7; PubChem: 7548; ChEBI: 29009; ChEMBL: CHEMBL507; 3DMET: B00753; NIKKAJI: J86.801I,cpd:C00860; cpd:C03140; cpd:C03771; cpd:C04752; cpd:C05127; cpd:C17928; cpd:C17929,6,11,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12N3,C6H10N3,125.0952974,126.1031224,124.08747231151,1296,cpd:C05130,Imidazole-4-acetaldehyde;,C5H6N2O,Imidazole-4-acetaldehyde; Imidazole acetaldehyde,R02150 R04065 R04874,Histidine metabolism,1.2.1.3; 1.4.3.22,NA,NA,CAS: 645-14-7; PubChem: 7550; ChEBI: 27398; 3DMET: B00754; NIKKAJI: J417.577H,cpd:C02560; cpd:C05130; cpd:C19265,5,6,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O1N2,C5H5O1N2,110.0480128,111.0558379,109.04018781152,1297,cpd:C05131,(1-Ribosylimidazole)-4-acetate,C10H14N2O6,(1-Ribosylimidazole)-4-acetate,R04479,Histidine metabolism,NA,NA,NA,PubChem: 7551; ChEBI: 141; 3DMET: B01811; NIKKAJI: J2.704.880C,cpd:C05131; cpd:C16744,10,14,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O6N2,C10H13O6N2,258.0851862,259.0930112,257.07736111153,1298,cpd:C05133,4-Imidazolone-5-acetate;,C5H6N2O3,4-Imidazolone-5-acetate; Imidazolone acetate; (5-Hydroxyimidazole)-4-acetate; 5-Hydroxy-4-imidazoleacetate,R04066 R04214,Histidine metabolism,1.14.13.5; 3.5.2.-,NA,NA,PubChem: 7553; ChEBI: 27850; 3DMET: B00755; NIKKAJI: J2.754.764H,cpd:C02144; cpd:C03088; cpd:C05133; cpd:C05281,5,6,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O3N2,C5H5O3N2,142.0378421,143.0456671,141.0300171154,1299,cpd:C05135,4-(beta-Acetylaminoethyl)imidazole;,C7H11N3O,4-(beta-Acetylaminoethyl)imidazole; N-Acetylhistamine,R02152,Histidine metabolism,2.3.1.-,NA,NA,PubChem: 7555; ChEBI: 28483; ChEMBL: CHEMBL1230893; PDB-CCD: AHN; 3DMET: B00757; NIKKAJI: J205.971A,cpd:C05135; cpd:C16399,7,11,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O1N3,C7H10O1N3,153.090212,154.098037,152.0823871155,1300,cpd:C05565,Hydantoin-5-propionate;,C6H8N2O4,Hydantoin-5-propionate; Hydantoin-propionate,R00069 R04875,Histidine metabolism,1.14.13.-; 1.17.3.2,NA,NA,PubChem: 7893; ChEBI: 28297; 3DMET: B05071; NIKKAJI: J2.368.416K,cpd:C00614; cpd:C04311; cpd:C05565; cpd:C06247; cpd:C13739; cpd:C14182; cpd:C20758; cpd:C20892; cpd:C20893,6,8,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O4N2,C6H7O4N2,172.0484067,173.0562318,171.04058171156,1301,cpd:C05568,Imidazole lactate;,C6H8N2O3,Imidazole lactate; Imidazole lactic acid; 2-Hydroxy-3-(1H-imidazol-5-yl)-propanoic acid,R04876,Histidine metabolism,NA,NA,NA,PubChem: 7894; ChEBI: 24773 27487; 3DMET: B05072; NIKKAJI: J1.107.342E,cpd:C03680; cpd:C03817; cpd:C04397; cpd:C04398; cpd:C05568; cpd:C19481; cpd:C20385,6,8,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O3N2,C6H7O3N2,156.0534921,157.0613172,155.04566711157,1302,cpd:C05570,Ergothioneine,C9H16N3O2S,Ergothioneine,R04877 R04878 R11023,Histidine metabolism,4.4.1.-,NA,NA,CAS: 497-30-3; PubChem: 7896; ChEBI: 4828 82707; 3DMET: B00790; NIKKAJI: J96.989C,cpd:C05570,9,16,2,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O2N3S1,C9H15O2N3S1,230.0963229,231.104148,229.08849791158,1303,cpd:C05571,Thiourocanic acid,C6H6N2O2S,Thiourocanic acid,R04877,Histidine metabolism,NA,NA,NA,PubChem: 7897; ChEBI: 9572; 3DMET: B00791; NIKKAJI: J2.368.053J,cpd:C05571,6,6,2,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O2N2S1,C6H5O2N2S1,170.0149986,171.0228236,169.00717361159,1304,cpd:C05572,4-Oxoglutaramate;,C5H7NO4,4-Oxoglutaramate; 4-Ketoglutaramate,R00270 R04283,Histidine metabolism,NA,NA,NA,PubChem: 7898; ChEBI: 27467 30883; 3DMET: B00792; NIKKAJI: J2.363.539I,cpd:C00940; cpd:C05572,5,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8O4N1,C5H6O4N1,145.0375077,146.0453327,144.02968271160,1305,cpd:C05575,Hercynine;,C9H16N3O2,"Hercynine; Nalpha,Nalpha,Nalpha-Trimethyl-L-histidine",R01169 R04436 R04878 R11013 R11014,Histidine metabolism,1.14.99.50; 1.14.99.51; 2.1.1.44,NA,NA,CAS: 534-30-5; PubChem: 7901; ChEBI: 15781 67049; PDB-CCD: AVJ; 3DMET: B00794,cpd:C05570; cpd:C05575; cpd:C07079,9,16,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O2N3,C9H15O2N3,198.1242518,199.1320768,197.11642671161,1306,cpd:C05827,Methylimidazole acetaldehyde;,C6H8N2O,Methylimidazole acetaldehyde; 1-Methylimidazole-4-acetaldehyde; Methylimidazoleacetaldehyde,R04674 R04996,Histidine metabolism,1.2.1.5; 1.4.3.4; 1.4.3.22,NA,NA,CAS: 19639-03-3; PubChem: 8121; ChEBI: 28104; 3DMET: B00856; NIKKAJI: J417.576J,cpd:C03007; cpd:C05827; cpd:C13711; cpd:C18389,6,8,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O1N2,C6H7O1N2,124.0636629,125.0714879,123.05583791162,1307,cpd:C05828,Methylimidazoleacetic acid;,C6H8N2O2,Methylimidazoleacetic acid; Tele-methylimidazoleacetic acid; 1-Methyl-4-imidazoleacetic acid; 1-Methylimidazole-4-acetate; Methylimidazoleacetate,R04996,Histidine metabolism,1.2.1.5,NA,NA,CAS: 2625-49-2; PubChem: 8122; ChEBI: 1606 28380; 3DMET: B00857; NIKKAJI: J257.475F,cpd:C01078; cpd:C03633; cpd:C03798; cpd:C05828; cpd:C07458; cpd:C13693; cpd:C20522,6,8,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O2N2,C6H7O2N2,140.0585775,141.0664025,139.05075251163,1308,cpd:C05829,N-Carbamyl-L-glutamate;,C6H10N2O5,N-Carbamyl-L-glutamate; Carglumic acid,R00254 R04875,Histidine metabolism,3.5.1.87,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;    A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;     A16AA Amino acids and derivatives;      A16AA05 Carglumic acid;       D07130  Carglumic acid (JAN/USAN/INN); USP drug classification [BR:br08302];  Therapeutic Nutrients/Minerals/Electrolytes;   Electrolyte/Mineral Replacement;    Carglumic acid;     D07130  Carglumic acid (JAN/USAN/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    399  Miscellaneous;     3999  Others;      D07130  Carglumic acid (JAN/USAN/INN); New drug approvals in the USA [br08319.html];  New Molecular Entity and New Therapeutic Biological Product Approvals;   D07130; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D07130; New drug approvals in Japan [br08318.html];  Drugs with new active ingredients;   D07130; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D07130; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D07130; Pharmacogenomic biomarkers in FDA drug labels [br08341.html];  Polymorphisms and germline mutations;   D07130",CAS: 1188-38-1; PubChem: 8123; ChEBI: 21693 71028; ChEMBL: CHEMBL1201780; 3DMET: B00858; NIKKAJI: J2.088.972A,cpd:C05829; cpd:C08266,6,10,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5N2,C6H9O5N2,190.0589714,191.0667965,189.05114641164,1309,cpd:C16673,Isoglutamine;,C5H10N2O3,"Isoglutamine; 4,5-Diamino-5-oxopentanoic acid; DL-Isoglutamine",R04879,Histidine metabolism,NA,NA,NA,CAS: 328-48-3; PubChem: 51090996; ChEBI: 21305; NIKKAJI: J1.199A,cpd:C00064; cpd:C00303; cpd:C00819; cpd:C01419; cpd:C05100; cpd:C16673; cpd:C21029,5,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O3N2,C5H9O3N2,146.0691422,147.0769672,145.06131721165,1310,cpd:C16674,Formylisoglutamine;,C6H10N2O4,Formylisoglutamine; DL-Formylisoglutamine,R04282 R04879,Histidine metabolism,NA,NA,NA,PubChem: 51090997; ChEBI: 80654; NIKKAJI: J2.804.254J,cpd:C00439; cpd:C16674,6,10,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O4N2,C6H9O4N2,174.0640568,175.0718818,173.05623181166,1311,cpd:C20522,Dihydrourocanate;,C6H8N2O2,Dihydrourocanate; Deaminohistidine; 3-(1H-Imidazol-4-yl)propanoate,R10330,Histidine metabolism,1.3.99.33,NA,NA,PubChem: 172232271,cpd:C01078; cpd:C03633; cpd:C03798; cpd:C05828; cpd:C07458; cpd:C13693; cpd:C20522,6,8,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O2N2,C6H7O2N2,140.0585775,141.0664025,139.05075251167,1312,cpd:C20994,S-(Hercyn-2-yl)-L-cysteine S-oxide,C12H21N4O5S,S-(Hercyn-2-yl)-L-cysteine S-oxide,R11014 R11021 R11023,Histidine metabolism,1.14.99.51; 3.5.1.118; 4.4.1.-,NA,NA,PubChem: 254741452,cpd:C20994,12,21,5,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H22O5N4S1,C12H20O5N4S1,333.123266,334.131091,332.11544091168,1313,cpd:C20995,gamma-L-Glutamyl-S-(hercyn-2-yl)-L-cysteine S-oxide,C17H28N5O8S,gamma-L-Glutamyl-S-(hercyn-2-yl)-L-cysteine S-oxide,R11013 R11021,Histidine metabolism,1.14.99.50; 3.5.1.118,NA,NA,PubChem: 254741453; PDB-CCD: 4NK,cpd:C20995,17,28,8,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C17H29O8N5S1,C17H27O8N5S1,462.1658591,463.1736841,461.1580341169,1314,cpd:C00146,Phenol;,C6H6O,Phenol; Benzenol; Hydroxybenzene; Phenic acid; Phenylic acid,R00728 R00815 R01238 R01239 R01241 R05625 R07697 R09539; R10042 R10043 R10608,Tyrosine metabolism; Chlorocyclohexane and chlorobenzene degradation; Benzoate degradation; Aminobenzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds; Protein digestion and absorption,1.14.13.7; 1.14.13.-; 1.14.-.-; 2.1.1.25; 2.4.2.55; 2.7.9.-; 3.1.1.2; 4.1.1.61; 4.1.1.91; 4.1.99.2,"Benzene degradation, benzene => catechol","Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00146  Phenol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C05 VASOPROTECTIVES;    C05B ANTIVARICOSE THERAPY;     C05BB Sclerosing agents for local injection;      C05BB05 Phenol;       D00033  Phenol (JP17/USP);  D DERMATOLOGICALS;   D08 ANTISEPTICS AND DISINFECTANTS;    D08A ANTISEPTICS AND DISINFECTANTS;     D08AE Phenol and derivatives;      D08AE03 Phenol;       D00033  Phenol (JP17/USP);  N NERVOUS SYSTEM;   N01 ANESTHETICS;    N01B ANESTHETICS, LOCAL;     N01BX Other local anesthetics;      N01BX03 Phenol;       D00033  Phenol (JP17/USP);  R RESPIRATORY SYSTEM;   R02 THROAT PREPARATIONS;    R02A THROAT PREPARATIONS;     R02AA Antiseptics;      R02AA19 Phenol;       D00033  Phenol (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   25  Urogenital and anal organ agents;    255  Hemorrhoidal preparations;     2559  Others;      D00033  Phenol (JP17/USP); Liquefied phenol (JP17); Phenol for disinfection (JP17);   26  Epidermides;    261  Antimicrobial agents;     2619  Others;      D00033  Phenol (JP17/USP); Liquefied phenol (JP17); Phenol for disinfection (JP17);   27  Dental preparations;    273  Analgesics and sedatives;     2730  Analgesics and sedatives;      D00033  Phenol (JP17/USP); Liquefied phenol (JP17); Phenol for disinfection (JP17);  7  Agents not mainly for therapeutic purpose;   73  Public health agents;    732  Germicides and disinfectants;     7322  Phenols and chlorophenols;      D00033  Phenol (JP17/USP); Liquefied phenol (JP17); Phenol for disinfection (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for otolaryngologic use;   71 Ear drops;    D00033  Phenol (JP17/USP);  Agents for dental and stomatological use;   75 Toothache and pyorrhea remedies;    D00033  Phenol (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Phenol;     D00033  Phenol (JP17/USP); Pharmaceutical additives [BR:br08316];  Antiseptic agent;   D00033  [001535] Liquefied phenol;   D00033  [001534] Phenol;  Preserving agent;   D00033  [001535] Liquefied phenol;   D00033  [001534] Phenol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00033  Phenol;   D00033  Liquefied phenol;   D00033  Phenol for disinfection; Anesthetics, analgesics and anti-inflammatory drugs [br08369.html];  Anesthetics;   D00033; Dermatological agents [br08370.html];  Non-steroidal topical agent;   D00033; Animal drugs in Japan [BR:br08331];  95  Agents for external use;   951  Antimicrobials for dermatologic use;    9519  Other antimicrobials for dermatologic use;     C00146  Phenol",CAS: 108-95-2; PubChem: 3446; ChEBI: 15882; ChEMBL: CHEMBL14060; KNApSAcK: C00002664; PDB-CCD: IPH; 3DMET: B00040; NIKKAJI: J2.873H,cpd:C00146; cpd:C00153; cpd:C01782; cpd:C01950; cpd:C02421; cpd:C12484; cpd:C15584; cpd:C20669,6,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O1,C6H5O1,94.04186481,95.04968985,93.034039781170,1315,cpd:C00355,"3,4-Dihydroxy-L-phenylalanine;",C9H11NO4,"3,4-Dihydroxy-L-phenylalanine; L-Dopa; 3-Hydroxy-L-tyrosine; L-beta-(3,4-Dihydroxyphenyl)alanine; Levodopa; Dihydroxy-L-phenylalanine",R00031 R00045 R00731 R01815 R02075 R02076 R02077 R02078; R02080 R03672 R07212 R08443 R08827 R08836 R08846 R08920,Tyrosine metabolism; Isoquinoline alkaloid biosynthesis; Betalain biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Dopaminergic synapse; Prolactin signaling pathway; Parkinson's disease; Cocaine addiction; Amphetamine addiction; Alcoholism,1.10.3.1; 1.13.11.29; 1.13.11.30; 1.13.11.-; 1.13.12.15; 1.14.16.2; 1.14.18.1; 2.6.1.49; 4.1.1.25; 4.1.1.28; 4.3.1.22,"Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00355  3,4-Dihydroxy-L-phenylalanine;  Hormones and transmitters;   Neurotransmitters;    Amino acids;     C00355  Dopa; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N04 ANTI-PARKINSON DRUGS;    N04B DOPAMINERGIC AGENTS;     N04BA Dopa and dopa derivatives;      N04BA01 Levodopa;       D00059  Levodopa (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   11  Agents affecting central nervous system;    116  Antiparkinsonian agents;     1164  Levodopas;      D00059  Levodopa (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Dopamine;     dopamine D1-receptor;      Levodopa;       D00059  Levodopa (JP17/USP/INN);     dopamine D2-receptor;      Levodopa;       D00059  Levodopa (JP17/USP/INN);     dopamine D3-receptor;      Levodopa;       D00059  Levodopa (JP17/USP/INN);     dopamine D4-receptor;      Levodopa;       D00059  Levodopa (JP17/USP/INN);     dopamine D5-receptor;      Levodopa;       D00059  Levodopa (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00059  Levodopa; Neurological agents [br08367.html];  Antiparkinson agents;   D00059",CAS: 59-92-7; PubChem: 3648; ChEBI: 15765; ChEMBL: CHEMBL1009; KNApSAcK: C00001357; PDB-CCD: DAH; 3DMET: B01224; NIKKAJI: J9.225H,cpd:C00355; cpd:C03004; cpd:C06870; cpd:C18746; cpd:C19715,9,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O4N1,C9H10O4N1,197.0688078,198.0766329,196.06098281171,1316,cpd:C00483,Tyramine;,C8H11NO,Tyramine; 2-(p-Hydroxyphenyl)ethylamine,R00736 R02382 R02383 R02384 R02385 R08436 R10902,Tyrosine metabolism; Methane metabolism; Isoquinoline alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites; Neuroactive ligand-receptor interaction; Protein digestion and absorption,1.4.3.4; 1.4.3.21; 1.4.9.2; 1.14.13.-; 1.14.18.1; 2.1.1.27; 2.3.1.110; 4.1.1.25; 4.1.1.28; 6.3.4.24,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C00483  Tyramine; Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Tyramine derivatives;     C00483  Tyramine,CAS: 51-67-2; PubChem: 3766; ChEBI: 15760; ChEMBL: CHEMBL11608; KNApSAcK: C00001435; PDB-CCD: AEF; 3DMET: B01260; NIKKAJI: J4.123H,cpd:C00483; cpd:C01183; cpd:C02735; cpd:C03473; cpd:C16570; cpd:C18396; cpd:C18782; cpd:C19216; cpd:C19376,8,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H12O1N1,C8H10O1N1,137.084064,138.091889,136.07623891172,1317,cpd:C00530,Hydroquinone;,C6H6O2,"Hydroquinone; p-Benzenediol; 1,4-Benzenediol; 1,4-Dihydroxybenzene; Benzene-1,4-diol; Quinol; 4-Hydroxyphenol",R01297 R01299 R02363 R02489 R05133 R05244 R05246 R05267; R05482 R05769 R06851 R06893 R09105,Tyrosine metabolism; Chlorocyclohexane and chlorobenzene degradation; Benzoate degradation; Bisphenol degradation; Aminobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.6.5.6; 1.13.11.66; 1.14.13.64; 1.14.13.-; 1.14.18.1; 2.4.1.218; 2.5.1.-; 3.1.1.2; 3.1.1.-; 3.2.1.86; 4.1.1.62,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00530  Hydroquinone; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D11 OTHER DERMATOLOGICAL PREPARATIONS;    D11A OTHER DERMATOLOGICAL PREPARATIONS;     D11AX Other dermatologicals;      D11AX11 Hydroquinone;       D00073  Hydroquinone (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00073  [102977] Hydroquinone; Target-based classification of drugs [BR:br08310];  Enzymes;   Oxidoreductases;    tyrosinase;     Hydroquinone;      D00073  Hydroquinone (USP),CAS: 123-31-9; PubChem: 3812; ChEBI: 17594; ChEMBL: CHEMBL537; KNApSAcK: C00002656; PDB-CCD: HQE; 3DMET: B00121; NIKKAJI: J2.929G,cpd:C00090; cpd:C00530; cpd:C00785; cpd:C01751; cpd:C01785; cpd:C02126; cpd:C02595; cpd:C05571; cpd:C06599; cpd:C07093; cpd:C11115; cpd:C15571; cpd:C16353; cpd:C16357; cpd:C16358; cpd:C19345,6,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O2,C6H5O2,110.0367794,111.0446045,109.02895441173,1318,cpd:C00547,L-Noradrenaline;,C8H11NO3,"L-Noradrenaline; Noradrenaline; Norepinephrine; Arterenol; 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol",R02532 R02533 R02534 R02535,Tyrosine metabolism; Metabolic pathways; Two-component system; Quorum sensing; cAMP signaling pathway; Neuroactive ligand-receptor interaction; Adrenergic signaling in cardiomyocytes; Vascular smooth muscle contraction; Gap junction; Synaptic vesicle cycle; Taste transduction; Regulation of lipolysis in adipocytes; Renin secretion; Salivary secretion,1.4.3.4; 1.14.17.1; 2.1.1.6; 2.1.1.28,"Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline",Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Other hormones;    Adrenalines;     C00547  Noradrenaline;   Neurotransmitters;    Biogenic amines;     C00547  Norepinephrine; Noradrenaline; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;     C01CA Adrenergic and dopaminergic agents;      C01CA03 Norepinephrine;       D00076  Noradrenaline (JP17); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    245  Adrenal hormone preparations;     2451  Epinephrines;      D00076  Noradrenaline (JP17); Norepinephrine (INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adrenaline;     alpha1-adrenergic receptor;      Norepinephrine;       D00076  Noradrenaline (JP17);     alpha2-adrenergic receptor;      Norepinephrine;       D00076  Noradrenaline (JP17);     beta1-adrenergic receptor;      Norepinephrine;       D00076  Noradrenaline (JP17);     beta2-adrenergic receptor;      Norepinephrine;       D00076  Noradrenaline (JP17);     beta3-adrenergic receptor;      Norepinephrine;       D00076  Noradrenaline (JP17); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00076  Noradrenaline;   D00076  Noradrenaline injection,CAS: 51-41-2; PubChem: 3828; ChEBI: 18357; ChEMBL: CHEMBL1437; KNApSAcK: C00001424; PDB-CCD: LNR; 3DMET: B01285; NIKKAJI: J9.223A,cpd:C00314; cpd:C00547,8,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H12O3N1,C8H10O3N1,169.0738932,170.0817182,168.06606821174,1319,cpd:C00628,"2,5-Dihydroxybenzoate;",C7H6O4,"2,5-Dihydroxybenzoate; 2,5-Dihydroxybenzoic acid; Gentisic acid; Hydroquinonecarboxylic acid; Gentisate",R02489 R02589 R02655 R02656 R02657 R07686 R07709 R07710,Tyrosine metabolism; Benzoate degradation; Naphthalene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.2.1.29; 1.2.3.1; 1.13.11.4; 1.14.13.24; 1.14.13.172; 4.1.1.62,"Salicylate degradation, salicylate => gentisate",NA,CAS: 490-79-9; PubChem: 3901; ChEBI: 17189; ChEMBL: CHEMBL1461; KNApSAcK: C00002648; PDB-CCD: GTQ; 3DMET: B00149; NIKKAJI: J6.046A,cpd:C00196; cpd:C00230; cpd:C00628; cpd:C06679; cpd:C07461; cpd:C11006; cpd:C11008; cpd:C14306; cpd:C16748; cpd:C18303; cpd:C18308; cpd:C19410; cpd:C19788; cpd:C21298,7,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O4,C7H5O4,154.0266087,155.0344337,153.01878361175,1320,cpd:C00642,4-Hydroxyphenylacetate;,C8H8O3,4-Hydroxyphenylacetate; 4-Hydroxyphenylacetic acid,R00042 R02514 R02516 R02695 R02697 R02698 R02699 R06790; R07312,Tyrosine metabolism; Phenylalanine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.5; 1.2.1.29; 1.2.1.53; 1.2.3.13; 1.14.13.18; 1.14.14.9; 4.1.1.83; 6.2.1.-,NA,NA,CAS: 156-38-7; PubChem: 3915; ChEBI: 18101; ChEMBL: CHEMBL1772; PDB-CCD: 4HP; 3DMET: B00153; NIKKAJI: J5.873D,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951911176,1321,cpd:C00788,L-Adrenaline;,C9H13NO3,"L-Adrenaline; (R)-(-)-Adrenaline; (R)-(-)-Epinephrine; (R)-(-)-Epirenamine; (R)-(-)-Adnephrine; 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol",R02533 R02919 R02920,Tyrosine metabolism; Metabolic pathways; Two-component system; Quorum sensing; cAMP signaling pathway; Neuroactive ligand-receptor interaction; Adrenergic signaling in cardiomyocytes; Regulation of lipolysis in adipocytes; Renin secretion,1.4.3.4; 2.1.1.6; 2.1.1.28,"Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline","Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Other hormones;    Adrenalines;     C00788  Adrenaline;   Neurotransmitters;    Biogenic amines;     C00788  Epinephrine; Adrenaline; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A01 STOMATOLOGICAL PREPARATIONS;    A01A STOMATOLOGICAL PREPARATIONS;     A01AD Other agents for local oral treatment;      A01AD01 Epinephrine;       D00095  Epinephrine (USP/INN);  B BLOOD AND BLOOD FORMING ORGANS;   B02 ANTIHEMORRHAGICS;    B02B VITAMIN K AND OTHER HEMOSTATICS;     B02BC Local hemostatics;      B02BC09 Epinephrine;       D00095  Epinephrine (USP/INN);  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;     C01CA Adrenergic and dopaminergic agents;      C01CA24 Epinephrine;       D00095  Epinephrine (USP/INN);  R RESPIRATORY SYSTEM;   R01 NASAL PREPARATIONS;    R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;     R01AA Sympathomimetics, plain;      R01AA14 Epinephrine;       D00095  Epinephrine (USP/INN);   R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;    R03A ADRENERGICS, INHALANTS;     R03AA Alpha- and beta-adrenoreceptor agonists;      R03AA01 Epinephrine;       D00095  Epinephrine (USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS;     S01EA Sympathomimetics in glaucoma therapy;      S01EA01 Epinephrine;       D00095  Epinephrine (USP/INN); USP drug classification [BR:br08302];  Respiratory Tract/Pulmonary Agents;   Bronchodilators, Sympathomimetic;    Epinephrine;     D00095  Epinephrine (USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    245  Adrenal hormone preparations;     2451  Epinephrines;      D00095  Epinephrine (USP/INN); Adrenaline (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Adrenaline (Epinephrine);     D00095  Epinephrine (USP/INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adrenaline;     alpha1-adrenergic receptor;      Epinephrine;       D00095  Epinephrine (USP/INN);     alpha2-adrenergic receptor;      Epinephrine;       D00095  Epinephrine (USP/INN);     beta1-adrenergic receptor;      Epinephrine;       D00095  Epinephrine (USP/INN);     beta2-adrenergic receptor;      Epinephrine;       D00095  Epinephrine (USP/INN);     beta3-adrenergic receptor;      Epinephrine;       D00095  Epinephrine (USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00095  Adrenaline;   D00095  Adrenaline solution;   D00095  Adrenaline injection; Respiratory agents [br08372.html];  Bronchodilator;   D00095",CAS: 51-43-4; PubChem: 4046; ChEBI: 28918; ChEMBL: CHEMBL679; KNApSAcK: C00029643; PDB-CCD: ALE; 3DMET: B01330; NIKKAJI: J9.224J,cpd:C00788; cpd:C05589; cpd:C11768; cpd:C17925,9,13,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O3N1,C9H12O3N1,183.0895433,184.0973683,182.08171821177,1322,cpd:C00822,Dopaquinone,C9H9NO4,Dopaquinone,R00045 R02078 R02962 R03672 R08848,Tyrosine metabolism; Betalain biosynthesis; Metabolic pathways,1.10.3.1; 1.14.18.1,NA,NA,CAS: 4430-97-1 25520-73-4; PubChem: 4080; ChEBI: 16852; 3DMET: B01340,cpd:C00822; cpd:C04274; cpd:C05604; cpd:C07588; cpd:C19631,9,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O4N1,C9H8O4N1,195.0531578,196.0609828,194.04533271178,1323,cpd:C01036,4-Maleylacetoacetate;,C8H8O6,4-Maleylacetoacetate; 4-Maleylacetoacetic acid,R02519 R03181,Tyrosine metabolism; Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.13.11.5; 5.2.1.2,"Tyrosine degradation, tyrosine => homogentisate",NA,CAS: 5698-52-2; PubChem: 4279; ChEBI: 17105 47904; ChEMBL: CHEMBL1743220; LIPIDMAPS: LMFA01170114; KNApSAcK: C00007508; 3DMET: B00226; NIKKAJI: J906.081B,cpd:C01036; cpd:C01061; cpd:C04642; cpd:C04783; cpd:C05592; cpd:C06318; cpd:C18314,8,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O6,C8H7O6,200.032088,201.039913,199.02426291179,1324,cpd:C01060,"3,5-Diiodo-L-tyrosine;",C9H9I2NO3,"3,5-Diiodo-L-tyrosine; 3,5-Diiodotyrosine; L-Diiodotyrosine",R03207 R03208 R03953 R03973 R09522 R10059,Tyrosine metabolism; Metabolic pathways; Thyroid hormone synthesis,1.11.1.8; 1.21.1.1; 2.6.1.24,"Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C01060  3,5-Diiodo-L-tyrosine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;   H03 THYROID THERAPY;    H03B ANTITHYROID PREPARATIONS;     H03BX Other antithyroid preparations;      H03BX01 Diiodotyrosine;       C01060  3,5-Diiodo-L-tyrosine",CAS: 300-39-0 66-02-4; PubChem: 4299; ChEBI: 15768; ChEMBL: CHEMBL1236469; PDB-CCD: TYI; 3DMET: B01373; NIKKAJI: J4.841K,cpd:C01060,9,9,3,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,C9H10O3N1I2,C9H8O3N1I2,432.8671572,433.8749822,431.85933211180,1325,cpd:C01061,4-Fumarylacetoacetate;,C8H8O6,4-Fumarylacetoacetate; 4-Fumarylacetoacetic acid; Fumarylacetoacetate,R01364 R03181,Tyrosine metabolism; Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.7.1.2; 5.2.1.2,"Tyrosine degradation, tyrosine => homogentisate",NA,CAS: 28613-33-4; PubChem: 4300; ChEBI: 18034 30907; LIPIDMAPS: LMFA01170066; KNApSAcK: C00007599; 3DMET: B00233; NIKKAJI: J817.612D,cpd:C01036; cpd:C01061; cpd:C04642; cpd:C04783; cpd:C05592; cpd:C06318; cpd:C18314,8,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O6,C8H7O6,200.032088,201.039913,199.02426291181,1326,cpd:C01161,"3,4-Dihydroxyphenylacetate;",C8H8O4,"3,4-Dihydroxyphenylacetate; 3,4-Dihydroxyphenylacetic acid; Homoprotocatechuate",R02698 R03299 R03300 R03302 R03303 R03304 R03306,Tyrosine metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds; Dopaminergic synapse; Cocaine addiction; Amphetamine addiction; Alcoholism,1.2.1.5; 1.2.1.29; 1.13.11.15; 1.14.12.9; 1.14.14.9; 2.1.1.6,"Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate",NA,CAS: 102-32-9; PubChem: 4388; ChEBI: 17612 41941; ChEMBL: CHEMBL1284; KNApSAcK: C00040996; PDB-CCD: DHY; 3DMET: B00250; NIKKAJI: J804D,cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272,8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O4,C8H7O4,168.0422587,169.0500838,167.03443371182,1327,cpd:C01207,"3-(3,4-Dihydroxyphenyl)lactate;",C9H10O5,"3-(3,4-Dihydroxyphenyl)lactate; 3,4-Dihydroxyphenyllactic acid",R03373 R03374 R08847,Tyrosine metabolism,1.1.1.237; 2.3.1.140,NA,NA,CAS: 23028-17-3; PubChem: 4430; ChEBI: 17807; KNApSAcK: C00031720; 3DMET: B04781; NIKKAJI: J493.965D,cpd:C01207; cpd:C05584; cpd:C10833; cpd:C18702; cpd:C21086,9,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O5,C9H9O5,198.0528234,199.0606485,197.04499841183,1328,cpd:C01384,Maleic acid;,C4H4O4,Maleic acid; Maleate; cis-Butenedioic acid,R01087 R02419 R03540 R11257,Tyrosine metabolism; Butanoate metabolism; Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,3.5.1.107; 3.7.1.23; 4.2.1.31; 5.2.1.1,"Nicotinate degradation, nicotinate => fumarate",Pharmaceutical additives [BR:br08316];  Stabilizing agent;   C01384  [108550] Maleic acid;  Solubilizing agent;   C01384  [108550] Maleic acid;  Buffering agent;   C01384  [108550] Maleic acid;  pH regulator;   C01384  [108550] Maleic acid,CAS: 110-16-7; PubChem: 4579; ChEBI: 18300; ChEMBL: CHEMBL539648; KNApSAcK: C00007417; PDB-CCD: MAE; 3DMET: B00280; NIKKAJI: J2.446E,cpd:C00122; cpd:C01384; cpd:C02150; cpd:C07780; cpd:C07783; cpd:C12574; cpd:C12896; cpd:C13424; cpd:C13540; cpd:C14029; cpd:C18572,4,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H5O4,C4H3O4,116.0109586,117.0187836,115.00313361184,1329,cpd:C01693,L-Dopachrome;,C9H7NO4,"L-Dopachrome; 2-L-Carboxy-2,3-dihydroindole-5,6-quinone",R03672 R03673 R03674,Tyrosine metabolism; Metabolic pathways,5.3.3.12,NA,NA,PubChem: 4834; ChEBI: 15772; 3DMET: B01479; NIKKAJI: J260.087K,cpd:C01693; cpd:C04185; cpd:C12468; cpd:C15566,9,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H8O4N1,C9H6O4N1,193.0375077,194.0453327,192.02968271185,1330,cpd:C01829,Thyroxine;,C15H11I4NO4,"Thyroxine; Levothyroxin; L-Thyroxine; O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine; 3,5,3'5'-Tetraiodo-L-thyronine; T4",R03208 R03734 R07230 R08525,Tyrosine metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction; Thyroid hormone synthesis; Thyroid hormone signaling pathway; Bile secretion; Autoimmune thyroid disease,1.11.1.8; 1.21.99.3; 1.21.99.4,NA,"Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C01829  L-Thyroxine;  Hormones and transmitters;   Other hormones;    Thyroid hormones;     C01829  Thyroxine;   Neurotransmitters;    Amino acids;     C01829  Thyroxine; USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid);   Levothyroxine;    D08125  Levothyroxine (BAN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Thyroid hormone receptor (THR);     thyroid hormone receptor, alpha;      Levothyroxine;       D08125  Levothyroxine (BAN);     thyroid hormone receptor, beta;      Levothyroxine;       D08125  Levothyroxine (BAN)",CAS: 51-48-9; PubChem: 4950; ChEBI: 18332; ChEMBL: CHEMBL1624; PDB-CCD: T44; 3DMET: B01505; NIKKAJI: J4.118A,cpd:C01829,15,11,4,1,0,0,0,4,0,0,0,0,0,0,0,0,0,0,C15H12O4N1I4,C15H10O4N1I4,776.6866358,777.6944609,775.67881081186,1331,cpd:C01850,Rosmarinate;,C18H16O8,Rosmarinate; Rosmarinic acid,R03374,Tyrosine metabolism,2.3.1.140,NA,Major components of natural products [BR:br08323];  Medicinal herbs;   Rosemary;    C01850  Rosmarinate,CAS: 20283-92-5 537-15-5; PubChem: 4967; ChEBI: 50371; ChEMBL: CHEMBL324842; KNApSAcK: C00002770; PDB-CCD: ROA; 3DMET: B01507; NIKKAJI: J15.542J,cpd:C01850; cpd:C04552; cpd:C08105; cpd:C08539; cpd:C09764; cpd:C09982; cpd:C10031; cpd:C10115; cpd:C10116; cpd:C10191; cpd:C17753; cpd:C17787; cpd:C17957; cpd:C20508,18,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H17O8,C18H15O8,360.0845175,361.0923425,359.07669241187,1332,cpd:C02167,Maleylpyruvate;,C7H6O6,Maleylpyruvate; Maleylpyruvic acid; 3-Maleylpyruvate,R02656 R03868 R10135 R11257,Tyrosine metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.13.11.4; 3.1.1.91; 3.7.1.23; 5.2.1.2; 5.2.1.4,NA,NA,PubChem: 5242; ChEBI: 16727 30859; LIPIDMAPS: LMFA01170065; 3DMET: B00394; NIKKAJI: J1.611.700E,cpd:C01163; cpd:C01278; cpd:C02167; cpd:C02514; cpd:C03666; cpd:C04480; cpd:C04484; cpd:C04553; cpd:C05375; cpd:C16199; cpd:C17101,7,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O6,C7H5O6,186.0164379,187.0242629,185.00861291188,1333,cpd:C02442,N-Methyltyramine,C9H13NO,N-Methyltyramine,R02384 R03943,Tyrosine metabolism,2.1.1.27; 2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Tyramine derivatives;     C02442  N-Methyltyramine,CAS: 370-98-9; PubChem: 5464; ChEBI: 17458; KNApSAcK: C00027432; 3DMET: B01573; NIKKAJI: J50.151D,cpd:C02343; cpd:C02442; cpd:C03711; cpd:C07911; cpd:C08300; cpd:C10158; cpd:C11776; cpd:C16719,9,13,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O1N1,C9H12O1N1,151.099714,152.1075391,150.0918891189,1334,cpd:C02465,Triiodothyronine;,C15H12I3NO4,"Triiodothyronine; 3,3',5-Triiodo-L-thyronine; L-3,5,3'-Triiodothyronine; 3,5,3'-Triiodothyronine; Liothyronine; 3,5,3'-Triiodo-L-thyronine; T3",R03734 R03952 R03953 R08524,Tyrosine metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction; Thyroid hormone synthesis; Thyroid hormone signaling pathway; Bile secretion; Autoimmune thyroid disease,1.11.1.8; 1.21.99.4; 2.6.1.26,"Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine","Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C02465  Triiodothyronine;  Hormones and transmitters;   Other hormones;    Thyroid hormones;     C02465  Triiodothyronine; USP drug classification [BR:br08302];  Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid);   Liothyronine;    D08128  Liothyronine (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Thyroid hormone receptor (THR);     thyroid hormone receptor, alpha;      Liothyronine;       D08128  Liothyronine (INN);     thyroid hormone receptor, beta;      Liothyronine;       D08128  Liothyronine (INN)",CAS: 6893-02-3; PubChem: 5481; ChEBI: 18258; ChEMBL: CHEMBL1544; PDB-CCD: T3; 3DMET: B01576; NIKKAJI: J85.948F,cpd:C02465; cpd:C07639,15,12,4,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,C15H13O4N1I3,C15H11O4N1I3,650.7900039,651.7978289,649.78217881190,1335,cpd:C02514,3-Fumarylpyruvate,C7H6O6,3-Fumarylpyruvate,R01085 R03868,Tyrosine metabolism; Metabolic pathways; Microbial metabolism in diverse environments,3.7.1.5; 3.7.1.20; 5.2.1.2; 5.2.1.4,NA,NA,PubChem: 5524; ChEBI: 1506 16854; 3DMET: B00456; NIKKAJI: J2.371.217B,cpd:C01163; cpd:C01278; cpd:C02167; cpd:C02514; cpd:C03666; cpd:C04480; cpd:C04484; cpd:C04553; cpd:C05375; cpd:C16199; cpd:C17101,7,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O6,C7H5O6,186.0164379,187.0242629,185.00861291191,1336,cpd:C02515,3-Iodo-L-tyrosine,C9H10INO3,3-Iodo-L-tyrosine,R03539 R03953 R03973 R09521 R09522,Tyrosine metabolism; Metabolic pathways; Thyroid hormone synthesis,1.11.1.8; 1.21.1.1,"Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C02515  3-Iodo-L-tyrosine,CAS: 70-78-0; PubChem: 5525; ChEBI: 27847; ChEMBL: CHEMBL479789; PDB-CCD: IYR; 3DMET: B01585; NIKKAJI: J4.880A,cpd:C02515,9,10,3,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,C9H11O3N1I1,C9H9O3N1I1,306.9705252,307.9783502,305.96270021192,1337,cpd:C03063,2-Oxohept-3-enedioate;,C7H8O5,"2-Oxohept-3-enedioate; 2-Oxohept-3-ene-1,7-dioate",R04131 R04132 R04133 R04134,Tyrosine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,4.1.1.68; 4.2.1.-; 5.3.3.-,"Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate",NA,PubChem: 5963; ChEBI: 1254 17205; 3DMET: B00533; NIKKAJI: J2.368.403I,cpd:C02637; cpd:C02652; cpd:C03063; cpd:C05600; cpd:C07478; cpd:C07479; cpd:C18306; cpd:C18318,7,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O5,C7H7O5,172.0371734,173.0449984,171.02934831193,1338,cpd:C03077,4-Chlorophenylacetate;,C8H7ClO2,4-Chlorophenylacetate; 4-Chlorophenylacetic acid,R03306 R04140 R05473 R05474,Tyrosine metabolism; DDT degradation; Microbial metabolism in diverse environments,1.14.12.9; 3.5.5.5,NA,NA,CAS: 1878-66-6; PubChem: 5975; ChEBI: 16237 30749; 3DMET: B00536; NIKKAJI: J7.798D,cpd:C03077; cpd:C06949,8,7,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C8H8O2Cl1,C8H6O2Cl1,170.0134571,171.0212822,169.00563211194,1339,cpd:C03758,Dopamine;,C8H11NO2,"Dopamine; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 3,4-Dihydroxyphenethylamine; 2-(3,4-Dihydroxyphenyl)ethylamine",R02080 R02383 R02535 R04084 R04300 R04301 R04305 R05749; R05750 R08444 R08445 R08447 R08513 R08832 R08835,Tyrosine metabolism; Isoquinoline alkaloid biosynthesis; Betalain biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; cAMP signaling pathway; Neuroactive ligand-receptor interaction; Gap junction; Synaptic vesicle cycle; Dopaminergic synapse; Prolactin signaling pathway; Bile secretion; Parkinson's disease; Cocaine addiction; Amphetamine addiction; Morphine addiction; Alcoholism,1.4.3.4; 1.4.3.21; 1.4.9.2; 1.10.3.-; 1.14.13.-; 1.14.17.1; 1.14.18.1; 2.1.1.6; 4.1.1.25; 4.1.1.28; 4.2.1.78; 4.3.3.3; 4.3.3.4,"Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline",Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C03758  Dopamine;  Hormones and transmitters;   Other hormones;    Dopamine;     C03758  Dopamine;   Neurotransmitters;    Biogenic amines;     C03758  Dopamine; Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Tyramine derivatives;     C03758  Dopamine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;     C01CA Adrenergic and dopaminergic agents;      C01CA04 Dopamine;       D07870  Dopamine (INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Dopamine;     dopamine D1-receptor;      Dopamine;       D07870  Dopamine (INN);     dopamine D2-receptor;      Dopamine;       D07870  Dopamine (INN);     dopamine D3-receptor;      Dopamine;       D07870  Dopamine (INN);     dopamine D4-receptor;      Dopamine;       D07870  Dopamine (INN);     dopamine D5-receptor;      Dopamine;       D07870  Dopamine (INN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   SLC22A2;    Dopamine;     D07870  Dopamine (INN); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     D07870  Dopamine (INN),CAS: 51-61-6; PubChem: 6517; ChEBI: 18243; ChEMBL: CHEMBL59; KNApSAcK: C00001408; PDB-CCD: LDP; 3DMET: B00634; NIKKAJI: J4.120C,cpd:C03758; cpd:C04227; cpd:C13415; cpd:C16666,8,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H12O2N1,C8H10O2N1,153.0789786,154.0868036,152.07115361195,1340,cpd:C03765,4-Hydroxyphenylacetaldehyde;,C8H8O2,4-Hydroxyphenylacetaldehyde; 2-(4-Hydroxyphenyl)acetaldehyde,R02382 R02695 R02697 R03341 R03358 R03359 R04304 R04305,Tyrosine metabolism; Isoquinoline alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,1.1.1.90; 1.2.1.5; 1.2.1.29; 1.2.1.53; 1.4.3.4; 1.4.3.21; 1.4.9.2; 4.1.1.80; 4.2.1.78; 4.2.1.87; 4.2.1.88,NA,NA,CAS: 7339-87-9; PubChem: 6521; ChEBI: 15621; 3DMET: B00637; NIKKAJI: J707.372K,cpd:C00548; cpd:C01454; cpd:C01526; cpd:C02061; cpd:C03765; cpd:C05613; cpd:C06224; cpd:C07085; cpd:C07086; cpd:C07189; cpd:C07211; cpd:C07215; cpd:C10700; cpd:C10761; cpd:C11151; cpd:C11252; cpd:C14087; cpd:C15250; cpd:C15583; cpd:C20645; cpd:C21166; cpd:C21328; cpd:C21375,8,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O2,C8H7O2,136.0524295,137.0602545,135.04460451196,1341,cpd:C04043,"3,4-Dihydroxyphenylacetaldehyde;",C8H8O3,"3,4-Dihydroxyphenylacetaldehyde; Protocatechuatealdehyde",R03300 R03302 R04084 R04300,Tyrosine metabolism; Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.2.1.5; 1.2.1.29; 1.4.3.4; 1.4.3.21; 1.4.9.2; 4.2.1.78,NA,NA,PubChem: 6744; ChEBI: 27978; 3DMET: B00668; NIKKAJI: J466.586D,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951911197,1342,cpd:C04045,"3-(3,4-Dihydroxyphenyl)pyruvate;",C9H8O5,"3-(3,4-Dihydroxyphenyl)pyruvate; 3,4-Dihydroxyphenylpyruvate",R02077 R03373 R08920,Tyrosine metabolism,1.1.1.237; 1.13.12.15; 2.6.1.49,NA,NA,PubChem: 6746; ChEBI: 19891; 3DMET: B00670; NIKKAJI: J506.232B,cpd:C04045; cpd:C04448,9,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O5,C9H7O5,196.0371734,197.0449984,195.02934831198,1343,cpd:C04052,5-Carboxy-2-oxohept-3-enedioate;,C8H8O7,"5-Carboxy-2-oxohept-3-enedioate; 5-Oxopent-3-ene-1,2,5-tricarboxylate",R04133 R04379 R04380,Tyrosine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,4.1.1.68; 5.3.3.10,"Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate",NA,PubChem: 6753; ChEBI: 15924; 3DMET: B04923; NIKKAJI: J2.378.574I,cpd:C04052; cpd:C04186; cpd:C18345,8,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O7,C8H7O7,216.0270026,217.0348276,215.01917761199,1344,cpd:C04185,"5,6-Dihydroxyindole-2-carboxylate;",C9H7NO4,"5,6-Dihydroxyindole-2-carboxylate; DHICA",R03673 R08965,Tyrosine metabolism; Metabolic pathways,1.14.18.-; 5.3.3.12,NA,NA,PubChem: 6861; ChEBI: 2003; ChEMBL: CHEMBL267855; 3DMET: B00687; NIKKAJI: J227.456F,cpd:C01693; cpd:C04185; cpd:C12468; cpd:C15566,9,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H8O4N1,C9H6O4N1,193.0375077,194.0453327,192.02968271200,1345,cpd:C04186,5-Carboxymethyl-2-hydroxymuconate,C8H8O7,5-Carboxymethyl-2-hydroxymuconate,R04379 R04418 R04419,Tyrosine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.312; 1.2.1.60; 5.3.3.10,"Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate",NA,PubChem: 6862; ChEBI: 2040; 3DMET: B00688; NIKKAJI: J1.192.171J,cpd:C04052; cpd:C04186; cpd:C18345,8,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O7,C8H7O7,216.0270026,217.0348276,215.01917761201,1346,cpd:C04368,3-Amino-3-(4-hydroxyphenyl)propanoate;,C9H11NO3,3-Amino-3-(4-hydroxyphenyl)propanoate; beta-Tyrosine,R00739,Tyrosine metabolism,5.4.3.6,NA,NA,PubChem: 7012; ChEBI: 16939; 3DMET: B04938; NIKKAJI: J2.370.463C,cpd:C00082; cpd:C01536; cpd:C03290; cpd:C04368; cpd:C06420; cpd:C14322; cpd:C19579; cpd:C19712; cpd:C20807; cpd:C21308,9,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O3N1,C9H10O3N1,181.0738932,182.0817182,180.06606821202,1347,cpd:C04642,2-Hydroxy-5-carboxymethylmuconate semialdehyde;,C8H8O6,2-Hydroxy-5-carboxymethylmuconate semialdehyde; 5-Carboxymethyl-2-hydroxymuconate semialdehyde; 5-Carboxymethyl-2-hydroxymuconic semialdehyde,R03303 R04418 R04419,Tyrosine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.312; 1.2.1.60; 1.13.11.15,"Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate",NA,CAS: 2461-62-3; PubChem: 7231; ChEBI: 17142; 3DMET: B00741; NIKKAJI: J1.427.764A,cpd:C01036; cpd:C01061; cpd:C04642; cpd:C04783; cpd:C05592; cpd:C06318; cpd:C18314,8,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O6,C8H7O6,200.032088,201.039913,199.02426291203,1348,cpd:C04796,"4-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde",C9H11NO6,"4-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde",R02075 R04598 R04599,Tyrosine metabolism,1.13.11.29,NA,NA,PubChem: 7358; ChEBI: 16098; 3DMET: B01789; NIKKAJI: J2.751.701C,cpd:C04796; cpd:C04797; cpd:C17758,9,11,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O6N1,C9H10O6N1,229.0586371,230.0664621,228.0508121204,1349,cpd:C04797,"5-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde",C9H11NO6,"5-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde",R02076 R04600 R04601,Tyrosine metabolism,1.13.11.30,NA,NA,PubChem: 7359; ChEBI: 17671; LIPIDMAPS: LMFA01170073; 3DMET: B01790; NIKKAJI: J2.751.703J,cpd:C04796; cpd:C04797; cpd:C17758,9,11,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O6N1,C9H10O6N1,229.0586371,230.0664621,228.0508121205,1350,cpd:C05338,4-Hydroxyphenylacetyl-CoA,C29H42N7O18P3S,4-Hydroxyphenylacetyl-CoA,R02699 R04776 R04777,Tyrosine metabolism,2.3.1.14; 2.3.1.-; 6.2.1.-,NA,NA,PubChem: 7716; ChEBI: 28773; 3DMET: B05011; NIKKAJI: J2.755.553E,cpd:C02577; cpd:C05338; cpd:C19975; cpd:C20062; cpd:C21312,29,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H43O18N7P3S1,C29H41O18N7P3S1,901.1519897,902.1598147,900.14416471206,1351,cpd:C05350,2-Hydroxy-3-(4-hydroxyphenyl)propenoate;,C9H8O4,2-Hydroxy-3-(4-hydroxyphenyl)propenoate; 4-Hydroxy-enol-phenylpyruvate,R03342,Tyrosine metabolism,5.3.2.1,NA,NA,PubChem: 7728; ChEBI: 27683; 3DMET: B00769; NIKKAJI: J898.634G,cpd:C01179; cpd:C01197; cpd:C01405; cpd:C01481; cpd:C04367; cpd:C05350; cpd:C12467; cpd:C12623; cpd:C13400; cpd:C17086; cpd:C18819; cpd:C21346,9,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O4,C9H7O4,180.0422587,181.0500838,179.03443371207,1352,cpd:C05576,"3,4-Dihydroxyphenylethyleneglycol",C8H10O4,"3,4-Dihydroxyphenylethyleneglycol",R04880 R04881,Tyrosine metabolism; Metabolic pathways,1.1.1.1; 2.1.1.6,NA,NA,CAS: 3343-19-9; PubChem: 7902; ChEBI: 1387; 3DMET: B05073; NIKKAJI: J45.947J,cpd:C04771; cpd:C05576; cpd:C06660; cpd:C06720; cpd:C06729; cpd:C06731; cpd:C07123; cpd:C16365; cpd:C16804; cpd:C18350; cpd:C19495; cpd:C21144,8,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O4,C8H9O4,170.0579088,171.0657338,169.05008381208,1353,cpd:C05577,"3,4-Dihydroxymandelaldehyde;",C8H8O4,"3,4-Dihydroxymandelaldehyde; 3,4-Dihydroxyphenylglycolaldehyde",R02532 R02919 R04880 R04882 R04883,Tyrosine metabolism; Metabolic pathways,1.1.1.1; 1.2.1.5; 1.4.3.4,NA,NA,CAS: 13023-73-9; PubChem: 7903; ChEBI: 27852; 3DMET: B05074; NIKKAJI: J678.576J,cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272,8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O4,C8H7O4,168.0422587,169.0500838,167.03443371209,1354,cpd:C05578,"5,6-Dihydroxyindole;",C8H7NO2,"5,6-Dihydroxyindole; DHI",R03674 R04884 R04885 R07313,Tyrosine metabolism; Metabolic pathways,1.14.18.1; 4.1.1.84; 4.1.1.-,NA,NA,CAS: 3131-52-0; PubChem: 7904; ChEBI: 27404; ChEMBL: CHEMBL92636; PDB-CCD: 3ID; 3DMET: B00795; NIKKAJI: J434.158I,cpd:C00650; cpd:C02775; cpd:C03574; cpd:C03742; cpd:C05578; cpd:C09957; cpd:C11130; cpd:C19062,8,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O2N1,C8H6O2N1,149.0476785,150.0555035,148.03985341210,1355,cpd:C05579,"Indole-5,6-quinone",C8H5NO2,"Indole-5,6-quinone",R04884 R04886,Tyrosine metabolism; Metabolic pathways,1.14.18.1,NA,NA,PubChem: 7905; ChEBI: 27406; 3DMET: B00796; NIKKAJI: J434.157K,cpd:C05579; cpd:C11129,8,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H6O2N1,C8H4O2N1,147.0320284,148.0398534,146.02420341211,1356,cpd:C05580,"3,4-Dihydroxymandelate;",C8H8O5,"3,4-Dihydroxymandelate; 3,4-Dihydroxymandelic acid; Dihydroxymandelic acid",R04882 R04883 R04887,Tyrosine metabolism; Metabolic pathways,1.2.1.5; 2.1.1.6,NA,NA,CAS: 775-01-9; PubChem: 7906; ChEBI: 27637; 3DMET: B05075; NIKKAJI: J128.158E,cpd:C05580; cpd:C05616; cpd:C18724; cpd:C19071,8,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O5,C8H7O5,184.0371734,185.0449984,183.02934831212,1357,cpd:C05581,3-Methoxy-4-hydroxyphenylacetaldehyde;,C9H10O3,3-Methoxy-4-hydroxyphenylacetaldehyde; (4-Hydroxy-3-methoxyphenyl)acetaldehyde; Homovanillin,R04888 R04889 R04890,Tyrosine metabolism; Metabolic pathways,1.2.1.5; 1.4.3.4,NA,NA,CAS: 5703-24-2; PubChem: 7907; ChEBI: 28111; 3DMET: B00797; NIKKAJI: J13.618B,cpd:C01198; cpd:C01456; cpd:C01744; cpd:C02201; cpd:C02363; cpd:C02515; cpd:C03080; cpd:C05581; cpd:C05607; cpd:C10712; cpd:C11380; cpd:C11457; cpd:C12206; cpd:C12462; cpd:C17079; cpd:C18397,9,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O3,C9H9O3,166.0629942,167.0708192,165.05516911213,1358,cpd:C05582,Homovanillate;,C9H10O4,Homovanillate; Homovanillic acid; 3-Methoxy-4-hydroxyphenylacetate,R03304 R04888 R04889,Tyrosine metabolism; Metabolic pathways; Dopaminergic synapse,1.2.1.5; 2.1.1.6,NA,NA,CAS: 306-08-1; PubChem: 7908; ChEBI: 545959; ChEMBL: CHEMBL1562; KNApSAcK: C00029504; 3DMET: B00798; NIKKAJI: J61.262F,cpd:C02333; cpd:C03672; cpd:C03964; cpd:C04044; cpd:C05582; cpd:C05583; cpd:C06663; cpd:C10447; cpd:C10680; cpd:C12622; cpd:C20953; cpd:C21085,9,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O4,C9H9O4,182.0579088,183.0657338,181.05008381214,1359,cpd:C05583,3-Methoxy-4-hydroxyphenylglycolaldehyde,C9H10O4,3-Methoxy-4-hydroxyphenylglycolaldehyde,R04891 R04892 R04893 R04894,Tyrosine metabolism; Metabolic pathways,1.2.1.5; 1.4.3.4,NA,NA,PubChem: 7909; ChEBI: 27932; 3DMET: B05076; NIKKAJI: J2.370.679B,cpd:C02333; cpd:C03672; cpd:C03964; cpd:C04044; cpd:C05582; cpd:C05583; cpd:C06663; cpd:C10447; cpd:C10680; cpd:C12622; cpd:C20953; cpd:C21085,9,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O4,C9H9O4,182.0579088,183.0657338,181.05008381215,1360,cpd:C05584,3-Methoxy-4-hydroxymandelate;,C9H10O5,3-Methoxy-4-hydroxymandelate; Vanillylmandelic acid,R04887 R04891 R04892,Tyrosine metabolism; Metabolic pathways,1.2.1.5; 2.1.1.6,NA,NA,CAS: 55-10-7; PubChem: 7910; ChEBI: 20106 27622; ChEMBL: CHEMBL1256396; 3DMET: B05077; NIKKAJI: J27.583B,cpd:C01207; cpd:C05584; cpd:C10833; cpd:C18702; cpd:C21086,9,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O5,C9H9O5,198.0528234,199.0606485,197.04499841216,1361,cpd:C05585,Gentisate aldehyde;,C7H6O3,"Gentisate aldehyde; 2,5-Dihydroxybenzaldehyde",R02518 R02520 R02655 R02657,Tyrosine metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.2.1.29; 1.2.3.1; 1.13.12.-; 4.1.1.-,NA,NA,PubChem: 7911; ChEBI: 28508; ChEMBL: CHEMBL243186; 3DMET: B00799; NIKKAJI: J7.451I,cpd:C00156; cpd:C00587; cpd:C00805; cpd:C05585; cpd:C08055; cpd:C10832; cpd:C12114; cpd:C14015; cpd:C16700; cpd:C17098; cpd:C18316; cpd:C20248,7,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O3,C7H5O3,138.0316941,139.0395191,137.0238691217,1362,cpd:C05587,3-Methoxytyramine,C9H13NO2,3-Methoxytyramine,R04301 R04890 R08831,Tyrosine metabolism; Betalain biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Dopaminergic synapse,1.4.3.4; 2.1.1.6,NA,NA,CAS: 554-52-9; PubChem: 7912; ChEBI: 1582; ChEMBL: CHEMBL1160785; KNApSAcK: C00042132; 3DMET: B00800; NIKKAJI: J31.076J,cpd:C01869; cpd:C04548; cpd:C05587; cpd:C07146; cpd:C07441; cpd:C07453; cpd:C07832; cpd:C08273; cpd:C19582,9,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O2N1,C9H12O2N1,167.0946287,168.1024537,166.08680361218,1363,cpd:C05588,L-Metanephrine,C10H15NO3,L-Metanephrine,R02920 R04894,Tyrosine metabolism; Metabolic pathways,1.4.3.4; 2.1.1.6,NA,NA,PubChem: 7913; ChEBI: 6270; ChEMBL: CHEMBL1741533; 3DMET: B05078; NIKKAJI: J363.335G,cpd:C05588; cpd:C08511; cpd:C20371,10,15,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O3N1,C10H14O3N1,197.1051933,198.1130184,196.09736831219,1364,cpd:C05589,L-Normetanephrine,C9H13NO3,L-Normetanephrine,R02534 R04893,Tyrosine metabolism; Metabolic pathways,1.4.3.4; 2.1.1.6,NA,NA,PubChem: 7914; ChEBI: 6277; ChEMBL: CHEMBL1559460; 3DMET: B05079; NIKKAJI: J342.886I,cpd:C00788; cpd:C05589; cpd:C11768; cpd:C17925,9,13,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O3N1,C9H12O3N1,183.0895433,184.0973683,182.08171821220,1365,cpd:C05593,3-Hydroxyphenylacetate;,C8H8O3,3-Hydroxyphenylacetate; 3-Hydroxyphenylacetic acid,R02515 R02517 R03299 R06791,Tyrosine metabolism; Phenylalanine metabolism; Styrene degradation; Microbial metabolism in diverse environments,1.14.13.63; 1.14.14.9,NA,NA,CAS: 621-37-4; PubChem: 7917; ChEBI: 17445; ChEMBL: CHEMBL190035; PDB-CCD: 3HP; 3DMET: B00801; NIKKAJI: J3.004J,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951911221,1366,cpd:C05594,3-Methoxy-4-hydroxyphenylethyleneglycol,C9H12O4,3-Methoxy-4-hydroxyphenylethyleneglycol,R04881,Tyrosine metabolism; Metabolic pathways,2.1.1.6,NA,NA,PubChem: 7918; ChEBI: 1576; ChEMBL: CHEMBL1322392; 3DMET: B05080; NIKKAJI: J227.869C,cpd:C04535; cpd:C05594; cpd:C06582; cpd:C10765; cpd:C11265; cpd:C11456; cpd:C11588; cpd:C11747; cpd:C16635; cpd:C18660,9,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13O4,C9H11O4,184.0735589,185.0813839,183.06573381222,1367,cpd:C05595,4-Hydroxyphenylacetylglutamic acid;,C13H15NO6,4-Hydroxyphenylacetylglutamic acid; p-Hydroxyphenylacetylglutamic acid; 4-Hydroxyphenylacetylglutamate; p-Hydroxyphenylacetylglutamate,R04776,Tyrosine metabolism,2.3.1.14,NA,NA,PubChem: 7919; ChEBI: 28036; 3DMET: B05081; NIKKAJI: J2.756.599I,cpd:C05595; cpd:C18938,13,15,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H16O6N1,C13H14O6N1,281.0899372,282.0977622,280.08211221223,1368,cpd:C05596,p-Hydroxyphenylacetylglycine;,C10H11NO4,p-Hydroxyphenylacetylglycine; 4-Hydroxyphenylacetylglycine,R04777,Tyrosine metabolism,2.3.1.-,NA,NA,PubChem: 7920; ChEBI: 28595; 3DMET: B00802; NIKKAJI: J628.638K,cpd:C03710; cpd:C05596; cpd:C16591,10,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H12O4N1,C10H10O4N1,209.0688078,210.0766329,208.06098281224,1369,cpd:C05600,"2-Hydroxyhepta-2,4-dienedioate;",C7H8O5,"2-Hydroxyhepta-2,4-dienedioate; 2-Hydroxyhepta-2,4-diene-1,7-dioate",R04134 R04380 R04895 R06897,Tyrosine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,4.1.1.68; 4.2.1.-; 5.3.3.-,"Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate",NA,PubChem: 7923; ChEBI: 1162; 3DMET: B00804; NIKKAJI: J2.756.600F,cpd:C02637; cpd:C02652; cpd:C03063; cpd:C05600; cpd:C07478; cpd:C07479; cpd:C18306; cpd:C18318,7,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O5,C7H7O5,172.0371734,173.0449984,171.02934831225,1370,cpd:C05604,"2-Carboxy-2,3-dihydro-5,6-dihydroxyindole;",C9H9NO4,"2-Carboxy-2,3-dihydro-5,6-dihydroxyindole; Leucodopachrome; cyclo-Dopa",R02962 R03672 R04885 R08816 R08821,Tyrosine metabolism; Betalain biosynthesis; Metabolic pathways,2.4.1.-; 4.1.1.-,NA,NA,CAS: 18766-67-1; PubChem: 7927; ChEBI: 28365 60872; 3DMET: B01875; NIKKAJI: J260.088I,cpd:C00822; cpd:C04274; cpd:C05604; cpd:C07588; cpd:C19631,9,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O4N1,C9H8O4N1,195.0531578,196.0609828,194.04533271226,1371,cpd:C06044,4-Hydroxyphenylethanol;,C8H10O2,4-Hydroxyphenylethanol; Tyrosol,R04304 R05083,Tyrosine metabolism,1.1.1.90; 2.4.1.-,NA,NA,CAS: 501-94-0; PubChem: 8315; ChEBI: 1879; ChEMBL: CHEMBL53566; KNApSAcK: C00029515; PDB-CCD: YRL; 3DMET: B00890; NIKKAJI: J68J,cpd:C03352; cpd:C04087; cpd:C06044; cpd:C06728; cpd:C07084; cpd:C07481; cpd:C11480; cpd:C13403; cpd:C13638; cpd:C16693; cpd:C19844; cpd:C20694,8,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O2,C8H9O2,138.0680796,139.0759046,137.06025451227,1372,cpd:C06046,Salidroside;,C14H20O7,Salidroside; p-Hydroxyphenethyl alcohol 1-O-beta-D-glucoside; Tyrosol glucoside,R05083,Tyrosine metabolism,2.4.1.-,NA,NA,CAS: 10338-51-9; PubChem: 8317; ChEBI: 9009; ChEMBL: CHEMBL465208; KNApSAcK: C00031274; 3DMET: B01958; NIKKAJI: J15.618C,cpd:C06046,14,20,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H21O7,C14H19O7,300.120903,301.128728,299.11307791228,1373,cpd:C06047,Stizolobate;,C9H9NO6,Stizolobate; Stizolobic acid,R04598 R04599,Tyrosine metabolism,1.13.11.29,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mushroom toxins;    Others;     C06047  Stizolobate,CAS: 15911-87-2; PubChem: 8318; ChEBI: 9274; 3DMET: B05153; NIKKAJI: J13.952A,cpd:C05655; cpd:C06047; cpd:C06048,9,9,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O6N1,C9H8O6N1,227.042987,228.050812,226.0351621229,1374,cpd:C06048,Stizolobinate;,C9H9NO6,Stizolobinate; Stizolobinic acid,R04600 R04601,Tyrosine metabolism,1.13.11.30,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mushroom toxins;    Others;     C06048  Stizolobinate,CAS: 17388-96-4; PubChem: 8319; ChEBI: 9275; 3DMET: B05154; NIKKAJI: J413.586E,cpd:C05655; cpd:C06047; cpd:C06048,9,9,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O6N1,C9H8O6N1,227.042987,228.050812,226.0351621230,1375,cpd:C06199,Hordenine;,C10H15NO,Hordenine; 4-[2-(Dimethylamino)ethyl]phenol,R03943,Tyrosine metabolism,2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Tyramine derivatives;     C06199  Hordenine,CAS: 539-15-1; PubChem: 8449; ChEBI: 5764; ChEMBL: CHEMBL505789; KNApSAcK: C00001417; 3DMET: B00918; NIKKAJI: J6.381I,cpd:C01575; cpd:C02765; cpd:C06199; cpd:C10841,10,15,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O1N1,C10H14O1N1,165.1153641,166.1231891,164.10753911231,1376,cpd:C06201,"2,4-Dihydroxyhept-2-enedioate;",C7H10O6,"2,4-Dihydroxyhept-2-enedioate; 2,4-Dihydroxyhept-2-1,7-dioate; 2,4-Dihydroxyhept-2-enedioic acid",R01647 R04132 R06897,Tyrosine metabolism; Microbial metabolism in diverse environments,4.1.2.52; 4.2.1.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0117 Dicarboxylic acids;     C06201  2,4-Dihydroxyhept-2-enedioc acid",PubChem: 8451; ChEBI: 58936 915; LIPIDMAPS: LMFA01170062; 3DMET: B05177; NIKKAJI: J2.371.913D,cpd:C00944; cpd:C03792; cpd:C04049; cpd:C05601; cpd:C06201; cpd:C17695; cpd:C20246; cpd:C20247,7,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O6,C7H9O6,190.047738,191.0555631,189.0399131232,1377,cpd:C10447,"3,4-Dihydroxyphenylpropanoate;",C9H10O4,"3,4-Dihydroxyphenylpropanoate; Dihydrocaffeic acid; 3,4-Dihydroxyphenylpropionic acid; 3-(3,4-Dihydroxyphenyl)propanoate",R08846 R08847 R11206,Tyrosine metabolism,2.8.3.23; 4.3.1.22,NA,NA,CAS: 1078-61-1; PubChem: 12630; ChEBI: 48400; ChEMBL: CHEMBL136927; KNApSAcK: C00002735; 3DMET: B03853; NIKKAJI: J12.480J,cpd:C02333; cpd:C03672; cpd:C03964; cpd:C04044; cpd:C05582; cpd:C05583; cpd:C06663; cpd:C10447; cpd:C10680; cpd:C12622; cpd:C20953; cpd:C21085,9,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O4,C9H9O4,182.0579088,183.0657338,181.05008381233,1378,cpd:C17935,Cysteinyldopa;,C12H16N2O6S,Cysteinyldopa; 5-S-Cysteinyl-DOPA,R08848 R08849,Tyrosine metabolism,NA,NA,NA,CAS: 19641-92-0; PubChem: 96024156; ChEBI: 81392; NIKKAJI: J1.105.655E,cpd:C17935,12,16,6,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H17O6N2S1,C12H15O6N2S1,316.0729074,317.0807324,315.06508241234,1379,cpd:C17938,"5,6-Indolequinone-2-carboxylic acid",C9H5NO4,"5,6-Indolequinone-2-carboxylic acid",R06612 R08965,Tyrosine metabolism; Metabolic pathways,1.14.18.-,NA,NA,PubChem: 96024159; ChEBI: 81394,cpd:C17938,9,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H6O4N1,C9H4O4N1,191.0218576,192.0296827,190.01403261235,1380,cpd:C02370,4-Chlorobenzoate;,C7H5ClO2,4-Chlorobenzoate; 4-Chlorobenzoic acid,R01307 R03932 R05252 R05359 R05472,DDT degradation; Fluorobenzoate degradation; Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.-.-; 3.7.1.8; 3.8.1.6; 6.2.1.33,"Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate",NA,CAS: 74-11-3; PubChem: 5412; ChEBI: 17861 30747; ChEMBL: CHEMBL618; PDB-CCD: 174; 3DMET: B00432; NIKKAJI: J5.259K,cpd:C02357; cpd:C02370; cpd:C03444,7,5,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C7H6O2Cl1,C7H4O2Cl1,155.9978071,157.0056321,154.98998211236,1381,cpd:C04596,"1,1-Dichloro-2,2-bis(4-chlorophenyl)ethylene;",C14H8Cl4,"1,1-Dichloro-2,2-bis(4-chlorophenyl)ethylene; 1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethylene; DDE",R04522 R05268 R05475 R05497,DDT degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.97.1.-; 4.5.1.1,NA,Endocrine disrupting compounds [BR:br08006];  Pesticides and herbicides;   Organochlorine pesticides;    C04596  DDE,CAS: 72-55-9; PubChem: 7193; ChEBI: 16598; ChEMBL: CHEMBL363207; PDB-CCD: 6WS; 3DMET: B00737; NIKKAJI: J2.817G,cpd:C04596; cpd:C06644; cpd:C06645; cpd:C14133,14,8,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C14H9Cl4,C14H7Cl4,315.938011,316.945836,314.9301861237,1382,cpd:C04623,DDT;,C14H9Cl5,"DDT; 1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane; 1,1,1-Trichloro-2,2-bis-(4'-chlorophenyl)ethane; Clofenotane; Dichlorodiphenyltrichloroethane",R04522 R05260 R05476 R05492,DDT degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.99.-; 4.5.1.1,NA,"Endocrine disrupting compounds [BR:br08006];  Pesticides and herbicides;   Organochlorine pesticides;    C04623  DDT; Pesticides [BR:br08007];  Pesticides;   Insecticides;    Organochlorine insecticides;     C04623  DDT; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C04623  DDT; Target-based classification of compounds [BR:br08010];  Ion channels;   Voltage-gated cation channels;    Na+ channel, SCN alpha, NaV1.x;     voltage-gated sodium channel;      C04623  DDT; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS;   P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS;    P03A ECTOPARASITICIDES, INCL. SCABICIDES;     P03AB Chlorine containing products;      P03AB01 Clofenotane;       D07367  Clofenotane (INN)",CAS: 50-29-3; PubChem: 7213; ChEBI: 16130; ChEMBL: CHEMBL416898; PDB-CCD: 6WT; 3DMET: B00739; NIKKAJI: J2.295K,cpd:C04623; cpd:C06650; cpd:C06651; cpd:C14187; cpd:C14301,14,9,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C14H10Cl5,C14H8Cl5,351.9146887,352.9225137,350.90686371238,1383,cpd:C06636,TDE;,C14H10Cl4,"TDE; DDD; 1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethane; Dichlorodiphenyldichloroethane",R05384 R05476,DDT degradation; Metabolic pathways; Microbial metabolism in diverse environments,4.5.1.-,NA,Endocrine disrupting compounds [BR:br08006];  Pesticides and herbicides;   Organochlorine pesticides;    C06636  DDD,CAS: 72-54-8; PubChem: 8862; ChEBI: 27841; ChEMBL: CHEMBL196590; 3DMET: B01005; NIKKAJI: J2.378G,cpd:C06636; cpd:C14714,14,10,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C14H11Cl4,C14H9Cl4,317.9536611,318.9614861,316.9458361239,1384,cpd:C06637,"1-Chloro-2,2-bis(4'-chlorophenyl)ethylene;",C14H9Cl3,"1-Chloro-2,2-bis(4'-chlorophenyl)ethylene; DDMU",R05255 R05268 R05384 R05398 R05497,DDT degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.-.-; 1.97.1.-; 4.5.1.-,NA,NA,CAS: 1022-22-6; PubChem: 8863; ChEBI: 27454; 3DMET: B01006; NIKKAJI: J7.222B,cpd:C06637,14,9,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C14H10Cl3,C14H8Cl3,281.9769833,282.9848084,280.96915831240,1385,cpd:C06638,"1-Chloro-2,2-bis(4'-chlorophenyl)ethane;",C14H11Cl3,"1-Chloro-2,2-bis(4'-chlorophenyl)ethane; DDMS",R05255 R05385 R05398 R05477,DDT degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.-.-; 4.5.1.-,NA,NA,CAS: 2642-80-0; PubChem: 8864; ChEBI: 28555; 3DMET: B01007; NIKKAJI: J71.387B,cpd:C06638; cpd:C14136; cpd:C15392,14,11,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C14H12Cl3,C14H10Cl3,283.9926334,285.0004584,282.98480841241,1386,cpd:C06639,"2,2-Bis(4'-chlorophenyl)ethanol;",C14H12Cl2O,"2,2-Bis(4'-chlorophenyl)ethanol; DDOH",R05251 R05477 R05478 R05481,DDT degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 2642-82-2; PubChem: 8865; ChEBI: 28410; 3DMET: B01008; NIKKAJI: J2.162H,cpd:C06639; cpd:C14905; cpd:C18804; cpd:C19023,14,12,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C14H13O1Cl2,C14H11O1Cl2,266.0265204,267.0343454,265.01869531242,1387,cpd:C06640,Bis(4'-chlorophenyl)acetate;,C14H10Cl2O2,Bis(4'-chlorophenyl)acetate; DDA,R05251 R05376 R05479 R05481,DDT degradation; Metabolic pathways; Microbial metabolism in diverse environments,4.1.1.-,NA,NA,CAS: 83-05-6; PubChem: 8866; ChEBI: 28139; ChEMBL: CHEMBL1879491; 3DMET: B01009; NIKKAJI: J3.870I,cpd:C02996; cpd:C06640; cpd:C14238,14,10,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C14H11O2Cl2,C14H9O2Cl2,280.0057849,281.01361,278.99795991243,1388,cpd:C06641,Bis(4'-chlorophenyl)methane;,C13H10Cl2,Bis(4'-chlorophenyl)methane; DDM,R05376 R05473,DDT degradation; Microbial metabolism in diverse environments,4.1.1.-,NA,NA,CAS: 101-76-8; PubChem: 8867; ChEBI: 28763; 3DMET: B01010; NIKKAJI: J8.624J,cpd:C06641; cpd:C11493; cpd:C14292; cpd:C14584; cpd:C14611; cpd:C18821; cpd:C19003,13,10,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C13H11Cl2,C13H9Cl2,236.0159557,237.0237807,235.00813071244,1389,cpd:C06642,unsym-Bis(4'-chlorophenyl)ethylene;,C14H10Cl2,unsym-Bis(4'-chlorophenyl)ethylene; DDNU,R05385 R05478,DDT degradation; Microbial metabolism in diverse environments,4.5.1.-,NA,NA,CAS: 2642-81-1; PubChem: 8868; ChEBI: 27377; 3DMET: B01011; NIKKAJI: J3.395B,cpd:C02996; cpd:C06640; cpd:C06642; cpd:C14238; cpd:C15083,14,10,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C14H11Cl2,C14H9Cl2,248.0159557,249.0237807,247.00813071245,1390,cpd:C06643,"4,4'-Dichlorobenzophenone;",C13H8Cl2O,"4,4'-Dichlorobenzophenone; DBP",R05479,DDT degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 90-98-2; PubChem: 8869; ChEBI: 27519; ChEMBL: CHEMBL1870191; 3DMET: B01012; NIKKAJI: J39.679F,cpd:C06643,13,8,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C13H9O1Cl2,C13H7O1Cl2,249.9952202,251.0030453,248.98739521246,1391,cpd:C06644,"1,1-Dichloro-2-(dihydroxy-4'-chlorophenyl)-2-(4'-chlorophenyl)ethylene",C14H8Cl4O2,"1,1-Dichloro-2-(dihydroxy-4'-chlorophenyl)-2-(4'-chlorophenyl)ethylene",R05256 R05475,DDT degradation; Microbial metabolism in diverse environments,1.13.11.-,NA,NA,PubChem: 8870; ChEBI: 28959; 3DMET: B01013; NIKKAJI: J2.762.571A,cpd:C06644,14,8,2,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C14H9O2Cl4,C14H7O2Cl4,347.9278402,348.9356653,346.92001521247,1392,cpd:C06645,"6-Oxo-2-hydroxy-7-(4'-chlorophenyl)-3,8,8-trichloroocta-2E,4E,7E-trienoate",C14H8Cl4O4,"6-Oxo-2-hydroxy-7-(4'-chlorophenyl)-3,8,8-trichloroocta-2E,4E,7E-trienoate",R05256 R05363,DDT degradation; Microbial metabolism in diverse environments,1.13.11.-; 3.7.1.-,NA,NA,PubChem: 8871; ChEBI: 2226 86006; 3DMET: B01014; NIKKAJI: J2.762.572J,cpd:C06645,14,8,4,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C14H9O4Cl4,C14H7O4Cl4,379.9176695,380.9254945,378.90984441248,1393,cpd:C06646,"2-(4'-Chlorophenyl)-3,3-dichloropropenoate",C9H5Cl3O2,"2-(4'-Chlorophenyl)-3,3-dichloropropenoate",R05363 R05474 R05480,DDT degradation; Microbial metabolism in diverse environments,3.7.1.-,NA,NA,PubChem: 8872; ChEBI: 28983; 3DMET: B01015; NIKKAJI: J1.243.414F,cpd:C06646,9,5,2,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C9H6O2Cl3,C9H4O2Cl3,249.9355124,250.9433375,248.92768741249,1394,cpd:C06647,4-Chloroacetophenone;,C8H7ClO,4-Chloroacetophenone; p-Chloroacetophenone,R05344 R05480,DDT degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 99-91-2; PubChem: 8873; ChEBI: 27538; ChEMBL: CHEMBL608419; 3DMET: B01016; NIKKAJI: J38.176D,cpd:C06647,8,7,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C8H8O1Cl1,C8H6O1Cl1,154.0185425,155.0263676,153.01071751250,1395,cpd:C06648,4-Chlorobenzaldehyde,C7H5ClO,4-Chlorobenzaldehyde,R05252 R05344,DDT degradation; Microbial metabolism in diverse environments,1.2.-.-,NA,NA,CAS: 104-88-1; PubChem: 8874; ChEBI: 28105; ChEMBL: CHEMBL1474; 3DMET: B01017; NIKKAJI: J96.206F,cpd:C06648; cpd:C13841; cpd:C19168,7,5,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C7H6O1Cl1,C7H4O1Cl1,140.0028925,141.0107175,138.99506741251,1396,cpd:C06649,"cis-2,3-Dihydrodiol 1,1,1-Trichloro-2,2-bis(4'-chlorophenyl)ethane;",C14H11Cl5O2,"cis-2,3-Dihydrodiol 1,1,1-Trichloro-2,2-bis(4'-chlorophenyl)ethane; cis-2,3-Dihydrodiol DDT",R05260 R05395 R05396 R05492,DDT degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.14.99.-,NA,NA,PubChem: 8875; ChEBI: 46743; NIKKAJI: J2.762.619J,cpd:C06649,14,11,2,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C14H12O2Cl5,C14H10O2Cl5,385.920168,386.927993,384.9123431252,1397,cpd:C06650,"2,3-Dihydroxy 1,1,1-Trichloro-2,2-bis(4'-chlorophenyl)ethane;",C14H9Cl5O2,"2,3-Dihydroxy 1,1,1-Trichloro-2,2-bis(4'-chlorophenyl)ethane; 2,3-Dihydroxy DDT",R05257 R05395 R05396,DDT degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.13.11.-,NA,NA,PubChem: 8876; ChEBI: 46745; NIKKAJI: J2.762.621A,cpd:C06650,14,9,2,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C14H10O2Cl5,C14H8O2Cl5,383.9045179,384.912343,382.89669291253,1398,cpd:C06651,"6-Oxo-2-hydroxy-7-(4'-chlorophenyl)-3,8,8,8-tetrachloroocta-2E,4E-dienoate",C14H9Cl5O4,"6-Oxo-2-hydroxy-7-(4'-chlorophenyl)-3,8,8,8-tetrachloroocta-2E,4E-dienoate",R05257 R05472,DDT degradation; Microbial metabolism in diverse environments,1.13.11.-,NA,NA,PubChem: 8877; ChEBI: 29000; 3DMET: B01018; NIKKAJI: J2.763.292K,cpd:C06651,14,9,4,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C14H10O4Cl5,C14H8O4Cl5,415.8943472,416.9021722,414.88652211254,1399,cpd:C00079,L-Phenylalanine;,C9H11NO2,L-Phenylalanine; (S)-alpha-Amino-beta-phenylpropionic acid,R00686 R00688 R00689 R00690 R00691 R00692 R00693 R00694; R00695 R00697 R00698 R00699 R01375 R01376 R01795 R03660; R06744 R07211 R08435 R08463 R08652 R08690 R09535 R09578; R09579 R10286 R10287 R10495 R10499 R10729 R11068,"Phenylalanine metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Cyanoamino acid metabolism; Phenylpropanoid biosynthesis; Tropane, piperidine and pyridine alkaloid biosynthesis; Glucosinolate biosynthesis; Aminoacyl-tRNA biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids; ABC transporters; Protein digestion and absorption; Mineral absorption; Central carbon metabolism in cancer",1.4.1.20; 1.4.3.2; 1.11.1.21; 1.13.12.9; 1.14.13.124; 1.14.16.1; 1.14.16.7; 2.3.1.53; 2.6.1.1; 2.6.1.5; 2.6.1.9; 2.6.1.28; 2.6.1.57; 2.6.1.58; 2.6.1.64; 2.6.1.70; 2.6.1.-; 3.4.17.23; 4.1.1.28; 4.1.1.53; 4.2.1.51; 4.2.1.91; 4.3.1.24; 4.3.1.25; 5.1.1.11; 5.4.3.10; 5.4.3.11; 6.1.1.20; 6.3.2.40,"Phenylalanine biosynthesis, chorismate => phenylalanine; Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol; Flavanone biosynthesis, phenylalanine => naringenin; Capsaicin biosynthesis, L-Phenylalanine => Capsaicin",Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Common amino acids;     C00079  Phenylalanine (Phe); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Phenylalanine;     D00021  Phenylalanine (USP/INN); Pharmaceutical additives [BR:br08316];  Diluting agent;   D00021  [002317] L-Phenylalanine; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00021  L-Phenylalanine,CAS: 63-91-2; PubChem: 3379; ChEBI: 17295; ChEMBL: CHEMBL301523; KNApSAcK: C00001386; PDB-CCD: PHE; 3DMET: B01151; NIKKAJI: J9.175H,cpd:C00079; cpd:C02057; cpd:C02265; cpd:C07527; cpd:C18090; cpd:C18747; cpd:C19565; cpd:C19578; cpd:C20487; cpd:C20488,9,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O2N1,C9H10O2N1,165.0789786,166.0868036,164.07115361255,1400,cpd:C00166,Phenylpyruvate;,C9H8O3,Phenylpyruvate; Phenylpyruvic acid; alpha-Ketohydrocinnamic acid; keto-Phenylpyruvate; 3-Phenyl-2-oxopropanoate; 2-Oxo-3-phenylpropanoate,R00688 R00689 R00692 R00694 R00695 R01370 R01371 R01372; R01373 R01374 R01375 R01376 R01377 R01378 R01582 R10431; R10499 R10500 R11068,"Phenylalanine metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; 2-Oxocarboxylic acid metabolism; Biosynthesis of amino acids",1.1.1.222; 1.1.1.237; 1.4.1.20; 1.4.3.2; 1.4.5.1; 1.13.11.27; 2.1.1.281; 2.3.3.-; 2.6.1.1; 2.6.1.5; 2.6.1.9; 2.6.1.21; 2.6.1.28; 2.6.1.57; 2.6.1.58; 2.6.1.64; 2.6.1.70; 2.6.1.-; 4.1.1.43; 4.1.1.-; 4.2.1.51; 4.2.1.91; 5.3.2.1,"Phenylalanine biosynthesis, chorismate => phenylalanine",NA,CAS: 156-06-9; PubChem: 3466; ChEBI: 18005 30851; ChEMBL: CHEMBL1162488; KNApSAcK: C00000751; PDB-CCD: PPY; 3DMET: B00048; NIKKAJI: J11.025F,cpd:C00166; cpd:C00811; cpd:C01772; cpd:C02763; cpd:C05838; cpd:C06738; cpd:C07114; cpd:C10945; cpd:C11020; cpd:C12463; cpd:C12621; cpd:C20685; cpd:C20687; cpd:C20939; cpd:C21345,9,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O3,C9H7O3,164.0473441,165.0551691,163.03951911256,1401,cpd:C00180,Benzoate;,C7H6O2,Benzoate; Benzoic acid; Benzenecarboxylic acid; Phenylformic acid; Dracylic acid,R01295 R01419 R01420 R01421 R01422 R01423 R01424 R01425; R01426 R01427 R02606 R05590 R05591 R05621 R05622 R06727; R06728 R07188 R07835 R08838 R09088 R10447,Phenylalanine metabolism; Benzoate degradation; Dioxin degradation; Toluene degradation; Aminobenzoate degradation; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.7; 1.2.1.28; 1.14.12.10; 1.14.13.12; 1.14.13.-; 2.1.1.273; 3.1.1.1; 3.1.1.84; 3.5.1.4; 3.5.1.32; 3.5.1.40; 3.5.5.1; 3.6.1.7; 3.6.1.20; 3.7.1.8; 6.2.1.25,"Toluene degradation, toluene => benzoate; Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate; Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",Therapeutic category of drugs in Japan [BR:br08301];  7  Agents not mainly for therapeutic purpose;   73  Public health agents;    731  Antiseptics;     7319  Others;      D00038  Benzoic acid (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Benzoic acid;     D00038  Benzoic acid (JP17/USP);  Second-class OTC drugs;   Inorganic and organic chemicals;    Benzoic acid;     D00038  Benzoic acid (JP17/USP);  Third-class OTC drugs;   Inorganic and organic chemicals;    Benzoic acid;     D00038  Benzoic acid (JP17/USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00038  [002023] Benzoic acid;  Buffering agent;   D00038  [002023] Benzoic acid;  Antiseptic agent;   D00038  [002023] Benzoic acid;  Preserving agent;   D00038  [002023] Benzoic acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00038  Benzoic acid; Major components of natural products [BR:br08323];  Crude drugs;   Benzoin;    C00180  Benzoate; Animal drugs in Japan [BR:br08331];  99  Agents for not mainly purpose of therapeutic;   992  Amphoteric soap and preparations;    9929  Other agents for disinfections;     C00180  Benzoate,CAS: 65-85-0; PubChem: 3480; ChEBI: 16150 30746; ChEMBL: CHEMBL541; KNApSAcK: C00000207; PDB-CCD: BEZ; 3DMET: B00053; NIKKAJI: J2.358B,cpd:C00180; cpd:C00539; cpd:C00633; cpd:C03067; cpd:C06202; cpd:C14181; cpd:C15474; cpd:C18302,7,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O2,C7H5O2,122.0367794,123.0446045,121.02895441257,1402,cpd:C00323,Caffeoyl-CoA;,C30H42N7O19P3S,"Caffeoyl-CoA; (2E)-3-(3,4-Dihydroxyphenyl)prop-2-enoyl-CoA",R01941 R01942 R01943 R01944 R01945 R01946 R03374 R07433; R07436 R07873 R07876 R07926 R07928 R07930 R07931 R07944; R07988 R11206,"Phenylalanine metabolism; Phenylpropanoid biosynthesis; Flavonoid biosynthesis; Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Degradation of aromatic compounds",1.2.1.44; 1.14.13.-; 2.1.1.104; 2.3.1.74; 2.3.1.99; 2.3.1.126; 2.3.1.133; 2.3.1.138; 2.3.1.140; 2.3.1.153; 2.3.1.215; 2.8.3.23; 6.2.1.12,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol; Capsaicin biosynthesis, L-Phenylalanine => Capsaicin",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Caffeate derivatives;     C00323  Caffeoyl-CoA,CAS: 53034-79-0; PubChem: 3617; ChEBI: 15518; KNApSAcK: C00007281; 3DMET: B04667; NIKKAJI: J869.389G,cpd:C00323,30,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H43O19N7P3S1,C30H41O19N7P3S1,929.1469043,930.1547294,928.13907931258,1403,cpd:C00512,Benzoyl-CoA;,C28H40N7O17P3S,Benzoyl-CoA; S-Benzoyl-coenzyme A,R00664 R01422 R02447 R02449 R02450 R02451 R02452 R02453; R05316 R05506 R05585 R05587 R06310 R08171 R08423 R08430; R09528 R09555 R09621 R10961,"Phenylalanine metabolism; Benzoate degradation; Toluene degradation; Aminobenzoate degradation; Ethylbenzene degradation; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds",1.2.1.58; 1.3.7.8; 1.3.7.9; 1.3.-.-; 1.4.-.-; 1.14.13.58; 1.14.13.208; 2.3.1.16; 2.3.1.71; 2.3.1.127; 2.3.1.144; 2.3.1.166; 2.3.1.177; 2.3.1.196; 2.3.1.220; 2.3.1.-; 6.2.1.25,"Toluene degradation, anaerobic, toluene => benzoyl-CoA; Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA",NA,CAS: 6756-74-7; PubChem: 3795; ChEBI: 15515; PDB-CCD: BYC; 3DMET: B04692; NIKKAJI: J397.338G,cpd:C00512,28,40,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H41O17N7P3S1,C28H39O17N7P3S1,871.141425,872.1492501,870.13361259,1404,cpd:C00582,Phenylacetyl-CoA;,C29H42N7O17P3S,Phenylacetyl-CoA; Phenylacetyl coenzyme A,R02539 R02576 R04868 R05841 R07222 R09838 R09840,Phenylalanine metabolism; Microbial metabolism in diverse environments,1.14.13.149; 1.17.5.1; 2.3.1.13; 2.3.1.14; 2.3.1.164; 2.3.1.192; 3.1.2.-; 6.2.1.30,NA,NA,PubChem: 3861; ChEBI: 15537; KNApSAcK: C00007536; PDB-CCD: FAQ; 3DMET: B04702; NIKKAJI: J363.723I,cpd:C00582,29,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H43O17N7P3S1,C29H41O17N7P3S1,885.1570751,886.1649001,884.14925011260,1405,cpd:C00596,"2-Hydroxy-2,4-pentadienoate;",C5H6O3,"2-Hydroxy-2,4-pentadienoate; cis-2-Hydroxypenta-2,4-dienoate; Oxopent-4-enoate; 2-Oxopent-4-enoate; 2-Hydroxypenta-2,4-dienoate",R02601 R02602 R02603 R02604 R02605 R02606 R05138 R05359; R05360 R05362 R05364 R05365 R05366 R06789 R07802,Phenylalanine metabolism; Benzoate degradation; Dioxin degradation; Xylene degradation; Ethylbenzene degradation; Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,3.7.1.8; 3.7.1.9; 3.7.1.13; 3.7.1.14; 3.7.1.-; 4.1.1.77; 4.2.1.80; 4.5.1.4,"Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate; Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate; Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate; Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",NA,CAS: 159694-16-3; PubChem: 3873; ChEBI: 1113 11641 37319; 3DMET: B00144; NIKKAJI: J2.142.292D,cpd:C00596; cpd:C02144; cpd:C03088; cpd:C05133; cpd:C05281; cpd:C05515; cpd:C07091; cpd:C18049; cpd:C21187,5,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O3,C5H5O3,114.0316941,115.0395191,113.0238691261,1406,cpd:C00601,Phenylacetaldehyde;,C8H8O,Phenylacetaldehyde; alpha-Tolualdehyde,R01377 R02536 R02537 R02611 R02612 R02613 R02615 R10697,Phenylalanine metabolism; Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.90; 1.2.1.5; 1.2.1.39; 1.4.3.4; 1.4.3.21; 1.4.9.2; 4.1.1.43; 4.1.1.-; 5.3.99.7,NA,NA,CAS: 122-78-1; PubChem: 3876; ChEBI: 16424; KNApSAcK: C00007535; PDB-CCD: HY1; 3DMET: B00145; NIKKAJI: J2.494E,cpd:C00601; cpd:C02083; cpd:C05627; cpd:C06758; cpd:C07113; cpd:C07209; cpd:C07214; cpd:C14494; cpd:C14619; cpd:C20782,8,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O1,C8H7O1,120.0575149,121.0653399,119.04968981262,1407,cpd:C00755,4-Hydroxy-3-methoxy-benzaldehyde;,C8H8O3,4-Hydroxy-3-methoxy-benzaldehyde; Vanillin; Vanillaldehyde; 4-Hydroxy-3-methoxybenzaldehyde,R00043 R02877 R05273 R05699 R05773 R08461 R11503,Phenylalanine metabolism; Aminobenzoate degradation; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,1.1.3.38; 1.2.1.67; 1.2.3.9; 1.11.1.16; 1.13.11.43; 4.1.2.41,"Capsaicin biosynthesis, L-Phenylalanine => Capsaicin","Pharmaceutical additives [BR:br08316];  Favoring agent, Fragrance;   D00091  [107548] Vanillin;  Refresher;   D00091  [107548] Vanillin",CAS: 121-33-5; PubChem: 4017; ChEBI: 18346; ChEMBL: CHEMBL13883; KNApSAcK: C00002683 C00029531; PDB-CCD: V55; 3DMET: B00167; NIKKAJI: J2.923H,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951911263,1408,cpd:C00805,Salicylate;,C7H6O3,Salicylate; o-Hydroxybenzoic acid; Salicylic acid,R00818 R02941 R02942 R05360 R05537 R06602 R06603 R06925; R07695 R07709 R07710 R08838 R09539 R10448,Phenylalanine metabolism; Dioxin degradation; Polycyclic aromatic hydrocarbon degradation; Naphthalene degradation; Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of phenylpropanoids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Degradation of aromatic compounds; Plant hormone signal transduction; Bile secretion,1.2.1.65; 1.2.1.-; 1.14.13.1; 1.14.13.172; 1.14.13.-; 2.1.1.274; 3.1.1.55; 3.7.1.8; 4.1.1.91; 4.1.1.-; 4.2.99.21,"Naphthalene degradation, naphthalene => salicylate; Salicylate degradation, salicylate => gentisate","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D01 ANTIFUNGALS FOR DERMATOLOGICAL USE;    D01A ANTIFUNGALS FOR TOPICAL USE;     D01AE Other antifungals for topical use;      D01AE12 Salicylic acid;       D00097  Salicylic acid (JP17/USP);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01B ANTIINFLAMMATORY AGENTS;     S01BC Antiinflammatory agents, non-steroids;      S01BC08 Salicylic acid;       D00097  Salicylic acid (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    265  Antiparasitic dermatosis agents;     2652  Salicylic acids for external use;      D00097  Salicylic acid (JP17/USP);    266  Emollients;     2661  Organic acids;      D00097  Salicylic acid (JP17/USP); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   56 Purulent skin remedies;    D00097  Salicylic acid (JP17/USP);   58 Ringworm drugs;    D00097  Salicylic acid (JP17/USP);   59 Skin emollient (incl. pus extrusion);    D00097  Salicylic acid (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Salicylic acid;     D00097  Salicylic acid (JP17/USP);  Second-class OTC drugs;   Inorganic and organic chemicals;    Salicylic acid;     D00097  Salicylic acid (JP17/USP); Pharmaceutical additives [BR:br08316];  Antiseptic agent;   D00097  [001274] Salicylic acid;  Preserving agent;   D00097  [001274] Salicylic acid; Cytochrome P450 interactions [BR:br08309];  Transporter inhibitors;   OAT2;    Salicylic acid;     D00097  Salicylic acid (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00097  Salicylic acid;   D00097  Salicylic acid spirit; Antifungals [br08352.html];  D00097; Dermatological agents [br08370.html];  Non-steroidal topical agent;   D00097; Animal drugs in Japan [BR:br08331];  95  Agents for external use;   951  Antimicrobials for dermatologic use;    9519  Other antimicrobials for dermatologic use;     C00805  Salicylate;   956  Bath and disinfectants preparations;    9562  Disinfectants preparations;     C00805  Salicylate;  99  Agents for not mainly purpose of therapeutic;   992  Amphoteric soap and preparations;    9929  Other agents for disinfections;     C00805  Salicylate",CAS: 69-72-7; PubChem: 4063; ChEBI: 16914 30762; ChEMBL: CHEMBL424; KNApSAcK: C00000206; PDB-CCD: SAL; 3DMET: B00179; NIKKAJI: J2.370A,cpd:C00156; cpd:C00587; cpd:C00805; cpd:C05585; cpd:C08055; cpd:C10832; cpd:C12114; cpd:C14015; cpd:C16700; cpd:C17098; cpd:C18316; cpd:C20248,7,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O3,C7H5O3,138.0316941,139.0395191,137.0238691264,1409,cpd:C01198,3-(2-Hydroxyphenyl)propanoate;,C9H10O3,3-(2-Hydroxyphenyl)propanoate; 2-Hydroxyphenylpropanoate; 3-(2-Hydroxyphenyl)propionic acid; Melilotate; 3-(2-Hydroxyphenyl)propionate,R03369 R03692 R03709 R04899 R05537,Phenylalanine metabolism; Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.1.11; 1.14.13.4; 3.1.1.35,NA,NA,CAS: 495-78-3; PubChem: 4423; ChEBI: 16104 46957; KNApSAcK: C00002756; 3DMET: B00259; NIKKAJI: J6.083F,cpd:C01198; cpd:C01456; cpd:C01744; cpd:C02201; cpd:C02363; cpd:C02515; cpd:C03080; cpd:C05581; cpd:C05607; cpd:C10712; cpd:C11380; cpd:C11457; cpd:C12206; cpd:C12462; cpd:C17079; cpd:C18397,9,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O3,C9H9O3,166.0629942,167.0708192,165.05516911265,1410,cpd:C01575,Ephedrine;,C10H15NO,Ephedrine; (-)-Ephedrine; L-Ephedrine,R03614 R08467,Phenylalanine metabolism; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways,1.5.1.18; 2.1.1.-,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Phenylalanine derived alkaloids;     C01575  Ephedrine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;     C01CA Adrenergic and dopaminergic agents;      C01CA26 Ephedrine;       D00124  Ephedrine (USP);  R RESPIRATORY SYSTEM;   R01 NASAL PREPARATIONS;    R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;     R01AA Sympathomimetics, plain;      R01AA03 Ephedrine;       D00124  Ephedrine (USP);     R01AB Sympathomimetics, combinations excl. corticosteroids;      R01AB05 Ephedrine;       D00124  Ephedrine (USP);   R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;    R03C ADRENERGICS FOR SYSTEMIC USE;     R03CA Alpha- and beta-adrenoreceptor agonists;      R03CA02 Ephedrine;       D00124  Ephedrine (USP);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01F MYDRIATICS AND CYCLOPLEGICS;     S01FB Sympathomimetics excl. antiglaucoma preparations;      S01FB02 Ephedrine;       D00124  Ephedrine (USP); USP drug classification [BR:br08302];  Respiratory Tract/Pulmonary Agents;   Bronchodilators, Sympathomimetic;    Ephedrine;     D00124  Ephedrine (USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Ephedrine;     D00124  Ephedrine (USP); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adrenaline;     alpha1-adrenergic receptor;      Ephedrine;       D00124  Ephedrine (USP);     alpha2-adrenergic receptor;      Ephedrine;       D00124  Ephedrine (USP);     beta1-adrenergic receptor;      Ephedrine;       D00124  Ephedrine (USP);     beta2-adrenergic receptor;      Ephedrine;       D00124  Ephedrine (USP);     beta3-adrenergic receptor;      Ephedrine;       D00124  Ephedrine (USP); Major components of natural products [BR:br08323];  Crude drugs;   Ephedra herb;    C01575  Ephedrine;  Medicinal herbs;   Ephedra;    C01575  Ephedrine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived by amination reactions;    Phenylalanine derived alkaloids;     D00124  Ephedrine (USP)",CAS: 299-42-3; PubChem: 4732; ChEBI: 15407; ChEMBL: CHEMBL211456 CHEMBL357080; KNApSAcK: C00001409; NIKKAJI: J9.314I,cpd:C01575; cpd:C02765; cpd:C06199; cpd:C10841,10,15,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O1N1,C10H14O1N1,165.1153641,166.1231891,164.10753911266,1411,cpd:C01586,Hippurate;,C9H9NO3,Hippurate; Hippuric acid; N-Benzoylglycine; Benzoylaminoacetic acid,R01424 R02452,Phenylalanine metabolism,2.3.1.71; 3.5.1.32,NA,NA,CAS: 495-69-2; PubChem: 4741; ChEBI: 18089; ChEMBL: CHEMBL461; KNApSAcK: C00030483; 3DMET: B00325; NIKKAJI: J1.562H,cpd:C01060; cpd:C01586; cpd:C03224; cpd:C03347; cpd:C06332; cpd:C06339; cpd:C11449; cpd:C17080; cpd:C17099; cpd:C19569; cpd:C21453,9,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O3N1,C9H8O3N1,179.0582432,180.0660682,178.05041811267,1412,cpd:C01772,trans-2-Hydroxycinnamate;,C9H8O3,trans-2-Hydroxycinnamate; trans-2-Hydroxycinnamic acid; 2-Hydroxycinnamate; 2-Coumaric acid; o-Coumaric acid; 2-Coumarate,R02254 R03709 R03710,Phenylalanine metabolism; Phenylpropanoid biosynthesis; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,1.3.1.11; 1.14.13.14; 2.4.1.114,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C01772  trans-2-Hydroxycinnamate,CAS: 614-60-8; PubChem: 4905; ChEBI: 18125; ChEMBL: CHEMBL52564; KNApSAcK: C00002729; PDB-CCD: 2HC; 3DMET: B00349; NIKKAJI: J55.415D,cpd:C00166; cpd:C00811; cpd:C01772; cpd:C02763; cpd:C05838; cpd:C06738; cpd:C07114; cpd:C10945; cpd:C11020; cpd:C12463; cpd:C12621; cpd:C20685; cpd:C20687; cpd:C20939; cpd:C21345,9,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O3,C9H7O3,164.0473441,165.0551691,163.03951911268,1413,cpd:C02137,alpha-Oxo-benzeneacetic acid;,C8H6O3,alpha-Oxo-benzeneacetic acid; Benzoylformate; Benzoylformic acid; Phenylglyoxylic acid; Phenylglyoxylate; 2-Oxo-2-phenylacetate,R01764 R02450 R03790 R03792 R03793 R07294 R07664,Phenylalanine metabolism; Aminobenzoate degradation; Microbial metabolism in diverse environments,1.1.1.379; 1.1.1.-; 1.1.99.31; 1.2.1.58; 3.1.2.25; 4.1.1.7,NA,NA,CAS: 611-73-4; PubChem: 5216; ChEBI: 18280; ChEMBL: CHEMBL950; PDB-CCD: 173; 3DMET: B00392; NIKKAJI: J2.992K,cpd:C02137; cpd:C03057; cpd:C03664; cpd:C06374; cpd:C10812; cpd:C18597,8,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O3,C8H5O3,150.0316941,151.0395191,149.0238691269,1414,cpd:C02232,3-Oxoadipyl-CoA;,C27H42N7O20P3S,3-Oxoadipyl-CoA; beta-Ketoadipyl-CoA,R00829 R02990 R06941,Phenylalanine metabolism; Benzoate degradation; Caprolactam degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.35; 1.1.1.157; 2.3.1.16; 2.3.1.174; 2.8.3.6,NA,NA,PubChem: 5296; ChEBI: 15490; NIKKAJI: J2.735.654K,cpd:C02232,27,42,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O20N7P3S1,C27H41O20N7P3S1,909.1418189,910.149644,908.13399391270,1415,cpd:C02265,D-Phenylalanine;,C9H11NO2,D-Phenylalanine; D-alpha-Amino-beta-phenylpropionic acid,R00686 R01374 R01582 R03903,Phenylalanine metabolism; Taste transduction,1.4.5.1; 2.3.1.36; 2.6.1.21; 5.1.1.11,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C02265  D-Phenylalanine,CAS: 673-06-3; PubChem: 5326; ChEBI: 16998; ChEMBL: CHEMBL379630; PDB-CCD: DPN; 3DMET: B01552; NIKKAJI: J9.200B,cpd:C00079; cpd:C02057; cpd:C02265; cpd:C07527; cpd:C18090; cpd:C18747; cpd:C19565; cpd:C19578; cpd:C20487; cpd:C20488,9,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O2N1,C9H10O2N1,165.0789786,166.0868036,164.07115361271,1416,cpd:C02505,2-Phenylacetamide;,C8H9NO,2-Phenylacetamide; alpha-Phenylacetamide,R00690 R00698 R02540 R07854,Phenylalanine metabolism; Styrene degradation; Microbial metabolism in diverse environments,1.11.1.21; 1.13.12.9; 3.5.1.4; 4.2.1.84,NA,NA,CAS: 103-81-1; PubChem: 5517; ChEBI: 16562; ChEMBL: CHEMBL347645; 3DMET: B01582; NIKKAJI: J55.331J,cpd:C02505; cpd:C03719; cpd:C07565; cpd:C15561; cpd:C16075; cpd:C19714,8,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O1N1,C8H8O1N1,135.0684139,136.0762389,134.06058891272,1417,cpd:C02763,2-Hydroxy-3-phenylpropenoate;,C9H8O3,2-Hydroxy-3-phenylpropenoate; enol-Phenylpyruvate; enol-Phenylpyruvic acid; enol-alpha-Ketohydrocinnamic acid,R01378,Phenylalanine metabolism,5.3.2.1,NA,NA,PubChem: 5719; ChEBI: 16815 32815; 3DMET: B00496; NIKKAJI: J899.575C,cpd:C00166; cpd:C00811; cpd:C01772; cpd:C02763; cpd:C05838; cpd:C06738; cpd:C07114; cpd:C10945; cpd:C11020; cpd:C12463; cpd:C12621; cpd:C20685; cpd:C20687; cpd:C20939; cpd:C21345,9,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O3,C9H7O3,164.0473441,165.0551691,163.03951911273,1418,cpd:C02765,(+)-Pseudoephedrine;,C10H15NO,(+)-Pseudoephedrine; Pseudoephedrine,R08465,Phenylalanine metabolism; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways,2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Phenylalanine derived alkaloids;     C02765  (+)-Pseudoephedrine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  R RESPIRATORY SYSTEM;   R01 NASAL PREPARATIONS;    R01B NASAL DECONGESTANTS FOR SYSTEMIC USE;     R01BA Sympathomimetics;      R01BA02 Pseudoephedrine;       D08449  Pseudoephedrine (INN); Risk category of Japanese OTC drugs [BR:br08312];  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Pseudoephedrine;     D08449  Pseudoephedrine (INN);  Second-class OTC drugs;   Inorganic and organic chemicals;    Pseudoephedrine;     D08449  Pseudoephedrine (INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adrenaline;     alpha1-adrenergic receptor;      Pseudoephedrine;       D08449  Pseudoephedrine (INN);     alpha2-adrenergic receptor;      Pseudoephedrine;       D08449  Pseudoephedrine (INN);     beta1-adrenergic receptor;      Pseudoephedrine;       D08449  Pseudoephedrine (INN);     beta2-adrenergic receptor;      Pseudoephedrine;       D08449  Pseudoephedrine (INN);     beta3-adrenergic receptor;      Pseudoephedrine;       D08449  Pseudoephedrine (INN); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived by amination reactions;    Phenylalanine derived alkaloids;     D08449  Pseudoephedrine (INN),CAS: 90-82-4; PubChem: 5721; ChEBI: 51209; ChEMBL: CHEMBL1590 CHEMBL357080; KNApSAcK: C00031097; NIKKAJI: J10.171K,cpd:C01575; cpd:C02765; cpd:C06199; cpd:C10841,10,15,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O1N1,C10H14O1N1,165.1153641,166.1231891,164.10753911274,1419,cpd:C03519,N-Acetyl-L-phenylalanine,C11H13NO3,N-Acetyl-L-phenylalanine,R00693,Phenylalanine metabolism,2.3.1.53,NA,NA,CAS: 2018-61-3; PubChem: 6328; ChEBI: 16259; PDB-CCD: 5CR; 3DMET: B00595; NIKKAJI: J27.562J,cpd:C03519; cpd:C05620; cpd:C09933; cpd:C09986; cpd:C20126,11,13,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H14O3N1,C11H12O3N1,207.0895433,208.0973683,206.08171821275,1420,cpd:C03589,4-Hydroxy-2-oxopentanoate;,C5H8O4,4-Hydroxy-2-oxopentanoate; 4-Hydroxy-2-oxovalerate,R00750 R02601 R04223,Phenylalanine metabolism; Benzoate degradation; Dioxin degradation; Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,4.1.1.-; 4.1.3.39; 4.2.1.80,"Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",NA,PubChem: 6380; ChEBI: 17655; 3DMET: B04904; NIKKAJI: J609.509G,cpd:C00489; cpd:C00707; cpd:C00900; cpd:C02352; cpd:C02674; cpd:C03409; cpd:C03589; cpd:C04106; cpd:C04181; cpd:C06010; cpd:C08298; cpd:C11838; cpd:C18061; cpd:C19483; cpd:C19885; cpd:C20232; cpd:C20846; cpd:C21177,5,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O4,C5H7O4,132.0422587,133.0500838,131.03443371276,1421,cpd:C04044,"3-(2,3-Dihydroxyphenyl)propanoate;",C9H10O4,"3-(2,3-Dihydroxyphenyl)propanoate; 2,3-Dihydroxyphenylpropanoate",R03369 R04376 R06784 R06786,Phenylalanine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.87; 1.13.11.16; 1.14.13.4; 1.14.13.127,NA,NA,PubChem: 6745; ChEBI: 18136 46951; 3DMET: B00669; NIKKAJI: J1.551.212A,cpd:C02333; cpd:C03672; cpd:C03964; cpd:C04044; cpd:C05582; cpd:C05583; cpd:C06663; cpd:C10447; cpd:C10680; cpd:C12622; cpd:C20953; cpd:C21085,9,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O4,C9H9O4,182.0579088,183.0657338,181.05008381277,1422,cpd:C04148,Phenylacetylglutamine;,C13H16N2O4,Phenylacetylglutamine; alpha-N-Phenylacetyl-L-glutamine; N2-(2-Phenylacetyl)-L-glutamine,R02576,Phenylalanine metabolism,2.3.1.14,NA,NA,CAS: 28047-15-6; PubChem: 6833; ChEBI: 17884 8087; 3DMET: B00684; NIKKAJI: J75.641E,cpd:C04148; cpd:C05642,13,16,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H17O4N2,C13H15O4N2,264.111007,265.118832,263.1031821278,1423,cpd:C04351,(R)-2-Methylimino-1-phenylpropan-1-ol,C10H13NO,(R)-2-Methylimino-1-phenylpropan-1-ol,R03614,Phenylalanine metabolism; Metabolic pathways,1.5.1.18,NA,NA,PubChem: 7000; ChEBI: 16825; NIKKAJI: J2.750.203B,cpd:C04351; cpd:C06746; cpd:C11487,10,13,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O1N1,C10H12O1N1,163.099714,164.1075391,162.0918891279,1424,cpd:C04479,"2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate;",C9H10O6,"2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate; (2Z,4E)-2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate",R02603 R04376,Phenylalanine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.16; 3.7.1.14,NA,NA,PubChem: 7099; ChEBI: 17367 61470; 3DMET: B00720; NIKKAJI: J891.762K,cpd:C04479; cpd:C21079,9,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O6,C9H9O6,214.047738,215.0555631,213.0399131280,1425,cpd:C05332,Phenethylamine;,C8H11N,Phenethylamine; 2-Phenylethylamine; beta-Phenylethylamine; Phenylethylamine,R00699 R02612 R02613 R07301,Phenylalanine metabolism,1.4.3.4; 1.4.3.21; 1.4.9.2; 3.5.1.85; 4.1.1.28; 4.1.1.53,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C05332  Phenethylamine,CAS: 64-04-0; PubChem: 7711; ChEBI: 18397; ChEMBL: CHEMBL610; KNApSAcK: C00001426; PDB-CCD: PEA; 3DMET: B00766; NIKKAJI: J4.833J,cpd:C00314; cpd:C00483; cpd:C00547; cpd:C01183; cpd:C02455; cpd:C02735; cpd:C02846; cpd:C03473; cpd:C03758; cpd:C04227; cpd:C04690; cpd:C05332; cpd:C05713; cpd:C07770; cpd:C11003; cpd:C11004; cpd:C13415; cpd:C13690; cpd:C13691; cpd:C14455; cpd:C16570; cpd:C16666; cpd:C18396; cpd:C18782; cpd:C18993; cpd:C19216; cpd:C19376,8,11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H12N1,C8H10N1,121.0891494,122.0969744,120.08132431281,1426,cpd:C05598,Phenylacetylglycine,C10H11NO3,Phenylacetylglycine,R05841,Phenylalanine metabolism,2.3.1.13; 2.3.1.192,NA,NA,CAS: 500-98-1; PubChem: 7922; ChEBI: 27480; ChEMBL: CHEMBL458497; 3DMET: B00803; NIKKAJI: J11.682C,cpd:C03450; cpd:C05598; cpd:C06726; cpd:C09962; cpd:C10581; cpd:C16587; cpd:C16595,10,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H12O3N1,C10H10O3N1,193.0738932,194.0817182,192.06606821282,1427,cpd:C05607,Phenyllactate;,C9H10O3,Phenyllactate; (R)-Phenyllactate,R01370 R01371 R07796,"Phenylalanine metabolism; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid",1.1.1.222; 1.1.1.237; 2.8.3.17,NA,NA,CAS: 7326-19-4; PubChem: 7930; ChEBI: 32978; KNApSAcK: C00000150; PDB-CCD: HF2; 3DMET: B05083; NIKKAJI: J70.490C,cpd:C01198; cpd:C01456; cpd:C01744; cpd:C02201; cpd:C02363; cpd:C02515; cpd:C03080; cpd:C05581; cpd:C05607; cpd:C10712; cpd:C11380; cpd:C11457; cpd:C12206; cpd:C12462; cpd:C17079; cpd:C18397,9,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O3,C9H9O3,166.0629942,167.0708192,165.05516911283,1428,cpd:C05620,N-Acetyl-D-phenylalanine,C11H13NO3,N-Acetyl-D-phenylalanine,R03903,Phenylalanine metabolism,2.3.1.36,NA,NA,CAS: 10172-89-1; PubChem: 7938; ChEBI: 28203; ChEMBL: CHEMBL174089; 3DMET: B01876; NIKKAJI: J207.899F,cpd:C03519; cpd:C05620; cpd:C09933; cpd:C09986; cpd:C20126,11,13,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H14O3N1,C11H12O3N1,207.0895433,208.0973683,206.08171821284,1429,cpd:C05629,Phenylpropanoate;,C9H10O2,Phenylpropanoate; 3-Phenyl-propionic acid; 3-Phenylpropanoic acid; 3-Phenylpropionic acid,R02252 R04899 R06780 R06782,Phenylalanine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.31; 1.14.12.19,NA,NA,CAS: 501-52-0; PubChem: 7943; ChEBI: 28631; ChEMBL: CHEMBL851; PDB-CCD: HCI; 3DMET: B00813; NIKKAJI: J2.601H,cpd:C01963; cpd:C02646; cpd:C03900; cpd:C05629; cpd:C07428; cpd:C08050; cpd:C11007; cpd:C11009; cpd:C11110; cpd:C11217; cpd:C12461; cpd:C13342; cpd:C15513; cpd:C16706; cpd:C17883; cpd:C19291; cpd:C20697; cpd:C21309,9,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O2,C9H9O2,150.0680796,151.0759046,149.06025451285,1430,cpd:C05852,2-Hydroxyphenylacetate;,C8H8O3,2-Hydroxyphenylacetate; 2-Hydroxyphenylacetic acid,R01372 R05001 R05450 R05487,Phenylalanine metabolism; Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.13.11.27; 1.14.13.-,NA,NA,CAS: 614-75-5; PubChem: 8145; ChEBI: 28478; ChEMBL: CHEMBL240714; PDB-CCD: OHP; 3DMET: B00868; NIKKAJI: J27.607C,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951911286,1431,cpd:C05853,Phenylethyl alcohol;,C8H10O,Phenylethyl alcohol; Phenethyl alcohol; 2-Phenylethanol,R02611,Phenylalanine metabolism,1.1.1.90,NA,Pharmaceutical additives [BR:br08316];  Antiseptic agent;   D00192  [105151] Phenylethyl alcohol;  Preserving agent;   D00192  [105151] Phenylethyl alcohol,CAS: 60-12-8; PubChem: 8146; ChEBI: 49000; ChEMBL: CHEMBL448500; KNApSAcK: C00002663; PDB-CCD: PEL; 3DMET: B00869; NIKKAJI: J1.924K,cpd:C05853; cpd:C06757; cpd:C07112; cpd:C07213; cpd:C07216; cpd:C11348; cpd:C13637; cpd:C14385; cpd:C14386; cpd:C14582; cpd:C17512; cpd:C19680,8,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O1,C8H9O1,122.0731649,123.08099,121.06533991287,1432,cpd:C06207,"2,6-Dihydroxyphenylacetate",C8H8O4,"2,6-Dihydroxyphenylacetate",R05001,Phenylalanine metabolism,NA,NA,NA,PubChem: 8457; ChEBI: 28440 952; 3DMET: B00922; NIKKAJI: J2.367.889F,cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272,8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O4,C8H7O4,168.0422587,169.0500838,167.03443371288,1433,cpd:C06866,Capsaicin,C18H27NO3,Capsaicin,R09091,Phenylalanine metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Inflammatory mediator regulation of TRP channels,NA,"Capsaicin biosynthesis, L-Phenylalanine => Capsaicin","Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Others;    Capsaicinoids and derivatives;     C06866  Capsaicin; Target-based classification of compounds [BR:br08010];  Ion channels;   Related to voltage-gated cation channels;    Transient receptor potential family, TRPV (Vanilloid);     transient receptor potential cation channel, subfamily V, member 1;      C06866  Capsaicin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  M MUSCULO-SKELETAL SYSTEM;   M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;    M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;     M02AB Capsaicin and similar agents;      M02AB01 Capsaicin;       D00250  Capsaicin (JAN/USP);  N NERVOUS SYSTEM;   N01 ANESTHETICS;    N01B ANESTHETICS, LOCAL;     N01BX Other local anesthetics;      N01BX04 Capsaicin;       D00250  Capsaicin (JAN/USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Capsaicin;     D00250  Capsaicin (JAN/USP); Target-based classification of drugs [BR:br08310];  Ion channels;   Related to voltage-gated cation channels;    Transient receptor potential family, TRPV (Vanilloid);     transient receptor potential cation channel, subfamily V, member 1 (TRPV1);      Capsaicin;       D00250  Capsaicin (JAN/USP); New drug approvals in the USA [br08319.html];  New Molecular Entity and New Therapeutic Biological Product Approvals;   D00250; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00250; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D00250; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00250; Major components of natural products [BR:br08323];  Crude drugs;   Capsicum;    C06866  Capsaicin;   Capsicum tincture;    C06866  Capsaicin;  Medicinal herbs;   Cayenne papper;    C06866  Capsaicin",CAS: 404-86-4; PubChem: 9083; ChEBI: 3374; ChEMBL: CHEMBL294199; PDB-CCD: 4DY; NIKKAJI: J1.529F,cpd:C06866,18,27,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H28O3N1,C18H26O3N1,305.1990937,306.2069188,304.19126871289,1434,cpd:C07086,Phenylacetic acid;,C8H8O2,Phenylacetic acid; Benzylformic acid; Phenylacetate; Benzeneacetic acid,R02536 R02537 R02539 R02540 R04103 R05487 R06790 R06791; R07855 R09840,Phenylalanine metabolism; Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.2.1.5; 1.2.1.39; 1.14.13.-; 3.1.2.-; 3.5.1.4; 3.5.1.11; 3.5.5.1; 6.2.1.30,NA,NA,CAS: 103-82-2; PubChem: 9297; ChEBI: 30745; ChEMBL: CHEMBL1044; KNApSAcK: C00000750; PDB-CCD: PAC; 3DMET: B02106; NIKKAJI: J10.117F,cpd:C00548; cpd:C01454; cpd:C01526; cpd:C02061; cpd:C03765; cpd:C05613; cpd:C06224; cpd:C07085; cpd:C07086; cpd:C07189; cpd:C07211; cpd:C07215; cpd:C10700; cpd:C10761; cpd:C11151; cpd:C11252; cpd:C14087; cpd:C15250; cpd:C15583; cpd:C20645; cpd:C21166; cpd:C21328; cpd:C21375,8,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O2,C8H7O2,136.0524295,137.0602545,135.04460451290,1435,cpd:C07303,4-Hydroxy-3-methoxyphenyl-beta-hydroxypropanoyl-CoA;,C31H46N7O20P3S,4-Hydroxy-3-methoxyphenyl-beta-hydroxypropanoyl-CoA; 4-Hydroxy-3-methoxyphenyl-beta-hydroxypropionyl-CoA; 3-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)propionyl-CoA,R05772 R05773,Phenylalanine metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,4.1.2.41; 4.2.1.101,"Capsaicin biosynthesis, L-Phenylalanine => Capsaicin",NA,PubChem: 9511; ChEBI: 17068; NIKKAJI: J2.765.022H,cpd:C07302; cpd:C07303,31,46,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H47O20N7P3S1,C31H45O20N7P3S1,961.1731191,962.1809441,960.1652941291,1436,cpd:C08300,D-Cathine;,C9H13NO,D-Cathine; Cathine; (+)-Norpseudoephedrine,R08464 R08465,Phenylalanine metabolism; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways,2.1.1.-,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Phenylalanine derived alkaloids;     C08300  D-Cathine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS;    A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS;     A08AA Centrally acting antiobesity products;      A08AA07 Cathine;       D07627  Cathine (INN); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived by amination reactions;    Phenylalanine derived alkaloids;     D07627  Cathine (INN)",CAS: 492-39-7; PubChem: 10498; ChEBI: 4109; ChEMBL: CHEMBL1412041; KNApSAcK: C00001405; NIKKAJI: J9.386F,cpd:C02343; cpd:C02442; cpd:C03711; cpd:C07911; cpd:C08300; cpd:C10158; cpd:C11776; cpd:C16719,9,13,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O1N1,C9H12O1N1,151.099714,152.1075391,150.0918891292,1437,cpd:C08301,D-Cathinone;,C9H11NO,D-Cathinone; Cathinone,R08463 R08464 R08466 R09089,Phenylalanine metabolism; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways,2.6.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Phenylalanine derived alkaloids;     C08301  D-Cathinone,CAS: 71031-15-7; PubChem: 10499; ChEBI: 4110; KNApSAcK: C00001406; NIKKAJI: J18.754B,cpd:C08301; cpd:C17236,9,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O1N1,C9H10O1N1,149.084064,150.091889,148.07623891293,1438,cpd:C11457,3-(3-Hydroxyphenyl)propanoic acid;,C9H10O3,3-(3-Hydroxyphenyl)propanoic acid; Dihydro-3-coumaric acid; 3-Hydroxyphenylpropanoate; 3-(3-Hydroxyphenyl)propanoate,R06780 R06786,Phenylalanine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.127,NA,NA,CAS: 621-54-5; PubChem: 13628; ChEBI: 1427; ChEMBL: CHEMBL134401; 3DMET: B04268; NIKKAJI: J59.910G,cpd:C01198; cpd:C01456; cpd:C01744; cpd:C02201; cpd:C02363; cpd:C02515; cpd:C03080; cpd:C05581; cpd:C05607; cpd:C10712; cpd:C11380; cpd:C11457; cpd:C12206; cpd:C12462; cpd:C17079; cpd:C18397,9,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O3,C9H9O3,166.0629942,167.0708192,165.05516911294,1439,cpd:C11588,"cis-3-(Carboxy-ethyl)-3,5-cyclo-hexadiene-1,2-diol;",C9H12O4,"cis-3-(Carboxy-ethyl)-3,5-cyclo-hexadiene-1,2-diol; cis-3-(2-Carboxy-ethyl)-3,5-cyclo-hexadiene-1,2-diol; 3-(cis-5,6-Dihydroxycyclohexa-1,3-dien-1-yl)propanoate",R06782 R06784,Phenylalanine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.87; 1.14.12.19,NA,NA,PubChem: 13753; ChEBI: 10472; 3DMET: B04275; NIKKAJI: J2.775.230F,cpd:C04535; cpd:C05594; cpd:C06582; cpd:C10765; cpd:C11265; cpd:C11456; cpd:C11588; cpd:C11747; cpd:C16635; cpd:C18660,9,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13O4,C9H11O4,184.0735589,185.0813839,183.06573381295,1440,cpd:C12621,trans-3-Hydroxycinnamate;,C9H8O3,trans-3-Hydroxycinnamate; (2E)-3-(3-Hydroxyphenyl)prop-2-enoate,R06781 R06787,Phenylalanine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.127,"Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA",NA,CAS: 14755-02-3; PubChem: 583011; ChEBI: 32357; ChEMBL: CHEMBL98521; 3DMET: B04535; NIKKAJI: J1.638A,cpd:C00166; cpd:C00811; cpd:C01772; cpd:C02763; cpd:C05838; cpd:C06738; cpd:C07114; cpd:C10945; cpd:C11020; cpd:C12463; cpd:C12621; cpd:C20685; cpd:C20687; cpd:C20939; cpd:C21345,9,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O3,C9H7O3,164.0473441,165.0551691,163.03951911296,1441,cpd:C12622,"cis-3-(3-Carboxyethenyl)-3,5-cyclohexadiene-1,2-diol;",C9H10O4,"cis-3-(3-Carboxyethenyl)-3,5-cyclohexadiene-1,2-diol; (2E)-3-(cis-5,6-Dihydroxycyclohexa-1,3-dien-1-yl)prop-2-enoate",R06783 R06785,Phenylalanine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.87; 1.14.12.19,"Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA",NA,PubChem: 583012; ChEBI: 61462; 3DMET: B04536; NIKKAJI: J2.783.722K,cpd:C02333; cpd:C03672; cpd:C03964; cpd:C04044; cpd:C05582; cpd:C05583; cpd:C06663; cpd:C10447; cpd:C10680; cpd:C12622; cpd:C20953; cpd:C21085,9,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O4,C9H9O4,182.0579088,183.0657338,181.05008381297,1442,cpd:C12623,"trans-2,3-Dihydroxycinnamate;",C9H8O4,"trans-2,3-Dihydroxycinnamate; (2E)-3-(2,3-Dihydroxyphenyl)prop-2-enoate",R06785 R06787 R06788,Phenylalanine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.87; 1.13.11.16; 1.14.13.127,"Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA",NA,PubChem: 583013; ChEBI: 32356; 3DMET: B04537; NIKKAJI: J2.121.218K,cpd:C01179; cpd:C01197; cpd:C01405; cpd:C01481; cpd:C04367; cpd:C05350; cpd:C12467; cpd:C12623; cpd:C13400; cpd:C17086; cpd:C18819; cpd:C21346,9,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O4,C9H7O4,180.0422587,181.0500838,179.03443371298,1443,cpd:C12624,2-Hydroxy-6-ketononatrienedioate;,C9H8O6,"2-Hydroxy-6-ketononatrienedioate; (2Z,4E,7E)-2-Hydroxy-6-oxonona-2,4,7-triene-1,9-dioate",R06788 R06789,Phenylalanine metabolism; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.16; 3.7.1.14,"Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA",NA,PubChem: 583014; ChEBI: 31082 66939; 3DMET: B04538; NIKKAJI: J2.783.742E,cpd:C04366; cpd:C12624; cpd:C18338,9,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O6,C9H7O6,212.032088,213.039913,211.02426291299,1444,cpd:C14144,5-Carboxy-2-pentenoyl-CoA;,C27H42N7O19P3S,"5-Carboxy-2-pentenoyl-CoA; 2,3-Didehydroadipyl-CoA",R06942 R06943 R09839,Phenylalanine metabolism; Caprolactam degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.99.-; 2.3.1.223; 4.2.1.17,NA,NA,CAS: 138149-18-5; PubChem: 7846956; ChEBI: 34453; NIKKAJI: J2.788.049E,cpd:C03231; cpd:C14144; cpd:C19682,27,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O19N7P3S1,C27H41O19N7P3S1,893.1469043,894.1547294,892.13907931300,1445,cpd:C14145,(3S)-3-Hydroxyadipyl-CoA,C27H44N7O20P3S,(3S)-3-Hydroxyadipyl-CoA,R06941 R06942,Phenylalanine metabolism; Caprolactam degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.35; 1.1.1.157; 4.2.1.17,NA,NA,PubChem: 7846957; ChEBI: 34002; NIKKAJI: J2.788.051G,cpd:C00356; cpd:C14145,27,44,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O20N7P3S1,C27H43O20N7P3S1,911.157469,912.165294,910.1496441301,1446,cpd:C15524,Phenylglyoxylyl-CoA,C29H40N7O18P3S,Phenylglyoxylyl-CoA,R07222 R07294,Phenylalanine metabolism,1.17.5.1; 3.1.2.25,NA,NA,PubChem: 17396516; ChEBI: 50117; NIKKAJI: J2.794.825A,cpd:C15524,29,40,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H41O18N7P3S1,C29H39O18N7P3S1,899.1363396,900.1441647,898.12851461302,1447,cpd:C16666,Vanillylamine,C8H11NO2,Vanillylamine,R08461 R09091,Phenylalanine metabolism; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,NA,"Capsaicin biosynthesis, L-Phenylalanine => Capsaicin",NA,CAS: 1196-92-5; PubChem: 51090990; ChEBI: 46958; NIKKAJI: J60.119E,cpd:C03758; cpd:C04227; cpd:C13415; cpd:C16666,8,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H12O2N1,C8H10O2N1,153.0789786,154.0868036,152.07115361303,1448,cpd:C16719,(-)-Norephedrine;,C9H13NO,(-)-Norephedrine; l-Phenylpropanolamine,R08466 R08467,Phenylalanine metabolism; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways,2.1.1.-,NA,NA,CAS: 492-41-1; PubChem: 96023243; ChEBI: 80680; ChEMBL: CHEMBL136560 CHEMBL1574804; NIKKAJI: J22.046I,cpd:C02343; cpd:C02442; cpd:C03711; cpd:C07911; cpd:C08300; cpd:C10158; cpd:C11776; cpd:C16719,9,13,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O1N1,C9H12O1N1,151.099714,152.1075391,150.0918891304,1449,cpd:C17268,Pyruvophenone;,C9H8O2,"Pyruvophenone; 1-Phenyl-1,2-propanedione",R09088 R09089,Phenylalanine metabolism; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways,2.6.1.-,NA,NA,CAS: 579-07-7; PubChem: 96023675; ChEBI: 63552; ChEMBL: CHEMBL192258; NIKKAJI: J95.015G,cpd:C00423; cpd:C02274; cpd:C04050; cpd:C05608; cpd:C07720; cpd:C07728; cpd:C07899; cpd:C10438; cpd:C14438; cpd:C17268,9,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O2,C9H7O2,148.0524295,149.0602545,147.04460451305,1450,cpd:C18202,8-Methyl-6-nonenoic acid,C10H18O2,8-Methyl-6-nonenoic acid,R09090 R09091,Phenylalanine metabolism; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,NA,"Capsaicin biosynthesis, L-Phenylalanine => Capsaicin",NA,PubChem: 96024417; ChEBI: 81581; NIKKAJI: J2.322.049K,cpd:C03092; cpd:C04433; cpd:C06185; cpd:C07276; cpd:C07640; cpd:C09790; cpd:C16255; cpd:C16462; cpd:C17621; cpd:C18020; cpd:C18027; cpd:C18066; cpd:C18202; cpd:C19082; cpd:C20326; cpd:C21139,10,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O2,C10H17O2,170.1306798,171.1385049,169.12285481306,1451,cpd:C19945,"3-Oxo-5,6-dehydrosuberyl-CoA;",C29H44N7O20P3S,"3-Oxo-5,6-dehydrosuberyl-CoA; 3-Oxo-5,6-didehydrosuberoyl-CoA",R09820 R09839,Phenylalanine metabolism; Microbial metabolism in diverse environments,1.2.1.91; 2.3.1.223,NA,NA,PubChem: 135626411,cpd:C19945,29,44,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H45O20N7P3S1,C29H43O20N7P3S1,935.157469,936.165294,934.1496441307,1452,cpd:C19946,"3-Oxo-5,6-dehydrosuberyl-CoA semialdehyde",C29H44N7O19P3S,"3-Oxo-5,6-dehydrosuberyl-CoA semialdehyde",R09820 R09836,Phenylalanine metabolism; Microbial metabolism in diverse environments,1.2.1.91; 3.3.2.12,NA,NA,PubChem: 135626412,cpd:C19946,29,44,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H45O19N7P3S1,C29H43O19N7P3S1,919.1625544,920.1703794,918.15472941308,1453,cpd:C19975,2-Oxepin-2(3H)-ylideneacetyl-CoA,C29H42N7O18P3S,2-Oxepin-2(3H)-ylideneacetyl-CoA,R09836 R09837,Phenylalanine metabolism; Microbial metabolism in diverse environments,3.3.2.12; 5.3.3.18,NA,NA,PubChem: 135626441,cpd:C02577; cpd:C05338; cpd:C19975; cpd:C20062; cpd:C21312,29,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H43O18N7P3S1,C29H41O18N7P3S1,901.1519897,902.1598147,900.14416471309,1454,cpd:C20062,"2-(1,2-Epoxy-1,2-dihydrophenyl)acetyl-CoA",C29H42N7O18P3S,"2-(1,2-Epoxy-1,2-dihydrophenyl)acetyl-CoA",R09837 R09838,Phenylalanine metabolism; Microbial metabolism in diverse environments,1.14.13.149; 5.3.3.18,NA,NA,PubChem: 135626528,cpd:C02577; cpd:C05338; cpd:C19975; cpd:C20062; cpd:C21312,29,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H43O18N7P3S1,C29H41O18N7P3S1,901.1519897,902.1598147,900.14416471310,1455,cpd:C00090,Catechol;,C6H6O2,"Catechol; 1,2-Benzenediol; o-Benzenediol; 1,2-Dihydroxybenzene; Brenzcatechin; Pyrocatechol",R00058 R00080 R00812 R00813 R00814 R00815 R00816 R00817; R00818 R00821 R00822 R00823 R00825 R00827 R00828 R01033; R05361 R07700 R07706 R07803 R08106 R08122 R10043,Chlorocyclohexane and chlorobenzene degradation; Benzoate degradation; Fluorobenzoate degradation; Dioxin degradation; Polycyclic aromatic hydrocarbon degradation; Naphthalene degradation; Aminobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.3.14; 1.3.1.19; 1.3.1.20; 1.3.1.25; 1.3.1.-; 1.10.3.1; 1.13.11.1; 1.13.11.2; 1.14.12.1; 1.14.12.13; 1.14.12.23; 1.14.13.1; 1.14.13.7; 1.14.13.31; 1.14.13.-; 1.14.18.1; 1.14.-.-; 2.1.1.6; 3.7.1.8; 4.1.1.46; 4.1.1.63,"Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol; Benzene degradation, benzene => catechol; Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol; Catechol ortho-cleavage, catechol => 3-oxoadipate; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA; Anthranilate degradation, anthranilate => catechol",Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C00090  Catechol,CAS: 120-80-9; PubChem: 3390; ChEBI: 18135; ChEMBL: CHEMBL280998; KNApSAcK: C00002644; PDB-CCD: CAQ; 3DMET: B00023; NIKKAJI: J2.921A,cpd:C00090; cpd:C00530; cpd:C00785; cpd:C01751; cpd:C01785; cpd:C02126; cpd:C02595; cpd:C05571; cpd:C06599; cpd:C07093; cpd:C11115; cpd:C15571; cpd:C16353; cpd:C16357; cpd:C16358; cpd:C19345,6,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O2,C6H5O2,110.0367794,111.0446045,109.02895441311,1456,cpd:C00160,Glycolate;,C2H4O3,Glycolate; Glycolic acid; Hydroxyacetic acid,R00465 R00475 R00476 R00717 R01333 R01334 R01335 R01336; R02336 R02857 R05287,Chlorocyclohexane and chlorobenzene degradation; Chloroalkane and chloroalkene degradation; Glyoxylate and dicarboxylate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism,1.1.1.26; 1.1.1.29; 1.1.1.79; 1.1.3.15; 1.1.99.14; 1.2.1.21; 3.1.3.18; 3.7.1.-; 3.8.1.2; 3.8.1.3; 4.2.99.12,Photorespiration,NA,CAS: 79-14-1; PubChem: 3460; ChEBI: 17497 29805; ChEMBL: CHEMBL252557; LipidBank: DFA0267; KNApSAcK: C00007461; PDB-CCD: GOA; 3DMET: B01175; NIKKAJI: J1.494J,cpd:C00160; cpd:C01010; cpd:C05710,2,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H5O3,C2H3O3,76.01604399,77.02386902,75.008218961312,1457,cpd:C00682,2-Hydroxymuconate semialdehyde;,C6H6O4,2-Hydroxymuconate semialdehyde; 2-Hydroxymuconic semialdehyde; 2-Hydroxymuconate-6-semialdehyde,R00816 R02604 R02762 R02763 R05504,Chlorocyclohexane and chlorobenzene degradation; Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.85; 1.13.11.2; 1.97.1.-; 3.7.1.9; 4.1.1.-,"Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",NA,CAS: 3270-98-2; PubChem: 3951; ChEBI: 17236 67110; 3DMET: B00155,cpd:C00682; cpd:C00850; cpd:C02180; cpd:C02480; cpd:C03586; cpd:C03647; cpd:C03743; cpd:C04105; cpd:C06603; cpd:C07459; cpd:C08042; cpd:C11283; cpd:C12849; cpd:C14516; cpd:C14610; cpd:C20448; cpd:C20900,6,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O4,C6H5O4,142.0266087,143.0344337,141.01878361313,1458,cpd:C01407,Benzene,C6H6,Benzene,R03543 R05536 R10042,Chlorocyclohexane and chlorobenzene degradation; Benzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.3; 1.14.13.-,"Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol; Benzene degradation, benzene => catechol",Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C01407  Benzene,CAS: 71-43-2; PubChem: 4596; ChEBI: 16716; ChEMBL: CHEMBL277500; PDB-CCD: BNZ; 3DMET: B00285; NIKKAJI: J2.375B,cpd:C00090; cpd:C00146; cpd:C00153; cpd:C00417; cpd:C00530; cpd:C00682; cpd:C00785; cpd:C00850; cpd:C01108; cpd:C01407; cpd:C01751; cpd:C01782; cpd:C01785; cpd:C01950; cpd:C01990; cpd:C02126; cpd:C02180; cpd:C02183; cpd:C02222; cpd:C02341; cpd:C02421; cpd:C02480; cpd:C02501; cpd:C02595; cpd:C02752; cpd:C02814; cpd:C03084; cpd:C03277; cpd:C03360; cpd:C03453; cpd:C03586; cpd:C03647; cpd:C03676; cpd:C03743; cpd:C03762; cpd:C04105; cpd:C05379; cpd:C05422; cpd:C05571; cpd:C05649; cpd:C06011; cpd:C06035; cpd:C06336; cpd:C06599; cpd:C06603; cpd:C06674; cpd:C06675; cpd:C06676; cpd:C06988; cpd:C06989; cpd:C07075; cpd:C07093; cpd:C07459; cpd:C08042; cpd:C11010; cpd:C11013; cpd:C11014; cpd:C11101; cpd:C11115; cpd:C11283; cpd:C11352; cpd:C11918; cpd:C12484; cpd:C12849; cpd:C14450; cpd:C14516; cpd:C14610; cpd:C15214; cpd:C15571; cpd:C15584; cpd:C16353; cpd:C16355; cpd:C16357; cpd:C16358; cpd:C16359; cpd:C16614; cpd:C18244; cpd:C18738; cpd:C19268; cpd:C19321; cpd:C19322; cpd:C19323; cpd:C19345; cpd:C19399; cpd:C20448; cpd:C20669; cpd:C20670; cpd:C20718; cpd:C20900; cpd:C20901,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7,C6H5,78.04695019,79.05477523,77.039125161314,1459,cpd:C02124,4-Chlorophenol;,C6H5ClO,4-Chlorophenol; p-Chlorophenol; Parachlorophenol,R05441 R05493,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.11.-; 1.14.13.20,NA,NA,CAS: 106-48-9; PubChem: 5203; ChEBI: 28078; ChEMBL: CHEMBL57053; PDB-CCD: 4CH; 3DMET: B00391; NIKKAJI: J3.611K,cpd:C02124; cpd:C14219; cpd:C14270,6,5,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O1Cl1,C6H4O1Cl1,128.0028925,129.0107175,126.99506741315,1460,cpd:C02222,2-Maleylacetate;,C6H6O5,2-Maleylacetate; 4-Oxohex-2-enedioate; Maleylacetate,R02988 R02989 R03891 R03892 R03893 R05236 R05355 R05420; R06838 R07781 R08120 R08121,Chlorocyclohexane and chlorobenzene degradation; Benzoate degradation; Fluorobenzoate degradation; Aminobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.61; 1.3.1.32; 1.13.11.37; 3.1.1.45; 3.1.1.92,NA,NA,CAS: 24740-88-3; PubChem: 5287; ChEBI: 1184 16468; KNApSAcK: C00013593; 3DMET: B00407; NIKKAJI: J847.097I,cpd:C02222; cpd:C02501; cpd:C03453; cpd:C03676; cpd:C06035; cpd:C06336; cpd:C06674; cpd:C18244; cpd:C20901,6,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O5,C6H5O5,158.0215233,159.0293483,157.01369831316,1461,cpd:C02375,4-Chlorocatechol,C6H5ClO2,4-Chlorocatechol,R04258 R05406 R05441 R07793,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.1; 1.13.11.2; 1.14.13.20; 1.14.-.-,NA,NA,CAS: 2138-22-9; PubChem: 5417; ChEBI: 27772; PDB-CCD: 4CL; 3DMET: B00434; NIKKAJI: J1.798A,cpd:C02375; cpd:C05618; cpd:C06601,6,5,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O2Cl1,C6H4O2Cl1,143.9978071,145.0056321,142.98998211317,1462,cpd:C02575,Pentachlorophenol;,C6HCl5O,Pentachlorophenol; PCP,R03982,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.13.50,NA,Endocrine disrupting compounds [BR:br08006];  Pesticides and herbicides;   Others;    C02575  Pentachlorophenol; Pesticides [BR:br08007];  Pesticides;   Insecticides;    Organochlorine insecticides;     C02575  Pentachlorophenol,CAS: 87-86-5; PubChem: 5570; ChEBI: 17642; ChEMBL: CHEMBL75967; KNApSAcK: C00007496; PDB-CCD: PCI; 3DMET: B00462; NIKKAJI: J3.904G,cpd:C02575,6,1,1,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C6H2O1Cl5,C6H0O1Cl5,263.8470031,264.8548281,262.8391781318,1463,cpd:C02625,"2,4-Dichlorophenol",C6H4Cl2O,"2,4-Dichlorophenol",R03997 R05419 R10487 R10542,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.11.43; 1.14.11.44; 1.14.11.-; 1.14.13.20,NA,"Endocrine disrupting compounds [BR:br08006];  Pesticides and herbicides;   Others;    C02625  2,4-Dichlorophenol",CAS: 120-83-2; PubChem: 5607; ChEBI: 16738; ChEMBL: CHEMBL1143; PDB-CCD: 5JC; NIKKAJI: J2.005B,cpd:C02625; cpd:C06602; cpd:C07096; cpd:C14462,6,4,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H5O1Cl2,C6H3O1Cl2,161.9639201,162.9717451,160.95609511319,1464,cpd:C02814,"Benzene-1,2,4-triol;",C6H6O3,"Benzene-1,2,4-triol; Hydroxyhydroquinone; 1,2,4-Benzenetriol; 1,2,4-Trihydroxybenzene; Hydroxyquinol",R01629 R01630 R03891 R04061 R05249 R05265 R05399 R06851; R06853 R09285 R09287 R11347 R11348,Chlorocyclohexane and chlorobenzene degradation; Benzoate degradation; Aminobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.-.-; 1.6.5.7; 1.13.11.37; 1.13.11.-; 1.14.13.64; 1.14.13.219; 1.14.13.220; 1.14.13.-; 1.14.14.27; 1.14.-.-,NA,NA,CAS: 533-73-3; PubChem: 5764; ChEBI: 16971; KNApSAcK: C00031480; PDB-CCD: HQN; 3DMET: B00506; NIKKAJI: J6.333I,cpd:C01108; cpd:C02183; cpd:C02752; cpd:C02814; cpd:C03277; cpd:C03762; cpd:C06011; cpd:C11101; cpd:C11918; cpd:C16355; cpd:C16359; cpd:C19268; cpd:C19321; cpd:C19322; cpd:C19323; cpd:C20670; cpd:C20718,6,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O3,C6H5O3,126.0316941,127.0395191,125.0238691320,1465,cpd:C02933,"3,5-Dichlorocatechol",C6H4Cl2O2,"3,5-Dichlorocatechol",R03997 R05407,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 1.14.13.20,NA,NA,CAS: 13673-92-2; PubChem: 5854; ChEBI: 15788; PDB-CCD: 35C; NIKKAJI: J81.665E,cpd:C02933; cpd:C06600; cpd:C07094; cpd:C07097; cpd:C11000,6,4,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H5O2Cl2,C6H3O2Cl2,177.9588347,178.9666598,176.95100971321,1466,cpd:C03434,Tetrachlorohydroquinone;,C6H2Cl4O2,"Tetrachlorohydroquinone; 2,3,5,6-Tetrachlorohydroquinone",R03982 R05402 R07191,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.13.50; 2.5.1.-,NA,NA,CAS: 87-87-6; PubChem: 6261; ChEBI: 17042; KNApSAcK: C00007485; 3DMET: B00583; NIKKAJI: J54.019F,cpd:C03434; cpd:C18240,6,2,2,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C6H3O2Cl4,C6H1O2Cl4,245.88089,246.8887151,244.8730651322,1467,cpd:C03572,"2-Chloro-cis,cis-muconate",C6H5ClO4,"2-Chloro-cis,cis-muconate",R06839 R06840,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.13.11.-; 5.5.1.7,NA,NA,PubChem: 6364; ChEBI: 27895; 3DMET: B00602; NIKKAJI: J592.693I,cpd:C03572; cpd:C03585; cpd:C04522; cpd:C07089; cpd:C16266,6,5,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O4Cl1,C6H4O4Cl1,175.9876363,176.9954614,174.97981131323,1468,cpd:C03585,"3-Chloro-cis,cis-muconate;",C6H5ClO4,"3-Chloro-cis,cis-muconate; (2E,4Z)-3-Chlorohexa-2,4-dienedioate",R04258 R04259 R05390 R05391,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.13.11.1; 5.5.1.1; 5.5.1.7,NA,NA,CAS: 22752-96-1; PubChem: 6376; ChEBI: 1472; 3DMET: B00607; NIKKAJI: J2.369.060H,cpd:C03572; cpd:C03585; cpd:C04522; cpd:C07089; cpd:C16266,6,5,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O4Cl1,C6H4O4Cl1,175.9876363,176.9954614,174.97981131324,1469,cpd:C03664,"2,4-Dichlorophenoxyacetate;",C8H6Cl2O3,"2,4-Dichlorophenoxyacetate; 2,4-Dichlorophenoxyacetic acid; 2,4-D",R05419 R05505,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.11.-; 1.97.1.-,NA,"Endocrine disrupting compounds [BR:br08006];  Pesticides and herbicides;   Phenoxy herbicides;    C03664  2,4-Dichlorophenoxyacetate; Pesticides [BR:br08007];  Pesticides;   Herbicides;    Phenoxy herbicides;     C03664  2,4-Dichlorophenoxyacetate",CAS: 94-75-7; PubChem: 6442; ChEBI: 28854; ChEMBL: CHEMBL367623; PDB-CCD: CFA; 3DMET: B00614; NIKKAJI: J3.947K,cpd:C03664; cpd:C18597,8,6,3,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C8H7O3Cl2,C8H5O3Cl2,219.9693994,220.9772244,218.96157441325,1470,cpd:C03918,"2,4-Dichloro-cis,cis-muconate",C6H4Cl2O4,"2,4-Dichloro-cis,cis-muconate",R04345 R05393 R05407,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.13.11.-; 5.5.1.11,NA,NA,CAS: 72945-11-0; PubChem: 6647; ChEBI: 17365; 3DMET: B00652; NIKKAJI: J1.613.603D J1.847.115I,cpd:C03918; cpd:C04625; cpd:C07095,6,4,4,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H5O4Cl2,C6H3O4Cl2,209.948664,210.956489,208.94083891326,1471,cpd:C04091,"cis-1,2-Dihydrobenzene-1,2-diol;",C6H8O2,"cis-1,2-Dihydrobenzene-1,2-diol; cis-Benzeneglycol; cis-Cyclohexa-3,5-diene-1,2-diol",R00812 R03543,Chlorocyclohexane and chlorobenzene degradation; Benzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.19; 1.14.12.3,"Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol",NA,PubChem: 6783; ChEBI: 16190; NIKKAJI: J208.448A,cpd:C01066; cpd:C01078; cpd:C03633; cpd:C03798; cpd:C04091; cpd:C04221; cpd:C05828; cpd:C06105; cpd:C07458; cpd:C08063; cpd:C08502; cpd:C13693; cpd:C14149; cpd:C16182; cpd:C18508; cpd:C20522,6,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O2,C6H7O2,112.0524295,113.0602545,111.04460451327,1472,cpd:C04431,cis-4-Carboxymethylenebut-2-en-4-olide;,C6H4O4,cis-4-Carboxymethylenebut-2-en-4-olide; 4-Carboxymethylenebut-2-en-4-olide,R03893 R04500 R05391,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,3.1.1.45; 5.5.1.7,NA,NA,CAS: 73237-79-3; PubChem: 7062; ChEBI: 18371; 3DMET: B00711; NIKKAJI: J316.362H,cpd:C03178; cpd:C03314; cpd:C03918; cpd:C04431; cpd:C04625; cpd:C07095; cpd:C12838; cpd:C14702; cpd:C19149; cpd:C20449,6,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H5O4,C6H3O4,140.0109586,141.0187836,139.00313361328,1473,cpd:C04522,"2-Chloro-2,5-dihydro-5-oxofuran-2-acetate;",C6H5ClO4,"2-Chloro-2,5-dihydro-5-oxofuran-2-acetate; 5-Chloro-2,5-dihydro-2-oxofuran-5-acetate; 2-Chloro-5-oxo-2,5-dihydrofuran-2-acetate; (2R)-2-Chloro-2,5-dihydro-5-oxofuran-2-acetate; (+)-4-Chloromuconolactone",R04259 R04500,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,5.5.1.7,NA,NA,PubChem: 7134; ChEBI: 17337; 3DMET: B00726; NIKKAJI: J316.368G,cpd:C03572; cpd:C03585; cpd:C04522; cpd:C07089; cpd:C16266,6,5,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O4Cl1,C6H4O4Cl1,175.9876363,176.9954614,174.97981131329,1474,cpd:C04706,"cis-2-Chloro-4-carboxymethylenebut-2-en-1,4-olide;",C6H3ClO4,"cis-2-Chloro-4-carboxymethylenebut-2-en-1,4-olide; cis-2-Chlorodienelactone; cis-4-Carboxymethylene-2-chlorobut-2-en-4-olide",R04576 R05511 R10097,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.1.1.45; 5.2.1.10,NA,NA,CAS: 115793-61-8; PubChem: 7279; ChEBI: 16211; 3DMET: B00743; NIKKAJI: J2.368.889A,cpd:C04706; cpd:C04729; cpd:C14397,6,3,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H4O4Cl1,C6H2O4Cl1,173.9719863,174.9798113,172.96416121330,1475,cpd:C04729,"trans-2-Chloro-4-carboxymethylenebut-2-en-1,4-olide;",C6H3ClO4,"trans-2-Chloro-4-carboxymethylenebut-2-en-1,4-olide; trans-2-Chlorodienelactone",R04576 R05392 R05393,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,5.2.1.10; 5.5.1.7; 5.5.1.11,NA,NA,CAS: 22752-93-8; PubChem: 7300; ChEBI: 16773; 3DMET: B00744; NIKKAJI: J2.368.888C,cpd:C04706; cpd:C04729; cpd:C14397,6,3,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H4O4Cl1,C6H2O4Cl1,173.9719863,174.9798113,172.96416121331,1476,cpd:C05618,3-Chlorocatechol,C6H5ClO2,3-Chlorocatechol,R06839 R06857 R07827,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.19; 1.13.11.39; 1.13.11.-,NA,NA,CAS: 4018-65-9; PubChem: 7936; ChEBI: 27715; PDB-CCD: 3CE; 3DMET: B00810; NIKKAJI: J254.943C,cpd:C02375; cpd:C05618; cpd:C06601,6,5,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O2Cl1,C6H4O2Cl1,143.9978071,145.0056321,142.98998211332,1477,cpd:C06328,"6-Chlorobenzene-1,2,4-triol;",C6H5ClO3,"6-Chlorobenzene-1,2,4-triol; 6-Chlorohydroxyquinol",R05153 R05445,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 8564; ChEBI: 2177; 3DMET: B00935; NIKKAJI: J654.744C,cpd:C06328; cpd:C07102,6,5,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O3Cl1,C6H4O3Cl1,159.9927217,161.0005467,158.98489671333,1478,cpd:C06329,2-Chloromaleylacetate,C6H5ClO5,2-Chloromaleylacetate,R05153 R05355 R05408 R05511,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.32; 1.13.11.-; 3.1.1.45,NA,NA,CAS: 24759-04-4; PubChem: 8565; ChEBI: 28489; KNApSAcK: C00007488; 3DMET: B00936; NIKKAJI: J2.761.960F,cpd:C06329,6,5,5,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O5Cl1,C6H4O5Cl1,191.9825509,192.990376,190.97472591334,1479,cpd:C06594,"1,2,4-Trichlorobenzene;",C6H3Cl3,"1,2,4-Trichlorobenzene; Trichlorobenzene A",R05483 R06831 R06849,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.-,NA,NA,CAS: 120-82-1; PubChem: 8820; ChEBI: 28222; ChEMBL: CHEMBL296348; 3DMET: B00987; NIKKAJI: J2.482A,cpd:C06594; cpd:C07098; cpd:C07099; cpd:C07101; cpd:C12831; cpd:C12833; cpd:C14310; cpd:C14408; cpd:C18243,6,3,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C6H4Cl3,C6H2Cl3,179.9300331,180.9378582,178.92220811335,1480,cpd:C06596,gamma-Pentachlorocyclohexene,C6H5Cl5,gamma-Pentachlorocyclohexene,R05386 R05387,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,4.5.1.-,NA,NA,CAS: 319-94-8; PubChem: 8822; ChEBI: 10576; NIKKAJI: J818.175F,cpd:C06596,6,5,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C6H6Cl5,C6H4Cl5,251.8833886,252.8912136,250.87556351336,1481,cpd:C06597,"1,3,4,6-Tetrachloro-1,4-cyclohexadiene",C6H4Cl4,"1,3,4,6-Tetrachloro-1,4-cyclohexadiene",R05369 R05387 R05483,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.8.1.5; 4.5.1.-,NA,NA,PubChem: 8823; ChEBI: 18904 513; NIKKAJI: J1.263.661J,cpd:C06597; cpd:C18238,6,4,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C6H5Cl4,C6H3Cl4,215.9067109,216.9145359,214.89888581337,1482,cpd:C06598,"2,4,5-Trichloro-2,5-cyclohexadiene-1-ol;",C6H5Cl3O,"2,4,5-Trichloro-2,5-cyclohexadiene-1-ol; 1-Hydroxyl-2,4,5-trichloro-2,5-cyclohexadiene",R05369 R05370 R05484,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,3.8.1.5,NA,NA,PubChem: 8824; ChEBI: 28989; NIKKAJI: J1.263.658J,cpd:C06598,6,5,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C6H6O1Cl3,C6H4O1Cl3,197.9405978,198.9484229,196.93277281338,1483,cpd:C06599,"2,5-Dichloro-2,5-cyclohexadiene-1,4-diol;",C6H6Cl2O2,"2,5-Dichloro-2,5-cyclohexadiene-1,4-diol; 1,4-Dihydroxyl-2,5-dichloro-2,5-cyclohexadiene",R05243 R05370,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.1.-; 3.8.1.5,NA,NA,PubChem: 8825; ChEBI: 28975; NIKKAJI: J1.263.660A,cpd:C06599; cpd:C07093,6,6,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H7O2Cl2,C6H5O2Cl2,179.9744848,180.9823098,178.96665981339,1484,cpd:C06600,"2,5-Dichlorohydroquinone;",C6H4Cl2O2,"2,5-Dichlorohydroquinone; 2,5-Dichloro-1,4-benzenediol",R05243 R05269 R05446 R11092,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.1.-; 1.14.14.-; 2.5.1.-,NA,NA,CAS: 824-69-1; PubChem: 8826; ChEBI: 27545; 3DMET: B00989; NIKKAJI: J134.688A,cpd:C02933; cpd:C06600; cpd:C07094; cpd:C07097; cpd:C11000,6,4,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H5O2Cl2,C6H3O2Cl2,177.9588347,178.9666598,176.95100971340,1485,cpd:C06601,Chlorohydroquinone;,C6H5ClO2,"Chlorohydroquinone; 1,4-Dihydroxyl-2-chlorobenzene; Chloroquinol",R05267 R05269,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,2.5.1.-,NA,NA,CAS: 615-67-8; PubChem: 8827; ChEBI: 27675; 3DMET: B00990; NIKKAJI: J86.748I,cpd:C02375; cpd:C05618; cpd:C06601,6,5,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O2Cl1,C6H4O2Cl1,143.9978071,145.0056321,142.98998211341,1486,cpd:C06602,"2,5-Dichlorophenol;",C6H4Cl2O,"2,5-Dichlorophenol; 2,5-DCP",R05484,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 583-78-8; PubChem: 8828; ChEBI: 27929; ChEMBL: CHEMBL1565192; 3DMET: B00991; NIKKAJI: J1.634I,cpd:C02625; cpd:C06602; cpd:C07096; cpd:C14462,6,4,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H5O1Cl2,C6H3O1Cl2,161.9639201,162.9717451,160.95609511342,1487,cpd:C06603,"cis,cis-4-Hydroxymuconic semialdehyde;",C6H6O4,"cis,cis-4-Hydroxymuconic semialdehyde; 4-Hydroxymuconic semialdehyde",R05236 R05246,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.2.1.61; 1.13.11.66,NA,NA,PubChem: 8829; ChEBI: 18301; 3DMET: B00992; NIKKAJI: J2.762.479K,cpd:C00682; cpd:C00850; cpd:C02180; cpd:C02480; cpd:C03586; cpd:C03647; cpd:C03743; cpd:C04105; cpd:C06603; cpd:C07459; cpd:C08042; cpd:C11283; cpd:C12849; cpd:C14516; cpd:C14610; cpd:C20448; cpd:C20900,6,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O4,C6H5O4,142.0266087,143.0344337,141.01878361343,1488,cpd:C06755,Chloroacetic acid;,C2H3ClO2,Chloroacetic acid; Chloroethanoic acid,R05286 R05287 R06855 R07096,Chlorocyclohexane and chlorobenzene degradation; Chloroalkane and chloroalkene degradation; Metabolism of xenobiotics by cytochrome P450; Metabolic pathways; Microbial metabolism in diverse environments,1.2.1.3; 3.8.1.2; 3.8.1.3,NA,Pesticides [BR:br08007];  Pesticides;   Herbicides;    Others;     C06755  Chloroacetic acid,CAS: 79-11-8; PubChem: 8976; ChEBI: 27869; ChEMBL: CHEMBL14090; LIPIDMAPS: LMFA01090068; PDB-CCD: R3W; NIKKAJI: J2.409K,cpd:C06755,2,3,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C2H4O2Cl1,C2H2O2Cl1,93.98215702,94.98998205,92.974331991344,1489,cpd:C06988,"beta-1,2,3,4,5,6-Hexachlorocyclohexane;",C6H6Cl6,"beta-1,2,3,4,5,6-Hexachlorocyclohexane; beta-Hexachlorocyclohexane; beta-BHC; beta-Lindane",R05533 R07669,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,3.8.1.5,NA,Animal drugs in Japan [BR:br08331];  99  Agents for not mainly purpose of therapeutic;   993  Insecticides and insect-repellents;    9939  Other insecticides and insect repellents;     C06988  beta-Hexachlorocyclohexane,CAS: 319-85-7; PubChem: 9201; ChEBI: 28428; ChEMBL: CHEMBL1526071 CHEMBL389022; NIKKAJI: J5.146B,cpd:C06988; cpd:C07075; cpd:C15214; cpd:C18738,6,6,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C6H7Cl6,C6H5Cl6,287.8600663,288.8678913,286.85224131345,1490,cpd:C06989,"delta-3,4,5,6-Tetrachlorocyclohexene;",C6H6Cl4,"delta-3,4,5,6-Tetrachlorocyclohexene; 3,4,5,6-Tetrachlorocyclohexene",R05533 R05534,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 9202; ChEBI: 28988; NIKKAJI: J721.960A,cpd:C06989,6,6,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C6H7Cl4,C6H5Cl4,217.9223609,218.930186,216.91453591346,1491,cpd:C06990,Chlorobenzene;,C6H5Cl,Chlorobenzene; Monochlorobenzene; Benzene chloride; Phenyl chloride,R05535 R06850 R06856,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.-,NA,NA,CAS: 108-90-7; PubChem: 9203; ChEBI: 28097; ChEMBL: CHEMBL16200; PDB-CCD: 8CL; NIKKAJI: J2.869J,cpd:C02124; cpd:C02375; cpd:C03572; cpd:C03585; cpd:C04522; cpd:C05618; cpd:C06328; cpd:C06329; cpd:C06601; cpd:C06990; cpd:C07089; cpd:C07102; cpd:C14219; cpd:C14270; cpd:C16266,6,5,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6Cl1,C6H4Cl1,112.0079778,113.0158029,111.00015281347,1492,cpd:C07075,Lindane;,C6H6Cl6,"Lindane; gamma-Hexachlorocyclohexane; 1,2,3,4,5,6-Hexachlorocyclohexane; Benzene hexachloride; gamma-BHC",R05386,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,4.5.1.-,NA,"Pesticides [BR:br08007];  Pesticides;   Insecticides;    Organochlorine insecticides;     C07075  Lindane; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS;   P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS;    P03A ECTOPARASITICIDES, INCL. SCABICIDES;     P03AB Chlorine containing products;      P03AB02 Lindane;       D00360  Lindane (USP/INN); USP drug classification [BR:br08302];  Antiparasitics;   Pediculicides/Scabicides;    Lindane;     D00360  Lindane (USP/INN)",CAS: 58-89-9; PubChem: 9286; ChEBI: 32888; ChEMBL: CHEMBL1526071 CHEMBL15891; NIKKAJI: J5.144F,cpd:C06988; cpd:C07075; cpd:C15214; cpd:C18738,6,6,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C6H7Cl6,C6H5Cl6,287.8600663,288.8678913,286.85224131348,1493,cpd:C07088,4-Chlorophenoxyacetate;,C8H7ClO3,4-Chlorophenoxyacetate; 4-CPA,R05493 R05505,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.11.-; 1.97.1.-,NA,Pesticides [BR:br08007];  Pesticides;   Plant growth regulators;    Auxins;     C07088  4-Chlorophenoxyacetate,CAS: 122-88-3; PubChem: 9299; ChEBI: 1808; ChEMBL: CHEMBL178018; NIKKAJI: J2.495C,cpd:C07088,8,7,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C8H8O3Cl1,C8H6O3Cl1,186.0083718,187.0161968,185.00054671349,1494,cpd:C07089,5-Chloro-2-hydroxymuconic semialdehyde,C6H5ClO4,5-Chloro-2-hydroxymuconic semialdehyde,R05406 R05504,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.13.11.2; 1.97.1.-,NA,NA,PubChem: 9300; ChEBI: 28642; 3DMET: B01061; NIKKAJI: J892.026E,cpd:C03572; cpd:C03585; cpd:C04522; cpd:C07089; cpd:C16266,6,5,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O4Cl1,C6H4O4Cl1,175.9876363,176.9954614,174.97981131350,1495,cpd:C07090,Protoanemonin;,C5H4O2,Protoanemonin; 4-Methylenebut-2-en-4-olide; cis-4-Methylenebut-2-en-4-olide,R05390 R05510,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,3.1.1.45; 5.5.1.1,NA,Phytochemical compounds [BR:br08003];  Others;   Others;    Others;     C07090  Protoanemonin; Natural toxins [BR:br08009];  Phytotoxins;   Others;    Others;     C07090  Protoanemonin,CAS: 108-28-1; PubChem: 9301; ChEBI: 28906; KNApSAcK: C00000301; 3DMET: B01062; NIKKAJI: J10.112E,cpd:C00385; cpd:C07090; cpd:C07599; cpd:C14279; cpd:C16613; cpd:C19915,5,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H5O2,C5H3O2,96.02112937,97.0289544,95.013304341351,1496,cpd:C07091,cis-Acetylacrylate,C5H6O3,cis-Acetylacrylate,R05510,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,3.1.1.45,NA,NA,PubChem: 9302; ChEBI: 28993; 3DMET: B01063; NIKKAJI: J1.481.171K,cpd:C00596; cpd:C02144; cpd:C03088; cpd:C05133; cpd:C05281; cpd:C05515; cpd:C07091; cpd:C18049; cpd:C21187,5,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O3,C5H5O3,114.0316941,115.0395191,113.0238691352,1497,cpd:C07092,"1,4-Dichlorobenzene;",C6H4Cl2,"1,4-Dichlorobenzene; p-Dichlorobenzene",R05429 R06849 R06850,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.-,NA,"Pesticides [BR:br08007];  Pesticides;   Others;    Fumigant;     C07092  1,4-Dichlorobenzene; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C07092  1,4-Dichlorobenzene",CAS: 106-46-7; PubChem: 9303; ChEBI: 28618; ChEMBL: CHEMBL190982; NIKKAJI: J4.033I,cpd:C02625; cpd:C02933; cpd:C03918; cpd:C04625; cpd:C06600; cpd:C06602; cpd:C07092; cpd:C07094; cpd:C07095; cpd:C07096; cpd:C07097; cpd:C11000; cpd:C12835; cpd:C14328; cpd:C14462; cpd:C19397,6,4,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H5Cl2,C6H3Cl2,145.9690055,146.9768305,144.96118051353,1498,cpd:C07093,"3,6-Dichloro-cis-1,2-dihydroxycyclohexa-3,5-diene",C6H6Cl2O2,"3,6-Dichloro-cis-1,2-dihydroxycyclohexa-3,5-diene",R05397 R05429,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.14.12.-,NA,NA,PubChem: 9304; ChEBI: 28957; NIKKAJI: J619.696I,cpd:C06599; cpd:C07093,6,6,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H7O2Cl2,C6H5O2Cl2,179.9744848,180.9823098,178.96665981354,1499,cpd:C07094,"3,6-Dichlorocatechol",C6H4Cl2O2,"3,6-Dichlorocatechol",R05397 R05409,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.13.11.-,NA,NA,CAS: 3938-16-7; PubChem: 9305; ChEBI: 28318; NIKKAJI: J79.882G,cpd:C02933; cpd:C06600; cpd:C07094; cpd:C07097; cpd:C11000,6,4,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H5O2Cl2,C6H3O2Cl2,177.9588347,178.9666598,176.95100971355,1500,cpd:C07095,"2,5-Dichloro-cis,cis-muconate",C6H4Cl2O4,"2,5-Dichloro-cis,cis-muconate",R05392 R05409,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.13.11.-; 5.5.1.7,NA,NA,PubChem: 9306; ChEBI: 28558; 3DMET: B01064; NIKKAJI: J2.376.689B,cpd:C03918; cpd:C04625; cpd:C07095,6,4,4,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H5O4Cl2,C6H3O4Cl2,209.948664,210.956489,208.94083891356,1501,cpd:C07096,"2,6-Dichlorophenol",C6H4Cl2O,"2,6-Dichlorophenol",R05448,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.-,NA,NA,CAS: 87-65-0; PubChem: 9307; ChEBI: 28457; ChEMBL: CHEMBL282597; NIKKAJI: J3.540H,cpd:C02625; cpd:C06602; cpd:C07096; cpd:C14462,6,4,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H5O1Cl2,C6H3O1Cl2,161.9639201,162.9717451,160.95609511357,1502,cpd:C07097,"2,6-Dichlorohydroquinone",C6H4Cl2O2,"2,6-Dichlorohydroquinone",R05403 R05408 R05445 R05448 R11091,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 1.14.13.-; 2.5.1.-,NA,NA,CAS: 20103-10-0; PubChem: 9308; ChEBI: 27633; KNApSAcK: C00007487; 3DMET: B01065; NIKKAJI: J82.929C,cpd:C02933; cpd:C06600; cpd:C07094; cpd:C07097; cpd:C11000,6,4,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H5O2Cl2,C6H3O2Cl2,177.9588347,178.9666598,176.95100971358,1503,cpd:C07098,"2,4,6-Trichlorophenol",C6H3Cl3O,"2,4,6-Trichlorophenol",R05449 R05754,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.14.14.-; 2.1.1.136,NA,NA,CAS: 88-06-2; PubChem: 9309; ChEBI: 28755; ChEMBL: CHEMBL309917; PDB-CCD: T6C; 3DMET: B01066; NIKKAJI: J3.543B,cpd:C07098; cpd:C07101,6,3,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C6H4O1Cl3,C6H2O1Cl3,195.9249478,196.9327728,194.91712271359,1504,cpd:C07099,"2,3,6-Trichlorohydroquinone",C6H3Cl3O2,"2,3,6-Trichlorohydroquinone",R05402 R05403,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,2.5.1.-,NA,NA,CAS: 608-94-6; PubChem: 9310; ChEBI: 28263; KNApSAcK: C00007486; NIKKAJI: J134.552D,cpd:C07099; cpd:C12831; cpd:C14310,6,3,2,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C6H4O2Cl3,C6H2O2Cl3,211.9198624,212.9276874,210.91203731360,1505,cpd:C07100,"2,4,5-Trichlorophenoxyacetic acid;",C8H5Cl3O3,"2,4,5-Trichlorophenoxyacetic acid; 2,4,5-T",R05418,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.13.-,NA,"Endocrine disrupting compounds [BR:br08006];  Pesticides and herbicides;   Phenoxy herbicides;    C07100  2,4,5-Trichlorophenoxyacetic acid; Pesticides [BR:br08007];  Obsolete pesticides;   Plant growth regulators;    Auxins;     C07100  2,4,5-Trichlorophenoxyacetic acid",CAS: 93-76-5; PubChem: 9311; ChEBI: 27903; ChEMBL: CHEMBL194458; 3DMET: B01067; NIKKAJI: J3.941A,cpd:C07100; cpd:C19057,8,5,3,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C8H6O3Cl3,C8H4O3Cl3,253.9304271,254.9382521,252.9226021361,1506,cpd:C07101,"2,4,5-Trichlorophenol",C6H3Cl3O,"2,4,5-Trichlorophenol",R05418 R05447,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.13.-; 1.14.14.-,NA,NA,CAS: 95-95-4; PubChem: 9312; ChEBI: 28520; ChEMBL: CHEMBL109095; PDB-CCD: TC7; 3DMET: B01068; NIKKAJI: J3.574B,cpd:C07098; cpd:C07101,6,3,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C6H4O1Cl3,C6H2O1Cl3,195.9249478,196.9327728,194.91712271362,1507,cpd:C07102,"5-Chloro-1,2,4-trihydroxybenzene",C6H5ClO3,"5-Chloro-1,2,4-trihydroxybenzene",R05388 R11093,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,4.5.1.-,NA,NA,CAS: 119290-91-4; PubChem: 9313; ChEBI: 27954; 3DMET: B01069; NIKKAJI: J725.522E,cpd:C06328; cpd:C07102,6,5,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O3Cl1,C6H4O3Cl1,159.9927217,161.0005467,158.98489671363,1508,cpd:C07103,"2-Hydroxy-1,4-benzoquinone;",C6H4O3,"2-Hydroxy-1,4-benzoquinone; Hydroxybenzoquinone",R05388 R05399 R06853 R06854,Chlorocyclohexane and chlorobenzene degradation; Aminobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.-.-; 1.6.5.7; 4.5.1.-,NA,NA,CAS: 2474-72-8; PubChem: 9314; ChEBI: 18400; 3DMET: B01070; NIKKAJI: J546.100F,cpd:C07103; cpd:C19189; cpd:C20899,6,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H5O3,C6H3O3,124.016044,125.023869,123.0082191364,1509,cpd:C11352,"5,6-Dichloro-1,3-cyclohexadiene",C6H6Cl2,"5,6-Dichloro-1,3-cyclohexadiene",R05534 R05535 R05536,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 13527; ChEBI: 1997; NIKKAJI: J1.998.183E,cpd:C06599; cpd:C07093; cpd:C07459; cpd:C11352; cpd:C18244; cpd:C19399,6,6,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H7Cl2,C6H5Cl2,147.9846556,148.9924806,146.97683051365,1510,cpd:C12831,"3,4,6-Trichlorocatechol",C6H3Cl3O2,"3,4,6-Trichlorocatechol",R06832 R06833,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.13.11.-,NA,NA,CAS: 32139-72-3; PubChem: 583220; ChEBI: 32971; NIKKAJI: J569.887A,cpd:C07099; cpd:C12831; cpd:C14310,6,3,2,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C6H4O2Cl3,C6H2O2Cl3,211.9198624,212.9276874,210.91203731366,1511,cpd:C12832,"3,4,6-Trichloro-cis-1,2-dihydroxycyclohexa-3,5-diene",C6H5Cl3O2,"3,4,6-Trichloro-cis-1,2-dihydroxycyclohexa-3,5-diene",R06831 R06832,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.14.12.-,NA,NA,PubChem: 583221; ChEBI: 19869; NIKKAJI: J2.783.847B,cpd:C12832,6,5,2,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C6H6O2Cl3,C6H4O2Cl3,213.9355124,214.9433375,212.92768741367,1512,cpd:C12833,"2,3,5-Trichloro-cis,cis-muconate",C6H3Cl3O4,"2,3,5-Trichloro-cis,cis-muconate",R06833 R06834,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.13.11.-; 5.5.1.7,NA,NA,PubChem: 583222; ChEBI: 19298 31069; NIKKAJI: J2.783.856A,cpd:C12833,6,3,4,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C6H4O4Cl3,C6H2O4Cl3,243.9096916,244.9175167,242.90186661368,1513,cpd:C12834,"2,5-Dichloro-carboxymethylenebut-2-en-4-olide",C6H2Cl2O4,"2,5-Dichloro-carboxymethylenebut-2-en-4-olide",R06834 R06835,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.1.1.45; 5.5.1.7,NA,NA,PubChem: 583223; ChEBI: 31075; NIKKAJI: J2.783.858H,cpd:C12834,6,2,4,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H3O4Cl2,C6H1O4Cl2,207.9330139,208.9408389,206.92518891369,1514,cpd:C12835,"2,5-Dichloro-4-oxohex-2-enedioate",C6H4Cl2O5,"2,5-Dichloro-4-oxohex-2-enedioate",R06835 R06848,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.1.32; 3.1.1.45,NA,NA,PubChem: 583224; ChEBI: 19373 31074; NIKKAJI: J2.783.869C,cpd:C12835,6,4,5,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H5O5Cl2,C6H3O5Cl2,225.9435786,226.9514036,224.93575361370,1515,cpd:C12836,2-Chloro-3-oxoadipate,C6H7ClO5,2-Chloro-3-oxoadipate,R06848 R06855,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.1.32,NA,NA,PubChem: 583225; ChEBI: 19500; NIKKAJI: J2.783.870G,cpd:C12836,6,7,5,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H8O5Cl1,C6H6O5Cl1,193.998201,195.006026,192.9903761371,1516,cpd:C12837,"3-Chloro-cis-1,2-dihydroxycyclohexa-3,5-diene",C6H7ClO2,"3-Chloro-cis-1,2-dihydroxycyclohexa-3,5-diene",R06856 R06857,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.19; 1.14.12.-,NA,NA,PubChem: 583226; ChEBI: 19981; NIKKAJI: J593.973I,cpd:C12837,6,7,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H8O2Cl1,C6H6O2Cl1,146.0134571,147.0212822,145.00563211372,1517,cpd:C12838,trans-4-Carboxymethylenebut-2-en-4-olide,C6H4O4,trans-4-Carboxymethylenebut-2-en-4-olide,R06838 R06840,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,3.1.1.45; 5.5.1.7,NA,NA,PubChem: 583227; ChEBI: 38107; NIKKAJI: J316.363F,cpd:C03178; cpd:C03314; cpd:C03918; cpd:C04431; cpd:C04625; cpd:C07095; cpd:C12838; cpd:C14702; cpd:C19149; cpd:C20449,6,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H5O4,C6H3O4,140.0109586,141.0187836,139.00313361373,1518,cpd:C14419,"2,4-Dichloroaniline;",C6H5Cl2N,"2,4-Dichloroaniline; 2,4-DCA",R07794,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.97.1.-,NA,NA,CAS: 554-00-7; PubChem: 17395419; ChEBI: 46635; ChEMBL: CHEMBL1528820; NIKKAJI: J1.616K,cpd:C02791; cpd:C14419; cpd:C14712,6,5,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H6N1Cl2,C6H4N1Cl2,160.9799045,161.9877296,159.97207951374,1519,cpd:C14450,4-Chloroaniline;,C6H6ClN,4-Chloroaniline; 1-Amino-4-chlorobenzene,R07793 R07794,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.14.-.-; 1.97.1.-,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C14450  4-Chloroaniline,CAS: 106-47-8; PubChem: 17395450; ChEBI: 20331; ChEMBL: CHEMBL15888; NIKKAJI: J4.034G,cpd:C14450; cpd:C20669; cpd:C20670,6,6,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H7N1Cl1,C6H5N1Cl1,127.0188769,128.0267019,126.01105181375,1520,cpd:C16181,"beta-2,3,4,5,6-Pentachlorocyclohexanol",C6H7Cl5O,"beta-2,3,4,5,6-Pentachlorocyclohexanol",R07669 R07670,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,3.8.1.5,NA,NA,PubChem: 47205490; ChEBI: 80364; NIKKAJI: J2.410.475C,cpd:C16181,6,7,1,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C6H8O1Cl5,C6H6O1Cl5,269.8939533,270.9017783,268.88612821376,1521,cpd:C16182,"beta-2,3,5,6-Tetrachloro-1,4-cyclohexanediol",C6H8Cl4O2,"beta-2,3,5,6-Tetrachloro-1,4-cyclohexanediol",R07670,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,3.8.1.5,NA,NA,PubChem: 47205491; ChEBI: 80365; NIKKAJI: J2.410.474E,cpd:C16182,6,8,2,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C6H9O2Cl4,C6H7O2Cl4,251.9278402,252.9356653,250.92001521377,1522,cpd:C16266,3-Chloro-2-hydroxymuconic semialdehyde,C6H5ClO4,3-Chloro-2-hydroxymuconic semialdehyde,R07827,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.13.11.39,NA,NA,PubChem: 47205574; ChEBI: 80409; NIKKAJI: J2.799.287K,cpd:C03572; cpd:C03585; cpd:C04522; cpd:C07089; cpd:C16266,6,5,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H6O4Cl1,C6H4O4Cl1,175.9876363,176.9954614,174.97981131378,1523,cpd:C18236,"1,2,3,4-Tetrachlorobenzene",C6H2Cl4,"1,2,3,4-Tetrachlorobenzene",R09130 R09131,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.-,NA,NA,CAS: 634-66-2; PubChem: 103061418; ChEBI: 18855; ChEMBL: CHEMBL46422,cpd:C03434; cpd:C15505; cpd:C18236; cpd:C18240; cpd:C18241,6,2,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C6H3Cl4,C6H1Cl4,213.8910608,214.8988858,212.88323581379,1524,cpd:C18238,cis-Chlorobenzene dihydrodiol,C6H4Cl4O2,cis-Chlorobenzene dihydrodiol,R09130 R09131 R09132 R09133,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.14.12.-,NA,NA,PubChem: 103061420; ChEBI: 23310,cpd:C18238,6,4,2,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C6H5O2Cl4,C6H3O2Cl4,247.8965401,248.9043651,246.88871511380,1525,cpd:C18240,Tetrachlorocatechol;,C6H2Cl4O2,"Tetrachlorocatechol; Tetrachloro-1,2-benzenediol",R09132 R09133 R09134,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.13.11.1,NA,NA,CAS: 1198-55-6; PubChem: 103061422; ChEBI: 26889; KNApSAcK: C00016089,cpd:C03434; cpd:C18240,6,2,2,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C6H3O2Cl4,C6H1O2Cl4,245.88089,246.8887151,244.8730651381,1526,cpd:C18241,"Tetrachloro-cis,cis-muconate",C6H2Cl4O4,"Tetrachloro-cis,cis-muconate",R09134 R09135,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.13.11.1; 5.5.1.7,NA,NA,PubChem: 103061423; ChEBI: 26887,cpd:C18241,6,2,4,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C6H3O4Cl4,C6H1O4Cl4,277.8707193,278.8785443,276.86289421382,1527,cpd:C18242,"2,3,5-Trichlorodienelactone",C6HCl3O4,"2,3,5-Trichlorodienelactone",R09135 R09136,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,3.1.1.45; 5.5.1.7,NA,NA,PubChem: 103061424; ChEBI: 19296,cpd:C18242,6,1,4,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C6H2O4Cl3,C6H0O4Cl3,241.8940416,242.9018666,240.88621651383,1528,cpd:C18243,"2,3,5-Trichloromaleylacetate",C6H3Cl3O5,"2,3,5-Trichloromaleylacetate",R09136 R09137 R09138,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.3.1.32; 3.1.1.45,NA,NA,PubChem: 103061425; ChEBI: 19297,cpd:C18243,6,3,5,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C6H4O5Cl3,C6H2O5Cl3,259.9046062,260.9124313,258.89678121384,1529,cpd:C18244,"2,4-Dichloro-3-oxoadipate",C6H6Cl2O5,"2,4-Dichloro-3-oxoadipate",R09137 R09138 R09139,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.3.1.32,NA,NA,PubChem: 103061426; ChEBI: 19345,cpd:C18244,6,6,5,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H7O5Cl2,C6H5O5Cl2,227.9592287,228.9670537,226.95140361385,1530,cpd:C21103,"2,6-Dichloro-p-benzoquinone;",C6H2Cl2O2,"2,6-Dichloro-p-benzoquinone; 2,6-Dichloro-1,4-benzoquinone",R05449 R11091,Chlorocyclohexane and chlorobenzene degradation; Microbial metabolism in diverse environments,1.14.14.-,NA,NA,CAS: 697-91-6; PubChem: 312642072,cpd:C21103; cpd:C21104,6,2,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H3O2Cl2,C6H1O2Cl2,175.9431847,176.9510097,174.93535961386,1531,cpd:C21104,"2,5-Dichloro-p-benzoquinone;",C6H2Cl2O2,"2,5-Dichloro-p-benzoquinone; 2,5-Dichloro-1,4-benzoquinone",R05447 R11092,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.14.-,NA,NA,CAS: 615-93-0; PubChem: 312642073,cpd:C21103; cpd:C21104,6,2,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C6H3O2Cl2,C6H1O2Cl2,175.9431847,176.9510097,174.93535961387,1532,cpd:C21105,5-Chloro-2-hydroxy-p-benzoquinone,C6H3ClO3,5-Chloro-2-hydroxy-p-benzoquinone,R05446 R11093,Chlorocyclohexane and chlorobenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.14.-,NA,NA,PubChem: 312642074,cpd:C21105,6,3,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H4O3Cl1,C6H2O3Cl1,157.9770716,158.9848967,156.96924661388,1533,cpd:C00196,"2,3-Dihydroxybenzoate;",C7H6O4,"2,3-Dihydroxybenzoate; 2,3-Dihydroxybenzoic acid",R00821 R00980 R01504 R01505 R01506 R01507 R01508 R07644,Benzoate degradation; Aminobenzoate degradation; Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics,1.3.1.28; 1.13.11.14; 1.13.11.28; 1.14.13.35; 1.14.99.23; 2.7.7.58; 4.1.1.46; 6.3.2.14,NA,NA,CAS: 303-38-8; PubChem: 3496; ChEBI: 18026 36654; ChEMBL: CHEMBL1432; KNApSAcK: C00002669; PDB-CCD: DBH; 3DMET: B00056; NIKKAJI: J79.590I,cpd:C00196; cpd:C00230; cpd:C00628; cpd:C06679; cpd:C07461; cpd:C11006; cpd:C11008; cpd:C14306; cpd:C16748; cpd:C18303; cpd:C18308; cpd:C19410; cpd:C19788; cpd:C21298,7,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O4,C7H5O4,154.0266087,155.0344337,153.01878361389,1534,cpd:C00230,"3,4-Dihydroxybenzoate;",C7H6O4,"3,4-Dihydroxybenzoate; 3,4-Dihydroxybenzoic acid; Protocatechuate; Protocatechuic acid",R00822 R01296 R01298 R01627 R01628 R01629 R01630 R01631; R01632 R01633 R01634 R01635 R01636 R01637 R05274 R05280; R07668 R10136 R11197 R11198,"Benzoate degradation; Phenylalanine, tyrosine and tryptophan biosynthesis; Toluene degradation; Polycyclic aromatic hydrocarbon degradation; Aminobenzoate degradation; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Degradation of aromatic compounds",1.3.1.53; 1.13.11.3; 1.13.11.8; 1.13.11.-; 1.14.12.8; 1.14.12.-; 1.14.13.2; 1.14.13.23; 1.14.13.33; 1.14.13.64; 1.14.13.82; 1.14.13.-; 2.1.1.-; 4.1.1.55; 4.1.1.63; 4.1.1.69; 4.2.1.118,"Phthalate degradation, phthalate => protocatechuate; Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate; Phthalate degradation, phthalate => protocatechuate",NA,CAS: 99-50-3; PubChem: 3529; ChEBI: 36062 36241; ChEMBL: CHEMBL37537; KNApSAcK: C00002668; PDB-CCD: DHB; 3DMET: B00064; NIKKAJI: J11.618A,cpd:C00196; cpd:C00230; cpd:C00628; cpd:C06679; cpd:C07461; cpd:C11006; cpd:C11008; cpd:C14306; cpd:C16748; cpd:C18303; cpd:C18308; cpd:C19410; cpd:C19788; cpd:C21298,7,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O4,C7H5O4,154.0266087,155.0344337,153.01878361390,1535,cpd:C00587,3-Hydroxybenzoate;,C7H6O3,3-Hydroxybenzoate; 3-Hydroxybenzoic acid; m-Hydroxybenzoic acid,R01427 R01508 R01628 R02589 R05375 R07666 R07667 R09589; R10597,"Benzoate degradation; Phenylalanine, tyrosine and tryptophan biosynthesis; Toluene degradation; Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds",1.2.1.7; 1.2.1.28; 1.2.1.64; 1.14.13.23; 1.14.13.24; 1.14.99.23; 4.1.1.55; 4.1.3.45; 6.2.1.37,NA,NA,CAS: 99-06-9; PubChem: 3866; ChEBI: 16193 30764; ChEMBL: CHEMBL65369; KNApSAcK: C00040822 C00048480; PDB-CCD: 3HB; 3DMET: B00140; NIKKAJI: J43.202D,cpd:C00156; cpd:C00587; cpd:C00805; cpd:C05585; cpd:C08055; cpd:C10832; cpd:C12114; cpd:C14015; cpd:C16700; cpd:C17098; cpd:C18316; cpd:C20248,7,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O3,C7H5O3,138.0316941,139.0395191,137.0238691391,1536,cpd:C00846,3-Oxoadipate;,C6H8O5,3-Oxoadipate; 3-Oxoadipic acid; 3-Keto-adipate,R02988 R02989 R02990 R02991,Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.32; 2.8.3.6; 3.1.1.24,"Catechol ortho-cleavage, catechol => 3-oxoadipate",NA,CAS: 689-31-6; PubChem: 4103; ChEBI: 15775 37440; LIPIDMAPS: LMFA01170096; 3DMET: B00187; NIKKAJI: J309.041H,cpd:C00322; cpd:C00846; cpd:C04287; cpd:C04305; cpd:C04361; cpd:C06379; cpd:C06891; cpd:C16159; cpd:C19128; cpd:C20781,6,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O5,C6H7O5,160.0371734,161.0449984,159.02934831392,1537,cpd:C01063,6-Carboxyhexanoyl-CoA;,C28H46N7O19P3S,6-Carboxyhexanoyl-CoA; Pimeloyl-CoA,R03209 R03210 R05311 R05592,Benzoate degradation; Biotin metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.62; 2.3.1.47; 3.1.2.-; 6.2.1.14,"Biotin biosynthesis, pimeloyl-ACP/CoA => biotin; Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA; Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin",NA,PubChem: 4302; ChEBI: 15504; 3DMET: B04761; NIKKAJI: J1.074.430J,cpd:C01063; cpd:C09824,28,46,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O19N7P3S1,C28H45O19N7P3S1,909.1782045,910.1860295,908.17037941393,1538,cpd:C01163,"3-Carboxy-cis,cis-muconate;",C7H6O6,"3-Carboxy-cis,cis-muconate; beta-Carboxy-cis,cis-muconate; cis,cis-Butadiene-1,2,4-tricarboxylate",R01631 R03307 R03308,Benzoate degradation; Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.3; 5.5.1.2; 5.5.1.5,NA,NA,CAS: 1116-26-3; PubChem: 4390; ChEBI: 15749; KNApSAcK: C00007499; 3DMET: B00251; NIKKAJI: J1.000.749F,cpd:C01163; cpd:C01278; cpd:C02167; cpd:C02514; cpd:C03666; cpd:C04480; cpd:C04484; cpd:C04553; cpd:C05375; cpd:C16199; cpd:C17101,7,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O6,C7H5O6,186.0164379,187.0242629,185.00861291394,1539,cpd:C01278,"2-Carboxy-2,5-dihydro-5-oxofuran-2-acetate;",C7H6O6,"2-Carboxy-2,5-dihydro-5-oxofuran-2-acetate; 5-Carboxy-2,5-dihydro-2-oxofuran-5-acetate; 4-Carboxymuconolactone; gamma-Carboxymuconolactone",R03307 R03470,Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,4.1.1.44; 5.5.1.2,NA,NA,PubChem: 4497; ChEBI: 16993; NIKKAJI: J1.705.604B,cpd:C01163; cpd:C01278; cpd:C02167; cpd:C02514; cpd:C03666; cpd:C04480; cpd:C04484; cpd:C04553; cpd:C05375; cpd:C16199; cpd:C17101,7,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O6,C7H5O6,186.0164379,187.0242629,185.00861291395,1540,cpd:C01751,Resorcinol;,C6H6O2,"Resorcinol; Resorcin; 1,3-Benzenediol; 1,3-Dihydroxybenzene; m-Hydroquinone",R05249 R05250 R11347 R11348 R11353,Benzoate degradation; Microbial metabolism in diverse environments,1.14.13.219; 1.14.13.220; 1.14.14.27; 4.1.1.103,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C01751  Resorcinol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D10 ANTI-ACNE PREPARATIONS;    D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE;     D10AX Other anti-acne preparations for topical use;      D10AX02 Resorcinol;       D00133  Resorcinol (USP);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AX Other antiinfectives;      S01AX06 Resorcinol;       D00133  Resorcinol (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    261  Antimicrobial agents;     2619  Others;      D00133  Resorcinol (USP); Resorcin (JAN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Resorcin;     D00133  Resorcinol (USP); Dermatological agents [br08370.html];  Non-steroidal topical agent;   D00133,CAS: 108-46-3; PubChem: 4884; ChEBI: 27810; ChEMBL: CHEMBL24147; KNApSAcK: C00002671; PDB-CCD: RCO; 3DMET: B00342; NIKKAJI: J2.863K,cpd:C00090; cpd:C00530; cpd:C00785; cpd:C01751; cpd:C01785; cpd:C02126; cpd:C02595; cpd:C05571; cpd:C06599; cpd:C07093; cpd:C11115; cpd:C15571; cpd:C16353; cpd:C16357; cpd:C16358; cpd:C19345,6,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O2,C6H5O2,110.0367794,111.0446045,109.02895441396,1541,cpd:C02411,Glutaconyl-1-CoA;,C26H40N7O19P3S,Glutaconyl-1-CoA; 4-Carboxybut-2-enoyl-CoA; Glutaconyl-CoA; (E)-Glutaconyl-CoA; (2E)-4-Carboxybut-2-enoyl-CoA,R03028 R03884 R03937 R05579 R10074,Benzoate degradation; Butanoate metabolism; Microbial metabolism in diverse environments,1.3.8.6; 1.3.99.32; 2.8.3.12; 4.1.1.70; 4.2.1.-,NA,NA,PubChem: 5444; ChEBI: 15497; 3DMET: B04850; NIKKAJI: J1.127.262B,cpd:C00531; cpd:C02411; cpd:C06028; cpd:C18323,26,40,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H41O19N7P3S1,C26H39O19N7P3S1,879.1312543,880.1390793,878.12342921397,1542,cpd:C02480,"cis,cis-Muconate;",C6H6O4,"cis,cis-Muconate; cis,cis-Hexadienedioate; cis,cis-2,4-Hexadienedioic acid",R00817 R03959 R06989,Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.1; 5.5.1.1,"Catechol ortho-cleavage, catechol => 3-oxoadipate",NA,CAS: 505-70-4; PubChem: 5495; ChEBI: 16508; LIPIDMAPS: LMFA01170077; KNApSAcK: C00007490; PDB-CCD: CCU; 3DMET: B00448; NIKKAJI: J73.682A,cpd:C00682; cpd:C00850; cpd:C02180; cpd:C02480; cpd:C03586; cpd:C03647; cpd:C03743; cpd:C04105; cpd:C06603; cpd:C07459; cpd:C08042; cpd:C11283; cpd:C12849; cpd:C14516; cpd:C14610; cpd:C20448; cpd:C20900,6,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O4,C6H5O4,142.0266087,143.0344337,141.01878361398,1543,cpd:C02501,2-Hydroxymuconate,C6H6O5,2-Hydroxymuconate,R02762 R03966 R05361 R07795 R11532,Benzoate degradation; Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.85; 1.13.11.2; 3.5.1.120; 3.7.1.8; 5.3.2.6,"Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",NA,PubChem: 5513; ChEBI: 64016 64037; 3DMET: B00454; NIKKAJI: J708.847G,cpd:C02222; cpd:C02501; cpd:C03453; cpd:C03676; cpd:C06035; cpd:C06336; cpd:C06674; cpd:C18244; cpd:C20901,6,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O5,C6H5O5,158.0215233,159.0293483,157.01369831399,1544,cpd:C02519,4-Methoxybenzoate;,C8H8O3,4-Methoxybenzoate; 4-Methoxybenzoic acid; 4-Anisic acid,R01306,Benzoate degradation; Degradation of aromatic compounds,1.14.99.15,NA,NA,CAS: 100-09-4; PubChem: 5529; ChEBI: 16639 40813; ChEMBL: CHEMBL21932; KNApSAcK: C00029536 C00041076; PDB-CCD: ANN; NIKKAJI: J3.229H,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951911400,1545,cpd:C03453,gamma-Oxalocrotonate;,C6H6O5,gamma-Oxalocrotonate; (Z)-5-Oxohex-2-enedioate; 4-Oxalocrotonate,R02602 R03246 R03887 R03966 R04223,Benzoate degradation; Tryptophan metabolism; Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.35; 3.5.99.5; 4.1.1.77; 4.1.1.-; 5.3.2.6,"Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",NA,PubChem: 6273; ChEBI: 16967 32808; 3DMET: B00584; NIKKAJI: J2.366.164K,cpd:C02222; cpd:C02501; cpd:C03453; cpd:C03676; cpd:C06035; cpd:C06336; cpd:C06674; cpd:C18244; cpd:C20901,6,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O5,C6H5O5,158.0215233,159.0293483,157.01369831401,1546,cpd:C03586,"2-Oxo-2,3-dihydrofuran-5-acetate;",C6H6O4,"2-Oxo-2,3-dihydrofuran-5-acetate; 3-Oxoadipate enol-lactone; 4,5-Dihydro-5-oxofuran-2-acetate; 5-Oxo-4,5-dihydrofuran-2-acetate",R02991 R03470 R04260 R06990,Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,3.1.1.24; 4.1.1.44; 5.3.3.4,"Catechol ortho-cleavage, catechol => 3-oxoadipate",NA,PubChem: 6377; ChEBI: 18267; KNApSAcK: C00007489; 3DMET: B00608; NIKKAJI: J937.928B,cpd:C00682; cpd:C00850; cpd:C02180; cpd:C02480; cpd:C03586; cpd:C03647; cpd:C03743; cpd:C04105; cpd:C06603; cpd:C07459; cpd:C08042; cpd:C11283; cpd:C12849; cpd:C14516; cpd:C14610; cpd:C20448; cpd:C20900,6,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O4,C6H5O4,142.0266087,143.0344337,141.01878361402,1547,cpd:C03671,"2-Pyrone-4,6-dicarboxylate",C7H4O6,"2-Pyrone-4,6-dicarboxylate",R03549 R04277 R04278 R04279 R04280 R09274,Benzoate degradation; Aminobenzoate degradation; Microbial metabolism in diverse environments,1.1.1.312; 1.13.11.3; 1.13.11.8; 1.13.11.-; 3.1.1.57,NA,NA,PubChem: 6447; ChEBI: 17872; PDB-CCD: 0GZ; 3DMET: B00616; NIKKAJI: J1.089.989C,cpd:C03671; cpd:C08476,7,4,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H5O6,C7H3O6,184.0007878,185.0086129,182.99296281403,1548,cpd:C03676,"3-Hydroxy-cis,cis-muconate",C6H6O5,"3-Hydroxy-cis,cis-muconate",R03892 R04061,Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.13.11.37,NA,NA,PubChem: 6451; ChEBI: 17419; LIPIDMAPS: LMFA01170071; 3DMET: B00617; NIKKAJI: J2.366.163B,cpd:C02222; cpd:C02501; cpd:C03453; cpd:C03676; cpd:C06035; cpd:C06336; cpd:C06674; cpd:C18244; cpd:C20901,6,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O5,C6H5O5,158.0215233,159.0293483,157.01369831404,1549,cpd:C04115,4-Carboxy-4-hydroxy-2-oxoadipate;,C7H8O8,"4-Carboxy-4-hydroxy-2-oxoadipate; 4-Hydroxy-4-carboxymethyl-2-oxoglutarate; 2-Hydroxy-4-oxobutane-1,2,4-tricarboxylate",R00350 R04399 R04478 R04781,Benzoate degradation; Microbial metabolism in diverse environments,4.1.3.17; 4.2.1.80; 4.2.1.83; 4.2.1.-,NA,NA,PubChem: 6804; ChEBI: 17250; 3DMET: B00682; NIKKAJI: J2.379.697J,cpd:C04115,7,8,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O8,C7H7O8,220.0219172,221.0297422,219.01409221405,1550,cpd:C04324,"(1E,3E)-4-Hydroxybuta-1,3-diene-1,2,4-tricarboxylate;",C7H6O7,"(1E,3E)-4-Hydroxybuta-1,3-diene-1,2,4-tricarboxylate; 2-Hydroxy-4-carboxyhexa-2,4-dienedioate; 4-Carboxy-2-hydroxy-cis,cis-muconate; 4-Carboxy-2-hydroxyhexa-2,4-cis,cis-dienedioate",R03550 R04399 R04453 R04482 R07839,Benzoate degradation; Microbial metabolism in diverse environments,1.13.11.8; 1.13.11.57; 4.2.1.-; 5.3.2.8; 5.3.3.10,NA,NA,PubChem: 6979; ChEBI: 17424; LIPIDMAPS: LMFA01170072; 3DMET: B00701; NIKKAJI: J2.374.674C,cpd:C04324; cpd:C04434; cpd:C05364,7,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O7,C7H5O7,202.0113525,203.0191776,201.00352751406,1551,cpd:C04434,"(1E)-4-Oxobut-1-ene-1,2,4-tricarboxylate;",C7H6O7,"(1E)-4-Oxobut-1-ene-1,2,4-tricarboxylate; 4-Oxalomesaconate; 4-Oxalmesaconic acid",R04277 R04478 R07839 R09273 R09565,Benzoate degradation; Aminobenzoate degradation; Microbial metabolism in diverse environments,1.13.11.8; 1.13.11.57; 3.1.1.57; 4.2.1.83; 5.3.2.8,NA,NA,CAS: 85179-60-8; PubChem: 7065; ChEBI: 15668; 3DMET: B00712; NIKKAJI: J82.431C,cpd:C04324; cpd:C04434; cpd:C05364,7,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O7,C7H5O7,202.0113525,203.0191776,201.00352751407,1552,cpd:C04480,3-Carboxy-2-hydroxymuconate semialdehyde,C7H6O6,3-Carboxy-2-hydroxymuconate semialdehyde,R01507 R02763,Benzoate degradation; Microbial metabolism in diverse environments,1.13.11.14; 4.1.1.-,NA,NA,PubChem: 7100; ChEBI: 18003; 3DMET: B00721; NIKKAJI: J2.371.231H,cpd:C01163; cpd:C01278; cpd:C02167; cpd:C02514; cpd:C03666; cpd:C04480; cpd:C04484; cpd:C04553; cpd:C05375; cpd:C16199; cpd:C17101,7,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O6,C7H5O6,186.0164379,187.0242629,185.00861291408,1553,cpd:C04484,4-Carboxy-2-hydroxymuconate semialdehyde;,C7H6O6,"4-Carboxy-2-hydroxymuconate semialdehyde; 4-Carboxy-2-hydroxy-cis,cis-muconate 6-semialdehyde",R01632 R04453 R04488 R04489,Benzoate degradation; Polycyclic aromatic hydrocarbon degradation; Aminobenzoate degradation; Microbial metabolism in diverse environments,1.13.11.8; 3.7.1.-,NA,NA,CAS: 28345-81-5; PubChem: 7103; ChEBI: 18046; 3DMET: B00722; NIKKAJI: J1.263.603B,cpd:C01163; cpd:C01278; cpd:C02167; cpd:C02514; cpd:C03666; cpd:C04480; cpd:C04484; cpd:C04553; cpd:C05375; cpd:C16199; cpd:C17101,7,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O6,C7H5O6,186.0164379,187.0242629,185.00861291409,1554,cpd:C04553,"3-Carboxy-2,5-dihydro-5-oxofuran-2-acetate;",C7H6O6,"3-Carboxy-2,5-dihydro-5-oxofuran-2-acetate; 4-Carboxy-2,5-dihydro-2-oxofuran-5-acetate",R03308,Benzoate degradation,5.5.1.5,NA,NA,PubChem: 7158; ChEBI: 16989; NIKKAJI: J1.557.068G,cpd:C01163; cpd:C01278; cpd:C02167; cpd:C02514; cpd:C03666; cpd:C04480; cpd:C04484; cpd:C04553; cpd:C05375; cpd:C16199; cpd:C17101,7,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O6,C7H5O6,186.0164379,187.0242629,185.00861291410,1555,cpd:C05375,"2-Hydroxy-2-hydropyrone-4,6-dicarboxylate",C7H6O6,"2-Hydroxy-2-hydropyrone-4,6-dicarboxylate",R04278 R04279 R04489,Benzoate degradation; Microbial metabolism in diverse environments,1.1.1.312,NA,NA,PubChem: 7749; ChEBI: 62011; NIKKAJI: J2.755.734A,cpd:C01163; cpd:C01278; cpd:C02167; cpd:C02514; cpd:C03666; cpd:C04480; cpd:C04484; cpd:C04553; cpd:C05375; cpd:C16199; cpd:C17101,7,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O6,C7H5O6,186.0164379,187.0242629,185.00861291411,1556,cpd:C06033,Parapyruvate;,C6H8O6,Parapyruvate; 4-Hydroxy-4-methyl-2-oxoglutarate,R00008 R03995 R05077 R05078,Benzoate degradation; C5-Branched dibasic acid metabolism; Microbial metabolism in diverse environments,4.1.3.17; 4.2.1.-,NA,NA,PubChem: 8305; ChEBI: 17801; 3DMET: B01956; NIKKAJI: J2.369.061F,cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364,6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O6,C6H7O6,176.032088,177.039913,175.02426291412,1557,cpd:C06035,4-Methylene-2-oxoglutarate;,C6H6O5,4-Methylene-2-oxoglutarate; 2-Methylidene-4-oxopentanedioic acid; 4-Carboxy-2-oxo-4-pentenoate,R02713 R04488 R05078 R05079 R09277,Benzoate degradation; C5-Branched dibasic acid metabolism; Microbial metabolism in diverse environments,3.7.1.-; 4.2.1.-,NA,NA,PubChem: 8307; ChEBI: 1898; LIPIDMAPS: LMFA01170047; 3DMET: B00889; NIKKAJI: J2.366.162D,cpd:C02222; cpd:C02501; cpd:C03453; cpd:C03676; cpd:C06035; cpd:C06336; cpd:C06674; cpd:C18244; cpd:C20901,6,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O5,C6H5O5,158.0215233,159.0293483,157.01369831413,1558,cpd:C06321,"(1R,6S)-1,6-Dihydroxycyclohexa-2,4-diene-1-carboxylate;",C7H8O4,"(1R,6S)-1,6-Dihydroxycyclohexa-2,4-diene-1-carboxylate; cis-1,2-Dihydroxycyclohexa-3,5-diene-1-carboxylate; cis-1,6-Dihydroxy-2,4-cyclohexadiene-1-carboxylic acid",R00813 R05621 R05622,Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.25; 1.14.12.10,"Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",NA,PubChem: 8557; ChEBI: 18340 37888; NIKKAJI: J1.936.395C,cpd:C04112; cpd:C04171; cpd:C04558; cpd:C04559; cpd:C04634; cpd:C06210; cpd:C06321; cpd:C06678; cpd:C06760; cpd:C07041; cpd:C13671; cpd:C18311; cpd:C20710,7,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O4,C7H7O4,156.0422587,157.0500838,155.03443371414,1559,cpd:C06322,"Cyclohexa-1,5-diene-1-carbonyl-CoA;",C28H42N7O17P3S,"Cyclohexa-1,5-diene-1-carbonyl-CoA; Cyclohexa-1,5-dienecarbonyl-CoA; S-1,5-Cyclohexadiene-1-carboxylate coenzymeA",R02451 R05597 R05609 R05610 R09252 R10961,Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.7.8; 1.3.8.10; 1.3.-.-; 4.2.1.100,"Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA",NA,CAS: 148471-94-7; PubChem: 8558; ChEBI: 15520; PDB-CCD: 4KX; NIKKAJI: J979.010A,cpd:C06322; cpd:C09809; cpd:C09810,28,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H43O17N7P3S1,C28H41O17N7P3S1,873.1570751,874.1649001,872.14925011415,1560,cpd:C06333,2-Aminobenzenesulfonate;,C6H7NO3S,2-Aminobenzenesulfonate; 2-Aminobenzenesulfonic acid; o-Aminobenzenesulfonic acid; Orthanilic acid,R05156,Benzoate degradation; Microbial metabolism in diverse environments,1.14.12.14,NA,NA,CAS: 88-21-1; PubChem: 8569; ChEBI: 1015 15942; ChEMBL: CHEMBL1372690; 3DMET: B00940; NIKKAJI: J4.290K,cpd:C06333; cpd:C06334; cpd:C06335,6,7,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O3N1S1,C6H6O3N1S1,173.0146643,174.0224893,172.00683921416,1561,cpd:C06336,3-Sulfocatechol;,C6H6O5S,"3-Sulfocatechol; 2,3-Dihydroxybenzenesulfonate",R05156 R07795,Benzoate degradation; Microbial metabolism in diverse environments,1.13.11.2; 1.14.12.14,NA,NA,PubChem: 8572; ChEBI: 27802 33565; 3DMET: B00942; NIKKAJI: J166.319D,cpd:C06336; cpd:C06674,6,6,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O5S1,C6H5O5S1,189.9935945,191.0014195,188.98576941417,1562,cpd:C06714,3-Hydroxypimeloyl-CoA;,C28H46N7O20P3S,3-Hydroxypimeloyl-CoA; 3-Hydroxypimelyl-CoA,R05305 R05593 R05594 R05601,Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.35; 1.1.1.259; 3.7.1.21; 4.2.1.-,"Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA",NA,PubChem: 8938; ChEBI: 15485; NIKKAJI: J2.763.604G,cpd:C06714,28,46,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O20N7P3S1,C28H45O20N7P3S1,925.1731191,926.1809441,924.1652941418,1563,cpd:C06715,3-Oxopimeloyl-CoA;,C28H44N7O20P3S,3-Oxopimeloyl-CoA; 3-Ketopimelyl-CoA,R05305 R05586,Benzoate degradation; Microbial metabolism in diverse environments,1.1.1.35; 1.1.1.259; 2.3.1.16,NA,NA,PubChem: 8939; ChEBI: 15492; NIKKAJI: J2.763.627F,cpd:C06715,28,44,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O20N7P3S1,C28H43O20N7P3S1,923.157469,924.165294,922.1496441419,1564,cpd:C06723,6-Carboxyhex-2-enoyl-CoA;,C28H44N7O19P3S,"6-Carboxyhex-2-enoyl-CoA; 2,3-Didehydro-pimeloyl-CoA",R05311 R05601,Benzoate degradation; Microbial metabolism in diverse environments,1.3.1.62; 4.2.1.-,NA,NA,PubChem: 8946; ChEBI: 15503; NIKKAJI: J2.763.701I,cpd:C06723; cpd:C09825,28,44,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O19N7P3S1,C28H43O19N7P3S1,907.1625544,908.1703794,906.15472941420,1565,cpd:C06749,6-Hydroxycyclohex-1-ene-1-carbonyl-CoA;,C28H44N7O18P3S,6-Hydroxycyclohex-1-ene-1-carbonyl-CoA; 6-Hydroxycyclohex-1-enecarbonyl-CoA; 6-Hydroxycyclohex-1-ene-1-carboxyl-CoA,R05581 R05597 R05602,Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.368; 4.2.1.100; 4.2.1.-,"Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA",NA,PubChem: 8970; ChEBI: 15505; NIKKAJI: J2.764.054K,cpd:C06749; cpd:C09813; cpd:C16471,28,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O18N7P3S1,C28H43O18N7P3S1,891.1676398,892.1754648,890.15981471421,1566,cpd:C09809,"Cyclohex-2,5-diene-1-carboxyl-CoA",C28H42N7O17P3S,"Cyclohex-2,5-diene-1-carboxyl-CoA",R05609,Benzoate degradation; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 11997; ChEBI: 27610; NIKKAJI: J2.771.134K,cpd:C06322; cpd:C09809; cpd:C09810,28,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H43O17N7P3S1,C28H41O17N7P3S1,873.1570751,874.1649001,872.14925011422,1567,cpd:C09810,"Cyclohex-1,4-diene-1-carboxyl-CoA",C28H42N7O17P3S,"Cyclohex-1,4-diene-1-carboxyl-CoA",R05610,Benzoate degradation; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 11998; ChEBI: 28443; NIKKAJI: J2.771.135I,cpd:C06322; cpd:C09809; cpd:C09810,28,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H43O17N7P3S1,C28H41O17N7P3S1,873.1570751,874.1649001,872.14925011423,1568,cpd:C09811,Cyclohex-1-ene-1-carboxyl-CoA,C28H44N7O17P3S,Cyclohex-1-ene-1-carboxyl-CoA,R05600 R05619 R09252 R10601,Benzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.8.10; 1.3.8.11; 1.3.-.-; 4.2.1.-,"Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA",NA,PubChem: 11999; ChEBI: 28005; NIKKAJI: J2.771.163D,cpd:C09811; cpd:C16468,28,44,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O17N7P3S1,C28H43O17N7P3S1,875.1727252,876.1805502,874.16490011424,1569,cpd:C09812,2-Hydroxycyclohexane-1-carboxyl-CoA,C28H46N7O18P3S,2-Hydroxycyclohexane-1-carboxyl-CoA,R05582 R05600,Benzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.-; 4.2.1.-,"Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA",NA,PubChem: 12000; ChEBI: 28169; NIKKAJI: J2.771.164B,cpd:C09812; cpd:C16469,28,46,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O18N7P3S1,C28H45O18N7P3S1,893.1832898,894.1911149,892.17546481425,1570,cpd:C09813,2-Ketocyclohexane-1-carboxyl-CoA;,C28H44N7O18P3S,2-Ketocyclohexane-1-carboxyl-CoA; 2-Oxocyclohexane-1-carbonyl-CoA,R05582 R05592,Benzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.-; 3.1.2.-,"Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA",NA,PubChem: 12001; ChEBI: 27664; NIKKAJI: J2.771.174J,cpd:C06749; cpd:C09813; cpd:C16471,28,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O18N7P3S1,C28H43O18N7P3S1,891.1676398,892.1754648,890.15981471426,1571,cpd:C09821,6-Oxocyclohex-1-ene-1-carbonyl-CoA;,C28H42N7O18P3S,6-Oxocyclohex-1-ene-1-carbonyl-CoA; 6-Ketoxycyclohex-1-ene-1-carboxyl-CoA,R05581 R05594 R10696,Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.368; 3.7.1.21,"Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA",NA,PubChem: 12009; ChEBI: 28168; NIKKAJI: J2.771.191J,cpd:C09821,28,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H43O18N7P3S1,C28H41O18N7P3S1,889.1519897,890.1598147,888.14416471427,1572,cpd:C09822,Cyclohexane-1-carboxylate;,C7H12O2,Cyclohexane-1-carboxylate; Cyclohexanecarboxylic acid; Hexahydrobenzoic acid,R05620,Benzoate degradation; Microbial metabolism in diverse environments,6.2.1.-,"Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA",NA,CAS: 98-89-5; PubChem: 12010; ChEBI: 36096; KNApSAcK: C00000334; 3DMET: B01117; NIKKAJI: J38.185C,cpd:C08487; cpd:C09822; cpd:C10921; cpd:C10976; cpd:C11950; cpd:C13714; cpd:C13717,7,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O2,C7H11O2,128.0837296,129.0915547,127.07590461428,1573,cpd:C09823,Cyclohexane-1-carboxyl-CoA,C28H46N7O17P3S,Cyclohexane-1-carboxyl-CoA,R05619 R05620 R10601,Benzoate degradation; Microbial metabolism in diverse environments,1.3.8.11; 1.3.-.-; 6.2.1.-,"Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA",NA,PubChem: 12011; ChEBI: 28557; NIKKAJI: J2.771.192H,cpd:C09823; cpd:C11949; cpd:C16470,28,46,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O17N7P3S1,C28H45O17N7P3S1,877.1883752,878.1962002,876.18055021429,1574,cpd:C14610,"(S)-5-Oxo-2,5-dihydrofuran-2-acetate;",C6H6O4,"(S)-5-Oxo-2,5-dihydrofuran-2-acetate; (+)-Muconolactone",R06989 R06990,Benzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,5.3.3.4; 5.5.1.1,"Catechol ortho-cleavage, catechol => 3-oxoadipate",NA,PubChem: 17395610; ChEBI: 48068; PDB-CCD: MUC; NIKKAJI: J738.332K,cpd:C00682; cpd:C00850; cpd:C02180; cpd:C02480; cpd:C03586; cpd:C03647; cpd:C03743; cpd:C04105; cpd:C06603; cpd:C07459; cpd:C08042; cpd:C11283; cpd:C12849; cpd:C14516; cpd:C14610; cpd:C20448; cpd:C20900,6,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O4,C6H5O4,142.0266087,143.0344337,141.01878361430,1575,cpd:C21298,"2,6-Dihydroxybenzoate;",C7H6O4,"2,6-Dihydroxybenzoate; gamma-Resorcylate",R11353,Benzoate degradation; Microbial metabolism in diverse environments,4.1.1.103,NA,NA,CAS: 303-07-1; PubChem: 318172278; PDB-CCD: GRE,cpd:C00196; cpd:C00230; cpd:C00628; cpd:C06679; cpd:C07461; cpd:C11006; cpd:C11008; cpd:C14306; cpd:C16748; cpd:C18303; cpd:C18308; cpd:C19410; cpd:C19788; cpd:C21298,7,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O4,C7H5O4,154.0266087,155.0344337,153.01878361431,1576,cpd:C00633,4-Hydroxybenzaldehyde;,C7H6O2,4-Hydroxybenzaldehyde; p-Hydroxybenzaldehyde,R01293 R01294 R01303 R02672 R02673 R02675 R02676 R06886; R07223,Bisphenol degradation; Toluene degradation; Aminobenzoate degradation; Biosynthesis of phenylpropanoids; Metabolic pathways; Microbial metabolism in diverse environments,1.1.3.19; 1.2.1.7; 1.2.1.28; 1.2.1.64; 1.2.1.96; 1.3.-.-; 1.14.99.-; 1.17.99.1; 4.1.1.7; 4.1.2.11,NA,NA,CAS: 123-08-0; PubChem: 3906; ChEBI: 17597; ChEMBL: CHEMBL14193; KNApSAcK: C00002657; PDB-CCD: HBA; 3DMET: B00151; NIKKAJI: J43.312H,cpd:C00180; cpd:C00539; cpd:C00633; cpd:C03067; cpd:C06202; cpd:C14181; cpd:C15474; cpd:C18302,7,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O2,C7H5O2,122.0367794,123.0446045,121.02895441432,1577,cpd:C10700,4'-Hydroxyacetophenone;,C8H8O2,4'-Hydroxyacetophenone; (4-Hydroxyphenyl)ethan-1-one,R06886 R06891 R06892,Bisphenol degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.-; 1.3.-.-; 1.14.13.84,NA,NA,CAS: 99-93-4; PubChem: 12883; ChEBI: 28032; ChEMBL: CHEMBL201083; KNApSAcK: C00002698; PDB-CCD: AC6; 3DMET: B04072; NIKKAJI: J4.976J,cpd:C00548; cpd:C01454; cpd:C01526; cpd:C02061; cpd:C03765; cpd:C05613; cpd:C06224; cpd:C07085; cpd:C07086; cpd:C07189; cpd:C07211; cpd:C07215; cpd:C10700; cpd:C10761; cpd:C11151; cpd:C11252; cpd:C14087; cpd:C15250; cpd:C15583; cpd:C20645; cpd:C21166; cpd:C21328; cpd:C21375,8,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O2,C8H7O2,136.0524295,137.0602545,135.04460451433,1578,cpd:C13620,Tetrabromobisphenol A;,C15H12Br4O2,"Tetrabromobisphenol A; 3,3',5,5'-Tetrabromobisphenol A",R06876,Bisphenol degradation; Microbial metabolism in diverse environments,1.97.1.-,NA,NA,CAS: 79-94-7; PubChem: 586238; ChEBI: 33217; ChEMBL: CHEMBL184450; PDB-CCD: XDI; NIKKAJI: J3.530K,cpd:C13620,15,12,2,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,C15H13O2Br4,C15H11O2Br4,539.75708,540.7649051,538.7492551434,1579,cpd:C13621,Tribromobisphenol A;,C15H13Br3O2,"Tribromobisphenol A; 3,3',5-Tribromobisphenol A",R06876 R06877,Bisphenol degradation; Microbial metabolism in diverse environments,1.97.1.-,NA,NA,CAS: 6386-73-8; PubChem: 586239; ChEBI: 33218; ChEMBL: CHEMBL184398; NIKKAJI: J207.000F,cpd:C13621,15,13,2,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,C15H14O2Br3,C15H12O2Br3,461.8465675,462.8543925,460.83874241435,1580,cpd:C13622,Dibromobisphenol A;,C15H14Br2O2,"Dibromobisphenol A; 3,3'-Dibromobisphenol A",R06877 R06878,Bisphenol degradation; Microbial metabolism in diverse environments,1.97.1.-,NA,NA,CAS: 29426-78-6; PubChem: 586240; NIKKAJI: J642.606I,cpd:C13622,15,14,2,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,C15H15O2Br2,C15H13O2Br2,383.9360549,384.9438799,382.92822991436,1581,cpd:C13623,Monobromobisphenol A;,C15H15BrO2,Monobromobisphenol A; 3-Monobromobisphenol A,R06878 R06879,Bisphenol degradation; Microbial metabolism in diverse environments,1.97.1.-,NA,NA,CAS: 6073-11-6; PubChem: 586241; ChEBI: 33220; NIKKAJI: J1.508.770F,cpd:C13623,15,15,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C15H16O2Br1,C15H14O2Br1,306.0255423,307.0333674,305.01771731437,1582,cpd:C13624,Bisphenol A;,C15H16O2,"Bisphenol A; 2,2-Bis(4-Hydroxyphenyl)propane",R06879 R06880 R06881 R06883 R06884,Bisphenol degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.13.-; 1.14.-.-; 1.97.1.-,NA,Endocrine disrupting compounds [BR:br08006];  Plasticizers and plastics;   Bisphenols;    C13624  Bisphenol A,CAS: 80-05-7; PubChem: 586242; ChEBI: 33216; ChEMBL: CHEMBL418971; PDB-CCD: 2OH; NIKKAJI: J3.531I,cpd:C10371; cpd:C11182; cpd:C13624; cpd:C15210; cpd:C17424; cpd:C18774; cpd:C18826; cpd:C19847; cpd:C20520,15,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H17O2,C15H15O2,228.1150298,229.1228548,227.10720471438,1583,cpd:C13625,"4-Methyl-2,4-bis-(p-hydroxyphenyl)pent-1-ene",C18H20O2,"4-Methyl-2,4-bis-(p-hydroxyphenyl)pent-1-ene",R06880,Bisphenol degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 13464-24-9; PubChem: 586243; ChEBI: 31129; NIKKAJI: J53.476E,cpd:C07620; cpd:C13625; cpd:C14392; cpd:C14498; cpd:C14650; cpd:C14738; cpd:C15168,18,20,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H21O2,C18H19O2,268.1463299,269.1541549,267.13850491439,1584,cpd:C13626,5-Hydroxybisphenol A;,C15H16O3,5-Hydroxybisphenol A; 5-Hydroxybisphenol; BPAcatechol,R06881 R06882,Bisphenol degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 79371-66-7; PubChem: 586244; ChEBI: 31133; NIKKAJI: J1.523.571C,cpd:C09280; cpd:C09404; cpd:C10247; cpd:C13626; cpd:C13629; cpd:C13631; cpd:C17425,15,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H17O3,C15H15O3,244.1099444,245.1177694,243.10211931440,1585,cpd:C13628,"4,5-Bisphenol-o-quinone;",C15H14O3,"4,5-Bisphenol-o-quinone; BPAquinone",R06882,Bisphenol degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 163405-36-5; PubChem: 586245; ChEBI: 31124; NIKKAJI: J667.193D,cpd:C02328; cpd:C06997; cpd:C07495; cpd:C07825; cpd:C09641; cpd:C10257; cpd:C10261; cpd:C10337; cpd:C10366; cpd:C10367; cpd:C11094; cpd:C13628; cpd:C14131; cpd:C20154; cpd:C21418,15,14,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O3,C15H13O3,242.0942943,243.1021193,241.08646931441,1586,cpd:C13629,"1,2-Bis(4-hydroxyphenyl)-2-propanol",C15H16O3,"1,2-Bis(4-hydroxyphenyl)-2-propanol",R06883 R06885,Bisphenol degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.-.-; 4.2.1.-,NA,NA,CAS: 154928-56-0; PubChem: 586246; ChEBI: 31035; NIKKAJI: J1.608.543J,cpd:C09280; cpd:C09404; cpd:C10247; cpd:C13626; cpd:C13629; cpd:C13631; cpd:C17425,15,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H17O3,C15H15O3,244.1099444,245.1177694,243.10211931442,1587,cpd:C13631,"2,2-Bis(4-hydroxyphenyl)-1-propanol",C15H16O3,"2,2-Bis(4-hydroxyphenyl)-1-propanol",R06884 R06887 R06888,Bisphenol degradation; Microbial metabolism in diverse environments,1.14.13.-; 1.14.-.-,NA,NA,CAS: 142648-65-5; PubChem: 586247; ChEBI: 33613; NIKKAJI: J1.321.973G,cpd:C09280; cpd:C09404; cpd:C10247; cpd:C13626; cpd:C13629; cpd:C13631; cpd:C17425,15,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H17O3,C15H15O3,244.1099444,245.1177694,243.10211931443,1588,cpd:C13632,"4,4'-Dihydroxy-alpha-methylstilbene",C15H14O2,"4,4'-Dihydroxy-alpha-methylstilbene",R06885 R06886,Bisphenol degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.-.-; 4.2.1.-,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes;     C13632  4,4'-Dihydroxy-alpha-methylstilbene",CAS: 72108-22-6; PubChem: 586248; ChEBI: 36028; ChEMBL: CHEMBL577240; LIPIDMAPS: LMPK13090004; NIKKAJI: J1.381.024I J907.565H,cpd:C02345; cpd:C05818; cpd:C07493; cpd:C09757; cpd:C10276; cpd:C10325; cpd:C13622; cpd:C13632; cpd:C18919; cpd:C18973; cpd:C20287; cpd:C21379; cpd:C21380,15,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O2,C15H13O2,226.0993797,227.1072047,225.09155471444,1589,cpd:C13633,"2,2-Bis(4-hydroxyphenyl)-propanoic acid",C15H14O4,"2,2-Bis(4-hydroxyphenyl)-propanoic acid",R06887,Bisphenol degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 92549-67-2; PubChem: 586249; ChEBI: 19287; NIKKAJI: J805.272G,cpd:C06877; cpd:C07758; cpd:C07759; cpd:C08465; cpd:C09273; cpd:C09283; cpd:C09618; cpd:C09980; cpd:C10268; cpd:C10352; cpd:C13633; cpd:C14115; cpd:C16929; cpd:C18485,15,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O4,C15H13O4,258.0892089,259.097034,257.08138391445,1590,cpd:C13634,"2,3-Bis(4-hydroxyphenyl)-1,2-propanediol",C15H16O4,"2,3-Bis(4-hydroxyphenyl)-1,2-propanediol",R06888 R06889,Bisphenol degradation; Microbial metabolism in diverse environments,1.13.-.-; 1.14.-.-,NA,NA,CAS: 139755-03-6; PubChem: 586250; ChEBI: 19304; NIKKAJI: J1.321.974E,cpd:C09392; cpd:C09495; cpd:C09680; cpd:C09923; cpd:C10950; cpd:C13634; cpd:C16812; cpd:C17162,15,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H17O4,C15H15O4,260.104859,261.112684,259.0970341446,1591,cpd:C13635,4-Hydroxyphenacyl alcohol;,C8H8O3,"4-Hydroxyphenacyl alcohol; 2,4'-Dihydroxyacetophenone",R01305 R06889,Bisphenol degradation; Microbial metabolism in diverse environments,1.13.11.41; 1.13.-.-,NA,NA,CAS: 5706-85-4; PubChem: 586251; ChEBI: 35164; ChEMBL: CHEMBL1908015; NIKKAJI: J81.083E,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951911447,1592,cpd:C13636,4-Hydroxyphenyl acetate,C8H8O3,4-Hydroxyphenyl acetate,R06892 R06893,Bisphenol degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.13.84; 3.1.1.2,NA,NA,CAS: 3233-32-7; PubChem: 586252; ChEBI: 31128; NIKKAJI: J83.249I,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951911448,1593,cpd:C13637,4-Ethylphenol;,C8H10O,4-Ethylphenol; p-Ethylphenol,R06890,Bisphenol degradation; Microbial metabolism in diverse environments,1.14.13.-,NA,NA,CAS: 123-07-9; PubChem: 586253; ChEBI: 49584; ChEMBL: CHEMBL108475; KNApSAcK: C00029528; PDB-CCD: ETY; NIKKAJI: J2.496A,cpd:C05853; cpd:C06757; cpd:C07112; cpd:C07213; cpd:C07216; cpd:C11348; cpd:C13637; cpd:C14385; cpd:C14386; cpd:C14582; cpd:C17512; cpd:C19680,8,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O1,C8H9O1,122.0731649,123.08099,121.06533991449,1594,cpd:C13638,1-(4'-Hydroxyphenyl)ethanol;,C8H10O2,1-(4'-Hydroxyphenyl)ethanol; 4-Hydroxy-alpha-methyl-benzenemethanol; 4-(1-Hydroxyethyl)phenol,R06890 R06891,Bisphenol degradation; Microbial metabolism in diverse environments,1.1.1.-; 1.14.13.-,NA,NA,CAS: 2380-91-8; PubChem: 586254; ChEBI: 31042; ChEMBL: CHEMBL507057; NIKKAJI: J213.243E,cpd:C03352; cpd:C04087; cpd:C06044; cpd:C06728; cpd:C07084; cpd:C07481; cpd:C11480; cpd:C13403; cpd:C13638; cpd:C16693; cpd:C19844; cpd:C20694,8,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O2,C8H9O2,138.0680796,139.0759046,137.06025451450,1595,cpd:C14220,"4,4'-Dihydroxybenzophenone",C13H10O3,"4,4'-Dihydroxybenzophenone",R09103 R09104,Bisphenol degradation; Microbial metabolism in diverse environments,1.1.-.-; 1.14.-.-,NA,NA,CAS: 611-99-4; PubChem: 7847030; ChEBI: 34365; ChEMBL: CHEMBL194859; PDB-CCD: DBE; NIKKAJI: J39.681H,cpd:C07722; cpd:C08455; cpd:C11493; cpd:C14163; cpd:C14215; cpd:C14220; cpd:C14284; cpd:C14507; cpd:C16262; cpd:C18821; cpd:C19003; cpd:C19404; cpd:C19405,13,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O3,C13H9O3,214.0629942,215.0708192,213.05516911451,1596,cpd:C14298,Bis(4-hydroxyphenyl)methane;,C13H12O2,"Bis(4-hydroxyphenyl)methane; 4,4'-Dihydroxydiphenylmethane; Bisphenol F",R09102,Bisphenol degradation; Microbial metabolism in diverse environments,1.14.-.-,NA,NA,CAS: 620-92-8; PubChem: 17395298; ChEBI: 34575; ChEMBL: CHEMBL138061; NIKKAJI: J6.829B,cpd:C07721; cpd:C08458; cpd:C08741; cpd:C13144; cpd:C14244; cpd:C14298; cpd:C14747; cpd:C19800; cpd:C20290; cpd:C21411; cpd:C21413,13,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H13O2,C13H11O2,200.0837296,201.0915547,199.07590461452,1597,cpd:C18215,Bis(4-hydroxyphenyl)methanol,C13H12O3,Bis(4-hydroxyphenyl)methanol,R09102 R09103,Bisphenol degradation; Microbial metabolism in diverse environments,1.1.-.-; 1.14.-.-,NA,NA,PubChem: 103061397; ChEBI: 81592; NIKKAJI: J1.270.853J,cpd:C09954; cpd:C11491; cpd:C14613; cpd:C18215; cpd:C20980,13,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H13O3,C13H11O3,216.0786442,217.0864693,215.07081921453,1598,cpd:C18216,4-Hydroxyphenyl-4-hydroxybenzoate,C13H10O4,4-Hydroxyphenyl-4-hydroxybenzoate,R09104 R09105,Bisphenol degradation; Microbial metabolism in diverse environments,1.14.-.-; 3.1.1.-,NA,NA,PubChem: 103061398; ChEBI: 81593; NIKKAJI: J872.901H,cpd:C06356; cpd:C07718; cpd:C07725; cpd:C07910; cpd:C09049; cpd:C12085; cpd:C16263; cpd:C18216; cpd:C18805,13,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O4,C13H9O4,230.0579088,231.0657338,229.05008381454,1599,cpd:C02357,2-Chlorobenzoate;,C7H5ClO2,2-Chlorobenzoate; 2-Chlorobenzoic acid; o-Chlorobenzoic acid,R01033,Fluorobenzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.13,NA,NA,CAS: 118-91-2; PubChem: 5404; ChEBI: 28303 30793; ChEMBL: CHEMBL115243; 3DMET: B00430; NIKKAJI: J26.900J,cpd:C02357; cpd:C02370; cpd:C03444,7,5,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C7H6O2Cl1,C7H4O2Cl1,155.9978071,157.0056321,154.98998211455,1600,cpd:C02359,2-Fluorobenzoate;,C7H5FO2,2-Fluorobenzoate; 2-Fluorobenzoic acid,R08100 R08101,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.10,NA,NA,CAS: 445-29-4; PubChem: 5405; ChEBI: 19577 27839; ChEMBL: CHEMBL114383; PDB-CCD: 3U4; NIKKAJI: J26.901H,cpd:C02359; cpd:C02364; cpd:C02371,7,5,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C7H6O2F1,C7H4O2F1,140.0273576,141.0351826,139.01953251456,1601,cpd:C02364,3-Fluorobenzoate;,C7H5FO2,3-Fluorobenzoate; 3-Fluorobenzoic acid,R08108 R08109,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.10,NA,NA,CAS: 455-38-9; PubChem: 5409; ChEBI: 20021 28665; ChEMBL: CHEMBL302365; NIKKAJI: J47.806G,cpd:C02359; cpd:C02364; cpd:C02371,7,5,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C7H6O2F1,C7H4O2F1,140.0273576,141.0351826,139.01953251457,1602,cpd:C02371,4-Fluorobenzoate;,C7H5FO2,4-Fluorobenzoate; 4-Fluorobenzoic acid,R08110 R08117,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.10; 6.2.1.33,NA,NA,CAS: 456-22-4; PubChem: 5413; ChEBI: 20364 27893; ChEMBL: CHEMBL316860; PDB-CCD: 1Y6; NIKKAJI: J43.545G,cpd:C02359; cpd:C02364; cpd:C02371,7,5,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C7H6O2F1,C7H4O2F1,140.0273576,141.0351826,139.01953251458,1603,cpd:C02802,4-Fluorobenzoyl-CoA,C28H39FN7O17P3S,4-Fluorobenzoyl-CoA,R08117 R08118,Fluorobenzoate degradation; Microbial metabolism in diverse environments,3.8.1.7; 6.2.1.33,NA,NA,PubChem: 5752; ChEBI: 27677; NIKKAJI: J1.798.410A,cpd:C02784; cpd:C02792; cpd:C02802,28,39,17,7,3,1,0,0,0,1,0,0,0,0,0,0,0,0,C28H40O17N7P3S1F1,C28H38O17N7P3S1F1,889.1320032,890.1398282,888.12417811459,1604,cpd:C03925,"3,5-Dibromo-4-hydroxybenzoate",C7H4Br2O3,"3,5-Dibromo-4-hydroxybenzoate",R04349 R07782 R07783,Fluorobenzoate degradation; Microbial metabolism in diverse environments,3.5.1.-; 3.5.5.6,NA,NA,CAS: 3337-62-0; PubChem: 6653; ChEBI: 1395; KNApSAcK: C00038243; 3DMET: B00655; NIKKAJI: J26.968I,cpd:C03925,7,4,3,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,C7H5O3Br2,C7H3O3Br2,293.8527192,294.8605442,292.84489421460,1605,cpd:C04178,Bromoxynil;,C7H3Br2NO,"Bromoxynil; 3,5-Dibromo-4-hydroxybenzonitrile",R04349 R07779 R07780,Fluorobenzoate degradation; Microbial metabolism in diverse environments,1.14.13.50; 3.5.5.6; 4.2.1.84,NA,Pesticides [BR:br08007];  Pesticides;   Herbicides;    Nitrile herbicides;     C04178  Bromoxynil,CAS: 1689-84-5; PubChem: 6856; ChEBI: 17192; ChEMBL: CHEMBL453905; 3DMET: B00685; NIKKAJI: J7.557D,cpd:C04178,7,3,1,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,C7H4O1N1Br2,C7H2O1N1Br2,274.8581389,275.865964,273.85031391461,1606,cpd:C06387,4-Chlorobenzoyl-CoA,C28H39ClN7O17P3S,4-Chlorobenzoyl-CoA,R03932 R04101 R05276,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.21.1.2; 3.8.1.7; 6.2.1.33,NA,NA,PubChem: 8623; ChEBI: 15498; NIKKAJI: J764.158C,cpd:C06387,28,39,17,7,3,1,1,0,0,0,0,0,0,0,0,0,0,0,C28H40O17N7P3S1Cl1,C28H38O17N7P3S1Cl1,905.1024527,906.1102777,904.09462761462,1607,cpd:C06670,"2,4-Dichlorobenzoate;",C7H4Cl2O2,"2,4-Dichlorobenzoate; 2,4-Dichlorobenzoic acid",R05451,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,6.2.1.-,NA,NA,CAS: 50-84-0; PubChem: 8895; ChEBI: 30748; ChEMBL: CHEMBL1492029; KNApSAcK: C00042066; 3DMET: B01020; NIKKAJI: J55.459F,cpd:C06670,7,4,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H5O2Cl2,C7H3O2Cl2,189.9588347,190.9666598,188.95100971463,1608,cpd:C06671,"2,4-Dichlorobenzoyl-CoA",C28H38Cl2N7O17P3S,"2,4-Dichlorobenzoyl-CoA",R05276 R05451,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.21.1.2; 6.2.1.-,NA,NA,PubChem: 8896; ChEBI: 15470; NIKKAJI: J727.496C,cpd:C06671,28,38,17,7,3,1,2,0,0,0,0,0,0,0,0,0,0,0,C28H39O17N7P3S1Cl2,C28H37O17N7P3S1Cl2,939.0634803,940.0713054,938.05565531464,1609,cpd:C11272,Fluorobenzene,C6H5F,Fluorobenzene,R08103 R08104,Fluorobenzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.-,NA,NA,CAS: 462-06-6; PubChem: 13449; ChEBI: 5115; ChEMBL: CHEMBL16070; NIKKAJI: J43.543K,cpd:C11272; cpd:C16472; cpd:C16473; cpd:C16474; cpd:C16475; cpd:C16476; cpd:C16477; cpd:C16485,6,5,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C6H6F1,C6H4F1,96.03752832,97.04535336,95.029703291465,1610,cpd:C16246,"3,5-Dibromo-4-hydroxybenzamide",C7H5Br2NO2,"3,5-Dibromo-4-hydroxybenzamide",R07780 R07782,Fluorobenzoate degradation; Microbial metabolism in diverse environments,3.5.1.-; 4.2.1.84,NA,NA,CAS: 3037-56-7; PubChem: 47205554; ChEBI: 19896; NIKKAJI: J1.273.121C,cpd:C16246,7,5,2,1,0,0,0,0,2,0,0,0,0,0,0,0,0,0,C7H6O2N1Br2,C7H4O2N1Br2,292.8687036,293.8765286,291.86087861466,1611,cpd:C16247,"2,6-Dibromophenol",C6H4Br2O,"2,6-Dibromophenol",R07783 R07784,Fluorobenzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,NA,NA,NA,CAS: 608-33-3; PubChem: 47205555; ChEBI: 19391; ChEMBL: CHEMBL111507; KNApSAcK: C00036465; NIKKAJI: J28.698B,cpd:C14521; cpd:C16247,6,4,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,C6H5O1Br2,C6H3O1Br2,249.8628899,250.870715,248.85506491467,1612,cpd:C16248,"2,6-Dibromohydroquinone",C6H4Br2O2,"2,6-Dibromohydroquinone",R07779 R07784 R07785,Fluorobenzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.50,NA,NA,CAS: 3333-25-3; PubChem: 47205556; ChEBI: 19390; NIKKAJI: J13.024I,cpd:C16248,6,4,2,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,C6H5O2Br2,C6H3O2Br2,265.8578046,266.8656296,264.84997951468,1613,cpd:C16249,2-Bromomaleylacetate,C6H5BrO5,2-Bromomaleylacetate,R07781 R07785,Fluorobenzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.32,NA,NA,PubChem: 47205557; ChEBI: 19480; NIKKAJI: J2.799.189K,cpd:C16249,6,5,5,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C6H6O5Br1,C6H4O5Br1,235.9320359,236.9398609,234.92421081469,1614,cpd:C16472,3-Fluorocatechol,C6H5FO2,3-Fluorocatechol,R08111 R08114 R08123,Fluorobenzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.25; 1.3.1.-; 1.13.11.1,NA,NA,CAS: 363-52-0; PubChem: 47205768; ChEBI: 39876; PDB-CCD: 3FA; NIKKAJI: J100.369K,cpd:C16472; cpd:C16473,6,5,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C6H6O2F1,C6H4O2F1,128.0273576,129.0351826,127.01953251470,1615,cpd:C16473,4-Fluorocatechol,C6H5FO2,4-Fluorocatechol,R08105 R08112 R08113 R08115,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.25; 1.3.1.-; 1.13.11.1,NA,NA,CAS: 367-32-8; PubChem: 47205769; ChEBI: 80515; PDB-CCD: 3N8; NIKKAJI: J634.609J,cpd:C16472; cpd:C16473,6,5,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C6H6O2F1,C6H4O2F1,128.0273576,129.0351826,127.01953251471,1616,cpd:C16474,"3-Fluoro-cis,cis-muconate",C6H5FO4,"3-Fluoro-cis,cis-muconate",R08115 R08116,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.13.11.1; 5.5.1.1,NA,NA,PubChem: 47205770; ChEBI: 80516; NIKKAJI: J2.802.656K,cpd:C16474; cpd:C16475; cpd:C16476; cpd:C16477,6,5,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C6H6O4F1,C6H4O4F1,160.0171868,161.0250118,159.00936181472,1617,cpd:C16475,"2-Fluoro-cis,cis-muconate",C6H5FO4,"2-Fluoro-cis,cis-muconate",R08114 R08119,Fluorobenzoate degradation; Microbial metabolism in diverse environments,1.13.11.1; 5.5.1.7,NA,NA,PubChem: 47205771; ChEBI: 80517; NIKKAJI: J2.802.671D,cpd:C16474; cpd:C16475; cpd:C16476; cpd:C16477,6,5,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C6H6O4F1,C6H4O4F1,160.0171868,161.0250118,159.00936181473,1618,cpd:C16476,4-Fluoromuconolactone,C6H5FO4,4-Fluoromuconolactone,R08116 R08121,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.1.1.45; 5.5.1.1,NA,NA,PubChem: 47205772; ChEBI: 80518; NIKKAJI: J316.367I,cpd:C16474; cpd:C16475; cpd:C16476; cpd:C16477,6,5,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C6H6O4F1,C6H4O4F1,160.0171868,161.0250118,159.00936181474,1619,cpd:C16477,5-Fluoromuconolactone,C6H5FO4,5-Fluoromuconolactone,R08119 R08120,Fluorobenzoate degradation; Microbial metabolism in diverse environments,3.1.1.45; 5.5.1.7,NA,NA,PubChem: 47205773; ChEBI: 80519; NIKKAJI: J1.959.876D,cpd:C16474; cpd:C16475; cpd:C16476; cpd:C16477,6,5,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C6H6O4F1,C6H4O4F1,160.0171868,161.0250118,159.00936181475,1620,cpd:C16478,"3-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",C7H7FO4,"3-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",R08108 R08111,Fluorobenzoate degradation; Microbial metabolism in diverse environments,1.3.1.25; 1.14.12.10,NA,NA,PubChem: 47205774; ChEBI: 80520; NIKKAJI: J2.802.674I,cpd:C16478; cpd:C16479; cpd:C16480; cpd:C16481; cpd:C16482,7,7,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C7H8O4F1,C7H6O4F1,174.0328369,175.0406619,173.02501181476,1621,cpd:C16479,"5-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",C7H7FO4,"5-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",R08109 R08112,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.25; 1.14.12.10,NA,NA,PubChem: 47205775; ChEBI: 80521; NIKKAJI: J2.802.675G,cpd:C16478; cpd:C16479; cpd:C16480; cpd:C16481; cpd:C16482,7,7,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C7H8O4F1,C7H6O4F1,174.0328369,175.0406619,173.02501181477,1622,cpd:C16480,"4-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",C7H7FO4,"4-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",R08110 R08113,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.25; 1.14.12.10,NA,NA,PubChem: 47205776; ChEBI: 80522; NIKKAJI: J2.802.686B,cpd:C16478; cpd:C16479; cpd:C16480; cpd:C16481; cpd:C16482,7,7,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C7H8O4F1,C7H6O4F1,174.0328369,175.0406619,173.02501181478,1623,cpd:C16481,"6-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",C7H7FO4,"6-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",R08101 R08123,Fluorobenzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.14.12.10,NA,NA,PubChem: 47205777; ChEBI: 80523; NIKKAJI: J2.802.687K,cpd:C16478; cpd:C16479; cpd:C16480; cpd:C16481; cpd:C16482,7,7,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C7H8O4F1,C7H6O4F1,174.0328369,175.0406619,173.02501181479,1624,cpd:C16482,"2-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",C7H7FO4,"2-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",R08100 R08122,Fluorobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.1.-; 1.14.12.10,NA,NA,PubChem: 47205778; ChEBI: 80524; NIKKAJI: J2.802.704D,cpd:C16478; cpd:C16479; cpd:C16480; cpd:C16481; cpd:C16482,7,7,4,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C7H8O4F1,C7H6O4F1,174.0328369,175.0406619,173.02501181480,1625,cpd:C16483,"4-Fluorocyclohexadiene-cis,cis-1,2-diol",C6H7FO2,"4-Fluorocyclohexadiene-cis,cis-1,2-diol",R08103 R08105,Fluorobenzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.14.12.-,NA,NA,PubChem: 47205779; ChEBI: 80525; NIKKAJI: J2.502.676D,cpd:C16483; cpd:C16484,6,7,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C6H8O2F1,C6H6O2F1,130.0430076,131.0508327,129.03518261481,1626,cpd:C16484,"1-Fluorocyclohexadiene-cis,cis-1,2-diol",C6H7FO2,"1-Fluorocyclohexadiene-cis,cis-1,2-diol",R08104 R08106,Fluorobenzoate degradation; Microbial metabolism in diverse environments,1.14.12.-,NA,NA,PubChem: 47205780; ChEBI: 80526; NIKKAJI: J2.802.725G,cpd:C16483; cpd:C16484,6,7,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C6H8O2F1,C6H6O2F1,130.0430076,131.0508327,129.03518261482,1627,cpd:C00845,2-Furoyl-CoA,C26H38N7O18P3S,2-Furoyl-CoA,R02986 R02987,Furfural degradation; Microbial metabolism in diverse environments,1.3.99.8; 6.2.1.31,NA,NA,PubChem: 4102; ChEBI: 15474; NIKKAJI: J2.730.859G,cpd:C00845,26,38,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H39O18N7P3S1,C26H37O18N7P3S1,861.1206896,862.1285146,860.11286451483,1628,cpd:C01546,2-Furoate;,C5H4O3,2-Furoate; 2-Furoic acid; 2-Furancarboxylic acid; Pyromucic acid,R02986 R10212 R10213,Furfural degradation; Microbial metabolism in diverse environments,6.2.1.31,NA,NA,CAS: 88-14-2; PubChem: 4705; ChEBI: 16739 30845; ChEMBL: CHEMBL1232797; KNApSAcK: C00000151; PDB-CCD: FOA; 3DMET: B00315; NIKKAJI: J4.288I,cpd:C00366; cpd:C01546; cpd:C17206,5,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H5O3,C5H3O3,112.016044,113.023869,111.0082191484,1629,cpd:C03724,S-(5-Hydroxy-2-furoyl)-CoA,C26H38N7O19P3S,S-(5-Hydroxy-2-furoyl)-CoA,R02987 R10211,Furfural degradation; Microbial metabolism in diverse environments,1.3.99.8; 3.1.1.-,NA,NA,PubChem: 6489; ChEBI: 15510; NIKKAJI: J2.745.205A,cpd:C03724,26,38,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H39O19N7P3S1,C26H37O19N7P3S1,877.1156042,878.1234292,876.10777921485,1630,cpd:C11101,5-Hydroxymethyl-2-furaldehyde;,C6H6O3,5-Hydroxymethyl-2-furaldehyde; HMF; 5-Hydroxymethylfurfural,R10216 R10218 R10853 R10858,Furfural degradation; Microbial metabolism in diverse environments,1.1.1.-; 1.1.3.47,NA,NA,CAS: 67-47-0; PubChem: 13283; ChEBI: 412516; ChEMBL: CHEMBL185885; KNApSAcK: C00029547; PDB-CCD: FUX; NIKKAJI: J4.850J,cpd:C01108; cpd:C02183; cpd:C02752; cpd:C02814; cpd:C03277; cpd:C03762; cpd:C06011; cpd:C11101; cpd:C11918; cpd:C16355; cpd:C16359; cpd:C19268; cpd:C19321; cpd:C19322; cpd:C19323; cpd:C20670; cpd:C20718,6,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O3,C6H5O3,126.0316941,127.0395191,125.0238691486,1631,cpd:C14279,Furfural;,C5H4O2,Furfural; 2-Furaldehyde,R10212 R10217,Furfural degradation; Microbial metabolism in diverse environments,1.1.1.-,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C14279  Furfural,CAS: 98-01-1; PubChem: 17395279; ChEBI: 34768; ChEMBL: CHEMBL189362; KNApSAcK: C00030331; PDB-CCD: FU2; NIKKAJI: J3.981K,cpd:C00385; cpd:C07090; cpd:C07599; cpd:C14279; cpd:C16613; cpd:C19915,5,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H5O2,C5H3O2,96.02112937,97.0289544,95.013304341487,1632,cpd:C20441,Furfuryl alcohol;,C5H6O2,Furfuryl alcohol; 2-Furancarbinol; 2-Furanmethanol,R10217,Furfural degradation; Microbial metabolism in diverse environments,1.1.1.-,NA,NA,CAS: 98-00-0; PubChem: 163312178; ChEBI: 207496,cpd:C00178; cpd:C02835; cpd:C20441; cpd:C20578,5,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O2,C5H5O2,98.03677943,99.04460446,97.02895441488,1633,cpd:C20443,5-Hydroxymethylfurfuryl alcohol;,C6H8O3,"5-Hydroxymethylfurfuryl alcohol; 2,5-Bis(hydroxymethyl)furan",R10218,Furfural degradation; Microbial metabolism in diverse environments,1.1.1.-,NA,NA,CAS: 1883-75-6; PubChem: 163312180,cpd:C01125; cpd:C03636; cpd:C03680; cpd:C03817; cpd:C04397; cpd:C04398; cpd:C05568; cpd:C06719; cpd:C06761; cpd:C11354; cpd:C19468; cpd:C19481; cpd:C20240; cpd:C20385; cpd:C20443; cpd:C20717,6,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O3,C6H7O3,128.0473441,129.0551691,127.03951911489,1634,cpd:C20447,2-Oxoglutaryl-CoA;,C26H40N7O20P3S,2-Oxoglutaryl-CoA; 2-Oxoglutaroyl-CoA,R10210 R10211,Furfural degradation; Microbial metabolism in diverse environments,3.1.1.-,NA,NA,PubChem: 163312184,cpd:C20447,26,40,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H41O20N7P3S1,C26H39O20N7P3S1,895.1261689,896.1339939,894.11834381490,1635,cpd:C20450,"2,5-Furandicarboxylate;",C6H4O5,"2,5-Furandicarboxylate; Furan-2,5-dicarboxylate",R10213 R10857 R10858,Furfural degradation; Microbial metabolism in diverse environments,1.1.3.47,NA,NA,CAS: 3238-40-2; PubChem: 163312187,cpd:C02496; cpd:C12835; cpd:C20450,6,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H5O5,C6H3O5,156.0058732,157.0136983,154.99804821491,1636,cpd:C00108,Anthranilate;,C7H7NO2,Anthranilate; Anthranilic acid; o-Aminobenzoic acid; Vitamin L1; 2-Aminobenzoate,R00823 R00825 R00980 R00982 R00983 R00984 R00985 R00986; R00987 R00988 R00989 R00990 R00991 R01073 R01816 R02453; R05365 R07734 R08473 R08477 R09517 R10451 R10495,"Tryptophan metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Dioxin degradation; Aminobenzoate degradation; Acridone alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Degradation of aromatic compounds; Biosynthesis of amino acids; Benzoic acid family",1.4.-.-; 1.13.11.23; 1.14.12.1; 1.14.13.35; 1.14.14.8; 1.14.16.3; 2.1.1.111; 2.1.1.277; 2.3.1.113; 2.3.1.144; 2.4.2.18; 3.5.1.9; 3.7.1.3; 3.7.1.13; 4.1.1.24; 4.1.3.27; 6.2.1.32; 6.3.2.40,"Tryptophan biosynthesis, chorismate => tryptophan; Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate; Anthranilate degradation, anthranilate => catechol",Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00108  Anthranilate,CAS: 118-92-3; PubChem: 3408; ChEBI: 16567 30754; ChEMBL: CHEMBL14173; KNApSAcK: C00007382; PDB-CCD: BE2; 3DMET: B00027; NIKKAJI: J2.912B,cpd:C00108; cpd:C00568; cpd:C01004; cpd:C14394; cpd:C16285; cpd:C19486; cpd:C19597,7,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O2N1,C7H6O2N1,137.0476785,138.0555035,136.03985341492,1637,cpd:C00328,L-Kynurenine;,C10H12N2O3,L-Kynurenine; 3-Anthraniloyl-L-alanine,R00987 R01956 R01957 R01959 R01960,Tryptophan metabolism; Metabolic pathways; African trypanosomiasis,1.14.13.9; 2.6.1.7; 2.6.1.63; 3.5.1.9; 3.7.1.3,"Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate",NA,CAS: 2922-83-0; PubChem: 3622; ChEBI: 16946; ChEMBL: CHEMBL498416; PDB-CCD: KYN; 3DMET: B01218; NIKKAJI: J208.656E J5.688J,cpd:C00328; cpd:C01718; cpd:C05647; cpd:C10965; cpd:C16880,10,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O3N2,C10H11O3N2,208.0847923,209.0926173,207.07696721493,1638,cpd:C00331,Indolepyruvate;,C11H9NO3,Indolepyruvate; Indolepyruvic acid; (Indol-3-yl)pyruvate; Indole-3-pyruvate; 3-(Indol-3-yl)pyruvate,R00675 R00676 R00677 R00684 R01376 R01971 R01972 R01973; R01974 R07161 R10180 R10181,Tryptophan metabolism; Metabolic pathways,1.1.1.110; 1.2.7.8; 1.4.1.19; 1.4.3.2; 1.14.13.168; 2.1.1.47; 2.6.1.27; 2.6.1.28; 2.6.1.99; 4.1.1.43; 4.1.1.74,NA,NA,CAS: 392-12-1; PubChem: 3625; ChEBI: 29750; ChEMBL: CHEMBL485012; KNApSAcK: C00007571; PDB-CCD: 3IO; 3DMET: B00089; NIKKAJI: J39.033J,cpd:C00331; cpd:C10127; cpd:C18928,11,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H10O3N1,C11H8O3N1,203.0582432,204.0660682,202.05041811494,1639,cpd:C00398,Tryptamine;,C10H12N2,Tryptamine; 3-(2-Aminoethyl)indole,R00685 R02173 R02174 R03738 R05895 R08479 R08481 R08482; R08483 R08484 R08604,Tryptophan metabolism; Indole alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Neuroactive ligand-receptor interaction,1.4.3.4; 1.4.3.22; 1.14.13.-; 2.1.1.49; 4.1.1.28; 4.3.3.2,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C00398  Tryptamine,CAS: 61-54-1; PubChem: 3688; ChEBI: 16765; ChEMBL: CHEMBL6640; KNApSAcK: C00001434; PDB-CCD: TSS; 3DMET: B00104; NIKKAJI: J4.816J,cpd:C00328; cpd:C00398; cpd:C00780; cpd:C01718; cpd:C02548; cpd:C02794; cpd:C03227; cpd:C05647; cpd:C05651; cpd:C07147; cpd:C07312; cpd:C07756; cpd:C09907; cpd:C10126; cpd:C10965; cpd:C14302; cpd:C16151; cpd:C16880; cpd:C16906; cpd:C17203; cpd:C18671; cpd:C21075; cpd:C21154,10,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13N2,C10H11N2,160.1000484,161.1078734,159.09222341495,1640,cpd:C00463,Indole;,C8H7N,"Indole; 2,3-Benzopyrrole",R00673 R00674 R02338 R02339 R02340 R07403 R08609 R09488,"Tryptophan metabolism; Phenylalanine, tyrosine and tryptophan biosynthesis; Benzoxazinoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Protein digestion and absorption",1.13.11.17; 1.14.13.137; 1.14.16.-; 2.5.1.-; 4.1.1.92; 4.1.2.8; 4.1.99.1; 4.2.1.20; 4.2.1.122,NA,NA,CAS: 120-72-9; PubChem: 3747; ChEBI: 16881; ChEMBL: CHEMBL15844; KNApSAcK: C00001418; PDB-CCD: IND; 3DMET: B01251; NIKKAJI: J2.920C,cpd:C00463; cpd:C00561; cpd:C00650; cpd:C00971; cpd:C02040; cpd:C02615; cpd:C02660; cpd:C02775; cpd:C02803; cpd:C03098; cpd:C03574; cpd:C03742; cpd:C03757; cpd:C03766; cpd:C04604; cpd:C05578; cpd:C05653; cpd:C05658; cpd:C06050; cpd:C06052; cpd:C06661; cpd:C09957; cpd:C10910; cpd:C11130; cpd:C12312; cpd:C15769; cpd:C15770; cpd:C15771; cpd:C16074; cpd:C19062; cpd:C21155,8,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8N1,C8H6N1,117.0578492,118.0656743,116.05002421496,1641,cpd:C00632,3-Hydroxyanthranilate;,C7H7NO3,3-Hydroxyanthranilate; 3-Hydroxyanthranilic acid,R01816 R02665 R02666 R02667 R02668 R02669 R02670 R02671; R07730 R09517,Tryptophan metabolism; Aminobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.10.3.5; 1.11.1.6; 1.11.1.21; 1.13.11.6; 1.14.14.8; 1.14.16.3; 2.1.1.97; 2.1.1.-; 3.7.1.3; 4.1.1.-; 5.4.99.-,"Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate",NA,CAS: 548-93-6; PubChem: 3905; ChEBI: 15793 36559; ChEMBL: CHEMBL445304; KNApSAcK: C00007568; PDB-CCD: 3HA; 3DMET: B00150; NIKKAJI: J1.608J,cpd:C00632; cpd:C01270; cpd:C02518; cpd:C06669; cpd:C07555; cpd:C11343; cpd:C12107; cpd:C12115; cpd:C14520; cpd:C16235; cpd:C19270,7,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O3N1,C7H6O3N1,153.0425931,154.0504181,152.03476811497,1642,cpd:C00637,Indole-3-acetaldehyde;,C10H9NO,Indole-3-acetaldehyde; 2-(Indol-3-yl)acetaldehyde; Indoleacetaldehyde,R01974 R02173 R02678 R02679 R02680 R02681 R08606,Tryptophan metabolism; Metabolic pathways,1.1.1.190; 1.1.1.191; 1.2.1.3; 1.2.3.7; 1.4.3.4; 1.4.3.22; 1.7.3.-; 4.1.1.43; 4.1.1.74,NA,NA,CAS: 2591-98-2; PubChem: 3910; ChEBI: 18086; KNApSAcK: C00000109; 3DMET: B00152; NIKKAJI: J398.271H,cpd:C00637; cpd:C06345; cpd:C10663; cpd:C11048; cpd:C14789; cpd:C19046; cpd:C19049,10,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O1N1,C10H8O1N1,159.0684139,160.0762389,158.06058891498,1643,cpd:C00643,5-Hydroxy-L-tryptophan;,C11H12N2O3,5-Hydroxy-L-tryptophan; Oxitriptan,R01814 R02700 R02701 R02702 R07213,Tryptophan metabolism; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Serotonergic synapse,1.13.11.52; 1.14.16.4; 2.6.1.27; 4.1.1.28,"Melatonin biosynthesis, tryptophan => serotonin => melatonin",Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N06 PSYCHOANALEPTICS;    N06A ANTIDEPRESSANTS;     N06AX Other antidepressants;      N06AX01 Oxitriptan;       D07339  Oxitriptan (INN),CAS: 4350-09-8; PubChem: 3916; ChEBI: 17780; ChEMBL: CHEMBL350221; KNApSAcK: C00001371; PDB-CCD: 4PQ; 3DMET: B01298; NIKKAJI: J4.572A,cpd:C00643; cpd:C01017; cpd:C09985; cpd:C19716,11,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O3N2,C11H11O3N2,220.0847923,221.0926173,219.07696721499,1644,cpd:C00780,Serotonin;,C10H12N2O,Serotonin; 3-(2-Aminoethyl)-1H-indol-5-ol; 5-Hydroxytryptamine; Enteramine,R02701 R02908 R02909 R02910 R02911 R02912,Tryptophan metabolism; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; cAMP signaling pathway; Neuroactive ligand-receptor interaction; Gap junction; Synaptic vesicle cycle; Serotonergic synapse; Taste transduction; Inflammatory mediator regulation of TRP channels; Bile secretion; Serotonin receptor agonists/antagonists,1.4.3.4; 1.13.11.52; 2.1.1.49; 2.1.1.-; 2.3.1.87; 4.1.1.28,"Melatonin biosynthesis, tryptophan => serotonin => melatonin",Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C00780  Serotonin;  Hormones and transmitters;   Neurotransmitters;    Biogenic amines;     C00780  Serotonin; Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C00780  Serotonin,CAS: 50-67-9; PubChem: 4041; ChEBI: 28790; ChEMBL: CHEMBL39; KNApSAcK: C00001429; PDB-CCD: SRO; 3DMET: B00173; NIKKAJI: J4.107F,cpd:C00780; cpd:C17203; cpd:C21075,10,12,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O1N2,C10H11O1N2,176.094963,177.102788,175.0871381500,1645,cpd:C00954,Indole-3-acetate;,C10H9NO2,Indole-3-acetate; Indole-3-acetic acid; (Indol-3-yl)acetate; Indoleacetate; Indoleacetic acid; IAA,R02678 R02681 R03092 R03093 R03094 R03095 R03096 R03097; R08609 R10181 R10452,Tryptophan metabolism; Biosynthesis of plant hormones; Metabolic pathways; Plant hormone signal transduction,1.2.1.3; 1.2.3.7; 1.13.11.-; 1.14.13.168; 2.1.1.278; 2.4.1.121; 2.5.1.-; 3.5.1.4; 3.5.5.1; 6.3.2.20,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C00954  Indole-3-acetate; Pesticides [BR:br08007];  Pesticides;   Plant growth regulators;    Auxins;     C00954  Indole-3-acetate,CAS: 87-51-4; PubChem: 4205; ChEBI: 16411; ChEMBL: CHEMBL82411; KNApSAcK: C00000100; PDB-CCD: IAC; 3DMET: B00206; NIKKAJI: J5.156J,cpd:C00954; cpd:C01386; cpd:C02298; cpd:C03230; cpd:C05634; cpd:C06331; cpd:C06344; cpd:C06525; cpd:C11504; cpd:C18754,10,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O2N1,C10H8O2N1,175.0633285,176.0711536,174.05550351501,1646,cpd:C00955,Indole-3-ethanol;,C10H11NO,Indole-3-ethanol; Tryptophol,R02679 R02680,Tryptophan metabolism,1.1.1.190; 1.1.1.191,NA,NA,CAS: 526-55-6; PubChem: 4206; ChEBI: 17890; ChEMBL: CHEMBL226545; KNApSAcK: C00000114; 3DMET: B00207; NIKKAJI: J6.661C,cpd:C00955; cpd:C09915,10,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H12O1N1,C10H10O1N1,161.084064,162.091889,160.07623891502,1647,cpd:C00978,N-Acetylserotonin;,C12H14N2O2,N-Acetylserotonin; N-Acetyl-5-hydroxytryptamine,R02911 R03130,Tryptophan metabolism; Metabolic pathways,2.1.1.4; 2.3.1.87,"Melatonin biosynthesis, tryptophan => serotonin => melatonin",NA,CAS: 1210-83-9; PubChem: 4227; ChEBI: 17697; ChEMBL: CHEMBL33103; PDB-CCD: ASE; 3DMET: B00212; NIKKAJI: J125.886I,cpd:C00978; cpd:C02983; cpd:C07371; cpd:C16831; cpd:C20130,12,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H15O2N2,C12H13O2N2,218.1055277,219.1133527,217.09770271503,1648,cpd:C01111,"7,8-Dihydroxykynurenate",C10H7NO5,"7,8-Dihydroxykynurenate",R03251 R03253,Tryptophan metabolism,1.3.1.18; 1.13.11.10,NA,NA,PubChem: 4343; ChEBI: 17508; 3DMET: B00242; NIKKAJI: J2.380.286D,cpd:C01111; cpd:C21307,10,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O5N1,C10H6O5N1,221.0324223,222.0402474,220.02459731504,1649,cpd:C01249,"7,8-Dihydro-7,8-dihydroxykynurenate",C10H9NO5,"7,8-Dihydro-7,8-dihydroxykynurenate",R03251 R03439 R03440 R03441,Tryptophan metabolism,1.3.1.18; 1.14.99.2,NA,NA,PubChem: 4469; ChEBI: 17109; 3DMET: B04787; NIKKAJI: J2.732.000G,cpd:C01249; cpd:C03147; cpd:C05645; cpd:C05652; cpd:C19686,10,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O5N1,C10H8O5N1,223.0480724,224.0558974,222.04024741505,1650,cpd:C01252,"4-(2-Aminophenyl)-2,4-dioxobutanoate",C10H9NO4,"4-(2-Aminophenyl)-2,4-dioxobutanoate",R01956 R01957 R03445,Tryptophan metabolism; Metabolic pathways,2.6.1.7; 2.6.1.63,NA,NA,PubChem: 4472; ChEBI: 17442; PDB-CCD: 3EE; 3DMET: B00265; NIKKAJI: J1.771.656E,cpd:C01252; cpd:C05835; cpd:C12466; cpd:C14801,10,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O4N1,C10H8O4N1,207.0531578,208.0609828,206.04533271506,1651,cpd:C01598,Melatonin;,C13H16N2O2,Melatonin; N-Acetyl-5-methoxytryptamine,R03130 R03628 R03629,Tryptophan metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction; Circadian entrainment,1.13.11.52; 1.14.14.1; 2.1.1.4,"Melatonin biosynthesis, tryptophan => serotonin => melatonin",Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Other hormones;    Melatonin;     C01598  Melatonin; Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C01598  Melatonin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N05 PSYCHOLEPTICS;    N05C HYPNOTICS AND SEDATIVES;     N05CH Melatonin receptor agonists;      N05CH01 Melatonin;       D08170  Melatonin; Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Melatonin;     melatonin receptor 1A;      Melatonin;       D08170  Melatonin;     melatonin receptor 1B;      Melatonin;       D08170  Melatonin; Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP1A2;    Melatonin;     D08170  Melatonin; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tryptophan and anthranillic acid;    Indole alkaloids;     D08170  Melatonin; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D08170,CAS: 73-31-4; PubChem: 4752; ChEBI: 16796; ChEMBL: CHEMBL319970; PDB-CCD: ML1; 3DMET: B00330; NIKKAJI: J5.258B,cpd:C01598; cpd:C07617,13,16,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H17O2N2,C13H15O2N2,232.1211778,233.1290028,231.11335271507,1652,cpd:C01717,4-Hydroxy-2-quinolinecarboxylic acid;,C10H7NO3,4-Hydroxy-2-quinolinecarboxylic acid; Kynurenic acid; Kynurenate,R03439 R03440 R03441 R03445 R03687,Tryptophan metabolism; Metabolic pathways,1.3.99.18; 1.14.99.2,NA,NA,CAS: 492-27-3; PubChem: 4854; ChEBI: 18344; ChEMBL: CHEMBL299155; KNApSAcK: C00026453 C00026494; PDB-CCD: KYA; 3DMET: B00336; NIKKAJI: J6.059C,cpd:C01717; cpd:C02172; cpd:C14800; cpd:C14802; cpd:C16715; cpd:C18621,10,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O3N1,C10H6O3N1,189.0425931,190.0504181,188.03476811508,1653,cpd:C01987,2-Aminophenol;,C6H7NO,2-Aminophenol; 2-Hydroxyaniline; 2-Aminobenzenol; o-Aminophenol,R00074 R02669 R05383 R05405 R08762,Tryptophan metabolism; Aminobenzoate degradation; Microbial metabolism in diverse environments,1.10.3.4; 1.13.11.74; 4.1.1.-; 5.4.4.1,NA,NA,CAS: 95-55-6; PubChem: 5084; ChEBI: 18112; ChEMBL: CHEMBL28319; KNApSAcK: C00007533; PDB-CCD: 2AF; 3DMET: B00377; NIKKAJI: J3.955A,cpd:C01987; cpd:C02372; cpd:C02720; cpd:C05058,6,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O1N1,C6H6O1N1,109.0527638,110.0605889,108.04493881509,1654,cpd:C02043,Indolelactate,C11H11NO3,Indolelactate,R01971,Tryptophan metabolism,1.1.1.110,NA,NA,CAS: 1821-52-9; PubChem: 5133; ChEBI: 17282 24813; ChEMBL: CHEMBL485011; 3DMET: B04834; NIKKAJI: J1.354.164G J101.661J,cpd:C02043; cpd:C05660; cpd:C09961; cpd:C10741,11,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H12O3N1,C11H10O3N1,205.0738932,206.0817182,204.06606821510,1655,cpd:C02161,2-Aminophenoxazin-3-one;,C12H8N2O2,2-Aminophenoxazin-3-one; 3-Aminophenoxazone; Isophenoxazine,R00074 R08763,Tryptophan metabolism,1.10.3.4,NA,NA,CAS: 1916-59-2; PubChem: 5237; ChEBI: 17293; ChEMBL: CHEMBL146710; KNApSAcK: C00018683; 3DMET: B00393,cpd:C02161,12,8,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H9O2N2,C12H7O2N2,212.0585775,213.0664025,211.05075251511,1656,cpd:C02172,N-Acetylisatin;,C10H7NO3,N-Acetylisatin; 1-Acetylisatin,R03873,Tryptophan metabolism,1.7.3.2,NA,NA,CAS: 574-17-4; PubChem: 5247; ChEBI: 16050; ChEMBL: CHEMBL223001; 3DMET: B00396; NIKKAJI: J6.554D,cpd:C01717; cpd:C02172; cpd:C14800; cpd:C14802; cpd:C16715; cpd:C18621,10,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O3N1,C10H6O3N1,189.0425931,190.0504181,188.03476811512,1657,cpd:C02220,2-Aminomuconate;,C6H7NO4,2-Aminomuconate; 2-Aminomuconic acid; o-Aminomuconate,R01937 R01938 R03887 R03889 R11532,Tryptophan metabolism; Metabolic pathways,1.2.1.32; 1.5.1.-; 3.5.1.120; 3.5.99.5,"Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate",NA,PubChem: 5285; ChEBI: 16886; LIPIDMAPS: LMFA01170082; 3DMET: B00406; NIKKAJI: J1.127.187A,cpd:C02220; cpd:C11327; cpd:C14293; cpd:C17358,6,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O4N1,C6H6O4N1,157.0375077,158.0453327,156.02968271513,1658,cpd:C02298,N-Acetylindoxyl;,C10H9NO2,N-Acetylindoxyl; Acetylindoxyl,R03873 R03911,Tryptophan metabolism,1.7.3.2,NA,NA,PubChem: 5353; ChEBI: 15363; 3DMET: B00421; NIKKAJI: J2.368.985E,cpd:C00954; cpd:C01386; cpd:C02298; cpd:C03230; cpd:C05634; cpd:C06331; cpd:C06344; cpd:C06525; cpd:C11504; cpd:C18754,10,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O2N1,C10H8O2N1,175.0633285,176.0711536,174.05550351514,1659,cpd:C02470,Xanthurenic acid;,C10H7NO4,Xanthurenic acid; Xanthurenate,R03954 R03955,Tryptophan metabolism,2.1.1.-,NA,NA,CAS: 59-00-7; PubChem: 5485; ChEBI: 71201; ChEMBL: CHEMBL312535; PDB-CCD: 4KL; 3DMET: B00447; NIKKAJI: J8.600B,cpd:C02470; cpd:C05663; cpd:C08480; cpd:C21306,10,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O4N1,C10H6O4N1,205.0375077,206.0453327,204.02968271515,1660,cpd:C02693,(Indol-3-yl)acetamide;,C10H10N2O,(Indol-3-yl)acetamide; Indole-3-acetamide,R00679 R03096 R04020,Tryptophan metabolism,1.13.12.3; 3.5.1.4; 4.2.1.84,NA,NA,CAS: 879-37-8; PubChem: 5661; ChEBI: 16031; KNApSAcK: C00000108; PDB-CCD: TSR; 3DMET: B00485; NIKKAJI: J128.124K,cpd:C02693; cpd:C02937; cpd:C13008; cpd:C14081; cpd:C16516,10,10,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O1N2,C10H9O1N2,174.079313,175.087138,173.07148791516,1661,cpd:C02700,L-Formylkynurenine;,C11H12N2O4,L-Formylkynurenine; N-Formyl-L-kynurenine; N-Formylkynurenine,R00678 R01959 R03936,Tryptophan metabolism; Metabolic pathways,1.13.11.11; 1.13.11.52; 3.5.1.9; 3.7.1.3,"Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate",NA,CAS: 1022-31-7; PubChem: 5664; ChEBI: 30249; KNApSAcK: C00007605; PDB-CCD: NFK; 3DMET: B01595; NIKKAJI: J426.764H,cpd:C02700; cpd:C15605; cpd:C19717,11,12,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O4N2,C11H11O4N2,236.0797069,237.0875319,235.07188181517,1662,cpd:C02775,"2,3-Dihydroxyindole;",C8H7NO2,"2,3-Dihydroxyindole; Dihydroxyindole",R00983,Tryptophan metabolism,1.13.11.23,NA,NA,PubChem: 5727; ChEBI: 17828; 3DMET: B01600; NIKKAJI: J41.053E,cpd:C00650; cpd:C02775; cpd:C03574; cpd:C03742; cpd:C05578; cpd:C09957; cpd:C11130; cpd:C19062,8,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O2N1,C8H6O2N1,149.0476785,150.0555035,148.03985341518,1663,cpd:C02937,Indole-3-acetaldehyde oxime;,C10H10N2O,Indole-3-acetaldehyde oxime; Indole-3-acetaldoxime; 3-Indoleacetaldoxime; (E)-Indol-3-ylacetaldoxime,R04093 R08160 R08168 R08605 R08606 R08607 R09585,Tryptophan metabolism; Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.7.3.-; 1.14.13.125; 1.14.-.-; 2.5.1.-; 4.99.1.6,"Glucosinolate biosynthesis, tryptophan => glucobrassicin",NA,PubChem: 5856; ChEBI: 17545; KNApSAcK: C00000110; 3DMET: B00517; NIKKAJI: J703.710D,cpd:C02693; cpd:C02937; cpd:C13008; cpd:C14081; cpd:C16516,10,10,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O1N2,C10H9O1N2,174.079313,175.087138,173.07148791519,1664,cpd:C02938,3-Indoleacetonitrile;,C10H8N2,3-Indoleacetonitrile; Indol-3-ylacetonitrile; Indole-3-acetonitrile; (Indol-3-yl)acetonitrile,R03093 R04020 R04093 R04094,Tryptophan metabolism,3.2.1.147; 3.5.5.1; 4.2.1.84; 4.99.1.6,NA,NA,CAS: 771-51-7; PubChem: 5857; ChEBI: 17566; ChEMBL: CHEMBL1812654; KNApSAcK: C00000107; 3DMET: B00518; NIKKAJI: J1.733G,cpd:C02938; cpd:C16731; cpd:C19959; cpd:C20381; cpd:C21109,10,8,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9N2,C10H7N2,156.0687483,157.0765733,155.06092321520,1665,cpd:C03227,3-Hydroxy-L-kynurenine,C10H12N2O4,3-Hydroxy-L-kynurenine,R01960 R02668 R04171 R04172,Tryptophan metabolism; Metabolic pathways,1.14.13.9; 2.6.1.7; 3.7.1.3; 4.1.1.-,"Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate",NA,CAS: 606-14-4; PubChem: 6099; ChEBI: 17380; KNApSAcK: C00007443; PDB-CCD: 3DJ; 3DMET: B01641; NIKKAJI: J14.711G,cpd:C02794; cpd:C03227; cpd:C05651; cpd:C07312,10,12,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O4N2,C10H11O4N2,224.0797069,225.0875319,223.07188181521,1666,cpd:C03230,(Indol-3-yl)glycolaldehyde;,C10H9NO2,(Indol-3-yl)glycolaldehyde; 3-Indoleglycolaldehyde,R00681,Tryptophan metabolism,1.13.99.3,NA,NA,PubChem: 6101; ChEBI: 15976; 3DMET: B04885; NIKKAJI: J2.368.984G,cpd:C00954; cpd:C01386; cpd:C02298; cpd:C03230; cpd:C05634; cpd:C06331; cpd:C06344; cpd:C06525; cpd:C11504; cpd:C18754,10,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O2N1,C10H8O2N1,175.0633285,176.0711536,174.05550351522,1667,cpd:C03574,2-Formylaminobenzaldehyde,C8H7NO2,2-Formylaminobenzaldehyde,R02338,Tryptophan metabolism,1.13.11.17,NA,NA,PubChem: 6366; ChEBI: 18033; 3DMET: B00603; NIKKAJI: J892.750B,cpd:C00650; cpd:C02775; cpd:C03574; cpd:C03742; cpd:C05578; cpd:C09957; cpd:C11130; cpd:C19062,8,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O2N1,C8H6O2N1,149.0476785,150.0555035,148.03985341523,1668,cpd:C03722,Quinolinate;,C7H5NO4,"Quinolinate; Pyridine-2,3-dicarboxylate; Quinolinic acid; 2,3-Pyridinedicarboxylic acid",R00915 R03348 R04292 R04293,"Tryptophan metabolism; beta-Alanine metabolism; Nicotinate and nicotinamide metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways",2.4.2.19; 2.5.1.72,"NAD biosynthesis, aspartate => NAD",NA,CAS: 89-00-9; PubChem: 6487; ChEBI: 16675; ChEMBL: CHEMBL286204; KNApSAcK: C00007381; PDB-CCD: NTM; 3DMET: B00627; NIKKAJI: J4.298F,cpd:C03722; cpd:C16234; cpd:C18625,7,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H6O4N1,C7H4O4N1,167.0218576,168.0296827,166.01403261524,1669,cpd:C03824,2-Aminomuconate semialdehyde;,C6H7NO3,2-Aminomuconate semialdehyde; 2-Aminomuconate 6-semialdehyde,R03889 R04323 R05405 R11022,Tryptophan metabolism; Aminobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.2.1.32; 1.13.11.74; 4.1.1.45,"Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate",NA,PubChem: 6567; ChEBI: 15745; LIPIDMAPS: LMFA01060191; KNApSAcK: C00007492; 3DMET: B00642; NIKKAJI: J1.127.187A,cpd:C03824; cpd:C04226; cpd:C06333; cpd:C06334; cpd:C06335; cpd:C09960,6,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O3N1,C6H6O3N1,141.0425931,142.0504181,140.03476811525,1670,cpd:C04409,2-Amino-3-carboxymuconate semialdehyde;,C7H7NO5,2-Amino-3-carboxymuconate semialdehyde; 2-Amino-3-(3-oxoprop-1-enyl)-but-2-enedioate; 2-Amino-3-(3-oxoprop-1-en-1-yl)but-2-enedioate,R02665 R04293 R04323,Tryptophan metabolism; Metabolic pathways,1.13.11.6; 4.1.1.45,"Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate",NA,PubChem: 7044; ChEBI: 995; 3DMET: B00709; NIKKAJI: J413.580F,cpd:C04409,7,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O5N1,C7H6O5N1,185.0324223,186.0402474,184.02459731526,1671,cpd:C05634,5-Hydroxyindoleacetaldehyde,C10H9NO2,5-Hydroxyindoleacetaldehyde,R02908 R04903 R04904,Tryptophan metabolism; Metabolic pathways,1.2.1.3; 1.2.3.1; 1.4.3.4,NA,NA,PubChem: 7945; ChEBI: 50157; 3DMET: B00814; NIKKAJI: J139.626I,cpd:C00954; cpd:C01386; cpd:C02298; cpd:C03230; cpd:C05634; cpd:C06331; cpd:C06344; cpd:C06525; cpd:C11504; cpd:C18754,10,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O2N1,C10H8O2N1,175.0633285,176.0711536,174.05550351527,1672,cpd:C05635,5-Hydroxyindoleacetate,C10H9NO3,5-Hydroxyindoleacetate,R04903 R04904 R04905 R04906,Tryptophan metabolism; Metabolic pathways; Serotonergic synapse,1.2.1.3; 1.2.3.1; 2.1.1.4; 6.3.2.-,NA,NA,PubChem: 7946; ChEBI: 27823; PDB-CCD: HID; 3DMET: B00815; NIKKAJI: J11.030B,cpd:C05635; cpd:C06725; cpd:C16596; cpd:C18483,10,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O3N1,C10H8O3N1,191.0582432,192.0660682,190.05041811528,1673,cpd:C05636,3-Hydroxykynurenamine,C9H12N2O2,3-Hydroxykynurenamine,R04172 R04907,Tryptophan metabolism,1.4.3.4; 4.1.1.-,NA,NA,PubChem: 7947; ChEBI: 27421; 3DMET: B00816; NIKKAJI: J2.069.296K,cpd:C05636; cpd:C05638; cpd:C12033; cpd:C19415,9,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13O2N2,C9H11O2N2,180.0898776,181.0977027,179.08205261529,1674,cpd:C05637,"4,8-Dihydroxyquinoline;",C9H7NO2,"4,8-Dihydroxyquinoline; Quinoline-4,8-diol",R04907,Tryptophan metabolism,1.4.3.4,NA,NA,PubChem: 7948; ChEBI: 28883; 3DMET: B00817; NIKKAJI: J1.576.862B,cpd:C05637; cpd:C05639; cpd:C06330; cpd:C06342; cpd:C11503; cpd:C16716; cpd:C19837,9,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H8O2N1,C9H6O2N1,161.0476785,162.0555035,160.03985341530,1675,cpd:C05638,5-Hydroxykynurenamine,C9H12N2O2,5-Hydroxykynurenamine,R04908 R04909,Tryptophan metabolism,1.4.3.4; 4.1.1.28,NA,NA,PubChem: 7949; ChEBI: 28715; 3DMET: B00818; NIKKAJI: J2.367.443B,cpd:C05636; cpd:C05638; cpd:C12033; cpd:C19415,9,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13O2N2,C9H11O2N2,180.0898776,181.0977027,179.08205261531,1676,cpd:C05639,"4,6-Dihydroxyquinoline;",C9H7NO2,"4,6-Dihydroxyquinoline; Quinoline-4,6-diol",R04908,Tryptophan metabolism,1.4.3.4,NA,NA,PubChem: 7950; ChEBI: 28799; 3DMET: B00819; NIKKAJI: J2.366.464J,cpd:C05637; cpd:C05639; cpd:C06330; cpd:C06342; cpd:C11503; cpd:C16716; cpd:C19837,9,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H8O2N1,C9H6O2N1,161.0476785,162.0555035,160.03985341532,1677,cpd:C05640,Cinnavalininate;,C14H8N2O6,Cinnavalininate; Cinnabarinic acid,R02670,Tryptophan metabolism,1.11.1.6; 1.11.1.21,NA,NA,CAS: 606-59-7; PubChem: 7951; ChEBI: 3715; 3DMET: B00820; NIKKAJI: J21.374H,cpd:C05640,14,8,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H9O6N2,C14H7O6N2,300.038236,301.046061,299.0304111533,1678,cpd:C05641,"5-(3'-Carboxy-3'-oxopropenyl)-4,6-dihydroxypicolinate;",C10H7NO7,"5-(3'-Carboxy-3'-oxopropenyl)-4,6-dihydroxypicolinate; 5-(3-Carboxy-3-oxopropenyl)-4,6-dihydroxypyridine-2-carboxylate",R03253 R04910,Tryptophan metabolism,1.3.1.-; 1.13.11.10,NA,NA,PubChem: 7952; ChEBI: 2012 86002; 3DMET: B05084; NIKKAJI: J2.756.633B,cpd:C05641,10,7,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O7N1,C10H6O7N1,253.0222516,254.0300766,252.01442651534,1679,cpd:C05642,Formyl-N-acetyl-5-methoxykynurenamine,C13H16N2O4,Formyl-N-acetyl-5-methoxykynurenamine,R03628,Tryptophan metabolism,1.13.11.52,NA,NA,PubChem: 7953; ChEBI: 28613; ChEMBL: CHEMBL1882218; 3DMET: B00821; NIKKAJI: J1.007.065A,cpd:C04148; cpd:C05642,13,16,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H17O4N2,C13H15O4N2,264.111007,265.118832,263.1031821535,1680,cpd:C05643,6-Hydroxymelatonin,C13H16N2O3,6-Hydroxymelatonin,R03629,Tryptophan metabolism,1.14.14.1,NA,NA,CAS: 2208-41-5; PubChem: 7954; ChEBI: 2198; ChEMBL: CHEMBL127421; 3DMET: B00822; NIKKAJI: J102.947I,cpd:C05643,13,16,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H17O3N2,C13H15O3N2,248.1160924,249.1239174,247.10826741536,1681,cpd:C05644,3-Methylindolepyruvate,C12H11NO3,3-Methylindolepyruvate,R01973,Tryptophan metabolism,2.1.1.47,NA,NA,PubChem: 7955; ChEBI: 28549; 3DMET: B05085; NIKKAJI: J2.756.638C,cpd:C05644; cpd:C18735; cpd:C21289,12,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H12O3N1,C12H10O3N1,217.0738932,218.0817182,216.06606821537,1682,cpd:C05645,"4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoate",C10H9NO5,"4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoate",R03954 R04171,Tryptophan metabolism,2.6.1.7,NA,NA,PubChem: 7956; ChEBI: 27593; 3DMET: B00823; NIKKAJI: J2.756.639A,cpd:C01249; cpd:C03147; cpd:C05645; cpd:C05652; cpd:C19686,10,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O5N1,C10H8O5N1,223.0480724,224.0558974,222.04024741538,1683,cpd:C05646,5-Hydroxyindolepyruvate,C11H9NO4,5-Hydroxyindolepyruvate,R02700,Tryptophan metabolism,2.6.1.27,NA,NA,PubChem: 7957; ChEBI: 27597; 3DMET: B00824; NIKKAJI: J2.756.640E,cpd:C05646; cpd:C05830,11,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H10O4N1,C11H8O4N1,219.0531578,220.0609828,218.04533271539,1684,cpd:C05647,Formyl-5-hydroxykynurenamine,C10H12N2O3,Formyl-5-hydroxykynurenamine,R02909,Tryptophan metabolism,1.13.11.52,NA,NA,PubChem: 7958; ChEBI: 28736; 3DMET: B00825; NIKKAJI: J2.756.641C,cpd:C00328; cpd:C01718; cpd:C05647; cpd:C10965; cpd:C16880,10,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O3N2,C10H11O3N2,208.0847923,209.0926173,207.07696721540,1685,cpd:C05648,5-Hydroxy-N-formylkynurenine;,C11H12N2O5,5-Hydroxy-N-formylkynurenine; 5-Hydroxy-N-formyl-L-kynurenine,R02702 R04911,Tryptophan metabolism,1.13.11.52; 3.5.1.9,NA,NA,PubChem: 7959; ChEBI: 2065 36407; 3DMET: B05086; NIKKAJI: J2.756.642A,cpd:C00918; cpd:C05648,11,12,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O5N2,C11H11O5N2,252.0746215,253.0824465,251.06679651541,1686,cpd:C05651,5-Hydroxykynurenine;,C10H12N2O4,5-Hydroxykynurenine; 5-Hydroxy-L-kynurenine,R04909 R04911 R04913,Tryptophan metabolism,2.6.1.-; 3.5.1.9; 4.1.1.28,NA,NA,PubChem: 7962; ChEBI: 36408; 3DMET: B05087; NIKKAJI: J2.756.656A,cpd:C02794; cpd:C03227; cpd:C05651; cpd:C07312,10,12,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O4N2,C10H11O4N2,224.0797069,225.0875319,223.07188181542,1687,cpd:C05652,"4-(2-Amino-5-hydroxyphenyl)-2,4-dioxobutanoate",C10H9NO5,"4-(2-Amino-5-hydroxyphenyl)-2,4-dioxobutanoate",R04913 R04914,Tryptophan metabolism,2.6.1.-,NA,NA,PubChem: 7963; ChEBI: 28350; 3DMET: B00826; NIKKAJI: J2.756.661H,cpd:C01249; cpd:C03147; cpd:C05645; cpd:C05652; cpd:C19686,10,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O5N1,C10H8O5N1,223.0480724,224.0558974,222.04024741543,1688,cpd:C05653,Formylanthranilate;,C8H7NO3,Formylanthranilate; N-Formylanthranilate; 2-(Formylamino)-benzoic acid,R00988 R03936 R04915 R05719,Tryptophan metabolism,1.13.11.47; 3.5.1.9; 3.7.1.3,NA,NA,CAS: 3342-77-6; PubChem: 7964; ChEBI: 36575; ChEMBL: CHEMBL1213015; 3DMET: B00827; NIKKAJI: J576.445I,cpd:C00971; cpd:C02803; cpd:C03757; cpd:C05653; cpd:C06052; cpd:C15769; cpd:C21155,8,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O3N1,C8H6O3N1,165.0425931,166.0504181,164.03476811544,1689,cpd:C05654,"5-(2'-Formylethyl)-4,6-dihydroxypicolinate;",C9H9NO5,"5-(2'-Formylethyl)-4,6-dihydroxypicolinate; 5-(beta-Formylethyl)-4,6-dihydroxypicolinate",R04916 R04917 R04918,Tryptophan metabolism,1.2.1.-,NA,NA,PubChem: 7965; ChEBI: 2010 86003; 3DMET: B05088; NIKKAJI: J2.377.150K,cpd:C04720; cpd:C05654; cpd:C08538,9,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O5N1,C9H8O5N1,211.0480724,212.0558974,210.04024741545,1690,cpd:C05655,"5-(2'-Carboxyethyl)-4,6-dihydroxypicolinate;",C9H9NO6,"5-(2'-Carboxyethyl)-4,6-dihydroxypicolinate; 5-(beta-Carboxyethyl)-4,6-dihydroxypicolinate",R04916 R04917,Tryptophan metabolism,1.2.1.-,NA,NA,PubChem: 7966; ChEBI: 2009 86004; 3DMET: B05089; NIKKAJI: J2.756.686C,cpd:C05655; cpd:C06047; cpd:C06048,9,9,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O6N1,C9H8O6N1,227.042987,228.050812,226.0351621546,1691,cpd:C05656,"5-(3'-Carboxy-3'-oxopropyl)-4,6-dihydroxypicolinate;",C10H9NO7,"5-(3'-Carboxy-3'-oxopropyl)-4,6-dihydroxypicolinate; 5-(gamma-Carboxy-gamma-oxopropyl)-4,6-dihydroxypicolinate",R04910 R04918,Tryptophan metabolism,1.3.1.-,NA,NA,PubChem: 7967; ChEBI: 2013 86005; 3DMET: B05090; NIKKAJI: J2.756.696K,cpd:C05656,10,9,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O7N1,C10H8O7N1,255.0379016,256.0457267,254.03007661547,1692,cpd:C05658,Indoxyl;,C8H7NO,Indoxyl; 1H-Indol-3-ol,R02339 R03911 R06048,Tryptophan metabolism,1.14.16.-; 2.4.1.220,NA,NA,CAS: 480-93-3; PubChem: 7969; ChEBI: 17840; 3DMET: B00828; NIKKAJI: J6.171I,cpd:C00561; cpd:C02040; cpd:C02615; cpd:C03766; cpd:C05658; cpd:C12312,8,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O1N1,C8H6O1N1,133.0527638,134.0605889,132.04493881548,1693,cpd:C05659,5-Methoxytryptamine;,C11H14N2O,5-Methoxytryptamine; 5-MeOT,R02912,Tryptophan metabolism,2.1.1.-,NA,NA,CAS: 608-07-1; PubChem: 7970; ChEBI: 2089; ChEMBL: CHEMBL8165; 3DMET: B00829; NIKKAJI: J7.009B,cpd:C05659; cpd:C06212; cpd:C10763; cpd:C13665,11,14,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O1N2,C11H13O1N2,190.1106131,191.1184381,189.1027881549,1694,cpd:C05660,5-Methoxyindoleacetate;,C11H11NO3,5-Methoxyindoleacetate; 5-Methoxyindoleacetic acid,R04905,Tryptophan metabolism,2.1.1.4,NA,NA,CAS: 3471-31-6; PubChem: 7971; ChEBI: 28281; ChEMBL: CHEMBL85433; PDB-CCD: MYI; 3DMET: B00830; NIKKAJI: J139.625K,cpd:C02043; cpd:C05660; cpd:C09961; cpd:C10741,11,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H12O3N1,C11H10O3N1,205.0738932,206.0817182,204.06606821550,1695,cpd:C05663,6-Hydroxykynurenate;,C10H7NO4,"6-Hydroxykynurenate; 6-Hydroxykynurenic acid; 4,6-Dihydroxyquinaldic acid",R04914,Tryptophan metabolism,NA,NA,NA,CAS: 3778-29-8; PubChem: 7973; ChEBI: 2195; KNApSAcK: C00001540; 3DMET: B00831; NIKKAJI: J101.665B,cpd:C02470; cpd:C05663; cpd:C08480; cpd:C21306,10,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O4N1,C10H6O4N1,205.0375077,206.0453327,204.02968271551,1696,cpd:C05830,8-Methoxykynurenate;,C11H9NO4,8-Methoxykynurenate; Xanthurenic acid 8-methyl ether,R03955,Tryptophan metabolism,2.1.1.-,NA,NA,CAS: 2929-14-8; PubChem: 8124; ChEBI: 2323; 3DMET: B00859; NIKKAJI: J13.735I,cpd:C05646; cpd:C05830,11,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H10O4N1,C11H8O4N1,219.0531578,220.0609828,218.04533271552,1697,cpd:C05831,3-Methoxyanthranilate;,C8H9NO3,3-Methoxyanthranilate; 3-Methoxyanthranilic acid,R02671,Tryptophan metabolism,2.1.1.-,NA,NA,PubChem: 8125; ChEBI: 20109 27440; 3DMET: B00860; NIKKAJI: J516.182G,cpd:C00250; cpd:C03493; cpd:C03986; cpd:C05831; cpd:C06051; cpd:C12323; cpd:C14170; cpd:C14171; cpd:C20821,8,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O3N1,C8H8O3N1,167.0582432,168.0660682,166.05041811553,1698,cpd:C05832,5-Hydroxyindoleacetylglycine,C12H12N2O4,5-Hydroxyindoleacetylglycine,R04906,Tryptophan metabolism,6.3.2.-,NA,NA,PubChem: 8126; ChEBI: 27631; 3DMET: B00861; NIKKAJI: J2.759.911G,cpd:C05832,12,12,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H13O4N2,C12H11O4N2,248.0797069,249.0875319,247.07188181554,1699,cpd:C05834,3-Methyldioxyindole;,C9H9NO2,3-Methyldioxyindole; 3-Hydroxy-3-methyloxindole,R03092,Tryptophan metabolism,NA,NA,NA,PubChem: 8127; ChEBI: 28254; 3DMET: B05121; NIKKAJI: J562.257C,cpd:C05834; cpd:C19567; cpd:C20810,9,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O2N1,C9H8O2N1,163.0633285,164.0711536,162.05550351555,1700,cpd:C05835,2-Formaminobenzoylacetate,C10H9NO4,2-Formaminobenzoylacetate,R00991 R03097,Tryptophan metabolism,1.13.11.-,NA,NA,PubChem: 8128; ChEBI: 1098; 3DMET: B00862; NIKKAJI: J1.771.655G,cpd:C01252; cpd:C05835; cpd:C12466; cpd:C14801,10,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O4N1,C10H8O4N1,207.0531578,208.0609828,206.04533271556,1701,cpd:C05837,Glucobrassicin;,C16H20N2O9S2,Glucobrassicin; Indolylmethyl glucosinolate,R04094 R08167,Tryptophan metabolism; Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.8.2.-; 3.2.1.147,"Glucosinolate biosynthesis, tryptophan => glucobrassicin",Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from tryptophan;     C05837  Glucobrassicin,CAS: 4356-52-9; PubChem: 8130; ChEBI: 29028 64962; KNApSAcK: C00000125; 3DMET: B05122; NIKKAJI: J37.088F,cpd:C05837,16,20,9,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C16H21O9N2S2,C16H19O9N2S2,448.0610226,449.0688476,447.05319751557,1702,cpd:C06212,N-Methylserotonin,C11H14N2O,N-Methylserotonin,R02910 R08537,Tryptophan metabolism,2.1.1.49,NA,NA,CAS: 1134-01-6; PubChem: 8459; ChEBI: 48294; ChEMBL: CHEMBL277362; 3DMET: B00924; NIKKAJI: J357.102E,cpd:C05659; cpd:C06212; cpd:C10763; cpd:C13665,11,14,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O1N2,C11H13O1N2,190.1106131,191.1184381,189.1027881558,1703,cpd:C06213,N-Methyltryptamine;,C11H14N2,N-Methyltryptamine; N-Methylindoleethylamine; 1-Methyl-2-(3-indolyl)ethylamine,R02174,Tryptophan metabolism,2.1.1.49,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C06213  N-Methyltryptamine,CAS: 61-49-4; PubChem: 8460; ChEBI: 28136; ChEMBL: CHEMBL348588; KNApSAcK: C00026521; PDB-CCD: 1HU; 3DMET: B00925; NIKKAJI: J213.548E,cpd:C05659; cpd:C06212; cpd:C06213; cpd:C07389; cpd:C07409; cpd:C07499; cpd:C07501; cpd:C08304; cpd:C10763; cpd:C12590; cpd:C13665; cpd:C16582; cpd:C16584; cpd:C17237; cpd:C17238; cpd:C19977; cpd:C20127; cpd:C20843,11,14,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15N2,C11H13N2,174.1156985,175.1235235,173.10787341559,1704,cpd:C10164,Picolinic acid;,C6H5NO2,Picolinic acid; 2-Pyridinecarboxylic acid,R11022,Tryptophan metabolism; Metabolic pathways,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C10164  Picolinic acid,CAS: 98-98-6; PubChem: 12350; ChEBI: 28747; ChEMBL: CHEMBL72628; KNApSAcK: C00002063; PDB-CCD: 6PC; 3DMET: B03598; NIKKAJI: J45.682I,cpd:C00253; cpd:C06813; cpd:C07446; cpd:C10164,6,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H6O2N1,C6H4O2N1,123.0320284,124.0398534,122.02420341560,1705,cpd:C16516,Indolylmethylthiohydroximate,C10H10N2OS,Indolylmethylthiohydroximate,R08164 R08170,Tryptophan metabolism; Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.4.1.195; 4.4.1.-,"Glucosinolate biosynthesis, tryptophan => glucobrassicin",NA,PubChem: 51090845; ChEBI: 80544; KNApSAcK: C00007397; NIKKAJI: J2.599.576G,cpd:C14081; cpd:C16516,10,10,1,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O1N2S1,C10H9O1N2S1,206.0513841,207.0592092,205.04355911561,1706,cpd:C16517,Indolylmethyl-desulfoglucosinolate,C16H20N2O6S,Indolylmethyl-desulfoglucosinolate,R08164 R08167,Tryptophan metabolism; Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.4.1.195; 2.8.2.-,"Glucosinolate biosynthesis, tryptophan => glucobrassicin",NA,PubChem: 51090846; ChEBI: 80545; KNApSAcK: C00007398; NIKKAJI: J542.180B,cpd:C01314; cpd:C16517,16,20,6,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C16H21O6N2S1,C16H19O6N2S1,368.1042075,369.1120326,367.09638251562,1707,cpd:C16518,S-(Indolylmethylthiohydroximoyl)-L-cysteine,C13H15N3O3S,S-(Indolylmethylthiohydroximoyl)-L-cysteine,R08168 R08170 R08608,Tryptophan metabolism; Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.14.-.-; 4.4.1.-,"Glucosinolate biosynthesis, tryptophan => glucobrassicin",NA,PubChem: 51090847; ChEBI: 80546; NIKKAJI: J2.803.444J,cpd:C16518,13,15,3,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C13H16O3N3S1,C13H14O3N3S1,293.0834125,294.0912376,292.07558751563,1708,cpd:C17203,N-Hydroxyl-tryptamine,C10H12N2O,N-Hydroxyl-tryptamine,R08604 R08605,Tryptophan metabolism,1.14.13.-; 2.5.1.-,NA,NA,PubChem: 96023612; ChEBI: 80959; KNApSAcK: C00007418; NIKKAJI: J281.875B,cpd:C00780; cpd:C17203; cpd:C21075,10,12,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O1N2,C10H11O1N2,176.094963,177.102788,175.0871381564,1709,cpd:C00254,Prephenate;,C10H10O6,Prephenate; Prephenic acid,R01373 R01715 R01728 R01730 R01731 R07276 R10934,"Phenylalanine, tyrosine and tryptophan biosynthesis; Novobiocin biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",1.3.1.12; 1.3.1.13; 2.6.1.57; 2.6.1.78; 2.6.1.79; 4.1.1.100; 4.2.1.51; 4.2.1.91; 5.4.99.5,"Phenylalanine biosynthesis, chorismate => phenylalanine; Tyrosine biosynthesis, chorismate => tyrosine; Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine; Bacilysin biosynthesis, prephenate => bacilysin",NA,CAS: 126-49-8; PubChem: 3553; ChEBI: 29934 84387; KNApSAcK: C00019632; PDB-CCD: PRE; 3DMET: B00074; NIKKAJI: J38.009A,cpd:C00251; cpd:C00254; cpd:C00885; cpd:C03721; cpd:C11631,10,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O6,C10H9O6,226.047738,227.0555631,225.0399131565,1710,cpd:C00296,Quinate;,C7H12O6,Quinate; Quinic acid; Kinic acid; Chinic acid; L-Quinic acid; L-Quinate; (-)-Quinic acid,R01872 R01873 R01945 R02195 R02997 R02998 R06846 R07432; R09322,"Phenylalanine, tyrosine and tryptophan biosynthesis",1.1.1.24; 1.1.1.282; 1.1.5.8; 2.3.1.98; 2.3.1.99; 2.3.1.133; 3.1.1.42,NA,NA,CAS: 77-95-2; PubChem: 3590; ChEBI: 17521 29751; ChEMBL: CHEMBL465398; KNApSAcK: C00001201; PDB-CCD: QIC; 3DMET: B01209; NIKKAJI: J9.262B,cpd:C00296; cpd:C00625; cpd:C01295; cpd:C03000; cpd:C12113; cpd:C17259; cpd:C17691; cpd:C17694; cpd:C21282,7,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O6,C7H11O6,192.0633881,193.0712131,191.05556311566,1711,cpd:C00354,"D-Fructose 1,6-bisphosphate",C6H14O12P2,"D-Fructose 1,6-bisphosphate",R00756 R00762 R00764 R00767 R00769 R00770 R01068 R05805; R09100 R10049,"Phenylalanine, tyrosine and tryptophan biosynthesis; Methane metabolism; Carbon fixation in photosynthetic organisms; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism; AMPK signaling pathway; Glucagon signaling pathway; Central carbon metabolism in cancer",2.2.1.11; 2.7.1.11; 2.7.1.90; 2.7.1.146; 3.1.3.11; 4.1.2.13,"Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P; Formaldehyde assimilation, xylulose monophosphate pathway; Formaldehyde assimilation, ribulose monophosphate pathway",NA,CAS: 488-69-7; PubChem: 3647; ChEBI: 16905 37736; ChEMBL: CHEMBL1089962 CHEMBL97893; KNApSAcK: C00007386; PDB-CCD: AFP FBP; 3DMET: B04673; NIKKAJI: J15.941G,cpd:C00354; cpd:C00665; cpd:C01220; cpd:C01231; cpd:C03693; cpd:C03785; cpd:C04062; cpd:C04063; cpd:C04064; cpd:C05378,6,14,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O12P2,C6H13O12P2,339.9960499,341.0038749,338.98822491567,1712,cpd:C00493,Shikimate;,C7H10O5,"Shikimate; Shikimic acid; 3,4,5-Trihydroxy-1-cyclohexenecarboxylic acid",R02412 R02413 R02415 R02416 R06847 R07433 R10701,"Phenylalanine, tyrosine and tryptophan biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",1.1.1.25; 1.1.1.282; 1.1.5.8; 2.3.1.133; 2.7.1.71; 3.1.1.-,"Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate",Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00493  Shikimate,CAS: 138-59-0; PubChem: 3776; ChEBI: 16119; ChEMBL: CHEMBL290345; KNApSAcK: C00001203; PDB-CCD: SKM; 3DMET: B01267; NIKKAJI: J3.267K,cpd:C00493; cpd:C04236; cpd:C16588; cpd:C17696; cpd:C18307; cpd:C18312; cpd:C20961; cpd:C21281,7,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O5,C7H9O5,174.0528234,175.0606485,173.04499841568,1713,cpd:C00826,L-Arogenate;,C10H13NO5,L-Arogenate; L-Arogenic acid; Pretyrosine,R00691 R00732 R00733 R01731 R07276,"Phenylalanine, tyrosine and tryptophan biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of amino acids",1.3.1.43; 1.3.1.78; 1.3.1.79; 2.6.1.57; 2.6.1.78; 2.6.1.79; 4.2.1.51; 4.2.1.91,"Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine",NA,CAS: 53078-86-7; PubChem: 4084; ChEBI: 17530; KNApSAcK: C00007338; 3DMET: B04732; NIKKAJI: J157.886C,cpd:C00826,10,13,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O5N1,C10H12O5N1,227.0793725,228.0871976,226.07154751569,1714,cpd:C00944,3-Dehydroquinate;,C7H10O6,3-Dehydroquinate; 3-Dehydroquinic acid; 5-Dehydroquinate; 5-Dehydroquinic acid,R01872 R01873 R03083 R03084 R06846 R08569 R09322,"Phenylalanine, tyrosine and tryptophan biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",1.1.1.24; 1.1.1.282; 1.1.5.8; 1.4.1.24; 4.2.1.10; 4.2.3.4,"Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate",NA,PubChem: 4196; ChEBI: 17947 32364; KNApSAcK: C00019664; PDB-CCD: DQA; 3DMET: B01356; NIKKAJI: J93.942K,cpd:C00944; cpd:C03792; cpd:C04049; cpd:C05601; cpd:C06201; cpd:C17695; cpd:C20246; cpd:C20247,7,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O6,C7H9O6,190.047738,191.0555631,189.0399131570,1715,cpd:C01269,5-O-(1-Carboxyvinyl)-3-phosphoshikimate;,C10H13O10P,5-O-(1-Carboxyvinyl)-3-phosphoshikimate; O5-(1-Carboxyvinyl)-3-phosphoshikimate,R01714 R03460,"Phenylalanine, tyrosine and tryptophan biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",2.5.1.19; 4.2.3.5,"Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate",NA,PubChem: 4488; ChEBI: 16257; ChEMBL: CHEMBL317037; KNApSAcK: C00007627; PDB-CCD: EPS; 3DMET: B01429; NIKKAJI: J630.842B,cpd:C01269; cpd:C03312,10,13,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O10P1,C10H12O10P1,324.0246336,325.0324586,323.01680861571,1716,cpd:C01302,1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate,C12H16NO9P,1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate,R03508 R03509,"Phenylalanine, tyrosine and tryptophan biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",4.1.1.48; 5.3.1.24,"Tryptophan biosynthesis, chorismate => tryptophan",NA,PubChem: 4520; ChEBI: 29112; KNApSAcK: C00007450; 3DMET: B04792; NIKKAJI: J2.634.852H,cpd:C01302; cpd:C04302,12,16,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H17O9N1P1,C12H15O9N1P1,349.0562681,350.0640931,348.04844311572,1717,cpd:C02637,3-Dehydroshikimate,C7H8O5,3-Dehydroshikimate,R01627 R02413 R02415 R03084 R06847,"Phenylalanine, tyrosine and tryptophan biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of phenylpropanoids; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",1.1.1.25; 1.1.1.282; 1.1.5.8; 4.2.1.10; 4.2.1.118,"Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate",NA,PubChem: 5617; ChEBI: 16630 30918; KNApSAcK: C00019663; PDB-CCD: 3DS; 3DMET: B01592; NIKKAJI: J412.314J,cpd:C02637; cpd:C02652; cpd:C03063; cpd:C05600; cpd:C07478; cpd:C07479; cpd:C18306; cpd:C18318,7,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O5,C7H7O5,172.0371734,173.0449984,171.02934831573,1718,cpd:C03175,Shikimate 3-phosphate;,C7H11O8P,Shikimate 3-phosphate; Shikimate 5-phosphate,R02412 R03460,"Phenylalanine, tyrosine and tryptophan biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",2.5.1.19; 2.7.1.71,"Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate",NA,PubChem: 6057; ChEBI: 17052; ChEMBL: CHEMBL95193; KNApSAcK: C00000002; PDB-CCD: S3P; 3DMET: B01636; NIKKAJI: J746.034A,cpd:C03175; cpd:C17697,7,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O8P1,C7H10O8P1,254.0191543,255.0269793,253.01132931574,1719,cpd:C03506,Indoleglycerol phosphate;,C11H14NO6P,"Indoleglycerol phosphate; 1-C-(Indol-3-yl)glycerol 3-phosphate; (3-Indolyl)-glycerol phosphate; C1-(3-Indolyl)-glycerol 3-phosphate; (1S,2R)-1-C-(Indol-3-yl)glycerol 3-phosphate; Indole-3-glycerol phosphate",R02340 R02722 R03508 R10349,"Phenylalanine, tyrosine and tryptophan biosynthesis; Benzoxazinoid biosynthesis; Indole diterpene alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",4.1.1.48; 4.1.2.8; 4.2.1.20,"Tryptophan biosynthesis, chorismate => tryptophan; Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline",NA,PubChem: 6317; ChEBI: 18299 51793; PDB-CCD: IGP; 3DMET: B04900; NIKKAJI: J39.032A,cpd:C03506,11,14,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O6N1P1,C11H13O6N1P1,287.0558742,288.0636992,286.04804911575,1720,cpd:C04302,N-(5-Phospho-D-ribosyl)anthranilate;,C12H16NO9P,N-(5-Phospho-D-ribosyl)anthranilate; N-(5-Phospho-beta-D-ribosyl)anthranilate; N-(5-Phosphoribosyl)anthranilic acid,R01073 R03509,"Phenylalanine, tyrosine and tryptophan biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",2.4.2.18; 5.3.1.24,"Tryptophan biosynthesis, chorismate => tryptophan",NA,PubChem: 6961; ChEBI: 18277 7091; KNApSAcK: C00007384; 3DMET: B01733; NIKKAJI: J1.544.460F,cpd:C01302; cpd:C04302,12,16,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H17O9N1P1,C12H15O9N1P1,349.0562681,350.0640931,348.04844311576,1721,cpd:C04691,2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate;,C7H13O10P,2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate; 3-Deoxy-D-arabino-hept-2-ulosonate 7-phosphate; 3-Deoxy-arabino-heptulonate 7-phosphate; 3-Deoxy-D-arabino-heptulosonic acid 7-phosphate; DAHP; 2-Dahp,R01826 R03083,"Phenylalanine, tyrosine and tryptophan biosynthesis; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Biosynthesis of amino acids",2.5.1.54; 4.2.3.4,"Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate",NA,CAS: 2627-73-8; PubChem: 7271; ChEBI: 18150; KNApSAcK: C00007497; 3DMET: B01776; NIKKAJI: J1.124.411D,cpd:C04691,7,13,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O10P1,C7H12O10P1,288.0246336,289.0324586,287.01680861577,1722,cpd:C16848,6-Deoxy-5-ketofructose 1-phosphate;,C6H11O8P,"6-Deoxy-5-ketofructose 1-phosphate; 1-Deoxy-D-threo-hexo-2,5-diulose 6-phosphate",R08568 R10049 R10050,"Phenylalanine, tyrosine and tryptophan biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics",2.2.1.10; 2.2.1.11,NA,NA,PubChem: 96023372; ChEBI: 51284; NIKKAJI: J2.072.088C,cpd:C04299; cpd:C16848,6,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O8P1,C6H10O8P1,242.0191543,243.0269793,241.01132931578,1723,cpd:C16850,"2-Amino-3,7-dideoxy-D-threo-hept-6-ulosonic acid",C7H13NO5,"2-Amino-3,7-dideoxy-D-threo-hept-6-ulosonic acid",R08568 R08569,"Phenylalanine, tyrosine and tryptophan biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics",1.4.1.24; 2.2.1.10,NA,NA,PubChem: 96023374; ChEBI: 51282; NIKKAJI: J2.805.603F,cpd:C16850; cpd:C21247,7,13,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O5N1,C7H12O5N1,191.0793725,192.0871976,190.07154751579,1724,cpd:C17235,L-Homophenylalanine,C10H13NO2,L-Homophenylalanine,R08655 R08690 R10503,"Phenylalanine, tyrosine and tryptophan biosynthesis; Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism",1.14.13.-; 2.6.1.-,NA,NA,CAS: 943-73-7; PubChem: 96023643; ChEBI: 43103; ChEMBL: CHEMBL1233389; PDB-CCD: HPE; NIKKAJI: J80.035J,cpd:C07591; cpd:C09642; cpd:C10146; cpd:C14579; cpd:C17235; cpd:C18771; cpd:C18887; cpd:C20895,10,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O2N1,C10H12O2N1,179.0946287,180.1024537,178.08680361580,1725,cpd:C20327,2-Oxo-4-phenylbutyric acid;,C10H10O3,2-Oxo-4-phenylbutyric acid; 2-Oxo-4-phenylbutanoic acid; 2-Oxo-4-phenylbutanoate,R10502 R10503,"Phenylalanine, tyrosine and tryptophan biosynthesis; 2-Oxocarboxylic acid metabolism",1.1.1.-; 2.6.1.-,NA,NA,CAS: 710-11-2; PubChem: 163312065; ChEMBL: CHEMBL16281,cpd:C00585; cpd:C01281; cpd:C01624; cpd:C01702; cpd:C02666; cpd:C05250; cpd:C10667; cpd:C12464; cpd:C14404; cpd:C14784; cpd:C16733; cpd:C20327; cpd:C20646,10,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O3,C10H9O3,178.0629942,179.0708192,177.05516911581,1726,cpd:C20653,2-Benzylmalic acid;,C11H12O5,2-Benzylmalic acid; 2-Benzylmalate,R10500 R10501,"Phenylalanine, tyrosine and tryptophan biosynthesis; 2-Oxocarboxylic acid metabolism",2.3.3.-; 4.2.1.-,NA,NA,CAS: 16947-49-2; PubChem: 172232376,cpd:C00482; cpd:C00918; cpd:C05648; cpd:C20653; cpd:C20654,11,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O5,C11H11O5,224.0684735,225.0762985,223.06064851582,1727,cpd:C20654,3-Benzylmalic acid;,C11H12O5,3-Benzylmalic acid; 3-Benzylmalate,R10501 R10502,"Phenylalanine, tyrosine and tryptophan biosynthesis; 2-Oxocarboxylic acid metabolism",1.1.1.-; 4.2.1.-,NA,NA,PubChem: 172232377,cpd:C00482; cpd:C00918; cpd:C05648; cpd:C20653; cpd:C20654,11,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O5,C11H11O5,224.0684735,225.0762985,223.06064851583,1728,cpd:C20710,"(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate;",C7H8O4,"(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate; (3R,4R)-3,4-Dihydroxycyclohexa-1,5-diene-1-carboxylate; DCDC",R10583,"Phenylalanine, tyrosine and tryptophan biosynthesis",3.3.2.13,NA,NA,PubChem: 254741179,cpd:C04112; cpd:C04171; cpd:C04558; cpd:C04559; cpd:C04634; cpd:C06210; cpd:C06321; cpd:C06678; cpd:C06760; cpd:C07041; cpd:C13671; cpd:C18311; cpd:C20710,7,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O4,C7H7O4,156.0422587,157.0500838,155.03443371584,1729,cpd:C05073,Coumermycin A1;,C55H59N5O20,Coumermycin A1; Coumermycin,R06768,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,"Antiinfectives [BR:br08307];  Antibacterials;   Nucleic acid synthesis inhibitor;    type II topoisomerase (DNA gyrase, topoisomerase IV) inhibitor;     Others;      Coumermycin;       D02333  Coumermycin (USAN); Phytochemicals used as drugs [BR:br08306];  Phenylpropanoids and related compounds;   Coumarins;    D02333  Coumermycin (USAN)",CAS: 4434-05-3; PubChem: 7522; ChEBI: 3907; KNApSAcK: C00002461; 3DMET: B01806; NIKKAJI: J31.903A,cpd:C05073,55,59,20,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C55H60O20N5,C55H58O20N5,1109.375339,1110.383164,1108.3675141585,1730,cpd:C05080,Novobiocin,C31H36N2O11,Novobiocin,R06772,Novobiocin biosynthesis; Biosynthesis of antibiotics,2.1.3.12,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Others;    Aromatic compounds;     C05080  Novobiocin,CAS: 303-81-1; PubChem: 7526; ChEBI: 28368; ChEMBL: CHEMBL1617799 CHEMBL36506; KNApSAcK: C00002487; PDB-CCD: NOV; 3DMET: B01808; NIKKAJI: J68.034F,cpd:C05080,31,36,11,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H37O11N2,C31H35O11N2,612.23191,613.239735,611.2240851586,1731,cpd:C12032,Clorobiocin;,C35H37ClN2O11,Clorobiocin; Chlorobiocin,R06775,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,CAS: 39868-96-7; PubChem: 14187; ChEBI: 47302; ChEMBL: CHEMBL303984; KNApSAcK: C00017954; PDB-CCD: CBN; NIKKAJI: J53.913I,cpd:C12032,35,37,11,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C35H38O11N2Cl1,C35H36O11N2Cl1,696.2085877,697.2164127,695.20076271587,1732,cpd:C12456,3-Dimethylallyl-4-hydroxyphenylpyruvate;,C14H16O4,3-Dimethylallyl-4-hydroxyphenylpyruvate; 3-[4-Hydroxy-3-(2-methylprop-1-en-1-yl)phenyl]-2-oxopropanoate,R06757 R06758 R06762,Novobiocin biosynthesis; Biosynthesis of antibiotics,2.5.1.111,NA,NA,PubChem: 582846; ChEBI: 31113 74408; 3DMET: B04522; NIKKAJI: J2.783.660G,cpd:C10487; cpd:C12456; cpd:C12685; cpd:C16788; cpd:C19065; cpd:C20426,14,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H17O4,C14H15O4,248.104859,249.112684,247.0970341588,1733,cpd:C12457,3-Dimethylallyl-4-hydroxymandelic acid,C13H16O4,3-Dimethylallyl-4-hydroxymandelic acid,R06758 R06759,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582847; ChEBI: 31112; 3DMET: B05646; NIKKAJI: J2.783.672K,cpd:C04148; cpd:C05642; cpd:C12457; cpd:C13229; cpd:C14343; cpd:C14580; cpd:C17559; cpd:C17562; cpd:C21273,13,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H17O4,C13H15O4,236.104859,237.112684,235.0970341589,1734,cpd:C12458,3-Dimethylallyl-4-hydroxybenzoate,C12H14O3,3-Dimethylallyl-4-hydroxybenzoate,R06759 R06763 R06776 R10453,Novobiocin biosynthesis; Biosynthesis of antibiotics,6.3.1.15,NA,NA,PubChem: 582848; ChEBI: 31111 74155; ChEMBL: CHEMBL452154; 3DMET: B04523; NIKKAJI: J438.852F,cpd:C04000; cpd:C05848; cpd:C10476; cpd:C11097; cpd:C12458; cpd:C14567; cpd:C17560; cpd:C18969,12,14,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H15O3,C12H13O3,206.0942943,207.1021193,205.08646931590,1735,cpd:C12459,3-Dimethylallyl-4-hydroxybenzaldehyde,C12H14O2,3-Dimethylallyl-4-hydroxybenzaldehyde,R06761 R06762 R06763,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582849; ChEBI: 31110; 3DMET: B04524; NIKKAJI: J1.891.160D,cpd:C00978; cpd:C02983; cpd:C06360; cpd:C07371; cpd:C09017; cpd:C11095; cpd:C12459; cpd:C16831; cpd:C16987; cpd:C17854; cpd:C19530; cpd:C20130; cpd:C21078,12,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H15O2,C12H13O2,190.0993797,191.1072047,189.09155471591,1741,cpd:C12468,"3-Amino-4,7-dihydroxycoumarin",C9H7NO4,"3-Amino-4,7-dihydroxycoumarin",R06765 R06766 R06777 R06778 R10453,Novobiocin biosynthesis; Biosynthesis of antibiotics,6.3.1.15,NA,NA,PubChem: 582858; ChEBI: 31107; 3DMET: B04526; NIKKAJI: J1.954.713B,cpd:C01693; cpd:C04185; cpd:C12468; cpd:C15566,9,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H8O4N1,C9H6O4N1,193.0375077,194.0453327,192.02968271592,1742,cpd:C12469,"3-Amino-4,7-dihydroxy-8-chlorocoumarin",C9H6ClNO4,"3-Amino-4,7-dihydroxy-8-chlorocoumarin",R06766 R06776,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582859; ChEBI: 31105; NIKKAJI: J2.783.680A,cpd:C12469,9,6,4,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C9H7O4N1Cl1,C9H5O4N1Cl1,226.9985354,228.0063604,225.99071031593,1744,cpd:C12471,Chlorobiocic acid,C21H18ClNO6,Chlorobiocic acid,R06773 R06776,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,CAS: 114515-20-7; PubChem: 582861; ChEBI: 31395; NIKKAJI: J2.783.682H,cpd:C12471,21,18,6,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C21H19O6N1Cl1,C21H17O6N1Cl1,415.082265,416.09009,414.074441594,1745,cpd:C12472,Novclobiocin 105,C28H30ClNO10,Novclobiocin 105,R06773 R06774,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582862; ChEBI: 31922; NIKKAJI: J2.783.683F,cpd:C12472,28,30,10,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C28H31O10N1Cl1,C28H29O10N1Cl1,575.1558238,576.1636489,574.14799881595,1746,cpd:C12473,Novclobiocin 104,C29H32ClNO10,Novclobiocin 104,R06774 R06775,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582863; ChEBI: 31921; NIKKAJI: J2.783.684D,cpd:C12473,29,32,10,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C29H33O10N1Cl1,C29H31O10N1Cl1,589.1714739,590.1792989,588.16364891596,1747,cpd:C12474,Novobiocic acid,C22H21NO6,Novobiocic acid,R06770 R10454,Novobiocin biosynthesis; Biosynthesis of antibiotics,2.1.1.284; 2.4.1.302,NA,NA,CAS: 485-23-4; PubChem: 582864; ChEBI: 31923; ChEMBL: CHEMBL240375; 3DMET: B04527; NIKKAJI: J1.895.111H,cpd:C12474,22,21,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H22O6N1,C22H20O6N1,395.1368874,396.1447124,394.12906241597,1748,cpd:C12475,Demethyldecarbamoylnovobiocin,C29H33NO10,Demethyldecarbamoylnovobiocin,R06770 R06771,Novobiocin biosynthesis; Biosynthesis of antibiotics,2.1.1.285; 2.4.1.302,NA,NA,PubChem: 582865; ChEBI: 31469; 3DMET: B04528; NIKKAJI: J2.783.698D,cpd:C12475; cpd:C20689,29,33,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H34O10N1,C29H32O10N1,555.2104463,556.2182713,554.20262121598,1749,cpd:C12476,Decarbamoylnovobiocin,C30H35NO10,Decarbamoylnovobiocin,R06771 R06772,Novobiocin biosynthesis; Biosynthesis of antibiotics,2.1.1.285; 2.1.3.12,NA,NA,PubChem: 582866; ChEBI: 31467; 3DMET: B04529; NIKKAJI: J2.783.701H,cpd:C09937; cpd:C12476; cpd:C18634,30,35,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H36O10N1,C30H34O10N1,569.2260963,570.2339214,568.21827131599,1750,cpd:C12477,"3-Methylpyrrole-2,4-dicarboxylic acid",C7H7NO4,"3-Methylpyrrole-2,4-dicarboxylic acid",R06777,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582867; ChEBI: 31119; 3DMET: B04530; NIKKAJI: J2.783.702F,cpd:C03340; cpd:C11465; cpd:C12477; cpd:C17385; cpd:C17386; cpd:C18315,7,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O4N1,C7H6O4N1,169.0375077,170.0453327,168.02968271600,1751,cpd:C12479,Coumermic acid,C27H21N3O10,Coumermic acid,R06767 R06778,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582869; ChEBI: 31433; 3DMET: B04532; NIKKAJI: J2.783.704B,cpd:C12479,27,21,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H22O10N3,C27H20O10N3,547.1226939,548.1305189,546.11486891601,1752,cpd:C12480,Coumermycin D,C43H49N3O18,Coumermycin D,R06767 R06768,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582870; ChEBI: 31434; 3DMET: B04533; NIKKAJI: J1.844.293K,cpd:C12480,43,49,18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H50O18N3,C43H48O18N3,895.3011117,896.3089368,894.29328671602,1753,cpd:C12481,dTDP-5-dimethyl-L-lyxose;,C17H28N2O15P2,dTDP-5-dimethyl-L-lyxose; dTDP-4-O-demethyl-beta-L-noviose,R06767 R06770 R06773 R10459,Novobiocin biosynthesis; Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.-; 2.4.1.302,dTDP-beta-L-noviose biosynthesis,NA,PubChem: 582871; ChEBI: 32333; 3DMET: B05647; NIKKAJI: J1.895.110J,cpd:C12481; cpd:C21350,17,28,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H29O15N2P2,C17H27O15N2P2,562.0964922,563.1043172,561.08866721603,1755,cpd:C20629,8-Demethylnovobiocic acid,C21H19NO6,8-Demethylnovobiocic acid,R10453 R10454,Novobiocin biosynthesis; Biosynthesis of antibiotics,2.1.1.284; 6.3.1.15,NA,NA,PubChem: 172232353,cpd:C20629,21,19,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H20O6N1,C21H18O6N1,381.1212373,382.1290624,380.11341231604,1756,cpd:C20637,"5-[[(4,7-Dihydroxy-2-oxo-2H-1-benzopyran-3-yl)amino]carbonyl]-4-methyl-1H-pyrrole-3-carboxylate",C16H12N2O7,"5-[[(4,7-Dihydroxy-2-oxo-2H-1-benzopyran-3-yl)amino]carbonyl]-4-methyl-1H-pyrrole-3-carboxylate",R06777 R06778,Novobiocin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 172232361,cpd:C20637,16,12,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O7N2,C16H11O7N2,344.0644507,345.0722758,343.05662571605,1757,cpd:C04831,DIMBOA-glucoside;,C15H19NO10,"DIMBOA-glucoside; 2,4-Dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one 2-D-glucoside; 2,4-Dihydroxy-7-methoxy-1,4-benzoxazin-3-one glucoside",R04579 R08973,Benzoxazinoid biosynthesis,2.1.1.241; 2.4.1.202,NA,NA,CAS: 18607-79-9; PubChem: 7392; ChEBI: 16603; ChEMBL: CHEMBL519905; KNApSAcK: C00001538; 3DMET: B01795; NIKKAJI: J632.914D,cpd:C04831; cpd:C15768,15,19,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H20O10N1,C15H18O10N1,373.1008958,374.1087208,372.09307081606,1758,cpd:C11130,3-Hydroxyindolin-2-one;,C8H7NO2,"3-Hydroxyindolin-2-one; 1,3-Dihydro-3-hydroxy-2H-indol-2-one; Dioxindole",R07421 R07422,Benzoxazinoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.138; 1.14.13.139,NA,NA,CAS: 61-71-2; PubChem: 13312; ChEBI: 28536; 3DMET: B05517; NIKKAJI: J4.817H,cpd:C00650; cpd:C02775; cpd:C03574; cpd:C03742; cpd:C05578; cpd:C09957; cpd:C11130; cpd:C19062,8,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O2N1,C8H6O2N1,149.0476785,150.0555035,148.03985341607,1759,cpd:C12312,Indolin-2-one,C8H7NO,Indolin-2-one,R07403 R07421,Benzoxazinoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.137; 1.14.13.138,NA,NA,PubChem: 582703; ChEBI: 31697; ChEMBL: CHEMBL40823; 3DMET: B04450; NIKKAJI: J1.393E,cpd:C00561; cpd:C02040; cpd:C02615; cpd:C03766; cpd:C05658; cpd:C12312,8,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O1N1,C8H6O1N1,133.0527638,134.0605889,132.04493881608,1760,cpd:C15769,HBOA;,C8H7NO3,"HBOA; 2-Hydroxy-1,4-benzoxazin-3-one",R07422 R07423,Benzoxazinoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.139; 1.14.13.140,NA,NA,PubChem: 47205095; ChEBI: 63559; ChEMBL: CHEMBL457386; KNApSAcK: C00036489; NIKKAJI: J391.989G,cpd:C00971; cpd:C02803; cpd:C03757; cpd:C05653; cpd:C06052; cpd:C15769; cpd:C21155,8,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O3N1,C8H6O3N1,165.0425931,166.0504181,164.03476811609,1761,cpd:C15770,DIBOA;,C8H7NO4,"DIBOA; 2,4-Dihydroxy-1,4-benzoxazin-3-one; 2,4-Dihydroxy-2H-1,4-benzoxazin-3(4H)-one",R07423 R07426,Benzoxazinoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.140; 2.4.1.202,NA,NA,CAS: 17359-54-5; PubChem: 47205096; ChEBI: 63558; ChEMBL: CHEMBL483002; KNApSAcK: C00036460; NIKKAJI: J67.842B,cpd:C06050; cpd:C15770,8,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O4N1,C8H6O4N1,181.0375077,182.0453327,180.02968271610,1762,cpd:C15772,DIBOA-glucoside;,C14H17NO9,"DIBOA-glucoside; 2,4-Dihydroxy-1,4-benzoxazin-3-one glucoside",R07426 R08972,Benzoxazinoid biosynthesis,1.14.20.2; 2.4.1.202,NA,NA,PubChem: 47205098; ChEBI: 80091; ChEMBL: CHEMBL484638; NIKKAJI: J510.854C,cpd:C15772,14,17,9,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H18O9N1,C14H16O9N1,343.0903311,344.0981562,342.08250611611,1763,cpd:C18062,TRIBOA-glucoside;,C14H17NO10,"TRIBOA-glucoside; 2,4,7-Trihydroxy-1,4-benzoxazin-3-one-glucoside; 2,4,7-Trihydroxy-2H-1,4-benzoxazin-3(4H)-one-glucoside",R08972 R08973,Benzoxazinoid biosynthesis,1.14.20.2; 2.1.1.241,NA,NA,PubChem: 96024281; ChEBI: 81477; NIKKAJI: J2.710.715J,cpd:C08342; cpd:C18062,14,17,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H18O10N1,C14H16O10N1,359.0852457,360.0930708,358.07742071612,1764,cpd:C13782,Paxilline,C27H33NO4,Paxilline,R10359 R10360 R10410,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Indole diterpene alkaloids;     C13782  Paxilline,CAS: 57186-25-1; PubChem: 854027; ChEBI: 34907; ChEMBL: CHEMBL1396845 CHEMBL410063; KNApSAcK: C00023582; NIKKAJI: J31.896E,cpd:C12342; cpd:C13782,27,33,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H34O4N1,C27H32O4N1,435.2409585,436.2487836,434.23313351613,1765,cpd:C20525,3-Geranylgeranylindole;,C28H39N,3-Geranylgeranylindole; 3-(Geranylgeranyl)indole,R10349 R10350,Indole diterpene alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.-,"Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline",NA,PubChem: 172232272,cpd:C20525; cpd:C20526; cpd:C20527; cpd:C20529; cpd:C20530; cpd:C20536,28,39,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H40N1,C28H38N1,389.3082503,390.3160753,388.30042521614,1766,cpd:C20526,"10,11-Epoxy-3-geranylgeranylindole",C28H39NO,"10,11-Epoxy-3-geranylgeranylindole",R10350 R10352,Indole diterpene alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.-,"Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline",NA,PubChem: 172232273,cpd:C20526; cpd:C20527,28,39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H40O1N1,C28H38O1N1,405.3031649,406.3109899,404.29533981615,1767,cpd:C20527,Emindole SB,C28H39NO,Emindole SB,R10351 R10352,Indole diterpene alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.-,"Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline",Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Indole diterpene alkaloids;     C20527  Emindole SB,PubChem: 172232274,cpd:C20526; cpd:C20527,28,39,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H40O1N1,C28H38O1N1,405.3031649,406.3109899,404.29533981616,1768,cpd:C20528,Terpendole B,C27H35NO3,Terpendole B,R10406 R10570 R10571,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 254741161,cpd:C20528; cpd:C20535; cpd:C20558,27,35,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H36O3N1,C27H34O3N1,421.261694,422.269519,420.2538691617,1769,cpd:C20529,"14,15-Epoxyemindole SB",C28H39NO2,"14,15-Epoxyemindole SB",R10351 R10353,Indole diterpene alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.-,"Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline",NA,PubChem: 172232275,cpd:C20529; cpd:C20530,28,39,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H40O2N1,C28H38O2N1,421.2980795,422.3059045,420.29025451618,1770,cpd:C20530,Paspaline,C28H39NO2,Paspaline,R10353 R10371 R10373,Indole diterpene alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.-,"Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline",Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Indole diterpene alkaloids;     C20530  Paspaline,CAS: 11024-56-9; PubChem: 172232276,cpd:C20529; cpd:C20530,28,39,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H40O2N1,C28H38O2N1,421.2980795,422.3059045,420.29025451619,1771,cpd:C20531,13-Desoxypaxilline;,C27H33NO3,13-Desoxypaxilline; 13-Deoxypaxilline,R10358 R10359 R10361,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 172232277,cpd:C14596; cpd:C20531,27,33,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H34O3N1,C27H32O3N1,419.2460439,420.253869,418.23821891620,1772,cpd:C20532,"20,21-Diprenylterpendole I",C37H51NO5,"20,21-Diprenylterpendole I",R10367 R10369,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 172232278,cpd:C20532,37,51,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H52O5N1,C37H50O5N1,589.3767237,590.3845488,588.36889871621,1773,cpd:C20534,"12-Demethyl-11,12-dehydropaspaline",C27H35NO2,"12-Demethyl-11,12-dehydropaspaline",R10356 R10357 R10379 R10570,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 172232280,cpd:C20534,27,35,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H36O2N1,C27H34O2N1,405.2667794,406.2746044,404.25895431622,1774,cpd:C20535,beta-PC-M6;,C27H35NO3,"beta-PC-M6; beta-10-Hydroxy-12-demethyl-11,12-dehydropaspaline",R10357 R10358,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 172232281,cpd:C20528; cpd:C20535; cpd:C20558,27,35,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H36O3N1,C27H34O3N1,421.261694,422.269519,420.2538691623,1775,cpd:C20536,Terpendole E,C28H39NO3,Terpendole E,R10373 R10376 R10405,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 172232282,cpd:C20536,28,39,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H40O3N1,C28H38O3N1,437.2929941,438.3008192,436.28516911624,1776,cpd:C20542,13-Desoxyterpendole I,C27H35NO4,13-Desoxyterpendole I,R10366 R10376 R10571,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 172232283,cpd:C20542; cpd:C20593,27,35,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H36O4N1,C27H34O4N1,437.2566086,438.2644336,436.24878361625,1777,cpd:C20543,Terpendole I,C27H35NO5,Terpendole I,R10366 R10369 R10379 R10380,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.5.1.-,NA,NA,PubChem: 172232284,cpd:C20543,27,35,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H36O5N1,C27H34O5N1,453.2515232,454.2593483,452.24369821626,1778,cpd:C20545,Terpendole J,C32H43NO5,Terpendole J,R10380 R10381 R10384,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.21.-; 2.5.1.-,NA,NA,PubChem: 172232285,cpd:C20545,32,43,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H44O5N1,C32H42O5N1,521.3141235,522.3219485,520.30629851627,1779,cpd:C20546,Terpendole C,C32H41NO5,Terpendole C,R10381 R10382 R10383,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.21.-,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Indole diterpene alkaloids;     C20546  Terpendole C,PubChem: 172232286,cpd:C20546,32,41,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H42O5N1,C32H40O5N1,519.2984734,520.3062985,518.29064841628,1780,cpd:C20548,Lolitriol,C37H49NO7,Lolitriol,R10367 R10370,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.5.1.-,NA,NA,PubChem: 172232287,cpd:C20548,37,49,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H50O7N1,C37H48O7N1,619.3509029,620.358728,618.34307791629,1781,cpd:C20550,Lolitrem E,C42H57NO7,Lolitrem E,R10368 R10370 R10692,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 1.14.21.-; 2.5.1.-,NA,NA,PubChem: 172232289,cpd:C20550,42,57,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H58O7N1,C42H56O7N1,687.4135032,688.4213282,686.40567811630,1782,cpd:C20551,Lolitrem B,C42H55NO7,Lolitrem B,R10368 R10694,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 1.14.21.-,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Indole diterpene alkaloids;     C20551  Lolitrem B,CAS: 81771-19-9; PubChem: 172232290,cpd:C20551,42,55,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H56O7N1,C42H54O7N1,685.3978531,686.4056781,684.39002811631,1783,cpd:C20552,Terpendole K,C32H39NO5,Terpendole K,R10382,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 172232291,cpd:C20552,32,39,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H40O5N1,C32H38O5N1,517.2828234,518.2906484,516.27499831632,1784,cpd:C20553,Paspalicine,C27H31NO3,Paspalicine,R10361 R10362,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Indole diterpene alkaloids;     C20553  Paspalicine,CAS: 11024-55-8; PubChem: 172232292,cpd:C20553,27,31,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O3N1,C27H30O3N1,417.2303939,418.2382189,416.22256881633,1785,cpd:C20554,Paspalinine,C27H31NO4,Paspalinine,R10362 R10365,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 2.5.1.-,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Indole diterpene alkaloids;     C20554  Paspalinine,CAS: 63722-91-8; PubChem: 172232293,cpd:C20554,27,31,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O4N1,C27H30O4N1,433.2253085,434.2331335,432.21748341634,1786,cpd:C20555,Aflatrem,C32H39NO4,Aflatrem,R10365,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,2.5.1.-,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Indole diterpene alkaloids;     C20555  Aflatrem,CAS: 70553-75-2; PubChem: 172232294,cpd:C06999; cpd:C20555,32,39,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H40O4N1,C32H38O4N1,501.2879087,502.2957338,500.28008371635,1787,cpd:C20561,"21,22-Diprenylpaxilline",C37H49NO4,"21,22-Diprenylpaxilline",R10360,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 172232298,cpd:C20561,37,49,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H50O4N1,C37H48O4N1,571.3661591,572.3739841,570.3583341636,1788,cpd:C20586,Terpendole G,C28H37NO4,Terpendole G,R10372 R10405 R10406,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 172232323,cpd:C20586,28,37,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H38O4N1,C28H36O4N1,451.2722587,452.2800837,450.26443361637,1789,cpd:C20587,Paspaline B,C28H37NO3,Paspaline B,R10356 R10371 R10372,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 172232324,cpd:C20587,28,37,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H38O3N1,C28H36O3N1,435.2773441,436.2851691,434.2695191638,1790,cpd:C20593,beta-Paxitriol;,C27H35NO4,beta-Paxitriol; 10beta-Hydroxypaxilline,R10410 R10566 R10569,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 254741162,cpd:C20542; cpd:C20593,27,35,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H36O4N1,C27H34O4N1,437.2566086,438.2644336,436.24878361639,1791,cpd:C20594,"20,21-Diprenylterpendole J",C42H59NO5,"20,21-Diprenylterpendole J",R10384 R10692,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 254741163,cpd:C20594,42,59,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H60O5N1,C42H58O5N1,657.439324,658.447149,656.4314991640,1792,cpd:C20595,"20,21-Diprenylterpendole C",C42H57NO5,"20,21-Diprenylterpendole C",R10383 R10694,Indole diterpene alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 254741164,cpd:C20595,42,57,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H58O5N1,C42H56O5N1,655.4236739,656.431499,654.41584891641,1793,cpd:C20596,Penitrem D,C37H45NO4,Penitrem D,R10566,Indole diterpene alkaloid biosynthesis,NA,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Indole diterpene alkaloids;     C20596  Penitrem D,CAS: 78213-64-6; PubChem: 254741165,cpd:C20596,37,45,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H46O4N1,C37H44O4N1,567.3348589,568.342684,566.32703391642,1794,cpd:C20601,Janthitrem C,C37H47NO4,Janthitrem C,R10569,Indole diterpene alkaloid biosynthesis,NA,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Indole diterpene alkaloids;     C20601  Janthitrem C,CAS: 73561-91-8; PubChem: 254741170,cpd:C20601,37,47,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H48O4N1,C37H46O4N1,569.350509,570.358334,568.3426841643,1795,cpd:C02079,Staurosporine;,C28H26N4O3,Staurosporine; STS,R05757,Staurosporine biosynthesis; Biosynthesis of antibiotics,2.1.1.139,"Staurosporine biosynthesis, tryptophan => staurosporine",NA,CAS: 62996-74-1; PubChem: 5165; ChEBI: 15738; ChEMBL: CHEMBL162 CHEMBL388978; KNApSAcK: C00018127; PDB-CCD: STU; NIKKAJI: J445.409J,cpd:C02079,28,26,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H27O3N4,C28H25O3N4,466.2004907,467.2083157,465.19266571644,1796,cpd:C07349,3'-Demethylstaurosporine;,C27H24N4O3,3'-Demethylstaurosporine; 3'-Demethoxy-3'-hydroxystaurosporine,R05757 R11129,Staurosporine biosynthesis; Biosynthesis of antibiotics,2.1.1.139,"Staurosporine biosynthesis, tryptophan => staurosporine",NA,CAS: 161743-35-7; PubChem: 9556; ChEBI: 15692; KNApSAcK: C00016476; NIKKAJI: J647.144G,cpd:C07349,27,24,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H25O3N4,C27H23O3N4,452.1848406,453.1926657,451.17701561645,1797,cpd:C12318,"dTDP-3-amino-2,3,6-trideoxy-4-keto-D-glucose;",C16H25N3O13P2,"dTDP-3-amino-2,3,6-trideoxy-4-keto-D-glucose; dTDP-3-amino-2,3,6-trideoxy-D-threo-hexopyranos-4-ulose; dTDP-3-amino-4-oxo-2,3,6-trideoxy-D-glucose",R06627 R06631 R11045 R11138,Staurosporine biosynthesis; Polyketide sugar unit biosynthesis; Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,2.1.1.-; 2.6.1.-,dTDP-L-megosamine biosynthesis,NA,PubChem: 582708; ChEBI: 32332; 3DMET: B05627; NIKKAJI: J1.464.416D,cpd:C12318; cpd:C17093; cpd:C21137,16,25,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O13N3P2,C16H24O13N3P2,529.0862619,530.0940869,528.07843681646,1798,cpd:C12491,Pyrrolnitrin,C10H6Cl2N2O2,Pyrrolnitrin,R11107,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.13.-,"Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin",Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D01 ANTIFUNGALS FOR DERMATOLOGICAL USE;    D01A ANTIFUNGALS FOR TOPICAL USE;     D01AA Antibiotics;      D01AA07 Pyrrolnitrin;       D01094  Pyrrolnitrin (JP17/USAN/INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   58 Ringworm drugs;    D01094  Pyrrolnitrin (JP17/USAN/INN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Pyrrolnitrin;     D01094  Pyrrolnitrin (JP17/USAN/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D01094  Pyrrolnitrin,CAS: 1018-71-9; PubChem: 582881; ChEBI: 32079; ChEMBL: CHEMBL97972; KNApSAcK: C00018726; NIKKAJI: J7.221D,cpd:C12491,10,6,2,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C10H7O2N2Cl2,C10H5O2N2Cl2,255.9806328,256.9884578,254.97280781647,1799,cpd:C18092,dTDP-L-ristosamine;,C16H27N3O13P2,"dTDP-L-ristosamine; dTDP-3-amino-2,3,6-trideoxy-L-allose; dTDP-3-amino-2,3,6-trideoxy-L-ribo-hexose",R11122 R11139,Staurosporine biosynthesis; Biosynthesis of antibiotics,2.1.1.-; 2.4.-.-; 2.6.1.-,NA,NA,PubChem: 96024309; ChEBI: 81495; NIKKAJI: J2.783.601A,cpd:C11910; cpd:C12443; cpd:C18030; cpd:C18092; cpd:C21355,16,27,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O13N3P2,C16H26O13N3P2,531.1019119,532.109737,530.09408691648,1800,cpd:C19687,7-Chloro-L-tryptophan,C11H11ClN2O2,7-Chloro-L-tryptophan,R09560 R09570 R11105,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.4.3.23; 1.14.19.9,"Rebeccamycin biosynthesis, tryptophan => rebeccamycin; Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin",NA,PubChem: 135626155; PDB-CCD: CTE,cpd:C18532; cpd:C19687,11,11,2,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C11H12O2N2Cl1,C11H10O2N2Cl1,238.0509053,239.0587303,237.04308031649,1801,cpd:C19688,2-Imino-3-(7-chloroindol-3-yl)propanoate;,C11H9ClN2O2,2-Imino-3-(7-chloroindol-3-yl)propanoate; 7-Chlorodehydrotryptophan,R09560 R09566,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.4.3.23; 1.21.98.2,"Rebeccamycin biosynthesis, tryptophan => rebeccamycin",NA,PubChem: 135626156,cpd:C19688,11,9,2,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C11H10O2N2Cl1,C11H8O2N2Cl1,236.0352552,237.0430803,235.02743021650,1802,cpd:C19698,"3,4-Bis(7-chloroindol-3-yl)pyrrole-2,5-dicarboxylate;",C22H13Cl2N3O4,"3,4-Bis(7-chloroindol-3-yl)pyrrole-2,5-dicarboxylate; Dichlorochromopyrrolate",R09566 R09567,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.13.12.17; 1.21.98.2,"Rebeccamycin biosynthesis, tryptophan => rebeccamycin",NA,PubChem: 135626166; PDB-CCD: 2CC,cpd:C19698,22,13,4,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C22H14O4N3Cl2,C22H12O4N3Cl2,453.0283113,454.0361363,452.02048621651,1803,cpd:C19699,Dichloroarcyriaflavin A;,C20H9Cl2N3O2,Dichloroarcyriaflavin A; Rebeccamycin aglycon,R09567 R09568,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.13.12.17; 4.3.3.5,"Rebeccamycin biosynthesis, tryptophan => rebeccamycin",NA,PubChem: 135626167; ChEMBL: CHEMBL139517,cpd:C19699,20,9,2,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C20H10O2N3Cl2,C20H8O2N3Cl2,393.0071819,394.0150069,391.99935691652,1804,cpd:C19700,4'-O-Demethylrebeccamycin,C26H19Cl2N3O7,4'-O-Demethylrebeccamycin,R09568 R09569,Staurosporine biosynthesis; Biosynthesis of antibiotics,2.1.1.164; 4.3.3.5,"Rebeccamycin biosynthesis, tryptophan => rebeccamycin",NA,PubChem: 135626168,cpd:C19700,26,19,7,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C26H20O7N3Cl2,C26H18O7N3Cl2,555.0600053,556.0678304,554.05218031653,1805,cpd:C19701,Rebeccamycin,C27H21Cl2N3O7,Rebeccamycin,R09569,Staurosporine biosynthesis; Biosynthesis of antibiotics,2.1.1.164,"Rebeccamycin biosynthesis, tryptophan => rebeccamycin",NA,CAS: 93908-02-2; PubChem: 135626169; ChEMBL: CHEMBL370100; KNApSAcK: C00017865,cpd:C19701,27,21,7,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C27H22O7N3Cl2,C27H20O7N3Cl2,569.0756554,570.0834804,568.06783041654,1806,cpd:C20045,Verruculogen;,C27H33N3O7,Verruculogen; TR 1; TR 1 toxin,R10341 R10445,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.11.38; 2.5.1.107,"Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A",Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Others;     C20045  Verruculogen,CAS: 12771-72-1; PubChem: 135626511; ChEBI: 72765; KNApSAcK: C00011299,cpd:C20045,27,33,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H34O7N3,C27H32O7N3,511.2318504,512.2396754,510.22402541655,1807,cpd:C20512,Tryprostatin B,C21H25N3O2,Tryprostatin B,R10321 R10340,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.13.176; 2.5.1.106,"Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A",NA,PubChem: 172232261,cpd:C07397; cpd:C20512; cpd:C20636,21,25,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H26O2N3,C21H24O2N3,351.1946771,352.2025021,350.1868521656,1808,cpd:C20513,6-Hydroxytryprostatin B;,C21H25N3O3,6-Hydroxytryprostatin B; Desmethyltryprostatin A,R10321 R10588,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.13.176; 2.1.1.293,"Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A",NA,PubChem: 172232262,cpd:C13494; cpd:C20513,21,25,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H26O3N3,C21H24O3N3,367.1895917,368.1974167,366.18176661657,1809,cpd:C20563,Brevianamide F;,C16H17N3O2,Brevianamide F; Cyclo(L-Trp-L-Pro),R10340 R10456 R10661,Staurosporine biosynthesis; Biosynthesis of antibiotics,2.5.1.106; 2.5.1.109,"Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A",NA,CAS: 38136-70-8; PubChem: 172232300; PDB-CCD: QRP,cpd:C20563,16,17,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H18O2N3,C16H16O2N3,283.1320768,284.1399018,282.12425181658,1810,cpd:C20564,Fumitremorgin A,C32H41N3O7,Fumitremorgin A,R10341,Staurosporine biosynthesis; Biosynthesis of antibiotics,2.5.1.107,"Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A",NA,CAS: 12626-18-5; PubChem: 172232301,cpd:C20564,32,41,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H42O7N3,C32H40O7N3,579.2944507,580.3022757,578.28662561659,1811,cpd:C20604,Fumitremorgin C,C22H25N3O3,Fumitremorgin C,R10414 R10416,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.13.177; 1.14.21.10,"Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A",NA,PubChem: 172232332,cpd:C15665; cpd:C20604,22,25,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H26O3N3,C22H24O3N3,379.1895917,380.1974167,378.18176661660,1812,cpd:C20605,"12alpha,13alpha-Dihydroxyfumitremorgin C;",C22H25N3O5,"12alpha,13alpha-Dihydroxyfumitremorgin C; 12,13-Dihydroxyfumitremorgin C",R10414 R10457,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.13.177; 2.5.1.110,"Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A",NA,PubChem: 172232333,cpd:C20605,22,25,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H26O5N3,C22H24O5N3,411.1794209,412.1872459,410.17159591661,1813,cpd:C20607,Tryprostatin A,C22H27N3O3,Tryprostatin A,R10416 R10588,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.21.10; 2.1.1.293,"Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A",NA,PubChem: 172232334,cpd:C20607,22,27,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H28O3N3,C22H26O3N3,381.2052417,382.2130668,380.19741671662,1814,cpd:C20630,Fumitremorgin B,C27H33N3O5,Fumitremorgin B,R10445 R10457,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.11.38; 2.5.1.110,"Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A",NA,CAS: 12626-17-4; PubChem: 172232354; PDB-CCD: 4Q1,cpd:C20630,27,33,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H34O5N3,C27H32O5N3,479.2420212,480.2498462,478.23419611663,1815,cpd:C21109,Aminopyrrolnitrin,C10H8Cl2N2,Aminopyrrolnitrin,R11106 R11107,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.13.-; 1.14.19.-,"Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin",NA,PubChem: 312642078,cpd:C21109,10,8,0,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C10H9N2Cl2,C10H7N2Cl2,226.0064536,227.0142787,224.99862861664,1816,cpd:C21110,Monodechloroaminopyrrolnitrin,C10H9ClN2,Monodechloroaminopyrrolnitrin,R11105 R11106,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.19.-,"Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin",NA,PubChem: 312642079,cpd:C21110,10,9,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C10H10N2Cl1,C10H8N2Cl1,192.045426,193.053251,191.03760091665,1817,cpd:C21124,IPA imine;,C11H10N2O2,IPA imine; 2-Imino-3-(indol-3-yl)propanoate,R11119 R11120 R11131,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.4.3.-,"Staurosporine biosynthesis, tryptophan => staurosporine; Violacein biosynthesis, tryptophan => violacein",NA,PubChem: 312642093,cpd:C06732; cpd:C10744; cpd:C21124,11,10,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O2N2,C11H9O2N2,202.0742276,203.0820526,201.06640251666,1818,cpd:C21125,Chromopyrrolate;,C22H15N3O4,Chromopyrrolate; Chromopyrrolic acid,R11120 R11121,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.13.12.-,"Staurosporine biosynthesis, tryptophan => staurosporine",NA,PubChem: 312642094; PDB-CCD: CRR,cpd:C21125,22,15,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H16O4N3,C22H14O4N3,385.106256,386.114081,384.09843091667,1819,cpd:C21126,K-252c,C20H13N3O,K-252c,R11121 R11122,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.13.12.-; 2.4.-.-,"Staurosporine biosynthesis, tryptophan => staurosporine",NA,PubChem: 312642095; PDB-CCD: K2C,cpd:C21126,20,13,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H14O1N3,C20H12O1N3,311.1058621,312.1136871,310.0980371668,1820,cpd:C21127,Holyrine A,C26H24N4O3,Holyrine A,R11122 R11123,Staurosporine biosynthesis; Biosynthesis of antibiotics,2.4.-.-,"Staurosporine biosynthesis, tryptophan => staurosporine",NA,PubChem: 312642096,cpd:C21127,26,24,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H25O3N4,C26H23O3N4,440.1848406,441.1926657,439.17701561669,1821,cpd:C21128,O-Demethyl-N-demethyl-staurosporine;,C26H22N4O3,O-Demethyl-N-demethyl-staurosporine; 3'-O-Demethyl-4'-N-demethyl-staurosporine,R11123 R11129,Staurosporine biosynthesis; Biosynthesis of antibiotics,NA,"Staurosporine biosynthesis, tryptophan => staurosporine",NA,PubChem: 312642097,cpd:C21128,26,22,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H23O3N4,C26H21O3N4,438.1691906,439.1770156,437.16136561670,1822,cpd:C21131,Protodeoxyviolaceinic acid;,C21H15N3O2,Protodeoxyviolaceinic acid; Protodeoxyviolaceinate,R11131 R11132 R11134 R11158 R11374,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.13.217; 1.14.13.224,"Violacein biosynthesis, tryptophan => violacein",NA,PubChem: 313046611,cpd:C21131,21,15,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H16O2N3,C21H14O2N3,341.1164267,342.1242518,340.10860171671,1823,cpd:C21132,Deoxyviolaceinic acid;,C21H15N3O3,Deoxyviolaceinic acid; Deoxyviolaceinate,R11132 R11133 R11374,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.13.224,NA,NA,PubChem: 313046612,cpd:C21132; cpd:C21134,21,15,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H16O3N3,C21H14O3N3,357.1113414,358.1191664,356.10351631672,1824,cpd:C21133,Deoxyviolacein,C20H13N3O2,Deoxyviolacein,R11133,Staurosporine biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 313046613; ChEBI: 131915,cpd:C21133,20,13,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H14O2N3,C20H12O2N3,327.1007767,328.1086017,326.09295161673,1825,cpd:C21134,Protoviolaceinic acid;,C21H15N3O3,Protoviolaceinic acid; Protoviolaceinate,R11134 R11135 R11158 R11373,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.13.217; 1.14.13.224,"Violacein biosynthesis, tryptophan => violacein",NA,PubChem: 313046614,cpd:C21132; cpd:C21134,21,15,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H16O3N3,C21H14O3N3,357.1113414,358.1191664,356.10351631674,1826,cpd:C21135,Violaceinic acid;,C21H15N3O4,Violaceinic acid; Violaceinate,R11135 R11136 R11373,Staurosporine biosynthesis; Biosynthesis of antibiotics,1.14.13.224,"Violacein biosynthesis, tryptophan => violacein",NA,PubChem: 313046615,cpd:C21135,21,15,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H16O4N3,C21H14O4N3,373.106256,374.114081,372.09843091675,1827,cpd:C21136,Violacein,C20H13N3O3,Violacein,R11136,Staurosporine biosynthesis; Biosynthesis of antibiotics,NA,"Violacein biosynthesis, tryptophan => violacein",NA,CAS: 548-54-9; PubChem: 313046616; ChEBI: 131914,cpd:C21136,20,13,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H14O3N3,C20H12O3N3,343.0956913,344.1035163,342.08786631676,1828,cpd:C21137,"dTDP-3-amino-4-oxo-2,3,6-trideoxy-L-allose;",C16H25N3O13P2,"dTDP-3-amino-4-oxo-2,3,6-trideoxy-L-allose; dTDP-3-amino-4-keto-2,3,6-trideoxy-L-allose",R11138 R11139,Staurosporine biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 313046617,cpd:C12318; cpd:C17093; cpd:C21137,16,25,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O13N3P2,C16H24O13N3P2,529.0862619,530.0940869,528.07843681677,1829,cpd:C00804,Propynoate;,C3H2O2,Propynoate; Propiolic acid; Acetylenecarboxylic acid; Acetylenemonocarboxylate,R01611 R02940 R03535,beta-Alanine metabolism; Propanoate metabolism,1.2.1.3; 1.2.5.2; 4.2.1.27,NA,NA,CAS: 471-25-0; PubChem: 4062; ChEBI: 15364 33199; ChEMBL: CHEMBL1213530; 3DMET: B00178; NIKKAJI: J5.941B,cpd:C00685; cpd:C00804; cpd:C08736; cpd:C18854,3,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H3O2,C3H1O2,70.0054793,71.01330434,68.997654271678,1830,cpd:C00864,Pantothenate;,C9H17NO5,Pantothenate; Pantothenic acid; (R)-Pantothenate,R02473 R02474 R02973 R03018 R03927 R10752 R10821,beta-Alanine metabolism; Pantothenate and CoA biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Vitamin digestion and absorption,2.7.1.33; 3.5.1.22; 3.5.1.92; 3.5.1.-; 6.3.2.1; 6.3.2.44,"Pantothenate biosynthesis, valine/L-aspartate => pantothenate; Coenzyme A biosynthesis, pantothenate => CoA",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Water-soluble vitamins;     C00864  Pantothenic acid (Vitamin B5); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Pantothenic acid;     D07413  Pantothenic acid (BAN),CAS: 79-83-4; PubChem: 4121; ChEBI: 29032 46905 7916; ChEMBL: CHEMBL1594; KNApSAcK: C00001550; PDB-CCD: PAU; 3DMET: B00193; NIKKAJI: J4.242K,cpd:C00864; cpd:C18893,9,17,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H18O5N1,C9H16O5N1,219.1106727,220.1184977,218.10284761679,1831,cpd:C00894,Propenoyl-CoA;,C24H38N7O17P3S,Propenoyl-CoA; Acryloyl-CoA; Acrylyl-CoA,R00919 R00924 R02963 R03045 R03046 R04432 R05509 R10161,beta-Alanine metabolism; Propanoate metabolism; Styrene degradation; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.3.1.84; 1.3.1.95; 1.3.1.-; 1.3.8.7; 2.8.3.12; 4.2.1.17; 4.2.1.54; 4.2.1.116; 4.3.1.6,"Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle",NA,CAS: 5776-58-9; PubChem: 4150; ChEBI: 15513; 3DMET: B04746; NIKKAJI: J1.210.753F,cpd:C00894,24,38,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C24H39O17N7P3S1,C24H37O17N7P3S1,821.125775,822.1336,820.11794991680,1832,cpd:C01073,N-Acetyl-beta-alanine,C5H9NO3,N-Acetyl-beta-alanine,R00909,beta-Alanine metabolism,3.5.1.21,NA,NA,CAS: 3025-95-4; PubChem: 4311; ChEBI: 16682; 3DMET: B00235; NIKKAJI: J135.888J,cpd:C00430; cpd:C01015; cpd:C01073; cpd:C01110; cpd:C01157; cpd:C01165; cpd:C03341; cpd:C03440; cpd:C03651; cpd:C03741; cpd:C05147; cpd:C06809; cpd:C12876; cpd:C19706,5,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O3N1,C5H8O3N1,131.0582432,132.0660682,130.05041811681,1833,cpd:C02335,beta-Alanyl-CoA,C24H41N8O17P3S,beta-Alanyl-CoA,R00914 R03046,beta-Alanine metabolism; Propanoate metabolism,2.8.3.-; 4.3.1.6,NA,NA,PubChem: 5385; ChEBI: 15507; 3DMET: B04849; NIKKAJI: J2.736.237K,cpd:C02335,24,41,17,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C24H42O17N8P3S1,C24H40O17N8P3S1,838.1523241,839.1601491,837.1444991682,1834,cpd:C03492,D-4'-Phosphopantothenate;,C9H18NO8P,D-4'-Phosphopantothenate; (R)-4'-Phosphopantothenate,R03018 R04230 R04231 R09379,beta-Alanine metabolism; Pantothenate and CoA biosynthesis; Metabolic pathways,2.7.1.33; 6.3.2.5; 6.3.2.36,"Coenzyme A biosynthesis, pantothenate => CoA",NA,PubChem: 6304; ChEBI: 15905; KNApSAcK: C00019685; PDB-CCD: PAZ; 3DMET: B00592; NIKKAJI: J1.877.906D,cpd:C03492,9,18,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H19O8N1P1,C9H17O8N1P1,299.0770035,300.0848286,298.06917851683,1835,cpd:C05340,beta-Alanyl-L-arginine,C9H19N5O3,beta-Alanyl-L-arginine,R00912 R03935,beta-Alanine metabolism,3.4.13.4; 6.3.2.11,NA,NA,PubChem: 7718; ChEBI: 28712; 3DMET: B00767; NIKKAJI: J2.755.554C,cpd:C05340,9,19,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H20O3N5,C9H18O3N5,245.1487895,246.1566145,244.14096451684,1836,cpd:C05341,beta-Alanyl-L-lysine,C9H19N3O3,beta-Alanyl-L-lysine,R00910 R00911,beta-Alanine metabolism,3.4.13.4; 6.3.2.11,NA,NA,PubChem: 7719; ChEBI: 27749; 3DMET: B00768; NIKKAJI: J2.008.870B,cpd:C05341; cpd:C15699,9,19,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H20O3N3,C9H18O3N3,217.1426415,218.1504665,216.13481651685,1837,cpd:C05665,3-Aminopropanal;,C3H7NO,3-Aminopropanal; beta-Aminopropion aldehyde,R00904 R03139 R09076 R09077,beta-Alanine metabolism,1.2.1.3; 1.2.1.5; 1.2.1.19; 1.4.3.21; 1.4.3.22; 1.5.3.16; 1.5.3.17,NA,NA,PubChem: 7975; ChEBI: 18090 27608; 3DMET: B00832; NIKKAJI: J676.182H,cpd:C01888; cpd:C01995; cpd:C03134; cpd:C05665,3,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O1N1,C3H6O1N1,73.05276385,74.06058888,72.044938821686,1838,cpd:C05668,3-Hydroxypropionyl-CoA;,C24H40N7O18P3S,3-Hydroxypropionyl-CoA; 3-Hydroxypropionyl coenzyme A; 3-Hydroxypropanoyl-CoA; 3-Hydroxypropanoyl coenzymeA; beta-Hydroxypropionyl-CoA,R03045 R03157 R03158 R04919 R09286,beta-Alanine metabolism; Propanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.1.1.-; 3.1.2.4; 4.2.1.17; 4.2.1.116; 6.2.1.36; 6.2.1.-,"Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA; Hydroxypropionate-hydroxybutylate cycle; 3-Hydroxypropionate bi-cycle",NA,PubChem: 7976; ChEBI: 27762; 3DMET: B05091; NIKKAJI: J2.757.150F,cpd:C00827; cpd:C05668,24,40,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O18N7P3S1,C24H39O18N7P3S1,839.1363396,840.1441647,838.12851461687,1839,cpd:C05669,beta-Nitropropanoate;,C3H5NO4,beta-Nitropropanoate; beta-Nitropropanoic acid; beta-Nitropropionic acid; 3-Nitropropanoate; 3-Nitropropionic acid,R00916 R03900,beta-Alanine metabolism,1.3.1.16,NA,NA,CAS: 504-88-1; PubChem: 7977; ChEBI: 16348; ChEMBL: CHEMBL451226; KNApSAcK: C00018684; PDB-CCD: 3NP; 3DMET: B00833; NIKKAJI: J12.998D,cpd:C00872; cpd:C03071; cpd:C05669,3,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H6O4N1,C3H4O4N1,119.0218576,120.0296827,118.01403261688,1840,cpd:C05670,3-Aminopropiononitrile;,C3H6N2,3-Aminopropiononitrile; beta-Aminopropionitrile,R00917 R03971 R06614,beta-Alanine metabolism; Cyanoamino acid metabolism,2.3.2.2; 4.1.1.-,NA,NA,CAS: 151-18-8; PubChem: 7978; ChEBI: 27413; ChEMBL: CHEMBL1618272; 3DMET: B00834; NIKKAJI: J10.983E,cpd:C00603; cpd:C02718; cpd:C02766; cpd:C05670; cpd:C05714; cpd:C06682; cpd:C08057; cpd:C10899; cpd:C11119; cpd:C14398; cpd:C19282; cpd:C19286,3,6,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7N2,C3H5N2,70.0530982,71.06092323,69.045273171689,1841,cpd:C00227,Acetyl phosphate,C2H5O5P,Acetyl phosphate,R00207 R00230 R00315 R00317 R00320 R00761 R01620 R01621; R05651 R07226 R07227 R07228,Taurine and hypotaurine metabolism; Pyruvate metabolism; Methane metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.2.3.3; 1.21.4.2; 1.21.4.3; 1.21.4.4; 2.3.1.8; 2.3.1.32; 2.3.3.15; 2.7.2.1; 2.7.2.12; 2.7.2.15; 3.6.1.7; 4.1.2.9; 4.1.2.22,"Methanogenesis, acetate => methane; Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate",NA,PubChem: 3527; ChEBI: 15350; KNApSAcK: C00019559; PDB-CCD: UVW; 3DMET: B00063; NIKKAJI: J37.490C,cpd:C00227; cpd:C05682,2,5,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H6O5P1,C2H4O5P1,139.9874603,140.9952853,138.97963521690,1842,cpd:C00519,Hypotaurine;,C2H7NO2S,Hypotaurine; 2-Aminoethanesulfinic acid,R01681 R02466 R02467,Taurine and hypotaurine metabolism; Metabolic pathways,1.8.1.3; 1.13.11.19; 4.1.1.15; 4.1.1.29,NA,NA,CAS: 300-84-5; PubChem: 3802; ChEBI: 16668; ChEMBL: CHEMBL1256480; 3DMET: B01277; NIKKAJI: J11.604A,cpd:C00519,2,7,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C2H8O2N1S1,C2H6O2N1S1,109.0197496,110.0275747,108.01192461691,1843,cpd:C00593,Sulfoacetaldehyde;,C2H4O4S,Sulfoacetaldehyde; 2-Sulfoacetaldehyde,R01684 R01685 R02600 R05651 R05652 R05774 R06980 R06981; R07167 R09153 R09557,Taurine and hypotaurine metabolism; Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.313; 1.1.2.-; 1.2.1.73; 1.2.1.81; 1.4.2.-; 1.4.99.2; 2.3.3.15; 2.6.1.55; 2.6.1.77; 4.1.1.79,Coenzyme M biosynthesis,NA,CAS: 32797-12-9; PubChem: 3872; ChEBI: 17717; KNApSAcK: C00000763; 3DMET: B00143; NIKKAJI: J914.381E,cpd:C00593; cpd:C13724,2,4,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C2H5O4S1,C2H3O4S1,123.9830298,124.9908548,122.97520471692,1844,cpd:C01678,Cysteamine;,C2H7NS,Cysteamine; 2-Aminoethanethiol; beta-Aminoethanethiol; beta-Mercaptoethylamine; Mercaptamine; Thioethanolamine,R02467 R02973 R03668,Taurine and hypotaurine metabolism; Metabolic pathways,1.13.11.19; 2.3.1.11; 3.5.1.92,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C01678  Cysteamine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;    A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;     A16AA Amino acids and derivatives;      A16AA04 Mercaptamine;       D03634  Cysteamine (USAN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01X OTHER OPHTHALMOLOGICALS;     S01XA Other ophthalmologicals;      S01XA21 Mercaptamine;       D03634  Cysteamine (USAN); USP drug classification [BR:br08302];  Enzyme Replacement/Modifiers;   Cysteamine;    D03634  Cysteamine (USAN),CAS: 60-23-1; PubChem: 4821; ChEBI: 17141; ChEMBL: CHEMBL602; PDB-CCD: DHL; 3DMET: B00335; NIKKAJI: J62.801H,cpd:C00245; cpd:C00519; cpd:C01678,2,7,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C2H8N1S1,C2H6N1S1,77.0299204,78.03774544,76.022095371693,1845,cpd:C01959,Taurocyamine,C3H9N3O3S,Taurocyamine,R01686 R03785,Taurine and hypotaurine metabolism,2.1.4.1; 2.7.3.4,NA,NA,CAS: 543-18-0; PubChem: 5060; ChEBI: 17228; ChEMBL: CHEMBL21832; PDB-CCD: 3S5; 3DMET: B00373; NIKKAJI: J11.554A,cpd:C01959,3,9,3,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H10O3N3S1,C3H8O3N3S1,167.0364623,168.0442874,166.02863731694,1846,cpd:C03149,N-Phosphotaurocyamine;,C3H10N3O6PS,N-Phosphotaurocyamine; Taurocyamine phosphate; N(omega)-Phosphotaurocyamine,R03785,Taurine and hypotaurine metabolism,2.7.3.4,NA,NA,PubChem: 6037; ChEBI: 16621; 3DMET: B00549; NIKKAJI: J2.740.856G,cpd:C03149,3,10,6,3,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H11O6N3P1S1,C3H9O6N3P1S1,247.0027932,248.0106183,245.99496821695,1847,cpd:C05123,2-Hydroxyethanesulfonate;,C2H6O4S,2-Hydroxyethanesulfonate; 2-Hydroxyethanesulfonic acid; 2-Hydroxyethane-1-sulfonic acid; Isethionic acid; Isethionate,R02600 R06981,Taurine and hypotaurine metabolism; Metabolic pathways,1.1.1.313; 1.1.2.-,NA,NA,CAS: 107-36-8; PubChem: 7545; ChEBI: 1157; ChEMBL: CHEMBL1909269; 3DMET: B00752; NIKKAJI: J5.057A,cpd:C05123; cpd:C19177,2,6,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C2H7O4S1,C2H5O4S1,125.9986798,127.0065049,124.99085481696,1848,cpd:C05844,5-L-Glutamyl-taurine;,C7H14N2O6S,5-L-Glutamyl-taurine; 5-Glutamyl-taurine; Glutaurine,R01687,Taurine and hypotaurine metabolism,2.3.2.2,NA,NA,CAS: 56488-60-9; PubChem: 8137; ChEBI: 27694; 3DMET: B01903; NIKKAJI: J12.619E,cpd:C05844,7,14,6,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O6N2S1,C7H13O6N2S1,254.0572574,255.0650824,253.04943231697,1849,cpd:C06735,Aminoacetaldehyde;,C2H5NO,Aminoacetaldehyde; 2-Aminoacetaldehyde,R05320 R06830 R10984 R10986,Taurine and hypotaurine metabolism,1.1.1.276; 1.1.1.387; 1.14.11.17,NA,NA,CAS: 6542-88-7; PubChem: 8957; ChEBI: 17628; ChEMBL: CHEMBL296723; PDB-CCD: GLZ; 3DMET: B01038; NIKKAJI: J24.178D,cpd:C02903; cpd:C06244; cpd:C06735; cpd:C11489,2,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H6O1N1,C2H4O1N1,59.03711379,60.04493882,58.029288751698,1850,cpd:C14179,Sulfoacetate;,C2H4O5S,Sulfoacetate; Sulfoacetic acid,R06980,Taurine and hypotaurine metabolism,1.2.1.73,NA,NA,CAS: 123-43-3; PubChem: 7846991; ChEBI: 50519; PDB-CCD: SAT; NIKKAJI: J21.744A,cpd:C14179,2,4,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C2H5O5S1,C2H3O5S1,139.9779444,140.9857694,138.97011941699,1851,cpd:C01438,Methane;,CH4,Methane; CH4,R01142 R01143 R04541 R09339 R09518 R10204,Phosphonate and phosphinate metabolism; Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Degradation of aromatic compounds; Protein digestion and absorption,1.14.13.25; 1.14.18.3; 2.8.4.1; 4.7.1.1; 4.99.1.2,"Methane oxidation, methanotroph, methane => formaldehyde; Methanogenesis, methanol => methane; Methanogenesis, acetate => methane; Methanogenesis, methylamine/dimethylamine/trimethylamine => methane; Methanogenesis, CO2 => methane",NA,CAS: 74-82-8; PubChem: 4618; ChEBI: 16183; ChEMBL: CHEMBL17564; 3DMET: B01450; NIKKAJI: J2.380I,cpd:C00086; cpd:C00132; cpd:C00169; cpd:C00375; cpd:C00409; cpd:C01438; cpd:C02436; cpd:C02704; cpd:C05703; cpd:C07044; cpd:C08087; cpd:C08091; cpd:C11145; cpd:C12560; cpd:C13167; cpd:C13168; cpd:C13524; cpd:C14053; cpd:C14054; cpd:C14055; cpd:C14415; cpd:C18361; cpd:C18902; cpd:C19432; cpd:C19568; cpd:C20306; cpd:C21398,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H5,C1H3,16.03130013,17.03912516,15.02347511700,1852,cpd:C02798,3-Phosphonopyruvate,C3H5O6P,3-Phosphonopyruvate,R00661 R04051 R04053 R08200 R08881,Phosphonate and phosphinate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics,2.6.1.-; 3.11.1.3; 4.1.1.82; 5.4.2.9,NA,NA,PubChem: 5748; ChEBI: 30935; KNApSAcK: C00000801; PDB-CCD: PPR; 3DMET: B00502; NIKKAJI: J366.747B,cpd:C00074; cpd:C02798; cpd:C16849,3,5,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H6O6P1,C3H4O6P1,167.9823749,168.9901999,166.97454981701,1853,cpd:C03167,Phosphonoacetaldehyde;,C2H5O4P,Phosphonoacetaldehyde; 2-Phosphonoacetaldehyde; 2-Oxoethylphosphonate,R00747 R04053 R04152 R04251 R08861 R08883 R08884 R08885; R08886 R09478,Phosphonate and phosphinate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics,1.1.1.309; 2.1.1.-; 2.6.1.37; 3.11.1.1; 4.1.1.82,NA,NA,CAS: 16051-76-6; PubChem: 6050; ChEBI: 18124; KNApSAcK: C00000799; PDB-CCD: POA; 3DMET: B00552; NIKKAJI: J431.380A,cpd:C03167,2,5,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H6O4P1,C2H4O4P1,123.9925456,125.0003707,122.98472061702,1854,cpd:C03557,2-Aminoethylphosphonate;,C2H8NO3P,2-Aminoethylphosphonate; (2-Aminoethyl)phosphonate; Ciliatine,R04152 R04247 R04248 R04249 R04250 R04252 R10724 R11479,Phosphonate and phosphinate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; ABC transporters,1.1.99.-; 1.14.11.46; 2.3.1.-; 2.6.1.37; 2.7.7.14; 4.99.1.-,NA,NA,CAS: 2041-14-7; PubChem: 6353; ChEBI: 15573; ChEMBL: CHEMBL1321977; PDB-CCD: P7I; 3DMET: B00598; NIKKAJI: J13.761H,cpd:C03557; cpd:C03782,2,8,3,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H9O3N1P1,C2H7O3N1P1,125.0241801,126.0320052,124.01635511703,1855,cpd:C04650,L-Phosphinothricin;,C5H12NO4P,L-Phosphinothricin; Phosphinothricin; L-Glufosinate; L-2-Amino-4-(hydroxymethylphosphinyl)butanoate,R08874 R08938 R11481,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,2.3.1.183,NA,NA,CAS: 35597-44-5; PubChem: 7238; ChEBI: 28030; ChEMBL: CHEMBL145114; KNApSAcK: C00000797; PDB-CCD: PPQ; NIKKAJI: J391.973K,cpd:C04650; cpd:C05042; cpd:C18662,5,12,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O4N1P1,C5H11O4N1P1,181.0503949,182.0582199,180.04256981704,1856,cpd:C05672,2-Amino-3-phosphonopropanoate;,C3H8NO5P,2-Amino-3-phosphonopropanoate; Phosphonoalanine,R04051,Phosphonate and phosphinate metabolism; Metabolic pathways,2.6.1.-,NA,NA,PubChem: 7979; ChEBI: 28388; ChEMBL: CHEMBL88621; 3DMET: B05092; NIKKAJI: J81.069J,cpd:C01705; cpd:C05672; cpd:C11638; cpd:C12021; cpd:C18564; cpd:C18565,3,8,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O5N1P1,C3H7O5N1P1,169.0140094,170.0218344,168.00618431705,1857,cpd:C05673,CMP-2-aminoethylphosphonate;,C11H20N4O10P2,CMP-2-aminoethylphosphonate; CMPciliatine,R04247 R04920 R04921,Phosphonate and phosphinate metabolism; Metabolic pathways,2.7.7.14; 2.7.8.1; 2.7.8.-,NA,NA,PubChem: 7980; ChEBI: 3276; 3DMET: B01882; NIKKAJI: J2.757.165D,cpd:C05673,11,20,10,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H21O10N4P2,C11H19O10N4P2,430.0654669,431.0732919,429.05764181706,1858,cpd:C05674,CMP-N-trimethyl-2-aminoethylphosphonate;,C14H27N4O10P2,CMP-N-trimethyl-2-aminoethylphosphonate; CMP-2-trimethylaminoethylphosphonate,R02590 R04922,Phosphonate and phosphinate metabolism; Metabolic pathways,2.7.7.15; 2.7.8.2,NA,NA,PubChem: 7981; ChEBI: 3281; 3DMET: B01883; NIKKAJI: J858C,cpd:C05674,14,27,10,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H28O10N4P2,C14H26O10N4P2,473.1202421,474.1280671,472.1124171707,1861,cpd:C05678,(2-Amino-1-hydroxyethyl)phosphonate;,C2H8NO4P,(2-Amino-1-hydroxyethyl)phosphonate; 1-Hydroxy-2-aminoethylphosphonate,R04249 R04924 R10722 R10724,Phosphonate and phosphinate metabolism,1.1.99.-; 1.13.11.78; 1.14.11.46,NA,NA,PubChem: 7985; ChEBI: 631; 3DMET: B05093; NIKKAJI: J431.383F,cpd:C00346; cpd:C05678,2,8,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H9O4N1P1,C2H7O4N1P1,141.0190947,142.0269198,140.01126971708,1862,cpd:C05679,N-Monomethyl-2-aminoethylphosphonate;,C3H10NO3P,N-Monomethyl-2-aminoethylphosphonate; 2-Methylaminoethylphosphonate,R04250 R04925,Phosphonate and phosphinate metabolism,NA,NA,NA,PubChem: 7986; ChEBI: 7328; 3DMET: B01884; NIKKAJI: J431.381J,cpd:C05679,3,10,3,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H11O3N1P1,C3H9O3N1P1,139.0398302,140.0476552,138.03200521709,1863,cpd:C05680,N-Dimethyl-2-aminoethylphosphonate;,C4H12NO3P,N-Dimethyl-2-aminoethylphosphonate; 2-Dimethylaminoethylphosphonate,R02592 R04925,Phosphonate and phosphinate metabolism,NA,NA,NA,PubChem: 7987; ChEBI: 7265; 3DMET: B00835; NIKKAJI: J431.382H,cpd:C05680,4,12,3,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H13O3N1P1,C4H11O3N1P1,153.0554802,154.0633053,152.04765521710,1865,cpd:C05682,Phosphonoacetate;,C2H5O5P,Phosphonoacetate; Phosphonoacetic acid; Fosfonet,R00318 R04251,Phosphonate and phosphinate metabolism; Microbial metabolism in diverse environments,3.11.1.2,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J05 ANTIVIRALS FOR SYSTEMIC USE;    J05A DIRECT ACTING ANTIVIRALS;     J05AD Phosphonic acid derivatives;      J05AD02 Fosfonet;       C05682  Phosphonoacetate,CAS: 4408-78-0; PubChem: 7989; ChEBI: 15732; ChEMBL: CHEMBL50300; PDB-CCD: PAE; 3DMET: B00836; NIKKAJI: J138.397C,cpd:C00227; cpd:C05682,2,5,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H6O5P1,C2H4O5P1,139.9874603,140.9952853,138.97963521711,1866,cpd:C05683,Ciliatocholate;,C26H46NO7P,Ciliatocholate; Ciliatocholic acid; 2-Aminoethylphosphocholate,R04252,Phosphonate and phosphinate metabolism,NA,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0402 C26 bile acids, alcohols, and derivatives;     C05683  2-Aminoethylphosphocholic acid",PubChem: 7990; ChEBI: 1019; 3DMET: B05094; NIKKAJI: J2.758.807G,cpd:C05683,26,46,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H47O7N1P1,C26H45O7N1P1,515.3011898,516.3090149,514.29336481712,1867,cpd:C06367,1-Carboxyvinyl carboxyphosphonate;,C4H5O7P,1-Carboxyvinyl carboxyphosphonate; Carboxyphosphonoenolpyruvate,R05165 R08868 R08887,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,2.7.8.23,NA,NA,PubChem: 8603; ChEBI: 17056; KNApSAcK: C00000783; NIKKAJI: J365.814G,cpd:C06367; cpd:C17946,4,5,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H6O7P1,C4H4O7P1,195.9772895,196.9851145,194.96946451713,1868,cpd:C06368,3-(Hydrohydroxyphosphoryl)pyruvate;,C3H5O5P,3-(Hydrohydroxyphosphoryl)pyruvate; (Hydroxyphosphinyl)pyruvate; 3-Phosphinopyruvate,R05165 R08869 R08870,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,2.7.8.23,NA,NA,PubChem: 8604; ChEBI: 18007; NIKKAJI: J431.387I,cpd:C06368,3,5,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H6O5P1,C3H4O5P1,151.9874603,152.9952853,150.97963521714,1869,cpd:C06451,2-Hydroxyethylphosphonate;,C2H7O4P,2-Hydroxyethylphosphonate; (2-Hydroxyethyl)-phosphonic acid,R08861 R08862 R08864 R09478 R10191,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,1.1.1.309; 1.13.11.72; 1.13.11.73; 2.1.1.308,NA,NA,CAS: 22987-21-9; PubChem: 8684; ChEBI: 1159; KNApSAcK: C00000916; PDB-CCD: 2HE; 3DMET: B00963; NIKKAJI: J21.058G,cpd:C06451,2,7,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H8O4P1,C2H6O4P1,126.0081957,127.0160207,125.00037071715,1870,cpd:C06452,(S)-2-Hydroxypropylphosphonate,C3H9O4P,(S)-2-Hydroxypropylphosphonate,R08862 R08863,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,1.1.3.-; 1.11.1.23; 2.1.1.308; 2.1.1.-,NA,NA,PubChem: 8685; ChEBI: 1171; PDB-CCD: S0H; 3DMET: B05195; NIKKAJI: J436.958K,cpd:C06452,3,9,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H10O4P1,C3H8O4P1,140.0238458,141.0316708,139.01602071716,1871,cpd:C06454,Fosfomycin;,C3H7O4P,"Fosfomycin; Phosphonomycin; (1R,2S)-Epoxypropylphosphonate",R08863,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,1.1.3.-; 1.11.1.23,NA,"Compounds with biological roles [BR:br08001];  Antibiotics;   Others;    Aliphatic compounds;     C06454  Fosfomycin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01X OTHER ANTIBACTERIALS;     J01XX Other antibacterials;      J01XX01 Fosfomycin;       D04253  Fosfomycin (USAN/INN); USP drug classification [BR:br08302];  Antibacterials;   Antibacterials, Other;    Fosfomycin;     D04253  Fosfomycin (USAN/INN); Antiinfectives [BR:br08307];  Antibacterials;   Cell wall biosynthesis inhibitor;    Others;     UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor;      Fosfomycin;       D04253  Fosfomycin (USAN/INN)",CAS: 23155-02-4; PubChem: 8687; ChEBI: 28915; ChEMBL: CHEMBL1757; KNApSAcK: C00000789; PDB-CCD: FCN; 3DMET: B02030; NIKKAJI: J34.117G,cpd:C06454,3,7,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O4P1,C3H6O4P1,138.0081957,139.0160207,137.00037071717,1872,cpd:C06455,Hydroxymethylphosphonate;,CH5O4P,Hydroxymethylphosphonate; P-(Hydroxymethyl)-phosphonic acid,R08864 R08865,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,1.13.11.72,NA,NA,CAS: 2617-47-2; PubChem: 8688; ChEBI: 5810; KNApSAcK: C00000791; 3DMET: B00964; NIKKAJI: J21.059E,cpd:C06455,1,5,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H6O4P1,C1H4O4P1,111.9925456,113.0003707,110.98472061718,1873,cpd:C06456,Phosphonoformate;,CH3O5P,Phosphonoformate; Foscarmet; Foscarnet,R08866 R08867,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,2.7.7.93,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J05 ANTIVIRALS FOR SYSTEMIC USE;    J05A DIRECT ACTING ANTIVIRALS;     J05AD Phosphonic acid derivatives;      J05AD01 Foscarnet;       C06456  Phosphonoformate,CAS: 4428-95-9; PubChem: 8689; ChEBI: 127780; ChEMBL: CHEMBL666; KNApSAcK: C00000800; PDB-CCD: PPF; 3DMET: B02031; NIKKAJI: J11.016G,cpd:C02405; cpd:C06456,1,3,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H4O5P1,C1H2O5P1,125.9718102,126.9796352,124.96398521719,1874,cpd:C06457,Bialaphos;,C11H22N3O6P,Bialaphos; Bilanafos; 2-Amino-4-(methylphosphino)butyrylalanylalanine; gamma-(Hydroxymethylphosphinyl)-L-alpha-aminobutyryl-L-alanyl-L-alanine; Phosphinothricin tripeptide,R08876 R11481,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,NA,NA,Pesticides [BR:br08007];  Pesticides;   Herbicides;    Organophosphorus herbicides;     C06457  Bialaphos,CAS: 35597-43-4; PubChem: 8690; ChEBI: 3088; KNApSAcK: C00000782; 3DMET: B02032; NIKKAJI: J17.889F,cpd:C06457,11,22,6,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H23O6N3P1,C11H21O6N3P1,323.1246224,324.1324475,322.11679741720,1875,cpd:C06459,N-Trimethyl-2-aminoethylphosphonate;,C5H15NO3P,N-Trimethyl-2-aminoethylphosphonate; 2-Trimethylaminoethylphosphonate,R02590 R02592,Phosphonate and phosphinate metabolism; Metabolic pathways,2.7.7.15,NA,NA,PubChem: 8691; ChEBI: 7347; 3DMET: B00965; NIKKAJI: J431.384D,cpd:C06459,5,15,3,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H16O3N1P1,C5H14O3N1P1,168.0789553,169.0867804,167.07113031721,1876,cpd:C17940,Rhizocticin B,C16H31N6O7P,Rhizocticin B,R08883,Phosphonate and phosphinate metabolism,NA,NA,NA,PubChem: 96024161; ChEBI: 81396; NIKKAJI: J2.713.868C,cpd:C17940,16,31,7,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H32O7N6P1,C16H30O7N6P1,450.1991844,451.2070094,449.19135931722,1877,cpd:C17941,2-Oxo-4-phosphonobutanoate;,C4H7O6P,2-Oxo-4-phosphonobutanoate; 2-Oxo-4-phosphonobutanoic acid,R08881 R08882,Phosphonate and phosphinate metabolism,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA00 Other Fatty Acyls;    C17941  2-Oxo-4-phosphonobutanoic acid,PubChem: 96024162; ChEBI: 81397,cpd:C01247; cpd:C01293; cpd:C01308; cpd:C03016; cpd:C03808; cpd:C03875; cpd:C04141; cpd:C04391; cpd:C04564; cpd:C04565; cpd:C04768; cpd:C17941,4,7,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H8O6P1,C4H6O6P1,181.9980249,183.00585,180.99019991723,1878,cpd:C17942,FR 900098;,C5H12NO5P,FR 900098; (3-(Acetylhydroxyamino)propyl)phosphonic acid,R08882,Phosphonate and phosphinate metabolism,NA,NA,NA,CAS: 66508-32-5; PubChem: 96024163; ChEBI: 81398; ChEMBL: CHEMBL205338; KNApSAcK: C00018262; PDB-CCD: F98; NIKKAJI: J431.385B,cpd:C13734; cpd:C17942,5,12,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O5N1P1,C5H11O5N1P1,197.0453095,198.0531345,196.03748451724,1879,cpd:C17943,Formylphosphonate;,CH3O4P,Formylphosphonate; Phosphonoformaldehyde; Formylphosphonic acid,R08865 R08866,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024164; ChEBI: 81399,cpd:C17943,1,3,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H4O4P1,C1H2O4P1,109.9768956,110.9847206,108.96907051725,1880,cpd:C17944,Rhizocticin A,C11H22N5O6P,Rhizocticin A,R08884,Phosphonate and phosphinate metabolism,NA,NA,NA,CAS: 114301-25-6; PubChem: 96024165; ChEBI: 81400; NIKKAJI: J2.713.867E,cpd:C17944,11,22,6,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H23O6N5P1,C11H21O6N5P1,351.1307704,352.1385955,350.12294541726,1881,cpd:C17945,Phosphonoformyl-CMP;,C10H15N3O12P2,Phosphonoformyl-CMP; CMP-5'-phosphonoformate,R08867 R08887,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,2.7.7.93,NA,NA,PubChem: 96024166; ChEBI: 131759,cpd:C17945,10,15,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O12N3P2,C10H14O12N3P2,431.0130969,432.020922,430.00527191727,1882,cpd:C17947,2-Phosphinomethylmalate;,C5H9O7P,2-Phosphinomethylmalate; 2-Phosphinomethylmalic acid; 2-(Hydrohydroxyphosphorylmethyl)malate,R08870 R11408,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,4.2.1.166,NA,NA,CAS: 95114-79-7; PubChem: 96024168; ChEBI: 81403; NIKKAJI: J431.391G,cpd:C05218; cpd:C17947; cpd:C20959; cpd:C20960; cpd:C21372,5,9,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O7P1,C5H8O7P1,212.0085896,213.0164147,211.00076461728,1883,cpd:C17948,Deamino-alpha-keto-demethylphosphinothricin;,C4H7O5P,Deamino-alpha-keto-demethylphosphinothricin; 4-(Hydroxyphosphinyl)-2-oxobutyric acid; 2-Oxo-4-phosphinobutanoate; 4-Hydrohydroxyphosphoryl-2-oxobutanoate,R08877 R08888,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024169; ChEBI: 81404; KNApSAcK: C00000796; NIKKAJI: J243.050I,cpd:C17948,4,7,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H8O5P1,C4H6O5P1,166.0031103,167.0109354,164.99528531729,1884,cpd:C17949,N-Acetyldemethylphosphinothricin;,C6H12NO5P,N-Acetyldemethylphosphinothricin; N-Adpt,R08871 R08872 R08873,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,2.1.1.326; 2.3.1.183,NA,NA,CAS: 135093-66-2; PubChem: 96024170; ChEBI: 81405,cpd:C17949,6,12,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O5N1P1,C6H11O5N1P1,209.0453095,210.0531345,208.03748451730,1885,cpd:C17950,N-Acetyldemethylphosphinothricin tripeptide,C12H22N3O7P,N-Acetyldemethylphosphinothricin tripeptide,R08872 R08875,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,2.1.1.326,NA,NA,PubChem: 96024171; ChEBI: 81406; NIKKAJI: J2.676.116F,cpd:C17950,12,22,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O7N3P1,C12H21O7N3P1,351.1195371,352.1273621,350.1117121731,1886,cpd:C17951,N-Acetylbialaphos;,C13H24N3O7P,N-Acetylbialaphos; N-Acetylphosphinothricin tripeptide,R08875 R08876,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,2.1.1.326,NA,NA,CAS: 97412-78-7; PubChem: 96024172; ChEBI: 81407; NIKKAJI: J2.177.492H,cpd:C17951,13,24,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H25O7N3P1,C13H23O7N3P1,365.1351871,366.1430122,364.12736211732,1887,cpd:C17952,N-Acetylphosphinothricin;,C7H14NO5P,N-Acetylphosphinothricin; L-N-Acetylphosphinothricin; N-Acetyl-L-Glufosinate; N-Acetylphinothricin,R08873 R08874 R08938,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,2.1.1.326; 2.3.1.183,NA,NA,PubChem: 96024173; ChEBI: 131436; NIKKAJI: J2.177.493F,cpd:C13735; cpd:C17952; cpd:C18663,7,14,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O5N1P1,C7H13O5N1P1,223.0609596,224.0687846,222.05313451733,1888,cpd:C17960,Rhizocticin C,C17H33N6O7P,Rhizocticin C,R08885,Phosphonate and phosphinate metabolism,NA,NA,NA,PubChem: 96024180; ChEBI: 81412; NIKKAJI: J2.713.869A,cpd:C17960; cpd:C17961,17,33,7,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H34O7N6P1,C17H32O7N6P1,464.2148344,465.2226595,463.20700941734,1889,cpd:C17961,Rhizocticin D,C17H33N6O7P,Rhizocticin D,R08886,Phosphonate and phosphinate metabolism,NA,NA,NA,PubChem: 96024181; ChEBI: 81413; NIKKAJI: J2.705.050F,cpd:C17960; cpd:C17961,17,33,7,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H34O7N6P1,C17H32O7N6P1,464.2148344,465.2226595,463.20700941735,1890,cpd:C17962,Demethylphosphinothricin;,C4H10NO4P,Demethylphosphinothricin; (2S)-2-Amino-4-(hydroxyphosphinyl)butanoic acid,R08871 R08877,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,2.3.1.183,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0110 Amino fatty acids;     C17962  (2S)-2-Amino-4-(hydroxyphosphinyl)butanoic acid,CAS: 85178-62-7; PubChem: 96024182; ChEBI: 81414; ChEMBL: CHEMBL241972,cpd:C17962; cpd:C21403,4,10,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O4N1P1,C4H9O4N1P1,167.0347448,168.0425698,166.02691981736,1891,cpd:C20396,Methylphosphonate,CH5O3P,Methylphosphonate,R10185 R10191,Phosphonate and phosphinate metabolism,1.13.11.73; 2.7.8.37,NA,NA,CAS: 993-13-5; PubChem: 163312134; PDB-CCD: GB,cpd:C20396,1,5,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H6O3P1,C1H4O3P1,95.99763102,97.00545605,94.989805991737,1892,cpd:C20422,alpha-D-Ribose 1-methylphosphonate 5-triphosphate,C6H16O16P4,alpha-D-Ribose 1-methylphosphonate 5-triphosphate,R10185 R10186,Phosphonate and phosphinate metabolism,2.7.8.37; 3.6.1.63,NA,NA,PubChem: 163312159,cpd:C20422,6,16,16,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H17O16P4,C6H15O16P4,467.9388824,468.9467075,466.93105741738,1893,cpd:C20423,alpha-D-Ribose 1-methylphosphonate 5-phosphate,C6H14O10P2,alpha-D-Ribose 1-methylphosphonate 5-phosphate,R10186 R10204,Phosphonate and phosphinate metabolism,3.6.1.63; 4.7.1.1,NA,NA,PubChem: 163312160,cpd:C01143; cpd:C20423; cpd:C20848,6,14,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O10P2,C6H13O10P2,308.0062206,309.0140457,306.99839561739,1894,cpd:C20440,"alpha-D-Ribose 1,2-cyclic phosphate 5-phosphate;",C5H10O10P2,"alpha-D-Ribose 1,2-cyclic phosphate 5-phosphate; 5-Phospho-alpha-D-ribose 1,2-cyclic phosphate",R10204 R10205 R10972,Phosphonate and phosphinate metabolism,3.1.4.55; 3.1.4.57; 4.7.1.1,NA,NA,PubChem: 163312177,cpd:C20440,5,10,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O10P2,C5H9O10P2,291.9749205,292.9827455,290.96709551740,1895,cpd:C20986,"D-Ribose 2,5-bisphosphate",C5H12O11P2,"D-Ribose 2,5-bisphosphate",R10972 R10973,Phosphonate and phosphinate metabolism,3.1.4.57,NA,NA,PubChem: 254741445,cpd:C01095; cpd:C01151; cpd:C01182; cpd:C20986,5,12,11,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O11P2,C5H11O11P2,309.9854852,310.9933102,308.97766021741,1896,cpd:C21372,3-Phosphinomethylmalate;,C5H9O7P,3-Phosphinomethylmalate; 3-(Hydrohydroxyphosphorylmethyl)malate,R08888 R11408,Phosphonate and phosphinate metabolism; Biosynthesis of antibiotics,4.2.1.166,NA,NA,PubChem: 319902602,cpd:C05218; cpd:C17947; cpd:C20959; cpd:C20960; cpd:C21372,5,9,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O7P1,C5H8O7P1,212.0085896,213.0164147,211.00076461742,1897,cpd:C21403,2-Acetamidoethylphosphonate,C4H10NO4P,2-Acetamidoethylphosphonate,R11479 R11480,Phosphonate and phosphinate metabolism,2.3.1.-,NA,NA,PubChem: 328082946,cpd:C17962; cpd:C21403,4,10,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O4N1P1,C4H9O4N1P1,167.0347448,168.0425698,166.02691981743,1898,cpd:C21404,N-Ethylacetamide,C4H9NO,N-Ethylacetamide,R11480,Phosphonate and phosphinate metabolism,NA,NA,NA,PubChem: 328082947,cpd:C00555; cpd:C03219; cpd:C03537; cpd:C14452; cpd:C19332; cpd:C20315; cpd:C20339; cpd:C21404,4,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O1N1,C4H8O1N1,87.06841391,88.07623895,86.060588881744,1901,cpd:C02535,Dimethyl selenide,C2H6Se,Dimethyl selenide,R09369 R09370,Selenocompound metabolism,2.1.1.96; 2.1.1.-,NA,NA,CAS: 593-79-3; PubChem: 5542; ChEBI: 4610; KNApSAcK: C00033776; NIKKAJI: J6.769E,cpd:C02535,2,6,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C2H7Se1,C2H5Se1,109.9634692,110.9712942,108.95564421745,1903,cpd:C05335,L-Selenomethionine,C5H11NO2Se,L-Selenomethionine,R04770 R04771 R04772 R04773 R04774 R04775 R09365,Selenocompound metabolism,2.1.1.12; 2.1.1.13; 2.1.1.14; 2.5.1.6; 4.4.1.1; 4.4.1.11; 6.1.1.10,NA,NA,CAS: 3211-76-5; PubChem: 7713; ChEBI: 30021; ChEMBL: CHEMBL113178; PDB-CCD: MSE; 3DMET: B05009; NIKKAJI: J13.127J,cpd:C05335,5,11,2,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C5H12O2N1Se1,C5H10O2N1Se1,196.9954976,198.0033226,195.98767261746,1906,cpd:C05686,Adenylylselenate;,C10H14N5O10PSe,Adenylylselenate; Adenosine-5'-phosphoselenate,R04927 R04928 R04929,Selenocompound metabolism,1.8.99.2; 2.7.1.25; 2.7.7.4,NA,NA,PubChem: 7993; 3DMET: B01886; NIKKAJI: J2.758.815H,cpd:C05686,10,14,10,5,1,0,0,0,0,0,1,0,0,0,0,0,0,0,C10H15O10N5P1Se1,C10H13O10N5P1Se1,474.9643477,475.9721727,473.95652261747,1907,cpd:C05688,L-Selenocysteine,C3H7NO2Se,L-Selenocysteine,R03599 R03601 R04930 R04931 R04932 R04933 R04934 R04944; R04945 R04946 R10430,Selenocompound metabolism; Metabolic pathways,2.1.1.9; 2.1.1.280; 2.5.1.47; 2.5.1.48; 4.4.1.1; 4.4.1.16,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C05688  Selenocysteine (Sec),CAS: 10236-58-5; PubChem: 7995; ChEBI: 16633 26632; ChEMBL: CHEMBL109962; PDB-CCD: SEC; 3DMET: B05095; NIKKAJI: J401.997K,cpd:C05688,3,7,2,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C3H8O2N1Se1,C3H6O2N1Se1,168.9641975,169.9720225,167.95637241748,1908,cpd:C05689,Se-Methyl-L-selenocysteine,C4H9NO2Se,Se-Methyl-L-selenocysteine,R04931 R04935 R09366 R09373 R10430,Selenocompound metabolism,2.1.1.9; 2.1.1.280; 2.3.2.2; 2.6.1.-; 4.4.1.1; 4.4.1.13,NA,NA,PubChem: 7996; ChEBI: 27812; ChEMBL: CHEMBL62382; KNApSAcK: C00001382 C00034232; 3DMET: B05096; NIKKAJI: J362.852C,cpd:C05689; cpd:C05698,4,9,2,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C4H10O2N1Se1,C4H8O2N1Se1,182.9798475,183.9876726,181.97202251749,1909,cpd:C05690,Se-Methylselenomethionine,C6H14NO2Se,Se-Methylselenomethionine,R04772,Selenocompound metabolism,2.1.1.12,NA,NA,PubChem: 7997; ChEBI: 28513; 3DMET: B05097; NIKKAJI: J1.656.498B,cpd:C05690,6,14,2,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C6H15O2N1Se1,C6H13O2N1Se1,212.0189727,213.0267977,211.01114771750,1910,cpd:C05695,gamma-Glutamyl-Se-methylselenocysteine;,C9H16N2O5Se,gamma-Glutamyl-Se-methylselenocysteine; 5-L-Glutamyl-Se-methylselenocysteine,R04935,Selenocompound metabolism,2.3.2.2,NA,NA,PubChem: 8002; ChEBI: 28776; 3DMET: B05099; NIKKAJI: J948.875H,cpd:C05695,9,16,5,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C9H17O5N2Se1,C9H15O5N2Se1,312.0224406,313.0302657,311.01461561751,1912,cpd:C05698,Selenohomocysteine,C4H9NO2Se,Selenohomocysteine,R04774 R04936 R04941 R04942 R04943 R09365,Selenocompound metabolism,2.1.1.13; 2.1.1.14; 3.3.1.1; 4.2.1.22; 4.4.1.8,NA,NA,PubChem: 8005; ChEBI: 9096; 3DMET: B05100; NIKKAJI: J1.427.504E,cpd:C05689; cpd:C05698,4,9,2,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C4H10O2N1Se1,C4H8O2N1Se1,182.9798475,183.9876726,181.97202251752,1913,cpd:C05699,L-Selenocystathionine,C7H14N2O4Se,L-Selenocystathionine,R04930 R04941 R04942 R04944 R04945 R04946,Selenocompound metabolism,2.5.1.48; 4.2.1.22; 4.4.1.1; 4.4.1.8,NA,NA,PubChem: 8006; ChEBI: 27760; KNApSAcK: C00001392; 3DMET: B05101; NIKKAJI: J2.765.550E,cpd:C05699,7,14,4,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C7H15O4N2Se1,C7H13O4N2Se1,270.0118759,271.019701,269.00405091753,1914,cpd:C05703,Methaneselenol;,CH4Se,Methaneselenol; Methylselenol,R04770 R09366 R09369 R09371 R09372,Selenocompound metabolism,1.8.1.9; 2.1.1.-; 4.4.1.1; 4.4.1.11; 4.4.1.13,NA,NA,CAS: 6486-05-1; PubChem: 8010; ChEBI: 64685; 3DMET: B01888; NIKKAJI: J151.317F,cpd:C05703; cpd:C18902,1,4,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C1H5Se1,C1H3Se1,95.94781913,96.95564416,94.93999411754,1918,cpd:C18870,Selenodiglutathione;,C20H32N6O12S2Se,Selenodiglutathione; GSSeSG,R09367 R09368,Selenocompound metabolism,NA,NA,NA,PubChem: 124489542; ChEBI: 26634,cpd:C18870,20,32,12,6,0,2,0,0,0,0,1,0,0,0,0,0,0,0,C20H33O12N6S2Se1,C20H31O12N6S2Se1,692.0684818,693.0763069,691.06065681755,1919,cpd:C18871,Glutathioselenol;,C10H17N3O6SSe,Glutathioselenol; GSSeH,R09368,Selenocompound metabolism,NA,NA,NA,PubChem: 124489543; ChEBI: 64729,cpd:C18871,10,17,6,3,0,1,0,0,0,0,1,0,0,0,0,0,0,0,C10H18O6N3S1Se1,C10H16O6N3S1Se1,387.0003255,388.0081505,385.99250041756,1920,cpd:C18872,Trimethylselenonium,C3H9Se,Trimethylselenonium,R09370,Selenocompound metabolism,2.1.1.96,NA,NA,PubChem: 124489544; ChEBI: 77058,cpd:C18872,3,9,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C3H10Se1,C3H8Se1,124.9869443,125.9947693,123.97911931757,1921,cpd:C18893,1-Methylseleno-N-acetyl-D-galactosamine,C9H17NO5Se,1-Methylseleno-N-acetyl-D-galactosamine,NA,Selenocompound metabolism,NA,NA,NA,PubChem: 124489565; ChEBI: 77010,cpd:C18893,9,17,5,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C9H18O5N1Se1,C9H16O5N1Se1,299.0271917,300.0350167,298.01936661758,1922,cpd:C18902,Methylselenic acid;,CH4O2Se,Methylselenic acid; Methylseleninate,R09372,Selenocompound metabolism,1.8.1.9,NA,NA,PubChem: 124489574; ChEBI: 77012; ChEMBL: CHEMBL399906,cpd:C18902,1,4,2,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C1H5O2Se1,C1H3O2Se1,127.9376484,128.9454734,126.92982331759,1923,cpd:C18904,Methylselenopyruvate;,C4H6O3Se,Methylselenopyruvate; beta-Methylselenopyruvate,R09373,Selenocompound metabolism,2.6.1.-,NA,NA,PubChem: 124489576; ChEBI: 82049,cpd:C18904,4,6,3,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C4H7O3Se1,C4H5O3Se1,181.9482131,182.9560381,180.9403881760,1924,cpd:C18905,Methylselenocysteine Se-oxide;,C4H9NO3Se,Methylselenocysteine Se-oxide; Methylselenocysteine selenooxide,NA,Selenocompound metabolism,NA,NA,NA,PubChem: 124489577; ChEBI: 82050,cpd:C18905,4,9,3,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,C4H10O3N1Se1,C4H8O3N1Se1,198.9747622,199.9825872,197.96693711761,1925,cpd:C00302,Glutamate;,C5H9NO4,Glutamate; Glutaminic acid; 2-Aminoglutaric acid,R00896 R01887,Cyanoamino acid metabolism,2.6.1.1; 3.5.5.1,NA,Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Glutamic acid;     D04341  Glutamic acid (USAN),CAS: 617-65-2; PubChem: 3596; ChEBI: 18237; ChEMBL: CHEMBL276389; 3DMET: B00085; NIKKAJI: J44.437E,cpd:C00025; cpd:C00217; cpd:C00302; cpd:C00979; cpd:C03618; cpd:C03727; cpd:C03790; cpd:C05574; cpd:C05938; cpd:C05941; cpd:C12269,5,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O4N1,C5H8O4N1,147.0531578,148.0609828,146.04533271762,1926,cpd:C00488,Formamide;,CH3NO,Formamide; Methanamide,R00524 R01408 R02285,Cyanoamino acid metabolism; Nitrogen metabolism; Carbon metabolism,3.5.1.49; 3.5.3.8; 4.2.1.66,NA,NA,CAS: 75-12-7; PubChem: 3771; ChEBI: 16397; ChEMBL: CHEMBL266160; PDB-CCD: ARF; 3DMET: B01262; NIKKAJI: J1.941K,cpd:C00488,1,3,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H4O1N1,C1H2O1N1,45.02146372,46.02928875,44.013638691763,1927,cpd:C00561,Mandelonitrile;,C8H7NO,Mandelonitrile; Benzaldehyde cyanohydrin; (R)-Mandelonitrile,R01767 R02558 R03642 R10637 R10638 R11380,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,1.1.3.49; 3.2.1.21; 3.2.1.118; 3.2.1.119; 4.1.2.10,NA,NA,PubChem: 3841; PDB-CCD: MXN; 3DMET: B00132; NIKKAJI: J6.985J,cpd:C00561; cpd:C02040; cpd:C02615; cpd:C03766; cpd:C05658; cpd:C12312,8,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O1N1,C8H6O1N1,133.0527638,134.0605889,132.04493881764,1928,cpd:C00844,Prunasin;,C14H17NO6,Prunasin; (R)-Prunasin,R02558 R02985 R10638 R10639,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,3.2.1.21; 3.2.1.117; 3.2.1.118,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Cyanogenic glucosides;    Cyanogenic glucosides derived from phenylalanine;     C00844  Prunasin; Natural toxins [BR:br08009];  Phytotoxins;   Glycosides;    Cyanogenic glycosides;     C00844  Prunasin,CAS: 99-18-3; PubChem: 4101; ChEBI: 17396 27761; ChEMBL: CHEMBL1778417; KNApSAcK: C00001454 C00034206; NIKKAJI: J113.483C,cpd:C00844; cpd:C04273; cpd:C08481; cpd:C18873,14,17,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H18O6N1,C14H16O6N1,295.1055873,296.1134123,294.09776221765,1929,cpd:C01326,Hydrogen cyanide;,CHN,Hydrogen cyanide; HCN; Cyanide,R00152 R01408 R01410 R01553 R01650 R01767 R02676 R03106; R03524 R05704 R07779 R08511 R09358,Cyanoamino acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.4.99.5; 1.14.13.50; 2.5.1.18; 2.8.1.2; 3.5.5.-; 4.1.2.10; 4.1.2.11; 4.1.2.46; 4.2.1.66; 4.4.1.9,NA,NA,CAS: 74-90-8; PubChem: 4537; ChEBI: 18407; ChEMBL: CHEMBL183419; KNApSAcK: C00007569; 3DMET: B00275; NIKKAJI: J2.584D,cpd:C01326; cpd:C01417; cpd:C01658; cpd:C01755,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H2N1,C1H0N1,27.01089904,28.01872407,26.0030741766,1930,cpd:C01401,Alanine;,C3H7NO2,Alanine; 2-Aminopropionic acid; 2-Aminopropanoic acid,R03542 R05840,Cyanoamino acid metabolism,3.5.5.1,NA,Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    L-Alanine;     C01401  Alanine,CAS: 302-72-7; PubChem: 4590; ChEBI: 16449; ChEMBL: CHEMBL12198; 3DMET: B04793; NIKKAJI: J44.439A,cpd:C00041; cpd:C00097; cpd:C00099; cpd:C00133; cpd:C00213; cpd:C00736; cpd:C00793; cpd:C01401; cpd:C01537; cpd:C01962; cpd:C02116; cpd:C05688; cpd:C11488,3,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O2N1,C3H6O2N1,89.04767847,90.0555035,88.039853441767,1931,cpd:C01594,Linamarin;,C10H17NO6,Linamarin; Phaseolunatin,R03625 R10040,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,2.4.1.63; 3.2.1.21,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Cyanogenic glucosides;    Cyanogenic glucosides derived from valine or isoleucine;     C01594  Linamarin,CAS: 554-35-8; PubChem: 4749; ChEBI: 16441; KNApSAcK: C00001446; NIKKAJI: J6.462I,cpd:C01594; cpd:C19976,10,17,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O6N1,C10H16O6N1,247.1055873,248.1134123,246.09776221768,1932,cpd:C02512,3-Cyano-L-alanine;,C4H6N2O2,3-Cyano-L-alanine; L-3-Cyanoalanine; L-beta-Cyanoalanine,R00486 R01267 R02846 R03524 R03970 R06614,Cyanoamino acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.3.2.2; 3.5.5.4; 4.1.1.-; 4.2.1.65; 4.4.1.9,NA,NA,CAS: 6232-19-5; PubChem: 5522; ChEBI: 16934; KNApSAcK: C00001350; 3DMET: B01584; NIKKAJI: J51.820D,cpd:C00429; cpd:C02065; cpd:C02248; cpd:C02512; cpd:C02565; cpd:C02743; cpd:C02777; cpd:C08311; cpd:C13695; cpd:C15811; cpd:C15812; cpd:C21440,4,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O2N2,C4H5O2N2,114.0429274,115.0507525,113.03510241769,1933,cpd:C02659,Acetone cyanohydrin;,C4H7NO,Acetone cyanohydrin; alpha-Hydroxyisobutyronitrile; 2-Hydroxy-2-methylpropanenitrile; 2-Methyllactonitrile; Acetone cyanhydrin; 2-Hydroxyisobutyronitrile,R01553 R03625 R10038 R10040,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,2.4.1.63; 3.2.1.21; 4.1.2.46,NA,NA,CAS: 75-86-5; PubChem: 5632; ChEBI: 15348; PDB-CCD: CNH; 3DMET: B00479; NIKKAJI: J1.468K,cpd:C02659,4,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H8O1N1,C4H6O1N1,85.05276385,86.06058888,84.044938821770,1934,cpd:C03004,N-Hydroxy-L-tyrosine,C9H11NO4,N-Hydroxy-L-tyrosine,R00730 R04460 R06585,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,1.14.14.36,"Cyanogenic glycoside biosynthesis, tyrosine => dhurrin",NA,PubChem: 5913; ChEBI: 28089; 3DMET: B01619; NIKKAJI: J2.373.905D,cpd:C00355; cpd:C03004; cpd:C06870; cpd:C18746; cpd:C19715,9,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O4N1,C9H10O4N1,197.0688078,198.0766329,196.06098281771,1935,cpd:C03219,(E)-2-Methylpropanal oxime;,C4H9NO,(E)-2-Methylpropanal oxime; (E)-Isobutyraldehyde oxime; (E)-Isobutanal oxime,R04169 R08663 R10033 R10034,Cyanoamino acid metabolism; Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.14.13.117; 1.14.13.118; 2.1.1.91,NA,NA,PubChem: 6092; ChEBI: 17502 61143; 3DMET: B00562; NIKKAJI: J53.649K,cpd:C00555; cpd:C03219; cpd:C03537; cpd:C14452; cpd:C19332; cpd:C20315; cpd:C20339; cpd:C21404,4,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O1N1,C4H8O1N1,87.06841391,88.07623895,86.060588881772,1936,cpd:C03742,(S)-4-Hydroxymandelonitrile,C8H7NO2,(S)-4-Hydroxymandelonitrile,R02676 R02708 R04296 R05728 R10035,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,1.14.14.37; 2.4.1.85; 3.2.1.21; 4.1.2.11,"Cyanogenic glycoside biosynthesis, tyrosine => dhurrin",NA,PubChem: 6505; ChEBI: 16660; PDB-CCD: DHR; 3DMET: B01688; NIKKAJI: J231.681A,cpd:C00650; cpd:C02775; cpd:C03574; cpd:C03742; cpd:C05578; cpd:C09957; cpd:C11130; cpd:C19062,8,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O2N1,C8H6O2N1,149.0476785,150.0555035,148.03985341773,1937,cpd:C04350,(E)-4-Hydroxyphenylacetaldehyde oxime;,C8H9NO2,(E)-4-Hydroxyphenylacetaldehyde oxime; (E)-[4-Hydroxyphenylacetaldehyde oxime],R05728 R06585 R07190 R10671 R10672 R11442,Cyanoamino acid metabolism; Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.14.14.36; 1.14.14.37; 1.14.-.-,"Cyanogenic glycoside biosynthesis, tyrosine => dhurrin",NA,PubChem: 6999; ChEBI: 15666; 3DMET: B00704; NIKKAJI: J2.750.202D J640.420K,cpd:C02012; cpd:C02709; cpd:C03005; cpd:C03522; cpd:C04350; cpd:C04353; cpd:C06804; cpd:C07301; cpd:C16571; cpd:C17239; cpd:C17755; cpd:C17756; cpd:C18623; cpd:C20634,8,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O2N1,C8H8O2N1,151.0633285,152.0711536,150.05550351774,1938,cpd:C05143,Dhurrin;,C14H17NO7,Dhurrin; (S)-4-Hydroxymandelonitrile beta-D-glucoside,R04296 R10035,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,2.4.1.85; 3.2.1.21,"Cyanogenic glycoside biosynthesis, tyrosine => dhurrin",Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Cyanogenic glucosides;    Cyanogenic glucosides derived from thyrosine;     C05143  Dhurrin,CAS: 499-20-7; PubChem: 7561; ChEBI: 27826; KNApSAcK: C00001442; 3DMET: B01815; NIKKAJI: J10.589I,cpd:C01855; cpd:C05143; cpd:C08330; cpd:C08345,14,17,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H18O7N1,C14H16O7N1,311.1005019,312.1083269,310.09267691775,1939,cpd:C05711,gamma-Glutamyl-beta-cyanoalanine,C9H13N3O5,gamma-Glutamyl-beta-cyanoalanine,R03970,Cyanoamino acid metabolism,2.3.2.2,NA,NA,CAS: 16051-95-9; PubChem: 8018; ChEBI: 10565; 3DMET: B05107; NIKKAJI: J640.876A,cpd:C00475; cpd:C02961; cpd:C05711,9,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O5N3,C9H12O5N3,243.0855205,244.0933456,242.07769551776,1940,cpd:C05714,alpha-Aminopropiononitrile,C3H6N2,alpha-Aminopropiononitrile,R01410 R03542,Cyanoamino acid metabolism,3.5.5.1,NA,NA,PubChem: 8021; ChEBI: 27959; 3DMET: B05108; NIKKAJI: J27.747I,cpd:C00603; cpd:C02718; cpd:C02766; cpd:C05670; cpd:C05714; cpd:C06682; cpd:C08057; cpd:C10899; cpd:C11119; cpd:C14398; cpd:C19282; cpd:C19286,3,6,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7N2,C3H5N2,70.0530982,71.06092323,69.045273171777,1941,cpd:C05715,gamma-Amino-gamma-cyanobutanoate;,C5H8N2O2,gamma-Amino-gamma-cyanobutanoate; 4-Amino-4-cyanobutanoic acid,R01650 R01887,Cyanoamino acid metabolism,3.5.5.1,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0110 Amino fatty acids;     C05715  4-Amino-4-cyanobutanoic acid;    FA0111 Cyano fatty acids;     C05715  4-Amino-4-cyanobutanoic acid,PubChem: 8022; ChEBI: 28474; LIPIDMAPS: LMFA01100037; 3DMET: B05109; NIKKAJI: J2.361.768D,cpd:C00906; cpd:C03800; cpd:C05715; cpd:C05717; cpd:C21028,5,8,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O2N2,C5H7O2N2,128.0585775,129.0664025,127.05075251778,1942,cpd:C06114,gamma-Glutamyl-beta-aminopropiononitrile;,C8H13N3O3,gamma-Glutamyl-beta-aminopropiononitrile; gamma-Glutamyl-3-aminopropiononitrile,R03971,Cyanoamino acid metabolism,2.3.2.2,NA,NA,PubChem: 8376; ChEBI: 28092; 3DMET: B01974; NIKKAJI: J2.761.127C,cpd:C06114,8,13,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H14O3N3,C8H12O3N3,199.0956913,200.1035163,198.08786631779,1943,cpd:C08325,Amygdalin;,C20H27NO11,Amygdalin; (R)-Amygdalin; (R)-Amygdaloside; (R)-Laenitrile,R02985 R10639,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,3.2.1.21; 3.2.1.117,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Cyanogenic glucosides;    Cyanogenic glucosides derived from phenylalanine;     C08325  Amygdalin; Natural toxins [BR:br08009];  Phytotoxins;   Glycosides;    Cyanogenic glycosides;     C08325  Amygdalin; Major components of natural products [BR:br08323];  Crude drugs;   Apricot kernel water;    C08325  Amygdalin;   Apricot kernel;    C08325  Amygdalin;   Peach kernel;    C08325  Amygdalin,CAS: 29883-15-6; PubChem: 10523; ChEBI: 17019; ChEMBL: CHEMBL2007233 CHEMBL461727; KNApSAcK: C00001437; NIKKAJI: J21.549J,cpd:C08325,20,27,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H28O11N1,C20H26O11N1,457.1584107,458.1662357,456.15058571780,1944,cpd:C08334,Lotaustralin,C11H19NO6,Lotaustralin,R10037 R10039,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,2.4.1.63; 3.2.1.21,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Cyanogenic glucosides;    Cyanogenic glucosides derived from valine or isoleucine;     C08334  Lotaustralin,CAS: 534-67-8; PubChem: 10532; ChEBI: 6542; KNApSAcK: C00001448; NIKKAJI: J412.304B,cpd:C08332; cpd:C08334; cpd:C10607,11,19,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H20O6N1,C11H18O6N1,261.1212373,262.1290624,260.11341231781,1945,cpd:C15503,"N,N-Dihydroxy-L-tyrosine",C9H11NO5,"N,N-Dihydroxy-L-tyrosine",R04460 R07190,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,1.14.14.36,"Cyanogenic glycoside biosynthesis, tyrosine => dhurrin",NA,PubChem: 17396495; ChEBI: 12532; NIKKAJI: J2.794.788C,cpd:C15503; cpd:C17699,9,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O5N1,C9H10O5N1,213.0637225,214.0715475,212.05589741782,1946,cpd:C16074,Phenylacetonitrile;,C8H7N,Phenylacetonitrile; Benzyl cyanide,R07638 R07854 R07855,Cyanoamino acid metabolism; Styrene degradation; Microbial metabolism in diverse environments,3.5.5.1; 4.2.1.84; 4.99.1.7,NA,NA,CAS: 140-29-4; PubChem: 47205384; ChEBI: 25979; KNApSAcK: C00007674 C00048326; NIKKAJI: J5.653G,cpd:C00463; cpd:C00561; cpd:C00650; cpd:C00971; cpd:C02040; cpd:C02615; cpd:C02660; cpd:C02775; cpd:C02803; cpd:C03098; cpd:C03574; cpd:C03742; cpd:C03757; cpd:C03766; cpd:C04604; cpd:C05578; cpd:C05653; cpd:C05658; cpd:C06050; cpd:C06052; cpd:C06661; cpd:C09957; cpd:C10910; cpd:C11130; cpd:C12312; cpd:C15769; cpd:C15770; cpd:C15771; cpd:C16074; cpd:C19062; cpd:C21155,8,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8N1,C8H6N1,117.0578492,118.0656743,116.05002421783,1947,cpd:C16075,(Z)-Phenylacetaldehyde oxime;,C8H9NO,(Z)-Phenylacetaldehyde oxime; Z-Phenylacetaldoxime,R07638 R08652 R08653 R10041 R10637,Cyanoamino acid metabolism; Styrene degradation; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,1.14.13.124; 1.14.-.-; 4.99.1.7,NA,NA,PubChem: 47205385; ChEBI: 50723; NIKKAJI: J81.316H,cpd:C02505; cpd:C03719; cpd:C07565; cpd:C15561; cpd:C16075; cpd:C19714,8,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O1N1,C8H8O1N1,135.0684139,136.0762389,134.06058891784,1948,cpd:C18796,(2R)-2-Hydroxy-2-methylbutanenitrile;,C5H9NO,(2R)-2-Hydroxy-2-methylbutanenitrile; 2-Hydroxy-2-methylbutanenitrile,R09358 R10036 R10037 R10039,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,2.4.1.63; 3.2.1.21; 4.1.2.46,NA,NA,PubChem: 124489470; ChEBI: 60908,cpd:C11118; cpd:C18796,5,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O1N1,C5H8O1N1,99.06841391,100.0762389,98.060588881785,1949,cpd:C19491,(E)-2-Methylbutanal oxime,C5H11NO,(E)-2-Methylbutanal oxime,R09403 R10029 R10030,Cyanoamino acid metabolism; Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.14.13.117; 1.14.13.118,NA,NA,PubChem: 124490163; ChEBI: 61136,cpd:C01842; cpd:C03982; cpd:C10974; cpd:C12455; cpd:C17241; cpd:C17243; cpd:C17255; cpd:C19274; cpd:C19491; cpd:C20312,5,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O1N1,C5H10O1N1,101.084064,102.091889,100.07623891786,1950,cpd:C19712,N-Hydroxy-L-phenylalanine;,C9H11NO3,N-Hydroxy-L-phenylalanine; 2-(Hydroxyamino)-3-phenylpropanoate,R09579 R09580,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,1.14.13.124,NA,NA,PubChem: 135626180,cpd:C00082; cpd:C01536; cpd:C03290; cpd:C04368; cpd:C06420; cpd:C14322; cpd:C19579; cpd:C19712; cpd:C20807; cpd:C21308,9,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O3N1,C9H10O3N1,181.0738932,182.0817182,180.06606821787,1951,cpd:C19714,(E)-Phenylacetaldoxime;,C8H9NO,(E)-Phenylacetaldoxime; (E)-Phenylacetaldehyde oxime,R09578 R09581 R10041 R10670,Cyanoamino acid metabolism; Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.14.13.124; 1.14.-.-,NA,NA,PubChem: 135626182; KNApSAcK: C00007327,cpd:C02505; cpd:C03719; cpd:C07565; cpd:C15561; cpd:C16075; cpd:C19714,8,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O1N1,C8H8O1N1,135.0684139,136.0762389,134.06058891788,1952,cpd:C19715,"N,N-Dihydroxy-L-phenylalanine",C9H11NO4,"N,N-Dihydroxy-L-phenylalanine",R09580 R09581,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,1.14.13.124,NA,NA,PubChem: 135626183,cpd:C00355; cpd:C03004; cpd:C06870; cpd:C18746; cpd:C19715,9,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O4N1,C9H10O4N1,197.0688078,198.0766329,196.06098281789,1953,cpd:C20310,N-Hydroxy-L-isoleucine,C6H13NO3,N-Hydroxy-L-isoleucine,R10027 R10028,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,1.14.13.117; 1.14.13.118,NA,NA,PubChem: 163312048,cpd:C02824; cpd:C10144; cpd:C20310; cpd:C20802,6,13,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O3N1,C6H12O3N1,147.0895433,148.0973683,146.08171821790,1954,cpd:C20311,"N,N-Dihydroxy-L-isoleucine",C6H13NO4,"N,N-Dihydroxy-L-isoleucine",R10028 R10029,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,1.14.13.117; 1.14.13.118,NA,NA,PubChem: 163312049,cpd:C10141; cpd:C10143; cpd:C15478; cpd:C15479; cpd:C16843; cpd:C17580; cpd:C20311,6,13,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O4N1,C6H12O4N1,163.0844579,164.0922829,162.07663291791,1955,cpd:C20312,(Z)-2-Methylbutanal oxime,C5H11NO,(Z)-2-Methylbutanal oxime,R10030 R10036,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 163312050,cpd:C01842; cpd:C03982; cpd:C10974; cpd:C12455; cpd:C17241; cpd:C17243; cpd:C17255; cpd:C19274; cpd:C19491; cpd:C20312,5,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O1N1,C5H10O1N1,101.084064,102.091889,100.07623891792,1956,cpd:C20313,N-Hydroxy-L-valine,C5H11NO3,N-Hydroxy-L-valine,R10031 R10032,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,1.14.13.117; 1.14.13.118,NA,NA,PubChem: 163312051,cpd:C02989; cpd:C05708; cpd:C15998; cpd:C15999; cpd:C20313,5,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O3N1,C5H10O3N1,133.0738932,134.0817182,132.06606821793,1957,cpd:C20314,"N,N-Dihydroxy-L-valine",C5H11NO4,"N,N-Dihydroxy-L-valine",R10032 R10033,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,1.14.13.117; 1.14.13.118,NA,NA,PubChem: 163312052,cpd:C20314; cpd:C20931,5,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O4N1,C5H10O4N1,149.0688078,150.0766329,148.06098281794,1958,cpd:C20315,(Z)-2-Methylpropanal oxime,C4H9NO,(Z)-2-Methylpropanal oxime,R10034 R10038,Cyanoamino acid metabolism; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 163312053,cpd:C00555; cpd:C03219; cpd:C03537; cpd:C14452; cpd:C19332; cpd:C20315; cpd:C20339; cpd:C21404,4,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O1N1,C4H8O1N1,87.06841391,88.07623895,86.060588881795,1959,cpd:C00217,D-Glutamate;,C5H9NO4,D-Glutamate; D-Glutamic acid; D-Glutaminic acid; D-2-Aminoglutaric acid,R00260 R00279 R01148 R01578 R01579 R01580 R01581 R01582; R01583 R02783 R03063 R05839,D-Glutamine and D-glutamate metabolism; Metabolic pathways,1.4.3.7; 1.4.3.15; 2.6.1.21; 2.6.1.54; 2.6.1.74; 3.5.1.2; 3.5.1.35; 3.5.1.38; 3.5.1.82; 4.2.1.48; 5.1.1.3; 6.3.2.9,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00217  D-Glutamic acid,CAS: 6893-26-1; PubChem: 3517; ChEBI: 15966; ChEMBL: CHEMBL76232; KNApSAcK: C00019577; PDB-CCD: DGL FGA; 3DMET: B01192; NIKKAJI: J9.214B,cpd:C00025; cpd:C00217; cpd:C00302; cpd:C00979; cpd:C03618; cpd:C03727; cpd:C03790; cpd:C05574; cpd:C05938; cpd:C05941; cpd:C12269,5,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O4N1,C5H8O4N1,147.0531578,148.0609828,146.04533271796,1960,cpd:C00692,UDP-N-acetylmuramoyl-L-alanyl-D-glutamate;,C28H43N5O23P2,UDP-N-acetylmuramoyl-L-alanyl-D-glutamate; UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate,R02783 R02786 R02788 R09596,D-Glutamine and D-glutamate metabolism; Peptidoglycan biosynthesis; Metabolic pathways,6.3.2.7; 6.3.2.9; 6.3.2.13; 6.3.2.37,NA,NA,PubChem: 3960; ChEBI: 16970 46143; PDB-CCD: UAG; 3DMET: B04718; NIKKAJI: J2.730.233E,cpd:C00692,28,43,23,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H44O23N5P2,C28H42O23N5P2,879.1824067,880.1902317,878.17458161797,1961,cpd:C00819,D-Glutamine;,C5H10N2O3,D-Glutamine; D-2-Aminoglutaramic acid,R00579 R01579 R02959 R04012,D-Glutamine and D-glutamate metabolism; Metabolic pathways,2.3.2.1; 3.5.1.2; 3.5.1.35; 3.5.1.38; 5.1.1.10,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00819  D-Glutamine,CAS: 5959-95-5; PubChem: 4077; ChEBI: 17061; ChEMBL: CHEMBL1232207; PDB-CCD: DGN; 3DMET: B01338; NIKKAJI: J9.211H,cpd:C00064; cpd:C00303; cpd:C00819; cpd:C01419; cpd:C05100; cpd:C16673; cpd:C21029,5,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O3N2,C5H9O3N2,146.0691422,147.0769672,145.06131721798,1962,cpd:C01050,UDP-N-acetylmuramate;,C20H31N3O19P2,UDP-N-acetylmuramate; UDP-N-acetyl-alpha-D-muramate; UDP-N-acetylmuramic acid; UDP-MurNAc,R03191 R03192 R03193 R10901 R11025,D-Glutamine and D-glutamate metabolism; Amino sugar and nucleotide sugar metabolism; Peptidoglycan biosynthesis; Metabolic pathways,1.3.1.98; 2.7.7.-; 6.3.2.8; 6.3.2.45,NA,NA,PubChem: 4292; ChEBI: 70765; PDB-CCD: EPZ; 3DMET: B04759; NIKKAJI: J710.466I,cpd:C01050,20,31,19,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H32O19N3P2,C20H30O19N3P2,679.1026998,680.1105248,678.09487471799,1963,cpd:C01212,UDP-N-acetylmuramoyl-L-alanine;,C23H36N4O20P2,UDP-N-acetylmuramoyl-L-alanine; UDP-N-acetyl-alpha-D-muramoyl-L-alanine,R02783 R03193,D-Glutamine and D-glutamate metabolism; Peptidoglycan biosynthesis; Metabolic pathways,6.3.2.8; 6.3.2.9,NA,NA,PubChem: 4434; ChEBI: 84726; PDB-CCD: UMA; 3DMET: B04782; NIKKAJI: J890.604A,cpd:C01212,23,36,20,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H37O20N4P2,C23H35O20N4P2,750.1398136,751.1476386,749.13198851800,1964,cpd:C02237,5-Oxo-D-proline;,C5H7NO3,5-Oxo-D-proline; D-Pyroglutamic acid; D-5-Pyrrolidone-2-carboxylic acid,R01583,D-Glutamine and D-glutamate metabolism,4.2.1.48,NA,NA,CAS: 4042-36-8; PubChem: 5301; ChEBI: 16924; 3DMET: B01549; NIKKAJI: J53.019K,cpd:C01877; cpd:C01879; cpd:C02237; cpd:C03541; cpd:C03801; cpd:C04281; cpd:C04282; cpd:C05723; cpd:C05929,5,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8O3N1,C5H6O3N1,129.0425931,130.0504181,128.03476811801,1968,cpd:C00515,D-Ornithine,C5H12N2O2,D-Ornithine,R00672 R02457 R02458 R02459 R02460 R02461,D-Arginine and D-ornithine metabolism; Metabolic pathways,1.4.3.3; 2.6.1.21; 3.5.3.10; 5.1.1.9; 5.1.1.10; 5.1.1.12; 5.4.3.5,NA,NA,CAS: 348-66-3; PubChem: 3798; ChEBI: 16176; ChEMBL: CHEMBL103686; PDB-CCD: ORD; 3DMET: B01276; NIKKAJI: J9.191J,cpd:C00077; cpd:C00515; cpd:C01602; cpd:C03943; cpd:C11320; cpd:C16550; cpd:C16555,5,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O2N2,C5H11O2N2,132.0898776,133.0977027,131.08205261802,1969,cpd:C00792,D-Arginine;,C6H14N4O2,D-Arginine; D-2-Amino-5-guanidinovaleric acid,R00567 R02458 R02923 R02924 R11016 R11018,D-Arginine and D-ornithine metabolism; Metabolic pathways,1.4.3.3; 1.4.99.6; 2.6.1.21; 3.5.3.10; 5.1.1.9,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00792  D-Arginine,CAS: 157-06-2; PubChem: 4050; ChEBI: 15816; ChEMBL: CHEMBL212301; PDB-CCD: DAR; 3DMET: B01331; NIKKAJI: J9.186C,cpd:C00062; cpd:C00792; cpd:C02385,6,14,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O2N4,C6H13O2N4,174.1116757,175.1195007,173.10385071803,1970,cpd:C03341,2-Amino-4-oxopentanoic acid;,C5H9NO3,2-Amino-4-oxopentanoic acid; 2-Amino-4-oxopentanoate,R00399 R04200 R04201,D-Arginine and D-ornithine metabolism,1.4.1.12; 2.3.1.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C03341  2-Amino-4-oxopentanoic acid,PubChem: 6184; ChEBI: 15914; LIPIDMAPS: LMFA01060171; 3DMET: B00578; NIKKAJI: J1.145.297C,cpd:C00430; cpd:C01015; cpd:C01073; cpd:C01110; cpd:C01157; cpd:C01165; cpd:C03341; cpd:C03440; cpd:C03651; cpd:C03741; cpd:C05147; cpd:C06809; cpd:C12876; cpd:C19706,5,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O3N1,C5H8O3N1,131.0582432,132.0660682,130.05041811804,1971,cpd:C03943,"(2R,4S)-2,4-Diaminopentanoate;",C5H12N2O2,"(2R,4S)-2,4-Diaminopentanoate; D-threo-2,4-Diaminopentanoate; 2,4-Diaminopentanoate",R02461 R04200 R04201,D-Arginine and D-ornithine metabolism,1.4.1.12; 5.4.3.5,NA,NA,PubChem: 6667; ChEBI: 4280; 3DMET: B01702; NIKKAJI: J2.362.123A,cpd:C00077; cpd:C00515; cpd:C01602; cpd:C03943; cpd:C11320; cpd:C16550; cpd:C16555,5,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O2N2,C5H11O2N2,132.0898776,133.0977027,131.08205261805,1972,cpd:C00133,D-Alanine;,C3H7NO2,D-Alanine; D-2-Aminopropionic acid; D-Ala,R00399 R00401 R01147 R01148 R01149 R01150 R01225 R01344; R02718 R04369 R04611 R05861 R07651 R08850 R09588 R09595,D-Alanine metabolism; Peptidoglycan biosynthesis; Metabolic pathways; Vancomycin resistance; Cationic antimicrobial peptide (CAMP) resistance; Taste transduction,1.4.3.3; 1.4.3.19; 2.1.2.7; 2.3.1.-; 2.3.2.14; 2.6.1.21; 3.4.13.22; 3.4.17.8; 5.1.1.1; 6.1.1.13; 6.1.2.1; 6.3.2.4; 6.3.2.16; 6.3.2.35,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00133  D-Alanine,CAS: 338-69-2; PubChem: 3433; ChEBI: 15570; ChEMBL: CHEMBL66693; KNApSAcK: C00019654; PDB-CCD: DAL; 3DMET: B00036; NIKKAJI: J9.190A,cpd:C00041; cpd:C00097; cpd:C00099; cpd:C00133; cpd:C00213; cpd:C00736; cpd:C00793; cpd:C01401; cpd:C01537; cpd:C01962; cpd:C02116; cpd:C05688; cpd:C11488,3,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O2N1,C3H6O2N1,89.04767847,90.0555035,88.039853441806,1973,cpd:C00993,D-Alanyl-D-alanine;,C6H12N2O3,D-Alanyl-D-alanine; D-Ala-D-Ala,R01150 R04573 R04617 R07651,D-Alanine metabolism; Peptidoglycan biosynthesis; Metabolic pathways; Vancomycin resistance,3.4.13.22; 6.3.2.4; 6.3.2.10,NA,Compounds with biological roles [BR:br08001];  Peptides;   Peptides;    Dipeptides;     C00993  D-Alanyl-D-alanine,CAS: 923-16-0; PubChem: 4239; ChEBI: 16576; ChEMBL: CHEMBL1814491 CHEMBL190534 CHEMBL299420; KNApSAcK: C00019576; 3DMET: B01365; NIKKAJI: J80.011B,cpd:C00993; cpd:C03153; cpd:C03922; cpd:C06442; cpd:C10996; cpd:C19929,6,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O3N2,C6H11O3N2,160.0847923,161.0926173,159.07696721807,1976,cpd:C00127,Glutathione disulfide;,C20H32N6O12S2,Glutathione disulfide; GSSG; Oxiglutatione; Oxidized glutathione,R00094 R00115 R00120 R00274 R01108 R01109 R01110 R01111; R01113 R01292 R01875 R02824 R03167 R03915 R03984 R04039; R05267 R05269 R05402 R05403 R05717 R05748 R07034 R07035; R09338 R09367 R09368,Glutathione metabolism; Thyroid hormone synthesis,1.5.4.1; 1.8.1.7; 1.8.3.3; 1.8.4.1; 1.8.4.2; 1.8.4.3; 1.8.4.4; 1.8.4.7; 1.8.4.9; 1.8.5.1; 1.11.1.9; 1.11.1.12; 1.20.4.2; 2.5.1.-; 2.8.1.3,NA,Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   13  Agents affecting sensory organs;    131  Ophthalmic agents;     1319  Others;      D00031  Oxiglutatione (JAN/INN),CAS: 27025-41-8; PubChem: 3427; ChEBI: 17858; ChEMBL: CHEMBL1372; PDB-CCD: GDS; 3DMET: B01166; NIKKAJI: J415.688I,cpd:C00127; cpd:C18870,20,32,12,6,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O12N6S2,C20H31O12N6S2,612.1519628,613.1597879,611.14413781808,1978,cpd:C00669,gamma-L-Glutamyl-L-cysteine;,C8H14N2O5S,gamma-L-Glutamyl-L-cysteine; L-gamma-Glutamylcysteine; 5-L-Glutamyl-L-cysteine; gamma-Glutamylcysteine,R00497 R00894 R02741 R02742 R02743 R11013,Glutathione metabolism; Metabolic pathways,1.8.1.13; 1.14.99.50; 2.3.2.4; 6.3.2.2; 6.3.2.3; 6.3.2.23,"Glutathione biosynthesis, glutamate => glutathione",NA,CAS: 636-58-8; PubChem: 3938; ChEBI: 17515; ChEMBL: CHEMBL460831; KNApSAcK: C00007507; PDB-CCD: 3GC; 3DMET: B01305; NIKKAJI: J40.069F,cpd:C00669,8,14,5,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O5N2S1,C8H13O5N2S1,250.0623427,251.0701678,249.05451771809,1980,cpd:C01419,Cys-Gly;,C5H10N2O3S,Cys-Gly; L-Cysteinylglycine,R00494 R00899 R01262,Glutathione metabolism; Metabolic pathways,2.3.2.2; 3.4.11.1; 3.4.11.2; 3.4.11.23; 3.4.13.-; 3.4.19.13,NA,NA,CAS: 19246-18-5; PubChem: 4606; ChEBI: 4047; ChEMBL: CHEMBL371579; 3DMET: B01448; NIKKAJI: J36.789C,cpd:C01419,5,10,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O3N2S1,C5H9O3N2S1,178.0412134,179.0490384,177.03338831810,1981,cpd:C01879,Pidolic acid;,C5H7NO3,Pidolic acid; 5-Oxoproline; Pyroglutamic acid; 5-Pyrrolidone-2-carboxylic acid; Pyroglutamate; 5-Oxo-L-proline; L-Pyroglutamic acid; L-5-Pyrrolidone-2-carboxylic acid,R00251 R02743 R03749 R08910,Glutathione metabolism,2.3.2.4; 3.5.2.9; 4.3.2.6,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C01879  Pidolic acid,CAS: 98-79-3; PubChem: 4992; ChEBI: 18183; ChEMBL: CHEMBL397976; KNApSAcK: C00007403; PDB-CCD: PCA; 3DMET: B00365; NIKKAJI: J4.959J,cpd:C01877; cpd:C01879; cpd:C02237; cpd:C03541; cpd:C03801; cpd:C04281; cpd:C04282; cpd:C05723; cpd:C05929,5,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8O3N1,C5H6O3N1,129.0425931,130.0504181,128.03476811811,1982,cpd:C02090,Trypanothione;,C27H49N9O10S2,"Trypanothione; N1,N8-Bis(gamma-L-glutamyl-L-cysteinyl-glycyl)spermidine; N1,N8-Bis(glutathionyl)spermidine; Reduced trypanothione",R03821 R03822 R08350 R08358 R08361 R08362 R08364,Glutathione metabolism; Metabolic pathways,1.8.1.12; 1.11.1.15; 1.17.4.1; 3.5.1.-; 6.3.1.9,NA,NA,PubChem: 5175; ChEBI: 17842; PDB-CCD: GCG; NIKKAJI: J634.980C,cpd:C02090,27,49,10,9,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C27H50O10N9S2,C27H48O10N9S2,723.3043812,724.3122062,722.29655611812,1984,cpd:C03170,Trypanothione disulfide;,C27H47N9O10S2,Trypanothione disulfide; Oxidized trypanothione,R03821 R08358 R08361 R08362 R08364,Glutathione metabolism; Metabolic pathways,1.8.1.12; 1.11.1.15; 1.17.4.1,NA,NA,CAS: 96304-42-6; PubChem: 6053; ChEBI: 35490; PDB-CCD: TS2; NIKKAJI: J634.980C,cpd:C03170,27,47,10,9,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C27H48O10N9S2,C27H46O10N9S2,721.2887311,722.2965561,720.28090611813,1985,cpd:C03646,Bis-gamma-glutamylcystine;,C16H26N4O10S2,Bis-gamma-glutamylcystine; Oxidized gamma-glutamylcysteine; Bis-gamma-L-glutamyl-L-cystine; Oxidized gamma-L-glutamyl-L-cysteine,R02742,Glutathione metabolism,1.8.1.13,NA,NA,PubChem: 6427; ChEBI: 17257; 3DMET: B04908; NIKKAJI: J1.707.057F,cpd:C03646,16,26,10,4,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O10N4S2,C16H25O10N4S2,498.1090354,499.1168604,497.10121041814,1990,cpd:C05730,Glutathionylspermidine;,C17H34N6O5S,Glutathionylspermidine; N1-(gamma-L-Glutamyl-L-cysteinyl-glycyl)-spermidine,R01917 R01918 R03822 R08350,Glutathione metabolism; Metabolic pathways,3.5.1.78; 3.5.1.-; 6.3.1.8; 6.3.1.9,NA,NA,CAS: 33932-35-3; PubChem: 8032; ChEBI: 16613; PDB-CCD: TS5; 3DMET: B01889,cpd:C05730,17,34,5,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C17H35O5N6S1,C17H33O5N6S1,434.2311394,435.2389644,433.22331441815,1991,cpd:C16562,Glutathionylspermine,C20H41N7O5S,Glutathionylspermine,R08352 R08353,Glutathione metabolism,6.3.1.9,NA,NA,PubChem: 51090891; ChEBI: 80568; NIKKAJI: J2.803.707D,cpd:C16562,20,41,5,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H42O5N7S1,C20H40O5N7S1,491.2889886,492.2968137,490.28116361816,1992,cpd:C16563,Bis(glutathionyl)spermine;,C30H56N10O10S2,"Bis(glutathionyl)spermine; N1,N12-Bis(glutathionyl)spermine",R08353 R08356,Glutathione metabolism,1.8.1.12; 6.3.1.9,NA,NA,PubChem: 51090892; ChEBI: 80569; NIKKAJI: J1.941.269E,cpd:C16563,30,56,10,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C30H57O10N10S2,C30H55O10N10S2,780.3622304,781.3700554,779.35440541817,1993,cpd:C16564,Bis(glutathionyl)spermine disulfide,C30H54N10O10S2,Bis(glutathionyl)spermine disulfide,R08356,Glutathione metabolism,1.8.1.12,NA,NA,PubChem: 51090893; ChEBI: 80570; NIKKAJI: J2.803.717A,cpd:C16564,30,54,10,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C30H55O10N10S2,C30H53O10N10S2,778.3465803,779.3544054,777.33875531818,1994,cpd:C16565,Aminopropylcadaverine,C8H21N3,Aminopropylcadaverine,R08354 R08359,Glutathione metabolism,2.5.1.16; 6.3.1.9,NA,NA,CAS: 56-19-9; PubChem: 51090894; ChEBI: 64860; ChEMBL: CHEMBL89035; NIKKAJI: J575.711H,cpd:C06366; cpd:C16565,8,21,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H22N3,C8H20N3,159.1735477,160.1813727,158.16572271819,1995,cpd:C16566,Glutathionylaminopropylcadaverine,C18H36N6O5S,Glutathionylaminopropylcadaverine,R08351 R08354 R08355,Glutathione metabolism,3.5.1.-; 6.3.1.9,NA,NA,PubChem: 51090895; ChEBI: 80571; NIKKAJI: J1.828.071J,cpd:C16566,18,36,5,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C18H37O5N6S1,C18H35O5N6S1,448.2467895,449.2546145,447.23896441820,1996,cpd:C16567,Homotrypanothione;,C28H51N9O10S2,"Homotrypanothione; N1,N9-Bis(glutathionyl)aminopropylcadaverine",R08351 R08355 R08357,Glutathione metabolism,1.8.1.12; 3.5.1.-; 6.3.1.9,NA,NA,PubChem: 51090896; ChEBI: 80572; NIKKAJI: J2.803.729E,cpd:C16567,28,51,10,9,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C28H52O10N9S2,C28H50O10N9S2,737.3200312,738.3278563,736.31220621821,1997,cpd:C16568,Homotrypanothione disulfide,C28H49N9O10S2,Homotrypanothione disulfide,R08357,Glutathione metabolism,1.8.1.12,NA,NA,PubChem: 51090897; ChEBI: 80573; NIKKAJI: J2.803.729E,cpd:C16568,28,49,10,9,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C28H50O10N9S2,C28H48O10N9S2,735.3043812,736.3122062,734.29655611822,1998,cpd:C00085,D-Fructose 6-phosphate;,C6H13O9P,D-Fructose 6-phosphate; D-Fructose 6-phosphoric acid; Neuberg ester,R00756 R00758 R00760 R00761 R00762 R00763 R00764 R00765; R00766 R00767 R00768 R00769 R00770 R00771 R00772 R00876; R01067 R01140 R05339 R05805 R06073 R07133 R08406 R08575; R08947,Starch and sucrose metabolism; Methane metabolism; Carbon fixation in photosynthetic organisms; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; AMPK signaling pathway; Glucagon signaling pathway; Insulin resistance; Central carbon metabolism in cancer,1.1.1.17; 1.1.1.140; 2.2.1.1; 2.2.1.2; 2.4.1.14; 2.4.1.246; 2.6.1.16; 2.7.1.1; 2.7.1.4; 2.7.1.11; 2.7.1.61; 2.7.1.90; 2.7.1.146; 3.1.3.11; 3.1.3.46; 3.5.99.6; 4.1.2.22; 5.3.1.8; 5.3.1.9; 5.3.1.27,"Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P; Formaldehyde assimilation, xylulose monophosphate pathway; Formaldehyde assimilation, ribulose monophosphate pathway",NA,CAS: 643-13-0; PubChem: 3385; ChEBI: 15946 61553; ChEMBL: CHEMBL604196; KNApSAcK: C00007305; PDB-CCD: F6P P6P; 3DMET: B04628; NIKKAJI: J92.807K,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.0218941823,1999,cpd:C00092,D-Glucose 6-phosphate;,C6H13O9P,D-Glucose 6-phosphate; Glucose 6-phosphate; Robison ester,R00299 R00303 R00725 R00771 R00834 R00835 R00836 R00837; R00838 R00839 R00850 R01139 R02168 R02185 R03921 R05767; R05804 R06043 R06044 R06112 R06113 R06115 R06125 R07324; R08125 R08404 R08617 R08639 R09550 R10519 R10520 R11310,"Starch and sucrose metabolism; Streptomycin biosynthesis; Neomycin, kanamycin and gentamicin biosynthesis; Inositol phosphate metabolism; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of antibiotics; Two-component system; Phosphotransferase system (PTS); Insulin secretion; Prolactin signaling pathway; Thyroid hormone synthesis; Insulin resistance; Carbohydrate digestion and absorption; Biofilm formation - Vibrio cholerae; Central carbon metabolism in cancer",1.1.1.49; 1.1.1.200; 1.1.1.361; 1.1.1.363; 1.1.1.388; 1.1.98.2; 2.4.1.15; 2.4.1.36; 2.4.1.216; 2.7.1.1; 2.7.1.2; 2.7.1.61; 2.7.1.63; 2.7.1.142; 2.7.1.147; 3.1.3.9; 3.1.3.58; 3.2.1.26; 3.2.1.86; 3.2.1.93; 3.2.1.122; 3.5.-.-; 4.2.3.124; 5.3.1.9; 5.4.2.2; 5.4.2.5; 5.4.2.6; 5.5.1.4,NA,NA,CAS: 56-73-5; PubChem: 3392; ChEBI: 4170; ChEMBL: CHEMBL257975; KNApSAcK: C00007306; PDB-CCD: BG6 G6P; 3DMET: B04630; NIKKAJI: J166.116G J40.066A,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.0218941824,2000,cpd:C00185,Cellobiose;,C12H22O11,Cellobiose; 1-beta-D-Glucopyranosyl-4-D-glucopyranose,R00026 R00306 R00952 R01441 R01442 R01443 R01444 R01445; R02365 R02886 R02887 R11172 R11308,Starch and sucrose metabolism; Metabolic pathways; ABC transporters; Phosphotransferase system (PTS),1.1.99.18; 2.4.1.20; 2.7.1.85; 2.7.1.205; 3.2.1.4; 3.2.1.21; 3.2.1.74; 3.2.1.91; 5.1.3.11,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Oligosaccharides;    Disaccharides;     C00185  Cellobiose,CAS: 16462-44-5; PubChem: 3485; ChEBI: 17057; PDB-CCD: CBI CBK; 3DMET: B04644; NIKKAJI: J6.676A,cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336,12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O11,C12H21O11,342.1162115,343.1240366,341.10838651825,2001,cpd:C00208,Maltose;,C12H22O11,Maltose; Malt sugar; alpha-D-Glucopyranosyl-(1->4)-D-glucopyranose,R00028 R00957 R01555 R01556 R01557 R02112 R04111 R05196; R09945 R10486 R11262,Starch and sucrose metabolism; Metabolic pathways; ABC transporters; Bacterial chemotaxis; Phosphotransferase system (PTS); Taste transduction; Carbohydrate digestion and absorption,2.3.1.79; 2.4.1.8; 2.4.1.25; 2.4.1.139; 2.7.1.175; 2.7.1.208; 3.1.3.90; 3.2.1.1; 3.2.1.2; 3.2.1.20; 3.2.1.133; 5.4.99.16,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Oligosaccharides;    Disaccharides;     C00208  Maltose; Malt sugar,CAS: 69-79-4; PubChem: 3508; ChEBI: 17306; ChEMBL: CHEMBL1908365; KNApSAcK: C00001140; PDB-CCD: MAL N9S; 3DMET: B04649; NIKKAJI: J4.871B,cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336,12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O11,C12H21O11,342.1162115,343.1240366,341.10838651826,2002,cpd:C00252,Isomaltose;,C12H22O11,Isomaltose; Brachiose,R01718 R11309,Starch and sucrose metabolism,3.2.1.10; 3.2.1.11,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Oligosaccharides;    Disaccharides;     C00252  Isomaltose,CAS: 499-40-1; PubChem: 3551; ChEBI: 28189; ChEMBL: CHEMBL134478 CHEMBL136400 CHEMBL417686 CHEMBL66675; KNApSAcK: C00018660; 3DMET: B04654; NIKKAJI: J150.529G,cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336,12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O11,C12H21O11,342.1162115,343.1240366,341.10838651827,2005,cpd:C00394,GDP-glucose;,C16H25N5O16P2,GDP-glucose; GDP-D-glucose; GDP-alpha-D-glucose,R00337 R00954 R01233 R02168 R02890 R09752,Starch and sucrose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.4.1.29; 2.4.1.36; 2.7.7.34; 2.7.7.78; 3.2.1.42; 3.6.1.-,NA,NA,PubChem: 3684; ChEBI: 17383 29062 62254; ChEMBL: CHEMBL228228; 3DMET: B04677; NIKKAJI: J631.154G,cpd:C00096; cpd:C00394; cpd:C01581; cpd:C02280; cpd:C15925,16,25,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O16N5P2,C16H24O16N5P2,605.0771537,606.0849788,604.06932871828,2006,cpd:C00498,ADP-glucose;,C16H25N5O15P2,ADP-glucose; ADP-alpha-D-glucose; Adenosine diphosphoglucose,R00948 R00951 R02420 R02421 R05328 R08515 R08676 R08946; R09665 R11530,Starch and sucrose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.4.1.13; 2.4.1.21; 2.4.1.113; 2.4.1.213; 2.4.1.242; 2.4.1.245; 2.4.1.268; 2.4.1.342; 2.7.7.27; 2.7.7.36; 3.6.1.21,"Trehalose biosynthesis, D-glucose 1P => trehalose",NA,PubChem: 3781; ChEBI: 15751; ChEMBL: CHEMBL227552; PDB-CCD: ADQ; 3DMET: B01269; NIKKAJI: J14.393F,cpd:C00325; cpd:C00498; cpd:C02977; cpd:C03117; cpd:C05386; cpd:C06192,16,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O15N5P2,C16H24O15N5P2,589.0822391,590.0900642,588.07441411829,2007,cpd:C00501,CDP-glucose;,C15H25N3O16P2,CDP-glucose; CDP-D-Glucose,R00956 R02426,Starch and sucrose metabolism; Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.7.7.33; 4.2.1.45,NA,NA,PubChem: 3784; ChEMBL: CHEMBL227515; PDB-CCD: C5G; 3DMET: B01272; NIKKAJI: J631.153I,cpd:C00501; cpd:C02200; cpd:C02467; cpd:C12211; cpd:C19794,15,25,16,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O16N3P2,C15H24O16N3P2,565.0710057,566.0788308,564.06318071830,2008,cpd:C00663,beta-D-Glucose 1-phosphate,C6H13O9P,beta-D-Glucose 1-phosphate,R01555 R02727 R02728 R05767 R06040 R06044 R06053 R07264; R09941 R10098 R11127 R11140 R11310,Starch and sucrose metabolism,2.4.1.8; 2.4.1.64; 2.4.1.216; 2.4.1.230; 2.4.1.279; 2.4.1.282; 2.4.1.332; 2.4.1.334; 5.4.2.6,NA,NA,PubChem: 3932; ChEBI: 16218; ChEMBL: CHEMBL67622; KNApSAcK: C00019553; PDB-CCD: XGP; 3DMET: B01301; NIKKAJI: J351.176F,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.0218941831,2009,cpd:C00689,"alpha,alpha'-Trehalose 6-phosphate;",C12H23O14P,"alpha,alpha'-Trehalose 6-phosphate; Trehalose 6-phosphate",R00836 R00837 R02168 R02737 R02778 R02780 R05767,Starch and sucrose metabolism; Metabolic pathways; Phosphotransferase system (PTS); Retrograde endocannabinoid signaling,2.4.1.15; 2.4.1.36; 2.4.1.216; 2.7.1.201; 3.1.3.12; 3.2.1.93; 3.2.1.122,NA,NA,CAS: 4484-88-2; PubChem: 3958; ChEBI: 18283; KNApSAcK: C00007451; PDB-CCD: T6P; 3DMET: B01312; NIKKAJI: J741.923F,cpd:C00689; cpd:C02591; cpd:C02995; cpd:C04534; cpd:C05396; cpd:C16687; cpd:C16688; cpd:C18050; cpd:C20237,12,23,14,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O14P1,C12H22O14P1,422.0825424,423.0903674,421.07471741832,2016,cpd:C01083,"alpha,alpha-Trehalose;",C12H22O11,"alpha,alpha-Trehalose; alpha,alpha'-Trehalose; Trehalose",R00010 R01557 R02727 R02778 R02780 R07248 R07265 R08946; R09995 R10525 R10971 R11256 R11306,Starch and sucrose metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; ABC transporters; Phosphotransferase system (PTS),2.3.1.122; 2.4.1.64; 2.4.1.231; 2.4.1.245; 2.7.1.201; 2.8.2.37; 3.1.3.12; 3.2.1.28; 3.2.1.141; 5.4.99.16,"Trehalose biosynthesis, D-glucose 1P => trehalose",Compounds with biological roles [BR:br08001];  Carbohydrates;   Oligosaccharides;    Disaccharides;     C01083  Trehalose; Pharmaceutical additives [BR:br08316];  Flavoring substance;   C01083  [999999] Trehalose;  Diluting agent;   C01083  [999999] Trehalose,CAS: 99-20-7; PubChem: 4320; ChEBI: 16551; KNApSAcK: C00001152; PDB-CCD: TRE; 3DMET: B01375; NIKKAJI: J4.965D,cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336,12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O11,C12H21O11,342.1162115,343.1240366,341.10838651833,2017,cpd:C01231,"alpha-D-Glucose 1,6-bisphosphate;",C6H14O12P2,"alpha-D-Glucose 1,6-bisphosphate; alpha-D-Glucose 1,6-biphosphate; D-Glucose 1,6-bisphosphate",R00949 R00960 R01660,Starch and sucrose metabolism,2.7.1.10; 2.7.1.41; 2.7.1.106,NA,NA,CAS: 10139-18-1; PubChem: 4453; ChEBI: 18148; PDB-CCD: G16; 3DMET: B01418; NIKKAJI: J40.064E,cpd:C00354; cpd:C00665; cpd:C01220; cpd:C01231; cpd:C03693; cpd:C03785; cpd:C04062; cpd:C04063; cpd:C04064; cpd:C05378,6,14,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O12P2,C6H13O12P2,339.9960499,341.0038749,338.98822491834,2018,cpd:C01725,Levanbiose,C12H22O11,Levanbiose,R10784 R11311,Starch and sucrose metabolism,3.2.1.64; 3.2.1.65,NA,NA,CAS: 17669-60-2; PubChem: 4862; ChEBI: 6435; PDB-CCD: LBS; NIKKAJI: J547.924J,cpd:C00089; cpd:C00185; cpd:C00208; cpd:C00243; cpd:C00252; cpd:C00420; cpd:C00771; cpd:C00897; cpd:C01083; cpd:C01235; cpd:C01518; cpd:C01711; cpd:C01725; cpd:C01728; cpd:C01742; cpd:C01898; cpd:C01935; cpd:C01970; cpd:C01971; cpd:C02048; cpd:C02493; cpd:C02964; cpd:C03486; cpd:C04034; cpd:C04147; cpd:C04219; cpd:C04417; cpd:C05400; cpd:C05402; cpd:C06215; cpd:C06400; cpd:C06421; cpd:C06422; cpd:C07064; cpd:C08240; cpd:C08250; cpd:C15548; cpd:C17207; cpd:C18068; cpd:C19632; cpd:C19633; cpd:C19634; cpd:C19636; cpd:C19773; cpd:C20236; cpd:C20861; cpd:C21335; cpd:C21336,12,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O11,C12H21O11,342.1162115,343.1240366,341.10838651835,2021,cpd:C02591,Sucrose 6'-phosphate;,C12H23O14P,Sucrose 6'-phosphate; Sucrose 6F-phosphate,R00766 R00805 R10987,Starch and sucrose metabolism; Metabolic pathways,2.4.1.14; 2.4.1.329; 3.1.3.24,NA,NA,PubChem: 5583; ChEBI: 16308; PDB-CCD: SUP; 3DMET: B01590; NIKKAJI: J1.723.920A,cpd:C00689; cpd:C02591; cpd:C02995; cpd:C04534; cpd:C05396; cpd:C16687; cpd:C16688; cpd:C18050; cpd:C20237,12,23,14,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O14P1,C12H22O14P1,422.0825424,423.0903674,421.07471741836,2022,cpd:C02995,Maltose 6'-phosphate,C12H23O14P,Maltose 6'-phosphate,R00838 R04111 R10486,Starch and sucrose metabolism; Phosphotransferase system (PTS),2.7.1.208; 3.1.3.90; 3.2.1.122,NA,NA,PubChem: 5904; ChEBI: 15703; 3DMET: B01617; NIKKAJI: J2.740.326C,cpd:C00689; cpd:C02591; cpd:C02995; cpd:C04534; cpd:C05396; cpd:C16687; cpd:C16688; cpd:C18050; cpd:C20237,12,23,14,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O14P1,C12H22O14P1,422.0825424,423.0903674,421.07471741837,2024,cpd:C04534,"6-Phospho-beta-D-glucosyl-(1,4)-D-glucose;",C12H23O14P,"6-Phospho-beta-D-glucosyl-(1,4)-D-glucose; Cellobiose 6'-phosphate; Cellobiose 6-phosphate",R00839 R01441 R11172,Starch and sucrose metabolism; Phosphotransferase system (PTS),2.7.1.85; 2.7.1.205; 3.2.1.86,NA,NA,PubChem: 7141; ChEBI: 2233,cpd:C00689; cpd:C02591; cpd:C02995; cpd:C04534; cpd:C05396; cpd:C16687; cpd:C16688; cpd:C18050; cpd:C20237,12,23,14,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O14P1,C12H22O14P1,422.0825424,423.0903674,421.07471741838,2025,cpd:C05731,3-Ketosucrose;,C12H20O11,3-Ketosucrose; 3-Dehydro-alpha-D-glucosyl-beta-D-fructofuranoside,R00807 R00808,Starch and sucrose metabolism,1.1.99.13,NA,NA,CAS: 1883-12-1; PubChem: 8033; ChEBI: 17429; 3DMET: B01890,cpd:C00930; cpd:C01093; cpd:C02412; cpd:C02695; cpd:C04276; cpd:C05403; cpd:C05731; cpd:C05796,12,20,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H21O11,C12H19O11,340.1005615,341.1083865,339.09273641839,2028,cpd:C16688,Sucrose 6-phosphate;,C12H23O14P,Sucrose 6-phosphate; 6-Phosphosucrose; 6-O-Phosphonosucrose; beta-D-Fructofuranosyl-6-O-phosphono-alpha-D-glucopyranoside,R00811 R03921,Starch and sucrose metabolism; Phosphotransferase system (PTS),2.7.1.211; 3.2.1.26,NA,NA,PubChem: 51091010; ChEBI: 131603; KNApSAcK: C00007452; NIKKAJI: J1.510.114H,cpd:C00689; cpd:C02591; cpd:C02995; cpd:C04534; cpd:C05396; cpd:C16687; cpd:C16688; cpd:C18050; cpd:C20237,12,23,14,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O14P1,C12H22O14P1,422.0825424,423.0903674,421.07471741840,2029,cpd:C20237,alpha-Maltose 1-phosphate,C12H23O14P,alpha-Maltose 1-phosphate,R09945 R09994 R11530,Starch and sucrose metabolism; Metabolic pathways,2.4.1.342; 2.4.99.16; 2.7.1.175,NA,NA,PubChem: 163311980; PDB-CCD: M1F,cpd:C00689; cpd:C02591; cpd:C02995; cpd:C04534; cpd:C05396; cpd:C16687; cpd:C16688; cpd:C18050; cpd:C20237,12,23,14,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O14P1,C12H22O14P1,422.0825424,423.0903674,421.07471741841,2037,cpd:C00043,UDP-N-acetyl-alpha-D-glucosamine;,C17H27N3O17P2,UDP-N-acetyl-alpha-D-glucosamine; UDP-N-acetyl-D-glucosamine; UDP-N-acetylglucosamine,R00414 R00416 R00417 R00418 R00420 R00421 R00422 R00423; R00504 R00660 R01007 R01008 R01996 R02335 R02654 R02717; R02789 R02790 R03513 R03514 R04291 R04451 R04493 R04494; R04567 R04575 R04619 R04636 R04642 R04653 R04654 R04659; R04662 R04665 R05032 R05327 R05662 R05969 R07258 R07259; R07334 R07397 R08856 R08894 R08900 R09634 R09676 R09677; R09697 R09946 R10137 R10266 R10596 R10785 R11115 R11282,"Amino sugar and nucleotide sugar metabolism; Neomycin, kanamycin and gentamicin biosynthesis; Lipopolysaccharide biosynthesis; Peptidoglycan biosynthesis; Metabolic pathways; Biosynthesis of antibiotics; Vancomycin resistance; Insulin resistance",1.1.1.136; 1.1.1.374; 2.3.1.129; 2.4.1.16; 2.4.1.39; 2.4.1.56; 2.4.1.70; 2.4.1.94; 2.4.1.102; 2.4.1.138; 2.4.1.141; 2.4.1.143; 2.4.1.144; 2.4.1.145; 2.4.1.146; 2.4.1.147; 2.4.1.148; 2.4.1.149; 2.4.1.150; 2.4.1.153; 2.4.1.155; 2.4.1.164; 2.4.1.198; 2.4.1.201; 2.4.1.206; 2.4.1.212; 2.4.1.223; 2.4.1.224; 2.4.1.227; 2.4.1.250; 2.4.1.255; 2.4.1.283; 2.4.1.285; 2.4.1.312; 2.4.1.-; 2.5.1.7; 2.7.1.176; 2.7.7.23; 2.7.8.15; 2.7.8.17; 2.7.8.18; 2.7.8.33; 2.7.8.35; 3.2.1.183; 4.2.1.115; 4.2.1.135; 5.1.3.2; 5.1.3.7; 5.1.3.14,"Lipopolysaccharide biosynthesis, KDO2-lipid A",NA,CAS: 528-04-1; PubChem: 3345; ChEBI: 16264; ChEMBL: CHEMBL388154 CHEMBL611228; KNApSAcK: C00019358; PDB-CCD: UD1; 3DMET: B04624; NIKKAJI: J506.541K,cpd:C00043; cpd:C00203; cpd:C01170,17,27,17,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H28O17N3P2,C17H26O17N3P2,607.0815704,608.0893954,606.07374541842,2038,cpd:C00128,CMP-N-acetylneuraminate;,C20H31N4O16P,CMP-N-acetylneuraminate; CMP-N-acetyl-beta-neuraminate,R01115 R01117 R01119 R01120 R03468 R03488 R03489 R04532; R04564 R04583 R04590 R04596 R04630 R04632 R04635 R04647; R04648 R04649 R04656 R04660 R04661 R05113 R05114 R05116; R05580,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,1.14.18.2; 2.4.99.1; 2.4.99.2; 2.4.99.4; 2.4.99.5; 2.4.99.6; 2.4.99.7; 2.4.99.8; 2.4.99.9; 2.4.99.10; 2.4.99.-; 2.7.7.43,NA,NA,CAS: 3063-71-6; PubChem: 3428; ChEBI: 16556; PDB-CCD: NCC; 3DMET: B01167; NIKKAJI: J472.301E,cpd:C00128,20,31,16,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H32O16N4P1,C20H30O16N4P1,614.1472679,615.155093,613.13944291843,2039,cpd:C00140,N-Acetyl-D-glucosamine;,C8H15NO6,N-Acetyl-D-glucosamine; N-Acetylchitosamine; 2-Acetamido-2-deoxy-D-glucose; GlcNAc,R00022 R01200 R01201 R01203 R01204 R01205 R01206 R01207; R01266 R04373 R05199 R05326 R06055 R06057 R06081 R06141; R07809 R07816 R08968 R09323 R09672 R09673 R09942 R10829; R10831 R11316 R11317,Amino sugar and nucleotide sugar metabolism; Metabolic pathways; ABC transporters; Phosphotransferase system (PTS),1.1.3.29; 2.3.1.3; 2.4.1.90; 2.4.1.211; 2.4.1.280; 2.4.1.320; 2.7.1.59; 2.7.1.162; 2.7.1.193; 2.7.1.-; 3.1.4.45; 3.2.1.14; 3.2.1.50; 3.2.1.52; 3.2.1.169; 3.2.2.11; 3.5.1.33; 5.1.3.8,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Amino sugars;     C00140  N-Acetyl-D-glucosamine,CAS: 7512-17-6; PubChem: 3440; ChEBI: 506227; ChEMBL: CHEMBL240524 CHEMBL447878; PDB-CCD: NAG NDG; 3DMET: B04639; NIKKAJI: J81.413J,cpd:C00140; cpd:C00645; cpd:C01132; cpd:C02711; cpd:C03136; cpd:C03878; cpd:C05021; cpd:C20328; cpd:C21036; cpd:C21039; cpd:C21049; cpd:C21052; cpd:C21061,8,15,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O6N1,C8H14O6N1,221.0899372,222.0977622,220.08211221844,2040,cpd:C00190,UDP-D-xylose;,C14H22N2O16P2,UDP-D-xylose; UDP-xylose; UDP-alpha-D-xylose,R01384 R01471 R01472 R01473 R01474 R02119 R03268 R03928; R06811 R06814 R09642 R10256 R10257 R10290 R10291 R10292; R10609 R11289,Amino sugar and nucleotide sugar metabolism; Zeatin biosynthesis; Metabolic pathways,2.4.2.24; 2.4.2.32; 2.4.2.35; 2.4.2.40; 2.4.2.50; 2.4.2.51; 2.4.2.56; 2.4.2.-; 2.7.7.11; 2.7.7.64; 2.7.8.32; 4.1.1.35; 5.1.3.5,NA,NA,CAS: 3616-06-6; PubChem: 3490; ChEBI: 16082; PDB-CCD: UDX; 3DMET: B04645,cpd:C00190; cpd:C00935; cpd:C01623; cpd:C18094,14,22,16,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H23O16N2P2,C14H21O16N2P2,536.0444566,537.0522817,535.03663161845,2041,cpd:C00203,UDP-N-acetyl-D-galactosamine;,C17H27N3O17P2,UDP-N-acetyl-D-galactosamine; UDP-N-acetyl-alpha-D-galactosamine,R00418 R01537 R02183 R03490 R04182 R04423 R04584 R04603; R04615 R04645 R05108 R05109 R05631 R06894 R10183 R10188; R10435 R10465 R10620,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,1.1.1.-; 2.4.1.40; 2.4.1.41; 2.4.1.79; 2.4.1.88; 2.4.1.92; 2.4.1.165; 2.4.1.175; 2.4.1.290; 2.4.1.306; 2.4.1.313; 2.7.7.83; 2.7.8.40; 5.1.3.2; 5.1.3.7,NA,NA,PubChem: 3503; ChEBI: 67168; PDB-CCD: UD2; 3DMET: B04647; NIKKAJI: J443.675J,cpd:C00043; cpd:C00203; cpd:C01170,17,27,17,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H28O17N3P2,C17H26O17N3P2,607.0815704,608.0893954,606.07374541846,2042,cpd:C00270,N-Acetylneuraminate;,C11H19NO9,"N-Acetylneuraminate; N-Acetylneuraminic acid; 5-Acetamido-3,5-dideoxy-D-glycero-D-galacto-2-nonulosonic acid; Neu5Ac",R01117 R01803 R01804 R01805 R01806 R01807 R01808 R01810; R01811 R03491 R04018 R04634 R04650 R05115 R05117 R05996; R05998 R05999 R06012 R06147 R06253 R08600 R08601,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,1.14.18.2; 2.3.1.44; 2.3.1.45; 2.5.1.56; 2.7.7.43; 3.1.1.53; 3.1.3.29; 3.2.1.18; 4.1.3.3,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Amino sugars;     C00270  N-Acetylneuraminic acid,CAS: 131-48-6; PubChem: 3568; ChEBI: 17012; ChEMBL: CHEMBL1234621 CHEMBL165084; KNApSAcK: C00019584; PDB-CCD: SIA SLB; 3DMET: B04658; NIKKAJI: J10.009I,cpd:C00270; cpd:C03525; cpd:C08415; cpd:C19909; cpd:C19910; cpd:C21053,11,19,9,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H20O9N1,C11H18O9N1,309.1059812,310.1138062,308.09815621847,2043,cpd:C00329,D-Glucosamine;,C6H13NO5,D-Glucosamine; Chitosamine; 2-Amino-2-deoxy-D-glucose,R01200 R01204 R01961 R01962 R01963 R01964 R01965 R01966; R02631 R06225 R08715,Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Phosphotransferase system (PTS),1.1.3.-; 2.3.1.3; 2.7.1.1; 2.7.1.8; 2.7.1.-; 3.2.1.165; 3.5.1.33; 3.10.1.1,NA,"Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Amino sugars;     C00329  D-Glucosamine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  M MUSCULO-SKELETAL SYSTEM;   M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;    M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS;     M01AX Other antiinflammatory and antirheumatic agents, non-steroids;      M01AX05 Glucosamine;       D04334  Glucosamine (USAN/INN)",CAS: 3416-24-8; PubChem: 3623; ChEBI: 47977; ChEMBL: CHEMBL234432 CHEMBL493287 CHEMBL606759; PDB-CCD: GCS PA1; 3DMET: B04670; NIKKAJI: J10.582A,cpd:C00329; cpd:C01214; cpd:C02262; cpd:C03570; cpd:C06763; cpd:C08349; cpd:C12212; cpd:C17578; cpd:C21035; cpd:C21038; cpd:C21048; cpd:C21051; cpd:C21060,6,13,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O5N1,C6H12O5N1,179.0793725,180.0871976,178.07154751848,2044,cpd:C00357,N-Acetyl-D-glucosamine 6-phosphate,C8H16NO9P,N-Acetyl-D-glucosamine 6-phosphate,R01201 R02058 R02059 R02087 R05199 R08193 R08555,Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of antibiotics; Phosphotransferase system (PTS),2.3.1.4; 2.7.1.59; 2.7.1.193; 3.5.1.25; 4.2.1.126; 5.1.3.9; 5.4.2.3,NA,NA,PubChem: 3650; ChEBI: 15784; PDB-CCD: 16G 4QY; 3DMET: B01225; NIKKAJI: J1.734.828K,cpd:C00357; cpd:C04256; cpd:C04257; cpd:C04501; cpd:C06376; cpd:C18055; cpd:C18060,8,16,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O9N1P1,C8H15O9N1P1,301.0562681,302.0640931,300.04844311849,2046,cpd:C00617,UDP-D-galacturonate;,C15H22N2O18P2,UDP-D-galacturonate; UDPgalacturonate; UDP-alpha-D-galacturonate,R00501 R01385 R02634 R02636 R04343 R05191,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,1.1.1.-; 2.4.1.43; 2.7.7.-; 4.1.1.67; 5.1.3.6,NA,NA,PubChem: 3891; ChEBI: 16085; PDB-CCD: UGB; 3DMET: B04705; NIKKAJI: J634.611A,cpd:C00167; cpd:C00617; cpd:C02330,15,22,18,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O18N2P2,C15H21O18N2P2,580.0342859,581.0421109,579.02646081850,2047,cpd:C00645,N-Acetyl-D-mannosamine;,C8H15NO6,N-Acetyl-D-mannosamine; 2-Acetamido-2-deoxy-D-mannose,R00414 R01207 R01804 R01811 R02705 R02706 R02707,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.5.1.56; 2.7.1.60; 3.1.3.-; 3.2.1.183; 3.2.1.-; 4.1.3.3; 5.1.3.8; 5.1.3.14,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Amino sugars;     C00645  N-Acetyl-D-mannosamine,CAS: 3615-17-6; PubChem: 3918; ChEBI: 17122 63153; ChEMBL: CHEMBL1231391; KNApSAcK: C00019583; PDB-CCD: BM3 BM7; 3DMET: B04710; NIKKAJI: J149.444I,cpd:C00140; cpd:C00645; cpd:C01132; cpd:C02711; cpd:C03136; cpd:C03878; cpd:C05021; cpd:C20328; cpd:C21036; cpd:C21039; cpd:C21049; cpd:C21052; cpd:C21061,8,15,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O6N1,C8H14O6N1,221.0899372,222.0977622,220.08211221851,2049,cpd:C00935,UDP-L-arabinose;,C14H22N2O16P2,UDP-L-arabinose; UDP-L-arabinopyranose; UDP-beta-L-arabinopyranose,R01473 R02636 R03077 R03079 R04335 R09009,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.4.2.34; 2.7.7.64; 4.1.1.67; 5.1.3.5; 5.4.99.9; 5.4.99.30,NA,NA,PubChem: 4187; ChEBI: 17983; 3DMET: B04751; NIKKAJI: J1.270.526C,cpd:C00190; cpd:C00935; cpd:C01623; cpd:C18094,14,22,16,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H23O16N2P2,C14H21O16N2P2,536.0444566,537.0522817,535.03663161852,2050,cpd:C01170,UDP-N-acetyl-D-mannosamine;,C17H27N3O17P2,UDP-N-acetyl-D-mannosamine; UDP-N-acetyl-alpha-D-mannosamine,R00420 R02707 R03317 R05566,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,1.1.1.336; 2.4.1.187; 3.2.1.-; 5.1.3.14,NA,NA,PubChem: 4397; ChEBI: 68678; ChEMBL: CHEMBL611228; 3DMET: B04778; NIKKAJI: J743.395F,cpd:C00043; cpd:C00203; cpd:C01170,17,27,17,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H28O17N3P2,C17H26O17N3P2,607.0815704,608.0893954,606.07374541853,2051,cpd:C01219,CDP-4-dehydro-6-deoxy-D-glucose,C15H23N3O15P2,CDP-4-dehydro-6-deoxy-D-glucose,R02426 R03391 R03392,Amino sugar and nucleotide sugar metabolism,1.17.1.1; 4.2.1.45; 4.2.1.-,NA,NA,PubChem: 4441; ChEBI: 17494; 3DMET: B01410; NIKKAJI: J679.102F,cpd:C01219,15,23,15,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H24O15N3P2,C15H22O15N3P2,547.060441,548.0682661,546.0526161854,2052,cpd:C01623,UDP-apiose;,C14H22N2O16P2,UDP-apiose; UDP-D-apiose; UDP-alpha-D-apiose,R01386 R04526,Amino sugar and nucleotide sugar metabolism,2.4.2.25,NA,NA,PubChem: 4774; ChEBI: 73886; 3DMET: B01472; NIKKAJI: J1.489.570A,cpd:C00190; cpd:C00935; cpd:C01623; cpd:C18094,14,22,16,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H23O16N2P2,C14H21O16N2P2,536.0444566,537.0522817,535.03663161855,2053,cpd:C01674,Chitobiose;,C16H28N2O11,"Chitobiose; Diacetylchitobiose; N,N'-Diacetylchitobiose",R00022 R02334 R06082 R09942 R11170,Amino sugar and nucleotide sugar metabolism; Metabolic pathways; ABC transporters; Phosphotransferase system (PTS),2.4.1.280; 2.7.1.196; 3.2.1.14; 3.2.1.52,NA,NA,CAS: 35061-50-8; PubChem: 4818; ChEBI: 28681; ChEMBL: CHEMBL1169569 CHEMBL467754; PDB-CCD: CBS; 3DMET: B04807; NIKKAJI: J392.525K,cpd:C01674,16,28,11,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H29O11N2,C16H27O11N2,424.1693097,425.1771348,423.16148471856,2054,cpd:C01788,CDP-abequose;,C15H25N3O14P2,CDP-abequose; CDP-alpha-D-abequose,R04581 R08711,Amino sugar and nucleotide sugar metabolism,1.1.1.341; 2.4.1.60; 4.2.1.-,NA,NA,PubChem: 4916; ChEBI: 70799; NIKKAJI: J1.150.934G,cpd:C01788; cpd:C03598; cpd:C03599; cpd:C17327,15,25,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O14N3P2,C15H24O14N3P2,533.0811765,534.0890015,532.07335151857,2055,cpd:C02199,UDP-L-rhamnose;,C15H24N2O16P2,UDP-L-rhamnose; UDP-rhamnose; UDP-beta-L-rhamnose,R03879 R03880 R04900 R06802 R06818 R06820 R06826 R06829; R07337 R07903 R08022 R08705 R09754 R09802 R09803,Amino sugar and nucleotide sugar metabolism,1.1.1.-; 2.4.1.159; 2.4.1.236; 2.4.1.273; 2.4.1.-,NA,NA,CAS: 1955-26-6; PubChem: 5267; ChEBI: 84725; 3DMET: B04842; NIKKAJI: J2.432.559H,cpd:C01009; cpd:C02199,15,24,16,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O16N2P2,C15H23O16N2P2,550.0601067,551.0679317,549.05228171858,2056,cpd:C02330,UDP-L-iduronate,C15H22N2O18P2,UDP-L-iduronate,R01387,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,5.1.3.12,NA,NA,PubChem: 5380; ChEBI: 88243; 3DMET: B04847; NIKKAJI: J2.390.949I,cpd:C00167; cpd:C00617; cpd:C02330,15,22,18,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O18N2P2,C15H21O18N2P2,580.0342859,581.0421109,579.02646081859,2057,cpd:C02336,beta-D-Fructose;,C6H12O6,beta-D-Fructose; beta-Fruit sugar; beta-D-arabino-Hexulose; beta-Levulose; Fructose,R00802 R03920 R06088 R06102,Amino sugar and nucleotide sugar metabolism,2.7.1.1; 2.7.1.4; 3.2.1.20; 3.2.1.26; 3.2.1.48,NA,NA,CAS: 53188-23-1; PubChem: 5386; ChEBI: 28645; ChEMBL: CHEMBL604608; PDB-CCD: FRU; 3DMET: B01561; NIKKAJI: J4.580B,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.05556311860,2060,cpd:C02713,N-Acetylmuramate;,C11H19NO8,N-Acetylmuramate; N-Acetylmuramic acid; N-Acetyl-D-muramoate,R04112 R08559 R11024,Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Phosphotransferase system (PTS),2.7.1.192; 2.7.1.-; 3.5.1.28,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Amino sugars;     C02713  N-Acetylmuramic acid,CAS: 61633-75-8; PubChem: 5676; ChEBI: 21615 28881; PDB-CCD: AMU MUB; 3DMET: B04861; NIKKAJI: J227.021H,cpd:C02713,11,19,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H20O8N1,C11H18O8N1,293.1110666,294.1188916,292.10324151861,2061,cpd:C03410,N-Glycoloyl-neuraminate;,C11H19NO10,N-Glycoloyl-neuraminate; N-Glycolylneuraminate; Neu5Gc,R01803 R04215,Amino sugar and nucleotide sugar metabolism,1.14.18.2; 2.7.7.43,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Amino sugars;     C03410  N-Glycoloyl-neuraminate,PubChem: 6239; ChEBI: 29025; ChEMBL: CHEMBL496421; PDB-CCD: NGC NGE; 3DMET: B04895; NIKKAJI: J2.742.226H,cpd:C03410; cpd:C08425,11,19,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H20O10N1,C11H18O10N1,325.1008958,326.1087208,324.09307081862,2062,cpd:C03598,"CDP-3,6-dideoxy-D-glucose;",C15H25N3O14P2,"CDP-3,6-dideoxy-D-glucose; CDPparatose; CDP-alpha-D-paratose",R04265 R04266,Amino sugar and nucleotide sugar metabolism,1.1.1.342; 5.1.3.10,NA,NA,PubChem: 6389; ChEBI: 70802; 3DMET: B04906; NIKKAJI: J1.150.933I,cpd:C01788; cpd:C03598; cpd:C03599; cpd:C17327,15,25,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O14N3P2,C15H24O14N3P2,533.0811765,534.0890015,532.07335151863,2063,cpd:C03599,"CDP-3,6-dideoxy-D-mannose;",C15H25N3O14P2,"CDP-3,6-dideoxy-D-mannose; CDPtyvelose",R04266,Amino sugar and nucleotide sugar metabolism,5.1.3.10,NA,NA,PubChem: 6390; ChEBI: 88237; 3DMET: B04907; NIKKAJI: J1.150.932K,cpd:C01788; cpd:C03598; cpd:C03599; cpd:C17327,15,25,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O14N3P2,C15H24O14N3P2,533.0811765,534.0890015,532.07335151864,2064,cpd:C03691,CMP-N-glycoloylneuraminate;,C20H31N4O17P,CMP-N-glycoloylneuraminate; CMP-N-glycolylneuraminate; CMP-Neu5Gc,R01115 R04215 R04289,Amino sugar and nucleotide sugar metabolism,1.14.18.2; 2.7.7.43,NA,NA,PubChem: 6465; ChEBI: 18098; 3DMET: B01686; NIKKAJI: J891.254H,cpd:C03691,20,31,17,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H32O17N4P1,C20H30O17N4P1,630.1421825,631.1500076,629.13435751865,2065,cpd:C03906,beta-L-Arabinose 1-phosphate,C5H11O8P,beta-L-Arabinose 1-phosphate,R01754 R03077,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.7.1.46; 2.7.7.64,NA,NA,PubChem: 6637; ChEBI: 15807; 3DMET: B01696; NIKKAJI: J2.744.551I,cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814,5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O8P1,C5H10O8P1,230.0191543,231.0269793,229.01132931866,2066,cpd:C04037,1-Phospho-alpha-D-galacturonate;,C6H11O10P,1-Phospho-alpha-D-galacturonate; D-Galacturonate 1-phosphate,R01980 R02634,Amino sugar and nucleotide sugar metabolism,2.7.1.44; 2.7.7.-,NA,NA,PubChem: 6740; ChEBI: 17543; 3DMET: B01712; NIKKAJI: J2.324.903K,cpd:C01218; cpd:C04037; cpd:C05385; cpd:C14899,6,11,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O10P1,C6H10O10P1,274.0089835,275.0168086,273.00115851867,2067,cpd:C04089,UDP-4-dehydro-6-deoxy-D-glucose;,C15H22N2O16P2,UDP-4-dehydro-6-deoxy-D-glucose; UDP-4-keto-6-deoxy-D-glucose; UDP-4-oxo-6-deoxy-D-glucose; UDP-4-dehydro-6-deoxy-alpha-D-glucose,R00293 R03879 R08704,Amino sugar and nucleotide sugar metabolism,1.1.1.-; 4.2.1.76; 5.1.3.-,NA,NA,PubChem: 6781; ChEBI: 85804; 3DMET: B01717; NIKKAJI: J1.002.106E,cpd:C04089; cpd:C17328,15,22,16,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O16N2P2,C15H21O16N2P2,548.0444566,549.0522817,547.03663161868,2068,cpd:C04257,N-Acetyl-D-mannosamine 6-phosphate;,C8H16NO9P,N-Acetyl-D-mannosamine 6-phosphate; N-Acetylmannosamine 6-phosphate,R02087 R02705 R02706 R04435,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.5.1.56; 2.5.1.57; 2.7.1.60; 3.1.3.-; 5.1.3.9,NA,NA,PubChem: 6922; ChEBI: 28273 62168; PDB-CCD: BMX; 3DMET: B01726; NIKKAJI: J1.506.097B,cpd:C00357; cpd:C04256; cpd:C04257; cpd:C04501; cpd:C06376; cpd:C18055; cpd:C18060,8,16,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O9N1P1,C8H15O9N1P1,301.0562681,302.0640931,300.04844311869,2069,cpd:C04297,"CDP-4-dehydro-3,6-dideoxy-D-glucose;",C15H23N3O14P2,"CDP-4-dehydro-3,6-dideoxy-D-glucose; CDP-3,6-dideoxy-D-erythro-hexos-4-ulose; CDP-4-dehydro-3,6-dideoxy-alpha-D-glucose",R03391 R03392 R04265 R08708 R08711,Amino sugar and nucleotide sugar metabolism,1.1.1.341; 1.1.1.342; 1.17.1.1; 4.2.1.-; 5.1.3.-,NA,NA,PubChem: 6956; ChEBI: 70800; 3DMET: B01732; NIKKAJI: J679.103D,cpd:C04297; cpd:C17326,15,23,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H24O14N3P2,C15H22O14N3P2,531.0655264,532.0733515,530.05770141870,2070,cpd:C04501,N-Acetyl-alpha-D-glucosamine 1-phosphate,C8H16NO9P,N-Acetyl-alpha-D-glucosamine 1-phosphate,R00416 R05332 R08193 R08968 R09942,Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of antibiotics,2.3.1.157; 2.4.1.280; 2.7.1.162; 2.7.1.-; 2.7.7.23; 5.4.2.3,NA,NA,PubChem: 7115; ChEBI: 16446; PDB-CCD: GN1; 3DMET: B01749; NIKKAJI: J442.512J,cpd:C00357; cpd:C04256; cpd:C04257; cpd:C04501; cpd:C06376; cpd:C18055; cpd:C18060,8,16,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O9N1P1,C8H15O9N1P1,301.0562681,302.0640931,300.04844311871,2071,cpd:C04573,UDP-N-acetyl-2-amino-2-deoxy-D-glucuronate;,C17H25N3O18P2,UDP-N-acetyl-2-amino-2-deoxy-D-glucuronate; UDP-N-acetyl-D-glucosaminuronate; UDP-N-acetyl-2-amino-2-deoxy-alpha-D-glucuronate,R00421 R08706 R10140,Amino sugar and nucleotide sugar metabolism,1.1.1.136; 1.1.1.335; 5.1.3.-,NA,NA,PubChem: 7174; ChEBI: 15886 52775 65047; PDB-CCD: HP7; 3DMET: B01758; NIKKAJI: J2.436.806H,cpd:C04573; cpd:C06240; cpd:C13952,17,25,18,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H26O18N3P2,C17H24O18N3P2,621.060835,622.06866,620.05300991872,2072,cpd:C04613,"UDP-2-acetamido-4-dehydro-2,6-dideoxyglucose;",C17H25N3O16P2,"UDP-2-acetamido-4-dehydro-2,6-dideoxyglucose; UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hexos-4-ulose; UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hex-4-ulose",R04529 R10266,Amino sugar and nucleotide sugar metabolism,2.6.1.34; 4.2.1.135,NA,NA,PubChem: 7204; ChEBI: 17867 62420; PDB-CCD: UD7; NIKKAJI: J2.752.243B,cpd:C04613; cpd:C19823,17,25,16,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H26O16N3P2,C17H24O16N3P2,589.0710057,590.0788308,588.06318071873,2073,cpd:C04630,"UDP-2-acetamido-4-amino-2,4,6-trideoxy-alpha-D-glucose;",C17H28N4O15P2,"UDP-2-acetamido-4-amino-2,4,6-trideoxy-alpha-D-glucose; UDP-4-amino-4,6-dideoxy-N-acetyl-alpha-D-glucosamine; UDP-N-acetylbacillosamine",R04529 R10099,Amino sugar and nucleotide sugar metabolism,2.3.1.203; 2.6.1.34,NA,NA,PubChem: 7219; ChEBI: 63273; PDB-CCD: UD4; NIKKAJI: J2.752.432J,cpd:C04630; cpd:C19961,17,28,15,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H29O15N4P2,C17H27O15N4P2,590.1026402,591.1104652,589.09481521874,2074,cpd:C04631,UDP-N-acetyl-3-(1-carboxyvinyl)-D-glucosamine;,C20H29N3O19P2,UDP-N-acetyl-3-(1-carboxyvinyl)-D-glucosamine; UDP-N-acetyl-3-O-(1-carboxyvinyl)-D-glucosamine; UDP-N-acetylglucosamine-3-O-pyruvateether; UDP-N-acetylglucosamine enolpyruvate; UDP-N-acetyl-3-O-(1-carboxyvinyl)-alpha-D-glucosamine,R00660 R03191 R03192,Amino sugar and nucleotide sugar metabolism; Peptidoglycan biosynthesis; Metabolic pathways,1.3.1.98; 2.5.1.7,NA,NA,CAS: 70222-94-5; PubChem: 7220; ChEBI: 68507; KNApSAcK: C00019554; PDB-CCD: EPU; 3DMET: B01767; NIKKAJI: J711.509A,cpd:C04631,20,29,19,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H30O19N3P2,C20H28O19N3P2,677.0870497,678.0948747,676.07922471875,2076,cpd:C06156,alpha-D-Glucosamine 1-phosphate;,C6H14NO8P,alpha-D-Glucosamine 1-phosphate; D-Glucosamine 1-phosphate,R02060 R05332,Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Biosynthesis of antibiotics; Insulin resistance,2.3.1.157; 5.4.2.10,NA,NA,CAS: 2152-75-2; PubChem: 8412; ChEBI: 27625; KNApSAcK: C00019579; PDB-CCD: GP1 L1L; 3DMET: B01976; NIKKAJI: J1.531.908I,cpd:C00352; cpd:C01283; cpd:C03783; cpd:C06156; cpd:C06377; cpd:C12213; cpd:C12214,6,14,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O8N1P1,C6H13O8N1P1,259.0457034,260.0535284,258.03787841876,2077,cpd:C06240,UDP-N-acetyl-D-mannosaminouronate;,C17H25N3O18P2,UDP-N-acetyl-D-mannosaminouronate; UDP-N-acetyl-2-amino-2-deoxy-D-mannuronate; UDP-N-acetyl-D-mannosaminuronic acid; UDP-N-acetyl-alpha-D-mannosaminuronate,R03317 R04477,Amino sugar and nucleotide sugar metabolism,1.1.1.336; 2.4.1.180,NA,NA,PubChem: 8481; ChEBI: 70738; PDB-CCD: SAJ; 3DMET: B01999; NIKKAJI: J2.414.047D,cpd:C04573; cpd:C06240; cpd:C13952,17,25,18,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H26O18N3P2,C17H24O18N3P2,621.060835,622.06866,620.05300991877,2078,cpd:C06241,N-Acetylneuraminate 9-phosphate,C11H20NO12P,N-Acetylneuraminate 9-phosphate,R01805 R04435,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.5.1.56; 2.5.1.57; 3.1.3.29,NA,NA,PubChem: 8482; ChEBI: 27438; 3DMET: B05181; NIKKAJI: J2.761.995I,cpd:C06241,11,20,12,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H21O12N1P1,C11H19O12N1P1,389.0723121,390.0801371,388.06448711878,2079,cpd:C11521,UDP-6-sulfoquinovose,C15H24N2O19P2S,UDP-6-sulfoquinovose,R05775 R06867,Amino sugar and nucleotide sugar metabolism; Glycerolipid metabolism,3.13.1.1,NA,NA,PubChem: 13689; ChEBI: 15855; PDB-CCD: USQ; 3DMET: B04271; NIKKAJI: J2.774.860K,cpd:C11521,15,24,19,2,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O19N2P2S1,C15H23O19N2P2S1,630.0169217,631.0247468,629.00909671879,2080,cpd:C13952,UDP-N-acetyl-D-galactosaminuronic acid,C17H25N3O18P2,UDP-N-acetyl-D-galactosaminuronic acid,R06894 R08706,Amino sugar and nucleotide sugar metabolism,1.1.1.-; 5.1.3.-,NA,NA,PubChem: 854195; ChEBI: 35041; 3DMET: B05687; NIKKAJI: J2.787.816D,cpd:C04573; cpd:C06240; cpd:C13952,17,25,18,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H26O18N3P2,C17H24O18N3P2,621.060835,622.06866,620.05300991880,2081,cpd:C16153,UDP-L-Ara4N;,C14H23N3O15P2,UDP-L-Ara4N; UDP-4-amino-4-deoxy-L-arabinose; UDP-4-amino-4-deoxy-beta-L-arabinopyranose,R07659 R07660,Amino sugar and nucleotide sugar metabolism,2.1.2.13; 2.6.1.87,"Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N",NA,PubChem: 47205463; ChEBI: 47025; PDB-CCD: G3N; NIKKAJI: J2.798.390A,cpd:C16153,14,23,15,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H24O15N3P2,C14H22O15N3P2,535.060441,536.0682661,534.0526161881,2082,cpd:C16154,UDP-L-Ara4FN;,C15H23N3O16P2,UDP-L-Ara4FN; Uridine 5'-diphospho-beta-(4-deoxy-4-formamido-L-arabinose); UDP-4-deoxy-4-formamido-beta-L-arabinopyranose,R07660 R07661,Amino sugar and nucleotide sugar metabolism,2.1.2.13; 2.4.2.53,"Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N",NA,PubChem: 47205464; ChEBI: 47027; NIKKAJI: J2.798.391J,cpd:C16154,15,23,16,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H24O16N3P2,C15H22O16N3P2,563.0553557,564.0631807,562.04753061882,2083,cpd:C16155,UDP-L-Ara4O;,C14H20N2O16P2,UDP-L-Ara4O; UDP-4''-ketopentose; Uridine 5'-diphospho-beta-(L-threo-pentapyranosyl-4''-ulose); UDP-beta-L-threo-pentapyranos-4-ulose; UDP-4-keto-D-xylose,R07658 R07659,Amino sugar and nucleotide sugar metabolism,1.1.1.305; 2.6.1.87,"Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N",NA,PubChem: 47205465; ChEBI: 47028; NIKKAJI: J2.731.941F,cpd:C16155,14,20,16,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H21O16N2P2,C14H19O16N2P2,534.0288066,535.0366316,533.02098151883,2084,cpd:C16156,Undecaprenyl phosphate alpha-L-Ara4FN;,C61H100NO8P,"Undecaprenyl phosphate alpha-L-Ara4FN; 4-Deoxy-4-formamido-alpha-L-arabinopyranosyl ditrans,octacis-undecaprenyl phosphate",R07661 R07662,Amino sugar and nucleotide sugar metabolism,2.4.2.53; 3.5.1.-,"Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N",Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0302 Bactoprenol monophosphates;     C16156  Undecaprenyl phosphate alpha-L-Ara4FN,PubChem: 47205466; ChEBI: 53028; NIKKAJI: J2.798.392H,cpd:C16156,61,100,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C61H101O8N1P1,C61H99O8N1P1,1005.718656,1006.726481,1004.7108311884,2085,cpd:C16157,Undecaprenyl phosphate alpha-L-Ara4N;,C60H100NO7P,"Undecaprenyl phosphate alpha-L-Ara4N; 4-Amino-4-deoxy-alpha-L-arabinopyranosyl ditrans,octacis-undecaprenyl phosphate",R07662 R09773 R09774 R09781,Amino sugar and nucleotide sugar metabolism,2.4.2.43; 3.5.1.-,"Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N",Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0302 Bactoprenol monophosphates;     C16157  Undecaprenyl phosphate alpha-L-Ara4N,PubChem: 47205467; ChEBI: 47039; LIPIDMAPS: LMPR03020005; NIKKAJI: J2.798.393F,cpd:C16157,60,100,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C60H101O7N1P1,C60H99O7N1P1,977.7237416,978.7315666,976.71591651885,2086,cpd:C16698,N-Acetylmuramic acid 6-phosphate;,C11H20NO11P,N-Acetylmuramic acid 6-phosphate; N-Acetylmuramate 6-phosphate; MurNAc 6-phosphate,R08555 R08559,Amino sugar and nucleotide sugar metabolism; Metabolic pathways; Phosphotransferase system (PTS),2.7.1.192; 4.2.1.126,NA,NA,PubChem: 51091020; ChEBI: 47968; NIKKAJI: J2.224.719K,cpd:C16698; cpd:C19770; cpd:C21027,11,20,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H21O11N1P1,C11H19O11N1P1,373.0773975,374.0852225,372.06957241886,2087,cpd:C17326,"CDP-4-dehydro-3,6-dideoxy-D-glucose epimer",C15H23N3O14P2,"CDP-4-dehydro-3,6-dideoxy-D-glucose epimer",R08708 R08709 R08710,Amino sugar and nucleotide sugar metabolism,1.1.1.-; 5.1.3.-,NA,NA,PubChem: 96023690; ChEBI: 81010; NIKKAJI: J2.806.268K,cpd:C04297; cpd:C17326,15,23,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H24O14N3P2,C15H22O14N3P2,531.0655264,532.0733515,530.05770141887,2088,cpd:C17327,CDP-ascarylose,C15H25N3O14P2,CDP-ascarylose,R08709 R08710,Amino sugar and nucleotide sugar metabolism,1.1.1.-,NA,NA,PubChem: 96023691; ChEBI: 81011; NIKKAJI: J653.506B,cpd:C01788; cpd:C03598; cpd:C03599; cpd:C17327,15,25,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O14N3P2,C15H24O14N3P2,533.0811765,534.0890015,532.07335151888,2089,cpd:C17328,UDP-4-keto-rhamnose,C15H22N2O16P2,UDP-4-keto-rhamnose,R08704 R08705,Amino sugar and nucleotide sugar metabolism,1.1.1.-; 5.1.3.-,NA,NA,PubChem: 96023692; ChEBI: 81012; NIKKAJI: J2.806.269I,cpd:C04089; cpd:C17328,15,22,16,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O16N2P2,C15H21O16N2P2,548.0444566,549.0522817,547.03663161889,2090,cpd:C18094,UDP-L-arabinofuranose;,C14H22N2O16P2,UDP-L-arabinofuranose; UDP-beta-L-arabinofuranose,R03078 R09009,Amino sugar and nucleotide sugar metabolism,5.4.99.9; 5.4.99.30,NA,NA,PubChem: 96024311; ChEBI: 81497; ChEMBL: CHEMBL518773; NIKKAJI: J2.542.334H,cpd:C00190; cpd:C00935; cpd:C01623; cpd:C18094,14,22,16,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H23O16N2P2,C14H21O16N2P2,536.0444566,537.0522817,535.03663161890,2091,cpd:C19725,"UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronate;",C19H28N4O18P2,"UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronate; UDP-alpha-D-GlcNAc3NAcA; UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronic acid",R09600 R10100 R11224,Amino sugar and nucleotide sugar metabolism,2.3.1.201; 2.4.1.335; 5.1.3.23,NA,NA,PubChem: 135626192,cpd:C19725; cpd:C19745,19,28,18,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O18N4P2,C19H27O18N4P2,662.0873841,663.0952091,661.0795591891,2092,cpd:C19745,"UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronate;",C19H28N4O18P2,"UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronate; UDP-alpha-D-ManNAc3NAcA; UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronic acid",R09600,Amino sugar and nucleotide sugar metabolism,5.1.3.23,NA,NA,PubChem: 135626212,cpd:C19725; cpd:C19745,19,28,18,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H29O18N4P2,C19H27O18N4P2,662.0873841,663.0952091,661.0795591892,2093,cpd:C19823,"UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hexos-4-ulose;",C17H25N3O16P2,"UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hexos-4-ulose; UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose",R09697 R09825 R10665,Amino sugar and nucleotide sugar metabolism,1.1.1.367; 2.6.1.92; 4.2.1.115,NA,NA,PubChem: 135626290,cpd:C04613; cpd:C19823,17,25,16,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H26O16N3P2,C17H24O16N3P2,589.0710057,590.0788308,588.06318071893,2094,cpd:C19961,"UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine;",C17H28N4O15P2,"UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine; UDP-4-amino-4,6-dideoxy-beta-L-AltNAc; UDP-2-acetamido-4-amino-2,4,6-trideoxy-beta-L-altrose",R09825 R09842,Amino sugar and nucleotide sugar metabolism,2.3.1.202; 2.6.1.92,NA,NA,PubChem: 135626427,cpd:C04630; cpd:C19961,17,28,15,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H29O15N4P2,C17H27O15N4P2,590.1026402,591.1104652,589.09481521894,2095,cpd:C19971,"UDP-2,4-bis(acetamido)-2,4,6-trideoxy-beta-L-altropyranose;",C19H30N4O16P2,"UDP-2,4-bis(acetamido)-2,4,6-trideoxy-beta-L-altropyranose; UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altrose",R09834 R09842,Amino sugar and nucleotide sugar metabolism,2.3.1.202; 3.6.1.57,NA,NA,PubChem: 135626437,cpd:C19971; cpd:C20357,19,30,16,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H31O16N4P2,C19H29O16N4P2,632.1132049,633.1210299,631.10537991895,2096,cpd:C19972,"2,4-Bis(acetamido)-2,4,6-trideoxy-beta-L-altropyranose",C10H18N2O5,"2,4-Bis(acetamido)-2,4,6-trideoxy-beta-L-altropyranose",R09834 R09841,Amino sugar and nucleotide sugar metabolism,2.5.1.97; 3.6.1.57,NA,NA,PubChem: 135626438; ChEBI: 63283,cpd:C19972; cpd:C20424,10,18,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O5N2,C10H17O5N2,246.1215717,247.1293967,245.11374671896,2097,cpd:C20082,Pseudaminic acid;,C13H22N2O8,"Pseudaminic acid; 5,7-Bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid",R09841 R09843,Amino sugar and nucleotide sugar metabolism,2.5.1.97; 2.7.7.81,NA,NA,PubChem: 135626542,cpd:C20082; cpd:C20418,13,22,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H23O8N2,C13H21O8N2,334.1376157,335.1454407,333.12979061897,2098,cpd:C20083,CMP-pseudaminic acid,C22H34N5O15P,CMP-pseudaminic acid,R09843,Amino sugar and nucleotide sugar metabolism,2.7.7.81,NA,NA,PubChem: 135626543,cpd:C20083; cpd:C20419,22,34,15,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H35O15N5P1,C22H33O15N5P1,639.1789024,640.1867274,638.17107741898,2099,cpd:C20357,"UDP-N,N'-Diacetylbacillosamine;",C19H30N4O16P2,"UDP-N,N'-Diacetylbacillosamine; UDP-2,4-Diacetamido-2,4,6-trideoxy-alpha-D-glucopyranose",R10099 R10184 R10187,Amino sugar and nucleotide sugar metabolism,2.3.1.203; 2.7.8.36; 3.2.1.184,NA,NA,PubChem: 163312095; ChEBI: 67178,cpd:C19971; cpd:C20357,19,30,16,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H31O16N4P2,C19H29O16N4P2,632.1132049,633.1210299,631.10537991899,2100,cpd:C20359,"UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronate",C17H26N4O17P2,"UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronate",R10100 R10141,Amino sugar and nucleotide sugar metabolism,2.3.1.201; 2.6.1.98,NA,NA,PubChem: 163312097; PDB-CCD: MJZ,cpd:C20359,17,26,17,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H27O17N4P2,C17H25O17N4P2,620.0768194,621.0846444,619.06899441900,2101,cpd:C20395,UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate;,C17H23N3O18P2,UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate; UDP-3-keto-GlcNAcA,R10140 R10141,Amino sugar and nucleotide sugar metabolism,1.1.1.335; 2.6.1.98,NA,NA,PubChem: 163312133,cpd:C20395,17,23,18,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H24O18N3P2,C17H22O18N3P2,619.0451849,620.0530099,618.03735991901,2102,cpd:C20418,"N,N'-Diacetyllegionaminate",C13H22N2O8,"N,N'-Diacetyllegionaminate",R10182 R10304,Amino sugar and nucleotide sugar metabolism,2.5.1.101; 2.7.7.82,NA,NA,PubChem: 163312155,cpd:C20082; cpd:C20418,13,22,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H23O8N2,C13H21O8N2,334.1376157,335.1454407,333.12979061902,2103,cpd:C20419,"CMP-N,N'-diacetyllegionaminate",C22H34N5O15P,"CMP-N,N'-diacetyllegionaminate",R10182,Amino sugar and nucleotide sugar metabolism,2.7.7.82,NA,NA,PubChem: 163312156,cpd:C20083; cpd:C20419,22,34,15,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H35O15N5P1,C22H33O15N5P1,639.1789024,640.1867274,638.17107741903,2104,cpd:C20424,"2,4-Diacetamido-2,4,6-trideoxy-D-mannopyranose;",C10H18N2O5,"2,4-Diacetamido-2,4,6-trideoxy-D-mannopyranose; 2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",R10187 R10304,Amino sugar and nucleotide sugar metabolism,2.5.1.101; 3.2.1.184,NA,NA,PubChem: 163312161,cpd:C19972; cpd:C20424,10,18,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O5N2,C10H17O5N2,246.1215717,247.1293967,245.11374671904,2105,cpd:C20638,"GDP-4-amino-4,6-dideoxy-alpha-D-mannose;",C16H26N6O14P2,"GDP-4-amino-4,6-dideoxy-alpha-D-mannose; GDP-alpha-D-perosamine",R10460 R10514,Amino sugar and nucleotide sugar metabolism,2.3.1.227; 2.6.1.102,NA,NA,PubChem: 172232362; PDB-CCD: JB2,cpd:C20638,16,26,14,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O14N6P2,C16H25O14N6P2,588.0982235,589.1060486,587.09039851905,2106,cpd:C20672,"GDP-4-acetamido-4,6-dideoxy-alpha-D-mannose;",C18H28N6O15P2,"GDP-4-acetamido-4,6-dideoxy-alpha-D-mannose; GDP-N-acetyl-alpha-D-perosamine",R10514,Amino sugar and nucleotide sugar metabolism,2.3.1.227,NA,NA,PubChem: 172232392; PDB-CCD: JB3,cpd:C20672,18,28,15,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H29O15N6P2,C18H27O15N6P2,630.1087882,631.1166133,629.10096321906,2107,cpd:C21027,N-Acetylmuramic acid alpha-1-phosphate;,C11H20NO11P,N-Acetylmuramic acid alpha-1-phosphate; N-Acetylmuramate alpha-1-phosphate; MurNAc alpha-1-phosphate; N-Acetyl-alpha-D-muramate 1-phosphate,R11024 R11025,Amino sugar and nucleotide sugar metabolism; Metabolic pathways,2.7.1.-; 2.7.7.-,NA,NA,PubChem: 254816252; PDB-CCD: 491,cpd:C16698; cpd:C19770; cpd:C21027,11,20,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H21O11N1P1,C11H19O11N1P1,373.0773975,374.0852225,372.06957241907,2108,cpd:C00413,Streptomycin,C21H39N7O12,Streptomycin,R02225 R02226 R02227 R02228,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.7.1.72; 2.7.1.87; 2.7.7.47; 3.1.3.39,NA,"Compounds with biological roles [BR:br08001];  Antibiotics;   Aminoglycosides;    Streptidines;     C00413  Streptomycin; Pesticides [BR:br08007];  Pesticides;   Fungicides;    Antibiotic fungicides;     C00413  Streptomycin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;    A07A INTESTINAL ANTIINFECTIVES;     A07AA Antibiotics;      A07AA04 Streptomycin;       D08531  Streptomycin (INN);  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01G AMINOGLYCOSIDE ANTIBACTERIALS;     J01GA Streptomycins;      J01GA01 Streptomycin;       D08531  Streptomycin (INN); USP drug classification [BR:br08302];  Antibacterials;   Aminoglycosides;    Streptomycin;     D08531  Streptomycin (INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Aminoglycosides;      Streptomycin;       D08531  Streptomycin (INN)",CAS: 57-92-1; PubChem: 3703; ChEBI: 17076; ChEMBL: CHEMBL63266; PDB-CCD: SRY; 3DMET: B01239; NIKKAJI: J4.500D,cpd:C00413,21,39,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H40O12N7,C21H38O12N7,581.2656697,582.2734948,580.25784471908,2109,cpd:C00688,dTDP-4-dehydro-beta-L-rhamnose;,C16H24N2O15P2,dTDP-4-dehydro-beta-L-rhamnose; dTDP-4-dehydro-6-deoxy-beta-L-mannose; dTDP-4-oxo-6-deoxy-L-mannose; dTDP-4-oxo-L-rhamnose,R02776 R02777 R06445 R06514 R10190,Streptomycin biosynthesis; Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.133; 1.1.1.134; 1.1.1.339; 1.1.1.344; 5.1.3.13,dTDP-L-rhamnose biosynthesis,NA,PubChem: 3957; ChEBI: 15744 45868; PDB-CCD: TDO; 3DMET: B04717; NIKKAJI: J1.118.397B,cpd:C00688; cpd:C11907; cpd:C11908; cpd:C11926; cpd:C19960; cpd:C21362,16,24,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O15N2P2,C16H23O15N2P2,546.0651921,547.0730171,545.0573671909,2110,cpd:C00691,"2,4,6/3,5-Pentahydroxycyclohexanone;",C6H10O6,"2,4,6/3,5-Pentahydroxycyclohexanone; scyllo-Inosose; 2-Inosose",R01183 R02781 R02782 R05659 R09952 R09953 R09954,Streptomycin biosynthesis; Inositol phosphate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Biosynthesis of antibiotics,1.1.1.18; 1.1.1.370; 1.1.1.371; 2.6.1.50; 4.2.1.44; 5.3.99.11,NA,NA,CAS: 488-64-2; PubChem: 3959; ChEBI: 17811; PDB-CCD: ISE; 3DMET: B01313; NIKKAJI: J431.500F,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.0399131910,2111,cpd:C00842,dTDP-glucose;,C16H26N2O16P2,dTDP-glucose; dTDP-D-glucose; dTDP-alpha-D-glucose,R02328 R02983 R02984 R06513 R11471,Streptomycin biosynthesis; Polyketide sugar unit biosynthesis; Acarbose and validamycin biosynthesis; Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,1.1.1.-; 2.7.7.24; 4.2.1.46; 5.1.3.2,dTDP-L-rhamnose biosynthesis,NA,CAS: 2196-62-5; PubChem: 4099; ChEBI: 15700; ChEMBL: CHEMBL412989; KNApSAcK: C00007456; PDB-CCD: DAU; 3DMET: B04735; NIKKAJI: J631.152K,cpd:C00842; cpd:C02097,16,26,16,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O16N2P2,C16H25O16N2P2,564.0757568,565.0835818,563.06793171911,2112,cpd:C01121,Streptidine 6-phosphate,C8H19N6O7P,Streptidine 6-phosphate,R04222 R05547,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.4.2.27,NA,NA,PubChem: 4352; ChEBI: 17913; 3DMET: B01387; NIKKAJI: J2.731.597F,cpd:C01121,8,19,7,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H20O7N6P1,C8H18O7N6P1,342.105284,343.113109,341.09745891912,2113,cpd:C01138,Streptomycin 6-phosphate,C21H40N7O15P,Streptomycin 6-phosphate,R02225 R02228 R05515,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.7.1.72; 3.1.3.39,NA,NA,PubChem: 4369; ChEBI: 16479; 3DMET: B01390; NIKKAJI: J541.201C,cpd:C01138; cpd:C03731,21,40,15,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H41O15N7P1,C21H39O15N7P1,661.2320006,662.2398256,660.22417561913,2114,cpd:C01214,1-Amino-1-deoxy-scyllo-inositol;,C6H13NO5,1-Amino-1-deoxy-scyllo-inositol; scyllo-Inosamine,R02781 R03384,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.6.1.50; 2.7.1.65,NA,NA,PubChem: 4436; ChEBI: 16181; 3DMET: B01408; NIKKAJI: J783.484E,cpd:C00329; cpd:C01214; cpd:C02262; cpd:C03570; cpd:C06763; cpd:C08349; cpd:C12212; cpd:C17578; cpd:C21035; cpd:C21038; cpd:C21048; cpd:C21051; cpd:C21060,6,13,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O5N1,C6H12O5N1,179.0793725,180.0871976,178.07154751914,2115,cpd:C01221,Dihydrostreptomycin 6-phosphate,C21H42N7O15P,Dihydrostreptomycin 6-phosphate,R03395 R05515 R06365,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.7.1.88,NA,NA,CAS: 33014-54-9; PubChem: 4443; ChEBI: 16505; 3DMET: B01412; NIKKAJI: J2.442.993H,cpd:C01221; cpd:C04191; cpd:C04382,21,42,15,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H43O15N7P1,C21H41O15N7P1,663.2476507,664.2554757,662.23982561915,2116,cpd:C01283,1-Amino-1-deoxy-scyllo-inositol 4-phosphate;,C6H14NO8P,1-Amino-1-deoxy-scyllo-inositol 4-phosphate; scyllo-Inosamine 4-phosphate,R03384 R03477,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.1.4.2; 2.7.1.65,NA,NA,PubChem: 4502; ChEBI: 17928; 3DMET: B01432; NIKKAJI: J995.833I,cpd:C00352; cpd:C01283; cpd:C03783; cpd:C06156; cpd:C06377; cpd:C12213; cpd:C12214,6,14,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O8N1P1,C6H13O8N1P1,259.0457034,260.0535284,258.03787841916,2117,cpd:C01294,1-Guanidino-1-deoxy-scyllo-inositol 4-phosphate;,C7H16N3O8P,1-Guanidino-1-deoxy-scyllo-inositol 4-phosphate; N-Amidino-scyllo-inosamine 4-phosphate,R03477 R03496,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.1.4.2; 3.1.3.40,NA,NA,PubChem: 4513; ChEBI: 16143; 3DMET: B01435; NIKKAJI: J995.834G,cpd:C01294,7,16,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H17O8N3P1,C7H15O8N3P1,301.0675015,302.0753265,300.05967651917,2118,cpd:C01298,"1D-1-Guanidino-3-amino-1,3-dideoxy-scyllo-inositol;",C7H16N4O4,"1D-1-Guanidino-3-amino-1,3-dideoxy-scyllo-inositol; Amidinostreptamine",R03502 R08844,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.6.1.56; 2.7.1.-,NA,NA,PubChem: 4516; ChEBI: 17156; NIKKAJI: J2.732.423A,cpd:C01298,7,16,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H17O4N4,C7H15O4N4,220.117155,221.12498,219.109331918,2119,cpd:C03319,dTDP-L-rhamnose;,C16H26N2O15P2,dTDP-L-rhamnose; dTDP-6-deoxy-L-mannose; dTDP-6-deoxy-beta-L-mannose; dTDP-beta-L-rhamnose,R02777 R05516 R08857 R08935 R10175 R10279 R10955 R11469,Streptomycin biosynthesis; Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.133; 1.1.1.-; 2.1.1.-; 2.4.1.289; 2.4.1.331; 2.4.1.-; 5.1.3.25,dTDP-L-rhamnose biosynthesis,NA,PubChem: 6171; ChEBI: 15774; PDB-CCD: TRH; 3DMET: B04888; NIKKAJI: J818.234E,cpd:C03187; cpd:C03319; cpd:C03442; cpd:C07277; cpd:C11912; cpd:C20682,16,26,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O15N2P2,C16H25O15N2P2,548.0808421,549.0886672,547.07301711919,2120,cpd:C03442,dTDP-L-dihydrostreptose,C16H26N2O15P2,dTDP-L-dihydrostreptose,R04222 R05516,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.4.2.27,NA,NA,PubChem: 6266; ChEBI: 16081; 3DMET: B01660; NIKKAJI: J2.742.584D,cpd:C03187; cpd:C03319; cpd:C03442; cpd:C07277; cpd:C11912; cpd:C20682,16,26,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O15N2P2,C16H25O15N2P2,548.0808421,549.0886672,547.07301711920,2121,cpd:C04006,1D-myo-Inositol 3-phosphate;,C6H13O9P,1D-myo-Inositol 3-phosphate; D-myo-Inositol 3-phosphate; myo-Inositol 3-phosphate; Inositol 3-phosphate; 1D-myo-Inositol 3-monophosphate; D-myo-Inositol 3-monophosphate; myo-Inositol 3-monophosphate; Inositol 3-monophosphate; 1L-myo-Inositol 1-phosphate; L-myo-Inositol 1-phosphate,R01187 R04372 R07279 R07324 R09634 R09669 R09670 R10464,Streptomycin biosynthesis; Inositol phosphate metabolism; Metabolic pathways; Biosynthesis of antibiotics; Phosphatidylinositol signaling system,2.4.1.250; 2.7.1.64; 2.7.7.74; 2.7.8.34; 2.7.8.39; 3.1.3.25; 3.1.3.66; 5.5.1.4,"Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol",NA,PubChem: 6716; ChEBI: 18169; PDB-CCD: LIP; 3DMET: B01710; NIKKAJI: J373.685G,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.0218941921,2122,cpd:C04280,1-Guanidino-1-deoxy-scyllo-inositol;,C7H15N3O5,1-Guanidino-1-deoxy-scyllo-inositol; Amidino-scyllo-inosamine,R03496 R08843,Streptomycin biosynthesis; Biosynthesis of antibiotics,3.1.3.40,NA,NA,PubChem: 6942; ChEBI: 17110; NIKKAJI: J2.749.618K,cpd:C04280,7,15,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O5N3,C7H14O5N3,221.1011706,222.1089956,220.09334561922,2123,cpd:C04673,1D-1-Guanidino-1-deoxy-3-dehydro-scyllo-inositol;,C7H13N3O5,1D-1-Guanidino-1-deoxy-3-dehydro-scyllo-inositol; Amidino-3-keto-scyllo-inosamine,R03502 R08843,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.6.1.56,NA,NA,PubChem: 7254; ChEBI: 17845; NIKKAJI: J2.752.845G,cpd:C04673,7,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O5N3,C7H12O5N3,219.0855205,220.0933456,218.07769551923,2124,cpd:C04767,O-(1->4)-alpha-L-Dihydrostreptosyl-streptidine 6-phosphate;,C14H29N6O11P,O-(1->4)-alpha-L-Dihydrostreptosyl-streptidine 6-phosphate; alpha-L-Dihydrostreptosyl-(1->4)-streptidine 6-phosphate,R04222 R06365,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.4.2.27,NA,NA,PubChem: 7334; ChEBI: 17265; 3DMET: B01786; NIKKAJI: J2.753.589E,cpd:C04767,14,29,11,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H30O11N6P1,C14H28O11N6P1,488.1631928,489.1710178,487.15536771924,2126,cpd:C11351,N1-Amidinostreptamine 6-phosphate;,C7H17N4O7P,"N1-Amidinostreptamine 6-phosphate; 1D-1-Guanidino-3-amino-1,3-dideoxy-scyllo-inositol 6-phosphate",R05547 R08844,Streptomycin biosynthesis; Biosynthesis of antibiotics,2.7.1.-,NA,NA,PubChem: 13526; ChEBI: 28399; NIKKAJI: J2.754.651J,cpd:C04812; cpd:C11351,7,17,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H18O7N4P1,C7H16O7N4P1,300.0834859,301.0913109,299.07566091925,2127,cpd:C11907,dTDP-4-oxo-6-deoxy-D-glucose;,C16H24N2O15P2,"dTDP-4-oxo-6-deoxy-D-glucose; dTDP-4-dehydro-6-deoxy-D-glucose; dTDP-4-dehydro-6-deoxy-alpha-D-glucose; dTDP-4-dehydro-6-deoxy-alpha-D-glucopyranose; dTDP-4-oxo-6-deoxy-alpha-D-glucose; dTDP-4-dehydro-6-deoxy-alpha-D-galactose; dTDP-4-dehydro-6-deoxy-D-galactose; dTDP-6-deoxy-D-xylo-hexos-4-ulose; dTDP-6-deoxy-D-xylo-4-hexulose; 4,6-Dideoxy-4-oxo-dTDP-D-glucose",R02772 R02773 R04438 R05518 R05687 R06424 R06428 R06437; R06513 R06514 R08935 R09904,Streptomycin biosynthesis; Polyketide sugar unit biosynthesis; Acarbose and validamycin biosynthesis; Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,1.1.1.266; 1.1.1.-; 2.6.1.33; 2.6.1.59; 4.2.1.46; 4.2.1.159; 5.1.3.13; 5.1.3.27; 5.3.2.3; 5.3.2.4,dTDP-L-rhamnose biosynthesis; dTDP-6-deoxy-D-allose biosynthesis; dTDP-beta-L-noviose biosynthesis; dTDP-D-mycaminose biosynthesis; dTDP-D-desosamine biosynthesis; dTDP-L-mycarose biosynthesis; dTDP-L-oleandrose biosynthesis; dTDP-L-megosamine biosynthesis; dTDP-L-olivose biosynthesis; dTDP-D-forosamine biosynthesis; dTDP-D-angolosamine biosynthesis,NA,PubChem: 14069; ChEBI: 16128; PDB-CCD: T46; 3DMET: B05554; NIKKAJI: J870.166K,cpd:C00688; cpd:C11907; cpd:C11908; cpd:C11926; cpd:C19960; cpd:C21362,16,24,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O15N2P2,C16H23O15N2P2,546.0651921,547.0730171,545.0573671926,2128,cpd:C00744,Macrocin;,C45H75NO17,Macrocin; Tylosin C,R02858 R02859,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.1.1.101; 2.1.1.102,"Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C00744  Macrocin,CAS: 11049-15-3; PubChem: 4006; ChEBI: 17371; ChEMBL: CHEMBL263259; KNApSAcK: C00018716; PDB-CCD: 3ZP; 3DMET: B01321; NIKKAJI: J147.592D,cpd:C00744,45,75,17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C45H76O17N1,C45H74O17N1,901.5035,902.511325,900.49567491927,2129,cpd:C01033,2-Methylbutanoyl-CoA;,C26H44N7O17P3S,2-Methylbutanoyl-CoA; 2-Methylbutyryl-CoA,R03169 R03173 R06480 R06481,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.3.8.5; 1.3.99.12,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 4276; ChEBI: 15477; 3DMET: B04757; NIKKAJI: J1.204.889K,cpd:C00888; cpd:C01033; cpd:C02939; cpd:C15980,26,44,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H45O17N7P3S1,C26H43O17N7P3S1,851.1727252,852.1805502,850.16490011928,2130,cpd:C01457,Tylosin,C46H77NO17,Tylosin,R02858,"Biosynthesis of 12-, 14- and 16-membered macrolides; Type I polyketide structures; Biosynthesis of antibiotics",2.1.1.101,"Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin",Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Macrolides;     C01457  Tylosin; Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C01457  Tylosin; Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    50S subunit inhibitor;     Macrolides;      Tylosin; Veterinary;       D02490  Tylosin (USP/INN); Animal drugs in Japan [BR:br08331];  97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants);   976  Antibiotic preparations;    9762  Antibiotic preparations for peroral and feed additive use;     C01457  Tylosin,CAS: 1401-69-0; PubChem: 4634; ChEBI: 17658; ChEMBL: CHEMBL42743; LIPIDMAPS: LMPK04000004; PDB-CCD: TYK; 3DMET: B01453; NIKKAJI: J58.426F,cpd:C01457,46,77,17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H78O17N1,C46H76O17N1,915.51915,916.5269751,914.5113251929,2131,cpd:C01912,Erythromycin;,C37H67NO13,Erythromycin; Erythromycin A; Abomacetin,R05519 R05520 R05521,"Biosynthesis of 12-, 14- and 16-membered macrolides; Type I polyketide structures; Biosynthesis of antibiotics",1.14.13.154; 2.1.1.254,"Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B","Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Macrolides;     C01912  Erythromycin; Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C01912  Erythromycin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D10 ANTI-ACNE PREPARATIONS;    D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE;     D10AF Antiinfectives for treatment of acne;      D10AF02 Erythromycin;       D00140  Erythromycin (JP17/USP/INN);  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS;     J01FA Macrolides;      J01FA01 Erythromycin;       D00140  Erythromycin (JP17/USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA17 Erythromycin;       D00140  Erythromycin (JP17/USP/INN); USP drug classification [BR:br08302];  Antibacterials;   Macrolides;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  6  Agents against pathologic organisms and parasites;   61  Antibiotics;    614  Acting mainly on gram-positive bacteria and mycoplasma;     6141  Erythromycins;      D00140  Erythromycin (JP17/USP/INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    50S subunit inhibitor;     Macrolides;      Erythromycin;       D00140  Erythromycin (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C19;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN);   CYP3A4;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN);   CYP3A7;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN);   CYP3A;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN);  CYP substrates;   CYP3A4;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN);   CYP3A5;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN);   CYP3A7;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN);  Transporter inhibitors;   ABCB1;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN);   SLCO1B1;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN);  Transporter substrates;   ABCC2;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN);   OAT2;    Erythromycin;     D00140  Erythromycin (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00140  Erythromycin;   D00140  Erythromycin enteric-coated tablets; Antibacterials [br08350.html];  D00140",CAS: 114-07-8; PubChem: 5020; ChEBI: 42355; ChEMBL: CHEMBL532; LIPIDMAPS: LMPK04000006; PDB-CCD: ERY; 3DMET: B01517; NIKKAJI: J2.892D,cpd:C01912,37,67,13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H68O13N1,C37H66O13N1,733.4612412,734.4690663,732.45341621930,2132,cpd:C01946,Oleandomycin;,C35H61NO12,Oleandomycin; Amimycin; Landomycin; Matromycin; Romicil,R03780 R06457,"Biosynthesis of 12-, 14- and 16-membered macrolides; Type I polyketide structures; Biosynthesis of antibiotics; ABC transporters",2.7.1.136,"Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin","Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Macrolides;     C01946  Oleandomycin; Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C01946  Oleandomycin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS;     J01FA Macrolides;      J01FA05 Oleandomycin;       C01946  Oleandomycin; Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    50S subunit inhibitor;     Macrolides;      Oleandomycin;       C01946  Oleandomycin",CAS: 3922-90-5; PubChem: 5050; ChEBI: 16869; ChEMBL: CHEMBL606258; LIPIDMAPS: LMPK04000007; 3DMET: B01521; NIKKAJI: J10.660G,cpd:C01946,35,61,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H62O12N1,C35H60O12N1,687.4193764,688.4272014,686.41155141931,2133,cpd:C02400,Demethylmacrocin;,C44H73NO17,Demethylmacrocin; 2'''-O-Demethyllactenocin,R02859 R06452,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.1.1.102; 2.4.1.318,"Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin",NA,PubChem: 5434; ChEBI: 15906; KNApSAcK: C00018437; 3DMET: B01570; NIKKAJI: J138.421J,cpd:C02400,44,73,17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C44H74O17N1,C44H72O17N1,887.4878499,888.4956749,886.48002491932,2134,cpd:C02557,Methylmalonyl-CoA;,C25H40N7O19P3S,Methylmalonyl-CoA; Methylmalonyl coenzyme A; 2-Methylmalonyl-CoA,R05189 R05373 R06448 R06453 R06480 R06481 R06482 R06483; R11450 R11451,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.3.1.111; 2.3.1.252; 4.1.1.9,"Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin; Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin",NA,CAS: 1264-45-5; PubChem: 5558; ChEBI: 16625; PDB-CCD: MCA; 3DMET: B04856; NIKKAJI: J1.074.511J,cpd:C00091; cpd:C00683; cpd:C01213; cpd:C02557,25,40,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O19N7P3S1,C25H39O19N7P3S1,867.1312543,868.1390793,866.12342921933,2135,cpd:C03240,6-Deoxyerythronolide B,C21H38O6,6-Deoxyerythronolide B,R00918 R05270,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.13.188; 2.3.1.94,"Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C03240  6-Deoxyerythronolide B,CAS: 15797-36-1; PubChem: 6110; ChEBI: 16089; LIPIDMAPS: LMPK04000002; PDB-CCD: DEB; 3DMET: B01642; NIKKAJI: J96.988E,cpd:C03240,21,38,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H39O6,C21H37O6,386.2668389,387.274664,385.25901391934,2136,cpd:C06616,Erythromycin C,C36H65NO13,Erythromycin C,R05520 R05522 R06506,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.13.154; 2.1.1.254,"Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C06616  Erythromycin C,PubChem: 8842; ChEBI: 64258 64273; LIPIDMAPS: LMPK04000009; 3DMET: B05215; NIKKAJI: J15.156D,cpd:C06616,36,65,13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H66O13N1,C36H64O13N1,719.4455912,720.4534162,718.43776611935,2137,cpd:C06630,3-O-alpha-Mycarosylerythronolide B;,C28H50O10,"3-O-alpha-Mycarosylerythronolide B; 3-alpha-L-Mycarosylerythronolide B; 4-(4,5-Dihydroxy-4,6-dimethyl-tetrahydro-pyran-2-yloxy)-14-ethyl-6,7,12-trihydroxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",R05530 R05531,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.4.1.278; 2.4.1.328,"Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B",NA,CAS: 34698-88-9; PubChem: 8856; ChEBI: 28343; 3DMET: B02078; NIKKAJI: J941.080E,cpd:C06630,28,50,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H51O10,C28H49O10,546.3403978,547.3482228,545.33257281936,2138,cpd:C06633,Erythromycin D,C36H65NO12,Erythromycin D,R05522 R05531 R05532,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.13.154; 2.1.1.254; 2.4.1.278,"Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C06633  Erythromycin D,PubChem: 8859; ChEBI: 28331; LIPIDMAPS: LMPK04000010; PDB-CCD: EY5; 3DMET: B05218; NIKKAJI: J318B,cpd:C06633,36,65,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H66O12N1,C36H64O12N1,703.4506765,704.4585016,702.44285151937,2139,cpd:C06634,Erythromycin E,C37H65NO14,Erythromycin E,R05519,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C06634  Erythromycin E,PubChem: 8860; ChEBI: 28239; LIPIDMAPS: LMPK04000011; 3DMET: B05219; NIKKAJI: J328J,cpd:C06634,37,65,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H66O14N1,C37H64O14N1,747.4405058,748.4483308,746.43268071938,2140,cpd:C06635,Erythronolide B,C21H38O7,Erythronolide B,R05270 R05530,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.13.188; 2.4.1.328,"Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B",NA,CAS: 3225-82-9; PubChem: 8861; ChEBI: 27977; 3DMET: B02079; NIKKAJI: J14.506H,cpd:C06635,21,38,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H39O7,C21H37O7,402.2617536,403.2695786,401.25392851939,2141,cpd:C06653,Erythromycin B;,C37H67NO12,Erythromycin B; Berythromycin,R05521 R05532,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.13.154; 2.1.1.254,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C06653  Erythromycin B,PubChem: 8878; ChEBI: 28196; ChEMBL: CHEMBL320272; LIPIDMAPS: LMPK04000012; PDB-CCD: ERB; 3DMET: B05220; NIKKAJI: J69H,cpd:C06653,37,67,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H68O12N1,C37H66O12N1,717.4663266,718.4741516,716.45850161940,2142,cpd:C11911,dTDP-D-desosamine;,C18H31N3O13P2,"dTDP-D-desosamine; dTDP-3-dimethylamino-3,4,6-trideoxy-D-glucose; dTDP-alpha-D-desosamine; dTDP-3-dimethylamino-3,4,6-trideoxy-alpha-D-glucose; dTDP-3-dimethylamino-3,4,6-trideoxy-alpha-D-glucopyranose",R05531 R06427 R06457 R06460 R06461 R10876,"Biosynthesis of 12-, 14- and 16-membered macrolides; Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics",2.1.1.234; 2.4.1.277; 2.4.1.278; 2.4.1.-,dTDP-D-desosamine biosynthesis,NA,PubChem: 14073; ChEBI: 27948; 3DMET: B05558; NIKKAJI: J1.336.798A,cpd:C11911; cpd:C11919; cpd:C18031; cpd:C18643; cpd:C20765; cpd:C21356,18,31,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H32O13N3P2,C18H30O13N3P2,559.1332121,560.1410371,558.1253871941,2143,cpd:C11912,dTDP-6-deoxy-D-allose;,C16H26N2O15P2,dTDP-6-deoxy-D-allose; dTDP-6-deoxy-alpha-D-allose,R06438 R06451 R10573 R10874,"Biosynthesis of 12-, 14- and 16-membered macrolides; Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics",1.1.1.364; 2.4.1.317; 2.4.1.-,dTDP-6-deoxy-D-allose biosynthesis,NA,PubChem: 14074; ChEBI: 29726; 3DMET: B05559; NIKKAJI: J2.777.756B,cpd:C03187; cpd:C03319; cpd:C03442; cpd:C07277; cpd:C11912; cpd:C20682,16,26,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O15N2P2,C16H25O15N2P2,548.0808421,549.0886672,547.07301711942,2144,cpd:C11916,dTDP-L-mycarose;,C17H28N2O14P2,"dTDP-L-mycarose; dTDP-beta-L-mycarose; dTDP-2,6-dideoxy-3-C-methyl-beta-L-ribo-hexose",R05530 R06436 R06452,"Biosynthesis of 12-, 14- and 16-membered macrolides; Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics",1.1.1.-; 2.4.1.318; 2.4.1.328,dTDP-L-mycarose biosynthesis,NA,PubChem: 14077; ChEBI: 10525 27801; 3DMET: B05561; NIKKAJI: J2.287.506J,cpd:C11916; cpd:C11921; cpd:C12444,17,28,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H29O14N2P2,C17H27O14N2P2,546.1015776,547.1094026,545.09375251943,2145,cpd:C11920,dTDP-L-olivose,C16H26N2O14P2,dTDP-L-olivose,R06434 R06455,"Biosynthesis of 12-, 14- and 16-membered macrolides; Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics",NA,dTDP-L-olivose biosynthesis,NA,PubChem: 14081; ChEBI: 29733; 3DMET: B05563; NIKKAJI: J1.620.255J,cpd:C11920; cpd:C11923; cpd:C12446; cpd:C18636,16,26,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O14N2P2,C16H25O14N2P2,532.0859275,533.0937525,531.07810251944,2146,cpd:C11921,dTDP-L-oleandrose,C17H28N2O14P2,dTDP-L-oleandrose,R06484 R06485 R06486 R06487 R06488 R06489 R06490 R06491; R06492 R06493 R06494 R06495 R06496 R06497 R06498 R06499; R11042,"Biosynthesis of 12-, 14- and 16-membered macrolides; Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics",2.4.1.-,dTDP-L-oleandrose biosynthesis,NA,CAS: 130832-66-5; PubChem: 14082; ChEBI: 29732; 3DMET: B05564; NIKKAJI: J2.777.786D,cpd:C11916; cpd:C11921; cpd:C12444,17,28,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H29O14N2P2,C17H27O14N2P2,546.1015776,547.1094026,545.09375251945,2147,cpd:C11933,dTDP-D-mycaminose;,C18H31N3O14P2,dTDP-D-mycaminose; dTDP-alpha-D-mycaminose,R06439 R06450,"Biosynthesis of 12-, 14- and 16-membered macrolides; Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics",2.1.1.235; 2.4.1.316,dTDP-D-mycaminose biosynthesis,NA,PubChem: 14094; ChEBI: 29728; PDB-CCD: QDM; 3DMET: B05576; NIKKAJI: J2.648.613K,cpd:C11933; cpd:C19948; cpd:C20766,18,31,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H32O14N3P2,C18H30O14N3P2,575.1281267,576.1359517,574.12030171946,2148,cpd:C11953,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''2b'' aglycone",C33H48O8,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''2b'' aglycone",R06468 R06482,"Biosynthesis of 12-, 14- and 16-membered macrolides",1.14.-.-,NA,NA,PubChem: 14114; 3DMET: B04387; NIKKAJI: J2.778.506I,cpd:C11953,33,48,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H49O8,C33H47O8,572.3349185,573.3427435,571.32709351947,2149,cpd:C11954,5-Oxoavermectin ''2b'' aglycone,C33H46O9,5-Oxoavermectin ''2b'' aglycone,R06468 R06474,"Biosynthesis of 12-, 14- and 16-membered macrolides",1.14.-.-,NA,NA,PubChem: 14115; NIKKAJI: J2.778.550F,cpd:C11954,33,46,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H47O9,C33H45O9,586.3141831,587.3220081,585.3063581948,2150,cpd:C11955,Avermectin B2b aglycone,C33H48O9,Avermectin B2b aglycone,R06474 R06478 R06492,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.1.1.-; 2.4.1.-,NA,NA,PubChem: 14116; ChEBI: 29544; NIKKAJI: J2.778.581F,cpd:C11955,33,48,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H49O9,C33H47O9,588.3298331,589.3376582,587.32200811949,2151,cpd:C11956,Avermectin A2b aglycone,C34H50O9,Avermectin A2b aglycone,R06478 R06494,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.1.1.-; 2.4.1.-,NA,NA,PubChem: 14117; ChEBI: 29532; NIKKAJI: J2.778.582D,cpd:C08033; cpd:C08034; cpd:C11956; cpd:C11971,34,50,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H51O9,C34H49O9,602.3454832,603.3533082,601.33765821950,2152,cpd:C11957,Avermectin B2b monosaccharide,C40H60O12,Avermectin B2b monosaccharide,R06492 R06493,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.4.1.-,NA,NA,PubChem: 14118; ChEBI: 29545; ChEMBL: CHEMBL279011; NIKKAJI: J2.778.583B,cpd:C11957,40,60,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H61O12,C40H59O12,732.4084774,733.4163024,731.40065231951,2153,cpd:C11958,Avermectin A2b monosaccharide,C41H62O12,Avermectin A2b monosaccharide,R06494 R06495,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.4.1.-,NA,NA,PubChem: 14119; ChEBI: 29533; NIKKAJI: J2.778.597B,cpd:C11958; cpd:C11973,41,62,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H63O12,C41H61O12,746.4241274,747.4319525,745.41630241952,2154,cpd:C11959,Avermectin B2b,C47H72O15,Avermectin B2b,R06493,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11959  Avermectin B2b,CAS: 65195-58-6; PubChem: 14120; ChEBI: 29543; ChEMBL: CHEMBL277305; LIPIDMAPS: LMPK04000018; NIKKAJI: J91.852K,cpd:C11959,47,72,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C47H73O15,C47H71O15,876.4871216,877.4949466,875.47929661953,2155,cpd:C11960,Avermectin A2b,C48H74O15,Avermectin A2b,R06495,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11960  Avermectin A2b,CAS: 65195-54-2; PubChem: 14121; ChEBI: 29531; LIPIDMAPS: LMPK04000019; NIKKAJI: J91.851B,cpd:C11960; cpd:C11975,48,74,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C48H75O15,C48H73O15,890.5027717,891.5105967,889.49494661954,2156,cpd:C11961,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''1b'' aglycone",C33H46O7,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''1b'' aglycone",R06470 R06483,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.-.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14122; 3DMET: B04388; NIKKAJI: J2.778.598K,cpd:C11961,33,46,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H47O7,C33H45O7,554.3243538,555.3321789,553.31652881955,2157,cpd:C11962,5-Oxoavermectin ''1b'' aglycone,C33H44O8,5-Oxoavermectin ''1b'' aglycone,R06470 R06475,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.-.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14123; NIKKAJI: J2.778.602B,cpd:C11962,33,44,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H45O8,C33H43O8,568.3036184,569.3114434,567.29579331956,2158,cpd:C11963,Avermectin B1b aglycone,C33H46O8,Avermectin B1b aglycone,R06475 R06479 R06496,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.1.1.-; 2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14124; ChEBI: 29538; NIKKAJI: J2.778.604I,cpd:C11963,33,46,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H47O8,C33H45O8,570.3192684,571.3270935,569.31144341957,2159,cpd:C11964,Avermectin A1b aglycone,C34H48O8,Avermectin A1b aglycone,R06479 R06498,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.1.1.-; 2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14125; ChEBI: 29526; NIKKAJI: J2.778.605G,cpd:C09108; cpd:C11964; cpd:C11979,34,48,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H49O8,C34H47O8,584.3349185,585.3427435,583.32709351958,2160,cpd:C11965,Avermectin B1b monosaccharide,C40H58O11,Avermectin B1b monosaccharide,R06496 R06497,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14126; ChEBI: 29539; ChEMBL: CHEMBL14831; NIKKAJI: J2.778.606E,cpd:C11965,40,58,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H59O11,C40H57O11,714.3979127,715.4057377,713.39008771959,2161,cpd:C11966,Avermectin A1b monosaccharide,C41H60O11,Avermectin A1b monosaccharide,R06498 R06499,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14127; ChEBI: 29527; NIKKAJI: J2.778.607C,cpd:C11966; cpd:C11981,41,60,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H61O11,C41H59O11,728.4135627,729.4213878,727.40573771960,2162,cpd:C11967,Avermectin B1b,C47H70O14,Avermectin B1b,R06497,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11967  Avermectin B1b,CAS: 65195-56-4; PubChem: 14128; ChEBI: 29537; ChEMBL: CHEMBL14886 CHEMBL158998; LIPIDMAPS: LMPK04000020; NIKKAJI: J33.375A,cpd:C11967; cpd:C20012,47,70,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C47H71O14,C47H69O14,858.4765569,859.484382,857.46873191961,2163,cpd:C11968,Avermectin A1b;,C48H72O14,"Avermectin A1b; Avermectin A1a, 25-de(1-methylpropyl)-25-(1-methylethyl)-",R06499,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11968  Avermectin A1b,CAS: 65195-52-0; PubChem: 14129; ChEBI: 29525; LIPIDMAPS: LMPK04000021; NIKKAJI: J91.850D,cpd:C11968; cpd:C11983,48,72,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C48H73O14,C48H71O14,872.492207,873.500032,871.4843821962,2164,cpd:C11969,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''2a'' aglycone",C34H50O8,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''2a'' aglycone",R06465 R06480,"Biosynthesis of 12-, 14- and 16-membered macrolides",1.14.-.-,NA,NA,PubChem: 14130; 3DMET: B04389; NIKKAJI: J2.778.608A,cpd:C11969,34,50,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H51O8,C34H49O8,586.3505686,587.3583936,585.34274351963,2165,cpd:C11970,5-Oxoavermectin ''2a'' aglycone,C34H48O9,5-Oxoavermectin ''2a'' aglycone,R06465 R06472,"Biosynthesis of 12-, 14- and 16-membered macrolides",1.14.-.-,NA,NA,PubChem: 14131; 3DMET: B05588; NIKKAJI: J2.778.609J,cpd:C11970,34,48,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H49O9,C34H47O9,600.3298331,601.3376582,599.32200811964,2166,cpd:C11971,Avermectin B2a aglycone,C34H50O9,Avermectin B2a aglycone,R06472 R06476 R06484,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.1.1.-; 2.4.1.-,NA,NA,PubChem: 14132; ChEBI: 29541; 3DMET: B05589; NIKKAJI: J2.778.610C,cpd:C08033; cpd:C08034; cpd:C11956; cpd:C11971,34,50,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H51O9,C34H49O9,602.3454832,603.3533082,601.33765821965,2167,cpd:C11972,Avermectin A2a aglycone,C35H52O9,Avermectin A2a aglycone,R06476 R06486,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.1.1.-; 2.4.1.-,NA,NA,PubChem: 14133; ChEBI: 29529; 3DMET: B05590; NIKKAJI: J2.778.611A,cpd:C11972,35,52,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H53O9,C35H51O9,616.3611333,617.3689583,615.35330821966,2168,cpd:C11973,Avermectin B2a monosaccharide,C41H62O12,Avermectin B2a monosaccharide,R06484 R06485,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.4.1.-,NA,NA,PubChem: 14134; ChEBI: 29542; 3DMET: B05591; NIKKAJI: J2.778.612J,cpd:C11958; cpd:C11973,41,62,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H63O12,C41H61O12,746.4241274,747.4319525,745.41630241967,2169,cpd:C11974,Avermectin A2a monosaccharide,C42H64O12,Avermectin A2a monosaccharide,R06486 R06487,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.4.1.-,NA,NA,PubChem: 14135; ChEBI: 29530; 3DMET: B05592; NIKKAJI: J2.778.613H,cpd:C11974,42,64,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H65O12,C42H63O12,760.4397775,761.4476025,759.43195251968,2170,cpd:C11975,Avermectin B2a,C48H74O15,Avermectin B2a,R06485,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11975  Avermectin B2a,CAS: 65195-57-5; PubChem: 14136; ChEBI: 29540; ChEMBL: CHEMBL264975; LIPIDMAPS: LMPK04000022; KNApSAcK: C00016540; 3DMET: B05593; NIKKAJI: J33.376J,cpd:C11960; cpd:C11975,48,74,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C48H75O15,C48H73O15,890.5027717,891.5105967,889.49494661969,2171,cpd:C11976,Avermectin A2a;,C49H76O15,"Avermectin A2a; Avermectin A1a, 22,23-dihydro-23-hydroxy-, (23S)-",R06487,"Biosynthesis of 12-, 14- and 16-membered macrolides",2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11976  Avermectin A2a,CAS: 65195-53-1; PubChem: 14137; ChEBI: 29528; ChEMBL: CHEMBL429339; LIPIDMAPS: LMPK04000023; 3DMET: B05594; NIKKAJI: J33.373E,cpd:C11976,49,76,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C49H77O15,C49H75O15,904.5184217,905.5262468,903.51059671970,2172,cpd:C11977,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''1a'' aglycone",C34H48O7,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''1a'' aglycone",R06467 R06481,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.-.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14138; 3DMET: B04390; NIKKAJI: J2.778.614F,cpd:C11977,34,48,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H49O7,C34H47O7,568.3400039,569.3478289,567.33217891971,2173,cpd:C11978,5-Oxoavermectin ''1a'' aglycone,C34H46O8,5-Oxoavermectin ''1a'' aglycone,R06467 R06473,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.-.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14139; 3DMET: B05595; NIKKAJI: J2.778.773H,cpd:C11978,34,46,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H47O8,C34H45O8,582.3192684,583.3270935,581.31144341972,2174,cpd:C11979,Avermectin B1a aglycone,C34H48O8,Avermectin B1a aglycone,R06473 R06477 R06488,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.1.1.-; 2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14140; ChEBI: 29535; 3DMET: B05596; NIKKAJI: J2.778.789D,cpd:C09108; cpd:C11964; cpd:C11979,34,48,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H49O8,C34H47O8,584.3349185,585.3427435,583.32709351973,2175,cpd:C11980,Avermectin A1a aglycone,C35H50O8,Avermectin A1a aglycone,R06477 R06490,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.1.1.-; 2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14141; ChEBI: 29523; 3DMET: B05597; NIKKAJI: J2.778.802E,cpd:C11980,35,50,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H51O8,C35H49O8,598.3505686,599.3583936,597.34274351974,2176,cpd:C11981,Avermectin B1a monosaccharide,C41H60O11,Avermectin B1a monosaccharide,R06488 R06489,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14142; ChEBI: 29536; ChEMBL: CHEMBL314293; 3DMET: B05598; NIKKAJI: J419.687B,cpd:C11966; cpd:C11981,41,60,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H61O11,C41H59O11,728.4135627,729.4213878,727.40573771975,2177,cpd:C11982,Avermectin A1a monosaccharide,C42H62O11,Avermectin A1a monosaccharide,R06490 R06491,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",NA,PubChem: 14143; ChEBI: 29524; 3DMET: B05599; NIKKAJI: J2.778.829G,cpd:C11982,42,62,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H63O11,C42H61O11,742.4292128,743.4370378,741.42138781976,2178,cpd:C11983,Avermectin B1a,C48H72O14,Avermectin B1a,R06489,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11983  Avermectin B1a,CAS: 65195-55-3; PubChem: 14144; ChEBI: 29534; ChEMBL: CHEMBL1630577 CHEMBL80025; LIPIDMAPS: LMPK04000024; 3DMET: B05600; NIKKAJI: J33.374C,cpd:C11968; cpd:C11983,48,72,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C48H73O14,C48H71O14,872.492207,873.500032,871.4843821977,2179,cpd:C11984,Avermectin A1a,C49H74O14,Avermectin A1a,R06491,"Biosynthesis of 12-, 14- and 16-membered macrolides; Type I polyketide structures; Biosynthesis of antibiotics",2.4.1.-,"Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11984  Avermectin A1a,CAS: 65195-51-9; PubChem: 14145; ChEBI: 29522; ChEMBL: CHEMBL267790; LIPIDMAPS: LMPK04000025; 3DMET: B05601; NIKKAJI: J91.849K,cpd:C11984,49,74,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C49H75O14,C49H73O14,886.5078571,887.5156821,885.5000321978,2180,cpd:C11985,Megalomicin A,C44H80N2O15,Megalomicin A,R06503 R06504 R06505 R06506,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11985  Megalomicin A,CAS: 28022-11-9; PubChem: 14146; ChEBI: 29624; LIPIDMAPS: LMPK04000026; 3DMET: B04391; NIKKAJI: J19.399B,cpd:C11985,44,80,15,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C44H81O15N2,C44H79O15N2,876.5558699,877.5636949,875.54804481979,2181,cpd:C11986,Megalomicin B;,C46H82N2O16,Megalomicin B; 4'-Acetylmegalomycin A,R06503,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11986  Megalomicin B,CAS: 49669-75-2; PubChem: 14147; ChEBI: 29625; LIPIDMAPS: LMPK04000027; 3DMET: B04392; NIKKAJI: J78.367F,cpd:C11986,46,82,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H83O16N2,C46H81O16N2,918.5664346,919.5742596,917.55860951980,2182,cpd:C11987,Megalomicin C1,C48H84N2O17,Megalomicin C1,R06504,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11987  Megalomicin C1,CAS: 49669-76-3; PubChem: 14148; ChEBI: 29626; LIPIDMAPS: LMPK04000028; 3DMET: B04393,cpd:C11987,48,84,17,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C48H85O17N2,C48H83O17N2,960.5769992,961.5848243,959.56917421981,2183,cpd:C11988,Megalomicin C2,C49H86N2O17,Megalomicin C2,R06505,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11988  Megalomicin C2,CAS: 49669-77-4; PubChem: 14149; ChEBI: 29627; LIPIDMAPS: LMPK04000029; 3DMET: B04394,cpd:C11988,49,86,17,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C49H87O17N2,C49H85O17N2,974.5926493,975.6004743,973.58482431982,2184,cpd:C11989,"8,8a-Deoxyoleandolide",C20H36O6,"8,8a-Deoxyoleandolide",R06453 R06454,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",NA,"Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin","Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11989  8,8a-Deoxyoleandolide",CAS: 53428-54-9; PubChem: 14150; ChEBI: 29504; LIPIDMAPS: LMPK04000030; 3DMET: B04395; NIKKAJI: J1.338.841E,cpd:C11989,20,36,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H37O6,C20H35O6,372.2511889,373.2590139,371.24336381983,2185,cpd:C11990,Oleandolide,C20H34O7,Oleandolide,R06454 R06455,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",NA,"Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11990  Oleandolide,CAS: 68540-16-9; PubChem: 14151; LIPIDMAPS: LMPK04000031; 3DMET: B04396; NIKKAJI: J82.354F,cpd:C11990,20,34,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O7,C20H33O7,386.2304534,387.2382785,385.22262841984,2186,cpd:C11991,L-Olivosyl-oleandolide,C26H44O10,L-Olivosyl-oleandolide,R06455 R06456,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.1.1.239,"Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11991  L-Olivosyl-oleandolide,PubChem: 14152; ChEBI: 29614; LIPIDMAPS: LMPK04000032; 3DMET: B04397; NIKKAJI: J2.778.847E,cpd:C11991,26,44,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H45O10,C26H43O10,516.2934476,517.3012726,515.28562261985,2187,cpd:C11992,L-Oleandrosyl-oleandolide,C27H46O10,L-Oleandrosyl-oleandolide,R06456 R06457,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.1.1.239,"Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11992  L-Oleandrosyl-oleandolide,PubChem: 14153; ChEBI: 29613; LIPIDMAPS: LMPK04000033; 3DMET: B04398; NIKKAJI: J2.779.893D,cpd:C11992,27,46,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H47O10,C27H45O10,530.3090977,531.3169227,529.30127261986,2188,cpd:C11993,10-Deoxymethynolide,C17H28O4,10-Deoxymethynolide,R06458 R06460,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.3.1.239; 2.4.1.277,"Pikromycin/methymycin/neomethymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin/neomethymycin",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11993  10-Deoxymethynolide,CAS: 81644-19-1; PubChem: 14154; ChEBI: 29461; LIPIDMAPS: LMPK04000034; PDB-CCD: E4H; 3DMET: B04399; NIKKAJI: J1.051.072D,cpd:C02195; cpd:C11993,17,28,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H29O4,C17H27O4,296.1987594,297.2065844,295.19093431987,2189,cpd:C11994,10-Deoxymethymycin;,C25H43NO6,10-Deoxymethymycin; YC-17,R06460 R06462 R06463 R10628,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.13.185; 2.4.1.277,"Pikromycin/methymycin/neomethymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin/neomethymycin",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11994  10-Deoxymethymycin,CAS: 11091-33-1; PubChem: 14155; ChEBI: 29706; ChEMBL: CHEMBL326421; LIPIDMAPS: LMPK04000035; 3DMET: B04400; NIKKAJI: J19.352F,cpd:C11994,25,43,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H44O6N1,C25H42O6N1,453.3090381,454.3168631,452.30121311988,2190,cpd:C11995,Neomethymycin,C25H43NO7,Neomethymycin,R06462,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.13.185,"Pikromycin/methymycin/neomethymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin/neomethymycin",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11995  Neomethymycin,CAS: 497-73-4; PubChem: 14156; ChEBI: 29656; ChEMBL: CHEMBL521954; LIPIDMAPS: LMPK04000036; 3DMET: B04401; NIKKAJI: J9.389K,cpd:C05210; cpd:C11995; cpd:C11996,25,43,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H44O7N1,C25H42O7N1,469.3039527,470.3117778,468.29612771989,2191,cpd:C11996,Methymycin,C25H43NO7,Methymycin,R06463,"Biosynthesis of 12-, 14- and 16-membered macrolides; Type I polyketide structures; Biosynthesis of antibiotics",1.14.13.185,"Pikromycin/methymycin/neomethymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin/neomethymycin",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11996  Methymycin,CAS: 497-72-3; PubChem: 14157; ChEBI: 29630; ChEMBL: CHEMBL489347; LIPIDMAPS: LMPK04000037; PDB-CCD: MT9; 3DMET: B04402; NIKKAJI: J39.491B,cpd:C05210; cpd:C11995; cpd:C11996,25,43,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H44O7N1,C25H42O7N1,469.3039527,470.3117778,468.29612771990,2192,cpd:C11997,Narbonolide,C20H32O5,Narbonolide,R06459 R06461,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.3.1.240; 2.4.1.277,"Pikromycin/methymycin/neomethymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin/neomethymycin",NA,PubChem: 14158; ChEBI: 29650; 3DMET: B04403; NIKKAJI: J342.292E,cpd:C00427; cpd:C00584; cpd:C00696; cpd:C01312; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04853; cpd:C05960; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C11997; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C17652; cpd:C17656,20,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O5,C20H31O5,352.2249741,353.2327992,351.21714911991,2193,cpd:C11998,Narbomycin,C28H47NO7,Narbomycin,R06461 R06464 R10626 R10627,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.13.185; 2.4.1.277,"Pikromycin/methymycin/neomethymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin/neomethymycin",NA,CAS: 6036-25-5; PubChem: 14159; ChEBI: 29649; ChEMBL: CHEMBL106096; 3DMET: B04404; NIKKAJI: J39.493I,cpd:C11998,28,47,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H48O7N1,C28H46O7N1,509.3352529,510.3430779,508.32742781992,2194,cpd:C11999,Pikromycin,C28H47NO8,Pikromycin,R06464,"Biosynthesis of 12-, 14- and 16-membered macrolides; Type I polyketide structures; Biosynthesis of antibiotics",1.14.13.185,"Pikromycin/methymycin/neomethymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin/neomethymycin",Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C11999  Pikromycin,CAS: 19721-56-3; PubChem: 14160; ChEBI: 29665; LIPIDMAPS: LMPK04000038; KNApSAcK: C00018659; 3DMET: B04405; NIKKAJI: J13.351E,cpd:C11999; cpd:C20739,28,47,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H48O8N1,C28H46O8N1,525.3301675,526.3379925,524.32234241993,2195,cpd:C12000,Tylactone;,C23H38O5,Tylactone; Protylonolide,R06448 R06450,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.4.1.316,"Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin",NA,CAS: 74758-60-4; PubChem: 14161; ChEBI: 29700; 3DMET: B04406; NIKKAJI: J128.611K,cpd:C12000; cpd:C16345,23,38,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H39O5,C23H37O5,394.2719243,395.2797494,393.26409931994,2196,cpd:C12001,5-O-beta-D-Mycaminosyltylactone,C31H53NO8,5-O-beta-D-Mycaminosyltylactone,R06449 R06450,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.4.1.316,"Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin",NA,PubChem: 14162; ChEBI: 29491; ChEMBL: CHEMBL296286; 3DMET: B04407; NIKKAJI: J2.779.934E,cpd:C12001,31,53,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H54O8N1,C31H52O8N1,567.3771177,568.3849427,566.36929261995,2197,cpd:C12002,5-O-beta-D-Mycaminosyltylonolide,C31H51NO10,5-O-beta-D-Mycaminosyltylonolide,R06451 R10656,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.13.186; 2.4.1.317,"Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin",NA,PubChem: 14163; ChEBI: 77011; ChEMBL: CHEMBL380675 CHEMBL44949; 3DMET: B04408; NIKKAJI: J700.988G,cpd:C12002,31,51,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H52O10N1,C31H50O10N1,597.3512968,598.3591219,596.34347181996,2198,cpd:C12003,Demethyllactenocin,C37H61NO14,Demethyllactenocin,R06451 R06452,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",2.4.1.317; 2.4.1.318,"Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin",NA,PubChem: 14164; ChEBI: 29572; 3DMET: B04409; NIKKAJI: J2.779.940J,cpd:C12003; cpd:C14062,37,61,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H62O14N1,C37H60O14N1,743.4092056,744.4170307,742.40138061997,2199,cpd:C20760,20-Oxo-5-O-beta-mycaminosyltylactone;,C31H51NO9,20-Oxo-5-O-beta-mycaminosyltylactone; 23-Deoxy-5-O-beta-mycaminosyltylonolide,R06449 R10656,"Biosynthesis of 12-, 14- and 16-membered macrolides; Biosynthesis of antibiotics",1.14.13.186,"Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin",NA,PubChem: 254741228,cpd:C20760,31,51,9,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H52O9N1,C31H50O9N1,581.3563822,582.3642073,580.34855721998,2200,cpd:C03187,dTDP-6-deoxy-beta-L-talose;,C16H26N2O15P2,dTDP-6-deoxy-beta-L-talose; dTDP-beta-L-pneumose,R02776 R10190 R10279,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.134; 1.1.1.339; 1.1.1.344; 5.1.3.25,NA,NA,PubChem: 6066; ChEBI: 68679; 3DMET: B01637; NIKKAJI: J1.003.358F,cpd:C03187; cpd:C03319; cpd:C03442; cpd:C07277; cpd:C11912; cpd:C20682,16,26,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O15N2P2,C16H25O15N2P2,548.0808421,549.0886672,547.07301711999,2201,cpd:C04268,"dTDP-4-amino-4,6-dideoxy-D-glucose;",C16H27N3O14P2,"dTDP-4-amino-4,6-dideoxy-D-glucose; dTDP-4-amino-4,6-dideoxy-alpha-D-glucose; dTDP-viosamine; dTDP-4-amino-4,6-dideoxy-alpha-D-glucopyranose",R02773 R08583 R10174 R11247 R11468,Polyketide sugar unit biosynthesis; Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,1.14.15.-; 2.3.1.209; 2.4.-.-; 2.6.1.33; 4.3.1.30,"dTDP-D-desosamine biosynthesis; Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose",NA,PubChem: 6932; ChEBI: 15952 68523; PDB-CCD: 0FX; NIKKAJI: J2.749.614H,cpd:C04268; cpd:C04346; cpd:C11925; cpd:C17087; cpd:C19947; cpd:C21363,16,27,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O14N3P2,C16H26O14N3P2,547.0968266,548.1046516,546.08900152000,2202,cpd:C06017,dTDP-D-glucuronate,C16H24N2O17P2,dTDP-D-glucuronate,R02983 R11471 R11472,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.-,NA,NA,PubChem: 8289; ChEBI: 28504; 3DMET: B01950,cpd:C03034; cpd:C06017,16,24,17,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O17N2P2,C16H23O17N2P2,578.0550213,579.0628463,577.04719632001,2203,cpd:C06620,"dTDP-3,4-dioxo-2,6-dideoxy-D-glucose;",C16H22N2O14P2,"dTDP-3,4-dioxo-2,6-dideoxy-D-glucose; dTDP-3,4-didehydro-2,6-dideoxy-alpha-D-glucose",R05518 R05526 R06443 R06631 R08927 R11034 R11051,Polyketide sugar unit biosynthesis; Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,1.1.1.384; 1.1.1.-; 2.6.1.-; 4.2.1.159,dTDP-L-mycarose biosynthesis; dTDP-L-oleandrose biosynthesis; dTDP-L-megosamine biosynthesis; dTDP-L-olivose biosynthesis; dTDP-D-forosamine biosynthesis; dTDP-D-angolosamine biosynthesis,NA,PubChem: 8846; ChEBI: 28511; NIKKAJI: J2.762.492H,cpd:C06620; cpd:C11930; cpd:C11931; cpd:C17139,16,22,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H23O14N2P2,C16H21O14N2P2,528.0546274,529.0624524,527.04680242002,2204,cpd:C07277,dTDP-D-fucose;,C16H26N2O15P2,dTDP-D-fucose; dTDP-alpha-D-fucopyranose,R05687 R10536,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.266; 5.4.99.59,NA,NA,PubChem: 9486; ChEBI: 73950; PDB-CCD: 1JB; 3DMET: B05245; NIKKAJI: J2.663.700G,cpd:C03187; cpd:C03319; cpd:C03442; cpd:C07277; cpd:C11912; cpd:C20682,16,26,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O15N2P2,C16H25O15N2P2,548.0808421,549.0886672,547.07301712003,2205,cpd:C11447,"dTDP-4-dimethylamino-4,6-dideoxy-5-C-methyl-D-allose",C19H33N3O14P2,"dTDP-4-dimethylamino-4,6-dideoxy-5-C-methyl-D-allose",R11465,Polyketide sugar unit biosynthesis; Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.1.1.-,NA,NA,PubChem: 13619; ChEBI: 10512; NIKKAJI: J2.774.472I,cpd:C11447,19,33,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H34O14N3P2,C19H32O14N3P2,589.1437767,590.1516018,588.13595172004,2206,cpd:C11460,dTDP-4-oxo-5-C-methyl-L-rhamnose;,C17H26N2O15P2,dTDP-4-oxo-5-C-methyl-L-rhamnose; dTDP-4-oxo-6-deoxy-5-C-methyl-L-mannose,R10459 R11020 R11464,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.-; 2.1.1.-,dTDP-beta-L-noviose biosynthesis,NA,PubChem: 13631; ChEBI: 10516; NIKKAJI: J2.774.601B,cpd:C11460,17,26,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H27O15N2P2,C17H25O15N2P2,560.0808421,561.0886672,559.07301712005,2207,cpd:C11461,"dTDP-4-amino-4,6-dideoxy-5-C-methyl-D-allose",C17H29N3O14P2,"dTDP-4-amino-4,6-dideoxy-5-C-methyl-D-allose",R11464 R11465,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.-,NA,NA,PubChem: 13632; ChEBI: 10506; NIKKAJI: J2.774.603I,cpd:C11461,17,29,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H30O14N3P2,C17H28O14N3P2,561.1124766,562.1203017,560.10465162006,2208,cpd:C11908,"3,6-Dideoxy-3-oxo-dTDP-D-glucose;",C16H24N2O15P2,"3,6-Dideoxy-3-oxo-dTDP-D-glucose; dTDP-3-oxo-6-deoxy-D-glucose; dTDP-3-oxo-6-deoxy-alpha-D-glucose; dTDP-3-dehydro-6-deoxy-alpha-D-glucopyranose; dTDP-6-deoxy-D-ribo-hexos-3-ulose",R06423 R06424,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.6.1.89; 2.-.-.-; 5.3.2.4,dTDP-D-mycaminose biosynthesis,NA,PubChem: 14070; ChEBI: 27678; 3DMET: B05555; NIKKAJI: J1.150.879K,cpd:C00688; cpd:C11907; cpd:C11908; cpd:C11926; cpd:C19960; cpd:C21362,16,24,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O15N2P2,C16H23O15N2P2,546.0651921,547.0730171,545.0573672007,2209,cpd:C11909,"dTDP-3-oxo-4,6-dideoxy-D-glucose;",C16H24N2O14P2,"dTDP-3-oxo-4,6-dideoxy-D-glucose; dTDP-3-oxo-4,6-dideoxy-alpha-D-glucose; dTDP-3-dehydro-4,6-dideoxy-alpha-D-glucopyranose",R06426 R08583,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.6.1.106; 4.3.1.30,dTDP-D-desosamine biosynthesis,NA,PubChem: 14071; ChEBI: 27645 30906; 3DMET: B05556; NIKKAJI: J2.250.875J,cpd:C06622; cpd:C11909; cpd:C11922; cpd:C11927; cpd:C11928; cpd:C11932; cpd:C18029,16,24,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O14N2P2,C16H23O14N2P2,530.0702775,531.0781025,529.06245242008,2210,cpd:C11910,"dTDP-3-amino-3,4,6-trideoxy-D-glucose;",C16H27N3O13P2,"dTDP-3-amino-3,4,6-trideoxy-D-glucose; dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucose",R06426 R06427,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.-.-.-; 2.1.1.234; 2.6.1.106,dTDP-D-desosamine biosynthesis,NA,PubChem: 14072; ChEBI: 10502; 3DMET: B05557; NIKKAJI: J1.336.794I,cpd:C11910; cpd:C12443; cpd:C18030; cpd:C18092; cpd:C21355,16,27,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O13N3P2,C16H26O13N3P2,531.1019119,532.109737,530.09408692009,2211,cpd:C11915,"dTDP-3-methyl-4-oxo-2,6-dideoxy-L-allose",C17H26N2O14P2,"dTDP-3-methyl-4-oxo-2,6-dideoxy-L-allose",R06436 R08934,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.-; 2.1.1.-; 5.1.3.-,dTDP-L-mycarose biosynthesis,NA,PubChem: 14076; ChEBI: 27498; 3DMET: B05560; NIKKAJI: J2.777.762G,cpd:C11915; cpd:C18035; cpd:C21071,17,26,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H27O14N2P2,C17H25O14N2P2,544.0859275,545.0937525,543.07810252010,2212,cpd:C11918,Maltol,C6H6O3,Maltol,R06443,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,NA,NA,Phytochemical compounds [BR:br08003];  Polyketides;   Pyrones;    Monocyclic gamma-pyrones;     C11918  Maltol; Pharmaceutical additives [BR:br08316];  Refresher;   C11918  [103960] Maltol,CAS: 118-71-8; PubChem: 14079; ChEBI: 69438; ChEMBL: CHEMBL31422; KNApSAcK: C00037471; 3DMET: B04379; NIKKAJI: J2.910F,cpd:C01108; cpd:C02183; cpd:C02752; cpd:C02814; cpd:C03277; cpd:C03762; cpd:C06011; cpd:C11101; cpd:C11918; cpd:C16355; cpd:C16359; cpd:C19268; cpd:C19321; cpd:C19322; cpd:C19323; cpd:C20670; cpd:C20718,6,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O3,C6H5O3,126.0316941,127.0395191,125.0238692011,2213,cpd:C11919,dTDP-L-megosamine,C18H31N3O13P2,dTDP-L-megosamine,R06506 R11047,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.-,dTDP-L-megosamine biosynthesis,NA,PubChem: 14080; ChEBI: 29730; 3DMET: B05562; NIKKAJI: J2.777.778C,cpd:C11911; cpd:C11919; cpd:C18031; cpd:C18643; cpd:C20765; cpd:C21356,18,31,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H32O13N3P2,C18H30O13N3P2,559.1332121,560.1410371,558.1253872012,2214,cpd:C11922,"dTDP-4-oxo-2,6-dideoxy-D-glucose;",C16H24N2O14P2,"dTDP-4-oxo-2,6-dideoxy-D-glucose; dTDP-4-oxo-2,6-dideoxy-alpha-D-glucose; dTDP-4-dehydro-2,6-dideoxy-alpha-D-glucose; dTDP-4-keto-2,6-dideoxy-D-glucose",R05526 R06446 R08597 R08930,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.384; 4.2.1.164; 5.1.3.-,dTDP-L-olivose biosynthesis; dTDP-D-forosamine biosynthesis,NA,PubChem: 14083; ChEBI: 30940 85368; PDB-CCD: 3YN; 3DMET: B05565; NIKKAJI: J1.084.637D,cpd:C06622; cpd:C11909; cpd:C11922; cpd:C11927; cpd:C11928; cpd:C11932; cpd:C18029,16,24,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O14N2P2,C16H23O14N2P2,530.0702775,531.0781025,529.06245242013,2215,cpd:C11925,"dTDP-3-amino-3,6-dideoxy-D-glucose",C16H27N3O14P2,"dTDP-3-amino-3,6-dideoxy-D-glucose",R06423 R06439,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.235; 2.6.1.89,dTDP-D-mycaminose biosynthesis,NA,PubChem: 14086; ChEBI: 63264; PDB-CCD: T3Q; 3DMET: B05568; NIKKAJI: J1.150.878B,cpd:C04268; cpd:C04346; cpd:C11925; cpd:C17087; cpd:C19947; cpd:C21363,16,27,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O14N3P2,C16H26O14N3P2,547.0968266,548.1046516,546.08900152014,2216,cpd:C11926,dTDP-4-oxo-6-deoxy-D-allose;,C16H24N2O15P2,dTDP-4-oxo-6-deoxy-D-allose; dTDP-4-dehydro-6-deoxy-alpha-D-allose; dTDP-4-dehydro-6-deoxy-alpha-D-gulose,R06437 R06438 R10573 R11020,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.364; 2.1.1.-; 5.1.3.27,dTDP-6-deoxy-D-allose biosynthesis; dTDP-beta-L-noviose biosynthesis,NA,PubChem: 14087; ChEBI: 76289; 3DMET: B05569; NIKKAJI: J2.777.805D,cpd:C00688; cpd:C11907; cpd:C11908; cpd:C11926; cpd:C19960; cpd:C21362,16,24,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O15N2P2,C16H23O15N2P2,546.0651921,547.0730171,545.0573672015,2217,cpd:C11927,"dTDP-4-oxo-2,6-dideoxy-L-mannose",C16H24N2O14P2,"dTDP-4-oxo-2,6-dideoxy-L-mannose",R06433 R06434 R06445 R08597 R11041,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.-; 5.1.3.-; 5.3.1.-,dTDP-L-oleandrose biosynthesis; dTDP-L-olivose biosynthesis,NA,PubChem: 14088; ChEBI: 29724; 3DMET: B05570; NIKKAJI: J2.777.820H,cpd:C06622; cpd:C11909; cpd:C11922; cpd:C11927; cpd:C11928; cpd:C11932; cpd:C18029,16,24,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O14N2P2,C16H23O14N2P2,530.0702775,531.0781025,529.06245242016,2218,cpd:C11928,"dTDP-4-oxo-2,6-dideoxy-D-allose",C16H24N2O14P2,"dTDP-4-oxo-2,6-dideoxy-D-allose",R06433 R08933 R11051 R11470,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.-; 2.1.1.-; 5.1.3.-,dTDP-L-mycarose biosynthesis; dTDP-L-oleandrose biosynthesis,NA,PubChem: 14089; ChEBI: 29722; 3DMET: B05571; NIKKAJI: J1.179.583H,cpd:C06622; cpd:C11909; cpd:C11922; cpd:C11927; cpd:C11928; cpd:C11932; cpd:C18029,16,24,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O14N2P2,C16H23O14N2P2,530.0702775,531.0781025,529.06245242017,2219,cpd:C18029,"dTDP-3-oxo-2,6-dideoxy-D-glucose;",C16H24N2O14P2,"dTDP-3-oxo-2,6-dideoxy-D-glucose; dTDP-(2,6-dideoxy-alpha-D-erythro-hexopyranos-3-ulos-1-yl) ester",R08927 R08928,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,NA,dTDP-D-angolosamine biosynthesis,NA,PubChem: 96024249; ChEBI: 81458; NIKKAJI: J882.662E,cpd:C06622; cpd:C11909; cpd:C11922; cpd:C11927; cpd:C11928; cpd:C11932; cpd:C18029,16,24,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O14N2P2,C16H23O14N2P2,530.0702775,531.0781025,529.06245242018,2220,cpd:C18030,"dTDP-2,6-dideoxy-D-kanosamine;",C16H27N3O13P2,"dTDP-2,6-dideoxy-D-kanosamine; dTDP-(3-amino-2,3,6-trideoxy-alpha-D-arabino-hexopyranosyl) ester",R08928 R08929,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,NA,dTDP-D-angolosamine biosynthesis,NA,PubChem: 96024250; ChEBI: 81459,cpd:C11910; cpd:C12443; cpd:C18030; cpd:C18092; cpd:C21355,16,27,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O13N3P2,C16H26O13N3P2,531.1019119,532.109737,530.09408692019,2221,cpd:C18031,dTDP-D-angolosamine,C18H31N3O13P2,dTDP-D-angolosamine,R08929,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,NA,dTDP-D-angolosamine biosynthesis,NA,PubChem: 96024251; ChEBI: 81460,cpd:C11911; cpd:C11919; cpd:C18031; cpd:C18643; cpd:C20765; cpd:C21356,18,31,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H32O13N3P2,C18H30O13N3P2,559.1332121,560.1410371,558.1253872020,2222,cpd:C18032,"dTDP-4-oxo-2,3,6-trideoxy-D-glucose;",C16H24N2O13P2,"dTDP-4-oxo-2,3,6-trideoxy-D-glucose; dTDP-[(2R,6R)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl] ester; dTDP-4-dehydro-2,3,6-trideoxy-alpha-D-hexopyranose",R08930 R08931,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.6.1.110; 4.2.1.164,dTDP-D-forosamine biosynthesis,NA,PubChem: 96024252,cpd:C18032,16,24,13,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O13N2P2,C16H23O13N2P2,514.0753628,515.0831879,513.06753782021,2223,cpd:C18033,"dTDP-4-amino-2,3,4,6-tetradeoxy-D-glucose;",C16H27N3O12P2,"dTDP-4-amino-2,3,4,6-tetradeoxy-D-glucose; dTDP-[(2R,5S,6R)-5-aminotetrahydro-6-methyl-2H-pyran-2-yl] ester; dTDP-4-amino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose",R08931 R08932 R11452,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.324; 2.6.1.110,dTDP-D-forosamine biosynthesis,NA,PubChem: 96024253; ChEBI: 81462,cpd:C18033,16,27,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O12N3P2,C16H26O12N3P2,515.1069973,516.1148223,514.09917232022,2224,cpd:C18034,dTDP-D-forosamine;,C18H31N3O12P2,"dTDP-D-forosamine; dTDP-alpha-D-forosamine; dTDP-[(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl] ester; dTDP-4-(dimethylamino)-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose",R08932 R11453,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.324,dTDP-D-forosamine biosynthesis,NA,PubChem: 96024254; ChEBI: 81463,cpd:C18034,18,31,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H32O12N3P2,C18H30O12N3P2,543.1382974,544.1461225,542.13047242023,2225,cpd:C18035,"dTDP-3-methyl-4-oxo-2,6-dideoxy-D-glucose;",C17H26N2O14P2,"dTDP-3-methyl-4-oxo-2,6-dideoxy-D-glucose; dTDP-(2,6-dideoxy-3-C-methyl-alpha-D-threo-hexopyranos-4-ulos-1-yl) ester",R08933 R08934,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.-; 5.1.3.-,dTDP-L-mycarose biosynthesis,NA,PubChem: 96024255; ChEBI: 81464,cpd:C11915; cpd:C18035; cpd:C21071,17,26,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H27O14N2P2,C17H25O14N2P2,544.0859275,545.0937525,543.07810252024,2226,cpd:C19947,"dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose",C16H27N3O14P2,"dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose",R09821 R09824 R09873,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.236; 2.3.1.197; 2.6.1.90,NA,NA,PubChem: 135626413; PDB-CCD: T3F,cpd:C04268; cpd:C04346; cpd:C11925; cpd:C17087; cpd:C19947; cpd:C21363,16,27,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O14N3P2,C16H26O14N3P2,547.0968266,548.1046516,546.08900152025,2227,cpd:C19948,"dTDP-3-dimethylamino-3,6-dideoxy-alpha-D-galactopyranose;",C18H31N3O14P2,"dTDP-3-dimethylamino-3,6-dideoxy-alpha-D-galactopyranose; dTDP-D-ravidosamine",R09821,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.236,NA,NA,PubChem: 135626414,cpd:C11933; cpd:C19948; cpd:C20766,18,31,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H32O14N3P2,C18H30O14N3P2,575.1281267,576.1359517,574.12030172026,2228,cpd:C19960,dTDP-3-dehydro-6-deoxy-alpha-D-galactopyranose;,C16H24N2O15P2,dTDP-3-dehydro-6-deoxy-alpha-D-galactopyranose; dTDP-6-deoxy-D-xylo-hexos-3-ulose; dTDP-6-deoxy-D-xylo-hex-3-ulose,R09824 R09904,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.6.1.90; 5.3.2.3,NA,NA,PubChem: 135626426,cpd:C00688; cpd:C11907; cpd:C11908; cpd:C11926; cpd:C19960; cpd:C21362,16,24,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O15N2P2,C16H23O15N2P2,546.0651921,547.0730171,545.0573672027,2229,cpd:C20156,"dTDP-3-acetamido-3,6-dideoxy-alpha-D-galactopyranose",C18H29N3O15P2,"dTDP-3-acetamido-3,6-dideoxy-alpha-D-galactopyranose",R09873,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.3.1.197,NA,NA,PubChem: 135626615,cpd:C06018; cpd:C20156; cpd:C20415,18,29,15,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H30O15N3P2,C18H28O15N3P2,589.1073912,590.1152163,588.09956622028,2230,cpd:C20682,dTDP-alpha-D-fucofuranose,C16H26N2O15P2,dTDP-alpha-D-fucofuranose,R10536,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,5.4.99.59,NA,NA,PubChem: 172232402,cpd:C03187; cpd:C03319; cpd:C03442; cpd:C07277; cpd:C11912; cpd:C20682,16,26,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O15N2P2,C16H25O15N2P2,548.0808421,549.0886672,547.07301712029,2231,cpd:C21071,"dTDP-3-O-methyl-4-oxo-2,6-dideoxy-L-mannose;",C17H26N2O14P2,"dTDP-3-O-methyl-4-oxo-2,6-dideoxy-L-mannose; dTDP-4-keto-3-O-methyl-2,6-dideoxy-L-mannose",R11041 R11042,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.-,dTDP-L-oleandrose biosynthesis,NA,PubChem: 295369333,cpd:C11915; cpd:C18035; cpd:C21071,17,26,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H27O14N2P2,C17H25O14N2P2,544.0859275,545.0937525,543.07810252030,2232,cpd:C21073,"dTDP-3-N,N-dimethylamino-2,3,6-trideoxy-4-keto-D-glucose;",C18H29N3O13P2,"dTDP-3-N,N-dimethylamino-2,3,6-trideoxy-4-keto-D-glucose; dTDP-3-N,N-dimethylamino-4-oxo-2,3,6-trideoxy-D-glucose",R11045 R11046,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.-; 5.1.3.-,dTDP-L-megosamine biosynthesis,NA,PubChem: 295369335,cpd:C21073; cpd:C21074,18,29,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H30O13N3P2,C18H28O13N3P2,557.117562,558.125387,556.1097372031,2233,cpd:C21074,"dTDP-3-N,N-dimethylamino-4-oxo-2,3,6-trideoxy-L-allose;",C18H29N3O13P2,"dTDP-3-N,N-dimethylamino-4-oxo-2,3,6-trideoxy-L-allose; dTDP-3-N,N-dimethylamino-4-keto-2,3,6-trideoxy-L-allose",R11046 R11047,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,5.1.3.-,dTDP-L-megosamine biosynthesis,NA,PubChem: 295369336,cpd:C21073; cpd:C21074,18,29,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H30O13N3P2,C18H28O13N3P2,557.117562,558.125387,556.1097372032,2234,cpd:C21348,"dTDP-4-hydroxyamino-4,6-dideoxy-alpha-D-glucose",C16H27N3O15P2,"dTDP-4-hydroxyamino-4,6-dideoxy-alpha-D-glucose",R11417 R11468,Polyketide sugar unit biosynthesis; Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,1.14.15.-; 2.4.1.-,NA,NA,PubChem: 319902587,cpd:C21348,16,27,15,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O15N3P2,C16H26O15N3P2,563.0917412,564.0995662,562.08391612033,2235,cpd:C21349,dTDP-4-deoxy-4-thio-alpha-D-digitoxose,C16H26N2O13P2S,dTDP-4-deoxy-4-thio-alpha-D-digitoxose,R11418 R11470,Polyketide sugar unit biosynthesis; Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.4.1.-,NA,NA,PubChem: 319902588,cpd:C21349,16,26,13,2,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O13N2P2S1,C16H25O13N2P2S1,548.0630841,549.0709091,547.0552592034,2236,cpd:C21350,dTDP-3-O-methyl-beta-L-rhamnose,C17H28N2O15P2,dTDP-3-O-methyl-beta-L-rhamnose,R11422 R11423 R11469,Polyketide sugar unit biosynthesis; Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.1.1.-; 2.4.1.-,NA,NA,PubChem: 319902589,cpd:C12481; cpd:C21350,17,28,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H29O15N2P2,C17H27O15N2P2,562.0964922,563.1043172,561.08866722035,2237,cpd:C21351,dTDP-4-oxo-alpha-D-xylose;,C15H22N2O15P2,dTDP-4-oxo-alpha-D-xylose; dTDP-4-keto-alpha-D-xylose; dTDP-4-dehydro-alpha-D-xylose,R11466 R11472 R11473,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.-; 2.1.1.-; 4.2.1.-,NA,NA,PubChem: 319902590,cpd:C21351,15,22,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O15N2P2,C15H21O15N2P2,532.049542,533.057367,531.0417172036,2238,cpd:C21352,dTDP-4-oxo-2-deoxy-alpha-D-pentos-2-ene;,C15H20N2O14P2,dTDP-4-oxo-2-deoxy-alpha-D-pentos-2-ene; dTDP-2-deoxy-4-keto-alpha-D-pentos-2-ene,R11473 R11474,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.-; 4.2.1.-,NA,NA,PubChem: 328082920,cpd:C21352,15,20,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O14N2P2,C15H19O14N2P2,514.0389773,515.0468024,513.03115232037,2239,cpd:C21353,dTDP-4-oxo-2-deoxy-beta-L-xylose;,C15H22N2O14P2,dTDP-4-oxo-2-deoxy-beta-L-xylose; dTDP-4-keto-2-deoxy-beta-L-xylose; dTDP-4-dehydro-2-deoxy-beta-L-xylose,R11474 R11475,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,1.1.1.-; 2.6.1.-,NA,NA,PubChem: 328082921,cpd:C21353,15,22,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O14N2P2,C15H21O14N2P2,516.0546274,517.0624524,515.04680242038,2240,cpd:C21354,"dTDP-4-amino-2,4-dideoxy-beta-L-xylose",C15H25N3O13P2,"dTDP-4-amino-2,4-dideoxy-beta-L-xylose",R11475 R11476,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.-; 2.6.1.-,NA,NA,PubChem: 328082922,cpd:C21354,15,25,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O13N3P2,C15H24O13N3P2,517.0862619,518.0940869,516.07843682039,2241,cpd:C21355,"dTDP-4-methylamino-2,4-dideoxy-beta-L-xylose",C16H27N3O13P2,"dTDP-4-methylamino-2,4-dideoxy-beta-L-xylose",R11476,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.-,NA,NA,PubChem: 328082923,cpd:C11910; cpd:C12443; cpd:C18030; cpd:C18092; cpd:C21355,16,27,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O13N3P2,C16H26O13N3P2,531.1019119,532.109737,530.09408692040,2242,cpd:C21356,"dTDP-4-ethylamino-3-O-methyl-2,4-dideoxy-L-threo-pentopyranose",C18H31N3O13P2,"dTDP-4-ethylamino-3-O-methyl-2,4-dideoxy-L-threo-pentopyranose",R11420 R11421,Polyketide sugar unit biosynthesis; Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.4.2.-,NA,NA,PubChem: 319902591,cpd:C11911; cpd:C11919; cpd:C18031; cpd:C18643; cpd:C20765; cpd:C21356,18,31,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H32O13N3P2,C18H30O13N3P2,559.1332121,560.1410371,558.1253872041,2243,cpd:C21362,dTDP-3-methyl-4-oxo-alpha-D-ribopyranose,C16H24N2O15P2,dTDP-3-methyl-4-oxo-alpha-D-ribopyranose,R11466 R11467,Polyketide sugar unit biosynthesis; Biosynthesis of antibiotics,2.1.1.-,NA,NA,PubChem: 328082924,cpd:C00688; cpd:C11907; cpd:C11908; cpd:C11926; cpd:C19960; cpd:C21362,16,24,15,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O15N2P2,C16H23O15N2P2,546.0651921,547.0730171,545.0573672042,2244,cpd:C21363,dTDP-madurosamine;,C16H27N3O14P2,dTDP-madurosamine; dTDP-4-amino-3-methyl-4-deoxy-alpha-D-ribopyranose,R11467,Polyketide sugar unit biosynthesis; Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 328082925,cpd:C04268; cpd:C04346; cpd:C11925; cpd:C17087; cpd:C19947; cpd:C21363,16,27,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O14N3P2,C16H26O14N3P2,547.0968266,548.1046516,546.08900152043,2245,cpd:C00397,Tobramycin;,C18H37N5O9,Tobramycin; Nebramycin factor 6; 3'-Deoxykanamycin B,R10543 R10767 R11278,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.1.-; 6.1.2.2,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01G AMINOGLYCOSIDE ANTIBACTERIALS;     J01GB Other aminoglycosides;      J01GB01 Tobramycin;       D00063  Tobramycin (JP17/USP);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA12 Tobramycin;       D00063  Tobramycin (JP17/USP); USP drug classification [BR:br08302];  Antibacterials;   Aminoglycosides;    Tobramycin;     D00063  Tobramycin (JP17/USP);  Respiratory Tract/Pulmonary Agents;   Cystic Fibrosis Agents;    Tobramycin dry-powder inhaler;     D00063  Tobramycin (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   13  Agents affecting sensory organs;    131  Ophthalmic agents;     1317  Ophthalmic antibiotics;      D00063  Tobramycin (JP17/USP);  6  Agents against pathologic organisms and parasites;   61  Antibiotics;    612  Acting mainly on gram-negative bacteria;     6123  Amino sugars;      D00063  Tobramycin (JP17/USP); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Aminoglycosides;      Tobramycin;       D00063  Tobramycin (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00063  Tobramycin;   D00063 Tobramycin injection; Antibacterials [br08350.html];  D00063; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00063; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00063,CAS: 32986-56-4; PubChem: 3687; ChEBI: 28864; ChEMBL: CHEMBL1747; PDB-CCD: TOY; NIKKAJI: J4.533K,cpd:C00397,18,37,9,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H38O9N5,C18H36O9N5,467.2591278,468.2669528,466.25130282044,2246,cpd:C00825,Kanamycin B;,C18H37N5O10,Kanamycin B; Bekanamycin; Nebramycin factor 5,R01889 R10312 R10425 R11270 R11279,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.14.11.37; 2.3.1.82; 2.4.1.301; 2.6.1.94; 6.1.2.2,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01G AMINOGLYCOSIDE ANTIBACTERIALS;     J01GB Other aminoglycosides;      J01GB13 Bekanamycin;       D07497  Bekanamycin (INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Aminoglycosides;      Bekanamycin;       D07497  Bekanamycin (INN),CAS: 4696-76-8; PubChem: 4083; ChEBI: 28098; ChEMBL: CHEMBL176; KNApSAcK: C00018692; PDB-CCD: 9CS; NIKKAJI: J8.763G,cpd:C00825,18,37,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H38O10N5,C18H36O10N5,483.2540424,484.2618674,482.24621742045,2247,cpd:C00832,Paromomycin;,C23H45N5O14,Paromomycin; Paromomycin I; Aminosidin; Catenulin; Hydroxymycin; Monomycin A; Zygomycin A1; Neomycin E,R11286,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",5.1.3.-,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;    A07A INTESTINAL ANTIINFECTIVES;     A07AA Antibiotics;      A07AA06 Paromomycin;       D07467  Paromomycin (INN); USP drug classification [BR:br08302];  Antibacterials;   Aminoglycosides;    Paromomycin;     D07467  Paromomycin (INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Aminoglycosides;      Paromomycin;       D07467  Paromomycin (INN)",CAS: 7542-37-2; PubChem: 4090; ChEBI: 7934; ChEMBL: CHEMBL370143; PDB-CCD: PAR; NIKKAJI: J8.952D,cpd:C00832; cpd:C17588; cpd:C17712,23,45,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H46O14N5,C23H44O14N5,615.2963011,616.3041262,614.28847612046,2248,cpd:C00908,Gentamicin C1a,C19H39N5O7,Gentamicin C1a,R03056 R11302,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.3.1.59,NA,NA,CAS: 26098-04-4; PubChem: 4163; ChEBI: 27784; ChEMBL: CHEMBL194126; PDB-CCD: LLL; NIKKAJI: J17.060G,cpd:C00908,19,39,7,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H40O7N5,C19H38O7N5,449.2849486,450.2927736,448.27712362047,2249,cpd:C01441,Neamine;,C12H26N4O6,Neamine; Neomycin A,R08897 R08898 R10425 R11272 R11275,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.1.301; 2.4.2.49; 2.6.1.93,NA,NA,CAS: 3947-65-7; PubChem: 4619; ChEBI: 7489; ChEMBL: CHEMBL427409; PDB-CCD: XXX; NIKKAJI: J4.461J,cpd:C01441,12,26,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H27O6N4,C12H25O6N4,322.1852346,323.1930596,321.17740952048,2250,cpd:C01555,Apramycin,C21H41N5O11,Apramycin,NA,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",NA,NA,Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Aminoglycosides;      Apramycin;       D02322  Apramycin (USAN/INN),CAS: 37321-09-8; PubChem: 4713; ChEBI: 2790; ChEMBL: CHEMBL1909452; PDB-CCD: AM2; NIKKAJI: J139.315D,cpd:C01555,21,41,11,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H42O11N5,C21H40O11N5,539.2802572,540.2880822,538.27243212049,2251,cpd:C01737,Neomycin B;,C23H46N6O13,Neomycin B; Fradiomycin B; Framycetin,R08904,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",5.1.3.-,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Aminoglycosides;    2-Deoxystreptamines;     C01737  Neomycin B; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D09 MEDICATED DRESSINGS;    D09A MEDICATED DRESSINGS;     D09AA Medicated dressings with antiinfectives;      D09AA01 Framycetin;       D05140  Framycetin (INN);  R RESPIRATORY SYSTEM;   R01 NASAL PREPARATIONS;    R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;     R01AX Other nasal preparations;      R01AX08 Framycetin;       D05140  Framycetin (INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA07 Framycetin;       D05140  Framycetin (INN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Fradiomycin;     D05140  Framycetin (INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Aminoglycosides;      Framycetin;       D05140  Framycetin (INN),CAS: 119-04-0; PubChem: 4872; ChEBI: 7508; ChEMBL: CHEMBL184618; PDB-CCD: NMY; 3DMET: B04810; NIKKAJI: J4.458J,cpd:C01737; cpd:C15652,23,46,13,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H47O13N6,C23H45O13N6,614.3122856,615.3201106,613.30446052050,2252,cpd:C01743,Paromamine;,C12H25N3O7,Paromamine; Neomycin D,R08895 R08896 R10426 R11274 R11280 R11289,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.43; 2.4.1.301; 2.4.2.-; 3.5.1.112,NA,NA,CAS: 534-47-4; PubChem: 4877; ChEBI: 7933; ChEMBL: CHEMBL606552; NIKKAJI: J92.781C,cpd:C01743; cpd:C20350,12,25,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H26O7N3,C12H24O7N3,323.1692502,324.1770752,322.16142512051,2253,cpd:C01759,Ribostamycin;,C17H34N4O10,Ribostamycin; Vistamycin,R08899 R08900 R08909 R11265,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.-; 2.3.2.19; 2.4.1.285; 3.1.3.88,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01G AMINOGLYCOSIDE ANTIBACTERIALS;     J01GB Other aminoglycosides;      J01GB10 Ribostamycin;       D08478  Ribostamycin (INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Aminoglycosides;      Ribostamycin;       D08478  Ribostamycin (INN),CAS: 25546-65-0; PubChem: 4892; ChEBI: 45257; ChEMBL: CHEMBL221572; KNApSAcK: C00018782; PDB-CCD: RIO; NIKKAJI: J20.066B,cpd:C01759; cpd:C17584; cpd:C21266,17,34,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H35O10N4,C17H33O10N4,454.2274933,455.2353183,453.21966832052,2254,cpd:C01822,Kanamycin A,C18H36N4O11,Kanamycin A,R01888 R10417 R10424 R10544 R10768 R11269,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.355; 2.4.1.301; 2.6.1.94; 2.7.1.95; 6.1.2.2,NA,NA,CAS: 59-01-8; PubChem: 4946; ChEBI: 17630; ChEMBL: CHEMBL1384; PDB-CCD: KAN; NIKKAJI: J4.492J,cpd:C01822; cpd:C01823; cpd:C08046; cpd:C21254,18,36,11,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H37O11N4,C18H35O11N4,484.238058,485.245883,483.2302332053,2255,cpd:C01823,Kanamycin C,C18H36N4O11,Kanamycin C,R10426 R11268,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.-; 2.4.1.301,NA,NA,CAS: 2280-32-2; PubChem: 4947; ChEBI: 28185; KNApSAcK: C00018690; PDB-CCD: KNC; NIKKAJI: J96.765C,cpd:C01822; cpd:C01823; cpd:C08046; cpd:C21254,18,36,11,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H37O11N4,C18H35O11N4,484.238058,485.245883,483.2302332054,2256,cpd:C01917,Gentamicin A,C18H36N4O10,Gentamicin A,R09047 R11292 R11293,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.1.1.-; 2.7.7.46,NA,NA,CAS: 13291-74-2; PubChem: 5024; ChEBI: 28418; NIKKAJI: J54.339J,cpd:C01917,18,36,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H37O10N4,C18H35O10N4,468.2431434,469.2509684,467.23531832055,2257,cpd:C02033,Gentamicin C2,C20H41N5O7,Gentamicin C2,R11300 R11304,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,CAS: 25876-11-3; PubChem: 5126; ChEBI: 28292; ChEMBL: CHEMBL220884; NIKKAJI: J37.114I,cpd:C02033; cpd:C17706; cpd:C21270,20,41,7,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H42O7N5,C20H40O7N5,463.3005987,464.3084237,462.29277362056,2258,cpd:C02627,2-Deoxystreptamine,C6H14N2O3,2-Deoxystreptamine,R08891 R08894 R10096,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.1.283; 2.4.1.284; 2.6.1.101,NA,NA,CAS: 2037-48-1; PubChem: 5608; ChEBI: 28295; ChEMBL: CHEMBL264001; PDB-CCD: 2TB CYY NEB; NIKKAJI: J82.032F,cpd:C01028; cpd:C02627; cpd:C16741; cpd:C16742; cpd:C21041,6,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O3N2,C6H13O3N2,162.1004423,163.1082674,161.09261732057,2259,cpd:C07656,Gentamicin C1,C21H43N5O7,Gentamicin C1,NA,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,CAS: 25876-10-2; PubChem: 9858; ChEBI: 27412; ChEMBL: CHEMBL195892; PDB-CCD: 51G; NIKKAJI: J37.113K,cpd:C07656,21,43,7,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H44O7N5,C21H42O7N5,477.3162487,478.3240738,476.30842372058,2260,cpd:C12210,UDP-3-ketoglucose;,C15H22N2O17P2,UDP-3-ketoglucose; UDP-3-keto-D-glucose,R06586 R06594,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of ansamycins; Biosynthesis of antibiotics",1.1.1.-; 2.6.1.-,NA,NA,PubChem: 14355; ChEBI: 32274; 3DMET: B05614; NIKKAJI: J2.781.468I,cpd:C12210,15,22,17,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O17N2P2,C15H21O17N2P2,564.0393712,565.0471963,563.03154622059,2261,cpd:C12211,UDP-kanosamine;,C15H25N3O16P2,UDP-kanosamine; UDP-D-kanosamine; UDP-alpha-D-kanosamine,R06586 R06587 R10424 R10425 R10426 R10427 R11278,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of ansamycins; Biosynthesis of antibiotics",2.4.1.301; 2.4.1.-; 2.6.1.-,NA,NA,PubChem: 14356; ChEBI: 32275; 3DMET: B05615; NIKKAJI: J1.531.919D,cpd:C00501; cpd:C02200; cpd:C02467; cpd:C12211; cpd:C19794,15,25,16,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O16N3P2,C15H24O16N3P2,565.0710057,566.0788308,564.06318072060,2262,cpd:C15652,Neomycin C,C23H46N6O13,Neomycin C,R08903 R08904,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.6.1.95; 5.1.3.-,NA,NA,CAS: 66-86-4; PubChem: 47204993; ChEBI: 53634; ChEMBL: CHEMBL1200466; NIKKAJI: J4.457A,cpd:C01737; cpd:C15652,23,46,13,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H47O13N6,C23H45O13N6,614.3122856,615.3201106,613.30446052061,2263,cpd:C17209,2-Deoxy-scyllo-inosose;,C6H10O5,2-Deoxy-scyllo-inosose; 2-Deoxyinosose; 2-Deoxy-L-scyllo-inosose,R08617 R08890,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.6.1.100; 4.2.3.124,NA,NA,PubChem: 96023617; ChEBI: 64796; NIKKAJI: J485.865D,cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335,6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5,C6H9O5,162.0528234,163.0606485,161.04499842062,2264,cpd:C17580,2-Deoxy-scyllo-inosamine,C6H13NO4,2-Deoxy-scyllo-inosamine,R08890 R08892 R08893 R10130,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.329; 1.1.99.38; 2.6.1.100,NA,NA,CAS: 72075-06-0; PubChem: 96023925; ChEBI: 65046; PDB-CCD: 25W; NIKKAJI: J1.521.043E,cpd:C10141; cpd:C10143; cpd:C15478; cpd:C15479; cpd:C16843; cpd:C17580; cpd:C20311,6,13,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O4N1,C6H12O4N1,163.0844579,164.0922829,162.07663292063,2265,cpd:C17581,"3-Amino-2,3-dideoxy-scyllo-inosose;",C6H11NO4,"3-Amino-2,3-dideoxy-scyllo-inosose; 2-Deoxy-3-keto-scyllo-inosamine",R08891 R08892 R08893 R10130,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.329; 1.1.99.38; 2.6.1.101,NA,NA,PubChem: 96023926; ChEBI: 65027; NIKKAJI: J1.840.720E,cpd:C00734; cpd:C00956; cpd:C01046; cpd:C01077; cpd:C02207; cpd:C03210; cpd:C05016; cpd:C06234; cpd:C17581; cpd:C19694,6,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O4N1,C6H10O4N1,161.0688078,162.0766329,160.06098282064,2266,cpd:C17582,2'-N-Acetylparomamine,C14H27N3O8,2'-N-Acetylparomamine,R08894 R08895,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.1.283; 3.5.1.112,NA,NA,PubChem: 96023927; ChEBI: 65018; NIKKAJI: J2.437.275H,cpd:C17582,14,27,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H28O8N3,C14H26O8N3,365.1798148,366.1876399,364.17198982065,2267,cpd:C17583,6'-Dehydro-6'-oxoparomamine;,C12H23N3O7,6'-Dehydro-6'-oxoparomamine; 6'-Dehydroparomamine; 6'-Oxoparomamine,R08896 R08897,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.43; 2.6.1.93,NA,NA,PubChem: 96023928; ChEBI: 65008,cpd:C17583,12,23,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O7N3,C12H22O7N3,321.1536001,322.1614251,320.14577512066,2268,cpd:C17584,Xylostasin,C17H34N4O10,Xylostasin,R11266,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.-,NA,NA,CAS: 50474-67-4; PubChem: 96023929; ChEBI: 81199; NIKKAJI: J10.328D,cpd:C01759; cpd:C17584; cpd:C21266,17,34,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H35O10N4,C17H33O10N4,454.2274933,455.2353183,453.21966832067,2269,cpd:C17585,Butirosin A,C21H41N5O12,Butirosin A,R08911,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",NA,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Aminoglycosides;    2-Deoxystreptamines;     C17585  Butirosin A,CAS: 34291-02-6; PubChem: 96023930; ChEBI: 65112; ChEMBL: CHEMBL428032 CHEMBL608336; PDB-CCD: B31; NIKKAJI: J87.141I,cpd:C17585; cpd:C17586; cpd:C17997,21,41,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H42O12N5,C21H40O12N5,555.2751718,556.2829968,554.26734672068,2270,cpd:C17586,Butirosin B,C21H41N5O12,Butirosin B,R08910 R08911,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",4.3.2.6,NA,NA,CAS: 34291-03-7; PubChem: 96023931; ChEBI: 65110; NIKKAJI: J92.782A,cpd:C17585; cpd:C17586; cpd:C17997,21,41,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H42O12N5,C21H40O12N5,555.2751718,556.2829968,554.26734672069,2271,cpd:C17587,2'''-N-Acetyl-6'''-deamino-6'''-hydroxyneomycin C,C25H47N5O15,2'''-N-Acetyl-6'''-deamino-6'''-hydroxyneomycin C,R08900 R08901,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.1.285; 3.5.1.113,NA,NA,PubChem: 96023932; ChEBI: 65044,cpd:C17587,25,47,15,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H48O15N5,C25H46O15N5,657.3068658,658.3146909,656.29904082070,2272,cpd:C17588,6'''-Deamino-6'''-hydroxyneomycin C;,C23H45N5O14,6'''-Deamino-6'''-hydroxyneomycin C; 6'''-Hydroxyneomycin C; Neomycin Y2,R08901 R08902,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.44; 3.5.1.113,NA,NA,PubChem: 96023933; ChEBI: 65043,cpd:C00832; cpd:C17588; cpd:C17712,23,45,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H46O14N5,C23H44O14N5,615.2963011,616.3041262,614.28847612071,2273,cpd:C17589,6'''-Deamino-6'''-oxoneomycin C;,C23H43N5O14,6'''-Deamino-6'''-oxoneomycin C; 6'''-Oxoneomycin C; 6'''-Deamino-6'''-dehydro-6'''-oxoneomycin C,R08902 R08903,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.44; 2.6.1.95,NA,NA,PubChem: 96023934; ChEBI: 65098,cpd:C17589,23,43,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H44O14N5,C23H42O14N5,613.2806511,614.2884761,612.2728262072,2274,cpd:C17701,Gentamicin A2,C17H33N3O11,Gentamicin A2,R11289 R11290,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.-; 2.4.2.-,NA,NA,CAS: 55715-66-7; PubChem: 96024031; ChEBI: 81279; NIKKAJI: J12.408G,cpd:C17701; cpd:C18002,17,33,11,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H34O11N3,C17H32O11N3,455.2115089,456.2193339,454.20368392073,2275,cpd:C17702,Gentamicin X2,C19H38N4O10,Gentamicin X2,R11293 R11294 R11295,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.1.1.-,NA,NA,CAS: 36889-17-5; PubChem: 96024032; ChEBI: 81280; KNApSAcK: C00018397; NIKKAJI: J87.127C,cpd:C17702,19,38,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H39O10N4,C19H37O10N4,482.2587934,483.2666185,481.25096842074,2276,cpd:C17703,Antibiotic G-418;,C20H40N4O10,Antibiotic G-418; G418; Geneticin,R11294 R11296,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.1.1.-,NA,NA,CAS: 49863-47-0; PubChem: 96024033; ChEBI: 42768; ChEMBL: CHEMBL215226; KNApSAcK: C00018398; PDB-CCD: GET; NIKKAJI: J147.239I,cpd:C17703,20,40,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H41O10N4,C20H39O10N4,496.2744435,497.2822685,495.26661852075,2277,cpd:C17704,Antibiotic JI-20A;,C19H39N5O9,Antibiotic JI-20A; JI-20A,R11297 R11302,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.6.1.-,NA,NA,CAS: 51846-97-0; PubChem: 96024034; ChEBI: 81281; NIKKAJI: J87.136B,cpd:C17704,19,39,9,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H40O9N5,C19H38O9N5,481.2747779,482.2826029,480.26695282076,2278,cpd:C17705,Antibiotic JI-20B;,C20H41N5O9,Antibiotic JI-20B; JI-20B,R11299 R11301 R11304,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.6.1.-,NA,NA,CAS: 51846-98-1; PubChem: 96024035; ChEBI: 81282; NIKKAJI: J161.414B,cpd:C17705; cpd:C21269,20,41,9,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H42O9N5,C20H40O9N5,495.2904279,496.298253,494.28260292077,2279,cpd:C17706,Gentamicin C2b;,C20H41N5O7,Gentamicin C2b; Sagamicin,NA,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA22 Micronomicin;       D08219  Micronomicin (DCF); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Aminoglycosides;      Micronomicin;       D08219  Micronomicin (DCF),CAS: 52093-21-7; PubChem: 96024036; ChEBI: 81283; KNApSAcK: C00018016; NIKKAJI: J9.787J,cpd:C02033; cpd:C17706; cpd:C21270,20,41,7,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H42O7N5,C20H40O7N5,463.3005987,464.3084237,462.29277362078,2280,cpd:C17707,Lividomycin A,C29H55N5O18,Lividomycin A,NA,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,CAS: 36441-41-5; PubChem: 96024037; ChEBI: 71961; ChEMBL: CHEMBL389029; PDB-CCD: LIV; NIKKAJI: J17.684B,cpd:C17707,29,55,18,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H56O18N5,C29H54O18N5,761.3542099,762.362035,760.34638492079,2281,cpd:C17712,Paromomycin II;,C23H45N5O14,Paromomycin II; Neomycin F,R11285 R11286 R11287,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.6.1.-; 5.1.3.-,NA,NA,CAS: 51795-47-2; PubChem: 96024042; ChEBI: 81287; ChEMBL: CHEMBL1201296; NIKKAJI: J87.130C,cpd:C00832; cpd:C17588; cpd:C17712,23,45,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H46O14N5,C23H44O14N5,615.2963011,616.3041262,614.28847612080,2282,cpd:C17997,Oxyapramycin,C21H41N5O12,Oxyapramycin,NA,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,CAS: 56283-52-4; PubChem: 96024217; ChEBI: 81448,cpd:C17585; cpd:C17586; cpd:C17997,21,41,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H42O12N5,C21H40O12N5,555.2751718,556.2829968,554.26734672081,2283,cpd:C18000,Nebramycin factor 4;,C19H38N6O11,Nebramycin factor 4; 6''-O-Carbamoylkanamycin B,R11279,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",6.1.2.2,NA,NA,CAS: 51736-76-6; PubChem: 96024220; NIKKAJI: J87.118D,cpd:C18000,19,38,11,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H39O11N6,C19H37O11N6,526.2598561,527.2676811,525.2520312082,2284,cpd:C18001,Nebramycin 5';,C19H38N6O10,Nebramycin 5'; Nebramycin factor 5'; 6''-O-Carbamoyltobramycin,R10543 R10767,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",6.1.2.2,NA,NA,CAS: 51736-77-7; PubChem: 96024221; ChEBI: 73686; NIKKAJI: J87.119B,cpd:C18001,19,38,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H39O10N6,C19H37O10N6,510.2649414,511.2727665,509.25711642083,2285,cpd:C18002,5-Ribosylparomamine;,C17H33N3O11,5-Ribosylparomamine; Ribosylparomamine,R11281 R11282,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.1.-; 3.1.3.-,NA,NA,CAS: 55781-25-4; PubChem: 96024222; ChEBI: 81450; ChEMBL: CHEMBL387934,cpd:C17701; cpd:C18002,17,33,11,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H34O11N3,C17H32O11N3,455.2115089,456.2193339,454.20368392084,2286,cpd:C18003,Lividomycin B;,C23H45N5O13,Lividomycin B; 3'-Deoxyparomomycin I,R11288,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",5.1.3.-,NA,NA,CAS: 37636-51-4; PubChem: 96024223; ChEBI: 71962; KNApSAcK: C00018808; NIKKAJI: J87.134F,cpd:C18003; cpd:C21264,23,45,13,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H46O13N5,C23H44O13N5,599.3013865,600.3092116,598.29356152085,2287,cpd:C18004,5''-Phosphoribostamycin,C17H35N4O13P,5''-Phosphoribostamycin,R08898 R08899,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.2.49; 3.1.3.88,NA,NA,PubChem: 96024224; ChEBI: 65113,cpd:C18004,17,35,13,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H36O13N4P1,C17H34O13N4P1,534.1938242,535.2016492,533.18599922086,2288,cpd:C18005,gamma-L-Glutamyl-butirosin B,C26H48N6O15,gamma-L-Glutamyl-butirosin B,R08909 R08910,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.3.2.19; 4.3.2.6,NA,NA,PubChem: 96024225; ChEBI: 65108,cpd:C18005,26,48,15,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H49O15N6,C26H47O15N6,684.3177649,685.3255899,683.30993982087,2293,cpd:C20350,2'-Deamino-2'-hydroxyneamine,C12H25N3O7,2'-Deamino-2'-hydroxyneamine,R10094 R10424 R11271,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.1.301; 2.6.1.94,NA,NA,PubChem: 163312088,cpd:C01743; cpd:C20350,12,25,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H26O7N3,C12H24O7N3,323.1692502,324.1770752,322.16142512088,2294,cpd:C20351,2'-Deamino-2'-hydroxy-6'-dehydroparomamine,C12H22N2O8,2'-Deamino-2'-hydroxy-6'-dehydroparomamine,R10094 R10207,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.-; 2.6.1.94,NA,NA,PubChem: 163312089,cpd:C20351,12,22,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O8N2,C12H21O8N2,322.1376157,323.1454407,321.12979062089,2295,cpd:C20353,2'-Deamino-2'-hydroxyparomamine,C12H24N2O8,2'-Deamino-2'-hydroxyparomamine,R10096 R10207 R10427,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.-; 2.4.1.284; 2.4.1.301,NA,NA,PubChem: 163312091,cpd:C17981; cpd:C20353,12,24,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H25O8N2,C12H23O8N2,324.1532657,325.1610908,323.14544072090,2296,cpd:C20509,2'-Dehydrokanamycin A;,C18H34N4O11,2'-Dehydrokanamycin A; 2'-Oxokanamycin,R10312 R10417,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.355; 1.14.11.37,NA,NA,PubChem: 172232258,cpd:C20509; cpd:C21252,18,34,11,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H35O11N4,C18H33O11N4,482.2224079,483.230233,481.21458292091,2297,cpd:C20614,Kanamycin X,C18H35N3O12,Kanamycin X,R10427 R11267,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.-; 2.4.1.301,NA,NA,PubChem: 172232339,cpd:C17999; cpd:C20614; cpd:C21253,18,35,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H36O12N3,C18H34O12N3,485.2220736,486.2298986,484.21424852092,2298,cpd:C20699,6''-O-Carbamoylkanamycin A,C19H37N5O12,6''-O-Carbamoylkanamycin A,R10544 R10768,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",6.1.2.2,NA,NA,PubChem: 172232419,cpd:C20699,19,37,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H38O12N5,C19H36O12N5,527.2438716,528.2516967,526.23604662093,2299,cpd:C21176,3''-Oxoribostamycin,C17H32N4O10,3''-Oxoribostamycin,R11265 R11266,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.-,NA,NA,PubChem: 313369436,cpd:C21176,17,32,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H33O10N4,C17H31O10N4,452.2118432,453.2196683,451.20401822094,2300,cpd:C21251,6'-Oxokanamycin X,C18H33N3O12,6'-Oxokanamycin X,R11267 R11269,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.-; 2.6.1.94,NA,NA,PubChem: 315661350,cpd:C21251,18,33,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H34O12N3,C18H32O12N3,483.2064235,484.2142485,482.19859852095,2301,cpd:C21252,6'-Oxokanamycin C,C18H34N4O11,6'-Oxokanamycin C,R11268 R11270,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.-; 2.6.1.94,NA,NA,PubChem: 315661351,cpd:C20509; cpd:C21252,18,34,11,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H35O11N4,C18H33O11N4,482.2224079,483.230233,481.21458292096,2302,cpd:C21253,Kanamycin D,C18H35N3O12,Kanamycin D,R11271,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.1.301,NA,NA,PubChem: 315661352,cpd:C17999; cpd:C20614; cpd:C21253,18,35,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H36O12N3,C18H34O12N3,485.2220736,486.2298986,484.21424852097,2303,cpd:C21254,3''-Deamino-3''-hydroxykanamycin B;,C18H36N4O11,3''-Deamino-3''-hydroxykanamycin B; Nebramycin factor 3,R11272,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.1.301,NA,NA,CAS: 31077-70-0; PubChem: 315661353,cpd:C01822; cpd:C01823; cpd:C08046; cpd:C21254,18,36,11,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H37O11N4,C18H35O11N4,484.238058,485.245883,483.2302332098,2304,cpd:C21255,Lividamine,C12H25N3O6,Lividamine,R11273 R11276,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.-; 1.1.3.-,NA,NA,PubChem: 315661354,cpd:C21255,12,25,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H26O6N3,C12H24O6N3,307.1743355,308.1821606,306.16651052099,2305,cpd:C21256,6'-Oxolividamine,C12H23N3O6,6'-Oxolividamine,R11273,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.-,NA,NA,PubChem: 315661355,cpd:C21256; cpd:C21257,12,23,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O6N3,C12H22O6N3,305.1586855,306.1665105,304.15086042100,2306,cpd:C21257,4'-Oxolividamine;,C12H23N3O6,4'-Oxolividamine; 3'-Deoxy-4'-oxoparomamine,R11274 R11276,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.-,NA,NA,PubChem: 315661356; ChEBI: 132423,cpd:C21256; cpd:C21257,12,23,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O6N3,C12H22O6N3,305.1586855,306.1665105,304.15086042101,2307,cpd:C21258,4'-Oxonebramine,C12H24N4O5,4'-Oxonebramine,R11275 R11277,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.-,NA,NA,PubChem: 315661357,cpd:C21258,12,24,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H25O5N4,C12H23O5N4,304.1746699,305.1824949,303.16684492102,2308,cpd:C21259,Nebramine;,C12H26N4O5,Nebramine; 3'-Deoxyneamine,R11277 R11278,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.-; 2.4.1.-,NA,NA,PubChem: 315661358,cpd:C21259,12,26,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H27O5N4,C12H25O5N4,306.19032,307.198145,305.18249492103,2309,cpd:C21260,5''-Phosphoribosylparomamine,C17H34N3O14P,5''-Phosphoribosylparomamine,R11280 R11281,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.2.-; 3.1.3.-,NA,NA,PubChem: 315661359,cpd:C21260,17,34,14,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H35O14N3P1,C17H33O14N3P1,535.1778398,536.1856648,534.17001472104,2310,cpd:C21261,2'''-N-Acetyl-6'''-deamino-6'''-hydroxyparomomycin II,C25H46N4O16,2'''-N-Acetyl-6'''-deamino-6'''-hydroxyparomomycin II,R11282 R11283,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.4.1.-; 3.5.1.-,NA,NA,PubChem: 315661360,cpd:C21261,25,46,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H47O16N4,C25H45O16N4,658.2908814,659.2987064,657.28305642105,2311,cpd:C21262,6'''-Deamino-6'''-hydroxyparomomycin II,C23H44N4O15,6'''-Deamino-6'''-hydroxyparomomycin II,R11283 R11284,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.-; 3.5.1.-,NA,NA,PubChem: 315661361,cpd:C21262,23,44,15,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H45O15N4,C23H43O15N4,616.2803167,617.2881418,615.27249172106,2312,cpd:C21263,6'''-Deamino-6'''-oxoparomomycin II,C23H42N4O15,6'''-Deamino-6'''-oxoparomomycin II,R11284 R11285,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.3.-; 2.6.1.-,NA,NA,PubChem: 315661362,cpd:C21263,23,42,15,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H43O15N4,C23H41O15N4,614.2646667,615.2724917,613.25684162107,2313,cpd:C21264,5'''-epi-Lividomycin B,C23H45N5O13,5'''-epi-Lividomycin B,R11287 R11288,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",5.1.3.-,NA,NA,PubChem: 315661363,cpd:C18003; cpd:C21264,23,45,13,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H46O13N5,C23H44O13N5,599.3013865,600.3092116,598.29356152108,2314,cpd:C21265,3''-Oxogentamicin A2,C17H31N3O11,3''-Oxogentamicin A2,R11290 R11291,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",1.1.1.-; 2.6.1.-,NA,NA,PubChem: 315661364,cpd:C21265,17,31,11,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H32O11N3,C17H30O11N3,453.1958588,454.2036839,452.18803382109,2315,cpd:C21266,3''-Amino-3''-deoxygentamicin A2;,C17H34N4O10,3''-Amino-3''-deoxygentamicin A2; 3''-Demethyl-gentamicin A,R11291 R11292,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.1.1.-; 2.6.1.-,NA,NA,PubChem: 315661365,cpd:C01759; cpd:C17584; cpd:C21266,17,34,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H35O10N4,C17H33O10N4,454.2274933,455.2353183,453.21966832110,2316,cpd:C21267,6'-Oxogentamicin X2,C19H36N4O10,6'-Oxogentamicin X2,R11295 R11297,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.6.1.-,NA,NA,PubChem: 315661366,cpd:C21267,19,36,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H37O10N4,C19H35O10N4,480.2431434,481.2509684,479.23531832111,2317,cpd:C21268,6'-Oxo-G418,C20H38N4O10,6'-Oxo-G418,R11296 R11298 R11299,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.6.1.-,NA,NA,PubChem: 315661367,cpd:C21268,20,38,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H39O10N4,C20H37O10N4,494.2587934,495.2666185,493.25096842112,2318,cpd:C21269,Antibiotic JI-20Ba;,C20H41N5O9,Antibiotic JI-20Ba; JI-20Ba,R11298 R11301 R11303,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",2.6.1.-,NA,NA,PubChem: 315661368,cpd:C17705; cpd:C21269,20,41,9,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H42O9N5,C20H40O9N5,495.2904279,496.298253,494.28260292113,2319,cpd:C21270,Gentamicin C2a,C20H41N5O7,Gentamicin C2a,R11300 R11303,"Neomycin, kanamycin and gentamicin biosynthesis; Biosynthesis of antibiotics",NA,NA,NA,CAS: 59751-72-3; PubChem: 315661369,cpd:C02033; cpd:C17706; cpd:C21270,20,41,7,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H42O7N5,C20H40O7N5,463.3005987,464.3084237,462.29277362114,2320,cpd:C06802,Acarbose,C25H43NO18,Acarbose,R11184 R11305,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.7.1.187,"Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A10 DRUGS USED IN DIABETES;    A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS;     A10BF Alpha glucosidase inhibitors;      A10BF01 Acarbose;       D00216  Acarbose (JAN/USAN/INN); USP drug classification [BR:br08302];  Blood Glucose Regulators;   Antidiabetic Agents;    Acarbose;     D00216  Acarbose (JAN/USAN/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    396  Antidiabetic agents;     3969  Others;      D00216  Acarbose (JAN/USAN/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Hydrolases;    alpha-amylase;     Acarbose;      D00216  Acarbose (JAN/USAN/INN);    alpha-glucosidase;     Acarbose;      D00216  Acarbose (JAN/USAN/INN); Antidiabetics [br08361.html];  D00216",CAS: 56180-94-0; PubChem: 9021; ChEBI: 2376; ChEMBL: CHEMBL1566 CHEMBL404271; KNApSAcK: C00016021; PDB-CCD: ACR QPS; NIKKAJI: J33.395F,cpd:C06802,25,43,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H44O18N1,C25H42O18N1,645.2480135,646.2558386,644.24018852115,2321,cpd:C12112,Validamycin A;,C20H35NO13,Validamycin A; Validacin; Validamycin; Valimon,R11241 R11340,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,1.14.11.52; 2.4.1.338,"Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",Pesticides [BR:br08007];  Pesticides;   Fungicides;    Antibiotic fungicides;     C12112  Validamycin A,CAS: 37248-47-8; PubChem: 14259; ChEBI: 29703; ChEMBL: CHEMBL1923413; KNApSAcK: C00018797; NIKKAJI: J108.001F,cpd:C12112,20,35,13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H36O13N1,C20H34O13N1,497.2108402,498.2186652,496.20301522116,2322,cpd:C17691,2-epi-5-epi-Valiolone;,C7H12O6,"2-epi-5-epi-Valiolone; (2S,3S,4S,5R)-2,3,4,5-Tetrahydroxy-5-(hydroxymethyl)cyclohexan-1-one",R10937 R11079 R11185,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.7.1.188; 4.2.3.152; 5.1.3.33,"Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose; Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,PubChem: 254741156,cpd:C00296; cpd:C00625; cpd:C01295; cpd:C03000; cpd:C12113; cpd:C17259; cpd:C17691; cpd:C17694; cpd:C21282,7,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O6,C7H11O6,192.0633881,193.0712131,191.05556312117,2323,cpd:C17692,2-epi-5-epi-Valiolone 7-phosphate,C7H13O9P,2-epi-5-epi-Valiolone 7-phosphate,R11081 R11185,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.7.1.188; 5.1.3.35,"Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose",NA,PubChem: 254741157,cpd:C00686; cpd:C04136; cpd:C05974; cpd:C17692; cpd:C17693; cpd:C18125,7,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O9P1,C7H12O9P1,272.029719,273.037544,271.0218942118,2324,cpd:C17693,5-epi-Valiolone 7-phosphate,C7H13O9P,5-epi-Valiolone 7-phosphate,R11081 R11243,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,1.1.1.-; 5.1.3.35,"Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose",NA,PubChem: 254741158,cpd:C00686; cpd:C04136; cpd:C05974; cpd:C17692; cpd:C17693; cpd:C18125,7,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O9P1,C7H12O9P1,272.029719,273.037544,271.0218942119,2325,cpd:C17694,5-epi-Valiolone,C7H12O6,5-epi-Valiolone,R11079 R11233 R11253,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,4.2.1.-; 5.1.3.33,"Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,PubChem: 254741159,cpd:C00296; cpd:C00625; cpd:C01295; cpd:C03000; cpd:C12113; cpd:C17259; cpd:C17691; cpd:C17694; cpd:C21282,7,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O6,C7H11O6,192.0633881,193.0712131,191.05556312120,2326,cpd:C17695,2-Keto-5-epi-valiolone,C7H10O6,2-Keto-5-epi-valiolone,R11253 R11254,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 315431295,cpd:C00944; cpd:C03792; cpd:C04049; cpd:C05601; cpd:C06201; cpd:C17695; cpd:C20246; cpd:C20247,7,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O6,C7H9O6,190.047738,191.0555631,189.0399132121,2327,cpd:C17696,Valienone,C7H10O5,Valienone,R11233 R11234,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.7.1.214; 4.2.1.-,"Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,PubChem: 315431296,cpd:C00493; cpd:C04236; cpd:C16588; cpd:C17696; cpd:C18307; cpd:C18312; cpd:C20961; cpd:C21281,7,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O5,C7H9O5,174.0528234,175.0606485,173.04499842122,2328,cpd:C17697,Valienone 7-phosphate,C7H11O8P,Valienone 7-phosphate,R11234 R11235 R11236 R11498,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.7.1.214,"Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,PubChem: 315431297,cpd:C03175; cpd:C17697,7,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O8P1,C7H10O8P1,254.0191543,255.0269793,253.01132932123,2329,cpd:C17698,Salbostatin,C13H23NO8,Salbostatin,R11251,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,3.1.3.-,NA,NA,PubChem: 315431298,cpd:C17698,13,23,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H24O8N1,C13H22O8N1,321.1423667,322.1501917,320.13454172124,2330,cpd:C17699,Cetoniacytone A,C9H11NO5,Cetoniacytone A,R11255,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 316933493,cpd:C15503; cpd:C17699,9,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O5N1,C9H10O5N1,213.0637225,214.0715475,212.05589742125,2331,cpd:C17700,Validoxylamine A,C14H25NO8,Validoxylamine A,R11240 R11241,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.4.1.338; 3.1.3.101,"Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,PubChem: 315431299; PDB-CCD: VDM,cpd:C17700,14,25,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H26O8N1,C14H24O8N1,335.1580168,336.1658418,334.15019172126,2332,cpd:C20956,alpha-D-Sedoheptulopyranose 7-phosphate,C7H15O10P,alpha-D-Sedoheptulopyranose 7-phosphate,R10937,Acarbose and validamycin biosynthesis,4.2.3.152,"Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose; Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,PubChem: 254741417; ChEBI: 133983,cpd:C05382; cpd:C06222; cpd:C07836; cpd:C07838; cpd:C19878; cpd:C19880; cpd:C19882; cpd:C20956,7,15,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O10P1,C7H14O10P1,290.0402837,291.0481087,289.03245862127,2333,cpd:C21156,Acarbose 7IV-phosphate;,C25H44NO21P,Acarbose 7IV-phosphate; Acarbose 7-phosphate,R11184 R11248 R11305,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.7.1.187,"Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose",NA,PubChem: 313369416,cpd:C21156,25,44,21,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H45O21N1P1,C25H43O21N1P1,725.2143444,726.2221695,724.20651942128,2334,cpd:C21204,5-epi-Valiolol 7-phosphate,C7H15O9P,5-epi-Valiolol 7-phosphate,R11243 R11244,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,1.1.1.-,"Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose",NA,PubChem: 315431319,cpd:C04359; cpd:C21204,7,15,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O9P1,C7H14O9P1,274.0453691,275.0531941,273.0375442129,2335,cpd:C21205,1-epi-Valienol 7-phosphate,C7H13O8P,1-epi-Valienol 7-phosphate,R11235 R11244 R11245 R11249,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,NA,"Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose",NA,PubChem: 315431320,cpd:C21205; cpd:C21209; cpd:C21218; cpd:C21367; cpd:C21415,7,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O8P1,C7H12O8P1,256.0348044,257.0426294,255.02697932130,2336,cpd:C21206,"1,7-diphospho-1-epi-valienol",C7H14O11P2,"1,7-diphospho-1-epi-valienol",R11245 R11246,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.7.7.91,"Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose",NA,PubChem: 315431321,cpd:C21206,7,14,11,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O11P2,C7H13O11P2,336.0011353,337.0089603,334.99331022131,2338,cpd:C21208,dTDP-acarviose-7-phosphate,C23H38N3O21P3,dTDP-acarviose-7-phosphate,R11247 R11248,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.4.-.-,"Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose",NA,PubChem: 315431323,cpd:C21208,23,38,21,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H39O21N3P3,C23H37O21N3P3,785.1210662,786.1288913,784.11324122132,2339,cpd:C21209,1-epi-Valienol 1-phosphate,C7H13O8P,1-epi-Valienol 1-phosphate,R11237 R11249,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.7.7.91,NA,NA,PubChem: 315431324,cpd:C21205; cpd:C21209; cpd:C21218; cpd:C21367; cpd:C21415,7,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O8P1,C7H12O8P1,256.0348044,257.0426294,255.02697932133,2341,cpd:C21211,Salbostatin 6'-phosphate,C13H24NO11P,Salbostatin 6'-phosphate,R11250 R11251,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.5.1.135; 3.1.3.-,NA,NA,PubChem: 315431326,cpd:C21211,13,24,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H25O11N1P1,C13H23O11N1P1,401.1086976,402.1165226,400.10087262134,2342,cpd:C21216,Validamine 7-phosphate,C7H16NO7P,Validamine 7-phosphate,R11238 R11239 R11497,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.5.1.135,"Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,PubChem: 315431331,cpd:C21216,7,16,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H17O7N1P1,C7H15O7N1P1,257.0664389,258.0742639,256.05861382135,2343,cpd:C21218,Validone 7-phosphate,C7H13O8P,Validone 7-phosphate,R11236 R11238 R11406,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.7.1.214,"Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,PubChem: 315431333,cpd:C21205; cpd:C21209; cpd:C21218; cpd:C21367; cpd:C21415,7,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O8P1,C7H12O8P1,256.0348044,257.0426294,255.02697932136,2344,cpd:C21219,Validoxylamine A 7'-phosphate,C14H26NO11P,Validoxylamine A 7'-phosphate,R11239 R11240 R11497,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.5.1.135; 3.1.3.101,"Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A",NA,PubChem: 315431334; PDB-CCD: VDO,cpd:C21219,14,26,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H27O11N1P1,C14H25O11N1P1,415.1243477,416.1321727,414.11652262137,2345,cpd:C21247,2-Amino-5-epi-valiolone,C7H13NO5,2-Amino-5-epi-valiolone,R11252 R11254,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 315431336,cpd:C16850; cpd:C21247,7,13,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O5N1,C7H12O5N1,191.0793725,192.0871976,190.07154752138,2346,cpd:C21248,2-Aminovalienone,C7H11NO4,2-Aminovalienone,R11252,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 315431337,cpd:C01250; cpd:C12121; cpd:C17366; cpd:C21248,7,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O4N1,C7H10O4N1,173.0688078,174.0766329,172.06098282139,2347,cpd:C21249,Cetoniacytone B,C7H9NO4,Cetoniacytone B,R11255,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 315431338,cpd:C03972; cpd:C12108; cpd:C17356; cpd:C21249,7,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O4N1,C7H8O4N1,171.0531578,172.0609828,170.04533272140,2348,cpd:C21293,Validamycin B,C20H35NO14,Validamycin B,R11340,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,1.14.11.52,NA,NA,PubChem: 318172273,cpd:C21293,20,35,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H36O14N1,C20H34O14N1,513.2057548,514.2135798,512.19792982141,2349,cpd:C21367,Valienol 1-phosphate,C7H13O8P,Valienol 1-phosphate,R11402 R11499,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.7.7.91,NA,NA,PubChem: 319902597,cpd:C21205; cpd:C21209; cpd:C21218; cpd:C21367; cpd:C21415,7,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O8P1,C7H12O8P1,256.0348044,257.0426294,255.02697932142,2350,cpd:C21368,GDP-valienol,C17H25N5O15P2,GDP-valienol,R11402 R11497,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,2.5.1.135; 2.7.7.91,NA,NA,PubChem: 319902598,cpd:C20658; cpd:C21368,17,25,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H26O15N5P2,C17H24O15N5P2,601.0822391,602.0900642,600.07441412143,2351,cpd:C21415,Valienol 7-phosphate,C7H13O8P,Valienol 7-phosphate,R11498 R11499,Acarbose and validamycin biosynthesis; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 328082958,cpd:C21205; cpd:C21209; cpd:C21218; cpd:C21367; cpd:C21415,7,13,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O8P1,C7H12O8P1,256.0348044,257.0426294,255.02697932144,2358,cpd:C01112,D-Arabinose 5-phosphate,C5H11O8P,D-Arabinose 5-phosphate,R01530 R01573 R03254,Lipopolysaccharide biosynthesis; Metabolic pathways,2.5.1.55; 2.7.1.54; 5.3.1.13,CMP-KDO biosynthesis,NA,CAS: 13137-52-5; PubChem: 4344; ChEBI: 16241; ChEMBL: CHEMBL1162524; 3DMET: B04768; NIKKAJI: J652.796E,cpd:C00117; cpd:C00199; cpd:C00231; cpd:C00620; cpd:C01101; cpd:C01112; cpd:C03291; cpd:C03736; cpd:C03737; cpd:C03906; cpd:C06238; cpd:C06239; cpd:C06441; cpd:C06814,5,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O8P1,C5H10O8P1,230.0191543,231.0269793,229.01132932145,2359,cpd:C01187,3-Deoxy-D-manno-octulosonate;,C8H14O8,3-Deoxy-D-manno-octulosonate; Ketodeoxyoctonate; KDO; 2-Dehydro-3-deoxy-D-octonate; 3-Deoxy-D-manno-2-octulosonate; 3-Deoxyoctulosonic acid,R01576 R03350 R03351 R06054 R11394,Lipopolysaccharide biosynthesis; Metabolic pathways,1.1.3.48; 2.7.7.38; 3.1.3.45; 3.2.1.144; 4.1.2.23,CMP-KDO biosynthesis,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Sugar acids;     C01187  3-Deoxy-D-manno-octulosonic acid,CAS: 10149-14-1; PubChem: 4413; ChEBI: 16064 32817; 3DMET: B04780; NIKKAJI: J34.222J,cpd:C01187; cpd:C01241; cpd:C12987; cpd:C21063,8,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O8,C8H13O8,238.0688674,239.0766924,237.06104242146,2360,cpd:C04121,CMP-3-deoxy-D-manno-octulosonate;,C17H26N3O15P,CMP-3-deoxy-D-manno-octulosonate; CMP-KDO; CMP-beta-KDO,R03351 R04658 R05074 R06285 R09763 R09764 R09765 R09766,Lipopolysaccharide biosynthesis; Metabolic pathways,2.4.99.12; 2.4.99.13; 2.4.99.14; 2.4.99.15; 2.7.7.38,CMP-KDO biosynthesis,NA,PubChem: 6808; ChEBI: 86284; PDB-CCD: CMK; 3DMET: B04928; NIKKAJI: J2.746.452A,cpd:C04121,17,26,15,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H27O15N3P1,C17H25O15N3P1,543.1101541,544.1179792,542.10232912147,2361,cpd:C04478,3-Deoxy-D-manno-octulosonate 8-phosphate;,C8H15O11P,3-Deoxy-D-manno-octulosonate 8-phosphate; 2-Dehydro-3-deoxy-D-octonate 8-phosphate,R03254 R03350,Lipopolysaccharide biosynthesis; Metabolic pathways,2.5.1.55; 3.1.3.45,CMP-KDO biosynthesis,NA,PubChem: 7098; ChEBI: 18069; PDB-CCD: KD0; 3DMET: B04944; NIKKAJI: J90.143A,cpd:C04478,8,15,11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O11P1,C8H14O11P1,318.0351983,319.0430233,317.02737332148,2362,cpd:C04652,"UDP-2,3-bis(3-hydroxytetradecanoyl)glucosamine;",C43H77N3O20P2,"UDP-2,3-bis(3-hydroxytetradecanoyl)glucosamine; UDP-2,3-bis(beta-hydroxymyristoyl)-D-glucosamine; UDP-2,3-bis(3-hydroxytetradecanoyl)-D-glucosamine; UDP-2,3-bis[O-(3R)-3-hydroxymyristoyl]-alpha-D-glucosamine",R04549 R04550 R04606,Lipopolysaccharide biosynthesis; Metabolic pathways,2.3.1.191; 2.4.1.182; 3.6.1.54,"Lipopolysaccharide biosynthesis, KDO2-lipid A","Lipids [BR:br08002];  SL  Saccharolipids;   SL01 Acylaminosugars;    SL0102 Diacylaminosugars;     C04652  UDP-2,3-bis(3-hydroxytetradecanoyl)-D-glucosamine",PubChem: 7239; ChEBI: 17787; PDB-CCD: UDG; 3DMET: B04950; NIKKAJI: J2.752.732I,cpd:C04652,43,77,20,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H78O20N3P2,C43H76O20N3P2,1017.457566,1018.465391,1016.4497412149,2363,cpd:C04738,UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine;,C31H53N3O19P2,UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine; UDP-3-O-(beta-hydroxymyristoyl)-N-acetylglucosamine; UDP-3-O-[(3R)-3-hydroxymyristoyl]-N-acetylglucosamine,R04567 R04587,Lipopolysaccharide biosynthesis; Metabolic pathways,2.3.1.129; 3.5.1.108,"Lipopolysaccharide biosynthesis, KDO2-lipid A",Lipids [BR:br08002];  SL  Saccharolipids;   SL01 Acylaminosugars;    SL0101 Monoacylaminosugars;     C04738  UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine,PubChem: 7309; ChEBI: 61537; PDB-CCD: U20; 3DMET: B04959; NIKKAJI: J2.753.465A,cpd:C04738,31,53,19,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H54O19N3P2,C31H52O19N3P2,833.2748505,834.2826755,832.26702552150,2364,cpd:C04824,Lipid X;,C34H66NO12P,"Lipid X; 2,3-Diacylglucosamine 1-phosphate; 2,3-Bis[(3R)-3-hydroxymyristoyl]-alpha-D-glucosaminyl 1-phosphate; 2,3-Bis(3-hydroxytetradecanoyl)-alpha-D-glucosaminyl 1-phosphate",R04549 R04606,Lipopolysaccharide biosynthesis; Metabolic pathways,2.4.1.182; 3.6.1.54,"Lipopolysaccharide biosynthesis, KDO2-lipid A",Lipids [BR:br08002];  SL  Saccharolipids;   SL01 Acylaminosugars;    SL0102 Diacylaminosugars;     C04824  Lipid X,PubChem: 7385; ChEBI: 16942; ChEMBL: CHEMBL328132; LipidBank: CLS2077; PDB-CCD: LP5; 3DMET: B04964; NIKKAJI: J2.754.713C,cpd:C04824,34,66,12,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H67O12N1P1,C34H65O12N1P1,711.4322636,712.4400886,710.42443852151,2365,cpd:C04919,"2,3,2'3'-Tetrakis(3-hydroxytetradecanoyl)-D-glucosaminyl-1,6-beta-D-glucosamine 1,4'-bisphosphate;",C68H130N2O23P2,"2,3,2'3'-Tetrakis(3-hydroxytetradecanoyl)-D-glucosaminyl-1,6-beta-D-glucosamine 1,4'-bisphosphate; 2,3,2'3'-Tetrakis(beta-hydroxymyristoyl)-D-glucosaminyl-1,6-beta-D-glucosamine 1,4'-bisphosphate; Lipid A disaccharide bisphosphate; Lipid IV(A); 2-Deoxy-2-{[(3R)-3-hydroxytetradecanoyl]amino}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phospho-beta-D-glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phospho-alpha-D-glucopyranose",R04657 R04658 R09773,Lipopolysaccharide biosynthesis; Metabolic pathways,2.4.2.43; 2.4.99.12; 2.7.1.130,"Lipopolysaccharide biosynthesis, KDO2-lipid A",Lipids [BR:br08002];  SL  Saccharolipids;   SL01 Acylaminosugars;    SL0104 Tetraacylaminosugars;     C04919  Lipid IV(A),PubChem: 7466; ChEBI: 29056; LipidBank: CLS2002 CLS2005 CLS2008; 3DMET: B04973; NIKKAJI: J2.754.274C,cpd:C04919,68,130,23,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C68H131O23N2P2,C68H129O23N2P2,1404.853962,1405.861787,1403.8461372152,2366,cpd:C04932,Lipid A disaccharide;,C68H129N2O20P,"Lipid A disaccharide; Tetraacyldisaccharide 1-phosphate; [2-N,3-O-Bis(3-hydroxytetradecanoyl)-beta-D-glucosaminyl]-(1->6)-[2-N,3-O-bis(3-hydroxytetradecanoyl)-alpha-D-glucosaminyl phosphate]; 2,3-Bis[(3R)-3-hydroxytetradecanoyl]-beta-D-glucosaminyl-(1->6)-2,3-bis[(3R)-3-hydroxytetradecanoyl]-alpha-D-glucosaminyl 1-phosphate",R04606 R04657,Lipopolysaccharide biosynthesis; Metabolic pathways,2.4.1.182; 2.7.1.130,"Lipopolysaccharide biosynthesis, KDO2-lipid A",Lipids [BR:br08002];  SL  Saccharolipids;   SL01 Acylaminosugars;    SL0104 Tetraacylaminosugars;     C04932  Lipid A disaccharide,PubChem: 7476; ChEBI: 18380; ChEMBL: CHEMBL437287; LipidBank: CLS2125; 3DMET: B04974; NIKKAJI: J2.754.547E,cpd:C04932,68,129,20,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C68H130O20N2P1,C68H128O20N2P1,1324.887632,1325.895457,1323.8798072153,2367,cpd:C06022,UDP-3-O-(3-hydroxytetradecanoyl)-D-glucosamine;,C29H51N3O18P2,UDP-3-O-(3-hydroxytetradecanoyl)-D-glucosamine; UDP-3-O-(beta-hydroxymyristoyl)-D-glucosamine; UDP-3-O-[(3R)-3-hydroxymyristoyl]-D-glucosamine; UDP-3-O-[(3R)-3-hydroxymyristoyl]-alpha-D-glucosamine,R04550 R04587,Lipopolysaccharide biosynthesis; Metabolic pathways,2.3.1.191; 3.5.1.108,"Lipopolysaccharide biosynthesis, KDO2-lipid A",Lipids [BR:br08002];  SL  Saccharolipids;   SL01 Acylaminosugars;    SL0101 Monoacylaminosugars;     C06022  UDP-3-O-(3-hydroxytetradecanoyl)-D-glucosamine,PubChem: 8294; ChEBI: 71619; PDB-CCD: 24G; 3DMET: B05147; NIKKAJI: J2.760.898A,cpd:C06022,29,51,18,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H52O18N3P2,C29H50O18N3P2,791.2642858,792.2721108,790.25646082154,2368,cpd:C06024,3-Deoxy-D-manno-octulosonyl-lipid IV(A);,C76H142N2O30P2,"3-Deoxy-D-manno-octulosonyl-lipid IV(A); KDO-lipid IV(A); 3-Deoxy-D-manno-octulosonyl-2',3',2',3'-tetrakis(beta-hydroxymyristoyl)-D-glucosaminyl-1,6-beta-D-glucosamine 1,4'-bisphosphate",R04658 R05074 R09767,Lipopolysaccharide biosynthesis; Metabolic pathways,2.4.99.12; 2.4.99.13; 2.7.1.166,"Lipopolysaccharide biosynthesis, KDO2-lipid A",Lipids [BR:br08002];  SL  Saccharolipids;   SL02 Acylaminosugar glycans;    C06024  KDO-lipid IV(A),PubChem: 8296; ChEBI: 27439; 3DMET: B05148; NIKKAJI: J2.760.943K,cpd:C06024,76,142,30,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C76H143O30N2P2,C76H141O30N2P2,1624.912265,1625.92009,1623.904442155,2369,cpd:C06025,Di[3-deoxy-D-manno-octulosonyl]-lipid IV(A);,C84H154N2O37P2,Di[3-deoxy-D-manno-octulosonyl]-lipid IV(A); KDO2-lipid IV(A),R05074 R05146 R09763 R09774 R10906 R11205,Lipopolysaccharide biosynthesis; Metabolic pathways,2.3.1.241; 2.3.1.242; 2.4.2.43; 2.4.99.13; 2.4.99.14; 2.7.8.42,"Lipopolysaccharide biosynthesis, KDO2-lipid A",Lipids [BR:br08002];  SL  Saccharolipids;   SL02 Acylaminosugar glycans;    C06025  KDO2-lipid IV(A),PubChem: 8297; ChEBI: 28526; 3DMET: B05149; NIKKAJI: J2.760.959G,cpd:C06025,84,154,37,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C84H155O37N2P2,C84H153O37N2P2,1844.970568,1845.978393,1843.9627432156,2370,cpd:C06026,Di[3-deoxy-D-manno-octulosonyl]-lipid A;,C110H202N2O39P2,Di[3-deoxy-D-manno-octulosonyl]-lipid A; KDO2-lipid A; alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid A; Dodecanoyl-(tetradecanoyl)-KDO2-lipid IV(A),R05075 R09781 R11186 R11204 R11555 R11556,Lipopolysaccharide biosynthesis; Metabolic pathways; Cationic antimicrobial peptide (CAMP) resistance,2.3.1.243; 2.4.2.43; 2.7.4.29; 2.7.8.42; 2.7.8.43,"Lipopolysaccharide biosynthesis, KDO2-lipid A; Lipopolysaccharide biosynthesis, inner core => outer core => O-antigen",Lipids [BR:br08002];  SL  Saccharolipids;   SL02 Acylaminosugar glycans;    C06026  KDO2-lipid A,PubChem: 8298; ChEBI: 27963; 3DMET: B05150; NIKKAJI: J2.760.960K,cpd:C06026,110,202,39,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C110H203O39N2P2,C110H201O39N2P2,2237.335999,2238.343824,2236.3281742157,2371,cpd:C06251,Lauroyl-KDO2-lipid IV(A);,C96H176N2O38P2,Lauroyl-KDO2-lipid IV(A); Dodecanoyl-KDO2-lipid IV(A),R05075 R05146,Lipopolysaccharide biosynthesis; Metabolic pathways,2.3.1.241; 2.3.1.243,"Lipopolysaccharide biosynthesis, KDO2-lipid A",Lipids [BR:br08002];  SL  Saccharolipids;   SL02 Acylaminosugar glycans;    C06251  Lauroyl-KDO2-lipid IV(A),PubChem: 8490; ChEBI: 27422; 3DMET: B05182; NIKKAJI: J2.761.781F,cpd:C06251,96,176,38,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C96H177O38N2P2,C96H175O38N2P2,2027.137633,2028.145458,2026.1298082158,2372,cpd:C06397,ADP-D-glycero-beta-D-manno-heptose,C17H27N5O16P2,ADP-D-glycero-beta-D-manno-heptose,R05176 R05644,Lipopolysaccharide biosynthesis; Metabolic pathways,2.7.7.70; 5.1.3.20,ADP-L-glycero-D-manno-heptose biosynthesis,NA,PubChem: 8633; ChEBI: 16693; 3DMET: B05188; NIKKAJI: J1.982.936G,cpd:C06397; cpd:C06398,17,27,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H28O16N5P2,C17H26O16N5P2,619.0928038,620.1006288,618.08497882159,2373,cpd:C06398,ADP-L-glycero-beta-D-manno-heptose,C17H27N5O16P2,ADP-L-glycero-beta-D-manno-heptose,R05176,Lipopolysaccharide biosynthesis; Metabolic pathways,5.1.3.20,"ADP-L-glycero-D-manno-heptose biosynthesis; Lipopolysaccharide biosynthesis, inner core => outer core => O-antigen",NA,PubChem: 8634; ChEBI: 15915; 3DMET: B05189; NIKKAJI: J1.691.272G,cpd:C06397; cpd:C06398,17,27,16,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H28O16N5P2,C17H26O16N5P2,619.0928038,620.1006288,618.08497882160,2374,cpd:C07836,D-glycero-beta-D-manno-Heptose 7-phosphate,C7H15O10P,D-glycero-beta-D-manno-Heptose 7-phosphate,R05645 R05646,Lipopolysaccharide biosynthesis; Metabolic pathways,2.7.1.167; 5.3.1.28,ADP-L-glycero-D-manno-heptose biosynthesis,NA,PubChem: 10038; ChEBI: 28723; ChEMBL: CHEMBL481560; PDB-CCD: M7B; 3DMET: B05257; NIKKAJI: J2.185.467K,cpd:C05382; cpd:C06222; cpd:C07836; cpd:C07838; cpd:C19878; cpd:C19880; cpd:C19882; cpd:C20956,7,15,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O10P1,C7H14O10P1,290.0402837,291.0481087,289.03245862161,2375,cpd:C07838,D-glycero-beta-D-manno-Heptose 1-phosphate,C7H15O10P,D-glycero-beta-D-manno-Heptose 1-phosphate,R05644 R05647,Lipopolysaccharide biosynthesis; Metabolic pathways,2.7.7.70; 3.1.3.82,ADP-L-glycero-D-manno-heptose biosynthesis,NA,PubChem: 10040; ChEBI: 28137; 3DMET: B05258; NIKKAJI: J2.765.347B,cpd:C05382; cpd:C06222; cpd:C07836; cpd:C07838; cpd:C19878; cpd:C19880; cpd:C19882; cpd:C20956,7,15,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O10P1,C7H14O10P1,290.0402837,291.0481087,289.03245862162,2376,cpd:C11472,"D-glycero-beta-D-manno-Heptose 1,7-bisphosphate",C7H16O13P2,"D-glycero-beta-D-manno-Heptose 1,7-bisphosphate",R05646 R05647,Lipopolysaccharide biosynthesis; Metabolic pathways,2.7.1.167; 3.1.3.82,ADP-L-glycero-D-manno-heptose biosynthesis,NA,PubChem: 13642; ChEBI: 4188; PDB-CCD: GMZ; 3DMET: B05531; NIKKAJI: J2.774.645D,cpd:C00447; cpd:C11472; cpd:C19879,7,16,13,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H17O13P2,C7H15O13P2,370.0066146,371.0144396,368.99878952163,2377,cpd:C19877,4-O-Phospho-alpha-Kdo-(2->6)-lipid IVA,C76H143N2O33P3,4-O-Phospho-alpha-Kdo-(2->6)-lipid IVA,R09767,Lipopolysaccharide biosynthesis,2.7.1.166,NA,NA,PubChem: 135626343,cpd:C19877,76,143,33,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C76H144O33N2P3,C76H142O33N2P3,1704.878596,1705.886421,1703.8707712164,2378,cpd:C19878,D-glycero-alpha-D-manno-Heptose 7-phosphate,C7H15O10P,D-glycero-alpha-D-manno-Heptose 7-phosphate,R09769 R09770,Lipopolysaccharide biosynthesis,2.7.1.168; 5.3.1.28,NA,NA,PubChem: 135626344; ChEMBL: CHEMBL481560; PDB-CCD: M7P,cpd:C05382; cpd:C06222; cpd:C07836; cpd:C07838; cpd:C19878; cpd:C19880; cpd:C19882; cpd:C20956,7,15,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O10P1,C7H14O10P1,290.0402837,291.0481087,289.03245862165,2379,cpd:C19879,"D-glycero-alpha-D-manno-Heptose 1,7-bisphosphate",C7H16O13P2,"D-glycero-alpha-D-manno-Heptose 1,7-bisphosphate",R09770 R09771,Lipopolysaccharide biosynthesis,2.7.1.168; 3.1.3.83,NA,NA,PubChem: 135626345,cpd:C00447; cpd:C11472; cpd:C19879,7,16,13,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H17O13P2,C7H15O13P2,370.0066146,371.0144396,368.99878952166,2380,cpd:C19880,D-glycero-alpha-D-manno-Heptose 1-phosphate,C7H15O10P,D-glycero-alpha-D-manno-Heptose 1-phosphate,R09771 R09772,Lipopolysaccharide biosynthesis,2.7.7.71; 3.1.3.83,NA,NA,PubChem: 135626346,cpd:C05382; cpd:C06222; cpd:C07836; cpd:C07838; cpd:C19878; cpd:C19880; cpd:C19882; cpd:C20956,7,15,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O10P1,C7H14O10P1,290.0402837,291.0481087,289.03245862167,2381,cpd:C19881,GDP-D-glycero-alpha-D-manno-heptose,C17H27N5O17P2,GDP-D-glycero-alpha-D-manno-heptose,R09772,Lipopolysaccharide biosynthesis,2.7.7.71,NA,NA,PubChem: 135626347,cpd:C19881,17,27,17,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H28O17N5P2,C17H26O17N5P2,635.0877184,636.0955435,634.07989342168,2382,cpd:C04574,"di-trans,poly-cis-Undecaprenyl diphosphate;",C55H92O7P2,"di-trans,poly-cis-Undecaprenyl diphosphate; Undecaprenyl diphosphate; Bactoprenyl diphosphate; ditrans,octacis-Undecaprenyl diphosphate",R04519 R05627 R06177 R06178 R06179 R06447 R07269 R11186,Peptidoglycan biosynthesis; Terpenoid backbone biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,2.4.1.129; 2.5.1.31; 2.5.1.-; 2.7.4.29; 3.6.1.27,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0303 Bactoprenol diphosphates;     C04574  di-trans,poly-cis-Undecaprenyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Others;    Polyterpenoids;     C04574  di-trans,poly-cis-Undecaprenyl diphosphate",PubChem: 7175; ChEBI: 18197; LIPIDMAPS: LMPR03030008; LipidBank: IIP0027; 3DMET: B01759; NIKKAJI: J1.283.781J,cpd:C04574; cpd:C19852,55,92,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C55H93O7P2,C55H91O7P2,926.6318293,927.6396543,925.62400432169,2383,cpd:C04702,UDPMurNAc(oyl-L-Ala-D-gamma-Glu-L-Lys-D-Ala-D-Ala);,C40H65N9O26P2,UDPMurNAc(oyl-L-Ala-D-gamma-Glu-L-Lys-D-Ala-D-Ala); UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine; UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-alanine,R04573 R04611 R04613 R05629,Peptidoglycan biosynthesis; Metabolic pathways; beta-Lactam resistance; Vancomycin resistance,2.3.2.10; 2.7.8.13; 3.4.17.8; 6.3.2.10,NA,NA,PubChem: 7277; ChEBI: 70768; 3DMET: B04954; NIKKAJI: J2.755.974C J956.512D,cpd:C04702,40,65,26,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H66O26N9P2,C40H64O26N9P2,1149.351597,1150.359422,1148.3437722170,2384,cpd:C04851,MurAc(oyl-L-Ala-D-gamma-Glu-L-Lys-D-Ala-D-Ala)-diphospho-undecaprenol;,C86H143N7O21P2,MurAc(oyl-L-Ala-D-gamma-Glu-L-Lys-D-Ala-D-Ala)-diphospho-undecaprenol; Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine,R05629 R05662,Peptidoglycan biosynthesis; Metabolic pathways,2.4.1.227; 2.7.8.13,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0303 Bactoprenol diphosphates;     C04851  MurAc(oyl-L-Ala-D-gamma-Glu-L-Lys-D-Ala-D-Ala)-diphospho-undecaprenol,PubChem: 7408; ChEBI: 37738; 3DMET: B04969; NIKKAJI: J2.756.131D,cpd:C04851,86,143,21,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C86H144O21N7P2,C86H142O21N7P2,1671.981229,1672.989054,1670.9734042171,2385,cpd:C05892,UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysine;,C34H55N7O24P2,UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysine; UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysine; UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-gamma-D-glutamyl-L-lysine,R02786 R04573,Peptidoglycan biosynthesis; Metabolic pathways; Vancomycin resistance,6.3.2.7; 6.3.2.10,NA,NA,PubChem: 8180; ChEBI: 16329; ChEMBL: CHEMBL1777829; PDB-CCD: UML; 3DMET: B05129; NIKKAJI: J2.760.227D,cpd:C04700; cpd:C05892; cpd:C19720,34,55,24,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H56O24N7P2,C34H54O24N7P2,1007.27737,1008.285195,1006.2695452172,2386,cpd:C05893,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine;,C94H156N8O26P2,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine; GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol; GlcNAc-(1->4)-MurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol,R05030 R05662 R06178 R08779 R08855,Peptidoglycan biosynthesis; Metabolic pathways,2.3.2.10; 2.4.1.129; 2.4.1.227; 6.3.5.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0303 Bactoprenol diphosphates;     C05893  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine,PubChem: 8181; ChEBI: 27692; 3DMET: B05130; NIKKAJI: J2.760.261D,cpd:C05893; cpd:C11826,94,156,26,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C94H157O26N8P2,C94H155O26N8P2,1875.060601,1876.068426,1874.0527762173,2387,cpd:C05894,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-D-alanyl-D-alanine,C94H157N9O25P2,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-D-alanyl-D-alanine,R05030 R08776 R08855,Peptidoglycan biosynthesis; Metabolic pathways,2.3.2.10; 2.3.2.16; 6.3.5.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0303 Bactoprenol diphosphates;     C05894  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-D-alanyl-D-alanine,PubChem: 8182; 3DMET: B05131; NIKKAJI: J2.760.275D,cpd:C05894,94,157,25,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C94H158O25N9P2,C94H156O25N9P2,1874.076586,1875.084411,1873.0687612174,2388,cpd:C05895,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)5-D-alanyl-D-alanine,C104H172N14O30P2,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)5-D-alanyl-D-alanine,R08778,Peptidoglycan biosynthesis; Metabolic pathways,2.3.2.10; 2.3.2.18,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0303 Bactoprenol diphosphates;     C05895  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)5-D-alanyl-D-alanine,PubChem: 8183; ChEBI: 27457; 3DMET: B05132; NIKKAJI: J2.760.310F,cpd:C05895,104,172,30,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C104H173O30N14P2,C104H171O30N14P2,2159.183904,2160.191729,2158.1760792175,2389,cpd:C05897,"Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",C87H143N7O23P2,"Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",R05032 R05630,Peptidoglycan biosynthesis,2.4.1.227; 2.7.8.13,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0303 Bactoprenol diphosphates;     C05897  Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",PubChem: 8185; ChEBI: 28214; 3DMET: B05133; NIKKAJI: J2.760.323H,cpd:C05897,87,143,23,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C87H144O23N7P2,C87H142O23N7P2,1715.971058,1716.978883,1714.9632332176,2390,cpd:C05898,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",C95H156N8O28P2,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",R04519 R05032,Peptidoglycan biosynthesis,2.4.1.129; 2.4.1.227,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0303 Bactoprenol diphosphates;     C05898  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",PubChem: 8186; ChEBI: 28138; 3DMET: B05134; NIKKAJI: J2.760.508G,cpd:C05898; cpd:C11827,95,156,28,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C95H157O28N8P2,C95H155O28N8P2,1919.05043,1920.058255,1918.0426052177,2391,cpd:C17541,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)-D-alanyl-D-alanine;,C96H160N10O26P2,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)-D-alanyl-D-alanine; Und-PP-MurNAc-(GlcNAc)-L-Ala-D-isoglutaminyl-L-Lys-(Gly)-D-Ala-D-Ala,R08776 R08777,Peptidoglycan biosynthesis; Metabolic pathways,2.3.2.16; 2.3.2.17,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0303 Bactoprenol diphosphates;     C17541  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)-D-alanyl-D-alanine,PubChem: 96023886; ChEBI: 62232,cpd:C17541,96,160,26,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C96H161O26N10P2,C96H159O26N10P2,1931.098049,1932.105874,1930.0902242178,2392,cpd:C17542,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)3-D-alanyl-D-alanine;,C100H166N12O28P2,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)3-D-alanyl-D-alanine; Und-PP-MurNAc-(GlcNAc)-L-Ala-D-isoglutaminyl-L-Lys-(Gly)3-D-Ala-D-Ala,R08777 R08778,Peptidoglycan biosynthesis; Metabolic pathways,2.3.2.17; 2.3.2.18,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0303 Bactoprenol diphosphates;     C17542  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)3-D-alanyl-D-alanine,PubChem: 96023887; ChEBI: 62231,cpd:C17542,100,166,28,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C100H167O28N12P2,C100H165O28N12P2,2045.140977,2046.148802,2044.1331522179,2393,cpd:C17549,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-(L-alanyl-L-alanyl)-D-alanyl-D-alanine,C100H166N10O28P2,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-(L-alanyl-L-alanyl)-D-alanyl-D-alanine,R08780,Peptidoglycan biosynthesis,2.3.2.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0303 Bactoprenol diphosphates;     C17549  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-(L-alanyl-L-alanyl)-D-alanyl-D-alanine,PubChem: 96023894; ChEBI: 81176,cpd:C17549,100,166,28,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C100H167O28N10P2,C100H165O28N10P2,2017.134829,2018.142654,2016.1270042180,2394,cpd:C17550,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-(L-alanyl)-D-alanyl-D-alanine,C97H161N9O27P2,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-(L-alanyl)-D-alanyl-D-alanine,R08779 R08780,Peptidoglycan biosynthesis,2.3.2.10; 2.3.2.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0303 Bactoprenol diphosphates;     C17550  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-(L-alanyl)-D-alanyl-D-alanine,PubChem: 96023895; ChEBI: 81177,cpd:C17550,97,161,27,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C97H162O27N9P2,C97H160O27N9P2,1946.097715,1947.10554,1945.089892181,2395,cpd:C17556,"di-trans,poly-cis-Undecaprenyl phosphate;",C55H91O4P,"di-trans,poly-cis-Undecaprenyl phosphate; Undecaprenyl phosphate; ditrans,octacis-Undecaprenyl phosphate",R01535 R05626 R05627 R05629 R05630 R07257 R07661 R08856; R09641 R09773 R09774 R09781 R10465 R11186,Peptidoglycan biosynthesis,2.4.1.54; 2.4.2.43; 2.4.2.53; 2.7.1.66; 2.7.4.29; 2.7.8.6; 2.7.8.13; 2.7.8.31; 2.7.8.33; 2.7.8.40; 3.6.1.27,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR03 Polyprenols;    PR0302 Bactoprenol monophosphates;     C17556  di-trans,poly-cis-Undecaprenyl phosphate",PubChem: 96023901; ChEBI: 60468; LIPIDMAPS: LMPR03020001; NIKKAJI: J2.167.536I,cpd:C00348; cpd:C17556; cpd:C20420,55,91,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C55H92O4P1,C55H90O4P1,846.6654984,847.6733234,845.65767342182,2396,cpd:C17558,"di-trans,poly-cis-Undecaprenol;",C55H90O,"di-trans,poly-cis-Undecaprenol; Undecaprenol",R05626,Peptidoglycan biosynthesis,2.7.1.66,NA,NA,PubChem: 96023903; ChEBI: 81181,cpd:C17558,55,90,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C55H91O1,C55H89O1,766.6991675,767.7069926,765.69134252183,2397,cpd:C00093,sn-Glycerol 3-phosphate;,C3H9O6P,sn-Glycerol 3-phosphate; Glycerophosphoric acid; D-Glycerol 1-phosphate,R00841 R00842 R00844 R00845 R00846 R00847 R00848 R00849; R00850 R00851 R00853 R00854 R00855 R00856 R00857 R01030; R01193 R01470 R01801 R02027 R02617 R05328 R06872 R08657; R09380,Glycerolipid metabolism; Glycerophospholipid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; ABC transporters; Choline metabolism in cancer,1.1.1.8; 1.1.1.94; 1.1.1.177; 1.1.3.21; 1.1.5.3; 2.3.1.15; 2.3.1.198; 2.4.1.96; 2.4.1.137; 2.4.1.213; 2.7.1.30; 2.7.1.142; 2.7.7.39; 2.7.8.5; 3.1.3.21; 3.1.4.2; 3.1.4.3; 3.1.4.44; 3.1.4.46; 3.1.4.-; 3.6.1.16,Triacylglycerol biosynthesis,Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Calcium glycerophosphate;     C00093  sn-Glycerol 3-phosphate,CAS: 17989-41-2; PubChem: 3393; ChEBI: 15978; ChEMBL: CHEMBL1232920; KNApSAcK: C00007288; PDB-CCD: G3P GP9; 3DMET: B01157; NIKKAJI: J4.456C,cpd:C00093; cpd:C00623; cpd:C02768; cpd:C02979; cpd:C03189; cpd:C04508,3,9,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H10O6P1,C3H8O6P1,172.013675,173.0215,171.005852184,2398,cpd:C00184,Glycerone;,C3H6O3,"Glycerone; Dihydroxyacetone; 1,3-Dihydroxyacetone; 1,3-Dihydroxy-2-propanone; 1,3-Dihydroxypropan-2-one",R01010 R01011 R01012 R01034 R01039 R01045 R01440 R06862,Glycerolipid metabolism; Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.1.1.6; 1.1.1.156; 1.1.99.22; 2.2.1.3; 2.7.1.29; 2.7.1.121; 3.1.3.1; 3.1.3.2,"Formaldehyde assimilation, xylulose monophosphate pathway",Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C00184  Dihydroxyacetone,CAS: 96-26-4; PubChem: 3484; ChEBI: 16016; ChEMBL: CHEMBL1229937; PDB-CCD: 2HA; 3DMET: B00055; NIKKAJI: J4.719H,cpd:C00184; cpd:C00186; cpd:C00256; cpd:C00577; cpd:C01013; cpd:C01432; cpd:C02154; cpd:C02426; cpd:C03726; cpd:C05823; cpd:C10899; cpd:C12677; cpd:C19286; cpd:C19296,3,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O3,C3H5O3,90.03169405,91.03951908,89.023869022185,2403,cpd:C00969,3-Hydroxypropanal,C3H6O2,3-Hydroxypropanal,R01047 R03119,Glycerolipid metabolism,1.1.1.202; 4.2.1.30,NA,NA,CAS: 2134-29-4; PubChem: 4219; ChEBI: 17871; 3DMET: B00209; NIKKAJI: J298.720A,cpd:C00163; cpd:C00424; cpd:C00937; cpd:C00969; cpd:C01021; cpd:C02634; cpd:C02635; cpd:C02638; cpd:C02718; cpd:C02749; cpd:C02882; cpd:C03148; cpd:C03173; cpd:C04080; cpd:C05235; cpd:C05726; cpd:C05999; cpd:C06682; cpd:C08057; cpd:C10920; cpd:C16632; cpd:C17266; cpd:C17530,3,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O2,C3H5O2,74.03677943,75.04460446,73.02895442186,2405,cpd:C02457,"Propane-1,3-diol;",C3H8O2,"Propane-1,3-diol; 1,3-Propanediol; Trimethylene glycol",R03119,Glycerolipid metabolism,1.1.1.202,NA,NA,CAS: 504-63-2; PubChem: 5477; ChEBI: 16109; ChEMBL: CHEMBL379652; PDB-CCD: PDO; 3DMET: B00444; NIKKAJI: J2.606I,cpd:C00583; cpd:C02457; cpd:C02912; cpd:C02917; cpd:C03401; cpd:C06381; cpd:C06393,3,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O2,C3H7O2,76.0524295,77.06025453,75.044604462187,2421,cpd:C01177,Inositol 1-phosphate;,C6H13O9P,Inositol 1-phosphate; myo-Inositol 1-phosphate; 1D-myo-Inositol 1-phosphate; D-myo-Inositol 1-phosphate; 1D-myo-Inositol 1-monophosphate,R01185 R03330 R03331 R03332 R03333,Inositol phosphate metabolism; ABC transporters; Phosphatidylinositol signaling system,2.7.1.64; 3.1.3.25; 3.1.3.64; 3.1.4.3; 3.1.4.11; 3.1.4.43; 4.6.1.13,NA,NA,PubChem: 4404; ChEBI: 18297; KNApSAcK: C00007483; PDB-CCD: IPD; 3DMET: B01403; NIKKAJI: J6.548J,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.0218942188,2423,cpd:C01204,Phytic acid;,C6H18O24P6,"Phytic acid; Phytate; myo-Inositol hexakisphosphate; 1D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate; D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate; myo-Inositol 1,2,3,4,5,6-hexakisphosphate; Inositol 1,2,3,4,5,6-hexakisphosphate; 1D-myo-Inositol hexakisphosphate",R03371 R03372 R05202 R05779 R05799 R07583 R07584 R09087,Inositol phosphate metabolism; Metabolic pathways; Phosphatidylinositol signaling system,2.7.1.158; 2.7.4.21; 2.7.4.24; 3.1.3.8; 3.1.3.26; 3.1.3.62; 3.1.3.72; 3.6.1.52,"Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate",Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Phytin;     C01204  Phytic acid; Pharmaceutical additives [BR:br08316];  Diluting agent;   C01204  [502121] Phytic acid,CAS: 83-86-3; PubChem: 4428; ChEBI: 17401; PDB-CCD: I6P IHP; 3DMET: B00260; NIKKAJI: J9.332G,cpd:C01204,6,18,24,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H19O24P6,C6H17O24P6,659.8613734,660.8691985,658.85354842189,2424,cpd:C01220,"1D-myo-Inositol 1,4-bisphosphate;",C6H14O12P2,"1D-myo-Inositol 1,4-bisphosphate; D-myo-Inositol 1,4-bisphosphate; myo-Inositol 1,4-bisphosphate; Inositol 1,4-bisphosphate",R03393 R03394 R10952,Inositol phosphate metabolism; Metabolic pathways; Phosphatidylinositol signaling system,3.1.3.56; 3.1.3.57; 3.1.4.11,NA,NA,CAS: 74465-19-3; PubChem: 4442; ChEBI: 17816; KNApSAcK: C00007484; 3DMET: B01411; NIKKAJI: J281.780B,cpd:C00354; cpd:C00665; cpd:C01220; cpd:C01231; cpd:C03693; cpd:C03785; cpd:C04062; cpd:C04063; cpd:C04064; cpd:C05378,6,14,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O12P2,C6H13O12P2,339.9960499,341.0038749,338.98822492190,2425,cpd:C01243,"1D-myo-Inositol 1,3,4-trisphosphate;",C6H15O15P3,"1D-myo-Inositol 1,3,4-trisphosphate; D-myo-Inositol 1,3,4-trisphosphate; Inositol 1,3,4-trisphosphate",R03427 R03428 R03429 R03430 R10950,Inositol phosphate metabolism; Metabolic pathways; Phosphatidylinositol signaling system,2.7.1.159; 3.1.3.56; 3.1.3.57; 3.1.3.66,"Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol; Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate",NA,PubChem: 4464; ChEBI: 18228; ChEMBL: CHEMBL1160776 CHEMBL329137; PDB-CCD: I3S; 3DMET: B01421; NIKKAJI: J386.725K,cpd:C01243; cpd:C01245,6,15,15,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H16O15P3,C6H14O15P3,419.9623808,420.9702058,418.95455572191,2426,cpd:C01245,"D-myo-Inositol 1,4,5-trisphosphate;",C6H15O15P3,"D-myo-Inositol 1,4,5-trisphosphate; 1D-myo-Inositol 1,4,5-trisphosphate; Inositol 1,4,5-trisphosphate; Ins(1,4,5)P3",R03394 R03433 R03434 R03435 R05800 R10065,Inositol phosphate metabolism; Metabolic pathways; MAPK signaling pathway; ErbB signaling pathway; Ras signaling pathway; Calcium signaling pathway; cGMP-PKG signaling pathway; cAMP signaling pathway; Chemokine signaling pathway; NF-kappa B signaling pathway; HIF-1 signaling pathway; Phosphatidylinositol signaling system; Sphingolipid signaling pathway; Phospholipase D signaling pathway; Oocyte meiosis; Adrenergic signaling in cardiomyocytes; Vascular smooth muscle contraction; VEGF signaling pathway; Apelin signaling pathway; Osteoclast differentiation; Gap junction; Platelet activation; NOD-like receptor signaling pathway; Natural killer cell mediated cytotoxicity; Th1 and Th2 cell differentiation; Th17 cell differentiation; T cell receptor signaling pathway; B cell receptor signaling pathway; Fc epsilon RI signaling pathway; Fc gamma R-mediated phagocytosis; Long-term potentiation; Neurotrophin signaling pathway; Retrograde endocannabinoid signaling; Glutamatergic synapse; Cholinergic synapse; Serotonergic synapse; Dopaminergic synapse; Long-term depression; Taste transduction; Phototransduction - fly; Inflammatory mediator regulation of TRP channels; Insulin secretion; GnRH signaling pathway; Estrogen signaling pathway; Melanogenesis; Thyroid hormone synthesis; Thyroid hormone signaling pathway; Oxytocin signaling pathway; Glucagon signaling pathway; Renin secretion; Aldosterone synthesis and secretion; AGE-RAGE signaling pathway in diabetic complications; Endocrine and other factor-regulated calcium reabsorption; Salivary secretion; Gastric acid secretion; Pancreatic secretion; Alzheimer's disease; Huntington's disease; Vibrio cholerae infection; Chagas disease (American trypanosomiasis); African trypanosomiasis; Amoebiasis; Epstein-Barr virus infection; Pathways in cancer; Glioma; Non-small cell lung cancer,2.7.1.127; 2.7.1.151; 3.1.3.56; 3.1.3.62; 3.1.4.11,"Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4",NA,CAS: 85166-31-0; PubChem: 4466; ChEBI: 16595; ChEMBL: CHEMBL1161131 CHEMBL279107; KNApSAcK: C00007460; PDB-CCD: I3P; 3DMET: B01422; NIKKAJI: J260.291A,cpd:C01243; cpd:C01245,6,15,15,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H16O15P3,C6H14O15P3,419.9623808,420.9702058,418.95455572192,2427,cpd:C01272,"1D-myo-Inositol 1,3,4,5-tetrakisphosphate;",C6H16O18P4,"1D-myo-Inositol 1,3,4,5-tetrakisphosphate; D-myo-Inositol 1,3,4,5-tetrakisphosphate; Inositol 1,3,4,5-tetrakisphosphate",R03428 R03430 R03433 R03434 R10953,Inositol phosphate metabolism; Metabolic pathways; Phosphatidylinositol signaling system,2.7.1.127; 2.7.1.151; 2.7.1.159; 3.1.3.56; 3.1.3.62,"Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4; Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol",NA,PubChem: 4491; ChEBI: 16783; ChEMBL: CHEMBL23552; PDB-CCD: 4IP; 3DMET: B01430; NIKKAJI: J292.127H,cpd:C01272; cpd:C04477; cpd:C04520; cpd:C11555,6,16,18,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H17O18P4,C6H15O18P4,499.9287117,500.9365367,498.92088662193,2429,cpd:C01284,"1D-myo-Inositol 1,3,4,5,6-pentakisphosphate;",C6H17O21P5,"1D-myo-Inositol 1,3,4,5,6-pentakisphosphate; D-myo-Inositol 1,3,4,5,6-pentakisphosphate; Inositol 1,3,4,5,6-pentakisphosphate",R03478 R03479 R05202 R05801 R10065 R10953,Inositol phosphate metabolism; Metabolic pathways; Phosphatidylinositol signaling system,2.7.1.134; 2.7.1.140; 2.7.1.151; 2.7.1.158,"Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate",NA,PubChem: 4503; ChEBI: 16322; PDB-CCD: 5MY; 3DMET: B01433; NIKKAJI: J493.218H,cpd:C01284; cpd:C04563; cpd:C04579; cpd:C15990; cpd:C15991,6,17,21,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H18O21P5,C6H16O21P5,579.8950426,580.9028676,578.88721752194,2430,cpd:C03546,myo-Inositol 4-phosphate;,C6H13O9P,myo-Inositol 4-phosphate; D-myo-Inositol 4-phosphate; 1D-myo-Inositol 4-phosphate; 1D-myo-Inositol 4-monophosphate; Inositol 4-phosphate,R01186 R03393,Inositol phosphate metabolism; Metabolic pathways; Phosphatidylinositol signaling system,3.1.3.25; 3.1.3.57,NA,NA,CAS: 46495-39-0; PubChem: 6349; ChEBI: 18384; PDB-CCD: I4D; 3DMET: B01669; NIKKAJI: J392.708C,cpd:C00085; cpd:C00092; cpd:C00103; cpd:C00275; cpd:C00446; cpd:C00636; cpd:C00663; cpd:C00668; cpd:C01002; cpd:C01094; cpd:C01097; cpd:C01113; cpd:C01171; cpd:C01172; cpd:C01177; cpd:C02888; cpd:C02962; cpd:C02965; cpd:C03251; cpd:C03267; cpd:C03384; cpd:C03546; cpd:C03606; cpd:C03654; cpd:C03735; cpd:C03811; cpd:C04006; cpd:C05001; cpd:C05345; cpd:C06019; cpd:C06155; cpd:C06312; cpd:C15924; cpd:C15926; cpd:C18096,6,13,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O9P1,C6H12O9P1,260.029719,261.037544,259.0218942195,2431,cpd:C03659,D-Bornesitol;,C7H14O6,D-Bornesitol; (-)-Bornesitol; 1-O-Methyl-myo-inositol; 1D-1-O-Methyl-myo-inositol,R01188,Inositol phosphate metabolism,2.1.1.40,NA,NA,PubChem: 6437; ChEBI: 18427; KNApSAcK: C00048928; 3DMET: B01682; NIKKAJI: J13.105I,cpd:C03365; cpd:C03619; cpd:C03659; cpd:C03660; cpd:C03844; cpd:C05163; cpd:C05844; cpd:C06352; cpd:C06353; cpd:C08257,7,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O6,C7H13O6,194.0790382,195.0868632,193.07121312196,2432,cpd:C03660,L-Bornesitol;,C7H14O6,L-Bornesitol; (+)-Bornesitol; 3-O-Methyl-myo-inositol; 1D-3-O-Methyl-myo-inositol,R01189,Inositol phosphate metabolism,2.1.1.39,NA,NA,PubChem: 6438; ChEBI: 28310; 3DMET: B01683; NIKKAJI: J1.061.249G,cpd:C03365; cpd:C03619; cpd:C03659; cpd:C03660; cpd:C03844; cpd:C05163; cpd:C05844; cpd:C06352; cpd:C06353; cpd:C08257,7,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O6,C7H13O6,194.0790382,195.0868632,193.07121312197,2433,cpd:C04062,"D-myo-Inositol 1,3-bisphosphate;",C6H14O12P2,"D-myo-Inositol 1,3-bisphosphate; 1D-myo-Inositol 1,3-bisphosphate; myo-Inositol 1,3-bisphosphate; Inositol 1,3-bisphosphate",R03330 R10950,Inositol phosphate metabolism; Phosphatidylinositol signaling system,3.1.3.64; 3.1.3.66,NA,NA,CAS: 103597-56-4; PubChem: 6759; ChEBI: 18225; PDB-CCD: ITP; 3DMET: B01713; NIKKAJI: J447.870C,cpd:C00354; cpd:C00665; cpd:C01220; cpd:C01231; cpd:C03693; cpd:C03785; cpd:C04062; cpd:C04063; cpd:C04064; cpd:C05378,6,14,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O12P2,C6H13O12P2,339.9960499,341.0038749,338.98822492198,2434,cpd:C04063,"D-myo-Inositol 3,4-bisphosphate;",C6H14O12P2,"D-myo-Inositol 3,4-bisphosphate; 1D-myo-Inositol 3,4-bisphosphate; Inositol 3,4-bisphosphate",R03427 R04372,Inositol phosphate metabolism; Metabolic pathways; Phosphatidylinositol signaling system,3.1.3.57; 3.1.3.66,"Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol",NA,PubChem: 6760; ChEBI: 28858; 3DMET: B01714; NIKKAJI: J709.339J,cpd:C00354; cpd:C00665; cpd:C01220; cpd:C01231; cpd:C03693; cpd:C03785; cpd:C04062; cpd:C04063; cpd:C04064; cpd:C05378,6,14,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O12P2,C6H13O12P2,339.9960499,341.0038749,338.98822492199,2435,cpd:C04287,"3D-3,5/4-Trihydroxycyclohexane-1,2-dione;",C6H8O5,"3D-3,5/4-Trihydroxycyclohexane-1,2-dione; D-2,3-Diketo-4-deoxy-epi-inositol; (3R,4S,5R)-3,4,5-Trihydroxy-1,2-cyclohexanedione; 3,5/4-Trihydroxycyclohexa-1,2-dione",R02782 R08603,Inositol phosphate metabolism; Metabolic pathways; Microbial metabolism in diverse environments,3.7.1.22; 4.2.1.44,NA,NA,CAS: 949461-91-0; PubChem: 6949; ChEBI: 16145 28446; 3DMET: B01730; NIKKAJI: J2.749.622I,cpd:C00322; cpd:C00846; cpd:C04287; cpd:C04305; cpd:C04361; cpd:C06379; cpd:C06891; cpd:C16159; cpd:C19128; cpd:C20781,6,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O5,C6H7O5,160.0371734,161.0449984,159.02934832200,2436,cpd:C04477,"1D-myo-Inositol 1,3,4,6-tetrakisphosphate;",C6H16O18P4,"1D-myo-Inositol 1,3,4,6-tetrakisphosphate; D-myo-Inositol 1,3,4,6-tetrakisphosphate; Inositol 1,3,4,6-tetrakisphosphate",R03429 R03478,Inositol phosphate metabolism; Metabolic pathways; Phosphatidylinositol signaling system,2.7.1.140; 2.7.1.159,"Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate",NA,PubChem: 7097; ChEBI: 16155; PDB-CCD: I4P; 3DMET: B01746; NIKKAJI: J488.540F,cpd:C01272; cpd:C04477; cpd:C04520; cpd:C11555,6,16,18,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H17O18P4,C6H15O18P4,499.9287117,500.9365367,498.92088662201,2437,cpd:C04520,"1D-myo-Inositol 3,4,5,6-tetrakisphosphate;",C6H16O18P4,"1D-myo-Inositol 3,4,5,6-tetrakisphosphate; D-myo-Inositol 3,4,5,6-tetrakisphosphate; Inositol 3,4,5,6-tetrakisphosphate",R03479,Inositol phosphate metabolism,2.7.1.134,NA,NA,PubChem: 7132; ChEBI: 15844; ChEMBL: CHEMBL23050; PDB-CCD: 4MY; 3DMET: B01752; NIKKAJI: J709.342J,cpd:C01272; cpd:C04477; cpd:C04520; cpd:C11555,6,16,18,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H17O18P4,C6H15O18P4,499.9287117,500.9365367,498.92088662202,2439,cpd:C04563,"D-myo-Inositol 1,2,4,5,6-pentakisphosphate;",C6H17O21P5,"D-myo-Inositol 1,2,4,5,6-pentakisphosphate; 1D-myo-Inositol 1,2,4,5,6-pentakisphosphate; myo-Inositol 1,2,4,5,6-pentakisphosphate; Inositol 1,2,4,5,6-pentakisphosphate",R03371,Inositol phosphate metabolism,3.1.3.8; 3.1.3.62,NA,NA,CAS: 20298-95-7; PubChem: 7166; ChEBI: 16507; 3DMET: B01757; NIKKAJI: J608.454K,cpd:C01284; cpd:C04563; cpd:C04579; cpd:C15990; cpd:C15991,6,17,21,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H18O21P5,C6H16O21P5,579.8950426,580.9028676,578.88721752203,2440,cpd:C04579,"Inositol 1,2,3,5,6-pentakisphosphate;",C6H17O21P5,"Inositol 1,2,3,5,6-pentakisphosphate; myo-Inositol 1,2,3,5,6-pentakisphosphate; 1D-myo-Inositol 1,2,3,5,6-pentakisphosphate; 1L-myo-Inositol 1,2,3,4,5-pentakisphosphate",R03372,Inositol phosphate metabolism,3.1.3.26; 3.1.3.62,NA,NA,PubChem: 7180; ChEBI: 18345 48405; 3DMET: B01763; NIKKAJI: J885.458K,cpd:C01284; cpd:C04563; cpd:C04579; cpd:C15990; cpd:C15991,6,17,21,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H18O21P5,C6H16O21P5,579.8950426,580.9028676,578.88721752204,2443,cpd:C06153,scyllo-Inositol;,C6H12O6,scyllo-Inositol; Scyllitol,R09953 R09954,Inositol phosphate metabolism; Microbial metabolism in diverse environments,1.1.1.370; 1.1.1.371,NA,NA,CAS: 488-59-5; PubChem: 8409; ChEBI: 10642; ChEMBL: CHEMBL468154; PDB-CCD: 2H3; NIKKAJI: J92.778C,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.05556312205,2444,cpd:C06892,2-Deoxy-5-keto-D-gluconic acid;,C6H10O6,2-Deoxy-5-keto-D-gluconic acid; DKH; 5-Dehydro-2-deoxy-D-gluconate; 2-Deoxy-D-threo-hex-5-ulosonic acid,R05661 R08503,Inositol phosphate metabolism; Metabolic pathways; Microbial metabolism in diverse environments,2.7.1.92; 5.3.1.30,NA,NA,PubChem: 9109; ChEBI: 27972; 3DMET: B02098; NIKKAJI: J2.369.909E,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.0399132206,2445,cpd:C06893,2-Deoxy-5-keto-D-gluconic acid 6-phosphate;,C6H11O9P,2-Deoxy-5-keto-D-gluconic acid 6-phosphate; 6-Phospho-5-dehydro-2-deoxy-D-gluconate; DKHP,R05378 R05661,Inositol phosphate metabolism; Metabolic pathways; Microbial metabolism in diverse environments,2.7.1.92; 4.1.2.29,NA,NA,PubChem: 9110; 3DMET: B02099; NIKKAJI: J2.584.516A,cpd:C01236; cpd:C01286; cpd:C04442; cpd:C06893; cpd:C20668,6,11,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O9P1,C6H10O9P1,258.0140689,259.021894,257.00624392207,2447,cpd:C11555,"1D-myo-Inositol 1,4,5,6-tetrakisphosphate;",C6H16O18P4,"1D-myo-Inositol 1,4,5,6-tetrakisphosphate; D-myo-Inositol 1,4,5,6-tetrakisphosphate; Inositol 1,4,5,6-tetrakisphosphate",R05800 R05801,Inositol phosphate metabolism; Phosphatidylinositol signaling system,2.7.1.151,NA,NA,CAS: 121010-58-0; PubChem: 13722; ChEBI: 16067; ChEMBL: CHEMBL282059; PDB-CCD: I0P; 3DMET: B04274; NIKKAJI: J281.781K,cpd:C01272; cpd:C04477; cpd:C04520; cpd:C11555,6,16,18,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H17O18P4,C6H15O18P4,499.9287117,500.9365367,498.92088662208,2450,cpd:C16737,5-Deoxy-D-glucuronate;,C6H10O6,5-Deoxy-D-glucuronate; 5-Deoxy-D-glucuronic acid; 5-Deoxy-D-xylo-hexuronic acid,R08503 R08603,Inositol phosphate metabolism; Metabolic pathways; Microbial metabolism in diverse environments,3.7.1.22; 5.3.1.30,NA,NA,PubChem: 96023261; ChEBI: 50923; NIKKAJI: J2.805.474B,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.0399132209,2451,cpd:C19794,CDP-1L-myo-inositol,C15H25N3O16P2,CDP-1L-myo-inositol,R09669 R09670,Inositol phosphate metabolism,2.7.7.74; 2.7.8.34,NA,NA,PubChem: 135626261,cpd:C00501; cpd:C02200; cpd:C02467; cpd:C12211; cpd:C19794,15,25,16,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O16N3P2,C15H24O16N3P2,565.0710057,566.0788308,564.06318072210,2452,cpd:C19799,"Bis(1L-myo-inositol)-3,1'-phosphate 1-phosphate",C12H24O17P2,"Bis(1L-myo-inositol)-3,1'-phosphate 1-phosphate",R09670,Inositol phosphate metabolism,2.7.8.34,NA,NA,PubChem: 135626266; ChEBI: 62574,cpd:C19799,12,24,17,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H25O17P2,C12H23O17P2,502.0488733,503.0566983,501.04104832211,2453,cpd:C19891,1D-chiro-Inositol;,C6H12O6,"1D-chiro-Inositol; 1,2,4/3,5,6-Cyclohexane-1,2,3,4,5,6-hexol; (+)-Inositol",R09951,Inositol phosphate metabolism; Microbial metabolism in diverse environments,1.1.1.369,NA,NA,CAS: 643-12-9; PubChem: 135626357; ChEMBL: CHEMBL1231671; PDB-CCD: CBU,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.05556312212,2454,cpd:C20251,1-Keto-D-chiro-inositol;,C6H10O6,"1-Keto-D-chiro-inositol; 2D-2,3,5/4,6-Pentahydroxycyclohexanone",R09951 R09952,Inositol phosphate metabolism; Microbial metabolism in diverse environments,1.1.1.369; 5.3.99.11,NA,NA,PubChem: 163311994; ChEMBL: CHEMBL124109,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.0399132213,2457,cpd:C00189,Ethanolamine;,C2H7NO,Ethanolamine; Aminoethanol; 2-Hydroxyethylamine,R00749 R01468 R01469 R01470 R02041 R02051 R04248 R04362; R05381 R06870 R07376 R07385 R07386 R07388 R09536 R11062,Glycerophospholipid metabolism; Metabolic pathways; Retrograde endocannabinoid signaling,1.4.3.8; 2.6.-.-; 2.7.1.82; 2.7.8.29; 2.7.8.-; 3.1.3.75; 3.1.4.2; 3.1.4.4; 3.1.4.39; 3.1.4.46; 3.5.1.60; 3.5.1.99; 4.3.1.7; 4.3.3.-; 4.99.1.-,"Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE",Compounds with biological roles [BR:br08001];  Peptides;   Amines;    Biogenic amines;     C00189  Ethanolamine; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D05074  [104313] Monoethanol amine;  Buffering agent;   D05074  [104313] Monoethanol amine;  pH regulator;   D05074  [104313] Monoethanol amine;  Solubilization agent;   D05074  [104313] Monoethanol amine,CAS: 141-43-5; PubChem: 3489; ChEBI: 16000; ChEMBL: CHEMBL104943; KNApSAcK: C00007279; PDB-CCD: ETA; 3DMET: B01183; NIKKAJI: J2.536D,cpd:C00189,2,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H8O1N1,C2H6O1N1,61.05276385,62.06058888,60.044938822214,2459,cpd:C00307,CDP-choline;,C14H26N4O11P2,CDP-choline; Cytidine 5'-diphosphocholine; Citicoline,R01321 R01890 R01891 R01929 R03110 R04321 R07389 R09538,Glycerophospholipid metabolism; Metabolic pathways; Choline metabolism in cancer,2.7.7.15; 2.7.8.2; 2.7.8.3; 2.7.8.10; 2.7.8.22; 3.6.1.53,"Phosphatidylcholine (PC) biosynthesis, choline => PC","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N06 PSYCHOANALEPTICS;    N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS;     N06BX Other psychostimulants and nootropics;      N06BX06 Citicoline;       D00057  Citicoline (JP17/INN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   21  Cardiovascular agents;    219  Miscellaneous;     2190  Miscellaneous;      D00057  Citicoline (JP17/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00057  Citicoline",CAS: 987-78-0; PubChem: 3601; ChEBI: 16436; ChEMBL: CHEMBL1618340 CHEMBL1716199; KNApSAcK: C00007231; PDB-CCD: CDC; 3DMET: B01213; NIKKAJI: J55.713G,cpd:C00307,14,26,11,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H27O11N4P2,C14H25O11N4P2,488.1073317,489.1151567,487.09950662215,2461,cpd:C00346,Ethanolamine phosphate;,C2H8NO4P,Ethanolamine phosphate; O-Phosphorylethanolamine; Phosphoethanolamine; O-Phosphoethanolamine,R00748 R01468 R02037 R02038 R02052 R02464 R02817 R06516; R06870 R07380 R07381,Glycerophospholipid metabolism; Sphingolipid metabolism; Metabolic pathways; Cationic antimicrobial peptide (CAMP) resistance; Sphingolipid signaling pathway,2.1.1.103; 2.7.1.82; 2.7.7.14; 3.1.3.75; 3.1.4.3; 3.1.4.13; 3.1.4.-; 4.1.2.27; 4.1.2.-; 4.2.3.2,"Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE; Sphingosine degradation",NA,CAS: 1071-23-4; PubChem: 3639; ChEBI: 17553; ChEMBL: CHEMBL146972; PDB-CCD: OPE; 3DMET: B00092; NIKKAJI: J12.176B,cpd:C00346; cpd:C05678,2,8,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H9O4N1P1,C2H7O4N1P1,141.0190947,142.0269198,140.01126972216,2462,cpd:C00513,CDP-glycerol,C12H21N3O13P2,CDP-glycerol,R00855 R00856 R04042 R11558,Glycerophospholipid metabolism,2.7.7.39; 2.7.8.12; 2.7.8.44; 3.6.1.16,NA,NA,PubChem: 3796; ChEBI: 17885; 3DMET: B04693; NIKKAJI: J14.062G,cpd:C00513,12,21,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H22O13N3P2,C12H20O13N3P2,477.0549617,478.0627868,476.04713672217,2463,cpd:C00570,CDP-ethanolamine;,C11H20N4O11P2,CDP-ethanolamine; Cytidine diphosphate ethanolamine,R01503 R02038 R02057 R02563 R06364 R07384,Glycerophospholipid metabolism; Metabolic pathways,2.7.7.14; 2.7.8.1; 2.7.8.4; 2.7.8.-,"Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE",NA,CAS: 3036-18-8; PubChem: 3849; ChEBI: 16732; 3DMET: B01288; NIKKAJI: J14.936E,cpd:C00570,11,20,11,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H21O11N4P2,C11H19O11N4P2,446.0603815,447.0682065,445.05255642218,2464,cpd:C00588,Choline phosphate;,C5H15NO4P,Choline phosphate; Phosphorylcholine; Phosphocholine; O-Phosphocholine,R01021 R01312 R01890 R02541 R02591 R06869 R06871 R09538,Glycerophospholipid metabolism; Metabolic pathways; Choline metabolism in cancer,2.1.1.103; 2.7.1.32; 2.7.7.15; 3.1.3.75; 3.1.4.3; 3.1.4.12; 3.1.4.38; 3.6.1.53,"Phosphatidylcholine (PC) biosynthesis, choline => PC",Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Phosphorylcholine;     C00588  Choline phosphate; Pharmaceutical additives [BR:br08316];  Dispersant;   C00588  [109154] Choline phosphate,CAS: 107-73-3; PubChem: 3867; ChEBI: 18132; ChEMBL: CHEMBL323804; KNApSAcK: C00007299; PDB-CCD: PC; 3DMET: B00141; NIKKAJI: J215.288F,cpd:C00588,5,15,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H16O4N1P1,C5H14O4N1P1,184.07387,185.081695,183.06604492219,2465,cpd:C00623,sn-Glycerol 1-phosphate;,C3H9O6P,sn-Glycerol 1-phosphate; sn-Gro-1-P; L-Glycerol 1-phosphate,R01044 R04158 R05679 R05680 R07298,Glycerophospholipid metabolism,1.1.1.261; 2.5.1.41; 2.7.1.79; 3.1.3.21,NA,NA,CAS: 5746-57-6; PubChem: 3896; ChEBI: 16221; PDB-CCD: 1GP; NIKKAJI: J4.455E,cpd:C00093; cpd:C00623; cpd:C02768; cpd:C02979; cpd:C03189; cpd:C04508,3,9,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H10O6P1,C3H8O6P1,172.013675,173.0215,171.005852220,2466,cpd:C00670,sn-Glycero-3-phosphocholine;,C8H21NO6P,sn-Glycero-3-phosphocholine; Glycerophosphocholine,R01030 R01309 R02591 R02744 R02745 R02746 R02747 R07291,Glycerophospholipid metabolism; Ether lipid metabolism; Choline metabolism in cancer,3.1.1.5; 3.1.4.2; 3.1.4.38; 3.1.4.46; 3.3.2.2,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N07 OTHER NERVOUS SYSTEM DRUGS;    N07A PARASYMPATHOMIMETICS;     N07AX Other parasympathomimetics;      N07AX02 Choline alfoscerate;       D07349  Choline alfoscerate (INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Acetylcholine (muscarinic);     muscarinic cholinergic receptor;      Choline alfoscerate;       D07349  Choline alfoscerate (INN),CAS: 28319-77-9; PubChem: 3939; ChEBI: 16870; ChEMBL: CHEMBL1567463; PDB-CCD: CH5; 3DMET: B01306; NIKKAJI: J247.898F,cpd:C00670,8,21,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H22O6N1P1,C8H20O6N1P1,258.1106494,259.1184744,257.10282442221,2467,cpd:C01210,N-Methylethanolamine phosphate,C3H10NO4P,N-Methylethanolamine phosphate,R02037 R03375 R06868,Glycerophospholipid metabolism,2.1.1.103; 2.7.7.57,NA,NA,PubChem: 4432; ChEBI: 16463; PDB-CCD: 1SH; 3DMET: B01407; NIKKAJI: J2.731.879G,cpd:C01210; cpd:C04122; cpd:C04126,3,10,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H11O4N1P1,C3H9O4N1P1,155.0347448,156.0425698,154.02691982222,2468,cpd:C01233,sn-Glycero-3-phosphoethanolamine;,C5H14NO6P,sn-Glycero-3-phosphoethanolamine; Glycerophosphoethanolamine,R01470 R03415 R03416 R03417,Glycerophospholipid metabolism; Ether lipid metabolism,3.1.1.5; 3.1.4.2; 3.1.4.46; 3.3.2.2,NA,NA,PubChem: 4454; ChEBI: 16929; PDB-CCD: GPE; 3DMET: B04786; NIKKAJI: J247.900A,cpd:C01233,5,14,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H15O6N1P1,C5H13O6N1P1,215.0558742,216.0636992,214.04804912223,2470,cpd:C01996,Acetylcholine;,C7H16NO2,Acetylcholine; O-Acetylcholine,R01023 R01026,Glycerophospholipid metabolism; cAMP signaling pathway; Neuroactive ligand-receptor interaction; Synaptic vesicle cycle; Cholinergic synapse; Taste transduction; Regulation of actin cytoskeleton; Insulin secretion; Salivary secretion; Gastric acid secretion; Pancreatic secretion; Bile secretion; Nicotine addiction,2.3.1.6; 3.1.1.7; 3.1.1.8,NA,Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Neurotransmitters;    Acetylcholine;     C01996  Acetylcholine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS;     S01EB Parasympathomimetics;      S01EB09 Acetylcholine;       C01996  Acetylcholine,CAS: 51-84-3; PubChem: 5093; ChEBI: 15355; ChEMBL: CHEMBL667; PDB-CCD: ACH; 3DMET: B00379; NIKKAJI: J4.127K,cpd:C01181; cpd:C01996; cpd:C08201,7,16,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H17O2N1,C7H15O2N1,146.1181038,147.1259288,145.11027872224,2473,cpd:C03872,L-Serine-phosphoethanolamine;,C5H13N2O6P,L-Serine-phosphoethanolamine; Serine phosphoethanolamine,R02563 R02817,Glycerophospholipid metabolism,2.7.8.4; 3.1.4.13,NA,NA,PubChem: 6606; ChEBI: 16542; 3DMET: B01695; NIKKAJI: J2.744.403B,cpd:C03872,5,13,6,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H14O6N2P1,C5H12O6N2P1,228.0511231,229.0589482,227.04329812225,2480,cpd:C04590,3-(O-Geranylgeranyl)-sn-glycerol 1-phosphate,C23H41O6P,3-(O-Geranylgeranyl)-sn-glycerol 1-phosphate,R04158 R04520,Glycerophospholipid metabolism,2.5.1.41; 2.5.1.42,NA,Lipids [BR:br08002];  GP  Glycerophospholipids;   GP10 Glycerophosphates;    GP1006 Monoalkylglycerophosphates;     C04590  sn-3-O-(Geranylgeranyl)glycerol 1-phosphate,PubChem: 7189; ChEBI: 16206; LIPIDMAPS: LMGP10060002; NIKKAJI: J548.475H,cpd:C04590,23,41,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H42O6P1,C23H40O6P1,444.264076,445.2719011,443.2562512226,2481,cpd:C04638,"2,3-Bis-O-(geranylgeranyl)glycerol 1-phosphate;",C43H73O6P,"2,3-Bis-O-(geranylgeranyl)glycerol 1-phosphate; 2,3-Bis-O-(geranylgeranyl)-sn-glycerol-1-phosphate; 2,3-Digeranylgeranyl sn-glycerol 1-phosphate",R04520 R08966 R10325 R10326 R10331,Glycerophospholipid metabolism,1.3.1.101; 1.3.7.11; 2.5.1.42; 2.7.7.67,NA,NA,PubChem: 7227; ChEBI: 16266 50725; NIKKAJI: J1.283.068H,cpd:C04638,43,73,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H74O6P1,C43H72O6P1,716.5144771,717.5223021,715.5066522227,2486,cpd:C06771,Triethanolamine;,C6H15NO3,Triethanolamine; Trolamine,R05382,Glycerophospholipid metabolism,4.3.3.-,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C06771  Triethanolamine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;    D03A CICATRIZANTS;     D03AX Other cicatrizants;      D03AX12 Trolamine;       D00215  Trolamine (NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00215  [001446] Triethanolamine;  Buffering agent;   D00215  [001446] Triethanolamine;  Base;   D00215  [001446] Triethanolamine;  Emulsion;   D00215  [001446] Triethanolamine;  pH regulator;   D00215  [001446] Triethanolamine;  Solubilization agent;   D00215  [001446] Triethanolamine,CAS: 102-71-6; PubChem: 8991; ChEBI: 28621; ChEMBL: CHEMBL446061; PDB-CCD: 211; 3DMET: B01049; NIKKAJI: J805B,cpd:C06771,6,15,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H16O3N1,C6H14O3N1,149.1051933,150.1130184,148.09736832228,2487,cpd:C06772,Diethanolamine,C4H11NO2,Diethanolamine,R05381 R05382,Glycerophospholipid metabolism,4.3.3.-,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C06772  Diethanolamine; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D02337  [101808] Diethanolamine;  Buffering agent;   D02337  [101808] Diethanolamine;  Solubilization agent;   D02337  [101808] Diethanolamine,CAS: 111-42-2; PubChem: 8992; ChEBI: 28123; ChEMBL: CHEMBL119604; 3DMET: B01050; NIKKAJI: J808G,cpd:C06772; cpd:C11260,4,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H12O2N1,C4H10O2N1,105.0789786,106.0868036,104.07115362229,2488,cpd:C13482,Phosphodimethylethanolamine,C4H12NO4P,Phosphodimethylethanolamine,R06868 R06869,Glycerophospholipid metabolism,2.1.1.103,NA,NA,PubChem: 586220; ChEBI: 31997; 3DMET: B04573; NIKKAJI: J8.863C,cpd:C13482,4,12,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H13O4N1P1,C4H11O4N1P1,169.0503949,170.0582199,168.04256982230,2489,cpd:C18059,"CDP-2,3-bis-O-(geranylgeranyl)-sn-glycerol",C52H85N3O13P2,"CDP-2,3-bis-O-(geranylgeranyl)-sn-glycerol",R08966 R10255,Glycerophospholipid metabolism,2.7.7.67; 2.7.8.38,NA,"Lipids [BR:br08002];  GP  Glycerophospholipids;   GP13 CDP-Glycerols;    GP1304 CDP-Dialkylglycerols;     C18059  CDP-2,3-bis-O-(geranylgeranyl)-sn-glycerol",PubChem: 96024278; ChEBI: 50726,cpd:C18059,52,85,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C52H86O13N3P2,C52H84O13N3P2,1021.555764,1022.563589,1020.5479392231,2495,cpd:C20466,"2,3-Bis-O-(geranylgeranyl)-sn-glycero-1-phospho-L-serine",C46H78NO8P,"2,3-Bis-O-(geranylgeranyl)-sn-glycero-1-phospho-L-serine",R10255,Glycerophospholipid metabolism,2.7.8.38,NA,NA,PubChem: 163312203,cpd:C20466,46,78,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H79O8N1P1,C46H77O8N1P1,803.5465055,804.5543305,802.53868042232,2496,cpd:C20518,"2,3-Bis-(O-phytanyl)-sn-glycerol 1-phosphate",C43H89O6P,"2,3-Bis-(O-phytanyl)-sn-glycerol 1-phosphate",R10325 R10326 R10331,Glycerophospholipid metabolism,1.3.1.101; 1.3.7.11,NA,NA,PubChem: 172232267; PDB-CCD: L1P,cpd:C20518,43,89,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H90O6P1,C43H88O6P1,732.6396776,733.6475026,731.63185262233,2519,cpd:C00219,Arachidonate;,C20H32O2,"Arachidonate; Arachidonic acid; (5Z,8Z,11Z,14Z)-Icosatetraenoic acid; cis-5,8,11,14-Eicosatetraenoic acid",R01317 R01590 R01593 R01594 R01595 R01596 R01598 R01599; R07038 R07041 R07046 R07047 R07048 R07049 R07050 R07051; R07052 R07053 R07054 R08183 R08527 R09536,Arachidonic acid metabolism; Linoleic acid metabolism; Biosynthesis of unsaturated fatty acids; Metabolic pathways; Vascular smooth muscle contraction; Platelet activation; Fc epsilon RI signaling pathway; Fc gamma R-mediated phagocytosis; Retrograde endocannabinoid signaling; Serotonergic synapse; Long-term depression; Phototransduction - fly; Inflammatory mediator regulation of TRP channels; GnRH signaling pathway; Ovarian steroidogenesis; Oxytocin signaling pathway; Regulation of lipolysis in adipocytes; Aldosterone synthesis and secretion; Leishmaniasis; Amoebiasis; Eicosanoids,1.13.11.31; 1.13.11.33; 1.13.11.34; 1.13.11.40; 1.13.11.-; 1.14.13.-; 1.14.14.1; 1.14.15.3; 1.14.99.1; 3.1.1.4; 3.1.2.2; 3.5.1.99; 6.2.1.15,NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C00219  Arachidonic acid (20:4;5,8,11,14); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C00219  (5Z,8Z,11Z,14Z)-Icosatetra-5,8,11,14-enoic acid",CAS: 506-32-1; PubChem: 3519; ChEBI: 15843; ChEMBL: CHEMBL15594; LIPIDMAPS: LMFA01030001; LipidBank: DFA0213; KNApSAcK: C00000388; PDB-CCD: ACD; 3DMET: B00061; NIKKAJI: J12.228I,cpd:C00219; cpd:C09057; cpd:C09124; cpd:C11897; cpd:C14493; cpd:C14605; cpd:C14956; cpd:C15176; cpd:C15252; cpd:C15367; cpd:C17920; cpd:C20329,20,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O2,C20H31O2,304.2402303,305.2480553,303.23240522234,2520,cpd:C00427,Prostaglandin H2;,C20H32O5,"Prostaglandin H2; (5Z,13E)-(15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate; (5Z,13E,15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate; PGH2; (5Z,9alpha,11alpha,13E,15S)-9,11-Epidioxy-15-hydroxy-prosta-5,13-dienoate",R00073 R01599 R02264 R02265 R02266 R02267 R02268 R09506,Arachidonic acid metabolism; Metabolic pathways; Platelet activation; Retrograde endocannabinoid signaling; Serotonergic synapse; Oxytocin signaling pathway; Eicosanoids; Prostaglandins,1.11.1.20; 1.14.99.1; 5.3.99.2; 5.3.99.3; 5.3.99.4; 5.3.99.5,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Prostaglandins;     C00427  Prostaglandin H2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C00427  Prostaglandin H2,CAS: 42935-17-1; PubChem: 3717; ChEBI: 15554; ChEMBL: CHEMBL1743209; LIPIDMAPS: LMFA03010010; LipidBank: XPR1798; 3DMET: B01243; NIKKAJI: J16.429A,cpd:C00427; cpd:C00584; cpd:C00696; cpd:C01312; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04853; cpd:C05960; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C11997; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C17652; cpd:C17656,20,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O5,C20H31O5,352.2249741,353.2327992,351.21714912235,2521,cpd:C00584,Prostaglandin E2;,C20H32O5,"Prostaglandin E2; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate; (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate; Dinoprostone; PGE2",R02265 R02580 R02581 R02583,Arachidonic acid metabolism; Metabolic pathways; cAMP signaling pathway; Neuroactive ligand-receptor interaction; Serotonergic synapse; Inflammatory mediator regulation of TRP channels; Oxytocin signaling pathway; Regulation of lipolysis in adipocytes; Renin secretion; Bile secretion; Leishmaniasis; African trypanosomiasis; Amoebiasis; Pathways in cancer; Rheumatoid arthritis,1.1.1.141; 1.1.1.184; 1.1.1.189; 5.3.99.3,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Prostaglandins;     C00584  Prostaglandin E2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C00584  Prostaglandin E2; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G02 OTHER GYNECOLOGICALS;    G02A UTEROTONICS;     G02AD Prostaglandins;      G02AD02 Dinoprostone;       D00079  Dinoprostone (JAN/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    249  Miscellaneous;     2499  Others;      D00079  Dinoprostone (JAN/USP/INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Prostaglandin;     Prostaglandin E2 receptor EP2 subtype;      Dinoprostone;       D00079  Dinoprostone (JAN/USP/INN); Endocrine and hormonal agents [br08373.html];  Other gynecological agents;   D00079,CAS: 363-24-6; PubChem: 3863; ChEBI: 15551; ChEMBL: CHEMBL548; LIPIDMAPS: LMFA03010003; LipidBank: XPR1401; PDB-CCD: P2E; 3DMET: B01290; NIKKAJI: J9.243F,cpd:C00427; cpd:C00584; cpd:C00696; cpd:C01312; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04853; cpd:C05960; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C11997; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C17652; cpd:C17656,20,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O5,C20H31O5,352.2249741,353.2327992,351.21714912236,2522,cpd:C00639,Prostaglandin F2alpha;,C20H34O5,"Prostaglandin F2alpha; (5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate; (+)-Prostaglandin F2a; 7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid; 9a,11a-PGF2; Amoglandin; Cyclosin; Dinoprost; Enzaprost; Enzaprost F; Panacelan; PGF2a; 9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid; Prostaglandin F2a; Prostin F 2 alpha; Protamodin; U 14583; (5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoate",R02264 R02581 R02683 R02684 R09506,Arachidonic acid metabolism; Metabolic pathways; Phospholipase D signaling pathway; Neuroactive ligand-receptor interaction; Serotonergic synapse; Ovarian steroidogenesis; Oxytocin signaling pathway; Bile secretion,1.1.1.141; 1.1.1.184; 1.1.1.188; 1.1.1.189; 1.1.1.196; 1.11.1.20,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Prostaglandins;     C00639  Prostaglandin F2alpha; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C00639  Prostaglandin F2alpha; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G02 OTHER GYNECOLOGICALS;    G02A UTEROTONICS;     G02AD Prostaglandins;      G02AD01 Dinoprost;       D00081  Dinoprost (JP17/USAN/INN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    249  Miscellaneous;     2499  Others;      D00081  Dinoprost (JP17/USAN/INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Prostaglandin;     prostaglandin F receptor;      Dinoprost;       D00081  Dinoprost (JP17/USAN/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00081  Dinoprost; Endocrine and hormonal agents [br08373.html];  Other gynecological agents;   D00081; Animal drugs in Japan [BR:br08331];  94  Agents for breeding;   941  Hormone preparations (except posterior-pituitary hormone and preparations);    9419  Other hormone preparations;     C00639  Dinoprost,CAS: 551-11-1; PubChem: 3912; ChEBI: 15553; ChEMBL: CHEMBL1903583 CHEMBL815; LIPIDMAPS: LMFA03010002; LipidBank: XPR1501; 3DMET: B01297; NIKKAJI: J9.246K,cpd:C00639; cpd:C02314; cpd:C04741; cpd:C04843; cpd:C05959; cpd:C06438; cpd:C12786; cpd:C13548; cpd:C13809; cpd:C14782; cpd:C14809; cpd:C14811; cpd:C14814,20,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O5,C20H33O5,354.2406242,355.2484492,353.23279922237,2523,cpd:C00696,Prostaglandin D2;,C20H32O5,"Prostaglandin D2; (5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate; (5Z,13E,15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate; PGD2",R02266 R02684 R02799 R02800 R02801,Arachidonic acid metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction; Fc epsilon RI signaling pathway; Serotonergic synapse; African trypanosomiasis; Asthma,1.1.1.188; 1.1.1.196; 5.3.99.2,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Prostaglandins;     C00696  Prostaglandin D2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C00696  Prostaglandin D2,CAS: 41598-07-6; PubChem: 3964; ChEBI: 15555; ChEMBL: CHEMBL1235252 CHEMBL165001; LIPIDMAPS: LMFA03010004; LipidBank: XPR1301; PDB-CCD: PG2; 3DMET: B01315; NIKKAJI: J16.416J,cpd:C00427; cpd:C00584; cpd:C00696; cpd:C01312; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04853; cpd:C05960; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C11997; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C17652; cpd:C17656,20,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O5,C20H31O5,352.2249741,353.2327992,351.21714912238,2524,cpd:C00909,Leukotriene A4;,C20H30O3,"Leukotriene A4; LTA4; (7E,9E,11Z,14Z)-(5S,6S)-5,6-Epoxyeicosa-7,9,11,14-tetraenoic acid; (7E,9E,11Z,14Z)-(5S,6S)-5,6-Epoxyeicosa-7,9,11,14-tetraenoate; (7E,9E,11Z,14Z)-(5S,6S)-5,6-Epoxyicosa-7,9,11,14-tetraenoate; (5S,6S,7E,9E,11Z,14Z)-5,6-Epoxyicosa-7,9,11,14-tetraenoate",R03057 R03058 R03059 R08527,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse; Eicosanoids,1.13.11.34; 3.3.2.6; 4.4.1.20,NA,"Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Leukotrienes;     C00909  Leukotriene A4; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0107 Epoxy fatty acids;     C00909  (7E,9E,11Z,14Z)-(5S,6S)-5,6-Epoxyeicosa-7,9,11,14-tetraenoic acid;   FA03 Eicosanoids;    FA0302 Leukotrienes;     C00909  Leukotriene A4",CAS: 72059-45-1; PubChem: 4164; ChEBI: 15651; ChEMBL: CHEMBL69439; LIPIDMAPS: LMFA03020023; LipidBank: XPR3001; 3DMET: B01350; NIKKAJI: J138.393K,cpd:C00909; cpd:C02645; cpd:C04170; cpd:C04577; cpd:C07052; cpd:C09079; cpd:C09110; cpd:C11875; cpd:C13843; cpd:C14555; cpd:C14628; cpd:C14665; cpd:C14683; cpd:C14732; cpd:C14807; cpd:C14891; cpd:C14929; cpd:C14945; cpd:C14980; cpd:C15354; cpd:C15434; cpd:C17498; cpd:C17956; cpd:C18177; cpd:C20212,20,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O3,C20H29O3,318.2194948,319.2273199,317.21166982239,2525,cpd:C01312,Prostaglandin I2;,C20H32O5,"Prostaglandin I2; (5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate; Prostacyclin; PGI2; Epoprostenol",R02267 R03520 R03521,Arachidonic acid metabolism; Metabolic pathways; cAMP signaling pathway; Neuroactive ligand-receptor interaction; Vascular smooth muscle contraction; VEGF signaling pathway; Platelet activation,1.1.1.231; 5.3.99.4,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Prostaglandins;     C01312  Prostaglandin I2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C01312  Prostaglandin I2; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B01 ANTITHROMBOTIC AGENTS;    B01A ANTITHROMBOTIC AGENTS;     B01AC Platelet aggregation inhibitors excl. heparin;      B01AC09 Epoprostenol;       D00106  Epoprostenol (USAN/INN); USP drug classification [BR:br08302];  Respiratory Tract/Pulmonary Agents;   Pulmonary Antihypertensives;    Epoprostenol;     D00106  Epoprostenol (USAN/INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Prostacyclin;     prostaglandin I2 receptor;      Epoprostenol;       D00106  Epoprostenol (USAN/INN),CAS: 35121-78-9; PubChem: 4527; ChEBI: 15552; ChEMBL: CHEMBL1139 CHEMBL1742490 CHEMBL417790; LIPIDMAPS: LMFA03010087; LipidBank: XPR1801; 3DMET: B01438; NIKKAJI: J17.550A,cpd:C00427; cpd:C00584; cpd:C00696; cpd:C01312; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04853; cpd:C05960; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C11997; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C17652; cpd:C17656,20,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O5,C20H31O5,352.2249741,353.2327992,351.21714912240,2526,cpd:C02165,Leukotriene B4;,C20H32O4,"Leukotriene B4; (6Z,8E,10E,14Z)-(5S,12R)-5,12-Dihydroxyeicosa-6,8,10,14-tetraenoate; (6Z,8E,10E,14Z)-(5S,12R)-5,12-Dihydroxyicosa-6,8,10,14-tetraenoate; LTB4",R03057 R03863 R03864 R03866,Arachidonic acid metabolism; Metabolic pathways; PPAR signaling pathway; Neuroactive ligand-receptor interaction; Serotonergic synapse; Inflammatory mediator regulation of TRP channels; Bile secretion; Eicosanoids,1.14.13.30; 3.3.2.6,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Leukotrienes;     C02165  Leukotriene B4; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0302 Leukotrienes;     C02165  Leukotriene B4,CAS: 71160-24-2; PubChem: 5240; ChEBI: 15647; ChEMBL: CHEMBL65061; LIPIDMAPS: LMFA03020001; LipidBank: XPR3101; PDB-CCD: LTB; 3DMET: B01542; NIKKAJI: J240.041C,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452241,2527,cpd:C02166,Leukotriene C4;,C30H47N3O9S,Leukotriene C4; LTC4,R03059 R03867 R09875,Arachidonic acid metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction; Fc epsilon RI signaling pathway; Serotonergic synapse; Bile secretion; Asthma,2.3.2.2; 3.4.19.14; 4.4.1.20,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Leukotrienes;     C02166  Leukotriene C4; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0302 Leukotrienes;     C02166  Leukotriene C4,CAS: 72025-60-6; PubChem: 5241; ChEBI: 16978; ChEMBL: CHEMBL451509; LIPIDMAPS: LMFA03020003; LipidBank: XPR3201; PDB-CCD: LTX; 3DMET: B01543; NIKKAJI: J263.860F,cpd:C02166,30,47,9,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H48O9N3S1,C30H46O9N3S1,625.3033013,626.3111263,624.29547622242,2528,cpd:C02198,Thromboxane A2;,C20H32O5,"Thromboxane A2; (5Z,13E)-(15S)-9alpha,11alpha-Epoxy-15-hydroxythromboxa-5,13-dienoate; (5Z,9alpha,11alpha,13E,15S)-9,11-Epoxy-15-hydroxythromboxa-5,13-dien-1-oic acid; TXA2",R02268 R03878,Arachidonic acid metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction; Platelet activation; Serotonergic synapse; Eicosanoids,5.3.99.5,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Thromboxanes;     C02198  Thromboxane A2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0303 Thromboxanes;     C02198  Thromboxane A2,CAS: 57576-52-0; PubChem: 5266; ChEBI: 15627; ChEMBL: CHEMBL157628; LIPIDMAPS: LMFA03030001; LipidBank: XPR2001; 3DMET: B01544; NIKKAJI: J40.890E,cpd:C00427; cpd:C00584; cpd:C00696; cpd:C01312; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04853; cpd:C05960; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C11997; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C17652; cpd:C17656,20,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O5,C20H31O5,352.2249741,353.2327992,351.21714912243,2529,cpd:C03577,20-Hydroxyleukotriene E4;,C23H37NO6S,20-Hydroxyleukotriene E4; 20-OH-LTE4; 20-OH-Leukotriene E4,R04256,Arachidonic acid metabolism,1.14.13.34,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0302 Leukotrienes;     C03577  20-Hydroxy-leukotriene E4,CAS: 111844-33-8; PubChem: 6369; ChEBI: 28700; LIPIDMAPS: LMFA03020025; LipidBank: XPR3120; 3DMET: B01671; NIKKAJI: J541.638H,cpd:C03577,23,37,6,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C23H38O6N1S1,C23H36O6N1S1,455.2341591,456.2419841,454.22633412244,2530,cpd:C04577,15-OxoETE;,C20H30O3,"15-OxoETE; (5Z,8Z,11Z,13E)-15-Oxoicosa-5,8,11,13-tetraenoic acid; 15-Oxo-5,8,11-cis-13-trans-eicosatetraenoate; 15-Oxo-5,8,11-cis-13-trans-icosatetraenoate",R04517 R04518,Arachidonic acid metabolism,1.1.1.232,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C04577  15-OxoETE,CAS: 81416-72-0; PubChem: 7178; ChEBI: 15559; ChEMBL: CHEMBL418941; LIPIDMAPS: LMFA03060051; LipidBank: DFA8158; 3DMET: B00733; NIKKAJI: J716.153K,cpd:C00909; cpd:C02645; cpd:C04170; cpd:C04577; cpd:C07052; cpd:C09079; cpd:C09110; cpd:C11875; cpd:C13843; cpd:C14555; cpd:C14628; cpd:C14665; cpd:C14683; cpd:C14732; cpd:C14807; cpd:C14891; cpd:C14929; cpd:C14945; cpd:C14980; cpd:C15354; cpd:C15434; cpd:C17498; cpd:C17956; cpd:C18177; cpd:C20212,20,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O3,C20H29O3,318.2194948,319.2273199,317.21166982245,2531,cpd:C04742,"(15S)-15-Hydroxy-5,8,11-cis-13-trans-eicosatetraenoate;",C20H32O3,"(15S)-15-Hydroxy-5,8,11-cis-13-trans-eicosatetraenoate; (15S)-15-Hydroxy-5,8,11-cis-13-trans-icosatetraenoate; (5Z,8Z,11Z,13E)-(15S)-15-Hydroxyicosa-5,8,11,13-tetraenoic acid; 15(S)-HETE",R04517 R04518 R07035,Arachidonic acid metabolism; Inflammatory mediator regulation of TRP channels,1.1.1.232; 1.11.1.9,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C04742  15(S)-HETE,CAS: 54845-95-3; PubChem: 7313; ChEBI: 15558; ChEMBL: CHEMBL594621; LIPIDMAPS: LMFA03060001; LipidBank: DFA8140; 3DMET: B01783; NIKKAJI: J303.917J,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992246,2532,cpd:C04805,5(S)-HETE;,C20H32O3,"5(S)-HETE; 5-Hydroxyeicosatetraenoate; 5-HETE; (6E,8Z,11Z,14Z)-(5S)-5-Hydroxyicosa-6,8,11,14-tetraenoic acid",R07034,Arachidonic acid metabolism; Inflammatory mediator regulation of TRP channels,1.11.1.9,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C04805  5(S)-HETE,CAS: 70608-72-9; PubChem: 7367; ChEBI: 28209; ChEMBL: CHEMBL164813; LIPIDMAPS: LMFA03060002; LipidBank: DFA8129; 3DMET: B01791; NIKKAJI: J390.336B,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992247,2533,cpd:C04822,8(R)-HPETE;,C20H32O4,"8(R)-HPETE; (5Z,9E,11Z,14Z)-(8R)-8-Hydroperoxyeicosa-5,9,11,14-tetraenoate; (5Z,9E,11Z,14Z)-(8R)-8-Hydroperoxyicosa-5,9,11,14-tetraenoate",R01594,Arachidonic acid metabolism; Serotonergic synapse,1.13.11.40,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C04822  8(R)-HPETE,PubChem: 7383; ChEBI: 15629; LIPIDMAPS: LMFA03060037; LipidBank: XPR6014; 3DMET: B01793; NIKKAJI: J1.084.991H,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452248,2534,cpd:C04853,20-OH-Leukotriene B4;,C20H32O5,"20-OH-Leukotriene B4; 20-OH-LTB4; 20-Hydroxy-leukotriene B4; (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyeicosa-6,8,10,14-tetraenoate; (6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyicosa-6,8,10,14-tetraenoate",R03866 R04616,Arachidonic acid metabolism,1.14.13.30,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0302 Leukotrienes;     C04853  20-Hydroxy-leukotriene B4,PubChem: 7409; ChEBI: 15646; ChEMBL: CHEMBL1593789; LIPIDMAPS: LMFA03020018; LipidBank: XPR3120; 3DMET: B01798; NIKKAJI: J381.079H,cpd:C00427; cpd:C00584; cpd:C00696; cpd:C01312; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04853; cpd:C05960; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C11997; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C17652; cpd:C17656,20,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O5,C20H31O5,352.2249741,353.2327992,351.21714912249,2535,cpd:C05356,5(S)-HPETE;,C20H32O4,"5(S)-HPETE; 5(S)-Hydroperoxy-6-trans-8,11,14-cis-eicosatetraenoic acid; (6E,8Z,11Z,14Z)-(5S)-5-Hydroperoxyeicosa-6,8,11,14-tetraenoate; (6E,8Z,11Z,14Z)-(5S)-5-Hydroperoxyeicosa-6,8,11,14-tetraenoic acid; (5S,6E,8Z,11Z,14Z)-5-Hydroperoxyicosa-6,8,11,14-tetraenoate",R01595 R03058 R07034,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse; Ovarian steroidogenesis; Eicosanoids,1.11.1.9; 1.13.11.34,NA,"Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Leukotrienes;     C05356  5-HPETE; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0104 Hydroperoxy fatty acids;     C05356  (6E,8Z,11Z,14Z)-(5S)-5-Hydroperoxyicosa-6,8,11,14-tetraenoic acid;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C05356  5(S)-HPETE",PubChem: 7733; ChEBI: 15632; ChEMBL: CHEMBL1743204; LIPIDMAPS: LMFA03060012; LipidBank: XPR6001; 3DMET: B01847; NIKKAJI: J360.970G,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452250,2536,cpd:C05949,12-Keto-leukotriene B4;,C20H30O4,"12-Keto-leukotriene B4; 12-Keto-LTB4; 5-Hydroxy-12-oxo-Delta5,8,11,14-eicosapolyenoic acid",R03863 R03864,Arachidonic acid metabolism,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0302 Leukotrienes;     C05949  12-Keto-leukotriene B4,PubChem: 8233; ChEBI: 27814; LIPIDMAPS: LMFA03020024; LipidBank: XPR3111; 3DMET: B01923; NIKKAJI: J662.082E,cpd:C05949; cpd:C05953; cpd:C05954; cpd:C05955; cpd:C05957; cpd:C05958; cpd:C09125; cpd:C09150; cpd:C11256; cpd:C11876; cpd:C14504; cpd:C14815; cpd:C14913; cpd:C15159; cpd:C18173,20,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O4,C20H29O4,334.2144094,335.2222345,333.20658442251,2537,cpd:C05950,20-COOH-Leukotriene B4;,C20H30O6,"20-COOH-Leukotriene B4; 20-COOH-LTB4; 20-Carboxy-leukotriene B4; 5,12-Dihydroxy-Delta5,8,11,14-eicosapolyendioic acid",R04616,Arachidonic acid metabolism,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0302 Leukotrienes;     C05950  20-Carboxy-leukotriene B4,PubChem: 8234; ChEBI: 27562; ChEMBL: CHEMBL1592630; LIPIDMAPS: LMFA03020016; LipidBank: XPR3118; 3DMET: B01924; NIKKAJI: J2.760.808F,cpd:C05950; cpd:C08758; cpd:C15438,20,30,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O6,C20H29O6,366.2042387,367.2120637,365.19641372252,2538,cpd:C05951,Leukotriene D4;,C25H40N2O6S,Leukotriene D4; LTD4,R03867 R05055 R09875,Arachidonic acid metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction; Fc epsilon RI signaling pathway; Asthma,2.3.2.2; 2.3.2.-; 3.4.19.14,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Leukotrienes;     C05951  Leukotriene D4; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0302 Leukotrienes;     C05951  Leukotriene D4,CAS: 73836-78-9; PubChem: 8235; ChEBI: 28666; ChEMBL: CHEMBL1521056 CHEMBL288943; LIPIDMAPS: LMFA03020006; LipidBank: XPR3301; PDB-CCD: LTD; 3DMET: B01925; NIKKAJI: J591.181H,cpd:C05951,25,40,6,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O6N2S1,C25H39O6N2S1,496.2607082,497.2685332,495.25288322253,2539,cpd:C05952,Leukotriene E4;,C23H37NO5S,"Leukotriene E4; LTE4; (7E,9E,11Z,14Z)-(5S,6R)-6-(Cystein-S-yl)-5-hydroxyeicosa-7,9,11,14-tetraenoate; (7E,9E,11Z,14Z)-(5S,6R)-6-(Cystein-S-yl)-5-hydroxyicosa-7,9,11,14-tetraenoate",R04256 R05055 R05207,Arachidonic acid metabolism; Metabolic pathways; Neuroactive ligand-receptor interaction; Fc epsilon RI signaling pathway,1.14.13.34; 2.3.2.-,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Leukotrienes;     C05952  Leukotriene E4; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0302 Leukotrienes;     C05952  Leukotriene E4,CAS: 75715-89-8; PubChem: 8236; ChEBI: 15650; ChEMBL: CHEMBL509456; LIPIDMAPS: LMFA03020002; LipidBank: XPR3401; 3DMET: B01926; NIKKAJI: J264.600E,cpd:C05952,23,37,5,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C23H38O5N1S1,C23H36O5N1S1,439.2392445,440.2470695,438.23141942254,2540,cpd:C05953,Prostaglandin A2;,C20H30O4,Prostaglandin A2; PGA2; Medullin,R02583 R05056,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse,NA,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Prostaglandins;     C05953  Prostaglandin A2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C05953  Prostaglandin A2,PubChem: 8237; ChEBI: 27820; ChEMBL: CHEMBL1084643; LIPIDMAPS: LMFA03010035 LMFA03010100; LipidBank: XPR1001; 3DMET: B01927; NIKKAJI: J15.713I,cpd:C05949; cpd:C05953; cpd:C05954; cpd:C05955; cpd:C05957; cpd:C05958; cpd:C09125; cpd:C09150; cpd:C11256; cpd:C11876; cpd:C14504; cpd:C14815; cpd:C14913; cpd:C15159; cpd:C18173,20,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O4,C20H29O4,334.2144094,335.2222345,333.20658442255,2541,cpd:C05954,Prostaglandin B2;,C20H30O4,Prostaglandin B2; PGB2,R05057,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse,NA,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Prostaglandins;     C05954  Prostaglandin B2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C05954  Prostaglandin B2,CAS: 13367-85-6; PubChem: 8238; ChEBI: 28099; ChEMBL: CHEMBL1901620; LIPIDMAPS: LMFA03010018; LipidBank: XPR1101; 3DMET: B01928; NIKKAJI: J16.062H,cpd:C05949; cpd:C05953; cpd:C05954; cpd:C05955; cpd:C05957; cpd:C05958; cpd:C09125; cpd:C09150; cpd:C11256; cpd:C11876; cpd:C14504; cpd:C14815; cpd:C14913; cpd:C15159; cpd:C18173,20,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O4,C20H29O4,334.2144094,335.2222345,333.20658442256,2542,cpd:C05955,Prostaglandin C2;,C20H30O4,Prostaglandin C2; PGC2,R05056 R05057,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse,NA,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Prostaglandins;     C05955  Prostaglandin C2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C05955  Prostaglandin C2,PubChem: 8239; ChEBI: 27555; LIPIDMAPS: LMFA03010133; LipidBank: XPR1201; 3DMET: B01929; NIKKAJI: J10.364K,cpd:C05949; cpd:C05953; cpd:C05954; cpd:C05955; cpd:C05957; cpd:C05958; cpd:C09125; cpd:C09150; cpd:C11256; cpd:C11876; cpd:C14504; cpd:C14815; cpd:C14913; cpd:C15159; cpd:C18173,20,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O4,C20H29O4,334.2144094,335.2222345,333.20658442257,2543,cpd:C05956,Prostaglandin G2;,C20H32O6,Prostaglandin G2; PGG2,R00073 R01590,Arachidonic acid metabolism; Metabolic pathways; Platelet activation; Serotonergic synapse; Eicosanoids,1.14.99.1,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Prostaglandins;     C05956  Prostaglandin G2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C05956  Prostaglandin G2,CAS: 51982-36-6; PubChem: 8240; ChEBI: 27647; LIPIDMAPS: LMFA03010009; LipidBank: XPR1601; PDB-CCD: PGX; 3DMET: B01930; NIKKAJI: J10.404C,cpd:C05956; cpd:C05962; cpd:C05964; cpd:C12202; cpd:C17653; cpd:C17655,20,32,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O6,C20H31O6,368.2198887,369.2277138,367.21206372258,2544,cpd:C05957,Prostaglandin J2;,C20H30O4,Prostaglandin J2; PGJ2,R02801 R05058,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse,NA,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Prostaglandins;     C05957  Prostaglandin J2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C05957  Prostaglandin J2,CAS: 60203-57-8; PubChem: 8241; ChEBI: 27485; ChEMBL: CHEMBL1397260 CHEMBL353489; LIPIDMAPS: LMFA03010019; LipidBank: XPR1901; 3DMET: B01931; NIKKAJI: J39.531E,cpd:C05949; cpd:C05953; cpd:C05954; cpd:C05955; cpd:C05957; cpd:C05958; cpd:C09125; cpd:C09150; cpd:C11256; cpd:C11876; cpd:C14504; cpd:C14815; cpd:C14913; cpd:C15159; cpd:C18173,20,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O4,C20H29O4,334.2144094,335.2222345,333.20658442259,2545,cpd:C05958,Delta-12-Prostaglandin J2;,C20H30O4,Delta-12-Prostaglandin J2; Delta-12-PGJ2,R05058 R07067,Arachidonic acid metabolism; Metabolic pathways,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C05958  delta-12-Prostaglandin J2,CAS: 87893-54-7; PubChem: 8242; ChEBI: 28130; ChEMBL: CHEMBL519797; LIPIDMAPS: LMFA03010020; LipidBank: XPR1726; 3DMET: B01932; NIKKAJI: J351.577J,cpd:C05949; cpd:C05953; cpd:C05954; cpd:C05955; cpd:C05957; cpd:C05958; cpd:C09125; cpd:C09150; cpd:C11256; cpd:C11876; cpd:C14504; cpd:C14815; cpd:C14913; cpd:C15159; cpd:C18173,20,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O4,C20H29O4,334.2144094,335.2222345,333.20658442260,2546,cpd:C05959,11-epi-Prostaglandin F2alpha;,C20H34O5,11-epi-Prostaglandin F2alpha; 11-epi-Prostaglandin F2a; 11-epi-PGF2alpha; 11-epi-PGF2a,R02799,Arachidonic acid metabolism,1.1.1.188,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C05959  11-epi-Prostaglandin F2alpha,PubChem: 8243; ChEBI: 27595; ChEMBL: CHEMBL1369536; LIPIDMAPS: LMFA03010036; LipidBank: XPR1719; 3DMET: B01933; NIKKAJI: J401.553C,cpd:C00639; cpd:C02314; cpd:C04741; cpd:C04843; cpd:C05959; cpd:C06438; cpd:C12786; cpd:C13548; cpd:C13809; cpd:C14782; cpd:C14809; cpd:C14811; cpd:C14814,20,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O5,C20H33O5,354.2406242,355.2484492,353.23279922261,2547,cpd:C05960,15-Keto-prostaglandin F2alpha;,C20H32O5,15-Keto-prostaglandin F2alpha; 15-Keto-prostaglandin F2a; 15-Keto-PGF2alpha; 15-Keto-PGF2a,R02683,Arachidonic acid metabolism,1.1.1.141; 1.1.1.196,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C05960  15-Keto-prostaglandin F2alpha,PubChem: 8244; ChEBI: 28442; ChEMBL: CHEMBL50069; LIPIDMAPS: LMFA03010026; LipidBank: XPR1511; 3DMET: B01934; NIKKAJI: J366.794D,cpd:C00427; cpd:C00584; cpd:C00696; cpd:C01312; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04853; cpd:C05960; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C11997; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C17652; cpd:C17656,20,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O5,C20H31O5,352.2249741,353.2327992,351.21714912262,2548,cpd:C05961,6-Keto-prostaglandin F1alpha;,C20H34O6,6-Keto-prostaglandin F1alpha; 6-Keto-prostaglandin F1a; 6-Keto-PGF1alpha; 6-Keto-PGF1a,R03521 R05059,Arachidonic acid metabolism; Metabolic pathways,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C05961  6-Keto-prostaglandin F1alpha,CAS: 58962-34-8; PubChem: 8245; ChEBI: 28158; LIPIDMAPS: LMFA03010001; LipidBank: XPR1811; 3DMET: B01935; NIKKAJI: J240.195I,cpd:C05961; cpd:C05963,20,34,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O6,C20H33O6,370.2355388,371.2433638,369.22771382263,2549,cpd:C05962,6-Keto-prostaglandin E1;,C20H32O6,6-Keto-prostaglandin E1; 6-Keto-PGE1,R05059,Arachidonic acid metabolism; Metabolic pathways,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C05962  6-Keto-prostaglandin E1,CAS: 67786-53-2; PubChem: 8246; ChEBI: 28269; ChEMBL: CHEMBL138482; LIPIDMAPS: LMFA03010012; LipidBank: XPR1430; 3DMET: B01936; NIKKAJI: J428.385F,cpd:C05956; cpd:C05962; cpd:C05964; cpd:C12202; cpd:C17653; cpd:C17655,20,32,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O6,C20H31O6,368.2198887,369.2277138,367.21206372264,2550,cpd:C05963,Thromboxane B2;,C20H34O6,Thromboxane B2; TXB2,R03878 R05060,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse; Bile secretion,NA,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Thromboxanes;     C05963  Thromboxane B2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0303 Thromboxanes;     C05963  Thromboxane B2,CAS: 54397-85-2; PubChem: 8247; ChEBI: 28728; ChEMBL: CHEMBL1552426; LIPIDMAPS: LMFA03030002; LipidBank: XPR2101; 3DMET: B01937; NIKKAJI: J37.201C,cpd:C05961; cpd:C05963,20,34,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O6,C20H33O6,370.2355388,371.2433638,369.22771382265,2551,cpd:C05964,11-Dehydro-thromboxane B2,C20H32O6,11-Dehydro-thromboxane B2,R05060,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse,NA,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Thromboxanes;     C05964  11-Dehydro-thromboxane B2; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0303 Thromboxanes;     C05964  11-Dehydro-thromboxane B2,CAS: 67910-12-7; PubChem: 8248; ChEBI: 28667; ChEMBL: CHEMBL1405272; LIPIDMAPS: LMFA03030004; LipidBank: XPR2121; 3DMET: B01938; NIKKAJI: J265.059B,cpd:C05956; cpd:C05962; cpd:C05964; cpd:C12202; cpd:C17653; cpd:C17655,20,32,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O6,C20H31O6,368.2198887,369.2277138,367.21206372266,2552,cpd:C05965,12(S)-HPETE;,C20H32O4,"12(S)-HPETE; (5Z,8Z,10E,14Z)-(12S)-12-Hydroperoxyicosa-5,8,10,14-tetraenoic acid; (5Z,8Z,10E,14Z)-(12S)-12-Hydroperoxyicosa-5,8,10,14-tetraenoate; 12-Hydroperoxyeicosatetraenoate; 12-Hydroperoxyicosatetraenoate; 12-Hydroperoxyeicosatetraenoic acid; 12-Hydroperoxyicosatetraenoic acid",R01596 R07039 R07040,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse; Inflammatory mediator regulation of TRP channels,1.13.11.31; 5.4.4.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0104 Hydroperoxy fatty acids;     C05965  (5Z,8Z,10E,14Z)-(12S)-12-Hydroperoxyicosa-5,8,10,14-tetraenoic acid;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C05965  12(S)-HPETE",PubChem: 8249; ChEBI: 15626; ChEMBL: CHEMBL1447811; LIPIDMAPS: LMFA03060013; LipidBank: XPR6002; 3DMET: B01939; NIKKAJI: J341.562G,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452267,2553,cpd:C05966,15(S)-HPETE;,C20H32O4,"15(S)-HPETE; (5Z,8Z,11Z,13E)-(15S)-15-Hydroperoxyicosa-5,8,11,13-tetraenoic acid; 15-Hydroperoxyeicosatetraenoate; 15-Hydroperoxyicosatetraenoate; 15-Hydroperoxyeicosatetraenoic acid; 15-Hydroperoxyicosatetraenoic acid; (5Z,8Z,11Z,13E)-(15S)-15-Hydroperoxyicosa-5,8,11,13-tetraenoate",R01593 R07035 R07042 R07043,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse; Inflammatory mediator regulation of TRP channels; Ovarian steroidogenesis,1.11.1.9; 1.13.11.33; 1.14.14.1,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0104 Hydroperoxy fatty acids;     C05966  (5Z,8Z,11Z,13E)-(15S)-15-Hydroperoxyicosa-5,8,11,13-tetraenoic acid;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C05966  15(S)-HPETE",PubChem: 8250; ChEBI: 15628; ChEMBL: CHEMBL1606580; LIPIDMAPS: LMFA03060014; LipidBank: XPR6003; KNApSAcK: C00000400; 3DMET: B01940; NIKKAJI: J461.011C,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452268,2554,cpd:C06314,Lipoxin A4;,C20H32O5,"Lipoxin A4; LXA4; 5S,6R,15S-Trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid; (7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoic acid",R07031,Arachidonic acid metabolism; Neuroactive ligand-receptor interaction; Toxoplasmosis,3.3.2.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0304 Lipoxins;     C06314  Lipoxin A4; Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: other receptors;    Cysteinyl leukotriene;     cysteinyl leukotriene receptor 1;      C06314  Lipoxin A4,CAS: 89663-86-5; PubChem: 8550; ChEBI: 6498; ChEMBL: CHEMBL392438; LIPIDMAPS: LMFA03040001; LipidBank: DFA8153 XPR4001; 3DMET: B02008; NIKKAJI: J138.388D,cpd:C00427; cpd:C00584; cpd:C00696; cpd:C01312; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04853; cpd:C05960; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C11997; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C17652; cpd:C17656,20,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O5,C20H31O5,352.2249741,353.2327992,351.21714912269,2555,cpd:C06315,Lipoxin B4;,C20H32O5,"Lipoxin B4; LXB4; 5S,14R,15S-Trihydroxy-6E,8Z,10E,12E-eicosatetraenoic acid; (6E,8Z,10E,12E)-(5S,14R,15S)-Trihydroxyicosa-6,8,10,12-tetraenoic acid",R07032,Arachidonic acid metabolism,3.3.2.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0304 Lipoxins;     C06315  Lipoxin B4; Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: other receptors;    Cysteinyl leukotriene;     cysteinyl leukotriene receptor 1;      C06315  Lipoxin B4,CAS: 98049-69-5; PubChem: 8551; ChEBI: 6499; LIPIDMAPS: LMFA03040002; LipidBank: XPR4101; 3DMET: B02009; NIKKAJI: J304.437H,cpd:C00427; cpd:C00584; cpd:C00696; cpd:C01312; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04853; cpd:C05960; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C11997; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C17652; cpd:C17656,20,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O5,C20H31O5,352.2249741,353.2327992,351.21714912270,2556,cpd:C06462,Leukotriene F4;,C28H44N2O8S,Leukotriene F4; LTF4,R05207,Arachidonic acid metabolism; Metabolic pathways,2.3.2.-,NA,Compounds with biological roles [BR:br08001];  Lipids;   Eicosanoids;    Leukotrienes;     C06462  Leukotriene F4; Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0302 Leukotrienes;     C06462  Leukotriene F4,PubChem: 8694; ChEBI: 27491; LIPIDMAPS: LMFA03020009; LipidBank: XPR3501; 3DMET: B02033; NIKKAJI: J314.102K,cpd:C06462,28,44,8,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H45O8N2S1,C28H43O8N2S1,568.2818376,569.2896626,567.27401252271,2557,cpd:C13809,"9,11,15-Trihydroxy-prosta-5,13-dien-1-oic acid;",C20H34O5,"9,11,15-Trihydroxy-prosta-5,13-dien-1-oic acid; 8-Isoprostaglandin F2alpha; 8-Isoprostane; 8-epi-Prostaglandin F2alpha",NA,Arachidonic acid metabolism,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0311 Isoprostanes;     C13809  8-Isoprostaglandin F2alpha,PubChem: 854054; ChEBI: 34505; ChEMBL: CHEMBL1592632; LIPIDMAPS: LMFA03110001; LipidBank: XPR1788; 3DMET: B04585; NIKKAJI: J493.589F,cpd:C00639; cpd:C02314; cpd:C04741; cpd:C04843; cpd:C05959; cpd:C06438; cpd:C12786; cpd:C13548; cpd:C13809; cpd:C14782; cpd:C14809; cpd:C14811; cpd:C14814,20,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O5,C20H33O5,354.2406242,355.2484492,353.23279922272,2558,cpd:C14717,"15-Deoxy-Delta12,14-PGJ2;",C20H28O3,"15-Deoxy-Delta12,14-PGJ2; 15-Deoxy-Delta12,14-prostaglandin J2; 15-Deoxy-PGJ2",R07067,Arachidonic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C14717  15-Deoxy-delta-12,14-Prostaglandin J2",PubChem: 17395716; ChEBI: 34159; ChEMBL: CHEMBL482477; LIPIDMAPS: LMFA03010021; LipidBank: XPR1766; NIKKAJI: J2.788.586A,cpd:C06093; cpd:C07851; cpd:C09066; cpd:C09163; cpd:C09182; cpd:C09196; cpd:C09706; cpd:C09845; cpd:C14242; cpd:C14615; cpd:C14717; cpd:C14887; cpd:C15126; cpd:C15192; cpd:C15282; cpd:C15287; cpd:C16677; cpd:C16679; cpd:C16680; cpd:C18016,20,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O3,C20H27O3,316.2038448,317.2116698,315.19601972273,2559,cpd:C14732,5-OxoETE;,C20H30O3,"5-OxoETE; (6E,8Z,11Z,14Z)-5-Oxoicosa-6,8,11,14-tetraenoic acid; 5-Oxoeicosatetraenoic acid; 5-Oxoicosatetraenoic acid",NA,Arachidonic acid metabolism,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14732  5-OxoETE,PubChem: 17395731; ChEBI: 52449; ChEMBL: CHEMBL18028; LIPIDMAPS: LMFA03060011; LipidBank: DFA8156; NIKKAJI: J661.539B,cpd:C00909; cpd:C02645; cpd:C04170; cpd:C04577; cpd:C07052; cpd:C09079; cpd:C09110; cpd:C11875; cpd:C13843; cpd:C14555; cpd:C14628; cpd:C14665; cpd:C14683; cpd:C14732; cpd:C14807; cpd:C14891; cpd:C14929; cpd:C14945; cpd:C14980; cpd:C15354; cpd:C15434; cpd:C17498; cpd:C17956; cpd:C18177; cpd:C20212,20,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O3,C20H29O3,318.2194948,319.2273199,317.21166982274,2560,cpd:C14748,20-HETE;,C20H32O3,"20-HETE; (5Z,8Z,11Z,14Z)-20-Hydroxyicosa-5,8,11,14-tetraenoic acid; 20-Hydroxyeicosatetraenoic acid; 20-Hydroxyicosatetraenoic acid; 20-Hydroxy arachidonic acid",R07041,Arachidonic acid metabolism; Metabolic pathways; Vascular smooth muscle contraction,1.14.15.3,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14748  20-HETE,CAS: 79551-86-3; PubChem: 17395746; ChEBI: 34306; LIPIDMAPS: LMFA03060009; LipidBank: DFA8141; NIKKAJI: J455.066H,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992275,2561,cpd:C14749,19(S)-HETE;,C20H32O3,19(S)-HETE; (19S)-Hydroxyeicosatetraenoic acid; (19S)-Hydroxyicosatetraenoic acid; (19S)-Hydroxy arachidonic acid,R07046,Arachidonic acid metabolism; Metabolic pathways,1.14.13.-; 1.14.14.1; 1.14.15.3,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14749  19(S)-HETE,CAS: 79551-85-2; PubChem: 17395747; ChEBI: 34185; LIPIDMAPS: LMFA03060074; NIKKAJI: J455.067F,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992276,2562,cpd:C14768,"5,6-EET;",C20H32O3,"5,6-EET; (8Z,11Z,14Z)-5,6-Epoxyeicosa-8,11,14-trienoic acid; (8Z,11Z,14Z)-5,6-Epoxyicosa-8,11,14-trienoic acid",R07052 R07111,Arachidonic acid metabolism; Metabolic pathways; Vascular smooth muscle contraction; Serotonergic synapse; Inflammatory mediator regulation of TRP channels; Ovarian steroidogenesis,1.14.13.-; 1.14.14.1; 3.3.2.10,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;     C14768  5,6-EET",PubChem: 17395766; ChEBI: 34450; ChEMBL: CHEMBL1893588; LIPIDMAPS: LMFA03080002; LipidBank: DFA8110 XPR6300; NIKKAJI: J185.459C,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992277,2563,cpd:C14769,"8,9-EET;",C20H32O3,"8,9-EET; (5Z,11Z,14Z)-8,9-Epoxyeicosa-5,11,14-trienoic acid; (5Z,11Z,14Z)-8,9-Epoxyicosa-5,11,14-trienoic acid",R07051 R07110,Arachidonic acid metabolism; Metabolic pathways; Vascular smooth muscle contraction; Serotonergic synapse; Inflammatory mediator regulation of TRP channels; Ovarian steroidogenesis,1.14.13.-; 1.14.14.1; 3.3.2.10,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;     C14769  8,9-EET",PubChem: 17395767; ChEBI: 34490; ChEMBL: CHEMBL1437769; LIPIDMAPS: LMFA03080003; LipidBank: DFA8111 XPR6301; NIKKAJI: J428.162D,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992278,2564,cpd:C14770,"11,12-EET;",C20H32O3,"11,12-EET; (5Z,8Z,14Z)-11,12-Epoxyeicosa-5,8,14-trienoic acid; (5Z,8Z,14Z)-11,12-Epoxyicosa-5,8,14-trienoic acid",R07050 R07109,Arachidonic acid metabolism; Metabolic pathways; Vascular smooth muscle contraction; Serotonergic synapse; Ovarian steroidogenesis,1.14.13.-; 1.14.14.1; 3.3.2.10,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;     C14770  11,12-EET",PubChem: 17395768; ChEBI: 34130; ChEMBL: CHEMBL128339; LIPIDMAPS: LMFA03080004; LipidBank: DFA8112 XPR6302; NIKKAJI: J428.163B,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992279,2565,cpd:C14771,"14,15-EET;",C20H32O3,"14,15-EET; (5Z,8Z,11Z)-14,15-Epoxyeicosa-5.8.11-trienoic acid; (5Z,8Z,11Z)-14,15-Epoxyicosa-5.8.11-trienoic acid",R07048 R07108,Arachidonic acid metabolism; Metabolic pathways; Vascular smooth muscle contraction; Serotonergic synapse,1.14.13.-; 1.14.14.1; 3.3.2.10,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;     C14771  14,15-EET",PubChem: 17395769; ChEBI: 34157; ChEMBL: CHEMBL269319; LIPIDMAPS: LMFA03080005; LipidBank: DFA8113 XPR6303; NIKKAJI: J185.460G,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992280,2566,cpd:C14772,"5,6-DHET;",C20H34O4,"5,6-DHET; (8Z,11Z,14Z)-5,6-Dihydroxyeicosa-8,11,14-trienoic acid; (8Z,11Z,14Z)-5,6-Dihydroxyicosa-8,11,14-trienoic acid",R07111,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse,3.3.2.10,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;     C14772  5,6-DHET",PubChem: 17395770; ChEBI: 63974; LIPIDMAPS: LMFA03050004; LipidBank: DFA8106; NIKKAJI: J373.279G,cpd:C06088; cpd:C09205; cpd:C14772; cpd:C14773; cpd:C14774; cpd:C14775; cpd:C21171,20,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O4,C20H33O4,338.2457096,339.2535346,337.23788452281,2567,cpd:C14773,"8,9-DHET;",C20H34O4,"8,9-DHET; (5Z,11Z,14Z)-8,9-Dihydroxyeicosa-5,11,14-trienoic acid; (5Z,11Z,14Z)-8,9-Dihydroxyicosa-5,11,14-trienoic acid",R07110,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse,3.3.2.10,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;     C14773  8,9-DHET",PubChem: 17395771; ChEBI: 63970; LIPIDMAPS: LMFA03050006; LipidBank: DFA8107; NIKKAJI: J472.252C,cpd:C06088; cpd:C09205; cpd:C14772; cpd:C14773; cpd:C14774; cpd:C14775; cpd:C21171,20,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O4,C20H33O4,338.2457096,339.2535346,337.23788452282,2568,cpd:C14774,"11,12-DHET;",C20H34O4,"11,12-DHET; (5Z,8Z,14Z)-11,12-Dihydroxyeicosa-5,8,14-trienoic acid; (5Z,8Z,14Z)-11,12-Dihydroxyicosa-5,8,14-trienoic acid",R07109,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse,3.3.2.10,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;     C14774  11,12-DHET",PubChem: 17395772; ChEBI: 63969; LIPIDMAPS: LMFA03050008; LipidBank: DFA8108; NIKKAJI: J1.455.638I,cpd:C06088; cpd:C09205; cpd:C14772; cpd:C14773; cpd:C14774; cpd:C14775; cpd:C21171,20,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O4,C20H33O4,338.2457096,339.2535346,337.23788452283,2569,cpd:C14775,"14,15-DHET;",C20H34O4,"14,15-DHET; (5Z,8Z,11Z)-14,15-Dihydroxyeicosa-5,8,11-trienoic acid; (5Z,8Z,11Z)-14,15-Dihydroxyicosa-5,8,11-trienoic acid",R07108,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse,3.3.2.10,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;     C14775  14,15-DHET",PubChem: 17395773; ChEBI: 63966; ChEMBL: CHEMBL7514; LIPIDMAPS: LMFA03050010; LipidBank: DFA8109; NIKKAJI: J1.455.640K,cpd:C06088; cpd:C09205; cpd:C14772; cpd:C14773; cpd:C14774; cpd:C14775; cpd:C21171,20,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O4,C20H33O4,338.2457096,339.2535346,337.23788452284,2570,cpd:C14776,8(S)-HETE;,C20H32O3,"8(S)-HETE; (5Z,9E,11Z,14Z)-(8S)-8-Hydroxyeicosa-5,9,11,14-tetraenoic acid; (5Z,9E,11Z,14Z)-(8S)-8-Hydroxyicosa-5,9,11,14-tetraenoic acid",NA,Arachidonic acid metabolism; Metabolic pathways; PPAR signaling pathway,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14776  8(S)-HETE,CAS: 98462-03-4; PubChem: 17395774; ChEBI: 34486; LIPIDMAPS: LMFA03060006 LMFA03060086; LipidBank: DFA8131; NIKKAJI: J855.517F,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992285,2571,cpd:C14777,12(S)-HETE;,C20H32O3,"12(S)-HETE; (5Z,8Z,10E,14Z)-(12S)-12-Hydroxyeicosa-5,8,10,14-tetraenoic acid; (5Z,8Z,10E,14Z)-(12S)-12-Hydroxyicosa-5,8,10,14-tetraenoic acid",NA,Arachidonic acid metabolism; Ovarian steroidogenesis; Aldosterone synthesis and secretion,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14777  12(S)-HETE; Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: other receptors;    Leukotriene B4 receptor;     leukotriene B4 receptor 1;      C14777  12(S)-HETE;     leukotriene B4 receptor 2;      C14777  12(S)-HETE,CAS: 54397-83-0; PubChem: 17395775; ChEBI: 34146; ChEMBL: CHEMBL1526258; LIPIDMAPS: LMFA03060007; LipidBank: DFA8138; NIKKAJI: J356.353G,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992286,2572,cpd:C14778,16(R)-HETE;,C20H32O3,"16(R)-HETE; (5Z,8Z,11Z,14Z)-(16R)-16-Hydroxyeicosa-5,8,11,14-tetraenoic acid; (5Z,8Z,11Z,14Z)-(16R)-16-Hydroxyicosa-5,8,11,14-tetraenoic acid",R07054,Arachidonic acid metabolism,1.14.14.1,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14778  16(R)-HETE,PubChem: 17395776; ChEBI: 34162; LIPIDMAPS: LMFA03060069; NIKKAJI: J1.367.106K,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992287,2573,cpd:C14779,9(S)-HETE;,C20H32O3,"9(S)-HETE; (5Z,7E,11Z,14Z)-(9S)-9-Hydroxyeicosa-5,7,11,14-tetraenoic acid; (5Z,7E,11Z,14Z)-(9S)-9-Hydroxyicosa-5,7,11,14-tetraenoic acid",NA,Arachidonic acid metabolism,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14779  9(S)-HETE,CAS: 107656-13-3; PubChem: 17395777; ChEBI: 34495; LIPIDMAPS: LMFA03060027; LipidBank: DFA8133; KNApSAcK: C00000420; NIKKAJI: J852.254E,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992288,2574,cpd:C14780,11(R)-HETE;,C20H32O3,"11(R)-HETE; (5Z,8Z,12E,14Z)-(11R)-Hydroxyeicosa-5,8,12,14-tetraenoic acid; (5Z,8Z,12E,14Z)-(11R)-Hydroxyicosa-5,8,12,14-tetraenoic acid",NA,Arachidonic acid metabolism,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14780  11(R)-HETE,CAS: 73347-43-0; PubChem: 17395778; ChEBI: 34126; LIPIDMAPS: LMFA03060028; LipidBank: DFA8134; NIKKAJI: J750.054H,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992289,2575,cpd:C14781,"15H-11,12-EETA;",C20H32O4,"15H-11,12-EETA; 15-Hydroxy-11,12-epoxyeicosatrienoic acid; (5Z,8Z,13E)-(15S)-11,12-Epoxy-15-hydroxyeicosa-5,8,13-trienoic acid; (5Z,8Z,13E)-(15S)-11,12-Epoxy-15-hydroxyicosa-5,8,13-trienoic acid",R07042 R07044,Arachidonic acid metabolism; Metabolic pathways,1.14.14.1,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0308 Epoxyeicosatrienoic acids;     C14781  15-Hydroxy-11,12-EETA",PubChem: 17395779; ChEBI: 34160; LIPIDMAPS: LMFA03080007; NIKKAJI: J2.789.311B,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452290,2576,cpd:C14782,"11,12,15-THETA;",C20H34O5,"11,12,15-THETA; 11,12,15-Trihydroxyicosatrienoic acid; (5Z,8Z,13E)-(15S)-11,12,15-Trihydroxyeicosa-5,8,12-trienoic acid; (5Z,8Z,13E)-(15S)-11,12,15-Trihydroxyicosa-5,8,12-trienoic acid",R07044,Arachidonic acid metabolism; Metabolic pathways,1.14.14.1,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;     C14782  11,12,15-THETA",PubChem: 17395780; ChEBI: 34128; LIPIDMAPS: LMFA03050017; NIKKAJI: J2.323.051H,cpd:C00639; cpd:C02314; cpd:C04741; cpd:C04843; cpd:C05959; cpd:C06438; cpd:C12786; cpd:C13548; cpd:C13809; cpd:C14782; cpd:C14809; cpd:C14811; cpd:C14814,20,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O5,C20H33O5,354.2406242,355.2484492,353.23279922291,2577,cpd:C14794,"2,3-Dinor-8-iso prostaglandin F2alpha;",C18H30O5,"2,3-Dinor-8-iso prostaglandin F2alpha; 2,3-Dinor-8-iso PGF2alpha",NA,Arachidonic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C14794  2,3-Dinor-8-iso prostaglandin F2alpha;    FA0311 Isoprostanes;     C14794  2,3-Dinor-8-iso prostaglandin F2alpha",CAS: 221664-05-7; PubChem: 17395792; ChEBI: 34230; LIPIDMAPS: LMFA03110010; NIKKAJI: J1.052.712K,cpd:C14794,18,30,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O5,C18H29O5,326.2093241,327.2171491,325.2014992292,2578,cpd:C14795,"2,3-Dinor-8-iso prostaglandin F1alpha;",C18H32O5,"2,3-Dinor-8-iso prostaglandin F1alpha; 2,3-Dinor-8-iso PGF1alpha",NA,Arachidonic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0301 Prostaglandins;     C14795  2,3-Dinor-8-iso prostaglandin F1alpha",PubChem: 17395793; ChEBI: 34229; LIPIDMAPS: LMFA03010154; NIKKAJI: J761.064E,cpd:C14795,18,32,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O5,C18H31O5,328.2249741,329.2327992,327.21714912293,2579,cpd:C14807,12-OxoETE;,C20H30O3,"12-OxoETE; 12-KETE; (5Z,8Z,10E,14Z)-12-Oxoeicosa-5,8,10,14-tetraenoic acid; (5Z,8Z,10E,14Z)-12-Oxoicosa-5,8,10,14-tetraenoic acid",NA,Arachidonic acid metabolism,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14807  12-OxoETE,CAS: 108437-64-5; PubChem: 17395805; ChEBI: 34151; LIPIDMAPS: LMFA03060019; LipidBank: DFA8157; NIKKAJI: J1.453.622A,cpd:C00909; cpd:C02645; cpd:C04170; cpd:C04577; cpd:C07052; cpd:C09079; cpd:C09110; cpd:C11875; cpd:C13843; cpd:C14555; cpd:C14628; cpd:C14665; cpd:C14683; cpd:C14732; cpd:C14807; cpd:C14891; cpd:C14929; cpd:C14945; cpd:C14980; cpd:C15354; cpd:C15434; cpd:C17498; cpd:C17956; cpd:C18177; cpd:C20212,20,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O3,C20H29O3,318.2194948,319.2273199,317.21166982294,2580,cpd:C14808,Hepoxilin A3;,C20H32O4,"Hepoxilin A3; (5Z,9E,14Z)-(11S,12S)-11,12-Epoxy-8-hydroxyeicosa-5,9,14-trienoic acid; (5Z,9E,14Z)-(11S,12S)-11,12-Epoxy-8-hydroxyicosa-5,9,14-trienoic acid",R07036 R07039,Arachidonic acid metabolism,3.3.2.7; 5.4.4.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0309 Hepoxilins;     C14808  Hepoxilin A3,PubChem: 17395806; ChEBI: 36190; LIPIDMAPS: LMFA03090005; LipidBank: XPR5001; NIKKAJI: J640.451K,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452295,2581,cpd:C14809,Trioxilin A3;,C20H34O5,"Trioxilin A3; (5Z,9E,14Z)-(11R,12S)-8,11,12-Trihydroxyeicosa-5,9,14-trienoic acid; (5Z,9E,14Z)-(11R,12S)-8,11,12-Trihydroxyicosa-5,9,14-trienoic acid",R07036,Arachidonic acid metabolism,3.3.2.7,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0309 Hepoxilins;     C14809  Trioxilin A3,PubChem: 17395807; ChEBI: 36203; LIPIDMAPS: LMFA03090002; LipidBank: XPR5011; NIKKAJI: J2.755.942E,cpd:C00639; cpd:C02314; cpd:C04741; cpd:C04843; cpd:C05959; cpd:C06438; cpd:C12786; cpd:C13548; cpd:C13809; cpd:C14782; cpd:C14809; cpd:C14811; cpd:C14814,20,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O5,C20H33O5,354.2406242,355.2484492,353.23279922296,2582,cpd:C14810,Hepoxilin B3;,C20H32O4,"Hepoxilin B3; (5Z,8Z,14Z)-(11S,12S)-11,12-Epoxy-10-hydroxyeicosa-5,8,14-trienoic acid; (5Z,8Z,14Z)-(11S,12S)-11,12-Epoxy-10-hydroxyicosa-5,8,14-trienoic acid",R07037 R07040,Arachidonic acid metabolism,3.3.2.-; 5.4.4.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0309 Hepoxilins;     C14810  Hepoxilin B3,PubChem: 17395808; ChEBI: 34784; LIPIDMAPS: LMFA03090003; LipidBank: XPR5101; NIKKAJI: J343.414A,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452297,2583,cpd:C14811,Trioxilin B3;,C20H34O5,"Trioxilin B3; (5Z,8Z,14Z)-(11R,12R)-10,11,12-Trihydroxyeicosa-5,8,14-trienoic acid; (5Z,8Z,14Z)-(11R,12R)-10,11,12-Trihydroxyicosa-5,8,14-trienoic acid",R07037,Arachidonic acid metabolism,3.3.2.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0309 Hepoxilins;     C14811  Trioxilin B3,PubChem: 17395809; ChEBI: 35032; LIPIDMAPS: LMFA03090004; LipidBank: XPR5111; NIKKAJI: J506.629H,cpd:C00639; cpd:C02314; cpd:C04741; cpd:C04843; cpd:C05959; cpd:C06438; cpd:C12786; cpd:C13548; cpd:C13809; cpd:C14782; cpd:C14809; cpd:C14811; cpd:C14814,20,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O5,C20H33O5,354.2406242,355.2484492,353.23279922298,2584,cpd:C14812,12(R)-HPETE;,C20H32O4,"12(R)-HPETE; (5Z,8Z,10E,14Z)-(12R)-12-Hydroperoxyeicosa-5,8,10,14-tetraenoic acid; (5Z,8Z,10E,14Z)-(12R)-12-Hydroperoxyicosa-5,8,10,14-tetraenoic acid",R07038,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse,1.13.11.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14812  12(R)-HPETE,PubChem: 17395810; ChEBI: 34145; LIPIDMAPS: LMFA03060070; LipidBank: XPR6002; NIKKAJI: J1.936.474G,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452299,2585,cpd:C14813,"11H-14,15-EETA;",C20H32O4,"11H-14,15-EETA; 11-Hydroxy-14,15-EETA; 11-Hydroxy-14,15-epoxyeicosatrienoic acid; (5Z,8Z,12E)-14,15-Epoxy-11-hydroxyeicosa-5,8,12-trienoic acid; (5Z,8Z,12E)-14,15-Epoxy-11-hydroxyicosa-5,8,12-trienoic acid",R07043 R07045,Arachidonic acid metabolism; Metabolic pathways,1.14.14.1,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0308 Epoxyeicosatrienoic acids;     C14813  11-Hydroxy-14,15-EETA",PubChem: 17395811; ChEBI: 34137; LIPIDMAPS: LMFA03080008; NIKKAJI: J1.034.925G,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452300,2586,cpd:C14814,"11,14,15-THETA;",C20H34O5,"11,14,15-THETA; 11,14,15-Trihydroxyicosatrienoic acid; (5Z,8Z,12E)-11,14,15-Trihydroxyeicosa-5,8,12-trienoic acid; (5Z,8Z,12E)-11,14,15-Trihydroxyicosa-5,8,12-trienoic acid",R07045,Arachidonic acid metabolism; Metabolic pathways,1.14.14.1,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0305 Hydroxy/hydroperoxyeicosatrienoic acids;     C14814  11,14,15-THETA",PubChem: 17395812; ChEBI: 34131; LIPIDMAPS: LMFA03050018; NIKKAJI: J1.034.922B,cpd:C00639; cpd:C02314; cpd:C04741; cpd:C04843; cpd:C05959; cpd:C06438; cpd:C12786; cpd:C13548; cpd:C13809; cpd:C14782; cpd:C14809; cpd:C14811; cpd:C14814,20,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O5,C20H33O5,354.2406242,355.2484492,353.23279922301,2587,cpd:C14815,"5,6-Epoxytetraene;",C20H30O4,"5,6-Epoxytetraene; (7E,9E,11Z,13E)-(5S,6S,15S)-5,6-Epoxy-15-hydroxyeicosa-7,9,11,13-tetraenoic acid; (7E,9E,11Z,13E)-(5S,6S,15S)-5,6-Epoxy-15-hydroxyicosa-7,9,11,13-tetraenoic acid",R07031 R07032,Arachidonic acid metabolism,3.3.2.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14815  5,6-Epoxytetraene",PubChem: 17395813; ChEBI: 64095; LIPIDMAPS: LMFA03060075; NIKKAJI: J2.789.455K,cpd:C05949; cpd:C05953; cpd:C05954; cpd:C05955; cpd:C05957; cpd:C05958; cpd:C09125; cpd:C09150; cpd:C11256; cpd:C11876; cpd:C14504; cpd:C14815; cpd:C14913; cpd:C15159; cpd:C18173,20,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O4,C20H29O4,334.2144094,335.2222345,333.20658442302,2588,cpd:C14820,11(R)-HPETE;,C20H32O4,"11(R)-HPETE; (5Z,8Z,12E,14Z)-(11R)-Hydroperoxyeicosa-5,8,12,14-tetraenoic acid; (5Z,8Z,12E,14Z)-(11R)-Hydroperoxyicosa-5,8,12,14-tetraenoic acid",R07047,Arachidonic acid metabolism; Serotonergic synapse,1.13.11.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14820  11(R)-HPETE,PubChem: 17395818; ChEBI: 34127; LIPIDMAPS: LMFA03060071; LipidBank: DFA8082; NIKKAJI: J2.789.468B,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452303,2589,cpd:C14821,9(S)-HPETE;,C20H32O4,"9(S)-HPETE; (5Z,7E,11Z,14Z)-(9S)-9-Hydroperoxyeicosa-5,7,11,14-tetraenoic acid; (5Z,7E,11Z,14Z)-(9S)-9-Hydroperoxyicosa-5,7,11,14-tetraenoic acid",R07049,Arachidonic acid metabolism; Serotonergic synapse,1.13.11.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14821  9(S)-HPETE,PubChem: 17395819; ChEBI: 34497; LIPIDMAPS: LMFA03060072; LipidBank: DFA8081; NIKKAJI: J1.057.873F,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452304,2590,cpd:C14822,12(R)-HETE;,C20H32O3,"12(R)-HETE; (5Z,8Z,10E,14Z)-(12R)-12-Hydroxyeicosa-5,8,10,14-tetraenoic acid; (5Z,8Z,10E,14Z)-(12R)-12-Hydroxyicosa-5,8,10,14-tetraenoic acid",NA,Arachidonic acid metabolism; Metabolic pathways; Aldosterone synthesis and secretion,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14822  12(R)-HETE,PubChem: 17395820; ChEBI: 34144; ChEMBL: CHEMBL1435825; LIPIDMAPS: LMFA03060008; LipidBank: DFA8136; KNApSAcK: C00000424; NIKKAJI: J260.110I,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992305,2591,cpd:C14823,8(S)-HPETE;,C20H32O4,"8(S)-HPETE; (5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyeicosa-5,9,11,14-tetraenoic acid; (5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyicosa-5,9,11,14-tetraenoic acid",R07053,Arachidonic acid metabolism; Metabolic pathways; Serotonergic synapse,1.13.11.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14823  8(S)-HPETE,PubChem: 17395821; ChEBI: 34487; LIPIDMAPS: LMFA03060073; LipidBank: DFA8080; NIKKAJI: J648.945A,cpd:C00959; cpd:C02165; cpd:C04685; cpd:C04686; cpd:C04822; cpd:C04849; cpd:C05356; cpd:C05965; cpd:C05966; cpd:C09087; cpd:C09175; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14823,20,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O4,C20H31O4,336.2300595,337.2378845,335.22223452306,2592,cpd:C14824,8(R)-HETE;,C20H32O3,"8(R)-HETE; (5Z,9E,11Z,14Z)-(8R)-8-Hydroxyeicosa-5,9,11,14-tetraenoate; (5Z,9E,11Z,14Z)-(8R)-8-Hydroxyicosa-5,9,11,14-tetraenoate; (5Z,9E,11Z,14Z)-(8R)-8-Hydroxyeicosa-5,9,11,14-tetraenoic acid; (5Z,9E,11Z,14Z)-(8R)-8-Hydroxyicosa-5,9,11,14-tetraenoic acid",NA,Arachidonic acid metabolism,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA03 Eicosanoids;    FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids;     C14824  8(R)-HETE,PubChem: 17395822; ChEBI: 34484; LIPIDMAPS: LMFA03060021; LipidBank: XPR6114; NIKKAJI: J867.978I,cpd:C04742; cpd:C04805; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14822; cpd:C14824; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15138; cpd:C15349; cpd:C18416,20,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O3,C20H31O3,320.2351449,321.2429699,319.22731992307,2593,cpd:C01595,Linoleate;,C18H32O2,"Linoleate; Linoleic acid; (9Z,12Z)-Octadecadienoic acid; 9-cis,12-cis-Octadecadienoate; 9-cis,12-cis-Octadecadienoic acid",R03626 R03627 R05718 R05740 R07055 R07056 R07057 R07061; R07063 R07064 R08177 R09811 R10577,Linoleic acid metabolism; Biosynthesis of unsaturated fatty acids; Biosynthesis of plant secondary metabolites; Metabolic pathways,1.13.11.12; 1.13.11.33; 1.13.11.45; 1.13.11.58; 1.13.11.60; 1.13.11.62; 1.13.11.77; 1.14.13.-; 1.14.14.1; 1.14.19.3; 1.14.19.39; 3.1.1.4; 3.1.2.2; 5.2.1.5,NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C01595  Linoleic acid (18:2;9,12); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C01595  (9Z,12Z)-Octadeca-9,12-dienoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Unsaturated fatty acids;     C01595  Linoleic acid; Target-based classification of compounds [BR:br08010];  Enzymes;   Oxidoreductases;    tyrosinase;     C01595  Linoleate; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Linoleate;     C01595  Linoleate; Major components of natural products [BR:br08323];  Medicinal herbs;   Evening promrose;    C01595  Linoleate",CAS: 60-33-3; PubChem: 4750; ChEBI: 17351 30245; ChEMBL: CHEMBL267476; LIPIDMAPS: LMFA01030120; LipidBank: DFA0159; KNApSAcK: C00001224; PDB-CCD: EIC; 3DMET: B00328; NIKKAJI: J4.801A,cpd:C01595; cpd:C04056; cpd:C08282; cpd:C08321; cpd:C08459,18,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O2,C18H31O2,280.2402303,281.2480553,279.23240522308,2594,cpd:C03242,"(8Z,11Z,14Z)-Icosatrienoic acid;",C20H34O2,"(8Z,11Z,14Z)-Icosatrienoic acid; Dihomo-gamma-linolenic acid; (Z,Z,Z)-8,11,14-Eicosatrienoic acid; (Z,Z,Z)-8,11,14-Icosatrienoic acid; (Z,Z,Z)-8,11,14-Eicosatrienoate; (Z,Z,Z)-8,11,14-Icosatrienoate; 8,11,14-Eicosatrienoate; 8,11,14-Icosatrienoate",R08182,Linoleic acid metabolism; Biosynthesis of unsaturated fatty acids; Metabolic pathways,3.1.2.2,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C03242  (8Z,11Z,14Z)-Icosatri-8,11,14-enoic acid",CAS: 1783-84-2; PubChem: 6112; ChEBI: 53486; ChEMBL: CHEMBL465183; LIPIDMAPS: LMFA01030158; LipidBank: DFA0197; PDB-CCD: LAX; 3DMET: B01643; NIKKAJI: J110.768B,cpd:C03242; cpd:C09072; cpd:C13273; cpd:C14882; cpd:C15058; cpd:C15376; cpd:C15399; cpd:C16522,20,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O2,C20H33O2,306.2558803,307.2637054,305.24805532309,2595,cpd:C04056,"9-cis,11-trans-Octadecadienoate;",C18H32O2,"9-cis,11-trans-Octadecadienoate; (9Z,11E)-Octadecadienoic acid",R03627,Linoleic acid metabolism,5.2.1.5,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C04056  (9Z,11E)-Octadeca-9,11-dienoic acid",PubChem: 6756; ChEBI: 32798; LIPIDMAPS: LMFA01030118; LipidBank: DFA0156; 3DMET: B00672; NIKKAJI: J604.211B,cpd:C01595; cpd:C04056; cpd:C08282; cpd:C08321; cpd:C08459,18,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O2,C18H31O2,280.2402303,281.2480553,279.23240522310,2596,cpd:C04717,"(9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid;",C18H32O4,"(9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid; (9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoate; 13(S)-HPODE; 13S-Hydroperoxy-9Z,11E-octadecadienoic acid",R03626,Linoleic acid metabolism; Metabolic pathways,1.13.11.12; 1.13.11.33,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0104 Hydroperoxy fatty acids;     C04717  (9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid",CAS: 33964-75-9; PubChem: 7289; ChEBI: 15655; ChEMBL: CHEMBL1229641; LIPIDMAPS: LMFA02000034; LipidBank: DFA8002; PDB-CCD: 13S; 3DMET: B01779; NIKKAJI: J293.198B,cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703,18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O4,C18H31O4,312.2300595,313.2378845,311.22223452311,2597,cpd:C06426,"(6Z,9Z,12Z)-Octadecatrienoic acid;",C18H30O2,"(6Z,9Z,12Z)-Octadecatrienoic acid; 6,9,12-Octadecatrienoic acid; gamma-Linolenic acid; Gamolenic acid",R07063 R08181,Linoleic acid metabolism; Biosynthesis of unsaturated fatty acids; Metabolic pathways,1.14.19.3; 3.1.2.2,NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C06426  gamma-Linolenic acid (18:3;6,9,12); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C06426  (6Z,9Z,12Z)-Octadeca-6,9,12-trienoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Unsaturated fatty acids;     C06426  gamma-Linolenic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D11 OTHER DERMATOLOGICAL PREPARATIONS;    D11A OTHER DERMATOLOGICAL PREPARATIONS;     D11AX Other dermatologicals;      D11AX02 Gamolenic acid;       D07213  Gamolenic acid (INN); Major components of natural products [BR:br08323];  Medicinal herbs;   Flaxseed;    C06426  (6Z,9Z,12Z)-Octadecatrienoic acid",CAS: 506-26-3; PubChem: 8661; ChEBI: 28661; ChEMBL: CHEMBL464982; LIPIDMAPS: LMFA01030141; LipidBank: DFA0180; KNApSAcK: C00001226; 3DMET: B02021; NIKKAJI: J12.229G,cpd:C06426; cpd:C06427; cpd:C07289; cpd:C08315; cpd:C08364; cpd:C15201,18,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O2,C18H29O2,278.2245802,279.2324052,277.21675522312,2598,cpd:C07289,Crepenynate;,C18H30O2,Crepenynate; (9Z)-Octadec-9-en-12-ynoate; (Z)-9-Octadecen-12-ynoic acid; Crepenynic acid,R05740,Linoleic acid metabolism; Biosynthesis of plant secondary metabolites,1.14.19.39,NA,NA,CAS: 2277-31-8; PubChem: 9498; ChEBI: 14030 16423; LIPIDMAPS: LMFA01030742; KNApSAcK: C00001278; 3DMET: B01085; NIKKAJI: J13.791J,cpd:C06426; cpd:C06427; cpd:C07289; cpd:C08315; cpd:C08364; cpd:C15201,18,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O2,C18H29O2,278.2245802,279.2324052,277.21675522313,2599,cpd:C07338,"(9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoic acid;",C18H32O4,"(9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoic acid; (9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoate",R05718,Linoleic acid metabolism,1.13.11.45,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0104 Hydroperoxy fatty acids;     C07338  (9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoic acid",PubChem: 9545; ChEBI: 15657; LIPIDMAPS: LMFA02000115; 3DMET: B02117; NIKKAJI: J997.708B,cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703,18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O4,C18H31O4,312.2300595,313.2378845,311.22223452314,2600,cpd:C07354,"(7S,8S)-DiHODE;",C18H32O4,"(7S,8S)-DiHODE; (9Z,12Z)-(7S,8S)-Dihydroxyoctadeca-9,12-dienoic acid; (7S,8S,9Z,12Z)-7,8-Dihydroxyoctadeca-9,12-dienoate",R07062,Linoleic acid metabolism,5.4.4.6,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0105 Hydroxy fatty acids;     C07354  (9Z,12Z)-(7S,8S)-Dihydroxyoctadeca-9,12-dienoic acid",CAS: 143288-65-7; PubChem: 9559; ChEBI: 15658; LIPIDMAPS: LMFA02000224; KNApSAcK: C00000399; 3DMET: B02118; NIKKAJI: J992.156G,cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703,18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O4,C18H31O4,312.2300595,313.2378845,311.22223452315,2601,cpd:C14762,13(S)-HODE;,C18H32O3,"13(S)-HODE; (13S)-Hydroxyoctadecadienoic acid; (9Z,11E)-(13S)-13-Hydroxyoctadeca-9,11-dienoic acid",R07058,Linoleic acid metabolism; PPAR signaling pathway,1.1.1.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14762  (9Z, 11E)-(13S)-13-Hydroxyoctadeca-9,11-dienoic acid",PubChem: 17395760; ChEBI: 34154; ChEMBL: CHEMBL451721; LIPIDMAPS: LMFA02000228; LipidBank: DFA8023; PDB-CCD: 243; NIKKAJI: J425.680H,cpd:C08318; cpd:C08368; cpd:C14762; cpd:C14767; cpd:C14825; cpd:C14826; cpd:C19617,18,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O3,C18H31O3,296.2351449,297.2429699,295.22731992316,2602,cpd:C14765,13-OxoODE;,C18H30O3,"13-OxoODE; 13-KODE; (9Z,11E)-13-Oxooctadeca-9,11-dienoic acid",R07058,Linoleic acid metabolism,1.1.1.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14765  (9Z,11E)-13-Oxooctadeca-9,11-dienoic acid",PubChem: 17395763; ChEBI: 68947; ChEMBL: CHEMBL1378466; LIPIDMAPS: LMFA02000016; LipidBank: DFA8047; NIKKAJI: J462.852G,cpd:C04594; cpd:C04780; cpd:C13798; cpd:C14765; cpd:C14766; cpd:C16316; cpd:C16326; cpd:C16342; cpd:C16346; cpd:C19613; cpd:C19827,18,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O3,C18H29O3,294.2194948,295.2273199,293.21166982317,2603,cpd:C14766,9-OxoODE;,C18H30O3,"9-OxoODE; 9-KODE; (10E,12Z)-9-Oxooctadeca-10,12-dienoic acid",NA,Linoleic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14766  (10E,12Z)-9-Oxooctadeca-10,12-dienoic acid",PubChem: 17395764; ChEBI: 72842; LIPIDMAPS: LMFA02000274; LipidBank: DFA8046; NIKKAJI: J711.801E,cpd:C04594; cpd:C04780; cpd:C13798; cpd:C14765; cpd:C14766; cpd:C16316; cpd:C16326; cpd:C16342; cpd:C16346; cpd:C19613; cpd:C19827,18,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O3,C18H29O3,294.2194948,295.2273199,293.21166982318,2604,cpd:C14767,9(S)-HODE;,C18H32O3,"9(S)-HODE; (9S)-Hydroxyoctadecadienoic acid; (10E,12Z)-(9S)-9-Hydroxyoctadeca-10,12-dienoic acid",NA,Linoleic acid metabolism; PPAR signaling pathway,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14767  (10E,12Z)-(9S)-9-Hydroxyoctadeca-10,12-dienoic acid",CAS: 73543-67-6; PubChem: 17395765; ChEBI: 34496; LIPIDMAPS: LMFA02000188; LipidBank: DFA8022; PDB-CCD: 9HO; NIKKAJI: J365.920H,cpd:C08318; cpd:C08368; cpd:C14762; cpd:C14767; cpd:C14825; cpd:C14826; cpd:C19617,18,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O3,C18H31O3,296.2351449,297.2429699,295.22731992319,2605,cpd:C14825,9(10)-EpOME;,C18H32O3,"9(10)-EpOME; (9R,10S)-(12Z)-9,10-Epoxyoctadecenoic acid",R07055 R07122,Linoleic acid metabolism; Metabolic pathways,1.14.13.-; 1.14.14.1; 3.3.2.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14825  (9R,10S)-(12Z)-9,10-Epoxyoctadecenoic acid",PubChem: 17395823; ChEBI: 86022; LIPIDMAPS: LMFA02000037 LMFA02000283; LipidBank: DFA8007; NIKKAJI: J15.563B,cpd:C08318; cpd:C08368; cpd:C14762; cpd:C14767; cpd:C14825; cpd:C14826; cpd:C19617,18,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O3,C18H31O3,296.2351449,297.2429699,295.22731992320,2606,cpd:C14826,12(13)-EpOME;,C18H32O3,"12(13)-EpOME; (12R,13S)-(9Z)-12,13-Epoxyoctadecenoic acid",R07056 R07121,Linoleic acid metabolism; Metabolic pathways,1.14.13.-; 1.14.14.1; 3.3.2.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14826  (12R,13S)-(9Z)-12,13-Epoxyoctadecenoic acid",PubChem: 17395824; ChEBI: 38300; LIPIDMAPS: LMFA02000038; LipidBank: DFA8008; PDB-CCD: T25; NIKKAJI: J532.640K,cpd:C08318; cpd:C08368; cpd:C14762; cpd:C14767; cpd:C14825; cpd:C14826; cpd:C19617,18,32,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O3,C18H31O3,296.2351449,297.2429699,295.22731992321,2607,cpd:C14827,9(S)-HPODE;,C18H32O4,"9(S)-HPODE; 9(S)-HPOD; (10E,12Z)-(9S)-9-Hydroperoxyoctadeca-10,12-dienoic acid; (9S,10E,12Z)-9-Hydroperoxy-10,12-octadecadienoate",R07057 R09699,Linoleic acid metabolism; Metabolic pathways,1.13.11.58; 4.2.1.121,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14827  (10E,12Z)-(9S)-9-Hydroperoxyoctadeca-10,12-dienoic acid",CAS: 29774-12-7; PubChem: 17395825; ChEBI: 34498; ChEMBL: CHEMBL1594141; LIPIDMAPS: LMFA02000012; LipidBank: DFA8001; NIKKAJI: J293.200H,cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703,18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O4,C18H31O4,312.2300595,313.2378845,311.22223452322,2608,cpd:C14828,"9,10-DHOME;",C18H34O4,"9,10-DHOME; 9,10-DHOA; (12Z)-9,10-Dihydroxyoctadec-12-enoic acid",R07122,Linoleic acid metabolism,3.3.2.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0105 Hydroxy fatty acids;     C14828  (12Z)-9,10-Dihydroxyoctadec-12-enoic acid",PubChem: 17395826; ChEBI: 72663; LIPIDMAPS: LMFA02000229; LipidBank: DFA8024; NIKKAJI: J1.376.220A,cpd:C07355; cpd:C14828; cpd:C14829; cpd:C19620; cpd:C20702,18,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H35O4,C18H33O4,314.2457096,315.2535346,313.23788452323,2609,cpd:C14829,"12,13-DHOME;",C18H34O4,"12,13-DHOME; 12,13-DHOA; (9Z)-12,13-Dihydroxyoctadec-9-enoic acid",R07121,Linoleic acid metabolism,3.3.2.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0105 Hydroxy fatty acids;     C14829  (9Z)-12,13-Dihydroxyoctadec-9-enoic acid",PubChem: 17395827; ChEBI: 72665; LIPIDMAPS: LMFA02000230; LipidBank: DFA8027; NIKKAJI: J470.613G,cpd:C07355; cpd:C14828; cpd:C14829; cpd:C19620; cpd:C20702,18,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H35O4,C18H33O4,314.2457096,315.2535346,313.23788452324,2610,cpd:C14831,8(R)-HPODE;,C18H32O4,"8(R)-HPODE; (9Z,12Z)-(8R)-8-Hydroperoxyoctadeca-9,12-dienoic acid; (8R,9Z,12Z)-8-Hydroperoxyoctadeca-9,12-dienoate",R07061 R07062 R09905,Linoleic acid metabolism,1.13.11.60; 5.4.4.5; 5.4.4.6,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14831  (9Z,12Z)-(8R)-8-Hydroperoxyoctadeca-9,12-dienoic acid",CAS: 143343-95-7; PubChem: 17395829; ChEBI: 34485; LIPIDMAPS: LMFA02000113; LipidBank: DFA8005; NIKKAJI: J646.349E,cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703,18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O4,C18H31O4,312.2300595,313.2378845,311.22223452325,2611,cpd:C14832,"12,13-Epoxy-9-hydroxy-10-octadecenoate;",C18H32O4,"12,13-Epoxy-9-hydroxy-10-octadecenoate; 12(R),13(S)-Epoxy-9(S)-hydroxy-10(E)-octadecenoic acid; (10E)-(9S,12R,13S)-12,13-Epoxy-9-hydroxyoctadec-10-enoic acid",NA,Linoleic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14832  (10E)-(9S,12R,13S)-12,13-Epoxy-9-hydroxyoctadec-10-enoic acid",PubChem: 17395830; ChEBI: 34148; LIPIDMAPS: LMFA02000013; LipidBank: DFA8013; NIKKAJI: J2.789.509C,cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703,18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O4,C18H31O4,312.2300595,313.2378845,311.22223452326,2612,cpd:C14833,"9,12,13-TriHOME;",C18H34O5,"9,12,13-TriHOME; 9(S),12(S),13(S)-Trihydroxy-10(E)-octadecenoic acid; (10E)-(9S,12S,13S)-9,12,13-Trihydroxyoctadec-10-enoic acid",NA,Linoleic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14833  (10E)-(9S,12S,13S)-9,12,13-Trihydroxyoctadec-10-enoic acid",PubChem: 17395831; ChEBI: 34506; LIPIDMAPS: LMFA02000014; LipidBank: DFA8032; NIKKAJI: J408.840I,cpd:C14833; cpd:C14835; cpd:C14837,18,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H35O5,C18H33O5,330.2406242,331.2484492,329.23279922327,2613,cpd:C14834,"9,10-Epoxy-13-hydroxy-11-octadecenoate;",C18H32O4,"9,10-Epoxy-13-hydroxy-11-octadecenoate; (11E)-9,10-Epoxyoctadecenoic acid",NA,Linoleic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14834  (11E)-9,10-Epoxyoctadecenoic acid",PubChem: 17395832; ChEBI: 34504; LIPIDMAPS: LMFA02000278; LipidBank: DFA8012; NIKKAJI: J2.789.522K,cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703,18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O4,C18H31O4,312.2300595,313.2378845,311.22223452328,2614,cpd:C14835,"9,10,13-TriHOME;",C18H34O5,"9,10,13-TriHOME; 9,10,13-Trihydroxyoctadec-11-enoic acid; (11E)-9,10,13-Trihydroxyoctadec-11-enoic acid",NA,Linoleic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14835  (11E)-9,10,13-Trihydroxyoctadec-11-enoic acid",PubChem: 17395833; ChEBI: 34499; LIPIDMAPS: LMFA02000168; LipidBank: DFA8031; NIKKAJI: J1.435.253H,cpd:C14833; cpd:C14835; cpd:C14837,18,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H35O5,C18H33O5,330.2406242,331.2484492,329.23279922329,2615,cpd:C14836,"9,10-12,13-Diepoxyoctadecanoate;",C18H32O4,"9,10-12,13-Diepoxyoctadecanoate; 9,10-12,13-Diepoxyoctadecanoic acid",NA,Linoleic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14836  9,10-12,13-Diepoxyoctadecanoic acid",PubChem: 17395834; ChEBI: 34500; NIKKAJI: J34.601B,cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703,18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O4,C18H31O4,312.2300595,313.2378845,311.22223452330,2616,cpd:C14837,"9,10-Dihydroxy-12,13-epoxyoctadecanoate;",C18H34O5,"9,10-Dihydroxy-12,13-epoxyoctadecanoate; 9,10-Dihydroxy-12,13-epoxyoctadecanoic acid",NA,Linoleic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C14837  9,10-Dihydroxy-12,13-epoxyoctadecanoic acid",PubChem: 17395835; ChEBI: 34503; NIKKAJI: J2.789.538G,cpd:C14833; cpd:C14835; cpd:C14837,18,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H35O5,C18H33O5,330.2406242,331.2484492,329.23279922331,2617,cpd:C19937,"(8E,10R,12Z)-10-Hydroperoxy-8,12-octadecadienoate",C18H32O4,"(8E,10R,12Z)-10-Hydroperoxy-8,12-octadecadienoate",R09811,Linoleic acid metabolism,1.13.11.62,NA,NA,PubChem: 135626403; LIPIDMAPS: LMFA02000285,cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703,18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O4,C18H31O4,312.2300595,313.2378845,311.22223452332,2618,cpd:C20186,"5S,8R-DiHODE;",C18H32O4,"5S,8R-DiHODE; (5S,8R)-DiHODE; (5S,8R,9Z,12Z)-5,8-Dihydroxyoctadeca-9,12-dienoate",R09905,Linoleic acid metabolism,5.4.4.5,NA,NA,PubChem: 163311929; LIPIDMAPS: LMFA02000284,cpd:C04717; cpd:C07338; cpd:C07354; cpd:C14827; cpd:C14831; cpd:C14832; cpd:C14834; cpd:C14836; cpd:C19618; cpd:C19937; cpd:C20186; cpd:C20703,18,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O4,C18H31O4,312.2300595,313.2378845,311.22223452333,2619,cpd:C01226,12-OPDA;,C18H28O3,"12-OPDA; (15Z)-12-Oxophyto-10,15-dienoate; (15Z)-12-Oxophyto-10,15-dienoic acid; 9(S),13(S)-12-Oxo-PDA; 12-Oxo-10,15(Z)-phytodienoic acid",R03401 R03402,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.42; 5.3.99.6,Jasmonic acid biosynthesis,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0201 12-oxophytodienoic acid metabolites;     C01226  (15Z)-12-Oxophyto-10,15-dienoic acid",PubChem: 4448; ChEBI: 15560; LIPIDMAPS: LMFA02010001; KNApSAcK: C00000365; 3DMET: B01414; NIKKAJI: J264.010D,cpd:C01226; cpd:C04672; cpd:C08319; cpd:C13816; cpd:C14911; cpd:C16319; cpd:C16320; cpd:C16324; cpd:C16325; cpd:C18866; cpd:C19147,18,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H29O3,C18H27O3,292.2038448,293.2116698,291.19601972334,2620,cpd:C04672,"(9Z,15Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoic acid;",C18H28O3,"(9Z,15Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoic acid; (9Z,15Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoate; (9Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoate; 12,13(S)-EOT; 12,13(S)-EOTrE",R03402 R07863,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.1.92; 5.3.99.6,Jasmonic acid biosynthesis,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0107 Epoxy fatty acids;     C04672  (9Z,15Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoic acid",PubChem: 7253; ChEBI: 15653 36438; LIPIDMAPS: LMFA02000053; 3DMET: B01772; NIKKAJI: J1.145.932C,cpd:C01226; cpd:C04672; cpd:C08319; cpd:C13816; cpd:C14911; cpd:C16319; cpd:C16320; cpd:C16324; cpd:C16325; cpd:C18866; cpd:C19147,18,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H29O3,C18H27O3,292.2038448,293.2116698,291.19601972335,2621,cpd:C04780,"8-[(1R,2R)-3-Oxo-2-{(Z)-pent-2-enyl}cyclopentyl]octanoate;",C18H30O3,"8-[(1R,2R)-3-Oxo-2-{(Z)-pent-2-enyl}cyclopentyl]octanoate; OPC-8:0",R03401 R07887,alpha-Linolenic acid metabolism; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.42; 6.2.1.-,Jasmonic acid biosynthesis,NA,PubChem: 7344; ChEBI: 15720; LIPIDMAPS: LMFA02010007; KNApSAcK: C00000366; 3DMET: B01787; NIKKAJI: J1.078.810B,cpd:C04594; cpd:C04780; cpd:C13798; cpd:C14765; cpd:C14766; cpd:C16316; cpd:C16326; cpd:C16342; cpd:C16346; cpd:C19613; cpd:C19827,18,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O3,C18H29O3,294.2194948,295.2273199,293.21166982336,2622,cpd:C04785,13(S)-HPOT;,C18H30O4,"13(S)-HPOT; (9Z,11E,15Z)-(13S)-Hydroperoxyoctadeca-9,11,15-trienoate; (9Z,11E,15Z)-(13S)-13-Hydroperoxyoctadeca-9,11,15-trienoic acid; 13(S)-HpOTrE; 13-HPOT",R07863 R07869 R07870 R07871,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.13.11.12; 4.2.1.92,Jasmonic acid biosynthesis,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0104 Hydroperoxy fatty acids;     C04785  (9Z,11E,14Z)-(13S)-13-Hydroperoxyoctadeca-9,11,14-trienoic acid",PubChem: 7348; ChEBI: 48905; LIPIDMAPS: LMFA02000052; KNApSAcK: C00000364; 3DMET: B01788; NIKKAJI: J2.753.619K,cpd:C04785; cpd:C07357; cpd:C15753; cpd:C16321; cpd:C16341; cpd:C19936; cpd:C20704,18,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O4,C18H29O4,310.2144094,311.2222345,309.20658442337,2623,cpd:C06427,"(9Z,12Z,15Z)-Octadecatrienoic acid;",C18H30O2,"(9Z,12Z,15Z)-Octadecatrienoic acid; alpha-Linolenic acid; 9,12,15-Octadecatrienoic acid; Linolenate; alpha-Linolenate",R07859 R07860 R07861 R07864 R07869 R08178 R09810 R10578,alpha-Linolenic acid metabolism; Biosynthesis of unsaturated fatty acids; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites,1.13.11.12; 1.13.11.61; 1.13.11.77; 1.14.19.-; 3.1.1.4; 3.1.1.32; 3.1.2.2,Jasmonic acid biosynthesis,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C06427  alpha-Linolenic acid (18:3;9,12,15); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C06427  (9Z,12Z,15Z)-Octadeca-9,12,15-trienoic acid; Major components of natural products [BR:br08323];  Medicinal herbs;   Flaxseed;    C06427  (9Z,12Z,15Z)-Octadecatrienoic acid",CAS: 463-40-1; PubChem: 8662; ChEBI: 27432; ChEMBL: CHEMBL8739; LIPIDMAPS: LMFA01030152; LipidBank: DFA0191; KNApSAcK: C00007247; PDB-CCD: LNL; 3DMET: B02022; NIKKAJI: J5.773H,cpd:C06426; cpd:C06427; cpd:C07289; cpd:C08315; cpd:C08364; cpd:C15201,18,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O2,C18H29O2,278.2245802,279.2324052,277.21675522338,2624,cpd:C08491,(-)-Jasmonic acid;,C12H18O3,"(-)-Jasmonic acid; Jasmonic acid; {(1R,2R)-3-Oxo-2-[(Z)pent-2-enyl]cyclopent-2-enyl}acetic acid; Jasmonate; (-)-Jasmonate",R05759 R11446,alpha-Linolenic acid metabolism; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Plant hormone signal transduction,1.14.13.228; 2.1.1.141,Jasmonic acid biosynthesis,Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0202 jasmonic acids;     C08491  (-)-Jasmonic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Others;     C08491  Jasmonate,CAS: 6894-38-8; PubChem: 10684; ChEBI: 18292; ChEMBL: CHEMBL449572; LIPIDMAPS: LMFA02020001; KNApSAcK: C00000218 C00049053; PDB-CCD: JAA; 3DMET: B02184; NIKKAJI: J15.678G,cpd:C07148; cpd:C08491; cpd:C16317,12,18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H19O3,C12H17O3,210.1255944,211.1334195,209.11776942339,2625,cpd:C08492,3-Hexenol;,C6H12O,3-Hexenol; Leaf alcohol; 3-Hexen-1-ol; (3Z)-3-Hexen-1-ol; cis-3-Hexen-1-ol; (3Z)-Hex-3-en-1-ol,R09631 R10783,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,1.1.1.1; 2.3.1.195,NA,NA,CAS: 928-96-1; PubChem: 10685; ChEBI: 28857; LIPIDMAPS: LMFA05000059; KNApSAcK: C00000356; NIKKAJI: J6.411D,cpd:C00854; cpd:C01952; cpd:C02373; cpd:C02837; cpd:C02893; cpd:C05328; cpd:C08492; cpd:C19263; cpd:C19350; cpd:C19543; cpd:C19809; cpd:C21098,6,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O1,C6H11O1,100.088815,101.09664,99.080989972340,2626,cpd:C11512,Methyl jasmonate;,C13H20O3,Methyl jasmonate; (-)-Methyl jasmonate,R05759,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,2.1.1.141,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0202 jasmonic acids;     C11512  Methyl jasmonate,CAS: 1211-29-6; PubChem: 13682; ChEBI: 15929; LIPIDMAPS: LMFA02020010; KNApSAcK: C00000219; 3DMET: B04270; NIKKAJI: J128.619F,cpd:C01760; cpd:C04166; cpd:C11512; cpd:C16318,13,20,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H21O3,C13H19O3,224.1412445,225.1490695,223.13341952341,2627,cpd:C16300,Stearidonic acid;,C18H28O2,"Stearidonic acid; 6,9,12,15-Octadecatetraenoic acid; (6Z,9Z,12Z,15Z)-Octadecatetraenoic acid",R07861,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,1.14.19.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C16300  (6Z,9Z,12Z,15Z)-Octadecatetraenoic acid",CAS: 20290-75-9; PubChem: 47205608; ChEBI: 32389; ChEMBL: CHEMBL484430; LIPIDMAPS: LMFA01030357; KNApSAcK: C00000405; NIKKAJI: J381.480G,cpd:C13797; cpd:C16300; cpd:C19042,18,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H29O2,C18H27O2,276.2089301,277.2167552,275.20110512342,2628,cpd:C16308,Traumatic acid;,C12H20O4,Traumatic acid; (2E)-Dodecenedioic acid; Dodec-2-enedioic acid,NA,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,NA,NA,NA,CAS: 6402-36-4; PubChem: 47205616; ChEBI: 545687; ChEMBL: CHEMBL470062; LIPIDMAPS: LMFA01170002; NIKKAJI: J5.789D,cpd:C11769; cpd:C16254; cpd:C16308; cpd:C20515,12,20,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H21O4,C12H19O4,228.1361591,229.1439842,227.12833412343,2629,cpd:C16309,Traumatin;,C12H20O3,Traumatin; (10E)-12-Oxododecenoic acid,R07872,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,5.3.3.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C16309  (10E)-12-Oxododecenoic acid,CAS: 65410-38-0; PubChem: 47205617; ChEBI: 19144; LIPIDMAPS: LMFA01060093; NIKKAJI: J1.414.065D,cpd:C05010; cpd:C07309; cpd:C07807; cpd:C08482; cpd:C08509; cpd:C16309; cpd:C16311,12,20,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H21O3,C12H19O3,212.1412445,213.1490695,211.13341952344,2630,cpd:C16310,3-Hexenal;,C6H10O,3-Hexenal; (3Z)-Hexenal,R07870 R10783,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,1.1.1.1,NA,NA,PubChem: 47205618; ChEBI: 23292; LIPIDMAPS: LMFA06000110; LipidBank: DLD0003; KNApSAcK: C00000352 C00000353; NIKKAJI: J59.820H,cpd:C00414; cpd:C06936; cpd:C07600; cpd:C08497; cpd:C16310,6,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O1,C6H9O1,98.07316494,99.08098997,97.065339912345,2631,cpd:C16311,12-Oxo-9(Z)-dodecenoic acid,C12H20O3,12-Oxo-9(Z)-dodecenoic acid,R07870 R07872,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,5.3.3.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C16311  12-Oxo-9(Z)-dodecenoic acid,PubChem: 47205619; ChEBI: 19143; LIPIDMAPS: LMFA01060167; NIKKAJI: J670.143D,cpd:C05010; cpd:C07309; cpd:C07807; cpd:C08482; cpd:C08509; cpd:C16309; cpd:C16311,12,20,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H21O3,C12H19O3,212.1412445,213.1490695,211.13341952346,2632,cpd:C16316,13(S)-HOT;,C18H30O3,"13(S)-HOT; (9Z,11E,15Z)-(13S)-Hydroxyoctadeca-9,11,15-trienoate; (9Z,11E,15Z)-(13S)-13-Hydroxyoctadeca-9,11,15-trienoic acid; (9Z,11E,13S,15Z)-13-Hydroxyoctadeca-9,11,15-trienoic acid; 13(S)-HOTrE",NA,alpha-Linolenic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C16316  (9Z,11E,14Z)-(13S)-13-Hydroxyoctadeca-9,11,14-trienoic acid",PubChem: 47205624; ChEBI: 80442; LIPIDMAPS: LMFA02000051; PDB-CCD: T24; NIKKAJI: J2.801.743J,cpd:C04594; cpd:C04780; cpd:C13798; cpd:C14765; cpd:C14766; cpd:C16316; cpd:C16326; cpd:C16342; cpd:C16346; cpd:C19613; cpd:C19827,18,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O3,C18H29O3,294.2194948,295.2273199,293.21166982347,2633,cpd:C16317,(+)-7-Isojasmonic acid,C12H18O3,(+)-7-Isojasmonic acid,R07902,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,3.2.1.-,Jasmonic acid biosynthesis,Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0202 jasmonic acids;     C16317  (+)-7-Isojasmonic acid,PubChem: 47205625; ChEBI: 18435; LIPIDMAPS: LMFA02020003; KNApSAcK: C00000446; NIKKAJI: J128.620J,cpd:C07148; cpd:C08491; cpd:C16317,12,18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H19O3,C12H17O3,210.1255944,211.1334195,209.11776942348,2634,cpd:C16318,(+)-7-Isomethyljasmonate,C13H20O3,(+)-7-Isomethyljasmonate,NA,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0202 jasmonic acids;     C16318  (+)-7-Isomethyljasmonate,PubChem: 47205626; ChEBI: 25242; LIPIDMAPS: LMFA02020016; NIKKAJI: J415.509B,cpd:C01760; cpd:C04166; cpd:C11512; cpd:C16318,13,20,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H21O3,C13H19O3,224.1412445,225.1490695,223.13341952349,2635,cpd:C16319,Etherolenic acid;,C18H28O3,"Etherolenic acid; (9Z,11E,1'E,3'Z)-12-(1',3'-Hexadienyloxy)-9,11-dodecadienoic acid",R07871,alpha-Linolenic acid metabolism,NA,NA,NA,PubChem: 47205627; ChEBI: 80443; NIKKAJI: J1.511.089I,cpd:C01226; cpd:C04672; cpd:C08319; cpd:C13816; cpd:C14911; cpd:C16319; cpd:C16320; cpd:C16324; cpd:C16325; cpd:C18866; cpd:C19147,18,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H29O3,C18H27O3,292.2038448,293.2116698,291.19601972350,2636,cpd:C16320,Colnelenic acid;,C18H28O3,"Colnelenic acid; (8E)-9-[(1E,3Z,6Z)-Nona-1,3,6-trien-1-yloxy]non-8-enoate",R07867,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,4.2.1.121,NA,NA,CAS: 52591-16-9; PubChem: 47205628; ChEBI: 60959; LIPIDMAPS: LMFA10000002; KNApSAcK: C00000448; NIKKAJI: J825.434F,cpd:C01226; cpd:C04672; cpd:C08319; cpd:C13816; cpd:C14911; cpd:C16319; cpd:C16320; cpd:C16324; cpd:C16325; cpd:C18866; cpd:C19147,18,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H29O3,C18H27O3,292.2038448,293.2116698,291.19601972351,2637,cpd:C16321,9(S)-HPOT;,C18H30O4,"9(S)-HPOT; (10E,12Z,15Z)-(9S)-9-Hydroperoxyoctadeca-10,12,15-trienoic acid; 9(S)-HpOTrE; (9S,10E,12Z,15Z)-9-Hydroperoxy-10,12,15-octadecatrienoate",R07864 R07865 R07867 R07868,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,1.13.11.12; 4.2.1.92; 4.2.1.121,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C16321  (10E,12Z,15Z)-(9S)-9-Hydroperoxyoctadeca-10,12,15-trienoic acid",CAS: 111004-08-1; PubChem: 47205629; ChEBI: 60961 60962; LIPIDMAPS: LMFA02000018; LipidBank: DFA8050; NIKKAJI: J466.508B,cpd:C04785; cpd:C07357; cpd:C15753; cpd:C16321; cpd:C16341; cpd:C19936; cpd:C20704,18,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O4,C18H29O4,310.2144094,311.2222345,309.20658442352,2638,cpd:C16322,9-Oxononanoic acid,C9H16O3,9-Oxononanoic acid,R07868,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C16322  9-Oxononanoic acid,CAS: 2553-17-5; PubChem: 47205630; ChEBI: 78700; LIPIDMAPS: LMFA01060160; NIKKAJI: J564.228K,cpd:C01223; cpd:C04130; cpd:C06656; cpd:C16322; cpd:C17224; cpd:C20021,9,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O3,C9H15O3,172.1099444,173.1177694,171.10211932353,2639,cpd:C16323,"3,6-Nonadienal",C9H14O,"3,6-Nonadienal",R07868,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 47205631; ChEBI: 80444; NIKKAJI: J53.070K,cpd:C08499; cpd:C14743; cpd:C16323; cpd:C16757; cpd:C16758,9,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O1,C9H13O1,138.1044651,139.1122901,137.096642354,2640,cpd:C16324,"9,10-EOT;",C18H28O3,"9,10-EOT; 9,10-Epoxyoctadecatrienoic acid; (9S)-(10E,12Z,15Z)-9,10-Epoxyoctadecatri-10,12,15-enoic acid; 9,10-EOTrE",R07865 R07866,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,4.2.1.92,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C16324  (9S)-(10E,12Z,15Z)-9,10-Epoxyoctadecatri-10,12,15-enoic acid",PubChem: 47205632; ChEBI: 80445; NIKKAJI: J2.801.744H,cpd:C01226; cpd:C04672; cpd:C08319; cpd:C13816; cpd:C14911; cpd:C16319; cpd:C16320; cpd:C16324; cpd:C16325; cpd:C18866; cpd:C19147,18,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H29O3,C18H27O3,292.2038448,293.2116698,291.19601972355,2641,cpd:C16325,10-OPDA;,C18H28O3,"10-OPDA; 10-Oxo-11,15-phytodienoic acid; (11Z,15Z)-10-Oxo-11,15-phytodienoic acid",R07866,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C16325  (11Z,15Z)-10-Oxo-11,15-phytodienoic acid",PubChem: 47205633; ChEBI: 80446; NIKKAJI: J264.010D,cpd:C01226; cpd:C04672; cpd:C08319; cpd:C13816; cpd:C14911; cpd:C16319; cpd:C16320; cpd:C16324; cpd:C16325; cpd:C18866; cpd:C19147,18,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H29O3,C18H27O3,292.2038448,293.2116698,291.19601972356,2642,cpd:C16326,9(S)-HOT;,C18H30O3,"9(S)-HOT; (9S)-(10E,12Z,15Z)-9-Hydroxyoctadecatri-10,12,15-enoic acid; 9(S)-HOTrE",NA,alpha-Linolenic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C16326  (9S)-(10E,12Z,15Z)-9-Hydroxyoctadecatri-10,12,15-enoic acid",PubChem: 47205634; ChEBI: 80447; LIPIDMAPS: LMFA02000024; KNApSAcK: C00048303; NIKKAJI: J761.732A,cpd:C04594; cpd:C04780; cpd:C13798; cpd:C14765; cpd:C14766; cpd:C16316; cpd:C16326; cpd:C16342; cpd:C16346; cpd:C19613; cpd:C19827,18,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O3,C18H29O3,294.2194948,295.2273199,293.21166982357,2643,cpd:C16327,OPC8-CoA,C39H64N7O18P3S,OPC8-CoA,R07887 R07888,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.6; 6.2.1.-,Jasmonic acid biosynthesis,NA,PubChem: 47205635; ChEBI: 80448; NIKKAJI: J2.801.815K,cpd:C16327,39,64,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H65O18N7P3S1,C39H63O18N7P3S1,1043.32414,1044.331965,1042.3163152358,2644,cpd:C16328,trans-2-Enoyl-OPC8-CoA,C39H62N7O18P3S,trans-2-Enoyl-OPC8-CoA,R07888 R07889,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.6; 4.2.1.17; 4.2.1.74,Jasmonic acid biosynthesis,NA,PubChem: 47205636; ChEBI: 80449; NIKKAJI: J2.801.816I,cpd:C16328,39,62,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H63O18N7P3S1,C39H61O18N7P3S1,1041.30849,1042.316315,1040.3006652359,2645,cpd:C16330,3-Oxo-OPC8-CoA,C39H62N7O19P3S,3-Oxo-OPC8-CoA,R07890 R07891,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.35; 1.1.1.211; 2.3.1.16,Jasmonic acid biosynthesis,NA,PubChem: 47205638; ChEBI: 80451; NIKKAJI: J2.801.818E,cpd:C16330,39,62,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H63O19N7P3S1,C39H61O19N7P3S1,1057.303405,1058.31123,1056.295582360,2646,cpd:C16331,OPC6-CoA,C37H60N7O18P3S,OPC6-CoA,R07891 R07892,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.6; 2.3.1.16,Jasmonic acid biosynthesis,NA,PubChem: 47205639; ChEBI: 80452; NIKKAJI: J2.801.820G,cpd:C16331,37,60,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C37H61O18N7P3S1,C37H59O18N7P3S1,1015.29284,1016.300665,1014.2850152361,2647,cpd:C16332,trans-2-Enoyl-OPC6-CoA,C37H58N7O18P3S,trans-2-Enoyl-OPC6-CoA,R07892 R07893,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.6; 4.2.1.17; 4.2.1.74,Jasmonic acid biosynthesis,NA,PubChem: 47205640; ChEBI: 80453; NIKKAJI: J2.801.821E,cpd:C16332,37,58,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C37H59O18N7P3S1,C37H57O18N7P3S1,1013.27719,1014.285015,1012.2693652362,2648,cpd:C16334,3-Oxo-OPC6-CoA,C37H58N7O19P3S,3-Oxo-OPC6-CoA,R07894 R07895,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.35; 1.1.1.211; 2.3.1.16,Jasmonic acid biosynthesis,NA,PubChem: 47205642; ChEBI: 80455; NIKKAJI: J2.802.271I,cpd:C16334,37,58,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C37H59O19N7P3S1,C37H57O19N7P3S1,1029.272105,1030.27993,1028.264282363,2649,cpd:C16335,OPC4-CoA,C35H56N7O18P3S,OPC4-CoA,R07895 R07896,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.6; 2.3.1.16,Jasmonic acid biosynthesis,NA,PubChem: 47205643; ChEBI: 80456; NIKKAJI: J2.802.272G,cpd:C16335,35,56,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C35H57O18N7P3S1,C35H55O18N7P3S1,987.2615402,988.2693652,986.25371512364,2650,cpd:C16336,trans-2-Enoyl-OPC4-CoA,C35H54N7O18P3S,trans-2-Enoyl-OPC4-CoA,R07896 R07897,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.6; 4.2.1.17; 4.2.1.74,Jasmonic acid biosynthesis,NA,PubChem: 47205644; ChEBI: 80457; NIKKAJI: J2.802.273E,cpd:C16336,35,54,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C35H55O18N7P3S1,C35H53O18N7P3S1,985.2458901,986.2537151,984.23806512365,2651,cpd:C16338,3-Oxo-OPC4-CoA,C35H54N7O19P3S,3-Oxo-OPC4-CoA,R07898 R07899,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.35; 1.1.1.211; 2.3.1.16,Jasmonic acid biosynthesis,NA,PubChem: 47205646; ChEBI: 80459; NIKKAJI: J2.802.275A,cpd:C16338,35,54,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C35H55O19N7P3S1,C35H53O19N7P3S1,1001.240805,1002.24863,1000.232982366,2652,cpd:C16339,(+)-7-Isojasmonic acid CoA,C33H52N7O18P3S,(+)-7-Isojasmonic acid CoA,R07899 R07902,alpha-Linolenic acid metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.3.1.16; 3.2.1.-,Jasmonic acid biosynthesis,NA,PubChem: 47205647; ChEBI: 80460; NIKKAJI: J2.802.276J,cpd:C16339,33,52,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C33H53O18N7P3S1,C33H51O18N7P3S1,959.23024,960.2380651,958.2224152367,2653,cpd:C16341,2(R)-HPOT;,C18H30O4,"2(R)-HPOT; (2R)-(9Z,12Z,15Z)-2-Hydroperoxyoctadecatri-9,12,15-enoic acid; 2(R)-HpOTrE",NA,alpha-Linolenic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C16341  (2R)-(9Z,12Z,15Z)-2-Hydroperoxyoctadecatri-9,12,15-enoic acid",PubChem: 47205649; ChEBI: 76236; NIKKAJI: J1.150.308J,cpd:C04785; cpd:C07357; cpd:C15753; cpd:C16321; cpd:C16341; cpd:C19936; cpd:C20704,18,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O4,C18H29O4,310.2144094,311.2222345,309.20658442368,2654,cpd:C16342,2(R)-HOT;,C18H30O3,"2(R)-HOT; (2R)-(9Z,12Z,15Z)-2-Hydroxyoctadecatri-9,12,15-enoic acid; 2(R)-HOTrE",NA,alpha-Linolenic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C16342  (2R)-(9Z,12Z,15Z)-2-Hydroxyoctadecatri-9,12,15-enoic acid",PubChem: 47205650; ChEBI: 76234; LIPIDMAPS: LMFA02000033; NIKKAJI: J1.999.011G,cpd:C04594; cpd:C04780; cpd:C13798; cpd:C14765; cpd:C14766; cpd:C16316; cpd:C16326; cpd:C16342; cpd:C16346; cpd:C19613; cpd:C19827,18,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O3,C18H29O3,294.2194948,295.2273199,293.21166982369,2655,cpd:C16343,Heptadecatrienal;,C17H28O,"Heptadecatrienal; (8Z,11Z,14Z)-8,11,14-Heptadecatrienal",NA,alpha-Linolenic acid metabolism,NA,NA,NA,PubChem: 47205651; ChEBI: 76151; LIPIDMAPS: LMFA06000111; NIKKAJI: J282.830H,cpd:C00370; cpd:C07530; cpd:C16343,17,28,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H29O1,C17H27O1,248.2140155,249.2218406,247.20619052370,2656,cpd:C16344,Heptadecatrienoic acid;,C17H28O2,"Heptadecatrienoic acid; (8Z,11Z,14Z)-8,11,14-Heptadecatrienoic acid",NA,alpha-Linolenic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C16344  (8Z,11Z,14Z)-8,11,14-Heptadecatrienoic acid",PubChem: 47205652; ChEBI: 76235; LIPIDMAPS: LMFA01030756; NIKKAJI: J1.663.817J,cpd:C16344,17,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H29O2,C17H27O2,264.2089301,265.2167552,263.20110512371,2657,cpd:C16345,Volicitin;,C23H38N2O5,Volicitin; N-(17-Hydroxylinolenoyl)-L-glutamine,NA,alpha-Linolenic acid metabolism,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA00 Other Fatty Acyls;    C16345  Volicitin,PubChem: 47205653; ChEBI: 80462; NIKKAJI: J1.492.965G,cpd:C16345,23,38,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H39O5N2,C23H37O5N2,422.2780723,423.2858974,421.27024732372,2658,cpd:C16346,17-Hydroxylinolenic acid;,C18H30O3,"17-Hydroxylinolenic acid; (9Z,12Z,15Z)-17-Hydroxyoctadecatri-9,12,15-enoic acid",NA,alpha-Linolenic acid metabolism,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA02 Octadecanoids;    FA0200 Other Octadecanoids;     C16346  (9Z,12Z,15Z)-17-Hydroxyoctadecatri-9,12,15-enoic acid",PubChem: 47205654; ChEBI: 80463; NIKKAJI: J1.365.747E,cpd:C04594; cpd:C04780; cpd:C13798; cpd:C14765; cpd:C14766; cpd:C16316; cpd:C16326; cpd:C16342; cpd:C16346; cpd:C19613; cpd:C19827,18,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H31O3,C18H29O3,294.2194948,295.2273199,293.21166982373,2659,cpd:C19757,(Z)-3-Hexen-1-ol acetate;,C8H14O2,(Z)-3-Hexen-1-ol acetate; (3Z)-Hex-3-en-1-yl acetate; cis-3-Hexenyl acetate,R09631,alpha-Linolenic acid metabolism; Biosynthesis of secondary metabolites,2.3.1.195,NA,NA,CAS: 3681-71-8; PubChem: 135626224; LIPIDMAPS: LMFA07010181; KNApSAcK: C00048964,cpd:C00725; cpd:C03151; cpd:C03152; cpd:C07841; cpd:C11549; cpd:C11550; cpd:C12104; cpd:C12297; cpd:C16241; cpd:C16648; cpd:C16653; cpd:C16654; cpd:C19318; cpd:C19757,8,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O2,C8H13O2,142.0993797,143.1072047,141.09155472374,2661,cpd:C00319,Sphingosine;,C18H37NO2,Sphingosine; Sphingenine; Sphingoid; Sphing-4-enine,R01493 R01494 R01496 R01926 R01928 R01929 R02979 R06521,Sphingolipid metabolism; Metabolic pathways; Sphingolipid signaling pathway; Apoptosis,1.3.99.-; 2.3.1.24; 2.4.1.23; 2.7.1.91; 2.7.8.10; 3.1.3.4; 3.1.3.-; 3.5.1.23,Sphingosine biosynthesis; Sphingosine degradation,Lipids [BR:br08002];  SP  Sphingolipids;   SP01 Sphingoid bases;    SP0101 Sphing-4-enines (Sphingosines);     C00319  Sphing-4-enine,CAS: 123-78-4; PubChem: 3613; ChEBI: 16393; ChEMBL: CHEMBL67166; LIPIDMAPS: LMSP01010001; LipidBank: DLB0019; PDB-CCD: SQS; 3DMET: B01215; NIKKAJI: J10.894D,cpd:C00319; cpd:C02934; cpd:C16512,18,37,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H38O2N1,C18H36O2N1,299.2824294,300.2902545,298.27460442375,2663,cpd:C00836,Sphinganine;,C18H39NO2,"Sphinganine; Dihydrosphingosine; 2-Amino-1,3-dihydroxyoctadecane",R02976 R02978 R02979 R06517 R06518 R06520 R06525,Sphingolipid metabolism; Metabolic pathways; Sphingolipid signaling pathway,1.1.1.102; 1.3.99.-; 1.14.18.5; 2.3.1.24; 2.7.1.91; 3.1.3.4; 3.1.3.-; 3.5.1.23,Ceramide biosynthesis; Sphingosine biosynthesis,Lipids [BR:br08002];  SP  Sphingolipids;   SP01 Sphingoid bases;    SP0102 Sphinganines;     C00836  Sphinganine,CAS: 764-22-7; PubChem: 4094; ChEBI: 16566; ChEMBL: CHEMBL448741; LIPIDMAPS: LMSP01020001; LipidBank: DLB0010; KNApSAcK: C00007540; 3DMET: B04734; NIKKAJI: J14.383I,cpd:C00836,18,39,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H40O2N1,C18H38O2N1,301.2980795,302.3059045,300.29025452376,2664,cpd:C01120,Sphinganine 1-phosphate;,C18H40NO5P,Sphinganine 1-phosphate; Dihydrosphingosine 1-phosphate,R02464 R02976 R06520,Sphingolipid metabolism; Neuroactive ligand-receptor interaction,2.7.1.91; 3.1.3.4; 3.1.3.-; 4.1.2.27,NA,Lipids [BR:br08002];  SP  Sphingolipids;   SP01 Sphingoid bases;    SP0105 Sphingoid base 1-phosphates;     C01120  Sphinganine 1-phosphate,CAS: 19794-97-9; PubChem: 4351; ChEBI: 16893; ChEMBL: CHEMBL78494; LIPIDMAPS: LMSP01050002; LipidBank: PSP6003; 3DMET: B04771; NIKKAJI: J773.227I,cpd:C01120,18,40,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H41O5N1P1,C18H39O5N1P1,381.2644104,382.2722354,380.25658542377,2667,cpd:C01747,Psychosine;,C24H47NO7,Psychosine; Galactosylsphingosine; O-Galactosylsphingosine,R01928 R03700,Sphingolipid metabolism,2.4.1.23; 2.8.2.13,NA,Lipids [BR:br08002];  SP  Sphingolipids;   SP01 Sphingoid bases;    SP0108 Sphingoid base analogs;     C01747  Psychosine;   SP07 Basic glycosphingolipids;    C01747  Psychosine,CAS: 2238-90-6; PubChem: 4881; ChEBI: 16874; LIPIDMAPS: LMSP07000001; LipidBank: GSG1140; 3DMET: B01491; NIKKAJI: J39.570F,cpd:C01747; cpd:C03108,24,47,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H48O7N1,C24H46O7N1,461.3352529,462.3430779,460.32742782378,2669,cpd:C02934,3-Dehydrosphinganine;,C18H37NO2,3-Dehydrosphinganine; 3-Dehydro-D-sphinganine,R01281 R02978 R04092,Sphingolipid metabolism; Metabolic pathways,1.1.1.102; 2.3.1.50,Ceramide biosynthesis; Sphingosine biosynthesis,Lipids [BR:br08002];  SP  Sphingolipids;   SP01 Sphingoid bases;    SP0101 Sphing-4-enines (Sphingosines);     C02934  3-Dehydrosphinganine,PubChem: 5855; ChEBI: 17862; LIPIDMAPS: LMSP01020002; LipidBank: DLB0241; 3DMET: B01613; NIKKAJI: J866.542G,cpd:C00319; cpd:C02934; cpd:C16512,18,37,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H38O2N1,C18H36O2N1,299.2824294,300.2902545,298.27460442379,2671,cpd:C03640,Sphingosyl-phosphocholine,C23H50N2O5P,Sphingosyl-phosphocholine,R01929 R02543,Sphingolipid metabolism,2.3.1.24; 2.7.8.10,NA,Lipids [BR:br08002];  SP  Sphingolipids;   SP01 Sphingoid bases;    SP0106 Lysosphingomyelins and lysoglycosphingolipids;     C03640  Sphingosyl-phosphocholine,PubChem: 6422; ChEBI: 52897; ChEMBL: CHEMBL1481114; LIPIDMAPS: LMSP01060001; PDB-CCD: SPU; 3DMET: B01677; NIKKAJI: J619.421D,cpd:C03640,23,50,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H51O5N2P1,C23H49O5N2P1,465.3457347,466.3535597,464.33790972380,2673,cpd:C06124,Sphingosine 1-phosphate;,C18H38NO5P,Sphingosine 1-phosphate; Sphing-4-enine 1-phosphate; S1P,R01926 R06516 R06521,Sphingolipid metabolism; Metabolic pathways; Calcium signaling pathway; Sphingolipid signaling pathway; Phospholipase D signaling pathway; Neuroactive ligand-receptor interaction; Apelin signaling pathway; Fc gamma R-mediated phagocytosis; Tuberculosis,2.7.1.91; 3.1.3.4; 3.1.3.-; 4.1.2.27; 4.1.2.-,Sphingosine degradation,Lipids [BR:br08002];  SP  Sphingolipids;   SP01 Sphingoid bases;    SP0105 Sphingoid base 1-phosphates;     C06124  Sphingosine 1-phosphate,CAS: 26993-30-6; PubChem: 8381; ChEBI: 37550; ChEMBL: CHEMBL225155; LIPIDMAPS: LMSP01050001; LipidBank: PSP6001; PDB-CCD: S1P; 3DMET: B05165; NIKKAJI: J627.163D,cpd:C06124,18,38,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H39O5N1P1,C18H37O5N1P1,379.2487603,380.2565854,378.24093532381,2679,cpd:C12144,Phytosphingosine;,C18H39NO3,Phytosphingosine; 4-D-Hydroxysphinganine,R06525 R06527 R06528,Sphingolipid metabolism; Metabolic pathways,1.14.18.5; 2.3.1.24; 3.5.1.23,NA,Lipids [BR:br08002];  SP  Sphingolipids;   SP01 Sphingoid bases;    SP0103 4-Hydroxysphinganines (Phytosphingosines);     C12144  4-D-Hydroxysphinganine,CAS: 554-62-1; PubChem: 14291; ChEBI: 46961; ChEMBL: CHEMBL236036; LIPIDMAPS: LMSP01030001; LipidBank: DLB0039; 3DMET: B04437; NIKKAJI: J13.584D,cpd:C12144,18,39,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H40O3N1,C18H38O3N1,317.2929941,318.3008192,316.28516912382,2681,cpd:C00058,Formate;,CH2O2,Formate; Methanoic acid; Formic acid,R00134 R00152 R00212 R00424 R00425 R00518 R00519 R00521; R00522 R00524 R00525 R00526 R00527 R00604 R00614 R00653; R00753 R00943 R00944 R00988 R01305 R01959 R02238 R02351; R02509 R02604 R03087 R03146 R03204 R03215 R03472 R03728; R03907 R04268 R04283 R04488 R04911 R05046 R05296 R05635; R05640 R05731 R05865 R06940 R06974 R06975 R06987 R07281; R07290 R07303 R07363 R07364 R07662 R07983 R08060 R08451; R08864 R09094 R09126 R09145 R09152 R09185 R09374 R09481; R09494 R09556 R10301 R10348 R10356 R10376 R10511 R10515; R10797 R11037 R11313,Pyruvate metabolism; Chloroalkane and chloroalkene degradation; Glyoxylate and dicarboxylate metabolism; Methane metabolism; Carbon fixation pathways in prokaryotes; Nitrogen metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Degradation of aromatic compounds,1.1.1.306; 1.1.5.6; 1.1.99.33; 1.2.1.2; 1.2.1.43; 1.2.1.46; 1.2.2.1; 1.2.2.3; 1.2.98.1; 1.2.99.5; 1.2.99.9; 1.13.11.41; 1.13.11.53; 1.13.11.54; 1.13.11.72; 1.13.11.81; 1.14.12.11; 1.14.13.70; 1.14.13.-; 1.14.14.14; 1.14.99.21; 2.1.2.-; 2.3.1.54; 2.7.2.6; 2.8.3.16; 3.1.2.10; 3.1.2.12; 3.5.1.8; 3.5.1.9; 3.5.1.10; 3.5.1.15; 3.5.1.31; 3.5.1.49; 3.5.1.56; 3.5.1.68; 3.5.1.88; 3.5.1.91; 3.5.1.102; 3.5.1.106; 3.5.1.-; 3.5.4.16; 3.5.4.25; 3.5.4.39; 3.5.5.-; 3.7.1.9; 3.7.1.-; 4.1.1.2; 4.1.2.36; 4.1.2.44; 4.1.3.-; 4.1.99.5; 4.1.99.12; 4.1.99.17; 6.3.4.3; 6.3.4.17; 6.3.4.23,Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway),Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Monocarboxylic acids;     C00058  Formate; Methanoate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C00058  Formic acid,CAS: 64-18-6; PubChem: 3358; ChEBI: 15740 30751; ChEMBL: CHEMBL116736; LIPIDMAPS: LMFA01010040; LipidBank: DFA0001; KNApSAcK: C00001182; PDB-CCD: FMT; 3DMET: B01142; NIKKAJI: J1.402H,cpd:C00058; cpd:C01707; cpd:C06443,1,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H3O2,C1H1O2,46.0054793,47.01330434,44.997654272383,2682,cpd:C00256,(R)-Lactate;,C3H6O3,(R)-Lactate; D-Lactate; D-Lactic acid; D-2-Hydroxypropanoic acid; D-2-Hydroxypropionic acid,R00197 R00198 R00297 R00704 R01448 R01450 R01735 R01736; R08555 R09588 R09796 R11562 R11563 R11564,Pyruvate metabolism; Microbial metabolism in diverse environments; Vancomycin resistance,1.1.1.28; 1.1.2.4; 1.1.2.5; 1.1.99.6; 1.2.1.23; 3.1.2.6; 3.1.6.17; 3.5.1.124; 4.2.1.126; 4.2.1.130; 5.1.2.1; 6.1.2.1,NA,NA,CAS: 10326-41-7; PubChem: 3555; ChEBI: 16004 42111; ChEMBL: CHEMBL358850; KNApSAcK: C00019549; PDB-CCD: LAC; 3DMET: B00075; NIKKAJI: J9.141C,cpd:C00184; cpd:C00186; cpd:C00256; cpd:C00577; cpd:C01013; cpd:C01432; cpd:C02154; cpd:C02426; cpd:C03726; cpd:C05823; cpd:C10899; cpd:C12677; cpd:C19286; cpd:C19296,3,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O3,C3H5O3,90.03169405,91.03951908,89.023869022384,2683,cpd:C00937,(R)-Lactaldehyde;,C3H6O2,(R)-Lactaldehyde; D-Lactaldehyde; D-2-Hydroxypropionaldehyde,R01735 R02527 R03080 R03081 R03082,Pyruvate metabolism,1.1.1.77; 1.1.1.78; 1.1.1.79; 1.2.1.23; 4.1.2.18,NA,NA,PubChem: 4189; ChEBI: 17167; 3DMET: B00204; NIKKAJI: J2.583F,cpd:C00163; cpd:C00424; cpd:C00937; cpd:C00969; cpd:C01021; cpd:C02634; cpd:C02635; cpd:C02638; cpd:C02718; cpd:C02749; cpd:C02882; cpd:C03148; cpd:C03173; cpd:C04080; cpd:C05235; cpd:C05726; cpd:C05999; cpd:C06682; cpd:C08057; cpd:C10920; cpd:C16632; cpd:C17266; cpd:C17530,3,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O2,C3H5O2,74.03677943,75.04460446,73.02895442385,2684,cpd:C02488,(R)-2-Ethylmalate,C6H10O5,(R)-2-Ethylmalate,R00998,Pyruvate metabolism,2.3.3.6,NA,NA,PubChem: 5501; ChEBI: 15583; 3DMET: B00450; NIKKAJI: J2.023.768F,cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335,6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5,C6H9O5,162.0528234,163.0606485,161.04499842386,2685,cpd:C03248,Acetylenedicarboxylate;,C4H2O4,Acetylenedicarboxylate; Acetylenedicarboxylic acid; 2-Butynedioic acid,R00218 R04177,Pyruvate metabolism,4.1.1.78,NA,NA,CAS: 142-45-0; PubChem: 6117; ChEBI: 15357 30781; ChEMBL: CHEMBL1874364; 3DMET: B00569; NIKKAJI: J2.544E,cpd:C02111; cpd:C03248; cpd:C15997,4,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H3O4,C4H1O4,113.9953085,115.0031336,112.98748352387,2686,cpd:C03451,(R)-S-Lactoylglutathione;,C13H21N3O8S,(R)-S-Lactoylglutathione; S-D-Lactoylglutathione,R01736 R02530 R03082,Pyruvate metabolism,3.1.2.6; 4.4.1.5,NA,NA,PubChem: 6272; ChEBI: 15694; 3DMET: B01661; NIKKAJI: J524.698I,cpd:C03451,13,21,8,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C13H22O8N3S1,C13H20O8N3S1,379.1049358,380.1127609,378.09711082388,2687,cpd:C03981,2-Hydroxyethylenedicarboxylate;,C4H4O5,2-Hydroxyethylenedicarboxylate; enol-Oxaloacetate; enol-Oxaloacetic acid; 2-Hydroxybut-2-enedioic acid,R00219 R00363 R04177,Pyruvate metabolism,4.1.1.78; 4.1.1.-; 5.3.2.2,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0117 Dicarboxylic acids;     C03981  2-Hydroxybut-2-enedioic acid,PubChem: 6698; ChEBI: 28394; LIPIDMAPS: LMFA01170061; 3DMET: B00660; NIKKAJI: J1.250.029G,cpd:C00036; cpd:C03548; cpd:C03981; cpd:C20341,4,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H5O5,C4H3O5,132.0058732,133.0136983,130.99804822389,2688,cpd:C05994,2-Propylmalate;,C7H12O5,"2-Propylmalate; 2-Propylmalic acid; Malic acid, 2-propyl-",R05063,Pyruvate metabolism,4.1.3.-,NA,NA,PubChem: 8268; ChEBI: 28652; 3DMET: B00886; NIKKAJI: J2.369.079I,cpd:C02123; cpd:C02504; cpd:C03328; cpd:C04411; cpd:C05994; cpd:C17210; cpd:C17212; cpd:C21371,7,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O5,C7H11O5,176.0684735,177.0762985,175.06064852390,2689,cpd:C01273,"2-Hydroxy-6-oxo-6-phenylhexa-2,4-dienoate;",C12H10O4,"2-Hydroxy-6-oxo-6-phenylhexa-2,4-dienoate; 2,6-Dioxo-6-phenylhexa-3-enoate",R02606 R03462 R03463,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.40; 1.13.11.39; 3.7.1.8,"Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate",NA,PubChem: 4492; ChEBI: 17820; 3DMET: B00271; NIKKAJI: J922.501C,cpd:C01273; cpd:C03837; cpd:C07733; cpd:C08164; cpd:C10300; cpd:C14216; cpd:C16811; cpd:C20857,12,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11O4,C12H9O4,218.0579088,219.0657338,217.05008382391,2690,cpd:C02526,"Biphenyl-2,3-diol;",C12H10O2,"Biphenyl-2,3-diol; 2,3-Dihydroxybiphenyl; 3-Phenylcatechol",R03462 R03964 R05239,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.56; 1.13.11.39; 1.14.13.44,"Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate",NA,CAS: 1133-63-7; PubChem: 5534; ChEBI: 16205; PDB-CCD: BPY; 3DMET: B00457; NIKKAJI: J631.139C,cpd:C01727; cpd:C02526; cpd:C03209; cpd:C04167; cpd:C06721; cpd:C08448; cpd:C10310; cpd:C11122; cpd:C13014; cpd:C14297; cpd:C19750; cpd:C20803,12,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11O2,C12H9O2,186.0680796,187.0759046,185.06025452392,2691,cpd:C03569,"2,2',3-Trihydroxybiphenyl",C12H10O3,"2,2',3-Trihydroxybiphenyl",R05411 R05434,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 1.14.12.-,NA,NA,CAS: 91368-55-7; PubChem: 6361; ChEBI: 28517; 3DMET: B00601; NIKKAJI: J691.387C,cpd:C03569; cpd:C06742; cpd:C18750; cpd:C20805; cpd:C20856,12,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11O3,C12H9O3,202.0629942,203.0708192,201.05516912393,2692,cpd:C06584,4-Chlorobiphenyl;,C12H9Cl,4-Chlorobiphenyl; 1-Chloro-4-phenyl benzene; 4-Monochloro-biphenyl,R05261 R05262,Dioxin degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.18,"Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate",NA,CAS: 2051-62-9; PubChem: 8812; ChEBI: 27757; ChEMBL: CHEMBL276334; 3DMET: B00982; NIKKAJI: J47.611K,cpd:C06584; cpd:C06586; cpd:C06587; cpd:C14191; cpd:C14195; cpd:C14353; cpd:C14755; cpd:C15202; cpd:C18874; cpd:C19030,12,9,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C12H10Cl1,C12H8Cl1,188.039278,189.047103,187.03145292394,2693,cpd:C06585,"cis-2,3-Dihydro-2,3-dihydroxy-4'-chlorobiphenyl",C12H11ClO2,"cis-2,3-Dihydro-2,3-dihydroxy-4'-chlorobiphenyl",R05241 R05261 R05262,Dioxin degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.56; 1.14.12.18,"Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate",NA,PubChem: 8813; ChEBI: 28974; NIKKAJI: J2.762.455C,cpd:C06585,12,11,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C12H12O2Cl1,C12H10O2Cl1,222.0447573,223.0525823,221.03693222395,2694,cpd:C06586,"2,3-Dihydroxy-4'-chlorobiphenyl",C12H9ClO2,"2,3-Dihydroxy-4'-chlorobiphenyl",R05241 R05245,Dioxin degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.56; 1.13.11.39,"Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate",NA,PubChem: 8814; ChEBI: 28979; 3DMET: B00983; NIKKAJI: J681.467K,cpd:C06586; cpd:C14191,12,9,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C12H10O2Cl1,C12H8O2Cl1,220.0291072,221.0369322,219.02128222396,2695,cpd:C06587,"2-Hydroxy-6-oxo-6-(4'-chlorophenyl)-hexa-2,4-dienoate",C12H9ClO4,"2-Hydroxy-6-oxo-6-(4'-chlorophenyl)-hexa-2,4-dienoate",R05245 R05359,Dioxin degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.39; 3.7.1.8,"Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate",NA,PubChem: 8815; ChEBI: 28978; 3DMET: B00984; NIKKAJI: J2.762.473A,cpd:C06587,12,9,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C12H10O4Cl1,C12H8O4Cl1,252.0189365,253.0267615,251.01111142397,2696,cpd:C06588,Biphenyl;,C12H10,"Biphenyl; Phenylbenzene; 1,1'-Biphenyl; 1,1'-Diphenyl",R05263 R05264,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.18,"Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate",Pesticides [BR:br08007];  Pesticides;   Fungicides;    Others;     C06588  Biphenyl,CAS: 92-52-4; PubChem: 8816; ChEBI: 17097; ChEMBL: CHEMBL14092; PDB-CCD: BNL; 3DMET: B00985; NIKKAJI: J3.929B,cpd:C01273; cpd:C01727; cpd:C02499; cpd:C02526; cpd:C03209; cpd:C03569; cpd:C03837; cpd:C04167; cpd:C04486; cpd:C06588; cpd:C06721; cpd:C06742; cpd:C07731; cpd:C07733; cpd:C07734; cpd:C08052; cpd:C08164; cpd:C08448; cpd:C09209; cpd:C10300; cpd:C10310; cpd:C11100; cpd:C11122; cpd:C13014; cpd:C14216; cpd:C14224; cpd:C14297; cpd:C14342; cpd:C14569; cpd:C14742; cpd:C15042; cpd:C16811; cpd:C16927; cpd:C18604; cpd:C18750; cpd:C18851; cpd:C19225; cpd:C19226; cpd:C19312; cpd:C19334; cpd:C19433; cpd:C19479; cpd:C19750; cpd:C20319; cpd:C20803; cpd:C20805; cpd:C20856; cpd:C20857; cpd:C20938; cpd:C21001; cpd:C21475,12,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11,C12H9,154.0782503,155.0860754,153.07042532398,2697,cpd:C06589,"cis-2,3-Dihydro-2,3-dihydroxybiphenyl;",C12H12O2,"cis-2,3-Dihydro-2,3-dihydroxybiphenyl; cis-3-Phenylcyclohexa-3,5-diene-1,2-diol; (1S,2R)-3-Phenylcyclohexa-3,5-diene-1,2-diol",R05239 R05263 R05264,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.56; 1.14.12.18,"Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate",NA,PubChem: 8817; ChEBI: 15599 32922; NIKKAJI: J658.815H,cpd:C06589; cpd:C07666; cpd:C11744; cpd:C16924,12,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H13O2,C12H11O2,188.0837296,189.0915547,187.07590462399,2698,cpd:C07557,"2,3,7,8-Tetrachlorodibenzodioxin;",C12H4Cl4O2,"2,3,7,8-Tetrachlorodibenzodioxin; Tetrachlorodibenzodioxin; 2,3,7,8-Tetrachlorodibenzo-p-dioxin; TCDD; PCDD 48",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDDs;    C07557  2,3,7,8-Tetrachlorodibenzodioxin (PCDD 48); Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C07557  2,3,7,8-Tetrachlorodibenzodioxin",CAS: 1746-01-6; PubChem: 9760; ChEBI: 28119; ChEMBL: CHEMBL30327; NIKKAJI: J3.677C,cpd:C07557; cpd:C11058; cpd:C11059,12,4,2,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C12H5O2Cl4,C12H3O2Cl4,319.8965401,320.9043651,318.88871512400,2699,cpd:C07729,Dibenzofuran;,C12H8O,Dibenzofuran; Diphenylene oxide,R05434,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.-,NA,NA,CAS: 132-64-9; PubChem: 9931; ChEBI: 28145; ChEMBL: CHEMBL277497; PDB-CCD: 1IT; 3DMET: B01101; NIKKAJI: J2.522D,cpd:C07729; cpd:C08398; cpd:C13718; cpd:C13748; cpd:C14192; cpd:C14193; cpd:C14370; cpd:C14371; cpd:C14734; cpd:C14736; cpd:C18124; cpd:C21149; cpd:C21477,12,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H9O1,C12H7O1,168.0575149,169.0653399,167.04968982401,2700,cpd:C07731,"2-Hydroxy-6-oxo-6-(2-hydroxyphenyl)-hexa-2,4-dienoate",C12H10O5,"2-Hydroxy-6-oxo-6-(2-hydroxyphenyl)-hexa-2,4-dienoate",R05360 R05411,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 3.7.1.8,NA,NA,PubChem: 9933; ChEBI: 1135 36538; 3DMET: B01102; NIKKAJI: J2.548.883K,cpd:C07731; cpd:C08052; cpd:C21001,12,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11O5,C12H9O5,234.0528234,235.0606485,233.04499842402,2701,cpd:C07732,Dibenzo-p-dioxin,C12H8O2,Dibenzo-p-dioxin,R05439,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.-,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07732  Dibenzo-p-dioxin,CAS: 262-12-4; PubChem: 9934; ChEBI: 28891; 3DMET: B01103; NIKKAJI: J34.854F,cpd:C02161; cpd:C06722; cpd:C07732; cpd:C14409; cpd:C18831; cpd:C21150,12,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H9O2,C12H7O2,184.0524295,185.0602545,183.04460452403,2702,cpd:C07733,"2,2',3-Trihydroxydiphenylether",C12H10O4,"2,2',3-Trihydroxydiphenylether",R05413 R05439,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 1.14.12.-,NA,NA,PubChem: 9935; ChEBI: 27381; 3DMET: B01104; NIKKAJI: J1.068.226F,cpd:C01273; cpd:C03837; cpd:C07733; cpd:C08164; cpd:C10300; cpd:C14216; cpd:C16811; cpd:C20857,12,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11O4,C12H9O4,218.0579088,219.0657338,217.05008382404,2703,cpd:C07734,"2-Hydroxy-6-oxo-6-(2-hydroxyphenoxy)-hexa-2,4-dienoate",C12H10O6,"2-Hydroxy-6-oxo-6-(2-hydroxyphenoxy)-hexa-2,4-dienoate",R05361 R05413,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 3.7.1.8,NA,NA,PubChem: 9936; ChEBI: 19327 28990; 3DMET: B01105; NIKKAJI: J2.765.266B,cpd:C07734; cpd:C18851; cpd:C20938,12,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11O6,C12H9O6,250.047738,251.0555631,249.0399132405,2704,cpd:C08060,Carbazole;,C12H9N,Carbazole; 9H-Carbazole,R05414 R09512,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.22,"Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate",Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C08060  Carbazole,CAS: 86-74-8; PubChem: 10260; ChEBI: 27543 3391; ChEMBL: CHEMBL243580; KNApSAcK: C00024693; PDB-CCD: 9CA; 3DMET: B01106; NIKKAJI: J3.896B,cpd:C05720; cpd:C08060; cpd:C10660; cpd:C10697; cpd:C10736; cpd:C10981; cpd:C19269; cpd:C19473; cpd:C20316,12,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H10N1,C12H8N1,167.0734993,168.0813243,166.06567432406,2705,cpd:C08061,"2'-Aminobiphenyl-2,3-diol",C12H11NO2,"2'-Aminobiphenyl-2,3-diol",R05414 R05415 R09512,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 1.14.12.22,"Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate",NA,PubChem: 10261; ChEBI: 29010; 3DMET: B01107; NIKKAJI: J533.219B,cpd:C07491; cpd:C08061; cpd:C18833,12,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H12O2N1,C12H10O2N1,201.0789786,202.0868036,200.07115362407,2706,cpd:C08062,"2-Hydroxy-6-oxo-(2'-aminophenyl)-hexa-2,4-dienoate",C12H11NO4,"2-Hydroxy-6-oxo-(2'-aminophenyl)-hexa-2,4-dienoate",R05365 R05415,Dioxin degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 3.7.1.13,"Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate",NA,PubChem: 10262; ChEBI: 36537; 3DMET: B01108; NIKKAJI: J533.220F,cpd:C08062; cpd:C10654; cpd:C14206; cpd:C18921,12,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H12O4N1,C12H10O4N1,233.0688078,234.0766329,232.06098282408,2707,cpd:C11057,"3,4,3',4'-Tetrachlorobiphenyl;",C12H6Cl4,"3,4,3',4'-Tetrachlorobiphenyl; PCB 77",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Non-ortho (coplanar) PCBs;    C11057  3,4,3',4'-Tetrachlorobiphenyl (PCB 77)",CAS: 32598-13-3; PubChem: 13239; ChEBI: 1367; ChEMBL: CHEMBL344161; NIKKAJI: J70.045B,cpd:C07967; cpd:C11057; cpd:C14190; cpd:C14194; cpd:C14196; cpd:C14199; cpd:C14247; cpd:C14360; cpd:C14361; cpd:C14362; cpd:C14363; cpd:C14364; cpd:C14376; cpd:C14380; cpd:C14733; cpd:C15248; cpd:C18114; cpd:C18451; cpd:C19025; cpd:C19032,12,6,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C12H7Cl4,C12H5Cl4,289.9223609,290.930186,288.91453592409,2708,cpd:C14573,"3,3',4,4',5-Pentachlorobiphenyl;",C12H5Cl5,"3,3',4,4',5-Pentachlorobiphenyl; PCB 126",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Non-ortho (coplanar) PCBs;    C14573  3,3',4,4',5-Pentachlorobiphenyl (PCB 126); Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C14573  3,3',4,4',5-Pentachlorobiphenyl",CAS: 57465-28-8; PubChem: 17395573; ChEBI: 34317; ChEMBL: CHEMBL342696; NIKKAJI: J164.843H,cpd:C11044; cpd:C14365; cpd:C14366; cpd:C14372; cpd:C14373; cpd:C14374; cpd:C14375; cpd:C14377; cpd:C14378; cpd:C14379; cpd:C14381; cpd:C14471; cpd:C14573; cpd:C14729; cpd:C14756; cpd:C18116; cpd:C18117; cpd:C18118; cpd:C18119,12,5,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C12H6Cl5,C12H4Cl5,323.8833886,324.8912136,322.87556352410,2709,cpd:C18099,"1,2,3,7,8-Pentachlorodibenzodioxin;",C12H3Cl5O2,"1,2,3,7,8-Pentachlorodibenzodioxin; 1,2,3,7,8-Pentachlorodibenzo-p-dioxin; 1,2,3,7,8-PeCDD; PCDD 54",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDDs;    C18099  1,2,3,7,8-Pentachlorodibenzodioxin (PCDD 54)",CAS: 40321-76-4; PubChem: 96024316; ChEBI: 81501; ChEMBL: CHEMBL137220; NIKKAJI: J34.849J,cpd:C15244; cpd:C18099,12,3,2,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C12H4O2Cl5,C12H2O2Cl5,353.8575677,354.8653928,352.84974272411,2710,cpd:C18100,"1,2,3,4,7,8-Hexachlorodibenzodioxin;",C12H2Cl6O2,"1,2,3,4,7,8-Hexachlorodibenzodioxin; 1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin; 1,2,3,4,7,8-HxCDD; PCDD 66",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDDs;    C18100  1,2,3,4,7,8-Hexachlorodibenzodioxin (PCDD 66)",CAS: 39227-28-6; PubChem: 96024317; ChEBI: 81502; ChEMBL: CHEMBL136116; NIKKAJI: J42.206A,cpd:C18100; cpd:C18101; cpd:C18102,12,2,2,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C12H3O2Cl6,C12H1O2Cl6,387.8185954,388.8264204,386.81077042412,2711,cpd:C18101,"1,2,3,6,7,8-Hexachlorodibenzodioxin;",C12H2Cl6O2,"1,2,3,6,7,8-Hexachlorodibenzodioxin; 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin; 1,2,3,6,7,8-HxCDD; PCDD 67",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDDs;    C18101  1,2,3,6,7,8-Hexachlorodibenzodioxin (PCDD 67)",CAS: 57653-85-7; PubChem: 96024318; ChEBI: 81503; NIKKAJI: J34.852J,cpd:C18100; cpd:C18101; cpd:C18102,12,2,2,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C12H3O2Cl6,C12H1O2Cl6,387.8185954,388.8264204,386.81077042413,2712,cpd:C18102,"1,2,3,7,8,9-Hexachlorodibenzodioxin;",C12H2Cl6O2,"1,2,3,7,8,9-Hexachlorodibenzodioxin; 1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin; 1,2,3,7,8,9-HxCDD; PCDD 70",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDDs;    C18102  1,2,3,7,8,9-Hexachlorodibenzodioxin (PCDD 70)",CAS: 19408-74-3; PubChem: 96024319; ChEBI: 81504; NIKKAJI: J34.851A,cpd:C18100; cpd:C18101; cpd:C18102,12,2,2,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C12H3O2Cl6,C12H1O2Cl6,387.8185954,388.8264204,386.81077042414,2713,cpd:C18103,"1,2,3,4,6,7,8-Heptachlorodibenzodioxin;",C12HCl7O2,"1,2,3,4,6,7,8-Heptachlorodibenzodioxin; 1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin; 1,2,3,4,6,7,8-HpCDD; PCDD 73",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDDs;    C18103  1,2,3,4,6,7,8-Heptachlorodibenzodioxin (PCDD 73)",CAS: 35822-46-9; PubChem: 96024320; ChEBI: 81505; NIKKAJI: J74.770J,cpd:C18103,12,1,2,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,C12H2O2Cl7,C12H0O2Cl7,421.779623,422.7874481,420.7717982415,2714,cpd:C18104,"2,3,7,8-Tetrachlorodibenzofuran;",C12H4Cl4O,"2,3,7,8-Tetrachlorodibenzofuran; 2,3,7,8-TCDF; PCDF 83",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDFs;    C18104  2,3,7,8-Tetrachlorodibenzofuran (PCDF 83)",CAS: 51207-31-9; PubChem: 96024321; ChEBI: 81506; ChEMBL: CHEMBL136710; NIKKAJI: J366.845B,cpd:C18104,12,4,1,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C12H5O1Cl4,C12H3O1Cl4,303.9016255,304.9094505,302.89380042416,2715,cpd:C18105,"1,2,3,7,8-Pentachlorodibenzofuran;",C12H3Cl5O,"1,2,3,7,8-Pentachlorodibenzofuran; 1,2,3,7,8-PeCDF; PCDF 94",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDFs;    C18105  1,2,3,7,8-Pentachlorodibenzofuran (PCDF 94)",CAS: 57117-41-6; PubChem: 96024322; ChEBI: 81507; ChEMBL: CHEMBL137304; NIKKAJI: J364.336K,cpd:C18105; cpd:C18106,12,3,1,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C12H4O1Cl5,C12H2O1Cl5,337.8626531,338.8704782,336.85482812417,2716,cpd:C18106,"2,3,4,7,8-Pentachlorodibenzofuran;",C12H3Cl5O,"2,3,4,7,8-Pentachlorodibenzofuran; 2,3,4,7,8-PeCDF; PCDF 114",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDFs;    C18106  2,3,4,7,8-Pentachlorodibenzofuran (PCDF 114); Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C18106  2,3,4,7,8-Pentachlorodibenzofuran",CAS: 57117-31-4; PubChem: 96024323; ChEBI: 81508; ChEMBL: CHEMBL335558; NIKKAJI: J364.337I,cpd:C18105; cpd:C18106,12,3,1,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C12H4O1Cl5,C12H2O1Cl5,337.8626531,338.8704782,336.85482812418,2717,cpd:C18107,"1,2,3,4,7,8-Hexachlorodibenzofuran;",C12H2Cl6O,"1,2,3,4,7,8-Hexachlorodibenzofuran; 1,2,3,4,7,8-HxCDF; PCDF 118",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDFs;    C18107  1,2,3,4,7,8-Hexachlorodibenzofuran (PCDF 118)",CAS: 70648-26-9; PubChem: 96024324; ChEBI: 81509; ChEMBL: CHEMBL342717; NIKKAJI: J364.338G,cpd:C18107; cpd:C18108; cpd:C18109; cpd:C18110,12,2,1,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C12H3O1Cl6,C12H1O1Cl6,371.8236808,372.8315058,370.81585572419,2718,cpd:C18108,"1,2,3,7,8,9-Hexachlorodibenzofuran;",C12H2Cl6O,"1,2,3,7,8,9-Hexachlorodibenzofuran; 1,2,3,7,8,9-HxCDF; PCDF 124",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDFs;    C18108  1,2,3,7,8,9-Hexachlorodibenzofuran (PCDF 124)",CAS: 72918-21-9; PubChem: 96024325; ChEBI: 81510; NIKKAJI: J364.340I,cpd:C18107; cpd:C18108; cpd:C18109; cpd:C18110,12,2,1,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C12H3O1Cl6,C12H1O1Cl6,371.8236808,372.8315058,370.81585572420,2719,cpd:C18109,"1,2,3,6,7,8-Hexachlorodibenzofuran;",C12H2Cl6O,"1,2,3,6,7,8-Hexachlorodibenzofuran; 1,2,3,6,7,8-HxCDF; PCDF 121",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDFs;    C18109  1,2,3,6,7,8-Hexachlorodibenzofuran (PCDF 121)",CAS: 57117-44-9; PubChem: 96024326; ChEBI: 81511; ChEMBL: CHEMBL343494; NIKKAJI: J364.339E,cpd:C18107; cpd:C18108; cpd:C18109; cpd:C18110,12,2,1,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C12H3O1Cl6,C12H1O1Cl6,371.8236808,372.8315058,370.81585572421,2720,cpd:C18110,"2,3,4,6,7,8-Hexachlorodibenzofuran;",C12H2Cl6O,"2,3,4,6,7,8-Hexachlorodibenzofuran; 2,3,4,6,7,8-HxCDF; PCDF 130",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDFs;    C18110  2,3,4,6,7,8-Hexachlorodibenzofuran (PCDF 130)",CAS: 60851-34-5; PubChem: 96024327; ChEBI: 81512; ChEMBL: CHEMBL343049; NIKKAJI: J364.341G,cpd:C18107; cpd:C18108; cpd:C18109; cpd:C18110,12,2,1,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C12H3O1Cl6,C12H1O1Cl6,371.8236808,372.8315058,370.81585572422,2721,cpd:C18111,"1,2,3,4,6,7,8-Heptachlorodibenzofuran;",C12HCl7O,"1,2,3,4,6,7,8-Heptachlorodibenzofuran; 1,2,3,4,6,7,8-HpCDF; PCDF 131",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDFs;    C18111  1,2,3,4,6,7,8-Heptachlorodibenzofuran (PCDF 131)",CAS: 67562-39-4; PubChem: 96024328; ChEBI: 81513; NIKKAJI: J401.107D,cpd:C18111; cpd:C18112,12,1,1,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,C12H2O1Cl7,C12H0O1Cl7,405.7847084,406.7925335,404.77688342423,2722,cpd:C18112,"1,2,3,4,7,8,9-Heptachlorodibenzofuran;",C12HCl7O,"1,2,3,4,7,8,9-Heptachlorodibenzofuran; 1,2,3,4,7,8,9-HpCDF; PCDF 134",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   PCDFs;    C18112  1,2,3,4,7,8,9-Heptachlorodibenzofuran (PCDF 134)",CAS: 55673-89-7; PubChem: 96024329; ChEBI: 81514; NIKKAJI: J401.110D,cpd:C18111; cpd:C18112,12,1,1,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,C12H2O1Cl7,C12H0O1Cl7,405.7847084,406.7925335,404.77688342424,2724,cpd:C18114,"3,4,4',5-Tetrachlorobiphenyl;",C12H6Cl4,"3,4,4',5-Tetrachlorobiphenyl; PCB 81",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Non-ortho (coplanar) PCBs;    C18114  3,4,4',5-Tetrachlorobiphenyl (PDB 81)",CAS: 70362-50-4; PubChem: 96024331; ChEBI: 81516; ChEMBL: CHEMBL137799; NIKKAJI: J431.701G,cpd:C07967; cpd:C11057; cpd:C14190; cpd:C14194; cpd:C14196; cpd:C14199; cpd:C14247; cpd:C14360; cpd:C14361; cpd:C14362; cpd:C14363; cpd:C14364; cpd:C14376; cpd:C14380; cpd:C14733; cpd:C15248; cpd:C18114; cpd:C18451; cpd:C19025; cpd:C19032,12,6,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,C12H7Cl4,C12H5Cl4,289.9223609,290.930186,288.91453592425,2725,cpd:C18115,"3,4,5,3',4',5'-Hexachlorobiphenyl;",C12H4Cl6,"3,4,5,3',4',5'-Hexachlorobiphenyl; PCB 169",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Non-ortho (coplanar) PCBs;    C18115  3,4,5,3',4',5'-Hexachlorobiphenyl (PCB 169)",CAS: 32774-16-6; PubChem: 96024332; ChEBI: 81517; ChEMBL: CHEMBL14658; NIKKAJI: J79.027C,cpd:C14197; cpd:C14198; cpd:C14201; cpd:C14202; cpd:C14203; cpd:C14367; cpd:C14369; cpd:C14728; cpd:C14730; cpd:C18115; cpd:C18120; cpd:C18121; cpd:C18122,12,4,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C12H5Cl6,C12H3Cl6,357.8444162,358.8522413,356.83659122426,2726,cpd:C18116,"2,3,4,3',4'-Pentachlorobiphenyl;",C12H5Cl5,"2,3,4,3',4'-Pentachlorobiphenyl; PCB 105",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Mono-ortho PCBs;    C18116  2,3,4,3',4'-Pentachlorobiphenyl (PCB 105)",CAS: 32598-14-4; PubChem: 96024333; ChEBI: 81518; ChEMBL: CHEMBL341816; NIKKAJI: J70.043F,cpd:C11044; cpd:C14365; cpd:C14366; cpd:C14372; cpd:C14373; cpd:C14374; cpd:C14375; cpd:C14377; cpd:C14378; cpd:C14379; cpd:C14381; cpd:C14471; cpd:C14573; cpd:C14729; cpd:C14756; cpd:C18116; cpd:C18117; cpd:C18118; cpd:C18119,12,5,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C12H6Cl5,C12H4Cl5,323.8833886,324.8912136,322.87556352427,2727,cpd:C18117,"2,3,4,4',5-Pentachlorobiphenyl;",C12H5Cl5,"2,3,4,4',5-Pentachlorobiphenyl; PCB 114",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Mono-ortho PCBs;    C18117  2,3,4,4',5-Pentachlorobiphenyl (PCB 114)",CAS: 74472-37-0; PubChem: 96024334; ChEBI: 81519; ChEMBL: CHEMBL273442; NIKKAJI: J164.824A,cpd:C11044; cpd:C14365; cpd:C14366; cpd:C14372; cpd:C14373; cpd:C14374; cpd:C14375; cpd:C14377; cpd:C14378; cpd:C14379; cpd:C14381; cpd:C14471; cpd:C14573; cpd:C14729; cpd:C14756; cpd:C18116; cpd:C18117; cpd:C18118; cpd:C18119,12,5,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C12H6Cl5,C12H4Cl5,323.8833886,324.8912136,322.87556352428,2728,cpd:C18118,"2,3',4,4',5-Pentachlorobiphenyl;",C12H5Cl5,"2,3',4,4',5-Pentachlorobiphenyl; PCB 118",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Mono-ortho PCBs;    C18118  2,3',4,4',5-Pentachlorobiphenyl (PCB 118)",CAS: 31508-00-6; PubChem: 96024335; ChEBI: 81520; ChEMBL: CHEMBL137264; NIKKAJI: J126.396J,cpd:C11044; cpd:C14365; cpd:C14366; cpd:C14372; cpd:C14373; cpd:C14374; cpd:C14375; cpd:C14377; cpd:C14378; cpd:C14379; cpd:C14381; cpd:C14471; cpd:C14573; cpd:C14729; cpd:C14756; cpd:C18116; cpd:C18117; cpd:C18118; cpd:C18119,12,5,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C12H6Cl5,C12H4Cl5,323.8833886,324.8912136,322.87556352429,2729,cpd:C18119,"2,3',4,4',5'-Pentachlorobiphenyl;",C12H5Cl5,"2,3',4,4',5'-Pentachlorobiphenyl; PCB 123",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Mono-ortho PCBs;    C18119  2,3',4,4',5'-Pentachlorobiphenyl (PCB 123)",CAS: 65510-44-3; PubChem: 96024336; ChEBI: 81521; ChEMBL: CHEMBL137662; NIKKAJI: J164.840C,cpd:C11044; cpd:C14365; cpd:C14366; cpd:C14372; cpd:C14373; cpd:C14374; cpd:C14375; cpd:C14377; cpd:C14378; cpd:C14379; cpd:C14381; cpd:C14471; cpd:C14573; cpd:C14729; cpd:C14756; cpd:C18116; cpd:C18117; cpd:C18118; cpd:C18119,12,5,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,C12H6Cl5,C12H4Cl5,323.8833886,324.8912136,322.87556352430,2730,cpd:C18120,"2,3,3',4,4',5-Hexachlorobiphenyl;",C12H4Cl6,"2,3,3',4,4',5-Hexachlorobiphenyl; PCB 156",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Mono-ortho PCBs;    C18120  2,3,3',4,4',5-Hexachlorobiphenyl (PCB 156)",CAS: 38380-08-4; PubChem: 96024337; ChEBI: 81522; ChEMBL: CHEMBL136496; NIKKAJI: J151.552G,cpd:C14197; cpd:C14198; cpd:C14201; cpd:C14202; cpd:C14203; cpd:C14367; cpd:C14369; cpd:C14728; cpd:C14730; cpd:C18115; cpd:C18120; cpd:C18121; cpd:C18122,12,4,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C12H5Cl6,C12H3Cl6,357.8444162,358.8522413,356.83659122431,2731,cpd:C18121,"2,3,3',4,4',5'-Hexachlorobiphenyl;",C12H4Cl6,"2,3,3',4,4',5'-Hexachlorobiphenyl; PCB 157",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Mono-ortho PCBs;    C18121  2,3,3',4,4',5'-Hexachlorobiphenyl (PCB 157)",CAS: 69782-90-7; PubChem: 96024338; ChEBI: 81523; ChEMBL: CHEMBL136129; NIKKAJI: J126.400A,cpd:C14197; cpd:C14198; cpd:C14201; cpd:C14202; cpd:C14203; cpd:C14367; cpd:C14369; cpd:C14728; cpd:C14730; cpd:C18115; cpd:C18120; cpd:C18121; cpd:C18122,12,4,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C12H5Cl6,C12H3Cl6,357.8444162,358.8522413,356.83659122432,2732,cpd:C18122,"2,3',4,4',5,5'-Hexachlorobiphenyl;",C12H4Cl6,"2,3',4,4',5,5'-Hexachlorobiphenyl; PCB 167",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Mono-ortho PCBs;    C18122  2,3',4,4',5,5'-Hexachlorobiphenyl (PCB 167)",CAS: 52663-72-6; PubChem: 96024339; ChEBI: 81524; ChEMBL: CHEMBL136151; NIKKAJI: J126.399D,cpd:C14197; cpd:C14198; cpd:C14201; cpd:C14202; cpd:C14203; cpd:C14367; cpd:C14369; cpd:C14728; cpd:C14730; cpd:C18115; cpd:C18120; cpd:C18121; cpd:C18122,12,4,0,0,0,0,6,0,0,0,0,0,0,0,0,0,0,0,C12H5Cl6,C12H3Cl6,357.8444162,358.8522413,356.83659122433,2733,cpd:C18123,"2,3,3',4,4',5,5'-Heptachlorobiphenyl;",C12H3Cl7,"2,3,3',4,4',5,5'-Heptachlorobiphenyl; PCB 189",NA,Dioxin degradation,NA,NA,"Endocrine disrupting compounds [BR:br08006];  Dioxins and dioxin-like compounds;   Mono-ortho PCBs;    C18123  2,3,3',4,4',5,5'-Heptachlorobiphenyl (PCB 189)",CAS: 39635-31-9; PubChem: 96024340; ChEBI: 81525; NIKKAJI: J126.414A,cpd:C14382; cpd:C14726; cpd:C15213; cpd:C18123,12,3,0,0,0,0,7,0,0,0,0,0,0,0,0,0,0,0,C12H4Cl7,C12H2Cl7,391.8054439,392.8132689,390.79761882434,2735,cpd:C00479,Propanal;,C3H6O,Propanal; Propionaldehyde,R00038 R02376 R02377 R05298 R09097,Xylene degradation; Propanoate metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.202; 1.2.1.87; 4.1.2.35; 4.1.3.43; 4.2.1.28,"Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",NA,CAS: 123-38-6; PubChem: 3762; ChEBI: 17153; ChEMBL: CHEMBL275626; PDB-CCD: CBG; 3DMET: B01258; NIKKAJI: J2.497J,cpd:C00207; cpd:C00479; cpd:C02001; cpd:C08389; cpd:C11119; cpd:C11506; cpd:C11507; cpd:C14399; cpd:C15508; cpd:C19175; cpd:C19224; cpd:C19282,3,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O1,C3H5O1,58.04186481,59.04968985,57.034039782435,2736,cpd:C01454,Toluate;,C8H8O2,Toluate; p-Toluate; p-Toluic acid; 4-Methylbenzoic acid; Toluenecarboxylic acid; Crithminic acid,R05289 R05290 R05291,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.7; 1.2.1.28; 1.14.12.-,"Xylene degradation, xylene => methylbenzoate; Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",NA,CAS: 99-94-5; PubChem: 4631; ChEBI: 28856 36635; ChEMBL: CHEMBL21708; PDB-CCD: 4MA; 3DMET: B00292; NIKKAJI: J5.162D,cpd:C00548; cpd:C01454; cpd:C01526; cpd:C02061; cpd:C03765; cpd:C05613; cpd:C06224; cpd:C07085; cpd:C07086; cpd:C07189; cpd:C07211; cpd:C07215; cpd:C10700; cpd:C10761; cpd:C11151; cpd:C11252; cpd:C14087; cpd:C15250; cpd:C15583; cpd:C20645; cpd:C21166; cpd:C21328; cpd:C21375,8,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O2,C8H7O2,136.0524295,137.0602545,135.04460452436,2737,cpd:C02923,"2,3-Dihydroxytoluene;",C7H8O2,"2,3-Dihydroxytoluene; 3-Methylcatechol",R03566 R03608 R04088 R04089 R05309 R05314 R06915,Xylene degradation; Toluene degradation; Naphthalene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.19; 1.3.1.68; 1.3.1.-; 1.13.11.2; 1.13.11.-; 1.14.13.1; 1.14.13.7; 1.14.13.-,"Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol; Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",NA,CAS: 488-17-5; PubChem: 5846; ChEBI: 18404; ChEMBL: CHEMBL1173328; PDB-CCD: MBD; 3DMET: B00515; NIKKAJI: J46.544E,cpd:C00615; cpd:C00727; cpd:C01502; cpd:C02323; cpd:C02923; cpd:C03351; cpd:C05842; cpd:C05843; cpd:C06409; cpd:C06410; cpd:C06730; cpd:C07130; cpd:C07480; cpd:C13747; cpd:C15572; cpd:C16398; cpd:C17467; cpd:C18301; cpd:C18320; cpd:C19601; cpd:C20663,7,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O2,C7H7O2,124.0524295,125.0602545,123.04460452437,2738,cpd:C06210,"2-Hydroxy-6-keto-2,4-heptadienoate;",C7H8O4,"2-Hydroxy-6-keto-2,4-heptadienoate; 2-Hydroxy-6-oxo-hept-2,4-dienoate",R04089 R05138,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.2; 1.13.11.-; 3.7.1.-,NA,NA,PubChem: 8458; ChEBI: 1132; 3DMET: B00923; NIKKAJI: J2.761.908H,cpd:C04112; cpd:C04171; cpd:C04558; cpd:C04559; cpd:C04634; cpd:C06210; cpd:C06321; cpd:C06678; cpd:C06760; cpd:C07041; cpd:C13671; cpd:C18311; cpd:C20710,7,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O4,C7H7O4,156.0422587,157.0500838,155.03443372438,2739,cpd:C06575,p-Cymene,C10H14,p-Cymene,R05266,Xylene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.-,"Cymene degradation, p-cymene => p-cumate",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C06575  p-Cymene; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C06575  p-Cymene; Major components of natural products [BR:br08323];  Essential oils;   Rosemary oil;    C06575  p-Cymene;   Thyme oil;    C06575  p-Cymene,CAS: 99-87-6; PubChem: 8804; ChEBI: 28768; ChEMBL: CHEMBL442915; LIPIDMAPS: LMPR0102090014; KNApSAcK: C00003040; PDB-CCD: MML; 3DMET: B00975; NIKKAJI: J11.621A,cpd:C00020; cpd:C00104; cpd:C00144; cpd:C00214; cpd:C00224; cpd:C00342; cpd:C00360; cpd:C00362; cpd:C00745; cpd:C00821; cpd:C00931; cpd:C00939; cpd:C00946; cpd:C01056; cpd:C01297; cpd:C01337; cpd:C01344; cpd:C01347; cpd:C01367; cpd:C01469; cpd:C01767; cpd:C01868; cpd:C01951; cpd:C01977; cpd:C02289; cpd:C02485; cpd:C02576; cpd:C02952; cpd:C03037; cpd:C03043; cpd:C04378; cpd:C04466; cpd:C04583; cpd:C05131; cpd:C05686; cpd:C05924; cpd:C06070; cpd:C06180; cpd:C06193; cpd:C06575; cpd:C06576; cpd:C06579; cpd:C06604; cpd:C06606; cpd:C06870; cpd:C07024; cpd:C07159; cpd:C07559; cpd:C07819; cpd:C07826; cpd:C09777; cpd:C09791; cpd:C09792; cpd:C09840; cpd:C09841; cpd:C09843; cpd:C09853; cpd:C09868; cpd:C09884; cpd:C09887; cpd:C09896; cpd:C09908; cpd:C09911; cpd:C09913; cpd:C10448; cpd:C10960; cpd:C11357; cpd:C11383; cpd:C11394; cpd:C11475; cpd:C11924; cpd:C11939; cpd:C11940; cpd:C13048; cpd:C13708; cpd:C14130; cpd:C14138; cpd:C14139; cpd:C14142; cpd:C14188; cpd:C14200; cpd:C14351; cpd:C14464; cpd:C14515; cpd:C14534; cpd:C14583; cpd:C14614; cpd:C14741; cpd:C15986; cpd:C16150; cpd:C16386; cpd:C16569; cpd:C16616; cpd:C16619; cpd:C16644; cpd:C16744; cpd:C16955; cpd:C17062; cpd:C17103; cpd:C17106; cpd:C17109; cpd:C17324; cpd:C17369; cpd:C17454; cpd:C17622; cpd:C17690; cpd:C17822; cpd:C17823; cpd:C17824; cpd:C17825; cpd:C17964; cpd:C18025; cpd:C18150; cpd:C18239; cpd:C18343; cpd:C18352; cpd:C18380; cpd:C19086; cpd:C19351; cpd:C19431; cpd:C19968; cpd:C19970; cpd:C20271; cpd:C20320; cpd:C20361; cpd:C20459; cpd:C20648; cpd:C20789; cpd:C20822; cpd:C20944,10,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15,C10H13,134.1095505,135.1173755,133.10172542439,2740,cpd:C06576,p-Cumic alcohol,C10H14O,p-Cumic alcohol,R05232 R05266,Xylene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.-,"Cymene degradation, p-cymene => p-cumate",Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C06576  p-Cumic alcohol,CAS: 536-60-7; PubChem: 8805; ChEBI: 27628; KNApSAcK: C00032864; 3DMET: B00976; NIKKAJI: J6.353C,cpd:C01056; cpd:C01767; cpd:C01868; cpd:C01951; cpd:C02289; cpd:C02485; cpd:C02576; cpd:C03043; cpd:C06576; cpd:C09840; cpd:C09843; cpd:C09868; cpd:C09884; cpd:C09908; cpd:C09911; cpd:C09913; cpd:C11383; cpd:C11394; cpd:C11939; cpd:C14130; cpd:C14138; cpd:C14139; cpd:C14188; cpd:C14200; cpd:C14464; cpd:C14741; cpd:C16569; cpd:C16955; cpd:C17062; cpd:C17103; cpd:C18025; cpd:C20361; cpd:C20944,10,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1,C10H13O1,150.1044651,151.1122901,149.096642440,2741,cpd:C06577,4-Isopropylbenzaldehyde;,C10H12O,4-Isopropylbenzaldehyde; p-Cumic aldehyde; Cuminaldehyde,R05232 R05235,Xylene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.29,"Cymene degradation, p-cymene => p-cumate",Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C06577  p-Cumic aldehyde,CAS: 122-03-2; PubChem: 8806; ChEBI: 28671; ChEMBL: CHEMBL161577; KNApSAcK: C00003039; 3DMET: B00977; NIKKAJI: J5.347C,cpd:C00780; cpd:C06577; cpd:C10428; cpd:C10452; cpd:C14309; cpd:C17203; cpd:C17965; cpd:C21075,10,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O1,C10H11O1,148.088815,149.09664,147.080992441,2742,cpd:C06578,p-Cumate,C10H12O2,p-Cumate,R05235 R05247,Xylene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.29; 1.14.12.25,"Cymene degradation, p-cymene => p-cumate; Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate",NA,CAS: 536-66-3; PubChem: 8807; ChEBI: 25822 28122; ChEMBL: CHEMBL116158; KNApSAcK: C00036581; 3DMET: B00978; NIKKAJI: J6.354A,cpd:C06578; cpd:C09858; cpd:C09904; cpd:C09905; cpd:C09907; cpd:C10453; cpd:C10469; cpd:C12303; cpd:C14506; cpd:C16151; cpd:C17104; cpd:C18950; cpd:C19018; cpd:C19229; cpd:C19349; cpd:C19729,10,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O2,C10H11O2,164.0837296,165.0915547,163.07590462442,2743,cpd:C06579,"cis-2,3-Dihydroxy-2,3-dihydro-p-cumate;",C10H14O4,"cis-2,3-Dihydroxy-2,3-dihydro-p-cumate; cis-5,6-Dihydroxy-4-isopropylcyclohexa-1,3-dienecarboxylate; (2R,3S)-2,3-Dihydroxy-2,3-dihydro-p-cumate",R05240 R05247,Xylene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.58; 1.14.12.25,"Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate",NA,PubChem: 8808; ChEBI: 18242; NIKKAJI: J2.374.143A,cpd:C00342; cpd:C00931; cpd:C00939; cpd:C06579; cpd:C06870; cpd:C07819; cpd:C09853; cpd:C16644; cpd:C17369; cpd:C17454; cpd:C20789,10,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O4,C10H13O4,198.0892089,199.097034,197.08138392443,2744,cpd:C06580,"2,3-Dihydroxy-p-cumate",C10H12O4,"2,3-Dihydroxy-p-cumate",R05240 R05248,Xylene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.58; 1.13.11.-,"Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate",NA,PubChem: 8809; ChEBI: 16725 36647; 3DMET: B00979; NIKKAJI: J1.608.435B,cpd:C00343; cpd:C01736; cpd:C02794; cpd:C03227; cpd:C05512; cpd:C05651; cpd:C06580; cpd:C07312; cpd:C07351; cpd:C07930; cpd:C10664; cpd:C10684; cpd:C10726; cpd:C11266; cpd:C12205; cpd:C15586; cpd:C16778; cpd:C17455; cpd:C21102,10,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O4,C10H11O4,196.0735589,197.0813839,195.06573382444,2745,cpd:C06581,"2-Hydroxy-3-carboxy-6-oxo-7-methylocta-2,4-dienoate",C10H12O6,"2-Hydroxy-3-carboxy-6-oxo-7-methylocta-2,4-dienoate",R05248 R05377,Xylene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 4.1.1.-,"Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate",NA,PubChem: 8810; ChEBI: 79383; 3DMET: B00980; NIKKAJI: J2.762.445F,cpd:C00575; cpd:C00895; cpd:C01762; cpd:C02353; cpd:C02507; cpd:C06581; cpd:C20935,10,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O6,C10H11O6,228.0633881,229.0712131,227.05556312445,2746,cpd:C06582,"2-Hydroxy-6-oxo-7-methylocta-2,4-dienoate",C9H12O4,"2-Hydroxy-6-oxo-7-methylocta-2,4-dienoate",R05364 R05377,Xylene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,3.7.1.-; 4.1.1.-,"Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate",NA,PubChem: 8811; ChEBI: 28961; 3DMET: B00981; NIKKAJI: J2.762.452I,cpd:C04535; cpd:C05594; cpd:C06582; cpd:C10765; cpd:C11265; cpd:C11456; cpd:C11588; cpd:C11747; cpd:C16635; cpd:C18660,9,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13O4,C9H11O4,184.0735589,185.0813839,183.06573382446,2747,cpd:C06720,"1,6-Dihydroxy-5-methylcyclohexa-2,4-dienecarboxylate;",C8H10O4,"1,6-Dihydroxy-5-methylcyclohexa-2,4-dienecarboxylate; 1,2-Dihydroxy-3-methylcyclohexa-3,5-dienecarboxylate",R05309 R05665,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.14.12.-,"Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",NA,PubChem: 8943; ChEBI: 17641; NIKKAJI: J2.368.058K,cpd:C04771; cpd:C05576; cpd:C06660; cpd:C06720; cpd:C06729; cpd:C06731; cpd:C07123; cpd:C16365; cpd:C16804; cpd:C18350; cpd:C19495; cpd:C21144,8,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O4,C8H9O4,170.0579088,171.0657338,169.05008382447,2748,cpd:C06729,"cis-1,2-Dihydroxy-4-methylcyclohexa-3,5-diene-1-carboxylate;",C8H10O4,"cis-1,2-Dihydroxy-4-methylcyclohexa-3,5-diene-1-carboxylate; 4-Methylcyclohexa-3,5-diene-1,2-cis-diol-1-carboxylic acid",R05290 R05291 R05292 R05293,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.67; 1.14.12.-,"Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",NA,PubChem: 8951; ChEBI: 17095; NIKKAJI: J2.368.064E,cpd:C04771; cpd:C05576; cpd:C06660; cpd:C06720; cpd:C06729; cpd:C06731; cpd:C07123; cpd:C16365; cpd:C16804; cpd:C18350; cpd:C19495; cpd:C21144,8,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O4,C8H9O4,170.0579088,171.0657338,169.05008382448,2749,cpd:C06730,4-Methylcatechol;,C7H8O2,"4-Methylcatechol; 3,4-Dihydroxytoluene; 1,2-Dihydroxy-4-methylbenzene; 4-Methyl-1,2-benzenediol",R03568 R05292 R05293 R05294 R05295 R05299 R06939,Xylene degradation; Toluene degradation; Naphthalene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.67; 1.13.11.1; 1.13.11.2; 1.14.12.-; 1.14.13.1; 1.14.13.7,"Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol; Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",NA,CAS: 452-86-8; PubChem: 8952; ChEBI: 17254; ChEMBL: CHEMBL158766; KNApSAcK: C00002660; PDB-CCD: MCT; 3DMET: B01036; NIKKAJI: J5.755J,cpd:C00615; cpd:C00727; cpd:C01502; cpd:C02323; cpd:C02923; cpd:C03351; cpd:C05842; cpd:C05843; cpd:C06409; cpd:C06410; cpd:C06730; cpd:C07130; cpd:C07480; cpd:C13747; cpd:C15572; cpd:C16398; cpd:C17467; cpd:C18301; cpd:C18320; cpd:C19601; cpd:C20663,7,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O2,C7H7O2,124.0524295,125.0602545,123.04460452449,2750,cpd:C06731,"1,2-Dihydroxy-6-methylcyclohexa-3,5-dienecarboxylate",C8H10O4,"1,2-Dihydroxy-6-methylcyclohexa-3,5-dienecarboxylate",R05314 R05428,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.68; 1.14.12.-,"Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",NA,PubChem: 8953; ChEBI: 16100; NIKKAJI: J2.368.061K,cpd:C04771; cpd:C05576; cpd:C06660; cpd:C06720; cpd:C06729; cpd:C06731; cpd:C07123; cpd:C16365; cpd:C16804; cpd:C18350; cpd:C19495; cpd:C21144,8,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O4,C8H9O4,170.0579088,171.0657338,169.05008382450,2751,cpd:C06756,p-Xylene;,C8H10,"p-Xylene; 1,4-Dimethylbenzene; p-Methyltoluene",R05288,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.-; 1.14.15.-,"Xylene degradation, xylene => methylbenzoate",NA,CAS: 106-42-3; PubChem: 8977; ChEBI: 27417; ChEMBL: CHEMBL31561; PDB-CCD: PXY; 3DMET: B01044; NIKKAJI: J3.609I,cpd:C00018; cpd:C01960; cpd:C03352; cpd:C04087; cpd:C04771; cpd:C05576; cpd:C05853; cpd:C06044; cpd:C06317; cpd:C06660; cpd:C06720; cpd:C06728; cpd:C06729; cpd:C06731; cpd:C06756; cpd:C06757; cpd:C07084; cpd:C07111; cpd:C07112; cpd:C07123; cpd:C07208; cpd:C07212; cpd:C07213; cpd:C07216; cpd:C07481; cpd:C07665; cpd:C10787; cpd:C11348; cpd:C11480; cpd:C12599; cpd:C13403; cpd:C13637; cpd:C13638; cpd:C13646; cpd:C13673; cpd:C13681; cpd:C14001; cpd:C14228; cpd:C14385; cpd:C14386; cpd:C14582; cpd:C15347; cpd:C16361; cpd:C16365; cpd:C16693; cpd:C16804; cpd:C17512; cpd:C18350; cpd:C18513; cpd:C18937; cpd:C19495; cpd:C19680; cpd:C19844; cpd:C20581; cpd:C20694; cpd:C21144; cpd:C21325; cpd:C21326,8,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11,C8H9,106.0782503,107.0860754,105.07042532451,2752,cpd:C06757,4-Methylbenzyl alcohol;,C8H10O,4-Methylbenzyl alcohol; alpha-Hydroxy-p-xylene; 4-Tolylcarbinol,R05282 R05288,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.90; 1.14.13.-; 1.14.15.-,"Xylene degradation, xylene => methylbenzoate",NA,CAS: 589-18-4; PubChem: 8978; ChEBI: 1895; ChEMBL: CHEMBL90100; 3DMET: B01045; NIKKAJI: J28.550A,cpd:C05853; cpd:C06757; cpd:C07112; cpd:C07213; cpd:C07216; cpd:C11348; cpd:C13637; cpd:C14385; cpd:C14386; cpd:C14582; cpd:C17512; cpd:C19680,8,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O1,C8H9O1,122.0731649,123.08099,121.06533992452,2753,cpd:C06758,p-Tolualdehyde;,C8H8O,p-Tolualdehyde; p-Methylbenzaldehyde; 4-Methylbenzaldehyde; 4-Toluylaldehyde; p-Formyltoluene,R05282 R05289,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.90; 1.2.1.7; 1.2.1.28,"Xylene degradation, xylene => methylbenzoate",NA,CAS: 104-87-0; PubChem: 8979; ChEBI: 28617; ChEMBL: CHEMBL190927; KNApSAcK: C00047546; 3DMET: B01046; NIKKAJI: J5.036I,cpd:C00601; cpd:C02083; cpd:C05627; cpd:C06758; cpd:C07113; cpd:C07209; cpd:C07214; cpd:C14494; cpd:C14619; cpd:C20782,8,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O1,C8H7O1,120.0575149,121.0653399,119.04968982453,2754,cpd:C06760,"2-Hydroxy-5-methyl-cis,cis-muconic semialdehyde;",C7H8O4,"2-Hydroxy-5-methyl-cis,cis-muconic semialdehyde; (2E,4Z)-2-Hydroxy-5-methyl-6-oxohexa-2,4-dienoate",R05295 R05296 R05353 R05865,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.85; 1.13.11.2; 3.7.1.9,"Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",NA,PubChem: 8980; ChEBI: 28027; 3DMET: B01047; NIKKAJI: J2.764.055I,cpd:C04112; cpd:C04171; cpd:C04558; cpd:C04559; cpd:C04634; cpd:C06210; cpd:C06321; cpd:C06678; cpd:C06760; cpd:C07041; cpd:C13671; cpd:C18311; cpd:C20710,7,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O4,C7H7O4,156.0422587,157.0500838,155.03443372454,2755,cpd:C06762,4-Hydroxy-2-oxohexanoic acid;,C6H10O4,4-Hydroxy-2-oxohexanoic acid; 4-Hydroxy-2-oxohexanoate,R05297 R05298 R05864 R09960,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,4.1.3.43; 4.2.1.80; 4.2.1.132,"Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0105 Hydroxy fatty acids;     C06762  4-Hydroxy-2-oxohexanoic acid,PubChem: 8982; ChEBI: 27530 53800; LIPIDMAPS: LMFA01050343; 3DMET: B05228; NIKKAJI: J1.592.318K,cpd:C00439; cpd:C00659; cpd:C00772; cpd:C00966; cpd:C01053; cpd:C04237; cpd:C04327; cpd:C04556; cpd:C06006; cpd:C06104; cpd:C06762; cpd:C13811; cpd:C14463; cpd:C16272; cpd:C16674; cpd:C18379; cpd:C18384; cpd:C18719; cpd:C21465,6,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O4,C6H9O4,146.0579088,147.0657338,145.05008382455,2756,cpd:C07208,m-Xylene;,C8H10,"m-Xylene; 1,3-Dimethylbenzene; 1,3-Xylene",R05443,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.-; 1.14.15.-,"Xylene degradation, xylene => methylbenzoate",NA,CAS: 108-38-3; PubChem: 9417; ChEBI: 28488; ChEMBL: CHEMBL286727; KNApSAcK: C00035778; 3DMET: B01076; NIKKAJI: J2.421J,cpd:C00018; cpd:C01960; cpd:C03352; cpd:C04087; cpd:C04771; cpd:C05576; cpd:C05853; cpd:C06044; cpd:C06317; cpd:C06660; cpd:C06720; cpd:C06728; cpd:C06729; cpd:C06731; cpd:C06756; cpd:C06757; cpd:C07084; cpd:C07111; cpd:C07112; cpd:C07123; cpd:C07208; cpd:C07212; cpd:C07213; cpd:C07216; cpd:C07481; cpd:C07665; cpd:C10787; cpd:C11348; cpd:C11480; cpd:C12599; cpd:C13403; cpd:C13637; cpd:C13638; cpd:C13646; cpd:C13673; cpd:C13681; cpd:C14001; cpd:C14228; cpd:C14385; cpd:C14386; cpd:C14582; cpd:C15347; cpd:C16361; cpd:C16365; cpd:C16693; cpd:C16804; cpd:C17512; cpd:C18350; cpd:C18513; cpd:C18937; cpd:C19495; cpd:C19680; cpd:C19844; cpd:C20581; cpd:C20694; cpd:C21144; cpd:C21325; cpd:C21326,8,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11,C8H9,106.0782503,107.0860754,105.07042532456,2757,cpd:C07209,3-Methylbenzaldehyde;,C8H8O,3-Methylbenzaldehyde; m-Tolualdehyde,R05347 R05664,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.90; 1.2.1.7; 1.2.1.28,"Xylene degradation, xylene => methylbenzoate",NA,CAS: 620-23-5; PubChem: 9418; ChEBI: 28476; 3DMET: B01077; NIKKAJI: J45.959C,cpd:C00601; cpd:C02083; cpd:C05627; cpd:C06758; cpd:C07113; cpd:C07209; cpd:C07214; cpd:C14494; cpd:C14619; cpd:C20782,8,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O1,C8H7O1,120.0575149,121.0653399,119.04968982457,2758,cpd:C07211,m-Methylbenzoate;,C8H8O2,m-Methylbenzoate; m-Toluic Acid; beta-Bethylbenzoic acid; m-Toluylic acid,R05664 R05665,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.7; 1.2.1.28; 1.14.12.-,"Xylene degradation, xylene => methylbenzoate; Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",NA,CAS: 99-04-7; PubChem: 9420; ChEBI: 10589 28795; ChEMBL: CHEMBL67450; 3DMET: B01078; NIKKAJI: J47.804K,cpd:C00548; cpd:C01454; cpd:C01526; cpd:C02061; cpd:C03765; cpd:C05613; cpd:C06224; cpd:C07085; cpd:C07086; cpd:C07189; cpd:C07211; cpd:C07215; cpd:C10700; cpd:C10761; cpd:C11151; cpd:C11252; cpd:C14087; cpd:C15250; cpd:C15583; cpd:C20645; cpd:C21166; cpd:C21328; cpd:C21375,8,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O2,C8H7O2,136.0524295,137.0602545,135.04460452458,2759,cpd:C07212,o-Xylene;,C8H10,o-Xylene; o-Dimethylbenzene; o-Methyltoluene,R05442,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.-; 1.14.15.-,"Xylene degradation, xylene => methylbenzoate",NA,CAS: 95-47-6; PubChem: 9421; ChEBI: 28063; ChEMBL: CHEMBL45005; PDB-CCD: OXE; 3DMET: B01079; NIKKAJI: J3.563G,cpd:C00018; cpd:C01960; cpd:C03352; cpd:C04087; cpd:C04771; cpd:C05576; cpd:C05853; cpd:C06044; cpd:C06317; cpd:C06660; cpd:C06720; cpd:C06728; cpd:C06729; cpd:C06731; cpd:C06756; cpd:C06757; cpd:C07084; cpd:C07111; cpd:C07112; cpd:C07123; cpd:C07208; cpd:C07212; cpd:C07213; cpd:C07216; cpd:C07481; cpd:C07665; cpd:C10787; cpd:C11348; cpd:C11480; cpd:C12599; cpd:C13403; cpd:C13637; cpd:C13638; cpd:C13646; cpd:C13673; cpd:C13681; cpd:C14001; cpd:C14228; cpd:C14385; cpd:C14386; cpd:C14582; cpd:C15347; cpd:C16361; cpd:C16365; cpd:C16693; cpd:C16804; cpd:C17512; cpd:C18350; cpd:C18513; cpd:C18937; cpd:C19495; cpd:C19680; cpd:C19844; cpd:C20581; cpd:C20694; cpd:C21144; cpd:C21325; cpd:C21326,8,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11,C8H9,106.0782503,107.0860754,105.07042532459,2760,cpd:C07213,2-Methylbenzyl alcohol,C8H10O,2-Methylbenzyl alcohol,R05348 R05442,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.90; 1.14.13.-; 1.14.15.-,"Xylene degradation, xylene => methylbenzoate",NA,CAS: 89-95-2; PubChem: 9422; ChEBI: 27724; 3DMET: B01080; NIKKAJI: J132.821B,cpd:C05853; cpd:C06757; cpd:C07112; cpd:C07213; cpd:C07216; cpd:C11348; cpd:C13637; cpd:C14385; cpd:C14386; cpd:C14582; cpd:C17512; cpd:C19680,8,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O1,C8H9O1,122.0731649,123.08099,121.06533992460,2761,cpd:C07214,2-Methylbenzaldehyde;,C8H8O,2-Methylbenzaldehyde; o-Toluic aldehyde; 2-Formyltoluene; o-Tolualdehyde,R05348 R05663,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.90; 1.2.1.7; 1.2.1.28,"Xylene degradation, xylene => methylbenzoate",NA,CAS: 529-20-4; PubChem: 9423; ChEBI: 27434; ChEMBL: CHEMBL1487138; 3DMET: B01081; NIKKAJI: J6.680J,cpd:C00601; cpd:C02083; cpd:C05627; cpd:C06758; cpd:C07113; cpd:C07209; cpd:C07214; cpd:C14494; cpd:C14619; cpd:C20782,8,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O1,C8H7O1,120.0575149,121.0653399,119.04968982461,2762,cpd:C07215,o-Toluate;,C8H8O2,o-Toluate; o-Methylbenzoate; o-Toluic Acid; 2-Methylbenzoic acid,R05428 R05663,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.7; 1.2.1.28; 1.14.12.-,"Xylene degradation, xylene => methylbenzoate; Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol",NA,CAS: 118-90-1; PubChem: 9424; ChEBI: 28872 36632; ChEMBL: CHEMBL114957; PDB-CCD: 3SK; 3DMET: B01082; NIKKAJI: J10.074I,cpd:C00548; cpd:C01454; cpd:C01526; cpd:C02061; cpd:C03765; cpd:C05613; cpd:C06224; cpd:C07085; cpd:C07086; cpd:C07189; cpd:C07211; cpd:C07215; cpd:C10700; cpd:C10761; cpd:C11151; cpd:C11252; cpd:C14087; cpd:C15250; cpd:C15583; cpd:C20645; cpd:C21166; cpd:C21328; cpd:C21375,8,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O2,C8H7O2,136.0524295,137.0602545,135.04460452462,2763,cpd:C07216,3-Methylbenzyl alcohol,C8H10O,3-Methylbenzyl alcohol,R05347 R05443,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.90; 1.14.13.-; 1.14.15.-,"Xylene degradation, xylene => methylbenzoate",NA,CAS: 587-03-1; PubChem: 9425; ChEBI: 27995; 3DMET: B01083; NIKKAJI: J134.611C,cpd:C05853; cpd:C06757; cpd:C07112; cpd:C07213; cpd:C07216; cpd:C11348; cpd:C13637; cpd:C14385; cpd:C14386; cpd:C14582; cpd:C17512; cpd:C19680,8,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O1,C8H9O1,122.0731649,123.08099,121.06533992463,2764,cpd:C07478,"2-Hydroxy-5-methyl-cis,cis-muconate",C7H8O5,"2-Hydroxy-5-methyl-cis,cis-muconate",R05353 R05389,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.85; 5.3.2.6,"Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",NA,PubChem: 9681; ChEBI: 28249; 3DMET: B01089; NIKKAJI: J2.765.057K,cpd:C02637; cpd:C02652; cpd:C03063; cpd:C05600; cpd:C07478; cpd:C07479; cpd:C18306; cpd:C18318,7,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O5,C7H7O5,172.0371734,173.0449984,171.02934832464,2765,cpd:C07479,2-Oxo-5-methyl-cis-muconate,C7H8O5,2-Oxo-5-methyl-cis-muconate,R05374 R05389,Xylene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,4.1.1.77; 5.3.2.6,"Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",NA,PubChem: 9682; ChEBI: 1243; 3DMET: B01090; NIKKAJI: J2.765.058I,cpd:C02637; cpd:C02652; cpd:C03063; cpd:C05600; cpd:C07478; cpd:C07479; cpd:C18306; cpd:C18318,7,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O5,C7H7O5,172.0371734,173.0449984,171.02934832465,2766,cpd:C11354,"2-Hydroxy-cis-hex-2,4-dienoate",C6H8O3,"2-Hydroxy-cis-hex-2,4-dienoate",R05374 R05864 R05865,Xylene degradation; Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,3.7.1.9; 4.1.1.77; 4.2.1.132,"Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA",NA,PubChem: 13529; ChEBI: 1142; NIKKAJI: J2.774.164I,cpd:C01125; cpd:C03636; cpd:C03680; cpd:C03817; cpd:C04397; cpd:C04398; cpd:C05568; cpd:C06719; cpd:C06761; cpd:C11354; cpd:C19468; cpd:C19481; cpd:C20240; cpd:C20385; cpd:C20443; cpd:C20717,6,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O3,C6H7O3,128.0473441,129.0551691,127.03951912466,2767,cpd:C00261,Benzaldehyde;,C7H6O,Benzaldehyde; Benzoic aldehyde,R00027 R01419 R01420 R01763 R01764 R01766 R01767,Toluene degradation; Aminobenzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.90; 1.2.1.7; 1.2.1.28; 4.1.1.7; 4.1.2.10; 4.1.2.26; 4.1.2.38,"Toluene degradation, toluene => benzoate",NA,CAS: 100-52-7; PubChem: 3559; ChEBI: 17169; ChEMBL: CHEMBL15972; KNApSAcK: C00034452; PDB-CCD: HBX; 3DMET: B00077; NIKKAJI: J4.010J,cpd:C00193; cpd:C00261; cpd:C00484; cpd:C01402; cpd:C11731,7,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O1,C7H5O1,106.0418648,107.0496898,105.03403982467,2768,cpd:C00556,Benzyl alcohol;,C7H8O,Benzyl alcohol; alpha-Hydroxytoluene; Benzenemethanol; Phenylmethanol; Phenylcarbinol; Hydroxymethylbenzene,R01763 R02550 R02551 R02552 R03612 R09528 R10473,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.90; 1.14.13.-; 2.3.1.196; 2.3.1.224; 3.1.1.70; 3.5.1.58; 3.5.1.64,"Toluene degradation, toluene => benzoate","Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS;   P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS;    P03A ECTOPARASITICIDES, INCL. SCABICIDES;     P03AX Other ectoparasiticides, incl. scabicides;      P03AX06 Benzyl alcohol;       D00077  Benzyl alcohol (JP17/NF/INN); USP drug classification [BR:br08302];  Antiparasitics;   Pediculicides/Scabicides;    Benzyl alcohol;     D00077  Benzyl alcohol (JP17/NF/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Benzyl alcohol;     D00077  Benzyl alcohol (JP17/NF/INN); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00077  [001574] Benzyl alcohol;  Base;   D00077  [001574] Benzyl alcohol;  Suspending agent;   D00077  [001574] Benzyl alcohol;  Tonicity agent;   D00077  [001574] Benzyl alcohol;  Antiseptic agent;   D00077  [001574] Benzyl alcohol;  Preserving agent;   D00077  [001574] Benzyl alcohol;  Soothing agent;   D00077  [001574] Benzyl alcohol;  Solubilizer;   D00077  [001574] Benzyl alcohol;  Solubilization agent;   D00077  [001574] Benzyl alcohol;  Solvent;   D00077  [001574] Benzyl alcohol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00077  Benzyl alcohol; New drug approvals in the USA [br08319.html];  New Molecular Entity and New Therapeutic Biological Product Approvals;   D00077; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D00077",CAS: 100-51-6; PubChem: 3836; ChEBI: 17987; ChEMBL: CHEMBL720; KNApSAcK: C00029811; PDB-CCD: 010; 3DMET: B00130; NIKKAJI: J4.009F,cpd:C00556; cpd:C01403; cpd:C01467; cpd:C01468; cpd:C01542; cpd:C03485,7,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O1,C7H7O1,108.0575149,109.0653399,107.04968982468,2769,cpd:C01455,Toluene;,C7H8,Toluene; Methylbenzene; Toluol,R02550 R03559 R03560 R03562 R05598 R05666,Toluene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.11; 1.14.13.-; 1.14.15.-; 4.1.99.11,"Toluene degradation, anaerobic, toluene => benzoyl-CoA; Toluene degradation, toluene => benzoate; Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol",Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C01455  Toluene,CAS: 108-88-3; PubChem: 4632; ChEBI: 17578; ChEMBL: CHEMBL9113; PDB-CCD: MBN; 3DMET: B00293; NIKKAJI: J2.868A,cpd:C00556; cpd:C00615; cpd:C00727; cpd:C01403; cpd:C01455; cpd:C01467; cpd:C01468; cpd:C01502; cpd:C01542; cpd:C01784; cpd:C02323; cpd:C02637; cpd:C02652; cpd:C02923; cpd:C03063; cpd:C03095; cpd:C03338; cpd:C03351; cpd:C03485; cpd:C04002; cpd:C04112; cpd:C04115; cpd:C04171; cpd:C04225; cpd:C04558; cpd:C04559; cpd:C04634; cpd:C05533; cpd:C05600; cpd:C05842; cpd:C05843; cpd:C06210; cpd:C06246; cpd:C06321; cpd:C06409; cpd:C06410; cpd:C06677; cpd:C06678; cpd:C06730; cpd:C06760; cpd:C07041; cpd:C07130; cpd:C07478; cpd:C07479; cpd:C07480; cpd:C10792; cpd:C11514; cpd:C11515; cpd:C13129; cpd:C13671; cpd:C13747; cpd:C14110; cpd:C14623; cpd:C15572; cpd:C15663; cpd:C16356; cpd:C16360; cpd:C16398; cpd:C16401; cpd:C16579; cpd:C17467; cpd:C18301; cpd:C18306; cpd:C18311; cpd:C18317; cpd:C18318; cpd:C18320; cpd:C19169; cpd:C19366; cpd:C19469; cpd:C19601; cpd:C20362; cpd:C20663; cpd:C20710; cpd:C21250,7,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9,C7H7,92.06260026,93.07042529,91.054775232469,2770,cpd:C01467,3-Cresol;,C7H8O,3-Cresol; m-Cresol; 3-Hydroxytoluene,R03562 R03566 R03567 R07665,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.7; 1.14.13.-; 4.1.1.52,NA,Pharmaceutical additives [BR:br08316];  Antiseptic agent;   D04951  [103907] m-Cresol;  Preserving agent;   D04951  [103907] m-Cresol,CAS: 108-39-4; PubChem: 4642; ChEBI: 17231; ChEMBL: CHEMBL298312; KNApSAcK: C00035128; PDB-CCD: CRS; 3DMET: B00294; NIKKAJI: J1.186J,cpd:C00556; cpd:C01403; cpd:C01467; cpd:C01468; cpd:C01542; cpd:C03485,7,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O1,C7H7O1,108.0575149,109.0653399,107.04968982470,2771,cpd:C01468,4-Cresol;,C7H8O,4-Cresol; p-Cresol; 4-Hydroxytoluene; 4-Methylphenol,R02675 R03568 R05666 R07223 R07312 R07663 R08041 R10246,Toluene degradation; Nitrotoluene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds; Protein digestion and absorption,1.14.13.7; 1.14.13.-; 1.14.15.-; 1.17.99.1; 4.1.1.83; 4.1.99.19,NA,NA,CAS: 106-44-5; PubChem: 4643; ChEBI: 17847; ChEMBL: CHEMBL16645; KNApSAcK: C00002645; PDB-CCD: PCR; 3DMET: B00295; NIKKAJI: J1.185A,cpd:C00556; cpd:C01403; cpd:C01467; cpd:C01468; cpd:C01542; cpd:C03485,7,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O1,C7H7O1,108.0575149,109.0653399,107.04968982471,2772,cpd:C01542,o-Cresol;,C7H8O,o-Cresol; 2-Hydroxytoluene; o-Methylphenol,R03560 R03608,Toluene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.-,NA,NA,CAS: 95-48-7; PubChem: 4703; ChEBI: 28054; ChEMBL: CHEMBL46931; KNApSAcK: C00030878; PDB-CCD: JZ0; 3DMET: B00313; NIKKAJI: J1.176B,cpd:C00556; cpd:C01403; cpd:C01467; cpd:C01468; cpd:C01542; cpd:C03485,7,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O1,C7H7O1,108.0575149,109.0653399,107.04968982472,2773,cpd:C02236,4-Sulfobenzoate;,C7H6O5S,4-Sulfobenzoate; 4-Sulfobenzoic acid,R01636 R05272,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.62; 1.14.12.8,NA,NA,CAS: 636-78-2; PubChem: 5300; ChEBI: 20476 30789; 3DMET: B00410; NIKKAJI: J135.893F,cpd:C02236,7,6,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O5S1,C7H5O5S1,201.9935945,203.0014195,200.98576942473,2774,cpd:C03067,3-Hydroxybenzaldehyde,C7H6O2,3-Hydroxybenzaldehyde,R04136 R07666 R07667,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.97; 1.2.1.7; 1.2.1.28; 1.2.1.64,NA,NA,CAS: 100-83-4; PubChem: 5967; ChEBI: 16207; ChEMBL: CHEMBL243816; 3DMET: B00535; NIKKAJI: J43.313F,cpd:C00180; cpd:C00539; cpd:C00633; cpd:C03067; cpd:C06202; cpd:C14181; cpd:C15474; cpd:C18302,7,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O2,C7H5O2,122.0367794,123.0446045,121.02895442474,2775,cpd:C03351,3-Hydroxybenzyl alcohol;,C7H8O2,3-Hydroxybenzyl alcohol; 3-Hydroxybenzenemethanol,R04136 R07665,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.97; 1.14.13.-,NA,NA,CAS: 620-24-6; PubChem: 6192; ChEBI: 17069; KNApSAcK: C00000776; PDB-CCD: 3HY; 3DMET: B00579; NIKKAJI: J1.672A,cpd:C00615; cpd:C00727; cpd:C01502; cpd:C02323; cpd:C02923; cpd:C03351; cpd:C05842; cpd:C05843; cpd:C06409; cpd:C06410; cpd:C06730; cpd:C07130; cpd:C07480; cpd:C13747; cpd:C15572; cpd:C16398; cpd:C17467; cpd:C18301; cpd:C18320; cpd:C19601; cpd:C20663,7,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O2,C7H7O2,124.0524295,125.0602545,123.04460452475,2776,cpd:C04112,"3-Methyl-cis,cis-hexadienedioate;",C7H8O4,"3-Methyl-cis,cis-hexadienedioate; 3-Methyl-cis,cis-muconate",R05299 R05300 R09229,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.1; 5.5.1.1,NA,NA,PubChem: 6802; ChEBI: 28958; 3DMET: B00680; NIKKAJI: J738.331B,cpd:C04112; cpd:C04171; cpd:C04558; cpd:C04559; cpd:C04634; cpd:C06210; cpd:C06321; cpd:C06678; cpd:C06760; cpd:C07041; cpd:C13671; cpd:C18311; cpd:C20710,7,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O4,C7H7O4,156.0422587,157.0500838,155.03443372476,2777,cpd:C04558,3-Methylmuconolactone;,C7H8O4,"3-Methylmuconolactone; 4-Carboxymethyl-3-methylbut-2-en-1,4-olide",R04510 R09225 R09229,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,5.3.3.-; 5.4.99.14; 5.5.1.1; 5.5.1.-,NA,NA,PubChem: 7162; ChEBI: 16754; NIKKAJI: J971.109K,cpd:C04112; cpd:C04171; cpd:C04558; cpd:C04559; cpd:C04634; cpd:C06210; cpd:C06321; cpd:C06678; cpd:C06760; cpd:C07041; cpd:C13671; cpd:C18311; cpd:C20710,7,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O4,C7H7O4,156.0422587,157.0500838,155.03443372477,2778,cpd:C04559,4-Methylmuconolactone;,C7H8O4,"4-Methylmuconolactone; 4-Carboxymethyl-4-methylbut-2-en-1,4-olide",R04510 R05300,Toluene degradation; Microbial metabolism in diverse environments,5.4.99.14; 5.5.1.1,NA,NA,PubChem: 7163; ChEBI: 16766; NIKKAJI: J1.004.626B,cpd:C04112; cpd:C04171; cpd:C04558; cpd:C04559; cpd:C04634; cpd:C06210; cpd:C06321; cpd:C06678; cpd:C06760; cpd:C07041; cpd:C13671; cpd:C18311; cpd:C20710,7,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O4,C7H7O4,156.0422587,157.0500838,155.03443372478,2779,cpd:C04592,Toluene-cis-dihydrodiol;,C7H10O2,"Toluene-cis-dihydrodiol; (1S,2R)-3-Methylcyclohexa-3,5-diene-1,2-diol",R03559 R04088,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.19; 1.14.12.11,"Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol",NA,PubChem: 7190; ChEBI: 15565; NIKKAJI: J463.417I,cpd:C04592; cpd:C07106; cpd:C07615; cpd:C08290; cpd:C12101; cpd:C19102,7,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O2,C7H9O2,126.0680796,127.0759046,125.06025452479,2780,cpd:C06677,Toluene-4-sulfonate;,C7H8O3S,Toluene-4-sulfonate; Tosylate,R05281 R05294 R07663,Toluene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.-; 1.14.13.-,NA,NA,CAS: 104-15-4; PubChem: 8902; ChEBI: 27849; ChEMBL: CHEMBL541253; PDB-CCD: TSU; 3DMET: B01025; NIKKAJI: J5.025C,cpd:C06677; cpd:C13129,7,8,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O3S1,C7H7O3S1,172.0194153,173.0272403,171.01159032480,2781,cpd:C06678,4-Sulfobenzyl alcohol;,C7H8O4S,4-Sulfobenzyl alcohol; 4-(Hydroxymethyl)benzenesulfonate,R05271 R05281,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.257; 1.14.13.-,NA,NA,PubChem: 8903; ChEBI: 18312; 3DMET: B01026; NIKKAJI: J2.371.445K,cpd:C06678,7,8,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O4S1,C7H7O4S1,188.0143299,189.0221549,187.00650492481,2782,cpd:C06679,4-Sulfobenzaldehyde;,C7H6O4S,4-Sulfobenzaldehyde; 4-Formylbenzenesulfonate,R05271 R05272,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.257; 1.2.1.62,NA,NA,PubChem: 8904; ChEBI: 18256; 3DMET: B01027; NIKKAJI: J28.740G,cpd:C06679,7,6,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O4S1,C7H5O4S1,185.9986798,187.0065049,184.99085482482,2783,cpd:C09816,Benzylsuccinate;,C11H12O4,Benzylsuccinate; (R)-2-Benzylsuccinate,R05588 R05598,Toluene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,2.8.3.15; 4.1.99.11,"Toluene degradation, anaerobic, toluene => benzoyl-CoA",NA,PubChem: 12004; ChEBI: 16054 41241; ChEMBL: CHEMBL259621; PDB-CCD: BZS; NIKKAJI: J1.216.713J,cpd:C02381; cpd:C02700; cpd:C05610; cpd:C09816; cpd:C15605; cpd:C18756; cpd:C19717,11,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O4,C11H11O4,208.0735589,209.0813839,207.06573382483,2784,cpd:C09817,Benzylsuccinyl-CoA;,C32H46N7O19P3S,Benzylsuccinyl-CoA; (R)-2-Benzylsuccinyl-CoA,R05584 R05588,Toluene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.8.3; 2.8.3.15,"Toluene degradation, anaerobic, toluene => benzoyl-CoA",NA,PubChem: 12005; ChEBI: 10970 3060; NIKKAJI: J2.771.187A,cpd:C09817,32,46,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H47O19N7P3S1,C32H45O19N7P3S1,957.1782045,958.1860295,956.17037942484,2785,cpd:C09818,E-Phenylitaconyl-CoA;,C32H44N7O19P3S,E-Phenylitaconyl-CoA; (E)-2-Benzylidenesuccinyl-CoA,R05584 R05599,Toluene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.8.3; 4.2.1.-,"Toluene degradation, anaerobic, toluene => benzoyl-CoA",NA,PubChem: 12006; ChEBI: 27639; NIKKAJI: J2.771.188J,cpd:C09818; cpd:C17740,32,44,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H45O19N7P3S1,C32H43O19N7P3S1,955.1625544,956.1703794,954.15472942485,2786,cpd:C09819,(Hydroxymethylphenyl)succinyl-CoA,C32H46N7O20P3S,(Hydroxymethylphenyl)succinyl-CoA,R05575 R05599,Toluene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.35; 4.2.1.-,"Toluene degradation, anaerobic, toluene => benzoyl-CoA",NA,PubChem: 12007; ChEBI: 28202; NIKKAJI: J2.771.189H,cpd:C00411; cpd:C09819,32,46,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H47O20N7P3S1,C32H45O20N7P3S1,973.1731191,974.1809441,972.1652942486,2787,cpd:C09820,Benzoylsuccinyl-CoA;,C32H44N7O20P3S,Benzoylsuccinyl-CoA; 2-Benzoylsuccinyl-CoA,R05575 R05587,Toluene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.35; 2.3.1.-,"Toluene degradation, anaerobic, toluene => benzoyl-CoA",NA,PubChem: 12008; ChEBI: 28882; NIKKAJI: J2.771.190A,cpd:C03160; cpd:C09820,32,44,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H45O20N7P3S1,C32H43O20N7P3S1,971.157469,972.165294,970.1496442487,2788,cpd:C14582,"2,4-Dimethylphenol;",C8H10O,"2,4-Dimethylphenol; 2,4-Xylenol; 1-Hydroxy-2,4-dimethylbenzene",R11194,Toluene degradation; Microbial metabolism in diverse environments,1.17.99.1,NA,NA,CAS: 105-67-9; PubChem: 17395582; ChEBI: 34241; ChEMBL: CHEMBL29878; NIKKAJI: J3.606D,cpd:C05853; cpd:C06757; cpd:C07112; cpd:C07213; cpd:C07216; cpd:C11348; cpd:C13637; cpd:C14385; cpd:C14386; cpd:C14582; cpd:C17512; cpd:C19680,8,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O1,C8H9O1,122.0731649,123.08099,121.06533992488,2789,cpd:C18300,"2,4-Dichlorotoluene",C7H6Cl2,"2,4-Dichlorotoluene",R09201,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.-,NA,NA,CAS: 95-73-8; PubChem: 103061482; ChEBI: 81651,cpd:C18300; cpd:C18302; cpd:C18303; cpd:C18308; cpd:C19165,7,6,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H7Cl2,C7H5Cl2,159.9846556,160.9924806,158.97683052489,2790,cpd:C18301,"4,6-Dichloro-3-methyl-cis-1,2-dihydroxycyclohexa-3,5-diene",C7H8Cl2O2,"4,6-Dichloro-3-methyl-cis-1,2-dihydroxycyclohexa-3,5-diene",R09201 R09213,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.14.12.-,NA,NA,PubChem: 103061483; ChEBI: 81652,cpd:C18301,7,8,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H9O2Cl2,C7H7O2Cl2,193.9901349,194.9979599,192.98230982490,2791,cpd:C18302,"4,6-Dichloro-3-methylcatechol",C7H6Cl2O2,"4,6-Dichloro-3-methylcatechol",R09213 R09214,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.13.11.-,NA,NA,PubChem: 103061484; ChEBI: 81653,cpd:C18302,7,6,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H7O2Cl2,C7H5O2Cl2,191.9744848,192.9823098,190.96665982491,2792,cpd:C18303,"3,5-Dichloro-2-methylmuconate",C7H6Cl2O4,"3,5-Dichloro-2-methylmuconate",R09214 R09215 R09221,Toluene degradation; Microbial metabolism in diverse environments,1.13.11.-; 5.5.1.7,NA,NA,PubChem: 103061485; ChEBI: 81654,cpd:C18303; cpd:C18308,7,6,4,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H7O4Cl2,C7H5O4Cl2,223.964314,224.9721391,222.9564892492,2793,cpd:C18304,2-Chloro-5-methyl-cis-dienelactone,C7H5ClO4,2-Chloro-5-methyl-cis-dienelactone,R09221 R09222,Toluene degradation; Microbial metabolism in diverse environments,3.1.1.45; 5.5.1.7,NA,NA,PubChem: 103061486; ChEBI: 81655,cpd:C18304; cpd:C18309,7,5,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C7H6O4Cl1,C7H4O4Cl1,187.9876363,188.9954614,186.97981132493,2794,cpd:C18305,2-Chloro-5-methylmaleylacetate,C7H7ClO5,2-Chloro-5-methylmaleylacetate,R09222 R09223,Toluene degradation; Microbial metabolism in diverse environments,1.3.1.32; 3.1.1.45,NA,NA,PubChem: 103061487; ChEBI: 81656,cpd:C18305; cpd:C18310,7,7,5,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C7H8O5Cl1,C7H6O5Cl1,205.998201,207.006026,204.9903762494,2795,cpd:C18306,5-Methylmaleylacetate,C7H8O5,5-Methylmaleylacetate,R09223 R09224,Toluene degradation; Microbial metabolism in diverse environments,1.3.1.32,NA,NA,PubChem: 103061488; ChEBI: 81657,cpd:C02637; cpd:C02652; cpd:C03063; cpd:C05600; cpd:C07478; cpd:C07479; cpd:C18306; cpd:C18318,7,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O5,C7H7O5,172.0371734,173.0449984,171.02934832495,2796,cpd:C18307,2-Methyl-3-oxoadipate,C7H10O5,2-Methyl-3-oxoadipate,R09224,Toluene degradation; Microbial metabolism in diverse environments,1.3.1.32,NA,NA,PubChem: 103061489; ChEBI: 81658,cpd:C00493; cpd:C04236; cpd:C16588; cpd:C17696; cpd:C18307; cpd:C18312; cpd:C20961; cpd:C21281,7,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O5,C7H9O5,174.0528234,175.0606485,173.04499842496,2797,cpd:C18308,"3,5-Dichloro-2-methylmuconolactone",C7H6Cl2O4,"3,5-Dichloro-2-methylmuconolactone",R09215 R09217,Toluene degradation; Microbial metabolism in diverse environments,5.5.1.7,NA,NA,PubChem: 103061490; ChEBI: 81659,cpd:C18303; cpd:C18308,7,6,4,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H7O4Cl2,C7H5O4Cl2,223.964314,224.9721391,222.9564892497,2798,cpd:C18309,3-Chloro-2-methyldienelactone,C7H5ClO4,3-Chloro-2-methyldienelactone,R09217 R09220,Toluene degradation; Microbial metabolism in diverse environments,3.1.1.45; 5.5.1.7,NA,NA,PubChem: 103061491; ChEBI: 81660,cpd:C18304; cpd:C18309,7,5,4,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C7H6O4Cl1,C7H4O4Cl1,187.9876363,188.9954614,186.97981132498,2799,cpd:C18310,3-Chloro-2-methylmaleylacetate,C7H7ClO5,3-Chloro-2-methylmaleylacetate,R09220,Toluene degradation; Microbial metabolism in diverse environments,3.1.1.45,NA,NA,PubChem: 103061492; ChEBI: 81661,cpd:C18305; cpd:C18310,7,7,5,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C7H8O5Cl1,C7H6O5Cl1,205.998201,207.006026,204.9903762499,2800,cpd:C18311,4-Methyl-3-oxoadipate-enol-lactone,C7H8O4,4-Methyl-3-oxoadipate-enol-lactone,R09225 R09226,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,3.1.1.-; 5.3.3.-; 5.5.1.-,NA,NA,PubChem: 103061493; ChEBI: 81662,cpd:C04112; cpd:C04171; cpd:C04558; cpd:C04559; cpd:C04634; cpd:C06210; cpd:C06321; cpd:C06678; cpd:C06760; cpd:C07041; cpd:C13671; cpd:C18311; cpd:C20710,7,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O4,C7H7O4,156.0422587,157.0500838,155.03443372500,2801,cpd:C18312,4-Methyl-3-oxoadipate,C7H10O5,4-Methyl-3-oxoadipate,R09226,Toluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,3.1.1.-,NA,NA,PubChem: 103061494; ChEBI: 81663,cpd:C00493; cpd:C04236; cpd:C16588; cpd:C17696; cpd:C18307; cpd:C18312; cpd:C20961; cpd:C21281,7,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O5,C7H9O5,174.0528234,175.0606485,173.04499842501,2802,cpd:C21166,4-Hydroxy-3-methylbenzaldehyde,C8H8O2,4-Hydroxy-3-methylbenzaldehyde,R11194 R11195,Toluene degradation; Microbial metabolism in diverse environments,1.2.1.96; 1.17.99.1,NA,NA,CAS: 15174-69-3; PubChem: 313369426,cpd:C00548; cpd:C01454; cpd:C01526; cpd:C02061; cpd:C03765; cpd:C05613; cpd:C06224; cpd:C07085; cpd:C07086; cpd:C07189; cpd:C07211; cpd:C07215; cpd:C10700; cpd:C10761; cpd:C11151; cpd:C11252; cpd:C14087; cpd:C15250; cpd:C15583; cpd:C20645; cpd:C21166; cpd:C21328; cpd:C21375,8,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O2,C8H7O2,136.0524295,137.0602545,135.04460452502,2803,cpd:C21167,4-Hydroxy-3-methylbenzoate;,C8H8O3,4-Hydroxy-3-methylbenzoate; 4-Hydroxy-m-toluate,R11195 R11196,Toluene degradation; Microbial metabolism in diverse environments,1.2.1.96,NA,NA,CAS: 499-76-3; PubChem: 313369427,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951912503,2804,cpd:C21168,4-Hydroxyisophthalate;,C8H6O5,"4-Hydroxyisophthalate; 4-Hydroxy-1,3-benzenedicarboxylate",R11196 R11197 R11198,Toluene degradation; Microbial metabolism in diverse environments,1.14.13.-,NA,NA,CAS: 636-46-4; PubChem: 313369428,cpd:C01853; cpd:C06680; cpd:C07268; cpd:C12325; cpd:C14097; cpd:C21168,8,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O5,C8H5O5,182.0215233,183.0293483,181.01369832504,2805,cpd:C01504,Indanone;,C9H8O,"Indanone; Hydrindone; 1-Indanone; 1H-Inden-1-one, 2,3-dihydro-",R03582 R03583 R05430 R05431 R05432 R05433 R05540,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.1.1.112; 1.14.12.-,NA,NA,CAS: 83-33-0; PubChem: 4672; ChEBI: 17404; PDB-CCD: 1ON; 3DMET: B00309; NIKKAJI: J4.629I,cpd:C00903; cpd:C01504; cpd:C07727; cpd:C13844; cpd:C16592; cpd:C18812,9,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O1,C9H7O1,132.0575149,133.0653399,131.04968982505,2806,cpd:C01606,Phthalate;,C8H6O4,"Phthalate; o-Phthalic acid; 1,2-Benzenedicarboxylic acid",R03630 R05167 R05643 R07703 R07802 R09227 R10915,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds; ABC transporters,1.2.1.78; 1.3.1.19; 1.11.1.19; 1.14.12.7; 1.14.12.-; 3.5.1.79; 3.7.1.-,"Phthalate degradation, phthalate => protocatechuate; Phthalate degradation, phthalate => protocatechuate",NA,CAS: 88-99-3; PubChem: 4759; ChEBI: 17563 29069; ChEMBL: CHEMBL1045; PDB-CCD: PHT; 3DMET: B00332; NIKKAJI: J3.547E,cpd:C01606; cpd:C03590; cpd:C06337; cpd:C14096; cpd:C14100; cpd:C19240,8,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O4,C8H5O4,166.0266087,167.0344337,165.01878362506,2807,cpd:C02274,Dihydrocoumarin;,C9H8O2,"Dihydrocoumarin; 3,4-Dihydrocoumarin",R03692 R05430 R05432,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.12.-; 3.1.1.35,NA,NA,CAS: 119-84-6; PubChem: 5334; ChEBI: 16151; ChEMBL: CHEMBL89306; 3DMET: B00414; NIKKAJI: J36.832F,cpd:C00423; cpd:C02274; cpd:C04050; cpd:C05608; cpd:C07720; cpd:C07728; cpd:C07899; cpd:C10438; cpd:C14438; cpd:C17268,9,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O2,C9H7O2,148.0524295,149.0602545,147.04460452507,2808,cpd:C03012,"Naphthalene-1,2-diol;",C10H8O2,"Naphthalene-1,2-diol; 1,2-Naphthalenediol; beta-Naphthohydroquinone; 1,2-Dihydroxynaphthalene",R04115 R04117 R05632 R07015 R07017 R07020 R07698 R07699; R09818,Polycyclic aromatic hydrocarbon degradation; Naphthalene degradation; Metabolism of xenobiotics by cytochrome P450; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds; Chemical carcinogenesis,1.3.1.20; 1.3.1.29; 1.13.11.56; 1.14.13.1; 1.14.13.135; 1.14.99.-,"Naphthalene degradation, naphthalene => salicylate",NA,CAS: 574-00-5; PubChem: 5919; ChEBI: 17435; ChEMBL: CHEMBL204543; PDB-CCD: D1N; 3DMET: B00527; NIKKAJI: J135.090K,cpd:C03012; cpd:C07719; cpd:C07726; cpd:C14785; cpd:C16213; cpd:C18929,10,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O2,C10H7O2,160.0524295,161.0602545,159.04460452508,2809,cpd:C03057,2-Carboxybenzaldehyde;,C8H6O3,2-Carboxybenzaldehyde; Phthalaldehydic acid; o-Formylbenzoic acid; 2-Formylbenzoic acid; 2-Formylbenzoate,R03465 R05643 R07713,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.2.1.78; 4.1.2.34,NA,NA,CAS: 119-67-5; PubChem: 5957; ChEBI: 17605; ChEMBL: CHEMBL234213; 3DMET: B00532; NIKKAJI: J95.028I,cpd:C02137; cpd:C03057; cpd:C03664; cpd:C06374; cpd:C10812; cpd:C18597,8,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O3,C8H5O3,150.0316941,151.0395191,149.0238692509,2810,cpd:C03164,"Phenanthrene-3,4-diol;",C14H10O2,"Phenanthrene-3,4-diol; 3,4-Dihydroxyphenanthrene",R04151 R05650 R09166,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.49; 1.3.-.-; 1.13.11.-,NA,NA,PubChem: 6048; ChEBI: 16760; 3DMET: B00550; NIKKAJI: J135.088I,cpd:C02996; cpd:C03164; cpd:C06640; cpd:C10596; cpd:C13038; cpd:C13835; cpd:C14238; cpd:C16204; cpd:C16206; cpd:C19330; cpd:C20226,14,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O2,C14H9O2,210.0680796,211.0759046,209.06025452510,2811,cpd:C03203,1-Hydroxy-2-naphthoate;,C11H8O3,1-Hydroxy-2-naphthoate; 1-Hydroxy-2-naphthoic acid; 1-Naphthol-2-carboxylic acid,R03466 R05632 R05649 R06902 R07657 R09818,Polycyclic aromatic hydrocarbon degradation; Naphthalene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.-; 1.13.11.38; 1.14.13.1; 1.14.13.135,NA,NA,CAS: 86-48-6; PubChem: 6079; ChEBI: 15992 36108; ChEMBL: CHEMBL229299; PDB-CCD: 1HN; 3DMET: B00558; NIKKAJI: J4.260I,cpd:C02740; cpd:C03203; cpd:C10387; cpd:C10398; cpd:C16212,11,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O3,C11H7O3,188.0473441,189.0551691,187.03951912511,2812,cpd:C03223,"3,4-Dihydroxyphthalate;",C8H6O6,"3,4-Dihydroxyphthalate; 3,4-Dihydroxyphthalic acid",R01634 R09228,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 4.1.1.69,"Phthalate degradation, phthalate => protocatechuate",NA,CAS: 82784-82-5; PubChem: 6095; ChEBI: 17416; 3DMET: B00564; NIKKAJI: J663.860K,cpd:C03223; cpd:C03233,8,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O6,C8H5O6,198.0164379,199.0242629,197.00861292512,2813,cpd:C03233,"4,5-Dihydroxyphthalate;",C8H6O6,"4,5-Dihydroxyphthalate; 4,5-Dihydroxyphthalic acid",R01635 R05275,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.64; 4.1.1.55,"Phthalate degradation, phthalate => protocatechuate",NA,CAS: 63958-66-7; PubChem: 6104; ChEBI: 17199; 3DMET: B00566; NIKKAJI: J18.347D,cpd:C03223; cpd:C03233,8,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O6,C8H5O6,198.0164379,199.0242629,197.00861292513,2814,cpd:C04468,"(+)-cis-3,4-Dihydrophenanthrene-3,4-diol;",C14H12O2,"(+)-cis-3,4-Dihydrophenanthrene-3,4-diol; cis-3,4-Dihydroxy-3,4-dihydrophenanthrene",R04151 R05843,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.49; 1.13.11.-,NA,NA,PubChem: 7091; ChEBI: 15386; NIKKAJI: J1.263.551F,cpd:C01408; cpd:C01745; cpd:C04468; cpd:C04485; cpd:C10971; cpd:C10972; cpd:C11428; cpd:C12537; cpd:C14233; cpd:C16203; cpd:C16205; cpd:C19236; cpd:C20227; cpd:C20228,14,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H13O2,C14H11O2,212.0837296,213.0915547,211.07590462514,2815,cpd:C04783,"cis-4,5-Dihydroxycyclohexa-1(6),2-diene-1,2-dicarboxylate;",C8H8O6,"cis-4,5-Dihydroxycyclohexa-1(6),2-diene-1,2-dicarboxylate; Phthalate-4,5-cis-dihydrodiol",R03630 R05275,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.64; 1.14.12.7,"Phthalate degradation, phthalate => protocatechuate",NA,CAS: 130073-64-2; PubChem: 7346; ChEBI: 17692; NIKKAJI: J478.875C,cpd:C01036; cpd:C01061; cpd:C04642; cpd:C04783; cpd:C05592; cpd:C06318; cpd:C18314,8,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O6,C8H7O6,200.032088,201.039913,199.02426292515,2816,cpd:C06318,"(3S,4R)-3,4-Dihydroxycyclohexa-1,5-diene-1,4-dicarboxylate;",C8H8O6,"(3S,4R)-3,4-Dihydroxycyclohexa-1,5-diene-1,4-dicarboxylate; (1R,6S)-Dihydroxycyclohexa-2,4-diene-1,4-dicarboxylate; Terephthalate-1,2-cis-dihydrodiol; cis-4,5-Dihydroxycyclohexa-1(6),2-diene-1,4-dicarboxylate",R01633 R05148,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.53; 1.14.12.15,"Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate",NA,CAS: 161578-47-8; PubChem: 8554; ChEBI: 15564; NIKKAJI: J2.374.430I,cpd:C01036; cpd:C01061; cpd:C04642; cpd:C04783; cpd:C05592; cpd:C06318; cpd:C18314,8,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O6,C8H7O6,200.032088,201.039913,199.02426292516,2817,cpd:C06337,Terephthalate;,C8H6O4,"Terephthalate; Terephthalic acid; 1,4-Benzenedicarboxylic acid",R05148 R07835 R11541,Polycyclic aromatic hydrocarbon degradation; Aminobenzoate degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.15; 3.1.1.102,"Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate",NA,CAS: 100-21-0; PubChem: 8573; ChEBI: 15702 30043; ChEMBL: CHEMBL1374420; 3DMET: B00943; NIKKAJI: J3.588B,cpd:C01606; cpd:C03590; cpd:C06337; cpd:C14096; cpd:C14100; cpd:C19240,8,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O4,C8H5O4,166.0266087,167.0344337,165.01878362517,2818,cpd:C06680,4-Hydroxyphthalate,C8H6O5,4-Hydroxyphthalate,R05375,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,4.1.1.55,NA,NA,CAS: 610-35-5; PubChem: 8905; ChEBI: 27600; 3DMET: B01028; NIKKAJI: J27.657J,cpd:C01853; cpd:C06680; cpd:C07268; cpd:C12325; cpd:C14097; cpd:C21168,8,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O5,C8H5O5,182.0215233,183.0293483,181.01369832518,2819,cpd:C06711,Fluoren-9-ol;,C13H10O,Fluoren-9-ol; 9-Fluorenol; 9-Hydroxyfluorene; Diphenylene carbinol,R05349 R05350 R05422,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.256; 1.14.12.12; 1.14.12.-,NA,NA,CAS: 1689-64-1; PubChem: 8936; ChEBI: 16904; ChEMBL: CHEMBL571548; 3DMET: B01030; NIKKAJI: J7.758E,cpd:C01464; cpd:C01748; cpd:C06354; cpd:C06711; cpd:C08399; cpd:C12143; cpd:C14460; cpd:C16918; cpd:C18907,13,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O1,C13H9O1,182.0731649,183.08099,181.06533992519,2820,cpd:C06712,Fluoren-9-one;,C13H8O,Fluoren-9-one; 9-Fluorenone,R05349 R05350 R05435 R05436 R07799,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.256; 1.14.12.-,NA,NA,CAS: 486-25-9; PubChem: 8937; ChEBI: 17922; ChEMBL: CHEMBL571655; 3DMET: B01031; NIKKAJI: J2.596H,cpd:C06643; cpd:C06712,13,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H9O1,C13H7O1,180.0575149,181.0653399,179.04968982520,2821,cpd:C07535,Benzo[a]pyrene;,C20H12,Benzo[a]pyrene; Benzpyrene,R07079 R07080 R07081 R09159 R09160 R09204 R09209 R09210,Polycyclic aromatic hydrocarbon degradation; Metabolism of xenobiotics by cytochrome P450; Microbial metabolism in diverse environments; Chemical carcinogenesis,1.14.12.12; 1.14.12.-; 1.14.13.-; 1.14.14.1; 1.14.-.-,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C07535  Benzo[a]pyrene,CAS: 50-32-8; PubChem: 9738; ChEBI: 29865; ChEMBL: CHEMBL31184; NIKKAJI: J2.297G,cpd:C07535; cpd:C10355; cpd:C12368; cpd:C12439; cpd:C14320; cpd:C14321; cpd:C14435; cpd:C14459; cpd:C14461; cpd:C14556; cpd:C14557; cpd:C14558; cpd:C14559; cpd:C14560; cpd:C14563; cpd:C14564; cpd:C14565; cpd:C14576; cpd:C14849; cpd:C14850; cpd:C14851; cpd:C14854; cpd:C14951; cpd:C18271; cpd:C18272; cpd:C18277; cpd:C18278; cpd:C18279; cpd:C18280; cpd:C18286; cpd:C19195; cpd:C19196; cpd:C19336; cpd:C19341; cpd:C19358; cpd:C19497,20,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13,C20H11,252.0939004,253.1017254,251.08607542521,2822,cpd:C07715,Fluorene;,C13H10,"Fluorene; Diphenylenemethane; 2,2'-Methylenebiphenyl",R05422 R05423 R05541 R05542,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.12.12; 1.14.12.-,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07715  Fluorene,CAS: 86-73-7; PubChem: 9917; ChEBI: 28266; ChEMBL: CHEMBL16236; PDB-CCD: 9FL; 3DMET: B01091; NIKKAJI: J3.895D,cpd:C01464; cpd:C01748; cpd:C02162; cpd:C06354; cpd:C06355; cpd:C06356; cpd:C06641; cpd:C06673; cpd:C06711; cpd:C07715; cpd:C07717; cpd:C07718; cpd:C07722; cpd:C07724; cpd:C07725; cpd:C07910; cpd:C08399; cpd:C08447; cpd:C08455; cpd:C08457; cpd:C09049; cpd:C09285; cpd:C09951; cpd:C10406; cpd:C11290; cpd:C11493; cpd:C12085; cpd:C12143; cpd:C14163; cpd:C14215; cpd:C14220; cpd:C14230; cpd:C14284; cpd:C14292; cpd:C14460; cpd:C14507; cpd:C14584; cpd:C14611; cpd:C16262; cpd:C16263; cpd:C16264; cpd:C16918; cpd:C16926; cpd:C17856; cpd:C18216; cpd:C18389; cpd:C18805; cpd:C18821; cpd:C18907; cpd:C19003; cpd:C19404; cpd:C19405; cpd:C20981; cpd:C21412,13,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11,C13H9,166.0782503,167.0860754,165.07042532522,2823,cpd:C07717,"3,4-Dihydroxyfluorene",C13H10O2,"3,4-Dihydroxyfluorene",R05410 R05541 R07804,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.1.-; 1.13.11.-,NA,NA,CAS: 42523-20-6; PubChem: 9919; ChEBI: 28752; 3DMET: B01092; NIKKAJI: J2.374.015J,cpd:C07717; cpd:C07724; cpd:C08447; cpd:C11290; cpd:C14230; cpd:C14292; cpd:C16926; cpd:C17856; cpd:C20981; cpd:C21412,13,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O2,C13H9O2,198.0680796,199.0759046,197.06025452523,2824,cpd:C07718,"2-Hydroxy-4-(1-oxo-1,3-dihydro-2H-inden-2-ylidene)-but-2-enoic acid",C13H10O4,"2-Hydroxy-4-(1-oxo-1,3-dihydro-2H-inden-2-ylidene)-but-2-enoic acid",R05410 R05538,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.13.11.-,NA,NA,PubChem: 9920; ChEBI: 1126; 3DMET: B01093; NIKKAJI: J2.765.233F,cpd:C06356; cpd:C07718; cpd:C07725; cpd:C07910; cpd:C09049; cpd:C12085; cpd:C16263; cpd:C18216; cpd:C18805,13,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O4,C13H9O4,230.0579088,231.0657338,229.05008382524,2825,cpd:C07719,2-Formyl-1-indanone,C10H8O2,2-Formyl-1-indanone,R05538 R05540,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 56794-24-2; PubChem: 9921; ChEBI: 27534; NIKKAJI: J2.366.424K,cpd:C03012; cpd:C07719; cpd:C07726; cpd:C14785; cpd:C16213; cpd:C18929,10,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O2,C10H7O2,160.0524295,161.0602545,159.04460452525,2826,cpd:C07720,3-Hydroxy-1-indanone,C9H8O2,3-Hydroxy-1-indanone,R05431 R05433,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.12.-,NA,NA,CAS: 26976-59-0; PubChem: 9922; ChEBI: 28438; 3DMET: B01094; NIKKAJI: J815.791J,cpd:C00423; cpd:C02274; cpd:C04050; cpd:C05608; cpd:C07720; cpd:C07728; cpd:C07899; cpd:C10438; cpd:C14438; cpd:C17268,9,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O2,C9H7O2,148.0524295,149.0602545,147.04460452526,2827,cpd:C07721,"(+)-(3S,4R)-cis-3,4-Dihydroxy-3,4-dihydrofluorene",C13H12O2,"(+)-(3S,4R)-cis-3,4-Dihydroxy-3,4-dihydrofluorene",R05423 R07804,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.1.-; 1.14.12.12,NA,NA,PubChem: 9923; ChEBI: 28234; NIKKAJI: J2.374.460K,cpd:C07721; cpd:C08458; cpd:C08741; cpd:C13144; cpd:C14244; cpd:C14298; cpd:C14747; cpd:C19800; cpd:C20290; cpd:C21411; cpd:C21413,13,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H13O2,C13H11O2,200.0837296,201.0915547,199.07590462527,2828,cpd:C07722,"3,4-Dihydroxy-3,4-dihydro-9-fluorenone",C13H10O3,"3,4-Dihydroxy-3,4-dihydro-9-fluorenone",R05435 R05436 R05543,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.12.-,NA,NA,PubChem: 9924; ChEBI: 27473; NIKKAJI: J2.765.237I,cpd:C07722; cpd:C08455; cpd:C11493; cpd:C14163; cpd:C14215; cpd:C14220; cpd:C14284; cpd:C14507; cpd:C16262; cpd:C18821; cpd:C19003; cpd:C19404; cpd:C19405,13,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O3,C13H9O3,214.0629942,215.0708192,213.05516912528,2829,cpd:C07723,4-Hydroxy-9-fluorenone,C13H8O2,4-Hydroxy-9-fluorenone,R05543,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 1986-00-1; PubChem: 9925; ChEBI: 27665; 3DMET: B01095; NIKKAJI: J49.651K,cpd:C07723; cpd:C16211; cpd:C21442,13,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H9O2,C13H7O2,196.0524295,197.0602545,195.04460452529,2830,cpd:C07724,"1,2-Dihydroxyfluorene",C13H10O2,"1,2-Dihydroxyfluorene",R05412 R05542,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.13.11.-,NA,NA,CAS: 42523-11-5; PubChem: 9926; ChEBI: 28565; 3DMET: B01096; NIKKAJI: J2.373.999B,cpd:C07717; cpd:C07724; cpd:C08447; cpd:C11290; cpd:C14230; cpd:C14292; cpd:C16926; cpd:C17856; cpd:C20981; cpd:C21412,13,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O2,C13H9O2,198.0680796,199.0759046,197.06025452530,2831,cpd:C07725,"2-Hydroxy-4-(2-oxo-1,3-dihydro-2H-inden-1-ylidene)but-2-enoic acid",C13H10O4,"2-Hydroxy-4-(2-oxo-1,3-dihydro-2H-inden-1-ylidene)but-2-enoic acid",R05412 R05544,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.13.11.-,NA,NA,PubChem: 9927; ChEBI: 1127; 3DMET: B01097; NIKKAJI: J2.765.243C,cpd:C06356; cpd:C07718; cpd:C07725; cpd:C07910; cpd:C09049; cpd:C12085; cpd:C16263; cpd:C18216; cpd:C18805,13,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O4,C13H9O4,230.0579088,231.0657338,229.05008382531,2832,cpd:C07726,1-Formyl-2-indanone,C10H8O2,1-Formyl-2-indanone,R05544 R05545,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 9928; ChEBI: 28779; 3DMET: B01098; NIKKAJI: J2.366.425I,cpd:C03012; cpd:C07719; cpd:C07726; cpd:C14785; cpd:C16213; cpd:C18929,10,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O2,C10H7O2,160.0524295,161.0602545,159.04460452532,2833,cpd:C07727,2-Indanone;,C9H8O,"2-Indanone; 2H-Inden-2-one, 1,3-dihydro-",R05437 R05438 R05545,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.12.-,NA,NA,CAS: 615-13-4; PubChem: 9929; ChEBI: 27930; ChEMBL: CHEMBL195557; 3DMET: B01099; NIKKAJI: J7.027K,cpd:C00903; cpd:C01504; cpd:C07727; cpd:C13844; cpd:C16592; cpd:C18812,9,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O1,C9H7O1,132.0575149,133.0653399,131.04968982533,2834,cpd:C07728,3-Isochromanone;,C9H8O2,"3-Isochromanone; 1,4-Dihydro-3H-2-benzopyran-3-one",R05437 R05438 R05539 R07803,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.12.-,NA,NA,CAS: 4385-35-7; PubChem: 9930; ChEBI: 28170; ChEMBL: CHEMBL447815; 3DMET: B01100; NIKKAJI: J13.284E,cpd:C00423; cpd:C02274; cpd:C04050; cpd:C05608; cpd:C07720; cpd:C07728; cpd:C07899; cpd:C10438; cpd:C14438; cpd:C17268,9,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O2,C9H7O2,148.0524295,149.0602545,147.04460452534,2835,cpd:C11422,Phenanthrene;,C14H10,Phenanthrene; Phenanthracene,R05653 R05654 R05655 R05843,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 1.14.13.-,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C11422  Phenanthrene,CAS: 85-01-8; PubChem: 13596; ChEBI: 28851; ChEMBL: CHEMBL46730; PDB-CCD: PEY; NIKKAJI: J3.885G,cpd:C01572; cpd:C02996; cpd:C03164; cpd:C04524; cpd:C06636; cpd:C06640; cpd:C06642; cpd:C06831; cpd:C06939; cpd:C07323; cpd:C07995; cpd:C10052; cpd:C10053; cpd:C10066; cpd:C10069; cpd:C10070; cpd:C10081; cpd:C10087; cpd:C10092; cpd:C10322; cpd:C10362; cpd:C10596; cpd:C11422; cpd:C11425; cpd:C11426; cpd:C11429; cpd:C11430; cpd:C11431; cpd:C11432; cpd:C11446; cpd:C13038; cpd:C13546; cpd:C13706; cpd:C13835; cpd:C14238; cpd:C14315; cpd:C14714; cpd:C15083; cpd:C15218; cpd:C15296; cpd:C16204; cpd:C16206; cpd:C16209; cpd:C16210; cpd:C16411; cpd:C16412; cpd:C16413; cpd:C16838; cpd:C17671; cpd:C18856; cpd:C18883; cpd:C19330; cpd:C19346; cpd:C19357; cpd:C19600; cpd:C20226; cpd:C21410; cpd:C21474,14,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11,C14H9,178.0782503,179.0860754,177.07042532535,2836,cpd:C11425,2-Hydroxy-2H-benzo[h]chromene-2-carboxylate,C14H10O4,2-Hydroxy-2H-benzo[h]chromene-2-carboxylate,R05642 R05650,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 5.1.2.-,NA,NA,PubChem: 13597; ChEBI: 28953; NIKKAJI: J2.774.373K,cpd:C10322; cpd:C11425; cpd:C11426; cpd:C15296; cpd:C16209; cpd:C16210; cpd:C19346; cpd:C21410; cpd:C21474,14,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O4,C14H9O4,242.0579088,243.0657338,241.05008382536,2837,cpd:C11426,cis-4-(1'-Hydroxynaphth-2'-yl)-2-oxobut-3-enoate,C14H10O4,cis-4-(1'-Hydroxynaphth-2'-yl)-2-oxobut-3-enoate,R05642 R05648,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,4.1.2.-; 5.1.2.-,NA,NA,PubChem: 13598; ChEBI: 29011; NIKKAJI: J2.774.374I,cpd:C10322; cpd:C11425; cpd:C11426; cpd:C15296; cpd:C16209; cpd:C16210; cpd:C19346; cpd:C21410; cpd:C21474,14,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O4,C14H9O4,242.0579088,243.0657338,241.05008382537,2838,cpd:C11427,1-Hydroxy-2-naphthaldehyde,C11H8O2,1-Hydroxy-2-naphthaldehyde,R05648 R05649,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.-; 4.1.2.-,NA,NA,CAS: 574-96-9; PubChem: 13599; ChEBI: 28091; NIKKAJI: J534.105A,cpd:C05377; cpd:C08446; cpd:C08774; cpd:C11427; cpd:C14091; cpd:C14101; cpd:C18891,11,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O2,C11H7O2,172.0524295,173.0602545,171.04460452538,2839,cpd:C11428,"trans-9(S),10(S)-Dihydrodiolphenanthrene",C14H12O2,"trans-9(S),10(S)-Dihydrodiolphenanthrene",R05658 R07708,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,3.3.2.-,NA,NA,PubChem: 13600; ChEBI: 28951; NIKKAJI: J88.133C,cpd:C01408; cpd:C01745; cpd:C04468; cpd:C04485; cpd:C10971; cpd:C10972; cpd:C11428; cpd:C12537; cpd:C14233; cpd:C16203; cpd:C16205; cpd:C19236; cpd:C20227; cpd:C20228,14,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H13O2,C14H11O2,212.0837296,213.0915547,211.07590462539,2840,cpd:C11429,"Phenanthrene-9,10-oxide",C14H10O,"Phenanthrene-9,10-oxide",R05653 R05658 R07707,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.13.-; 3.3.2.-,NA,NA,CAS: 585-08-0; PubChem: 13601; ChEBI: 27950; NIKKAJI: J1.636E,cpd:C11429; cpd:C11430; cpd:C11431; cpd:C11432; cpd:C13546,14,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O1,C14H9O1,194.0731649,195.08099,193.06533992540,2841,cpd:C11430,9-Hydroxyphenanthrene;,C14H10O,9-Hydroxyphenanthrene; 9-Phenanthrol,R07707 R07708,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 484-17-3; PubChem: 13602; ChEBI: 28820; NIKKAJI: J69.853I,cpd:C11429; cpd:C11430; cpd:C11431; cpd:C11432; cpd:C13546,14,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O1,C14H9O1,194.0731649,195.08099,193.06533992541,2842,cpd:C11431,"Phenanthrene-1,2-oxide",C14H10O,"Phenanthrene-1,2-oxide",R05654 R05656,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.13.-,NA,NA,CAS: 66226-25-3; PubChem: 13603; ChEBI: 28668 37094; NIKKAJI: J2.774.408G,cpd:C11429; cpd:C11430; cpd:C11431; cpd:C11432; cpd:C13546,14,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O1,C14H9O1,194.0731649,195.08099,193.06533992542,2843,cpd:C11432,1-Phenanthrol;,C14H10O,1-Phenanthrol; 1-Hydroxyphenanthrene,R05655 R05656 R05657,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.13.-; 2.1.1.-,NA,NA,CAS: 2433-56-9; PubChem: 13604; ChEBI: 27528; NIKKAJI: J130.703G,cpd:C11429; cpd:C11430; cpd:C11431; cpd:C11432; cpd:C13546,14,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O1,C14H9O1,194.0731649,195.08099,193.06533992543,2844,cpd:C11433,1-Methoxyphenanthrene,C15H12O,1-Methoxyphenanthrene,R05657,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,2.1.1.-,NA,NA,CAS: 834-99-1; PubChem: 13605; ChEBI: 27753; NIKKAJI: J101.757H,cpd:C01484; cpd:C06868; cpd:C10688; cpd:C11433; cpd:C14904; cpd:C15121; cpd:C15589,15,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O1,C15H11O1,208.088815,209.09664,207.080992544,2845,cpd:C14315,Anthracene,C14H10,Anthracene,R07687 R07704,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.12.12; 1.14.-.-,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C14315  Anthracene,CAS: 120-12-7; PubChem: 17395315; ChEBI: 35298; ChEMBL: CHEMBL333179; PDB-CCD: AN3; NIKKAJI: J2.916E,cpd:C01572; cpd:C02996; cpd:C03164; cpd:C04524; cpd:C06636; cpd:C06640; cpd:C06642; cpd:C06831; cpd:C06939; cpd:C07323; cpd:C07995; cpd:C10052; cpd:C10053; cpd:C10066; cpd:C10069; cpd:C10070; cpd:C10081; cpd:C10087; cpd:C10092; cpd:C10322; cpd:C10362; cpd:C10596; cpd:C11422; cpd:C11425; cpd:C11426; cpd:C11429; cpd:C11430; cpd:C11431; cpd:C11432; cpd:C11446; cpd:C13038; cpd:C13546; cpd:C13706; cpd:C13835; cpd:C14238; cpd:C14315; cpd:C14714; cpd:C15083; cpd:C15218; cpd:C15296; cpd:C16204; cpd:C16206; cpd:C16209; cpd:C16210; cpd:C16411; cpd:C16412; cpd:C16413; cpd:C16838; cpd:C17671; cpd:C18856; cpd:C18883; cpd:C19330; cpd:C19346; cpd:C19357; cpd:C19600; cpd:C20226; cpd:C21410; cpd:C21474,14,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11,C14H9,178.0782503,179.0860754,177.07042532545,2846,cpd:C14335,Pyrene,C16H10,Pyrene,R09161 R09167 R09169,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.-.-,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C14335  Pyrene,CAS: 129-00-0; PubChem: 17395335; ChEBI: 39106; ChEMBL: CHEMBL279564; NIKKAJI: J2.940H,cpd:C08722; cpd:C10202; cpd:C10467; cpd:C10522; cpd:C10541; cpd:C11591; cpd:C13830; cpd:C14335; cpd:C14519; cpd:C16226; cpd:C16729; cpd:C18250; cpd:C18252; cpd:C18254; cpd:C18263; cpd:C18264; cpd:C18265; cpd:C18266; cpd:C18267; cpd:C18268; cpd:C18269; cpd:C19372; cpd:C19425; cpd:C19531; cpd:C19587; cpd:C19727; cpd:C20124,16,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11,C16H9,202.0782503,203.0860754,201.07042532546,2847,cpd:C14519,1-Hydroxypyrene,C16H10O,1-Hydroxypyrene,R09170 R09171 R09174 R09177 R09181,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.-.-; 2.1.1.-; 2.8.2.-,NA,NA,CAS: 5315-79-7; PubChem: 17395519; ChEBI: 34093; NIKKAJI: J353.424C,cpd:C14519; cpd:C18254; cpd:C18267; cpd:C18268,16,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O1,C16H9O1,218.0731649,219.08099,217.06533992547,2848,cpd:C16149,(3Z)-4-(2-Carboxyphenyl)-2-oxobut-3-enoate;,C11H8O5,(3Z)-4-(2-Carboxyphenyl)-2-oxobut-3-enoate; cis-2'-Carboxybenzalpyruvate,R07657 R07713,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.13.11.38; 4.1.2.34,NA,NA,PubChem: 47205459; ChEBI: 49222; NIKKAJI: J2.798.388J,cpd:C01275; cpd:C04621; cpd:C04622; cpd:C09964; cpd:C16149; cpd:C16214; cpd:C19558; cpd:C21320,11,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O5,C11H7O5,220.0371734,221.0449984,219.02934832548,2849,cpd:C16203,"Anthracene-cis-1,2-dihydrodiol;",C14H12O2,"Anthracene-cis-1,2-dihydrodiol; cis-1,2-Dihydroanthracene-1,2-diol",R07704 R07705,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.1.29; 1.14.12.12,NA,NA,PubChem: 47205511; ChEBI: 80375; NIKKAJI: J2.798.806G,cpd:C01408; cpd:C01745; cpd:C04468; cpd:C04485; cpd:C10971; cpd:C10972; cpd:C11428; cpd:C12537; cpd:C14233; cpd:C16203; cpd:C16205; cpd:C19236; cpd:C20227; cpd:C20228,14,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H13O2,C14H11O2,212.0837296,213.0915547,211.07590462549,2850,cpd:C16204,"1,2-Anthracenediol",C14H10O2,"1,2-Anthracenediol",R07694 R07701 R07702 R07705,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.1.29; 1.13.11.-,NA,NA,CAS: 577-95-7; PubChem: 47205512; ChEBI: 80376; NIKKAJI: J1.611.610F,cpd:C02996; cpd:C03164; cpd:C06640; cpd:C10596; cpd:C13038; cpd:C13835; cpd:C14238; cpd:C16204; cpd:C16206; cpd:C19330; cpd:C20226,14,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O2,C14H9O2,210.0680796,211.0759046,209.06025452550,2851,cpd:C16205,"Anthracene-9,10-dihydrodiol",C14H12O2,"Anthracene-9,10-dihydrodiol",R07687 R07688,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.1.-.-; 1.14.-.-,NA,NA,PubChem: 47205513; ChEBI: 80377; NIKKAJI: J664.757J,cpd:C01408; cpd:C01745; cpd:C04468; cpd:C04485; cpd:C10971; cpd:C10972; cpd:C11428; cpd:C12537; cpd:C14233; cpd:C16203; cpd:C16205; cpd:C19236; cpd:C20227; cpd:C20228,14,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H13O2,C14H11O2,212.0837296,213.0915547,211.07590462551,2852,cpd:C16206,"9,10-Dihydroxyanthracene;",C14H10O2,"9,10-Dihydroxyanthracene; 9,10-Anthracenediol",R07688 R07689,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.1.-.-,NA,NA,CAS: 4981-66-2; PubChem: 47205514; ChEBI: 80378; NIKKAJI: J11.015I,cpd:C02996; cpd:C03164; cpd:C06640; cpd:C10596; cpd:C13038; cpd:C13835; cpd:C14238; cpd:C16204; cpd:C16206; cpd:C19330; cpd:C20226,14,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O2,C14H9O2,210.0680796,211.0759046,209.06025452552,2853,cpd:C16207,Anthraquinone;,C14H8O2,"Anthraquinone; 9,10-Anthraquinone",R07689,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,Pesticides [BR:br08007];  Pesticides;   Others;    Bird repellent;     C16207  Anthraquinone; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C16207  Anthraquinone,CAS: 84-65-1; PubChem: 47205515; ChEBI: 40448; ChEMBL: CHEMBL55659; KNApSAcK: C00043271; PDB-CCD: 9TA; NIKKAJI: J294A,cpd:C03243; cpd:C06644; cpd:C09212; cpd:C11445; cpd:C16207,14,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H9O2,C14H7O2,208.0524295,209.0602545,207.04460452553,2854,cpd:C16208,1-Methoxy-2-hydroxyanthracene,C15H12O2,1-Methoxy-2-hydroxyanthracene,R07694,Polycyclic aromatic hydrocarbon degradation,NA,NA,NA,PubChem: 47205516; ChEBI: 80379; NIKKAJI: J2.798.849K,cpd:C00766; cpd:C01927; cpd:C02099; cpd:C07443; cpd:C07492; cpd:C07496; cpd:C09321; cpd:C13410; cpd:C13620; cpd:C14231; cpd:C14232; cpd:C14237; cpd:C14528; cpd:C16208; cpd:C16601; cpd:C16602; cpd:C18364,15,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O2,C15H11O2,224.0837296,225.0915547,223.07590462554,2855,cpd:C16209,3-(2-Carboxyvinyl)naphthalene-2-carboxylic acid,C14H10O4,3-(2-Carboxyvinyl)naphthalene-2-carboxylic acid,R07702,Polycyclic aromatic hydrocarbon degradation,1.13.11.-,NA,NA,PubChem: 47205517; ChEBI: 80380; NIKKAJI: J1.611.611D,cpd:C10322; cpd:C11425; cpd:C11426; cpd:C15296; cpd:C16209; cpd:C16210; cpd:C19346; cpd:C21410; cpd:C21474,14,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O4,C14H9O4,242.0579088,243.0657338,241.05008382555,2856,cpd:C16210,4-(3-Hydroxy-2-naphthyl)-2-oxobut-3-enoic acid,C14H10O4,4-(3-Hydroxy-2-naphthyl)-2-oxobut-3-enoic acid,R07692 R07693 R07701,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.13.11.-,NA,NA,PubChem: 47205518; ChEBI: 80381; NIKKAJI: J2.798.860A,cpd:C10322; cpd:C11425; cpd:C11426; cpd:C15296; cpd:C16209; cpd:C16210; cpd:C19346; cpd:C21410; cpd:C21474,14,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O4,C14H9O4,242.0579088,243.0657338,241.05008382556,2857,cpd:C16211,"6,7-Benzocoumarin",C13H8O2,"6,7-Benzocoumarin",R07693,Polycyclic aromatic hydrocarbon degradation,NA,NA,NA,PubChem: 47205519; ChEBI: 80382; NIKKAJI: J883.001K,cpd:C07723; cpd:C16211; cpd:C21442,13,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H9O2,C13H7O2,196.0524295,197.0602545,195.04460452557,2858,cpd:C16212,3-Hydroxy-2-naphthoate,C11H8O3,3-Hydroxy-2-naphthoate,R07691 R07692 R07696,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.13.11.-,NA,NA,CAS: 92-70-6; PubChem: 47205520; ChEBI: 80383; ChEMBL: CHEMBL229301; NIKKAJI: J4.659K,cpd:C02740; cpd:C03203; cpd:C10387; cpd:C10398; cpd:C16212,11,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O3,C11H7O3,188.0473441,189.0551691,187.03951912558,2859,cpd:C16213,"2,3-Dihydroxynaphthalene",C10H8O2,"2,3-Dihydroxynaphthalene",R07695 R07696,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 92-44-4; PubChem: 47205521; ChEBI: 38135; ChEMBL: CHEMBL205007; NIKKAJI: J30.353D,cpd:C03012; cpd:C07719; cpd:C07726; cpd:C14785; cpd:C16213; cpd:C18929,10,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O2,C10H7O2,160.0524295,161.0602545,159.04460452559,2860,cpd:C16214,"3-[6-(Carboxymethylene)cyclohexa-2,4-dien-1-ylidene]-2-oxopropanate",C11H8O5,"3-[6-(Carboxymethylene)cyclohexa-2,4-dien-1-ylidene]-2-oxopropanate",R07690 R07691,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.13.11.-,NA,NA,PubChem: 47205522; ChEBI: 80384; NIKKAJI: J2.798.868G,cpd:C01275; cpd:C04621; cpd:C04622; cpd:C09964; cpd:C16149; cpd:C16214; cpd:C19558; cpd:C21320,11,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O5,C11H7O5,220.0371734,221.0449984,219.02934832560,2861,cpd:C16215,"1,2-Dihydrophthalic acid;",C8H8O4,"1,2-Dihydrophthalic acid; Cyclohexa-3,5-diene-1,2-dicarboxylate",R07690 R07703,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.1.19,NA,NA,CAS: 22919-28-4; PubChem: 47205523; ChEBI: 80385; NIKKAJI: J83.236G,cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272,8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O4,C8H7O4,168.0422587,169.0500838,167.03443372561,2862,cpd:C16262,"1-Hydro-1,1a-dihydroxy-9-fluorenone",C13H10O3,"1-Hydro-1,1a-dihydroxy-9-fluorenone",R07799 R07800,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.-.-; 1.14.12.-,NA,NA,PubChem: 47205570; ChEBI: 80405; NIKKAJI: J2.799.279J,cpd:C07722; cpd:C08455; cpd:C11493; cpd:C14163; cpd:C14215; cpd:C14220; cpd:C14284; cpd:C14507; cpd:C16262; cpd:C18821; cpd:C19003; cpd:C19404; cpd:C19405,13,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O3,C13H9O3,214.0629942,215.0708192,213.05516912562,2863,cpd:C16263,"2,3-Dihydroxy-2'-carboxybiphenyl",C13H10O4,"2,3-Dihydroxy-2'-carboxybiphenyl",R07800 R07801,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.-.-; 1.13.-.-,NA,NA,PubChem: 47205571; ChEBI: 80406; NIKKAJI: J676.697H,cpd:C06356; cpd:C07718; cpd:C07725; cpd:C07910; cpd:C09049; cpd:C12085; cpd:C16263; cpd:C18216; cpd:C18805,13,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O4,C13H9O4,230.0579088,231.0657338,229.05008382563,2864,cpd:C16264,"2-Hydroxy-6-oxo-6-(2-carboxyphenyl)-hexa-2,4-dienoate",C13H10O6,"2-Hydroxy-6-oxo-6-(2-carboxyphenyl)-hexa-2,4-dienoate",R07801 R07802,Polycyclic aromatic hydrocarbon degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.13.-.-; 3.7.1.-,NA,NA,PubChem: 47205572; ChEBI: 80407; NIKKAJI: J2.799.285D,cpd:C09951; cpd:C16264,13,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O6,C13H9O6,262.047738,263.0555631,261.0399132564,2865,cpd:C18249,"cis-4,5-Dihydroxy-4,5-dihydropyrene;",C16H12O2,"cis-4,5-Dihydroxy-4,5-dihydropyrene; cis-4,5-Dihydro-4,5-pyrenediol",R09161 R09162,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.1.29; 1.14.-.-,NA,NA,PubChem: 103061431; ChEBI: 81600,cpd:C09231; cpd:C18249; cpd:C18255; cpd:C20280; cpd:C20281,16,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O2,C16H11O2,236.0837296,237.0915547,235.07590462565,2866,cpd:C18250,"4,5-Dihydroxypyrene",C16H10O2,"4,5-Dihydroxypyrene",R09162 R09163 R09219 R09239,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.1.29; 1.6.5.-; 1.13.11.-,NA,NA,PubChem: 103061432; ChEBI: 81601,cpd:C13830; cpd:C18250; cpd:C18263; cpd:C18264; cpd:C18265; cpd:C18266,16,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O2,C16H9O2,234.0680796,235.0759046,233.06025452566,2867,cpd:C18251,"Pyrene-4,5-dione;",C16H8O2,"Pyrene-4,5-dione; 4,5-Pyrenequinone",R09218 R09219 R09239,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.6.5.-; 1.6.-.-,NA,NA,CAS: 6217-22-7; PubChem: 103061433; ChEBI: 81602,cpd:C17084; cpd:C18251; cpd:C18257; cpd:C18258,16,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H9O2,C16H7O2,232.0524295,233.0602545,231.04460452567,2868,cpd:C18252,"Phenanthrene-4,5-dicarboxylate",C16H10O4,"Phenanthrene-4,5-dicarboxylate",R09163 R09164 R09218,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.6.-.-; 1.13.11.-; 4.1.1.-,NA,NA,CAS: 5462-82-8; PubChem: 103061434; ChEBI: 81603,cpd:C16729; cpd:C18252; cpd:C18269,16,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O4,C16H9O4,266.0579088,267.0657338,265.05008382568,2869,cpd:C18253,Phenanthrene-4-carboxylate;,C15H10O2,Phenanthrene-4-carboxylate; 4-Phenanthroic acid,R09164 R09165,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.12.-; 4.1.1.-,NA,NA,CAS: 42156-92-3; PubChem: 103061435; ChEBI: 81604,cpd:C00799; cpd:C07584; cpd:C10043; cpd:C10405; cpd:C13699; cpd:C14350; cpd:C15608; cpd:C18253; cpd:C19453,15,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O2,C15H9O2,222.0680796,223.0759046,221.06025452569,2870,cpd:C18254,"Pyrene-4,5-oxide;",C16H10O,"Pyrene-4,5-oxide; Pyrene-4,5-epoxide",R09167 R09168,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.-.-; 3.3.2.-,NA,NA,CAS: 37496-00-7; PubChem: 103061436; ChEBI: 81605; ChEMBL: CHEMBL47703,cpd:C14519; cpd:C18254; cpd:C18267; cpd:C18268,16,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O1,C16H9O1,218.0731649,219.08099,217.06533992570,2871,cpd:C18255,"trans-4,5-Dihydroxy-4,5-dihydropyrene;",C16H12O2,"trans-4,5-Dihydroxy-4,5-dihydropyrene; trans-4,5-Pyrenedihydrodiol",R09168,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,3.3.2.-,NA,NA,CAS: 56183-12-1; PubChem: 103061437; ChEBI: 81606,cpd:C09231; cpd:C18249; cpd:C18255; cpd:C20280; cpd:C20281,16,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O2,C16H11O2,236.0837296,237.0915547,235.07590462571,2872,cpd:C18256,"cis-3,4-Phenanthrenedihydrodiol-4-carboxylate",C15H12O4,"cis-3,4-Phenanthrenedihydrodiol-4-carboxylate",R09165 R09166,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.-.-; 1.14.12.-,NA,NA,PubChem: 103061438; ChEBI: 81607,cpd:C02465; cpd:C04271; cpd:C07639; cpd:C08650; cpd:C09762; cpd:C09827; cpd:C10262; cpd:C15609; cpd:C16404; cpd:C16760; cpd:C18256; cpd:C18527; cpd:C18716,15,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O4,C15H11O4,256.0735589,257.0813839,255.06573382572,2873,cpd:C18257,"Pyrene-1,6-dione;",C16H8O2,"Pyrene-1,6-dione; 1,6-Pyrenequinone",R09173,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 1785-51-9; PubChem: 103061439; ChEBI: 81608,cpd:C17084; cpd:C18251; cpd:C18257; cpd:C18258,16,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H9O2,C16H7O2,232.0524295,233.0602545,231.04460452573,2874,cpd:C18258,"Pyrene-1,8-dione;",C16H8O2,"Pyrene-1,8-dione; 1,8-Pyrenequinone",R09176,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 2304-85-0; PubChem: 103061440; ChEBI: 81609,cpd:C17084; cpd:C18251; cpd:C18257; cpd:C18258,16,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H9O2,C16H7O2,232.0524295,233.0602545,231.04460452574,2875,cpd:C18259,1-Methoxypyrene,C17H12O,1-Methoxypyrene,R09177 R09178,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.-.-; 2.1.1.-,NA,NA,CAS: 34246-96-3; PubChem: 103061441; ChEBI: 81610,cpd:C11185; cpd:C11226; cpd:C18259; cpd:C18932,17,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O1,C17H11O1,232.088815,233.09664,231.080992575,2876,cpd:C18260,"1,6-Dimethoxypyrene",C18H14O2,"1,6-Dimethoxypyrene",R09180,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,2.1.1.-,NA,NA,PubChem: 103061442; ChEBI: 81611,cpd:C16612; cpd:C18260; cpd:C18454,18,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H15O2,C18H13O2,262.0993797,263.1072047,261.09155472576,2877,cpd:C18261,1-Hydroxy-6-methoxypyrene;,C17H12O2,1-Hydroxy-6-methoxypyrene; 6-Methoxy-1-pyrenol,R09179 R09180,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,2.1.1.-,NA,NA,PubChem: 103061443; ChEBI: 81612,cpd:C11704; cpd:C11705; cpd:C18261; cpd:C18262; cpd:C18273; cpd:C18274,17,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O2,C17H11O2,248.0837296,249.0915547,247.07590462577,2878,cpd:C18262,"1-Methoxypyrene-6,7-oxide",C17H12O2,"1-Methoxypyrene-6,7-oxide",R09178 R09179,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.-.-,NA,NA,PubChem: 103061444; ChEBI: 81613,cpd:C11704; cpd:C11705; cpd:C18261; cpd:C18262; cpd:C18273; cpd:C18274,17,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O2,C17H11O2,248.0837296,249.0915547,247.07590462578,2879,cpd:C18263,"1,6-Dihydroxypyrene;",C16H10O2,"1,6-Dihydroxypyrene; 1,6-Pyrenediol",R09172 R09173,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 10262-84-7; PubChem: 103061445; ChEBI: 81614,cpd:C13830; cpd:C18250; cpd:C18263; cpd:C18264; cpd:C18265; cpd:C18266,16,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O2,C16H9O2,234.0680796,235.0759046,233.06025452579,2880,cpd:C18264,"1,8-Dihydroxypyrene;",C16H10O2,"1,8-Dihydroxypyrene; 1,8-Pyrenediol",R09175 R09176,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 78078-85-0; PubChem: 103061446; ChEBI: 81615,cpd:C13830; cpd:C18250; cpd:C18263; cpd:C18264; cpd:C18265; cpd:C18266,16,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O2,C16H9O2,234.0680796,235.0759046,233.06025452580,2881,cpd:C18265,"1-Hydroxypyrene-6,7-oxide",C16H10O2,"1-Hydroxypyrene-6,7-oxide",R09171 R09172,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.-.-,NA,NA,PubChem: 103061447; ChEBI: 81616,cpd:C13830; cpd:C18250; cpd:C18263; cpd:C18264; cpd:C18265; cpd:C18266,16,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O2,C16H9O2,234.0680796,235.0759046,233.06025452581,2882,cpd:C18266,"1-Hydroxypyrene-7,8-oxide",C16H10O2,"1-Hydroxypyrene-7,8-oxide",R09174 R09175,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.-.-,NA,NA,PubChem: 103061448; ChEBI: 81617,cpd:C13830; cpd:C18250; cpd:C18263; cpd:C18264; cpd:C18265; cpd:C18266,16,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O2,C16H9O2,234.0680796,235.0759046,233.06025452582,2883,cpd:C18267,"Pyrene-1,2-oxide",C16H10O,"Pyrene-1,2-oxide",R09169 R09170,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.-.-,NA,NA,PubChem: 103061449; ChEBI: 81618,cpd:C14519; cpd:C18254; cpd:C18267; cpd:C18268,16,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O1,C16H9O1,218.0731649,219.08099,217.06533992583,2884,cpd:C18269,1-Pyrenylsulfate,C16H10O4S,1-Pyrenylsulfate,R09181,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,2.8.2.-,NA,NA,PubChem: 103061451; ChEBI: 81620,cpd:C18269,16,10,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O4S1,C16H9O4S1,298.02998,299.037805,297.02215492584,2885,cpd:C18270,"Benzo[a]pyrene-cis-4,5-dihydrodiol",C20H14O2,"Benzo[a]pyrene-cis-4,5-dihydrodiol",R09204 R09205,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.-.-; 1.14.12.-,NA,NA,PubChem: 103061452; ChEBI: 81621,cpd:C14852; cpd:C18270; cpd:C18275; cpd:C18276; cpd:C18284; cpd:C18285,20,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O2,C20H13O2,286.0993797,287.1072047,285.09155472585,2886,cpd:C18271,cis-4-(7-Hydroxtpyren-8-yl)-2-oxobut-3-enoate,C20H12O4,cis-4-(7-Hydroxtpyren-8-yl)-2-oxobut-3-enoate,R09182 R09202,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 103061453; ChEBI: 81622,cpd:C18271; cpd:C18272; cpd:C18277,20,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O4,C20H11O4,316.0735589,317.0813839,315.06573382586,2887,cpd:C18272,cis-4-(8-Hydroxypyren-7-yl)-2-oxobut-3-enoate,C20H12O4,cis-4-(8-Hydroxypyren-7-yl)-2-oxobut-3-enoate,R09184 R09185 R09203,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.13.11.-; 4.1.3.-,NA,NA,PubChem: 103061454; ChEBI: 81623,cpd:C18271; cpd:C18272; cpd:C18277,20,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O4,C20H11O4,316.0735589,317.0813839,315.06573382587,2888,cpd:C18273,"7,8-Dihydropyrene-8-carboxylate;",C17H12O2,"7,8-Dihydropyrene-8-carboxylate; 1,2-Dihydropyrene-1-carboxylate",R09202,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 103061455; ChEBI: 81624,cpd:C11704; cpd:C11705; cpd:C18261; cpd:C18262; cpd:C18273; cpd:C18274,17,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O2,C17H11O2,248.0837296,249.0915547,247.07590462588,2889,cpd:C18274,"7,8-Dihydropyrene-7-carboxylate;",C17H12O2,"7,8-Dihydropyrene-7-carboxylate; 1,2-Dihydropyrene-2-carboxylate",R09203,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 103061456; ChEBI: 81625,cpd:C11704; cpd:C11705; cpd:C18261; cpd:C18262; cpd:C18273; cpd:C18274,17,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O2,C17H11O2,248.0837296,249.0915547,247.07590462589,2890,cpd:C18275,"Benzo[a]pyrene-cis-7,8-dihydrodiol",C20H14O2,"Benzo[a]pyrene-cis-7,8-dihydrodiol",R09160 R09182,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.12.-,NA,NA,PubChem: 103061457; ChEBI: 81626,cpd:C14852; cpd:C18270; cpd:C18275; cpd:C18276; cpd:C18284; cpd:C18285,20,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O2,C20H13O2,286.0993797,287.1072047,285.09155472590,2891,cpd:C18276,"Benzo[a]pyrene-cis-9,10-dihydrodiol",C20H14O2,"Benzo[a]pyrene-cis-9,10-dihydrodiol",R09159 R09183,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.1.29; 1.14.12.12,NA,NA,CAS: 56484-47-0; PubChem: 103061458; ChEBI: 81627,cpd:C14852; cpd:C18270; cpd:C18275; cpd:C18276; cpd:C18284; cpd:C18285,20,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O2,C20H13O2,286.0993797,287.1072047,285.09155472591,2892,cpd:C18277,"4,5-Chrysenedicarboxylate",C20H12O4,"4,5-Chrysenedicarboxylate",R09206 R09207 R09208,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.13.11.-; 4.1.1.-,NA,NA,PubChem: 103061459; ChEBI: 81628,cpd:C18271; cpd:C18272; cpd:C18277,20,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O4,C20H11O4,316.0735589,317.0813839,315.06573382592,2893,cpd:C18278,"9,10-Dihydroxybenzo[a]pyrene;",C20H12O2,"9,10-Dihydroxybenzo[a]pyrene; Benzo[a]pyrene-9,10-diol",R09183 R09184,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.1.29; 1.13.11.-,NA,NA,CAS: 57303-98-7; PubChem: 103061460; ChEBI: 81629,cpd:C14854; cpd:C14951; cpd:C18278; cpd:C18279; cpd:C18280,20,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O2,C20H11O2,284.0837296,285.0915547,283.07590462593,2894,cpd:C18279,"4,5-Dihydroxybenzo[a]pyrene;",C20H12O2,"4,5-Dihydroxybenzo[a]pyrene; Benzo[a]pyrene-4,5-diol",R09205 R09206,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.-.-; 1.13.11.-,NA,NA,CAS: 57304-00-4; PubChem: 103061461; ChEBI: 81630; ChEMBL: CHEMBL1908013,cpd:C14854; cpd:C14951; cpd:C18278; cpd:C18279; cpd:C18280,20,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O2,C20H11O2,284.0837296,285.0915547,283.07590462594,2895,cpd:C18280,"11,12-Dihydroxybenzo[a]pyrene;",C20H12O2,"11,12-Dihydroxybenzo[a]pyrene; Benzo[a]pyrene-11,12-diol",R09212 R09216,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.-.-,NA,NA,CAS: 65277-41-0; PubChem: 103061462; ChEBI: 81631,cpd:C14854; cpd:C14951; cpd:C18278; cpd:C18279; cpd:C18280,20,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O2,C20H11O2,284.0837296,285.0915547,283.07590462595,2896,cpd:C18281,10-Oxabenzo[def]chrysen-9-one;,C19H10O2,"10-Oxabenzo[def]chrysen-9-one; 9H-Pyreno[1,2-b]pyran-9-one",R09185,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,4.1.3.-,NA,NA,PubChem: 103061463; ChEBI: 81632; ChEMBL: CHEMBL1970575,cpd:C18281,19,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H11O2,C19H9O2,270.0680796,271.0759046,269.06025452596,2897,cpd:C18282,5-Chrysenecarboxylate,C19H12O2,5-Chrysenecarboxylate,R09208,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,4.1.1.-,NA,NA,PubChem: 103061464; ChEBI: 81633,cpd:C18282; cpd:C18283,19,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H13O2,C19H11O2,272.0837296,273.0915547,271.07590462597,2898,cpd:C18283,4-Chrysenecarboxylate,C19H12O2,4-Chrysenecarboxylate,R09207,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,4.1.1.-,NA,NA,PubChem: 103061465; ChEBI: 81634,cpd:C18282; cpd:C18283,19,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H13O2,C19H11O2,272.0837296,273.0915547,271.07590462598,2899,cpd:C18284,"Benzo[a]pyrene-cis-11,12-dihydrodiol",C20H14O2,"Benzo[a]pyrene-cis-11,12-dihydrodiol",R09209 R09216,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.-.-; 1.14.12.-,NA,NA,CAS: 64283-13-2; PubChem: 103061466; ChEBI: 81635,cpd:C14852; cpd:C18270; cpd:C18275; cpd:C18276; cpd:C18284; cpd:C18285,20,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O2,C20H13O2,286.0993797,287.1072047,285.09155472599,2900,cpd:C18285,"Benzo[a]pyrene-trans-11,12-dihydrodiol",C20H14O2,"Benzo[a]pyrene-trans-11,12-dihydrodiol",R09211 R09212,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.3.-.-; 3.3.2.-,NA,NA,CAS: 60657-27-4; PubChem: 103061467; ChEBI: 81636,cpd:C14852; cpd:C18270; cpd:C18275; cpd:C18276; cpd:C18284; cpd:C18285,20,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O2,C20H13O2,286.0993797,287.1072047,285.09155472600,2901,cpd:C18286,"Benzo[a]pyrene-11,12-epoxide",C20H12O,"Benzo[a]pyrene-11,12-epoxide",R09210 R09211,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments,1.14.-.-; 3.3.2.-,NA,NA,CAS: 60448-19-3; PubChem: 103061468; ChEBI: 81637,cpd:C14459; cpd:C14461; cpd:C14556; cpd:C14557; cpd:C14558; cpd:C14559; cpd:C14560; cpd:C14563; cpd:C14564; cpd:C14565; cpd:C14576; cpd:C14849; cpd:C14850; cpd:C14851; cpd:C18286,20,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O1,C20H11O1,268.088815,269.09664,267.080992601,2902,cpd:C18314,"Phthalate 3,4-cis-dihydrodiol",C8H8O6,"Phthalate 3,4-cis-dihydrodiol",R09227 R09228,Polycyclic aromatic hydrocarbon degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.-; 1.14.12.-,"Phthalate degradation, phthalate => protocatechuate",NA,PubChem: 103061496; ChEBI: 81665,cpd:C01036; cpd:C01061; cpd:C04642; cpd:C04783; cpd:C05592; cpd:C06318; cpd:C18314,8,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O6,C8H7O6,200.032088,201.039913,199.02426292602,2903,cpd:C00067,Formaldehyde;,CH2O,Formaldehyde; Methanal; Oxomethane; Oxomethylene; Methylene oxide; Formalin,R00602 R00603 R00604 R00605 R00606 R00608 R00609 R00610; R00611 R00612 R00614 R01014 R01146 R01216 R01264 R01306; R01440 R01564 R01565 R01588 R01851 R02511 R02512 R03345; R03523 R03697 R03698 R05126 R05127 R05274 R05307 R05338; R06154 R06862 R06982 R07939 R07954 R07955 R07956 R07957; R07958 R07959 R07960 R07961 R07962 R07963 R07964 R07965; R07966 R07967 R07968 R07969 R07970 R07971 R07972 R07973; R07974 R07975 R07976 R08058 R08264 R08265 R09093 R09275; R09402 R09431 R09432 R09510 R09511 R09513 R09553 R09786; R10056 R10102 R10203 R10206 R10302 R11345 R11457,Chloroalkane and chloroalkene degradation; Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.1.1.244; 1.1.2.7; 1.1.3.13; 1.1.99.37; 1.2.1.46; 1.2.1.-; 1.2.98.1; 1.4.3.21; 1.4.9.1; 1.5.3.1; 1.5.3.2; 1.5.3.4; 1.5.3.10; 1.5.3.19; 1.5.8.1; 1.5.8.2; 1.5.8.3; 1.5.8.4; 1.5.99.5; 1.8.3.4; 1.11.1.6; 1.11.1.7; 1.11.1.21; 1.13.12.-; 1.14.11.27; 1.14.11.31; 1.14.11.32; 1.14.11.51; 1.14.13.82; 1.14.13.111; 1.14.13.128; 1.14.13.131; 1.14.13.178; 1.14.13.179; 1.14.13.-; 1.14.14.1; 1.14.14.5; 1.14.14.34; 1.14.14.35; 1.14.99.15; 2.1.2.11; 2.2.1.3; 3.8.1.1; 4.1.2.2; 4.1.2.12; 4.1.2.24; 4.1.2.32; 4.1.2.43; 4.2.1.147; 4.4.1.22; 4.5.1.3,"Methane oxidation, methanotroph, methane => formaldehyde; Formaldehyde assimilation, xylulose monophosphate pathway; Formaldehyde assimilation, ribulose monophosphate pathway",Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C00067  Formaldehyde; Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    261  Antimicrobial agents;     2619  Others;      D00017  Formaldehyde (USP); Formalin (JP17);   27  Dental preparations;    273  Analgesics and sedatives;     2730  Analgesics and sedatives;      D00017  Formaldehyde (USP); Formalin (JP17);  7  Agents not mainly for therapeutic purpose;   73  Public health agents;    732  Germicides and disinfectants;     7321  Alcohols and aldehydes;      D00017  Formaldehyde (USP); Formalin (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for sanitation;   81 Disinfectants;    D00017  Formaldehyde (USP); Risk category of Japanese OTC drugs [BR:br08312];  Drugs requiring guidance;   Powerful drugs;    Formalin;     D00017  Formaldehyde (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00017  [001595] Formalin;  Preserving agent;   D00017  [001595] Formalin;  Solvent;   D00017  [001595] Formalin; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00017  Formalin,CAS: 50-00-0; PubChem: 3367; ChEBI: 16842; ChEMBL: CHEMBL1255; PDB-CCD: FOR; 3DMET: B00018; NIKKAJI: J2.294B,cpd:C00067; cpd:C00241; cpd:C01612; cpd:C01663; cpd:C01813; cpd:C02658; cpd:C03620; cpd:C06049; cpd:C12942; cpd:C17261,1,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H3O1,C1H1O1,30.01056468,31.01838972,29.002739652603,2904,cpd:C00209,Oxalate;,C2H2O4,Oxalate; Oxalic acid; Ethanedioic acid,R00273 R00338 R00466 R00522 R00646 R01558 R01559 R07290; R09157 R09396 R09486 R10614,Chloroalkane and chloroalkene degradation; Glyoxylate and dicarboxylate metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.2.3.4; 1.2.3.5; 1.2.7.10; 2.5.1.77; 2.8.3.2; 2.8.3.16; 2.8.3.19; 3.7.1.1; 3.8.1.-; 4.1.1.2; 6.2.1.8,NA,Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Dicarboxylic acids;     C00209  Oxalate,CAS: 144-62-7; PubChem: 3509; ChEBI: 16995 30623; ChEMBL: CHEMBL146755; KNApSAcK: C00001198; PDB-CCD: OXD OXL; 3DMET: B00059; NIKKAJI: J2.954H,cpd:C00209; cpd:C02028; cpd:C04025,2,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H3O4,C2H1O4,89.99530854,91.00313357,88.987483512604,2906,cpd:C01380,Ethylene glycol;,C2H6O2,"Ethylene glycol; 1,2-Ethanediol; Ethane-1,2-diol",R01781 R05842 R11541,Chloroalkane and chloroalkene degradation; Glyoxylate and dicarboxylate metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.77; 3.1.1.102; 3.3.2.10,NA,Pharmaceutical additives [BR:br08316];  Unclassified;   C01380  [102265] Ethylene glycol,CAS: 107-21-1; PubChem: 4575; ChEBI: 30742; ChEMBL: CHEMBL457299; KNApSAcK: C00007409; PDB-CCD: EDO; 3DMET: B00278; NIKKAJI: J4.061D,cpd:C01380; cpd:C02390; cpd:C06384; cpd:C11142; cpd:C15588; cpd:C20301,2,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H7O2,C2H5O2,62.03677943,63.04460446,61.02895442605,2907,cpd:C01548,Acetylene;,C2H2,Acetylene; Ethyne,R05380 R05496,Chloroalkane and chloroalkene degradation; Microbial metabolism in diverse environments,1.18.6.1; 4.2.1.112,NA,NA,CAS: 74-86-2; PubChem: 4707; ChEBI: 27518; ChEMBL: CHEMBL116336; 3DMET: B00316; NIKKAJI: J1.940B,cpd:C00012; cpd:C00017; cpd:C00048; cpd:C00098; cpd:C00209; cpd:C00403; cpd:C00722; cpd:C01372; cpd:C01392; cpd:C01398; cpd:C01548; cpd:C01706; cpd:C02028; cpd:C02038; cpd:C02103; cpd:C02179; cpd:C02303; cpd:C02318; cpd:C02429; cpd:C02434; cpd:C02805; cpd:C02986; cpd:C03011; cpd:C03193; cpd:C03303; cpd:C03881; cpd:C03904; cpd:C03905; cpd:C04025; cpd:C04342; cpd:C04506; cpd:C04748; cpd:C04848; cpd:C05157; cpd:C05234; cpd:C05718; cpd:C06791; cpd:C06792; cpd:C11149; cpd:C14039; cpd:C14448; cpd:C14705; cpd:C14857; cpd:C14858; cpd:C14859; cpd:C15564; cpd:C16739; cpd:C18588; cpd:C18992; cpd:C19212; cpd:C19360; cpd:C19367; cpd:C19534; cpd:C19547; cpd:C20119; cpd:C20120; cpd:C20123; cpd:C20318; cpd:C21386; cpd:C21387; cpd:C21388; cpd:C21455; cpd:C21456; cpd:C21457; cpd:C21458; cpd:C21465,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H3,C2H1,26.01565006,27.0234751,25.007825032606,2908,cpd:C02271,Dichloromethane;,CH2Cl2,Dichloromethane; Methylene chloride; Methylene dichloride,R00603,Chloroalkane and chloroalkene degradation; Microbial metabolism in diverse environments,4.5.1.3,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C02271  Dichloromethane; Pharmaceutical additives [BR:br08316];  Solubilization agent;   D02330  [101797] Dichloromethane,CAS: 75-09-2; PubChem: 5331; ChEBI: 15767; ChEMBL: CHEMBL45967; 3DMET: B00413; NIKKAJI: J2.389B,cpd:C02271,1,2,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C1H3Cl2,C1H1Cl2,83.95335543,84.96118046,82.94553042607,2909,cpd:C06548,Ethylene oxide,C2H4O,Ethylene oxide,R05351 R05444 R05842,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Chemical carcinogenesis,1.1.1.-; 1.14.13.69; 3.3.2.10,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C06548  Ethylene oxide; Therapeutic category of drugs in Japan [BR:br08301];  7  Agents not mainly for therapeutic purpose;   73  Public health agents;    732  Germicides and disinfectants;     7329  Others;      D03474  Ethylene oxide; Classification of Japanese OTC drugs [BR:br08313];  Agents for sanitation;   81 Disinfectants;    D03474  Ethylene oxide; Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Not used for human;    Disinfectants;     D03474  Ethylene oxide; Animal drugs in Japan [BR:br08331];  99  Agents for not mainly purpose of therapeutic;   992  Amphoteric soap and preparations;    9929  Other agents for disinfections;     C06548  Ethylene oxide,CAS: 75-21-8; PubChem: 8778; ChEBI: 27561; ChEMBL: CHEMBL1743219; 3DMET: B00967; NIKKAJI: J1.942I,cpd:C00084; cpd:C00980; cpd:C01857; cpd:C02998; cpd:C06548; cpd:C11317; cpd:C11623; cpd:C11624; cpd:C11625; cpd:C18675; cpd:C19158; cpd:C20305,2,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H5O1,C2H3O1,44.02621475,45.03403978,43.018389722608,2910,cpd:C06609,"trans-1,3-Dichloropropene;",C3H4Cl2,"trans-1,3-Dichloropropene; trans-3-Chloroallyl chloride",R05367,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.8.1.5,NA,NA,CAS: 10061-02-6; PubChem: 8835; ChEBI: 18624; ChEMBL: CHEMBL155926; 3DMET: B00996; NIKKAJI: J4.434B,cpd:C06609; cpd:C06610; cpd:C07517; cpd:C18600; cpd:C18627,3,4,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C3H5Cl2,C3H3Cl2,109.9690055,110.9768305,108.96118052609,2911,cpd:C06610,"cis-1,3-Dichloropropene",C3H4Cl2,"cis-1,3-Dichloropropene",R05368,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.8.1.5,NA,NA,CAS: 10061-01-5; PubChem: 8836; ChEBI: 18809; 3DMET: B00997; NIKKAJI: J4.433D,cpd:C06609; cpd:C06610; cpd:C07517; cpd:C18600; cpd:C18627,3,4,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C3H5Cl2,C3H3Cl2,109.9690055,110.9768305,108.96118052610,2912,cpd:C06611,trans-3-Chloro-2-propene-1-ol;,C3H5ClO,trans-3-Chloro-2-propene-1-ol; trans-3-Chloroallyl alcohol,R05233 R05367,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.1; 3.8.1.5,NA,NA,CAS: 4643-06-5; PubChem: 8837; ChEBI: 28960; 3DMET: B00998; NIKKAJI: J353.538J,cpd:C06611; cpd:C06612; cpd:C06925; cpd:C14449,3,5,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C3H6O1Cl1,C3H4O1Cl1,92.00289246,93.01071749,90.995067432611,2913,cpd:C06612,cis-3-Chloro-2-propene-1-ol;,C3H5ClO,cis-3-Chloro-2-propene-1-ol; cis-3-Chloroallyl alcohol,R05234 R05368,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.1; 3.8.1.5,NA,NA,PubChem: 8838; ChEBI: 28967; 3DMET: B00999; NIKKAJI: J353.537A,cpd:C06611; cpd:C06612; cpd:C06925; cpd:C14449,3,5,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C3H6O1Cl1,C3H4O1Cl1,92.00289246,93.01071749,90.995067432612,2914,cpd:C06613,trans-3-Chloroallyl aldehyde;,C3H3ClO,trans-3-Chloroallyl aldehyde; trans-3-Chloro-2-propenal,R05233 R05237,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.1; 1.2.1.3,NA,NA,PubChem: 8839; ChEBI: 28452; 3DMET: B01000; NIKKAJI: J83.949C,cpd:C06613; cpd:C08735; cpd:C16348,3,3,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C3H4O1Cl1,C3H2O1Cl1,89.9872424,90.99506743,88.979417372613,2915,cpd:C06614,trans-3-Chloroacrylic acid,C3H3ClO2,trans-3-Chloroacrylic acid,R05237 R05371,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.2.1.3; 3.8.1.-,NA,NA,CAS: 2345-61-1; PubChem: 8840; ChEBI: 19982 28404; LIPIDMAPS: LMFA01090071; 3DMET: B01001; NIKKAJI: J1.807D,cpd:C06614; cpd:C06615; cpd:C20609,3,3,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C3H4O2Cl1,C3H2O2Cl1,105.982157,106.9899821,104.9743322614,2916,cpd:C06615,cis-3-Chloroacrylic acid,C3H3ClO2,cis-3-Chloroacrylic acid,R05238 R05372,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.2.1.3; 3.8.1.-,NA,NA,CAS: 1609-93-4; PubChem: 8841; ChEBI: 27397; 3DMET: B01002; NIKKAJI: J1.773F,cpd:C06614; cpd:C06615; cpd:C20609,3,3,2,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C3H4O2Cl1,C3H2O2Cl1,105.982157,106.9899821,104.9743322615,2917,cpd:C06752,"1,2-Dichloroethane;",C2H4Cl2,"1,2-Dichloroethane; Ethylene dichloride; Glycol dichloride; Dutch liquid",R05284,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Chemical carcinogenesis,3.8.1.5,NA,"Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C06752  1,2-Dichloroethane",CAS: 107-06-2; PubChem: 8973; ChEBI: 27789; ChEMBL: CHEMBL16370; PDB-CCD: DCE; 3DMET: B01041; NIKKAJI: J4.049E,cpd:C06752; cpd:C14860; cpd:C18247; cpd:C19158; cpd:C20305,2,4,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C2H5Cl2,C2H3Cl2,97.96900549,98.97683053,96.961180462616,2918,cpd:C06753,2-Chloroethanol;,C2H5ClO,2-Chloroethanol; Ethylene chlorohydrin; Glycol chlorohydrin,R05284 R05285 R09128,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.2.7; 1.1.2.8; 3.8.1.5,NA,NA,CAS: 107-07-3; PubChem: 8974; ChEBI: 28200; ChEMBL: CHEMBL191244; 3DMET: B01042; NIKKAJI: J4.050I,cpd:C06753; cpd:C19160,2,5,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C2H6O1Cl1,C2H4O1Cl1,80.00289246,81.01071749,78.995067432617,2919,cpd:C06754,Chloroacetaldehyde;,C2H3ClO,Chloroacetaldehyde; 2-Chloroethanal,R05285 R05286 R08276 R08286 R08287 R09128,Chloroalkane and chloroalkene degradation; Drug metabolism - cytochrome P450; Metabolic pathways; Microbial metabolism in diverse environments; Chemical carcinogenesis,1.1.2.7; 1.1.2.8; 1.2.1.3; 1.14.13.-; 1.14.14.1,NA,NA,CAS: 107-20-0; PubChem: 8975; ChEBI: 27871; ChEMBL: CHEMBL506976; 3DMET: B01043; NIKKAJI: J4.060F,cpd:C06754; cpd:C20303,2,3,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C2H4O1Cl1,C2H2O1Cl1,77.9872424,78.99506743,76.979417372618,2921,cpd:C06790,Trichloroethene;,C2HCl3,Trichloroethene; Trichloroethylene; TCE,R05499 R05500 R05501 R05753 R07098 R07099 R07100 R09141; R09146 R09147 R09151 R09152,Chloroalkane and chloroalkene degradation; Metabolism of xenobiotics by cytochrome P450; Metabolic pathways; Microbial metabolism in diverse environments; Chemical carcinogenesis,1.14.12.11; 1.14.13.25; 1.14.13.-; 1.14.14.1; 1.14.-.-; 1.97.1.8; 2.5.1.18,NA,"Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C06790  Trichloroethene; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N01 ANESTHETICS;    N01A ANESTHETICS, GENERAL;     N01AB Halogenated hydrocarbons;      N01AB05 Trichloroethylene;       C06790  Trichloroethene",CAS: 79-01-6; PubChem: 9010; ChEBI: 16602; ChEMBL: CHEMBL279816; PDB-CCD: TCV; 3DMET: B01052; NIKKAJI: J4.408C,cpd:C06790; cpd:C11148; cpd:C11150; cpd:C14866; cpd:C14867; cpd:C19088,2,1,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C2H2Cl3,C2H0Cl3,129.9143831,130.9222081,128.9065582619,2922,cpd:C06791,"trans-1,2-Dichloroethene;",C2H2Cl2,"trans-1,2-Dichloroethene; trans-Acetylene dichloride",R05500 R05502,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.97.1.8; 1.97.1.-,NA,NA,CAS: 540-59-0; PubChem: 9011; ChEBI: 29027; ChEMBL: CHEMBL157026; 3DMET: B01053; NIKKAJI: J3.642K,cpd:C06791; cpd:C06792; cpd:C11149; cpd:C14039; cpd:C14857; cpd:C14858; cpd:C14859; cpd:C18992; cpd:C20318,2,2,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C2H3Cl2,C2H1Cl2,95.95335543,96.96118046,94.94553042620,2923,cpd:C06792,"cis-1,2-Dichloroethene;",C2H2Cl2,"cis-1,2-Dichloroethene; cis-Acetylene dichloride",R05501 R05503,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.97.1.8; 1.97.1.-,NA,NA,CAS: 156-59-2; PubChem: 9012; ChEBI: 28805; ChEMBL: CHEMBL1441128; 3DMET: B01054; NIKKAJI: J2.558E,cpd:C06791; cpd:C06792; cpd:C11149; cpd:C14039; cpd:C14857; cpd:C14858; cpd:C14859; cpd:C18992; cpd:C20318,2,2,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C2H3Cl2,C2H1Cl2,95.95335543,96.96118046,94.94553042621,2924,cpd:C06793,Vinyl chloride;,C2H3Cl,Vinyl chloride; Chloroethylene,R05498 R05502 R05503,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Chemical carcinogenesis,1.97.1.-,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C06793  Vinyl chloride,CAS: 75-01-4; PubChem: 9013; ChEBI: 28509; 3DMET: B01055; NIKKAJI: J2.387F,cpd:C06754; cpd:C06755; cpd:C06793; cpd:C18992; cpd:C19508; cpd:C19546; cpd:C20303,2,3,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C2H4Cl1,C2H2Cl1,61.99232778,63.00015281,60.984502752622,2925,cpd:C07490,Trichloroethanol;,C2H3Cl3O,"Trichloroethanol; 2,2,2-Trichloroethanol",R07105 R07106 R07107 R09148 R09149,Chloroalkane and chloroalkene degradation; Metabolism of xenobiotics by cytochrome P450; Microbial metabolism in diverse environments; Chemical carcinogenesis; Hypnotics,1.1.1.1; 1.1.-.-; 1.14.13.25; 1.14.13.-; 2.4.1.17,NA,NA,CAS: 115-20-8; PubChem: 9693; ChEBI: 28094; ChEMBL: CHEMBL1171; NIKKAJI: J2.895I,cpd:C07490,2,3,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C2H4O1Cl3,C2H2O1Cl3,147.9249478,148.9327728,146.91712272623,2926,cpd:C11148,TCE epoxide;,C2HCl3O,TCE epoxide; Trichloroethylene epoxide; Trichloroepoxyethane,R07098 R07102 R09141 R09142 R09143 R09144 R09145 R09147,Chloroalkane and chloroalkene degradation; Metabolism of xenobiotics by cytochrome P450; Microbial metabolism in diverse environments; Chemical carcinogenesis,1.14.13.25; 1.14.13.-; 1.14.14.1; 1.14.-.-,NA,NA,CAS: 16967-79-6; PubChem: 13330; ChEBI: 28888; NIKKAJI: J974.086D,cpd:C11148; cpd:C14866; cpd:C14867,2,1,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C2H2O1Cl3,C2H0O1Cl3,145.9092977,146.9171227,144.90147272624,2927,cpd:C11149,Dichloroacetate,C2H2Cl2O2,Dichloroacetate,R07103 R07123 R09143,Chloroalkane and chloroalkene degradation; Metabolism of xenobiotics by cytochrome P450; Microbial metabolism in diverse environments; Chemical carcinogenesis,NA,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C11149  Dichloroacetate,CAS: 79-43-6; PubChem: 13331; ChEBI: 36386; ChEMBL: CHEMBL13960; LIPIDMAPS: LMFA01090070; PDB-CCD: TF4; NIKKAJI: J2.834G,cpd:C11149,2,2,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C2H3O2Cl2,C2H1O2Cl2,127.9431847,128.9510097,126.93535962625,2928,cpd:C11150,Trichloroacetate;,C2HCl3O2,Trichloroacetate; Trichloroacetic acid; TCA,R07104 R07107 R07123 R09150 R09157 R09158,Chloroalkane and chloroalkene degradation; Metabolism of xenobiotics by cytochrome P450; Microbial metabolism in diverse environments; Chemical carcinogenesis,1.1.-.-; 1.2.1.5; 1.14.13.-; 3.8.1.-,NA,Pesticides [BR:br08007];  Pesticides;   Herbicides;    Others;     C11150  TCA; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C11150  Trichloroacetate,CAS: 76-03-9; PubChem: 13332; ChEBI: 30956; ChEMBL: CHEMBL14053; NIKKAJI: J2.400G,cpd:C11150; cpd:C19088,2,1,2,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C2H2O2Cl3,C2H0O2Cl3,161.9042123,162.9120373,160.89638732626,2929,cpd:C14866,Chloral;,C2HCl3O,Chloral; Trichloroacetaldehyde,R07099 R07101 R09146 R09149 R09150,Chloroalkane and chloroalkene degradation; Metabolism of xenobiotics by cytochrome P450; Microbial metabolism in diverse environments; Chemical carcinogenesis,1.1.-.-; 1.14.13.-; 1.14.14.1; 1.14.-.-,NA,Carcinogens [BR:br08008];  Group 2A: Probably carcinogenic to humans;   Compounds;    C14866  Chloral,CAS: 75-87-6; PubChem: 17395864; ChEBI: 48814; ChEMBL: CHEMBL27551; PDB-CCD: CLX; NIKKAJI: J1.469I,cpd:C11148; cpd:C14866; cpd:C14867,2,1,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C2H2O1Cl3,C2H0O1Cl3,145.9092977,146.9171227,144.90147272627,2930,cpd:C16348,cis-3-Chloroallyl aldehyde;,C3H3ClO,cis-3-Chloroallyl aldehyde; cis-3-Chloro-2-propenal,R05234 R05238,Chloroalkane and chloroalkene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.1; 1.2.1.3,NA,NA,PubChem: 47205656; ChEBI: 80465; NIKKAJI: J2.802.291C,cpd:C06613; cpd:C08735; cpd:C16348,3,3,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C3H4O1Cl1,C3H2O1Cl1,89.9872424,90.99506743,88.979417372628,2931,cpd:C18246,"1,1,1-Trichloroethane;",C2H3Cl3,"1,1,1-Trichloroethane; Methylchloroform",R09148 R09154,Chloroalkane and chloroalkene degradation; Microbial metabolism in diverse environments,1.14.13.25; 1.97.1.-,NA,"Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C18246  1,1,1-Trichloroethane; Pharmaceutical additives [BR:br08316];  Solvent;   C18246  [107431] Trichloroethane",CAS: 71-55-6; PubChem: 103061428; ChEBI: 36015; ChEMBL: CHEMBL16080,cpd:C06899; cpd:C07490; cpd:C18246; cpd:C19536,2,3,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C2H4Cl3,C2H2Cl3,131.9300331,132.9378582,130.92220812629,2932,cpd:C18247,"1,1-Dichloroethane",C2H4Cl2,"1,1-Dichloroethane",R09154 R09155,Chloroalkane and chloroalkene degradation; Microbial metabolism in diverse environments,1.97.1.-,NA,NA,CAS: 75-34-3; PubChem: 103061429; ChEBI: 81599; ChEMBL: CHEMBL45079,cpd:C06752; cpd:C14860; cpd:C18247; cpd:C19158; cpd:C20305,2,4,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C2H5Cl2,C2H3Cl2,97.96900549,98.97683053,96.961180462630,2933,cpd:C18248,Chloroethane;,C2H5Cl,Chloroethane; Ethyl chloride,R09155 R09156,Chloroalkane and chloroalkene degradation; Microbial metabolism in diverse environments,1.13.12.-; 1.14.99.39; 1.97.1.-,NA,"Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C18248  Chloroethane; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N01 ANESTHETICS;    N01B ANESTHETICS, LOCAL;     N01BX Other local anesthetics;      N01BX01 Ethyl chloride;       D04088  Ethyl chloride (USP)",CAS: 75-00-3; PubChem: 103061430; ChEBI: 47554; ChEMBL: CHEMBL46058,cpd:C06753; cpd:C18248; cpd:C19160,2,5,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C2H6Cl1,C2H4Cl1,64.00797784,65.01580288,63.000152812631,2934,cpd:C00829,Naphthalene,C10H8,Naphthalene,R02968 R07000 R07001,Naphthalene degradation; Metabolism of xenobiotics by cytochrome P450; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds; Naphthalene family,1.14.12.12; 1.14.13.-; 1.14.14.1,"Naphthalene degradation, naphthalene => salicylate",Pesticides [BR:br08007];  Obsolete pesticides;   Others;    Fumigants;     C00829  Naphthalene; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C00829  Naphthalene,CAS: 91-20-3; PubChem: 4087; ChEBI: 16482; ChEMBL: CHEMBL16293; KNApSAcK: C00001259; PDB-CCD: NPY; 3DMET: B00183; NIKKAJI: J2.839H,cpd:C00829; cpd:C01173; cpd:C01752; cpd:C01938; cpd:C02938; cpd:C03012; cpd:C03081; cpd:C03830; cpd:C04033; cpd:C04798; cpd:C05155; cpd:C06203; cpd:C06204; cpd:C07719; cpd:C07726; cpd:C09265; cpd:C09268; cpd:C10290; cpd:C11323; cpd:C11585; cpd:C11713; cpd:C11714; cpd:C13127; cpd:C13254; cpd:C13392; cpd:C14785; cpd:C14786; cpd:C14787; cpd:C15648; cpd:C16193; cpd:C16194; cpd:C16196; cpd:C16198; cpd:C16201; cpd:C16202; cpd:C16213; cpd:C16731; cpd:C16913; cpd:C18077; cpd:C18079; cpd:C18570; cpd:C18929; cpd:C19245; cpd:C19959; cpd:C20381; cpd:C20462; cpd:C20772; cpd:C21109; cpd:C21414; cpd:C21451,10,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9,C10H7,128.0626003,129.0704253,127.05477522632,2935,cpd:C02909,(2-Naphthyl)methanol;,C11H10O,(2-Naphthyl)methanol; 2-Naphthalenemethanol; 2-Hydroxymethylnaphthalene,R06926 R06927 R06930,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.1; 1.14.12.12; 1.14.13.-,NA,NA,CAS: 1592-38-7; PubChem: 5834; ChEBI: 27615; ChEMBL: CHEMBL150445; PDB-CCD: 2NA; NIKKAJI: J149.365E,cpd:C02909; cpd:C10659; cpd:C14089; cpd:C18550; cpd:C19116; cpd:C20289,11,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O1,C11H9O1,158.0731649,159.08099,157.06533992633,2936,cpd:C04314,"cis-1,2-Dihydronaphthalene-1,2-diol;",C10H10O2,"cis-1,2-Dihydronaphthalene-1,2-diol; (1R,2S)-1,2-Dihydronaphthalene-1,2-diol",R02968 R04115,Naphthalene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.29; 1.14.12.12,"Naphthalene degradation, naphthalene => salicylate",NA,PubChem: 6972; ChEBI: 15561 44343; PDB-CCD: NDH; NIKKAJI: J89.614D,cpd:C04314; cpd:C04514; cpd:C06205; cpd:C06358; cpd:C07658; cpd:C10472; cpd:C10475; cpd:C10490; cpd:C12088; cpd:C14266; cpd:C15419; cpd:C17204; cpd:C19115; cpd:C20269,10,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O2,C10H9O2,162.0680796,163.0759046,161.06025452634,2937,cpd:C06202,Salicylaldehyde;,C7H6O2,Salicylaldehyde; o-Hydroxybenzaldehyde; 2-Hydroxybenzaldehyde,R02941 R05136,Naphthalene degradation; Biosynthesis of phenylpropanoids; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.65; 1.2.1.-; 4.1.2.45,"Naphthalene degradation, naphthalene => salicylate",NA,CAS: 90-02-8; PubChem: 8452; ChEBI: 16008; ChEMBL: CHEMBL108925; KNApSAcK: C00031273; PDB-CCD: NK; 3DMET: B00919; NIKKAJI: J10.607K,cpd:C00180; cpd:C00539; cpd:C00633; cpd:C03067; cpd:C06202; cpd:C14181; cpd:C15474; cpd:C18302,7,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O2,C7H5O2,122.0367794,123.0446045,121.02895442635,2938,cpd:C06203,trans-o-Hydroxybenzylidenepyruvate;,C10H8O4,trans-o-Hydroxybenzylidenepyruvate; (3E)-4-(2-Hydroxyphenyl)-2-oxobut-3-enoate,R05136 R05137,Naphthalene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,4.1.2.45; 5.99.1.4,"Naphthalene degradation, naphthalene => salicylate",NA,PubChem: 8453; ChEBI: 59354; 3DMET: B00920; NIKKAJI: J1.321.886B,cpd:C01752; cpd:C01938; cpd:C03830; cpd:C04033; cpd:C06203; cpd:C06204; cpd:C10290; cpd:C16913; cpd:C18077; cpd:C18079; cpd:C20462; cpd:C21414; cpd:C21451,10,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O4,C10H7O4,192.0422587,193.0500838,191.03443372636,2939,cpd:C06204,2-Hydroxychromene-2-carboxylate;,C10H8O4,2-Hydroxychromene-2-carboxylate; 2-Hydroxy-2H-chromene-2-carboxylate,R04117 R05137,Naphthalene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.56; 5.99.1.4,"Naphthalene degradation, naphthalene => salicylate",NA,PubChem: 8454; ChEBI: 28992; NIKKAJI: J2.372.221F,cpd:C01752; cpd:C01938; cpd:C03830; cpd:C04033; cpd:C06203; cpd:C06204; cpd:C10290; cpd:C16913; cpd:C18077; cpd:C18079; cpd:C20462; cpd:C21414; cpd:C21451,10,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O4,C10H7O4,192.0422587,193.0500838,191.03443372637,2940,cpd:C14082,1-Methylnaphthalene;,C11H10,1-Methylnaphthalene; alpha-Methylnaphthalene,R06909 R06916,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds; Naphthalene family,1.14.12.12; 1.14.13.-,NA,NA,CAS: 90-12-0; PubChem: 854318; ChEBI: 50717; ChEMBL: CHEMBL383808; NIKKAJI: J3.552A,cpd:C02730; cpd:C02909; cpd:C06732; cpd:C07126; cpd:C07886; cpd:C09012; cpd:C09271; cpd:C09311; cpd:C10496; cpd:C10659; cpd:C10744; cpd:C11052; cpd:C11125; cpd:C12264; cpd:C12344; cpd:C14082; cpd:C14084; cpd:C14085; cpd:C14086; cpd:C14089; cpd:C14092; cpd:C14098; cpd:C14105; cpd:C14106; cpd:C14107; cpd:C15102; cpd:C17479; cpd:C17480; cpd:C17916; cpd:C18550; cpd:C19060; cpd:C19116; cpd:C19136; cpd:C19180; cpd:C19244; cpd:C20210; cpd:C20289; cpd:C21124,11,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11,C11H9,142.0782503,143.0860754,141.07042532638,2941,cpd:C14083,"cis-1,2-Dihydroxy-1,2-dihydro-8-methylnaphthalene",C11H12O2,"cis-1,2-Dihydroxy-1,2-dihydro-8-methylnaphthalene",R06909 R06910,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.29; 1.14.12.12,NA,NA,CAS: 156757-20-9; PubChem: 854319; ChEBI: 23269; NIKKAJI: J2.787.848B,cpd:C00078; cpd:C00525; cpd:C00806; cpd:C06359; cpd:C07839; cpd:C08217; cpd:C08453; cpd:C10389; cpd:C10743; cpd:C10968; cpd:C12299; cpd:C14083; cpd:C14102; cpd:C14111; cpd:C14916,11,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O2,C11H11O2,176.0837296,177.0915547,175.07590462639,2942,cpd:C14084,"1,2-Dihydroxy-8-methylnaphthalene",C11H10O2,"1,2-Dihydroxy-8-methylnaphthalene",R06910 R06911,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.29; 1.13.-.-,NA,NA,PubChem: 854320; ChEBI: 38136; NIKKAJI: J2.787.849K,cpd:C06732; cpd:C07126; cpd:C10744; cpd:C12344; cpd:C14084; cpd:C19060; cpd:C21124,11,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O2,C11H9O2,174.0680796,175.0759046,173.06025452640,2943,cpd:C14085,2-Hydroxy-8-methylchromene-2-carboxylate,C11H10O4,2-Hydroxy-8-methylchromene-2-carboxylate,R06911 R06912,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.-.-; 5.3.99.-,NA,NA,CAS: 156605-21-9; PubChem: 854321; ChEBI: 34285; NIKKAJI: J2.787.853I,cpd:C09012; cpd:C09311; cpd:C14085; cpd:C14086; cpd:C14092; cpd:C20210,11,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O4,C11H9O4,206.0579088,207.0657338,205.05008382641,2944,cpd:C14086,2-Hydroxy-3-methylbenzalpyruvate,C11H10O4,2-Hydroxy-3-methylbenzalpyruvate,R06912 R06913,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,4.2.1.-; 5.3.99.-,NA,NA,PubChem: 854322; ChEBI: 34281; NIKKAJI: J2.787.854G,cpd:C09012; cpd:C09311; cpd:C14085; cpd:C14086; cpd:C14092; cpd:C20210,11,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O4,C11H9O4,206.0579088,207.0657338,205.05008382642,2945,cpd:C14087,3-Methylsalicylaldehyde;,C8H8O2,3-Methylsalicylaldehyde; 2-Hydroxy-3-methylbenzaldehyde,R06913 R06914,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.-; 4.2.1.-,NA,NA,CAS: 824-42-0; PubChem: 854323; ChEBI: 20110; NIKKAJI: J526.376J,cpd:C00548; cpd:C01454; cpd:C01526; cpd:C02061; cpd:C03765; cpd:C05613; cpd:C06224; cpd:C07085; cpd:C07086; cpd:C07189; cpd:C07211; cpd:C07215; cpd:C10700; cpd:C10761; cpd:C11151; cpd:C11252; cpd:C14087; cpd:C15250; cpd:C15583; cpd:C20645; cpd:C21166; cpd:C21328; cpd:C21375,8,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O2,C8H7O2,136.0524295,137.0602545,135.04460452643,2946,cpd:C14088,3-Methylsalicylate,C8H8O3,3-Methylsalicylate,R06914 R06915,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.-; 1.14.13.1,NA,NA,CAS: 45848-87-1; PubChem: 854324; ChEBI: 20141; ChEMBL: CHEMBL448399; KNApSAcK: C00044054; NIKKAJI: J2.787.855E,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951912644,2947,cpd:C14089,1-Hydroxymethylnaphthalene;,C11H10O,1-Hydroxymethylnaphthalene; 1-Naphthalenemethanol,R06916 R06917,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.1; 1.14.13.-,NA,NA,CAS: 4780-79-4; PubChem: 854325; ChEBI: 38137; ChEMBL: CHEMBL1288; NIKKAJI: J215A,cpd:C02909; cpd:C10659; cpd:C14089; cpd:C18550; cpd:C19116; cpd:C20289,11,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O1,C11H9O1,158.0731649,159.08099,157.06533992645,2948,cpd:C14090,1-Naphthaldehyde;,C11H8O,1-Naphthaldehyde; 1-Formylnaphthalene,R06917 R06918,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.1; 1.2.1.-,NA,NA,CAS: 66-77-3; PubChem: 854326; ChEBI: 52367; NIKKAJI: J4.846A,cpd:C14090; cpd:C14099; cpd:C18458; cpd:C18737,11,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O1,C11H7O1,156.0575149,157.0653399,155.04968982646,2949,cpd:C14091,1-Naphthoic acid;,C11H8O2,1-Naphthoic acid; 1-Carboxynaphthalene; alpha-Naphthoic acid,R06918 R06919,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.-; 1.14.12.-,NA,NA,CAS: 86-55-5; PubChem: 854327; ChEBI: 36466; ChEMBL: CHEMBL1160; KNApSAcK: C00019348; NIKKAJI: J10.616J,cpd:C05377; cpd:C08446; cpd:C08774; cpd:C11427; cpd:C14091; cpd:C14101; cpd:C18891,11,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O2,C11H7O2,172.0524295,173.0602545,171.04460452647,2950,cpd:C14092,"cis-1,2-Dihydroxy-1,2-dihydro-8-carboxynaphthalene",C11H10O4,"cis-1,2-Dihydroxy-1,2-dihydro-8-carboxynaphthalene",R06919 R06920,Naphthalene degradation; Microbial metabolism in diverse environments,1.1.-.-; 1.14.12.-,NA,NA,CAS: 162794-84-5; PubChem: 854328; ChEBI: 23268; NIKKAJI: J2.787.857A,cpd:C09012; cpd:C09311; cpd:C14085; cpd:C14086; cpd:C14092; cpd:C20210,11,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O4,C11H9O4,206.0579088,207.0657338,205.05008382648,2951,cpd:C14093,"1,2-Dihydroxy-8-carboxynaphthalene;",C11H8O4,"1,2-Dihydroxy-8-carboxynaphthalene; 7,8-Dihydroxy-1-naphthalenecarboxylic acid",R06920 R06921,Naphthalene degradation; Microbial metabolism in diverse environments,1.1.-.-; 1.13.-.-,NA,NA,CAS: 162794-82-3; PubChem: 854329; ChEBI: 18891; NIKKAJI: J2.787.858J,cpd:C03657; cpd:C06986; cpd:C10335; cpd:C13429; cpd:C14093; cpd:C17018,11,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O4,C11H7O4,204.0422587,205.0500838,203.03443372649,2952,cpd:C14094,2-Carboxy-2-hydroxy-8-carboxychromene,C11H8O6,2-Carboxy-2-hydroxy-8-carboxychromene,R06921 R06922,Naphthalene degradation; Microbial metabolism in diverse environments,1.13.-.-; 5.3.99.-,NA,NA,PubChem: 854330; ChEBI: 34265; NIKKAJI: J2.787.870I,cpd:C14094; cpd:C14095; cpd:C21321,11,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O6,C11H7O6,236.032088,237.039913,235.02426292650,2953,cpd:C14095,2-Hydroxy-3-carboxybenzalpyruvate;,C11H8O6,2-Hydroxy-3-carboxybenzalpyruvate; 3-(3-Carboxy-3-oxo-1-propenyl)-2-hydroxy-benzoic acid,R06922 R06923,Naphthalene degradation; Microbial metabolism in diverse environments,4.2.1.-; 5.3.99.-,NA,NA,CAS: 162794-83-4; PubChem: 854331; ChEBI: 19602; NIKKAJI: J2.787.873C,cpd:C14094; cpd:C14095; cpd:C21321,11,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O6,C11H7O6,236.032088,237.039913,235.02426292651,2954,cpd:C14096,3-Formylsalicylic acid;,C8H6O4,3-Formylsalicylic acid; 2-Hydroxyisophthalaldehydic acid,R06923 R06924,Naphthalene degradation; Microbial metabolism in diverse environments,1.2.3.-; 4.2.1.-,NA,NA,CAS: 610-04-8; PubChem: 854332; ChEBI: 34334; PDB-CCD: 7ZS; NIKKAJI: J765.258E,cpd:C01606; cpd:C03590; cpd:C06337; cpd:C14096; cpd:C14100; cpd:C19240,8,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O4,C8H5O4,166.0266087,167.0344337,165.01878362652,2955,cpd:C14097,2-Hydroxyisophthalic acid;,C8H6O5,"2-Hydroxyisophthalic acid; 2-Hydroxy-1,3-benzenedicarboxylic acid",R06924 R06925,Naphthalene degradation; Microbial metabolism in diverse environments,1.2.3.-; 4.1.1.-,NA,NA,CAS: 606-19-9; PubChem: 854333; ChEBI: 19643; NIKKAJI: J94.854C,cpd:C01853; cpd:C06680; cpd:C07268; cpd:C12325; cpd:C14097; cpd:C21168,8,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O5,C8H5O5,182.0215233,183.0293483,181.01369832653,2956,cpd:C14098,2-Methylnaphthalene;,C11H10,2-Methylnaphthalene; beta-Methylnaphthalene,R06903 R06926 R06937,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds; Naphthalene family,1.14.12.12; 1.14.13.-; 4.1.99.-,NA,NA,CAS: 91-57-6; PubChem: 854334; ChEBI: 50720; ChEMBL: CHEMBL195895; NIKKAJI: J3.557B,cpd:C02730; cpd:C02909; cpd:C06732; cpd:C07126; cpd:C07886; cpd:C09012; cpd:C09271; cpd:C09311; cpd:C10496; cpd:C10659; cpd:C10744; cpd:C11052; cpd:C11125; cpd:C12264; cpd:C12344; cpd:C14082; cpd:C14084; cpd:C14085; cpd:C14086; cpd:C14089; cpd:C14092; cpd:C14098; cpd:C14105; cpd:C14106; cpd:C14107; cpd:C15102; cpd:C17479; cpd:C17480; cpd:C17916; cpd:C18550; cpd:C19060; cpd:C19116; cpd:C19136; cpd:C19180; cpd:C19244; cpd:C20210; cpd:C20289; cpd:C21124,11,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11,C11H9,142.0782503,143.0860754,141.07042532654,2957,cpd:C14099,2-Naphthaldehyde;,C11H8O,2-Naphthaldehyde; 2-Naphthalenecarboxaldehyde,R06927 R06928 R06929,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.1; 1.2.1.-,NA,NA,CAS: 66-99-9; PubChem: 854335; ChEBI: 52368; NIKKAJI: J4.847J,cpd:C14090; cpd:C14099; cpd:C18458; cpd:C18737,11,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O1,C11H7O1,156.0575149,157.0653399,155.04968982655,2958,cpd:C14100,4-Formylsalicylic acid;,C8H6O4,4-Formylsalicylic acid; 4-Formyl-2-hydroxybenzoic acid,R06929,Naphthalene degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 51572-88-4; PubChem: 854336; ChEBI: 20367; NIKKAJI: J1.288.474E,cpd:C01606; cpd:C03590; cpd:C06337; cpd:C14096; cpd:C14100; cpd:C19240,8,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O4,C8H5O4,166.0266087,167.0344337,165.01878362656,2959,cpd:C14101,2-Naphthoic acid;,C11H8O2,2-Naphthoic acid; 2-Naphthalenecarboxylic acid; beta-Naphthoic acid,R06898 R06902 R06928 R07881,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.-; 2.8.3.-,NA,NA,CAS: 93-09-4; PubChem: 854337; ChEBI: 36106; ChEMBL: CHEMBL114648; PDB-CCD: FIV; NIKKAJI: J10.599F,cpd:C05377; cpd:C08446; cpd:C08774; cpd:C11427; cpd:C14091; cpd:C14101; cpd:C18891,11,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O2,C11H7O2,172.0524295,173.0602545,171.04460452657,2960,cpd:C14102,"cis-1,2-Dihydroxy-1,2-dihydro-7-methylnaphthalene",C11H12O2,"cis-1,2-Dihydroxy-1,2-dihydro-7-methylnaphthalene",R06937 R06938,Naphthalene degradation; Microbial metabolism in diverse environments,1.14.12.12,NA,NA,CAS: 127926-10-7; PubChem: 854338; ChEBI: 23267; NIKKAJI: J702.306E,cpd:C00078; cpd:C00525; cpd:C00806; cpd:C06359; cpd:C07839; cpd:C08217; cpd:C08453; cpd:C10389; cpd:C10743; cpd:C10968; cpd:C12299; cpd:C14083; cpd:C14102; cpd:C14111; cpd:C14916,11,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O2,C11H11O2,176.0837296,177.0915547,175.07590462658,2961,cpd:C14103,4-Methylsalicylate;,C8H8O3,4-Methylsalicylate; m-Cresotic acid; 2-Hydroxy-4-methylbenzoic acid,R06938 R06939,Naphthalene degradation; Microbial metabolism in diverse environments,1.14.13.1,NA,NA,CAS: 50-85-1; PubChem: 854339; ChEBI: 20450; ChEMBL: CHEMBL1650625; NIKKAJI: J4.108D,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951912659,2962,cpd:C14104,"cis-1,2-Dihydroxy-1,2-dihydro-7-hydroxymethylnaphthalene",C11H12O3,"cis-1,2-Dihydroxy-1,2-dihydro-7-hydroxymethylnaphthalene",R06930 R06931,Naphthalene degradation; Microbial metabolism in diverse environments,1.3.1.29; 1.14.12.12,NA,NA,PubChem: 854340; ChEBI: 23266; NIKKAJI: J2.787.874A,cpd:C00643; cpd:C01017; cpd:C09985; cpd:C10435; cpd:C10480; cpd:C10493; cpd:C12343; cpd:C12540; cpd:C12616; cpd:C14104; cpd:C16896; cpd:C17840; cpd:C19716; cpd:C20465,11,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O3,C11H11O3,192.0786442,193.0864693,191.07081922660,2963,cpd:C14105,"1,2-Dihydroxy-7-hydroxymethylnaphthalene",C11H10O3,"1,2-Dihydroxy-7-hydroxymethylnaphthalene",R06931 R06932,Naphthalene degradation; Microbial metabolism in diverse environments,1.3.1.29; 1.13.-.-,NA,NA,PubChem: 854341; ChEBI: 18890; NIKKAJI: J2.787.877F,cpd:C11052; cpd:C11125; cpd:C14105; cpd:C15102; cpd:C17916,11,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O3,C11H9O3,190.0629942,191.0708192,189.05516912661,2964,cpd:C14106,2-Hydroxy-7-hydroxymethylchromene-2-carboxylate,C11H10O5,2-Hydroxy-7-hydroxymethylchromene-2-carboxylate,R06932 R06933,Naphthalene degradation; Microbial metabolism in diverse environments,1.13.-.-; 5.3.99.-,NA,NA,CAS: 156605-24-2; PubChem: 854342; ChEBI: 19623; NIKKAJI: J2.787.878D,cpd:C02730; cpd:C09271; cpd:C10496; cpd:C12264; cpd:C14106; cpd:C14107; cpd:C17479; cpd:C17480,11,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O5,C11H9O5,222.0528234,223.0606485,221.04499842662,2965,cpd:C14107,2-Hydroxy-4-hydroxymethylbenzalpyruvate,C11H10O5,2-Hydroxy-4-hydroxymethylbenzalpyruvate,R06933 R06934,Naphthalene degradation; Microbial metabolism in diverse environments,4.2.1.-; 5.3.99.-,NA,NA,PubChem: 854343; ChEBI: 34282; NIKKAJI: J2.787.879B,cpd:C02730; cpd:C09271; cpd:C10496; cpd:C12264; cpd:C14106; cpd:C14107; cpd:C17479; cpd:C17480,11,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O5,C11H9O5,222.0528234,223.0606485,221.04499842663,2966,cpd:C14108,4-Hydroxymethylsalicylaldehyde;,C8H8O3,4-Hydroxymethylsalicylaldehyde; 2-Hydroxy-4-hydroxymethyl-benzaldehyde,R06934 R06935,Naphthalene degradation; Microbial metabolism in diverse environments,1.2.1.-; 4.2.1.-,NA,NA,CAS: 156605-23-1; PubChem: 854344; ChEBI: 20414; NIKKAJI: J2.787.880F,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951912664,2967,cpd:C14109,4-Hydroxymethylsalicylate;,C8H8O4,4-Hydroxymethylsalicylate; 2-Hydroxy-4-hydroxymethylbenzoic acid,R06935 R06936,Naphthalene degradation; Microbial metabolism in diverse environments,1.2.1.-; 1.14.13.1,NA,NA,CAS: 106420-93-3; PubChem: 854345; ChEBI: 20415; NIKKAJI: J2.787.883K,cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272,8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O4,C8H7O4,168.0422587,169.0500838,167.03443372665,2968,cpd:C14110,4-Hydroxymethylcatechol;,C7H8O3,"4-Hydroxymethylcatechol; 3,4-Dihydroxybenzyl alcohol",R06936,Naphthalene degradation; Microbial metabolism in diverse environments,1.14.13.1,NA,NA,CAS: 3897-89-0; PubChem: 854346; ChEBI: 20412; ChEMBL: CHEMBL440107; NIKKAJI: J79.872J,cpd:C03095; cpd:C03338; cpd:C06677; cpd:C10792; cpd:C13129; cpd:C14110; cpd:C16356; cpd:C16360; cpd:C16401; cpd:C18317; cpd:C19469; cpd:C20362,7,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O3,C7H7O3,140.0473441,141.0551691,139.03951912666,2969,cpd:C14111,"5,6,7,8-Tetrahydro-2-naphthoic acid",C11H12O2,"5,6,7,8-Tetrahydro-2-naphthoic acid",R06898 R06899 R06900 R06901,Naphthalene degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 1131-63-1; PubChem: 854347; ChEBI: 34447; NIKKAJI: J203.377A,cpd:C00078; cpd:C00525; cpd:C00806; cpd:C06359; cpd:C07839; cpd:C08217; cpd:C08453; cpd:C10389; cpd:C10743; cpd:C10968; cpd:C12299; cpd:C14083; cpd:C14102; cpd:C14111; cpd:C14916,11,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O2,C11H11O2,176.0837296,177.0915547,175.07590462667,2970,cpd:C14112,cis-2-Carboxycyclohexyl-acetic acid,C9H14O4,cis-2-Carboxycyclohexyl-acetic acid,R06900,Naphthalene degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 14715-37-8; PubChem: 854348; ChEBI: 35078; NIKKAJI: J1.713.279B,cpd:C14112,9,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O4,C9H13O4,186.0892089,187.097034,185.08138392668,2971,cpd:C14113,Decahydro-2-naphthoic acid;,C11H18O2,Decahydro-2-naphthoic acid; Decahydro-2-naphthalenecarboxylic acid,R06899,Naphthalene degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 13032-41-2; PubChem: 854349; ChEBI: 34667; NIKKAJI: J761.591D,cpd:C07521; cpd:C11079; cpd:C12294; cpd:C14113; cpd:C17486,11,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H19O2,C11H17O2,182.1306798,183.1385049,181.12285482669,2972,cpd:C14114,Tetralin;,C10H12,"Tetralin; 1,2,3,4-Tetrahydronaphthalene",R06901,Naphthalene degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 119-64-2; PubChem: 854350; ChEBI: 35008; ChEMBL: CHEMBL1575635; NIKKAJI: J2.002H,cpd:C00294; cpd:C00328; cpd:C00343; cpd:C00398; cpd:C00575; cpd:C00590; cpd:C00780; cpd:C00895; cpd:C00942; cpd:C00968; cpd:C01445; cpd:C01718; cpd:C01736; cpd:C01762; cpd:C02353; cpd:C02507; cpd:C02548; cpd:C02794; cpd:C03227; cpd:C05512; cpd:C05513; cpd:C05647; cpd:C05651; cpd:C06194; cpd:C06577; cpd:C06578; cpd:C06580; cpd:C06581; cpd:C06953; cpd:C07025; cpd:C07147; cpd:C07312; cpd:C07342; cpd:C07351; cpd:C07756; cpd:C07771; cpd:C07930; cpd:C09858; cpd:C09904; cpd:C09905; cpd:C09907; cpd:C10126; cpd:C10428; cpd:C10452; cpd:C10453; cpd:C10469; cpd:C10664; cpd:C10674; cpd:C10684; cpd:C10726; cpd:C10965; cpd:C11018; cpd:C11155; cpd:C11266; cpd:C12205; cpd:C12303; cpd:C14114; cpd:C14302; cpd:C14309; cpd:C14411; cpd:C14506; cpd:C15475; cpd:C15586; cpd:C16151; cpd:C16778; cpd:C16880; cpd:C16906; cpd:C17104; cpd:C17203; cpd:C17455; cpd:C17965; cpd:C18237; cpd:C18344; cpd:C18671; cpd:C18950; cpd:C18966; cpd:C19018; cpd:C19229; cpd:C19349; cpd:C19729; cpd:C19766; cpd:C19768; cpd:C20343; cpd:C20463; cpd:C20935; cpd:C21075; cpd:C21102; cpd:C21154,10,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13,C10H11,132.0939004,133.1017254,131.08607542670,2973,cpd:C14115,2-Naphtylmethylsuccinic acid;,C15H14O4,2-Naphtylmethylsuccinic acid; Naphthyl-2-methyl-succinic acid,R06903 R06904,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,2.8.3.-; 4.1.99.-,NA,NA,CAS: 350044-88-1; PubChem: 854351; ChEBI: 34883; NIKKAJI: J1.713.275J,cpd:C06877; cpd:C07758; cpd:C07759; cpd:C08465; cpd:C09273; cpd:C09283; cpd:C09618; cpd:C09980; cpd:C10268; cpd:C10352; cpd:C13633; cpd:C14115; cpd:C16929; cpd:C18485,15,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O4,C15H13O4,258.0892089,259.097034,257.08138392671,2974,cpd:C14116,Naphthyl-2-methyl-succinyl-CoA,C36H48N7O19P3S,Naphthyl-2-methyl-succinyl-CoA,R06904 R06905,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.99.-; 2.8.3.-,NA,NA,CAS: 830357-87-4; PubChem: 854352; ChEBI: 34884; NIKKAJI: J2.787.884I,cpd:C14116,36,48,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C36H49O19N7P3S1,C36H47O19N7P3S1,1007.193855,1008.20168,1006.1860292672,2975,cpd:C14117,Naphthyl-2-methylene-succinyl-CoA,C36H46N7O19P3S,Naphthyl-2-methylene-succinyl-CoA,R06905 R06906,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.99.-; 4.2.1.-,NA,NA,PubChem: 854353; ChEBI: 34885; NIKKAJI: J2.788.026F,cpd:C14117,36,46,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C36H47O19N7P3S1,C36H45O19N7P3S1,1005.178204,1006.186029,1004.1703792673,2976,cpd:C14118,Naphthyl-2-hydroxymethyl-succinyl CoA,C36H48N7O20P3S,Naphthyl-2-hydroxymethyl-succinyl CoA,R06906 R06907,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.-.-; 4.2.1.-,NA,NA,PubChem: 854354; ChEBI: 34882; NIKKAJI: J2.788.027D,cpd:C14118,36,48,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C36H49O20N7P3S1,C36H47O20N7P3S1,1023.188769,1024.196594,1022.1809442674,2977,cpd:C14119,Naphthyl-2-oxomethyl-succinyl-CoA,C36H46N7O20P3S,Naphthyl-2-oxomethyl-succinyl-CoA,R06907 R06908,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.-.-; 2.3.1.-,NA,NA,PubChem: 854355; ChEBI: 34886; NIKKAJI: J2.788.028B,cpd:C14119,36,46,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C36H47O20N7P3S1,C36H45O20N7P3S1,1021.173119,1022.180944,1020.1652942675,2978,cpd:C14120,2-Naphthoyl-CoA,C32H42N7O17P3S,2-Naphthoyl-CoA,R06908 R07881,Naphthalene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,2.3.1.-; 2.8.3.-,NA,NA,PubChem: 854356; ChEBI: 34300; NIKKAJI: J2.788.029K,cpd:C14120,32,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H43O17N7P3S1,C32H41O17N7P3S1,921.1570751,922.1649001,920.14925012676,2979,cpd:C16193,"1,6-Naphthalenedisulfonic acid",C10H8O6S2,"1,6-Naphthalenedisulfonic acid",R07682,Naphthalene degradation,1.14.99.-,NA,NA,CAS: 525-37-1; PubChem: 47205501; ChEBI: 30891; NIKKAJI: J6.649D,cpd:C13254; cpd:C16193; cpd:C16194,10,8,6,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O6S2,C10H7O6S2,287.9762303,288.9840554,286.96840532677,2980,cpd:C16194,"2,6-Naphthalenedisulfonic acid",C10H8O6S2,"2,6-Naphthalenedisulfonic acid",R07683,Naphthalene degradation,1.14.99.-,NA,NA,CAS: 581-75-9; PubChem: 47205502; ChEBI: 41070; ChEMBL: CHEMBL1206869; PDB-CCD: BIH; NIKKAJI: J7.437C,cpd:C13254; cpd:C16193; cpd:C16194,10,8,6,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O6S2,C10H7O6S2,287.9762303,288.9840554,286.96840532678,2981,cpd:C16196,"1,2-Dihydroxynaphthalene-6-sulfonate",C10H8O5S,"1,2-Dihydroxynaphthalene-6-sulfonate",R07682 R07683 R07684,Naphthalene degradation,1.13.11.-; 1.14.99.-,NA,NA,PubChem: 47205504; ChEBI: 18896; NIKKAJI: J2.798.780J,cpd:C16196,10,8,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O5S1,C10H7O5S1,240.0092445,241.0170696,239.00141952679,2982,cpd:C16198,(Z)-4-(2-Hydroxy-5-sulfonatophenyl)-2-oxo-3-butenoate,C10H8O7S,(Z)-4-(2-Hydroxy-5-sulfonatophenyl)-2-oxo-3-butenoate,R07684 R07685,Naphthalene degradation,1.13.11.-,NA,NA,PubChem: 47205506; ChEBI: 18814; NIKKAJI: J2.798.799K,cpd:C16198,10,8,7,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O7S1,C10H7O7S1,271.9990738,273.0068988,270.99124872680,2983,cpd:C16199,5-Sulfosalicylate;,C7H6O6S,5-Sulfosalicylate; Sulfosalicylic acid,R07685 R07686,Naphthalene degradation,NA,NA,NA,CAS: 97-05-2; PubChem: 47205507; ChEBI: 68555; ChEMBL: CHEMBL229241; NIKKAJI: J8.317H,cpd:C16199,7,6,6,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O6S1,C7H5O6S1,217.9885091,218.9963341,216.98068412681,2984,cpd:C16201,1-Naphthalenesulfonic acid;,C10H8O3S,1-Naphthalenesulfonic acid; Naphthalene-1-sulfonate,R07698,Naphthalene degradation,1.14.99.-,NA,NA,CAS: 85-47-2; PubChem: 47205509; ChEBI: 30895; ChEMBL: CHEMBL1160029; NIKKAJI: J124.113C,cpd:C16201; cpd:C16202,10,8,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O3S1,C10H7O3S1,208.0194153,209.0272403,207.01159032682,2985,cpd:C16202,2-Naphthalenesulfonic acid;,C10H8O3S,2-Naphthalenesulfonic acid; Naphthalene-2-sulfonate,R07699,Naphthalene degradation,1.14.99.-,NA,NA,CAS: 120-18-3; PubChem: 47205510; ChEBI: 44229; PDB-CCD: NAS; NIKKAJI: J5.321J,cpd:C16201; cpd:C16202,10,8,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O3S1,C10H7O3S1,208.0194153,209.0272403,207.01159032683,2986,cpd:C00292,Aniline;,C6H7N,Aniline; Phenylamine; Benzenamine; Arylamine,R00990 R01860 R01861 R01862 R02387 R02388 R05711 R07700; R10772 R11561,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.7.1.6; 1.14.-.-; 2.3.1.5; 2.4.1.71; 2.8.2.3; 3.5.1.13; 3.5.1.123; 4.1.1.24; 6.3.1.18,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00292  Aniline,CAS: 62-53-3; PubChem: 3586; ChEBI: 17296; ChEMBL: CHEMBL538; PDB-CCD: ANL; 3DMET: B00082; NIKKAJI: J2.349C,cpd:C00292; cpd:C01987; cpd:C02220; cpd:C02372; cpd:C02441; cpd:C02720; cpd:C02854; cpd:C03824; cpd:C04226; cpd:C05058; cpd:C06333; cpd:C06334; cpd:C06335; cpd:C09960; cpd:C11327; cpd:C14293; cpd:C14447; cpd:C14602; cpd:C14604; cpd:C16671; cpd:C17358; cpd:C18351,6,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8N1,C6H6N1,93.05784923,94.06567426,92.05002422684,2987,cpd:C00472,p-Benzoquinone;,C6H4O2,"p-Benzoquinone; Quinone; Chinone; 2,5-Cyclohexadiene-1,4-dione; 1,4-Benzoquinone",R02363 R05244 R05258 R06852 R06854,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.1.-.-; 1.4.-.-; 1.6.5.6; 1.14.13.167; 1.14.18.1,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00472  para-Quinone,CAS: 106-51-4; PubChem: 3755; ChEBI: 16509; ChEMBL: CHEMBL8320; PDB-CCD: PLQ; 3DMET: B01254; NIKKAJI: J5.052K,cpd:C00472; cpd:C02351; cpd:C02933; cpd:C03212; cpd:C06600; cpd:C07094; cpd:C07097; cpd:C11000; cpd:C14407; cpd:C14456; cpd:C16248; cpd:C18238; cpd:C19364,6,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H5O2,C6H3O2,108.0211294,109.0289544,107.01330432685,2988,cpd:C00568,4-Aminobenzoate;,C7H7NO2,4-Aminobenzoate; ABEE; 4-Aminobenzoic acid; p-Aminobenzoate,R01860 R02561 R02562 R03066 R03067 R05277 R05280 R05553; R10337,Aminobenzoate degradation; Folate biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Microbial metabolism in diverse environments,1.7.1.-; 1.14.12.-; 1.14.13.27; 2.4.2.54; 2.5.1.15; 4.1.1.24; 4.1.3.38,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00568  4-Aminobenzoate; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D02 EMOLLIENTS AND PROTECTIVES;    D02B PROTECTIVES AGAINST UV-RADIATION;     D02BA Protectives against UV-radiation for topical use;      D02BA01 Aminobenzoic acid;       D02456  Aminobenzoic acid (USP),CAS: 150-13-0; PubChem: 3847; ChEBI: 17836 30753; ChEMBL: CHEMBL542; KNApSAcK: C00001401; PDB-CCD: PAB; 3DMET: B00134; NIKKAJI: J5.852A,cpd:C00108; cpd:C00568; cpd:C01004; cpd:C14394; cpd:C16285; cpd:C19486; cpd:C19597,7,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O2N1,C7H6O2N1,137.0476785,138.0555035,136.03985342686,2989,cpd:C00870,4-Nitrophenol;,C6H5NO3,4-Nitrophenol; p-Nitrophenol; PNP; Niphen; 4-Hydroxynitrobenzene,R03023 R03024 R05258 R05421 R05548,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.14.13.29; 1.14.13.167; 3.1.3.1; 3.1.3.2; 3.1.3.41; 3.1.8.1,NA,Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Nitrophenol;     C00870  4-Nitrophenol,CAS: 100-02-7; PubChem: 4127; ChEBI: 16836; ChEMBL: CHEMBL14130; PDB-CCD: NPO; NIKKAJI: J4.001K,cpd:C00870; cpd:C01020; cpd:C01988; cpd:C14418; cpd:C18620,6,5,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H6O3N1,C6H4O3N1,139.026943,140.0347681,138.0191182687,2990,cpd:C01108,"1,2,3-Trihydroxybenzene;",C6H6O3,"1,2,3-Trihydroxybenzene; Pyrogallol; Pyrogallic acid; 1,2,3-Benzenetriol",R03246 R03247 R04297 R05250,Aminobenzoate degradation; Microbial metabolism in diverse environments; Catecholamine transferase inhibitors,1.13.11.35; 1.97.1.2; 4.1.1.59,NA,"Phytochemical compounds [BR:br08003];  Others;   Tannins and galloyl derivatives;    Gallotannins;     C01108  Pyrogallol; Target-based classification of compounds [BR:br08010];  Enzymes;   Transferases;    catechol O-methyltransferase;     C01108  1,2,3-Trihydroxybenzene",CAS: 87-66-1; PubChem: 4340; ChEBI: 16164; ChEMBL: CHEMBL307145; KNApSAcK: C00002670; PDB-CCD: PYG; 3DMET: B00240; NIKKAJI: J3.903I,cpd:C01108; cpd:C02183; cpd:C02752; cpd:C02814; cpd:C03277; cpd:C03762; cpd:C06011; cpd:C11101; cpd:C11918; cpd:C16355; cpd:C16359; cpd:C19268; cpd:C19321; cpd:C19322; cpd:C19323; cpd:C20670; cpd:C20718,6,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O3,C6H5O3,126.0316941,127.0395191,125.0238692688,2991,cpd:C01424,Gallate;,C7H6O5,"Gallate; Gallic acid; 3,4,5-Trihydroxybenzoic acid; 3,4,5-Trihydroxybenzoate; Pyrogallol-5-carboxylic acid",R00053 R01637 R03247 R03297 R03549 R03550 R03551 R09271; R09565,Aminobenzoate degradation; Biosynthesis of phenylpropanoids; Microbial metabolism in diverse environments,1.13.11.3; 1.13.11.8; 1.13.11.57; 2.1.1.-; 2.4.1.136; 3.1.1.20; 4.1.1.59,NA,Phytochemical compounds [BR:br08003];  Others;   Tannins and galloyl derivatives;    Galloyl derivatives;     C01424  Gallate,CAS: 149-91-7; PubChem: 4609; ChEBI: 16918 30778; ChEMBL: CHEMBL288114; KNApSAcK: C00002647; PDB-CCD: GDE; 3DMET: B00289; NIKKAJI: J7.408J,cpd:C01424; cpd:C02236; cpd:C18653; cpd:C21159,7,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O5,C7H5O5,170.0215233,171.0293483,169.01369832689,2992,cpd:C01983,(R)-Mandelate;,C8H8O3,(R)-Mandelate; (R)-2-Hydroxy-2-phenylacetic acid; (R)-2-Hydroxy-2-phenylacetate; (R)-Mandelic acid,R03790 R03791 R05783,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.1.1.379; 3.5.1.86; 5.1.2.2,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05C IRRIGATING SOLUTIONS;     B05CA Antiinfectives;      B05CA06 Mandelic acid;       C01983  (R)-Mandelate;  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01X OTHER ANTIBACTERIALS;     J01XX Other antibacterials;      J01XX06 Mandelic acid;       C01983  (R)-Mandelate,PubChem: 5080; ChEBI: 17656 32382; ChEMBL: CHEMBL292411; PDB-CCD: RMN; NIKKAJI: J43.326H,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951912690,2993,cpd:C01984,(S)-Mandelate;,C8H8O3,(S)-Mandelate; (S)-2-Hydroxy-2-phenylacetic acid; (S)-2-Hydroxy-2-phenylacetate; (S)-Mandelic acid,R03791 R03792 R03793 R03794 R07664,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.1.1.-; 1.1.99.31; 1.14.16.6; 5.1.2.2,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05C IRRIGATING SOLUTIONS;     B05CA Antiinfectives;      B05CA06 Mandelic acid;       C01984  (S)-Mandelate;  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01X OTHER ANTIBACTERIALS;     J01XX Other antibacterials;      J01XX06 Mandelic acid;       C01984  (S)-Mandelate,CAS: 17199-29-0; PubChem: 5081; ChEBI: 17756 32800; ChEMBL: CHEMBL58910; KNApSAcK: C00037426; PDB-CCD: SMN; 3DMET: B00376; NIKKAJI: J74.069A,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951912691,2994,cpd:C02183,Phloroglucinol;,C6H6O3,"Phloroglucinol; 1,3,5-Benzenetriol; 1,3,5-Trihydroxybenzene",R02901 R04297 R05308 R10967,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.3.1.57; 1.97.1.2; 2.3.1.253; 3.7.1.4,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;    A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;     A03AX Other drugs for functional gastrointestinal disorders;      A03AX12 Phloroglucinol;       D00152  Phloroglucinol (JAN); Target-based classification of drugs [BR:br08310];  Enzymes;   Transferases;    catechol O-methyltransferase (COMT);     Phloroglucinol;      D00152  Phloroglucinol (JAN),CAS: 108-73-6; PubChem: 5254; ChEBI: 16204; ChEMBL: CHEMBL473159; KNApSAcK: C00002665; PDB-CCD: 13X; 3DMET: B00398; NIKKAJI: J2.866E,cpd:C01108; cpd:C02183; cpd:C02752; cpd:C02814; cpd:C03277; cpd:C03762; cpd:C06011; cpd:C11101; cpd:C11918; cpd:C16355; cpd:C16359; cpd:C19268; cpd:C19321; cpd:C19322; cpd:C19323; cpd:C20670; cpd:C20718,6,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O3,C6H5O3,126.0316941,127.0395191,125.0238692692,2995,cpd:C02235,4-Nitrocatechol,C6H5NO4,4-Nitrocatechol,R03023 R05265,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.14.13.29; 1.14.-.-,NA,NA,CAS: 3316-09-4; PubChem: 5299; ChEBI: 16318; ChEMBL: CHEMBL42423; PDB-CCD: 4NC; NIKKAJI: J205.396I,cpd:C02235; cpd:C15523,6,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H6O4N1,C6H4O4N1,155.0218576,156.0296827,154.01403262693,2996,cpd:C02247,Anthraniloyl-CoA;,C28H41N8O17P3S,Anthraniloyl-CoA; 2-Aminobenzoyl-CoA,R00982 R03998 R03999 R05585 R10589 R10590 R10681,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.4.-.-; 1.14.13.40; 2.3.1.230; 2.3.1.232; 6.2.1.32,NA,NA,PubChem: 5310; ChEBI: 15472; PDB-CCD: COW; NIKKAJI: J653.552F,cpd:C02247,28,41,17,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H42O17N8P3S1,C28H40O17N8P3S1,886.1523241,887.1601491,885.1444992694,2997,cpd:C02372,4-Hydroxyaniline;,C6H7NO,4-Hydroxyaniline; 4-Aminophenol; p-Aminophenol; 4-Aminobenzenol,R02561 R02562 R05482 R05485 R06852,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.4.-.-; 1.14.13.27,NA,NA,CAS: 123-30-8; PubChem: 5414; ChEBI: 17602; ChEMBL: CHEMBL1142; PDB-CCD: 4NL; NIKKAJI: J3.620J,cpd:C01987; cpd:C02372; cpd:C02720; cpd:C05058,6,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O1N1,C6H6O1N1,109.0527638,110.0605889,108.04493882695,2998,cpd:C02720,Hydroxylaminobenzene;,C6H7NO,Hydroxylaminobenzene; (Hydroxyamino)benzene,R04024 R05383 R05400,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.7.1.-; 2.3.1.118; 5.4.4.1,NA,NA,CAS: 100-65-2; PubChem: 5682; ChEBI: 28902; ChEMBL: CHEMBL320474; NIKKAJI: J29.543D,cpd:C01987; cpd:C02372; cpd:C02720; cpd:C05058,6,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O1N1,C6H6O1N1,109.0527638,110.0605889,108.04493882696,2999,cpd:C02734,Phenolic phosphate;,C6H7O4P,Phenolic phosphate; Phenylphosphate,R05603 R05625,Aminobenzoate degradation; Microbial metabolism in diverse environments,2.7.9.-; 6.4.1.-,NA,NA,CAS: 701-64-4; PubChem: 5695; ChEBI: 37548; ChEMBL: CHEMBL26128; PDB-CCD: HPS; 3DMET: B00494; NIKKAJI: J32.914B,cpd:C02734,6,7,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O4P1,C6H6O4P1,174.0081957,175.0160207,173.00037072697,3000,cpd:C03360,4-Nitrophenyl phosphate,C6H6NO6P,4-Nitrophenyl phosphate,R03024,Aminobenzoate degradation; Microbial metabolism in diverse environments,3.1.3.1; 3.1.3.2; 3.1.3.41,NA,NA,CAS: 330-13-2; PubChem: 6198; ChEBI: 17440; ChEMBL: CHEMBL24231; PDB-CCD: 4NP; NIKKAJI: J32.922C,cpd:C03360,6,6,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O6N1P1,C6H5O6N1P1,218.9932739,220.0010989,217.98544892698,3001,cpd:C05165,2-Amino-5-oxocyclohex-1-enecarbonyl-CoA;,C28H43N8O18P3S,2-Amino-5-oxocyclohex-1-enecarbonyl-CoA; 2-Amino-5-oxocyclohex-1-enecarboxyl-CoA,R03998 R03999 R05546,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.14.13.40,NA,NA,PubChem: 7580; ChEBI: 18206; NIKKAJI: J653.557G,cpd:C05165,28,43,18,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H44O18N8P3S1,C28H42O18N8P3S1,904.1628887,905.1707138,903.15506372699,3002,cpd:C05616,3-O-Methylgallate;,C8H8O5,3-O-Methylgallate; 3-O-Methylgallic acid,R03551 R04280 R09270 R09271 R09272,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.13.11.8; 1.13.11.-; 2.1.1.-,NA,NA,PubChem: 7935; ChEBI: 28647; 3DMET: B00809; NIKKAJI: J217.773K,cpd:C05580; cpd:C05616; cpd:C18724; cpd:C19071,8,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O5,C8H7O5,184.0371734,185.0449984,183.02934832700,3003,cpd:C06206,Benzoyl phosphate,C7H7O5P,Benzoyl phosphate,R01421,Aminobenzoate degradation; Microbial metabolism in diverse environments,3.6.1.7,NA,NA,CAS: 6659-26-3; PubChem: 8456; ChEBI: 3038; 3DMET: B00921; NIKKAJI: J1.084.447I,cpd:C06206,7,7,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O5P1,C7H6O5P1,202.0031103,203.0109354,200.99528532701,3004,cpd:C06317,Vanillyl alcohol;,C8H10O3,Vanillyl alcohol; 4-Hydroxy-3-methoxy-benzenemethanol; 4-Hydroxy-3-methoxybenzyl alcohol; 4-Hydroxy-3-methoxybenzenemethanol,R02877,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.1.3.38,NA,Major components of natural products [BR:br08323];  Crude drugs;   Gastrodia tuber;    C06317  Vanillyl alcohol,CAS: 498-00-0; PubChem: 8553; ChEBI: 18353; 3DMET: B00930; NIKKAJI: J28.483A,cpd:C06317; cpd:C10787; cpd:C12599; cpd:C16361; cpd:C18513; cpd:C18937; cpd:C21325; cpd:C21326,8,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O3,C8H9O3,154.0629942,155.0708192,153.05516912702,3005,cpd:C06335,4-Aminobenzenesulfonate;,C6H7NO3S,4-Aminobenzenesulfonate; 4-Aminobenzenesulfonic acid; p-Aminobenzenesulfonic acid; Sulfanilic acid,R05277 R05279,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.7.1.-; 1.14.12.-,NA,NA,CAS: 121-57-3; PubChem: 8571; ChEBI: 27500; ChEMBL: CHEMBL1566888; 3DMET: B00941; NIKKAJI: J2.924F,cpd:C06333; cpd:C06334; cpd:C06335,6,7,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O3N1S1,C6H6O3N1S1,173.0146643,174.0224893,172.00683922703,3006,cpd:C06604,Parathion;,C10H14NO5PS,"Parathion; O,O-Diethyl O-p-nitrophenyl phosphorothioate; Thiophos; DNTP",R05259 R05346 R05421 R08579,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.14.14.1; 1.14.-.-; 3.1.8.1,NA,Endocrine disrupting compounds [BR:br08006];  Pesticides and herbicides;   Others;    C06604  Parathion; Pesticides [BR:br08007];  Pesticides;   Insecticides;    Organophosphorus insecticides;     C06604  Parathion; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C06604  Parathion; Target-based classification of compounds [BR:br08010];  Enzymes;   Hydrolases;    ACHE; acetylcholinesterase;     C06604  Parathion,CAS: 56-38-2; PubChem: 8830; ChEBI: 27928; ChEMBL: CHEMBL261919; NIKKAJI: J2.318C,cpd:C06604,10,14,5,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O5N1P1S1,C10H13O5N1P1S1,291.0330307,292.0408558,290.02520572704,3007,cpd:C06605,Aminoparathion,C10H16NO3PS,Aminoparathion,R05346 R05485,Aminobenzoate degradation,NA,NA,Target-based classification of compounds [BR:br08010];  Enzymes;   Hydrolases;    ACHE; acetylcholinesterase;     C06605  Aminoparathion,CAS: 3735-01-1; PubChem: 8831; ChEBI: 28055; 3DMET: B00993; NIKKAJI: J124.965G,cpd:C06605,10,16,3,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O3N1P1S1,C10H15O3N1P1S1,261.0588516,262.0666766,260.05102652705,3008,cpd:C06606,Paraoxon;,C10H14NO6P,"Paraoxon; O,O-Diethyl-O-p-nitrophenylphosphoric acid",R05259 R05548 R08579,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.14.14.1; 1.14.-.-; 3.1.8.1,NA,Target-based classification of compounds [BR:br08010];  Enzymes;   Hydrolases;    ACHE; acetylcholinesterase;     C06606  Paraoxon; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS;     S01EB Parasympathomimetics;      S01EB10 Paraoxon;       D10529  Paraoxon; Target-based classification of drugs [BR:br08310];  Enzymes;   Hydrolases;    acetylcholinesterase (AChE);     Paraoxon;      D10529  Paraoxon,CAS: 311-45-5; PubChem: 8832; ChEBI: 27827; ChEMBL: CHEMBL23838; NIKKAJI: J5.657J,cpd:C06606,10,14,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O6N1P1,C10H13O6N1P1,275.0558742,276.0636992,274.04804912706,3009,cpd:C06607,Diethylthiophosphoric acid;,C4H11O3PS,Diethylthiophosphoric acid; DETP,R05421 R05485 R05486,Aminobenzoate degradation,3.1.8.1,NA,NA,CAS: 5871-17-0; PubChem: 8833; ChEBI: 28006; PDB-CCD: DPJ; 3DMET: B00994; NIKKAJI: J81.110F,cpd:C06607,4,11,3,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C4H12O3P1S1,C4H10O3P1S1,170.0166524,171.0244774,169.00882742707,3010,cpd:C06608,Diethylphosphoric acid;,C4H11O4P,"Diethylphosphoric acid; O,O-Diethylphosphoric acid",R05486 R05548,Aminobenzoate degradation,3.1.8.1,NA,NA,CAS: 598-02-7; PubChem: 8834; ChEBI: 27708; PDB-CCD: DPF; 3DMET: B00995; NIKKAJI: J1.649G,cpd:C06608,4,11,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H12O4P1,C4H10O4P1,154.0394958,155.0473209,153.03167082708,3011,cpd:C06672,Vanillate;,C8H8O4,Vanillate; Vanillic acid; 4-Hydroxy-3-methoxybenzoate; 4-Hydroxy-3-methoxybenzoic acid,R05273 R05274 R05699 R07668 R09278 R10136 R10259 R10296; R10297,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.2.1.67; 1.2.3.9; 1.14.13.82; 2.1.1.-; 2.4.1.300,NA,NA,CAS: 121-34-6; PubChem: 8897; ChEBI: 16632 30816; ChEMBL: CHEMBL120568; KNApSAcK: C00002682; PDB-CCD: VNL; 3DMET: B01021; NIKKAJI: J5.337F,cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272,8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O4,C8H7O4,168.0422587,169.0500838,167.03443372709,3012,cpd:C06673,4-Carboxy-4'-sulfoazobenzene,C13H10N2O5S,4-Carboxy-4'-sulfoazobenzene,R05277,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,NA,PubChem: 8898; ChEBI: 28585; 3DMET: B01022; NIKKAJI: J960.410C,cpd:C06673,13,10,5,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O5N2S1,C13H9O5N2S1,306.0310426,307.0388676,305.02321762710,3013,cpd:C06674,4-Sulfocatechol,C6H6O5S,4-Sulfocatechol,R05278 R05279,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.13.11.-; 1.14.12.-,NA,NA,CAS: 7134-09-0; PubChem: 8899; ChEBI: 20478 27758; PDB-CCD: 4SX; 3DMET: B01023; NIKKAJI: J166.321F,cpd:C06336; cpd:C06674,6,6,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O5S1,C6H5O5S1,189.9935945,191.0014195,188.98576942711,3014,cpd:C06675,3-Sulfomuconate,C6H6O7S,3-Sulfomuconate,R05278 R05394,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.13.11.-; 5.5.1.-,NA,NA,PubChem: 8900; ChEBI: 27942; 3DMET: B01024; NIKKAJI: J762.758K,cpd:C06675; cpd:C06676,6,6,7,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O7S1,C6H5O7S1,221.9834237,222.9912487,220.97559872712,3015,cpd:C06676,4-Sulfolactone;,C6H6O7S,4-Sulfolactone; 4-Carboxymethyl-4-sulfobut-2-en-4-olide; 4-Sulfomuconolactone,R05394 R05420,Aminobenzoate degradation; Microbial metabolism in diverse environments,3.1.1.92; 5.5.1.-,NA,NA,PubChem: 8901; ChEBI: 28947; NIKKAJI: J2.763.432J,cpd:C06675; cpd:C06676,6,6,7,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O7S1,C6H5O7S1,221.9834237,222.9912487,220.97559872713,3016,cpd:C06719,Dihydrophloroglucinol,C6H8O3,Dihydrophloroglucinol,R05308 R07831,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.3.1.57; 3.7.1.-,NA,NA,PubChem: 8942; ChEBI: 16370; 3DMET: B01032; NIKKAJI: J2.763.667E,cpd:C01125; cpd:C03636; cpd:C03680; cpd:C03817; cpd:C04397; cpd:C04398; cpd:C05568; cpd:C06719; cpd:C06761; cpd:C11354; cpd:C19468; cpd:C19481; cpd:C20240; cpd:C20385; cpd:C20443; cpd:C20717,6,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O3,C6H7O3,128.0473441,129.0551691,127.03951912714,3017,cpd:C06813,Nitrobenzene;,C6H5NO2,Nitrobenzene; Nitrobenzol,R05401 R07706,Aminobenzoate degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.7.1.-; 1.14.12.23,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C06813  Nitrobenzene,CAS: 98-95-3; PubChem: 9032; ChEBI: 27798; ChEMBL: CHEMBL15750; PDB-CCD: NBZ; 3DMET: B01056; NIKKAJI: J3.989F,cpd:C00253; cpd:C06813; cpd:C07446; cpd:C10164,6,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H6O2N1,C6H4O2N1,123.0320284,124.0398534,122.02420342715,3018,cpd:C06876,Nitrosobenzene,C6H5NO,Nitrosobenzene,R05400 R05401,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,NA,CAS: 586-96-9; PubChem: 9093; ChEBI: 27986; ChEMBL: CHEMBL98797; PDB-CCD: NBE; 3DMET: B01057; NIKKAJI: J71.610C,cpd:C06876; cpd:C07327; cpd:C17500,6,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H6O1N1,C6H4O1N1,107.0371138,108.0449388,106.02928882716,3019,cpd:C07301,(R)-Mandelamide,C8H9NO2,(R)-Mandelamide,R05783,Aminobenzoate degradation; Microbial metabolism in diverse environments,3.5.1.86,NA,NA,PubChem: 9509; ChEBI: 17352; NIKKAJI: J74.046B,cpd:C02012; cpd:C02709; cpd:C03005; cpd:C03522; cpd:C04350; cpd:C04353; cpd:C06804; cpd:C07301; cpd:C16571; cpd:C17239; cpd:C17755; cpd:C17756; cpd:C18623; cpd:C20634,8,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O2N1,C8H8O2N1,151.0633285,152.0711536,150.05550352717,3020,cpd:C08063,"1,4-Cyclohexanedione",C6H8O2,"1,4-Cyclohexanedione",R05546,Aminobenzoate degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 637-88-7; PubChem: 10263; ChEBI: 28286; 3DMET: B01109; NIKKAJI: J23.544J,cpd:C01066; cpd:C01078; cpd:C03633; cpd:C03798; cpd:C04091; cpd:C04221; cpd:C05828; cpd:C06105; cpd:C07458; cpd:C08063; cpd:C08502; cpd:C13693; cpd:C14149; cpd:C16182; cpd:C18508; cpd:C20522,6,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O2,C6H7O2,112.0524295,113.0602545,111.04460452718,3021,cpd:C09814,Benzonitrile;,C7H5N,Benzonitrile; Phenyl cyanide; Cyanobenzene,R05591 R05596 R07838,Aminobenzoate degradation; Microbial metabolism in diverse environments,3.5.5.1; 4.2.1.84,NA,NA,CAS: 100-47-0; PubChem: 12002; ChEBI: 27991; ChEMBL: CHEMBL15819; 3DMET: B01115; NIKKAJI: J3.590D,cpd:C03083; cpd:C03722; cpd:C04584; cpd:C09814; cpd:C10934; cpd:C11041; cpd:C12283; cpd:C13104; cpd:C14437; cpd:C16234; cpd:C16246; cpd:C18625; cpd:C19056; cpd:C19789; cpd:C20367,7,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H6N1,C7H4N1,103.0421992,104.0500242,102.03437412719,3022,cpd:C09815,Benzamide,C7H7NO,Benzamide,R05590 R05596,Aminobenzoate degradation; Microbial metabolism in diverse environments,3.5.1.4; 4.2.1.84,NA,NA,CAS: 55-21-0; PubChem: 12003; ChEBI: 28179; ChEMBL: CHEMBL267373; KNApSAcK: C00042277; PDB-CCD: UNU; 3DMET: B01116; NIKKAJI: J1.374I,cpd:C09815; cpd:C16283,7,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O1N1,C7H6O1N1,121.0527638,122.0605889,120.04493882720,3023,cpd:C10833,Syringic acid;,C9H10O5,"Syringic acid; Syringate; 4-Hydroxy-3,5-dimethoxybenzoate; Gallic acid 3,5-dimethyl ether",R09270,Aminobenzoate degradation; Microbial metabolism in diverse environments,2.1.1.-,NA,NA,CAS: 530-57-4; PubChem: 13016; ChEBI: 68329; ChEMBL: CHEMBL1414; KNApSAcK: C00002674; 3DMET: B04167; NIKKAJI: J11.712I,cpd:C01207; cpd:C05584; cpd:C10833; cpd:C18702; cpd:C21086,9,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O5,C9H9O5,198.0528234,199.0606485,197.04499842721,3024,cpd:C14418,3-Nitrophenol;,C6H5NO3,3-Nitrophenol; m-Hydroxynitrobenzene,R09288,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,NA,CAS: 554-84-7; PubChem: 17395418; ChEBI: 34346; ChEMBL: CHEMBL13888; NIKKAJI: J2.655G,cpd:C00870; cpd:C01020; cpd:C01988; cpd:C14418; cpd:C18620,6,5,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H6O3N1,C6H4O3N1,139.026943,140.0347681,138.0191182722,3025,cpd:C14602,3-Hydroxyaminophenol;,C6H7NO2,3-Hydroxyaminophenol; 3-Hydroxylaminophenol,R06988 R09284 R09288,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.7.1.-; 5.4.4.3,NA,NA,PubChem: 17395602; NIKKAJI: J832.953B,cpd:C02441; cpd:C02854; cpd:C14602; cpd:C14604; cpd:C16671; cpd:C18351,6,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O2N1,C6H6O2N1,125.0476785,126.0555035,124.03985342723,3026,cpd:C14604,Aminohydroquinone,C6H7NO2,Aminohydroquinone,R06988 R09287,Aminobenzoate degradation; Microbial metabolism in diverse environments,5.4.4.3,NA,NA,PubChem: 17395604; NIKKAJI: J305.036J,cpd:C02441; cpd:C02854; cpd:C14602; cpd:C14604; cpd:C16671; cpd:C18351,6,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O2N1,C6H6O2N1,125.0476785,126.0555035,124.03985342724,3027,cpd:C16200,Phenylboronic acid;,C6H7BO2,Phenylboronic acid; Benzeneboronic acid,R07697,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.14.-.-,NA,NA,CAS: 98-80-6; PubChem: 47205508; ChEBI: 44923; ChEMBL: CHEMBL21485; PDB-CCD: PBC; NIKKAJI: J119.652I,cpd:C16200,6,7,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,C6H8O2B1,C6H6O2B1,122.0522645,123.0600895,121.04443942725,3028,cpd:C16234,o-Nitrobenzoate;,C7H5NO4,o-Nitrobenzoate; 2-Nitrobenzoic acid,R07727,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,NA,CAS: 552-16-9; PubChem: 47205542; ChEBI: 25620; ChEMBL: CHEMBL114719; NIKKAJI: J1.613F,cpd:C03722; cpd:C16234; cpd:C18625,7,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H6O4N1,C7H4O4N1,167.0218576,168.0296827,166.01403262726,3029,cpd:C16235,o-Hydroxylaminobenzoate;,C7H7NO3,o-Hydroxylaminobenzoate; 2-Hydroxylaminobenzoic acid,R07727 R07730 R07734,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.4.-.-; 1.7.1.-; 5.4.99.-,NA,NA,PubChem: 47205543; ChEBI: 25618; KNApSAcK: C00007557; NIKKAJI: J1.228.969C,cpd:C00632; cpd:C01270; cpd:C02518; cpd:C06669; cpd:C07555; cpd:C11343; cpd:C12107; cpd:C12115; cpd:C14520; cpd:C16235; cpd:C19270,7,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O3N1,C7H6O3N1,153.0425931,154.0504181,152.03476812727,3030,cpd:C16267,Cyclopropanecarboxylate,C4H6O2,Cyclopropanecarboxylate,R07828,Aminobenzoate degradation; Microbial metabolism in diverse environments,6.2.1.-,NA,NA,CAS: 1759-53-1; PubChem: 47205575; ChEBI: 23500; NIKKAJI: J23.483D,cpd:C00429; cpd:C00741; cpd:C01770; cpd:C01771; cpd:C01892; cpd:C02065; cpd:C02248; cpd:C02497; cpd:C02512; cpd:C02565; cpd:C02743; cpd:C02777; cpd:C06143; cpd:C08311; cpd:C11551; cpd:C11552; cpd:C12282; cpd:C13695; cpd:C15811; cpd:C15812; cpd:C16267; cpd:C16835; cpd:C19118; cpd:C19201; cpd:C19309; cpd:C19443; cpd:C19546; cpd:C21440,4,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O2,C4H5O2,86.03677943,87.04460446,85.02895442728,3031,cpd:C16268,Cyclopropanecarboxyl-CoA,C25H40N7O17P3S,Cyclopropanecarboxyl-CoA,R07828 R07829,Aminobenzoate degradation; Microbial metabolism in diverse environments,5.5.1.-; 6.2.1.-,NA,NA,CAS: 52530-01-5; PubChem: 47205576; ChEBI: 80410; NIKKAJI: J2.799.289G,cpd:C00877; cpd:C02331; cpd:C03460; cpd:C16268,25,40,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O17N7P3S1,C25H39O17N7P3S1,835.141425,836.1492501,834.13362729,3032,cpd:C16272,3-Hydroxy-5-oxohexanoate,C6H10O4,3-Hydroxy-5-oxohexanoate,R07831 R07832,Aminobenzoate degradation; Microbial metabolism in diverse environments,2.8.3.8; 3.7.1.-,NA,NA,CAS: 109138-72-9; PubChem: 47205580; ChEBI: 37032; NIKKAJI: J2.799.329J,cpd:C00439; cpd:C00659; cpd:C00772; cpd:C00966; cpd:C01053; cpd:C04237; cpd:C04327; cpd:C04556; cpd:C06006; cpd:C06104; cpd:C06762; cpd:C13811; cpd:C14463; cpd:C16272; cpd:C16674; cpd:C18379; cpd:C18384; cpd:C18719; cpd:C21465,6,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O4,C6H9O4,146.0579088,147.0657338,145.05008382730,3033,cpd:C16273,3-Hydroxy-5-oxohexanoyl-CoA,C27H44N7O19P3S,3-Hydroxy-5-oxohexanoyl-CoA,R07832 R07833,Aminobenzoate degradation; Microbial metabolism in diverse environments,2.3.1.-; 2.8.3.8,NA,NA,PubChem: 47205581; ChEBI: 20052; NIKKAJI: J2.799.346J,cpd:C14143; cpd:C16273; cpd:C18834,27,44,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O19N7P3S1,C27H43O19N7P3S1,895.1625544,896.1703794,894.15472942731,3034,cpd:C16281,Thiobenzamide,C7H7NS,Thiobenzamide,R07836,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.14.13.-,NA,NA,CAS: 2227-79-4; PubChem: 47205589; ChEBI: 80418; NIKKAJI: J29.488H,cpd:C14520; cpd:C16281; cpd:C16283; cpd:C16285,7,7,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H8N1S1,C7H6N1S1,137.0299204,138.0377454,136.02209542732,3035,cpd:C16283,Thiobenzamide S-oxide,C7H7NOS,Thiobenzamide S-oxide,R07836 R07837,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.14.13.-,NA,NA,CAS: 20199-04-6; PubChem: 47205591; ChEBI: 80420; NIKKAJI: J576.126C,cpd:C16283,7,7,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O1N1S1,C7H6O1N1S1,153.024835,154.0326601,152.017012733,3036,cpd:C16285,"Thiobenzamide S,S-dioxide",C7H7NO2S,"Thiobenzamide S,S-dioxide",R07837 R07838,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.14.13.-,NA,NA,PubChem: 47205593; ChEBI: 80422; NIKKAJI: J2.799.374E,cpd:C16285,7,7,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O2N1S1,C7H6O2N1S1,169.0197496,170.0275747,168.01192462734,3037,cpd:C18338,5-Carboxyvanillic acid;,C9H8O6,"5-Carboxyvanillic acid; 5-Carboxyvanillate; 4-Hydroxy-5-methoxy-1,3-benzenedicarboxylate; 4-Hydroxy-5-methoxyisophthalate",R09277 R09278,Aminobenzoate degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 2134-91-0; PubChem: 124489012; ChEBI: 81684,cpd:C04366; cpd:C12624; cpd:C18338,9,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O6,C9H7O6,212.032088,213.039913,211.02426292735,3038,cpd:C18345,"4-Carboxy-2-hydroxy-6-methoxy-6-oxohexa-2,4-dienoate",C8H8O7,"4-Carboxy-2-hydroxy-6-methoxy-6-oxohexa-2,4-dienoate",R09272 R09273 R09274,Aminobenzoate degradation; Microbial metabolism in diverse environments,1.13.11.8; 1.13.11.-,NA,NA,PubChem: 124489019; ChEBI: 81691,cpd:C04052; cpd:C04186; cpd:C18345,8,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O7,C8H7O7,216.0270026,217.0348276,215.01917762736,3039,cpd:C18347,"5,5'-Dehydrodivanillate",C16H14O8,"5,5'-Dehydrodivanillate",R09275,Aminobenzoate degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 2134-90-9; PubChem: 124489021; ChEBI: 81693,cpd:C09770; cpd:C18347,16,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O8,C16H13O8,334.0688674,335.0766924,333.06104242737,3040,cpd:C18348,"2,2',3-Trihydroxy-3'-methoxy-5,5'-dicarboxybiphenyl",C15H12O8,"2,2',3-Trihydroxy-3'-methoxy-5,5'-dicarboxybiphenyl",R09275 R09276,Aminobenzoate degradation; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 124489022; ChEBI: 81694,cpd:C02906; cpd:C03052; cpd:C18348,15,12,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O8,C15H11O8,320.0532173,321.0610424,319.04539232738,3041,cpd:C18349,4-[2-(5-Carboxy-2-hydroxy-3-methoxyphenyl)-2-oxoethylidene]-2-hydroxy-2-pentenedioate,C15H12O10,4-[2-(5-Carboxy-2-hydroxy-3-methoxyphenyl)-2-oxoethylidene]-2-hydroxy-2-pentenedioate,R09276 R09277,Aminobenzoate degradation; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 124489023; ChEBI: 81695,cpd:C18349,15,12,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O10,C15H11O10,352.0430466,353.0508716,351.03522162739,3042,cpd:C18351,4-Aminocatechol;,C6H7NO2,"4-Aminocatechol; 4-Amino-1,2-benzenediol; 3,4-Dihydroxyaniline",R09284 R09285,Aminobenzoate degradation; Microbial metabolism in diverse environments,5.4.4.3,NA,NA,CAS: 13047-04-6; PubChem: 124489025; ChEBI: 81697,cpd:C02441; cpd:C02854; cpd:C14602; cpd:C14604; cpd:C16671; cpd:C18351,6,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O2N1,C6H6O2N1,125.0476785,126.0555035,124.03985342740,3044,cpd:C00313,Oxalyl-CoA,C23H36N7O19P3S,Oxalyl-CoA,R00468 R01558 R01559 R01908 R04211 R07290 R10614,Glyoxylate and dicarboxylate metabolism; Metabolic pathways,1.2.1.17; 2.3.1.58; 2.8.3.2; 2.8.3.16; 2.8.3.19; 4.1.1.8; 6.2.1.8,NA,NA,PubChem: 3607; ChEBI: 15535; PDB-CCD: OXK; 3DMET: B04666; NIKKAJI: J2.729.378F,cpd:C00313; cpd:C03188,23,36,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C23H37O19N7P3S1,C23H35O19N7P3S1,839.0999541,840.1077792,838.09212912741,3045,cpd:C00552,meso-Tartaric acid;,C4H6O6,meso-Tartaric acid; meso-Tartrate,R02544 R02545 R02546 R02547,Glyoxylate and dicarboxylate metabolism,1.1.1.93; 1.3.1.7; 3.3.2.4; 5.1.2.5,NA,NA,CAS: 147-73-9; PubChem: 3833; ChEBI: 15673; ChEMBL: CHEMBL225983; PDB-CCD: SRT; 3DMET: B04699; NIKKAJI: J134.706C,cpd:C00552; cpd:C00898; cpd:C02107; cpd:C12959; cpd:C13500,4,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O6,C4H5O6,150.0164379,151.0242629,149.00861292742,3046,cpd:C00798,Formyl-CoA,C22H36N7O17P3S,Formyl-CoA,R00521 R01908 R07290,Glyoxylate and dicarboxylate metabolism; Metabolic pathways,2.8.3.16; 3.1.2.10; 4.1.1.8,NA,NA,PubChem: 4056; ChEBI: 15522; PDB-CCD: FYN; 3DMET: B04726; NIKKAJI: J838.103H,cpd:C00798,22,36,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C22H37O17N7P3S1,C22H35O17N7P3S1,795.1101249,796.1179499,794.10229992743,3047,cpd:C00888,Pentanoyl-CoA;,C26H44N7O17P3S,Pentanoyl-CoA; Valeryl-coenzyme A,R03040,Glyoxylate and dicarboxylate metabolism,2.3.3.12,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C00888  Pentanoyl-CoA,CAS: 4752-33-4; PubChem: 4144; ChEBI: 15536; 3DMET: B04745,cpd:C00888; cpd:C01033; cpd:C02939; cpd:C15980,26,44,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H45O17N7P3S1,C26H43O17N7P3S1,851.1727252,852.1805502,850.16490012744,3048,cpd:C00898,"(R,R)-Tartaric acid;",C4H6O6,"(R,R)-Tartaric acid; (R,R)-Tartrate; L-Tartaric acid; Tartaric acid; Tartrate; 2,3-Dihydroxybutanedioic acid; (2R,3R)-Tartaric acid; (+)-Tartaric acid",R00339 R01751 R02546 R06180,Glyoxylate and dicarboxylate metabolism,1.1.1.93; 4.1.1.73; 4.2.1.32; 5.1.2.5,NA,"Therapeutic category of drugs in Japan [BR:br08301];  7  Agents not mainly for therapeutic purpose;   71  Dispensing medicines;    714  Flavorings, deodorants, coloring agents;     7149  Others;      D00103  Tartaric acid (JP17/NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00103  [001325] Tartaric acid;  Solubilizing agent;   D00103  [001325] Tartaric acid;  Buffering agent;   D00103  [001325] Tartaric acid;  Base;   D00103  [001325] Tartaric acid;  Flavoring substance;   D00103  [001325] Tartaric acid;  Bloating agent;   D00103  [001325] Tartaric acid;  pH regulator;   D00103  [001325] Tartaric acid;  Diluting agent;   D00103  [001325] Tartaric acid;  Solubilizer;   D00103  [001325] Tartaric acid;  Solubilization agent;   D00103  [001325] Tartaric acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00103  Tartaric acid",CAS: 87-69-4; PubChem: 4154; ChEBI: 15671 15674 30924; ChEMBL: CHEMBL1236315; KNApSAcK: C00001206; PDB-CCD: TLA; 3DMET: B04747; NIKKAJI: J31.839F,cpd:C00552; cpd:C00898; cpd:C02107; cpd:C12959; cpd:C13500,4,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O6,C4H5O6,150.0164379,151.0242629,149.00861292745,3049,cpd:C00975,Dihydroxyfumarate;,C4H4O6,Dihydroxyfumarate; Dihydroxyfumaric acid,R01390 R02544 R03127 R03128,Glyoxylate and dicarboxylate metabolism,1.3.1.7; 4.1.1.54,NA,NA,CAS: 133-38-0; PubChem: 4224; ChEBI: 17795 4593; ChEMBL: CHEMBL41028; LIPIDMAPS: LMFA01060194; 3DMET: B00211; NIKKAJI: J69.683H,cpd:C00975; cpd:C03459,4,4,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H5O6,C4H3O6,148.0007878,149.0086129,146.99296282746,3050,cpd:C00988,2-Phosphoglycolate;,C2H5O6P,2-Phosphoglycolate; Phosphoglycolic acid,R01334 R03140,Glyoxylate and dicarboxylate metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics; Carbon metabolism,3.1.3.18; 4.1.1.39,Photorespiration,NA,PubChem: 4234; ChEBI: 17150; ChEMBL: CHEMBL47181; KNApSAcK: C00007561; PDB-CCD: PGA; 3DMET: B00215; NIKKAJI: J631.157A,cpd:C00988,2,5,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H6O6P1,C2H4O6P1,155.9823749,156.9901999,154.97454982747,3051,cpd:C01127,4-Hydroxy-2-oxoglutarate;,C5H6O6,4-Hydroxy-2-oxoglutarate; 4-Hydroxy-2-oxoglutaric acid,R00470 R03266,Glyoxylate and dicarboxylate metabolism,2.6.1.23; 4.1.3.16; 4.1.3.42,NA,NA,PubChem: 4358; ChEBI: 17742 30923; 3DMET: B00245; NIKKAJI: J536.231H,cpd:C01127; cpd:C05946; cpd:C20485,5,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O6,C5H5O6,162.0164379,163.0242629,161.00861292748,3052,cpd:C01182,"D-Ribulose 1,5-bisphosphate",C5H12O11P2,"D-Ribulose 1,5-bisphosphate",R00024 R01523 R03140 R10555,Glyoxylate and dicarboxylate metabolism; Carbon fixation in photosynthetic organisms; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Biosynthesis of antibiotics; Carbon metabolism,2.7.1.19; 4.1.1.39; 5.3.1.29,"Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P; Photorespiration",NA,CAS: 24218-00-6; PubChem: 4409; ChEBI: 16710; KNApSAcK: C00007293; PDB-CCD: RUB; 3DMET: B04779; NIKKAJI: J531.240J,cpd:C01095; cpd:C01151; cpd:C01182; cpd:C20986,5,12,11,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O11P2,C5H11O11P2,309.9854852,310.9933102,308.97766022749,3053,cpd:C01732,Mesaconate;,C5H6O4,Mesaconate; 2-Methylfumarate; Mesaconic acid; Methylfumaric acid; (E)-2-Methyl-2-butenedioic acid,R03693 R03694 R03695 R03696 R10904,Glyoxylate and dicarboxylate metabolism; C5-Branched dibasic acid metabolism; Metabolic pathways; Carbon metabolism,2.8.3.-; 4.2.1.34; 4.3.1.2,Methylaspartate cycle,NA,CAS: 498-24-8; PubChem: 4868; ChEBI: 16600 36986; LIPIDMAPS: LMFA01170116; PDB-CCD: MEZ; 3DMET: B00338; NIKKAJI: J6.107G,cpd:C00337; cpd:C00433; cpd:C00490; cpd:C01732; cpd:C02132; cpd:C02214; cpd:C02226; cpd:C02800; cpd:C02871; cpd:C03306; cpd:C03703; cpd:C10600; cpd:C20756; cpd:C20757,5,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O4,C5H5O4,130.0266087,131.0344337,129.01878362750,3054,cpd:C01989,3-Ethylmalate,C6H10O5,3-Ethylmalate,R01180,Glyoxylate and dicarboxylate metabolism,2.3.3.7,NA,NA,PubChem: 5086; ChEBI: 15591; 3DMET: B04828; NIKKAJI: J1.306.755D,cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335,6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5,C6H9O5,162.0528234,163.0606485,161.04499842751,3055,cpd:C01990,3-Oxalomalate;,C6H6O8,3-Oxalomalate; 3-Oxalomalic acid,R00477,Glyoxylate and dicarboxylate metabolism,4.1.3.13,NA,NA,CAS: 3687-15-8; PubChem: 5087; ChEBI: 15593 30926; 3DMET: B04829,cpd:C01990,6,6,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O8,C6H5O8,206.0062671,207.0140922,204.99844212752,3056,cpd:C02123,3-Propylmalate,C7H12O5,3-Propylmalate,R03040,Glyoxylate and dicarboxylate metabolism,2.3.3.12,NA,NA,PubChem: 5202; ChEBI: 15594 30850; LIPIDMAPS: LMFA01170064; 3DMET: B04839; NIKKAJI: J2.735.522F,cpd:C02123; cpd:C02504; cpd:C03328; cpd:C04411; cpd:C05994; cpd:C17210; cpd:C17212; cpd:C21371,7,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O5,C7H11O5,176.0684735,177.0762985,175.06064852753,3057,cpd:C02405,Formyl phosphate,CH3O5P,Formyl phosphate,R00518,Glyoxylate and dicarboxylate metabolism,2.7.2.6,NA,NA,PubChem: 5438; ChEBI: 16729; PDB-CCD: XPO; 3DMET: B00441; NIKKAJI: J852.762H,cpd:C02405; cpd:C06456,1,3,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H4O5P1,C1H2O5P1,125.9718102,126.9796352,124.96398522754,3058,cpd:C03217,2-Hydroxy-3-oxoadipate,C6H8O6,2-Hydroxy-3-oxoadipate,R00474,Glyoxylate and dicarboxylate metabolism,2.2.1.5,NA,NA,PubChem: 6090; ChEBI: 16278; 3DMET: B00561; NIKKAJI: J2.369.068C,cpd:C00072; cpd:C00470; cpd:C01768; cpd:C02670; cpd:C03217; cpd:C03289; cpd:C03387; cpd:C04053; cpd:C04349; cpd:C04471; cpd:C04810; cpd:C05144; cpd:C05392; cpd:C06033; cpd:C06430; cpd:C06440; cpd:C19806; cpd:C20364,6,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O6,C6H7O6,176.032088,177.039913,175.02426292755,3059,cpd:C03459,2-Hydroxy-3-oxosuccinate;,C4H4O6,2-Hydroxy-3-oxosuccinate; Oxaloglycolate,R01749 R01750 R02545 R03128 R06180,Glyoxylate and dicarboxylate metabolism,1.1.1.92; 1.1.1.93,NA,NA,PubChem: 6279; ChEBI: 17778; 3DMET: B00587; NIKKAJI: J1.796.992G,cpd:C00975; cpd:C03459,4,4,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H5O6,C4H3O6,148.0007878,149.0086129,146.99296282756,3060,cpd:C03548,"trans-2,3-Epoxysuccinate",C4H4O5,"trans-2,3-Epoxysuccinate",R02547,Glyoxylate and dicarboxylate metabolism,3.3.2.4,NA,NA,PubChem: 6351; ChEBI: 15900; PDB-CCD: EPO; 3DMET: B01670; NIKKAJI: J135.998C,cpd:C00036; cpd:C03548; cpd:C03981; cpd:C20341,4,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H5O5,C4H3O5,132.0058732,133.0136983,130.99804822757,3061,cpd:C03618,L-threo-3-Methylaspartate;,C5H9NO4,"L-threo-3-Methylaspartate; (2S,3S)-3-Methylaspartate",R00262 R03696 R04269,Glyoxylate and dicarboxylate metabolism; C5-Branched dibasic acid metabolism; Metabolic pathways; Carbon metabolism,4.3.1.2; 5.4.99.1,Methylaspartate cycle,NA,PubChem: 6402; ChEBI: 47980; ChEMBL: CHEMBL274998 CHEMBL76739; PDB-CCD: 2AS; 3DMET: B01676; NIKKAJI: J750.143I,cpd:C00025; cpd:C00217; cpd:C00302; cpd:C00979; cpd:C03618; cpd:C03727; cpd:C03790; cpd:C05574; cpd:C05938; cpd:C05941; cpd:C12269,5,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O4N1,C5H8O4N1,147.0531578,148.0609828,146.04533272758,3062,cpd:C04348,L-Malyl-CoA;,C25H40N7O20P3S,L-Malyl-CoA; (S)-Malyl-CoA; Malyl-CoA; (3S)-3-Carboxy-3-hydroxypropanoyl-CoA; (3S)-3-Carboxy-3-hydroxypropionyl-CoA,R00406 R00473 R01256 R10612,Glyoxylate and dicarboxylate metabolism; Methane metabolism; Carbon fixation pathways in prokaryotes; Microbial metabolism in diverse environments; Carbon metabolism,2.8.3.22; 3.1.2.30; 4.1.3.24; 6.2.1.9,"Formaldehyde assimilation, serine pathway; Ethylmalonyl pathway; 3-Hydroxypropionate bi-cycle; Methylaspartate cycle",NA,PubChem: 6997; ChEBI: 15454; 3DMET: B04937; NIKKAJI: J2.750.198B,cpd:C04348; cpd:C20747,25,40,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O20N7P3S1,C25H39O20N7P3S1,883.1261689,884.1339939,882.11834382759,3063,cpd:C06027,L-erythro-3-Methylmalyl-CoA;,C26H42N7O20P3S,"L-erythro-3-Methylmalyl-CoA; beta-Methylmalyl-CoA; (2R,3S)-2-Methylmalyl-CoA; L-erythro-beta-Methylmalyl-CoA; (2R,3S)-2-Methyl-3-carboxy-3-hydroxypropanoyl-CoA",R00934 R05076,Glyoxylate and dicarboxylate metabolism; C5-Branched dibasic acid metabolism; Carbon fixation pathways in prokaryotes; Microbial metabolism in diverse environments; Carbon metabolism,4.1.3.24; 4.2.1.148,Ethylmalonyl pathway; 3-Hydroxypropionate bi-cycle; Methylaspartate cycle,NA,PubChem: 8299; 3DMET: B05151; NIKKAJI: J2.760.961I,cpd:C00904; cpd:C01011; cpd:C03058; cpd:C06027; cpd:C20746,26,42,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H43O20N7P3S1,C26H41O20N7P3S1,897.1418189,898.149644,896.13399392760,3064,cpd:C06028,2-Methylfumaryl-CoA;,C26H40N7O19P3S,2-Methylfumaryl-CoA; Mesaconyl-CoA; Mesaconyl-C1-CoA; (E)-3-Carboxy-2-methylprop-2-enoyl-CoA,R03695 R05076 R09283 R09293 R10904,Glyoxylate and dicarboxylate metabolism; C5-Branched dibasic acid metabolism; Carbon fixation pathways in prokaryotes; Microbial metabolism in diverse environments; Carbon metabolism,1.3.8.12; 2.8.3.-; 4.2.1.148; 5.4.1.3,Ethylmalonyl pathway; 3-Hydroxypropionate bi-cycle; Methylaspartate cycle,NA,PubChem: 8300; ChEBI: 27969; 3DMET: B05152; NIKKAJI: J2.760.962G,cpd:C00531; cpd:C02411; cpd:C06028; cpd:C18323,26,40,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H41O19N7P3S1,C26H39O19N7P3S1,879.1312543,880.1390793,878.12342922761,3066,cpd:C18026,(2S)-Ethylmalonyl-CoA;,C26H42N7O19P3S,(2S)-Ethylmalonyl-CoA; (S)-Ethylmalonyl-CoA; Ethylmalonyl-CoA; Ethylmalonyl coenzyme A,R06448 R08924 R09291 R09958 R09979,Glyoxylate and dicarboxylate metabolism; Microbial metabolism in diverse environments; Carbon metabolism,1.3.1.85; 4.1.1.94; 5.1.99.1; 6.4.1.3,Ethylmalonyl pathway,NA,PubChem: 96024246; ChEBI: 81456; NIKKAJI: J890.615G,cpd:C00527; cpd:C18026; cpd:C18324; cpd:C20238,26,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H43O19N7P3S1,C26H41O19N7P3S1,881.1469043,882.1547294,880.13907932762,3067,cpd:C18324,(2S)-Methylsuccinyl-CoA;,C26H42N7O19P3S,(2S)-Methylsuccinyl-CoA; Methylsuccinyl-CoA; Methylsuccinyl-coenzyme A,R09292 R09293,Glyoxylate and dicarboxylate metabolism; Microbial metabolism in diverse environments; Carbon metabolism,1.3.8.12; 5.4.99.63,Ethylmalonyl pathway,NA,PubChem: 103061505; ChEBI: 81672,cpd:C00527; cpd:C18026; cpd:C18324; cpd:C20238,26,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H43O19N7P3S1,C26H41O19N7P3S1,881.1469043,882.1547294,880.13907932763,3068,cpd:C20238,(2R)-Ethylmalonyl-CoA,C26H42N7O19P3S,(2R)-Ethylmalonyl-CoA,R09292 R09979,Glyoxylate and dicarboxylate metabolism; Microbial metabolism in diverse environments; Carbon metabolism,5.1.99.1; 5.4.99.63,Ethylmalonyl pathway,NA,PubChem: 163311981,cpd:C00527; cpd:C18026; cpd:C18324; cpd:C20238,26,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H43O19N7P3S1,C26H41O19N7P3S1,881.1469043,882.1547294,880.13907932764,3069,cpd:C11006,"2,4-Dinitrotoluene;",C7H6N2O4,"2,4-Dinitrotoluene; 2,4-DNT",R09231 R09232 R09233 R09241 R09242,Nitrotoluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.7.1.-; 1.14.12.24,NA,"Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C11006  2,4-Dinitrotoluene",CAS: 121-14-2; PubChem: 13189; ChEBI: 920; ChEMBL: CHEMBL259865; NIKKAJI: J2.922J,cpd:C11006; cpd:C11008; cpd:C14306; cpd:C19410; cpd:C19788,7,6,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O4N2,C7H5O4N2,182.0327567,183.0405817,181.02493162765,3070,cpd:C14401,"2,4-Diaminotoluene",C7H10N2,"2,4-Diaminotoluene",R09230 R09235 R09240 R09243,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,"Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C14401  2,4-Diaminotoluene",CAS: 95-80-7; PubChem: 17395401; ChEBI: 34237; ChEMBL: CHEMBL541230; NIKKAJI: J3.958F,cpd:C03531; cpd:C03994; cpd:C04142; cpd:C07106; cpd:C07569; cpd:C07615; cpd:C11765; cpd:C13672; cpd:C14401; cpd:C19218; cpd:C19386; cpd:C19482; cpd:C20961; cpd:C21468,7,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11N2,C7H9N2,122.0843983,123.0922234,121.07657332766,3071,cpd:C16391,Trinitrotoluene;,C7H5N3O6,"Trinitrotoluene; 2,4,6-Trinitrotoluene",R08014 R08017 R08042,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.-.-.-,NA,"Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C16391  2,4,6-Trinitrotoluene",CAS: 118-96-7; PubChem: 47205689; ChEBI: 46053; ChEMBL: CHEMBL1236345; PDB-CCD: TNL; NIKKAJI: J2.477E,cpd:C16391,7,5,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H6O6N3,C7H4O6N3,227.0178349,228.0256599,226.01000992767,3072,cpd:C16392,"4-Hydroxylamino-2,6-dinitrotoluene",C7H7N3O5,"4-Hydroxylamino-2,6-dinitrotoluene",R08014 R08015 R08017 R08018 R08019 R08020 R08037,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.7.1.-; 1.-.-.-,NA,NA,CAS: 59283-75-9; PubChem: 47205690; ChEBI: 20408; NIKKAJI: J652.388I,cpd:C16392; cpd:C16393,7,7,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O5N3,C7H6O5N3,213.0385703,214.0463954,212.03074532768,3073,cpd:C16393,"2-Hydroxylamino-4,6-dinitrotoluene",C7H7N3O5,"2-Hydroxylamino-4,6-dinitrotoluene",R08037 R08038 R08042 R08043,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.7.1.-; 1.-.-.-,NA,NA,CAS: 59283-76-0; PubChem: 47205691; ChEBI: 19644; NIKKAJI: J429.387H,cpd:C16392; cpd:C16393,7,7,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O5N3,C7H6O5N3,213.0385703,214.0463954,212.03074532769,3074,cpd:C16394,"4-Amino-2,6-dinitrotoluene",C7H7N3O4,"4-Amino-2,6-dinitrotoluene",R08018 R08019 R08046 R08047,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,NA,CAS: 19406-51-0; PubChem: 47205692; ChEBI: 77424; NIKKAJI: J489.741B,cpd:C16394; cpd:C16395,7,7,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O4N3,C7H6O4N3,197.0436557,198.0514807,196.03583072770,3075,cpd:C16395,"2-Amino-4,6-dinitrotoluene",C7H7N3O4,"2-Amino-4,6-dinitrotoluene",R08033 R08043 R08044 R08045,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,NA,CAS: 35572-78-2; PubChem: 47205693; ChEBI: 19452; NIKKAJI: J48.076B,cpd:C16394; cpd:C16395,7,7,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O4N3,C7H6O4N3,197.0436557,198.0514807,196.03583072771,3076,cpd:C16396,"2,4-Diamino-6-nitrotoluene",C7H9N3O2,"2,4-Diamino-6-nitrotoluene",R08027 R08034 R08036 R08045 R08046 R08049,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.2.7.1; 1.2.7.4; 1.7.1.-; 1.12.99.6; 2.3.1.5,NA,NA,CAS: 6629-29-4; PubChem: 47205694; ChEBI: 19342; NIKKAJI: J499.320I,cpd:C16396; cpd:C16397,7,9,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O2N3,C7H8O2N3,167.0694765,168.0773016,166.06165152772,3077,cpd:C16397,"2,6-Diamino-4-nitrotoluene",C7H9N3O2,"2,6-Diamino-4-nitrotoluene",R08030 R08044,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,NA,CAS: 59229-75-3; PubChem: 47205695; ChEBI: 19389; NIKKAJI: J90.032J,cpd:C16396; cpd:C16397,7,9,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O2N3,C7H8O2N3,167.0694765,168.0773016,166.06165152773,3078,cpd:C16398,2-Amino-4-nitrotoluene;,C7H8N2O2,2-Amino-4-nitrotoluene; 5-Nitro-o-toluidine,R08033 R09230 R09231 R09240 R09241,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C16398  5-Nitro-o-toluidine,CAS: 99-55-8; PubChem: 47205696; ChEBI: 66891; ChEMBL: CHEMBL324642; NIKKAJI: J95.089K,cpd:C05842; cpd:C05843; cpd:C16398; cpd:C18320,7,8,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O2N2,C7H7O2N2,152.0585775,153.0664025,151.05075252774,3079,cpd:C16399,"2,4-Diamino-6-hydroxylaminotoluene",C7H11N3O,"2,4-Diamino-6-hydroxylaminotoluene",R08034 R08035,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.2.7.1; 1.2.7.4; 1.8.99.5; 1.12.99.6,NA,NA,PubChem: 47205697; NIKKAJI: J1.347.981J,cpd:C05135; cpd:C16399,7,11,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O1N3,C7H10O1N3,153.090212,154.098037,152.0823872775,3080,cpd:C16400,"2,4,6-Triaminotoluene",C7H11N3,"2,4,6-Triaminotoluene",R08027 R08030 R08035 R08040,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.8.99.5,NA,NA,CAS: 88-02-8; PubChem: 47205698; ChEBI: 19332; NIKKAJI: J192.651I,cpd:C01152; cpd:C02315; cpd:C02461; cpd:C03298; cpd:C05135; cpd:C16399; cpd:C16400; cpd:C20858; cpd:C20966; cpd:C20967,7,11,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12N3,C7H10N3,137.0952974,138.1031224,136.08747232776,3081,cpd:C16401,"2,4,6-Trihydroxytoluene;",C7H8O3,"2,4,6-Trihydroxytoluene; 2-Methylphloroglucinol",R08040 R08041,Nitrotoluene degradation; Microbial metabolism in diverse environments,NA,NA,NA,CAS: 88-03-9; PubChem: 47205699; ChEBI: 19336; NIKKAJI: J4.284F,cpd:C03095; cpd:C03338; cpd:C06677; cpd:C10792; cpd:C13129; cpd:C14110; cpd:C16356; cpd:C16360; cpd:C16401; cpd:C18317; cpd:C19469; cpd:C20362,7,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O3,C7H7O3,140.0473441,141.0551691,139.03951912777,3082,cpd:C16402,"2,4-Dihydroxylamino-6-nitrotoluene",C7H9N3O4,"2,4-Dihydroxylamino-6-nitrotoluene",R08015 R08016 R08048,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,NA,PubChem: 47205700; ChEBI: 19357; NIKKAJI: J928.566K,cpd:C03584; cpd:C08289; cpd:C15178; cpd:C16402; cpd:C16414,7,9,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O4N3,C7H8O4N3,199.0593058,200.0671308,198.05148072778,3083,cpd:C16403,4-Amino-2-hydroxylamino-6-nitrotoluene,C7H9N3O3,4-Amino-2-hydroxylamino-6-nitrotoluene,R08016 R08047 R08049,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,NA,PubChem: 47205701; NIKKAJI: J934.744E,cpd:C02582; cpd:C16403,7,9,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O3N3,C7H8O3N3,183.0643912,184.0722162,182.05656612779,3084,cpd:C16411,"4,4',6,6'-Tetranitro-2,2'-azoxytoluene",C14H10N6O9,"4,4',6,6'-Tetranitro-2,2'-azoxytoluene",R08038,Nitrotoluene degradation,NA,NA,NA,CAS: 35212-01-2; PubChem: 47205709; ChEBI: 20260; NIKKAJI: J697.736G,cpd:C16411; cpd:C16412; cpd:C16413,14,10,9,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O9N6,C14H9O9N6,406.0509259,407.058751,405.04310092780,3085,cpd:C16412,"2,4',6,6'-Tetranitro-2',4-azoxytoluene",C14H10N6O9,"2,4',6,6'-Tetranitro-2',4-azoxytoluene",R08037,Nitrotoluene degradation,NA,NA,NA,CAS: 51856-71-4; PubChem: 47205710; ChEBI: 80487; NIKKAJI: J697.739A,cpd:C16411; cpd:C16412; cpd:C16413,14,10,9,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O9N6,C14H9O9N6,406.0509259,407.058751,405.04310092781,3086,cpd:C16413,"2,2',6,6'-Tetranitro-4,4'-azoxytoluene",C14H10N6O9,"2,2',6,6'-Tetranitro-4,4'-azoxytoluene",R08020,Nitrotoluene degradation,NA,NA,NA,CAS: 51857-25-1; PubChem: 47205711; ChEBI: 19279; NIKKAJI: J697.738C,cpd:C16411; cpd:C16412; cpd:C16413,14,10,9,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H11O9N6,C14H9O9N6,406.0509259,407.058751,405.04310092782,3087,cpd:C16414,2-Amino-5-hydroxyl-4-hydroxylamino-6-nitrotoluene;,C7H9N3O4,2-Amino-5-hydroxyl-4-hydroxylamino-6-nitrotoluene; 4-Amino-6-hydroxylamino-3-methyl-2-nitrophenol,R08048,Nitrotoluene degradation,NA,NA,NA,PubChem: 47205712; ChEBI: 19463; NIKKAJI: J2.802.586F,cpd:C03584; cpd:C08289; cpd:C15178; cpd:C16402; cpd:C16414,7,9,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O4N3,C7H8O4N3,199.0593058,200.0671308,198.05148072783,3088,cpd:C16420,4-Acetamido-2-amino-6-nitrotoluene,C9H11N3O3,4-Acetamido-2-amino-6-nitrotoluene,R08036,Nitrotoluene degradation; Microbial metabolism in diverse environments,2.3.1.5,NA,NA,PubChem: 47205718; ChEBI: 20302; NIKKAJI: J960.990C,cpd:C16420,9,11,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O3N3,C9H10O3N3,209.0800412,210.0878663,208.07221622784,3089,cpd:C18315,4-Methyl-5-nitrocatechol,C7H7NO4,4-Methyl-5-nitrocatechol,R09233 R09234 R11150,Nitrotoluene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.24; 1.14.13.210,NA,NA,CAS: 68906-21-8; PubChem: 103061497; ChEBI: 81666; ChEMBL: CHEMBL288833,cpd:C03340; cpd:C11465; cpd:C12477; cpd:C17385; cpd:C17386; cpd:C18315,7,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O4N1,C7H6O4N1,169.0375077,170.0453327,168.02968272785,3090,cpd:C18316,2-Hydroxy-5-methylquinone;,C7H6O3,"2-Hydroxy-5-methylquinone; 2-Hydroxy-5-methyl-1,4-benzoquinone",R09234 R09236 R11150,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.1.1.-; 1.14.13.210,NA,NA,CAS: 615-91-8; PubChem: 103061498; ChEBI: 81667,cpd:C00156; cpd:C00587; cpd:C00805; cpd:C05585; cpd:C08055; cpd:C10832; cpd:C12114; cpd:C14015; cpd:C16700; cpd:C17098; cpd:C18316; cpd:C20248,7,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O3,C7H5O3,138.0316941,139.0395191,137.0238692786,3091,cpd:C18317,"2,4,5-Trihydroxytoluene",C7H8O3,"2,4,5-Trihydroxytoluene",R09236 R09237,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.1.1.-; 1.13.11.-,NA,NA,CAS: 1124-09-0; PubChem: 103061499; ChEBI: 81668,cpd:C03095; cpd:C03338; cpd:C06677; cpd:C10792; cpd:C13129; cpd:C14110; cpd:C16356; cpd:C16360; cpd:C16401; cpd:C18317; cpd:C19469; cpd:C20362,7,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O3,C7H7O3,140.0473441,141.0551691,139.03951912787,3092,cpd:C18318,"cis,cis-2,4-Dihydroxy-5-methyl-6-oxo-2,4-hexadienoate",C7H8O5,"cis,cis-2,4-Dihydroxy-5-methyl-6-oxo-2,4-hexadienoate",R09237 R09238,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.13.11.-; 3.7.1.-,NA,NA,PubChem: 103061500; ChEBI: 81669,cpd:C02637; cpd:C02652; cpd:C03063; cpd:C05600; cpd:C07478; cpd:C07479; cpd:C18306; cpd:C18318,7,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O5,C7H7O5,172.0371734,173.0449984,171.02934832788,3093,cpd:C18320,4-Amino-2-nitrotoluene,C7H8N2O2,4-Amino-2-nitrotoluene,R09232 R09235 R09242 R09243,Nitrotoluene degradation; Microbial metabolism in diverse environments,1.7.1.-,NA,NA,CAS: 119-32-4; PubChem: 103061502; ChEBI: 81670; ChEMBL: CHEMBL1350617,cpd:C05842; cpd:C05843; cpd:C16398; cpd:C18320,7,8,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O2N2,C7H7O2N2,152.0585775,153.0664025,151.05075252789,3094,cpd:C00132,Methanol;,CH4O,Methanol; Methyl alcohol; CH3OH,R00602 R00605 R00608 R00614 R01142 R01143 R01144 R01145; R01146 R02362 R02624 R03551 R04280 R04384 R04409 R04608; R05825 R06250 R06685 R06729 R08149 R08150 R08974 R08975; R09061 R09098 R09273 R09274 R09337 R09518 R09553 R09725; R09846 R10319 R10320 R10545 R10681 R10705 R10983 R11166; R11189,Propanoate metabolism; Methane metabolism; Indole alkaloid biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Degradation of aromatic compounds,1.1.1.244; 1.1.2.7; 1.1.3.13; 1.1.99.37; 1.2.98.1; 1.11.1.6; 1.11.1.7; 1.11.1.21; 1.13.11.8; 1.13.11.-; 1.14.13.25; 1.14.13.175; 1.14.18.3; 2.1.1.90; 2.1.1.246; 2.3.1.152; 2.3.1.232; 3.1.1.11; 3.1.1.44; 3.1.1.59; 3.1.1.61; 3.1.1.78; 3.1.1.82; 3.1.1.85; 3.1.1.95; 3.1.1.97; 3.1.1.100; 3.1.1.-; 3.1.6.16; 3.3.2.14,"Methane oxidation, methanotroph, methane => formaldehyde; Methanogenesis, methanol => methane",Pharmaceutical additives [BR:br08316];  Solubilization agent;   D02309  [104129] Methanol;  Solvent;   D02309  [104129] Methanol,CAS: 67-56-1; PubChem: 3432; ChEBI: 17790; ChEMBL: CHEMBL14688; PDB-CCD: MOH; 3DMET: B01170; NIKKAJI: J2.364G,cpd:C00086; cpd:C00132; cpd:C19568; cpd:C20306,1,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H5O1,C1H3O1,32.02621475,33.03403978,31.018389722790,3095,cpd:C00163,Propanoate;,C3H6O2,Propanoate; Propionate; Propanoic acid; Propionic acid,R00920 R00925 R00928 R01353 R01354 R01355 R01449 R05366,Propanoate metabolism; Ethylbenzene degradation; Nicotinate and nicotinamide metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds; Carbohydrate digestion and absorption; Protein digestion and absorption,2.7.2.1; 2.7.2.15; 2.8.3.1; 3.7.1.-; 4.1.3.32; 6.2.1.1; 6.2.1.13; 6.2.1.17,NA,Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Monocarboxylic acids;     C00163  Propionate; Propanoate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C00163  Propanoic acid; Pharmaceutical additives [BR:br08316];  Solubilization agent;   D02310  [105628] Propionic acid;  Solvent;   D02310  [105628] Propionic acid,CAS: 79-09-4; PubChem: 3463; ChEBI: 17272 30768; ChEMBL: CHEMBL14021; LIPIDMAPS: LMFA01010003; LipidBank: DFA0003; KNApSAcK: C00044287; PDB-CCD: PPI; 3DMET: B01176; NIKKAJI: J1.963A,cpd:C00163; cpd:C00424; cpd:C00937; cpd:C00969; cpd:C01021; cpd:C02634; cpd:C02635; cpd:C02638; cpd:C02718; cpd:C02749; cpd:C02882; cpd:C03148; cpd:C03173; cpd:C04080; cpd:C05235; cpd:C05726; cpd:C05999; cpd:C06682; cpd:C08057; cpd:C10920; cpd:C16632; cpd:C17266; cpd:C17530,3,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O2,C3H5O2,74.03677943,75.04460446,73.02895442791,3096,cpd:C00583,"Propane-1,2-diol;",C3H8O2,"Propane-1,2-diol; 1,2-Propanediol; Propylene glycol",R02257 R02259 R02376 R02577 R10717,Propanoate metabolism,1.1.1.6; 1.1.1.21; 1.1.1.55; 1.1.1.77; 4.2.1.28,NA,Therapeutic category of drugs in Japan [BR:br08301];  7  Agents not mainly for therapeutic purpose;   71  Dispensing medicines;    713  Solvents;     7139  Others;      D00078  Propylene glycol (JP17/USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00078  [002328] Propylene glycol;  Plasticizer;   D00078  [002328] Propylene glycol;  Solubilizing agent;   D00078  [002328] Propylene glycol;  Base;   D00078  [002328] Propylene glycol;  Bonding agent;   D00078  [002328] Propylene glycol;  Suspending agent;   D00078  [002328] Propylene glycol;  Coating agent;   D00078  [002328] Propylene glycol;  Wetting agent;   D00078  [002328] Propylene glycol;  Wetting adjuster;   D00078  [002328] Propylene glycol;  Tonicity agent;   D00078  [002328] Propylene glycol;  Flexibilizer;   D00078  [002328] Propylene glycol;  Emulsion;   D00078  [002328] Propylene glycol;  Adhesive;   D00078  [002328] Propylene glycol;  Adhesion-enhancing agent;   D00078  [002328] Propylene glycol;  Tenacious agent;   D00078  [002328] Propylene glycol;  Diluting agent;   D00078  [002328] Propylene glycol;  Dispersant;   D00078  [002328] Propylene glycol;  Preserving agent;   D00078  [002328] Propylene glycol;  Soothing agent;   D00078  [002328] Propylene glycol;  Solubilizer;   D00078  [002328] Propylene glycol;  Solubilization agent;   D00078  [002328] Propylene glycol;  Solvent;   D00078  [002328] Propylene glycol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00078  Propylene glycol; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   964  Saccharide preparations and blood substitutes;    9646  Propylene glycol and preparations;     C00583  Propylene glycol,CAS: 57-55-6; PubChem: 3862; ChEBI: 16997; ChEMBL: CHEMBL286398; KNApSAcK: C00007410; 3DMET: B04703; NIKKAJI: J1.918F,cpd:C00583; cpd:C02457; cpd:C02912; cpd:C02917; cpd:C03401; cpd:C06381; cpd:C06393,3,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O2,C3H7O2,76.0524295,77.06025453,75.044604462792,3097,cpd:C00827,Lactoyl-CoA,C24H40N7O18P3S,Lactoyl-CoA,R01449 R02963 R05508,Propanoate metabolism; Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments,2.8.3.1; 4.2.1.54,NA,NA,PubChem: 4085; ChEBI: 15529; 3DMET: B04733; NIKKAJI: J2.660.140A,cpd:C00827; cpd:C05668,24,40,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O18N7P3S1,C24H39O18N7P3S1,839.1363396,840.1441647,838.12851462793,3098,cpd:C01845,Propan-2-ol;,C3H8O,Propan-2-ol; 2-Propanol; Isopropanol; Isopropyl alcohol,R01550 R10702 R10703,Propanoate metabolism,1.1.1.80; 1.1.1.-; 1.14.13.227,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C01845  Isopropyl alcohol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D08 ANTISEPTICS AND DISINFECTANTS;    D08A ANTISEPTICS AND DISINFECTANTS;     D08AX Other antiseptics and disinfectants;      D08AX05 Isopropanol;       D00137  Isopropyl alcohol (USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    261  Antimicrobial agents;     2615  Alcohols;      D00137  Isopropyl alcohol (USP); Isopropanol (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   54 Disinfectants (incl. special bandages);    D00137  Isopropyl alcohol (USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Isopropanol;     D00137  Isopropyl alcohol (USP); Pharmaceutical additives [BR:br08316];  Solubilizing agent;   D00137  [001060] Isopropanol;  Base;   D00137  [001060] Isopropanol;  Preserving agent;   D00137  [001060] Isopropanol;  Solubilization agent;   D00137  [001060] Isopropanol;  Solvent;   D00137  [001060] Isopropanol; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00137  Isopropanol,CAS: 67-63-0; PubChem: 4963; ChEBI: 17824; ChEMBL: CHEMBL582; KNApSAcK: C00048438; PDB-CCD: IPA; 3DMET: B00359; NIKKAJI: J1.411G,cpd:C01845; cpd:C02924; cpd:C05979; cpd:C16364; cpd:C19281; cpd:C19779,3,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O1,C3H7O1,60.05751488,61.06533991,59.049689852794,3099,cpd:C02225,2-Methylcitrate;,C7H10O7,"2-Methylcitrate; (2S,3S)-2-Methylcitrate; 2-Hydroxybutane-1,2,3-tricarboxylate; (2S,3S)-2-Hydroxybutane-1,2,3-tricarboxylate",R00931 R04424 R11263,Propanoate metabolism,2.3.3.5; 4.2.1.79; 4.2.1.117,NA,NA,PubChem: 5290; ChEBI: 10860 15598 30836; 3DMET: B01547; NIKKAJI: J363.014E,cpd:C01251; cpd:C02225; cpd:C04593; cpd:C05662,7,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O7,C7H9O7,206.0426527,207.0504777,205.03482762795,3100,cpd:C02876,Propanoyl phosphate;,C3H7O5P,Propanoyl phosphate; Propionyl phosphate,R00921 R00993 R01353,Propanoate metabolism; C5-Branched dibasic acid metabolism; Metabolic pathways,1.2.3.-; 2.3.1.8; 2.3.1.222; 2.7.2.1; 2.7.2.15,NA,NA,PubChem: 5809; ChEBI: 8478; 3DMET: B00510; NIKKAJI: J2.365.532B,cpd:C02768; cpd:C02876; cpd:C03505; cpd:C03947; cpd:C20898,3,7,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O5P1,C3H6O5P1,154.0031103,155.0109354,152.99528532796,3101,cpd:C04225,"(Z)-But-2-ene-1,2,3-tricarboxylate;",C7H8O6,"(Z)-But-2-ene-1,2,3-tricarboxylate; cis-2-Methylaconitate",R04424 R04425 R11264,Propanoate metabolism,4.2.1.79; 4.2.1.99; 5.2.1.-,NA,NA,PubChem: 6896; ChEBI: 16717; 3DMET: B00694; NIKKAJI: J678.271J,cpd:C04002; cpd:C04225; cpd:C06246; cpd:C11514; cpd:C11515; cpd:C16579; cpd:C21250,7,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O6,C7H7O6,188.032088,189.039913,187.02426292797,3102,cpd:C04593,"(2S,3R)-3-Hydroxybutane-1,2,3-tricarboxylate;",C7H10O7,"(2S,3R)-3-Hydroxybutane-1,2,3-tricarboxylate; Methylisocitrate; Methylisocitric acid",R00409 R04425,Propanoate metabolism,4.1.3.30; 4.2.1.99,NA,NA,PubChem: 7191; ChEBI: 15607; PDB-CCD: MIC; 3DMET: B01764; NIKKAJI: J1.534.785F,cpd:C01251; cpd:C02225; cpd:C04593; cpd:C05662,7,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O7,C7H9O7,206.0426527,207.0504777,205.03482762798,3103,cpd:C05235,Hydroxyacetone;,C3H6O2,Hydroxyacetone; Acetol; 1-Hydroxy-2-propanone; 2-Ketopropyl alcohol; Acetone alcohol; Pyruvinalcohol; Pyruvic alcohol; Methylketol,R02528 R10717 R10718,Propanoate metabolism,1.1.1.6; 1.1.1.-,NA,NA,CAS: 116-09-6; PubChem: 7630; ChEBI: 27957; KNApSAcK: C00019558; PDB-CCD: 4Y8; 3DMET: B00761; NIKKAJI: J2.470H,cpd:C00163; cpd:C00424; cpd:C00937; cpd:C00969; cpd:C01021; cpd:C02634; cpd:C02635; cpd:C02638; cpd:C02718; cpd:C02749; cpd:C02882; cpd:C03148; cpd:C03173; cpd:C04080; cpd:C05235; cpd:C05726; cpd:C05999; cpd:C06682; cpd:C08057; cpd:C10920; cpd:C16632; cpd:C17266; cpd:C17530,3,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O2,C3H5O2,74.03677943,75.04460446,73.02895442799,3104,cpd:C05979,Propane-1-ol;,C3H8O,Propane-1-ol; Propanol; 1-Propanol; Propan-1-ol; Propyl alcohol; 1-Hydroxypropane; Ethylcarbinol; n-Propanol; n-Propyl alcohol; Optal; Osmosol extra; UN 1274,R02377 R05061,Propanoate metabolism,1.1.1.202; 2.3.1.152,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D08 ANTISEPTICS AND DISINFECTANTS;    D08A ANTISEPTICS AND DISINFECTANTS;     D08AX Other antiseptics and disinfectants;      D08AX03 Propanol;       C05979  Propane-1-ol; Pharmaceutical additives [BR:br08316];  Solvent;   C05979  [504322] Propanol,CAS: 71-23-8; PubChem: 8258; ChEBI: 28831; ChEMBL: CHEMBL14687; LIPIDMAPS: LMFA05000101; PDB-CCD: POL; 3DMET: B00883; NIKKAJI: J1.422B,cpd:C01845; cpd:C02924; cpd:C05979; cpd:C16364; cpd:C19281; cpd:C19779,3,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O1,C3H7O1,60.05751488,61.06533991,59.049689852800,3105,cpd:C05983,Propionyladenylate;,C13H18N5O8P,Propionyladenylate; Propionyl-adenosine monophosphate,R00926 R01354,Propanoate metabolism,6.2.1.1; 6.2.1.17,NA,NA,PubChem: 8261; ChEBI: 62415; 3DMET: B01941; NIKKAJI: J1.735.026I,cpd:C05983,13,18,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H19O8N5P1,C13H17O8N5P1,403.0892996,404.0971246,402.08147452801,3106,cpd:C05984,2-Hydroxybutanoic acid;,C4H8O3,2-Hydroxybutanoic acid; 2-Hydroxybutyrate; 2-Hydroxybutyric acid,R01000,Propanoate metabolism,1.1.1.27,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0105 Hydroxy fatty acids;     C05984  2-Hydroxybutanoic acid,PubChem: 8262; ChEBI: 1148 50613; LIPIDMAPS: LMFA01050004 LMFA01050342; LipidBank: DFA0270; 3DMET: B01942; NIKKAJI: J57.683B,cpd:C00152; cpd:C00989; cpd:C01043; cpd:C01089; cpd:C01188; cpd:C01905; cpd:C01991; cpd:C02037; cpd:C02642; cpd:C03197; cpd:C03804; cpd:C05984; cpd:C06001; cpd:C14601; cpd:C15533; cpd:C16438; cpd:C19258; cpd:C19301; cpd:C21297,4,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O3,C4H7O3,104.0473441,105.0551691,103.03951912802,3107,cpd:C05989,3-Oxopropionyl-CoA;,C24H38N7O18P3S,3-Oxopropionyl-CoA; 3-Oxopropanoyl-CoA; Malonyl semialdehyde-CoA,R00744 R04919 R10946 R10947,Propanoate metabolism; Metabolic pathways,1.1.1.-; 4.2.1.155,NA,NA,PubChem: 8265; ChEBI: 28673; 3DMET: B05142; NIKKAJI: J2.760.831K,cpd:C05989,24,38,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C24H39O18N7P3S1,C24H37O18N7P3S1,837.1206896,838.1285146,836.11286452803,3108,cpd:C17530,Methyl acetate;,C3H6O2,Methyl acetate; Devoton; Tereton,R10704 R10705,Propanoate metabolism,1.14.13.226; 3.1.1.-,NA,NA,CAS: 79-20-9; PubChem: 96023875; ChEBI: 77700; ChEMBL: CHEMBL14079; KNApSAcK: C00048479; NIKKAJI: J1.965H,cpd:C00163; cpd:C00424; cpd:C00937; cpd:C00969; cpd:C01021; cpd:C02634; cpd:C02635; cpd:C02638; cpd:C02718; cpd:C02749; cpd:C02882; cpd:C03148; cpd:C03173; cpd:C04080; cpd:C05235; cpd:C05726; cpd:C05999; cpd:C06682; cpd:C08057; cpd:C10920; cpd:C16632; cpd:C17266; cpd:C17530,3,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O2,C3H5O2,74.03677943,75.04460446,73.02895442804,3109,cpd:C20783,Propane,C3H8,Propane,R10702,Propanoate metabolism,1.14.13.227,NA,NA,CAS: 74-98-6; PubChem: 254741250; PDB-CCD: TME,cpd:C00116; cpd:C00236; cpd:C00583; cpd:C01005; cpd:C01159; cpd:C01705; cpd:C01845; cpd:C02457; cpd:C02532; cpd:C02912; cpd:C02917; cpd:C02924; cpd:C03120; cpd:C03166; cpd:C03339; cpd:C03401; cpd:C03920; cpd:C03968; cpd:C05672; cpd:C05979; cpd:C06381; cpd:C06393; cpd:C08390; cpd:C08391; cpd:C10922; cpd:C11638; cpd:C12021; cpd:C16364; cpd:C18564; cpd:C18565; cpd:C18789; cpd:C19239; cpd:C19281; cpd:C19675; cpd:C19779; cpd:C20783; cpd:C20797,3,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9,C3H7,44.06260026,45.07042529,43.054775232805,3110,cpd:C21017,2-(alpha-Hydroxypropyl)thiamine diphosphate;,C15H25N4O8P2S,2-(alpha-Hydroxypropyl)thiamine diphosphate; 2-Hydroxypropyl-ThPP,R10996 R10997,Propanoate metabolism,1.2.4.4,NA,NA,PubChem: 254741471,cpd:C21017,15,25,8,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H26O8N4P2S1,C15H24O8N4P2S1,483.086834,484.094659,482.07900892806,3112,cpd:C21250,2-Methyl-trans-aconitate,C7H8O6,2-Methyl-trans-aconitate,R11263 R11264,Propanoate metabolism,4.2.1.117; 5.2.1.-,NA,NA,PubChem: 315661349,cpd:C04002; cpd:C04225; cpd:C06246; cpd:C11514; cpd:C11515; cpd:C16579; cpd:C21250,7,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O6,C7H7O6,188.032088,189.039913,187.02426292807,3113,cpd:C06727,"cis-1,2-Dihydro-3-ethylcatechol;",C8H12O2,"cis-1,2-Dihydro-3-ethylcatechol; cis-2,3-Dihydroxy-2,3-dihydroethylbenzene; cis-3-Ethyl-cyclohexa-3,5-diene-1,2-diol",R05313 R05440,Ethylbenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.66; 1.14.12.-,NA,NA,CAS: 66008-19-3; PubChem: 8949; ChEBI: 16843; NIKKAJI: J1.327.215H,cpd:C00534; cpd:C06727; cpd:C11846; cpd:C13710; cpd:C16656; cpd:C18011; cpd:C19105; cpd:C19311,8,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O2,C8H11O2,140.0837296,141.0915547,139.07590462808,3114,cpd:C06728,3-Ethylcatechol;,C8H10O2,"3-Ethylcatechol; 2,3-Dihydroxyethylbenzene; 3-Ethyl-benzene-1,2-diol",R05313 R05416,Ethylbenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.66; 1.13.11.-,NA,NA,CAS: 933-99-3; PubChem: 8950; ChEBI: 16572; 3DMET: B01035; NIKKAJI: J801.879K,cpd:C03352; cpd:C04087; cpd:C06044; cpd:C06728; cpd:C07084; cpd:C07481; cpd:C11480; cpd:C13403; cpd:C13638; cpd:C16693; cpd:C19844; cpd:C20694,8,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O2,C8H9O2,138.0680796,139.0759046,137.06025452809,3115,cpd:C07083,Styrene;,C8H8,Styrene; Phenylethylene,R05417 R05424 R05488 R11070,Ethylbenzene degradation; Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.12; 1.14.12.-; 1.14.14.11; 4.1.1.102,NA,Endocrine disrupting compounds [BR:br08006];  Plasticizers and plastics;   Styrenes;    C07083  Styrene; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C07083  Styrene,CAS: 100-42-5; PubChem: 9294; ChEBI: 27452; ChEMBL: CHEMBL285235; KNApSAcK: C00037855; PDB-CCD: SYN; NIKKAJI: J4.006A,cpd:C00544; cpd:C00548; cpd:C00601; cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01036; cpd:C01061; cpd:C01161; cpd:C01454; cpd:C01526; cpd:C01819; cpd:C01839; cpd:C01983; cpd:C01984; cpd:C02061; cpd:C02083; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03198; cpd:C03235; cpd:C03663; cpd:C03765; cpd:C04043; cpd:C04052; cpd:C04186; cpd:C04642; cpd:C04783; cpd:C05343; cpd:C05380; cpd:C05577; cpd:C05580; cpd:C05592; cpd:C05593; cpd:C05613; cpd:C05616; cpd:C05627; cpd:C05852; cpd:C06207; cpd:C06224; cpd:C06318; cpd:C06672; cpd:C06758; cpd:C07034; cpd:C07040; cpd:C07083; cpd:C07085; cpd:C07086; cpd:C07087; cpd:C07113; cpd:C07189; cpd:C07209; cpd:C07211; cpd:C07214; cpd:C07215; cpd:C07504; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C10675; cpd:C10700; cpd:C10761; cpd:C10804; cpd:C11151; cpd:C11252; cpd:C11527; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14087; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C14109; cpd:C14494; cpd:C14619; cpd:C15250; cpd:C15348; cpd:C15583; cpd:C16215; cpd:C16623; cpd:C17900; cpd:C18314; cpd:C18345; cpd:C18346; cpd:C18724; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C19071; cpd:C19272; cpd:C19506; cpd:C19573; cpd:C19575; cpd:C20645; cpd:C20782; cpd:C21166; cpd:C21167; cpd:C21328; cpd:C21375; cpd:C21376,8,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9,C8H7,104.0626003,105.0704253,103.05477522810,3116,cpd:C07111,Ethylbenzene;,C8H10,Ethylbenzene; Phenylethane; Ethylbenzol; Ethylenzene,R05424 R05425 R05440 R05495 R05745,Ethylbenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.12.12; 1.14.12.-; 1.17.99.2; 1.17.-.-,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C07111  Ethylbenzene,CAS: 100-41-4; PubChem: 9322; ChEBI: 16101; ChEMBL: CHEMBL371561; PDB-CCD: PYJ; 3DMET: B01071; NIKKAJI: J3.589K,cpd:C00018; cpd:C01960; cpd:C03352; cpd:C04087; cpd:C04771; cpd:C05576; cpd:C05853; cpd:C06044; cpd:C06317; cpd:C06660; cpd:C06720; cpd:C06728; cpd:C06729; cpd:C06731; cpd:C06756; cpd:C06757; cpd:C07084; cpd:C07111; cpd:C07112; cpd:C07123; cpd:C07208; cpd:C07212; cpd:C07213; cpd:C07216; cpd:C07481; cpd:C07665; cpd:C10787; cpd:C11348; cpd:C11480; cpd:C12599; cpd:C13403; cpd:C13637; cpd:C13638; cpd:C13646; cpd:C13673; cpd:C13681; cpd:C14001; cpd:C14228; cpd:C14385; cpd:C14386; cpd:C14582; cpd:C15347; cpd:C16361; cpd:C16365; cpd:C16693; cpd:C16804; cpd:C17512; cpd:C18350; cpd:C18513; cpd:C18937; cpd:C19495; cpd:C19680; cpd:C19844; cpd:C20581; cpd:C20694; cpd:C21144; cpd:C21325; cpd:C21326,8,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11,C8H9,106.0782503,107.0860754,105.07042532811,3117,cpd:C07113,Acetophenone;,C8H8O,Acetophenone; 1-Phenylethanone; Phenyl methyl ketone; Acetylbenzene; Methyl phenyl ketone,R05352 R05426 R05427 R05453,Ethylbenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.311; 1.14.12.12; 6.4.1.8,NA,NA,CAS: 98-86-2; PubChem: 9324; ChEBI: 27632; ChEMBL: CHEMBL274467; KNApSAcK: C00002685; PDB-CCD: AC0; 3DMET: B01072; NIKKAJI: J3.225E,cpd:C00601; cpd:C02083; cpd:C05627; cpd:C06758; cpd:C07113; cpd:C07209; cpd:C07214; cpd:C14494; cpd:C14619; cpd:C20782,8,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O1,C8H7O1,120.0575149,121.0653399,119.04968982812,3118,cpd:C07114,3-Oxo-3-phenylpropanoate;,C9H8O3,3-Oxo-3-phenylpropanoate; Benzoylacetate; 3-Oxo-3-phenylpropionate; 3-Oxo-3-phenylpropionic acid,R05452 R05453,Ethylbenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,6.2.1.-; 6.4.1.8,NA,NA,CAS: 29285-17-4 614-20-0; PubChem: 9325; ChEBI: 28759; 3DMET: B01073; NIKKAJI: J2.764.895I,cpd:C00166; cpd:C00811; cpd:C01772; cpd:C02763; cpd:C05838; cpd:C06738; cpd:C07114; cpd:C10945; cpd:C11020; cpd:C12463; cpd:C12621; cpd:C20685; cpd:C20687; cpd:C20939; cpd:C21345,9,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O3,C9H7O3,164.0473441,165.0551691,163.03951912813,3119,cpd:C07118,Benzoylacetyl-CoA;,C30H42N7O18P3S,Benzoylacetyl-CoA; Benzoylacetyl coenzyme A,R05452 R05506,Ethylbenzene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,2.3.1.16; 2.3.1.-; 6.2.1.-,NA,NA,PubChem: 9329; ChEBI: 27388; NIKKAJI: J2.764.903C,cpd:C00223; cpd:C07118,30,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H43O18N7P3S1,C30H41O18N7P3S1,913.1519897,914.1598147,912.14416472814,3120,cpd:C07123,"2-Hydroxy-6-oxo-octa-2,4-dienoate",C8H10O4,"2-Hydroxy-6-oxo-octa-2,4-dienoate",R05366 R05416,Ethylbenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.-; 3.7.1.-,NA,NA,PubChem: 9333; ChEBI: 1139; 3DMET: B01074; NIKKAJI: J960.409J,cpd:C04771; cpd:C05576; cpd:C06660; cpd:C06720; cpd:C06729; cpd:C06731; cpd:C07123; cpd:C16365; cpd:C16804; cpd:C18350; cpd:C19495; cpd:C21144,8,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O4,C8H9O4,170.0579088,171.0657338,169.05008382815,3121,cpd:C07189,2-Hydroxyacetophenone;,C8H8O2,2-Hydroxyacetophenone; omega-Hydroxyacetophenone,R05427,Ethylbenzene degradation; Microbial metabolism in diverse environments,1.14.12.12,NA,NA,CAS: 582-24-1; PubChem: 9398; ChEBI: 28341; PDB-CCD: HXT; 3DMET: B01075; NIKKAJI: J20.038G,cpd:C00548; cpd:C01454; cpd:C01526; cpd:C02061; cpd:C03765; cpd:C05613; cpd:C06224; cpd:C07085; cpd:C07086; cpd:C07189; cpd:C07211; cpd:C07215; cpd:C10700; cpd:C10761; cpd:C11151; cpd:C11252; cpd:C14087; cpd:C15250; cpd:C15583; cpd:C20645; cpd:C21166; cpd:C21328; cpd:C21375,8,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O2,C8H7O2,136.0524295,137.0602545,135.04460452816,3122,cpd:C11348,(S)-1-Phenylethanol;,C8H10O,(S)-1-Phenylethanol; (S)-1-Phenethyl alcohol,R05352 R05425 R05426 R05745,Ethylbenzene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.311; 1.14.12.12; 1.17.99.2,NA,NA,CAS: 1445-91-6; PubChem: 13523; ChEBI: 16346; ChEMBL: CHEMBL348446; PDB-CCD: SS1; NIKKAJI: J56.778G,cpd:C05853; cpd:C06757; cpd:C07112; cpd:C07213; cpd:C07216; cpd:C11348; cpd:C13637; cpd:C14385; cpd:C14386; cpd:C14582; cpd:C17512; cpd:C19680,8,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O1,C8H9O1,122.0731649,123.08099,121.06533992817,3123,cpd:C00511,Acrylic acid;,C3H4O2,Acrylic acid; Propenoate; Acrylate; 2-Propenoic acid; Vinylformic acid,R02574 R05358 R05362 R05509 R05551,Styrene degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,2.8.3.12; 3.5.1.4; 3.5.5.7; 3.7.1.9; 4.4.1.3,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00511  Acrylic acid,CAS: 79-10-7; PubChem: 3794; ChEBI: 18308 37080; ChEMBL: CHEMBL1213529; LIPIDMAPS: LMFA01030193; LipidBank: DFA0040; KNApSAcK: C00034423; PDB-CCD: AKR; 3DMET: B00118; NIKKAJI: J1.493A,cpd:C00511; cpd:C00546; cpd:C01271; cpd:C03129; cpd:C05146; cpd:C05197; cpd:C08734; cpd:C18600; cpd:C19246; cpd:C19297; cpd:C19440; cpd:C19501; cpd:C21430,3,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O2,C3H3O2,72.02112937,73.0289544,71.013304342818,3124,cpd:C01659,Acrylamide;,C3H5NO,Acrylamide; 2-Propenamide,R05379 R05551,Styrene degradation; Microbial metabolism in diverse environments,3.5.1.4; 4.2.1.84,NA,Carcinogens [BR:br08008];  Group 2A: Probably carcinogenic to humans;   Compounds;    C01659  Acrylamide,CAS: 79-06-1; PubChem: 4808; ChEBI: 28619; ChEMBL: CHEMBL348107; PDB-CCD: 1HC; 3DMET: B00333; NIKKAJI: J2.408B,cpd:C01659,3,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H6O1N1,C3H4O1N1,71.03711379,72.04493882,70.029288752819,3125,cpd:C01998,Acrylonitrile;,C3H3N,Acrylonitrile; Propenenitrile; Vinyl cyanide,R05358 R05379,Styrene degradation; Microbial metabolism in diverse environments,3.5.5.7; 4.2.1.84,NA,Pesticides [BR:br08007];  Obsolete pesticides;   Others;    Fumigants;     C01998  Acrylonitrile; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C01998  Acrylonitrile,CAS: 107-13-1; PubChem: 5095; ChEBI: 28217; ChEMBL: CHEMBL445612; PDB-CCD: 6AC; 3DMET: B00380; NIKKAJI: J4.055J,cpd:C01998; cpd:C02231; cpd:C02850; cpd:C03523; cpd:C06378; cpd:C07280; cpd:C19573; cpd:C20891,3,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H4N1,C3H2N1,53.0265491,54.03437413,52.018724072820,3126,cpd:C07084,"Styrene-cis-2,3-dihydrodiol;",C8H10O2,"Styrene-cis-2,3-dihydrodiol; cis-3-Ethenylcyclohexa-3,5-diene-1,2-diol",R05354 R05417,Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.19; 1.14.12.-,NA,NA,PubChem: 9295; ChEBI: 28980 51007; NIKKAJI: J2.764.885A,cpd:C03352; cpd:C04087; cpd:C06044; cpd:C06728; cpd:C07084; cpd:C07481; cpd:C11480; cpd:C13403; cpd:C13638; cpd:C16693; cpd:C19844; cpd:C20694,8,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O2,C8H9O2,138.0680796,139.0759046,137.06025452821,3127,cpd:C07085,3-Vinylcatechol,C8H8O2,3-Vinylcatechol,R05354 R05404,Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.1.19; 1.13.11.2,NA,NA,PubChem: 9296; ChEBI: 27739; 3DMET: B01059; NIKKAJI: J808.688E,cpd:C00548; cpd:C01454; cpd:C01526; cpd:C02061; cpd:C03765; cpd:C05613; cpd:C06224; cpd:C07085; cpd:C07086; cpd:C07189; cpd:C07211; cpd:C07215; cpd:C10700; cpd:C10761; cpd:C11151; cpd:C11252; cpd:C14087; cpd:C15250; cpd:C15583; cpd:C20645; cpd:C21166; cpd:C21328; cpd:C21375,8,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O2,C8H7O2,136.0524295,137.0602545,135.04460452822,3128,cpd:C07087,"2-Hydroxy-6-oxoocta-2,4,7-trienoate",C8H8O4,"2-Hydroxy-6-oxoocta-2,4,7-trienoate",R05362 R05404,Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.2; 3.7.1.9,NA,NA,PubChem: 9298; ChEBI: 1141; 3DMET: B01060; NIKKAJI: J2.367.873J,cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272,8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O4,C8H7O4,168.0422587,169.0500838,167.03443372823,3129,cpd:C20782,(S)-2-Phenyloxirane;,C8H8O,(S)-2-Phenyloxirane; (S)-Styrene oxide,R05488 R10697,Styrene degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.14.11; 5.3.99.7,NA,NA,CAS: 20780-54-5; PubChem: 254741249,cpd:C00601; cpd:C02083; cpd:C05627; cpd:C06758; cpd:C07113; cpd:C07209; cpd:C07214; cpd:C14494; cpd:C14619; cpd:C20782,8,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O1,C8H7O1,120.0575149,121.0653399,119.04968982824,3130,cpd:C00246,Butanoic acid;,C4H8O2,Butanoic acid; Butanoate; Butyrate; Butyric acid,R01176 R01179 R01365 R01688 R01689 R01690 R03781 R04119,Butanoate metabolism; Metabolic pathways; Carbohydrate digestion and absorption; Protein digestion and absorption,1.3.1.31; 2.7.2.7; 2.8.3.8; 2.8.3.9; 3.1.1.51; 3.6.1.20; 3.7.1.7; 6.2.1.2,NA,Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Monocarboxylic acids;     C00246  Butyrate; Butanoate;  Lipids;   Fatty acids;    Saturated fatty acids;     C00246  Butyric acid (4:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C00246  Butanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C00246  Butyric acid,CAS: 107-92-6; PubChem: 3545; ChEBI: 17968 30772; ChEMBL: CHEMBL14227; LIPIDMAPS: LMFA01010004; LipidBank: DFA0004; KNApSAcK: C00001180; PDB-CCD: BUA; 3DMET: B00070; NIKKAJI: J4.068A,cpd:C00246; cpd:C00466; cpd:C00810; cpd:C00849; cpd:C01119; cpd:C01769; cpd:C02632; cpd:C04371; cpd:C06484; cpd:C08276; cpd:C14440; cpd:C16622; cpd:C19283; cpd:C19348; cpd:C19484; cpd:C21291,4,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O2,C4H7O2,88.0524295,89.06025453,87.044604462825,3131,cpd:C00497,(R)-Malate;,C4H6O5,(R)-Malate; D-Malate; D-Malic acid,R00215 R02419 R10641,Butanoate metabolism,1.1.1.83; 2.8.3.20; 4.2.1.31,NA,NA,CAS: 636-61-3; PubChem: 3780; ChEBI: 15588 30796; ChEMBL: CHEMBL225986; PDB-CCD: MLT; 3DMET: B01268; NIKKAJI: J14.674I,cpd:C00149; cpd:C00497; cpd:C00711; cpd:C03064; cpd:C14873,4,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O5,C4H5O5,134.0215233,135.0293483,133.01369832826,3132,cpd:C00741,Diacetyl;,C4H6O2,"Diacetyl; Biacetyl; Dimethylglyoxal; 2,3-Butanedione",R02343 R02855 R02856 R09078 R10506,Butanoate metabolism,1.1.1.303; 1.1.1.304,NA,NA,CAS: 431-03-8; PubChem: 4004; ChEBI: 16583; ChEMBL: CHEMBL365809; LIPIDMAPS: LMFA12000012; 3DMET: B00164; NIKKAJI: J2.586K,cpd:C00429; cpd:C00741; cpd:C01770; cpd:C01771; cpd:C01892; cpd:C02065; cpd:C02248; cpd:C02497; cpd:C02512; cpd:C02565; cpd:C02743; cpd:C02777; cpd:C06143; cpd:C08311; cpd:C11551; cpd:C11552; cpd:C12282; cpd:C13695; cpd:C15811; cpd:C15812; cpd:C16267; cpd:C16835; cpd:C19118; cpd:C19201; cpd:C19309; cpd:C19443; cpd:C19546; cpd:C21440,4,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O2,C4H5O2,86.03677943,87.04460446,85.02895442827,3133,cpd:C00810,(R)-Acetoin;,C4H8O2,(R)-Acetoin; (R)-2-Acetoin; (R)-3-Hydroxy-2-butanone; (R)-Dimethylketol; (R)-3-Hydroxybutan-2-one,R02855 R02856 R02946 R02948 R02949 R10505,Butanoate metabolism; C5-Branched dibasic acid metabolism,1.1.1.4; 1.1.1.303; 1.1.1.-; 4.1.1.5; 5.1.2.4,NA,NA,CAS: 53584-56-8; PubChem: 4068; ChEBI: 15686; LIPIDMAPS: LMFA12000064; PDB-CCD: HBR; 3DMET: B00180; NIKKAJI: J2.623I,cpd:C00246; cpd:C00466; cpd:C00810; cpd:C00849; cpd:C01119; cpd:C01769; cpd:C02632; cpd:C04371; cpd:C06484; cpd:C08276; cpd:C14440; cpd:C16622; cpd:C19283; cpd:C19348; cpd:C19484; cpd:C21291,4,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O2,C4H7O2,88.0524295,89.06025453,87.044604462828,3134,cpd:C00989,4-Hydroxybutanoic acid;,C4H8O3,4-Hydroxybutanoic acid; 4-Hydroxybutanoate; 4-Hydroxybutyric acid,R01644 R05336 R09279 R09281 R10758,Butanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.1.1.61; 1.1.1.-; 2.8.3.-; 6.2.1.40; 6.2.1.-,Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle,"Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Hydroxycarboxylic acids;     C00989  4-Hydroxybutanoate; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N01 ANESTHETICS;    N01A ANESTHETICS, GENERAL;     N01AX Other general anesthetics;      N01AX11 Hydroxybutyric acid;       C00989  4-Hydroxybutanoic acid;   N07 OTHER NERVOUS SYSTEM DRUGS;    N07X OTHER NERVOUS SYSTEM DRUGS;     N07XX Other nervous system drugs;      N07XX04 Hydroxybutyric acid;       C00989  4-Hydroxybutanoic acid",CAS: 591-81-1; PubChem: 4235; ChEBI: 16724 30830; ChEMBL: CHEMBL1342; LIPIDMAPS: LMFA01050006; LipidBank: DFA0272; 3DMET: B00216; NIKKAJI: J2.691C,cpd:C00152; cpd:C00989; cpd:C01043; cpd:C01089; cpd:C01188; cpd:C01905; cpd:C01991; cpd:C02037; cpd:C02642; cpd:C03197; cpd:C03804; cpd:C05984; cpd:C06001; cpd:C14601; cpd:C15533; cpd:C16438; cpd:C19258; cpd:C19301; cpd:C21297,4,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O3,C4H7O3,104.0473441,105.0551691,103.03951912829,3135,cpd:C01412,Butanal;,C4H8O,Butanal; Butyraldehyde,R01172 R01173 R03544 R03545 R11343 R11344,Butanoate metabolism,1.1.1.-; 1.1.2.9; 1.1.5.11; 1.2.1.10; 1.2.1.57; 1.2.1.87,NA,NA,CAS: 123-72-8; PubChem: 4600; ChEBI: 15743; ChEMBL: CHEMBL1478334; 3DMET: B00287; NIKKAJI: J2.501A,cpd:C01412; cpd:C02845; cpd:C08305; cpd:C14688; cpd:C15535; cpd:C18007; cpd:C19127; cpd:C19237; cpd:C19285,4,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O1,C4H7O1,72.05751488,73.06533991,71.049689852830,3136,cpd:C01769,(S)-Acetoin;,C4H8O2,(S)-Acetoin; (S)-2-Acetoin,R02949 R03707 R09078 R10504,Butanoate metabolism,1.1.1.76; 1.1.1.304; 1.1.1.-; 5.1.2.4,NA,NA,PubChem: 4902; ChEBI: 15687 15688; PDB-CCD: HBS; 3DMET: B04813; NIKKAJI: J51.758E,cpd:C00246; cpd:C00466; cpd:C00810; cpd:C00849; cpd:C01119; cpd:C01769; cpd:C02632; cpd:C04371; cpd:C06484; cpd:C08276; cpd:C14440; cpd:C16622; cpd:C19283; cpd:C19348; cpd:C19484; cpd:C21291,4,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O2,C4H7O2,88.0524295,89.06025453,87.044604462831,3137,cpd:C02331,Vinylacetyl-CoA;,C25H40N7O17P3S,Vinylacetyl-CoA; 3-Butenoyl-CoA; But-3-enoyl-CoA,R03031 R05337,Butanoate metabolism,5.3.3.3,NA,NA,PubChem: 5381; ChEBI: 15543; 3DMET: B04848; NIKKAJI: J2.736.219B,cpd:C00877; cpd:C02331; cpd:C03460; cpd:C16268,25,40,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O17N7P3S1,C25H39O17N7P3S1,835.141425,836.1492501,834.13362832,3138,cpd:C02527,Butanoylphosphate;,C4H9O5P,Butanoylphosphate; Butanoyl phosphate,R01174 R01688,Butanoate metabolism; Metabolic pathways,2.3.1.19; 2.7.2.7,NA,NA,PubChem: 5535; ChEBI: 17260; 3DMET: B00458; NIKKAJI: J2.367.846B,cpd:C02527; cpd:C03754,4,9,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O5P1,C4H8O5P1,168.0187604,169.0265854,167.01093542833,3139,cpd:C02630,2-Hydroxyglutarate;,C5H8O5,2-Hydroxyglutarate; alpha-Hydroxyglutarate,R00932 R03534 R04000 R08198,Butanoate metabolism; C5-Branched dibasic acid metabolism,1.1.1.95; 1.1.99.2; 2.3.3.11; 2.8.3.12,NA,NA,CAS: 2889-31-8; PubChem: 5610; ChEBI: 17084; 3DMET: B00467; NIKKAJI: J527.822H,cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031,5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O5,C5H7O5,148.0371734,149.0449984,147.02934832834,3140,cpd:C03044,"(R,R)-Butane-2,3-diol;",C4H10O2,"(R,R)-Butane-2,3-diol; (R,R)-2,3-Butanediol; (R,R)-2,3-Butylene glycol",R02946,Butanoate metabolism,1.1.1.4,NA,NA,CAS: 24347-58-8; PubChem: 5947; ChEBI: 16982; PDB-CCD: BU3; 3DMET: B01625; NIKKAJI: J9.308D,cpd:C00265; cpd:C00950; cpd:C03044; cpd:C03046; cpd:C03283; cpd:C08291; cpd:C11764; cpd:C13773; cpd:C14687; cpd:C20335; cpd:C20657; cpd:C21290,4,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O2,C4H9O2,90.06807956,91.07590459,89.060254532835,3141,cpd:C03046,"(S,S)-Butane-2,3-diol;",C4H10O2,"(S,S)-Butane-2,3-diol; (S,S)-2,3-Butanediol; (S,S)-2,3-Butylene glycol; (2S,3S)-Butane-2,3-diol",R02344 R03707,Butanoate metabolism,1.1.1.76,NA,NA,CAS: 19132-06-0; PubChem: 5949; ChEBI: 16812; PDB-CCD: BUD; 3DMET: B01626; NIKKAJI: J208.152K,cpd:C00265; cpd:C00950; cpd:C03044; cpd:C03046; cpd:C03283; cpd:C08291; cpd:C11764; cpd:C13773; cpd:C14687; cpd:C20335; cpd:C20657; cpd:C21290,4,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O2,C4H9O2,90.06807956,91.07590459,89.060254532836,3142,cpd:C03058,2-Hydroxyglutaryl-CoA,C26H42N7O20P3S,2-Hydroxyglutaryl-CoA,R03937 R04000,Butanoate metabolism,2.8.3.12; 4.2.1.-,NA,NA,PubChem: 5958; ChEBI: 28578; 3DMET: B04878; NIKKAJI: J1.907.425K,cpd:C00904; cpd:C01011; cpd:C03058; cpd:C06027; cpd:C20746,26,42,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H43O20N7P3S1,C26H41O20N7P3S1,897.1418189,898.149644,896.13399392837,3143,cpd:C04546,(R)-3-((R)-3-Hydroxybutanoyloxy)butanoate,C8H14O5,(R)-3-((R)-3-Hydroxybutanoyloxy)butanoate,R00048 R05118,Butanoate metabolism,3.1.1.22; 3.1.1.75,NA,NA,PubChem: 7152; ChEBI: 10979 17663; KNApSAcK: C00044453; 3DMET: B01755; NIKKAJI: J992.259H,cpd:C00669; cpd:C03738; cpd:C04546; cpd:C17214; cpd:C17215; cpd:C18967; cpd:C20957; cpd:C20958,8,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O5,C8H13O5,190.0841235,191.0919486,189.07629852838,3144,cpd:C06142,1-Butanol;,C4H10O,1-Butanol; n-Butanol; Butan-1-ol,R03544 R03545 R11343 R11344 R11448,Butanoate metabolism; Degradation of aromatic compounds,1.1.1.-; 1.1.2.9; 1.1.5.11; 1.14.13.230,NA,Pharmaceutical additives [BR:br08316];  Solubilization agent;   D03200  [101088] Butanol;  Solvent;   D03200  [101088] Butanol,PubChem: 8398; ChEBI: 28885; ChEMBL: CHEMBL14245; LIPIDMAPS: LMFA05000109; KNApSAcK: C00035814; PDB-CCD: 1BO; 3DMET: B00907; NIKKAJI: J2.374D,cpd:C06142; cpd:C13240; cpd:C14422; cpd:C14710; cpd:C21389,4,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O1,C4H9O1,74.07316494,75.08098997,73.065339912839,3146,cpd:C06144,3-Butynoate;,C4H4O2,3-Butynoate; But-3-ynoate,R01367 R05119 R05120,Butanoate metabolism,4.2.1.27,NA,NA,CAS: 2345-51-9; PubChem: 8400; ChEBI: 1461 62211; 3DMET: B00908; NIKKAJI: J247.950H,cpd:C00106; cpd:C02648; cpd:C06144; cpd:C16734; cpd:C17601; cpd:C17602; cpd:C18474,4,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H5O2,C4H3O2,84.02112937,85.0289544,83.013304342840,3147,cpd:C06145,3-Butyn-1-al,C4H4O,3-Butyn-1-al,R05119 R05120 R05121,Butanoate metabolism,NA,NA,NA,CAS: 52844-23-2; PubChem: 8401; ChEBI: 28180; 3DMET: B00909; NIKKAJI: J694.532E,cpd:C06145; cpd:C14275; cpd:C19304,4,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H5O1,C4H3O1,68.02621475,69.03403978,67.018389722841,3148,cpd:C06146,3-Butyn-1-ol,C4H6O,3-Butyn-1-ol,R05121,Butanoate metabolism,NA,NA,NA,CAS: 927-74-2; PubChem: 8402; ChEBI: 27444; 3DMET: B00910; NIKKAJI: J1.744B,cpd:C04051; cpd:C05562; cpd:C06146; cpd:C14700; cpd:C17721; cpd:C19377; cpd:C20701,4,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O1,C4H5O1,70.04186481,71.04968985,69.034039782842,3149,cpd:C11062,4-Hydroxybutyryl-CoA;,C25H42N7O18P3S,4-Hydroxybutyryl-CoA; 4-Hydroxybutanoyl-CoA,R05336 R05337 R09279 R10758 R10782,Butanoate metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,2.8.3.-; 4.2.1.120; 6.2.1.40; 6.2.1.-,Dicarboxylate-hydroxybutyrate cycle; Hydroxypropionate-hydroxybutylate cycle,NA,PubChem: 13244; ChEBI: 28522; NIKKAJI: J907.603D,cpd:C01144; cpd:C03561; cpd:C04047; cpd:C05116; cpd:C06000; cpd:C11062; cpd:C21287,25,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C25H43O18N7P3S1,C25H41O18N7P3S1,853.1519897,854.1598147,852.14416472843,3150,cpd:C20657,"meso-2,3-Butanediol",C4H10O2,"meso-2,3-Butanediol",R10504 R10505,Butanoate metabolism,1.1.1.-,NA,NA,CAS: 5341-95-7; PubChem: 172232379; PDB-CCD: BU9,cpd:C00265; cpd:C00950; cpd:C03044; cpd:C03046; cpd:C03283; cpd:C08291; cpd:C11764; cpd:C13773; cpd:C14687; cpd:C20335; cpd:C20657; cpd:C21290,4,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O2,C4H9O2,90.06807956,91.07590459,89.060254532844,3151,cpd:C21390,Butane;,C4H10,Butane; Butan,R11448,Butanoate metabolism; Degradation of aromatic compounds,1.14.13.230,NA,NA,CAS: 106-97-8; PubChem: 328082933; PDB-CCD: NBU,cpd:C00265; cpd:C00503; cpd:C00950; cpd:C01102; cpd:C02272; cpd:C02305; cpd:C03044; cpd:C03046; cpd:C03283; cpd:C05702; cpd:C06055; cpd:C06142; cpd:C07973; cpd:C08270; cpd:C08291; cpd:C11764; cpd:C12147; cpd:C12215; cpd:C12839; cpd:C13240; cpd:C13660; cpd:C13773; cpd:C13811; cpd:C14422; cpd:C14426; cpd:C14687; cpd:C14689; cpd:C14706; cpd:C14710; cpd:C16884; cpd:C17962; cpd:C19278; cpd:C19637; cpd:C20335; cpd:C20657; cpd:C21290; cpd:C21389; cpd:C21390; cpd:C21403,4,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11,C4H9,58.07825032,59.08607535,57.070425292845,3152,cpd:C00490,Itaconate;,C5H6O4,Itaconate; Itaconic acid; Methylenesuccinic acid,R02243 R02404 R02405 R02406 R02407 R10600,C5-Branched dibasic acid metabolism,2.8.3.-; 4.1.1.6; 6.2.1.4; 6.2.1.5,NA,NA,CAS: 97-65-4; PubChem: 3773; ChEBI: 17240 30838; ChEMBL: CHEMBL359159; LIPIDMAPS: LMFA01170063; KNApSAcK: C00033964; PDB-CCD: ITN; 3DMET: B01264; NIKKAJI: J38.149G,cpd:C00337; cpd:C00433; cpd:C00490; cpd:C01732; cpd:C02132; cpd:C02214; cpd:C02226; cpd:C02800; cpd:C02871; cpd:C03306; cpd:C03703; cpd:C10600; cpd:C20756; cpd:C20757,5,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O4,C5H5O4,130.0266087,131.0344337,129.01878362846,3153,cpd:C00531,Itaconyl-CoA,C26H40N7O19P3S,Itaconyl-CoA,R02404 R02405 R02406 R02407 R02490 R02491 R10600,C5-Branched dibasic acid metabolism,2.8.3.-; 4.2.1.56; 6.2.1.4; 6.2.1.5,NA,NA,PubChem: 3813; ChEBI: 15528; 3DMET: B04696; NIKKAJI: J2.729.652A,cpd:C00531; cpd:C02411; cpd:C06028; cpd:C18323,26,40,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H41O19N7P3S1,C26H39O19N7P3S1,879.1312543,880.1390793,878.12342922847,3154,cpd:C00651,4-Methylene-L-glutamate,C6H9NO4,4-Methylene-L-glutamate,R02711 R02712 R02713,C5-Branched dibasic acid metabolism,3.5.1.67; 6.3.1.7,NA,NA,PubChem: 3922; ChEBI: 48031; ChEMBL: CHEMBL38499; 3DMET: B01299; NIKKAJI: J479.213K,cpd:C00651; cpd:C03623,6,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O4N1,C6H8O4N1,159.0531578,160.0609828,158.04533272848,3155,cpd:C01011,(3S)-Citramalyl-CoA;,C26H42N7O20P3S,(3S)-Citramalyl-CoA; L-Citramalyl-CoA; (S)-Citramalyl-CoA; (3S)-3-Carboxy-3-hydroxybutanoyl-CoA,R00237 R02491 R02955 R03153 R03154 R09282,C5-Branched dibasic acid metabolism; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,2.8.3.11; 2.8.3.22; 4.1.3.25; 4.2.1.56; 4.2.1.153,3-Hydroxypropionate bi-cycle,NA,PubChem: 4256; ChEBI: 36882; 3DMET: B04754; NIKKAJI: J2.731.084B,cpd:C00904; cpd:C01011; cpd:C03058; cpd:C06027; cpd:C20746,26,42,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H43O20N7P3S1,C26H41O20N7P3S1,897.1418189,898.149644,896.13399392849,3156,cpd:C01109,4-Methylene-L-glutamine,C6H10N2O3,4-Methylene-L-glutamine,R02711 R02712,C5-Branched dibasic acid metabolism,3.5.1.67; 6.3.1.7,NA,NA,PubChem: 4341; ChEBI: 16747; 3DMET: B01384; NIKKAJI: J227.459K,cpd:C01109; cpd:C03625; cpd:C03895; cpd:C15653; cpd:C16432; cpd:C21378,6,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O3N2,C6H9O3N2,158.0691422,159.0769672,157.06131722850,3157,cpd:C02614,(S)-2-Methylmalate;,C5H8O5,(S)-2-Methylmalate; (S)-2-Methylmalic acid; (S)-Citramalate; (S)-Citramalic acid; (S)-alpha-Hydroxypyrotartaric acid; L-Citramalate; L-Citramalic acid; L-alpha-Hydroxypyrotartaric acid; (2S)-2-Hydroxy-2-methylbutanedioate; (S)-2-Hydroxy-2-methylsuccinic acid,R00325 R03153 R03154 R03693,C5-Branched dibasic acid metabolism; Metabolic pathways,2.8.3.11; 2.8.3.22; 4.1.3.22; 4.2.1.34,NA,NA,CAS: 6236-09-5; PubChem: 5599; ChEBI: 29003 30936; KNApSAcK: C00001181; 3DMET: B00466; NIKKAJI: J73.969C,cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031,5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O5,C5H7O5,148.0371734,149.0449984,147.02934832851,3158,cpd:C06029,L-threo-3-Methylmalate,C5H8O5,L-threo-3-Methylmalate,R03694,C5-Branched dibasic acid metabolism,NA,NA,NA,PubChem: 8301; ChEBI: 28456; 3DMET: B01953; NIKKAJI: J1.436.825F,cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031,5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O5,C5H7O5,148.0371734,149.0449984,147.02934832852,3159,cpd:C06030,Methyloxaloacetate,C5H6O5,Methyloxaloacetate,R00995 R04269,C5-Branched dibasic acid metabolism,4.1.1.3,NA,NA,PubChem: 8302; ChEBI: 6885; 3DMET: B00888; NIKKAJI: J2.760.963E,cpd:C00026; cpd:C00165; cpd:C00641; cpd:C02715; cpd:C03716; cpd:C03957; cpd:C05406; cpd:C06030; cpd:C06316; cpd:C06380; cpd:C06437; cpd:C12248,5,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O5,C5H5O5,146.0215233,147.0293483,145.01369832853,3160,cpd:C06031,D-threo-3-Methylmalate,C5H8O5,D-threo-3-Methylmalate,R03897,C5-Branched dibasic acid metabolism,NA,NA,NA,PubChem: 8303; ChEBI: 27736; 3DMET: B01954; NIKKAJI: J1.773.645K,cpd:C00039; cpd:C00351; cpd:C00434; cpd:C00438; cpd:C00652; cpd:C00684; cpd:C00815; cpd:C00821; cpd:C00856; cpd:C00871; cpd:C00929; cpd:C00938; cpd:C01087; cpd:C01114; cpd:C02128; cpd:C02266; cpd:C02270; cpd:C02374; cpd:C02410; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02753; cpd:C02967; cpd:C02994; cpd:C03110; cpd:C03196; cpd:C03391; cpd:C03826; cpd:C04209; cpd:C04250; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C05405; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C11475; cpd:C16691; cpd:C17509; cpd:C17510; cpd:C21031,5,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O5,C5H7O5,148.0371734,149.0449984,147.02934832854,3161,cpd:C06034,4-Hydroxy-4-methylglutamate,C6H11NO5,4-Hydroxy-4-methylglutamate,R05077,C5-Branched dibasic acid metabolism,NA,NA,NA,PubChem: 8306; ChEBI: 1848 20384; 3DMET: B01957; NIKKAJI: J2.369.635E,cpd:C03168; cpd:C06034; cpd:C17576; cpd:C20844; cpd:C20845,6,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O5N1,C6H10O5N1,177.0637225,178.0715475,176.05589742855,3162,cpd:C06234,4-Methyl-L-glutamate,C6H11NO4,4-Methyl-L-glutamate,R05079,C5-Branched dibasic acid metabolism,NA,NA,NA,CAS: 14561-55-8; PubChem: 8476; ChEBI: 1893 20440; ChEMBL: CHEMBL41221; 3DMET: B05180; NIKKAJI: J39.919A,cpd:C00734; cpd:C00956; cpd:C01046; cpd:C01077; cpd:C02207; cpd:C03210; cpd:C05016; cpd:C06234; cpd:C17581; cpd:C19694,6,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O4N1,C6H10O4N1,161.0688078,162.0766329,160.06098282856,3163,cpd:C00234,10-Formyltetrahydrofolate;,C20H23N7O7,10-Formyltetrahydrofolate; 10-Formyl-THF,R00941 R00943 R00944 R01654 R01655 R03940 R04325 R04560; R07660,One carbon pool by folate; Carbon fixation pathways in prokaryotes; Aminoacyl-tRNA biosynthesis; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Antifolate resistance,1.5.1.6; 2.1.2.2; 2.1.2.3; 2.1.2.9; 2.1.2.13; 3.5.1.10; 3.5.4.9; 6.3.2.12; 6.3.2.17; 6.3.4.3,"C1-unit interconversion, prokaryotes; C1-unit interconversion, eukaryotes; Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway)",NA,CAS: 2800-34-2; PubChem: 3533; ChEBI: 15637; 3DMET: B04652; NIKKAJI: J356.348K,cpd:C00234; cpd:C03479,20,23,7,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H24O7N7,C20H22O7N7,473.1658961,474.1737211,472.15807112857,3164,cpd:C00415,Dihydrofolate;,C19H21N7O6,"Dihydrofolate; Dihydrofolic acid; 7,8-Dihydrofolate; 7,8-Dihydrofolic acid; 7,8-Dihydropteroylglutamate",R00936 R00939 R01670 R02101 R02235 R02236 R02237 R02238,One carbon pool by folate; Folate biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Antifolate resistance,1.5.1.3; 2.1.1.45; 2.1.1.54; 6.3.2.12; 6.3.2.17; 6.3.4.17,"Tetrahydrofolate biosynthesis, GTP => THF",NA,CAS: 4033-27-6; PubChem: 3705; ChEBI: 15633; ChEMBL: CHEMBL46294; KNApSAcK: C00007248; PDB-CCD: DHF; 3DMET: B01240; NIKKAJI: J373.767E,cpd:C00415,19,21,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H22O6N7,C19H20O6N7,443.1553314,444.1631565,442.14750642858,3165,cpd:C00440,5-Methyltetrahydrofolate,C20H25N7O6,5-Methyltetrahydrofolate,R00946 R01217 R01224 R02289 R02573 R02912 R07168 R09270; R09271 R10136 R10243 R10333,One carbon pool by folate; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism; Antifolate resistance,1.5.1.20; 1.5.7.1; 2.1.1.13; 2.1.1.19; 2.1.1.258; 2.1.1.269; 2.1.1.-; 2.3.1.169,Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway),NA,CAS: 134-35-0; PubChem: 3729; ChEBI: 15641; ChEMBL: CHEMBL1221561 CHEMBL1231574; KNApSAcK: C00007252; PDB-CCD: C2F THH; 3DMET: B04681; NIKKAJI: J356.349I,cpd:C00440,20,25,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H26O6N7,C20H24O6N7,459.1866316,460.1944566,458.17880652859,3166,cpd:C00445,"5,10-Methenyltetrahydrofolate",C20H22N7O6,"5,10-Methenyltetrahydrofolate",R01218 R01220 R01655 R02300 R02301 R02302 R04326,One carbon pool by folate; Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.5.1.5; 1.5.1.15; 2.1.2.2; 2.1.2.10; 3.5.4.9; 4.3.1.4; 6.3.3.2,"C1-unit interconversion, prokaryotes; C1-unit interconversion, eukaryotes; Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway)",NA,PubChem: 3733; ChEBI: 15638; 3DMET: B04682; NIKKAJI: J1.213.619F,cpd:C00445,20,22,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H23O6N7,C20H21O6N7,456.1631565,457.1709815,455.15533142860,3167,cpd:C00504,Folate;,C19H19N7O6,Folate; Pteroylglutamic acid; Folic acid,R00937 R00940 R02235 R02236,One carbon pool by folate; Folate biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Antifolate resistance; Bile secretion; Vitamin digestion and absorption,1.5.1.3,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Water-soluble vitamins;     C00504  Folic acid (Vitamin B9); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B03 ANTIANEMIC PREPARATIONS;    B03B VITAMIN B12 AND FOLIC ACID;     B03BB Folic acid and derivatives;      B03BB01 Folic acid;       D00070  Folic acid (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    313  Vitamin B preparations;     3135  Folic acids;      D00070  Folic acid (JP17/USP/INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for circulatory system and blood;   24 Anemia drugs;    D00070  Folic acid (JP17/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Folic acid;     D00070  Folic acid (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00070  Folic acid;   D00070  Folic acid tablets;   D00070  Folic acid injection,CAS: 59-30-3; PubChem: 3787; ChEBI: 27470; ChEMBL: CHEMBL1622; KNApSAcK: C00001539; PDB-CCD: FOL; 3DMET: B01273; NIKKAJI: J1.392G,cpd:C00504,19,19,6,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H20O6N7,C19H18O6N7,441.1396814,442.1475064,440.13185632861,3168,cpd:C00664,5-Formiminotetrahydrofolate;,C20H24N8O6,5-Formiminotetrahydrofolate; 5-Formimidoyltetrahydrofolate,R02287 R02302 R02729,One carbon pool by folate; Metabolic pathways,2.1.2.4; 2.1.2.5; 4.3.1.4,NA,NA,PubChem: 3933; ChEBI: 15639; 3DMET: B04712; NIKKAJI: J2.729.864H,cpd:C00664,20,24,6,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O6N8,C20H23O6N8,472.1818805,473.1897056,471.17405552862,3169,cpd:C03479,Folinic acid;,C20H23N7O7,"Folinic acid; Leucovorin; 5-Formyltetrahydrofolate; L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid",R02300 R02301 R03189 R08701,One carbon pool by folate; Metabolic pathways,2.1.2.5; 2.1.2.10; 6.3.3.2,NA,"USP drug classification [BR:br08302];  Antineoplastics;   Antineoplastics, Other;    Leucovorin;     D07986  Folinic acid (BAN)",CAS: 58-05-9; PubChem: 6294; ChEBI: 15640; ChEMBL: CHEMBL69905; PDB-CCD: FFO FOZ; 3DMET: B04899; NIKKAJI: J9.322J,cpd:C00234; cpd:C03479,20,23,7,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H24O7N7,C20H22O7N7,473.1658961,474.1737211,472.15807112863,3170,cpd:C00218,Methylamine;,CH5N,Methylamine; Methanamine,R00606 R01584 R01585 R01586 R01587 R01588 R01589 R02919; R03359 R03620 R04894 R05862 R06154 R07227 R08347 R09471; R09998 R09999 R10014 R10015 R10101 R10103 R11178,Methane metabolism; Microbial metabolism in diverse environments; Carbon metabolism,1.4.1.17; 1.4.3.4; 1.4.3.19; 1.4.3.21; 1.4.3.24; 1.4.9.1; 1.5.3.21; 1.5.8.1; 1.21.4.3; 2.1.1.21; 2.1.1.247; 2.1.1.248; 2.1.1.249; 3.5.1.36; 3.5.1.39; 3.5.3.16; 4.2.1.88; 6.3.4.12,"Methanogenesis, methylamine/dimethylamine/trimethylamine => methane",NA,CAS: 74-89-5; PubChem: 3518; ChEBI: 16830; ChEMBL: CHEMBL43280; PDB-CCD: NME; 3DMET: B00060; NIKKAJI: J1.431A,cpd:C00218,1,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H6N1,C1H4N1,31.04219917,32.0500242,30.034374132864,3171,cpd:C00543,Dimethylamine;,C2H7N,Dimethylamine; (CH3)2NH,R01588 R02509 R02511 R02512 R02513 R08346 R09124 R09999; R10015 R10016,Methane metabolism; Microbial metabolism in diverse environments; Carbon metabolism,1.4.3.4; 1.5.8.1; 1.5.8.2; 2.1.1.247; 2.1.1.249; 2.1.1.250; 3.5.1.56; 3.5.3.18; 4.1.2.32,"Methanogenesis, methylamine/dimethylamine/trimethylamine => methane",NA,CAS: 124-40-3; PubChem: 3824; ChEBI: 17170; ChEMBL: CHEMBL120433; PDB-CCD: DMN; 3DMET: B00125; NIKKAJI: J2.933E,cpd:C00189; cpd:C00245; cpd:C00519; cpd:C00543; cpd:C00797; cpd:C01678,2,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H8N1,C2H6N1,45.05784923,46.06567426,44.05002422865,3172,cpd:C00565,Trimethylamine;,C3H9N,"Trimethylamine; (CH3)3N; N,N-Dimethylmethanamine",R02511 R02559 R02560 R04877 R05623 R07228 R09124 R10016; R10017 R10285,Methane metabolism; Microbial metabolism in diverse environments; Carbon metabolism,1.5.8.2; 1.6.6.9; 1.14.13.148; 1.21.4.4; 2.1.1.247; 2.1.1.250; 2.1.1.252; 4.3.99.4,"Methanogenesis, methylamine/dimethylamine/trimethylamine => methane",NA,CAS: 75-50-3; PubChem: 3844; ChEBI: 18139; ChEMBL: CHEMBL439723; KNApSAcK: C00001433; PDB-CCD: KEN; 3DMET: B00133; NIKKAJI: J1.457E,cpd:C00565; cpd:C01104; cpd:C03194; cpd:C03349; cpd:C05771; cpd:C06057; cpd:C06748; cpd:C18564,3,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H10N1,C3H8N1,59.07349929,60.08132433,58.065674262866,3173,cpd:C00862,Methanofuran;,C34H44N4O15,Methanofuran; Carbon dioxide reduction factor,R03015 R03390 R08060,Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.2.99.5; 2.3.1.101,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00862  Methanofuran,CAS: 89873-36-9; PubChem: 4119; ChEBI: 17448; 3DMET: B04737; NIKKAJI: J884.451H,cpd:C00862,34,44,15,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H45O15N4,C34H43O15N4,748.2803167,749.2881418,747.27249172867,3174,cpd:C00876,Coenzyme F420;,C29H36N5O18P,Coenzyme F420; Oxidized coenzyme F420,R03025 R04456 R04464 R05459 R09192 R09400 R09401 R09550; R09749 R10572 R10574 R10602 R10603 R10797 R10803,Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.1.98.2; 1.1.98.4; 1.1.98.5; 1.2.99.9; 1.3.98.4; 1.5.1.40; 1.5.3.22; 1.5.7.2; 1.5.98.1; 1.5.98.2; 1.8.98.3; 1.12.98.1; 6.3.2.32; 6.3.2.34,F420 biosynthesis,NA,CAS: 64885-97-8; PubChem: 4132; ChEBI: 16848; PDB-CCD: F42; 3DMET: B04739,cpd:C00876,29,36,18,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H37O18N5P1,C29H35O18N5P1,773.1792963,774.1871214,772.17147132868,3175,cpd:C01001,Formylmethanofuran,C35H44N4O16,Formylmethanofuran,R03015 R03390 R08060,Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.2.99.5; 2.3.1.101,"Methanogenesis, CO2 => methane",NA,CAS: 94483-60-0; PubChem: 4247; ChEBI: 16314; 3DMET: B04753; NIKKAJI: J634.979J,cpd:C01001,35,44,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H45O16N4,C35H43O16N4,776.2752313,777.2830564,775.26740632869,3176,cpd:C01031,S-Formylglutathione,C11H17N3O7S,S-Formylglutathione,R00527 R06983 R07140,Methane metabolism; Microbial metabolism in diverse environments,1.1.1.284; 3.1.2.12,NA,NA,CAS: 50409-81-9; PubChem: 4274; ChEBI: 16225; 3DMET: B01368; NIKKAJI: J1.171.612A,cpd:C01031,11,17,7,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H18O7N3S1,C11H16O7N3S1,335.0787211,336.0865461,334.0708962870,3177,cpd:C01046,N-Methyl-L-glutamate;,C6H11NO4,N-Methyl-L-glutamate; N-Methyl-L-glutamic acid,R00609 R01586,Methane metabolism; Microbial metabolism in diverse environments,1.5.99.5; 2.1.1.21,NA,NA,PubChem: 4288; ChEBI: 16440; PDB-CCD: EME; 3DMET: B01370; NIKKAJI: J253.918G,cpd:C00734; cpd:C00956; cpd:C01046; cpd:C01077; cpd:C02207; cpd:C03210; cpd:C05016; cpd:C06234; cpd:C17581; cpd:C19694,6,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O4N1,C6H10O4N1,161.0688078,162.0766329,160.06098282871,3178,cpd:C01080,Reduced coenzyme F420,C29H38N5O18P,Reduced coenzyme F420,R03025 R04456 R04464 R05459 R09192 R09550 R09749 R10572; R10574 R10602 R10603 R10797 R10803,Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.1.98.2; 1.1.98.4; 1.1.98.5; 1.2.99.9; 1.3.98.4; 1.5.1.40; 1.5.3.22; 1.5.7.2; 1.5.98.1; 1.5.98.2; 1.8.98.3; 1.12.98.1,NA,NA,PubChem: 4318; ChEBI: 15823; 3DMET: B04763; NIKKAJI: J2.731.209H,cpd:C01080,29,38,18,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H39O18N5P1,C29H37O18N5P1,775.1949464,776.2027714,774.18712142872,3179,cpd:C01104,Trimethylamine N-oxide;,C3H9NO,Trimethylamine N-oxide; (CH3)3NO,R02512 R02559 R02560 R05623,Methane metabolism; Microbial metabolism in diverse environments; Two-component system,1.6.6.9; 1.14.13.148; 4.1.2.32,NA,NA,CAS: 1184-78-7; PubChem: 4338; ChEBI: 15724; PDB-CCD: TMO; 3DMET: B01382; NIKKAJI: J7.304K,cpd:C01104; cpd:C03194; cpd:C05771,3,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H10O1N1,C3H8O1N1,75.06841391,76.07623895,74.060588882873,3180,cpd:C01217,"5,6,7,8-Tetrahydromethanopterin;",C30H45N6O16P,"5,6,7,8-Tetrahydromethanopterin; H4MPT; THMPT; Tetrahydromethanopterin",R03388 R03390 R04347 R08058 R09096 R09099 R09594 R10332; R10802,Methane metabolism; Folate biosynthesis; Microbial metabolism in diverse environments; Carbon metabolism,1.5.1.47; 1.5.99.15; 2.1.1.86; 2.1.2.1; 2.3.1.101; 2.3.1.-; 4.2.1.147; 6.3.2.33,NA,"Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C01217  5,6,7,8-Tetrahydromethanopterin",CAS: 92481-94-2; PubChem: 4439; ChEBI: 17321; 3DMET: B01409; NIKKAJI: J1.153.548H,cpd:C01217,30,45,16,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H46O16N6P1,C30H44O16N6P1,776.2629664,777.2707914,775.25514142874,3181,cpd:C01274,"5-Formyl-5,6,7,8-tetrahydromethanopterin;",C31H45N6O17P,"5-Formyl-5,6,7,8-tetrahydromethanopterin; 5-Formyl-H4MPT",R03390 R03464,Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,2.3.1.101; 3.5.4.27,"Methanogenesis, CO2 => methane",NA,CAS: 99451-79-3; PubChem: 4493; ChEBI: 17114; PDB-CCD: H4Z; 3DMET: B01431; NIKKAJI: J1.629.926J,cpd:C01274,31,45,17,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H46O17N6P1,C31H44O17N6P1,804.257881,805.265706,803.2500562875,3182,cpd:C03576,Coenzyme M;,C2H6O3S2,Coenzyme M; 2-Mercaptoethanesulfonate; Reduced coenzyme M; HS-CoM; CoM,R04347 R04540 R05713 R05761 R05762 R09092 R09098 R09124; R09153 R09997 R09998 R09999 R10000 R10660,Methane metabolism; Microbial metabolism in diverse environments; Carbon metabolism,1.3.4.1; 1.8.1.5; 1.8.98.1; 2.1.1.86; 2.1.1.90; 2.1.1.246; 2.1.1.247; 2.1.1.248; 2.1.1.249; 2.1.1.250; 2.1.1.251; 2.1.1.253; 4.4.1.23,"Coenzyme M biosynthesis; Methanogenesis, CO2 => methane",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C03576  Coenzyme M,CAS: 3375-50-6; PubChem: 6368; ChEBI: 17905; ChEMBL: CHEMBL1098319; KNApSAcK: C00000761; PDB-CCD: COM; 3DMET: B00605; NIKKAJI: J135.783B,cpd:C03576,2,6,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C2H7O3S2,C2H5O3S2,141.9758364,142.9836614,140.96801142876,3183,cpd:C03920,2-(Methylthio)ethanesulfonate;,C3H8O3S2,2-(Methylthio)ethanesulfonate; Methylcoenzyme M; Methyl-CoM,R04347 R04541 R09098 R09124 R09997 R09998 R09999 R10000,Methane metabolism; Sulfur metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,2.1.1.86; 2.1.1.90; 2.1.1.246; 2.1.1.247; 2.1.1.248; 2.1.1.249; 2.1.1.250; 2.1.1.251; 2.1.1.253; 2.8.4.1,"Methanogenesis, methanol => methane; Methanogenesis, acetate => methane; Methanogenesis, methylamine/dimethylamine/trimethylamine => methane; Methanogenesis, CO2 => methane",NA,PubChem: 6649; ChEBI: 17827; KNApSAcK: C00000762; 3DMET: B00654; NIKKAJI: J814.297A,cpd:C03920,3,8,3,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O3S2,C3H7O3S2,155.9914865,156.9993115,154.98366142877,3184,cpd:C04330,"5,10-Methenyltetrahydromethanopterin;",C31H44N6O16P,"5,10-Methenyltetrahydromethanopterin; 5,10-Methenyl-5,6,7,8-tetrahydromethanopterin; N5,N10-Methenyltetrahydromethanopterin",R03464 R04455 R04456 R08059,Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.5.1.-; 1.5.98.1; 1.12.98.2; 3.5.4.27,"Methanogenesis, CO2 => methane",NA,PubChem: 6982; ChEBI: 17975; PDB-CCD: E4M; 3DMET: B01734; NIKKAJI: J2.750.003J,cpd:C04330,31,44,16,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H45O16N6P1,C31H43O16N6P1,787.2551414,788.2629664,786.24731632878,3185,cpd:C04377,"5,10-Methylenetetrahydromethanopterin;",C31H45N6O16P,"5,10-Methylenetetrahydromethanopterin; N5,N10-Methylenetetrahydromethanopterin",R04455 R04456 R04464 R08058 R08059 R09099,Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.5.1.-; 1.5.98.1; 1.5.98.2; 1.12.98.2; 2.1.2.1; 4.2.1.147,"Methanogenesis, CO2 => methane",NA,PubChem: 7018; ChEBI: 16568; PDB-CCD: H4M; 3DMET: B01737,cpd:C04377,31,45,16,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H46O16N6P1,C31H44O16N6P1,788.2629664,789.2707914,787.25514142879,3186,cpd:C04488,"5-Methyl-5,6,7,8-tetrahydromethanopterin;",C31H47N6O16P,"5-Methyl-5,6,7,8-tetrahydromethanopterin; 5-Methyltetrahydromethanopterin; 5-Methyl-H4MPT; 5-Methyl-THMPT",R04347 R04464 R09096,Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.5.98.2; 2.1.1.86; 2.3.1.-,"Methanogenesis, acetate => methane; Methanogenesis, CO2 => methane",NA,CAS: 92481-97-5; PubChem: 7107; 3DMET: B01747; NIKKAJI: J2.751.521E,cpd:C04488,31,47,16,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H48O16N6P1,C31H46O16N6P1,790.2786165,791.2864415,789.27079142880,3187,cpd:C04628,Coenzyme B;,C11H22NO7PS,Coenzyme B; N-(7-Mercaptoheptanoyl)threonine 3-O-phosphate; N-(7-Mercaptoheptanoyl)threonine O3-phosphate; HTP,R04540 R04541 R08217 R09092 R10660,Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.3.4.1; 1.8.98.1; 2.7.1.-; 2.8.4.1,"Methanogenesis, methanol => methane; Methanogenesis, acetate => methane; Methanogenesis, methylamine/dimethylamine/trimethylamine => methane; Methanogenesis, CO2 => methane",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C04628  Coenzyme B,CAS: 104302-77-4; PubChem: 7217; ChEBI: 28890; KNApSAcK: C00000760; PDB-CCD: TP7; 3DMET: B01766; NIKKAJI: J372.864A,cpd:C04628,11,22,7,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H23O7N1P1S1,C11H21O7N1P1S1,343.0854602,344.0932853,342.07763522881,3188,cpd:C04732,5-Amino-6-(1-D-ribitylamino)uracil;,C9H16N4O6,"5-Amino-6-(1-D-ribitylamino)uracil; 5-Amino-6-(D-ribitylamino)uracil; 6-(1-D-Ribitylamino)-5-amino-2,4-dihydroxypyrimidine; 6-(1-D-Ribitylamino)-5-aminouracil; 4-(1-D-Ribitylamino)-5-amino-2,6-dihydroxypyrimidine",R00066 R04457 R07280 R09396,Methane metabolism; Riboflavin metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments,2.5.1.9; 2.5.1.77; 2.5.1.78; 3.1.3.104,"Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD; F420 biosynthesis",NA,PubChem: 7303; ChEBI: 15934; 3DMET: B04958; NIKKAJI: J642.641G,cpd:C04732,9,16,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O6N4,C9H15O6N4,276.1069843,277.1148093,275.09915922882,3189,cpd:C04832,Coenzyme M 7-mercaptoheptanoylthreonine-phosphate heterodisulfide;,C13H26NO10PS3,Coenzyme M 7-mercaptoheptanoylthreonine-phosphate heterodisulfide; Coenzyme M-HTP heterodisulfide; CoM-S-S-CoB; N-{7-[(2-Sulfoethyl)dithio]heptanoyl}-3-O-phospho-L-threonine,R04540 R04541 R09092 R10660,Methane metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,1.3.4.1; 1.8.98.1; 2.8.4.1,"Methanogenesis, methanol => methane; Methanogenesis, acetate => methane; Methanogenesis, methylamine/dimethylamine/trimethylamine => methane; Methanogenesis, CO2 => methane",NA,PubChem: 7393; ChEBI: 18209; 3DMET: B01796; NIKKAJI: J977.616H,cpd:C04832,13,26,10,1,1,3,0,0,0,0,0,0,0,0,0,0,0,0,C13H27O10N1P1S3,C13H25O10N1P1S3,483.0456466,484.0534716,482.03782152883,3190,cpd:C11536,(2R)-O-Phospho-3-sulfolactate;,C3H7O9PS,(2R)-O-Phospho-3-sulfolactate; (2R)-Phosphosulfolactate,R05789 R07476,Methane metabolism; Microbial metabolism in diverse environments,3.1.3.71; 4.4.1.19,Coenzyme M biosynthesis,NA,PubChem: 13703; ChEBI: 32896; NIKKAJI: J1.682.158F,cpd:C11536,3,7,9,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O9P1S1,C3H6O9P1S1,249.95484,250.962665,248.94701492884,3191,cpd:C14180,S-(Hydroxymethyl)glutathione,C11H19N3O7S,S-(Hydroxymethyl)glutathione,R06982 R06983 R07140,Methane metabolism; Microbial metabolism in diverse environments,1.1.1.284; 4.4.1.22,NA,NA,CAS: 32260-87-0; PubChem: 7846992; ChEBI: 48926; PDB-CCD: AHE; NIKKAJI: J634.596D,cpd:C14180,11,19,7,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H20O7N3S1,C11H18O7N3S1,337.0943711,338.1021962,336.08654612885,3192,cpd:C16583,(R)-(Homo)2-citrate;,C8H12O7,"(R)-(Homo)2-citrate; (R)-2-Hydroxy-1,2,5-pentanetricarboxylate; (R)-2-Hydroxy-1,2,5-pentanetricarboxylic acid",R08331 R10391 R10392,Methane metabolism; Microbial metabolism in diverse environments; 2-Oxocarboxylic acid metabolism,2.3.3.-; 4.2.1.114,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,PubChem: 51090911; ChEBI: 72694; NIKKAJI: J2.803.990E,cpd:C16583; cpd:C16597,8,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O7,C8H11O7,220.0583027,221.0661278,219.05047772886,3193,cpd:C16588,2-Oxopimelate;,C7H10O5,2-Oxopimelate; alpha-Ketopimelate; 2-Oxoheptanedionic acid,R08214 R08332,Methane metabolism; Microbial metabolism in diverse environments; 2-Oxocarboxylic acid metabolism,1.1.1.-; 2.3.3.-,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C16588  2-Oxopimelate,PubChem: 51090915; ChEBI: 72700 72701; ChEMBL: CHEMBL185075; KNApSAcK: C00000771; PDB-CCD: 6GT; NIKKAJI: J318.156A,cpd:C00493; cpd:C04236; cpd:C16588; cpd:C17696; cpd:C18307; cpd:C18312; cpd:C20961; cpd:C21281,7,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O5,C7H9O5,174.0528234,175.0606485,173.04499842887,3194,cpd:C16589,2-Oxosuberate;,C8H12O5,2-Oxosuberate; 2-Oxooctanedionic acid; alpha-Ketosuberate,R08215 R08328,Methane metabolism; Microbial metabolism in diverse environments; 2-Oxocarboxylic acid metabolism,1.1.1.-,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    2-Oxocarboxylic acids;     C16589  2-Oxosuberate,PubChem: 51090916; ChEBI: 80587; KNApSAcK: C00000773; NIKKAJI: J986.934D,cpd:C11184; cpd:C11262; cpd:C16589; cpd:C17359,8,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O5,C8H11O5,188.0684735,189.0762985,187.06064852888,3195,cpd:C16590,7-Oxoheptanoic acid;,C7H12O3,7-Oxoheptanoic acid; 7-Ketoheptanoic acid,R08328 R10397,Methane metabolism; Microbial metabolism in diverse environments,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C16590  7-Oxoheptanoic acid,PubChem: 51090917; ChEBI: 80588; NIKKAJI: J319.562G,cpd:C03022; cpd:C04404; cpd:C16362; cpd:C16590; cpd:C17216; cpd:C19092,7,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O3,C7H11O3,144.0786442,145.0864693,143.07081922889,3196,cpd:C16593,7-Mercaptoheptanoic acid,C7H14O2S,7-Mercaptoheptanoic acid,R08323 R10397,Methane metabolism; Microbial metabolism in diverse environments,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0113 Thia fatty acids;     C16593  7-Mercaptoheptanoic acid,CAS: 52000-32-5; PubChem: 51090920; ChEBI: 80591; KNApSAcK: C00000772; NIKKAJI: J659.994J,cpd:C11015; cpd:C16593; cpd:C18645,7,14,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O2S1,C7H13O2S1,162.0714509,163.0792759,161.06362582890,3197,cpd:C16594,7-Mercaptoheptanoylthreonine,C11H21NO4S,7-Mercaptoheptanoylthreonine,R08217 R08323,Methane metabolism; Microbial metabolism in diverse environments,2.7.1.-,NA,NA,PubChem: 51090921; ChEBI: 80592; KNApSAcK: C00000768; NIKKAJI: J2.804.049K,cpd:C16594,11,21,4,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H22O4N1S1,C11H20O4N1S1,263.1191293,264.1269544,262.11130432891,3198,cpd:C16597,(-)-threo-Iso(homo)2-citrate;,C8H12O7,"(-)-threo-Iso(homo)2-citrate; (-)-threo-1-Hydroxy-1,2,5-pentanetricarboxylic acid; 1-Hydroxypentane-1,2,5-tricarboxylate; threo-(Homo)2-isocitrate",R08214 R10391 R10393,Methane metabolism; Microbial metabolism in diverse environments; 2-Oxocarboxylic acid metabolism,1.1.1.-; 4.2.1.114,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,PubChem: 51090924; ChEBI: 72713; ChEMBL: CHEMBL225984; NIKKAJI: J2.804.050D,cpd:C16583; cpd:C16597,8,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O7,C8H11O7,220.0583027,221.0661278,219.05047772892,3199,cpd:C16598,(R)-(Homo)3-citrate;,C9H14O7,"(R)-(Homo)3-citrate; (R)-2-Hydroxy-1,2,6-hexanetricarboxylate; (R)-2-Hydroxy-1,2,6-hexanetricarboxylic acid",R08332 R10394 R10395,Methane metabolism; Microbial metabolism in diverse environments; 2-Oxocarboxylic acid metabolism,2.3.3.-; 4.2.1.114,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,PubChem: 51090925; ChEBI: 72698; NIKKAJI: J2.804.053I,cpd:C00239; cpd:C00856; cpd:C02399; cpd:C03536; cpd:C03637; cpd:C05925; cpd:C16598; cpd:C16600; cpd:C20566,9,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O7,C9H13O7,234.0739528,235.0817778,233.06612782893,3200,cpd:C16600,(-)-threo-Iso(homo)3-citrate;,C9H14O7,"(-)-threo-Iso(homo)3-citrate; (-)-threo-1-Hydroxy-1,2,6-hexanetricarboxylic acid; 1-Hydroxyhexane-1,2,6-tricarboxylate; threo-(Homo)3-isocitrate",R08215 R10394 R10396,Methane metabolism; Microbial metabolism in diverse environments; 2-Oxocarboxylic acid metabolism,1.1.1.-; 4.2.1.114,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,PubChem: 51090926; ChEBI: 80595; ChEMBL: CHEMBL390799; NIKKAJI: J2.804.054G,cpd:C00239; cpd:C00856; cpd:C02399; cpd:C03536; cpd:C03637; cpd:C05925; cpd:C16598; cpd:C16600; cpd:C20566,9,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O7,C9H13O7,234.0739528,235.0817778,233.06612782894,3201,cpd:C19151,Coenzyme F420-3,C34H43N6O21P,Coenzyme F420-3,R09401,Methane metabolism; Microbial metabolism in diverse environments,6.3.2.32,NA,NA,CAS: 106324-58-7; PubChem: 124489823; ChEBI: 59537; PDB-CCD: 6J4,cpd:C19151,34,43,21,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H44O21N6P1,C34H42O21N6P1,902.2218894,903.2297145,901.21406442895,3202,cpd:C19152,Coenzyme F420-1,C24H29N4O15P,Coenzyme F420-1,R09399 R09400,Methane metabolism; Microbial metabolism in diverse environments,6.3.2.31; 6.3.2.34,F420 biosynthesis,NA,PubChem: 124489824; ChEBI: 59536,cpd:C19152,24,29,15,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H30O15N4P1,C24H28O15N4P1,644.1367032,645.1445283,643.12887822896,3203,cpd:C19153,Coenzyme F420-0,C19H22N3O12P,Coenzyme F420-0,R09398 R09399,Methane metabolism; Microbial metabolism in diverse environments,2.7.8.28; 6.3.2.31,F420 biosynthesis,NA,PubChem: 124489825; ChEBI: 59532; PDB-CCD: 6J2,cpd:C19153,19,22,12,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O12N3P1,C19H21O12N3P1,515.0941102,516.1019352,514.08628512897,3204,cpd:C19154,"7,8-Didemethyl-8-hydroxy-5-deazariboflavin",C16H17N3O7,"7,8-Didemethyl-8-hydroxy-5-deazariboflavin",R09396 R09398,Methane metabolism; Microbial metabolism in diverse environments,2.5.1.77; 2.7.8.28,F420 biosynthesis,NA,CAS: 37333-48-5; PubChem: 124489826; ChEBI: 43034; KNApSAcK: C00017667; PDB-CCD: FO1,cpd:C06887; cpd:C19154,16,17,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H18O7N3,C16H16O7N3,363.1066499,364.1144749,362.09882492898,3205,cpd:C19155,(2S)-Lactyl-2-diphospho-5'-guanosine,C13H19N5O13P2,(2S)-Lactyl-2-diphospho-5'-guanosine,R09397 R09398,Methane metabolism; Microbial metabolism in diverse environments,2.7.7.68; 2.7.8.28,F420 biosynthesis,NA,PubChem: 124489827; ChEBI: 59436,cpd:C02509; cpd:C19155,13,19,13,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H20O13N5P2,C13H18O13N5P2,515.0454597,516.0532847,514.03763472899,3206,cpd:C19156,(2S)-2-Phospholactate,C3H7O6P,(2S)-2-Phospholactate,R09397,Methane metabolism; Microbial metabolism in diverse environments,2.7.7.68,F420 biosynthesis,NA,PubChem: 124489828; ChEBI: 45013; ChEMBL: CHEMBL1235229; PDB-CCD: PEQ,cpd:C00111; cpd:C00118; cpd:C00661; cpd:C05217; cpd:C12935; cpd:C19156,3,7,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O6P1,C3H6O6P1,169.9980249,171.00585,168.99019992900,3207,cpd:C20581,cis-(Homo)2-aconitate,C8H10O6,cis-(Homo)2-aconitate,R10392 R10393,Methane metabolism; Microbial metabolism in diverse environments; 2-Oxocarboxylic acid metabolism,4.2.1.114,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,PubChem: 172232318,cpd:C00018; cpd:C20581,8,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O6,C8H9O6,202.047738,203.0555631,201.0399132901,3208,cpd:C20582,cis-(Homo)3-aconitate,C9H12O6,cis-(Homo)3-aconitate,R10395 R10396,Methane metabolism; Microbial metabolism in diverse environments; 2-Oxocarboxylic acid metabolism,4.2.1.114,"2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate",NA,PubChem: 172232319,cpd:C00299; cpd:C02067; cpd:C06501; cpd:C16745; cpd:C20567; cpd:C20582,9,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13O6,C9H11O6,216.0633881,217.0712131,215.05556312902,3209,cpd:C20926,gamma-Glutamyltyramine;,C13H18N2O4,gamma-Glutamyltyramine; gamma-L-Glutamyltyramine,R10902 R11040,Methane metabolism,2.5.1.131; 6.3.4.24,NA,NA,PubChem: 254741389,cpd:C17370; cpd:C17405; cpd:C20926,13,18,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H19O4N2,C13H17O4N2,266.1266571,267.1344821,265.1188322903,3210,cpd:C20954,(5-Formylfuran-3-yl)methyl phosphate;,C6H7O6P,(5-Formylfuran-3-yl)methyl phosphate; 2-Furaldehyde phosphate; 4-HFC-P; 4-(Hydroxymethyl)-2-furancarboxaldehyde phosphate,R10935 R11038,Methane metabolism,2.6.1.108; 4.2.3.153,NA,NA,PubChem: 254741415,cpd:C20954,6,7,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O6P1,C6H6O6P1,205.9980249,207.00585,204.99019992904,3211,cpd:C21068,[5-(Aminomethyl)furan-3-yl]methyl phosphate;,C6H10NO5P,[5-(Aminomethyl)furan-3-yl]methyl phosphate; 5-(Aminomethyl)-3-furanmethanol phosphate,R11038 R11039,Methane metabolism,2.6.1.108; 2.7.4.31,NA,NA,PubChem: 295369330,cpd:C21068,6,10,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5N1P1,C6H9O5N1P1,207.0296594,208.0374845,206.02183442905,3212,cpd:C21069,[5-(Aminomethyl)furan-3-yl]methyl diphosphate;,C6H11NO8P2,[5-(Aminomethyl)furan-3-yl]methyl diphosphate; 5-(Aminomethyl)-3-furanmethanol diphosphate,R11039 R11040,Methane metabolism,2.5.1.131; 2.7.4.31,NA,NA,PubChem: 295369331,cpd:C21069,6,11,8,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O8N1P2,C6H10O8N1P2,286.9959903,288.0038153,285.98816532906,3213,cpd:C21070,(4-{4-[2-(gamma-L-Glutamylamino)ethyl]phenoxymethyl}furan-2-yl)methanamine;,C19H25N3O5,(4-{4-[2-(gamma-L-Glutamylamino)ethyl]phenoxymethyl}furan-2-yl)methanamine; 4-[N-(gamma-L-Glutamyl)-p-(beta-aminoethyl)phenoxymethyl]-2-(aminomethyl)furan; APMF-Glu,R11040,Methane metabolism,2.5.1.131,NA,NA,PubChem: 295369332,cpd:C21070,19,25,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H26O5N3,C19H24O5N3,375.1794209,376.1872459,374.17159592907,3214,cpd:C00447,"Sedoheptulose 1,7-bisphosphate;",C7H16O13P2,"Sedoheptulose 1,7-bisphosphate; D-Sedoheptulose 1,7-bisphosphate; D-altro-Heptulose 1,7-biphosphate",R01829 R01843 R01845,Carbon fixation in photosynthetic organisms; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,2.7.1.11; 3.1.3.11; 3.1.3.37; 4.1.2.13,"Reductive pentose phosphate cycle (Calvin cycle); Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P",NA,CAS: 815-91-8; PubChem: 3735; ChEBI: 17969; 3DMET: B04683; NIKKAJI: J604.571E,cpd:C00447; cpd:C11472; cpd:C19879,7,16,13,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H17O13P2,C7H15O13P2,370.0066146,371.0144396,368.99878952908,3215,cpd:C02076,Sedoheptulose;,C7H14O7,Sedoheptulose; D-altro-Heptulose; D-Sedoheptulose; Volemulose,R01844 R03819,Carbon fixation in photosynthetic organisms,2.7.1.3; 2.7.1.14,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Ketoses;     C02076  Sedoheptulose,CAS: 3019-74-7; PubChem: 5162; ChEBI: 16802 27520; 3DMET: B04838; NIKKAJI: J14.590D,cpd:C02076; cpd:C08236; cpd:C08355; cpd:C19612; cpd:C21042; cpd:C21043,7,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O7,C7H13O7,210.0739528,211.0817778,209.06612782909,3216,cpd:C00288,HCO3-;,HCO3,HCO3-; Bicarbonate; Hydrogen carbonate; Acid carbonate,R00344 R00575 R00742 R00774 R01859 R03494 R03546 R04138; R04385 R05453 R07404 R07641 R08201 R08924 R09795 R10079; R10092 R10191 R10463 R10667 R10948,Carbon fixation pathways in prokaryotes; Nitrogen metabolism; ABC transporters; cAMP signaling pathway; Meiosis - yeast; Proximal tubule bicarbonate reclamation; Collecting duct acid secretion; Salivary secretion; Gastric acid secretion; Pancreatic secretion; Bile secretion; Mineral absorption,1.13.11.73; 2.5.1.120; 2.7.7.87; 4.1.1.93; 4.2.1.1; 4.2.1.104; 6.3.4.6; 6.3.4.14; 6.3.4.18; 6.3.5.5; 6.4.1.1; 6.4.1.2; 6.4.1.3; 6.4.1.4; 6.4.1.5; 6.4.1.7; 6.4.1.8,NA,NA,CAS: 71-52-3; PubChem: 3583; ChEBI: 17544; PDB-CCD: BCT; 3DMET: B00080,cpd:C00288; cpd:C12603; cpd:C18606,1,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H2O3,C1H0O3,60.99256889,62.00039392,59.984743862910,3217,cpd:C00566,(3S)-Citryl-CoA,C27H42N7O22P3S,(3S)-Citryl-CoA,R00354 R01322 R01323,Carbon fixation pathways in prokaryotes; Metabolic pathways; Microbial metabolism in diverse environments; Carbon metabolism,2.8.3.10; 4.1.3.34; 6.2.1.18,Reductive citrate cycle (Arnon-Buchanan cycle),NA,PubChem: 3845; ChEBI: 15459; 3DMET: B04701; NIKKAJI: J2.729.701C,cpd:C00566,27,42,22,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O22N7P3S1,C27H41O22N7P3S1,941.1316482,942.1394732,940.12382322911,3218,cpd:C18323,3-Methylfumaryl-CoA;,C26H40N7O19P3S,3-Methylfumaryl-CoA; (E)-3-Carboxybut-2-enoyl-CoA; Mesaconyl-C4-CoA,R09282 R09283,Carbon fixation pathways in prokaryotes; Microbial metabolism in diverse environments; Carbon metabolism,4.2.1.153; 5.4.1.3,3-Hydroxypropionate bi-cycle,NA,PubChem: 103061504; ChEBI: 75856,cpd:C00531; cpd:C02411; cpd:C06028; cpd:C18323,26,40,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H41O19N7P3S1,C26H39O19N7P3S1,879.1312543,880.1390793,878.12342922912,3219,cpd:C00018,Pyridoxal phosphate;,C8H10NO6P,Pyridoxal phosphate; Pyridoxal 5-phosphate; Pyridoxal 5'-phosphate; PLP,R00173 R00174 R00277 R00278 R01147 R01580 R07456 R10088; R10089 R10686,Thiamine metabolism; Vitamin B6 metabolism; Metabolic pathways; Vitamin digestion and absorption,1.4.3.5; 2.6.1.54; 2.7.1.35; 3.1.3.74; 4.3.3.6,"Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00018  PLP; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA06 Pyridoxal phosphate;       C00018  Pyridoxal phosphate,CAS: 54-47-7; PubChem: 3320; ChEBI: 18405; ChEMBL: CHEMBL82202; KNApSAcK: C00007503; PDB-CCD: PLP; 3DMET: B00005; NIKKAJI: J10.690I,cpd:C00018,8,10,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O6N1P1,C8H9O6N1P1,247.024574,248.0323991,246.0167492913,3220,cpd:C00378,Thiamine;,C12H17N4OS,Thiamine; Thiamin; Vitamin B1; Aneurin; Antiberiberi factor,R00033 R00619 R02132 R02133 R02134 R02135 R02863 R11314,Thiamine metabolism; Metabolic pathways; ABC transporters; Sulfur relay system; Vitamin digestion and absorption,1.1.3.23; 2.5.1.2; 2.7.1.89; 2.7.6.2; 3.1.3.1; 3.1.3.2; 3.1.3.100; 3.5.99.2,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Water-soluble vitamins;     C00378  Thiamine (Vitamin B1),PubChem: 3668; ChEBI: 18385; ChEMBL: CHEMBL1547; KNApSAcK: C00000775; PDB-CCD: VIB; 3DMET: B00096; NIKKAJI: J203.781E,cpd:C00378,12,17,1,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H18O1N4S1,C12H16O1N4S1,265.1123074,266.1201324,264.10448232914,3221,cpd:C01081,Thiamin monophosphate;,C12H18N4O4PS,Thiamin monophosphate; Thiamine monophosphate; Thiamin phosphate; Thiamine phosphate; TMP,R00615 R00617 R02134 R02135 R03223 R10712 R11312,Thiamine metabolism; Metabolic pathways,2.5.1.3; 2.7.1.89; 2.7.4.16; 3.1.3.1; 3.1.3.2; 3.1.3.100; 3.6.1.15; 3.6.1.-,"Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P",NA,PubChem: 4319; ChEBI: 9533; ChEMBL: CHEMBL1236378; KNApSAcK: C00019628; PDB-CCD: TPS; 3DMET: B00237; NIKKAJI: J221.489J,cpd:C01081,12,18,4,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H19O4N4P1S1,C12H17O4N4P1S1,345.0786382,346.0864633,344.07081322915,3222,cpd:C01279,4-Amino-5-hydroxymethyl-2-methylpyrimidine;,C6H9N3O,4-Amino-5-hydroxymethyl-2-methylpyrimidine; Toxopyrimidine; 4-Amino-2-methyl-5-pyrimidinemethanol,R02133 R03471 R09993,Thiamine metabolism; Metabolic pathways; ABC transporters,2.7.1.49; 3.5.99.2; 3.5.99.-,NA,NA,CAS: 73-67-6; PubChem: 4498; ChEBI: 16892; KNApSAcK: C00007494; PDB-CCD: HMH; 3DMET: B00273; NIKKAJI: J544.797F,cpd:C01279; cpd:C01929,6,9,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O1N3,C6H8O1N3,139.0745619,140.082387,138.06673692916,3223,cpd:C02892,Thiamine acetic acid;,C12H15N4O2S,Thiamine acetic acid; Thiamin acetic acid,R00072 R02132,Thiamine metabolism; Metabolic pathways,1.1.3.23,NA,NA,PubChem: 5821; ChEBI: 18306; 3DMET: B00511; NIKKAJI: J2.743.653F,cpd:C02892,12,15,2,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H16O2N4S1,C12H14O2N4S1,279.0915719,280.0993969,278.08374692917,3224,cpd:C03028,Thiamin triphosphate;,C12H20N4O10P3S,Thiamin triphosphate; Thiamine triphosphate,R00616 R00618 R11319,Thiamine metabolism; Metabolic pathways,2.7.4.3; 2.7.4.15; 3.6.1.28,NA,NA,CAS: 15666-52-1 3475-65-8; PubChem: 5933; ChEBI: 9534; PDB-CCD: V4E; 3DMET: B01622; NIKKAJI: J791.117C,cpd:C03028,12,20,10,4,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H21O10N4P3S1,C12H19O10N4P3S1,505.0113,506.0191251,504.0034752918,3225,cpd:C04294,5-(2-Hydroxyethyl)-4-methylthiazole;,C6H9NOS,5-(2-Hydroxyethyl)-4-methylthiazole; 4-Methyl-5-(2'-hydroxyethyl)-thiazole; 4-Methyl-5-(2-hydroxyethyl)-thiazole,R02133 R02721 R02863 R04448,Thiamine metabolism; Metabolic pathways,2.5.1.2; 2.7.1.50; 3.5.99.2,"Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P",Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Thiazole alkaloids;     C04294  5-(2-Hydroxyethyl)-4-methylthiazole,CAS: 137-00-8; PubChem: 6954; ChEBI: 17957; KNApSAcK: C00007610; PDB-CCD: TZE; 3DMET: B00700; NIKKAJI: J5.626J,cpd:C04294,6,9,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O1N1S1,C6H8O1N1S1,143.0404851,144.0483101,142.03266012919,3226,cpd:C04327,4-Methyl-5-(2-phosphooxyethyl)thiazole;,C6H10NO4PS,4-Methyl-5-(2-phosphooxyethyl)thiazole; 4-Methyl-5-(2-phosphonooxyethyl)thiazole; 5-(2-Hydroxyethyl)-4-methylthiazole phosphate,R03223 R04448,Thiamine metabolism; Metabolic pathways,2.5.1.3; 2.7.1.50,"Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P",Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Thiazole alkaloids;     C04327  4-Methyl-5-(2-phosphoethyl)-thiazole,PubChem: 6980; ChEBI: 17857; KNApSAcK: C00007608; PDB-CCD: TZP; 3DMET: B00702; NIKKAJI: J870.164D,cpd:C04327,6,10,4,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O4N1P1S1,C6H9O4N1P1S1,223.006816,224.014641,221.99899092920,3227,cpd:C04556,4-Amino-2-methyl-5-(phosphooxymethyl)pyrimidine;,C6H10N3O4P,4-Amino-2-methyl-5-(phosphooxymethyl)pyrimidine; (4-Amino-2-methylpyrimidin-5-yl)methyl phosphate; 4-Amino-5-hydroxymethyl-2-methylpyrimidine phosphate,R03471 R03472 R04509 R10686,Thiamine metabolism; Metabolic pathways,2.7.1.49; 2.7.4.7; 4.1.99.17,"Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P",NA,PubChem: 7161; ChEBI: 18032; KNApSAcK: C00007607; PDB-CCD: MP5; 3DMET: B00732; NIKKAJI: J1.028.201B,cpd:C04556,6,10,4,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O4N3P1,C6H9O4N3P1,219.0408928,220.0487178,218.03306782921,3228,cpd:C04752,4-Amino-5-hydroxymethyl-2-methylpyrimidine diphosphate;,C6H11N3O7P2,4-Amino-5-hydroxymethyl-2-methylpyrimidine diphosphate; 4-Amino-2-methyl-5-(diphosphooxymethyl)pyrimidine,R03223 R04509 R10712 R11312,Thiamine metabolism; Metabolic pathways,2.5.1.3; 2.7.4.7,"Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P",NA,PubChem: 7322; ChEBI: 16629; KNApSAcK: C00007609; 3DMET: B01785; NIKKAJI: J852.283I,cpd:C04752,6,11,7,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O7N3P2,C6H10O7N3P2,299.0072237,300.0150487,297.99939872922,3229,cpd:C05856,Thiamine aldehyde;,C12H15N4OS,Thiamine aldehyde; Thiamin aldehyde,R00033 R00072,Thiamine metabolism; Metabolic pathways,1.1.3.23,NA,NA,PubChem: 8149; ChEBI: 27824; 3DMET: B00871; NIKKAJI: J2.760.166I,cpd:C05856,12,15,1,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H16O1N4S1,C12H14O1N4S1,263.0966573,264.1044823,262.08883232923,3230,cpd:C11437,1-Deoxy-D-xylulose 5-phosphate,C5H11O7P,1-Deoxy-D-xylulose 5-phosphate,R05636 R05688 R05838 R10247,Thiamine metabolism; Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.1.1.267; 2.2.1.7; 2.6.99.2; 2.8.1.10,"C5 isoprenoid biosynthesis, non-mevalonate pathway",NA,PubChem: 13609; ChEBI: 16493; KNApSAcK: C00007292; PDB-CCD: DXP; 3DMET: B04265; NIKKAJI: J866.535D,cpd:C00653; cpd:C00672; cpd:C00673; cpd:C02270; cpd:C04111; cpd:C11437; cpd:C16637,5,11,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O7P1,C5H10O7P1,214.0242397,215.0320647,213.01641472924,3231,cpd:C15809,Iminoglycine;,C2H3NO2,Iminoglycine; Iminoacetic acid; 2-Iminoacetate,R07463 R10245 R10246 R10247,Thiamine metabolism; Metabolic pathways,1.4.3.19; 2.8.1.10; 4.1.99.19,NA,NA,CAS: 4472-12-2; PubChem: 47205134; ChEBI: 53647; NIKKAJI: J478.944J,cpd:C02623; cpd:C03317; cpd:C15809,2,3,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H4O2N1,C2H2O2N1,73.01637834,74.02420337,72.008553312925,3237,cpd:C19872,N-Formyl-4-amino-5-aminomethyl-2-methylpyrimidine;,C7H10N4O,N-Formyl-4-amino-5-aminomethyl-2-methylpyrimidine; 2-Methyl-4-amino-5-(formylaminomethyl)pyrimidine; FAMP,R11313 R11314,Thiamine metabolism; Metabolic pathways; ABC transporters,3.5.1.-,NA,NA,PubChem: 135626338; ChEBI: 85895; PDB-CCD: NFM,cpd:C19872,7,10,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O1N4,C7H9O1N4,166.085461,167.093286,165.07763592926,3238,cpd:C20246,"2-[(2R,5Z)-2-Carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate",C7H10NO6PS,"2-[(2R,5Z)-2-Carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate",R09977 R10247 R11312,Thiamine metabolism; Metabolic pathways,2.5.1.3; 2.8.1.10; 5.3.99.10,NA,NA,PubChem: 163311989,cpd:C20246; cpd:C20247,7,10,6,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O6N1P1S1,C7H9O6N1P1S1,266.9966452,268.0044702,265.98882022927,3239,cpd:C20247,2-(2-Carboxy-4-methylthiazol-5-yl)ethyl phosphate;,C7H10NO6PS,"2-(2-Carboxy-4-methylthiazol-5-yl)ethyl phosphate; 4-Methyl-5-[2-(phosphonooxy)ethyl]-1,3-thiazole-2-carboxylate; cThz-P",R09977 R10711 R10712,Thiamine metabolism; Metabolic pathways,2.5.1.3; 5.3.99.10,NA,NA,PubChem: 163311990; PDB-CCD: 3NM,cpd:C20246; cpd:C20247,7,10,6,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H11O6N1P1S1,C7H9O6N1P1S1,266.9966452,268.0044702,265.98882022928,3240,cpd:C20267,4-Amino-5-aminomethyl-2-methylpyrimidine,C6H10N4,4-Amino-5-aminomethyl-2-methylpyrimidine,R09993 R11313,Thiamine metabolism; Metabolic pathways,3.5.1.-; 3.5.99.2; 3.5.99.-,NA,NA,PubChem: 163312007; PDB-CCD: NSP,cpd:C06553; cpd:C13692; cpd:C17931; cpd:C20267,6,10,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11N4,C6H9N4,138.0905463,139.0983714,137.08272132929,3241,cpd:C20784,ADP-5-ethyl-4-methylthiazole-2-carboxylate;,C17H22N6O12P2S,ADP-5-ethyl-4-methylthiazole-2-carboxylate; Adenosine diphospho-5-beta-ethyl-4-methylthiazole-2-carboxylic acid,R10685 R10711,Thiamine metabolism; Metabolic pathways,NA,NA,NA,PubChem: 254741251; ChEBI: 134399; PDB-CCD: AHZ,cpd:C20784,17,22,12,6,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C17H23O12N6P2S1,C17H21O12N6P2S1,596.0491653,597.0569904,595.04134032930,3242,cpd:C00016,FAD;,C27H33N9O15P2,FAD; Flavin adenine dinucleotide,R00160 R00161 R00408 R00807 R00848 R00924 R01175 R01257; R01279 R01741 R02205 R02487 R02560 R02925 R02979 R03295; R03534 R03683 R03704 R03777 R03857 R03978 R03990 R04092; R04095 R04547 R04592 R04751 R04754 R05446 R05447 R05449; R05456 R05488 R05537 R06233 R06747 R06902 R06943 R07220; R07636 R07653 R07888 R07892 R07896 R07934 R07950 R08092; R08553 R09517 R09520 R09570 R09690 R09719 R09744 R09745; R09746 R09748 R10112 R10507 R10613 R10731 R11106 R11130; R11295 R11296 R11348 R11368 R11393 R11401 R11403 R11478,Riboflavin metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Vitamin digestion and absorption,1.1.5.3; 1.1.5.4; 1.1.98.3; 1.1.99.2; 1.1.99.3; 1.1.99.13; 1.1.99.21; 1.3.3.6; 1.3.8.1; 1.3.8.2; 1.3.8.4; 1.3.8.6; 1.3.8.7; 1.3.8.8; 1.3.8.9; 1.3.8.-; 1.3.99.-; 1.5.1.30; 1.5.1.36; 1.5.1.37; 1.5.1.45; 1.5.99.3; 1.5.-.-; 1.6.6.9; 1.8.99.2; 1.14.14.8; 1.14.14.11; 1.14.14.15; 1.14.14.18; 1.14.14.27; 1.14.14.30; 1.14.14.-; 1.14.19.9; 1.14.19.49; 1.14.19.-; 1.17.8.1; 2.1.1.74; 2.7.1.180; 2.7.7.2; 3.6.1.9; 3.6.1.18; 4.6.1.15,"Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00016  FAD; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Flavin adenine dinucleotide;     D00005  Flavin adenine dinucleotide (JAN),CAS: 146-14-5; PubChem: 3318; ChEBI: 16238; ChEMBL: CHEMBL1232653; KNApSAcK: C00001500; PDB-CCD: FAD FAE; 3DMET: B04619; NIKKAJI: J39.053D,cpd:C00016,27,33,15,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H34O15N9P2,C27H32O15N9P2,785.1571354,786.1649604,784.14931042931,3243,cpd:C00255,Riboflavin;,C17H20N4O6,"Riboflavin; Lactoflavin; 7,8-Dimethyl-10-ribitylisoalloxazine; Vitamin B2",R00066 R00548 R00549 R00550 R01732 R01734 R05707 R08574; R09750,Riboflavin metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Vitamin digestion and absorption,1.5.1.30; 1.5.1.36; 1.5.1.41; 2.5.1.9; 2.7.1.26; 2.7.1.42; 2.7.1.161; 3.1.3.2; 3.1.3.102; 3.5.99.1,"Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Water-soluble vitamins;     C00255  Riboflavin (Vitamin B2); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA04 Riboflavin (vit B2);       D00050  Riboflavin (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    313  Vitamin B preparations;     3131  Vitamin B2 preparations;      D00050  Riboflavin (JP17/USP/INN); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   36 Vitamin B2 based drugs;    D00050  Riboflavin (JP17/USP/INN);   40 Vitamin B2B6 based drugs;    D00050  Riboflavin (JP17/USP/INN);   43 Vitamin containing supplements;    D00050  Riboflavin (JP17/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Riboflavin;     D00050  Riboflavin (JP17/USP/INN); Pharmaceutical additives [BR:br08316];  Coloring agent;   D00050  [001669] Riboflavin; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00050  Riboflavin;   D00050  Riboflavin powder; Dermatological agents [br08370.html];  Non-steroidal oral agent;   D00050,CAS: 83-88-5; PubChem: 3554; ChEBI: 17015; ChEMBL: CHEMBL1534; KNApSAcK: C00001552; PDB-CCD: RBF; 3DMET: B01201; NIKKAJI: J3.876H,cpd:C00255,17,20,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H21O6N4,C17H19O6N4,376.1382844,377.1461094,375.13045932932,3244,cpd:C01007,Reduced riboflavin,C17H22N4O6,Reduced riboflavin,R05707 R09750,Riboflavin metabolism; Metabolic pathways,1.5.1.30; 1.5.1.36; 1.5.1.41,NA,NA,PubChem: 4252; ChEBI: 17607; NIKKAJI: J377.891F,cpd:C01007,17,22,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H23O6N4,C17H21O6N4,378.1539344,379.1617595,377.14610942933,3245,cpd:C01268,5-Amino-6-(5'-phosphoribosylamino)uracil;,C9H15N4O9P,"5-Amino-6-(5'-phosphoribosylamino)uracil; 5-Amino-6-(ribosylamino)-2,4-(1H,3H)-pyrimidinedione 5'-phosphate; 5-Amino-6-(5-phosphoribosylamino)uracil",R03458 R03459,Riboflavin metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.193; 3.5.4.26,"Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD",NA,PubChem: 4487; ChEBI: 18337; KNApSAcK: C00019665; PDB-CCD: AOF; 3DMET: B01428; NIKKAJI: J1.722.459J,cpd:C01268,9,15,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16O9N4P1,C9H14O9N4P1,354.0576651,355.0654901,353.049842934,3246,cpd:C01304,"2,5-Diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one;",C9H16N5O8P,"2,5-Diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one; 2,5-Diamino-6-(1-D-ribosylamino)pyrimidin-4(3H)-one 5'-phosphate",R00425 R03459 R09374 R09375 R09376 R11072,Riboflavin metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.302; 3.5.1.102; 3.5.4.25; 3.5.4.26; 4.2.1.160,"Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD",NA,PubChem: 4522; ChEBI: 29114 59546; 3DMET: B01437; NIKKAJI: J1.557.013J,cpd:C01304,9,16,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O8N5P1,C9H15O8N5P1,353.0736495,354.0814745,352.06582452935,3247,cpd:C01352,FADH2,C27H35N9O15P2,FADH2,R00408 R00807 R00848 R00924 R01175 R01257 R01279 R01741; R02205 R02487 R02560 R02925 R02979 R03295 R03534 R03683; R03704 R03777 R03857 R03978 R03990 R04092 R04095 R04547; R04592 R04751 R04754 R05446 R05447 R05449 R05456 R05488; R05537 R06233 R06747 R06902 R06943 R07220 R07653 R07888; R07892 R07896 R07934 R07950 R08092 R08553 R09517 R09520; R09570 R09690 R09719 R09744 R09745 R09746 R09748 R10112; R10507 R10731 R11106 R11130 R11295 R11296 R11348 R11368; R11393 R11401 R11403 R11478,Riboflavin metabolism; Metabolic pathways,1.1.5.3; 1.1.5.4; 1.1.98.3; 1.1.99.2; 1.1.99.3; 1.1.99.13; 1.1.99.21; 1.3.3.6; 1.3.8.1; 1.3.8.2; 1.3.8.4; 1.3.8.6; 1.3.8.7; 1.3.8.8; 1.3.8.9; 1.3.8.-; 1.3.99.-; 1.5.1.30; 1.5.1.36; 1.5.1.37; 1.5.1.45; 1.5.99.3; 1.5.-.-; 1.6.6.9; 1.8.99.2; 1.14.14.8; 1.14.14.11; 1.14.14.15; 1.14.14.18; 1.14.14.27; 1.14.14.30; 1.14.14.-; 1.14.19.9; 1.14.19.49; 1.14.19.-; 1.17.8.1; 2.1.1.74,NA,NA,PubChem: 4556; ChEBI: 17877; PDB-CCD: FDA; NIKKAJI: J792.632D,cpd:C01352,27,35,15,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H36O15N9P2,C27H34O15N9P2,787.1727855,788.1806105,786.16496042936,3248,cpd:C01727,Lumichrome;,C12H10N4O2,"Lumichrome; 7,8-Dimethylalloxazine",R01732,Riboflavin metabolism,3.5.99.1,NA,NA,CAS: 1086-80-2; PubChem: 4864; ChEBI: 17781; KNApSAcK: C00030694; PDB-CCD: LUM; 3DMET: B00337; NIKKAJI: J9.483H,cpd:C01727,12,10,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11O2N4,C12H9O2N4,242.0803756,243.0882006,241.07255052937,3249,cpd:C01847,Reduced FMN;,C17H23N4O9P,Reduced FMN; FMNH2,R00025 R05218 R05705 R05706 R07210 R07664 R08908 R09083; R09313 R09314 R09559 R09798 R09819 R09936 R09937 R10203; R10206 R10551 R11161 R11162 R11163 R11164 R11225 R11404; R11454 R11455 R11456 R11457,Riboflavin metabolism; Biosynthesis of type II polyketide products; Metabolic pathways,1.1.99.31; 1.3.99.24; 1.5.1.36; 1.5.1.38; 1.5.1.39; 1.5.1.41; 1.5.1.42; 1.5.1.-; 1.13.11.79; 1.13.12.16; 1.14.14.3; 1.14.14.5; 1.14.14.10; 1.14.14.12; 1.14.14.13; 1.14.14.21; 1.14.14.22; 1.14.14.30; 1.14.14.33; 1.14.14.34; 1.14.14.35; 1.14.14.-; 1.14.99.46; 1.16.8.1; 2.5.1.129,NA,NA,PubChem: 4964; ChEBI: 16048; PDB-CCD: FNR; NIKKAJI: J1.888.371F,cpd:C01847,17,23,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H24O9N4P1,C17H22O9N4P1,458.1202653,459.1280904,457.11244032938,3250,cpd:C03114,Dimethylbenzimidazole;,C9H10N2,"Dimethylbenzimidazole; 5,6-Dimethylbenzimidazole",R01734 R04148 R09083,Riboflavin metabolism; Porphyrin and chlorophyll metabolism; Metabolic pathways,1.13.11.79; 2.4.2.21,"Cobalamin biosynthesis, cobinamide => cobalamin",NA,CAS: 582-60-5; PubChem: 6009; ChEBI: 15890; ChEMBL: CHEMBL351132; PDB-CCD: DMD; 3DMET: B00544; NIKKAJI: J69.209C,cpd:C03114; cpd:C07428; cpd:C10160; cpd:C11007; cpd:C11009; cpd:C13840; cpd:C18428; cpd:C18702; cpd:C21079,9,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11N2,C9H9N2,146.0843983,147.0922234,145.07657332939,3251,cpd:C04332,"6,7-Dimethyl-8-(D-ribityl)lumazine",C13H18N4O6,"6,7-Dimethyl-8-(D-ribityl)lumazine",R00066 R04457 R04458,Riboflavin metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.5.1.9; 2.5.1.78,"Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD",NA,CAS: 5118-16-1; PubChem: 6983; ChEBI: 17601; KNApSAcK: C00019640; PDB-CCD: DLZ; 3DMET: B04936; NIKKAJI: J643.571H,cpd:C04332,13,18,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H19O6N4,C13H17O6N4,326.1226343,327.1304593,325.11480932940,3252,cpd:C04454,5-Amino-6-(5'-phospho-D-ribitylamino)uracil;,C9H17N4O9P,"5-Amino-6-(5'-phospho-D-ribitylamino)uracil; 5-Amino-2,6-dioxy-4-(5'-phospho-D-ribitylamino)pyrimidine; 5-Amino-6-(5-phospho-D-ribitylamino)uracil",R03458 R07280 R09377,Riboflavin metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.193; 3.1.3.104,"Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD",NA,PubChem: 7081; ChEBI: 18247; 3DMET: B04942; NIKKAJI: J1.722.458A,cpd:C04454,9,17,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H18O9N4P1,C9H16O9N4P1,356.0733151,357.0811402,355.06549012941,3253,cpd:C05995,7-Hydroxy-6-methyl-8-ribityllumazine;,C12H16N4O7,7-Hydroxy-6-methyl-8-ribityllumazine; 7-Oxolumazine; 6-Methyl-7-oxo-8-ribityllumazine,R04458,Riboflavin metabolism,NA,NA,NA,PubChem: 8269; ChEBI: 27581; PDB-CCD: 1VY; 3DMET: B01945; NIKKAJI: J2.760.844B,cpd:C05995,12,16,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H17O7N4,C12H15O7N4,328.1018989,329.1097239,327.09407382942,3254,cpd:C15556,"L-3,4-Dihydroxybutan-2-one 4-phosphate;",C4H9O6P,"L-3,4-Dihydroxybutan-2-one 4-phosphate; 1-Deoxy-L-glycero-tetrulose 4-phosphate; 2-Hydroxy-3-oxobutyl phosphate",R04457 R07281,Riboflavin metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.5.1.78; 4.1.99.12,"Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD",NA,PubChem: 17396548; ChEBI: 50606; NIKKAJI: J1.171.796I,cpd:C04399; cpd:C15556,4,9,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O6P1,C4H8O6P1,184.013675,185.0215,183.005852943,3255,cpd:C15563,2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one,C10H16N5O9P,2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one,R07306 R09374,Riboflavin metabolism; Metabolic pathways,3.5.1.102; 3.5.4.29,NA,NA,PubChem: 17396555; ChEBI: 11515; NIKKAJI: J1.853.892J,cpd:C15563,10,16,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O9N5P1,C10H15O9N5P1,381.0685641,382.0763891,380.06073912944,3256,cpd:C18910,"2,5-Diamino-6-(5-phospho-D-ribitylamino)pyrimidin-4(3H)-one;",C9H18N5O8P,"2,5-Diamino-6-(5-phospho-D-ribitylamino)pyrimidin-4(3H)-one; 2,5-Diamino-6-(1-D-ribitylamino)pyrimidin-4(3H)-one 5'-phosphate",R09375 R09376 R09377,Riboflavin metabolism; Metabolic pathways,1.1.1.302,NA,NA,PubChem: 124489582; ChEBI: 52402,cpd:C18910,9,18,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H19O8N5P1,C9H17O8N5P1,355.0892996,356.0971246,354.08147452945,3257,cpd:C00250,Pyridoxal,C8H9NO3,Pyridoxal,R00173 R00174 R01707 R01708 R01709 R01710 R01711 R01712; R01713 R05839,Vitamin B6 metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Vitamin digestion and absorption,1.1.1.65; 1.1.1.107; 1.1.3.12; 1.2.3.1; 1.2.3.8; 1.4.3.5; 2.6.1.30; 2.6.1.31; 2.6.1.54; 2.7.1.35; 3.1.3.74,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Water-soluble vitamins;     C00250  Pyridoxal (Vitamin B6); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Pyridoxine hydrochloride;     C00250  Pyridoxal,CAS: 66-72-8; PubChem: 3549; ChEBI: 17310; ChEMBL: CHEMBL102970; KNApSAcK: C00007509; PDB-CCD: PXL; 3DMET: B00072; NIKKAJI: J2.361B,cpd:C00250; cpd:C03493; cpd:C03986; cpd:C05831; cpd:C06051; cpd:C12323; cpd:C14170; cpd:C14171; cpd:C20821,8,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O3N1,C8H8O3N1,167.0582432,168.0660682,166.05041812946,3258,cpd:C00314,Pyridoxine;,C8H11NO3,Pyridoxine; Pyridoxol,R01708 R01711 R01909 R01910 R01911 R01912 R01913 R05840; R07154,Vitamin B6 metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.65; 1.1.3.12; 1.1.99.9; 1.4.3.5; 2.4.1.160; 2.7.1.35; 3.1.3.74,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Water-soluble vitamins;     C00314  Pyridoxine (Vitamin B6); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA02 Pyridoxine (vit B6);       D08454  Pyridoxine (INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Pyridoxine hydrochloride;     D08454  Pyridoxine (INN),CAS: 65-23-6; PubChem: 3608; ChEBI: 16709; ChEMBL: CHEMBL1364; KNApSAcK: C00001551; PDB-CCD: UEG; 3DMET: B00087; NIKKAJI: J2.356F,cpd:C00314; cpd:C00547,8,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H12O3N1,C8H10O3N1,169.0738932,170.0817182,168.06606822947,3259,cpd:C00534,Pyridoxamine;,C8H12N2O2,Pyridoxamine; PM,R01710 R01712 R01713 R02493 R02494 R05839,Vitamin B6 metabolism; Metabolic pathways; Microbial metabolism in diverse environments; Vitamin digestion and absorption,1.4.3.5; 2.6.1.30; 2.6.1.31; 2.6.1.54; 2.7.1.35; 3.1.3.74,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Water-soluble vitamins;     C00534  Pyridoxamine (Vitamin B6); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Pyridoxine hydrochloride;     C00534  Pyridoxamine,CAS: 85-87-0; PubChem: 3816; ChEBI: 16410; ChEMBL: CHEMBL593019; KNApSAcK: C00007504; PDB-CCD: PXM; 3DMET: B00123; NIKKAJI: J3.891A,cpd:C00534; cpd:C11846; cpd:C13710,8,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O2N2,C8H11O2N2,168.0898776,169.0977027,167.08205262948,3260,cpd:C00627,Pyridoxine phosphate;,C8H12NO6P,Pyridoxine phosphate; Pyridoxine 5-phosphate; Pyridoxine 5'-phosphate; Pyridoxol 5'-phosphate,R00278 R01909 R01911 R05838,Vitamin B6 metabolism; Metabolic pathways,1.4.3.5; 2.6.99.2; 2.7.1.35; 3.1.3.74,"Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P",NA,CAS: 447-05-2; PubChem: 3900; ChEBI: 28803; KNApSAcK: C00007505; PDB-CCD: PXP; 3DMET: B00148; NIKKAJI: J196.145D,cpd:C00627,8,12,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O6N1P1,C8H11O6N1P1,249.0402241,250.0480491,248.03239912949,3261,cpd:C00647,Pyridoxamine phosphate;,C8H13N2O5P,Pyridoxamine phosphate; Pyridoxamine 5-phosphate; Pyridoxamine 5'-phosphate,R00277 R01147 R01580 R02493 R02494,Vitamin B6 metabolism; Metabolic pathways; Vitamin digestion and absorption,1.4.3.5; 2.6.1.54; 2.7.1.35; 3.1.3.74,NA,NA,CAS: 529-96-4; PubChem: 3919; ChEBI: 18335; ChEMBL: CHEMBL1235353; KNApSAcK: C00007506; PDB-CCD: PMP; 3DMET: B00154; NIKKAJI: J11.364F,cpd:C00647,8,13,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H14O5N2P1,C8H12O5N2P1,248.0562085,249.0640336,247.04838352950,3262,cpd:C00847,4-Pyridoxate;,C8H9NO4,4-Pyridoxate; 4-Pyridoxic acid,R01709 R02992 R02993,Vitamin B6 metabolism; Metabolic pathways; Microbial metabolism in diverse environments,1.1.1.-; 1.2.3.1; 1.2.3.8; 3.1.1.27,NA,NA,CAS: 82-82-6; PubChem: 4104; ChEBI: 17405; 3DMET: B00188; NIKKAJI: J41.097G,cpd:C00847; cpd:C04447; cpd:C04773; cpd:C11466; cpd:C12026,8,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O4N1,C8H8O4N1,183.0531578,184.0609828,182.04533272951,3263,cpd:C00971,4-Pyridoxolactone;,C8H7NO3,4-Pyridoxolactone; 4-Pyridoxic acid lactone,R01707 R02992,Vitamin B6 metabolism; Microbial metabolism in diverse environments,1.1.1.107; 3.1.1.27,NA,NA,CAS: 4753-19-9; PubChem: 4220; ChEBI: 16871; PDB-CCD: 4PL; 3DMET: B00210; NIKKAJI: J101.559A,cpd:C00971; cpd:C02803; cpd:C03757; cpd:C05653; cpd:C06052; cpd:C15769; cpd:C21155,8,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O3N1,C8H6O3N1,165.0425931,166.0504181,164.03476812952,3264,cpd:C01215,2-(Acetamidomethylene)succinate,C7H9NO5,2-(Acetamidomethylene)succinate,R01649 R03385 R03386,Vitamin B6 metabolism; Microbial metabolism in diverse environments,1.14.12.4; 3.5.1.29,NA,NA,PubChem: 4437; ChEBI: 16253; 3DMET: B00261; NIKKAJI: J2.371.437J,cpd:C01215; cpd:C20258,7,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O5N1,C7H8O5N1,187.0480724,188.0558974,186.04024742953,3265,cpd:C01270,3-Hydroxy-2-methylpyridine-5-carboxylate,C7H7NO3,3-Hydroxy-2-methylpyridine-5-carboxylate,R03385 R03386 R03461,Vitamin B6 metabolism; Microbial metabolism in diverse environments,1.14.12.4; 4.1.1.51,NA,NA,PubChem: 4489; ChEBI: 15821; PDB-CCD: 3HM; 3DMET: B00270; NIKKAJI: J831.772K,cpd:C00632; cpd:C01270; cpd:C02518; cpd:C06669; cpd:C07555; cpd:C11343; cpd:C12107; cpd:C12115; cpd:C14520; cpd:C16235; cpd:C19270,7,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O3N1,C7H6O3N1,153.0425931,154.0504181,152.03476812954,3266,cpd:C03393,4-Phospho-D-erythronate;,C4H9O8P,4-Phospho-D-erythronate; 4-Phosphoerythronate,R01825 R04210,Vitamin B6 metabolism; Metabolic pathways,1.1.1.290; 1.2.1.72,"Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P",NA,PubChem: 6224; ChEBI: 49003; ChEMBL: CHEMBL1160945; PDB-CCD: DEZ; 3DMET: B04893; NIKKAJI: J1.988.006K,cpd:C03356; cpd:C03393,4,9,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O8P1,C4H8O8P1,216.0035042,217.0113293,214.99567922955,3267,cpd:C04106,2-(Hydroxymethyl)-4-oxobutanoate;,C5H8O4,2-(Hydroxymethyl)-4-oxobutanoate; alpha-Hydroxymethyl succinate semialdehyde; 2-Hydroxymethyl succinate semialdehyde,R04397,Vitamin B6 metabolism,3.5.1.66,NA,NA,PubChem: 6797; ChEBI: 17413; 3DMET: B04927; NIKKAJI: J2.362.074J,cpd:C00489; cpd:C00707; cpd:C00900; cpd:C02352; cpd:C02674; cpd:C03409; cpd:C03589; cpd:C04106; cpd:C04181; cpd:C06010; cpd:C08298; cpd:C11838; cpd:C18061; cpd:C19483; cpd:C19885; cpd:C20232; cpd:C20846; cpd:C21177,5,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O4,C5H7O4,132.0422587,133.0500838,131.03443372956,3268,cpd:C04604,"3-Hydroxy-2-methylpyridine-4,5-dicarboxylate",C8H7NO5,"3-Hydroxy-2-methylpyridine-4,5-dicarboxylate",R03461 R04524,Vitamin B6 metabolism; Microbial metabolism in diverse environments,1.2.1.-; 4.1.1.51,NA,NA,PubChem: 7197; ChEBI: 17978; 3DMET: B00738; NIKKAJI: J102.235K,cpd:C04604; cpd:C06661; cpd:C15771,8,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O5N1,C8H6O5N1,197.0324223,198.0402474,196.02459732957,3269,cpd:C04690,2-(Hydroxymethyl)-3-(acetamidomethylene)succinate;,C8H11NO6,2-(Hydroxymethyl)-3-(acetamidomethylene)succinate; 2-(Acetamidomethylene)-3-(hydroxymethyl)succinate,R04397 R04570,Vitamin B6 metabolism,1.14.12.5; 3.5.1.66,NA,NA,PubChem: 7270; ChEBI: 16216; 3DMET: B04952; NIKKAJI: J2.752.935F,cpd:C04690; cpd:C05713,8,11,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H12O6N1,C8H10O6N1,217.0586371,218.0664621,216.0508122958,3270,cpd:C04773,3-Hydroxy-4-hydroxymethyl-2-methylpyridine-5-carboxylate;,C8H9NO4,3-Hydroxy-4-hydroxymethyl-2-methylpyridine-5-carboxylate; 5-Pyridoxate; 5-Pyridoxic acid,R04570 R04593,Vitamin B6 metabolism,1.14.12.5,NA,NA,PubChem: 7338; ChEBI: 16409 30960; PDB-CCD: 5PR; 3DMET: B00745; NIKKAJI: J458.723E,cpd:C00847; cpd:C04447; cpd:C04773; cpd:C11466; cpd:C12026,8,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O4N1,C8H8O4N1,183.0531578,184.0609828,182.04533272959,3271,cpd:C06050,2-Methyl-3-hydroxy-5-formylpyridine-4-carboxylate;,C8H7NO4,2-Methyl-3-hydroxy-5-formylpyridine-4-carboxylate; 5-Formyl-3-hydroxy-2-methylpyridine-4-carboxylate,R02993 R04524,Vitamin B6 metabolism; Microbial metabolism in diverse environments,1.1.1.-; 1.2.1.-,NA,NA,PubChem: 8321; ChEBI: 28038; 3DMET: B00892; NIKKAJI: J101.922H,cpd:C06050; cpd:C15770,8,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O4N1,C8H6O4N1,181.0375077,182.0453327,180.02968272960,3272,cpd:C06051,Isopyridoxal,C8H9NO3,Isopyridoxal,R01910 R05084 R07154,Vitamin B6 metabolism,1.1.99.9,NA,NA,CAS: 6560-46-9; PubChem: 8322; ChEBI: 17889; 3DMET: B00893; NIKKAJI: J100.295C,cpd:C00250; cpd:C03493; cpd:C03986; cpd:C05831; cpd:C06051; cpd:C12323; cpd:C14170; cpd:C14171; cpd:C20821,8,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O3N1,C8H8O3N1,167.0582432,168.0660682,166.05041812961,3273,cpd:C06052,5-Pyridoxolactone,C8H7NO3,5-Pyridoxolactone,R04593 R05084,Vitamin B6 metabolism,NA,NA,NA,PubChem: 8323; ChEBI: 2124; PDB-CCD: 5PN; 3DMET: B00894; NIKKAJI: J101.560E,cpd:C00971; cpd:C02803; cpd:C03757; cpd:C05653; cpd:C06052; cpd:C15769; cpd:C21155,8,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H8O3N1,C8H6O3N1,165.0425931,166.0504181,164.03476812962,3274,cpd:C06054,2-Oxo-3-hydroxy-4-phosphobutanoate;,C4H7O8P,2-Oxo-3-hydroxy-4-phosphobutanoate; alpha-Keto-3-hydroxy-4-phosphobutyrate; (3R)-3-Hydroxy-2-oxo-4-phosphonooxybutanoate,R04210 R05085,Vitamin B6 metabolism; Metabolic pathways,1.1.1.290; 2.6.1.52,"Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P",NA,PubChem: 8324; ChEBI: 27951; 3DMET: B01959; NIKKAJI: J2.761.015C,cpd:C06054,4,7,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H8O8P1,C4H6O8P1,213.9878542,214.9956792,212.98002912963,3275,cpd:C06055,O-Phospho-4-hydroxy-L-threonine;,C4H10NO7P,O-Phospho-4-hydroxy-L-threonine; 4-(Phosphonooxy)-threonine; 4-(Phosphonooxy)-L-threonine,R05085 R05086 R05681 R05837,Vitamin B6 metabolism; Metabolic pathways,1.1.1.262; 2.6.1.52; 4.2.3.1,"Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P",NA,PubChem: 8325; ChEBI: 18336; PDB-CCD: 4TP; 3DMET: B01960; NIKKAJI: J695.803F,cpd:C06055,4,10,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O7N1P1,C4H9O7N1P1,215.0194887,216.0273137,214.01166362964,3276,cpd:C06056,4-Hydroxy-L-threonine;,C4H9NO4,4-Hydroxy-L-threonine; Hydroxythreonine,R01913 R05086 R05087,Vitamin B6 metabolism,4.1.1.-; 4.2.3.1,NA,NA,CAS: 21768-45-6; PubChem: 8326; ChEBI: 28330; PDB-CCD: TH6; 3DMET: B01961; NIKKAJI: J694.566J,cpd:C03059; cpd:C06056,4,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O4N1,C4H8O4N1,135.0531578,136.0609828,134.04533272965,3277,cpd:C07335,2-Amino-3-oxo-4-phosphonooxybutyrate;,C4H8NO7P,2-Amino-3-oxo-4-phosphonooxybutyrate; L-2-Amino-3-oxo-4-phosphonooxybutyrate; (2S)-2-Amino-3-oxo-4-phosphonooxybutanoate,R05681 R07406,Vitamin B6 metabolism; Metabolic pathways,1.1.1.262,"Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P",NA,PubChem: 9542; ChEBI: 64186; 3DMET: B02116; NIKKAJI: J2.765.027I,cpd:C03082; cpd:C07335,4,8,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O7N1P1,C4H7O7N1P1,213.0038386,214.0116636,211.99601362966,3278,cpd:C11638,3-Amino-2-oxopropyl phosphate;,C3H8NO5P,3-Amino-2-oxopropyl phosphate; 1-Amino-3-(phosphohydroxy)propan-2-one,R05837 R05838 R07406,Vitamin B6 metabolism; Metabolic pathways,1.1.1.262; 2.6.99.2,"Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P",NA,PubChem: 13803; ChEBI: 1449; 3DMET: B04280; NIKKAJI: J1.328.431H,cpd:C01705; cpd:C05672; cpd:C11638; cpd:C12021; cpd:C18564; cpd:C18565,3,8,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H9O5N1P1,C3H7O5N1P1,169.0140094,170.0218344,168.00618432967,3279,cpd:C00153,Nicotinamide;,C6H6N2O,Nicotinamide; Nicotinic acid amide; Niacinamide; Vitamin PP,R00102 R00119 R00555 R01268 R01269 R01270 R01271 R01273; R02294 R03447 R04074 R04176 R10629 R10631 R10633 R10634; R10685,Nicotinate and nicotinamide metabolism; Metabolic pathways; Longevity regulating pathway - worm; Vitamin digestion and absorption,2.1.1.1; 2.4.2.1; 2.4.2.12; 2.4.2.30; 2.4.2.31; 2.4.2.36; 2.4.2.37; 2.4.99.20; 3.2.2.1; 3.2.2.3; 3.2.2.5; 3.2.2.6; 3.2.2.14; 3.5.1.19; 3.5.1.-,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Water-soluble vitamins;     C00153  Nicotinamide (Vitamin B3); Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     C00153  Nicotinamide; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA01 Nicotinamide;       D00036  Niacinamide (USP); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    313  Vitamin B preparations;     3132  Nicotinic acids;      D00036  Niacinamide (USP); Nicotinamide (JP17/INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for otolaryngologic use;   72 Other agents for otolaryngologic use;    D00036  Niacinamide (USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Nicotinamide;     D00036  Niacinamide (USP); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00036  [001463] Nicotinamide;  Tonicity agent;   D00036  [001463] Nicotinamide;  Solubilization agent;   D00036  [001463] Nicotinamide; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00036  Nicotinamide; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     D00036  Nicotinamide (JP15/INN); Niacinamide (USP); Dermatological agents [br08370.html];  Non-steroidal oral agent;   D00036,CAS: 98-92-0; PubChem: 3453; ChEBI: 17154; ChEMBL: CHEMBL1140; KNApSAcK: C00000209; PDB-CCD: NCA; 3DMET: B00044; NIKKAJI: J3.988H,cpd:C00153; cpd:C01950; cpd:C02421,6,6,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H7O1N2,C6H5O1N2,122.0480128,123.0558379,121.04018782968,3280,cpd:C00253,Nicotinate;,C6H5NO2,Nicotinate; Nicotinic acid; Niacin; 3-Pyridinecarboxylic acid,R00119 R01268 R01720 R01721 R01722 R01723 R01724 R01725; R02295 R02861 R04148 R05128 R06779 R08426 R09473 R10046; R10608 R10632,"Nicotinate and nicotinamide metabolism; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Microbial metabolism in diverse environments; Pertussis",1.17.1.5; 1.17.2.1; 2.1.1.7; 2.4.1.196; 2.4.2.1; 2.4.2.21; 2.4.2.55; 2.4.99.20; 3.2.2.3; 3.5.1.19; 6.3.4.21,"Nicotinate degradation, nicotinate => fumarate","Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Water-soluble vitamins;     C00253  Nicotinic acid (Vitamin B3); Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     C00253  Nicotinate; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C04 PERIPHERAL VASODILATORS;    C04A PERIPHERAL VASODILATORS;     C04AC Nicotinic acid and derivatives;      C04AC01 Nicotinic acid;       D00049  Niacin (USP);   C10 LIPID MODIFYING AGENTS;    C10A LIPID MODIFYING AGENTS, PLAIN;     C10AD Nicotinic acid and derivatives;      C10AD02 Nicotinic acid;       D00049  Niacin (USP); USP drug classification [BR:br08302];  Cardiovascular Agents;   Dyslipidemics, Other;    Niacin;     D00049  Niacin (USP); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    313  Vitamin B preparations;     3132  Nicotinic acids;      D00049  Niacin (USP); Nicotinic acid (JP17/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Nicotinic acid;     D00049  Niacin (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00049  Nicotinic acid;   D00049  Nicotinic acid injection; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     D00049  Nicotinic acid (JP15/INN); Niacin (USP); Dermatological agents [br08370.html];  Non-steroidal oral agent;   D00049; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   962  Vitamin preparations;    9623  Vitamin B and preparations (except vitamin B1 preparations);     C00253  Nicotinate",CAS: 59-67-6; PubChem: 3552; ChEBI: 15940; ChEMBL: CHEMBL573; KNApSAcK: C00000208; PDB-CCD: NIO; 3DMET: B00073; NIKKAJI: J2.809F,cpd:C00253; cpd:C06813; cpd:C07446; cpd:C10164,6,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H6O2N1,C6H4O2N1,123.0320284,124.0398534,122.02420342969,3281,cpd:C00455,Nicotinamide D-ribonucleotide;,C11H15N2O8P,Nicotinamide D-ribonucleotide; NMN; Nicotinamide mononucleotide; Nicotinamide ribonucleotide; Nicotinamide nucleotide; beta-Nicotinamide D-ribonucleotide; beta-Nicotinamide ribonucleotide; beta-Nicotinamide mononucleotide,R00103 R00137 R00382 R01270 R01271 R02322 R02323 R02324,Nicotinate and nicotinamide metabolism; Metabolic pathways,2.4.2.12; 2.7.1.22; 2.7.7.1; 2.7.7.18; 3.1.3.5; 3.1.3.-; 3.2.2.14; 3.5.1.42; 3.6.1.9; 3.6.1.22; 6.5.1.2; 6.5.1.6,NA,NA,CAS: 1094-61-7; PubChem: 3741; ChEBI: 16171; ChEMBL: CHEMBL378538 CHEMBL603721 CHEMBL610238; KNApSAcK: C00019694; PDB-CCD: NMN; 3DMET: B01247; NIKKAJI: J9.877I,cpd:C00455,11,15,8,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H16O8N2P1,C11H14O8N2P1,334.0566024,335.0644275,333.04877742970,3282,cpd:C00857,Deamino-NAD+;,C21H27N6O15P2,Deamino-NAD+; Deamido-NAD+; Deamido-NAD,R00189 R00257 R03004 R03005,Nicotinate and nicotinamide metabolism; Metabolic pathways,2.7.7.1; 2.7.7.18; 3.6.1.9; 3.6.1.22; 6.3.1.5; 6.3.5.1,"NAD biosynthesis, aspartate => NAD",NA,PubChem: 4114; ChEBI: 18304; PDB-CCD: DND NXX; 3DMET: B01343,cpd:C00857; cpd:C04423,21,27,15,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H28O15N6P2,C21H26O15N6P2,665.1009632,666.1087882,664.09313822971,3283,cpd:C00922,"2,3-Dimethylmaleate;",C6H8O4,"2,3-Dimethylmaleate; Dimethylmaleic acid",R03069 R03070,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,4.2.1.85; 5.3.3.6,NA,NA,CAS: 488-21-1; PubChem: 4176; ChEBI: 17081 23812; 3DMET: B00200; NIKKAJI: J662.562B,cpd:C00614; cpd:C00922; cpd:C01757; cpd:C02295; cpd:C02930; cpd:C03454; cpd:C04311; cpd:C05565; cpd:C06247; cpd:C07460; cpd:C13739; cpd:C14182; cpd:C19821; cpd:C19822; cpd:C19826; cpd:C20758; cpd:C20892; cpd:C20893,6,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O4,C6H7O4,144.0422587,145.0500838,143.03443372972,3284,cpd:C01004,N-Methylnicotinate;,C7H7NO2,N-Methylnicotinate; Trigonelline; Trigenelline; 1-Methylpyridinio-3-carboxylate; Betaine nicotinate; Caffearin; Gynesine,R01721,Nicotinate and nicotinamide metabolism,2.1.1.7,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     C01004  N-Methylnicotinate; Major components of natural products [BR:br08323];  Crude drugs;   Benincasa seed;    C01004  N-Methylnicotinate,CAS: 535-83-1; PubChem: 4250; ChEBI: 18123; ChEMBL: CHEMBL1187085 CHEMBL350675; KNApSAcK: C00001555; NIKKAJI: J6.346K,cpd:C00108; cpd:C00568; cpd:C01004; cpd:C14394; cpd:C16285; cpd:C19486; cpd:C19597,7,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O2N1,C7H6O2N1,137.0476785,138.0555035,136.03985342973,3285,cpd:C01020,6-Hydroxynicotinate;,C6H5NO3,6-Hydroxynicotinate; 6-Hydroxynicotinic acid,R00047 R01720 R03164 R07221 R08764 R09473,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.3.7.1; 1.14.13.114; 1.14.99.-; 1.17.1.5; 1.17.2.1; 1.17.3.3,"Nicotinate degradation, nicotinate => fumarate",Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     C01020  6-Hydroxynicotinate,CAS: 5006-66-6; PubChem: 4265; ChEBI: 16168; ChEMBL: CHEMBL95293; KNApSAcK: C00007415; 3DMET: B00222; NIKKAJI: J208I,cpd:C00870; cpd:C01020; cpd:C01988; cpd:C14418; cpd:C18620,6,5,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H6O3N1,C6H4O3N1,139.026943,140.0347681,138.0191182974,3286,cpd:C01056,(S)-6-Hydroxynicotine,C10H14N2O,(S)-6-Hydroxynicotine,R02860 R03202 R11048,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.5.3.5; 1.5.99.4,"Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde",NA,PubChem: 4296; ChEBI: 17532; PDB-CCD: HNL; 3DMET: B01372; NIKKAJI: J38.661H,cpd:C01056; cpd:C03043; cpd:C16569; cpd:C20361,10,14,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1N2,C10H13O1N2,178.1106131,179.1184381,177.1027882975,3287,cpd:C01059,"2,5-Dihydroxypyridine",C5H5NO2,"2,5-Dihydroxypyridine",R00047 R03204 R03206 R08764 R09125 R09472,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.13.11.9; 1.14.13.114; 1.14.13.163; 1.14.99.26; 1.14.99.-,"Nicotinate degradation, nicotinate => fumarate; Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde",NA,CAS: 5154-01-8; PubChem: 4298; ChEBI: 16364; 3DMET: B00232; NIKKAJI: J356.061I,cpd:C01059; cpd:C02932; cpd:C03056; cpd:C03927; cpd:C05942,5,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H6O2N1,C5H4O2N1,111.0320284,112.0398534,110.02420342976,3288,cpd:C01185,Nicotinate D-ribonucleotide;,C11H15NO9P,Nicotinate D-ribonucleotide; beta-Nicotinate D-ribonucleotide; Nicotinate ribonucleotide; Nicotinic acid ribonucleotide,R01724 R02322 R03004 R03005 R03346 R03347 R03348 R04148; R10608,Nicotinate and nicotinamide metabolism; Metabolic pathways,2.4.2.19; 2.4.2.21; 2.4.2.55; 2.7.1.173; 2.7.7.1; 2.7.7.18; 3.1.3.5; 3.1.3.-; 3.5.1.42; 3.6.1.9; 3.6.1.22; 6.3.4.21,"NAD biosynthesis, aspartate => NAD",Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     C01185  Nicotinate D-ribonucleotide,PubChem: 4411; ChEBI: 15763; KNApSAcK: C00007447; PDB-CCD: NCN; 3DMET: B01404; NIKKAJI: J1.028.429E,cpd:C01185,11,15,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H16O9N1P1,C11H14O9N1P1,336.0484431,337.0562681,335.0406182977,3289,cpd:C01297,6-Hydroxypseudooxynicotine;,C10H14N2O2,6-Hydroxypseudooxynicotine; 1-(6-Hydroxypyridin-3-yl)-4-(methylamino)butan-1-one,R03202 R07170 R07514 R09471 R11049,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.5.3.5; 1.5.3.6; 1.5.99.14,"Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde",NA,PubChem: 4515; ChEBI: 37754; PDB-CCD: HNM; 3DMET: B01436; NIKKAJI: J1.264.110I,cpd:C01297; cpd:C17964,10,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O2N2,C10H13O2N2,194.1055277,195.1133527,193.09770272978,3290,cpd:C01596,Maleamate;,C4H5NO3,Maleamate; Maleamic acid,R03204 R03540 R05781 R07949 R07983 R09126,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,3.5.1.106; 3.5.1.107; 3.5.2.16,"Nicotinate degradation, nicotinate => fumarate",NA,CAS: 557-24-4; PubChem: 4751; ChEBI: 29045; 3DMET: B00329; NIKKAJI: J53.672E,cpd:C01596; cpd:C20735,4,5,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H6O3N1,C4H4O3N1,115.026943,116.0347681,114.0191182979,3291,cpd:C02295,Methylitaconate;,C6H8O4,Methylitaconate; 2-Methylene-3-methylsuccinate,R03070 R03908,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,5.3.3.6; 5.4.99.4,NA,NA,PubChem: 5351; ChEBI: 16093; 3DMET: B00419; NIKKAJI: J1.895.610A,cpd:C00614; cpd:C00922; cpd:C01757; cpd:C02295; cpd:C02930; cpd:C03454; cpd:C04311; cpd:C05565; cpd:C06247; cpd:C07460; cpd:C13739; cpd:C14182; cpd:C19821; cpd:C19822; cpd:C19826; cpd:C20758; cpd:C20892; cpd:C20893,6,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O4,C6H7O4,144.0422587,145.0500838,143.03443372980,3292,cpd:C02918,1-Methylnicotinamide;,C7H9N2O,1-Methylnicotinamide; N(1)-Methylnicotinamide,R01269 R04085 R08408,Nicotinate and nicotinamide metabolism; Metabolic pathways; Bile secretion,1.2.3.1; 2.1.1.1,NA,NA,CAS: 3106-60-3; PubChem: 5841; ChEBI: 16797; ChEMBL: CHEMBL71733; 3DMET: B00512; NIKKAJI: J66.624F,cpd:C02918; cpd:C07400,7,9,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O1N2,C7H8O1N2,137.0714879,138.079313,136.06366292981,3293,cpd:C02930,2-Methyleneglutarate;,C6H8O4,2-Methyleneglutarate; alpha-Methylene glutarate,R01725 R03908 R07986,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,5.4.99.4,NA,NA,CAS: 3621-79-2; PubChem: 5852; ChEBI: 17207; 3DMET: B00516; NIKKAJI: J38.893I,cpd:C00614; cpd:C00922; cpd:C01757; cpd:C02295; cpd:C02930; cpd:C03454; cpd:C04311; cpd:C05565; cpd:C06247; cpd:C07460; cpd:C13739; cpd:C14182; cpd:C19821; cpd:C19822; cpd:C19826; cpd:C20758; cpd:C20892; cpd:C20893,6,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O4,C6H7O4,144.0422587,145.0500838,143.03443372982,3294,cpd:C03043,(R)-6-Hydroxynicotine,C10H14N2O,(R)-6-Hydroxynicotine,R07170 R07946 R11050,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.5.3.6; 1.5.99.4,"Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde",NA,PubChem: 5946; ChEBI: 18226; PDB-CCD: HNK; 3DMET: B01624; NIKKAJI: J2.226.867H,cpd:C01056; cpd:C03043; cpd:C16569; cpd:C20361,10,14,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1N2,C10H13O1N2,178.1106131,179.1184381,177.1027882983,3295,cpd:C03056,"2,6-Dihydroxypyridine",C5H5NO2,"2,6-Dihydroxypyridine",R04130 R07515,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.14.13.10; 3.7.1.19,"Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde",NA,CAS: 626-06-2; PubChem: 5956; ChEBI: 17681; 3DMET: B00531; NIKKAJI: J58.008B,cpd:C01059; cpd:C02932; cpd:C03056; cpd:C03927; cpd:C05942,5,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H6O2N1,C5H4O2N1,111.0320284,112.0398534,110.02420342984,3296,cpd:C03150,Nicotinamide-beta-riboside;,C11H15N2O5,Nicotinamide-beta-riboside; N-Ribosylnicotinamide; 1-(beta-D-Ribofuranosyl)nicotinamide,R01273 R02294 R02323 R02324 R07361,Nicotinate and nicotinamide metabolism; Metabolic pathways; Longevity regulating pathway - worm,1.10.5.1; 2.4.2.1; 2.7.1.22; 3.1.3.5; 3.1.3.-; 3.2.2.1; 3.2.2.3,NA,NA,CAS: 1341-23-7; PubChem: 6038; ChEBI: 15927; ChEMBL: CHEMBL438497; PDB-CCD: NNR; 3DMET: B01635; NIKKAJI: J490.568G,cpd:C03150,11,15,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H16O5N2,C11H14O5N2,255.0980966,256.1059216,254.09027162985,3297,cpd:C03458,"2,3,6-Trihydroxypyridine",C5H5NO3,"2,3,6-Trihydroxypyridine",R04130 R07948 R07949,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.14.13.10,NA,NA,PubChem: 6278; ChEBI: 16683; 3DMET: B00586; NIKKAJI: J1.264.112E,cpd:C03458; cpd:C19721,5,5,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H6O3N1,C5H4O3N1,127.026943,128.0347681,126.0191182986,3298,cpd:C03652,"(2R,3S)-2,3-Dimethylmalate",C6H10O5,"(2R,3S)-2,3-Dimethylmalate",R01355 R03069,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,4.1.3.32; 4.2.1.85,NA,NA,PubChem: 6432; ChEBI: 15582; 3DMET: B01680; NIKKAJI: J2.743.794J,cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335,6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5,C6H9O5,162.0528234,163.0606485,161.04499842987,3299,cpd:C04226,"6-Oxo-1,4,5,6-tetrahydronicotinate;",C6H7NO3,"6-Oxo-1,4,5,6-tetrahydronicotinate; 1,4,5,6-Tetrahydro-6-oxonicotinate; 1,4,5,6-Tetrahydro-6-oxonicotinic acid",R03164 R07984,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.3.7.1; 3.5.2.18,NA,NA,PubChem: 6897; ChEBI: 16453; 3DMET: B00695; NIKKAJI: J1.264.107I,cpd:C03824; cpd:C04226; cpd:C06333; cpd:C06334; cpd:C06335; cpd:C09960,6,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O3N1,C6H6O3N1,141.0425931,142.0504181,140.03476812988,3300,cpd:C05380,Nicotinurate;,C8H8N2O3,Nicotinurate; Nicotinuric acid; Nicotinylglycine,R01723,Nicotinate and nicotinamide metabolism,NA,NA,NA,CAS: 583-08-4; PubChem: 7754; ChEBI: 7563; ChEMBL: CHEMBL458725; 3DMET: B00772; NIKKAJI: J11.524J,cpd:C00875; cpd:C05380; cpd:C07504; cpd:C16623,8,8,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3N2,C8H7O3N2,180.0534921,181.0613172,179.04566712989,3301,cpd:C05840,Iminoaspartate;,C4H5NO4,Iminoaspartate; Iminoaspartic acid; Iminosuccinate,R00481 R04292 R07407 R07410,Nicotinate and nicotinamide metabolism; Metabolic pathways,1.4.1.21; 1.4.3.16; 2.5.1.72,"NAD biosynthesis, aspartate => NAD",NA,PubChem: 8133; ChEBI: 50616; LIPIDMAPS: LMFA01170110; KNApSAcK: C00007565; 3DMET: B00865; NIKKAJI: J1.894.303D,cpd:C02362; cpd:C05840; cpd:C13058,4,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H6O4N1,C4H4O4N1,131.0218576,132.0296827,130.01403262990,3302,cpd:C05841,Nicotinate D-ribonucleoside;,C11H14NO6,Nicotinate D-ribonucleoside; beta-D-Ribosylnicotinate,R02295 R03346 R03347 R10046,Nicotinate and nicotinamide metabolism; Metabolic pathways,2.4.2.1; 2.7.1.173; 3.1.3.5; 3.1.3.-; 3.2.2.3,NA,NA,PubChem: 8134; ChEBI: 27748; ChEMBL: CHEMBL396943; 3DMET: B01901; NIKKAJI: J2.759.974E,cpd:C03506; cpd:C05841,11,14,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O6N1,C11H13O6N1,256.0821122,257.0899372,255.07428712991,3303,cpd:C05842,N1-Methyl-2-pyridone-5-carboxamide;,C7H8N2O2,N1-Methyl-2-pyridone-5-carboxamide; N'-Methyl-2-pyridone-5-carboxamide; 1-Methyl-5-carboxylamide-2-pyridone,R08408,Nicotinate and nicotinamide metabolism; Metabolic pathways,1.2.3.1,NA,NA,CAS: 701-44-0; PubChem: 8135; ChEBI: 27410; 3DMET: B00866; NIKKAJI: J121.846H,cpd:C05842; cpd:C05843; cpd:C16398; cpd:C18320,7,8,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O2N2,C7H7O2N2,152.0585775,153.0664025,151.05075252992,3304,cpd:C05843,N1-Methyl-4-pyridone-5-carboxamide;,C7H8N2O2,N1-Methyl-4-pyridone-5-carboxamide; N'-Methyl-4-pyridone-5-carboxamide; 1-Methyl-4-pyridone-3-carboximide,R04085,Nicotinate and nicotinamide metabolism; Metabolic pathways,1.2.3.1,NA,NA,CAS: 769-49-3; PubChem: 8136; ChEBI: 27838; 3DMET: B01902; NIKKAJI: J367.452E,cpd:C05842; cpd:C05843; cpd:C16398; cpd:C18320,7,8,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O2N2,C7H7O2N2,152.0585775,153.0664025,151.05075252993,3305,cpd:C06178,1-Methylpyrrolinium;,C5H10N,1-Methylpyrrolinium; 1-Methyl-Delta(1)-pyrrolinium,R02861 R04027 R05335 R06727 R06732 R08427 R08428 R08429; R08431,"Nicotinate and nicotinamide metabolism; Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",1.4.3.21,NA,NA,CAS: 16032-02-3; PubChem: 8429; ChEBI: 27435; KNApSAcK: C00034612; 3DMET: B00914; NIKKAJI: J493.544F,cpd:C03287; cpd:C03734; cpd:C05765; cpd:C06178; cpd:C19511; cpd:C19570; cpd:C19599,5,10,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11N1,C5H9N1,84.08132433,85.08914936,83.073499292994,3306,cpd:C15523,"2,6-Dihydroxynicotinate",C6H5NO4,"2,6-Dihydroxynicotinate",R07221 R07983,Nicotinate and nicotinamide metabolism,1.17.3.3,NA,NA,PubChem: 17396515; ChEBI: 49087; NIKKAJI: J662.711K,cpd:C02235; cpd:C15523,6,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H6O4N1,C6H4O4N1,155.0218576,156.0296827,154.01403262995,3307,cpd:C15986,"2,6-Dihydroxypseudooxynicotine;",C10H14N2O3,"2,6-Dihydroxypseudooxynicotine; 1-(2,6-Dihydroxypyridin-3-yl)-4-(methylamino)butan-1-one",R07514 R07515 R07947,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.5.99.14; 3.7.1.19,"Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde",NA,PubChem: 47205299; ChEBI: 28220; NIKKAJI: J1.264.111G,cpd:C07826; cpd:C15986; cpd:C20822,10,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O3N2,C10H13O3N2,210.1004423,211.1082674,209.09261732996,3308,cpd:C15987,4-Methylaminobutyrate;,C5H11NO2,4-Methylaminobutyrate; gamma-N-Methylaminobutyrate,R07515 R10101 R10102,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.5.3.19; 1.5.3.21; 3.7.1.19,"Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde",NA,CAS: 1119-48-8; PubChem: 47205300; ChEBI: 37755; NIKKAJI: J231.911J,cpd:C00073; cpd:C00183; cpd:C00431; cpd:C00719; cpd:C00855; cpd:C01733; cpd:C01799; cpd:C01826; cpd:C03571; cpd:C05335; cpd:C06417; cpd:C07418; cpd:C07457; cpd:C15987; cpd:C16436,5,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O2N1,C5H10O2N1,117.0789786,118.0868036,116.07115362997,3309,cpd:C16150,"(R,S)-Nicotine;",C10H14N2,"(R,S)-Nicotine; (+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine",R02860 R07946 R11175 R11177,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.5.3.-; 1.5.99.4,"Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde; Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde",NA,CAS: 22083-74-5; PubChem: 47205460; ChEBI: 18723; ChEMBL: CHEMBL440464; NIKKAJI: J23.948H,cpd:C00214; cpd:C00745; cpd:C00931; cpd:C01056; cpd:C01297; cpd:C03043; cpd:C05131; cpd:C06180; cpd:C06870; cpd:C07826; cpd:C11357; cpd:C15986; cpd:C16150; cpd:C16386; cpd:C16569; cpd:C16744; cpd:C17369; cpd:C17964; cpd:C19086; cpd:C19431; cpd:C20361; cpd:C20822,10,14,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15N2,C10H13N2,162.1156985,163.1235235,161.10787342998,3310,cpd:C16151,"2,6-Dihydroxy-N-methylmyosmine",C10H12N2O2,"2,6-Dihydroxy-N-methylmyosmine",R07947,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,NA,NA,NA,PubChem: 47205461; ChEBI: 80354; NIKKAJI: J2.798.389H,cpd:C09907; cpd:C16151,10,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O2N2,C10H11O2N2,192.0898776,193.0977027,191.08205262999,3311,cpd:C16152,Blue pigment;,C10H6N2O6,"Blue pigment; Nicotine blue; (E)-2,2',5,5'-Tetrahydroxy-6H,6'H-[3,3'-bipyridinylidene]-6,6'-dione",R07948 R10131 R10132,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.1.1.328,NA,NA,PubChem: 47205462; ChEBI: 80355; NIKKAJI: J2.486.577K,cpd:C16152,10,6,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H7O6N2,C10H5O6N2,250.0225859,251.030411,249.01476093000,3312,cpd:C16159,2-Formylglutarate,C6H8O5,2-Formylglutarate,R07984 R07985,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.1.1.291; 3.5.2.18,NA,NA,PubChem: 47205469; ChEBI: 49075; NIKKAJI: J2.668.380G,cpd:C00322; cpd:C00846; cpd:C04287; cpd:C04305; cpd:C04361; cpd:C06379; cpd:C06891; cpd:C16159; cpd:C19128; cpd:C20781,6,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O5,C6H7O5,160.0371734,161.0449984,159.02934833001,3313,cpd:C16390,(S)-2-(Hydroxymethyl)glutarate,C6H10O5,(S)-2-(Hydroxymethyl)glutarate,R07985 R07986,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.1.1.291,NA,NA,PubChem: 47205688; ChEBI: 49076 49077; NIKKAJI: J2.802.556D,cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335,6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5,C6H9O5,162.0528234,163.0606485,161.04499843002,3314,cpd:C18232,N-Formylmaleamic acid,C5H5NO4,N-Formylmaleamic acid,R09125 R09126,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.13.11.9; 3.5.1.106,"Nicotinate degradation, nicotinate => fumarate",NA,PubChem: 103061414; ChEBI: 59930,cpd:C18232,5,5,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H6O4N1,C5H4O4N1,143.0218576,144.0296827,142.01403263003,3315,cpd:C19567,4-Oxo-1-(3-pyridyl)-1-butanone;,C9H9NO2,4-Oxo-1-(3-pyridyl)-1-butanone; gamma-Oxo-3-pyridinebutanal; 4-Oxo-4-(pyridin-3-yl)butanal; 3-Succinoylsemialdehyde-pyridine,R09433 R10103 R10105,Nicotinate and nicotinamide metabolism; Metabolism of xenobiotics by cytochrome P450; Microbial metabolism in diverse environments; Chemical carcinogenesis,1.2.1.83; 1.4.3.24,"Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde",NA,CAS: 76014-80-7; PubChem: 124490239; ChEBI: 66879,cpd:C05834; cpd:C19567; cpd:C20810,9,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O2N1,C9H8O2N1,163.0633285,164.0711536,162.05550353004,3316,cpd:C19569,3-Succinoylpyridine;,C9H9NO3,3-Succinoylpyridine; 4-Oxo-4-(pyridin-3-yl)butanoate,R09438 R10105 R11178 R11179,Nicotinate and nicotinamide metabolism; Metabolism of xenobiotics by cytochrome P450; Microbial metabolism in diverse environments; Chemical carcinogenesis,1.2.1.83; 1.5.99.-,"Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde",NA,CAS: 4192-31-8; PubChem: 124490241; ChEBI: 66951,cpd:C01060; cpd:C01586; cpd:C03224; cpd:C03347; cpd:C06332; cpd:C06339; cpd:C11449; cpd:C17080; cpd:C17099; cpd:C19569; cpd:C21453,9,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O3N1,C9H8O3N1,179.0582432,180.0660682,178.05041813005,3317,cpd:C19631,6-Hydroxy-3-succinoylpyridine;,C9H9NO4,6-Hydroxy-3-succinoylpyridine; 4-(6-Hydroxypyridin-3-yl)-4-oxobutanoate,R09471 R09472 R11179,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.5.99.-; 1.14.13.163,"Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde",NA,PubChem: 124490283; PDB-CCD: 6HY,cpd:C00822; cpd:C04274; cpd:C05604; cpd:C07588; cpd:C19631,9,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O4N1,C9H8O4N1,195.0531578,196.0609828,194.04533273006,3318,cpd:C20361,Pseudooxynicotine;,C10H14N2O,Pseudooxynicotine; 4-(Methylamino)-1-(pyridin-3-yl)butan-1-one,R10103 R11176 R11177 R11178,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.4.3.24; 1.5.3.-,"Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde",NA,CAS: 2055-23-4; PubChem: 163312099,cpd:C01056; cpd:C03043; cpd:C16569; cpd:C20361,10,14,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1N2,C10H13O1N2,178.1106131,179.1184381,177.1027883007,3319,cpd:C20381,"3,3'-Bipyridine-2,2',5,5',6,6'-hexol",C10H8N2O6,"3,3'-Bipyridine-2,2',5,5',6,6'-hexol",R10131 R10132,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.1.1.328,NA,NA,PubChem: 163312119,cpd:C19959; cpd:C20381,10,8,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O6N2,C10H7O6N2,252.038236,253.046061,251.0304113008,3320,cpd:C21075,"5-(N-Methyl-4,5-dihydro-1H-pyrrol-2-yl)pyridin-2-ol;",C10H12N2O,"5-(N-Methyl-4,5-dihydro-1H-pyrrol-2-yl)pyridin-2-ol; 6-Hydroxy-N-methylmyosmine",R11048 R11049 R11050,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.5.3.5; 1.5.3.6,"Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde",NA,PubChem: 295369337; PDB-CCD: HNH,cpd:C00780; cpd:C17203; cpd:C21075,10,12,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O1N2,C10H11O1N2,176.094963,177.102788,175.0871383009,3321,cpd:C21154,N-Methylmyosmine;,C10H12N2,"N-Methylmyosmine; 3-(4,5-Dihydro-1-methyl-1H-pyrrol-2-yl)pyridine",R11175 R11176,Nicotinate and nicotinamide metabolism; Microbial metabolism in diverse environments,1.5.3.-,"Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde",NA,CAS: 525-74-6; PubChem: 313369414,cpd:C00328; cpd:C00398; cpd:C00780; cpd:C01718; cpd:C02548; cpd:C02794; cpd:C03227; cpd:C05647; cpd:C05651; cpd:C07147; cpd:C07312; cpd:C07756; cpd:C09907; cpd:C10126; cpd:C10965; cpd:C14302; cpd:C16151; cpd:C16880; cpd:C16906; cpd:C17203; cpd:C18671; cpd:C21075; cpd:C21154,10,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13N2,C10H11N2,160.1000484,161.1078734,159.09222343010,3322,cpd:C00522,(R)-Pantoate;,C6H12O4,(R)-Pantoate; Pantoate; Pantoic acid,R02471 R02472 R02473 R02474 R09378 R10821,Pantothenate and CoA biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.106; 1.1.1.169; 2.7.1.169; 3.5.1.22; 6.3.2.1; 6.3.2.44,"Pantothenate biosynthesis, valine/L-aspartate => pantothenate",NA,CAS: 470-29-1; PubChem: 3805; ChEBI: 14737 15980 18697; ChEMBL: CHEMBL1794671; KNApSAcK: C00007622; PDB-CCD: PAF; 3DMET: B00120; NIKKAJI: J23.325K,cpd:C00418; cpd:C00491; cpd:C00522; cpd:C01100; cpd:C01420; cpd:C02104; cpd:C03089; cpd:C03348; cpd:C04104; cpd:C05704; cpd:C06007; cpd:C06471; cpd:C13522; cpd:C14445; cpd:C18988; cpd:C19719; cpd:C21045; cpd:C21054; cpd:C21055; cpd:C21062; cpd:C21397,6,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O4,C6H11O4,148.0735589,149.0813839,147.06573383011,3323,cpd:C00882,Dephospho-CoA;,C21H35N7O13P2S,Dephospho-CoA; Dephosphocoenzyme A; 3'-Dephospho-CoA,R00130 R03035 R03036 R09675,Pantothenate and CoA biosynthesis; Metabolic pathways,2.4.2.52; 2.7.1.24; 2.7.7.3; 3.6.1.9,"Coenzyme A biosynthesis, pantothenate => CoA",NA,CAS: 3633-59-8; PubChem: 4138; ChEBI: 15468; KNApSAcK: C00007257; PDB-CCD: COD; 3DMET: B04743,cpd:C00882,21,35,13,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C21H36O13N7P2S1,C21H34O13N7P2S1,687.1488794,688.1567044,686.14105443012,3324,cpd:C00900,2-Acetolactate,C5H8O4,2-Acetolactate,R00006 R03050 R03051 R03052,Pantothenate and CoA biosynthesis,1.1.1.86; 2.2.1.6; 5.4.99.3,NA,NA,PubChem: 4156; ChEBI: 16444; KNApSAcK: C00019658; 3DMET: B04748; NIKKAJI: J431.537E,cpd:C00489; cpd:C00707; cpd:C00900; cpd:C02352; cpd:C02674; cpd:C03409; cpd:C03589; cpd:C04106; cpd:C04181; cpd:C06010; cpd:C08298; cpd:C11838; cpd:C18061; cpd:C19483; cpd:C19885; cpd:C20232; cpd:C20846; cpd:C21177,5,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O4,C5H7O4,132.0422587,133.0500838,131.03443373013,3325,cpd:C00966,2-Dehydropantoate,C6H10O4,2-Dehydropantoate,R01216 R01226 R02472,Pantothenate and CoA biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.169; 2.1.2.11; 4.1.2.12,"Pantothenate biosynthesis, valine/L-aspartate => pantothenate",NA,PubChem: 4217; ChEBI: 11561 17094; KNApSAcK: C00007477; PDB-CCD: KPL; 3DMET: B01362; NIKKAJI: J934.784D,cpd:C00439; cpd:C00659; cpd:C00772; cpd:C00966; cpd:C01053; cpd:C04237; cpd:C04327; cpd:C04556; cpd:C06006; cpd:C06104; cpd:C06762; cpd:C13811; cpd:C14463; cpd:C16272; cpd:C16674; cpd:C18379; cpd:C18384; cpd:C18719; cpd:C21465,6,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O4,C6H9O4,146.0579088,147.0657338,145.05008383014,3326,cpd:C01053,(R)-4-Dehydropantoate,C6H10O4,(R)-4-Dehydropantoate,R02471 R03198,Pantothenate and CoA biosynthesis,1.1.1.106; 1.2.1.33,NA,NA,PubChem: 4294; ChEBI: 16654; 3DMET: B04760; NIKKAJI: J2.731.114H,cpd:C00439; cpd:C00659; cpd:C00772; cpd:C00966; cpd:C01053; cpd:C04237; cpd:C04327; cpd:C04556; cpd:C06006; cpd:C06104; cpd:C06762; cpd:C13811; cpd:C14463; cpd:C16272; cpd:C16674; cpd:C18379; cpd:C18384; cpd:C18719; cpd:C21465,6,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O4,C6H9O4,146.0579088,147.0657338,145.05008383015,3327,cpd:C01088,"(R)-3,3-Dimethylmalate",C6H10O5,"(R)-3,3-Dimethylmalate",R01211 R03198,Pantothenate and CoA biosynthesis,1.1.1.84; 1.2.1.33,NA,NA,PubChem: 4323; ChEBI: 15587; 3DMET: B00238; NIKKAJI: J2.366.630H,cpd:C00420; cpd:C00478; cpd:C00718; cpd:C00760; cpd:C00771; cpd:C00965; cpd:C00973; cpd:C01088; cpd:C01654; cpd:C01898; cpd:C01935; cpd:C01989; cpd:C02360; cpd:C02488; cpd:C02490; cpd:C02492; cpd:C02493; cpd:C02616; cpd:C02991; cpd:C03018; cpd:C03652; cpd:C03761; cpd:C03827; cpd:C03956; cpd:C03979; cpd:C04417; cpd:C05829; cpd:C06158; cpd:C06159; cpd:C06215; cpd:C06400; cpd:C06474; cpd:C06478; cpd:C06485; cpd:C08266; cpd:C11592; cpd:C16390; cpd:C17207; cpd:C17209; cpd:C18028; cpd:C20902; cpd:C21068; cpd:C21335,6,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O5,C6H9O5,162.0528234,163.0606485,161.04499843016,3328,cpd:C04039,"2,3-Dihydroxy-3-methylbutanoate;",C5H10O4,"2,3-Dihydroxy-3-methylbutanoate; 2,3-Dihydroxy-isovalerate; 2,3-Dihydroxy-isovaleric acid",R01209 R03051,Pantothenate and CoA biosynthesis,1.1.1.86; 4.2.1.9,NA,NA,PubChem: 6741; ChEBI: 15689; KNApSAcK: C00019678; 3DMET: B00667; NIKKAJI: J2.316.717D,cpd:C01801; cpd:C02783; cpd:C04039; cpd:C04272; cpd:C06257; cpd:C08347; cpd:C11497,5,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O4,C5H9O4,134.0579088,135.0657338,133.05008383017,3329,cpd:C04079,N-((R)-Pantothenoyl)-L-cysteine;,C12H22N2O6S,N-((R)-Pantothenoyl)-L-cysteine; D-Pantothenoyl-L-cysteine; N-Pantothenoylcysteine,R02972 R04391,Pantothenate and CoA biosynthesis,2.7.1.33; 4.1.1.30,NA,NA,PubChem: 6773; ChEBI: 18416; 3DMET: B01715; NIKKAJI: J2.746.251K,cpd:C04079,12,22,6,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O6N2S1,C12H21O6N2S1,322.1198576,323.1276826,321.11203263018,3330,cpd:C04352,(R)-4'-Phosphopantothenoyl-L-cysteine;,C12H23N2O9PS,(R)-4'-Phosphopantothenoyl-L-cysteine; N-[(R)-4'-Phosphopantothenoyl]-L-cysteine,R03269 R04230 R04231 R04391,Pantothenate and CoA biosynthesis; Metabolic pathways,2.7.1.33; 4.1.1.36; 6.3.2.5,"Coenzyme A biosynthesis, pantothenate => CoA",NA,PubChem: 7001; ChEBI: 15769; KNApSAcK: C00019633; 3DMET: B01735; NIKKAJI: J1.572.366A,cpd:C04352,12,23,9,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O9N2P1S1,C12H22O9N2P1S1,402.0861885,403.0940135,401.07836353019,3331,cpd:C05944,Pantothenol;,C9H19NO4,"Pantothenol; (R)-2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide; Dexpanthenol; 2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide; (+)-Panthenol; Bepanthen; Bepanthene; Bepantol; D-(+)-2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide; Cozyme; D(+)-Panthenol; D(+)-Pantothenyl alcohol; D-P-A Injection; D-Panthenol; d-Pantothenol; d-Pantothenyl alcohol; Ilopan; Motilyn; Panadon; Panthenol; Panthoderm; Pantol; Pantothenyl alcohol; N-Pantoyl-propanolamine; Provitamin B; Synapan; Thenalton; Zentinic",R03927,Pantothenate and CoA biosynthesis,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA30 Dexpanthenol;       D00193  Dexpanthenol (USP/INN);  D DERMATOLOGICALS;   D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;    D03A CICATRIZANTS;     D03AX Other cicatrizants;      D03AX03 Dexpanthenol;       D00193  Dexpanthenol (USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01X OTHER OPHTHALMOLOGICALS;     S01XA Other ophthalmologicals;      S01XA12 Dexpanthenol;       D00193  Dexpanthenol (USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    313  Vitamin B preparations;     3133  Pantothenic acids;      D00193  Dexpanthenol (USP/INN); Panthenol (JAN); Classification of Japanese OTC drugs [BR:br08313];  Agents for ophthalmologic use;   62 General eye drops;    D00193  Dexpanthenol (USP/INN);  Agents for dental and stomatological use;   74 Stomatitis remedies;    D00193  Dexpanthenol (USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Panthenol;     D00193  Dexpanthenol (USP/INN); Dermatological agents [br08370.html];  Non-steroidal injection;   D00193,CAS: 81-13-0; PubChem: 8228; ChEBI: 27373; ChEMBL: CHEMBL1200979; 3DMET: B00882; NIKKAJI: J4.605A,cpd:C05944,9,19,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H20O4N1,C9H18O4N1,205.1314081,206.1392331,204.12358313020,3332,cpd:C18911,(R)-4-Phosphopantoate,C6H13O7P,(R)-4-Phosphopantoate,R09378 R09379,Pantothenate and CoA biosynthesis; Metabolic pathways,2.7.1.169; 6.3.2.36,NA,NA,PubChem: 124489583; ChEBI: 61291; PDB-CCD: 2JD,cpd:C01107; cpd:C04188; cpd:C04438; cpd:C04582; cpd:C05973; cpd:C18911; cpd:C20847,6,13,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O7P1,C6H12O7P1,228.0398898,229.0477148,227.03206473021,3333,cpd:C00120,Biotin;,C10H16N2O3S,Biotin; D-Biotin; Vitamin H; Coenzyme R,R01074 R01075 R01076 R01077 R01078 R04562 R04563 R04582; R04604 R10127,Biotin metabolism; Metabolic pathways; ABC transporters; Vitamin digestion and absorption,1.-.-.-; 2.8.1.6; 3.5.1.12; 6.2.1.11; 6.3.4.9; 6.3.4.10; 6.3.4.11; 6.3.4.15,"Biotin biosynthesis, pimeloyl-ACP/CoA => biotin; Biotin biosynthesis, BioI pathway, long-chain-acyl-ACP => pimeloyl-ACP => biotin; Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00120  Biotin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA05 Biotin;       D00029  Biotin (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    319  Miscellaneous vitamins;     3190  Miscellaneous vitamins;      D00029  Biotin (JP17/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Biotin;     D00029  Biotin (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00029  Biotin; Dermatological agents [br08370.html];  Non-steroidal oral agent;   D00029;  Non-steroidal injection;   D00029,CAS: 58-85-5; PubChem: 3420; ChEBI: 15956; ChEMBL: CHEMBL857; KNApSAcK: C00000756; PDB-CCD: BTN; 3DMET: B01165; NIKKAJI: J94.599D,cpd:C00120; cpd:C20818,10,16,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O3N2S1,C10H15O3N2S1,244.0881636,245.0959886,243.08033853022,3334,cpd:C01037,"7,8-Diaminononanoate;",C9H20N2O2,"7,8-Diaminononanoate; 7,8-Diaminopelargonic acid; DAPA",R03182 R03231 R10699,Biotin metabolism; Metabolic pathways,2.6.1.62; 2.6.1.105; 6.3.3.3,"Biotin biosynthesis, pimeloyl-ACP/CoA => biotin; Biotin biosynthesis, BioI pathway, long-chain-acyl-ACP => pimeloyl-ACP => biotin; Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin",NA,PubChem: 4280; ChEBI: 17830 2247; 3DMET: B04758; NIKKAJI: J511.020C,cpd:C01037; cpd:C03793; cpd:C18885,9,20,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H21O2N2,C9H19O2N2,188.1524779,189.1603029,187.14465293023,3335,cpd:C01092,8-Amino-7-oxononanoate;,C9H17NO3,8-Amino-7-oxononanoate; 8-Amino-7-oxononanoic acid; 7-Keto-8-aminopelargonic acid; KAPA,R03210 R03231 R10124 R10699,Biotin metabolism; Metabolic pathways,2.3.1.47; 2.6.1.62; 2.6.1.105,"Biotin biosynthesis, pimeloyl-ACP/CoA => biotin; Biotin biosynthesis, BioI pathway, long-chain-acyl-ACP => pimeloyl-ACP => biotin; Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin",Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C01092  8-Amino-7-oxononanoic acid,PubChem: 4327; ChEBI: 12266 15830; LIPIDMAPS: LMFA01060168; 3DMET: B04764; NIKKAJI: J511.019J,cpd:C01092; cpd:C12029,9,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H18O3N1,C9H16O3N1,187.1208434,188.1286684,186.11301843024,3336,cpd:C01894,Biotinyl-CoA,C31H50N9O18P3S2,Biotinyl-CoA,R01075 R03762,Biotin metabolism,6.2.1.11,NA,NA,PubChem: 5007; ChEBI: 15516; 3DMET: B04820; NIKKAJI: J2.734.787H,cpd:C01894,31,50,18,9,3,2,0,0,0,0,0,0,0,0,0,0,0,0,C31H51O18N9P3S2,C31H49O18N9P3S2,993.1928091,994.2006342,992.18498413025,3337,cpd:C01909,Dethiobiotin;,C10H18N2O3,Dethiobiotin; Desthiobiotin,R01078 R03182,Biotin metabolism; Metabolic pathways,2.8.1.6; 6.3.3.3,"Biotin biosynthesis, pimeloyl-ACP/CoA => biotin; Biotin biosynthesis, BioI pathway, long-chain-acyl-ACP => pimeloyl-ACP => biotin; Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin",NA,CAS: 533-48-2; PubChem: 5017; ChEBI: 16691; KNApSAcK: C00000757; 3DMET: B04822; NIKKAJI: J9.406D,cpd:C01909,10,18,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O3N2,C10H17O3N2,214.1317424,215.1395675,213.12391743026,3338,cpd:C02656,Pimelate;,C7H12O4,Pimelate; Pimelic acid; Heptanedioic acid; 6-Carboxyhexanoate,R03209,Biotin metabolism; Metabolic pathways,6.2.1.14,"Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin",Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Dicarboxylic acids;     C02656  Pimelate; Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0117 Dicarboxylic acids;     C02656  Heptanedioic acid,CAS: 111-16-0; PubChem: 5629; ChEBI: 30531; LIPIDMAPS: LMFA01170051; KNApSAcK: C00001199; PDB-CCD: PML; 3DMET: B00476; NIKKAJI: J5.105E,cpd:C02656; cpd:C02851; cpd:C02986; cpd:C04687; cpd:C11490; cpd:C16657; cpd:C20729; cpd:C20918; cpd:C20920; cpd:C21437,7,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O4,C7H11O4,160.0735589,161.0813839,159.06573383027,3339,cpd:C05552,Biocytin;,C16H28N4O4S,Biocytin; N6-D-Biotinyl-L-lysine; epsilon-N-Biotinyl-L-lysine,R01077 R04869,Biotin metabolism; Metabolic pathways; Vitamin digestion and absorption,3.4.-.-; 3.5.1.12,NA,NA,CAS: 576-19-2; PubChem: 7886; ChEBI: 27870; ChEMBL: CHEMBL1473893; PDB-CCD: BYT; 3DMET: B05069; NIKKAJI: J9.428E,cpd:C05552,16,28,4,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C16H29O4N4S1,C16H27O4N4S1,372.1831266,373.1909516,371.17530153028,3340,cpd:C05921,Biotinyl-5'-AMP,C20H28N7O9PS,Biotinyl-5'-AMP,R01074 R03762 R05145,Biotin metabolism; Metabolic pathways,6.2.1.11; 6.3.4.9; 6.3.4.10; 6.3.4.11; 6.3.4.15,NA,NA,PubChem: 8209; ChEBI: 3110; PDB-CCD: BT5; 3DMET: B05138; NIKKAJI: J734.022B,cpd:C05921,20,28,9,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O9N7P1S1,C20H27O9N7P1S1,573.1406837,574.1485087,572.13285873029,3352,cpd:C20384,Bisnorbiotin,C8H12N2O3S,Bisnorbiotin,NA,Biotin metabolism,NA,NA,NA,CAS: 16968-98-2; PubChem: 163312122,cpd:C02954; cpd:C20384,8,12,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O3N2S1,C8H11O3N2S1,216.0568634,217.0646885,215.04903843030,3353,cpd:C20385,Tetranorbiotin,C6H8N2O3S,Tetranorbiotin,NA,Biotin metabolism,NA,NA,NA,PubChem: 163312123,cpd:C20385,6,8,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O3N2S1,C6H7O3N2S1,188.0255633,189.0333883,187.01773833031,3354,cpd:C20386,Biotin sulfoxide,C10H16N2O4S,Biotin sulfoxide,R10127,Biotin metabolism; Metabolic pathways,1.-.-.-,NA,NA,PubChem: 163312124; PDB-CCD: BSO,cpd:C20386,10,16,4,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O4N2S1,C10H15O4N2S1,260.0830782,261.0909032,259.07525313032,3355,cpd:C20387,Biotin sulfone,C10H16N2O5S,Biotin sulfone,NA,Biotin metabolism,NA,NA,NA,CAS: 40720-05-6; PubChem: 163312125,cpd:C20387,10,16,5,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O5N2S1,C10H15O5N2S1,276.0779928,277.0858178,275.07016783033,3358,cpd:C16238,Lipoyl-AMP,C18H26N5O8PS2,Lipoyl-AMP,R07770 R07771,Lipoic acid metabolism; Metabolic pathways,6.3.1.20,NA,NA,PubChem: 47205546; ChEBI: 55451; PDB-CCD: LAQ; NIKKAJI: J2.799.182C,cpd:C16238,18,26,8,5,1,2,0,0,0,0,0,0,0,0,0,0,0,0,C18H27O8N5P1S2,C18H25O8N5P1S2,535.0960422,536.1038672,534.08821713034,3360,cpd:C16241,(R)-Lipoate;,C8H14O2S2,"(R)-Lipoate; (R)-Lipoic acid; (R)-(+)-Lipoate; R-(+)-Lipoic acid; 1,2-Dithiolane-3R-pentanoic acid",R07770 R11143,Lipoic acid metabolism; Metabolic pathways,6.3.1.20,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0113 Thia fatty acids;     C16241  (R)-Lipoic acid,CAS: 1200-22-2; PubChem: 47205549; ChEBI: 30314; ChEMBL: CHEMBL134342; LIPIDMAPS: LMFA01130001; KNApSAcK: C00000754; PDB-CCD: LPA; NIKKAJI: J9.331I,cpd:C00725; cpd:C16241,8,14,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O2S2,C8H13O2S2,206.043522,207.0513471,205.0356973035,3361,cpd:C00268,Dihydrobiopterin;,C9H13N5O3,"Dihydrobiopterin; 6,7-Dihydrobiopterin; Quinoid-dihydrobiopterin; (6R)-6-(L-erythro-1,2-Dihydroxypropyl)-7,8-dihydro-6H-pterin",R01793 R01794 R01795 R01814 R01815 R01816 R03794 R04044; R04734,Folate biosynthesis; Metabolic pathways,1.5.1.34; 1.14.16.1; 1.14.16.2; 1.14.16.3; 1.14.16.4; 1.14.16.5; 1.14.16.6; 4.2.1.96,NA,NA,PubChem: 3566; ChEBI: 20680 43120; PDB-CCD: H2B; 3DMET: B04657; NIKKAJI: J959.455H,cpd:C00268; cpd:C02953; cpd:C04244; cpd:C20263,9,13,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O3N5,C9H12O3N5,239.1018393,240.1096643,238.09401433036,3362,cpd:C00272,Tetrahydrobiopterin;,C9H15N5O3,"Tetrahydrobiopterin; 5,6,7,8-Tetrahydrobiopterin; 2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone; L-erythro-Tetrahydrobiopterin",R01793 R01794 R01795 R01812 R01813 R01814 R01815 R01816; R03794 R04044 R07211 R07212 R07213 R08208 R10729,Folate biosynthesis; Metabolic pathways; Fluid shear stress and atherosclerosis,1.1.1.153; 1.5.1.33; 1.5.1.34; 1.14.16.1; 1.14.16.2; 1.14.16.3; 1.14.16.4; 1.14.16.5; 1.14.16.6; 1.14.16.7,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00272  Tetrahydrobiopterin,CAS: 17528-72-2; PubChem: 3570; ChEBI: 15372 59560; ChEMBL: CHEMBL1201774; KNApSAcK: C00018229; PDB-CCD: H4B; 3DMET: B04659; NIKKAJI: J247.815C,cpd:C00272; cpd:C20264,9,15,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16O3N5,C9H14O3N5,241.1174894,242.1253144,240.10966433037,3363,cpd:C00921,Dihydropteroate;,C14H14N6O3,"Dihydropteroate; 7,8-Dihydropteroate",R02237 R03066 R03067,Folate biosynthesis; Metabolic pathways,2.5.1.15; 6.3.2.12; 6.3.2.17,"Tetrahydrofolate biosynthesis, GTP => THF",NA,PubChem: 4175; ChEBI: 17839 4581; KNApSAcK: C00007228; PDB-CCD: 78H; 3DMET: B01352; NIKKAJI: J670.934F,cpd:C00921,14,14,3,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H15O3N6,C14H13O3N6,314.1127383,315.1205634,313.10491333038,3364,cpd:C01300,"2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine",C7H9N5O2,"2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine",R03066 R03503 R03504,Folate biosynthesis; Metabolic pathways,2.5.1.15; 2.7.6.3; 4.1.2.25,"Tetrahydrofolate biosynthesis, GTP => THF",NA,PubChem: 4518; ChEBI: 17083 44841; KNApSAcK: C00007501; PDB-CCD: PH2; 3DMET: B00274; NIKKAJI: J976.377E,cpd:C01300,7,9,2,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O2N5,C7H8O2N5,195.0756246,196.0834496,194.06779953039,3365,cpd:C02587,Pyrimidodiazepine;,C9H11N5O2,"Pyrimidodiazepine; 2-Amino-6-acetyl-3,7,8,9-tetrahydro-3H-pyrimido[4,5-b][1,4]diazepin-4-one",R03984,Folate biosynthesis,1.5.4.1,NA,NA,PubChem: 5579; NIKKAJI: J2.378.467J,cpd:C02587,9,11,2,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O2N5,C9H10O2N5,221.0912746,222.0990996,220.08344963040,3367,cpd:C03684,6-Pyruvoyltetrahydropterin;,C9H11N5O3,"6-Pyruvoyltetrahydropterin; 6-(1,2-Dioxopropyl)-5,6,7,8-tetrahydropterin; 6-Pyruvoyl-5,6,7,8-tetrahydropterin",R03984 R04285 R04286 R08208 R09990,Folate biosynthesis; Metabolic pathways,1.1.1.153; 1.1.1.220; 1.1.1.325; 1.5.4.1; 4.2.3.12,NA,NA,PubChem: 6459; ChEBI: 17804; 3DMET: B04910; NIKKAJI: J413.614D,cpd:C00835; cpd:C03684; cpd:C06313,9,11,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O3N5,C9H10O3N5,237.0861892,238.0940143,236.07836423041,3368,cpd:C04244,"6-Lactoyl-5,6,7,8-tetrahydropterin",C9H13N5O3,"6-Lactoyl-5,6,7,8-tetrahydropterin",R01813 R04285,Folate biosynthesis; Metabolic pathways,1.1.1.153; 1.1.1.220,NA,NA,PubChem: 6909; ChEBI: 17248; 3DMET: B04932; NIKKAJI: J774.306H,cpd:C00268; cpd:C02953; cpd:C04244; cpd:C20263,9,13,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O3N5,C9H12O3N5,239.1018393,240.1096643,238.09401433042,3369,cpd:C04807,"2-Amino-7,8-dihydro-4-hydroxy-6-(diphosphooxymethyl)pteridine;",C7H11N5O8P2,"2-Amino-7,8-dihydro-4-hydroxy-6-(diphosphooxymethyl)pteridine; 2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate; 7,8-Dihydropterin pyrophosphate",R03067 R03503 R10339,Folate biosynthesis; Metabolic pathways,2.5.1.15; 2.5.1.105; 2.7.6.3,"Tetrahydrofolate biosynthesis, GTP => THF",NA,PubChem: 7369; ChEBI: 15998 73083; ChEMBL: CHEMBL1229984; PDB-CCD: 2PH; 3DMET: B01792; NIKKAJI: J843.576F,cpd:C04807,7,11,8,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O8N5P2,C7H10O8N5P2,355.0082863,356.0161114,354.00046133043,3370,cpd:C04874,"2-Amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-dihydropteridine;",C9H13N5O4,"2-Amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-dihydropteridine; Dihydroneopterin; 7,8-Dihydroneopterin",R03504 R04620 R04621 R04622 R11037 R11073,Folate biosynthesis; Metabolic pathways,1.13.11.81; 3.1.3.1; 3.6.1.-; 4.1.2.25; 5.1.99.8,"Tetrahydrofolate biosynthesis, GTP => THF",NA,PubChem: 7426; ChEBI: 17001; KNApSAcK: C00007312; 3DMET: B04970; NIKKAJI: J976.376G,cpd:C04874; cpd:C21008,9,13,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O4N5,C9H12O4N5,255.0967539,256.104579,254.08892893044,3371,cpd:C04895,"7,8-Dihydroneopterin 3'-triphosphate;",C9H16N5O13P3,"7,8-Dihydroneopterin 3'-triphosphate; 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate; 6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin; 6-[(1S,2R)-1,2-Dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin",R00424 R04286 R04620 R04638 R04639 R09959 R11082,Folate biosynthesis; Metabolic pathways,3.1.3.1; 3.5.4.16; 3.6.1.67; 4.1.2.50; 4.2.3.12; 5.1.99.7,"Tetrahydrofolate biosynthesis, GTP => THF",NA,PubChem: 7446; ChEBI: 18372; KNApSAcK: C00007510; 3DMET: B01801; NIKKAJI: J642.224A,cpd:C04895; cpd:C21094,9,16,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O13N5P3,C9H15O13N5P3,494.9957466,496.0035716,493.98792163045,3372,cpd:C05922,Formamidopyrimidine nucleoside triphosphate,C10H18N5O15P3,Formamidopyrimidine nucleoside triphosphate,R00428 R05046,Folate biosynthesis; Metabolic pathways,3.5.4.16,"Tetrahydrofolate biosynthesis, GTP => THF",NA,PubChem: 8210; ChEBI: 27985; 3DMET: B01913; NIKKAJI: J1.129.374C,cpd:C05922,10,18,15,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O15N5P3,C10H17O15N5P3,541.0012259,542.0090509,539.99340093046,3373,cpd:C05923,"2,5-Diaminopyrimidine nucleoside triphosphate",C9H18N5O14P3,"2,5-Diaminopyrimidine nucleoside triphosphate",R05046 R05048,Folate biosynthesis; Metabolic pathways,3.5.4.16,"Tetrahydrofolate biosynthesis, GTP => THF",NA,PubChem: 8211; ChEBI: 929; 3DMET: B01914; NIKKAJI: J2.760.614H,cpd:C05923; cpd:C06148,9,18,14,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H19O14N5P3,C9H17O14N5P3,513.0063113,514.0141363,511.99848623047,3374,cpd:C05924,Molybdopterin;,C10H14N5O6PS2,Molybdopterin; Pyranopterin; H2Dtpp-mP,R09395 R09726,Folate biosynthesis; Metabolic pathways; Sulfur relay system,2.7.7.75; 2.8.1.12,NA,NA,PubChem: 8212; ChEBI: 44074; KNApSAcK: C00000774; PDB-CCD: MTE; 3DMET: B05139; NIKKAJI: J1.100.870D,cpd:C05924,10,14,6,5,1,2,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O6N5P1S2,C10H13O6N5P1S2,395.0123125,396.0201376,394.00448753048,3375,cpd:C05925,Dihydroneopterin phosphate;,C9H14N5O7P,"Dihydroneopterin phosphate; 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine phosphate; 7,8-Dihydroneopterin 3'-phosphate",R04621 R04638 R10344 R11072,Folate biosynthesis,3.1.4.56; 3.6.1.67; 3.6.1.-; 4.2.1.160,NA,NA,PubChem: 8213; ChEBI: 48954; 3DMET: B05140; NIKKAJI: J2.760.636I,cpd:C05925; cpd:C20566,9,14,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H15O7N5P1,C9H13O7N5P1,335.0630848,336.0709098,334.05525983049,3376,cpd:C05926,Neopterin;,C9H11N5O4,"Neopterin; [S-(R*,S*)]-2-amino-6-(1,2,3-trihydroxypropyl)-1H-pteridin-4-one; [S-(R*,S*)]-2-amino-6-(1,2,3-trihydroxypropyl)-1H-pteridine-4-one; [S-(R*,S*)]-2-Amino-6-(1,2,3-trihydroxypropyl)-1H-pteridin-4-on; 6-(D-erythro-1,2,3-Trihydroxypropyl)pterin; 6-D-erythro-Neopterin; D-erythro-Neopterin; D-Neopterin",R04622,Folate biosynthesis,NA,NA,NA,CAS: 2009-64-5; PubChem: 8214; ChEBI: 28670; PDB-CCD: NEU; 3DMET: B01915; NIKKAJI: J108.020B,cpd:C05926,9,11,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O4N5,C9H10O4N5,253.0811039,254.0889289,252.07327883050,3377,cpd:C05927,"7,8-Dihydromethanopterin",C30H43N6O16P,"7,8-Dihydromethanopterin",R03388 R10332 R10802,Folate biosynthesis,1.5.1.47; 1.5.99.15,NA,NA,PubChem: 8215; ChEBI: 2251; 3DMET: B01916; NIKKAJI: J2.760.657A,cpd:C05927,30,43,16,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H44O16N6P1,C30H42O16N6P1,774.2473163,775.2551414,773.23949133051,3378,cpd:C06148,"2,5-Diamino-6-(5'-triphosphoryl-3',4'-trihydroxy-2'-oxopentyl)-amino-4-oxopyrimidine",C9H18N5O14P3,"2,5-Diamino-6-(5'-triphosphoryl-3',4'-trihydroxy-2'-oxopentyl)-amino-4-oxopyrimidine",R04639 R05048 R05122,Folate biosynthesis; Metabolic pathways,3.5.4.16,"Tetrahydrofolate biosynthesis, GTP => THF",NA,PubChem: 8404; ChEBI: 28003; 3DMET: B05166; NIKKAJI: J2.761.598H,cpd:C05923; cpd:C06148,9,18,14,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H19O14N5P3,C9H17O14N5P3,513.0063113,514.0141363,511.99848623052,3379,cpd:C06149,"6-(3'-Triphosphoryl-1'-methylglyceryl)-7-methyl-7,8-dihydrobiopterin",C11H20N5O13P3,"6-(3'-Triphosphoryl-1'-methylglyceryl)-7-methyl-7,8-dihydrobiopterin",R05122,Folate biosynthesis,NA,NA,NA,PubChem: 8405; ChEBI: 28244; 3DMET: B05167; NIKKAJI: J2.761.608I,cpd:C06149,11,20,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H21O13N5P3,C11H19O13N5P3,523.0270467,524.0348717,522.01922173053,3380,cpd:C09332,THF-L-glutamate;,C24H30N8O9,THF-L-glutamate; Tetrahydropteroyldiglutamate; (6S)-H4PteGlu2,R00942,Folate biosynthesis,6.3.2.17,NA,NA,PubChem: 11523; ChEBI: 27650; 3DMET: B05350; NIKKAJI: J2.769.210I,cpd:C03541; cpd:C09332,24,30,9,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H31O9N8,C24H29O9N8,574.2135746,575.2213996,573.20574953054,3381,cpd:C11355,4-Amino-4-deoxychorismate;,C10H11NO5,4-Amino-4-deoxychorismate; ADC,R01716 R05552 R05553,Folate biosynthesis,2.6.1.85; 4.1.3.38,NA,NA,PubChem: 13530; ChEBI: 18198 35181; KNApSAcK: C00000730; 3DMET: B04223; NIKKAJI: J1.639.267G,cpd:C11355; cpd:C18054,10,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H12O5N1,C10H10O5N1,225.0637225,226.0715475,224.05589743055,3382,cpd:C15996,7-Cyano-7-carbaguanine;,C7H5N5O,7-Cyano-7-carbaguanine; 7-Cyano-7-deazaguanine,R07605 R09978,Folate biosynthesis; Metabolic pathways,1.7.1.13; 6.3.4.20,NA,NA,PubChem: 47205307; ChEBI: 45075; ChEMBL: CHEMBL577120; PDB-CCD: PQ0; NIKKAJI: J2.722.757K,cpd:C15996,7,5,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H6O1N5,C7H4O1N5,175.0494098,176.0572348,174.04158483056,3383,cpd:C16675,7-Aminomethyl-7-carbaguanine;,C7H9N5O,7-Aminomethyl-7-carbaguanine; 7-Aminomethyl-7-deazaguanine,R07605 R10209,Folate biosynthesis; Metabolic pathways,1.7.1.13; 2.4.2.29,NA,NA,PubChem: 51090998; ChEBI: 45126; PDB-CCD: PRF; NIKKAJI: J687.905E,cpd:C16675,7,9,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O1N5,C7H8O1N5,179.0807099,180.088535,178.07288493057,3384,cpd:C18237,Molybdoenzyme molybdenum cofactor;,C10H12MoN5O8PS2,Molybdoenzyme molybdenum cofactor; Molybdenum cofactor,R09735,Folate biosynthesis; Metabolic pathways; Sulfur relay system,2.10.1.1,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C18237  Molybdenum cofactor,CAS: 73508-07-3; PubChem: 103061419; ChEBI: 21437,cpd:C18237,10,12,8,5,1,2,0,0,0,0,0,0,1,0,0,0,0,0,C10H13O8N5P1S2Mo1,C10H11O8N5P1S2Mo1,522.8919027,523.8997277,521.88407773058,3385,cpd:C18239,Precursor Z;,C10H14N5O8P,Precursor Z; Cyclic pyranopterin monophosphate; Cyclic pyranopterin phosphate; cPMP,R09395 R11372,Folate biosynthesis; Metabolic pathways; Sulfur relay system,2.8.1.12; 4.6.1.17,NA,NA,PubChem: 103061421; ChEBI: 60210; KNApSAcK: C00019569,cpd:C00144; cpd:C01977; cpd:C06193; cpd:C18239; cpd:C19968,10,14,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O8N5P1,C10H13O8N5P1,363.0579994,364.0658245,362.05017443059,3386,cpd:C18802,Tetrahydrosarcinapterin;,C35H52N7O19P,"Tetrahydrosarcinapterin; H4SPT; 5,6,7,8-Tetrahydrosarcinapterin",R09594 R10219 R10385,Folate biosynthesis,2.1.1.245; 2.3.1.-; 6.3.2.33,NA,NA,CAS: 137360-17-9; PubChem: 124489476; ChEBI: 59345,cpd:C18802,35,52,19,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H53O19N7P1,C35H51O19N7P1,905.3055595,906.3133845,904.29773443060,3387,cpd:C19848,Adenylated molybdopterin;,C20H26N10O12P2S2,Adenylated molybdopterin; Adenylyl-molybdopterin,R09726 R09735,Folate biosynthesis; Metabolic pathways,2.7.7.75; 2.10.1.1,NA,NA,PubChem: 135626315,cpd:C19848,20,26,12,10,2,2,0,0,0,0,0,0,0,0,0,0,0,0,C20H27O12N10P2S2,C20H25O12N10P2S2,724.0648327,725.0726577,723.05700763061,3388,cpd:C20239,"6-Carboxy-5,6,7,8-tetrahydropterin;",C7H9N5O3,"6-Carboxy-5,6,7,8-tetrahydropterin; 6-Carboxytetrahydropterin",R09959 R10002,Folate biosynthesis; Metabolic pathways,4.1.2.50; 4.3.99.3,NA,NA,PubChem: 163311982,cpd:C20239,7,9,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O3N5,C7H8O3N5,211.0705392,212.0783642,210.06271413062,3389,cpd:C20248,7-Carboxy-7-carbaguanine;,C7H6N4O3,7-Carboxy-7-carbaguanine; 7-Carboxy-7-deazaguanine,R09978 R10002,Folate biosynthesis; Metabolic pathways,4.3.99.3; 6.3.4.20,NA,NA,PubChem: 163311991; PDB-CCD: 2KA,cpd:C20248,7,6,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O3N4,C7H5O3N4,194.0439901,195.0518151,193.0361653063,3390,cpd:C21310,"(8S)-3',8-Cyclo-7,8-dihydroguanosine 5'-triphosphate",C10H16N5O14P3,"(8S)-3',8-Cyclo-7,8-dihydroguanosine 5'-triphosphate",R09394 R11372,Folate biosynthesis; Metabolic pathways,4.1.99.22; 4.6.1.17,NA,NA,PubChem: 319075052,cpd:C00044; cpd:C19967; cpd:C21310,10,16,14,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O14N5P3,C10H15O14N5P3,522.9906612,523.9984862,521.98283623064,3391,cpd:C01566,Cyanamide;,CH2N2,Cyanamide; Carbodiimide,R00778,Atrazine degradation; Microbial metabolism in diverse environments,4.2.1.69,NA,Pesticides [BR:br08007];  Pesticides;   Plant growth regulators;    Others;     C01566  Cyanamide; Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    393  Habitual intoxication agents;     3932  Cyanamides;      D00123  Cyanamide (JP17); Target-based classification of drugs [BR:br08310];  Enzymes;   Oxidoreductases;    aldehyde dehydrogenase;     Cyanamide;      D00123  Cyanamide (JP17); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00123  Cyanamide,CAS: 420-04-2; PubChem: 4723; ChEBI: 16698; ChEMBL: CHEMBL56279; PDB-CCD: CNN; 3DMET: B00322; NIKKAJI: J2.584D,cpd:C01566; cpd:C19387,1,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H3N2,C1H1N2,42.02179807,43.02962311,41.013973043065,3392,cpd:C06551,Atrazine,C8H14ClN5,Atrazine,R05558 R05564 R05565,Atrazine degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.15.-; 3.8.1.8,NA,Endocrine disrupting compounds [BR:br08006];  Pesticides and herbicides;   Triazine herbicides;    C06551  Atrazine; Pesticides [BR:br08007];  Pesticides;   Herbicides;    Triazine herbicides;     C06551  Atrazine; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C06551  Atrazine,CAS: 1912-24-9; PubChem: 8780; ChEBI: 15930; ChEMBL: CHEMBL15063; PDB-CCD: ATZ; NIKKAJI: J3.685D,cpd:C06551,8,14,0,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C8H15N5Cl1,C8H13N5Cl1,215.0937732,216.1015982,214.08594813066,3393,cpd:C06552,Hydroxyatrazine;,C8H15N5O,"Hydroxyatrazine; 4-(Ethylamino)-2-hydroxy-6-(isopropylamino)-1,3,5-triazine",R05558 R05559,Atrazine degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.5.4.43; 3.8.1.8,NA,NA,CAS: 2163-68-0; PubChem: 8781; ChEBI: 18316; NIKKAJI: J9.489G,cpd:C06552,8,15,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O1N5,C8H14O1N5,197.1276601,198.1354852,196.11983513067,3394,cpd:C06553,N-Isopropylammelide,C6H10N4O2,N-Isopropylammelide,R05559 R05560,Atrazine degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.5.4.42; 3.5.4.43,NA,NA,CAS: 35200-63-6; PubChem: 8782; ChEBI: 17247; NIKKAJI: J1.190.495E,cpd:C06553,6,10,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O2N4,C6H9O2N4,170.0803756,171.0882006,169.07255053068,3395,cpd:C06554,Cyanuric acid,C3H3N3O3,Cyanuric acid,R05560 R05561 R05573 R06967 R06972 R07305,Atrazine degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.5.2.15; 3.5.4.42; 3.5.4.-,NA,NA,CAS: 108-80-5; PubChem: 8783; ChEBI: 38028; ChEMBL: CHEMBL243087; PDB-CCD: WDL; 3DMET: B00968; NIKKAJI: J2.429E,cpd:C06554,3,3,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H4O3N3,C3H2O3N3,129.017441,130.025266,128.00961593069,3396,cpd:C06555,Biuret,C2H5N3O2,Biuret,R05561 R05563 R07305,Atrazine degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.5.1.84; 3.5.2.15,NA,NA,CAS: 108-19-0; PubChem: 8784; ChEBI: 18138; ChEMBL: CHEMBL1889026; 3DMET: B00969; NIKKAJI: J2.416C,cpd:C06555; cpd:C14595,2,5,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H6O2N3,C2H4O2N3,103.0381764,104.0460014,102.03035143070,3397,cpd:C06556,Deisopropylatrazine,C5H8ClN5,Deisopropylatrazine,R05564 R05567 R05572,Atrazine degradation; Microbial metabolism in diverse environments,1.14.15.-; 3.8.1.-,NA,NA,CAS: 1007-28-9; PubChem: 8785; ChEBI: 27399; ChEMBL: CHEMBL1895845; 3DMET: B00970; NIKKAJI: J1.756F,cpd:C06556,5,8,0,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C5H9N5Cl1,C5H7N5Cl1,173.046823,174.054648,172.03899793071,3398,cpd:C06557,Deisopropylhydroxyatrazine,C5H9N5O,Deisopropylhydroxyatrazine,R05572 R05574,Atrazine degradation; Microbial metabolism in diverse environments,3.5.4.-; 3.8.1.-,NA,NA,CAS: 7313-54-4; PubChem: 8786; ChEBI: 28363; NIKKAJI: J113.316K,cpd:C06557,5,9,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O1N5,C5H8O1N5,155.0807099,156.088535,154.07288493072,3399,cpd:C06558,N-Ethylammelide;,C5H8N4O2,"N-Ethylammelide; 2,4-Dihydroxy-6-(N'-ethyl)amino-1,3,5-triazine",R05573 R05574,Atrazine degradation; Microbial metabolism in diverse environments,3.5.4.-,NA,NA,CAS: 2630-10-6; PubChem: 8787; ChEBI: 27900; 3DMET: B00971; NIKKAJI: J928.975E,cpd:C06558; cpd:C11345,5,8,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O2N4,C5H7O2N4,156.0647255,157.0725505,155.05690053073,3400,cpd:C06559,Deethylatrazine,C6H10ClN5,Deethylatrazine,R05565 R05568,Atrazine degradation; Microbial metabolism in diverse environments,1.14.15.-,NA,NA,CAS: 6190-65-4; PubChem: 8788; ChEBI: 28212; NIKKAJI: J285.118K,cpd:C06559,6,10,0,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C6H11N5Cl1,C6H9N5Cl1,187.062473,188.0702981,186.0546483074,3401,cpd:C06560,Deisopropyldeethylatrazine,C3H4ClN5,Deisopropyldeethylatrazine,R05567 R05568 R05569,Atrazine degradation; Microbial metabolism in diverse environments,1.14.15.-; 3.8.1.8,NA,NA,CAS: 3397-62-4; PubChem: 8789; ChEBI: 27726; ChEMBL: CHEMBL1872965; 3DMET: B00972; NIKKAJI: J80.717F,cpd:C06560,3,4,0,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C3H5N5Cl1,C3H3N5Cl1,145.0155228,146.0233479,144.00769783075,3402,cpd:C08733,Ammeline;,C3H5N5O,"Ammeline; 2-Hydroxy-4,6-diamino-1,3,5-triazine",R06968 R06969,Atrazine degradation; Microbial metabolism in diverse environments,3.5.4.-; 3.8.1.8,NA,NA,CAS: 645-92-1; PubChem: 10926; ChEBI: 28646; PDB-CCD: 6AM; NIKKAJI: J9.460I,cpd:C08733,3,5,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H6O1N5,C3H4O1N5,127.0494098,128.0572348,126.04158483076,3403,cpd:C08734,Ammelide;,C3H4N4O2,"Ammelide; 2,4-Dihydroxy-6-amino-1,3,5-triazine",R06966 R06967 R06969,Atrazine degradation; Microbial metabolism in diverse environments,3.5.4.42; 3.5.4.43; 3.5.4.-,NA,NA,CAS: 645-93-2; PubChem: 10927; ChEBI: 28134; NIKKAJI: J9.461G,cpd:C08734,3,4,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O2N4,C3H3O2N4,128.0334254,129.0412504,127.02560043077,3404,cpd:C08735,"2-Chloro-4-hydroxy-6-amino-1,3,5-triazine",C3H3ClN4O,"2-Chloro-4-hydroxy-6-amino-1,3,5-triazine",R05569 R06966,Atrazine degradation; Microbial metabolism in diverse environments,3.5.4.43; 3.8.1.8,NA,NA,CAS: 38862-29-2; PubChem: 10928; ChEBI: 27797; 3DMET: B01112; NIKKAJI: J1.614.296D,cpd:C08735,3,3,1,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C3H4O1N4Cl1,C3H2O1N4Cl1,145.9995384,147.0073634,144.99171343078,3405,cpd:C08737,Melamine;,C3H6N6,"Melamine; 2,4,6-Triamino-1,3,5-triazine",R06968,Atrazine degradation; Microbial metabolism in diverse environments,3.8.1.8,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C08737  Melamine; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   C08737  [104052] Melamine;  Smoking suppressant;   C08737  [104052] Melamine,CAS: 108-78-1; PubChem: 10930; ChEBI: 27915; ChEMBL: CHEMBL1231106; PDB-CCD: AX2; NIKKAJI: J2.428G,cpd:C08737,3,6,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7N6,C3H5N6,126.0653942,127.0732193,125.05756923079,3406,cpd:C14147,Cyromazine;,C6H10N6,"Cyromazine; Cyclopropylmelamine; 2-Cyclopropylamino-4,6-diamino-s-triazine",R06970,Atrazine degradation; Microbial metabolism in diverse environments,3.5.4.-,NA,Pesticides [BR:br08007];  Pesticides;   Insect growth regulators;    Chitin synthesis inhibitors;     C14147  Cyromazine; Animal drugs in Japan [BR:br08331];  99  Agents for not mainly purpose of therapeutic;   993  Insecticides and insect-repellents;    9939  Other insecticides and insect repellents;     C14147  Cyromazine,CAS: 66215-27-8; PubChem: 7846959; ChEBI: 30260; ChEMBL: CHEMBL1231107; PDB-CCD: AX3; NIKKAJI: J18.757G,cpd:C06936; cpd:C14147,6,10,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11N6,C6H9N6,166.0966943,167.1045194,165.08886933080,3407,cpd:C14148,N-Cyclopropylammeline;,C6H9N5O,"N-Cyclopropylammeline; 2-Hydroxy-4-amino-6-(cyclopropylamino)-1,3,5-triazine",R06970 R06971,Atrazine degradation; Microbial metabolism in diverse environments,3.5.4.-,NA,NA,PubChem: 7846960; ChEBI: 34869; NIKKAJI: J2.788.052E,cpd:C14148,6,9,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O1N5,C6H8O1N5,167.0807099,168.088535,166.07288493081,3408,cpd:C14149,N-Cyclopropylammelide;,C6H8N4O2,"N-Cyclopropylammelide; 2,4-Dihydroxy-6-(cyclopropylamino)-1,3,5-triazine",R06971 R06972,Atrazine degradation; Microbial metabolism in diverse environments,3.5.4.-,NA,NA,PubChem: 7846961; ChEBI: 21695; NIKKAJI: J2.788.070C,cpd:C14149,6,8,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O2N4,C6H7O2N4,168.0647255,169.0725505,167.05690053082,3409,cpd:C00376,Retinal;,C20H28O,Retinal; Vitamin A aldehyde; Retinene; all-trans-Retinal; all-trans-Vitamin A aldehyde; all-trans-Retinene,R00032 R02123 R02124 R02125 R02126 R02127 R02128 R02129; R08379 R09601,Retinol metabolism; Metabolic pathways; Phototransduction; Vitamin digestion and absorption,1.1.1.1; 1.1.1.105; 1.1.1.300; 1.1.1.-; 1.2.1.36; 1.2.3.1; 1.13.11.63; 1.13.11.75,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C00376  Retinal,CAS: 116-31-4; PubChem: 3666; ChEBI: 17898; ChEMBL: CHEMBL81379; LIPIDMAPS: LMPR01090002; LipidBank: VVA0012; PDB-CCD: RET; 3DMET: B00095; NIKKAJI: J5.279E,cpd:C00376; cpd:C02110; cpd:C09191; cpd:C13037; cpd:C14655; cpd:C15016; cpd:C15170; cpd:C15262; cpd:C16681,20,28,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O1,C20H27O1,284.2140155,285.2218406,283.20619053083,3410,cpd:C00473,Retinol;,C20H30O,Retinol; all-trans-Retinol; Vitamin A; Vitamin A1,R02124 R02366 R02367 R02368 R02369 R07163 R08379 R08387,Retinol metabolism; Metabolic pathways; Vitamin digestion and absorption,1.1.1.1; 1.1.1.105; 1.1.1.300; 1.1.1.-; 1.3.99.23; 2.3.1.76; 2.3.1.135; 3.1.1.-,NA,"Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Vitamins;    Fat-soluble vitamins;     C00473  Retinol (Vitamin A); Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C00473  Retinol; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Thyroid hormone like receptors;    Retinoic acid receptor;     NR1B; nuclear receptor, subfamily 1, group B;      C00473  Retinol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;     A11CA Vitamin A, plain;      A11CA01 Retinol (vit A);       D06543  Vitamin A (USP);  D DERMATOLOGICALS;   D10 ANTI-ACNE PREPARATIONS;    D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE;     D10AD Retinoids for topical use in acne;      D10AD02 Retinol;       D06543  Vitamin A (USP);  R RESPIRATORY SYSTEM;   R01 NASAL PREPARATIONS;    R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;     R01AX Other nasal preparations;      R01AX02 Retinol;       D06543  Vitamin A (USP);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01X OTHER OPHTHALMOLOGICALS;     S01XA Other ophthalmologicals;      S01XA02 Retinol;       D06543  Vitamin A (USP); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    311  Vitamins A and D preparations;     3111  Synthetic vitamin A preparations;      D06543  Vitamin A (USP); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   32 Vitamin A based drugs;    D06543  Vitamin A (USP);   39 Vitamin AD based drugs;    D06543  Vitamin A (USP);   43 Vitamin containing supplements;    D06543  Vitamin A (USP); Risk category of Japanese OTC drugs [BR:br08312];  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Retinol;     D06543  Vitamin A (USP);  Second-class OTC drugs;   Inorganic and organic chemicals;    Vitamin A;     D06543  Vitamin A (USP);  Third-class OTC drugs;   Inorganic and organic chemicals;    Vitamin A;     D06543  Vitamin A (USP); Pharmaceutical additives [BR:br08316];  Unclassified;   D06543  [111331] Dry formed vitamin A; Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Retinoic acid receptor (RAR);     retinoic acid receptor;      Retinol;       D06543  Vitamin A (USP); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2C8;    Retinol;     D06543  Vitamin A (USP); Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   962  Vitamin preparations;    9621  Vitamin A, D and preparations;     C00473  Vitamin A",CAS: 68-26-8 11103-57-4; PubChem: 3756; ChEBI: 17336; ChEMBL: CHEMBL986; LIPIDMAPS: LMPR01090000 LMPR01090001; LipidBank: VVA0001; KNApSAcK: C00031437; PDB-CCD: RTL; 3DMET: B01255; NIKKAJI: J1.417F J203.784J,cpd:C00473; cpd:C00899; cpd:C09092; cpd:C11873; cpd:C11885; cpd:C11886; cpd:C11887; cpd:C16682; cpd:C17276; cpd:C18220; cpd:C18222; cpd:C19962; cpd:C20148,20,30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O1,C20H29O1,286.2296656,287.2374906,285.22184063084,3411,cpd:C00777,Retinoate;,C20H28O2,"Retinoate; Retinoic acid; Vitamin A acid; all-trans-Retinoate; Acide retinoique (French) (DSL); Tretinoine (French) (EINECS); 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL); (all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; beta-Retinoic acid; AGN 100335; all-(E)-Retinoic acid; all-trans-beta-Retinoic acid; all-trans-Retinoic acid; all-trans-Tretinoin; all-trans-Vitamin A acid; Ro 1-5488; trans-Retinoic acid; Tretin M; all-trans-Vitamin A1 acid",R02123 R02125 R02902 R08390 R08391 R08392,Retinol metabolism; Metabolic pathways; Th17 cell differentiation; Intestinal immune network for IgA production; Pathways in cancer; Small cell lung cancer; Non-small cell lung cancer,1.2.1.36; 1.2.3.1; 1.14.13.-; 1.14.14.1; 1.14.15.3; 2.4.1.17,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C00777  Retinoate; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D10 ANTI-ACNE PREPARATIONS;    D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE;     D10AD Retinoids for topical use in acne;      D10AD01 Tretinoin;       D00094  Tretinoin (JAN/USP/INN);  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01X OTHER ANTINEOPLASTIC AGENTS;     L01XX Other antineoplastic agents;      L01XX14 Tretinoin;       D00094  Tretinoin (JAN/USP/INN); USP drug classification [BR:br08302];  Antineoplastics;   Retinoids;    Tretinoin;     D00094  Tretinoin (JAN/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    429  Miscellaneous;     4291  Other Antitumors;      D00094  Tretinoin (JAN/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Retinoic acid receptor (RAR);     retinoic acid receptor;      Tretinoin;       D00094  Tretinoin (JAN/USP/INN); Antineoplastics [br08340.html];  D00094; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00094; Pharmacogenomic biomarkers in FDA drug labels [br08341.html];  Companion diagnostics;   D00094,CAS: 302-79-4; PubChem: 4038; ChEBI: 15367 35291; ChEMBL: CHEMBL38; LIPIDMAPS: LMPR01090019; LipidBank: VVA0018; PDB-CCD: REA; 3DMET: B00172; NIKKAJI: J1.518K,cpd:C00777; cpd:C07058; cpd:C09188; cpd:C12078; cpd:C14489; cpd:C14652; cpd:C14684; cpd:C14910; cpd:C14925; cpd:C15263; cpd:C15307; cpd:C15353; cpd:C15493; cpd:C16683; cpd:C18195; cpd:C18196; cpd:C18603; cpd:C20428; cpd:C20429,20,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O2,C20H27O2,300.2089301,301.2167552,299.20110513085,3413,cpd:C00899,11-cis-Retinol,C20H30O,11-cis-Retinol,R02369 R03048 R03049 R08380 R08381 R08388 R08389,Retinol metabolism,1.1.1.315; 1.1.1.-; 2.3.1.76; 2.3.1.135; 3.1.1.63; 3.1.1.64,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C00899  11-cis-Retinol,CAS: 22737-96-8; PubChem: 4155; ChEBI: 16302; LIPIDMAPS: LMPR01090005; LipidBank: VVA0004; 3DMET: B00196; NIKKAJI: J641.433H,cpd:C00473; cpd:C00899; cpd:C09092; cpd:C11873; cpd:C11885; cpd:C11886; cpd:C11887; cpd:C16682; cpd:C17276; cpd:C18220; cpd:C18222; cpd:C19962; cpd:C20148,20,30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O1,C20H29O1,286.2296656,287.2374906,285.22184063086,3415,cpd:C02094,beta-Carotene;,C40H56,beta-Carotene; all-trans-beta-Carotene,R00032 R03823 R03824 R05345 R07558 R07560 R07857 R08988; R09747 R10282 R10559,Retinol metabolism; Carotenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Vitamin digestion and absorption,1.13.11.63; 1.13.11.71; 1.14.13.129; 1.14.13.-; 5.2.1.14; 5.5.1.19,"beta-Carotene biosynthesis, GGAP => beta-carotene; Abscisic acid biosynthesis, beta-carotene => abscisic acid","Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C02094  beta-Carotene; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C02094  beta-Carotene; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;     A11CA Vitamin A, plain;      A11CA02 Betacarotene;       D03101  beta Carotene (USP);  D DERMATOLOGICALS;   D02 EMOLLIENTS AND PROTECTIVES;    D02B PROTECTIVES AGAINST UV-RADIATION;     D02BB Protectives against UV-radiation for systemic use;      D02BB01 Betacarotene;       D03101  beta Carotene (USP); Pharmaceutical additives [BR:br08316];  Coloring agent;   D03101  [122101] beta-Carotene; Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Tetraterpenoids (C40);    Carotenoids;     D03101  beta Carotene (USP)",CAS: 7235-40-7; PubChem: 5178; ChEBI: 17579; ChEMBL: CHEMBL1293; LIPIDMAPS: LMPR01070000 LMPR01070001; LipidBank: VCA0001; KNApSAcK: C00000919; PDB-CCD: BCR; 3DMET: B00389; NIKKAJI: J3.095C,cpd:C02094; cpd:C05432; cpd:C05433; cpd:C05435; cpd:C06098; cpd:C08579; cpd:C08584; cpd:C08585; cpd:C08586; cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08594; cpd:C08599; cpd:C08601; cpd:C08602; cpd:C08603; cpd:C08605; cpd:C08606; cpd:C08611; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15716; cpd:C15858; cpd:C15860; cpd:C15874; cpd:C15919; cpd:C15932; cpd:C15933; cpd:C15981; cpd:C16270; cpd:C16274; cpd:C16276; cpd:C16282; cpd:C16284; cpd:C20331; cpd:C20484,40,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57,C40H55,536.4382018,537.4460268,535.43037683087,3416,cpd:C02110,11-cis-Retinal;,C20H28O,11-cis-Retinal; 11-cis-Vitamin A aldehyde; 11-cis-Retinene,R02126 R02904 R03048 R03836 R08380,Retinol metabolism; Metabolic pathways; Phototransduction,1.1.1.315; 1.1.1.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C02110  11-cis-Retinal,PubChem: 5192; ChEBI: 16066; ChEMBL: CHEMBL1255087; LIPIDMAPS: LMPR01090003; LipidBank: VVA0015; 3DMET: B00390; NIKKAJI: J439.005I,cpd:C00376; cpd:C02110; cpd:C09191; cpd:C13037; cpd:C14655; cpd:C15016; cpd:C15170; cpd:C15262; cpd:C16681,20,28,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O1,C20H27O1,284.2140155,285.2218406,283.20619053088,3417,cpd:C02588,Retinyl palmitate;,C36H60O2,Retinyl palmitate; Vitamin A palmitate; all-trans-Retinyl palmitate; Retinol palmitate,R02367 R02368,Retinol metabolism,2.3.1.76; 3.1.1.-,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C02588  Retinyl palmitate; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;     A11CA Vitamin A, plain;      A11CA01 Retinol (vit A);       D00164  Retinol palmitate (JP17);  D DERMATOLOGICALS;   D10 ANTI-ACNE PREPARATIONS;    D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE;     D10AD Retinoids for topical use in acne;      D10AD02 Retinol;       D00164  Retinol palmitate (JP17);  R RESPIRATORY SYSTEM;   R01 NASAL PREPARATIONS;    R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;     R01AX Other nasal preparations;      R01AX02 Retinol;       D00164  Retinol palmitate (JP17);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01X OTHER OPHTHALMOLOGICALS;     S01XA Other ophthalmologicals;      S01XA02 Retinol;       D00164  Retinol palmitate (JP17); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    311  Vitamins A and D preparations;     3111  Synthetic vitamin A preparations;      D00164  Retinol palmitate (JP17); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   32 Vitamin A based drugs;    D00164  Retinol palmitate (JP17);   43 Vitamin containing supplements;    D00164  Retinol palmitate (JP17);  Agents for ophthalmologic use;   62 General eye drops;    D00164  Retinol palmitate (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Retinol palmitate;     D00164  Retinol palmitate (JP17);  Second-class OTC drugs;   Inorganic and organic chemicals;    Retinol palmitate;     D00164  Retinol palmitate (JP17);  Third-class OTC drugs;   Inorganic and organic chemicals;    Retinol palmitate;     D00164  Retinol palmitate (JP17); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Retinoic acid receptor (RAR);     retinoic acid receptor;      Retinol;       D00164  Retinol palmitate (JP17); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2C8;    Retinol;     D00164  Retinol palmitate (JP17); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00164  Retinol palmitate; Dermatological agents [br08370.html];  Non-steroidal topical agent;   D00164;  Non-steroidal injection;   D00164; Animal drugs in Japan [BR:br08331];  95  Agents for external use;   958  Agents for protective skin;    9582  Vitamin preparations (for external use);     C02588  Retinyl palmitate",CAS: 79-81-2; PubChem: 5580; ChEBI: 17616; ChEMBL: CHEMBL1675; LIPIDMAPS: LMPR01090013; 3DMET: B00464; NIKKAJI: J3.849K,cpd:C02588; cpd:C03455,36,60,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H61O2,C36H59O2,524.4593312,525.4671562,523.45150613089,3418,cpd:C03455,11-cis-Retinyl palmitate,C36H60O2,11-cis-Retinyl palmitate,R03049 R08381 R08389,Retinol metabolism,2.3.1.76; 2.3.1.135; 3.1.1.63,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C03455  11-cis-Retinyl palmitate,PubChem: 6275; ChEBI: 16254; LIPIDMAPS: LMPR01090052; 3DMET: B00585; NIKKAJI: J1.321.777G,cpd:C02588; cpd:C03455,36,60,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H61O2,C36H59O2,524.4593312,525.4671562,523.45150613090,3423,cpd:C11061,all-trans-Retinoyl-beta-glucuronide;,C26H36O8,all-trans-Retinoyl-beta-glucuronide; Retinoyl glucuronide,R02902,Retinol metabolism,2.4.1.17,NA,NA,CAS: 401-10-5; PubChem: 13243; ChEBI: 28870; LIPIDMAPS: LMPR01090051; 3DMET: B04204; NIKKAJI: J431.685A,cpd:C11061,26,36,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H37O8,C26H35O8,476.2410181,477.2488431,475.23319313091,3424,cpd:C15492,"all-trans-13,14-Dihydroretinol;",C20H32O,"all-trans-13,14-Dihydroretinol; 13,14-Dihydroretinol",R07163,Retinol metabolism,1.3.99.23,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C15492  all-trans-13,14-Dihydroretinol",PubChem: 17396484; ChEBI: 52075; LIPIDMAPS: LMPR01090047; NIKKAJI: J2.127.566B,cpd:C11872; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11895; cpd:C14906; cpd:C15101; cpd:C15140; cpd:C15492; cpd:C16858; cpd:C18219; cpd:C18221; cpd:C20146; cpd:C20147; cpd:C20150,20,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O1,C20H31O1,288.2453157,289.2531407,287.23749063092,3425,cpd:C15493,9-cis-Retinoic acid,C20H28O2,9-cis-Retinoic acid,R08384 R08385,Retinol metabolism; PPAR signaling pathway; Intestinal immune network for IgA production; Adipocytokine signaling pathway; Pathways in cancer; Small cell lung cancer; Non-small cell lung cancer,1.2.1.36; 1.2.3.1,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C15493  9-cis-Retinoic acid; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Thyroid hormone like receptors;    Retinoic acid receptor;     NR1B; nuclear receptor, subfamily 1, group B;      C15493  9-cis-Retinoic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D11 OTHER DERMATOLOGICAL PREPARATIONS;    D11A OTHER DERMATOLOGICAL PREPARATIONS;     D11AH Agents for dermatitis, excluding corticosteroids;      D11AH04 Alitretinoin;       D02815  Alitretinoin (USAN);  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01X OTHER ANTINEOPLASTIC AGENTS;     L01XX Other antineoplastic agents;      L01XX22 Alitretinoin;       D02815  Alitretinoin (USAN); USP drug classification [BR:br08302];  Antineoplastics;   Retinoids;    Alitretinoin;     D02815  Alitretinoin (USAN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Thyroid hormone like receptors;    Retinoic acid receptor (RAR);     retinoic acid receptor;      Alitretinoin;       D02815  Alitretinoin (USAN);   Hepatocyte nuclear factor 4 like receptors;    Retinoid X receptor (RXR);     retinoid receptor;      Alitretinoin;       D02815  Alitretinoin (USAN); Antineoplastics [br08340.html];  D02815; New drug approvals in the USA [br08319.html];  New Molecular Entity and New Therapeutic Biological Product Approvals;   D02815; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D02815; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D02815; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D02815",CAS: 5300-03-8; PubChem: 17396485; ChEBI: 50648; ChEMBL: CHEMBL705; LIPIDMAPS: LMPR01090022; PDB-CCD: 9CR; NIKKAJI: J528.606I,cpd:C00777; cpd:C07058; cpd:C09188; cpd:C12078; cpd:C14489; cpd:C14652; cpd:C14684; cpd:C14910; cpd:C14925; cpd:C15263; cpd:C15307; cpd:C15353; cpd:C15493; cpd:C16683; cpd:C18195; cpd:C18196; cpd:C18603; cpd:C20428; cpd:C20429,20,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O2,C20H27O2,300.2089301,301.2167552,299.20110513093,3426,cpd:C16677,all-trans-4-Hydroxyretinoic acid,C20H28O3,all-trans-4-Hydroxyretinoic acid,R08392,Retinol metabolism; Metabolic pathways,1.14.13.-; 1.14.14.1,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C16677  all-trans-4-Hydroxyretinoic acid,PubChem: 51091000; ChEBI: 63795; ChEMBL: CHEMBL1329343; LIPIDMAPS: LMPR01090025; NIKKAJI: J557.295I,cpd:C06093; cpd:C07851; cpd:C09066; cpd:C09163; cpd:C09182; cpd:C09196; cpd:C09706; cpd:C09845; cpd:C14242; cpd:C14615; cpd:C14717; cpd:C14887; cpd:C15126; cpd:C15192; cpd:C15282; cpd:C15287; cpd:C16677; cpd:C16679; cpd:C16680; cpd:C18016,20,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O3,C20H27O3,316.2038448,317.2116698,315.19601973094,3427,cpd:C16678,all-trans-4-Oxoretinoic acid,C20H26O3,all-trans-4-Oxoretinoic acid,NA,Retinol metabolism; Metabolic pathways,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C16678  all-trans-4-Oxoretinoic acid,PubChem: 51091001; ChEBI: 80656; ChEMBL: CHEMBL104049; LIPIDMAPS: LMPR01090026; NIKKAJI: J362.532J,cpd:C06496; cpd:C09119; cpd:C09194; cpd:C14670; cpd:C14930; cpd:C14999; cpd:C15228; cpd:C16678; cpd:C18015,20,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H27O3,C20H25O3,314.1881947,315.1960197,313.18036973095,3428,cpd:C16679,all-trans-18-Hydroxyretinoic acid,C20H28O3,all-trans-18-Hydroxyretinoic acid,R08390,Retinol metabolism,1.14.13.-; 1.14.14.1; 1.14.15.3,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C16679  all-trans-18-Hydroxyretinoic acid,PubChem: 51091002; ChEBI: 80657; NIKKAJI: J362.533H,cpd:C06093; cpd:C07851; cpd:C09066; cpd:C09163; cpd:C09182; cpd:C09196; cpd:C09706; cpd:C09845; cpd:C14242; cpd:C14615; cpd:C14717; cpd:C14887; cpd:C15126; cpd:C15192; cpd:C15282; cpd:C15287; cpd:C16677; cpd:C16679; cpd:C16680; cpd:C18016,20,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O3,C20H27O3,316.2038448,317.2116698,315.19601973096,3429,cpd:C16680,"all-trans-5,6-Epoxyretinoic acid;",C20H28O3,"all-trans-5,6-Epoxyretinoic acid; all-trans-5,6-Epoxy-5,6-dihydroretinoic acid",R08391,Retinol metabolism,1.14.13.-; 1.14.14.1,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C16680  all-trans-5,6-Epoxyretinoic acid",PubChem: 51091003; ChEBI: 80658; ChEMBL: CHEMBL455053; NIKKAJI: J121.832H,cpd:C06093; cpd:C07851; cpd:C09066; cpd:C09163; cpd:C09182; cpd:C09196; cpd:C09706; cpd:C09845; cpd:C14242; cpd:C14615; cpd:C14717; cpd:C14887; cpd:C15126; cpd:C15192; cpd:C15282; cpd:C15287; cpd:C16677; cpd:C16679; cpd:C16680; cpd:C18016,20,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O3,C20H27O3,316.2038448,317.2116698,315.19601973097,3430,cpd:C16681,9-cis-Retinal,C20H28O,9-cis-Retinal,R08382 R08383 R08384 R08385,Retinol metabolism,1.1.1.315; 1.1.1.-; 1.2.1.36; 1.2.3.1,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C16681  9-cis-Retinal,PubChem: 51091004; ChEBI: 78273; ChEMBL: CHEMBL257381; LIPIDMAPS: LMPR01090017; NIKKAJI: J121.827A,cpd:C00376; cpd:C02110; cpd:C09191; cpd:C13037; cpd:C14655; cpd:C15016; cpd:C15170; cpd:C15262; cpd:C16681,20,28,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O1,C20H27O1,284.2140155,285.2218406,283.20619053098,3431,cpd:C16682,9-cis-Retinol,C20H30O,9-cis-Retinol,R08382 R08383,Retinol metabolism,1.1.1.315; 1.1.1.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C16682  9-cis-Retinol,PubChem: 51091005; ChEBI: 78272; LIPIDMAPS: LMPR01090009; NIKKAJI: J641.040E,cpd:C00473; cpd:C00899; cpd:C09092; cpd:C11873; cpd:C11885; cpd:C11886; cpd:C11887; cpd:C16682; cpd:C17276; cpd:C18220; cpd:C18222; cpd:C19962; cpd:C20148,20,30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O1,C20H29O1,286.2296656,287.2374906,285.22184063099,3432,cpd:C16683,4-Oxoretinol,C20H28O2,4-Oxoretinol,NA,Retinol metabolism,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0109 Retinoids;     C16683  4-Oxoretinol,CAS: 62702-55-0; PubChem: 51091006; ChEBI: 44597; PDB-CCD: OXR; NIKKAJI: J648.935D,cpd:C00777; cpd:C07058; cpd:C09188; cpd:C12078; cpd:C14489; cpd:C14652; cpd:C14684; cpd:C14910; cpd:C14925; cpd:C15263; cpd:C15307; cpd:C15353; cpd:C15493; cpd:C16683; cpd:C18195; cpd:C18196; cpd:C18603; cpd:C20428; cpd:C20429,20,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O2,C20H27O2,300.2089301,301.2167552,299.20110513100,3433,cpd:C00032,Heme;,C34H32FeN4O4,Heme; Haem; Protoheme; Heme B; Protoheme IX,R00310 R00311 R00312 R00313 R00314 R02480 R03684 R04977; R07411 R10468 R10510 R11522,Porphyrin and chlorophyll metabolism; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; ABC transporters; Mineral absorption,1.11.1.-; 1.14.14.18; 1.14.99.48; 2.5.1.-; 4.4.1.17; 4.99.1.1,"Heme biosynthesis, glutamate => protoheme/siroheme",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00032  Heme B,CAS: 14875-96-8; PubChem: 3334; ChEBI: 17627 26355 30413; PDB-CCD: HEM,cpd:C00032; cpd:C06767,34,32,4,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,C34H33O4N4Fe1,C34H31O4N4Fe1,616.1756515,617.1834766,615.16782653101,3434,cpd:C00194,Cobamide coenzyme;,C72H100CoN18O17P,"Cobamide coenzyme; Adenosylcobalamin; Adenosylcob(III)alamin; Deoxyadenosylcobalamin; Cobamamide; Vitamin B12 coenzyme; 5,6-Dimethylbenzimidazolyl-5-deoxyadenosyl-cobamide; (5'-Deoxy-5'-adenosyl)cobamide coenzyme; (5,6-Dimethylbenzimidazolyl)cobamide coenzyme; alpha-(5,6-Dimethylbenzimidazolyl)cobamide coenzyme; 5'-Deoxy-5'-adenosylcobalamin; 5'-Deoxy-5'-adenosyl vitamin B12; 5'-Deoxy-5'-adenosyl-5,6-dimethylbenzimidazolylcobamide; 5,6-Dimethylbenzimidazolyl-Co-5'-deoxy-5'-adenosylcobamide; Calomide; Cobalamin coenzyme; Coenzyme B12; DMBC coenzyme; Dibencozide; Funacomide",R01492 R05223 R11173,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.5.1.17; 2.7.8.26; 3.1.3.73,"Cobalamin biosynthesis, cobinamide => cobalamin",Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C00194  Cobamamide; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B03 ANTIANEMIC PREPARATIONS;    B03B VITAMIN B12 AND FOLIC ACID;     B03BA Vitamin B12 (cyanocobalamin and analogues);      B03BA04 Cobamamide;       D00042  Cobamamide (JAN/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    313  Vitamin B preparations;     3136  Vitamin B12 preparations;      D00042  Cobamamide (JAN/INN),CAS: 13870-90-1; PubChem: 3494; ChEBI: 18408; NIKKAJI: J2.221.278H,cpd:C00194,72,100,17,18,1,0,0,0,0,0,0,0,0,0,1,0,0,0,C72H101O17N18P1Co1,C72H99O17N18P1Co1,1578.658347,1579.666172,1577.6505223102,3435,cpd:C00486,Bilirubin,C33H36N4O6,Bilirubin,R00062 R02389 R02391 R02393 R02394,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites; Bile secretion,1.3.1.24; 1.3.3.5; 2.4.1.17; 2.4.1.95,NA,NA,CAS: 635-65-4; PubChem: 3769; ChEBI: 16990; ChEMBL: CHEMBL501680; KNApSAcK: C00029828; PDB-CCD: BLR; 3DMET: B01261; NIKKAJI: J674.476A,cpd:C00486; cpd:C05913; cpd:C11630,33,36,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H37O6N4,C33H35O6N4,584.2634849,585.2713099,583.25565993103,3436,cpd:C00500,Biliverdin;,C33H34N4O6,Biliverdin; Biliverdin IX alpha,R00311 R02391 R02393 R02394 R03678 R03683 R05817 R05818; R09491,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.24; 1.3.3.5; 1.3.7.2; 1.3.7.4; 1.3.7.5; 1.3.7.6; 1.14.14.18,NA,NA,CAS: 114-25-0; PubChem: 3783; ChEBI: 17033; ChEMBL: CHEMBL455477; 3DMET: B01271; NIKKAJI: J10.100A,cpd:C00500,33,34,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H35O6N4,C33H33O6N4,582.2478348,583.2556599,581.24000983104,3437,cpd:C00541,Cob(II)alamin;,C62H88CoN13O14P,Cob(II)alamin; Vitamin B12r,R00097 R00099 R00107 R08862 R08873 R08875 R11293 R11294,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.16.1.3; 1.16.1.4; 1.16.1.5; 2.1.1.308; 2.1.1.326; 2.1.1.-,NA,NA,CAS: 14463-33-3; PubChem: 3822; ChEBI: 16304,cpd:C00541; cpd:C05776,62,88,14,13,1,0,0,0,0,0,0,0,0,0,1,0,0,0,C62H89O14N13P1Co1,C62H87O14N13P1Co1,1328.564333,1329.572158,1327.5565083105,3438,cpd:C00748,Siroheme,C42H44FeN4O16,Siroheme,R02864,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,4.99.1.4,"Heme biosynthesis, glutamate => protoheme/siroheme",NA,PubChem: 4010; ChEBI: 28599; 3DMET: B01324,cpd:C00748,42,44,16,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,C42H45O16N4Fe1,C42H43O16N4Fe1,916.2085273,917.2163524,915.20070233106,3439,cpd:C00853,Cob(I)alamin;,C62H89CoN13O14P,Cob(I)alamin; Cbl; Vitamin B12s,R00099 R01492 R02999 R07668,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.16.1.4; 1.16.1.6; 2.1.1.-; 2.5.1.17,NA,NA,CAS: 18534-66-2; PubChem: 4110; ChEBI: 15982; NIKKAJI: J10.492B,cpd:C00853; cpd:C06409,62,89,14,13,1,0,0,0,0,0,0,0,0,0,1,0,0,0,C62H90O14N13P1Co1,C62H88O14N13P1Co1,1329.572158,1330.579983,1328.5643333107,3440,cpd:C00931,Porphobilinogen,C10H14N2O4,Porphobilinogen,R00036 R00084,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.5.1.61; 4.2.1.24,"Heme biosynthesis, glutamate => protoheme/siroheme",NA,CAS: 487-90-1; PubChem: 4184; ChEBI: 17381; KNApSAcK: C00007339; PDB-CCD: PBG; 3DMET: B00202; NIKKAJI: J6.026G,cpd:C00931; cpd:C06870; cpd:C17369,10,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O4N2,C10H13O4N2,226.0953569,227.103182,225.08753193108,3441,cpd:C00992,Aquacob(III)alamin;,C62H90CoN13O15P,Aquacob(III)alamin; Aquacobalamin,R00097 R00107,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.16.1.3; 1.16.1.5; 2.1.1.-,NA,NA,CAS: 13422-52-1; PubChem: 4238; ChEBI: 15852,cpd:C00992,62,90,15,13,1,0,0,0,0,0,0,0,0,0,1,0,0,0,C62H91O15N13P1Co1,C62H89O15N13P1Co1,1346.574897,1347.582722,1345.5670723109,3442,cpd:C01024,Hydroxymethylbilane,C40H46N4O17,Hydroxymethylbilane,R00084 R03165 R03166,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.5.1.61; 4.2.1.75,"Heme biosynthesis, glutamate => protoheme/siroheme",NA,CAS: 71861-60-4; PubChem: 4269; ChEBI: 16645; ChEMBL: CHEMBL273676; KNApSAcK: C00007374; 3DMET: B00223; NIKKAJI: J618.630K,cpd:C01024,40,46,17,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H47O17N4,C40H45O17N4,854.285796,855.2936211,853.2779713110,3443,cpd:C01051,Uroporphyrinogen III,C40H44N4O16,Uroporphyrinogen III,R03165 R03194 R03195 R03197 R07237,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.1.1.107; 4.1.1.37; 4.2.1.75,"Heme biosynthesis, glutamate => protoheme/siroheme",NA,CAS: 1976-85-8; PubChem: 4293; ChEBI: 15437; KNApSAcK: C00007373; PDB-CCD: UP2; 3DMET: B00231; NIKKAJI: J39.044E,cpd:C01051; cpd:C05766,40,44,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H45O16N4,C40H43O16N4,836.2752313,837.2830564,835.26740633111,3444,cpd:C01079,Protoporphyrinogen IX,C34H40N4O4,Protoporphyrinogen IX,R03220 R03222 R06895 R09489,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.3; 1.3.3.4; 1.3.5.3; 1.3.98.3,"Heme biosynthesis, glutamate => protoheme/siroheme",NA,CAS: 7412-77-3; PubChem: 4317; ChEBI: 15435; KNApSAcK: C00007371; 3DMET: B00236; NIKKAJI: J1.944.003F,cpd:C01079; cpd:C09994; cpd:C10002,34,40,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H41O4N4,C34H39O4N4,568.3049558,569.3127808,567.29713083112,3445,cpd:C02139,Chlorophyllide;,C35H34MgN4O5,Chlorophyllide; Chlorophyllide a,R03845 R04795 R05618 R06272 R06282 R06284 R08203 R09033; R09053 R09059 R09061 R09066 R10080,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.33; 1.3.1.75; 1.3.7.7; 1.3.7.15; 1.14.13.122; 2.5.1.62; 3.1.1.14; 3.1.1.100; 4.2.1.165,NA,NA,CAS: 14897-06-4 724691-52-5; PubChem: 5218; ChEBI: 16900; KNApSAcK: C00007316; 3DMET: B01537,cpd:C02139; cpd:C11829; cpd:C21441,35,34,5,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H35O5N4Mg1,C35H33O5N4Mg1,614.2379632,615.2457882,613.23013823113,3446,cpd:C02191,Protoporphyrin;,C34H34N4O4,Protoporphyrin; Protoporphyrin IX; Porphyrinogen IX,R00310 R03222 R03877 R09489,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.4; 1.3.5.3; 4.99.1.1; 6.6.1.1,"Heme biosynthesis, glutamate => protoheme/siroheme",NA,CAS: 553-12-8; PubChem: 5261; ChEBI: 15430; ChEMBL: CHEMBL1325592; KNApSAcK: C00007370; 3DMET: B00399; NIKKAJI: J136.582G J15.490C,cpd:C02191,34,34,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H35O4N4,C34H33O4N4,562.2580056,563.2658306,561.25018063114,3447,cpd:C02463,Precorrin 2;,C42H48N4O16,Precorrin 2; Dihydrosirohydrochlorin,R03194 R03947 R03948 R03951 R07238,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.76; 2.1.1.107; 2.1.1.130,"Heme biosynthesis, glutamate => protoheme/siroheme",NA,CAS: 82542-92-5; PubChem: 5480; ChEBI: 50602; KNApSAcK: C00007375; 3DMET: B01575; NIKKAJI: J966.387H,cpd:C02463,42,48,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H49O16N4,C42H47O16N4,864.3065315,865.3143565,863.29870643115,3448,cpd:C02469,Uroporphyrin III,C40H38N4O16,Uroporphyrin III,R03195 R03950,Porphyrin and chlorophyll metabolism,2.1.1.107,NA,NA,CAS: 18273-06-8; PubChem: 5484; ChEBI: 15436; 3DMET: B00446; NIKKAJI: J19.164G,cpd:C02469; cpd:C05767,40,38,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H39O16N4,C40H37O16N4,830.2282812,831.2361062,829.22045613116,3449,cpd:C02800,"4,5-Dioxopentanoate;",C5H6O4,"4,5-Dioxopentanoate; 4-Oxoglutarate semialdehyde",R02271,Porphyrin and chlorophyll metabolism,2.6.1.43,NA,NA,PubChem: 5750; ChEBI: 17204; PDB-CCD: HKV; 3DMET: B00503; NIKKAJI: J690.683D,cpd:C00337; cpd:C00433; cpd:C00490; cpd:C01732; cpd:C02132; cpd:C02214; cpd:C02226; cpd:C02800; cpd:C02871; cpd:C03306; cpd:C03703; cpd:C10600; cpd:C20756; cpd:C20757,5,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H7O4,C5H5O4,130.0266087,131.0344337,129.01878363117,3450,cpd:C02823,Cyanocobalamin;,C63H88CoN14O14P,Cyanocobalamin; Cyanocob(III)alamin; Dicopac; Vitamin B12 complex,R02999,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.16.1.6,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B03 ANTIANEMIC PREPARATIONS;    B03B VITAMIN B12 AND FOLIC ACID;     B03BA Vitamin B12 (cyanocobalamin and analogues);      B03BA01 Cyanocobalamin;       D00166  Cyanocobalamin (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   13  Agents affecting sensory organs;    131  Ophthalmic agents;     1319  Others;      D00166  Cyanocobalamin (JP17/USP/INN);  3  Agents affecting metabolism;   31  Vitamins;    313  Vitamin B preparations;     3136  Vitamin B12 preparations;      D00166  Cyanocobalamin (JP17/USP/INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for circulatory system and blood;   24 Anemia drugs;    D00166  Cyanocobalamin (JP17/USP/INN);  Nourishing tonics and health supplements;   42 Vitamin B1B6B12 based drugs;    D00166  Cyanocobalamin (JP17/USP/INN);   43 Vitamin containing supplements;    D00166  Cyanocobalamin (JP17/USP/INN);  Agents for ophthalmologic use;   62 General eye drops;    D00166  Cyanocobalamin (JP17/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Cyanocobalamin;     D00166  Cyanocobalamin (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00166  Cyanocobalamin;   D00166  Cyanocobalamin injection; Animal drugs in Japan [BR:br08331];  96  Agents affecting metabolism;   962  Vitamin preparations;    9623  Vitamin B and preparations (except vitamin B1 preparations);     C02823  Cyanocob(III)alamin,CAS: 68-19-9; PubChem: 5771; ChEBI: 17439; ChEMBL: CHEMBL1908357; KNApSAcK: C00001534; NIKKAJI: J203.514F,cpd:C02823,63,88,14,14,1,0,0,0,0,0,0,0,0,0,1,0,0,0,C63H89O14N14P1Co1,C63H87O14N14P1Co1,1354.567407,1355.575232,1353.5595823118,3451,cpd:C02880,Protochlorophyllide;,C35H32MgN4O5,Protochlorophyllide; Protochlorophyllide a,R03845 R06271 R06282 R06896 R11519,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.33; 1.3.1.75; 1.3.7.7; 1.3.7.13,NA,NA,CAS: 20369-67-9 708964-46-9; PubChem: 5811; ChEBI: 16673; 3DMET: B01607,cpd:C02880; cpd:C11830; cpd:C11832,35,32,5,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H33O5N4Mg1,C35H31O5N4Mg1,612.2223131,613.2301382,611.21448813119,3453,cpd:C03263,Coproporphyrinogen III,C36H44N4O8,Coproporphyrinogen III,R03197 R03220 R04178 R06895,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.3; 1.3.3.15; 1.3.98.3; 4.1.1.37,"Heme biosynthesis, glutamate => protoheme/siroheme",NA,CAS: 2624-63-7; PubChem: 6127; ChEBI: 15439; ChEMBL: CHEMBL1231891; KNApSAcK: C00007284; PDB-CCD: CP3; 3DMET: B00571; NIKKAJI: J313.191B,cpd:C03263; cpd:C05768,36,44,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H45O8N4,C36H43O8N4,660.3159144,661.3237394,659.30808943120,3454,cpd:C03516,Magnesium protoporphyrin;,C34H32MgN4O4,Magnesium protoporphyrin; Magnesium protoporphyrin IX; Mg-protoporphyrin IX,R03877 R04237,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.1.1.11; 6.6.1.1,NA,NA,PubChem: 6325; ChEBI: 15431; KNApSAcK: C00007369; 3DMET: B01666,cpd:C03516,34,32,4,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C34H33O4N4Mg1,C34H31O4N4Mg1,584.2273985,585.2352236,583.21957353121,3455,cpd:C03741,(S)-4-Amino-5-oxopentanoate;,C5H9NO3,(S)-4-Amino-5-oxopentanoate; L-Glutamate 1-semialdehyde,R02272 R04109,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.2.1.70; 5.4.3.8,"Heme biosynthesis, glutamate => protoheme/siroheme",NA,PubChem: 6504; ChEBI: 15757; KNApSAcK: C00007379 C00019659; 3DMET: B00630; NIKKAJI: J1.256.054K,cpd:C00430; cpd:C01015; cpd:C01073; cpd:C01110; cpd:C01157; cpd:C01165; cpd:C03341; cpd:C03440; cpd:C03651; cpd:C03741; cpd:C05147; cpd:C06809; cpd:C12876; cpd:C19706,5,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O3N1,C5H8O3N1,131.0582432,132.0660682,130.05041813122,3456,cpd:C04122,D-1-Aminopropan-2-ol O-phosphate;,C3H10NO4P,D-1-Aminopropan-2-ol O-phosphate; (R)-1-Aminopropan-2-yl phosphate,R06529 R06530,Porphyrin and chlorophyll metabolism,4.1.1.81; 6.3.1.10,NA,NA,PubChem: 6809; ChEBI: 28390; 3DMET: B01719; NIKKAJI: J933.541B,cpd:C01210; cpd:C04122; cpd:C04126,3,10,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H11O4N1P1,C3H9O4N1P1,155.0347448,156.0425698,154.02691983123,3457,cpd:C04536,Magnesium protoporphyrin monomethyl ester;,C35H34MgN4O4,Magnesium protoporphyrin monomethyl ester; Magnesium-protoporphyrin IX 13-monomethyl ester; Mg-Protoporphyrin IX 13-monomethyl ester; Magnesium protoporphyrin IX 13-methyl ester,R04237 R06265 R06268 R10068 R11494,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.81; 1.21.98.3; 2.1.1.11,NA,NA,PubChem: 7143; ChEBI: 15432; KNApSAcK: C00007372; 3DMET: B01754,cpd:C04536,35,34,4,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H35O4N4Mg1,C35H33O4N4Mg1,598.2430486,599.2508736,597.23522363124,3458,cpd:C04778,"N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole;",C14H19N2O7P,"N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole; alpha-Ribazole 5'-phosphate",R04148 R04594 R11174,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.4.2.21; 2.7.8.26; 3.1.3.73,"Cobalamin biosynthesis, cobinamide => cobalamin",NA,CAS: 975-91-7; PubChem: 7342; ChEBI: 16837; PDB-CCD: RBZ; NIKKAJI: J863.623K,cpd:C04778,14,19,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H20O7N2P1,C14H18O7N2P1,358.092988,359.100813,357.08516293125,3459,cpd:C05306,Chlorophyll a,C55H72MgN4O5,Chlorophyll a,R05618 R06284 R06288 R08584 R08585 R09071,Porphyrin and chlorophyll metabolism; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites,1.17.7.2; 2.5.1.62; 3.1.1.14,NA,NA,CAS: 479-61-8; PubChem: 7688; ChEBI: 18230; KNApSAcK: C00001528; NIKKAJI: J246.979K,cpd:C05306,55,72,5,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C55H73O5N4Mg1,C55H71O5N4Mg1,892.5353144,893.5431395,891.52748943126,3460,cpd:C05307,Chlorophyll b,C55H70MgN4O6,Chlorophyll b,R08585 R09067 R09068 R09069 R09070,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.294; 2.5.1.62; 3.1.1.14,NA,NA,CAS: 519-62-0; PubChem: 7689; ChEBI: 27888; KNApSAcK: C00007376; NIKKAJI: J246.980D,cpd:C05307,55,70,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C55H71O6N4Mg1,C55H69O6N4Mg1,906.514579,907.522404,905.5067543127,3461,cpd:C05766,Uroporphyrinogen I,C40H44N4O16,Uroporphyrinogen I,R03166 R04971 R04972,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,4.1.1.37,NA,NA,PubChem: 8061; ChEBI: 28766; 3DMET: B00837; NIKKAJI: J39.042I,cpd:C01051; cpd:C05766,40,44,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H45O16N4,C40H43O16N4,836.2752313,837.2830564,835.26740633128,3462,cpd:C05767,Uroporphyrin I,C40H38N4O16,Uroporphyrin I,R04971,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,NA,NA,NA,CAS: 607-14-7; PubChem: 8062; ChEBI: 27484; 3DMET: B00838; NIKKAJI: J12.288B,cpd:C02469; cpd:C05767,40,38,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H39O16N4,C40H37O16N4,830.2282812,831.2361062,829.22045613129,3463,cpd:C05768,Coproporphyrinogen I,C36H44N4O8,Coproporphyrinogen I,R04972 R04973,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,4.1.1.37,NA,NA,PubChem: 8063; ChEBI: 28607; PDB-CCD: 1CP; 3DMET: B00839; NIKKAJI: J357.100I,cpd:C03263; cpd:C05768,36,44,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H45O8N4,C36H43O8N4,660.3159144,661.3237394,659.30808943130,3464,cpd:C05769,Coproporphyrin I,C36H38N4O8,Coproporphyrin I,R04973,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,NA,CAS: 531-14-6; PubChem: 8064; ChEBI: 28421; 3DMET: B00840; NIKKAJI: J14.377D,cpd:C05769; cpd:C05770,36,38,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H39O8N4,C36H37O8N4,654.2689642,655.2767892,653.26113923131,3465,cpd:C05770,Coproporphyrin III,C36H38N4O8,Coproporphyrin III,R04178 R11329,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.15; 4.99.1.9,NA,NA,CAS: 14643-66-4; PubChem: 8065; ChEBI: 27609; 3DMET: B00841; NIKKAJI: J14.910A,cpd:C05769; cpd:C05770,36,38,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H39O8N4,C36H37O8N4,654.2689642,655.2767892,653.26113923132,3466,cpd:C05772,Precorrin 3A,C43H50N4O16,Precorrin 3A,R03948 R05217,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.14.13.83; 2.1.1.130,NA,NA,PubChem: 8067; ChEBI: 28307; 3DMET: B01891,cpd:C05772; cpd:C16243,43,50,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H51O16N4,C43H49O16N4,878.3221815,879.3300066,877.31435653133,3467,cpd:C05773,Cobyrinate;,C45H59CoN4O14,Cobyrinate; Cobyrinic acid; Cob(II)yrinate; Cob(II)yrinic acid,R04975 R05814 R05815 R09598,Porphyrin and chlorophyll metabolism; Metabolic pathways,5.4.99.60; 6.3.5.11,NA,NA,PubChem: 8068; ChEBI: 33907; 3DMET: B01892,cpd:C05773; cpd:C11545,45,59,14,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C45H60O14N4Co1,C45H58O14N4Co1,938.3359786,939.3438036,937.32815363134,3468,cpd:C05774,Cobinamide;,C48H72CoN11O8,Cobinamide; Cob(I)inamide,R04975 R07268,Porphyrin and chlorophyll metabolism,2.5.1.17,NA,NA,PubChem: 8069; ChEBI: 28956,cpd:C05774,48,72,8,11,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C48H73O8N11Co1,C48H71O8N11Co1,989.4897343,990.4975594,988.48190933135,3469,cpd:C05775,alpha-Ribazole;,C14H18N2O4,"alpha-Ribazole; N1-(alpha-D-Ribosyl)-5,6-dimethylbenzimidazole",R04594 R05223,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.7.8.26; 3.1.3.73,"Cobalamin biosynthesis, cobinamide => cobalamin",NA,CAS: 132-13-8; PubChem: 8070; ChEBI: 10329; 3DMET: B05111; NIKKAJI: J10.013G,cpd:C05775; cpd:C18753,14,18,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H19O4N2,C14H17O4N2,278.1266571,279.1344821,277.1188323136,3470,cpd:C05777,Coenzyme F430;,C42H51N6NiO13,Coenzyme F430; Factor F430,R03951,Porphyrin and chlorophyll metabolism,NA,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C05777  Coenzyme F430,CAS: 73145-13-8; PubChem: 8072; ChEBI: 28265; PDB-CCD: F43; 3DMET: B05112; NIKKAJI: J1.996.004H,cpd:C05777,42,51,13,6,0,0,0,0,0,0,0,0,0,0,0,0,1,0,C42H52O13N6Ni1,C42H50O13N6Ni1,905.2867597,906.2945848,904.27893473137,3471,cpd:C05778,Sirohydrochlorin,C42H46N4O16,Sirohydrochlorin,R02864 R03947 R03950 R05807,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.76; 2.1.1.107; 4.99.1.3; 4.99.1.4,"Heme biosynthesis, glutamate => protoheme/siroheme",NA,CAS: 65207-12-7; PubChem: 8073; ChEBI: 18023; KNApSAcK: C00007315; 3DMET: B01893; NIKKAJI: J18.481K,cpd:C05778,42,46,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H47O16N4,C42H45O16N4,862.2908814,863.2987064,861.28305643138,3472,cpd:C05786,(3Z)-Phycocyanobilin,C33H38N4O6,(3Z)-Phycocyanobilin,R04978 R05040 R05817,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.3.7.5,NA,NA,PubChem: 8081; ChEBI: 15617; 3DMET: B01894; NIKKAJI: J2.759.269D,cpd:C05786; cpd:C05912; cpd:C16641,33,38,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H39O6N4,C33H37O6N4,586.279135,587.28696,585.27130993139,3473,cpd:C05787,Bilirubin beta-diglucuronide;,C45H52N4O18,Bilirubin beta-diglucuronide; Bilirubin-bisglucuronoside,R00062 R02389 R04979,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.-.-.-; 2.4.1.17; 2.4.1.95; 3.2.1.31,NA,NA,CAS: 17459-92-6; PubChem: 8082; ChEBI: 18392; ChEMBL: CHEMBL1743142; 3DMET: B01895; NIKKAJI: J345.141K,cpd:C05787,45,52,18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C45H53O18N4,C45H51O18N4,936.3276608,937.3354859,935.31983583140,3474,cpd:C05789,L-Urobilinogen;,C33H48N4O6,L-Urobilinogen; L-Stercobilinogen; Stercobilinogen,R06255 R06257,Porphyrin and chlorophyll metabolism,NA,NA,NA,PubChem: 8084; ChEBI: 36479 6320; 3DMET: B05113; NIKKAJI: J37.259E,cpd:C05789,33,48,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H49O6N4,C33H47O6N4,596.3573853,597.3652103,595.34956023141,3475,cpd:C05790,I-Urobilinogen;,C33H44N4O6,I-Urobilinogen; Mesobilirubinogen; Urobilinogen,R06254 R06256 R06257,Porphyrin and chlorophyll metabolism,NA,NA,NA,CAS: 14684-37-8; PubChem: 8085; ChEBI: 29026; 3DMET: B05114; NIKKAJI: J710.141D,cpd:C05790,33,44,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H45O6N4,C33H43O6N4,592.3260852,593.3339102,591.31826013142,3476,cpd:C05791,D-Urobilinogen,C33H42N4O6,D-Urobilinogen,R00070 R04979 R06256,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.-.-.-; 3.2.1.31,NA,NA,PubChem: 8086; ChEBI: 4260; 3DMET: B05115; NIKKAJI: J2.759.294E,cpd:C05791; cpd:C05794,33,42,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H43O6N4,C33H41O6N4,590.3104351,591.3182601,589.30261013143,3477,cpd:C05793,L-Urobilin;,C33H46N4O6,L-Urobilin; L-Stercobilin; Stercobilin,R06255,Porphyrin and chlorophyll metabolism,NA,NA,NA,CAS: 34217-90-8; PubChem: 8088; ChEBI: 29023; 3DMET: B05116; NIKKAJI: J37.198J,cpd:C05793,33,46,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H47O6N4,C33H45O6N4,594.3417352,595.3495602,593.33391023144,3478,cpd:C05794,Urobilin;,C33H42N4O6,Urobilin; I-Urobilin,R06254,Porphyrin and chlorophyll metabolism,NA,NA,NA,CAS: 1856-98-0; PubChem: 8089; ChEBI: 36378; 3DMET: B05117; NIKKAJI: J31.894I,cpd:C05791; cpd:C05794,33,42,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H43O6N4,C33H41O6N4,590.3104351,591.3182601,589.30261013145,3479,cpd:C05795,D-Urobilin,C33H40N4O6,D-Urobilin,R00070,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 8090; ChEBI: 4259; 3DMET: B05118; NIKKAJI: J2.759.311I,cpd:C05795; cpd:C19704,33,40,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H41O6N4,C33H39O6N4,588.294785,589.3026101,587.286963146,3480,cpd:C05797,Pheophytin a,C55H74N4O5,Pheophytin a,R08584,Porphyrin and chlorophyll metabolism,NA,NA,NA,PubChem: 8092; ChEBI: 44898 8108; PDB-CCD: PHO; 3DMET: B01896; NIKKAJI: J37.089D,cpd:C05797,55,74,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C55H75O5N4,C55H73O5N4,870.5659215,871.5737465,869.55809653147,3481,cpd:C05798,Bacteriopheophytin;,C55H76N4O6,Bacteriopheophytin; Bacteriopheophytin a,R04795,Porphyrin and chlorophyll metabolism,NA,NA,NA,CAS: 17453-58-6; PubChem: 8093; ChEBI: 2978; PDB-CCD: BPH; 3DMET: B01897; NIKKAJI: J679.042I,cpd:C05798,55,76,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C55H77O6N4,C55H75O6N4,888.5764862,889.5843112,887.56866123148,3482,cpd:C05912,(3Z)-Phycoerythrobilin,C33H38N4O6,(3Z)-Phycoerythrobilin,R04978 R05819 R09491,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.3.7.3; 1.3.7.6,NA,NA,PubChem: 8200; ChEBI: 15618 36741; 3DMET: B01911; NIKKAJI: J2.372.358A,cpd:C05786; cpd:C05912; cpd:C16641,33,38,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H39O6N4,C33H37O6N4,586.279135,587.28696,585.27130993149,3483,cpd:C05913,(3Z)-Phytochromobilin,C33H36N4O6,(3Z)-Phytochromobilin,R03678 R05040,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.3.7.4,NA,NA,PubChem: 8201; ChEBI: 15619; 3DMET: B01912; NIKKAJI: J654.602A,cpd:C00486; cpd:C05913; cpd:C11630,33,36,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H37O6N4,C33H35O6N4,584.2634849,585.2713099,583.25565993150,3484,cpd:C06319,Precorrin 6Y;,C44H56N4O16,Precorrin 6Y; Precorrin 6B,R05149 R05150,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.3.1.54; 2.1.1.132,NA,NA,PubChem: 8555; ChEBI: 27858; 3DMET: B05183; NIKKAJI: J2.760.995C,cpd:C06319,44,56,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C44H57O16N4,C44H55O16N4,896.3691317,897.3769568,895.36130673151,3485,cpd:C06320,Precorrin 6X;,C44H54N4O16,Precorrin 6X; Precorrin 6A,R05150 R05219,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.3.1.54; 2.1.1.152,NA,NA,PubChem: 8556; ChEBI: 27513; 3DMET: B02010; NIKKAJI: J2.760.996A,cpd:C06320,44,54,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C44H55O16N4,C44H53O16N4,894.3534817,895.3613067,893.34565663152,3486,cpd:C06399,Hydrogenobyrinate;,C45H60N4O14,Hydrogenobyrinate; Hydrogenobyrinic acid,R05177 R05224,Porphyrin and chlorophyll metabolism; Metabolic pathways,5.4.99.61; 6.3.5.9,NA,NA,PubChem: 8635; ChEBI: 17926; 3DMET: B05190; NIKKAJI: J2.144.750A,cpd:C06399; cpd:C06408,45,60,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C45H61O14N4,C45H59O14N4,880.4106026,881.4184277,879.40277763153,3487,cpd:C06406,Precorrin 3B,C43H50N4O17,Precorrin 3B,R05180 R05217,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.14.13.83; 2.1.1.131,NA,NA,PubChem: 8641; ChEBI: 27711; 3DMET: B02013; NIKKAJI: J2.767.299J,cpd:C06406,43,50,17,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H51O17N4,C43H49O17N4,894.3170962,895.3249212,893.30927113154,3488,cpd:C06407,Precorrin 4,C44H52N4O17,Precorrin 4,R05180 R05181,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.1.1.131; 2.1.1.133,NA,NA,PubChem: 8642; ChEBI: 16430; 3DMET: B05191; NIKKAJI: J2.763.145B,cpd:C06407,44,52,17,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C44H53O17N4,C44H51O17N4,908.3327462,909.3405713,907.32492123155,3489,cpd:C06408,Precorrin 8X;,C45H60N4O14,Precorrin 8X; Precorrin 8; Precorrin-8X,R05149 R05177,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.1.1.132; 5.4.99.61,NA,NA,PubChem: 8643; ChEBI: 28629; 3DMET: B05192; NIKKAJI: J2.763.156H,cpd:C06399; cpd:C06408,45,60,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C45H61O14N4,C45H59O14N4,880.4106026,881.4184277,879.40277763156,3490,cpd:C06416,Precorrin 5,C45H54N4O17,Precorrin 5,R05181 R05219,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.1.1.133; 2.1.1.152,NA,NA,PubChem: 8651; ChEBI: 27630; 3DMET: B05193; NIKKAJI: J2.763.198C,cpd:C06416,45,54,17,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C45H55O17N4,C45H53O17N4,922.3483963,923.3562213,921.34057133157,3491,cpd:C06503,"Hydrogenobyrinate a,c diamide;",C45H62N6O12,"Hydrogenobyrinate a,c diamide; Hydrogenobyrinate diamide; Hydrogenobyrinic acid a,c-diamide",R05224 R05227,Porphyrin and chlorophyll metabolism; Metabolic pathways,6.3.5.9; 6.6.1.2,NA,NA,PubChem: 8734; ChEBI: 27914; 3DMET: B05208; NIKKAJI: J2.762.431F,cpd:C06503,45,62,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C45H63O12N6,C45H61O12N6,878.4425715,879.4503965,877.43474643158,3492,cpd:C06504,"Cob(II)yrinate a,c diamide;",C45H61CoN6O12,"Cob(II)yrinate a,c diamide; Cob(II)yrinate diamide; Cob(II)yrinic acid a,c-diamide; Cobyrinate a,c-diamide; Cobyrinic acid a,c-diamide",R05218 R05227 R05815 R09599,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.16.8.1; 6.3.5.11; 6.6.1.2,NA,NA,PubChem: 8735; ChEBI: 27937; 3DMET: B02038,cpd:C06504; cpd:C06505,45,61,12,6,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C45H62O12N6Co1,C45H60O12N6Co1,936.3679474,937.3757725,935.36012243159,3493,cpd:C06505,"Cob(I)yrinate a,c diamide;",C45H61CoN6O12,"Cob(I)yrinate a,c diamide; Cob(I)yrinate diamide; Cob(I)yrinic acid a,c-diamide",R05218 R05220,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.16.8.1; 2.5.1.17,"Cobalamin biosynthesis, cobinamide => cobalamin",NA,PubChem: 8736; ChEBI: 28531,cpd:C06504; cpd:C06505,45,61,12,6,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C45H62O12N6Co1,C45H60O12N6Co1,936.3679474,937.3757725,935.36012243160,3494,cpd:C06506,"Adenosyl cobyrinate a,c diamide;",C55H73CoN11O15,"Adenosyl cobyrinate a,c diamide; Adenosyl cobyrinate diamide; Adenosylcob(III)yrinic acid a,c-diamide; Adenosylcobyrinic acid a,c-diamide",R05220 R05225,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.5.1.17; 6.3.5.10,"Cobalamin biosynthesis, cobinamide => cobalamin",NA,PubChem: 8737; ChEBI: 2482,cpd:C06506,55,73,15,11,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C55H74O15N11Co1,C55H72O15N11Co1,1186.461962,1187.469787,1185.4541373161,3495,cpd:C06507,Adenosyl cobyrinate hexaamide;,C55H77CoN15O11,Adenosyl cobyrinate hexaamide; Adenosylcobyric acid,R05225 R05226 R06529 R07302,Porphyrin and chlorophyll metabolism; Metabolic pathways,3.5.1.90; 6.3.1.10; 6.3.5.10,"Cobalamin biosynthesis, cobinamide => cobalamin",NA,PubChem: 8738; ChEBI: 2483,cpd:C06507,55,77,11,15,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C55H78O11N15Co1,C55H76O11N15Co1,1182.525899,1183.533724,1181.5180743162,3496,cpd:C06508,Adenosyl cobinamide;,C58H84CoN16O11,Adenosyl cobinamide; Adenosylcobinamide,R05221 R05226 R06558 R07268 R07302,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.5.1.17; 2.7.1.156; 3.5.1.90; 6.3.1.10,"Cobalamin biosynthesis, cobinamide => cobalamin",NA,PubChem: 8739; ChEBI: 2480,cpd:C06508,58,84,11,16,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C58H85O11N16Co1,C58H83O11N16Co1,1239.583749,1240.591574,1238.5759243163,3497,cpd:C06509,Adenosyl cobinamide phosphate;,C58H85CoN16O14P,Adenosyl cobinamide phosphate; Adenosylcobinamide phosphate,R05221 R05222 R06529 R06558,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.7.1.156; 2.7.7.62; 6.3.1.10,"Cobalamin biosynthesis, cobinamide => cobalamin",NA,PubChem: 8740; ChEBI: 2481,cpd:C06509,58,85,14,16,1,0,0,0,0,0,0,0,0,0,1,0,0,0,C58H86O14N16P1Co1,C58H84O14N16P1Co1,1319.550079,1320.557905,1318.5422543164,3498,cpd:C06510,Adenosine-GDP-cobinamide;,C68H97CoN21O21P2,Adenosine-GDP-cobinamide; Adenosylcobinamide-GDP,R05222 R05223 R11174,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.7.7.62; 2.7.8.26,"Cobalamin biosynthesis, cobinamide => cobalamin",NA,PubChem: 8741; ChEBI: 2479,cpd:C06510,68,97,21,21,2,0,0,0,0,0,0,0,0,0,1,0,0,0,C68H98O21N21P2Co1,C68H96O21N21P2Co1,1664.597514,1665.605339,1663.5896893165,3499,cpd:C11242,Bacteriochlorophyll a,C55H74MgN4O6,Bacteriochlorophyll a,R11226,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.3.1.111,NA,NA,PubChem: 13420; ChEBI: 30033,cpd:C11242,55,74,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C55H75O6N4Mg1,C55H73O6N4Mg1,910.5458791,911.5537042,909.53805413166,3500,cpd:C11243,Bacteriochlorophyll b,C55H72MgN4O6,Bacteriochlorophyll b,R11518,Porphyrin and chlorophyll metabolism,1.3.1.111,NA,NA,PubChem: 13421; ChEBI: 30034,cpd:C11243; cpd:C18151,55,72,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C55H73O6N4Mg1,C55H71O6N4Mg1,908.5302291,909.5380541,907.5224043167,3501,cpd:C11538,Cobalt-sirohydrochlorin;,C42H44CoN4O16,Cobalt-sirohydrochlorin; Cobalt-factor II,R05807 R05808,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.1.1.151; 4.99.1.3,NA,NA,PubChem: 13705; ChEBI: 3790 52491; 3DMET: B05535,cpd:C11538,42,44,16,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C42H45O16N4Co1,C42H43O16N4Co1,919.2084323,920.2162574,918.20060733168,3502,cpd:C11539,Cobalt-precorrin 3,C43H48CoN4O16,Cobalt-precorrin 3,R05809 R08716,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.1.1.131,NA,NA,PubChem: 13706; ChEBI: 3791; 3DMET: B05536,cpd:C11539,43,48,16,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C43H49O16N4Co1,C43H47O16N4Co1,935.2397325,936.2475575,934.23190743169,3503,cpd:C11540,Cobalt-precorrin 4,C44H50CoN4O16,Cobalt-precorrin 4,R05809 R05810,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.1.1.131; 2.1.1.271,NA,NA,PubChem: 13707; ChEBI: 3792; 3DMET: B05537,cpd:C11540,44,50,16,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C44H51O16N4Co1,C44H49O16N4Co1,949.2553825,950.2632076,948.24755753170,3504,cpd:C11542,Cobalt-precorrin 6;,C44H53CoN4O16,Cobalt-precorrin 6; Cobalt-precorrin 6A,R05811 R05812 R07773,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.3.1.106; 2.1.1.195; 2.1.1.-,NA,NA,PubChem: 13709; ChEBI: 3794; 3DMET: B04272,cpd:C11542,44,53,16,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C44H54O16N4Co1,C44H52O16N4Co1,952.2788576,953.2866827,951.27103263171,3505,cpd:C11543,Cobalt-dihydro-precorrin 6;,C44H55CoN4O16,Cobalt-dihydro-precorrin 6; Cobalt-precorrin 6B,R05812 R05813 R07774,Porphyrin and chlorophyll metabolism; Metabolic pathways,1.3.1.106; 2.1.1.196,NA,NA,PubChem: 13710; ChEBI: 3789; 3DMET: B04273,cpd:C11543,44,55,16,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C44H56O16N4Co1,C44H54O16N4Co1,954.2945077,955.3023327,953.28668273172,3506,cpd:C11545,Cobalt-precorrin 8;,C45H59CoN4O14,Cobalt-precorrin 8; Cobalt-precorrin-8,R05813 R05814 R07775,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.1.1.289; 5.4.99.60,NA,NA,PubChem: 13712; ChEBI: 3795; 3DMET: B05538,cpd:C05773; cpd:C11545,45,59,14,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C45H60O14N4Co1,C45H58O14N4Co1,938.3359786,939.3438036,937.32815363173,3507,cpd:C11630,"15,16-Dihydrobiliverdin;",C33H36N4O6,"15,16-Dihydrobiliverdin; 15,16-Dihydrobiliverdin IXalpha; 15,16-Dihydrobiliverdin ixa",R05818 R05819,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.3.7.2; 1.3.7.3,NA,NA,CAS: 137429-14-2; PubChem: 13795; ChEBI: 16790; PDB-CCD: DBV; 3DMET: B04277; NIKKAJI: J2.775.653K,cpd:C00486; cpd:C05913; cpd:C11630,33,36,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H37O6N4,C33H35O6N4,584.2634849,585.2713099,583.25565993174,3508,cpd:C11829,13(1)-Hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester;,C35H34MgN4O5,13(1)-Hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester; 13(1)-Hydroxy-Mg-protoporphyrin IX 13-monomethyl ester,R06265 R06266 R06268 R06269,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.14.13.81; 1.21.98.3,NA,NA,PubChem: 13993; ChEBI: 15434; 3DMET: B05547,cpd:C02139; cpd:C11829; cpd:C21441,35,34,5,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H35O5N4Mg1,C35H33O5N4Mg1,614.2379632,615.2457882,613.23013823175,3509,cpd:C11830,13(1)-Oxo-magnesium-protoporphyrin IX 13-monomethyl ester;,C35H32MgN4O5,13(1)-Oxo-magnesium-protoporphyrin IX 13-monomethyl ester; 13(1)-Oxo-Mg-protoporphyrin IX 13-monomethyl ester,R06266 R06267 R06269 R06270,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.14.13.81; 1.21.98.3,NA,NA,PubChem: 13994; ChEBI: 15433; 3DMET: B04326,cpd:C02880; cpd:C11830; cpd:C11832,35,32,5,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H33O5N4Mg1,C35H31O5N4Mg1,612.2223131,613.2301382,611.21448813176,3510,cpd:C11831,Divinylprotochlorophyllide;,C35H30MgN4O5,"Divinylprotochlorophyllide; 2,4-Divinylprotochlorophyllide; Mg-2,4-Divinyl-phaeoporphyrin a5-monomethylester; 3,8-Divinyl protochlorophyllide a",R06267 R06270 R06271 R06286 R06896 R10068 R11494 R11519,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.33; 1.3.1.75; 1.3.7.13; 1.14.13.81; 1.21.98.3,NA,NA,CAS: 18433-30-2; PubChem: 13995; ChEBI: 30619; 3DMET: B04327,cpd:C11831,35,30,5,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H31O5N4Mg1,C35H29O5N4Mg1,610.2066631,611.2144881,609.19883813177,3511,cpd:C11832,Divinyl chlorophyllide a;,C35H32MgN4O5,"Divinyl chlorophyllide a; 3,8-Divinyl chlorophyllide a",R06272 R06286 R06287 R11531,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.3.1.33; 1.3.1.75; 1.3.7.14,NA,NA,PubChem: 13996; ChEBI: 38259; 3DMET: B04328,cpd:C02880; cpd:C11830; cpd:C11832,35,32,5,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H33O5N4Mg1,C35H31O5N4Mg1,612.2223131,613.2301382,611.21448813178,3512,cpd:C11850,Divinylchlorophyll a,C55H70MgN4O5,Divinylchlorophyll a,R06287 R06288,Porphyrin and chlorophyll metabolism,NA,NA,NA,PubChem: 14012; ChEBI: 73113; 3DMET: B04331,cpd:C11850,55,70,5,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C55H71O5N4Mg1,C55H69O5N4Mg1,890.5196644,891.5274894,889.51183933179,3514,cpd:C12147,L-Threonine O-3-phosphate;,C4H10NO6P,L-Threonine O-3-phosphate; L-Threonine phosphate; O-Phospho-L-threonine,R06530 R06531,Porphyrin and chlorophyll metabolism,2.7.1.177; 4.1.1.81,NA,NA,PubChem: 14294; ChEBI: 37525; PDB-CCD: TPO; 3DMET: B04438; NIKKAJI: J203.332A,cpd:C01102; cpd:C05702; cpd:C12147; cpd:C12215,4,10,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O6N1P1,C4H9O6N1P1,199.024574,200.0323991,198.0167493180,3517,cpd:C15670,Heme A,C49H56FeN4O6,Heme A,R07412,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C15670  Heme A,PubChem: 47204997; ChEBI: 36163,cpd:C15670,49,56,6,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,C49H57O6N4Fe1,C49H55O6N4Fe1,852.3532815,853.3611066,851.34545653181,3518,cpd:C15672,Heme O,C49H58FeN4O5,Heme O,R07411 R07412,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,2.5.1.-,NA,Compounds with biological roles [BR:br08001];  Vitamins and Cofactors;   Cofactors;    Coenzymes;     C15672  Heme O,CAS: 137397-56-9; PubChem: 47204998; ChEBI: 24480,cpd:C15672,49,58,5,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,C49H59O5N4Fe1,C49H57O5N4Fe1,838.374017,839.381842,837.3661923182,3519,cpd:C16242,Cobalt-precorrin 5A,C45H52CoN4O16,Cobalt-precorrin 5A,R05810 R07772,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.1.1.271; 3.7.1.12,NA,NA,PubChem: 47205550; ChEBI: 52488,cpd:C16242,45,52,16,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C45H53O16N4Co1,C45H51O16N4Co1,963.2710326,964.2788576,962.26320763183,3520,cpd:C16243,Cobalt-precorrin 5B,C43H50CoN4O16,Cobalt-precorrin 5B,R07772 R07773,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.1.1.195; 3.7.1.12,NA,NA,PubChem: 47205551; ChEBI: 52489,cpd:C16243,43,50,16,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C43H51O16N4Co1,C43H49O16N4Co1,937.2553825,938.2632076,936.24755753184,3521,cpd:C16244,Cobalt-precorrin 7,C44H57CoN4O14,Cobalt-precorrin 7,R07774 R07775,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.1.1.196; 2.1.1.289,NA,NA,PubChem: 47205552; ChEBI: 52490,cpd:C16244,44,57,14,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C44H58O14N4Co1,C44H56O14N4Co1,924.3203285,925.3281536,923.31250353185,3522,cpd:C16540,7(1)-Hydroxychlorophyllide a,C35H34MgN4O6,7(1)-Hydroxychlorophyllide a,R08203 R08204 R08914 R08915 R09066,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.294; 1.14.13.122,NA,NA,PubChem: 51090869; ChEBI: 48396,cpd:C16540; cpd:C18156,35,34,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H35O6N4Mg1,C35H33O6N4Mg1,630.2328778,631.2407029,629.22505283186,3523,cpd:C16541,Chlorophyllide b,C35H32MgN4O6,Chlorophyllide b,R08204 R08914 R08915 R09067 R09068 R10080,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.294; 1.14.13.122; 2.5.1.62; 3.1.1.14,NA,NA,PubChem: 51090870; ChEBI: 38209,cpd:C16541,35,32,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H33O6N4Mg1,C35H31O6N4Mg1,628.2172278,629.2250528,627.20940273187,3524,cpd:C17401,Cobalt-factor III,C43H46CoN4O16,Cobalt-factor III,R05808 R08716,Porphyrin and chlorophyll metabolism; Metabolic pathways,2.1.1.151,NA,NA,PubChem: 96023754; ChEBI: 73373,cpd:C17401,43,46,16,4,0,0,0,0,0,0,0,0,0,0,1,0,0,0,C43H47O16N4Co1,C43H45O16N4Co1,933.2240824,934.2319074,932.21625743188,3525,cpd:C18021,Pheophorbide a,C35H36N4O5,Pheophorbide a,R08921 R08974 R08975 R09033 R11227,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.14.15.17; 3.1.1.82,NA,NA,CAS: 15664-29-6; PubChem: 96024241; ChEBI: 38257; ChEMBL: CHEMBL510103; KNApSAcK: C00048505; NIKKAJI: J37.194G J431.514F,cpd:C18021; cpd:C18152,35,36,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H37O5N4,C35H35O5N4,592.2685703,593.2763953,591.26074523189,3526,cpd:C18022,Red chlorophyll catabolite,C35H38N4O7,Red chlorophyll catabolite,R08921 R09032 R11228,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.3.7.12; 1.14.15.17,NA,NA,PubChem: 96024242; ChEBI: 47899; PDB-CCD: RCC,cpd:C18022,35,38,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H39O7N4,C35H37O7N4,626.2740496,627.2818746,625.26622453190,3527,cpd:C18064,Pyropheophorbide a,C33H34N4O3,Pyropheophorbide a,R08974 R08976,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,3.1.1.82,NA,Natural toxins [BR:br08009];  Marine biotoxins;   Others;    Others;     C18064  Pyropheophorbide a,PubChem: 96024283; ChEBI: 48398; ChEMBL: CHEMBL520220; NIKKAJI: J55.605J,cpd:C15096; cpd:C18064,33,34,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H35O3N4,C33H33O3N4,534.263091,535.270916,533.25526593191,3528,cpd:C18098,Primary fluorescent chlorophyll catabolite,C35H40N4O7,Primary fluorescent chlorophyll catabolite,R09032,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.3.7.12,NA,NA,PubChem: 96024315; ChEBI: 47951; NIKKAJI: J1.261.562K J1.261.563I,cpd:C18098,35,40,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H41O7N4,C35H39O7N4,628.2896996,629.2975247,627.28187463192,3529,cpd:C18151,7(1)-Hydroxychlorophyll a;,C55H72MgN4O6,7(1)-Hydroxychlorophyll a; 7-Hydroxymethylchlorophyll a,R09069 R09070 R09071,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.294; 1.17.7.2,NA,NA,PubChem: 96024368; ChEBI: 76032,cpd:C11243; cpd:C18151,55,72,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C55H73O6N4Mg1,C55H71O6N4Mg1,908.5302291,909.5380541,907.5224043193,3530,cpd:C18152,3-Vinylbacteriochlorophyllide a;,C35H36MgN4O5,3-Vinylbacteriochlorophyllide a; 3-Deacetyl-3-vinylbacteriochlorophyllide a,R09053 R09054,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.3.7.15; 4.2.1.165,NA,NA,PubChem: 96024369; ChEBI: 74628,cpd:C18152,35,36,5,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H37O5N4Mg1,C35H35O5N4Mg1,616.2536133,617.2614383,615.24578823194,3531,cpd:C18153,3-Hydroxyethylbacteriochlorophyllide a;,C35H38MgN4O6,3-Hydroxyethylbacteriochlorophyllide a; 3-Deacetyl-3-(1-hydroxyethyl)bacteriochlorophyllide a,R09054 R09055 R09060,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.1.1.396; 1.3.7.15; 4.2.1.165,NA,NA,PubChem: 96024370; ChEBI: 81544,cpd:C18153,35,38,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H39O6N4Mg1,C35H37O6N4Mg1,634.264178,635.272003,633.25635293195,3532,cpd:C18154,3-Hydroxyethylchlorophyllide a;,C35H36MgN4O6,3-Hydroxyethylchlorophyllide a; 3-Devinyl-3-(1-hydroxyethyl)chlorophyllide a,R09059 R09060,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.3.7.15; 4.2.1.165,NA,NA,PubChem: 96024371; ChEBI: 81545,cpd:C18154; cpd:C18155,35,36,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H37O6N4Mg1,C35H35O6N4Mg1,632.2485279,633.2563529,631.24070293196,3533,cpd:C18155,Bacteriochlorophyllide a,C35H36MgN4O6,Bacteriochlorophyllide a,R09055 R09056 R11514,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.1.1.396; 2.5.1.133,NA,NA,PubChem: 96024372; ChEBI: 81546,cpd:C18154; cpd:C18155,35,36,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H37O6N4Mg1,C35H35O6N4Mg1,632.2485279,633.2563529,631.24070293197,3534,cpd:C18156,Bacteriochlorophyllide b,C35H34MgN4O6,Bacteriochlorophyllide b,R09056 R11517,Porphyrin and chlorophyll metabolism,2.5.1.133,NA,NA,PubChem: 96024373; ChEBI: 81547,cpd:C16540; cpd:C18156,35,34,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H35O6N4Mg1,C35H33O6N4Mg1,630.2328778,631.2407029,629.22505283198,3535,cpd:C18157,8-Ethyl-12-methyl-3-vinylbacteriochlorophyllide d,C33H32MgN4O3,8-Ethyl-12-methyl-3-vinylbacteriochlorophyllide d,R09061 R11507 R11510,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,2.1.1.331; 3.1.1.100; 4.2.1.169,NA,NA,PubChem: 96024374; ChEBI: 81548,cpd:C18157,33,32,3,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C33H33O3N4Mg1,C33H31O3N4Mg1,556.2324839,557.2403089,555.22465893199,3540,cpd:C21217,Geranylgeranyl bacteriochlorophyllide a,C55H68MgN4O6,Geranylgeranyl bacteriochlorophyllide a,R11226 R11514,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,1.3.1.111; 2.5.1.133,NA,NA,PubChem: 315431332,cpd:C21217,55,68,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C55H69O6N4Mg1,C55H67O6N4Mg1,904.4989289,905.506754,903.49110393200,3541,cpd:C21284,Fe-coproporphyrin III;,C36H36FeN4O8,Fe-coproporphyrin III; Coproheme III,R11329 R11522,Porphyrin and chlorophyll metabolism; Metabolic pathways; Biosynthesis of secondary metabolites,1.11.1.-; 4.99.1.9,NA,NA,PubChem: 318172264,cpd:C21284,36,36,8,4,0,0,0,0,0,0,0,0,0,1,0,0,0,0,C36H37O8N4Fe1,C36H35O8N4Fe1,708.1866101,709.1944352,707.17878513201,3542,cpd:C21427,"8,12-Diethyl-3-vinylbacteriochlorophyllide d",C34H34MgN4O3,"8,12-Diethyl-3-vinylbacteriochlorophyllide d",R11507 R11508 R11511,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,2.1.1.331; 2.1.1.332; 4.2.1.169,NA,NA,PubChem: 329728050,cpd:C21427,34,34,3,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C34H35O3N4Mg1,C34H33O3N4Mg1,570.248134,571.255959,569.24030893202,3543,cpd:C21428,12-Ethyl-8-propyl-3-vinylbacteriochlorophyllide d,C35H36MgN4O3,12-Ethyl-8-propyl-3-vinylbacteriochlorophyllide d,R11508 R11509 R11512,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,2.1.1.332; 4.2.1.169,NA,NA,PubChem: 329728051,cpd:C21428,35,36,3,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H37O3N4Mg1,C35H35O3N4Mg1,584.263784,585.2716091,583.2559593203,3544,cpd:C21429,12-Ethyl-8-isobutyl-3-vinylbacteriochlorophyllide d,C36H38MgN4O3,12-Ethyl-8-isobutyl-3-vinylbacteriochlorophyllide d,R11509 R11513,Porphyrin and chlorophyll metabolism; Biosynthesis of secondary metabolites,2.1.1.332; 4.2.1.169,NA,NA,PubChem: 329728052,cpd:C21429,36,38,3,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C36H39O3N4Mg1,C36H37O3N4Mg1,598.2794341,599.2872591,597.27160913204,3545,cpd:C21431,8-Ethyl-12-methylbacteriochlorophyllide d,C33H34MgN4O4,8-Ethyl-12-methylbacteriochlorophyllide d,R11510,Porphyrin and chlorophyll metabolism,4.2.1.169,NA,NA,PubChem: 329728054,cpd:C21431,33,34,4,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C33H35O4N4Mg1,C33H33O4N4Mg1,574.2430486,575.2508736,573.23522363205,3546,cpd:C21432,"8,12-Diethylbacteriochlorophyllide d",C34H36MgN4O4,"8,12-Diethylbacteriochlorophyllide d",R11511,Porphyrin and chlorophyll metabolism,4.2.1.169,NA,NA,PubChem: 329728055,cpd:C21432,34,36,4,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C34H37O4N4Mg1,C34H35O4N4Mg1,588.2586987,589.2665237,587.25087363206,3547,cpd:C21433,12-Ethyl-8-propylbacteriochlorophyllide d,C35H38MgN4O4,12-Ethyl-8-propylbacteriochlorophyllide d,R11512,Porphyrin and chlorophyll metabolism,4.2.1.169,NA,NA,PubChem: 329728056,cpd:C21433,35,38,4,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C35H39O4N4Mg1,C35H37O4N4Mg1,602.2743487,603.2821738,601.26652373207,3548,cpd:C21434,12-Ethyl-8-isobutylbacteriochlorophyllide d,C36H40MgN4O4,12-Ethyl-8-isobutylbacteriochlorophyllide d,R11513,Porphyrin and chlorophyll metabolism,4.2.1.169,NA,NA,PubChem: 329728057,cpd:C21434,36,40,4,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C36H41O4N4Mg1,C36H39O4N4Mg1,616.2899988,617.2978238,615.28217383208,3549,cpd:C21435,Geranylgeranyl bacteriochlorophyllide b,C55H66MgN4O6,Geranylgeranyl bacteriochlorophyllide b,R11517 R11518,Porphyrin and chlorophyll metabolism,1.3.1.111; 2.5.1.133,NA,NA,PubChem: 329728058,cpd:C21435,55,66,6,4,0,0,0,0,0,0,0,0,0,0,0,1,0,0,C55H67O6N4Mg1,C55H65O6N4Mg1,902.4832789,903.4911039,901.47545383209,3550,cpd:C00129,Isopentenyl diphosphate;,C5H12O7P2,Isopentenyl diphosphate; Delta3-Isopentenyl diphosphate; Delta3-Methyl-3-butenyl diphosphate,R01121 R01123 R01658 R01659 R02003 R02061 R03917 R05555; R05556 R05611 R05612 R05613 R05884 R06447 R07267 R07269; R07475 R08400 R08528 R08747 R08748 R08749 R08750 R08751; R08752 R08753 R09244 R09245 R09246 R09247 R09248 R09249; R09250 R09251 R09633 R09730 R09731 R10093,Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.17.7.4; 2.5.1.1; 2.5.1.10; 2.5.1.20; 2.5.1.28; 2.5.1.29; 2.5.1.30; 2.5.1.31; 2.5.1.68; 2.5.1.81; 2.5.1.82; 2.5.1.83; 2.5.1.84; 2.5.1.85; 2.5.1.86; 2.5.1.87; 2.5.1.88; 2.5.1.89; 2.5.1.90; 2.5.1.91; 2.5.1.92; 2.5.1.-; 2.7.4.26; 4.1.1.33; 5.3.3.2,"C5 isoprenoid biosynthesis, mevalonate pathway; C5 isoprenoid biosynthesis, non-mevalonate pathway; C10-C20 isoprenoid biosynthesis, bacteria; C10-C20 isoprenoid biosynthesis, archaea; C10-C20 isoprenoid biosynthesis, plants; C10-C20 isoprenoid biosynthesis, non-plant eukaryotes",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0101 C5 isoprenoids (hemiterpenes);     C00129  Isopentenyl diphosphate,CAS: 358-71-4; PubChem: 3429; ChEBI: 16584; ChEMBL: CHEMBL356362; LIPIDMAPS: LMPR01010008; LipidBank: IIP0001; KNApSAcK: C00000848; PDB-CCD: IPE; 3DMET: B00035; NIKKAJI: J38.556E,cpd:C00129; cpd:C00235; cpd:C04093; cpd:C05847,5,12,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O7P2,C5H11O7P2,246.0058267,247.0136518,244.99800173210,3551,cpd:C00235,Dimethylallyl diphosphate;,C5H12O7P2,Dimethylallyl diphosphate; 2-Isopentenyl diphosphate; Delta2-Isopentenyl diphosphate; Dimethylallyl pyrophosphate; DMAPP; Monoprenyl diphosphate; Prenyl diphosphate,R01122 R01123 R01657 R01658 R01659 R02943 R03799 R04038; R06757 R07271 R07272 R08003 R08051 R08052 R08199 R08210; R08948 R08950 R08951 R08952 R09633 R09638 R10201 R10340; R10341 R10360 R10365 R10369 R10370 R10380 R10383 R10384; R10456 R10457 R10966 R10968,Terpenoid backbone biosynthesis; Zeatin biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.17.7.4; 2.5.1.1; 2.5.1.27; 2.5.1.28; 2.5.1.34; 2.5.1.35; 2.5.1.36; 2.5.1.67; 2.5.1.69; 2.5.1.70; 2.5.1.71; 2.5.1.75; 2.5.1.80; 2.5.1.92; 2.5.1.100; 2.5.1.106; 2.5.1.107; 2.5.1.109; 2.5.1.110; 2.5.1.111; 2.5.1.112; 2.5.1.121; 2.5.1.122; 2.5.1.-; 4.2.3.27; 5.3.3.2,"C5 isoprenoid biosynthesis, mevalonate pathway; C5 isoprenoid biosynthesis, non-mevalonate pathway; C10-C20 isoprenoid biosynthesis, bacteria; C10-C20 isoprenoid biosynthesis, archaea; C10-C20 isoprenoid biosynthesis, plants; C10-C20 isoprenoid biosynthesis, non-plant eukaryotes",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0101 C5 isoprenoids (hemiterpenes);     C00235  Dimethylallyl diphosphate,CAS: 358-72-5; PubChem: 3534; ChEBI: 16057; ChEMBL: CHEMBL343480; LIPIDMAPS: LMPR01010001; LipidBank: IIP0002; KNApSAcK: C00007294; PDB-CCD: DMA; 3DMET: B01196; NIKKAJI: J39.581A,cpd:C00129; cpd:C00235; cpd:C04093; cpd:C05847,5,12,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O7P2,C5H11O7P2,246.0058267,247.0136518,244.99800173211,3552,cpd:C00418,(R)-Mevalonate;,C6H12O4,"(R)-Mevalonate; Mevalonic acid; 3,5-Dihydroxy-3-methylvaleric acid",R02081 R02082 R02245 R02246 R02247 R10779,Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.1.1.32; 1.1.1.33; 1.1.1.34; 1.1.1.88; 2.7.1.36; 2.7.1.185,"C5 isoprenoid biosynthesis, mevalonate pathway",NA,CAS: 17817-88-8; PubChem: 3708; ChEBI: 17710 36464; LIPIDMAPS: LMFA01050352; KNApSAcK: C00001195; PDB-CCD: MEV; 3DMET: B01241; NIKKAJI: J5.859I,cpd:C00418; cpd:C00491; cpd:C00522; cpd:C01100; cpd:C01420; cpd:C02104; cpd:C03089; cpd:C03348; cpd:C04104; cpd:C05704; cpd:C06007; cpd:C06471; cpd:C13522; cpd:C14445; cpd:C18988; cpd:C19719; cpd:C21045; cpd:C21054; cpd:C21055; cpd:C21062; cpd:C21397,6,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O4,C6H11O4,148.0735589,149.0813839,147.06573383212,3553,cpd:C01107,(R)-5-Phosphomevalonate;,C6H13O7P,(R)-5-Phosphomevalonate; (R)-5-Phosphomevaloonic acid; (R)-Mevalonic acid 5-phosphate,R02245 R03245 R10561,Terpenoid backbone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.7.1.36; 2.7.4.2; 4.1.1.99,"C5 isoprenoid biosynthesis, mevalonate pathway",NA,PubChem: 4339; ChEBI: 17436; LIPIDMAPS: LMFA01050415; KNApSAcK: C00007304; PDB-CCD: PMV; 3DMET: B01383; NIKKAJI: J956.436E,cpd:C01107; cpd:C04188; cpd:C04438; cpd:C04582; cpd:C05973; cpd:C18911; cpd:C20847,6,13,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O7P1,C6H12O7P1,228.0398898,229.0477148,227.03206473213,3554,cpd:C01126,"(2E,6E)-Farnesol;",C15H26O,"(2E,6E)-Farnesol; 2-trans,6-trans-Farnesol; trans-Farnesol",R03264 R03265 R08144 R08697 R09848 R09849 R10412 R11381,Terpenoid backbone biosynthesis; Sesquiterpenoid and triterpenoid biosynthesis; Insect hormone biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.1.1.216; 1.1.1.354; 1.1.3.-; 2.7.1.-; 3.1.3.-; 3.1.7.6; 5.2.1.9,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010301 Acyclic farnesane sesquiterpenoids;      C01126  2-trans,6-trans-Farnesol; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Farnesenes;     C01126  trans-Farnesol",CAS: 106-28-5; PubChem: 4357; ChEBI: 16619; ChEMBL: CHEMBL25308; LipidBank: IIP0051; KNApSAcK: C00003132 C00035092; 3DMET: B00244; NIKKAJI: J5.049K,cpd:C01126; cpd:C03220; cpd:C09621; cpd:C09628; cpd:C09631; cpd:C09651; cpd:C09663; cpd:C09664; cpd:C09676; cpd:C09682; cpd:C09698; cpd:C09704; cpd:C09705; cpd:C10771; cpd:C10780; cpd:C16143; cpd:C16813; cpd:C16970; cpd:C17124; cpd:C17193; cpd:C18245; cpd:C19743; cpd:C19744; cpd:C19746; cpd:C19755; cpd:C19756; cpd:C19893; cpd:C19974; cpd:C20172; cpd:C20181; cpd:C20184; cpd:C20479; cpd:C20576,15,26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O1,C15H25O1,222.1983655,223.2061905,221.19054043214,3555,cpd:C01143,(R)-5-Diphosphomevalonate,C6H14O10P2,(R)-5-Diphosphomevalonate,R01121 R03245,Terpenoid backbone biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.7.4.2; 4.1.1.33,"C5 isoprenoid biosynthesis, mevalonate pathway",NA,PubChem: 4374; ChEBI: 15899; ChEMBL: CHEMBL235881; LIPIDMAPS: LMFA01050416; KNApSAcK: C00007615; PDB-CCD: DP6; 3DMET: B01392; NIKKAJI: J2.731.654I,cpd:C01143; cpd:C20423; cpd:C20848,6,14,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O10P2,C6H13O10P2,308.0062206,309.0140457,306.99839563215,3557,cpd:C03461,"2-trans,6-trans-Farnesal;",C15H24O,"2-trans,6-trans-Farnesal; trans,trans-Farnesal; Farnesal; (2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienal; (2E,6E)-Farnesal",R03264 R08146 R09562 R09848 R10412 R11381,Terpenoid backbone biosynthesis; Sesquiterpenoid and triterpenoid biosynthesis; Insect hormone biosynthesis; Biosynthesis of antibiotics,1.1.1.216; 1.1.1.354; 1.1.3.-; 1.2.1.3; 1.8.3.5; 1.8.3.6,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010301 Acyclic farnesane sesquiterpenoids;      C03461  2-trans,6-trans-Farnesal; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Farnesenes;     C03461  2-trans,6-trans-Farnesal",CAS: 502-67-0; PubChem: 6281; ChEBI: 15894; LIPIDMAPS: LMPR0103010012; KNApSAcK: C00030246 C00035091; 3DMET: B00588; NIKKAJI: J102.721B,cpd:C03461; cpd:C09719; cpd:C09720; cpd:C10752; cpd:C10772; cpd:C10774; cpd:C14550; cpd:C14693; cpd:C16908; cpd:C16945; cpd:C16974; cpd:C17442; cpd:C17462; cpd:C17915; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19676; cpd:C19711; cpd:C19938; cpd:C20229; cpd:C20307; cpd:C20325,15,24,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O1,C15H23O1,220.1827154,221.1905404,219.17489043216,3558,cpd:C04216,all-trans-Heptaprenyl diphosphate,C35H60O7P2,all-trans-Heptaprenyl diphosphate,R05611 R05612 R09247 R10009,Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.30; 2.5.1.-; 4.2.3.130,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Others;    Polyterpenoids;     C04216  all-trans-Heptaprenyl diphosphate,PubChem: 6889; ChEBI: 17613; LIPIDMAPS: LMPR03030006; 3DMET: B01723; NIKKAJI: J1.002.608C,cpd:C04216; cpd:C17436,35,60,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H61O7P2,C35H59O7P2,654.3814283,655.3892533,653.37360323217,3562,cpd:C11434,2-C-Methyl-D-erythritol 4-phosphate,C5H13O7P,2-C-Methyl-D-erythritol 4-phosphate,R05633 R05688,Terpenoid backbone biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.1.1.267; 2.7.7.60,"C5 isoprenoid biosynthesis, non-mevalonate pathway",NA,PubChem: 13606; ChEBI: 17764; KNApSAcK: C00007297; 3DMET: B04262; NIKKAJI: J865.583I,cpd:C11434,5,13,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H14O7P1,C5H12O7P1,216.0398898,217.0477148,215.03206473218,3563,cpd:C11435,4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol,C14H25N3O14P2,4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol,R05633 R05634,Terpenoid backbone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.7.1.148; 2.7.7.60,"C5 isoprenoid biosynthesis, non-mevalonate pathway",NA,PubChem: 13607; ChEBI: 16578; KNApSAcK: C00034394; PDB-CCD: CDM; 3DMET: B04263; NIKKAJI: J1.231.800F,cpd:C11435,14,25,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H26O14N3P2,C14H24O14N3P2,521.0811765,522.0890015,520.07335153219,3564,cpd:C11436,2-Phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol,C14H26N3O17P3,2-Phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol,R05634 R05637,Terpenoid backbone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.7.1.148; 4.6.1.12,"C5 isoprenoid biosynthesis, non-mevalonate pathway",NA,PubChem: 13608; ChEBI: 16840; PDB-CCD: SUD; 3DMET: B04264; NIKKAJI: J1.304.453H,cpd:C11436,14,26,17,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H27O17N3P3,C14H25O17N3P3,601.0475074,602.0553324,600.03968233220,3565,cpd:C11453,"2-C-Methyl-D-erythritol 2,4-cyclodiphosphate;",C5H12O9P2,"2-C-Methyl-D-erythritol 2,4-cyclodiphosphate; 3-Methyl-1,2,3,4-tetrahydroxybutane-1,3-cyclic bisphosphate",R05637 R08689 R10859,Terpenoid backbone biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.17.7.1; 1.17.7.3; 4.6.1.12,"C5 isoprenoid biosynthesis, non-mevalonate pathway",NA,CAS: 143488-44-2; PubChem: 13625; ChEBI: 18425; KNApSAcK: C00007295; PDB-CCD: CDI; 3DMET: B04266; NIKKAJI: J726.915C,cpd:C11453,5,12,9,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O9P2,C5H11O9P2,277.995656,279.003481,276.98783093221,3566,cpd:C11811,1-Hydroxy-2-methyl-2-butenyl 4-diphosphate;,C5H12O8P2,1-Hydroxy-2-methyl-2-butenyl 4-diphosphate; (E)-4-Hydroxy-3-methyl-but-2-enyl diphosphate; (E)-4-Hydroxy-3-methylbut-2-en-1-yl diphosphate,R05884 R08210 R08689 R10859,Terpenoid backbone biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.17.7.1; 1.17.7.3; 1.17.7.4,"C5 isoprenoid biosynthesis, non-mevalonate pathway",NA,PubChem: 13975; ChEBI: 15664; ChEMBL: CHEMBL145233; LIPIDMAPS: LMPR01010009; KNApSAcK: C00007567; PDB-CCD: H6P; 3DMET: B04320; NIKKAJI: J1.669.907A,cpd:C11811,5,12,8,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H13O8P2,C5H11O8P2,262.0007413,263.0085664,260.99291633222,3567,cpd:C16521,Isoprene;,C5H8,"Isoprene; 2-Methyl-1,3-butadiene",R08199,Terpenoid backbone biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,4.2.3.27,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Hemiterpenoids (C5);    C16521  Isoprene; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C16521  Isoprene,CAS: 78-79-5; PubChem: 51090850; ChEBI: 35194; ChEMBL: CHEMBL1566132; KNApSAcK: C00046784; PDB-CCD: 61G; NIKKAJI: J1.958E,cpd:C00039; cpd:C00046; cpd:C00066; cpd:C00110; cpd:C00141; cpd:C00172; cpd:C00351; cpd:C00381; cpd:C00390; cpd:C00399; cpd:C00419; cpd:C00434; cpd:C00438; cpd:C00444; cpd:C00489; cpd:C00557; cpd:C00621; cpd:C00652; cpd:C00684; cpd:C00707; cpd:C00815; cpd:C00821; cpd:C00828; cpd:C00856; cpd:C00868; cpd:C00871; cpd:C00886; cpd:C00900; cpd:C00906; cpd:C00929; cpd:C00938; cpd:C00960; cpd:C01048; cpd:C01087; cpd:C01114; cpd:C01180; cpd:C01191; cpd:C01196; cpd:C01199; cpd:C01240; cpd:C01246; cpd:C01764; cpd:C01884; cpd:C01931; cpd:C01972; cpd:C01977; cpd:C01978; cpd:C02031; cpd:C02047; cpd:C02056; cpd:C02061; cpd:C02073; cpd:C02100; cpd:C02128; cpd:C02163; cpd:C02211; cpd:C02233; cpd:C02240; cpd:C02266; cpd:C02270; cpd:C02282; cpd:C02321; cpd:C02339; cpd:C02352; cpd:C02374; cpd:C02377; cpd:C02410; cpd:C02412; cpd:C02430; cpd:C02447; cpd:C02521; cpd:C02536; cpd:C02553; cpd:C02554; cpd:C02612; cpd:C02614; cpd:C02630; cpd:C02674; cpd:C02702; cpd:C02707; cpd:C02753; cpd:C02764; cpd:C02789; cpd:C02839; cpd:C02867; cpd:C02905; cpd:C02928; cpd:C02967; cpd:C02984; cpd:C02987; cpd:C02988; cpd:C02992; cpd:C02994; cpd:C03110; cpd:C03125; cpd:C03127; cpd:C03196; cpd:C03273; cpd:C03294; cpd:C03391; cpd:C03402; cpd:C03409; cpd:C03446; cpd:C03463; cpd:C03475; cpd:C03511; cpd:C03512; cpd:C03589; cpd:C03617; cpd:C03638; cpd:C03730; cpd:C03799; cpd:C03800; cpd:C03826; cpd:C03862; cpd:C03880; cpd:C03924; cpd:C03983; cpd:C04075; cpd:C04093; cpd:C04106; cpd:C04117; cpd:C04152; cpd:C04153; cpd:C04154; cpd:C04155; cpd:C04156; cpd:C04157; cpd:C04158; cpd:C04159; cpd:C04160; cpd:C04181; cpd:C04209; cpd:C04212; cpd:C04213; cpd:C04239; cpd:C04250; cpd:C04258; cpd:C04312; cpd:C04328; cpd:C04365; cpd:C04381; cpd:C04432; cpd:C04500; cpd:C04510; cpd:C04511; cpd:C04537; cpd:C04545; cpd:C04615; cpd:C04678; cpd:C04696; cpd:C04728; cpd:C04779; cpd:C04802; cpd:C04833; cpd:C05156; cpd:C05157; cpd:C05336; cpd:C05405; cpd:C05715; cpd:C05717; cpd:C05727; cpd:C05807; cpd:C05808; cpd:C05818; cpd:C05819; cpd:C05847; cpd:C05848; cpd:C05859; cpd:C05860; cpd:C05861; cpd:C05864; cpd:C05868; cpd:C06010; cpd:C06029; cpd:C06031; cpd:C06032; cpd:C06081; cpd:C06112; cpd:C06113; cpd:C06255; cpd:C06481; cpd:C06482; cpd:C06556; cpd:C06558; cpd:C06751; cpd:C07330; cpd:C07764; cpd:C08279; cpd:C08298; cpd:C11074; cpd:C11345; cpd:C11475; cpd:C11478; cpd:C11838; cpd:C12470; cpd:C12518; cpd:C13726; cpd:C14527; cpd:C15499; cpd:C15604; cpd:C16140; cpd:C16250; cpd:C16467; cpd:C16521; cpd:C16638; cpd:C16669; cpd:C16691; cpd:C16693; cpd:C17022; cpd:C17027; cpd:C17322; cpd:C17323; cpd:C17324; cpd:C17325; cpd:C17509; cpd:C17510; cpd:C17551; cpd:C17552; cpd:C17554; cpd:C17559; cpd:C17560; cpd:C17561; cpd:C17562; cpd:C17927; cpd:C18006; cpd:C18061; cpd:C18450; cpd:C19078; cpd:C19080; cpd:C19085; cpd:C19238; cpd:C19483; cpd:C19485; cpd:C19504; cpd:C19722; cpd:C19723; cpd:C19776; cpd:C19803; cpd:C19847; cpd:C19853; cpd:C19858; cpd:C19859; cpd:C19885; cpd:C20232; cpd:C20265; cpd:C20446; cpd:C20451; cpd:C20458; cpd:C20459; cpd:C20580; cpd:C20647; cpd:C20648; cpd:C20649; cpd:C20652; cpd:C20659; cpd:C20660; cpd:C20661; cpd:C20662; cpd:C20688; cpd:C20691; cpd:C20751; cpd:C20752; cpd:C20753; cpd:C20754; cpd:C20755; cpd:C20796; cpd:C20846; cpd:C20862; cpd:C20863; cpd:C20864; cpd:C21028; cpd:C21031; cpd:C21177; cpd:C21212; cpd:C21213; cpd:C21373,5,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9,C5H7,68.06260026,69.07042529,67.054775233223,3568,cpd:C16826,"2-cis,6-trans-Farnesyl diphosphate;",C15H28O7P2,"2-cis,6-trans-Farnesyl diphosphate; (2Z,6E)-Farnesyl diphosphate",R08528 R08746 R09244 R09610 R09731,Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.68; 2.5.1.86; 2.5.1.88; 4.2.3.62,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010301 Acyclic farnesane sesquiterpenoids;      C16826  2-cis,6-trans-Farnesyl diphosphate",PubChem: 96023350; ChEBI: 19515; ChEMBL: CHEMBL1160060; NIKKAJI: J1.333.744F,cpd:C00448; cpd:C06111; cpd:C16826; cpd:C19760; cpd:C19853,15,28,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H29O7P2,C15H27O7P2,382.1310272,383.1388523,381.12320223224,3569,cpd:C18321,"(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-Decaprenyl diphosphate",C50H84O7P2,"(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-Decaprenyl diphosphate",R09244,Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.86,NA,NA,PubChem: 103061503; ChEBI: 81671; LIPIDMAPS: LMPR03030011,cpd:C04509; cpd:C17432; cpd:C18321,50,84,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C50H85O7P2,C50H83O7P2,858.569229,859.5770541,857.5614043225,3570,cpd:C19691,Farnesylcysteine;,C18H31NO2S,"Farnesylcysteine; S-(2E,6E)-Farnesyl-L-cysteine; S-trans-trans-Farnesylcysteine",R09562 R09847,Terpenoid backbone biosynthesis; Biosynthesis of antibiotics,1.8.3.5; 1.8.3.6,NA,NA,CAS: 68000-92-0; PubChem: 135626159,cpd:C19691,18,31,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C18H32O2N1S1,C18H30O2N1S1,325.2075504,326.2153754,324.19972543226,3571,cpd:C19760,"(2Z,6Z)-Farnesyl diphosphate",C15H28O7P2,"(2Z,6Z)-Farnesyl diphosphate",R09607 R09608 R09609 R09633 R10284,Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites,2.5.1.92; 4.2.3.50; 4.2.3.53; 4.2.3.54; 4.2.3.142,NA,"Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Farnesenes;     C19760  (2Z,6Z)-Farnesyl diphosphate",PubChem: 135626227,cpd:C00448; cpd:C06111; cpd:C16826; cpd:C19760; cpd:C19853,15,28,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H29O7P2,C15H27O7P2,382.1310272,383.1388523,381.12320223227,3572,cpd:C19852,"tritrans,heptacis-Undecaprenyl diphosphate",C55H92O7P2,"tritrans,heptacis-Undecaprenyl diphosphate",R09730,Terpenoid backbone biosynthesis,2.5.1.89,NA,NA,PubChem: 135626319; ChEBI: 70764,cpd:C04574; cpd:C19852,55,92,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C55H93O7P2,C55H91O7P2,926.6318293,927.6396543,925.62400433228,3575,cpd:C20121,"trans,trans-Farnesyl phosphate;",C15H27O4P,"trans,trans-Farnesyl phosphate; Farnesyl phosphate; (2E,6E)-Farnesyl phosphate",R09849 R09850,Terpenoid backbone biosynthesis; Biosynthesis of antibiotics,2.7.1.-,NA,NA,PubChem: 135626581; ChEBI: 90236,cpd:C20121,15,27,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H28O4P1,C15H26O4P1,302.1646963,303.1725214,301.15687133229,3576,cpd:C20345,Isopentenyl phosphate,C5H11O4P,Isopentenyl phosphate,R10093 R10561 R10781,Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.7.4.26; 4.1.1.99,NA,NA,PubChem: 163312083; ChEMBL: CHEMBL342070; PDB-CCD: IP8,cpd:C01048; cpd:C20345; cpd:C21214,5,11,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O4P1,C5H10O4P1,166.0394958,167.0473209,165.03167083230,3577,cpd:C20847,(R)-Mevalonate 3-phosphate;,C6H13O7P,(R)-Mevalonate 3-phosphate; (R)-3-Phosphomevalonate,R10779 R10780,Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.7.1.185; 2.7.1.186,NA,NA,PubChem: 254741313; PDB-CCD: 3S4,cpd:C01107; cpd:C04188; cpd:C04438; cpd:C04582; cpd:C05973; cpd:C18911; cpd:C20847,6,13,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O7P1,C6H12O7P1,228.0398898,229.0477148,227.03206473231,3578,cpd:C20848,"(R)-Mevalonate 3,5-bisphosphate;",C6H14O10P2,"(R)-Mevalonate 3,5-bisphosphate; (R)-3,5-Diphosphomevalonate; (R)-3,5-Bisphosphomevalonate",R10780 R10781,Terpenoid backbone biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,2.7.1.186,NA,NA,PubChem: 254741314,cpd:C01143; cpd:C20423; cpd:C20848,6,14,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O10P2,C6H13O10P2,308.0062206,309.0140457,306.99839563232,3579,cpd:C01091,Deacetylvindoline;,C23H30N2O5,Deacetylvindoline; 17-O-Deacetylvindoline; Desacetylvindoline,R03229 R03230 R05857,Indole alkaloid biosynthesis,1.14.11.20; 2.1.1.94; 2.3.1.107,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C01091  Deacetylvindoline,PubChem: 4326; ChEBI: 18362; KNApSAcK: C00024529; 3DMET: B01376; NIKKAJI: J833.365C,cpd:C01091,23,30,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H31O5N2,C23H29O5N2,414.2154721,415.2232971,413.2076473233,3580,cpd:C01626,Vindoline,C25H32N2O6,Vindoline,R03230 R05858,Indole alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway,2.3.1.107,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C01626  Vindoline; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Indole alkaloids;     C01626  Vindoline,CAS: 2182-14-1; PubChem: 4777; ChEBI: 16380; ChEMBL: CHEMBL1317962 CHEMBL2001832 CHEMBL526546; KNApSAcK: C00001784 C00024613; 3DMET: B01473; NIKKAJI: J215.732B,cpd:C01626,25,32,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H33O6N2,C25H31O6N2,456.2260368,457.2338618,455.21821173234,3581,cpd:C01761,Vomilenine,C21H22N2O3,Vomilenine,R03703 R05877 R05878 R05882,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.5.1.32; 1.14.13.75; 2.4.1.219; 3.2.1.125,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C01761  Vomilenine,CAS: 6880-50-8; PubChem: 4894; ChEBI: 16408; KNApSAcK: C00024322 C00024338; 3DMET: B01494; NIKKAJI: J358.663D,cpd:C01761; cpd:C11632; cpd:C11680; cpd:C11681; cpd:C19932,21,22,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O3N2,C21H21O3N2,350.1630426,351.1708676,349.15521753235,3582,cpd:C01852,Secologanin;,C17H24O10,Secologanin; (-)-Secologanin,R03555 R03738 R05749 R05750 R05834 R08500,Indole alkaloid biosynthesis; Monoterpenoid biosynthesis; Isoquinoline alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of alkaloids derived from terpenoid and polyketide; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.9; 2.1.1.50; 4.3.3.2; 4.3.3.3; 4.3.3.4,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;      C01852  Secologanin; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Secoiridoids;     C01852  Secologanin",CAS: 19351-63-4; PubChem: 4969; ChEBI: 18002; LIPIDMAPS: LMPR0102070002; KNApSAcK: C00003098; PDB-CCD: SCG; 3DMET: B01508; NIKKAJI: J15.538A,cpd:C01852; cpd:C01978; cpd:C09781; cpd:C09802,17,24,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H25O10,C17H23O10,388.136947,389.144772,387.12912193236,3583,cpd:C02074,Raucaffricine;,C27H32N2O8,Raucaffricine; Vomilenine beta-D-glucoside,R03703 R05882,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,2.4.1.219; 3.2.1.125,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C02074  Raucaffricine,CAS: 31282-07-2; PubChem: 5160; ChEBI: 17400; KNApSAcK: C00024300 C00024346; 3DMET: B01530; NIKKAJI: J342.469C,cpd:C02074,27,32,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H33O8N2,C27H31O8N2,512.215866,513.223691,511.2080413237,3584,cpd:C02151,Geissoschizine,C21H24N2O3,Geissoschizine,R03860 R05829,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.36,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C02151  Geissoschizine,CAS: 439-66-7; PubChem: 5228; ChEBI: 17037; 3DMET: B01540; NIKKAJI: J11.376J,cpd:C02151; cpd:C09024; cpd:C09026; cpd:C09253; cpd:C11642; cpd:C11643; cpd:C11676; cpd:C11682; cpd:C11683; cpd:C11808; cpd:C15086; cpd:C19931,21,24,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O3N2,C21H23O3N2,352.1786926,353.1865177,351.17086763238,3585,cpd:C02673,Desacetoxyvindoline;,C23H30N2O4,"Desacetoxyvindoline; 16-Methoxy-2,3-dihydro-3-hydroxy-N-methyltabersonine; Deacetoxyvindoline",R04013 R05857,Indole alkaloid biosynthesis,1.14.11.20; 2.1.1.99,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C02673  Desacetoxyvindoline,PubChem: 5644; ChEBI: 16957; 3DMET: B01593; NIKKAJI: J2.354.396F,cpd:C02673; cpd:C09226,23,30,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H31O4N2,C23H29O4N2,398.2205575,399.2283825,397.21273243239,3586,cpd:C03309,Strictosidine aglycone,C21H24N2O4,Strictosidine aglycone,R03820 R05844,Indole alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,3.2.1.105,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C03309  Strictosidine aglycone,CAS: 85925-13-9; PubChem: 6162; ChEBI: 17096; 3DMET: B01650; NIKKAJI: J2.741.534B,cpd:C03309; cpd:C09045; cpd:C09227; cpd:C11677; cpd:C11678; cpd:C17593; cpd:C17594; cpd:C17595; cpd:C17596; cpd:C17597; cpd:C17598,21,24,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O4N2,C21H23O4N2,368.1736073,369.1814323,367.16578223240,3587,cpd:C03470,3-alpha(S)-Strictosidine;,C27H34N2O9,3-alpha(S)-Strictosidine; Strictosidine,R03738 R03820 R08487 R08495 R08496,Indole alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,3.2.1.105; 4.3.3.2,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C03470  3-alpha(S)-Strictosidine,CAS: 20824-29-7; PubChem: 6287; ChEBI: 17559; ChEMBL: CHEMBL402211; KNApSAcK: C00029058; 3DMET: B01662; NIKKAJI: J15.956E,cpd:C03470,27,34,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H35O9N2,C27H33O9N2,530.2264307,531.2342557,529.21860563241,3588,cpd:C03677,"4,21-Dehydrogeissoschizine",C21H23N2O3,"4,21-Dehydrogeissoschizine",R03860 R05824 R05846 R05852 R05873,Indole alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.36,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C03677  4,21-Dehydrogeissoschizine",CAS: 73385-56-5; PubChem: 6452; ChEBI: 17294; 3DMET: B01684; NIKKAJI: J82.188H,cpd:C03677; cpd:C11679,21,23,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H24O3N2,C21H22O3N2,351.1708676,352.1786926,350.16304263242,3589,cpd:C04578,"16-Methoxy-2,3-dihydro-3-hydroxytabersonine",C22H28N2O4,"16-Methoxy-2,3-dihydro-3-hydroxytabersonine",R04013 R05856,Indole alkaloid biosynthesis,2.1.1.99,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C04578  16-Methoxy-2,3-dihydro-3-hydroxytabersonine",PubChem: 7179; ChEBI: 18430; 3DMET: B01762; NIKKAJI: J2.752.044H,cpd:C04578; cpd:C09236; cpd:C16980,22,28,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H29O4N2,C22H27O4N2,384.2049074,385.2127324,383.19708243243,3590,cpd:C06542,Ajmaline,C20H26N2O2,Ajmaline,R05881 R07513,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,3.1.1.80,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C06542  Ajmaline; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01B ANTIARRHYTHMICS, CLASS I AND III;     C01BA Antiarrhythmics, class Ia;      C01BA05 Ajmaline;       D00199  Ajmaline (JP17); Target-based classification of drugs [BR:br08310];  Ion channels;   Voltage-gated cation channels;    Na+ channel, SCN alpha, NaV1.x;     voltage-gated sodium channel (SCN1A);      Ajmaline;       D00199  Ajmaline (JP17);     voltage-gated sodium channel (SCN2A);      Ajmaline;       D00199  Ajmaline (JP17);     voltage-gated sodium channel (SCN3A);      Ajmaline;       D00199  Ajmaline (JP17);     voltage-gated sodium channel (SCN4A);      Ajmaline;       D00199  Ajmaline (JP17);     voltage-gated sodium channel (SCN5A);      Ajmaline;       D00199  Ajmaline (JP17);     voltage-gated sodium channel (SCN8A);      Ajmaline;       D00199  Ajmaline (JP17);     voltage-gated sodium channel (SCN9A);      Ajmaline;       D00199  Ajmaline (JP17); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2D6;    Ajmaline;     D00199  Ajmaline (JP17); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00199  Ajmaline;   D00199  Ajmaline tablets; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tryptophan and anthranillic acid;    Indole alkaloids;     D00199  Ajmaline (JP15)",CAS: 4360-12-7; PubChem: 8772; ChEBI: 28462; KNApSAcK: C00001679 C00024294; 3DMET: B02065; NIKKAJI: J15.133E,cpd:C06542; cpd:C09217; cpd:C10696; cpd:C12260,20,26,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H27O2N2,C20H25O2N2,326.1994281,327.2072531,325.19160313244,3591,cpd:C07201,Vinblastine,C46H58N4O9,Vinblastine,R05859 R05860,Indole alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites; Bile secretion,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C07201  Vinblastine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Indole alkaloids;     C07201  Vinblastine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS;     L01CA Vinca alkaloids and analogues;      L01CA01 Vinblastine;       D08675  Vinblastine (INN); Target-based classification of drugs [BR:br08310];  Others;   Other;    beta-tubulin;     Vinblastine;      D08675  Vinblastine (INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Vinblastine;     D08675  Vinblastine (INN);  Transporter substrates;   ABCB1;    Vinblastine;     D08675  Vinblastine (INN);   ABCB4;    Vinblastine;     D08675  Vinblastine (INN); Major components of natural products [BR:br08323];  Crude drugs;   Madagascar periwinkle;    C07201  Vinblastine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tryptophan and anthranillic acid;    Indole alkaloids;     D08675  Vinblastine (INN),CAS: 865-21-4; PubChem: 9410; ChEBI: 27375; ChEMBL: CHEMBL22969; KNApSAcK: C00001781; 3DMET: B02109; NIKKAJI: J10.131A,cpd:C07201; cpd:C09218; cpd:C11626,46,58,9,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H59O9N4,C46H57O9N4,810.4203795,811.4282045,809.41255443245,3592,cpd:C07204,Vincristine;,C46H56N4O10,Vincristine; 22-Oxovincaleukoblastine,R05860,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C07204  Vincristine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Indole alkaloids;     C07204  Vincristine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS;     L01CA Vinca alkaloids and analogues;      L01CA02 Vincristine;       D08679  Vincristine (INN); Target-based classification of drugs [BR:br08310];  Others;   Other;    beta-tubulin;     Vincristine;      D08679  Vincristine (INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Vincristine;     D08679  Vincristine (INN); Major components of natural products [BR:br08323];  Crude drugs;   Madagascar periwinkle;    C07204  Vincristine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tryptophan and anthranillic acid;    Indole alkaloids;     D08679  Vincristine (INN),CAS: 57-22-7; PubChem: 9413; ChEBI: 28445; ChEMBL: CHEMBL90555; KNApSAcK: C00001783; 3DMET: B02110; NIKKAJI: J10.132J,cpd:C07204; cpd:C13974,46,56,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H57O10N4,C46H55O10N4,824.399644,825.4074691,823.3918193246,3593,cpd:C09024,Ajmalicine;,C21H24N2O3,Ajmalicine; Raubasine,R05847 R05849,Indole alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C09024  Ajmalicine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tryptophan and anthranillic acid;    Indole alkaloids;     D08470  Ajmalicine,CAS: 483-04-5; PubChem: 11216; ChEBI: 2524; ChEMBL: CHEMBL123325 CHEMBL14742; KNApSAcK: C00001678; PDB-CCD: AJN; 3DMET: B02622; NIKKAJI: J13.108C,cpd:C02151; cpd:C09024; cpd:C09026; cpd:C09253; cpd:C11642; cpd:C11643; cpd:C11676; cpd:C11682; cpd:C11683; cpd:C11808; cpd:C15086; cpd:C19931,21,24,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O3N2,C21H23O3N2,352.1786926,353.1865177,351.17086763247,3594,cpd:C09107,Catharanthine,C21H24N2O2,Catharanthine,R05854 R05858,Indole alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C09107  Catharanthine,CAS: 2468-21-5; PubChem: 11299; ChEBI: 3469; KNApSAcK: C00001704; 3DMET: B05320; NIKKAJI: J15.154H,cpd:C09035; cpd:C09107; cpd:C09244,21,24,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O2N2,C21H23O2N2,336.183778,337.1916031,335.1759533248,3595,cpd:C09239,Sarpagine,C19H22N2O2,Sarpagine,R05828,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.91,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C09239  Sarpagine,CAS: 482-68-8; PubChem: 11430; ChEBI: 9036; KNApSAcK: C00001767; 3DMET: B05340; NIKKAJI: J9.376I,cpd:C06530; cpd:C09239,19,22,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O2N2,C19H21O2N2,310.168128,311.175953,309.16030293249,3596,cpd:C09241,Serpentine;,C21H20N2O3,Serpentine; Serpentine (alkaloid),R05849,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C09241  Serpentine,CAS: 18786-24-8; PubChem: 11432; ChEBI: 9119; ChEMBL: CHEMBL14755; KNApSAcK: C00001769; 3DMET: B02794; NIKKAJI: J10.977K J247.674F,cpd:C09028; cpd:C09241,21,20,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O3N2,C21H19O3N2,348.1473925,349.1552175,347.13956753250,3597,cpd:C09244,Tabersonine,C21H24N2O2,Tabersonine,R05853 R05855 R05866 R05868 R05869 R05872 R05886,Indole alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.73,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C09244  Tabersonine,CAS: 4429-63-4; PubChem: 11435; ChEBI: 16776; KNApSAcK: C00001773; 3DMET: B02796; NIKKAJI: J62.335K,cpd:C09035; cpd:C09107; cpd:C09244,21,24,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O2N2,C21H23O2N2,336.183778,337.1916031,335.1759533251,3598,cpd:C11632,Polyneuridine aldehyde,C21H22N2O3,Polyneuridine aldehyde,R05825 R05829,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,3.1.1.78,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11632  Polyneuridine aldehyde,PubChem: 13797; ChEBI: 16829; 3DMET: B05540; NIKKAJI: J2.775.679D,cpd:C01761; cpd:C11632; cpd:C11680; cpd:C11681; cpd:C19932,21,22,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O3N2,C21H21O3N2,350.1630426,351.1708676,349.15521753252,3599,cpd:C11633,16-Epivellosimine,C19H20N2O,16-Epivellosimine,R05825 R05826 R05876,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,2.3.1.160; 3.1.1.78,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11633  16-Epivellosimine,PubChem: 13798; ChEBI: 16425; KNApSAcK: C00045433 C00048226; PDB-CCD: EVS; NIKKAJI: J2.775.680H,cpd:C11633; cpd:C11634; cpd:C16726; cpd:C16846,19,20,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H21O1N2,C19H19O1N2,292.1575633,293.1653883,291.14973823253,3600,cpd:C11634,Vellosimine,C19H20N2O,Vellosimine,R05826 R05827,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.273,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11634  Vellosimine,CAS: 6874-98-2; PubChem: 13799; ChEBI: 18057; KNApSAcK: C00045433 C00048226; NIKKAJI: J9.640G,cpd:C11633; cpd:C11634; cpd:C16726; cpd:C16846,19,20,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H21O1N2,C19H19O1N2,292.1575633,293.1653883,291.14973823254,3601,cpd:C11635,10-Deoxysarpagine;,C19H22N2O,10-Deoxysarpagine; Sarpagan-17-ol,R05827 R05828,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.273; 1.14.13.91,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11635  10-Deoxysarpagine,CAS: 604-99-9; PubChem: 13800; ChEBI: 16060; KNApSAcK: C00025193; 3DMET: B05541; NIKKAJI: J16.227B,cpd:C06528; cpd:C09149; cpd:C11379; cpd:C11635; cpd:C16735,19,22,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O1N2,C19H21O1N2,294.1732133,295.1810384,293.16538833255,3602,cpd:C11641,"3',4'-Anhydrovinblastine",C46H56N4O8,"3',4'-Anhydrovinblastine",R05858 R05859,Indole alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11641  3',4'-Anhydrovinblastine",CAS: 38390-45-3; PubChem: 13806; ChEBI: 1322; 3DMET: B04281; NIKKAJI: J397.714E,cpd:C11641,46,56,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H57O8N4,C46H55O8N4,792.4098148,793.4176398,791.40198973256,3603,cpd:C11642,19-Hydroxytabersonine,C21H24N2O3,19-Hydroxytabersonine,R05871 R05872,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11642  19-Hydroxytabersonine,PubChem: 13807; ChEBI: 797; KNApSAcK: C00024501; 3DMET: B04282; NIKKAJI: J2.775.700F,cpd:C02151; cpd:C09024; cpd:C09026; cpd:C09253; cpd:C11642; cpd:C11643; cpd:C11676; cpd:C11682; cpd:C11683; cpd:C11808; cpd:C15086; cpd:C19931,21,24,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O3N2,C21H23O3N2,352.1786926,353.1865177,351.17086763257,3604,cpd:C11643,16-Hydroxytabersonine,C21H24N2O3,16-Hydroxytabersonine,R05855 R05885,Indole alkaloid biosynthesis,1.14.13.73; 2.1.1.94,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11643  16-Hydroxytabersonine,PubChem: 13808; ChEBI: 17699; KNApSAcK: C00024480; 3DMET: B04283; NIKKAJI: J1.309.174I,cpd:C02151; cpd:C09024; cpd:C09026; cpd:C09253; cpd:C11642; cpd:C11643; cpd:C11676; cpd:C11682; cpd:C11683; cpd:C11808; cpd:C15086; cpd:C19931,21,24,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O3N2,C21H23O3N2,352.1786926,353.1865177,351.17086763258,3605,cpd:C11675,16-Methoxytabersonine,C22H26N2O3,16-Methoxytabersonine,R05856 R05885,Indole alkaloid biosynthesis,2.1.1.94,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11675  16-Methoxytabersonine,PubChem: 13840; ChEBI: 769; ChEMBL: CHEMBL1165751; KNApSAcK: C00024481; 3DMET: B04305; NIKKAJI: J450.691J,cpd:C09040; cpd:C11675; cpd:C16971; cpd:C17872,22,26,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H27O3N2,C22H25O3N2,366.1943427,367.2021677,365.18651773259,3606,cpd:C11676,Lochnericine,C21H24N2O3,Lochnericine,R05866 R05867,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11676  Lochnericine,PubChem: 13841; ChEBI: 6510; KNApSAcK: C00024457; 3DMET: B05542; NIKKAJI: J7.577I,cpd:C02151; cpd:C09024; cpd:C09026; cpd:C09253; cpd:C11642; cpd:C11643; cpd:C11676; cpd:C11682; cpd:C11683; cpd:C11808; cpd:C15086; cpd:C19931,21,24,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O3N2,C21H23O3N2,352.1786926,353.1865177,351.17086763260,3607,cpd:C11677,Horhammericine,C21H24N2O4,Horhammericine,R05867 R05868 R05871,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11677  Horhammericine,PubChem: 13842; ChEBI: 5765; KNApSAcK: C00024500; 3DMET: B05543; NIKKAJI: J2.489.143G,cpd:C03309; cpd:C09045; cpd:C09227; cpd:C11677; cpd:C11678; cpd:C17593; cpd:C17594; cpd:C17595; cpd:C17596; cpd:C17597; cpd:C17598,21,24,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O4N2,C21H23O4N2,368.1736073,369.1814323,367.16578223261,3608,cpd:C11678,Dialdehyde,C21H24N2O4,Dialdehyde,R05844 R05845,Indole alkaloid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11678  Dialdehyde,CAS: 85955-83-5; PubChem: 13843; ChEBI: 4484; 3DMET: B04306; NIKKAJI: J2.775.793F,cpd:C03309; cpd:C09045; cpd:C09227; cpd:C11677; cpd:C11678; cpd:C17593; cpd:C17594; cpd:C17595; cpd:C17596; cpd:C17597; cpd:C17598,21,24,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O4N2,C21H23O4N2,368.1736073,369.1814323,367.16578223262,3609,cpd:C11679,"4,21-Dehydrocorynantheine aldehyde",C21H23N2O3,"4,21-Dehydrocorynantheine aldehyde",R05824 R05845,Indole alkaloid biosynthesis,NA,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11679  4,21-Dehydrocorynantheine aldehyde",CAS: 85925-15-1; PubChem: 13844; ChEBI: 1737; 3DMET: B04307; NIKKAJI: J2.775.794D,cpd:C03677; cpd:C11679,21,23,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H24O3N2,C21H22O3N2,351.1708676,352.1786926,350.16304263263,3610,cpd:C11680,Cathenamine,C21H22N2O3,Cathenamine,R05846 R05847 R05848,Indole alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11680  Cathenamine,CAS: 63661-74-5; PubChem: 13845; ChEBI: 3472; 3DMET: B04308; NIKKAJI: J18.738K,cpd:C01761; cpd:C11632; cpd:C11680; cpd:C11681; cpd:C19932,21,22,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O3N2,C21H21O3N2,350.1630426,351.1708676,349.15521753264,3611,cpd:C11681,19-epi-Cathenamine,C21H22N2O3,19-epi-Cathenamine,R05873 R05874,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11681  19-epi-Cathenamine,CAS: 73326-87-1; PubChem: 13846; ChEBI: 802; 3DMET: B04309; NIKKAJI: J723.744H,cpd:C01761; cpd:C11632; cpd:C11680; cpd:C11681; cpd:C19932,21,22,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O3N2,C21H21O3N2,350.1630426,351.1708676,349.15521753265,3612,cpd:C11682,Tetrahydroalstonine,C21H24N2O3,Tetrahydroalstonine,R05848,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11682  Tetrahydroalstonine,CAS: 6474-90-4; PubChem: 13847; ChEBI: 9479; ChEMBL: CHEMBL14742 CHEMBL498734; KNApSAcK: C00025214; 3DMET: B04310; NIKKAJI: J109.490D,cpd:C02151; cpd:C09024; cpd:C09026; cpd:C09253; cpd:C11642; cpd:C11643; cpd:C11676; cpd:C11682; cpd:C11683; cpd:C11808; cpd:C15086; cpd:C19931,21,24,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O3N2,C21H23O3N2,352.1786926,353.1865177,351.17086763266,3613,cpd:C11683,19-epi-Ajmalicine,C21H24N2O3,19-epi-Ajmalicine,R05874,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11683  19-epi-Ajmalicine,CAS: 25532-45-0; PubChem: 13848; ChEBI: 801; KNApSAcK: C00025138; 3DMET: B04311; NIKKAJI: J393.324E,cpd:C02151; cpd:C09024; cpd:C09026; cpd:C09253; cpd:C11642; cpd:C11643; cpd:C11676; cpd:C11682; cpd:C11683; cpd:C11808; cpd:C15086; cpd:C19931,21,24,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O3N2,C21H23O3N2,352.1786926,353.1865177,351.17086763267,3614,cpd:C11691,Stemmadenine,C21H26N2O3,Stemmadenine,R05852 R05853 R05854,Indole alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11691  Stemmadenine,CAS: 10012-73-4; PubChem: 13856; ChEBI: 9260; KNApSAcK: C00026041; 3DMET: B04312; NIKKAJI: J15.606J,cpd:C09251; cpd:C09256; cpd:C11691; cpd:C11783; cpd:C11809,21,26,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H27O3N2,C21H25O3N2,354.1943427,355.2021677,353.18651773268,3615,cpd:C11783,Minovincinine,C21H26N2O3,Minovincinine,R05869 R05870,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11783  Minovincinine,PubChem: 13947; ChEBI: 6941; KNApSAcK: C00024459 C00024472; 3DMET: B04315; NIKKAJI: J15.953K,cpd:C09251; cpd:C09256; cpd:C11691; cpd:C11783; cpd:C11809,21,26,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H27O3N2,C21H25O3N2,354.1943427,355.2021677,353.18651773269,3616,cpd:C11784,Echitovenine,C23H28N2O4,Echitovenine,R05870,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11784  Echitovenine,PubChem: 13948; ChEBI: 4752; 3DMET: B05544; NIKKAJI: J143.635J,cpd:C11784,23,28,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H29O4N2,C23H27O4N2,396.2049074,397.2127324,395.19708243270,3617,cpd:C11807,Vinorine,C21H22N2O2,Vinorine,R05876 R05877,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.75; 2.3.1.160,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11807  Vinorine,PubChem: 13971; ChEBI: 16791; KNApSAcK: C00024291 C00024313; 3DMET: B04316; NIKKAJI: J696.386B,cpd:C06522; cpd:C11807,21,22,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O2N2,C21H21O2N2,334.168128,335.175953,333.16030293271,3618,cpd:C11808,"1,2-Dihydrovomilenine;",C21H24N2O3,"1,2-Dihydrovomilenine; 2-beta-(R)-1,2-Dihydrovomilenine",R05878 R05879,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.73; 1.5.1.32,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11808  1,2-Dihydrovomilenine",PubChem: 13972; ChEBI: 17372; 3DMET: B04317; NIKKAJI: J2.777.549G,cpd:C02151; cpd:C09024; cpd:C09026; cpd:C09253; cpd:C11642; cpd:C11643; cpd:C11676; cpd:C11682; cpd:C11683; cpd:C11808; cpd:C15086; cpd:C19931,21,24,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O3N2,C21H23O3N2,352.1786926,353.1865177,351.17086763272,3619,cpd:C11809,17-O-Acetylnorajmaline,C21H26N2O3,17-O-Acetylnorajmaline,R05879 R05880,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.73; 3.1.1.80,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11809  17-O-Acetylnorajmaline,PubChem: 13973; ChEBI: 17384; 3DMET: B04318; NIKKAJI: J2.777.550K,cpd:C09251; cpd:C09256; cpd:C11691; cpd:C11783; cpd:C11809,21,26,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H27O3N2,C21H25O3N2,354.1943427,355.2021677,353.18651773273,3620,cpd:C11810,Norajmaline,C19H24N2O2,Norajmaline,R05880 R05881,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,3.1.1.80,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11810  Norajmaline,PubChem: 13974; ChEBI: 7621; KNApSAcK: C00024277; 3DMET: B04319; NIKKAJI: J1.781.738H,cpd:C07367; cpd:C11810,19,24,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O2N2,C19H23O2N2,312.183778,313.1916031,311.1759533274,3621,cpd:C11812,Lochnerinine,C22H26N2O4,Lochnerinine,R05886,Indole alkaloid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C11812  Lochnerinine,PubChem: 13976; ChEBI: 6511; KNApSAcK: C00024458; 3DMET: B05545; NIKKAJI: J492.789C,cpd:C06958; cpd:C09027; cpd:C09037; cpd:C10904; cpd:C11812,22,26,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H27O4N2,C22H25O4N2,382.1892573,383.1970824,381.18143233275,3622,cpd:C00400,(-)-Menthol;,C10H20O,(-)-Menthol; L-Menthol,R02177 R02178 R02179 R08530,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites; Inflammatory mediator regulation of TRP channels,1.1.1.207; 1.14.13.46; 2.3.1.69; 2.4.1.127,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C00400  (-)-Menthol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C00400  (-)-Menthol; Therapeutic category of drugs in Japan [BR:br08301];  7  Agents not mainly for therapeutic purpose;   71  Dispensing medicines;    714  Flavorings, deodorants, coloring agents;     7149  Others;      D00064  l-Menthol (JP17);   79  Other agents not mainly for therapeutic purpose;    799  Miscellaneous;     7990  Miscellaneous;      D00064  l-Menthol (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches);    D00064  l-Menthol (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Menthol;     D00064  l-Menthol (JP17); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D00064  [001642] l-Menthol;  Flavoring substance;   D00064  [001642] l-Menthol;  Fragrance;   D00064  [001642] l-Menthol;  Algefacient;   D00064  [001642] l-Menthol;  Favoring agent, Fragrance;   D00064  [001642] l-Menthol;  Refresher;   D00064  [001642] l-Menthol;  Antiseptic agent;   D00064  [001642] l-Menthol; Target-based classification of drugs [BR:br08310];  Ion channels;   Related to voltage-gated cation channels;    Transient receptor potential family, TRPM (Melastatin/Long TRP);     transient receptor potential cation channel, subfamily M, member 8 (TRPM8);      Menthol;       D00064  l-Menthol (JP17);    Transient receptor potential family, TRPA (ANKTM1);     transient receptor potential cation channel, subfamily A, member 1 TRPA1;      Menthol;       D00064  l-Menthol (JP17); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00064  l-Menthol; Major components of natural products [BR:br08323];  Crude drugs;   Mentha water;    C00400  (-)-Menthol;   Mentha herb;    C00400  (-)-Menthol;   Mentha oil;    C00400  (-)-Menthol;  Essential oils;   Mentha oil;    C00400  (-)-Menthol;   Peppermint oil;    C00400  (-)-Menthol;  Medicinal herbs;   Peppermint;    C00400  (-)-Menthol; Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Monoterpenoids (C10);    D00064  l-Menthol (JP15); Animal drugs in Japan [BR:br08331];  95  Agents for external use;   953  Analgesics, anti-itchings, astringents and antiinflammatory agents;    9539  Other analgesics, anti-itchings, astringents and inflammatory agents;     C00400  L-Menthol",CAS: 2216-51-5; PubChem: 3690; ChEBI: 15409; ChEMBL: CHEMBL470670; LIPIDMAPS: LMPR0102090001; KNApSAcK: C00000810; 3DMET: B01234; NIKKAJI: J9.251G,cpd:C00400; cpd:C00553; cpd:C09849; cpd:C11386; cpd:C12307,10,20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H21O1,C10H19O1,156.1514153,157.1592403,155.14359023276,3623,cpd:C00521,(-)-Limonene;,C10H16,(-)-Limonene; (-)-(S)-Limonene; (-)-(4S)-Limonene,R02013 R02468 R02469 R02470 R09385 R09389,Monoterpenoid biosynthesis; Limonene and pinene degradation; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.47; 1.14.13.48; 1.14.13.49; 1.14.13.107; 4.2.3.16,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C00521  (-)-Limonene; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C00521  (-)-Limonene,CAS: 5989-54-8; PubChem: 3804; ChEBI: 15383; LIPIDMAPS: LMPR0102090002; KNApSAcK: C00000803; 3DMET: B01278; NIKKAJI: J85.992C,cpd:C00002; cpd:C00044; cpd:C00120; cpd:C00131; cpd:C00284; cpd:C00286; cpd:C00363; cpd:C00521; cpd:C00591; cpd:C00808; cpd:C00809; cpd:C00848; cpd:C00884; cpd:C00964; cpd:C01123; cpd:C01262; cpd:C01425; cpd:C01499; cpd:C01806; cpd:C01843; cpd:C01889; cpd:C02073; cpd:C02108; cpd:C02173; cpd:C02213; cpd:C02320; cpd:C02452; cpd:C02759; cpd:C02863; cpd:C02967; cpd:C03110; cpd:C03448; cpd:C03495; cpd:C03614; cpd:C03843; cpd:C03933; cpd:C03997; cpd:C04138; cpd:C04155; cpd:C04312; cpd:C04381; cpd:C04435; cpd:C04718; cpd:C05282; cpd:C06066; cpd:C06069; cpd:C06074; cpd:C06075; cpd:C06076; cpd:C06078; cpd:C06099; cpd:C06304; cpd:C06305; cpd:C06306; cpd:C06307; cpd:C06308; cpd:C06605; cpd:C06952; cpd:C06969; cpd:C06976; cpd:C07271; cpd:C07362; cpd:C07827; cpd:C08437; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09839; cpd:C09842; cpd:C09847; cpd:C09854; cpd:C09859; cpd:C09873; cpd:C09875; cpd:C09877; cpd:C09880; cpd:C09882; cpd:C09885; cpd:C09893; cpd:C09898; cpd:C09900; cpd:C09906; cpd:C11120; cpd:C11382; cpd:C11387; cpd:C11391; cpd:C11392; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11402; cpd:C11403; cpd:C11405; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11414; cpd:C11415; cpd:C11418; cpd:C11419; cpd:C11478; cpd:C11651; cpd:C11937; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11943; cpd:C11944; cpd:C11951; cpd:C13311; cpd:C13733; cpd:C13742; cpd:C15563; cpd:C16461; cpd:C16690; cpd:C16691; cpd:C16777; cpd:C17623; cpd:C18018; cpd:C18019; cpd:C18369; cpd:C18658; cpd:C18813; cpd:C19079; cpd:C19081; cpd:C19083; cpd:C19084; cpd:C19112; cpd:C19731; cpd:C19818; cpd:C19967; cpd:C19969; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20230; cpd:C20241; cpd:C20242; cpd:C20244; cpd:C20260; cpd:C20322; cpd:C20323; cpd:C20324; cpd:C20386; cpd:C20387; cpd:C20425; cpd:C20818; cpd:C20825; cpd:C20859; cpd:C20912; cpd:C20943; cpd:C20949; cpd:C21012; cpd:C21031; cpd:C21310,10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17,C10H15,136.1252005,137.1330255,135.11737553277,3624,cpd:C00553,(+)-Neomenthol,C10H20O,(+)-Neomenthol,R02548 R08531,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.208; 2.3.1.69,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C00553  (+)-Neomenthol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C00553  (+)-Neomenthol,CAS: 2216-52-6; PubChem: 3834; ChEBI: 15402; ChEMBL: CHEMBL1907991; LIPIDMAPS: LMPR0102090003; KNApSAcK: C00000825; 3DMET: B01286; NIKKAJI: J215.948A J9.252E,cpd:C00400; cpd:C00553; cpd:C09849; cpd:C11386; cpd:C12307,10,20,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H21O1,C10H19O1,156.1514153,157.1592403,155.14359023278,3625,cpd:C00808,(+)-Camphor;,C10H16O,(+)-Camphor; d-Camphor,R02944 R03818 R10045 R10047,Monoterpenoid biosynthesis; Inflammatory mediator regulation of TRP channels,1.1.1.198; 1.14.13.161; 1.14.15.1; 1.14.15.10,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C00808  (+)-Camphor; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C00808  (+)-Camphor; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01E OTHER CARDIAC PREPARATIONS;     C01EB Other cardiac preparations;      C01EB02 Camphora;       D06392  d-Camphor (JP17); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    264  Analgesics, anti-itchings, astringents, anti-inflammatory agents;     2645  Peppermint rubber and camphor peppermint;      D06392  d-Camphor (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches);    D06392  d-Camphor (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Crude drugs;    Camphor;     D06392  d-Camphor (JP17); Pharmaceutical additives [BR:br08316];  Flavoring substance;   D06392  [001208] d-Camphor;  Algefacient;   D06392  [001208] d-Camphor;  Favoring agent, Fragrance;   D06392  [001208] d-Camphor;  Refresher;   D06392  [001208] d-Camphor; Target-based classification of drugs [BR:br08310];  Ion channels;   Related to voltage-gated cation channels;    Transient receptor potential family, TRPA (ANKTM1);     transient receptor potential cation channel, subfamily A, member 1 TRPA1;      Camphora;       D06392  d-Camphor (JP17); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D06392  d-Camphor; Crude drugs [BR:br08305];  Other flowering plants;   Lauraceae (laurel family);    D06392  d-Camphor; Major components of natural products [BR:br08323];  Crude drugs;   Camphor tree;    C00808  (+)-Camphor; Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Monoterpenoids (C10);    D06392  d-Camphor (JP15)",CAS: 464-49-3; PubChem: 4066; ChEBI: 15396; ChEMBL: CHEMBL1316134; LIPIDMAPS: LMPR0102120001; KNApSAcK: C00000819; 3DMET: B04729; NIKKAJI: J4.364H J43.294F,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013279,3626,cpd:C00843,(-)-Menthone;,C10H18O,(-)-Menthone; l-Menthone; p-Menthan-3-one,R02177 R02548 R06419 R08925,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.207; 1.1.1.208; 1.3.1.81; 1.14.13.105,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C00843  (-)-Menthone; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C00843  (-)-Menthone,CAS: 14073-97-3; PubChem: 4100; ChEBI: 15410; ChEMBL: CHEMBL276311; LIPIDMAPS: LMPR0102090004; KNApSAcK: C00000811; 3DMET: B01341; NIKKAJI: J9.142A,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023280,3627,cpd:C00848,6-Oxocineole;,C10H16O2,"6-Oxocineole; (1R,4S)-1,3,3-Trimethyl-2-oxabicyclo[2.2.2]octan-6-one; 2-Oxo-1,8-cineole",R02994 R02995,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.241; 1.14.13.51,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C00848  6-Oxocineole,CAS: 70222-88-7; PubChem: 4105; ChEBI: 16123; LIPIDMAPS: LMPR0102090064; 3DMET: B04736; NIKKAJI: J288.891B,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.10720473281,3628,cpd:C00964,(-)-trans-Carveol,C10H16O,(-)-trans-Carveol,R02468 R03114,Monoterpenoid biosynthesis; Limonene and pinene degradation; Biosynthesis of secondary metabolites,1.1.1.243; 1.14.13.48,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C00964  (-)-trans-Carveol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C00964  (-)-trans-Carveol,PubChem: 4215; ChEBI: 15389; ChEMBL: CHEMBL1907992; LIPIDMAPS: LMPR0102090005; KNApSAcK: C00000814; 3DMET: B01361; NIKKAJI: J9.137E,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013282,3629,cpd:C01123,(-)-trans-Isopiperitenol,C10H16O,(-)-trans-Isopiperitenol,R02469 R03261,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.223; 1.14.13.47,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C01123  (-)-trans-Isopiperitenol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C01123  (-)-trans-Isopiperitenol,PubChem: 4354; ChEBI: 15406; LIPIDMAPS: LMPR0102090006; KNApSAcK: C00000815; 3DMET: B01388; NIKKAJI: J487.293B,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013283,3630,cpd:C01433,Loganin,C17H26O10,Loganin,R03554 R03555 R03556,Monoterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.3.9; 1.14.13.74; 2.1.1.50,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;      C01433  Loganin; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Iridoids;     C01433  Loganin; Major components of natural products [BR:br08323];  Crude drugs;   Cornus fruit;    C01433  Loganin",CAS: 18524-94-2; PubChem: 4616; ChEBI: 15771; ChEMBL: CHEMBL1081584 CHEMBL1589904; LIPIDMAPS: LMPR0102070001; KNApSAcK: C00003088; 3DMET: B01449; NIKKAJI: J13.561E,cpd:C01433,17,26,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H27O10,C17H25O10,390.152597,391.1604221,389.1447723284,3631,cpd:C01512,Loganate;,C16H24O10,Loganate; Loganic acid,R03554 R05832 R05833 R05898,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.3.3.9; 1.14.13.74; 2.1.1.50,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Iridoids;     C01512  Loganate,CAS: 22255-40-9; PubChem: 4678; ChEBI: 18052 30632; ChEMBL: CHEMBL1081585; KNApSAcK: C00010604; 3DMET: B01457; NIKKAJI: J15.893C,cpd:C01512; cpd:C11661,16,24,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O10,C16H23O10,376.136947,377.144772,375.12912193285,3632,cpd:C01765,(+)-Borneol;,C10H18O,"(+)-Borneol; d-Borneol; Borneocamphor; endo-2-Bornanol; Sumatra camphor; (1R,2S,4R)-(+)-Borneol",R02944 R08529 R08532,Monoterpenoid biosynthesis,1.1.1.198; 2.3.1.69; 3.1.7.3,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C01765  (+)-Borneol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C01765  (+)-Borneol; Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Borneol;     C01765  (+)-Borneol; Pharmaceutical additives [BR:br08316];  Flavoring substance;   C01765  [009752] d-Borneol;  Algefacient;   C01765  [009752] d-Borneol;  Masticatory;   C01765  [009752] d-Borneol;  Favoring agent, Fragrance;   C01765  [009752] d-Borneol;  Coloring agent;   C01765  [009752] d-Borneol;  Refresher;   C01765  [009752] d-Borneol;  Antiseptic agent;   C01765  [009752] d-Borneol",CAS: 464-43-7; PubChem: 4898; ChEBI: 15393; LIPIDMAPS: LMPR0102120003; KNApSAcK: C00011023; 3DMET: B04811; NIKKAJI: J9.305J,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023286,3633,cpd:C01767,(-)-Carvone;,C10H14O,(-)-Carvone; (4R)-Carvone,R03114 R06373 R06374,Monoterpenoid biosynthesis; Limonene and pinene degradation; Biosynthesis of secondary metabolites,1.1.1.243; 1.3.99.25,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C01767  (-)-Carvone; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C01767  (-)-Carvone; Major components of natural products [BR:br08323];  Essential oils;   Spearmint oil;    C01767  (-)-Carvone,CAS: 6485-40-1; PubChem: 4900; ChEBI: 15400; LIPIDMAPS: LMPR0102090007; KNApSAcK: C00000807; PDB-CCD: 07V; 3DMET: B01496; NIKKAJI: J15.688D,cpd:C01056; cpd:C01767; cpd:C01868; cpd:C01951; cpd:C02289; cpd:C02485; cpd:C02576; cpd:C03043; cpd:C06576; cpd:C09840; cpd:C09843; cpd:C09868; cpd:C09884; cpd:C09908; cpd:C09911; cpd:C09913; cpd:C11383; cpd:C11394; cpd:C11939; cpd:C14130; cpd:C14138; cpd:C14139; cpd:C14188; cpd:C14200; cpd:C14464; cpd:C14741; cpd:C16569; cpd:C16955; cpd:C17062; cpd:C17103; cpd:C18025; cpd:C20361; cpd:C20944,10,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1,C10H13O1,150.1044651,151.1122901,149.096643287,3634,cpd:C01957,Secologanate,C16H22O10,Secologanate,R05833 R05834,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.3.3.9; 2.1.1.50,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Secoiridoids;     C01957  Secologanate,PubChem: 5058; ChEBI: 9075; KNApSAcK: C00034978; 3DMET: B01522; NIKKAJI: J37.628K,cpd:C01957; cpd:C09800; cpd:C11673; cpd:C16963,16,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H23O10,C16H21O10,374.1212969,375.1291219,373.11347193288,3635,cpd:C02344,(-)-endo-Fenchol;,C10H18O,(-)-endo-Fenchol; (-)-alpha-Fenchyl alcohol,R02004 R09984 R09985,Monoterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,1.1.1.322; 4.2.3.10,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C02344  (-)-endo-Fenchol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C02344  Fenchyl alcohol,CAS: 512-13-0; PubChem: 5393; ChEBI: 15405; LIPIDMAPS: LMPR0102120005; KNApSAcK: C00035801; 3DMET: B01562; NIKKAJI: J7.537J,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023289,3636,cpd:C02452,Perillyl alcohol;,C10H16O,"Perillyl alcohol; (-)-Perillyl alcohol; p-Mentha-1,8-dien-7-ol; (-)-Perillylalcohol",R02470 R03945,Monoterpenoid biosynthesis; Limonene and pinene degradation; Biosynthesis of secondary metabolites,1.1.1.144; 1.14.13.49,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C02452  Perillyl alcohol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C02452  Perillyl alcohol,CAS: 18457-55-1; PubChem: 5472; ChEBI: 10782; ChEMBL: CHEMBL236687; LIPIDMAPS: LMPR0102090008; KNApSAcK: C00010885; 3DMET: B00443; NIKKAJI: J86.014J,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013290,3637,cpd:C02462,Sabinene hydrate,C10H18O,Sabinene hydrate,R02006,Monoterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.3.11,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C02462  Sabinene hydrate; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C02462  Sabinene hydrate,CAS: 15537-55-0; PubChem: 5479; ChEBI: 16377; LIPIDMAPS: LMPR0102120006; KNApSAcK: C00000830; 3DMET: B01574; NIKKAJI: J321.027H,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023291,3638,cpd:C02485,(-)-Isopiperitenone;,C10H14O,(-)-Isopiperitenone; (-)-(4R)-Isopiperitenone,R03261 R06417,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.223; 1.3.1.82,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C02485  (-)-Isopiperitenone; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C02485  (-)-Isopiperitenone,CAS: 80995-97-7; PubChem: 5498; ChEBI: 15408; LIPIDMAPS: LMPR0102090009; KNApSAcK: C00000809; PDB-CCD: IT9; 3DMET: B01579; NIKKAJI: J818.274D,cpd:C01056; cpd:C01767; cpd:C01868; cpd:C01951; cpd:C02289; cpd:C02485; cpd:C02576; cpd:C03043; cpd:C06576; cpd:C09840; cpd:C09843; cpd:C09868; cpd:C09884; cpd:C09908; cpd:C09911; cpd:C09913; cpd:C11383; cpd:C11394; cpd:C11939; cpd:C14130; cpd:C14138; cpd:C14139; cpd:C14188; cpd:C14200; cpd:C14464; cpd:C14741; cpd:C16569; cpd:C16955; cpd:C17062; cpd:C17103; cpd:C18025; cpd:C20361; cpd:C20944,10,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1,C10H13O1,150.1044651,151.1122901,149.096643292,3639,cpd:C03092,6-endo-Hydroxycineole;,C10H18O2,"6-endo-Hydroxycineole; 2-endo-Hydroxy-1,8-cineole",R02994 R08784,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.241; 1.14.13.156,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C03092  6-endo-Hydroxycineole,PubChem: 5990; ChEBI: 16271; LIPIDMAPS: LMPR0102090065; 3DMET: B04880; NIKKAJI: J1.452.673K,cpd:C03092; cpd:C04433; cpd:C06185; cpd:C07276; cpd:C07640; cpd:C09790; cpd:C16255; cpd:C16462; cpd:C17621; cpd:C18020; cpd:C18027; cpd:C18066; cpd:C18202; cpd:C19082; cpd:C20326; cpd:C21139,10,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O2,C10H17O2,170.1306798,171.1385049,169.12285483293,3640,cpd:C03190,(+)-Bornyl diphosphate,C10H20O7P2,(+)-Bornyl diphosphate,R02007 R08529,Monoterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,3.1.7.3; 5.5.1.8,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C03190  (+)-Bornyl-diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C03190  (+)-Bornyl-diphosphate,PubChem: 6069; ChEBI: 15395; LIPIDMAPS: LMPR0102120009; KNApSAcK: C00000817; 3DMET: B04882; NIKKAJI: J968.877C,cpd:C00341; cpd:C02569; cpd:C03190; cpd:C05308; cpd:C18051; cpd:C18052; cpd:C20664,10,20,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H21O7P2,C10H19O7P2,314.068427,315.076252,313.06060193294,3641,cpd:C04433,"(E)-3,7-Dimethylocta-1,6-diene-3,8-diol;",C10H18O2,"(E)-3,7-Dimethylocta-1,6-diene-3,8-diol; (6E)-8-Hydroxylinalool",R04366 R09922 R09923 R09924,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.151,NA,NA,PubChem: 7064; ChEBI: 15662 18627; LIPIDMAPS: LMFA05000099; NIKKAJI: J487.697K,cpd:C03092; cpd:C04433; cpd:C06185; cpd:C07276; cpd:C07640; cpd:C09790; cpd:C16255; cpd:C16462; cpd:C17621; cpd:C18020; cpd:C18027; cpd:C18066; cpd:C18202; cpd:C19082; cpd:C20326; cpd:C21139,10,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O2,C10H17O2,170.1306798,171.1385049,169.12285483295,3642,cpd:C04718,"1,6,6-Trimethyl-2,7-dioxabicyclo[3.2.2]nonan-3-one",C10H16O3,"1,6,6-Trimethyl-2,7-dioxabicyclo[3.2.2]nonan-3-one",R02995 R04578,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.51,NA,NA,PubChem: 7290; ChEBI: 29064; 3DMET: B04955; NIKKAJI: J2.376.607H,cpd:C00120; cpd:C00884; cpd:C01262; cpd:C01843; cpd:C03843; cpd:C04138; cpd:C04718; cpd:C06066; cpd:C06605; cpd:C07827; cpd:C11405; cpd:C11419; cpd:C19079; cpd:C19084; cpd:C20324; cpd:C20818; cpd:C21012,10,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O3,C10H15O3,184.1099444,185.1177694,183.10211933296,3643,cpd:C06066,"4,5-Dihydro-5,5-dimethyl-4-(3-oxobutyl)furan-2(3H)-one",C10H16O3,"4,5-Dihydro-5,5-dimethyl-4-(3-oxobutyl)furan-2(3H)-one",R04578,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 8333; ChEBI: 27908; NIKKAJI: J1.398.309G,cpd:C00120; cpd:C00884; cpd:C01262; cpd:C01843; cpd:C03843; cpd:C04138; cpd:C04718; cpd:C06066; cpd:C06605; cpd:C07827; cpd:C11405; cpd:C11419; cpd:C19079; cpd:C19084; cpd:C20324; cpd:C20818; cpd:C21012,10,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O3,C10H15O3,184.1099444,185.1177694,183.10211933297,3644,cpd:C06069,Iridodial;,C10H16O2,Iridodial; cis-trans-Iridodial,R02008 R05089,Monoterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;      C06069  Iridodial; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Iridoids;     C06069  Iridodial",CAS: 550-45-8; PubChem: 8336; ChEBI: 5964; KNApSAcK: C00003085; 3DMET: B05156; NIKKAJI: J20.701B,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.10720473298,3645,cpd:C06070,Iridotrial;,C10H14O3,"Iridotrial; (1S,2R,3S)-2-Formyl-alpha-(hydroxymethylene)-3-methylcyclopentaneacetaldehyde",R05089 R05090 R08786,Monoterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;      C06070  Iridotrial; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Iridoids;     C06070  Iridotrial",CAS: 69098-42-6; PubChem: 8337; ChEBI: 5968; LIPIDMAPS: LMPR0102070004; 3DMET: B05157; NIKKAJI: J2.370.749G,cpd:C02952; cpd:C06070; cpd:C07159; cpd:C07826; cpd:C10448; cpd:C15986; cpd:C17822; cpd:C17823; cpd:C17825; cpd:C19351; cpd:C20271; cpd:C20822,10,14,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O3,C10H13O3,182.0942943,183.1021193,181.08646933299,3646,cpd:C06071,Deoxyloganin;,C17H26O9,Deoxyloganin; 7-Deoxyloganin,R03556 R05090 R10835,Monoterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.74; 2.4.1.324,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;      C06071  Deoxyloganin; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Iridoids;     C06071  Deoxyloganin",CAS: 26660-57-1; PubChem: 8338; ChEBI: 18370; LIPIDMAPS: LMPR0102070005; KNApSAcK: C00003077; 3DMET: B01963; NIKKAJI: J17.142E,cpd:C06071; cpd:C11648,17,26,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H27O9,C17H25O9,374.1576824,375.1655074,373.14985743300,3647,cpd:C06074,Myrcene;,C10H16,Myrcene; beta-Myrcene,R02009 R09702 R11055,Monoterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,1.14.14.31; 4.2.1.127; 4.2.3.15,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C06074  Myrcene; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C06074  Myrcene,CAS: 123-35-3; PubChem: 8340; ChEBI: 17221; ChEMBL: CHEMBL455491; LIPIDMAPS: LMPR0102010005; KNApSAcK: C00000853; 3DMET: B00896; NIKKAJI: J2.010I,cpd:C00002; cpd:C00044; cpd:C00120; cpd:C00131; cpd:C00284; cpd:C00286; cpd:C00363; cpd:C00521; cpd:C00591; cpd:C00808; cpd:C00809; cpd:C00848; cpd:C00884; cpd:C00964; cpd:C01123; cpd:C01262; cpd:C01425; cpd:C01499; cpd:C01806; cpd:C01843; cpd:C01889; cpd:C02073; cpd:C02108; cpd:C02173; cpd:C02213; cpd:C02320; cpd:C02452; cpd:C02759; cpd:C02863; cpd:C02967; cpd:C03110; cpd:C03448; cpd:C03495; cpd:C03614; cpd:C03843; cpd:C03933; cpd:C03997; cpd:C04138; cpd:C04155; cpd:C04312; cpd:C04381; cpd:C04435; cpd:C04718; cpd:C05282; cpd:C06066; cpd:C06069; cpd:C06074; cpd:C06075; cpd:C06076; cpd:C06078; cpd:C06099; cpd:C06304; cpd:C06305; cpd:C06306; cpd:C06307; cpd:C06308; cpd:C06605; cpd:C06952; cpd:C06969; cpd:C06976; cpd:C07271; cpd:C07362; cpd:C07827; cpd:C08437; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09839; cpd:C09842; cpd:C09847; cpd:C09854; cpd:C09859; cpd:C09873; cpd:C09875; cpd:C09877; cpd:C09880; cpd:C09882; cpd:C09885; cpd:C09893; cpd:C09898; cpd:C09900; cpd:C09906; cpd:C11120; cpd:C11382; cpd:C11387; cpd:C11391; cpd:C11392; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11402; cpd:C11403; cpd:C11405; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11414; cpd:C11415; cpd:C11418; cpd:C11419; cpd:C11478; cpd:C11651; cpd:C11937; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11943; cpd:C11944; cpd:C11951; cpd:C13311; cpd:C13733; cpd:C13742; cpd:C15563; cpd:C16461; cpd:C16690; cpd:C16691; cpd:C16777; cpd:C17623; cpd:C18018; cpd:C18019; cpd:C18369; cpd:C18658; cpd:C18813; cpd:C19079; cpd:C19081; cpd:C19083; cpd:C19084; cpd:C19112; cpd:C19731; cpd:C19818; cpd:C19967; cpd:C19969; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20230; cpd:C20241; cpd:C20242; cpd:C20244; cpd:C20260; cpd:C20322; cpd:C20323; cpd:C20324; cpd:C20386; cpd:C20387; cpd:C20425; cpd:C20818; cpd:C20825; cpd:C20859; cpd:C20912; cpd:C20943; cpd:C20949; cpd:C21012; cpd:C21031; cpd:C21310,10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17,C10H15,136.1252005,137.1330255,135.11737553301,3648,cpd:C06099,d-Limonene;,C10H16,d-Limonene; (+)-Limonene; (+)-(R)-Limonene; (+)-(4R)-Limonene,R06119 R06120 R06398 R09393,Monoterpenoid biosynthesis; Limonene and pinene degradation; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.80; 1.14.13.107; 4.2.3.20,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C06099  (+)-Limonene; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C06099  (+)-Limonene; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C06099  d-Limonene; Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Monoterpenoids (C10);    D00194  d-Limonene (JAN),CAS: 5989-27-5; PubChem: 8364; ChEBI: 15382; ChEMBL: CHEMBL449062; LIPIDMAPS: LMPR0102090013; KNApSAcK: C00010868; 3DMET: B00899; NIKKAJI: J9.591E,cpd:C00002; cpd:C00044; cpd:C00120; cpd:C00131; cpd:C00284; cpd:C00286; cpd:C00363; cpd:C00521; cpd:C00591; cpd:C00808; cpd:C00809; cpd:C00848; cpd:C00884; cpd:C00964; cpd:C01123; cpd:C01262; cpd:C01425; cpd:C01499; cpd:C01806; cpd:C01843; cpd:C01889; cpd:C02073; cpd:C02108; cpd:C02173; cpd:C02213; cpd:C02320; cpd:C02452; cpd:C02759; cpd:C02863; cpd:C02967; cpd:C03110; cpd:C03448; cpd:C03495; cpd:C03614; cpd:C03843; cpd:C03933; cpd:C03997; cpd:C04138; cpd:C04155; cpd:C04312; cpd:C04381; cpd:C04435; cpd:C04718; cpd:C05282; cpd:C06066; cpd:C06069; cpd:C06074; cpd:C06075; cpd:C06076; cpd:C06078; cpd:C06099; cpd:C06304; cpd:C06305; cpd:C06306; cpd:C06307; cpd:C06308; cpd:C06605; cpd:C06952; cpd:C06969; cpd:C06976; cpd:C07271; cpd:C07362; cpd:C07827; cpd:C08437; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09839; cpd:C09842; cpd:C09847; cpd:C09854; cpd:C09859; cpd:C09873; cpd:C09875; cpd:C09877; cpd:C09880; cpd:C09882; cpd:C09885; cpd:C09893; cpd:C09898; cpd:C09900; cpd:C09906; cpd:C11120; cpd:C11382; cpd:C11387; cpd:C11391; cpd:C11392; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11402; cpd:C11403; cpd:C11405; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11414; cpd:C11415; cpd:C11418; cpd:C11419; cpd:C11478; cpd:C11651; cpd:C11937; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11943; cpd:C11944; cpd:C11951; cpd:C13311; cpd:C13733; cpd:C13742; cpd:C15563; cpd:C16461; cpd:C16690; cpd:C16691; cpd:C16777; cpd:C17623; cpd:C18018; cpd:C18019; cpd:C18369; cpd:C18658; cpd:C18813; cpd:C19079; cpd:C19081; cpd:C19083; cpd:C19084; cpd:C19112; cpd:C19731; cpd:C19818; cpd:C19967; cpd:C19969; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20230; cpd:C20241; cpd:C20242; cpd:C20244; cpd:C20260; cpd:C20322; cpd:C20323; cpd:C20324; cpd:C20386; cpd:C20387; cpd:C20425; cpd:C20818; cpd:C20825; cpd:C20859; cpd:C20912; cpd:C20943; cpd:C20949; cpd:C21012; cpd:C21031; cpd:C21310,10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17,C10H15,136.1252005,137.1330255,135.11737553302,3649,cpd:C06304,(+)-Camphene;,C10H16,(+)-Camphene; (+)-Comphene,R09971,Monoterpenoid biosynthesis; Biosynthesis of terpenoids and steroids,4.2.3.116,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C06304  (+)-Camphene; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C06304  (+)-Camphene,CAS: 5794-03-6; PubChem: 8540; ChEBI: 20; ChEMBL: CHEMBL510535; LIPIDMAPS: LMPR0102120011; KNApSAcK: C00000818; 3DMET: B02000; NIKKAJI: J39.021F,cpd:C00002; cpd:C00044; cpd:C00120; cpd:C00131; cpd:C00284; cpd:C00286; cpd:C00363; cpd:C00521; cpd:C00591; cpd:C00808; cpd:C00809; cpd:C00848; cpd:C00884; cpd:C00964; cpd:C01123; cpd:C01262; cpd:C01425; cpd:C01499; cpd:C01806; cpd:C01843; cpd:C01889; cpd:C02073; cpd:C02108; cpd:C02173; cpd:C02213; cpd:C02320; cpd:C02452; cpd:C02759; cpd:C02863; cpd:C02967; cpd:C03110; cpd:C03448; cpd:C03495; cpd:C03614; cpd:C03843; cpd:C03933; cpd:C03997; cpd:C04138; cpd:C04155; cpd:C04312; cpd:C04381; cpd:C04435; cpd:C04718; cpd:C05282; cpd:C06066; cpd:C06069; cpd:C06074; cpd:C06075; cpd:C06076; cpd:C06078; cpd:C06099; cpd:C06304; cpd:C06305; cpd:C06306; cpd:C06307; cpd:C06308; cpd:C06605; cpd:C06952; cpd:C06969; cpd:C06976; cpd:C07271; cpd:C07362; cpd:C07827; cpd:C08437; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09839; cpd:C09842; cpd:C09847; cpd:C09854; cpd:C09859; cpd:C09873; cpd:C09875; cpd:C09877; cpd:C09880; cpd:C09882; cpd:C09885; cpd:C09893; cpd:C09898; cpd:C09900; cpd:C09906; cpd:C11120; cpd:C11382; cpd:C11387; cpd:C11391; cpd:C11392; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11402; cpd:C11403; cpd:C11405; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11414; cpd:C11415; cpd:C11418; cpd:C11419; cpd:C11478; cpd:C11651; cpd:C11937; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11943; cpd:C11944; cpd:C11951; cpd:C13311; cpd:C13733; cpd:C13742; cpd:C15563; cpd:C16461; cpd:C16690; cpd:C16691; cpd:C16777; cpd:C17623; cpd:C18018; cpd:C18019; cpd:C18369; cpd:C18658; cpd:C18813; cpd:C19079; cpd:C19081; cpd:C19083; cpd:C19084; cpd:C19112; cpd:C19731; cpd:C19818; cpd:C19967; cpd:C19969; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20230; cpd:C20241; cpd:C20242; cpd:C20244; cpd:C20260; cpd:C20322; cpd:C20323; cpd:C20324; cpd:C20386; cpd:C20387; cpd:C20425; cpd:C20818; cpd:C20825; cpd:C20859; cpd:C20912; cpd:C20943; cpd:C20949; cpd:C21012; cpd:C21031; cpd:C21310,10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17,C10H15,136.1252005,137.1330255,135.11737553303,3650,cpd:C06305,(-)-Camphene;,C10H16,(-)-Camphene; (-)-Comphene,R09972,Monoterpenoid biosynthesis,4.2.3.117,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C06305  (-)-Camphene; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C06305  (-)-Camphene,PubChem: 8541; ChEBI: 89; ChEMBL: CHEMBL506889; KNApSAcK: C00003029; 3DMET: B02001; NIKKAJI: J39.022D,cpd:C00002; cpd:C00044; cpd:C00120; cpd:C00131; cpd:C00284; cpd:C00286; cpd:C00363; cpd:C00521; cpd:C00591; cpd:C00808; cpd:C00809; cpd:C00848; cpd:C00884; cpd:C00964; cpd:C01123; cpd:C01262; cpd:C01425; cpd:C01499; cpd:C01806; cpd:C01843; cpd:C01889; cpd:C02073; cpd:C02108; cpd:C02173; cpd:C02213; cpd:C02320; cpd:C02452; cpd:C02759; cpd:C02863; cpd:C02967; cpd:C03110; cpd:C03448; cpd:C03495; cpd:C03614; cpd:C03843; cpd:C03933; cpd:C03997; cpd:C04138; cpd:C04155; cpd:C04312; cpd:C04381; cpd:C04435; cpd:C04718; cpd:C05282; cpd:C06066; cpd:C06069; cpd:C06074; cpd:C06075; cpd:C06076; cpd:C06078; cpd:C06099; cpd:C06304; cpd:C06305; cpd:C06306; cpd:C06307; cpd:C06308; cpd:C06605; cpd:C06952; cpd:C06969; cpd:C06976; cpd:C07271; cpd:C07362; cpd:C07827; cpd:C08437; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09839; cpd:C09842; cpd:C09847; cpd:C09854; cpd:C09859; cpd:C09873; cpd:C09875; cpd:C09877; cpd:C09880; cpd:C09882; cpd:C09885; cpd:C09893; cpd:C09898; cpd:C09900; cpd:C09906; cpd:C11120; cpd:C11382; cpd:C11387; cpd:C11391; cpd:C11392; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11402; cpd:C11403; cpd:C11405; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11414; cpd:C11415; cpd:C11418; cpd:C11419; cpd:C11478; cpd:C11651; cpd:C11937; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11943; cpd:C11944; cpd:C11951; cpd:C13311; cpd:C13733; cpd:C13742; cpd:C15563; cpd:C16461; cpd:C16690; cpd:C16691; cpd:C16777; cpd:C17623; cpd:C18018; cpd:C18019; cpd:C18369; cpd:C18658; cpd:C18813; cpd:C19079; cpd:C19081; cpd:C19083; cpd:C19084; cpd:C19112; cpd:C19731; cpd:C19818; cpd:C19967; cpd:C19969; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20230; cpd:C20241; cpd:C20242; cpd:C20244; cpd:C20260; cpd:C20322; cpd:C20323; cpd:C20324; cpd:C20386; cpd:C20387; cpd:C20425; cpd:C20818; cpd:C20825; cpd:C20859; cpd:C20912; cpd:C20943; cpd:C20949; cpd:C21012; cpd:C21031; cpd:C21310,10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17,C10H15,136.1252005,137.1330255,135.11737553304,3651,cpd:C06307,(-)-beta-Pinene;,C10H16,"(-)-beta-Pinene; (1S,5S)-6,6-Dimethyl-2-methylenebicyclo[3.1.1]heptane",R05766,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.120,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C06307  (-)-beta-Pinene; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C06307  (-)-beta-Pinene,CAS: 18172-67-3; PubChem: 8543; ChEBI: 28359; LIPIDMAPS: LMPR0102120013; KNApSAcK: C00000806; 3DMET: B02003; NIKKAJI: J108.666I,cpd:C00002; cpd:C00044; cpd:C00120; cpd:C00131; cpd:C00284; cpd:C00286; cpd:C00363; cpd:C00521; cpd:C00591; cpd:C00808; cpd:C00809; cpd:C00848; cpd:C00884; cpd:C00964; cpd:C01123; cpd:C01262; cpd:C01425; cpd:C01499; cpd:C01806; cpd:C01843; cpd:C01889; cpd:C02073; cpd:C02108; cpd:C02173; cpd:C02213; cpd:C02320; cpd:C02452; cpd:C02759; cpd:C02863; cpd:C02967; cpd:C03110; cpd:C03448; cpd:C03495; cpd:C03614; cpd:C03843; cpd:C03933; cpd:C03997; cpd:C04138; cpd:C04155; cpd:C04312; cpd:C04381; cpd:C04435; cpd:C04718; cpd:C05282; cpd:C06066; cpd:C06069; cpd:C06074; cpd:C06075; cpd:C06076; cpd:C06078; cpd:C06099; cpd:C06304; cpd:C06305; cpd:C06306; cpd:C06307; cpd:C06308; cpd:C06605; cpd:C06952; cpd:C06969; cpd:C06976; cpd:C07271; cpd:C07362; cpd:C07827; cpd:C08437; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09839; cpd:C09842; cpd:C09847; cpd:C09854; cpd:C09859; cpd:C09873; cpd:C09875; cpd:C09877; cpd:C09880; cpd:C09882; cpd:C09885; cpd:C09893; cpd:C09898; cpd:C09900; cpd:C09906; cpd:C11120; cpd:C11382; cpd:C11387; cpd:C11391; cpd:C11392; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11402; cpd:C11403; cpd:C11405; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11414; cpd:C11415; cpd:C11418; cpd:C11419; cpd:C11478; cpd:C11651; cpd:C11937; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11943; cpd:C11944; cpd:C11951; cpd:C13311; cpd:C13733; cpd:C13742; cpd:C15563; cpd:C16461; cpd:C16690; cpd:C16691; cpd:C16777; cpd:C17623; cpd:C18018; cpd:C18019; cpd:C18369; cpd:C18658; cpd:C18813; cpd:C19079; cpd:C19081; cpd:C19083; cpd:C19084; cpd:C19112; cpd:C19731; cpd:C19818; cpd:C19967; cpd:C19969; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20230; cpd:C20241; cpd:C20242; cpd:C20244; cpd:C20260; cpd:C20322; cpd:C20323; cpd:C20324; cpd:C20386; cpd:C20387; cpd:C20425; cpd:C20818; cpd:C20825; cpd:C20859; cpd:C20912; cpd:C20943; cpd:C20949; cpd:C21012; cpd:C21031; cpd:C21310,10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17,C10H15,136.1252005,137.1330255,135.11737553305,3652,cpd:C06308,(-)-alpha-Pinene;,C10H16,"(-)-alpha-Pinene; (1S,5S)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene",R05765,Monoterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.3.119,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C06308  (-)-alpha-Pinene; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C06308  (-)-alpha-Pinene,CAS: 7785-26-4; PubChem: 8544; ChEBI: 28660; KNApSAcK: C00035786; 3DMET: B02004; NIKKAJI: J95.400D,cpd:C00002; cpd:C00044; cpd:C00120; cpd:C00131; cpd:C00284; cpd:C00286; cpd:C00363; cpd:C00521; cpd:C00591; cpd:C00808; cpd:C00809; cpd:C00848; cpd:C00884; cpd:C00964; cpd:C01123; cpd:C01262; cpd:C01425; cpd:C01499; cpd:C01806; cpd:C01843; cpd:C01889; cpd:C02073; cpd:C02108; cpd:C02173; cpd:C02213; cpd:C02320; cpd:C02452; cpd:C02759; cpd:C02863; cpd:C02967; cpd:C03110; cpd:C03448; cpd:C03495; cpd:C03614; cpd:C03843; cpd:C03933; cpd:C03997; cpd:C04138; cpd:C04155; cpd:C04312; cpd:C04381; cpd:C04435; cpd:C04718; cpd:C05282; cpd:C06066; cpd:C06069; cpd:C06074; cpd:C06075; cpd:C06076; cpd:C06078; cpd:C06099; cpd:C06304; cpd:C06305; cpd:C06306; cpd:C06307; cpd:C06308; cpd:C06605; cpd:C06952; cpd:C06969; cpd:C06976; cpd:C07271; cpd:C07362; cpd:C07827; cpd:C08437; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09839; cpd:C09842; cpd:C09847; cpd:C09854; cpd:C09859; cpd:C09873; cpd:C09875; cpd:C09877; cpd:C09880; cpd:C09882; cpd:C09885; cpd:C09893; cpd:C09898; cpd:C09900; cpd:C09906; cpd:C11120; cpd:C11382; cpd:C11387; cpd:C11391; cpd:C11392; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11402; cpd:C11403; cpd:C11405; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11414; cpd:C11415; cpd:C11418; cpd:C11419; cpd:C11478; cpd:C11651; cpd:C11937; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11943; cpd:C11944; cpd:C11951; cpd:C13311; cpd:C13733; cpd:C13742; cpd:C15563; cpd:C16461; cpd:C16690; cpd:C16691; cpd:C16777; cpd:C17623; cpd:C18018; cpd:C18019; cpd:C18369; cpd:C18658; cpd:C18813; cpd:C19079; cpd:C19081; cpd:C19083; cpd:C19084; cpd:C19112; cpd:C19731; cpd:C19818; cpd:C19967; cpd:C19969; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20230; cpd:C20241; cpd:C20242; cpd:C20244; cpd:C20260; cpd:C20322; cpd:C20323; cpd:C20324; cpd:C20386; cpd:C20387; cpd:C20425; cpd:C20818; cpd:C20825; cpd:C20859; cpd:C20912; cpd:C20943; cpd:C20949; cpd:C21012; cpd:C21031; cpd:C21310,10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17,C10H15,136.1252005,137.1330255,135.11737553306,3653,cpd:C09769,Asperuloside,C18H22O11,Asperuloside,R05900,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Iridoids;     C09769  Asperuloside,CAS: 14259-45-1; PubChem: 11957; ChEBI: 2881; ChEMBL: CHEMBL461910; KNApSAcK: C00003072; 3DMET: B03267; NIKKAJI: J15.445H,cpd:C09769; cpd:C09795,18,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H23O11,C18H21O11,414.1162115,415.1240366,413.10838653307,3654,cpd:C09844,"1,8-Cineole;",C10H18O,"1,8-Cineole; 1,8-Cineol; Eucalyptol",R06422 R08784 R09964 R10076,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites; Inflammatory mediator regulation of TRP channels,1.14.13.156; 1.14.13.157; 4.2.3.108,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C09844  1,8-Cineole; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C09844  1,8-Cineole; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  R RESPIRATORY SYSTEM;   R05 COUGH AND COLD PREPARATIONS;    R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;     R05CA Expectorants;      R05CA13 Cineole;       D04115  Eucalyptol (USAN); Major components of natural products [BR:br08323];  Crude drugs;   Bitter cardamon;    C09844  1,8-Cineole;   Alpinia offcinarum rhizome;    C09844  1,8-Cineole;  Essential oils;   Spike oil;    C09844  1,8-Cineole;   Sage oil (Spanish);    C09844  1,8-Cineole;   Eucalyptus oil;    C09844  1,8-Cineole;   Lemon oil;    C09844  1,8-Cineole;   Cardamom oil;    C09844  1,8-Cineole; Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Monoterpenoids (C10);    D04115  Eucalyptol (USAN); Animal drugs in Japan [BR:br08331];  99  Agents for not mainly purpose of therapeutic;   993  Insecticides and insect-repellents;    9939  Other insecticides and insect repellents;     D04115  Eucalyptol",CAS: 470-82-6; PubChem: 12031; ChEBI: 27961; ChEMBL: CHEMBL1397305 CHEMBL485259; LIPIDMAPS: LMPR0102090019; KNApSAcK: C00000136; PDB-CCD: CNL; 3DMET: B01118; NIKKAJI: J3.281F,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023308,3655,cpd:C09893,Pulegone;,C10H16O,Pulegone; (+)-Pulegone,R06418 R06419 R06420 R08923,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.81; 1.14.13.104,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C09893  Pulegone; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C09893  (+)-Pulegone; Animal drugs in Japan [BR:br08331];  99  Agents for not mainly purpose of therapeutic;   993  Insecticides and insect-repellents;    9939  Other insecticides and insect repellents;     C09893  Pulegone,CAS: 89-82-7; PubChem: 12079; ChEBI: 35596; LIPIDMAPS: LMPR0102090025; KNApSAcK: C00000827; 3DMET: B03356; NIKKAJI: J3.216F,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013309,3656,cpd:C11383,(+)-(S)-Carvone;,C10H14O,(+)-(S)-Carvone; Carvol; (+)-Carvone; Carvone,R06117 R06372 R06375,Monoterpenoid biosynthesis; Limonene and pinene degradation; Biosynthesis of secondary metabolites,1.1.1.275; 1.3.99.25,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11383  (+)-(S)-Carvone; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11383  (+)-(S)-Carvone; Major components of natural products [BR:br08323];  Essential oils;   Caraway oil;    C11383  (+)-(S)-Carvone;   Spearmint oil;    C11383  (+)-(S)-Carvone,CAS: 2244-16-8; PubChem: 13557; ChEBI: 15399; ChEMBL: CHEMBL501949; KNApSAcK: C00010891; PDB-CCD: 0WU; 3DMET: B04232; NIKKAJI: J9.490K,cpd:C01056; cpd:C01767; cpd:C01868; cpd:C01951; cpd:C02289; cpd:C02485; cpd:C02576; cpd:C03043; cpd:C06576; cpd:C09840; cpd:C09843; cpd:C09868; cpd:C09884; cpd:C09908; cpd:C09911; cpd:C09913; cpd:C11383; cpd:C11394; cpd:C11939; cpd:C14130; cpd:C14138; cpd:C14139; cpd:C14188; cpd:C14200; cpd:C14464; cpd:C14741; cpd:C16569; cpd:C16955; cpd:C17062; cpd:C17103; cpd:C18025; cpd:C20361; cpd:C20944,10,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1,C10H13O1,150.1044651,151.1122901,149.096643310,3657,cpd:C11388,(-)-Linalool;,C10H18O,(-)-Linalool; (R)-(-)-Linalool; (3R)-Linalool,R07632 R09923,Monoterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.14.13.151; 4.2.3.26,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C11388  (-)-Linalool; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C11388  (-)-Linalool; Major components of natural products [BR:br08323];  Essential oils;   Coriander oil;    C11388  (-)-Linalool;   Lavender oil;    C11388  (-)-Linalool;   Lavandin oil;    C11388  (-)-Linalool;   Neroli oil;    C11388  (-)-Linalool;   Rosewood oil;    C11388  (-)-Linalool,CAS: 126-91-0; PubChem: 13562; ChEBI: 28; ChEMBL: CHEMBL235672; LIPIDMAPS: LMPR0102010013; KNApSAcK: C00003047 C00034888; 3DMET: B04235; NIKKAJI: J9.271A,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023311,3658,cpd:C11389,(+)-Linalool;,C10H18O,(+)-Linalool; (S)-(+)-Linalool; (3S)-Linalool,R07631 R09702 R09708 R09922,Monoterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.14.13.151; 4.2.1.127; 4.2.3.25; 5.4.4.4,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010201 Acyclic monoterpenoids;      C11389  (+)-Linalool; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C11389  (+)-Linalool; Major components of natural products [BR:br08323];  Essential oils;   Coriander oil;    C11389  (+)-Linalool;   Lavender oil;    C11389  (+)-Linalool;   Lavandin oil;    C11389  (+)-Linalool;   Neroli oil;    C11389  (+)-Linalool;   Rosewood oil;    C11389  (+)-Linalool,CAS: 126-90-9; PubChem: 13563; ChEBI: 98; KNApSAcK: C00010301; 3DMET: B04236; NIKKAJI: J9.270C,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023312,3659,cpd:C11393,(-)-alpha-Terpineol;,C10H18O,(-)-alpha-Terpineol; (L)-alpha-Terpineol,R06421 R06422,Monoterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.3.108; 4.2.3.111,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11393  (-)-alpha-Terpineol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11393  (-)-alpha-Terpineol,CAS: 10482-56-1; PubChem: 13567; ChEBI: 128; ChEMBL: CHEMBL447597; KNApSAcK: C00010932; 3DMET: B04240; NIKKAJI: J9.809D,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023313,3660,cpd:C11409,(+)-trans-Carveol;,C10H16O,"(+)-trans-Carveol; (4S,6R)-trans-Carveol",R06117 R06119,Monoterpenoid biosynthesis; Limonene and pinene degradation; Biosynthesis of secondary metabolites,1.1.1.275; 1.14.13.80,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11409  (+)-trans-Carveol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11409  (+)-trans-Carveol,PubChem: 13583; ChEBI: 15388; KNApSAcK: C00010883; 3DMET: B04252; NIKKAJI: J9.143J,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013314,3661,cpd:C11636,7-Deoxyloganate,C16H24O9,7-Deoxyloganate,R05832 R08786 R10834,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.74; 2.4.1.323,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Iridoids;     C11636  7-Deoxyloganate,PubChem: 13801; ChEBI: 2260; KNApSAcK: C00036651; 3DMET: B04278; NIKKAJI: J617.358F,cpd:C11636; cpd:C11649,16,24,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O9,C16H23O9,360.1420323,361.1498574,359.13420733315,3662,cpd:C11672,10-Deoxygeniposidic acid,C16H22O9,10-Deoxygeniposidic acid,R05898 R05899,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Iridoids;     C11672  10-Deoxygeniposidic acid,PubChem: 13837; ChEBI: 695; KNApSAcK: C00049601; 3DMET: B04303; NIKKAJI: J471.970K,cpd:C06566; cpd:C06667; cpd:C11654; cpd:C11672; cpd:C17071,16,22,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H23O9,C16H21O9,358.1263823,359.1342073,357.11855733316,3663,cpd:C11673,Geniposidic acid,C16H22O10,Geniposidic acid,R05899 R05900,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Iridoids;     C11673  Geniposidic acid,CAS: 27741-01-1; PubChem: 13838; ChEBI: 5301; ChEMBL: CHEMBL460031; KNApSAcK: C00010564; 3DMET: B04304; NIKKAJI: J17.202B,cpd:C01957; cpd:C09800; cpd:C11673; cpd:C16963,16,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H23O10,C16H21O10,374.1212969,375.1291219,373.11347193317,3664,cpd:C11951,(+)-cis-Isopulegone,C10H16O,(+)-cis-Isopulegone,R06417 R06418,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.82,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11951  (+)-cis-Isopulegone; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11951  (+)-cis-Isopulegone,PubChem: 14112; ChEBI: 37047; LIPIDMAPS: LMPR0102090043; KNApSAcK: C00000820; 3DMET: B04385; NIKKAJI: J372.105A,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013318,3665,cpd:C11952,(+)-Isomenthone,C10H18O,(+)-Isomenthone,R06420,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.81,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11952  (+)-Isomenthone; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11952  (+)-Isomenthone,CAS: 1196-31-2; PubChem: 14113; ChEBI: 36492; LIPIDMAPS: LMPR0102090044; KNApSAcK: C00010902; 3DMET: B04386; NIKKAJI: J109.970A,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023319,3666,cpd:C17621,(6E)-8-Hydroxygeraniol;,C10H18O2,(6E)-8-Hydroxygeraniol; 10-Hydroxygeraniol; 8-Hydroxygeraniol,R08499 R08785 R09926 R09928,Monoterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.324; 1.14.13.152,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C17621  10-Hydroxygeraniol,PubChem: 96023965; ChEBI: 64235; NIKKAJI: J37.635C,cpd:C03092; cpd:C04433; cpd:C06185; cpd:C07276; cpd:C07640; cpd:C09790; cpd:C16255; cpd:C16462; cpd:C17621; cpd:C18020; cpd:C18027; cpd:C18066; cpd:C18202; cpd:C19082; cpd:C20326; cpd:C21139,10,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O2,C10H17O2,170.1306798,171.1385049,169.12285483320,3667,cpd:C17622,(6E)-8-Oxogeranial;,C10H14O2,(6E)-8-Oxogeranial; 10-Oxogeranial; 8-Oxogeranial,R02008 R08499 R09927 R09929,Monoterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.324,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Linear monoterpenes;     C17622  10-Oxogeranial,PubChem: 96023966; ChEBI: 64239; PDB-CCD: XOG; NIKKAJI: J1.586.658F,cpd:C01297; cpd:C03037; cpd:C09777; cpd:C09791; cpd:C09792; cpd:C09841; cpd:C09887; cpd:C09896; cpd:C10960; cpd:C11924; cpd:C11940; cpd:C13708; cpd:C14351; cpd:C14515; cpd:C17622; cpd:C17690; cpd:C17824; cpd:C17964; cpd:C18343; cpd:C18352; cpd:C20320,10,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O2,C10H13O2,166.0993797,167.1072047,165.09155473321,3668,cpd:C18025,(+)-Menthofuran;,C10H14O,(+)-Menthofuran; (R)-Menthofuran,R08923,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.104,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C18025  (+)-Menthofuran,PubChem: 96024245; ChEBI: 6750; KNApSAcK: C00003049; NIKKAJI: J330.675E,cpd:C01056; cpd:C01767; cpd:C01868; cpd:C01951; cpd:C02289; cpd:C02485; cpd:C02576; cpd:C03043; cpd:C06576; cpd:C09840; cpd:C09843; cpd:C09868; cpd:C09884; cpd:C09908; cpd:C09911; cpd:C09913; cpd:C11383; cpd:C11394; cpd:C11939; cpd:C14130; cpd:C14138; cpd:C14139; cpd:C14188; cpd:C14200; cpd:C14464; cpd:C14741; cpd:C16569; cpd:C16955; cpd:C17062; cpd:C17103; cpd:C18025; cpd:C20361; cpd:C20944,10,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1,C10H13O1,150.1044651,151.1122901,149.096643322,3669,cpd:C18027,"(4R,7S)-7-Isopropyl-4-methyloxepan-2-one;",C10H18O2,"(4R,7S)-7-Isopropyl-4-methyloxepan-2-one; (4R,7S)-4-Methyl-7-(1-methylethyl)-2-Oxepanone; Mentholactone",R08925,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.105,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C18027  (4R,7S)-7-Isopropyl-4-methyloxepan-2-one",CAS: 68330-67-6; PubChem: 96024247; ChEBI: 50250; KNApSAcK: C00000838; NIKKAJI: J334.144E,cpd:C03092; cpd:C04433; cpd:C06185; cpd:C07276; cpd:C07640; cpd:C09790; cpd:C16255; cpd:C16462; cpd:C17621; cpd:C18020; cpd:C18027; cpd:C18066; cpd:C18202; cpd:C19082; cpd:C20326; cpd:C21139,10,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O2,C10H17O2,170.1306798,171.1385049,169.12285483323,3670,cpd:C20221,(6E)-8-Oxolinalool;,C10H16O2,(6E)-8-Oxolinalool; trans-8-Oxolinalool,R09924 R09925,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.151,NA,NA,PubChem: 163311964,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.10720473324,3671,cpd:C20943,(R)-Ipsdienol;,C10H16O,"(R)-Ipsdienol; (4R)-2-Methyl-6-methyleneocta-2,7-dien-4-ol",R10918 R10919 R11055,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.386; 1.14.14.31,NA,NA,CAS: 60894-97-5; PubChem: 254741405,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013325,3672,cpd:C20944,Ipsdienone;,C10H14O,"Ipsdienone; 2-Methyl-6-methyleneocta-2,7-dien-4-one",R10918 R10919,Monoterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.386,NA,NA,PubChem: 254741406,cpd:C01056; cpd:C01767; cpd:C01868; cpd:C01951; cpd:C02289; cpd:C02485; cpd:C02576; cpd:C03043; cpd:C06576; cpd:C09840; cpd:C09843; cpd:C09868; cpd:C09884; cpd:C09908; cpd:C09911; cpd:C09913; cpd:C11383; cpd:C11394; cpd:C11939; cpd:C14130; cpd:C14138; cpd:C14139; cpd:C14188; cpd:C14200; cpd:C14464; cpd:C14741; cpd:C16569; cpd:C16955; cpd:C17062; cpd:C17103; cpd:C18025; cpd:C20361; cpd:C20944,10,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1,C10H13O1,150.1044651,151.1122901,149.096643326,3673,cpd:C21203,Geranyl phosphate,C10H19O4P,Geranyl phosphate,R11551 R11552,Monoterpenoid biosynthesis,3.6.1.68,NA,NA,PubChem: 315431318,cpd:C18974; cpd:C21203,10,19,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H20O4P1,C10H18O4P1,234.1020961,235.1099211,233.09427113327,3674,cpd:C02576,Perillyl aldehyde;,C10H14O,Perillyl aldehyde; Perillaldehyde,R03945 R06366,Limonene and pinene degradation,1.1.1.144; 1.2.1.3,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C02576  Perillyl aldehyde; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C02576  Perillyl aldehyde; Major components of natural products [BR:br08323];  Crude drugs;   Perilla herb;    C02576  Perillyl aldehyde,CAS: 2111-75-3; PubChem: 5571; ChEBI: 15421; ChEMBL: CHEMBL469537; LIPIDMAPS: LMPR0102090010; KNApSAcK: C00003050; 3DMET: B00463; NIKKAJI: J2.142C,cpd:C01056; cpd:C01767; cpd:C01868; cpd:C01951; cpd:C02289; cpd:C02485; cpd:C02576; cpd:C03043; cpd:C06576; cpd:C09840; cpd:C09843; cpd:C09868; cpd:C09884; cpd:C09908; cpd:C09911; cpd:C09913; cpd:C11383; cpd:C11394; cpd:C11939; cpd:C14130; cpd:C14138; cpd:C14139; cpd:C14188; cpd:C14200; cpd:C14464; cpd:C14741; cpd:C16569; cpd:C16955; cpd:C17062; cpd:C17103; cpd:C18025; cpd:C20361; cpd:C20944,10,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1,C10H13O1,150.1044651,151.1122901,149.096643328,3675,cpd:C02759,alpha-Pinene-oxide,C10H16O,alpha-Pinene-oxide,R04040 R06406,Limonene and pinene degradation,1.14.13.-; 5.5.1.10,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C02759  alpha-Pinene-oxide; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C02759  alpha-Pinene-oxide,CAS: 72936-74-4; PubChem: 5716; ChEBI: 29060; LIPIDMAPS: LMPR0102120007; KNApSAcK: C00034794; 3DMET: B04864; NIKKAJI: J909.024J,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013329,3676,cpd:C04435,"(Z)-2-Methyl-5-isopropylhexa-2,5-dienal;",C10H16O,"(Z)-2-Methyl-5-isopropylhexa-2,5-dienal; cis-2-Methyl-5-isopropylhexa-2,5-dienal",R04040 R06407,Limonene and pinene degradation,1.2.1.-; 5.5.1.10,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010202 Irregular acyclic monoterpenoids;      C04435  cis-2-Methyl-5-isopropylhexa-2,5-dienal",CAS: 112164-19-9; PubChem: 7066; ChEBI: 17546; LIPIDMAPS: LMPR0102020001; 3DMET: B00713; NIKKAJI: J1.871.103F,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013330,3677,cpd:C07271,"Limonene-1,2-epoxide;",C10H16O,"Limonene-1,2-epoxide; Limonene oxide; (4R)-Limonene-1,2-epoxide",R05784 R06398 R09393,Limonene and pinene degradation,1.14.13.107; 3.3.2.8,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C07271  Limonene-1,2-epoxide; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C07271  Limonene-1,2-epoxide",CAS: 1195-92-2; PubChem: 9480; ChEBI: 35672; LIPIDMAPS: LMPR0102090015; KNApSAcK: C00035852; PDB-CCD: LEO; 3DMET: B05244; NIKKAJI: J27.205A,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013331,3678,cpd:C07276,"Limonene-1,2-diol;",C10H18O2,"Limonene-1,2-diol; (1S,2S,4R)-Limonene-1,2-diol; (1S,2S,4R)-Menth-8-ene-1,2-diol",R05784 R06399,Limonene and pinene degradation,1.1.1.297; 3.3.2.8,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C07276  Limonene-1,2-diol",PubChem: 9485; ChEBI: 17219 18515; LIPIDMAPS: LMPR0102090016; KNApSAcK: C00041256; 3DMET: B02112; NIKKAJI: J490.629B,cpd:C03092; cpd:C04433; cpd:C06185; cpd:C07276; cpd:C07640; cpd:C09790; cpd:C16255; cpd:C16462; cpd:C17621; cpd:C18020; cpd:C18027; cpd:C18066; cpd:C18202; cpd:C19082; cpd:C20326; cpd:C21139,10,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O2,C10H17O2,170.1306798,171.1385049,169.12285483332,3679,cpd:C09880,alpha-Pinene,C10H16,alpha-Pinene,R06401 R06404 R06406,Limonene and pinene degradation; Biosynthesis of secondary metabolites,1.14.13.-; 1.14.-.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C09880  alpha-Pinene; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C09880  alpha-Pinene; Major components of natural products [BR:br08323];  Essential oils;   Labdanum oil;    C09880  alpha-Pinene;   Olibanum oil;    C09880  alpha-Pinene;   Nutmeg oil (Indonesia);    C09880  alpha-Pinene;   Turpentine oil;    C09880  alpha-Pinene,CAS: 80-56-8 2437-95-8; PubChem: 12066; ChEBI: 36740; ChEMBL: CHEMBL442565; KNApSAcK: C00000805; 3DMET: B05392; NIKKAJI: J196.322H J3.210G,cpd:C00002; cpd:C00044; cpd:C00120; cpd:C00131; cpd:C00284; cpd:C00286; cpd:C00363; cpd:C00521; cpd:C00591; cpd:C00808; cpd:C00809; cpd:C00848; cpd:C00884; cpd:C00964; cpd:C01123; cpd:C01262; cpd:C01425; cpd:C01499; cpd:C01806; cpd:C01843; cpd:C01889; cpd:C02073; cpd:C02108; cpd:C02173; cpd:C02213; cpd:C02320; cpd:C02452; cpd:C02759; cpd:C02863; cpd:C02967; cpd:C03110; cpd:C03448; cpd:C03495; cpd:C03614; cpd:C03843; cpd:C03933; cpd:C03997; cpd:C04138; cpd:C04155; cpd:C04312; cpd:C04381; cpd:C04435; cpd:C04718; cpd:C05282; cpd:C06066; cpd:C06069; cpd:C06074; cpd:C06075; cpd:C06076; cpd:C06078; cpd:C06099; cpd:C06304; cpd:C06305; cpd:C06306; cpd:C06307; cpd:C06308; cpd:C06605; cpd:C06952; cpd:C06969; cpd:C06976; cpd:C07271; cpd:C07362; cpd:C07827; cpd:C08437; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09839; cpd:C09842; cpd:C09847; cpd:C09854; cpd:C09859; cpd:C09873; cpd:C09875; cpd:C09877; cpd:C09880; cpd:C09882; cpd:C09885; cpd:C09893; cpd:C09898; cpd:C09900; cpd:C09906; cpd:C11120; cpd:C11382; cpd:C11387; cpd:C11391; cpd:C11392; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11402; cpd:C11403; cpd:C11405; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11414; cpd:C11415; cpd:C11418; cpd:C11419; cpd:C11478; cpd:C11651; cpd:C11937; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11943; cpd:C11944; cpd:C11951; cpd:C13311; cpd:C13733; cpd:C13742; cpd:C15563; cpd:C16461; cpd:C16690; cpd:C16691; cpd:C16777; cpd:C17623; cpd:C18018; cpd:C18019; cpd:C18369; cpd:C18658; cpd:C18813; cpd:C19079; cpd:C19081; cpd:C19083; cpd:C19084; cpd:C19112; cpd:C19731; cpd:C19818; cpd:C19967; cpd:C19969; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20230; cpd:C20241; cpd:C20242; cpd:C20244; cpd:C20260; cpd:C20322; cpd:C20323; cpd:C20324; cpd:C20386; cpd:C20387; cpd:C20425; cpd:C20818; cpd:C20825; cpd:C20859; cpd:C20912; cpd:C20943; cpd:C20949; cpd:C21012; cpd:C21031; cpd:C21310,10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17,C10H15,136.1252005,137.1330255,135.11737553333,3680,cpd:C09884,Pinocarvone,C10H14O,Pinocarvone,R06405,Limonene and pinene degradation,1.1.-.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C09884  Pinocarvone; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C09884  Pinocarvone,CAS: 30460-92-5; PubChem: 12070; ChEBI: 28996; LIPIDMAPS: LMPR0102090023; KNApSAcK: C00003053 C00037652; 3DMET: B05394; NIKKAJI: J265.105J,cpd:C01056; cpd:C01767; cpd:C01868; cpd:C01951; cpd:C02289; cpd:C02485; cpd:C02576; cpd:C03043; cpd:C06576; cpd:C09840; cpd:C09843; cpd:C09868; cpd:C09884; cpd:C09908; cpd:C09911; cpd:C09913; cpd:C11383; cpd:C11394; cpd:C11939; cpd:C14130; cpd:C14138; cpd:C14139; cpd:C14188; cpd:C14200; cpd:C14464; cpd:C14741; cpd:C16569; cpd:C16955; cpd:C17062; cpd:C17103; cpd:C18025; cpd:C20361; cpd:C20944,10,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1,C10H13O1,150.1044651,151.1122901,149.096643334,3681,cpd:C11395,"(4R,6R)-cis-Carveol",C10H16O,"(4R,6R)-cis-Carveol",R06374,Limonene and pinene degradation,NA,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11395  (4R,6R)-cis-Carveol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11395  (4R,6R)-cis-Carveol",CAS: 2102-59-2; PubChem: 13569; ChEBI: 227; LIPIDMAPS: LMPR0102090030; KNApSAcK: C00029971; 3DMET: B04241; NIKKAJI: J9.138C,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013335,3682,cpd:C11396,"(1R,2R,4R)-Dihydrocarveol;",C10H18O,"(1R,2R,4R)-Dihydrocarveol; (-)-Dihydrocarveol",R06376,Limonene and pinene degradation,1.1.1.296,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11396  (1R,2R,4R)-Dihydrocarveol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11396  (1R,2R,4R)-Dihydrocarveol",CAS: 20549-47-7; PubChem: 13570; ChEBI: 149; LIPIDMAPS: LMPR0102090031; KNApSAcK: C00010937; 3DMET: B04242; NIKKAJI: J15.351F,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023336,3683,cpd:C11397,"(1R,2S,4R)-Neo-dihydrocarveol",C10H18O,"(1R,2S,4R)-Neo-dihydrocarveol",R06378,Limonene and pinene degradation; Degradation of aromatic compounds,1.1.1.296,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11397  (1R,2S,4R)-Neo-dihydrocarveol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11397  (1R,2S,4R)-Neo-dihydrocarveol",CAS: 20549-48-8; PubChem: 13571; ChEBI: 152; LIPIDMAPS: LMPR0102090032; KNApSAcK: C00030810; 3DMET: B04243; NIKKAJI: J86.004B,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023337,3684,cpd:C11398,"(1R,4R)-Dihydrocarvone",C10H16O,"(1R,4R)-Dihydrocarvone",R06373 R06376 R06378 R06380 R06386,Limonene and pinene degradation; Degradation of aromatic compounds,1.1.1.296; 1.3.99.25; 1.14.13.105,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11398  (1R,4R)-Dihydrocarvone",PubChem: 13572; ChEBI: 154; LIPIDMAPS: LMPR0102090033; KNApSAcK: C00033439 C00037051; 3DMET: B04244; NIKKAJI: J995.644A,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013338,3685,cpd:C11399,"(1S,2S,4R)-Iso-dihydrocarveol",C10H18O,"(1S,2S,4R)-Iso-dihydrocarveol",R06382,Limonene and pinene degradation,1.1.1.296,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11399  (1S,2S,4R)-Iso-dihydrocarveol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11399  (1S,2S,4R)-Iso-dihydrocarveol",PubChem: 13573; ChEBI: 50233; LIPIDMAPS: LMPR0102090034; 3DMET: B04245; NIKKAJI: J759.142J,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023339,3686,cpd:C11400,"(1S,2R,4R)-Neoiso-dihydrocarveol",C10H18O,"(1S,2R,4R)-Neoiso-dihydrocarveol",R06384,Limonene and pinene degradation,1.1.1.296,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11400  (1S,2R,4R)-Neoiso-dihydrocarveol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11400  (1S,2R,4R)-Neoiso-dihydrocarveol",CAS: 51773-45-6; PubChem: 13574; ChEBI: 50232; LIPIDMAPS: LMPR0102090035; 3DMET: B04246; NIKKAJI: J86.002F,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023340,3687,cpd:C11401,"(1S,4R)-Iso-dihydrocarvone",C10H16O,"(1S,4R)-Iso-dihydrocarvone",R06380 R06382 R06384 R06388,Limonene and pinene degradation,1.1.1.296; 1.14.13.105,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11401  (1S,4R)-Iso-dihydrocarvone",PubChem: 13575; ChEBI: 166; LIPIDMAPS: LMPR0102090036; KNApSAcK: C00010947; 3DMET: B04247; NIKKAJI: J479.690J,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013341,3688,cpd:C11402,"(4R,7R)-4-Isopropenyl-7-methyl-2-oxo-oxepanone",C10H16O2,"(4R,7R)-4-Isopropenyl-7-methyl-2-oxo-oxepanone",R06386 R06390,Limonene and pinene degradation; Degradation of aromatic compounds,1.14.13.105; 3.1.1.83,NA,NA,PubChem: 13576; ChEBI: 228; LIPIDMAPS: LMPR0102090058; 3DMET: B04248; NIKKAJI: J2.774.301C,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.10720473342,3689,cpd:C11403,"(3S,6R)-6-Isopropenyl-3-methyl-2-oxo-oxepanone",C10H16O2,"(3S,6R)-6-Isopropenyl-3-methyl-2-oxo-oxepanone",R06388 R06391,Limonene and pinene degradation,1.14.13.105; 3.1.1.83,NA,NA,PubChem: 13577; ChEBI: 64231; 3DMET: B04249; NIKKAJI: J2.490.914J,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.10720473343,3690,cpd:C11404,(3R)-6-Hydroxy-3-isopropenyl-heptanoate,C10H18O3,(3R)-6-Hydroxy-3-isopropenyl-heptanoate,R06390 R06394,Limonene and pinene degradation; Degradation of aromatic compounds,3.1.1.83,NA,NA,PubChem: 13578; ChEBI: 204; 3DMET: B05525; NIKKAJI: J2.774.313G,cpd:C01909; cpd:C02217; cpd:C11404; cpd:C11406; cpd:C11417; cpd:C11420; cpd:C13945; cpd:C17228; cpd:C17620; cpd:C20714,10,18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O3,C10H17O3,186.1255944,187.1334195,185.11776943344,3691,cpd:C11405,(3R)-3-Isopropenyl-6-oxoheptanoate;,C10H16O3,(3R)-3-Isopropenyl-6-oxoheptanoate; (3R)-3-Isopropenyl-6-oxoheptanoic acid,R06394 R06396 R06515 R09392,Limonene and pinene degradation; Degradation of aromatic compounds,1.14.13.105; 6.2.1.-,NA,NA,PubChem: 13579; ChEBI: 29001 37287; LIPIDMAPS: LMFA01060179; 3DMET: B04250; NIKKAJI: J1.121.165H,cpd:C00120; cpd:C00884; cpd:C01262; cpd:C01843; cpd:C03843; cpd:C04138; cpd:C04718; cpd:C06066; cpd:C06605; cpd:C07827; cpd:C11405; cpd:C11419; cpd:C19079; cpd:C19084; cpd:C20324; cpd:C20818; cpd:C21012,10,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O3,C10H15O3,184.1099444,185.1177694,183.10211933345,3692,cpd:C11406,(5R)-6-Hydroxy-5-isopropenyl-2-methylhexanoate,C10H18O3,(5R)-6-Hydroxy-5-isopropenyl-2-methylhexanoate,R06391,Limonene and pinene degradation,3.1.1.83,NA,NA,PubChem: 13580; ChEBI: 241; 3DMET: B05526; NIKKAJI: J2.774.315C,cpd:C01909; cpd:C02217; cpd:C11404; cpd:C11406; cpd:C11417; cpd:C11420; cpd:C13945; cpd:C17228; cpd:C17620; cpd:C20714,10,18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O3,C10H17O3,186.1255944,187.1334195,185.11776943346,3693,cpd:C11407,(3R)-3-Isopropenyl-6-oxoheptanoyl-CoA,C31H50N7O18P3S,(3R)-3-Isopropenyl-6-oxoheptanoyl-CoA,R06396 R06515,Limonene and pinene degradation; Degradation of aromatic compounds,6.2.1.-,NA,NA,PubChem: 13581; ChEBI: 29004; 3DMET: B05527; NIKKAJI: J2.774.322F,cpd:C11407; cpd:C11421; cpd:C11934; cpd:C11948,31,50,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H51O18N7P3S1,C31H49O18N7P3S1,933.21459,934.222415,932.20676493347,3694,cpd:C11408,"(4S,6S)-cis-Carveol",C10H16O,"(4S,6S)-cis-Carveol",R06375,Limonene and pinene degradation,NA,NA,"Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11408  (4S,6S)-cis-Carveol",PubChem: 13582; ChEBI: 232; ChEMBL: CHEMBL1908058; KNApSAcK: C00010883; 3DMET: B04251; NIKKAJI: J9.139A,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013348,3695,cpd:C11410,"(1R,2S,4S)- Neoiso-dihydrocarveol",C10H18O,"(1R,2S,4S)- Neoiso-dihydrocarveol",R06379,Limonene and pinene degradation,1.1.1.296,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11410  (1R,2S,4S)- Neoiso-dihydrocarveol",PubChem: 13584; ChEBI: 153; 3DMET: B04253; NIKKAJI: J86.001H,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023349,3696,cpd:C11411,"(1R,2R,4S)-Iso-dihydrocarveol",C10H18O,"(1R,2R,4S)-Iso-dihydrocarveol",R06377,Limonene and pinene degradation,1.1.1.296,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11411  (1R,2R,4S)-Iso-dihydrocarveol",PubChem: 13585; ChEBI: 150; 3DMET: B04254; NIKKAJI: J759.143H,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023350,3697,cpd:C11412,"(1R,4S)-Iso-dihydrocarvone",C10H16O,"(1R,4S)-Iso-dihydrocarvone",R06372 R06377 R06379 R06381 R06387,Limonene and pinene degradation,1.1.1.296; 1.3.99.25; 1.14.13.105,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11412  (1R,4S)-Iso-dihydrocarvone",PubChem: 13586; ChEBI: 155; LIPIDMAPS: LMPR0102090037; 3DMET: B04255; NIKKAJI: J995.645J,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013351,3698,cpd:C11413,"(1S,2S,4S)-Dihydrocarveol;",C10H18O,"(1S,2S,4S)-Dihydrocarveol; (+)-Dihydrocarveol",R06383,Limonene and pinene degradation,1.1.1.296,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11413  (1S,2S,4S)-Dihydrocarveol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11413  (1S,2S,4S)-Dihydrocarveol",PubChem: 13587; ChEBI: 50235; LIPIDMAPS: LMPR0102090038; 3DMET: B04256; NIKKAJI: J259.613J,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023352,3699,cpd:C11414,"(4S,7R)-4-Isopropenyl-7-methyl-2-oxo-oxepanone;",C10H16O2,"(4S,7R)-4-Isopropenyl-7-methyl-2-oxo-oxepanone; 4-Isopropenyl-7-methyloxepan-2-one",R06387 R06392,Limonene and pinene degradation,1.14.13.105; 3.1.1.83,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11414  (4S,7R)-4-Isopropenyl-7-methyl-2-oxo-oxepanone",PubChem: 13588; ChEBI: 233; LIPIDMAPS: LMPR0102090059; 3DMET: B04257; NIKKAJI: J2.490.915H,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.10720473353,3700,cpd:C11415,"(1S,4S)-Dihydrocarvone",C10H16O,"(1S,4S)-Dihydrocarvone",R06381 R06383 R06385 R06389,Limonene and pinene degradation,1.1.1.296; 1.14.13.105,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11415  (1S,4S)-Dihydrocarvone",PubChem: 13589; ChEBI: 168; LIPIDMAPS: LMPR0102090039; 3DMET: B04258; NIKKAJI: J138.969F,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013354,3701,cpd:C11416,"(1S,2R,4S)-Neo-dihydrocarveol",C10H18O,"(1S,2R,4S)-Neo-dihydrocarveol",R06385,Limonene and pinene degradation,1.1.1.296,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11416  (1S,2R,4S)-Neo-dihydrocarveol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11416  (1S,2R,4S)-Neo-dihydrocarveol",PubChem: 13590; ChEBI: 158; LIPIDMAPS: LMPR0102090040; 3DMET: B04259; NIKKAJI: J1.369.828G,cpd:C00843; cpd:C01411; cpd:C01500; cpd:C01765; cpd:C01766; cpd:C02344; cpd:C02462; cpd:C02484; cpd:C03039; cpd:C03985; cpd:C06081; cpd:C09844; cpd:C09848; cpd:C09871; cpd:C09902; cpd:C11384; cpd:C11388; cpd:C11389; cpd:C11390; cpd:C11393; cpd:C11396; cpd:C11397; cpd:C11399; cpd:C11400; cpd:C11410; cpd:C11411; cpd:C11413; cpd:C11416; cpd:C11952; cpd:C16772; cpd:C16909; cpd:C17073; cpd:C17125; cpd:C17384; cpd:C17517; cpd:C17518; cpd:C17611; cpd:C18017; cpd:C20261,10,18,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O1,C10H17O1,154.1357652,155.1435902,153.12794023355,3702,cpd:C11417,(3S)-6-Hydroxy-3-isopropenyl-heptanoate;,C10H18O3,(3S)-6-Hydroxy-3-isopropenyl-heptanoate; 6-Hydroxy-3-isopropenylheptanoate,R06392 R06395,Limonene and pinene degradation,3.1.1.83,NA,NA,PubChem: 13591; ChEBI: 214; 3DMET: B05528; NIKKAJI: J2.774.366H,cpd:C01909; cpd:C02217; cpd:C11404; cpd:C11406; cpd:C11417; cpd:C11420; cpd:C13945; cpd:C17228; cpd:C17620; cpd:C20714,10,18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O3,C10H17O3,186.1255944,187.1334195,185.11776943356,3703,cpd:C11418,"(3S,6S)-6-Isopropenyl-3-methyl-2-oxo-oxepanone",C10H16O2,"(3S,6S)-6-Isopropenyl-3-methyl-2-oxo-oxepanone",R06389 R06393,Limonene and pinene degradation,1.14.13.105; 3.1.1.83,NA,NA,PubChem: 13592; ChEBI: 64232; 3DMET: B04260; NIKKAJI: J2.774.367F,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.10720473357,3704,cpd:C11419,(3S)-3-Isopropenyl-6-oxoheptanoate;,C10H16O3,(3S)-3-Isopropenyl-6-oxoheptanoate; (3S)-3-Isopropenyl-6-oxoheptanoic acid,R06395 R06397 R09391,Limonene and pinene degradation,1.14.13.105; 6.2.1.-,NA,NA,PubChem: 13593; ChEBI: 211 37291; LIPIDMAPS: LMFA01060180; 3DMET: B04261; NIKKAJI: J1.121.166F,cpd:C00120; cpd:C00884; cpd:C01262; cpd:C01843; cpd:C03843; cpd:C04138; cpd:C04718; cpd:C06066; cpd:C06605; cpd:C07827; cpd:C11405; cpd:C11419; cpd:C19079; cpd:C19084; cpd:C20324; cpd:C20818; cpd:C21012,10,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O3,C10H15O3,184.1099444,185.1177694,183.10211933358,3705,cpd:C11420,(5S)-6-Hydroxy-5-isopropenyl-2-methylhexanoate,C10H18O3,(5S)-6-Hydroxy-5-isopropenyl-2-methylhexanoate,R06393,Limonene and pinene degradation,3.1.1.83,NA,NA,PubChem: 13594; ChEBI: 242; 3DMET: B05529; NIKKAJI: J2.774.368D,cpd:C01909; cpd:C02217; cpd:C11404; cpd:C11406; cpd:C11417; cpd:C11420; cpd:C13945; cpd:C17228; cpd:C17620; cpd:C20714,10,18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O3,C10H17O3,186.1255944,187.1334195,185.11776943359,3706,cpd:C11421,(3S)-3-Isopropenyl-6-oxoheptanoyl-CoA,C31H50N7O18P3S,(3S)-3-Isopropenyl-6-oxoheptanoyl-CoA,R06397,Limonene and pinene degradation,6.2.1.-,NA,NA,PubChem: 13595; ChEBI: 212; 3DMET: B05530; NIKKAJI: J2.774.370F,cpd:C11407; cpd:C11421; cpd:C11934; cpd:C11948,31,50,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H51O18N7P3S1,C31H49O18N7P3S1,933.21459,934.222415,932.20676493360,3707,cpd:C11924,Perillic acid,C10H14O2,Perillic acid,R06366 R06367 R06368,Limonene and pinene degradation,1.2.1.3; 6.2.1.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11924  Perillic acid; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11924  Perillic acid,CAS: 7694-45-3; PubChem: 14085; ChEBI: 36999; ChEMBL: CHEMBL1373981; LIPIDMAPS: LMPR0102090041; KNApSAcK: C00010870; 3DMET: B05567; NIKKAJI: J13.588G,cpd:C01297; cpd:C03037; cpd:C09777; cpd:C09791; cpd:C09792; cpd:C09841; cpd:C09887; cpd:C09896; cpd:C10960; cpd:C11924; cpd:C11940; cpd:C13708; cpd:C14351; cpd:C14515; cpd:C17622; cpd:C17690; cpd:C17824; cpd:C17964; cpd:C18343; cpd:C18352; cpd:C20320,10,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O2,C10H13O2,166.0993797,167.1072047,165.09155473361,3708,cpd:C11929,Perillyl-CoA,C31H48N7O17P3S,Perillyl-CoA,R06367 R06368 R06369,Limonene and pinene degradation; Degradation of aromatic compounds,4.2.1.-; 6.2.1.-,NA,NA,PubChem: 14090; ChEBI: 37002; 3DMET: B05572; NIKKAJI: J2.777.828C,cpd:C11929,31,48,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H49O17N7P3S1,C31H47O17N7P3S1,915.2040253,916.2118503,914.19620023362,3709,cpd:C11934,2-Hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA,C31H50N7O18P3S,2-Hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA,R06369 R06370,Limonene and pinene degradation; Degradation of aromatic compounds,1.1.-.-; 4.2.1.-,NA,NA,PubChem: 14095; ChEBI: 29473; 3DMET: B05577; NIKKAJI: J2.777.861E,cpd:C11407; cpd:C11421; cpd:C11934; cpd:C11948,31,50,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H51O18N7P3S1,C31H49O18N7P3S1,933.21459,934.222415,932.20676493363,3710,cpd:C11935,4-Isopropenyl-2-oxy-cyclohexanecarboxyl-CoA;,C31H48N7O18P3S,4-Isopropenyl-2-oxy-cyclohexanecarboxyl-CoA; 4-Isopropenyl-2-ketocyclohexane-1-carboxyl-CoA,R06370 R06371,Limonene and pinene degradation; Degradation of aromatic compounds,1.1.-.-; 3.7.1.-,NA,NA,PubChem: 14096; ChEBI: 29489; 3DMET: B05578; NIKKAJI: J2.777.864J,cpd:C07160; cpd:C11935,31,48,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H49O18N7P3S1,C31H47O18N7P3S1,931.1989399,932.2067649,930.19111493364,3711,cpd:C11936,3-Isopropenylpimelyl-CoA,C31H50N7O19P3S,3-Isopropenylpimelyl-CoA,R06371,Limonene and pinene degradation; Degradation of aromatic compounds,3.7.1.-,NA,NA,PubChem: 14097; ChEBI: 37439; NIKKAJI: J2.777.868B,cpd:C11936,31,50,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H51O19N7P3S1,C31H49O19N7P3S1,949.2095046,950.2173296,948.20167963365,3712,cpd:C11937,"(1S,4R)-1-Hydroxy-2-oxolimonene;",C10H16O2,"(1S,4R)-1-Hydroxy-2-oxolimonene; (1S,4R)-1-Hydroxymenth-8-en-2-one",R06399 R06400,Limonene and pinene degradation,1.1.1.297; 1.14.13.105,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010209 Menthane monoterpenoids;      C11937  (1S,4R)-1-Hydroxy-2-oxolimonene",CAS: 24047-73-2; PubChem: 14098; ChEBI: 38249; LIPIDMAPS: LMPR0102090042; 3DMET: B04380; NIKKAJI: J1.121.167D,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.10720473366,3713,cpd:C11938,Myrtenol;,C10H16O,Myrtenol; 2-Pinen-10-ol,R06401 R06402,Limonene and pinene degradation,1.1.-.-; 1.14.-.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C11938  Myrtenol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11938  Myrtenol,CAS: 515-00-4; PubChem: 14099; ChEBI: 25460; ChEMBL: CHEMBL443408; LIPIDMAPS: LMPR0102120022; KNApSAcK: C00037531; 3DMET: B05579; NIKKAJI: J2.625E,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013367,3714,cpd:C11939,Myrtenal,C10H14O,Myrtenal,R06402 R06403,Limonene and pinene degradation,1.1.-.-; 1.2.-.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C11939  Myrtenal; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11939  Myrtenal,CAS: 23727-16-4; PubChem: 14100; ChEBI: 25458; LIPIDMAPS: LMPR0102120023; KNApSAcK: C00030803; 3DMET: B05580; NIKKAJI: J16.457G,cpd:C01056; cpd:C01767; cpd:C01868; cpd:C01951; cpd:C02289; cpd:C02485; cpd:C02576; cpd:C03043; cpd:C06576; cpd:C09840; cpd:C09843; cpd:C09868; cpd:C09884; cpd:C09908; cpd:C09911; cpd:C09913; cpd:C11383; cpd:C11394; cpd:C11939; cpd:C14130; cpd:C14138; cpd:C14139; cpd:C14188; cpd:C14200; cpd:C14464; cpd:C14741; cpd:C16569; cpd:C16955; cpd:C17062; cpd:C17103; cpd:C18025; cpd:C20361; cpd:C20944,10,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1,C10H13O1,150.1044651,151.1122901,149.096643368,3715,cpd:C11940,Myrtenic acid;,C10H14O2,"Myrtenic acid; 6,6-Dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylic acid",R06403,Limonene and pinene degradation,1.2.-.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C11940  Myrtenic acid; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11940  Myrtenic acid,CAS: 19250-17-0; PubChem: 14101; ChEBI: 25459; LIPIDMAPS: LMPR0102120024; KNApSAcK: C00011042; 3DMET: B05581; NIKKAJI: J14.071F,cpd:C01297; cpd:C03037; cpd:C09777; cpd:C09791; cpd:C09792; cpd:C09841; cpd:C09887; cpd:C09896; cpd:C10960; cpd:C11924; cpd:C11940; cpd:C13708; cpd:C14351; cpd:C14515; cpd:C17622; cpd:C17690; cpd:C17824; cpd:C17964; cpd:C18343; cpd:C18352; cpd:C20320,10,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O2,C10H13O2,166.0993797,167.1072047,165.09155473369,3716,cpd:C11941,Pinocarveol,C10H16O,Pinocarveol,R06404 R06405,Limonene and pinene degradation,1.1.-.-; 1.14.-.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C11941  Pinocarveol; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C11941  Pinocarveol,CAS: 5947-36-4; PubChem: 14102; ChEBI: 26137; LIPIDMAPS: LMPR0102120025; KNApSAcK: C00000829 C00011040; 3DMET: B05582; NIKKAJI: J21.517A,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013370,3717,cpd:C11942,"trans-2-Methyl-5-isopropylhexa-2,5-dienal",C10H16O,"trans-2-Methyl-5-isopropylhexa-2,5-dienal",R06408,Limonene and pinene degradation,1.2.1.-,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010202 Irregular acyclic monoterpenoids;      C11942  trans-2-Methyl-5-isopropylhexa-2,5-dienal",CAS: 112077-94-8; PubChem: 14103; ChEBI: 27049; 3DMET: B04381; NIKKAJI: J2.002.540I,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013371,3718,cpd:C11943,"trans-2-Methyl-5-isopropylhexa-2,5-dienoic acid",C10H16O2,"trans-2-Methyl-5-isopropylhexa-2,5-dienoic acid",R06408 R06410,Limonene and pinene degradation,1.2.1.-; 6.2.1.-,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010202 Irregular acyclic monoterpenoids;      C11943  trans-2-Methyl-5-isopropylhexa-2,5-dienoic acid",CAS: 65860-54-0; PubChem: 14104; ChEBI: 27050; 3DMET: B04382; NIKKAJI: J2.002.542E,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.10720473372,3719,cpd:C11944,"cis-2-Methyl-5-isopropylhexa-2,5-dienoic acid",C10H16O2,"cis-2-Methyl-5-isopropylhexa-2,5-dienoic acid",R06407 R06409,Limonene and pinene degradation,1.2.1.-; 6.2.1.-,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010202 Irregular acyclic monoterpenoids;      C11944  cis-2-Methyl-5-isopropylhexa-2,5-dienoic acid",CAS: 65860-56-2; PubChem: 14105; ChEBI: 23285; 3DMET: B04383; NIKKAJI: J2.725.401B,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.10720473373,3720,cpd:C11945,"trans-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA",C31H50N7O17P3S,"trans-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA",R06410 R06412,Limonene and pinene degradation,4.2.1.17; 6.2.1.-,NA,NA,PubChem: 14106; ChEBI: 29742; 3DMET: B05583; NIKKAJI: J2.777.890I,cpd:C01920; cpd:C11945; cpd:C11946; cpd:C16465,31,50,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H51O17N7P3S1,C31H49O17N7P3S1,917.2196753,918.2275004,916.21185033374,3721,cpd:C11946,"cis-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA",C31H50N7O17P3S,"cis-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA",R06409 R06411,Limonene and pinene degradation,4.2.1.17; 6.2.1.-,NA,NA,PubChem: 14107; ChEBI: 29714; 3DMET: B05584; NIKKAJI: J2.777.892E,cpd:C01920; cpd:C11945; cpd:C11946; cpd:C16465,31,50,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H51O17N7P3S1,C31H49O17N7P3S1,917.2196753,918.2275004,916.21185033375,3722,cpd:C11947,"3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA",C31H52N7O18P3S,"3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA",R06411 R06412 R06413,Limonene and pinene degradation,1.1.-.-; 4.2.1.17,NA,NA,PubChem: 14108; ChEBI: 29478; 3DMET: B05585; NIKKAJI: J2.777.895J,cpd:C05265; cpd:C11947,31,52,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H53O18N7P3S1,C31H51O18N7P3S1,935.23024,936.2380651,934.2224153376,3723,cpd:C11948,"2,6-Dimethyl-5-methylene-3-oxo-heptanoyl-CoA",C31H50N7O18P3S,"2,6-Dimethyl-5-methylene-3-oxo-heptanoyl-CoA",R06413 R06414,Limonene and pinene degradation,1.1.-.-; 2.3.1.-,NA,NA,PubChem: 14109; ChEBI: 29469; 3DMET: B05586; NIKKAJI: J2.777.898D,cpd:C11407; cpd:C11421; cpd:C11934; cpd:C11948,31,50,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H51O18N7P3S1,C31H49O18N7P3S1,933.21459,934.222415,932.20676493377,3724,cpd:C11949,3-Isopropylbut-3-enoyl-CoA,C28H46N7O17P3S,3-Isopropylbut-3-enoyl-CoA,R06414 R06415,Limonene and pinene degradation,2.3.1.-; 3.1.2.-,NA,NA,PubChem: 14110; ChEBI: 29483; 3DMET: B05587; NIKKAJI: J2.777.905K,cpd:C09823; cpd:C11949; cpd:C16470,28,46,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O17N7P3S1,C28H45O17N7P3S1,877.1883752,878.1962002,876.18055023378,3725,cpd:C11950,3-Isopropyl-3-butenoic acid;,C7H12O2,3-Isopropyl-3-butenoic acid; 3-Isopropylbut-3-enoic acid,R06415,Limonene and pinene degradation,3.1.2.-,NA,NA,CAS: 65860-53-9; PubChem: 14111; ChEBI: 20092; LIPIDMAPS: LMFA01020123; 3DMET: B04384; NIKKAJI: J1.476.933A,cpd:C08487; cpd:C09822; cpd:C10921; cpd:C10976; cpd:C11950; cpd:C13714; cpd:C13717,7,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O2,C7H11O2,128.0837296,129.0915547,127.07590463379,3726,cpd:C19079,(4R)-7-Hydroxy-4-isopropenyl-7-methyl-2-oxo-oxepanone;,C10H16O3,(4R)-7-Hydroxy-4-isopropenyl-7-methyl-2-oxo-oxepanone; (4R)-7-Hydroxy-4-isopropenyl-7-methyloxepan-2-one,R06400 R09392,Limonene and pinene degradation,1.14.13.105,NA,NA,PubChem: 124489751; ChEBI: 82204,cpd:C00120; cpd:C00884; cpd:C01262; cpd:C01843; cpd:C03843; cpd:C04138; cpd:C04718; cpd:C06066; cpd:C06605; cpd:C07827; cpd:C11405; cpd:C11419; cpd:C19079; cpd:C19084; cpd:C20324; cpd:C20818; cpd:C21012,10,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O3,C10H15O3,184.1099444,185.1177694,183.10211933380,3727,cpd:C19081,"(4S)-Limonene-1,2-epoxide",C10H16O,"(4S)-Limonene-1,2-epoxide",R09385 R09387 R09389,Limonene and pinene degradation,1.14.13.107; 3.3.2.8,NA,NA,PubChem: 124489753; ChEBI: 82206,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229013381,3728,cpd:C19082,"(1R,2R,4S)-Limonene-1,2-diol;",C10H18O2,"(1R,2R,4S)-Limonene-1,2-diol; (1R,2R,4S)-Menth-8-ene-1,2-diol",R09387 R09388,Limonene and pinene degradation,1.1.1.297; 3.3.2.8,NA,NA,PubChem: 124489754; ChEBI: 50244,cpd:C03092; cpd:C04433; cpd:C06185; cpd:C07276; cpd:C07640; cpd:C09790; cpd:C16255; cpd:C16462; cpd:C17621; cpd:C18020; cpd:C18027; cpd:C18066; cpd:C18202; cpd:C19082; cpd:C20326; cpd:C21139,10,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O2,C10H17O2,170.1306798,171.1385049,169.12285483382,3729,cpd:C19083,"(1R,4S)-1-Hydroxy-2-oxolimonene",C10H16O2,"(1R,4S)-1-Hydroxy-2-oxolimonene",R09388 R09390,Limonene and pinene degradation,1.1.1.297; 1.14.13.105,NA,NA,PubChem: 124489755; ChEBI: 50245,cpd:C00848; cpd:C02108; cpd:C03448; cpd:C06069; cpd:C07362; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09842; cpd:C09854; cpd:C11402; cpd:C11403; cpd:C11414; cpd:C11418; cpd:C11651; cpd:C11937; cpd:C11943; cpd:C11944; cpd:C13311; cpd:C16461; cpd:C18019; cpd:C19083; cpd:C19112; cpd:C19731; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20322; cpd:C20323,10,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O2,C10H15O2,168.1150298,169.1228548,167.10720473383,3730,cpd:C19084,(4S)-7-Hydroxy-4-isopropenyl-7-methyl-2-oxo-oxepanone;,C10H16O3,(4S)-7-Hydroxy-4-isopropenyl-7-methyl-2-oxo-oxepanone; (4S)-7-Hydroxy-4-isopropenyl-7-methyloxepan-2-one,R09390 R09391,Limonene and pinene degradation,1.14.13.105,NA,NA,PubChem: 124489756; ChEBI: 82207,cpd:C00120; cpd:C00884; cpd:C01262; cpd:C01843; cpd:C03843; cpd:C04138; cpd:C04718; cpd:C06066; cpd:C06605; cpd:C07827; cpd:C11405; cpd:C11419; cpd:C19079; cpd:C19084; cpd:C20324; cpd:C20818; cpd:C21012,10,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O3,C10H15O3,184.1099444,185.1177694,183.10211933384,3731,cpd:C00859,Gibberellin A1;,C19H24O6,Gibberellin A1; Gibberellin 1,R03008 R03009 R06619,Diterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Plant hormone signal transduction,1.14.11.13; 1.14.11.15,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C00859  Gibberellin A1; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C00859  Gibberellin A1,CAS: 545-97-1; PubChem: 4116; ChEBI: 27717; LIPIDMAPS: LMPR0104170001; KNApSAcK: C00000001; 3DMET: B01344; NIKKAJI: J4.738D,cpd:C00859; cpd:C04597; cpd:C04844; cpd:C06096; cpd:C08358; cpd:C08759; cpd:C09356; cpd:C09407; cpd:C09520; cpd:C09539; cpd:C09554; cpd:C11868; cpd:C16910,19,24,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O6,C19H23O6,348.1572885,349.1651135,347.14946353385,3732,cpd:C01414,Casbene,C20H32,Casbene,R02064,Diterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.3.8,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010429 Casbane diterpenoids;      C01414  Casbene; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Cembrenes;     C01414  Casbene,CAS: 24286-51-9; PubChem: 4602; ChEBI: 17695; LIPIDMAPS: LMPR0104290001; KNApSAcK: C00000864; 3DMET: B04795; NIKKAJI: J244.553K,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763386,3733,cpd:C01699,Gibberellin A3;,C19H22O6,Gibberellin A3; Gibberellic acid; Gibberellin,R03680 R06347 R06618,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.11.-; 2.4.1.176,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C01699  Gibberellin A3; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C01699  Gibberellin A3; Pesticides [BR:br08007];  Pesticides;   Plant growth regulators;    Others;     C01699  Gibberellin A3,CAS: 77-06-5; PubChem: 4839; ChEBI: 28833; ChEMBL: CHEMBL1232952 CHEMBL1371721; LIPIDMAPS: LMPR0104170002; KNApSAcK: C00000003; PDB-CCD: GA3; 3DMET: B01481; NIKKAJI: J8.602I,cpd:C01699; cpd:C09062; cpd:C09104; cpd:C09174; cpd:C09190; cpd:C09385; cpd:C09512; cpd:C09547; cpd:C11210; cpd:C11855; cpd:C11856; cpd:C11869,19,22,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O6,C19H21O6,346.1416384,347.1494635,345.13381343387,3734,cpd:C02034,Gibberellin A19;,C20H26O6,Gibberellin A19; Gibberellin 19,R03806 R03807 R06331 R07184,Diterpenoid biosynthesis,1.14.11.12,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C02034  Gibberellin A19; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C02034  Gibberellin A19,CAS: 6980-44-5; PubChem: 5127; ChEBI: 28731; LIPIDMAPS: LMPR0104170039; KNApSAcK: C00000019; 3DMET: B04832; NIKKAJI: J4.744I,cpd:C02034; cpd:C09090; cpd:C09184; cpd:C09395; cpd:C09442; cpd:C09451; cpd:C09474; cpd:C11862; cpd:C18167; cpd:C19145; cpd:C20456,20,26,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H27O6,C20H25O6,362.1729386,363.1807636,361.16511353388,3735,cpd:C02035,Gibberellin A20;,C19H24O5,Gibberellin A20; Gibberellin 20,R03009 R03807 R03809 R06332 R06346,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.11.12; 1.14.11.13; 1.14.11.15; 1.14.11.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C02035  Gibberellin A20; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C02035  Gibberellin A20,CAS: 19143-87-4; PubChem: 5128; ChEBI: 27742; LIPIDMAPS: LMPR0104170004; KNApSAcK: C00000020; 3DMET: B01526; NIKKAJI: J4.750C,cpd:C02035; cpd:C08111; cpd:C09742; cpd:C11864; cpd:C11865,19,24,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O5,C19H23O5,332.1623739,333.1701989,331.15454883389,3736,cpd:C03579,Gibberellin A8;,C19H24O7,Gibberellin A8; 2beta-Hydroxygibberellin 1,R03008 R06345,Diterpenoid biosynthesis,1.14.11.13,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C03579  Gibberellin A8; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C03579  Gibberellin A8,CAS: 7044-72-6; PubChem: 6371; ChEBI: 28861; LIPIDMAPS: LMPR0104170005; KNApSAcK: C00000008; 3DMET: B01672; NIKKAJI: J4.745G,cpd:C03579; cpd:C09359; cpd:C09585; cpd:C09607,19,24,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O7,C19H23O7,364.1522031,365.1600281,363.14437813390,3737,cpd:C06086,Pimaradiene;,C20H32,"Pimaradiene; Pimara-8(14),15-diene",R06299,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.147,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010408 Pimarane diterpenoids;      C06086  Pimaradiene; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Pimaranes;     C06086  Pimaradiene,PubChem: 8352; ChEBI: 8210; KNApSAcK: C00048512; 3DMET: B01967; NIKKAJI: J440.693A,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763391,3738,cpd:C06087,Abietate;,C20H30O2,Abietate; Abietic acid,R06357,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.2.1.74,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010405 Abietane diterpenoids;      C06087  Abietic acid; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Abietanes;     C06087  Abietate; Major components of natural products [BR:br08323];  Crude drugs;   Rosin;    C06087  Abietate,CAS: 514-10-3; PubChem: 8353; ChEBI: 28987; ChEMBL: CHEMBL71893; LIPIDMAPS: LMPR0104050001; KNApSAcK: C00000871; PDB-CCD: A9H; 3DMET: B01968; NIKKAJI: J10.135D,cpd:C06087; cpd:C06428; cpd:C07198; cpd:C09118; cpd:C09148; cpd:C09159; cpd:C11874; cpd:C11888; cpd:C11889; cpd:C12077; cpd:C12083; cpd:C14255; cpd:C14490; cpd:C14588; cpd:C14890; cpd:C15003; cpd:C15008; cpd:C15017; cpd:C15036; cpd:C15070; cpd:C15184; cpd:C15188; cpd:C15259; cpd:C15318; cpd:C15412; cpd:C15460; cpd:C20149; cpd:C20208,20,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O2,C20H29O2,302.2245802,303.2324052,301.21675523392,3739,cpd:C06088,Aphidicolin,C20H34O4,Aphidicolin,R06316 R06317,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Aphidicolane;     C06088  Aphidicolin,CAS: 38966-21-1; PubChem: 8354; ChEBI: 2766; ChEMBL: CHEMBL29711; KNApSAcK: C00000873 C00023944; PDB-CCD: 2ZE; NIKKAJI: J19.324K,cpd:C06088; cpd:C09205; cpd:C14772; cpd:C14773; cpd:C14774; cpd:C14775; cpd:C21171,20,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O4,C20H33O4,338.2457096,339.2535346,337.23788453393,3740,cpd:C06089,ent-Copalyl diphosphate;,C20H36O7P2,ent-Copalyl diphosphate; (-)-Copalyl diphosphate,R02068 R05092 R09119 R09120 R09121 R09681 R09903,Diterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.3.19; 4.2.3.28; 4.2.3.29; 4.2.3.30; 4.2.3.31; 4.2.3.103; 5.5.1.13,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010403 Labdane and halimane diterpenoids;      C06089  ent-Copalyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Labdanes;     C06089  ent-Copalyl diphosphate,PubChem: 8355; ChEBI: 23375 28151; LIPIDMAPS: LMPR0104030001; KNApSAcK: C00000880; PDB-CCD: ECP; 3DMET: B01969; NIKKAJI: J748.296E,cpd:C00353; cpd:C05859; cpd:C06089; cpd:C11356; cpd:C11901; cpd:C11902; cpd:C19815; cpd:C19836,20,36,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H37O7P2,C20H35O7P2,450.1936275,451.2014525,449.18580253394,3741,cpd:C06090,ent-Kaurene;,C20H32,ent-Kaurene; ent-Kaur-16-ene,R05092 R06195 R06196 R06291 R08401 R10066,Diterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.78; 4.2.3.19,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010413 Kaurane and phyllocladane diterpenoids;      C06090  ent-Kaurene; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Kaurenes;     C06090  ent-Kaurene,CAS: 562-28-7; PubChem: 8356; ChEBI: 15415; LIPIDMAPS: LMPR0104130002; KNApSAcK: C00007253; 3DMET: B05159; NIKKAJI: J144.066G,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763395,3742,cpd:C06091,Aconitine,C34H47NO11,Aconitine,R06195,Diterpenoid biosynthesis; Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Terpenoid alkaloids;     C06091  Aconitine; Natural toxins [BR:br08009];  Phytotoxins;   Terpenoids;    Diterpenoids;     C06091  Aconitine; Major components of natural products [BR:br08323];  Crude drugs;   Processed aconite root;    C06091  Aconitine,CAS: 302-27-2; PubChem: 8357; ChEBI: 2430; ChEMBL: CHEMBL1979562; KNApSAcK: C00001611; 3DMET: B01970; NIKKAJI: J9.871J,cpd:C06091,34,47,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H48O11N1,C34H46O11N1,645.3149113,646.3227364,644.30708633396,3743,cpd:C06092,Veatchine,C22H33NO2,Veatchine,R06196,Diterpenoid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Terpenoid alkaloids;     C06092  Veatchine,CAS: 76-53-9; PubChem: 8358; ChEBI: 9938; KNApSAcK: C00001672; 3DMET: B05160; NIKKAJI: J4.177G,cpd:C06092; cpd:C08660; cpd:C08672; cpd:C08680; cpd:C08685; cpd:C10814; cpd:C20059,22,33,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H34O2N1,C22H32O2N1,343.2511293,344.2589543,342.24330433397,3744,cpd:C06093,Gibberellin A12 aldehyde,C20H28O3,Gibberellin A12 aldehyde,R06295 R06297 R06328 R06341,Diterpenoid biosynthesis; Biosynthesis of plant hormones; Biosynthesis of secondary metabolites,1.14.13.79,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C06093  Gibberellin A12 aldehyde; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C06093  Gibberellin A12 aldehyde,CAS: 19436-07-8; PubChem: 8359; ChEBI: 15610; LIPIDMAPS: LMPR0104170040; KNApSAcK: C00000886; 3DMET: B05161; NIKKAJI: J555.881F,cpd:C06093; cpd:C07851; cpd:C09066; cpd:C09163; cpd:C09182; cpd:C09196; cpd:C09706; cpd:C09845; cpd:C14242; cpd:C14615; cpd:C14717; cpd:C14887; cpd:C15126; cpd:C15192; cpd:C15282; cpd:C15287; cpd:C16677; cpd:C16679; cpd:C16680; cpd:C18016,20,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O3,C20H27O3,316.2038448,317.2116698,315.19601973398,3745,cpd:C06094,Gibberellin A53,C20H28O5,Gibberellin A53,R05097 R06329 R06340,Diterpenoid biosynthesis,1.14.11.12,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C06094  Gibberellin A53; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C06094  Gibberellin A53,CAS: 51576-08-0; PubChem: 8360; ChEBI: 27433; LIPIDMAPS: LMPR0104170007; KNApSAcK: C00000053; 3DMET: B01971; NIKKAJI: J4.770H,cpd:C06094; cpd:C06977; cpd:C07124; cpd:C08021; cpd:C09112; cpd:C11858; cpd:C11860,20,28,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O5,C20H27O5,348.193674,349.201499,347.1858493399,3746,cpd:C06095,Gibberellin A44 diacid;,C20H28O6,Gibberellin A44 diacid; Gibberellin A44 open lactone,R03806 R05097 R06330,Diterpenoid biosynthesis,1.14.11.12,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C06095  Gibberellin A44 diacid; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C06095  Gibberellin A44 diacid,CAS: 88373-65-3; PubChem: 8361; ChEBI: 27531; LIPIDMAPS: LMPR0104170008; 3DMET: B01972; NIKKAJI: J2.761.056K,cpd:C06095; cpd:C09155; cpd:C09178; cpd:C09414; cpd:C09535; cpd:C11859; cpd:C17642; cpd:C21093,20,28,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O6,C20H27O6,364.1885886,365.1964137,363.18076363400,3747,cpd:C06096,Gibberellin A29,C19H24O6,Gibberellin A29,R03809 R06344,Diterpenoid biosynthesis,1.14.11.13,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C06096  Gibberellin A29; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C06096  Gibberellin A29,PubChem: 8362; ChEBI: 28040; LIPIDMAPS: LMPR0104170036; KNApSAcK: C00000029; 3DMET: B05162; NIKKAJI: J4.759G,cpd:C00859; cpd:C04597; cpd:C04844; cpd:C06096; cpd:C08358; cpd:C08759; cpd:C09356; cpd:C09407; cpd:C09520; cpd:C09539; cpd:C09554; cpd:C11868; cpd:C16910,19,24,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O6,C19H23O6,348.1572885,349.1651135,347.14946353401,3748,cpd:C07394,Paclitaxel,C47H51NO14,Paclitaxel,R06320 R08171,Diterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites; Bile secretion,2.3.1.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010439 Taxane and abeotaxane diterpenoids;      C07394  Paclitaxel; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Taxanes;     C07394  Paclitaxel; Natural toxins [BR:br08009];  Phytotoxins;   Terpenoids;    Diterpenoids;     C07394  Paclitaxel; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS;     L01CD Taxanes;      L01CD01 Paclitaxel;       D00491  Paclitaxel (JAN/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    424  Plant extract preparations;     4240  Plant extract preparations;      D00491  Paclitaxel (JAN/USP/INN); Target-based classification of drugs [BR:br08310];  Others;   Other;    beta-tubulin;     Paclitaxel;      D00491  Paclitaxel (JAN/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2C8;    Paclitaxel;     D00491  Paclitaxel (JAN/USP/INN);   CYP3A4;    Paclitaxel;     D00491  Paclitaxel (JAN/USP/INN);  Transporter substrates;   ABCB1;    Paclitaxel;     D00491  Paclitaxel (JAN/USP/INN);   ABCB4;    Paclitaxel;     D00491  Paclitaxel (JAN/USP/INN); Major components of natural products [BR:br08323];  Crude drugs;   Yew;    C07394  Paclitaxel; Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Diterpenoids (C20);    D00491  Paclitaxel (JAN/USP/INN); Antineoplastics [br08340.html];  D00491; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00491; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00491,CAS: 33069-62-4; PubChem: 9598; ChEBI: 45863; ChEMBL: CHEMBL352705 CHEMBL367230 CHEMBL418410 CHEMBL428647 CHEMBL48; LIPIDMAPS: LMPR0104390001; KNApSAcK: C00002365; PDB-CCD: TA1; 3DMET: B05246; NIKKAJI: J17.834I,cpd:C07394,47,51,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C47H52O14N1,C47H50O14N1,853.3309553,854.3387804,852.32313033402,3749,cpd:C09092,Ferruginol;,C20H30O,"Ferruginol; Abieta-8,11,13-trien-12-ol",R10727,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.190,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Abietanes;     C09092  Ferruginol,CAS: 514-62-5; PubChem: 11284; ChEBI: 78274; ChEMBL: CHEMBL197308; KNApSAcK: C00003426; 3DMET: B02677; NIKKAJI: J17.558G,cpd:C00473; cpd:C00899; cpd:C09092; cpd:C11873; cpd:C11885; cpd:C11886; cpd:C11887; cpd:C16682; cpd:C17276; cpd:C18220; cpd:C18222; cpd:C19962; cpd:C20148,20,30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O1,C20H29O1,286.2296656,287.2374906,285.22184063403,3750,cpd:C09094,Geranylgeraniol;,C20H34O,"Geranylgeraniol; 2,6,10,14-Hexadecatetraen-1-ol, 3,7,11,15-tetramethyl-",R08993 R09122,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.110; 3.1.7.5,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010401 Acyclic diterpenoids;      C09094  Geranylgeraniol; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Linear diterpenes;     C09094  Geranylgeraniol,CAS: 24034-73-9; PubChem: 11286; ChEBI: 46762; ChEMBL: CHEMBL478589; LipidBank: IIP0008 IIP0108; KNApSAcK: C00003428; 3DMET: B02679; NIKKAJI: J133.911G,cpd:C09094; cpd:C11890; cpd:C15316; cpd:C19817; cpd:C19963; cpd:C19964; cpd:C20158; cpd:C20481; cpd:C20681; cpd:C20834; cpd:C20923; cpd:C20924,20,34,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O1,C20H33O1,290.2609657,291.2687907,289.25314073404,3751,cpd:C09118,Isopimaric acid,C20H30O2,Isopimaric acid,R09114,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010408 Pimarane diterpenoids;      C09118  Isopimaric acid; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Pimaranes;     C09118  Isopimaric acid,CAS: 5835-26-7; PubChem: 11310; ChEBI: 6039; ChEMBL: CHEMBL512164; LIPIDMAPS: LMPR0104080010; KNApSAcK: C00003444; 3DMET: B02695; NIKKAJI: J8.075F,cpd:C06087; cpd:C06428; cpd:C07198; cpd:C09118; cpd:C09148; cpd:C09159; cpd:C11874; cpd:C11888; cpd:C11889; cpd:C12077; cpd:C12083; cpd:C14255; cpd:C14490; cpd:C14588; cpd:C14890; cpd:C15003; cpd:C15008; cpd:C15017; cpd:C15036; cpd:C15070; cpd:C15184; cpd:C15188; cpd:C15259; cpd:C15318; cpd:C15412; cpd:C15460; cpd:C20149; cpd:C20208,20,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O2,C20H29O2,302.2245802,303.2324052,301.21675523405,3752,cpd:C09183,Sclareol;,C20H36O2,"Sclareol; (13R)-Labd-14-ene-8alpha,13-diol",R08992 R10241,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.141,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010403 Labdane and halimane diterpenoids;      C09183  Sclareol; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Labdanes;     C09183  Sclareol,CAS: 515-03-7; PubChem: 11375; ChEBI: 9053; ChEMBL: CHEMBL294740; KNApSAcK: C00000894; 3DMET: B02750; NIKKAJI: J13.989K,cpd:C09183; cpd:C16525,20,36,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H37O2,C20H35O2,308.2715304,309.2793554,307.26370543406,3753,cpd:C11700,10-Deacetylbaccatin III,C29H36O10,10-Deacetylbaccatin III,R06310 R06311,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.3.1.166; 2.3.1.167,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Taxanes;     C11700  10-Deacetylbaccatin III; Natural toxins [BR:br08009];  Phytotoxins;   Terpenoids;    Diterpenoids;     C11700  10-Deacetylbaccatin III,CAS: 32981-86-5; PubChem: 13865; ChEBI: 18193; ChEMBL: CHEMBL1565880 CHEMBL393912; KNApSAcK: C00035995; 3DMET: B04314; NIKKAJI: J510.941H,cpd:C11700,29,36,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H37O10,C29H35O10,544.2308474,545.2386724,543.22302233407,3754,cpd:C11853,Gibberellin A14 aldehyde,C20H28O4,Gibberellin A14 aldehyde,R06339 R06341,Diterpenoid biosynthesis,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11853  Gibberellin A14 aldehyde; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11853  Gibberellin A14 aldehyde,CAS: 35470-76-9; PubChem: 14015; ChEBI: 29589; LIPIDMAPS: LMPR0104170010; KNApSAcK: C00007331; 3DMET: B04332; NIKKAJI: J2.777.627B,cpd:C09067; cpd:C09081; cpd:C09128; cpd:C09177; cpd:C10564; cpd:C11853; cpd:C11857; cpd:C11905; cpd:C15068; cpd:C15459; cpd:C18175,20,28,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O4,C20H27O4,332.1987594,333.2065844,331.19093433408,3755,cpd:C11854,Gibberellin A51-catabolite,C19H22O5,Gibberellin A51-catabolite,R06343,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.11.13,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11854  Gibberellin A51-catabolite; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11854  Gibberellin A51-catabolite,PubChem: 14016; ChEBI: 29600; LIPIDMAPS: LMPR0104170011; 3DMET: B04333; NIKKAJI: J2.777.633G,cpd:C09173; cpd:C11854; cpd:C11867; cpd:C11871; cpd:C18037,19,22,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O5,C19H21O5,330.1467238,331.1545488,329.13889883409,3756,cpd:C11855,Gibberellin A29-catabolite,C19H22O6,Gibberellin A29-catabolite,R06344,Diterpenoid biosynthesis,1.14.11.13,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11855  Gibberellin A29-catabolite; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11855  Gibberellin A29-catabolite,CAS: 76040-29-4; PubChem: 14017; ChEBI: 29592; LIPIDMAPS: LMPR0104170012; 3DMET: B04334; NIKKAJI: J2.777.635C,cpd:C01699; cpd:C09062; cpd:C09104; cpd:C09174; cpd:C09190; cpd:C09385; cpd:C09512; cpd:C09547; cpd:C11210; cpd:C11855; cpd:C11856; cpd:C11869,19,22,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O6,C19H21O6,346.1416384,347.1494635,345.13381343410,3757,cpd:C11857,Gibberellin A12,C20H28O4,Gibberellin A12,R06297 R06322 R06329 R06333 R10067,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.11.12; 1.14.13.79,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11857  Gibberellin A12; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11857  Gibberellin A12,CAS: 1164-45-0; PubChem: 14019; ChEBI: 30088; LIPIDMAPS: LMPR0104170014; KNApSAcK: C00000012; 3DMET: B04336; NIKKAJI: J4.741D,cpd:C09067; cpd:C09081; cpd:C09128; cpd:C09177; cpd:C10564; cpd:C11853; cpd:C11857; cpd:C11905; cpd:C15068; cpd:C15459; cpd:C18175,20,28,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O4,C20H27O4,332.1987594,333.2065844,331.19093433411,3758,cpd:C11858,Gibberellin A14,C20H28O5,Gibberellin A14,R06324 R06333 R06339,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11858  Gibberellin A14; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11858  Gibberellin A14,CAS: 4955-22-0; PubChem: 14020; ChEBI: 29588; LIPIDMAPS: LMPR0104170015; KNApSAcK: C00000014; 3DMET: B04337; NIKKAJI: J8.619C,cpd:C06094; cpd:C06977; cpd:C07124; cpd:C08021; cpd:C09112; cpd:C11858; cpd:C11860,20,28,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O5,C20H27O5,348.193674,349.201499,347.1858493412,3759,cpd:C11859,Gibberellin A37 open lactone,C20H28O6,Gibberellin A37 open lactone,R06324 R06325 R06334,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11859  Gibberellin A37 open lactone; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11859  Gibberellin A37 open lactone,PubChem: 14021; ChEBI: 29596; LIPIDMAPS: LMPR0104170016; 3DMET: B04338; NIKKAJI: J2.777.642F,cpd:C06095; cpd:C09155; cpd:C09178; cpd:C09414; cpd:C09535; cpd:C11859; cpd:C17642; cpd:C21093,20,28,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O6,C20H27O6,364.1885886,365.1964137,363.18076363413,3760,cpd:C11860,Gibberellin A15 open lactone,C20H28O5,Gibberellin A15 open lactone,R06322 R06323 R06330 R06334,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.11.12,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11860  Gibberellin A15 open lactone; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11860  Gibberellin A15 open lactone,CAS: 88373-66-4; PubChem: 14022; ChEBI: 29590; LIPIDMAPS: LMPR0104170017; 3DMET: B04339; NIKKAJI: J2.777.645K,cpd:C06094; cpd:C06977; cpd:C07124; cpd:C08021; cpd:C09112; cpd:C11858; cpd:C11860,20,28,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O5,C20H27O5,348.193674,349.201499,347.1858493414,3761,cpd:C11861,Gibberellin A24,C20H26O5,Gibberellin A24,R06323 R06326 R06331 R06335,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.11.12,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11861  Gibberellin A24; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11861  Gibberellin A24,CAS: 19427-32-8; PubChem: 14023; ChEBI: 32906; LIPIDMAPS: LMPR0104170018; KNApSAcK: C00000024; 3DMET: B04340; NIKKAJI: J4.752J,cpd:C09509; cpd:C09518; cpd:C11861; cpd:C12308; cpd:C14161; cpd:C20633,20,26,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H27O5,C20H25O5,346.1780239,347.185849,345.17019893415,3762,cpd:C11862,Gibberellin A36,C20H26O6,Gibberellin A36,R06325 R06327 R06335,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11862  Gibberellin A36; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11862  Gibberellin A36,CAS: 38076-57-2; PubChem: 14024; ChEBI: 29595; LIPIDMAPS: LMPR0104170019; KNApSAcK: C00000036; 3DMET: B04341; NIKKAJI: J4.768F,cpd:C02034; cpd:C09090; cpd:C09184; cpd:C09395; cpd:C09442; cpd:C09451; cpd:C09474; cpd:C11862; cpd:C18167; cpd:C19145; cpd:C20456,20,26,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H27O6,C20H25O6,362.1729386,363.1807636,361.16511353416,3763,cpd:C11863,Gibberellin A9,C19H24O4,Gibberellin A9,R06326 R06332 R06336 R06337 R06349 R10449,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.11.12; 1.14.11.13; 1.14.11.15; 1.14.11.-; 2.1.1.275,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11863  Gibberellin A9; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11863  Gibberellin A9,CAS: 427-77-0; PubChem: 14025; ChEBI: 29605; LIPIDMAPS: LMPR0104170020; KNApSAcK: C00000009; 3DMET: B04342; NIKKAJI: J4.735J,cpd:C04793; cpd:C07805; cpd:C11863; cpd:C14347; cpd:C14946; cpd:C15456; cpd:C17789; cpd:C17795,19,24,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O4,C19H23O4,316.1674593,317.1752843,315.15963423417,3764,cpd:C11864,Gibberellin A4,C19H24O5,Gibberellin A4,R06327 R06336 R06338 R06617 R06619 R10450,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites; Plant hormone signal transduction,1.14.11.13; 1.14.11.15; 2.1.1.276,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11864  Gibberellin A4; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11864  Gibberellin A4,CAS: 468-44-0; PubChem: 14026; ChEBI: 32902; LIPIDMAPS: LMPR0104170021; KNApSAcK: C00000004; PDB-CCD: GA4; 3DMET: B04343; NIKKAJI: J4.736H,cpd:C02035; cpd:C08111; cpd:C09742; cpd:C11864; cpd:C11865,19,24,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O5,C19H23O5,332.1623739,333.1701989,331.15454883418,3765,cpd:C11865,Gibberellin A51,C19H24O5,Gibberellin A51,R06337 R06343,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.11.13,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11865  Gibberellin A51; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11865  Gibberellin A51,CAS: 56978-14-4; PubChem: 14027; ChEBI: 29599; LIPIDMAPS: LMPR0104170022; KNApSAcK: C00000051; 3DMET: B04344; NIKKAJI: J4.776G,cpd:C02035; cpd:C08111; cpd:C09742; cpd:C11864; cpd:C11865,19,24,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O5,C19H23O5,332.1623739,333.1701989,331.15454883419,3766,cpd:C11866,"2,3-Dehydro-gibberellin A9;",C19H22O4,"2,3-Dehydro-gibberellin A9; 2,3-Didehydro-gibberellin A9",R06349 R06350,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.11.-,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11866  2,3-Dehydro-gibberellin A9; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11866  2,3-Dehydro-gibberellin A9",CAS: 2531-21-7; PubChem: 14028; ChEBI: 29467; LIPIDMAPS: LMPR0104170023; KNApSAcK: C00000866; 3DMET: B04345; NIKKAJI: J2.777.646I,cpd:C04303; cpd:C06167; cpd:C07661; cpd:C09267; cpd:C11866; cpd:C13980; cpd:C19061,19,22,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O4,C19H21O4,314.1518092,315.1596342,313.14398423420,3767,cpd:C11867,Gibberellin A7,C19H22O5,Gibberellin A7,R06350 R06617 R06618,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.11.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11867  Gibberellin A7; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11867  Gibberellin A7,CAS: 510-75-8; PubChem: 14029; ChEBI: 32903; LIPIDMAPS: LMPR0104170024; KNApSAcK: C00000007; 3DMET: B04346; NIKKAJI: J4.737F,cpd:C09173; cpd:C11854; cpd:C11867; cpd:C11871; cpd:C18037,19,22,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O5,C19H21O5,330.1467238,331.1545488,329.13889883421,3768,cpd:C11868,Gibberellin A34,C19H24O6,Gibberellin A34,R06338 R06342,Diterpenoid biosynthesis,1.14.11.13,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11868  Gibberellin A34; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11868  Gibberellin A34,CAS: 32630-92-5; PubChem: 14030; ChEBI: 29593; LIPIDMAPS: LMPR0104170025; KNApSAcK: C00000034; 3DMET: B04347; NIKKAJI: J4.763E,cpd:C00859; cpd:C04597; cpd:C04844; cpd:C06096; cpd:C08358; cpd:C08759; cpd:C09356; cpd:C09407; cpd:C09520; cpd:C09539; cpd:C09554; cpd:C11868; cpd:C16910,19,24,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O6,C19H23O6,348.1572885,349.1651135,347.14946353422,3769,cpd:C11869,Gibberellin A34-catabolite,C19H22O6,Gibberellin A34-catabolite,R06342,Diterpenoid biosynthesis,1.14.11.13,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11869  Gibberellin A34-catabolite; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11869  Gibberellin A34-catabolite,PubChem: 14031; ChEBI: 29594; LIPIDMAPS: LMPR0104170026; 3DMET: B04348; NIKKAJI: J2.777.648E,cpd:C01699; cpd:C09062; cpd:C09104; cpd:C09174; cpd:C09190; cpd:C09385; cpd:C09512; cpd:C09547; cpd:C11210; cpd:C11855; cpd:C11856; cpd:C11869,19,22,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O6,C19H21O6,346.1416384,347.1494635,345.13381343423,3770,cpd:C11870,Gibberellin A8-catabolite,C19H22O7,Gibberellin A8-catabolite,R06345,Diterpenoid biosynthesis,1.14.11.13,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11870  Gibberellin A8-catabolite; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11870  Gibberellin A8-catabolite,CAS: 78791-79-4; PubChem: 14032; ChEBI: 29604; LIPIDMAPS: LMPR0104170027; 3DMET: B04349; NIKKAJI: J2.777.649C,cpd:C09138; cpd:C09583; cpd:C11870,19,22,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O7,C19H21O7,362.136553,363.1443781,361.1287283424,3771,cpd:C11871,Gibberellin A5,C19H22O5,Gibberellin A5,R06346 R06347 R06348,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.11.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11871  Gibberellin A5; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11871  Gibberellin A5,CAS: 561-56-8; PubChem: 14033; ChEBI: 29598; LIPIDMAPS: LMPR0104170028; KNApSAcK: C00000005; 3DMET: B04350; NIKKAJI: J4.739B,cpd:C09173; cpd:C11854; cpd:C11867; cpd:C11871; cpd:C18037,19,22,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O5,C19H21O5,330.1467238,331.1545488,329.13889883425,3772,cpd:C11872,Kaur-16-en-18-ol;,C20H32O,Kaur-16-en-18-ol; (-)-Kaur-16-en-18-ol; Kaurenol; ent-Kaur-16-en-19-ol,R06291 R06292,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.78,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010413 Kaurane and phyllocladane diterpenoids;      C11872  Kaur-16-en-18-ol; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Kaurenes;     C11872  Kaur-16-en-18-ol,CAS: 2300-11-0; PubChem: 14034; ChEBI: 29611; ChEMBL: CHEMBL224479 CHEMBL590263; KNApSAcK: C00007360; 3DMET: B04351; NIKKAJI: J440.124G,cpd:C11872; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11895; cpd:C14906; cpd:C15101; cpd:C15140; cpd:C15492; cpd:C16858; cpd:C18219; cpd:C18221; cpd:C20146; cpd:C20147; cpd:C20150,20,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O1,C20H31O1,288.2453157,289.2531407,287.23749063426,3773,cpd:C11873,Kaur-16-en-18-al;,C20H30O,Kaur-16-en-18-al; (-)-Kaur-16-en-18-al; 4alpha-Kaur-16-en-18-al; Kaurenal; ent-Kaurenal; ent-Kaur-16-en-19-al,R06292 R06293,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.78,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010413 Kaurane and phyllocladane diterpenoids;      C11873  Kaur-16-en-18-al; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Kaurenes;     C11873  Kaur-16-en-18-al,CAS: 14046-84-5; PubChem: 14035; ChEBI: 29609; 3DMET: B04352; NIKKAJI: J451.849G,cpd:C00473; cpd:C00899; cpd:C09092; cpd:C11873; cpd:C11885; cpd:C11886; cpd:C11887; cpd:C16682; cpd:C17276; cpd:C18220; cpd:C18222; cpd:C19962; cpd:C20148,20,30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O1,C20H29O1,286.2296656,287.2374906,285.22184063427,3774,cpd:C11874,Kaur-16-en-18-oic acid;,C20H30O2,Kaur-16-en-18-oic acid; (-)-Kaur-16-en-19-oic acid; Kaurenic acid; Kaurenoic acid; ent-Kaur-16(17)-en-19-oic acid; ent-Kaurenoic acid; ent-Kaur-16-en-19-oic acid; ent-Kaur-16-en-19-oate,R06293 R06294 R10066 R10067,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.78; 1.14.13.79,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010413 Kaurane and phyllocladane diterpenoids;      C11874  Kaur-16-en-18-oic acid; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Kaurenes;     C11874  Kaurenoic acid,CAS: 6730-83-2; PubChem: 14036; ChEBI: 15417; KNApSAcK: C00000881; 3DMET: B04353; NIKKAJI: J133.946J,cpd:C06087; cpd:C06428; cpd:C07198; cpd:C09118; cpd:C09148; cpd:C09159; cpd:C11874; cpd:C11888; cpd:C11889; cpd:C12077; cpd:C12083; cpd:C14255; cpd:C14490; cpd:C14588; cpd:C14890; cpd:C15003; cpd:C15008; cpd:C15017; cpd:C15036; cpd:C15070; cpd:C15184; cpd:C15188; cpd:C15259; cpd:C15318; cpd:C15412; cpd:C15460; cpd:C20149; cpd:C20208,20,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O2,C20H29O2,302.2245802,303.2324052,301.21675523428,3775,cpd:C11875,ent-7alpha-Hydroxykaur-16-en-19-oic acid;,C20H30O3,ent-7alpha-Hydroxykaur-16-en-19-oic acid; (-)-Kaur-16-en-7beta-ol-19-oic acid; ent-7alpha-Hydroxykaur-16-en-19-oate,R06294 R06295 R06296,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.79,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010413 Kaurane and phyllocladane diterpenoids;      C11875  ent-7alpha-Hydroxykaur-16-en-19-oic acid;     PR010454 Ginkgolides and Bilobalides;      C11875  ent-7alpha-Hydroxykaur-16-en-19-oic acid; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Kaurenes;     C11875  ent-7alpha-Hydroxykaur-16-en-19-oic acid,CAS: 21435-01-8; PubChem: 14037; ChEBI: 15419; KNApSAcK: C00000877; 3DMET: B04354; NIKKAJI: J15.376A,cpd:C00909; cpd:C02645; cpd:C04170; cpd:C04577; cpd:C07052; cpd:C09079; cpd:C09110; cpd:C11875; cpd:C13843; cpd:C14555; cpd:C14628; cpd:C14665; cpd:C14683; cpd:C14732; cpd:C14807; cpd:C14891; cpd:C14929; cpd:C14945; cpd:C14980; cpd:C15354; cpd:C15434; cpd:C17498; cpd:C17956; cpd:C18177; cpd:C20212,20,30,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O3,C20H29O3,318.2194948,319.2273199,317.21166983429,3776,cpd:C11876,"6beta,7beta-Dihydroxykaurenoic acid;",C20H30O4,"6beta,7beta-Dihydroxykaurenoic acid; ent-6alpha,7alpha-Dihydroxykaur-16-en-19-oic acid",R06296,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.79,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010413 Kaurane and phyllocladane diterpenoids;      C11876  6beta,7beta-Dihydroxykaurenoic acid; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Kaurenes;     C11876  6beta,7beta-Dihydroxykaurenoic acid",CAS: 26109-32-0; PubChem: 14038; ChEBI: 29502; 3DMET: B04355; NIKKAJI: J2.182.302C,cpd:C05949; cpd:C05953; cpd:C05954; cpd:C05955; cpd:C05957; cpd:C05958; cpd:C09125; cpd:C09150; cpd:C11256; cpd:C11876; cpd:C14504; cpd:C14815; cpd:C14913; cpd:C15159; cpd:C18173,20,30,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O4,C20H29O4,334.2144094,335.2222345,333.20658443430,3777,cpd:C11877,(+)-Sandaracopimaradiene;,C20H32,"(+)-Sandaracopimaradiene; ent-Sandaracopimara-8(14),15-diene",R09120,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.29,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010408 Pimarane diterpenoids;      C11877  (+)-Sandaracopimaradiene; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Pimaranes;     C11877  (+)-Sandaracopimaradiene,CAS: 21738-16-9; PubChem: 14039; ChEBI: 50061; LIPIDMAPS: LMPR0104080001; KNApSAcK: C00000883; 3DMET: B04356; NIKKAJI: J16.237J,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763431,3778,cpd:C11878,(-)-Abietadiene;,C20H32,(-)-Abietadiene; Abietadiene,R06301 R06351,Diterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.108; 4.2.3.18,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010405 Abietane diterpenoids;      C11878  (-)-Abietadiene; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Abietanes;     C11878  (-)-Abietadiene,CAS: 35241-40-8; PubChem: 14040; ChEBI: 30232; LIPIDMAPS: LMPR0104050002; KNApSAcK: C00000868; 3DMET: B04357; NIKKAJI: J668.689C,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763432,3779,cpd:C11879,Levopimaradiene;,C20H32,"Levopimaradiene; Abieta-8(14),12-diene",R06302 R06352,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 4.2.3.32,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Abietanes;     C11879  Levopimaradiene,CAS: 122712-77-0; PubChem: 14041; ChEBI: 29616; LIPIDMAPS: LMPR0104050007; 3DMET: B04358; NIKKAJI: J1.551.927D,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763433,3780,cpd:C11880,Neoabietadiene,C20H32,Neoabietadiene,R06303 R06353,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 4.2.3.132,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010405 Abietane diterpenoids;      C11880  Neoabietadiene; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Abietanes;     C11880  Neoabietadiene,CAS: 57119-12-7; PubChem: 14042; ChEBI: 29651; LIPIDMAPS: LMPR0104050003; 3DMET: B04359; NIKKAJI: J776.732C,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763434,3781,cpd:C11881,Palustradiene,C20H32,Palustradiene,R06304 R09108,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 4.2.3.32,NA,NA,CAS: 41577-36-0; PubChem: 14043; ChEBI: 29659; 3DMET: B04360; NIKKAJI: J776.731E,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763435,3782,cpd:C11882,Abietinol;,C20H32O,Abietinol; Abietol,R06351 R06354 R10077,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.108; 1.14.13.109,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010405 Abietane diterpenoids;      C11882  Abietinol,CAS: 666-84-2; PubChem: 14044; ChEBI: 29510; ChEMBL: CHEMBL304954; LIPIDMAPS: LMPR0104050006; KNApSAcK: C00000870; 3DMET: B04361; NIKKAJI: J37.478D,cpd:C11872; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11895; cpd:C14906; cpd:C15101; cpd:C15140; cpd:C15492; cpd:C16858; cpd:C18219; cpd:C18221; cpd:C20146; cpd:C20147; cpd:C20150,20,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O1,C20H31O1,288.2453157,289.2531407,287.23749063436,3783,cpd:C11883,Levopimarinol,C20H32O,Levopimarinol,R06352 R06355,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,CAS: 97640-46-5; PubChem: 14045; ChEBI: 52482; 3DMET: B04362; NIKKAJI: J428.788F,cpd:C11872; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11895; cpd:C14906; cpd:C15101; cpd:C15140; cpd:C15492; cpd:C16858; cpd:C18219; cpd:C18221; cpd:C20146; cpd:C20147; cpd:C20150,20,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O1,C20H31O1,288.2453157,289.2531407,287.23749063437,3784,cpd:C11884,Neoabietinol;,C20H32O,Neoabietinol; Neoabietol,R06353 R06356,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010405 Abietane diterpenoids;      C11884  Neoabietinol,CAS: 640-42-6; PubChem: 14046; ChEBI: 29654; 3DMET: B04363; NIKKAJI: J428.787H,cpd:C11872; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11895; cpd:C14906; cpd:C15101; cpd:C15140; cpd:C15492; cpd:C16858; cpd:C18219; cpd:C18221; cpd:C20146; cpd:C20147; cpd:C20150,20,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O1,C20H31O1,288.2453157,289.2531407,287.23749063438,3785,cpd:C11885,Neoabietal;,C20H30O,Neoabietal; Neoabietinal,R06356 R06359,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010405 Abietane diterpenoids;      C11885  Neoabietal,CAS: 19898-57-8; PubChem: 14047; ChEBI: 29652; 3DMET: B04364; NIKKAJI: J428.790H,cpd:C00473; cpd:C00899; cpd:C09092; cpd:C11873; cpd:C11885; cpd:C11886; cpd:C11887; cpd:C16682; cpd:C17276; cpd:C18220; cpd:C18222; cpd:C19962; cpd:C20148,20,30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O1,C20H29O1,286.2296656,287.2374906,285.22184063439,3786,cpd:C11886,Levopimarinal,C20H30O,Levopimarinal,R06355 R06358,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,CAS: 103654-28-0; PubChem: 14048; ChEBI: 52483; 3DMET: B04365; NIKKAJI: J428.791F,cpd:C00473; cpd:C00899; cpd:C09092; cpd:C11873; cpd:C11885; cpd:C11886; cpd:C11887; cpd:C16682; cpd:C17276; cpd:C18220; cpd:C18222; cpd:C19962; cpd:C20148,20,30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O1,C20H29O1,286.2296656,287.2374906,285.22184063440,3787,cpd:C11887,Abietal;,C20H30O,Abietal; Abietaldehyde; Abietinal,R06354 R06357 R10078,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.2.1.74; 1.14.13.109,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010405 Abietane diterpenoids;      C11887  Abietal,CAS: 6704-50-3; PubChem: 14049; ChEBI: 29509; ChEMBL: CHEMBL563793; KNApSAcK: C00000869; 3DMET: B04366; NIKKAJI: J15.229C,cpd:C00473; cpd:C00899; cpd:C09092; cpd:C11873; cpd:C11885; cpd:C11886; cpd:C11887; cpd:C16682; cpd:C17276; cpd:C18220; cpd:C18222; cpd:C19962; cpd:C20148,20,30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O1,C20H29O1,286.2296656,287.2374906,285.22184063441,3788,cpd:C11888,Levopimaric acid;,C20H30O2,Levopimaric acid; L-Pimaric acid,R06358,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Pimaranes;     C11888  Levopimaric acid,CAS: 79-54-9; PubChem: 14050; ChEBI: 29615; 3DMET: B04367; NIKKAJI: J4.233A,cpd:C06087; cpd:C06428; cpd:C07198; cpd:C09118; cpd:C09148; cpd:C09159; cpd:C11874; cpd:C11888; cpd:C11889; cpd:C12077; cpd:C12083; cpd:C14255; cpd:C14490; cpd:C14588; cpd:C14890; cpd:C15003; cpd:C15008; cpd:C15017; cpd:C15036; cpd:C15070; cpd:C15184; cpd:C15188; cpd:C15259; cpd:C15318; cpd:C15412; cpd:C15460; cpd:C20149; cpd:C20208,20,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O2,C20H29O2,302.2245802,303.2324052,301.21675523442,3789,cpd:C11889,Neoabietic acid,C20H30O2,Neoabietic acid,R06359,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010405 Abietane diterpenoids;      C11889  Neoabietic acid; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Abietanes;     C11889  Neoabietic acid,CAS: 471-77-2; PubChem: 14051; ChEBI: 29653; LIPIDMAPS: LMPR0104050004; 3DMET: B04368; NIKKAJI: J67.044H,cpd:C06087; cpd:C06428; cpd:C07198; cpd:C09118; cpd:C09148; cpd:C09159; cpd:C11874; cpd:C11888; cpd:C11889; cpd:C12077; cpd:C12083; cpd:C14255; cpd:C14490; cpd:C14588; cpd:C14890; cpd:C15003; cpd:C15008; cpd:C15017; cpd:C15036; cpd:C15070; cpd:C15184; cpd:C15188; cpd:C15259; cpd:C15318; cpd:C15412; cpd:C15460; cpd:C20149; cpd:C20208,20,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O2,C20H29O2,302.2245802,303.2324052,301.21675523443,3790,cpd:C11890,Aphidicolan-16beta-ol,C20H34O,Aphidicolan-16beta-ol,R06313 R06316,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.42,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010416 Aphidicolane diterpenoids;      C11890  Aphidicolan-16beta-ol; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Aphidicolane;     C11890  Aphidicolan-16beta-ol,CAS: 101143-85-5; PubChem: 14052; ChEBI: 29519; LIPIDMAPS: LMPR0104160002,cpd:C09094; cpd:C11890; cpd:C15316; cpd:C19817; cpd:C19963; cpd:C19964; cpd:C20158; cpd:C20481; cpd:C20681; cpd:C20834; cpd:C20923; cpd:C20924,20,34,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O1,C20H33O1,290.2609657,291.2687907,289.25314073444,3791,cpd:C11893,Cembrene;,C20H32,Cembrene; Thunbergen; (+)-Thunbergen; (+)-Cembrene,R06321,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010419 Cembrane diterpenoids;      C11893  Cembrene; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Cembrenes;     C11893  Cembrene,CAS: 1898-13-1; PubChem: 14055; ChEBI: 29550; LIPIDMAPS: LMPR0104190002; 3DMET: B05553; NIKKAJI: J14.398G,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763445,3792,cpd:C11894,"Taxa-4(5),11(12)-diene;",C20H32,"Taxa-4(5),11(12)-diene; Taxa-4,11-diene",R06305 R06306,Diterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.99.37; 4.2.3.17,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010439 Taxane and abeotaxane diterpenoids;      C11894  Taxa-4(5),11(12)-diene; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Taxanes;     C11894  Taxa-4(5),11(12)-diene",CAS: 163594-75-0; PubChem: 14056; ChEBI: 30037; LIPIDMAPS: LMPR0104390002; KNApSAcK: C00000900; 3DMET: B04369; NIKKAJI: J651.843E,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763446,3793,cpd:C11895,"Taxa-4(20),11(12)-dien-5alpha-ol;",C20H32O,"Taxa-4(20),11(12)-dien-5alpha-ol; Taxa-4(20),11-dien-5alpha-ol",R06306 R06307 R06308,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.77; 1.14.99.37; 2.3.1.162,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010439 Taxane and abeotaxane diterpenoids;      C11895  Taxa-4(20),11(12)-dien-5alpha-ol",CAS: 178888-02-3; PubChem: 14057; ChEBI: 30038; LIPIDMAPS: LMPR0104390003; 3DMET: B04370; NIKKAJI: J1.110.894F,cpd:C11872; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11895; cpd:C14906; cpd:C15101; cpd:C15140; cpd:C15492; cpd:C16858; cpd:C18219; cpd:C18221; cpd:C20146; cpd:C20147; cpd:C20150,20,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O1,C20H31O1,288.2453157,289.2531407,287.23749063447,3794,cpd:C11896,"Taxa-4(20),11(12)-dien-5alpha-yl acetate",C22H34O2,"Taxa-4(20),11(12)-dien-5alpha-yl acetate",R06307 R06309,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.76; 2.3.1.162,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010439 Taxane and abeotaxane diterpenoids;      C11896  Taxa-4(20),11(12)-dien-5alpha-yl acetate",CAS: 214628-37-2; PubChem: 14058; ChEBI: 30042; LIPIDMAPS: LMPR0104390004; 3DMET: B04371; NIKKAJI: J1.250.576K,cpd:C11896; cpd:C13364; cpd:C15106; cpd:C15413; cpd:C15421; cpd:C16184; cpd:C16513,22,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H35O2,C22H33O2,330.2558803,331.2637054,329.24805533448,3795,cpd:C11897,"Taxa-4(20),11(12)-dien-5alpha,13alpha-diol",C20H32O2,"Taxa-4(20),11(12)-dien-5alpha,13alpha-diol",R06308 R06318,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.77,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010439 Taxane and abeotaxane diterpenoids;      C11897  Taxa-4(20),11(12)-dien-5alpha,13alpha-diol",CAS: 357436-25-0; PubChem: 14059; ChEBI: 30041; LIPIDMAPS: LMPR0104390005; 3DMET: B04372; NIKKAJI: J2.611.931F,cpd:C00219; cpd:C09057; cpd:C09124; cpd:C11897; cpd:C14493; cpd:C14605; cpd:C14956; cpd:C15176; cpd:C15252; cpd:C15367; cpd:C17920; cpd:C20329,20,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O2,C20H31O2,304.2402303,305.2480553,303.23240523449,3796,cpd:C11898,"Taxa-4(20),11(12)-dien-5alpha-acetoxy-10beta-ol;",C22H34O3,"Taxa-4(20),11(12)-dien-5alpha-acetoxy-10beta-ol; 10beta-Hydroxytaxa-4(20),11-dien-5alpha-yl acetate; 5alpha-Acetoxytaxa-4(20),11(12)-dien-10beta-ol",R06309 R09867,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.76; 1.14.13.146,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010439 Taxane and abeotaxane diterpenoids;      C11898  Taxa-4(20),11(12)-dien-5alpha-acetoxy-10beta-ol",CAS: 337515-55-6; PubChem: 14060; ChEBI: 50436; LIPIDMAPS: LMPR0104390006; 3DMET: B04373; NIKKAJI: J1.788.047K,cpd:C10794; cpd:C11898; cpd:C14976,22,34,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H35O3,C22H33O3,346.250795,347.25862,345.24296993450,3797,cpd:C11899,10-Deacetyl-2-debenzoylbaccatin III,C22H32O9,10-Deacetyl-2-debenzoylbaccatin III,R06310 R06318 R06319,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.3.1.166,NA,NA,PubChem: 14061; ChEBI: 32897; 3DMET: B04374; NIKKAJI: J2.777.713I,cpd:C11899,22,32,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H33O9,C22H31O9,440.2046326,441.2124576,439.19680763451,3798,cpd:C11900,Baccatin III,C31H38O11,Baccatin III,R06311 R06320 R08172,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.3.1.167; 2.3.2.-,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Taxanes;     C11900  Baccatin III,CAS: 27548-93-2; PubChem: 14062; ChEBI: 32898; ChEMBL: CHEMBL288043; KNApSAcK: C00036790 C00040892; 3DMET: B04375; NIKKAJI: J82.234E,cpd:C11900,31,38,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H39O11,C31H37O11,586.241412,587.2492371,585.2335873452,3799,cpd:C11901,Copalyl diphosphate;,C20H36O7P2,Copalyl diphosphate; (+)-Copalyl diphosphate; Labdadienyl diphosphate,R06298 R06299 R06301 R06302 R06303 R06304 R08402 R09111; R09686 R10585,Diterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.3.18; 4.2.3.32; 4.2.3.44; 4.2.3.45; 4.2.3.131; 4.2.3.132; 4.2.3.147; 5.5.1.12,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010403 Labdane and halimane diterpenoids;      C11901  Copalyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Labdanes;     C11901  Copalyl diphosphate,PubChem: 14063; ChEBI: 30939; LIPIDMAPS: LMPR0104030002; KNApSAcK: C00000876; 3DMET: B04376; NIKKAJI: J1.305.745A J1.457.020I,cpd:C00353; cpd:C05859; cpd:C06089; cpd:C11356; cpd:C11901; cpd:C11902; cpd:C19815; cpd:C19836,20,36,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H37O7P2,C20H35O7P2,450.1936275,451.2014525,449.18580253453,3800,cpd:C11902,9alpha-Copalyl diphosphate;,C20H36O7P2,9alpha-Copalyl diphosphate; syn-Copalyl diphosphate,R06312 R06313 R06314 R06315 R09115 R09116 R09117 R09899,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.33; 4.2.3.34; 4.2.3.35; 4.2.3.42; 4.2.3.99; 5.5.1.14,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010403 Labdane and halimane diterpenoids;      C11902  9alpha-Copalyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Labdanes;     C11902  9alpha-Copalyl diphosphate,PubChem: 14064; ChEBI: 29739; LIPIDMAPS: LMPR0104030003; KNApSAcK: C00000899; 3DMET: B04377; NIKKAJI: J1.556.818F,cpd:C00353; cpd:C05859; cpd:C06089; cpd:C11356; cpd:C11901; cpd:C11902; cpd:C19815; cpd:C19836,20,36,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H37O7P2,C20H35O7P2,450.1936275,451.2014525,449.18580253454,3801,cpd:C11905,Gibberellin A53 aldehyde,C20H28O4,Gibberellin A53 aldehyde,R06328 R06340,Diterpenoid biosynthesis,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010417 Gibberellins;      C11905  Gibberellin A53 aldehyde; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Gibberellins;     C11905  Gibberellin A53 aldehyde,CAS: 85344-33-8; PubChem: 14067; ChEBI: 29601; LIPIDMAPS: LMPR0104170029; 3DMET: B04378; NIKKAJI: J2.777.716C,cpd:C09067; cpd:C09081; cpd:C09128; cpd:C09177; cpd:C10564; cpd:C11853; cpd:C11857; cpd:C11905; cpd:C15068; cpd:C15459; cpd:C18175,20,28,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O4,C20H27O4,332.1987594,333.2065844,331.19093433455,3802,cpd:C12077,Palustric acid;,C20H30O2,"Palustric acid; NSC 148945; 8,13-Abietadien-18-oic acid",R09110,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,CAS: 1945-53-5; PubChem: 14228; ChEBI: 29660; NIKKAJI: J12.734E,cpd:C06087; cpd:C06428; cpd:C07198; cpd:C09118; cpd:C09148; cpd:C09159; cpd:C11874; cpd:C11888; cpd:C11889; cpd:C12077; cpd:C12083; cpd:C14255; cpd:C14490; cpd:C14588; cpd:C14890; cpd:C15003; cpd:C15008; cpd:C15017; cpd:C15036; cpd:C15070; cpd:C15184; cpd:C15188; cpd:C15259; cpd:C15318; cpd:C15412; cpd:C15460; cpd:C20149; cpd:C20208,20,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O2,C20H29O2,302.2245802,303.2324052,301.21675523456,3803,cpd:C13273,Plaunotol;,C20H34O2,Plaunotol; 18-Hydroxygeranylgeraniol,R09122,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.110,NA,Major components of natural products [BR:br08323];  Crude drugs;   Plau-noi;    C13273  Plaunotol,CAS: 64218-02-6; PubChem: 586017; ChEBI: 32023; ChEMBL: CHEMBL285815,cpd:C03242; cpd:C09072; cpd:C13273; cpd:C14882; cpd:C15058; cpd:C15376; cpd:C15399; cpd:C16522,20,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O2,C20H33O2,306.2558803,307.2637054,305.24805533457,3804,cpd:C16523,3'-N-Debenzoyl-2'-deoxytaxol;,C40H47NO12,3'-N-Debenzoyl-2'-deoxytaxol; beta-Phenylalanoyl baccatin III; 13-O-beta-Phenylalanoylbaccatin III,R08172 R08173,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.-.-; 2.3.2.-,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Taxanes;     C16523  3'-N-Debenzoyl-2'-deoxytaxol,PubChem: 51090852; ChEBI: 74030; NIKKAJI: J2.803.547K,cpd:C16523,40,47,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H48O12N1,C40H46O12N1,733.309826,734.317651,732.30200093458,3805,cpd:C16524,3'-N-Debenzoyltaxol;,C40H47NO13,3'-N-Debenzoyltaxol; 13-O-3-Phenylisoserinoyl baccatin III,R08171 R08173,Diterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.-.-; 2.3.1.-,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Taxanes;     C16524  3'-N-Debenzoyltaxol,CAS: 133524-70-6; PubChem: 51090853; ChEBI: 63862; ChEMBL: CHEMBL297485 CHEMBL366419; NIKKAJI: J631.874F,cpd:C16524,40,47,13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H48O13N1,C40H46O13N1,749.3047406,750.3125656,748.29691553459,3806,cpd:C18015,Momilactone A,C20H26O3,Momilactone A,R08916 R08917,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.295,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010408 Pimarane diterpenoids;      C18015  Momilactone A,CAS: 51415-07-7; PubChem: 96024235; ChEBI: 49191; KNApSAcK: C00000259; NIKKAJI: J221.703A,cpd:C06496; cpd:C09119; cpd:C09194; cpd:C14670; cpd:C14930; cpd:C14999; cpd:C15228; cpd:C16678; cpd:C18015,20,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H27O3,C20H25O3,314.1881947,315.1960197,313.18036973460,3807,cpd:C18016,"3beta-Hydroxy-9beta-pimara-7,15-diene-19,6beta-olide",C20H28O3,"3beta-Hydroxy-9beta-pimara-7,15-diene-19,6beta-olide",R08916 R08917 R09118,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.295,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010408 Pimarane diterpenoids;      C18016  3beta-Hydroxy-9beta-pimara-7,15-diene-19,6beta-olide",PubChem: 96024236; ChEBI: 49195; NIKKAJI: J1.610.782D,cpd:C06093; cpd:C07851; cpd:C09066; cpd:C09163; cpd:C09182; cpd:C09196; cpd:C09706; cpd:C09845; cpd:C14242; cpd:C14615; cpd:C14717; cpd:C14887; cpd:C15126; cpd:C15192; cpd:C15282; cpd:C15287; cpd:C16677; cpd:C16679; cpd:C16680; cpd:C18016,20,28,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O3,C20H27O3,316.2038448,317.2116698,315.19601973461,3808,cpd:C18211,"Isopimara-7,15-diene",C20H32,"Isopimara-7,15-diene",R09111 R09112,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-; 4.2.3.44,NA,NA,PubChem: 103061393; ChEBI: 52280; KNApSAcK: C00034866; NIKKAJI: J112.499D,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763462,3809,cpd:C18219,Palustradienol,C20H32O,Palustradienol,R09108 R09109,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 103061401; ChEBI: 81594,cpd:C11872; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11895; cpd:C14906; cpd:C15101; cpd:C15140; cpd:C15492; cpd:C16858; cpd:C18219; cpd:C18221; cpd:C20146; cpd:C20147; cpd:C20150,20,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O1,C20H31O1,288.2453157,289.2531407,287.23749063463,3810,cpd:C18220,Palustradienal,C20H30O,Palustradienal,R09109 R09110,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 103061402; ChEBI: 81595,cpd:C00473; cpd:C00899; cpd:C09092; cpd:C11873; cpd:C11885; cpd:C11886; cpd:C11887; cpd:C16682; cpd:C17276; cpd:C18220; cpd:C18222; cpd:C19962; cpd:C20148,20,30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O1,C20H29O1,286.2296656,287.2374906,285.22184063464,3811,cpd:C18221,Isopimaradienol,C20H32O,Isopimaradienol,R09112 R09113,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 103061403; ChEBI: 52484,cpd:C11872; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11895; cpd:C14906; cpd:C15101; cpd:C15140; cpd:C15492; cpd:C16858; cpd:C18219; cpd:C18221; cpd:C20146; cpd:C20147; cpd:C20150,20,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O1,C20H31O1,288.2453157,289.2531407,287.23749063465,3812,cpd:C18222,Isopimaradienal,C20H30O,Isopimaradienal,R09113 R09114,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,NA,PubChem: 103061404; ChEBI: 52485,cpd:C00473; cpd:C00899; cpd:C09092; cpd:C11873; cpd:C11885; cpd:C11886; cpd:C11887; cpd:C16682; cpd:C17276; cpd:C18220; cpd:C18222; cpd:C19962; cpd:C20148,20,30,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O1,C20H29O1,286.2296656,287.2374906,285.22184063466,3813,cpd:C18223,Stemar-13-ene,C20H32,Stemar-13-ene,R09115,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.33,NA,NA,PubChem: 103061405; ChEBI: 50069; KNApSAcK: C00000897,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763467,3814,cpd:C18224,Stemod-13(17)-ene,C20H32,Stemod-13(17)-ene,R09116 R09921,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.144; 4.2.3.34,NA,NA,PubChem: 103061406; ChEBI: 50068,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763468,3815,cpd:C18225,"9beta-Pimara-7,15-diene",C20H32,"9beta-Pimara-7,15-diene",R09117 R09862 R09865,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.144; 4.2.3.35,NA,NA,PubChem: 103061407; ChEBI: 50067; KNApSAcK: C00000867,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763469,3816,cpd:C18226,"ent-Cassa-12,15-diene",C20H32,"ent-Cassa-12,15-diene",R09119 R09866,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.145; 4.2.3.28,NA,NA,PubChem: 103061408; ChEBI: 50060; KNApSAcK: C00033813,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763470,3817,cpd:C18228,"ent-Pimara-8(14),15-diene",C20H32,"ent-Pimara-8(14),15-diene",R09121,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.30,NA,NA,PubChem: 103061410; ChEBI: 50063,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763471,3818,cpd:C18229,"Fusicocca-2,10(14)-diene",C20H32,"Fusicocca-2,10(14)-diene",R09123,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.43,NA,NA,PubChem: 103061411; ChEBI: 52463,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763472,3819,cpd:C19817,Phyllocladan-16alpha-ol,C20H34O,Phyllocladan-16alpha-ol,R09686,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.45,NA,NA,PubChem: 135626284,cpd:C09094; cpd:C11890; cpd:C15316; cpd:C19817; cpd:C19963; cpd:C19964; cpd:C20158; cpd:C20481; cpd:C20681; cpd:C20834; cpd:C20923; cpd:C20924,20,34,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O1,C20H33O1,290.2609657,291.2687907,289.25314073473,3820,cpd:C20145,ent-Isokaurene;,C20H32,ent-Isokaurene; Kaur-15-ene; Kryptomeren,R09861 R09903,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.143; 4.2.3.103,NA,NA,PubChem: 135626605,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763474,3821,cpd:C20146,ent-2alpha-Hydroxyisokaurene,C20H32O,ent-2alpha-Hydroxyisokaurene,R09861,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.143,NA,NA,PubChem: 135626606,cpd:C11872; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11895; cpd:C14906; cpd:C15101; cpd:C15140; cpd:C15492; cpd:C16858; cpd:C18219; cpd:C18221; cpd:C20146; cpd:C20147; cpd:C20150,20,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O1,C20H31O1,288.2453157,289.2531407,287.23749063475,3822,cpd:C20149,"9beta-Pimara-7,15-dien-19-oate",C20H30O2,"9beta-Pimara-7,15-dien-19-oate",R09118 R09864 R09865,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.144,NA,NA,PubChem: 135626609,cpd:C06087; cpd:C06428; cpd:C07198; cpd:C09118; cpd:C09148; cpd:C09159; cpd:C11874; cpd:C11888; cpd:C11889; cpd:C12077; cpd:C12083; cpd:C14255; cpd:C14490; cpd:C14588; cpd:C14890; cpd:C15003; cpd:C15008; cpd:C15017; cpd:C15036; cpd:C15070; cpd:C15184; cpd:C15188; cpd:C15259; cpd:C15318; cpd:C15412; cpd:C15460; cpd:C20149; cpd:C20208,20,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O2,C20H29O2,302.2245802,303.2324052,301.21675523476,3823,cpd:C20150,"ent-11beta-Hydroxycassa-12,15-diene",C20H32O,"ent-11beta-Hydroxycassa-12,15-diene",R09866,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.145,NA,NA,PubChem: 135626610,cpd:C11872; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11895; cpd:C14906; cpd:C15101; cpd:C15140; cpd:C15492; cpd:C16858; cpd:C18219; cpd:C18221; cpd:C20146; cpd:C20147; cpd:C20150,20,32,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33O1,C20H31O1,288.2453157,289.2531407,287.23749063477,3824,cpd:C20151,"10beta,14beta-Dihydroxytaxa-4(20),11-dien-5alpha-yl acetate;",C22H34O4,"10beta,14beta-Dihydroxytaxa-4(20),11-dien-5alpha-yl acetate; 5alpha-Acetoxy-10beta,14beta-dihydroxytaxadiene",R06319 R09867,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.146,NA,NA,PubChem: 135626611,cpd:C14575; cpd:C20151,22,34,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H35O4,C22H33O4,362.2457096,363.2535346,361.23788453478,3825,cpd:C20158,"(13E)-Labda-7,13-dien-15-ol",C20H34O,"(13E)-Labda-7,13-dien-15-ol",R09874,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,3.1.7.10,NA,NA,PubChem: 163311901,cpd:C09094; cpd:C11890; cpd:C15316; cpd:C19817; cpd:C19963; cpd:C19964; cpd:C20158; cpd:C20481; cpd:C20681; cpd:C20834; cpd:C20923; cpd:C20924,20,34,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O1,C20H33O1,290.2609657,291.2687907,289.25314073479,3826,cpd:C20185,"(12E)-9alpha-Labda-8(17),12,14-triene;",C20H32,"(12E)-9alpha-Labda-8(17),12,14-triene; syn-Labda-8(17),12E,14-triene; (4aS,5R,8aS)-1,1,4a-Trimethyl-6-methylidene-5-[(2E)-3-methylpenta-2,4-dien-1-yl]decahydronaphthalene",R09899,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.99,NA,NA,PubChem: 163311928,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763480,3827,cpd:C20208,syn-Stemoden-19-oate,C20H30O2,syn-Stemoden-19-oate,R09921,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.144,NA,NA,PubChem: 163311951,cpd:C06087; cpd:C06428; cpd:C07198; cpd:C09118; cpd:C09148; cpd:C09159; cpd:C11874; cpd:C11888; cpd:C11889; cpd:C12077; cpd:C12083; cpd:C14255; cpd:C14490; cpd:C14588; cpd:C14890; cpd:C15003; cpd:C15008; cpd:C15017; cpd:C15036; cpd:C15070; cpd:C15184; cpd:C15188; cpd:C15259; cpd:C15318; cpd:C15412; cpd:C15460; cpd:C20149; cpd:C20208,20,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O2,C20H29O2,302.2245802,303.2324052,301.21675523481,3828,cpd:C20270,Copal-8-ol diphosphate;,C20H38O8P2,Copal-8-ol diphosphate; (13E)-8alpha-Hydroxylabd-13-en-15-yl diphosphate,R09967 R10241 R10276,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.1.133; 4.2.3.140; 4.2.3.141,NA,NA,PubChem: 163312010,cpd:C20270,20,38,8,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H39O8P2,C20H37O8P2,468.2041922,469.2120172,467.19636713482,3829,cpd:C20481,cis-Abienol;,C20H34O,"cis-Abienol; (12Z)-Labda-12,14-dien-8alpha-ol",R10276,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.140,NA,NA,CAS: 25578-83-0; PubChem: 163312218,cpd:C09094; cpd:C11890; cpd:C15316; cpd:C19817; cpd:C19963; cpd:C19964; cpd:C20158; cpd:C20481; cpd:C20681; cpd:C20834; cpd:C20923; cpd:C20924,20,34,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O1,C20H33O1,290.2609657,291.2687907,289.25314073483,3830,cpd:C20681,"(E,E)-Geranyllinalool",C20H34O,"(E,E)-Geranyllinalool",R10533 R10562,Diterpenoid biosynthesis,1.14.-.-; 4.2.3.144,NA,NA,CAS: 1113-21-9; PubChem: 172232401,cpd:C09094; cpd:C11890; cpd:C15316; cpd:C19817; cpd:C19963; cpd:C19964; cpd:C20158; cpd:C20481; cpd:C20681; cpd:C20834; cpd:C20923; cpd:C20924,20,34,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O1,C20H33O1,290.2609657,291.2687907,289.25314073484,3831,cpd:C20700,"(E,E)-4,8,12-Trimethyltrideca-1,3,7,11-tetraene;",C16H26,"(E,E)-4,8,12-Trimethyltrideca-1,3,7,11-tetraene; TMTT",R10562,Diterpenoid biosynthesis,1.14.-.-,NA,NA,CAS: 62235-06-7; PubChem: 172232420,cpd:C00842; cpd:C01675; cpd:C02097; cpd:C03187; cpd:C03319; cpd:C03442; cpd:C03646; cpd:C04696; cpd:C04834; cpd:C07277; cpd:C07383; cpd:C07895; cpd:C08510; cpd:C09693; cpd:C09694; cpd:C09860; cpd:C09874; cpd:C11656; cpd:C11670; cpd:C11912; cpd:C11920; cpd:C11923; cpd:C12446; cpd:C12447; cpd:C12869; cpd:C13106; cpd:C13727; cpd:C16503; cpd:C16508; cpd:C17055; cpd:C17403; cpd:C17634; cpd:C17635; cpd:C17636; cpd:C17637; cpd:C18636; cpd:C20638; cpd:C20682; cpd:C20700; cpd:C21349,16,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27,C16H25,218.2034508,219.2112759,217.19562583485,3832,cpd:C20711,Miltiradiene,C20H32,Miltiradiene,R10585 R10727,Diterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.190; 4.2.3.131,NA,NA,PubChem: 254741180,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425763486,3833,cpd:C08814,Brassinolide,C28H48O6,Brassinolide,R07471 R09762 R10682,Brassinosteroid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Plant hormone signal transduction,1.14.-.-,NA,Compounds with biological roles [BR:br08001];  Steroids;   28-Carbon atoms;    Campestane derivatives;     C08814  Brassinolide; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0114 Brassinolides and derivatives;     C08814  Brassinolide; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Ergostane;     C08814  Brassinolide,CAS: 72962-43-7; PubChem: 11007; ChEBI: 28277; LIPIDMAPS: LMST01140001; KNApSAcK: C00000176; PDB-CCD: BLD; 3DMET: B02433; NIKKAJI: J11.958J,cpd:C08814; cpd:C11049; cpd:C19873,28,48,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O6,C28H47O6,480.3450893,481.3529143,479.33726423487,3834,cpd:C15784,Campest-4-en-3beta-ol;,C28H48O,Campest-4-en-3beta-ol; (24R)-Ergost-4-en-3beta-ol,R07427 R07428,Brassinosteroid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15784  Campest-4-en-3beta-ol,PubChem: 47205109; ChEBI: 18535; LIPIDMAPS: LMST01031016; NIKKAJI: J2.796.412E,cpd:C01789; cpd:C05110; cpd:C05111; cpd:C08825; cpd:C08833; cpd:C15784; cpd:C15786; cpd:C19652; cpd:C21106,28,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O1,C28H47O1,400.3705162,401.3783412,399.36269113488,3835,cpd:C15785,Campest-4-en-3-one;,C28H46O,Campest-4-en-3-one; (24R)-Ergost-4-en-3-one,R07428 R07429 R07452,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.22; 1.14.13.-,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15785  Campest-4-en-3-one,PubChem: 47205110; ChEBI: 18534; LIPIDMAPS: LMST01030122; NIKKAJI: J1.322.687C,cpd:C04453; cpd:C04525; cpd:C05103; cpd:C06957; cpd:C08813; cpd:C15777; cpd:C15781; cpd:C15785; cpd:C18192,28,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O1,C28H45O1,398.3548661,399.3626911,397.34704113489,3836,cpd:C15786,5alpha-Campestan-3-one;,C28H48O,5alpha-Campestan-3-one; (24R)-5alpha-Ergostan-3-one,R07429 R07453 R07466,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.22; 1.14.13.-,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15786  5alpha-Campestan-3-one,PubChem: 47205111; ChEBI: 18533; LIPIDMAPS: LMST01030123; NIKKAJI: J2.796.413C,cpd:C01789; cpd:C05110; cpd:C05111; cpd:C08825; cpd:C08833; cpd:C15784; cpd:C15786; cpd:C19652; cpd:C21106,28,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O1,C28H47O1,400.3705162,401.3783412,399.36269113490,3837,cpd:C15787,Campestanol;,C28H50O,Campestanol; 5alpha-Campestanol; (24R)-5alpha-Ergostan-3beta-ol,R07454 R07466 R07467,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.-,NA,Compounds with biological roles [BR:br08001];  Steroids;   28-Carbon atoms;    Campestane derivatives;     C15787  Campestanol,CAS: 474-60-2; PubChem: 47205112; ChEBI: 36799; LIPIDMAPS: LMST01030103; KNApSAcK: C00007516; NIKKAJI: J166.111F,cpd:C15787; cpd:C19651,28,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H51O1,C28H49O1,402.3861662,403.3939913,401.37834123491,3838,cpd:C15788,6alpha-Hydroxycampestanol,C28H50O2,6alpha-Hydroxycampestanol,R07467 R07468,Brassinosteroid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15788  6alpha-Hydroxycampestanol,PubChem: 47205113; NIKKAJI: J678.297C,cpd:C15788; cpd:C15798; cpd:C16251,28,50,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H51O2,C28H49O2,418.3810809,419.3889059,417.37325583492,3839,cpd:C15789,6-Oxocampestanol,C28H48O2,6-Oxocampestanol,R07430 R07468,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.-,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15789  6-Oxocampestanol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Ergostane;     C15789  6-Oxocampestanol,PubChem: 47205114; ChEBI: 20747; KNApSAcK: C00007273; NIKKAJI: J678.298A,cpd:C02483; cpd:C14152; cpd:C15789; cpd:C15795; cpd:C15797; cpd:C15883,28,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O2,C28H47O2,416.3654308,417.3732558,415.35760583493,3840,cpd:C15790,Cathasterone,C28H48O3,Cathasterone,R07430 R07431,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.-; 1.14.-.-,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15790  Cathasterone; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Ergostane;     C15790  Cathasterone,PubChem: 47205115; ChEBI: 23057; KNApSAcK: C00007275; NIKKAJI: J675.077J,cpd:C15790; cpd:C15800; cpd:C16252,28,48,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O3,C28H47O3,432.3603454,433.3681704,431.35252043494,3841,cpd:C15791,Teasterone,C28H48O4,Teasterone,R07431 R07444 R07455 R08840,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.14.-; 1.14.-.-,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15791  Teasterone,PubChem: 47205116; ChEBI: 26863; NIKKAJI: J417.942K,cpd:C15791; cpd:C15793,28,48,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O4,C28H47O4,448.35526,449.3630851,447.3474353495,3842,cpd:C15792,3-Dehydroteasterone,C28H46O4,3-Dehydroteasterone,R07444 R07457 R07469,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.-.-,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15792  3-Dehydroteasterone,PubChem: 47205117; ChEBI: 20000; NIKKAJI: J590.103K,cpd:C14158; cpd:C14505; cpd:C14578; cpd:C15792,28,46,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O4,C28H45O4,446.33961,447.347435,445.33178493496,3843,cpd:C15793,Typhasterol,C28H48O4,Typhasterol,R07458 R07469 R07470 R08841,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.14.-; 1.14.-.-,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15793  Typhasterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Ergostane;     C15793  Typhasterol,PubChem: 47205118; ChEBI: 27173; KNApSAcK: C00000185; NIKKAJI: J146.606B,cpd:C15791; cpd:C15793,28,48,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O4,C28H47O4,448.35526,449.3630851,447.3474353497,3844,cpd:C15794,Castasterone,C28H48O5,Castasterone,R07451 R07470 R07471 R09761 R10669,Brassinosteroid biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.-.-,"Castasterone biosynthesis, campesterol => castasterone",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15794  Castasterone; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Ergostane;     C15794  Castasterone,CAS: 80736-41-0; PubChem: 47205119; ChEBI: 23051; KNApSAcK: C00000181; NIKKAJI: J146.604F,cpd:C15794; cpd:C17733; cpd:C17735,28,48,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O5,C28H47O5,464.3501746,465.3579997,463.34234963498,3845,cpd:C15795,22alpha-Hydroxy-campesterol;,C28H48O2,22alpha-Hydroxy-campesterol; (22S)-22-Hydroxy-campesterol,R07445 R07446 R07786,Brassinosteroid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.112; 1.14.13.-,"Castasterone biosynthesis, campesterol => castasterone",Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Ergostane;     C15795  22alpha-Hydroxy-campesterol,PubChem: 47205120; ChEBI: 72331; KNApSAcK: C00007518; NIKKAJI: J2.796.417F,cpd:C02483; cpd:C14152; cpd:C15789; cpd:C15795; cpd:C15797; cpd:C15883,28,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O2,C28H47O2,416.3654308,417.3732558,415.35760583499,3846,cpd:C15796,22alpha-Hydroxy-campest-4-en-3-one;,C28H46O2,"22alpha-Hydroxy-campest-4-en-3-one; (22S,24R)-22-Hydroxy-ergost-4 en-3-one",R07446 R07447 R07452 R07787,Brassinosteroid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.22; 1.14.13.112; 1.14.13.-,"Castasterone biosynthesis, campesterol => castasterone",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15796  22alpha-Hydroxy-campest-4-en-3-one,PubChem: 47205121; ChEBI: 72330; NIKKAJI: J1.831.609I,cpd:C04416; cpd:C15796,28,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O2,C28H45O2,414.3497807,415.3576058,413.34195573500,3847,cpd:C15797,22alpha-Hydroxy-5alpha-campestan-3-one;,C28H48O2,"22alpha-Hydroxy-5alpha-campestan-3-one; (22S,24R)-22-Hydroxy-5alpha-ergostan-3-one",R07447 R07453 R07472 R07788 R07791,Brassinosteroid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.22; 1.14.13.112; 1.14.13.-,"Castasterone biosynthesis, campesterol => castasterone",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15797  22alpha-Hydroxy-5alpha-campestan-3-one,PubChem: 47205122; ChEBI: 59411; NIKKAJI: J1.831.610B,cpd:C02483; cpd:C14152; cpd:C15789; cpd:C15795; cpd:C15797; cpd:C15883,28,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O2,C28H47O2,416.3654308,417.3732558,415.35760583501,3848,cpd:C15798,6-Deoxocathasterone,C28H50O2,6-Deoxocathasterone,R07448 R07454 R07472,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.-; 1.14.-.-,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15798  6-Deoxocathasterone,PubChem: 47205123; ChEBI: 20714; NIKKAJI: J1.050.804E,cpd:C15788; cpd:C15798; cpd:C16251,28,50,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H51O2,C28H49O2,418.3810809,419.3889059,417.37325583502,3849,cpd:C15799,6-Deoxoteasterone,C28H50O3,6-Deoxoteasterone,R07448 R07449 R07455 R10684,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.-.-,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15799  6-Deoxoteasterone,PubChem: 47205124; ChEBI: 20716; NIKKAJI: J817.820H,cpd:C15799; cpd:C15801,28,50,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H51O3,C28H49O3,434.3759955,435.3838205,433.36817043503,3850,cpd:C15800,3-Dehydro-6-deoxoteasterone,C28H48O3,3-Dehydro-6-deoxoteasterone,R07449 R07457 R07473 R07790 R07791,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.112; 1.14.-.-,"Castasterone biosynthesis, campesterol => castasterone",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15800  3-Dehydro-6-deoxoteasterone,PubChem: 47205125; ChEBI: 20710; NIKKAJI: J642.180F,cpd:C15790; cpd:C15800; cpd:C16252,28,48,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O3,C28H47O3,432.3603454,433.3681704,431.35252043504,3851,cpd:C15801,6-Deoxotyphasterol,C28H50O3,6-Deoxotyphasterol,R07458 R07473 R07474 R07792 R10683,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.112; 1.14.-.-,"Castasterone biosynthesis, campesterol => castasterone",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15801  6-Deoxotyphasterol,PubChem: 47205126; ChEBI: 20717; NIKKAJI: J641.851A,cpd:C15799; cpd:C15801,28,50,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H51O3,C28H49O3,434.3759955,435.3838205,433.36817043505,3852,cpd:C15802,6-Deoxocastasterone,C28H50O4,6-Deoxocastasterone,R07450 R07474 R10669 R10682,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.-.-,"Castasterone biosynthesis, campesterol => castasterone",Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0103 Ergosterols and C24-methyl derivatives;     C15802  6-Deoxocastasterone,PubChem: 47205127; ChEBI: 20712; NIKKAJI: J146.605D,cpd:C10135; cpd:C15802,28,50,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H51O4,C28H49O4,450.3709101,451.3787351,449.36308513506,3853,cpd:C15803,6alpha-Hydroxy-castasterone,C28H50O5,6alpha-Hydroxy-castasterone,R07450 R07451,Brassinosteroid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.-.-,"Castasterone biosynthesis, campesterol => castasterone",NA,PubChem: 47205128; ChEBI: 80098; NIKKAJI: J1.076.361D,cpd:C15803,28,50,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H51O5,C28H49O5,466.3658247,467.3736497,465.35799973507,3854,cpd:C16251,3-epi-6-Deoxocathasterone,C28H50O2,3-epi-6-Deoxocathasterone,R07788 R07792,Brassinosteroid biosynthesis,1.14.13.112,NA,NA,PubChem: 47205559; ChEBI: 59410; NIKKAJI: J1.831.611K,cpd:C15788; cpd:C15798; cpd:C16251,28,50,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H51O2,C28H49O2,418.3810809,419.3889059,417.37325583508,3855,cpd:C16252,"(22R,23R)-22,23-Dihydroxycampesterol",C28H48O3,"(22R,23R)-22,23-Dihydroxycampesterol",R07786 R07789,Brassinosteroid biosynthesis,1.14.13.112,NA,NA,PubChem: 47205560; ChEBI: 80401; NIKKAJI: J727.002J,cpd:C15790; cpd:C15800; cpd:C16252,28,48,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O3,C28H47O3,432.3603454,433.3681704,431.35252043509,3856,cpd:C16253,"(22R,23R)-22,23-Dihydroxy-campest-4-en-3-one",C28H46O3,"(22R,23R)-22,23-Dihydroxy-campest-4-en-3-one",R07787 R07789 R07790,Brassinosteroid biosynthesis,1.14.13.112,NA,NA,PubChem: 47205561; ChEBI: 80402; NIKKAJI: J2.799.238B,cpd:C04746; cpd:C14157; cpd:C14159; cpd:C14160; cpd:C16253,28,46,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H47O3,C28H45O3,430.3446953,431.3525204,429.33687033510,3857,cpd:C17733,7-Oxateasterone;,C28H48O5,"7-Oxateasterone; (22R,23R,24S)-3beta,22,23-Trihydroxy-7-oxa-5alpha-ergostane-6-one",R08840 R08842 R10684,Brassinosteroid biosynthesis,1.14.14.-; 1.14.-.-,NA,NA,PubChem: 96024063; ChEBI: 81305; NIKKAJI: J491.113J,cpd:C15794; cpd:C17733; cpd:C17735,28,48,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O5,C28H47O5,464.3501746,465.3579997,463.34234963511,3858,cpd:C17735,7-Oxatyphasterol;,C28H48O5,"7-Oxatyphasterol; (22R,23R,24S)-3alpha,22,23-Trihydroxy-7-oxa-5alpha-ergostane-6-one",R08841 R08842 R10683,Brassinosteroid biosynthesis,1.14.14.-; 1.14.-.-,NA,NA,PubChem: 96024065; ChEBI: 81307; NIKKAJI: J491.112A,cpd:C15794; cpd:C17733; cpd:C17735,28,48,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O5,C28H47O5,464.3501746,465.3579997,463.34234963512,3859,cpd:C19873,26-Hydroxycastasterone,C28H48O6,26-Hydroxycastasterone,R09761,Brassinosteroid biosynthesis,1.14.-.-,NA,NA,PubChem: 135626339; ChEBI: 133216,cpd:C08814; cpd:C11049; cpd:C19873,28,48,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O6,C28H47O6,480.3450893,481.3529143,479.33726423513,3860,cpd:C19874,26-Hydroxybrassinolide,C28H48O7,26-Hydroxybrassinolide,R09762,Brassinosteroid biosynthesis,1.14.-.-,NA,NA,PubChem: 135626340; ChEBI: 133461,cpd:C11050; cpd:C11051; cpd:C19874,28,48,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H49O7,C28H47O7,496.3400039,497.3478289,495.33217893514,3861,cpd:C03427,Prephytoene diphosphate,C40H68O7P2,Prephytoene diphosphate,R02065 R04218 R07270,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.5.1.32; 2.5.1.99,"beta-Carotene biosynthesis, GGAP => beta-carotene",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C03427  Prephytoene diphosphate,PubChem: 6254; ChEBI: 17090; LIPIDMAPS: LMPR01070253; 3DMET: B01657; NIKKAJI: J2.742.538K,cpd:C03427; cpd:C04146; cpd:C17437,40,68,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H69O7P2,C40H67O7P2,722.4440285,723.4518536,721.43620353515,3862,cpd:C05413,all-trans-Phytoene,C40H64,all-trans-Phytoene,R04786 R07270 R07916,Carotenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones,1.3.5.5; 2.5.1.32; 2.5.1.99,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C05413  Phytoene; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C05413  Phytoene,CAS: 540-04-5; PubChem: 7779; ChEBI: 8191; ChEMBL: CHEMBL1988265; LIPIDMAPS: LMPR01070254; LipidBank: VCA1001; KNApSAcK: C00000905; 3DMET: B00773; NIKKAJI: J14.118F,cpd:C05413; cpd:C05421; cpd:C11186; cpd:C11827; cpd:C20869,40,64,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H65,C40H63,544.5008021,545.5086271,543.4929773516,3863,cpd:C05414,all-trans-Phytofluene,C40H62,all-trans-Phytofluene,R04786 R04787 R09692,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.5.5; 1.3.99.28; 1.3.99.29; 1.3.99.30; 1.3.99.31,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C05414  Phytofluene; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C05414  all-trans-Phytofluene,CAS: 27664-65-9; PubChem: 7780; ChEBI: 28129; LIPIDMAPS: LMPR01070084 LMPR01070299; KNApSAcK: C00000913; 3DMET: B00774; NIKKAJI: J6.385A,cpd:C05414; cpd:C19765; cpd:C20971,40,62,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H63,C40H61,542.485152,543.492977,541.4773273517,3864,cpd:C05421,15-cis-Phytoene;,C40H64,15-cis-Phytoene; Phytoene,R04218 R07510 R09652 R09653 R09691 R09692 R09693 R09703; R09716 R10177,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.5.5; 1.3.99.28; 1.3.99.29; 1.3.99.30; 1.3.99.31; 1.14.99.-; 2.5.1.32,"beta-Carotene biosynthesis, GGAP => beta-carotene",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C05421  cis-Phytoene; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C05421  15-cis-Phytoene,PubChem: 7785; ChEBI: 27787; LIPIDMAPS: LMPR01070255; KNApSAcK: C00000905; 3DMET: B00775; NIKKAJI: J39.585D,cpd:C05413; cpd:C05421; cpd:C11186; cpd:C11827; cpd:C20869,40,64,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H65,C40H63,544.5008021,545.5086271,543.4929773518,3865,cpd:C05430,all-trans-zeta-Carotene,C40H60,all-trans-zeta-Carotene,R04787 R04798 R04799 R09659 R09693,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.5.5; 1.3.5.6; 1.3.99.26; 1.3.99.28; 1.3.99.29; 1.3.99.30; 1.3.99.31,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C05430  zeta-Carotene; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C05430  all-trans-zeta-Carotene,PubChem: 7794; ChEBI: 27362 28068; LIPIDMAPS: LMPR01070256; LipidBank: VCA1003; KNApSAcK: C00000934; 3DMET: B00776; NIKKAJI: J39.830F,cpd:C05430; cpd:C08966; cpd:C11957; cpd:C15857; cpd:C15892; cpd:C19764; cpd:C19894,40,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H61,C40H59,540.4695019,541.477327,539.46167693519,3866,cpd:C05431,all-trans-Neurosporene,C40H58,all-trans-Neurosporene,R04798 R04800 R04801 R06960 R07532 R09691,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.5.6; 1.3.99.26; 1.3.99.28; 1.3.99.30; 1.3.99.31; 4.2.1.131; 5.5.1.18; 5.5.1.19,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C05431  Neurosporene,CAS: 502-64-7; PubChem: 7795; ChEBI: 16833; LIPIDMAPS: LMPR01070086; KNApSAcK: C00000912; 3DMET: B00777; NIKKAJI: J12.234C,cpd:C05431; cpd:C05434; cpd:C11965; cpd:C14146; cpd:C15859; cpd:C15898; cpd:C15907; cpd:C16291; cpd:C19759; cpd:C19795; cpd:C20332,40,58,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H59,C40H57,538.4538519,539.4616769,537.44602683520,3867,cpd:C05432,Lycopene;,C40H56,Lycopene; all-trans-Lycopene,R03823 R04799 R04800 R05341 R06963 R07512 R07518 R07519; R07844 R07846 R09659 R09716,Carotenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.5.6; 1.3.99.26; 1.3.99.30; 1.3.99.31; 4.2.1.131; 5.2.1.13; 5.5.1.18; 5.5.1.19,"beta-Carotene biosynthesis, GGAP => beta-carotene",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C05432  Lycopene; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C05432  Lycopene,CAS: 502-65-8; PubChem: 7796; ChEBI: 15948; ChEMBL: CHEMBL501174; LIPIDMAPS: LMPR01070257; LipidBank: VCA0010; KNApSAcK: C00000911; PDB-CCD: LYC; 3DMET: B00778; NIKKAJI: J6.206E,cpd:C02094; cpd:C05432; cpd:C05433; cpd:C05435; cpd:C06098; cpd:C08579; cpd:C08584; cpd:C08585; cpd:C08586; cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08594; cpd:C08599; cpd:C08601; cpd:C08602; cpd:C08603; cpd:C08605; cpd:C08606; cpd:C08611; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15716; cpd:C15858; cpd:C15860; cpd:C15874; cpd:C15919; cpd:C15932; cpd:C15933; cpd:C15981; cpd:C16270; cpd:C16274; cpd:C16276; cpd:C16282; cpd:C16284; cpd:C20331; cpd:C20484,40,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57,C40H55,536.4382018,537.4460268,535.43037683521,3868,cpd:C05433,alpha-Carotene,C40H56,alpha-Carotene,R06962 R06964 R07530 R07850,Carotenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.129; 1.14.99.45; 5.5.1.19,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C05433  alpha-Carotene; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C05433  alpha-Carotene,CAS: 7488-99-5; PubChem: 7797; ChEBI: 28425; LIPIDMAPS: LMPR01070258; LipidBank: VCA0009; KNApSAcK: C00003765; 3DMET: B00779; NIKKAJI: J5.728B,cpd:C02094; cpd:C05432; cpd:C05433; cpd:C05435; cpd:C06098; cpd:C08579; cpd:C08584; cpd:C08585; cpd:C08586; cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08594; cpd:C08599; cpd:C08601; cpd:C08602; cpd:C08603; cpd:C08605; cpd:C08606; cpd:C08611; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15716; cpd:C15858; cpd:C15860; cpd:C15874; cpd:C15919; cpd:C15932; cpd:C15933; cpd:C15981; cpd:C16270; cpd:C16274; cpd:C16276; cpd:C16282; cpd:C16284; cpd:C20331; cpd:C20484,40,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57,C40H55,536.4382018,537.4460268,535.43037683522,3869,cpd:C05434,beta-Zeacarotene,C40H58,beta-Zeacarotene,R04801 R04803 R07856,Carotenoid biosynthesis,5.5.1.19,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C05434  beta-Zeacarotene,PubChem: 7798; ChEBI: 27533; LIPIDMAPS: LMPR01070259; LipidBank: VCA1008; KNApSAcK: C00022807; NIKKAJI: J276.705H,cpd:C05431; cpd:C05434; cpd:C11965; cpd:C14146; cpd:C15859; cpd:C15898; cpd:C15907; cpd:C16291; cpd:C19759; cpd:C19795; cpd:C20332,40,58,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H59,C40H57,538.4538519,539.4616769,537.44602683523,3870,cpd:C05435,gamma-Carotene,C40H56,gamma-Carotene,R03824 R04803 R05341 R07516 R07540 R07541 R07542 R07548; R07552 R07555 R07852,Carotenoid biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.1.131; 5.5.1.19,"beta-Carotene biosynthesis, GGAP => beta-carotene",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C05435  gamma-Carotene; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C05435  gamma-Carotene,CAS: 472-93-5; PubChem: 7799; ChEBI: 27740; LIPIDMAPS: LMPR01070260; LipidBank: VCA1007; KNApSAcK: C00000926; 3DMET: B00781; NIKKAJI: J5.953F,cpd:C02094; cpd:C05432; cpd:C05433; cpd:C05435; cpd:C06098; cpd:C08579; cpd:C08584; cpd:C08585; cpd:C08586; cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08594; cpd:C08599; cpd:C08601; cpd:C08602; cpd:C08603; cpd:C08605; cpd:C08606; cpd:C08611; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15716; cpd:C15858; cpd:C15860; cpd:C15874; cpd:C15919; cpd:C15932; cpd:C15933; cpd:C15981; cpd:C16270; cpd:C16274; cpd:C16276; cpd:C16282; cpd:C16284; cpd:C20331; cpd:C20484,40,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57,C40H55,536.4382018,537.4460268,535.43037683524,3871,cpd:C06082,Abscisate;,C15H20O4,Abscisate; Abscisic acid; (+)-Abscisic acid; ABA,R06956 R06957 R06959 R07202 R07575 R09723,Carotenoid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Plant hormone signal transduction,1.2.3.14; 1.14.13.93; 2.4.1.263; 3.2.1.175,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010305 Cyclofarnesane sesquiterpenoids;      C06082  Abscisate; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Apocarotenoids;     C06082  Abscisate,CAS: 21293-29-8; PubChem: 8348; ChEBI: 2365 37569; ChEMBL: CHEMBL288040; KNApSAcK: C00000134; PDB-CCD: A8S; 3DMET: B00898; NIKKAJI: J9.144H,cpd:C06082; cpd:C06806; cpd:C09291; cpd:C09304; cpd:C09349; cpd:C09355; cpd:C09381; cpd:C09453; cpd:C09456; cpd:C09470; cpd:C09481; cpd:C09498; cpd:C09506; cpd:C09530; cpd:C09531; cpd:C09540; cpd:C09542; cpd:C09574; cpd:C09600; cpd:C09683; cpd:C09688; cpd:C09708; cpd:C10766; cpd:C11060; cpd:C13778; cpd:C13820; cpd:C20399; cpd:C20402,15,20,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O4,C15H19O4,264.1361591,265.1439842,263.12833413525,3872,cpd:C06098,Zeaxanthin,C40H56O2,Zeaxanthin,R06946 R07179 R07559 R07571 R07574 R07580 R07841 R09603; R09747 R10055 R10070 R10192 R10843,Carotenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites,1.13.11.65; 1.14.13.129; 1.14.13.-; 1.14.15.21; 1.14.99.42; 1.23.5.1; 2.4.1.276,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C06098  Zeaxanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C06098  Zeaxanthin,CAS: 144-68-3; PubChem: 8363; ChEBI: 27547; LIPIDMAPS: LMPR01070261; LipidBank: VCA0007; KNApSAcK: C00000931; 3DMET: B01973; NIKKAJI: J5.830K,cpd:C06098; cpd:C08599; cpd:C08601; cpd:C15933; cpd:C16270,40,56,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O2,C40H55O2,568.428031,569.4358561,567.4202063526,3873,cpd:C08579,Antheraxanthin,C40H56O3,Antheraxanthin,R06946 R06947 R07178 R07179 R07321,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.15.21; 1.23.5.1; 5.3.99.8,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08579  Antheraxanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C08579  Antheraxanthin,CAS: 640-03-9; PubChem: 10772; ChEBI: 27867; LIPIDMAPS: LMPR01070262; LipidBank: VCA1012; KNApSAcK: C00003760; 3DMET: B02237; NIKKAJI: J17.015A,cpd:C08579; cpd:C08584; cpd:C08594; cpd:C08602; cpd:C15919; cpd:C16282,40,56,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O3,C40H55O3,584.4229457,585.4307707,583.41512063527,3874,cpd:C08580,Astaxanthin,C40H52O4,Astaxanthin,R07572 R07573 R08102,Carotenoid biosynthesis,1.14.13.129,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08580  Astaxanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C08580  Astaxanthin,CAS: 472-61-7; PubChem: 10773; ChEBI: 40968; LIPIDMAPS: LMPR01070263; LipidBank: VCA0002; KNApSAcK: C00000918; PDB-CCD: AXT; 3DMET: B02238; NIKKAJI: J11.883D,cpd:C08580,40,52,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H53O4,C40H51O4,596.3865602,597.3943852,595.37873513528,3875,cpd:C08583,Canthaxanthin,C40H52O2,Canthaxanthin,R07563 R07568,Carotenoid biosynthesis,1.14.13.129,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08583  Canthaxanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C08583  Canthaxanthin,CAS: 514-78-3; PubChem: 10776; ChEBI: 3362; ChEMBL: CHEMBL1329004; LIPIDMAPS: LMPR01070264; LipidBank: VCA0040; KNApSAcK: C00000922; PDB-CCD: 45D; 3DMET: B02241; NIKKAJI: J6.290A,cpd:C08583,40,52,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H53O2,C40H51O2,564.3967309,565.4045559,563.38890593529,3876,cpd:C08584,Capsanthin,C40H56O3,Capsanthin,R07321,Carotenoid biosynthesis,5.3.99.8,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08584  Capsanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C08584  Capsanthin,CAS: 465-42-9; PubChem: 10777; ChEBI: 3375; ChEMBL: CHEMBL1519371; LIPIDMAPS: LMPR01070265; LipidBank: VCA0045; KNApSAcK: C00003763; 3DMET: B02242; NIKKAJI: J5.891B,cpd:C08579; cpd:C08584; cpd:C08594; cpd:C08602; cpd:C15919; cpd:C16282,40,56,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O3,C40H55O3,584.4229457,585.4307707,583.41512063530,3877,cpd:C08585,Capsorubin,C40H56O4,Capsorubin,R07320,Carotenoid biosynthesis,5.3.99.8,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08585  Capsorubin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C08585  Capsorubin,CAS: 470-38-2; PubChem: 10778; ChEBI: 3378; LIPIDMAPS: LMPR01070048; KNApSAcK: C00003764; 3DMET: B02243; NIKKAJI: J5.936F,cpd:C08585; cpd:C08606; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15932; cpd:C16274; cpd:C16284,40,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O4,C40H55O4,600.4178603,601.4256853,599.41003533531,3878,cpd:C08586,delta-Carotene,C40H56,delta-Carotene,R06961 R06962 R06963 R07840,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,5.5.1.18; 5.5.1.19,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08586  delta-Carotene; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C08586  delta-Carotene,CAS: 472-92-4; PubChem: 10779; ChEBI: 27705; LIPIDMAPS: LMPR01070266; LipidBank: VCA1043; KNApSAcK: C00003766; 3DMET: B02244; NIKKAJI: J11.881H,cpd:C02094; cpd:C05432; cpd:C05433; cpd:C05435; cpd:C06098; cpd:C08579; cpd:C08584; cpd:C08585; cpd:C08586; cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08594; cpd:C08599; cpd:C08601; cpd:C08602; cpd:C08603; cpd:C08605; cpd:C08606; cpd:C08611; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15716; cpd:C15858; cpd:C15860; cpd:C15874; cpd:C15919; cpd:C15932; cpd:C15933; cpd:C15981; cpd:C16270; cpd:C16274; cpd:C16276; cpd:C16282; cpd:C16284; cpd:C20331; cpd:C20484,40,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57,C40H55,536.4382018,537.4460268,535.43037683532,3879,cpd:C08590,Zeinoxanthin;,C40H56O,"Zeinoxanthin; 3-Hydroxy-alpha-carotene; (3R,6'R)-beta,epsilon-Caroten-3-ol",R07530 R07531,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.129; 1.14.99.45,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08590  Zeinoxanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C08590  Zeinoxanthin,CAS: 24480-38-4; PubChem: 10783; ChEBI: 65244; LIPIDMAPS: LMPR01070268; LipidBank: VCA1158; KNApSAcK: C00003770; 3DMET: B02247; NIKKAJI: J16.690A,cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08603; cpd:C08605; cpd:C08611; cpd:C15860; cpd:C15874; cpd:C15981; cpd:C20331,40,56,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O1,C40H55O1,552.4331164,553.4409415,551.42529143533,3880,cpd:C08591,beta-Cryptoxanthin,C40H56O,beta-Cryptoxanthin,R07558 R07559 R07564 R07565 R07578,Carotenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.129,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08591  beta-Cryptoxanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C08591  beta-Cryptoxanthin,CAS: 472-70-8; PubChem: 10784; ChEBI: 10362; LIPIDMAPS: LMPR01070269; LipidBank: VCA1013; KNApSAcK: C00000920; PDB-CCD: RRX; 3DMET: B02248; NIKKAJI: J5.952H,cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08603; cpd:C08605; cpd:C08611; cpd:C15860; cpd:C15874; cpd:C15981; cpd:C20331,40,56,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O1,C40H55O1,552.4331164,553.4409415,551.42529143534,3881,cpd:C08592,Echinenone,C40H54O,Echinenone,R05345 R07561 R07562 R07563,Carotenoid biosynthesis,1.14.13.129,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08592  Echinenone,CAS: 432-68-8; PubChem: 10785; ChEBI: 4746; LIPIDMAPS: LMPR01070060; KNApSAcK: C00000925; PDB-CCD: ECH; 3DMET: B01110; NIKKAJI: J11.386G,cpd:C08592; cpd:C15911,40,54,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H55O1,C40H53O1,550.4174664,551.4252914,549.40964133535,3882,cpd:C08601,Lutein;,C40H56O2,Lutein; Xanthophyll,R06964 R07531 R07851,Carotenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.129; 1.14.99.45,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08601  Lutein; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C08601  Lutein,CAS: 127-40-2; PubChem: 10794; ChEBI: 28838; ChEMBL: CHEMBL173929; LIPIDMAPS: LMPR01070274; LipidBank: VCA0016; KNApSAcK: C00003776; 3DMET: B02256; NIKKAJI: J5.394E,cpd:C06098; cpd:C08599; cpd:C08601; cpd:C15933; cpd:C16270,40,56,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O2,C40H55O2,568.428031,569.4358561,567.4202063536,3883,cpd:C08606,Neoxanthin;,C40H56O4,Neoxanthin; all-trans-Neoxanthin,R06948 R06949,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,5.3.99.9,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08606  Neoxanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C08606  Neoxanthin,CAS: 30743-41-0; PubChem: 10799; ChEBI: 25501 32446; LIPIDMAPS: LMPR01070290; LipidBank: VCA0059; KNApSAcK: C00003780; 3DMET: B02260; NIKKAJI: J246.977D,cpd:C08585; cpd:C08606; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15932; cpd:C16274; cpd:C16284,40,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O4,C40H55O4,600.4178603,601.4256853,599.41003533537,3884,cpd:C08607,Neurosporaxanthin;,C35H46O2,Neurosporaxanthin; all-trans-Neurosporaxanthin,R09783,Carotenoid biosynthesis; Metabolic pathways,1.2.1.82,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08607  Neurosporaxanthin,CAS: 2468-88-4; PubChem: 10800; ChEBI: 7540; LIPIDMAPS: LMPR01070206; LipidBank: VCA1124; KNApSAcK: C00003781; 3DMET: B02261; NIKKAJI: J13.795B,cpd:C08607,35,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H47O2,C35H45O2,498.3497807,499.3576058,497.34195573538,3885,cpd:C08613,Torulene,C40H54,Torulene,R09782 R10508,Carotenoid biosynthesis; Metabolic pathways,1.13.11.59; 5.5.1.19,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08613  Torulene,CAS: 547-23-9; PubChem: 10806; ChEBI: 9638; LIPIDMAPS: LMPR01070088; KNApSAcK: C00003786; 3DMET: B02267; NIKKAJI: J674.606C,cpd:C08592; cpd:C08593; cpd:C08613; cpd:C15724; cpd:C15849; cpd:C15867; cpd:C15910; cpd:C15911; cpd:C15928; cpd:C15965; cpd:C15966; cpd:C15968; cpd:C16347; cpd:C19920; cpd:C19921,40,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H55,C40H53,534.4225517,535.4303768,533.41472673539,3886,cpd:C08614,Violaxanthin;,C40H56O4,Violaxanthin; all-trans-Violaxanthin,R06947 R06948 R06950 R07178 R07320 R10055 R10070,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.15.21; 1.23.5.1; 5.3.99.8; 5.3.99.9,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C08614  Violaxanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C08614  Violaxanthin,CAS: 126-29-4; PubChem: 10807; ChEBI: 35288; LIPIDMAPS: LMPR01070282; LipidBank: VCA0060; KNApSAcK: C00003787; PDB-CCD: XAT; 3DMET: B02268; NIKKAJI: J8.626F,cpd:C08585; cpd:C08606; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15932; cpd:C16274; cpd:C16284,40,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O4,C40H55O4,600.4178603,601.4256853,599.41003533540,3887,cpd:C09190,Strigol,C19H22O6,Strigol,R08990,Carotenoid biosynthesis; Biosynthesis of plant hormones; Biosynthesis of secondary metabolites,1.14.13.-,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Apocarotenoids;     C09190  Strigol,CAS: 11017-56-4; PubChem: 11382; ChEBI: 9290; KNApSAcK: C00003486; 3DMET: B02756; NIKKAJI: J465.547H,cpd:C01699; cpd:C09062; cpd:C09104; cpd:C09174; cpd:C09190; cpd:C09385; cpd:C09512; cpd:C09547; cpd:C11210; cpd:C11855; cpd:C11856; cpd:C11869,19,22,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O6,C19H21O6,346.1416384,347.1494635,345.13381343541,3888,cpd:C09707,Phaseic acid,C15H20O5,Phaseic acid,R07576 R07577,Carotenoid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Others;     C09707  Phaseic acid,CAS: 24394-14-7; PubChem: 11896; ChEBI: 28205; KNApSAcK: C00003170; 3DMET: B03211; NIKKAJI: J55.601G,cpd:C09346; cpd:C09480; cpd:C09707; cpd:C15514,15,20,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O5,C15H19O5,280.1310737,281.1388988,279.12324873542,3889,cpd:C13431,9'-cis-Neoxanthin,C40H56O4,9'-cis-Neoxanthin,R06949 R06951 R06952,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.13.11.51; 5.3.99.9,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C13431  9'-cis-Neoxanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C13431  9'-cis-Neoxanthin,CAS: 14660-91-4; PubChem: 586173; ChEBI: 32446 35306; LIPIDMAPS: LMPR01070291; LipidBank: VCA0059; KNApSAcK: C00003780; PDB-CCD: NEX; 3DMET: B05650; NIKKAJI: J246.977D,cpd:C08585; cpd:C08606; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15932; cpd:C16274; cpd:C16284,40,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O4,C40H55O4,600.4178603,601.4256853,599.41003533543,3890,cpd:C13433,9-cis-Violaxanthin,C40H56O4,9-cis-Violaxanthin,R06950 R06951 R06953,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.13.11.51; 5.3.99.9,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C13433  9-cis-Violaxanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C13433  9-cis-Violaxanthin,PubChem: 586175; ChEBI: 35305; LIPIDMAPS: LMPR01070284; KNApSAcK: C00045500; 3DMET: B04572; NIKKAJI: J387.832E,cpd:C08585; cpd:C08606; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15932; cpd:C16274; cpd:C16284,40,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O4,C40H55O4,600.4178603,601.4256853,599.41003533544,3891,cpd:C13453,Xanthoxin;,C15H22O3,"Xanthoxin; 2-cis,4-trans-Xanthoxin",R06952 R06953 R06954 R06955 R09682,Carotenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.288; 1.13.11.51,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",NA,CAS: 8066-07-7; PubChem: 586193; ChEBI: 32304; KNApSAcK: C00007240 C00036906; NIKKAJI: J15.578K,cpd:C01670; cpd:C07020; cpd:C09295; cpd:C09689; cpd:C09711; cpd:C09748; cpd:C13453; cpd:C13456; cpd:C14716; cpd:C18325; cpd:C20403; cpd:C20405,15,22,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O3,C15H21O3,250.1568946,251.1647196,249.14906953545,3892,cpd:C13454,Xanthoxic acid,C15H22O4,Xanthoxic acid,R06955 R06956,Carotenoid biosynthesis,NA,NA,NA,PubChem: 586194; ChEBI: 32303; NIKKAJI: J821.718A,cpd:C09702; cpd:C09717; cpd:C10840; cpd:C13454,15,22,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O4,C15H21O4,266.1518092,267.1596342,265.14398423546,3893,cpd:C13455,Abscisic aldehyde,C15H20O3,Abscisic aldehyde,R06954 R06957 R06958,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.288; 1.2.3.14,"Abscisic acid biosynthesis, beta-carotene => abscisic acid",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010305 Cyclofarnesane sesquiterpenoids;      C13455  Abscisic aldehyde,PubChem: 586195; ChEBI: 31157; KNApSAcK: C00007236; NIKKAJI: J489.427H J751.663K,cpd:C02771; cpd:C07609; cpd:C09301; cpd:C09345; cpd:C09378; cpd:C09386; cpd:C09440; cpd:C09488; cpd:C09507; cpd:C09534; cpd:C09537; cpd:C09544; cpd:C09556; cpd:C09562; cpd:C09626; cpd:C09660; cpd:C09687; cpd:C13455; cpd:C17887; cpd:C20400,15,20,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O3,C15H19O3,248.1412445,249.1490695,247.13341953547,3894,cpd:C13456,Abscisic alcohol,C15H22O3,Abscisic alcohol,R06958 R06959,Carotenoid biosynthesis,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010305 Cyclofarnesane sesquiterpenoids;      C13456  Abscisic alcohol,PubChem: 586196; ChEBI: 22145; NIKKAJI: J886.508F,cpd:C01670; cpd:C07020; cpd:C09295; cpd:C09689; cpd:C09711; cpd:C09748; cpd:C13453; cpd:C13456; cpd:C14716; cpd:C18325; cpd:C20403; cpd:C20405,15,22,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O3,C15H21O3,250.1568946,251.1647196,249.14906953548,3895,cpd:C15514,8'-Hydroxyabscisate;,C15H20O5,8'-Hydroxyabscisate; 8'-Hydroxyabscisic acid,R07202 R07576,Carotenoid biosynthesis,1.14.13.93,NA,NA,PubChem: 17396506; ChEBI: 20805; NIKKAJI: J575.846G,cpd:C09346; cpd:C09480; cpd:C09707; cpd:C15514,15,20,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O5,C15H19O5,280.1310737,281.1388988,279.12324873549,3896,cpd:C15857,"9,9'-dicis-zeta-Carotene;",C40H60,"9,9'-dicis-zeta-Carotene; 9,9'-Di-cis-zeta-carotene",R07510 R07511 R09655 R09656,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.5.6; 1.14.99.-; 5.2.1.12,"beta-Carotene biosynthesis, GGAP => beta-carotene","Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15857  9,9'-Di-cis-zeta-carotene",PubChem: 47205177; ChEBI: 48716; LIPIDMAPS: LMPR01070295; NIKKAJI: J11.953I,cpd:C05430; cpd:C08966; cpd:C11957; cpd:C15857; cpd:C15892; cpd:C19764; cpd:C19894,40,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H61,C40H59,540.4695019,541.477327,539.46167693550,3897,cpd:C15858,"7,9,7',9'-tetracis-Lycopene;",C40H56,"7,9,7',9'-tetracis-Lycopene; 7,9,7',9'-Tetra-cis-lycopene",R07511 R07512 R09658,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.5.6; 5.2.1.13,"beta-Carotene biosynthesis, GGAP => beta-carotene","Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15858  7,9,7',9'-Tetra-cis-lycopene",PubChem: 47205178; ChEBI: 62466; KNApSAcK: C00000909; NIKKAJI: J276.706F,cpd:C02094; cpd:C05432; cpd:C05433; cpd:C05435; cpd:C06098; cpd:C08579; cpd:C08584; cpd:C08585; cpd:C08586; cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08594; cpd:C08599; cpd:C08601; cpd:C08602; cpd:C08603; cpd:C08605; cpd:C08606; cpd:C08611; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15716; cpd:C15858; cpd:C15860; cpd:C15874; cpd:C15919; cpd:C15932; cpd:C15933; cpd:C15981; cpd:C16270; cpd:C16274; cpd:C16276; cpd:C16282; cpd:C16284; cpd:C20331; cpd:C20484,40,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57,C40H55,536.4382018,537.4460268,535.43037683551,3898,cpd:C15859,1'-Hydroxy-gamma-carotene,C40H58O,1'-Hydroxy-gamma-carotene,R07516 R07517 R07546,Carotenoid biosynthesis,1.14.99.-; 4.2.1.131,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15859  1'-Hydroxy-gamma-carotene,PubChem: 47205179; ChEBI: 80133; LIPIDMAPS: LMPR01070118; KNApSAcK: C00022847; NIKKAJI: J15.092D,cpd:C15859; cpd:C15898; cpd:C19795,40,58,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H59O1,C40H57O1,554.4487665,555.4565915,553.44094153552,3899,cpd:C15860,1'-Hydroxytorulene;,C40H56O,1'-Hydroxytorulene; Myxocoxanthin,R07517 R07862,Carotenoid biosynthesis,1.14.99.-,NA,NA,PubChem: 47205180; ChEBI: 80134; KNApSAcK: C00022845; NIKKAJI: J639.119B,cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08603; cpd:C08605; cpd:C08611; cpd:C15860; cpd:C15874; cpd:C15981; cpd:C20331,40,56,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O1,C40H55O1,552.4331164,553.4409415,551.42529143553,3900,cpd:C15861,1'-Hydroxy-gamma-carotene glucoside,C46H68O6,1'-Hydroxy-gamma-carotene glucoside,R07546 R07547,Carotenoid biosynthesis,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15861  1'-Hydroxy-gamma-carotene glucoside,PubChem: 47205181; ChEBI: 80135; NIKKAJI: J659.448D,cpd:C15861,46,68,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H69O6,C46H67O6,716.5015899,717.5094149,715.49376493554,3902,cpd:C15867,"3,4-Dehydrolycopene;",C40H54,"3,4-Dehydrolycopene; all-trans-3,4-Didehydrolycopene",R07518 R09703 R10508,Carotenoid biosynthesis; Metabolic pathways,1.3.99.30; 5.5.1.19,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15867  3,4-Dehydrolycopene",PubChem: 47205187; ChEBI: 62474; LIPIDMAPS: LMPR01070087; KNApSAcK: C00022822; NIKKAJI: J1.332.395J,cpd:C08592; cpd:C08593; cpd:C08613; cpd:C15724; cpd:C15849; cpd:C15867; cpd:C15910; cpd:C15911; cpd:C15928; cpd:C15965; cpd:C15966; cpd:C15968; cpd:C16347; cpd:C19920; cpd:C19921,40,54,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H55,C40H53,534.4225517,535.4303768,533.41472673555,3903,cpd:C15874,"3,4-Dehydrorhodopin;",C40H56O,"3,4-Dehydrorhodopin; 3,4-Didehydrorhodopin; 1-Hydroxy-3,4-didehydro-1,2-dihydrolycopene",R07520 R07521,Carotenoid biosynthesis; Metabolic pathways,1.3.99.27; 2.1.1.210,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15874  3,4-Dehydrorhodopin",PubChem: 47205194; ChEBI: 62481; LIPIDMAPS: LMPR01070115; NIKKAJI: J14.063E,cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08603; cpd:C08605; cpd:C08611; cpd:C15860; cpd:C15874; cpd:C15981; cpd:C20331,40,56,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O1,C40H55O1,552.4331164,553.4409415,551.42529143556,3904,cpd:C15877,Anhydrorhodovibrin,C41H58O,Anhydrorhodovibrin,R07521 R07522,Carotenoid biosynthesis; Metabolic pathways,2.1.1.210; 4.2.1.131,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15877  Anhydrorhodovibrin,PubChem: 47205197; ChEBI: 80148; LIPIDMAPS: LMPR01070135; KNApSAcK: C00022852; NIKKAJI: J15.730I,cpd:C15877,41,58,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H59O1,C41H57O1,566.4487665,567.4565915,565.44094153557,3905,cpd:C15878,Rhodovibrin,C41H60O2,Rhodovibrin,R07522 R07523,Carotenoid biosynthesis; Metabolic pathways,1.3.99.27; 4.2.1.131,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15878  Rhodovibrin,PubChem: 47205198; ChEBI: 80149; LIPIDMAPS: LMPR01070136; KNApSAcK: C00022894; NIKKAJI: J16.334A,cpd:C15878,41,60,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H61O2,C41H59O2,584.4593312,585.4671562,583.45150613558,3906,cpd:C15879,Hydroxyspirilloxanthin;,C41H58O2,Hydroxyspirilloxanthin; Monodemethyl spirilloxanthin,R07523 R07524,Carotenoid biosynthesis; Metabolic pathways,1.3.99.27; 2.1.1.210,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15879  Hydroxyspirilloxanthin,PubChem: 47205199; ChEBI: 80150; LIPIDMAPS: LMPR01070137; KNApSAcK: C00022891; NIKKAJI: J2.795.056F,cpd:C15879; cpd:C15903; cpd:C16277; cpd:C16279,41,58,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H59O2,C41H57O2,582.4436811,583.4515061,581.43585613559,3907,cpd:C15881,Spirilloxanthin;,C42H60O2,Spirilloxanthin; Rhodoviolascin,R07524 R07525,Carotenoid biosynthesis; Metabolic pathways,1.14.15.9; 2.1.1.210,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15881  Spirilloxanthin,CAS: 34255-08-8; PubChem: 47205201; ChEBI: 35328; LIPIDMAPS: LMPR01070122; KNApSAcK: C00022893; NIKKAJI: J82.098I,cpd:C15881,42,60,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H61O2,C42H59O2,596.4593312,597.4671562,595.45150613560,3908,cpd:C15884,2-Ketospirilloxanthin;,C42H58O3,2-Ketospirilloxanthin; 2-Oxospirilloxanthin,R07525 R07526,Carotenoid biosynthesis; Metabolic pathways,1.14.15.9,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15884  2-Ketospirilloxanthin,PubChem: 47205204; ChEBI: 64792; LIPIDMAPS: LMPR01070153; KNApSAcK: C00023013; NIKKAJI: J1.083.650F,cpd:C15884,42,58,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H59O3,C42H57O3,610.4385957,611.4464208,609.43077073561,3909,cpd:C15885,"2,2'-Diketospirilloxanthin;",C42H56O4,"2,2'-Diketospirilloxanthin; 2,2'-Dioxospirilloxanthin",R07526,Carotenoid biosynthesis; Metabolic pathways,1.14.15.9,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15885  2,2'-Diketospirilloxanthin",PubChem: 47205205; ChEBI: 64793; LIPIDMAPS: LMPR01070154; KNApSAcK: C00023064; NIKKAJI: J1.083.651D J104.508C,cpd:C15885,42,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H57O4,C42H55O4,624.4178603,625.4256853,623.41003533562,3910,cpd:C15886,"3,4-Dihydroanhydrorhodovibrin",C41H60O,"3,4-Dihydroanhydrorhodovibrin",R07527 R07528,Carotenoid biosynthesis; Metabolic pathways,2.1.1.210; 4.2.1.131,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15886  3,4-Dihydroanhydrorhodovibrin",PubChem: 47205206; ChEBI: 80152; LIPIDMAPS: LMPR01070138; NIKKAJI: J2.795.105H,cpd:C15886; cpd:C15900,41,60,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H61O1,C41H59O1,568.4644166,569.4722416,567.45659153563,3911,cpd:C15887,"3',4'-Dihydrorhodovibrin",C41H62O2,"3',4'-Dihydrorhodovibrin",R07528 R07529,Carotenoid biosynthesis; Metabolic pathways,2.1.1.210; 4.2.1.131,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15887  3',4'-Dihydrorhodovibrin",PubChem: 47205207; ChEBI: 80153; LIPIDMAPS: LMPR01070139; NIKKAJI: J2.795.136H,cpd:C15887; cpd:C15902,41,62,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H63O2,C41H61O2,586.4749812,587.4828063,585.46715623564,3912,cpd:C15888,"3,4,3',4'-Tetrahydrospirilloxanthin",C42H64O2,"3,4,3',4'-Tetrahydrospirilloxanthin",R07529,Carotenoid biosynthesis; Metabolic pathways,2.1.1.210,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15888  3,4,3',4'-Tetrahydrospirilloxanthin",PubChem: 47205208; ChEBI: 80154; LIPIDMAPS: LMPR01070140; KNApSAcK: C00022898; NIKKAJI: J104.497D,cpd:C15888,42,64,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H65O2,C42H63O2,600.4906313,601.4984563,599.48280633565,3913,cpd:C15892,Chloroxanthin;,C40H60O,Chloroxanthin; Hydroxyneurosporene,R07532 R07533 R07534,Carotenoid biosynthesis; Metabolic pathways,1.3.99.27; 2.1.1.210; 4.2.1.131,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15892  Chloroxanthin,PubChem: 47205212; ChEBI: 80158; LIPIDMAPS: LMPR01070113; KNApSAcK: C00000927; NIKKAJI: J13.852E,cpd:C15892,40,60,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H61O1,C40H59O1,556.4644166,557.4722416,555.45659153566,3914,cpd:C15895,"3,4-Dihydrospheroidene;",C41H62O,"3,4-Dihydrospheroidene; Methoxyneurosporene",R07533,Carotenoid biosynthesis; Metabolic pathways,2.1.1.210,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15895  3,4-Dihydrospheroidene",PubChem: 47205215; LIPIDMAPS: LMPR01070149; KNApSAcK: C00000928; NIKKAJI: J812.272E,cpd:C15895,41,62,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H63O1,C41H61O1,570.4800666,571.4878917,569.47224163567,3915,cpd:C15898,Demethylspheroidene,C40H58O,Demethylspheroidene,R07534 R07535,Carotenoid biosynthesis; Metabolic pathways,1.3.99.27; 2.1.1.210,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15898  Demethylspheroidene,PubChem: 47205217; ChEBI: 62505; LIPIDMAPS: LMPR01070120; KNApSAcK: C00000923; NIKKAJI: J1.629.941C,cpd:C15859; cpd:C15898; cpd:C19795,40,58,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H59O1,C40H57O1,554.4487665,555.4565915,553.44094153568,3916,cpd:C15900,Spheroidene,C41H60O,Spheroidene,R07535 R07536 R07537,Carotenoid biosynthesis; Metabolic pathways,1.14.15.9; 2.1.1.210; 4.2.1.131,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15900  Spheroidene,CAS: 13836-61-8; PubChem: 47205219; ChEBI: 35330; LIPIDMAPS: LMPR01070119; KNApSAcK: C00000930; NIKKAJI: J13.215B,cpd:C15886; cpd:C15900,41,60,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H61O1,C41H59O1,568.4644166,569.4722416,567.45659153569,3917,cpd:C15902,Hydroxyspheroidene,C41H62O2,Hydroxyspheroidene,R07536 R07538,Carotenoid biosynthesis; Metabolic pathways,1.14.15.9; 4.2.1.131,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15902  Hydroxyspheroidene,CAS: 1191-20-4; PubChem: 47205221; ChEBI: 80162; LIPIDMAPS: LMPR01070150; KNApSAcK: C00022902; NIKKAJI: J1.083.648D,cpd:C15887; cpd:C15902,41,62,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H63O2,C41H61O2,586.4749812,587.4828063,585.46715623570,3918,cpd:C15903,Spheroidenone;,C41H58O2,Spheroidenone; Spheroiden-2-one,R07537 R07539,Carotenoid biosynthesis; Metabolic pathways,1.14.15.9; 4.2.1.131,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15903  Spheroidenone,CAS: 13836-70-9; PubChem: 47205222; ChEBI: 62480; LIPIDMAPS: LMPR01070121; KNApSAcK: C00000914; NIKKAJI: J13.216K,cpd:C15879; cpd:C15903; cpd:C16277; cpd:C16279,41,58,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H59O2,C41H57O2,582.4436811,583.4515061,581.43585613571,3919,cpd:C15905,Hydroxyspheroidenone,C41H60O3,Hydroxyspheroidenone,R07538 R07539,Carotenoid biosynthesis; Metabolic pathways,1.14.15.9; 4.2.1.131,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15905  Hydroxyspheroidenone,PubChem: 47205224; ChEBI: 80164; LIPIDMAPS: LMPR01070151; NIKKAJI: J2.405.070J,cpd:C15905,41,60,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H61O3,C41H59O3,600.4542458,601.4620708,599.44642083572,3920,cpd:C15908,Chlorobactene,C40H52,Chlorobactene,R07541 R07543,Carotenoid biosynthesis,4.2.1.131,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15908  Chlorobactene,CAS: 2932-09-4; PubChem: 47205227; ChEBI: 80167; LIPIDMAPS: LMPR01070163; KNApSAcK: C00022819; NIKKAJI: J14.438J,cpd:C08580; cpd:C08583; cpd:C13849; cpd:C15908; cpd:C15967; cpd:C16340,40,52,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H53,C40H51,532.4069017,533.4147267,531.39907663573,3921,cpd:C15911,Hydroxychlorobactene,C40H54O,Hydroxychlorobactene,R07543 R07544,Carotenoid biosynthesis,4.2.1.131,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15911  Hydroxychlorobactene,PubChem: 47205229; ChEBI: 80169; LIPIDMAPS: LMPR01070165; KNApSAcK: C00022851; NIKKAJI: J2.796.859G,cpd:C08592; cpd:C15911,40,54,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H55O1,C40H53O1,550.4174664,551.4252914,549.40964133574,3922,cpd:C15914,Hydroxychlorobactene glucoside,C46H64O6,Hydroxychlorobactene glucoside,R07544 R07545,Carotenoid biosynthesis,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15914  Hydroxychlorobactene glucoside,PubChem: 47205232; ChEBI: 80172; NIKKAJI: J1.119.317J,cpd:C15914,46,64,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H65O6,C46H63O6,712.4702898,713.4781148,711.46246473575,3924,cpd:C15935,"(2'S)-Deoxymyxol 2'-(2,4-di-O-methyl-alpha-L-fucoside)",C48H70O6,"(2'S)-Deoxymyxol 2'-(2,4-di-O-methyl-alpha-L-fucoside)",R07553 R07554 R07852,Carotenoid biosynthesis,1.14.13.-,NA,NA,PubChem: 47205252; ChEBI: 80189; NIKKAJI: J2.797.013C,cpd:C15935,48,70,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C48H71O6,C48H69O6,742.51724,743.525065,741.50941493576,3925,cpd:C15937,"(3R,2'S)-Myxol 2'-(2,4-di-O-methyl-alpha-L-fucoside)",C48H70O7,"(3R,2'S)-Myxol 2'-(2,4-di-O-methyl-alpha-L-fucoside)",R07554,Carotenoid biosynthesis,1.14.13.-,NA,NA,PubChem: 47205254; ChEBI: 80191; NIKKAJI: J2.797.014A,cpd:C15937,48,70,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C48H71O7,C48H69O7,758.5121546,759.5199796,757.50432963577,3926,cpd:C15940,(2'S)-Deoxymyxol 2'-alpha-L-fucoside,C46H66O6,(2'S)-Deoxymyxol 2'-alpha-L-fucoside,R07555 R07556,Carotenoid biosynthesis,1.14.13.-,NA,NA,PubChem: 47205256; ChEBI: 80193; NIKKAJI: J2.797.050H,cpd:C15940,46,66,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H67O6,C46H65O6,714.4859398,715.4937649,713.47811483578,3927,cpd:C15941,"(3R,2'S)-Myxol 2'-alpha-L-fucoside",C46H66O7,"(3R,2'S)-Myxol 2'-alpha-L-fucoside",R07556 R07557,Carotenoid biosynthesis,1.14.13.-,NA,NA,PubChem: 47205257; ChEBI: 80194; NIKKAJI: J2.659.267D,cpd:C15941; cpd:C16271,46,66,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H67O7,C46H65O7,730.4808545,731.4886795,729.47302943579,3928,cpd:C15942,"(3S,2'S)-4-Ketomyxol 2'-alpha-L-fucoside",C46H64O8,"(3S,2'S)-4-Ketomyxol 2'-alpha-L-fucoside",R07557,Carotenoid biosynthesis,NA,NA,NA,PubChem: 47205258; ChEBI: 80195; NIKKAJI: J2.797.059A,cpd:C15942,46,64,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H65O8,C46H63O8,744.460119,745.4679441,743.4522943580,3929,cpd:C15943,Isorenieratene,C40H48,Isorenieratene,R07560 R07858,Carotenoid biosynthesis,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15943  Isorenieratene,PubChem: 47205259; ChEBI: 80196; LIPIDMAPS: LMPR01070124; KNApSAcK: C00022816; NIKKAJI: J450.759B,cpd:C07919; cpd:C09085; cpd:C09200; cpd:C09242; cpd:C15943,40,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H49,C40H47,528.3756015,529.3834266,527.36777653581,3930,cpd:C15965,3'-Hydroxyechinenone,C40H54O2,3'-Hydroxyechinenone,R07561 R07564 R07566 R07569,Carotenoid biosynthesis,1.14.13.129,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15965  3'-Hydroxyechinenone,PubChem: 47205278; ChEBI: 80214; LIPIDMAPS: LMPR01070098; PDB-CCD: EQ3; NIKKAJI: J651.142B,cpd:C08593; cpd:C15965; cpd:C15966; cpd:C19920,40,54,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H55O2,C40H53O2,566.412381,567.420206,565.40455593582,3931,cpd:C15966,3-Hydroxyechinenone,C40H54O2,3-Hydroxyechinenone,R07562 R07565 R07567 R07570,Carotenoid biosynthesis,1.14.13.129,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15966  3-Hydroxyechinenone,PubChem: 47205279; ChEBI: 80215; LIPIDMAPS: LMPR01070097; NIKKAJI: J652.597K,cpd:C08593; cpd:C15965; cpd:C15966; cpd:C19920,40,54,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H55O2,C40H53O2,566.412381,567.420206,565.40455593583,3932,cpd:C15967,Phoenicoxanthin;,C40H52O3,Phoenicoxanthin; Adonirubin,R07566 R07567 R07568 R07572,Carotenoid biosynthesis,1.14.13.129,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15967  Phoenicoxanthin,PubChem: 47205280; ChEBI: 80216; LIPIDMAPS: LMPR01070096; NIKKAJI: J652.203C,cpd:C15967,40,52,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H53O3,C40H51O3,580.3916455,581.3994706,579.38382053584,3933,cpd:C15968,Adonixanthin;,C40H54O3,Adonixanthin; 4-Ketozeaxanthin,R07569 R07570 R07571 R07573,Carotenoid biosynthesis,1.14.13.129,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15968  Adonixanthin,PubChem: 47205281; ChEBI: 80217; LIPIDMAPS: LMPR01070016; KNApSAcK: C00000917; NIKKAJI: J652.204A,cpd:C15968; cpd:C16347; cpd:C19921,40,54,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H55O3,C40H53O3,582.4072956,583.4151206,581.39947063585,3934,cpd:C15969,Zeaxanthin diglucoside;,C52H76O12,Zeaxanthin diglucoside; Zeaxanthin-beta-D-diglucoside,R07574,Carotenoid biosynthesis,2.4.1.276,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15969  Zeaxanthin diglucoside,PubChem: 47205282; ChEBI: 63067; KNApSAcK: C00000932; NIKKAJI: J856.112E,cpd:C15969; cpd:C16275,52,76,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C52H77O12,C52H75O12,892.5336779,893.5415029,891.52585293586,3935,cpd:C15970,Abscisic acid glucose ester;,C21H30O9,Abscisic acid glucose ester; Abscisic acid-beta-D-glucopyranosyl ester; beta-D-Glucopyranosyl abscisate,R07575 R09723,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.4.1.263; 3.2.1.175,NA,NA,PubChem: 47205283; ChEBI: 22151; KNApSAcK: C00029293; NIKKAJI: J679.803I,cpd:C15970,21,30,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H31O9,C21H29O9,426.1889825,427.1968076,425.18115753587,3936,cpd:C15971,Dihydrophaseic acid;,C15H22O5,Dihydrophaseic acid; (-)-Dihydrophaseic acid,R07577,Carotenoid biosynthesis,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010305 Cyclofarnesane sesquiterpenoids;      C15971  Dihydrophaseic acid,PubChem: 47205284; ChEBI: 23757; NIKKAJI: J330.632A,cpd:C00019; cpd:C09482; cpd:C09538; cpd:C15971,15,22,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O5,C15H21O5,282.1467238,283.1545488,281.13889883588,3937,cpd:C15981,alpha-Cryptoxanthin;,C40H56O,"alpha-Cryptoxanthin; (3'R,6'R)-beta,epsilon-Caroten-3'-ol",R07850 R07851,Carotenoid biosynthesis,1.14.13.129; 1.14.99.45,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C15981  alpha-Cryptoxanthin; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C15981  alpha-Cryptoxanthin,PubChem: 47205294; ChEBI: 10223; LipidBank: VCA1159; KNApSAcK: C00003770; NIKKAJI: J2.799.848H,cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08603; cpd:C08605; cpd:C08611; cpd:C15860; cpd:C15874; cpd:C15981; cpd:C20331,40,56,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O1,C40H55O1,552.4331164,553.4409415,551.42529143589,3941,cpd:C16144,"4,4'-Diapophytoene;",C30H48,"4,4'-Diapophytoene; Dehydrosqualene; 15-cis-4,4'-Diapophytoene",R07652 R07653 R09690 R09719 R09793,Carotenoid biosynthesis,1.3.8.2; 2.5.1.96,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C16144  4,4'-Diapophytoene",CAS: 53872-54-1 11051-27-7; PubChem: 47205454; ChEBI: 62738; KNApSAcK: C00000915; NIKKAJI: J419.919G,cpd:C08617; cpd:C08619; cpd:C08623; cpd:C08804; cpd:C08808; cpd:C08942; cpd:C08988; cpd:C15688; cpd:C15852; cpd:C16144; cpd:C16466; cpd:C16912; cpd:C16939; cpd:C16967; cpd:C16990; cpd:C17067; cpd:C17070; cpd:C17148; cpd:C17394; cpd:C17420; cpd:C17422; cpd:C17460; cpd:C17538; cpd:C17841; cpd:C17890; cpd:C19943; cpd:C20510; cpd:C20946,30,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H49,C30H47,408.3756015,409.3834266,407.36777653590,3942,cpd:C16145,"4,4'-Diaponeurosporene",C30H42,"4,4'-Diaponeurosporene",R07653 R07654 R09727 R09745 R09746,Carotenoid biosynthesis,1.3.8.2; 1.14.99.44,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C16145  4,4'-Diaponeurosporene",CAS: 53872-50-7; PubChem: 47205455; ChEBI: 62743; LIPIDMAPS: LMPR01070132; KNApSAcK: C00023134; NIKKAJI: J419.922G,cpd:C00223; cpd:C00323; cpd:C00540; cpd:C06733; cpd:C07118; cpd:C08800; cpd:C08806; cpd:C08860; cpd:C09990; cpd:C10599; cpd:C11225; cpd:C12148; cpd:C12816; cpd:C16145; cpd:C16256,30,42,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H43,C30H41,402.3286514,403.3364764,401.32082633591,3943,cpd:C16146,"4,4'-Diaponeurosporenic acid",C30H40O2,"4,4'-Diaponeurosporenic acid",R07654 R07655 R09728,Carotenoid biosynthesis,1.14.99.44; 2.4.1.-,NA,NA,PubChem: 47205456; ChEBI: 80352 83048; KNApSAcK: C00023144; NIKKAJI: J2.798.373A,cpd:C16146; cpd:C20894,30,40,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H41O2,C30H39O2,432.3028305,433.3106556,431.29500553592,3944,cpd:C16147,"Glycosyl-4,4'-diaponeurosporenoate",C36H50O7,"Glycosyl-4,4'-diaponeurosporenoate",R07655 R07656,Carotenoid biosynthesis,2.3.1.-; 2.4.1.-,NA,NA,PubChem: 47205457; ChEBI: 80353; NIKKAJI: J2.798.387A,cpd:C16147,36,50,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H51O7,C36H49O7,594.3556539,595.363479,593.34782893593,3945,cpd:C16148,Staphyloxanthin,C51H78O8,Staphyloxanthin,R07656,Carotenoid biosynthesis,2.3.1.-,NA,NA,CAS: 71869-01-7; PubChem: 47205458; ChEBI: 71690; NIKKAJI: J2.237.134G,cpd:C16148,51,78,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C51H79O8,C51H77O8,818.5696695,819.5774945,817.56184443594,3946,cpd:C16270,Rhodopinal,C40H56O2,Rhodopinal,R07834 R07843,Carotenoid biosynthesis,NA,NA,NA,PubChem: 47205578; ChEBI: 80411; NIKKAJI: J112.626A,cpd:C06098; cpd:C08599; cpd:C08601; cpd:C15933; cpd:C16270,40,56,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O2,C40H55O2,568.428031,569.4358561,567.4202063595,3947,cpd:C16271,Rhodopinal glucoside,C46H66O7,Rhodopinal glucoside,R07843,Carotenoid biosynthesis,NA,NA,NA,PubChem: 47205579; ChEBI: 45365; NIKKAJI: J2.799.328A,cpd:C15941; cpd:C16271,46,66,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C46H67O7,C46H65O7,730.4808545,731.4886795,729.47302943596,3948,cpd:C16274,"(2S,2'S)-Oscillol",C40H56O4,"(2S,2'S)-Oscillol",R07844 R07845,Carotenoid biosynthesis,NA,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C16274  (2S,2'S)-Oscillol",PubChem: 47205582; ChEBI: 80412; NIKKAJI: J2.799.347H,cpd:C08585; cpd:C08606; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15932; cpd:C16274; cpd:C16284,40,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O4,C40H55O4,600.4178603,601.4256853,599.41003533597,3949,cpd:C16275,"(2S,2'S)-Oscillol 2,2'-di(alpha-L-fucoside)",C52H76O12,"(2S,2'S)-Oscillol 2,2'-di(alpha-L-fucoside)",R07845,Carotenoid biosynthesis,NA,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C16275  (2S,2'S)-Oscillol 2,2'-di(alpha-L-fucoside)",PubChem: 47205583; ChEBI: 80413; NIKKAJI: J2.799.352D,cpd:C15969; cpd:C16275,52,76,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C52H77O12,C52H75O12,892.5336779,893.5415029,891.52585293598,3950,cpd:C16276,epsilon-Carotene,C40H56,epsilon-Carotene,R07840,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,5.5.1.18,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C16276  epsilon-Carotene; Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Carotenoids;     C16276  epsilon-Carotene,PubChem: 47205584; ChEBI: 32549; KNApSAcK: C00022813; NIKKAJI: J11.882F,cpd:C02094; cpd:C05432; cpd:C05433; cpd:C05435; cpd:C06098; cpd:C08579; cpd:C08584; cpd:C08585; cpd:C08586; cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08594; cpd:C08599; cpd:C08601; cpd:C08602; cpd:C08603; cpd:C08605; cpd:C08606; cpd:C08611; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15716; cpd:C15858; cpd:C15860; cpd:C15874; cpd:C15919; cpd:C15932; cpd:C15933; cpd:C15981; cpd:C16270; cpd:C16274; cpd:C16276; cpd:C16282; cpd:C16284; cpd:C20331; cpd:C20484,40,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57,C40H55,536.4382018,537.4460268,535.43037683599,3951,cpd:C16277,R.g.-Keto I,C41H58O2,R.g.-Keto I,R07846 R07847 R07848,Carotenoid biosynthesis,NA,NA,NA,PubChem: 47205585; ChEBI: 80414; KNApSAcK: C00022999; NIKKAJI: J2.799.369I,cpd:C15879; cpd:C15903; cpd:C16277; cpd:C16279,41,58,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H59O2,C41H57O2,582.4436811,583.4515061,581.43585613600,3952,cpd:C16278,R.g.-Keto III,C42H60O4,R.g.-Keto III,R07847,Carotenoid biosynthesis,NA,NA,NA,PubChem: 47205586; ChEBI: 80415; KNApSAcK: C00023065; NIKKAJI: J2.799.370B,cpd:C16278,42,60,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H61O4,C42H59O4,628.4491604,629.4569854,627.44133543601,3953,cpd:C16279,Thiothece-474,C41H58O2,Thiothece-474,R07848 R07849,Carotenoid biosynthesis,NA,NA,NA,PubChem: 47205587; ChEBI: 80416; KNApSAcK: C00022996; NIKKAJI: J19.151E,cpd:C15879; cpd:C15903; cpd:C16277; cpd:C16279,41,58,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H59O2,C41H57O2,582.4436811,583.4515061,581.43585613602,3954,cpd:C16280,Okenone,C41H54O2,Okenone,R07849,Carotenoid biosynthesis,NA,NA,NA,PubChem: 47205588; ChEBI: 80417; KNApSAcK: C00022998; NIKKAJI: J69.999C,cpd:C16280,41,54,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H55O2,C41H53O2,578.412381,579.420206,577.40455593603,3955,cpd:C16282,Caloxanthin,C40H56O3,Caloxanthin,R07841 R07842,Carotenoid biosynthesis,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C16282  Caloxanthin,PubChem: 47205590; ChEBI: 80419; LIPIDMAPS: LMPR01070134; KNApSAcK: C00022906; NIKKAJI: J39.990F,cpd:C08579; cpd:C08584; cpd:C08594; cpd:C08602; cpd:C15919; cpd:C16282,40,56,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O3,C40H55O3,584.4229457,585.4307707,583.41512063604,3956,cpd:C16284,Nostoxanthin,C40H56O4,Nostoxanthin,R07842,Carotenoid biosynthesis,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C16284  Nostoxanthin,PubChem: 47205592; ChEBI: 80421; LIPIDMAPS: LMPR01070104; KNApSAcK: C00022921; NIKKAJI: J69.977B,cpd:C08585; cpd:C08606; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15932; cpd:C16274; cpd:C16284,40,56,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57O4,C40H55O4,600.4178603,601.4256853,599.41003533605,3957,cpd:C16291,"7,8-Dihydro-beta-carotene",C40H58,"7,8-Dihydro-beta-carotene",R07856,Carotenoid biosynthesis,5.5.1.19,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C16291  7,8-Dihydro-beta-carotene",PubChem: 47205599; ChEBI: 80427; LIPIDMAPS: LMPR01070091; KNApSAcK: C00023214; NIKKAJI: J1.844.471B,cpd:C05431; cpd:C05434; cpd:C11965; cpd:C14146; cpd:C15859; cpd:C15898; cpd:C15907; cpd:C16291; cpd:C19759; cpd:C19795; cpd:C20332,40,58,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H59,C40H57,538.4538519,539.4616769,537.44602683606,3958,cpd:C16340,beta-Isorenieratene,C40H52,beta-Isorenieratene,R07857 R07858,Carotenoid biosynthesis,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C16340  beta-Isorenieratene,PubChem: 47205648; ChEBI: 80461; LIPIDMAPS: LMPR01070123; KNApSAcK: C00022804; NIKKAJI: J2.802.290E,cpd:C08580; cpd:C08583; cpd:C13849; cpd:C15908; cpd:C15967; cpd:C16340,40,52,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H53,C40H51,532.4069017,533.4147267,531.39907663607,3960,cpd:C18036,Strigolactone ABC-rings,C14H18O3,Strigolactone ABC-rings,R08988 R08989,Carotenoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 96024256; ChEBI: 81465,cpd:C01965; cpd:C07844; cpd:C09232; cpd:C10896; cpd:C12460; cpd:C18036; cpd:C18406,14,18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H19O3,C14H17O3,234.1255944,235.1334195,233.11776943608,3961,cpd:C18037,5-Deoxystrigol,C19H22O5,5-Deoxystrigol,R08989 R08990,Carotenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.-,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Carotenoids and apocarotenoids;    Apocarotenoids;     C18037  5-Deoxystrigol,PubChem: 96024257; ChEBI: 81466; KNApSAcK: C00033500; NIKKAJI: J2.176.606B,cpd:C09173; cpd:C11854; cpd:C11867; cpd:C11871; cpd:C18037,19,22,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O5,C19H21O5,330.1467238,331.1545488,329.13889883609,3962,cpd:C19759,"7,9,9'-tricis-Neurosporene;",C40H58,"7,9,9'-tricis-Neurosporene; 7,9,9'-tri-cis-Neurosporene",R09656 R09658,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.5.6,"beta-Carotene biosynthesis, GGAP => beta-carotene",NA,PubChem: 135626226; KNApSAcK: C00007592,cpd:C05431; cpd:C05434; cpd:C11965; cpd:C14146; cpd:C15859; cpd:C15898; cpd:C15907; cpd:C16291; cpd:C19759; cpd:C19795; cpd:C20332,40,58,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H59,C40H57,538.4538519,539.4616769,537.44602683610,3963,cpd:C19764,"9,15,9'-tricis-zeta-Carotene",C40H60,"9,15,9'-tricis-zeta-Carotene",R09652 R09654 R09655,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.5.5; 5.2.1.12,"beta-Carotene biosynthesis, GGAP => beta-carotene",NA,PubChem: 135626231; LIPIDMAPS: LMPR01070296,cpd:C05430; cpd:C08966; cpd:C11957; cpd:C15857; cpd:C15892; cpd:C19764; cpd:C19894,40,60,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H61,C40H59,540.4695019,541.477327,539.46167693611,3964,cpd:C19765,"15,9'-dicis-Phytofluene",C40H62,"15,9'-dicis-Phytofluene",R09653 R09654,Carotenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.5.5,"beta-Carotene biosynthesis, GGAP => beta-carotene",NA,PubChem: 135626232,cpd:C05414; cpd:C19765; cpd:C20971,40,62,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H63,C40H61,542.485152,543.492977,541.4773273612,3965,cpd:C19795,"1-Hydroxy-1,2-dihydrolycopene;",C40H58O,"1-Hydroxy-1,2-dihydrolycopene; Rhodopin; 1-Hydroxylycopene",R07519 R07520 R07527 R07834 R09790,Carotenoid biosynthesis; Metabolic pathways,1.3.99.27; 2.1.1.210; 4.2.1.131,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0107 C40 isoprenoids (tetraterpenes);     C19795  Rhodopin,PubChem: 135626262; ChEBI: 35331; LIPIDMAPS: LMPR01070114; KNApSAcK: C00022854,cpd:C15859; cpd:C15898; cpd:C19795,40,58,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H59O1,C40H57O1,554.4487665,555.4565915,553.44094153613,3966,cpd:C19797,"4,4'-Diapolycopene",C30H40,"4,4'-Diapolycopene",R09671 R09690 R09746,Carotenoid biosynthesis,1.3.8.2; 1.14.99.44,NA,NA,PubChem: 135626264; LIPIDMAPS: LMPR01070143,cpd:C08633; cpd:C09143; cpd:C09198; cpd:C09286; cpd:C16146; cpd:C19728; cpd:C19797; cpd:C19839; cpd:C20894; cpd:C20936,30,40,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H41,C30H39,400.3130013,401.3208263,399.30517633614,3967,cpd:C19798,"4,4'-Diapolycopenedial",C30H36O2,"4,4'-Diapolycopenedial",R09671,Carotenoid biosynthesis,1.14.99.44,NA,NA,PubChem: 135626265; KNApSAcK: C00023142,cpd:C19798,30,36,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H37O2,C30H35O2,428.2715304,429.2793554,427.26370543615,3968,cpd:C19892,"4'-Apo-beta,psi-caroten-4'-al;",C35H46O,"4'-Apo-beta,psi-caroten-4'-al; beta-Apo-4'-carotenal",R09782 R09783,Carotenoid biosynthesis; Metabolic pathways,1.2.1.82; 1.13.11.59,NA,NA,PubChem: 135626358,cpd:C19892,35,46,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H47O1,C35H45O1,482.3548661,483.3626911,481.34704113616,3969,cpd:C20484,9-cis-beta-Carotene,C40H56,9-cis-beta-Carotene,R10282 R10557,Carotenoid biosynthesis,1.13.11.68; 5.2.1.14,NA,NA,PubChem: 163312221,cpd:C02094; cpd:C05432; cpd:C05433; cpd:C05435; cpd:C06098; cpd:C08579; cpd:C08584; cpd:C08585; cpd:C08586; cpd:C08587; cpd:C08590; cpd:C08591; cpd:C08594; cpd:C08599; cpd:C08601; cpd:C08602; cpd:C08603; cpd:C08605; cpd:C08606; cpd:C08611; cpd:C08614; cpd:C13431; cpd:C13433; cpd:C15716; cpd:C15858; cpd:C15860; cpd:C15874; cpd:C15919; cpd:C15932; cpd:C15933; cpd:C15981; cpd:C16270; cpd:C16274; cpd:C16276; cpd:C16282; cpd:C16284; cpd:C20331; cpd:C20484,40,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H57,C40H55,536.4382018,537.4460268,535.43037683617,3970,cpd:C20692,9-cis-10'-Apo-beta-carotenal,C27H36O,9-cis-10'-Apo-beta-carotenal,R10557 R10558,Carotenoid biosynthesis,1.13.11.68; 1.13.11.69,NA,NA,PubChem: 172232412,cpd:C20692; cpd:C20695,27,36,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H37O1,C27H35O1,376.2766158,377.2844408,375.26879073618,3971,cpd:C20693,Carlactone,C19H26O3,Carlactone,R10558,Carotenoid biosynthesis,1.13.11.69,NA,NA,PubChem: 172232413,cpd:C04676; cpd:C05140; cpd:C05284; cpd:C05290; cpd:C05295; cpd:C05296; cpd:C05302; cpd:C11709; cpd:C14256; cpd:C14269; cpd:C14337; cpd:C14593; cpd:C14907; cpd:C15072; cpd:C15103; cpd:C15216; cpd:C15390; cpd:C20693,19,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H27O3,C19H25O3,302.1881947,303.1960197,301.18036973619,3973,cpd:C00371,Zeatin;,C10H13N5O,Zeatin; N6-(4-Hydroxyisopentenyl)adenine; (E)-2-Methyl-4-(1H-purin-6-ylamino)but-2-en-1-ol; trans-Zeatin,R02118 R02119 R03133 R05702 R08068 R08073 R08075,Zeatin biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites; Plant hormone signal transduction,1.3.1.69; 2.4.1.203; 2.4.1.-; 2.4.2.40; 2.5.1.50,NA,NA,CAS: 1637-39-4; PubChem: 3661; ChEBI: 16522; ChEMBL: CHEMBL525239; KNApSAcK: C00000091; PDB-CCD: ZEA; 3DMET: B01232; NIKKAJI: J7.540J,cpd:C00371; cpd:C15545,10,13,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O1N5,C10H12O1N5,219.1120101,220.1198351,218.1041853620,3974,cpd:C01513,Lupinate;,C13H18N6O3,Lupinate; Lupinic acid; 3-[N6-(4-Hydroxyisopentenyl)adeninyl]-L-alanine; (S)-2-Amino-3-{[(E)-4-hydroxy-3-methylbut-2-enylamino]purin-9-yl}propanoic acid,R03133,Zeatin biosynthesis; Biosynthesis of secondary metabolites,2.5.1.50,NA,NA,CAS: 67392-79-4; PubChem: 4679; ChEBI: 15877 30886 6572; 3DMET: B01458; NIKKAJI: J14.630G,cpd:C01513,13,18,3,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H19O3N6,C13H17O3N6,306.1440385,307.1518635,305.13621343621,3975,cpd:C01804,Discadenine;,C14H20N6O2,Discadenine; 3-(3-Amino-3-carboxypropyl)-N6-(Delta2-isopentenyl)-adenine,R03726,Zeatin biosynthesis; Biosynthesis of secondary metabolites,2.5.1.24,NA,NA,PubChem: 4930; ChEBI: 15955; 3DMET: B01501; NIKKAJI: J18.112I,cpd:C01804,14,20,2,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H21O2N6,C14H19O2N6,304.1647739,305.1725989,303.15694893622,3976,cpd:C02029,Dihydrozeatin;,C10H15N5O,Dihydrozeatin; 2-Methyl-4-(1H-purin-6-ylamino)butan-1-ol; N6-(4-Hydroxyisopentanyl)adenine,R05702 R08074 R08076,Zeatin biosynthesis; Biosynthesis of secondary metabolites; Plant hormone signal transduction,1.3.1.69; 2.4.1.-,NA,NA,CAS: 23599-75-9; PubChem: 5123; ChEBI: 17874; KNApSAcK: C00000093; 3DMET: B01525; NIKKAJI: J20.658J,cpd:C02029,10,15,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O1N5,C10H14O1N5,221.1276601,222.1354852,220.11983513623,3977,cpd:C03300,O-beta-D-Xylosylzeatin;,C15H21N5O5,O-beta-D-Xylosylzeatin; O-beta-D-Xyloxylzeatin,R02119,Zeatin biosynthesis; Biosynthesis of secondary metabolites,2.4.2.40,NA,NA,PubChem: 6156; ChEBI: 17438; 3DMET: B01649; NIKKAJI: J1.510.395G,cpd:C03300; cpd:C16431; cpd:C16449,15,21,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H22O5N5,C15H20O5N5,351.1542688,352.1620938,350.14644383624,3978,cpd:C03423,O-beta-D-Glucosylzeatin;,C16H23N5O6,O-beta-D-Glucosylzeatin; O-beta-D-Glucosyl-trans-zeatin; trans-Zeatin-O-glucoside,R02118,Zeatin biosynthesis; Biosynthesis of secondary metabolites,2.4.1.203,NA,NA,PubChem: 6250; ChEBI: 38266; 3DMET: B01656; NIKKAJI: J510.863B,cpd:C03423; cpd:C15546; cpd:C16443,16,23,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H24O6N5,C16H22O6N5,381.1648335,382.1726585,380.15700843625,3979,cpd:C04083,N6-(Delta2-Isopentenyl)-adenine;,C10H13N5,"N6-(Delta2-Isopentenyl)-adenine; N6-(3-Methylbut-2-enyl)adenine; 6-(gamma,gamma-Dimethylallylamino)purine; N6-Dimethylallyladenine",R03726 R05708 R08068 R08072,Zeatin biosynthesis; Biosynthesis of secondary metabolites; Plant hormone signal transduction,1.5.99.12; 2.5.1.24,NA,Pesticides [BR:br08007];  Pesticides;   Plant growth regulators;    Cytokinins;     C04083  N6-(delta2-Isopentenyl)-adenine,CAS: 2365-40-4; PubChem: 6776; ChEBI: 17660; ChEMBL: CHEMBL476189; KNApSAcK: C00000094; PDB-CCD: ZIP; 3DMET: B01716; NIKKAJI: J120.788A,cpd:C00212; cpd:C00330; cpd:C00371; cpd:C00387; cpd:C00559; cpd:C04083; cpd:C05198; cpd:C07195; cpd:C07210; cpd:C08431; cpd:C08432; cpd:C08435; cpd:C15545,10,13,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14N5,C10H12N5,203.1170954,204.1249205,202.10927043626,3981,cpd:C04713,N6-(delta2-Isopentenyl)-adenosine 5'-monophosphate;,C15H22N5O7P,N6-(delta2-Isopentenyl)-adenosine 5'-monophosphate; N6-(Dimethylallyl)adenosine 5'-phosphate; Isopentenyl-AMP,R04038 R08055 R08062 R08069,Zeatin biosynthesis; Biosynthesis of secondary metabolites,2.5.1.27,NA,NA,PubChem: 7285; ChEBI: 15819; KNApSAcK: C00007239; 3DMET: B01778; NIKKAJI: J394.925G,cpd:C04432; cpd:C04713; cpd:C20755,15,22,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O7N5P1,C15H21O7N5P1,415.1256851,416.1335101,414.117863627,3982,cpd:C07330,3-Methyl-2-butenal;,C5H8O,"3-Methyl-2-butenal; 3-Methylbut-2-enal; 3,3-Dimethyl-acrylaldehyde; Senecialdehyde; Prenal",R05708 R09782,Zeatin biosynthesis,1.5.99.12; 1.13.11.59,NA,NA,CAS: 107-86-8; PubChem: 9538; ChEBI: 15825; ChEMBL: CHEMBL453815; 3DMET: B02115; NIKKAJI: J9.338F,cpd:C00557; cpd:C07330; cpd:C12470; cpd:C15604; cpd:C16250; cpd:C21373,5,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O1,C5H7O1,84.05751488,85.06533991,83.049689853628,3983,cpd:C15545,cis-Zeatin;,C10H13N5O,cis-Zeatin; (Z)-2-Methyl-4-(1H-purin-6-ylamino)but-2-en-1-ol,R07260 R08080,Zeatin biosynthesis; Biosynthesis of plant hormones; Metabolic pathways; Biosynthesis of secondary metabolites,2.4.1.215,NA,NA,PubChem: 17396537; ChEBI: 46570; KNApSAcK: C00007325; PDB-CCD: ZEZ; NIKKAJI: J484.112C,cpd:C00371; cpd:C15545,10,13,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O1N5,C10H12O1N5,219.1120101,220.1198351,218.1041853629,3984,cpd:C15546,O-beta-D-Glucopyranosyl-cis-zeatin;,C16H23N5O6,O-beta-D-Glucopyranosyl-cis-zeatin; cis-Zeatin-O-glucoside,R07260,Zeatin biosynthesis,2.4.1.215,NA,NA,PubChem: 17396538; ChEBI: 29043; NIKKAJI: J676.541F,cpd:C03423; cpd:C15546; cpd:C16443,16,23,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H24O6N5,C16H22O6N5,381.1648335,382.1726585,380.15700843630,3985,cpd:C16424,Isopentenyladenosine-5'-triphosphate;,C15H24N5O13P3,Isopentenyladenosine-5'-triphosphate; Isopentenyl-ATP; N6-(Dimethylallyl)adenosine 5'-triphosphate,R08051 R08053 R08061,Zeatin biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.5.1.112,NA,NA,PubChem: 47205722; ChEBI: 71679; NIKKAJI: J2.802.615C,cpd:C16424,15,24,13,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O13N5P3,C15H23O13N5P3,575.0583468,576.0661719,574.05052183631,3986,cpd:C16426,Isopentenyladenosine-5'-diphosphate;,C15H23N5O10P2,Isopentenyladenosine-5'-diphosphate; Isopentenyl-ADP; N6-(Dimethylallyl)adenosine 5'-diphosphate,R08052 R08054 R08061 R08062,Zeatin biosynthesis,2.5.1.112,NA,NA,PubChem: 47205723; ChEBI: 71678; NIKKAJI: J1.923.854G,cpd:C16426,15,23,10,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H24O10N5P2,C15H22O10N5P2,495.092016,496.099841,494.08419093632,3987,cpd:C16427,Isopentenyl adenosine,C15H21N5O4,Isopentenyl adenosine,R08066 R08069 R08072,Zeatin biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,CAS: 7724-76-7; PubChem: 47205724; ChEBI: 62881; ChEMBL: CHEMBL452867 CHEMBL610981; KNApSAcK: C00007324; PDB-CCD: ZIR; NIKKAJI: J8.966D,cpd:C16427,15,21,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H22O4N5,C15H20O4N5,335.1593542,336.1671792,334.15152913633,3988,cpd:C16428,trans-Zeatin riboside triphosphate,C15H24N5O14P3,trans-Zeatin riboside triphosphate,R08053 R08063,Zeatin biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 47205725; ChEBI: 71938; NIKKAJI: J2.802.624B,cpd:C16428,15,24,14,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O14N5P3,C15H23O14N5P3,591.0532615,592.0610865,590.04543643634,3989,cpd:C16429,trans-Zeatin riboside diphosphate,C15H23N5O11P2,trans-Zeatin riboside diphosphate,R08054 R08063 R08064,Zeatin biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 47205726; ChEBI: 71875; NIKKAJI: J1.923.855E,cpd:C16429,15,23,11,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H24O11N5P2,C15H22O11N5P2,511.0869306,512.0947556,510.07910553635,3990,cpd:C16430,trans-Zeatin riboside  monophosphate,C15H22N5O8P,trans-Zeatin riboside  monophosphate,R08055 R08064 R08065 R08070,Zeatin biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 47205727; ChEBI: 71719; NIKKAJI: J510.866G,cpd:C16430; cpd:C16441; cpd:C16467,15,22,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O8N5P1,C15H21O8N5P1,431.1205997,432.1284247,430.11277473636,3991,cpd:C16431,trans-Zeatin riboside,C15H21N5O5,trans-Zeatin riboside,R08066 R08067 R08070 R08073,Zeatin biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 47205728; ChEBI: 71693; NIKKAJI: J120.777F,cpd:C03300; cpd:C16431; cpd:C16449,15,21,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H22O5N5,C15H20O5N5,351.1542688,352.1620938,350.14644383637,3992,cpd:C16441,cis-Zeatin riboside monophosphate,C15H22N5O8P,cis-Zeatin riboside monophosphate,R08078 R08079,Zeatin biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 47205737; ChEBI: 80493; NIKKAJI: J2.380.382H,cpd:C16430; cpd:C16441; cpd:C16467,15,22,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O8N5P1,C15H21O8N5P1,431.1205997,432.1284247,430.11277473638,3993,cpd:C16443,trans-Zeatin-7-beta-D-glucoside,C16H23N5O6,trans-Zeatin-7-beta-D-glucoside,R08075,Zeatin biosynthesis; Biosynthesis of secondary metabolites,2.4.1.-,NA,NA,PubChem: 47205739; ChEBI: 80494; NIKKAJI: J1.701.115D,cpd:C03423; cpd:C15546; cpd:C16443,16,23,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H24O6N5,C16H22O6N5,381.1648335,382.1726585,380.15700843639,3994,cpd:C16445,Dihydrozeatin riboside monophosphate,C15H24N5O8P,Dihydrozeatin riboside monophosphate,R08065 R08071,Zeatin biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 47205741; ChEBI: 80496; NIKKAJI: J510.865I,cpd:C16445,15,24,8,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O8N5P1,C15H23O8N5P1,433.1362498,434.1440748,432.12842473640,3995,cpd:C16447,Dihydrozeatin riboside,C15H23N5O5,Dihydrozeatin riboside,R08067 R08071 R08074,Zeatin biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 47205743; ChEBI: 80498; NIKKAJI: J120.779B,cpd:C16447,15,23,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H24O5N5,C15H22O5N5,353.1699189,354.1777439,352.16209383641,3996,cpd:C16448,Dihydrozeatin-O-glucoside,C16H25N5O6,Dihydrozeatin-O-glucoside,R08076,Zeatin biosynthesis; Biosynthesis of secondary metabolites,2.4.1.-,NA,NA,PubChem: 47205744; ChEBI: 80499; NIKKAJI: J510.861F,cpd:C16448,16,25,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O6N5,C16H24O6N5,383.1804835,384.1883086,382.17265853642,3997,cpd:C16449,cis-Zeatin riboside,C15H21N5O5,cis-Zeatin riboside,R08079 R08080,Zeatin biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 47205745; ChEBI: 20833; NIKKAJI: J486.816A,cpd:C03300; cpd:C16431; cpd:C16449,15,21,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H22O5N5,C15H20O5N5,351.1542688,352.1620938,350.14644383643,3999,cpd:C01841,Pentalenene,C15H24,Pentalenene,R02305 R09812 R09814,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of antibiotics,1.14.13.133; 4.2.3.7,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010374 Pentalenane sesquiterpenoids;      C01841  Pentalenene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Humulenes;     C01841  Pentalenene,CAS: 73306-73-7; PubChem: 4959; ChEBI: 17251; KNApSAcK: C00021799; NIKKAJI: J137.919D,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573644,4000,cpd:C01860,Trichodiene,C15H24,Trichodiene,R02306 R03740,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.6,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010318 Trichothecane sesquiterpenoids;      C01860  Trichodiene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C01860  Trichodiene,CAS: 28624-60-4; PubChem: 4975; ChEBI: 15861; LIPIDMAPS: LMPR0103180001; KNApSAcK: C00012601; 3DMET: B01510; NIKKAJI: J17.359B,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573645,4001,cpd:C02004,Aristolochene;,C15H24,Aristolochene; (+)-Aristolochene,R02307 R03798,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.3.9,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010327 Aristolane sesquiterpenoids;      C02004  Aristolochene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C02004  Aristolochene,CAS: 123408-96-8; PubChem: 5100; ChEBI: 18027 43445; LIPIDMAPS: LMPR0103270003; KNApSAcK: C00036300; PDB-CCD: ION; 3DMET: B01524; NIKKAJI: J790.281F,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573646,4002,cpd:C03220,"(2Z,6E)-Farnesol;",C15H26O,"(2Z,6E)-Farnesol; 2-cis,6-trans-Farnesol",R03265,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,5.2.1.9,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010301 Acyclic farnesane sesquiterpenoids;      C03220  2-cis,6-trans-Farnesol; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Farnesenes;     C03220  2-cis,6-trans-Farnesol",CAS: 3790-71-4; PubChem: 6093; ChEBI: 16774; LIPIDMAPS: LMPR0103010013; 3DMET: B00563; NIKKAJI: J133.568E,cpd:C01126; cpd:C03220; cpd:C09621; cpd:C09628; cpd:C09631; cpd:C09651; cpd:C09663; cpd:C09664; cpd:C09676; cpd:C09682; cpd:C09698; cpd:C09704; cpd:C09705; cpd:C10771; cpd:C10780; cpd:C16143; cpd:C16813; cpd:C16970; cpd:C17124; cpd:C17193; cpd:C18245; cpd:C19743; cpd:C19744; cpd:C19746; cpd:C19755; cpd:C19756; cpd:C19893; cpd:C19974; cpd:C20172; cpd:C20181; cpd:C20184; cpd:C20479; cpd:C20576,15,26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O1,C15H25O1,222.1983655,223.2061905,221.19054043647,4003,cpd:C06079,PR-toxin;,C17H20O6,PR-toxin; PR Toxin,R03798,Sesquiterpenoid and triterpenoid biosynthesis,NA,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Others;     C06079  PR-toxin,CAS: 56299-00-4; PubChem: 8345; ChEBI: 7883; KNApSAcK: C00003176; 3DMET: B01964; NIKKAJI: J86.060C,cpd:C00255; cpd:C06079; cpd:C07177; cpd:C09298; cpd:C09373; cpd:C20380; cpd:C21422,17,20,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H21O6,C17H19O6,320.1259884,321.1338134,319.11816333648,4004,cpd:C06080,Nivalenol,C15H20O7,Nivalenol,R03740,Sesquiterpenoid and triterpenoid biosynthesis,NA,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C06080  Nivalenol; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Trichothecenes;     C06080  Nivalenol,CAS: 23282-20-4; PubChem: 8346; ChEBI: 7599; KNApSAcK: C00003167; 3DMET: B01965; NIKKAJI: J54.417E,cpd:C05855; cpd:C06080; cpd:C12076,15,20,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O7,C15H19O7,312.120903,313.128728,311.11307793649,4005,cpd:C06083,Tetrahymanol,C30H52O,Tetrahymanol,R02875,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.1.123,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010621 Arborinane and stictane triterpenoids;      C06083  Tetrahymanol; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Hopanes;     C06083  Tetrahymanol,CAS: 2130-17-8; PubChem: 8349; ChEBI: 9493; ChEMBL: CHEMBL485801; LIPIDMAPS: LMPR0106210001; 3DMET: B01966; NIKKAJI: J14.985C,cpd:C05109; cpd:C06083; cpd:C06309; cpd:C17123,30,52,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H53O1,C30H51O1,428.4018163,429.4096413,427.39399133650,4006,cpd:C06309,Diplopterol;,C30H52O,Diplopterol; 22-Hopanol; Hopan-22-ol,R07323,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.1.129,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR04 Hopanoids;    C06309  Hopan-22-ol,CAS: 1721-59-1; PubChem: 8545; ChEBI: 36484; ChEMBL: CHEMBL1992196; LIPIDMAPS: LMPR04000002; 3DMET: B02005; NIKKAJI: J7.814J,cpd:C05109; cpd:C06083; cpd:C06309; cpd:C17123,30,52,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H53O1,C30H51O1,428.4018163,429.4096413,427.39399133651,4007,cpd:C06310,Diploptene;,C30H50,Diploptene; 22(29)-Hopene; Hop-22(29)-ene,R07322 R11112,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.17,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR04 Hopanoids;    C06310  Hop-22(29)-ene,CAS: 1615-91-4; PubChem: 8546; ChEBI: 4648; ChEMBL: CHEMBL455613; 3DMET: B02006; NIKKAJI: J7.532I,cpd:C00751; cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C03685; cpd:C04930; cpd:C04934; cpd:C06310; cpd:C08615; cpd:C08616; cpd:C08618; cpd:C08622; cpd:C08624; cpd:C08625; cpd:C08626; cpd:C08628; cpd:C08634; cpd:C08636; cpd:C08637; cpd:C08789; cpd:C08931; cpd:C08980; cpd:C11523; cpd:C15274; cpd:C16783; cpd:C16958; cpd:C16973; cpd:C17419; cpd:C17421; cpd:C17459; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19732; cpd:C19733; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19834; cpd:C19835; cpd:C19918; cpd:C19942; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C20432; cpd:C20945; cpd:C21116,30,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51,C30H49,410.3912516,411.3990766,409.38342663652,4008,cpd:C06394,delta-Cadinene;,C15H24,delta-Cadinene; (+)-delta-Cadinene,R02311 R08371,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.3.13,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010333 Cadinane sesquiterpenoids;      C06394  (+)-delta-Cadinene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Cadinanes;     C06394  delta-Cadinene,CAS: 483-76-1; PubChem: 8630; ChEBI: 15385; ChEMBL: CHEMBL445759; LIPIDMAPS: LMPR0103330001; KNApSAcK: C00007636; 3DMET: B02012; NIKKAJI: J12.841D,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573653,4009,cpd:C07667,Gossypol,C30H30O8,Gossypol,R08371,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010333 Cadinane sesquiterpenoids;      C07667  Gossypol; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Cadinanes;     C07667  Gossypol,CAS: 303-45-7; PubChem: 9869; ChEBI: 28584; ChEMBL: CHEMBL51483; LIPIDMAPS: LMPR0103330002; KNApSAcK: C00003136 C00038078 C00038103; 3DMET: B02137; NIKKAJI: J21.393D,cpd:C07667,30,30,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H31O8,C30H29O8,518.1940679,519.201893,517.18624293654,4010,cpd:C08615,alpha-Amyrin,C30H50O,alpha-Amyrin,R06471,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.40,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010617 Pachysanane triterpenoids;      C08615  alpha-Amyrin; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Ursanes;     C08615  alpha-Amyrin,CAS: 638-95-9; PubChem: 10808; ChEBI: 10213; ChEMBL: CHEMBL455357; LIPIDMAPS: LMPR0106170001; LipidBank: SST0135 SST9141; KNApSAcK: C00003737; 3DMET: B02269; NIKKAJI: J6.928K,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123655,4011,cpd:C08616,beta-Amyrin;,C30H50O,beta-Amyrin; beta-Amyrenol,R06469 R06501 R09604 R09815 R09817 R10921 R10924,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,1.14.13.134; 1.14.13.201; 1.14.99.43; 5.4.99.39,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010614 Lupane triterpenoids;      C08616  beta-Amyrin; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Oleananes;     C08616  beta-Amyrin,CAS: 559-70-6; PubChem: 10809; ChEBI: 10352; ChEMBL: CHEMBL455098; LIPIDMAPS: LMPR0106150015; LipidBank: SST0136 SST9145; KNApSAcK: C00003738; 3DMET: B02270; NIKKAJI: J6.490D,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123656,4012,cpd:C08628,Lupeol,C30H50O,Lupeol,R06466,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,5.4.99.41,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010613 Baccharane triterpenoids;      C08628  Lupeol; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Lupanes;     C08628  Lupeol,CAS: 545-47-1; PubChem: 10821; ChEBI: 6570; ChEMBL: CHEMBL289191; LIPIDMAPS: LMPR0106130001; KNApSAcK: C00003749; 3DMET: B02281; NIKKAJI: J6.423H,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123657,4013,cpd:C08637,Taraxerol,C30H50O,Taraxerol,R09476,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,5.4.99.35,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010616 Taraxerane, multiflorane, glutinane and friedelane triterpenoids;      C08637  Taraxerol; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Dammarenes;     C08637  Taraxerol",CAS: 127-22-0; PubChem: 10830; ChEBI: 9402; ChEMBL: CHEMBL511822; KNApSAcK: C00003758; 3DMET: B02290; NIKKAJI: J108.005I,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123658,4014,cpd:C09382,Costunolide;,C15H20O2,Costunolide; (+)-Costunolide,R09575,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.120,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C09382  Costunolide,CAS: 553-21-9; PubChem: 11573; ChEBI: 3900; KNApSAcK: C00003240; 3DMET: B02916; NIKKAJI: J22.569J,cpd:C09289; cpd:C09382; cpd:C09383; cpd:C09384; cpd:C09408; cpd:C09454; cpd:C09466; cpd:C09484; cpd:C09692; cpd:C09710; cpd:C10755; cpd:C17488; cpd:C17884; cpd:C17886; cpd:C20519,15,20,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O2,C15H19O2,232.1463299,233.1541549,231.13850493659,4015,cpd:C09627,Capsidiol,C15H24O2,Capsidiol,R09573,Sesquiterpenoid and triterpenoid biosynthesis,1.14.13.119,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010325 Eremophilane sesquiterpenoids;      C09627  Capsidiol; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C09627  Capsidiol,CAS: 37208-05-2; PubChem: 11817; ChEBI: 28283; LIPIDMAPS: LMPR0103250002; KNApSAcK: C00003108; 3DMET: B03142; NIKKAJI: J39.968J,cpd:C02293; cpd:C02621; cpd:C07526; cpd:C09627; cpd:C09678; cpd:C09681; cpd:C09700; cpd:C09733; cpd:C10749; cpd:C10769; cpd:C10776; cpd:C16502; cpd:C16946; cpd:C17069; cpd:C17493; cpd:C17604; cpd:C20233,15,24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O2,C15H23O2,236.17763,237.185455,235.1698053660,4016,cpd:C09629,beta-Caryophyllene;,C15H24,beta-Caryophyllene; Caryophyllene; (-)-beta-Caryophyllene,R08541,Sesquiterpenoid and triterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.3.57,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010312 Caryophyllane sesquiterpenoids;      C09629  beta-Caryophyllene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Humulenes;     C09629  beta-Caryophyllene,CAS: 87-44-5; PubChem: 11819; ChEBI: 10357; ChEMBL: CHEMBL445740; LIPIDMAPS: LMPR0103120001; KNApSAcK: C00003110; 3DMET: B03144; NIKKAJI: J3.212C,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573661,4017,cpd:C09665,alpha-Farnesene;,C15H24,"alpha-Farnesene; (3E,6E)-alpha-Farnesene",R08696,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.46,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Farnesenes;     C09665  alpha-Farnesene,CAS: 502-61-4; PubChem: 11855; ChEBI: 10280; KNApSAcK: C00003130; 3DMET: B03178; NIKKAJI: J47.112G,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573662,4018,cpd:C09666,beta-Farnesene;,C15H24,beta-Farnesene; (E)-beta-Farnesene,R08695,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.47,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Farnesenes;     C09666  beta-Farnesene,CAS: 18794-84-8; PubChem: 11856; ChEBI: 10418; LIPIDMAPS: LMFA11000040; KNApSAcK: C00003131; 3DMET: B03179; NIKKAJI: J10.900B,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573663,4019,cpd:C09672,Germacrene B;,C15H24,"Germacrene B; (E,E)-Germacrene B; (E,E)-1,5-Dimethyl-8-(1-methylethylidene)-1,5-cyclodecadiene",R08545,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.71,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010309 Germacrane sesquiterpenoids;      C09672  Germacrene B; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C09672  Germacrene B,CAS: 15423-57-1; PubChem: 11862; ChEBI: 5337; ChEMBL: CHEMBL448125; LIPIDMAPS: LMPR0103090007; KNApSAcK: C00003134; 3DMET: B03184; NIKKAJI: J16.137C,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573664,4020,cpd:C09684,Humulene;,C15H24,Humulene; alpha-Humulene,R08373 R09934,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of terpenoids and steroids,1.14.13.150; 4.2.3.104,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010311 Humulane sesquiterpenoids;      C09684  Humulene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Humulenes;     C09684  Humulene,CAS: 6753-98-6; PubChem: 11874; ChEBI: 5768; ChEMBL: CHEMBL251280; LIPIDMAPS: LMPR0103110001; KNApSAcK: C00003147; 3DMET: B03192; NIKKAJI: J8.436K,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573665,4021,cpd:C09699,Longifolene,C15H24,Longifolene,R08542,Sesquiterpenoid and triterpenoid biosynthesis; Metabolic pathways,4.2.3.58,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010350 Longifolane sesquiterpenoids;      C09699  Longifolene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Humulenes;     C09699  Longifolene,CAS: 475-20-7; PubChem: 11889; ChEBI: 6530; KNApSAcK: C00003162; 3DMET: B05373; NIKKAJI: J12.093F,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573666,4022,cpd:C09704,Nerolidol;,C15H26O,"Nerolidol; (3S,6E)-Nerolidol",R08374,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways,4.2.3.48,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010301 Acyclic farnesane sesquiterpenoids;      C09704  Nerolidol; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Farnesenes;     C09704  Nerolidol; Major components of natural products [BR:br08323];  Crude drugs;   Loquat leaf;    C09704  Nerolidol,CAS: 7212-44-4; PubChem: 11893; ChEBI: 59958; ChEMBL: CHEMBL1923157; LIPIDMAPS: LMPR0103010005; KNApSAcK: C00003166; 3DMET: B03209; NIKKAJI: J8.909E,cpd:C01126; cpd:C03220; cpd:C09621; cpd:C09628; cpd:C09631; cpd:C09651; cpd:C09663; cpd:C09664; cpd:C09676; cpd:C09682; cpd:C09698; cpd:C09704; cpd:C09705; cpd:C10771; cpd:C10780; cpd:C16143; cpd:C16813; cpd:C16970; cpd:C17124; cpd:C17193; cpd:C18245; cpd:C19743; cpd:C19744; cpd:C19746; cpd:C19755; cpd:C19756; cpd:C19893; cpd:C19974; cpd:C20172; cpd:C20181; cpd:C20184; cpd:C20479; cpd:C20576,15,26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O1,C15H25O1,222.1983655,223.2061905,221.19054043667,4023,cpd:C09723,beta-Selinene,C15H24,beta-Selinene,R08546,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.66,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010319 Eudesmane sesquiterpenoids;      C09723  beta-Selinene;     PR010388 Gymnomitrane sesquiterpenoids;      C09723  beta-Selinene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C09723  beta-Selinene,CAS: 17066-67-0; PubChem: 11911; ChEBI: 10443; LIPIDMAPS: LMPR0103190014; KNApSAcK: C00003186; 3DMET: B03222; NIKKAJI: J13.951C,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573668,4024,cpd:C09737,Solavetivone,C15H22O,Solavetivone,R09577 R10073,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.121,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010365 Spirovetivane sesquiterpenoids;      C09737  Solavetivone; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C09737  Solavetivone,CAS: 54878-25-0; PubChem: 11925; ChEBI: 9192; ChEMBL: CHEMBL465907; KNApSAcK: C00003191; 3DMET: B03236,cpd:C07528; cpd:C09729; cpd:C09730; cpd:C09737; cpd:C09744; cpd:C09745; cpd:C09938; cpd:C10764; cpd:C10775; cpd:C14568; cpd:C16779; cpd:C16966; cpd:C17090; cpd:C17117; cpd:C17118; cpd:C17184; cpd:C17494; cpd:C17501; cpd:C17914; cpd:C17954; cpd:C19677; cpd:C19939; cpd:C20262; cpd:C20308,15,22,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O1,C15H21O1,218.1670653,219.1748904,217.15924033669,4025,cpd:C12142,Vetispiradiene;,C15H24,Vetispiradiene; (-)-Vetispiradiene; (-)-Premnaspirodiene,R06523 R09576 R10073,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,1.14.13.121; 4.2.3.21,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010365 Spirovetivane sesquiterpenoids;      C12142  Vetispiradiene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C12142  Vetispiradiene,PubChem: 14289; ChEBI: 46971; LIPIDMAPS: LMPR0103650003; KNApSAcK: C00040067; PDB-CCD: 6BW; 3DMET: B04436; NIKKAJI: J960.798F,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573670,4026,cpd:C16028,"Amorpha-4,11-diene",C15H24,"Amorpha-4,11-diene",R07630 R10023 R10026,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.14.13.158; 4.2.3.24,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010333 Cadinane sesquiterpenoids;      C16028  Amorpha-4,11-diene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C16028  Amorpha-4,11-diene",PubChem: 47205338; ChEBI: 52026; LIPIDMAPS: LMPR0103330005; KNApSAcK: C00017520 C00034408; NIKKAJI: J1.220.953C,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573671,4027,cpd:C16141,(+)-Germacrene A;,C15H24,(+)-Germacrene A; (+)-(R)-Germacrene A,R07649 R09549,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,1.14.13.123; 4.2.3.23,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010309 Germacrane sesquiterpenoids;      C16141  (+)-Germacrene A; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C16141  (+)-Germacrene A,CAS: 28028-64-0; PubChem: 47205451; ChEBI: 41595; KNApSAcK: C00036308; NIKKAJI: J1.049.582B,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573672,4028,cpd:C16142,(-)-Germacrene D,C15H24,(-)-Germacrene D,R07648,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.75,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010309 Germacrane sesquiterpenoids;      C16142  (-)-Germacrene D; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C16142  (-)-Germacrene D,PubChem: 47205452; ChEBI: 49044; KNApSAcK: C00011720; NIKKAJI: J17.213H,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573673,4029,cpd:C16143,"(1E,4S,5E,7R)-Germacra-1(10),5-dien-11-ol;",C15H26O,"(1E,4S,5E,7R)-Germacra-1(10),5-dien-11-ol; Germacradienol",R07647 R09487,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,4.1.99.16; 4.2.3.22,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010309 Germacrane sesquiterpenoids;      C16143  (1E,4S,5E,7R)-Germacra-1(10),5-dien-11-ol; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C16143  Germacradienol",PubChem: 47205453; ChEBI: 80351; NIKKAJI: J2.561.677D,cpd:C01126; cpd:C03220; cpd:C09621; cpd:C09628; cpd:C09631; cpd:C09651; cpd:C09663; cpd:C09664; cpd:C09676; cpd:C09682; cpd:C09698; cpd:C09704; cpd:C09705; cpd:C10771; cpd:C10780; cpd:C16143; cpd:C16813; cpd:C16970; cpd:C17124; cpd:C17193; cpd:C18245; cpd:C19743; cpd:C19744; cpd:C19746; cpd:C19755; cpd:C19756; cpd:C19893; cpd:C19974; cpd:C20172; cpd:C20181; cpd:C20184; cpd:C20479; cpd:C20576,15,26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O1,C15H25O1,222.1983655,223.2061905,221.19054043674,4030,cpd:C16269,(+)-epi-Isozizaene,C15H24,(+)-epi-Isozizaene,R07830 R08851 R08853 R10072,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.14.13.106; 4.2.3.37,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010370 Zizaane and prezizaane sesquiterpenoids;      C16269  (+)-epi-Isozizaene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C16269  (+)-epi-Isozizaene,PubChem: 47205577; ChEBI: 51458; PDB-CCD: EL3; NIKKAJI: J2.799.299D,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573675,4031,cpd:C16286,Geosmin;,C12H22O,"Geosmin; (-)-Geosmin; trans-1,10-Dimethyl-trans-9-decalol",R08543 R09487,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.1.99.16; 4.2.3.22,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010309 Germacrane sesquiterpenoids;      C16286  Geosmin; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C16286  Geosmin,CAS: 19700-21-1; PubChem: 47205594; ChEBI: 46702; ChEMBL: CHEMBL1397502; KNApSAcK: C00013224; NIKKAJI: J3.785K,cpd:C16286,12,22,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O1,C12H21O1,182.1670653,183.1748904,181.15924033676,4032,cpd:C16814,gamma-Bisabolene;,C15H24,gamma-Bisabolene; (Z)-gamma-Bisabolene,R09620,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.40,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010306 Bisabolane sesquiterpenoids;      C16814  gamma-Bisabolene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C16814  gamma-Bisabolene,CAS: 495-62-5; PubChem: 96023338; ChEBI: 49238; KNApSAcK: C00035441 C00048335; NIKKAJI: J37.988C,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573677,4033,cpd:C16829,gamma-Humulene,C15H24,gamma-Humulene,R08540,Sesquiterpenoid and triterpenoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.3.56,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010311 Humulane sesquiterpenoids;      C16829  gamma-Humulene; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Humulenes;     C16829  gamma-Humulene,PubChem: 96023353; ChEBI: 49292; NIKKAJI: J17.061E,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573678,4034,cpd:C17277,(+)-Valencene,C15H24,(+)-Valencene,R08691,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.73,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C17277  (+)-Valencene,CAS: 4630-07-3; PubChem: 96023682; ChEBI: 61700; KNApSAcK: C00034741; NIKKAJI: J12.786H,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573679,4035,cpd:C17953,(5S)-Albaflavenol,C15H24O,(5S)-Albaflavenol,R08851 R08852,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of antibiotics,1.14.13.106,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010370 Zizaane and prezizaane sesquiterpenoids;      C17953  (5S)-Albaflavenol; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C17953  (5S)-Albaflavenol,PubChem: 96024174; ChEBI: 51480; NIKKAJI: J2.799.619A,cpd:C03461; cpd:C09719; cpd:C09720; cpd:C10752; cpd:C10772; cpd:C10774; cpd:C14550; cpd:C14693; cpd:C16908; cpd:C16945; cpd:C16974; cpd:C17442; cpd:C17462; cpd:C17915; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19676; cpd:C19711; cpd:C19938; cpd:C20229; cpd:C20307; cpd:C20325,15,24,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O1,C15H23O1,220.1827154,221.1905404,219.17489043680,4036,cpd:C17954,Albaflavenone,C15H22O,Albaflavenone,R08852 R08854 R10072,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of antibiotics,1.14.13.106,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010370 Zizaane and prezizaane sesquiterpenoids;      C17954  Albaflavenone; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C17954  Albaflavenone,PubChem: 96024175; ChEBI: 51460; KNApSAcK: C00016952; NIKKAJI: J577.415B,cpd:C07528; cpd:C09729; cpd:C09730; cpd:C09737; cpd:C09744; cpd:C09745; cpd:C09938; cpd:C10764; cpd:C10775; cpd:C14568; cpd:C16779; cpd:C16966; cpd:C17090; cpd:C17117; cpd:C17118; cpd:C17184; cpd:C17494; cpd:C17501; cpd:C17914; cpd:C17954; cpd:C19677; cpd:C19939; cpd:C20262; cpd:C20308,15,22,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O1,C15H21O1,218.1670653,219.1748904,217.15924033681,4037,cpd:C17955,(5R)-Albaflavenol,C15H24O,(5R)-Albaflavenol,R08853 R08854,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of antibiotics,1.14.13.106,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010370 Zizaane and prezizaane sesquiterpenoids;      C17955  (5R)-Albaflavenol; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C17955  (5R)-Albaflavenol,PubChem: 96024176; ChEBI: 51479; NIKKAJI: J2.799.619A,cpd:C03461; cpd:C09719; cpd:C09720; cpd:C10752; cpd:C10772; cpd:C10774; cpd:C14550; cpd:C14693; cpd:C16908; cpd:C16945; cpd:C16974; cpd:C17442; cpd:C17462; cpd:C17915; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19676; cpd:C19711; cpd:C19938; cpd:C20229; cpd:C20307; cpd:C20325,15,24,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O1,C15H23O1,220.1827154,221.1905404,219.17489043682,4038,cpd:C18245,8-epi-Cedrol,C15H26O,8-epi-Cedrol,R09140,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.39,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C18245  8-epi-Cedrol,PubChem: 103061427; ChEBI: 81598,cpd:C01126; cpd:C03220; cpd:C09621; cpd:C09628; cpd:C09631; cpd:C09651; cpd:C09663; cpd:C09664; cpd:C09676; cpd:C09682; cpd:C09698; cpd:C09704; cpd:C09705; cpd:C10771; cpd:C10780; cpd:C16143; cpd:C16813; cpd:C16970; cpd:C17124; cpd:C17193; cpd:C18245; cpd:C19743; cpd:C19744; cpd:C19746; cpd:C19755; cpd:C19756; cpd:C19893; cpd:C19974; cpd:C20172; cpd:C20181; cpd:C20184; cpd:C20479; cpd:C20576,15,26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O1,C15H25O1,222.1983655,223.2061905,221.19054043683,4039,cpd:C19676,"Germacra-1(10),4,11(13)-trien-12-ol",C15H24O,"Germacra-1(10),4,11(13)-trien-12-ol",R09546 R09548 R09549,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.314; 1.14.13.123,NA,"Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C19676  Germacra-1(10),4,11(13)-trien-12-ol",PubChem: 135626144,cpd:C03461; cpd:C09719; cpd:C09720; cpd:C10752; cpd:C10772; cpd:C10774; cpd:C14550; cpd:C14693; cpd:C16908; cpd:C16945; cpd:C16974; cpd:C17442; cpd:C17462; cpd:C17915; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19676; cpd:C19711; cpd:C19938; cpd:C20229; cpd:C20307; cpd:C20325,15,24,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O1,C15H23O1,220.1827154,221.1905404,219.17489043684,4040,cpd:C19678,Germacrene A acid;,C15H22O2,"Germacrene A acid; Germacra-1(10),4,11(13)-trien-12-oate",R09547 R09548 R09575,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.314; 1.14.13.120,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C19678  Germacrene A acid,PubChem: 135626146; KNApSAcK: C00037175,cpd:C09350; cpd:C09376; cpd:C09399; cpd:C09409; cpd:C09677; cpd:C09686; cpd:C09712; cpd:C09721; cpd:C09739; cpd:C09743; cpd:C10754; cpd:C10953; cpd:C16942; cpd:C16949; cpd:C17489; cpd:C17491; cpd:C17492; cpd:C17504; cpd:C17609; cpd:C19050; cpd:C19678; cpd:C20309; cpd:C20404,15,22,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O2,C15H21O2,234.1619799,235.169805,233.15415493685,4041,cpd:C19708,5-Epiaristolochene;,C15H24,5-Epiaristolochene; (+)-5-Epiaristolochene; 5-epi-Aristolochene; (+)-5-epi-Aristolochene,R09573 R09574,Sesquiterpenoid and triterpenoid biosynthesis,1.14.13.119; 4.2.3.61,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C19708  5-Epiaristolochene,PubChem: 135626176; KNApSAcK: C00029559,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573686,4042,cpd:C19711,Solavetivol,C15H24O,Solavetivol,R09576 R09577,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.121,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C19711  Solavetivol,PubChem: 135626179,cpd:C03461; cpd:C09719; cpd:C09720; cpd:C10752; cpd:C10772; cpd:C10774; cpd:C14550; cpd:C14693; cpd:C16908; cpd:C16945; cpd:C16974; cpd:C17442; cpd:C17462; cpd:C17915; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19676; cpd:C19711; cpd:C19938; cpd:C20229; cpd:C20307; cpd:C20325,15,24,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O1,C15H23O1,220.1827154,221.1905404,219.17489043687,4043,cpd:C19732,24-Hydroxy-beta-amyrin;,C30H50O2,"24-Hydroxy-beta-amyrin; Olean-12-ene-3beta,24-diol",R09604,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.99.43,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Oleananes;     C19732  24-Hydroxy-beta-amyrin,PubChem: 135626199; ChEMBL: CHEMBL353837 CHEMBL489551,cpd:C08618; cpd:C08622; cpd:C15274; cpd:C19732; cpd:C19733; cpd:C19942; cpd:C20945,30,50,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O2,C30H49O2,442.3810809,443.3889059,441.37325583688,4044,cpd:C19736,(+)-alpha-Santalene,C15H24,(+)-alpha-Santalene,R09608 R10733,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.50; 4.2.3.82,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C19736  (+)-alpha-Santalene,CAS: 512-61-8; PubChem: 135626203; KNApSAcK: C00021850,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573689,4045,cpd:C19740,(+)-alpha-Barbatene,C15H24,(+)-alpha-Barbatene,R09614,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.69,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Others;     C19740  (+)-alpha-Barbatene,PubChem: 135626207; KNApSAcK: C00007243,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573690,4046,cpd:C19742,(+)-delta-Selinene,C15H24,(+)-delta-Selinene,R09616,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.76,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C19742  (+)-delta-Selinene,PubChem: 135626209; KNApSAcK: C00007634,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573691,4047,cpd:C19746,"(3R,6E)-Nerolidol",C15H26O,"(3R,6E)-Nerolidol",R09618,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.49,NA,"Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Farnesenes;     C19746  (3R,6E)-Nerolidol",CAS: 7212-44-4; PubChem: 135626213; KNApSAcK: C00029339; PDB-CCD: 28U,cpd:C01126; cpd:C03220; cpd:C09621; cpd:C09628; cpd:C09631; cpd:C09651; cpd:C09663; cpd:C09664; cpd:C09676; cpd:C09682; cpd:C09698; cpd:C09704; cpd:C09705; cpd:C10771; cpd:C10780; cpd:C16143; cpd:C16813; cpd:C16970; cpd:C17124; cpd:C17193; cpd:C18245; cpd:C19743; cpd:C19744; cpd:C19746; cpd:C19755; cpd:C19756; cpd:C19893; cpd:C19974; cpd:C20172; cpd:C20181; cpd:C20184; cpd:C20479; cpd:C20576,15,26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O1,C15H25O1,222.1983655,223.2061905,221.19054043692,4048,cpd:C19747,Germacrene C,C15H24,Germacrene C,R09624,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.60,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Germacrenes;     C19747  Germacrene C,PubChem: 135626214; KNApSAcK: C00011717,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573693,4049,cpd:C19748,(E)-gamma-Bisabolene,C15H24,(E)-gamma-Bisabolene,R09619,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.59,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C19748  (E)-gamma-Bisabolene,PubChem: 135626215; KNApSAcK: C00011631,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573694,4050,cpd:C19749,(E)-alpha-Bisabolene,C15H24,(E)-alpha-Bisabolene,R08370,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.3.38,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C19749  (E)-alpha-Bisabolene,PubChem: 135626216; KNApSAcK: C00007632 C00050259,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573695,4051,cpd:C19751,(S)-beta-Bisabolene,C15H24,(S)-beta-Bisabolene,R09623 R09625,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.55; 5.5.1.17,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C19751  (S)-beta-Bisabolene,PubChem: 135626218; ChEMBL: CHEMBL1077088; KNApSAcK: C00007242,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573696,4052,cpd:C19752,(S)-beta-Macrocarpene,C15H24,(S)-beta-Macrocarpene,R09625,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,5.5.1.17,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C19752  (S)-beta-Macrocarpene,PubChem: 135626219,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573697,4053,cpd:C19753,"cis-Muurola-3,5-diene",C15H24,"cis-Muurola-3,5-diene",R09626,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.67,NA,"Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Cadinanes;     C19753  cis-Muurola-3,5-diene",PubChem: 135626220,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573698,4054,cpd:C19755,Patchoulol,C15H26O,Patchoulol,R09629,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.70,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C19755  Patchoulol,PubChem: 135626222; KNApSAcK: C00003168,cpd:C01126; cpd:C03220; cpd:C09621; cpd:C09628; cpd:C09631; cpd:C09651; cpd:C09663; cpd:C09664; cpd:C09676; cpd:C09682; cpd:C09698; cpd:C09704; cpd:C09705; cpd:C10771; cpd:C10780; cpd:C16143; cpd:C16813; cpd:C16970; cpd:C17124; cpd:C17193; cpd:C18245; cpd:C19743; cpd:C19744; cpd:C19746; cpd:C19755; cpd:C19756; cpd:C19893; cpd:C19974; cpd:C20172; cpd:C20181; cpd:C20184; cpd:C20479; cpd:C20576,15,26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O1,C15H25O1,222.1983655,223.2061905,221.19054043699,4055,cpd:C19801,Isomultiflorenol,C30H50O,Isomultiflorenol,R09711,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.36,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Dammarenes;     C19801  Isomultiflorenol,PubChem: 135626268,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123700,4056,cpd:C19819,Cucurbitadienol,C30H50O,Cucurbitadienol,R09688,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,5.4.99.33,NA,NA,PubChem: 135626286; ChEMBL: CHEMBL497823,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123701,4057,cpd:C19820,Protostadienol;,C30H50O,"Protostadienol; (17Z)-Protosta-17(20),24-dien-3beta-ol",R09689,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.32,NA,NA,PubChem: 135626287,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123702,4058,cpd:C19828,Arabidiol;,C30H52O2,"Arabidiol; (13R,14R,17E)-Malabarica-17,21-diene-3beta,14-diol",R09700,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,4.2.1.124,NA,NA,PubChem: 135626295,cpd:C08621; cpd:C19828; cpd:C19829; cpd:C19863,30,52,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H53O2,C30H51O2,444.3967309,445.4045559,443.38890593703,4059,cpd:C19829,Dammarenediol II;,C30H52O2,"Dammarenediol II; (20S)-Dammar-24-ene-3beta,20-diol; Dammar-24-ene-3beta,20-diol",R09701 R10540,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.183; 4.2.1.125,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Dammarenes;     C19829  Dammarenediol II,CAS: 14351-29-2; PubChem: 135626296; ChEMBL: CHEMBL478945; KNApSAcK: C00038920,cpd:C08621; cpd:C19828; cpd:C19829; cpd:C19863,30,52,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H53O2,C30H51O2,444.3967309,445.4045559,443.38890593704,4060,cpd:C19832,Thalianol,C30H50O,Thalianol,R09709,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,5.4.99.31,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Others;     C19832  Thalianol,PubChem: 135626299,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123705,4061,cpd:C19833,Germanicol;,C30H50O,Germanicol; (3beta)-Olean-18-en-3-ol,R09710,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.34,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Dammarenes;     C19833  Germanicol,CAS: 465-02-1; PubChem: 135626300; KNApSAcK: C00037176,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123706,4062,cpd:C19834,"Dammara-20,24-diene;",C30H50,"Dammara-20,24-diene; Dammara-18(28),21-diene",R09712,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.37,NA,"Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Dammarenes;     C19834  Dammara-20,24-diene",PubChem: 135626301,cpd:C00751; cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C03685; cpd:C04930; cpd:C04934; cpd:C06310; cpd:C08615; cpd:C08616; cpd:C08618; cpd:C08622; cpd:C08624; cpd:C08625; cpd:C08626; cpd:C08628; cpd:C08634; cpd:C08636; cpd:C08637; cpd:C08789; cpd:C08931; cpd:C08980; cpd:C11523; cpd:C15274; cpd:C16783; cpd:C16958; cpd:C16973; cpd:C17419; cpd:C17421; cpd:C17459; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19732; cpd:C19733; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19834; cpd:C19835; cpd:C19918; cpd:C19942; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C20432; cpd:C20945; cpd:C21116,30,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51,C30H49,410.3912516,411.3990766,409.38342663707,4063,cpd:C19835,Camelliol C,C30H50O,Camelliol C,R09713,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.38,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Liner triterpenes;     C19835  Camelliol C,PubChem: 135626302; ChEMBL: CHEMBL463552; KNApSAcK: C00045251 C00049365,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123708,4064,cpd:C19863,"Lupan-3beta,20-diol;",C30H52O2,"Lupan-3beta,20-diol; 3beta,20-Dihydroxylupane; Monogynol A",R09743,Sesquiterpenoid and triterpenoid biosynthesis,4.2.1.128,NA,"Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Lupanes;     C19863  Lupan-3beta,20-diol",PubChem: 135626330; ChEMBL: CHEMBL2004530,cpd:C08621; cpd:C19828; cpd:C19829; cpd:C19863,30,52,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H53O2,C30H51O2,444.3967309,445.4045559,443.38890593709,4065,cpd:C19908,(+)-beta-Chamigrene,C15H24,(+)-beta-Chamigrene,R10598,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.78,NA,NA,PubChem: 135626374,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573710,4066,cpd:C19918,Parkeol;,C30H50O,Parkeol; Lanost-9(11)-en-3beta-ol,R09907,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.47,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Dammarenes;     C19918  Parkeol,CAS: 514-45-4; PubChem: 135626384; KNApSAcK: C00023785,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123711,4067,cpd:C19939,Pentalen-13-al,C15H22O,Pentalen-13-al,R09813 R09814 R11315,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of antibiotics,1.14.13.133,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Humulenes;     C19939  Pentalen-13-al,PubChem: 135626405,cpd:C07528; cpd:C09729; cpd:C09730; cpd:C09737; cpd:C09744; cpd:C09745; cpd:C09938; cpd:C10764; cpd:C10775; cpd:C14568; cpd:C16779; cpd:C16966; cpd:C17090; cpd:C17117; cpd:C17118; cpd:C17184; cpd:C17494; cpd:C17501; cpd:C17914; cpd:C17954; cpd:C19677; cpd:C19939; cpd:C20262; cpd:C20308,15,22,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O1,C15H21O1,218.1670653,219.1748904,217.15924033712,4068,cpd:C19973,(+)-beta-Caryophyllene,C15H24,(+)-beta-Caryophyllene,R09835 R09889,Sesquiterpenoid and triterpenoid biosynthesis,4.2.1.138; 4.2.3.89,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Humulenes;     C19973  (+)-beta-Caryophyllene,CAS: 10579-93-8; PubChem: 135626439; KNApSAcK: C00044032,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573713,4069,cpd:C19974,(+)-Caryolan-1-ol,C15H26O,(+)-Caryolan-1-ol,R09835,Sesquiterpenoid and triterpenoid biosynthesis,4.2.1.138,NA,NA,PubChem: 135626440,cpd:C01126; cpd:C03220; cpd:C09621; cpd:C09628; cpd:C09631; cpd:C09651; cpd:C09663; cpd:C09664; cpd:C09676; cpd:C09682; cpd:C09698; cpd:C09704; cpd:C09705; cpd:C10771; cpd:C10780; cpd:C16143; cpd:C16813; cpd:C16970; cpd:C17124; cpd:C17193; cpd:C18245; cpd:C19743; cpd:C19744; cpd:C19746; cpd:C19755; cpd:C19756; cpd:C19893; cpd:C19974; cpd:C20172; cpd:C20181; cpd:C20184; cpd:C20479; cpd:C20576,15,26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O1,C15H25O1,222.1983655,223.2061905,221.19054043714,4070,cpd:C20159,7-epi-alpha-Selinene;,C15H24,"7-epi-alpha-Selinene; (-)-7-epi-alpha-Selinene; (2S,4aR,8aR)-4a,8-Dimethyl-2-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene",R09886,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.86,NA,NA,PubChem: 163311902,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573715,4071,cpd:C20163,5-epi-alpha-Selinene;,C15H24,"5-epi-alpha-Selinene; 5beta-Eudesma-3,11-diene; (2R,4aR,8aS)-1,2,3,4,4a,5,6,8a-Octahydro-4a,8-dimethyl-2-(prop-1-en-2-yl)naphthalene; 8a-epi-alpha-Selinene; (2R,4aR,8aS)-1,2,3,4,4a,5,6,8a-Octahydro-4a,8-dimethyl-2-(1-methylethenyl)naphthalene",R09890,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.90,NA,NA,PubChem: 163311906,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573716,4072,cpd:C20181,Avermitilol,C15H26O,Avermitilol,R09896,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.96,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Others;     C20181  Avermitilol,PubChem: 163311924,cpd:C01126; cpd:C03220; cpd:C09621; cpd:C09628; cpd:C09631; cpd:C09651; cpd:C09663; cpd:C09664; cpd:C09676; cpd:C09682; cpd:C09698; cpd:C09704; cpd:C09705; cpd:C10771; cpd:C10780; cpd:C16143; cpd:C16813; cpd:C16970; cpd:C17124; cpd:C17193; cpd:C18245; cpd:C19743; cpd:C19744; cpd:C19746; cpd:C19755; cpd:C19756; cpd:C19893; cpd:C19974; cpd:C20172; cpd:C20181; cpd:C20184; cpd:C20479; cpd:C20576,15,26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O1,C15H25O1,222.1983655,223.2061905,221.19054043717,4073,cpd:C20187,Achilleol B,C30H50O,Achilleol B,R09908,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.48,NA,NA,PubChem: 163311930,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123718,4074,cpd:C20191,alpha-Seco-amyrin;,C30H50O,"alpha-Seco-amyrin; 8,14-Secoursa-7,13-diene-3beta-ol",R09912,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.52,NA,NA,PubChem: 163311934,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123719,4075,cpd:C20192,Marneral,C30H50O,Marneral,R09913,Sesquiterpenoid and triterpenoid biosynthesis; Biosynthesis of secondary metabolites,5.4.99.53,NA,NA,PubChem: 163311935,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123720,4076,cpd:C20193,beta-Seco-amyrin;,C30H50O,"beta-Seco-amyrin; 8,14-Secooleana-7,13-diene-3beta-ol",R09914,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.54,NA,NA,PubChem: 163311936,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123721,4077,cpd:C20195,"Tirucalla-7,24-dien-3beta-ol",C30H50O,"Tirucalla-7,24-dien-3beta-ol",R09916,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.56,NA,NA,PubChem: 163311938; ChEMBL: CHEMBL1835433,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123722,4078,cpd:C20200,Baruol,C30H50O,Baruol,R09917,Sesquiterpenoid and triterpenoid biosynthesis,5.4.99.57,NA,NA,PubChem: 163311943,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834123723,4079,cpd:C20478,(E)-2-epi-beta-Caryophyllene;,C15H24,(E)-2-epi-beta-Caryophyllene; 2-epi-(E)-beta-Caryophyllene,R10273,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.137,NA,NA,PubChem: 163312215,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573724,4080,cpd:C20724,(+)-Thujopsene,C15H24,(+)-Thujopsene,R10599,Sesquiterpenoid and triterpenoid biosynthesis,4.2.3.79,NA,NA,PubChem: 254741193,cpd:C00029; cpd:C00052; cpd:C01009; cpd:C01841; cpd:C01860; cpd:C02004; cpd:C02199; cpd:C02293; cpd:C02474; cpd:C02621; cpd:C02702; cpd:C03246; cpd:C03461; cpd:C03733; cpd:C04215; cpd:C04340; cpd:C06394; cpd:C07526; cpd:C09625; cpd:C09627; cpd:C09629; cpd:C09630; cpd:C09635; cpd:C09637; cpd:C09639; cpd:C09645; cpd:C09647; cpd:C09648; cpd:C09665; cpd:C09666; cpd:C09672; cpd:C09678; cpd:C09681; cpd:C09684; cpd:C09691; cpd:C09699; cpd:C09700; cpd:C09718; cpd:C09719; cpd:C09720; cpd:C09723; cpd:C09733; cpd:C09740; cpd:C09749; cpd:C09750; cpd:C10748; cpd:C10749; cpd:C10752; cpd:C10769; cpd:C10772; cpd:C10774; cpd:C10776; cpd:C11002; cpd:C11521; cpd:C12142; cpd:C14550; cpd:C14693; cpd:C16028; cpd:C16141; cpd:C16142; cpd:C16269; cpd:C16424; cpd:C16428; cpd:C16445; cpd:C16502; cpd:C16504; cpd:C16775; cpd:C16776; cpd:C16814; cpd:C16815; cpd:C16829; cpd:C16908; cpd:C16945; cpd:C16946; cpd:C16974; cpd:C17011; cpd:C17065; cpd:C17069; cpd:C17088; cpd:C17094; cpd:C17120; cpd:C17277; cpd:C17395; cpd:C17442; cpd:C17462; cpd:C17493; cpd:C17502; cpd:C17505; cpd:C17604; cpd:C17605; cpd:C17607; cpd:C17612; cpd:C17915; cpd:C17933; cpd:C17953; cpd:C17955; cpd:C18158; cpd:C19619; cpd:C19676; cpd:C19708; cpd:C19711; cpd:C19734; cpd:C19735; cpd:C19736; cpd:C19737; cpd:C19738; cpd:C19740; cpd:C19741; cpd:C19742; cpd:C19747; cpd:C19748; cpd:C19749; cpd:C19751; cpd:C19752; cpd:C19753; cpd:C19754; cpd:C19908; cpd:C19938; cpd:C19973; cpd:C20159; cpd:C20161; cpd:C20162; cpd:C20163; cpd:C20173; cpd:C20174; cpd:C20175; cpd:C20177; cpd:C20178; cpd:C20179; cpd:C20180; cpd:C20182; cpd:C20229; cpd:C20233; cpd:C20272; cpd:C20273; cpd:C20274; cpd:C20275; cpd:C20307; cpd:C20325; cpd:C20476; cpd:C20477; cpd:C20478; cpd:C20480; cpd:C20486; cpd:C20724; cpd:C20804; cpd:C20811; cpd:C21151,15,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25,C15H23,204.1878008,205.1956258,203.17997573725,4087,cpd:C01417,Cyanate;,CHNO,Cyanate; Cyanic acid,R03546 R10079,Nitrogen metabolism; ABC transporters,4.2.1.104,NA,NA,CAS: 420-05-3 71000-82-3; PubChem: 4604; ChEBI: 28024 29195; ChEMBL: CHEMBL1161700; PDB-CCD: 0NM; 3DMET: B00288; NIKKAJI: J263.680H J3.280H,cpd:C01417; cpd:C01658,1,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H2O1N1,C1H0O1N1,43.00581366,44.01363869,41.997988623726,4091,cpd:C00580,Dimethyl sulfide;,C2H6S,Dimethyl sulfide; Methyl sulfide; Methyl thioether,R02572 R02573 R02574 R09500 R09501 R09786 R11546,Sulfur metabolism,1.8.2.4; 1.8.5.3; 1.14.13.131; 2.1.1.19; 2.1.1.96; 2.1.1.334; 4.4.1.3,NA,NA,CAS: 75-18-3; PubChem: 3859; ChEBI: 17437; ChEMBL: CHEMBL15580; PDB-CCD: MSM; 3DMET: B00138; NIKKAJI: J1.443E,cpd:C00580; cpd:C00928; cpd:C05123; cpd:C11142; cpd:C11143; cpd:C19177; cpd:C19181,2,6,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C2H7S1,C2H5S1,62.01902137,63.0268464,61.011196343727,4094,cpd:C04022,"S,S-Dimethyl-beta-propiothetin;",C5H10O2S,"S,S-Dimethyl-beta-propiothetin; S-Dimethylsulfonium propionic acid; Dimethylpropiothetin; DMPT; DMSP",R02574 R10333,Sulfur metabolism,2.1.1.269; 4.4.1.3,NA,NA,CAS: 7314-30-9; PubChem: 6728; ChEBI: 16457; KNApSAcK: C00001355; NIKKAJI: J227.511B,cpd:C04022; cpd:C11196,5,10,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O2S1,C5H9O2S1,134.0401507,135.0479758,133.03232573728,4095,cpd:C11142,Dimethyl sulfone;,C2H6O2S,Dimethyl sulfone; Sulfonylbismethane,R09498 R10203 R11457,Sulfur metabolism,1.8.1.17; 1.14.14.35,NA,NA,CAS: 67-71-0; PubChem: 13324; ChEBI: 9349; ChEMBL: CHEMBL25028; NIKKAJI: J1.412E,cpd:C11142,2,6,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C2H7O2S1,C2H5O2S1,94.00885061,95.01667564,93.001025573729,4096,cpd:C11143,Dimethyl sulfoxide;,C2H6OS,Dimethyl sulfoxide; DMSO,R09498 R09500 R09501,Sulfur metabolism,1.8.1.17; 1.8.2.4; 1.8.5.3,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G04 UROLOGICALS;    G04B UROLOGICALS;     G04BX Other urologicals;      G04BX13 Dimethyl sulfoxide;       D01043  Dimethyl sulfoxide (USP/INN);  M MUSCULO-SKELETAL SYSTEM;   M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;    M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;     M02AX Other topical products for joint and muscular pain;      M02AX03 Dimethyl sulfoxide;       D01043  Dimethyl sulfoxide (USP/INN); Endocrine and hormonal agents [br08373.html];  Other urological agents;   D01043,CAS: 67-68-5; PubChem: 13325; ChEBI: 28262; ChEMBL: CHEMBL504; PDB-CCD: DMS; NIKKAJI: J1.933J,cpd:C00928; cpd:C11143,2,6,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C2H7O1S1,C2H5O1S1,78.01393599,79.02176102,77.006110963730,4097,cpd:C11145,Methanesulfonic acid;,CH4SO3,Methanesulfonic acid; Methanesulfonate,R09513 R10203 R10206,Sulfur metabolism,1.14.13.111; 1.14.14.5; 1.14.14.34,NA,Pharmaceutical additives [BR:br08316];  pH regulator;   C11145  [104128] Methanesulfonic acid,CAS: 75-75-2; PubChem: 13327; ChEBI: 27376; PDB-CCD: 03S; NIKKAJI: J1.465F,cpd:C08087; cpd:C08091; cpd:C11145; cpd:C12560; cpd:C13167; cpd:C13168; cpd:C13524; cpd:C14053; cpd:C14054; cpd:C14055; cpd:C18361; cpd:C19432,1,4,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C1H5O3S1,C1H3O3S1,95.98811516,96.99594019,94.980290133731,4100,cpd:C20870,3-(Methylthio)propanoyl-CoA,C25H42N7O17P3S2,3-(Methylthio)propanoyl-CoA,R10820 R11130,Sulfur metabolism,1.3.8.-; 6.2.1.44,NA,NA,PubChem: 254741336; PDB-CCD: 1HE,cpd:C20870,25,42,17,7,3,2,0,0,0,0,0,0,0,0,0,0,0,0,C25H43O17N7P3S2,C25H41O17N7P3S2,869.1291463,870.1369713,868.12132123732,4101,cpd:C20955,3-(Methylthio)acryloyl-CoA;,C25H40N7O17P3S2,3-(Methylthio)acryloyl-CoA; Methylthioacryloyl-CoA,R10936 R10945 R11130,Sulfur metabolism,1.3.8.-; 4.2.1.155,NA,NA,PubChem: 254741416; PDB-CCD: 1GZ,cpd:C20955,25,40,17,7,3,2,0,0,0,0,0,0,0,0,0,0,0,0,C25H41O17N7P3S2,C25H39O17N7P3S2,867.1134962,868.1213212,866.10567123733,4102,cpd:C00414,Cyclohexanone,C6H10O,Cyclohexanone,R02229 R02231 R02232 R02233 R02234,Caprolactam degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.163; 1.1.1.245; 1.3.99.14; 1.4.3.12; 1.14.13.22; 4.1.3.35,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00414  Cyclohexanone; Pharmaceutical additives [BR:br08316];  Solubilization agent;   C00414  [101626] Cyclohexanone;  Solvent;   C00414  [101626] Cyclohexanone,CAS: 108-94-1; PubChem: 3704; ChEBI: 17854; ChEMBL: CHEMBL18850; PDB-CCD: CYH; 3DMET: B00106; NIKKAJI: J2.872J,cpd:C00414; cpd:C06936; cpd:C07600; cpd:C08497; cpd:C16310,6,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O1,C6H9O1,98.07316494,99.08098997,97.065339913734,4103,cpd:C00571,Cyclohexylamine;,C6H13N,Cyclohexylamine; Cyclohexanamine,R02233 R02564 R06940,Caprolactam degradation; Microbial metabolism in diverse environments,1.4.3.12; 3.5.1.-; 3.10.1.2,NA,NA,CAS: 108-91-8; PubChem: 3850; ChEBI: 15773; ChEMBL: CHEMBL1794762; KNApSAcK: C00044142; PDB-CCD: HAI; 3DMET: B00135; NIKKAJI: J2.870C,cpd:C00123; cpd:C00329; cpd:C00407; cpd:C00571; cpd:C01075; cpd:C01214; cpd:C01570; cpd:C01777; cpd:C01933; cpd:C02262; cpd:C02264; cpd:C02378; cpd:C02486; cpd:C02824; cpd:C03570; cpd:C03752; cpd:C03789; cpd:C04438; cpd:C05973; cpd:C06418; cpd:C06763; cpd:C08263; cpd:C08349; cpd:C10141; cpd:C10143; cpd:C10144; cpd:C11227; cpd:C12212; cpd:C15478; cpd:C15479; cpd:C16434; cpd:C16439; cpd:C16647; cpd:C16843; cpd:C17213; cpd:C17245; cpd:C17578; cpd:C17580; cpd:C20310; cpd:C20311; cpd:C20802; cpd:C20988; cpd:C21035; cpd:C21038; cpd:C21048; cpd:C21051; cpd:C21060; cpd:C21092; cpd:C21096,6,13,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14N1,C6H12N1,99.10479942,100.1126245,98.096974393735,4104,cpd:C00854,Cyclohexanol;,C6H12O,Cyclohexanol; Hexalin; Hexahydrophenol; Cyclohexan-1-ol,R02229 R06945,Caprolactam degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.163; 1.1.1.245; 1.14.13.-; 1.14.15.3,NA,NA,CAS: 108-93-0; PubChem: 4111; ChEBI: 18099; ChEMBL: CHEMBL32010; PDB-CCD: CXL; 3DMET: B00190; NIKKAJI: J2.871A,cpd:C00854; cpd:C01952; cpd:C02373; cpd:C02837; cpd:C02893; cpd:C05328; cpd:C08492; cpd:C19263; cpd:C19350; cpd:C19543; cpd:C19809; cpd:C21098,6,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O1,C6H11O1,100.088815,101.09664,99.080989973736,4105,cpd:C01147,2-Hydroxycyclohexan-1-one;,C6H10O2,2-Hydroxycyclohexan-1-one; 2-Hydroxycyclohexanone; Adipoin,R03278 R03279 R03281 R06621 R06622,Caprolactam degradation; Microbial metabolism in diverse environments,1.1.1.174; 1.14.13.22; 1.14.13.66,NA,NA,CAS: 533-60-8; PubChem: 4377; ChEBI: 17878; NIKKAJI: J11.716A,cpd:C01147; cpd:C01880; cpd:C03023; cpd:C03228; cpd:C05205; cpd:C06231; cpd:C06553; cpd:C11072; cpd:C15426; cpd:C19120; cpd:C21377,6,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O2,C6H9O2,114.0680796,115.0759046,113.06025453737,4106,cpd:C01255,N-(6-Aminohexanoyl)-6-aminohexanoate,C12H24N2O3,N-(6-Aminohexanoyl)-6-aminohexanoate,R00059 R03448 R10979,Caprolactam degradation; Microbial metabolism in diverse environments,3.5.1.46; 3.5.1.117; 3.5.2.12,NA,NA,PubChem: 4475; ChEBI: 16780 49255; LIPIDMAPS: LMFA00000009; 3DMET: B00266; NIKKAJI: J796.788H,cpd:C01255; cpd:C11332,12,24,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H25O3N2,C12H23O3N2,244.1786926,245.1865177,243.17086763738,4107,cpd:C01880,epsilon-Caprolactone;,C6H10O2,epsilon-Caprolactone; 6-Hexanolide; 1-Oxa-2-oxocycloheptane; 2-Oxepanone; Hexano-6-lactone,R02231 R03751,Caprolactam degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.14.13.22; 3.1.1.17; 3.1.1.83,NA,NA,CAS: 502-44-3; PubChem: 4993; ChEBI: 17915; ChEMBL: CHEMBL373123; PDB-CCD: ECE; 3DMET: B00366; NIKKAJI: J1.566K,cpd:C01147; cpd:C01880; cpd:C03023; cpd:C03228; cpd:C05205; cpd:C06231; cpd:C06553; cpd:C11072; cpd:C15426; cpd:C19120; cpd:C21377,6,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O2,C6H9O2,114.0680796,115.0759046,113.06025453739,4108,cpd:C02378,6-Aminohexanoate;,C6H13NO2,6-Aminohexanoate; 6-Aminohexanoic acid; Epsilcapramine; 6-Aminocaproic acid,R00059 R05356 R05507 R10975,Caprolactam degradation; Metabolic pathways; Microbial metabolism in diverse environments,2.6.1.-; 3.5.1.46; 3.5.2.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0110 Amino fatty acids;     C02378  6-Aminohexanoic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B02 ANTIHEMORRHAGICS;    B02A ANTIFIBRINOLYTICS;     B02AA Amino acids;      B02AA01 Aminocaproic acid;       D00160  Aminocaproic acid (USP/INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for ophthalmologic use;   62 General eye drops;    D00160  Aminocaproic acid (USP/INN);   67 Eyewash;    D00160  Aminocaproic acid (USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Epsilon-Aminocaproic acid;     D00160  Aminocaproic acid (USP/INN); Pharmaceutical additives [BR:br08316];  Buffering agent;   D00160  [102180] epsilon-Aminocaproic acid; Target-based classification of drugs [BR:br08310];  Enzymes;   Hydrolases;    plasmin;     Aminocaproic acid;      D00160  Aminocaproic acid (USP/INN),CAS: 60-32-2; PubChem: 5420; ChEBI: 16586 32396; ChEMBL: CHEMBL1046; LIPIDMAPS: LMFA01100035; PDB-CCD: ACA; 3DMET: B00436; NIKKAJI: J1.398F,cpd:C00123; cpd:C00407; cpd:C01570; cpd:C01777; cpd:C01933; cpd:C02378; cpd:C02486; cpd:C06418; cpd:C08263; cpd:C11227; cpd:C16434; cpd:C16439; cpd:C16647; cpd:C17213; cpd:C20988; cpd:C21092; cpd:C21096,6,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O2N1,C6H12O2N1,131.0946287,132.1024537,130.08680363740,4109,cpd:C02824,Cyclohexylsulfamate;,C6H13NO3S,Cyclohexylsulfamate; Cyclohexylsulfamic acid; Cylamic acid; Cyclohexylamide sulfate,R02564,Caprolactam degradation; Microbial metabolism in diverse environments,3.10.1.2,NA,NA,CAS: 100-88-9; PubChem: 5772; ChEBI: 15964; ChEMBL: CHEMBL1206440; NIKKAJI: J4.986G,cpd:C02824,6,13,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O3N1S1,C6H12O3N1S1,179.0616145,180.0694395,178.05378943741,4110,cpd:C03241,6-Hydroxyhexan-6-olide;,C6H10O3,6-Hydroxyhexan-6-olide; 6-Hydroxy-6-hexanolactone,R03281 R05098,Caprolactam degradation,1.14.13.66,NA,NA,PubChem: 6111; ChEBI: 17075; 3DMET: B00568; NIKKAJI: J2.741.422B,cpd:C00233; cpd:C00671; cpd:C00902; cpd:C01012; cpd:C01109; cpd:C02122; cpd:C02129; cpd:C03241; cpd:C03465; cpd:C03467; cpd:C03500; cpd:C03625; cpd:C03895; cpd:C05535; cpd:C06008; cpd:C06102; cpd:C12314; cpd:C14530; cpd:C15606; cpd:C15653; cpd:C16432; cpd:C17211; cpd:C21378,6,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O3,C6H9O3,130.0629942,131.0708192,129.05516913742,4111,cpd:C03739,"trans-1,2-Cyclohexanediol;",C6H12O2,"trans-1,2-Cyclohexanediol; trans-Cyclohexane-1,2-diol",R03279,Caprolactam degradation; Microbial metabolism in diverse environments,1.1.1.174,NA,NA,CAS: 1460-57-7; PubChem: 6502; ChEBI: 16931; PDB-CCD: 40O; NIKKAJI: J237.203G,cpd:C01585; cpd:C02948; cpd:C03739; cpd:C07997; cpd:C12293; cpd:C12304; cpd:C12313; cpd:C16837; cpd:C18472; cpd:C19006; cpd:C20602; cpd:C21026; cpd:C21399,6,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O2,C6H11O2,116.0837296,117.0915547,115.07590463743,4112,cpd:C04277,"1,8-Diazacyclotetradecane-2,9-dione",C12H22N2O2,"1,8-Diazacyclotetradecane-2,9-dione",R03448,Caprolactam degradation; Microbial metabolism in diverse environments,3.5.2.12,NA,NA,PubChem: 6940; ChEBI: 16968; 3DMET: B00697; NIKKAJI: J450.663D,cpd:C04277; cpd:C20514,12,22,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O2N2,C12H21O2N2,226.168128,227.175953,225.16030293744,4113,cpd:C06102,Adipate semialdehyde;,C6H10O3,Adipate semialdehyde; Hexan-1-one-6-carboxylate; 6-Oxohexanoate; 6-Oxohexanoic acid,R05098 R05099 R05100 R05231 R05283 R05507,Caprolactam degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.2; 1.1.1.258; 1.2.1.4; 1.2.1.63; 2.6.1.-; 3.7.1.11,NA,NA,PubChem: 8366; ChEBI: 18322 2490; 3DMET: B00901; NIKKAJI: J12.274B,cpd:C00233; cpd:C00671; cpd:C00902; cpd:C01012; cpd:C01109; cpd:C02122; cpd:C02129; cpd:C03241; cpd:C03465; cpd:C03467; cpd:C03500; cpd:C03625; cpd:C03895; cpd:C05535; cpd:C06008; cpd:C06102; cpd:C12314; cpd:C14530; cpd:C15606; cpd:C15653; cpd:C16432; cpd:C17211; cpd:C21378,6,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O3,C6H9O3,130.0629942,131.0708192,129.05516913745,4114,cpd:C06103,6-Hydroxyhexanoic acid;,C6H12O3,6-Hydroxyhexanoic acid; 6-Hydroxyhexanoate,R03751 R05231 R05283,Caprolactam degradation; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.1.1.2; 1.1.1.258; 3.1.1.17; 3.1.1.83,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0105 Hydroxy fatty acids;     C06103  6-Hydroxyhexanoic acid,CAS: 1191-25-9; PubChem: 8367; ChEBI: 17869; ChEMBL: CHEMBL2006530; LIPIDMAPS: LMFA01050015; LipidBank: DFA0281; 3DMET: B00902; NIKKAJI: J262.001D,cpd:C00993; cpd:C02699; cpd:C03153; cpd:C03264; cpd:C03499; cpd:C03922; cpd:C06103; cpd:C06442; cpd:C07834; cpd:C10996; cpd:C18999; cpd:C19378; cpd:C19929; cpd:C20603,6,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O3,C6H11O3,132.0786442,133.0864693,131.07081923746,4115,cpd:C06104,Adipate;,C6H10O4,"Adipate; Adipic acid; Hexanedioate; Hexan-1,6-dicarboxylate",R05099 R06944,Caprolactam degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.2.1.4; 1.2.1.63; 6.2.1.-,NA,Compounds with biological roles [BR:br08001];  Organic acids;   Carboxylic acids;    Dicarboxylic acids;     C06104  Adipate; Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D08839  [100297] Adipic acid;  pH regulator;   D08839  [100297] Adipic acid;  Disintegrant;   D08839  [100297] Adipic acid (NF);  Solubilization agent;   D08839  [100297] Adipic acid,CAS: 124-04-9; PubChem: 8368; ChEBI: 30832; ChEMBL: CHEMBL1157; LIPIDMAPS: LMFA01170048; KNApSAcK: C00001178; PDB-CCD: 0L1; 3DMET: B00903; NIKKAJI: J10.057I,cpd:C00439; cpd:C00659; cpd:C00772; cpd:C00966; cpd:C01053; cpd:C04237; cpd:C04327; cpd:C04556; cpd:C06006; cpd:C06104; cpd:C06762; cpd:C13811; cpd:C14463; cpd:C16272; cpd:C16674; cpd:C18379; cpd:C18384; cpd:C18719; cpd:C21465,6,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O4,C6H9O4,146.0579088,147.0657338,145.05008383747,4116,cpd:C06105,"Cyclohexane-1,2-dione",C6H8O2,"Cyclohexane-1,2-dione",R03278 R05100,Caprolactam degradation; Microbial metabolism in diverse environments,1.1.1.174; 3.7.1.11,NA,NA,CAS: 765-87-7; PubChem: 8369; ChEBI: 41674; ChEMBL: CHEMBL189727; PDB-CCD: CXO; 3DMET: B00904; NIKKAJI: J75.392K,cpd:C01066; cpd:C01078; cpd:C03633; cpd:C03798; cpd:C04091; cpd:C04221; cpd:C05828; cpd:C06105; cpd:C07458; cpd:C08063; cpd:C08502; cpd:C13693; cpd:C14149; cpd:C16182; cpd:C18508; cpd:C20522,6,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H9O2,C6H7O2,112.0524295,113.0602545,111.04460453748,4117,cpd:C06593,epsilon-Caprolactam,C6H11NO,epsilon-Caprolactam,R05356,Caprolactam degradation; Metabolic pathways; Microbial metabolism in diverse environments,3.5.2.-,NA,Carcinogens [BR:br08008];  Group 4: Probably not carcinogenic to humans;   Compound;    C06593  epsilon-Caprolactam,CAS: 105-60-2; PubChem: 8819; ChEBI: 28579; ChEMBL: CHEMBL276218; KNApSAcK: C00000318; PDB-CCD: ICC; 3DMET: B00986; NIKKAJI: J3.605F,cpd:C06593; cpd:C19492; cpd:C20988; cpd:C20990,6,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O1N1,C6H10O1N1,113.084064,114.091889,112.07623893749,4118,cpd:C11249,Cyclohexane,C6H12,Cyclohexane,R06945,Caprolactam degradation; Microbial metabolism in diverse environments,1.14.13.-; 1.14.15.3,NA,NA,CAS: 110-82-7; PubChem: 13426; ChEBI: 29005; ChEMBL: CHEMBL15980; PDB-CCD: CHX; NIKKAJI: J2.882G,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00257; cpd:C00267; cpd:C00418; cpd:C00491; cpd:C00507; cpd:C00514; cpd:C00522; cpd:C00586; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00770; cpd:C00795; cpd:C00800; cpd:C00817; cpd:C00854; cpd:C00861; cpd:C00880; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C00993; cpd:C01018; cpd:C01019; cpd:C01067; cpd:C01100; cpd:C01420; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01585; cpd:C01680; cpd:C01684; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01721; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C01952; cpd:C02095; cpd:C02101; cpd:C02104; cpd:C02209; cpd:C02336; cpd:C02338; cpd:C02347; cpd:C02373; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02699; cpd:C02781; cpd:C02782; cpd:C02827; cpd:C02837; cpd:C02893; cpd:C02948; cpd:C03089; cpd:C03153; cpd:C03215; cpd:C03264; cpd:C03348; cpd:C03499; cpd:C03739; cpd:C03847; cpd:C03922; cpd:C03999; cpd:C04010; cpd:C04104; cpd:C04384; cpd:C04475; cpd:C05003; cpd:C05328; cpd:C05704; cpd:C06007; cpd:C06103; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06442; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C06471; cpd:C07326; cpd:C07641; cpd:C07834; cpd:C07997; cpd:C08038; cpd:C08258; cpd:C08259; cpd:C08351; cpd:C08352; cpd:C08356; cpd:C08492; cpd:C10906; cpd:C10996; cpd:C11160; cpd:C11249; cpd:C11553; cpd:C12293; cpd:C12304; cpd:C12313; cpd:C13522; cpd:C14445; cpd:C15923; cpd:C15930; cpd:C16538; cpd:C16837; cpd:C17949; cpd:C18472; cpd:C18988; cpd:C18999; cpd:C19006; cpd:C19263; cpd:C19305; cpd:C19350; cpd:C19378; cpd:C19543; cpd:C19719; cpd:C19809; cpd:C19891; cpd:C19929; cpd:C20602; cpd:C20603; cpd:C20829; cpd:C20830; cpd:C20835; cpd:C20836; cpd:C21026; cpd:C21032; cpd:C21033; cpd:C21045; cpd:C21050; cpd:C21054; cpd:C21055; cpd:C21058; cpd:C21062; cpd:C21066; cpd:C21098; cpd:C21182; cpd:C21397; cpd:C21399,6,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13,C6H11,84.09390039,85.10172542,83.086075353750,4119,cpd:C11519,N-Cyclohexylformamide,C7H13NO,N-Cyclohexylformamide,R05771 R06940,Caprolactam degradation; Microbial metabolism in diverse environments,3.5.1.-; 4.2.1.103,NA,NA,CAS: 766-93-8; PubChem: 13687; ChEBI: 17945; ChEMBL: CHEMBL46778; PDB-CCD: CXF; NIKKAJI: J49.655C,cpd:C11519,7,13,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O1N1,C7H12O1N1,127.099714,128.1075391,126.0918893751,4120,cpd:C11520,Cyclohexyl isocyanide;,C7H11N,Cyclohexyl isocyanide; N-Cyclohexylisocyanide; Cyclohexaneisonitrile,R05771,Caprolactam degradation; Microbial metabolism in diverse environments,4.2.1.103,NA,NA,CAS: 931-53-3; PubChem: 13688; ChEBI: 17966; PDB-CCD: CYI; NIKKAJI: J298.513F,cpd:C00624; cpd:C01250; cpd:C03871; cpd:C07411; cpd:C07505; cpd:C08233; cpd:C08287; cpd:C10128; cpd:C11520; cpd:C12109; cpd:C12121; cpd:C16821; cpd:C17361; cpd:C17366; cpd:C17724; cpd:C20828; cpd:C21248,7,11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12N1,C7H10N1,109.0891494,110.0969744,108.08132433752,4121,cpd:C12313,"cis-1,2-Cyclohexanediol;",C6H12O2,"cis-1,2-Cyclohexanediol; cis-Cyclohexane-1,2-diol",R06621,Caprolactam degradation; Microbial metabolism in diverse environments,1.1.1.174,NA,NA,CAS: 1792-81-0; PubChem: 582704; ChEBI: 32329; NIKKAJI: J46.541K,cpd:C01585; cpd:C02948; cpd:C03739; cpd:C07997; cpd:C12293; cpd:C12304; cpd:C12313; cpd:C16837; cpd:C18472; cpd:C19006; cpd:C20602; cpd:C21026; cpd:C21399,6,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O2,C6H11O2,116.0837296,117.0915547,115.07590463753,4122,cpd:C14143,Adipyl-CoA;,C27H44N7O19P3S,Adipyl-CoA; 5-Carboxypentanoyl-CoA,R06943 R06944,Caprolactam degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.3.99.-; 6.2.1.-,NA,NA,PubChem: 7846955; ChEBI: 34528; NIKKAJI: J2.788.048G,cpd:C14143; cpd:C16273; cpd:C18834,27,44,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O19N7P3S1,C27H43O19N7P3S1,895.1625544,896.1703794,894.15472943754,4125,cpd:C00411,Sinapoyl-CoA,C32H46N7O20P3S,Sinapoyl-CoA,R02220 R02221 R02899 R03861 R03965 R06578 R11199,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.2.1.44; 2.1.1.104; 2.3.1.106; 2.3.1.131; 2.3.1.132; 2.3.1.248; 6.2.1.12,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Sinapate derivatives;     C00411  Sinapoyl-CoA,CAS: 54429-80-0; PubChem: 3701; ChEBI: 15540; KNApSAcK: C00007283; 3DMET: B04679,cpd:C00411; cpd:C09819,32,46,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H47O20N7P3S1,C32H45O20N7P3S1,973.1731191,974.1809441,972.1652943755,4126,cpd:C00482,Sinapate;,C11H12O5,"Sinapate; Sinapic acid; 3,5-Dimethoxy-4-hydroxycinnamic acid",R02221 R02379 R02380 R02381 R07441 R07442 R08533 R10261; R10298 R10299,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.2.1.68; 2.1.1.68; 2.4.1.120; 2.4.1.126; 2.4.1.299; 3.1.1.49; 6.2.1.12,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Sinapate derivatives;     C00482  Sinapate,CAS: 530-59-6 7362-37-0; PubChem: 3765; ChEBI: 15714 77131; ChEMBL: CHEMBL109341; KNApSAcK: C00002776 C00034327; PDB-CCD: SXX; 3DMET: B01259; NIKKAJI: J11.713G,cpd:C00482; cpd:C00918; cpd:C05648; cpd:C20653; cpd:C20654,11,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O5,C11H11O5,224.0684735,225.0762985,223.06064853756,4127,cpd:C00540,Cinnamoyl-CoA;,C30H42N7O17P3S,Cinnamoyl-CoA; S-(Cinnamoyl) coenzyme A,R02255 R02505 R02506 R07987 R08815,"Phenylpropanoid biosynthesis; Flavonoid biosynthesis; Stilbenoid, diarylheptanoid and gingerol biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; Degradation of aromatic compounds",1.2.1.44; 1.14.13.11; 2.3.1.74; 2.3.1.146; 6.2.1.12,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C00540  Cinnamoyl-CoA,PubChem: 3821; ChEBI: 15463 23253; KNApSAcK: C00007263; 3DMET: B04697; NIKKAJI: J1.050.827D,cpd:C00540; cpd:C16256,30,42,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H43O17N7P3S1,C30H41O17N7P3S1,897.1570751,898.1649001,896.14925013757,4128,cpd:C00590,Coniferyl alcohol;,C10H12O3,Coniferyl alcohol; Coniferol; 4-(3-Hydroxy-1-propenyl)-2-methoxyphenol; trans-Coniferyl alcohol,R02593 R02594 R02595 R02596 R06573 R06575 R10253,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.194; 1.1.1.195; 1.11.1.7; 1.11.1.21; 1.14.13.-; 2.1.1.68; 2.3.1.-; 2.4.1.111; 3.2.1.126,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Coniferyl alcohol derivatives;     C00590  Coniferyl alcohol,CAS: 32811-40-8 458-35-5; PubChem: 3869; ChEBI: 17745; ChEMBL: CHEMBL501870; KNApSAcK: C00000614 C00043990; PDB-CCD: N7I; 3DMET: B00142; NIKKAJI: J5.761D,cpd:C00328; cpd:C00590; cpd:C01718; cpd:C05647; cpd:C06953; cpd:C07342; cpd:C10965; cpd:C11018; cpd:C15475; cpd:C16880; cpd:C18966; cpd:C19766; cpd:C19768; cpd:C20343; cpd:C20463,10,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O3,C10H11O3,180.0786442,181.0864693,179.07081923758,4129,cpd:C00761,Coniferin,C16H22O8,Coniferin,R02594 R02595,Phenylpropanoid biosynthesis,2.4.1.111; 3.2.1.126,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Coniferyl alcohol derivatives;     C00761  Coniferin,CAS: 531-29-3; PubChem: 4023; ChEBI: 16220; ChEMBL: CHEMBL459056; KNApSAcK: C00002727; 3DMET: B01326; NIKKAJI: J6.979E,cpd:C00761; cpd:C11370,16,22,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H23O8,C16H21O8,342.1314677,343.1392927,341.12364263759,4130,cpd:C00852,Chlorogenate;,C16H18O9,Chlorogenate; Chlorogenic acid; Caffeoyl quinic acid; trans-5-O-Caffeoyl-D-quinate,R01945 R02997 R02998 R04342,"Phenylpropanoid biosynthesis; Flavonoid biosynthesis; Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",1.14.13.36; 2.3.1.98; 2.3.1.99; 2.3.1.133; 3.1.1.42,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Caffeate derivatives;     C00852  Chlorogenate,CAS: 327-97-9 202650-88-2; PubChem: 4109; ChEBI: 16112; ChEMBL: CHEMBL1419611 CHEMBL284616; KNApSAcK: C00002724 C00049091; 3DMET: B01342; NIKKAJI: J108.009A J954.882C,cpd:C00852; cpd:C01527; cpd:C04712; cpd:C08996; cpd:C17147,16,18,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H19O9,C16H17O9,354.0950822,355.1029072,353.08725713760,4131,cpd:C00903,Cinnamaldehyde,C9H8O,Cinnamaldehyde,R02506 R03054,Phenylpropanoid biosynthesis; Biosynthesis of plant secondary metabolites; Metabolic pathways; Biosynthesis of secondary metabolites; Inflammatory mediator regulation of TRP channels,1.1.1.195; 1.2.1.44,NA,"Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C00903  Cinnamaldehyde; Target-based classification of compounds [BR:br08010];  Ion channels;   Related to voltage-gated cation channels;    Transient receptor potential family, TRPA (ANKTM1);     transient receptor potential cation channel, subfamily A, member 1;      C00903  Cinnamaldehyde; Pharmaceutical additives [BR:br08316];  Flavoring substance;   C00903  [120326] Cinnamaldehyde;  Favoring agent, Fragrance;   C00903  [120326] Cinnamaldehyde; Major components of natural products [BR:br08323];  Crude drugs;   Cinnamon bark;    C00903  Cinnamaldehyde;   Cylindrical Cinnamon bark;    C00903  Cinnamaldehyde;  Essential oils;   Cinnamon oil;    C00903  Cinnamaldehyde;   Cassia oil;    C00903  Cinnamaldehyde",CAS: 104-55-2; PubChem: 4158; ChEBI: 16731; ChEMBL: CHEMBL293492; KNApSAcK: C00002725 C00035187; 3DMET: B00198; NIKKAJI: J2.850I,cpd:C00903; cpd:C01504; cpd:C07727; cpd:C13844; cpd:C16592; cpd:C18812,9,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O1,C9H7O1,132.0575149,133.0653399,131.04968983761,4132,cpd:C00933,Sinapine;,C16H24NO5,Sinapine; Sinapoylcholine,R02381 R03075,Phenylpropanoid biosynthesis,2.3.1.91; 3.1.1.49,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Sinapate derivatives;     C00933  Sinapine,CAS: 18696-26-9; PubChem: 4185; ChEBI: 16353; KNApSAcK: C00002777; 3DMET: B00203; NIKKAJI: J7.403I,cpd:C00933,16,24,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O5N1,C16H23O5N1,310.1654479,311.1732729,309.15762283762,4133,cpd:C01175,1-O-Sinapoyl-beta-D-glucose;,C17H22O10,1-O-Sinapoyl-beta-D-glucose; 1-O-Sinapoyl beta-D-glucoside,R00063 R02380 R03075 R03323 R10261 R10298 R10299,Phenylpropanoid biosynthesis,2.3.1.91; 2.3.1.92; 2.3.1.103; 2.4.1.120; 2.4.1.126; 2.4.1.299,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Sinapate derivatives;     C01175  1-O-Sinapoyl-beta-D-glucose,PubChem: 4402; ChEBI: 16546; KNApSAcK: C00013592; PDB-CCD: SGS; 3DMET: B01401; NIKKAJI: J613.283I,cpd:C01175; cpd:C02919; cpd:C08423; cpd:C08424,17,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H23O10,C17H21O10,386.1212969,387.1291219,385.11347193763,4134,cpd:C01197,Caffeate;,C9H8O4,"Caffeate; Caffeic acid; 3,4-Dihydroxy-trans-cinnamate; trans-Caffeate; (2E)-3-(3,4-Dihydroxyphenyl)prop-2-enoate",R01943 R02950 R02997 R03365 R03366 R03367 R07826 R10701; R11206,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites; Degradation of aromatic compounds,1.13.11.22; 1.14.13.-; 1.14.18.1; 2.1.1.68; 2.8.3.23; 3.1.1.42; 3.1.1.-; 4.1.1.102; 6.2.1.12,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Caffeate derivatives;     C01197  Caffeate,CAS: 501-16-6; PubChem: 4422; ChEBI: 16433; ChEMBL: CHEMBL145; KNApSAcK: C00000615; PDB-CCD: DHC; 3DMET: B00258; NIKKAJI: J1.524E,cpd:C01179; cpd:C01197; cpd:C01405; cpd:C01481; cpd:C04367; cpd:C05350; cpd:C12467; cpd:C12623; cpd:C13400; cpd:C17086; cpd:C18819; cpd:C21346,9,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O4,C9H7O4,180.0422587,181.0500838,179.03443373764,4135,cpd:C01494,Ferulate;,C10H10O4,Ferulate; Ferulic acid; 4-Hydroxy-3-methoxycinnamic acid; 3-Methoxy-4-hydroxy-trans-cinnamate; 4-Hydroxy-3-methoxycinnamate,R02194 R03366 R03579 R05700 R05701 R05744 R07292 R07440; R08839 R11071,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.2.1.68; 1.14.13.-; 2.1.1.68; 2.4.1.120; 2.4.1.126; 3.1.1.73; 3.5.1.71; 4.1.1.102; 6.2.1.12; 6.2.1.34,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Coniferyl alcohol derivatives;     C01494  Ferulate,CAS: 537-98-4; PubChem: 4664; ChEBI: 17620; ChEMBL: CHEMBL32749; KNApSAcK: C00002743 C00034325; PDB-CCD: FER; 3DMET: B00304; NIKKAJI: J7.273G,cpd:C00779; cpd:C01494; cpd:C02379; cpd:C09974; cpd:C10470; cpd:C10477; cpd:C11233; cpd:C12204; cpd:C12465; cpd:C16982; cpd:C17532; cpd:C21347; cpd:C21361,10,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O4,C10H9O4,194.0579088,195.0657338,193.05008383765,4136,cpd:C01527,Scopolin,C16H18O9,Scopolin,R03594,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,2.4.1.128,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Coumarins;     C01527  Scopolin,CAS: 531-44-2; PubChem: 4689; ChEBI: 16065; ChEMBL: CHEMBL225024; KNApSAcK: C00002500; 3DMET: B01459; NIKKAJI: J821.135C,cpd:C00852; cpd:C01527; cpd:C04712; cpd:C08996; cpd:C17147,16,18,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H19O9,C16H17O9,354.0950822,355.1029072,353.08725713766,4137,cpd:C01533,Syringin;,C17H24O9,Syringin; Eleutheroside B,R03604 R03605,Phenylpropanoid biosynthesis,2.4.1.111; 3.2.1.126,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Sinapate derivatives;     C01533  Syringin; Major components of natural products [BR:br08323];  Crude drugs;   Eleutherococcus senticosus rhizome;    C01533  Syringin;  Medicinal herbs;   Eleuthero;    C01533  Syringin,CAS: 118-34-3; PubChem: 4695; ChEBI: 9380; ChEMBL: CHEMBL250872; KNApSAcK: C00000010 C00030167; 3DMET: B04802; NIKKAJI: J246.058K,cpd:C01533,17,24,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H25O9,C17H23O9,372.1420323,373.1498574,371.13420733767,4138,cpd:C01752,Scopoletin,C10H8O4,Scopoletin,R03594 R11550,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,2.4.1.128,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Coumarins;     C01752  Scopoletin; Major components of natural products [BR:br08323];  Crude drugs;   Dolichos seed;    C01752  Scopoletin,CAS: 92-61-5; PubChem: 4885; ChEBI: 17488; ChEMBL: CHEMBL71851; KNApSAcK: C00002499; 3DMET: B00343; NIKKAJI: J4.658B,cpd:C01752; cpd:C01938; cpd:C03830; cpd:C04033; cpd:C06203; cpd:C06204; cpd:C10290; cpd:C16913; cpd:C18077; cpd:C18079; cpd:C20462; cpd:C21414; cpd:C21451,10,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O4,C10H7O4,192.0422587,193.0500838,191.03443373768,4139,cpd:C02325,Sinapyl alcohol;,C11H14O4,Sinapyl alcohol; Sinapoyl alcohol,R03604 R03605 R03918 R03919 R06577,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.195; 1.11.1.7; 1.11.1.21; 2.1.1.68; 2.4.1.111; 3.2.1.126,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Sinapate derivatives;     C02325  Sinapyl alcohol,CAS: 537-33-7; PubChem: 5377; ChEBI: 28813 64557; ChEMBL: CHEMBL1800816; KNApSAcK: C00002778 C00034298; PDB-CCD: 55B; 3DMET: B00425; NIKKAJI: J304.419J,cpd:C02325; cpd:C02957; cpd:C04229; cpd:C07350; cpd:C07501; cpd:C10709; cpd:C17238; cpd:C18951; cpd:C19787,11,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O4,C11H13O4,210.0892089,211.097034,209.08138393769,4140,cpd:C02646,4-Coumaryl alcohol;,C9H10O2,4-Coumaryl alcohol; 4-Hydroxycinnamyl alcohol; p-Coumaryl alcohol,R04005 R04006 R04007 R06580 R07437 R10254,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.195; 1.11.1.7; 1.11.1.21; 2.3.1.-; 2.4.1.111; 3.2.1.126,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Paracoumaryl alcohol derivatives;     C02646  4-Coumaryl alcohol,CAS: 3690-05-9; PubChem: 5623; ChEBI: 28386 64555; ChEMBL: CHEMBL109034; KNApSAcK: C00000613 C00031420; 3DMET: B00473; NIKKAJI: J117.130E,cpd:C01963; cpd:C02646; cpd:C03900; cpd:C05629; cpd:C07428; cpd:C08050; cpd:C11007; cpd:C11009; cpd:C11110; cpd:C11217; cpd:C12461; cpd:C13342; cpd:C15513; cpd:C16706; cpd:C17883; cpd:C19291; cpd:C20697; cpd:C21309,9,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O2,C9H9O2,150.0680796,151.0759046,149.06025453770,4141,cpd:C02666,Coniferyl aldehyde;,C10H10O3,Coniferyl aldehyde; Coniferaldehyde; 4-Hydroxy-3-methoxycinnamaldehyde; Ferulaldehyde,R02193 R02593 R05700 R05701 R06572 R06574,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.194; 1.1.1.195; 1.2.1.44; 1.2.1.68; 1.14.13.-; 2.1.1.68,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Coniferyl alcohol derivatives;     C02666  Coniferyl aldehyde,CAS: 458-36-6; PubChem: 5637; ChEBI: 16547; ChEMBL: CHEMBL242529; KNApSAcK: C00002728 C00035949; PDB-CCD: CIY; 3DMET: B00482; NIKKAJI: J196.170E,cpd:C00585; cpd:C01281; cpd:C01624; cpd:C01702; cpd:C02666; cpd:C05250; cpd:C10667; cpd:C12464; cpd:C14404; cpd:C14784; cpd:C16733; cpd:C20327; cpd:C20646,10,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O3,C10H9O3,178.0629942,179.0708192,177.05516913771,4142,cpd:C02887,Sinapoyl malate;,C15H16O9,Sinapoyl malate; Sinapoyl-(S)-malate,R03323,Phenylpropanoid biosynthesis,2.3.1.92,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Sinapate derivatives;     C02887  Sinapoyl malate,PubChem: 5818; ChEBI: 15596; 3DMET: B01608,cpd:C01421; cpd:C02887; cpd:C09206; cpd:C09264,15,16,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H17O9,C15H15O9,340.0794321,341.0872571,339.07160713772,4143,cpd:C02947,4-Coumaroylshikimate;,C16H16O7,4-Coumaroylshikimate; trans-5-O-(4-Coumaroyl)shikimate,R02416 R06582,"Phenylpropanoid biosynthesis; Flavonoid biosynthesis; Stilbenoid, diarylheptanoid and gingerol biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites",1.14.13.36; 2.3.1.133,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Paracoumaryl alcohol derivatives;     C02947  4-Coumaroylshikimate,PubChem: 5866; ChEBI: 16428; ChEMBL: CHEMBL34615; PDB-CCD: SKT; 3DMET: B01614; NIKKAJI: J2.380.119A,cpd:C02947; cpd:C08106; cpd:C08113; cpd:C11586; cpd:C18358,16,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O7,C16H15O7,320.0896029,321.0974279,319.08177783773,4144,cpd:C04366,"3-(2-Carboxyethenyl)-cis,cis-muconate",C9H8O6,"3-(2-Carboxyethenyl)-cis,cis-muconate",R03365,Phenylpropanoid biosynthesis,1.13.11.22,NA,NA,PubChem: 7010; ChEBI: 16281; 3DMET: B00706; NIKKAJI: J2.377.463A,cpd:C04366; cpd:C12624; cpd:C18338,9,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O6,C9H7O6,212.032088,213.039913,211.02426293774,4145,cpd:C05158,trans-beta-D-Glucosyl-2-hydroxycinnamate;,C15H18O8,trans-beta-D-Glucosyl-2-hydroxycinnamate; beta-D-Glucosyl-2-coumarate,R03710 R04686,Phenylpropanoid biosynthesis; Biosynthesis of secondary metabolites,2.4.1.114; 5.2.1.-,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C05158  trans-beta-D-Glucosyl-2-hydroxycinnamate,PubChem: 7575; ChEBI: 17531; ChEMBL: CHEMBL374212; 3DMET: B01816; NIKKAJI: J7.037H,cpd:C04415; cpd:C05158; cpd:C05839; cpd:C06739; cpd:C07605; cpd:C15666; cpd:C16827,15,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H19O8,C15H17O8,326.1001675,327.1079926,325.09234253775,4146,cpd:C05608,4-Hydroxycinnamyl aldehyde;,C9H8O2,4-Hydroxycinnamyl aldehyde; p-Coumaraldehyde,R01615 R06579 R07437,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.195; 1.2.1.44; 1.14.13.-,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Paracoumaryl alcohol derivatives;     C05608  4-Hydroxycinnamyl aldehyde,CAS: 2538-87-6; PubChem: 7931; ChEBI: 28353; ChEMBL: CHEMBL431836; KNApSAcK: C00031014 C00031422; 3DMET: B00806; NIKKAJI: J460.239K,cpd:C00423; cpd:C02274; cpd:C04050; cpd:C05608; cpd:C07720; cpd:C07728; cpd:C07899; cpd:C10438; cpd:C14438; cpd:C17268,9,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O2,C9H7O2,148.0524295,149.0602545,147.04460453776,4147,cpd:C05610,Sinapoyl aldehyde;,C11H12O4,Sinapoyl aldehyde; Sinapaldehyde,R02220 R03918 R06576 R07441 R07442,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.195; 1.2.1.44; 1.2.1.68; 2.1.1.68,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Sinapate derivatives;     C05610  Sinapoyl aldehyde,CAS: 4206-58-0; PubChem: 7932; ChEBI: 27949; ChEMBL: CHEMBL225067; KNApSAcK: C00002775 C00031384; PDB-CCD: SNY; 3DMET: B00807; NIKKAJI: J329.696B,cpd:C02381; cpd:C02700; cpd:C05610; cpd:C09816; cpd:C15605; cpd:C18756; cpd:C19717,11,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O4,C11H11O4,208.0735589,209.0813839,207.06573383777,4148,cpd:C05619,5-Hydroxyferulic acid methyl ester,C10H10O5,5-Hydroxyferulic acid methyl ester,R02379 R06583 R07440,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.-; 2.1.1.68; 6.2.1.12,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Coniferyl alcohol derivatives;     C05619  5-Hydroxyferulate,CAS: 2041-35-2; PubChem: 7937; ChEBI: 2069; KNApSAcK: C00007336; 3DMET: B00811; NIKKAJI: J821.082I,cpd:C01993; cpd:C05619; cpd:C21450,10,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O5,C10H9O5,210.0528234,211.0606485,209.04499843778,4149,cpd:C05627,4-Hydroxystyrene;,C8H8O,4-Hydroxystyrene; 4-Vinylphenol,R02952,Phenylpropanoid biosynthesis,4.1.1.102,NA,NA,CAS: 2628-17-3; PubChem: 7942; ChEBI: 1883; ChEMBL: CHEMBL349881; PDB-CCD: 4VP; 3DMET: B00812; NIKKAJI: J38.247G,cpd:C00601; cpd:C02083; cpd:C05627; cpd:C06758; cpd:C07113; cpd:C07209; cpd:C07214; cpd:C14494; cpd:C14619; cpd:C20782,8,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O1,C8H7O1,120.0575149,121.0653399,119.04968983779,4150,cpd:C05838,cis-2-Hydroxycinnamate;,C9H8O3,cis-2-Hydroxycinnamate; 2-Coumarinate,R04998 R04999,Phenylpropanoid biosynthesis; Biosynthesis of secondary metabolites,3.2.1.21,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C05838  cis-2-Hydroxycinnamate,PubChem: 8131; ChEBI: 28873; 3DMET: B00864; NIKKAJI: J2.367.125E,cpd:C00166; cpd:C00811; cpd:C01772; cpd:C02763; cpd:C05838; cpd:C06738; cpd:C07114; cpd:C10945; cpd:C11020; cpd:C12463; cpd:C12621; cpd:C20685; cpd:C20687; cpd:C20939; cpd:C21345,9,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O3,C9H7O3,164.0473441,165.0551691,163.03951913780,4151,cpd:C05839,cis-beta-D-Glucosyl-2-hydroxycinnamate;,C15H18O8,cis-beta-D-Glucosyl-2-hydroxycinnamate; beta-D-Glucosyl-2-coumarinate,R04686 R04998,Phenylpropanoid biosynthesis; Biosynthesis of secondary metabolites,3.2.1.21; 5.2.1.-,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C05839  cis-beta-D-Glucosyl-2-hydroxycinnamate,PubChem: 8132; ChEBI: 62223 62251; 3DMET: B01900; NIKKAJI: J1.836.894C,cpd:C04415; cpd:C05158; cpd:C05839; cpd:C06739; cpd:C07605; cpd:C15666; cpd:C16827,15,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H19O8,C15H17O8,326.1001675,327.1079926,325.09234253781,4152,cpd:C05851,Coumarin;,C9H6O2,"Coumarin; Coumarine; Cumarin; 2H-1-Benzopyran-2-one; 1,2-Benzopyrone; 2-Propenoic acid, 3-(2-hydroxyphenyl)-, delta-lactone; 5,6-Benzo-2-pyrone; Benzo-alpha-pyrone; cis-o-Coumarinic acid lactone; Coumarinic anhydride; o-Hydroxycinnamic acid lactone; Rattex; Tonka bean camphor",R04999,Phenylpropanoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Coumarins;     C05851  Coumarin; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C05851  Coumarin; Phytochemicals used as drugs [BR:br08306];  Phenylpropanoids and related compounds;   Coumarins;    D07751  Coumarin (DCF),CAS: 91-64-5; PubChem: 8144; ChEBI: 28794; ChEMBL: CHEMBL6466; KNApSAcK: C00002460; PDB-CCD: COU; 3DMET: B00867; NIKKAJI: J3.218B,cpd:C05851; cpd:C18624,9,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H7O2,C9H5O2,146.0367794,147.0446045,145.02895443782,4153,cpd:C05855,4-Hydroxycinnamyl alcohol 4-D-glucoside;,C15H20O7,4-Hydroxycinnamyl alcohol 4-D-glucoside; p-Coumaryl alcohol 4-O-glucoside,R04005 R04006,Phenylpropanoid biosynthesis,2.4.1.111; 3.2.1.126,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Paracoumaryl alcohol derivatives;     C05855  4-Hydroxycinnamyl alcohol 4-D-glucoside,PubChem: 8148; ChEBI: 27588; 3DMET: B01904; NIKKAJI: J712.075C,cpd:C05855; cpd:C06080; cpd:C12076,15,20,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O7,C15H19O7,312.120903,313.128728,311.11307793783,4154,cpd:C06224,"3,4-Dihydroxystyrene",C8H8O2,"3,4-Dihydroxystyrene",R03367,Phenylpropanoid biosynthesis,4.1.1.102,NA,"Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Caffeate derivatives;     C06224  3,4-Dihydroxystyrene",PubChem: 8467; ChEBI: 1390; 3DMET: B00926; NIKKAJI: J136.559B,cpd:C00548; cpd:C01454; cpd:C01526; cpd:C02061; cpd:C03765; cpd:C05613; cpd:C06224; cpd:C07085; cpd:C07086; cpd:C07189; cpd:C07211; cpd:C07215; cpd:C10700; cpd:C10761; cpd:C11151; cpd:C11252; cpd:C14087; cpd:C15250; cpd:C15583; cpd:C20645; cpd:C21166; cpd:C21328; cpd:C21375,8,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O2,C8H7O2,136.0524295,137.0602545,135.04460453784,4155,cpd:C10428,Anethole;,C10H12O,Anethole; t-Anethole; trans-Anethole,R10252,Phenylpropanoid biosynthesis,2.1.1.279,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C10428  Anethole; Major components of natural products [BR:br08323];  Crude drugs;   Fennel oil;    C10428  Anethole;   Fennel;    C10428  Anethole;  Essential oils;   Fennel oil;    C10428  Anethole;   Anise oil;    C10428  Anethole;   Star anise oil (China);    C10428  Anethole;   Star anise oil (Vietnam);    C10428  Anethole;  Medicinal herbs;   Fennel;    C10428  Anethole,CAS: 4180-23-8 104-46-1; PubChem: 12613; ChEBI: 35616; ChEMBL: CHEMBL452630; KNApSAcK: C00002713 C00029334; 3DMET: B03836; NIKKAJI: J4.026F,cpd:C00780; cpd:C06577; cpd:C10428; cpd:C10452; cpd:C14309; cpd:C17203; cpd:C17965; cpd:C21075,10,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O1,C10H11O1,148.088815,149.09664,147.080993785,4156,cpd:C10434,5-O-Caffeoylshikimic acid,C16H16O8,5-O-Caffeoylshikimic acid,R06582 R07433 R10701,"Phenylpropanoid biosynthesis; Flavonoid biosynthesis; Stilbenoid, diarylheptanoid and gingerol biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites",1.14.13.36; 2.3.1.133; 3.1.1.-,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Caffeate derivatives;     C10434  5-O-Caffeoylshikimic acid,CAS: 73263-62-4; PubChem: 12619; ChEBI: 2106; KNApSAcK: C00002720; 3DMET: B03842; NIKKAJI: J139.306E,cpd:C06894; cpd:C10296; cpd:C10434,16,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O8,C16H15O8,336.0845175,337.0923425,335.07669243786,4157,cpd:C10452,Estragole;,C10H12O,Estragole; 1-Methoxy-4-(2-propenyl)benzene; Methylchavicol,R10251,Phenylpropanoid biosynthesis,2.1.1.146,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C10452  Estragole; Major components of natural products [BR:br08323];  Essential oils;   Basil oil;    C10452  Estragole,CAS: 140-67-0; PubChem: 12635; ChEBI: 4867; ChEMBL: CHEMBL470671; KNApSAcK: C00002740; 3DMET: B03858; NIKKAJI: J5.794K,cpd:C00780; cpd:C06577; cpd:C10428; cpd:C10452; cpd:C14309; cpd:C17203; cpd:C17965; cpd:C21075,10,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O1,C10H11O1,148.088815,149.09664,147.080993787,4158,cpd:C10453,Eugenol,C10H12O2,Eugenol,R09930 R10248 R10250,Phenylpropanoid biosynthesis,1.1.1.318; 2.1.1.146,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C10453  Eugenol; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C10453  Eugenol; Classification of Japanese OTC drugs [BR:br08313];  Agents for dental and stomatological use;   75 Toothache and pyorrhea remedies;    D04117  Eugenol (USP); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Eugenol;     D04117  Eugenol (USP); Pharmaceutical additives [BR:br08316];  Flavoring substance;   D04117  [102290] Eugenol;  Refresher;   D04117  [102290] Eugenol; Major components of natural products [BR:br08323];  Essential oils;   Bay oil;    C10453  Eugenol;   Pimento berry oil;    C10453  Eugenol;   Cinnamon leaf oil;    C10453  Eugenol; Animal drugs in Japan [BR:br08331];  91  Agents affecting nervous system;   911  General anesthetics;    9119  Other general anesthetics;     C10453  Eugenol,CAS: 97-53-0; PubChem: 12636; ChEBI: 4917; ChEMBL: CHEMBL42710; KNApSAcK: C00000619; PDB-CCD: EOL; 3DMET: B03859; NIKKAJI: J3.977B,cpd:C06578; cpd:C09858; cpd:C09904; cpd:C09905; cpd:C09907; cpd:C10453; cpd:C10469; cpd:C12303; cpd:C14506; cpd:C16151; cpd:C17104; cpd:C18950; cpd:C19018; cpd:C19229; cpd:C19349; cpd:C19729,10,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O2,C10H11O2,164.0837296,165.0915547,163.07590463788,4159,cpd:C10454,Methyleugenol;,C11H14O2,Methyleugenol; O-Methyleugenol; Eugenol methyl ether,R10250,Phenylpropanoid biosynthesis,2.1.1.146,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C10454  Methyleugenol; Major components of natural products [BR:br08323];  Crude drugs;   Asiasarum root;    C10454  Methyleugenol,CAS: 93-15-2; PubChem: 12637; ChEBI: 4918; ChEMBL: CHEMBL108861; KNApSAcK: C00002741; 3DMET: B03860; NIKKAJI: J4.669H,cpd:C05808; cpd:C07499; cpd:C10454; cpd:C10478; cpd:C11165; cpd:C12590; cpd:C14535; cpd:C14709; cpd:C17551; cpd:C17663; cpd:C17665; cpd:C17666; cpd:C17782,11,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O2,C11H13O2,178.0993797,179.1072047,177.09155473789,4160,cpd:C10469,Isoeugenol,C10H12O2,Isoeugenol,R07240 R09931,Phenylpropanoid biosynthesis,1.1.1.319; 2.1.1.146; 2.1.1.279,NA,NA,CAS: 97-54-1; PubChem: 12652; ChEBI: 18224 50545; ChEMBL: CHEMBL193598; KNApSAcK: C00000620 C00035095; PDB-CCD: EUG H7Y; 3DMET: B03874; NIKKAJI: J3.221B,cpd:C06578; cpd:C09858; cpd:C09904; cpd:C09905; cpd:C09907; cpd:C10453; cpd:C10469; cpd:C12303; cpd:C14506; cpd:C16151; cpd:C17104; cpd:C18950; cpd:C19018; cpd:C19229; cpd:C19349; cpd:C19729,10,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O2,C10H11O2,164.0837296,165.0915547,163.07590463790,4161,cpd:C10478,Methylisoeugenol;,C11H14O2,Methylisoeugenol; trans-Methylisoeugenol; Isomethyleugenol,R07240,Phenylpropanoid biosynthesis,2.1.1.146; 2.1.1.279,NA,NA,CAS: 6379-72-2; PubChem: 12661; ChEBI: 6877; ChEMBL: CHEMBL465829; KNApSAcK: C00002760 C00035131; 3DMET: B03883; NIKKAJI: J15.690F,cpd:C05808; cpd:C07499; cpd:C10454; cpd:C10478; cpd:C11165; cpd:C12590; cpd:C14535; cpd:C14709; cpd:C17551; cpd:C17663; cpd:C17665; cpd:C17666; cpd:C17782,11,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O2,C11H13O2,178.0993797,179.1072047,177.09155473791,4162,cpd:C10945,Caffeic aldehyde;,C9H8O3,"Caffeic aldehyde; 3,4-Dihydroxycinnamaldehyde; Caffeyl aldehyde",R01941 R06571 R06574 R06579,Phenylpropanoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.195; 1.2.1.44; 1.14.13.-; 2.1.1.68,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Caffeate derivatives;     C10945  Caffeic aldehyde,PubChem: 13128; ChEBI: 28323; ChEMBL: CHEMBL17291; KNApSAcK: C00007511; 3DMET: B04200; NIKKAJI: J1.712.035B,cpd:C00166; cpd:C00811; cpd:C01772; cpd:C02763; cpd:C05838; cpd:C06738; cpd:C07114; cpd:C10945; cpd:C11020; cpd:C12463; cpd:C12621; cpd:C20685; cpd:C20687; cpd:C20939; cpd:C21345,9,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O3,C9H7O3,164.0473441,165.0551691,163.03951913792,4163,cpd:C12203,5-Hydroxyferuloyl-CoA,C31H44N7O20P3S,5-Hydroxyferuloyl-CoA,R06569 R06578 R06583 R06584,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.2.1.44; 2.1.1.104; 6.2.1.12,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Coniferyl alcohol derivatives;     C12203  5-Hydroxyferuloyl-CoA,CAS: 59862-14-5; PubChem: 14349; ChEBI: 31136; KNApSAcK: C00007361; PDB-CCD: FRE; 3DMET: B05611; NIKKAJI: J985.469J,cpd:C12203; cpd:C21459,31,44,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H45O20N7P3S1,C31H43O20N7P3S1,959.157469,960.165294,958.1496443793,4164,cpd:C12204,5-Hydroxyconiferaldehyde,C10H10O4,5-Hydroxyconiferaldehyde,R06569 R06570 R06572 R06576,Phenylpropanoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.195; 1.2.1.44; 1.14.13.-; 2.1.1.68,"Monolignol biosynthesis, phenylalanine/tyrosine  => monolignol",Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Sinapate derivatives;     C12204  5-Hydroxyconiferaldehyde,CAS: 249647-14-1; PubChem: 14350; ChEBI: 31134; KNApSAcK: C00007611; 3DMET: B04444; NIKKAJI: J1.181.065I J1.273.258I,cpd:C00779; cpd:C01494; cpd:C02379; cpd:C09974; cpd:C10470; cpd:C10477; cpd:C11233; cpd:C12204; cpd:C12465; cpd:C16982; cpd:C17532; cpd:C21347; cpd:C21361,10,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O4,C10H9O4,194.0579088,195.0657338,193.05008383794,4165,cpd:C12205,5-Hydroxyconiferyl alcohol,C10H12O4,5-Hydroxyconiferyl alcohol,R06570 R06573 R06577 R07443,Phenylpropanoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.195; 1.11.1.7; 1.11.1.21; 1.14.13.-; 2.1.1.68,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Sinapate derivatives;     C12205  5-Hydroxyconiferyl alcohol,CAS: 1782-47-4; PubChem: 14351; ChEBI: 86068; KNApSAcK: C00007337; 3DMET: B04445; NIKKAJI: J2.011.749D J901.552C,cpd:C00343; cpd:C01736; cpd:C02794; cpd:C03227; cpd:C05512; cpd:C05651; cpd:C06580; cpd:C07312; cpd:C07351; cpd:C07930; cpd:C10664; cpd:C10684; cpd:C10726; cpd:C11266; cpd:C12205; cpd:C15586; cpd:C16778; cpd:C17455; cpd:C21102,10,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O4,C10H11O4,196.0735589,197.0813839,195.06573383795,4166,cpd:C12206,Caffeyl alcohol,C9H10O3,Caffeyl alcohol,R06571 R06575 R06580,Phenylpropanoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.195; 2.1.1.68,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Caffeate derivatives;     C12206  Caffeyl alcohol,PubChem: 14352; ChEBI: 86071; ChEMBL: CHEMBL1321891; KNApSAcK: C00007310; 3DMET: B04446; NIKKAJI: J1.140.570C,cpd:C01198; cpd:C01456; cpd:C01744; cpd:C02201; cpd:C02363; cpd:C02515; cpd:C03080; cpd:C05581; cpd:C05607; cpd:C10712; cpd:C11380; cpd:C11457; cpd:C12206; cpd:C12462; cpd:C17079; cpd:C18397,9,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O3,C9H9O3,166.0629942,167.0708192,165.05516913796,4167,cpd:C12208,p-Coumaroyl quinic acid;,C16H18O8,p-Coumaroyl quinic acid; trans-5-O-(4-Coumaroyl)-D-quinate,R04342 R07432,"Phenylpropanoid biosynthesis; Flavonoid biosynthesis; Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",1.14.13.36; 2.3.1.133,NA,NA,PubChem: 14353; ChEBI: 15937; ChEMBL: CHEMBL284243; KNApSAcK: C00029511; 3DMET: B05612; NIKKAJI: J93.937D,cpd:C10432; cpd:C10441; cpd:C12208,16,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H19O8,C16H17O8,338.1001675,339.1079926,337.09234253797,4168,cpd:C16930,Chavicol,C9H10O,Chavicol,R10249 R10251,Phenylpropanoid biosynthesis,1.1.1.318; 2.1.1.146,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Monolignols;    Others;     C16930  Chavicol,CAS: 501-92-8; PubChem: 96023422; ChEBI: 50158; ChEMBL: CHEMBL108862; KNApSAcK: C00000621; NIKKAJI: J6.195F,cpd:C01710; cpd:C02394; cpd:C13840; cpd:C15512; cpd:C16930; cpd:C18428; cpd:C20464,9,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O1,C9H9O1,134.0731649,135.08099,133.06533993798,4169,cpd:C18069,"N1,N5,N10-Tricoumaroyl spermidine",C34H37N3O6,"N1,N5,N10-Tricoumaroyl spermidine",R08983 R08984,Phenylpropanoid biosynthesis,1.14.13.-,NA,NA,PubChem: 96024287; ChEBI: 61514; NIKKAJI: J346.406G,cpd:C18069,34,37,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H38O6N3,C34H36O6N3,583.2682359,584.276061,582.26041093799,4170,cpd:C18070,"N1,N5,N10-Tricaffeoyl spermidine",C34H37N3O9,"N1,N5,N10-Tricaffeoyl spermidine",R08984 R08985,Phenylpropanoid biosynthesis,1.14.13.-; 2.1.1.-,NA,NA,PubChem: 96024288; ChEBI: 81478; NIKKAJI: J682.359I,cpd:C18070,34,37,9,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H38O9N3,C34H36O9N3,631.2529798,632.2608048,630.24515473800,4171,cpd:C18071,"N1,N5,N10-Triferuloyl spermidine",C37H43N3O9,"N1,N5,N10-Triferuloyl spermidine",R08985 R08986,Phenylpropanoid biosynthesis,1.14.13.-; 2.1.1.-,NA,NA,PubChem: 96024289; ChEBI: 81479; NIKKAJI: J1.954.618G,cpd:C18071,37,43,9,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H44O9N3,C37H42O9N3,673.29993,674.307755,672.29210493801,4172,cpd:C18072,"N1,N5,N10-Tri(hydroxyferuloyl) spermidine",C37H43N3O12,"N1,N5,N10-Tri(hydroxyferuloyl) spermidine",R08986 R08987,Phenylpropanoid biosynthesis,1.14.13.-; 2.1.1.-,NA,NA,PubChem: 96024290; ChEBI: 81480; KNApSAcK: C00024665,cpd:C18072,37,43,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H44O12N3,C37H42O12N3,721.2846738,722.2924989,720.27684883802,4173,cpd:C18073,"N1,N5-Di(hydroxyferuloyl)-N10-sinapoyl spermidine",C38H45N3O12,"N1,N5-Di(hydroxyferuloyl)-N10-sinapoyl spermidine",R08987,Phenylpropanoid biosynthesis,2.1.1.-,NA,NA,PubChem: 96024291; ChEBI: 61516; NIKKAJI: J2.763.719A,cpd:C18073,38,45,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C38H46O12N3,C38H44O12N3,735.3003239,736.3081489,734.29249893803,4174,cpd:C20225,Coniferyl acetate,C12H14O4,Coniferyl acetate,R09931 R10248 R10253,Phenylpropanoid biosynthesis,1.1.1.318; 1.1.1.319; 2.3.1.-,NA,NA,PubChem: 163311968,cpd:C07630; cpd:C10429; cpd:C10449; cpd:C14175; cpd:C14432; cpd:C17554; cpd:C18654; cpd:C18925; cpd:C19228; cpd:C20225,12,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H15O4,C12H13O4,222.0892089,223.097034,221.08138393804,4175,cpd:C20464,Isochavicol;,C9H10O,Isochavicol; t-Anol; trans-Anol; (E)-4-Propenylphenol; (E)-4-Hydroxypropenylbenzene,R10252 R10289,Phenylpropanoid biosynthesis,1.1.1.319; 2.1.1.279,NA,NA,CAS: 20649-39-2 539-12-8; PubChem: 163312201,cpd:C01710; cpd:C02394; cpd:C13840; cpd:C15512; cpd:C16930; cpd:C18428; cpd:C20464,9,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O1,C9H9O1,134.0731649,135.08099,133.06533993805,4176,cpd:C20465,Coumaryl acetate,C11H12O3,Coumaryl acetate,R10249 R10254 R10289,Phenylpropanoid biosynthesis,1.1.1.318; 1.1.1.319; 2.3.1.-,NA,NA,PubChem: 163312202; ChEBI: 73346,cpd:C00643; cpd:C01017; cpd:C09985; cpd:C10435; cpd:C10480; cpd:C10493; cpd:C12343; cpd:C12540; cpd:C12616; cpd:C14104; cpd:C16896; cpd:C17840; cpd:C19716; cpd:C20465,11,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O3,C11H11O3,192.0786442,193.0864693,191.07081923806,4177,cpd:C21459,6-Hydroxyferuloyl-CoA,C31H44N7O20P3S,6-Hydroxyferuloyl-CoA,R11549 R11550,Phenylpropanoid biosynthesis; Biosynthesis of secondary metabolites,1.14.11.-,NA,NA,PubChem: 329728082,cpd:C12203; cpd:C21459,31,44,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C31H45O20N7P3S1,C31H43O20N7P3S1,959.157469,960.165294,958.1496443807,4178,cpd:C00389,Quercetin;,C15H10O7,"Quercetin; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone",R02156 R02157 R02158 R02159 R02160 R02436 R06538 R06810; R09803 R10258,Flavonoid biosynthesis; Flavone and flavonol biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites; AMPK signaling pathway,1.13.11.24; 1.14.11.23; 1.14.13.21; 1.14.13.88; 2.1.1.76; 2.4.1.91; 2.4.1.237; 2.4.1.-; 2.8.2.25; 3.2.1.66,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C00389  Quercetin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C00389  Quercetin; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C00389  Quercetin; Target-based classification of compounds [BR:br08010];  Transporters;   Solute carrier family;    SLC22;     SLC22A8;      C00389  Quercetin; Cytochrome P450 interactions [BR:br08309];  Transporter inhibitors;   ABCB1;    Quercetin;     C00389  Quercetin,CAS: 117-39-5; PubChem: 3679; ChEBI: 16243; ChEMBL: CHEMBL50; LIPIDMAPS: LMPK12110004; KNApSAcK: C00004631; PDB-CCD: QUE; 3DMET: B00102; NIKKAJI: J2.907F,cpd:C00389; cpd:C02806; cpd:C03662; cpd:C08577; cpd:C10068; cpd:C10072; cpd:C10078; cpd:C10079; cpd:C10105; cpd:C10177; cpd:C10192; cpd:C15031,15,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O7,C15H9O7,302.0426527,303.0504777,301.03482763808,4179,cpd:C00509,Naringenin;,C15H12O5,"Naringenin; 4',5,7-Trihydroxyflavanone; (2S)-Naringenin; (-)-(2S)-Naringenin",R02442 R02444 R02445 R02446 R02897 R06553 R06610 R07778; R08026 R08129 R08951 R09791,Flavonoid biosynthesis; Isoflavonoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.234; 1.14.11.9; 1.14.11.22; 1.14.13.21; 1.14.13.88; 1.14.13.136; 2.1.1.232; 2.4.1.185; 2.5.1.70; 5.5.1.6,"Flavanone biosynthesis, phenylalanine => naringenin; Flavonoid biosynthesis, naringenin => pelargonidin",Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C00509  Naringenin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C00509  Naringenin,CAS: 480-41-1; PubChem: 3792; ChEBI: 17846; ChEMBL: CHEMBL9352; LIPIDMAPS: LMPK12140001; KNApSAcK: C00000982; PDB-CCD: NAR; 3DMET: B01275; NIKKAJI: J325.849A,cpd:C00509; cpd:C01263; cpd:C01592; cpd:C03567; cpd:C06561; cpd:C08578; cpd:C09047; cpd:C09614; cpd:C09751; cpd:C09826; cpd:C12087; cpd:C14458; cpd:C15567; cpd:C15598; cpd:C16232; cpd:C17673,15,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O5,C15H11O5,272.0684735,273.0762985,271.06064853809,4180,cpd:C00974,Dihydrokaempferol;,C15H12O6,Dihydrokaempferol; Aromadendrin; (+)-Dihydrokaempferol; (+)-Aromadendrin,R02444 R03123 R03124 R03126 R06540,Flavonoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.219; 1.14.11.9; 1.14.11.19; 1.14.11.23; 1.14.13.21; 1.14.13.88,"Flavonoid biosynthesis, naringenin => pelargonidin",Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Dihyroflavonols;     C00974  Dihydrokaempferol,CAS: 480-20-6; PubChem: 4223; ChEBI: 15401; ChEMBL: CHEMBL9323; KNApSAcK: C00007234; 3DMET: B01364; NIKKAJI: J12.461C,cpd:C00974; cpd:C01378; cpd:C05631; cpd:C08724; cpd:C09277; cpd:C10060; cpd:C10064; cpd:C10083; cpd:C10091; cpd:C10415; cpd:C12631; cpd:C15525; cpd:C16233; cpd:C16940,15,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O6,C15H11O6,288.0633881,289.0712131,287.05556313810,4181,cpd:C01378,Fustin;,C15H12O6,"Fustin; 2,3-Dihydrofisetin",R07997 R07999 R08001 R08032,Flavonoid biosynthesis,1.1.1.219; 1.14.11.9; 1.14.13.21,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Dihyroflavonols;     C01378  Fustin,CAS: 20725-03-5; PubChem: 4573; ChEBI: 5202; ChEMBL: CHEMBL470267; KNApSAcK: C00000963; 3DMET: B01445; NIKKAJI: J231.369C,cpd:C00974; cpd:C01378; cpd:C05631; cpd:C08724; cpd:C09277; cpd:C10060; cpd:C10064; cpd:C10083; cpd:C10091; cpd:C10415; cpd:C12631; cpd:C15525; cpd:C16233; cpd:C16940,15,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O6,C15H11O6,288.0633881,289.0712131,287.05556313811,4182,cpd:C01460,Vitexin;,C21H20O10,Vitexin; Apigenin 8-C-glucoside,R03565 R06822 R06823 R08130,Flavonoid biosynthesis; Flavone and flavonol biosynthesis,2.4.1.105,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C01460  Vitexin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C01460  Vitexin,CAS: 3681-93-4; PubChem: 4637; ChEBI: 16954; ChEMBL: CHEMBL1332209 CHEMBL487417; KNApSAcK: C00001110; 3DMET: B01454; NIKKAJI: J14.961F,cpd:C01460; cpd:C01714; cpd:C04608; cpd:C09126; cpd:C10345; cpd:C10420; cpd:C16911,21,20,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O10,C21H19O10,432.1056468,433.1134719,431.09782183812,4183,cpd:C01477,Apigenin;,C15H10O5,"Apigenin; 4',5,7-Trihydroxyflavone; 5,7,4'-Trihydroxyflavone",R02445 R03571 R03574 R06537 R06792 R06822 R06825,Flavonoid biosynthesis; Isoflavonoid biosynthesis; Flavone and flavonol biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.11.22; 1.14.13.21; 1.14.13.88; 2.1.1.75; 2.4.1.81,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C01477  Apigenin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C01477  Apigenin,CAS: 520-36-5; PubChem: 4649; ChEBI: 18388; ChEMBL: CHEMBL28; LIPIDMAPS: LMPK12110005; KNApSAcK: C00003817; PDB-CCD: AGI; 3DMET: B00300; NIKKAJI: J6.601J,cpd:C01477; cpd:C02495; cpd:C06563; cpd:C08730; cpd:C10023; cpd:C10037; cpd:C10044; cpd:C10113; cpd:C10294; cpd:C10343; cpd:C10369; cpd:C10376; cpd:C10379; cpd:C10397; cpd:C14313; cpd:C14314; cpd:C15222; cpd:C16796,15,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O5,C15H9O5,270.0528234,271.0606485,269.04499843813,4184,cpd:C01514,Luteolin;,C15H10O6,"Luteolin; 3',4',5,7-Tetrahydroxyflavone; 5,7,3',4'-Tetrahydroxyflavone",R03587 R03588 R03589 R03590 R06537 R10260,Flavonoid biosynthesis; Flavone and flavonol biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.11.22; 1.14.13.21; 1.14.13.88; 2.1.1.42; 2.4.1.81; 2.4.1.189,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C01514  Luteolin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C01514  Luteolin; Major components of natural products [BR:br08323];  Crude drugs;   Chrysanthemum flower;    C01514  Luteolin,CAS: 491-70-3; PubChem: 4680; ChEBI: 15864; ChEMBL: CHEMBL151; LIPIDMAPS: LMPK12110006; KNApSAcK: C00000674; PDB-CCD: LU2; 3DMET: B00310; NIKKAJI: J1.554G,cpd:C01514; cpd:C05903; cpd:C08576; cpd:C08720; cpd:C10036; cpd:C10041; cpd:C10097; cpd:C10184; cpd:C10510; cpd:C12134; cpd:C17786; cpd:C17810; cpd:C18736,15,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O6,C15H9O6,286.047738,287.0555631,285.0399133814,4185,cpd:C01617,Taxifolin;,C15H12O7,Taxifolin; Dihydroquercetin; (+)-Dihydroquercetin; (+)-Taxifolin; trans-Dihydroquercetin,R02160 R03124 R03636 R03637 R03638 R03639 R03640 R05723,Flavonoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.219; 1.14.11.9; 1.14.11.19; 1.14.11.23; 1.14.13.19; 1.14.13.21; 1.14.13.88,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Dihyroflavonols;     C01617  Taxifolin,CAS: 480-18-2; PubChem: 4769; ChEBI: 17948; ChEMBL: CHEMBL66; KNApSAcK: C00000677; PDB-CCD: DQH; 3DMET: B01471; NIKKAJI: J90.394I,cpd:C01617; cpd:C05911; cpd:C12316,15,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O7,C15H11O7,304.0583027,305.0661278,303.05047773815,4186,cpd:C01709,Hesperetin;,C16H14O6,"Hesperetin; 3',5,7-Trihydroxy-4'-methoxyflavanone",R08021 R08026 R09534,Flavonoid biosynthesis,2.4.1.185; 3.2.1.168,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C01709  Hesperetin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C01709  Hesperetin,CAS: 520-33-2; PubChem: 4847; ChEBI: 28230; ChEMBL: CHEMBL399121; LIPIDMAPS: LMPK12140003; KNApSAcK: C00000968; PDB-CCD: 6JP; 3DMET: B01483; NIKKAJI: J9.235E,cpd:C01709; cpd:C09756; cpd:C09931; cpd:C10377; cpd:C10419; cpd:C12436; cpd:C16405,16,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O6,C16H13O6,302.0790382,303.0868632,301.07121313816,4187,cpd:C02906,Dihydromyricetin;,C15H12O8,Dihydromyricetin; Ampelopsin; (+)-Dihydromyricetin; (+)-Ampelopsin,R03639 R05038 R05039 R06539,Flavonoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.219; 1.14.11.9; 1.14.11.23; 1.14.13.88,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Dihyroflavonols;     C02906  Dihydromyricetin,CAS: 27200-12-0; PubChem: 5833; ChEBI: 28429; KNApSAcK: C00000938; 3DMET: B01611; NIKKAJI: J17.065H,cpd:C02906; cpd:C03052; cpd:C18348,15,12,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O8,C15H11O8,320.0532173,321.0610424,319.04539233817,4188,cpd:C03648,"cis-3,4-Leucopelargonidin",C15H14O6,"cis-3,4-Leucopelargonidin",R03123 R04276 R06540 R06615,Flavonoid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.219; 1.14.11.19; 1.17.1.3,"Flavonoid biosynthesis, naringenin => pelargonidin","Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3,4-diols;     C03648  cis-3,4-Leucopelargonidin",PubChem: 6429; ChEBI: 17343; KNApSAcK: C00020638; 3DMET: B01679; NIKKAJI: J862.802E,cpd:C03648; cpd:C05907; cpd:C06562; cpd:C08117; cpd:C08739; cpd:C08742; cpd:C09030; cpd:C09511; cpd:C09727; cpd:C09728; cpd:C09736; cpd:C09787; cpd:C09796; cpd:C14021; cpd:C14079; cpd:C17590,15,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O6,C15H13O6,290.0790382,291.0868632,289.07121313818,4189,cpd:C05631,Eriodictyol,C15H12O6,Eriodictyol,R02442 R03590 R03640 R04901 R04902 R07991 R08012,Flavonoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.234; 1.14.11.9; 1.14.11.22; 1.14.13.21; 1.14.13.88,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C05631  Eriodictyol; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C05631  Eriodictyol,CAS: 552-58-9; PubChem: 7944; ChEBI: 28412; ChEMBL: CHEMBL8996; LIPIDMAPS: LMPK12140002; KNApSAcK: C00000960; PDB-CCD: ERD; 3DMET: B01880; NIKKAJI: J139.243C,cpd:C00974; cpd:C01378; cpd:C05631; cpd:C08724; cpd:C09277; cpd:C10060; cpd:C10064; cpd:C10083; cpd:C10091; cpd:C10415; cpd:C12631; cpd:C15525; cpd:C16233; cpd:C16940,15,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O6,C15H11O6,288.0633881,289.0712131,287.05556313819,4190,cpd:C05903,Kaempferol;,C15H10O6,"Kaempferol; 3,4',5,7-Tetrahydroxyflavone; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 5,7,4'-Trihydroxyflavonol; C.I. 75640; Indigo yellow; Kaempherol; Kempferol; Nimbecetin; Pelargidenolon; Populnetin; Rhamnolutein; Rhamnolutin; Robigenin; Swartziol; Trifolitin",R03126 R05035 R06538 R06611 R06807 R06808 R09802 R10609,Flavonoid biosynthesis; Flavone and flavonol biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.11.23; 1.14.13.21; 1.14.13.88; 2.1.1.76; 2.1.1.155; 2.4.1.91; 2.4.1.234; 2.4.1.-; 2.4.2.56,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C05903  Kaempferol; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C05903  Kaempferol; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C05903  Kaempferol; Major components of natural products [BR:br08323];  Crude drugs;   Tribulus fruit;    C05903  Kaempferol,CAS: 520-18-3; PubChem: 8191; ChEBI: 28499; ChEMBL: CHEMBL150; LIPIDMAPS: LMPK12110003; KNApSAcK: C00004565; PDB-CCD: KMP; 3DMET: B00874; NIKKAJI: J1.575J,cpd:C01514; cpd:C05903; cpd:C08576; cpd:C08720; cpd:C10036; cpd:C10041; cpd:C10097; cpd:C10184; cpd:C10510; cpd:C12134; cpd:C17786; cpd:C17810; cpd:C18736,15,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O6,C15H9O6,286.047738,287.0555631,285.0399133820,4191,cpd:C05904,Pelargonidin;,C15H11O5,"Pelargonidin; 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)benzopyrylium chloride; 3,4',5,7-Tetrahydroxyflavylium chloride; Pelargonidin chloride; Pelargonidol chloride",R04276 R06534 R06541,Flavonoid biosynthesis; Anthocyanin biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.77; 1.14.11.19; 2.4.1.115,"Flavonoid biosynthesis, naringenin => pelargonidin",Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C05904  Pelargonidin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C05904  Pelargonidin,CAS: 134-04-3; PubChem: 8192; ChEBI: 25863 28510; ChEMBL: CHEMBL1197905; LIPIDMAPS: LMPK12010003; KNApSAcK: C00007232; 3DMET: B01905; NIKKAJI: J244.797E,cpd:C05904; cpd:C08652; cpd:C11068,15,11,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H12O5,C15H10O5,271.0606485,272.0684735,270.05282343821,4192,cpd:C05905,Cyanidin;,C15H11O6,"Cyanidin; 3,3',4',5,7-Pentahydroxyflavylium chloride; Chlorure de 3,3',4',5,7-pentahydroxyflavylium; 3,3',4',5,7-Pentahydroxyflavyliumchlorid; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyrylium chloride; 3,3',4',5,7-Pentahydroxy-2-phenylbenzopyrylium chloride; Cyanidin chloride; Cyanidine; Cyanidol; Cyanidol chloride; IdB 1027",R05036 R06535 R06542 R07908 R10240,Flavonoid biosynthesis; Anthocyanin biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.3.1.77; 1.14.11.19; 2.4.1.115; 2.4.1.294; 2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C05905  Cyanidin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C05905  Cyanidin,CAS: 528-58-5; PubChem: 8193; ChEBI: 27843; ChEMBL: CHEMBL404515; LIPIDMAPS: LMPK12010002; KNApSAcK: C00006614; 3DMET: B01906; NIKKAJI: J401.296H,cpd:C05905; cpd:C08575,15,11,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H12O6,C15H10O6,287.0555631,288.0633881,286.0477383822,4193,cpd:C05906,Leucocyanidin;,C15H14O7,"Leucocyanidin; 2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,4,5,7-tetrol; 3,3',4,4',5,7-Flavanhexol; 3,4-Cyanidiol; Leucoanthocyanidol; Leucocianidol; Leucocyanidol; Leukocyanidine; Procyanidol; Resivit; 2,3-trans-3,4-cis-Leucocyanidin",R03636 R05036 R05723 R06532 R07366,Flavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.1.1.219; 1.14.11.19; 1.17.1.3,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1202 Flavans, Flavanols and Leucoanthocyanidins;     C05906  Leucocyanidin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3,4-diols;     C05906  Leucocyanidin",CAS: 93527-39-0; PubChem: 8194; ChEBI: 11412 15758; ChEMBL: CHEMBL124022; LIPIDMAPS: LMPK12020203; KNApSAcK: C00008991; 3DMET: B01907; NIKKAJI: J862.804A,cpd:C05906; cpd:C12127; cpd:C12136; cpd:C18855,15,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O7,C15H13O7,306.0739528,307.0817778,305.06612783823,4194,cpd:C05907,Luteoforol;,C15H14O6,Luteoforol; 3-Deoxyleucocyanidin,R04901,Flavonoid biosynthesis,1.1.1.234,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1202 Flavans, Flavanols and Leucoanthocyanidins;     C05907  Luteoforol; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 4-ols;     C05907  Luteoforol",CAS: 24897-98-1; PubChem: 8195; ChEBI: 27686; KNApSAcK: C00008977; 3DMET: B05137; NIKKAJI: J972.193B,cpd:C03648; cpd:C05907; cpd:C06562; cpd:C08117; cpd:C08739; cpd:C08742; cpd:C09030; cpd:C09511; cpd:C09727; cpd:C09728; cpd:C09736; cpd:C09787; cpd:C09796; cpd:C14021; cpd:C14079; cpd:C17590,15,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O6,C15H13O6,290.0790382,291.0868632,289.07121313824,4195,cpd:C05908,Delphinidin;,C15H11O7,"Delphinidin; 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)benzopyrylium chloride; Chlorure de 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)benzopyrylium; 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)benzopyryliumchlorid; 3,3',4',5,5',7-Hexahydroxy-2-phenylbenzopyrylium chloride; 3,3',4',5,5',7-Hexahydroxyflavylium chloride; Delfinidol chloride; Delphinidin chloride; Delphinidine; Delphinidol; Ephdine; IdB 1056",R05037 R06536 R06543,Flavonoid biosynthesis; Anthocyanin biosynthesis; Biosynthesis of secondary metabolites,1.3.1.77; 1.14.11.19; 2.4.1.115,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C05908  Delphinidin,CAS: 528-53-0; PubChem: 8196; ChEBI: 28436; ChEMBL: CHEMBL276780; LIPIDMAPS: LMPK12010001; KNApSAcK: C00020091; PDB-CCD: DLM; 3DMET: B01908; NIKKAJI: J402.606C,cpd:C05908; cpd:C08646,15,11,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H12O7,C15H10O7,303.0504777,304.0583027,302.04265273825,4196,cpd:C05909,Leucodelphinidin,C15H14O8,Leucodelphinidin,R05037 R05038 R06533,Flavonoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.219; 1.14.11.19; 1.17.1.3,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3,4-diols;     C05909  Leucodelphinidin",PubChem: 8197; ChEBI: 6417; LIPIDMAPS: LMPK12020209; KNApSAcK: C00008992; 3DMET: B01909; NIKKAJI: J2.768.814D,cpd:C05909,15,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O8,C15H13O8,322.0688674,323.0766924,321.06104243826,4197,cpd:C05911,Pentahydroxyflavanone;,C15H12O7,Pentahydroxyflavanone; Dihydrotricetin,R04902 R05039 R06551,Flavonoid biosynthesis; Biosynthesis of secondary metabolites,1.14.11.9; 1.14.11.22; 1.14.13.88,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C05911  Pentahydroxyflavanone,PubChem: 8199; ChEBI: 48026; 3DMET: B01910,cpd:C01617; cpd:C05911; cpd:C12316,15,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O7,C15H11O7,304.0583027,305.0661278,303.05047773827,4198,cpd:C06561,Naringenin chalcone;,C15H12O5,"Naringenin chalcone; 2',4,4',6'-Tetrahydroxychalcone; Isosalipurpol; Chalconaringenin",R01613 R02446 R07224 R08003 R08006 R08013,Flavonoid biosynthesis; Biosynthesis of phenylpropanoids; Metabolic pathways; Biosynthesis of secondary metabolites,1.21.3.6; 2.3.1.74; 2.4.1.286; 2.4.1.-; 5.5.1.6,"Flavanone biosynthesis, phenylalanine => naringenin",Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1212 Chalcones and dihydrochalcones;     C06561  Naringenin chalcone; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Chalcones;     C06561  Naringenin chalcone,CAS: 25515-46-2; PubChem: 8790; ChEBI: 15413; ChEMBL: CHEMBL338066; LIPIDMAPS: LMPK12120264; KNApSAcK: C00007233; 3DMET: B00973; NIKKAJI: J16.987K,cpd:C00509; cpd:C01263; cpd:C01592; cpd:C03567; cpd:C06561; cpd:C08578; cpd:C09047; cpd:C09614; cpd:C09751; cpd:C09826; cpd:C12087; cpd:C14458; cpd:C15567; cpd:C15598; cpd:C16232; cpd:C17673,15,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O5,C15H11O5,272.0684735,273.0762985,271.06064853828,4199,cpd:C06562,(+)-Catechin;,C15H14O6,"(+)-Catechin; D-Catechin; Cyanidanol; (2R-trans)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol; (2R,3S)-Catechin; (2R,3S)-(+)-Catechin; Cianidanol",R06532,Flavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.17.1.3,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1202 Flavans, Flavanols and Leucoanthocyanidins;     C06562  (+)-Catechin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3-ols;     C06562  (+)-Catechin; Major components of natural products [BR:br08323];  Crude drugs;   Gambir;    C06562  (+)-Catechin",CAS: 154-23-4; PubChem: 8791; ChEBI: 15600; ChEMBL: CHEMBL311498; LIPIDMAPS: LMPK12020001; KNApSAcK: C00000947; PDB-CCD: KXN; 3DMET: B02068; NIKKAJI: J9.391B,cpd:C03648; cpd:C05907; cpd:C06562; cpd:C08117; cpd:C08739; cpd:C08742; cpd:C09030; cpd:C09511; cpd:C09727; cpd:C09728; cpd:C09736; cpd:C09787; cpd:C09796; cpd:C14021; cpd:C14079; cpd:C17590,15,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O6,C15H13O6,290.0790382,291.0868632,289.07121313829,4200,cpd:C08578,Butein,C15H12O5,Butein,R07994 R07995,Flavonoid biosynthesis,5.5.1.6,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1212 Chalcones and dihydrochalcones;     C08578  Butein; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Chalcones;     C08578  Butein,CAS: 487-52-5; PubChem: 10771; ChEBI: 3237; ChEMBL: CHEMBL128000; LIPIDMAPS: LMPK12120111; KNApSAcK: C00006941; PDB-CCD: BUN; 3DMET: B02236; NIKKAJI: J11.660B,cpd:C00509; cpd:C01263; cpd:C01592; cpd:C03567; cpd:C06561; cpd:C08578; cpd:C09047; cpd:C09614; cpd:C09751; cpd:C09826; cpd:C12087; cpd:C14458; cpd:C15567; cpd:C15598; cpd:C16232; cpd:C17673,15,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O5,C15H11O5,272.0684735,273.0762985,271.06064853830,4201,cpd:C08650,Isoliquiritigenin,C15H12O4,Isoliquiritigenin,R06556 R06568 R07242 R07994,Flavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,2.1.1.154; 2.3.1.170; 5.5.1.6,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1212 Chalcones and dihydrochalcones;     C08650  Isoliquiritigenin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Chalcones;     C08650  Isoliquiritigenin,CAS: 961-29-5; PubChem: 10843; ChEBI: 310312; ChEMBL: CHEMBL129795; LIPIDMAPS: LMPK12120096; KNApSAcK: C00006925 C00035173; PDB-CCD: HCC; 3DMET: B01111; NIKKAJI: J74.686J,cpd:C02465; cpd:C04271; cpd:C07639; cpd:C08650; cpd:C09762; cpd:C09827; cpd:C10262; cpd:C15609; cpd:C16404; cpd:C16760; cpd:C18256; cpd:C18527; cpd:C18716,15,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O4,C15H11O4,256.0735589,257.0813839,255.06573383831,4202,cpd:C09099,Naringenin 7-O-beta-D-glucoside;,C21H22O10,Naringenin 7-O-beta-D-glucoside; Prunin,R02897 R06820,Flavonoid biosynthesis,2.4.1.185; 2.4.1.236,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C09099  Naringenin 7-O-beta-D-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C09099  Naringenin 7-O-beta-D-glucoside,CAS: 529-55-5; PubChem: 11291; ChEBI: 28327; ChEMBL: CHEMBL469654; KNApSAcK: C00000998; 3DMET: B02682; NIKKAJI: J182.295K,cpd:C09099; cpd:C16406; cpd:C16407; cpd:C16492,21,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O10,C21H21O10,434.1212969,435.1291219,433.11347193832,4203,cpd:C09320,Afzelechin;,C15H14O5,"Afzelechin; 3,5,7,4'-Tetrahydroxyflavan",R06615,Flavonoid biosynthesis; Biosynthesis of secondary metabolites,1.17.1.3,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1202 Flavans, Flavanols and Leucoanthocyanidins;     C09320  Afzelechin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3-ols;     C09320  Afzelechin",CAS: 2545-00-8; PubChem: 11511; ChEBI: 2507; LIPIDMAPS: LMPK12020035; KNApSAcK: C00000937; 3DMET: B02860; NIKKAJI: J14.392H,cpd:C00774; cpd:C08929; cpd:C08948; cpd:C09029; cpd:C09320; cpd:C09735; cpd:C09952; cpd:C12122; cpd:C12124; cpd:C12128; cpd:C13767; cpd:C16415,15,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O5,C15H13O5,274.0841235,275.0919486,273.07629853833,4204,cpd:C09614,Butin;,C15H12O5,"Butin; (-)-Butin; 7,3',4'-Trihydroxyflavanone",R07995 R07997 R08002,Flavonoid biosynthesis,1.14.11.9; 1.14.13.21; 5.5.1.6,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C09614  Butin,CAS: 492-14-8; PubChem: 11805; ChEBI: 27725; ChEMBL: CHEMBL451168; LIPIDMAPS: LMPK12140075; KNApSAcK: C00000945; 3DMET: B03130; NIKKAJI: J19.368B,cpd:C00509; cpd:C01263; cpd:C01592; cpd:C03567; cpd:C06561; cpd:C08578; cpd:C09047; cpd:C09614; cpd:C09751; cpd:C09826; cpd:C12087; cpd:C14458; cpd:C15567; cpd:C15598; cpd:C16232; cpd:C17673,15,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O5,C15H11O5,272.0684735,273.0762985,271.06064853834,4205,cpd:C09727,(-)-Epicatechin,C15H14O6,(-)-Epicatechin,R06542,Flavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.3.1.77,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1202 Flavans, Flavanols and Leucoanthocyanidins;     C09727  (-)-Epicatechin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3-ols;     C09727  (-)-Epicatechin",CAS: 490-46-0; PubChem: 11915; ChEBI: 90; ChEMBL: CHEMBL583912 CHEMBL80941; LIPIDMAPS: LMPK12020003; KNApSAcK: C00000956; PDB-CCD: 28E; 3DMET: B03226; NIKKAJI: J21.603H,cpd:C03648; cpd:C05907; cpd:C06562; cpd:C08117; cpd:C08739; cpd:C08742; cpd:C09030; cpd:C09511; cpd:C09727; cpd:C09728; cpd:C09736; cpd:C09787; cpd:C09796; cpd:C14021; cpd:C14079; cpd:C17590,15,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O6,C15H13O6,290.0790382,291.0868632,289.07121313835,4206,cpd:C09736,Fisetinidol-4beta-ol;,C15H14O6,"Fisetinidol-4beta-ol; (-)-Mollisacacidin; Fisetinin-3,4-diol; 5-Deoxyleucocyanidin",R07999 R08001,Flavonoid biosynthesis,1.1.1.219,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1202 Flavans, Flavanols and Leucoanthocyanidins;     C09736  Fisetinidol-4beta-ol; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3,4-diols;     C09736  5-Deoxyleucocyanidin",CAS: 967-30-6; PubChem: 11924; ChEBI: 5067; LIPIDMAPS: LMPK12020178; KNApSAcK: C00000962; 3DMET: B03235; NIKKAJI: J2.019.002G,cpd:C03648; cpd:C05907; cpd:C06562; cpd:C08117; cpd:C08739; cpd:C08742; cpd:C09030; cpd:C09511; cpd:C09727; cpd:C09728; cpd:C09736; cpd:C09787; cpd:C09796; cpd:C14021; cpd:C14079; cpd:C17590,15,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O6,C15H13O6,290.0790382,291.0868632,289.07121313836,4207,cpd:C09751,Garbanzol;,C15H12O5,"Garbanzol; 3,7,4'-Trihydroxyflavanone",R07996 R07998 R08000 R08032,Flavonoid biosynthesis,1.1.1.219; 1.14.11.9; 1.14.13.21,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Dihyroflavonols;     C09751  Garbanzol,CAS: 1226-22-8; PubChem: 11939; ChEBI: 27587; ChEMBL: CHEMBL254051; KNApSAcK: C00000964; 3DMET: B03249; NIKKAJI: J1.902.445H,cpd:C00509; cpd:C01263; cpd:C01592; cpd:C03567; cpd:C06561; cpd:C08578; cpd:C09047; cpd:C09614; cpd:C09751; cpd:C09826; cpd:C12087; cpd:C14458; cpd:C15567; cpd:C15598; cpd:C16232; cpd:C17673,15,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O5,C15H11O5,272.0684735,273.0762985,271.06064853837,4208,cpd:C09756,Homoeriodictyol;,C16H14O6,Homoeriodictyol; Eriodictyol 3'-methyl ether,R07992 R08012,Flavonoid biosynthesis,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C09756  Homoeriodictyol; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C09756  Homoeriodictyol,CAS: 446-71-9; PubChem: 11944; ChEBI: 74960; ChEMBL: CHEMBL490170; LIPIDMAPS: LMPK12140449; KNApSAcK: C00000969; 3DMET: B03254; NIKKAJI: J95.423C,cpd:C01709; cpd:C09756; cpd:C09931; cpd:C10377; cpd:C10419; cpd:C12436; cpd:C16405,16,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O6,C16H13O6,302.0790382,303.0868632,301.07121313838,4209,cpd:C09762,Liquiritigenin;,C15H12O4,"Liquiritigenin; 7,4'-Dihydroxyflavanone",R06554 R06556 R07198 R07711 R07712 R07777 R07996 R08002,Flavonoid biosynthesis; Isoflavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.14.11.9; 1.14.13.21; 1.14.13.87; 1.14.13.136; 1.14.13.-; 5.5.1.6,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C09762  Liquiritigenin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C09762  Liquiritigenin,CAS: 578-86-9; PubChem: 11950; ChEBI: 28777; ChEMBL: CHEMBL252642; LIPIDMAPS: LMPK12140061; KNApSAcK: C00000977; PDB-CCD: DFV; 3DMET: B03260; NIKKAJI: J22.604A,cpd:C02465; cpd:C04271; cpd:C07639; cpd:C08650; cpd:C09762; cpd:C09827; cpd:C10262; cpd:C15609; cpd:C16404; cpd:C16760; cpd:C18256; cpd:C18527; cpd:C18716,15,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O4,C15H11O4,256.0735589,257.0813839,255.06573383839,4210,cpd:C09789,Naringin;,C27H32O14,Naringin; Naringenin 7-O-neohesperidoside; Naringenin 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside],R06820 R08024,Flavonoid biosynthesis,2.4.1.236,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C09789  Naringin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C09789  Naringin; Major components of natural products [BR:br08323];  Crude drugs;   Immature orange;    C09789  Naringin,CAS: 10236-47-2; PubChem: 11977; ChEBI: 28819; ChEMBL: CHEMBL1970019 CHEMBL451512 CHEMBL451532; LIPIDMAPS: LMPK12140235; KNApSAcK: C00000983; 3DMET: B03286; NIKKAJI: J10.482E,cpd:C09789; cpd:C09793; cpd:C10307; cpd:C16423; cpd:C16799,27,32,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H33O14,C27H31O14,580.1792057,581.1870307,579.17138073840,4211,cpd:C09806,Neohesperidin;,C28H34O15,Neohesperidin; Hesperetin 7-O-neohesperidoside,R08022,Flavonoid biosynthesis,2.4.1.236,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C09806  Neohesperidin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C09806  Neohesperidin,CAS: 13241-33-3; PubChem: 11994; ChEBI: 59016; ChEMBL: CHEMBL1885559 CHEMBL506398; KNApSAcK: C00000987; 3DMET: B03303; NIKKAJI: J15.272B,cpd:C09755; cpd:C09806,28,34,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H35O15,C28H33O15,610.1897704,611.1975954,609.18194543841,4212,cpd:C09826,Pinobanksin;,C15H12O5,"Pinobanksin; 3,5,7-Trihydroxyflavanone",R07993 R08028 R08082,Flavonoid biosynthesis,1.14.11.9; 1.14.11.23,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Dihyroflavonols;     C09826  Pinobanksin,CAS: 548-82-3; PubChem: 12014; ChEBI: 28103; ChEMBL: CHEMBL608410; KNApSAcK: C00000991; 3DMET: B03305; NIKKAJI: J257.661I,cpd:C00509; cpd:C01263; cpd:C01592; cpd:C03567; cpd:C06561; cpd:C08578; cpd:C09047; cpd:C09614; cpd:C09751; cpd:C09826; cpd:C12087; cpd:C14458; cpd:C15567; cpd:C15598; cpd:C16232; cpd:C17673,15,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O5,C15H11O5,272.0684735,273.0762985,271.06064853842,4213,cpd:C09827,Pinocembrin;,C15H12O4,"Pinocembrin; 5,7-Dihydroxyflavanone",R07990 R07993 R08029 R08081,Flavonoid biosynthesis,1.14.11.9; 1.14.11.22; 5.5.1.6,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C09827  Pinocembrin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C09827  Pinocembrin,CAS: 480-39-7; PubChem: 12015; ChEBI: 28157; ChEMBL: CHEMBL399910; LIPIDMAPS: LMPK12140214; KNApSAcK: C00000992; 3DMET: B03306; NIKKAJI: J12.347A,cpd:C02465; cpd:C04271; cpd:C07639; cpd:C08650; cpd:C09762; cpd:C09827; cpd:C10262; cpd:C15609; cpd:C16404; cpd:C16760; cpd:C18256; cpd:C18527; cpd:C18716,15,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O4,C15H11O4,256.0735589,257.0813839,255.06573383843,4214,cpd:C10028,Chrysin;,C15H10O4,"Chrysin; 5,7-Dihydroxyflavone",R08081,Flavonoid biosynthesis,1.14.11.22,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C10028  Chrysin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C10028  Chrysin,CAS: 480-40-0; PubChem: 12214; ChEBI: 75095; ChEMBL: CHEMBL117; LIPIDMAPS: LMPK12110189; KNApSAcK: C00003794; PDB-CCD: 57D; 3DMET: B03471; NIKKAJI: J1.544J,cpd:C08212; cpd:C08644; cpd:C10028; cpd:C10121; cpd:C10200; cpd:C10208; cpd:C10291; cpd:C10315; cpd:C10327; cpd:C10329; cpd:C10402; cpd:C12123; cpd:C14265; cpd:C14344,15,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O4,C15H9O4,254.0579088,255.0657338,253.05008383844,4215,cpd:C10044,Galangin;,C15H10O5,"Galangin; 3,5,7-Trihydroxyflavone",R08082,Flavonoid biosynthesis,1.14.11.23,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C10044  Galangin,CAS: 548-83-4; PubChem: 12230; ChEBI: 5262; ChEMBL: CHEMBL309490; LIPIDMAPS: LMPK12111653; KNApSAcK: C00004533; 3DMET: B03487; NIKKAJI: J1.607A,cpd:C01477; cpd:C02495; cpd:C06563; cpd:C08730; cpd:C10023; cpd:C10037; cpd:C10044; cpd:C10113; cpd:C10294; cpd:C10343; cpd:C10369; cpd:C10376; cpd:C10379; cpd:C10397; cpd:C14313; cpd:C14314; cpd:C15222; cpd:C16796,15,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O5,C15H9O5,270.0528234,271.0606485,269.04499843845,4216,cpd:C10107,Myricetin;,C15H10O8,"Myricetin; 3,5,7,3',4',5'-Hexahydroxyflavone",R06539 R06815 R10258,Flavonoid biosynthesis; Flavone and flavonol biosynthesis,1.14.11.23; 1.14.13.88; 2.1.1.267,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C10107  Myricetin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C10107  Myricetin,CAS: 529-44-2; PubChem: 12293; ChEBI: 18152; ChEMBL: CHEMBL164; LIPIDMAPS: LMPK12110001; KNApSAcK: C00001071; PDB-CCD: MYC; 3DMET: B01120; NIKKAJI: J1.585G,cpd:C04109; cpd:C10107; cpd:C10122,15,10,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O8,C15H9O8,318.0375673,319.0453923,317.02974223846,4217,cpd:C10192,Tricetin;,C15H10O7,"Tricetin; 5,7,3',4',5'-Pentahydroxyflavone",R06551 R09611 R09612 R09679 R10260,Flavonoid biosynthesis,1.14.11.22; 1.14.13.88; 2.1.1.169; 2.1.1.175,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C10192  Tricetin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C10192  Tricetin,CAS: 520-31-0; PubChem: 12378; ChEBI: 507499; ChEMBL: CHEMBL247484; LIPIDMAPS: LMPK12110847; KNApSAcK: C00013328; PDB-CCD: MYF; 3DMET: B01121; NIKKAJI: J11.687D,cpd:C00389; cpd:C02806; cpd:C03662; cpd:C08577; cpd:C10068; cpd:C10072; cpd:C10078; cpd:C10079; cpd:C10105; cpd:C10177; cpd:C10192; cpd:C15031,15,10,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O7,C15H9O7,302.0426527,303.0504777,301.03482763847,4218,cpd:C12123,"7,4'-Dihydroxyflavone",C15H10O4,"7,4'-Dihydroxyflavone",R07712 R07714,Flavonoid biosynthesis; Isoflavonoid biosynthesis,NA,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C12123  7,4'-Dihydroxyflavone; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C12123  7,4'-Dihydroxyflavone",CAS: 2196-14-7; PubChem: 14270; ChEBI: 29503; ChEMBL: CHEMBL294878; LIPIDMAPS: LMPK12110035; KNApSAcK: C00003800; 3DMET: B04424; NIKKAJI: J78.045F,cpd:C08212; cpd:C08644; cpd:C10028; cpd:C10121; cpd:C10200; cpd:C10208; cpd:C10291; cpd:C10315; cpd:C10327; cpd:C10329; cpd:C10402; cpd:C12123; cpd:C14265; cpd:C14344,15,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O4,C15H9O4,254.0579088,255.0657338,253.05008383848,4219,cpd:C12124,Apiforol,C15H14O5,Apiforol,R06610,Flavonoid biosynthesis,1.1.1.234,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 4-ols;     C12124  Apiforol,CAS: 55167-29-8; PubChem: 14271; ChEBI: 74812; KNApSAcK: C00008975; 3DMET: B05607; NIKKAJI: J972.197E,cpd:C00774; cpd:C08929; cpd:C08948; cpd:C09029; cpd:C09320; cpd:C09735; cpd:C09952; cpd:C12122; cpd:C12124; cpd:C12128; cpd:C13767; cpd:C16415,15,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O5,C15H13O5,274.0841235,275.0919486,273.07629853849,4220,cpd:C12127,(+)-Gallocatechin;,C15H14O7,(+)-Gallocatechin; Gallocatechol,R06533,Flavonoid biosynthesis; Biosynthesis of secondary metabolites,1.17.1.3,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1202 Flavans, Flavanols and Leucoanthocyanidins;     C12127  (+)-Gallocatechin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3-ols;     C12127  (+)-Gallocatechin",CAS: 970-73-0; PubChem: 14274; ChEBI: 31018 68330; ChEMBL: CHEMBL125743; LIPIDMAPS: LMPK12020002; KNApSAcK: C00008817 C00035626; 3DMET: B04426; NIKKAJI: J277.679K,cpd:C05906; cpd:C12127; cpd:C12136; cpd:C18855,15,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O7,C15H13O7,306.0739528,307.0817778,305.06612783850,4221,cpd:C12128,(-)-Epiafzelechin;,C15H14O5,(-)-Epiafzelechin; epi-Afzelechin,R06541,Flavonoid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.77,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3-ols;     C12128  (-)-Epiafzelechin,PubChem: 14275; ChEBI: 31028; ChEMBL: CHEMBL159303; LIPIDMAPS: LMPK12020036; KNApSAcK: C00008805; 3DMET: B04427; NIKKAJI: J18.806I,cpd:C00774; cpd:C08929; cpd:C08948; cpd:C09029; cpd:C09320; cpd:C09735; cpd:C09952; cpd:C12122; cpd:C12124; cpd:C12128; cpd:C13767; cpd:C16415,15,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O5,C15H13O5,274.0841235,275.0919486,273.07629853851,4222,cpd:C12136,(-)-Epigallocatechin;,C15H14O7,(-)-Epigallocatechin; Epigallocatechol,R06543,Flavonoid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.77,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1202 Flavans, Flavanols and Leucoanthocyanidins;     C12136  (-)-Epigallocatechin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3-ols;     C12136  (-)-Epigallocatechin",CAS: 970-74-1; PubChem: 14283; ChEBI: 42255; ChEMBL: CHEMBL47386; LIPIDMAPS: LMPK12020004; KNApSAcK: C00008818; PDB-CCD: EGT; 3DMET: B04430; NIKKAJI: J277.681B,cpd:C05906; cpd:C12127; cpd:C12136; cpd:C18855,15,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O7,C15H13O7,306.0739528,307.0817778,305.06612783852,4223,cpd:C15525,Eriodictyol chalcone;,C15H12O6,"Eriodictyol chalcone; 2',3,4,4',6'-Pentahydroxychalcone",R07225 R07988 R07991 R08005 R08007 R08031,Flavonoid biosynthesis,1.21.3.6; 2.3.1.74; 2.4.1.286,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Chalcones;     C15525  Eriodictyol chalcone,PubChem: 17396517; ChEBI: 10836 48967; ChEMBL: CHEMBL127409; LIPIDMAPS: LMPK12120271; KNApSAcK: C00006973; NIKKAJI: J295.250E,cpd:C00974; cpd:C01378; cpd:C05631; cpd:C08724; cpd:C09277; cpd:C10060; cpd:C10064; cpd:C10083; cpd:C10091; cpd:C10415; cpd:C12631; cpd:C15525; cpd:C16233; cpd:C16940,15,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O6,C15H11O6,288.0633881,289.0712131,287.05556313853,4224,cpd:C16404,Pinocembrin chalcone,C15H12O4,Pinocembrin chalcone,R07987 R07990,Flavonoid biosynthesis,2.3.1.74; 5.5.1.6,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Chalcones;     C16404  Pinocembrin chalcone,PubChem: 47205702; ChEBI: 80484; ChEMBL: CHEMBL129371; LIPIDMAPS: LMPK12120243; KNApSAcK: C00006933; NIKKAJI: J258.619C,cpd:C02465; cpd:C04271; cpd:C07639; cpd:C08650; cpd:C09762; cpd:C09827; cpd:C10262; cpd:C15609; cpd:C16404; cpd:C16760; cpd:C18256; cpd:C18527; cpd:C18716,15,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O4,C15H11O4,256.0735589,257.0813839,255.06573383854,4225,cpd:C16405,Homoeriodictyol chalcone,C16H14O6,Homoeriodictyol chalcone,R07989 R07992 R08031,Flavonoid biosynthesis,2.3.1.74,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Chalcones;     C16405  Homoeriodictyol chalcone,PubChem: 47205703; ChEBI: 80485; LIPIDMAPS: LMPK12120274; KNApSAcK: C00006974; NIKKAJI: J279.484E,cpd:C01709; cpd:C09756; cpd:C09931; cpd:C10377; cpd:C10419; cpd:C12436; cpd:C16405,16,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O6,C16H13O6,302.0790382,303.0868632,301.07121313855,4226,cpd:C16406,Phlorizin chalcone;,C21H22O10,Phlorizin chalcone; Chalcone 2'-O-glucoside,R08013,Flavonoid biosynthesis,2.4.1.-,NA,NA,CAS: 4547-85-7; PubChem: 47205704; ChEBI: 80486; KNApSAcK: C00007881; NIKKAJI: J107.406G,cpd:C09099; cpd:C16406; cpd:C16407; cpd:C16492,21,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O10,C21H21O10,434.1212969,435.1291219,433.11347193856,4227,cpd:C16407,"2',4,4',6'-Tetrahydroxychalcone 4'-O-glucoside;",C21H22O10,"2',4,4',6'-Tetrahydroxychalcone 4'-O-glucoside; THC 4'-glucoside; Chalconaringenin 4'-glucoside; 2',4,4',6'-Tetrahydroxychalcone 4'-O-beta-D-glucoside",R08006 R08008,Flavonoid biosynthesis,1.21.3.6; 2.4.1.286,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Chalcones;     C16407  2',4,4',6'-Tetrahydroxychalcone 4'-O-glucoside",PubChem: 47205705; ChEBI: 66906; KNApSAcK: C00007882; NIKKAJI: J1.863.016H,cpd:C09099; cpd:C16406; cpd:C16407; cpd:C16492,21,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O10,C21H21O10,434.1212969,435.1291219,433.11347193857,4228,cpd:C16408,"2',3,4,4',6'-Peptahydroxychalcone 4'-O-glucoside;",C21H22O11,"2',3,4,4',6'-Peptahydroxychalcone 4'-O-glucoside; PHC 4'-O-glucoside; 2',3,4,4',6'-Pentahydroxychalcone 4'-O-beta-D-glucoside",R08007 R08009 R08010,Flavonoid biosynthesis,1.21.3.6; 2.4.1.286,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Chalcones;     C16408  2',3,4,4',6'-Peptahydroxychalcone 4'-O-glucoside",PubChem: 47205706; ChEBI: 66904; KNApSAcK: C00007915; NIKKAJI: J1.863.019B,cpd:C09803; cpd:C16408; cpd:C17449; cpd:C17675,21,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O11,C21H21O11,450.1162115,451.1240366,449.10838653858,4229,cpd:C16409,Aureusidin 6-O-glucoside;,C21H20O11,Aureusidin 6-O-glucoside; Aureusidin 6-O-beta-D-glucoside,R08008 R08010,Flavonoid biosynthesis,1.21.3.6,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Aurones;     C16409  Aureusidin 6-O-glucoside,CAS: 633-15-8; PubChem: 47205707; ChEBI: 66905; KNApSAcK: C00008046; NIKKAJI: J37.392C,cpd:C01750; cpd:C01821; cpd:C03951; cpd:C08598; cpd:C10042; cpd:C10114; cpd:C12249; cpd:C12626; cpd:C16409; cpd:C17056,21,20,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O11,C21H19O11,448.1005615,449.1083865,447.09273643859,4230,cpd:C16410,Bracteatin 6-O-glucoside;,C21H20O12,Bracteatin 6-O-glucoside; Bracteatin 6-O-beta-D-glucoside,R08009,Flavonoid biosynthesis,1.21.3.6,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Aurones;     C16410  Bracteatin 6-O-glucoside,PubChem: 47205708; ChEBI: 66907; NIKKAJI: J2.802.585H,cpd:C05623; cpd:C10050; cpd:C10073; cpd:C10108; cpd:C12639; cpd:C16410; cpd:C17763,21,20,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O12,C21H19O12,464.0954761,465.1033011,463.0876513860,4231,cpd:C16415,5-Deoxyleucopelargonidin,C15H14O5,5-Deoxyleucopelargonidin,R07998 R08000,Flavonoid biosynthesis,1.1.1.219,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3,4-diols;     C16415  5-Deoxyleucopelargonidin",PubChem: 47205713; ChEBI: 80488; KNApSAcK: C00020071; NIKKAJI: J2.802.589K,cpd:C00774; cpd:C08929; cpd:C08948; cpd:C09029; cpd:C09320; cpd:C09735; cpd:C09952; cpd:C12122; cpd:C12124; cpd:C12128; cpd:C13767; cpd:C16415,15,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O5,C15H13O5,274.0841235,275.0919486,273.07629853861,4232,cpd:C16416,Desmethylxanthohumol,C20H20O5,Desmethylxanthohumol,R08003 R08004,Flavonoid biosynthesis,2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Chalcones;     C16416  Desmethylxanthohumol,CAS: 115063-39-3; PubChem: 47205714; ChEBI: 80489; ChEMBL: CHEMBL466143; KNApSAcK: C00035575; NIKKAJI: J1.068.808F,cpd:C04418; cpd:C09753; cpd:C09832; cpd:C10418; cpd:C10616; cpd:C15509; cpd:C15510; cpd:C16416; cpd:C18023,20,20,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H21O5,C20H19O5,340.1310737,341.1388988,339.12324873862,4233,cpd:C16417,Xanthohumol,C21H22O5,Xanthohumol,R08004,Flavonoid biosynthesis,2.1.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1212 Chalcones and dihydrochalcones;     C16417  Xanthohumol; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Chalcones;     C16417  Xanthohumol,CAS: 6754-58-1; PubChem: 47205715; ChEBI: 66331; ChEMBL: CHEMBL253896; LIPIDMAPS: LMPK12120294; KNApSAcK: C00007099; NIKKAJI: J17.881K,cpd:C07250; cpd:C10206; cpd:C10574; cpd:C16417; cpd:C17499,21,22,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O5,C21H21O5,354.1467238,355.1545488,353.13889883863,4234,cpd:C16418,Pinobanksin 3-O-acetate,C17H14O6,Pinobanksin 3-O-acetate,R08028,Flavonoid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Dihyroflavonols;     C16418  Pinobanksin 3-O-acetate,CAS: 52117-69-8; PubChem: 47205716; ChEBI: 80490; ChEMBL: CHEMBL1094265; KNApSAcK: C00008731; NIKKAJI: J894.646I,cpd:C10407; cpd:C10471; cpd:C10516; cpd:C15100; cpd:C16418; cpd:C16753; cpd:C17784; cpd:C17785; cpd:C19584,17,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H15O6,C17H13O6,314.0790382,315.0868632,313.07121313864,4235,cpd:C16419,Pinostrobin,C16H14O4,Pinostrobin,R08029,Flavonoid biosynthesis,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C16419  Pinostrobin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C16419  Pinostrobin,CAS: 480-37-5; PubChem: 47205717; ChEBI: 80491; ChEMBL: CHEMBL254613; KNApSAcK: C00008144; NIKKAJI: J196.197G,cpd:C01729; cpd:C04606; cpd:C08993; cpd:C09053; cpd:C09269; cpd:C09939; cpd:C10503; cpd:C11021; cpd:C15531; cpd:C16419; cpd:C16976,16,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O4,C16H13O4,270.0892089,271.097034,269.08138393865,4236,cpd:C16422,Hesperetin 7-O-glucoside,C22H24O11,Hesperetin 7-O-glucoside,R08021 R08022,Flavonoid biosynthesis,2.4.1.185; 2.4.1.236,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1214 Flavanones;     C16422  Hesperetin 7-O-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C16422  Hesperetin 7-O-glucoside,CAS: 31712-49-9; PubChem: 47205720; ChEBI: 59015; KNApSAcK: C00008297; NIKKAJI: J667.152G,cpd:C16422,22,24,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H25O11,C22H23O11,464.1318616,465.1396866,463.12403663866,4237,cpd:C16492,8-C-Glucosylnaringenin,C21H22O10,8-C-Glucosylnaringenin,R08129 R08130,Flavonoid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavanones;     C16492  8-C-Glucosylnaringenin,PubChem: 47205788; ChEBI: 80529; KNApSAcK: C00006092; NIKKAJI: J2.802.749D,cpd:C09099; cpd:C16406; cpd:C16407; cpd:C16492,21,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O10,C21H21O10,434.1212969,435.1291219,433.11347193867,4238,cpd:C08604,Chrysanthemin;,C21H21O11,Chrysanthemin; Cyanidin 3-O-glucoside; Cyanidin 3-O-beta-D-glucoside,R06535 R06544 R06546 R06548 R06817 R06818 R07878 R07928; R09635 R10259 R10261 R10291,Anthocyanin biosynthesis,2.3.1.171; 2.3.1.215; 2.4.1.115; 2.4.1.254; 2.4.1.297; 2.4.1.298; 2.4.1.299; 2.4.1.300; 2.4.1.-; 2.4.2.51,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C08604  Chrysanthemin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C08604  Chrysanthemin,CAS: 7084-24-4; PubChem: 10797; ChEBI: 28426; ChEMBL: CHEMBL257839; KNApSAcK: C00002374 C00042427; 3DMET: B02259; NIKKAJI: J231.541F,cpd:C08604; cpd:C08647; cpd:C16298,21,21,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H22O11,C21H20O11,449.1083865,450.1162115,448.10056153868,4239,cpd:C08620,Cyanidin 3-O-rutinoside;,C27H31O15,Cyanidin 3-O-rutinoside; Cyanidin 3-O-rhamnosylglucoside; Keracyanin,R06818 R06819 R07900,Anthocyanin biosynthesis,2.4.1.116; 2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C08620  Cyanidin 3-O-rutinoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C08620  Cyanidin 3-O-rutinoside,CAS: 28338-59-2; PubChem: 10813; ChEBI: 28064; ChEMBL: CHEMBL505251; 3DMET: B02274; NIKKAJI: J231.166F,cpd:C04491; cpd:C08620; cpd:C08725; cpd:C16305; cpd:C20495,27,31,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O15,C27H30O15,595.1662953,596.1741203,594.15847033869,4240,cpd:C08639,Cyanin;,C27H31O16,"Cyanin; Cyanidin 3,5-di-O-glucoside; Cyanidin 3,5-O-diglucoside; Cyanidin 3,5-di-O-beta-D-glucoside",R06545 R06546 R07882 R07909 R07931 R10261,Anthocyanin biosynthesis,2.3.1.153; 2.3.1.215; 2.4.1.298; 2.4.1.299; 2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C08639  Cyanin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C08639  Cyanin,CAS: 20905-74-2; PubChem: 10832; ChEBI: 3978; KNApSAcK: C00038883; 3DMET: B02292; NIKKAJI: J294.525H,cpd:C08639; cpd:C16306; cpd:C16315; cpd:C20469,27,31,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O16,C27H30O16,611.1612099,612.1690349,610.15338493870,4241,cpd:C08641,Gentiodelphin,C51H53O28,Gentiodelphin,R07924 R07925,Anthocyanin biosynthesis,2.3.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C08641  Gentiodelphin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C08641  Gentiodelphin,CAS: 84331-34-0; PubChem: 10834; ChEBI: 5319; KNApSAcK: C00002379; 3DMET: B02294; NIKKAJI: J660.004B,cpd:C08641,51,53,28,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C51H54O28,C51H52O28,1113.272336,1114.280161,1112.2645113871,4242,cpd:C08725,Pelargonin;,C27H31O15,"Pelargonin; Pelargonidin 3,5-di-beta-D-glucoside",R07874 R07876 R07880 R07930 R10298,Anthocyanin biosynthesis,2.3.1.153; 2.3.1.215; 2.4.1.298; 2.4.1.299,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C08725  Pelargonin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C08725  Pelargonin,CAS: 17334-58-6; PubChem: 10918; ChEBI: 133365; KNApSAcK: C00002387; 3DMET: B02357; NIKKAJI: J243.859C,cpd:C04491; cpd:C08620; cpd:C08725; cpd:C16305; cpd:C20495,27,31,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O15,C27H30O15,595.1662953,596.1741203,594.15847033872,4243,cpd:C12095,Cyanidin 3-O-(6-O-p-coumaroyl)glucoside,C30H27O13,Cyanidin 3-O-(6-O-p-coumaroyl)glucoside,R06544 R06547,Anthocyanin biosynthesis,2.3.1.215; 2.4.1.298,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C12095  Cyanidin 3-O-(6-O-p-coumaroyl)glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12095  Cyanidin 3-O-(6-O-p-coumaroyl)glucoside,PubChem: 14243; ChEBI: 29560; KNApSAcK: C00006800; 3DMET: B04418; NIKKAJI: J657.837C,cpd:C12095; cpd:C16297,30,27,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H28O13,C30H26O13,595.1451659,596.152991,594.13734093873,4244,cpd:C12096,Cyanidin 3-O-(6-O-p-coumaroyl)glucoside-5-O-glucoside;,C36H37O18,Cyanidin 3-O-(6-O-p-coumaroyl)glucoside-5-O-glucoside; Shisonin,R06545 R06547 R07910,Anthocyanin biosynthesis,2.3.1.172; 2.3.1.215; 2.4.1.298,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12096  Cyanidin 3-O-(6-O-p-coumaroyl)glucoside-5-O-glucoside,PubChem: 14244; ChEBI: 29561; KNApSAcK: C00006819; 3DMET: B04419; NIKKAJI: J710.243G,cpd:C12096; cpd:C12640; cpd:C16350; cpd:C16371,36,37,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H38O18,C36H36O18,757.1979893,758.2058144,756.19016433874,4245,cpd:C12137,Pelargonidin 3-O-glucoside;,C21H21O10,Pelargonidin 3-O-glucoside; Pelargonidin 3-glucoside; Pelargonidin 3-O-beta-D-glucoside,R06534 R06798 R06801 R06802 R07873 R07874 R07877 R07927; R10290 R10296 R10298,Anthocyanin biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.3.1.171; 2.3.1.215; 2.4.1.115; 2.4.1.297; 2.4.1.298; 2.4.1.299; 2.4.1.300; 2.4.1.-; 2.4.2.51,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C12137  Pelargonidin 3-O-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12137  Pelargonidin 3-O-glucoside,CAS: 18466-51-8; PubChem: 14284; ChEBI: 31967; KNApSAcK: C00006630; 3DMET: B04431; NIKKAJI: J243.772D,cpd:C12137,21,21,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H22O10,C21H20O10,433.1134719,434.1212969,432.10564683875,4246,cpd:C12138,Delphinidin 3-O-glucoside;,C21H21O12,Delphinidin 3-O-glucoside; Mirtillin; Delphinidin 3-glucoside; Delphinidin 3-O-beta-D-glucoside,R06536 R06549 R06550 R07879 R07903 R07911 R07926 R07929; R07938 R10292 R10297 R10299,Anthocyanin biosynthesis,2.3.1.171; 2.3.1.215; 2.4.1.115; 2.4.1.297; 2.4.1.298; 2.4.1.299; 2.4.1.300; 2.4.1.-; 2.4.2.51,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C12138  Delphinidin 3-O-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12138  Delphinidin 3-O-glucoside,CAS: 6906-38-3 50986-17-9; PubChem: 14285; ChEBI: 31463; ChEMBL: CHEMBL518846; KNApSAcK: C00006698 C00038964; 3DMET: B04432; NIKKAJI: J363.282B,cpd:C12138,21,21,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H22O12,C21H20O12,465.1033011,466.1111261,464.09547613876,4247,cpd:C12139,Petunidin 3-O-glucoside;,C22H23O12,Petunidin 3-O-glucoside; Petunidin 3-glucoside,R06549,Anthocyanin biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12139  Petunidin 3-O-glucoside,CAS: 6988-81-4 71991-88-3; PubChem: 14286; ChEBI: 31985; ChEMBL: CHEMBL1784264; KNApSAcK: C00006722; 3DMET: B04433; NIKKAJI: J292.686E,cpd:C12139,22,23,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H24O12,C22H22O12,479.1189512,480.1267762,478.11112613877,4248,cpd:C12140,Malvidin 3-O-glucoside;,C23H25O12,Malvidin 3-O-glucoside; Enin; Malvidin-3-glucoside,R06550,Anthocyanin biosynthesis,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C12140  Malvidin 3-O-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12140  Malvidin 3-O-glucoside,CAS: 18470-06-9; PubChem: 14287; ChEBI: 31799; ChEMBL: CHEMBL403236; KNApSAcK: C00039728; 3DMET: B04434; NIKKAJI: J220.342A,cpd:C12140,23,25,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H26O12,C23H24O12,493.1346012,494.1424263,492.12677623878,4249,cpd:C12141,Peonidin 3-O-glucoside;,C22H23O11,Peonidin 3-O-glucoside; Peonidin-3-glucoside,R06548,Anthocyanin biosynthesis,NA,NA,NA,CAS: 68795-37-9; PubChem: 14288; ChEBI: 74793; ChEMBL: CHEMBL1784263; 3DMET: B04435; NIKKAJI: J291.386K,cpd:C12141,22,23,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H24O11,C22H22O11,463.1240366,464.1318616,462.11621153879,4250,cpd:C12640,Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside) 5-O-beta-D-glucoside;,C36H37O18,Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside) 5-O-beta-D-glucoside; Bisdemalonylsalvianin,R06798 R06799 R07875 R07876,Anthocyanin biosynthesis,2.3.1.172; 2.3.1.215; 2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C12640  Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside) 5-O-beta-D-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12640  Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside) 5-O-beta-D-glucoside,CAS: 168753-26-2; PubChem: 583030; ChEBI: 31966; KNApSAcK: C00006767; 3DMET: B04546; NIKKAJI: J499.043I,cpd:C12096; cpd:C12640; cpd:C16350; cpd:C16371,36,37,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H38O18,C36H36O18,757.1979893,758.2058144,756.19016433880,4251,cpd:C12641,4'''-Demalonylsalvianin;,C39H39O21,4'''-Demalonylsalvianin; Monodemalonylsalvianin,R06799 R06800,Anthocyanin biosynthesis,2.3.1.172; 2.3.1.214,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C12641  4'''-Demalonylsalvianin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12641  4'''-Demalonylsalvianin,CAS: 168753-27-3; PubChem: 583031; ChEBI: 31121; KNApSAcK: C00006775; 3DMET: B04547; NIKKAJI: J493.646I,cpd:C12641; cpd:C16299,39,39,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C39H40O21,C39H38O21,843.1983833,844.2062083,842.19055823881,4252,cpd:C12642,Pelargonidin 3-O-(6-O-malonyl-beta-D-glucoside),C24H23O13,Pelargonidin 3-O-(6-O-malonyl-beta-D-glucoside),R06801 R07884,Anthocyanin biosynthesis,2.3.1.171; 2.3.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C12642  Pelargonidin 3-O-(6-O-malonyl-beta-D-glucoside); Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12642  Pelargonidin 3-O-(6-O-malonyl-beta-D-glucoside),CAS: 165070-68-8; PubChem: 583032; ChEBI: 31965; KNApSAcK: C00006755; 3DMET: B04548; NIKKAJI: J648.898F,cpd:C12642,24,23,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H24O13,C24H22O13,519.1138658,520.1216908,518.10604083882,4253,cpd:C12643,Cyanidin 3-O-(6-O-malonyl-beta-D-glucoside);,C24H23O14,Cyanidin 3-O-(6-O-malonyl-beta-D-glucoside); Cyanidin 3-O-(6'-O-malonylglucoside); Cyanidin-3-(6'-malonylglucoside),R06817 R07885 R07932,Anthocyanin biosynthesis,2.3.1.171; 2.3.1.-; 2.4.1.254,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12643  Cyanidin 3-O-(6-O-malonyl-beta-D-glucoside),CAS: 171828-62-9; PubChem: 583033; ChEBI: 31442; KNApSAcK: C00006796; 3DMET: B04549; NIKKAJI: J727.276F,cpd:C12643,24,23,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H24O14,C24H22O14,535.1087804,536.1166054,534.10095543883,4254,cpd:C12644,Pelargonidin 3-O-rutinoside,C27H31O14,Pelargonidin 3-O-rutinoside,R06802 R06803,Anthocyanin biosynthesis,2.4.1.116; 2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C12644  Pelargonidin 3-O-rutinoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12644  Pelargonidin 3-O-rutinoside,PubChem: 583034; ChEBI: 31968; 3DMET: B04550; NIKKAJI: J947.541I,cpd:C12644,27,31,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O14,C27H30O14,579.1713807,580.1792057,578.16355563884,4255,cpd:C12645,Pelargonidin 3-O-rutinoside 5-O-beta-D-glucoside;,C33H41O19,Pelargonidin 3-O-rutinoside 5-O-beta-D-glucoside; Pelargonidin 3-rutinoside-5-glucopyranoside,R06803,Anthocyanin biosynthesis,2.4.1.116,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C12645  Pelargonidin 3-O-rutinoside 5-O-beta-D-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12645  Pelargonidin 3-O-rutinoside 5-O-beta-D-glucoside,CAS: 202338-79-2; PubChem: 583035; ChEBI: 31969; 3DMET: B04551; NIKKAJI: J1.120.914I,cpd:C12645,33,41,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H42O19,C33H40O19,741.2242041,742.2320291,740.21637913885,4256,cpd:C12646,Cyanidin 3-O-rutinoside 5-O-beta-D-glucoside;,C33H41O20,Cyanidin 3-O-rutinoside 5-O-beta-D-glucoside; Cyanidin 3-rutinoside 5-glucoside,R06819,Anthocyanin biosynthesis,2.4.1.116,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12646  Cyanidin 3-O-rutinoside 5-O-beta-D-glucoside,CAS: 135558-26-8; PubChem: 583036; ChEBI: 16596; 3DMET: B04552; NIKKAJI: J2.609.922F,cpd:C04787; cpd:C12646,33,41,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H42O20,C33H40O20,757.2191187,758.2269437,756.21129373886,4257,cpd:C12647,Salvianin,C42H41O24,Salvianin,R06800,Anthocyanin biosynthesis,2.3.1.214,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C12647  Salvianin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C12647  Salvianin,PubChem: 583037; ChEBI: 32115; KNApSAcK: C00006778; 3DMET: B04553; NIKKAJI: J493.647G,cpd:C12647,42,41,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H42O24,C42H40O24,929.1987772,930.2066022,928.19095223887,4258,cpd:C16288,"Pelargonidin 3-O-3'',6''-O-dimalonylglucoside",C27H25O16,"Pelargonidin 3-O-3'',6''-O-dimalonylglucoside",R07884,Anthocyanin biosynthesis,2.3.1.-,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16288  Pelargonidin 3-O-3'',6''-O-dimalonylglucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16288  Pelargonidin 3-O-3'',6''-O-dimalonylglucoside",PubChem: 47205596; ChEBI: 80424; NIKKAJI: J2.799.375C,cpd:C16288,27,25,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H26O16,C27H24O16,605.1142597,606.1220848,604.10643473888,4259,cpd:C16289,"Cyanidin 3-O-3'',6''-O-dimalonylglucoside",C27H25O17,"Cyanidin 3-O-3'',6''-O-dimalonylglucoside",R07885,Anthocyanin biosynthesis,2.3.1.-,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16289  Cyanidin 3-O-3'',6''-O-dimalonylglucoside",PubChem: 47205597; ChEBI: 80425; KNApSAcK: C00006799; NIKKAJI: J791.113K,cpd:C16289,27,25,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H26O17,C27H24O17,621.1091743,622.1169994,620.10134933889,4260,cpd:C16290,"Delphinidin 3-O-3'',6''-O-dimalonylglucoside",C27H25O18,"Delphinidin 3-O-3'',6''-O-dimalonylglucoside",R07886,Anthocyanin biosynthesis,2.3.1.-,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16290  Delphinidin 3-O-3'',6''-O-dimalonylglucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16290  Delphinidin 3-O-3'',6''-O-dimalonylglucoside",PubChem: 47205598; ChEBI: 80426; NIKKAJI: J2.003.088G,cpd:C16290,27,25,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H26O18,C27H24O18,637.104089,638.111914,636.09626393890,4261,cpd:C16292,Cyanidin-3-(p-coumaroyl)-rutinoside-5-glucoside,C42H47O22,Cyanidin-3-(p-coumaroyl)-rutinoside-5-glucoside,R07900 R07901,Anthocyanin biosynthesis,2.1.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16292  Cyanidin-3-(p-coumaroyl)-rutinoside-5-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16292  Cyanidin-3-(p-coumaroyl)-rutinoside-5-glucoside,PubChem: 47205600; ChEBI: 80428; NIKKAJI: J2.799.413J,cpd:C16292,42,47,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H48O22,C42H46O22,903.2558981,904.2637232,902.24807313891,4262,cpd:C16293,Peonidin-3-(p-coumaroyl)-rutinoside-5-glucoside,C43H49O22,Peonidin-3-(p-coumaroyl)-rutinoside-5-glucoside,R07901,Anthocyanin biosynthesis,2.1.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16293  Peonidin-3-(p-coumaroyl)-rutinoside-5-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16293  Peonidin-3-(p-coumaroyl)-rutinoside-5-glucoside,PubChem: 47205601; ChEBI: 80429; NIKKAJI: J949.112K,cpd:C16293,43,49,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H50O22,C43H48O22,917.2715482,918.2793732,916.26372323892,4263,cpd:C16294,Delphinidin-3-(p-coumaroyl)-rutinoside-5-glucoside,C42H47O23,Delphinidin-3-(p-coumaroyl)-rutinoside-5-glucoside,R07904 R07905 R07907,Anthocyanin biosynthesis,2.1.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16294  Delphinidin-3-(p-coumaroyl)-rutinoside-5-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16294  Delphinidin-3-(p-coumaroyl)-rutinoside-5-glucoside,PubChem: 47205602; ChEBI: 80430; NIKKAJI: J2.041.098A,cpd:C16294,42,47,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H48O23,C42H46O23,919.2508128,920.2586378,918.24298773893,4264,cpd:C16295,Petunidin-3-(p-coumaroyl)-rutinoside-5-glucoside,C43H49O23,Petunidin-3-(p-coumaroyl)-rutinoside-5-glucoside,R07905 R07906,Anthocyanin biosynthesis,2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16295  Petunidin-3-(p-coumaroyl)-rutinoside-5-glucoside,PubChem: 47205603; ChEBI: 80431; NIKKAJI: J949.113I,cpd:C16295,43,49,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H50O23,C43H48O23,933.2664628,934.2742879,932.25863783894,4265,cpd:C16296,Malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside,C44H51O23,Malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside,R07906 R07907,Anthocyanin biosynthesis,2.1.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16296  Malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16296  Malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside,PubChem: 47205604; ChEBI: 80432; NIKKAJI: J674.364A,cpd:C16296,44,51,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C44H52O23,C44H50O23,947.2821129,948.2899379,946.27428793895,4266,cpd:C16297,Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside),C30H27O13,Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside),R07873 R07875,Anthocyanin biosynthesis,2.3.1.215; 2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16297  Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside); Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16297  Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside),PubChem: 47205605; ChEBI: 80433; KNApSAcK: C00006757; NIKKAJI: J2.799.436I,cpd:C12095; cpd:C16297,30,27,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H28O13,C30H26O13,595.1451659,596.152991,594.13734093896,4267,cpd:C16298,Cyanidin 5-O-glucoside,C21H21O11,Cyanidin 5-O-glucoside,R07908 R07909,Anthocyanin biosynthesis,2.4.1.-,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16298  Cyanidin 5-O-glucoside,PubChem: 47205606; ChEBI: 80434; NIKKAJI: J2.799.438E,cpd:C08604; cpd:C08647; cpd:C16298,21,21,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H22O11,C21H20O11,449.1083865,450.1162115,448.10056153897,4268,cpd:C16299,Malonylshisonin,C39H39O21,Malonylshisonin,R07910,Anthocyanin biosynthesis,2.3.1.172,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16299  Malonylshisonin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16299  Malonylshisonin,PubChem: 47205607; ChEBI: 80435; KNApSAcK: C00006824; NIKKAJI: J346.164E,cpd:C12641; cpd:C16299,39,39,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C39H40O21,C39H38O21,843.1983833,844.2062083,842.19055823898,4269,cpd:C16301,Delphinidin 3-O-(6''-O-malonyl)-beta-D-glucoside,C24H23O15,Delphinidin 3-O-(6''-O-malonyl)-beta-D-glucoside,R07886 R07913 R07938 R10063,Anthocyanin biosynthesis,2.3.1.171; 2.3.1.-; 2.4.1.238; 2.4.1.249,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16301  Delphinidin 3-O-(6-O-malonyl-beta-D-glucoside); Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16301  Delphinidin 3-O-(6''-O-malonyl-beta-D-glucoside),PubChem: 47205609; ChEBI: 55334; KNApSAcK: C00006877; NIKKAJI: J727.275H,cpd:C16301,24,23,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H24O15,C24H22O15,551.103695,552.1115201,550.095873899,4270,cpd:C16302,Ternatin A1,C96H107O53,Ternatin A1,R07915,Anthocyanin biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16302  Ternatin A1,PubChem: 47205610; ChEBI: 80436; NIKKAJI: J1.379.217H,cpd:C16302,96,107,53,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C96H108O53,C96H106O53,2107.567753,2108.575578,2106.5599283900,4271,cpd:C16303,Ternatin C5;,C36H43O25,"Ternatin C5; Delphinidin 3-O-(6''-O-malonyl)-beta-D-glucoside-3',5'-di-O-beta-D-glucoside",R07914 R07915 R10063,Anthocyanin biosynthesis,2.4.1.249,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16303  Ternatin C5; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16303  Ternatin C5,PubChem: 47205611; ChEBI: 55335; KNApSAcK: C00014808; NIKKAJI: J1.034.459J,cpd:C16303,36,43,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H44O25,C36H42O25,875.2093419,876.2171669,874.20151683901,4272,cpd:C16304,Delphinidin 3-O-(6''-O-malonyl)-beta-glucoside-3'-O-beta-glucoside;,C30H33O20,Delphinidin 3-O-(6''-O-malonyl)-beta-glucoside-3'-O-beta-glucoside; Delphinidin 3-O-(6''-O-malonyl)-beta-D-glucoside-3'-O-beta-D-glucoside,R07913 R07914,Anthocyanin biosynthesis,2.4.1.238; 2.4.1.249,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16304  Delphinidin 3-O-(6''-O-malonyl)-beta-glucoside-3'-O-beta-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16304  Delphinidin 3-O-(6''-O-malonyl)-beta-glucoside-3'-O-beta-glucoside,PubChem: 47205612; ChEBI: 55336; NIKKAJI: J1.830.378G,cpd:C16304,30,33,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H34O20,C30H32O20,713.1565185,714.1643435,712.14869343902,4273,cpd:C16305,Pelargonidin 3-O-sophoroside,C27H31O15,Pelargonidin 3-O-sophoroside,R07877,Anthocyanin biosynthesis,2.4.1.297,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16305  Pelargonidin 3-O-sophoroside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16305  Pelargonidin 3-O-sophoroside,PubChem: 47205613; ChEBI: 80437; KNApSAcK: C00006636; NIKKAJI: J400.942H,cpd:C04491; cpd:C08620; cpd:C08725; cpd:C16305; cpd:C20495,27,31,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O15,C27H30O15,595.1662953,596.1741203,594.15847033903,4274,cpd:C16306,Cyanidin 3-O-sophoroside,C27H31O16,Cyanidin 3-O-sophoroside,R07878,Anthocyanin biosynthesis,2.4.1.297,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16306  Cyanidin 3-O-sophoroside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16306  Cyanidin 3-O-sophoroside,PubChem: 47205614; ChEBI: 80438; KNApSAcK: C00006658; NIKKAJI: J735.618H,cpd:C08639; cpd:C16306; cpd:C16315; cpd:C20469,27,31,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O16,C27H30O16,611.1612099,612.1690349,610.15338493904,4275,cpd:C16307,Delphinidin 3-O-sophoroside,C27H31O17,Delphinidin 3-O-sophoroside,R07879,Anthocyanin biosynthesis,2.4.1.297,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16307  Delphinidin 3-O-sophoroside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16307  Delphinidin 3-O-sophoroside,PubChem: 47205615; ChEBI: 80439; KNApSAcK: C00006705; NIKKAJI: J2.418.075A,cpd:C16307; cpd:C16312; cpd:C20496,27,31,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O17,C27H30O17,627.1561245,628.1639496,626.14829953905,4276,cpd:C16312,Delphin;,C27H31O17,"Delphin; Delphinidin 3,5-diglucoside",R07883 R07911 R07912 R07944 R10299,Anthocyanin biosynthesis,2.3.1.153; 2.4.1.238; 2.4.1.298; 2.4.1.299,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16312  Delphin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16312  Delphin,PubChem: 47205620; ChEBI: 55455; KNApSAcK: C00037021; NIKKAJI: J238.030G,cpd:C16307; cpd:C16312; cpd:C20496,27,31,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O17,C27H30O17,627.1561245,628.1639496,626.14829953906,4277,cpd:C16313,Delphinidin 3-glucoside 5-caffoyl-glucoside,C36H37O20,Delphinidin 3-glucoside 5-caffoyl-glucoside,R07923 R07944,Anthocyanin biosynthesis,2.3.1.153; 2.4.1.238,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16313  Delphinidin 3-glucoside 5-caffoyl-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16313  Delphinidin 3-glucoside 5-caffoyl-glucoside,PubChem: 47205621; ChEBI: 80440; NIKKAJI: J2.801.741C,cpd:C16313,36,37,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H38O20,C36H36O20,789.1878186,790.1956436,788.17999363907,4278,cpd:C16314,"Delphinidin 3,5,3'-triglucoside",C33H41O22,"Delphinidin 3,5,3'-triglucoside",R07912 R07925,Anthocyanin biosynthesis,2.4.1.238,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16314  Delphinidin 3,5,3'-triglucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16314  Delphinidin 3,5,3'-triglucoside",PubChem: 47205622; ChEBI: 55456; NIKKAJI: J2.801.742A,cpd:C08640; cpd:C16314,33,41,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H42O22,C33H40O22,789.208948,790.216773,788.20112293908,4279,cpd:C16315,Tulipanin;,C27H31O16,Tulipanin; Delphinidin 3-O-rutinoside,R07903 R07904,Anthocyanin biosynthesis,2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16315  Tulipanin;     C16315  Tulipanin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16315  Tulipanin,PubChem: 47205623; ChEBI: 80441; NIKKAJI: J400.935E,cpd:C08639; cpd:C16306; cpd:C16315; cpd:C20469,27,31,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O16,C27H30O16,611.1612099,612.1690349,610.15338493909,4280,cpd:C16349,Pelargonidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),C36H37O17,Pelargonidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),R07880,Anthocyanin biosynthesis,2.3.1.153,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16349  Pelargonidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside); Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16349  Pelargonidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),PubChem: 47205657; ChEBI: 80466; NIKKAJI: J2.802.292A,cpd:C16349,36,37,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H38O17,C36H36O17,741.2030747,742.2108998,740.19524973910,4281,cpd:C16350,Cyanidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),C36H37O18,Cyanidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),R07882,Anthocyanin biosynthesis,2.3.1.153,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16350  Cyanidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),PubChem: 47205658; ChEBI: 80467; KNApSAcK: C00006820; NIKKAJI: J2.802.293J,cpd:C12096; cpd:C12640; cpd:C16350; cpd:C16371,36,37,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H38O18,C36H36O18,757.1979893,758.2058144,756.19016433911,4282,cpd:C16351,Delphinidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),C36H37O19,Delphinidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),R07883,Anthocyanin biosynthesis,2.3.1.153,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16351  Delphinidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside); Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16351  Delphinidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),PubChem: 47205659; ChEBI: 80468; KNApSAcK: C00014820; NIKKAJI: J2.802.294H,cpd:C16351; cpd:C16372,36,37,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H38O19,C36H36O19,773.192904,774.200729,772.18507893912,4283,cpd:C16354,Albireodelphin;,C42H47O25,"Albireodelphin; Delphinidin 3,3'-diglucoside 5-(6-caffeoyl)glucoside",R07923 R07924,Anthocyanin biosynthesis,2.3.1.-; 2.4.1.238,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16354  Albireodelphin,PubChem: 47205662; ChEBI: 80469; KNApSAcK: C00014781; NIKKAJI: J660.003D,cpd:C16354,42,47,25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H48O25,C42H46O25,951.240642,952.248467,950.2328173913,4284,cpd:C16367,Delphinidin 3-O-(6-caffeoyl-beta-D-glucoside),C30H27O15,Delphinidin 3-O-(6-caffeoyl-beta-D-glucoside),R07926,Anthocyanin biosynthesis,2.3.1.215,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16367  Delphinidin 3-O-(6-caffeoyl-beta-D-glucoside); Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16367  Delphinidin 3-O-(6-caffeoyl-beta-D-glucoside),PubChem: 47205675; ChEBI: 80474; KNApSAcK: C00006879; NIKKAJI: J1.002.891D,cpd:C05821; cpd:C16367,30,27,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H28O15,C30H26O15,627.1349952,628.1428202,626.12717013914,4285,cpd:C16368,Pelargonidin 3-(6-p-coumaroyl)glucoside,C30H27O12,Pelargonidin 3-(6-p-coumaroyl)glucoside,R07927,Anthocyanin biosynthesis,2.3.1.215,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16368  Pelargonidin 3-(6-p-coumaroyl)glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16368  Pelargonidin 3-(6-p-coumaroyl)glucoside,PubChem: 47205676; ChEBI: 80475; KNApSAcK: C00006756; NIKKAJI: J2.802.459B,cpd:C16368,30,27,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H28O12,C30H26O12,579.1502513,580.1580763,578.14242633915,4286,cpd:C16369,Cyanidin 3-(6-p-caffeoyl)glucoside,C30H27O14,Cyanidin 3-(6-p-caffeoyl)glucoside,R07928,Anthocyanin biosynthesis,2.3.1.215,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16369  Cyanidin 3-(6-p-caffeoyl)glucoside,PubChem: 47205677; ChEBI: 80476; KNApSAcK: C00006801; NIKKAJI: J2.802.462B,cpd:C16369; cpd:C16370,30,27,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H28O14,C30H26O14,611.1400805,612.1479056,610.13225553916,4287,cpd:C16370,Delphinidin 3-(6-p-coumaroyl)glucoside,C30H27O14,Delphinidin 3-(6-p-coumaroyl)glucoside,R07929,Anthocyanin biosynthesis,2.3.1.215,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16370  Delphinidin 3-(6-p-coumaroyl)glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16370  Delphinidin 3-(6-p-coumaroyl)glucoside,PubChem: 47205678; ChEBI: 75677; KNApSAcK: C00006878; NIKKAJI: J657.836E,cpd:C16369; cpd:C16370,30,27,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H28O14,C30H26O14,611.1400805,612.1479056,610.13225553917,4288,cpd:C16371,Pelargonidin 3-glucoside 5-caffeoylglucoside,C36H37O18,Pelargonidin 3-glucoside 5-caffeoylglucoside,R07930,Anthocyanin biosynthesis,2.3.1.153,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1201 Anthocyanidins;     C16371  Pelargonidin 3-glucoside 5-caffeoylglucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16371  Pelargonidin 3-glucoside 5-caffeoylglucoside,PubChem: 47205679; ChEBI: 80477; NIKKAJI: J2.802.475D,cpd:C12096; cpd:C12640; cpd:C16350; cpd:C16371,36,37,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H38O18,C36H36O18,757.1979893,758.2058144,756.19016433918,4289,cpd:C16372,Cyanidin 3-glucoside 5-caffeoylglucoside,C36H37O19,Cyanidin 3-glucoside 5-caffeoylglucoside,R07931,Anthocyanin biosynthesis,2.3.1.153,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16372  Cyanidin 3-glucoside 5-caffeoylglucoside,PubChem: 47205680; ChEBI: 80478; KNApSAcK: C00006822; NIKKAJI: J2.802.491F,cpd:C16351; cpd:C16372,36,37,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H38O19,C36H36O19,773.192904,774.200729,772.18507893919,4290,cpd:C16373,Cyanidin-3-O-(6''-O-malonyl-2''-O-glucuronyl)glucoside,C30H31O20,Cyanidin-3-O-(6''-O-malonyl-2''-O-glucuronyl)glucoside,R07932,Anthocyanin biosynthesis,2.4.1.254,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Anthocyanidins and anthocyanins;     C16373  Cyanidin-3-O-(6''-O-malonyl-2''-O-glucuronyl)glucoside,PubChem: 47205681; ChEBI: 80479; KNApSAcK: C00006811; NIKKAJI: J448.206I,cpd:C16373,30,31,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H32O20,C30H30O20,711.1408684,712.1486934,710.13304343920,4291,cpd:C19762,Cyanidin 3-O-(2-O-beta-D-glucuronosyl)-beta-D-glucoside,C27H29O17,Cyanidin 3-O-(2-O-beta-D-glucuronosyl)-beta-D-glucoside,R09635,Anthocyanin biosynthesis,2.4.1.254,NA,NA,PubChem: 135626229,cpd:C19762,27,29,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H30O17,C27H28O17,625.1404745,626.1482995,624.13264943921,4292,cpd:C20469,"Cyanidin 3,7-di-O-beta-D-glucoside",C27H31O16,"Cyanidin 3,7-di-O-beta-D-glucoside",R10259,Anthocyanin biosynthesis,2.4.1.300,NA,NA,PubChem: 163312206,cpd:C08639; cpd:C16306; cpd:C16315; cpd:C20469,27,31,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O16,C27H30O16,611.1612099,612.1690349,610.15338493922,4293,cpd:C20489,Pelargonidin 3-O-beta-D-sambubioside,C26H29O14,Pelargonidin 3-O-beta-D-sambubioside,R10290 R10293,Anthocyanin biosynthesis,2.4.1.295; 2.4.2.51,NA,NA,PubChem: 172232238; ChEBI: 74809,cpd:C20489,26,29,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H30O14,C26H28O14,565.1557306,566.1635556,564.14790563923,4294,cpd:C20490,Cyanidin 3-O-beta-D-sambubioside,C26H29O15,Cyanidin 3-O-beta-D-sambubioside,R10291 R10294,Anthocyanin biosynthesis,2.4.1.295; 2.4.2.51,NA,NA,PubChem: 172232239; ChEBI: 74811,cpd:C20468; cpd:C20490,26,29,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H30O15,C26H28O15,581.1506452,582.1584703,580.14282023924,4295,cpd:C20491,Delphinidin 3-O-beta-D-sambubioside,C26H29O16,Delphinidin 3-O-beta-D-sambubioside,R10292 R10295,Anthocyanin biosynthesis,2.4.1.295; 2.4.2.51,NA,NA,PubChem: 172232240; ChEBI: 74810,cpd:C20491,26,29,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H30O16,C26H28O16,597.1455598,598.1533849,596.13773483925,4296,cpd:C20492,Pelargonidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside,C32H39O19,Pelargonidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside,R10293,Anthocyanin biosynthesis,2.4.1.295,NA,NA,PubChem: 172232241,cpd:C20492,32,39,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H40O19,C32H38O19,727.208554,728.2163791,726.2007293926,4297,cpd:C20493,Cyanidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside,C32H39O20,Cyanidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside,R10294,Anthocyanin biosynthesis,2.4.1.295,NA,NA,PubChem: 172232242,cpd:C08612; cpd:C20493,32,39,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H40O20,C32H38O20,743.2034686,744.2112937,742.19564363927,4298,cpd:C20494,Delphinidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside,C32H39O21,Delphinidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside,R10295,Anthocyanin biosynthesis,2.4.1.295,NA,NA,PubChem: 172232243,cpd:C20494,32,39,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H40O21,C32H38O21,759.1983833,760.2062083,758.19055823928,4299,cpd:C20495,"Pelargonidin 3,7-di-O-beta-D-glucoside",C27H31O15,"Pelargonidin 3,7-di-O-beta-D-glucoside",R10296,Anthocyanin biosynthesis,2.4.1.300,NA,NA,PubChem: 172232244,cpd:C04491; cpd:C08620; cpd:C08725; cpd:C16305; cpd:C20495,27,31,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O15,C27H30O15,595.1662953,596.1741203,594.15847033929,4300,cpd:C20496,"Delphinidin 3,7-di-O-beta-D-glucoside",C27H31O17,"Delphinidin 3,7-di-O-beta-D-glucoside",R10297,Anthocyanin biosynthesis,2.4.1.300,NA,NA,PubChem: 172232245,cpd:C16307; cpd:C16312; cpd:C20496,27,31,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O17,C27H30O17,627.1561245,628.1639496,626.14829953930,4301,cpd:C00786,(-)-Vestitone;,C16H14O5,(-)-Vestitone; Vestitone,R02915 R06562 R06565 R07737,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.348; 1.3.1.45,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C00786  (-)-Vestitone; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavanones;     C00786  (-)-Vestitone,CAS: 158112-50-6; PubChem: 4044; ChEBI: 16786; KNApSAcK: C00002584; 3DMET: B00174; NIKKAJI: J19.190F,cpd:C00786; cpd:C02675; cpd:C02922; cpd:C05334; cpd:C08844; cpd:C08974; cpd:C09044; cpd:C09282; cpd:C09833; cpd:C09920; cpd:C09975; cpd:C10274; cpd:C10508; cpd:C12434; cpd:C16190; cpd:C18481; cpd:C18835,16,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O5,C16H13O5,286.0841235,287.0919486,285.07629853931,4302,cpd:C00814,Biochanin A,C16H12O5,Biochanin A,R02931 R02954 R06561 R06795 R07776,Isoflavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.3.1.46; 1.14.13.52; 1.14.13.89; 2.1.1.212; 2.4.1.170,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C00814  Biochanin A; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C00814  Biochanin A,CAS: 491-80-5; PubChem: 4072; ChEBI: 17574; ChEMBL: CHEMBL131921; LIPIDMAPS: LMPK12050229; KNApSAcK: C00002510; PDB-CCD: QSO; 3DMET: B00181; NIKKAJI: J11.761G,cpd:C00814; cpd:C01448; cpd:C01470; cpd:C01562; cpd:C02920; cpd:C10046; cpd:C10047; cpd:C10197; cpd:C10323; cpd:C10370; cpd:C10502; cpd:C10504; cpd:C10521; cpd:C10536; cpd:C11577; cpd:C14536; cpd:C16229; cpd:C17039; cpd:C17045,16,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O5,C16H11O5,284.0684735,285.0762985,283.06064853932,4303,cpd:C00858,Formononetin,C16H12O4,Formononetin,R03006 R06560 R06564 R07723 R07729 R07733,Isoflavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.14.13.52; 1.14.13.53; 1.14.13.89; 2.1.1.212; 2.4.1.170; 4.2.1.105,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C00858  Formononetin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C00858  Formononetin; Major components of natural products [BR:br08323];  Crude drugs;   Astragalus root;    C00858  Formononetin,CAS: 485-72-3; PubChem: 4115; ChEBI: 18088; ChEMBL: CHEMBL242341; LIPIDMAPS: LMPK12050037; KNApSAcK: C00002525; 3DMET: B00192; NIKKAJI: J12.525C,cpd:C00858; cpd:C10414; cpd:C11621; cpd:C12125; cpd:C15110; cpd:C15203; cpd:C18849; cpd:C19121; cpd:C19403,16,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O4,C16H11O4,268.0735589,269.0813839,267.06573383933,4304,cpd:C01263,"3,6,9-Trihydroxypterocarpan;",C15H12O5,"3,6,9-Trihydroxypterocarpan; (6aS,11aS)-3,6a,9-Trihydroxypterocarpan; (-)-Glycinol",R03452 R07271 R07272,Isoflavonoid biosynthesis,1.14.13.28; 2.5.1.36,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C01263  (6aS,11aS)-3,6a,9-Trihydroxypterocarpan; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C01263  3,6,9-Trihydroxypterocarpan",CAS: 69393-95-9; PubChem: 4482; ChEBI: 15649; LIPIDMAPS: LMPK12070128; KNApSAcK: C00002532; 3DMET: B01427; NIKKAJI: J156.714D,cpd:C00509; cpd:C01263; cpd:C01592; cpd:C03567; cpd:C06561; cpd:C08578; cpd:C09047; cpd:C09614; cpd:C09751; cpd:C09826; cpd:C12087; cpd:C14458; cpd:C15567; cpd:C15598; cpd:C16232; cpd:C17673,15,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O5,C15H11O5,272.0684735,273.0762985,271.06064853934,4305,cpd:C01562,Calycosin,C16H12O5,Calycosin,R03006 R07744 R07745,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.52; 1.14.21.8,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C01562  Calycosin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C01562  Calycosin,CAS: 20575-57-9; PubChem: 4720; ChEBI: 17793; ChEMBL: CHEMBL241608; LIPIDMAPS: LMPK12050056; KNApSAcK: C00009389; 3DMET: B00319; NIKKAJI: J16.804A,cpd:C00814; cpd:C01448; cpd:C01470; cpd:C01562; cpd:C02920; cpd:C10046; cpd:C10047; cpd:C10197; cpd:C10323; cpd:C10370; cpd:C10502; cpd:C10504; cpd:C10521; cpd:C10536; cpd:C11577; cpd:C14536; cpd:C16229; cpd:C17039; cpd:C17045,16,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O5,C16H11O5,284.0684735,285.0762985,283.06064853935,4306,cpd:C01701,(-)-Glyceollin I;,C20H18O5,(-)-Glyceollin I; Glyceollin,R07197,Isoflavonoid biosynthesis,1.14.13.85,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C01701  (-)-Glyceollin I; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C01701  (-)-Glyceollin I,CAS: 57103-57-8; PubChem: 4841; ChEBI: 16470; ChEMBL: CHEMBL1774987; LIPIDMAPS: LMPK12070123; KNApSAcK: C00002530; 3DMET: B01482; NIKKAJI: J193.292F,cpd:C01701; cpd:C09360; cpd:C10049; cpd:C10360; cpd:C10422; cpd:C10542; cpd:C11576; cpd:C11581; cpd:C15511; cpd:C17742,20,18,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O5,C20H17O5,338.1154237,339.1232487,337.10759863936,4307,cpd:C02495,2'-Hydroxydaidzein;,C15H10O5,"2'-Hydroxydaidzein; 3-(2,4-Dihydroxyphenyl)-7-hydroxychromen-4-one",R03962 R06606,Isoflavonoid biosynthesis,1.3.1.51; 1.14.13.89,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C02495  2'-Hydroxydaidzein; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C02495  2'-Hydroxydaidzein,CAS: 7678-85-5; PubChem: 5507; ChEBI: 27479; ChEMBL: CHEMBL6694; LIPIDMAPS: LMPK12050083; KNApSAcK: C00009383; 3DMET: B01580; NIKKAJI: J1.005.532F,cpd:C01477; cpd:C02495; cpd:C06563; cpd:C08730; cpd:C10023; cpd:C10037; cpd:C10044; cpd:C10113; cpd:C10294; cpd:C10343; cpd:C10369; cpd:C10376; cpd:C10379; cpd:C10397; cpd:C14313; cpd:C14314; cpd:C15222; cpd:C16796,15,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O5,C15H9O5,270.0528234,271.0606485,269.04499843937,4308,cpd:C02675,Dihydrobiochanin A;,C16H14O5,"Dihydrobiochanin A; 2,3-Dihydrobiochanin A",R02954,Isoflavonoid biosynthesis,1.3.1.46,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C02675  Dihydrobiochanin A; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavanones;     C02675  Dihydrobiochanin A,CAS: 83920-62-1; PubChem: 5646; ChEBI: 15712; LIPIDMAPS: LMPK12050475; KNApSAcK: C00009553; 3DMET: B04860; NIKKAJI: J303.867J,cpd:C00786; cpd:C02675; cpd:C02922; cpd:C05334; cpd:C08844; cpd:C08974; cpd:C09044; cpd:C09282; cpd:C09833; cpd:C09920; cpd:C09975; cpd:C10274; cpd:C10508; cpd:C12434; cpd:C16190; cpd:C18481; cpd:C18835,16,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O5,C16H13O5,286.0841235,287.0919486,285.07629853938,4309,cpd:C02920,2'-Hydroxyformononetin;,C16H12O5,2'-Hydroxyformononetin; 2'-Hydroformononetin,R06560 R06562 R07735,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.45; 1.14.13.53; 1.14.13.89,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C02920  2'-Hydroxyformononetin,CAS: 1890-99-9; PubChem: 5843; ChEBI: 17678; ChEMBL: CHEMBL253514; LIPIDMAPS: LMPK12050081; KNApSAcK: C00000257; 3DMET: B00513; NIKKAJI: J413.187H,cpd:C00814; cpd:C01448; cpd:C01470; cpd:C01562; cpd:C02920; cpd:C10046; cpd:C10047; cpd:C10197; cpd:C10323; cpd:C10370; cpd:C10502; cpd:C10504; cpd:C10521; cpd:C10536; cpd:C11577; cpd:C14536; cpd:C16229; cpd:C17039; cpd:C17045,16,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O5,C16H11O5,284.0684735,285.0762985,283.06064853939,4310,cpd:C03567,2'-Hydroxydihydrodaidzein;,C15H12O5,"2'-Hydroxydihydrodaidzein; 2'-Hydroxy-2,3-dihydrodaidzein",R03962 R07728,Isoflavonoid biosynthesis,1.3.1.51,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C03567  2'-Hydroxydihydrodaidzein; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavanones;     C03567  2'-Hydroxydihydrodaidzein,PubChem: 6359; ChEBI: 16035; LIPIDMAPS: LMPK12050463; KNApSAcK: C00009535; 3DMET: B00600; NIKKAJI: J346.405I,cpd:C00509; cpd:C01263; cpd:C01592; cpd:C03567; cpd:C06561; cpd:C08578; cpd:C09047; cpd:C09614; cpd:C09751; cpd:C09826; cpd:C12087; cpd:C14458; cpd:C15567; cpd:C15598; cpd:C16232; cpd:C17673,15,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O5,C15H11O5,272.0684735,273.0762985,271.06064853940,4311,cpd:C04271,"3,9-Dihydroxypterocarpan;",C15H12O4,"3,9-Dihydroxypterocarpan; (6aR,11aR)-3,9-Dihydroxypterocarpan",R03452 R07728,Isoflavonoid biosynthesis,1.14.13.28,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C04271  3,9-Dihydroxypterocarpan",CAS: 61135-91-9; PubChem: 6934; ChEBI: 15648; ChEMBL: CHEMBL1098413; KNApSAcK: C00009610; 3DMET: B01728; NIKKAJI: J346.404K,cpd:C02465; cpd:C04271; cpd:C07639; cpd:C08650; cpd:C09762; cpd:C09827; cpd:C10262; cpd:C15609; cpd:C16404; cpd:C16760; cpd:C18256; cpd:C18527; cpd:C18716,15,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O4,C15H11O4,256.0735589,257.0813839,255.06573383941,4312,cpd:C05376,Biochanin A-beta-D-glucoside;,C22H22O10,Biochanin A-beta-D-glucoside; Biochanin A 7-O-beta-D-glucoside; Sissotrin,R06795 R06796,Isoflavonoid biosynthesis,2.3.1.115; 2.4.1.170,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C05376  Biochanin A-beta-D-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C05376  Biochanin A-beta-D-glucoside,CAS: 5928-26-7; PubChem: 7750; ChEBI: 28751; KNApSAcK: C00010112; 3DMET: B01849; NIKKAJI: J14.104F,cpd:C05376; cpd:C10381; cpd:C10384; cpd:C10538; cpd:C16195; cpd:C17835; cpd:C18359,22,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H23O10,C22H21O10,446.1212969,447.1291219,445.11347193942,4313,cpd:C06563,Genistein;,C15H10O5,"Genistein; 5,7,4'-Trihydroxyisoflavone",R02931 R02932 R06553 R06607 R06793 R06794,Isoflavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.14.13.89; 2.1.1.150; 2.1.1.212; 2.4.1.170; 4.2.1.105,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C06563  Genistein; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C06563  Genistein,CAS: 446-72-0; PubChem: 8792; ChEBI: 28088; ChEMBL: CHEMBL44; LIPIDMAPS: LMPK12050218; KNApSAcK: C00002526; PDB-CCD: GEN; 3DMET: B00974; NIKKAJI: J39.883G,cpd:C01477; cpd:C02495; cpd:C06563; cpd:C08730; cpd:C10023; cpd:C10037; cpd:C10044; cpd:C10113; cpd:C10294; cpd:C10343; cpd:C10369; cpd:C10376; cpd:C10379; cpd:C10397; cpd:C14313; cpd:C14314; cpd:C15222; cpd:C16796,15,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O5,C15H9O5,270.0528234,271.0606485,269.04499843943,4314,cpd:C07593,Rotenone,C23H22O6,Rotenone,R07744,Isoflavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites; Parkinson's disease,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1206 Rotenoid flavonoids;     C07593  Rotenone; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Rotenones;     C07593  Rotenone; Pesticides [BR:br08007];  Pesticides;   Insecticides;    Others;     C07593  Rotenone; Animal drugs in Japan [BR:br08331];  95  Agents for external use;   954  Anti-dermoinfectives;    9549  Other anti-dermoinfectives;     C07593  Rotenone,CAS: 83-79-4; PubChem: 9795; ChEBI: 28201; ChEMBL: CHEMBL429023; LIPIDMAPS: LMPK12060007; KNApSAcK: C00002568; 3DMET: B02130; NIKKAJI: J108.000H,cpd:C07593; cpd:C10076; cpd:C10417; cpd:C11752,23,22,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H23O6,C23H21O6,394.1416384,395.1494635,393.13381343944,4315,cpd:C09126,Genistein 7-O-beta-D-glucoside;,C21H20O10,Genistein 7-O-beta-D-glucoside; Genistein,R02932 R07757,Isoflavonoid biosynthesis,2.3.1.115; 2.4.1.170,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C09126  Genistein 7-O-beta-D-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C09126  Genistein 7-O-beta-D-glucoside,CAS: 529-59-9; PubChem: 11318; ChEBI: 27514; ChEMBL: CHEMBL486625; KNApSAcK: C00002528; 3DMET: B02701; NIKKAJI: J40.719D,cpd:C01460; cpd:C01714; cpd:C04608; cpd:C09126; cpd:C10345; cpd:C10420; cpd:C16911,21,20,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O10,C21H19O10,432.1056468,433.1134719,431.09782183945,4316,cpd:C10200,Anhydroglycinol;,C15H10O4,"Anhydroglycinol; 3,9-Dihydroxypterocarpen",R07725 R07726,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C10200  Anhydroglycinol; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C10200  Anhydroglycinol,CAS: 67685-22-7; PubChem: 12386; ChEBI: 2727; LIPIDMAPS: LMPK12070149; KNApSAcK: C00002508; 3DMET: B03631; NIKKAJI: J1.174.672A,cpd:C08212; cpd:C08644; cpd:C10028; cpd:C10121; cpd:C10200; cpd:C10208; cpd:C10291; cpd:C10315; cpd:C10327; cpd:C10329; cpd:C10402; cpd:C12123; cpd:C14265; cpd:C14344,15,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O4,C15H9O4,254.0579088,255.0657338,253.05008383946,4317,cpd:C10205,Coumestrol,C15H8O5,Coumestrol,R07726,Isoflavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1209 Coumestan flavonoids;     C10205  Coumestrol; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Coumestanes;     C10205  Coumestrol,CAS: 479-13-0; PubChem: 12391; ChEBI: 3908; ChEMBL: CHEMBL30707; LIPIDMAPS: LMPK12090018; KNApSAcK: C00002514; PDB-CCD: CUE; 3DMET: B03635; NIKKAJI: J9.392K,cpd:C10205,15,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H9O5,C15H7O5,268.0371734,269.0449984,267.02934833947,4318,cpd:C10208,Daidzein,C15H10O4,Daidzein,R06554 R06564 R06606 R07317 R07720 R07724 R07725,Isoflavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.14.13.89; 2.1.1.150; 2.1.1.212; 2.4.1.170; 4.2.1.105,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C10208  Daidzein; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C10208  Daidzein; Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP1A2;    Daidzein;     C10208  Daidzein,CAS: 486-66-8; PubChem: 12394; ChEBI: 28197; ChEMBL: CHEMBL8145; LIPIDMAPS: LMPK12050038; KNApSAcK: C00009380; 3DMET: B01122; NIKKAJI: J6.014C,cpd:C08212; cpd:C08644; cpd:C10028; cpd:C10121; cpd:C10200; cpd:C10208; cpd:C10291; cpd:C10315; cpd:C10327; cpd:C10329; cpd:C10402; cpd:C12123; cpd:C14265; cpd:C14344,15,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O4,C15H9O4,254.0579088,255.0657338,253.05008383948,4319,cpd:C10216,Daidzin;,C21H20O9,Daidzin; Daidzein 7-O-glucoside,R07720 R07721,Isoflavonoid biosynthesis,2.3.1.115; 2.4.1.170,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C10216  Daidzin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C10216  Daidzin,CAS: 552-66-9; PubChem: 12402; ChEBI: 42202; ChEMBL: CHEMBL486422; KNApSAcK: C00002518; PDB-CCD: DZN; 3DMET: B03643; NIKKAJI: J22.589D,cpd:C10216; cpd:C10316; cpd:C10346; cpd:C10524; cpd:C15580,21,20,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O9,C21H19O9,416.1107322,417.1185573,415.10290723949,4320,cpd:C10422,(-)-Glyceollin II,C20H18O5,(-)-Glyceollin II,R07195,Isoflavonoid biosynthesis,1.14.13.85,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C10422  (-)-Glyceollin II; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C10422  (-)-Glyceollin II,CAS: 67314-98-1; PubChem: 12608; ChEBI: 52127; LIPIDMAPS: LMPK12070124; KNApSAcK: C00002531; 3DMET: B03831; NIKKAJI: J193.293D,cpd:C01701; cpd:C09360; cpd:C10049; cpd:C10360; cpd:C10422; cpd:C10542; cpd:C11576; cpd:C11581; cpd:C15511; cpd:C17742,20,18,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O5,C20H17O5,338.1154237,339.1232487,337.10759863950,4321,cpd:C10502,(-)-Maackiain;,C16H12O5,(-)-Maackiain; Inermin,R07752 R07753 R07756,Isoflavonoid biosynthesis,2.4.1.170,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C10502  (-)-Maackiain; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C10502  (-)-Maackiain,CAS: 2035-15-6; PubChem: 12685; ChEBI: 99; ChEMBL: CHEMBL334918; LIPIDMAPS: LMPK12070050; KNApSAcK: C00002546; 3DMET: B03905; NIKKAJI: J14.944F,cpd:C00814; cpd:C01448; cpd:C01470; cpd:C01562; cpd:C02920; cpd:C10046; cpd:C10047; cpd:C10197; cpd:C10323; cpd:C10370; cpd:C10502; cpd:C10504; cpd:C10521; cpd:C10536; cpd:C11577; cpd:C14536; cpd:C16229; cpd:C17039; cpd:C17045,16,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O5,C16H11O5,284.0684735,285.0762985,283.06064853951,4322,cpd:C10503,Medicarpin;,C16H14O4,Medicarpin; (-)-Medicarpin,R02915 R06565 R07738 R07739 R07740 R07743,Isoflavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.23.1.-; 2.4.1.170; 4.2.1.139,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C10503  (-)-Medicarpin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C10503  (-)-Medicarpin,CAS: 32383-76-9; PubChem: 12686; ChEBI: 100; ChEMBL: CHEMBL238845; LIPIDMAPS: LMPK12070028; KNApSAcK: C00002547; 3DMET: B03906; NIKKAJI: J92.506C,cpd:C01729; cpd:C04606; cpd:C08993; cpd:C09053; cpd:C09269; cpd:C09939; cpd:C10503; cpd:C11021; cpd:C15531; cpd:C16419; cpd:C16976,16,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O4,C16H13O4,270.0892089,271.097034,269.08138393952,4323,cpd:C10509,Ononin;,C22H22O9,Ononin; Formononetin 7-O-glucoside,R07729 R07731 R07732 R07733,Isoflavonoid biosynthesis,2.3.1.115; 2.4.1.170,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C10509  Ononin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C10509  Ononin,CAS: 486-62-4; PubChem: 12692; ChEBI: 7775; ChEMBL: CHEMBL465980; KNApSAcK: C00002553; 3DMET: B03912; NIKKAJI: J12.916J,cpd:C10509; cpd:C18296,22,22,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H23O9,C22H21O9,430.1263823,431.1342073,429.11855733953,4324,cpd:C10516,Pisatin;,C17H14O6,Pisatin; (+)-Pisatin,R07750,Isoflavonoid biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,2.1.1.270,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C10516  Pisatin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C10516  Pisatin,CAS: 469-01-2; PubChem: 12699; ChEBI: 67347; ChEMBL: CHEMBL1784262; LIPIDMAPS: LMPK12070126; KNApSAcK: C00000651; 3DMET: B03919; NIKKAJI: J93.187J,cpd:C10407; cpd:C10471; cpd:C10516; cpd:C15100; cpd:C16418; cpd:C16753; cpd:C17784; cpd:C17785; cpd:C19584,17,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H15O6,C17H13O6,314.0790382,315.0868632,313.07121313954,4325,cpd:C10520,Pratensein,C16H12O6,Pratensein,R07776 R09602,Isoflavonoid biosynthesis,1.14.13.52; 1.14.21.8,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C10520  Pratensein; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C10520  Pratensein,CAS: 2284-31-3; PubChem: 12703; ChEBI: 8359; ChEMBL: CHEMBL252904; LIPIDMAPS: LMPK12050265; KNApSAcK: C00002563; 3DMET: B03922; NIKKAJI: J7.387C,cpd:C04293; cpd:C05902; cpd:C08651; cpd:C10038; cpd:C10058; cpd:C10098; cpd:C10203; cpd:C10520; cpd:C10534; cpd:C12135; cpd:C16227; cpd:C16228; cpd:C16230; cpd:C17059; cpd:C17811,16,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O6,C16H11O6,300.0633881,301.0712131,299.05556313955,4326,cpd:C10521,Prunetin,C16H12O5,Prunetin,R06794,Isoflavonoid biosynthesis,2.1.1.150,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C10521  Prunetin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C10521  Prunetin,CAS: 552-59-0; PubChem: 12704; ChEBI: 8600; ChEMBL: CHEMBL491174; LIPIDMAPS: LMPK12050353; KNApSAcK: C00002564; 3DMET: B01123; NIKKAJI: J61.257J,cpd:C00814; cpd:C01448; cpd:C01470; cpd:C01562; cpd:C02920; cpd:C10046; cpd:C10047; cpd:C10197; cpd:C10323; cpd:C10370; cpd:C10502; cpd:C10504; cpd:C10521; cpd:C10536; cpd:C11577; cpd:C14536; cpd:C16229; cpd:C17039; cpd:C17045,16,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O5,C16H11O5,284.0684735,285.0762985,283.06064853956,4327,cpd:C10522,Pseudobaptigenin,C16H10O5,Pseudobaptigenin,R07745 R07746,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.89; 1.14.21.8,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C10522  Pseudobaptigenin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C10522  Pseudobaptigenin,CAS: 90-29-9; PubChem: 12705; ChEBI: 8602; ChEMBL: CHEMBL486176; LIPIDMAPS: LMPK12050053; KNApSAcK: C00002565; 3DMET: B03923; NIKKAJI: J10.602J,cpd:C08722; cpd:C10522,16,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O5,C16H9O5,282.0528234,283.0606485,281.04499843957,4328,cpd:C10538,Trifolirhizin;,C22H22O10,Trifolirhizin; (-)-Maackiain 3-O-glucoside,R07753 R07754 R07755 R07756,Isoflavonoid biosynthesis,2.3.1.115; 2.4.1.170,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C10538  Trifolirhizin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C10538  Trifolirhizin,CAS: 6807-83-6; PubChem: 12721; ChEBI: 9714; ChEMBL: CHEMBL454878; KNApSAcK: C00010186; 3DMET: B03937; NIKKAJI: J20.549D,cpd:C05376; cpd:C10381; cpd:C10384; cpd:C10538; cpd:C16195; cpd:C17835; cpd:C18359,22,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H23O10,C22H21O10,446.1212969,447.1291219,445.11347193958,4329,cpd:C12125,Isoformononetin;,C16H12O4,Isoformononetin; 4'-Hydroxy-7-methoxyisoflavone,R07724,Isoflavonoid biosynthesis; Biosynthesis of phenylpropanoids,2.1.1.150,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C12125  Isoformononetin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C12125  Isoformononetin,PubChem: 14272; ChEBI: 29608; ChEMBL: CHEMBL453280; LIPIDMAPS: LMPK12050039; KNApSAcK: C00009382; PDB-CCD: HMO; 3DMET: B04425; NIKKAJI: J11.633E,cpd:C00858; cpd:C10414; cpd:C11621; cpd:C12125; cpd:C15110; cpd:C15203; cpd:C18849; cpd:C19121; cpd:C19403,16,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O4,C16H11O4,268.0735589,269.0813839,267.06573383959,4330,cpd:C12134,2'-Hydroxygenistein;,C15H10O6,"2'-Hydroxygenistein; 2',4',5,7-Tetrahydroxyisoflavone",R06607,Isoflavonoid biosynthesis,1.14.13.89,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C12134  2'-Hydroxygenistein; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C12134  2'-Hydroxygenistein,CAS: 1156-78-1; PubChem: 14281; ChEBI: 70031; ChEMBL: CHEMBL6665; LIPIDMAPS: LMPK12050327; KNApSAcK: C00009453; 3DMET: B04428; NIKKAJI: J397.872I,cpd:C01514; cpd:C05903; cpd:C08576; cpd:C08720; cpd:C10036; cpd:C10041; cpd:C10097; cpd:C10184; cpd:C10510; cpd:C12134; cpd:C17786; cpd:C17810; cpd:C18736,15,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O6,C15H9O6,286.047738,287.0555631,285.0399133960,4331,cpd:C12135,2'-Hydroxybiochanin A;,C16H12O6,2'-Hydroxybiochanin A; Dehydroferreirin,R06561 R06563,Isoflavonoid biosynthesis,1.3.1.45; 1.14.13.89,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C12135  2'-Hydroxybiochanin A; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C12135  2'-Hydroxybiochanin A,PubChem: 14282; ChEBI: 31064; ChEMBL: CHEMBL403228; LIPIDMAPS: LMPK12050328; KNApSAcK: C00009457; 3DMET: B04429; NIKKAJI: J1.007.246H,cpd:C04293; cpd:C05902; cpd:C08651; cpd:C10038; cpd:C10058; cpd:C10098; cpd:C10203; cpd:C10520; cpd:C10534; cpd:C12135; cpd:C16227; cpd:C16228; cpd:C16230; cpd:C17059; cpd:C17811,16,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O6,C16H11O6,300.0633881,301.0712131,299.05556313961,4332,cpd:C12625,Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside);,C25H24O13,Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside); Biochanin A 7-O-beta-D-glucoside 6''-O-malonate,R06796,Isoflavonoid biosynthesis,2.3.1.115,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C12625  Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside); Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C12625  Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside),CAS: 34232-17-2; PubChem: 583015; ChEBI: 28556; KNApSAcK: C00010117; 3DMET: B04539; NIKKAJI: J642.115F,cpd:C12625; cpd:C16197; cpd:C16231,25,24,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H25O13,C25H23O13,532.1216908,533.1295159,531.11386583962,4333,cpd:C12631,"2-Hydroxy-2,3-dihydrogenistein",C15H12O6,"2-Hydroxy-2,3-dihydrogenistein",R06792 R06793 R07778,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.136; 4.2.1.105,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavanones;     C12631  2-Hydroxy-2,3-dihydrogenistein",PubChem: 583021; ChEBI: 31080; KNApSAcK: C00034377; 3DMET: B05648; NIKKAJI: J949.035C,cpd:C00974; cpd:C01378; cpd:C05631; cpd:C08724; cpd:C09277; cpd:C10060; cpd:C10064; cpd:C10083; cpd:C10091; cpd:C10415; cpd:C12631; cpd:C15525; cpd:C16233; cpd:C16940,15,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O6,C15H11O6,288.0633881,289.0712131,287.05556313963,4334,cpd:C14314,"4',6,7-Trihydroxyisoflavone;",C15H10O5,"4',6,7-Trihydroxyisoflavone; 6-Hydroxydaidzein",R07716 R07717,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,CAS: 17817-31-1; PubChem: 17395314; ChEBI: 74957; ChEMBL: CHEMBL239156; LIPIDMAPS: LMPK12050102; KNApSAcK: C00009385; NIKKAJI: J254.133E,cpd:C01477; cpd:C02495; cpd:C06563; cpd:C08730; cpd:C10023; cpd:C10037; cpd:C10044; cpd:C10113; cpd:C10294; cpd:C10343; cpd:C10369; cpd:C10376; cpd:C10379; cpd:C10397; cpd:C14313; cpd:C14314; cpd:C15222; cpd:C16796,15,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O5,C15H9O5,270.0528234,271.0606485,269.04499843964,4335,cpd:C14536,Glycitein;,C16H12O5,"Glycitein; 7,4'-Dihydroxy-6-methoxyisoflavone",R07717 R07718,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,2.4.1.170,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C14536  Glycitein; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C14536  Glycitein,CAS: 40957-83-3; PubChem: 17395536; ChEBI: 34778; ChEMBL: CHEMBL513024; LIPIDMAPS: LMPK12050104; KNApSAcK: C00009392; NIKKAJI: J17.583H,cpd:C00814; cpd:C01448; cpd:C01470; cpd:C01562; cpd:C02920; cpd:C10046; cpd:C10047; cpd:C10197; cpd:C10323; cpd:C10370; cpd:C10502; cpd:C10504; cpd:C10521; cpd:C10536; cpd:C11577; cpd:C14536; cpd:C16229; cpd:C17039; cpd:C17045,16,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O5,C16H11O5,284.0684735,285.0762985,283.06064853965,4336,cpd:C15509,Glyceocarpin;,C20H20O5,"Glyceocarpin; 2-Dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan",R07195 R07196 R07271 R07356,Isoflavonoid biosynthesis,1.14.13.85; 2.5.1.36,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C15509  2-Dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C15509  Glyceocarpin",CAS: 77979-22-7; PubChem: 17396501; ChEBI: 50118; LIPIDMAPS: LMPK12070004; KNApSAcK: C00009688; NIKKAJI: J156.715B,cpd:C04418; cpd:C09753; cpd:C09832; cpd:C10418; cpd:C10616; cpd:C15509; cpd:C15510; cpd:C16416; cpd:C18023,20,20,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H21O5,C20H19O5,340.1310737,341.1388988,339.12324873966,4337,cpd:C15510,4-Glyceollidin;,C20H20O5,"4-Glyceollidin; 4-Dimethylallylglycinol; 4-Dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan",R07197 R07272 R07357,Isoflavonoid biosynthesis,1.14.13.85; 2.5.1.36,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C15510  4-Glyceollidin,CAS: 77979-21-6; PubChem: 17396502; ChEBI: 50036; KNApSAcK: C00009689; NIKKAJI: J156.716K,cpd:C04418; cpd:C09753; cpd:C09832; cpd:C10418; cpd:C10616; cpd:C15509; cpd:C15510; cpd:C16416; cpd:C18023,20,20,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H21O5,C20H19O5,340.1310737,341.1388988,339.12324873967,4338,cpd:C15511,Glyceollin III,C20H18O5,Glyceollin III,R07196,Isoflavonoid biosynthesis,1.14.13.85,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C15511  Glyceollin III; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C15511  Glyceollin III,CAS: 61080-23-7; PubChem: 17396503; ChEBI: 52086; KNApSAcK: C00009685; NIKKAJI: J193.294B,cpd:C01701; cpd:C09360; cpd:C10049; cpd:C10360; cpd:C10422; cpd:C10542; cpd:C11576; cpd:C11581; cpd:C15511; cpd:C17742,20,18,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O5,C20H17O5,338.1154237,339.1232487,337.10759863968,4339,cpd:C15567,"2,7,4'-Trihydroxyisoflavanone",C15H12O5,"2,7,4'-Trihydroxyisoflavanone",R07317 R07714 R07722 R07777,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.136; 2.1.1.212; 4.2.1.105,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavanones;     C15567  2,7,4'-Trihydroxyisoflavanone",PubChem: 17396559; ChEBI: 52047; NIKKAJI: J1.865.655H,cpd:C00509; cpd:C01263; cpd:C01592; cpd:C03567; cpd:C06561; cpd:C08578; cpd:C09047; cpd:C09614; cpd:C09751; cpd:C09826; cpd:C12087; cpd:C14458; cpd:C15567; cpd:C15598; cpd:C16232; cpd:C17673,15,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O5,C15H11O5,272.0684735,273.0762985,271.06064853969,4340,cpd:C16187,"7,2'-Dihydroxy-4'-methoxy-isoflavanol;",C16H16O5,"7,2'-Dihydroxy-4'-methoxy-isoflavanol; DMI; (3R,4R)-4'-Methoxyisoflavan-2',4,7-triol",R07737 R07738,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.348; 4.2.1.139,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavanes;     C16187  7,2'-Dihydroxy-4'-methoxy-isoflavanol",PubChem: 47205495; ChEBI: 71335; NIKKAJI: J2.798.747H,cpd:C09471; cpd:C10292; cpd:C12435; cpd:C16187; cpd:C17412,16,16,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O5,C16H15O5,288.0997736,289.1075986,287.09194863970,4341,cpd:C16188,"7-Hydroxy-2',4',5'-trimethoxyisoflavone",C18H16O6,"7-Hydroxy-2',4',5'-trimethoxyisoflavone",R07735 R07736,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C16188  7-Hydroxy-2',4',5'-trimethoxyisoflavone; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C16188  7-Hydroxy-2',4',5'-trimethoxyisoflavone",PubChem: 47205496; ChEBI: 80369; ChEMBL: CHEMBL455048; LIPIDMAPS: LMPK12050089; KNApSAcK: C00009413; NIKKAJI: J2.798.749D,cpd:C09479; cpd:C14985; cpd:C14986; cpd:C16188; cpd:C16189; cpd:C17475,18,16,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H17O6,C18H15O6,328.0946882,329.1025133,327.08686323971,4342,cpd:C16189,9-Demethylmunduserone,C18H16O6,9-Demethylmunduserone,R07736,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,NA,PubChem: 47205497; ChEBI: 80370; NIKKAJI: J2.798.751F,cpd:C09479; cpd:C14985; cpd:C14986; cpd:C16188; cpd:C16189; cpd:C17475,18,16,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H17O6,C18H15O6,328.0946882,329.1025133,327.08686323972,4343,cpd:C16190,"2,7-Dihydroxy-4'-methoxyisoflavanone",C16H14O5,"2,7-Dihydroxy-4'-methoxyisoflavanone",R07722 R07723,Isoflavonoid biosynthesis,2.1.1.212; 4.2.1.105,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavanones;     C16190  2,7-Dihydroxy-4'-methoxyisoflavanone",PubChem: 47205498; ChEBI: 62734; NIKKAJI: J1.865.694I,cpd:C00786; cpd:C02675; cpd:C02922; cpd:C05334; cpd:C08844; cpd:C08974; cpd:C09044; cpd:C09282; cpd:C09833; cpd:C09920; cpd:C09975; cpd:C10274; cpd:C10508; cpd:C12434; cpd:C16190; cpd:C18481; cpd:C18835,16,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O5,C16H13O5,286.0841235,287.0919486,285.07629853973,4344,cpd:C16191,Malonyldaidzin,C24H22O12,Malonyldaidzin,R07721,Isoflavonoid biosynthesis,2.3.1.115,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C16191  Malonyldaidzin,PubChem: 47205499; ChEBI: 80371; KNApSAcK: C00019384; NIKKAJI: J485.133A,cpd:C16191,24,22,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H23O12,C24H21O12,502.1111261,503.1189512,501.10330113974,4345,cpd:C16192,Malonylgenistin,C24H22O13,Malonylgenistin,R07757,Isoflavonoid biosynthesis,2.3.1.115,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C16192  Malonylgenistin,PubChem: 47205500; ChEBI: 80372; KNApSAcK: C00010110; NIKKAJI: J485.134J,cpd:C10020; cpd:C15540; cpd:C16192,24,22,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H23O13,C24H21O13,518.1060408,519.1138658,517.09821573975,4346,cpd:C16195,Glycitin;,C22H22O10,Glycitin; Glycitein 7-O-glucoside,R07718 R07719,Isoflavonoid biosynthesis,2.3.1.115; 2.4.1.170,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C16195  Glycitin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C16195  Glycitin,CAS: 40246-10-4; PubChem: 47205503; ChEBI: 80373; KNApSAcK: C00010089; NIKKAJI: J396.591K,cpd:C05376; cpd:C10381; cpd:C10384; cpd:C10538; cpd:C16195; cpd:C17835; cpd:C18359,22,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H23O10,C22H21O10,446.1212969,447.1291219,445.11347193976,4347,cpd:C16197,Malonylglycitin,C25H24O13,Malonylglycitin,R07719,Isoflavonoid biosynthesis,2.3.1.115,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C16197  Malonylglycitin,PubChem: 47205505; ChEBI: 80374; NIKKAJI: J759.938B,cpd:C12625; cpd:C16197; cpd:C16231,25,24,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H25O13,C25H23O13,532.1216908,533.1295159,531.11386583977,4348,cpd:C16222,Formononetin 7-O-glucoside-6''-O-malonate,C25H24O12,Formononetin 7-O-glucoside-6''-O-malonate,R07731 R07732,Isoflavonoid biosynthesis,2.3.1.115,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1205 Isoflavonoids;     C16222  Formononetin 7-O-glucoside-6''-O-malonate; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C16222  Formononetin 7-O-glucoside-6''-O-malonate,PubChem: 47205530; ChEBI: 80389; KNApSAcK: C00010083; NIKKAJI: J642.114H,cpd:C10445; cpd:C10468; cpd:C16222,25,24,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H25O12,C25H23O12,516.1267762,517.1346012,515.11895123978,4349,cpd:C16223,(-)-Medicocarpin;,C22H24O9,(-)-Medicocarpin; Medicarpin 3-O-glucoside,R07740 R07741 R07742 R07743,Isoflavonoid biosynthesis,2.3.1.115; 2.4.1.170,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C16223  (-)-Medicocarpin; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C16223  (-)-Medicocarpin,PubChem: 47205531; ChEBI: 80390; ChEMBL: CHEMBL517330; KNApSAcK: C00010183; NIKKAJI: J842.366K,cpd:C06624; cpd:C13055; cpd:C14942; cpd:C14953; cpd:C16223; cpd:C21391,22,24,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H25O9,C22H23O9,432.1420323,433.1498574,431.13420733979,4350,cpd:C16224,Medicarpin 3-O-glucoside-6'-malonate,C25H26O12,Medicarpin 3-O-glucoside-6'-malonate,R07741 R07742,Isoflavonoid biosynthesis,2.3.1.115,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C16224  Medicarpin 3-O-glucoside-6'-malonate; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C16224  Medicarpin 3-O-glucoside-6'-malonate,PubChem: 47205532; ChEBI: 80391; KNApSAcK: C00010184; NIKKAJI: J2.799.129G,cpd:C16224,25,26,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H27O12,C25H25O12,518.1424263,519.1502513,517.13460123980,4351,cpd:C16225,(-)-Vestitol,C16H16O4,(-)-Vestitol,R07739,Isoflavonoid biosynthesis,1.23.1.-,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavanes;     C16225  (-)-Vestitol,CAS: 35878-41-2; PubChem: 47205533; ChEBI: 80392; ChEMBL: CHEMBL479145; KNApSAcK: C00019387; NIKKAJI: J11.830C,cpd:C04547; cpd:C08109; cpd:C09014; cpd:C09644; cpd:C10340; cpd:C10372; cpd:C10540; cpd:C13705; cpd:C16225; cpd:C18133; cpd:C18417; cpd:C18420,16,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O4,C16H15O4,272.104859,273.112684,271.0970343981,4352,cpd:C16226,"2',7-Dihydroxy-4',5'-methylenedioxyisoflavone;",C16H10O6,"2',7-Dihydroxy-4',5'-methylenedioxyisoflavone; DMI",R07746 R07747 R07751,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.45; 1.14.13.89,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavones;     C16226  2',7-Dihydroxy-4',5'-methylenedioxyisoflavone",PubChem: 47205534; ChEBI: 80393; LIPIDMAPS: LMPK12050082; KNApSAcK: C00000649; NIKKAJI: J1.103.717H,cpd:C10202; cpd:C10467; cpd:C11591; cpd:C16226; cpd:C19587; cpd:C19727,16,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H11O6,C16H9O6,298.047738,299.0555631,297.0399133982,4353,cpd:C16227,(+)-Sophorol,C16H12O6,(+)-Sophorol,R07747 R07748,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,1.3.1.45,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavanones;     C16227  (+)-Sophorol,CAS: 524-08-3; PubChem: 47205535; ChEBI: 80394; KNApSAcK: C00009539; NIKKAJI: J91.456H,cpd:C04293; cpd:C05902; cpd:C08651; cpd:C10038; cpd:C10058; cpd:C10098; cpd:C10203; cpd:C10520; cpd:C10534; cpd:C12135; cpd:C16227; cpd:C16228; cpd:C16230; cpd:C17059; cpd:C17811,16,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O6,C16H11O6,300.0633881,301.0712131,299.05556313983,4354,cpd:C16228,(-)-Sophorol,C16H12O6,(-)-Sophorol,R07751 R07752,Isoflavonoid biosynthesis,1.3.1.45,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavanones;     C16228  (-)-Sophorol,PubChem: 47205536; ChEBI: 80395; LIPIDMAPS: LMPK12050461; KNApSAcK: C00000650; NIKKAJI: J2.297.370C,cpd:C04293; cpd:C05902; cpd:C08651; cpd:C10038; cpd:C10058; cpd:C10098; cpd:C10203; cpd:C10520; cpd:C10534; cpd:C12135; cpd:C16227; cpd:C16228; cpd:C16230; cpd:C17059; cpd:C17811,16,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O6,C16H11O6,300.0633881,301.0712131,299.05556313984,4355,cpd:C16229,(+)-Maackiain,C16H12O5,(+)-Maackiain,R07748 R07749,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C16229  (+)-Maackiain,PubChem: 47205537; ChEBI: 73030; ChEMBL: CHEMBL445279; KNApSAcK: C00019173; NIKKAJI: J330.617H,cpd:C00814; cpd:C01448; cpd:C01470; cpd:C01562; cpd:C02920; cpd:C10046; cpd:C10047; cpd:C10197; cpd:C10323; cpd:C10370; cpd:C10502; cpd:C10504; cpd:C10521; cpd:C10536; cpd:C11577; cpd:C14536; cpd:C16229; cpd:C17039; cpd:C17045,16,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O5,C16H11O5,284.0684735,285.0762985,283.06064853985,4356,cpd:C16230,(+)-6a-Hydroxymaackiain,C16H12O6,(+)-6a-Hydroxymaackiain,R07749 R07750,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,2.1.1.270,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1207 Pterocarpans;     C16230  (+)-6a-Hydroxymaackiain; Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C16230  (+)-6a-Hydroxymaackiain,PubChem: 47205538; ChEBI: 43129; KNApSAcK: C00009677; PDB-CCD: HMK; NIKKAJI: J893.901B,cpd:C04293; cpd:C05902; cpd:C08651; cpd:C10038; cpd:C10058; cpd:C10098; cpd:C10203; cpd:C10520; cpd:C10534; cpd:C12135; cpd:C16227; cpd:C16228; cpd:C16230; cpd:C17059; cpd:C17811,16,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O6,C16H11O6,300.0633881,301.0712131,299.05556313986,4357,cpd:C16231,(-)-Maackiain-3-O-glucosyl-6''-O-malonate,C25H24O13,(-)-Maackiain-3-O-glucosyl-6''-O-malonate,R07754 R07755,Isoflavonoid biosynthesis,2.3.1.115,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Pterocarpans;     C16231  (-)-Maackiain-3-O-glucosyl-6''-O-malonate,PubChem: 47205539; ChEBI: 80396; KNApSAcK: C00019473; NIKKAJI: J778.692A,cpd:C12625; cpd:C16197; cpd:C16231,25,24,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H25O13,C25H23O13,532.1216908,533.1295159,531.11386583987,4358,cpd:C16232,"6,7,4'-Trihydroxyflavanone",C15H12O5,"6,7,4'-Trihydroxyflavanone",R07711 R07715,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.136; 1.14.13.-,NA,NA,PubChem: 47205540; ChEBI: 78026; NIKKAJI: J2.799.166A,cpd:C00509; cpd:C01263; cpd:C01592; cpd:C03567; cpd:C06561; cpd:C08578; cpd:C09047; cpd:C09614; cpd:C09751; cpd:C09826; cpd:C12087; cpd:C14458; cpd:C15567; cpd:C15598; cpd:C16232; cpd:C17673,15,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O5,C15H11O5,272.0684735,273.0762985,271.06064853988,4359,cpd:C16233,"2,6,7,4'-Tetrahydroxyisoflavanone",C15H12O6,"2,6,7,4'-Tetrahydroxyisoflavanone",R07715 R07716,Isoflavonoid biosynthesis; Biosynthesis of secondary metabolites,1.14.13.136,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Isoflavonoids;    Isoflavanones;     C16233  2,6,7,4'-Tetrahydroxyisoflavanone",PubChem: 47205541; ChEBI: 80397; NIKKAJI: J2.799.169F,cpd:C00974; cpd:C01378; cpd:C05631; cpd:C08724; cpd:C09277; cpd:C10060; cpd:C10064; cpd:C10083; cpd:C10091; cpd:C10415; cpd:C12631; cpd:C15525; cpd:C16233; cpd:C16940,15,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O6,C15H11O6,288.0633881,289.0712131,287.05556313989,4360,cpd:C00616,Quercetin 3-sulfate,C15H10O10S,Quercetin 3-sulfate,R02159 R02632 R02633,Flavone and flavonol biosynthesis,2.8.2.25; 2.8.2.26; 2.8.2.27,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C00616  Quercetin 3-sulfate; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C00616  Quercetin 3-sulfate,PubChem: 3890; ChEBI: 17730; ChEMBL: CHEMBL1207957; LIPIDMAPS: LMPK12112304; KNApSAcK: C00004956; 3DMET: B00146; NIKKAJI: J87.897I,cpd:C00616,15,10,10,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O10S1,C15H9O10S1,381.9994677,383.0072927,380.99164273990,4361,cpd:C01155,"Quercetin 3,3'-bissulfate",C15H10O13S2,"Quercetin 3,3'-bissulfate",R02632 R03289,Flavone and flavonol biosynthesis,2.8.2.26; 2.8.2.28,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C01155  Quercetin 3,3'-bissulfate; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C01155  Quercetin 3,3'-bissulfate",PubChem: 4383; ChEBI: 17875; LIPIDMAPS: LMPK12112308; KNApSAcK: C00004960; 3DMET: B00248; NIKKAJI: J2.731.657C,cpd:C01155; cpd:C01156,15,10,13,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O13S2,C15H9O13S2,461.9562827,462.9641078,460.94845773991,4362,cpd:C01156,"Quercetin 3,4'-bissulfate",C15H10O13S2,"Quercetin 3,4'-bissulfate",R02633 R06809,Flavone and flavonol biosynthesis,2.8.2.27; 2.8.2.28,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C01156  Quercetin 3,4'-bissulfate; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C01156  Quercetin 3,4'-bissulfate",PubChem: 4384; ChEBI: 18030; LIPIDMAPS: LMPK12112309; KNApSAcK: C00004961; 3DMET: B00249; NIKKAJI: J2.731.658A,cpd:C01155; cpd:C01156,15,10,13,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O13S2,C15H9O13S2,461.9562827,462.9641078,460.94845773992,4363,cpd:C01265,"3,7-Di-O-methylquercetin;",C17H14O7,"3,7-Di-O-methylquercetin; 3',4',5-Trihydroxy-3,7-dimethoxyflavone",R03456 R05323,Flavone and flavonol biosynthesis,2.1.1.82; 2.1.1.83,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C01265  3,7-Di-O-methylquercetin",CAS: 2068-02-2; PubChem: 4484; ChEBI: 18010; ChEMBL: CHEMBL164861; LIPIDMAPS: LMPK12112731; KNApSAcK: C00004638; 3DMET: B00268; NIKKAJI: J885K,cpd:C01265; cpd:C03036; cpd:C03040; cpd:C10033; cpd:C10193; cpd:C10424; cpd:C12478; cpd:C13702; cpd:C16754; cpd:C17670,17,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H15O7,C17H13O7,330.0739528,331.0817778,329.06612783993,4364,cpd:C01470,Acacetin;,C16H12O5,"Acacetin; 5,7-Dihydroxy-4'-methoxyflavone; 4'-Methoxy-5,7-dihydroxyflavone",R03571,Flavone and flavonol biosynthesis,2.1.1.75,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C01470  Acacetin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C01470  Acacetin,CAS: 480-44-4; PubChem: 4645; ChEBI: 15335; ChEMBL: CHEMBL243664; LIPIDMAPS: LMPK12110468; KNApSAcK: C00003820; 3DMET: B00296; NIKKAJI: J6.166B,cpd:C00814; cpd:C01448; cpd:C01470; cpd:C01562; cpd:C02920; cpd:C10046; cpd:C10047; cpd:C10197; cpd:C10323; cpd:C10370; cpd:C10502; cpd:C10504; cpd:C10521; cpd:C10536; cpd:C11577; cpd:C14536; cpd:C16229; cpd:C17039; cpd:C17045,16,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O5,C16H11O5,284.0684735,285.0762985,283.06064853994,4365,cpd:C01714,Isovitexin;,C21H20O10,Isovitexin; Saponaretin; Apigenin-6-C-glucoside; 6-C-Glucosylapigenin; Apigenin 6-C-glucoside,R03686 R06825 R08126,Flavone and flavonol biosynthesis,2.4.1.106,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C01714  Apigenin-6-C-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C01714  Isovitexin,CAS: 38953-85-4; PubChem: 4851; ChEBI: 18330; ChEMBL: CHEMBL465360; KNApSAcK: C00001059; 3DMET: B01485; NIKKAJI: J16.502F,cpd:C01460; cpd:C01714; cpd:C04608; cpd:C09126; cpd:C10345; cpd:C10420; cpd:C16911,21,20,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O10,C21H19O10,432.1056468,433.1134719,431.09782183995,4366,cpd:C01750,Quercitrin;,C21H20O11,Quercitrin; Quercetin 3-L-rhamnoside; Quercetin 3-O-alpha-L-rhamnopyranoside,R02436 R09803 R09804,Flavone and flavonol biosynthesis,2.4.1.-; 3.2.1.66,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C01750  Quercitrin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C01750  Quercitrin,CAS: 522-12-3; PubChem: 4883; ChEBI: 17558; ChEMBL: CHEMBL1437696 CHEMBL82242; KNApSAcK: C00005374; PDB-CCD: QCT; 3DMET: B01492; NIKKAJI: J1.578D,cpd:C01750; cpd:C01821; cpd:C03951; cpd:C08598; cpd:C10042; cpd:C10114; cpd:C12249; cpd:C12626; cpd:C16409; cpd:C17056,21,20,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O11,C21H19O11,448.1005615,449.1083865,447.09273643996,4367,cpd:C03515,Luteolin 7-O-glucuronide;,C21H18O12,Luteolin 7-O-glucuronide; Luteolin 7-O-beta-D-glucuronide,R03589 R06827,Flavone and flavonol biosynthesis,2.4.1.189; 2.4.1.190,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C03515  Luteolin 7-O-glucuronide; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C03515  Luteolin 7-O-glucuronide,PubChem: 6324; ChEBI: 18128; ChEMBL: CHEMBL464224; KNApSAcK: C00004268; 3DMET: B01665; NIKKAJI: J387.924K,cpd:C03515,21,18,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H19O12,C21H17O12,462.079826,463.087651,461.0720013997,4368,cpd:C03897,"Quercetin 3,3',7-trissulfate",C15H10O16S3,"Quercetin 3,3',7-trissulfate",R03289,Flavone and flavonol biosynthesis,2.8.2.28,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C03897  Quercetin 3,3',7-trissulfate; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C03897  Quercetin 3,3',7-trissulfate",PubChem: 6629; ChEBI: 16557; LIPIDMAPS: LMPK12112310; KNApSAcK: C00004962; 3DMET: B00650; NIKKAJI: J2.744.538A,cpd:C03897; cpd:C03898,15,10,16,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O16S3,C15H9O16S3,541.9130978,542.9209228,540.90527273998,4369,cpd:C03898,"Quercetin 3,4',7-trissulfate",C15H10O16S3,"Quercetin 3,4',7-trissulfate",R06809,Flavone and flavonol biosynthesis,2.8.2.28,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C03898  Quercetin 3,4',7-trissulfate; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C03898  Quercetin 3,4',7-trissulfate",PubChem: 6630; ChEBI: 28167; LIPIDMAPS: LMPK12112311; KNApSAcK: C00004963; 3DMET: B00651; NIKKAJI: J2.744.539J,cpd:C03897; cpd:C03898,15,10,16,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O16S3,C15H9O16S3,541.9130978,542.9209228,540.90527273999,4370,cpd:C03951,Luteolin 7-O-beta-D-glucoside;,C21H20O11,"Luteolin 7-O-beta-D-glucoside; Luteolin 7-O-glucoside; 7-O-beta-D-Glucosyl-5,7,3',4'-tetrahydroxyflavone",R03588 R06829,Flavone and flavonol biosynthesis,2.4.1.81; 2.4.1.236,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C03951  Luteolin 7-O-beta-D-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C03951  Luteolin 7-O-beta-D-glucoside,CAS: 5373-11-5; PubChem: 6673; ChEBI: 27994; ChEMBL: CHEMBL233929; KNApSAcK: C00004266; 3DMET: B01704; NIKKAJI: J94.450E,cpd:C01750; cpd:C01821; cpd:C03951; cpd:C08598; cpd:C10042; cpd:C10114; cpd:C12249; cpd:C12626; cpd:C16409; cpd:C17056,21,20,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O11,C21H19O11,448.1005615,449.1083865,447.09273644000,4371,cpd:C04024,Vitexin 2''-O-beta-D-glucoside;,C27H30O15,Vitexin 2''-O-beta-D-glucoside; Flavosativaside; 2''-O-Glucosylvitexin,R03565,Flavone and flavonol biosynthesis,2.4.1.105,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C04024  Vitexin 2''-O-beta-D-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C04024  Vitexin 2''-O-beta-D-glucoside,CAS: 61360-94-9; PubChem: 6730; ChEBI: 16631; KNApSAcK: C00006392; NIKKAJI: J2.201.333E,cpd:C03870; cpd:C04024; cpd:C04199; cpd:C08064; cpd:C10195; cpd:C10513; cpd:C12630; cpd:C17600,27,30,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H31O15,C27H29O15,594.1584703,595.1662953,593.15064524001,4372,cpd:C04199,Isovitexin 2''-O-beta-D-glucoside,C27H30O15,Isovitexin 2''-O-beta-D-glucoside,R03686,Flavone and flavonol biosynthesis,2.4.1.106,NA,NA,PubChem: 6872; ChEBI: 17379 75432; NIKKAJI: J322.831B,cpd:C03870; cpd:C04024; cpd:C04199; cpd:C08064; cpd:C10195; cpd:C10513; cpd:C12630; cpd:C17600,27,30,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H31O15,C27H29O15,594.1584703,595.1662953,593.15064524002,4373,cpd:C04293,Chrysoeriol;,C16H12O6,"Chrysoeriol; 5,7,4'-Trihydroxy-3'-methoxyflavone; 3'-O-Methylluteolin",R03587,Flavone and flavonol biosynthesis,2.1.1.42,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C04293  Chrysoeriol,CAS: 491-71-4; PubChem: 6953; ChEBI: 16514; ChEMBL: CHEMBL214321; LIPIDMAPS: LMPK12110799; KNApSAcK: C00001029; 3DMET: B00699; NIKKAJI: J90.397C,cpd:C04293; cpd:C05902; cpd:C08651; cpd:C10038; cpd:C10058; cpd:C10098; cpd:C10203; cpd:C10520; cpd:C10534; cpd:C12135; cpd:C16227; cpd:C16228; cpd:C16230; cpd:C17059; cpd:C17811,16,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O6,C16H11O6,300.0633881,301.0712131,299.05556314003,4374,cpd:C04443,3-O-Methylquercetin;,C16H12O7,"3-O-Methylquercetin; 3',4',5,7-Tetrahydroxy-3-methoxyflavone; 3-Methoxy-5,7,3',4'-tetrahydroxyflavone",R02157 R05323,Flavone and flavonol biosynthesis,2.1.1.76; 2.1.1.82,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C04443  3-O-Methylquercetin,PubChem: 7072; ChEBI: 16860; ChEMBL: CHEMBL163316; LIPIDMAPS: LMPK12112729; KNApSAcK: C00004632; 3DMET: B00714; NIKKAJI: J876A,cpd:C04443; cpd:C08999; cpd:C10022; cpd:C10084; cpd:C10119; cpd:C10120; cpd:C10176; cpd:C10185; cpd:C10188; cpd:C19739; cpd:C20637,16,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O7,C16H11O7,316.0583027,317.0661278,315.05047774004,4375,cpd:C04444,"3,7,4'-Tri-O-methylquercetin;",C18H16O7,"3,7,4'-Tri-O-methylquercetin; 3',5-Dihydroxy-3,4',7-trimethoxyflavone",R03456,Flavone and flavonol biosynthesis,2.1.1.83,NA,"Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C04444  3,7,4'-Tri-O-methylquercetin",PubChem: 7073; ChEBI: 27825; ChEMBL: CHEMBL74898; LIPIDMAPS: LMPK12112762; KNApSAcK: C00004647; 3DMET: B00715; NIKKAJI: J11.536C,cpd:C04444; cpd:C10032; cpd:C10040; cpd:C10101; cpd:C10111; cpd:C10117; cpd:C10180; cpd:C10189; cpd:C14476; cpd:C17040; cpd:C19807,18,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H17O7,C18H15O7,344.0896029,345.0974279,343.08177784005,4376,cpd:C04608,Apigenin 7-O-beta-D-glucoside;,C21H20O10,"Apigenin 7-O-beta-D-glucoside; 7-O-beta-D-Glucosyl-5,7,4'-trihydroxyflavone; Apigenin 7-O-glucoside; Apigetrin; 7-(beta-D-Glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Cosmetin; Cosmosiin",R03574 R04526 R06821 R06826,Flavone and flavonol biosynthesis,2.3.1.115; 2.4.1.81; 2.4.1.236; 2.4.2.25,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C04608  Apigenin 7-O-beta-D-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C04608  Apigenin 7-O-beta-D-glucoside,CAS: 578-74-5; PubChem: 7199; ChEBI: 16778; ChEMBL: CHEMBL487017; KNApSAcK: C00001017; 3DMET: B01765; NIKKAJI: J22.571A,cpd:C01460; cpd:C01714; cpd:C04608; cpd:C09126; cpd:C10345; cpd:C10420; cpd:C16911,21,20,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O10,C21H19O10,432.1056468,433.1134719,431.09782184006,4377,cpd:C04858,Apigenin 7-O-[beta-D-apiosyl-(1->2)-beta-D-glucoside];,C26H28O14,"Apigenin 7-O-[beta-D-apiosyl-(1->2)-beta-D-glucoside]; 7-O-(beta-D-Apiofuranosyl-1,2-beta-D-glucosyl)-5,7,4'-trihydroxyflavone; Apiin; 7-[(2-O-D-Apio-beta-D-furanosyl-beta-D-glucopyranosyl)oxy]-5-hydroxy-2-(4-hydroxy-phenyl)-4H-1-benzopyran-4-one; Apioside",R04526 R04618,Flavone and flavonol biosynthesis,2.3.1.115; 2.4.2.25,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C04858  Apigenin 7-O-[beta-D-apiosyl-(1->2)-beta-D-glucoside],CAS: 26544-34-3; PubChem: 7413; ChEBI: 15932; ChEMBL: CHEMBL1535342; KNApSAcK: C00001019; 3DMET: B01799; NIKKAJI: J41.409C,cpd:C04858; cpd:C10110; cpd:C10181; cpd:C16491; cpd:C16803,26,28,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H29O14,C26H27O14,564.1479056,565.1557306,563.14008054007,4378,cpd:C04900,Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]-4'-O-beta-D-glucuronide,C33H34O24,Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]-4'-O-beta-D-glucuronide,R06828 R08127,Flavone and flavonol biosynthesis,2.4.1.191; 3.2.1.31,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C04900  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]-4'-O-beta-D-glucuronide; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C04900  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]-4'-O-beta-D-glucuronide,PubChem: 7450; ChEBI: 37645; 3DMET: B01803; NIKKAJI: J2.471.143I,cpd:C04900,33,34,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H35O24,C33H33O24,814.144002,815.151827,813.13617694008,4379,cpd:C05622,Malonylapiin;,C29H30O17,Malonylapiin; Apigenin 7-O-[beta-D-apiosyl-(1->2)-(6-malonyl-beta-D-glucoside)],R04618,Flavone and flavonol biosynthesis,2.3.1.115,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C05622  Malonylapiin,PubChem: 7939; ChEBI: 6664; 3DMET: B01877; NIKKAJI: J2.433.390F,cpd:C05622,29,30,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H31O17,C29H29O17,650.1482995,651.1561245,649.14047454009,4380,cpd:C05623,Quercetin 3-O-glucoside;,C21H20O12,"Quercetin 3-O-glucoside; Isoquercitrin; 2-(3,4-Dihidroxyphenyl)-3-(beta-D-glucofuranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one; Isotrifoliin",R02158 R04900 R06797 R06812 R06814,Flavone and flavonol biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.3.1.116; 2.4.1.91; 2.4.1.159; 2.4.1.239; 2.4.2.35,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C05623  Quercetin 3-O-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C05623  Quercetin 3-O-glucoside,CAS: 21637-25-2; PubChem: 7940; ChEBI: 28299 68352; ChEMBL: CHEMBL250450; KNApSAcK: C00005373; 3DMET: B01878; NIKKAJI: J11.252F,cpd:C05623; cpd:C10050; cpd:C10073; cpd:C10108; cpd:C12639; cpd:C16410; cpd:C17763,21,20,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O12,C21H19O12,464.0954761,465.1033011,463.0876514010,4381,cpd:C05625,Rutin;,C27H30O16,"Rutin; 3-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; Quercetin 3-rutinoside; Rutoside; Phytomelin",R04900 R06811,Flavone and flavonol biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.4.1.159; 2.4.2.35,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C05625  Rutin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C05 VASOPROTECTIVES;    C05C CAPILLARY STABILIZING AGENTS;     C05CA Bioflavonoids;      C05CA01 Rutoside;       D08499  Rutoside (INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Rutin;     D08499  Rutoside (INN),CAS: 153-18-4; PubChem: 7941; ChEBI: 28527; ChEMBL: CHEMBL226335 CHEMBL502782; KNApSAcK: C00005413; PDB-CCD: RUT; 3DMET: B01879; NIKKAJI: J818D,cpd:C05625; cpd:C10102; cpd:C12634; cpd:C16490; cpd:C17563; cpd:C19796,27,30,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H31O16,C27H29O16,610.1533849,611.1612099,609.14555984011,4382,cpd:C10098,Kaempferide;,C16H12O6,Kaempferide; Kempferide; Kaempferol 4'-methyl ether,R06807,Flavone and flavonol biosynthesis,2.1.1.155,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C10098  Kaempferide; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C10098  Kaempferide,CAS: 491-54-3; PubChem: 12284; ChEBI: 6099; ChEMBL: CHEMBL40919; LIPIDMAPS: LMPK12110563; KNApSAcK: C00001060; 3DMET: B01119; NIKKAJI: J13.293D,cpd:C04293; cpd:C05902; cpd:C08651; cpd:C10038; cpd:C10058; cpd:C10098; cpd:C10203; cpd:C10520; cpd:C10534; cpd:C12135; cpd:C16227; cpd:C16228; cpd:C16230; cpd:C17059; cpd:C17811,16,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O6,C16H11O6,300.0633881,301.0712131,299.05556314012,4383,cpd:C10175,Quercetin 3-(2G-xylosylrutinoside),C32H38O20,Quercetin 3-(2G-xylosylrutinoside),R06811,Flavone and flavonol biosynthesis,2.4.2.35,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C10175  Quercetin 3-(2G-xylosylrutinoside); Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C10175  Quercetin 3-(2G-xylosylrutinoside),CAS: 129235-39-8; PubChem: 12361; ChEBI: 28402; KNApSAcK: C00005452; 3DMET: B03608; NIKKAJI: J452.037H,cpd:C10175,32,38,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H39O20,C32H37O20,742.1956436,743.2034686,741.18781864013,4384,cpd:C11620,Syringetin;,C17H14O8,"Syringetin; 3',5'-O-Dimethylmyricetin; 3,5,7,4'-Tetrahydroxy-3',5'-dimethoxyflavone",R06816,Flavone and flavonol biosynthesis,2.1.1.267,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C11620  Syringetin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C11620  Syringetin,CAS: 4423-37-4; PubChem: 13785; ChEBI: 18215; ChEMBL: CHEMBL489142; LIPIDMAPS: LMPK12112498; KNApSAcK: C00004767; 3DMET: B04276; NIKKAJI: J13.513E,cpd:C04581; cpd:C09967; cpd:C10021; cpd:C11620; cpd:C17788; cpd:C19588; cpd:C19589,17,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H15O8,C17H13O8,346.0688674,347.0766924,345.06104244014,4385,cpd:C12249,Kaempferol 3-O-glucoside;,C21H20O11,Kaempferol 3-O-glucoside; Kaempferol 3-O-beta-D-glucoside; Astragalin,R06611 R06804,Flavone and flavonol biosynthesis; Biosynthesis of secondary metabolites,2.4.1.91; 2.4.1.239,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C12249  Astragalin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C12249  Kaempferol 3-O-glucoside,CAS: 480-10-4; PubChem: 14394; ChEBI: 30200; ChEMBL: CHEMBL233930; KNApSAcK: C00005138; 3DMET: B04447; NIKKAJI: J12.462A,cpd:C01750; cpd:C01821; cpd:C03951; cpd:C08598; cpd:C10042; cpd:C10114; cpd:C12249; cpd:C12626; cpd:C16409; cpd:C17056,21,20,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O11,C21H19O11,448.1005615,449.1083865,447.09273644015,4386,cpd:C12626,Kaempferol-3-O-galactoside;,C21H20O11,Kaempferol-3-O-galactoside; Kaempferol 3-O-beta-D-galactoside; Trifolin,R06808 R08128,Flavone and flavonol biosynthesis,2.4.1.234,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C12626  Kaempferol 3-O-beta-D-galactoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C12626  Kaempferol-3-O-galactoside,CAS: 23627-87-4; PubChem: 583016; ChEBI: 31742; ChEMBL: CHEMBL453290; KNApSAcK: C00005137; 3DMET: B04540; NIKKAJI: J16.943I,cpd:C01750; cpd:C01821; cpd:C03951; cpd:C08598; cpd:C10042; cpd:C10114; cpd:C12249; cpd:C12626; cpd:C16409; cpd:C17056,21,20,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O11,C21H19O11,448.1005615,449.1083865,447.09273644016,4387,cpd:C12627,Apigenin 7-O-neohesperidoside;,C27H30O14,Apigenin 7-O-neohesperidoside; Rhoifolin; Rhoifoloside,R06826,Flavone and flavonol biosynthesis,2.4.1.236,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C12627  Apigenin 7-O-neohesperidoside,CAS: 17306-46-6; PubChem: 583017; ChEBI: 31227; ChEMBL: CHEMBL395990; KNApSAcK: C00004157; NIKKAJI: J13.923H,cpd:C10196; cpd:C12627; cpd:C12628; cpd:C16802; cpd:C16981,27,30,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H31O14,C27H29O14,578.1635556,579.1713807,577.15573064017,4388,cpd:C12628,Vitexin 2''-O-beta-L-rhamnoside;,C27H30O14,Vitexin 2''-O-beta-L-rhamnoside; 2''-O-Rhamnosylvitexin; Vitexin 2''-rhamnoside,R06823 R06824,Flavone and flavonol biosynthesis,2.1.1.153,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C12628  Vitexin 2''-O-beta-L-rhamnoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C12628  Vitexin 2''-O-beta-L-rhamnoside,CAS: 64820-99-1; PubChem: 583018; ChEBI: 32298; ChEMBL: CHEMBL1685070; KNApSAcK: C00006217; NIKKAJI: J533.636H,cpd:C10196; cpd:C12627; cpd:C12628; cpd:C16802; cpd:C16981,27,30,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H31O14,C27H29O14,578.1635556,579.1713807,577.15573064018,4389,cpd:C12629,Isoswertisin 2''-rhamnoside;,C28H32O14,Isoswertisin 2''-rhamnoside; 7-O-Methylvitexin 2''-O-beta-L-rhamnoside; 2''-O-Rhamnosylisoswertisin,R06824,Flavone and flavonol biosynthesis,2.1.1.153,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C12629  7-O-Methylvitexin 2''-O-beta-L-rhamnoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C12629  Isoswertisin 2''-rhamnoside,CAS: 64821-00-7; PubChem: 583019; ChEBI: 31143; KNApSAcK: C00006278; NIKKAJI: J2.398.940I,cpd:C04275; cpd:C12629,28,32,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H33O14,C28H31O14,592.1792057,593.1870307,591.17138074019,4390,cpd:C12630,Scolymoside;,C27H30O15,Scolymoside; Luteolin 7-O-neohesperidoside; Veronicastroside,R06829,Flavone and flavonol biosynthesis,2.4.1.236,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C12630  Luteolin 7-O-neohesperidoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C12630  Scolymoside,CAS: 25694-72-8; PubChem: 583020; ChEBI: 31788; ChEMBL: CHEMBL452979; KNApSAcK: C00004283; NIKKAJI: J567.144B,cpd:C03870; cpd:C04024; cpd:C04199; cpd:C08064; cpd:C10195; cpd:C10513; cpd:C12630; cpd:C17600,27,30,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H31O15,C27H29O15,594.1584703,595.1662953,593.15064524020,4391,cpd:C12632,Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide];,C27H26O18,Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]; Luteolin 7-O-beta-D-diglucuronide,R06827 R06828 R08127,Flavone and flavonol biosynthesis,2.4.1.190; 2.4.1.191; 3.2.1.31,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C12632  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavones;     C12632  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide],PubChem: 583022; ChEBI: 16559 60077; KNApSAcK: C00004288; 3DMET: B04541; NIKKAJI: J702.439H,cpd:C12632,27,26,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H27O18,C27H25O18,638.111914,639.119739,637.1040894021,4392,cpd:C12633,Laricitrin;,C16H12O8,Laricitrin; 3'-O-Methylmyricetin,R06815 R06816,Flavone and flavonol biosynthesis,2.1.1.267,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C12633  Laricitrin; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C12633  Laricitrin,PubChem: 583023; ChEBI: 31763; LIPIDMAPS: LMPK12112482; KNApSAcK: C00004763; 3DMET: B04542; NIKKAJI: J695.655F,cpd:C04527; cpd:C10118; cpd:C12633,16,12,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O8,C16H11O8,332.0532173,333.0610424,331.04539234022,4393,cpd:C12634,Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside;,C27H30O16,Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside; Kaempferol 3-O-beta-D-sophoroside; Sophoraflavonoloside,R06804 R06805,Flavone and flavonol biosynthesis,2.4.1.239; 2.4.1.240,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C12634  Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside,CAS: 19895-95-5; PubChem: 583024; ChEBI: 31743; KNApSAcK: C00005165; 3DMET: B04543; NIKKAJI: J94.447E,cpd:C05625; cpd:C10102; cpd:C12634; cpd:C16490; cpd:C17563; cpd:C19796,27,30,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H31O16,C27H29O16,610.1533849,611.1612099,609.14555984023,4394,cpd:C12635,Kaempferol 3-sophorotrioside;,C33H40O21,Kaempferol 3-sophorotrioside; Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside,R06805 R06806,Flavone and flavonol biosynthesis,2.3.1.173; 2.4.1.240,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C12635  Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C12635  Kaempferol 3-sophorotrioside,CAS: 80714-53-0; PubChem: 583025; ChEBI: 31744; KNApSAcK: C00005208; 3DMET: B04544; NIKKAJI: J678.245K,cpd:C12635,33,40,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H41O21,C33H39O21,772.2062083,773.2140333,771.19838334024,4395,cpd:C12636,Kaempferol 3-O-[6-(4-coumaroyl)-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside],C42H46O23,Kaempferol 3-O-[6-(4-coumaroyl)-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside],R06806,Flavone and flavonol biosynthesis,2.3.1.173,NA,NA,CAS: 370883-67-3; PubChem: 583026; ChEBI: 31741; NIKKAJI: J1.538.484K,cpd:C12636,42,46,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H47O23,C42H45O23,918.2429877,919.2508128,917.23516274025,4396,cpd:C12637,Quercetin 3-O-[beta-D-xylosyl-(1->2)-beta-D-glucoside],C26H28O16,Quercetin 3-O-[beta-D-xylosyl-(1->2)-beta-D-glucoside],R06814,Flavone and flavonol biosynthesis,2.4.2.35,NA,NA,PubChem: 583027; ChEBI: 32081; ChEMBL: CHEMBL455758; NIKKAJI: J460.249H,cpd:C12637,26,28,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H29O16,C26H27O16,596.1377348,597.1455598,595.12990984026,4397,cpd:C12638,Quercetin 3-O-(6-O-malonyl-beta-D-glucoside);,C24H22O15,Quercetin 3-O-(6-O-malonyl-beta-D-glucoside); Quercetin 3-O-malonylglucoside; Quercetin-3-O-(6''-malonylglucoside),R06797,Flavone and flavonol biosynthesis,2.3.1.116,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C12638  Quercetin 3-O-(6-O-malonyl-beta-D-glucoside),CAS: 96862-01-0; PubChem: 583028; ChEBI: 32080; KNApSAcK: C00005956; 3DMET: B04545; NIKKAJI: J343.430C,cpd:C12638,24,22,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H23O15,C24H21O15,550.09587,551.103695,549.0880454027,4398,cpd:C12667,Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside;,C27H30O17,Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside; Baimaside; Quercetin 3-beta-D-sophoroside; Quercetin 3-O-sophoroside; QUOSP,R06812 R06813,Flavone and flavonol biosynthesis,2.4.1.239; 2.4.1.240,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C12667  Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C12667  Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside,CAS: 18609-17-1; PubChem: 583057; ChEBI: 32082; KNApSAcK: C00005409; NIKKAJI: J343.429J,cpd:C12667,27,30,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H31O17,C27H29O17,626.1482995,627.1561245,625.14047454028,4399,cpd:C12668,Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside;,C33H40O22,Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside; Quercetin 3-sophorotrioside,R06813,Flavone and flavonol biosynthesis,2.4.1.240,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C12668  Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside,CAS: 38681-85-5; PubChem: 583058; ChEBI: 32083; KNApSAcK: C00005446; NIKKAJI: J678.244B,cpd:C12668,33,40,22,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H41O22,C33H39O22,788.2011229,789.208948,787.19329794029,4400,cpd:C16490,Kaempferol 3-O-beta-D-glucosylgalactoside,C27H30O16,Kaempferol 3-O-beta-D-glucosylgalactoside,R08128,Flavone and flavonol biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavonols;     C16490  Kaempferol 3-O-beta-D-glucosylgalactoside,PubChem: 47205786; ChEBI: 80528; ChEMBL: CHEMBL500233; KNApSAcK: C00005157; NIKKAJI: J94.494G,cpd:C05625; cpd:C10102; cpd:C12634; cpd:C16490; cpd:C17563; cpd:C19796,27,30,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H31O16,C27H29O16,610.1533849,611.1612099,609.14555984030,4401,cpd:C16911,Afzelin;,C21H20O10,Afzelin; Kaempferin; Kaempferol 3-O-alpha-L-rhamnoside,R09802,Flavone and flavonol biosynthesis,2.4.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1211 Flavones and Flavonols;     C16911  Afzelin,CAS: 482-39-3; PubChem: 96023404; ChEBI: 80790; ChEMBL: CHEMBL240528; KNApSAcK: C00005140; PDB-CCD: AFE; NIKKAJI: J12.243B,cpd:C01460; cpd:C01714; cpd:C04608; cpd:C09126; cpd:C10345; cpd:C10420; cpd:C16911,21,20,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O10,C21H19O10,432.1056468,433.1134719,431.09782184031,4402,cpd:C19796,Quercetin 3-O-rhamnoside 7-O-glucoside,C27H30O16,Quercetin 3-O-rhamnoside 7-O-glucoside,R09804,Flavone and flavonol biosynthesis,2.4.1.-,NA,NA,PubChem: 135626263,cpd:C05625; cpd:C10102; cpd:C12634; cpd:C16490; cpd:C17563; cpd:C19796,27,30,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H31O16,C27H29O16,610.1533849,611.1612099,609.14555984032,4403,cpd:C01745,Pinosylvin;,C14H12O2,"Pinosylvin; 3,5-Stilbenediol",R02505,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",2.3.1.146,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes;     C01745  Pinosylvin; Phytochemical compounds [BR:br08003];  Skimate / acetate-malonate pathway derived compounds;   Stilbenoids;    Stilbenes;     C01745  Pinosylvin",CAS: 102-61-4; PubChem: 4879; ChEBI: 17323 36011; ChEMBL: CHEMBL101506; LIPIDMAPS: LMPK13090001; KNApSAcK: C00002897; 3DMET: B00340; NIKKAJI: J10.798K,cpd:C01408; cpd:C01745; cpd:C04468; cpd:C04485; cpd:C10971; cpd:C10972; cpd:C11428; cpd:C12537; cpd:C14233; cpd:C16203; cpd:C16205; cpd:C19236; cpd:C20227; cpd:C20228,14,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H13O2,C14H11O2,212.0837296,213.0915547,211.07590464033,4404,cpd:C03582,Resveratrol;,C14H12O3,"Resveratrol; 3,4',5-Trihydroxystilbene; trans-Resveratrol",R01614 R04257 R09870 R09872,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites; Longevity regulating pathway; Longevity regulating pathway - worm",1.14.-.-; 2.1.1.240; 2.3.1.95,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes;     C03582  3,4',5-Trihydroxystilbene; Phytochemical compounds [BR:br08003];  Skimate / acetate-malonate pathway derived compounds;   Stilbenoids;    Stilbenes;     C03582  Resveratrol",CAS: 501-36-0; PubChem: 6374; ChEBI: 27881 45713; ChEMBL: CHEMBL165; LIPIDMAPS: LMPK13090005; KNApSAcK: C00002903 C00044435; PDB-CCD: STL; 3DMET: B00606; NIKKAJI: J11.775G,cpd:C03582; cpd:C04711; cpd:C07320; cpd:C07582; cpd:C09312; cpd:C09314; cpd:C09317; cpd:C09925; cpd:C14285; cpd:C14393; cpd:C15196; cpd:C19538,14,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H13O3,C14H11O3,228.0786442,229.0864693,227.07081924034,4405,cpd:C05901,Piceatannol;,C14H12O4,"Piceatannol; 3,3',4'5-Tetrahydroxystilbene",R04257,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",1.14.-.-,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes;     C05901  3,3',4'5-Tetrahydroxystilbene; Phytochemical compounds [BR:br08003];  Skimate / acetate-malonate pathway derived compounds;   Stilbenoids;    Stilbenes;     C05901  Piceatannol",CAS: 10083-24-6; PubChem: 8189; ChEBI: 28814; ChEMBL: CHEMBL69863; LIPIDMAPS: LMPK13090006; KNApSAcK: C00002895; PDB-CCD: PIT; 3DMET: B00872; NIKKAJI: J61.264B,cpd:C05901; cpd:C08466; cpd:C08743; cpd:C09778; cpd:C10273; cpd:C12090; cpd:C14283; cpd:C14589; cpd:C19054; cpd:C21409,14,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H13O4,C14H11O4,244.0735589,245.0813839,243.06573384035,4406,cpd:C10287,Pterostilbene,C16H16O3,Pterostilbene,R09871 R09872,"Stilbenoid, diarylheptanoid and gingerol biosynthesis",2.1.1.240,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes;     C10287  Pterostilbene; Phytochemical compounds [BR:br08003];  Skimate / acetate-malonate pathway derived compounds;   Stilbenoids;    Stilbenes;     C10287  Pterostilbene",CAS: 537-42-8; PubChem: 12473; ChEBI: 8630; ChEMBL: CHEMBL83527; LIPIDMAPS: LMPK13090015; KNApSAcK: C00002902; PDB-CCD: 3RL; 3DMET: B03709; NIKKAJI: J11.562B,cpd:C06499; cpd:C07693; cpd:C08731; cpd:C09505; cpd:C09650; cpd:C10267; cpd:C10272; cpd:C10287; cpd:C14492; cpd:C18559; cpd:C20265,16,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O3,C16H15O3,256.1099444,257.1177694,255.10211934036,4407,cpd:C10443,Curcumin;,C21H20O6,Curcumin; Kacha haldi,R08810 R08812 R08813,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",2.3.1.217; 2.4.1.-,NA,Phytochemical compounds [BR:br08003];  Skimate / acetate-malonate pathway derived compounds;   Others;    Diarylheptanoids;     C10443  Curcumin; Cytochrome P450 interactions [BR:br08309];  Transporter inhibitors;   ABCG2;    Curcumin;     C10443  Curcumin; Major components of natural products [BR:br08323];  Crude drugs;   Termeric;    C10443  Curcumin;  Medicinal herbs;   Turmeric;    C10443  Curcumin,CAS: 458-37-7; PubChem: 12626; ChEBI: 3962; ChEMBL: CHEMBL116438; KNApSAcK: C00002731; 3DMET: B03849; NIKKAJI: J5.762B,cpd:C07290; cpd:C10443; cpd:C10551; cpd:C11580,21,20,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H21O6,C21H19O6,368.1259884,369.1338134,367.11816334037,4408,cpd:C10462,[6]-Gingerol;,C17H26O4,[6]-Gingerol; (S)-(+)-[6]Gingerol; 6-Gingerol,R08800 R08804,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Skimate / acetate-malonate pathway derived compounds;   Others;    Zingiber derived compounds;     C10462  [6]-Gingerol; Major components of natural products [BR:br08323];  Crude drugs;   Processed ginger;    C10462  [6]-Gingerol;   Ginger;    C10462  [6]-Gingerol;  Medicinal herbs;   Ginger;    C10462  [6]-Gingerol,CAS: 23513-14-6; PubChem: 12645; ChEBI: 10136; ChEMBL: CHEMBL402978; KNApSAcK: C00002748; 3DMET: B03867; NIKKAJI: J46.683B,cpd:C09709; cpd:C10342; cpd:C10462; cpd:C11708,17,26,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H27O4,C17H25O4,294.1831093,295.1909343,293.17528434038,4409,cpd:C17740,p-Coumaroyl-diketide-CoA;,C32H44N7O19P3S,p-Coumaroyl-diketide-CoA; (4-Coumaroyl)acetyl-CoA,R08805 R08807 R08808,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",2.3.1.217; 2.3.1.218; 2.3.1.219,NA,NA,PubChem: 96024067; ChEBI: 71215,cpd:C09818; cpd:C17740,32,44,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H45O19N7P3S1,C32H43O19N7P3S1,955.1625544,956.1703794,954.15472944039,4410,cpd:C17741,Feruloyl-diketide-CoA;,C33H46N7O20P3S,Feruloyl-diketide-CoA; Feruloylacetyl-CoA,R08806 R08809 R08810,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",2.3.1.217; 2.3.1.218; 2.3.1.219,NA,NA,PubChem: 96024068; ChEBI: 71236,cpd:C17741,33,46,20,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C33H47O20N7P3S1,C33H45O20N7P3S1,985.1731191,986.1809441,984.1652944040,4411,cpd:C17742,Demethoxycurcumin,C20H18O5,Demethoxycurcumin,R08808 R08809 R08811 R08812,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",2.3.1.217; 2.3.1.219,NA,NA,CAS: 22608-11-3; PubChem: 96024069; ChEBI: 65737; ChEMBL: CHEMBL179512; KNApSAcK: C00037023; NIKKAJI: J1.939.853F J468.369B J877.764K J949.191K,cpd:C01701; cpd:C09360; cpd:C10049; cpd:C10360; cpd:C10422; cpd:C10542; cpd:C11576; cpd:C11581; cpd:C15511; cpd:C17742,20,18,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O5,C20H17O5,338.1154237,339.1232487,337.10759864041,4412,cpd:C17743,Bisdemethoxycurcumin,C19H16O4,Bisdemethoxycurcumin,R08807 R08811 R10233,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",2.3.1.211; 2.3.1.219,NA,NA,CAS: 24939-16-0; PubChem: 96024070; ChEBI: 71045; ChEMBL: CHEMBL131770; KNApSAcK: C00032769,cpd:C01541; cpd:C01926; cpd:C11123; cpd:C17743; cpd:C20129,19,16,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H17O4,C19H15O4,308.104859,309.112684,307.0970344042,4413,cpd:C17744,"1-(4-Hydroxyphenyl)-1-decene-3,5-dione",C16H20O3,"1-(4-Hydroxyphenyl)-1-decene-3,5-dione",R08796 R08798 R08801,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",NA,NA,NA,PubChem: 96024071; ChEBI: 81309,cpd:C09695; cpd:C11494; cpd:C11495; cpd:C17744; cpd:C18135,16,20,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H21O3,C16H19O3,260.1412445,261.1490695,259.13341954043,4414,cpd:C17745,"1-(3,4-Dihydroxyphenyl)-1-decene-3,5-dione",C16H20O4,"1-(3,4-Dihydroxyphenyl)-1-decene-3,5-dione",R08799 R08801 R08803,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",2.1.1.-,NA,NA,PubChem: 96024072; ChEBI: 81310,cpd:C08146; cpd:C09548; cpd:C10734; cpd:C10735; cpd:C17745,16,20,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H21O4,C16H19O4,276.1361591,277.1439842,275.12833414044,4415,cpd:C17746,1-Dehydro-[6]-gingerdione,C17H22O4,1-Dehydro-[6]-gingerdione,R08797 R08800 R08803,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",2.1.1.-,NA,NA,PubChem: 96024073; ChEBI: 81311; ChEMBL: CHEMBL1096043; NIKKAJI: J435.248C J467.914H,cpd:C09492; cpd:C09564; cpd:C09566; cpd:C10648; cpd:C17746,17,22,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H23O4,C17H21O4,290.1518092,291.1596342,289.14398424045,4416,cpd:C17747,5-Hydroxy-1-(4-hydroxyphenyl)-3-decanone,C16H24O3,5-Hydroxy-1-(4-hydroxyphenyl)-3-decanone,R08798 R08802,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",NA,NA,NA,PubChem: 96024074; ChEBI: 81312; ChEMBL: CHEMBL1950586,cpd:C06874; cpd:C09657; cpd:C17747,16,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O3,C16H23O3,264.1725446,265.1803697,263.16471964046,4417,cpd:C17748,"1-(3,4-Dihydroxyphenyl)-5-hydroxy-3-decanone",C16H24O4,"1-(3,4-Dihydroxyphenyl)-5-hydroxy-3-decanone",R08799 R08802 R08804,"Stilbenoid, diarylheptanoid and gingerol biosynthesis; Biosynthesis of secondary metabolites",2.1.1.-,NA,NA,PubChem: 96024075; ChEBI: 81313; NIKKAJI: J431.374G,cpd:C00732; cpd:C17748; cpd:C19417,16,24,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H25O4,C16H23O4,280.1674593,281.1752843,279.15963424047,4418,cpd:C17749,Curcumin monoglucoside,C27H30O11,Curcumin monoglucoside,R08813 R08814,"Stilbenoid, diarylheptanoid and gingerol biosynthesis",2.4.1.-,NA,NA,PubChem: 96024076; ChEBI: 81314; NIKKAJI: J1.964.531B,cpd:C17749,27,30,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H31O11,C27H29O11,530.1788118,531.1866368,529.17098674048,4419,cpd:C17750,Curcumin diglucoside,C33H40O16,Curcumin diglucoside,R08814,"Stilbenoid, diarylheptanoid and gingerol biosynthesis",2.4.1.-,NA,NA,PubChem: 96024077; ChEBI: 81315; NIKKAJI: J2.829.453K,cpd:C17750,33,40,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H41O16,C33H39O16,692.2316352,693.2394602,691.22381024049,4420,cpd:C00757,Berberine;,C20H18NO4,Berberine; Umbellatine,R00044 R02880 R07169,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites; AMPK signaling pathway,1.3.3.8; 1.5.1.31; 1.21.3.2,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C00757  Berberine; Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Berberine;     C00757  Berberine;  Third-class OTC drugs;   Inorganic and organic chemicals;    Coptis rhizome;     C00757  Berberine; Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP3A;    Berberine;     C00757  Berberine;  Transporter substrates;   ABCB1;    Berberine;     C00757  Berberine; Major components of natural products [BR:br08323];  Crude drugs;   Phellodendron bark;    C00757  Berberine;   Coptis rhizome;    C00757  Berberine;  Medicinal herbs;   Goldenseal;    C00757  Berberine,CAS: 2086-83-1; PubChem: 4019; ChEBI: 16118; ChEMBL: CHEMBL295124; KNApSAcK: C00001819; PDB-CCD: BER; 3DMET: B00169; NIKKAJI: J7.320B,cpd:C00757; cpd:C12679,20,18,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O4N1,C20H17O4N1,336.1235831,337.1314081,335.1157584050,4421,cpd:C01516,Morphine,C17H19NO3,Morphine,R03591 R03592 R03697 R08262 R08263 R08265 R09402,Isoquinoline alkaloid biosynthesis; Drug metabolism - cytochrome P450; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Neuroactive ligand-receptor interaction,1.1.1.218; 1.14.11.32; 1.14.14.1; 2.4.1.17,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C01516  Morphine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N02 ANALGESICS;    N02A OPIOIDS;     N02AA Natural opium alkaloids;      N02AA01 Morphine;       D08233  Morphine (BAN); USP drug classification [BR:br08302];  Analgesics;   Opioid Analgesics, Long-acting;    Morphine;     D08233  Morphine (BAN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Opioid;     mu-opioid receptor;      Morphine;       D08233  Morphine (BAN); Major components of natural products [BR:br08323];  Crude drugs;   Opium, powdered;    C01516  Morphine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     D08233  Morphine (BAN)",CAS: 57-27-2; PubChem: 4681; ChEBI: 17303; ChEMBL: CHEMBL281120 CHEMBL417008 CHEMBL70; KNApSAcK: C00001889; PDB-CCD: MOI; 3DMET: B04801; NIKKAJI: J2.323J,cpd:C01516; cpd:C03882; cpd:C06161; cpd:C06348; cpd:C06349; cpd:C07042; cpd:C08534; cpd:C09422; cpd:C10844; cpd:C12167; cpd:C16576,17,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H20O3N1,C17H18O3N1,285.1364935,286.1443185,284.12866844051,4422,cpd:C01735,Morphinone,C17H17NO3,Morphinone,R03591 R03592 R03698,Isoquinoline alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.1.1.218; 1.14.11.31,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C01735  Morphinone,CAS: 467-02-7; PubChem: 4870; ChEBI: 16315; ChEMBL: CHEMBL255467; 3DMET: B01490; NIKKAJI: J2.323J,cpd:C01735; cpd:C10634,17,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H18O3N1,C17H16O3N1,283.1208434,284.1286684,282.11301844052,4423,cpd:C01795,Columbamine,C20H20NO4,Columbamine,R00044 R03721 R03722,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,1.3.3.8; 1.21.3.2; 2.1.1.118,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C01795  Columbamine,CAS: 3621-36-1; PubChem: 4922; ChEBI: 15920; ChEMBL: CHEMBL400345; KNApSAcK: C00024667; 3DMET: B00352; NIKKAJI: J8.189B,cpd:C01795; cpd:C06163; cpd:C09553; cpd:C18607,20,20,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H21O4N1,C20H19O4N1,338.1392331,339.1470582,337.13140814053,4424,cpd:C02105,(S)-Reticuline;,C19H23NO4,(S)-Reticuline; (+)-Reticuline,R03831 R03832 R03833 R05211 R08460 R08787 R08790 R10605,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.5.-.-; 1.14.21.-; 1.21.3.3; 2.1.1.115; 2.1.1.116; 2.1.1.291,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C02105  (S)-Reticuline,CAS: 485-19-8; PubChem: 5187; ChEBI: 16718; ChEMBL: CHEMBL235212; KNApSAcK: C00001910; PDB-CCD: REN; 3DMET: B01532; NIKKAJI: J12.961E,cpd:C02105; cpd:C05178; cpd:C05220; cpd:C09643; cpd:C10852; cpd:C12328; cpd:C17899,19,23,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H24O4N1,C19H22O4N1,329.1627082,330.1705333,328.15488324054,4425,cpd:C02106,(S)-Scoulerine;,C19H21NO4,"(S)-Scoulerine; (13aS)-5,8,13,13a-Tetrahydro-3,10-dimethoxy-6H-dibenzo[a,g]quinolizine-2,9-diol",R03831 R03834 R03835 R11405,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.21.2; 1.14.21.12; 1.21.3.3; 2.1.1.117,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C02106  (S)-Scoulerine,CAS: 6451-73-6; PubChem: 5188; ChEBI: 17129; ChEMBL: CHEMBL1235966; KNApSAcK: C00026092; PDB-CCD: SLX; 3DMET: B01533; NIKKAJI: J92.838K,cpd:C02106; cpd:C05179; cpd:C07252; cpd:C09365; cpd:C09366; cpd:C09400; cpd:C09410; cpd:C09541; cpd:C11778; cpd:C11781; cpd:C12326; cpd:C17591,19,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H22O4N1,C19H20O4N1,327.1470582,328.1548832,326.13923314055,4426,cpd:C02134,Allocryptopine,C21H23NO5,Allocryptopine,R03842,Isoquinoline alkaloid biosynthesis,1.14.13.37,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C02134  Allocryptopine,CAS: 24240-04-8 485-91-6; PubChem: 5213; ChEBI: 17390; ChEMBL: CHEMBL520043; KNApSAcK: C00001799; 3DMET: B01536; NIKKAJI: J12.568G,cpd:C02134; cpd:C06534; cpd:C09444; cpd:C10990; cpd:C12257,21,23,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H24O5N1,C21H22O5N1,369.1576228,370.1654479,368.14979784056,4427,cpd:C02890,Tetrahydropalmatine;,C21H25NO4,Tetrahydropalmatine; (S)-Tetrahydropalmatine,R04077 R08795,Isoquinoline alkaloid biosynthesis,1.3.3.8; 2.1.1.89,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C02890  Tetrahydropalmatine,CAS: 483-14-7; PubChem: 5820; ChEBI: 16563; ChEMBL: CHEMBL487182; KNApSAcK: C00025252; 3DMET: B01610; NIKKAJI: J31.846I,cpd:C02890; cpd:C09341; cpd:C09446; cpd:C09671; cpd:C20770,21,25,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H26O4N1,C21H24O4N1,355.1783583,356.1861833,354.17053334057,4428,cpd:C02915,(S)-cis-N-Methylcanadine,C21H24NO4,(S)-cis-N-Methylcanadine,R03842 R08789,Isoquinoline alkaloid biosynthesis,1.14.13.37; 2.1.1.122,NA,NA,PubChem: 5838; ChEBI: 16512; KNApSAcK: C00026136; NIKKAJI: J551.203D,cpd:C02915,21,24,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H25O4N1,C21H23O4N1,354.1705333,355.1783583,353.16270824058,4429,cpd:C02916,(S)-Norlaudanosoline;,C16H17NO4,(S)-Norlaudanosoline; (S)-Tetrahydropapaveroline,R04084 R05214,Isoquinoline alkaloid biosynthesis; Biosynthesis of secondary metabolites,2.1.1.128; 4.2.1.78,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C02916  (S)-Norlaudanosoline,PubChem: 5839; ChEBI: 28651; ChEMBL: CHEMBL348881; PDB-CCD: 2H4; 3DMET: B01612; NIKKAJI: J761.884K,cpd:C02916; cpd:C06350; cpd:C06351; cpd:C08519; cpd:C08532; cpd:C10444; cpd:C12164; cpd:C12185; cpd:C12186; cpd:C12194,16,17,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H18O4N1,C16H16O4N1,287.115758,288.1235831,286.1079334059,4430,cpd:C03329,(S)-Canadine;,C20H21NO4,"(S)-Canadine; (S)-Tetrahydroberberine; (13aS)-5,8,13,13a-Tetrahydro-9,10-dimethoxy-6H-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine; (-)-Canadine",R02880 R04400 R08789,Isoquinoline alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.3.3.8; 1.14.21.5; 2.1.1.122,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C03329  (S)-Canadine,CAS: 5096-57-1; PubChem: 6176; ChEBI: 16592; ChEMBL: CHEMBL490533; KNApSAcK: C00001827 C00028005; 3DMET: B01651; NIKKAJI: J71.178K,cpd:C03329; cpd:C06533; cpd:C09426; cpd:C10666; cpd:C11818; cpd:C17426; cpd:C17898; cpd:C19985,20,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H22O4N1,C20H20O4N1,339.1470582,340.1548832,338.13923314060,4431,cpd:C04118,Isocorypalmine;,C20H23NO4,"Isocorypalmine; 5,8,13,13a-Tetrahydrocolumbamine; (S)-Tetrahydrocolumbamine; (13aS)-5,8,13,13a-Tetrahydro-3,9,10-trimethoxy-6H-dibenzo[a,g]quinolizin-2-ol",R03722 R03835 R04077 R04400,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,1.3.3.8; 1.14.21.5; 2.1.1.89; 2.1.1.117,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C04118  (S)-Tetrahydrocolumbamine,CAS: 483-34-1; PubChem: 6807; ChEBI: 17772; KNApSAcK: C00025632; 3DMET: B01718; NIKKAJI: J34.147I,cpd:C04118; cpd:C07253; cpd:C09377; cpd:C09411; cpd:C09549; cpd:C20771,20,23,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H24O4N1,C20H22O4N1,341.1627082,342.1705333,340.15488324061,4432,cpd:C05174,(S)-Cheilanthifoline;,C19H19NO4,"(S)-Cheilanthifoline; (6aS)-6,6a,11,14-Tetrahydro-8-methoxy-12H-benzo[a]-1,3-benzodioxolo[4,5-g]quinolizim-9-ol",R03834 R04690,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.21.1; 1.14.21.2,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05174  (S)-Cheilanthifoline,CAS: 483-44-3; PubChem: 7585; ChEBI: 16233; KNApSAcK: C00026087; 3DMET: B01818; NIKKAJI: J12.996H,cpd:C05174; cpd:C09333; cpd:C09334; cpd:C09367; cpd:C09389; cpd:C19980; cpd:C21370,19,19,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H20O4N1,C19H18O4N1,325.1314081,326.1392331,324.12358314062,4433,cpd:C05175,Stylopine;,C19H17NO4,"Stylopine; (S)-Stylopine; l-Tetrahydrocoptisine; 6,7,12b,13e-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine",R04690 R04691,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.21.1; 2.1.1.122,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05175  Stylopine,CAS: 84-39-9; PubChem: 7586; ChEBI: 18285; ChEMBL: CHEMBL1922602; KNApSAcK: C00026095; 3DMET: B00759; NIKKAJI: J34.134G,cpd:C05175; cpd:C10739,19,17,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H18O4N1,C19H16O4N1,323.115758,324.1235831,322.1079334063,4434,cpd:C05176,(S)-N-Methylcoclaurine;,C18H21NO3,"(S)-N-Methylcoclaurine; (S)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinol",R04692 R04693 R04694 R05732 R08458 R08459,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.71; 1.14.18.1; 1.14.21.3; 2.1.1.115; 2.1.1.140,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05176  (S)-N-Methylcoclaurine,CAS: 3423-07-2; PubChem: 7587; ChEBI: 17041; ChEMBL: CHEMBL513109; KNApSAcK: C00025268; 3DMET: B01819; NIKKAJI: J351.144H,cpd:C05176; cpd:C05243; cpd:C06174; cpd:C08024; cpd:C09594; cpd:C11779; cpd:C15366,18,21,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H22O3N1,C18H20O3N1,299.1521435,300.1599686,298.14431854064,4435,cpd:C05177,Berbamunine;,C36H40N2O6,"Berbamunine; (1S)-1,2,3,4-Tetrahydro-1-[[4-[2-hydroxy-5-[[(1R)-1,2,3,4-tetrahydro-7-hydroxy-6-methoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]phenyl]methyl]-6-methoxy-2-methyl-7-isoquinolinol",R04694,Isoquinoline alkaloid biosynthesis,1.14.21.3,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05177  Berbamunine,CAS: 485-18-7; PubChem: 7588; ChEBI: 16777; ChEMBL: CHEMBL1187468; KNApSAcK: C00025262 C00027522; 3DMET: B01820; NIKKAJI: J2.403.084I,cpd:C05177; cpd:C06511; cpd:C06515,36,40,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H41O6N2,C36H39O6N2,596.288637,597.296462,595.2808124065,4436,cpd:C05178,(R)-Reticuline;,C19H23NO4,"(R)-Reticuline; (1R)-1,2,3,4-Tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinol",R04695 R04696 R05216 R08788 R10606,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.5.1.27; 1.14.21.4; 2.1.1.115; 2.1.1.291,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05178  (R)-Reticuline,CAS: 3968-19-2; PubChem: 7589; ChEBI: 17428; ChEMBL: CHEMBL401501; 3DMET: B01821; NIKKAJI: J471.974C,cpd:C02105; cpd:C05178; cpd:C05220; cpd:C09643; cpd:C10852; cpd:C12328; cpd:C17899,19,23,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H24O4N1,C19H22O4N1,329.1627082,330.1705333,328.15488324066,4437,cpd:C05179,Salutaridine;,C19H21NO4,"Salutaridine; Sinoacutine; 5,6,8,14-Tetradehydro-4-hydroxy-3,6-dimethoxy-17-methyl-morphinan-7-one",R04696 R04697,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.248; 1.14.21.4,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05179  Salutaridine,CAS: 1936-18-1; PubChem: 7590; ChEBI: 17225; ChEMBL: CHEMBL404097; KNApSAcK: C00001916; 3DMET: B01822; NIKKAJI: J7.824G,cpd:C02106; cpd:C05179; cpd:C07252; cpd:C09365; cpd:C09366; cpd:C09400; cpd:C09410; cpd:C09541; cpd:C11778; cpd:C11781; cpd:C12326; cpd:C17591,19,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H22O4N1,C19H20O4N1,327.1470582,328.1548832,326.13923314067,4438,cpd:C05189,Protopine,C20H19NO5,Protopine,R04699 R04700,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.37; 1.14.13.55,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05189  Protopine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Isoquinoline alkaloids;     C05189  Protopine; Major components of natural products [BR:br08323];  Crude drugs;   Corydalis tuber;    C05189  Protopine,CAS: 130-86-9; PubChem: 7594; ChEBI: 16415; ChEMBL: CHEMBL453019; KNApSAcK: C00001906; 3DMET: B01823; NIKKAJI: J40.085H,cpd:C05189; cpd:C09599; cpd:C12242,20,19,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H20O5N1,C20H18O5N1,353.1263227,354.1341477,352.11849774068,4439,cpd:C05190,6-Hydroxyprotopine,C20H19NO6,6-Hydroxyprotopine,R04699 R04701,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.55,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05190  6-Hydroxyprotopine,PubChem: 7595; ChEBI: 17104; 3DMET: B04986; NIKKAJI: J2.754.865B,cpd:C05190; cpd:C09393,20,19,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H20O6N1,C20H18O6N1,369.1212373,370.1290624,368.11341234069,4440,cpd:C05191,Dihydrosanguinarine;,C20H15NO4,"Dihydrosanguinarine; 13,14-Dihydro-13-methyl-[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine",R04701 R04702 R04703 R10798 R10799,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.107; 1.5.3.12; 1.14.13.56,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05191  Dihydrosanguinarine,CAS: 3606-45-9; PubChem: 7596; ChEBI: 17209; ChEMBL: CHEMBL465678; KNApSAcK: C00001847 C00024647; PDB-CCD: SGE; 3DMET: B01824; NIKKAJI: J394.144B,cpd:C05191; cpd:C12226,20,15,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H16O4N1,C20H14O4N1,333.100108,334.107933,332.09228294070,4441,cpd:C05193,12-Hydroxydihydrochelirubine;,C21H17NO6,12-Hydroxydihydrochelirubine; 12-Hydroxychelirubine,R04705 R04708,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.57; 2.1.1.120,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05193  12-Hydroxydihydrochelirubine,CAS: 131984-77-5; PubChem: 7598; ChEBI: 15716; KNApSAcK: C00027673; 3DMET: B01825; NIKKAJI: J612.408I,cpd:C05193,21,17,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H18O6N1,C21H16O6N1,379.1055873,380.1134123,378.09776224071,4442,cpd:C05194,Dihydrochelirubine;,C21H17NO5,"Dihydrochelirubine; 13,14-Dihydro-5-methoxy-13-methyl-[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine",R04706 R04707 R04708 R10800 R10801,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.3.1.107; 1.5.3.12; 1.14.13.57; 2.1.1.119,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05194  Dihydrochelirubine,CAS: 28342-26-9; PubChem: 7599; ChEBI: 17789; ChEMBL: CHEMBL518879; KNApSAcK: C00024643; 3DMET: B01826; NIKKAJI: J452.140D,cpd:C05194; cpd:C12225,21,17,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H18O5N1,C21H16O5N1,363.1106727,364.1184977,362.10284764072,4443,cpd:C05202,3'-Hydroxy-N-methyl-(S)-coclaurine;,C18H21NO4,3'-Hydroxy-N-methyl-(S)-coclaurine; (S)-3'-Hydroxy-N-methylcoclaurine,R03832 R04693 R05732 R08794,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.71; 1.14.18.1; 2.1.1.115; 2.1.1.116,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05202  3'-Hydroxy-N-methyl-(S)-coclaurine,PubChem: 7607; ChEBI: 17079; 3DMET: B01827; NIKKAJI: J351.145F,cpd:C05202; cpd:C05317; cpd:C06516; cpd:C06518; cpd:C06520; cpd:C08018; cpd:C08026; cpd:C10580; cpd:C12329; cpd:C15018; cpd:C15362,18,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H22O4N1,C18H20O4N1,315.1470582,316.1548832,314.13923314073,4444,cpd:C05220,Salutaridinol;,C19H23NO4,"Salutaridinol; 5,6,8,14-Tetradehydro-3,6-dimethoxy-17-methyl-morphinan-4,7-diol",R04697 R04723,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.248; 2.3.1.150,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05220  Salutaridinol,CAS: 3271-79-2; PubChem: 7619; ChEBI: 18373; ChEMBL: CHEMBL255882; 3DMET: B01828; NIKKAJI: J13.021D,cpd:C02105; cpd:C05178; cpd:C05220; cpd:C09643; cpd:C10852; cpd:C12328; cpd:C17899,19,23,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H24O4N1,C19H22O4N1,329.1627082,330.1705333,328.15488324074,4445,cpd:C05243,(R)-N-Methylcoclaurine;,C18H21NO3,"(R)-N-Methylcoclaurine; (R)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinol",R04694 R05210 R05215 R08458,Isoquinoline alkaloid biosynthesis,1.14.21.3,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05243  (R)-N-Methylcoclaurine,CAS: 5096-70-8; PubChem: 7636; ChEBI: 16387; KNApSAcK: C00025619; 3DMET: B01830; NIKKAJI: J564.027J,cpd:C05176; cpd:C05243; cpd:C06174; cpd:C08024; cpd:C09594; cpd:C11779; cpd:C15366,18,21,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H22O3N1,C18H20O3N1,299.1521435,300.1599686,298.14431854075,4446,cpd:C05247,10-Hydroxydihydrosanguinarine,C20H15NO5,10-Hydroxydihydrosanguinarine,R04702 R04707,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.56; 2.1.1.119,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05247  10-Hydroxydihydrosanguinarine,PubChem: 7637; ChEBI: 15878; 3DMET: B01831; NIKKAJI: J2.187.611I,cpd:C05247,20,15,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H16O5N1,C20H14O5N1,349.0950226,350.1028476,348.08719764076,4447,cpd:C05315,Palmatine;,C21H22NO4,"Palmatine; 5,6-Dihydro-2,3,9,10-tetramethoxydibenzo[a,g]quinolizinium",R03721 R07241 R08795,Isoquinoline alkaloid biosynthesis,1.3.3.8; 2.1.1.118; 2.1.1.147,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05315  Palmatine; Major components of natural products [BR:br08323];  Crude drugs;   Calumba;    C05315  Palmatine,CAS: 3486-67-7; PubChem: 7697; ChEBI: 16096; ChEMBL: CHEMBL206106; KNApSAcK: C00001898 C00027159; 3DMET: B00765; NIKKAJI: J12.970D,cpd:C05315; cpd:C18583,21,22,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O4N1,C21H21O4N1,352.1548832,353.1627082,351.14705824077,4448,cpd:C05316,Dihydromacarpine;,C22H19NO6,"Dihydromacarpine; 13,14-Dihydro-5,7-dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine",R04705 R04768,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.5.3.12; 2.1.1.120,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05316  Dihydromacarpine,CAS: 77785-12-7; PubChem: 7698; ChEBI: 18029; KNApSAcK: C00024644 C00028198; 3DMET: B01842; NIKKAJI: J613.285E,cpd:C05316,22,19,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H20O6N1,C22H18O6N1,393.1212373,394.1290624,392.11341234078,4449,cpd:C05322,7-O-Acetylsalutaridinol;,C21H25NO5,7-O-Acetylsalutaridinol; Salutaridinol acetate,R04723 R04769,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,2.3.1.150,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C05322  7-O-Acetylsalutaridinol,PubChem: 7704; ChEBI: 16184; 3DMET: B01843; NIKKAJI: J727.867E,cpd:C05322; cpd:C09371; cpd:C10569; cpd:C11250; cpd:C16708; cpd:C16713,21,25,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H26O5N1,C21H24O5N1,371.1732729,372.1810979,370.16544794079,4450,cpd:C06160,(S)-Norcoclaurine;,C16H17NO3,"(S)-Norcoclaurine; 6,7-Dihydroxy-(1S)-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline",R04305 R05123,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,2.1.1.128; 4.2.1.78,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06160  (S)-Norcoclaurine,CAS: 22672-77-1; PubChem: 8416; ChEBI: 17729; ChEMBL: CHEMBL470491; KNApSAcK: C00034613; 3DMET: B01977; NIKKAJI: J444.134F,cpd:C06160; cpd:C06346; cpd:C06347; cpd:C08521; cpd:C10174; cpd:C11785; cpd:C12162; cpd:C12193; cpd:C16703; cpd:C21405; cpd:C21406,16,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H18O3N1,C16H16O3N1,271.1208434,272.1286684,270.11301844080,4451,cpd:C06161,(S)-Coclaurine;,C17H19NO3,"(S)-Coclaurine; Coclaurine; (S)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-7-isoquinolinol; 1-(p-Hydroxybenzyl)-6-methoxy-7-hydroxy-1,2,3,4-tetrahydroisoquinoline",R04692 R05123 R05210 R08456,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.21.3; 2.1.1.115; 2.1.1.128; 2.1.1.140,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06161  (S)-Coclaurine,CAS: 486-39-5; PubChem: 8417; ChEBI: 15950; ChEMBL: CHEMBL446211; KNApSAcK: C00025812; 3DMET: B01978; NIKKAJI: J6.009G,cpd:C01516; cpd:C03882; cpd:C06161; cpd:C06348; cpd:C06349; cpd:C07042; cpd:C08534; cpd:C09422; cpd:C10844; cpd:C12167; cpd:C16576,17,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H20O3N1,C17H18O3N1,285.1364935,286.1443185,284.12866844081,4452,cpd:C06162,Sanguinarine,C20H14NO4,Sanguinarine,R04703 R10798 R10799,Isoquinoline alkaloid biosynthesis,1.3.1.107; 1.5.3.12,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06162  Sanguinarine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Isoquinoline alkaloids;     C06162  Sanguinarine,CAS: 2447-54-3; PubChem: 8418; ChEBI: 17183; ChEMBL: CHEMBL417799; KNApSAcK: C00001917 C00024663; PDB-CCD: SAU; 3DMET: B00911; NIKKAJI: J7.576K,cpd:C06162,20,14,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O4N1,C20H13O4N1,332.0922829,333.100108,331.08445794082,4453,cpd:C06163,(S)-cis-N-Methylstylopine,C20H20NO4,(S)-cis-N-Methylstylopine,R04691 R04700,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.13.37; 2.1.1.122,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06163  (S)-cis-N-methylstylopine,PubChem: 8419; ChEBI: 444; KNApSAcK: C00026083 C00026110; 3DMET: B05170; NIKKAJI: J1.767.334C,cpd:C01795; cpd:C06163; cpd:C09553; cpd:C18607,20,20,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H21O4N1,C20H19O4N1,338.1392331,339.1470582,337.13140814083,4454,cpd:C06165,Macarpine,C22H18NO6,Macarpine,R04768,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.5.3.12,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06165  Macarpine,CAS: 23594-80-1; PubChem: 8420; ChEBI: 17101; KNApSAcK: C00001883; 3DMET: B00912; NIKKAJI: J361.279A,cpd:C06165,22,18,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H19O6N1,C22H17O6N1,392.1134123,393.1212373,391.10558734084,4455,cpd:C06167,"1,2-Dehydroreticuline;",C19H22NO4,"1,2-Dehydroreticuline; 1,2-Dehydroreticulinium; 3,4-Dihydro-7-hydroxy-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-(methyl-14C)-isoquinolinium",R03833 R04695,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.5.1.27; 1.5.-.-,NA,NA,CAS: 16202-17-8; PubChem: 8421; ChEBI: 18363; KNApSAcK: C00027111; 3DMET: B00913; NIKKAJI: J471.975A,cpd:C06167,19,22,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O4N1,C19H21O4N1,328.1548832,329.1627082,327.14705824085,4456,cpd:C06171,Codeinone;,C18H19NO3,"Codeinone; (5alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-one",R05124 R05125,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.247,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06171  Codeinone,CAS: 467-13-0; PubChem: 8422; ChEBI: 18399; ChEMBL: CHEMBL257627; KNApSAcK: C00027603; 3DMET: B01979; NIKKAJI: J11.325E,cpd:C06171; cpd:C06172; cpd:C06175; cpd:C09340; cpd:C09457; cpd:C15087; cpd:C17077,18,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H20O3N1,C18H18O3N1,297.1364935,298.1443185,296.12866844086,4457,cpd:C06172,Neopinone,C18H19NO3,Neopinone,R05125 R05126,Isoquinoline alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites,1.14.11.31,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06172  Neopinone,PubChem: 8423; ChEBI: 7510; 3DMET: B05171; NIKKAJI: J1.972.242B,cpd:C06171; cpd:C06172; cpd:C06175; cpd:C09340; cpd:C09457; cpd:C15087; cpd:C17077,18,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H20O3N1,C18H18O3N1,297.1364935,298.1443185,296.12866844087,4458,cpd:C06173,Thebaine,C19H21NO3,Thebaine,R04769 R05126 R05127,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites; Opioid analgesics,1.14.11.31; 1.14.11.32,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06173  Thebaine,CAS: 115-37-7; PubChem: 8424; ChEBI: 9519; ChEMBL: CHEMBL1318110 CHEMBL403893; KNApSAcK: C00001924; 3DMET: B01980; NIKKAJI: J5.266C,cpd:C06173; cpd:C09550; cpd:C09611; cpd:C11787,19,21,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H22O3N1,C19H20O3N1,311.1521435,312.1599686,310.14431854088,4459,cpd:C06174,Codeine;,C18H21NO3,"Codeine; (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",R03697 R05124 R08261 R08264 R09402,Isoquinoline alkaloid biosynthesis; Drug metabolism - cytochrome P450; Metabolic pathways; Biosynthesis of secondary metabolites,1.1.1.247; 1.14.11.32; 1.14.13.-; 1.14.14.1; 2.4.1.17,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06174  Codeine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  R RESPIRATORY SYSTEM;   R05 COUGH AND COLD PREPARATIONS;    R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS;     R05DA Opium alkaloids and derivatives;      R05DA04 Codeine;       C06174  Codeine; Risk category of Japanese OTC drugs [BR:br08312];  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Codeine;     C06174  Codeine;  Second-class OTC drugs;   Inorganic and organic chemicals;    Codeine;     C06174  Codeine",CAS: 76-57-3; PubChem: 8425; ChEBI: 16714; ChEMBL: CHEMBL22662 CHEMBL485; KNApSAcK: C00001837; 3DMET: B01981; NIKKAJI: J4.178E,cpd:C05176; cpd:C05243; cpd:C06174; cpd:C08024; cpd:C09594; cpd:C11779; cpd:C15366,18,21,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H22O3N1,C18H20O3N1,299.1521435,300.1599686,298.14431854089,4460,cpd:C06175,Oripavine,C18H19NO3,Oripavine,R03698 R05127,Isoquinoline alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.11.31; 1.14.11.32,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06175  Oripavine,PubChem: 8426; ChEBI: 7782; ChEMBL: CHEMBL437602; KNApSAcK: C00028775; 3DMET: B01982; NIKKAJI: J12.064B,cpd:C06171; cpd:C06172; cpd:C06175; cpd:C09340; cpd:C09457; cpd:C15087; cpd:C17077,18,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H20O3N1,C18H18O3N1,297.1364935,298.1443185,296.12866844090,4461,cpd:C06327,Chelirubine,C21H16NO5,Chelirubine,R04706 R10800 R10801,Isoquinoline alkaloid biosynthesis,1.3.1.107; 1.5.3.12,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06327  Chelirubine,CAS: 18203-11-7; PubChem: 8563; ChEBI: 17031; KNApSAcK: C00001821 C00024636; 3DMET: B00934; NIKKAJI: J361.278C,cpd:C06327,21,16,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H17O5N1,C21H15O5N1,362.1028476,363.1106727,361.09502264091,4462,cpd:C06511,Guattegaumerine;,C36H40N2O6,"Guattegaumerine; N,N'-Dimethyllindoldhamine",R05215,Isoquinoline alkaloid biosynthesis,1.14.21.3,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06511  Guattegaumerine,CAS: 21446-35-5; PubChem: 8742; ChEBI: 5568; KNApSAcK: C00025616; 3DMET: B02039; NIKKAJI: J2.403.102K,cpd:C05177; cpd:C06511; cpd:C06515,36,40,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H41O6N2,C36H39O6N2,596.288637,597.296462,595.2808124092,4463,cpd:C06512,2'-Norberbamunine,C35H38N2O6,2'-Norberbamunine,R05210,Isoquinoline alkaloid biosynthesis,1.14.21.3,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06512  2'-Norberbamunine,PubChem: 8743; ChEBI: 845; 3DMET: B02040; NIKKAJI: J2.392.460I,cpd:C06512,35,38,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H39O6N2,C35H37O6N2,582.272987,583.280812,581.26516194093,4464,cpd:C06516,(R)-Norreticuline;,C18H21NO4,(R)-Norreticuline; N-Norreticuline,R05216 R08456 R08457,Isoquinoline alkaloid biosynthesis; Biosynthesis of secondary metabolites,2.1.1.115,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06516  (R)-Norreticuline,PubChem: 8747; ChEBI: 28658; ChEMBL: CHEMBL160579; 3DMET: B02043; NIKKAJI: J836.242D,cpd:C05202; cpd:C05317; cpd:C06516; cpd:C06518; cpd:C06520; cpd:C08018; cpd:C08026; cpd:C10580; cpd:C12329; cpd:C15018; cpd:C15362,18,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H22O4N1,C18H20O4N1,315.1470582,316.1548832,314.13923314094,4465,cpd:C06517,(S)-6-O-Methylnorlaudanosoline;,C17H19NO4,(S)-6-O-Methylnorlaudanosoline; (S)-3'-Hydroxycoclaurine,R05212 R05213 R05214 R08794,Isoquinoline alkaloid biosynthesis; Biosynthesis of secondary metabolites,2.1.1.115; 2.1.1.116; 2.1.1.121; 2.1.1.128,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06517  (S)-6-O-Methylnorlaudanosoline,PubChem: 8748; ChEBI: 27460; 3DMET: B02044; NIKKAJI: J1.547.786E,cpd:C05203; cpd:C06517; cpd:C08019; cpd:C08525; cpd:C08527; cpd:C10941; cpd:C11078; cpd:C11786; cpd:C12163; cpd:C12190; cpd:C12191; cpd:C12192; cpd:C12327,17,19,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H20O4N1,C17H18O4N1,301.1314081,302.1392331,300.12358314095,4466,cpd:C06518,(S)-Nororientaline,C18H21NO4,(S)-Nororientaline,R05213,Isoquinoline alkaloid biosynthesis,2.1.1.121,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06518  (S)-Nororientaline,PubChem: 8749; ChEBI: 28594; 3DMET: B02045; NIKKAJI: J2.762.434K,cpd:C05202; cpd:C05317; cpd:C06516; cpd:C06518; cpd:C06520; cpd:C08018; cpd:C08026; cpd:C10580; cpd:C12329; cpd:C15018; cpd:C15362,18,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H22O4N1,C18H20O4N1,315.1470582,316.1548832,314.13923314096,4467,cpd:C06520,(S)-Norreticuline,C18H21NO4,(S)-Norreticuline,R05211 R05212,Isoquinoline alkaloid biosynthesis; Biosynthesis of secondary metabolites,2.1.1.115; 2.1.1.116,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06520  (S)-Norreticuline,PubChem: 8751; ChEBI: 28611; ChEMBL: CHEMBL349584; KNApSAcK: C00039868; 3DMET: B02047; NIKKAJI: J836.243B,cpd:C05202; cpd:C05317; cpd:C06516; cpd:C06518; cpd:C06520; cpd:C08018; cpd:C08026; cpd:C10580; cpd:C12329; cpd:C15018; cpd:C15362,18,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H22O4N1,C18H20O4N1,315.1470582,316.1548832,314.13923314097,4468,cpd:C06533,Papaverine,C20H21NO4,Papaverine,R08457,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C06533  Papaverine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;    A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;     A03AD Papaverine and derivatives;      A03AD01 Papaverine;       D07425  Papaverine (BAN);  G GENITO URINARY SYSTEM AND SEX HORMONES;   G04 UROLOGICALS;    G04B UROLOGICALS;     G04BE Drugs used in erectile dysfunction;      G04BE02 Papaverine;       D07425  Papaverine (BAN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Papaverine;     D07425  Papaverine (BAN); Target-based classification of drugs [BR:br08310];  Enzymes;   Hydrolases;    phosphodiesterase (PDE);     Papaverine;      D07425  Papaverine (BAN); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     D07425  Papaverine (BAN),CAS: 58-74-2; PubChem: 8763; ChEBI: 28241; ChEMBL: CHEMBL19224; KNApSAcK: C00001899 C00027467; PDB-CCD: EV1; 3DMET: B02056; NIKKAJI: J10.638K,cpd:C03329; cpd:C06533; cpd:C09426; cpd:C10666; cpd:C11818; cpd:C17426; cpd:C17898; cpd:C19985,20,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H22O4N1,C20H20O4N1,339.1470582,340.1548832,338.13923314098,4469,cpd:C07304,Deacetylisoipecoside,C25H33NO11,Deacetylisoipecoside,R05750 R05889 R05891,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,4.3.3.3,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C07304  Deacetylisoipecoside,PubChem: 9512; ChEBI: 17286; 3DMET: B02113; NIKKAJI: J845.735B,cpd:C07304; cpd:C07307,25,33,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H34O11N1,C25H32O11N1,523.2053609,524.2131859,522.19753594099,4470,cpd:C07307,Deacetylipecoside,C25H33NO11,Deacetylipecoside,R05749 R05887,Isoquinoline alkaloid biosynthesis,4.3.3.4,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C07307  Deacetylipecoside,PubChem: 9515; ChEBI: 18106; 3DMET: B02114; NIKKAJI: J845.734D,cpd:C07304; cpd:C07307,25,33,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H34O11N1,C25H32O11N1,523.2053609,524.2131859,522.19753594100,4471,cpd:C07592,Colchicine,C22H25NO6,Colchicine,R08453,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C07592  Colchicine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Isoquinoline alkaloids;     C07592  Colchicine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  M MUSCULO-SKELETAL SYSTEM;   M04 ANTIGOUT PREPARATIONS;    M04A ANTIGOUT PREPARATIONS;     M04AC Preparations with no effect on uric acid metabolism;      M04AC01 Colchicine;       D00570  Colchicine (JP17/USP); USP drug classification [BR:br08302];  Antigout Agents;   Colchicine;    D00570  Colchicine (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    394  Gout preparations;     3941  Colchicines;      D00570  Colchicine (JP17/USP); Target-based classification of drugs [BR:br08310];  Others;   Other;    beta-tubulin;     Colchicine;      D00570  Colchicine (JP17/USP); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Colchicine;     D00570  Colchicine (JP17/USP);   CYP3A;    Colchicine;     D00570  Colchicine (JP17/USP);  Transporter substrates;   ABCB1;    Colchicine;     D00570  Colchicine (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00570  Colchicine; Major components of natural products [BR:br08323];  Crude drugs;   Colchicum seed; Colchicum bulb;    C07592  Colchicine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     D00570  Colchicine (JP15/USP); Antirheumatic and antigout drugs [br08366.html];  Antigout drugs;   D00570; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00570,CAS: 64-86-8; PubChem: 9794; ChEBI: 27882; ChEMBL: CHEMBL107; KNApSAcK: C00002327; PDB-CCD: LOC; 3DMET: B02129; NIKKAJI: J9.267C,cpd:C07592; cpd:C16710,22,25,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H26O6N1,C22H24O6N1,399.1681875,400.1760126,398.16036254101,4472,cpd:C08526,Galanthamine;,C17H21NO3,Galanthamine; Galantamine,R08441,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C08526  Galanthamine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Isoquinoline alkaloids;     C08526  Galanthamine; Target-based classification of compounds [BR:br08010];  Enzymes;   Hydrolases;    ACHE; acetylcholinesterase;     C08526  Galanthamine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N06 PSYCHOANALEPTICS;    N06D ANTI-DEMENTIA DRUGS;     N06DA Anticholinesterases;      N06DA04 Galantamine;       D04292  Galantamine (USAN/INN); USP drug classification [BR:br08302];  Antidementia Agents;   Cholinesterase Inhibitors;    Galantamine;     D04292  Galantamine (USAN/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Hydrolases;    acetylcholinesterase (AChE);     Galantamine;      D04292  Galantamine (USAN/INN),CAS: 357-70-0; PubChem: 10719; ChEBI: 42944; ChEMBL: CHEMBL1624158 CHEMBL312966 CHEMBL659; KNApSAcK: C00001570; PDB-CCD: GNT; 3DMET: B02196; NIKKAJI: J11.407C,cpd:C06991; cpd:C07239; cpd:C08526; cpd:C09223; cpd:C11782; cpd:C12195,17,21,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H22O3N1,C17H20O3N1,287.1521435,288.1599686,286.14431854102,4473,cpd:C08532,Lycorine,C16H17NO4,Lycorine,R08438,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C08532  Lycorine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Isoquinoline alkaloids;     C08532  Lycorine,CAS: 476-28-8; PubChem: 10725; ChEBI: 6601; ChEMBL: CHEMBL224745 CHEMBL400092; KNApSAcK: C00001576; PDB-CCD: 3KD; 3DMET: B02202; NIKKAJI: J5.973K,cpd:C02916; cpd:C06350; cpd:C06351; cpd:C08519; cpd:C08532; cpd:C10444; cpd:C12164; cpd:C12185; cpd:C12186; cpd:C12194,16,17,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H18O4N1,C16H16O4N1,287.115758,288.1235831,286.1079334103,4474,cpd:C09248,Tubulosine,C29H37N3O3,Tubulosine,R05894,Isoquinoline alkaloid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C09248  Tubulosine,CAS: 2632-29-3; PubChem: 11439; ChEBI: 9775; ChEMBL: CHEMBL518568; KNApSAcK: C00001778; 3DMET: B02798; NIKKAJI: J14.798B,cpd:C09248; cpd:C09328,29,37,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H38O3N3,C29H36O3N3,475.2834921,476.2913171,474.2756674104,4475,cpd:C09328,Alangimarckine,C29H37N3O3,Alangimarckine,R05896,Isoquinoline alkaloid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C09328  Alangimarckine,CAS: 13849-53-1; PubChem: 11519; ChEBI: 2536; KNApSAcK: C00001796; 3DMET: B02867; NIKKAJI: J38.518B,cpd:C09248; cpd:C09328,29,37,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H38O3N3,C29H36O3N3,475.2834921,476.2913171,474.2756674105,4476,cpd:C09330,Alangiside,C25H31NO10,Alangiside,R05888,Isoquinoline alkaloid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C09330  Alangiside,CAS: 34482-51-4; PubChem: 11521; ChEBI: 2538; ChEMBL: CHEMBL486383; KNApSAcK: C00001798; 3DMET: B02869; NIKKAJI: J38.519K,cpd:C09330; cpd:C11815,25,31,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H32O10N1,C25H30O10N1,505.1947962,506.2026212,504.18697124106,4477,cpd:C09337,Ankorine,C19H29NO4,Ankorine,R05897,Isoquinoline alkaloid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C09337  Ankorine,CAS: 13849-54-2; PubChem: 11528; ChEBI: 2740; KNApSAcK: C00001805; 3DMET: B02874; NIKKAJI: J15.452K,cpd:C09337,19,29,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H30O4N1,C19H28O4N1,335.2096584,336.2174834,334.20183344107,4478,cpd:C09390,Cephaeline,C28H38N2O4,Cephaeline,R05893,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C09390  Cephaeline,CAS: 483-17-0; PubChem: 11581; ChEBI: 3533; ChEMBL: CHEMBL255708; KNApSAcK: C00001835; 3DMET: B02924; NIKKAJI: J5.985D,cpd:C09390,28,38,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H39O4N2,C28H37O4N2,466.2831577,467.2909827,465.27533274108,4479,cpd:C09421,Emetine,C29H40N2O4,Emetine,R05892,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C09421  Emetine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS;   P01 ANTIPROTOZOALS;    P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;     P01AX Other agents against amoebiasis and other protozoal diseases;      P01AX02 Emetine;       C09421  Emetine; Antiinfectives [BR:br08307];  Antiparasitics;   Agents against Amebiasis and other antiprotozoals;    Others;     Emetine;      C09421  Emetine; Major components of natural products [BR:br08323];  Crude drugs;   Ipecac;    C09421  Emetine;   Ipecac syrup;    C09421  Emetine",CAS: 483-18-1; PubChem: 11612; ChEBI: 4781; ChEMBL: CHEMBL1624688 CHEMBL50588; KNApSAcK: C00001849; 3DMET: B02952; NIKKAJI: J9.377G,cpd:C09421,29,40,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H41O4N2,C29H39O4N2,480.2988078,481.3066328,479.29098274109,4480,cpd:C09581,Magnoflorine,C20H24NO4,Magnoflorine,R08791,Isoquinoline alkaloid biosynthesis; Biosynthesis of secondary metabolites,2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C09581  Magnoflorine,CAS: 2141-09-5; PubChem: 11772; ChEBI: 6641; ChEMBL: CHEMBL235428; KNApSAcK: C00001885; 3DMET: B03100; NIKKAJI: J9.488I,cpd:C09581; cpd:C17046,20,24,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O4N1,C20H23O4N1,342.1705333,343.1783583,341.16270824110,4481,cpd:C11250,Demecolcine;,C21H25NO5,Demecolcine; Colcemid,R08451 R08452,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C11250  Demecolcine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS;     L01CC Colchicine derivatives;      L01CC01 Demecolcine;       C11250  Demecolcine,CAS: 477-30-5; PubChem: 13427; ChEBI: 4393; ChEMBL: CHEMBL433632; KNApSAcK: C00027138; NIKKAJI: J9.231B,cpd:C05322; cpd:C09371; cpd:C10569; cpd:C11250; cpd:C16708; cpd:C16713,21,25,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H26O5N1,C21H24O5N1,371.1732729,372.1810979,370.16544794111,4482,cpd:C11813,Demethylalangiside,C24H29NO10,Demethylalangiside,R05887 R05888,Isoquinoline alkaloid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C11813  Demethylalangiside,CAS: 47763-23-5; PubChem: 13977; ChEBI: 4394; KNApSAcK: C00028162; 3DMET: B04321; NIKKAJI: J419.042D,cpd:C11813; cpd:C11814,24,29,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H30O10N1,C24H28O10N1,491.1791461,492.1869712,490.17132114112,4483,cpd:C11814,Demethylisoalangiside,C24H29NO10,Demethylisoalangiside,R05889 R05890,Isoquinoline alkaloid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C11814  Demethylisoalangiside,PubChem: 13978; ChEBI: 4397; KNApSAcK: C00027342; 3DMET: B04322,cpd:C11813; cpd:C11814,24,29,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H30O10N1,C24H28O10N1,491.1791461,492.1869712,490.17132114113,4484,cpd:C11815,Isoalangiside,C25H31NO10,Isoalangiside,R05890,Isoquinoline alkaloid biosynthesis,NA,NA,NA,CAS: 57128-91-3; PubChem: 13979; ChEBI: 5980; KNApSAcK: C00027550; 3DMET: B04323; NIKKAJI: J690.452A,cpd:C09330; cpd:C11815,25,31,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H32O10N1,C25H30O10N1,505.1947962,506.2026212,504.18697124114,4485,cpd:C11816,Protoemetine,C19H27NO3,Protoemetine,R05891 R05892 R05893 R05894 R05895 R05897,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Metabolic pathways; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C11816  Protoemetine,CAS: 549-91-7; PubChem: 13980; ChEBI: 8589; KNApSAcK: C00027472; 3DMET: B04324; NIKKAJI: J15.491A,cpd:C11168; cpd:C11816; cpd:C12508,19,27,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H28O3N1,C19H26O3N1,317.1990937,318.2069188,316.19126874115,4486,cpd:C11817,Deoxytubulosine,C29H37N3O2,Deoxytubulosine,R05895 R05896,Isoquinoline alkaloid biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C11817  Deoxytubulosine,PubChem: 13981; ChEBI: 4433; KNApSAcK: C00026848; 3DMET: B04325; NIKKAJI: J419.042D,cpd:C11817,29,37,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H38O2N3,C29H36O2N3,459.2885774,460.2964025,458.28075244116,4487,cpd:C11818,(R)-Canadine,C20H21NO4,(R)-Canadine,R07169,Isoquinoline alkaloid biosynthesis,1.5.1.31,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C11818  (R)-Canadine,CAS: 2086-96-6; PubChem: 13982; ChEBI: 18146; ChEMBL: CHEMBL476501; NIKKAJI: J9.574E,cpd:C03329; cpd:C06533; cpd:C09426; cpd:C10666; cpd:C11818; cpd:C17426; cpd:C17898; cpd:C19985,20,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H22O4N1,C20H20O4N1,339.1470582,340.1548832,338.13923314117,4488,cpd:C12162,Crinine,C16H17NO3,Crinine,R08439,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C12162  Crinine,PubChem: 14309; ChEBI: 31437; ChEMBL: CHEMBL1221864; KNApSAcK: C00024384; NIKKAJI: J964.437G,cpd:C06160; cpd:C06346; cpd:C06347; cpd:C08521; cpd:C10174; cpd:C11785; cpd:C12162; cpd:C12193; cpd:C16703; cpd:C21405; cpd:C21406,16,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H18O3N1,C16H16O3N1,271.1208434,272.1286684,270.11301844118,4489,cpd:C12173,Norgalanthamine;,C16H19NO3,Norgalanthamine; N-Demethylgalanthamine,R08441 R08442,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,1.1.1.-; 2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C12173  Norgalanthamine,PubChem: 14320; ChEBI: 31919; ChEMBL: CHEMBL1385; KNApSAcK: C00024414 C00027607; NIKKAJI: J661.286E,cpd:C06531; cpd:C06532; cpd:C10711; cpd:C12173; cpd:C12180; cpd:C12232; cpd:C15360; cpd:C16702,16,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H20O3N1,C16H18O3N1,273.1364935,274.1443185,272.12866844119,4490,cpd:C15530,Corydaline;,C22H27NO4,Corydaline; (+)-Corydaline,R07241,Isoquinoline alkaloid biosynthesis,2.1.1.147,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C15530  Corydaline,CAS: 518-69-4; PubChem: 17396522; ChEBI: 14027; KNApSAcK: C00026115; NIKKAJI: J34.125H,cpd:C08714; cpd:C15530,22,27,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H28O4N1,C22H26O4N1,369.1940084,370.2018334,368.18618334120,4491,cpd:C16700,"3,4-Dihydroxybenzaldehyde;",C7H6O3,"3,4-Dihydroxybenzaldehyde; Protocatechualdehyde",R08435 R08436,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,NA,CAS: 139-85-5; PubChem: 96023224; ChEBI: 50205; ChEMBL: CHEMBL222021; KNApSAcK: C00018099; NIKKAJI: J5.647B,cpd:C00156; cpd:C00587; cpd:C00805; cpd:C05585; cpd:C08055; cpd:C10832; cpd:C12114; cpd:C14015; cpd:C16700; cpd:C17098; cpd:C18316; cpd:C20248,7,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O3,C7H5O3,138.0316941,139.0395191,137.0238694121,4492,cpd:C16701,Norbelladine,C15H17NO3,Norbelladine,R08436 R08437,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,2.1.1.336,NA,NA,PubChem: 96023225; ChEBI: 80666; NIKKAJI: J2.395.942I,cpd:C12253; cpd:C16701; cpd:C16721,15,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H18O3N1,C15H16O3N1,259.1208434,260.1286684,258.11301844122,4493,cpd:C16702,4'-O-Methylnorbelladine,C16H19NO3,4'-O-Methylnorbelladine,R08437 R08438 R08439 R08440 R11482 R11483,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,1.14.19.50; 2.1.1.336,NA,NA,PubChem: 96023226; ChEBI: 80667; NIKKAJI: J1.010.314B,cpd:C06531; cpd:C06532; cpd:C10711; cpd:C12173; cpd:C12180; cpd:C12232; cpd:C15360; cpd:C16702,16,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H20O3N1,C16H18O3N1,273.1364935,274.1443185,272.12866844123,4494,cpd:C16703,N-Demethylnarwedine,C16H17NO3,N-Demethylnarwedine,R08440 R08442,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,1.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C16703  N-Demethylnarwedine,PubChem: 96023227; ChEBI: 80668; NIKKAJI: J1.854.928J,cpd:C06160; cpd:C06346; cpd:C06347; cpd:C08521; cpd:C10174; cpd:C11785; cpd:C12162; cpd:C12193; cpd:C16703; cpd:C21405; cpd:C21406,16,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H18O3N1,C16H16O3N1,271.1208434,272.1286684,270.11301844124,4495,cpd:C16706,4-Hydroxydihydrocinnamaldehyde;,C9H10O2,4-Hydroxydihydrocinnamaldehyde; 3-(p-Hydroxyphenyl)propanal,R08447,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,NA,PubChem: 96023230; ChEBI: 80671; NIKKAJI: J1.334.121D,cpd:C01963; cpd:C02646; cpd:C03900; cpd:C05629; cpd:C07428; cpd:C08050; cpd:C11007; cpd:C11009; cpd:C11110; cpd:C11217; cpd:C12461; cpd:C13342; cpd:C15513; cpd:C16706; cpd:C17883; cpd:C19291; cpd:C20697; cpd:C21309,9,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O2,C9H9O2,150.0680796,151.0759046,149.06025454125,4496,cpd:C16707,(S)-Autumnaline;,C21H27NO5,(S)-Autumnaline; Autumnaline,R08447 R08448 R08454,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C16707  (S)-Autumnaline,CAS: 23068-65-7; PubChem: 96023231; ChEBI: 80672; NIKKAJI: J16.287F,cpd:C09459; cpd:C16707; cpd:C18807,21,27,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H28O5N1,C21H26O5N1,373.188923,374.196748,372.18109794126,4497,cpd:C16708,Isoandrocymbine,C21H25NO5,Isoandrocymbine,R08448 R08449,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C16708  Isoandrocymbine,PubChem: 96023232; ChEBI: 80673; NIKKAJI: J781.868H,cpd:C05322; cpd:C09371; cpd:C10569; cpd:C11250; cpd:C16708; cpd:C16713,21,25,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H26O5N1,C21H24O5N1,371.1732729,372.1810979,370.16544794127,4498,cpd:C16709,O-Methylandrocymbine,C22H27NO5,O-Methylandrocymbine,R08449 R08450,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C16709  O-Methylandrocymbine,PubChem: 96023233; ChEBI: 80674; NIKKAJI: J1.013.205C,cpd:C16709; cpd:C16714,22,27,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H28O5N1,C22H26O5N1,385.188923,386.196748,384.18109794128,4499,cpd:C16710,N-Formyldemecolcine,C22H25NO6,N-Formyldemecolcine,R08450 R08451,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C16710  N-Formyldemecolcine,CAS: 14686-61-4; PubChem: 96023234; ChEBI: 80675; ChEMBL: CHEMBL315193; NIKKAJI: J67.641A,cpd:C07592; cpd:C16710,22,25,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H26O6N1,C22H24O6N1,399.1681875,400.1760126,398.16036254129,4500,cpd:C16712,Deacetylcolchicine;,C20H23NO5,Deacetylcolchicine; Trimethylcolchicinic acid methyl ether,R08452 R08453,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,NA,CAS: 3476-50-4; PubChem: 96023236; ChEBI: 80676; ChEMBL: CHEMBL1063; NIKKAJI: J55.416B,cpd:C16712,20,23,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H24O5N1,C20H22O5N1,357.1576228,358.1654479,356.14979784130,4501,cpd:C16713,Floramultine,C21H25NO5,Floramultine,R08454 R08455,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway,2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C16713  Floramultine,PubChem: 96023237; ChEBI: 80677; KNApSAcK: C00027412; NIKKAJI: J15.330C,cpd:C05322; cpd:C09371; cpd:C10569; cpd:C11250; cpd:C16708; cpd:C16713,21,25,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H26O5N1,C21H24O5N1,371.1732729,372.1810979,370.16544794131,4502,cpd:C16714,Kreysigine,C22H27NO5,Kreysigine,R08455,Isoquinoline alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway,2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C16714  Kreysigine,PubChem: 96023238; ChEBI: 80678; KNApSAcK: C00027632; NIKKAJI: J15.994H,cpd:C16709; cpd:C16714,22,27,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H28O5N1,C22H26O5N1,385.188923,386.196748,384.18109794132,4503,cpd:C17591,(S)-Corytuberine,C19H21NO4,(S)-Corytuberine,R08790 R08791,Isoquinoline alkaloid biosynthesis; Biosynthesis of secondary metabolites,1.14.21.-; 2.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C17591  (S)-Corytuberine,PubChem: 96023936; ChEBI: 81200; ChEMBL: CHEMBL227965; KNApSAcK: C00025655; NIKKAJI: J6.577C,cpd:C02106; cpd:C05179; cpd:C07252; cpd:C09365; cpd:C09366; cpd:C09400; cpd:C09410; cpd:C09541; cpd:C11778; cpd:C11781; cpd:C12326; cpd:C17591,19,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H22O4N1,C19H20O4N1,327.1470582,328.1548832,326.13923314133,4504,cpd:C17592,Laudanine,C20H25NO4,Laudanine,R08787 R08788,Isoquinoline alkaloid biosynthesis,2.1.1.291,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C17592  Laudanine,CAS: 85-64-3; PubChem: 96023937; ChEBI: 76103 76106; ChEMBL: CHEMBL1425007; KNApSAcK: C00028453; NIKKAJI: J358.586G J4.921B,cpd:C09555; cpd:C15430; cpd:C17592; cpd:C20712,20,25,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H26O4N1,C20H24O4N1,343.1783583,344.1861833,342.17053334134,4505,cpd:C00729,Tropine;,C8H15NO,Tropine; 3alpha-Tropanol,R02832 R03563 R03564 R06735 R08432 R08712,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",1.1.1.206; 2.3.1.185; 2.3.1.-; 3.1.1.10,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C00729  Tropine,CAS: 120-29-6; PubChem: 3994; ChEBI: 15884; ChEMBL: CHEMBL113555 CHEMBL1356617; KNApSAcK: C00002306; PDB-CCD: PTO; 3DMET: B04719; NIKKAJI: J265.579I,cpd:C00248; cpd:C00729; cpd:C02066; cpd:C06179; cpd:C06182; cpd:C10864; cpd:C11359; cpd:C12440,8,15,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O1N1,C8H14O1N1,141.1153641,142.1231891,140.10753914135,4506,cpd:C00745,Nicotine;,C10H14N2,Nicotine; (S)-3-(1-Methylpyrrolidin-2-yl)pyridine; (S)-Nicotine,R02861 R06738,"Tropane, piperidine and pyridine alkaloid biosynthesis; Metabolism of xenobiotics by cytochrome P450; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites; Nicotine addiction",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     C00745  Nicotine; Pesticides [BR:br08007];  Pesticides;   Insecticides;    Others;     C00745  Nicotine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Others;     C00745  Nicotine; Target-based classification of compounds [BR:br08010];  Ion channels;   Cys-loop superfamily;    Acetylcholine (nicotinic);     nicotinic cholinergic receptor;      C00745  Nicotine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N07 OTHER NERVOUS SYSTEM DRUGS;    N07B DRUGS USED IN ADDICTIVE DISORDERS;     N07BA Drugs used in nicotine dependence;      N07BA01 Nicotine;       D03365  Nicotine (USP); USP drug classification [BR:br08302];  Anti-Addiction/Substance Abuse Treatment Agents;   Smoking Cessation Agents;    Nicotine;     D03365  Nicotine (USP); Therapeutic category of drugs in Japan [BR:br08301];  7  Agents not mainly for therapeutic purpose;   79  Other agents not mainly for therapeutic purpose;    799  Miscellaneous;     7990  Miscellaneous;      D03365  Nicotine (USP); Classification of Japanese OTC drugs [BR:br08313];  Stop smoking aid;   77 Stop smoking aid;    D03365  Nicotine (USP); Risk category of Japanese OTC drugs [BR:br08312];  First-class OTC drugs;   Inorganic and organic chemicals;    Nicotine;     D03365  Nicotine (USP);  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Nicotine;     D03365  Nicotine (USP);  Second-class OTC drugs;   Inorganic and organic chemicals;    Nicotine;     D03365  Nicotine (USP); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP1A2;    Nicotine;     D03365  Nicotine (USP);   CYP2A6;    Nicotine;     D03365  Nicotine (USP); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     D03365  Nicotine (USP); Rx-to-OTC switch list in the USA [br08315.html];  D03365; Rx-to-OTC switch list in Japan [br08314.html];  D03365,CAS: 54-11-5; PubChem: 4007; ChEBI: 17688; ChEMBL: CHEMBL3; KNApSAcK: C00002057; PDB-CCD: NCT; 3DMET: B01322; NIKKAJI: J9.266E,cpd:C00214; cpd:C00745; cpd:C00931; cpd:C01056; cpd:C01297; cpd:C03043; cpd:C05131; cpd:C06180; cpd:C06870; cpd:C07826; cpd:C11357; cpd:C15986; cpd:C16150; cpd:C16386; cpd:C16569; cpd:C16744; cpd:C17369; cpd:C17964; cpd:C19086; cpd:C19431; cpd:C20361; cpd:C20822,10,14,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15N2,C10H13N2,162.1156985,163.1235235,161.10787344136,4507,cpd:C00783,Tropinone;,C8H13NO,Tropinone; 3-Tropanone,R02832 R06733 R06734 R08431,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",1.1.1.206; 1.1.1.236,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C00783  Tropinone,CAS: 532-24-1; PubChem: 4042; ChEBI: 16656; KNApSAcK: C00037960; PDB-CCD: TNE; 3DMET: B04722; NIKKAJI: J11.723D,cpd:C00783; cpd:C10400; cpd:C16697,8,13,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H14O1N1,C8H12O1N1,139.099714,140.1075391,138.0918894137,4508,cpd:C01416,Cocaine;,C17H21NO4,Cocaine; l-Cocain; beta-Cocain,R06727 R06728 R06745 R08430,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",2.3.1.-; 3.1.1.1; 3.1.1.84,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C01416  Cocaine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N01 ANESTHETICS;    N01B ANESTHETICS, LOCAL;     N01BC Esters of benzoic acid;      N01BC01 Cocaine;       D00110  Cocaine (USP);  R RESPIRATORY SYSTEM;   R02 THROAT PREPARATIONS;    R02A THROAT PREPARATIONS;     R02AD Anesthetics, local;      R02AD03 Cocaine;       D00110  Cocaine (USP);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01H LOCAL ANESTHETICS;     S01HA Local anesthetics;      S01HA01 Cocaine;       D00110  Cocaine (USP);   S02 OTOLOGICALS;    S02D OTHER OTOLOGICALS;     S02DA Analgesics and anesthetics;      S02DA02 Cocaine;       D00110  Cocaine (USP); Target-based classification of drugs [BR:br08310];  Ion channels;   Voltage-gated cation channels;    Na+ channel, SCN alpha, NaV1.x;     voltage-gated sodium channel (SCN1A);      Cocaine;       D00110  Cocaine (USP);     voltage-gated sodium channel (SCN2A);      Cocaine;       D00110  Cocaine (USP);     voltage-gated sodium channel (SCN3A);      Cocaine;       D00110  Cocaine (USP);     voltage-gated sodium channel (SCN4A);      Cocaine;       D00110  Cocaine (USP);     voltage-gated sodium channel (SCN5A);      Cocaine;       D00110  Cocaine (USP);     voltage-gated sodium channel (SCN8A);      Cocaine;       D00110  Cocaine (USP);     voltage-gated sodium channel (SCN9A);      Cocaine;       D00110  Cocaine (USP);     voltage-gated sodium channel (SCN10A);      Cocaine;       D00110  Cocaine (USP);    K+ channel, KCNH, Kv10-12.x (Ether-a-go-go);     voltage-gated potassium channel (KCNH2);      Cocaine;       D00110  Cocaine (USP);  Transporters;   Solute carrier family;    SLC6;     SLC6A2 (noradrenalin transporter);      Cocaine;       D00110  Cocaine (USP);     SLC6A3 (dopamine transporter);      Cocaine;       D00110  Cocaine (USP);     SLC6A4 (serotonin transporter);      Cocaine;       D00110  Cocaine (USP); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2D6;    Cocaine;     D00110  Cocaine (USP); Major components of natural products [BR:br08323];  Crude drugs;   Coca leaf;    C01416  Cocaine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     D00110  Cocaine (USP)",CAS: 50-36-2; PubChem: 4603; ChEBI: 27958; KNApSAcK: C00002285; PDB-CCD: COC; 3DMET: B01447; NIKKAJI: J43.264D,cpd:C01416; cpd:C01851; cpd:C08523; cpd:C12172; cpd:C18563,17,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H22O4N1,C17H20O4N1,303.1470582,304.1548832,302.13923314138,4509,cpd:C01456,Tropate;,C9H10O3,Tropate; Tropic acid; alpha-(Hydroxymethyl)phenylacetic acid,R03563 R03564 R06744,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",3.1.1.10,NA,NA,CAS: 529-64-6 552-63-6; PubChem: 4633; ChEBI: 17000 30765; KNApSAcK: C00035885; 3DMET: B04796; NIKKAJI: J237.326B J6.688E,cpd:C01198; cpd:C01456; cpd:C01744; cpd:C02201; cpd:C02363; cpd:C02515; cpd:C03080; cpd:C05581; cpd:C05607; cpd:C10712; cpd:C11380; cpd:C11457; cpd:C12206; cpd:C12462; cpd:C17079; cpd:C18397,9,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O3,C9H9O3,166.0629942,167.0708192,165.05516914139,4510,cpd:C01479,Atropine;,C17H23NO3,Atropine; dl-Hyoscyamine,R03563,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of secondary metabolites",3.1.1.10,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C01479  Atropine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Tropan alkaloids;     C01479  Atropine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;    A03B BELLADONNA AND DERIVATIVES, PLAIN;     A03BA Belladonna alkaloids, tertiary amines;      A03BA01 Atropine;       D00113  Atropine (USP);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01F MYDRIATICS AND CYCLOPLEGICS;     S01FA Anticholinergics;      S01FA01 Atropine;       D00113  Atropine (USP); USP drug classification [BR:br08302];  Gastrointestinal Agents;   Antispasmodics, Gastrointestinal;    Atropine;     D00113  Atropine (USP); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Acetylcholine (muscarinic);     muscarinic cholinergic receptor;      Atropine;       D00113  Atropine (USP); Major components of natural products [BR:br08323];  Crude drugs;   Scopolia rhizome;    C01479  Atropine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     D00113  Atropine (USP)",CAS: 51-55-8; PubChem: 4651; ChEBI: 16684 78734; ChEMBL: CHEMBL517712; KNApSAcK: C00002277; 3DMET: B04797; NIKKAJI: J231.179H,cpd:C01479; cpd:C02046; cpd:C09224; cpd:C10859; cpd:C10860; cpd:C12233; cpd:C14884; cpd:C14908; cpd:C15081,17,23,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H24O3N1,C17H22O3N1,289.1677936,290.1756186,288.15996864140,4511,cpd:C01746,Piperidine;,C5H11N,Piperidine; Azacyclohexane; Hexahydropyridine,R03994 R09052,"Tropane, piperidine and pyridine alkaloid biosynthesis; Protein digestion and absorption",2.3.1.145,NA,NA,CAS: 110-89-4; PubChem: 4880; ChEBI: 18049; ChEMBL: CHEMBL15487; PDB-CCD: PIP; 3DMET: B00341; NIKKAJI: J2.884C,cpd:C00073; cpd:C00183; cpd:C00431; cpd:C00719; cpd:C00855; cpd:C01616; cpd:C01733; cpd:C01746; cpd:C01799; cpd:C01826; cpd:C01842; cpd:C02989; cpd:C03571; cpd:C03982; cpd:C05335; cpd:C05708; cpd:C06417; cpd:C07115; cpd:C07418; cpd:C07457; cpd:C10917; cpd:C10974; cpd:C11473; cpd:C11474; cpd:C12455; cpd:C15987; cpd:C15998; cpd:C15999; cpd:C16436; cpd:C17241; cpd:C17243; cpd:C17255; cpd:C19150; cpd:C19274; cpd:C19491; cpd:C20312; cpd:C20313; cpd:C20314; cpd:C20809; cpd:C20931,5,11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12N1,C5H10N1,85.08914936,86.09697439,84.081324334141,4512,cpd:C01851,Scopolamine;,C17H21NO4,Scopolamine; (-)-Hyoscine,R03737,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",1.14.11.14,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C01851  Scopolamine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Tropan alkaloids;     C01851  Scopolamine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A04 ANTIEMETICS AND ANTINAUSEANTS;    A04A ANTIEMETICS AND ANTINAUSEANTS;     A04AD Other antiemetics;      A04AD01 Scopolamine;       D00138  Scopolamine (INN);  N NERVOUS SYSTEM;   N05 PSYCHOLEPTICS;    N05C HYPNOTICS AND SEDATIVES;     N05CM Other hypnotics and sedatives;      N05CM05 Scopolamine;       D00138  Scopolamine (INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01F MYDRIATICS AND CYCLOPLEGICS;     S01FA Anticholinergics;      S01FA02 Scopolamine;       D00138  Scopolamine (INN); USP drug classification [BR:br08302];  Antiemetics;   Antiemetics, Other;    Scopolamine;     D00138  Scopolamine (INN);  Gastrointestinal Agents;   Antispasmodics, Gastrointestinal;    Scopolamine;     D00138  Scopolamine (INN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Scopolamine;     D00138  Scopolamine (INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Acetylcholine (muscarinic);     muscarinic cholinergic receptor;      Scopolamine;       D00138  Scopolamine (INN); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     D00138  Scopolamine (INN)",CAS: 51-34-3; PubChem: 4968; ChEBI: 16794; ChEMBL: CHEMBL1187846 CHEMBL1906925 CHEMBL569713; KNApSAcK: C00002292; 3DMET: B04818; NIKKAJI: J47.151H,cpd:C01416; cpd:C01851; cpd:C08523; cpd:C12172; cpd:C18563,17,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H22O4N1,C17H20O4N1,303.1470582,304.1548832,302.13923314142,4513,cpd:C02046,L-Hyoscyamine;,C17H23NO3,L-Hyoscyamine; L-Tropine tropate; Daturine; Duboisine,R03564 R03812 R08434,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",1.14.11.11,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C02046  L-Hyoscyamine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Tropan alkaloids;     C02046  L-Hyoscyamine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;    A03B BELLADONNA AND DERIVATIVES, PLAIN;     A03BA Belladonna alkaloids, tertiary amines;      A03BA03 Hyoscyamine;       D00147  Hyoscyamine (USP); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Acetylcholine (muscarinic);     muscarinic cholinergic receptor;      Hyoscyamine;       D00147  Hyoscyamine (USP); Major components of natural products [BR:br08323];  Crude drugs;   Belladonna extract; Belladonna;    C02046  L-Hyoscyamine;   Belladonna root;    C02046  L-Hyoscyamine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     D00147  Hyoscyamine (USP)",CAS: 101-31-5; PubChem: 5135; ChEBI: 17486; ChEMBL: CHEMBL1331216; KNApSAcK: C00002293; 3DMET: B01527; NIKKAJI: J9.268A,cpd:C01479; cpd:C02046; cpd:C09224; cpd:C10859; cpd:C10860; cpd:C12233; cpd:C14884; cpd:C14908; cpd:C15081,17,23,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H24O3N1,C17H22O3N1,289.1677936,290.1756186,288.15996864143,4514,cpd:C02066,Pseudotropine,C8H15NO,Pseudotropine,R06734 R06736 R06737 R08713,"Tropane, piperidine and pyridine alkaloid biosynthesis",1.1.1.236; 2.3.1.186,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C02066  Pseudotropine,CAS: 135-97-7; PubChem: 5154; ChEBI: 15742; ChEMBL: CHEMBL113555 CHEMBL1356617; KNApSAcK: C00002301; PDB-CCD: PTO; 3DMET: B04837; NIKKAJI: J184.397D,cpd:C00248; cpd:C00729; cpd:C02066; cpd:C06179; cpd:C06182; cpd:C10864; cpd:C11359; cpd:C12440,8,15,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O1N1,C8H14O1N1,141.1153641,142.1231891,140.10753914144,4515,cpd:C02621,13-Hydroxylupanine;,C15H24N2O2,13-Hydroxylupanine; 13-Hydroxylupinine; (+)-13alpha-Hydroxylupanine,R04205 R09050,"Tropane, piperidine and pyridine alkaloid biosynthesis",2.3.1.93,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Quinolizidine alkaloids;     C02621  13-Hydroxylupanine,CAS: 15358-48-2; PubChem: 5604; ChEBI: 18328; KNApSAcK: C00002221; NIKKAJI: J10.354C,cpd:C02621; cpd:C07526; cpd:C10749; cpd:C10769; cpd:C10776; cpd:C17069; cpd:C20233,15,24,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O2N2,C15H23O2N2,264.183778,265.1916031,263.1759534145,4516,cpd:C02723,N-Methylputrescine,C5H14N2,N-Methylputrescine,R01153 R04027 R05334,"Tropane, piperidine and pyridine alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites",1.4.3.21; 2.1.1.53,NA,NA,PubChem: 5685; ChEBI: 17166; KNApSAcK: C00034611; 3DMET: B01597; NIKKAJI: J386.707B,cpd:C01672; cpd:C02723; cpd:C07651,5,14,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H15N2,C5H13N2,102.1156985,103.1235235,101.10787344146,4517,cpd:C03325,(6S)-Hydroxyhyoscyamine;,C17H23NO4,(6S)-Hydroxyhyoscyamine; (6S)-6-Hydroxyhyoscyamine,R03737 R03812,"Tropane, piperidine and pyridine alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites",1.14.11.11; 1.14.11.14,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C03325  (6S)-Hydroxyhyoscyamine,PubChem: 6173; ChEBI: 15645; KNApSAcK: C00002274; 3DMET: B04889; NIKKAJI: J33.369G,cpd:C01564; cpd:C03325; cpd:C10613; cpd:C10710; cpd:C10842; cpd:C10854,17,23,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H24O4N1,C17H22O4N1,305.1627082,306.1705333,304.15488324147,4518,cpd:C03882,Piperine;,C17H19NO3,"Piperine; N-[(E,E)-Piperoyl]piperidine; 1-Piperoyl-piperidine",R03994,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid",2.3.1.145,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C03882  Piperine; Target-based classification of compounds [BR:br08010];  Ion channels;   Related to voltage-gated cation channels;    Transient receptor potential family, TRPV (Vanilloid);     transient receptor potential cation channel, subfamily V, member 1;      C03882  Piperine; Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP1A2;    Piperine;     C03882  Piperine",CAS: 94-62-2; PubChem: 6615; ChEBI: 28821; ChEMBL: CHEMBL43185; KNApSAcK: C00002065; 3DMET: B00649; NIKKAJI: J4.701E,cpd:C01516; cpd:C03882; cpd:C06161; cpd:C06348; cpd:C06349; cpd:C07042; cpd:C08534; cpd:C09422; cpd:C10844; cpd:C12167; cpd:C16576,17,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H20O3N1,C17H18O3N1,285.1364935,286.1443185,284.12866844148,4519,cpd:C04170,13-(2-Methylcrotonoyl)oxylupanine;,C20H30N2O3,13-(2-Methylcrotonoyl)oxylupanine; 13-(2-Methylcrotonoyl)oxylupinine; (+)-13alpha-Tigloyloxylupanine,R04205,"Tropane, piperidine and pyridine alkaloid biosynthesis",2.3.1.93,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Quinolizidine alkaloids;     C04170  13-(2-Methylcrotonoyl)oxylupanine,PubChem: 6851; ChEBI: 18360; NIKKAJI: J586.876I,cpd:C04170,20,30,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O3N2,C20H29O3N2,346.2256428,347.2334679,345.21781784149,4520,cpd:C06176,Senecionine,C18H25NO5,Senecionine,R06726 R07373,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",1.14.13.101,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Pyrrolizidine alkaloids;     C06176  Senecionine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Pyrrolizidine alkaloids;     C06176  Senecionine,CAS: 130-01-8; PubChem: 8427; ChEBI: 9107; ChEMBL: CHEMBL362153; KNApSAcK: C00002116; 3DMET: B01983; NIKKAJI: J2.941F,cpd:C06176; cpd:C10328; cpd:C10393; cpd:C10410,18,25,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H26O5N1,C18H24O5N1,335.1732729,336.1810979,334.16544794150,4521,cpd:C06177,Retronecine,C8H13NO2,Retronecine,R06725 R06726,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Pyrrolizidine alkaloids;     C06177  Retronecine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Pyrrolizidine alkaloids;     C06177  Retronecine,CAS: 480-85-3; PubChem: 8428; ChEBI: 8821; KNApSAcK: C00002108; 3DMET: B01984; NIKKAJI: J12.338B,cpd:C06177; cpd:C10129; cpd:C10321; cpd:C10866,8,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H14O2N1,C8H12O2N1,155.0946287,156.1024537,154.08680364151,4522,cpd:C06179,Hygrine;,C8H15NO,Hygrine; (+)-Hygrine,R06732 R06733,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Pyrrolidine alkaloids;     C06179  Hygrine,CAS: 496-49-1; PubChem: 8430; ChEBI: 46750; KNApSAcK: C00002046; 3DMET: B01985; NIKKAJI: J6.093C,cpd:C00248; cpd:C00729; cpd:C02066; cpd:C06179; cpd:C06182; cpd:C10864; cpd:C11359; cpd:C12440,8,15,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O1N1,C8H14O1N1,141.1153641,142.1231891,140.10753914152,4523,cpd:C06180,Anabasine,C10H14N2,Anabasine,R05128 R06743,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     C06180  Anabasine,CAS: 13078-04-1; PubChem: 8431; ChEBI: 28986; ChEMBL: CHEMBL280963; KNApSAcK: C00002015; 3DMET: B05172; NIKKAJI: J540.732J,cpd:C00214; cpd:C00745; cpd:C00931; cpd:C01056; cpd:C01297; cpd:C03043; cpd:C05131; cpd:C06180; cpd:C06870; cpd:C07826; cpd:C11357; cpd:C15986; cpd:C16150; cpd:C16386; cpd:C16569; cpd:C16744; cpd:C17369; cpd:C17964; cpd:C19086; cpd:C19431; cpd:C20361; cpd:C20822,10,14,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15N2,C10H13N2,162.1156985,163.1235235,161.10787344153,4524,cpd:C06182,Pelletierine,C8H15NO,Pelletierine,R05129 R05130 R05131,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C06182  Pelletierine,CAS: 4396-01-4; PubChem: 8433; ChEBI: 7952; KNApSAcK: C00002062; 3DMET: B05173; NIKKAJI: J113.934G,cpd:C00248; cpd:C00729; cpd:C02066; cpd:C06179; cpd:C06182; cpd:C10864; cpd:C11359; cpd:C12440,8,15,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O1N1,C8H14O1N1,141.1153641,142.1231891,140.10753914154,4525,cpd:C06183,L-(+)-Anaferine;,C13H24N2O,L-(+)-Anaferine; Anapheline,R05130,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C06183  L-(+)-Anaferine,CAS: 19519-53-0; PubChem: 8434; ChEBI: 2702; KNApSAcK: C00002016; 3DMET: B01986; NIKKAJI: J82.871H,cpd:C06183; cpd:C06521; cpd:C11358,13,24,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H25O1N2,C13H23O1N2,224.1888634,225.1966884,223.18103844155,4526,cpd:C06184,N-Methylpelletierine,C9H17NO,N-Methylpelletierine,R05131 R08425,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C06184  N-Methylpelletierine,CAS: 18747-42-7; PubChem: 8435; ChEBI: 7321; 3DMET: B05174; NIKKAJI: J259.505B,cpd:C06184; cpd:C11086,9,17,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H18O1N1,C9H16O1N1,155.1310142,156.1388392,154.12318914156,4527,cpd:C06185,Slaframine;,C10H18N2O2,Slaframine; (-)-Slaframine,R08417,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Indolizidine alkaloids;     C06185  Slaframine,CAS: 20084-93-9; PubChem: 8436; ChEBI: 9173; KNApSAcK: C00002073; 3DMET: B05175; NIKKAJI: J15.531D,cpd:C06185,10,18,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O2N2,C10H17O2N2,198.1368278,199.1446529,197.12900284157,4528,cpd:C06366,sym-Homospermidine;,C8H21N3,sym-Homospermidine; Homospermidine,R00018 R01919 R06724,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",2.5.1.44; 2.5.1.45,NA,NA,CAS: 4427-76-3; PubChem: 8602; ChEBI: 16554; ChEMBL: CHEMBL36119; PDB-CCD: 37Z; 3DMET: B00954; NIKKAJI: J13.626C,cpd:C06366; cpd:C16565,8,21,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H22N3,C8H20N3,159.1735477,160.1813727,158.16572274158,4529,cpd:C06521,Cuscohygrine;,C13H24N2O,Cuscohygrine; Cuskhygrine,R08427,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Pyrrolidine alkaloids;     C06521  Cuscohygrine,CAS: 454-14-8; PubChem: 8752; ChEBI: 27920; KNApSAcK: C00002034; 3DMET: B05209; NIKKAJI: J5.756H,cpd:C06183; cpd:C06521; cpd:C11358,13,24,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H25O1N2,C13H23O1N2,224.1888634,225.1966884,223.18103844159,4530,cpd:C06524,Nornicotine,C9H12N2,Nornicotine,R06738,"Tropane, piperidine and pyridine alkaloid biosynthesis",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     C06524  Nornicotine,CAS: 494-97-3; PubChem: 8755; ChEBI: 28313; ChEMBL: CHEMBL1132; KNApSAcK: C00042792; 3DMET: B05210; NIKKAJI: J6.079H,cpd:C00299; cpd:C00526; cpd:C02067; cpd:C04242; cpd:C05636; cpd:C05638; cpd:C06524; cpd:C11224; cpd:C11360; cpd:C11747; cpd:C12033; cpd:C16634; cpd:C16745; cpd:C19415,9,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13N2,C9H11N2,148.1000484,149.1078734,147.09222344160,4531,cpd:C07475,Lobeline;,C22H27NO2,Lobeline; (-)-Lobeline,R08424,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C07475  Lobeline; Target-based classification of drugs [BR:br08310];  Ion channels;   Cys-loop superfamily;    Acetylcholine (nicotinic);     nicotinic cholinergic receptor;      Lobeline;       D02364  Lobeline (INN); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     D02364  Lobeline (INN),CAS: 90-69-7; PubChem: 9678; ChEBI: 48723; ChEMBL: CHEMBL122270; KNApSAcK: C00002053; PDB-CCD: L0B; 3DMET: B02122; NIKKAJI: J9.320C,cpd:C06938; cpd:C07475,22,27,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H28O2N1,C22H26O2N1,337.2041791,338.2120041,336.19635414161,4532,cpd:C10126,Anatabine;,C10H12N2,Anatabine; (-)-Anatabine,R06779,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     C10126  Anatabine,CAS: 581-49-7; PubChem: 12312; ChEBI: 2705; KNApSAcK: C00002017; 3DMET: B03564; NIKKAJI: J58.211E,cpd:C00328; cpd:C00398; cpd:C00780; cpd:C01718; cpd:C02548; cpd:C02794; cpd:C03227; cpd:C05647; cpd:C05651; cpd:C07147; cpd:C07312; cpd:C07756; cpd:C09907; cpd:C10126; cpd:C10965; cpd:C14302; cpd:C16151; cpd:C16880; cpd:C16906; cpd:C17203; cpd:C18671; cpd:C21075; cpd:C21154,10,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13N2,C10H11N2,160.1000484,161.1078734,159.09222344162,4533,cpd:C10157,Lobelanine,C22H25NO2,Lobelanine,R08423 R08424,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C10157  Lobelanine,CAS: 579-21-5; PubChem: 12343; ChEBI: 6508; ChEMBL: CHEMBL331161; KNApSAcK: C00002052; 3DMET: B03592; NIKKAJI: J215.842F,cpd:C10157,22,25,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H26O2N1,C22H24O2N1,335.188529,336.1963541,334.1807044163,4534,cpd:C10171,(-)-Sedamine,C14H21NO,(-)-Sedamine,R08422,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C10171  (-)-Sedamine,CAS: 497-88-1; PubChem: 12357; ChEBI: 116; ChEMBL: CHEMBL122723; KNApSAcK: C00002072; 3DMET: B03604; NIKKAJI: J15.188B,cpd:C09949; cpd:C10171; cpd:C18760,14,21,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H22O1N1,C14H20O1N1,219.1623143,220.1701393,218.15448934164,4535,cpd:C10173,Swainsonine,C8H15NO3,Swainsonine,R08416,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Indolizidine alkaloids;     C10173  Swainsonine,CAS: 72741-87-8; PubChem: 12359; ChEBI: 9367; ChEMBL: CHEMBL302300 CHEMBL371197 CHEMBL63139 CHEMBL65098; KNApSAcK: C00002075; PDB-CCD: SWA; 3DMET: B03606; NIKKAJI: J12.698E,cpd:C02710; cpd:C10173,8,15,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O3N1,C8H14O3N1,173.1051933,174.1130184,172.09736834165,4536,cpd:C10763,Cytisine,C11H14N2O,Cytisine,R08420,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Quinolizidine alkaloids;     C10763  Cytisine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from lysine;    Quinolizidine alkaloids;     D07770  Cytisine,CAS: 485-35-8; PubChem: 12946; ChEBI: 4055; ChEMBL: CHEMBL47039; KNApSAcK: C00002218; 3DMET: B05480; NIKKAJI: J9.571K,cpd:C05659; cpd:C06212; cpd:C10763; cpd:C13665,11,14,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O1N2,C11H13O1N2,190.1106131,191.1184381,189.1027884166,4537,cpd:C10772,Lupanine;,C15H24N2O,Lupanine; (+)-Lupanine,R08421 R09049 R09050 R09938,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid",1.17.2.2,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Quinolizidine alkaloids;     C10772  Lupanine,CAS: 550-90-3; PubChem: 12955; ChEBI: 28193; ChEMBL: CHEMBL459396; KNApSAcK: C00002225; NIKKAJI: J10.587B,cpd:C10752; cpd:C10772; cpd:C10774; cpd:C17442; cpd:C18158,15,24,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O1N2,C15H23O1N2,248.1888634,249.1966884,247.18103844167,4538,cpd:C10773,Lupinine,C10H19NO,Lupinine,R08418,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Quinolizidine alkaloids;     C10773  Lupinine,CAS: 486-70-4; PubChem: 12956; ChEBI: 28012; ChEMBL: CHEMBL459397; KNApSAcK: C00002226; 3DMET: B04118; NIKKAJI: J37.652C,cpd:C10163; cpd:C10773,10,19,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H20O1N1,C10H18O1N1,169.1466642,170.1544893,168.13883924168,4539,cpd:C10783,(-)-Sparteine;,C15H26N2,(-)-Sparteine; Sparteine,R08419 R08420,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Quinolizidine alkaloids;     C10783  (-)-Sparteine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01B ANTIARRHYTHMICS, CLASS I AND III;     C01BA Antiarrhythmics, class Ia;      C01BA04 Sparteine;       D01041  Sparteine (INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2D6;    Sparteine;     D01041  Sparteine (INN); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from lysine;    Quinolizidine alkaloids;     D01041  Sparteine (INN)",CAS: 90-39-1; PubChem: 12966; ChEBI: 28827; ChEMBL: CHEMBL44625; KNApSAcK: C00002236; NIKKAJI: J4.317F,cpd:C10756; cpd:C10771; cpd:C10780; cpd:C10783; cpd:C17418; cpd:C17970,15,26,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27N2,C15H25N2,234.2095988,235.2174239,233.20177384169,4540,cpd:C10850,Calystegin A3;,C7H13NO3,Calystegin A3; Calystegine A3,R06737,"Tropane, piperidine and pyridine alkaloid biosynthesis",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C10850  Calystegin A3,CAS: 131580-36-4; PubChem: 13033; ChEBI: 3336; KNApSAcK: C00002282; 3DMET: B05496; NIKKAJI: J890.605J,cpd:C02712; cpd:C03087; cpd:C08269; cpd:C10151; cpd:C10850,7,13,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O3N1,C7H12O3N1,159.0895433,160.0973683,158.08171824170,4541,cpd:C10858,Ecgonine,C9H15NO3,Ecgonine,R06729 R06730,"Tropane, piperidine and pyridine alkaloid biosynthesis",3.1.1.-; 5.1.-.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C10858  Ecgonine,CAS: 481-37-8; PubChem: 13041; ChEBI: 4743; ChEMBL: CHEMBL612017; KNApSAcK: C00002291; 3DMET: B05504; NIKKAJI: J12.430C,cpd:C10356; cpd:C10858; cpd:C12449; cpd:C20673,9,15,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16O3N1,C9H14O3N1,185.1051933,186.1130184,184.09736834171,4542,cpd:C10860,Littorine,C17H23NO3,Littorine,R08432 R08434,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",2.3.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C10860  Littorine,CAS: 21956-47-8; PubChem: 13043; ChEBI: 6506; KNApSAcK: C00002295; 3DMET: B05506; NIKKAJI: J15.896H,cpd:C01479; cpd:C02046; cpd:C09224; cpd:C10859; cpd:C10860; cpd:C12233; cpd:C14884; cpd:C14908; cpd:C15081,17,23,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H24O3N1,C17H22O3N1,289.1677936,290.1756186,288.15996864172,4543,cpd:C10865,Pseudopelletierine,C9H15NO,Pseudopelletierine,R08425,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Piperidine alkaloids;     C10865  Pseudopelletierine,CAS: 552-70-5; PubChem: 13048; ChEBI: 8607; ChEMBL: CHEMBL1329064; KNApSAcK: C00002300; 3DMET: B05511; NIKKAJI: J14.215H,cpd:C10865,9,15,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16O1N1,C9H14O1N1,153.1153641,154.1231891,152.10753914173,4544,cpd:C12440,Trachelanthamidine,C8H15NO,Trachelanthamidine,R06724 R06725,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Pyrrolizidine alkaloids;     C12440  Trachelanthamidine,CAS: 526-64-7; PubChem: 582830; ChEBI: 32249; 3DMET: B04519; NIKKAJI: J8.644D,cpd:C00248; cpd:C00729; cpd:C02066; cpd:C06179; cpd:C06182; cpd:C10864; cpd:C11359; cpd:C12440,8,15,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O1N1,C8H14O1N1,141.1153641,142.1231891,140.10753914174,4545,cpd:C12448,Ecgonine methyl ester;,C10H17NO3,Ecgonine methyl ester; Methyl ecgonine,R06728 R06729 R08429 R08430 R10114,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Metabolic pathways; Biosynthesis of secondary metabolites",1.1.1.334; 2.3.1.-; 3.1.1.1; 3.1.1.84; 3.1.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C12448  Ecgonine methyl ester,CAS: 7143-09-1; PubChem: 582838; ChEBI: 31529; ChEMBL: CHEMBL1232472 CHEMBL612016; PDB-CCD: ECG; 3DMET: B05640; NIKKAJI: J276.362A,cpd:C10411; cpd:C12448; cpd:C21197,10,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O3N1,C10H16O3N1,199.1208434,200.1286684,198.11301844175,4546,cpd:C12449,Pseudoecgonine,C9H15NO3,Pseudoecgonine,R06730 R06731,"Tropane, piperidine and pyridine alkaloid biosynthesis",5.1.-.-; 6.2.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C12449  Pseudoecgonine,PubChem: 582839; ChEBI: 32072; 3DMET: B05641; NIKKAJI: J122.031D,cpd:C10356; cpd:C10858; cpd:C12449; cpd:C20673,9,15,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16O3N1,C9H14O3N1,185.1051933,186.1130184,184.09736834176,4547,cpd:C12450,Pseudoecgonyl-CoA,C30H49N8O18P3S,Pseudoecgonyl-CoA,R06731,"Tropane, piperidine and pyridine alkaloid biosynthesis",6.2.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C12450  Pseudoecgonyl-CoA,PubChem: 582840; ChEBI: 32073; 3DMET: B05642; NIKKAJI: J2.783.623B,cpd:C12450,30,49,18,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H50O18N8P3S1,C30H48O18N8P3S1,934.2098389,935.217664,933.20201394177,4548,cpd:C12452,Acetyltropine;,C10H17NO2,Acetyltropine; 3-Acetyltropine,R06735,"Tropane, piperidine and pyridine alkaloid biosynthesis",2.3.1.185,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C12452  Acetyltropine,CAS: 3423-27-6; PubChem: 582842; ChEMBL: CHEMBL193341; KNApSAcK: C00025551; 3DMET: B05643; NIKKAJI: J132.951K,cpd:C12452; cpd:C12453,10,17,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O2N1,C10H16O2N1,183.1259288,184.1337538,182.11810384178,4549,cpd:C12453,Acetylpseudotropine,C10H17NO2,Acetylpseudotropine,R06736,"Tropane, piperidine and pyridine alkaloid biosynthesis",2.3.1.186,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Tropane alkaloids;     C12453  Acetylpseudotropine,CAS: 3423-26-5; PubChem: 582843; ChEBI: 31167; ChEMBL: CHEMBL193341; KNApSAcK: C00025556; 3DMET: B05644; NIKKAJI: J132.951K,cpd:C12452; cpd:C12453,10,17,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O2N1,C10H16O2N1,183.1259288,184.1337538,182.11810384179,4550,cpd:C12454,Anatalline,C15H17N3,Anatalline,R06743,"Tropane, piperidine and pyridine alkaloid biosynthesis",NA,NA,NA,PubChem: 582844; ChEBI: 31211; KNApSAcK: C00025768; 3DMET: B05645; NIKKAJI: J92.905K,cpd:C11121; cpd:C12454; cpd:C13716; cpd:C13796; cpd:C18720; cpd:C21162; cpd:C21163,15,17,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H18N3,C15H16N3,239.1422476,240.1500726,238.13442254180,4551,cpd:C12455,5-Aminopentanal,C5H11NO,5-Aminopentanal,R06740 R06741,"Tropane, piperidine and pyridine alkaloid biosynthesis; Metabolic pathways; Biosynthesis of secondary metabolites",1.4.3.21,NA,NA,PubChem: 582845; ChEBI: 31130; 3DMET: B04521; NIKKAJI: J492.786I,cpd:C01842; cpd:C03982; cpd:C10974; cpd:C12455; cpd:C17241; cpd:C17243; cpd:C17255; cpd:C19274; cpd:C19491; cpd:C20312,5,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O1N1,C5H10O1N1,101.084064,102.091889,100.07623894181,4552,cpd:C15612,Senecionine N-oxide,C18H25NO6,Senecionine N-oxide,R07373,"Tropane, piperidine and pyridine alkaloid biosynthesis",1.14.13.101,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Pyrrolizidine alkaloids;     C15612  Senecionine N-oxide,PubChem: 17396603; ChEBI: 52070; ChEMBL: CHEMBL471683; NIKKAJI: J371.923E,cpd:C10277; cpd:C10279; cpd:C10339; cpd:C10364; cpd:C10413; cpd:C15612,18,25,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H26O6N1,C18H24O6N1,351.1681875,352.1760126,350.16036254182,4553,cpd:C16257,(R)-Phenyllactyl-CoA,C30H44N7O18P3S,(R)-Phenyllactyl-CoA,R07796 R08432,"Tropane, piperidine and pyridine alkaloid biosynthesis",2.3.1.-; 2.8.3.17,NA,NA,PubChem: 47205565; ChEBI: 11010; NIKKAJI: J2.799.274I,cpd:C16257; cpd:C21313,30,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H45O18N7P3S1,C30H43O18N7P3S1,915.1676398,916.1754648,914.15981474183,4554,cpd:C16671,"3,6-Dihydronicotinic acid",C6H7NO2,"3,6-Dihydronicotinic acid",R08426 R09051,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of secondary metabolites",NA,NA,NA,PubChem: 51090994; ChEBI: 80653; NIKKAJI: J492.788E,cpd:C02441; cpd:C02854; cpd:C14602; cpd:C14604; cpd:C16671; cpd:C18351,6,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O2N1,C6H6O2N1,125.0476785,126.0555035,124.03985344184,4555,cpd:C16697,1-Indolizidinone;,C8H13NO,1-Indolizidinone; 1-Ketooctahydroindolizine,R08415 R08416 R08417,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,NA,PubChem: 51091019; ChEBI: 80665; NIKKAJI: J2.783.733F,cpd:C00783; cpd:C10400; cpd:C16697,8,13,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H14O1N1,C8H12O1N1,139.099714,140.1075391,138.0918894185,4556,cpd:C16933,"3,6-Dihydropyridine",C5H7N,"3,6-Dihydropyridine",R06779 R09051,"Tropane, piperidine and pyridine alkaloid biosynthesis; Biosynthesis of secondary metabolites",NA,NA,NA,PubChem: 96023425; ChEBI: 80807; NIKKAJI: J469.501A,cpd:C00940; cpd:C01044; cpd:C01843; cpd:C01877; cpd:C01879; cpd:C02237; cpd:C03541; cpd:C03564; cpd:C03801; cpd:C03912; cpd:C04281; cpd:C04282; cpd:C04322; cpd:C04445; cpd:C05572; cpd:C05723; cpd:C05929; cpd:C07275; cpd:C16817; cpd:C16933; cpd:C20317,5,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H8N1,C5H6N1,81.05784923,82.06567426,80.05002424186,4557,cpd:C18158,17-Oxosparteine,C15H24N2O,17-Oxosparteine,R09048 R09049,"Tropane, piperidine and pyridine alkaloid biosynthesis",NA,NA,NA,PubChem: 96024375; ChEBI: 81549; NIKKAJI: J102.990H,cpd:C10752; cpd:C10772; cpd:C10774; cpd:C17442; cpd:C18158,15,24,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O1N2,C15H23O1N2,248.1888634,249.1966884,247.18103844187,4558,cpd:C08537,Amaranthin,C30H34N2O19,Amaranthin,R08818 R08819 R08824,Betalain biosynthesis,2.3.1.-; 2.4.1.-,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Betalains;    Betacyanins;     C08537  Amaranthin,CAS: 15167-84-7; PubChem: 10730; ChEBI: 2621; KNApSAcK: C00001581; 3DMET: B02207; NIKKAJI: J139.428B,cpd:C08537,30,34,19,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H35O19N2,C30H33O19N2,726.1755769,727.1834019,725.16775184188,4559,cpd:C08538,Betalamic acid,C9H9NO5,Betalamic acid,R08818 R08820 R08821 R08825 R08827 R08831 R08834 R08835; R08837,Betalain biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Betalains;    Others;     C08538  Betalamic acid,CAS: 18766-66-0; PubChem: 10731; ChEBI: 27483; KNApSAcK: C00001582; 3DMET: B02208; NIKKAJI: J373.303C,cpd:C04720; cpd:C05654; cpd:C08538,9,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O5N1,C9H8O5N1,211.0480724,212.0558974,210.04024744189,4560,cpd:C08539,Betanidin;,C18H16N2O8,"Betanidin; (2S)-4-[2-[(2S)-2-Carboxy-2,3-dihydro-5,6-dihydroxy-1H-indol-1-yl]ethenyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",R08821 R08822 R08829 R08830,Betalain biosynthesis; Biosynthesis of secondary metabolites,2.4.1.-,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Betalains;    Betacyanins;     C08539  Betanidin,CAS: 2181-76-2; PubChem: 10732; ChEBI: 3079; KNApSAcK: C00001583; 3DMET: B02209; NIKKAJI: J325.712F,cpd:C08539; cpd:C17753,18,16,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H17O8N2,C18H15O8N2,388.0906655,389.0984905,387.08284044190,4561,cpd:C08540,Betanin,C24H26N2O13,Betanin,R08820 R08822 R08823 R08824,Betalain biosynthesis; Biosynthesis of secondary metabolites,2.3.1.-; 2.4.1.-,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Betalains;    Betacyanins;     C08540  Betanin,CAS: 7659-95-2; PubChem: 10733; ChEBI: 3080; ChEMBL: CHEMBL1172614; KNApSAcK: C00001584; 3DMET: B02210; NIKKAJI: J208.046J,cpd:C08540; cpd:C08544; cpd:C08551,24,26,13,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H27O13N2,C24H25O13N2,550.1434889,551.1513139,549.13566394191,4562,cpd:C08542,Celosianin II,C40H42N2O22,Celosianin II,R08819,Betalain biosynthesis,2.3.1.-,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Betalains;    Betacyanins;     C08542  Celosianin II,CAS: 114847-18-6; PubChem: 10735; ChEBI: 3530; KNApSAcK: C00001586; 3DMET: B02212; NIKKAJI: J1.529.028E,cpd:C08542,40,42,22,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H43O22N2,C40H41O22N2,902.222921,903.230746,901.2150964192,4563,cpd:C08543,Dopaxanthin,C18H18N2O8,Dopaxanthin,R08826 R08827 R08828,Betalain biosynthesis; Biosynthesis of secondary metabolites,1.10.3.-; 1.14.18.-,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Betalains;    Betaxanthins;     C08543  Dopaxanthin,CAS: 71199-31-0; PubChem: 10736; ChEBI: 4700; KNApSAcK: C00001587; 3DMET: B02213; NIKKAJI: J18.773I,cpd:C08543,18,18,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H19O8N2,C18H17O8N2,390.1063155,391.1141406,389.09849054193,4564,cpd:C08544,Gomphrenin-I,C24H26N2O13,Gomphrenin-I,R08830,Betalain biosynthesis,2.4.1.-,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Betalains;    Betacyanins;     C08544  Gomphrenin-I,CAS: 17008-59-2; PubChem: 10737; ChEBI: 5518; KNApSAcK: C00001588; 3DMET: B02214; NIKKAJI: J624.061E,cpd:C08540; cpd:C08544; cpd:C08551,24,26,13,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H27O13N2,C24H25O13N2,550.1434889,551.1513139,549.13566394194,4565,cpd:C08552,Lampranthin II,C34H34N2O16,Lampranthin II,R08823,Betalain biosynthesis,2.3.1.-,NA,NA,CAS: 32074-65-0; PubChem: 10745; ChEBI: 6368; KNApSAcK: C00001594; 3DMET: B02220; NIKKAJI: J338.613I,cpd:C08547; cpd:C08552,34,34,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H35O16N2,C34H33O16N2,726.190833,727.1986581,725.1830084195,4566,cpd:C08557,Miraxanthin-V,C17H18N2O6,Miraxanthin-V,R08835,Betalain biosynthesis; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Betalains;    Betaxanthins;     C08557  Miraxanthin-V,CAS: 5375-64-4; PubChem: 10750; ChEBI: 6948; KNApSAcK: C00001598; 3DMET: B05266; NIKKAJI: J412.458H,cpd:C06869; cpd:C07266; cpd:C08557,17,18,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H19O6N2,C17H17O6N2,346.1164863,347.1243113,345.10866134196,4567,cpd:C08565,Portulacaxanthin II,C18H18N2O7,Portulacaxanthin II,R08825 R08826,Betalain biosynthesis; Biosynthesis of secondary metabolites,1.14.18.-,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Betalains;    Betaxanthins;     C08565  Portulacaxanthin II,CAS: 135545-98-1; PubChem: 10758; ChEBI: 8341; KNApSAcK: C00001604; 3DMET: B02226; NIKKAJI: J410.417J,cpd:C08565,18,18,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H19O7N2,C18H17O7N2,374.1114009,375.119226,373.10357594197,4568,cpd:C17751,cyclo-Dopa 5-O-glucoside,C15H19NO9,cyclo-Dopa 5-O-glucoside,R08816 R08817 R08820,Betalain biosynthesis,2.4.1.-,NA,NA,PubChem: 96024078; ChEBI: 81316; NIKKAJI: J1.475.643D,cpd:C17751,15,19,9,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H20O9N1,C15H18O9N1,357.1059812,358.1138062,356.09815624198,4569,cpd:C17752,cyclo-Dopa-glucuronylglucoside,C21H27NO15,cyclo-Dopa-glucuronylglucoside,R08817 R08818,Betalain biosynthesis,2.4.1.-,NA,NA,PubChem: 96024079; ChEBI: 81317,cpd:C17752,21,27,15,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H28O15N1,C21H26O15N1,533.1380692,534.1458942,532.13024414199,4570,cpd:C17753,Dopaxanthin quinone,C18H16N2O8,Dopaxanthin quinone,R08826 R08828 R08829,Betalain biosynthesis; Biosynthesis of secondary metabolites,1.10.3.-; 1.14.18.-,NA,NA,PubChem: 96024080; ChEBI: 81318,cpd:C08539; cpd:C17753,18,16,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H17O8N2,C18H15O8N2,388.0906655,389.0984905,387.08284044200,4571,cpd:C17754,3-Methoxytyramine-betaxanthin,C18H20N2O6,3-Methoxytyramine-betaxanthin,R08831,Betalain biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Betalains;    Betaxanthins;     C17754  3-Methoxytyramine-betaxanthin,PubChem: 96024081; ChEBI: 81319; NIKKAJI: J1.667.336F,cpd:C07713; cpd:C17754,18,20,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H21O6N2,C18H19O6N2,360.1321364,361.1399614,359.12431134201,4572,cpd:C17755,Dopamine quinone,C8H9NO2,Dopamine quinone,R08832 R08833,Betalain biosynthesis,1.10.3.-,NA,NA,CAS: 50673-96-6; PubChem: 96024082; ChEBI: 74684; NIKKAJI: J646.351G,cpd:C02012; cpd:C02709; cpd:C03005; cpd:C03522; cpd:C04350; cpd:C04353; cpd:C06804; cpd:C07301; cpd:C16571; cpd:C17239; cpd:C17755; cpd:C17756; cpd:C18623; cpd:C20634,8,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O2N1,C8H8O2N1,151.0633285,152.0711536,150.05550354202,4573,cpd:C17756,2-Descarboxy-cyclo-dopa;,C8H9NO2,"2-Descarboxy-cyclo-dopa; Indoline-5,6-diol; 5,6-Indolinediol",R08833 R08834,Betalain biosynthesis,NA,NA,NA,CAS: 29539-03-5; PubChem: 96024083; ChEBI: 74683; NIKKAJI: J88.608D,cpd:C02012; cpd:C02709; cpd:C03005; cpd:C03522; cpd:C04350; cpd:C04353; cpd:C06804; cpd:C07301; cpd:C16571; cpd:C17239; cpd:C17755; cpd:C17756; cpd:C18623; cpd:C20634,8,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O2N1,C8H8O2N1,151.0633285,152.0711536,150.05550354203,4574,cpd:C17757,2-Descarboxy-betanidin,C17H17N2O6,2-Descarboxy-betanidin,R08834,Betalain biosynthesis,NA,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Betalains;    Betacyanins;     C17757  2-Descarboxy-betanidin,PubChem: 96024084; ChEBI: 81320; NIKKAJI: J1.549.411E,cpd:C17757,17,17,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H18O6N2,C17H16O6N2,345.1086613,346.1164863,344.10083624204,4575,cpd:C17758,"4,5-seco-Dopa",C9H11NO6,"4,5-seco-Dopa",R08836 R08837,Betalain biosynthesis,1.13.11.-,NA,NA,PubChem: 96024085; ChEBI: 16098; NIKKAJI: J2.751.701C,cpd:C04796; cpd:C04797; cpd:C17758,9,11,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O6N1,C9H10O6N1,229.0586371,230.0664621,228.0508124205,4576,cpd:C01069,Desulfoglucotropeolin,C14H19NO6S,Desulfoglucotropeolin,R03213 R03214,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.4.1.195; 2.8.2.24,NA,NA,PubChem: 4308; ChEBI: 15911; NIKKAJI: J2.731.144J,cpd:C01069,14,19,6,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C14H20O6N1S1,C14H18O6N1S1,329.0933085,330.1011335,328.08548354206,4577,cpd:C02153,Glucotropaeolin;,C14H19NO9S2,Glucotropaeolin; Glucotropeolin; Benzyl glucosinolate,R03214,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.8.2.24,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from phenylalanine;     C02153  Benzyl glucosinolate,CAS: 499-26-3; PubChem: 5230; ChEBI: 17127; KNApSAcK: C00007346; NIKKAJI: J473.415G,cpd:C02153,14,19,9,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C14H20O9N1S2,C14H18O9N1S2,409.0501235,410.0579486,408.04229854207,4578,cpd:C03719,Phenylacetothiohydroximate,C8H9NOS,Phenylacetothiohydroximate,R03213 R08654,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.4.1.195; 4.4.1.-,NA,NA,PubChem: 6485; ChEBI: 17520; KNApSAcK: C00007672; 3DMET: B00626; NIKKAJI: J2.745.198E,cpd:C03719,8,9,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O1N1S1,C8H8O1N1S1,167.0404851,168.0483101,166.03266014208,4579,cpd:C08401,Glucoberteroin;,C13H25NO9S3,Glucoberteroin; 5-Methylthiopentyl glucosinolate,NA,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,NA,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from methionine;     C08401  5-Methylthiopentyl glucosinolate,CAS: 29611-01-6; PubChem: 10597; ChEBI: 5396 79324; KNApSAcK: C00007593; NIKKAJI: J2.736.865D,cpd:C08401,13,25,9,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C13H26O9N1S3,C13H24O9N1S3,435.0691449,436.0769699,434.06131994209,4580,cpd:C08407,Glucocochlearin;,C11H21NO9S2,Glucocochlearin; 1-Methylpropyl glucosinolate,NA,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,NA,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from isoleucine;     C08407  1-Methylpropyl glucosinolate,CAS: 499-24-1; PubChem: 10603; ChEBI: 5402 79329; NIKKAJI: J2.359.684I,cpd:C08407; cpd:C17256,11,21,9,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C11H22O9N1S2,C11H20O9N1S2,375.0657736,376.0735986,374.05794864210,4581,cpd:C08409,Glucoerucin;,C12H23NO9S3,Glucoerucin; 4-Methylthiobutyl glucosinolate,R08671,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.8.2.-,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from methionine;     C08409  4-Methylthiobutyl glucosinolate,CAS: 21973-56-8; PubChem: 10605; ChEBI: 5404 79325; KNApSAcK: C00007344; NIKKAJI: J225.496D,cpd:C08409,12,23,9,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O9N1S3,C12H22O9N1S3,421.0534948,422.0613199,420.04566984211,4582,cpd:C08412,Glucoiberverin;,C11H21NO9S3,Glucoiberverin; 3-Methylthiopropyl glucosinolate,R08669,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.8.2.-,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from methionine;     C08412  3-Methylthiopropyl glucosinolate,CAS: 26888-03-9; PubChem: 10608; ChEBI: 5407 79326; KNApSAcK: C00001473; NIKKAJI: J700.062F,cpd:C08412,11,21,9,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C11H22O9N1S3,C11H20O9N1S3,407.0378448,408.0456698,406.03001974212,4583,cpd:C08417,Gluconasturtiin;,C15H21NO9S2,Gluconasturtiin; 2-Phenylethyl glucosinolate,NA,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,NA,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from phenylalanine;     C08417  2-Phenylethyl glucosinolate,CAS: 499-30-9; PubChem: 10613; ChEBI: 5413 79347; KNApSAcK: C00007350; NIKKAJI: J390.323K,cpd:C08417,15,21,9,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C15H22O9N1S2,C15H20O9N1S2,423.0657736,424.0735986,422.05794864213,4584,cpd:C08418,Glucoputranjivin;,C10H19NO9S2,Glucoputranjivin; 1-Methylethyl glucosinolate,NA,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,NA,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from valine;     C08418  Glucoputranjivin,CAS: 18432-16-1; PubChem: 10614; ChEBI: 5414 79331; KNApSAcK: C00001479; NIKKAJI: J2.766.020G,cpd:C08418,10,19,9,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C10H20O9N1S2,C10H18O9N1S2,361.0501235,362.0579486,360.04229854214,4585,cpd:C08426,Sinalbin;,C14H19NO10S2,Sinalbin; p-Hydroxybenzyl glucosinolate,R08662,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.8.2.-,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from tyrosine;     C08426  p-Hydroxybenzyl glucosinolate,CAS: 20196-67-2; PubChem: 10621; ChEBI: 9151; KNApSAcK: C00001487; NIKKAJI: J493.608F,cpd:C08426,14,19,10,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C14H20O10N1S2,C14H18O10N1S2,425.0450382,426.0528632,424.03721314215,4586,cpd:C17210,2-(2'-Methylthio)ethylmalic acid;,C7H12O5S,2-(2'-Methylthio)ethylmalic acid; 2-(2'-Methylthio)ethylmalate,R08619 R08620,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.3.3.17; 4.2.1.170,NA,NA,PubChem: 96023618; ChEBI: 50261; KNApSAcK: C00007647; NIKKAJI: J2.805.977I,cpd:C17210; cpd:C17212,7,12,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O5S1,C7H11O5S1,208.0405447,209.0483697,207.03271964216,4587,cpd:C17211,2-Oxo-5-methylthiopentanoic acid;,C6H10O3S,2-Oxo-5-methylthiopentanoic acid; 5-(Methylthio)-2-oxo-pentanoic acid,R08621 R08622 R08623,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.1.1.-; 2.3.3.17; 2.6.1.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C17211  2-Oxo-5-methylthiopentanoic acid,PubChem: 96023619; ChEBI: 50260; KNApSAcK: C00007476; NIKKAJI: J2.805.979E,cpd:C03895; cpd:C05535; cpd:C15606; cpd:C15653; cpd:C17211; cpd:C21378,6,10,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O3S1,C6H9O3S1,162.0350654,163.0428904,161.02724034217,4588,cpd:C17212,3-(2'-Methylthio)ethylmalic acid;,C7H12O5S,3-(2'-Methylthio)ethylmalic acid; 3-(2'-Methylthio)ethylmalate,R08620 R08621,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.1.1.-; 4.2.1.170,NA,NA,PubChem: 96023620; ChEBI: 80963; NIKKAJI: J2.805.980I,cpd:C17210; cpd:C17212,7,12,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O5S1,C7H11O5S1,208.0405447,209.0483697,207.03271964218,4589,cpd:C17213,Homomethionine,C6H13NO2S,Homomethionine,R08622 R08665,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.14.13.-; 2.6.1.-,NA,NA,PubChem: 96023621; ChEBI: 50707; NIKKAJI: J16.130F,cpd:C11227; cpd:C17213,6,13,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O2N1S1,C6H12O2N1S1,163.0666998,164.0745249,162.05887484219,4590,cpd:C17214,2-(3'-Methylthio)propylmalic acid;,C8H14O5S,2-(3'-Methylthio)propylmalic acid; 2-(3'-Methylthio)propylmalate,R08623 R08624,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,2.3.3.17; 4.2.1.170,NA,NA,PubChem: 96023622; ChEBI: 50262; KNApSAcK: C00007646; NIKKAJI: J2.805.984A,cpd:C00669; cpd:C17214; cpd:C17215,8,14,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O5S1,C8H13O5S1,222.0561947,223.0640198,221.04836974220,4591,cpd:C17215,3-(3'-Methylthio)propylmalic acid;,C8H14O5S,3-(3'-Methylthio)propylmalic acid; 3-(3'-Methylthio)propylmalate,R08624 R08625,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.1.1.-; 4.2.1.170,NA,NA,PubChem: 96023623; ChEBI: 80964; NIKKAJI: J2.805.985J,cpd:C00669; cpd:C17214; cpd:C17215,8,14,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O5S1,C8H13O5S1,222.0561947,223.0640198,221.04836974221,4592,cpd:C17216,2-Oxo-6-methylthiohexanoic acid;,C7H12O3S,2-Oxo-6-methylthiohexanoic acid; 6-(Methylthio)-2-oxo-hexanoic acid,R08625 R08626 R08627,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.1.1.-; 2.3.3.17; 2.6.1.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C17216  2-Oxo-6-methylthiohexanoic acid,PubChem: 96023624; ChEBI: 80965; KNApSAcK: C00007648; NIKKAJI: J2.805.986H,cpd:C17216,7,12,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O3S1,C7H11O3S1,176.0507154,177.0585405,175.04289044222,4593,cpd:C17217,Dihomomethionine,C7H15NO2S,Dihomomethionine,R08626 R08670,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.13.-; 2.6.1.-,NA,NA,PubChem: 96023625; ChEBI: 50710; KNApSAcK: C00007594; NIKKAJI: J1.570.412H,cpd:C17217,7,15,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O2N1S1,C7H14O2N1S1,177.0823499,178.0901749,176.07452494223,4594,cpd:C17218,2-(4'-Methylthio)butylmalic acid;,C9H16O5S,2-(4'-Methylthio)butylmalic acid; 2-(4'-Methylthio)butylmalate,R08627 R08628,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,2.3.3.17; 4.2.1.170,NA,NA,PubChem: 96023626; ChEBI: 80966; KNApSAcK: C00007644; NIKKAJI: J2.805.987F,cpd:C17218; cpd:C17219,9,16,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O5S1,C9H15O5S1,236.0718448,237.0796698,235.06401984224,4595,cpd:C17219,3-(4'-Methylthio)butylmalic acid;,C9H16O5S,3-(4'-Methylthio)butylmalic acid; 3-(4'-Methylthio)butylmalate,R08628 R08629,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.1.1.-; 4.2.1.170,NA,NA,PubChem: 96023627; ChEBI: 80967; NIKKAJI: J2.806.001G,cpd:C17218; cpd:C17219,9,16,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O5S1,C9H15O5S1,236.0718448,237.0796698,235.06401984225,4596,cpd:C17220,2-Oxo-7-methylthioheptanoic acid;,C8H14O3S,2-Oxo-7-methylthioheptanoic acid; 7-(Methylthio)-2-oxo-heptanoic acid,R08629 R08630 R08631,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.1.1.-; 2.3.3.17; 2.6.1.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C17220  2-Oxo-7-methylthioheptanoic acid,PubChem: 96023628; ChEBI: 80968; KNApSAcK: C00007645; NIKKAJI: J2.806.002E,cpd:C17220,8,14,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O3S1,C8H13O3S1,190.0663655,191.0741905,189.05854054226,4597,cpd:C17221,Trihomomethionine;,C8H17NO2S,Trihomomethionine; 2-Amino-7-(methylsulfanyl)heptanoic acid,R08630 R08672,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.13.-; 2.6.1.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0110 Amino fatty acids;     C17221  2-Amino-7-(methylsulfanyl)heptanoic acid,PubChem: 96023629; ChEBI: 50711; NIKKAJI: J1.570.413F,cpd:C17221,8,17,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C8H18O2N1S1,C8H16O2N1S1,191.098,192.105825,190.09017494227,4598,cpd:C17222,2-(5'-Methylthio)pentylmalic acid;,C10H18O5S,2-(5'-Methylthio)pentylmalic acid; 2-(5'-Methylthio)pentylmalate,R08631 R08634,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,2.3.3.17; 4.2.1.170,NA,NA,PubChem: 96023630; ChEBI: 80969; KNApSAcK: C00007642; NIKKAJI: J2.806.003C,cpd:C17222; cpd:C17223; cpd:C19689,10,18,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O5S1,C10H17O5S1,250.0874949,251.0953199,249.07966984228,4599,cpd:C17223,3-(5'-Methylthio)pentylmalic acid;,C10H18O5S,3-(5'-Methylthio)pentylmalic acid; 3-(5'-Methylthio)pentylmalate,R08634 R08636,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.1.1.-; 4.2.1.170,NA,NA,PubChem: 96023631; ChEBI: 80970; NIKKAJI: J2.806.004A,cpd:C17222; cpd:C17223; cpd:C19689,10,18,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O5S1,C10H17O5S1,250.0874949,251.0953199,249.07966984229,4600,cpd:C17224,2-Oxo-8-methylthiooctanoic acid;,C9H16O3S,2-Oxo-8-methylthiooctanoic acid; 8-Methylthio-2-octanoic acid,R08636 R08638 R08640,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.1.1.-; 2.3.3.17; 2.6.1.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C17224  2-Oxo-8-methylthiooctanoic acid,PubChem: 96023632; ChEBI: 80971; KNApSAcK: C00007643; NIKKAJI: J2.806.018A,cpd:C17224,9,16,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C9H17O3S1,C9H15O3S1,204.0820155,205.0898406,203.07419054230,4601,cpd:C17225,Tetrahomomethionine,C9H19NO2S,Tetrahomomethionine,R08638 R08673,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.13.-; 2.6.1.-,NA,NA,PubChem: 96023633; ChEBI: 50712; NIKKAJI: J2.806.043B,cpd:C17225,9,19,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C9H20O2N1S1,C9H18O2N1S1,205.11365,206.1214751,204.1058254231,4602,cpd:C17226,2-(6'-Methylthio)hexylmalic acid;,C11H20O5S,2-(6'-Methylthio)hexylmalic acid; 2-(6'-Methylthio)hexylmalate,R08640 R08641,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,2.3.3.17; 4.2.1.170,NA,NA,PubChem: 96023634; ChEBI: 80972; KNApSAcK: C00007653; NIKKAJI: J2.806.057B,cpd:C17226; cpd:C17227,11,20,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H21O5S1,C11H19O5S1,264.1031449,265.1109699,263.09531994232,4603,cpd:C17227,3-(6'-Methylthio)hexylmalic acid;,C11H20O5S,3-(6'-Methylthio)hexylmalic acid; 3-(6'-Methylthio)hexylmalate,R08641 R08642,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.1.1.-; 4.2.1.170,NA,NA,PubChem: 96023635; ChEBI: 80973; NIKKAJI: J2.806.075K,cpd:C17226; cpd:C17227,11,20,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H21O5S1,C11H19O5S1,264.1031449,265.1109699,263.09531994233,4604,cpd:C17228,2-Oxo-9-methylthiononanoic acid;,C10H18O3S,2-Oxo-9-methylthiononanoic acid; 9-Methylthio-2-nonanoic acid,R08642 R08643 R08644,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.1.1.-; 2.3.3.17; 2.6.1.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C17228  2-Oxo-9-methylthiononanoic acid,PubChem: 96023636; ChEBI: 80974; KNApSAcK: C00007654; NIKKAJI: J2.806.101C,cpd:C17228,10,18,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O3S1,C10H17O3S1,218.0976656,219.1054906,217.08984064234,4605,cpd:C17229,Pentahomomethionine,C10H21NO2S,Pentahomomethionine,R08643 R08674,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.13.-; 2.6.1.-,NA,NA,PubChem: 96023637; ChEBI: 50713; KNApSAcK: C00007652; NIKKAJI: J2.806.127G,cpd:C17229,10,21,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H22O2N1S1,C10H20O2N1S1,219.1293001,220.1371251,218.12147514235,4606,cpd:C17230,2-(7'-Methylthio)heptylmalic acid;,C12H22O5S,2-(7'-Methylthio)heptylmalic acid; 2-(7'-Methylthio)heptylmalate,R08644 R08645,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,2.3.3.17; 4.2.1.170,NA,NA,PubChem: 96023638; ChEBI: 80975; KNApSAcK: C00007650; NIKKAJI: J2.806.128E,cpd:C17230; cpd:C17231,12,22,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O5S1,C12H21O5S1,278.118795,279.12662,277.11096994236,4607,cpd:C17231,3-(7'-Methylthio)heptylmalic acid;,C12H22O5S,3-(7'-Methylthio)heptylmalic acid; 3-(7'-Methylthio)heptylmalate,R08645 R08646,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.1.1.-; 4.2.1.170,NA,NA,PubChem: 96023639; ChEBI: 80976; NIKKAJI: J2.806.164A,cpd:C17230; cpd:C17231,12,22,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H23O5S1,C12H21O5S1,278.118795,279.12662,277.11096994237,4608,cpd:C17232,2-Oxo-10-methylthiodecanoic acid;,C11H20O3S,2-Oxo-10-methylthiodecanoic acid; 10-Methylthio-2-decanoic acid,R08646 R08647,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.1.1.-; 2.6.1.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0106 Oxo fatty acids;     C17232  2-Oxo-10-methylthiodecanoic acid,PubChem: 96023640; ChEBI: 80977; KNApSAcK: C00007651; NIKKAJI: J2.806.179J,cpd:C17232; cpd:C18403,11,20,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H21O3S1,C11H19O3S1,232.1133157,233.1211407,231.10549064238,4609,cpd:C17233,Hexahomomethionine,C11H23NO2S,Hexahomomethionine,R08647 R08675,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.13.-; 2.6.1.-,NA,NA,PubChem: 96023641; ChEBI: 50714; KNApSAcK: C00007649; NIKKAJI: J2.806.180C,cpd:C17233,11,23,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H24O2N1S1,C11H22O2N1S1,233.1449502,234.1527752,232.13712514239,4610,cpd:C17236,3-Phenylpropionaldoxim,C9H11NO,3-Phenylpropionaldoxim,R08655,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.13.-,NA,NA,PubChem: 96023644; ChEBI: 80978; NIKKAJI: J372.443C,cpd:C08301; cpd:C17236,9,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O1N1,C9H10O1N1,149.084064,150.091889,148.07623894240,4611,cpd:C17237,S-(Phenylacetothiohydroximoyl)-L-cysteine,C11H14N2O3S,S-(Phenylacetothiohydroximoyl)-L-cysteine,R08653 R08654 R10670,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.14.-.-; 4.4.1.-,NA,NA,PubChem: 96023645; ChEBI: 80979; NIKKAJI: J2.806.183H,cpd:C17237,11,14,3,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O3N2S1,C11H13O3N2S1,254.0725135,255.0803385,253.06468854241,4612,cpd:C17238,S-(Hydroxyphenylacetothiohydroximoyl)-L-cysteine,C11H14N2O4S,S-(Hydroxyphenylacetothiohydroximoyl)-L-cysteine,R08659 R08660 R10672,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.-.-; 4.4.1.-,NA,NA,PubChem: 96023646; ChEBI: 80980; NIKKAJI: J2.806.191I,cpd:C17238,11,14,4,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O4N2S1,C11H13O4N2S1,270.0674281,271.0752531,269.05960314242,4613,cpd:C17239,p-Hydroxyphenylacetothiohydroximate,C8H9NO2S,p-Hydroxyphenylacetothiohydroximate,R08660 R08661,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,2.4.1.195; 4.4.1.-,NA,NA,PubChem: 96023647; ChEBI: 80981; NIKKAJI: J2.806.196J,cpd:C17239,8,9,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O2N1S1,C8H8O2N1S1,183.0353997,184.0432247,182.02757474243,4614,cpd:C17240,p-Hydroxybenzyldesulphoglucosinolate;,C14H19NO7S,p-Hydroxybenzyldesulphoglucosinolate; Desulfo-p-hydroxybenzylglucosinolate,R08661 R08662,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,2.4.1.195; 2.8.2.-,NA,NA,PubChem: 96023648; ChEBI: 80982; NIKKAJI: J991.759D,cpd:C17240,14,19,7,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C14H20O7N1S1,C14H18O7N1S1,345.0882231,346.0960482,344.08039814244,4615,cpd:C17241,4-Methylthiobutanaldoxime,C5H11NOS,4-Methylthiobutanaldoxime,R08665 R08666,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.14.13.-; 1.14.-.-,NA,NA,PubChem: 96023649; ChEBI: 50705; NIKKAJI: J2.806.206K,cpd:C17241,5,11,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O1N1S1,C5H10O1N1S1,133.0561352,134.0639602,132.04831014245,4616,cpd:C17242,S-(4-Methylthiobutylthiohydroximoyl)-L-cysteine,C8H16N2O3S2,S-(4-Methylthiobutylthiohydroximoyl)-L-cysteine,R08666 R08667,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.14.-.-; 4.4.1.-,NA,NA,PubChem: 96023650; ChEBI: 80983; NIKKAJI: J2.806.207I,cpd:C17242,8,16,3,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O3N2S2,C8H15O3N2S2,252.0602347,253.0680598,251.05240974246,4617,cpd:C17243,4-Methylthiobutylthiohydroximate,C5H11NOS2,4-Methylthiobutylthiohydroximate,R08667 R08668,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.4.1.195; 4.4.1.-,NA,NA,PubChem: 96023651; ChEBI: 80984; NIKKAJI: J2.806.208G,cpd:C17243,5,11,1,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O1N1S2,C5H10O1N1S2,165.0282063,166.0360314,164.02038134247,4618,cpd:C17244,3-Methylthiopropyl-desulfoglucosinolate,C11H21NO6S2,3-Methylthiopropyl-desulfoglucosinolate,R08668 R08669,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,2.4.1.195; 2.8.2.-,NA,NA,PubChem: 96023652; ChEBI: 80985; NIKKAJI: J2.806.224I,cpd:C17244,11,21,6,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C11H22O6N1S2,C11H20O6N1S2,327.0810297,328.0888548,326.07320474248,4619,cpd:C17245,5-Methylthiopentanaldoxime,C6H13NOS,5-Methylthiopentanaldoxime,R08670,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.13.-,NA,NA,PubChem: 96023653; ChEBI: 50700; NIKKAJI: J1.570.410A,cpd:C17245,6,13,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O1N1S1,C6H12O1N1S1,147.0717852,148.0796102,146.06396024249,4620,cpd:C17246,6-Methylthiohexanaldoxime,C7H15NOS,6-Methylthiohexanaldoxime,R08672,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.13.-,NA,NA,PubChem: 96023654; ChEBI: 50701; NIKKAJI: J1.570.411J,cpd:C17246; cpd:C19095,7,15,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O1N1S1,C7H14O1N1S1,161.0874353,162.0952603,160.07961024250,4621,cpd:C17248,4-Methylthiobutyl-desulfoglucosinolate,C12H23NO6S2,4-Methylthiobutyl-desulfoglucosinolate,R08671,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,2.8.2.-,NA,NA,PubChem: 96023655; ChEBI: 80986; NIKKAJI: J542.092J,cpd:C17248,12,23,6,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C12H24O6N1S2,C12H22O6N1S2,341.0966798,342.1045048,340.08885484251,4622,cpd:C17249,7-Methylthioheptanaldoxime;,C8H17NOS,7-Methylthioheptanaldoxime; 7-(Methylsulfanyl)heptanal oxime,R08673,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.13.-,NA,NA,PubChem: 96023656; ChEBI: 50702; NIKKAJI: J2.806.229J,cpd:C17249,8,17,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C8H18O1N1S1,C8H16O1N1S1,175.1030853,176.1109104,174.09526034252,4623,cpd:C17250,Glucolesquerellin;,C14H27NO9S3,Glucolesquerellin; 6-Methylthiohexyl glucosinolate,NA,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,NA,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from methionine;     C17250  6-Methylthiohexyl glucosinolate,PubChem: 96023657; ChEBI: 80987; NIKKAJI: J2.736.863H,cpd:C17250,14,27,9,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C14H28O9N1S3,C14H26O9N1S3,449.084795,450.09262,448.07696994253,4624,cpd:C17251,8-Methylthiooctanaldoxime,C9H19NOS,8-Methylthiooctanaldoxime,R08674,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.13.-,NA,NA,PubChem: 96023658; ChEBI: 50703; KNApSAcK: C00007676; NIKKAJI: J2.806.230C,cpd:C11081; cpd:C17251,9,19,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C9H20O1N1S1,C9H18O1N1S1,189.1187354,190.1265604,188.11091044254,4625,cpd:C17252,7-Methylthioheptyl glucosinolate,C15H29NO9S3,7-Methylthioheptyl glucosinolate,NA,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,NA,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from methionine;     C17252  7-Methylthioheptyl glucosinolate,PubChem: 96023659; ChEBI: 80988; NIKKAJI: J2.806.231A,cpd:C17252,15,29,9,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C15H30O9N1S3,C15H28O9N1S3,463.100445,464.1082701,462.092624255,4626,cpd:C17253,9-Methylthiononanaldoxime,C10H21NOS,9-Methylthiononanaldoxime,R08675,Glucosinolate biosynthesis; 2-Oxocarboxylic acid metabolism,1.14.13.-,NA,NA,PubChem: 96023660; ChEBI: 50704; KNApSAcK: C00007677; NIKKAJI: J2.806.250H,cpd:C17253; cpd:C18755; cpd:C19097,10,21,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H22O1N1S1,C10H20O1N1S1,203.1343855,204.1422105,202.12656044256,4627,cpd:C17254,8-Methylthiooctyl glucosinolate,C16H31NO9S3,8-Methylthiooctyl glucosinolate,NA,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,NA,NA,NA,PubChem: 96023661; ChEBI: 80989; NIKKAJI: J2.806.251F,cpd:C17254,16,31,9,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C16H32O9N1S3,C16H30O9N1S3,477.1160951,478.1239201,476.10827014257,4628,cpd:C17255,3-Methylbutyraldehyde oxime,C5H11NO,3-Methylbutyraldehyde oxime,R08664,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,1.14.13.-,NA,NA,CAS: 626-90-4; PubChem: 96023662; ChEBI: 80990; NIKKAJI: J134.731D,cpd:C01842; cpd:C03982; cpd:C10974; cpd:C12455; cpd:C17241; cpd:C17243; cpd:C17255; cpd:C19274; cpd:C19491; cpd:C20312,5,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O1N1,C5H10O1N1,101.084064,102.091889,100.07623894258,4629,cpd:C17256,2-Methylpropyl glucosinolate;,C11H21NO9S2,2-Methylpropyl glucosinolate; Isobutyl glucosinolate,NA,Glucosinolate biosynthesis; Biosynthesis of secondary metabolites; 2-Oxocarboxylic acid metabolism,NA,NA,Phytochemical compounds [BR:br08003];  Amino acid related compounds;   Glucosinolates;    Glucosinolates derived from leucine;     C17256  2-Methylpropyl glucosinolate,PubChem: 96023663; ChEBI: 79338; NIKKAJI: J2.806.252D,cpd:C08407; cpd:C17256,11,21,9,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C11H22O9N1S2,C11H20O9N1S2,375.0657736,376.0735986,374.05794864259,4654,cpd:C02617,"1,4-Naphthoquinone;",C10H6O2,"1,4-Naphthoquinone; 1,4-Naphthalenedione",R07019,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 130-15-4; PubChem: 5602; ChEBI: 27418; ChEMBL: CHEMBL55934; NIKKAJI: J5.430E,cpd:C02617; cpd:C03797; cpd:C12491; cpd:C14783; cpd:C18584; cpd:C18766,10,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H7O2,C10H5O2,158.0367794,159.0446045,157.02895444260,4655,cpd:C06205,"1,2-Dihydronaphthalene-1,2-diol",C10H10O2,"1,2-Dihydronaphthalene-1,2-diol",R07013 R07014 R07015 R07016,Metabolism of xenobiotics by cytochrome P450,1.3.1.20; 3.3.2.9,NA,NA,PubChem: 8455; ChEBI: 28516; NIKKAJI: J81.355I,cpd:C04314; cpd:C04514; cpd:C06205; cpd:C06358; cpd:C07658; cpd:C10472; cpd:C10475; cpd:C10490; cpd:C12088; cpd:C14266; cpd:C15419; cpd:C17204; cpd:C19115; cpd:C20269,10,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O2,C10H9O2,162.0680796,163.0759046,161.06025454261,4656,cpd:C06899,Chloral hydrate,C2H3Cl3O2,Chloral hydrate,R07101 R07104 R07105,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.1.1.1; 1.2.1.5,NA,"Carcinogens [BR:br08008];  Group 2A: Probably carcinogenic to humans;   Compounds;    C06899  Chloral hydrate; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N05 PSYCHOLEPTICS;    N05C HYPNOTICS AND SEDATIVES;     N05CC Aldehydes and derivatives;      N05CC01 Chloral hydrate;       D00265  Chloral hydrate (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   11  Agents affecting central nervous system;    112  Hypnotics and sedatives, anxiolytics;     1123  Chloral hydrates;      D00265  Chloral hydrate (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00265  Chloral hydrate; Psychiatric agents [br08363.html];  Hypnotics;   D00265",CAS: 302-17-0; PubChem: 9116; ChEBI: 28142; ChEMBL: CHEMBL455917; NIKKAJI: J1.517B,cpd:C06899,2,3,2,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C2H4O2Cl3,C2H2O2Cl3,163.9198624,164.9276874,162.91203734262,4657,cpd:C11036,Bromobenzene,C6H5Br,Bromobenzene,R07066 R07068,Metabolism of xenobiotics by cytochrome P450,1.14.13.-,NA,NA,CAS: 108-86-1; PubChem: 13219; ChEBI: 3179; ChEMBL: CHEMBL16068; NIKKAJI: J2.867C,cpd:C11036; cpd:C14453; cpd:C14839; cpd:C14840; cpd:C14841; cpd:C14843; cpd:C14845; cpd:C16249,6,5,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C6H6Br1,C6H4Br1,155.9574628,156.9652878,154.94963774263,4658,cpd:C11088,"1,2-Dibromoethane;",C2H4Br2,"1,2-Dibromoethane; Ethylene dibromide",R07112 R07113,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 2.5.1.18,NA,Carcinogens [BR:br08008];  Group 2A: Probably carcinogenic to humans;   Compounds;    C11088  Ethylene dibromide,CAS: 106-93-4; PubChem: 13270; ChEBI: 28534; ChEMBL: CHEMBL452370; NIKKAJI: J4.038J,cpd:C11088,2,4,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,C2H5Br2,C2H3Br2,185.8679753,186.8758004,184.86015034264,4659,cpd:C11278,"Aflatoxin B1exo-8,9-epoxide-GSH;",C27H29N3O13S,"Aflatoxin B1exo-8,9-epoxide-GSH; 8,9-Dihydro-8-(S-glutathionyl)-9-hydroxyaflatoxin B1",R09409,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C11278  Aflatoxin B1exo-8,9-epoxide-GSH",CAS: 68385-50-2; PubChem: 13455; ChEBI: 2505; LIPIDMAPS: LMPK10000005; 3DMET: B05518; NIKKAJI: J777.385D,cpd:C11278,27,29,13,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C27H30O13N3S1,C27H28O13N3S1,635.1421092,636.1499342,634.13428414265,4660,cpd:C11713,2-Naphthol;,C10H8O,2-Naphthol; beta-Naphthol,R07011 R07012 R07020,Metabolism of xenobiotics by cytochrome P450; Naphthalene family,NA,NA,Pharmaceutical additives [BR:br08316];  Antiseptic agent;   C11713  [100122] 2-Naphthol,CAS: 135-19-3; PubChem: 13878; ChEBI: 10432; ChEMBL: CHEMBL14126; PDB-CCD: 03V; NIKKAJI: J2.530E,cpd:C11713; cpd:C11714; cpd:C13127; cpd:C14786; cpd:C14787; cpd:C18570,10,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O1,C10H7O1,144.0575149,145.0653399,143.04968984266,4661,cpd:C11714,1-Naphthol;,C10H8O,1-Naphthol; alpha-Naphthol,R07009 R07010 R07018,Metabolism of xenobiotics by cytochrome P450; Naphthalene family,NA,NA,NA,CAS: 90-15-3; PubChem: 13879; ChEBI: 10319; ChEMBL: CHEMBL122617; PDB-CCD: 1NP; NIKKAJI: J3.911J,cpd:C11713; cpd:C11714; cpd:C13127; cpd:C14786; cpd:C14787; cpd:C18570,10,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O1,C10H7O1,144.0575149,145.0653399,143.04968984267,4662,cpd:C14039,"1,1-Dichloroethylene;",C2H2Cl2,"1,1-Dichloroethylene; Vinylidene chloride; 1,1-DCE",R07088 R07089 R07090,Metabolism of xenobiotics by cytochrome P450,1.14.13.-,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C14039  Vinylidene chloride,CAS: 75-35-4; PubChem: 7846933; ChEBI: 34031; ChEMBL: CHEMBL156455; NIKKAJI: J2.391D,cpd:C06791; cpd:C06792; cpd:C11149; cpd:C14039; cpd:C14857; cpd:C14858; cpd:C14859; cpd:C18992; cpd:C20318,2,2,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C2H3Cl2,C2H1Cl2,95.95335543,96.96118046,94.94553044268,4663,cpd:C14040,1-Nitronaphthalene,C10H7NO2,1-Nitronaphthalene,R07021 R07022 R07028,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 1.14.14.1,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C14040  1-Nitronaphthalene,CAS: 86-57-7; PubChem: 7846934; ChEBI: 34104; ChEMBL: CHEMBL165373; NIKKAJI: J3.536J,cpd:C06325; cpd:C06414; cpd:C10987; cpd:C14040; cpd:C19474,10,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O2N1,C10H6O2N1,173.0476785,174.0555035,172.03985344269,4664,cpd:C14453,4-Bromophenol,C6H5BrO,4-Bromophenol,R07073 R07075,Metabolism of xenobiotics by cytochrome P450,1.14.13.-,NA,NA,CAS: 106-41-2; PubChem: 17395453; ChEBI: 47248; ChEMBL: CHEMBL57284; KNApSAcK: C00036569; PDB-CCD: BML; NIKKAJI: J3.608K,cpd:C14453; cpd:C14839; cpd:C14840; cpd:C14841,6,5,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C6H6O1Br1,C6H4O1Br1,171.9523774,172.9602024,170.94455234270,4665,cpd:C14556,9-Hydroxybenzo[a]pyrene,C20H12O,9-Hydroxybenzo[a]pyrene,R07086 R07087,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1,NA,NA,CAS: 17573-21-6; PubChem: 17395556; ChEBI: 34512; ChEMBL: CHEMBL351406; NIKKAJI: J2.748K,cpd:C14459; cpd:C14461; cpd:C14556; cpd:C14557; cpd:C14558; cpd:C14559; cpd:C14560; cpd:C14563; cpd:C14564; cpd:C14565; cpd:C14576; cpd:C14849; cpd:C14850; cpd:C14851; cpd:C18286,20,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O1,C20H11O1,268.088815,269.09664,267.080994271,4666,cpd:C14783,"1,2-Naphthoquinone;",C10H6O2,"1,2-Naphthoquinone; 1,2-Naphthalenedione",R07017,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,NA,NA,NA,CAS: 524-42-5; PubChem: 17395781; ChEBI: 34055; ChEMBL: CHEMBL52347; NIKKAJI: J6.639G,cpd:C02617; cpd:C03797; cpd:C12491; cpd:C14783; cpd:C18584; cpd:C18766,10,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H7O2,C10H5O2,158.0367794,159.0446045,157.02895444272,4667,cpd:C14784,"1,2-Dihydroxy-3,4-epoxy-1,2,3,4-tetrahydronaphthalene",C10H10O3,"1,2-Dihydroxy-3,4-epoxy-1,2,3,4-tetrahydronaphthalene",R07016,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 75947-54-5; PubChem: 17395782; ChEBI: 34048; NIKKAJI: J2.789.312K,cpd:C00585; cpd:C01281; cpd:C01624; cpd:C01702; cpd:C02666; cpd:C05250; cpd:C10667; cpd:C12464; cpd:C14404; cpd:C14784; cpd:C16733; cpd:C20327; cpd:C20646,10,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H11O3,C10H9O3,178.0629942,179.0708192,177.05516914273,4668,cpd:C14785,"1,4-Dihydroxynaphthalene;",C10H8O2,"1,4-Dihydroxynaphthalene; 1,4-Naphthohydroquinone; Naphthalene-1,4-diol",R07018 R07019,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 571-60-8; PubChem: 17395783; ChEBI: 34063; ChEMBL: CHEMBL206816; NIKKAJI: J6.537D,cpd:C03012; cpd:C07719; cpd:C07726; cpd:C14785; cpd:C16213; cpd:C18929,10,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O2,C10H7O2,160.0524295,161.0602545,159.04460454274,4669,cpd:C14786,"(1R,2S)-Naphthalene 1,2-oxide;",C10H8O,"(1R,2S)-Naphthalene 1,2-oxide; (1R,2S)-Naphthalene epoxide",R07000 R07002 R07009 R07011 R07013,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 1.14.14.1; 2.5.1.18; 3.3.2.9,NA,NA,CAS: 73136-20-6; PubChem: 17395784; ChEBI: 33998; NIKKAJI: J442.342I,cpd:C11713; cpd:C11714; cpd:C13127; cpd:C14786; cpd:C14787; cpd:C18570,10,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O1,C10H7O1,144.0575149,145.0653399,143.04968984275,4670,cpd:C14787,"(1S,2R)-Naphthalene 1,2-oxide;",C10H8O,"(1S,2R)-Naphthalene 1,2-oxide; (1S,2R)-Naphthalene epoxide",R07001 R07003 R07004 R07010 R07012 R07014,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 1.14.14.1; 2.5.1.18; 3.3.2.9,NA,NA,PubChem: 17395785; ChEBI: 34001; NIKKAJI: J88.300J,cpd:C11713; cpd:C11714; cpd:C13127; cpd:C14786; cpd:C14787; cpd:C18570,10,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H9O1,C10H7O1,144.0575149,145.0653399,143.04968984276,4671,cpd:C14788,1-Nitrosonaphthalene,C10H7NO,1-Nitrosonaphthalene,R07028 R07029,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 21711-65-9; PubChem: 17395786; ChEBI: 34108; NIKKAJI: J34.572E,cpd:C14788,10,7,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O1N1,C10H6O1N1,157.0527638,158.0605889,156.04493884277,4672,cpd:C14789,N-Hydroxy-1-aminonaphthalene;,C10H9NO,N-Hydroxy-1-aminonaphthalene; 1-Naphthylhydroxylamine,R07029 R07030,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 607-30-7; PubChem: 17395787; ChEBI: 34871; ChEMBL: CHEMBL261899; NIKKAJI: J2.985H,cpd:C00637; cpd:C06345; cpd:C10663; cpd:C11048; cpd:C14789; cpd:C19046; cpd:C19049,10,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O1N1,C10H8O1N1,159.0684139,160.0762389,158.06058894278,4673,cpd:C14790,1-Naphthylamine,C10H9N,1-Naphthylamine,R07030,Metabolism of xenobiotics by cytochrome P450,NA,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C14790  1-Naphthylamine,CAS: 134-32-7; PubChem: 17395788; ChEBI: 50450; ChEMBL: CHEMBL57394; NIKKAJI: J2.528C,cpd:C00637; cpd:C00954; cpd:C01249; cpd:C01252; cpd:C01386; cpd:C02227; cpd:C02298; cpd:C03147; cpd:C03230; cpd:C05634; cpd:C05635; cpd:C05645; cpd:C05652; cpd:C05656; cpd:C05835; cpd:C06331; cpd:C06344; cpd:C06345; cpd:C06525; cpd:C06725; cpd:C10663; cpd:C11048; cpd:C11504; cpd:C12466; cpd:C14789; cpd:C14790; cpd:C14801; cpd:C16596; cpd:C18483; cpd:C18754; cpd:C19046; cpd:C19049; cpd:C19686,10,9,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10N1,C10H8N1,143.0734993,144.0813243,142.06567434279,4674,cpd:C14791,"(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene",C20H25N3O7S,"(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene",R07002 R07005,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395789; ChEBI: 33995; NIKKAJI: J2.789.352J,cpd:C14791; cpd:C14792; cpd:C14793,20,25,7,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H26O7N3S1,C20H24O7N3S1,451.1413213,452.1491464,450.13349634280,4675,cpd:C14792,"(1S)-Hydroxy-(2S)-glutathionyl-1,2-dihydronaphthalene",C20H25N3O7S,"(1S)-Hydroxy-(2S)-glutathionyl-1,2-dihydronaphthalene",R07004 R07008,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395790; ChEBI: 34000; NIKKAJI: J2.789.353H,cpd:C14791; cpd:C14792; cpd:C14793,20,25,7,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H26O7N3S1,C20H24O7N3S1,451.1413213,452.1491464,450.13349634281,4676,cpd:C14793,"(1R)-Glutathionyl-(2R)-hydroxy-1,2-dihydronaphthalene",C20H25N3O7S,"(1R)-Glutathionyl-(2R)-hydroxy-1,2-dihydronaphthalene",R07003 R07006 R07007,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395791; ChEBI: 33993; NIKKAJI: J2.789.363E,cpd:C14791; cpd:C14792; cpd:C14793,20,25,7,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H26O7N3S1,C20H24O7N3S1,451.1413213,452.1491464,450.13349634282,4677,cpd:C14796,"(1R)-Hydroxy-(2R)-N-acetyl-L-cysteinyl-1,2-dihydronaphthalene",C15H17NO4S,"(1R)-Hydroxy-(2R)-N-acetyl-L-cysteinyl-1,2-dihydronaphthalene",R07005,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,PubChem: 17395794; ChEBI: 33994; NIKKAJI: J564.066K,cpd:C12089; cpd:C14796; cpd:C14797; cpd:C14798,15,17,4,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H18O4N1S1,C15H16O4N1S1,307.0878292,308.0956542,306.08000424283,4678,cpd:C14797,"(1R)-N-Acetyl-L-cysteinyl-(2R)-hydroxy-1,2-dihydronaphthalene",C15H17NO4S,"(1R)-N-Acetyl-L-cysteinyl-(2R)-hydroxy-1,2-dihydronaphthalene",R07006,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,PubChem: 17395795; ChEBI: 33996; NIKKAJI: J564.068G,cpd:C12089; cpd:C14796; cpd:C14797; cpd:C14798,15,17,4,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H18O4N1S1,C15H16O4N1S1,307.0878292,308.0956542,306.08000424284,4679,cpd:C14798,"(1S)-Hydroxy-(2S)-N-acetyl-L-cysteinyl-1,2-dihydronaphthalene",C15H17NO4S,"(1S)-Hydroxy-(2S)-N-acetyl-L-cysteinyl-1,2-dihydronaphthalene",R07008,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,PubChem: 17395796; ChEBI: 33999; NIKKAJI: J564.067I,cpd:C12089; cpd:C14796; cpd:C14797; cpd:C14798,15,17,4,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H18O4N1S1,C15H16O4N1S1,307.0878292,308.0956542,306.08000424285,4680,cpd:C14799,"(1R,2R)-3-[(1,2-Dihydro-2-hydroxy-1-naphthalenyl)thio]-2-oxopropanoic acid",C13H12O4S,"(1R,2R)-3-[(1,2-Dihydro-2-hydroxy-1-naphthalenyl)thio]-2-oxopropanoic acid",R07007,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,PubChem: 17395797; ChEBI: 33997; NIKKAJI: J2.789.421F,cpd:C14799; cpd:C20288,13,12,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C13H13O4S1,C13H11O4S1,264.04563,265.0534551,263.0378054286,4681,cpd:C14800,"1-Nitronaphthalene-5,6-oxide",C10H7NO3,"1-Nitronaphthalene-5,6-oxide",R07022 R07025 R07026 R07027,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 1.14.14.1; 2.5.1.18; 3.3.2.9,NA,NA,PubChem: 17395798; ChEBI: 34105; NIKKAJI: J2.789.422D,cpd:C01717; cpd:C02172; cpd:C14800; cpd:C14802; cpd:C16715; cpd:C18621,10,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O3N1,C10H6O3N1,189.0425931,190.0504181,188.03476814287,4682,cpd:C14801,"1-Nitro-5,6-dihydroxy-dihydronaphthalene;",C10H9NO4,"1-Nitro-5,6-dihydroxy-dihydronaphthalene; 1,2-Dihydro-5-nitro-1,2-naphthalenediol",R07027,Metabolism of xenobiotics by cytochrome P450,3.3.2.9,NA,NA,PubChem: 17395799; ChEBI: 34099; NIKKAJI: J2.789.427E,cpd:C01252; cpd:C05835; cpd:C12466; cpd:C14801,10,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O4N1,C10H8O4N1,207.0531578,208.0609828,206.04533274288,4683,cpd:C14802,"1-Nitronaphthalene-7,8-oxide",C10H7NO3,"1-Nitronaphthalene-7,8-oxide",R07021 R07023 R07024,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 1.14.14.1; 2.5.1.18,NA,NA,PubChem: 17395800; ChEBI: 34106; NIKKAJI: J2.789.430E,cpd:C01717; cpd:C02172; cpd:C14800; cpd:C14802; cpd:C16715; cpd:C18621,10,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O3N1,C10H6O3N1,189.0425931,190.0504181,188.03476814289,4684,cpd:C14803,"1-Nitro-7-hydroxy-8-glutathionyl-7,8-dihydronaphthalene",C20H24N4O9S,"1-Nitro-7-hydroxy-8-glutathionyl-7,8-dihydronaphthalene",R07023,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395801; ChEBI: 34103; NIKKAJI: J2.789.435F,cpd:C14803; cpd:C14804; cpd:C14805; cpd:C14806,20,24,9,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O9N4S1,C20H23O9N4S1,496.1263995,497.1342246,495.11857454290,4685,cpd:C14804,"1-Nitro-7-glutathionyl-8-hydroxy-7,8-dihydronaphthalene",C20H24N4O9S,"1-Nitro-7-glutathionyl-8-hydroxy-7,8-dihydronaphthalene",R07024,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395802; ChEBI: 34102; NIKKAJI: J2.789.436D,cpd:C14803; cpd:C14804; cpd:C14805; cpd:C14806,20,24,9,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O9N4S1,C20H23O9N4S1,496.1263995,497.1342246,495.11857454291,4686,cpd:C14805,"1-Nitro-5-hydroxy-6-glutathionyl-5,6-dihydronaphthalene",C20H24N4O9S,"1-Nitro-5-hydroxy-6-glutathionyl-5,6-dihydronaphthalene",R07025,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395803; ChEBI: 34101; NIKKAJI: J2.789.442I,cpd:C14803; cpd:C14804; cpd:C14805; cpd:C14806,20,24,9,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O9N4S1,C20H23O9N4S1,496.1263995,497.1342246,495.11857454292,4687,cpd:C14806,"1-Nitro-5-glutathionyl-6-hydroxy-5,6-dihydronaphthalene",C20H24N4O9S,"1-Nitro-5-glutathionyl-6-hydroxy-5,6-dihydronaphthalene",R07026,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395804; ChEBI: 34100; NIKKAJI: J2.789.446A,cpd:C14803; cpd:C14804; cpd:C14805; cpd:C14806,20,24,9,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O9N4S1,C20H23O9N4S1,496.1263995,497.1342246,495.11857454293,4688,cpd:C14839,"Bromobenzene-3,4-oxide;",C6H5BrO,"Bromobenzene-3,4-oxide; Bromobenzene-3,4-epoxide",R07066 R07069 R07071 R07073,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 2.5.1.18; 3.3.2.9,NA,NA,CAS: 51981-75-0; PubChem: 17395837; ChEBI: 34589; NIKKAJI: J578.529D,cpd:C14453; cpd:C14839; cpd:C14840; cpd:C14841,6,5,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C6H6O1Br1,C6H4O1Br1,171.9523774,172.9602024,170.94455234294,4689,cpd:C14840,"Bromobenzene-2,3-oxide;",C6H5BrO,"Bromobenzene-2,3-oxide; Bromobenzene-2,3-epoxide",R07068 R07070 R07072 R07074,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 2.5.1.18; 3.3.2.9,NA,NA,CAS: 71942-12-6; PubChem: 17395838; ChEBI: 34587; NIKKAJI: J2.790.485H,cpd:C14453; cpd:C14839; cpd:C14840; cpd:C14841,6,5,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C6H6O1Br1,C6H4O1Br1,171.9523774,172.9602024,170.94455234295,4690,cpd:C14841,2-Bromophenol;,C6H5BrO,2-Bromophenol; o-Bromophenol,R07074,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 95-56-7; PubChem: 17395839; ChEBI: 34264; ChEMBL: CHEMBL186007; KNApSAcK: C00036481; PDB-CCD: 2BR; NIKKAJI: J3.565C,cpd:C14453; cpd:C14839; cpd:C14840; cpd:C14841,6,5,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C6H6O1Br1,C6H4O1Br1,171.9523774,172.9602024,170.94455234296,4691,cpd:C14842,"Bromobenzene-2,3-dihydrodiol;",C6H7BrO2,"Bromobenzene-2,3-dihydrodiol; 3-Bromo-3,5-cyclohexadiene-1,2-diol",R07072,Metabolism of xenobiotics by cytochrome P450,3.3.2.9,NA,NA,CAS: 82683-92-9; PubChem: 17395840; ChEBI: 34586; NIKKAJI: J2.790.486F,cpd:C14842; cpd:C14844,6,7,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C6H8O2Br1,C6H6O2Br1,189.9629421,190.9707671,188.9551174297,4692,cpd:C14843,4-Bromocatechol,C6H5BrO2,4-Bromocatechol,R07076 R07077 R07078,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 17345-77-6; PubChem: 17395841; ChEBI: 34388; NIKKAJI: J287.015K,cpd:C14843; cpd:C14845,6,5,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C6H6O2Br1,C6H4O2Br1,187.947292,188.955117,186.9394674298,4693,cpd:C14844,"Bromobenzene-3,4-dihydrodiol;",C6H7BrO2,"Bromobenzene-3,4-dihydrodiol; 4-Bromo-3,5-cyclohexadiene-1,2-diol",R07071 R07078,Metabolism of xenobiotics by cytochrome P450,3.3.2.9,NA,NA,CAS: 82683-93-0; PubChem: 17395842; ChEBI: 34588; NIKKAJI: J2.790.487D,cpd:C14842; cpd:C14844,6,7,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C6H8O2Br1,C6H6O2Br1,189.9629421,190.9707671,188.9551174299,4694,cpd:C14845,"4-Bromophenol-2,3-epoxide",C6H5BrO2,"4-Bromophenol-2,3-epoxide",R07075 R07076,Metabolism of xenobiotics by cytochrome P450,1.14.13.-,NA,NA,PubChem: 17395843; ChEBI: 34390; NIKKAJI: J2.789.551D,cpd:C14843; cpd:C14845,6,5,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C6H6O2Br1,C6H4O2Br1,187.947292,188.955117,186.9394674300,4695,cpd:C14846,"4-Bromo-3,5-cyclohexadiene-1,2-dione;",C6H3BrO2,"4-Bromo-3,5-cyclohexadiene-1,2-dione; 4-Bromo-1,2-benzoquinone",R07077,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,PubChem: 17395844; ChEBI: 34387; NIKKAJI: J1.591.166B,cpd:C14846,6,3,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C6H4O2Br1,C6H2O2Br1,185.9316419,186.939467,184.92381694301,4696,cpd:C14847,"3,4-Dihydro-3-hydroxy-4-S-glutathionyl bromobenzene",C16H22BrN3O7S,"3,4-Dihydro-3-hydroxy-4-S-glutathionyl bromobenzene",R07069,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395845; ChEBI: 34324; NIKKAJI: J2.789.570K,cpd:C14847; cpd:C14848,16,22,7,3,0,1,0,0,1,0,0,0,0,0,0,0,0,0,C16H23O7N3S1Br1,C16H21O7N3S1Br1,479.0361838,480.0440089,478.02835884302,4697,cpd:C14848,"2,3-Dihydro-2-S-glutathionyl-3-hydroxy bromobenzene",C16H22BrN3O7S,"2,3-Dihydro-2-S-glutathionyl-3-hydroxy bromobenzene",R07070,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395846; ChEBI: 34228; NIKKAJI: J2.789.571I,cpd:C14847; cpd:C14848,16,22,7,3,0,1,0,0,1,0,0,0,0,0,0,0,0,0,C16H23O7N3S1Br1,C16H21O7N3S1Br1,479.0361838,480.0440089,478.02835884303,4698,cpd:C14849,"Benzo[a]pyrene-9,10-oxide;",C20H12O,"Benzo[a]pyrene-9,10-oxide; Benzo[a]pyrene-9,10-epoxide",R07079 R07086,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1,NA,NA,CAS: 36504-66-2; PubChem: 17395847; ChEBI: 34564; NIKKAJI: J54.529E,cpd:C14459; cpd:C14461; cpd:C14556; cpd:C14557; cpd:C14558; cpd:C14559; cpd:C14560; cpd:C14563; cpd:C14564; cpd:C14565; cpd:C14576; cpd:C14849; cpd:C14850; cpd:C14851; cpd:C18286,20,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O1,C20H11O1,268.088815,269.09664,267.080994304,4699,cpd:C14850,"Benzo[a]pyrene-7,8-oxide;",C20H12O,"Benzo[a]pyrene-7,8-oxide; Benzo[a]pyrene-7,8-epoxide",R07080 R07082,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1; 3.3.2.9,NA,NA,CAS: 36504-65-1; PubChem: 17395848; ChEBI: 34563; NIKKAJI: J31.838H,cpd:C14459; cpd:C14461; cpd:C14556; cpd:C14557; cpd:C14558; cpd:C14559; cpd:C14560; cpd:C14563; cpd:C14564; cpd:C14565; cpd:C14576; cpd:C14849; cpd:C14850; cpd:C14851; cpd:C18286,20,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O1,C20H11O1,268.088815,269.09664,267.080994305,4700,cpd:C14851,"Benzo[a]pyrene-4,5-oxide;",C20H12O,"Benzo[a]pyrene-4,5-oxide; Benzo[a]pyrene-4,5-epoxide",R07081 R07083,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1; 2.5.1.18,NA,NA,CAS: 37574-47-3; PubChem: 17395849; ChEBI: 34560; NIKKAJI: J9.301G,cpd:C14459; cpd:C14461; cpd:C14556; cpd:C14557; cpd:C14558; cpd:C14559; cpd:C14560; cpd:C14563; cpd:C14564; cpd:C14565; cpd:C14576; cpd:C14849; cpd:C14850; cpd:C14851; cpd:C18286,20,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O1,C20H11O1,268.088815,269.09664,267.080994306,4701,cpd:C14852,"Benzo[a]pyrene-7,8-diol;",C20H14O2,"Benzo[a]pyrene-7,8-diol; Benzo[a]pyrene-7,8-dihydrodiol",R07082 R07084 R07085,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1; 2.5.1.18; 3.3.2.9,NA,NA,CAS: 13345-25-0; PubChem: 17395850; ChEBI: 34562; NIKKAJI: J36.050C,cpd:C14852; cpd:C18270; cpd:C18275; cpd:C18276; cpd:C18284; cpd:C18285,20,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O2,C20H13O2,286.0993797,287.1072047,285.09155474307,4702,cpd:C14853,"Benzo[a]pyrene-7,8-dihydrodiol-9,10-oxide;",C20H14O3,"Benzo[a]pyrene-7,8-dihydrodiol-9,10-oxide; 7,8-Dihydro-7,8-dihydroxybenzo[a]pyrene 9,10-oxide",R07085,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1,NA,NA,CAS: 55097-80-8; PubChem: 17395851; ChEBI: 30614; ChEMBL: CHEMBL1743211; NIKKAJI: J282.916I,cpd:C14853,20,14,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O3,C20H13O3,302.0942943,303.1021193,301.08646934308,4703,cpd:C14854,"9-Hydroxybenzo[a]pyrene-4,5-oxide;",C20H12O2,"9-Hydroxybenzo[a]pyrene-4,5-oxide; 9-Hydroxybenzo[a]pyrene-4,5-epoxide",R07087,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1,NA,NA,CAS: 61133-85-5; PubChem: 17395852; ChEBI: 34513; NIKKAJI: J1.461.319F,cpd:C14854; cpd:C14951; cpd:C18278; cpd:C18279; cpd:C18280,20,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O2,C20H11O2,284.0837296,285.0915547,283.07590464309,4704,cpd:C14855,"4,5-Dihydro-4-hydroxy-5-S-glutathionyl-benzo[a]pyrene",C30H29N3O7S,"4,5-Dihydro-4-hydroxy-5-S-glutathionyl-benzo[a]pyrene",R07083,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,2.5.1.18,NA,NA,PubChem: 17395853; ChEBI: 34374; NIKKAJI: J2.789.588C,cpd:C14855; cpd:C14856,30,29,7,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H30O7N3S1,C30H28O7N3S1,575.1726215,576.1804465,574.16479644310,4705,cpd:C14856,"7,8-Dihydro-7-hydroxy-8-S-glutathionyl-benzo[a]pyrene",C30H29N3O7S,"7,8-Dihydro-7-hydroxy-8-S-glutathionyl-benzo[a]pyrene",R07084,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,2.5.1.18,NA,NA,PubChem: 17395854; ChEBI: 34479; NIKKAJI: J2.789.589A,cpd:C14855; cpd:C14856,30,29,7,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H30O7N3S1,C30H28O7N3S1,575.1726215,576.1804465,574.16479644311,4706,cpd:C14857,"1,1-Dichloroethylene epoxide;",C2H2Cl2O,"1,1-Dichloroethylene epoxide; 2,2-Dichlorooxirane",R07089 R07092,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 2.5.1.18,NA,NA,CAS: 68226-83-5; PubChem: 17395855; ChEBI: 34032; NIKKAJI: J814.795G,cpd:C14857; cpd:C14858; cpd:C14859,2,2,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C2H3O1Cl2,C2H1O1Cl2,111.94827,112.9560951,110.9404454312,4707,cpd:C14858,"2,2-Dichloroacetaldehyde",C2H2Cl2O,"2,2-Dichloroacetaldehyde",R07088 R07091 R07095,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 2.5.1.18,NA,NA,CAS: 79-02-7; PubChem: 17395856; ChEBI: 34214; NIKKAJI: J35.925D,cpd:C14857; cpd:C14858; cpd:C14859,2,2,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C2H3O1Cl2,C2H1O1Cl2,111.94827,112.9560951,110.9404454313,4708,cpd:C14859,Chloroacetyl chloride,C2H2Cl2O,Chloroacetyl chloride,R07090 R07093 R07096,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 2.5.1.18,NA,NA,CAS: 79-04-9; PubChem: 17395857; ChEBI: 34624; NIKKAJI: J1.490G,cpd:C14857; cpd:C14858; cpd:C14859,2,2,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C2H3O1Cl2,C2H1O1Cl2,111.94827,112.9560951,110.9404454314,4709,cpd:C14860,"2,2-Dichloro-1,1-ethanediol",C2H4Cl2O2,"2,2-Dichloro-1,1-ethanediol",R07095,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 16086-14-9; PubChem: 17395858; ChEBI: 34213; NIKKAJI: J286.813J,cpd:C14860,2,4,2,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C2H5O2Cl2,C2H3O2Cl2,129.9588347,130.9666598,128.95100974315,4710,cpd:C14861,"S-(2,2-Dichloro-1-hydroxy)ethyl glutathione",C12H19Cl2N3O7S,"S-(2,2-Dichloro-1-hydroxy)ethyl glutathione",R07091,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395859; ChEBI: 34958; NIKKAJI: J2.789.590E,cpd:C14861,12,19,7,3,0,1,2,0,0,0,0,0,0,0,0,0,0,0,C12H20O7N3S1Cl2,C12H18O7N3S1Cl2,419.0320765,420.0399015,418.02425154316,4711,cpd:C14862,2-S-Glutathionyl acetate;,C12H19N3O8S,2-S-Glutathionyl acetate; S-(Carboxymethyl)glutathione,R07097 R07124,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 10463-61-3; PubChem: 17395860; ChEBI: 34302; NIKKAJI: J638.833G,cpd:C14862,12,19,8,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H20O8N3S1,C12H18O8N3S1,365.0892858,366.0971108,364.08146074317,4712,cpd:C14863,2-(S-Glutathionyl)acetyl glutathione,C22H34N6O13S2,2-(S-Glutathionyl)acetyl glutathione,R07094 R07124,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395861; ChEBI: 34254; NIKKAJI: J2.789.599I,cpd:C14863,22,34,13,6,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C22H35O13N6S2,C22H33O13N6S2,654.1625275,655.1703526,653.15470254318,4713,cpd:C14864,S-(2-Chloroacetyl)glutathione,C12H18ClN3O7S,S-(2-Chloroacetyl)glutathione,R07093,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,CAS: 113668-38-5; PubChem: 17395862; ChEBI: 34959; NIKKAJI: J755.658F,cpd:C14864; cpd:C14865,12,18,7,3,0,1,1,0,0,0,0,0,0,0,0,0,0,0,C12H19O7N3S1Cl1,C12H17O7N3S1Cl1,383.0553988,384.0632238,382.04757384319,4714,cpd:C14865,2-(S-Glutathionyl)acetyl chloride,C12H18ClN3O7S,2-(S-Glutathionyl)acetyl chloride,R07092 R07094 R07097,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395863; ChEBI: 34253; NIKKAJI: J2.789.620K,cpd:C14864; cpd:C14865,12,18,7,3,0,1,1,0,0,0,0,0,0,0,0,0,0,0,C12H19O7N3S1Cl1,C12H17O7N3S1Cl1,383.0553988,384.0632238,382.04757384320,4715,cpd:C14867,Dichloroacetyl chloride,C2HCl3O,Dichloroacetyl chloride,R07102 R07103,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,NA,NA,NA,CAS: 79-36-7; PubChem: 17395865; ChEBI: 34688; ChEMBL: CHEMBL449486; NIKKAJI: J3.841E,cpd:C11148; cpd:C14866; cpd:C14867,2,1,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C2H2O1Cl3,C2H0O1Cl3,145.9092977,146.9171227,144.90147274321,4716,cpd:C14868,"S-(1,2-Dichlorovinyl)glutathione;",C12H17Cl2N3O6S,"S-(1,2-Dichlorovinyl)glutathione; DCVG",R07100,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,2.5.1.18,NA,NA,PubChem: 17395866; ChEBI: 34957; NIKKAJI: J1.095.308A,cpd:C14868,12,17,6,3,0,1,2,0,0,0,0,0,0,0,0,0,0,0,C12H18O6N3S1Cl2,C12H16O6N3S1Cl2,401.0215118,402.0293368,400.01368684322,4717,cpd:C14869,Trichloroethanol glucuronide;,C8H11Cl3O7,"Trichloroethanol glucuronide; Urochloralic acid; 2,2,2-Trichloroethyl beta-D-glucopyranosiduronic acid",R07106,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,2.4.1.17,NA,NA,CAS: 97-25-6; PubChem: 17395867; ChEBI: 35021; NIKKAJI: J4.728G,cpd:C14869,8,11,7,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C8H12O7Cl3,C8H10O7Cl3,323.9570357,324.9648608,322.94921074323,4718,cpd:C14870,2-Bromoacetaldehyde,C2H3BrO,2-Bromoacetaldehyde,R07112 R07116,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 2.5.1.18,NA,NA,CAS: 17157-48-1; PubChem: 17395868; ChEBI: 34263; NIKKAJI: J330.645C,cpd:C14870,2,3,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C2H4O1Br1,C2H2O1Br1,121.9367273,122.9445523,120.92890234324,4719,cpd:C14871,S-(Formylmethyl)glutathione,C12H19N3O7S,S-(Formylmethyl)glutathione,R07114 R07115 R07116 R07120,Metabolism of xenobiotics by cytochrome P450,2.5.1.18,NA,NA,PubChem: 17395869; ChEBI: 34962; NIKKAJI: J2.789.623E,cpd:C14861; cpd:C14871,12,19,7,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H20O7N3S1,C12H18O7N3S1,349.0943711,350.1021962,348.08654614325,4720,cpd:C14872,Thiodiacetic acid,C4H6O4S,Thiodiacetic acid,R07114,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 123-93-3; PubChem: 17395870; ChEBI: 35012; ChEMBL: CHEMBL1570500; PDB-CCD: 9X6; NIKKAJI: J5.546H,cpd:C14872,4,6,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O4S1,C4H5O4S1,149.9986798,151.0065049,148.99085484326,4721,cpd:C14873,Thiodiacetic acid sulfoxide,C4H6O5S,Thiodiacetic acid sulfoxide,R07115,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 33388-14-6; PubChem: 17395871; ChEBI: 35013; NIKKAJI: J437.664A,cpd:C14873,4,6,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O5S1,C4H5O5S1,165.9935945,167.0014195,164.98576944327,4722,cpd:C14874,Glutathione episulfonium ion,C12H20N3O6S,Glutathione episulfonium ion,R07113 R07117 R07119,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,2.5.1.18,NA,NA,PubChem: 17395872; ChEBI: 34777; NIKKAJI: J665.777J,cpd:C14874; cpd:C20304,12,20,6,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H21O6N3S1,C12H19O6N3S1,334.1072815,335.1151066,333.09945654328,4723,cpd:C14875,S-(2-Hydroxyethyl)glutathione,C12H21N3O7S,S-(2-Hydroxyethyl)glutathione,R07117 R07118 R07120,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 28747-20-8; PubChem: 17395873; ChEBI: 35896; NIKKAJI: J2.790.495E,cpd:C14875,12,21,7,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H22O7N3S1,C12H20O7N3S1,351.1100212,352.1178462,350.10219624329,4724,cpd:C14876,S-(2-Hydroxyethyl)-N-acetyl-L-cysteine,C7H13NO4S,S-(2-Hydroxyethyl)-N-acetyl-L-cysteine,R07118,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,CAS: 15060-26-1; PubChem: 17395874; ChEBI: 34960; NIKKAJI: J410.590G,cpd:C14876,7,13,4,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O4N1S1,C7H12O4N1S1,207.0565291,208.0643541,206.0487044330,4725,cpd:C14877,S-[2-(N7-Guanyl)ethyl]-N-acetyl-L-cysteine,C12H16N6O4S,S-[2-(N7-Guanyl)ethyl]-N-acetyl-L-cysteine,R07119,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,PubChem: 17395875; ChEBI: 34964; NIKKAJI: J2.789.643J,cpd:C14877,12,16,4,6,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H17O4N6S1,C12H15O4N6S1,340.0953742,341.1031992,339.08754924331,4726,cpd:C16453,4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone;,C10H13N3O2,4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone; NNK,R09420 R09421 R09423 R09429,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.1.1.146; 1.1.1.184; 1.3.1.20; 1.14.13.-; 1.14.14.1,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C16453  4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone,CAS: 64091-91-4; PubChem: 47205749; ChEBI: 32692; PDB-CCD: 0QA; NIKKAJI: J1.123A,cpd:C15418; cpd:C16453; cpd:C16627,10,13,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O2N3,C10H12O2N3,207.1007767,208.1086017,206.09295164332,4727,cpd:C16756,Aflatoxin M1,C17H12O7,Aflatoxin M1,R09405 R09406,Metabolism of xenobiotics by cytochrome P450,1.14.14.1,NA,Lipids [BR:br08002];  PK  Polyketides;   PK10 Aflatoxins and related substances;    C16756  Aflatoxin M1; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C16756  Aflatoxin M1; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Aflatoxins;     C16756  Aflatoxin M1,CAS: 6795-23-9; PubChem: 96023280; ChEBI: 78576; KNApSAcK: C00023620; NIKKAJI: J5.140C,cpd:C10198; cpd:C16755; cpd:C16756; cpd:C19585; cpd:C19586; cpd:C19595,17,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O7,C17H11O7,328.0583027,329.0661278,327.05047774333,4728,cpd:C19488,"7,12-Dimethylbenz[a]anthracene;",C20H16,"7,12-Dimethylbenz[a]anthracene; DMBA",R09416 R09441 R09442,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1,NA,NA,CAS: 57-97-6; PubChem: 124490160; ChEBI: 254496; ChEMBL: CHEMBL329673,cpd:C01897; cpd:C09430; cpd:C10194; cpd:C10523; cpd:C10529; cpd:C10880; cpd:C10951; cpd:C12366; cpd:C12382; cpd:C12401; cpd:C14134; cpd:C14223; cpd:C17083; cpd:C17939; cpd:C18556; cpd:C18629; cpd:C18709; cpd:C19488; cpd:C19489; cpd:C19561; cpd:C19562; cpd:C19604; cpd:C20503; cpd:C20505; cpd:C20574,20,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17,C20H15,256.1252005,257.1330255,255.11737554334,4729,cpd:C19489,"1a,11b-Dihydro-4,9-dimethylbenz[a]anthra[3,4-b]oxirene",C20H16O,"1a,11b-Dihydro-4,9-dimethylbenz[a]anthra[3,4-b]oxirene",R09416 R09417,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.14.1; 3.3.2.9,NA,NA,PubChem: 124490161; ChEBI: 82517,cpd:C19489; cpd:C19561; cpd:C19604,20,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O1,C20H15O1,272.1201151,273.1279402,271.11229014335,4730,cpd:C19490,"trans-3,4-Dihydro-3,4-dihydroxy-7,12-dimethylbenz[a]anthracene;",C20H18O2,"trans-3,4-Dihydro-3,4-dihydroxy-7,12-dimethylbenz[a]anthracene; trans-DMBA-3,4-dihydrodiol",R09417 R09418,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.14.1; 3.3.2.9,NA,NA,CAS: 68162-13-0; PubChem: 124490162; ChEBI: 82518,cpd:C18728; cpd:C19490; cpd:C19607,20,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O2,C20H17O2,290.1306798,291.1385049,289.12285484336,4731,cpd:C19559,"(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol",C20H18O3,"(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol",R09418,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.14.1,NA,NA,CAS: 86941-58-4; PubChem: 124490231; ChEBI: 82558,cpd:C19559,20,18,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O3,C20H17O3,306.1255944,307.1334195,305.11776944337,4732,cpd:C19561,7-Hydroxymethyl-12-methylbenz[a]anthracene;,C20H16O,7-Hydroxymethyl-12-methylbenz[a]anthracene; 12-Methylbenz[a]anthracene-7-methanol,R09441 R09444,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 2.8.2.14,NA,NA,CAS: 568-75-2; PubChem: 124490233; ChEBI: 82559,cpd:C19489; cpd:C19561; cpd:C19604,20,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O1,C20H15O1,272.1201151,273.1279402,271.11229014338,4733,cpd:C19562,7-Hydroxymethyl-12-methylbenz[a]anthracene sulfate,C20H16O4S,7-Hydroxymethyl-12-methylbenz[a]anthracene sulfate,R09444,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,2.8.2.14,NA,NA,CAS: 80733-96-6; PubChem: 124490234; ChEBI: 82560,cpd:C19562,20,16,4,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O4S1,C20H15O4S1,352.0769302,353.0847552,351.06910514339,4734,cpd:C19563,4-[(Hydroxymethyl)nitrosoamino]-1-(3-pyridinyl)-1-butanone,C10H13N3O3,4-[(Hydroxymethyl)nitrosoamino]-1-(3-pyridinyl)-1-butanone,R09421 R09431,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1,NA,NA,PubChem: 124490235; ChEBI: 82561,cpd:C19563; cpd:C19566; cpd:C19602,10,13,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O3N3,C10H12O3N3,223.0956913,224.1035163,222.08786634340,4735,cpd:C19564,4-(Nitrosoamino)-1-(3-pyridinyl)-1-butanone,C9H11N3O2,4-(Nitrosoamino)-1-(3-pyridinyl)-1-butanone,R09431 R09435,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,NA,NA,NA,PubChem: 124490236; ChEBI: 82562,cpd:C19564,9,11,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O2N3,C9H10O2N3,193.0851266,194.0929516,192.07730164341,4736,cpd:C19565,4-Hydroxy-1-(3-pyridinyl)-1-butanone,C9H11NO2,4-Hydroxy-1-(3-pyridinyl)-1-butanone,R09435 R09438,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,NA,NA,NA,CAS: 59578-62-0; PubChem: 124490237; ChEBI: 82563; ChEMBL: CHEMBL17416,cpd:C00079; cpd:C02057; cpd:C02265; cpd:C07527; cpd:C18090; cpd:C18747; cpd:C19565; cpd:C19578; cpd:C20487; cpd:C20488,9,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O2N1,C9H10O2N1,165.0789786,166.0868036,164.07115364342,4737,cpd:C19566,4-Hydroxy-4-(methylnitrosoamino)-1-(3-pyridinyl)-1-butanone,C10H13N3O3,4-Hydroxy-4-(methylnitrosoamino)-1-(3-pyridinyl)-1-butanone,R09423 R09433,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1,NA,NA,PubChem: 124490238; ChEBI: 82564,cpd:C19563; cpd:C19566; cpd:C19602,10,13,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O3N3,C10H12O3N3,223.0956913,224.1035163,222.08786634343,4738,cpd:C19568,N-Nitrosomethanamine,CH4N2O,N-Nitrosomethanamine,R09433 R09434,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,NA,NA,NA,CAS: 64768-29-2; PubChem: 124490240; ChEBI: 82565,cpd:C00086; cpd:C19568; cpd:C20306,1,4,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H5O1N2,C1H3O1N2,60.03236276,61.04018779,59.024537734344,4739,cpd:C19574,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol;,C10H15N3O2,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol; NNAL,R09420 R09424 R09425 R09426 R09427 R09430,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.1.1.146; 1.1.1.184; 1.3.1.20; 1.14.13.-; 1.14.14.1; 2.4.1.17,NA,NA,CAS: 76014-81-8; PubChem: 124490246; ChEBI: 82569,cpd:C19574,10,15,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O2N3,C10H14O2N3,209.1164267,210.1242518,208.10860174345,4740,cpd:C19577,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",C10H15N3O3,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",R09424 R09434,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1,NA,NA,PubChem: 124490249; ChEBI: 82571,cpd:C19577; cpd:C19580; cpd:C19603,10,15,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O3N3,C10H14O3N3,225.1113414,226.1191664,224.10351634346,4741,cpd:C19578,5-(3-Pyridyl)-2-hydroxytetrahydrofuran,C9H11NO2,5-(3-Pyridyl)-2-hydroxytetrahydrofuran,R09434 R09439,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,NA,NA,NA,CAS: 53798-73-5; PubChem: 124490250; ChEBI: 82572; ChEMBL: CHEMBL279109,cpd:C00079; cpd:C02057; cpd:C02265; cpd:C07527; cpd:C18090; cpd:C18747; cpd:C19565; cpd:C19578; cpd:C20487; cpd:C20488,9,11,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O2N1,C9H10O2N1,165.0789786,166.0868036,164.07115364347,4742,cpd:C19579,gamma-Hydroxy-3-pyridinebutanoate,C9H11NO3,gamma-Hydroxy-3-pyridinebutanoate,R09439 R09440,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,NA,NA,NA,CAS: 15569-97-8; PubChem: 124490251; ChEBI: 82573,cpd:C00082; cpd:C01536; cpd:C03290; cpd:C04368; cpd:C06420; cpd:C14322; cpd:C19579; cpd:C19712; cpd:C20807; cpd:C21308,9,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O3N1,C9H10O3N1,181.0738932,182.0817182,180.06606824348,4743,cpd:C19580,alpha-[3-[(Hydroxymethyl)nitrosoamino]propyl]-3-pyridinemethanol,C10H15N3O3,alpha-[3-[(Hydroxymethyl)nitrosoamino]propyl]-3-pyridinemethanol,R09425 R09432,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1,NA,NA,PubChem: 124490252; ChEBI: 82574,cpd:C19577; cpd:C19580; cpd:C19603,10,15,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O3N3,C10H14O3N3,225.1113414,226.1191664,224.10351634349,4744,cpd:C19581,alpha-[3-(Nitrosoamino)propyl]-3-pyridinemethanol,C9H13N3O2,alpha-[3-(Nitrosoamino)propyl]-3-pyridinemethanol,R09432 R09436,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,NA,NA,NA,PubChem: 124490253; ChEBI: 82575,cpd:C19581,9,13,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O2N3,C9H12O2N3,195.1007767,196.1086017,194.09295164350,4745,cpd:C19582,"1-(3-Pyridinyl)-1,4-butanediol",C9H13NO2,"1-(3-Pyridinyl)-1,4-butanediol",R09436 R09440,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,NA,NA,NA,CAS: 76014-83-0; PubChem: 124490254; ChEBI: 82576,cpd:C01869; cpd:C04548; cpd:C05587; cpd:C07146; cpd:C07441; cpd:C07453; cpd:C07832; cpd:C08273; cpd:C19582,9,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O2N1,C9H12O2N1,167.0946287,168.1024537,166.08680364351,4746,cpd:C19585,Aflatoxin Q1,C17H12O7,Aflatoxin Q1,R09404,Metabolism of xenobiotics by cytochrome P450,1.14.13.-; 1.14.14.1,NA,NA,CAS: 52819-96-2; PubChem: 124490257; ChEBI: 78582; KNApSAcK: C00023624,cpd:C10198; cpd:C16755; cpd:C16756; cpd:C19585; cpd:C19586; cpd:C19595,17,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O7,C17H11O7,328.0583027,329.0661278,327.05047774352,4747,cpd:C19586,"Aflatoxin B1-exo-8,9-epoxide;",C17H12O7,"Aflatoxin B1-exo-8,9-epoxide; 2,3-Epoxyaflatoxin B1",R09408 R09409 R09410,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,1.14.13.-; 1.14.14.1; 2.5.1.18; 3.3.2.9,NA,NA,CAS: 42583-46-0; PubChem: 124490258; ChEBI: 30725,cpd:C10198; cpd:C16755; cpd:C16756; cpd:C19585; cpd:C19586; cpd:C19595,17,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O7,C17H11O7,328.0583027,329.0661278,327.05047774353,4748,cpd:C19588,Aflatoxin B1 diol;,C17H14O8,"Aflatoxin B1 diol; Aflatoxin B1-2,3-dihydrodiol",R09410 R09411,Metabolism of xenobiotics by cytochrome P450,3.3.2.9,NA,NA,CAS: 50668-79-6; PubChem: 124490260; ChEBI: 82580,cpd:C04581; cpd:C09967; cpd:C10021; cpd:C11620; cpd:C17788; cpd:C19588; cpd:C19589,17,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H15O8,C17H13O8,346.0688674,347.0766924,345.06104244354,4749,cpd:C19589,Aflatoxin B1 dialdehyde,C17H14O8,Aflatoxin B1 dialdehyde,R09411 R09412 R09413,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,PubChem: 124490261,cpd:C04581; cpd:C09967; cpd:C10021; cpd:C11620; cpd:C17788; cpd:C19588; cpd:C19589,17,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H15O8,C17H13O8,346.0688674,347.0766924,345.06104244355,4750,cpd:C19590,"6-[2,3-Dihydroxy-1-(hydroxymethyl)propyl]-1,2-dihydro-7-hydroxy-9-methoxy-cyclopenta[c][1]benzopyran-3,4-dione",C17H18O8,"6-[2,3-Dihydroxy-1-(hydroxymethyl)propyl]-1,2-dihydro-7-hydroxy-9-methoxy-cyclopenta[c][1]benzopyran-3,4-dione",R09414 R09415,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,PubChem: 124490262; ChEBI: 82581,cpd:C06433; cpd:C19590,17,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H19O8,C17H17O8,350.1001675,351.1079926,349.09234254356,4751,cpd:C19591,"1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal",C17H16O8,"1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal",R09412 R09414,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,PubChem: 124490263; ChEBI: 82582,cpd:C19591; cpd:C19592,17,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H17O8,C17H15O8,348.0845175,349.0923425,347.07669244357,4752,cpd:C19592,"alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde",C17H16O8,"alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde",R09413 R09415,Metabolism of xenobiotics by cytochrome P450,NA,NA,NA,PubChem: 124490264; ChEBI: 82583,cpd:C19591; cpd:C19592,17,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H17O8,C17H15O8,348.0845175,349.0923425,347.07669244358,4753,cpd:C19594,"Aflatoxin-M1-8,9-epoxide",C17H12O8,"Aflatoxin-M1-8,9-epoxide",R09406,Metabolism of xenobiotics by cytochrome P450,1.14.14.1,NA,NA,CAS: 161596-64-1; PubChem: 124490265; ChEBI: 78577 82584,cpd:C10836; cpd:C19594,17,12,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O8,C17H11O8,344.0532173,345.0610424,343.04539234359,4754,cpd:C19595,"Aflatoxin B1-endo-8,9-epoxide",C17H12O7,"Aflatoxin B1-endo-8,9-epoxide",R09407,Metabolism of xenobiotics by cytochrome P450,1.14.14.1,NA,NA,CAS: 141899-13-0; PubChem: 124490266; ChEBI: 78586 82585,cpd:C10198; cpd:C16755; cpd:C16756; cpd:C19585; cpd:C19586; cpd:C19595,17,12,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H13O7,C17H11O7,328.0583027,329.0661278,327.05047774360,4755,cpd:C19602,4-(Methylnitrosamino)-1-(1-oxido-3-pyridinyl)-1-butanone;,C10H13N3O3,4-(Methylnitrosamino)-1-(1-oxido-3-pyridinyl)-1-butanone; 4-(Methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanone; NNK-N-oxide,R09429,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,NA,NA,NA,CAS: 76014-82-9; PubChem: 124490271; ChEBI: 82588,cpd:C19563; cpd:C19566; cpd:C19602,10,13,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O3N3,C10H12O3N3,223.0956913,224.1035163,222.08786634361,4756,cpd:C19603,4-(Methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanol;,C10H15N3O3,4-(Methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanol; NNAL-N-oxide,R09430,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,NA,NA,NA,CAS: 85352-99-4; PubChem: 124490272; ChEBI: 82589,cpd:C19577; cpd:C19580; cpd:C19603,10,15,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O3N3,C10H14O3N3,225.1113414,226.1191664,224.10351634362,4757,cpd:C19604,"7,12-Dimethylbenz[a]anthracene 5,6-oxide;",C20H16O,"7,12-Dimethylbenz[a]anthracene 5,6-oxide; DMBA-5,6-epoxide",R09442 R09443,Metabolism of xenobiotics by cytochrome P450,1.14.14.1; 3.3.2.9,NA,NA,CAS: 39834-38-3; PubChem: 124490273; ChEBI: 82590,cpd:C19489; cpd:C19561; cpd:C19604,20,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O1,C20H15O1,272.1201151,273.1279402,271.11229014363,4758,cpd:C19605,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronide;,C16H23N3O8,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronide; NNAL-O-glucuronide,R09426,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,2.4.1.17,NA,NA,CAS: 131119-04-5; PubChem: 124490274; ChEBI: 82591,cpd:C19605; cpd:C19606,16,23,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H24O8N3,C16H22O8N3,385.1485147,386.1563397,384.14068974364,4759,cpd:C19606,NNAL-N-glucuronide,C16H23N3O8,NNAL-N-glucuronide,R09427,Metabolism of xenobiotics by cytochrome P450; Chemical carcinogenesis,2.4.1.17,NA,NA,PubChem: 124490275; ChEBI: 82592,cpd:C19605; cpd:C19606,16,23,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H24O8N3,C16H22O8N3,385.1485147,386.1563397,384.14068974365,4760,cpd:C19607,"trans-5,6-Dihydro-5,6-dihydroxy-7,12-dimethylbenz[a]anthracene;",C20H18O2,"trans-5,6-Dihydro-5,6-dihydroxy-7,12-dimethylbenz[a]anthracene; trans-DMBA-5,6-dihydrodiol",R09443,Metabolism of xenobiotics by cytochrome P450,3.3.2.9,NA,NA,CAS: 16644-15-8; PubChem: 124490276; ChEBI: 82593,cpd:C18728; cpd:C19490; cpd:C19607,20,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H19O2,C20H17O2,290.1306798,291.1385049,289.12285484366,4761,cpd:C00477,Ecdysone,C27H44O6,Ecdysone,R02373 R02374 R02375 R08135 R08141 R08142,Insect hormone biosynthesis; Apoptosis - fly,1.1.1.-; 1.1.3.16; 1.14.99.22; 1.-.-.-; 2.3.1.139,NA,Compounds with biological roles [BR:br08001];  Steroids;   27-Carbon atoms;    Cholestane derivatives;     C00477  Ecdysone;  Hormones and transmitters;   Steroid hormones;    Others;     C00477  Ecdysone; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Cholestane;     C00477  Ecdysone; Target-based classification of compounds [BR:br08010];  Nuclear receptors;   Thyroid hormone like receptors;    Liver X receptor like receptor;     ecdysone receptor;      C00477  Ecdysone,CAS: 3604-87-3; PubChem: 3760; ChEBI: 16688; ChEMBL: CHEMBL1456897 CHEMBL549300; LIPIDMAPS: LMST01010210; KNApSAcK: C00003651 C00048314; 3DMET: B01257; NIKKAJI: J8.177I,cpd:C00477; cpd:C08835; cpd:C16496,27,44,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O6,C27H43O6,464.3137891,465.3216142,463.30596414367,4762,cpd:C02513,3-Dehydroecdysone,C27H42O6,3-Dehydroecdysone,R02373 R08139 R08140 R08141,Insect hormone biosynthesis,1.1.1.-; 1.1.3.16,NA,NA,CAS: 39750-00-0; PubChem: 5523; ChEBI: 17058; LIPIDMAPS: LMST01010172; 3DMET: B04853; NIKKAJI: J576.787C,cpd:C02513; cpd:C08832; cpd:C11726; cpd:C15739,27,42,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O6,C27H41O6,462.2981391,463.3059641,461.2903144368,4763,cpd:C02633,20-Hydroxyecdysone;,C27H44O7,20-Hydroxyecdysone; Crustecdysone; Ecdysterone,R02374 R08143,Insect hormone biosynthesis,1.14.99.22; 1.14.-.-,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Cholestane;     C02633  20-Hydroxyecdysone; Major components of natural products [BR:br08323];  Crude drugs;   Achyranthes root;    C02633  20-Hydroxyecdysone,CAS: 5289-74-7; PubChem: 5613; ChEBI: 16587; ChEMBL: CHEMBL224128 CHEMBL490151; LIPIDMAPS: LMST01010209; KNApSAcK: C00003654; PDB-CCD: 20E; 3DMET: B04858; NIKKAJI: J13.425B,cpd:C02633; cpd:C08811; cpd:C08819; cpd:C08838; cpd:C16499; cpd:C16992,27,44,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O7,C27H43O7,480.3087038,481.3165288,479.30087874369,4764,cpd:C09694,Juvenile hormone III,C16H26O3,Juvenile hormone III,R08148 R08149 R08151 R08153 R08155,Insect hormone biosynthesis,1.14.13.202; 2.1.1.325; 3.1.1.59,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010301 Acyclic farnesane sesquiterpenoids;      C09694  Juvenile hormone III; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Farnesenes;     C09694  Juvenile hormone III,CAS: 22963-93-5; PubChem: 11884; ChEBI: 27493; LIPIDMAPS: LMPR0103010004; KNApSAcK: C00003157; PDB-CCD: JH3; 3DMET: B03202; NIKKAJI: J37.976J,cpd:C04834; cpd:C07383; cpd:C07895; cpd:C09693; cpd:C09694,16,26,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O3,C16H25O3,266.1881947,267.1960197,265.18036974370,4765,cpd:C16493,"3beta,5beta-Ketodiol;",C27H44O3,"3beta,5beta-Ketodiol; 2,22,25-Trideoxyecdysone; 3beta,14alpha-Dihydroxy-5beta-cholest-7-en-6-one",R08133 R08137,Insect hormone biosynthesis,NA,NA,NA,CAS: 39219-57-3; PubChem: 47205789; ChEBI: 19290; LIPIDMAPS: LMST01010179; NIKKAJI: J658.879D,cpd:C01673; cpd:C03963; cpd:C07712; cpd:C08127; cpd:C08913; cpd:C08914; cpd:C12919; cpd:C15633; cpd:C16493; cpd:C16819; cpd:C17331; cpd:C17332; cpd:C17333; cpd:C17336; cpd:C17339; cpd:C19648; cpd:C19649; cpd:C19650,27,44,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O3,C27H43O3,416.3290453,417.3368703,415.32122024371,4766,cpd:C16494,"3beta,5beta-Ketotriol;",C27H44O4,"3beta,5beta-Ketotriol; 2,22-Dideoxyecdysone",R08133 R08134,Insect hormone biosynthesis,NA,NA,NA,PubChem: 47205790; ChEBI: 80530; NIKKAJI: J372.643F,cpd:C08899; cpd:C16494; cpd:C17003; cpd:C17335; cpd:C18231,27,44,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O4,C27H43O4,432.3239599,433.3317849,431.31613494372,4767,cpd:C16495,2-Deoxyecdysone,C27H44O5,2-Deoxyecdysone,R08134 R08135,Insect hormone biosynthesis,NA,NA,NA,CAS: 31575-91-4; PubChem: 47205791; ChEBI: 19566; LIPIDMAPS: LMST01010182; NIKKAJI: J39.048H,cpd:C08890; cpd:C08896; cpd:C16495,27,44,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O5,C27H43O5,448.3188745,449.3266995,447.31104954373,4768,cpd:C16496,3-Epiecdysone,C27H44O6,3-Epiecdysone,R08140,Insect hormone biosynthesis,1.1.1.-,NA,NA,PubChem: 47205792; ChEBI: 80531; NIKKAJI: J39.049F,cpd:C00477; cpd:C08835; cpd:C16496,27,44,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O6,C27H43O6,464.3137891,465.3216142,463.30596414374,4769,cpd:C16497,3-Dehydro-2-deoxyecdysone,C27H42O5,3-Dehydro-2-deoxyecdysone,R08138 R08139,Insect hormone biosynthesis,NA,NA,NA,PubChem: 47205793; ChEBI: 80532; NIKKAJI: J2.567.491J,cpd:C16497,27,42,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O5,C27H41O5,446.3032245,447.3110495,445.29539944375,4770,cpd:C16498,"2,22-Dideoxy-3-dehydroecdysone",C27H42O4,"2,22-Dideoxy-3-dehydroecdysone",R08136 R08138,Insect hormone biosynthesis,NA,NA,NA,PubChem: 47205794; ChEBI: 80533; NIKKAJI: J2.802.768K,cpd:C04715; cpd:C08891; cpd:C08902; cpd:C08909; cpd:C16498; cpd:C17337; cpd:C17891,27,42,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O4,C27H41O4,430.3083098,431.3161349,429.30048484376,4771,cpd:C16499,26-Hydroxyecdysone,C27H44O7,26-Hydroxyecdysone,R08142,Insect hormone biosynthesis,1.-.-.-,NA,NA,CAS: 52717-49-4; PubChem: 47205795; ChEBI: 80534; NIKKAJI: J530.119J,cpd:C02633; cpd:C08811; cpd:C08819; cpd:C08838; cpd:C16499; cpd:C16992,27,44,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O7,C27H43O7,480.3087038,481.3165288,479.30087874377,4772,cpd:C16500,"20,26-Dihydroxyecdysone",C27H44O8,"20,26-Dihydroxyecdysone",R08143,Insect hormone biosynthesis,1.14.-.-,NA,NA,CAS: 19458-46-9; PubChem: 47205796; ChEBI: 19793; LIPIDMAPS: LMST01010184; NIKKAJI: J16.079B,cpd:C08834; cpd:C16500,27,44,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O8,C27H43O8,496.3036184,497.3114434,495.29579334378,4773,cpd:C16502,Farnesoic acid;,C15H24O2,"Farnesoic acid; trans,trans-Farnesoic acid; (2E,6E)-Farnesoate",R08146 R08147 R10925,Insect hormone biosynthesis,1.2.1.3; 1.14.13.203; 2.1.1.325,NA,NA,CAS: 462-11-3; PubChem: 47205798; ChEBI: 84162; ChEMBL: CHEMBL369779; NIKKAJI: J14.294H,cpd:C02293; cpd:C02621; cpd:C07526; cpd:C09627; cpd:C09678; cpd:C09681; cpd:C09700; cpd:C09733; cpd:C10749; cpd:C10769; cpd:C10776; cpd:C16502; cpd:C16946; cpd:C17069; cpd:C17493; cpd:C17604; cpd:C20233,15,24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O2,C15H23O2,236.17763,237.185455,235.1698054379,4774,cpd:C16503,Methyl farnesoate;,C16H26O2,"Methyl farnesoate; Methyl (2E,6E)-farnesoate",R08147 R08148,Insect hormone biosynthesis,1.14.13.202; 2.1.1.325,NA,NA,CAS: 10485-70-8; PubChem: 47205799; ChEBI: 80535; ChEMBL: CHEMBL171329; NIKKAJI: J38.779G,cpd:C08510; cpd:C09874; cpd:C16503,16,26,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O2,C16H25O2,250.1932801,251.2011051,249.1854554380,4775,cpd:C16504,Juvenile hormone III acid;,C15H24O3,"Juvenile hormone III acid; Juvenile-hormone-III carboxylate; (2E,6E,10R)-10,11-Epoxy-3,7,11-trimethyldodeca-2,6-dienoate",R08149 R08151 R08152 R10925,Insect hormone biosynthesis,1.14.13.203; 2.1.1.325; 3.1.1.59,NA,NA,PubChem: 47205800; ChEBI: 80536; NIKKAJI: J665.876H,cpd:C09645; cpd:C16504; cpd:C17502; cpd:C17605; cpd:C17607; cpd:C17612,15,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H25O3,C15H23O3,252.1725446,253.1803697,251.16471964381,4776,cpd:C16505,(10S)-Juvenile hormone III diol,C16H28O4,(10S)-Juvenile hormone III diol,R08150 R08153 R08154,Insect hormone biosynthesis,3.1.1.59,NA,NA,PubChem: 47205801; ChEBI: 80537; NIKKAJI: J2.802.823G,cpd:C05552; cpd:C08092; cpd:C08093; cpd:C16505,16,28,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H29O4,C16H27O4,284.1987594,285.2065844,283.19093434382,4777,cpd:C16506,(10S)-Juvenile hormone III acid diol,C15H26O4,(10S)-Juvenile hormone III acid diol,R08150 R08152,Insect hormone biosynthesis,3.1.1.59,NA,NA,PubChem: 47205802; ChEBI: 80538; NIKKAJI: J2.802.895D,cpd:C16506,15,26,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O4,C15H25O4,270.1831093,271.1909343,269.17528434383,4778,cpd:C16507,(10S)-Juvenile hormone III diol phosphate,C16H29O7P,(10S)-Juvenile hormone III diol phosphate,R08154,Insect hormone biosynthesis,NA,NA,NA,PubChem: 47205803; ChEBI: 80539; NIKKAJI: J2.802.902K,cpd:C16507,16,29,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H30O7P1,C16H28O7P1,364.1650903,365.1729153,363.15726524384,4779,cpd:C16508,12-trans-Hydroxy juvenile hormone III,C16H26O4,12-trans-Hydroxy juvenile hormone III,R08155,Insect hormone biosynthesis,NA,NA,NA,PubChem: 47205804; ChEBI: 80540; NIKKAJI: J2.802.927F,cpd:C12869; cpd:C16508; cpd:C17403,16,26,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H27O4,C16H25O4,282.1831093,283.1909343,281.17528434385,4780,cpd:C16509,"14alpha-Hydroxy-5beta-cholest-7-ene-3,6-dione;",C27H42O3,"14alpha-Hydroxy-5beta-cholest-7-ene-3,6-dione; Diketol",R08132 R08136 R08137,Insect hormone biosynthesis,NA,NA,NA,PubChem: 47205805; ChEBI: 80541; NIKKAJI: J2.802.941A,cpd:C08898; cpd:C08918; cpd:C14994; cpd:C16509; cpd:C20839; cpd:C21076; cpd:C21077,27,42,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O3,C27H41O3,414.3133952,415.3212202,413.30557024386,4781,cpd:C01471,Acrolein;,C3H4O,Acrolein; Acrylaldehyde; Acrylic aldehyde; Propenal,R03572 R08279 R08289,Drug metabolism - cytochrome P450,1.1.1.54,NA,"Pesticides [BR:br08007];  Pesticides;   Herbicides;    Others;     C01471  Acrolein; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C01471  Acrolein; Target-based classification of compounds [BR:br08010];  Ion channels;   Related to voltage-gated cation channels;    Transient receptor potential family, TRPA (ANKTM1);     transient receptor potential cation channel, subfamily A, member 1;      C01471  Acrolein",CAS: 107-02-8; PubChem: 4646; ChEBI: 15368; ChEMBL: CHEMBL721; 3DMET: B00297; NIKKAJI: J4.045B,cpd:C00173; cpd:C01471; cpd:C05986; cpd:C06195; cpd:C07517; cpd:C20382; cpd:C20683,3,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H5O1,C3H3O1,56.02621475,57.03403978,55.018389724387,4782,cpd:C05011,Hydroxytamoxifen;,C26H29NO2,Hydroxytamoxifen; 4-Hydroxytamoxifen,R08267 R08269,Drug metabolism - cytochrome P450,1.14.13.-; 1.14.14.1,NA,NA,CAS: 68047-06-3; PubChem: 7494; ChEBI: 44616; ChEMBL: CHEMBL489; PDB-CCD: OHT; NIKKAJI: J370.403C,cpd:C05011; cpd:C14296; cpd:C16544; cpd:C16545,26,29,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H30O2N1,C26H28O2N1,387.2198292,388.2276542,386.21200414388,4783,cpd:C06868,Carbamazepine,C15H12N2O,Carbamazepine,R08312 R08313 R08317,Drug metabolism - cytochrome P450,1.14.13.-; 1.14.14.1,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N03 ANTIEPILEPTICS;    N03A ANTIEPILEPTICS;     N03AF Carboxamide derivatives;      N03AF01 Carbamazepine;       D00252  Carbamazepine (JP17/USP/INN); USP drug classification [BR:br08302];  Anticonvulsants;   Sodium Channel Agents;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN);  Bipolar Agents;   Mood Stabilizers;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   11  Agents affecting central nervous system;    113  Antiepileptics;     1139  Others;      D00252  Carbamazepine (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  Ion channels;   Voltage-gated cation channels;    Na+ channel, SCN alpha, NaV1.x;     voltage-gated sodium channel (SCN1A);      Carbamazepine;       D00252  Carbamazepine (JP17/USP/INN);     voltage-gated sodium channel (SCN2A);      Carbamazepine;       D00252  Carbamazepine (JP17/USP/INN);     voltage-gated sodium channel (SCN3A);      Carbamazepine;       D00252  Carbamazepine (JP17/USP/INN);     voltage-gated sodium channel (SCN4A);      Carbamazepine;       D00252  Carbamazepine (JP17/USP/INN);     voltage-gated sodium channel (SCN5A);      Carbamazepine;       D00252  Carbamazepine (JP17/USP/INN);     voltage-gated sodium channel (SCN8A);      Carbamazepine;       D00252  Carbamazepine (JP17/USP/INN);     voltage-gated sodium channel (SCN9A);      Carbamazepine;       D00252  Carbamazepine (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C19;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN);  CYP inducers;   CYP2C9;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN);   CYP2C19;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN);   CYP3A4;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN);   CYP3A5;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN);   CYP3A7;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN);   CYP3A;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN);  CYP substrates;   CYP2B6;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN);   CYP2C8;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN);   CYP3A4;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN);  Transporter inducers;   ABCB1;    Carbamazepine;     D00252  Carbamazepine (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00252  Carbamazepine; Neurological agents [br08367.html];  Antiepileptic agents;   D00252; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00252; Pharmacogenomic biomarkers in FDA drug labels [br08341.html];  Polymorphisms and germline mutations;   D00252",CAS: 298-46-4; PubChem: 9085; ChEBI: 3387; ChEMBL: CHEMBL108; NIKKAJI: J8.590A,cpd:C06868; cpd:C10688; cpd:C14904; cpd:C15121,15,12,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O1N2,C15H11O1N2,236.094963,237.102788,235.0871384389,4784,cpd:C07047,Ifosfamide;,C7H15Cl2N2O2P,Ifosfamide; Isophosphamide,R08285 R08286 R08287,Drug metabolism - cytochrome P450,1.14.13.-; 1.14.14.1,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07047  Isophosphamide; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01A ALKYLATING AGENTS;     L01AA Nitrogen mustard analogues;      L01AA06 Ifosfamide;       D00343  Ifosfamide (JAN/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    421  Alkylating agents;     4211  Chlorethylamines;      D00343  Ifosfamide (JAN/USP/INN); Target-based classification of drugs [BR:br08310];  Others;   Nucleic acid;    DNA;     Ifosfamide;      D00343  Ifosfamide (JAN/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2B6;    Ifosfamide;     D00343  Ifosfamide (JAN/USP/INN);   CYP3A4;    Ifosfamide;     D00343  Ifosfamide (JAN/USP/INN); Antineoplastics [br08340.html];  D00343; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00343,CAS: 3778-73-2; PubChem: 9259; ChEBI: 5864; ChEMBL: CHEMBL1024; NIKKAJI: J2.196B,cpd:C06933; cpd:C07047; cpd:C07888,7,15,2,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H16O2N2P1Cl2,C7H14O2N2P1Cl2,260.0248201,261.0326451,259.01699514390,4785,cpd:C07073,Lidocaine,C14H22N2O,Lidocaine,R08293 R08294 R08300,Drug metabolism - cytochrome P450,1.14.13.-; 1.14.14.1; 3.1.1.1,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01B ANTIARRHYTHMICS, CLASS I AND III;     C01BB Antiarrhythmics, class Ib;      C01BB01 Lidocaine;       D00358  Lidocaine (JP17/USP/INN);   C05 VASOPROTECTIVES;    C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;     C05AD Local anesthetics;      C05AD01 Lidocaine;       D00358  Lidocaine (JP17/USP/INN);  D DERMATOLOGICALS;   D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.;    D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.;     D04AB Anesthetics for topical use;      D04AB01 Lidocaine;       D00358  Lidocaine (JP17/USP/INN);  N NERVOUS SYSTEM;   N01 ANESTHETICS;    N01B ANESTHETICS, LOCAL;     N01BB Amides;      N01BB02 Lidocaine;       D00358  Lidocaine (JP17/USP/INN);  R RESPIRATORY SYSTEM;   R02 THROAT PREPARATIONS;    R02A THROAT PREPARATIONS;     R02AD Anesthetics, local;      R02AD02 Lidocaine;       D00358  Lidocaine (JP17/USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01H LOCAL ANESTHETICS;     S01HA Local anesthetics;      S01HA07 Lidocaine;       D00358  Lidocaine (JP17/USP/INN);   S02 OTOLOGICALS;    S02D OTHER OTOLOGICALS;     S02DA Analgesics and anesthetics;      S02DA01 Lidocaine;       D00358  Lidocaine (JP17/USP/INN); USP drug classification [BR:br08302];  Anesthetics;   Local Anesthetics;    Lidocaine;     D00358  Lidocaine (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   12  Agents affecting peripheral nervous system;    121  Local anesthetics;     1214  Xylidines;      D00358  Lidocaine (JP17/USP/INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for  urogenital organs and anus;   30 Hemorrhoid drugs for external use;    D00358  Lidocaine (JP17/USP/INN);  Agents for integumentary system;   57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches);    D00358  Lidocaine (JP17/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Lidocaine;     D00358  Lidocaine (JP17/USP/INN); Pharmaceutical additives [BR:br08316];  Soothing agent;   D00358  [001667] Lidocaine;  Solubilizer;   D00358  [001667] Lidocaine;  Solubilization agent;   D00358  [001667] Lidocaine;  Solvent;   D00358  [001667] Lidocaine; Target-based classification of drugs [BR:br08310];  Ion channels;   Voltage-gated cation channels;    Na+ channel, SCN alpha, NaV1.x;     voltage-gated sodium channel (SCN1A);      Lidocaine;       D00358  Lidocaine (JP17/USP/INN);     voltage-gated sodium channel (SCN2A);      Lidocaine;       D00358  Lidocaine (JP17/USP/INN);     voltage-gated sodium channel (SCN3A);      Lidocaine;       D00358  Lidocaine (JP17/USP/INN);     voltage-gated sodium channel (SCN4A);      Lidocaine;       D00358  Lidocaine (JP17/USP/INN);     voltage-gated sodium channel (SCN5A);      Lidocaine;       D00358  Lidocaine (JP17/USP/INN);     voltage-gated sodium channel (SCN8A);      Lidocaine;       D00358  Lidocaine (JP17/USP/INN);     voltage-gated sodium channel (SCN9A);      Lidocaine;       D00358  Lidocaine (JP17/USP/INN);     voltage-gated sodium channel (SCN10A);      Lidocaine;       D00358  Lidocaine (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP1A2;    Lidocaine;     D00358  Lidocaine (JP17/USP/INN);   CYP2D6;    Lidocaine;     D00358  Lidocaine (JP17/USP/INN);   CYP3A4;    Lidocaine;     D00358  Lidocaine (JP17/USP/INN);  Transporter substrates;   SLC22A3;    Lidocaine;     D00358  Lidocaine (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00358  Lidocaine;   D00358  Lidocaine injection; Anesthetics, analgesics and anti-inflammatory drugs [br08369.html];  Anesthetics;   D00358; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00358",CAS: 137-58-6; PubChem: 9284; ChEBI: 6456; ChEMBL: CHEMBL79; PDB-CCD: LQZ; NIKKAJI: J5.631F,cpd:C07073; cpd:C10751,14,22,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H23O1N2,C14H21O1N2,234.1732133,235.1810384,233.16538834391,4786,cpd:C07108,Tamoxifen,C26H29NO,Tamoxifen,R08266 R08267 R08268 R08271,Drug metabolism - cytochrome P450,1.14.13.8; 1.14.13.-; 1.14.14.1,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C07108  Tamoxifen; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L02 ENDOCRINE THERAPY;    L02B HORMONE ANTAGONISTS AND RELATED AGENTS;     L02BA Anti-estrogens;      L02BA01 Tamoxifen;       D08559  Tamoxifen (INN); USP drug classification [BR:br08302];  Antineoplastics;   Antiestrogens/Modifiers;    Tamoxifen;     D08559  Tamoxifen (INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    Estrogen receptor;     estrogen receptor 1;      Tamoxifen;       D08559  Tamoxifen (INN);     estrogen receptor 2;      Tamoxifen;       D08559  Tamoxifen (INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP1A2;    Tamoxifen;     D08559  Tamoxifen (INN);   CYP2C9;    Tamoxifen;     D08559  Tamoxifen (INN);   CYP2D6;    Tamoxifen;     D08559  Tamoxifen (INN);   CYP3A4;    Tamoxifen;     D08559  Tamoxifen (INN);  Transporter inhibitors;   ABCC2;    Tamoxifen;     D08559  Tamoxifen (INN),CAS: 10540-29-1; PubChem: 9319; ChEBI: 41774; ChEMBL: CHEMBL83; PDB-CCD: CTX; NIKKAJI: J10.452C,cpd:C07108,26,29,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H30O1N1,C26H28O1N1,371.2249146,372.2327396,370.21708954392,4787,cpd:C07163,Methadone,C21H27NO,Methadone,R08339,Drug metabolism - cytochrome P450,1.14.13.-,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N07 OTHER NERVOUS SYSTEM DRUGS;    N07B DRUGS USED IN ADDICTIVE DISORDERS;     N07BC Drugs used in opioid dependence;      N07BC02 Methadone;       D08195  Methadone (BAN); USP drug classification [BR:br08302];  Analgesics;   Opioid Analgesics, Long-acting;    Methadone;     D08195  Methadone (BAN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Opioid;     mu-opioid receptor;      Methadone;       D08195  Methadone (BAN);  Ion channels;   Glutamate-gated cation channels;    Glutamate (ionotropic), NMDA;     N-methyl-D-aspartate receptor;      Methadone;       D08195  Methadone (BAN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2D6;    Methadone;     D08195  Methadone (BAN);  CYP substrates;   CYP2B6;    Methadone;     D08195  Methadone (BAN);   CYP3A4;    Methadone;     D08195  Methadone (BAN)",CAS: 76-99-3; PubChem: 9372; ChEBI: 6807; ChEMBL: CHEMBL651; NIKKAJI: J4.190D,cpd:C06961; cpd:C07163,21,27,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H28O1N1,C21H26O1N1,309.2092645,310.2170895,308.20143954393,4788,cpd:C07185,Valproic acid,C8H16O2,Valproic acid,R08324 R08325 R08326 R08327 R08336 R08337,Drug metabolism - cytochrome P450; Bile secretion,1.14.13.-,NA,"Target-based classification of compounds [BR:br08010];  Enzymes;   Transferases;    4-aminobutyrate aminotransferase;     C07185  Valproic acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N03 ANTIEPILEPTICS;    N03A ANTIEPILEPTICS;     N03AG Fatty acid derivatives;      N03AG01 Valproic acid;       D00399  Valproic acid (USP); USP drug classification [BR:br08302];  Anticonvulsants;   Gamma-aminobutyric Acid (GABA) Augmenting Agents;    Valproate;     D00399  Valproic acid (USP);  Antimigraine Agents;   Prophylactic;    Valproate;     D00399  Valproic acid (USP);  Bipolar Agents;   Mood Stabilizers;    Valproate;     D00399  Valproic acid (USP); Target-based classification of drugs [BR:br08310];  Ion channels;   Voltage-gated cation channels;    Ca2+ channel, CACN alpha-1, CaVx.x;     calcium channel T type;      Valproic acid;       D00399  Valproic acid (USP);  Enzymes;   Transferases;    histone acetyltransferase;     Valproic acid;      D00399  Valproic acid (USP);    GABA transaminase;     Valproic acid;      D00399  Valproic acid (USP);   Hydrolases;    histone deacetylase;     Valproic acid;      D00399  Valproic acid (USP); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2C9;    Valproic acid;     D00399  Valproic acid (USP);   CYP3A4;    Valproic acid;     D00399  Valproic acid (USP); Neurological agents [br08367.html];  Antiepileptic agents;   D00399; Pharmacogenomic biomarkers in FDA drug labels [br08341.html];  Polymorphisms and germline mutations;   D00399",CAS: 99-66-1; PubChem: 9394; ChEBI: 39867; ChEMBL: CHEMBL109; LIPIDMAPS: LMFA01020291; PDB-CCD: 2PP; NIKKAJI: J4.972G,cpd:C02147; cpd:C06423; cpd:C07185,8,16,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O2,C8H15O2,144.1150298,145.1228548,143.10720474394,4789,cpd:C07492,Oxcarbazepine,C15H12N2O2,Oxcarbazepine,R08321,Drug metabolism - cytochrome P450,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N03 ANTIEPILEPTICS;    N03A ANTIEPILEPTICS;     N03AF Carboxamide derivatives;      N03AF02 Oxcarbazepine;       D00533  Oxcarbazepine (JAN/USAN/INN); USP drug classification [BR:br08302];  Anticonvulsants;   Sodium Channel Agents;    Oxcarbazepine;     D00533  Oxcarbazepine (JAN/USAN/INN); Target-based classification of drugs [BR:br08310];  Ion channels;   Voltage-gated cation channels;    Na+ channel, SCN alpha, NaV1.x;     voltage-gated sodium channel (SCN1A);      Oxcarbazepine;       D00533  Oxcarbazepine (JAN/USAN/INN);     voltage-gated sodium channel (SCN2A);      Oxcarbazepine;       D00533  Oxcarbazepine (JAN/USAN/INN);     voltage-gated sodium channel (SCN3A);      Oxcarbazepine;       D00533  Oxcarbazepine (JAN/USAN/INN);     voltage-gated sodium channel (SCN4A);      Oxcarbazepine;       D00533  Oxcarbazepine (JAN/USAN/INN);     voltage-gated sodium channel (SCN5A);      Oxcarbazepine;       D00533  Oxcarbazepine (JAN/USAN/INN);     voltage-gated sodium channel (SCN8A);      Oxcarbazepine;       D00533  Oxcarbazepine (JAN/USAN/INN);     voltage-gated sodium channel (SCN9A);      Oxcarbazepine;       D00533  Oxcarbazepine (JAN/USAN/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C19;    Oxcarbazepine;     D00533  Oxcarbazepine (JAN/USAN/INN);  CYP inducers;   CYP3A5;    Oxcarbazepine;     D00533  Oxcarbazepine (JAN/USAN/INN);   CYP3A7;    Oxcarbazepine;     D00533  Oxcarbazepine (JAN/USAN/INN); New drug approvals in Japan [br08318.html];  Drugs with new active ingredients;   D00533",CAS: 28721-07-5; PubChem: 9695; ChEBI: 7824; ChEMBL: CHEMBL1068; NIKKAJI: J21.258J,cpd:C07443; cpd:C07492; cpd:C07496; cpd:C16601; cpd:C16602,15,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O2N2,C15H11O2N2,252.0898776,253.0977027,251.08205264395,4790,cpd:C07493,10-Hydroxycarbazepine;,C15H14N2O2,10-Hydroxycarbazepine; 10-Hydroxycarbamazepine; GP 47779,R08321 R08322,Drug metabolism - cytochrome P450; Anticonvulsants,NA,NA,NA,CAS: 29331-92-8; PubChem: 9696; ChEBI: 701; ChEMBL: CHEMBL1067; NIKKAJI: J394.865J,cpd:C07493,15,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O2N2,C15H13O2N2,254.1055277,255.1133527,253.09770274396,4791,cpd:C07495,Dihydroxycarbazepine;,C15H14N2O3,"Dihydroxycarbazepine; 10,11-Dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide; 10,11-Dihydroxycarbamazepine",R08314 R08322,Drug metabolism - cytochrome P450,3.3.2.-,NA,NA,CAS: 35079-97-1; PubChem: 9698; ChEBI: 4592; NIKKAJI: J372.992C,cpd:C07495,15,14,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O3N2,C15H13O3N2,270.1004423,271.1082674,269.09261734397,4792,cpd:C07496,"Carbamazepine-10,11-epoxide;",C15H12N2O2,"Carbamazepine-10,11-epoxide; Carbamazepine epoxide",R08312 R08314,Drug metabolism - cytochrome P450,1.14.13.-; 1.14.14.1; 3.3.2.-,NA,NA,CAS: 36507-30-9; PubChem: 9699; ChEBI: 3388; ChEMBL: CHEMBL1258; NIKKAJI: J9.164B,cpd:C07443; cpd:C07492; cpd:C07496; cpd:C16601; cpd:C16602,15,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O2N2,C15H11O2N2,252.0898776,253.0977027,251.08205264398,4793,cpd:C07501,Felbamate,C11H14N2O4,Felbamate,R08303 R08304 R08305,Drug metabolism - cytochrome P450,1.14.13.-,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N03 ANTIEPILEPTICS;    N03A ANTIEPILEPTICS;     N03AX Other antiepileptics;      N03AX10 Felbamate;       D00536  Felbamate (USAN/INN); USP drug classification [BR:br08302];  Anticonvulsants;   Glutamate Reducing Agents;    Felbamate;     D00536  Felbamate (USAN/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C19;    Felbamate;     D00536  Felbamate (USAN/INN); Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00536,CAS: 25451-15-4; PubChem: 9704; ChEBI: 4995; ChEMBL: CHEMBL1094; NIKKAJI: J50.906J,cpd:C07501; cpd:C17238,11,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O4N2,C11H13O4N2,238.0953569,239.103182,237.08753194399,4794,cpd:C07572,Citalopram,C20H21FN2O,Citalopram,R08343 R08344 R08346,Drug metabolism - cytochrome P450,1.4.3.4; 1.14.13.-; 1.14.14.1,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N06 PSYCHOANALEPTICS;    N06A ANTIDEPRESSANTS;     N06AB Selective serotonin reuptake inhibitors;      N06AB04 Citalopram;       D07704  Citalopram (USP/INN); USP drug classification [BR:br08302];  Antidepressants;   SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors);    Citalopram;     D07704  Citalopram (USP/INN); Target-based classification of drugs [BR:br08310];  Transporters;   Solute carrier family;    SLC6;     SLC6A4 (serotonin transporter);      Citalopram;       D07704  Citalopram (USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2D6;    Citalopram;     D07704  Citalopram (USP/INN);   CYP3A4;    Citalopram;     D07704  Citalopram (USP/INN);  Transporter substrates;   ABCB1;    Citalopram;     D07704  Citalopram (USP/INN),CAS: 59729-33-8; PubChem: 9775; ChEBI: 3723 77397; ChEMBL: CHEMBL549; NIKKAJI: J18.081E,cpd:C07572,20,21,1,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C20H22O1N2F1,C20H20O1N2F1,324.1637915,325.1716165,323.15596644400,4795,cpd:C07643,4-Hydroxycyclophosphamide,C7H15Cl2N2O3P,4-Hydroxycyclophosphamide,R08275 R08277 R08278,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,CAS: 40277-05-2; PubChem: 9845; ChEBI: 1864; ChEMBL: CHEMBL731; NIKKAJI: J65.704B,cpd:C07643; cpd:C07645; cpd:C16553; cpd:C16556,7,15,3,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H16O3N2P1Cl2,C7H14O3N2P1Cl2,276.0197347,277.0275597,275.01190974401,4796,cpd:C07644,4-Ketocyclophosphamide,C7H13Cl2N2O3P,4-Ketocyclophosphamide,R08277,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,CAS: 27046-19-1; PubChem: 9846; ChEBI: 1887; NIKKAJI: J78.702G,cpd:C07644; cpd:C16554,7,13,3,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H14O3N2P1Cl2,C7H12O3N2P1Cl2,274.0040846,275.0119097,272.99625964402,4797,cpd:C07645,Aldophosphamide,C7H15Cl2N2O3P,Aldophosphamide,R08278 R08279 R08280 R08281 R08282 R08283,Drug metabolism - cytochrome P450,1.1.1.1; 1.2.1.5; 2.5.1.18,NA,NA,CAS: 35144-64-0; PubChem: 9847; ChEBI: 2560; ChEMBL: CHEMBL1593; NIKKAJI: J415.698F,cpd:C07643; cpd:C07645; cpd:C16553; cpd:C16556,7,15,3,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H16O3N2P1Cl2,C7H14O3N2P1Cl2,276.0197347,277.0275597,275.01190974403,4798,cpd:C07646,Carboxyphosphamide;,C7H15Cl2N2O4P,Carboxyphosphamide; Carboxycyclophosphamide,R08282 R08283 R08284,Drug metabolism - cytochrome P450,1.2.1.5,NA,NA,CAS: 22788-18-7; PubChem: 9848; ChEBI: 3410; NIKKAJI: J16.758D,cpd:C07646; cpd:C16557,7,15,4,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H16O4N2P1Cl2,C7H14O4N2P1Cl2,292.0146493,293.0224744,291.00682434404,4799,cpd:C07647,Phosphoramide mustard;,C4H11Cl2N2O2P,Phosphoramide mustard; Phosphamide mustard,R08279,Drug metabolism - cytochrome P450,NA,NA,NA,CAS: 10159-53-2; PubChem: 9849; ChEBI: 8163; ChEMBL: CHEMBL525; NIKKAJI: J227.454J,cpd:C07647; cpd:C16559,4,11,2,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C4H12O2N2P1Cl2,C4H10O2N2P1Cl2,219.99352,221.001345,218.98569494405,4800,cpd:C07888,Cyclophosphamide,C7H15Cl2N2O2P,Cyclophosphamide,R08275 R08276,Drug metabolism - cytochrome P450,1.14.13.-,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C07888  Cyclophosphamide; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01A ALKYLATING AGENTS;     L01AA Nitrogen mustard analogues;      L01AA01 Cyclophosphamide;       D07760  Cyclophosphamide (INN); USP drug classification [BR:br08302];  Antineoplastics;   Alkylating Agents;    Cyclophosphamide;     D07760  Cyclophosphamide (INN); Target-based classification of drugs [BR:br08310];  Others;   Nucleic acid;    DNA;     Cyclophosphamide;      D07760  Cyclophosphamide (INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2B6;    Cyclophosphamide;     D07760  Cyclophosphamide (INN);   CYP2C8;    Cyclophosphamide;     D07760  Cyclophosphamide (INN);   CYP2C9;    Cyclophosphamide;     D07760  Cyclophosphamide (INN);   CYP3A4;    Cyclophosphamide;     D07760  Cyclophosphamide (INN),CAS: 50-18-0; PubChem: 10090; ChEBI: 4027; ChEMBL: CHEMBL88; NIKKAJI: J2.793F,cpd:C06933; cpd:C07047; cpd:C07888,7,15,2,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H16O2N2P1Cl2,C7H14O2N2P1Cl2,260.0248201,261.0326451,259.01699514406,4801,cpd:C08012,Levomethadyl acetate;,C23H31NO2,Levomethadyl acetate; LAAM,R08341,Drug metabolism - cytochrome P450,1.14.13.-,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N07 OTHER NERVOUS SYSTEM DRUGS;    N07B DRUGS USED IN ADDICTIVE DISORDERS;     N07BC Drugs used in opioid dependence;      N07BC03 Levacetylmethadol;       D04716  Levomethadyl acetate (USAN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Opioid;     mu-opioid receptor;      Levacetylmethadol;       D04716  Levomethadyl acetate (USAN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Levacetylmethadol;     D04716  Levomethadyl acetate (USAN),CAS: 1477-40-3; PubChem: 10212; ChEBI: 6441; ChEMBL: CHEMBL1514; NIKKAJI: J41.405K,cpd:C08012,23,31,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H32O2N1,C23H30O2N1,353.2354792,354.2433043,352.22765424407,4802,cpd:C11004,"2,6-Dimethylaniline;",C8H11N,"2,6-Dimethylaniline; 2,6-DMA; 2,6-Xylidine",R08295 R08299 R08300 R08301 R08302,Drug metabolism - cytochrome P450,3.1.1.1,NA,"Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C11004  2,6-Dimethylaniline",CAS: 87-62-7; PubChem: 13187; ChEBI: 28738; ChEMBL: CHEMBL1340793; NIKKAJI: J43.456F,cpd:C00314; cpd:C00483; cpd:C00547; cpd:C01183; cpd:C02455; cpd:C02735; cpd:C02846; cpd:C03473; cpd:C03758; cpd:C04227; cpd:C04690; cpd:C05332; cpd:C05713; cpd:C07770; cpd:C11003; cpd:C11004; cpd:C13415; cpd:C13690; cpd:C13691; cpd:C14455; cpd:C16570; cpd:C16666; cpd:C18396; cpd:C18782; cpd:C18993; cpd:C19216; cpd:C19376,8,11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H12N1,C8H10N1,121.0891494,122.0969744,120.08132434408,4803,cpd:C11583,4-Glutathionyl cyclophosphamide,C17H30Cl2N5O8PS,4-Glutathionyl cyclophosphamide,R08280,Drug metabolism - cytochrome P450,2.5.1.18,NA,NA,PubChem: 13748; ChEBI: 1831; NIKKAJI: J625.455A,cpd:C11583,17,30,8,5,1,1,2,0,0,0,0,0,0,0,0,0,0,0,C17H31O8N5P1S1Cl2,C17H29O8N5P1S1Cl2,565.0929765,566.1008015,564.08515154409,4804,cpd:C11785,Normorphine,C16H17NO3,Normorphine,R08265,Drug metabolism - cytochrome P450,1.14.14.1,NA,NA,CAS: 466-97-7; PubChem: 13949; ChEBI: 7633; ChEMBL: CHEMBL1227; NIKKAJI: J5.905F,cpd:C06160; cpd:C06346; cpd:C06347; cpd:C08521; cpd:C10174; cpd:C11785; cpd:C12162; cpd:C12193; cpd:C16703; cpd:C21405; cpd:C21406,16,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H18O3N1,C16H16O3N1,271.1208434,272.1286684,270.11301844410,4805,cpd:C16544,alpha-Hydroxytamoxifen,C26H29NO2,alpha-Hydroxytamoxifen,R08271,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,CAS: 97151-02-5; PubChem: 51090873; ChEBI: 80553; ChEMBL: CHEMBL1908109; NIKKAJI: J707.465D,cpd:C05011; cpd:C14296; cpd:C16544; cpd:C16545,26,29,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H30O2N1,C26H28O2N1,387.2198292,388.2276542,386.21200414411,4806,cpd:C16545,Tamoxifen N-oxide,C26H29NO2,Tamoxifen N-oxide,R08266,Drug metabolism - cytochrome P450,1.14.13.8,NA,NA,CAS: 75504-34-6; PubChem: 51090874; ChEBI: 63825; NIKKAJI: J365.967D,cpd:C05011; cpd:C14296; cpd:C16544; cpd:C16545,26,29,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H30O2N1,C26H28O2N1,387.2198292,388.2276542,386.21200414412,4807,cpd:C16546,N-Desmethyltamoxifen,C25H27NO,N-Desmethyltamoxifen,R08268 R08270 R08272 R08274,Drug metabolism - cytochrome P450,1.14.13.-; 1.14.14.1,NA,NA,CAS: 31750-48-8; PubChem: 51090875; ChEBI: 80554; NIKKAJI: J90.393K,cpd:C16546,25,27,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H28O1N1,C25H26O1N1,357.2092645,358.2170895,356.20143954413,4808,cpd:C16547,Endoxifen;,C25H27NO2,Endoxifen; 4-Hydroxy-N-desmethyltamoxifen,R08269 R08270,Drug metabolism - cytochrome P450; Endocrine resistance,1.14.13.-; 1.14.14.1,NA,NA,CAS: 112093-28-4; PubChem: 51090876; ChEBI: 80555; ChEMBL: CHEMBL1093458; NIKKAJI: J393.650C,cpd:C16547; cpd:C16549,25,27,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H28O2N1,C25H26O2N1,373.2041791,374.2120041,372.19635414414,4809,cpd:C16548,"N,N-Didesmethyltamoxifen",C24H25NO,"N,N-Didesmethyltamoxifen",R08272,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,CAS: 80234-20-4; PubChem: 51090877; ChEBI: 80556; ChEMBL: CHEMBL1743350; NIKKAJI: J351.580J,cpd:C16548,24,25,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H26O1N1,C24H24O1N1,343.1936144,344.2014395,342.18578944415,4810,cpd:C16549,alpha-Hydroxy-N-desmethyltamoxifen,C25H27NO2,alpha-Hydroxy-N-desmethyltamoxifen,R08274,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,PubChem: 51090878; ChEBI: 80557; NIKKAJI: J573.431B,cpd:C16547; cpd:C16549,25,27,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H28O2N1,C25H26O2N1,373.2041791,374.2120041,372.19635414416,4811,cpd:C16550,Dechloroethylcyclophosphamide;,C5H12ClN2O2P,Dechloroethylcyclophosphamide; 3-Dechloroethylifosfamide,R08276 R08286,Drug metabolism - cytochrome P450,1.14.13.-; 1.14.14.1,NA,NA,CAS: 36761-83-8; PubChem: 51090879; ChEBI: 80558; ChEMBL: CHEMBL87658; NIKKAJI: J426.680C,cpd:C16550; cpd:C16555,5,12,2,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,C5H13O2N2P1Cl1,C5H11O2N2P1Cl1,198.0324923,199.0403173,197.02466734417,4812,cpd:C16551,Alcophosphamide,C7H17Cl2N2O3P,Alcophosphamide,R08281,Drug metabolism - cytochrome P450,1.1.1.1,NA,NA,CAS: 52336-54-6; PubChem: 51090880; ChEBI: 80559; NIKKAJI: J562.727C,cpd:C16551; cpd:C16558,7,17,3,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H18O3N2P1Cl2,C7H16O3N2P1Cl2,278.0353848,279.0432098,277.02755974418,4813,cpd:C16552,Nornitrogen mustard,C4H9Cl2N,Nornitrogen mustard,R08284,Drug metabolism - cytochrome P450,NA,NA,NA,CAS: 334-22-5; PubChem: 51090881; ChEBI: 37599; ChEMBL: CHEMBL913; NIKKAJI: J126.297A,cpd:C16552,4,9,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C4H10N1Cl2,C4H8N1Cl2,141.0112047,142.0190297,140.00337964419,4814,cpd:C16553,4-Hydroxyifosfamide,C7H15Cl2N2O3P,4-Hydroxyifosfamide,R08285 R08288 R08291,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,PubChem: 51090882; ChEBI: 80560; ChEMBL: CHEMBL733; NIKKAJI: J2.235.734D,cpd:C07643; cpd:C07645; cpd:C16553; cpd:C16556,7,15,3,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H16O3N2P1Cl2,C7H14O3N2P1Cl2,276.0197347,277.0275597,275.01190974420,4815,cpd:C16554,4-Ketoifosfamide,C7H13Cl2N2O3P,4-Ketoifosfamide,R08291,Drug metabolism - cytochrome P450,NA,NA,NA,CAS: 42436-20-4; PubChem: 51090883; ChEBI: 80561; ChEMBL: CHEMBL1319; NIKKAJI: J426.681A,cpd:C07644; cpd:C16554,7,13,3,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H14O3N2P1Cl2,C7H12O3N2P1Cl2,274.0040846,275.0119097,272.99625964421,4816,cpd:C16555,2-Dechloroethylifosfamide,C5H12ClN2O2P,2-Dechloroethylifosfamide,R08287,Drug metabolism - cytochrome P450,1.14.13.-; 1.14.14.1,NA,NA,CAS: 53459-55-5; PubChem: 51090884; ChEBI: 80562; ChEMBL: CHEMBL87851; NIKKAJI: J426.679J,cpd:C16550; cpd:C16555,5,12,2,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,C5H13O2N2P1Cl1,C5H11O2N2P1Cl1,198.0324923,199.0403173,197.02466734422,4817,cpd:C16556,Aldoifosfamide,C7H15Cl2N2O3P,Aldoifosfamide,R08288 R08289 R08290 R08292,Drug metabolism - cytochrome P450,NA,NA,NA,CAS: 120144-70-9; PubChem: 51090885; ChEBI: 80563; ChEMBL: CHEMBL1318; NIKKAJI: J468.180K,cpd:C07643; cpd:C07645; cpd:C16553; cpd:C16556,7,15,3,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H16O3N2P1Cl2,C7H14O3N2P1Cl2,276.0197347,277.0275597,275.01190974423,4818,cpd:C16557,Carboxyifosfamide,C7H15Cl2N2O4P,Carboxyifosfamide,R08292,Drug metabolism - cytochrome P450,NA,NA,NA,CAS: 53459-52-2; PubChem: 51090886; ChEBI: 80564; ChEMBL: CHEMBL161296; NIKKAJI: J458.782K,cpd:C07646; cpd:C16557,7,15,4,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H16O4N2P1Cl2,C7H14O4N2P1Cl2,292.0146493,293.0224744,291.00682434424,4819,cpd:C16558,Alcoifosfamide,C7H17Cl2N2O3P,Alcoifosfamide,R08290,Drug metabolism - cytochrome P450,NA,NA,NA,PubChem: 51090887; ChEBI: 80565; NIKKAJI: J2.803.703A,cpd:C16551; cpd:C16558,7,17,3,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C7H18O3N2P1Cl2,C7H16O3N2P1Cl2,278.0353848,279.0432098,277.02755974425,4820,cpd:C16559,Isophosphamide mustard,C4H11Cl2N2O2P,Isophosphamide mustard,R08289,Drug metabolism - cytochrome P450,NA,NA,Target-based classification of drugs [BR:br08310];  Others;   Nucleic acid;    DNA;     Palifosfamide;      D09364  Palifosfamide (USAN/INN),CAS: 31645-39-3; PubChem: 51090888; ChEBI: 80566; ChEMBL: CHEMBL889; NIKKAJI: J426.682J,cpd:C07647; cpd:C16559,4,11,2,2,1,0,2,0,0,0,0,0,0,0,0,0,0,0,C4H12O2N2P1Cl2,C4H10O2N2P1Cl2,219.99352,221.001345,218.98569494426,4821,cpd:C16560,3-Hydroxylidocaine,C14H22N2O2,3-Hydroxylidocaine,R08294 R08297,Drug metabolism - cytochrome P450,1.14.13.-; 1.14.14.1,NA,NA,CAS: 34604-55-2; PubChem: 51090889; ChEBI: 80567; NIKKAJI: J356.053H,cpd:C11766; cpd:C16560,14,22,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H23O2N2,C14H21O2N2,250.168128,251.175953,249.16030294427,4822,cpd:C16561,Monoethylglycinexylidide,C12H18N2O,Monoethylglycinexylidide,R08293 R08295 R08296 R08298,Drug metabolism - cytochrome P450,1.14.13.-; 1.14.14.1; 3.1.1.1,NA,NA,CAS: 7728-40-7; PubChem: 51090890; ChEBI: 222828; ChEMBL: CHEMBL1028; NIKKAJI: J55.345J,cpd:C07485; cpd:C11005; cpd:C16561,12,18,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H19O1N2,C12H17O1N2,206.1419132,207.1497382,205.13408824428,4823,cpd:C16569,Glycinexylidide;,C10H14N2O,Glycinexylidide; GX,R08296 R08299,Drug metabolism - cytochrome P450,NA,NA,NA,CAS: 18865-38-8; PubChem: 51090898; ChEBI: 357241; ChEMBL: CHEMBL1302; NIKKAJI: J401.554A,cpd:C01056; cpd:C03043; cpd:C16569; cpd:C20361,10,14,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O1N2,C10H13O1N2,178.1106131,179.1184381,177.1027884429,4824,cpd:C16570,"4-Hydroxy-2,6-dimethylaniline;",C8H11NO,"4-Hydroxy-2,6-dimethylaniline; 3,5-Dimethyl-4-aminophenol",R08301,Drug metabolism - cytochrome P450,NA,NA,NA,CAS: 3096-70-6; PubChem: 51090899; ChEBI: 55545; NIKKAJI: J107.276E,cpd:C00483; cpd:C01183; cpd:C02735; cpd:C03473; cpd:C16570; cpd:C18396; cpd:C18782; cpd:C19216; cpd:C19376,8,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H12O1N1,C8H10O1N1,137.084064,138.091889,136.07623894430,4825,cpd:C16571,2-Amino-3-methylbenzoate,C8H9NO2,2-Amino-3-methylbenzoate,R08302,Drug metabolism - cytochrome P450,NA,NA,NA,CAS: 4389-45-1; PubChem: 51090900; ChEBI: 80574; PDB-CCD: 3M0; NIKKAJI: J80.815F,cpd:C02012; cpd:C02709; cpd:C03005; cpd:C03522; cpd:C04350; cpd:C04353; cpd:C06804; cpd:C07301; cpd:C16571; cpd:C17239; cpd:C17755; cpd:C17756; cpd:C18623; cpd:C20634,8,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O2N1,C8H8O2N1,151.0633285,152.0711536,150.05550354431,4826,cpd:C16572,3-Hydroxymonoethylglycinexylidide,C12H18N2O2,3-Hydroxymonoethylglycinexylidide,R08297 R08298,Drug metabolism - cytochrome P450,NA,NA,NA,CAS: 34604-56-3; PubChem: 51090901; ChEBI: 80575; NIKKAJI: J356.054F,cpd:C07846; cpd:C11763; cpd:C16572; cpd:C18952,12,18,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H19O2N2,C12H17O2N2,222.1368278,223.1446529,221.12900284432,4827,cpd:C16576,Norcodeine;,C17H19NO3,Norcodeine; N-Desmethylcodeine,R08264,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,CAS: 467-15-2; PubChem: 51090905; ChEBI: 80579; ChEMBL: CHEMBL1319740 CHEMBL1908321; NIKKAJI: J5.907B,cpd:C01516; cpd:C03882; cpd:C06161; cpd:C06348; cpd:C06349; cpd:C07042; cpd:C08534; cpd:C09422; cpd:C10844; cpd:C12167; cpd:C16576,17,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H20O3N1,C17H18O3N1,285.1364935,286.1443185,284.12866844433,4828,cpd:C16577,Codeine-6-glucuronide,C24H29NO9,Codeine-6-glucuronide,R08261,Drug metabolism - cytochrome P450,2.4.1.17,NA,NA,CAS: 20736-11-2; PubChem: 51090906; ChEBI: 80580; ChEMBL: CHEMBL20056; NIKKAJI: J426.676E,cpd:C16577,24,29,9,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H30O9N1,C24H28O9N1,475.1842315,476.1920565,474.17640654434,4829,cpd:C16578,Morphine-6-glucuronide,C23H27NO9,Morphine-6-glucuronide,R08263,Drug metabolism - cytochrome P450; Bile secretion,2.4.1.17,NA,NA,CAS: 20290-10-2; PubChem: 51090907; ChEBI: 80581; ChEMBL: CHEMBL1330 CHEMBL19905 CHEMBL336066; NIKKAJI: J277.761D,cpd:C16578; cpd:C16643,23,27,9,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H28O9N1,C23H26O9N1,461.1685815,462.1764065,460.16075644435,4830,cpd:C16582,2-Hydroxyfelbamate,C11H14N2O5,2-Hydroxyfelbamate,R08304,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,PubChem: 51090910; ChEBI: 80583; NIKKAJI: J440.349E,cpd:C16582; cpd:C16584,11,14,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O5N2,C11H13O5N2,254.0902716,255.0980966,253.08244654436,4831,cpd:C16584,p-Hydroxyfelbamate,C11H14N2O5,p-Hydroxyfelbamate,R08303,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,PubChem: 51090912; ChEBI: 80584; NIKKAJI: J440.348G,cpd:C16582; cpd:C16584,11,14,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O5N2,C11H13O5N2,254.0902716,255.0980966,253.08244654437,4832,cpd:C16586,"2-Phenyl-1,3-propanediol monocarbamate",C10H13NO3,"2-Phenyl-1,3-propanediol monocarbamate",R08305 R08306,Drug metabolism - cytochrome P450,1.1.1.1,NA,NA,CAS: 25451-53-0; PubChem: 51090913; ChEBI: 80585; NIKKAJI: J440.350I,cpd:C03404; cpd:C07921; cpd:C10588; cpd:C11820; cpd:C16586; cpd:C18622; cpd:C20800,10,13,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O3N1,C10H12O3N1,195.0895433,196.0973683,194.08171824438,4833,cpd:C16587,3-Carbamoyl-2-phenylpropionaldehyde,C10H11NO3,3-Carbamoyl-2-phenylpropionaldehyde,R08306 R08307 R08308 R08309,Drug metabolism - cytochrome P450,1.1.1.1; 1.2.1.5,NA,NA,PubChem: 51090914; ChEBI: 80586; NIKKAJI: J2.804.004K,cpd:C03450; cpd:C05598; cpd:C06726; cpd:C09962; cpd:C10581; cpd:C16587; cpd:C16595,10,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H12O3N1,C10H10O3N1,193.0738932,194.0817182,192.06606824439,4834,cpd:C16591,3-Carbamoyl-2-phenylpropionic acid,C10H11NO4,3-Carbamoyl-2-phenylpropionic acid,R08307 R08311,Drug metabolism - cytochrome P450,1.2.1.5,NA,NA,CAS: 139262-66-1; PubChem: 51090918; ChEBI: 80589; NIKKAJI: J555.956A,cpd:C03710; cpd:C05596; cpd:C16591,10,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H12O4N1,C10H10O4N1,209.0688078,210.0766329,208.06098284440,4835,cpd:C16592,Atropaldehyde;,C9H8O,Atropaldehyde; 2-Phenylpropenal,R08308,Drug metabolism - cytochrome P450,NA,NA,NA,PubChem: 51090919; ChEBI: 80590; NIKKAJI: J337.792J,cpd:C00903; cpd:C01504; cpd:C07727; cpd:C13844; cpd:C16592; cpd:C18812,9,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O1,C9H7O1,132.0575149,133.0653399,131.04968984441,4836,cpd:C16595,"4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",C10H11NO3,"4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",R08309 R08310,Drug metabolism - cytochrome P450,1.1.1.1,NA,NA,PubChem: 51090922; ChEBI: 80593; NIKKAJI: J1.018.553J,cpd:C03450; cpd:C05598; cpd:C06726; cpd:C09962; cpd:C10581; cpd:C16587; cpd:C16595,10,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H12O3N1,C10H10O3N1,193.0738932,194.0817182,192.06606824442,4837,cpd:C16596,"5-Phenyl-1,3-oxazinane-2,4-dione",C10H9NO3,"5-Phenyl-1,3-oxazinane-2,4-dione",R08310 R08311,Drug metabolism - cytochrome P450,1.1.1.1,NA,NA,PubChem: 51090923; ChEBI: 80594; NIKKAJI: J1.287.315H,cpd:C05635; cpd:C06725; cpd:C16596; cpd:C18483,10,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O3N1,C10H8O3N1,191.0582432,192.0660682,190.05041814443,4838,cpd:C16601,2-Hydroxycarbamazepine,C15H12N2O2,2-Hydroxycarbamazepine,R08317 R08318 R08320,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,CAS: 68011-66-5; PubChem: 51090927; ChEBI: 80596; NIKKAJI: J620.201B,cpd:C07443; cpd:C07492; cpd:C07496; cpd:C16601; cpd:C16602,15,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O2N2,C15H11O2N2,252.0898776,253.0977027,251.08205264444,4839,cpd:C16602,3-Hydroxycarbamazepine,C15H12N2O2,3-Hydroxycarbamazepine,R08313 R08315,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,CAS: 68011-67-6; PubChem: 51090928; ChEBI: 80597; NIKKAJI: J620.202K,cpd:C07443; cpd:C07492; cpd:C07496; cpd:C16601; cpd:C16602,15,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O2N2,C15H11O2N2,252.0898776,253.0977027,251.08205264445,4840,cpd:C16603,"2,3-Dihydroxycarbamazepine",C15H12N2O3,"2,3-Dihydroxycarbamazepine",R08315 R08316 R08320,Drug metabolism - cytochrome P450,NA,NA,NA,PubChem: 51090929; ChEBI: 80598; NIKKAJI: J2.804.057A,cpd:C12117; cpd:C16603,15,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O3N2,C15H11O3N2,268.0847923,269.0926173,267.07696724446,4841,cpd:C16604,2-Hydroxyiminostilbene,C14H11NO,2-Hydroxyiminostilbene,R08318 R08319,Drug metabolism - cytochrome P450,1.14.13.-,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes;     C16604  2-Hydroxyiminostilbene",PubChem: 51090930; ChEBI: 80599; LIPIDMAPS: LMPK13090031; NIKKAJI: J1.051.924A,cpd:C16604,14,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H12O1N1,C14H10O1N1,209.084064,210.091889,208.07623894447,4842,cpd:C16605,"2H-Dibenz[b,f]azepin-2-one",C14H9NO,"2H-Dibenz[b,f]azepin-2-one",R08319,Drug metabolism - cytochrome P450,NA,NA,NA,PubChem: 51090931; ChEBI: 80600; NIKKAJI: J83.067D,cpd:C16605,14,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H10O1N1,C14H8O1N1,207.0684139,208.0762389,206.06058894448,4843,cpd:C16606,Carbamazepine-o-quinone,C15H10N2O3,Carbamazepine-o-quinone,R08316,Drug metabolism - cytochrome P450,NA,NA,NA,PubChem: 51090932; ChEBI: 80601; NIKKAJI: J2.804.058J,cpd:C12120; cpd:C16606; cpd:C17879; cpd:C18615,15,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O3N2,C15H9O3N2,266.0691422,267.0769672,265.06131724449,4844,cpd:C16607,Citalopram N-oxide,C20H21FN2O2,Citalopram N-oxide,R08344,Drug metabolism - cytochrome P450,1.14.14.1,NA,NA,PubChem: 51090933; ChEBI: 80602; NIKKAJI: J378.717F,cpd:C16607,20,21,2,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C20H22O2N2F1,C20H20O2N2F1,340.1587061,341.1665311,339.15088114450,4845,cpd:C16608,Demethylcitalopram,C19H19FN2O,Demethylcitalopram,R08343 R08345 R08347,Drug metabolism - cytochrome P450,1.4.3.4; 1.14.13.-; 1.14.14.1,NA,NA,CAS: 62498-67-3; PubChem: 51090934; ChEBI: 80603; ChEMBL: CHEMBL1649; NIKKAJI: J307.060C,cpd:C16608,19,19,1,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C19H20O1N2F1,C19H18O1N2F1,310.1481414,311.1559664,309.14031644451,4846,cpd:C16609,Didemethylcitalopram,C18H17FN2O,Didemethylcitalopram,R08345 R08348,Drug metabolism - cytochrome P450,1.4.3.4; 1.14.14.1,NA,NA,CAS: 62498-69-5; PubChem: 51090935; ChEBI: 80604; NIKKAJI: J324.094K,cpd:C16609,18,17,1,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C18H18O1N2F1,C18H16O1N2F1,296.1324913,297.1403164,295.12466634452,4847,cpd:C16610,Citalopram propionic acid,C18H14FNO3,Citalopram propionic acid,R08349,Drug metabolism - cytochrome P450,1.2.3.1,NA,NA,PubChem: 51090936; ChEBI: 80605; NIKKAJI: J676.479G,cpd:C16610,18,14,3,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C18H15O3N1F1,C18H13O3N1F1,311.0957715,312.1035965,310.08794644453,4848,cpd:C16612,Citalopram aldehyde,C18H14FNO2,Citalopram aldehyde,R08346 R08347 R08348 R08349,Drug metabolism - cytochrome P450,1.2.3.1; 1.4.3.4,NA,NA,PubChem: 51090938; ChEBI: 80607; NIKKAJI: J2.804.066K,cpd:C16612,18,14,2,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C18H15O2N1F1,C18H13O2N1F1,295.1008569,296.1086819,294.09303184454,4849,cpd:C16643,Morphine-3-glucuronide,C23H27NO9,Morphine-3-glucuronide,R08262,Drug metabolism - cytochrome P450; Bile secretion,2.4.1.17,NA,NA,CAS: 20290-09-9; PubChem: 51090968; ChEBI: 80631; ChEMBL: CHEMBL1329 CHEMBL435786; NIKKAJI: J125.691B,cpd:C16578; cpd:C16643,23,27,9,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H28O9N1,C23H26O9N1,461.1685815,462.1764065,460.16075644455,4850,cpd:C16648,2-n-Propyl-4-pentenoic acid;,C8H14O2,2-n-Propyl-4-pentenoic acid; 4-En-valproic acid; 4-Ene-VPA,R08324 R08329,Drug metabolism - cytochrome P450,1.14.13.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16648  2-n-Propyl-4-pentenoic acid,CAS: 1575-72-0; PubChem: 51090972; ChEBI: 80634; ChEMBL: CHEMBL1367; NIKKAJI: J362.530C,cpd:C00725; cpd:C03151; cpd:C03152; cpd:C07841; cpd:C11549; cpd:C11550; cpd:C12104; cpd:C12297; cpd:C16241; cpd:C16648; cpd:C16653; cpd:C16654; cpd:C19318; cpd:C19757,8,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O2,C8H13O2,142.0993797,143.1072047,141.09155474456,4851,cpd:C16649,4-Hydroxyvalproic acid;,C8H16O3,4-Hydroxyvalproic acid; 2-n-Propyl-4-hydroxypentanoic acid; 4-OH-VPA,R08325 R08330,Drug metabolism - cytochrome P450,1.14.13.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16649  4-Hydroxyvalproic acid,CAS: 60113-82-8; PubChem: 51090973; ChEBI: 80635; NIKKAJI: J362.523K,cpd:C02155; cpd:C02727; cpd:C03846; cpd:C03864; cpd:C03865; cpd:C12989; cpd:C16649; cpd:C16650; cpd:C16651; cpd:C16739; cpd:C17242; cpd:C17527; cpd:C19007; cpd:C20793; cpd:C21099; cpd:C21388,8,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O3,C8H15O3,160.1099444,161.1177694,159.10211934457,4852,cpd:C16650,5-Hydroxyvalproic acid;,C8H16O3,5-Hydroxyvalproic acid; 2-n-Propyl-5-hydroxypentanoic acid; 5-OH-VPA,R08326 R08334,Drug metabolism - cytochrome P450,1.14.13.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16650  5-Hydroxyvalproic acid,CAS: 53660-23-4; PubChem: 51090974; ChEBI: 80636; NIKKAJI: J362.524I,cpd:C02155; cpd:C02727; cpd:C03846; cpd:C03864; cpd:C03865; cpd:C12989; cpd:C16649; cpd:C16650; cpd:C16651; cpd:C16739; cpd:C17242; cpd:C17527; cpd:C19007; cpd:C20793; cpd:C21099; cpd:C21388,8,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O3,C8H15O3,160.1099444,161.1177694,159.10211934458,4853,cpd:C16651,3-Hydroxyvalproic acid;,C8H16O3,3-Hydroxyvalproic acid; 2-n-Propyl-3-hydroxypentanoic acid; 3-OH-VPA,R08327 R08335 R08338,Drug metabolism - cytochrome P450,1.14.13.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16651  3-Hydroxyvalproic acid,CAS: 58888-84-9; PubChem: 51090975; ChEBI: 80637; NIKKAJI: J362.522B,cpd:C02155; cpd:C02727; cpd:C03846; cpd:C03864; cpd:C03865; cpd:C12989; cpd:C16649; cpd:C16650; cpd:C16651; cpd:C16739; cpd:C17242; cpd:C17527; cpd:C19007; cpd:C20793; cpd:C21099; cpd:C21388,8,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O3,C8H15O3,160.1099444,161.1177694,159.10211934459,4854,cpd:C16652,3-Oxovalproic acid;,C8H14O3,3-Oxovalproic acid; 2-n-Propyl-3-oxopentanoic acid; 3-Keto-VPA,R08335,Drug metabolism - cytochrome P450,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16652  3-Oxovalproic acid,CAS: 60113-81-7; PubChem: 51090976; ChEBI: 80638; NIKKAJI: J415.931D,cpd:C02975; cpd:C16652; cpd:C16655; cpd:C17220,8,14,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O3,C8H13O3,158.0942943,159.1021193,157.08646934460,4855,cpd:C16653,2-n-Propyl-2-pentenoic acid;,C8H14O2,2-n-Propyl-2-pentenoic acid; 2-En-valproic acid; 2-Ene-VPA,R08336 R08338,Drug metabolism - cytochrome P450,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16653  2-n-Propyl-2-pentenoic acid,CAS: 60218-41-9; PubChem: 51090977; ChEBI: 80639; ChEMBL: CHEMBL117487; NIKKAJI: J362.528A,cpd:C00725; cpd:C03151; cpd:C03152; cpd:C07841; cpd:C11549; cpd:C11550; cpd:C12104; cpd:C12297; cpd:C16241; cpd:C16648; cpd:C16653; cpd:C16654; cpd:C19318; cpd:C19757,8,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O2,C8H13O2,142.0993797,143.1072047,141.09155474461,4856,cpd:C16654,2-n-Propyl-3-pentenoic acid;,C8H14O2,2-n-Propyl-3-pentenoic acid; 3-En-valproic acid; 3-Ene-VPA,R08337,Drug metabolism - cytochrome P450,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16654  2-n-Propyl-3-pentenoic acid,CAS: 72010-19-6; PubChem: 51090978; ChEBI: 80640; NIKKAJI: J362.529J,cpd:C00725; cpd:C03151; cpd:C03152; cpd:C07841; cpd:C11549; cpd:C11550; cpd:C12104; cpd:C12297; cpd:C16241; cpd:C16648; cpd:C16653; cpd:C16654; cpd:C19318; cpd:C19757,8,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O2,C8H13O2,142.0993797,143.1072047,141.09155474462,4857,cpd:C16655,2-n-Propyl-4-oxopentanoic acid;,C8H14O3,2-n-Propyl-4-oxopentanoic acid; 4-Oxovalproic acid; 4-Keto-VPA,R08330 R08333,Drug metabolism - cytochrome P450,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16655  2-n-Propyl-4-oxopentanoic acid,PubChem: 51090979; ChEBI: 80641; NIKKAJI: J601.804A,cpd:C02975; cpd:C16652; cpd:C16655; cpd:C17220,8,14,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O3,C8H13O3,158.0942943,159.1021193,157.08646934463,4858,cpd:C16656,"2-Propyl-2,4-pentadienoic acid;",C8H12O2,"2-Propyl-2,4-pentadienoic acid; 2,4-Diene-VPA",R08329,Drug metabolism - cytochrome P450,NA,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16656  2-Propyl-2,4-pentadienoic acid",CAS: 72010-18-5; PubChem: 51090980; ChEBI: 80642; NIKKAJI: J391.097K,cpd:C00534; cpd:C06727; cpd:C11846; cpd:C13710; cpd:C16656; cpd:C18011; cpd:C19105; cpd:C19311,8,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O2,C8H11O2,140.0837296,141.0915547,139.07590464464,4859,cpd:C16657,2-Propylsuccinic acid;,C7H12O4,2-Propylsuccinic acid; 2-PSA,R08333,Drug metabolism - cytochrome P450,NA,NA,NA,PubChem: 51090981; ChEBI: 80643; NIKKAJI: J135.629A,cpd:C02656; cpd:C02851; cpd:C02986; cpd:C04687; cpd:C11490; cpd:C16657; cpd:C20729; cpd:C20918; cpd:C20920; cpd:C21437,7,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H13O4,C7H11O4,160.0735589,161.0813839,159.06573384465,4860,cpd:C16658,2-Propylglutaric acid;,C8H14O4,2-Propylglutaric acid; 2-PGA,R08334,Drug metabolism - cytochrome P450,NA,NA,NA,CAS: 32806-62-5; PubChem: 51090982; ChEBI: 80644; NIKKAJI: J362.517F,cpd:C02301; cpd:C04504; cpd:C06658; cpd:C08271; cpd:C08278; cpd:C14570; cpd:C16658; cpd:C19402,8,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H15O4,C8H13O4,174.0892089,175.097034,173.08138394466,4861,cpd:C16659,"2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine;",C20H23N,"2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine; EDDP",R08339 R08340,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,CAS: 30223-73-5; PubChem: 51090983; ChEBI: 80645; ChEMBL: CHEMBL196431; NIKKAJI: J600.731G,cpd:C04118; cpd:C06824; cpd:C07107; cpd:C07253; cpd:C08529; cpd:C09377; cpd:C09411; cpd:C09549; cpd:C10386; cpd:C10929; cpd:C12171; cpd:C14917; cpd:C16659; cpd:C16712; cpd:C20771,20,23,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H24N1,C20H22N1,277.1830497,278.1908748,276.17522474467,4862,cpd:C16660,"2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline;",C19H21N,"2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline; EMDP",R08340,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,PubChem: 51090984; ChEBI: 80646; NIKKAJI: J769.262E,cpd:C02106; cpd:C05179; cpd:C06173; cpd:C06971; cpd:C07252; cpd:C07274; cpd:C07408; cpd:C09365; cpd:C09366; cpd:C09400; cpd:C09410; cpd:C09541; cpd:C09550; cpd:C09611; cpd:C10686; cpd:C11778; cpd:C11781; cpd:C11787; cpd:C12326; cpd:C16660; cpd:C17591,19,21,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H22N1,C19H20N1,263.1673997,264.1752247,262.15957464468,4863,cpd:C16661,L-alpha-Acetyl-N-normethadol;,C22H29NO2,L-alpha-Acetyl-N-normethadol; nor-LAAM,R08341 R08342,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,CAS: 43033-71-2; PubChem: 51090985; ChEBI: 80647; NIKKAJI: J474.573F,cpd:C07406; cpd:C10156; cpd:C16661,22,29,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H30O2N1,C22H28O2N1,339.2198292,340.2276542,338.21200414469,4864,cpd:C16662,"L-alpha-Acetyl-N,N-dinormethadol;",C21H27NO2,"L-alpha-Acetyl-N,N-dinormethadol; dinor-LAAM",R08342,Drug metabolism - cytochrome P450,1.14.13.-,NA,NA,CAS: 54276-34-5; PubChem: 51090986; ChEBI: 80648; ChEMBL: CHEMBL1201402; NIKKAJI: J474.574D,cpd:C12886; cpd:C16662,21,27,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H28O2N1,C21H26O2N1,325.2041791,326.2120041,324.19635414470,4865,cpd:C02380,6-Mercaptopurine;,C5H4N4S,6-Mercaptopurine; Mercaptopurine,R08234 R08235 R08236 R08237,Drug metabolism - other enzymes; Bile secretion,1.17.3.2; 2.1.1.67; 2.4.2.8,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C02380  6-Mercaptopurine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01B ANTIMETABOLITES;     L01BB Purine analogues;      L01BB02 Mercaptopurine;       D04931  Mercaptopurine (INN); USP drug classification [BR:br08302];  Antineoplastics;   Antimetabolites;    Mercaptopurine;     D04931  Mercaptopurine (INN);  Immunological Agents;   Immune Suppressants;    Mercaptopurine;     D04931  Mercaptopurine (INN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   SLC28A2;    Mercaptopurine;     D04931  Mercaptopurine (INN);   SLC28A3;    Mercaptopurine;     D04931  Mercaptopurine (INN);   SLC29A1;    Mercaptopurine;     D04931  Mercaptopurine (INN);   SLC29A2;    Mercaptopurine;     D04931  Mercaptopurine (INN),CAS: 50-44-2; PubChem: 5422; ChEBI: 2208 50667; ChEMBL: CHEMBL1425; PDB-CCD: PM6; NIKKAJI: J2.298E,cpd:C01756; cpd:C02380; cpd:C16613,5,4,0,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C5H5N4S1,C5H3N4S1,152.0156673,153.0234924,151.00784234471,4866,cpd:C04242,5-Fluorodeoxyuridine monophosphate,C9H12FN2O8P,5-Fluorodeoxyuridine monophosphate,R08233,Drug metabolism - other enzymes,2.7.1.21,NA,NA,PubChem: 6908; ChEBI: 2129; ChEMBL: CHEMBL886; PDB-CCD: UFP; NIKKAJI: J387.592J,cpd:C04242,9,12,8,2,1,0,0,0,0,1,0,0,0,0,0,0,0,0,C9H13O8N2P1F1,C9H11O8N2P1F1,326.0315305,327.0393555,325.02370554472,4867,cpd:C04646,6-Thioinosine-5'-monophosphate;,C10H13N4O7PS,6-Thioinosine-5'-monophosphate; 9-(5-Phospho-1-ribofuranosyl)-6-mercaptopurine,R08237 R08239 R08240 R08241 R08243,Drug metabolism - other enzymes,1.1.1.205; 2.1.1.67; 2.4.2.8; 2.7.4.-; 3.6.1.-,NA,NA,CAS: 53-83-8; PubChem: 7235; ChEBI: 2332; NIKKAJI: J213.539F,cpd:C04646,10,13,7,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O7N4P1S1,C10H12O7N4P1S1,364.0242569,365.032082,363.01643194473,4868,cpd:C06837,Azathioprine,C9H7N7O2S,Azathioprine,R08234,Drug metabolism - other enzymes,NA,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C06837  Azathioprine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L04 IMMUNOSUPPRESSANTS;    L04A IMMUNOSUPPRESSANTS;     L04AX Other immunosuppressants;      L04AX01 Azathioprine;       D00238  Azathioprine (JP17/USP/INN); USP drug classification [BR:br08302];  Immunological Agents;   Immune Suppressants;    Azathioprine;     D00238  Azathioprine (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    399  Miscellaneous;     3999  Others;      D00238  Azathioprine (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00238  Azathioprine;   D00238  Azathioprine tablets; Antirheumatic and antigout drugs [br08366.html];  Antirheumatic drugs;   D00238; Pharmacogenomic biomarkers in FDA drug labels [br08341.html];  Polymorphisms and germline mutations;   D00238,CAS: 446-86-6; PubChem: 9055; ChEBI: 2948; ChEMBL: CHEMBL1542; NIKKAJI: J2.047H,cpd:C06837,9,7,2,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C9H8O2N7S1,C9H6O2N7S1,277.0381937,278.0460187,276.03036864474,4869,cpd:C07054,Isoniazid,C6H7N3O,Isoniazid,R08248 R08251 R08253 R08254,Drug metabolism - other enzymes,2.3.1.5,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07054  Isoniazid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J04 ANTIMYCOBACTERIALS;    J04A DRUGS FOR TREATMENT OF TUBERCULOSIS;     J04AC Hydrazides;      J04AC01 Isoniazid;       D00346  Isoniazid (JP17/USP/INN); USP drug classification [BR:br08302];  Antimycobacterials;   Antituberculars;    Isoniazid;     D00346  Isoniazid (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  6  Agents against pathologic organisms and parasites;   62  Chemotherapeutics;    622  Tuberculosis preparations;     6222  Isoniazids;      D00346  Isoniazid (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Oxidoreductases;    monoamine oxidase (MAO);     Isoniazid;      D00346  Isoniazid (JP17/USP/INN); Antiinfectives [BR:br08307];  Antibacterials;   Others;    enoyl-[acyl-carrier-protein] reductase (NADH) inhibitor;     Isoniazid;      D00346  Isoniazid (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C9;    Isoniazid;     D00346  Isoniazid (JP17/USP/INN);   CYP3A;    Isoniazid;     D00346  Isoniazid (JP17/USP/INN);  CYP inducers;   CYP2E1;    Isoniazid;     D00346  Isoniazid (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00346  Isoniazid;   D00346  Isoniazid tablets;   D00346  Isoniazid injection; Antibacterials [br08350.html];  D00346,CAS: 54-85-3; PubChem: 9266; ChEBI: 6030; ChEMBL: CHEMBL64; PDB-CCD: NIZ; NIKKAJI: J1.371D,cpd:C07054,6,7,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O1N3,C6H6O1N3,137.0589119,138.0667369,136.05108684475,4870,cpd:C07446,Isonicotinic acid,C6H5NO2,Isonicotinic acid,R08249 R08251 R08252,Drug metabolism - other enzymes,3.5.1.-,NA,NA,CAS: 55-22-1; PubChem: 9649; ChEBI: 6032; ChEMBL: CHEMBL1203; NIKKAJI: J4.559D,cpd:C00253; cpd:C06813; cpd:C07446; cpd:C10164,6,5,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H6O2N1,C6H4O2N1,123.0320284,124.0398534,122.02420344476,4871,cpd:C07447,Acetylhydrazine,C2H6N2O,Acetylhydrazine,R08249 R08250,Drug metabolism - other enzymes,2.3.1.5; 3.5.1.-,NA,NA,CAS: 1068-57-1; PubChem: 9650; ChEBI: 2422; NIKKAJI: J7.446B,cpd:C02297; cpd:C07447; cpd:C14704; cpd:C16363,2,6,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H7O1N2,C2H5O1N2,74.04801282,75.05583785,73.040187794477,4872,cpd:C07585,N-Acetylisoniazid;,C8H9N3O2,N-Acetylisoniazid; (N)1-Acetylisoniazid,R08248 R08249,Drug metabolism - other enzymes,2.3.1.5; 3.5.1.-,NA,NA,CAS: 1078-38-2; PubChem: 9787; ChEBI: 7207; ChEMBL: CHEMBL1442231; NIKKAJI: J12.173H,cpd:C07585,8,9,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O2N3,C8H8O2N3,179.0694765,180.0773016,178.06165154478,4873,cpd:C07648,Thioguanine,C5H5N5S,Thioguanine,R08245,Drug metabolism - other enzymes,2.4.2.8,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01B ANTIMETABOLITES;     L01BB Purine analogues;      L01BB03 Tioguanine;       D08603  Tioguanine (INN); USP drug classification [BR:br08302];  Antineoplastics;   Antimetabolites;    Thioguanine;     D08603  Tioguanine (INN),CAS: 154-42-7; PubChem: 9850; ChEBI: 9555; ChEMBL: CHEMBL727; KNApSAcK: C00018807; PDB-CCD: DX4; NIKKAJI: J21.274A,cpd:C07648,5,5,0,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C5H6N5S1,C5H4N5S1,167.0265664,168.0343914,166.01874134479,4874,cpd:C07649,5-FU;,C4H3FN2O2,5-FU; Fluorouracil; 5-Fluorouracil,R08222 R08225 R08226 R08229 R08230 R08231,Drug metabolism - other enzymes; Bile secretion,1.3.1.2; 1.14.13.-; 2.4.2.3; 2.4.2.4; 2.4.2.10,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07649  5-Fluorouracil; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01B ANTIMETABOLITES;     L01BC Pyrimidine analogues;      L01BC02 Fluorouracil;       D00584  Fluorouracil (JP17/USP/INN); USP drug classification [BR:br08302];  Dermatological Agents;   Fluorouracil;    D00584  Fluorouracil (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    422  Antimetabolites;     4223  Fluorouracils;      D00584  Fluorouracil (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Transferases;    thymidylate synthase;     Fluorouracil;      D00584  Fluorouracil (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C9;    Fluorouracil;     D00584  Fluorouracil (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00584  Fluorouracil; Antineoplastics [br08340.html];  D00584; Pharmacogenomic biomarkers in FDA drug labels [br08341.html];  Polymorphisms and germline mutations;   D00584,CAS: 51-21-8; PubChem: 9851; ChEBI: 46345; ChEMBL: CHEMBL185; PDB-CCD: URF; NIKKAJI: J4.489J,cpd:C07649,4,3,2,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C4H4O2N2F1,C4H2O2N2F1,130.0178555,131.0256805,129.01003054480,4875,cpd:C11173,SN-38,C22H20N2O5,SN-38,R08255 R08258 R08259 R08260,Drug metabolism - other enzymes,2.4.1.17; 3.1.1.1; 3.2.1.31,NA,Target-based classification of compounds [BR:br08010];  Enzymes;   Isomerases;    DNA topoisomerase I;     C11173  SN-38,CAS: 86639-52-3; PubChem: 13355; ChEBI: 8988; ChEMBL: CHEMBL837; NIKKAJI: J353.490A,cpd:C11173,22,20,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H21O5N2,C22H19O5N2,392.1372218,393.1450468,391.12939674481,4876,cpd:C11376,SN38 glucuronide;,C28H28N2O11,SN38 glucuronide; SN-38G,R08259 R08260,Drug metabolism - other enzymes,2.4.1.17; 3.2.1.31,NA,NA,PubChem: 13550; ChEBI: 8990; NIKKAJI: J2.774.245I,cpd:C11376,28,28,11,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H29O11N2,C28H27O11N2,568.1693097,569.1771348,567.16148474482,4877,cpd:C11736,5-Fluorodeoxyuridine;,C9H11FN2O5,5-Fluorodeoxyuridine; Floxuridine,R08230 R08233,Drug metabolism - other enzymes,2.4.2.4; 2.7.1.21,NA,Target-based classification of drugs [BR:br08310];  Enzymes;   Transferases;    thymidylate synthase;     Floxuridine;      D04197  Floxuridine (USP/INN); Antineoplastics [br08340.html];  D04197,CAS: 50-91-9; PubChem: 13901; ChEBI: 60761; ChEMBL: CHEMBL917; NIKKAJI: J4.488A,cpd:C11736; cpd:C12739,9,11,5,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C9H12O5N2F1,C9H10O5N2F1,246.0651996,247.0730247,245.05737464483,4878,cpd:C12650,Capecitabine;,C15H22FN3O6,"Capecitabine; (1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester",R08220,Drug metabolism - other enzymes,3.1.1.1,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01B ANTIMETABOLITES;     L01BC Pyrimidine analogues;      L01BC06 Capecitabine;       D01223  Capecitabine (JAN/USAN/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    422  Antimetabolites;     4223  Fluorouracils;      D01223  Capecitabine (JAN/USAN/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Transferases;    thymidylate synthase;     Capecitabine;      D01223  Capecitabine (JAN/USAN/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C9;    Capecitabine;     D01223  Capecitabine (JAN/USAN/INN);  CYP substrates;   CYP2C9;    Capecitabine;     D01223  Capecitabine (JAN/USAN/INN); Antineoplastics [br08340.html];  D01223; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D01223; New drug approvals in Japan [br08318.html];  Drugs with new active ingredients;   D01223; Pharmacogenomic biomarkers in FDA drug labels [br08341.html];  Polymorphisms and germline mutations;   D01223,CAS: 154361-50-9; PubChem: 583040; ChEBI: 31348; ChEMBL: CHEMBL1773; NIKKAJI: J949.163E,cpd:C12650,15,22,6,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C15H23O6N3F1,C15H21O6N3F1,359.1492636,360.1570886,358.14143864484,4879,cpd:C12673,Tegafur,C8H9FN2O3,Tegafur,R08225,Drug metabolism - other enzymes,1.14.13.-,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01B ANTIMETABOLITES;     L01BC Pyrimidine analogues;      L01BC03 Tegafur;       D01244  Tegafur (JP17/USAN/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    422  Antimetabolites;     4223  Fluorouracils;      D01244  Tegafur (JP17/USAN/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Transferases;    thymidylate synthase;     Tegafur;      D01244  Tegafur (JP17/USAN/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C9;    Tegafur;     D01244  Tegafur (JP17/USAN/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D01244  Tegafur; Antineoplastics [br08340.html];  D01244,CAS: 17902-23-7; PubChem: 583063; ChEBI: 32188; ChEMBL: CHEMBL20883; NIKKAJI: J4.543H,cpd:C12673,8,9,3,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C8H10O3N2F1,C8H8O3N2F1,200.0597203,201.0675454,199.05189534485,4880,cpd:C12739,5'-Deoxy-5-fluorouridine;,C9H11FN2O5,5'-Deoxy-5-fluorouridine; Doxifluridine,R08221 R08222,Drug metabolism - other enzymes,2.4.2.4; 3.5.4.5,NA,Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    422  Antimetabolites;     4223  Fluorouracils;      D01309  Doxifluridine (JP17/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Transferases;    thymidylate synthase;     Doxifluridine;      D01309  Doxifluridine (JP17/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C9;    Doxifluridine;     D01309  Doxifluridine (JP17/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D01309  Doxifluridine;   D01309  Doxifluridine capsules; Antineoplastics [br08340.html];  D01309,CAS: 3094-09-5; PubChem: 583128; ChEBI: 31521; ChEMBL: CHEMBL1130 CHEMBL603299; NIKKAJI: J7.679A,cpd:C11736; cpd:C12739,9,11,5,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C9H12O5N2F1,C9H10O5N2F1,246.0651996,247.0730247,245.05737464486,4881,cpd:C16542,APC,C33H38N4O8,APC,R08256,Drug metabolism - other enzymes,1.14.13.-,NA,NA,PubChem: 51090871; ChEBI: 80551; NIKKAJI: J768.402I,cpd:C16542,33,38,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H39O8N4,C33H37O8N4,618.2689642,619.2767892,617.26113924487,4882,cpd:C16543,NPC,C28H30N4O6,NPC,R08257 R08258,Drug metabolism - other enzymes,1.14.13.-; 3.1.1.1,NA,NA,PubChem: 51090872; ChEBI: 80552; NIKKAJI: J981.210E,cpd:C16543,28,30,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H31O6N4,C28H29O6N4,518.2165347,519.2243597,517.20870974488,4883,cpd:C16613,6-Thiourate;,C5H4N4O2S,6-Thiourate; 6-Thiouric acid,R08235,Drug metabolism - other enzymes,1.17.3.2,NA,NA,CAS: 2002-60-0; PubChem: 51090939; ChEBI: 80608; NIKKAJI: J366.929G,cpd:C16613,5,4,2,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C5H5O2N4S1,C5H3O2N4S1,184.0054966,185.0133216,182.99767154489,4884,cpd:C16614,6-Methylmercaptopurine;,C6H6N4S,6-Methylmercaptopurine; Thiopurine S-methylether,R03701 R08236 R08238,Drug metabolism - other enzymes,2.1.1.67; 2.4.2.8,NA,NA,CAS: 50-66-8; PubChem: 51090940; ChEBI: 28279; ChEMBL: CHEMBL1178; PDB-CCD: XQG; NIKKAJI: J79.423F,cpd:C16614; cpd:C19268,6,6,0,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H7N4S1,C6H5N4S1,166.0313174,167.0391424,165.02349244490,4885,cpd:C16615,6-Methylthiopurine 5'-monophosphate ribonucleotide;,C11H15N4O7PS,6-Methylthiopurine 5'-monophosphate ribonucleotide; 6-Methylthioinosine-5'-monophosphate,R08238 R08239,Drug metabolism - other enzymes,2.1.1.67; 2.4.2.8,NA,NA,CAS: 7021-52-5; PubChem: 51090941; ChEBI: 80609; NIKKAJI: J437.666H,cpd:C16615,11,15,7,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H16O7N4P1S1,C11H14O7N4P1S1,378.039907,379.047732,377.0320824491,4886,cpd:C16616,6-Mercaptopurine ribonucleoside 5'-diphosphate;,C10H14N4O10P2S,6-Mercaptopurine ribonucleoside 5'-diphosphate; 6-Thioinosine-5'-diphosphate,R08241 R08242,Drug metabolism - other enzymes,2.7.4.-,NA,NA,CAS: 805-63-0; PubChem: 51090942; ChEBI: 80610; NIKKAJI: J2.804.087C,cpd:C16616,10,14,10,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O10N4P2S1,C10H13O10N4P2S1,443.9905878,444.9984129,442.98276284492,4887,cpd:C16617,6-Mercaptopurine ribonucleoside triphosphate;,C10H15N4O13P3S,6-Mercaptopurine ribonucleoside triphosphate; 6-Thioinosine-5'-triphosphate,R08242 R08243,Drug metabolism - other enzymes,2.7.4.-; 3.6.1.-,NA,NA,CAS: 27652-34-2; PubChem: 51090943; ChEBI: 80611; NIKKAJI: J413.561J,cpd:C16617,10,15,13,4,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O13N4P3S1,C10H14O13N4P3S1,523.9569187,524.9647438,522.94909374493,4888,cpd:C16618,6-Thioxanthine 5'-monophosphate,C10H13N4O8PS,6-Thioxanthine 5'-monophosphate,R08240 R08244,Drug metabolism - other enzymes,1.1.1.205; 6.3.5.2,NA,NA,CAS: 3237-49-8; PubChem: 51090944; ChEBI: 80612; NIKKAJI: J2.804.101B,cpd:C16618,10,13,8,4,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O8N4P1S1,C10H12O8N4P1S1,380.0191716,381.0269966,379.01134654494,4889,cpd:C16619,6-Thioguanosine monophosphate,C10H14N5O7PS,6-Thioguanosine monophosphate,R08244 R08245 R08246,Drug metabolism - other enzymes,2.1.1.67; 2.4.2.8; 6.3.5.2,NA,NA,CAS: 15867-02-4; PubChem: 51090945; ChEBI: 80613; ChEMBL: CHEMBL1812063; PDB-CCD: 71V; NIKKAJI: J622.130K,cpd:C16619,10,14,7,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C10H15O7N5P1S1,C10H13O7N5P1S1,379.035156,380.042981,378.0273314495,4890,cpd:C16620,6-Methylthioguanosine monophosphate,C11H16N5O7PS,6-Methylthioguanosine monophosphate,R08246,Drug metabolism - other enzymes,2.1.1.67,NA,NA,CAS: 34020-33-2; PubChem: 51090946; ChEBI: 80614; ChEMBL: CHEMBL1812064; NIKKAJI: J437.667F,cpd:C16620,11,16,7,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H17O7N5P1S1,C11H15O7N5P1S1,393.050806,394.0586311,392.0429814496,4891,cpd:C16621,1-Methyl-4-nitroimidazole,C4H5N3O2,1-Methyl-4-nitroimidazole,R08234,Drug metabolism - other enzymes,NA,NA,NA,CAS: 3034-41-1; PubChem: 51090947; ChEBI: 80615; NIKKAJI: J86.858B,cpd:C05516; cpd:C16621,4,5,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H6O2N3,C4H4O2N3,127.0381764,128.0460014,126.03035144497,4892,cpd:C16622,"N,N'-Diacetylhydrazine;",C4H8N2O2,"N,N'-Diacetylhydrazine; Diacetylhydrazine",R08250,Drug metabolism - other enzymes,2.3.1.5,NA,NA,CAS: 3148-73-0; PubChem: 51090948; ChEBI: 80616; NIKKAJI: J217.302F,cpd:C16622; cpd:C19283; cpd:C19484,4,8,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O2N2,C4H7O2N2,116.0585775,117.0664025,115.05075254498,4893,cpd:C16623,Isonicotinylglycine;,C8H8N2O3,Isonicotinylglycine; Isonicotinuric acid,R08252,Drug metabolism - other enzymes,NA,NA,NA,CAS: 2015-20-5; PubChem: 51090949; ChEBI: 80617; NIKKAJI: J21.232F,cpd:C00875; cpd:C05380; cpd:C07504; cpd:C16623,8,8,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3N2,C8H7O3N2,180.0534921,181.0613172,179.04566714499,4894,cpd:C16624,Isoniazid pyruvate,C9H9N3O3,Isoniazid pyruvate,R08253,Drug metabolism - other enzymes,NA,NA,NA,CAS: 1081-50-1; PubChem: 51090950; ChEBI: 80618; NIKKAJI: J27.998F,cpd:C10902; cpd:C16624,9,9,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O3N3,C9H8O3N3,207.0643912,208.0722162,206.05656614500,4895,cpd:C16625,Isoniazid alpha-ketoglutaric acid,C11H11N3O5,Isoniazid alpha-ketoglutaric acid,R08254,Drug metabolism - other enzymes,NA,NA,NA,CAS: 1152-31-4; PubChem: 51090951; ChEBI: 80619; NIKKAJI: J2.804.110A,cpd:C16625,11,11,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H12O5N3,C11H10O5N3,265.0698705,266.0776955,264.06204544501,4896,cpd:C16630,"5,6-Dihydro-5-fluorouracil;",C4H5FN2O2,"5,6-Dihydro-5-fluorouracil; 5-Fluorodihydrouracil",R08226 R08227,Drug metabolism - other enzymes,1.3.1.2; 3.5.2.2,NA,NA,CAS: 696-06-0; PubChem: 51090956; ChEBI: 80624; NIKKAJI: J153.932I,cpd:C16630,4,5,2,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C4H6O2N2F1,C4H4O2N2F1,132.0335056,133.0413306,131.02568054502,4897,cpd:C16631,alpha-Fluoro-beta-ureidopropionic acid;,C4H7FN2O3,alpha-Fluoro-beta-ureidopropionic acid; 2-Fluoro-3-ureidopropionic acid,R08227 R08228,Drug metabolism - other enzymes,3.5.1.6; 3.5.2.2,NA,NA,CAS: 5006-64-4; PubChem: 51090957; ChEBI: 80625; NIKKAJI: J128.647A,cpd:C16631,4,7,3,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C4H8O3N2F1,C4H6O3N2F1,150.0440703,151.0518953,149.03624524503,4898,cpd:C16632,alpha-Fluoro-beta-alanine;,C3H6FNO2,alpha-Fluoro-beta-alanine; 3-Amino-2-fluoropropionic acid,R08228,Drug metabolism - other enzymes,3.5.1.6,NA,NA,CAS: 3821-81-6; PubChem: 51090958; ChEBI: 80626; NIKKAJI: J79.862B,cpd:C02638; cpd:C16632,3,6,2,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C3H7O2N1F1,C3H5O2N1F1,107.0382566,108.0460816,106.03043164504,4899,cpd:C16633,5-Fluorouridine,C9H11FN2O6,5-Fluorouridine,R08229 R08232,Drug metabolism - other enzymes,2.4.2.3; 2.7.1.48,NA,NA,CAS: 316-46-1; PubChem: 51090959; ChEBI: 40154; ChEMBL: CHEMBL54918 CHEMBL603501; PDB-CCD: 5UD; NIKKAJI: J36.572F,cpd:C16633,9,11,6,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C9H12O6N2F1,C9H10O6N2F1,262.0601142,263.0679393,261.05228924505,4900,cpd:C16634,5-Fluorouridine monophosphate,C9H12FN2O9P,5-Fluorouridine monophosphate,R08231 R08232,Drug metabolism - other enzymes,2.4.2.10; 2.7.1.48,NA,NA,CAS: 796-66-7; PubChem: 51090960; ChEBI: 40101; ChEMBL: CHEMBL474163; PDB-CCD: 5FU; NIKKAJI: J540.442H,cpd:C16634,9,12,9,2,1,0,0,0,0,1,0,0,0,0,0,0,0,0,C9H13O9N2P1F1,C9H11O9N2P1F1,342.0264451,343.0342702,341.01862014506,4901,cpd:C16635,5'-Deoxy-5-fluorocytidine,C9H12FN3O4,5'-Deoxy-5-fluorocytidine,R08220 R08221,Drug metabolism - other enzymes,3.1.1.1; 3.5.4.5,NA,NA,PubChem: 51090961; ChEBI: 80627; ChEMBL: CHEMBL608226; NIKKAJI: J548.939C,cpd:C16635,9,12,4,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C9H13O4N3F1,C9H11O4N3F1,245.081184,246.0890091,244.0733594507,4902,cpd:C16641,Irinotecan,C33H38N4O6,Irinotecan,R08255 R08256 R08257,Drug metabolism - other enzymes,1.14.13.-; 3.1.1.1,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Quinoline alkaloids;     C16641  Irinotecan; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01X OTHER ANTINEOPLASTIC AGENTS;     L01XX Other antineoplastic agents;      L01XX19 Irinotecan;       D08086  Irinotecan (INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Isomerases;    topoisomerase I;     Irinotecan;      D08086  Irinotecan (INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Irinotecan;     D08086  Irinotecan (INN);   CYP3A5;    Irinotecan;     D08086  Irinotecan (INN);   CYP3A7;    Irinotecan;     D08086  Irinotecan (INN);  Transporter substrates;   ABCB1;    Irinotecan;     D08086  Irinotecan (INN);   ABCG2;    Irinotecan;     D08086  Irinotecan (INN); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tryptophan and anthranillic acid;    Quinoline alkaloids;     D08086  Irinotecan (INN),CAS: 97682-44-5; PubChem: 51090967; ChEBI: 80630; ChEMBL: CHEMBL481; PDB-CCD: CP0; NIKKAJI: J261.801J,cpd:C05786; cpd:C05912; cpd:C16641,33,38,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H39O6N4,C33H37O6N4,586.279135,587.28696,585.27130994508,4903,cpd:C00599,Cholest-4-en-3-one;,C27H44O,Cholest-4-en-3-one; Cholestenone; 4-Cholesten-3-one,R01459 R02609 R02610 R09859 R09920 R11357 R11358 R11361,Steroid degradation; Microbial metabolism in diverse environments,1.1.1.145; 1.1.3.6; 1.3.1.3; 1.3.1.22; 1.14.13.141; 1.14.13.221; 5.3.3.1,NA,NA,CAS: 601-57-0; PubChem: 3875; ChEBI: 16175; ChEMBL: CHEMBL63243; LIPIDMAPS: LMST01010015; LipidBank: SST9045; KNApSAcK: C00036093; PDB-CCD: K2B; 3DMET: B01291; NIKKAJI: J73F,cpd:C00599; cpd:C01164; cpd:C01802; cpd:C05104; cpd:C05437; cpd:C05439; cpd:C05443; cpd:C07711,27,44,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H45O1,C27H43O1,384.339216,385.3470411,383.3313914509,4904,cpd:C04793,"3,4-Dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione",C19H24O4,"3,4-Dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione",R04597 R09819,Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.25; 1.14.14.12,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C04793  3,4-Dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione",PubChem: 7356; ChEBI: 15896; LIPIDMAPS: LMST02020062; PDB-CCD: SDT; 3DMET: B00746; NIKKAJI: J2.055.970E,cpd:C04793; cpd:C07805; cpd:C11863; cpd:C14347; cpd:C14946; cpd:C15456; cpd:C17789; cpd:C17795,19,24,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O4,C19H23O4,316.1674593,317.1752843,315.15963424510,4905,cpd:C04844,"3-Hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate;",C19H24O6,"3-Hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate; (1E,2Z)-3-Hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate; DSHA",R04597 R09883,Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,1.13.11.25; 3.7.1.17,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C04844  3-Hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate",PubChem: 7401; ChEBI: 29086; LIPIDMAPS: LMST02020063; 3DMET: B00749; NIKKAJI: J1.927.771B,cpd:C00859; cpd:C04597; cpd:C04844; cpd:C06096; cpd:C08358; cpd:C08759; cpd:C09356; cpd:C09407; cpd:C09520; cpd:C09539; cpd:C09554; cpd:C11868; cpd:C16910,19,24,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O6,C19H23O6,348.1572885,349.1651135,347.14946354511,4906,cpd:C07635,Epiandrosterone,C19H30O2,Epiandrosterone,R09956,Steroid degradation; Microbial metabolism in diverse environments,1.1.1.51,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST02 Steroids;    ST0202 C19 steroids (androgens) and derivatives;     C07635  Epiandrosterone,CAS: 481-29-8; PubChem: 9837; ChEBI: 541975; ChEMBL: CHEMBL1342064 CHEMBL272195 CHEMBL419712; LIPIDMAPS: LMST02020023; LipidBank: SST0205; PDB-CCD: AOX; 3DMET: B02136; NIKKAJI: J9.233I,cpd:C00523; cpd:C01986; cpd:C03917; cpd:C04295; cpd:C04373; cpd:C05293; cpd:C07635; cpd:C14210; cpd:C14631; cpd:C14932; cpd:C15326; cpd:C15442,19,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H31O2,C19H29O2,290.2245802,291.2324052,289.21675524512,4907,cpd:C14909,"9alpha-Hydroxyandrosta-1,4-diene-3,17-dione",C19H24O3,"9alpha-Hydroxyandrosta-1,4-diene-3,17-dione",R09860 R09885,Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.13.142,NA,NA,PubChem: 17395907; ChEBI: 63641; NIKKAJI: J2.790.424F,cpd:C02197; cpd:C05285; cpd:C05297; cpd:C05299; cpd:C06494; cpd:C07063; cpd:C13326; cpd:C13676; cpd:C14587; cpd:C14909; cpd:C15150; cpd:C15200; cpd:C15295; cpd:C15386; cpd:C15406; cpd:C16991; cpd:C17567; cpd:C17850; cpd:C17851; cpd:C18510; cpd:C19944; cpd:C19982,19,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O3,C19H23O3,300.1725446,301.1803697,299.16471964513,4908,cpd:C19944,"3-Hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione;",C19H24O3,"3-Hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione; Secophenol",R09819 R09885,Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.14.14.12,NA,NA,CAS: 2394-69-6; PubChem: 135626410,cpd:C02197; cpd:C05285; cpd:C05297; cpd:C05299; cpd:C06494; cpd:C07063; cpd:C13326; cpd:C13676; cpd:C14587; cpd:C14909; cpd:C15150; cpd:C15200; cpd:C15295; cpd:C15386; cpd:C15406; cpd:C16991; cpd:C17567; cpd:C17850; cpd:C17851; cpd:C18510; cpd:C19944; cpd:C19982,19,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O3,C19H23O3,300.1725446,301.1803697,299.16471964514,4909,cpd:C20144,"Androsta-1,4-diene-3,17-dione",C19H24O2,"Androsta-1,4-diene-3,17-dione",R09860 R09884,Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments,1.3.99.4; 1.14.13.142,NA,NA,CAS: 897-06-3; PubChem: 135626604; ChEMBL: CHEMBL1078534; KNApSAcK: C00047005; PDB-CCD: ANB,cpd:C07367; cpd:C07420; cpd:C11810; cpd:C14257; cpd:C15194; cpd:C15211; cpd:C15255; cpd:C15323; cpd:C15454; cpd:C18572; cpd:C20144,19,24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O2,C19H23O2,284.17763,285.185455,283.1698054515,4910,cpd:C20199,"3-[(3aS,4S,7aS)-7a-Methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoate;",C13H18O4,"3-[(3aS,4S,7aS)-7a-Methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoate; 9,17-Dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic acid; DOHNAA; HIP",R09883 R10769,Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments; Degradation of aromatic compounds,3.7.1.17; 6.2.1.41,NA,NA,PubChem: 163311942; ChEBI: 63741,cpd:C17370; cpd:C17405; cpd:C20199; cpd:C20926,13,18,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H19O4,C13H17O4,238.1205091,239.1283341,237.1126844516,4911,cpd:C20252,"5-Androstene-3,17-dione",C19H26O2,"5-Androstene-3,17-dione",R09955 R09957,Steroid degradation; Microbial metabolism in diverse environments,1.1.1.51; 5.3.3.1,NA,NA,CAS: 571-36-8; PubChem: 163311995; ChEBI: 83865; ChEMBL: CHEMBL1743203,cpd:C00280; cpd:C14483; cpd:C14502; cpd:C15293; cpd:C15315; cpd:C20217; cpd:C20252,19,26,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H27O2,C19H25O2,286.1932801,287.2011051,285.1854554517,4912,cpd:C20838,"3-[(3aS,4S,7aS)-7a-Methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl-CoA;",C34H52N7O19P3S,"3-[(3aS,4S,7aS)-7a-Methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl-CoA; HIP-CoA",R10769,Steroid degradation; Metabolic pathways; Microbial metabolism in diverse environments,6.2.1.41,NA,NA,PubChem: 254741304; PDB-CCD: UCA,cpd:C20838,34,52,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C34H53O19N7P3S1,C34H51O19N7P3S1,987.2251546,988.2329797,986.21732964518,4913,cpd:C20839,(25R)-3-Oxocholest-4-en-26-oate;,C27H42O3,(25R)-3-Oxocholest-4-en-26-oate; 3-Oxo-4-cholesten-26-oate; 3-Oxo-4-cholesten-26-oic acid,R11360 R11361,Steroid degradation; Microbial metabolism in diverse environments,1.14.13.221,NA,NA,PubChem: 254741305; PDB-CCD: DL4,cpd:C08898; cpd:C08918; cpd:C14994; cpd:C16509; cpd:C20839; cpd:C21076; cpd:C21077,27,42,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O3,C27H41O3,414.3133952,415.3212202,413.30557024519,4914,cpd:C21076,Delta4-Dafachronic acid;,C27H42O3,"Delta4-Dafachronic acid; (25S),26-3-Keto-4-cholestenoic acid; (25S)-Delta4-Dafachronic acid; (25S)-3-Oxocholest-4-en-26-oate",R09919 R10770 R11356 R11357,Steroid degradation; Microbial metabolism in diverse environments; Longevity regulating pathway - worm,1.14.13.141; 6.2.1.42,NA,NA,PubChem: 295369338,cpd:C08898; cpd:C08918; cpd:C14994; cpd:C16509; cpd:C20839; cpd:C21076; cpd:C21077,27,42,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O3,C27H41O3,414.3133952,415.3212202,413.30557024520,4915,cpd:C00412,Stearoyl-CoA;,C39H70N7O17P3S,Stearoyl-CoA; Stearyl-CoA; Stearyl coenzyme A,R02222 R02224 R07761 R08174 R11451,Biosynthesis of unsaturated fatty acids; Biosynthesis of plant hormones; Fatty acid metabolism,1.3.1.38; 1.3.1.93; 1.14.19.1; 2.3.1.252; 3.1.2.2,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C00412  Octadecanoyl-CoA,CAS: 362-66-3; PubChem: 3702; ChEBI: 15541; LIPIDMAPS: LMFA07050004; PDB-CCD: ST9; 3DMET: B04680; NIKKAJI: J426.067H,cpd:C00412,39,70,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H71O17N7P3S1,C39H69O17N7P3S1,1033.376176,1034.384001,1032.3683514521,4916,cpd:C00510,Oleoyl-CoA;,C39H68N7O17P3S,Oleoyl-CoA; (9Z)-Octadecenoyl-CoA,R02222 R08176 R10999 R11043,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.13.204; 1.14.19.1; 1.14.19.6; 3.1.2.2,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C00510  (9Z)-Ocatadecenoyl-CoA,PubChem: 3793; ChEBI: 15534; PDB-CCD: 3VV; 3DMET: B04691; NIKKAJI: J203.108F,cpd:C00510; cpd:C16218,39,68,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H69O17N7P3S1,C39H67O17N7P3S1,1031.360526,1032.368351,1030.3527014522,4917,cpd:C02041,Eicosanoyl-CoA;,C41H74N7O17P3S,Eicosanoyl-CoA; Icosanoyl-CoA; Arachidoyl-CoA,R02224 R08175 R10926 R11450,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.19.10; 2.3.1.111; 3.1.2.2,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C02041  Icosanoyl-CoA,PubChem: 5132; ChEBI: 15527; LIPIDMAPS: LMFA07050006; 3DMET: B04833; NIKKAJI: J2.735.367C,cpd:C02041; cpd:C02060,41,74,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C41H75O17N7P3S1,C41H73O17N7P3S1,1061.407476,1062.415301,1060.3996514523,4918,cpd:C02050,Linoleoyl-CoA;,C39H66N7O17P3S,"Linoleoyl-CoA; (9Z,12Z)-Octadecadienoyl-CoA",R03814 R08177 R11000 R11043,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.13.204; 1.14.19.3; 1.14.19.6; 3.1.2.2,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C02050  (6Z,9Z)-Octadecadienoyl-CoA",PubChem: 5139; ChEBI: 15530; 3DMET: B04835; NIKKAJI: J2.735.439D,cpd:C02050,39,66,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H67O17N7P3S1,C39H65O17N7P3S1,1029.344876,1030.352701,1028.3370514524,4919,cpd:C02249,Arachidonyl-CoA;,C41H66N7O17P3S,"Arachidonyl-CoA; Arachidonoyl-CoA; (5Z,8Z,11Z,14Z)-Icosatetraenoyl-CoA",R01598 R01798 R08183 R11059,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism; Ovarian steroidogenesis,1.14.19.44; 3.1.2.2; 6.2.1.15,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C02249  (5Z,8Z,11Z,14Z)-Icosatetraenonyl-CoA",CAS: 17046-56-9; PubChem: 5312; ChEBI: 15514; LIPIDMAPS: LMFA07050007; 3DMET: B04843; NIKKAJI: J1.245.388D,cpd:C02249; cpd:C16164; cpd:C21083,41,66,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C41H67O17N7P3S1,C41H65O17N7P3S1,1053.344876,1054.352701,1052.3370514525,4920,cpd:C03035,gamma-Linolenoyl-CoA,C39H64N7O17P3S,gamma-Linolenoyl-CoA,R03814 R08181,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.19.3; 3.1.2.2,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C03035  (6Z,9Z,12Z)-Octadecatrienoyl-CoA",PubChem: 5940; ChEBI: 15508; 3DMET: B04875; NIKKAJI: J2.740.376J,cpd:C03035; cpd:C16162,39,64,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H65O17N7P3S1,C39H63O17N7P3S1,1027.329226,1028.337051,1026.3214014526,4921,cpd:C03595,"8,11,14-Eicosatrienoyl-CoA;",C41H68N7O17P3S,"8,11,14-Eicosatrienoyl-CoA; 8,11,14-Icosatrienoyl-CoA; (8Z,11Z,14Z)-Icosatrienoyl-CoA; (8Z,11Z,14Z)-Icosa-8,11,14-trienoyl-CoA",R08182 R11059,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.19.44; 3.1.2.2,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C03595  (8Z,11Z,14Z)-Icosatrienoyl-CoA",PubChem: 6386; ChEBI: 27979; LIPIDMAPS: LMFA07050011; 3DMET: B04905; NIKKAJI: J2.743.021J,cpd:C03595; cpd:C16179; cpd:C21082,41,68,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C41H69O17N7P3S1,C41H67O17N7P3S1,1055.360526,1056.368351,1054.3527014527,4922,cpd:C06425,Icosanoic acid;,C20H40O2,Icosanoic acid; Eicosanoic acid; Arachidic acid,R08175,Biosynthesis of unsaturated fatty acids,3.1.2.2,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C06425  Arachidic acid (20:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C06425  Icosanoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Saturated fatty acids;     C06425  Arachidic acid,CAS: 506-30-9; PubChem: 8660; ChEBI: 28822; ChEMBL: CHEMBL1173381; LIPIDMAPS: LMFA01010020; LipidBank: DFA0020; KNApSAcK: C00001209; PDB-CCD: DCR; 3DMET: B02020; NIKKAJI: J2.607G,cpd:C01607; cpd:C06425,20,40,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H41O2,C20H39O2,312.3028305,313.3106556,311.29500554528,4923,cpd:C06428,"(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid;",C20H30O2,"(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid; Eicosapentaenoic acid; 5,8,11,14,17-Icosapentaenoic acid; (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate",R06502 R08179,Biosynthesis of unsaturated fatty acids,3.1.2.2; 5.3.3.13,NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C06428  Eicosapentaenoic acid (20:5;5,8,11,14.17); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C06428  (5Z,8Z,11Z,14Z,17Z)-Icosapenta-5,8,11,14,17-enoic acid; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Liner triterpenes;     C06428  (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid",CAS: 10417-94-4; PubChem: 8663; ChEBI: 28364; ChEMBL: CHEMBL460026; LIPIDMAPS: LMFA01030759; LipidBank: DFA0220; KNApSAcK: C00000408 C00001215; PDB-CCD: EPA; 3DMET: B00962; NIKKAJI: J343.473G,cpd:C06087; cpd:C06428; cpd:C07198; cpd:C09118; cpd:C09148; cpd:C09159; cpd:C11874; cpd:C11888; cpd:C11889; cpd:C12077; cpd:C12083; cpd:C14255; cpd:C14490; cpd:C14588; cpd:C14890; cpd:C15003; cpd:C15008; cpd:C15017; cpd:C15036; cpd:C15070; cpd:C15184; cpd:C15188; cpd:C15259; cpd:C15318; cpd:C15412; cpd:C15460; cpd:C20149; cpd:C20208,20,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O2,C20H29O2,302.2245802,303.2324052,301.21675524529,4924,cpd:C06429,"(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid;",C22H32O2,"(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid; 4,7,10,13,16,19-Docosahexaenoic acid; Docosahexaenoic acid; Docosahexaenoate",R08180 R10795,Biosynthesis of unsaturated fatty acids,1.14.13.199; 3.1.2.2,NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C06429  Docosahexaenoic acid (22:6;4,7,10,13,16,19); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C06429  (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexa-4,7,10,13,16,19-enoic acid;   FA04 Docosanoids;    C06429  (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid",PubChem: 8664; ChEBI: 28125; ChEMBL: CHEMBL367149; LIPIDMAPS: LMFA01030185; LipidBank: DFA0224; PDB-CCD: HXA; 3DMET: B02023; NIKKAJI: J381.483A,cpd:C06429; cpd:C14586; cpd:C15116; cpd:C15265; cpd:C15299; cpd:C15322,22,32,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H33O2,C22H31O2,328.2402303,329.2480553,327.23240524530,4925,cpd:C08316,Erucic acid;,C22H42O2,Erucic acid; (13Z)-Docosenoic acid; cis-13-Docosenoic acid,R08187,Biosynthesis of unsaturated fatty acids,3.1.2.-,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C08316  Erucic acid (22:1;13); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Monounsaturated fatty acids;      C08316  (Z)-Docos-13-enoic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Unsaturated fatty acids;     C08316  Erucic acid,CAS: 112-86-7; PubChem: 10514; ChEBI: 28792; ChEMBL: CHEMBL1173380; LIPIDMAPS: LMFA01030089; LipidBank: DFA0128; KNApSAcK: C00001217; 3DMET: B02160; NIKKAJI: J10.102H,cpd:C08316,22,42,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H43O2,C22H41O2,338.3184806,339.3263056,337.31065564531,4926,cpd:C08320,Tetracosanoic acid;,C24H48O2,Tetracosanoic acid; Lignoceric acid,R08185,Biosynthesis of unsaturated fatty acids,3.1.2.-,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Saturated fatty acids;     C08320  Lignoceric acid (24:0); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0101 Straight chain fatty acids;     C08320  Tetracosanoic acid,CAS: 557-59-5; PubChem: 10518; ChEBI: 28866; ChEMBL: CHEMBL1173620; LIPIDMAPS: LMFA01010024; LipidBank: DFA0024; KNApSAcK: C00001223; 3DMET: B02164; NIKKAJI: J11.350F,cpd:C08320,24,48,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H49O2,C24H47O2,368.3654308,369.3732558,367.35760584532,4927,cpd:C08323,(15Z)-Tetracosenoic acid;,C24H46O2,(15Z)-Tetracosenoic acid; Nervonic acid; (Z)-15-Tetracosenoic acid,R08188,Biosynthesis of unsaturated fatty acids,3.1.2.-,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C08323  Nervonic acid (24:1;15); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Monounsaturated fatty acids;      C08323  (Z)-Tetracos-15-enoic acid,CAS: 506-37-6; PubChem: 10521; ChEBI: 44247; ChEMBL: CHEMBL1173379; LIPIDMAPS: LMFA01030092; LipidBank: DFA0131; KNApSAcK: C00001230; PDB-CCD: NER; 3DMET: B02167; NIKKAJI: J11.357C,cpd:C08323; cpd:C15398,24,46,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H47O2,C24H45O2,366.3497807,367.3576058,365.34195574533,4930,cpd:C16162,"(9Z,12Z,15Z)-Octadecatrienoyl-CoA;",C39H64N7O17P3S,"(9Z,12Z,15Z)-Octadecatrienoyl-CoA; alpha-Linolenoyl-CoA",R07933 R08178,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.19.3; 3.1.2.2,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16162  (9Z,12Z,15Z)-Octadecatrienoyl-CoA",PubChem: 47205472; ChEBI: 51985; NIKKAJI: J2.798.455J,cpd:C03035; cpd:C16162,39,64,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H65O17N7P3S1,C39H63O17N7P3S1,1027.329226,1028.337051,1026.3214014534,4931,cpd:C16163,"(6Z,9Z,12Z,15Z)-Octadecatetraenoyl-CoA;",C39H62N7O17P3S,"(6Z,9Z,12Z,15Z)-Octadecatetraenoyl-CoA; Stearidonoyl-CoA",R07933,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.19.3,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16163  (6Z,9Z,12Z,15Z)-Octadecatetraenoyl-CoA",PubChem: 47205473; ChEBI: 63545; NIKKAJI: J2.798.473H,cpd:C16163,39,62,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H63O17N7P3S1,C39H61O17N7P3S1,1025.313576,1026.321401,1024.3057514535,4932,cpd:C16164,"(8Z,11Z,14Z,17Z)-Icosatetraenoyl-CoA;",C41H66N7O17P3S,"(8Z,11Z,14Z,17Z)-Icosatetraenoyl-CoA; (8Z,11Z,14Z,17Z)-Icosa-8,11,14,17-tetraenoyl-CoA",R11060,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.19.44,NA,NA,PubChem: 47205474; NIKKAJI: J2.798.476B,cpd:C02249; cpd:C16164; cpd:C21083,41,66,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C41H67O17N7P3S1,C41H65O17N7P3S1,1053.344876,1054.352701,1052.3370514536,4933,cpd:C16165,"(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoyl-CoA;",C41H64N7O17P3S,"(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoyl-CoA; (5Z,8Z,11Z,14Z,17Z)-Icosa-5,8,11,14,17-pentaenoyl-CoA",R08179 R11060,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.19.44; 3.1.2.2,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16165  (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoyl-CoA",PubChem: 47205475; ChEBI: 63539; NIKKAJI: J2.798.477K,cpd:C16165,41,64,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C41H65O17N7P3S1,C41H63O17N7P3S1,1051.329226,1052.337051,1050.3214014537,4934,cpd:C16166,"(7Z,10Z,13Z,16Z,19Z)-Docosapentaenoyl-CoA",C43H68N7O17P3S,"(7Z,10Z,13Z,16Z,19Z)-Docosapentaenoyl-CoA",R08189,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,3.1.2.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16166  (7Z,10Z,13Z,16Z,19Z)-Docosapentaenoyl-CoA",PubChem: 47205476; ChEBI: 63541; NIKKAJI: J2.798.479G,cpd:C16166; cpd:C16173,43,68,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C43H69O17N7P3S1,C43H67O17N7P3S1,1079.360526,1080.368351,1078.3527014538,4935,cpd:C16167,"(9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoyl-CoA",C45H72N7O17P3S,"(9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoyl-CoA",R11110,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.19.3,NA,NA,PubChem: 47205477; ChEBI: 80359; NIKKAJI: J2.798.490H,cpd:C16167; cpd:C16172,45,72,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H73O17N7P3S1,C45H71O17N7P3S1,1107.391826,1108.399651,1106.3840014539,4936,cpd:C16168,"(6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahexaenoyl-CoA",C45H70N7O17P3S,"(6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahexaenoyl-CoA",R07934 R11110,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.3.3.6; 1.14.19.3,NA,NA,PubChem: 47205478; ChEBI: 63540; NIKKAJI: J2.798.500I,cpd:C16168; cpd:C16387,45,70,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H71O17N7P3S1,C45H69O17N7P3S1,1105.376176,1106.384001,1104.3683514540,4937,cpd:C16169,"(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoyl-CoA",C43H66N7O17P3S,"(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoyl-CoA",R07937 R08180,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,2.3.1.16; 3.1.2.2,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16169  (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoyl-CoA",PubChem: 47205479; ChEBI: 65132; NIKKAJI: J2.798.501G,cpd:C16169,43,66,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C43H67O17N7P3S1,C43H65O17N7P3S1,1077.344876,1078.352701,1076.3370514541,4938,cpd:C16170,"(7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA",C43H70N7O17P3S,"(7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA",R08191,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,3.1.2.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16170  (7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA",PubChem: 47205480; NIKKAJI: J2.798.502E,cpd:C16170,43,70,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C43H71O17N7P3S1,C43H69O17N7P3S1,1081.376176,1082.384001,1080.3683514542,4939,cpd:C16171,"(9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA",C45H74N7O17P3S,"(9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA",R11111,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.19.3,NA,NA,PubChem: 47205481; ChEBI: 63548; NIKKAJI: J2.798.503C,cpd:C16171,45,74,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H75O17N7P3S1,C45H73O17N7P3S1,1109.407476,1110.415301,1108.3996514543,4940,cpd:C16172,"(6Z,9Z,12Z,15Z,18Z)-Tetracosapentaenoyl-CoA",C45H72N7O17P3S,"(6Z,9Z,12Z,15Z,18Z)-Tetracosapentaenoyl-CoA",R07950 R11111,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.3.3.6; 1.14.19.3,NA,NA,PubChem: 47205482; ChEBI: 63546; NIKKAJI: J2.798.508D,cpd:C16167; cpd:C16172,45,72,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H73O17N7P3S1,C45H71O17N7P3S1,1107.391826,1108.399651,1106.3840014544,4941,cpd:C16173,"(4Z,7Z,10Z,13Z,16Z)-Docosapentaenoyl-CoA",C43H68N7O17P3S,"(4Z,7Z,10Z,13Z,16Z)-Docosapentaenoyl-CoA",R07953,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,2.3.1.16,NA,NA,PubChem: 47205483; ChEBI: 76450; NIKKAJI: J2.798.509B,cpd:C16166; cpd:C16173,43,68,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C43H69O17N7P3S1,C43H67O17N7P3S1,1079.360526,1080.368351,1078.3527014545,4942,cpd:C16179,"(11Z,14Z,17Z)-Icosatrienoyl-CoA;",C41H68N7O17P3S,"(11Z,14Z,17Z)-Icosatrienoyl-CoA; (11Z,14Z,17Z)-Icosa-11,14,17-trienoyl-CoA",R08192 R11058,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.19.37; 3.1.2.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16179  (11Z,14Z,17Z)-Icosatrienoyl-CoA",PubChem: 47205488; ChEBI: 74606; NIKKAJI: J2.798.563G,cpd:C03595; cpd:C16179; cpd:C21082,41,68,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C41H69O17N7P3S1,C41H67O17N7P3S1,1055.360526,1056.368351,1054.3527014546,4943,cpd:C16180,"(11Z,14Z)-Icosadienoyl-CoA;",C41H70N7O17P3S,"(11Z,14Z)-Icosadienoyl-CoA; (11Z,14Z)-Icosa-11,14-dienoyl-CoA",R08190 R11057,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,1.14.19.37; 3.1.2.-,NA,NA,PubChem: 47205489; ChEBI: 76534; NIKKAJI: J2.798.580G,cpd:C16180,41,70,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C41H71O17N7P3S1,C41H69O17N7P3S1,1057.376176,1058.384001,1056.3683514547,4944,cpd:C16513,"(7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid;",C22H34O2,"(7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid; Docosapentaenoic acid",R08189,Biosynthesis of unsaturated fatty acids,3.1.2.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C16513  (7Z,10Z,13Z,16Z,19Z)-Docosapenta-7,10,13,16,19-enoic acid;   FA04 Docosanoids;    C16513  (7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid",CAS: 24880-45-3; PubChem: 49661773; ChEBI: 53488; ChEMBL: CHEMBL496634; LIPIDMAPS: LMFA04000044; NIKKAJI: J490.555E,cpd:C11896; cpd:C13364; cpd:C15106; cpd:C15413; cpd:C15421; cpd:C16184; cpd:C16513,22,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H35O2,C22H33O2,330.2558803,331.2637054,329.24805534548,4945,cpd:C16522,Icosatrienoic acid;,C20H34O2,"Icosatrienoic acid; Eicosatrienoic acid; ETA; 11,14,17-Icosatrienoic acid; (11Z,14Z,17Z)-Icosa-11,14,17-trienoic acid; 11,14,17-Eicosatrienoic acid; (11Z,14Z,17Z)-Eicosa-11,14,17-trienoic acid",R08192,Biosynthesis of unsaturated fatty acids,3.1.2.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C16522  (11Z,14Z,17Z)-Icosatri-11,14,17-enoic acid",CAS: 17046-59-2; PubChem: 51090851; ChEBI: 53460; ChEMBL: CHEMBL453991; LIPIDMAPS: LMFA01030378; LipidBank: DFA0198; NIKKAJI: J323.446K,cpd:C03242; cpd:C09072; cpd:C13273; cpd:C14882; cpd:C15058; cpd:C15376; cpd:C15399; cpd:C16522,20,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O2,C20H33O2,306.2558803,307.2637054,305.24805534549,4946,cpd:C16525,Icosadienoic acid;,C20H36O2,"Icosadienoic acid; Eicosadienoic acid; 11,14-Icosadienoic acid; (11Z,14Z)-Icosa-11,14-dienoic acid; 11,14-Eicosadienoic acid; (11Z,14Z)-Eicosa-11,14-dienoic acid",R08190,Biosynthesis of unsaturated fatty acids,3.1.2.-,NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C16525  Icosadienoic acid (20:2;11,14); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C16525  (11Z,14Z)-Icosa-11,14-dienoic acid",PubChem: 51090854; ChEBI: 73731; ChEMBL: CHEMBL464983; LipidBank: DFA0169; NIKKAJI: J394.182E,cpd:C09183; cpd:C16525,20,36,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H37O2,C20H35O2,308.2715304,309.2793554,307.26370544550,4947,cpd:C16526,Icosenoic acid;,C20H38O2,Icosenoic acid; Eicosenoic acid; 11-Icosenoic acid; 11-Eicosenoic acid; (11Z)-Icosenoic acid; (11Z)-Eicosenoic acid; (Z)-Icosa-11-enoic acid,R08186,Biosynthesis of unsaturated fatty acids,3.1.2.-,NA,Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C16526  Icosenoic acid (20:1;11); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Monounsaturated fatty acids;      C16526  (Z)-Icos-11-enoic acid,PubChem: 51090855; ChEBI: 32425; LIPIDMAPS: LMFA01030085; LipidBank: DFA0124; KNApSAcK: C00035628; NIKKAJI: J12.741H,cpd:C02064; cpd:C16526,20,38,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H39O2,C20H37O2,310.2871805,311.2950055,309.27935544551,4948,cpd:C16527,"7,10,13,16-Docosatetraenoic acid;",C22H36O2,"7,10,13,16-Docosatetraenoic acid; (7Z,10Z,13Z,16Z)-Docosa-7,10,13,16-tetraenoic acid; Adrenic acid",R08191,Biosynthesis of unsaturated fatty acids,3.1.2.-,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C16527  (7Z,10Z,13Z,16Z)-Docosatetra-7,10,13,16-enoic acid;   FA04 Docosanoids;    C16527  (7Z,10Z,13Z,16Z)-Docosa-7,10,13,16-tetraenoic acid",CAS: 28874-58-0; PubChem: 51090856; ChEBI: 53487; ChEMBL: CHEMBL1491103; LIPIDMAPS: LMFA01030178 LMFA04000050; LipidBank: DFA0217; NIKKAJI: J13.758H,cpd:C15373; cpd:C16527,22,36,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H37O2,C22H35O2,332.2715304,333.2793554,331.26370544552,4949,cpd:C16528,Docosanoyl-CoA;,C43H78N7O17P3S,Docosanoyl-CoA; Behenoyl-CoA,R08184,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,3.1.2.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16528  Docosanoyl-CoA,PubChem: 51090857; ChEBI: 65088; NIKKAJI: J2.803.625F,cpd:C16528,43,78,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C43H79O17N7P3S1,C43H77O17N7P3S1,1089.438776,1090.446601,1088.4309514553,4950,cpd:C16529,Tetracosanoyl-CoA;,C45H82N7O17P3S,Tetracosanoyl-CoA; Lignoceroyl-CoA,R08185,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,3.1.2.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16529  Tetracosanoyl-CoA,PubChem: 51090858; ChEBI: 52974; NIKKAJI: J554.420C,cpd:C16529,45,82,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H83O17N7P3S1,C45H81O17N7P3S1,1117.470076,1118.477901,1116.4622514554,4951,cpd:C16530,Icosenoyl-CoA;,C41H72N7O17P3S,Icosenoyl-CoA; Eicosenoyl-CoA; (11Z)-Icosenoyl-CoA; (11Z)-Eicosenoyl-CoA,R08186,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,3.1.2.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16530  (11Z)-Icosenoyl-CoA,PubChem: 51090859; ChEBI: 74126; NIKKAJI: J2.803.547K,cpd:C16530; cpd:C20947,41,72,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C41H73O17N7P3S1,C41H71O17N7P3S1,1059.391826,1060.399651,1058.3840014555,4952,cpd:C16531,Docosenoyl-CoA;,C43H76N7O17P3S,Docosenoyl-CoA; (13Z)-Docosenoyl-CoA,R08187,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,3.1.2.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16531  (13Z)-Docosenoyl-CoA,PubChem: 51090860; ChEBI: 80548; NIKKAJI: J2.803.675B,cpd:C16531,43,76,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C43H77O17N7P3S1,C43H75O17N7P3S1,1087.423126,1088.430951,1086.4153014556,4953,cpd:C16532,Tetracosenoyl-CoA;,C45H80N7O17P3S,Tetracosenoyl-CoA; Nervonoyl-CoA; (15Z)-Tetracosenoyl-CoA,R08188,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,3.1.2.-,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16532  (15Z)-Tetracosenoyl-CoA,PubChem: 51090861; ChEBI: 74142; NIKKAJI: J2.803.678G,cpd:C16532,45,80,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H81O17N7P3S1,C45H79O17N7P3S1,1115.454426,1116.462251,1114.4466014557,4954,cpd:C16533,"13,16-Docosadienoic acid;",C22H40O2,"13,16-Docosadienoic acid; (13Z,16Z)-Docosa-13,16-dienoic acid",R08273,Biosynthesis of unsaturated fatty acids,3.1.2.-,NA,"Compounds with biological roles [BR:br08001];  Lipids;   Fatty acids;    Unsaturated fatty acids;     C16533  Docosadienoic acid (22:2;13,16); Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C16533  (13Z,16Z)-Docosadi-13,16-enoic acid;   FA04 Docosanoids;    C16533  (13Z,16Z)-Docosa-13,16-dienoic acid",PubChem: 51090862; ChEBI: 75117; LIPIDMAPS: LMFA01030405; LipidBank: DFA0171; NIKKAJI: J1.720.804G,cpd:C16533,22,40,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H41O2,C22H39O2,336.3028305,337.3106556,335.29500554558,4955,cpd:C16645,"(13Z,16Z)-Docosadi-13,16-enoyl-CoA",C43H74N7O17P3S,"(13Z,16Z)-Docosadi-13,16-enoyl-CoA",R08273,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,3.1.2.-,NA,NA,PubChem: 51090970; ChEBI: 80632; NIKKAJI: J2.804.193D,cpd:C16645,43,74,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C43H75O17N7P3S1,C43H73O17N7P3S1,1085.407476,1086.415301,1084.3996514559,4956,cpd:C01848,Rifamycin B,C39H49NO14,Rifamycin B,R03736 R06600,Biosynthesis of ansamycins; Type I polyketide structures; Biosynthesis of antibiotics,1.10.3.6,NA,Lipids [BR:br08002];  PK  Polyketides;   PK05 Ansamycins and related polyketides;    C01848  Rifamycin B,CAS: 13929-35-6; PubChem: 4965; ChEBI: 17876; LIPIDMAPS: LMPK05000003; 3DMET: B01506; NIKKAJI: J14.966G,cpd:C01848,39,49,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C39H50O14N1,C39H48O14N1,755.3153053,756.3231303,754.30748024560,4957,cpd:C12044,Rifamycin;,C37H47NO12,Rifamycin; Rifamycin SV,R06600 R06998 R06999,Biosynthesis of ansamycins; Biosynthesis of antibiotics,2.1.1.315,NA,Lipids [BR:br08002];  PK  Polyketides;   PK05 Ansamycins and related polyketides;    C12044  Rifamycin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J04 ANTIMYCOBACTERIALS;    J04A DRUGS FOR TREATMENT OF TUBERCULOSIS;     J04AB Antibiotics;      J04AB03 Rifamycin;       D02549  Rifamycin (USAN/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA16 Rifamycin;       D02549  Rifamycin (USAN/INN);   S02 OTOLOGICALS;    S02A ANTIINFECTIVES;     S02AA Antiinfectives;      S02AA12 Rifamycin;       D02549  Rifamycin (USAN/INN); Antiinfectives [BR:br08307];  Antibacterials;   Nucleic acid synthesis inhibitor;    RNA polymerase inhibitor;     Rifamycins;      Rifamycin;       D02549  Rifamycin (USAN/INN),CAS: 6998-60-3; PubChem: 14199; ChEBI: 29673; ChEMBL: CHEMBL437765; LIPIDMAPS: LMPK05000005; 3DMET: B04414; NIKKAJI: J8.871D,cpd:C12044,37,47,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H48O12N1,C37H46O12N1,697.309826,698.317651,696.30200094561,4958,cpd:C12045,Ansamitocin P-3;,C32H43ClN2O9,Ansamitocin P-3; Ansamitosin P-3; Antibiotic C15003P3; C15003P3; Maytansinol isobutyrate; 2'-De(acetylmethylamino)-2'-methylmaytansine,R09856,Biosynthesis of ansamycins; Type I polyketide structures; Biosynthesis of antibiotics,2.1.1.-,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C12045  Ansamitocin P3,CAS: 66584-72-3; PubChem: 14200; ChEBI: 29515; ChEMBL: CHEMBL359364 CHEMBL507305; LIPIDMAPS: LMPK04000039; KNApSAcK: C00018269; NIKKAJI: J18.568J,cpd:C12045,32,43,9,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C32H44O9N2Cl1,C32H42O9N2Cl1,634.2657087,635.2735337,633.25788364562,4959,cpd:C12106,AminoDAHP,C7H14NO9P,AminoDAHP,R06591 R06592,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 14253; ChEBI: 29512; 3DMET: B05606; NIKKAJI: J1.805.532E,cpd:C12106; cpd:C20644,7,14,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O9N1P1,C7H13O9N1P1,287.040618,288.0484431,286.0327934563,4960,cpd:C12107,3-Amino-5-hydroxybenzoate;,C7H7NO3,3-Amino-5-hydroxybenzoate; AHBA; 3-Amino-5-hydroxybenzoic acid; 3-Ahba,R06595,Biosynthesis of ansamycins; Biosynthesis of antibiotics,4.2.1.144,NA,NA,CAS: 76045-71-1; PubChem: 14254; ChEBI: 29507; 3DMET: B04421; NIKKAJI: J35.813D,cpd:C00632; cpd:C01270; cpd:C02518; cpd:C06669; cpd:C07555; cpd:C11343; cpd:C12107; cpd:C12115; cpd:C14520; cpd:C16235; cpd:C19270,7,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H8O3N1,C7H6O3N1,153.0425931,154.0504181,152.03476814564,4961,cpd:C12108,5-Amino-5-deoxy-3-dehydroshikimate;,C7H9NO4,5-Amino-5-deoxy-3-dehydroshikimate; AminoDHS; 5-Deoxy-5-amino-3-dehydroshikimic acid,R06593 R06595,Biosynthesis of ansamycins; Biosynthesis of antibiotics,4.2.1.144,NA,NA,PubChem: 14255; ChEBI: 29514; 3DMET: B04422; NIKKAJI: J788.086C,cpd:C03972; cpd:C12108; cpd:C17356; cpd:C21249,7,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O4N1,C7H8O4N1,171.0531578,172.0609828,170.04533274565,4962,cpd:C12109,AminoDHQ;,C7H11NO5,AminoDHQ; 5-Deoxy-5-amino-3-dehydroquinic acid,R06592 R06593,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 14256; ChEBI: 29513; 3DMET: B04423; NIKKAJI: J788.085E,cpd:C00624; cpd:C03871; cpd:C12109,7,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O5N1,C7H10O5N1,189.0637225,190.0715475,188.05589744566,4963,cpd:C12176,Proansamycin X,C35H47NO10,Proansamycin X,R06597 R06599,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK05 Ansamycins and related polyketides;    C12176  Proansamycin X,CAS: 246255-43-6; PubChem: 14322; ChEBI: 71970; LIPIDMAPS: LMPK05000006; 3DMET: B05610; NIKKAJI: J1.762.784H,cpd:C10619; cpd:C12176,35,47,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H48O10N1,C35H46O10N1,641.3199967,642.3278217,640.31217174567,4964,cpd:C12177,Proansamitocin,C25H33NO6,Proansamitocin,R09851,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 14323; ChEBI: 32054; NIKKAJI: J2.271.408B,cpd:C12177,25,33,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H34O6N1,C25H32O6N1,443.2307878,444.2386128,442.22296284568,4965,cpd:C12212,Kanosamine;,C6H13NO5,Kanosamine; D-Kanosamine; 3-Amino-3-deoxy-D-glucose,R06587 R06588 R10547,Biosynthesis of ansamycins; Biosynthesis of antibiotics,2.7.1.179; 3.1.3.92,NA,NA,PubChem: 14357; ChEBI: 72725; KNApSAcK: C00018737; PDB-CCD: TOA; 3DMET: B05616; NIKKAJI: J13.585B,cpd:C00329; cpd:C01214; cpd:C02262; cpd:C03570; cpd:C06763; cpd:C08349; cpd:C12212; cpd:C17578; cpd:C21035; cpd:C21038; cpd:C21048; cpd:C21051; cpd:C21060,6,13,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O5N1,C6H12O5N1,179.0793725,180.0871976,178.07154754569,4966,cpd:C12213,Kanosamine 6-phosphate;,C6H14NO8P,Kanosamine 6-phosphate; D-Kanosamine 6-phosphate,R06588 R06589 R10547 R10698,Biosynthesis of ansamycins; Biosynthesis of antibiotics,2.6.1.104; 2.7.1.179; 3.1.3.92; 5.3.1.-,NA,NA,PubChem: 14358; ChEBI: 31748; 3DMET: B05617; NIKKAJI: J1.749.266G,cpd:C00352; cpd:C01283; cpd:C03783; cpd:C06156; cpd:C06377; cpd:C12213; cpd:C12214,6,14,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O8N1P1,C6H13O8N1P1,259.0457034,260.0535284,258.03787844570,4967,cpd:C12214,Aminofructose 6-phosphate;,C6H14NO8P,Aminofructose 6-phosphate; Amino-D-fructose 6-phosphate,R06589 R06590,Biosynthesis of ansamycins; Biosynthesis of antibiotics,2.2.1.1; 5.3.1.-,NA,NA,PubChem: 14359; ChEBI: 31203; 3DMET: B05618; NIKKAJI: J2.781.581B,cpd:C00352; cpd:C01283; cpd:C03783; cpd:C06156; cpd:C06377; cpd:C12213; cpd:C12214,6,14,8,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O8N1P1,C6H13O8N1P1,259.0457034,260.0535284,258.03787844571,4968,cpd:C12215,Iminoerythrose 4-phosphate;,C4H10NO6P,Iminoerythrose 4-phosphate; Imino-D-erythrose 4-phosphate,R06590 R06591,Biosynthesis of ansamycins; Biosynthesis of antibiotics,2.2.1.1,NA,NA,PubChem: 14360; ChEBI: 31692; 3DMET: B05619; NIKKAJI: J1.682.370H,cpd:C01102; cpd:C05702; cpd:C12147; cpd:C12215,4,10,6,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O6N1P1,C4H9O6N1P1,199.024574,200.0323991,198.0167494572,4969,cpd:C12246,Protorifamycin I,C35H45NO10,Protorifamycin I,R06597 R06598,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK05 Ansamycins and related polyketides;    C12246  Protorifamycin I,CAS: 69239-55-0; PubChem: 14391; ChEBI: 32068; LIPIDMAPS: LMPK05000007; KNApSAcK: C00018209; 3DMET: B05620; NIKKAJI: J92.551I,cpd:C12246; cpd:C14721,35,45,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H46O10N1,C35H44O10N1,639.3043467,640.3121717,638.29652164573,4970,cpd:C12247,Rifamycin W,C35H45NO11,Rifamycin W,R06598 R06991 R06992 R06993,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Ansamycins;     C12247  Rifamycin W; Lipids [BR:br08002];  PK  Polyketides;   PK05 Ansamycins and related polyketides;    C12247  Rifamycin W,CAS: 53904-81-7; PubChem: 14392; ChEBI: 32099; LIPIDMAPS: LMPK05000008; 3DMET: B05621; NIKKAJI: J92.550K,cpd:C12247,35,45,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H46O11N1,C35H44O11N1,655.2992613,656.3070863,654.29143624574,4971,cpd:C14540,Rifamycin S,C37H45NO12,Rifamycin S,R06999,Biosynthesis of ansamycins; Biosynthesis of antibiotics; Rifamycins,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK05 Ansamycins and related polyketides;    C14540  Rifamycin S,CAS: 13553-79-2; PubChem: 17395540; ChEBI: 34948; ChEMBL: CHEMBL236921; NIKKAJI: J53.948A,cpd:C14540,37,45,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H46O12N1,C37H44O12N1,695.2941759,696.3020009,694.28635094575,4972,cpd:C14721,34a-Deoxy-rifamycin W,C35H45NO10,34a-Deoxy-rifamycin W,R06599 R06991,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,NA,CAS: 442871-33-2; PubChem: 17395720; ChEBI: 34349; KNApSAcK: C00015234; NIKKAJI: J1.718.322B,cpd:C12246; cpd:C14721,35,45,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H46O10N1,C35H44O10N1,639.3043467,640.3121717,638.29652164576,4973,cpd:C14722,Rifamycin W-hemiacetal,C35H43NO11,Rifamycin W-hemiacetal,R06992 R06994,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 17395721; ChEBI: 34949; NIKKAJI: J92.558F,cpd:C14722,35,43,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H44O11N1,C35H42O11N1,653.2836112,654.2914362,652.27578624577,4974,cpd:C14723,Rifamycin Z,C35H41NO11,Rifamycin Z,R06993 R06995,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK05 Ansamycins and related polyketides;    C14723  Rifamycin Z,CAS: 79486-49-0; PubChem: 17395722; ChEBI: 34950; KNApSAcK: C00018369; NIKKAJI: J56.289K,cpd:C14723,35,41,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H42O11N1,C35H40O11N1,651.2679611,652.2757862,650.26013614578,4975,cpd:C14724,Demethyl-desacetyl-rifamycin S,C34H41NO11,Demethyl-desacetyl-rifamycin S,R06994 R06995 R06996,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 17395723; ChEBI: 34669; NIKKAJI: J2.788.868B,cpd:C14724,34,41,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H42O11N1,C34H40O11N1,639.2679611,640.2757862,638.26013614579,4976,cpd:C14725,27-O-Demethyl-25-O-desacetylrifamycin SV;,C34H43NO11,27-O-Demethyl-25-O-desacetylrifamycin SV; Demethyl-desacetyl-rifamycin SV,R06996 R06997,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 17395724; ChEBI: 34670; NIKKAJI: J2.789.000H,cpd:C14725,34,43,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C34H44O11N1,C34H42O11N1,641.2836112,642.2914362,640.27578624580,4977,cpd:C14727,27-O-Demethylrifamycin SV,C36H45NO12,27-O-Demethylrifamycin SV,R06997 R06998,Biosynthesis of ansamycins; Biosynthesis of antibiotics,2.1.1.315,NA,NA,PubChem: 17395726; ChEBI: 34311; NIKKAJI: J1.892.199E,cpd:C14727,36,45,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H46O12N1,C36H44O12N1,683.2941759,684.3020009,682.28635094581,4978,cpd:C20134,19-Chloroproansamitocin,C25H32ClNO6,19-Chloroproansamitocin,R09851 R09852,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 135626594,cpd:C20134,25,32,6,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C25H33O6N1Cl1,C25H31O6N1Cl1,477.1918154,478.1996405,476.18399044582,4979,cpd:C20135,20-O-Methyl-19-chloroproansamitocin,C26H34ClNO6,20-O-Methyl-19-chloroproansamitocin,R09852 R09853,Biosynthesis of ansamycins; Biosynthesis of antibiotics,2.1.3.-,NA,NA,PubChem: 135626595,cpd:C20135,26,34,6,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C26H35O6N1Cl1,C26H33O6N1Cl1,491.2074655,492.2152905,490.19964054583,4980,cpd:C20136,N-Demethyl-desepoxymaytansinol;,C27H35ClN2O7,"N-Demethyl-desepoxymaytansinol; N-Desmethyl-4,5-desepoxymaytansinol",R09853 R09854,Biosynthesis of ansamycins; Biosynthesis of antibiotics,2.1.3.-,NA,NA,PubChem: 135626596,cpd:C20136,27,35,7,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C27H36O7N2Cl1,C27H34O7N2Cl1,534.2132792,535.2211042,533.20545414584,4981,cpd:C20137,N-Demethyl-desepoxyansamitocin P-3;,C31H41ClN2O8,N-Demethyl-desepoxyansamitocin P-3; N-Demethyl-desepoxy-AP-3,R09854 R09855,Biosynthesis of ansamycins; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 135626597,cpd:C20137,31,41,8,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C31H42O8N2Cl1,C31H40O8N2Cl1,604.255144,605.262969,603.24731894585,4982,cpd:C20138,N-Demethylansamitocin P-3;,C31H41ClN2O9,N-Demethylansamitocin P-3; N-Demethyl-AP-3; PND-3,R09855 R09856 R09857,Biosynthesis of ansamycins; Biosynthesis of antibiotics,2.1.1.-; 2.4.1.-,NA,NA,PubChem: 135626598; KNApSAcK: C00018394,cpd:C20138,31,41,9,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C31H42O9N2Cl1,C31H40O9N2Cl1,620.2500586,621.2578836,619.24223364586,4983,cpd:C20139,Ansamitocinoside P-3;,C37H51ClN2O14,Ansamitocinoside P-3; AGP-3,R09857 R09858,Biosynthesis of ansamycins; Biosynthesis of antibiotics,2.1.3.-; 2.4.1.-,NA,NA,PubChem: 135626599,cpd:C20139,37,51,14,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C37H52O14N2Cl1,C37H50O14N2Cl1,782.302882,783.310707,781.2950574587,4984,cpd:C20140,4''-O-Carbamoyl ansamitocinoside P-3;,C38H52ClN3O15,4''-O-Carbamoyl ansamitocinoside P-3; ACGP-3,R09858,Biosynthesis of ansamycins; Biosynthesis of antibiotics,2.1.3.-,NA,NA,PubChem: 135626600,cpd:C20140,38,52,15,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C38H53O15N3Cl1,C38H51O15N3Cl1,825.3086957,826.3165207,824.30087064588,4985,cpd:C01375,Tacrolimus;,C44H69NO12,Tacrolimus; FK506; FK 506,NA,Type I polyketide structures,NA,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C01375  Tacrolimus; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D11 OTHER DERMATOLOGICAL PREPARATIONS;    D11A OTHER DERMATOLOGICAL PREPARATIONS;     D11AH Agents for dermatitis, excluding corticosteroids;      D11AH01 Tacrolimus;       D08556  Tacrolimus (INN);  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L04 IMMUNOSUPPRESSANTS;    L04A IMMUNOSUPPRESSANTS;     L04AD Calcineurin inhibitors;      L04AD02 Tacrolimus;       D08556  Tacrolimus (INN); USP drug classification [BR:br08302];  Dermatological Agents;   Tacrolimus;    D08556  Tacrolimus (INN);  Immunological Agents;   Immune Suppressants;    Tacrolimus;     D08556  Tacrolimus (INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Hydrolases;    calcineurin;     Tacrolimus;      D08556  Tacrolimus (INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP3A;    Tacrolimus;     D08556  Tacrolimus (INN);  CYP substrates;   CYP3A4;    Tacrolimus;     D08556  Tacrolimus (INN);   CYP3A5;    Tacrolimus;     D08556  Tacrolimus (INN);   CYP3A7;    Tacrolimus;     D08556  Tacrolimus (INN);   CYP3A;    Tacrolimus;     D08556  Tacrolimus (INN);  Transporter inhibitors;   ABCB1;    Tacrolimus;     D08556  Tacrolimus (INN)",CAS: 104987-11-3; PubChem: 4572; ChEBI: 61049; ChEMBL: CHEMBL1331703 CHEMBL269732 CHEMBL405819; LIPIDMAPS: LMPK04000003; PDB-CCD: FK5; 3DMET: B01444; NIKKAJI: J313.679E,cpd:C01375,44,69,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C44H70O12N1,C44H68O12N1,803.4819767,804.4898017,802.47415164589,4986,cpd:C06573,Amphotericin B,C47H73NO17,Amphotericin B,NA,Type I polyketide structures,NA,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK06 Plyenes;    C06573  Amphotericin B; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A01 STOMATOLOGICAL PREPARATIONS;    A01A STOMATOLOGICAL PREPARATIONS;     A01AB Antiinfectives and antiseptics for local oral treatment;      A01AB04 Amphotericin B;       D00203  Amphotericin B (JP17/USP/INN);   A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;    A07A INTESTINAL ANTIINFECTIVES;     A07AA Antibiotics;      A07AA07 Amphotericin B;       D00203  Amphotericin B (JP17/USP/INN);  G GENITO URINARY SYSTEM AND SEX HORMONES;   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;    G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;     G01AA Antibiotics;      G01AA03 Amphotericin B;       D00203  Amphotericin B (JP17/USP/INN);  J ANTIINFECTIVES FOR SYSTEMIC USE;   J02 ANTIMYCOTICS FOR SYSTEMIC USE;    J02A ANTIMYCOTICS FOR SYSTEMIC USE;     J02AA Antibiotics;      J02AA01 Amphotericin B;       D00203  Amphotericin B (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  6  Agents against pathologic organisms and parasites;   61  Antibiotics;    617  Acting mainly on mold;     6173  Amphotericin B;      D00203  Amphotericin B (JP17/USP/INN); Antiinfectives [BR:br08307];  Antifungals;   Cell membrane function inhibitor;    Polyene macrolides;     Amphotericin B;      D00203  Amphotericin B (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00203  Amphotericin B;   D00203  Amphotericin B tablets;   D00203  Amphotericin B syrup;   D00203  Amphotericin B for injection; Antifungals [br08352.html];  D00203; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00203",CAS: 1397-89-3; PubChem: 8802; ChEBI: 2682; ChEMBL: CHEMBL1493655 CHEMBL267345 CHEMBL364143; LIPIDMAPS: LMPK06000002; 3DMET: B02075; NIKKAJI: J3.666H,cpd:C06573,47,73,17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C47H74O17N1,C47H72O17N1,923.4878499,924.4956749,922.48002494590,4987,cpd:C06690,Candicidin D;,C59H84N2O18,Candicidin D; FR-008-III,NA,Type I polyketide structures,NA,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Macrolides;     C06690  Candicidin D,CAS: 39372-30-0; PubChem: 8915; ChEBI: 3349; 3DMET: B05224; NIKKAJI: J2.763.506G,cpd:C06690,59,84,18,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C59H85O18N2,C59H83O18N2,1108.571914,1109.579739,1107.5640894591,4988,cpd:C07909,Sirolimus;,C51H79NO13,Sirolimus; Rapamycin,NA,Type I polyketide structures; Longevity regulating pathway; Longevity regulating pathway - worm,NA,NA,"Lipids [BR:br08002];  PK  Polyketides;   PK06 Plyenes;    C07909  Sirolimus; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L04 IMMUNOSUPPRESSANTS;    L04A IMMUNOSUPPRESSANTS;     L04AA Selective immunosuppressants;      L04AA10 Sirolimus;       D00753  Sirolimus (JAN/USAN/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01X OTHER OPHTHALMOLOGICALS;     S01XA Other ophthalmologicals;      S01XA23 Sirolimus;       D00753  Sirolimus (JAN/USAN/INN); USP drug classification [BR:br08302];  Immunological Agents;   Immune Suppressants;    Sirolimus;     D00753  Sirolimus (JAN/USAN/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    429  Miscellaneous;     4291  Other Antitumors;      D00753  Sirolimus (JAN/USAN/INN); Target-based classification of drugs [BR:br08310];  Protein kinases;   Serine/threonine protein kinases: Others;    PIKK family;     mammalian target of rapamycin (mTOR);      Sirolimus;       D00753  Sirolimus (JAN/USAN/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A;    Sirolimus;     D00753  Sirolimus (JAN/USAN/INN);  Transporter substrates;   ABCB1;    Sirolimus;     D00753  Sirolimus (JAN/USAN/INN); New drug approvals in the USA [br08319.html];  New Molecular Entity and New Therapeutic Biological Product Approvals;   D00753; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00753; New drug approvals in Japan [br08318.html];  Drugs with new active ingredients;   D00753; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D00753; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00753",CAS: 53123-88-9; PubChem: 10111; ChEBI: 9168; ChEMBL: CHEMBL1329171 CHEMBL295272 CHEMBL413; LIPIDMAPS: LMPK06000003; KNApSAcK: C00018055; PDB-CCD: RAP; 3DMET: B02141; NIKKAJI: J137.896A,cpd:C07909,51,79,13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C51H80O13N1,C51H78O13N1,913.5551416,914.5629666,912.54731664592,4989,cpd:C08073,Natamycin;,C33H47NO13,Natamycin; Pimaricin,NA,Type I polyketide structures,NA,NA,"Pesticides [BR:br08007];  Pesticides;   Fungicides;    Antibiotic fungicides;     C08073  Natamycin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A01 STOMATOLOGICAL PREPARATIONS;    A01A STOMATOLOGICAL PREPARATIONS;     A01AB Antiinfectives and antiseptics for local oral treatment;      A01AB10 Natamycin;       D00884  Natamycin (USP/INN);   A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;    A07A INTESTINAL ANTIINFECTIVES;     A07AA Antibiotics;      A07AA03 Natamycin;       D00884  Natamycin (USP/INN);  D DERMATOLOGICALS;   D01 ANTIFUNGALS FOR DERMATOLOGICAL USE;    D01A ANTIFUNGALS FOR TOPICAL USE;     D01AA Antibiotics;      D01AA02 Natamycin;       D00884  Natamycin (USP/INN);  G GENITO URINARY SYSTEM AND SEX HORMONES;   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;    G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;     G01AA Antibiotics;      G01AA02 Natamycin;       D00884  Natamycin (USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA10 Natamycin;       D00884  Natamycin (USP/INN); USP drug classification [BR:br08302];  Antifungals;   Natamycin;    D00884  Natamycin (USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   13  Agents affecting sensory organs;    131  Ophthalmic agents;     1317  Ophthalmic antibiotics;      D00884  Natamycin (USP/INN); Pimaricin (JP17); Antiinfectives [BR:br08307];  Antifungals;   Cell membrane function inhibitor;    Polyene macrolides;     Pimaricin;      D00884  Natamycin (USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00884  Pimaricin; Antifungals [br08352.html];  D00884",CAS: 7681-93-8; PubChem: 10273; ChEBI: 7488; ChEMBL: CHEMBL1200656; 3DMET: B05259; NIKKAJI: J3.429K,cpd:C08073,33,47,13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H48O13N1,C33H46O13N1,665.3047406,666.3125656,664.29691554593,4990,cpd:C11300,Soraphen A,C29H44O8,Soraphen A,NA,Type I polyketide structures,NA,NA,NA,CAS: 122547-72-2; PubChem: 13475; ChEBI: 9200; KNApSAcK: C00016927; PDB-CCD: S1A; 3DMET: B04219; NIKKAJI: J575.130F,cpd:C08816; cpd:C11300,29,44,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H45O8,C29H43O8,520.3036184,521.3114434,519.29579334594,4991,cpd:C12102,Immunomycin;,C43H69NO12,Immunomycin; Ascomycin; FK520,NA,Type I polyketide structures,NA,NA,NA,CAS: 104987-12-4; PubChem: 14249; ChEBI: 29582; ChEMBL: CHEMBL299798 CHEMBL8597; KNApSAcK: C00017631; 3DMET: B04420; NIKKAJI: J476.843D,cpd:C12102,43,69,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H70O12N1,C43H68O12N1,791.4819767,792.4898017,790.47415164595,4992,cpd:C12148,Stigmatellin A;,C30H42O7,Stigmatellin A; Stigmatellin,NA,Type I polyketide structures,NA,NA,NA,CAS: 91682-96-1; PubChem: 14295; ChEBI: 32155; ChEMBL: CHEMBL486556; KNApSAcK: C00018584; 3DMET: B04439; NIKKAJI: J55.620C,cpd:C08800; cpd:C12148,30,42,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H43O7,C30H41O7,514.2930537,515.3008787,513.28522874596,4993,cpd:C12151,Mycolactone,C44H70O9,Mycolactone,NA,Type I polyketide structures,NA,NA,NA,PubChem: 14298; ChEBI: 31871; 3DMET: B04440; NIKKAJI: J2.781.165E,cpd:C12151,44,70,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C44H71O9,C44H69O9,742.5019838,743.5098089,741.49415884597,4994,cpd:C12152,Niddamycin,C39H63NO14,Niddamycin,NA,Type I polyketide structures,NA,NA,NA,CAS: 20283-69-6; PubChem: 14299; ChEBI: 31908; 3DMET: B04441; NIKKAJI: J361.004G,cpd:C12152,39,63,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C39H64O14N1,C39H62O14N1,769.4248557,770.4326807,768.41703074598,4995,cpd:C12153,Epothilone A,C26H39NO6S,Epothilone A,NA,Type I polyketide structures,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK04 Macrolides and lactone polyketides;    C12153  Epothilone A,CAS: 152044-53-6; PubChem: 14300; ChEBI: 31549; ChEMBL: CHEMBL329993 CHEMBL582086; LIPIDMAPS: LMPK04000040; KNApSAcK: C00045298; PDB-CCD: EP; NIKKAJI: J1.408.121F,cpd:C12153,26,39,6,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C26H40O6N1S1,C26H38O6N1S1,493.2498092,494.2576342,492.24198414599,4996,cpd:C12155,Nystatin A1,C47H75NO17,Nystatin A1,NA,Type I polyketide structures,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK06 Plyenes;    C12155  Nystatin A1,CAS: 34786-70-4; PubChem: 14302; LIPIDMAPS: LMPK06000004; 3DMET: B04443; NIKKAJI: J9.845K,cpd:C06572; cpd:C12155,47,75,17,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C47H76O17N1,C47H74O17N1,925.5035,926.511325,924.49567494600,4997,cpd:C12157,Myxalamid S,C25H41NO4,Myxalamid S,NA,Type I polyketide structures,NA,NA,NA,PubChem: 14304; ChEBI: 31876; 3DMET: B05609; NIKKAJI: J2.781.169H,cpd:C12157,25,41,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H42O4N1,C25H40O4N1,419.3035588,420.3113838,418.29573384601,4998,cpd:C21275,Mycolactone C,C44H70O8,Mycolactone C,NA,Type I polyketide structures,NA,NA,NA,PubChem: 318016697,cpd:C21275,44,70,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C44H71O8,C44H69O8,726.5070692,727.5148942,725.49924424602,4999,cpd:C21276,Mycolactone D,C45H72O9,Mycolactone D,NA,Type I polyketide structures,NA,NA,NA,PubChem: 318016698,cpd:C21276,45,72,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C45H73O9,C45H71O9,756.5176339,757.5254589,755.50980894603,5000,cpd:C21277,Mycolactone E,C43H70O8,Mycolactone E,NA,Type I polyketide structures,NA,NA,NA,PubChem: 318016699,cpd:C21277,43,70,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H71O8,C43H69O8,714.5070692,715.5148942,713.49924424604,5001,cpd:C21278,Mycolactone F,C42H68O8,Mycolactone F,NA,Type I polyketide structures,NA,NA,NA,PubChem: 318016700,cpd:C21278,42,68,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H69O8,C42H67O8,700.4914191,701.4992442,699.48359414605,5002,cpd:C04171,"(2S,3S)-2,3-Dihydro-2,3-dihydroxybenzoate;",C7H8O4,"(2S,3S)-2,3-Dihydro-2,3-dihydroxybenzoate; (2S,3S)-2,3-Dihydroxy-2,3-dihydroxybenzoate",R01505 R03037,Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,1.3.1.28; 3.3.2.1,NA,NA,PubChem: 6852; ChEBI: 48968 58764; KNApSAcK: C00000737; NIKKAJI: J727.021F,cpd:C04112; cpd:C04171; cpd:C04558; cpd:C04559; cpd:C04634; cpd:C06210; cpd:C06321; cpd:C06678; cpd:C06760; cpd:C07041; cpd:C13671; cpd:C18311; cpd:C20710,7,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O4,C7H7O4,156.0422587,157.0500838,155.03443374606,5003,cpd:C05821,Enterochelin;,C30H27N3O15,"Enterochelin; Enterobactin; Tri-(2,3-dihydroxy-N-benzoyl-L-serine)-ester; Tri-(N-(2,3-dihydroxybenzoyl)-L-serine)-ester",R07644,Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,6.3.2.14,NA,NA,CAS: 28384-96-5; PubChem: 8116; ChEBI: 28855; ChEMBL: CHEMBL432995; KNApSAcK: C00000735; PDB-CCD: EB4; NIKKAJI: J17.543I,cpd:C05821,30,27,15,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H28O15N3,C30H26O15N3,669.1442172,670.1520422,668.13639214607,5004,cpd:C06769,Vibriobactin,C35H39N5O11,Vibriobactin,NA,Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,NA,NA,NA,CAS: 88217-23-6; PubChem: 8989; ChEBI: 9973; NIKKAJI: J168.849I,cpd:C06769,35,39,11,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H40O11N5,C35H38O11N5,705.2646071,706.2724321,704.25678214608,5005,cpd:C12037,Pyochelin,C14H16N2O3S2,Pyochelin,NA,Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,NA,NA,NA,CAS: 69772-54-9; PubChem: 14192; ChEBI: 29669; PDB-CCD: 488; NIKKAJI: J1.291.250A,cpd:C12037,14,16,3,2,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C14H17O3N2S2,C14H15O3N2S2,324.0602347,325.0680598,323.05240974609,5006,cpd:C12038,Yersiniabactin,C21H27N3O4S3,Yersiniabactin,NA,Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 14193; ChEBI: 29707; ChEMBL: CHEMBL1221692; KNApSAcK: C00029246; NIKKAJI: J678.306F,cpd:C12038,21,27,4,3,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C21H28O4N3S3,C21H26O4N3S3,481.1163699,482.1241949,480.10854494610,5007,cpd:C12216,Mycobactin S,C44H69N5O10,Mycobactin S,NA,Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA00 Other Fatty Acyls;    C12216  Mycobactin S,CAS: 26769-11-9; PubChem: 14361; ChEBI: 31870; NIKKAJI: J846.465K,cpd:C12216,44,69,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C44H70O10N5,C44H68O10N5,827.5044434,828.5122685,826.49661844611,5008,cpd:C12219,Corynebactin;,C39H42N6O18,Corynebactin; Bacillibactin,NA,Biosynthesis of siderophore group nonribosomal peptides; Biosynthesis of secondary metabolites; Biosynthesis of antibiotics,NA,NA,NA,CAS: 95536-41-7; PubChem: 14364; ChEBI: 31432; NIKKAJI: J1.709.027E,cpd:C12219,39,42,18,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C39H43O18N6,C39H41O18N6,882.2555585,883.2633836,881.24773354612,5009,cpd:C12220,Myxochelin A,C20H24N2O7,Myxochelin A,NA,Biosynthesis of siderophore group nonribosomal peptides,NA,NA,NA,CAS: 120243-02-9; PubChem: 14365; ChEBI: 31877; ChEMBL: CHEMBL515742; KNApSAcK: C00017648; NIKKAJI: J1.454.181K J2.378.312F,cpd:C12220,20,24,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O7N2,C20H23O7N2,404.1583511,405.1661762,403.15052614613,5010,cpd:C12221,Myxochelin B,C20H25N3O6,Myxochelin B,NA,Biosynthesis of siderophore group nonribosomal peptides,NA,NA,NA,PubChem: 14366; ChEBI: 7061; ChEMBL: CHEMBL522025; NIKKAJI: J942.664G,cpd:C12221,20,25,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H26O6N3,C20H24O6N3,403.1743355,404.1821606,402.16651054614,5011,cpd:C01540,Viomycin,C25H43N13O10,Viomycin,R03607,Nonribosomal peptide structures,2.7.1.103,NA,NA,CAS: 32988-50-4; PubChem: 4701; ChEBI: 15782; 3DMET: B01463; NIKKAJI: J358.703G,cpd:C01540,25,43,10,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H44O10N13,C25H42O10N13,685.3255846,686.3334097,684.31775964615,5012,cpd:C01895,Bleomycin B2,C55H84N20O21S2,Bleomycin B2,NA,Nonribosomal peptide structures,NA,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Non-ribosomal peptides;     C01895  Bleomycin B2; Lipids [BR:br08002];  PK  Polyketides;   PK14 Non-ribosomal peptide/polyketide hybrids;    C01895  Bleomycin B2,CAS: 9060-10-0; PubChem: 5008; ChEBI: 28641; LIPIDMAPS: LMPK14000002; KNApSAcK: C00018853; PDB-CCD: BLB; 3DMET: B01512; NIKKAJI: J25.637D,cpd:C01895,55,84,21,20,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C55H85O21N20S2,C55H83O21N20S2,1424.556132,1425.563957,1423.5483074616,5013,cpd:C05371,Microcystin LR;,C49H74N10O12,Microcystin LR; Microcystin-LR,NA,Nonribosomal peptide structures; Bile secretion,NA,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C05371  Microcystin-LR; Natural toxins [BR:br08009];  Cyanotoxins;   Peptides;    Microcystins;     C05371  Microcystin LR,CAS: 101043-37-2; PubChem: 7745; ChEBI: 6925; ChEMBL: CHEMBL444092; 3DMET: B01848,cpd:C05371,49,74,12,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C49H75O12N10,C49H73O12N10,994.5487679,995.5565929,993.54094284617,5014,cpd:C11218,Gramicidin S,C60H92N12O10,Gramicidin S,NA,Nonribosomal peptide structures,NA,NA,NA,CAS: 113-73-5; PubChem: 13398; ChEBI: 5530; ChEMBL: CHEMBL373496; 3DMET: B04212; NIKKAJI: J10.597J,cpd:C11218,60,92,10,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C60H93O10N12,C60H91O10N12,1140.705937,1141.713762,1139.6981124618,5015,cpd:C11615,Pristinamycin IA;,C45H54N8O10,Pristinamycin IA; Vernamycin B alpha; Mikamycin B; 4-[4-(Dimethylamino)-N-methyl-L-phenylalanine]virginiamycin S1; Streptogramin B,NA,Nonribosomal peptide structures,NA,NA,Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    50S subunit inhibitor;     Streptogramins;      Mikamycin B; Veterinary;       C11615  Mikamycin B,CAS: 3131-03-1; PubChem: 13780; ChEBI: 8417; KNApSAcK: C00018680; 3DMET: B05539; NIKKAJI: J20.721G,cpd:C11615,45,54,10,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C45H55O10N8,C45H53O10N8,866.39629,867.404115,865.38846494619,5017,cpd:C12041,Tyrocidine,C66H87N13O13,Tyrocidine,NA,Nonribosomal peptide structures,NA,NA,NA,CAS: 8011-61-8; PubChem: 14196; ChEBI: 29701 71947; ChEMBL: CHEMBL408504; 3DMET: B04412; NIKKAJI: J14.834B,cpd:C12041,66,87,13,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C66H88O13N13,C66H86O13N13,1269.65463,1270.662455,1268.6468054620,5018,cpd:C12042,Fengycin,C72H110N12O20,Fengycin,NA,Nonribosomal peptide structures,NA,NA,NA,CAS: 102577-03-7; PubChem: 14197; ChEBI: 29583; 3DMET: B05603; NIKKAJI: J1.136.910C,cpd:C12042,72,110,20,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C72H111O20N12,C72H109O20N12,1462.795934,1463.803759,1461.7881094621,5019,cpd:C12043,Surfactin,C53H93N7O13,Surfactin,NA,Nonribosomal peptide structures,NA,NA,NA,CAS: 24730-31-2; PubChem: 14198; ChEBI: 29681 71978; ChEMBL: CHEMBL508272; 3DMET: B04413; NIKKAJI: J690.160C,cpd:C12043,53,93,13,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C53H94O13N7,C53H92O13N7,1035.683136,1036.690961,1034.6753114622,5024,cpd:C15482,Bacitracin A,C66H103N17O16S,Bacitracin A,NA,Nonribosomal peptide structures,NA,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Non-ribosomal peptides;     C15482  Bacitracin A,CAS: 22601-59-8; PubChem: 17396476; ChEBI: 35862; ChEMBL: CHEMBL1200558 CHEMBL1868381; NIKKAJI: J201.471H,cpd:C15482,66,103,16,17,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C66H104O16N17S1,C66H102O16N17S1,1421.748941,1422.756767,1420.7411164623,5025,cpd:C06689,Vancomycin,C66H75Cl2N9O24,Vancomycin,R10833,Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics; Vancomycin resistance; Two-component system,2.4.1.322,NA,"Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Non-ribosomal peptides;     C06689  Vancomycin; Lipids [BR:br08002];  PK  Polyketides;   PK14 Non-ribosomal peptide/polyketide hybrids;    C06689  Vancomycin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;    A07A INTESTINAL ANTIINFECTIVES;     A07AA Antibiotics;      A07AA09 Vancomycin;       D00212  Vancomycin (USP);  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01X OTHER ANTIBACTERIALS;     J01XA Glycopeptide antibacterials;      J01XA01 Vancomycin;       D00212  Vancomycin (USP); USP drug classification [BR:br08302];  Antibacterials;   Antibacterials, Other;    Vancomycin;     D00212  Vancomycin (USP); Antiinfectives [BR:br08307];  Antibacterials;   Cell wall biosynthesis inhibitor;    Others;     Glycopeptides;      Vancomycin;       D00212  Vancomycin (USP)",CAS: 1404-90-6; PubChem: 8914; ChEBI: 28001; ChEMBL: CHEMBL262777; LIPIDMAPS: LMPK14000004; KNApSAcK: C00016052; NIKKAJI: J34.275K,cpd:C06689; cpd:C20721,66,75,24,9,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C66H76O24N9Cl2,C66H74O24N9Cl2,1447.4302,1448.438025,1446.4223754624,5026,cpd:C12014,Chloroeremomycin;,C73H88Cl2N10O26,Chloroeremomycin; Chloroorienticin A,NA,Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,NA,NA,NA,CAS: 118395-73-6; PubChem: 14172; ChEBI: 29556; ChEMBL: CHEMBL1688951; KNApSAcK: C00017622; NIKKAJI: J410.822A,cpd:C12014,73,88,26,10,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C73H89O26N10Cl2,C73H87O26N10Cl2,1590.524828,1591.532653,1589.5170034625,5027,cpd:C12026,"3,5-Dihydroxy-phenylglycine;",C8H9NO4,"3,5-Dihydroxy-phenylglycine; L-3,5-Dihydroxyphenylglycine; (S)-3,5-Dihydroxyphenylglycine",R06634,Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,2.6.1.103,NA,NA,CAS: 146255-66-5; PubChem: 14183; ChEBI: 29474; ChEMBL: CHEMBL39221; PDB-CCD: 3FG; 3DMET: B04411; NIKKAJI: J516.528H,cpd:C00847; cpd:C04447; cpd:C04773; cpd:C11466; cpd:C12026,8,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O4N1,C8H8O4N1,183.0531578,184.0609828,182.04533274626,5028,cpd:C12319,"dTDP-3-amino-2,3,6-trideoxy-C-methyl-D-erythro-hexopyranos-4-ulose",C17H27N3O13P2,"dTDP-3-amino-2,3,6-trideoxy-C-methyl-D-erythro-hexopyranos-4-ulose",R06627 R06628,Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,5.1.3.-,NA,NA,PubChem: 582709; ChEBI: 32331; PDB-CCD: JHZ; 3DMET: B05628; NIKKAJI: J2.781.730K,cpd:C12319; cpd:C12320,17,27,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H28O13N3P2,C17H26O13N3P2,543.1019119,544.109737,542.09408694627,5029,cpd:C12320,dTDP-L-4-oxovancosamine,C17H27N3O13P2,dTDP-L-4-oxovancosamine,R06628 R06629 R06630,Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,5.1.3.-,NA,NA,PubChem: 582710; ChEBI: 32334; 3DMET: B05629; NIKKAJI: J2.781.744K,cpd:C12319; cpd:C12320,17,27,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H28O13N3P2,C17H26O13N3P2,543.1019119,544.109737,542.09408694628,5030,cpd:C12321,dTDP-L-epivancosamine;,C17H29N3O13P2,"dTDP-L-epivancosamine; dTDP-beta-L-4-epi-vancosamine; dTDP-3-amino-2,3,6-trideoxy-3-methyl-beta-L-arabino-hexopyranose",R06629 R10595,Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,2.4.1.311,NA,NA,PubChem: 582711; ChEBI: 76056; 3DMET: B05630; NIKKAJI: J1.464.415F,cpd:C12321; cpd:C12322,17,29,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H30O13N3P2,C17H28O13N3P2,545.117562,546.125387,544.1097374629,5031,cpd:C12322,dTDP-L-vancosamine;,C17H29N3O13P2,dTDP-L-vancosamine; dTDP-beta-L-vancosamine,R06630 R10833,Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,2.4.1.322,NA,NA,PubChem: 582712; ChEBI: 32336; 3DMET: B05631; NIKKAJI: J2.781.745I,cpd:C12321; cpd:C12322,17,29,13,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H30O13N3P2,C17H28O13N3P2,545.117562,546.125387,544.1097374630,5032,cpd:C12324,"3,5-Dihydroxyphenylacetyl-CoA",C29H42N7O19P3S,"3,5-Dihydroxyphenylacetyl-CoA",R06624 R06625,Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,1.13.11.80; 2.3.1.246,NA,NA,PubChem: 582714; ChEBI: 31103; 3DMET: B05632; NIKKAJI: J1.736.341G,cpd:C12324,29,42,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H43O19N7P3S1,C29H41O19N7P3S1,917.1469043,918.1547294,916.13907934631,5033,cpd:C12325,"3,5-Dihydroxyphenylglyoxylate;",C8H6O5,"3,5-Dihydroxyphenylglyoxylate; 2-(3,5-Dihydroxyphenyl)-2-oxoacetate",R06624 R06634,Biosynthesis of vancomycin group antibiotics; Biosynthesis of antibiotics,1.13.11.80; 2.6.1.103,NA,NA,PubChem: 582715; ChEBI: 31104; 3DMET: B04452; NIKKAJI: J1.571.742D,cpd:C01853; cpd:C06680; cpd:C07268; cpd:C12325; cpd:C14097; cpd:C21168,8,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H7O5,C8H5O5,182.0215233,183.0293483,181.01369834632,5050,cpd:C01661,Doxorubicin;,C27H29NO11,Doxorubicin; Adriamycin,R06690,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.181,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Other polyketides;     C01661  Adriamycin; Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1305 Anthracyclinones;     C01661  Adriamycin; Carcinogens [BR:br08008];  Group 2A: Probably carcinogenic to humans;   Compounds;    C01661  Adriamycin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;     L01DB Anthracyclines and related substances;      L01DB01 Doxorubicin;       D03899  Doxorubicin (USAN/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Isomerases;    topoisomerase II;     Doxorubicin;      D03899  Doxorubicin (USAN/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2D6;    Doxorubicin;     D03899  Doxorubicin (USAN/INN);  Transporter substrates;   ABCB1;    Doxorubicin;     D03899  Doxorubicin (USAN/INN),CAS: 23214-92-8; PubChem: 4809; ChEBI: 28748; ChEMBL: CHEMBL179 CHEMBL53463 CHEMBL6608; LIPIDMAPS: LMPK13050001; PDB-CCD: DM2; 3DMET: B01475; NIKKAJI: J3.792C,cpd:C01661; cpd:C11230; cpd:C12427,27,29,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H30O11N1,C27H28O11N1,543.1740608,544.1818858,542.16623574633,5051,cpd:C01907,Daunorubicin;,C27H29NO10,Daunorubicin; Daunomycin; (+)-Daunomycin,R06689 R06690 R06693 R06694,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.181; 2.1.1.292,NA,Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1305 Anthracyclinones;     C01907  Daunorubicin; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C01907  Daunorubicin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;     L01DB Anthracyclines and related substances;      L01DB02 Daunorubicin;       D07776  Daunorubicin (INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Isomerases;    topoisomerase II;     Daunorubicin;      D07776  Daunorubicin (INN),CAS: 20830-81-3; PubChem: 5016; ChEBI: 41977; ChEMBL: CHEMBL178 CHEMBL9659; LIPIDMAPS: LMPK13050002; KNApSAcK: C00043440; PDB-CCD: DM1; 3DMET: B01516; NIKKAJI: J3.149F,cpd:C01907,27,29,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H30O10N1,C27H28O10N1,527.1791461,528.1869712,526.17132114634,5052,cpd:C06691,Actinorhodin;,C32H26O14,Actinorhodin; Actinorhodine,R06697,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Other polyketides;     C06691  Actinorhodine,CAS: 1397-77-9; PubChem: 8916; ChEBI: 2448; PDB-CCD: ZCT; 3DMET: B02090; NIKKAJI: J480.353A,cpd:C06691,32,26,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H27O14,C32H25O14,634.1322555,635.1400805,633.12443054635,5053,cpd:C06799,Granaticin,C22H20O10,Granaticin,NA,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 19879-06-2; PubChem: 9018; ChEBI: 5533; KNApSAcK: C00018030; NIKKAJI: J54.000E,cpd:C06799,22,20,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H21O10,C22H19O10,444.1056468,445.1134719,443.09782184636,5054,cpd:C06801,Tetracenomycin C,C23H20O11,Tetracenomycin C,R06704,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.200,"Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C",NA,CAS: 71135-22-3; PubChem: 9020; ChEBI: 9470; 3DMET: B02096; NIKKAJI: J479.691H,cpd:C06801,23,20,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H21O11,C23H19O11,472.1005615,473.1083865,471.09273644637,5055,cpd:C12366,Tetracenomycin F2;,C20H16O8,Tetracenomycin F2; Tcm F2,R06699 R09355 R10960,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.3.1.235; 4.2.1.154,"Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide; Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C",NA,CAS: 150547-38-9; PubChem: 582756; ChEBI: 32207; 3DMET: B04453; NIKKAJI: J906.086C,cpd:C12366; cpd:C18709; cpd:C20503,20,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O8,C20H15O8,384.0845175,385.0923425,383.07669244638,5056,cpd:C12367,Tetracenomycin F1,C20H14O7,Tetracenomycin F1,R06699 R06700 R06706 R06707,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.13.12.21; 4.2.1.154,"Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C",NA,CAS: 149791-45-7; PubChem: 582757; ChEBI: 32205; 3DMET: B04454; NIKKAJI: J751.185J,cpd:C10512; cpd:C12258; cpd:C12367,20,14,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O7,C20H13O7,366.0739528,367.0817778,365.06612784639,5057,cpd:C12368,Tetracenomycin D3,C20H12O8,Tetracenomycin D3,R06700 R06701 R06709 R06710,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.13.12.21,"Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C",NA,CAS: 117241-61-9; PubChem: 582758; ChEBI: 32202; KNApSAcK: C00017937; 3DMET: B04455; NIKKAJI: J575.133K,cpd:C12368,20,12,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H13O8,C20H11O8,380.0532173,381.0610424,379.04539234640,5058,cpd:C12369,Tetracenomycin B3,C21H14O8,Tetracenomycin B3,R06701 R06702 R06711 R06713,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.-,"Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C",NA,CAS: 117241-62-0; PubChem: 582759; ChEBI: 32200; KNApSAcK: C00017936; 3DMET: B04456; NIKKAJI: J575.134I,cpd:C10877; cpd:C12369; cpd:C12375,21,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H15O8,C21H13O8,394.0688674,395.0766924,393.06104244641,5059,cpd:C12370,Tetracenomycin E,C22H16O8,Tetracenomycin E,R06702 R06703,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.-,"Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C",NA,PubChem: 582760; 3DMET: B04457; NIKKAJI: J2.781.948F,cpd:C12370; cpd:C12378,22,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H17O8,C22H15O8,408.0845175,409.0923425,407.07669244642,5060,cpd:C12371,Tetracenomycin A2,C23H18O8,Tetracenomycin A2,R06703 R06704 R06714,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.200; 2.1.1.-,"Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C",NA,CAS: 82277-62-1; PubChem: 582761; ChEBI: 32197; 3DMET: B04458; NIKKAJI: J248.138C,cpd:C12371,23,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H19O8,C23H17O8,422.1001675,423.1079926,421.09234254643,5061,cpd:C12373,Tetracenomycin F1 methylester,C21H16O7,Tetracenomycin F1 methylester,R06706,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582763; ChEBI: 32206; 3DMET: B04459; NIKKAJI: J2.781.950H,cpd:C10559; cpd:C12373,21,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H17O7,C21H15O7,380.0896029,381.0974279,379.08177784644,5062,cpd:C12374,Decarboxytetracenomycin F1,C19H14O5,Decarboxytetracenomycin F1,R06707,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582764; ChEBI: 31458; 3DMET: B04460; NIKKAJI: J2.781.951F,cpd:C12374; cpd:C12396; cpd:C12600; cpd:C18682,19,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H15O5,C19H13O5,322.0841235,323.0919486,321.07629854645,5063,cpd:C12375,Tetracenomycin D3 methylester,C21H14O8,Tetracenomycin D3 methylester,R06709,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582765; ChEBI: 32203; 3DMET: B04461; NIKKAJI: J248.137E,cpd:C10877; cpd:C12369; cpd:C12375,21,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H15O8,C21H13O8,394.0688674,395.0766924,393.06104244646,5064,cpd:C12376,Tetracenomycin D1,C19H12O6,Tetracenomycin D1,R06710,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582766; ChEBI: 32201; 3DMET: B04462; NIKKAJI: J133.855B,cpd:C00796; cpd:C12376,19,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H13O6,C19H11O6,336.0633881,337.0712131,335.05556314647,5065,cpd:C12377,Tetracenomycin B1,C20H14O6,Tetracenomycin B1,R06711,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582767; ChEBI: 32198; 3DMET: B04463; NIKKAJI: J2.783.301B,cpd:C10295; cpd:C12377,20,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O6,C20H13O6,350.0790382,351.0868632,349.07121314648,5066,cpd:C12378,Tetracenomycin B2;,C22H16O8,Tetracenomycin B2; 8-Demethyltetracenomycin A2,R06713 R10954,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.200; 2.1.1.-,"Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C",NA,PubChem: 582768; ChEBI: 32199; 3DMET: B04464; NIKKAJI: J1.445.650C,cpd:C12370; cpd:C12378,22,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H17O8,C22H15O8,408.0845175,409.0923425,407.07669244649,5067,cpd:C12379,8-Demethyltetracenomycin C,C22H18O11,8-Demethyltetracenomycin C,R10954 R10955,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.200; 2.4.1.331,"Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C; Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,PubChem: 582769; ChEBI: 31144; NIKKAJI: J1.013.526E,cpd:C09731; cpd:C12379,22,18,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H19O11,C22H17O11,458.0849114,459.0927364,457.07708644650,5068,cpd:C12380,Tetracenomycin X,C24H22O11,Tetracenomycin X,R06714,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 121245-07-6; PubChem: 582770; ChEBI: 32209; 3DMET: B04465; NIKKAJI: J1.275.898G,cpd:C04385; cpd:C12380,24,22,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H23O11,C24H21O11,486.1162115,487.1240366,485.10838654651,5069,cpd:C12381,Elloramycin A,C32H36O15,Elloramycin A,R10959,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.-,"Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,CAS: 97218-42-3; PubChem: 582771; ChEBI: 78288; ChEMBL: CHEMBL1957887; KNApSAcK: C00017718; 3DMET: B04466; NIKKAJI: J33.912A,cpd:C12381,32,36,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H37O15,C32H35O15,660.2054205,661.2132455,659.19759544652,5070,cpd:C12382,4-Demethylpremithramycinone,C20H16O9,4-Demethylpremithramycinone,R06715,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.-,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,PubChem: 582772; ChEBI: 31125; 3DMET: B04467; NIKKAJI: J950.690J,cpd:C12382; cpd:C20505,20,16,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O9,C20H15O9,400.0794321,401.0872571,399.07160714653,5071,cpd:C12383,Premithramycinone,C21H18O9,Premithramycinone,R06715 R06716,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.-; 2.4.1.-,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,PubChem: 582773; ChEBI: 32051; 3DMET: B04468; NIKKAJI: J950.689F,cpd:C12383; cpd:C18632,21,18,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H19O9,C21H17O9,414.0950822,415.1029072,413.08725714654,5072,cpd:C12384,Premithramycin A1,C27H28O12,Premithramycin A1,R06716 R06717,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,PubChem: 582774; ChEBI: 32046; 3DMET: B04469; NIKKAJI: J1.260.374F,cpd:C12384,27,28,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H29O12,C27H27O12,544.1580763,545.1659014,543.15025134655,5073,cpd:C12385,Premithramycin A2',C33H38O15,Premithramycin A2',R06717 R06718,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,PubChem: 582775; ChEBI: 32047; 3DMET: B04470; NIKKAJI: J2.783.302K,cpd:C12385,33,38,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H39O15,C33H37O15,674.2210705,675.2288956,673.21324554656,5074,cpd:C12386,Premithramycin A3',C40H50O18,Premithramycin A3',R06718 R06719,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.-,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,PubChem: 582776; ChEBI: 32049; 3DMET: B04471; NIKKAJI: J2.783.303I,cpd:C12386,40,50,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H51O18,C40H49O18,818.2997148,819.3075398,817.29188974657,5075,cpd:C12387,Premithramycin A3,C41H52O18,Premithramycin A3,R06719 R09351,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.-; 2.4.1.-,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,PubChem: 582777; ChEBI: 32048; 3DMET: B04472; NIKKAJI: J2.783.304G,cpd:C12387,41,52,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H53O18,C41H51O18,832.3153648,833.3231899,831.30753984658,5076,cpd:C12388,Premithramycin B,C53H72O24,Premithramycin B,R09352 R09353,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.-; 2.4.1.-,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,PubChem: 582778; ChEBI: 32050; PDB-CCD: PM0; 3DMET: B04473; NIKKAJI: J2.783.305E,cpd:C12388; cpd:C18839,53,72,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C53H73O24,C53H71O24,1092.441353,1093.449178,1091.4335284659,5077,cpd:C12389,Mithramycin;,C52H76O24,Mithramycin; Plicamycin,R09354,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;     L01DC Other cytotoxic antibiotics;      L01DC02 Plicamycin;       D00468  Plicamycin (USP/INN); Target-based classification of drugs [BR:br08310];  Others;   Nucleic acid;    RNA synthesis;     Plicamycin;      D00468  Plicamycin (USP/INN),CAS: 18378-89-7; PubChem: 582779; ChEBI: 31856; ChEMBL: CHEMBL413720; KNApSAcK: C00049230; 3DMET: B04474; NIKKAJI: J13.354J,cpd:C12389,52,76,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C52H77O24,C52H75O24,1084.472653,1085.480478,1083.4648284660,5078,cpd:C12390,Dehydrorabelomycin,C19H12O5,Dehydrorabelomycin,R06671 R09343,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582780; ChEBI: 31461; KNApSAcK: C00015999; 3DMET: B04475; NIKKAJI: J817.407E,cpd:C12390; cpd:C12399,19,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H13O5,C19H11O5,320.0684735,321.0762985,319.06064854661,5079,cpd:C12391,Kinobscurinone;,C18H10O5,"Kinobscurinone; 4,9-Dihydroxy-2-methyl-11H-benzo[b]fluorene-5,10,11-trione",R06671 R06672,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582781; ChEBI: 31752; 3DMET: B04476; NIKKAJI: J767.637I,cpd:C12391,18,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H11O5,C18H9O5,306.0528234,307.0606485,305.04499844662,5080,cpd:C12392,Stealthin C,C18H13NO4,Stealthin C,R06672 R06673,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582782; ChEBI: 32153; 3DMET: B05634; NIKKAJI: J767.638G,cpd:C12392,18,13,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H14O4N1,C18H12O4N1,307.0844579,308.0922829,306.07663294663,5081,cpd:C12393,Prekinamycin,C18H10N2O4,Prekinamycin,R06673 R06674,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 120796-24-9; PubChem: 582783; ChEBI: 32045; KNApSAcK: C00017655; 3DMET: B04477; NIKKAJI: J818.255H,cpd:C12393,18,10,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H11O4N2,C18H9O4N2,318.0640568,319.0718818,317.05623184664,5082,cpd:C12394,Kinamycin D,C22H18N2O9,Kinamycin D,R06674,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 35303-14-1; PubChem: 582784; ChEBI: 31751; ChEMBL: CHEMBL215875; KNApSAcK: C00018813; 3DMET: B04478; NIKKAJI: J591.160E,cpd:C12394,22,18,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H19O9N2,C22H17O9N2,454.1012302,455.1090552,453.09340514665,5083,cpd:C12395,Jadomycin B,C30H31NO9,Jadomycin B,R06670,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,NA,NA,CAS: 149633-99-8; PubChem: 582785; ChEBI: 31738; ChEMBL: CHEMBL1631684; KNApSAcK: C00016835; 3DMET: B04479; NIKKAJI: J572.531C,cpd:C12395,30,31,9,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H32O9N1,C30H30O9N1,549.1998816,550.2077066,548.19205654666,5084,cpd:C12396,Tetrangomycin,C19H14O5,Tetrangomycin,R06650 R06656,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 7351-08-8; PubChem: 582786; ChEBI: 32211; 3DMET: B05635; NIKKAJI: J149.225J,cpd:C12374; cpd:C12396; cpd:C12600; cpd:C18682,19,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H15O5,C19H13O5,322.0841235,323.0919486,321.07629854667,5085,cpd:C12397,Tetrangulol,C19H12O4,Tetrangulol,R06650 R06651 R06653,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 7414-92-8; PubChem: 582787; ChEBI: 32212; ChEMBL: CHEMBL1668340; 3DMET: B04480; NIKKAJI: J797.618F,cpd:C12397,19,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H13O4,C19H11O4,304.0735589,305.0813839,303.06573384668,5086,cpd:C12398,8-O-Methyltetrangulol,C20H14O4,8-O-Methyltetrangulol,R06651 R06652,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582788; ChEBI: 31145; 3DMET: B04481; NIKKAJI: J326.580C,cpd:C06162; cpd:C12398; cpd:C14286; cpd:C20073,20,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O4,C20H13O4,318.0892089,319.097034,317.08138394669,5087,cpd:C12399,19-Hydroxytetrangulol,C19H12O5,19-Hydroxytetrangulol,R06653 R06654,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582789; ChEBI: 31063; 3DMET: B04482; NIKKAJI: J2.783.309H,cpd:C12390; cpd:C12399,19,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H13O5,C19H11O5,320.0684735,321.0762985,319.06064854670,5088,cpd:C12400,19-Hydroxy-8-O-methyltetrangulol,C20H14O5,19-Hydroxy-8-O-methyltetrangulol,R06652 R06654 R06655,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582790; ChEBI: 31062; ChEMBL: CHEMBL1965087; 3DMET: B04483; NIKKAJI: J2.783.311J,cpd:C12400,20,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O5,C20H13O5,334.0841235,335.0919486,333.07629854671,5089,cpd:C12401,PD116740,C20H16O7,PD116740,R06655,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582791; ChEBI: 31956; 3DMET: B04484; NIKKAJI: J1.757.519H,cpd:C10194; cpd:C12401; cpd:C18629; cpd:C20574,20,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O7,C20H15O7,368.0896029,369.0974279,367.08177784672,5090,cpd:C12402,Rabelomycin,C19H14O6,Rabelomycin,R06656 R09341 R09346,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK08 Angucyclines;    C12402  Rabelomycin,CAS: 28399-50-0; PubChem: 582792; ChEBI: 32086; KNApSAcK: C00017940; PDB-CCD: 2V4; 3DMET: B04485; NIKKAJI: J326.583H,cpd:C03686; cpd:C12402; cpd:C18294; cpd:C19979,19,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H15O6,C19H13O6,338.0790382,339.0868632,337.07121314673,5091,cpd:C12404,Urdamycinone B,C25H24O8,Urdamycinone B,R06659 R06661,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582794; ChEBI: 32283; 3DMET: B04487; NIKKAJI: J1.043.914K,cpd:C12404; cpd:C18683,25,24,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H25O8,C25H23O8,452.1471177,453.1549428,451.13929274674,5092,cpd:C12405,100-1,C31H34O10,100-1,R06659 R06660,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,NA,NA,PubChem: 582795; ChEBI: 31048; 3DMET: B04488; NIKKAJI: J533.514K,cpd:C12405,31,34,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H35O10,C31H33O10,566.2151973,567.2230223,565.20737234675,5093,cpd:C12406,Urdamycin B,C37H44O13,Urdamycin B,R06660,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,NA,NA,CAS: 104542-46-3; PubChem: 582796; ChEBI: 32280; KNApSAcK: C00017826; 3DMET: B04489; NIKKAJI: J533.512D,cpd:C12406,37,44,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H45O13,C37H43O13,696.2781915,697.2860165,695.27036644676,5094,cpd:C12407,104-2,C25H24O9,104-2,R06661 R06662,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582797; ChEBI: 31051; 3DMET: B04490; NIKKAJI: J533.515I,cpd:C12403; cpd:C12407; cpd:C18778,25,24,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H25O9,C25H23O9,468.1420323,469.1498574,467.13420734677,5095,cpd:C12408,100-2,C31H36O12,100-2,R06666 R06667,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582798; ChEBI: 31049; 3DMET: B04491; NIKKAJI: J533.513B,cpd:C12408,31,36,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H37O12,C31H35O12,600.2206766,601.2285016,599.21285164678,5096,cpd:C12409,124-1,C37H44O14,124-1,R06662,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582799; ChEBI: 31055; 3DMET: B04492; NIKKAJI: J533.516G,cpd:C12409; cpd:C18685,37,44,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H45O14,C37H43O14,712.2731061,713.2809311,711.26528114679,5097,cpd:C12410,Urdamycinone F,C25H28O11,Urdamycinone F,R06664 R06665,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582800; ChEBI: 32284; 3DMET: B04493,cpd:C08782; cpd:C12410,25,28,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H29O11,C25H27O11,504.1631617,505.1709867,503.15533674680,5098,cpd:C12411,Urdamycin F,C43H58O18,Urdamycin F,R06664,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 104562-12-1; PubChem: 582801; ChEBI: 32281; KNApSAcK: C00017830; 3DMET: B04494; NIKKAJI: J2.783.336E,cpd:C12411,43,58,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H59O18,C43H57O18,862.362315,863.3701401,861.354494681,5099,cpd:C12412,Aquayamycin,C25H26O10,Aquayamycin,R06665 R06666,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 26055-63-0; PubChem: 582802; ChEBI: 31230; KNApSAcK: C00018739; 3DMET: B04495; NIKKAJI: J161.360J,cpd:C12412,25,26,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H27O10,C25H25O10,486.152597,487.1604221,485.1447724682,5100,cpd:C12413,Urdamycin A;,C43H56O17,Urdamycin A; Kerriamycin B,R06668,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,NA,NA,CAS: 98474-21-6; PubChem: 582803; ChEBI: 32279; KNApSAcK: C00017825; 3DMET: B04496; NIKKAJI: J40.723B,cpd:C12413,43,56,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H57O17,C43H55O17,844.3517503,845.3595754,843.34392534683,5101,cpd:C12414,Urdamycin G;,C37H46O14,Urdamycin G; Aggreticin; OM 4842,R06667 R06668,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,NA,NA,CAS: 115626-67-0; PubChem: 582804; ChEBI: 32282; 3DMET: B04497; NIKKAJI: J227.738G,cpd:C12414,37,46,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H47O14,C37H45O14,714.2887562,715.2965812,713.28093114684,5102,cpd:C12415,Methyl nogalonate;,C21H16O8,"Methyl nogalonate; Nogalonic acid methyl ester; NAME; Methyl [4,5-dihydroxy-9,10-dioxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetate",R06675 R06676 R06678 R09328,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.-; 5.5.1.23; 5.5.1.26,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,PubChem: 582805; ChEBI: 31916; 3DMET: B04498; NIKKAJI: J2.293.651D,cpd:C12415; cpd:C12417; cpd:C12421; cpd:C18630,21,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H17O8,C21H15O8,396.0845175,397.0923425,395.07669244685,5103,cpd:C12416,Nogalonate;,C20H14O8,Nogalonate; Nogalonic acid,R06675 R09327,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.13.12.22; 2.1.1.-,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,PubChem: 582806; ChEBI: 31915; 3DMET: B04499; NIKKAJI: J2.231.100J,cpd:C06626; cpd:C10306; cpd:C12416,20,14,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H15O8,C20H13O8,382.0688674,383.0766924,381.06104244686,5104,cpd:C12417,Auraviketone,C21H16O8,Auraviketone,R06676 R06677,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.1.1.362; 5.5.1.23,NA,NA,PubChem: 582807; ChEBI: 31245; 3DMET: B05636; NIKKAJI: J2.783.342J,cpd:C12415; cpd:C12417; cpd:C12421; cpd:C18630,21,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H17O8,C21H15O8,396.0845175,397.0923425,395.07669244687,5105,cpd:C12418,Dihydro-NAME;,C21H18O8,Dihydro-NAME; Dihydro-nogalonic acid methyl ester,R06678,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582808; ChEBI: 31486; 3DMET: B05637; NIKKAJI: J1.203.620E,cpd:C12418; cpd:C12419; cpd:C18631,21,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H19O8,C21H17O8,398.1001675,399.1079926,397.09234254688,5106,cpd:C12419,Auramycinone,C21H18O8,Auramycinone,R06677,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.1.1.362,NA,NA,CAS: 78173-89-4; PubChem: 582809; ChEBI: 31244; 3DMET: B05638; NIKKAJI: J33.916D,cpd:C12418; cpd:C12419; cpd:C18631,21,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H19O8,C21H17O8,398.1001675,399.1079926,397.09234254689,5107,cpd:C12420,12-Deoxyaklanonic acid,C21H18O7,12-Deoxyaklanonic acid,R06679 R09326,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.13.12.-,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,PubChem: 582810; ChEBI: 31054; 3DMET: B04500; NIKKAJI: J679.239A,cpd:C10546; cpd:C12420,21,18,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H19O7,C21H17O7,382.1052529,383.1130779,381.09742794690,5108,cpd:C12421,Aklanonate;,C21H16O8,"Aklanonate; Aklanonic acid; [4,5-Dihydroxy-9,10-dioxo-3-(3-oxopentanoyl)-9,10-dihydroanthracen-2-yl]acetic acid",R06679 R06680,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.13.12.-; 2.1.1.288,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,CAS: 91432-47-2; PubChem: 582811; ChEBI: 31178; KNApSAcK: C00017707; 3DMET: B04501; NIKKAJI: J93.397J,cpd:C12415; cpd:C12417; cpd:C12421; cpd:C18630,21,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H17O8,C21H15O8,396.0845175,397.0923425,395.07669244691,5109,cpd:C12422,Methyl aklanonate;,C22H18O8,"Methyl aklanonate; Aklanonic acid methyl ester; AAME; Methyl [4,5-dihydroxy-9,10-dioxo-3-(3-oxopentanoyl)-9,10-dihydroanthracen-2-yl]acetate",R06680 R06681,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.288; 5.5.1.23,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,PubChem: 582812; ChEBI: 75311; 3DMET: B04502; NIKKAJI: J2.231.090I,cpd:C12422; cpd:C12423,22,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H19O8,C22H17O8,410.1001675,411.1079926,409.09234254692,5110,cpd:C12423,Aklaviketone;,C22H18O8,"Aklaviketone; Methyl (1R,2R)-2-ethyl-2,5,7-trihydroxy-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate",R06681 R06682,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.1.1.362; 5.5.1.23,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,CAS: 116235-59-7; PubChem: 582813; ChEBI: 75244; KNApSAcK: C00017921; 3DMET: B04503; NIKKAJI: J228.004C,cpd:C12422; cpd:C12423,22,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H19O8,C22H17O8,410.1001675,411.1079926,409.09234254693,5111,cpd:C12424,Aklavinone,C22H20O8,Aklavinone,R06682 R06683 R09331,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.1.1.362; 1.14.13.180; 2.4.1.326,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,CAS: 16234-96-1; PubChem: 582814; ChEBI: 31181; KNApSAcK: C00043257; PDB-CCD: VAK; 3DMET: B04504; NIKKAJI: J14.493B,cpd:C10875; cpd:C11253; cpd:C12424; cpd:C20046,22,20,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H21O8,C22H19O8,412.1158176,413.1236426,411.10799264694,5112,cpd:C12425,epsilon-Rhodomycinone;,C22H20O9,epsilon-Rhodomycinone; Rhodomycinone,R06683 R06684 R09336,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.180; 2.4.1.-,NA,NA,CAS: 21288-60-8; PubChem: 582815; ChEBI: 75291; ChEMBL: CHEMBL22025; KNApSAcK: C00043491; 3DMET: B04505; NIKKAJI: J16.250G,cpd:C12425,22,20,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H21O9,C22H19O9,428.1107322,429.1185573,427.10290724695,5113,cpd:C12426,Rhodomycin D,C28H31NO11,Rhodomycin D,R06684 R06685,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,NA,NA,PubChem: 582816; ChEBI: 32096; 3DMET: B04506; NIKKAJI: J2.783.379I,cpd:C12426,28,31,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H32O11N1,C28H30O11N1,557.1897108,558.1975359,556.18188584696,5114,cpd:C12427,10-Carboxy-13-deoxycarminomycin;,C27H29NO11,10-Carboxy-13-deoxycarminomycin; D 788-1,R06685 R06686,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 97583-07-8; PubChem: 582817; ChEBI: 31047; 3DMET: B04507; NIKKAJI: J91.946B,cpd:C01661; cpd:C11230; cpd:C12427,27,29,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H30O11N1,C27H28O11N1,543.1740608,544.1818858,542.16623574697,5115,cpd:C12428,13-Deoxycarminomycin,C26H29NO9,13-Deoxycarminomycin,R06686 R06687 R06691,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.181; 2.1.1.292,NA,NA,CAS: 76034-18-9; PubChem: 582818; ChEBI: 31056; ChEMBL: CHEMBL481439; 3DMET: B04508; NIKKAJI: J128.350B,cpd:C12428,26,29,9,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H30O9N1,C26H28O9N1,499.1842315,500.1920565,498.17640654698,5116,cpd:C12429,13-Deoxydaunorubicin;,C27H31NO9,13-Deoxydaunorubicin; Feudomycin A,R06687 R06688,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.181; 2.1.1.292,NA,Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1305 Anthracyclinones;     C12429  13-Deoxydaunorubicin,CAS: 79466-09-4; PubChem: 582819; ChEBI: 31057; LIPIDMAPS: LMPK13050003; KNApSAcK: C00018343; 3DMET: B04509; NIKKAJI: J128.352I,cpd:C12429,27,31,9,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O9N1,C27H30O9N1,513.1998816,514.2077066,512.19205654699,5117,cpd:C12430,13-Dihydrodaunorubicin,C27H31NO10,13-Dihydrodaunorubicin,R06688 R06689,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.181,NA,Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1305 Anthracyclinones;     C12430  13-Dihydrodaunorubicin,PubChem: 582820; ChEBI: 31059; LIPIDMAPS: LMPK13050004; 3DMET: B04510; NIKKAJI: J86.140E,cpd:C12430; cpd:C12433,27,31,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O10N1,C27H30O10N1,529.1947962,530.2026212,528.18697124700,5118,cpd:C12431,13-Dihydrocarminomycin,C26H29NO10,13-Dihydrocarminomycin,R06691 R06692,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.181,NA,NA,CAS: 62182-86-9; PubChem: 582821; ChEBI: 31058; 3DMET: B04511; NIKKAJI: J19.330E,cpd:C12431,26,29,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H30O10N1,C26H28O10N1,515.1791461,516.1869712,514.17132114701,5119,cpd:C12432,Carminomycin,C26H27NO10,Carminomycin,R06692 R06693,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.181; 2.1.1.292,NA,NA,CAS: 39472-31-6; PubChem: 582822; ChEBI: 31359; ChEMBL: CHEMBL275147 CHEMBL474260; 3DMET: B04512; NIKKAJI: J2.200.177I,cpd:C12432,26,27,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H28O10N1,C26H26O10N1,513.1634961,514.1713211,512.1556714702,5120,cpd:C12433,(13S)-13-Dihydrodaunorubicin;,C27H31NO10,(13S)-13-Dihydrodaunorubicin; Daunorubicinol; 13-Dihydrodaunorubicin,R06694,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1305 Anthracyclinones;     C12433  (13S)-13-Dihydrodaunorubicin,CAS: 28008-55-1; PubChem: 582823; ChEBI: 31031; ChEMBL: CHEMBL2008019; LIPIDMAPS: LMPK13050005; 3DMET: B04513; NIKKAJI: J86.140E,cpd:C12430; cpd:C12433,27,31,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H32O10N1,C27H30O10N1,529.1947962,530.2026212,528.18697124703,5121,cpd:C12434,(S)-DNPA;,C16H14O5,"(S)-DNPA; 4-Dihydro-9-hydroxy-1-methyl-10-oxo-3-H-naphtho[2,3-c]pyran-3-acetic acid",R06695 R09308,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,4.2.1.-,"Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin",NA,PubChem: 582824; ChEBI: 31034 49887; PDB-CCD: SDN; 3DMET: B04514; NIKKAJI: J1.354.584G,cpd:C00786; cpd:C02675; cpd:C02922; cpd:C05334; cpd:C08844; cpd:C08974; cpd:C09044; cpd:C09282; cpd:C09833; cpd:C09920; cpd:C09975; cpd:C10274; cpd:C10508; cpd:C12434; cpd:C16190; cpd:C18481; cpd:C18835,16,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O5,C16H13O5,286.0841235,287.0919486,285.07629854704,5122,cpd:C12435,6-Deoxydihydrokalafungin;,C16H16O5,6-Deoxydihydrokalafungin; DDHK,R06695 R06696 R09314,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.14.-,"Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin",NA,PubChem: 582825; ChEBI: 31131; 3DMET: B04515; NIKKAJI: J1.860.476K,cpd:C09471; cpd:C10292; cpd:C12435; cpd:C16187; cpd:C17412,16,16,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O5,C16H15O5,288.0997736,289.1075986,287.09194864705,5123,cpd:C12436,Dihydrokalafungin;,C16H14O6,Dihydrokalafungin; DHK,R06696 R06698 R09312 R09314,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.14.-,"Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin",NA,PubChem: 582826; ChEBI: 31491; 3DMET: B04516; NIKKAJI: J138.423F,cpd:C01709; cpd:C09756; cpd:C09931; cpd:C10377; cpd:C10419; cpd:C12436; cpd:C16405,16,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O6,C16H13O6,302.0790382,303.0868632,301.07121314706,5124,cpd:C12437,Medermycin,C24H27NO8,Medermycin,R06698,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 60227-09-0; PubChem: 582827; ChEBI: 31808; KNApSAcK: C00018096; 3DMET: B04517; NIKKAJI: J139.431B,cpd:C12437,24,27,8,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H28O8N1,C24H26O8N1,457.1736668,458.1814919,456.16584184707,5125,cpd:C12451,Fridamycin E,C19H16O7,Fridamycin E,NA,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 582841; ChEBI: 31636; KNApSAcK: C00035317; 3DMET: B04520; NIKKAJI: J2.172.944B,cpd:C12372; cpd:C12451; cpd:C13143; cpd:C19293,19,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H17O7,C19H15O7,356.0896029,357.0974279,355.08177784708,5127,cpd:C18354,(S)-Chiral alcohol,C16H16O6,(S)-Chiral alcohol,R09306 R09307,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.1.1.-,"Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin",NA,PubChem: 124489028; ChEBI: 81700,cpd:C04684; cpd:C07761; cpd:C08740; cpd:C08761; cpd:C18354; cpd:C18356; cpd:C18360; cpd:C18836,16,16,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O6,C16H15O6,304.0946882,305.1025133,303.08686324709,5129,cpd:C18356,(S)-Hemiketal,C16H16O6,(S)-Hemiketal,R09307 R09308,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,4.2.1.-,"Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin",NA,PubChem: 124489030; ChEBI: 81702,cpd:C04684; cpd:C07761; cpd:C08740; cpd:C08761; cpd:C18354; cpd:C18356; cpd:C18360; cpd:C18836,16,16,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O6,C16H15O6,304.0946882,305.1025133,303.08686324710,5131,cpd:C18358,DHKred-OH;,C16H16O7,DHKred-OH; Hydroxylated dihydrokalafungin dihydroquinone,R06697 R09313,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.14.-,NA,NA,PubChem: 124489032; ChEBI: 81704,cpd:C02947; cpd:C08106; cpd:C08113; cpd:C11586; cpd:C18358,16,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O7,C16H15O7,320.0896029,321.0974279,319.08177784711,5132,cpd:C18359,Dihydrogranaticin,C22H22O10,Dihydrogranaticin,NA,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 63999-06-4; PubChem: 124489033; ChEBI: 81705,cpd:C05376; cpd:C10381; cpd:C10384; cpd:C10538; cpd:C16195; cpd:C17835; cpd:C18359,22,22,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H23O10,C22H21O10,446.1212969,447.1291219,445.11347194712,5133,cpd:C18360,Dihydrokalafungin dihydroquinone form;,C16H16O6,Dihydrokalafungin dihydroquinone form; DHKred,R09312 R09313,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.14.-,NA,NA,PubChem: 124489034; ChEBI: 81706,cpd:C04684; cpd:C07761; cpd:C08740; cpd:C08761; cpd:C18354; cpd:C18356; cpd:C18360; cpd:C18836,16,16,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O6,C16H15O6,304.0946882,305.1025133,303.08686324713,5134,cpd:C18629,Deoxynogalonate;,C20H16O7,Deoxynogalonate; 12-Deoxynogalonic acid,R09325 R09327,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.13.12.22,"Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide; Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,PubChem: 124489303; ChEBI: 81873,cpd:C10194; cpd:C12401; cpd:C18629; cpd:C20574,20,16,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O7,C20H15O7,368.0896029,369.0974279,367.08177784714,5135,cpd:C18630,Nogalaviketone;,C21H16O8,"Nogalaviketone; Methyl 5,7-dihydroxy-2-methyl-4,6,11-trioxo-3,4,6,11-tetrahydrotetracene-1-carboxylate",R09328 R09329,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.1.1.-; 5.5.1.26,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,PubChem: 124489304; ChEBI: 81874,cpd:C12415; cpd:C12417; cpd:C12421; cpd:C18630,21,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H17O8,C21H15O8,396.0845175,397.0923425,395.07669244715,5136,cpd:C18631,Nogalavinone;,C21H18O8,Nogalavinone; Nogalamycinone,R09329 R09330,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.1.1.-,"Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone",NA,PubChem: 124489305; ChEBI: 81875,cpd:C12418; cpd:C12419; cpd:C18631,21,18,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H19O8,C21H17O8,398.1001675,399.1079926,397.09234254716,5137,cpd:C18632,1-OH-Nogalamycinone,C21H18O9,1-OH-Nogalamycinone,R09330,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 124489306; ChEBI: 81876,cpd:C12383; cpd:C18632,21,18,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H19O9,C21H17O9,414.0950822,415.1029072,413.08725714717,5138,cpd:C18633,Nogalamycin,C39H49NO16,Nogalamycin,NA,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 1404-15-5; PubChem: 124489307; ChEBI: 44504; ChEMBL: CHEMBL504459; PDB-CCD: NGM,cpd:C18633,39,49,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C39H50O16N1,C39H48O16N1,787.3051345,788.3129595,786.29730954718,5139,cpd:C18634,Aclacinomycin T;,C30H35NO10,Aclacinomycin T; Rhodosaminyl-aklavinone,R09331 R09332 R10545,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.326; 2.4.1.327; 3.1.1.95,NA,NA,CAS: 60504-57-6; PubChem: 124489308; ChEBI: 74351; PDB-CCD: 3VL,cpd:C09937; cpd:C12476; cpd:C18634,30,35,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H36O10N1,C30H34O10N1,569.2260963,570.2339214,568.21827134719,5140,cpd:C18635,Aclacinomycin S;,C36H45NO13,Aclacinomycin S; L-2-Deoxyfucosyl-L-rhodosaminyl-aklavinone,R09332 R09333,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.327,NA,NA,PubChem: 124489309; ChEBI: 79176,cpd:C18635,36,45,13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H46O13N1,C36H44O13N1,699.2890905,700.2969155,698.28126554720,5141,cpd:C18637,Aclacinomycin N,C42H55NO15,Aclacinomycin N,R09333 R09334,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.1.3.45,NA,NA,PubChem: 124489311; ChEBI: 75091,cpd:C18637,42,55,15,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H56O15N1,C42H54O15N1,813.3571701,814.3649951,812.3493454721,5142,cpd:C18638,Aclacinomycin A,C42H53NO15,Aclacinomycin A,R09334 R09335,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.1.3.45; 1.3.3.14,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;     L01DB Anthracyclines and related substances;      L01DB04 Aclarubicin;       D02756  Aclarubicin (USAN/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Isomerases;    topoisomerase I;     Aclarubicin;      D02756  Aclarubicin (USAN/INN);    topoisomerase II;     Aclarubicin;      D02756  Aclarubicin (USAN/INN),CAS: 57576-44-0; PubChem: 124489312; ChEBI: 74619; ChEMBL: CHEMBL2009694 CHEMBL45414 CHEMBL502620; KNApSAcK: C00018065,cpd:C18638,42,53,15,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H54O15N1,C42H52O15N1,811.34152,812.349345,810.3336954722,5143,cpd:C18639,Aclacinomycin Y,C42H51NO15,Aclacinomycin Y,R09335,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.3.3.14,NA,NA,CAS: 66789-14-8; PubChem: 124489313; ChEBI: 75093; KNApSAcK: C00018226,cpd:C18639,42,51,15,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C42H52O15N1,C42H50O15N1,809.3258699,810.333695,808.31804494723,5144,cpd:C18640,epsilon-Rhodomycin T,C30H35NO11,epsilon-Rhodomycin T,R09336 R09337,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,3.1.1.95,NA,NA,PubChem: 124489314; ChEBI: 81877,cpd:C18640,30,35,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H36O11N1,C30H34O11N1,585.2210109,586.228836,584.21318594724,5145,cpd:C18641,15-Demethoxy-epsilon-rhodomycin,C29H33NO11,15-Demethoxy-epsilon-rhodomycin,R09337 R09338,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,3.1.1.95,NA,NA,PubChem: 124489315; ChEBI: 81878,cpd:C18641,29,33,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H34O11N1,C29H32O11N1,571.2053609,572.2131859,570.19753594725,5146,cpd:C18642,beta-Rhodomycin;,C28H33NO10,beta-Rhodomycin; Rhodomycin B,R09338,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,CAS: 1404-52-0; PubChem: 124489316; ChEBI: 81879; KNApSAcK: C00018600,cpd:C18642,28,33,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H34O10N1,C28H32O10N1,543.2104463,544.2182713,542.20262124726,5147,cpd:C18678,UWM6,C19H18O6,UWM6,R09340 R09341 R09342 R09345,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,NA,NA,PubChem: 124489352; ChEBI: 81885,cpd:C14472; cpd:C15076; cpd:C18678,19,18,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H19O6,C19H17O6,342.1103383,343.1181633,341.10251334727,5148,cpd:C18679,"2,3-Dehydro-UWM6;",C19H16O5,"2,3-Dehydro-UWM6; Prejadomycin",R09342 R09343 R09344,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 124489353; ChEBI: 81886,cpd:C13756; cpd:C18679,19,16,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H17O5,C19H15O5,324.0997736,325.1075986,323.09194864728,5149,cpd:C18680,Jadomycin A;,C24H21NO6,Jadomycin A; Jadomycin B aglycon,R06670 R09344,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,NA,NA,PubChem: 124489354; ChEBI: 81887,cpd:C18680,24,21,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H22O6N1,C24H20O6N1,419.1368874,420.1447124,418.12906244729,5150,cpd:C18681,C1'-C9-Glycosylated UWM6,C25H28O9,C1'-C9-Glycosylated UWM6,R09345,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,NA,NA,PubChem: 124489355; ChEBI: 81888,cpd:C18681,25,28,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H29O9,C25H27O9,472.1733325,473.1811575,471.16550744730,5151,cpd:C18682,11-Deoxylandomycinone,C19H14O5,11-Deoxylandomycinone,R09346 R09347,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 124489356; ChEBI: 81889,cpd:C12374; cpd:C12396; cpd:C12600; cpd:C18682,19,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H15O5,C19H13O5,322.0841235,323.0919486,321.07629854731,5152,cpd:C18683,Landomycin H,C25H24O8,Landomycin H,R09347 R09357,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 124489357; ChEBI: 81890,cpd:C12404; cpd:C18683,25,24,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H25O8,C25H23O8,452.1471177,453.1549428,451.13929274732,5153,cpd:C18684,Landomycin D,C31H34O12,Landomycin D,R09348 R09349,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 124489358; ChEBI: 70060; ChEMBL: CHEMBL1668766,cpd:C18684,31,34,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H35O12,C31H33O12,598.2050265,599.2128516,597.19720154733,5154,cpd:C18685,Landomycin E,C37H44O14,Landomycin E,R09349 R09360,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 124489359; ChEBI: 81891,cpd:C12409; cpd:C18685,37,44,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H45O14,C37H43O14,712.2731061,713.2809311,711.26528114734,5155,cpd:C18709,Decaketide tricyclic intermediate,C20H16O8,Decaketide tricyclic intermediate,R09350,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,"Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide",NA,PubChem: 124489383; ChEBI: 81904,cpd:C12366; cpd:C18709; cpd:C20503,20,16,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O8,C20H15O8,384.0845175,385.0923425,383.07669244735,5156,cpd:C18710,3A-Deolivosylpremithramycin B,C47H62O21,3A-Deolivosylpremithramycin B,R09351 R09352,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.4.1.-,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,PubChem: 124489384; ChEBI: 81905,cpd:C18710,47,62,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C47H63O21,C47H61O21,962.378359,963.386184,961.3705344736,5157,cpd:C18711,Mithramycin DK,C52H74O24,Mithramycin DK,R09353 R09354,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,1.14.13.-,"Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin",NA,PubChem: 124489385; ChEBI: 81906,cpd:C18711,52,74,24,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C52H75O24,C52H73O24,1082.457003,1083.464828,1081.4491784737,5158,cpd:C18778,8-D-Olivosyl-landomycin;,C25H24O9,8-D-Olivosyl-landomycin; Landomycin I,R09348 R09357,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 124489452; ChEBI: 81954,cpd:C12403; cpd:C12407; cpd:C18778,25,24,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C25H25O9,C25H23O9,468.1420323,469.1498574,467.13420734738,5159,cpd:C18835,(R)-DNPA,C16H14O5,(R)-DNPA,R09311,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 124489509; ChEBI: 81996,cpd:C00786; cpd:C02675; cpd:C02922; cpd:C05334; cpd:C08844; cpd:C08974; cpd:C09044; cpd:C09282; cpd:C09833; cpd:C09920; cpd:C09975; cpd:C10274; cpd:C10508; cpd:C12434; cpd:C16190; cpd:C18481; cpd:C18835,16,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H15O5,C16H13O5,286.0841235,287.0919486,285.07629854739,5160,cpd:C20689,15-Demethylaclacinomycin T,C29H33NO10,15-Demethylaclacinomycin T,R10545,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,3.1.1.95,NA,NA,PubChem: 172232409,cpd:C12475; cpd:C20689,29,33,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H34O10N1,C29H32O10N1,555.2104463,556.2182713,554.20262124740,5161,cpd:C20974,8-Demethyl-8-alpha-L-rhamnosyltetracenomycin C,C28H28O15,8-Demethyl-8-alpha-L-rhamnosyltetracenomycin C,R10955 R10956,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.305; 2.4.1.331,"Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,PubChem: 254741433,cpd:C20974,28,28,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H29O15,C28H27O15,604.1428202,605.1506452,603.13499524741,5162,cpd:C20975,8-Demethyl-8-(2-O-methyl-alpha-L-rhamnosyl)tetracenomycin C,C29H30O15,8-Demethyl-8-(2-O-methyl-alpha-L-rhamnosyl)tetracenomycin C,R10956 R10957,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.305; 2.1.1.306,"Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,PubChem: 254741434,cpd:C20975,29,30,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H31O15,C29H29O15,618.1584703,619.1662953,617.15064524742,5163,cpd:C20976,"8-Demethyl-8-(2,3-di-O-methyl-alpha-L-rhamnosyl)tetracenomycin C",C30H32O15,"8-Demethyl-8-(2,3-di-O-methyl-alpha-L-rhamnosyl)tetracenomycin C",R10957 R10958,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.306; 2.1.1.307,"Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,PubChem: 254741435,cpd:C20976,30,32,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H33O15,C30H31O15,632.1741203,633.1819454,631.16629534743,5164,cpd:C20977,"8-Demethyl-8-(2,3,4-tri-O-methyl-alpha-L-rhamnosyl)tetracenomycin C",C31H34O15,"8-Demethyl-8-(2,3,4-tri-O-methyl-alpha-L-rhamnosyl)tetracenomycin C",R10958 R10959,Biosynthesis of type II polyketide products; Biosynthesis of antibiotics,2.1.1.307; 2.1.1.-,"Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A",NA,PubChem: 254741436,cpd:C20977,31,34,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H35O15,C31H33O15,646.1897704,647.1975954,645.18194544744,5165,cpd:C03005,N-Methylanthranilate;,C8H9NO2,N-Methylanthranilate; N-Methylanthranilic acid; 2-(Methylamino)benzoic acid,R00984 R07416,Acridone alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,2.1.1.111; 6.2.1.32,NA,NA,CAS: 119-68-6; PubChem: 5914; ChEBI: 16394 36557; ChEMBL: CHEMBL1528955; 3DMET: B01620; NIKKAJI: J5.315E,cpd:C02012; cpd:C02709; cpd:C03005; cpd:C03522; cpd:C04350; cpd:C04353; cpd:C06804; cpd:C07301; cpd:C16571; cpd:C17239; cpd:C17755; cpd:C17756; cpd:C18623; cpd:C20634,8,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O2N1,C8H8O2N1,151.0633285,152.0711536,150.05550354745,5166,cpd:C10632,Acronycine;,C20H19NO3,Acronycine; Acronine,R08471,Acridone alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Acridone alkaloids;     C10632  Acronycine,CAS: 7008-42-6; PubChem: 12815; ChEBI: 2437; ChEMBL: CHEMBL285852; KNApSAcK: C00002130; 3DMET: B04013; NIKKAJI: J8.881A,cpd:C10632; cpd:C18605,20,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H20O3N1,C20H18O3N1,321.1364935,322.1443185,320.12866844746,5167,cpd:C10722,Melicopicine,C18H19NO5,Melicopicine,R08470,Acridone alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Acridone alkaloids;     C10722  Melicopicine,CAS: 517-73-7; PubChem: 12905; ChEBI: 6734; ChEMBL: CHEMBL455628; KNApSAcK: C00002186; 3DMET: B04091; NIKKAJI: J11.812E,cpd:C10722; cpd:C12165; cpd:C12166; cpd:C12178,18,19,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H20O5N1,C18H18O5N1,329.1263227,330.1341477,328.11849774747,5168,cpd:C10738,Rutacridone,C19H17NO3,Rutacridone,R08472,Acridone alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Acridone alkaloids;     C10738  Rutacridone,CAS: 17948-33-3; PubChem: 12921; ChEBI: 8917; ChEMBL: CHEMBL2003193; KNApSAcK: C00002196; 3DMET: B05470; NIKKAJI: J146.949E,cpd:C10655; cpd:C10738; cpd:C15195,19,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H18O3N1,C19H16O3N1,307.1208434,308.1286684,306.11301844748,5169,cpd:C12092,N-Methylanthraniloyl-CoA,C29H43N8O17P3S,N-Methylanthraniloyl-CoA,R07250 R07416,Acridone alkaloid biosynthesis; Biosynthesis of secondary metabolites,2.3.1.159; 6.2.1.32,NA,NA,PubChem: 14241; ChEBI: 30305; 3DMET: B05605; NIKKAJI: J1.006.049D,cpd:C12092,29,43,17,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H44O17N8P3S1,C29H42O17N8P3S1,900.1679741,901.1757992,899.16014914749,5170,cpd:C12093,"1,3-Dihydroxy-N-methylacridone",C14H11NO3,"1,3-Dihydroxy-N-methylacridone",R07250 R08470 R08471 R08472,Acridone alkaloid biosynthesis; Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,2.3.1.159,NA,NA,CAS: 28333-02-0; PubChem: 14242; ChEBI: 30306; ChEMBL: CHEMBL1288777; 3DMET: B04417; NIKKAJI: J338.116A,cpd:C03141; cpd:C12093; cpd:C13630; cpd:C15268,14,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H12O3N1,C14H10O3N1,241.0738932,242.0817182,240.06606824750,5171,cpd:C02657,6-Methylsalicylate;,C8H8O3,6-Methylsalicylate; 6-Methylsalicylic acid; 2-Hydroxy-6-methylbenzoic acid; 6-Methyl-2-hydroxybenzenecarboxylate,R03567 R07253 R11370,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.3.1.165; 4.1.1.52; 6.2.1.-,"3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA",Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1301 Monocyclic aromatic polyketides;     C02657  6-Methylsalicylic acid,CAS: 567-61-3; PubChem: 5630; ChEBI: 17637 36658; ChEMBL: CHEMBL510026; LIPIDMAPS: LMPK13010002; KNApSAcK: C00000486; 3DMET: B00477; NIKKAJI: J6.524B,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951914751,5172,cpd:C11438,C-1027 Chromophore;,C43H42ClN3O13,C-1027 Chromophore; C-1027,NA,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 13610; ChEBI: 3252; ChEMBL: CHEMBL506048; NIKKAJI: J1.283.608B J1.608.793I,cpd:C11438,43,42,13,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C43H43O13N3Cl1,C43H41O13N3Cl1,843.2406161,844.2484411,842.23279114752,5173,cpd:C11442,Aromatized C-1027 chromophore,C43H44ClN3O13,Aromatized C-1027 chromophore,NA,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 13614; ChEBI: 2840; PDB-CCD: ROM; NIKKAJI: J1.283.610D,cpd:C11442,43,44,13,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C43H45O13N3Cl1,C43H43O13N3Cl1,845.2562662,846.2640912,844.24844114753,5174,cpd:C11448,"3,4-Dihydro-7-methoxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carbonyl-CoA;",C32H43N8O20P3S,"3,4-Dihydro-7-methoxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carbonyl-CoA; Benzoxazolinyl-CoA",R11365,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,NA,"C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA",NA,PubChem: 13620; ChEBI: 1373; NIKKAJI: J2.774.481H,cpd:C11448,32,43,20,8,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H44O20N8P3S1,C32H42O20N8P3S1,984.152718,985.160543,983.1448934754,5176,cpd:C11468,"3,4-Dihydro-7-methoxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylic acid;",C11H9NO5,"3,4-Dihydro-7-methoxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylic acid; Benzoxazolinate",R11364 R11365,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.1.1.-,"C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA",NA,CAS: 105897-30-1; PubChem: 13639; ChEBI: 1374; NIKKAJI: J387.985B,cpd:C11468,11,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H10O5N1,C11H8O5N1,235.0480724,236.0558974,234.04024744755,5177,cpd:C11469,Calicheamicin gamma(1)I;,C55H74IN3O21S4,Calicheamicin gamma(1)I; Calichemicin gamma1,R11421 R11422,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.4.1.-; 2.4.2.-,"Calicheamicin biosynthesis, calicheamicinone => calicheamicin",NA,CAS: 108212-75-5; PubChem: 13640; ChEBI: 3319; NIKKAJI: J634.691J,cpd:C11469,55,74,21,3,0,4,0,1,0,0,0,0,0,0,0,0,0,0,C55H75O21N3S4I1,C55H73O21N3S4I1,1367.274223,1368.282048,1366.2663984756,5178,cpd:C12049,Neocarzinostatin chromophore,C35H33NO12,Neocarzinostatin chromophore,NA,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,NA,NA,NA,CAS: 81604-85-5; PubChem: 14204; ChEBI: 29655; PDB-CCD: CHR; NIKKAJI: J1.527.685A,cpd:C12049,35,33,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H34O12N1,C35H32O12N1,659.2002755,660.2081005,658.19245054757,5179,cpd:C18054,2-Amino-2-deoxyisochorismate;,C10H11NO5,2-Amino-2-deoxyisochorismate; (2S)-2-Amino-4-deoxychorismate,R08956 R09559 R11463,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,1.3.99.24; 2.6.1.86; 3.3.2.15,"C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA",NA,PubChem: 96024274; ChEBI: 49197; PDB-CCD: QLI; NIKKAJI: J1.630.571E,cpd:C11355; cpd:C18054,10,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H12O5N1,C10H10O5N1,225.0637225,226.0715475,224.05589744758,5180,cpd:C19686,3-(1-Carboxyvinyloxy)anthranilate;,C10H9NO5,3-(1-Carboxyvinyloxy)anthranilate; 2-Amino-3-[(1-carboxyethenyl)oxy]benzoate,R09559 R11362,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,1.3.99.24,"C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA",NA,PubChem: 135626154,cpd:C01249; cpd:C03147; cpd:C05645; cpd:C05652; cpd:C19686,10,9,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O5N1,C10H8O5N1,223.0480724,224.0558974,222.04024744759,5182,cpd:C20841,2-Hydroxy-7-methoxy-5-methyl-1-naphthoate,C13H12O4,2-Hydroxy-7-methoxy-5-methyl-1-naphthoate,R10771 R10963,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.1.1.303; 6.2.1.43,"Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA",NA,PubChem: 254741307; PDB-CCD: 7NA,cpd:C09930; cpd:C14799; cpd:C20288; cpd:C20841,13,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H13O4,C13H11O4,232.0735589,233.0813839,231.06573384760,5183,cpd:C20842,2-Hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA,C34H46N7O19P3S,2-Hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA,R10771,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,6.2.1.43,"Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA",NA,PubChem: 254741308,cpd:C20842,34,46,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C34H47O19N7P3S1,C34H45O19N7P3S1,981.1782045,982.1860295,980.17037944761,5184,cpd:C20856,2-Hydroxy-5-methyl-1-naphthoate,C12H10O3,2-Hydroxy-5-methyl-1-naphthoate,R10796 R11125,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,1.14.99.49; 2.3.1.237,"Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA",NA,PubChem: 254741322; PDB-CCD: 5NA,cpd:C03569; cpd:C06742; cpd:C18750; cpd:C20805; cpd:C20856,12,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11O3,C12H9O3,202.0629942,203.0708192,201.05516914762,5185,cpd:C20857,"2,7-Dihydroxy-5-methyl-1-naphthoate",C12H10O4,"2,7-Dihydroxy-5-methyl-1-naphthoate",R10796 R10963,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,1.14.99.49; 2.1.1.303,"Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA",NA,PubChem: 254741323,cpd:C01273; cpd:C03837; cpd:C07733; cpd:C08164; cpd:C10300; cpd:C14216; cpd:C16811; cpd:C20857,12,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11O4,C12H9O4,218.0579088,219.0657338,217.05008384763,5186,cpd:C21292,Maduropeptin chromophore;,C40H43ClN2O12,Maduropeptin chromophore; (-)-Maduropeptin chromophore,NA,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 318172272,cpd:C21292,40,43,12,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C40H44O12N2Cl1,C40H42O12N2Cl1,778.2504525,779.2582775,777.24262754764,5187,cpd:C21301,Kedarcidin chromophore,C53H60ClN3O16,Kedarcidin chromophore,NA,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 318172281,cpd:C21301,53,60,16,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C53H61O16N3Cl1,C53H59O16N3Cl1,1029.366211,1030.374036,1028.3583864765,5188,cpd:C21306,"3,4-Dihydro-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylate",C10H7NO4,"3,4-Dihydro-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylate",R11362 R11363,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,1.14.-.-,"C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA",NA,PubChem: 319902554,cpd:C02470; cpd:C05663; cpd:C08480; cpd:C21306,10,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O4N1,C10H6O4N1,205.0375077,206.0453327,204.02968274766,5189,cpd:C21307,"3,4-Dihydro-7-hydroxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylate",C10H7NO5,"3,4-Dihydro-7-hydroxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylate",R11363 R11364,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,1.14.-.-; 2.1.1.-,"C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA",NA,PubChem: 319902555,cpd:C01111; cpd:C21307,10,7,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H8O5N1,C10H6O5N1,221.0324223,222.0402474,220.02459734767,5190,cpd:C21308,(S)-beta-Tyrosine,C9H11NO3,(S)-beta-Tyrosine,R11366 R11367,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,5.4.3.6; 6.2.1.-,"C-1027 beta-amino acid moiety biosynthesis, tyrosine => 3-chloro-4,5-dihydroxy-beta-phenylalanyl-PCP; Maduropeptin beta-hydroxy acid moiety biosynthesis, tyrosine => 3-(2-chloro-3-hydroxy-4-methoxyphenyl)-3-hydroxypropanoyl-PCP",NA,PubChem: 319902556,cpd:C00082; cpd:C01536; cpd:C03290; cpd:C04368; cpd:C06420; cpd:C14322; cpd:C19579; cpd:C19712; cpd:C20807; cpd:C21308,9,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H12O3N1,C9H10O3N1,181.0738932,182.0817182,180.06606824768,5193,cpd:C21312,6-Methylsalicylyl-CoA,C29H42N7O18P3S,6-Methylsalicylyl-CoA,R11370 R11371,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.1.1.-; 6.2.1.-,"3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA",NA,PubChem: 319902559,cpd:C02577; cpd:C05338; cpd:C19975; cpd:C20062; cpd:C21312,29,42,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C29H43O18N7P3S1,C29H41O18N7P3S1,901.1519897,902.1598147,900.14416474769,5194,cpd:C21313,"3,6-Dimethylsalicylyl-CoA",C30H44N7O18P3S,"3,6-Dimethylsalicylyl-CoA",R11371,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.1.1.-,"3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA",NA,PubChem: 319902560,cpd:C16257; cpd:C21313,30,44,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H45O18N7P3S1,C30H43O18N7P3S1,915.1676398,916.1754648,914.15981474770,5201,cpd:C21320,"3,6,8-Trihydroxy-2-naphthoate;",C11H8O5,"3,6,8-Trihydroxy-2-naphthoate; 3,6,8-Trihydroxy-2-naphthoic acid",R11387,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,1.14.-.-,"Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",NA,PubChem: 319902567,cpd:C01275; cpd:C04621; cpd:C04622; cpd:C09964; cpd:C16149; cpd:C16214; cpd:C19558; cpd:C21320,11,8,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O5,C11H7O5,220.0371734,221.0449984,219.02934834771,5202,cpd:C21321,"3,6,7,8-Tetrahydroxy-2-naphthoate",C11H8O6,"3,6,7,8-Tetrahydroxy-2-naphthoate",R11387 R11388,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,1.14.-.-; 2.1.1.-,"Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",NA,PubChem: 319902568,cpd:C14094; cpd:C14095; cpd:C21321,11,8,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O6,C11H7O6,236.032088,237.039913,235.02426294772,5203,cpd:C21322,"3-Hydroxy-6,7,8-trimethoxy-2-naphthoate",C14H14O6,"3-Hydroxy-6,7,8-trimethoxy-2-naphthoate",R11388 R11389,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.1.1.-,"Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",NA,PubChem: 319902569,cpd:C21322,14,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H15O6,C14H13O6,278.0790382,279.0868632,277.07121314773,5204,cpd:C21323,"3-Hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoate;",C16H18O6,"3-Hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoate; 3-Hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoic acid",R11389 R11390,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,NA,"Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",NA,PubChem: 319902570,cpd:C09000; cpd:C21323,16,18,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H19O6,C16H17O6,306.1103383,307.1181633,305.10251334774,5205,cpd:C21324,"3-Hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",C37H52N7O21P3S,"3-Hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",R11390,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,NA,"Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",NA,PubChem: 319902571,cpd:C21324,37,52,21,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C37H53O21N7P3S1,C37H51O21N7P3S1,1055.214984,1056.222809,1054.2071594775,5206,cpd:C21325,Azatyrosine;,C8H10N2O3,Azatyrosine; 2-Aza-L-tyrosine,R11391,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,5.4.3.-,"Kedarcidin 2-aza-3-chloro-beta-tyrosine moiety biosynthesis, azatyrosine => 2-aza-3-chloro-beta-tyrosyl-PCP",NA,CAS: 58525-82-9; PubChem: 319902572,cpd:C21325; cpd:C21326,8,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O3N2,C8H9O3N2,182.0691422,183.0769672,181.06131724776,5207,cpd:C21326,(R)-2-Aza-beta-tyrosine,C8H10N2O3,(R)-2-Aza-beta-tyrosine,R11391 R11392,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,5.4.3.-; 6.2.1.-,"Kedarcidin 2-aza-3-chloro-beta-tyrosine moiety biosynthesis, azatyrosine => 2-aza-3-chloro-beta-tyrosyl-PCP",NA,PubChem: 319902573,cpd:C21325; cpd:C21326,8,10,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H11O3N2,C8H9O3N2,182.0691422,183.0769672,181.06131724777,5210,cpd:C21337,Calicheamicinone,C18H17NO5S3,Calicheamicinone,R11417,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.4.1.-,"Calicheamicin biosynthesis, calicheamicinone => calicheamicin",NA,PubChem: 319902576,cpd:C21337,18,17,5,1,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C18H18O5N1S3,C18H16O5N1S3,423.0268862,424.0347112,422.01906114778,5211,cpd:C21338,Calicheamicin T0,C24H28N2O9S3,Calicheamicin T0,R11417 R11418,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.4.1.-,"Calicheamicin biosynthesis, calicheamicinone => calicheamicin",NA,PubChem: 319902577; PDB-CCD: C0T,cpd:C21338,24,28,9,2,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C24H29O9N2S3,C24H27O9N2S3,584.095694,585.103519,583.0878694779,5212,cpd:C21339,4-Deoxy-4-thio-alpha-D-digitoxosyl-calicheamicin T0,C30H38N2O11S4,4-Deoxy-4-thio-alpha-D-digitoxosyl-calicheamicin T0,R11418 R11419,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.4.1.-,"Calicheamicin biosynthesis, calicheamicinone => calicheamicin",NA,PubChem: 319902578,cpd:C21339,30,38,11,2,0,4,0,0,0,0,0,0,0,0,0,0,0,0,C30H39O11N2S4,C30H37O11N2S4,730.1358447,731.1436698,729.12801974780,5213,cpd:C21340,Calicheamicin PsAg,C40H47IN2O15S4,Calicheamicin PsAg,R11419 R11420 R11423,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.4.1.-; 2.4.2.-,"Calicheamicin biosynthesis, calicheamicinone => calicheamicin",NA,PubChem: 319902579,cpd:C21340,40,47,15,2,0,4,0,1,0,0,0,0,0,0,0,0,0,0,C40H48O15N2S4I1,C40H46O15N2S4I1,1050.090386,1051.098211,1049.082564781,5214,cpd:C21341,Calicheamicin alpha1(I),C48H62IN3O17S4,Calicheamicin alpha1(I),R11420 R11422,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.4.1.-; 2.4.2.-,"Calicheamicin biosynthesis, calicheamicinone => calicheamicin",NA,PubChem: 319902580,cpd:C21341,48,62,17,3,0,4,0,1,0,0,0,0,0,0,0,0,0,0,C48H63O17N3S4I1,C48H61O17N3S4I1,1207.200664,1208.208489,1206.1928394782,5215,cpd:C21342,Calicheamicin alpha3(I),C47H59IN2O19S4,Calicheamicin alpha3(I),R11421 R11423,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,2.4.1.-; 2.4.2.-,"Calicheamicin biosynthesis, calicheamicinone => calicheamicin",NA,PubChem: 319902581; PDB-CCD: CLJ,cpd:C21342,47,59,19,2,0,4,0,1,0,0,0,0,0,0,0,0,0,0,C47H60O19N2S4I1,C47H58O19N2S4I1,1210.163944,1211.171769,1209.1561194783,5222,cpd:C21358,"1,3,5,7,9,11,13-Pentadecaheptaene",C15H18,"1,3,5,7,9,11,13-Pentadecaheptaene",R11436,Biosynthesis of enediyne antibiotics; Biosynthesis of antibiotics,NA,NA,NA,PubChem: 319902593,cpd:C01313; cpd:C01632; cpd:C02206; cpd:C04164; cpd:C04415; cpd:C05158; cpd:C05839; cpd:C06681; cpd:C06739; cpd:C07540; cpd:C07605; cpd:C09015; cpd:C09287; cpd:C09292; cpd:C09300; cpd:C09302; cpd:C09344; cpd:C09354; cpd:C09363; cpd:C09379; cpd:C09387; cpd:C09394; cpd:C09396; cpd:C09406; cpd:C09450; cpd:C09472; cpd:C09473; cpd:C09476; cpd:C09485; cpd:C09502; cpd:C09504; cpd:C09508; cpd:C09523; cpd:C09528; cpd:C09545; cpd:C09552; cpd:C09570; cpd:C09601; cpd:C09605; cpd:C09606; cpd:C09658; cpd:C09675; cpd:C09701; cpd:C09897; cpd:C09983; cpd:C10431; cpd:C10433; cpd:C10932; cpd:C10949; cpd:C11268; cpd:C15134; cpd:C15666; cpd:C16827; cpd:C16943; cpd:C16960; cpd:C16988; cpd:C17085; cpd:C17490; cpd:C17885; cpd:C17912; cpd:C17913; cpd:C18440; cpd:C18456; cpd:C18494; cpd:C18496; cpd:C18518; cpd:C18519; cpd:C18579; cpd:C19022; cpd:C19260; cpd:C20397; cpd:C20398; cpd:C20521; cpd:C21358,15,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H19,C15H17,198.1408506,199.1486756,197.13302554784,5224,cpd:C00766,Flavanone;,C15H12O2,"Flavanone; 2,3-Dihydroflavone",R02898 R07333 R07344 R07367 R07369 R10069,Biosynthesis of plant secondary metabolites,1.14.11.22; 1.14.13.88; 2.4.1.185; 5.5.1.6,NA,NA,PubChem: 4028; ChEBI: 5070; NIKKAJI: J11.632G,cpd:C00766; cpd:C01927; cpd:C02099; cpd:C07443; cpd:C07492; cpd:C07496; cpd:C09321; cpd:C13410; cpd:C13620; cpd:C14231; cpd:C14232; cpd:C14237; cpd:C14528; cpd:C16208; cpd:C16601; cpd:C16602; cpd:C18364,15,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H13O2,C15H11O2,224.0837296,225.0915547,223.07590464785,5225,cpd:C01495,Flavonol,C15H10O3,Flavonol,R03267 R07338 R07368,Biosynthesis of plant secondary metabolites,1.14.11.23; 2.4.1.91; 2.4.1.237,NA,NA,PubChem: 4665; ChEBI: 5078; 3DMET: B00305; NIKKAJI: J1.628D,cpd:C01495; cpd:C02921; cpd:C10354; cpd:C11264; cpd:C12120; cpd:C14137; cpd:C15615; cpd:C16606; cpd:C17879; cpd:C18615; cpd:C20871,15,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H11O3,C15H9O3,238.0629942,239.0708192,237.05516914786,5227,cpd:C02394,Cinnamyl alcohol;,C9H10O,Cinnamyl alcohol; 3-Phenyl-2-propen-1-ol; Styrylcarbinol,R03054 R10474,Biosynthesis of plant secondary metabolites; Biosynthesis of secondary metabolites,1.1.1.195; 2.3.1.224,NA,NA,CAS: 104-54-1; PubChem: 5428; ChEBI: 17177 33227; ChEMBL: CHEMBL324794; KNApSAcK: C00032375 C00042390; 3DMET: B00439; NIKKAJI: J106.769I J9.304A,cpd:C01710; cpd:C02394; cpd:C13840; cpd:C15512; cpd:C16930; cpd:C18428; cpd:C20464,9,10,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O1,C9H9O1,134.0731649,135.08099,133.06533994787,5228,cpd:C06523,Coniine;,C8H17N,Coniine; (+)-Coniine; Cicutin,R08510,Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from terpenoid and polyketide,1.5.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Acetate derived alkaloids;     C06523  Coniine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Piperidine alkaloids;     C06523  Coniine,CAS: 458-88-8; PubChem: 8754; ChEBI: 28322; KNApSAcK: C00002031; 3DMET: B02049; NIKKAJI: J5.763K,cpd:C00579; cpd:C02852; cpd:C04461; cpd:C06523; cpd:C07708; cpd:C10152; cpd:C10168; cpd:C12067; cpd:C17221; cpd:C17249; cpd:C19983,8,17,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H18N1,C8H16N1,127.1360996,128.1439246,126.12827454788,5229,cpd:C08366,Sterculic acid,C19H34O2,Sterculic acid,NA,Biosynthesis of plant secondary metabolites,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0114 Carbocyclic fatty acids;     C08366  Sterculic acid; Phytochemical compounds [BR:br08003];  Fatty acids related compounds;   Fatty acids;    Others;     C08366  Sterculic acid,CAS: 738-87-4; PubChem: 10562; ChEBI: 9261; LIPIDMAPS: LMFA01140018; LipidBank: DFA0261; KNApSAcK: C00001239; 3DMET: B02174; NIKKAJI: J12.302A,cpd:C08366,19,34,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H35O2,C19H33O2,294.2558803,295.2637054,293.24805534789,5230,cpd:C08817,Fucosterol,C29H48O,Fucosterol,NA,Biosynthesis of plant secondary metabolites,NA,NA,Compounds with biological roles [BR:br08001];  Steroids;   29-Carbon atoms;    Stigmastane derivatives;     C08817  Fucosterol; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0104 Stigmasterols and C24-ethyl derivatives;     C08817  Fucosterol; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Stigmastane;     C08817  Fucosterol,CAS: 17605-67-3; PubChem: 11010; ChEBI: 27865; ChEMBL: CHEMBL519971; LipidBank: SST0071 SST9069; KNApSAcK: C00003653; 3DMET: B02435; NIKKAJI: J9.102B,cpd:C05108; cpd:C05442; cpd:C08817; cpd:C08821; cpd:C08836; cpd:C08840; cpd:C11522; cpd:C15776; cpd:C15782; cpd:C18193,29,48,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H49O1,C29H47O1,412.3705162,413.3783412,411.36269114790,5231,cpd:C08898,Diosgenin;,C27H42O3,"Diosgenin; (3beta,25R)-Spirost-5-en-3-ol",R10581,Biosynthesis of plant secondary metabolites,3.2.1.189,NA,Compounds with biological roles [BR:br08001];  Steroids;   27-Carbon atoms;    Spirostan derivatives;     C08898  Diosgenin; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Spirostan;     C08898  Diosgenin; Major components of natural products [BR:br08323];  Crude drugs;   Dioscorea rhizome;    C08898  Diosgenin,CAS: 512-04-9; PubChem: 11091; ChEBI: 4629; ChEMBL: CHEMBL1553328 CHEMBL412437; LIPIDMAPS: LMST01080037; KNApSAcK: C00003576; 3DMET: B02506; NIKKAJI: J6.272C,cpd:C08898; cpd:C08918; cpd:C14994; cpd:C16509; cpd:C20839; cpd:C21076; cpd:C21077,27,42,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O3,C27H41O3,414.3133952,415.3212202,413.30557024791,5232,cpd:C08902,Hecogenin,C27H42O4,Hecogenin,NA,Biosynthesis of plant secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Spirostan;     C08902  Hecogenin,CAS: 467-55-0; PubChem: 11095; ChEBI: 5633; LIPIDMAPS: LMST01080014; LipidBank: SST0078; KNApSAcK: C00003580; 3DMET: B02510; NIKKAJI: J12.118E,cpd:C04715; cpd:C08891; cpd:C08902; cpd:C08909; cpd:C16498; cpd:C17337; cpd:C17891,27,42,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O4,C27H41O4,430.3083098,431.3161349,429.30048484792,5233,cpd:C09010,Khellin,C14H12O5,Khellin,NA,Biosynthesis of plant secondary metabolites,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1311 Benzopyranoids;     C09010  Khellin; Phytochemical compounds [BR:br08003];  Polyketides;   Pyrones;    Chromones;     C09010  Khellin,CAS: 82-02-0; PubChem: 11202; ChEBI: 6133; ChEMBL: CHEMBL44746; LIPIDMAPS: LMPK13110001; KNApSAcK: C00002431; 3DMET: B02609; NIKKAJI: J24.827D,cpd:C09010,14,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H13O5,C14H11O5,260.0684735,261.0762985,259.06064854793,5234,cpd:C09049,Visnagin,C13H10O4,Visnagin,NA,Biosynthesis of plant secondary metabolites,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1311 Benzopyranoids;     C09049  Visnagin; Phytochemical compounds [BR:br08003];  Polyketides;   Pyrones;    Chromones;     C09049  Visnagin,CAS: 82-57-5; PubChem: 11241; ChEBI: 10002; ChEMBL: CHEMBL45176; LIPIDMAPS: LMPK13110003; KNApSAcK: C00002447; 3DMET: B02643; NIKKAJI: J4.613B,cpd:C06356; cpd:C07718; cpd:C07725; cpd:C07910; cpd:C09049; cpd:C12085; cpd:C16263; cpd:C18216; cpd:C18805,13,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O4,C13H9O4,230.0579088,231.0657338,229.05008384794,5235,cpd:C10138,gamma-Coniceine,C8H15N,gamma-Coniceine,R08509 R08510,Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from terpenoid and polyketide,1.5.1.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Acetate derived alkaloids;     C10138  gamma-Coniceine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Piperidine alkaloids;     C10138  gamma-Coniceine,CAS: 1604-01-9; PubChem: 12324; ChEBI: 10561; KNApSAcK: C00002030; 3DMET: B03576; NIKKAJI: J7.527B,cpd:C00140; cpd:C00248; cpd:C00645; cpd:C00729; cpd:C01132; cpd:C01133; cpd:C02066; cpd:C02256; cpd:C02710; cpd:C02711; cpd:C03136; cpd:C03146; cpd:C03521; cpd:C03878; cpd:C03953; cpd:C04132; cpd:C04255; cpd:C05021; cpd:C06179; cpd:C06182; cpd:C06326; cpd:C06751; cpd:C08283; cpd:C08404; cpd:C10124; cpd:C10132; cpd:C10138; cpd:C10155; cpd:C10173; cpd:C10864; cpd:C11359; cpd:C11843; cpd:C12440; cpd:C12535; cpd:C15480; cpd:C15481; cpd:C16265; cpd:C20328; cpd:C21036; cpd:C21039; cpd:C21046; cpd:C21049; cpd:C21052; cpd:C21056; cpd:C21061; cpd:C21333,8,15,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16N1,C8H14N1,125.1204495,126.1282745,124.11262454795,5236,cpd:C16724,Strictosamide,C26H30N2O8,Strictosamide,R08487 R08488,Biosynthesis of plant secondary metabolites; Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C16724  Strictosamide,CAS: 23141-25-5; PubChem: 96023248; ChEBI: 80684; ChEMBL: CHEMBL480522; KNApSAcK: C00032210; NIKKAJI: J412.421I,cpd:C16724,26,30,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H31O8N2,C26H29O8N2,498.2002159,499.208041,497.19239094796,5237,cpd:C00758,Bergaptol;,C11H6O4,Bergaptol; 5-Hydroxypsoralen; 5-Hydroxyfuranocoumarin,R02882,Biosynthesis of phenylpropanoids,2.1.1.69,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Furanocoumarins;     C00758  Bergaptol,CAS: 486-60-2; PubChem: 4020; ChEBI: 17377; ChEMBL: CHEMBL242711; KNApSAcK: C00000581; 3DMET: B00170; NIKKAJI: J12.566K,cpd:C00758; cpd:C00841; cpd:C18084; cpd:C18085,11,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H7O4,C11H5O4,202.0266087,203.0344337,201.01878364797,5238,cpd:C00841,Xanthotoxol;,C11H6O4,Xanthotoxol; 8-Hydroxypsoralen; 8-Hydroxyfuranocoumarin,R02982,Biosynthesis of phenylpropanoids,2.1.1.70,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Furanocoumarins;     C00841  Xanthotoxol,CAS: 2009-24-7; PubChem: 4098; ChEBI: 15709; ChEMBL: CHEMBL1192; KNApSAcK: C00000582; 3DMET: B00186; NIKKAJI: J7.847F,cpd:C00758; cpd:C00841; cpd:C18084; cpd:C18085,11,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H7O4,C11H5O4,202.0266087,203.0344337,201.01878364798,5239,cpd:C01158,1-O-Galloyl-beta-D-glucose;,C13H16O10,1-O-Galloyl-beta-D-glucose; 1-Galloyl-beta-glucose; beta-Glucogallin; 1-Galloyl-beta-D-glucose,R00049 R03297 R04498,Biosynthesis of phenylpropanoids,2.3.1.90; 2.3.1.143; 2.4.1.136,NA,NA,CAS: 554-37-0; PubChem: 4386; ChEBI: 15834; ChEMBL: CHEMBL480283; KNApSAcK: C00002652 C00038195; 3DMET: B01396,cpd:C01158,13,16,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H17O10,C13H15O10,332.0743467,333.0821717,331.06652174799,5240,cpd:C01557,Bergapten;,C12H8O4,Bergapten; 5-Methoxypsoralen; O-Methylbergaptol; 5-Methoxyfuranocoumarin,R02882,Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,2.1.1.69,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Furanocoumarins;     C01557  Bergapten; Carcinogens [BR:br08008];  Group 2A: Probably carcinogenic to humans;   Compounds;    C01557  5-Methoxypsoralen; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D05 ANTIPSORIATICS;    D05B ANTIPSORIATICS FOR SYSTEMIC USE;     D05BA Psoralens for systemic use;      D05BA03 Bergapten;       D07521  Bergaptene (DCF); Phytochemicals used as drugs [BR:br08306];  Phenylpropanoids and related compounds;   Coumarins;    D07521  Bergapten,CAS: 484-20-8; PubChem: 4715; ChEBI: 18293; ChEMBL: CHEMBL24171; KNApSAcK: C00000575; 3DMET: B00318; NIKKAJI: J12.563F,cpd:C01557; cpd:C01864; cpd:C17843; cpd:C18081; cpd:C18082; cpd:C19126,12,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H9O4,C12H7O4,216.0422587,217.0500838,215.03443374800,5241,cpd:C02162,Isopimpinellin;,C13H10O5,"Isopimpinellin; 5,8-Dimethoxypsoralen",R08538,Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,2.1.1.69,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Furanocoumarins;     C02162  Isopimpinellin,CAS: 482-27-9; PubChem: 5238; ChEMBL: CHEMBL140796; KNApSAcK: C00000583; 3DMET: B01541; NIKKAJI: J5.787H,cpd:C02162; cpd:C06355; cpd:C06673; cpd:C09285; cpd:C18389,13,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H11O5,C13H9O5,246.0528234,247.0606485,245.04499844801,5242,cpd:C04576,Pentagalloylglucose;,C41H32O26,"Pentagalloylglucose; 1,2,3,4,6-Pentakis-O-galloyl-beta-D-glucose; Pentagalloyl-beta-D-glucose",R04498,Biosynthesis of phenylpropanoids,2.3.1.143,NA,Phytochemical compounds [BR:br08003];  Others;   Tannins and galloyl derivatives;    Ellagitannins;     C04576  Pentagalloylglucose,CAS: 14937-32-7; PubChem: 7177; ChEBI: 18082; ChEMBL: CHEMBL1224764 CHEMBL382408; KNApSAcK: C00002933 C00037615; 3DMET: B01761; NIKKAJI: J277.746K,cpd:C04576,41,32,26,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H33O26,C41H31O26,940.1181811,941.1260062,939.11035614802,5243,cpd:C05366,(+)-Pinoresinol,C20H22O6,(+)-Pinoresinol,R10225,Biosynthesis of phenylpropanoids,1.23.1.1,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Lignans;    Lignans;     C05366  (+)-Pinoresinol,CAS: 487-36-5; PubChem: 7741; ChEBI: 40; KNApSAcK: C00007190; NIKKAJI: J322.968H,cpd:C00445; cpd:C05366; cpd:C08831; cpd:C09077; cpd:C09515; cpd:C09516; cpd:C10317; cpd:C10558; cpd:C10593; cpd:C10682; cpd:C17414; cpd:C17508; cpd:C17808; cpd:C20455,20,22,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H23O6,C20H21O6,358.1416384,359.1494635,357.13381344803,5244,cpd:C09060,Angelicin;,C11H6O3,Angelicin; Isopsoralen,R09002,Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.14.13.115,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Furanocoumarins;     C09060  Angelicin; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C09060  Angelicin (plus ultraviolet A radiation),CAS: 523-50-2; PubChem: 11252; ChEBI: 28928; ChEMBL: CHEMBL53569; KNApSAcK: C00002450; 3DMET: B02650; NIKKAJI: J1.579B,cpd:C09060; cpd:C09305,11,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H7O3,C11H5O3,186.0316941,187.0395191,185.0238694804,5245,cpd:C09263,Esculetin;,C9H6O4,Esculetin; Aesculetin,NA,Biosynthesis of phenylpropanoids,NA,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Coumarins;     C09263  Esculetin,CAS: 305-01-1; PubChem: 11454; ChEBI: 490095; ChEMBL: CHEMBL244743; KNApSAcK: C00002471; 3DMET: B02810; NIKKAJI: J5.493C,cpd:C01244; cpd:C03093; cpd:C04285; cpd:C04323; cpd:C09001; cpd:C09263; cpd:C12469; cpd:C16828,9,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H7O4,C9H5O4,178.0266087,179.0344337,177.01878364805,5246,cpd:C09276,Marmesin;,C14H14O4,Marmesin; (+)-Marmesin,R08207,Biosynthesis of phenylpropanoids,1.14.13.102,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Furanocoumarins;     C09276  Marmesin,CAS: 13849-08-6; PubChem: 11467; ChEBI: 6695; ChEMBL: CHEMBL442813; KNApSAcK: C00000584; 3DMET: B02821; NIKKAJI: J14.029E,cpd:C06880; cpd:C09210; cpd:C09259; cpd:C09276; cpd:C09278; cpd:C12675; cpd:C14434; cpd:C17672; cpd:C19707; cpd:C21408,14,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H15O4,C14H13O4,246.0892089,247.097034,245.08138394806,5247,cpd:C09305,Psoralen;,C11H6O3,Psoralen; Ficusin,R08207,Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.14.13.102,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Furanocoumarins;     C09305  Psoralen,CAS: 66-97-7; PubChem: 11496; ChEBI: 27616; ChEMBL: CHEMBL164660; KNApSAcK: C00000297; 3DMET: B02846; NIKKAJI: J2.363I,cpd:C09060; cpd:C09305,11,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H7O3,C11H5O3,186.0316941,187.0395191,185.0238694807,5248,cpd:C09315,Umbelliferone;,C9H6O3,Umbelliferone; 7-Hydroxycoumarin,NA,Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,2.5.1.-,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Coumarins;    Coumarins;     C09315  Umbelliferone,CAS: 93-35-6; PubChem: 11506; ChEBI: 27510; ChEMBL: CHEMBL51628; KNApSAcK: C00002503; PDB-CCD: 07L; 3DMET: B02855; NIKKAJI: J4.673F,cpd:C03474; cpd:C09315; cpd:C11090; cpd:C14164; cpd:C18775; cpd:C19123; cpd:C20414,9,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H7O3,C9H5O3,162.0316941,163.0395191,161.0238694808,5249,cpd:C09980,Yangonin;,C15H14O4,Yangonin; 4-Methoxy-6-[2-(4-methoxyphenyl)ethenyl]-2H-pyran-2-one,NA,Biosynthesis of phenylpropanoids,NA,NA,Phytochemical compounds [BR:br08003];  Polyketides;   Pyrones;    alpha-Pyrones;     C09980  Yangonin,CAS: 500-62-9; PubChem: 12166; ChEBI: 10089; ChEMBL: CHEMBL1098658; KNApSAcK: C00003024; 3DMET: B03429; NIKKAJI: J6.190E,cpd:C06877; cpd:C07758; cpd:C07759; cpd:C08465; cpd:C09273; cpd:C09283; cpd:C09618; cpd:C09980; cpd:C10268; cpd:C10352; cpd:C13633; cpd:C14115; cpd:C16929; cpd:C18485,15,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O4,C15H13O4,258.0892089,259.097034,257.08138394809,5250,cpd:C10682,Matairesinol;,C20H22O6,Matairesinol; (-)-Matairesinol,R10129 R11222,Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,1.1.1.331; 1.14.21.11,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Lignans;    Lignans;     C10682  Matairesinol,CAS: 580-72-3; PubChem: 12865; ChEBI: 6698; ChEMBL: CHEMBL425148; KNApSAcK: C00000606; PDB-CCD: MAX; 3DMET: B04057; NIKKAJI: J14.221B,cpd:C00445; cpd:C05366; cpd:C08831; cpd:C09077; cpd:C09515; cpd:C09516; cpd:C10317; cpd:C10558; cpd:C10593; cpd:C10682; cpd:C17414; cpd:C17508; cpd:C17808; cpd:C20455,20,22,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H23O6,C20H21O6,358.1416384,359.1494635,357.13381344810,5251,cpd:C10874,Podophyllotoxin,C22H22O8,Podophyllotoxin,NA,Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Lignans;    Lignans;     C10874  Podophyllotoxin; Natural toxins [BR:br08009];  Phytotoxins;   Others;    Others;     C10874  Podophyllotoxin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;    D06B CHEMOTHERAPEUTICS FOR TOPICAL USE;     D06BB Antivirals;      D06BB04 Podophyllotoxin;       D05529  Podofilox (USAN); USP drug classification [BR:br08302];  Dermatological Agents;   Podofilox;    D05529  Podofilox (USAN); Target-based classification of drugs [BR:br08310];  Others;   Other;    beta-tubulin;     Podophyllotoxin;      D05529  Podofilox (USAN); Phytochemicals used as drugs [BR:br08306];  Phenylpropanoids and related compounds;   Lignans;    Lignans;     D05529  Podofilox (USAN),CAS: 518-28-5; PubChem: 13057; ChEBI: 50305; ChEMBL: CHEMBL21260 CHEMBL61; KNApSAcK: C00000610; PDB-CCD: POD; 3DMET: B04178; NIKKAJI: J6.582J,cpd:C03206; cpd:C07654; cpd:C08029; cpd:C10871; cpd:C10874,22,22,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H23O8,C22H21O8,414.1314677,415.1392927,413.12364264811,5252,cpd:C10886,Steganacin;,C24H24O9,Steganacin; (-)-Steganacin,NA,Biosynthesis of phenylpropanoids; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Phenylpropanoids;   Lignans;    Lignans;     C10886  Steganacin; Target-based classification of compounds [BR:br08010];  Others;   Cytoskeleton proteins;    beta-tubulin;     C10886  Steganacin,CAS: 41451-68-7; PubChem: 13069; ChEBI: 9259; ChEMBL: CHEMBL154064 CHEMBL157001; KNApSAcK: C00000612; 3DMET: B04190; NIKKAJI: J360.503E,cpd:C10886,24,24,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H25O9,C24H23O9,456.1420323,457.1498574,455.13420734812,5253,cpd:C12305,Methyl salicylate;,C8H8O3,Methyl salicylate; Methyl 2-hydroxybenzoate,R10448,Biosynthesis of phenylpropanoids,2.1.1.274,NA,"Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   26  Epidermides;    264  Analgesics, anti-itchings, astringents, anti-inflammatory agents;     2641  Methyl salicylic acids;      D01087  Methyl salicylate (JP17/NF); Classification of Japanese OTC drugs [BR:br08313];  Agents for respiratory organs;   27 Gargles;    D01087  Methyl salicylate (JP17/NF);  Agents for integumentary system;   57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches);    D01087  Methyl salicylate (JP17/NF); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Methyl salicylate;     D01087  Methyl salicylate (JP17/NF); Pharmaceutical additives [BR:br08316];  Flavoring substance;   D01087  [002165] Methyl salicylate;  Algefacient;   D01087  [002165] Methyl salicylate;  Favoring agent, Fragrance;   D01087  [002165] Methyl salicylate;  Refresher;   D01087  [002165] Methyl salicylate; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D01087  Methyl salicylate; Major components of natural products [BR:br08323];  Essential oils;   Wintergreen oil;    C12305  Methyl salicylate; Animal drugs in Japan [BR:br08331];  95  Agents for external use;   953  Analgesics, anti-itchings, astringents and antiinflammatory agents;    9531  Methyl salicylate and preparations;     C12305  Methyl salicylate",CAS: 119-36-8; PubChem: 582696; ChEBI: 31832; ChEMBL: CHEMBL108545; KNApSAcK: C00030767; NIKKAJI: J2.915G,cpd:C00642; cpd:C00755; cpd:C00875; cpd:C01983; cpd:C01984; cpd:C02181; cpd:C02519; cpd:C02639; cpd:C02657; cpd:C03663; cpd:C04043; cpd:C05380; cpd:C05593; cpd:C05852; cpd:C07504; cpd:C10675; cpd:C10804; cpd:C12064; cpd:C12305; cpd:C13635; cpd:C13636; cpd:C14088; cpd:C14103; cpd:C14108; cpd:C16623; cpd:C17900; cpd:C18965; cpd:C18986; cpd:C19002; cpd:C21167; cpd:C21376,8,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O3,C8H7O3,152.0473441,153.0551691,151.03951914813,5254,cpd:C18080,Osthenol,C14H14O3,Osthenol,NA,Biosynthesis of phenylpropanoids,2.5.1.-,NA,NA,CAS: 484-14-0; PubChem: 96024297; ChEBI: 81485; ChEMBL: CHEMBL350475; KNApSAcK: C00030900; NIKKAJI: J12.528H,cpd:C00921; cpd:C01517; cpd:C08762; cpd:C09918; cpd:C09947; cpd:C10253; cpd:C10255; cpd:C11492; cpd:C18080; cpd:C18083; cpd:C18909; cpd:C19020; cpd:C19141,14,14,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H15O3,C14H13O3,230.0942943,231.1021193,229.08646934814,5255,cpd:C18083,Demethylsuberosin;,C14H14O3,Demethylsuberosin; 7-Demethylsuberosin,NA,Biosynthesis of phenylpropanoids,2.5.1.-,NA,NA,CAS: 21422-04-8; PubChem: 96024300; ChEBI: 69042; ChEMBL: CHEMBL502689; KNApSAcK: C00030108; NIKKAJI: J294.473A,cpd:C00921; cpd:C01517; cpd:C08762; cpd:C09918; cpd:C09947; cpd:C10253; cpd:C10255; cpd:C11492; cpd:C18080; cpd:C18083; cpd:C18909; cpd:C19020; cpd:C19141,14,14,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H15O3,C14H13O3,230.0942943,231.1021193,229.08646934815,5256,cpd:C19707,(+)-Columbianetin;,C14H14O4,(+)-Columbianetin; (S)-Columbianetin,R09002,Biosynthesis of phenylpropanoids,1.14.13.115,NA,NA,CAS: 3804-70-4; PubChem: 135626175; ChEMBL: CHEMBL201152; KNApSAcK: C00029297,cpd:C06880; cpd:C09210; cpd:C09259; cpd:C09276; cpd:C09278; cpd:C12675; cpd:C14434; cpd:C17672; cpd:C19707; cpd:C21408,14,14,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H15O4,C14H13O4,246.0892089,247.097034,245.08138394816,5257,cpd:C06076,Camphene;,C10H16,Camphene; Comphene,R02011,Biosynthesis of terpenoids and steroids; Metabolic pathways; Biosynthesis of secondary metabolites,4.2.3.-,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C06076  Camphene; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C06076  Camphene,CAS: 79-92-5; PubChem: 8342; ChEBI: 3830; KNApSAcK: C00000818 C00003029; NIKKAJI: J39.020H,cpd:C00002; cpd:C00044; cpd:C00120; cpd:C00131; cpd:C00284; cpd:C00286; cpd:C00363; cpd:C00521; cpd:C00591; cpd:C00808; cpd:C00809; cpd:C00848; cpd:C00884; cpd:C00964; cpd:C01123; cpd:C01262; cpd:C01425; cpd:C01499; cpd:C01806; cpd:C01843; cpd:C01889; cpd:C02073; cpd:C02108; cpd:C02173; cpd:C02213; cpd:C02320; cpd:C02452; cpd:C02759; cpd:C02863; cpd:C02967; cpd:C03110; cpd:C03448; cpd:C03495; cpd:C03614; cpd:C03843; cpd:C03933; cpd:C03997; cpd:C04138; cpd:C04155; cpd:C04312; cpd:C04381; cpd:C04435; cpd:C04718; cpd:C05282; cpd:C06066; cpd:C06069; cpd:C06074; cpd:C06075; cpd:C06076; cpd:C06078; cpd:C06099; cpd:C06304; cpd:C06305; cpd:C06306; cpd:C06307; cpd:C06308; cpd:C06605; cpd:C06952; cpd:C06969; cpd:C06976; cpd:C07271; cpd:C07362; cpd:C07827; cpd:C08437; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09839; cpd:C09842; cpd:C09847; cpd:C09854; cpd:C09859; cpd:C09873; cpd:C09875; cpd:C09877; cpd:C09880; cpd:C09882; cpd:C09885; cpd:C09893; cpd:C09898; cpd:C09900; cpd:C09906; cpd:C11120; cpd:C11382; cpd:C11387; cpd:C11391; cpd:C11392; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11402; cpd:C11403; cpd:C11405; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11414; cpd:C11415; cpd:C11418; cpd:C11419; cpd:C11478; cpd:C11651; cpd:C11937; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11943; cpd:C11944; cpd:C11951; cpd:C13311; cpd:C13733; cpd:C13742; cpd:C15563; cpd:C16461; cpd:C16690; cpd:C16691; cpd:C16777; cpd:C17623; cpd:C18018; cpd:C18019; cpd:C18369; cpd:C18658; cpd:C18813; cpd:C19079; cpd:C19081; cpd:C19083; cpd:C19084; cpd:C19112; cpd:C19731; cpd:C19818; cpd:C19967; cpd:C19969; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20230; cpd:C20241; cpd:C20242; cpd:C20244; cpd:C20260; cpd:C20322; cpd:C20323; cpd:C20324; cpd:C20386; cpd:C20387; cpd:C20425; cpd:C20818; cpd:C20825; cpd:C20859; cpd:C20912; cpd:C20943; cpd:C20949; cpd:C21012; cpd:C21031; cpd:C21310,10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17,C10H15,136.1252005,137.1330255,135.11737554817,5259,cpd:C07601,Ginkgolide A,C20H24O9,Ginkgolide A,R08402,Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010454 Ginkgolides and Bilobalides;      C07601  Ginkgolide A; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Ginkgolides;     C07601  Ginkgolide A; Major components of natural products [BR:br08323];  Medicinal herbs;   Ginkgo;    C07601  Ginkgolide A,CAS: 15291-75-5; PubChem: 9803; ChEBI: 5355; ChEMBL: CHEMBL465161; LIPIDMAPS: LMPR0104540001; KNApSAcK: C00003429; 3DMET: B05250; NIKKAJI: J37.103C,cpd:C07601; cpd:C09105; cpd:C09279; cpd:C14803; cpd:C14804; cpd:C14805; cpd:C14806,20,24,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O9,C20H23O9,408.1420323,409.1498574,407.13420734818,5260,cpd:C08624,Euphol,C30H50O,Euphol,R08376 R08377,Biosynthesis of terpenoids and steroids,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010609 Tirucallane/euphane triterpenoids;      C08624  Euphol; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Dammarenes;     C08624  Euphol,CAS: 514-47-6; PubChem: 10817; ChEBI: 4940; ChEMBL: CHEMBL465181; KNApSAcK: C00003745; 3DMET: B02278; NIKKAJI: J14.838E,cpd:C01054; cpd:C01724; cpd:C01902; cpd:C01943; cpd:C02141; cpd:C08615; cpd:C08616; cpd:C08624; cpd:C08626; cpd:C08628; cpd:C08636; cpd:C08637; cpd:C11523; cpd:C16958; cpd:C16973; cpd:C17901; cpd:C17966; cpd:C19655; cpd:C19657; cpd:C19801; cpd:C19819; cpd:C19820; cpd:C19832; cpd:C19833; cpd:C19835; cpd:C19918; cpd:C20187; cpd:C20188; cpd:C20189; cpd:C20191; cpd:C20192; cpd:C20193; cpd:C20194; cpd:C20195; cpd:C20200; cpd:C21116,30,50,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C30H51O1,C30H49O1,426.3861662,427.3939913,425.37834124819,5261,cpd:C08627,Hopane-29-acetate,C32H54O2,Hopane-29-acetate,R08535,Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR04 Hopanoids;    C08627  Hopane-29-acetate; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Hopanes;     C08627  Hopane-29-acetate,CAS: 58193-25-2; PubChem: 10820; ChEBI: 5760; LIPIDMAPS: LMPR04000003; KNApSAcK: C00003748; 3DMET: B05270; NIKKAJI: J294.466I,cpd:C08627,32,54,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H55O2,C32H53O2,470.412381,471.420206,469.40455594820,5262,cpd:C08748,Azadirachtin A;,C35H44O16,Azadirachtin A; Azadirachtin,R08377,Biosynthesis of terpenoids and steroids,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0106 C30 isoprenoids (triterpenes);     PR010610 Apotirucallane triterpenoids;      C08748  Azadirachtin A,CAS: 11141-17-6; PubChem: 10941; ChEBI: 2942; ChEMBL: CHEMBL509309; LIPIDMAPS: LMPR0106100001; KNApSAcK: C00003698; 3DMET: B02373; NIKKAJI: J649.024G,cpd:C01001; cpd:C08748; cpd:C11047,35,44,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H45O16,C35H43O16,720.2629353,721.2707604,719.25511034821,5263,cpd:C08797,Cucurbitacin E,C32H44O8,Cucurbitacin E,R08378,Biosynthesis of terpenoids and steroids,NA,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0101 Cholesterol and derivatives;     C08797  Cucurbitacin E; Phytochemical compounds [BR:br08003];  Terpenoids;   Triterpenoids (C30);    Cucurbitanes;     C08797  Cucurbitacin E,CAS: 18444-66-1; PubChem: 10990; ChEBI: 3944; ChEMBL: CHEMBL455056; LIPIDMAPS: LMST01010107; LipidBank: SST0177; KNApSAcK: C00003686; 3DMET: B02418; NIKKAJI: J14.209C,cpd:C08694; cpd:C08797,32,44,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H45O8,C32H43O8,556.3036184,557.3114434,555.29579334822,5264,cpd:C09189,Stevioside,C38H60O18,Stevioside,R08401,Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Kaurenes;     C09189  Stevioside,CAS: 57817-89-7; PubChem: 11381; ChEBI: 9271; ChEMBL: CHEMBL444122; KNApSAcK: C00003485; 3DMET: B02755; NIKKAJI: J27.441K,cpd:C09189,38,60,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C38H61O18,C38H59O18,804.3779651,805.3857901,803.37014014823,5265,cpd:C09621,(-)-alpha-Bisabolol;,C15H26O,(-)-alpha-Bisabolol; Levomenol,NA,Biosynthesis of terpenoids and steroids; Metabolic pathways,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010306 Bisabolane sesquiterpenoids;      C09621  (-)-alpha-Bisabolol; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Bisabolanes;     C09621  (-)-alpha-Bisabolol; Major components of natural products [BR:br08323];  Medicinal herbs;   German chamomile;    C09621  (-)-alpha-Bisabolol,CAS: 23089-26-1; PubChem: 11811; ChEBI: 125; ChEMBL: CHEMBL1096927 CHEMBL491186; LIPIDMAPS: LMPR0103060001; KNApSAcK: C00003103 C00011607; 3DMET: B03136; NIKKAJI: J38.588C,cpd:C01126; cpd:C03220; cpd:C09621; cpd:C09628; cpd:C09631; cpd:C09651; cpd:C09663; cpd:C09664; cpd:C09676; cpd:C09682; cpd:C09698; cpd:C09704; cpd:C09705; cpd:C10771; cpd:C10780; cpd:C16143; cpd:C16813; cpd:C16970; cpd:C17124; cpd:C17193; cpd:C18245; cpd:C19743; cpd:C19744; cpd:C19746; cpd:C19755; cpd:C19756; cpd:C19893; cpd:C19974; cpd:C20172; cpd:C20181; cpd:C20184; cpd:C20479; cpd:C20576,15,26,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O1,C15H25O1,222.1983655,223.2061905,221.19054044824,5266,cpd:C09839,Car-3-ene;,C10H16,Car-3-ene; (-)-3-Carene,R08395,Biosynthesis of terpenoids and steroids; Biosynthesis of secondary metabolites,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C09839  Car-3-ene; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C09839  (-)-3-Carene,CAS: 13466-78-9 20296-50-8; PubChem: 12026; ChEBI: 3381; LIPIDMAPS: LMPR0102120015; KNApSAcK: C00000839 C00011045; PDB-CCD: 3V4; 3DMET: B03313; NIKKAJI: J8.118C,cpd:C00002; cpd:C00044; cpd:C00120; cpd:C00131; cpd:C00284; cpd:C00286; cpd:C00363; cpd:C00521; cpd:C00591; cpd:C00808; cpd:C00809; cpd:C00848; cpd:C00884; cpd:C00964; cpd:C01123; cpd:C01262; cpd:C01425; cpd:C01499; cpd:C01806; cpd:C01843; cpd:C01889; cpd:C02073; cpd:C02108; cpd:C02173; cpd:C02213; cpd:C02320; cpd:C02452; cpd:C02759; cpd:C02863; cpd:C02967; cpd:C03110; cpd:C03448; cpd:C03495; cpd:C03614; cpd:C03843; cpd:C03933; cpd:C03997; cpd:C04138; cpd:C04155; cpd:C04312; cpd:C04381; cpd:C04435; cpd:C04718; cpd:C05282; cpd:C06066; cpd:C06069; cpd:C06074; cpd:C06075; cpd:C06076; cpd:C06078; cpd:C06099; cpd:C06304; cpd:C06305; cpd:C06306; cpd:C06307; cpd:C06308; cpd:C06605; cpd:C06952; cpd:C06969; cpd:C06976; cpd:C07271; cpd:C07362; cpd:C07827; cpd:C08437; cpd:C08489; cpd:C08498; cpd:C08546; cpd:C09785; cpd:C09786; cpd:C09804; cpd:C09836; cpd:C09839; cpd:C09842; cpd:C09847; cpd:C09854; cpd:C09859; cpd:C09873; cpd:C09875; cpd:C09877; cpd:C09880; cpd:C09882; cpd:C09885; cpd:C09893; cpd:C09898; cpd:C09900; cpd:C09906; cpd:C11120; cpd:C11382; cpd:C11387; cpd:C11391; cpd:C11392; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11402; cpd:C11403; cpd:C11405; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11414; cpd:C11415; cpd:C11418; cpd:C11419; cpd:C11478; cpd:C11651; cpd:C11937; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11943; cpd:C11944; cpd:C11951; cpd:C13311; cpd:C13733; cpd:C13742; cpd:C15563; cpd:C16461; cpd:C16690; cpd:C16691; cpd:C16777; cpd:C17623; cpd:C18018; cpd:C18019; cpd:C18369; cpd:C18658; cpd:C18813; cpd:C19079; cpd:C19081; cpd:C19083; cpd:C19084; cpd:C19112; cpd:C19731; cpd:C19818; cpd:C19967; cpd:C19969; cpd:C20221; cpd:C20222; cpd:C20223; cpd:C20230; cpd:C20241; cpd:C20242; cpd:C20244; cpd:C20260; cpd:C20322; cpd:C20323; cpd:C20324; cpd:C20386; cpd:C20387; cpd:C20425; cpd:C20818; cpd:C20825; cpd:C20859; cpd:C20912; cpd:C20943; cpd:C20949; cpd:C21012; cpd:C21031; cpd:C21310,10,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17,C10H15,136.1252005,137.1330255,135.11737554825,5267,cpd:C11356,"trans,trans,cis-Geranylgeranyl diphosphate;",C20H36O7P2,"trans,trans,cis-Geranylgeranyl diphosphate; trans,trans,cis-Geranylgeranyl pyrophosphate; Geranylneryl diphosphate; 2-cis,6-trans,10-trans-Geranylgeranyl diphosphate",R05555 R08748,Biosynthesis of terpenoids and steroids,2.5.1.-,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010401 Acyclic diterpenoids;      C11356  trans,trans,cis-Geranylgeranyl diphosphate; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Linear diterpenes;     C11356  trans,trans,cis-Geranylgeranyl diphosphate",PubChem: 13531; ChEBI: 10698; ChEMBL: CHEMBL1160061; LIPIDMAPS: LMPR0104010003; LipidBank: IIP0007; 3DMET: B04224; NIKKAJI: J1.283.779H,cpd:C00353; cpd:C05859; cpd:C06089; cpd:C11356; cpd:C11901; cpd:C11902; cpd:C19815; cpd:C19836,20,36,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H37O7P2,C20H35O7P2,450.1936275,451.2014525,449.18580254826,5268,cpd:C01897,Camptothecin,C20H16N2O4,Camptothecin,R08490,Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites; Antineoplastics - agents from natural products,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Quinoline alkaloids;     C01897  Camptothecin,CAS: 7689-03-4; PubChem: 5009; ChEBI: 27656; ChEMBL: CHEMBL65; KNApSAcK: C00002145; PDB-CCD: EHD; 3DMET: B01513; NIKKAJI: J2.266G,cpd:C01897,20,16,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H17O4N2,C20H15O4N2,348.111007,349.118832,347.1031824827,5269,cpd:C06332,N-Acetylanthranilate;,C9H9NO3,N-Acetylanthranilate; 2-(Acetylamino)-benzoic acid; N-Acetylanthranilic acid,R05155 R05720 R08478,Biosynthesis of alkaloids derived from shikimate pathway,1.13.11.48,NA,NA,CAS: 89-52-1; PubChem: 8568; ChEBI: 16803 36555; PDB-CCD: ZZ8; 3DMET: B00939; NIKKAJI: J60.455K,cpd:C01060; cpd:C01586; cpd:C03224; cpd:C03347; cpd:C06332; cpd:C06339; cpd:C11449; cpd:C17080; cpd:C17099; cpd:C19569; cpd:C21453,9,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H10O3N1,C9H8O3N1,179.0582432,180.0660682,178.05041814828,5270,cpd:C06522,Strychnine,C21H22N2O2,Strychnine,R08495,Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C06522  Strychnine; Pesticides [BR:br08007];  Pesticides;   Rodenticides;    Others;     C06522  Strychnine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Indole alkaloids;     C06522  Strychnine; Target-based classification of compounds [BR:br08010];  Ion channels;   Cys-loop superfamily;    Glycine;     glycine receptor alpha-1;      C06522  Strychnine; Risk category of Japanese OTC drugs [BR:br08312];  First-class OTC drugs;   Inorganic and organic chemicals;    Strychnine;     C06522  Strychnine; Major components of natural products [BR:br08323];  Crude drugs;   Nux vomica;    C06522  Strychnine;   Nux vomica tincture;    C06522  Strychnine;   Nux vomica extract;    C06522  Strychnine,CAS: 57-24-9; PubChem: 8753; ChEBI: 28973; ChEMBL: CHEMBL1446958 CHEMBL227934 CHEMBL33495; KNApSAcK: C00001770 C00025213; PDB-CCD: SY9; 3DMET: B02048; NIKKAJI: J4.576D,cpd:C06522; cpd:C11807,21,22,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H23O2N2,C21H21O2N2,334.168128,335.175953,333.16030294829,5271,cpd:C06526,Quinine;,C20H24N2O2,Quinine; (-)-Quinine,R05727 R08562,Biosynthesis of alkaloids derived from shikimate pathway; Taste transduction; Bile secretion,1.14.13.67,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS;   P01 ANTIPROTOZOALS;    P01B ANTIMALARIALS;     P01BC Methanolquinolines;      P01BC01 Quinine;       D08460  Quinine (BAN); USP drug classification [BR:br08302];  Antiparasitics;   Antiprotozoals;    Quinine;     D08460  Quinine (BAN); Antiinfectives [BR:br08307];  Antiparasitics;   Antmalarials;    Others;     Methanolquinolines;      Quinine;       D08460  Quinine (BAN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Quinine;     D08460  Quinine (BAN);   CYP3A5;    Quinine;     D08460  Quinine (BAN);   CYP3A7;    Quinine;     D08460  Quinine (BAN);  Transporter inhibitors;   SLC22A1;    Quinine;     D08460  Quinine (BAN);  Transporter substrates;   SLC22A1;    Quinine;     D08460  Quinine (BAN);   SLC22A2;    Quinine;     D08460  Quinine (BAN); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tryptophan and anthranillic acid;    Quinoline alkaloids;     D08460  Quinine (BAN)",CAS: 130-95-0; PubChem: 8757; ChEBI: 15854; ChEMBL: CHEMBL170 CHEMBL387326 CHEMBL522505; KNApSAcK: C00002193; PDB-CCD: QI9; 3DMET: B02051; NIKKAJI: J5.555G,cpd:C06526; cpd:C06527; cpd:C09021; cpd:C12259; cpd:C19432,20,24,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O2N2,C20H23O2N2,324.183778,325.1916031,323.1759534830,5272,cpd:C06527,Quinidine;,C20H24N2O2,Quinidine; (+)-Quinidine,R08494,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Quinoline alkaloids;     C06527  Quinidine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01B ANTIARRHYTHMICS, CLASS I AND III;     C01BA Antiarrhythmics, class Ia;      C01BA01 Quinidine;       D08458  Quinidine (BAN); USP drug classification [BR:br08302];  Cardiovascular Agents;   Antiarrhythmics;    Quinidine;     D08458  Quinidine (BAN); Target-based classification of drugs [BR:br08310];  Ion channels;   Voltage-gated cation channels;    Na+ channel, SCN alpha, NaV1.x;     voltage-gated sodium channel (SCN1A);      Quinidine;       D08458  Quinidine (BAN);     voltage-gated sodium channel (SCN2A);      Quinidine;       D08458  Quinidine (BAN);     voltage-gated sodium channel (SCN3A);      Quinidine;       D08458  Quinidine (BAN);     voltage-gated sodium channel (SCN4A);      Quinidine;       D08458  Quinidine (BAN);     voltage-gated sodium channel (SCN5A);      Quinidine;       D08458  Quinidine (BAN);     voltage-gated sodium channel (SCN8A);      Quinidine;       D08458  Quinidine (BAN);     voltage-gated sodium channel (SCN9A);      Quinidine;       D08458  Quinidine (BAN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2D6;    Quinidine;     D08458  Quinidine (BAN);  CYP substrates;   CYP3A4;    Quinidine;     D08458  Quinidine (BAN);   CYP3A;    Quinidine;     D08458  Quinidine (BAN);  Transporter inhibitors;   ABCB1;    Quinidine;     D08458  Quinidine (BAN);   SLC22A1;    Quinidine;     D08458  Quinidine (BAN);   SLC22A2;    Quinidine;     D08458  Quinidine (BAN);   MATE1;    Quinidine;     D08458  Quinidine (BAN);   MATE2;    Quinidine;     D08458  Quinidine (BAN);  Transporter substrates;   ABCB1;    Quinidine;     D08458  Quinidine (BAN);   SLC22A1;    Quinidine;     D08458  Quinidine (BAN);   SLC22A3;    Quinidine;     D08458  Quinidine (BAN); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tryptophan and anthranillic acid;    Quinoline alkaloids;     D08458  Quinidine (BAN)",CAS: 56-54-2; PubChem: 8758; ChEBI: 28593; ChEMBL: CHEMBL1294 CHEMBL1358565 CHEMBL21578; KNApSAcK: C00031117; PDB-CCD: QDN; 3DMET: B02052; NIKKAJI: J4.570E,cpd:C06526; cpd:C06527; cpd:C09021; cpd:C12259; cpd:C19432,20,24,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O2N2,C20H23O2N2,324.183778,325.1916031,323.1759534831,5273,cpd:C06528,Cinchonine;,C19H22N2O,Cinchonine; (9S)-Cinchonan-9-ol,R08492,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Quinoline alkaloids;     C06528  Cinchonine,CAS: 118-10-5; PubChem: 8759; ChEBI: 27509; ChEMBL: CHEMBL588619; 3DMET: B02053; NIKKAJI: J2.475I,cpd:C06528; cpd:C09149; cpd:C11379; cpd:C11635; cpd:C16735,19,22,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O1N2,C19H21O1N2,294.1732133,295.1810384,293.16538834832,5274,cpd:C06535,Physostigmine;,C15H21N3O2,Physostigmine; Eserine,R08481,Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Pyrroloindole alkaloids;     C06535  Physostigmine; Target-based classification of compounds [BR:br08010];  Enzymes;   Hydrolases;    ACHE; acetylcholinesterase;     C06535  Physostigmine;    BCHE; cholinesterase;     C06535  Physostigmine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS;     S01EB Parasympathomimetics;      S01EB05 Physostigmine;       D00196  Physostigmine (USP);  V VARIOUS;   V03 ALL OTHER THERAPEUTIC PRODUCTS;    V03A ALL OTHER THERAPEUTIC PRODUCTS;     V03AB Antidotes;      V03AB19 Physostigmine;       D00196  Physostigmine (USP); Target-based classification of drugs [BR:br08310];  Enzymes;   Hydrolases;    acetylcholinesterase (AChE);     Physostigmine;      D00196  Physostigmine (USP); Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from tryptophan and anthranillic acid;    Pyrroloindole alkaloids;     D00196  Physostigmine (USP),CAS: 57-47-6; PubChem: 8765; ChEBI: 27953; ChEMBL: CHEMBL94; KNApSAcK: C00001757; 3DMET: B02058; NIKKAJI: J4.579I,cpd:C06535,15,21,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H22O2N3,C15H20O2N3,275.1633769,276.171202,274.15555194833,5275,cpd:C06536,Harmaline,C13H14N2O,Harmaline,R08484 R08485 R08486,Biosynthesis of alkaloids derived from shikimate pathway,1.3.-.-; 1.5.-.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C06536  Harmaline; Target-based classification of compounds [BR:br08010];  Enzymes;   Oxidoreductases;    monoamine oxidase A (MAO-A);     C06536  Harmaline,CAS: 304-21-2; PubChem: 8766; ChEBI: 28172; ChEMBL: CHEMBL340807; KNApSAcK: C00001735; 3DMET: B02059; NIKKAJI: J11.607F,cpd:C06536,13,14,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H15O1N2,C13H13O1N2,214.1106131,215.1184381,213.1027884834,5276,cpd:C06538,Harmine,C13H12N2O,Harmine,R08485,Biosynthesis of alkaloids derived from shikimate pathway,1.3.-.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C06538  Harmine,CAS: 442-51-3; PubChem: 8768; ChEBI: 28121; ChEMBL: CHEMBL269538; KNApSAcK: C00001737; PDB-CCD: HRM; 3DMET: B02061; NIKKAJI: J11.378F,cpd:C06538,13,12,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H13O1N2,C13H11O1N2,212.094963,213.102788,211.0871384835,5277,cpd:C06546,Mescaline,C11H17NO3,Mescaline,R08444,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Tyramine derivatives;     C06546  Mescaline,CAS: 54-04-6; PubChem: 8776; ChEBI: 28346; ChEMBL: CHEMBL26687; KNApSAcK: C00001419; 3DMET: B02067; NIKKAJI: J4.150E,cpd:C06546; cpd:C07056; cpd:C07144; cpd:C07513; cpd:C11703,11,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H18O3N1,C11H16O3N1,211.1208434,212.1286684,210.11301844836,5278,cpd:C07544,Ergotamine,C33H35N5O5,Ergotamine,NA,Biosynthesis of alkaloids derived from shikimate pathway; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C07544  Ergotamine; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Ergot alkaloids;     C07544  Ergotamine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  G GENITO URINARY SYSTEM AND SEX HORMONES;   G02 OTHER GYNECOLOGICALS;    G02A UTEROTONICS;     G02AB Ergot alkaloids;      G02AB02 Ergot alkaloids;       D07906  Ergotamine (INN);  N NERVOUS SYSTEM;   N02 ANALGESICS;    N02C ANTIMIGRAINE PREPARATIONS;     N02CA Ergot alkaloids;      N02CA02 Ergotamine;       D07906  Ergotamine (INN); USP drug classification [BR:br08302];  Antimigraine Agents;   Ergot Alkaloids;    Ergotamine;     D07906  Ergotamine (INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adrenaline;     alpha1-adrenergic receptor;      Ergotamine;       D07906  Ergotamine (INN);      Ergot alkaloids;       D07906  Ergotamine (INN);    Dopamine;     dopamine D2-receptor;      Ergotamine;       D07906  Ergotamine (INN);      Ergot alkaloids;       D07906  Ergotamine (INN);    Serotonin;     5-HT1A-receptor;      Ergotamine;       D07906  Ergotamine (INN);      Ergot alkaloids;       D07906  Ergotamine (INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP3A;    Ergotamine;     D07906  Ergotamine (INN);  CYP substrates;   CYP3A4;    Ergotamine;     D07906  Ergotamine (INN);   CYP3A;    Ergotamine;     D07906  Ergotamine (INN),CAS: 113-15-5; PubChem: 9747; ChEBI: 64318; ChEMBL: CHEMBL442; KNApSAcK: C00001724; PDB-CCD: ERM; 3DMET: B05247; NIKKAJI: J2.889D,cpd:C07544,33,35,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H36O5N5,C33H34O5N5,581.2638192,582.2716443,580.25599424837,5279,cpd:C07547,Tubocurarine,C37H41N2O6,Tubocurarine,R08458,Biosynthesis of alkaloids derived from shikimate pathway; Nicotinic cholinergic receptor antagonists,NA,NA,"Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C07547  Tubocurarine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Isoquinoline alkaloids;     C07547  Tubocurarine; Target-based classification of compounds [BR:br08010];  Ion channels;   Cys-loop superfamily;    Acetylcholine (nicotinic);     nicotinic cholinergic receptor;      C07547  Tubocurarine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  M MUSCULO-SKELETAL SYSTEM;   M03 MUSCLE RELAXANTS;    M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS;     M03AA Curare alkaloids;      M03AA02 Tubocurarine;       C07547  Tubocurarine; Major components of natural products [BR:br08323];  Crude drugs;   Curare;    C07547  Tubocurarine",CAS: 57-95-4; PubChem: 9750; ChEBI: 9774; ChEMBL: CHEMBL339427; KNApSAcK: C00001927; PDB-CCD: TC9; 3DMET: B02127; NIKKAJI: J193.260H,cpd:C07547; cpd:C09580,37,41,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H42O6N2,C37H40O6N2,609.296462,610.3042871,608.2886374838,5280,cpd:C07576,Psilocybin;,C12H17N2O4P,Psilocybin; Psilocybine,R08480,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mushroom toxins;    Alkaloids;     C07576  Psilocybin,CAS: 520-52-5; PubChem: 9779; ChEBI: 8614; ChEMBL: CHEMBL194378; NIKKAJI: J6.604D,cpd:C07576,12,17,4,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H18O4N2P1,C12H16O4N2P1,284.092594,285.1004191,283.0847694839,5281,cpd:C08312,Psilocin,C12H16N2O,Psilocin,R08479 R08480,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mushroom toxins;    Alkaloids;     C08312  Psilocin,CAS: 520-53-6; PubChem: 10510; ChEBI: 8613; ChEMBL: CHEMBL65547; KNApSAcK: C00001427; NIKKAJI: J12.982H,cpd:C08299; cpd:C08312; cpd:C10760; cpd:C11188,12,16,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H17O1N2,C12H15O1N2,204.1262631,205.1340882,203.11843814840,5282,cpd:C09089,Calligonine;,C12H14N2,Calligonine; Elaeagnine; Tetrahydroharman,R08483,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,NA,CAS: 525-40-6; PubChem: 11281; ChEBI: 3323; KNApSAcK: C00001699; 3DMET: B02674; NIKKAJI: J144.137J,cpd:C00225; cpd:C00978; cpd:C02983; cpd:C07371; cpd:C08506; cpd:C09089; cpd:C14701; cpd:C16831; cpd:C18969; cpd:C19038; cpd:C19119; cpd:C20130,12,14,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H15N2,C12H13N2,186.1156985,187.1235235,185.10787344841,5283,cpd:C09209,Harman,C12H10N2,Harman,R08482,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C09209  Harman,CAS: 486-84-0; PubChem: 11400; ChEBI: 5623; ChEMBL: CHEMBL12014; KNApSAcK: C00001736; 3DMET: B02769; NIKKAJI: J1.550D,cpd:C08052; cpd:C09209; cpd:C11122; cpd:C14742; cpd:C15042; cpd:C19225; cpd:C19226; cpd:C19334; cpd:C19433; cpd:C19479; cpd:C20938; cpd:C21475,12,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11N2,C12H9N2,182.0843983,183.0922234,181.07657334842,5284,cpd:C09243,Tetrahydroharmine,C13H16N2O,Tetrahydroharmine,R08486,Biosynthesis of alkaloids derived from shikimate pathway,1.5.-.-,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Indole alkaloids;     C09243  Tetrahydroharmine,CAS: 17019-01-1; PubChem: 11434; ChEBI: 9485; KNApSAcK: C00001774; 3DMET: B02795; NIKKAJI: J512.276G,cpd:C09243; cpd:C10148,13,16,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H17O1N2,C13H15O1N2,216.1262631,217.1340882,215.11843814843,5285,cpd:C09541,(S)-Isoboldine;,C19H21NO4,"(S)-Isoboldine; (+)-Isoboldine; Isoboldine; 2,10-Dimethoxy-6aalpha-aporphine-1,9-diol",R08460,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C09541  (S)-Isoboldine,CAS: 3019-51-0; PubChem: 11732; ChEBI: 5986; ChEMBL: CHEMBL462880; KNApSAcK: C00001869; 3DMET: B03063; NIKKAJI: J14.552A,cpd:C02106; cpd:C05179; cpd:C07252; cpd:C09365; cpd:C09366; cpd:C09400; cpd:C09410; cpd:C09541; cpd:C11778; cpd:C11781; cpd:C12326; cpd:C17591,19,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H22O4N1,C19H20O4N1,327.1470582,328.1548832,326.13923314844,5286,cpd:C09642,(-)-Salsolinol;,C10H13NO2,"(-)-Salsolinol; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-methyl-, (S)-; Salsolinol",R08443,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C09642  (-)-Salsolinol,CAS: 27740-96-1; PubChem: 11832; ChEBI: 113; ChEMBL: CHEMBL1195032; KNApSAcK: C00001915; 3DMET: B03155; NIKKAJI: J21.391H,cpd:C07591; cpd:C09642; cpd:C10146; cpd:C14579; cpd:C17235; cpd:C18771; cpd:C18887; cpd:C20895,10,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O2N1,C10H12O2N1,179.0946287,180.1024537,178.08680364845,5287,cpd:C09654,(+)-Tetrandrine;,C38H42N2O6,(+)-Tetrandrine; Tetrandrine,R08459,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C09654  (+)-Tetrandrine,CAS: 518-34-3; PubChem: 11844; ChEBI: 49; ChEMBL: CHEMBL176045 CHEMBL504958; KNApSAcK: C00001919 C00025278; 3DMET: B03167; NIKKAJI: J130.138A,cpd:C09590; cpd:C09596; cpd:C09624; cpd:C09654; cpd:C17060; cpd:C17387,38,42,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C38H43O6N2,C38H41O6N2,622.3042871,623.3121121,621.2964624846,5288,cpd:C10660,Dictamnine,C12H9NO2,Dictamnine,R08475 R08476,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Quinoline alkaloids;     C10660  Dictamnine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Others;     C10660  Dictamnine,CAS: 484-29-7; PubChem: 12843; ChEBI: 4512; ChEMBL: CHEMBL22533; KNApSAcK: C00002151; 3DMET: B04037; NIKKAJI: J5.995A,cpd:C05720; cpd:C10660; cpd:C10697; cpd:C19269; cpd:C19473,12,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H10O2N1,C12H8O2N1,199.0633285,200.0711536,198.05550354847,5289,cpd:C10733,Peganine;,C11H12N2O,Peganine; Vasicine,R08477 R08478,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Quinazoline alkaloids;     C10733  Peganine,CAS: 6159-55-3; PubChem: 12916; ChEBI: 7949; ChEMBL: CHEMBL1456364; KNApSAcK: C00002191 C00026252; 3DMET: B04101; NIKKAJI: J8.351H,cpd:C10733; cpd:C13244,11,12,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O1N2,C11H11O1N2,188.094963,189.102788,187.0871384848,5290,cpd:C10740,Skimmianine,C14H13NO4,Skimmianine,R08476,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Quinoline alkaloids;     C10740  Skimmianine,CAS: 83-95-4; PubChem: 12923; ChEBI: 9172; ChEMBL: CHEMBL21396; KNApSAcK: C00002198; 3DMET: B04106; NIKKAJI: J4.887I,cpd:C10701; cpd:C10716; cpd:C10740,14,13,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H14O4N1,C14H12O4N1,259.0844579,260.0922829,258.07663294849,5291,cpd:C11379,Cinchonidine;,C19H22N2O,"Cinchonidine; (8alpha,9R)-Cinchonan-9-ol",R08561 R08563,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tryptophan and anthranilic acid;    Quinoline alkaloids;     C11379  Cinchonidine,CAS: 485-71-2; PubChem: 13553; ChEBI: 3703; ChEMBL: CHEMBL1213554 CHEMBL533841; KNApSAcK: C00002147; 3DMET: B05521; NIKKAJI: J6.003H,cpd:C06528; cpd:C09149; cpd:C11379; cpd:C11635; cpd:C16735,19,22,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O1N2,C19H21O1N2,294.1732133,295.1810384,293.16538834850,5292,cpd:C12231,Anhalamine;,C11H15NO3,Anhalamine; N-Demethylanhalidine,R08445,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,NA,PubChem: 14376; ChEBI: 31543; KNApSAcK: C00042228; NIKKAJI: J12.290D,cpd:C01458; cpd:C12231; cpd:C14262; cpd:C14334,11,15,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H16O3N1,C11H14O3N1,209.1051933,210.1130184,208.09736834851,5293,cpd:C16704,Anhalonidine,C12H17NO3,Anhalonidine,R08446 R08513,Biosynthesis of alkaloids derived from shikimate pathway,2.1.1.-,NA,NA,PubChem: 96023228; ChEBI: 80669; NIKKAJI: J82.131D,cpd:C12058; cpd:C13138; cpd:C16704,12,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H18O3N1,C12H16O3N1,223.1208434,224.1286684,222.11301844852,5294,cpd:C16705,Anhalonine;,C13H19NO3,Anhalonine; O-Methylanhalonidine,R08446,Biosynthesis of alkaloids derived from shikimate pathway,2.1.1.-,NA,NA,PubChem: 96023229; ChEBI: 80670; ChEMBL: CHEMBL1178706; NIKKAJI: J265.029K,cpd:C09445; cpd:C09604; cpd:C10278; cpd:C11085; cpd:C16705; cpd:C18394; cpd:C18989,13,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H20O3N1,C13H18O3N1,237.1364935,238.1443185,236.12866844853,5295,cpd:C16716,4-Hydroxy-2-quinolone;,C9H7NO2,"4-Hydroxy-2-quinolone; 4-Hydroxy-2(1H)-quinolone; 2,4-Dihydroxyquinoline",R08473 R08474 R10590,Biosynthesis of alkaloids derived from shikimate pathway,2.3.1.230,NA,NA,CAS: 86-95-3; PubChem: 96023240; ChEBI: 75926; ChEMBL: CHEMBL223449; KNApSAcK: C00026388; NIKKAJI: J3.897K,cpd:C05637; cpd:C05639; cpd:C06330; cpd:C06342; cpd:C11503; cpd:C16716; cpd:C19837,9,7,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H8O2N1,C9H6O2N1,161.0476785,162.0555035,160.03985344854,5296,cpd:C16721,Platydesmine,C15H17NO3,Platydesmine,R08474 R08475,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,NA,CAS: 2824-86-4; PubChem: 96023245; ChEBI: 80682; KNApSAcK: C00026361; NIKKAJI: J15.148C,cpd:C12253; cpd:C16701; cpd:C16721,15,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H18O3N1,C15H16O3N1,259.1208434,260.1286684,258.11301844855,5297,cpd:C16723,Pumiloside,C26H28N2O9,Pumiloside,R08488 R08489,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,NA,PubChem: 96023247; ChEBI: 80683; KNApSAcK: C00031110; NIKKAJI: J705.746F,cpd:C16723,26,28,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H29O9N2,C26H27O9N2,512.1794805,513.1873055,511.17165554856,5298,cpd:C16725,Deoxypumiloside,C26H28N2O8,Deoxypumiloside,R08489 R08490,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,NA,PubChem: 96023249; ChEBI: 80685; KNApSAcK: C00036264; NIKKAJI: J1.674.981H J705.747D,cpd:C16725,26,28,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H29O8N2,C26H27O8N2,496.1845659,497.1923909,495.17674084857,5299,cpd:C16726,Cinchoninone;,C19H20N2O,Cinchoninone; Cinchonan-9-one,R08491 R08492 R08560 R08561,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,NA,PubChem: 96023250; ChEBI: 80686; NIKKAJI: J2.804.734G,cpd:C11633; cpd:C11634; cpd:C16726; cpd:C16846,19,20,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H21O1N2,C19H19O1N2,292.1575633,293.1653883,291.14973824858,5300,cpd:C16727,Cinchonamine,C19H24N2O,Cinchonamine,R08498,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,NA,CAS: 482-28-0; PubChem: 96023251; ChEBI: 80687; ChEMBL: CHEMBL1590700; NIKKAJI: J9.865E,cpd:C07192; cpd:C09033; cpd:C09146; cpd:C10123; cpd:C16727,19,24,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H25O1N2,C19H23O1N2,296.1888634,297.1966884,295.18103844859,5301,cpd:C16728,Quinidinone,C20H22N2O2,Quinidinone,R08494 R08497 R08562,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,NA,CAS: 14528-53-1; PubChem: 96023252; ChEBI: 80688; NIKKAJI: J2.805.451C,cpd:C09025; cpd:C09207; cpd:C12072; cpd:C16728,20,22,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H23O2N2,C20H21O2N2,322.168128,323.175953,321.16030294860,5302,cpd:C16735,Corynantheal,C19H22N2O,Corynantheal,R08491 R08496 R08497 R08498 R08564,Biosynthesis of alkaloids derived from shikimate pathway,NA,NA,NA,PubChem: 96023259; ChEBI: 80695; NIKKAJI: J431.722J,cpd:C06528; cpd:C09149; cpd:C11379; cpd:C11635; cpd:C16735,19,22,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O1N2,C19H21O1N2,294.1732133,295.1810384,293.16538834861,5303,cpd:C02611,"(E,E)-Piperoyl-CoA",C33H44N7O19P3S,"(E,E)-Piperoyl-CoA",R03994,"Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid",2.3.1.145,NA,NA,PubChem: 5596; ChEBI: 15464; NIKKAJI: J2.739.243A,cpd:C02611,33,44,19,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C33H45O19N7P3S1,C33H43O19N7P3S1,967.1625544,968.1703794,966.15472944862,5304,cpd:C11359,(-)-Hygrine,C8H15NO,(-)-Hygrine,R08428,"Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid; Biosynthesis of secondary metabolites",NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from ornithine;    Pyrrolidine alkaloids;     C11359  (-)-Hygrine,CAS: 65941-22-2; PubChem: 13534; ChEBI: 92; KNApSAcK: C00002046; 3DMET: B04227; NIKKAJI: J918.167I,cpd:C00248; cpd:C00729; cpd:C02066; cpd:C06179; cpd:C06182; cpd:C10864; cpd:C11359; cpd:C12440,8,15,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H16O1N1,C8H14O1N1,141.1153641,142.1231891,140.10753914863,5305,cpd:C07474,Pilocarpine,C11H16N2O2,Pilocarpine,R08413,Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from histidine;    Imidazole alkaloids;     C07474  Pilocarpine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N07 OTHER NERVOUS SYSTEM DRUGS;    N07A PARASYMPATHOMIMETICS;     N07AX Other parasympathomimetics;      N07AX01 Pilocarpine;       D00525  Pilocarpine (JAN/USP);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS;     S01EB Parasympathomimetics;      S01EB01 Pilocarpine;       D00525  Pilocarpine (JAN/USP); USP drug classification [BR:br08302];  Dental and Oral Agents;   Pilocarpine;    D00525  Pilocarpine (JAN/USP);  Ophthalmic Agents;   Ophthalmic Antiglaucoma Agents;    Pilocarpine;     D00525  Pilocarpine (JAN/USP); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Acetylcholine (muscarinic);     muscarinic cholinergic receptor;      Pilocarpine;       D00525  Pilocarpine (JAN/USP); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2A6;    Pilocarpine;     D00525  Pilocarpine (JAN/USP); Major components of natural products [BR:br08323];  Crude drugs;   Jaborandi leaf;    C07474  Pilocarpine; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from histidine;    Imidazole alkaloids;     D00525  Pilocarpine (JAN/USP),CAS: 92-13-7; PubChem: 9677; ChEBI: 8207; ChEMBL: CHEMBL550; KNApSAcK: C00002355; PDB-CCD: 9PL; 3DMET: B02121; NIKKAJI: J9.328I,cpd:C07474; cpd:C11071; cpd:C18619,11,16,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H17O2N2,C11H15O2N2,208.1211778,209.1290028,207.11335274864,5306,cpd:C08262,3-Methylbutanoic acid;,C5H10O2,3-Methylbutanoic acid; Isovaleric acid; Isovalerate,R08411 R08412,Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of secondary metabolites; Protein digestion and absorption,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C08262  3-Methylbutanoic acid,CAS: 503-74-2; PubChem: 10461; ChEBI: 28484; ChEMBL: CHEMBL568737; LIPIDMAPS: LMFA01020181; LipidBank: DFA0226; KNApSAcK: C00001189 C00033067; PDB-CCD: IVA; 3DMET: B02153; NIKKAJI: J2.605K,cpd:C00803; cpd:C04022; cpd:C08262; cpd:C10140; cpd:C11196; cpd:C18319; cpd:C19199; cpd:C19409; cpd:C19511; cpd:C19780; cpd:C19783,5,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O2,C5H9O2,102.0680796,103.0759046,101.06025454865,5307,cpd:C16696,Dolichotheline,C10H17N3O,Dolichotheline,R08412,Biosynthesis of alkaloids derived from histidine and purine; Biosynthesis of secondary metabolites,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from histidine;    Imidazole alkaloids;     C16696  Dolichotheline,CAS: 23100-08-5; PubChem: 51091018; ChEBI: 80664; NIKKAJI: J16.769J,cpd:C16696,10,17,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O1N3,C10H16O1N3,195.1371622,196.1449872,194.12933714866,5308,cpd:C06525,Gentianine,C10H9NO2,Gentianine,NA,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,NA,CAS: 439-89-4; PubChem: 8756; ChEBI: 28981; KNApSAcK: C00001977; 3DMET: B02050; NIKKAJI: J11.377H,cpd:C00954; cpd:C01386; cpd:C02298; cpd:C03230; cpd:C05634; cpd:C06331; cpd:C06344; cpd:C06525; cpd:C11504; cpd:C18754,10,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H10O2N1,C10H8O2N1,175.0633285,176.0711536,174.05550354867,5309,cpd:C06543,Solanidine,C27H43NO,Solanidine,R08508,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0115 Solanidines and alkaloid derivatives;     C06543  Solanidine; Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Steroid alkaloids;     C06543  Solanidine,CAS: 80-78-4; PubChem: 8773; ChEBI: 28374; ChEMBL: CHEMBL1534747 CHEMBL1980466 CHEMBL363703; LIPIDMAPS: LMST01150007; LipidBank: SST0117; KNApSAcK: C00002261; 3DMET: B02066; NIKKAJI: J4.255B,cpd:C06543,27,43,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H44O1N1,C27H42O1N1,397.334465,398.34229,396.326644868,5310,cpd:C08660,Atisine,C22H33NO2,Atisine,NA,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Terpenoid alkaloids;     C08660  Atisine,CAS: 466-43-3; PubChem: 10853; ChEBI: 2909; KNApSAcK: C00001616; 3DMET: B05272; NIKKAJI: J12.048K,cpd:C06092; cpd:C08660; cpd:C08672; cpd:C08680; cpd:C08685; cpd:C10814; cpd:C20059,22,33,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H34O2N1,C22H32O2N1,343.2511293,344.2589543,342.24330434869,5311,cpd:C09782,Gentiopicrin;,C16H20O9,Gentiopicrin; Gentiopicroside,R08500,Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of secondary metabolites,NA,NA,"Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids;      C09782  Gentiopicrin; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Secoiridoids;     C09782  Gentiopicrin; Major components of natural products [BR:br08323];  Crude drugs;   Gentian;    C09782  Gentiopicrin;   Japanese gentian;    C09782  Gentiopicrin",CAS: 20831-76-9; PubChem: 11970; ChEBI: 5321; ChEMBL: CHEMBL508320; LIPIDMAPS: LMPR0102070009; KNApSAcK: C00003082; 3DMET: B03279; NIKKAJI: J40.726G,cpd:C05837; cpd:C09782; cpd:C17759,16,20,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H21O9,C16H19O9,356.1107322,357.1185573,355.10290724870,5312,cpd:C09910,Actinidine;,C10H13N,Actinidine; (-)-Actinidine,R08502,Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of secondary metabolites,NA,NA,NA,CAS: 524-03-8; PubChem: 12096; ChEBI: 2443; KNApSAcK: C00001961; 3DMET: B03372; NIKKAJI: J15.234J,cpd:C00826; cpd:C03404; cpd:C04201; cpd:C04351; cpd:C06746; cpd:C07194; cpd:C07591; cpd:C07921; cpd:C09642; cpd:C09910; cpd:C09946; cpd:C10146; cpd:C10588; cpd:C11107; cpd:C11487; cpd:C11820; cpd:C14579; cpd:C16586; cpd:C17235; cpd:C18622; cpd:C18771; cpd:C18887; cpd:C20800; cpd:C20801; cpd:C20895; cpd:C20911,10,13,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14N1,C10H12N1,147.1047994,148.1126245,146.09697444871,5313,cpd:C09943,Dendrobine,C16H25NO2,Dendrobine,NA,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,NA,CAS: 2115-91-5; PubChem: 12129; ChEBI: 4400; KNApSAcK: C00001970; 3DMET: B03400; NIKKAJI: J15.098C,cpd:C07153; cpd:C09851; cpd:C09864; cpd:C09943; cpd:C18949,16,25,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H26O2N1,C16H24O2N1,263.188529,264.1963541,262.1807044872,5314,cpd:C09945,Deoxynupharidine,C15H23NO,Deoxynupharidine,NA,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from lysine;    Quinolizidine alkaloids;     C09945  Deoxynupharidine,CAS: 1143-54-0; PubChem: 12131; ChEBI: 4427; ChEMBL: CHEMBL140758; KNApSAcK: C00001971; 3DMET: B03401; NIKKAJI: J14.022H,cpd:C09945; cpd:C14526; cpd:C18896,15,23,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H24O1N1,C15H22O1N1,233.1779644,234.1857894,232.17013934873,5315,cpd:C09987,beta-Skytanthine,C11H21N,beta-Skytanthine,R08501,Biosynthesis of alkaloids derived from terpenoid and polyketide; Biosynthesis of secondary metabolites,NA,NA,NA,CAS: 24282-31-3; PubChem: 12173; ChEBI: 10445; KNApSAcK: C00001982; 3DMET: B03435; NIKKAJI: J512.460C,cpd:C00958; cpd:C02862; cpd:C04301; cpd:C07511; cpd:C08405; cpd:C08407; cpd:C08408; cpd:C08411; cpd:C08412; cpd:C09987; cpd:C09989; cpd:C16594; cpd:C17244; cpd:C17256; cpd:C18780; cpd:C18830,11,21,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H22N1,C11H20N1,167.1673997,168.1752247,166.15957464874,5316,cpd:C09990,Thiobinupharidine,C30H42N2O2S,Thiobinupharidine,NA,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,NA,CAS: 30343-72-7; PubChem: 12176; ChEBI: 9548; ChEMBL: CHEMBL423545; KNApSAcK: C00001985; 3DMET: B03437; NIKKAJI: J34.260B,cpd:C09990,30,42,2,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C30H43O2N2S1,C30H41O2N2S1,494.2966998,495.3045248,493.28887474875,5317,cpd:C10165,Pinidine;,C9H17N,"Pinidine; Piperidine, 2-methyl-6-(1-propenyl)-, (2R-(2alpha,6alpha(E)))-; (-)-Pinidine",NA,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Acetate derived alkaloids;     C10165  Pinidine,CAS: 501-02-0; PubChem: 12351; ChEBI: 8217; KNApSAcK: C00002064; 3DMET: B03599; NIKKAJI: J12.240H J586.527A,cpd:C00864; cpd:C01092; cpd:C03539; cpd:C06184; cpd:C06469; cpd:C06470; cpd:C08413; cpd:C08507; cpd:C10165; cpd:C11086; cpd:C12029; cpd:C18893,9,17,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H18N1,C9H16N1,139.1360996,140.1439246,138.12827454876,5318,cpd:C10811,Jervine,C27H39NO3,Jervine,NA,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Steroid alkaloids;     C10811  Jervine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Steroid alkaloids;     C10811  Jervine,CAS: 469-59-0; PubChem: 12994; ChEBI: 6088; ChEMBL: CHEMBL1717145 CHEMBL186779; LipidBank: SST0249; KNApSAcK: C00002253; 3DMET: B04145; NIKKAJI: J5.926I,cpd:C10811,27,39,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H40O3N1,C27H38O3N1,425.2929941,426.3008192,424.28516914877,5319,cpd:C10820,Solanine;,C45H73NO15,Solanine; alpha-Solanin,NA,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Steroid alkaloids;     C10820  Solanine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Steroid alkaloids;     C10820  Solanine,CAS: 20562-02-1; PubChem: 13003; ChEBI: 9188; KNApSAcK: C00002262; 3DMET: B04154; NIKKAJI: J16.241H,cpd:C10819; cpd:C10820,45,73,15,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C45H74O15N1,C45H72O15N1,867.4980207,868.5058457,866.49019564878,5320,cpd:C10822,Solasodine,C27H43NO2,Solasodine,R08506,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0115 Solanidines and alkaloid derivatives;     C10822  Solasodine; Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Steroid alkaloids;     C10822  Solasodine,CAS: 126-17-0; PubChem: 13005; ChEBI: 9190; ChEMBL: CHEMBL518252; LipidBank: SST0119; KNApSAcK: C00002264; 3DMET: B04156; NIKKAJI: J59.535G,cpd:C10822,27,43,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H44O2N1,C27H42O2N1,413.3293796,414.3372047,412.32155464879,5321,cpd:C10824,Solasonine,C45H73NO16,Solasonine,NA,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Steroid alkaloids;     C10824  Solasonine,CAS: 19121-58-5; PubChem: 13007; ChEBI: 9191; ChEMBL: CHEMBL438956; KNApSAcK: C00002265; 3DMET: B04158; NIKKAJI: J13.552F,cpd:C10824,45,73,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C45H74O16N1,C45H72O16N1,883.4929353,884.5007603,882.48511024880,5322,cpd:C10826,Tomatidine,C27H45NO2,Tomatidine,R08507,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0115 Solanidines and alkaloid derivatives;     C10826  Tomatidine; Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Steroid alkaloids;     C10826  Tomatidine,CAS: 77-59-8; PubChem: 13009; ChEBI: 9629; ChEMBL: CHEMBL365417; KNApSAcK: C00002267; 3DMET: B04160; NIKKAJI: J512.483B,cpd:C10826,27,45,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H46O2N1,C27H44O2N1,415.3450297,416.3528547,414.33720474881,5323,cpd:C10827,Tomatine,C50H83NO21,Tomatine,NA,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0115 Solanidines and alkaloid derivatives;     C10827  Tomatine; Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Steroid alkaloids;     C10827  Tomatine,CAS: 17406-45-0; PubChem: 13010; ChEBI: 9630; ChEMBL: CHEMBL525778; LIPIDMAPS: LMST01150015; KNApSAcK: C00002268; 3DMET: B04161; NIKKAJI: J9.099I,cpd:C10827,50,83,21,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C50H84O21N1,C50H82O21N1,1033.545759,1034.553584,1032.5379344882,5324,cpd:C10829,Veratramine,C27H39NO2,Veratramine,NA,Biosynthesis of alkaloids derived from terpenoid and polyketide,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived by amination reactions;    Steroid alkaloids;     C10829  Veratramine; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Steroid alkaloids;     C10829  Veratramine,CAS: 60-70-8; PubChem: 13012; ChEBI: 9951; ChEMBL: CHEMBL464724; KNApSAcK: C00002270; 3DMET: B04163; NIKKAJI: J4.805D,cpd:C10829,27,39,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H40O2N1,C27H38O2N1,409.2980795,410.3059045,408.29025454883,5326,cpd:C02632,2-Methylpropanoate;,C4H8O2,2-Methylpropanoate; 2-Methylpropanoic acid; Isobutyric acid; Isobutanoate; Dimethylacetic acid; Isobutyrate,R04002 R05364,Microbial metabolism in diverse environments; Degradation of aromatic compounds; Protein digestion and absorption,2.7.2.14; 3.7.1.-,"Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate",NA,CAS: 79-31-2; PubChem: 5612; ChEBI: 16135; ChEMBL: CHEMBL108778; LIPIDMAPS: LMFA01020071; KNApSAcK: C00029462; PDB-CCD: ALQ; 3DMET: B00469; NIKKAJI: J3.840G,cpd:C00246; cpd:C00466; cpd:C00810; cpd:C00849; cpd:C01119; cpd:C01769; cpd:C02632; cpd:C04371; cpd:C06484; cpd:C08276; cpd:C14440; cpd:C16622; cpd:C19283; cpd:C19348; cpd:C19484; cpd:C21291,4,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H9O2,C4H7O2,88.0524295,89.06025453,87.044604464884,5327,cpd:C05343,(R)-4-Hydroxymandelate,C8H8O4,(R)-4-Hydroxymandelate,R04161,Microbial metabolism in diverse environments,5.1.2.2,NA,NA,PubChem: 7721; ChEBI: 27996 32803; NIKKAJI: J74.175B,cpd:C00544; cpd:C01161; cpd:C01839; cpd:C03198; cpd:C03235; cpd:C05343; cpd:C05577; cpd:C06207; cpd:C06672; cpd:C07087; cpd:C07763; cpd:C07767; cpd:C10331; cpd:C11527; cpd:C14109; cpd:C16215; cpd:C18346; cpd:C19272,8,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H9O4,C8H7O4,168.0422587,169.0500838,167.03443374885,5328,cpd:C12314,1-Oxa-2-oxo-3-hydroxycycloheptane,C6H10O3,1-Oxa-2-oxo-3-hydroxycycloheptane,R06622,Microbial metabolism in diverse environments,1.14.13.22,NA,NA,CAS: 80816-54-2; PubChem: 582705; ChEBI: 31046; NIKKAJI: J2.781.717C,cpd:C00233; cpd:C00671; cpd:C00902; cpd:C01012; cpd:C01109; cpd:C02122; cpd:C02129; cpd:C03241; cpd:C03465; cpd:C03467; cpd:C03500; cpd:C03625; cpd:C03895; cpd:C05535; cpd:C06008; cpd:C06102; cpd:C12314; cpd:C14530; cpd:C15606; cpd:C15653; cpd:C16432; cpd:C17211; cpd:C21378,6,10,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O3,C6H9O3,130.0629942,131.0708192,129.05516914886,5329,cpd:C00494,Sisomicin;,C19H37N5O7,Sisomicin; Antibiotic 6640; Dehydrogentamicin Cla; Rickamicin,NA,Biosynthesis of antibiotics,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01G AMINOGLYCOSIDE ANTIBACTERIALS;     J01GB Other aminoglycosides;      J01GB08 Sisomicin;       D02544  Sisomicin (USAN/INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Aminoglycosides;      Sisomicin;       D02544  Sisomicin (USAN/INN),CAS: 32385-11-8; PubChem: 3777; ChEBI: 9169; ChEMBL: CHEMBL221886; PDB-CCD: SIS; NIKKAJI: J342.544D,cpd:C00494; cpd:C01918; cpd:C11334,19,37,7,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H38O7N5,C19H36O7N5,447.2692986,448.2771236,446.26147354887,5330,cpd:C01854,Streptamine,C6H14N2O4,Streptamine,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 488-52-8; PubChem: 4971; ChEBI: 27955; NIKKAJI: J92.780E,cpd:C01854; cpd:C17574,6,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O4N2,C6H13O4N2,178.0953569,179.103182,177.08753194888,5331,cpd:C01925,Hygromycin B;,C20H37N3O13,Hygromycin B; Antibiotic A-396-II,R03770 R09729,Biosynthesis of antibiotics,2.7.1.119; 2.7.1.163,NA,NA,CAS: 31282-04-9; PubChem: 5031; ChEBI: 16976; PDB-CCD: HY0; NIKKAJI: J34.417F,cpd:C01688; cpd:C01925,20,37,13,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H38O13N3,C20H36O13N3,527.2326383,528.2404633,526.22481324889,5332,cpd:C02078,Spectinomycin,C14H24N2O7,Spectinomycin,NA,Biosynthesis of antibiotics,NA,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Aminoglycosides;    Actinamines;     C02078  Spectinomycin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01X OTHER ANTIBACTERIALS;     J01XX Other antibacterials;      J01XX04 Spectinomycin;       D08526  Spectinomycin (INN); Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Aminoglycosides;      Spectinomycin;       D08526  Spectinomycin (INN),CAS: 1695-77-8; PubChem: 5164; ChEBI: 9215; ChEMBL: CHEMBL1167; PDB-CCD: SCM; NIKKAJI: J7.562K,cpd:C02078; cpd:C11619,14,24,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H25O7N2,C14H23O7N2,332.1583511,333.1661762,331.15052614890,5333,cpd:C05551,Penicillin G;,C16H18N2O4S,Penicillin G; Benzylpenicillin,R04103 R04318 R04868,Biosynthesis of antibiotics; Bile secretion,2.3.1.164; 3.5.1.11; 3.5.2.6,NA,"Compounds with biological roles [BR:br08001];  Antibiotics;   beta-Lactams;    Penams;     C05551  Penicillin G; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS;     J01CE Beta-lactamase sensitive penicillins;      J01CE01 Benzylpenicillin;       D02336  Benzylpenicillin (INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AA Antibiotics;      S01AA14 Benzylpenicillin;       D02336  Benzylpenicillin (INN); USP drug classification [BR:br08302];  Antibacterials;   Beta-lactam, Penicillins;    Penicillin G;     D02336  Benzylpenicillin (INN); Antiinfectives [BR:br08307];  Antibacterials;   Cell wall biosynthesis inhibitor;    Penicillin binding proteins inhibitor;     Penam;      beta-Lactamase sensitive penicillin;       Benzylpenicillin;        D02336  Benzylpenicillin (INN); Cytochrome P450 interactions [BR:br08309];  Transporter inhibitors;   OAT1;    Benzylpenicillin;     D02336  Benzylpenicillin (INN);   OAT3;    Benzylpenicillin;     D02336  Benzylpenicillin (INN);  Transporter substrates;   OAT1;    Benzylpenicillin;     D02336  Benzylpenicillin (INN);   OAT3;    Benzylpenicillin;     D02336  Benzylpenicillin (INN)",CAS: 61-33-6; PubChem: 7885; ChEBI: 18208; ChEMBL: CHEMBL29; PDB-CCD: PNN; 3DMET: B01871; NIKKAJI: J2.342F,cpd:C05551,16,18,4,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C16H19O4N2S1,C16H17O4N2S1,334.0987282,335.1065533,333.09090324891,5334,cpd:C06668,Valclavam,C14H23N3O6,Valclavam,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 98359-78-5; PubChem: 8893; ChEBI: 9920,cpd:C06668,14,23,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H24O6N3,C14H22O6N3,329.1586855,330.1665105,328.15086044892,5335,cpd:C06681,Mitomycin;,C15H18N4O5,Mitomycin; Mitomycin C,NA,Biosynthesis of antibiotics,NA,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Others;    Quinones;     C06681  Mitomycin; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C06681  Mitomycin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;     L01DC Other cytotoxic antibiotics;      L01DC03 Mitomycin;       D00208  Mitomycin (USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    423  Antibiotics;     4231  Mytomycin C;      D00208  Mitomycin (USP/INN); Mitomycin C (JP17); Target-based classification of drugs [BR:br08310];  Others;   Nucleic acid;    DNA synthesis;     Mitomycin;      D00208  Mitomycin (USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00208  Mitomycin C;   D00208  Mitomycin C for injection; Antineoplastics [br08340.html];  D00208; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00208,CAS: 50-07-7; PubChem: 8906; ChEBI: 27504; ChEMBL: CHEMBL105; KNApSAcK: C00018668; 3DMET: B02086; NIKKAJI: J64.512E,cpd:C06681,15,18,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H19O5N4,C15H17O5N4,334.1277197,335.1355447,333.11989474893,5336,cpd:C06686,Griseofulvin,C17H17ClO6,Griseofulvin,NA,Biosynthesis of antibiotics,NA,NA,"Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Other polyketides;     C06686  Griseofulvin; Lipids [BR:br08002];  PK  Polyketides;   PK13 Aromatic polyketides;    PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones;     C06686  Griseofulvin; Pesticides [BR:br08007];  Obsolete pesticides;   Fungicides;    Antibiotic fungicides;     C06686  Griseofulvin; Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C06686  Griseofulvin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D01 ANTIFUNGALS FOR DERMATOLOGICAL USE;    D01A ANTIFUNGALS FOR TOPICAL USE;     D01AA Antibiotics;      D01AA08 Griseofulvin;       D00209  Griseofulvin (JAN/USP/INN);    D01B ANTIFUNGALS FOR SYSTEMIC USE;     D01BA Antifungals for systemic use;      D01BA01 Griseofulvin;       D00209  Griseofulvin (JAN/USP/INN); USP drug classification [BR:br08302];  Antifungals;   Griseofulvin;    D00209  Griseofulvin (JAN/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Griseofulvin;     D00209  Griseofulvin (JAN/USP/INN); Antifungals [br08352.html];  D00209",CAS: 126-07-8; PubChem: 8911; ChEBI: 27779; ChEMBL: CHEMBL562; LIPIDMAPS: LMPK13060001; KNApSAcK: C00002398; NIKKAJI: J4.418K,cpd:C06686,17,17,6,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C17H18O6Cl1,C17H16O6Cl1,352.0713659,353.079191,351.06354094894,5337,cpd:C06763,Nojirimycin;,C6H13NO5,Nojirimycin; 5-Amino-5-deoxy-D-glucopyranose,NA,Biosynthesis of antibiotics,NA,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Others;    Pure sugars;     C06763  Nojirimycin,CAS: 15218-38-9; PubChem: 8983; ChEBI: 28945; ChEMBL: CHEMBL120638; KNApSAcK: C00018724; 3DMET: B05229; NIKKAJI: J15.857G,cpd:C00329; cpd:C01214; cpd:C02262; cpd:C03570; cpd:C06763; cpd:C08349; cpd:C12212; cpd:C17578; cpd:C21035; cpd:C21038; cpd:C21048; cpd:C21051; cpd:C21060,6,13,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O5N1,C6H12O5N1,179.0793725,180.0871976,178.07154754895,5338,cpd:C07044,Hydroxyurea;,CH4N2O2,Hydroxyurea; Hydroxycarbamide,R10461 R10466,Biosynthesis of antibiotics,2.6.99.3; 3.5.3.25,"Cycloserine biosynthesis, arginine/serine => cycloserine",Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07044  Hydroxyurea; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01X OTHER ANTINEOPLASTIC AGENTS;     L01XX Other antineoplastic agents;      L01XX05 Hydroxycarbamide;       D00341  Hydroxyurea (USP); USP drug classification [BR:br08302];  Antineoplastics;   Antimetabolites;    Hydroxyurea;     D00341  Hydroxyurea (USP); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    422  Antimetabolites;     4229  Others;      D00341  Hydroxyurea (USP); Hydroxycarbamide (JAN/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Oxidoreductases;    ribonucleotide reductase M2;     Hydroxycarbamide;      D00341  Hydroxyurea (USP); Antineoplastics [br08340.html];  D00341; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00341; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00341,CAS: 127-07-1; PubChem: 9256; ChEBI: 44423; ChEMBL: CHEMBL467; PDB-CCD: NHY; NIKKAJI: J2.937H,cpd:C07044,1,4,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H5O2N2,C1H3O2N2,76.02727738,77.03510241,75.019452344896,5339,cpd:C08057,Cycloserine;,C3H6N2O2,Cycloserine; D-Cycloserine,R10470,Biosynthesis of antibiotics,6.3.3.5,"Cycloserine biosynthesis, arginine/serine => cycloserine",Lipids [BR:br08002];  PK  Polyketides;   PK14 Non-ribosomal peptide/polyketide hybrids;    C08057  Cycloserine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J04 ANTIMYCOBACTERIALS;    J04A DRUGS FOR TREATMENT OF TUBERCULOSIS;     J04AB Antibiotics;      J04AB01 Cycloserine;       D00877  Cycloserine (JP17/USP/INN); USP drug classification [BR:br08302];  Antimycobacterials;   Antituberculars;    Cycloserine;     D00877  Cycloserine (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  6  Agents against pathologic organisms and parasites;   61  Antibiotics;    616  Acting mainly on acid-fast bacteria;     6162  Cycloserines;      D00877  Cycloserine (JP17/USP/INN); Antiinfectives [BR:br08307];  Antibacterials;   Cell wall biosynthesis inhibitor;    Others;     alanine racemase inhibitor;      Cycloserine;       D00877  Cycloserine (JP17/USP/INN);     D-alanine-D-alanine ligase inhibitor;      Cycloserine;       D00877  Cycloserine (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00877  Cycloserine; Antibacterials [br08350.html];  D00877,CAS: 68-41-7; PubChem: 10257; ChEMBL: CHEMBL771; LIPIDMAPS: LMPK14000007; PDB-CCD: 4AX; 3DMET: B02142; NIKKAJI: J8.592H,cpd:C02718; cpd:C06682; cpd:C08057,3,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H7O2N2,C3H5O2N2,102.0429274,103.0507525,101.03510244897,5340,cpd:C12080,Resistomycin,C22H16O6,Resistomycin,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 20004-62-0; PubChem: 14231; ChEBI: 29671; ChEMBL: CHEMBL1320139; NIKKAJI: J14.238G,cpd:C12080,22,16,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H17O6,C22H15O6,376.0946882,377.1025133,375.08686324898,5341,cpd:C15680,Mycinamicin II;,C37H61NO13,Mycinamicin II; Mirosamicin,R10878,Biosynthesis of antibiotics,1.14.13.-,NA,Animal drugs in Japan [BR:br08331];  97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants);   976  Antibiotic preparations;    9761  Antibiotic preparations injection use;     C15680  Mirosamicin,CAS: 73684-69-2; PubChem: 47205006; ChEBI: 80018; KNApSAcK: C00018282; NIKKAJI: J134.049B,cpd:C15680,37,61,13,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H62O13N1,C37H60O13N1,727.414291,728.4221161,726.4064664899,5342,cpd:C15681,Mycinamicin III,C36H59NO11,Mycinamicin III,R09822 R09823,Biosynthesis of antibiotics,2.1.1.237; 2.1.1.238,NA,NA,CAS: 73684-70-5; PubChem: 47205007; ChEBI: 63207; KNApSAcK: C00018283; PDB-CCD: ZM3; NIKKAJI: J254.848H,cpd:C15681,36,59,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H60O11N1,C36H58O11N1,681.4088117,682.4166368,680.40098674900,5343,cpd:C15682,Mycinamicin VI,C35H57NO11,Mycinamicin VI,R09822 R10874,Biosynthesis of antibiotics,2.1.1.238; 2.4.1.-,NA,NA,PubChem: 47205008; ChEBI: 63285; KNApSAcK: C00018487; PDB-CCD: MVI; NIKKAJI: J254.851H,cpd:C15682,35,57,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H58O11N1,C35H56O11N1,667.3931617,668.4009867,666.38533664901,5344,cpd:C15683,Mycinamicin VII,C29H47NO7,Mycinamicin VII,R10874 R10875,Biosynthesis of antibiotics,1.14.13.-; 2.4.1.-,NA,NA,PubChem: 47205009; ChEBI: 80019; KNApSAcK: C00018488; NIKKAJI: J254.852F,cpd:C15683,29,47,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H48O7N1,C29H46O7N1,521.3352529,522.3430779,520.32742784902,5345,cpd:C15684,Mycinamicin VIII,C29H47NO6,Mycinamicin VIII,R10875 R10876,Biosynthesis of antibiotics,1.14.13.-; 2.4.1.-,NA,NA,PubChem: 47205010; ChEBI: 80020; KNApSAcK: C00017560; NIKKAJI: J2.795.750A,cpd:C15684,29,47,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H48O6N1,C29H46O6N1,505.3403382,506.3481633,504.33251324903,5346,cpd:C15685,Protomycinolide IV,C21H32O4,Protomycinolide IV,R10876,Biosynthesis of antibiotics,2.4.1.-,NA,NA,CAS: 79495-87-7; PubChem: 47205011; ChEBI: 80021; NIKKAJI: J923.967G,cpd:C05475; cpd:C05478; cpd:C05487; cpd:C14598; cpd:C15685,21,32,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H33O4,C21H31O4,348.2300595,349.2378845,347.22223454904,5347,cpd:C15824,Cephabacin F3;,C32H51N11O13S,Cephabacin F3; Cephabacin,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 47205149; ChEBI: 80109,cpd:C15824,32,51,13,11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C32H52O13N11S1,C32H50O13N11S1,829.3388519,830.346677,828.33102694905,5348,cpd:C16843,Deoxynojirimycin;,C6H13NO4,Deoxynojirimycin; Moranolin,NA,Biosynthesis of antibiotics,NA,NA,Target-based classification of drugs [BR:br08310];  Enzymes;   Hydrolases;    alpha-glucosidase;     Duvoglustat;      D09605  Duvoglustat (USAN/INN); Major components of natural products [BR:br08323];  Medicinal herbs;   Mulberry;    C16843  Deoxynojirimycin,CAS: 19130-96-2; PubChem: 96023367; ChEBI: 44369; ChEMBL: CHEMBL307429; KNApSAcK: C00029420; PDB-CCD: NOJ; NIKKAJI: J261.805B,cpd:C10141; cpd:C10143; cpd:C15478; cpd:C15479; cpd:C16843; cpd:C17580; cpd:C20311,6,13,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O4N1,C6H12O4N1,163.0844579,164.0922829,162.07663294906,5349,cpd:C17356,2-Formyloxymethylclavam,C7H9NO4,2-Formyloxymethylclavam,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96023709; ChEBI: 81025,cpd:C03972; cpd:C12108; cpd:C17356; cpd:C21249,7,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H10O4N1,C7H8O4N1,171.0531578,172.0609828,170.04533274907,5350,cpd:C17357,2-Hydroxymethylclavam,C6H9NO3,2-Hydroxymethylclavam,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 66036-39-3; PubChem: 96023710; ChEBI: 81026; ChEMBL: CHEMBL140225; NIKKAJI: J86.728D,cpd:C04515; cpd:C17357,6,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H10O3N1,C6H8O3N1,143.0582432,144.0660682,142.05041814908,5351,cpd:C17358,Clavam-2-carboxylate,C6H7NO4,Clavam-2-carboxylate,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96023711; ChEBI: 81027; NIKKAJI: J92.027D,cpd:C02220; cpd:C11327; cpd:C14293; cpd:C17358,6,7,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H8O4N1,C6H6O4N1,157.0375077,158.0453327,156.02968274909,5352,cpd:C17359,8-Hydroxyalanylclavam,C8H12N2O5,8-Hydroxyalanylclavam,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96023712; ChEBI: 81028; NIKKAJI: J2.806.283D,cpd:C17359,8,12,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O5N2,C8H11O5N2,216.0746215,217.0824465,215.06679654910,5353,cpd:C17360,Alanylclavam,C8H12N2O4,Alanylclavam,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96023713; ChEBI: 81029; KNApSAcK: C00018492; NIKKAJI: J82.045H,cpd:C02471; cpd:C02755; cpd:C06659; cpd:C17360,8,12,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O4N2,C8H11O4N2,200.0797069,201.0875319,199.07188184911,5354,cpd:C17361,2-Hydroxyethylclavam;,C7H11NO3,2-Hydroxyethylclavam; Hydroxyethylclavam,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 79416-52-7; PubChem: 96023714; ChEBI: 81030; NIKKAJI: J152.382A,cpd:C07411; cpd:C17361; cpd:C17724; cpd:C20828,7,11,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H12O3N1,C7H10O3N1,157.0738932,158.0817182,156.06606824912,5355,cpd:C17572,Bluensidine 6-phosphate,C8H17N4O9P,Bluensidine 6-phosphate,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96023917; ChEBI: 81192,cpd:C17572,8,17,9,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H18O9N4P1,C8H16O9N4P1,344.0733151,345.0811402,343.06549014913,5356,cpd:C17573,Bluensomycin,C21H39N5O14,Bluensomycin,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 11011-72-6; PubChem: 96023918; ChEBI: 81193; NIKKAJI: J78.084G,cpd:C17573,21,39,14,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H40O14N5,C21H38O14N5,585.249351,586.257176,584.24152594914,5357,cpd:C17574,2-epi-Streptamine,C6H14N2O4,2-epi-Streptamine,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96023919; ChEBI: 81194; NIKKAJI: J640.682C,cpd:C01854; cpd:C17574,6,14,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H15O4N2,C6H13O4N2,178.0953569,179.103182,177.08753194915,5358,cpd:C17575,Actinamine;,C8H18N2O4,Actinamine; Spectinamine,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96023920; ChEBI: 81195; NIKKAJI: J15.233A,cpd:C17575,8,18,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H19O4N2,C8H17O4N2,206.1266571,207.1344821,205.1188324916,5359,cpd:C17576,3-Keto-scyllo-inosamine,C6H11NO5,3-Keto-scyllo-inosamine,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96023921; ChEBI: 81196,cpd:C03168; cpd:C06034; cpd:C17576; cpd:C20844; cpd:C20845,6,11,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O5N1,C6H10O5N1,177.0637225,178.0715475,176.05589744917,5360,cpd:C17577,myo-Inosose-5,C6H10O6,myo-Inosose-5,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96023922; ChEBI: 81197,cpd:C00198; cpd:C00204; cpd:C00273; cpd:C00691; cpd:C01040; cpd:C01115; cpd:C01216; cpd:C02669; cpd:C02692; cpd:C02779; cpd:C03107; cpd:C03200; cpd:C03269; cpd:C03383; cpd:C03926; cpd:C05394; cpd:C05410; cpd:C06892; cpd:C07283; cpd:C16737; cpd:C16842; cpd:C17382; cpd:C17389; cpd:C17577; cpd:C19679; cpd:C20251; cpd:C20680; cpd:C20903,6,10,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O6,C6H9O6,178.047738,179.0555631,177.0399134918,5361,cpd:C17578,neo-Inosamine-2;,C6H13NO5,neo-Inosamine-2; 2L-2-Amino-2-deoxy-neo-inositol,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96023923; ChEBI: 81198; NIKKAJI: J2.807.355K,cpd:C00329; cpd:C01214; cpd:C02262; cpd:C03570; cpd:C06763; cpd:C08349; cpd:C12212; cpd:C17578; cpd:C21035; cpd:C21038; cpd:C21048; cpd:C21051; cpd:C21060,6,13,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H14O5N1,C6H12O5N1,179.0793725,180.0871976,178.07154754919,5362,cpd:C17579,Hygromycin A,C23H29NO12,Hygromycin A,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 6379-56-2; PubChem: 96023924; ChEBI: 69414; ChEMBL: CHEMBL267436; NIKKAJI: J152.079B,cpd:C17579,23,29,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H30O12N1,C23H28O12N1,511.1689754,512.1768004,510.16115034920,5363,cpd:C17708,Fortimicin A;,C17H35N5O6,Fortimicin A; Astromicin,NA,Biosynthesis of antibiotics,NA,NA,Antiinfectives [BR:br08307];  Antibacterials;   Protein biosynthesis inhibitor;    30S subunit inhibitor;     Aminoglycosides;      Astromicin;       D07470  Astromicin (INN),CAS: 55779-06-1; PubChem: 96024038; ChEBI: 37923; ChEMBL: CHEMBL115299; KNApSAcK: C00018137; NIKKAJI: J34.182G,cpd:C17708,17,35,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H36O6N5,C17H34O6N5,405.2587339,406.2665589,404.25090884921,5364,cpd:C17709,Fortimicin B,C15H32N4O5,Fortimicin B,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 54783-95-8; PubChem: 96024039; ChEBI: 81284; KNApSAcK: C00018138; NIKKAJI: J34.181I,cpd:C17709; cpd:C17976; cpd:C17977; cpd:C17978,15,32,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H33O5N4,C15H31O5N4,348.2372701,349.2450952,347.22944514922,5365,cpd:C17710,Sannamycin A;,C17H35N5O5,Sannamycin A; Istamycin A,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 72503-79-8; PubChem: 96024040; ChEBI: 81285; KNApSAcK: C00018248; NIKKAJI: J81.904B,cpd:C17710; cpd:C17991,17,35,5,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H36O5N5,C17H34O5N5,389.2638192,390.2716443,388.25599424923,5366,cpd:C17711,Sannamycin B;,C15H32N4O4,Sannamycin B; Istamycin A0,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 72503-80-1; PubChem: 96024041; ChEBI: 81286; KNApSAcK: C00018250; NIKKAJI: J122.674F,cpd:C17711; cpd:C17990,15,32,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H33O4N4,C15H31O4N4,332.2423555,333.2501806,331.23453054924,5367,cpd:C17967,Bluensidine,C8H16N4O6,Bluensidine,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024187; ChEBI: 81418; NIKKAJI: J92.783J,cpd:C17967,8,16,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O6N4,C8H15O6N4,264.1069843,265.1148093,263.09915924925,5368,cpd:C17968,Kasugamycin,C14H25N3O9,Kasugamycin,NA,Biosynthesis of antibiotics,NA,NA,Pesticides [BR:br08007];  Pesticides;   Fungicides;    Antibiotic fungicides;     C17968  Kasugamycin,CAS: 6980-18-3; PubChem: 96024188; ChEBI: 81419; ChEMBL: CHEMBL1631109; KNApSAcK: C00018722; PDB-CCD: KSG; NIKKAJI: J9.297E,cpd:C17968,14,25,9,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H26O9N3,C14H24O9N3,379.1590794,380.1669044,378.15125444926,5369,cpd:C17971,Fortimicin FU-10,C12H24N2O9,Fortimicin FU-10,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024191; ChEBI: 81422,cpd:C00734; cpd:C17971,12,24,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H25O9N2,C12H23O9N2,340.1481804,341.1560054,339.14035534927,5370,cpd:C17972,Fortimicin AO,C13H27N3O8,Fortimicin AO,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024192; ChEBI: 81423; NIKKAJI: J475.239B,cpd:C17972,13,27,8,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H28O8N3,C13H26O8N3,353.1798148,354.1876399,352.17198984928,5371,cpd:C17973,Fortimicin KL1,C13H28N4O7,Fortimicin KL1,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024193; ChEBI: 81424; NIKKAJI: J697.002H,cpd:C17973,13,28,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H29O7N4,C13H27O7N4,352.1957993,353.2036243,351.18797424929,5372,cpd:C17974,Fortimicin KK1,C14H30N4O7,Fortimicin KK1,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024194; ChEBI: 86409,cpd:C17974,14,30,7,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H31O7N4,C14H29O7N4,366.2114493,367.2192744,365.20362434930,5373,cpd:C17975,Fortimicin AP,C14H30N4O5,Fortimicin AP,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024195; ChEBI: 81426; NIKKAJI: J129.515B,cpd:C17975,14,30,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H31O5N4,C14H29O5N4,334.2216201,335.2294451,333.21379514931,5374,cpd:C17976,Fortimicin KH,C15H32N4O5,Fortimicin KH,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024196; ChEBI: 81427; NIKKAJI: J129.519E,cpd:C17709; cpd:C17976; cpd:C17977; cpd:C17978,15,32,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H33O5N4,C15H31O5N4,348.2372701,349.2450952,347.22944514932,5375,cpd:C17977,Fortimicin KR,C15H32N4O5,Fortimicin KR,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024197; ChEBI: 81428; NIKKAJI: J247.926E,cpd:C17709; cpd:C17976; cpd:C17977; cpd:C17978,15,32,5,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H33O5N4,C15H31O5N4,348.2372701,349.2450952,347.22944514933,5376,cpd:C17979,Formimidoyl-fortimicin A;,C18H36N6O6,Formimidoyl-fortimicin A; Dactimicin; SF-2052,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 73196-97-1; PubChem: 96024199; ChEBI: 81430; KNApSAcK: C00018260; NIKKAJI: J39.155G,cpd:C17979; cpd:C17980; cpd:C17988,18,36,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H37O6N6,C18H35O6N6,432.2696329,433.2774579,431.26180794934,5377,cpd:C17981,Istamycin FU-10,C12H24N2O8,Istamycin FU-10,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024201; ChEBI: 81432,cpd:C17981; cpd:C20353,12,24,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H25O8N2,C12H23O8N2,324.1532657,325.1610908,323.14544074935,5378,cpd:C17982,Istamycin AO,C13H27N3O7,Istamycin AO,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024202; ChEBI: 81433,cpd:C17982,13,27,7,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H28O7N3,C13H26O7N3,337.1849002,338.1927253,336.17707524936,5379,cpd:C17983,Istamycin KL1,C13H28N4O6,Istamycin KL1,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024203; ChEBI: 81434,cpd:C17983,13,28,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H29O6N4,C13H27O6N4,336.2008846,337.2087097,335.19305964937,5380,cpd:C17984,Istamycin AP,C13H28N4O4,Istamycin AP,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024204; ChEBI: 81435; NIKKAJI: J37.730I,cpd:C17984,13,28,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H29O4N4,C13H27O4N4,304.2110554,305.2188804,303.20323044938,5381,cpd:C17985,Istamycin Y0,C14H30N4O4,Istamycin Y0,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 73491-61-9; PubChem: 96024205; ChEBI: 81436; NIKKAJI: J122.682G,cpd:C17985; cpd:C17986,14,30,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H31O4N4,C14H29O4N4,318.2267055,319.2345305,317.21888044939,5382,cpd:C17986,Istamycin X0;,C14H30N4O4,Istamycin X0; Sannamycin G,NA,Biosynthesis of antibiotics,NA,NA,NA,CAS: 73522-72-2; PubChem: 96024206; ChEBI: 81437; NIKKAJI: J122.681I,cpd:C17985; cpd:C17986,14,30,4,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H31O4N4,C14H29O4N4,318.2267055,319.2345305,317.21888044940,5383,cpd:C17989,Istamycin A3,C18H36N6O5,Istamycin A3,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024209; ChEBI: 81440; NIKKAJI: J247.918D,cpd:C16566; cpd:C17989; cpd:C17993,18,36,5,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H37O5N6,C18H35O5N6,416.2747183,417.2825433,415.26689334941,5384,cpd:C17993,Istamycin B3,C18H36N6O5,Istamycin B3,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 96024213; ChEBI: 81444; NIKKAJI: J247.927C,cpd:C16566; cpd:C17989; cpd:C17993,18,36,5,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H37O5N6,C18H35O5N6,416.2747183,417.2825433,415.26689334942,5385,cpd:C18836,Griseophenone C,C16H16O6,Griseophenone C,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 124489510; ChEBI: 81997,cpd:C04684; cpd:C07761; cpd:C08740; cpd:C08761; cpd:C18354; cpd:C18356; cpd:C18360; cpd:C18836,16,16,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H17O6,C16H15O6,304.0946882,305.1025133,303.08686324943,5386,cpd:C18837,Griseophenone B,C16H15ClO6,Griseophenone B,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 124489511; ChEBI: 81998,cpd:C18837,16,15,6,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C16H16O6Cl1,C16H14O6Cl1,338.0557159,339.0635409,337.04789094944,5387,cpd:C18838,Dehydrogriseofulvin,C17H15ClO6,Dehydrogriseofulvin,NA,Biosynthesis of antibiotics,NA,NA,NA,PubChem: 124489512; ChEBI: 81999,cpd:C18838,17,15,6,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C17H16O6Cl1,C17H14O6Cl1,350.0557159,351.0635409,349.04789094945,5388,cpd:C18845,Mycinamicin I,C37H61NO12,Mycinamicin I,R10879,Biosynthesis of antibiotics,1.14.13.-,NA,NA,CAS: 73665-15-3; PubChem: 124489519; ChEBI: 82006; KNApSAcK: C00018281,cpd:C18845; cpd:C18847,37,61,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H62O12N1,C37H60O12N1,711.4193764,712.4272014,710.41155144946,5389,cpd:C18846,Mycinamicin IV,C37H61NO11,Mycinamicin IV,R09823 R10877 R10879,Biosynthesis of antibiotics,1.14.13.-; 2.1.1.237,NA,NA,CAS: 73684-71-6; PubChem: 135626100; KNApSAcK: C00018284; PDB-CCD: MIV,cpd:C18846,37,61,11,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H62O11N1,C37H60O11N1,695.4244618,696.4322868,694.41663684947,5390,cpd:C18847,Mycinamicin V,C37H61NO12,Mycinamicin V,R10877 R10878,Biosynthesis of antibiotics,1.14.13.-,NA,NA,CAS: 73684-72-7; PubChem: 135626101; KNApSAcK: C00018285; PDB-CCD: MYV,cpd:C18845; cpd:C18847,37,61,12,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H62O12N1,C37H60O12N1,711.4193764,712.4272014,710.41155144948,5391,cpd:C19814,Terpentetriene,C20H32,Terpentetriene,R09684 R11069,Biosynthesis of antibiotics,4.2.3.36,"Terpentecin biosynthesis, GGAP => terpentecin",NA,PubChem: 135626281,cpd:C00127; cpd:C00219; cpd:C00427; cpd:C00584; cpd:C00696; cpd:C00959; cpd:C01312; cpd:C01414; cpd:C02165; cpd:C02198; cpd:C04654; cpd:C04671; cpd:C04685; cpd:C04686; cpd:C04742; cpd:C04805; cpd:C04822; cpd:C04849; cpd:C04853; cpd:C05356; cpd:C05956; cpd:C05960; cpd:C05962; cpd:C05964; cpd:C05965; cpd:C05966; cpd:C06086; cpd:C06090; cpd:C06314; cpd:C06315; cpd:C06476; cpd:C09057; cpd:C09087; cpd:C09124; cpd:C09140; cpd:C09175; cpd:C11872; cpd:C11877; cpd:C11878; cpd:C11879; cpd:C11880; cpd:C11881; cpd:C11882; cpd:C11883; cpd:C11884; cpd:C11891; cpd:C11892; cpd:C11893; cpd:C11894; cpd:C11895; cpd:C11897; cpd:C11997; cpd:C12202; cpd:C13707; cpd:C13807; cpd:C13808; cpd:C14493; cpd:C14605; cpd:C14748; cpd:C14749; cpd:C14768; cpd:C14769; cpd:C14770; cpd:C14771; cpd:C14776; cpd:C14777; cpd:C14778; cpd:C14779; cpd:C14780; cpd:C14781; cpd:C14808; cpd:C14810; cpd:C14812; cpd:C14813; cpd:C14820; cpd:C14821; cpd:C14822; cpd:C14823; cpd:C14824; cpd:C14906; cpd:C14956; cpd:C14961; cpd:C15035; cpd:C15041; cpd:C15101; cpd:C15138; cpd:C15140; cpd:C15176; cpd:C15252; cpd:C15349; cpd:C15367; cpd:C15492; cpd:C16858; cpd:C17648; cpd:C17652; cpd:C17653; cpd:C17655; cpd:C17656; cpd:C17920; cpd:C18211; cpd:C18219; cpd:C18221; cpd:C18223; cpd:C18224; cpd:C18225; cpd:C18226; cpd:C18228; cpd:C18229; cpd:C18416; cpd:C18870; cpd:C19810; cpd:C19814; cpd:C19816; cpd:C20145; cpd:C20146; cpd:C20147; cpd:C20150; cpd:C20185; cpd:C20329; cpd:C20711; cpd:C20922,20,32,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H33,C20H31,272.250401,273.2582261,271.2425764949,5392,cpd:C19815,Terpentedienyl diphosphate,C20H36O7P2,Terpentedienyl diphosphate,R09684 R09714,Biosynthesis of antibiotics,4.2.3.36; 5.5.1.15,"Terpentecin biosynthesis, GGAP => terpentecin",NA,PubChem: 135626282,cpd:C00353; cpd:C05859; cpd:C06089; cpd:C11356; cpd:C11901; cpd:C11902; cpd:C19815; cpd:C19836,20,36,7,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H37O7P2,C20H35O7P2,450.1936275,451.2014525,449.18580254950,5393,cpd:C20397,Pentalenolactone F,C15H18O5,Pentalenolactone F,R10144 R10145 R10162,Biosynthesis of antibiotics,1.14.11.36; 1.14.19.8,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",NA,CAS: 85416-36-0; PubChem: 163312135; PDB-CCD: 7PF,cpd:C01632; cpd:C06681; cpd:C09302; cpd:C09354; cpd:C09363; cpd:C09379; cpd:C09485; cpd:C09983; cpd:C20397,15,18,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H19O5,C15H17O5,278.1154237,279.1232487,277.10759864951,5394,cpd:C20399,Pentalenolactone D,C15H20O4,Pentalenolactone D,R10143 R10145 R10154,Biosynthesis of antibiotics,1.14.11.36; 1.14.13.170,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",NA,PubChem: 163312137,cpd:C06082; cpd:C06806; cpd:C09291; cpd:C09304; cpd:C09349; cpd:C09355; cpd:C09381; cpd:C09453; cpd:C09456; cpd:C09470; cpd:C09481; cpd:C09498; cpd:C09506; cpd:C09530; cpd:C09531; cpd:C09540; cpd:C09542; cpd:C09574; cpd:C09600; cpd:C09683; cpd:C09688; cpd:C09708; cpd:C10766; cpd:C11060; cpd:C13778; cpd:C13820; cpd:C20399; cpd:C20402,15,20,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O4,C15H19O4,264.1361591,265.1439842,263.12833414952,5395,cpd:C20400,1-Deoxy-11-oxopentalenate,C15H20O3,1-Deoxy-11-oxopentalenate,R10154 R10155 R10156,Biosynthesis of antibiotics,1.1.1.340; 1.14.13.170; 1.14.13.171,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",NA,PubChem: 163312138,cpd:C02771; cpd:C07609; cpd:C09301; cpd:C09345; cpd:C09378; cpd:C09386; cpd:C09440; cpd:C09488; cpd:C09507; cpd:C09534; cpd:C09537; cpd:C09544; cpd:C09556; cpd:C09562; cpd:C09626; cpd:C09660; cpd:C09687; cpd:C13455; cpd:C17887; cpd:C20400,15,20,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O3,C15H19O3,248.1412445,249.1490695,247.13341954953,5396,cpd:C20403,1-Deoxy-11beta-hydroxypentalenate,C15H22O3,1-Deoxy-11beta-hydroxypentalenate,R10156 R10157,Biosynthesis of antibiotics,1.1.1.340; 1.14.11.35,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",NA,PubChem: 163312140,cpd:C01670; cpd:C07020; cpd:C09295; cpd:C09689; cpd:C09711; cpd:C09748; cpd:C13453; cpd:C13456; cpd:C14716; cpd:C18325; cpd:C20403; cpd:C20405,15,22,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O3,C15H21O3,250.1568946,251.1647196,249.14906954954,5397,cpd:C20404,1-Deoxypentalenate,C15H22O2,1-Deoxypentalenate,R10157 R10158 R11315,Biosynthesis of antibiotics,1.14.11.35; 1.14.15.11,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",NA,PubChem: 163312141,cpd:C09350; cpd:C09376; cpd:C09399; cpd:C09409; cpd:C09677; cpd:C09686; cpd:C09712; cpd:C09721; cpd:C09739; cpd:C09743; cpd:C10754; cpd:C10953; cpd:C16942; cpd:C16949; cpd:C17489; cpd:C17491; cpd:C17492; cpd:C17504; cpd:C17609; cpd:C19050; cpd:C19678; cpd:C20309; cpd:C20404,15,22,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H23O2,C15H21O2,234.1619799,235.169805,233.15415494955,5398,cpd:C20407,Pentalenolactone;,C15H16O5,Pentalenolactone; Arenaemycin E,R10162,Biosynthesis of antibiotics,1.14.19.8,"Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone",NA,CAS: 31501-48-1; PubChem: 163312144; PDB-CCD: 7PT,cpd:C08104; cpd:C09489; cpd:C09582; cpd:C09584; cpd:C09926; cpd:C10955; cpd:C17483; cpd:C17838; cpd:C20407,15,16,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H17O5,C15H15O5,276.0997736,277.1075986,275.09194864956,5399,cpd:C20636,Deoxybrevianamide E,C21H25N3O2,Deoxybrevianamide E,R10456,Biosynthesis of antibiotics,2.5.1.109,NA,NA,CAS: 34610-68-9; PubChem: 172232360,cpd:C07397; cpd:C20512; cpd:C20636,21,25,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H26O2N3,C21H24O2N3,351.1946771,352.2025021,350.1868524957,5400,cpd:C20639,O-Ureido-L-serine;,C4H9N3O4,O-Ureido-L-serine; (2S)-2-Amino-3-[(carbamoylamino)oxy]propanoate; (2S)-2-Amino-3-(carbamoylamino)oxypropanoic acid,R10461 R10488,Biosynthesis of antibiotics,2.6.99.3; 5.1.1.19,"Cycloserine biosynthesis, arginine/serine => cycloserine",NA,PubChem: 172232363,cpd:C20639; cpd:C20651,4,9,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O4N3,C4H8O4N3,163.0593058,164.0671308,162.05148074958,5401,cpd:C20651,O-Ureido-D-serine;,C4H9N3O4,O-Ureido-D-serine; (2R)-2-Amino-3-[(carbamoylamino)oxy]propanoate; (2R)-2-Amino-3-(carbamoylamino)oxypropanoic acid,R10470 R10488,Biosynthesis of antibiotics,5.1.1.19; 6.3.3.5,"Cycloserine biosynthesis, arginine/serine => cycloserine",NA,CAS: 53459-31-7; PubChem: 172232374,cpd:C20639; cpd:C20651,4,9,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H10O4N3,C4H8O4N3,163.0593058,164.0671308,162.05148074959,5402,cpd:C20940,L-Dihydroanticapsin,C9H15NO4,L-Dihydroanticapsin,R10917 R11068,Biosynthesis of antibiotics,1.1.1.385,"Bacilysin biosynthesis, prephenate => bacilysin",NA,PubChem: 254741402,cpd:C20940,9,15,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16O4N1,C9H14O4N1,201.100108,202.107933,200.09228294960,5403,cpd:C20941,L-Anticapsin;,C9H13NO4,L-Anticapsin; Anticapsin,R10917 R11064,Biosynthesis of antibiotics,1.1.1.385; 6.3.2.49,"Bacilysin biosynthesis, prephenate => bacilysin",NA,CAS: 28978-07-6; PubChem: 254741403,cpd:C20941,9,13,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O4N1,C9H12O4N1,199.0844579,200.0922829,198.07663294961,5404,cpd:C20942,Bacilysin,C12H18N2O5,Bacilysin,R11064,Biosynthesis of antibiotics,6.3.2.49,"Bacilysin biosynthesis, prephenate => bacilysin",NA,CAS: 29393-20-2; PubChem: 254741404,cpd:C08280; cpd:C20942,12,18,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H19O5N2,C12H17O5N2,270.1215717,271.1293967,269.11374674962,5405,cpd:C20953,"3-[(4R)-4-Hydroxycyclohexa-1,5-dien-1-yl]-2-oxopropanoate",C9H10O4,"3-[(4R)-4-Hydroxycyclohexa-1,5-dien-1-yl]-2-oxopropanoate",R10934 R11065,Biosynthesis of antibiotics,4.1.1.100; 5.3.3.19,"Bacilysin biosynthesis, prephenate => bacilysin",NA,PubChem: 254741414,cpd:C02333; cpd:C03672; cpd:C03964; cpd:C04044; cpd:C05582; cpd:C05583; cpd:C06663; cpd:C10447; cpd:C10680; cpd:C12622; cpd:C20953; cpd:C21085,9,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O4,C9H9O4,182.0579088,183.0657338,181.05008384963,5406,cpd:C21085,"3-[(1E,4R)-4-Hydroxycyclohex-2-en-1-ylidene]-2-oxopropanoate",C9H10O4,"3-[(1E,4R)-4-Hydroxycyclohex-2-en-1-ylidene]-2-oxopropanoate",R11065 R11066,Biosynthesis of antibiotics,5.3.3.19,"Bacilysin biosynthesis, prephenate => bacilysin",NA,PubChem: 310920466,cpd:C02333; cpd:C03672; cpd:C03964; cpd:C04044; cpd:C05582; cpd:C05583; cpd:C06663; cpd:C10447; cpd:C10680; cpd:C12622; cpd:C20953; cpd:C21085,9,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O4,C9H9O4,182.0579088,183.0657338,181.05008384964,5407,cpd:C21086,"(3E)-3-[(1R,5R,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]heptan-2-ylidene]-2-oxopropanoate;",C9H10O5,"(3E)-3-[(1R,5R,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]heptan-2-ylidene]-2-oxopropanoate; Epoxy-3E-H2HPP",R11066 R11067,Biosynthesis of antibiotics,NA,"Bacilysin biosynthesis, prephenate => bacilysin",NA,PubChem: 310920467,cpd:C01207; cpd:C05584; cpd:C10833; cpd:C18702; cpd:C21086,9,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H11O5,C9H9O5,198.0528234,199.0606485,197.04499844965,5408,cpd:C21087,"3-[(1R,2S,5R,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]-2-oxopropanoate;",C9H12O5,"3-[(1R,2S,5R,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]-2-oxopropanoate; Epoxy-4S-H4HPP",R11067 R11068,Biosynthesis of antibiotics,NA,"Bacilysin biosynthesis, prephenate => bacilysin",NA,PubChem: 310920468,cpd:C00526; cpd:C14442; cpd:C21087,9,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13O5,C9H11O5,200.0684735,201.0762985,199.06064854966,5409,cpd:C21093,Terpentecin,C20H28O6,Terpentecin,R11069,Biosynthesis of antibiotics,NA,"Terpentecin biosynthesis, GGAP => terpentecin",NA,CAS: 100440-25-3; PubChem: 310920474,cpd:C06095; cpd:C09155; cpd:C09178; cpd:C09414; cpd:C09535; cpd:C11859; cpd:C17642; cpd:C21093,20,28,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O6,C20H27O6,364.1885886,365.1964137,363.18076364967,5410,cpd:C05533,Oxaloglutarate,C7H8O7,Oxaloglutarate,R01936 R04862,2-Oxocarboxylic acid metabolism,1.1.1.87; 1.1.1.286,NA,NA,PubChem: 7875; ChEBI: 7814; 3DMET: B05068; NIKKAJI: J39.061E,cpd:C05533,7,8,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H9O7,C7H7O7,204.0270026,205.0348276,203.01917764968,5411,cpd:C16216,3-Oxostearoyl-CoA;,C39H68N7O18P3S,3-Oxostearoyl-CoA; 3-Oxooctadecanoyl-CoA; beta-Ketostearoyl-CoA; 3-Ketostearoyl-CoA,R07758 R07759,Fatty acid metabolism,1.1.1.330; 2.3.1.199,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16216  3-Oxooctadecanoyl-CoA,PubChem: 47205524; ChEBI: 50571; NIKKAJI: J2.798.869E,cpd:C16216; cpd:C21005,39,68,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H69O18N7P3S1,C39H67O18N7P3S1,1047.355441,1048.363266,1046.3476164969,5412,cpd:C16217,3-Hydroxyoctadecanoyl-CoA;,C39H70N7O18P3S,3-Hydroxyoctadecanoyl-CoA; 3-Hydroxystearoyl-CoA; beta-Hydroxystearoyl-CoA,R07759 R07760,Fatty acid metabolism,1.1.1.330; 4.2.1.134,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA07 Fatty esters;    FA0705 Fatty acyl CoAs;     C16217  3-Hydroxyoctadecanoyl-CoA,CAS: 42578-91-6; PubChem: 47205525; ChEBI: 50583; NIKKAJI: J2.798.870I,cpd:C16217,39,70,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H71O18N7P3S1,C39H69O18N7P3S1,1049.371091,1050.378916,1048.3632664970,5413,cpd:C16218,(2E)-Octadecenoyl-CoA;,C39H68N7O17P3S,(2E)-Octadecenoyl-CoA; trans-Octadec-2-enoyl-CoA,R07760 R07761,Fatty acid metabolism,1.3.1.38; 1.3.1.93; 4.2.1.134,NA,NA,PubChem: 47205526; ChEBI: 50570; NIKKAJI: J2.799.062B,cpd:C00510; cpd:C16218,39,68,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C39H69O17N7P3S1,C39H67O17N7P3S1,1031.360526,1032.368351,1030.3527014971,5414,cpd:C16374,"(2E,6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahepta-2,6,9,12,15,18,21-enoyl-CoA",C45H68N7O17P3S,"(2E,6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahepta-2,6,9,12,15,18,21-enoyl-CoA",R07934 R07935,Fatty acid metabolism,1.3.3.6; 4.2.1.-,NA,NA,PubChem: 47205682; ChEBI: 80480; NIKKAJI: J2.802.527K,cpd:C16374,45,68,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H69O17N7P3S1,C45H67O17N7P3S1,1103.360526,1104.368351,1102.3527014972,5415,cpd:C16375,"(6Z,9Z,12Z,15Z,18Z,21Z)-3-Hydroxytetracosahexa-6,9,12,15,18,21-enoyl-CoA",C45H70N7O18P3S,"(6Z,9Z,12Z,15Z,18Z,21Z)-3-Hydroxytetracosahexa-6,9,12,15,18,21-enoyl-CoA",R07935 R07936,Fatty acid metabolism,1.1.1.211; 4.2.1.-,NA,NA,PubChem: 47205683; ChEBI: 65130; NIKKAJI: J2.802.539D,cpd:C16375; cpd:C16389,45,70,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H71O18N7P3S1,C45H69O18N7P3S1,1121.371091,1122.378916,1120.3632664973,5416,cpd:C16376,"(6Z,9Z,12Z,15Z,18Z,21Z)-3-Oxotetracosahexa-6,9,12,15,18,21-enoyl-CoA",C45H68N7O18P3S,"(6Z,9Z,12Z,15Z,18Z,21Z)-3-Oxotetracosahexa-6,9,12,15,18,21-enoyl-CoA",R07936 R07937,Fatty acid metabolism,1.1.1.211; 2.3.1.16,NA,NA,PubChem: 47205684; ChEBI: 65131; NIKKAJI: J2.802.541F,cpd:C16376; cpd:C21472,45,68,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H69O18N7P3S1,C45H67O18N7P3S1,1119.355441,1120.363266,1118.3476164974,5417,cpd:C16387,"(2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexa-2,6,9,12,15,18-enoyl-CoA",C45H70N7O17P3S,"(2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexa-2,6,9,12,15,18-enoyl-CoA",R07950 R07951,Fatty acid metabolism,1.3.3.6; 4.2.1.-,NA,NA,PubChem: 47205685; ChEBI: 80481; NIKKAJI: J2.802.550E,cpd:C16168; cpd:C16387,45,70,17,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H71O17N7P3S1,C45H69O17N7P3S1,1105.376176,1106.384001,1104.3683514975,5418,cpd:C16388,"(6Z,9Z,12Z,15Z,18Z)-3-Hydroxytetracosapenta-6,9,12,15,18-enoyl-CoA",C45H72N7O18P3S,"(6Z,9Z,12Z,15Z,18Z)-3-Hydroxytetracosapenta-6,9,12,15,18-enoyl-CoA",R07951 R07952,Fatty acid metabolism,1.1.1.211; 4.2.1.-,NA,NA,PubChem: 47205686; ChEBI: 80482; NIKKAJI: J2.802.553J,cpd:C16388,45,72,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H73O18N7P3S1,C45H71O18N7P3S1,1123.386741,1124.394566,1122.3789164976,5419,cpd:C16389,"(6Z,9Z,12Z,15Z,18Z)-3-Oxotetracosapenta-6,9,12,15,18-enoyl-CoA",C45H70N7O18P3S,"(6Z,9Z,12Z,15Z,18Z)-3-Oxotetracosapenta-6,9,12,15,18-enoyl-CoA",R07952 R07953,Fatty acid metabolism,1.1.1.211; 2.3.1.16,NA,NA,PubChem: 47205687; ChEBI: 80483; NIKKAJI: J2.802.555F,cpd:C16375; cpd:C16389,45,70,18,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,C45H71O18N7P3S1,C45H69O18N7P3S1,1121.371091,1122.378916,1120.3632664977,5421,cpd:C06432,UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanine;,C37H60N8O25P2,UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanine; UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-L-lysyl-D-alanine,R04611,Vancomycin resistance,3.4.17.8,NA,NA,PubChem: 8666; ChEBI: 28081; NIKKAJI: J2.767.308B,cpd:C06432,37,60,25,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H61O25N8P2,C37H59O25N8P2,1078.314483,1079.322308,1077.3066584978,5423,cpd:C19694,D-Alanyl-(R)-lactate;,C6H11NO4,D-Alanyl-(R)-lactate; D-Alanyl-D-lactate; (2R)-2-(D-Alanyloxy)propanoic acid; (R)-2-[(R)-2-Aminopropanoyloxy]propanoic acid,R09588,Vancomycin resistance,6.1.2.1,NA,NA,CAS: 136577-07-6; PubChem: 135626162,cpd:C00734; cpd:C00956; cpd:C01046; cpd:C01077; cpd:C02207; cpd:C03210; cpd:C05016; cpd:C06234; cpd:C17581; cpd:C19694,6,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12O4N1,C6H10O4N1,161.0688078,162.0766329,160.06098284979,5424,cpd:C19719,D-Alanyl-D-serine,C6H12N2O4,D-Alanyl-D-serine,R09595,Vancomycin resistance,6.3.2.35,NA,NA,PubChem: 135626186,cpd:C00491; cpd:C01420; cpd:C05704; cpd:C19719; cpd:C21397,6,12,4,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O4N2,C6H11O4N2,176.0797069,177.0875319,175.07188184980,5425,cpd:C20869,UDPMurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Lac);,C40H64N8O27P2,UDPMurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Lac); UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-lactate; UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-lactate,NA,Vancomycin resistance,NA,NA,NA,PubChem: 254741335,cpd:C20869,40,64,27,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H65O27N8P2,C40H63O27N8P2,1150.335613,1151.343438,1149.3277884981,5426,cpd:C20873,UDPMurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ser);,C40H65N9O27P2,UDPMurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ser); UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-serine; UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-serine,NA,Vancomycin resistance,NA,NA,NA,PubChem: 254741339,cpd:C20873,40,65,27,9,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H66O27N9P2,C40H64O27N9P2,1165.346512,1166.354337,1164.3386874982,5427,cpd:C20874,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-serine;,C94H156N8O27P2,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-serine; GlcNAc-(1->4)-MurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ser)-diphosphoundecaprenol,NA,Vancomycin resistance,NA,NA,NA,PubChem: 254741340,cpd:C20874,94,156,27,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C94H157O27N8P2,C94H155O27N8P2,1891.055516,1892.063341,1890.0476914983,5428,cpd:C20875,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-lactate;,C94H155N7O27P2,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-lactate; GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Lac)-diphosphoundecaprenol; GlcNAc-(1->4)-MurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Lac)-diphosphoundecaprenol,NA,Vancomycin resistance,NA,NA,NA,PubChem: 254741341,cpd:C20875,94,155,27,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C94H156O27N7P2,C94H154O27N7P2,1876.044617,1877.052442,1875.0367924984,5429,cpd:C20880,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-LL-2,6-diaminopimeloyl-D-alanyl-D-lactate;",C41H64N8O29P2,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-LL-2,6-diaminopimeloyl-D-alanyl-D-lactate; UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimeloyl-D-alanyl-D-lactate",NA,Vancomycin resistance,NA,NA,NA,PubChem: 254741346,cpd:C20880,41,64,29,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H65O29N8P2,C41H63O29N8P2,1194.325442,1195.333267,1193.3176174985,5430,cpd:C20881,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-LL-2,6-diaminopimeloyl-D-alanyl-D-Lactate;",C95H155N7O29P2,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-LL-2,6-diaminopimeloyl-D-alanyl-D-Lactate; Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimeloyl-D-alanyl-D-Lactate",NA,Vancomycin resistance,NA,NA,NA,PubChem: 254741347,cpd:C20881,95,155,29,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C95H156O29N7P2,C95H154O29N7P2,1920.034446,1921.042271,1919.0266214986,5431,cpd:C20882,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-LL-2,6-diaminopimeloyl-(glycyl)-D-alanyl-D-lactate;",C97H158N8O30P2,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-LL-2,6-diaminopimeloyl-(glycyl)-D-alanyl-D-lactate; Und-PP-MurNAc-(GlcNAc)-L-Ala-D-Glu-LL-dap-(Gly)-D-Ala-D-Lac; Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimeloyl-(glycyl)-D-alanyl-D-lactate",NA,Vancomycin resistance,NA,NA,NA,PubChem: 254741348,cpd:C20882,97,158,30,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C97H159O30N8P2,C97H157O30N8P2,1977.05591,1978.063735,1976.0480854987,5432,cpd:C20886,"UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimelate;",C35H55N7O26P2,"UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimelate; UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminoheptanedioate",NA,Vancomycin resistance,NA,NA,NA,PubChem: 254741349,cpd:C04877; cpd:C20886,35,55,26,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H56O26N7P2,C35H54O26N7P2,1051.267199,1052.275024,1050.2593744988,5433,cpd:C11198,Melitten;,C131H229N39O31,Melitten; Melittin,NA,Cationic antimicrobial peptide (CAMP) resistance,NA,NA,Natural toxins [BR:br08009];  Venoms;   Bee venoms;    Peptides;     C11198  Melitten; Target-based classification of compounds [BR:br08010];  Enzymes;   Hydrolases;    phospholipase A2;     C11198  Melitten,CAS: 20449-79-0; PubChem: 13379; ChEBI: 6736; NIKKAJI: J390.575F J831.308C,cpd:C11198,131,229,31,39,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C131H230O31N39,C131H228O31N39,2844.754172,2845.761997,2843.7463474989,5434,cpd:C20931,4-Amino-4-deoxy-L-arabinose;,C5H11NO4,4-Amino-4-deoxy-L-arabinose; L-Ara4N,NA,Cationic antimicrobial peptide (CAMP) resistance,NA,NA,NA,PubChem: 254741394,cpd:C20314; cpd:C20931,5,11,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O4N1,C5H10O4N1,149.0688078,150.0766329,148.06098284990,5436,cpd:C11374,GW1843;,C27H24N4O6,GW1843; 1843U89,NA,Antifolate resistance,NA,NA,NA,CAS: 139987-54-5; PubChem: 13548; ChEBI: 42335; ChEMBL: CHEMBL169896; PDB-CCD: F89; NIKKAJI: J525.129J,cpd:C11374,27,24,6,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H25O6N4,C27H23O6N4,500.1695845,501.1774095,499.16175954991,5437,cpd:C21279,BGC 945;,C32H33N5O10,BGC 945; ONX 0801,NA,Antifolate resistance,NA,NA,NA,CAS: 501332-69-0; PubChem: 318172259; PDB-CCD: 1JY,cpd:C21279,32,33,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H34O10N5,C32H32O10N5,647.2227423,648.2305673,646.21491724992,5438,cpd:C21280,AG 2034,C18H21N5O6S2,AG 2034,NA,Antifolate resistance,NA,NA,NA,CAS: 177575-17-6; PubChem: 318172260,cpd:C21280,18,21,6,5,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C18H22O6N5S2,C18H20O6N5S2,467.0933258,468.1011508,466.08550074993,5446,cpd:C00503,Erythritol;,C4H10O4,Erythritol; Erythrol; Phycitol; Phycite; Erythrite,R02430 R11536,ABC transporters,1.1.1.162; 2.7.1.27; 2.7.1.215,NA,Pharmaceutical additives [BR:br08316];  Flavoring substance;   D08915  [120316] Erythritol,CAS: 149-32-6; PubChem: 3786; ChEBI: 17113 48299; ChEMBL: CHEMBL349605; KNApSAcK: C00001161; PDB-CCD: MRY; NIKKAJI: J43.360H,cpd:C00503; cpd:C14706; cpd:C16884; cpd:C17962; cpd:C21403,4,10,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H11O4,C4H9O4,122.0579088,123.0657338,121.05008384994,5448,cpd:C00855,D-Methionine;,C5H11NO2S,D-Methionine; D-2-Amino-4-(methylthio)butyric acid,R00655 R03001,ABC transporters,2.6.1.41; 5.1.1.2,NA,Compounds with biological roles [BR:br08001];  Peptides;   Amino acids;    Other amino acids;     C00855  D-Methionine,CAS: 348-67-4; PubChem: 4112; ChEBI: 16867; ChEMBL: CHEMBL1234268; PDB-CCD: MED; 3DMET: B00191; NIKKAJI: J9.192H,cpd:C00073; cpd:C00855; cpd:C01733; cpd:C07418,5,11,2,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C5H12O2N1S1,C5H10O2N1S1,149.0510498,150.0588748,148.04322474995,5450,cpd:C00919,Choline sulfate,C5H13NO4S,Choline sulfate,R01027 R01028,ABC transporters,2.8.2.6; 3.1.6.6,NA,NA,CAS: 4858-96-2; PubChem: 4173; ChEBI: 16822; KNApSAcK: C00001530; 3DMET: B00199; NIKKAJI: J814.134G,cpd:C00919,5,13,4,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C5H14O4N1S1,C5H12O4N1S1,183.0565291,184.0643541,182.0487044996,5453,cpd:C01630,Xylobiose,C10H18O9,Xylobiose,NA,ABC transporters,NA,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Oligosaccharides;    Disaccharides;     C01630  Xylobiose,CAS: 6860-47-5; PubChem: 4780; ChEBI: 28309; PDB-CCD: BXP XYB; NIKKAJI: J15.577B,cpd:C01630; cpd:C20568; cpd:C20570,10,18,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O9,C10H17O9,282.0950822,283.1029072,281.08725714997,5454,cpd:C01684,D-Rhamnose;,C6H12O5,D-Rhamnose; 6-Deoxy-D-mannose; D-Mannomethylose,NA,ABC transporters,NA,NA,Compounds with biological roles [BR:br08001];  Carbohydrates;   Monosaccharides;    Deoxy sugars;     C01684  D-Rhamnose,CAS: 634-74-2; PubChem: 4826; ChEBI: 28029 63152; PDB-CCD: XXR; 3DMET: B01478; NIKKAJI: J253.373A,cpd:C00507; cpd:C00586; cpd:C00861; cpd:C01018; cpd:C01019; cpd:C01684; cpd:C01721; cpd:C02095; cpd:C02338; cpd:C02431; cpd:C02476; cpd:C02522; cpd:C02781; cpd:C04384; cpd:C07326; cpd:C08258; cpd:C08259; cpd:C08352; cpd:C16538; cpd:C17949; cpd:C20835; cpd:C20836; cpd:C21033; cpd:C21058,6,12,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O5,C6H11O5,164.0684735,165.0762985,163.06064854998,5455,cpd:C01835,Maltotriose;,C18H32O16,Maltotriose; Amylotriose,NA,ABC transporters; Carbohydrate digestion and absorption,NA,NA,NA,CAS: 1109-28-0; PubChem: 4954; ChEBI: 27931 61993; PDB-CCD: 38J MLR; NIKKAJI: J208.710C,cpd:C00492; cpd:C00713; cpd:C00883; cpd:C01835; cpd:C02160; cpd:C03367; cpd:C03661; cpd:C03848; cpd:C05404; cpd:C06219; cpd:C08239; cpd:C08243; cpd:C08251; cpd:C21454,18,32,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O16,C18H31O16,504.1690349,505.17686,503.16120994999,5456,cpd:C02160,Isomaltotriose,C18H32O16,Isomaltotriose,NA,ABC transporters,NA,NA,NA,CAS: 3371-50-4; PubChem: 5236; ChEBI: 27649; NIKKAJI: J20.655E,cpd:C00492; cpd:C00713; cpd:C00883; cpd:C01835; cpd:C02160; cpd:C03367; cpd:C03661; cpd:C03848; cpd:C05404; cpd:C06219; cpd:C08239; cpd:C08243; cpd:C08251; cpd:C21454,18,32,16,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H33O16,C18H31O16,504.1690349,505.17686,503.16120995000,5458,cpd:C03619,Methyl beta-D-galactoside;,C7H14O6,Methyl beta-D-galactoside; Methyl beta-D-galactopyranoside,R04270 R06118,ABC transporters,3.2.1.63,NA,NA,CAS: 1824-94-8; PubChem: 6403; ChEBI: 17540; ChEMBL: CHEMBL320214 CHEMBL442951; PDB-CCD: MBG; NIKKAJI: J150.777J,cpd:C03365; cpd:C03619; cpd:C03659; cpd:C03660; cpd:C03844; cpd:C05163; cpd:C05844; cpd:C06352; cpd:C06353; cpd:C08257,7,14,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H15O6,C7H13O6,194.0790382,195.0868632,193.07121315001,5459,cpd:C04114,(E)-4-(Trimethylammonio)but-2-enoate;,C7H13NO2,(E)-4-(Trimethylammonio)but-2-enoate; Crotono-betaine; Crotonobetaine,R10643,ABC transporters,2.8.3.21,NA,NA,PubChem: 6803; ChEBI: 17237 1774; 3DMET: B00681; NIKKAJI: J526.836B,cpd:C04114; cpd:C10172; cpd:C15311,7,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H14O2N1,C7H12O2N1,143.0946287,144.1024537,142.08680365002,5460,cpd:C05349,Ciprofloxacin,C17H18FN3O3,Ciprofloxacin,NA,ABC transporters,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01M QUINOLONE ANTIBACTERIALS;     J01MA Fluoroquinolones;      J01MA02 Ciprofloxacin;       D00186  Ciprofloxacin (JP17/USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AE Fluoroquinolones;      S01AE03 Ciprofloxacin;       D00186  Ciprofloxacin (JP17/USP/INN);   S02 OTOLOGICALS;    S02A ANTIINFECTIVES;     S02AA Antiinfectives;      S02AA15 Ciprofloxacin;       D00186  Ciprofloxacin (JP17/USP/INN);   S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;    S03A ANTIINFECTIVES;     S03AA Antiinfectives;      S03AA07 Ciprofloxacin;       D00186  Ciprofloxacin (JP17/USP/INN); USP drug classification [BR:br08302];  Antibacterials;   Quinolones;    Ciprofloxacin;     D00186  Ciprofloxacin (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  6  Agents against pathologic organisms and parasites;   62  Chemotherapeutics;    624  Synthetic antibacterials;     6241  Pyridonecarboxylic acids;      D00186  Ciprofloxacin (JP17/USP/INN); Antiinfectives [BR:br08307];  Antibacterials;   Nucleic acid synthesis inhibitor;    type II topoisomerase (DNA gyrase, topoisomerase IV) inhibitor;     Fluoroquinolones;      Ciprofloxacin;       D00186  Ciprofloxacin (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP1A2;    Ciprofloxacin;     D00186  Ciprofloxacin (JP17/USP/INN);   CYP3A4;    Ciprofloxacin;     D00186  Ciprofloxacin (JP17/USP/INN);   CYP3A5;    Ciprofloxacin;     D00186  Ciprofloxacin (JP17/USP/INN);   CYP3A7;    Ciprofloxacin;     D00186  Ciprofloxacin (JP17/USP/INN);   CYP3A;    Ciprofloxacin;     D00186  Ciprofloxacin (JP17/USP/INN);  CYP substrates;   CYP1A2;    Ciprofloxacin;     D00186  Ciprofloxacin (JP17/USP/INN);   CYP3A4;    Ciprofloxacin;     D00186  Ciprofloxacin (JP17/USP/INN);  Transporter substrates;   OAT1;    Ciprofloxacin;     D00186  Ciprofloxacin (JP17/USP/INN);   OAT3;    Ciprofloxacin;     D00186  Ciprofloxacin (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00186  Ciprofloxacin; Antibacterials [br08350.html];  D00186",CAS: 85721-33-1; PubChem: 7727; ChEBI: 100241; ChEMBL: CHEMBL8; PDB-CCD: CPF; NIKKAJI: J21.732H,cpd:C05349; cpd:C11240; cpd:C13993,17,18,3,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C17H19O3N3F1,C17H17O3N3F1,331.1332196,332.1410446,330.12539465003,5463,cpd:C06228,Ferrichrome,C27H42FeN9O12,Ferrichrome,NA,ABC transporters,NA,NA,NA,PubChem: 8471; ChEBI: 5019; PDB-CCD: FCE,cpd:C06228,27,42,12,9,0,0,0,0,0,0,0,0,0,1,0,0,0,0,C27H43O12N9Fe1,C27H41O12N9Fe1,740.2285888,741.2364139,739.22076385004,5467,cpd:C06687,Norfloxacin,C16H18FN3O3,Norfloxacin,NA,ABC transporters,NA,NA,"Compounds with biological roles [BR:br08001];  Antibiotics;   Quinolones;    Fluoroquinolones;     C06687  Norfloxacin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01M QUINOLONE ANTIBACTERIALS;     J01MA Fluoroquinolones;      J01MA06 Norfloxacin;       D00210  Norfloxacin (JP17/USP/INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AE Fluoroquinolones;      S01AE02 Norfloxacin;       D00210  Norfloxacin (JP17/USP/INN); USP drug classification [BR:br08302];  Antibacterials;   Quinolones;    Norfloxacin;     D00210  Norfloxacin (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   13  Agents affecting sensory organs;    131  Ophthalmic agents;     1319  Others;      D00210  Norfloxacin (JP17/USP/INN);  6  Agents against pathologic organisms and parasites;   62  Chemotherapeutics;    624  Synthetic antibacterials;     6241  Pyridonecarboxylic acids;      D00210  Norfloxacin (JP17/USP/INN); Antiinfectives [BR:br08307];  Antibacterials;   Nucleic acid synthesis inhibitor;    type II topoisomerase (DNA gyrase, topoisomerase IV) inhibitor;     Fluoroquinolones;      Norfloxacin;       D00210  Norfloxacin (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP1A2;    Norfloxacin;     D00210  Norfloxacin (JP17/USP/INN);   CYP3A4;    Norfloxacin;     D00210  Norfloxacin (JP17/USP/INN);   CYP3A5;    Norfloxacin;     D00210  Norfloxacin (JP17/USP/INN);   CYP3A7;    Norfloxacin;     D00210  Norfloxacin (JP17/USP/INN);  CYP substrates;   CYP1A2;    Norfloxacin;     D00210  Norfloxacin (JP17/USP/INN);   CYP3A4;    Norfloxacin;     D00210  Norfloxacin (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00210  Norfloxacin; Antibacterials [br08350.html];  D00210; Animal drugs in Japan [BR:br08331];  97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants);   973  Synthetic antimicrobials;    9734  Quinolone, derivatives and preparations;     C06687  Norfloxacin",CAS: 70458-96-7; PubChem: 8912; ChEBI: 100246; ChEMBL: CHEMBL9; NIKKAJI: J1.144D,cpd:C06687,16,18,3,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C16H19O3N3F1,C16H17O3N3F1,319.1332196,320.1410446,318.12539465005,5468,cpd:C06767,Hemine;,C34H32ClFeN4O4,Hemine; Hemin,NA,ABC transporters,NA,NA,NA,PubChem: 8987; ChEBI: 50385,cpd:C06767,34,32,4,4,0,0,1,0,0,0,0,0,0,1,0,0,0,0,C34H33O4N4Cl1Fe1,C34H31O4N4Cl1Fe1,651.1445042,652.1523292,650.13667925006,5469,cpd:C07662,Sparfloxacin;,C19H22F2N4O3,"Sparfloxacin; cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid",NA,ABC transporters,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01M QUINOLONE ANTIBACTERIALS;     J01MA Fluoroquinolones;      J01MA09 Sparfloxacin;       D00590  Sparfloxacin (JAN/USAN/INN); Antiinfectives [BR:br08307];  Antibacterials;   Nucleic acid synthesis inhibitor;    type II topoisomerase (DNA gyrase, topoisomerase IV) inhibitor;     Fluoroquinolones;      Sparfloxacin;       D00590  Sparfloxacin (JAN/USAN/INN)",CAS: 110871-86-8; PubChem: 9864; ChEBI: 9212; ChEMBL: CHEMBL850; NIKKAJI: J324.247A,cpd:C07662,19,22,3,4,0,0,0,0,0,2,0,0,0,0,0,0,0,0,C19H23O3N4F2,C19H21O3N4F2,392.1659969,393.1738219,391.15817195007,5470,cpd:C07663,Moxifloxacin,C21H24FN3O4,Moxifloxacin,NA,ABC transporters,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01M QUINOLONE ANTIBACTERIALS;     J01MA Fluoroquinolones;      J01MA14 Moxifloxacin;       D08237  Moxifloxacin (INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AE Fluoroquinolones;      S01AE07 Moxifloxacin;       D08237  Moxifloxacin (INN); USP drug classification [BR:br08302];  Antibacterials;   Quinolones;    Moxifloxacin;     D08237  Moxifloxacin (INN); Antiinfectives [BR:br08307];  Antibacterials;   Nucleic acid synthesis inhibitor;    type II topoisomerase (DNA gyrase, topoisomerase IV) inhibitor;     Fluoroquinolones;      Moxifloxacin;       D08237  Moxifloxacin (INN)",CAS: 151096-09-2; PubChem: 9865; ChEBI: 63611; NIKKAJI: J1.495.215B,cpd:C07663; cpd:C08054,21,24,4,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C21H25O4N3F1,C21H23O4N3F1,401.1750844,402.1829095,400.16725945008,5473,cpd:C16421,AI-2;,C5H10BO7,AI-2; Autoinducer 2,NA,ABC transporters; Two-component system; Quorum sensing; Biofilm formation - Vibrio cholerae,NA,NA,NA,PubChem: 47205719; ChEBI: 40646; ChEMBL: CHEMBL1230903; PDB-CCD: AI2; NIKKAJI: J1.691.576I,cpd:C16421,5,10,7,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,C5H11O7B1,C5H9O7B1,193.0503127,194.0581377,192.04248765009,5474,cpd:C16692,Mannopine,C11H22N2O8,Mannopine,NA,ABC transporters,NA,NA,NA,CAS: 87084-52-4; PubChem: 51091014; ChEBI: 80662; PDB-CCD: MO0; NIKKAJI: J690.468H,cpd:C16692,11,22,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H23O8N2,C11H21O8N2,310.1376157,311.1454407,309.12979065010,5476,cpd:C20570,"alpha-1,5-L-Arabinobiose",C10H18O9,"alpha-1,5-L-Arabinobiose",NA,ABC transporters,NA,NA,NA,PubChem: 172232307,cpd:C01630; cpd:C20568; cpd:C20570,10,18,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H19O9,C10H17O9,282.0950822,283.1029072,281.08725715011,5477,cpd:C20571,"alpha-1,5-L-Arabinotriose",C15H26O13,"alpha-1,5-L-Arabinotriose",NA,ABC transporters,NA,NA,NA,PubChem: 172232308,cpd:C20571,15,26,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H27O13,C15H25O13,414.1373409,415.1451659,413.12951595012,5478,cpd:C20572,"alpha-1,5-L-Arabinotetraose",C20H34O17,"alpha-1,5-L-Arabinotetraose",NA,ABC transporters,NA,NA,NA,PubChem: 172232309,cpd:C20572,20,34,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H35O17,C20H33O17,546.1795996,547.1874247,545.17177465013,5479,cpd:C20573,Aldotetraouronic acid,C22H36O19,Aldotetraouronic acid,NA,ABC transporters,NA,NA,NA,PubChem: 172232310,cpd:C04909; cpd:C20573,22,36,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H37O19,C22H35O19,604.1850789,605.192904,603.17725395014,5484,cpd:C11842,N-(3-(S)-Hydroxybutyryl)homoserine lactone,C8H13NO4,N-(3-(S)-Hydroxybutyryl)homoserine lactone,NA,Two-component system,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA08 Fatty amides;    FA0803 Fatty acyl homoserine lactones;     C11842  N-(3-(S)-Hydroxybutyryl)homoserine lactone,PubChem: 14004; ChEBI: 29637; ChEMBL: CHEMBL446873; LIPIDMAPS: LMFA08030005; 3DMET: B05551; NIKKAJI: J2.777.594B,cpd:C03682; cpd:C05548; cpd:C11842; cpd:C12988; cpd:C21195,8,13,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H14O4N1,C8H12O4N1,187.0844579,188.0922829,186.07663295015,5485,cpd:C11849,3-Hydroxy-palmitic acid methyl ester,C17H34O3,3-Hydroxy-palmitic acid methyl ester,NA,Two-component system,NA,NA,NA,CAS: 51883-36-4; PubChem: 14011; ChEBI: 29479; NIKKAJI: J109.455F,cpd:C11849; cpd:C13947,17,34,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H35O3,C17H33O3,286.250795,287.25862,285.24296995016,5486,cpd:C12008,Ramoplanin A2,C119H154ClN21O40,Ramoplanin A2,NA,Two-component system,NA,NA,NA,CAS: 81988-88-7; PubChem: 14167; ChEBI: 29670; NIKKAJI: J369.929C,cpd:C12008,119,154,40,21,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C119H155O40N21Cl1,C119H153O40N21Cl1,2552.035047,2553.042872,2551.0272215017,5487,cpd:C16463,"3',5'-Cyclic diGMP;",C20H24N10O14P2,"3',5'-Cyclic diGMP; cdiGMP; 3',5'-Cyclic diguanylic acid; Bis-(3',5')-cyclic diGMP; Cyclic di-3',5'-guanylate",R08057 R08991,Two-component system; Quorum sensing; Biofilm formation - Pseudomonas aeruginosa; Biofilm formation - Escherichia coli; Cell cycle - Caulobacter; Biofilm formation - Vibrio cholerae,2.7.7.65; 3.1.4.52,NA,NA,CAS: 61093-23-0; PubChem: 47205759; ChEBI: 49537; PDB-CCD: C2E; NIKKAJI: J687.951I,cpd:C16463,20,24,14,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O14N10P2,C20H23O14N10P2,690.0948695,691.1026945,689.08704455018,5488,cpd:C16640,CAI-1;,C13H26O2,CAI-1; Cholerae autoinducer-1,NA,Two-component system; Quorum sensing; Biofilm formation - Vibrio cholerae,NA,NA,NA,PubChem: 51090966; ChEBI: 80629; ChEMBL: CHEMBL1922852; NIKKAJI: J2.533.880D,cpd:C16640; cpd:C17076,13,26,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H27O2,C13H25O2,214.1932801,215.2011051,213.1854555019,5489,cpd:C16665,12-Methyltetradecanoic acid,C15H30O2,12-Methyltetradecanoic acid,NA,Two-component system,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0102 Branched fatty acids;     C16665  12-Methyltetradecanoic acid,PubChem: 51090989; ChEBI: 39251; ChEMBL: CHEMBL495852; LIPIDMAPS: LMFA01020008; NIKKAJI: J387.978J,cpd:C16537; cpd:C16665,15,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H31O2,C15H29O2,242.2245802,243.2324052,241.21675525020,5490,cpd:C18206,cis-11-Methyl-2-dodecenoic acid,C13H24O2,cis-11-Methyl-2-dodecenoic acid,NA,Two-component system; Quorum sensing,NA,NA,NA,PubChem: 96024421; ChEBI: 81585; NIKKAJI: J2.017.966J,cpd:C15975; cpd:C15979; cpd:C18206,13,24,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H25O2,C13H23O2,212.17763,213.185455,211.1698055021,5491,cpd:C11837,N-Butyryl-L-homoserine lactone,C8H13NO3,N-Butyryl-L-homoserine lactone,R08939,Quorum sensing; Biofilm formation - Pseudomonas aeruginosa,2.3.1.184,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA08 Fatty amides;    FA0803 Fatty acyl homoserine lactones;     C11837  N-Butyrylhomoserine lactone,PubChem: 13999; ChEBI: 29643; ChEMBL: CHEMBL207316; LIPIDMAPS: LMFA08030002; PDB-CCD: HL4; 3DMET: B05548; NIKKAJI: J533.613I,cpd:C10284; cpd:C11837,8,13,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H14O3N1,C8H12O3N1,171.0895433,172.0973683,170.08171825022,5492,cpd:C11841,N-(3-Oxooctanoyl)homoserine lactone;,C12H19NO4,N-(3-Oxooctanoyl)homoserine lactone; N-(3-Oxooctanoyl)-L-homoserine lactone; OOHL,NA,Quorum sensing,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA08 Fatty amides;    FA0803 Fatty acyl homoserine lactones;     C11841  N-(3-Oxooctanoyl)homoserine lactone,CAS: 147795-39-9; PubChem: 14003; ChEBI: 43778; ChEMBL: CHEMBL463321; LIPIDMAPS: LMFA08030004; PDB-CCD: LAE; 3DMET: B04329; NIKKAJI: J533.603A,cpd:C11841,12,19,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H20O4N1,C12H18O4N1,241.1314081,242.1392331,240.12358315023,5493,cpd:C11844,N-Heptanoylhomoserine lactone,C11H19NO3,N-Heptanoylhomoserine lactone,NA,Quorum sensing,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA08 Fatty amides;    FA0803 Fatty acyl homoserine lactones;     C11844  N-Heptanoylhomoserine lactone,PubChem: 14006; ChEBI: 29644; ChEMBL: CHEMBL584972; LIPIDMAPS: LMFA08030006; 3DMET: B04330; NIKKAJI: J1.358.125H,cpd:C11844,11,19,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H20O3N1,C11H18O3N1,213.1364935,214.1443185,212.12866845024,5494,cpd:C11845,N-(3-Hydroxy-7-cis-tetradecenoyl)homoserine lactone,C18H31NO4,N-(3-Hydroxy-7-cis-tetradecenoyl)homoserine lactone,NA,Quorum sensing,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA08 Fatty amides;    FA0803 Fatty acyl homoserine lactones;     C11845  N-(3-Hydroxy-7-cis-tetradecenoyl)homoserine lactone,PubChem: 14007; ChEBI: 29638; LIPIDMAPS: LMFA08030007; 3DMET: B05552; NIKKAJI: J1.428.036G,cpd:C06852; cpd:C11845; cpd:C13800; cpd:C13958,18,31,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H32O4N1,C18H30O4N1,325.2253085,326.2331335,324.21748345025,5495,cpd:C11848,2-Heptyl-3-hydroxy-quinolone;,C16H21NO2,2-Heptyl-3-hydroxy-quinolone; 2-Heptyl-3-hydroxy-4(1H)-quinolone; 2-Heptyl-3-hydroxy-4-quinolone,R10467,Quorum sensing; Biofilm formation - Pseudomonas aeruginosa,1.14.13.182,NA,NA,PubChem: 14010; ChEBI: 29472; NIKKAJI: J147.303D,cpd:C04284; cpd:C07407; cpd:C11193; cpd:C11848,16,21,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H22O2N1,C16H20O2N1,259.1572289,260.165054,258.14940395026,5496,cpd:C20643,2-Heptyl-4(1H)-quinolone;,C16H21NO,2-Heptyl-4(1H)-quinolone; 2-Heptyl-4-quinolone; 2-Heptyl-4-hydroxyquinoline,R10467 R10589,Quorum sensing; Biofilm formation - Pseudomonas aeruginosa,1.14.13.182; 2.3.1.230,NA,NA,PubChem: 172232367,cpd:C10944; cpd:C20643,16,21,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H22O1N1,C16H20O1N1,243.1623143,244.1701393,242.15448935027,5497,cpd:C20677,N-(4-Coumaroyl)-L-homoserine lactone,C13H13NO4,N-(4-Coumaroyl)-L-homoserine lactone,R10529,Quorum sensing,2.3.1.229,NA,NA,PubChem: 172232397,cpd:C20677,13,13,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H14O4N1,C13H12O4N1,247.0844579,248.0922829,246.07663295028,5498,cpd:C20959,"(4S)-4-Hydroxy-5-phosphonooxypentane-2,3-dione;",C5H9O7P,"(4S)-4-Hydroxy-5-phosphonooxypentane-2,3-dione; Phospho-DPD; P-DPD",R10939 R11183,Quorum sensing,2.7.1.189; 5.3.1.32,NA,NA,PubChem: 254741420,cpd:C05218; cpd:C17947; cpd:C20959; cpd:C20960; cpd:C21372,5,9,7,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H10O7P1,C5H8O7P1,212.0085896,213.0164147,211.00076465029,5499,cpd:C21195,N-(3-Hydroxybutanoyl)-L-homoserine lactone;,C8H13NO4,N-(3-Hydroxybutanoyl)-L-homoserine lactone; 3-Hydroxy-C4-HSL; N-[(RS)-3-Hydroxybutyryl]-L-homoserine lactone,NA,Quorum sensing,NA,NA,NA,CAS: 1325550-06-8; PubChem: 316933494,cpd:C03682; cpd:C05548; cpd:C11842; cpd:C12988; cpd:C21195,8,13,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H14O4N1,C8H12O4N1,187.0844579,188.0922829,186.07663295030,5500,cpd:C21197,N-Hexanoyl-L-homoserine lactone;,C10H17NO3,N-Hexanoyl-L-homoserine lactone; C6-HSL; N-[(3S)-Tetrahydro-2-oxo-3-furanyl]-hexanamide,NA,Quorum sensing,NA,NA,NA,CAS: 147852-83-3; PubChem: 316933495; PDB-CCD: HL6,cpd:C10411; cpd:C12448; cpd:C21197,10,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H18O3N1,C10H16O3N1,199.1208434,200.1286684,198.11301845031,5501,cpd:C21198,N-(3-Oxohexanoyl)-L-homoserine lactone;,C10H15NO4,N-(3-Oxohexanoyl)-L-homoserine lactone; 3-Oxo-C6-HSL; N-(beta-Ketocaproyl)-L-homoserine lactone,NA,Quorum sensing,NA,NA,NA,CAS: 143537-62-6; PubChem: 316933496; PDB-CCD: 482,cpd:C11839; cpd:C12819; cpd:C17904; cpd:C21198,10,15,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H16O4N1,C10H14O4N1,213.100108,214.107933,212.09228295032,5502,cpd:C21199,N-Octanoyl-L-homoserine lactone;,C12H21NO3,N-Octanoyl-L-homoserine lactone; C8-HSL; N-[(3S)-Tetrahydro-2-oxo-3-furanyl]octanamide,NA,Quorum sensing,NA,NA,NA,CAS: 147852-84-4; PubChem: 316933497; PDB-CCD: HTF,cpd:C21199,12,21,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H22O3N1,C12H20O3N1,227.1521435,228.1599686,226.14431855033,5503,cpd:C21200,N-3-Hydroxyoctanoyl-L-homoserine lactone;,C12H21NO4,N-3-Hydroxyoctanoyl-L-homoserine lactone; 3-OH-C8-HSL; 3-Hydroxy-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octanamide,NA,Quorum sensing,NA,NA,NA,CAS: 192883-14-0; PubChem: 316933498,cpd:C01169; cpd:C21200,12,21,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H22O4N1,C12H20O4N1,243.1470582,244.1548832,242.13923315034,5504,cpd:C21201,N-3-Oxo-dodecanoyl-L-homoserine lactone;,C16H27NO4,N-3-Oxo-dodecanoyl-L-homoserine lactone; 3-Oxo-C12-HSL; 3-Oxo-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-dodecanamide,NA,Quorum sensing; Biofilm formation - Pseudomonas aeruginosa,NA,NA,NA,CAS: 168982-69-2; PubChem: 316933499; PDB-CCD: OHN,cpd:C11840; cpd:C21201,16,27,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H28O4N1,C16H26O4N1,297.1940084,298.2018334,296.18618335035,5505,cpd:C21382,R-THMF;,C5H10O5,"R-THMF; (2R,4S)-2-Methyl-2,3,3,4-tetrahydroxytetrahydrofuran",NA,Quorum sensing; Biofilm formation - Escherichia coli,NA,NA,NA,PubChem: 319902612; PDB-CCD: PAV,cpd:C00121; cpd:C00181; cpd:C00216; cpd:C00259; cpd:C00309; cpd:C00310; cpd:C00312; cpd:C00476; cpd:C00508; cpd:C01394; cpd:C01488; cpd:C01508; cpd:C01510; cpd:C02096; cpd:C02204; cpd:C02205; cpd:C02479; cpd:C02604; cpd:C05052; cpd:C06115; cpd:C08346; cpd:C08353; cpd:C08354; cpd:C11476; cpd:C16639; cpd:C20569; cpd:C21040; cpd:C21057; cpd:C21067; cpd:C21382,5,10,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O5,C5H9O5,150.0528234,151.0606485,149.04499845036,5506,cpd:C18076,5'-Phosphoguanylyl(3'->5')guanosine,C20H26N10O15P2,5'-Phosphoguanylyl(3'->5')guanosine,R08991,Biofilm formation - Pseudomonas aeruginosa; Biofilm formation - Vibrio cholerae,3.1.4.52,NA,NA,PubChem: 96024293; ChEBI: 48622; NIKKAJI: J2.585.053J,cpd:C18076,20,26,15,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H27O15N10P2,C20H25O15N10P2,708.1054342,709.1132592,707.09760915037,5507,cpd:C00716,Serine;,C3H7NO3,Serine; 2-Amino-3-hydroxypropionic acid; 3-Hydroxyalanine,R00223 R02818,Bacterial chemotaxis,4.3.1.15,NA,NA,CAS: 302-84-1; PubChem: 3982; ChEBI: 17822; LIPIDMAPS: LMFA01100045; NIKKAJI: J44.435I,cpd:C00065; cpd:C00716; cpd:C00740,3,7,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H8O3N1,C3H6O3N1,105.0425931,106.0504181,104.03476815038,5508,cpd:C01452,Sorbose;,C6H12O6,Sorbose; xylo-Hexulose,NA,Phosphotransferase system (PTS),NA,NA,NA,CAS: 3615-39-2; PubChem: 4629; ChEBI: 27922; PDB-CCD: SDD; NIKKAJI: J4.280C,cpd:C00031; cpd:C00095; cpd:C00124; cpd:C00137; cpd:C00159; cpd:C00221; cpd:C00247; cpd:C00267; cpd:C00737; cpd:C00738; cpd:C00764; cpd:C00795; cpd:C00936; cpd:C00962; cpd:C00984; cpd:C01452; cpd:C01487; cpd:C01582; cpd:C01680; cpd:C01698; cpd:C01719; cpd:C01720; cpd:C01825; cpd:C01906; cpd:C01934; cpd:C02101; cpd:C02209; cpd:C02336; cpd:C02347; cpd:C02782; cpd:C03999; cpd:C05003; cpd:C06151; cpd:C06152; cpd:C06153; cpd:C06464; cpd:C06465; cpd:C06466; cpd:C06467; cpd:C06468; cpd:C08351; cpd:C08356; cpd:C10906; cpd:C15923; cpd:C19891; cpd:C21032; cpd:C21050; cpd:C21066,6,12,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H13O6,C6H11O6,180.0633881,181.0712131,179.05556315039,5510,cpd:C16488,Fructoselysine,C12H24N2O7,Fructoselysine,R08124,Phosphotransferase system (PTS),2.7.1.-,NA,NA,PubChem: 47205784; ChEBI: 24109; NIKKAJI: J491.162H,cpd:C16488; cpd:C20978,12,24,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H25O7N2,C12H23O7N2,308.1583511,309.1661762,307.15052615040,5511,cpd:C16489,Fructoselysine 6-phosphate,C12H25N2O10P,Fructoselysine 6-phosphate,R08124 R08125,Phosphotransferase system (PTS),2.7.1.-; 3.5.-.-,NA,NA,PubChem: 47205785; ChEBI: 61437; NIKKAJI: J2.802.739G,cpd:C16489; cpd:C20979,12,25,10,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H26O10N2P1,C12H24O10N2P1,388.124682,389.132507,387.1168575041,5512,cpd:C16699,2-O-(6-Phospho-alpha-mannosyl)-D-glycerate;,C9H17O12P,2-O-(6-Phospho-alpha-mannosyl)-D-glycerate; 2-O-(6-Phospho-alpha-D-mannosyl)-D-glycerate,R09645 R11169,Phosphotransferase system (PTS),2.7.1.195; 3.2.1.170,NA,NA,PubChem: 51091021; ChEBI: 60331 61001; NIKKAJI: J2.804.412G,cpd:C11516; cpd:C16699; cpd:C19791; cpd:C21383,9,17,12,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H18O12P1,C9H16O12P1,348.045763,349.053588,347.03793795042,5513,cpd:C20978,Glucoselysine,C12H24N2O7,Glucoselysine,NA,Phosphotransferase system (PTS),NA,NA,NA,PubChem: 254741437,cpd:C16488; cpd:C20978,12,24,7,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H25O7N2,C12H23O7N2,308.1583511,309.1661762,307.15052615043,5514,cpd:C20979,Glucoselysine-6-phosphate,C12H25N2O10P,Glucoselysine-6-phosphate,NA,Phosphotransferase system (PTS),NA,NA,NA,PubChem: 254741438,cpd:C16489; cpd:C20979,12,25,10,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H26O10N2P1,C12H24O10N2P1,388.124682,389.132507,387.1168575044,5515,cpd:C21152,"N,N'-Diacetylchitobiose 6'-phosphate",C16H29N2O14P,"N,N'-Diacetylchitobiose 6'-phosphate",R11170,Phosphotransferase system (PTS),2.7.1.196,NA,NA,PubChem: 313369412,cpd:C21152,16,29,14,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H30O14N2P1,C16H28O14N2P1,504.1356406,505.1434656,503.12781565045,5517,cpd:C13050,Cyclic ADP-ribose;,C15H21N5O13P2,Cyclic ADP-ribose; cADPR,R10629 R10630,Calcium signaling pathway; Oxytocin signaling pathway; Salivary secretion; Pancreatic secretion,3.2.2.6,NA,NA,CAS: 119340-53-3; PubChem: 583439; ChEBI: 31445; ChEMBL: CHEMBL608904; NIKKAJI: J626.674F,cpd:C06743; cpd:C13050,15,21,13,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H22O13N5P2,C15H20O13N5P2,541.0611098,542.0689348,540.05328475046,5518,cpd:C13051,Nicotinic acid adenine dinucleotide phosphate;,C21H28N6O18P3,Nicotinic acid adenine dinucleotide phosphate; Nicotinate-adenine dinucleotide phosphate; NAADP,R00119 R10632,Calcium signaling pathway; Pancreatic secretion,2.4.99.20,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     C13051  Nicotinic acid adenine dinucleotide phosphate,CAS: 5502-96-5; PubChem: 583440; ChEBI: 76072; KNApSAcK: C00007537; PDB-CCD: DN4; NIKKAJI: J634.565D,cpd:C13051,21,28,18,6,3,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H29O18N6P3,C21H27O18N6P3,745.0672941,746.0751191,744.0594695047,5519,cpd:C00306,Bradykinin,C50H73N15O11,Bradykinin,NA,cGMP-PKG signaling pathway; Sphingolipid signaling pathway; Neuroactive ligand-receptor interaction; Complement and coagulation cascades; Inflammatory mediator regulation of TRP channels; Regulation of actin cytoskeleton; Chagas disease (American trypanosomiasis); African trypanosomiasis; Pathways in cancer,NA,NA,Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Peptide hormones;    Bradykinin;     C00306  Bradykinin; Bioactive peptides [BR:br08005];  Cardiovascular peptides;   Bradykinin;    C00306  Bradykinin; Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: peptide receptors;    Bradykinin;     bradykinin B2 receptor;      C00306  Bradykinin,CAS: 58-82-2; PubChem: 3600; ChEMBL: CHEMBL406291; 3DMET: B01212; NIKKAJI: J10.684D,cpd:C00306,50,73,11,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C50H74O11N15,C50H72O11N15,1059.561398,1060.569223,1058.5535735048,5521,cpd:C00746,Oxytocin;,C43H66N12O12S2,Oxytocin; Ocytocin; OT; OXT,NA,cAMP signaling pathway; Neuroactive ligand-receptor interaction,NA,NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Peptide hormones;    Oxytocin;     C00746  Oxytocin; Bioactive peptides [BR:br08005];  Pituitary hormones;   Posterior pituitary hormone;    C00746  Oxytocin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;   H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;    H01B POSTERIOR PITUITARY LOBE HORMONES;     H01BB Oxytocin and analogues;      H01BB02 Oxytocin;       D00089  Oxytocin (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   24  Hormones;    241  Pituitary hormone preparations;     2414  Posterior pituitary hormones;      D00089  Oxytocin (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Oxytocin;     oxytocin receptor;      Oxytocin;       D00089  Oxytocin (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00089  Oxytocin;   D00089  Oxytocin injection; Endocrine and hormonal agents [br08373.html];  Hormone related agents;   D00089;  Other gynecological agents;   D00089; Animal drugs in Japan [BR:br08331];  94  Agents for breeding;   942  Oxytocics;    9422  Posterior pituitary hormone and preparations;     C00746  Oxytocin",CAS: 50-56-6; PubChem: 4008; ChEBI: 7872; ChEMBL: CHEMBL395429; 3DMET: B01323; NIKKAJI: J1.360I,cpd:C00746,43,66,12,12,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C43H67O12N12S2,C43H65O12N12S2,1006.436458,1007.444283,1005.4286335049,5522,cpd:C20792,Oleoylethanolamide;,C20H39NO2,Oleoylethanolamide; OEA,NA,cAMP signaling pathway,NA,NA,NA,CAS: 111-58-0; PubChem: 254741259,cpd:C20792,20,39,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H40O2N1,C20H38O2N1,325.2980795,326.3059045,324.29025455050,5523,cpd:C20793,3-Hydroxyoctanoate;,C8H16O3,3-Hydroxyoctanoate; 3-Hydroxyoctanoic acid,NA,cAMP signaling pathway,NA,NA,NA,CAS: 14292-27-4; PubChem: 254741260,cpd:C02155; cpd:C02727; cpd:C03846; cpd:C03864; cpd:C03865; cpd:C12989; cpd:C16649; cpd:C16650; cpd:C16651; cpd:C16739; cpd:C17242; cpd:C17527; cpd:C19007; cpd:C20793; cpd:C21099; cpd:C21388,8,16,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H17O3,C8H15O3,160.1099444,161.1177694,159.10211935051,5525,cpd:C11174,1-Diphosinositol pentakisphosphate;,C6H19O27P7,"1-Diphosinositol pentakisphosphate; D-myo-Inositol, 2,3,4,5,6-pentakis(dihydrogen phosphate) 1-(trihydrogen diphosphate); Diphospho-myo-inositol pentakisphosphate; 1D-myo-Inositol 1-diphosphate 2,3,4,5,6-pentakisphosphate",R05799 R10548,Phosphatidylinositol signaling system,2.7.4.21; 2.7.4.24,NA,NA,CAS: 148077-18-3; PubChem: 13356; ChEBI: 62919; NIKKAJI: J1.026.048E,cpd:C11174; cpd:C11526,6,19,27,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H20O27P7,C6H18O27P7,739.8277043,740.8355294,738.81987935052,5526,cpd:C11526,5-PP-InsP5;,C6H19O27P7,"5-PP-InsP5; 5-Diphosphoinositol pentakisphosphate; 1D-myo-Inositol 5-diphosphate pentakisphosphate; 1D-myo-Inositol 5-diphosphate 1,2,3,4,6-pentakisphosphate",R05779 R08964 R09087,Phosphatidylinositol signaling system,2.7.4.21; 2.7.4.24; 3.6.1.52,NA,NA,PubChem: 13694; ChEBI: 30164; ChEMBL: CHEMBL1241856; PDB-CCD: I7P; NIKKAJI: J2.774.881C,cpd:C11174; cpd:C11526,6,19,27,0,7,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H20O27P7,C6H18O27P7,739.8277043,740.8355294,738.81987935053,5527,cpd:C20690,"1D-myo-Inositol 1,5-bis(diphosphate) 2,3,4,6-tetrakisphosphate",C6H20O30P8,"1D-myo-Inositol 1,5-bis(diphosphate) 2,3,4,6-tetrakisphosphate",R08964 R10548,Phosphatidylinositol signaling system,2.7.4.21; 2.7.4.24,NA,NA,PubChem: 172232410; PDB-CCD: I8P,cpd:C20690,6,20,30,0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H21O30P8,C6H19O30P8,819.7940352,820.8018603,818.78621025054,5529,cpd:C02135,Angiotensin II;,C50H71N13O12,Angiotensin II; Angiotensin; Angiotonin; Hypertensin,R09535,Phospholipase D signaling pathway; Neuroactive ligand-receptor interaction; Adrenergic signaling in cardiomyocytes; Vascular smooth muscle contraction; Renin-angiotensin system; Renin secretion; Aldosterone synthesis and secretion; Insulin resistance; AGE-RAGE signaling pathway in diabetic complications; Pathways in cancer; Hypertrophic cardiomyopathy (HCM); Dilated cardiomyopathy; Angiotensin receptor and endothelin receptor antagonists,3.4.17.23,NA,Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Peptide hormones;    Angiotensin;     C02135  Angiotensin II; Bioactive peptides [BR:br08005];  Cardiovascular peptides;   Angiotensin;    C02135  Angiotensin II,CAS: 11128-99-7 1407-47-2; PubChem: 5214; ChEBI: 2719; ChEMBL: CHEMBL408403; 3DMET: B04840; NIKKAJI: J240.229G,cpd:C02135,50,71,12,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C50H72O12N13,C50H70O12N13,1045.534515,1046.54234,1044.526695055,5530,cpd:C18699,(-)-Jasmonoyl-L-isoleucine;,C18H29NO4,(-)-Jasmonoyl-L-isoleucine; (-)-JA-L-Ile,NA,Plant hormone signal transduction,NA,NA,NA,PubChem: 124489373; ChEBI: 81897; PDB-CCD: JAI,cpd:C09878; cpd:C18699,18,29,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H30O4N1,C18H28O4N1,323.2096584,324.2174834,322.20183345056,5533,cpd:C07151,Metformin,C4H11N5,Metformin,NA,AMPK signaling pathway; Longevity regulating pathway; Bile secretion,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A10 DRUGS USED IN DIABETES;    A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS;     A10BA Biguanides;      A10BA02 Metformin;       D04966  Metformin (USAN/INN); USP drug classification [BR:br08302];  Blood Glucose Regulators;   Antidiabetic Agents;    Metformin;     D04966  Metformin (USAN/INN); Target-based classification of drugs [BR:br08310];  Protein kinases;   Serine/threonine protein kinases: CAMK group;    CAMKL family;     AMPK;      Metformin;       D04966  Metformin (USAN/INN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   SLC22A2;    Metformin;     D04966  Metformin (USAN/INN);   MATE1;    Metformin;     D04966  Metformin (USAN/INN);   MATE2;    Metformin;     D04966  Metformin (USAN/INN)",CAS: 657-24-9; PubChem: 9360; ChEBI: 6801; ChEMBL: CHEMBL1431; NIKKAJI: J9.463C,cpd:C07151,4,11,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H12N5,C4H10N5,129.1014454,130.1092704,128.09362035057,5534,cpd:C09731,Epigallocatechin 3-gallate,C22H18O11,Epigallocatechin 3-gallate,NA,AMPK signaling pathway,NA,NA,Lipids [BR:br08002];  PK  Polyketides;   PK12 Flavonoids;    PK1203 Proanthocyanidins;     C09731  Epigallocatechin 3-gallate; Phytochemical compounds [BR:br08003];  Flavonoids;   Flavonoids;    Flavan 3-ols;     C09731  Epigallocatechin 3-gallate,CAS: 989-51-5; PubChem: 11919; ChEBI: 4806; ChEMBL: CHEMBL297453; LIPIDMAPS: LMPK12030005; KNApSAcK: C00000958; PDB-CCD: KDH; 3DMET: B03230; NIKKAJI: J134.058A,cpd:C09731; cpd:C12379,22,18,11,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H19O11,C22H17O11,458.0849114,459.0927364,457.07708645058,5535,cpd:C21077,Delta7-Dafachronic acid;,C27H42O3,"Delta7-Dafachronic acid; 3-Keto-7,(5alpha)-cholestenoic acid; (25S)-Delta7-Dafachronic acid",NA,Longevity regulating pathway - worm,NA,NA,NA,PubChem: 295369339; PDB-CCD: D7S,cpd:C08898; cpd:C08918; cpd:C14994; cpd:C16509; cpd:C20839; cpd:C21076; cpd:C21077,27,42,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C27H43O3,C27H41O3,414.3133952,415.3212202,413.30557025059,5536,cpd:C07056,Isoproterenol;,C11H17NO3,Isoproterenol; Isoprenaline,NA,Adrenergic signaling in cardiomyocytes,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;     C01CA Adrenergic and dopaminergic agents;      C01CA02 Isoprenaline;       D08090  Isoprenaline (INN);  R RESPIRATORY SYSTEM;   R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;    R03A ADRENERGICS, INHALANTS;     R03AB Non-selective beta-adrenoreceptor agonists;      R03AB02 Isoprenaline;       D08090  Isoprenaline (INN);    R03C ADRENERGICS FOR SYSTEMIC USE;     R03CB Non-selective beta-adrenoreceptor agonists;      R03CB01 Isoprenaline;       D08090  Isoprenaline (INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Adrenaline;     beta1-adrenergic receptor;      Isoprenaline;       D08090  Isoprenaline (INN);     beta2-adrenergic receptor;      Isoprenaline;       D08090  Isoprenaline (INN);     beta3-adrenergic receptor;      Isoprenaline;       D08090  Isoprenaline (INN)",CAS: 7683-59-2; PubChem: 9268; ChEBI: 64317; ChEMBL: CHEMBL434; NIKKAJI: J28.477G,cpd:C06546; cpd:C07056; cpd:C07144; cpd:C07513; cpd:C11703,11,17,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H18O3N1,C11H16O3N1,211.1208434,212.1286684,210.11301845060,5537,cpd:C13662,Arg-vasopressin;,C46H65N15O12S2,Arg-vasopressin; Argipressin; 8-L-Arginine vasopressin; AVP; ADH,NA,Neuroactive ligand-receptor interaction; Vascular smooth muscle contraction,NA,NA,"Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Peptide hormones;    Arginine vasopressin;     C13662  Arg-vasopressin; Bioactive peptides [BR:br08005];  Pituitary hormones;   Posterior pituitary hormone;    C13662  Arg-vasopressin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;   H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;    H01B POSTERIOR PITUITARY LOBE HORMONES;     H01BA Vasopressin and analogues;      H01BA06 Argipressin;       D02983  Argipressin tannate (USAN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Vasopressin;     arginine vasopressin receptor 1A (AVPR1A);      Argipressin;       D02983  Argipressin tannate (USAN);     arginine vasopressin receptor 1B (AVPR1B);      Argipressin;       D02983  Argipressin tannate (USAN);     arginine vasopressin receptor 2 (AVPR2);      Argipressin;       D02983  Argipressin tannate (USAN)",CAS: 113-79-1; PubChem: 854003; ChEBI: 34543; NIKKAJI: J1.025A,cpd:C13662,46,65,12,15,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C46H66O12N15S2,C46H64O12N15S2,1083.437855,1084.44568,1082.430035061,5538,cpd:C20640,Cyclic GMP-AMP;,C20H24N10O13P2,Cyclic GMP-AMP; Cyclic Gp(2'-5')Ap(3'-5'); cGAMP(2'-5'),R10462,Cytosolic DNA-sensing pathway,2.7.7.86,NA,NA,PubChem: 172232364; PDB-CCD: 1SY,cpd:C19928; cpd:C20640,20,24,13,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H25O13N10P2,C20H23O13N10P2,674.0999549,675.1077799,673.09212985062,5541,cpd:C11695,Anandamide;,C22H37NO2,"Anandamide; Arachidonylethanolamide; N-(5Z,8Z,11Z,14Z-icosatetraenoyl)-ethanolamide; AEA",R09536,Neuroactive ligand-receptor interaction; Retrograde endocannabinoid signaling; Inflammatory mediator regulation of TRP channels,3.5.1.99,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA08 Fatty amides;    FA0804 N-acyl ethanolamides (endocannabinoids);     C11695  N-(5Z,8Z,11Z,14Z-icosatetraenoyl)-ethanolamide",CAS: 94421-68-8; PubChem: 13860; ChEBI: 2700; ChEMBL: CHEMBL15848; LIPIDMAPS: LMFA08040001; 3DMET: B04313; NIKKAJI: J535.861B,cpd:C11695,22,37,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H38O2N1,C22H36O2N1,347.2824294,348.2902545,346.27460445063,5542,cpd:C13856,2-Arachidonoylglycerol;,C23H38O4,2-Arachidonoylglycerol; 2-Arachidonoyl-sn-glycerol; 2-AG,NA,Neuroactive ligand-receptor interaction; Retrograde endocannabinoid signaling,NA,NA,Lipids [BR:br08002];  FA  Fatty acyls;   FA10 Fatty ethers;    C13856  2-Arachidonoyl-sn-glycerol;  GL  Glycerolipids;   GL01 Monoradylglycerols;    GL0101 Monoacylglycerols;     C13856  2-Arachidonoyl-sn-glycerol; Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: other receptors;    Lysophosphatidylinositol;     G protein-coupled receptor 55;      C13856  2-Arachidonoylglycerol,CAS: 53847-30-6; PubChem: 854101; ChEBI: 52392; ChEMBL: CHEMBL122972; LIPIDMAPS: LMGL01010023; LipidBank: NAG5233; 3DMET: B04604; NIKKAJI: J671.147B,cpd:C13856; cpd:C13857,23,38,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H39O4,C23H37O4,378.2770097,379.2848347,377.26918475064,5544,cpd:C19913,Phospho-anandamide,C22H37NO5P,Phospho-anandamide,NA,Retrograde endocannabinoid signaling,NA,NA,NA,PubChem: 135626379; ChEMBL: CHEMBL158956; LIPIDMAPS: LMFA08020002,cpd:C19913,22,37,5,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H38O5N1P1,C22H36O5N1P1,426.2409353,427.2487603,425.23311035065,5545,cpd:C01327,Hydrochloric acid;,HCl,Hydrochloric acid; HCl; Hydrogen chloride; Hydrochloride,R00052 R00603 R01031 R03306 R04500 R04522 R05267 R05269; R05276 R05284 R05287 R05367 R05368 R05369 R05370 R05371; R05372 R05384 R05385 R05386 R05387 R05388 R05390 R05391; R05392 R05393 R05402 R05403 R05408 R05445 R05477 R05483; R05484 R05498 R05499 R05500 R05501 R05502 R05503 R05558; R05572 R06834 R06840 R06848 R06966 R07092 R07093 R07094; R07100 R07669 R07670 R07794 R09135 R09137 R09138 R09151; R09152 R09154 R09155 R09156 R09157 R09217 R09221 R09223; R10097,Taste transduction; Protein digestion and absorption,1.3.1.32; 1.11.1.10; 1.13.11.-; 1.13.12.-; 1.14.12.9; 1.14.12.11; 1.14.99.39; 1.21.1.2; 1.97.1.8; 1.97.1.-; 2.5.1.18; 2.5.1.-; 3.5.4.43; 3.8.1.2; 3.8.1.3; 3.8.1.5; 3.8.1.8; 3.8.1.-; 4.5.1.1; 4.5.1.2; 4.5.1.3; 4.5.1.-; 5.5.1.1; 5.5.1.7; 5.5.1.11,NA,"Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C01327  Hydrochloric acid; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A09 DIGESTIVES, INCL. ENZYMES;    A09A DIGESTIVES, INCL. ENZYMES;     A09AB Acid preparations;      A09AB03 Hydrochloric acid;       D02057  Hydrochloric acid (JP17/NF);  B BLOOD AND BLOOD FORMING ORGANS;   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;    B05X I.V. SOLUTION ADDITIVES;     B05XA Electrolyte solutions;      B05XA13 Hydrochloric acid;       D02057  Hydrochloric acid (JP17/NF); Therapeutic category of drugs in Japan [BR:br08301];  7  Agents not mainly for therapeutic purpose;   71  Dispensing medicines;    719  Miscellaneous;     7190  Miscellaneous;      D02057  Hydrochloric acid (JP17/NF); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D02057  [001113] Hydrochloric acid;  Solubilizing agent;   D02057  [001113] Hydrochloric acid;  Flavoring substance;   D02057  [001113] Hydrochloric acid;  pH regulator;   D02057  [001113] Hydrochloric acid;  Solubilizer;   D02057  [001113] Hydrochloric acid;  Solubilization agent;   D02057  [001113] Hydrochloric acid;  Solvent;   D02057  [001113] Hydrochloric acid; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D02057  Hydrochloric acid",CAS: 7647-01-0; PubChem: 4538; ChEBI: 17883; ChEMBL: CHEMBL1231821; NIKKAJI: J3.745A,cpd:C01327; cpd:C01485; cpd:C01486; cpd:C07184; cpd:C07340; cpd:C07376; cpd:C07384; cpd:C07436; cpd:C07515; cpd:C07677; cpd:C07701; cpd:C07784; cpd:C07843; cpd:C07894; cpd:C07898; cpd:C07906; cpd:C07939; cpd:C07952; cpd:C07982; cpd:C08026; cpd:C08029; cpd:C08053; cpd:C08054; cpd:C08072; cpd:C08094; cpd:C08123; cpd:C11276; cpd:C11320; cpd:C11337; cpd:C11582; cpd:C11598; cpd:C11618; cpd:C11619; cpd:C11628; cpd:C11744; cpd:C12490; cpd:C12557; cpd:C12717; cpd:C12798; cpd:C12886; cpd:C12937; cpd:C12948; cpd:C12954; cpd:C13055; cpd:C13089; cpd:C13112; cpd:C13144; cpd:C13182; cpd:C13235; cpd:C13441; cpd:C13534; cpd:C13546; cpd:C13591; cpd:C13639; cpd:C13684; cpd:C13851; cpd:C13978; cpd:C13993; cpd:C14002; cpd:C14081; cpd:C14410; cpd:C14692; cpd:C15270; cpd:C15311; cpd:C15328; cpd:C15343; cpd:C15360; cpd:C15389; cpd:C15411; cpd:C15452; cpd:C15663; cpd:C18370; cpd:C18376; cpd:C19210; cpd:C19252; cpd:C19290; cpd:C19305; cpd:C19353; cpd:C19361; cpd:C19369; cpd:C19441; cpd:C19513; cpd:C19521; cpd:C19697,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,H2Cl1,H0Cl1,35.97667771,36.98450275,34.968852685066,5546,cpd:C11045,Aspartame,C14H18N2O5,Aspartame,NA,Taste transduction,NA,NA,Pharmaceutical additives [BR:br08316];  Sweetening agent;   D02381  [109295] Aspartame;  Flavoring substance;   D02381  [109295] Aspartame; alpha-Aspartyl-L-Phenylalanine methyl ester; Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Metabotropic glutamate receptor family;    Chemoreception;     taste receptor type 1;      Aspartame;       D02381  Aspartame (NF/INN),CAS: 22839-47-0; PubChem: 13228; ChEBI: 2877; ChEMBL: CHEMBL312245; PDB-CCD: PME; NIKKAJI: J11.477D,cpd:C11045,14,18,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H19O5N2,C14H17O5N2,294.1215717,295.1293967,293.11374675067,5547,cpd:C12283,Saccharin,C7H5NO3S,Saccharin,NA,Taste transduction,NA,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C12283  Saccharin; Pharmaceutical additives [BR:br08316];  Sweetening agent;   D01085  [106066] Saccharin;  Flavoring substance;   D01085  [106066] Saccharin; Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Metabotropic glutamate receptor family;    Chemoreception;     taste receptor type 1;      Saccharin;       D01085  Saccharin (JP17/NF); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D01085  Saccharin,CAS: 81-07-2; PubChem: 14427; ChEMBL: CHEMBL310671; PDB-CCD: LSA,cpd:C12283,7,5,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C7H6O3N1S1,C7H4O3N1S1,182.9990142,184.0068392,181.99118925068,5551,cpd:C18195,(3R)-11-cis-3-Hydroxyretinal,C20H28O2,(3R)-11-cis-3-Hydroxyretinal,R10192,Phototransduction - fly,1.13.11.65,NA,NA,PubChem: 96024410; ChEBI: 81574; NIKKAJI: J593.402H,cpd:C00777; cpd:C07058; cpd:C09188; cpd:C12078; cpd:C14489; cpd:C14652; cpd:C14684; cpd:C14910; cpd:C14925; cpd:C15263; cpd:C15307; cpd:C15353; cpd:C15493; cpd:C16683; cpd:C18195; cpd:C18196; cpd:C18603; cpd:C20428; cpd:C20429,20,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O2,C20H27O2,300.2089301,301.2167552,299.20110515069,5552,cpd:C18196,(3R)-all-trans-3-Hydroxyretinal,C20H28O2,(3R)-all-trans-3-Hydroxyretinal,R10192,Phototransduction - fly,1.13.11.65,NA,NA,PubChem: 96024411; ChEBI: 81575; LIPIDMAPS: LMPR01090049; NIKKAJI: J593.403F,cpd:C00777; cpd:C07058; cpd:C09188; cpd:C12078; cpd:C14489; cpd:C14652; cpd:C14684; cpd:C14910; cpd:C14925; cpd:C15263; cpd:C15307; cpd:C15353; cpd:C15493; cpd:C16683; cpd:C18195; cpd:C18196; cpd:C18603; cpd:C20428; cpd:C20429,20,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O2,C20H27O2,300.2089301,301.2167552,299.20110515070,5553,cpd:C20428,(3S)-11-cis-3-Hydroxyretinal,C20H28O2,(3S)-11-cis-3-Hydroxyretinal,NA,Phototransduction - fly,NA,NA,NA,PubChem: 163312165; LIPIDMAPS: LMPR01090048,cpd:C00777; cpd:C07058; cpd:C09188; cpd:C12078; cpd:C14489; cpd:C14652; cpd:C14684; cpd:C14910; cpd:C14925; cpd:C15263; cpd:C15307; cpd:C15353; cpd:C15493; cpd:C16683; cpd:C18195; cpd:C18196; cpd:C18603; cpd:C20428; cpd:C20429,20,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O2,C20H27O2,300.2089301,301.2167552,299.20110515071,5554,cpd:C20429,(3S)-all-trans-3-Hydroxyretinal,C20H28O2,(3S)-all-trans-3-Hydroxyretinal,NA,Phototransduction - fly,NA,NA,NA,PubChem: 163312166; LIPIDMAPS: LMPR01090050,cpd:C00777; cpd:C07058; cpd:C09188; cpd:C12078; cpd:C14489; cpd:C14652; cpd:C14684; cpd:C14910; cpd:C14925; cpd:C15263; cpd:C15307; cpd:C15353; cpd:C15493; cpd:C16683; cpd:C18195; cpd:C18196; cpd:C18603; cpd:C20428; cpd:C20429,20,28,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O2,C20H27O2,300.2089301,301.2167552,299.20110515072,5555,cpd:C00809,(-)-Camphor,C10H16O,(-)-Camphor,R02945,Inflammatory mediator regulation of TRP channels,1.1.1.227,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0102 C10 isoprenoids (monoterpenes);     PR010212 Bicyclic monoterpenoids;      C00809  (-)-Camphor; Phytochemical compounds [BR:br08003];  Terpenoids;   Monoterpenoids (C10);    Cyclic monoterpenes;     C00809  (-)-Camphor; Major components of natural products [BR:br08323];  Essential oils;   Sage oil (Spanish);    C00809  (-)-Camphor,CAS: 464-48-2; PubChem: 4067; ChEBI: 15397 36773; ChEMBL: CHEMBL15768; KNApSAcK: C00000135; 3DMET: B04730; NIKKAJI: J67.498B,cpd:C00808; cpd:C00809; cpd:C00964; cpd:C01123; cpd:C01499; cpd:C02213; cpd:C02452; cpd:C02759; cpd:C04435; cpd:C06976; cpd:C07271; cpd:C09847; cpd:C09859; cpd:C09885; cpd:C09893; cpd:C09906; cpd:C11120; cpd:C11387; cpd:C11395; cpd:C11398; cpd:C11401; cpd:C11408; cpd:C11409; cpd:C11412; cpd:C11415; cpd:C11938; cpd:C11941; cpd:C11942; cpd:C11951; cpd:C17623; cpd:C18018; cpd:C18369; cpd:C18813; cpd:C19081; cpd:C20260; cpd:C20425; cpd:C20943,10,16,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H17O1,C10H15O1,152.1201151,153.1279402,151.11229015073,5557,cpd:C07600,Allicin;,C6H10OS2,Allicin; 2-Propene-1-sulfinothioic acid S-2-propenyl ester,NA,Inflammatory mediator regulation of TRP channels,NA,NA,"Target-based classification of compounds [BR:br08010];  Ion channels;   Related to voltage-gated cation channels;    Transient receptor potential family, TRPA (ANKTM1);     transient receptor potential cation channel, subfamily A, member 1;      C07600  Allicin; Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C19;    Allicin;     C07600  Allicin",CAS: 539-86-6; PubChem: 9802; ChEBI: 28411; ChEMBL: CHEMBL359965; KNApSAcK: C00001242; NIKKAJI: J71.032F,cpd:C07600,6,10,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C6H11O1S2,C6H9O1S2,162.0173073,163.0251323,161.00948235074,5558,cpd:C09155,Phorbol,C20H28O6,Phorbol,NA,Inflammatory mediator regulation of TRP channels,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0104 C20 isoprenoids (diterpenes);     PR010433 Tigliane and ingenane diterpenoids;      C09155  Phorbol; Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Tiglianes;     C09155  Phorbol; Natural toxins [BR:br08009];  Phytotoxins;   Terpenoids;    Diterpenoids;     C09155  Phorbol,CAS: 17673-25-5; PubChem: 11347; ChEBI: 8116; ChEMBL: CHEMBL124518; LIPIDMAPS: LMPR0104330001; KNApSAcK: C00003465; 3DMET: B02725; NIKKAJI: J9.694F,cpd:C06095; cpd:C09155; cpd:C09178; cpd:C09414; cpd:C09535; cpd:C11859; cpd:C17642; cpd:C21093,20,28,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H29O6,C20H27O6,364.1885886,365.1964137,363.18076365075,5559,cpd:C09179,Resiniferatoxin;,C37H40O9,Resiniferatoxin; RTX,NA,Inflammatory mediator regulation of TRP channels,NA,NA,"Phytochemical compounds [BR:br08003];  Terpenoids;   Diterpenoids (C20);    Daphnanes;     C09179  Resiniferatoxin; Target-based classification of compounds [BR:br08010];  Ion channels;   Related to voltage-gated cation channels;    Transient receptor potential family, TRPV (Vanilloid);     transient receptor potential cation channel, subfamily V, member 1;      C09179  Resiniferatoxin",CAS: 57444-62-9; PubChem: 11371; ChEBI: 8809; KNApSAcK: C00003478; 3DMET: B05329; NIKKAJI: J282.917G,cpd:C09179,37,40,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H41O9,C37H39O9,628.2672329,629.2750579,627.25940785076,5560,cpd:C12083,"(5Z,7E,9E,14Z,17Z)-Eicosapentaenoic acid;",C20H30O2,"(5Z,7E,9E,14Z,17Z)-Eicosapentaenoic acid; (5Z,7E,9E,14Z,17Z)-Eicosapentaenoate",R06502,Inflammatory mediator regulation of TRP channels,5.3.3.13,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0103 Unsaturated fatty acids;     Polyunsaturated fatty acids;      C12083  (5Z,7E,9E,14Z,17Z)-Icosapenta-5,7,9,14,17-enoic acid",PubChem: 14234; LIPIDMAPS: LMFA01030760; KNApSAcK: C00000438; 3DMET: B04416; NIKKAJI: J606.986J,cpd:C06087; cpd:C06428; cpd:C07198; cpd:C09118; cpd:C09148; cpd:C09159; cpd:C11874; cpd:C11888; cpd:C11889; cpd:C12077; cpd:C12083; cpd:C14255; cpd:C14490; cpd:C14588; cpd:C14890; cpd:C15003; cpd:C15008; cpd:C15017; cpd:C15036; cpd:C15070; cpd:C15184; cpd:C15188; cpd:C15259; cpd:C15318; cpd:C15412; cpd:C15460; cpd:C20149; cpd:C20208,20,30,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H31O2,C20H29O2,302.2245802,303.2324052,301.21675525077,5561,cpd:C12271,N-Arachidonyl dopamine;,C28H41NO3,N-Arachidonyl dopamine; Arachidonoyl dopamine; NADA,NA,Neuroactive ligand-receptor interaction; Inflammatory mediator regulation of TRP channels,NA,NA,NA,PubChem: 14416; ChEBI: 31231; ChEMBL: CHEMBL138921; LIPIDMAPS: LMFA08020084; NIKKAJI: J1.042.178K,cpd:C12271,28,41,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C28H42O3N1,C28H40O3N1,439.3086442,440.3164692,438.30081925078,5562,cpd:C19317,Allyl isothiocyanate;,C4H5NS,Allyl isothiocyanate; Mustard oil,NA,Inflammatory mediator regulation of TRP channels,NA,NA,"Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C19317  Allyl isothiocyanate; Target-based classification of compounds [BR:br08010];  Ion channels;   Related to voltage-gated cation channels;    Transient receptor potential family, TRPA (ANKTM1);     transient receptor potential cation channel, subfamily A, member 1;      C19317  Allyl isothiocyanate; Pharmaceutical additives [BR:br08316];  Favoring agent, Fragrance;   D02818  [100395] Allyl isothiocyanate",CAS: 57-06-7; PubChem: 124489989; ChEBI: 73224; ChEMBL: CHEMBL233248,cpd:C11105; cpd:C19317,4,5,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C4H6N1S1,C4H4N1S1,99.01427034,100.0220954,98.006445315079,5563,cpd:C20171,Icilin;,C16H13N3O4,Icilin; AG 3-5,NA,Inflammatory mediator regulation of TRP channels,NA,NA,"Target-based classification of compounds [BR:br08010];  Ion channels;   Related to voltage-gated cation channels;    Transient receptor potential family, TRPM (Melastatin/Long TRP);     transient receptor potential cation channel, subfamily M, member 8;      C20171  Icilin;    Transient receptor potential family, TRPA (ANKTM1);     transient receptor potential cation channel, subfamily A, member 1;      C20171  Icilin",CAS: 36945-98-9; PubChem: 163311914; ChEMBL: CHEMBL258405,cpd:C20171,16,13,4,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H14O4N3,C16H12O4N3,311.0906059,312.0984309,310.08278095080,5564,cpd:C20698,2-Aminoethyl diphenylborinate;,C14H16BNO,2-Aminoethyl diphenylborinate; 2-APB,NA,Inflammatory mediator regulation of TRP channels,NA,NA,NA,CAS: 524-95-8; PubChem: 172232418; ChEBI: 131184,cpd:C20698,14,16,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,C14H17O1N1B1,C14H15O1N1B1,225.1308491,226.1386742,224.12302415081,5565,cpd:C14209,4-Hydroxyestradiol-17beta;,C18H24O3,4-Hydroxyestradiol-17beta; 4-OH-Estradiol,NA,Ovarian steroidogenesis,NA,NA,NA,CAS: 5976-61-4; PubChem: 7847019; ChEBI: 62845; ChEMBL: CHEMBL1412489; LIPIDMAPS: LMST02010028; NIKKAJI: J353.576B,cpd:C03935; cpd:C05141; cpd:C05301; cpd:C14209; cpd:C15385; cpd:C18415,18,24,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H25O3,C18H23O3,288.1725446,289.1803697,287.16471965082,5567,cpd:C07639,"3,3',5'-Triiodo-L-thyronine;",C15H12I3NO4,"3,3',5'-Triiodo-L-thyronine; 3,3',5'-Triiodothyronine; Reverse triiodothyronine; rT3",R07230,Thyroid hormone signaling pathway,1.21.99.3,NA,NA,CAS: 5817-39-0; PubChem: 9841; ChEBI: 11684 28774; ChEMBL: CHEMBL1743304; NIKKAJI: J402.028F,cpd:C02465; cpd:C07639,15,12,4,1,0,0,0,3,0,0,0,0,0,0,0,0,0,0,C15H13O4N1I3,C15H11O4N1I3,650.7900039,651.7978289,649.78217885083,5568,cpd:C00182,Glycogen,C24H42O21,Glycogen,NA,Glucagon signaling pathway,NA,NA,NA,CAS: 9005-79-2; PubChem: 3482; ChEBI: 28087; NIKKAJI: J98.335G,cpd:C00182; cpd:C01613; cpd:C02013; cpd:C02052; cpd:C03989; cpd:C04861; cpd:C08242; cpd:C08248,24,42,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H43O21,C24H41O21,666.2218584,667.2296834,665.21403335084,5569,cpd:C00873,Angiotensin I,C62H89N17O14,Angiotensin I,NA,Renin-angiotensin system; Renin secretion,NA,NA,Compounds with biological roles [BR:br08001];  Hormones and transmitters;   Peptide hormones;    Angiotensin;     C00873  Angiotensin I; Bioactive peptides [BR:br08005];  Cardiovascular peptides;   Angiotensin;    C00873  Angiotensin I,CAS: 9041-90-1 484-42-4; PubChem: 4130; ChEBI: 2718; ChEMBL: CHEMBL262670; 3DMET: B04738; NIKKAJI: J38.546H,cpd:C00873,62,89,14,17,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C62H90O14N17,C62H88O14N17,1295.677491,1296.685316,1294.6696665085,5570,cpd:C02107,"(S,S)-Tartaric acid;",C4H6O6,"(S,S)-Tartaric acid; (S,S)-Tartrate; D-Tartrate; D-Tartaric acid; (2S,3S)-Tartaric acid; (-)-Tartaric acid",R00340,Aldosterone synthesis and secretion,4.2.1.81,NA,Pharmaceutical additives [BR:br08316];  Flavoring substance;   C02107  [108382] D-Tartaric acid;  pH regulator;   C02107  [108382] D-Tartaric acid,CAS: 147-71-7; PubChem: 5189; ChEBI: 15672; ChEMBL: CHEMBL1200861; PDB-CCD: TAR; NIKKAJI: J9.264I,cpd:C00552; cpd:C00898; cpd:C02107; cpd:C12959; cpd:C13500,4,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C4H7O6,C4H5O6,150.0164379,151.0242629,149.00861295086,5571,cpd:C02571,O-Acetylcarnitine;,C9H18NO4,O-Acetylcarnitine; O-Acetyl-L-carnitine,R02396,Insulin resistance,2.3.1.7,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N06 PSYCHOANALEPTICS;    N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS;     N06BX Other psychostimulants and nootropics;      N06BX12 Acetylcarnitine;       C02571  O-Acetylcarnitine",PubChem: 5567; ChEBI: 15960 57589; ChEMBL: CHEMBL1358846 CHEMBL1697733; 3DMET: B01589; NIKKAJI: J370.408D,cpd:C02571,9,18,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H19O4N1,C9H17O4N1,204.1235831,205.1314081,203.1157585087,5576,cpd:C01353,Carbonic acid;,H2CO3,Carbonic acid; Dihydrogen carbonate; H2CO3,R00132 R05561 R07835,Proximal tubule bicarbonate reclamation; Collecting duct acid secretion; Salivary secretion; Gastric acid secretion; Pancreatic secretion; Bile secretion,3.5.2.15; 4.2.1.1,NA,NA,CAS: 463-79-6; PubChem: 4557; ChEBI: 28976; ChEMBL: CHEMBL1161632; PDB-CCD: BCT CO3; 3DMET: B00276; NIKKAJI: J148.096K,cpd:C01353; cpd:C03547,1,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H3O3,C1H1O3,62.00039392,63.00821896,60.992568895088,5580,cpd:C12285,Sucralose,C12H19Cl3O8,Sucralose,NA,Carbohydrate digestion and absorption,NA,NA,Pharmaceutical additives [BR:br08316];  Sweetening agent;   C12285  [999999] Sucralose;  Flavoring substance;   C12285  [999999] Sucralose,CAS: 56038-13-2; PubChem: 14429; ChEBI: 32159; PDB-CCD: 40J; NIKKAJI: J247.962A,cpd:C12285,12,19,8,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C12H20O8Cl3,C12H18O8Cl3,396.0145506,397.0223756,395.00672565089,5581,cpd:C18319,2-Methylbutyrate;,C5H10O2,2-Methylbutyrate; 2-Methylbutyric acid,NA,Protein digestion and absorption,NA,NA,NA,CAS: 116-53-0; PubChem: 103061501; ChEBI: 37070; ChEMBL: CHEMBL1160012; LIPIDMAPS: LMFA01020072; KNApSAcK: C00029461,cpd:C00803; cpd:C04022; cpd:C08262; cpd:C10140; cpd:C11196; cpd:C18319; cpd:C19199; cpd:C19409; cpd:C19511; cpd:C19780; cpd:C19783,5,10,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H11O2,C5H9O2,102.0680796,103.0759046,101.06025455090,5582,cpd:C01558,Bile salt;,C24H40O5,Bile salt; Bile acid,NA,Fat digestion and absorption; Vitamin digestion and absorption,NA,NA,NA,PubChem: 4716; ChEBI: 22868 3098; NIKKAJI: J8.604E,cpd:C00695; cpd:C01558; cpd:C04661; cpd:C17644; cpd:C17647; cpd:C17649; cpd:C17650; cpd:C17654; cpd:C17657; cpd:C17667; cpd:C17668; cpd:C17726; cpd:C17727; cpd:C17737; cpd:C20866; cpd:C20868,24,40,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H41O5,C24H39O5,408.2875744,409.2953994,407.27974945091,5583,cpd:C00318,L-Carnitine;,C7H15NO3,"L-Carnitine; L-gamma-Trimethyl-beta-hydroxybutyrobetaine; Vitamin BT; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt; Levocarnitine; (R)-Carnitine",R01922 R01923 R01924 R03779 R10643 R10644,Bile secretion,2.3.1.21; 2.3.1.137; 2.8.3.21; 3.1.1.28; 3.5.1.73,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;    A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;     A16AA Amino acids and derivatives;      A16AA01 Levocarnitine;       D02176  Levocarnitine (JAN/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    399  Miscellaneous;     3999  Others;      D02176  Levocarnitine (JAN/USP/INN); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Carnitine;     D02176  Levocarnitine (JAN/USP/INN); New drug approvals in Japan [br08318.html];  Drugs with new active ingredients;   D02176; New drug approvals in the USA, Europe and Japan [br08328.html];  Approval dates by FDA, EMA and PMDA;   D02176; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D02176",CAS: 541-15-1; PubChem: 3612; ChEBI: 16347; ChEMBL: CHEMBL1149 CHEMBL1229656; PDB-CCD: 152; NIKKAJI: J9.362I,cpd:C00318; cpd:C15025,7,15,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H16O3N1,C7H14O3N1,161.1051933,162.1130184,160.09736835092,5584,cpd:C01405,Aspirin;,C9H8O4,Aspirin; Acetylsalicylic acid; 2-Acetoxybenzenecarboxylic acid; Acetylsalicylate,R02942,Bile secretion,3.1.1.55,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A01 STOMATOLOGICAL PREPARATIONS;    A01A STOMATOLOGICAL PREPARATIONS;     A01AD Other agents for local oral treatment;      A01AD05 Acetylsalicylic acid;       D00109  Aspirin (JP17/USP);  B BLOOD AND BLOOD FORMING ORGANS;   B01 ANTITHROMBOTIC AGENTS;    B01A ANTITHROMBOTIC AGENTS;     B01AC Platelet aggregation inhibitors excl. heparin;      B01AC06 Acetylsalicylic acid;       D00109  Aspirin (JP17/USP);  N NERVOUS SYSTEM;   N02 ANALGESICS;    N02B OTHER ANALGESICS AND ANTIPYRETICS;     N02BA Salicylic acid and derivatives;      N02BA01 Acetylsalicylic acid;       D00109  Aspirin (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   11  Agents affecting central nervous system;    114  Antipyretics and analgesics, anti-inflammatory agents;     1143  Salicylates;      D00109  Aspirin (JP17/USP); Aspalon (JAN);  3  Agents affecting metabolism;   33  Blood and body fluid agents;    339  Miscellaneous;     3399  Others;      D00109  Aspirin (JP17/USP); Aspalon (JAN); Classification of Japanese OTC drugs [BR:br08313];  Agents for nervous and sensory systems;   01 Cold remedy (oral use);    D00109  Aspirin (JP17/USP);   03 Antipyretic analgesic agents;    D00109  Aspirin (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Designated second-class OTC drugs;   Inorganic and organic chemicals;    Aspirin;     D00109  Aspirin (JP17/USP);  Second-class OTC drugs;   Inorganic and organic chemicals;    Aspirin;     D00109  Aspirin (JP17/USP); Target-based classification of drugs [BR:br08310];  Enzymes;   Oxidoreductases;    cyclooxygenase-1 (COX-1);     Acetylsalicylic acid;      D00109  Aspirin (JP17/USP);    cyclooxygenase-2 (COX-2);     Acetylsalicylic acid;      D00109  Aspirin (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00109  Aspirin;   D00109  Aspirin tablets; Antirheumatic and antigout drugs [br08366.html];  Antirheumatic drugs;   D00109; Anesthetics, analgesics and anti-inflammatory drugs [br08369.html];  Anti-inflammatory drugs;   D00109; Rx-to-OTC switch list in the USA [br08315.html];  D00109",CAS: 50-78-2; PubChem: 4594; ChEBI: 15365; ChEMBL: CHEMBL25; PDB-CCD: AIN; 3DMET: B00284; NIKKAJI: J2.300K,cpd:C01179; cpd:C01197; cpd:C01405; cpd:C01481; cpd:C04367; cpd:C05350; cpd:C12467; cpd:C12623; cpd:C13400; cpd:C17086; cpd:C18819; cpd:C21346,9,8,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H9O4,C9H7O4,180.0422587,181.0500838,179.03443375093,5585,cpd:C01443,Ouabain;,C29H44O12,Ouabain; G-Strophanthin,NA,Bile secretion,NA,NA,Compounds with biological roles [BR:br08001];  Steroids;   23-Carbon atoms;    Cardanolide derivatives;     C01443  Ouabain; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0112 Cardanolides and derivatives;     C01443  Ouabain; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Cardanolide;     C01443  Ouabain; Natural toxins [BR:br08009];  Phytotoxins;   Glycosides;    Cardiac glycosides;     C01443  Ouabain; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01A CARDIAC GLYCOSIDES;     C01AC Strophantus glycosides;      C01AC01 G-strophanthin;       D00112  G-Strophanthin (JAN); Target-based classification of drugs [BR:br08310];  Enzymes;   Hydrolases;    sodium/potassium-transporting ATPase;     G-strophanthin;      D00112  G-Strophanthin (JAN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   SLCO1A2;    G-Strophanthin;     D00112  G-Strophanthin (JAN); Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Triterpenoids (C30) and related compounds;    D00112  G-Strophanthin (JAN),CAS: 630-60-4; PubChem: 4621; ChEBI: 472805; ChEMBL: CHEMBL1320401 CHEMBL222863; LIPIDMAPS: LMST01120022; KNApSAcK: C00003633; PDB-CCD: OBN; 3DMET: B01451; NIKKAJI: J6.892F,cpd:C01443,29,44,12,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H45O12,C29H43O12,584.2832769,585.2911019,583.27545185094,5586,cpd:C01576,Etoposide;,C29H32O13,Etoposide; VP-16,NA,Bile secretion,NA,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C01576  Etoposide (in combination with cisplatin and bleomycin); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS;     L01CB Podophyllotoxin derivatives;      L01CB01 Etoposide;       D00125  Etoposide (JP17/USP/INN); USP drug classification [BR:br08302];  Antineoplastics;   Enzyme Inhibitors;    Etoposide;     D00125  Etoposide (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    424  Plant extract preparations;     4240  Plant extract preparations;      D00125  Etoposide (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Isomerases;    topoisomerase II;     Etoposide;      D00125  Etoposide (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Etoposide;     D00125  Etoposide (JP17/USP/INN);  Transporter substrates;   ABCC2;    Etoposide;     D00125  Etoposide (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00125  Etoposide; Phytochemicals used as drugs [BR:br08306];  Phenylpropanoids and related compounds;   Lignans;    Lignans;     D00125  Etoposide (JP15/USP/INN); Antineoplastics [br08340.html];  D00125,CAS: 33419-42-0; PubChem: 4733; ChEBI: 4911; ChEMBL: CHEMBL268601 CHEMBL273394 CHEMBL298227 CHEMBL44657; PDB-CCD: EVP; NIKKAJI: J3.178J,cpd:C01576,29,32,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H33O13,C29H31O13,588.1842911,589.1921161,587.17646615095,5587,cpd:C01844,Pravastatin,C23H36O7,Pravastatin,NA,Bile secretion,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C10 LIPID MODIFYING AGENTS;    C10A LIPID MODIFYING AGENTS, PLAIN;     C10AA HMG CoA reductase inhibitors;      C10AA03 Pravastatin;       D08410  Pravastatin (INN); USP drug classification [BR:br08302];  Cardiovascular Agents;   Dyslipidemics, HMG CoA Reductase Inhibitors;    Pravastatin;     D08410  Pravastatin (INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Oxidoreductases;    hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase;     Pravastatin;      D08410  Pravastatin (INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Pravastatin;     D08410  Pravastatin (INN);  Transporter inhibitors;   ABCB11;    Pravastatin;     D08410  Pravastatin (INN);  Transporter substrates;   ABCB11;    Pravastatin;     D08410  Pravastatin (INN);   OAT3;    Pravastatin;     D08410  Pravastatin (INN);   SLCO1B1;    Pravastatin;     D08410  Pravastatin (INN);   SLCO1B3;    Pravastatin;     D08410  Pravastatin (INN)",CAS: 81093-37-0; PubChem: 4962; ChEBI: 63618; ChEMBL: CHEMBL1144; KNApSAcK: C00000565; NIKKAJI: J139.432K,cpd:C01844,23,36,7,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H37O7,C23H35O7,424.2461035,425.2539285,423.23827855096,5588,cpd:C01937,Methotrexate,C20H22N8O5,Methotrexate,NA,Bile secretion,NA,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C01937  Methotrexate; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01B ANTIMETABOLITES;     L01BA Folic acid analogues;      L01BA01 Methotrexate;       D00142  Methotrexate (JP17/USP/INN);   L04 IMMUNOSUPPRESSANTS;    L04A IMMUNOSUPPRESSANTS;     L04AX Other immunosuppressants;      L04AX03 Methotrexate;       D00142  Methotrexate (JP17/USP/INN); USP drug classification [BR:br08302];  Immunological Agents;   Immune Suppressants;    Methotrexate;     D00142  Methotrexate (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   39  Other agents affecting metabolism;    399  Miscellaneous;     3999  Others;      D00142  Methotrexate (JP17/USP/INN);  4  Agents affecting cellular function;   42  Antineoplastics;    422  Antimetabolites;     4222  Methotrexates;      D00142  Methotrexate (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Oxidoreductases;    dihydrofolate reductase;     Methotrexate;      D00142  Methotrexate (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   ABCC2;    Methotrexate;     D00142  Methotrexate (JP17/USP/INN);   ABCC3;    Methotrexate;     D00142  Methotrexate (JP17/USP/INN);   ABCC4;    Methotrexate;     D00142  Methotrexate (JP17/USP/INN);   ABCG2;    Methotrexate;     D00142  Methotrexate (JP17/USP/INN);    Methotrexate;     D00142  Methotrexate (JP17/USP/INN);   OAT1;    Methotrexate;     D00142  Methotrexate (JP17/USP/INN);   OAT3;    Methotrexate;     D00142  Methotrexate (JP17/USP/INN);   SLCO1A2;    Methotrexate;     D00142  Methotrexate (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00142  Methotrexate;   D00142  Methotrexate capsules; Antineoplastics [br08340.html];  D00142; Antirheumatic and antigout drugs [br08366.html];  Antirheumatic drugs;   D00142; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00142,CAS: 59-05-2; PubChem: 5042; ChEBI: 44185; ChEMBL: CHEMBL34259; PDB-CCD: MT1 MTX; NIKKAJI: J2.334E,cpd:C01937,20,22,5,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H23O5N8,C20H21O5N8,454.1713158,455.1791409,453.16349085097,5589,cpd:C03642,Taurolithocholate sulfate;,C26H45NO8S2,Taurolithocholate sulfate; 3alpha-Sulfatolithocholyltaurine; Taurolithocholic acid 3-sulfate,R03987,Bile secretion,2.8.2.14,NA,"Lipids [BR:br08002];  ST  Sterol Lipids;   ST04 Bile acids and derivatives;    ST0402 C26 bile acids, alcohols, and derivatives;     C03642  Taurolithocholate sulfate;   ST05 Steroid conjugates;    ST0502 Sulfates;     C03642  Taurolithocholate sulfate;    ST0504 Taurine conjugates;     C03642  Taurolithocholate sulfate",CAS: 15324-65-9; PubChem: 6424; ChEBI: 17864; ChEMBL: CHEMBL270493; LIPIDMAPS: LMST05020003; 3DMET: B01678; NIKKAJI: J682.199E,cpd:C03642,26,45,8,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C26H46O8N1S2,C26H44O8N1S2,563.2586598,564.2664848,562.25083475098,5590,cpd:C06688,Rifampicin;,C43H58N4O12,Rifampicin; Rifampin,R11151 R11152,Bile secretion,1.14.13.211,NA,Compounds with biological roles [BR:br08001];  Antibiotics;   Polyketides and nonribosomal peptides;    Ansamycins;     C06688  Rifampicin; Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C06688  Rifampicin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J04 ANTIMYCOBACTERIALS;    J04A DRUGS FOR TREATMENT OF TUBERCULOSIS;     J04AB Antibiotics;      J04AB02 Rifampicin;       D00211  Rifampin (USP); USP drug classification [BR:br08302];  Antimycobacterials;   Antituberculars;    Rifampin;     D00211  Rifampin (USP); Therapeutic category of drugs in Japan [BR:br08301];  6  Agents against pathologic organisms and parasites;   61  Antibiotics;    616  Acting mainly on acid-fast bacteria;     6164  Rifampicins;      D00211  Rifampin (USP); Rifampicin (JP17/INN); Antiinfectives [BR:br08307];  Antibacterials;   Nucleic acid synthesis inhibitor;    RNA polymerase inhibitor;     Rifamycins;      Rifampicin;       D00211  Rifampin (USP); Cytochrome P450 interactions [BR:br08309];  CYP inducers;   CYP2B6;    Rifampicin;     D00211  Rifampin (USP);   CYP2C8;    Rifampicin;     D00211  Rifampin (USP);   CYP2C9;    Rifampicin;     D00211  Rifampin (USP);   CYP2C19;    Rifampicin;     D00211  Rifampin (USP);   CYP2D6;    Rifampicin;     D00211  Rifampin (USP);   CYP3A4;    Rifampicin;     D00211  Rifampin (USP);   CYP3A;    Rifampicin;     D00211  Rifampin (USP);  CYP substrates;   CYP3A4;    Rifampicin;     D00211  Rifampin (USP);  Transporter inhibitors;   ABCC2;    Rifampicin;     D00211  Rifampin (USP);   SLCO1B1;    Rifampicin;     D00211  Rifampin (USP);   SLCO1B3;    Rifampicin;     D00211  Rifampin (USP);  Transporter inducers;   ABCB1;    Rifampicin;     D00211  Rifampin (USP);   ABCB11;    Rifampicin;     D00211  Rifampin (USP);   SLCO1A2;    Rifampicin;     D00211  Rifampin (USP);   SLCO1B1;    Rifampicin;     D00211  Rifampin (USP);   SLCO1B3;    Rifampicin;     D00211  Rifampin (USP);   SLCO2B1;    Rifampicin;     D00211  Rifampin (USP);  Transporter substrates;   SLCO1B1;    Rifampicin;     D00211  Rifampin (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00211  Rifampicin;   D00211  Rifampicin capsules; Antibacterials [br08350.html];  D00211; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00211,CAS: 13292-46-1; PubChem: 8913; ChEBI: 28077; ChEMBL: CHEMBL374478; PDB-CCD: RFP; 3DMET: B02089; NIKKAJI: J2.736G,cpd:C06688,43,58,12,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H59O12N4,C43H57O12N4,822.4051233,823.4129484,821.39729835099,5591,cpd:C06804,Acetaminophen;,C8H9NO2,Acetaminophen; Paracetamol,NA,Bile secretion,NA,NA,"Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C06804  Paracetamol; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N02 ANALGESICS;    N02B OTHER ANALGESICS AND ANTIPYRETICS;     N02BE Anilides;      N02BE01 Paracetamol;       D00217  Acetaminophen (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   11  Agents affecting central nervous system;    114  Antipyretics and analgesics, anti-inflammatory agents;     1141  Anilines;      D00217  Acetaminophen (JP17/USP); Paracetamol (INN); Classification of Japanese OTC drugs [BR:br08313];  Agents for nervous and sensory systems;   01 Cold remedy (oral use);    D00217  Acetaminophen (JP17/USP);   03 Antipyretic analgesic agents;    D00217  Acetaminophen (JP17/USP); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Acetaminophen;     D00217  Acetaminophen (JP17/USP); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP1A2;    Paracetamol;     D00217  Acetaminophen (JP17/USP);   CYP3A4;    Paracetamol;     D00217  Acetaminophen (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00217  Acetaminophen; Anesthetics, analgesics and anti-inflammatory drugs [br08369.html];  Anti-inflammatory drugs;   D00217; Rx-to-OTC switch list in the USA [br08315.html];  D00217; Animal drugs in Japan [BR:br08331];  91  Agents affecting nervous system;   913  Antipyretics, analgesics and antiinflammatory;    9139  Other antipyretics, analgesics and antiinflammatory;     C06804  Acetaminophen",CAS: 103-90-2; PubChem: 9023; ChEBI: 46195; ChEMBL: CHEMBL112; KNApSAcK: C00044491; PDB-CCD: TYL; NIKKAJI: J4.025H,cpd:C02012; cpd:C02709; cpd:C03005; cpd:C03522; cpd:C04350; cpd:C04353; cpd:C06804; cpd:C07301; cpd:C16571; cpd:C17239; cpd:C17755; cpd:C17756; cpd:C18623; cpd:C20634,8,9,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O2N1,C8H8O2N1,151.0633285,152.0711536,150.05550355100,5592,cpd:C06810,Acyclovir;,C8H11N5O3,Acyclovir; Aciclovir,NA,Bile secretion,NA,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C06810  Acyclovir; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  D DERMATOLOGICALS;   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;    D06B CHEMOTHERAPEUTICS FOR TOPICAL USE;     D06BB Antivirals;      D06BB03 Aciclovir;       D00222  Acyclovir (USP);  J ANTIINFECTIVES FOR SYSTEMIC USE;   J05 ANTIVIRALS FOR SYSTEMIC USE;    J05A DIRECT ACTING ANTIVIRALS;     J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors;      J05AB01 Aciclovir;       D00222  Acyclovir (USP);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AD Antivirals;      S01AD03 Aciclovir;       D00222  Acyclovir (USP); USP drug classification [BR:br08302];  Antivirals;   Antiherpetic Agents;    Acyclovir;     D00222  Acyclovir (USP); Therapeutic category of drugs in Japan [BR:br08301];  1  Agents affecting nervous system and sensory organs;   13  Agents affecting sensory organs;    131  Ophthalmic agents;     1319  Others;      D00222  Acyclovir (USP); Aciclovir (JP17/INN); Aciclovir granules (JP17); Aciclovir ophthalmic oinment (JP17); Aciclovir tablets (JP17);  6  Agents against pathologic organisms and parasites;   62  Chemotherapeutics;    625  Antivirals;     6250  Antivirals;      D00222  Acyclovir (USP); Aciclovir (JP17/INN); Aciclovir granules (JP17); Aciclovir ophthalmic oinment (JP17); Aciclovir tablets (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for integumentary system;   91 Antivirals;    D00222  Acyclovir (USP); Risk category of Japanese OTC drugs [BR:br08312];  First-class OTC drugs;   Inorganic and organic chemicals;    Aciclovir;     D00222  Acyclovir (USP); Antiinfectives [BR:br08307];  Antivirals;   Anti-HSV agents;    DNA polymerase inhibitor;     Purine analogue;      Aciclovir;       D00222  Acyclovir (USP); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP1A2;    Aciclovir;     D00222  Acyclovir (USP);  Transporter substrates;   OAT1;    Aciclovir;     D00222  Acyclovir (USP);   OAT3;    Aciclovir;     D00222  Acyclovir (USP);   SLC22A1;    Aciclovir;     D00222  Acyclovir (USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00222  Aciclovir;   D00222  Aciclovir tablets;   D00222  Aciclovir granules;   D00222  Aciclovir syrup;   D00222  Aciclovir for syrup;   D00222  Aciclovir injection;   D00222  Aciclovir for injection;   D00222  Aciclovir ophthalmic oinment;   D00222  Aciclovir ointment; Antivirals [br08351.html];  D00222; Rx-to-OTC switch list in Japan [br08314.html];  D00222,CAS: 59277-89-3; PubChem: 9029; ChEBI: 2453; ChEMBL: CHEMBL184; PDB-CCD: AC2; NIKKAJI: J11.247J,cpd:C06810,8,11,3,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H12O3N5,C8H10O3N5,225.0861892,226.0940143,224.07836425101,5593,cpd:C06880,Cefazolin,C14H14N8O4S3,Cefazolin,NA,Bile secretion,NA,NA,"Compounds with biological roles [BR:br08001];  Antibiotics;   beta-Lactams;    Cephems;     C06880  Cefazolin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01D OTHER BETA-LACTAM ANTIBACTERIALS;     J01DB First-generation cephalosporins;      J01DB04 Cefazolin;       D02299  Cefazolin (USP); USP drug classification [BR:br08302];  Antibacterials;   Beta-lactam, Cephalosporins;    Cefazolin;     D02299  Cefazolin (USP); Antiinfectives [BR:br08307];  Antibacterials;   Cell wall biosynthesis inhibitor;    Penicillin binding proteins inhibitor;     Cephem;      First-generation cephalosporin;       Cefazolin;        D02299  Cefazolin (USP); Animal drugs in Japan [BR:br08331];  97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants);   976  Antibiotic preparations;    9763  Antibiotic preparations for external use, pessaries and suppositories;     C06880  Cefazolin",CAS: 25953-19-9; PubChem: 9097; ChEBI: 474053; ChEMBL: CHEMBL1435; NIKKAJI: J17.146H,cpd:C06880,14,14,4,8,0,3,0,0,0,0,0,0,0,0,0,0,0,0,C14H15O4N8S3,C14H13O4N8S3,454.0300145,455.0378395,453.02218955102,5594,cpd:C06890,Ceftizoxime,C13H13N5O5S2,Ceftizoxime,NA,Bile secretion,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01D OTHER BETA-LACTAM ANTIBACTERIALS;     J01DD Third-generation cephalosporins;      J01DD07 Ceftizoxime;       D07658  Ceftizoxime (INN); Antiinfectives [BR:br08307];  Antibacterials;   Cell wall biosynthesis inhibitor;    Penicillin binding proteins inhibitor;     Cephem;      Third-generation cephalosporin;       Ceftizoxime;        D07658  Ceftizoxime (INN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   OAT3;    Ceftizoxime;     D07658  Ceftizoxime (INN),CAS: 68401-81-0; PubChem: 9107; ChEBI: 553473; ChEMBL: CHEMBL528; NIKKAJI: J37.178E,cpd:C06890,13,13,5,5,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C13H14O5N5S2,C13H12O5N5S2,383.0358109,384.0436359,382.02798595103,5595,cpd:C06956,Digoxin,C41H64O14,Digoxin,NA,Bile secretion,NA,NA,"Compounds with biological roles [BR:br08001];  Steroids;   23-Carbon atoms;    Cardanolide derivatives;     C06956  Digoxin; Lipids [BR:br08002];  ST  Sterol Lipids;   ST01 Sterols;    ST0112 Cardanolides and derivatives;     C06956  Digoxin; Phytochemical compounds [BR:br08003];  Terpenoids;   Steroids;    Cardanolide;     C06956  Digoxin; Natural toxins [BR:br08009];  Phytotoxins;   Glycosides;    Cardiac glycosides;     C06956  Digoxin; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C01 CARDIAC THERAPY;    C01A CARDIAC GLYCOSIDES;     C01AA Digitalis glycosides;      C01AA05 Digoxin;       D00298  Digoxin (JP17/USP); USP drug classification [BR:br08302];  Cardiovascular Agents;   Cardiovascular Agents, Other;    Digoxin;     D00298  Digoxin (JP17/USP); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   21  Cardiovascular agents;    211  Cardiotonics;     2113  Digitalis;      D00298  Digoxin (JP17/USP); Target-based classification of drugs [BR:br08310];  Enzymes;   Hydrolases;    sodium/potassium-transporting ATPase;     Digoxin;      D00298  Digoxin (JP17/USP); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   ABCB1;    Digoxin;     D00298  Digoxin (JP17/USP);   ABCB4;    Digoxin;     D00298  Digoxin (JP17/USP);   SLCO1A2;    Digoxin;     D00298  Digoxin (JP17/USP);   SLCO1B3;    Digoxin;     D00298  Digoxin (JP17/USP); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00298  Digoxin;   D00298  Digoxin tablets;   D00298  Digoxin injection; Phytochemicals used as drugs [BR:br08306];  Terpenoids;   Triterpenoids (C30) and related compounds;    D00298  Digoxin (JP15/USP); Cardiovascular agents [br08364.html];  Antiarrhythmics;   D00298",CAS: 20830-75-5; PubChem: 9171; ChEBI: 4551; ChEMBL: CHEMBL1751; KNApSAcK: C00003618; PDB-CCD: DGX; 3DMET: B05234; NIKKAJI: J4.082G,cpd:C06956; cpd:C08866,41,64,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C41H65O14,C41H63O14,780.4296067,781.4374318,779.42178175104,5596,cpd:C06999,Fexofenadine;,C32H39NO4,"Fexofenadine; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid",NA,Bile secretion,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  R RESPIRATORY SYSTEM;   R06 ANTIHISTAMINES FOR SYSTEMIC USE;    R06A ANTIHISTAMINES FOR SYSTEMIC USE;     R06AX Other antihistamines for systemic use;      R06AX26 Fexofenadine;       D07958  Fexofenadine (INN); Risk category of Japanese OTC drugs [BR:br08312];  Second-class OTC drugs;   Inorganic and organic chemicals;    Fexofenadine;     D07958  Fexofenadine (INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Histamine;     H1-receptor;      Fexofenadine;       D07958  Fexofenadine (INN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   ABCB1;    Fexofenadine;     D07958  Fexofenadine (INN);   ABCC3;    Fexofenadine;     D07958  Fexofenadine (INN);   OAT1;    Fexofenadine;     D07958  Fexofenadine (INN);   OAT3;    Fexofenadine;     D07958  Fexofenadine (INN);   SLCO1A2;    Fexofenadine;     D07958  Fexofenadine (INN);   SLCO1B1;    Fexofenadine;     D07958  Fexofenadine (INN);   SLCO1B3;    Fexofenadine;     D07958  Fexofenadine (INN);   SLCO2B1;    Fexofenadine;     D07958  Fexofenadine (INN),CAS: 83799-24-0; PubChem: 9212; ChEBI: 5050; ChEMBL: CHEMBL914; NIKKAJI: J413.164I,cpd:C06999; cpd:C20555,32,39,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C32H40O4N1,C32H38O4N1,501.2879087,502.2957338,500.28008375105,5597,cpd:C07014,Fluvastatin,C24H26FNO4,Fluvastatin,NA,Bile secretion,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C10 LIPID MODIFYING AGENTS;    C10A LIPID MODIFYING AGENTS, PLAIN;     C10AA HMG CoA reductase inhibitors;      C10AA04 Fluvastatin;       D07983  Fluvastatin (INN); USP drug classification [BR:br08302];  Cardiovascular Agents;   Dyslipidemics, HMG CoA Reductase Inhibitors;    Fluvastatin;     D07983  Fluvastatin (INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Oxidoreductases;    hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase;     Fluvastatin;      D07983  Fluvastatin (INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C9;    Fluvastatin;     D07983  Fluvastatin (INN);  CYP substrates;   CYP2C9;    Fluvastatin;     D07983  Fluvastatin (INN);   CYP3A4;    Fluvastatin;     D07983  Fluvastatin (INN);  Transporter inhibitors;   ABCB11;    Fluvastatin;     D07983  Fluvastatin (INN);  Transporter substrates;   SLCO1B1;    Fluvastatin;     D07983  Fluvastatin (INN);   SLCO1B3;    Fluvastatin;     D07983  Fluvastatin (INN)",CAS: 93957-54-1; PubChem: 9227; ChEBI: 38561; ChEMBL: CHEMBL350239; NIKKAJI: J360.319I,cpd:C07014,24,26,4,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C24H27O4N1F1,C24H25O4N1F1,411.1845865,412.1924115,410.17676155106,5598,cpd:C07051,Indinavir,C36H47N5O4,Indinavir,NA,Bile secretion; HIV protease inhibitors,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J05 ANTIVIRALS FOR SYSTEMIC USE;    J05A DIRECT ACTING ANTIVIRALS;     J05AE Protease inhibitors;      J05AE02 Indinavir;       C07051  Indinavir; Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A;    Indinavir;     C07051  Indinavir,CAS: 150378-17-9; PubChem: 9263; ChEBI: 44032; ChEMBL: CHEMBL115; PDB-CCD: MK1; NIKKAJI: J566.361J,cpd:C07051; cpd:C08089,36,47,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C36H48O4N5,C36H46O4N5,613.362805,614.37063,612.354985107,5599,cpd:C07065,Lamivudine;,C8H11N3O3S,"Lamivudine; 3TC; 2',3'-Dideoxy-3'-thiacytidine",NA,Bile secretion,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J05 ANTIVIRALS FOR SYSTEMIC USE;    J05A DIRECT ACTING ANTIVIRALS;     J05AF Nucleoside and nucleotide reverse transcriptase inhibitors;      J05AF05 Lamivudine;       D00353  Lamivudine (JAN/USP/INN); USP drug classification [BR:br08302];  Antivirals;   Anti-hepatitis B (HBV) Agents;    Lamivudine;     D00353  Lamivudine (JAN/USP/INN);   Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)v;    Lamivudine;     D00353  Lamivudine (JAN/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  6  Agents against pathologic organisms and parasites;   62  Chemotherapeutics;    625  Antivirals;     6250  Antivirals;      D00353  Lamivudine (JAN/USP/INN); Antiinfectives [BR:br08307];  Antivirals;   Anti-HBV agents;    Reverse transcriptase inhibitor (RTI);     Nucleoside and nucleotide reverse transcriptase inhibitor (NRTIs);      Lamivudine;       D00353  Lamivudine (JAN/USP/INN);   Anti-HIV agents;    Reverse transcriptase inhibitor (RTI);     Nucleoside and nucleotide reverse transcriptase inhibitor (NRTIs);      Lamivudine;       D00353  Lamivudine (JAN/USP/INN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   OAT1;    Lamivudine;     D00353  Lamivudine (JAN/USP/INN); Antivirals [br08351.html];  D00353; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00353; New drug approvals in Japan [br08318.html];  Drugs with new active ingredients;   D00353",CAS: 134678-17-4; PubChem: 9277; ChEBI: 63577; ChEMBL: CHEMBL141; PDB-CCD: 3TC; NIKKAJI: J457.051K,cpd:C07065,8,11,3,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C8H12O3N3S1,C8H10O3N3S1,229.0521124,230.0599374,228.04428745108,5601,cpd:C07207,Zalcitabine;,C9H13N3O3,"Zalcitabine; 2',3'-Dideoxycytidine",NA,Bile secretion,NA,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C07207  Zalcitabine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J05 ANTIVIRALS FOR SYSTEMIC USE;    J05A DIRECT ACTING ANTIVIRALS;     J05AF Nucleoside and nucleotide reverse transcriptase inhibitors;      J05AF03 Zalcitabine;       D00412  Zalcitabine (JAN/USP/INN); Antiinfectives [BR:br08307];  Antivirals;   Anti-HIV agents;    Reverse transcriptase inhibitor (RTI);     Nucleoside and nucleotide reverse transcriptase inhibitor (NRTIs);      Zalcitabine;       D00412  Zalcitabine (JAN/USP/INN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   OAT1;    Zalcitabine;     D00412  Zalcitabine (JAN/USP/INN);   OAT3;    Zalcitabine;     D00412  Zalcitabine (JAN/USP/INN); Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00412,CAS: 7481-89-2; PubChem: 9416; ChEBI: 10101; ChEMBL: CHEMBL853 CHEMBL87447; NIKKAJI: J277.119E,cpd:C07207,9,13,3,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O3N3,C9H12O3N3,211.0956913,212.1035163,210.08786635109,5602,cpd:C07210,Zidovudine;,C10H13N5O4,Zidovudine; Azidothymidine; 3'-Azido-3'-deoxythymidine; AZT,NA,Bile secretion,NA,NA,"Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C07210  Zidovudine; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J05 ANTIVIRALS FOR SYSTEMIC USE;    J05A DIRECT ACTING ANTIVIRALS;     J05AF Nucleoside and nucleotide reverse transcriptase inhibitors;      J05AF01 Zidovudine;       D00413  Zidovudine (JP17/USP/INN); USP drug classification [BR:br08302];  Antivirals;   Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)v;    Zidovudine;     D00413  Zidovudine (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  6  Agents against pathologic organisms and parasites;   62  Chemotherapeutics;    625  Antivirals;     6250  Antivirals;      D00413  Zidovudine (JP17/USP/INN); Antiinfectives [BR:br08307];  Antivirals;   Anti-HIV agents;    Reverse transcriptase inhibitor (RTI);     Nucleoside and nucleotide reverse transcriptase inhibitor (NRTIs);      Zidovudine;       D00413  Zidovudine (JP17/USP/INN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   OAT1;    Zidovudine;     D00413  Zidovudine (JP17/USP/INN);   OAT3;    Zidovudine;     D00413  Zidovudine (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00413  Zidovudine; Antivirals [br08351.html];  D00413; Orphan drugs in the USA [br08355.html];  Orphan drugs in the USA;   D00413",CAS: 30516-87-1; PubChem: 9419; ChEBI: 10110; ChEMBL: CHEMBL129; PDB-CCD: AZZ; NIKKAJI: J20.566D,cpd:C00212; cpd:C00330; cpd:C07195; cpd:C07210,10,13,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H14O4N5,C10H12O4N5,267.0967539,268.104579,266.08892895110,5603,cpd:C07240,Ritonavir,C37H48N6O5S2,Ritonavir,NA,Bile secretion,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J05 ANTIVIRALS FOR SYSTEMIC USE;    J05A DIRECT ACTING ANTIVIRALS;     J05AE Protease inhibitors;      J05AE03 Ritonavir;       D00427  Ritonavir (JAN/USAN/INN); USP drug classification [BR:br08302];  Antivirals;   Anti-HIV Agents, Protease Inhibitors;    Ritonavir;     D00427  Ritonavir (JAN/USAN/INN); Therapeutic category of drugs in Japan [BR:br08301];  6  Agents against pathologic organisms and parasites;   62  Chemotherapeutics;    625  Antivirals;     6250  Antivirals;      D00427  Ritonavir (JAN/USAN/INN); Antiinfectives [BR:br08307];  Antivirals;   Anti-HIV agents;    Protease inhibitor (PIs);     Peptidic;      Ritonavir;       D00427  Ritonavir (JAN/USAN/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2C19;    Ritonavir;     D00427  Ritonavir (JAN/USAN/INN);   CYP2D6;    Ritonavir;     D00427  Ritonavir (JAN/USAN/INN);   CYP3A;    Ritonavir;     D00427  Ritonavir (JAN/USAN/INN);  CYP inducers;   CYP2C19;    Ritonavir;     D00427  Ritonavir (JAN/USAN/INN);  CYP substrates;   CYP3A4;    Ritonavir;     D00427  Ritonavir (JAN/USAN/INN);  Transporter inhibitors;   ABCB1;    Ritonavir;     D00427  Ritonavir (JAN/USAN/INN);   SLCO1A2;    Ritonavir;     D00427  Ritonavir (JAN/USAN/INN);   SLCO1B1;    Ritonavir;     D00427  Ritonavir (JAN/USAN/INN);   SLCO1B3;    Ritonavir;     D00427  Ritonavir (JAN/USAN/INN); Antivirals [br08351.html];  D00427; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00427",CAS: 155213-67-5; PubChem: 9449; ChEBI: 45409; ChEMBL: CHEMBL160871 CHEMBL163; PDB-CCD: RIT; NIKKAJI: J659.314C,cpd:C07240,37,48,5,6,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C37H49O5N6S2,C37H47O5N6S2,720.312761,721.3205861,719.3049365111,5604,cpd:C07512,Tetraethylammonium,C8H20N,Tetraethylammonium,NA,Bile secretion,NA,NA,NA,CAS: 66-40-0; PubChem: 9715; ChEBI: 44296; ChEMBL: CHEMBL9324; PDB-CCD: NET; NIKKAJI: J91.253K,cpd:C04317; cpd:C07512,8,20,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H21N1,C8H19N1,130.1595746,131.1673997,129.15174965112,5605,cpd:C07660,Levofloxacin;,C18H20FN3O4,Levofloxacin; Ofloxacin S-(-)-form,NA,Bile secretion,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01M QUINOLONE ANTIBACTERIALS;     J01MA Fluoroquinolones;      J01MA12 Levofloxacin;       D08120  Levofloxacin (INN);  S SENSORY ORGANS;   S01 OPHTHALMOLOGICALS;    S01A ANTIINFECTIVES;     S01AE Fluoroquinolones;      S01AE05 Levofloxacin;       D08120  Levofloxacin (INN); USP drug classification [BR:br08302];  Antibacterials;   Quinolones;    Levofloxacin;     D08120  Levofloxacin (INN); Antiinfectives [BR:br08307];  Antibacterials;   Nucleic acid synthesis inhibitor;    type II topoisomerase (DNA gyrase, topoisomerase IV) inhibitor;     Fluoroquinolones;      Levofloxacin;       D08120  Levofloxacin (INN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   SLCO1A2;    Levofloxacin;     D08120  Levofloxacin (INN)",CAS: 100986-85-4; PubChem: 9862; ChEBI: 63598; ChEMBL: CHEMBL33; PDB-CCD: LFX; NIKKAJI: J142.436J,cpd:C07321; cpd:C07660,18,20,4,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C18H21O4N3F1,C18H19O4N3F1,361.1437843,362.1516093,360.13595935113,5606,cpd:C07966,Cerivastatin,C26H34FNO5,Cerivastatin,NA,Bile secretion,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  C CARDIOVASCULAR SYSTEM;   C10 LIPID MODIFYING AGENTS;    C10A LIPID MODIFYING AGENTS, PLAIN;     C10AA HMG CoA reductase inhibitors;      C10AA06 Cerivastatin;       D07661  Cerivastatin (INN); Target-based classification of drugs [BR:br08310];  Enzymes;   Oxidoreductases;    hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase;     Cerivastatin;      D07661  Cerivastatin (INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP2C8;    Cerivastatin;     D07661  Cerivastatin (INN);   CYP3A4;    Cerivastatin;     D07661  Cerivastatin (INN)",CAS: 145599-86-6; PubChem: 10167; ChEBI: 3558; ChEMBL: CHEMBL1477; NIKKAJI: J934.489F,cpd:C07966,26,34,5,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C26H35O5N1F1,C26H33O5N1F1,459.2421014,460.2499264,458.23427635114,5607,cpd:C08439,Phalloidin;,C35H48N8O11S,Phalloidin; Phalloidine,NA,Bile secretion,NA,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mushroom toxins;    Cyclic peptides;     C08439  Phalloidin,CAS: 17466-45-4; PubChem: 10633; ChEBI: 8040; KNApSAcK: C00001519; NIKKAJI: J152.082B,cpd:C08439,35,48,11,8,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C35H49O11N8S1,C35H47O11N8S1,788.3163256,789.3241506,787.30850055115,5608,cpd:C09955,Ochratoxin A,C20H18ClNO6,Ochratoxin A,NA,Bile secretion,NA,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C09955  Ochratoxin A; Natural toxins [BR:br08009];  Fungal toxins;   Mycotoxins;    Others;     C09955  Ochratoxin A,CAS: 303-47-9; PubChem: 12141; ChEBI: 7719; ChEMBL: CHEMBL589366; KNApSAcK: C00003008; NIKKAJI: J1.519I,cpd:C09955,20,18,6,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C20H19O6N1Cl1,C20H17O6N1Cl1,403.082265,404.09009,402.074445116,5609,cpd:C11158,Topotecan,C23H23N3O5,Topotecan,NA,Bile secretion,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01X OTHER ANTINEOPLASTIC AGENTS;     L01XX Other antineoplastic agents;      L01XX17 Topotecan;       D08618  Topotecan (BAN); USP drug classification [BR:br08302];  Antineoplastics;   Enzyme Inhibitors;    Topotecan;     D08618  Topotecan (BAN); Target-based classification of drugs [BR:br08310];  Enzymes;   Isomerases;    topoisomerase I;     Topotecan;      D08618  Topotecan (BAN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   ABCB1;    Topotecan;     D08618  Topotecan (BAN);   ABCC4;    Topotecan;     D08618  Topotecan (BAN);   ABCG2;    Topotecan;     D08618  Topotecan (BAN); New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D08618,CAS: 123948-87-8; PubChem: 13340; ChEBI: 63632; ChEMBL: CHEMBL84; PDB-CCD: TTC; NIKKAJI: J362.027A,cpd:C11158,23,23,5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H24O5N3,C23H22O5N3,421.1637709,422.1715959,420.15594585117,5610,cpd:C11231,Docetaxel anhydrous;,C43H53NO14,Docetaxel anhydrous; Docetaxel,NA,Bile secretion,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS;     L01CD Taxanes;      L01CD02 Docetaxel;       D07866  Docetaxel (JAN/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    424  Plant extract preparations;     4240  Plant extract preparations;      D07866  Docetaxel (JAN/INN); Target-based classification of drugs [BR:br08310];  Others;   Other;    beta-tubulin;     Docetaxel;      D07866  Docetaxel (JAN/INN); Cytochrome P450 interactions [BR:br08309];  CYP substrates;   CYP3A4;    Docetaxel;     D07866  Docetaxel (JAN/INN); Antineoplastics [br08340.html];  D07866; New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D07866,CAS: 114977-28-5; PubChem: 13410; ChEBI: 4672; ChEMBL: CHEMBL186069 CHEMBL355805 CHEMBL92; PDB-CCD: TXL; NIKKAJI: J314.049K,cpd:C11231,43,53,14,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C43H54O14N1,C43H52O14N1,807.3466054,808.3544304,806.33878045118,5611,cpd:C11245,Glucuronosyletoposide;,C35H39O19,Glucuronosyletoposide; Etoposide glucuronide,NA,Bile secretion,NA,NA,NA,CAS: 100007-55-4; PubChem: 13423; ChEBI: 5427; NIKKAJI: J2.773.498G,cpd:C11245,35,39,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H40O19,C35H38O19,763.208554,764.2163791,762.2007295119,5612,cpd:C11277,Adefovir;,C8H12N5O4P,Adefovir; PMEA; 9-(2-Phosphonylmethoxyethyl)adenine,NA,Bile secretion,NA,NA,USP drug classification [BR:br08302];  Antivirals;   Anti-hepatitis B (HBV) Agents;    Adefovir;     D02768  Adefovir (USAN/INN); Antiinfectives [BR:br08307];  Antivirals;   Anti-HBV agents;    Reverse transcriptase inhibitor (RTI);     Nucleoside and nucleotide reverse transcriptase inhibitor (NRTIs);      Adefovir;       D02768  Adefovir (USAN/INN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   ABCC4;    Adefovir;     D02768  Adefovir (USAN/INN);   OAT1;    Adefovir;     D02768  Adefovir (USAN/INN);   OAT3;    Adefovir;     D02768  Adefovir (USAN/INN),CAS: 106941-25-7; PubChem: 13454; ChEBI: 2469; ChEMBL: CHEMBL484; PDB-CCD: 5HG; NIKKAJI: J291.907I,cpd:C11277,8,12,4,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H13O4N5P1,C8H11O4N5P1,273.0626909,274.0705159,272.05486595120,5613,cpd:C11310,1-Methyl-4-phenylpyridinium;,C12H12N,1-Methyl-4-phenylpyridinium; N-Methyl-4-phenylpyridine; Cyperquat,NA,Bile secretion; Parkinson's disease,NA,NA,NA,CAS: 48134-75-4; PubChem: 13485; ChEBI: 641; ChEMBL: CHEMBL311617; NIKKAJI: J21.572D,cpd:C11310,12,12,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H13N1,C12H11N1,170.0969744,171.1047994,169.08914945121,5614,cpd:C11363,Sulfobromophthalein,C20H10Br4O10S2,Sulfobromophthalein,NA,Bile secretion,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  V VARIOUS;   V04 DIAGNOSTIC AGENTS;    V04C OTHER DIAGNOSTIC AGENTS;     V04CE Tests for liver functional capacity;      V04CE02 Sulfobromophthalein;       D08548  Sulphobromophthalein (BAN); Cytochrome P450 interactions [BR:br08309];  Transporter substrates;   SLCO1A2;    Sulfobromophthalein;     D08548  Sulphobromophthalein (BAN);   SLCO1B1;    Sulfobromophthalein;     D08548  Sulphobromophthalein (BAN);   SLCO1B3;    Sulfobromophthalein;     D08548  Sulphobromophthalein (BAN);   SLCO2B1;    Sulfobromophthalein;     D08548  Sulphobromophthalein (BAN),CAS: 297-83-6; PubChem: 13538; ChEBI: 63836; ChEMBL: CHEMBL574431; PDB-CCD: BSP; NIKKAJI: J107.144K,cpd:C11363,20,10,10,0,0,2,0,0,4,0,0,0,0,0,0,0,0,0,C20H11O10S2Br4,C20H9O10S2Br4,789.6448893,790.6527143,788.63706425122,5615,cpd:C11587,BQ 123;,C31H42N6O7,BQ 123; Cyclo[D-trp-D-asp-L-pro-D-val-L-leu],NA,Bile secretion,NA,NA,NA,CAS: 136553-81-6; PubChem: 13752; ChEBI: 2965; NIKKAJI: J449.797J,cpd:C11587,31,42,7,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H43O7N6,C31H41O7N6,610.3114977,611.3193227,609.30367275123,5616,cpd:C11754,Cephaloridine;,C19H17N3O4S2,Cephaloridine; Cefaloridine,NA,Bile secretion,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  J ANTIINFECTIVES FOR SYSTEMIC USE;   J01 ANTIBACTERIALS FOR SYSTEMIC USE;    J01D OTHER BETA-LACTAM ANTIBACTERIALS;     J01DB First-generation cephalosporins;      J01DB02 Cefaloridine;       D01075  Cephaloridine (USAN); Antiinfectives [BR:br08307];  Antibacterials;   Cell wall biosynthesis inhibitor;    Penicillin binding proteins inhibitor;     Cephem;      First-generation cephalosporin;       Cefaloridine;        D01075  Cephaloridine (USAN),CAS: 50-59-9; PubChem: 13918; ChEBI: 3537; ChEMBL: CHEMBL316157; NIKKAJI: J1.361G,cpd:C11754,19,17,4,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C19H18O4N3S2,C19H16O4N3S2,415.0660484,416.0738734,414.05822345124,5618,cpd:C05377,Menadione;,C11H8O2,"Menadione; Vitamin K3; 2-Methyl-1,4-naphthoquinone",NA,Vitamin digestion and absorption,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR02 Quinones and hydroquinones;    PR0203 Vitamin K;     C05377  Menadione (Vitamin K3); Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  B BLOOD AND BLOOD FORMING ORGANS;   B02 ANTIHEMORRHAGICS;    B02B VITAMIN K AND OTHER HEMOSTATICS;     B02BA Vitamin K;      B02BA02 Menadione;       D02335  Menadione (USP),CAS: 58-27-5; PubChem: 7751; ChEBI: 28869; ChEMBL: CHEMBL590; LipidBank: VVK0025; PDB-CCD: VK3; 3DMET: B01850; NIKKAJI: J4.591H,cpd:C05377; cpd:C08446; cpd:C08774; cpd:C11427; cpd:C14091; cpd:C14101; cpd:C18891,11,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H9O2,C11H7O2,172.0524295,173.0602545,171.04460455125,5619,cpd:C12981,dl-alpha-Tocopherol nicotinate;,C35H53NO3,dl-alpha-Tocopherol nicotinate; Tocopheryl nicotinate,NA,Vitamin digestion and absorption,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA03 Tocopherol (vit E);       D01530  Tocopherol nicotinate (JP17); Therapeutic category of drugs in Japan [BR:br08301];  2  Agents affecting individual organs;   21  Cardiovascular agents;    219  Miscellaneous;     2190  Miscellaneous;      D01530  Tocopherol nicotinate (JP17); Classification of Japanese OTC drugs [BR:br08313];  Nourishing tonics and health supplements;   34 Vitamin E based drugs;    D01530  Tocopherol nicotinate (JP17); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D01530  Tocopherol nicotinate; Phytochemicals used as drugs [BR:br08306];  Alkaloids;   Alkaloids derived from nicotinic acid;    Pyridine alkaloids;     D01530  Tocopherol nicotinate (JP15); Cardiovascular agents [br08364.html];  Antihypertensives;   D01530,CAS: 51898-34-1; PubChem: 583370; ChEBI: 32239; ChEMBL: CHEMBL1084541; NIKKAJI: J299.341D,cpd:C12981,35,53,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H54O3N1,C35H52O3N1,535.4025446,536.4103696,534.39471955126,5620,cpd:C13202,alpha-Tocopherol acetate;,C31H52O3,alpha-Tocopherol acetate; Tocopherol acetate,NA,Vitamin digestion and absorption,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A11 VITAMINS;    A11H OTHER PLAIN VITAMIN PREPARATIONS;     A11HA Other plain vitamin preparations;      A11HA03 Tocopherol (vit E);       D01735  Tocopherol acetate (JP17); Therapeutic category of drugs in Japan [BR:br08301];  3  Agents affecting metabolism;   31  Vitamins;    315  Vitamin E preparations;     3150  Vitamin E preparations;      D01735  Tocopherol acetate (JP17); Classification of Japanese OTC drugs [BR:br08313];  Agents for  urogenital organs and anus;   29 Hemorrhoid drugs for internal use;    D01735  Tocopherol acetate (JP17);  Nourishing tonics and health supplements;   34 Vitamin E based drugs;    D01735  Tocopherol acetate (JP17);   41 Vitamin EC based drugs;    D01735  Tocopherol acetate (JP17);   43 Vitamin containing supplements;    D01735  Tocopherol acetate (JP17);  Agents for integumentary system;   55 Chilblain and chap remedies;    D01735  Tocopherol acetate (JP17);  Agents for ophthalmologic use;   62 General eye drops;    D01735  Tocopherol acetate (JP17); Risk category of Japanese OTC drugs [BR:br08312];  Third-class OTC drugs;   Inorganic and organic chemicals;    Tocopherol acetate;     D01735  Tocopherol acetate (JP17); Pharmaceutical additives [BR:br08316];  Stabilizing agent;   D01735  [001263] Tocopherol acetate;  Antioxidant agent;   D01735  [001263] Tocopherol acetate; Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D01735  Tocopherol acetate; Animal drugs in Japan [BR:br08331];  95  Agents for external use;   958  Agents for protective skin;    9582  Vitamin preparations (for external use);     C13202  Tocopherol acetate;  96  Agents affecting metabolism;   962  Vitamin preparations;    9625  Vitamin E and preparations;     C13202  Tocopherol acetate,CAS: 7695-91-2; PubChem: 585946; ChEBI: 32321; ChEMBL: CHEMBL1047,cpd:C13202; cpd:C17423,31,52,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H53O3,C31H51O3,472.3916455,473.3994706,471.38382055127,5621,cpd:C04599,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine;",C12H15N,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPTP",R04523,Parkinson's disease,1.14.13.8,NA,NA,CAS: 28289-54-5; PubChem: 7196; ChEBI: 17963; ChEMBL: CHEMBL24172; NIKKAJI: J22.909A,cpd:C00925; cpd:C01619; cpd:C04452; cpd:C04599; cpd:C04731; cpd:C07934; cpd:C10134; cpd:C10846; cpd:C11028; cpd:C12853; cpd:C13534; cpd:C14291; cpd:C15476,12,15,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H16N1,C12H14N1,173.1204495,174.1282745,172.11262455128,5626,cpd:C11596,FMLP;,C21H31N3O5S,FMLP; N-Formyl-L-methionyl-L-leucyl-L-phenylalanine,NA,Staphylococcus aureus infection,NA,NA,NA,CAS: 59880-97-6; PubChem: 13761; ChEBI: 53490; ChEMBL: CHEMBL267179; NIKKAJI: J245.920E,cpd:C11596,21,31,5,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C21H32O5N3S1,C21H30O5N3S1,437.1984423,438.2062673,436.19061735129,5627,cpd:C04465,"alpha,alpha'-Trehalose 6,6'-bismycolate",C76H142O15,"alpha,alpha'-Trehalose 6,6'-bismycolate",R07248,Tuberculosis,2.3.1.122,NA,"Lipids [BR:br08002];  FA  Fatty acyls;   FA01 Fatty Acids and Conjugates;    FA0116 Mycolic acids;     C04465  alpha,alpha'-Trehalose 6,6'-bismycolate;  SL  Saccharolipids;   SL03 Acyltrehaloses;    C04465  alpha,alpha'-Trehalose 6,6'-bismycolate",PubChem: 7088; ChEBI: 18195; LIPIDMAPS: LMFA01160002; 3DMET: B04943; NIKKAJI: J2.751.156B,cpd:C04465,76,142,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C76H143O15,C76H141O15,1295.034874,1296.042699,1294.0270495130,5628,cpd:C19190,"Trehalose-6,6'-dibehenate",C56H106O13,"Trehalose-6,6'-dibehenate",NA,Tuberculosis,NA,NA,NA,CAS: 66758-35-8; PubChem: 124489862; ChEBI: 82287,cpd:C19190,56,106,13,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C56H107O13,C56H105O13,986.7633435,987.7711685,985.75551845131,5629,cpd:C07653,Flutamide,C11H11F3N2O3,Flutamide,NA,Pathways in cancer; Prostate cancer,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L02 ENDOCRINE THERAPY;    L02B HORMONE ANTAGONISTS AND RELATED AGENTS;     L02BB Anti-androgens;      L02BB01 Flutamide;       D00586  Flutamide (JP17/USP/INN); USP drug classification [BR:br08302];  Antineoplastics;   Antiandrogens;    Flutamide;     D00586  Flutamide (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    429  Miscellaneous;     4291  Other Antitumors;      D00586  Flutamide (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  Nuclear receptors;   Estrogen like receptors;    3-Ketosteroid receptor;     androgen receptor;      Flutamide;       D00586  Flutamide (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00586  Flutamide; Antineoplastics [br08340.html];  D00586,CAS: 13311-84-7; PubChem: 9855; ChEBI: 5132; ChEMBL: CHEMBL806; NIKKAJI: J8.099C,cpd:C07653,11,11,3,2,0,0,0,0,0,3,0,0,0,0,0,0,0,0,C11H12O3N2F3,C11H10O3N2F3,276.0721767,277.0800017,275.06435175132,5630,cpd:C16038,"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine;",C13H12N4,"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine; PhIP",NA,Pathways in cancer; Chemical carcinogenesis; Prostate cancer,NA,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C16038  PhIP,CAS: 105650-23-5; PubChem: 47205348; ChEBI: 76290; ChEMBL: CHEMBL1213271; PDB-CCD: PIQ; NIKKAJI: J258.694K,cpd:C16038; cpd:C20286; cpd:C20288; cpd:C20290,13,12,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H13N4,C13H11N4,224.1061964,225.1140214,223.09837145133,5631,cpd:C03621,N-Acetoxy-4-aminobiphenyl,C14H13NO2,N-Acetoxy-4-aminobiphenyl,R04271,Chemical carcinogenesis,2.3.1.56,NA,NA,PubChem: 6405; ChEBI: 16395; NIKKAJI: J2.743.702H,cpd:C03621; cpd:C04081; cpd:C10679,14,13,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H14O2N1,C14H12O2N1,227.0946287,228.1024537,226.08680365134,5632,cpd:C03622,N-Hydroxy-4-aminobiphenyl,C12H11NO,N-Hydroxy-4-aminobiphenyl,R04271,Chemical carcinogenesis,2.3.1.56,NA,NA,CAS: 1204-79-1; PubChem: 6406; ChEBI: 16580; NIKKAJI: J70.035E,cpd:C03622; cpd:C14333; cpd:C18533,12,11,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H12O1N1,C12H10O1N1,185.084064,186.091889,184.07623895135,5633,cpd:C07122,Melphalan,C13H18Cl2N2O2,Melphalan,NA,Chemical carcinogenesis,NA,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C07122  Melphalan; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01A ALKYLATING AGENTS;     L01AA Nitrogen mustard analogues;      L01AA03 Melphalan;       D00369  Melphalan (JP17/USP/INN); USP drug classification [BR:br08302];  Antineoplastics;   Alkylating Agents;    Melphalan;     D00369  Melphalan (JP17/USP/INN); Therapeutic category of drugs in Japan [BR:br08301];  4  Agents affecting cellular function;   42  Antineoplastics;    421  Alkylating agents;     4219  Others;      D00369  Melphalan (JP17/USP/INN); Target-based classification of drugs [BR:br08310];  Others;   Nucleic acid;    DNA;     Melphalan;      D00369  Melphalan (JP17/USP/INN); Drugs listed in the Japanese Pharmacopoeia [BR:br08311];  Chemicals;   D00369  Melphalan; Antineoplastics [br08340.html];  D00369,CAS: 148-82-3; PubChem: 9332; ChEMBL: CHEMBL852,cpd:C07122; cpd:C19256; cpd:C19442,13,18,2,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C13H19O2N2Cl2,C13H17O2N2Cl2,304.0745332,305.0823582,303.06670825136,5634,cpd:C07641,Thiotepa,C6H12N3PS,Thiotepa,NA,Chemical carcinogenesis,NA,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C07641  Thiotepa; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;   L01 ANTINEOPLASTIC AGENTS;    L01A ALKYLATING AGENTS;     L01AC Ethylene imines;      L01AC01 Thiotepa;       D00583  Thiotepa (JAN/USP/INN); Target-based classification of drugs [BR:br08310];  Others;   Nucleic acid;    DNA;     Thiotepa;      D00583  Thiotepa (JAN/USP/INN); Cytochrome P450 interactions [BR:br08309];  CYP inhbitors;   CYP2B6;    Thiotepa;     D00583  Thiotepa (JAN/USP/INN); New drug approvals in Europe [br08329.html];  European public assessment reports (EPAR) authorised medicine;   D00583,CAS: 52-24-4; PubChem: 9843; ChEBI: 9570; ChEMBL: CHEMBL671; NIKKAJI: J2.307H,cpd:C07641,6,12,0,3,1,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H13N3P1S1,C6H11N3P1S1,189.0489556,190.0567806,188.04113055137,5635,cpd:C10998,4-Aminobiphenyl,C12H11N,4-Aminobiphenyl,NA,Chemical carcinogenesis,NA,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C10998  4-Aminobiphenyl,CAS: 92-67-1; PubChem: 13181; ChEBI: 1784; ChEMBL: CHEMBL44201; NIKKAJI: J3.931D,cpd:C03622; cpd:C05644; cpd:C07491; cpd:C08061; cpd:C08062; cpd:C10654; cpd:C10998; cpd:C11016; cpd:C14206; cpd:C14333; cpd:C18533; cpd:C18735; cpd:C18833; cpd:C18921; cpd:C19319; cpd:C21289,12,11,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H12N1,C12H10N1,169.0891494,170.0969744,168.08132435138,5636,cpd:C14527,Methyl methacrylate;,C5H8O2,Methyl methacrylate; MMA; Methyl 2-methylpropenoate,NA,Chemical carcinogenesis,NA,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C14527  Methyl methacrylate,CAS: 80-62-6; PubChem: 17395527; ChEBI: 34840; ChEMBL: CHEMBL49996; NIKKAJI: J3.532G,cpd:C00906; cpd:C02240; cpd:C03800; cpd:C04075; cpd:C05715; cpd:C05717; cpd:C06558; cpd:C08279; cpd:C11074; cpd:C11345; cpd:C12518; cpd:C14527; cpd:C15499; cpd:C19238; cpd:C19504; cpd:C21028,5,8,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O2,C5H7O2,100.0524295,101.0602545,99.044604465139,5637,cpd:C14704,N-Nitrosodimethylamine;,C2H6N2O,N-Nitrosodimethylamine; Dimethylnitrosamine,NA,Chemical carcinogenesis,NA,NA,Carcinogens [BR:br08008];  Group 2A: Probably carcinogenic to humans;   Compounds;    C14704  N-Nitrosodimethylamine,CAS: 62-75-9; PubChem: 17395703; ChEBI: 35807; ChEMBL: CHEMBL117311; NIKKAJI: J1.928C,cpd:C02297; cpd:C07447; cpd:C14704; cpd:C16363,2,6,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H7O1N2,C2H5O1N2,74.04801282,75.05583785,73.040187795140,5639,cpd:C19164,Sulfur mustard;,C4H8Cl2S,Sulfur mustard; Mustard gas; Iprit,NA,Chemical carcinogenesis,NA,NA,Carcinogens [BR:br08008];  Group 1: Carcinogenic to humans;   Compounds;    C19164  Sulfur mustard,CAS: 505-60-2; PubChem: 124489836; ChEBI: 25434; ChEMBL: CHEMBL455341,cpd:C19164,4,8,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,C4H9S1Cl2,C4H7S1Cl2,157.9723768,158.9802018,156.96455185141,5640,cpd:C19180,"2-Amino-3-methylimidazo[4,5-f]quinoline;",C11H10N4,"2-Amino-3-methylimidazo[4,5-f]quinoline; IQ",NA,Chemical carcinogenesis,NA,NA,Carcinogens [BR:br08008];  Group 2A: Probably carcinogenic to humans;   Compounds;    C19180  IQ,CAS: 76180-96-6; PubChem: 124489852; ChEBI: 42725; PDB-CCD: GIQ,cpd:C11125; cpd:C19180; cpd:C19244; cpd:C20289,11,10,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11N4,C11H9N4,198.0905463,199.0983714,197.08272135142,5641,cpd:C19255,MeIQx;,C11H11N5,"MeIQx; 8-Methyl-IQX; 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",NA,Chemical carcinogenesis,NA,NA,Carcinogens [BR:br08008];  Group 2B: Possibly carcinogenic to humans;   Compounds;    C19255  MeIQx,CAS: 77500-04-0; PubChem: 124489927; ChEBI: 76604,cpd:C07429; cpd:C19232; cpd:C19255; cpd:C19289; cpd:C19290; cpd:C19897; cpd:C20291,11,11,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H12N5,C11H10N5,213.1014454,214.1092704,212.09362035143,5643,cpd:C19525,Sudan I;,C16H12N2O,Sudan I; C.I. Solvent Yellow 14,NA,Chemical carcinogenesis,NA,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C19525  Sudan I,CAS: 842-07-9; PubChem: 124490197; ChEBI: 30958; ChEMBL: CHEMBL1397023,cpd:C19525,16,12,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O1N2,C16H11O1N2,248.094963,249.102788,247.0871385144,5644,cpd:C20280,"1-Phenylazo-2,6-dihydroxynaphthalene;",C16H12N2O2,"1-Phenylazo-2,6-dihydroxynaphthalene; 6-OH-Sudan I",NA,Chemical carcinogenesis,NA,NA,NA,PubChem: 163312020,cpd:C09231; cpd:C20280; cpd:C20281,16,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O2N2,C16H11O2N2,264.0898776,265.0977027,263.08205265145,5645,cpd:C20281,1-(4-Hydroxyphenylazo)-2-naphthol;,C16H12N2O2,1-(4-Hydroxyphenylazo)-2-naphthol; 4'-OH-Sudan I,NA,Chemical carcinogenesis,NA,NA,NA,PubChem: 163312021,cpd:C09231; cpd:C20280; cpd:C20281,16,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O2N2,C16H11O2N2,264.0898776,265.0977027,263.08205265146,5646,cpd:C20282,"1-(4-Hydroxyphenylazo)-naphthalene-2,6-diol;",C16H12N2O3,"1-(4-Hydroxyphenylazo)-naphthalene-2,6-diol; 4',6-diOH-Sudan I",NA,Chemical carcinogenesis,NA,NA,NA,PubChem: 163312022,cpd:C16996; cpd:C20282; cpd:C20283,16,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O3N2,C16H11O3N2,280.0847923,281.0926173,279.07696725147,5647,cpd:C20283,"1-(3,4-Dihydroxyphenylazo)-2-naphthol;",C16H12N2O3,"1-(3,4-Dihydroxyphenylazo)-2-naphthol; 3',4'-diOH-Sudan I",NA,Chemical carcinogenesis,NA,NA,NA,PubChem: 163312023,cpd:C16996; cpd:C20282; cpd:C20283,16,12,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H13O3N2,C16H11O3N2,280.0847923,281.0926173,279.07696725148,5648,cpd:C20284,Benzenediazonium;,C6H5N2,Benzenediazonium; Benzenediazonium ion,NA,Chemical carcinogenesis,NA,NA,NA,CAS: 2684-02-8; PubChem: 163312024,cpd:C13689; cpd:C20284,6,5,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H6N2,C6H4N2,105.0452732,106.0530982,104.03744815149,5649,cpd:C20285,4-Acetylaminobiphenyl,C14H13NO,4-Acetylaminobiphenyl,NA,Chemical carcinogenesis,NA,NA,NA,CAS: 4075-79-0; PubChem: 163312025; ChEMBL: CHEMBL300429,cpd:C15427; cpd:C18913; cpd:C20285,14,13,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C14H14O1N1,C14H12O1N1,211.099714,212.1075391,210.0918895150,5650,cpd:C20286,"2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine;",C13H12N4O,"2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine; 2-Hydroxyamino-PhIP",NA,Chemical carcinogenesis,NA,NA,NA,CAS: 124489-20-9; PubChem: 163312026; ChEMBL: CHEMBL1743302,cpd:C20286,13,12,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H13O1N4,C13H11O1N4,240.101111,241.1089361,239.0932865151,5651,cpd:C20287,"2-Acetoxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine;",C15H14N4O2,"2-Acetoxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine; N-Acetoxy-PhIP",NA,Chemical carcinogenesis,NA,NA,NA,CAS: 142784-27-8; PubChem: 163312027,cpd:C20287,15,14,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H15O2N4,C15H13O2N4,282.1116757,283.1195007,281.10385075152,5652,cpd:C20288,N-Sulfonyloxy-PhIP,C13H12N4O4S,N-Sulfonyloxy-PhIP,NA,Chemical carcinogenesis,NA,NA,NA,PubChem: 163312028,cpd:C20288,13,12,4,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C13H13O4N4S1,C13H11O4N4S1,320.0579261,321.0657511,319.0501015153,5653,cpd:C20289,N-Hydroxy-IQ,C11H10N4O,N-Hydroxy-IQ,NA,Chemical carcinogenesis,NA,NA,NA,PubChem: 163312029,cpd:C20289,11,10,1,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H11O1N4,C11H9O1N4,214.085461,215.093286,213.07763595154,5654,cpd:C20290,N-Acetoxy-IQ,C13H12N4O2,N-Acetoxy-IQ,NA,Chemical carcinogenesis,NA,NA,NA,CAS: 115722-78-6; PubChem: 163312030,cpd:C20290,13,12,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H13O2N4,C13H11O2N4,256.0960256,257.1038507,255.08820065155,5655,cpd:C20291,N-Hydroxy-MeIQx,C11H11N5O,N-Hydroxy-MeIQx,NA,Chemical carcinogenesis,NA,NA,NA,CAS: 115044-41-2; PubChem: 163312031,cpd:C20291,11,11,1,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H12O1N5,C11H10O1N5,229.09636,230.104185,228.0885355156,5656,cpd:C20293,N-Acetoxy-MeIQx,C13H13N5O2,N-Acetoxy-MeIQx,NA,Chemical carcinogenesis,NA,NA,NA,CAS: 142038-32-2; PubChem: 163312033,cpd:C20293,13,13,2,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C13H14O2N5,C13H12O2N5,271.1069247,272.1147497,270.09909965157,5661,cpd:C20300,Dimethylarsinous acid,C2H7AsO,Dimethylarsinous acid,NA,Chemical carcinogenesis,NA,NA,NA,CAS: 55094-22-9; PubChem: 163312038,cpd:C20300,2,7,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,C2H8O1As1,C2H6O1As1,121.9712898,122.9791149,120.96346485158,5662,cpd:C20301,alpha-Hydroxy-NDMA;,C2H6N2O2,alpha-Hydroxy-NDMA; N-Nitrosohydroxymethylmethylamine,NA,Chemical carcinogenesis,NA,NA,NA,PubChem: 163312039,cpd:C02390; cpd:C06384; cpd:C20301,2,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H7O2N2,C2H5O2N2,90.04292744,91.05075247,89.035102415159,5663,cpd:C20302,Methyldiazonium ion;,CH3N2,Methyldiazonium ion; Methanediazonium,NA,Chemical carcinogenesis,NA,NA,NA,CAS: 20404-06-2; PubChem: 163312040,cpd:C20302,1,3,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H4N2,C1H2N2,43.02962311,44.03744814,42.021798075160,5664,cpd:C20303,Chloroethylene oxide,C2H3ClO,Chloroethylene oxide,NA,Chemical carcinogenesis,NA,NA,NA,CAS: 7763-77-1; PubChem: 163312041,cpd:C06754; cpd:C20303,2,3,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C2H4O1Cl1,C2H2O1Cl1,77.9872424,78.99506743,76.979417375161,5665,cpd:C20304,S-(2-Chloroethyl)glutathione,C12H20ClN3O6S,S-(2-Chloroethyl)glutathione,NA,Chemical carcinogenesis,NA,NA,NA,CAS: 75607-61-3; PubChem: 163312042,cpd:C20304,12,20,6,3,0,1,1,0,0,0,0,0,0,0,0,0,0,0,C12H21O6N3S1Cl1,C12H19O6N3S1Cl1,369.0761342,370.0839593,368.06830925162,5666,cpd:C20305,"1,2-Dichloroethanol",C2H4Cl2O,"1,2-Dichloroethanol",NA,Chemical carcinogenesis,NA,NA,NA,CAS: 74054-85-6; PubChem: 163312043,cpd:C19158; cpd:C20305,2,4,1,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C2H5O1Cl2,C2H3O1Cl2,113.9639201,114.9717451,112.95609515163,5667,cpd:C20306,Methyldiazohydroxide,CH4N2O,Methyldiazohydroxide,NA,Chemical carcinogenesis,NA,NA,NA,PubChem: 163312044,cpd:C00086; cpd:C19568; cpd:C20306,1,4,1,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C1H5O1N2,C1H3O1N2,60.03236276,61.04018779,59.024537735164,5668,cpd:C20316,4-Nitrosobiphenyl,C12H9NO,4-Nitrosobiphenyl,NA,Chemical carcinogenesis,NA,NA,NA,CAS: 10125-76-5; PubChem: 163312054,cpd:C20316,12,9,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H10O1N1,C12H8O1N1,183.0684139,184.0762389,182.06058895165,5669,cpd:C20317,"S-(1,2-Dichlorovinyl)-L-cysteine;",C5H7Cl2NO2S,"S-(1,2-Dichlorovinyl)-L-cysteine; DCVC",NA,Chemical carcinogenesis,NA,NA,NA,CAS: 627-72-5; PubChem: 163312055,cpd:C20317,5,7,2,1,0,1,2,0,0,0,0,0,0,0,0,0,0,0,C5H8O2N1S1Cl2,C5H6O2N1S1Cl2,214.957455,215.96528,213.949635166,5670,cpd:C20318,"S-(1,2-Dichlorovinyl)thiol;",C2H2Cl2S,"S-(1,2-Dichlorovinyl)thiol; DCVT",NA,Chemical carcinogenesis,NA,NA,NA,PubChem: 163312056,cpd:C20318,2,2,0,0,0,1,2,0,0,0,0,0,0,0,0,0,0,0,C2H3S1Cl2,C2H1S1Cl2,127.9254266,128.9332516,126.91760165167,5671,cpd:C20319,Hydronitroxide radical,C12H10NO,Hydronitroxide radical,NA,Chemical carcinogenesis,NA,NA,NA,PubChem: 163312057,cpd:C11100; cpd:C20319,12,10,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H11O1N1,C12H9O1N1,184.0762389,185.084064,183.06841395168,5676,cpd:C14492,Ulifloxacin;,C16H16FN3O3S,Ulifloxacin; NM 394,NA,Quinolones,NA,NA,NA,CAS: 112984-60-8; PubChem: 17395492; ChEBI: 35044; ChEMBL: CHEMBL345937; NIKKAJI: J462.718K,cpd:C14492,16,16,3,3,0,1,0,0,0,1,0,0,0,0,0,0,0,0,C16H17O3N3S1F1,C16H15O3N3S1F1,349.0896407,350.0974658,348.08181575169,5677,cpd:C14166,alpha-Eucaine,C19H27NO4,alpha-Eucaine,NA,Local analgesics,NA,NA,NA,CAS: 470-68-8; PubChem: 7846978; ChEBI: 35059; NIKKAJI: J2.788.083E,cpd:C14166,19,27,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H28O4N1,C19H26O4N1,333.1940084,334.2018334,332.18618335170,5678,cpd:C14167,beta-Eucaine,C15H21NO2,beta-Eucaine,NA,Local analgesics,NA,NA,NA,CAS: 500-34-5; PubChem: 7846979; ChEBI: 35068; NIKKAJI: J6.188C,cpd:C07128; cpd:C11792; cpd:C14167,15,21,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H22O2N1,C15H20O2N1,247.1572289,248.165054,246.14940395171,5679,cpd:C14168,3-(Dimethylamino)propyl benzoate,C12H17NO2,3-(Dimethylamino)propyl benzoate,NA,Local analgesics,NA,NA,NA,CAS: 25314-80-1; PubChem: 7846980; ChEBI: 34327; ChEMBL: CHEMBL1571562; NIKKAJI: J2.788.086J,cpd:C14168; cpd:C14425; cpd:C18956,12,17,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H18O2N1,C12H16O2N1,207.1259288,208.1337538,206.11810385172,5680,cpd:C14170,p-Aminosalicylic acid methyl ester,C8H9NO3,p-Aminosalicylic acid methyl ester,NA,Local analgesics,NA,NA,NA,CAS: 4136-97-4; PubChem: 7846982; ChEBI: 35089; ChEMBL: CHEMBL1458862; NIKKAJI: J45.062F,cpd:C00250; cpd:C03493; cpd:C03986; cpd:C05831; cpd:C06051; cpd:C12323; cpd:C14170; cpd:C14171; cpd:C20821,8,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O3N1,C8H8O3N1,167.0582432,168.0660682,166.05041815173,5681,cpd:C14171,Orthoform;,C8H9NO3,Orthoform; Orthocaine,NA,Local analgesics,NA,NA,NA,CAS: 536-25-4; PubChem: 7846983; ChEBI: 34904; NIKKAJI: J54.519H,cpd:C00250; cpd:C03493; cpd:C03986; cpd:C05831; cpd:C06051; cpd:C12323; cpd:C14170; cpd:C14171; cpd:C20821,8,9,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C8H10O3N1,C8H8O3N1,167.0582432,168.0660682,166.05041815174,5682,cpd:C14172,Hexylcaine,C16H23NO2,Hexylcaine,NA,Local analgesics,NA,NA,NA,CAS: 532-77-4; PubChem: 7846984; ChEBI: 34791; ChEMBL: CHEMBL1197; NIKKAJI: J38.383J,cpd:C09850; cpd:C09867; cpd:C13769; cpd:C14172; cpd:C14173,16,23,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H24O2N1,C16H22O2N1,261.172879,262.180704,260.1650545175,5683,cpd:C14173,Piperocaine;,C16H23NO2,Piperocaine; Metycaine,NA,Local analgesics,NA,NA,NA,CAS: 136-82-3; PubChem: 7846985; ChEBI: 34925; ChEMBL: CHEMBL127865; NIKKAJI: J290.025D,cpd:C09850; cpd:C09867; cpd:C13769; cpd:C14172; cpd:C14173,16,23,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H24O2N1,C16H22O2N1,261.172879,262.180704,260.1650545176,5684,cpd:C06530,Cupreine,C19H22N2O2,Cupreine,NA,Sulfonamide derivatives - sulfa drugs,NA,NA,NA,CAS: 524-63-0; PubChem: 8760; ChEBI: 28582; KNApSAcK: C00026411; 3DMET: B05211; NIKKAJI: J6.640K,cpd:C06530; cpd:C09239,19,22,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C19H23O2N2,C19H21O2N2,310.168128,311.175953,309.16030295177,5685,cpd:C14617,Chrysoidine free base;,C12H12N4,Chrysoidine free base; Grasan Chrysoidine,NA,Sulfonamide derivatives - sulfa drugs,NA,NA,NA,CAS: 495-54-5; PubChem: 17395617; ChEBI: 34640; ChEMBL: CHEMBL1739417; NIKKAJI: J1.561J,cpd:C14617; cpd:C19254; cpd:C19369,12,12,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H13N4,C12H11N4,212.1061964,213.1140214,211.09837145178,5686,cpd:C14539,Krm 1657,C50H62N4O13,Krm 1657,NA,Rifamycins,NA,NA,NA,CAS: 133633-12-2; PubChem: 17395539; ChEBI: 34806; NIKKAJI: J406.602B,cpd:C14539,50,62,13,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C50H63O13N4,C50H61O13N4,926.4313381,927.4391631,925.4235135179,5687,cpd:C13334,Pitavastatin;,C25H23FNO4,"Pitavastatin; (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate",NA,HMG-CoA reductase inhibitors,NA,NA,NA,CAS: 147511-69-1; PubChem: 586078; ChEBI: 32020 71260; ChEMBL: CHEMBL1201753,cpd:C13334,25,23,4,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C25H24O4N1F1,C25H22O4N1F1,420.1611114,421.1689364,419.15328645180,5688,cpd:C13963,Mevastatin;,C23H34O5,Mevastatin; Compactin; ML-236B,NA,HMG-CoA reductase inhibitors,NA,NA,NA,CAS: 73573-88-3; PubChem: 7846932; ChEBI: 34848; ChEMBL: CHEMBL300596 CHEMBL54440; KNApSAcK: C00000564; NIKKAJI: J12.081B,cpd:C13963; cpd:C15404,23,34,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C23H35O5,C23H33O5,390.2406242,391.2484492,389.23279925181,5689,cpd:C14531,Azomycin;,C3H3N3O2,Azomycin; 2-Nitroimidazole,R10133,Antifungal agents,3.5.99.9,NA,NA,CAS: 527-73-1; PubChem: 17395531; ChEBI: 67135; ChEMBL: CHEMBL433637; NIKKAJI: J3.641B,cpd:C14531; cpd:C19324,3,3,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C3H4O2N3,C3H2O2N3,113.0225263,114.0303514,112.01470135182,5690,cpd:C14816,Sch 59884,C41H49F2N8O9P,Sch 59884,NA,Antifungal agents,NA,NA,NA,CAS: 200346-83-4; PubChem: 17395814; ChEBI: 34971; NIKKAJI: J1.659.071A,cpd:C14816,41,49,9,8,1,0,0,0,0,2,0,0,0,0,0,0,0,0,C41H50O9N8P1F2,C41H48O9N8P1F2,866.3328185,867.3406435,865.32499355183,5691,cpd:C14817,BMS 379224,C23H20F2N5O5PS,BMS 379224,NA,Antifungal agents,NA,NA,NA,PubChem: 17395815; ChEBI: 34549; ChEMBL: CHEMBL333325; NIKKAJI: J2.789.459C,cpd:C14817,23,20,5,5,1,1,0,0,0,2,0,0,0,0,0,0,0,0,C23H21O5N5P1S1F2,C23H19O5N5P1S1F2,547.0890833,548.0969083,546.08125825184,5692,cpd:C14838,Y 23684;,C18H13ClN2O2S,"Y 23684; 2-(4-Chlorophenyl)-5,6-dihydro-[1]benzothepino[5,4-c]pyridazin-3(2H)-one-7-oxide",NA,Anxiolytics,NA,NA,NA,CAS: 118288-67-8; PubChem: 17395836; ChEBI: 79404; NIKKAJI: J386.851F,cpd:C14838,18,13,2,2,0,1,1,0,0,0,0,0,0,0,0,0,0,0,C18H14O2N2S1Cl1,C18H12O2N2S1Cl1,356.0386265,357.0464516,355.03080155185,5693,cpd:C07499,Phenylethylmalonamide;,C11H14N2O2,Phenylethylmalonamide; 2-Phenyl-2-ethylmalondiamide; PEMA,NA,Anticonvulsants,NA,NA,NA,CAS: 7206-76-0; PubChem: 9702; ChEBI: 8097; ChEMBL: CHEMBL249467; NIKKAJI: J125.795A,cpd:C07499; cpd:C12590,11,14,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H15O2N2,C11H13O2N2,206.1055277,207.1133527,205.09770275186,5694,cpd:C14916,Nirvanol,C11H12N2O2,Nirvanol,NA,Anticonvulsants,NA,NA,NA,CAS: 631-07-2; PubChem: 17395914; ChEBI: 79441; ChEMBL: CHEMBL1438; NIKKAJI: J9.448J,cpd:C00078; cpd:C00525; cpd:C00806; cpd:C07839; cpd:C10743; cpd:C10968; cpd:C14916,11,12,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C11H13O2N2,C11H11O2N2,204.0898776,205.0977027,203.08205265187,5695,cpd:C15341,Fluorofelbamate,C11H13FN2O4,Fluorofelbamate,NA,Anticonvulsants,NA,NA,NA,CAS: 726-99-8; PubChem: 17396338; ChEBI: 79843; NIKKAJI: J2.793.898A,cpd:C15341,11,13,4,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C11H14O4N2F1,C11H12O4N2F1,256.0859351,257.0937601,255.078115188,5697,cpd:C06855,Bretylium,C11H17BrN,Bretylium,NA,Antiarrhythmic drugs; Potassium channel blocking and opening drugs,NA,NA,NA,CAS: 59-41-6; PubChem: 9073; ChEBI: 3172; ChEMBL: CHEMBL1199080; NIKKAJI: J4.602G,cpd:C06855,11,17,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,C11H18N1Br1,C11H16N1Br1,242.0544372,243.0622622,241.04661215189,5698,cpd:C13772,Clofilium,C21H37ClN,Clofilium,NA,Antiarrhythmic drugs; Potassium channel blocking and opening drugs,NA,NA,NA,CAS: 68379-02-2; PubChem: 854018; ChEBI: 34649; ChEMBL: CHEMBL9484; NIKKAJI: J354.009J,cpd:C13772,21,37,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C21H38N1Cl1,C21H36N1Cl1,338.2614529,339.2692779,337.25362785190,5699,cpd:C13777,Azimilide,C23H28ClN5O3,Azimilide,NA,Antiarrhythmic drugs; Potassium channel blocking and opening drugs,NA,NA,NA,CAS: 149908-53-2; PubChem: 854022; ChEBI: 34545; ChEMBL: CHEMBL123558; NIKKAJI: J566.960J,cpd:C13777,23,28,3,5,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C23H29O3N5Cl1,C23H27O3N5Cl1,457.1880675,458.1958925,456.18024245191,5700,cpd:C11790,Phenazocine,C22H27NO,Phenazocine,NA,Opioid analgesics,NA,NA,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N02 ANALGESICS;    N02A OPIOIDS;     N02AD Benzomorphan derivatives;      N02AD02 Phenazocine;       C11790  Phenazocine,CAS: 127-35-5; PubChem: 13954; ChEBI: 8056; ChEMBL: CHEMBL295811 CHEMBL316632; NIKKAJI: J5.392I,cpd:C11790,22,27,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C22H28O1N1,C22H26O1N1,321.2092645,322.2170895,320.20143955192,5701,cpd:C11791,Bremazocine,C20H29NO2,Bremazocine,NA,Opioid analgesics,NA,NA,NA,CAS: 75684-07-0; PubChem: 13955; ChEBI: 3171; ChEMBL: CHEMBL1797687; NIKKAJI: J18.646E,cpd:C11791,20,29,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H30O2N1,C20H28O2N1,315.2198292,316.2276542,314.21200415193,5702,cpd:C07642,Triethylenemelamine;,C9H12N6,"Triethylenemelamine; Trisaziridinyltriazine; 2,4,6-Tris(1-aziridinyl)-s-triazine",NA,Antineoplastics - alkylating agents,NA,NA,Carcinogens [BR:br08008];  Group 3: Not classifiable as to its carcinogenicity to humans;   Compounds;    C07642  Triethylenemelamine,CAS: 51-18-3; PubChem: 9844; ChEBI: 27919; ChEMBL: CHEMBL502384; NIKKAJI: J4.112B,cpd:C07642; cpd:C11265,9,12,0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H13N6,C9H11N6,204.1123444,205.1201694,203.10451945194,5703,cpd:C14595,Methylnitrosourea;,C2H5N3O2,Methylnitrosourea; N-Methyl-N-nitrosourea; NMH,NA,Antineoplastics - alkylating agents,NA,NA,Carcinogens [BR:br08008];  Group 2A: Probably carcinogenic to humans;   Compounds;    C14595  N-Methyl-N-nitrosourea,CAS: 684-93-5; PubChem: 17395595; ChEBI: 50102; ChEMBL: CHEMBL288958; NIKKAJI: J3.020A,cpd:C06555; cpd:C14595,2,5,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C2H6O2N3,C2H4O2N3,103.0381764,104.0460014,102.03035145195,5704,cpd:C16250,MTIC,C5H8N6O,MTIC,NA,Antineoplastics - alkylating agents,NA,NA,NA,CAS: 3413-72-7; PubChem: 47205558; ChEBI: 72568; ChEMBL: CHEMBL1442; NIKKAJI: J54.029C,cpd:C16250,5,8,1,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C5H9O1N6,C5H7O1N6,168.0759589,169.0837839,167.06813395196,5705,cpd:C20266,AMD 070,C21H27N5,AMD 070,NA,Anti-HIV agents,NA,NA,Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: peptide receptors;    CXC Chemokine;     C-X-C chemokine receptor type 4;      C20266  AMD 070,CAS: 558447-26-0; PubChem: 163312006; ChEMBL: CHEMBL518924,cpd:C08115; cpd:C13269; cpd:C20266,21,27,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C21H28N5,C21H26N5,349.2266459,350.2344709,348.21882095197,5706,cpd:C07573,Prontosil;,C12H13N5O2S,Prontosil; Sulfamidochrysoidine; Prontosil rubrum,NA,Sulfonamide derivatives - overview,NA,NA,NA,CAS: 103-12-8; PubChem: 9776; ChEBI: 8464; ChEMBL: CHEMBL488279; NIKKAJI: J8.625H,cpd:C07573,12,13,2,5,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C12H14O2N5S1,C12H12O2N5S1,291.0789959,292.0868209,290.07117085198,5707,cpd:C14316,SB 218655,C17H16FN5,SB 218655,NA,"1,2-Diphenyl substitution family",NA,NA,NA,CAS: 165806-51-9; PubChem: 17395316; ChEBI: 45452; ChEMBL: CHEMBL590753; PDB-CCD: SB5; NIKKAJI: J2.788.255B,cpd:C14316,17,16,0,5,0,0,0,0,0,1,0,0,0,0,0,0,0,0,C17H17N5F1,C17H15N5F1,309.1389737,310.1467987,308.13114875199,5708,cpd:C14319,SR 141716;,C22H21Cl3N4O,SR 141716; Rimonabant,NA,"1,2-Diphenyl substitution family",NA,NA,"Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: other receptors;    Cannabinoid;     cannabinoid receptor 1;      C14319  SR 141716; Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  A ALIMENTARY TRACT AND METABOLISM;   A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS;    A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS;     A08AX Other antiobesity drugs;      A08AX01 Rimonabant;       D05731  Rimonabant (JAN/USAN/INN); Target-based classification of drugs [BR:br08310];  G Protein-coupled receptors;   Rhodopsin family;    Cannabinoid;     cannabinoid receptor 1;      Rimonabant;       D05731  Rimonabant (JAN/USAN/INN)",CAS: 168273-06-1; PubChem: 17395319; ChEBI: 34967; ChEMBL: CHEMBL111; NIKKAJI: J649.754C,cpd:C14319,22,21,1,4,0,0,3,0,0,0,0,0,0,0,0,0,0,0,C22H22O1N4Cl3,C22H20O1N4Cl3,462.0780944,463.0859194,461.07026935200,5709,cpd:C11688,Asperlicin,C31H29N5O4,Asperlicin,NA,Benzodiazepine family,NA,NA,NA,CAS: 93413-04-8; PubChem: 13853; ChEBI: 2880; ChEMBL: CHEMBL283117; KNApSAcK: C00017731; NIKKAJI: J41.423I,cpd:C11688,31,29,4,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H30O4N5,C31H28O4N5,535.2219544,536.2297795,534.21412945201,5710,cpd:C15026,L-365260;,C24H22N4O2,"L-365260; N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea",NA,Benzodiazepine family,NA,NA,NA,CAS: 118101-09-0; PubChem: 17396023; ChEBI: 79548; ChEMBL: CHEMBL9387; NIKKAJI: J258.436K,cpd:C15026,24,22,2,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C24H23O2N4,C24H21O2N4,398.174276,399.182101,397.16645095202,5711,cpd:C15040,GYKI 52466;,C17H15N3O2,"GYKI 52466; 4-(8-Methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)benzenamine",NA,Benzodiazepine family,NA,NA,NA,CAS: 102771-26-6; PubChem: 17396037; ChEBI: 79560; ChEMBL: CHEMBL275006; NIKKAJI: J347.048B,cpd:C15040,17,15,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H16O2N3,C17H14O2N3,293.1164267,294.1242518,292.10860175203,5712,cpd:C15094,GYKI 52895;,C17H17N3O2,"GYKI 52895; 4-(8,9-Dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)benzenamine",NA,Benzodiazepine family,NA,NA,NA,CAS: 869360-93-0 114460-08-1; PubChem: 17396091; ChEBI: 79613; ChEMBL: CHEMBL1256984; NIKKAJI: J662.271B,cpd:C15094,17,17,2,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H18O2N3,C17H16O2N3,295.1320768,296.1399018,294.12425185204,5713,cpd:C15096,GV 150013X;,C33H34N4O3,"GV 150013X; N-Phenyl-N'-[(3R)-2,3,4,5-tetrahydro-2,4-dioxo-1-phenyl-5-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-1H-1,5-benzodiazepin-3-yl]urea",NA,Benzodiazepine family,NA,NA,NA,PubChem: 17396093; ChEBI: 79615; ChEMBL: CHEMBL329305; NIKKAJI: J924.335F,cpd:C15096; cpd:C18064,33,34,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C33H35O3N4,C33H33O3N4,534.263091,535.270916,533.25526595205,5714,cpd:C15104,LY-202769;,C27H24ClN3O2,LY-202769; 2-[2-(5-Chloro-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4(3H)-quinazolinone,NA,Benzodiazepine family,NA,NA,NA,CAS: 139543-40-1; PubChem: 17396101; ChEBI: 79623; NIKKAJI: J2.792.870F,cpd:C15104,27,24,2,3,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C27H25O2N3Cl1,C27H23O2N3Cl1,457.1557047,458.1635297,456.14787975206,5716,cpd:C11772,DCI;,C11H15Cl2NO,DCI; Dichloroisoproterenol,NA,beta-Adrenergic receptor agonists/antagonists,NA,NA,NA,CAS: 59-61-0; PubChem: 13936; ChEBI: 4285; ChEMBL: CHEMBL1160738; NIKKAJI: J4.793G,cpd:C11772,11,15,1,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,C11H16O1N1Cl2,C11H14O1N1Cl2,247.0530695,248.0608945,246.04524445207,5717,cpd:C15474,Tropolone,C7H6O2,Tropolone,NA,Catecholamine transferase inhibitors,NA,NA,Target-based classification of compounds [BR:br08010];  Enzymes;   Transferases;    catechol O-methyltransferase;     C15474  Tropolone,CAS: 533-75-5; PubChem: 17396468; ChEBI: 79966; ChEMBL: CHEMBL121188; PDB-CCD: 0TR; NIKKAJI: J44.110D,cpd:C00180; cpd:C00539; cpd:C00633; cpd:C03067; cpd:C06202; cpd:C14181; cpd:C15474; cpd:C18302,7,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C7H7O2,C7H5O2,122.0367794,123.0446045,121.02895445208,5718,cpd:C15475,U 0521,C10H12O3,U 0521,NA,Catecholamine transferase inhibitors,NA,NA,Target-based classification of compounds [BR:br08010];  Enzymes;   Transferases;    catechol O-methyltransferase;     C15475  U 0521,CAS: 5466-89-7; PubChem: 17396469; ChEBI: 79967; ChEMBL: CHEMBL353187; NIKKAJI: J23.582B,cpd:C00328; cpd:C00590; cpd:C01718; cpd:C05647; cpd:C06953; cpd:C07342; cpd:C10965; cpd:C11018; cpd:C15475; cpd:C16880; cpd:C18966; cpd:C19766; cpd:C19768; cpd:C20343; cpd:C20463,10,12,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C10H13O3,C10H11O3,180.0786442,181.0864693,179.07081925209,5719,cpd:C15476,Norselegiline,C12H15N,Norselegiline,NA,Catecholamine transferase inhibitors,NA,NA,Target-based classification of compounds [BR:br08010];  Enzymes;   Oxidoreductases;    monoamine oxidase B (MAO-B);     C15476  Norselegiline,CAS: 56862-28-3; PubChem: 17396470; ChEBI: 79968; ChEMBL: CHEMBL145089; NIKKAJI: J324.820H,cpd:C00925; cpd:C01619; cpd:C04452; cpd:C04599; cpd:C04731; cpd:C07934; cpd:C10134; cpd:C10846; cpd:C11028; cpd:C12853; cpd:C13534; cpd:C14291; cpd:C15476,12,15,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H16N1,C12H14N1,173.1204495,174.1282745,172.11262455210,5720,cpd:C15477,CGP 28014,C12H19N3O,CGP 28014,NA,Catecholamine transferase inhibitors,NA,NA,Target-based classification of compounds [BR:br08010];  Enzymes;   Transferases;    catechol O-methyltransferase;     C15477  CGP 28014,CAS: 111757-17-6; PubChem: 17396471; ChEBI: 79969; NIKKAJI: J458.729D,cpd:C07376; cpd:C07402; cpd:C10566; cpd:C15477,12,19,1,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C12H20O1N3,C12H18O1N3,221.1528122,222.1606373,220.14498725211,5721,cpd:C11711,Succinylproline;,C9H13NO5,Succinylproline; Succinyl-L-proline,NA,Renin-angiotensin system inhibitors,NA,NA,NA,CAS: 63250-32-8; PubChem: 13876; ChEBI: 9308; ChEMBL: CHEMBL310578; NIKKAJI: J1.817.087F,cpd:C11711,9,13,5,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H14O5N1,C9H12O5N1,215.0793725,216.0871976,214.07154755212,5722,cpd:C11712,Teprotide,C53H76N14O12,Teprotide,NA,Renin-angiotensin system inhibitors,NA,NA,Target-based classification of drugs [BR:br08310];  Enzymes;   Hydrolases;    angiotensin-converting enzyme (ACE);     Teprotide;      D06076  Teprotide (USAN/INN),CAS: 35115-60-7; PubChem: 13877; ChEBI: 9444; ChEMBL: CHEMBL408983; NIKKAJI: J17.852G,cpd:C11712,53,76,12,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C53H77O12N14,C53H75O12N14,1100.576714,1101.584539,1099.5688895213,5723,cpd:C15659,TMC 126;,C28H38N2O8S,TMC 126; UIC 94003,NA,HIV protease inhibitors,NA,NA,NA,CAS: 206362-00-7; PubChem: 17396648; ChEBI: 49568; ChEMBL: CHEMBL302859 CHEMBL469086; PDB-CCD: DJR; NIKKAJI: J1.518.203B,cpd:C15659,28,38,8,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C28H39O8N2S1,C28H37O8N2S1,562.2348874,563.2427124,561.22706235214,5724,cpd:C15660,A 77003,C44H58N8O6,A 77003,NA,HIV protease inhibitors,NA,NA,NA,CAS: 134878-17-4; PubChem: 17396649; ChEBI: 40492; ChEMBL: CHEMBL266918; PDB-CCD: A77; NIKKAJI: J438.982D,cpd:C15660,44,58,6,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C44H59O6N8,C44H57O6N8,794.4479316,795.4557567,793.44010665215,5725,cpd:C15661,A 80987,C37H43N5O6,A 80987,NA,HIV protease inhibitors,NA,NA,NA,CAS: 144141-97-9; PubChem: 17396650; ChEBI: 80009; ChEMBL: CHEMBL347484; NIKKAJI: J566.362H,cpd:C15661,37,43,6,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H44O6N5,C37H42O6N5,653.3213341,654.3291592,652.31350915216,5726,cpd:C15662,Dmp 323,C35H38N2O5,Dmp 323,NA,HIV protease inhibitors,NA,NA,NA,CAS: 151867-81-1; PubChem: 17396651; ChEBI: 42082; ChEMBL: CHEMBL21145; PDB-CCD: DMP; NIKKAJI: J565.493I,cpd:C15662,35,38,5,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C35H39O5N2,C35H37O5N2,566.2780723,567.2858974,565.27024735217,5727,cpd:C07473,Muscarine,C9H20NO2,Muscarine,NA,Cholinergic and anticholinergic drugs,NA,NA,Natural toxins [BR:br08009];  Fungal toxins;   Mushroom toxins;    Alkaloids;     C07473  Muscarine,CAS: 300-54-9; PubChem: 9676; ChEBI: 7034; ChEMBL: CHEMBL105471 CHEMBL12587; KNApSAcK: C00001422; NIKKAJI: J13.471F,cpd:C07473,9,20,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H21O2N1,C9H19O2N1,174.1494039,175.1572289,173.14157895218,5728,cpd:C11760,Amprotropine,C18H29NO3,Amprotropine,NA,Cholinergic and anticholinergic drugs,NA,NA,NA,CAS: 148-32-3; PubChem: 13924; ChEBI: 2685; NIKKAJI: J5.845I,cpd:C06849; cpd:C11760; cpd:C16952,18,29,3,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C18H30O3N1,C18H28O3N1,307.2147438,308.2225688,306.20691885219,5729,cpd:C07548,Atracurium,C53H72N2O12,Atracurium,NA,Nicotinic cholinergic receptor antagonists,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  M MUSCULO-SKELETAL SYSTEM;   M03 MUSCLE RELAXANTS;    M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS;     M03AC Other quaternary ammonium compounds;      M03AC04 Atracurium;       C07548  Atracurium",CAS: 64228-79-1; PubChem: 9751; ChEBI: 2914; ChEMBL: CHEMBL1360; NIKKAJI: J292.641E,cpd:C07548,53,72,12,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C53H73O12N2,C53H71O12N2,928.5085258,929.5163508,927.50070075220,5730,cpd:C07550,Mivacurium,C58H80N2O14,Mivacurium,NA,Nicotinic cholinergic receptor antagonists,NA,NA,NA,CAS: 106791-40-6; PubChem: 9753; ChEBI: 6958; ChEMBL: CHEMBL1182833; NIKKAJI: J283.273I,cpd:C07550,58,80,14,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C58H81O14N2,C58H79O14N2,1028.560955,1029.56878,1027.553135221,5731,cpd:C07919,Metocurine,C40H48N2O6,Metocurine,NA,Nicotinic cholinergic receptor antagonists,NA,NA,NA,CAS: 5152-30-7; PubChem: 10121; ChEBI: 6900; ChEMBL: CHEMBL1259; PDB-CCD: CU9; NIKKAJI: J96.562F,cpd:C07919,40,48,6,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C40H49O6N2,C40H47O6N2,652.3512373,653.3590623,651.34341225222,5732,cpd:C11733,Decamethonium,C16H38N2,Decamethonium,NA,Nicotinic cholinergic receptor antagonists,NA,NA,Target-based classification of compounds [BR:br08010];  Ion channels;   Cys-loop superfamily;    Acetylcholine (nicotinic);     muscle-type nicotinic cholinergic receptor;      C11733  Decamethonium,CAS: 156-74-1; PubChem: 13898; ChEBI: 41934; ChEMBL: CHEMBL1190; PDB-CCD: DME; NIKKAJI: J6.129H,cpd:C11733,16,38,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H39N2,C16H37N2,258.3034992,259.3113243,257.29567425223,5733,cpd:C17302,AL-294;,C21H25ClO3,AL-294; Ethyl 2-chloro-3-(4-(2-methyl-2-phenylpropoxy)phenyl)propanoate,NA,Peroxisome proliferator-activated receptor (PPAR) agonists,NA,NA,NA,CAS: 62516-91-0; PubChem: 96023683; ChEBI: 81003; NIKKAJI: J40.896D,cpd:C07778; cpd:C13494; cpd:C17302,21,25,3,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,C21H26O3Cl1,C21H24O3Cl1,360.1492223,361.1570474,359.14139735224,5734,cpd:C17303,AL-321;,C20H21NO3S,"AL-321; 5-(4-(2-Methyl-2-phenylpropoxy)benzyl)thiazolidine-2,4-dione",NA,Peroxisome proliferator-activated receptor (PPAR) agonists,NA,NA,NA,CAS: 74772-68-2; PubChem: 96023684; ChEBI: 81004; NIKKAJI: J1.240.781E,cpd:C17303,20,21,3,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C20H22O3N1S1,C20H20O3N1S1,355.1242147,356.1320397,354.11638975225,5735,cpd:C16044,Nociceptin;,C79H129N27O22,Nociceptin; Orphanin FQ,NA,Opioid receptor agonists/antagonists,NA,NA,Bioactive peptides [BR:br08005];  Neuropeptides;   Endogenous opioid peptide;    C16044  Nociceptin; Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: peptide receptors;    Opioid;     nociceptin receptor;      C16044  Nociceptin,PubChem: 47205354; ChEBI: 80266; NIKKAJI: J764.295D,NA,79,129,22,27,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C79H130O22N27,C79H128O22N27,1807.980549,1808.988374,1806.9727245226,5736,cpd:C18010,Deltorphin A;,C44H62N10O10S2,Deltorphin A; Dermenkephalin,NA,Opioid receptor agonists/antagonists,NA,NA,Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: peptide receptors;    Opioid;     delta-opioid receptor;      C18010  Deltorphin A,CAS: 119975-64-3; PubChem: 96024230; ChEBI: 81455; ChEMBL: CHEMBL20775,cpd:C18010,44,62,10,10,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C44H63O10N10S2,C44H61O10N10S2,954.4091806,955.4170056,953.40135565227,5737,cpd:C18095,Deltorphin B;,C38H54N8O10,Deltorphin B; Deltorphin II,NA,Opioid receptor agonists/antagonists,NA,NA,Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: peptide receptors;    Opioid;     delta-opioid receptor;      C18095  Deltorphin B,CAS: 122752-16-3; PubChem: 96024312; ChEBI: 81498; ChEMBL: CHEMBL20226; NIKKAJI: J384.384J,cpd:C18095,38,54,10,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C38H55O10N8,C38H53O10N8,782.39629,783.404115,781.38846495228,5738,cpd:C18097,Deltorphin C;,C37H52N8O10,Deltorphin C; Deltorphin I,NA,Opioid receptor agonists/antagonists,NA,NA,Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: peptide receptors;    Opioid;     delta-opioid receptor;      C18097  Deltorphin C,CAS: 122752-15-2; PubChem: 96024314; ChEBI: 81500; ChEMBL: CHEMBL317956; NIKKAJI: J370.361D,cpd:C18097,37,52,10,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C37H53O10N8,C37H51O10N8,768.3806399,769.3884649,767.37281495229,5739,cpd:C18128,Naltrindole;,C26H26N2O3,Naltrindole; NTI,NA,Opioid receptor agonists/antagonists,NA,NA,Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: peptide receptors;    Opioid;     delta-opioid receptor;      C18128  Naltrindole,CAS: 111555-53-4; PubChem: 96024345; ChEBI: 81528; ChEMBL: CHEMBL567175; PDB-CCD: EJ4; NIKKAJI: J304.821G,cpd:C18128,26,26,3,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C26H27O3N2,C26H25O3N2,414.1943427,415.2021677,413.18651775230,5740,cpd:C07448,Burimamide,C9H16N4S,Burimamide,NA,Histamine H2/H3 receptor agonists/antagonists,NA,NA,NA,CAS: 34970-69-9; PubChem: 9651; ChEBI: 3221; ChEMBL: CHEMBL12160; NIKKAJI: J161.437A,cpd:C07448; cpd:C18436,9,16,0,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C9H17N4S1,C9H15N4S1,212.1095677,213.1173927,211.10174275231,5741,cpd:C07454,N-Guanylhistamine,C6H11N5,N-Guanylhistamine,NA,Histamine H2/H3 receptor agonists/antagonists,NA,NA,NA,CAS: 18431-51-1; PubChem: 9657; ChEBI: 28021; ChEMBL: CHEMBL170357; NIKKAJI: J161.436C,cpd:C07454,6,11,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12N5,C6H10N5,153.1014454,154.1092704,152.09362035232,5742,cpd:C11800,Thiaburimamide,C8H14N4S2,Thiaburimamide,NA,Histamine H2/H3 receptor agonists/antagonists,NA,NA,NA,CAS: 38603-23-5; PubChem: 13964; ChEBI: 9527; NIKKAJI: J126.249A,cpd:C11800,8,14,0,4,0,2,0,0,0,0,0,0,0,0,0,0,0,0,C8H15N4S2,C8H13N4S2,230.0659888,231.0738138,229.05816385233,5743,cpd:C17929,4-Methylhistamine,C6H11N3,4-Methylhistamine,NA,Histamine H2/H3 receptor agonists/antagonists,NA,NA,Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: amine receptors;    Histamine;     H2-receptor;      C17929  4-Methylhistamine,CAS: 36507-31-0; PubChem: 96024150; ChEBI: 74760; ChEMBL: CHEMBL275443; NIKKAJI: J86.802G,cpd:C00860; cpd:C03140; cpd:C03771; cpd:C04752; cpd:C05127; cpd:C17928; cpd:C17929,6,11,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C6H12N3,C6H10N3,125.0952974,126.1031224,124.08747235234,5744,cpd:C17930,Dimaprit,C6H15N3S,Dimaprit,NA,Histamine H2/H3 receptor agonists/antagonists,NA,NA,Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: amine receptors;    Histamine;     H2-receptor;      C17930  Dimaprit,CAS: 65119-89-3; PubChem: 96024151; ChEBI: 81389; ChEMBL: CHEMBL12344; NIKKAJI: J21.390J,cpd:C17930,6,15,0,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H16N3S1,C6H14N3S1,161.0986687,162.1064937,160.09084365235,5745,cpd:C17931,Imetit,C6H10N4S,Imetit,NA,Histamine H2/H3 receptor agonists/antagonists,NA,NA,Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: amine receptors;    Histamine;     H3-receptor;      C17931  Imetit,CAS: 102203-18-9; PubChem: 96024152; ChEBI: 64156; ChEMBL: CHEMBL19439; NIKKAJI: J506.341H,cpd:C17931,6,10,0,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C6H11N4S1,C6H9N4S1,170.0626175,171.0704425,169.05479255236,5746,cpd:C17932,Immepip,C9H15N3,Immepip,NA,Histamine H2/H3 receptor agonists/antagonists,NA,NA,Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: amine receptors;    Histamine;     H3-receptor;      C17932  Immepip,CAS: 151070-83-6; PubChem: 96024153; ChEBI: 81390; ChEMBL: CHEMBL18661; NIKKAJI: J578.070E,cpd:C00112; cpd:C00705; cpd:C01997; cpd:C04149; cpd:C08496; cpd:C17932; cpd:C18954; cpd:C20743,9,15,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C9H16N3,C9H14N3,165.1265975,166.1344225,164.11877255237,5747,cpd:C17933,Thioperamide,C15H24N4S,Thioperamide,NA,Histamine H2/H3 receptor agonists/antagonists,NA,NA,Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: amine receptors;    Histamine;     H3-receptor;      C17933  Thioperamide,CAS: 106243-16-7; PubChem: 96024154; ChEBI: 81391; ChEMBL: CHEMBL260374; PDB-CCD: FJZ; NIKKAJI: J248.127H,cpd:C17933,15,24,0,4,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H25N4S1,C15H23N4S1,292.172168,293.179993,291.16434295238,5748,cpd:C17934,Clobenpropit,C14H17ClN4S,Clobenpropit,NA,Histamine H2/H3 receptor agonists/antagonists,NA,NA,Target-based classification of compounds [BR:br08010];  G Protein-coupled receptors;   Rhodopsin family: amine receptors;    Histamine;     H3-receptor;      C17934  Clobenpropit,CAS: 145231-45-4; PubChem: 96024155; ChEBI: 64177; ChEMBL: CHEMBL14690; NIKKAJI: J506.353A,cpd:C17934,14,17,0,4,0,1,1,0,0,0,0,0,0,0,0,0,0,0,C14H18N4S1Cl1,C14H16N4S1Cl1,308.0862454,309.0940705,307.07842045239,5750,cpd:C15552,PD 123177,C29H28N4O3,PD 123177,NA,Angiotensin receptor and endothelin receptor antagonists,NA,NA,NA,CAS: 114785-12-5; PubChem: 17396544; ChEBI: 79978; ChEMBL: CHEMBL1188080; NIKKAJI: J386.726I,cpd:C15552,29,28,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C29H29O3N4,C29H27O3N4,480.2161408,481.2239658,479.20831575240,5751,cpd:C15553,PD 123319,C31H32N4O3,PD 123319,NA,Angiotensin receptor and endothelin receptor antagonists,NA,NA,NA,CAS: 130663-39-7; PubChem: 17396545; ChEBI: 61014; ChEMBL: CHEMBL321820; NIKKAJI: J449.507A,cpd:C15553,31,32,3,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C31H33O3N4,C31H31O3N4,508.2474409,509.2552659,507.23961595241,5752,cpd:C07521,Thiopental,C11H18N2O2S,Thiopental,NA,GABA-A receptor agonists/antagonists,NA,NA,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303];  N NERVOUS SYSTEM;   N01 ANESTHETICS;    N01A ANESTHETICS, GENERAL;     N01AF Barbiturates, plain;      N01AF03 Thiopental;       C07521  Thiopental;   N05 PSYCHOLEPTICS;    N05C HYPNOTICS AND SEDATIVES;     N05CA Barbiturates, plain;      N05CA19 Thiopental;       C07521  Thiopental",CAS: 76-75-5; PubChem: 9724; ChEBI: 102166; ChEMBL: CHEMBL441; NIKKAJI: J10.978I,cpd:C07521,11,18,2,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C11H19O2N2S1,C11H17O2N2S1,242.108899,243.116724,241.1010745242,5753,cpd:C09364,Bicuculline,C20H17NO6,Bicuculline,NA,GABA-A receptor agonists/antagonists,NA,NA,Phytochemical compounds [BR:br08003];  Alkaloids;   Alkaloids derived from tyrosine;    Isoquinoline alkaloids;     C09364  Bicuculline; Natural toxins [BR:br08009];  Phytotoxins;   Alkaloids;    Isoquinoline alkaloids;     C09364  Bicuculline; Target-based classification of compounds [BR:br08010];  Ion channels;   Cys-loop superfamily;    GABA-A;     GABAA-receptor;      C09364  Bicuculline,CAS: 485-49-4; PubChem: 11555; ChEBI: 3092; ChEMBL: CHEMBL417990; KNApSAcK: C00001820; 3DMET: B02898; NIKKAJI: J108.007E,cpd:C09364; cpd:C09372,20,17,6,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C20H18O6N1,C20H16O6N1,367.1055873,368.1134123,366.09776225243,5754,cpd:C09529,Picrotoxinin,C15H16O6,Picrotoxinin,NA,GABA-A receptor agonists/antagonists,NA,NA,Lipids [BR:br08002];  PR  Prenol Lipids;   PR01 Isoprenoids;    PR0103 C15 isoprenoids (sesquiterpenes);     PR010354 Picrotoxane sesquiterpenoids;      C09529  Picrotoxinin; Phytochemical compounds [BR:br08003];  Terpenoids;   Sesquiterpenoids (C15);    Others;     C09529  Picrotoxinin; Natural toxins [BR:br08009];  Phytotoxins;   Terpenoids;    Sesquiterpenoids;     C09529  Picrotoxinin; Target-based classification of compounds [BR:br08010];  Ion channels;   Cys-loop superfamily;    GABA-A;     GABAA-receptor;      C09529  Picrotoxinin,CAS: 17617-45-7; PubChem: 11720; ChEBI: 8206; ChEMBL: CHEMBL1496603 CHEMBL47244; KNApSAcK: C00003350; PDB-CCD: RI5; 3DMET: B03051; NIKKAJI: J10.347K,cpd:C07139; cpd:C08562; cpd:C09397; cpd:C09529,15,16,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C15H17O6,C15H15O6,292.0946882,293.1025133,291.08686325244,5756,cpd:C13776,E-4031,C21H27N3O3S,E-4031,NA,Potassium channel blocking and opening drugs,NA,NA,"Target-based classification of compounds [BR:br08010];  Ion channels;   Voltage-gated cation channels;    K+ channel, KCNH, Kv10-12.x (Ether-a-go-go);     potassium voltage-gated channel, subfamily H (eag-related), member 2;      C13776  E-4031",CAS: 113558-89-7; PubChem: 854021; ChEBI: 34732; ChEMBL: CHEMBL327980; NIKKAJI: J269.503K,cpd:C13776,21,27,3,3,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C21H28O3N3S1,C21H26O3N3S1,401.1773129,402.1851379,400.16948795245,5757,cpd:C13820,Chromanol 293B,C15H20N2O4S,Chromanol 293B,NA,Potassium channel blocking and opening drugs,NA,NA,"Target-based classification of compounds [BR:br08010];  Ion channels;   Voltage-gated cation channels;    K+ channel, KCNQ, Kv7.x (KQT-like);     potassium voltage-gated channel, KQT-like subfamily, member 1;      C13820  Chromanol 293B",CAS: 163163-23-3; PubChem: 854065; ChEBI: 34637; ChEMBL: CHEMBL434045; NIKKAJI: J758.770H,cpd:C06806; cpd:C13778; cpd:C13820,15,20,4,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,C15H21O4N2S1,C15H19O4N2S1,324.1143783,325.1222033,323.10655335246,5758,cpd:C07575,Phencyclidine,C17H25N,Phencyclidine,NA,N-Metyl-D-aspartic acid receptor antagonists,NA,NA,NA,CAS: 77-10-1; PubChem: 9778; ChEBI: 8058; ChEMBL: CHEMBL275528; PDB-CCD: 1PC; NIKKAJI: J4.441E,cpd:C04883; cpd:C06932; cpd:C07575; cpd:C07914; cpd:C09225; cpd:C09879; cpd:C09881; cpd:C09886; cpd:C12905; cpd:C18772; cpd:C18795,17,25,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C17H26N1,C17H24N1,243.1986998,244.2065248,242.19087485247,5759,cpd:C13737,Dizocilpine;,C16H15N,Dizocilpine; MK801,NA,N-Metyl-D-aspartic acid receptor antagonists,NA,NA,NA,CAS: 77086-21-6; PubChem: 586326; ChEBI: 34725; ChEMBL: CHEMBL268055 CHEMBL284237; NIKKAJI: J246.194C,cpd:C10643; cpd:C13737; cpd:C15122; cpd:C18500; cpd:C18531; cpd:C19374,16,15,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,C16H16N1,C16H14N1,221.1204495,222.1282745,220.1126245